

--- Page 1 ---



--- Page 2 ---

FreeRadicalsinBiologyandMedicine

--- Page 3 ---



--- Page 4 ---

Free Radicals in
Biology and Medicine
FIFTH EDITION
Barry Halliwell
B.A.(OXON),D.Phil.(OXON),D.SC(LOND)
and
John M.C. Gutteridge
PHD(LOND),D.Sc(LOND)
Donotfollowwherethepathmaylead.Goinsteadwherethereisnopathandleave
atrail.
MurielStrode
3
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 5 ---

3
GreatClarendonStreet,Oxford,OX26DP,
UnitedKingdom
OxfordUniversityPressisadepartmentoftheUniversityofOxford.
ItfurtherstheUniversity’sobjectiveofexcellenceinresearch,scholarship,
andeducationbypublishingworldwide.Oxfordisaregisteredtrademarkof
OxfordUniversityPressintheUKandincertainothercountries
©BarryHalliwellandJohnM.C.Gutteridge2015
Themoralrightsoftheauthorshavebeenasserted
FirstEditionpublishedin1985
SecondEditionpublishedin1989
ThirdEditionpublishedin1999
FourthEditionpublishedin2007
FifthEditionpublishedin2015
Impression:1
Allrightsreserved.Nopartofthispublicationmaybereproduced,storedin
aretrievalsystem,ortransmitted,inanyformorbyanymeans,withoutthe
priorpermissioninwritingofOxfordUniversityPress,orasexpresslypermitted
bylaw,bylicenceorundertermsagreedwiththeappropriatereprographics
rightsorganization.Enquiriesconcerningreproductionoutsidethescopeofthe
aboveshouldbesenttotheRightsDepartment,OxfordUniversityPress,atthe
addressabove
Youmustnotcirculatethisworkinanyotherform
andyoumustimposethissameconditiononanyacquirer
PublishedintheUnitedStatesofAmericabyOxfordUniversityPress
198MadisonAvenue,NewYork,NY10016,UnitedStatesofAmerica
BritishLibraryCataloguinginPublicationData
Dataavailable
LibraryofCongressControlNumber:2014955109
ISBN978–0–19–871747–8(hbk.)
ISBN978–0–19–871748–5(pbk.)
Printedandboundby
CPIGroup(UK)Ltd,Croydon,CR04YY
LinkstothirdpartywebsitesareprovidedbyOxfordingoodfaithand
forinformationonly.Oxforddisclaimsanyresponsibilityforthematerials
containedinanythirdpartywebsitereferencedinthiswork.

--- Page 6 ---

Preface to the fifth edition
When the first edition of Free Radicals in Biology and characterization of oxidative damage is gradually re-
Medicine appeared in 1985, free radicals were mainly placing TBA and carbonyl assays, and revealing a
studied by radiation chemists and those involved in wealthofnewinformationaboutmolecularprocesses
industrial processes and research relating to rubber, inageinganddisease.
plastics,oils,paint,andfood(tablebelow).Theseare After 1987, a new free radical, nitric oxide (NO•),
stillkeyresearchareas.Twomajorscientificadvances gained prominence, some of the discoverers of its
broadened the spectrum: the discovery of CuZnSOD biological role being awarded Nobel Prizes. Nitric
by Joe McCord and Irwin Fridovich in 1968, and the oxide research reinforced the increasingly recognized
reportbyBernieBabiorin1973thatactivatedneutro- concept that free radicals and other ROS have pur-
phils produce superoxide for microbicidal purposes. poseful and beneficial roles to play in biology. Far
At this time, most of our indirect methodology for fewer scientists are now sceptical about the role of
measuring the damage caused by free radicals came freeradicalsandantioxidantsinlivingorganisms.The
from the food industry, where the thiobarbituric acid authorsareconvincedthattheseagentspermeatethe
(TBA) assay was widely used to detect and measure wholeofbiologyandthatknowledgeofthemisessen-
lipidrancidity.Inhindsight,thissimple-to-dobutmis- tialtounderstandhowaerobiclifeevolvedandworks.
leading test distorted our interpretations by focusing Ineditionfivewehaveexpandedcoverageofthebio-
excessive attention on ‘lipid peroxidation’ in biology logicalrolesofoxygen-derivedspeciesandotherfree
and medicine at the expense of understanding better radicals and placed these roles in a clearer biological
how proteins, DNA, and individual lipids are dam- context.Superoxide,NO•,andhydrogenperoxideare
agedbyreactiveoxygenspecies(ROS),whatproducts poorly reactive (see editions 1, 2, and 3) and (unlike
are generated, and what biological effects they exert OH•) better suited to signalling functions than to
(good, bad, or indifferent). It also triggered a corres- destructive chemical reactions. Nevertheless, their
pondingrushtofindantioxidantsthatwouldprotect potentialforselectivecytotoxicityisclear.Inaddition,
against‘peroxidation’.Theexplosivegrowthofinterest wearelearninghowantioxidantdefencesystemsare
that followed this realization of the biological rele- carefully co-ordinated to allow signalling roles for
vance of free radicals necessitated the writing of a ROS, an area also expanded. To keep the book from
second edition four years later (1989). Our third edi- growingtoolarge,mucholderandnowless-relevant
tion (1999) reflected an enormous expansion in new materialhasbeenomitted.
methodologiestodetectandmeasureoxidativedam- We hope that the fifth edition will again serve to
agetoproteins,carbohydrates,DNA,andlipids,which bridgethegapbetweenexpertsandnovices.Wehave
helpedtoplacetheseprocessesinbetterphysiological triedtokeepthetextchattyandreadable.Willweneed
and pathological context. These changes quickly led asixthedition,andwhen?Wethinkso,thisisafield
totherealizationthatfreeradicalsandotherreactive thatisn’tgoingaway!
speciesareconsequentialtomost(butnotall)disease
processes,andthat,byimplication,antioxidantswould
B.H.
usually be limited and selective in their efficacy, as
TanChinTuanCentennialProfessor
indeedtheyare.
NationalUniversityofSingapore,Singapore
Thepresent(fifth)editionexpandsthisareatotake
inrecentadvancesinresearchmethodologies,theirap- J.M.C.G
plication and limitations, and the findings of clinical RetiredScientist
andnutritionalinterventionstudies.Precisemolecular UK
v

--- Page 7 ---

vi PREFACE TO THE FIFTH EDITION
Milestonesinfreeradicalresearch.
Discovery Year
Discoveryofoxygen(Scheelediscovereditin1772. 1775–1778
Priestleypublisheditfirstin1775,Lavoisierclarifieditsnature∗).
• •
Priestleyalsodiscoveredsevenothergases,namelyNO ,N2O,NO
2
,
SO2,HCl,CO,andNH3.
Demonstrationofoxygentoxicity 1775(JosephPriestley)
Discoveryofselenium 1817
Discoveryofhydrogenperoxide(eauoxygénée) 1818
FirstattemptstostudyoiloxidationbyO2uptake 1820
Oxygencausesrancidificationofnaturaloils 1822
Fentonreactiondescribed 1876
Firstreportofafreeradical(triphenylmethyl) 1900(byGomberg)
DiscoveryofvitaminE 1922
IsolationofvitaminC 1928
FungalglucoseoxidasethefirstenzymefoundtoproduceH2O2 1928
PostulationoftheHaber–Weissreaction 1934
Catalasepurifiedfrombovineliver 1937
Basicmechanismoflipidperoxidationelucidated 1940s
Spermdiscoveredtobesusceptibletooxidativedamage 1943
Discoveryofelectronspinresonance 1944
Proposalthatfreeradicalsaccountfordamagebyionizingradiation 1954
IdentificationofretinopathyofprematurityasanO2toxicity 1954
Proposalthatfreeradicalscauseageing 1956
UseofESRtodiscoverparamagnetic[Fe-S]proteins 1957
Discoveryofglutathioneperoxidase 1957
PhagocytesshowntoproduceH2O2 1961
MyeloperoxidasefoundtooxidizeCl–toabactericidalproduct 1967
Synergybetweenascorbateandα-tocopherolsuggested 1968
Spintrapsfirstdeveloped 1968
DiscoveryoftheSODactivityofCuZnSOD 1968–69
FirstidentificationofO
•–productionbyanenzyme
1969
2
FirstdescriptionofphagocyteO
•–production
1973
2
Phagocytesfrompatientswithchronicgranulomatousdiseasefoundto 1974
bedeficientinO
•–production
2
AromatichydroxylationintroducedasaninvivoassayforOH• 1975
Firstdescriptionoftheeffectsofoxygen-derivedspeciesonthevascular 1981
system
FIRSTEDITIONOFTHISBOOK 1985
Term‘oxidativestress’introduced 1985
Identificationofnitricoxideastheendothelium-derivedrelaxingfactor 1987
Linksmadebetweenhumanplasma/serumantioxidantlevelsandlower 1987onwards
diseaserisk
SECONDEDITIONOFTHISBOOK 1989
DiscoveryofOxyRandSoxR 1990
Introductionoftheisoprostanesasanassayforlipidperoxidation 1991
Oxygen-derivedspeciesreportedtoactivatethetranscriptionfactor 1991
NF-κBinsomesystems
Detailedcharacterizationofperoxiredoxins 1994onwards
THIRDEDITIONOFTHISBOOK 1999
FOURTHEDITIONOFTHISBOOK 2007
∗FreeRadicalscankillyou:Lavoisier’sOxygenRevolution.FASEBJ.24,649–52(2010);alsoseeAm.J.Physiol.306,L111,2014.

--- Page 8 ---

Acknowledgements
Productionofthefiftheditionwasaidedbyadviceand/orpermissiontoreproducetheirpublishedmaterialfrom
thefollowingexperts,acknowledgedinalphabeticalorderofsurname.Wearemostgratefulfortheirhelp,butthe
responsibilityforanyerrorsinthetextissolelyours.
DorisAbele(Germany) GerardEvan(UK)
JohnR.Aitken(Australia) PhilipEvans(UK)
PeterAndersen(Sweden) TorenFinkel(USA)
ShannonMBailey(USA) LisaFolkes(UK)
NeilR.Baker(UK) ChristineFoyer(UK)
CarolinaBarillas(USA) ErrolFriedberg(USA)
InesBatinic-Haberle(USA) Xin-YuanFu(Singapore)
JeffreyBlumberg(USA) NicholasR.J.Gascoigne(Singapore)
SusanBrain(UK) DavidGems(UK)
ReginaBrigelius-Flohé(Germany) GermanNutritionSociety
GaryBuettner(USA) ElizabethGetzoff(USA)
GrahamBurton(UK) MichaelGoodman(USA)
AllanButterfield(USA) Govindjee(USA)
IoavCabantchik(Israel) JanGruber(Singapore)
JeanCadet(France) TomaszGuzik(Poland)
KateCarroll(USA) VincentHearing(USA)
ChristopherChang(USA) HarriHemilä(Finland)
ChristopherChen(Singapore) RussellHepple(Canada)
KeeSengChia(Singapore) CeciliaHidalgo(Chile)
MarieVéroniqueClement(Singapore) RalphHueckelhoven(Germany)
JamesCobley(UK) DoraIlyasova(USA)
AndrewR.Collins(Norway) ShosukeIto(Japan)
MarcusS.Cooke(USA) YoshiakiIto(Singapore)
MortonJ.Cowan(USA) BalaramanKalyanaraman(USA)
DianeCritchlow(UK) FrankKelly(UK)
CarrollCross(USA) JanF.Kern(USA)
AndrewDas(NewZealand) SashiKesavapany(Singapore)
MichaelDavies(Australia) AnthonyKettle(NewZealand)
PeterDedon(USA) TomKirkwood(UK)
Jean-CharlesDeybach(France) WilliamH.Koppenol(Switzerland)
BryanDickinson(USA) PaulKubes(Canada)
MiralDizdaroglu(USA) DavidLambeth(USA)
LawrenceADonehower(USA) NickLane(UK)
JoëlR.Drevet(France) HenryLeese(UK)
GrantDrummond(Australia) Kah-LeongLim(Singapore)
GregoryDusting(Australia) StefanLiochev(USA)
vii

--- Page 9 ---

viii ACKNOWLEDGEMENTS
ValterLongo(USA) Ji-HwanRyu(Korea)
AlvinLoo(Singapore) SebastianSchaffer(Singapore)
JonO.Lundberg(Sweden) RaymondSeet(Singapore)
PaulMacary(Singapore) SasonShaik(Israel)
DannyManor(USA) ShenHanMing(Singapore)
StefanMarklund(Sweden) DavidShin(USA)
JennyMartin(Australia) HelmutSies(Germany)
RonaldMason(USA) VladimirSkulachev(Russia)
JohannesMessinger(Sweden) AlanJ.Slusarenko(Germany)
GingerMilne(USA) WilliamL.Smith(USA)
RonMittler(USA) SoongTuckWah(Singapore)
AlvaroMolina-Cruz(USA) IvanSpasojevic(Serbia)
VincentMonnier(USA) WilhelmStahl(Germany)
PhilipKeithMoore(Singapore) RolandStocker(Australia)
RichardI.Morimoto(USA) JoAnneStubbe(USA)
MartinMueller(Germany) RogerG.Sturmey(UK)
MahdiNajafpour(Iran) JohnTainer(USA)
PhilippNiethammer(USA) PaulTalalay(USA)
EtsuoNiki(Japan) MauroM.Teixeira(Brazil)
GrahamNoctor(UK) VinayTergaonkar(Singapore)
VesaOlkkonen(Finland) PaulJ.Thornalley(UK)
StenOrrenius(Sweden) ArtakTovmasyan(USA)
SampathParthasarathy(USA) ShinyaToyokuni(Japan)
RiccardoPercudani(Italy) MaretG.Traber(USA)
ShazibPervaiz(Singapore) GabrielTravis(USA)
AlfonsoPompella(Italy) AlbertvanderVliet(USA)
HenrikE.Poulsen(Denmark) MarkusWenk(Singapore)
ChristopherPutnam(USA) JohnWhitmarsh(USA)
GregoryJ.Quinlan(UK) ChristineWinterbourn(NewZealand)
RafaelRadi(Uruguay) PaulWinyard(UK)
RoxanaRadu(USA) KhayGuanYeoh(Singapore)
SueGooRhee(Korea) JuyoungYoon(Korea)
DavidRoss(USA) YongliangZhang(Singapore)

--- Page 10 ---

Contents
Abbreviations xxxii
1 Oxygen:boonyetbane—introducingoxygentoxicityandreactivespecies 1
1.1 Thehistoryofoxygen:anessentialairpollutant 1
1.1.1 Theparadoxofphotosynthesis 4
1.1.2 Hyperoxiainhistory? 4
1.1.3 Oxygeninsolution 5
1.2 Oxygenandanaerobes 7
1.2.1 Whydoesoxygeninjureanaerobes? 7
1.3 Oxygenandaerobes 8
1.3.1 Oxygentransportinmammals 8
1.3.2 Oxygensensing 8
1.3.3 Mitochondrialelectrontransport 9
1.3.4 Theevolutionofmitochondria 13
1.3.5 Nicotinamidenucleotidereduction 14
1.3.6 Bacterialelectrontransportchains 14
1.4 Oxidasesandoxygenasesinaerobes 14
1.4.1 CytochromesP450 15
1.5 Oxygentoxicityinaerobes 16
1.5.1 Bacteria,plants,insects,andalligators 16
1.5.2 Mammals 18
1.5.2.1 Retinopathyofprematurityandbraindamage 19
1.5.2.2 Resuscitationofnewborns 19
1.5.2.3 Factorsaffectingoxygentoxicity 19
1.6 Whatcausesthetoxiceffectsofoxygen? 20
1.7 Sofreeradicalscontributetooxygentoxicityandoxygenisoneof
them?Whatthenarefreeradicals? 20
1.8 Oxygenanditsradicals 22
1.8.1 Singletoxygen 22
1.8.2 Superoxideradical 23
1.9 Howtodescribethem:oxygenradicals,oxygen-derivedspecies,
reactiveoxygenspecies,oroxidants? 23
1.10 Sourcesofsuperoxideinaerobes 23
1.10.1 Enzymes 24
1.10.2 Auto-oxidationreactions 24
1.10.3 Haemproteins 25
1.10.4 Mitochondrialelectrontransport 25
1.10.4.1 MitochondrialDNA(mtDNA) 26
ix

--- Page 11 ---

x CONTENTS
1.10.5 Uncouplingproteinsasantioxidants? 27
1.10.6 Endoplasmicreticulum(ER) 27
1.10.7 Nuclearandplasmamembranes 27
1.10.8 Bacterialsuperoxideproductionandbiofilms 27
1.11 Thinkingaboutcellculture 28
1.12 Somenumbers 29
2 Redoxchemistry:theessentials 30
2.1 Introduction 30
2.2 Howdofreeradicalsreact? 30
2.3 Radicalchemistry:thermodynamicsversuskinetics 32
2.3.1 Redoxchemistry 32
2.3.1.1 Caveats 33
2.3.1.2 Thermodynamicsofoxygenreduction 33
2.3.2 Reactionratesandrateconstants 34
2.3.3 Measuringreactionratesandrateconstants 35
2.3.3.1 Pulseradiolysis 35
2.3.3.2 Stopped-flowmethods 36
2.4 Transitionmetals:biocatalyticfreeradicals 36
2.4.1 Iron 36
2.4.2 Copper 37
2.4.3 Manganese 38
2.4.4 TheFentonreaction 38
2.4.5 IronchelatorsandFentonchemistry:speedituporslowitdown? 39
2.4.6 ReactionofcopperionswithH2O2 39
2.5 Chemistryofotherbiologicallyimportantradicals 40
2.5.1 Hydroxylradical 40
2.5.1.1 Generation 40
2.5.1.2 Chemistry 41
2.5.2 Carbonateradical 43
2.5.3 Superoxideradical 43
2.5.3.1 Makingsuperoxideinthelaboratory 45
2.5.3.2 Reactionsofsuperoxide 46
2.5.3.3 Superoxide–ironinteractions 46
2.5.3.4 ReductantsandFentonchemistry 47
2.5.3.5 Semiquinonesandquinones 47
2.5.3.6 Superoxideinhydrophobicenvironments 48
2.5.4 Peroxylandalkoxylradicals 48
2.5.4.1 Chemistry 48
• •
2.5.4.2 GenerationofRO2 /RO radicals 49
2.5.5 Sulphurradicals 50
2.5.5.1 Formation 50
2.5.5.2 Reactions 50
2.5.5.3 Artefactsinvolvingsulphurcompounds 51
2.5.5.4 Theperilsofdithiothreitol,thiourea,andN-acetylcysteine 52
2.5.6 Nitricoxide 52
2.5.6.1 Basicchemistry 52
2.5.6.2 Nitricoxideasafreeradicalscavenger 53
2.5.6.3 Physiologicalroles 53

--- Page 12 ---

CONTENTS xi
2.5.6.4 Synthesisofnitricoxide 53
•
2.5.6.5 RemovalofNO invivo 55
2.5.6.6 Nitrate and nitrite: inert end-products or
•
physiologicallyimportantsourcesofNO ? 55
2.5.6.7 Nitricoxidedonors 56
2.6 Chemistryofbiologicallyimportantnon-radicals 58
2.6.1 Peroxynitrite 58
2.6.1.1 Howdoesperoxynitritecausedamage? 61
2.6.1.2 Toxicityofnitrotyrosineandnitratedproteins? 62
2.6.1.3 Nitricoxide,superoxide,peroxynitrite,andnitrated
lipids:abalance 62
2.6.1.4 Canperoxynitritebeantioxidant? 63
2.6.1.5 Morethingstobewareof 63
2.6.2 Hydrogenperoxide 63
2.6.2.1 ProductionofH2O2 63
2.6.2.2 ChemistryofH2O2 64
2.6.3 Hypohalousacidsandtheirderivatives 65
2.6.3.1 Chlorhydrins,chloramines,andhydroxylradical
fromHOCl 66
2.6.3.2 Atomicchlorine 67
2.6.4 Singletoxygen 67
2.6.4.1 SingletO2fromphotosensitization 67
2.6.4.2 TypeIandIIreactions 67
2.6.4.3 Biologicaldamagebyphotosensitization 67
2.6.4.4 Usesofphotosensitization 69
2.6.4.5 OthersourcesofsingletO2 71
2.6.4.6 Reactionsofsingletoxygen 71
2.6.5 Ozone,aradicalornot? 75
3 Antioxidantdefencessynthesizedinvivo 77
3.1 Introduction 77
3.2 Whatisanantioxidant? 77
3.3 Antioxidantdefences:generalprinciples 78
3.4 Thesimplestantioxidantdefence:minimizeexposuretooxygen 78
3.4.1 Protectingnitrogenases 79
3.4.2 Stemcells 79
3.5 Antioxidantdefenceenzymes:superoxidedismutases(SODs) 79
3.5.1 Copper–zincSOD 79
3.5.1.1 CuZnSODineukaryotesandprokaryotes 79
3.5.1.2 CatalyticabilityofCuZnSOD 80
3.5.1.3 CuZnSODstructure 81
3.5.1.4 InhibitorsofCuZnSOD 81
3.5.1.5 IsoenzymesofCuZnSOD 82
3.5.1.6 Pro-oxidanteffectsofCuZnSOD? 84
3.5.2 ManganeseSOD 85
3.5.2.1 WhereisMnSODfound? 85
3.5.2.2 RegulationofMnSODactivity 85
3.5.2.3 StructureofMnSOD 85
3.5.3 IronandcambialisticSODs 86
3.5.3.1 DistributionofFeSODs 87

--- Page 13 ---

xii CONTENTS
3.5.4 EvolutionofSODs 87
3.5.5 Nickel-containingSODs 87
3.5.6 AssayingSOD 87
3.5.6.1 DistinguishingbetweendifferenttypesofSOD 89
3.5.7 UsingSODenzymestoimplicatesuperoxide 90
3.6 Superoxidereductases 90
3.7 Superoxidedismutases:evidencefortheirroleinvivo? 91
3.7.1 Geneknockoutinbacteriaandyeasts 91
3.7.2 Transgenicanimals 91
3.7.2.1 Caveatsabouttransgenicanimals 93
3.7.3 RNAinterference 94
3.7.4 Inductionexperiments 94
3.7.5 SODandoxygentoxicityinanimals 94
3.7.6 SODandhibernation 95
3.8 Thesuperoxidetheoryofoxygentoxicity:variationsandanomalies 95
3.8.1 AnaerobeswithSODandaerobeswithoutSOD 95
3.8.2 ManganesecanreplaceSOD 95
3.9 Whyissuperoxidecytotoxic? 96
•
3.9.1 DirectdamagebysuperoxideorHO2 ? 96
3.9.2 Cytotoxicityofsuperoxide-derivedspecies 96
3.9.2.1 Hydrogenperoxideandperoxynitrite 96
3.9.2.2 Hydroxylradical 97
3.10 Glutathioneinmetabolismandcellularredoxstate 99
3.10.1 GSHasadirectantioxidant 100
3.10.2 Glutathionereductase 100
3.10.2.1 SourcesofNADPH 101
3.10.3 Glutathionebiosynthesisanddegradation 102
3.10.4 DefectsinGSHmetabolism:humansandotherorganisms 103
3.11 Glutathionylation:pathologicalorprotective? 105
3.12 Protein-disulphideisomerase 106
3.13 Peroxiredoxins:leadersinperoxidemetabolism 106
3.13.1 Introducingthioredoxins,cofactorsofperoxiredoxins 106
3.13.2 Theperoxiredoxinsthemselves 108
3.13.2.1 Reactionwithperoxynitrite 109
3.13.2.2 Hyperoxidation 109
3.13.2.3 Circadianrhythms 109
3.14 Antioxidantdefenceenzymes:theglutathioneperoxidasefamily 109
3.14.1 Afamilyofenzymes 110
3.14.2 Theroleofselenium 110
3.14.3 WatchingGPxinaction 111
3.14.4 ConsequencesofGPxdeficiency 111
3.15 Otherenzymesusingglutathione 111
3.15.1 Glyoxalases 111
3.15.2 TheglutathioneS-transferasesuperfamily 112
3.15.2.1 SubclassesofGST 112
3.15.2.2 GSTsandlipidperoxidation 113
3.16 Othersulphur-containingcompoundsandantioxidantdefence 113
3.16.1 Trypanothione:anantioxidantdefenceinsomeparasites 113
3.16.2 Ergothioneine 115

--- Page 14 ---

CONTENTS xiii
3.17 Antioxidantdefenceenzymes:catalases 115
3.17.1 Catalasestructure 115
3.17.2 Thereactionmechanismofcatalase 116
3.17.3 Catalaseinhibitors 117
3.17.4 Peroxidaticactivityofcatalase 117
3.17.5 Subcellularlocationofcatalase:theperoxisome 118
3.17.6 Manganese-containingcatalases 118
3.17.7 Doescatalasematter?Acatalasaemia 119
3.18 NADHoxidases 119
3.19 Antioxidantdefenceenzymes:anassortmentofotherperoxidases 119
3.19.1 Cytochromecperoxidase:anotherspecificperoxidase 119
3.19.2 ‘Non-specific’peroxidases 120
3.19.3 Horseradishperoxidase 120
3.19.4 Whydoplantshavesomuchperoxidase? 121
3.19.5 Chloroperoxidaseandbromoperoxidase 121
3.19.6 Ascorbateperoxidase 122
3.19.7 Peroxidase‘mimetics’ 122
3.20 Makingsenseofitall.Whatfitswhereinperoxidemetabolism? 122
3.20.1 Peroxisomesandmitochondria 122
3.20.2 Erythrocytes,lung,andyeast 122
3.20.3 Allowingredoxsignalling? 123
3.20.4 Bacteria 123
3.20.5 Seleniumdeficiency:reinterpretationofanoldparadigm 123
3.20.5.1 Humanseleniumdeficiency 123
3.20.5.2 Seleniumdeficiencyandantioxidantdefences 124
3.21 Furtherco-operation 124
3.21.1 Superoxidedismutasesandperoxide-metabolizingenzymes 124
3.21.2 Downsyndrome 125
3.22 Antioxidantdefence:sequestrationofmetalions 125
3.22.1 Ironmetabolism 126
3.22.1.1 Transferrin 127
3.22.1.2 Otheriron-bindingproteins 127
3.22.1.3 Ironwithincells 128
3.22.1.4 Ferritin 128
3.22.1.5 Regulationofcellularironbalance 130
3.22.2 Coppermetabolism 131
3.22.2.1 Caeruloplasminandcopperchaperones 131
3.22.2.2 Aphantomcopperpool? 131
3.22.2.3 Caeruloplasminasanoxidase 131
3.22.2.4 Caeruloplasminasaperoxidase 132
3.22.3 Haemandhaemproteins:powerfulpro-oxidants 132
3.22.4 Metalionsequestration:whydoit? 133
3.22.4.1 Keepingmicro-organismsatbay 133
3.22.4.2 Diminishingfree-radicalreactions 133
3.22.5 Metalionsequestration:whenitgoeswrong 134
3.22.5.1 Ironoverload:diet-derived 134
3.22.5.2 Ironoverload:genetic 134
3.22.5.3 Thalassaemias 135
3.22.5.4 Non-transferrin-boundiron:isitpro-oxidant? 136
3.22.5.5 Copperoverload 136

--- Page 15 ---

xiv CONTENTS
3.23 Metalionsandantioxidantdefence:comparingintracellularand
extracellularstrategies 137
3.23.1 Theintracellularenvironment:metalsandoxidativedamage 137
3.23.2 Metallothioneins 137
3.23.3 Extracellularantioxidantdefence 138
3.23.3.1 Lowantioxidantdefenceenzymesandlimitedmetal
ionavailability 138
3.23.3.2 Extracellularsuperoxidedismutase 138
3.23.3.3 OtherextracellularSODs 140
3.23.3.4 Bindinghaemandhaemoglobin 140
3.23.3.5 Albumin 141
3.23.3.6 Artefactswithalbumin 141
3.24 Haemoxygenase 142
3.25 Antioxidant protection by low-molecular-mass agents
synthesizedinvivo 143
3.25.1 Bilirubin 143
3.25.2 α-Ketoacids 144
3.25.3 Melatonin 144
3.25.4 Lipoicacid 144
3.25.5 CoenzymeQ 146
3.25.6 Uricacid 146
3.25.7 Histidine-containingdipeptides 148
3.25.8 Trehalose(α-D-glucopyranosyl-(1→1)-α-D-glucopyranoside) 149
3.25.9 Melanins:hair,skin,corals,fungi,andfish 149
3.26 Antioxidantdefence:aquestionofsex 151
4 Antioxidantsfromthediet 153
4.1 Introduction 153
4.2 Ascorbicacid(vitaminC) 155
4.2.1 Ascorbateasanantioxidant 157
4.2.2 ‘Recycling’ofascorbate 159
4.2.3 Pro-oxidanteffectsofascorbate 160
4.2.4 Takingascorbatesupplements? 161
4.3 VitaminE 161
4.3.1 Itsphysiologicalrole 161
4.3.2 WhatisvitaminE? 161
4.3.3 ChemistryofvitaminE 162
4.3.4 Recyclingofα-tocopherylradicals 162
4.3.5 Pro-oxidanteffectsofα-tocopherol? 165
4.3.6 ProcessingofdietaryvitaminE 165
4.3.7 Thefateofγ-tocopherol 167
4.3.8 α-Tocopheroldeficiency 167
4.3.9 VitaminE:onlyanantioxidant,orsomethingelseaswell? 169
4.4 Carotenoids 170
4.4.1 Carotenoidchemistry 170
4.4.2 Metabolicrolesofcarotenoids 171
4.4.3 CarotenoidsandvitaminAasantioxidants? 171
4.4.3.1 Docarotenoidsreactwithradicals? 172
4.4.3.2 Stabilityofcarotenoids 173
4.4.3.3 Theinterestingcaseoflycopene 173

--- Page 16 ---

CONTENTS xv
4.5 Flavonoidsandotherphenols 173
4.5.1 Phenolsinthediet 175
4.5.1.1 Dohumansandotheranimalsabsorbphenols? 176
4.5.2 Arephenolsantioxidantsinvivo? 177
4.5.2.1 Morethanantioxidants 178
4.5.3 Pro-oxidanteffectsofphenols? 178
4.5.4 Herbalmedicine 179
4.6 Dietaryantioxidants:insightsfromepidemiology 180
4.6.1 Problemsofinterpretation 182
4.6.2 Thegoldstandardofinterventiontrials:hopeunfulfilled 183
4.6.3 Theneedforbiomarkers 185
4.6.3.1 Dofruitsandvegetablesdecreasetheriskofdiseaseby
loweringoxidativedamage? 187
4.6.4 Cardiovascularinterventiontrials 188
4.6.5 Cancerpreventionbyantioxidants? 189
4.6.5.1 TheFinnishstudy(α-tocopherol/β-carotene[ATBC]
cancerpreventionstudy)andCARET 189
4.6.6 Someraysofhopeandagenderbias 190
4.6.7 Lycopene,othercarotenoids,andhumandisease 190
4.6.8 Antioxidantsandneuroprotection;insightsfromepidemiology? 190
4.7 Otherdietaryconstituentsandoxidativedamage 196
4.8 Whatdoesitallmean?Whatshouldwepoormortalseat? 197
5 Oxidativestressandredoxregulation:adaptation,damage,repair,
senescence,anddeath 199
5.1 Introduction 199
5.1.1 Definingoxidativestressandoxidativedamage 199
5.2 Consequencesofoxidativestress 200
5.2.1 Proliferation 200
5.2.2 Adaptation 201
5.2.3 Migrationandadhesion 202
5.2.4 Cellinjuryandsenescence 202
5.2.5 Poly(ADP–ribose)polymerase 203
5.3 Oxidativestresscauseschangesincellularionmetabolism 204
5.3.1 Basicprinciples 204
5.3.1.1 Cellvolumechanges 204
5.3.2 Calcium 204
5.3.2.1 Keepingitlow 204
5.3.2.2 OxidativestressraisesCa2+levels 206
5.3.2.3 Ca2+andmitochondria 207
5.3.3 Oxidativestressandtransitionmetalionmobilization 208
5.3.3.1 Demonstratingironmobilization 208
5.3.4 Copper 209
5.4 Consequencesofoxidativestress:celldeath 212
5.4.1 Basicdefinitions 212
5.4.2 Apoptosis 215
5.4.2.1 Molecularmechanismsofapoptosis 215
5.4.2.2 Reactivespeciesandapoptosis 218
5.5 Redoxregulation 219
5.5.1 Whatisitandhowdoesitwork? 219

--- Page 17 ---

xvi CONTENTS
5.5.2 Bacterialredoxregulation:oxyR,soxRSandHOCl-sensitive
transcriptionfactors 220
5.5.3 Redoxregulationinyeast 221
5.5.4 Redoxregulationinanimals:kinasesandphosphatases 221
5.5.4.1 Whatisitabout? 221
5.5.4.2 Proteinkinases 221
5.5.4.3 HowdoRSmodulatesignalling? 224
5.5.4.4 Reactivespeciesasmediatorsoftheactionsof
signallingmolecules? 225
5.5.5 MitochondrialcommunicationbyROS? 225
5.5.6 NF-κB 226
5.5.6.1 ROSornoROS? 228
5.5.7 AP-1 229
5.5.8 TheantioxidantresponseelementandNrf2 229
5.5.9 Co-operationandcombination 230
5.5.10 Physiologicalsignificanceofredoxregulationinanimals 230
5.5.11 Lessonsfromanamoeba 231
5.6 Heat-shockandrelated‘stress-induced’proteins;cross-talkwithROS 231
5.7 Cytokines,hormones,andredox-regulationoftheorganism 234
5.7.1 TNF-α 235
5.7.2 Interleukins 235
5.7.3 Transforminggrowthfactorsβ 236
5.7.4 Theacute-phaseresponse 236
5.8 Mechanismsofdamagetocellulartargetsbyoxidativestress:DNA 236
5.8.1 DNAstructure 236
5.8.2 DamagetoDNAbyreactivespecies 238
5.8.2.1 Hydroxylradical 238
5.8.2.2 Hydrogenperoxideandtheroleoftransitionmetals 240
5.8.2.3 Useofironandhydrogenperoxideforoxidative
‘footprinting’ 244
5.8.2.4 Singletoxygen 244
5.8.2.5 Carbonateradicalanion 244
5.8.2.6 Peroxylandalkoxylradicals 244
5.8.2.7 Hypohalousacids 244
5.8.2.8 Ozone 244
5.8.2.9 Reactivenitrogenspecies 244
5.8.2.10 Ultravioletlight 245
5.8.2.11 Oxidationofoxidationproducts 245
5.8.3 DamagetomitochondrialandchloroplastDNA 245
5.9 ConsequencesofdamagetoDNAandRNAbyreactivespecies 245
5.9.1 Mutation 245
5.9.2 Slowingproteinsynthesis 246
5.9.3 Misincorporation 246
5.9.4 Changesingeneexpression 247
5.9.5 Havingsex 247
5.10 RepairofoxidativeDNAdamage 247
5.10.1 Reversingthechemicalchange 247
5.10.2 Don’tletitin:sanitizationofthenucleotidepool 248
5.10.3 Cutitout:excisionrepair 248
5.10.4 Mismatchrepair 250
5.10.5 Repairof8-hydroxyguanine(8OHG) 250

--- Page 18 ---

CONTENTS xvii
5.10.6 Repairofdouble-strandbreaks 250
5.10.7 MitochondrialDNArepair 250
5.10.8 IsDNArepairimportant? 251
5.10.8.1 Bacteriatomice 251
5.10.8.2 Micetomen 251
5.10.9 Polymorphismsingenesencodingantioxidantandrepairenzymes 252
5.10.10 DealingwithoxidativeRNAdamage 252
5.11 Mechanismsofdamagetocellulartargetsbyoxidativestress:lipid
peroxidation 252
5.11.1 Ahistoryofperoxidation:fromoilsandtextilestobreast
implants,fishmeal,andplasticwrapping 252
5.11.2 Targetsofattack:membranelipidsandproteins 253
5.11.2.1 What’sinamembrane? 253
5.11.2.2 Membranestructure 253
5.11.3 Targetsofattack:dietarylipidsandlipoproteins 256
5.11.4 Howdoeslipidperoxidationbegin? 256
5.11.5 Propagationoflipidperoxidation 257
5.11.6 Transitionmetalsandlipidperoxidation 259
5.11.6.1 Iron 259
5.11.6.2 Copper 263
5.11.6.3 Othermetals 263
5.11.7 Microsomallipidperoxidation 264
5.11.8 Accelerationoflipidperoxidationbyspeciesotherthan
oxygenradicals 264
5.11.8.1 Singletoxygen 264
5.11.8.2 Reactivehalogenspecies 265
5.11.8.3 Addingorganicperoxidesorazoinitiators 265
5.12 Lipidperoxidationproducts:bad,good,orindifferent? 265
5.12.1 Generaleffects 265
5.12.2 Lipidhydroperoxides(ROOH) 266
5.12.3 Isoprostanes,isoketals,andcyclopentenonecompounds 267
5.12.4 Cholesteroloxidationproducts(COPs) 268
5.12.5 Decompositionproductsoflipidperoxides:yetmore
bioactiveproducts 269
5.12.5.1 Ethaneandpentane 269
5.12.5.2 Malondialdehyde 270
5.12.5.3 4-Hydroxy-2-trans-nonenal(HNE),acrolein,and
otherunsaturatedaldehydes 270
5.12.6 Peroxidationofothermolecules 274
5.12.7 Repairingoxidizedlipids? 274
5.12.8 Lipidsasantioxidants? 274
5.12.8.1 Theplasmalogens 274
5.13 Mechanismsofdamagetocellulartargetsbyoxidativestress:
proteindamage 275
5.13.1 Doesproteindamagematter? 275
5.13.2 Howdoesproteindamageoccur? 275
5.13.3 Chemistryofproteindamage 276
5.13.4 Damagetospecificaminoacidresidues 276
5.13.4.1 Cysteineandmethionine 276

--- Page 19 ---

xviii CONTENTS
5.13.4.2 Histidine 277
5.13.4.3 Proline,lysine,andarginine 277
5.13.4.4 Tryptophan 277
5.13.4.5 Tyrosineandphenylalanine 277
5.13.4.6 Valine,leucine,andotheraliphaticaminoacids 277
5.13.4.7 Hydroxy-aminoacids(serineandthreonine) 277
5.14 Dealingwithoxidativeproteindamage 280
5.14.1 Repairofmethionineresidues 280
5.14.1.1 Amethioninecycle? 280
5.14.2 Removal:spatialsegregation 280
5.14.3 Removal:proteolysis 280
5.14.3.1 Autophagy 280
5.14.3.2 Lonproteinaseandtheproteasome 281
5.14.3.3 Anyroleforubiquitin? 282
5.14.3.4 Clogginguptheproteasome 282
5.15 Summary:oxidativestressandcellinjury 283
6 Measurementofreactivespecies 284
6.1 Introduction 284
6.1.1 Trapping 284
6.1.2 Fingerprinting:thebiomarkerconcept 284
6.2 ESRandspintrapping 285
6.2.1 WhatisESR? 285
6.2.2 Measurementofoxygen 287
6.2.3 Spintrapping 287
6.2.4 DMPO,DEPMO,andPBN 289
6.2.5 Exvivotrappinginhumans 290
6.2.6 Cautionsintheuseofspintraps 291
6.2.7 Trappingthiylradicals 292
6.2.8 SpintrappingwithoutESR? 293
6.3 Othertrappingmethods,asexemplifiedbyhydroxylradical
trapping 293
6.3.1 Aromatichydroxylation 293
6.3.1.1 Aromatichydroxylationinvivo 294
6.3.2 Useofhydroxylradicalscavengers 296
6.3.3 Thedeoxyriboseassay 296
•
6.3.4 MeasurementofrateconstantsforOH reactions 296
6.3.5 Othertrappingmethodsforhydroxylradical 299
6.4 Detectionofsuperoxide 299
6.4.1 Theaconitaseassayforsuperoxide 300
6.4.2 RateconstantsforreactionswithO
•–
300
2
6.4.3 Triphenylradical-basedprobes 300
6.4.4 Histochemicaldetection 300
6.5 Detectionofnitricoxide 302
6.5.1 Calibration 302
6.6 Detectionofperoxynitrite 302
6.6.1 Probesforperoxynitrite 302
6.6.2 Nitrationassays 302
6.6.2.1 Specificityforperoxynitrite? 306
6.6.2.2 Accuracyofnitrationassays? 306

--- Page 20 ---

CONTENTS xix
6.7 Detectionofreactivehalogenspecies 307
6.8 Detectionofsingletoxygen 307
6.8.1 Directdetection 307
6.8.2 Useofscavengersandtraps 307
6.8.3 Deuteriumoxide(D2O) 309
6.9 Studiesof‘generalized’lightemission(luminescence/fluorescence) 309
6.10 Changesingeneexpression:ROSbiosensors? 309
6.11 Detectionofhydrogenperoxide 310
6.11.1 Fluorescent‘probes’forH2O2 310
6.12 Othermethodstomeasurereactivespeciesinculturedcells:bewary
ofDCFHDA! 316
6.12.1 2’,7’-Dichlorodihydrofluoresceindiacetate 316
6.12.2 Dihydrorhodamine123(DHR) 320
6.12.3 Dihydroethidium 320
6.12.4 Luminol,lucigenin,andL-012 321
6.12.5 Alternativeluminescentprobesforsuperoxide 321
6.12.6 Effectsofreactivespeciesonotherprobes 321
6.13 Biomarkers:oxidationofbilirubinandofurate 321
6.14 Biomarkers:oxidativeDNAdamage 322
6.14.1 DNAdamage:whymeasureit? 322
6.14.2 CharacterizingDNAdamage:whattomeasure? 322
6.14.3 CharacterizingDNAdamage:howtomeasureit 323
6.14.4 Steady-statedamage:theartefactproblem 325
6.14.5 Overcomingtheartefact 325
6.14.5.1 Thecometassay 326
6.14.6 Interpretingtheresults:measureDNAlevelsorurinary
excretion?Whatdothelevelsmean? 326
6.14.7 Reactivenitrogenandchlorinespecies 328
6.14.8 Gene-specificoxidativedamage 328
6.14.9 RNAoxidation 328
6.14.10 DNA–aldehydeadducts 328
6.15 Biomarkersoflipidperoxidation 329
6.15.1 Whymeasurelipidperoxidation? 329
6.15.2 Measurementofperoxidationandperoxidizability 329
6.15.3 Lossofsubstrates 329
6.15.4 Measurementofintermediates 330
6.15.4.1 Radicals 330
6.15.4.2 Dieneconjugates 330
6.15.5 Measurementofend-products:peroxides 331
6.15.6 Measurementofend-products:isoprostanes(IsoPs),
isofurans(IsoFs),andisoketals(IsoKs) 331
6.15.7 Measurementofendproducts:aldehydes 335
6.15.8 Thethiobarbituricacid(TBA)assay 337
6.15.8.1 Problem1:mostTBARS(TBA-reactivesubstances)
aregeneratedduringtheassay 337
6.15.8.2 Problem2:falsechromogens 338
6.15.8.3 Problem3:realchromogensbutnotfromlipids 338
6.15.8.4 UrinaryTBARS 338
6.15.8.5 ShouldtheTBAassaybeabandoned? 338

--- Page 21 ---

xx CONTENTS
6.15.9 Measurementofend-products:breathanalysis 339
6.15.10 Measuringlipidperoxidation:lightemission 339
6.15.11 Whatisthebestmethodtomeasurelipidperoxidationin
tissues,cells,andbodyfluids? 340
6.15.12 Visualizinglipidperoxidation 341
6.16 Biomarkersofproteindamagebyreactivespecies 343
6.16.1 Damagebyreactiveoxygenspecies 343
6.16.2 Damagebyreactivehalogenandnitrogenspecies 344
6.16.3 Thecarbonylassay 346
6.16.4 Glutathioneoxidationandsynthesis 347
6.16.5 γ-Glutamyltranspeptidase 348
6.16.6 The‘thiol-ome’ 348
6.16.7 Advancedoxidationproductsandmodifiedalbumin 348
6.17 ‘Indirect’approaches 348
6.17.1 Erythrocyteandplasmaenzymes 348
6.17.2 Vascularreactivity 349
6.17.3 Assaysoftotal(‘non-enzymic’)antioxidantcapacity 349
6.17.3.1 Whatdochangesintotalantioxidantcapacitymean? 352
6.18 Isthereasinglebiomarkerofoxidativestressoroxidativedamage? 353
7 Reactivespeciescanposespecialproblemsneedingspecialsolutions:
someexamples 354
7.1 Introduction 354
7.2 Thegastrointestinaltract 354
7.2.1 Thethreatsitfaces 354
7.2.2 Defencesystems 355
7.2.2.1 Saliva 355
7.2.2.2 Antioxidantsfromdiet? 356
7.3 Therespiratorytract 357
7.3.1 Thechallenges 357
7.3.2 Defendingtherespiratorytract 358
7.3.3 Asthmaandantioxidants 359
7.4 Erythrocytes 360
7.4.1 Whatproblemsdoerythrocytesface? 360
7.4.2 Solutions:antioxidantdefenceenzymes 360
7.4.3 Solutions:diet-derivedantioxidants 361
7.4.4 Erythrocyteperoxidationinhealthanddisease 362
7.4.4.1 Problemsinbloodtransfusion 362
7.4.5 Glucose-6-phosphatedehydrogenase(G6PDH)deficiency 363
7.4.6 Solutions:destruction 363
7.5 Erythrocytesastargetsfortoxins 363
7.5.1 Hydrazines 363
7.5.2 Sulphur-containinghaemolyticdrugs 366
7.5.3 Favism 366
7.5.4 Erythrocyteapoptosis 366
7.6 Bloodthirstyparasites:problemsforthemandforus 367
7.6.1 Malaria,oxidativestress,andanancientChineseherb 367
7.7 Theproblemsofplants 369

--- Page 22 ---

CONTENTS xxi
7.8 Thekeytolife:photosyntheticoxygenproduction 369
7.8.1 Trappingoflightenergy 370
7.8.2 Thewatersplittingmechanism:aradicalprocessandthe
reasonforthisbook 374
7.8.3 Whatproblemsdogreenleavesface? 374
7.8.4 Solutions:minimizingtheproblem 377
7.8.5 Thexanthophyllcycle 378
7.8.6 Solutions:antioxidantdefenceenzymescontrol,butdonot
eliminate,reactivespecies 379
7.8.6.1 Superoxidedismutases 379
7.8.6.2 Removalofhydrogenperoxide 379
7.8.6.3 Redoxsignallinginplants 380
7.8.7 Ascorbateandglutathione 380
7.8.8 Planttocopherols 381
7.8.9 Solutions:sequesteringtransitionmetalions 381
7.8.10 Solutions:repairandreplacement 382
7.8.11 Thespecialcaseoftherootnodule 382
7.9 Plantsastargetsforstressandtoxins 382
7.9.1 Inhibitionofelectrontransportandcarotenoidsynthesis 382
7.9.2 Bipyridylherbicides 383
7.9.2.1 Redoxcycling 383
7.9.2.2 EvidencethatROSareimportantinparaquattoxicity 384
7.9.3 Environmentalstress:airpollutants(ozone,sulphurdioxide,
nitrogendioxide) 384
7.9.4 Environmentalstress:heat,cold,anddrought 385
7.9.5 Coralreefbleachingandtoxicalgalblooms:examplesof
plant-dependentoxidativestress? 386
7.10 Theeye 386
7.10.1 Whatproblemsdoestheeyeface? 387
7.10.1.1 Maculardegeneration,lipofuscin,andsingletoxygen 388
7.10.2 Protectingtheeye 390
7.10.2.1 Screening,prevention,andcrying 390
7.10.2.2 Antioxidantsintheeye 391
7.10.2.3 Sequestrationofmetalions 392
7.10.2.4 Repairofdamage 392
7.10.3 Toxins,inflammationandtheeye 393
7.10.4 Ocularcarotenoids:aChineseherbgoodfortheeyes? 393
7.10.5 Antioxidants,cataractandmaculardegeneration 393
7.11 Reproductionandoxidativestress 394
7.11.1 Pre-conception:spermatozoafaceproblems 394
7.11.2 Spermatozoa:thesolutions 395
7.11.3 Spermatozoaastargetsfortoxins 395
7.11.4 Thefemalestory 395
7.11.5 Problemsoftheembryo 396
7.11.6 Problemsofpregnancy:normalandabnormalO2levels 397
7.11.6.1 Endometriosis 398
7.11.7 Theembryo/foetusasatargetfortoxins 398
7.11.8 Birth 399
7.11.8.1 Acoldhyperoxicshock 399

--- Page 23 ---

xxii CONTENTS
7.11.8.2 Prematurity 399
7.11.8.3 Antioxidantsandbabies 400
7.11.8.4 Ironmetabolisminthenewborn 400
7.11.8.5 Parenteralnutrition 401
7.11.8.6 Antioxidants,PUFAsandiron 401
7.12 Theear 401
7.13 Theskin 402
7.13.1 Whatproblemsdoestheskinface? 402
7.13.1.1 Photosensitization 403
7.13.1.2 Ultravioletlight 404
7.13.1.3 Inflammation 405
7.13.1.4 Airpollutants 406
7.13.2 Protectingtheskin 406
7.13.3 Woundsandburns 407
7.14 Skeletalmuscle:isexerciseacauseoforaprotectionagainst
oxidativestress? 408
7.14.1 Exercise,lackofexerciseandoxidativedamage 408
7.14.1.1 Antioxidantsupplementsandexercise 409
7.14.2 Exercise,healthandfreeradicals 410
8 Reactivespeciescanbeuseful:somemoreexamples 411
8.1 Introduction 411
8.2 Radicalenzymes:ribonucleotidereductaseanditscolleagues 411
8.2.1 Theenzymemechanism 411
8.2.2 InhibitorsofRNRs 412
8.2.3 ClassIIIribonucleotidereductasesandother‘sonsofSAM’enzymes 413
8.2.4 ClassIIribonucleotidereductasesandothercobalamin
radicalenzymes 413
8.3 Pyruvate–formatelyase:asimilarmechanism 413
8.3.1 Pyruvate–ferredoxinoxidoreductase 413
8.4 Assortedoxidases 414
8.4.1 Galactoseoxidase 414
8.4.2 Indoleamineandtryptophandioxygenases 415
8.5 Usefulperoxidases 415
8.5.1 An‘antimolestation’spray 415
8.5.2 Seaurchinsandbrineshrimp 415
8.5.3 Makinganddegradinglignin 417
8.5.3.1 Makinglignin 417
8.5.3.2 Breakinglignindown 419
8.5.3.3 Aroleforhydroxylradical? 420
8.6 Lightproduction 420
8.6.1 Greenfluorescentprotein:anotherexampleofautocatalyticoxidation 420
8.7 Phagocytosis 421
8.7.1 Settingthescene 421
8.7.2 Neutrophils,monocytes,andmacrophages 421
8.7.3 Phagocyterecruitment,adhesion,activation,anddisappearance 427
8.7.3.1 Gettingtotherightplace 427
8.7.3.2 Whatmustneutrophilsdo? 430

--- Page 24 ---

CONTENTS xxiii
8.7.4 Howdophagocyteskill? 431
8.7.4.1 Phagocytesshowarespiratoryburst 431
8.7.4.2 Primingoftherespiratoryburst 432
8.7.4.3 Therespiratoryburstmakessuperoxide 432
8.7.4.4 Superoxideisrequiredtokillsomebacteria 433
8.7.4.5 Sohowdoessuperoxidekill?ViaH2O2? 434
8.7.4.6 Viahydroxylradical? 435
8.7.4.7 ViasingletO2? 435
8.7.4.8 Viaperoxynitrite? 435
8.7.4.9 Byfacilitatingtheactionofothermicrobicidalagents? 435
8.7.4.10 Interferencewithquorumsensing 436
8.7.4.11 ByNETsformation 436
8.7.4.12 Fittingittogether 436
8.7.5 Myeloperoxidase(MPO) 436
8.7.5.1 Hypochlorousacidproduction 436
8.7.5.2 TheMPOreactionmechanism 438
8.7.5.3 SingletO2fromMPO? 438
8.7.5.4 TheenigmaofMPO 439
8.7.5.5 NitrationbyMPO 439
8.7.5.6 Peroxidasins 439
8.7.5.7 Otherdefensiveperoxidases 440
8.7.5.8 Fittingittogether(part2) 440
8.8 Otherphagocytes:similarbutdifferent 440
8.9 Whatdophagocyte-derivedreactivespecies(RS)dotothehost? 441
8.9.1 ExtracellularRS:whatcantheydo? 441
8.9.2 Signalling 442
8.9.3 Damagetothephagocyte 442
8.9.4 RS:promotersorsuppressorsofchronicinflammation? 443
8.9.5 Whatdoesitallmean?AreRSbothpro-andanti-inflammatory? 444
8.9.6 Defeatingthedefences:bacterialandfungalavoidancestrategies 444
8.10 NADPHoxidasesinothercelltypes 445
8.10.1 Thegastrointestinalandrespiratorytracts 447
8.10.2 Thyroidhormonesynthesis 447
8.10.2.1 Iodideasanantioxidant 448
8.10.3 C.elegans 448
8.10.4 Bloodvesselwallsandtheregulationofbloodpressure 448
8.10.5 Lymphocytes 449
8.10.6 Renalfunctionandoxygensensing 449
8.10.7 Platelets 450
8.10.8 Boneformationanddegradation 451
8.10.9 Otherredoxsystems 451
8.11 Plantsusereactivespeciesfordefenceandregulation 451
8.11.1 PlantNOXes 451
8.11.2 Thehypersensitiveresponse 452
8.11.3 Plantlipoxygenases 453
8.11.4 Theinjuryresponseandoxylipinsignalling 455
8.11.5 Germinationandsenescence 455
8.12 Animallipoxygenasesandcyclooxygenases:stereospecificlipid
peroxidation 456
8.12.1 OxidationofPUFAsbyenzymes 456

--- Page 25 ---

xxiv CONTENTS
8.12.2 Eicosanoids:prostaglandinsandleukotrienes 456
8.12.3 Prostaglandinsandthromboxanes 456
8.12.4 Prostaglandinsynthesis 458
8.12.5 Regulationby‘peroxidetone’ 458
8.12.6 Prostaglandinsfromisoprostanes?Cross-talkofthesystems 460
8.12.7 Levuglandins 460
8.12.8 Prostacyclinsandthromboxanes 460
8.12.9 Leukotrienesandotherlipoxygenaseproducts 462
9 Reactivespeciescanbepoisonous:theirroleintoxicology 463
9.1 Introduction 463
9.1.1 Whatistoxicology? 463
9.1.2 Principlesoftoxinmetabolism 463
9.1.3 Howcanreactivespeciescontributetotoxicity? 464
9.2 Carbontetrachloride 465
9.2.1 Carbontetrachloridesynthesis:afree-radicalchainreaction 465
9.2.2 ToxicityofCCl4 466
9.2.3 HowdoesCCl4causedamage? 467
9.3 Otherhalogenatedhydrocarbons 468
9.3.1 Chloroformandbromotrichloromethane 469
9.3.2 Pentachlorophenolandrelatedenvironmentalpollutants 469
9.4 Redox-cyclingtoxins:bipyridylherbicides 470
9.4.1 Toxicitytobacteria 470
9.4.2 Toxicitytoanimals 470
9.4.3 Whyisparaquattoxictothelung? 470
9.5 Redox-cyclingtoxins:diphenols,quinones,andrelatedmolecules 471
9.5.1 InteractionwithO2andsuperoxide 471
9.5.2 Interactionwithmetals 471
9.5.3 Mechanismsoftoxicity 473
9.5.4 Quinonereductase 474
9.5.5 Catecholoestrogens 475
9.5.6 Substituteddihydroxyphenylalaninesand‘manganesemadness’ 475
9.5.7 Neurotoxicityof6-hydroxydopamine 475
9.5.8 Benzeneanditsderivatives 476
9.5.9 Toxic-oilsyndromeandanewSociety 476
9.6 Redox-cyclingagents:toxinsderivedfromPseudomonasaeruginosa 477
9.7 Diabetogenicdrugs 477
9.7.1 Alloxan 477
9.7.2 Streptozotocin 478
9.8 Alcohols 479
9.8.1 Ethanol 479
9.8.1.1 EthanolmetabolismandCYP2E1 480
9.8.1.2 Ethanoltoxicity 481
9.8.1.3 DoesethanolincreaseRSformation? 482
9.8.1.4 Howdoesethanolcauseoxidativestress? 482
9.8.1.5 Doesoxidativedamageexplainethanoltoxicity? 482
9.8.1.6 Otherliverdiseases 483
9.8.1.7 Therapeuticoptions? 483
9.8.2 Allylalcoholandacrolein 483
9.9 Otherrecreationaldrugs 484

--- Page 26 ---

CONTENTS xxv
9.10 Paracetamol(acetaminophen)andnaphthalene,glutathione-
depletingtoxins 484
9.11 Chlorinegas 487
9.12 Airpollutants 487
9.12.1 Ozone 487
9.12.2 Nitrogendioxide 488
9.12.2.1 Nitrogendioxideasafreeradical 488
9.12.2.2 Antioxidantsandnitrogendioxide 489
9.12.3 Sulphurdioxide 489
9.13 Toxicityofmixtures:‘real’airpollution,cigarettesmoke,andother
toxicsmokes 490
9.13.1 Chemistryoftobaccosmoke 491
9.13.2 Mechanismsofdamagebycigarettesmoke 492
9.13.3 Howdoestherespiratorytractdefenditself? 493
9.13.4 Adaptation 494
9.13.5 Environmentaltobaccosmoke(ETS) 494
9.13.6 Othertobaccousage 494
9.13.7 Othersmokes,fumes,anddusts 495
9.14 Dieselexhaustandairborneparticulates 495
9.14.1 Nanoparticles 496
9.15 Toxicityofasbestosandsilica 496
9.16 Toxicityofmetals 497
9.16.1 Causeorconsequence? 497
9.16.2 Arsenic 497
9.16.3 Nickel 498
9.16.4 Chromium 498
9.16.5 Cobalt 499
9.16.6 Cadmium 499
9.16.7 Mercury 499
9.16.8 Lead 500
9.16.9 Vanadium 500
9.16.10 Titanium 500
9.16.11 Aluminium 501
9.16.12 Zinc 501
9.17 Antibiotics 502
9.17.1 Tetracyclinesaspro-andantioxidants 502
9.17.2 Quinoneantibiotics 502
9.17.3 Aminoglycosidenephrotoxicity 503
9.18 Stress 503
9.19 Nitroandazocompounds 505
9.19.1 Nitroradicalsandredoxcycling 505
9.19.2 Furtherreductionofnitroradicals 505
9.19.3 Azocompounds 505
9.20 Ionizingradiation 507
9.20.1 Theoxygeneffect 507
9.20.1.1 Aroleforsuperoxide? 508
9.20.2 Antioxidantsandradiotherapy 509
9.20.3 Hypoxiccellsensitizers 509
9.20.4 Foodirradiation 509
9.21 Summaryandconclusion 510

--- Page 27 ---

xxvi CONTENTS
10 Reactivespeciesindisease:friendsorfoes? 511
10.1 Settingthescene 511
10.2 Doesoxidativestressmatter? 511
10.2.1 Establishingimportance 514
10.3 Atherosclerosis 516
10.3.1 Whatisatherosclerosis? 516
10.3.2 Predictorsofatherosclerosis 517
10.3.3 Whatinitiatesatherosclerosis? 517
10.3.4 LDLoxidationandthefoamcell 519
10.3.5 MechanismsofLDLoxidation 520
10.3.5.1 Reactivenitrogenandchlorinespecies 521
10.3.5.2 Metalions 521
10.3.5.3 Lipoxygenases 522
10.3.5.4 Summingitup:whichpro-oxidant(s)oxidize
LDLinvivo? 523
10.3.6 OtheraspectsoftheinvolvementofRSinatherosclerosis 523
10.3.7 Doesevidencesupportthe‘oxidativemodification
hypothesis’ofatherosclerosis? 523
10.3.8 ChemistryofLDLoxidation:isinvitroLDLoxidationa
relevantmodel? 525
10.3.8.1 Theroleof‘seedingperoxides’ 526
10.3.8.2 AntioxidantsandLDLoxidation 526
10.3.8.3 Pro-oxidanteffectsofantioxidants 528
10.3.8.4 Relevanceofthemodel 529
10.3.8.5 Anartefactofeating? 529
10.3.8.6 SubclassesofLDL 530
10.3.9 Theroleofhigh-densitylipoproteins(HDL) 530
10.3.10 Lipoprotein(a) 531
10.3.11 Unansweredquestions 531
10.4 Obesityanditsopposite 531
10.5 Diabetes 532
10.5.1 Canoxidativestresscausediabetes? 533
10.5.2 ROSinnormalinsulinfunctionandinsulinresistance 533
10.5.3 Oxidativestressindiabeticpatients 534
10.5.4 Howdoestheoxidativestressoriginate? 535
10.5.5 Non-enzymaticglycationandglycoxidation 535
10.5.5.1 ReversingAGEing? 538
10.5.6 Othermechanismsofglucosetoxicity 538
10.5.7 Asummary:howimportantisoxidativestressindiabetes? 539
10.5.7.1 Doantioxidantsupplementshelpdiabeticpatients? 539
10.6 Ischaemia–reperfusion 539
10.6.1 Reoxygenationinjury 540
10.6.2 Aroleforxanthineoxidase? 541
10.6.3 Intestinalischaemia–reoxygenation 541
10.6.4 Cardiacischaemia–reoxygenation 542
10.6.4.1 Thephenomenon 542
10.6.4.2 Importanceofthemodelused 543
10.6.4.3 Therelevanceofxanthineoxidase 544
10.6.4.4 Therelevanceoftransitionmetals 544

--- Page 28 ---

CONTENTS xxvii
10.6.4.5 Nitricoxide:goodorbad? 545
10.6.4.6 Heartfailure 545
10.6.4.7 Clinicalrelevance 545
10.6.4.8 Cardiopulmonarybypass 546
10.6.5 Angioplasty,restenosis,andbypassgrafting 546
10.6.6 Ischaemicpreconditioning 546
10.6.7 Shock-andsepsis-relatedischaemia–reoxygenation 547
10.6.7.1 Aneurysm 548
10.6.8 Theeye 548
10.6.9 Chemicalischaemia–reperfusion:carbonmonoxidepoisoning 549
10.6.10 Coldandfreezinginjury:theenigmaofbiopsies 549
10.6.11 Sleepapnoea 549
10.7 Organpreservation,transplantation,andreattachmentofseveredtissues 550
10.7.1 Heart 550
10.7.2 Kidney 550
10.7.3 Liverandpancreas 551
10.7.4 Limbs,digits,andsexorgans 551
10.7.5 Organpreservationfluids 552
10.7.6 Otherexamples 552
10.8 Lungtransplants,shock,andARDS 553
10.8.1 OxidativestressinARDS:doesitoccuranddoesitmatter? 554
10.9 Cysticfibrosis 554
10.9.1 Cysticfibrosisandcarotenoids 555
10.10 Someautoimmunediseases 556
10.10.1 Adversedrugreactions 557
10.10.2 AreRSimportantmediatorsofautoimmunediseases? 557
10.10.2.1 Artefacts to watch for: contamination of
commercialantioxidantsandoxidationonsample
storage 557
10.10.2.2 Periodontaldisease:amissedopportunity? 558
10.11 Rheumatoidarthritis 558
10.11.1 Thenormaljoint 558
10.11.2 TheRAjoint 558
10.11.3 HowdoesincreasedoxidativedamageariseinRA? 560
10.11.4 DoesoxidativedamagematterinRA? 561
10.11.5 DrugstotreatRA:antioxidant,pro-oxidant,orneither? 562
10.11.6 Ironandrheumatoidarthritis 565
10.12 Inflammatoryboweldisease 565
10.12.1 Thesalazines 566
10.12.2 Coeliacdisease 566
10.13 Inflammationofotherpartsofthegastrointestinaltract 567
10.13.1 Pancreas 567
10.13.2 Oesophagusandstomach 567
10.13.3 Liver 567
10.14 Oxidativestressandcancer:acomplexrelationship 568
10.14.1 Thecellcycle 568
10.14.2 Tumours 569
10.14.3 Carcinogenesis 570
10.14.3.1 Initiation 570
10.14.3.2 Tumourpromoters 571
10.14.3.3 Progression 572

--- Page 29 ---

xxviii CONTENTS
10.14.4 Genesandcancer 572
10.14.4.1 Oncogenes 572
10.14.4.2 Tumoursuppressorgenes 573
10.14.4.3 Stabilitygenes 574
10.14.4.4 Angiogenesisandcancer 574
10.14.5 Reactivespeciesandcarcinogenesis:basicconcepts 574
10.14.6 p53andROS 575
10.14.7 Changesinantioxidantdefencesincancer 576
10.14.8 ROSandcancer 577
10.14.8.1 DNAdamagebyRS 577
10.14.8.2 IsthereincreasedoxidativeDNAdamageincancer? 577
10.14.8.3 Aroleforreactivenitrogenandchlorinespecies 579
10.14.8.4 Epigenetics,cellproliferation,andHIF-1α 579
10.14.8.5 Intercellularcommunication 581
10.14.8.6 Suppressingapoptosis 581
10.14.8.7 Metastasisandangiogenesis 581
10.14.8.8 Affectingstemcells 581
10.14.9 Cancerandcachexia 582
10.14.10 Aremalignantcellstrulyunderoxidativestress? 582
10.14.11 Chronicinflammationandcancer:acloselinkbutisit
duetoreactivespecies? 582
10.14.12 Transitionmetalsandcancer 583
10.15 Carcinogens:oxygenandothers 584
10.15.1 Carcinogenmetabolism 584
10.15.1.1 CarcinogenscanmakeRS 584
10.15.2 CarcinogensandoxidativeDNAdamage 587
10.15.2.1 Peroxisomeproliferators 587
10.15.3 Carcinogenicreactivenitrogenspecies? 588
10.16 Cancerchemotherapyandreactiveoxygenspecies 588
10.16.1 Oxidativestressandchemotherapy 590
10.16.2 Theanthracyclinesandotherquinones 591
10.16.2.1 Mechanismsofcardiotoxicity:redoxcycling
andothers 592
10.16.2.2 Ironandanthracyclines 592
10.16.3 Bleomycin 593
10.16.3.1 Side-effectsofbleomycin 594
10.16.4 Shouldcancerpatientsconsumeantioxidants? 595
10.17 Oxidativestressanddisordersofthenervoussystem:settingthescene 595
10.17.1 Introductiontothebrain 595
10.17.2 Energymetabolisminthebrain 598
10.17.3 Glutamate,calcium,andnitricoxide 599
10.17.4 Excitotoxicity 599
10.17.5 Whyshouldthebrainbepronetooxidativestress?ROS
arebothusefulanddeleterious 600
10.17.6 Antioxidantdefencesinthebrain 603
10.17.6.1 Keepingoxygenlow 603
10.17.6.2 Superoxidedismutasesandperoxide-removing
enzymes 603
10.17.6.3 Glutathioneandergothioneine 603
10.17.6.4 Protectingbrainmitochondria 604
10.17.6.5 Ascorbate 604

--- Page 30 ---

CONTENTS xxix
10.17.6.6 VitaminE 604
10.17.6.7 CoenzymeQ 605
10.17.6.8 Histidine-containingdipeptides 605
10.17.6.9 Plasmalogens 605
10.17.6.10 Carotenoidsandflavonoids 605
10.17.6.11 Metal-bindingandrelatedprotectiveproteins 605
10.17.6.12 Repairofoxidativedamage 606
10.17.6.13 Defenceoftheblood–brainbarrier 606
10.18 Oxidativestressinischaemia,inflammation,andtraumainthe
nervoussystem 606
10.18.1 Inflammation:acommonfeature 606
10.18.2 Multiplesclerosis 607
10.18.3 Braininjury:stroke 607
10.18.3.1 Mediatorsofdamage 608
10.18.3.2 Therapeuticinterventions? 610
10.18.4 Traumaticinjury 611
10.19 Oxidativestressandneurodegenerativediseases:somegeneralconcepts 611
10.19.1 Theroleofiron 614
10.19.2 Areaggregatestoxic? 615
10.20 Parkinsondisease 615
10.20.1 Geneticsorenvironment? 616
10.20.2 Treatment 616
10.20.3 EnvironmentaltoxinsandPD 617
10.20.4 Theviciouscycle:proteasomaldysfunction,oxidative
stress,andmitochondrialdefectsinPD 620
10.20.4.1 Earlyorlate? 621
10.20.5 Summingitup;insightsfromPINK1andDJ-1 621
10.21 Alzheimerdisease 622
10.21.1 Definitionandpathology 622
10.21.2 GeneticsofAD 624
10.21.3 Mechanismsofneurodegeneration 625
10.21.4 OxidativedamageinAD:causeorconsequence? 627
10.21.5 Impairmentofproteolysis 628
10.21.6 Anoldredherring:aluminiuminAD 628
10.21.7 Diet,lifestyle,andAD 628
10.21.8 Otheramyloiddiseases 629
10.21.9 Priondiseases 629
10.22 Amyotrophiclateralsclerosis(ALS) 630
10.22.1 FamilialALS(FALS)andsuperoxidedismutase 631
10.22.2 OxidativedamageandexcitotoxicityinALS 632
10.22.2.1 Therapies 632
10.23 Otherdiseasesofthebrainandnervoussystem 633
10.23.1 Friedreichataxia 633
10.23.2 Huntingtondisease 633
10.23.3 Neuronalceroidlipofuscinoses 635
10.24 Pain 635
10.25 Oxidativestressandviralinfections 636
10.25.1 Reactivespecies,antioxidants,andHIV 637
10.25.1.1 Changesinglutathione? 637
10.25.2 Redoxregulationofviralexpression 638
10.25.3 Side-effectsoftherapy 638

--- Page 31 ---

xxx CONTENTS
11 Ageing,nutrition,disease,andtherapy:aroleforantioxidants? 639
11.1 Introduction 639
11.2 Theoriesofageing;thebasics 639
11.2.1 Generalprinciples 639
11.2.2 Whatfeaturesofageingmusttheoriesexplain? 640
11.2.2.1 Caloricrestriction(CR) 640
11.2.2.2 Obesity,oxidativestress,andCR 640
11.3 Whattheoriesofageingexist? 641
11.3.1 Dogenesinfluenceageing?ThestoryofC.elegans 641
11.3.1.1 Whataboutmammals? 642
11.3.2 Genesandhumanlongevity 645
11.3.3 Prematurehumanageing 645
11.3.4 Mechanismsofcaloricrestriction;learningfromyeast 646
11.3.5 Telomeresandcellularsenescence 647
11.3.5.1 Anartefactofcellculture? 648
11.4 Oxidativedamage:alinkbetweenthetheoriesofageing? 649
11.4.1 Introductiontothefree-radicaltheoryofageing 649
11.4.2 DoROSproductionandoxidativedamageincreasewithage? 653
11.4.2.1 Becautiouswithglobalbiomarkers 654
11.4.3 Istheriseinoxidativedamageduetofailureofantioxidant
protectionwithage? 654
11.4.4 Isthereafailuretorepairoxidativedamagewithage? 655
11.4.5 Testing the free-radical theory of ageing: altering
antioxidantlevels 655
11.4.5.1 Transgenicorganisms:aconfusingpicture 656
11.4.6 ‘Rapidlyageing’rodents 658
11.4.7 Lipofuscinandceroid;fluorescent‘redherrings’? 658
11.4.8 Istheoxidativedamagetheoryofageingageingbadly? 659
11.4.9 Howtolivealongtime 659
11.4.10 Iron,ageing,anddisease:anothergendergap 660
11.5 Antioxidantstotreatdisease 660
11.5.1 Therapeuticantioxidants 661
11.5.2 Approachestoantioxidantcharacterization 663
11.5.3 Superoxidedismutases,catalases,andnanoparticles 663
11.5.3.1 Viralvectors 665
11.5.4 SODmimeticsandrelatedredox-activemolecules 666
11.5.5 Spintraps/nitroxides 669
11.5.6 VitaminsCandE,carnosine,andtheirderivatives 672
11.5.7 CoenzymeQandsyntheticchain-breakingantioxidants 673
11.5.8 Dualactionmoleculesandedaravone 680
11.5.9 Thiolcompounds 680
11.5.9.1 Glutathione 681
11.5.9.2 N-Acetylcysteine 681
11.5.9.3 Otherthiols 682
11.5.9.4 Thiolsasradioprotectors 682
11.5.10 Glutathioneperoxidase‘mimetics’ 683
11.5.11 ‘Pro-oxidants’andNrf2activators 683
11.5.12 Mitochondriallytargetedantioxidants 684

--- Page 32 ---

CONTENTS xxxi
11.6 Ironandcopperionchelators 686
11.6.1 Desferrioxamine 686
11.6.2 Otheriron-chelatingagents 692
11.7 Inhibitorsofthegenerationofreactivespecies 693
11.7.1 Xanthineoxidase(XO)inhibitors 693
11.7.2 Myeloperoxidaseinhibitors 694
11.7.3 Inhibitorsofphagocyteaction 694
11.7.4 NADPHoxidaseinhibitors 694
11.8 Agentstowatch 695
Appendix:Somebasicchemistry 697
A1 Atomicstructure 697
A2 Bondingbetweenatoms 702
A2.1 Ionicbonding 702
A2.2 Covalentbonding 702
A2.3 Non-idealcharacterofbonds 703
A2.4 Hydrocarbonsandelectrondelocalization 704
A3 Molesandmolarity 705
A4 pHandpKa 705
References 707
Index 823

--- Page 33 ---

Abbreviations
Wherethesameabbreviationisusedformorethanoneitem,theonelistedfirstisthatmostcommonlyusedinthisbook.
AA Arachidonicacid APF 2-[6-(4 (cid:4) -Amino)
A2E N-retinylidene-N-retinylethanolamine phenoxy-3H-xanthen-3-on-9-yl]benzoic
A2PE-H2 Dihydro-N-retinylidene-N-retinyl- acid
phosphatidylethanolamine apoA1 ApolipoproteinA1
(cid:4)
AAPH 2,2-Azobis(2-amidinopropane) apoA2 ApolipoproteinA2
dihydrochloride apoB ApolipoproteinB
Aβ Beta-amyloidpeptides apoE ApolipoproteinE
ABAD Amyloidβ-bindingalcohol APP Amyloidprecursorprotein
dehydrogenase APS Antiphospholipidsyndrome
(cid:4)
ABTS 2,2-Azinobis ARDS Acuterespiratorydistresssyndrome
(3-ethylbenzothiazoline-6-sulphonicacid) ARE Antioxidantresponseelement
ACE Angiotensinconvertingenzyme AREDS Age-relatedeyediseasestudy
AD Alzheimerdisease ARP Aldehyde-reactiveprobe
AdhE AlcoholdehydrogenaseE(E.coli) ASAP Antioxidantsupplementationin
ADMA NG,NGdimethyl-L-arginine atherosclerosisprevention(trial)
AEOL Aeolus(pharmaceuticals) ASK Apoptosissignal-regulatingkinase
AGE Advancedglycationend-product At Arabidopsisthaliana
AHPR Alkylhydroperoxidereductase ATBC α-Tocopherol/β-carotenecancer
AHR Arylhydrocarbonreceptor preventionstudy
AHSP α-Haemoglobinstabilizingprotein ATM Ataxiatelangiectasiamutated
AIDS Acquiredimmunodeficiencysyndrome ATP Adenosine-5 (cid:4) -triphosphate
(cid:4)
AIPH 2,2-Azobis[2-(2-imidazolin-2-yl)propane] ATR ATMandRad-3related
dihydrochloride AVED AtaxiawithisolatedvitaminEdeficiency
ALA 5-Aminolaevulinicacid AZN Azulenylnitrone
ALS Amyotrophiclateralsclerosis AZT Azidodeoxythymidine
AMD Age-relatedmaculardegeneration BAL Britishanti-lewisite
AMPA α-Amino-3-hydroxy-5-methyl-4-isoxazole BAT Brownadiposetissue
propionate BB Biobreeding(rat)
AMPK AMP-activatedproteinkinase BCDO2 β-Carotenedioxygenase2
(cid:4)
AMVN 2,2-Azobis(2,4-dimethylvaleronitrile) BCI Bleomycin-chelatableiron
AOC Alleneoxidecyclase BCMO1 β-Carotenemonooxygenaseenzyme
AOPP Advancedoxidationproteinproducts BCNU N,N-Bis(2-chloroethyl)-N-nitrosourea
AOS Alleneoxidesynthase BDNF Brain-derivedneurotrophicfactor
AP Apurinic/apyrimidinic(site)oralternative BER Baseexcisionrepair
pathway BH • Trihydrobiopterinradical
3
α 1-AP α 1-Antiproteinase BH4 Tetrahydrobiopterin
AP-1 Activatorprotein1 BHA Butylatedhydroxyanisole
APAF-1 Apoptoticproteinaseactivatingfactor1 BHF BritishHeartFoundation
APE1 Apurinic/apyrimidinicendonuclease1 BHT Butylatedhydroxytoluene
xxxii

--- Page 34 ---

ABBREVIATIONS xxxiii
BLM Bleomycin COPs Cholesteroloxidationproducts
BM Basementmembrane CoQ CoenzymeQ(ubiquinone)
BNB tert-Butylnitrosobenzene CoQH2 ReducedcoenzymeQ(ubiquinol)
BOSS Biomarkersofoxidativestress COX Cyclooxygenase
BPD Bronchopulmonarydysplasia CP Classicalpathway
BPDS Bathophenanthrolinedisulphonate CR Caloricrestriction
(cid:4)
BrdU 5-Bromo-2-deoxyuridine CRP C-reactiveprotein
BSD BypassSODdeficiency(gene) 11cRAL 11-cis-Retinal
BSE Bovinespongiformencephalopathy 11cROL 11-cis-Retinol
BSO Buthioninesulphoximine CS CockaynesyndromeorCigarettesmoke
C11-BODIPY581/591 CSF CerebrospinalfluidorColony-stimulating
4,4-Difluoro-5-(4-phenyl-1,3-butadienyl)-4- factor
bora-3a,4a-diaza-s-indacene-3-undecanoic CuZnSOD Copper-and-zinc-containingsuperoxide
acid dismutase
CAD Caspase-activateddeoxyribonuclease CUPRAC Cupricreducingantioxidantcapacity
(cid:4) (cid:4)
CAL Calcein CyclodA 8,5-Cyclo-2-deoxyadenosine
(cid:4) (cid:4)
CALPAIN Calcium-activatednon-lysosomal CyclodG 8,5-Cyclo-2-deoxyguanosine
proteinase CYP CytochromeP450
CaMKII Calcium-calmodulindependentkinaseII DAB Diaminobenzidine
CARET β-Caroteneandretinolefficiencytrial DABCO 1,4-Diazabicyclooctane
CARS Compensatoryanti-inflammatory DAF-2DA 4,5-Diaminofluoresceindiacetate
responsesyndrome DAG Diacylglycerol
CASPASE Cysteine-aspartyl-specificprotease DAMP Damage-associatedmolecularpattern
CBA Coumarin-7-boronate DBNBS 3,5-Dibromo-4-nitroso-benzene-sulphonic
CBD Cannabidiol acid
(cid:4) (cid:4)
CCA Coumarin-3-carboxylicacid DCF 2,7-Dichlorofluorescein
(cid:4) (cid:4)
CCP Cytochromecperoxidase DCFH 2,7-Dichlorodihydrofluorescein
(cid:4) (cid:4)
CCS CopperchaperoneforSOD DCFHDA 2,7-Dichlorodihydrofluoresceindiacetate
CD Clusterofdifferentiation DCT DOPAchrometautomerase
2-S-CD 2-S-Cysteinyldopa ddC Dideoxycytidine
5-S-CD 5-S-Cysteinyldopa ddI Dideoxyinosine
CdK Cyclin-dependentproteinkinase DDTC Diethyldithiocarbamate
CDNB 1-Chloro-2,4-dinitrobenzene DED Deatheffectordomain
α-CEHC 2,5,7,8-Tetramethyl-2-(2 (cid:4) -carboxyethyl)-6- DEPMPO 5-Diethoxyphosphoryl-5-methyl-1-
hydroxychroman pyrroline-N-oxide
γ-CEHC 2,7,8-Trimethyl-2-(2 (cid:4) DETAPAC Diethylenetriaminepenta-aceticacid
carboxyethyl)-6-hydroxychroman DFO Desferrioxamine
CEP Carboxyethylpyrrole DHA DehydroascorbateorDocosahexaenoic
CF Cysticfibrosis acid
CFTR Cysticfibrosistransmembrane 2,3-DHB 2,3-Dihydroxybenzoate
conductanceregulator 2,5-DHB 2,5-Dihydroxybenzoate
CGD Chronicgranulomatousdisease DHE Dihydroethidium
CHAOS Cambridgeheartantioxidantstudy DHF Dihydroxyfumarate
CHD Coronaryheartdisease DHI 5,6-Dihydroxyindole
CHO Chinesehamsterovary DHICA 5,6-Dihydroxyindole-2-carboxylicacid
CJD Creutzfeldt–Jakobdisease DHLA Dihydrolipoate
vCJD VariantCreutzfeldt–Jakobdisease DHR Dihydrorhodamine123
CK Creatinekinase DIABLO Directinhibitorofapoptosisprotein
CLA Conjugatedlinoleicacid bindingproteinwithlowpI
CLAS Cholesterolloweringatherosclerosisstudy DISC Death-inducedsignallingcomplex
Clk-1 Clock-1(gene) DMEM Dulbecco’sModifiedEagle’sMedium
CNS Centralnervoussystem DMF Dimethylformamide
CNTF Ciliaryneurotrophicfactor DMPO 5,5-Dimethylpyrroline-N-oxide
COMT Catechol-O-methyltransferase DMSO Dimethylsulphoxide
COPD Chronicobstructivepulmonarydisease DMT1 Divalentmetaltransporter-1

--- Page 35 ---

xxxiv ABBREVIATIONS
DMTU Dimethylthiourea G3PDH Glyceraldehyde-3-phosphate
DNPH 2,4-Dinitrophenylhydrazine dehydrogenase
(cid:4) (cid:4)
DOD-8C (N-[4-dodecyloxy-2-(7-carboxy-hept-1- G6PDH Glucose-6-phosphatedehydrogenase
yloxy)benzylidene]-N-tert-butylamine GA Glucuronicacid
N-oxide) GABA γ-Aminobutyrate
DOPA L-Dihydroxyphenylalanine GADD GrowtharrestonDNAdamage
DOPAC 3,4-Dihydroxyphenylaceticacid GC Gaschromatography
DPI Diphenyleneiodonium GFP Greenfluorescentprotein
(cid:4)
DPPD N,N-Diphenyl-p-phenylenediamine GHz Gigahertz
DPPH 1,1-Diphenyl-2-picrylhydrazyl GI-GPx Intestinalglutathioneperoxidase(see
Dpr Dps-likeperoxideresistanceprotein GPx2)
Dps DNAbindingproteinduringstationary GItract Gastrointestinaltract
phase GM-CSF Granulocyte-macrophagecolony
DQ Dopaquinone stimulatingfactor
DS Downsyndrome GO Galactoseoxidase
(cid:4)
DTNB 5,5-Dithiobis(2-nitrobenzoicacid) GOT Glutamate-oxaloacetatetransaminase
DUOX Dualoxidase GPx Glutathioneperoxidase
EBV Epstein–Barrvirus GPx2 Intestinalglutathioneperoxidase
EC-SOD Extracellularsuperoxidedismutase (seeGI-GPx)
EDRF Endothelium-derivedrelaxingfactor GPx3 Extracellularglutathioneperoxidase
EDTA Ethylenediaminetetraaceticacid GPx4 Phospholipidhydroperoxideglutathione
EGF Epidermalgrowthfactor peroxidase
EGFR Epidermalgrowthfactorreceptor GPT Glutamate-pyruvatetransaminase
EL Ethyllinoleate GR Glutathionereductase
EMPO 5-Ethoxycarbonyl-5-methyl-1-pyrroline-N- GSH Reducedglutathione
oxide GSSG Oxidizedglutathione
EPA Eicosapentaenoicacid GST Glutathione-S-transferase
EPO Eosinophilperoxidase Gy Gray(radiationdose)
EPR Electronparamagneticresonance HATS HDL-atherosclerosistreatmentstudy
ER Endoplasmicreticulum HBED N,N-bis(2-hydroxybenzyl)
ERK Extracellularsignalrelatedkinase ethylenediamine-N,N-diaceticacid
Ero Endoplasmicreticulumoxidoreductase HBO Hyperbaricoxygen
ESR Electronspinresonance HBV HepatitisBvirus
ETS Environmentaltobaccosmoke HCS Hypoxiccellsensitizer
ETYA 5,8,11,14-Eicosatetraynoicacid HCV HepatitisCvirus
EUK Eukarion(company) HD Huntingtondisease
EURAMIC EuropeanCommunitymulticentrestudy HDC 6-Hydroxy-1,4-dimethylcarbazole
onantioxidants,myocardialinfarctionand HDL High-densitylipoproteins
breastcancer 12-HETE 12-Hydroxy-5,8,10,14-eicosatetraenoicacid
FA FreidreichataxiaorFanconianaemia HGF Hepatocytegrowthfactor
FAD Flavinadeninedinucleotide HHE Trans-4-Hydroxy-2-hexenal
FADH2 Reducedflavinadeninedinucleotide HHT 12-Hydroxy-5,8,10-heptadecatrienoicacid
FAK Focaladhesionkinase HIF Hypoxiainduciblefactor
FALS Familialamyotrophiclateralsclerosis HIU 5-Hydroxyisourate
FAPyG 2,6-Diamino-4-hydroxy-5- HIV Humanimmunodeficiencyvirus
formamidopyrimidine HL Hydroperoxidelyase
Fas Fibroblast-associatedcellsurface HMGB1 Highmobilitygroup1protein
FAS Foetalalcoholsyndrome HNE 4-Hydroxy-2-trans-nonenal
FGF Fibroblastgrowthfactor HNF-1α Hepaticnuclearfactor1α
FMN Flavinmononucleotide HO Haemoxygenase
FMNH2 Reducedflavinmononucleotide HOPE Heartoutcomespreventionevaluation
FOXO Forkheadtranscriptionfactor,classO (study)
Fur Ferricuptakeregulator HPI HydroperoxidaseI
γGCS γ-Glutamylcysteinesynthetase HPII HydroperoxidaseII
γGGT γ-Glutamyltransferase HPD Haematoporphyinderivative

--- Page 36 ---

ABBREVIATIONS xxxv
12-HPETE 12-Hydroperoxy-5,8,10,14-eicosatetraenoic LOX Lipoxygenase
acid LOX-1 Lipoxygenase-1orLectin-likeoxidizedlow
(cid:4)
HPF 2-[6-(4-Hydroxyl)phenoxyl-3H-xanthen-3- densitylipoproteinreceptor-1
on-9-yl]benzoicacid LP Lectinpathway
HPLC High-performanceliquidchromatography LPL Lipoproteinlipase
HPO High-pressureoxygen LPO Lactoperoxidase
HPS Heartprotectionstudy LPS Lipopolysaccharide
HRP Horseradishperoxidase LRAT Lecithinretinolacyltransferase
HSF Heat-shocktranscriptionfactor LRP1 LDLreceptor-relatedprotein1
HSP Heat-shockprotein LTA4 LeukotrieneA4
5-HT 5-Hydroxytryptamine LTB4 LeukotrieneB4
HTGL Hepatictriglyceridelipase LTC4 LeukotrieneC4
HTLV HumanT-cellleukaemiavirus LTD4 LeukotrieneD4
HX Hypoxanthine LTE4 LeukotrieneE4
IAP Inhibitorofapoptosisprotein M Molar
IBD Inflammatoryboweldisease μM Micromolar
ICAD Inhibitorofcaspase-activated mM Millimolar
deoxyribonuclease nM Nanomolar
ICAM Intercellularadhesionmolecule pM Picomolar
ICE Interleukin-1βconvertingenzyme M1G Pyrimido[1,2α]purine-10(3H)-one
IDO Indoleaminedioxygenase MAC Membraneattackcomplex
IEISS Indianexperimentofinfarctsurvivalstudy MAO-A MonoamineoxidaseA
IgA ImmunoglobulinA MAO-B MonoamineoxidaseB
IgE ImmunoglobulinE MAP Mitogenactivatedprotein(kinase)
IGF-1 Insulin-likegrowthfactor1 MAT Methionineadenosyltransferase
IgG ImmunoglobulinG MBL Mannosebindinglectin
IgM ImmunoglobulinM MCI Mildcognitiveimpairment
IL-1 Interleukin-1 MCLA 2-Methyl-6-(4-methoxyphenyl)-3,7-
ILBD IncidentalLewybodydisease dihydroimidazo[1,2-α]pyrazin-3-one
IMA Ischaemia-modifiedalbumin MCP-1 Monocytechemoattractantprotein1
IMT Intima-mediathickness MCSF Macrophagecolony-stimulatingfactor
IP-10 Inducibleprotein10 MDA Malondialdehydeor
IP3 Inositoltriphosphate 3,4-Methylenedioxyamphetamine
IRE Ironresponsiveelement MDMA 3,4-Methylenedioxymethylamphetamine
IRP Ironregulatoryprotein MDT Marine-derivedtocopherol
IsoP Isoprostane MEG Mercaptoethylguanidine
I-TAC Interferon-inducibleT-cell MELAS Mitochondrialencephalomyopathy,lactic
α-chemoattractant acidosisandstroke-likeepisodes
JNK c-JunN-terminalkinase MEOS Microsomalethanol-oxidizingsystem
KA Kainicacid fMet-leu-phe N-formylmethionylleucylphenylalanine
Keap1 Kelch-like(erythroidcell-derivedprotein MI Myocardialinfarction
withCNChomology)-associatedprotein-1 MICRO-HOPE Microalbuminuria,cardiovascular,and
αKGDH α-Ketoglutaratedehydrogenase renaloutcomesintheHOPEstudy
KGF Keratinocytegrowthfactor Mig Monokineinducedbyinterferon-γ
kJ Kilojoule MIP Monocyteinflammatoryprotein
LA Lipoicacid MMP Matrixmetalloproteinase
LCAT Lecithin-cholesterolacyltransferase MnSOD Manganese-containingsuperoxide
LDH Lactatedehydrogenase dismutase
LDL Low-densitylipoproteins MODS Multipleorgandysfunctionsyndrome
LEC Long–EvansCinnamon(rat) MODY Maturityonsetdiabetesoftheyoung
LFA Lymphocytefunctionantigen MOG Myelinoligodendrocyteglycoprotein
LGD2 LevuglandinD2 MOX Mitogenicoxidase
LGE2 LevuglandinE2 MPB 3-(N-maleimidylpropionyl)biocytin
LHON Leberhereditaryopticneuropathy MPDP+ 1-Methyl-4-phenyl-2,3-dihydropyridine
LIP Labileironpool ion

--- Page 37 ---

xxxvi ABBREVIATIONS
MPG Mercaptopropionylglycine eNOS Endothelialnitricoxidesynthase
MPO Myeloperoxidase iNOS Induciblenitricoxidesynthase
MPP+ 1-Methyl-4-phenylpyridiniumion nNOS Neuronalnitricoxidesynthase
MPT Mitochondrialpermeabilitytransition NP Neuroprostane
MPTP 1-Methyl-4-phenyl-1,2,3,6- NQO NAD(P)H-quinoneoxidoreductase
tetrahydropyridine Nramp1 Naturalmurineresistanceassociated
MR Methaemoglobinreductase macrophageprotein-1
MRC MedicalResearchCouncil(UK) N-ret-PE N-Retinylidene-
MRI Magneticresonanceimaging phosphatidylethanolamine
MS Multiplesclerosis NRF1 Nuclearrespiratoryfactor1
Msr Methioninesulphoxidereductase Nrf2 Nuclearfactorerythroid2p4–5-related
MT Metallothionein factor2
MTH1 MutThomologueone NRF2 Nuclearrespiratoryfactor2
MTT 3-(4,5Dimethylthiazol-2-yl)-2,5-diphenyl NSAID Non-steroidalanti-inflammatorydrug
tetrazoliumbromide Nt Nicotianatabacum
MVP Multivitaminsandprobucoltrial NTA Nitrilotriacetate
MYA Millionyearsago NTBI Non-transferrin-boundiron
hMYH HumanmutYanalogue ODS OsteogenicdisorderShionogi(rat)
NAAQS Nationalambientairquality OHCU 2-Oxo-4-hydroxy-4-carboxy-5-
standard(USA) ureidoimidazoline
NAc N-acetylcysteine 6-OHDA 6-Hydroxydopamine
NAD+ Nicotinamideadeninedinucleotide 8OHdG 8-Hydroxy-2 (cid:4) -deoxyguanosine
NADH Reducednicotinamideadenine 8OHG 8-Hydroxyguanine
dinucleotide 8OHGua 8-Hydroxyguanosine
NADP+ Nicotinamideadeninedinucleotide (8-hydroxyguanine-ribose)
phosphate ORAC Oxygenradicalabsorbancecapacity
NADPH Reducednicotinamideadenine OTC L-2-Oxothiazolidine-4-carboxylate
dinucleotidephosphate OxLDL Oxidizedlow-densitylipoprotein
(cid:4)
NAFLD Non-alcoholicfattyliverdisease 8oxodG 8-Oxo-7-hydro-2-deoxyguanosine
NAG N-Acetylglucosamine OxPAPC Oxidized1-palmitoyl-2-arachidonoyl-sn-
NASH Non-alcoholicsteatohepatitis glycero-3-phosphorylcholine
NBT Nitrobluetetrazolium PAF Platelet-activatingfactor
NCL Neuronalceroidlipofuscinoses PAL Presentatmosphericlevel
NDGA Nordihydroguaiareticacid PAMP Pathogen-associatedmolecularpattern
NER Nucleotideexcisionrepair PAPC 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-
NETs Neutrophilextracellulartraps phosphorylcholine
8-NG 8-Nitroguanine PARP Poly(ADP-ribose)polymerase
NGF Nervegrowthfactor PBG Porphobilinogen
NHANES NationalHealthandNutrition PBN α-Phenyl-tert-butylnitrone
ExaminationSurvey PC PlastocyaninorPhosphatidylcholine
NHPA 3-Nitro-4-hydroxyphenylacetate PCC Phenanthroline-chelatablecopper
NIA NationalInstituteofAging(USA) PCD Programmedcelldeath
NiSOD Nickel-containingsuperoxide PCP Pentachlorophenol
dismutase PCR Polymerasechainreaction
NIST NationalInstituteofStandardsand PD Parkinsondisease
Technology(USA) PDGF Platelet-derivedgrowthfactor
NK Naturalkiller(cell) PDH Pyruvatedehydrogenase
NMDA N-Methyl-D-aspartate PDI Proteindisulphideisomerase
NMMA NG-Monomethyl-L-arginine PDK Phosphoinositide-dependentkinase
NMP 3-Nitratomethyl-PROXYL PE Phosphatidylethanolamine
NNK 4-(Methylnitrosamine)-1-(3-pyridyl)-1- PECAM Platelet-endothelialcelladhesionmolecule
butanone PEG Polyethyleneglycol
NNO Nitronylnitroxide PFL Pyruvate–formatelyase
NOD Non-obesediabetic(mouse) PFOR Pyruvate–ferredoxinoxidoreductase
NOS Nitricoxidesynthase PG Prostaglandin

--- Page 38 ---

ABBREVIATIONS xxxvii
PGC-1α Peroxisome-proliferator-activated-receptor RPE Retinalpigmentepithelium
γco-activator-1α RS Reactivespecies
pGPx Plasmaglutathioneperoxidase RSS Reactivesulphurspecies
(alsoseeGPx3) RSV Respiratorysyncytialvirus
PHGPx Phospholipidhydroperoxideglutathione RTK Receptortyrosinekinase
peroxidase(alsoseeGPx4) SAA SerumamyloidAprotein
Phox Phagocyteoxidase SAM S-Adenosylmethionine
PHS Physicians‘healthstudy SAP SerumamyloidPprotein
PI Propidiumiodide SAR Systemicacquiredresistance
PIH Pyridoxalisonicotinoylhydrazone SCA Senescentcellantigen
PKA ProteinkinaseA SCID Severecombinedimmunodeficient
PKB ProteinkinaseB SCPS Skincancerpreventionstudy
PKC ProteinkinaseC SDA Semidehydroascorbate
PLC PhospholipaseC SDS Sodiumdodecylsulphate
PLD PhospholipaseD SELECT SeleniumandvitaminEcancerprevention
PMA Phorbolmyristateacetate trial
4-POBN α-(4-Pyridyl-1-oxide)-N-tert-butylnitrone SERPIN Serineproteinaseinhibitor
Polγ DNApolymeraseγ SF Synovialfluid
PON-1 Paraoxonase-1 SFRR SocietyforFreeRadicalResearch
POP Phytosteroloxidationproduct SHEEP Stockholmheartepidemiologyprogramme
PP Peroxisomeproliferator SHR Spontaneouslyhypertensiverat
PPAR Peroxisomeproliferatoractivatedreceptor SIH Salicylaldehydeisonicotinoylhydrazone
PPP Pentosephosphatepathway Sir Silentinformationregulator
PQ Plastoquinone SIRS Systemicinflammatoryresponse
PR Promethazine syndrome
Prx Peroxiredoxin SIRT Sirtuin
PS Phosphatidylserine Sirtuin Silentinformationregulator-likeprotein
PSI PhotosystemI SMAC Secondmitochondria-derivedactivatorof
PSII PhotosystemII caspases
PTEN Phosphataseandtensinhomologue SLE Systemiclupuserythematosus
deletedonchromosome10 SLOS Smith-Lemli-Opitzsyndrome
PUFA Polyunsaturatedfattyacid SN Substantianigra
PUVA PsoralenultravioletA(therapy) SNAP S-nitroso-N-acetyl-DL-penicillamine
PVC Polyvinylchloride SNP Sodiumnitroprusside
QR Quinonereductase SOD Superoxidedismutase
RA Rheumatoidarthritis SOR Superoxidereductase
RAGE Receptorforadvancedglycation SOTS Di-(4-carboxybenzyl)hyponitrite
end-products SPACE Secondarypreventionwithantioxidantsof
atRAL all-trans-Retinal cardiovasculardiseaseinendstagerenal
RANK ReceptorforactivatorofNF-κB disease
RANKL ReceptorforactivatorofNF-κB,ligand SPL Sporephotoproductlyase
RANTES Regulationuponactivation,normalT-cell SRA ScavengerreceptorsA
expressedandsecreted SREBP Sterolregulatoryelementbindingprotein
RBOH Respiratoryburstoxidasehomologue SS Szeto-Schiller
RBS Reactivebrominespecies STAZN Stilbazulenylnitrone
RCS Reactivechlorinespecies SUVIMAX Supplementationenvitaminsetmineraux
RDA Recommendeddietaryallowance antioxidant
atRE all-trans-Retinylesters SVCT Sodium-vitaminCtransporter
Ref-1 Redoxeffectorfactor1 TAC Totalantioxidantcapacity
RIP1 Receptorinteractingprotein-1 Tat Transactivatoroftranscription
RNR Ribonucleotidereductase TBA Thiobarbituricacid
RNS Reactivenitrogenspecies TBARS Thiobarbituricacid-reactivesubstances
atROL all-trans-Retinol TBHQ tert-Butylhydroquinone
ROS Reactiveoxygenspecies TCBQ Tetrachlorobenzoquinone
ROP Retinopathyofprematurity TCDD 2,3,7,8-Tetrachlorodibenzo-p-dioxin

--- Page 39 ---

xxxviii ABBREVIATIONS
TCHQ Tetrachlorohydroquinone α-TTP α-Tocopheroltransferprotein
TCR Transcription-coupledrepair TUNEL TdT-mediatedX-dUTPnickend-labelling
TDO Tryptophan2,3-dioxygenase TX Thromboxane
TDS TranslesionalDNAsynthesis TXNIP Thioredoxin-interactingprotein
TdT Terminaldeoxynucleotidyltransferase UCHL1 Ubiquitincarboxy-terminalhydrolaseL1
TEAC Troloxequivalentantioxidantcapacity UV Ultraviolet
TGF-β Transforminggrowthfactorβ
VA Veratrylalcohol
THC Tetrahydrocannabinol VAP Vascularadhesionprotein
THF Tetrahydrofolate VCAM Vascularcelladhesionmolecule
THOX Thyroidoxidase VDAC Voltage-dependentanion-selective
TIBS TrendsinBiochemicalSciences channel
TIC Tumourinitiatingcell VEAPS VitaminEatherosclerosisprevention
TIMP Tissueinhibitorofmetalloproteinases study
TiP Thioredoxininteractingprotein VEGF Vascularendothelialgrowthfactor
TLR Toll-likereceptors VHL vonHippel-Lindau
TMINO 1,1,3-Trimethyl-isoindoleN-oxide VITAL Vitaminsandlifestylestudy
tNB(NtB) tert-Nitrosobutane(nitroso-tert-butane) VLDL Verylow-densitylipoproteins
TNB Thionitrobenzoate Vtc-mutant VitaminCmutant(inArabidopsis)
TNF Tumournecrosisfactor WACS Women’santioxidantandcardiovascular
TPO Thyroidperoxidase study
TPP Thiaminepyrophosphateor WAVE Women’sangiographicvitaminand
Triphenylphosphonium oestrogen(trial)
TRADD Tumournecrosisfactorreceptor-associated WR WalterReed(armyhospital,USA)
deathdomain XDH Xanthinedehydrogenase
TRAP Total(peroxyl)radicaltrapping XIAP X-linkedinhibitorofapoptosis
antioxidantparameter XO Xanthineoxidase
TRAIL Tumournecrosisfactorrelatedapoptosis XOR Xanthineoxidoreductase
inducingligand XP Xerodermapigmentosum
TRBP Telomererepeatbindingprotein XTT 2,3-bis(2-Methoxy-4-nitro-5-
TRPM Transientreceptorpotential sulphophenyl)-2H-tetrazolium
melastatin-related(ionchannels) 5-carboxyanilide
Trx Thioredoxin ZDF Zuckerdiabeticfat(rat)

--- Page 40 ---

A Sarcomere B C
SR
LD Mitochondrion
1
4
2
3
Cytoskeleton
Transient membrane
3D mitochondrial rupture during
reticular network mitochondrial isolation Uniform fragmented
around sarcomeres morphology
Plate1 SeeFigure1.8.

--- Page 41 ---

Plate2 SeeFigure2.13.

--- Page 42 ---

Plate3 SeeFigure3.3.
(a) (b)
(c) (d)
Plate4 SeeFigure3.4.

--- Page 43 ---

(a)
(b)
Plate5 SeeFigure3.6.
Plate6 SeeFigure3.7.

--- Page 44 ---

Plate7 SeeFigure3.11.
(a) (b)
His75 Phe153
water
Arg112
Asn148
TTrrpp118866
PPhhee115544 VVaall VV 11 aa 11 11 66 7744 haem
PPhhee115533
Arg365
Tyr358 Arg354
TTyyrr335588
Plate8 SeeFigure3.17.
A BEFORE STRETCH B AFTER STRETCH
Sarcolemma Sarcolemma
T-T p22 p47 p40 SR T-T p22 p47 p40 SR
gp91phox p67 gp91phox p67
rac1
rac1
VGCC VGCC
ROS RyR2 RyR2
Ca2+
Plate9 SeeFigure5.4.

--- Page 45 ---

((aa)) (b)
(c) (d)
(e) (f)
(g)
Plate10 SeeFigure6.7.

--- Page 46 ---

(a) (b)
YFP YFP /YFP
500 500 420
1-cell stage 3 days after fertilization Cut tail fin
HyPer mRNA
YFP
420
YFP YFP /YFP
500 500 420
(c) (d)
3 min after wounding
YFP
420
YFP YFP /YFP
500 500 420
YFP 420
(e)
gnidnuow
retfa
nim
3
gnidnuow
retfa
nim
71
gnidnuow
retfa
nim
16
8.0
0.5
3 min after
wounding
snarT
2DERsD
Distance from wound
margin (μm)
19 min after 35 min after 51 min after 67 min after 83 min after 99 min after
wounding wounding wounding wounding wounding wounding
0.5 3.5
oitar
rePyH
oitar
rePyH
oitar
rePyH
Average arrival of first
leukocyte (+ – s.d.)
5.5 7 17 min after wounding
61 min after wounding
4.5 5
3.5 3
2.5 1
3 23 43 63 0 100 200 300
Time after wounding (min)
Plate11 SeeFigure6.9.
Plate12 SeeFigure6.14.

--- Page 47 ---

(a) (b)
(c) (d)
Plate13 SeeFigure6.18.

--- Page 48 ---

(a)
(b)
Plate14 SeeFigure6.21.

--- Page 49 ---

(a)
(b)
(c)
(d)
0.5 10 20 30
Time (min)
% oxidized
0 50 100
Plate15 SeeFigure6.22.

--- Page 50 ---

Plate16 SeeFigure6.24.
Stroma
Lumen
Photosystem II
–1.6
–1 ps
–1.2
40–200 ps
15–200 ns
–0.8 200–500 ns 2 NADPH 10 ps < 1–125 μs –0.4 hv – 1ms
200 ps 2 NADP+ 0.0 100–600 μs 1 ms
1–20 ms 0.4 hv < 1 ms 200 μs
2 H 2 O50 μs–1.5 ms
0.8
O 2 20 ns–35 μs
+
4 H+
)stlov(
E m
2 HO 2
Cytochrome bf Photosystem I ATP synthase
6
1.2
1.6
mn
4
hv
hv
NADP+ CF 1
NADPH
LHCII 2 H+ 2 H+ FeS Fd
Q A Q B FNR
PQ
Pheo PQH 2 PQH 2 Cyt A 1
A P680 PQ 0
Y PQH 2 FeS
Z P700
Mn 4 Cyt f
PC
4 H+
FC 0
ATP 3 H+ ATP + P i
H+
3 H+
ICHL ICHL b 6
PC
4 H+
955b
tyC
Y
D
O 2
(a)
P
700*
A 0
Photosystem II A
1 F P 680° x F AB Fd Pheo Cyt bf FNR
6 Q Complex A Q B PQ
FeS Cyt f PC P 700
Photosystem I
Mn
4
Y
Z
P 680
(b)
Plate17 SeeFigure7.10.

--- Page 51 ---

Plate18 SeeFigure7.12.
Vessel Lumen
2 3 2 3 11
1 Draining
Lymph node
4
Ti
i
s
n
s
j
u
u
e ry 6 9
5 9
7
12
8 10
M1 M2 Mres
Productive phase Transition phase Resolving phase
- Production of inflammatory mediators (1) - PMN and monocyte recruitment (2,3) - M2 Mres transition (10)
- Vessel permeability - PMN and macrophage effector function (5) - Production of resolution mediators:-
- Vasodilation - PMN apoptosis (6) - ‘Find-me’ and ‘eat-me’ Lipoxins, resolvins, protections, IL-10 etc. by
- Blood flow signals on apoptotic PMN Mres (9)
- Oedema - Efferocytosis (7) - Lymphocyte repopulation (11)
- Beginning of leukocyte recruitment (2,3) - M1 M2 transition (8) - Macrophages apoptosis or lymphatic
- Monocytes Macrophages (4) - M2 production of anti-inflammatory drainage (12)
- PMN and macrophage effector function (5) molecules (IL-10 and TGF-β)
eussit
demaflnI
(c)
flux
Leukocyte
in
Plate19 SeeFigure8.9.

--- Page 52 ---

Plate20 SeeFigure8.10.

--- Page 53 ---

Airway epithelium (DUOX1/2, NOX2)
Beneficial role: Defence against infection
in airways and alveoli
Potential deleterious role: Mucus metaplasia,
chronic epithelial wound response and inflammation
Dendritic cells (NOX2)
Antigen processing, Airway smooth muscle (NOX4)
inflammasome signalling Beneficial role: Helps control pulmonary vessel tone
Potential deleterious role: Smooth muscle
hyperplasia, airway hyper-responsiveness
(e.g. in asthma)
Lymphocytes (NOX2, DUOX1)
Beneficial role: T and B cell signalling
and proliferation
Potential deleterious role:
Participation in chronic
inflammation Neutrophils/Eosinophils (NOX2)
Beneficial role: Pathogen killing,
regulation of apoptosis
Potential deleterious role: Pro-inflammatory
signalling, extracellular oxidative injury
Pulmonary fibroblasts (NOX4)
Beneficial role: Regulation of
proliferation and differentiation
Potential deleterious role: Fibrosis
Plate21 SeeFigure8.16.
Plate22 SeeFigure8.18.

--- Page 54 ---

(a)
Normal p53
Antioxidant ROS Prevention or repair
genes
p53 of mutations
No stress/mild
reversible damage
Normal cell growth
(b)
Normal p53
p53
p53
Elimination of cells
p53 Pro-oxidant ROS with mutations
genes
p53
Extended stress/
irreparable damage Cell death
(c)
Mutant p53
Accumulation
p53
of mutations
ROS
Tumorigenesis
Plate23 SeeFigure10.17.
Ubiquitin-activating enzyme (E1)
ATP
Monomeric Activated
ubiquitin ubiquitin
Ubiquitin carboxy-
terminal hydrolase
Ubiquitin-conjugating
(UCHL1 missense
enzyme (E2)
mutation causes
familial PD)
Polyubiquitin
chain Activated Abnormal/
damaged/mutant
ublquitin/E2
proteins
Short
( -synuclein
peptide
missense
fragments ATP
mutations cause
26S proteasome familial PD)
(inhibited in sporadic PD) Polyubiquitin-protein Ubiquitin ligase (E3)
conjugate (parkin deletions and point
mutations cause juvenile PD)
Plate24 SeeFigure10.30.

--- Page 55 ---

Plate25 SeeFigure11.3.
Plate26 SeeFigure11.4.

--- Page 56 ---

CHAPTER 1
Oxygen: boon yet bane—introducing
oxygen toxicity and reactive species
Oxygenhasbeenatrouble-makersincetheverybeginning.
DorisAbele1
1.1 Thehistoryofoxygen:anessential ledtoformationoftheozone(O )layerinthestrato-
3
airpollutant sphereanditremovedferrous(Fe2+)ironfromaqueous
environments, helping to prevent Fenton chemistry
The element oxygen (chemical symbol O) surrounds (Section2.4.4).Ferrousironwasabundantatthetime,
usasadiatomicmolecule,O 2 .1–5 Over99%oftheO 2 whichhelpstoexplainwhyorganismsuseditsomuch
in the atmosphere (about 3.7×109 moles in total!)2 (e.g.inFe-Sclusters)tocatalyseredoxreactions.When
is the isotope oxygen-16, but there are also traces O came, free Fe2+ posed a threat, as did the vul-
2
of oxygen-17 and oxygen-18 (see the Appendix for nerability of iron-containing enzymes to O and its
2
details). Except for some anaerobic and aerotolerant derivatives(Section3.9).Ironisthefourthmostabun-
species,allorganismsrequireO 2 forefficientproduc- dantelementontheEarth,andbyforminginsoluble,
tionofenergy,bytheuseofelectrontransportchains unreactive ferric complexes, most Fe2+ was precipi-
thatultimatelydonateelectronstoO 2 ,suchasthosein tatedfromsolution,leavingseawatertodaycontaining
themitochondriaofeukaryoticcellsandthecellmem- only trace amounts of soluble iron. The ability of O
3
branesofmanybacteria.ThisneedforO 2 obscuresthe andO 2 tofilteroutmuchoftheintensesolarultraviolet
factthatitisatoxic,mutagenicgasandaseriousfire (UV-C)radiationbombardingtheEarthhelpedliving
risk;aerobessurviveonlybecausetheyhaveevolved organismstoleavetheseaandcolonizetheland.
antioxidantdefences,whichareexploredinChapter3. YettheincreasingO posedproblems.Whenliving
2
Oxygen appeared in significant amounts in the organismsfirstappearedonEarth,theydidsounder
Earth’satmosphereover2.2billionyearsago(Figs1.1 anatmospherecontainingmuchN andCO ,butvery
2 2
and1.2),almostentirelyduetotheevolutionofphoto- littleO ,i.e.theywereanaerobes.Anaerobesstillexist
2
synthesisbycyanobacteria,ausingenergyfromthesun
today,butusuallytheirgrowthisinhibitedandoften
to split water. Thereby, they gained reducing power they are killed by exposure to 21% O , the current
2
(hydrogen atoms) to drive their metabolism, but the atmospheric level. As the O content of the atmos-
2
by-product, O 2 , was discarded into the atmosphere. phere rose, many such species must have died out.
Initially, most of this O 2 was consumed by the for- Present-day anaerobes are mostly the descendants of
mationofthemetaloxidedepositsthatexistinrocks organismsthatfollowedtheevolutionarypathof‘ad-
and ores today, and by other ‘O 2 sinks’ (Fig. 1.1).4,5 apting’ to rising atmospheric O 2 levels by restricting
OnlywhenthiswaslargelycompletedidO 2 buildup themselves to environments from which O 2 is absent
in the atmosphere. The rise in atmospheric O 2 was (Fig. 1.3). Other organisms instead began to develop
advantageoustolifeonEarthinatleasttwoways:it antioxidant defences (evolving new ones as well as
realigningancientmoleculestonewfunctions)topro-
a Cyanobacteria (previously called blue–green algae) are tectagainstO toxicity.Inretrospect,thiswasafruitful
2
prokaryotesthatcombineplant-typephotosynthesisandcyto-
path to follow. Organisms that tolerated O could
chromeoxidase-basedrespirationinthesamecell.Agoodre- 2
also evolve to use it for metabolic transformations
viewofhowpresent-daycyanobacteriaresistoxidativestress
maybefoundinref6. catalysed by oxidase, oxygenase, and hydroxylase
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 57 ---

2 FREE RADICALS IN BIOLOGY AND MEDICINE
Million
years ago
1800
Uranium reactors
First multicellular algae
Present day 1900
Rise in O to
2
about 5–18%
2000
of present
atmospheric 2100 Oxidized fossil soils
level deduced
First eukaryotic fossils?
from oxidized
2200
minerals and Global tectonic activity
sulphate-reducing 2300
bacteria
2400
2500
Rise in O
2
to about 1% 2600
of present
atmospheric 2700
level deduced
from sulphate- 2800
reducing bacteria
2900
3000
3100
3200
3300
3400
3500 Fossil stromatolites
Fossil photosynthetic bacteria
3600
3700
3800
Carbon signatures
3900 in Greenland rocks
sdeb-deR
snoitamrof
nori-dednaB
0
First eukaryotes with mitochondria?
500 Cambrian
explosion
1000 Snowball Earth
1500
2000
2500
3000
3500
4000
4500
Figure1.1 Geologicaltimelineexpandingthemid-Precambrianperiod(ArchaeanandearlyProterozoic).Notetheburstofevolutionaryactivityin
theperiod2.3to2billionyearsago,asoxygenlevelsrosetoabout5–18%ofpresentatmosphericlevels;inspiteofO2toxicity,itspresence
triggeredtherapidevolutionofan‘explosion’ofdifferentlifeforms.Oxygenmayhaveeliminatedmanyanaerobesbutitalsoprovidedthemeans
formulticellularorganismstoevolve.‘SnowballEarth’referstoaniceage.IthasbeensuggestedthattheriseinO2contributedtothisbyremoving
someofthe‘greenhousegas’methane(CH4)fromtheatmosphere,sopromotingglobalcooling.DiagramadaptedfromOxygen,theMoleculethat
MadetheWorld,OxfordUniversityPress,2002bycourtesyofDrNickLaneandOxfordUniversityPress.Itshouldbenotedthatthesetimelines
remainatopicofcontroversy.2,5

--- Page 58 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 3
Million
years ago
500
0 Present day
Cambrian explosion
Oxygenation of deep waters
O levels reach
2 Vendobionts and worms
500 100% of present
Cambrian
explosion atmospheric level Radiation of sulphur bacteria
600 First fossil metazoans
1000
Alternating isotope
Snowball Earth period
1500 patterns implying
3 worldwide glaciations
oxygenation of air
and surface waters
700
2000
2500
800
3000
First metazoans?
(deduced from molecular clocks)
3500
900
4000
4500
1000
Figure1.2 GeologicaltimelineexpandingthelatePrecambrianperiodandCambrianexplosion.DiagramadaptedfromOxygen,theMolecule
thatMadetheWorld,OxfordUniversityPress,2002bycourtesyofDrNickLaneandOxfordUniversityPress.Theexacttimelinesremainatopicof
controversy.2,5
enzymes, such as tyrosine hydroxylase, cytochromes Best of all, O could facilitate efficient energy pro-
2
P450, enzymes that demethylate DNA (essential for duction,employingelectrontransportchainswithO
2
epigenetic signalling), and the proline (often written as the terminal electron acceptor, the rudiments of
as prolyl) and lysine (lysyl) hydroxylases needed for whichmayalreadyhavebeenpresent,butmaybeus-
collagenbiosynthesisandO sensing.Inseveralcases, ingotherelectronacceptorssuchasNO–orNO–.3This
2 2 3
these O -requiring enzymes replaced less efficient switch to aerobic metabolism substantially increased
2
older enzymes that took oxygen atoms from H O.7 the yield of ATP that could be made from food mol-
2
In others (e.g. collagen hydroxylases and DNA de- ecules,suchasglucose.Mitochondria,awordarising
methylases),thebiochemistrywascompletelynovel. fromtheGreekwordsmitos(thread-like)andkhondros

--- Page 59 ---

4 FREE RADICALS IN BIOLOGY AND MEDICINE
First living organisms
Anaerobes
(very limited exposure to oxidative stress, e.g. H O in rainwater, trace levels (<<0.1%) of O in air)
2 2 2
Stress with oxygen at increasing levels
Evolve antioxidant Die Restrict to anaerobic
defences environments
Figure1.3 EvolutionaryadaptationstotheappearanceofO2.DevelopmentofantioxidantdefencesallowedevolutionofO2-usingenzymesand
electron-transportchains,enablingoxidationoffoodmaterialmoreefficiently.Aerobicrespirationproducesmoreenergyperunitmassoffood,
facilitatingthedevelopmentofcomplexmulticellularorganisms.ThebiggerorganismsthenhavetodevelopmechanismsfordeliveringO2atthe
rightleveltotheircells,sothatmanycellsareshieldedfromthefullbruntof21%O2;perhapsadrivingforcefortheevolutionofmulticellularity.
(granule), make 80% or more of the ATP needed by evidenceislacking)thatthepartofthephotosynthetic
almost all animal cells, and the lethal effects of in- systemthatsplitswater,photosystemII(Section7.8.2),
hibiting this, for example by cyanide, show how im- could have evolved from a manganese-containing
portantmitochondrianoware.Anothereffect,theuse formoftheenzymecatalase.2,3,10Iftrue,thencatalase-
of O -containing signalling molecules (e.g. nitric ox- like enzymes must have been present prior to a rise
2
ideandH O )becameincreasinglyimportantascells in atmospheric O levels. How can this be? Catalase
2 2 2
evolved and became compartmentalized, and when is specific for H O ; was H O present to drive its
2 2 2 2
multicellularityarose.8 evolution?Maybeitwas.
Evolutionofefficientenergyproductionallowedthe UnderanatmospheremainlycomposedofN and
2
developmentofcomplexmulticellularorganismswith CO withnoO screen,UVradiationmusthavebom-
2 3
increasedbodysize,9whichthenalsoneededsystems bardedthefaceoftheEarth.EvenatthelowO levels
2
toensurethatO couldbedistributedthroughoutthe present3.5billionyearsago(<0.1%),therecouldhave
2
organism (Fig. 1.3). A further advantage of evolving been substantial H O levels in rainwater generated
2 2
suchsystemsisthatdeliveryofO canbecontrolled; byphotochemicalreactionswithtracesofO .3Inadd-
2 2
most cells in the human body are never exposed to ition, it would have taken a substantial time to form
the full force of atmospheric O (Fig. 1.4). Mechan- the O layer when O began to rise. Iron was freely
2 3 2
ismsformonitoringO levelsinthebodyandaltering available then in a soluble form, Fe2+. Hence Fenton
2
respiration rate and blood flow to control O sup- chemistry (Section 2.4.4) was a threat, so H O must
2 2 2
ply are then needed. As multicellular organisms be- beeliminated.Onesuggestionisthattheevolutionary
camebigger,theyneededstructuralsupport:skeletons precursors of photosystem II used H O as a sub-
2 2
andconnectivetissue.Hencecollagenbiosynthesis(an strate,10 andonlylaterevolvedtheincreasedchemical
O -requiringprocess)cameintoprominence,sincecol- ferocityneededtosplitwater.Doremember,however,
2
lagenisamajorproteininconnectivetissueandbone. that decomposition of H O by catalase generates O
2 2 2
(Section3.17).
1.1.1 Theparadoxofphotosynthesis
1.1.2 Hyperoxiainhistory?
Since O is poisonous and photosynthetic organisms
2 OxygenisnowthecommonestelementintheEarth’s
exposethemselvestohighO levels,howwasitpos-
2 crust(atomicabundance53.8%)andis21%oftheat-
sible for cyanobacteria to evolve photosynthesis in a
mosphere. The barometric pressure of dry air at sea
‘pre-antioxidant’ world? Even in present-day plants,
levelis760mmmercury,bgivinganO partialpressure
much of the protein synthesis in illuminated chloro- 2
ofabout159mmHg.
plasts is used to repair the oxidative damage be-
ing done (Section 7.8.10). Were some antioxidants in
place already? It has been speculated (although hard b 1atmosphere=760mmHg=0.1013megapascals.

--- Page 60 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 5
Hyperoxia and
oxygen toxicity
O 2 Red blood cells (Hb 95% saturated)
100 Normal lung
capillaries
Aorta
90
80
Oxygen partial
Arterioles
pressure
(mmHg)
70
60 Oxygen diffusion to cells
Capillary maintaining intracellular oxygen
(Hb 70% saturated) pO 2 tension of ~1–20 mmHg (0.5 mmHg
in mitochondria)
50
40
Hypoxia with
loss of consciousness
30
Figure1.4 ApproximateO2concentrationsinthehumanbody.MostcellsareonlyexposedtofairlylowO2concentrations;thismayberegarded
asanantioxidantdefencemechanism,althoughitalsorendersaerobiccellsvulnerabletointerruptionsoftheO2transportmechanism.Thecornea
andrespiratorytractareobviousexceptions,buttheskinissomewhatshieldedbyitsouterlayerofdeadcells(Section7.13.1).Cellscirculatingin
theblood(excepterythrocytes)andcellsinthevesselwalls(especiallyvascularendothelium,whichhasahighmetabolicactivity)willconsume
someoftheO2unloadedfromhaemoglobin(Hb)beforeitdiffusesintothetissues.
Oxygen levels may have been even higher at peri- at lower O levels.11 The plants and animals existing
2
odsintheEarth’shistory.2InthemidtolateDevonian in Carboniferous times must presumably have had
period,O increasedfromabout18%to20%,butthen enhanced antioxidant defences, which would be fas-
2
rose sharply to ~30% by the late Carboniferous as cinating to study if they could be resurrected. High
plant life flourished, CO levels fell drastically, and O levelswouldalsobeexpectedtoincreasethenum-
2 2
huge deposits of coal and oil formed (Fig. 1.5). This ber and severity of wildfires, another contributor to
increased O concentration may have permitted in- evolution(Fig.1.5).
2
sects (whose O distribution system depends largely
2
on diffusion) to become larger.11 For example the gi-
1.1.3 Oxygeninsolution
ant Carboniferous dragonfly Meganeura monyi had a
wingspan of up to 75 cm and a thoracic diameter of Oxygen is also found dissolved in seas, lakes, rivers,
about 2.8 cm, compared with about 10 cm and 1 cm, and other bodies of water. The solubility of O in
2
respectively, for present-day dragonflies. Most of the sea water exposed to air at 10◦C is about 0.284 mil-
insectsthatattainedexceptionallylargebodysizesdur- limolar (mM), and decreases at higher temperatures
ingtheCarboniferousdidnotpersistafterthePermian, (e.g.0.212mMat25◦C),e.g.ArcticandAntarcticwa-
when O concentrations fell again, perhaps because tersdissolvemoreO thantemperatewaters.Oxygen
2 2
theycouldnotdevelopasufficientdistributionsystem ismoresolubleinfreshwater,e.g.indistilledwaterits

--- Page 61 ---

6 FREE RADICALS IN BIOLOGY AND MEDICINE
35
30
25
PAL
20
PAL
negyxo
%
edixoid
nobrac
%
(a) Oxygen
15
10
5
C O S D C P Tr J K T
(b) Carbon dioxide
0.5
0.4
0.3
0.2
0.1
C O S D C P Tr J K T
–600 –500 –400 –300 –200 –100 0
Time (mya)
Figure1.5 ChangesinO2andCO2duringtheEarth’shistory.(a)CalculatedpalaeoatmosphericO2concentrationshowingtheestimate(solid
line)anditsrange(dashedlines).BetweenthemidtolateDevonian(380–360millionyearsago(mya)),O2increasedfrom~18to20%,andthen
rosesharplyto30%ormorebylateCarboniferous(286mya),probablymainlyduetotheevolutionoflargelandplantswithhighphotosynthetic
activity.Thepresentatmosphericlevel(PAL)of21%isindicated.OxygensteadilydeclinedthroughoutthePermian(286–250mya)anddroppedto
about15%bytheendofthePalaeozoic(250mya),causingmanyspecies‘adapted’tohighO2todieout(Science308,398,2005;ref11).This
dropinO2seemstoberelatedtodecreasesinthenumbersofforests,perhapsduetoaridity,fires,andsomelossofwetlands(Geochim.
Cosmochim.Acta69,3211,2005).(b)PalaeozoicatmosphericCO2model.Thisgaswaspresentinrelativelylargeamountsinthe
Ordovician–Silurian,fellprecipitouslyduringtheDevonian–Carboniferous,andincreasedinthelatePermian.Theminimumvalueshownforthelate
CarboniferousandearlyPermianapproximatespresentCO2levels(about0.036%;dottedline).DatafromNature375,118,1995,bycourtesy
ofDrJ.B.Grahamandhiscolleaguesandthepublishers.Notethattheexacttimingsofthesechangesremainasubjectofcontroversy.2,5
solubilityis0.258mMat25◦Cand0.355mMat10◦C.c so one way of diminishing O toxicity has been to
2
The O concentration experienced by cells within a decrease the concentration to which cells within the
2
multicellularorganismwilldependonhowfartheO bodyareexposed(Fig.1.4).Withinmostoralleukary-
2
hastomovetoreachthem,aswellasonhowquickly oticcells,thereisanO gradient,decreasinginconcen-
2
itisconsumedbythemandothercellsaroundthem. tration from the cell membrane to the O -consuming
2
MitochondrialrespirationcanfunctionwellatlowO , mitochondria(Fig.1.4).
2
However,O ismuchmoresolubleinorganicsolv-
2
ents than in water (about tenfold for hydrocarbon
c For a detailed discussion of O2 solubility, see Geochim.
solvents and even greater for fluorocarbons), a point
Cosmochim.Acta74,5631,2010.

--- Page 62 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 7
to consider when exploring oxidative damage to the Even so-called ‘strict anaerobes’ display a spectrum
hydrophobic interior of biological membranes (Sec- of O tolerance. Some are killed by a brief exposure
2
tion 5.11). One practical consequence of this is the toO whereasforothers,O inhibitsgrowthbutdoes
2 2
inability of some plastic culture vessels to maintain not kill. Sometimes the induction of antioxidant de-
anoxiainlaboratoryexperiments;O canpassthrough fences (Section 3.7.4), including antioxidant enzymes
2
manytypesofplastic.12 Arelatedphenomenonoften orFe2+-bindingproteins,isinvolvedinsuchtolerance,
overlooked,antioxidantsandotherchemicalscanleach e.g.inB.fragilis18andDesulphovibriovulgaris.19
fromplastictubes,syringes,dishes,andpipesandthus Many terrestrial and aquatic environments have a
confuse experimental results.13,14 However, the obvi- sufficiently low O concentration to harbour anaer-
2
ous biological advantage is that O readily diffuses obes. For example, in the human mouth, anaerobes
2
across membranes, an essential ability as internally canbeculturedfrompocketsinthegums,fromdecay-
compartmentalized eukaryotic cells and multicellular ingteeth,andfromthedeeperlayersofdentalplaque
organismsevolved. (e.g. T. denticola); whereas less strict anaerobes and
microaerophiles are found in the superficial layers of
plaque.16 The human colon (over 90% of faecal bac-
1.2 Oxygenandanaerobes
teriaareanaerobes),rottingmaterial,pollutedwaters,
AsO levelsroseintheatmosphere,livingorganisms thedeeplayersofsoilandoftheocean,andgangren-
2
begantoexperienceO toxicity:oxidationsofkeymol- ouswoundsallprovidenichesforanaerobestothrive.
2
eculesessentialtotheorganismwhichhaltedgrowth Bacterial biofilms (Section 1.10.8) provide a range of
and were in some cases lethal. This created pressure O 2 levels,withlevelsoftenverylowdeepwithinthe
to evolve protective mechanisms and/or to retreat to biofilm.
anoxicenvironments(Fig.1.3).
Theterm‘anaerobicorganism’coversawiderange
1.2.1 Whydoesoxygeninjureanaerobes?
of biological variation.2,15–19 There are ‘strict’ anaer-
obes,suchasthebacteriaTreponemadenticola,Prevotella The damaging effects of O on anaerobes are, in es-
2
melaninogenica, and several Clostridium spp., that will sence, due to oxidation of essential cellular compo-
grow only if O is absent (or at least as absent as nents.17,19,20 Byoxidizingsuchessentialbiomolecules
2
it can ever be; it is almost impossible to eliminate it as thiols, iron–sulphur clusters in enzymes, and re-
completelyinthelaboratory).Indeed,thetreatmentof duced pteridines, O can halt metabolism. These ox-
2
gangreneduetoClostridiuminfectionsbyexposingpa- idations often simultaneously reduce O to oxygen
2
tientstopureO atpressureshigherthanatmospheric freeradicals(e.g.superoxide,Section2.5.3)andother
2
(hyperbaric oxygen (HBO) therapy) is in part based toxic‘reactiveoxygenspecies’(ROS;Table2.2).Some
onthesensitivityofClostridiumspp.toO .Hyperbaric enzymesinanaerobesareinhibiteddirectlybyO ,al-
2 2
treatment is not without problems, however (Section thoughmoreoftenenzymeinactivationisduetoROS.
1.5.2). The so-called strict anaerobe Bacteroides fragilis BecauseO isitselfaradical,itreactsrapidlywithother
2
even seems to benefit from nanomolar (10–9M) levels radicals(Section1.8).Certainenzymesessentialtoan-
of O , and has been called a nanaerobe, although it aerobic metabolism (such as pyruvate–formate lyase
2
cannot grow at higher O levels.18 The difficulty in andribonucleotidereductasetypeIII;Sections8.2and
2
maintainingverylowO levelsinthelaboratorysug- 8.3) use glycyl radicals as catalytic intermediates,
2
gests that much early work on the O tolerance of and these are rapidly destroyed by O . Others need
2 2
bacteria needs re-evaluation. One must also consider [Fe-S] clusters, also attackable (often by superoxide,
thatdeathordamagecansometimesbecausedbycyto- Section 3.9). The nitrogen-fixing nitrogenase enzyme
toxic oxidation products of molecules in the growth ofClostridiumpasteurianumisinactivatedbyoxidation
media(Section1.11),ratherthandirectactionofO on ofessentialcomponentsatitsactivesite.Nitrogenase
2
theorganismbeingstudied. catalyses reduction of atmospheric N to ammonia
2
‘Moderate’anaerobescangrowunderatmospheres (NH ), and is essential for growth in environments
3
containinguptoabout10%O (e.g.Clostridiumnovyi poorinnitrogencompounds.Indeed,mostknownni-
2
Type A), whereas microaerophiles, such as Campylo- trogenaseenzymesareinactivatedbyO .Surprisingly,
2
bacterjejuni(amajorcauseofdiarrhoeainhumans)and perhaps,notallN -fixingspeciesarestrictanaerobes,
2
Treponema pallidum (the causative agent of syphilis), andtheyusevariouswaystocopewiththisproblem
require some O for growth but cannot tolerate 21%. (Section3.4.1).
2

--- Page 63 ---

8 FREE RADICALS IN BIOLOGY AND MEDICINE
Studyinganaerobesrevealsalotabouttheevolution Theheartandmanyothermuscles(theso-called‘red
of antioxidant defences, hence we return to them in muscles’) contain myoglobin. This contains a single
Chapter3. polypeptidechain(bearingonehaem),whosestructure
resemblesthatofthehaemoglobinsubunits.Myoglo-
binappearstoactasastoreofO intissues:itbindsO
2 2
1.3 Oxygenandaerobes
moretightlythanhaemoglobinandonlyreleasesitif
O levelsbecomeabnormallylow,e.g.lackofmyoglo-
1.3.1 Oxygentransportinmammals 2
bin impairs cardiac function in mice.21 A monomeric
Complex multicellular organisms, such as mammals, neuroglobin22 found in severalorgans, includingthe
have evolved mechanisms to ensure that O is de- eye (Section 7.10.1) and the brain (Section 10.17.6.1),
2
livered to all cells that need it. Some O travels dis- isthoughttohelpprotecttheseorgansagainstfallsin
2
solved in blood plasma, but the solubility of O 2 in intracellular pO 2 . Cytoglobins, found in the nucleus
water at body temperature is limited (Section 1.1.3). andcytoplasmofseveralmammaliancelltypes,may
Most O in mammalian blood is carried by haemo- play a similar role.22 All of these proteins may also
2
globin. This protein has four subunits: two α-chains participateinnitricoxidemetabolism(Sections2.5.6.5
andtwoβ-chains.Eachcarriesahaemgroup(Fig.1.6) and2.5.6.6).
withironintheFe2+ state.TheO reversiblyattaches Haem is made not only by animals, but also by
2
to haem, binding at high O concentrations as blood manybacteria,includingsomeanaerobes.Indeed,the
2
flowsthroughthelungsanddissociatingagainatthe existence of a wide range of types of haemoglobin
lowerO levelsintissues(Fig.1.4). in bacteria suggests that these proteins evolved for
2
manyroles,andtheO -transportfunctionmayinfact
2
Fe2++O 2 (cid:2)Fe2+–O 2 bearecenteventinevolution.Forexample,bacterial
flavohaemoglobins can oxidize NO• to nitrate, NO–,
3
Only the ferrous form (Fe2+) of haemoglobin can at the same time, consuming O and protecting the
2
bindO 2 .HaemoglobinalsohelpstocontrolthepHof bacteria23againsthighlevelsofnitricoxide.Twosteps
bodyfluids. in the haem biosynthetic pathway, catalysed by the
enzymescoproporphyrinogenoxidaseandprotopor-
phyrinogenoxidase,useO ineukaryotes(Fig.2.12),
2
COO– COO– butotherelectronacceptorsinanaerobicbacteria(Sec-
tion 8.2.3).24 The anaerobic bacterium Porphyromonas
CH 2 CH 2 gingivalis,involvedinthedevelopmentofperiodontal
CH 2 H CH 2 diseaseinhumans,useshaeminadifferentway.Itre-
C C C quires haem for growth (e.g. as a cofactor for certain
H 3 C C C C C CH 3 enzymes),butalsoconvertsitintoadarkpigmentthat
appears to be able to bind O and act as an ‘oxidant
2
C N N C buffer’,protectingtheorganismburieddeepinthegin-
HC Fe CH givalpocketsagainsttransientrisesinO 2 .Thepigment
canalsocatalyseH O degradation.25
C N N C 2 2
H C
2 C C C C C CH 3 1.3.2 Oxygensensing26
H C C C
CH 3 H C Multicellular organisms respiring with O 2 (as almost
H CH 2 allofthemdo,barafewmetazoansinthedeeplayers
oftheocean)3 mustactquicklyatthewholeorganism
Figure1.6 Thestructureofhaem.Theporphyrinringcontainsfour (e.g. to increase respiration rates) and cellular levels
pyrroleunitslinkedbymethene(–CH=)bridges.Haemgives iftheO supplyfaltersandhypoxia(abnormallylow
2
haemoglobinandmyoglobintheirdistinctivereddish-browncolour.
O concentration) results. For example, humans have
InhaemoglobinandmyoglobintheFe2+ isco-ordinatedtothefour 2
evolved complex circulatory, respiratory, and neuro-
nitrogensintheprotoporphyrinIXring.Italsoligandstoahistidine
endocrine systems that aim to keep organ O levels
residuefromtheprotein,andO2formsthesixthligandinthe 2
oxy-proteins.Haemin,theoxidized,Fe(III),formofhaem,isinvolved approximatelyconstant.Thecarotidbodiesthatsense
inregulationofgeneexpressionincertaincells(Pharm.Ther.111, O 2 inthecarotidarteries,andtheneuroepithelialbod-
327,2006;J.Biol.Chem.288,13194,2013). iesthatdetectO intherespiratorytract,playkeyroles
2

--- Page 64 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 9
in regulating breathing and heart rate to control O cancer development (Section 10.14.4.4) and HIF-2α is
2
supply.TheO sensorinthecarotidbodyisgenerally involved in the regulation of intestinal iron uptake
2
thoughttoinvolvetheenzymehaemoxygenase(Sec- (Section3.22.5.2).
tion 3.24) although roles for oxygen-derived species SinceprolinehydroxylaseisFe-dependent,itcanbe
have also been proposed, whereas that in the neuro- inhibitedbyironchelators,whichcanthussometimes
epithelialcellsystemmayinvolveanNADPHoxidase exert a ‘hypoxia-like’ effect (Section 11.6.1). Cobalt
that produces superoxide radical (Section 8.10.6).27 (Co2+)ionscanalso‘mimichypoxia’bydisplacingthe
Activationofthecarotidbodiessendsnerveimpulses iron to generate an inactive enzyme (Section 9.16.5).
tothebrain’srespiratorycentretoincreasebreathing. Inaddition,therearesuggestionsthatincellsexposed
Inhypoxia,cellsshifttheirmetabolism,breakingdown to acute hypoxia, production of H O by mitochon-
2 2
glycogen (if present) and/or taking in more glucose, driamayhelptostabilizeHIF-1αlevels,28althoughthe
and thus accelerating glycolysis (Fig. 1.7). Energy is mechanismofthisisunclear(seealsoSection5.5.5).
temporarily reallocated, RNA and protein synthesis
ratesbeingdecreasedtospareATPformoreessential
1.3.3 Mitochondrialelectrontransport
processes,suchasmaintainingiongradients.
Ifhypoxiapersiststhecellsmustadapt,andthehyp- MitochondriaarethemajorsourceofATPinanimals,
oxiainduciblefactors(HIFs),especiallyHIF-1,playa non-photosynthetic plant tissues, and leaves in the
key role. HIFs are transcription factors that promote dark, and they use more than 80% of the O 2 that we
expression of genes encoding proteins that both help breathein.TheyalsoplaykeyrolesinCa2+ handling
the cell to adapt to low O and act on the organism and cell death mechanisms (Sections 5.3.2 and 5.4),
2
toimprovetheO supply.Theseproteinsincludeglu- among other processes. We know a great deal about
2
cosetransporterstocarrymoreglucoseintothecells, them, although studies on isolated mitochondria can
vascular endothelial growth factor (VEGF) to pro- be misleading: mitochondria in vivo form a complex
moteangiogenesis(thegrowthofnewbloodvessels), inter-linkednetworkwithconstantfissionandfusion;
and erythropoietin, a hormone required for eryth- each ‘mitochondrion’ exists for only a short time be-
ropoiesis,theformationofnewredbloodcells.Others forere-fusingwithothersorsplittingupintosmaller
includetransferrin,transferrinreceptors,andcaerulo- mitochondria.Fusioncanhelptomitigatedamageby
plasmin, proteins involved in iron delivery to cells mixing the contents of damaged mitochondria with
(Section3.22.1). fresh ones. Isolation artificially separates organelles
TheHIFsareheterodimersofαandβsubunits;three from this network and can change their properties
types of each exist (1–α;2-α;3-α;1-β;2-β;3-β). Cells (Fig.1.8).29,30Damagedmitochondriacanberemoved
maintainapproximatelyconstantlevelsofHIF-1β.Al- in vivo by autophagy (Section 5.14.3); fission creates
though HIF-1α subunits are produced, they are de- newmitochondriaandintheprocessmayclusterthe
graded rapidly by the ubiquitin-proteasome system damage into those mitochondria that are selected for
(Section 5.14.3) at normal O levels. Degradation is autophagy.
2
promoted by the hydroxylation of proline residues Metabolic energy production is simple in essence
in HIF-1α by prolyl hydroxylase enzymes which re- (butnotindetail!):foodmaterialsareoxidized,losing
semble those involved in collagen biosynthesis (Sec- electrons that are captured by electron carriers. The
tions 1.4 and 4.2). When O is limited the enzymes most important carriers are nicotinamide adenine
2
cannotwork,theprolinesremainunmolested,andthe dinucleotide (NAD+) and flavins (flavin mononuc-
HIF-1α is not degraded, allowing complete HIF-1 to leotide, FMN, and flavin adenine dinucleotide,
assemble, bind to DNA, and promote transcription. FAD). The resulting reduced nicotinamide adenine
As usual in life it’s a bit more complicated; vari- dinucleotide (NADH) and reduced flavins (FMNH 2
ous growth factors and cytokines also act to stabilize and FADH 2 ) (Fig. 1.7) are reoxidized by O 2 in mito-
HIF-1α, and phosphorylation is involved in the ulti- chondria,producinglargeamountsofATP.Oxidation
mate activation of HIF-1 to a functional transcription is catalysed in several steps to release the energy
factor. Also, transcription of the gene encoding HIF- gradually. This is achieved by the electron transport
1αincreasesinhypoxia.AnO -dependentasparagine chainintheinnermitochondrialmembrane(Fig.1.8).
2
hydroxylaseenzymeprovidesasecond‘O -checking’ ElectronspassfromNADHtonon-haemironproteins,
2
step: if the enzyme is active, hydroxylation of which accept the electrons by converting their iron
asparagine residues prevents HIF-1α from working fromFe(III)toFe2+.Theypassontheelectronsbyreox-
as a transcription factor. The HIFs are implicated in idizing to Fe(III). Later in the chain, the cytochromes

--- Page 65 ---

10 FREE RADICALS IN BIOLOGY AND MEDICINE
Glucose Fatty acids
NAD+ NADH NAD+ NADH
Glyceraldehyde–3–
phosphate dehydrogenase
Flavin flavin
ox red
NAD+
Pyruvate dehydrogenase
lactate pyruvate
CH 3 CHOHCOO– CH 3 COCOO– acetyl coenzyme A
NADH Some amino
acids
oxaloacetate
NAD+ NADH
malate citrate
Aconitase
Fumarase
isocitrate
fumarate
Isocitrate dehydrogenase
NAD+ NADH
flavin Flavin
ox red
CO
Succinyl α 2
succinate -ketoglutarate
coenzyme A
α
-ketoglutarate
dehydrogenase
Figure1.7 Theessenceofaerobicmetabolisminhigherplantsandanimals:theKrebscycleanditsinputs.Enzymesthatarepotentialtargetsof
oxidativedamageandinactivationaredenotedby*.Henceoxygen-derivedspeciescanimpairmitochondrialmetabolism.Bycontrast,lowlevelsof
H2O2caninactivatepyruvatedehydrogenasekinase2,leadingtoincreasedpyruvatedehydrogenaseactivity(J.Biol.Chem.287,35153,2012).
AminoacidsoftengeneratevariousintermediatesoftheKrebscycleinsteadof,orinadditionto,acetylcoenzymeA.Glyceraldehyde-3-
phosphatedehydrogenase(G3PDH)isanessentialenzymeinglycolysis,thepathwayconvertingglucosetopyruvate.Glycolysisgeneratestwo
ATPmoleculesperglucoseandisstimulatedbyHIFs(Section1.3.2).ThecofactorNAD+acceptstwoelectrons.
NAD++H++2e–(cid:2)NADH
Cellscontain‘pools’ofNAD+andNADH;theratiooftheirconcentrationsisonefactorregulatingtheactivityofNAD+-utilisingenzymes.Theactive
partofNAD+isderivedfromtheB-vitaminnicotinamide.Flavoproteinscontainderivativesofthevitaminriboflavin,eitherFMNorFAD.They
alsoaccepttwoelectrons.
FMN+2e–+2H+(cid:2)FMNH2
(FAD) (FADH2)
FMNorFADareusuallyattachedtotheactivesitesoftheenzymesthatusethem,andnotfreeasapool.MostenzymesintheKrebscycleuse
NAD+asanelectronacceptor,butoneenzymeinfattyacidmetabolismandtheKrebscycleenzymesuccinatedehydrogenase,areflavoproteins.
succinate+FAD(cid:2)fumarate+FADH2
IfO2isabsent,glycolysisstopsatpyruvate,whichisreducedtoL-lactatetoregenerateNAD+,bylactatedehydrogenase(LDH),
CH3COCOO–+NADH+H+ (cid:2)CH3CHOHCOO–+NAD+
andonlytwoATPcanbemadeperglucose.WhenO2isrestored,LDHcatalysesthereversereactionandnormalmetabolismresumes.Lacticacid
accumulationcausesacidosis,abnormallylowpH.α-Ketoglutarateisoftencalled2-oxoglutarate.BoththisandpyruvatecanreactwithH2O2
(Section3.25.2).

--- Page 66 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 11
Sarcomere
A B C
SR
LD Mitochondrion
1
4
2
3
Cytoskeleton
3D mitochondrial Transient membrane
reticular network rupture during Uniform fragmented
around sarcomeres mitochondrial isolation morphology
D
NADH 2e–NADH—
coenzyme Q
NAD+ reductase
O
C
O H 3 CO CH 3
E H CO
N 3 R
Z O
Oxidized Q
Y CH
M 1e– 1H+ 3
E O where R is (CH CH C CH ) H
2 210
Q CH
H CO 3
P 3
O H 3 CO R
O O
L Partially reduced (semiquinone)
1e– 1H+
OH
CH
H CO 3
3
H CO
3 R
OH
Fully reduced (CoQH )
2
CoQH—cytochrome c
2
reductase
Cytochrome c
Cytochrome
oxidase
O 2H O (per 4e– taken in)
2 2

--- Page 67 ---

12 FREE RADICALS IN BIOLOGY AND MEDICINE
(cid:3)
Figure1.8 (colourplate1)Mitochondrialisolationfragmentsmitochondriaandaltersmitochondrialfunction:anexamplefrom
muscle.(A)Mitochondriainmuscleinvivoexistinacomplexthree-dimensionalnetworkarrangementaroundsarcomeres.Inaddition,
mitochondriainteractwiththesarcoplasmicreticulum(SR),lipiddroplets(LD),andcytoskeleton.(B)Duringmitochondrialisolation,muscleis
homogenized,whichseparatesmitochondriaandrupturesmitochondrialmembranes.Thistransientruptureofmitochondrialmembraneshas
severaleffects:(1)itallowssolublemitochondrialmoleculestoescape,therebydilutingmatrixmetabolitesnecessaryformetabolicpathwayssuch
astheKrebscycle,oxidativephosphorylation,orantioxidantdefence(e.g.GSH);(2)itcausesdisruptionoftheinnermitochondrialmembraneand
thestructuralintegrityofitssupramolecularcomplexes;(3)itallowssolublemoleculesfromthehomogenizationmediumtoenterthemitochondria;
(4)itallowswaterinthemediumtoenterthematrixcausingswellinganddilutionofmatrixconstituents;and(5)itdisruptsinteractionsbetween
mitochondria,SR,LDs,andcytoskeleton.(C)Theendresultofmitochondrialisolationisarelativelyhomogeneouspopulationofspherical
organelleswithswollenmorphology,disorganizedcristae,anddilutedmatrixcontent.Together,theseeffectsresultinalteredfunctional
characteristicsofisolatedmitochondria,e.g.whencomparedwithintactmitochondriafrompermeabilizedmyofibres.TakenfromJ.Physiol589,
4413,2011bycourtesyofDrR.T.Heppleandhiscolleagues,andthepublishers.Themitochondrialmatrixcontainsmanyenzymes,includingthose
oftheKrebscycle(Fig.1.7),andthosethatbreakdownfattyacidstoacetylcoenzymeA.(D)Asimplifiedversionoftheelectrontransportchain.
Asitoperates,NADHisoxidizedtoNAD+bythemultienzymecomplexNADH–coenzymeQreductase(sometimescalledNADH
dehydrogenaseorcomplexI)andthetwoelectronsreleasedareeventuallypassedontocoenzymeQ(ubiquinone).Thenumberof‘repeats’
inthecoenzymeQsidechainisvariable;itismostoftenteninhumans(CoQ10,showninthefigure),butitisnine(CoQ9)inratsandtheworm
C.elegans,andeight(CoQ8)inE.coli(Section11.3.1).TheNADH–coenzymeQcomplexcontainsflavoproteins(FMNatactivesite)and
non-haem-ironproteins(ironionsarepresentbutnotinhaem).CoenzymeQcanacceptoneelectrontoformasemiquinone(freeradical)or
twotoformafullyreduced(ubiquinol)form.Rrepresentsthesidechain.CoenzymeQalsoacceptselectronsfromreducedflavoproteins
generatedbytheKrebscycle(succinatedehydrogenase)andβ-oxidationoffattyacids.Theenzymedihydrooroticaciddehydrogenase,which
catalysesastepinpyrimidinesynthesis,alsofeedselectronsintotheelectrontransportchainatseveralpointsintheregionofCoQ(FreeRadic.
Biol.Med.72,149,2014).TheassemblyofproteinstransferringelectronsfromsuccinatetoCoQiscalledcomplexIIandelectronsarefedinfrom
theFADH2generatedbysuccinatedehydrogenase(Fig.1.7).FromQtheelectronspassthroughanothermultiproteincomplex(coenzyme
Q–cytochromecreductaseorcomplexIII,whichcontainsaniron–sulphurproteinpluscytochromesbandc1),andontocytochromec.
CytochromesarehaemproteinsthatreversiblyacceptsingleelectronsbyallowingFe(III)atthecentreofthehaemringtobereducedtoFe2+,
cytochrome–Fe(III)+e–(cid:2)cytochrome–Fe2+
Differentcytochromes,designatedbysmallletters,containdifferentproteinsanddifferenthaemgroups.Finally,reducedcytochromecisreoxidized
byamultienzymecomplex,cytochromecoxidase(complexIV)whichcontainscytochromea,cytochromea3,andcopperionsembeddedinits
proteins.ForeveryfourelectronstakeninbycomplexIV,oneO2moleculeisreducedtotwomoleculesofwater.Theelectrontransportchainisa
gradientofreductionpotential(Section2.3);aselectronstravelthroughtheelectrontransportchain,protonsaretakenfromthemitochondrial
matrixanddeliveredtotheinter-membranespace,creatingapHdifferenceplusachargedifference(anelectrochemicalgradient)acrossthe
innermitochondrialmembrane.TheenergyofthisgradientisusedbyanATPsynthaseenzyme(complexV)togenerateATP(oxidative
phosphorylation).ATPistransferredacrosstheinnermembraneinexchangeforADPbyanadeninenucleotidetranslocaseprotein,andthus
madeavailabletotherestofthecell.LikecertainKrebscycleenzymes(Fig.1.7)thistranslocasecanbeatargetofoxidativedamage
(Section11.4.2.1).
Theoutermitochondrialmembraneismorepermeabletometabolitesthantheinnermembrane,whichhasveryrestrictedpermeabilitydueto
theneedtomaintaintheelectrochemicalgradient.However,theinnermembraneisnottotallyimpermeabletoprotons(Fig.1.9,legend);thereisa
protonleak.Thisinvolvesleakageofprotonsthroughtheadeninenucleotidetranslocatoraswellasuncouplingproteins(Section1.10.6).
workin thesameway,exceptthattheirironionsare partiallyreducedoxygenspeciesaredamagingandso
presentinhaem(Fig.1.8,legend). cytochromeoxidasemustkeepthemsafelybounduntil
The segment of the electron transport chain that theycanbefullyreducedtowater.31 Thefourredox-
uses O is the terminal oxidase, cytochrome oxidase. active metal centres (Cu , Cu , haem a, haem a ) in
2 A b 3
It removes one electron from each of four reduced cytochromeoxidaseplaykeyrolesinbothO reduction
2
(Fe2+–haem) cytochrome c molecules, oxidizing them andsafebinding.Mammaliancytochromeoxidasehas
toferriccytochromec.Itaddsthefourelectronsonto ahighaffinityforO :itstillworksatO levelsofless
2 2
O ;theoverallreactionis than 1 mmHg. Hence ATP production by mitochon-
2
driacancontinueatlowO levels.Thisabilityisvery
2
O +4H++4e–→2H O important—cellsdeepwithinatissuemayexperience
2 2
O levelsofonly5to15mmHg,andO stillhastocross
2 2
However,itisimpossibletoaddfourelectronstoO thecelltoreachmitochondria(Fig.1.4).
2
at once—it must be done in stages (Sections 1.8 and The sequestration of partially reduced species by
2.3.1).Cytochromeoxidaseisalargeandcomplexmul- cytochrome oxidase and the continued operation of
tiproteinassembly,inpartbecauseitcatalysesseveral mitochondria at low intracellular pO 2 can be inter-
reductionsteps.Anotherreasonforcomplexityisthat pretedasattemptstominimizedamagebyO 2 ,i.e.as

--- Page 68 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 13
ORGANS HOW THE WHERE HEAT
USING ATP IS USED COMES FROM
OXYGEN
Liver
Stomach
and gut
Na+, K+-ATPase Oxidative
phosphorylation
and
Brain Protein proton leak
synthesis
Muscle (varies Myosin ATPase
with activity) (varies with
muscle activity)
Heart
Calcium-
ATPase
Kidney
Substrate cycling
Lung Na+, K+-ATPase
Other Na+, K+-leak
Other Other
Figure1.9 Energyutilizationinrestingadulthumans.Indicatedwithineachcolumnaretheapproximaterelativecontributionsto(fromleftto
right):O2utilizationbyvariousorgans;thecontributionofvariouscellularprocessestoATPutilization;theprocessescontributingtoheat
production.Theinnermitochondrialmembraneisnotcompletelyimpermeabletoprotons,sothatsomeleakback.Thisisamajorcontributortothe
body’sheatproduction.Ifmitochondriaaresubjectedtoseverestress(e.g.highlevelsofoxygen-derivedspeciesandCa2+),poresopenintheinner
membrane,makingitsuddenlypermeabletolowmolecularmassbiomolecules,includingH+.Asaresult,ATPproductionfalls,andthematrix
swells.Thisso-calledmitochondrialpermeabilitytransition(MPT)canbeblockedbythedrugcyclosporin(Section5.3.2.3).Thepore
openingleadingtotheMPTusuallyinvolvesarearrangementofproteinsinthemitochondria(includingtheadeninenucleotidetranslocase,the
cyclophilinDprotein,andthevoltage-dependentaniontransporter(VDAC),sometimescalledporin,intheoutermembrane)tocreatea
non-specific‘pore’acrossthemembranes,althoughMPTcanstilloccurinmicelackingthetranslocatororVDAC,i.e.otherproteinscansubstitute
forthemandevencyclophilinImaynotbeessential.MPTcauseslossofmembranepotential,swellingofthemitochondria,increasedsuperoxide
radicalproduction,andsometimesruptureoftheoutermembraneandthereleaseofmolecules(e.g.cytochromec;Section5.4.2)tothecytosol.
FullactivationofMPToftenplaysakeyroleincelldeathinducedbyO2deprivationandinapoptosis(Section5.4.2).Sometimesporesopen
partiallyandtransientlyandtheoxygen-derivedspeciesproducedmayhavesignallingroles,e.g.inischaemia-reperfusion(Section10.6.6).Adapted
fromTheBiochemist,April2000issue,bycourtesyofDrGuyBrownandtheUKBiochemicalSociety.Formorerecentreviews,seeAntioxid.Redox
Signal.18,556,2013andBiochim.Biophys.Acta1817,2072,2012.
antioxidant defences. Mitochondria are also a major engulfment, the cell wall was eventually lost, and
sourceofheat,helpingtomaintainbodytemperature exchange transporter systems (such as the adenine
inmammals(Fig.1.9). nucleotide translocase, legend of Fig. 1.8) evolved to
swapmetabolites,sothatthecellcoulddeliveroxidiz-
ablesubstratestotheprokaryotesandcollecttheATP
1.3.4 Theevolutionofmitochondria
theyproduced.Therewasatransferofgenes,sothat
It is still widely believed that mitochondria evolved now the great majority of mitochondrial proteins are
following the engulfment of an early prokaryote encoded in the nuclear genome rather than in mito-
by precursors of eukaryotic cells.3,30,32 Studies of chondrial DNA, and the mitochondria are perman-
superoxidedismutases(Section3.5.4)andcardiolipins ently enslaved. Hence mitochondrial protein import
(Section 5.11.2) are consistent with this view. After mechanisms also had to evolve, as had mechanisms

--- Page 69 ---

14 FREE RADICALS IN BIOLOGY AND MEDICINE
tocoordinatetheexpressionofnuclearandmitochon- electron acceptors.17,20,24 Thus in anaerobic E. coli, a
drialgenomes(Section5.5.5). fumaratereductasesystemdonateselectronstofumar-
What was the advantage to the eukaryotic cells of atetogivesuccinate,nitratereductasesreducenitrate
the engulfment, prior to the evolution of metabol- (NO–) to nitrite (NO–), and sulphoxide reductases
3 2
ite transport systems? Perhaps some metabolites just workonsulphoxides,suchasdimethylsulphoxide.For
leakedoutwithoutspecifictransporters.Anothersug- example,E.coliinthecolonmaymetabolizeNO– and
2
gestionisthatthecapacityoftheseearlyprokaryotes NO– (Section 10.12). If no electron acceptor is avail-
3
forconsumingO andreducingittowaterconstituted able,E.coliswitchestofermentationasa(lessefficient)
2
an early antioxidant defence mechanism for primi- sourceofenergy.
tiveeukaryoticcells.Thishypothesisislosingfavour: InthepresenceofO ,E.colioxidizessubstratessuch
2
possessing mitochondria may increase O
•–
and H O as glucose by various metabolic pathways, including
2 2 2
production(Section1.10.4),especiallybeforetheaden- the Krebs cycle (Fig. 1.7), and electrons are fed into
inenucleotidetranslocaseevolvedtodeliverADPand anelectrontransportchaincontainingquinones,b-type
preventover-reductionoftheelectrontransportchain cytochromes, and cytochrome oxidases, either cyto-
(Section 1.10.4). Some early eukaryotes then went on chrome bo or cytochrome bd type oxidases.17 The
tolosefunctionalmitochondria,e.g.astheyadaptedto former(unlikemammaliancytochromeoxidase)have
environmentswithlowO levels.3 a low affinity for O (K ~200nM) but a high max-
2 2 m
imumvelocity;theycouldservetoconsumeO rapidly
2
when O is abundant (another antioxidant defence
1.3.5 Nicotinamidenucleotidereduction 2
perhaps?).AtlowerO levelscytochromebdoxidase,
2
Mitochondriacontainanicotinamidenucleotidetran- with a much greater affinity (K
m
~3–8nM) for O
2
, is
shydrogenase33 (NNT) in the inner mitochondrial used. The oxygen level regulates both the rate and
membrane,associatedwithcomplexI.Itcatalysesthe (viavarioustranscriptionfactors)theamountofthese
reversible reduction ofd NADP+, coupled to proton twocytochromeoxidases,whicharefoundinawide
movement rangeofbacteria.WhenO 2 islow,forexample,levels
ofcytochromebofall,whereasthoseofbdrise.
NADH+NADP+(cid:2)NADPH+NAD+
andproductionofNADPHisfavouredatnormalpro-
tongradients.ItappearstoplaysomeroleinNADPH
1.4 Oxidasesandoxygenasesinaerobes
generation to aid mitochondrial antioxidant defence
(Section 3.10.2.1), and perhaps in regulation of elec- The small fraction of O taken up by aerobic eu-
2
trontransporttominimizesuperoxidegeneration(Sec- karyotes that is not used in mitochondria is mostly
tion10.5.2).MicelackingNNTactivityshowimpaired consumed by oxidase and oxygenase enzymes. For
insulin and cortisol production (Section 10.5.2), and example,D-aminoacidoxidaseusesO
2
tooxidizeun-
some humans with familial glucocorticoid deficiency wantedD-aminoacids,andxanthineoxidaseoxidizes
(araredisorderinwhichtheadrenalglandsaredefi- xanthine and hypoxanthine into uric acid (Fig 1.10).
cientincortisolproduction)havemutationsinthegene During collagen synthesis, proline and lysine hy-
encodingNNT.Thedecreasedhormonesecretionmay droxylasesuseO toadd–OHgroupsontoprolineand
2
beduetoexcessproductionofoxygen-derivedspecies lysine residues. Like the proline hydroxylase acting
intheadrenalglands.33 on HIF-1α (Section 1.3.2), collagen proline and lysine
hydroxylases require ascorbate and α-ketoglutarate
as cofactors. Synthesis of the hormones epinephrine
1.3.6 Bacterialelectrontransportchains
(adrenalin) and norepinephrine (noradrenalin) be-
Many bacteria, such as Salmonella typhimurium and gins with addition of an –OH group to the amino
Escherichiacoli,cangrowunderbothaerobicandanaer- acidtyrosinebyanO
2
-requiringtyrosinehydroxylase
obic conditions. E. coli, like many bacteria, can adapt enzyme.
its respiratory chain to work with different terminal In general, oxidases and oxygenases have much
loweraffinityforO thancytochromeoxidase.Hence
2
theyareoftenO -limitedintheiractionatnormalcel-
d NADP+ is NAD+ with one extra phosphate group. 2
It undergoes reduction and oxidation in the same way. lular O 2 concentrations and their activities can thus
NADP++2e–+H+ (cid:2)NADPH. increaseifO
2
levelsrise.34

--- Page 70 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 15
O O O
HN N O 2 HN N O 2 HN NH
O
N NH O N NH O N NH
H H
hypoxanthine xanthine uric acid
OH O
HN xanthine HN
N N
oxidase
N NH O N NH
H
allopurinol
oxypurinol
(4-hydroxypyrazo[3,4-d]
(4,6-dihydroxypyrazo[3,4-d]
pyrimidine)
pyrimidine)
(H 3 C) 3 C O (H 3 C) 2 C H O
S
NC N NC
COOH COOH
N N
Y-700 TEI-6720 CH 3
Figure1.10 Xanthineoxidase(XO)catalysesoxidationofhypoxanthinetoxanthineandontouricacidwhilstreducingO2tobothsuperoxide
(O •
2
–)andH2O2.TheratioofO •
2
–toH2O2producedvarieswithreactionconditions,especiallyO2level;higherO2levelsfavourO •
2
–production
whereasH2O2isthemajorproductatlowerO2levels(FreeRadic.Biol.Med.48,493,2010).XOalsoactsonmanyothersubstrates,including
acetaldehyde(ethanal,CH3CHO).Allopurinolstructurallyresemblesxanthineandisapowerfulinhibitor.ItisoxidizedbyXOtooxypurinol,
whichbindstightlytotheactivesiteandcausestheinhibition.Indeed,oxypurinolisthemajormetaboliteofallopurinolinhumans.Hence
allopurinolhasbeencalleda‘suicidesubstrate’ofXO.Allopurinoliswidelyusedinclinicalmedicinetoinhibituricacidaccumulation,inthe
treatmentofgout.MorepowerfulinhibitorsofXOareY-700(J.Pharm.Exp.Ther.311,519,2004)andTEl-6720(2-(3-cyano-4-isobutoxyphenyl)-
4-methyl-5-thiazolecarboxylicacid.Thelatterisusedclinicallyasfebuxostat(BMCMusculoskelet.Dis.9,13,2012).CommercialXOisoftenused
asalaboratorysourceofO
•–,e.g.inassaysofSOD.Thecommercialenzymeisoftenobtainedfromcream,andthepurificationprocessemployed
2
bysomemanufacturersinvolvestheuseofproteolyticenzymestofreetheoxidasefromthemilkfatglobulemembranes.Sometimesthese
proteasesarestillpresentinthefinalpreparationandcancausebiologicaleffectsthatcanbemistakenlyattributedtoO
•–(e.g.Circ.Res.78,
2
1016,1996;Arch.Biochem.Biophys.426,11,2004).PhospholipasesmayalsocontaminatecommercialXOpreparations,andchelatingagents
suchasEDTAareoftenpresent.Ifcontaminatingironionsarepresentinthereactionmixture(astheyusuallyare),Fe-EDTAcanconvertO
•–and
2
H2O2toOH•(Section2.5.3.4;Table6.3).MicelackingXDHdieyoung,mostlyofkidneydamage(Hypertension54,868,2009).
1.4.1 CytochromesP450 xenobiotics,steroids,certainfat-solublevitamins,ara-
chidonicacid,eicosanoids,andretinoicacid(Table1.1).
The endoplasmic reticulum (ER) and most other or- Other substrates for CYPs include insecticides such
ganelles(includingmitochondria)ofanimalandplant as heptachlor and aldrin, and hydrocarbons such as
tissues contain cytochromes, known collectively as benzopyrene(Section10.15.1).SomeCYPsplayspecific
cytochromes P450.35 Fifty-seven genes encoding the metabolicroles,butmosthavebroadsubstratespecifi-
cytochrome P450 (often abbreviated to CYP) super- cityandcandealwithxenobioticscommonlyfoundin
familyhavebeendescribedinthehumangenometo dietsrichinplants(dietswidelyconsumedbyouran-
date. The name P450 was given because the reduced cestors),suchasterpenes,stilbenes,andalkaloids.This
forms of CYPs bind carbon monoxide, generating an broadspecificityofCYPshastakenonanewaspectin
adductthatabsorbslightstronglyat450nm. recentyearsastheycandealwiththeincreasingnum-
Cytochromes P450 are involved in the metabolism bers of drugs and environmental pollutants to which
of drugs (e.g. amphetamine, paracetamol) and other we are exposed. Liver ER is especially rich in CYPs,

--- Page 71 ---

16 FREE RADICALS IN BIOLOGY AND MEDICINE
Table1.1 AfewofthemanyformsofcytochromeP450foundinhumans.
Family Examples Examples Examplesofinducers Representativesubstrates
ofsubfamilies ofisoenzymes
CYP1(polycyclicaromatic CYP1A CYP1A1(arylhydrocarbon 3-methylcholanthrene,TCDD 7-ethoxyresorufin,benzopyrene,
hydrocarbon-inducible) hydroxylase) (Section9.3.2) benzanthracene
CYP2(phenobarbital CYP2B CYP2B1 phenobarbital,aroclor olefins,acetylenes,
family) dimethylbenzanthracene,
benzphetamine
CYP2E CYP2E1 phenobarbital,ethanol,ether, dimethylbenzanthracene,
acetone,dimethylsulphoxide ethanol,otheralcohols,toluene,
xylenes,chlorzoxazone(a
musclerelaxant)
CYP3(steroid-inducible) CYP3A CYP3A4 rifampicin methadone,oestradiol,
testosterone
CYP4 CYP4A clofibrateandsomeother prostaglandins,fattyacids
peroxisomeproliferators
(Section10.15.2.1)
OtherfamiliesincludeCYP11(mitochondrialproteins;steroidmetabolism),CYP17(steroid17α-hydroxylase),CYP21(steroid21-hydroxylase),CYP19(aromatase),and
CYP46,involvedinbraincholesterolmetabolism(Section10.17.5).ThetypesofP450presentvarybetweendifferentorganisms,tissuesandcellsandcanbeaffected
bychangesingeneexpressioninducedbythepresenceofCYPsubstrates.CYP3A4inhumanliverandintestinecanbeupto50%oftotalP450activitypresent.Each
CYPfamily(identifiedbasedonaminoacidsequencesimilaritiesanddenotedbyanumber)isdividedintosubfamilies(denotedbyacapitalletter)andthemembersof
eachsubfamilyareidentifiedbynumbers.Membersofafamilyareatleast40%identicalinsequence;thosewith55%ormorehomologybelongtothesamesubfamily
(Phil.Trans.RSoc.Lond.BBiol.Sci.368,20120431,2013andref35).
dealing with compounds absorbed by the GI tract as products that are less toxic and more readily metab-
bloodfromitpassesthroughtheliver. olized and excreted, but in a few cases the oxidation
The CYPs catalyse oxidation of substrates by O . productsaremoredamagingthanthestartingmaterial
2
One oxygen atom enters the substrate and the other (e.g.Sections9.2,9.10,and10.15).
forms water, such a reaction being known as mono- In liver, the electrons required by CYPs come
oxygenase ormixed function oxidase reaction. A re- from NADPH, via the enzyme NADPH–cytochrome
ducingagent(RH )isneeded,andtheoverallreaction P450reductase,whichcontainsFMNandFAD.Bycon-
2
canusuallyberepresentedbythefollowingequation, trast, adrenal cortex mitochondria contain a CYP in-
whereSHisthesubstrate(Fig.1.11), volved in the hydroxylation of cholesterol to give
the adrenal steroid hormones (e.g. aldosterone, hy-
SH+O +RH →SOH+R+H O drocortisone,andcorticosterone);thisenzymereceives
2 2 2
electronsfromanon-haem-ironprotein,adrenodoxin.
TheCYPsarehaemproteinscontainingasinglepoly- AflavoproteinenzymetransferselectronsfromNADH
peptidechain;fourligandstotheironareprovidedby toadrenodoxin.
the haem and a fifth as a thiolate anion (S–) from a
cysteineresidue.Inthe‘resting’enzymes,thesixthlig-
andiswater.Figure1.11showsacommonlyaccepted
1.5 Oxygentoxicityinaerobes
mechanism for substrate hydroxylation by CYPs, but
theexactchemicalnatureofthehydroxylatingspecies
1.5.1 Bacteria,plants,insects,andalligators
attheactivesiteisstilldebated.36
Feeding their substrates to animals often increases In spite of its many advantages, even 21% O dam-
2
thelevelsofCYPs.Onesuchinduceristhebarbiturate ages aerobes, as scientists realized when they began
phenobarbital, hydroxylation of which increases its tomeasureoxidativedamageinaerobesunderambi-
solubilityandaidsitsexcretionfromthebody.Exces- entO ,andfoundsignificantlevels(Chapters5and6).
2
siveintakeofethanolbymammalsincreasessynthesis More usually, O toxicity has been studied as the ef-
2
of CYP2E1, the ethanol-inducible cytochrome P450 fectsofexposingorganismstoelevatedO .Oxygenat
2
(Section9.8.1.1).UsuallyCYPsoxidizexenobioticsinto levels above 21% has been known for decades to be

--- Page 72 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 17
OH SH SH
2
FeIII + SH FeIII + e– FeII
–H O
2
SCys SCys SCys
+ O
+ H O –SOH(oxidized 2
2
substrate
H release)
SO SH O SH
O
FeIII
FeII A1
FeIII + O
2
(cid:129)–
A3
SCys SCys
SCys
+e– H 2 O 2
2
OH O– SH A3
SH SH SH
O O O
FeIV(cid:129)+ +H+ FeIII +H+ FeIII FeII + O 2 (cid:129)–
–H 2 O A2 SCys
SCys SCys SCys
B
H O
2 2
Figure1.11 AgeneralizedP450cycleincluding‘abortive’oxygenreduction.Thesubstrate(SH)bindstotheFe(III)stateofaCYP,displacingH2O.
Oneelectronreduction(e.g.byNADPH–cytochromeP450reductaseinliver)convertstheirontoFe2+,andO2binds.ThisFe2+-O2orferric-
s
F
u
e(
p
II
e
I
r
)-
o
O
xi
O
d
2
e
–
s
,
p
w
e
h
ci
i
e
c
s
h
c
p
a
r
n
ot
o
o
c
n
c
a
a
t
s
e
i
s
on
to
al
F
ly
e(
‘
I
l
I
e
I
a
)-
k
O
’
O
O
H
•
2 .
–
T
a
h
n
is
d
c
r
a
e
n
ge
s
n
o
e
m
ra
e
t
t
e
im
P
e
4
s
5
b
0
re
(p
a
a
k
th
d
w
ow
ay
n
A
to
1)
r
.
e
M
le
o
as
re
e
u
H
s
2
u
O
a
2
lly
(
,
p
a
at
s
h
e
w
co
a
n
y
d
B)
r
,
ed
a
u
ls
c
o
ti
p
o
r
n
od
st
u
e
c
p
ed
ge
b
n
y
e
d
ra
is
t
m
es
u
a
ta
f
t
e
io
rr
n
ic
o
p
f
e
O
ro
• 2
x
–
y,
(
F
p
e
a
O
t
3
h
+
w
,
a
F
y
e
s
(
A
V)
1,
=
A
O
2,
,
A
or
3)(cid:2).
F
P
e
r
(
o
IV
to
)
n
=
at
O
io(cid:3)n
•+
fo
.
l
I
l
t
o
i
w
s
e
li
d
ke
b
ly
y
t
l
o
os
b
s
e
o
a
f
n
w
F
a
e
te
(I
r
V
f
)
ro
o
m
xop
Fe
o
O
rp
O
h
H
yri
g
n
e
r
n
a
e
d
r
i
a
c
t
a
e
l
s
c
a
a
n
tio
o
n
x
,
o
r
-
e
h
s
a
e
e
m
m
b
s
li
p
n
e
g
ci
t
e
h
s
a
,
t
v
i
a
n
ri
p
o
e
u
r
s
o
ly
xi
w
da
r
s
it
e
te
c
n
om
in
p
d
o
if
u
f
n
e
d
re
I
ntpapersas
(Section3.19.3).Forthemajorityofsubstrates,thispowerfullyoxidizingspeciesabstractshydrogenfromSH,generatingasubstrateradicalwhich
immediatelyrecombinesinanoxygenreboundwiththehaem-boundreactiveoxygenspecies.Theoxidizedsubstrate(SOH)isreleasedandthe
cyclerepeats.Bycontrast,theferric-superoxidecomplexseemspoorlyreactive.36AdaptedwithpermissionfromChem.Res.Toxicol.,14,611,
2001,bycourtesyofProfessorFPGuengerichand36bycourtesyofDrSasonShaik.Copyright2001and2011AmericanChemicalSociety
respectively.Seealso,Science,330,924,2010.
toxictoplants,animals,andbacteria.Theextentofthe Plots of the logarithm of survival time against the
damagedependsonO concentration,exposuretime, logarithm of O partial pressure show inverse rela-
2 2
andthespeciesexamined.37–39 Indeed,studiesofbac- tionshipsformanyspecies,includingprotozoa,mice,
terial chemotaxis to O (aerotaxis) show that several rats, rabbits, fish, and insects.38 Of course, these are
2
strains swim away from regions of high O concen- short-termexperiments,e.g.insectsdidadapttohyper-
2
trationandtendtosettleinregionsofoptimal‘redox oxia during evolution and increased their body size
state’fortheirgrowth.ThenematodeC.elegans,much (Section 1.1.2), and this can be mimicked in the la-
usedinresearchintoageing(Section11.3.1)andapop- boratory by rearing Drosophila at high O over sev-
2
tosis, lives in soil, where O levels can vary sharply. eralgenerations.41Astudyonembryonicdevelopment
2
ItavoidsO levelsoutsidetherange5to12%.Athigher oftheAmericanalligatorAlligatormississippiensis,ex-
2
levels,thewormsclusterandfeedtogether;atoptimal posed to O levels from 16 to 35% (based on those
2
O levelstheyareloners.Perhapstheclusterconsumes seen during evolution; Section 1.1.2), showed posi-
2
O faster,protectingthewormsinthemiddle.40 tiveeffectsofO onbodysize,developmentrate,and
2 2

--- Page 73 ---

18 FREE RADICALS IN BIOLOGY AND MEDICINE
bone composition at up to about 27% O , beyond
2
which O toxicity began to predominate.39 Plants are
2
damagedatelevatedO —thereisinhibitionofchloro-
2
plastdevelopment,decreaseinseedviabilityandroot
growth,membranedamage,shrivelling,andshedding
of leaves.37 Photosynthetic plant tissues have a par-
ticularproblem,sincetheyproduceO duringphoto-
2
synthesis(Section7.8).Onestudyrevealedthatraising
thesurroundingO levelfrom21to35%decreasedthe
2
growthrateofallplantsexamined,butthe‘evolution-
arily older’ groups of plants that evolved during the
Carboniferous period (e.g. ferns, ginkgo, and cycads)
faredbetterthanthosethatevolvedmorerecently.42Is
thisbecausetheyarebetterprotected,havingevolved
duringaneraofelevatedO (Section1.1.2)? 2
Figure 1.12 shows a bacterial example of O tox- 2
icity: exposure of E. coli to high pressure O causes 2
6.0
4.0
2.0
14C valine
added
1.0
HPO
0.2
0 60 120 180
Time (minutes)
)
(C41
sa
,llec
rep
)7–01x(
selucelom(
noitaroprocni
enilaV
)λmn005(
ecnabrosba
erutluC
rapid growth inhibition. This is temporarily reversed
byaddingcertainaminoacids(e.g.valine)tothecul-
turemedium,indicatingthatonedeleteriouseffectof
excessO istointerferewiththeirsynthesis.However,
2
growth soon ceases again due to problems in other
metabolicpathways(Fig.1.12,legend).
1.5.2 Mammals
The toxicity of O to animals occurs constantly and
2
contributes to disease development and possibly to
ageing(Chapters10and11).38,43More-acuteO toxicity
2
canbeseenindiving,underwaterswimming,thecare
of premature babies, and in the use of hyperbaric O
2
therapy(HBO).HBOhasbeenusedinthetreatmentof
somecancers(combinedwithradiation),badlyhealing
wounds(e.g.diabeticulcers),infectionsbyanaerobes,
and (experimentally) to treat multiple sclerosis. Rises
intheO partialpressuretowhichanorganismissub-
2
jected can result from an increase in the percentage
of O in the air and/or from an increase in the total 2
pressure,asindivingatdepth.Oneinterestingaction
of HBO is to mobilize stem cells from the bone mar-
rowintothecirculation,whichmightcontributetoits
(alleged)beneficialeffects.44
High-pressureO (≥3atm)cancauseacutelungand
2
central nervous system toxicity in animals (including
humans), producing convulsions. The lung damage
may,inpart,becausedbysignalsfromthebrainthat
leadtoexcessivepressureinlungbloodvessels.45Oxy-
genat1atmdoesnotdothis,butinspiredO levelsof
2
360mmHgormoregraduallydamagethelungs.For
example,adultratsshowseverelungdamageafter72h
of exposure to 100% O and often die within 4 to
2
7days.38 Even28%O for1hincreaseslipidperoxid-
2
ationintherespiratorytract(Section7.3.2).Exposure
of humans to pure O at 1 atm for as little as 6 h
2
leadsinsomesubjectstochestsoreness,cough,anda
sorethroat;24hexposureusuallydamagesthealveoli.
Lunginjuryisfirstmanifestedasoedema,mainlydue
to damage to the capillary/interstitial barrier, allow-
ing proteins to leak from the blood plasma into the
Figure1.12 InhibitionofthegrowthofE.colibyexposureto interstitialspace.Thisoccursbecauseendothelialcells
h g i l g u h co -p se re , s a s n u d re a O m 2 in ( o HP a O ci ) d . s T ( h n e o g v r a o l w in t e h ) m at e 3 d 7 iu ◦ m C. w A a t s t m he in p e o ra in l t sa m lt a s r , ked lining the capillaries are injured by elevated O 2 . Fur-
therO exposurecausesthedeathofalveolarepithelial
2
HPO,theatmospherewaschangedfromairto80%O2at5atmtotal
cells,andthepenetrationofprotein-richfluidintothe
pressure.Whenvalinewasadded,growthwasrestored.Closed
alveoli,interferingwithgasexchange.46
symbols:HPOexperiment;opensymbols:normalaircontrol.Growth
The lung is an important target of O toxicity, one
soonceasesagain,however,becauseofdamagetootherenzymes,for 2
examplequinolinatesynthetase,anenzymeinvolvedinthe reasonbeingitsexposuretohigherO 2 levelsthanother
biosynthesisofNAD(P)+;Arch.Biochem.Biophys.284,106,1991. body tissues (Fig. 1.4). The epithelium lining the al-
FromBrownandYein,Biochem.Biophys.Res.Commun.(1978)85, veoli is a monolayer containing thin so-called type I
1219,bycourtesyoftheauthorsandAcademicPress. cells and the more cuboidal type II cells. The latter

--- Page 74 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 19
secretesurfactant,anagentthatlowerssurfacetension to ameliorate the severity of ROP, but the extent of
and permits the alveoli to function. Type I cells have the benefit is uncertain,49,50 and debate continues as
evolvedtoaiddiffusionofgasfromalveolitotheblood towhetherrecombinanthumansuperoxidedismutase
capillariessurroundingthem:theirsurfaceareaislarge hasanyvalue(Section7.11.8.3).
andtypeIcellscovermostofthealveolarsurface.Type WhatgoeswronginROP?Asimilarsyndromeisob-
I cells are more easily damaged/killed by excess O servedinnewbornrats,rabbits,andkittensexposedto
2
(andbymanyothertoxins)thanaretypeIIcells;after elevatedO .ThenormalretinaalreadyexperiencesO
2 2
reversible injury, type II cells usually proliferate and levelshigherthanmostbodytissues,at40–60mmHg
differentiateintotype1cells.However,typeIIcellscan (Section7.10).ApplicationofexcessO appearstoin-
2
alsobeinjuredbyexcessO ,e.g.surfactantproduction hibitthegrowthofretinalbloodvessels.Onreturnto
2
canbedecreased.Lungdamagecaneventuallyresult air, the resulting hypoxia induces retinal cells to se-
inthelayingdownofinelasticfibrousmaterialinthe crete angiogenic agents (especially VEGF) that cause
lung(fibrosis),permanentlyimpairinggasexchange. excessive regrowth of blood capillaries, which some-
Reactiveoxygenspeciesareofteninvolvedinfibrosis times occurs to an extent that causes detachment of
(Section5.2.1).Oxygenmayalsoworsenlungdamage theretinaandsubsequentblindness.Thenewvessels
causedbyothermeans,evenatconcentrationsthought lack structural integrity and often bleed. Hyperoxia
tobe‘safe’,i.e.ifthelungsarealreadyinjured,elevated can also damage the brains of premature babies, po-
O canaggravatetheinjury.Ironically,briefperiodsof tentiallyleadingtocognitive,behavioural,andmotor
2
exposuretohyperbaricO canrenderthelungsofani- defects(Section7.11.8.2).
2
malsmoreresistanttodamagebyprolongedhyperoxia
(Section10.18.3). 1.5.2.2 Resuscitationofnewborns
1.5.2.1 Retinopathyofprematurity Resuscitationofnon-breathingnewbornbabiesisoften
andbraindamage done using pure O 2 . However, this has been ques-
tioned: use of room air may be equally effective and
Tissues other than lung are also damaged by hyper-
causelesslipidperoxidation.50 Similarly,thevalueof
oxia. High O levels can cause a general ‘stress reac-
2 O (rather than air) administration to patients with
tion’inanimals,whichstimulateshormoneproduction 2
acutemyocardialinfarctionhasbeenquestioned.51
by some endocrine glands.38,46 Removal of the thy-
roid gland or the testicles decreases the pulmonary
1.5.2.3 Factorsaffectingoxygentoxicity
andothertoxiceffectsofO insomeanimals,whereas
2
administrationofthyroxine,testosterone,cortisone,or The damaging effects of O on aerobes vary with
2
adrenalin can worsen O toxicity.38,47,48 Exposure of the species used, its sex (e.g. female rodents are of-
2
pregnantanimalstoelevatedO hasbeenreportedto ten less sensitive to O toxicity; Section 3.26), genetic
2 2
increasetheriskoffoetalabnormalities.38 background,age,physiologicalstate,temperature(es-
The condition originally called retrolental fibro- peciallyincold-bloodedspecies),anddiet.38 Different
plasia(fromtheLatinfor‘formationoffibroustissue tissues and different cells within tissues (e.g. type I
behindthelens’),butnowmoreusuallycalledretinop- versus type II cells in the lung; Section 1.5.2) can be
athyofprematurity(ROP),appearedintheearly1940s affected differently. For example, buoyancy in many
among human infants born prematurely, and quickly fishisregulatedbytheswimbladder,whichisfilled
became widespread. Premature babies have not yet mainlywithO ,plussomeN andCO .Withincreas-
2 2 2
completed development of their antioxidant defence ingpressureathigherdepths,manyfishkeeptheswim
systems, and so are unprepared to tolerate even 21% bladdervolumeconstantbyincreasingitsO content,
2
O , let alone higher levels (Section 7.11.8). Not until oftenupto90%ofthetotalgas.TheO partialpressure
2 2
1954 was it accepted that ROP is associated with the intheswimbladderofdeep-seafishcanbehundreds
use of high O in incubators for premature babies,49 oftimesgreaterthanambient,yetthebladderremains
2
and careful control of O use (continuous monitor- undamaged.52Thefishasawholecannottoleratesuch
2
ing, with supplemental O given only when needed O levels,andsoitsswimbladder(andthegasgland
2 2
to maintain blood pO ) has decreased the severity of responsible for filling it with O ) must somehow be
2 2
ROP. Sadly, the problem has not vanished, since the protected. Cold-blooded animals, such as turtles and
mostprematurebabies(birthweightsof1000gorless) crocodiles,arefairlyresistanttoO toxicityatlowen-
2
needhighO levelsinordertosurvive.50Administra- vironmentaltemperatures,butbecomemoresensitive
2
tionofα-tocopherolhasbeenreportedinsomestudies at higher temperatures. Newborn rats appear more

--- Page 75 ---

20 FREE RADICALS IN BIOLOGY AND MEDICINE
resistant to O than adult rats, but begin to lose this withO
•–togeneratethecytotoxicspeciesperoxynitrite
2 2
advantagewhenabout30daysold.38 (Section2.6.1).58Thelungdamagecausedbyexposure
Whataboutdiet?TheamountsofvitaminsA,E,and ofanimalstoelevatedO atnormalpressuresalsoin-
2
C, zinc, iron, copper, synthetic antioxidants (now ad- volvesfreeradicals,bothgeneratedinthelungitself(in
dedtomanyanimalandhumanfoods),andthelipid partbyO
•–-producingNADPHoxidaseenzymes;Fig.
2
composition (e.g. the percentage of saturated versus 8.16),andproducedbyphagocytesthatarerecruitedto
polyunsaturated fatty acid residues) can all make a thesiteofinjury.60,61Micelackingendothelialnitricox-
difference.Inrecentyears,increasedamountsofanti- idesynthase(Section2.5.6.4)werelesssensitivetoROP
oxidants such as α-tocopherol have been added to andaroleforperoxynitriteincausingretinaldamage
the diets of laboratory animals, sometimes making it hasbeenproposed.59IncreasedactivityofNADPHoxi-
difficulttorepeatobservationsintheolderliterature.53 daseenzymesagain seemstobeinvolved,e.g.inthe
excess VEGF production (Section 8.10). Indeed, mice
lackingtheantioxidantenzymeglutathioneperoxidase
1.6 Whatcausesthetoxiceffects were more prone to O 2 -induced retinal damage (Sec-
tion3.14.4).Themobilizationofstemcellsinducedby
ofoxygen?
HBO also seems to involve44 NO•. Increased oxida-
An early suggestion was that O directly inhibits es- tiveDNAdamagehasbeenobservedinlymphocytes
2
sential enzymes.54 Indeed it can, as we have seen for inhumanssubjectedtoHBO.Thisdamageisquickly
nitrogenaseandglycylradicalenzymes(Section1.2.1).
repaired,however,soitsimportanceisunclear.62
Another example comes from plants, where O in-
2
hibits the first enzyme in the metabolic pathway of
photosyntheticCO fixation(Section7.8.3).37 1.7 Sofreeradicalscontributetooxygen
2
However, most enzymes in aerobes are unaffected toxicityandoxygenisoneofthem?What
by O , and for those that are, the rates of direct in-
2 thenarefreeradicals?
activation by O are often too slow to account for
2
O toxicity. In a seminal paper in 1954, Rebecca Ger- Tofollowthissection,thereadermustunderstandsuch
2
shman and Dan Gilbert drew a parallel between the terms as ‘Pauli principle’, ‘atomic orbital’, ‘antibond-
effects of O and of ionizing radiation, and proposed ing molecular orbital’, ‘spin quantum number’, and
2
that most of the damaging effects of O are due to ‘Hund’srule’.Wehaveprovidedanappendixifhelp
2
oxygenradicals.43Indeed,valinesynthesisinE.coliex- is needed. Although we focus this section on oxygen
posedtohyperbaricO (Fig.1.11)isimpaired,because freeradicals,manyothertypesoffreeradicalexist,as
2
theenzymedihydroxyaciddehydratase,requiredfor discussedinChapter2.
valine production, is inactivated. The enzyme is not Thereareseveraldefinitionsof‘freeradical’,aswell
directly inhibited by O , but rather by oxygen rad- as debates about whether the word ‘free’ is super-
2
icals such as superoxide.20 However, the distinction fluous. The authors use a simple definition: a free
is blurred because O itself is a radical! (Section 1.8). radical is any species capable of independent ex-
2
Other enzymes inactivated by superoxide (O
•–)
in istence (hence the term ‘free’) that contains one or
2
E.coliexposedtohigh-pressureO includetheKrebs moreunpairedelectrons.Anunpairedelectronisone
2
cycleenzymesaconitaseandfumarase(Fig.1.7).E.coli thatoccupiesanatomicormolecularorbitalbyitself.
contains three fumarases: fumarases A and B are in- Asuperscriptdotafterthechemicalformulaisusedto
activatedbyO
•–
whereasfumaraseCisnot.Levelsof denoteafreeradical.Perhapsthesimplestfreeradical
2
fumarase C increase when E. coli is exposed to oxi- isatomichydrogen,H•.Ahydrogenatomhasonlyone
dizing conditions, perhaps as a ‘replacement’ for the electron,whichmustthereforebeunpaired.Onemight
O
•–-sensitivefumarasesAandB.55
Aconitasecanalso arguethatthehydratedelectron(Section2.3.3.1)isan
2
beanimportanttargetofdamagebyO
•–
inmamma- evensimplerfreeradical!
2
liantissuesexposedtohyperoxia.56 Anotherexample, Thepresenceofoneormoreunpairedelectronsusu-
DNA damage by oxygen radicals leads to mutations ally causes free radicals to be attracted slightly to a
inthestrictanaerobePrevotellamelaninogenicawhenit magneticfield(i.e.tobeparamagnetic),andsometimes
encountersO .57 makesthemhighlyreactive,althoughthechemicalre-
2
The neurological effects of HBO may also involve activityofradicalsvarieswidely.Italsoenablestheir
oxygen radical formation.58 Nitric oxide plays a role, detectionbythetechniqueofelectronspinresonance
since inhibition of its formation delays the onset of (Section 6.2). Many free radicals exist in living sys-
convulsions in animals. Nitric oxide may be reacting tems,althoughmostmoleculesinvivoarenon-radicals.

--- Page 76 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 21
Radicalscanbeformedbylosingasingleelectronfrom generatefreeradicalsbymechanicaldamagetocova-
anon-radical,leavingbehindanunpairedelectronand lentbonds,mostlyinthecollagenthatispresent.65The
apositivecharge processoffreeze-drying(lyophilization)cangenerate
radicalscapableofdamagingmanybiomolecules,and
X–e–→X •+(radicalcation)
this is a serious problem in the manufacture of pro-
teinsandpeptidesforclinicalorlaboratoryuseandin
orbygainingasingleelectron
thestorageofmeat,poultry,orfish.Biomoleculescan
Y+e–→Y •–(radicalanion) bedirectlydamagedbyradicals,and/orby-products
generatedfromradicalattackuponmolecules(usually
Radicalsarealsoformedifacovalentbondisbroken carbohydrates), added to proteins to ‘stabilize’ them
to leave one electron from the bonding pair on each during the lyophilization procedure.66 For example,
atom, a process known as homolytic fission.63 The the killing of yeast cells by freeze–thawing seems to
energy required to break covalent bonds can be pro- involveO •–(Section1.10.4).
2
vided by heat, ultraviolet light, or ionizing radiation, IfAandBaretwocovalentlybondedatoms(:repre-
forexample.Manycovalentbondsonlybreakathigh sentingthesharedpairofelectrons),homolyticfission
temperatures, e.g. 450to600◦C is often required to canbewrittenas
ruptureC–C,C–H,orC–Obonds.Hencemanystud-
ies of free radical chemistry have been carried out A:B→A • +B •
in the gas phase at high temperatures; combustion is
well known to be a free radical process,64 the gen- Forexample,homolyticfissionofoneoftheO–Hco-
eration of tobacco smoke and fire smoke being good valent bonds in water will yield a hydrogen radical
examples (Section 9.13). Other covalent bonds frag- (H•) and a hydroxyl radical (usually written as OH•;
mentmoreeasily:merelycuttingyourfingernailscan although some authors write it as •OH, presumably
cleave disulphide bonds to generate sulphur radicals toemphasizethattheunpairedelectronislocatedon
(Section2.5.5).65Thefractureandgrindingofbonecan the oxygen). By contrast, in heterolytic fission, one
H+ + OH–
WATER
ionization of water
H ÷ O ÷ H Hydrogen ion Hydroxide ion
Two covalent bonds Both electrons go to 1 proton 9 protons
oxygen (O) 0 electrons (giving 10 electrons (5
HETEROLYTIC positive charge) pairs) (negative
BOND FISSION charge)
NEITHER IS A FREE RADICAL
One electron to
oxygen and one
radiolysis of water to hydrogen
HOMOLYTIC
BOND FISSION
H(cid:129) + OH(cid:129)
(hydrogen radical) (hydroxyl radical)
1 proton 9 protons
1 electron 9 electrons (4 pairs + 1 unpaired)
(no charge) (no charge)
BOTH ARE FREE RADICALS
Figure1.13 Homolyticorheterolyticfissionofwater.Watercanbesplitintoions(withallelectronspairedinOH–andnoelectronsinH+)orfree
radicals(withunpairedelectrons).Moleculescan,ofcourse,bebothradicalsandions;theyarethencalledradicalcationsorradicalanions,as
explainedabove.

--- Page 77 ---

22 FREE RADICALS IN BIOLOGY AND MEDICINE
σ*2p
π*2p
π 2p
σ 2p
σ* 2s
σ 2s
σ* 1s
σ 1s
Ground-state O Singlet O Superoxide Peroxide ion Singlet O
2 2 2
(3Σg–O
2
) (1Δg O
2
) (O
2
– ) (O
2
2–) (1Σg+O
2
)
Figure1.14 Asimplifiedversionofbondinginthediatomicoxygenmoleculeanditsderivatives.Theoxygenatomhaseightelectrons,O2
16electrons.Forfurtherinformation,seeActiveOxygeninChemistry,edsCSFooteetal,BlackiePublishers,1995.
atom receives both electrons when a covalent bond ofelectronsfromit,bothelectronsmusthavethesame
breaks,i.e. spininordertofitintothevacantspacesintheπ*or-
bitals (Fig. 1.14). A pair of electrons in an atomic or
A:B→A–+B+
molecularorbitalcannotmeetthiscriterion,sincethey
have opposite spins, in accordance with Pauli’s Prin-
A receives both electrons. This gives A a negative
ciple.Thisspinrestriction makesO prefertoaccept
2
charge,Bisleftwithapositivecharge,andneitherspe-
itselectronsoneatatime,andcontributestoexplaining
ciesisafreeradical.Heterolyticfissionofwatergives
whyO reactssluggishlywithmostnon-radicals.43Ac-
the hydrogen ion H+ and the hydroxide (sometimes 2
cordingtobasicthermodynamics,thecomplexorganic
calledhydroxyl)ion,OH–.Purewaterisslightlyion-
compounds of the human body should immediately
izedinthiswayandcontains10–7moles/dm3 eachof
combustintheO oftheair(Section2.3).Fortunately,
H+ andOH–ionsat25◦C,givingapHof7.Hydroxyl 2
the spin restriction and other factors slow our oxida-
radicalandhydroxideionaresometimesconfusedin
tionrate.Oxygencanreactfastwithotherradicals,but
the biomedical literature: Fig. 1.13 clarifies the differ-
by single electron transfers. Fortunately again, most
encesbetweenthem.
moleculesinthehumanbodyarenon-radicals,orelse
Let us now examine O and its derivatives to see
2 wewoulddeteriorateandagemuchfasterthanwedo.
which are and are not free radicals. Over 60% of the
humanbodyiswater,fortunatelynotafreeradical.
1.8.1 Singletoxygen
1.8 Oxygenanditsradicals More-reactiveformsofO ,thesingletoxygens,canbe
2
generatedbyaninputofenergy(discussedindetailin
Figure1.14revealsthatthediatomicoxygenmolecule Section2.6.4).The1(cid:6)gO state(Fig.1.14)hasanenergy
2
is itself a free radical: it has two unpaired electrons, 93.6kJ(22.4kcal)eabovethegroundstate.The1(cid:7)g+O
each located in a different π* antibonding orbital. 2
stateisevenmorereactive,157kJ(37.5kcal)abovethe
•
We should thus writeit as O 2 , but nobody ever does groundstate.SingletO 2 1(cid:6)gisnotaradical:thereareno
so we won’t either. The two electrons in O have the
2 unpairedelectrons(Fig.1.14).Inbothformsofsinglet
same spin quantum number (or, as is often written,
O thespinrestrictionisremovedandsotheoxidizing
2
theyhaveparallelspins).Thisisthemoststablestate,
abilityoftheO isgreatlyincreased.
2
orgroundstate,ofO andistheformittakesintheair
2
aroundus.Oxygencanactasanoxidizingagent(for
e Energiesshouldbyconventionbeexpressedinkilojoules
definitions see Table 1.2). However, if O attempts to
2 (kJ),buttheuseofkilocaloriesisstillwidespread.1kcalis
oxidizeanotheratomormoleculebyacceptingapair 4.18kJ.

--- Page 78 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 23
Table1.2 Definitionsofoxidationandreduction.
Term Definitions Example
Oxidation Lossofhydrogen C+O2 → CO2(carbonisoxidizedtocarbondioxide)
or
gainofoxygen Na → Na+ +e–(asodiumatomisoxidizedtoasodiumion)
or
lossofelectrons O •
2
–→O2+e–(asuperoxideradicalisoxidizedtooxygen)
Reduction Lossofoxygen CO2+C → 2CO(CO2isreducedtocarbonmonoxide;CisoxidizedtoCO)
or
gainofhydrogen C+2H2 → CH4(carbonisreducedtomethane)
or
gainofelectrons O2+e–→O •
2
–(oxygenisreducedtosuperoxideradical)
Oxidizingagent Oxidizesanotheratomormoleculebytakingelectronsfromit,orbytakinghydrogen,orbyaddingoxygen
Reducingagent Reducesanotheratomormoleculebysupplyingelectronstoit,bysupplyinghydrogenorbyremovingoxygen
1.8.2 Superoxideradical someotheroxygenradicals,butalsosomenon-radical
derivativesofO (Table2.1),suchasH O andhypo-
If one electron is added to the ground-state O mo- 2 2 2
lecule, it enters one of the π* antibonding or 2 bitals chlorous acid (HOCl). Hence all oxygen radicals are
(Fig.1.14).Theproductissuperoxideradical,O • 2 –.With R iv O e’ S i , s b a u r t el n a o ti t ve all te R rm O ; S O a •– re an o d xy H gen O ra a d re ic s a e ls le . c ‘ t R iv e e ac i t n -
only one unpaired electron, superoxide is less ‘rad- 2 2 2
theirreactionswithbiologicalmolecules,leavingmost
ical’ than O , despite its ‘super’ name. Addition of
anotherelect
2
rontoO
•–willgiveO2–,theperoxideion, of them unscathed, whereas OH• attacks everything
anon-radical.Sincet 2 heextraelect 2 ronsinO •– andO2– aroundit(Section2.5.1).Hencesomeauthorspreferthe
2 2 termoxygen-derivedspeciestoROS.Strictly,however,
arelocatedinantibondingorbitals,thestrengthofthe
waterisclassifiableasanO -derivedspecies,butitis
oxygen–oxygen bond drops. In ground-state O the 2
2 notmuchofathreattousunlesswedrowninit,and
atoms are effectively bonded by two covalent bonds,
but in O •– only by one-and-a-half bonds (there is an itislessreactivethanO 2 (sonotaROSbytheabove
2 definition).Anothercollectivetermsometimesusedis
extra electron in an antibonding orbital), and in O2 2 – oxidants. However, since O •–, H O , and some other
byonebondonly.Hencetheoxygen–oxygenbondin 2 2 2
ROScanactaseitheroxidizingorreducingagentsin
O2– isweakerthaninO .Additionoftwomoreelec-
2 2 different systems (Chapter 2), we do not recommend
tronstoO2–eliminatesthebondentirelysincetheygo
intotheσ*2 2 porbitals,givingtwoO2–(oxideions).Usu- thisterm.Thetermreactivespecieshasbeenexpanded
toincludereactivenitrogen,chlorine,bromine,iron,
ally in biology, the two-electron reduction product of
and sulphur species (Section 2.1). The term ROS is
O ishydrogenperoxide(H O ),andthefour-electron
2 2 2 widely used in the literature (the authors are guilty
product, water (e.g. as catalysed by cytochrome oxi-
as well, in this book and in some of their published
dase,Section1.3.3).
papers). In fact, terms such as ‘ROS-dependent’ or
O −−−−tw−o−-e−le−ctr−o−n−→ H O (protonatedformofO2–) ‘ROS-mediated’conveylittleusefulinformation,un-
2 reduction(plus2H+) 2 2 2 less the exact species and the molecules they react
withareclarified.
O −−−f−ou−r−-e−le−ct−ro−n−→ 2H O(protonatedformofO2–)
2 2
reduction(plus4H+)
1.10 Sourcesofsuperoxideinaerobes
1.9 Howtodescribethem:oxygen
radicals,oxygen-derivedspecies,reactive A popular theory to explain O 2 toxicity is the super-
oxide theory of O toxicity, introduced by Irwin
oxygenspecies,oroxidants? 2
Fridovich and his colleagues,67 which proposes that
Reactiveoxygenspecies(ROS)isacollectivetermfor excess O causes over-production of O
•–
that dam-
2 2
species derived from O that are more reactive than agesimportantbiomolecules.Weevaluatethistheory
2
O itself. The term includes not only superoxide and in Chapter 3, after reviewing the chemistry of O
•–
in
2 2

--- Page 79 ---

24 FREE RADICALS IN BIOLOGY AND MEDICINE
Chapter 2; but letus firstexaminebriefly howO
•–
is whentissuesareinjured,andleadstoO
•–
production
2 2
producedinvivo. (Section 10.6). Xanthine dehydrogenase and XO may
alsocatalyseO -dependentoxidationofNADH,gener-
2
atingO
•–.InthepresenceofNADHor(hypo)xanthine,
2
1.10.1 Enzymes theycanreduceNO– toNO–,andNO– toNO • under
3 2 2
Some O
•–
is produced ‘deliberately’ in vivo, for ex-
hypoxic conditions. The physiological significance of
2 thesereactionsisasyetuncertain.69
amplebyNADPHoxidaseenzymesinphagocyticcells
andelsewhere(Sections8.7to8.11).Severalotheren-
zymes reduce O to O
•–
(Table 1.3), one of the most
1.10.2 Auto-oxidationreactions
2 2
studiedbeingxanthineoxidase(XO)(Fig.1.10).How- Many molecules can be oxidized by O , a process
2
ever,mostofthexanthine/hypoxanthineoxidationin calledauto-oxidation,oftenshortenedtoautoxidation.
vivoiscatalysedbyaxanthinedehydrogenase(XDH) Autoxidation is widely used in industry to produce
enzyme,whichtransferselectronsfromthesubstrates certainorganicchemicals.Ontheotherhanditisvery
toNAD+ ratherthantoO 2 ,andsodoesnotproduce important to control autoxidation, not only in living
O • 2 –.Thetermxanthineoxidoreductase(XOR)issome- systems, but also in rubber, plastics, oils, foods, and
timesusedtorefertobothXOandXDH.XORenzymes wines.
containmolybdenum,FAD,andiron–sulphurcentres, Many biomolecules react with O to produce O •–:
2 2
allessentialforcatalyticactivity.XDHcanbeconverted theyincludeglyceraldehyde,FMNH ,FADH ,adren-
2 2
toXObyproteolyticenzymes(anirreversiblereaction) alin,noradrenalin,L-DOPA(dihydroxyphenylalanine),
orbyoxidationofthiol(–SH)groups(reversibleifthe dopamine,tetrahydrobiopterinandothertetrahydrop-
groupsarere-reduced).68Conversioncanoccurinvivo teridines, and thiol compounds such as cysteine.54 In
Table1.3 Someenzymesthatgeneratesuperoxideradical.
Enzyme Location Comments/representativereferences
CytochromesP450 Widespread Fig.1.11;Table1.1
Xanthineoxidase Widespread,especiallyininjuredtissues Fig.1.10
Peroxidases Plantsandbacteria,someanimaltissues O
•–canbeproducedduringtheoxidasereactions(Section3.19)
2
Cellobioseoxidase White-rotfungus(Sporotrichum ContainsFADandab-typecytochromeOxidizesarangeof
pulverulentum) disaccharides,O
•–produced(Section8.5.3)
2
Nitropropanedioxygenase Hansenulamrakii(ayeast),Neurospora Catalysesoxidationofpropyl-2-nitronateformedfrom
crassa(afungus) 2-nitropropaneintoacetone.Superoxideproducedandinvolvedin
thecatalyticmechanism.Superoxidedismutaseinhibitstheoxidation
(J.Biol.Chem.253,226,1978;Arch.Biochem.Biophys.433,157,
2005)
Nitricoxidesynthases Mostmammaliancells GeneratenitricoxidefromL-arginine.CanreleaseO •
2
–when
(NOS) tetrahydrobiopterin(BH4)levelsarelow.This‘uncoupling’ofNOS,
leadingtolessNO
•
andmoreO
•–generation,cancontributeto
2
vasculardysfunction(Section2.5.6.4;alsoVasc.Pharmacol.57,
168,2012)
Indoleamine Mostanimaltissues,especiallysmall ConvertstryptophantoN-formylkynurenine.Superoxideinvolvedin
2,3-dioxygenase intestine,notliver thecatalyticmechanisminvitrobutitsroleinvivoisunclear
(Section8.4.2andJ.Biol.Chem.238,12014,2008)
Tryptophandioxygenase Liver Samereactionasabove,butspecificfortryptophan(Biochem.Soc.
Trans.36,1120,2008)
Aldehydeoxidase Mostlyliver Containsmolybdenum,iron,FAD.Broadsubstratespecificity;
oxidizesarangeofaldehydesaswellasNADH,producesO
•–and
H2O2(Biochemistry51,2930,2012).CanalsoreduceNO–
2
2 toNO • .
Highactivityinliver,involvedinthemetabolismofseveraldrugs.
Inhibitedbydiphenyleneiodonium(Fig.8.13)

--- Page 80 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 25
general,autoxidationreactionsstartslowlybecauseof playimportantphysiologicalroles(Sections2.5.6.5and
the low reactivity of O . However, once some O
•–
is 2.5.6.6).
2 2
produced it can further oxidize the compound, set- As mentioned in Section 1.3.1, bacteria and yeasts
ting up a chain reaction and generating more O
•–.
cancontainhaemoglobin-ormyoglobin-likeproteins,
2
SometimesthesereactionsareusedtoassaySOD(Sec- oftendimerichaem-containingproteinsormonomeric
tion3.5.6). haem flavoproteins. For example the flavohaemo-
Since O is poorly reactive, how can these ‘auto- globinHmp,foundinE.coli,containshaemandFAD,
2
oxidations’ begin? Their rates are greatly accelerated andreadilyreducesO toO
•–
invitro.Bacterialflavo-
2 2
byaddingtransitionmetalions,especiallymanganese, haemoglobinshaveseveralmetabolicroles,including
iron,andcopperions.Sinceitisimpossibletofreela- protectionagainstNO • (Section1.3.1).23Similarly,both
boratory solutions from contaminating metal ions, it haemoglobinandmyoglobinmayparticipateinmetab-
•
ispossiblethatall‘autoxidations’needtracesofmetal olismofNO inanimals(Sections2.5.6.5and2.5.6.6).
ionstooccuratall.
1.10.4 Mitochondrialelectrontransport75
1.10.3 Haemproteins
It is frequently said (but in fact not proven) that the
The iron in the haem of haemoglobin and myog- most important source of O • 2 – in vivo in aerobic eu-
lobin22,23isintheFe2+ state.Itmostlyremainssowhen karyotic cells is the mitochondrial electron transport
O binds,althoughsomeelectrondelocalizationtakes chain (we discuss chloroplasts, which might be big-
2
place ger generators of O • 2 – in illuminated green plants,
in Section 7.8). The drastic phenotype of mice lack-
haem–Fe2+–O
2
↔haem–Fe(III)–O •
2
–
ing mitochondrial superoxide dismutase (SOD) (Sec-
tion 3.7.2) is consistent with the potential damaging
T to he O 2 b , o a n n d d in F g e( i I s II) in b t o e n rm de e d di t a o te O b • 2 – e . tw O e c e c n asi F o e n 2 a + lly b , o O n • 2 d – e i d s e v f a f t e i c o t n so th f a m t i y to e c a h st on ce d l r ls ia w lO it • 2 h – o g u e t n m er i a t t o i c o h n o , n a d s r is ia t l h e e le o c b t s r e o r n -
released.70,71
transportcansurvivedeletionsofthegenesencoding
haem–Fe2+–O →O •–+haem–Fe(III) SODs (Section 3.7.1) better than normal yeast. Mito-
2 2
chondrial O
•–
production can be a bad thing, but (at
2
The Fe(III) product (methaemoglobin or metmyo- the right levels only!) it might also serve useful pur-
globin) cannot bind O . It has been estimated that posesinredoxregulation(Section5.5.5),andcaneven
2
about 3% of the haemoglobin present in human slow down the ageing process in some organisms
erythrocytesundergoesoxidationeveryday,70 andso (Section11.4.8)!
these cells are exposed to a constant flux of O
•–.
Sec- Whereas animal cytochrome c oxidases release no
2
tion7.4exploreshowtheycope.Somefishhaemoglo- ROSduringtheirnormaloperations,someearliercom-
bins oxidize much faster.71 Several abnormal haemo- ponentsofthemitochondrialelectrontransportchain
globins resulting from gene mutations also oxidize canleakelectronsdirectlytoO ,althoughpassingthe
2
fasterthannormal,asdotheisolatedα-orβ-chainsthat bulk of them on to the next component in the chain.
accumulateinthalassaemia;Section3.22.5.3). ThisleakagegeneratesO
•–.Whereasmammaliancyto-
2
Haemoglobinandmyoglobinoxidationareacceler- chrome oxidase is saturated at low O tensions, the
2
atedbynitrite(NO–)orbycertaintransitionmetalions, rate of electron leakage (and hence O •– production)
2 2
especiallycopper.71–74Thepresenceofexcessivenitrate bymitochondriais,ingeneral,increasedbyraisingO
2
inthewatersupplyofsomeruralareas,duetooveruse levels(althoughit’snotquitesosimple;leakageisalso
ofinorganicfertilizers,hascausedproblemsinbottle- favouredbyhighlevelsofreducedcarriers,whichcan
fedbabies:NO–inthewaterusedtomakeupfeedsis decreasewhenO ishigh).Forexample,inslicesofrat
3 2
reducedbygutbacteriatoNO–,whichisthenabsorbed lungexposedtoair,about9%ofO uptakeledtoO •–
2 2 2
and causes sufficient methaemoglobin formation to formation,butunder85%O ,O
•–formationaccounted
2 2
interfere with tissue oxygenation and cause cyanosis for18%oftotalO uptake.76
2
(the‘bluebaby’syndrome).74 Thisisfacilitatedbythe Itisoftenwrittenthat1–3%oftheO consumedby
2
poor ability of newborns to convert methaemoglobin mitochondriamayformO
•–.Thetruerateisprobably
2
backtohaemoglobin(Section7.11.8.1).However,NO– lower (maybe 0.1–0.2%), since many experiments are
2
maynotbeasbadasitlooks,NO–andNO–andtheir donewithmitochondriaexposedtoroomair,whichis
2 3
interactions with myoglobin and haemoglobin may grosslyhyperoxicforthem(Fig.1.4).Theleakagerate

--- Page 81 ---

26 FREE RADICALS IN BIOLOGY AND MEDICINE
invivoiskeptlowbyatleastthreefactors.First,low produce more H O than isolated rat liver mitochon-
2 2
intra-mitochondrial O concentration. Second, the ar- dria, and avian mitochondria produce less O
•–
than
2 2
rangementofelectroncarriersintocomplexes(Fig.1.8) the rat ones.81 Mitochondria have multiple enzymes
facilitates electron movement to the next component that remove H O (Section 3.20.1), as well as others
2 2
of the chain rather than escape to O . Third is the that produce it (e.g. monoamine oxidase in the outer
2
uncoupling proteins (Section 1.10.6). It follows that mitochondrial membrane, Section 10.17), so measur-
damagetomitochondrialorganizationcanfavourleak- ingH O productionisnotanaccurateestimateofO
•–
2 2 2
age and increase O •– production. Freeze–thawing of production. The Krebs cycle enzyme α-ketoglutarate
2
yeastdisruptsmembranesandincreasesmitochondrial dehydrogenase (Fig. 1.7) is not only a target of dam-
O •– generation, for example.77 An intramitochondrial agebyROS(especiallyinneurodegenerativediseases;
2
O •– concentration of 10–11to10–12 M during normal Section 10.19), but may also be able to generate O •–
2 2
respirationhasbeenestimated.78 Leakageofelectrons fromitsflavoproteinconstituentsifsubstrateispresent
to O to form O •– can take place from components butNAD+levelsareverylow,sothatelectronscannot
2 2
of complexes I and III and, under certain circum- be passed on.82 Whether this occurs in vivo is uncer-
stances, from complex II or the FAD-containing en- tain.Pyruvatedehydrogenasekinaseisalsoaffectedby
zyme glycerol-3-phosphate dehydrogenase, present H O (Fig.1.7).
2 2
ontheoutersurfaceoftheinnermitochondrialmem- Potentialartefactstobearinmindwhendetermin-
brane in some tissues (e.g. brown fat, muscle, and ing mitochondrial O
•–/H
O production include the
2 2 2
braininmice,alsohighlevelsininsectflightmuscles). presence of contaminating catalase, interference with
Most O
•–
generated in mitochondria (e.g. from com- the assays of O
•–
and H O by endogenous mol-
2 2 2 2
plexI)isreleasedintothematrix,butsomeofthatfrom ecules such as ascorbate (Section 6.11), and rapid de-
complex III into the intermembrane space. The rela- pletions of O in the reaction mixtures due to fast
2
tiverole of each complex in formingO
•–
dependson respiration;asO falls,lessO
•–
shouldbemade.Dis-
2 2 2
the source of the mitochondria (e.g. complex I seems ruption of the cellular mitochondrial network during
to be the major source in brain mitochondria) and theirisolationmayalsoartefactuallyincreaseO
•–pro-
2
theredoxstateoftheelectrontransportchain.Super- duction (Section 1.3.3). The protein p66shc can also
oxide’smajorfateinmitochondriaisprobablydismu- affectO
•–productioninmitochondria(Sections5.4.2.2
2
tation to H O by SODs present in both matrix and and 11.3.1.1). Some authors have suggested that O
•–
2 2 2
inter-membranespace(Section3.5),butcytochromec productioninmitochondriaoccursatalowbasalrate
might also intercept some O
•–
since it reacts rapidly but with frequent short bursts, superoxide flashes,
2
withit(Section2.5.3). but some (or perhaps all!) of this observation could
Inhibitors of electron transport such as rotenone beduetoproblemswiththemeasurementtechniques
(actsoncomplexIbutisnotspecific;Section10.20.3), (Section6.10).80,83
antimycinA(targetscytochromebc),andcyanide(in-
hibitscytochromeoxidase)canincreasemitochondrial
O •– production, presumably by increasing the levels 1.10.4.1 MitochondrialDNA(mtDNA)
2
of reduced carriers and facilitating electron leakage Human mitochondria contain several double-
to O 2 .79 Blocking electron transport should also in- stranded, circular DNA molecules, each containing
creaseintra-mitochondrialO 2 levelsandfurtherraise about 16,500 base pairs and coated with various
O
•–
production, a double whammy. By contrast, un- proteins. Mitochondrial DNA encodes only 13 of
2
coupling agents (such as 2,4-dinitrophenol), which the mitochondrial proteins (seven of the subunits
decrease the proton gradient and accelerate electron in complex I, one in complex III, three in complex
transport,usuallydecreaseO
•–
production.However, IV, two in complex V), 22 transfer RNAs, and two
2
uncouplingbythemitochondrialpermeabilitytransi- ribosomal RNAs. Most mitochondrial proteins are
tion(MPT;Fig.1.9)can,undercertaincircumstances, encoded in nuclear DNA, synthesized on ribosomes
increaseO • 2 –productionbydistortingthearrangement in the cytosol, and are then imported. Mutations in
ofelectroncarriersincomplexI.80 mtDNA (especially deletions of base sequences and
There is a wide variation in rates of O • 2 – or H 2 O 2 basesubstitutions)accumulateinoldtissues.Thismay
production by isolated mitochondria from different contribute to ageing and is frequently (but possibly
species and tissues, and even from apparently simi- erroneously; Section 11.4.1) attributed to oxidative
lar mitochondrial preparations in different laborat- DNAdamage.MutationsinmitochondrialDNAcause
ories. For example, isolated rat heart mitochondria several human diseases, including Leber hereditary

--- Page 82 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 27
optic neuropathy, LHON (degeneration of the optic both glycerol-3-phosphate dehydrogenase and en-
nerve) and mitochondrial encephalomyopathy, lactic zymesinvolvedinβ-oxidationoffattyacids.
acidosis,andstroke-likeepisodes,MELAS.Theformer
is caused by mutations in genes encoding constitu-
1.10.6 Endoplasmicreticulum(ER)
ents of complex I, and the latter (in most cases) by
mutationsingenesencodingatransferRNAcarrying
Isolated subcellular fractions containing ER (micro-
the amino acid leucine. Optic nerve degeneration in
somalfractions)rapidlyproduceO
•–andH
O when
LHON has been suggested to involve increased O
•– 2 2 2
2 incubated with NADPH in the laboratory, and even
production, as indeed may the pathological effects moresoatelevatedO concentrations,86sincethecata-
2
observed in some or all of the other mitochondrial
lytic cycle of CYPs can short circuit to release O
•–
disorders.75,84 2
andH O (Fig.1.11).Phenobarbital-inducible(CYP2B)
IfO
•–
orH O producedbymitochondriacanform
2 2
2 2 2 andethanol-inducible(CYP2E1)CYPsshowespecially
more-reactive species such as OH•, they may cause
highratesofO reductioninvitro.Inaddition,electrons
2
damage to mitochondrial proteins, lipids, and DNA.
can escape to O from the flavins in the NADPH-
2
However, some claims that the level of oxidative
P450 reductase enzyme or other CYP-reducing sys-
DNAdamageinmtDNAishigherthanthatinnuclear
tems.Themechanismthatcellsuseforfoldingproteins
DNA do not rest on a firm experimental foundation
intheERmayalsocontributetoROSgeneration(Sec-
(Section6.14).
tion5.4.2).
DoCYPSgenerateO
•–
andH O invivo?Probably
2 2 2
1.10.5 Uncouplingproteinsasantioxidants? yes,insomecases(e.g.forCYP2E1;Section9.8.1.1),but
at a slower rate (in part because O levels are much
2
Mitochondria in brown adipose tissue (BAT) contain lower).87
an uncoupling protein (UCP1) in their inner mem-
brane,whichallowsthepassageofprotonsandsocol-
lapsestheprotongradient.Asaresult,mostorallofthe 1.10.7 Nuclearandplasmamembranes
energyreleasedbyelectrontransportappearsasheat
Early reports of production of O
•–
by nuclear mem-
ratherthanATP,explainingthespecializedroleofBAT 2
branes in the presence of NADH or NADPH may
inheatproduction.HomologuesofUCP1(UCP2and
havebeenduetothepresenceofanNADPHoxidase
UCP3) have been detected in mitochondria of other
enzyme (Section 8.10). The O
•–/H
O produced have
tissues, at lower abundances. It has been proposed 2 2 2
the potential to damage nuclear components, espe-
thattheseproteinsactsasantioxidants,75 byallowing
ciallyDNA,andcausemutationiftheyareconverted
some proton leak and preventinga ‘back up’ of elec-
intoOH•.
trons that could escape to O . They perhaps act by
2
Plasma membranes contain redox systems that
othermechanismsinaddition(e.g.actingasa‘channel’
transfer electrons from NADH to external elec-
totransportmitochondrialROSoutofthisorganelle).
tron acceptors, such as ascorbate, dichlorophenol–
Indeed,knockoutofUCP3inmiceledtoincreasedoxi-
indophenol,andferricyanide(Section8.10.9andref88).
dative damage in skeletal muscle, where this protein
In most cases the physiological role of plasma mem-
isnormallyexpressed.Formationwithinmitochondria
of O
•–
or of hydroxynonenal (HNE), an end product
braneredoxsystemsisunknown,butsometimesitis,
2 oneexamplebeingthereductionofironionstofacili-
of lipid peroxidation (Section 5.12.5), seems to lead
tate their uptake in the gut (Section 3.22). Sometimes
to activation of UCPs, which should then decrease
theiractivitiesincreasewithage.88
themembranepotentialandhencelimitformationof
moreO
•–.BywhatmechanismO •–mightdothisisun-
2 2
certain given its limited reactivity (Section 2.5.3), but
1.10.8 Bacterialsuperoxideproductionand
HNEcanreadilymodifyvariousresiduesonproteins
biofilms
(Section5.12.5).UCPsmayalsoberegulatedbygluta-
thionylation (Section 3.11), which decreases their H+ StudiesinE.colisuggestthat,althoughsomecytosolic
conductance. enzymes might be able to generate O
•–,
most comes
2
Given their uncoupling, mitochondria from BAT from electron transport chains, including NAD(P)H
might be expected to generate fewer ROS. However, dehydrogenases, sulphite reductase, succinate de-
isolatedBATmitochondriawerereported85toproduce hydrogenase, and fumarate reductase. The last is
considerable amounts of H O , apparently involving especiallyactiveinO
•–
production,asisalsothecase
2 2 2

--- Page 83 ---

28 FREE RADICALS IN BIOLOGY AND MEDICINE
in Bacteroides fragilis and some other species. Most fieldisaffected,likemanyothers,bythewidespread
O
•–
arises by oxidation of partially reduced, solvent- contaminationandmis-identificationofcelllines;how
2
exposed flavins (accessible to O ) in these enzyme many labs bother to check for this? Even if it is the
2
complexes.20Notethatmanyofthesestudiesarebased ‘correct’ cell, did it originate from a male or female
on work with isolated enzyme complexes exposed donor, and what genetic polymorphisms does it con-
to air, and electron leakage may be slower in vivo. tain? These are all important questions.96,97 Culture
Nevertheless, fumarate reductase and the flavopro- mediaareoftendeficientinantioxidants(e.g.vitamins
tein enzyme nadB, which catalyses the first step in C and E) and antioxidant precursors (e.g. selenium;
thesynthesisofnicotinamidefromaspartate,doseem Section 3.20.5) and contain ‘free’ metal ions, present
to generate O •– in vivo.89 The rate of O •– production as contaminants or even added deliberately. For
2 2
in E.coli has been estimated as 5 μM/s, which, given example, iron(III) salts are added to the widely used
bacteriallevelsofSOD,translates20 toaveryapprox- Dulbecco’smodifiedEagle’smedium,DMEM.Given
imate steady-state concentration of less than 10–10M. that most animal cells are cultured as a monolayer
Forcomparison,inE.coligrownonglucose-containing under 95% air/5% CO (about 152 mmHg O ), they
2 2
medium,levelsofintracellularH O wereestimatedas arealsoinahyperoxicenvironment,whichislikelyto
2 2
about10–8M.89 increase their rates of O •–/H O formation and alter
2 2 2
Onepointtoponderisthatbacteriaareusuallystud- metabolism and cell behaviour. For example, studies
ied in the laboratory as monocultures of individual of telomeres and cellular senescence are affected by
species, which have no doubt adapted to laboratory this(Section11.3.5).TheO levelsalsofluctuatewildly,
2
growth conditions by altering their metabolism and high when cells are placed in culture and dropping
antioxidantdefences(e.g.inresponsetotheavailabil- as cells grow, proliferate, and consume O . Often an
2
ity in the growth medium of such metals as Fe, Cu, O gradient is established between the surface of the
2
Mn,andZn:Sections3.5.3and3.8.2).However,inthe medium and the cells beneath. When the medium
‘real world’ most bacteria exist surrounded by other is changed, cells can therefore switch from relative
species in complex colonies. Often these are encased hypoxia to hyperoxia and suffer the equivalent of a
inamatrix,producingbiofilms.Theseallowmoreof hypoxia-reperfusioninjury(Section10.6).Thedensity
thebacteriapresenttosurviveadverseconditions,and ofthecellsunderstudyisalsoimportanttoconsider:
theresistanceofbacteriainbiofilmstoantibioticsisa the denser they are the faster O will be consumed,
2
major problem in clinical medicine. Biofilms form on and products such as H O can more readily diffuse
2 2
teeth and on catheters, for example. Reactive oxygen intoadjacentcellsformetabolism.Highglucoselevels
speciesseemtobeintimatelyinvolvedinbiofilmfor- in culture media can also increase O
•–
production in
2
mation. For example, some species produce H O to cells(Section10.5).
2 2
modulatetheproliferationofothers,90andithasbeen Cells respond to this ‘culture shock’ by altering
arguedthatsuch‘internal’oxidativestresscandamage ROSproduction(e.g.bydecreasinglevelsofCYPs),98
DNAandgeneratediversityandadaptability,allowing antioxidant defences, other ‘stress responses’ (e.g.
thebiofilmtoadaptrapidlytoexternalthreatssuchas autophagy and p53 activity [Section 10.14.4.2]),
antibiotics.91,92 and some metabolic pathways and by remodelling
Anotherpointtoconsideristhatbacteriaareoften mitochondria.99 Oneexampleistheincreasedactivity
grown in the laboratory in media containing autox- ofthepentosephosphatepathwayinChinesehamster
idizable molecules, such as thiols. This can confuse ovary (CHO) cells needed to provide more NADPH
studies of O toxicity in at least two ways. First, (Section 3.10.2.1), as an apparent adaptation to the
2
some of these agents can directly scavenge certain oxidative stress of cell culture.100 Another may be
ROS. Second, some media constituents can be oxi- the tendency of cells (e.g. embryonic stem cells) to
dized when the culture is exposed to O to generate undergo increased rates of mutation in culture.101
2
extracellularO
•–
andotherROSthatcoulddamagethe An older example is the secretion of pyruvate by
2
bacteria.93,94 culturedcells,102 apparentlyasanantioxidantdefence
mechanism, since pyruvate scavenges H O (Sec-
2 2
tion3.25.2).Thecultureprocesscanaltertheresponse
1.11 Thinkingaboutcellculture
of cells to toxins, e.g. mitomycin C (Section 10.16),
Artefacts can also affect the interpretation of cell acetaminophen,103 or viral proteins (Section 10.25.1),
culturestudies.95Thefreeradical/antioxidantresearch andinfluencecellsusceptibilitytoapoptosis.96,104

--- Page 84 ---

OXYGEN: BOON YET BANE—INTRODUCING OXYGEN TOXICITY AND REACTIVE SPECIES 29
Onemustalsobecautiouswheninterpretingeffects About 0.5% of electrons from respiratory substrates
of autoxidizable compounds (which include many in E. coli have been estimated to form O
•–.
In mito-
2
‘antioxidants’,suchasascorbate,thiols,andpolyphen- chondria, 1 to 3% of electrons are often said to form
ols) on cells in culture. Ascorbate, flavonoids, other O
•–.Thesenumbersdonotseemlarge,butpleasere-
2
polyphenols, and many other agents oxidize rapidly memberthataerobescanconsumealotofO 2 during
incertaincellculturemedia(especiallyDMEM,since respiration.HenceO • 2 – canbemadeinlargeamounts
Fe(III)isadded),generatingO •–,H O and,fromphen- (Box1.1).
2 2 2
ols,quinones,andsemiquinones.Allthesespecieswill
altercellfunction.105 Otherproblemswithcellculture
includetheuseofproteinasessuchastrypsininsub- Box1.1 Howmuchsuperoxideismade
culturing(whichcandepleteGSHlevels),andthefact inthehumanbody?
that cells are no longer exposed to growth factors,
hormones,andtheinfluenceofsurroundingcells.For An adult at rest utilizes approximately 3.5ml/kg/min
example, neurons in culture are often delicate, but in O or352.8litresperday(assuming70kgbodymass)
2
thebraingliahelptoprotectthem(Section10.17). or14.7molperday.If1%makesO •– thisis0.147mol
2
perdayor53.66molperyearorabout1.7kgperyear
(ofO
•–).Eveniftherateis0.1%(Section1.10.4),thisis
1.12 Somenumbers 2
still170gperyear!ThiscalculationistakenfromNutr.
Production of O •– is thought to occur within all aer- Rev.52,255,1994.
2
obiccells,toanextentdependentonO concentration.
2

--- Page 85 ---

CHAPTER 2
Redox chemistry: the essentials
Lifeisnothingbutanelectronlookingforaplacetorest.
AlbertSzent-György
2.1 Introduction However,mostbiologicalmoleculesarenon-radicals.
When a free radical reacts with a non-radical, a new
Although Chapter 1 focused on oxygen radicals and
radicalresults,andchainreactionsmayoccur:
otherreactiveoxygenspecies(ROS),manytypesoffree
radicalcanbegeneratedinvivo.Forexample,carbon- 1. Aradical(X•)mayaddontoanothermolecule.The
centredradicalsareintermediatesinlipidperoxidation adductmuststillhaveanunpairedelectron
(Section5.11).Nitrogen-centredradicalscanbeformed
X • + Y→[X – Y] •
from antioxidants bearing –NH groups (Table 11.7),
inthemetabolismofphenylhydrazine(Section7.5.1), Example:OH•addstoposition8intheringstructure
and they are used in vitro to assay ‘total antioxidant
ofguanineinDNA;theinitialproductisaradical
capacity’(Section6.17.3).Transitionmetalionsqual-
(Section5.8.2).
ify as free radicals under our broad definition. Some
2. Aradicalmaybeareducingagent,donatingasingle
• •
oxides of nitrogen (NO , NO ) are free radicals: in-
2 electrontoanon-radical.Therecipientthenhasan
deed, just as the term ROS has been introduced into
unpairedelectron
biology, so have the terms reactive nitrogen species
(RNS),reactivechlorinespecies(RCS),reactivebrom- X • +Y→X++Y •–
inespecies(RBS),andreactivesulphurspecies(Table
Example: carbon dioxide radical, CO
•–,
reduces
2.1).1 The purpose of this chapter is to introduce the 2
Cu+toCu
basicchemistryofthesevariousspecies,whichwillfa-
cilitateunderstandingofwhattheycan(orcannot!)do CO •–+Cu+→CO +Cu
2 2
invivo.ItwillalsorevealthattermslikeROS,RNSetc.,
although widely used, convey little specific chemical 3. Aradicalmay bean oxidizingagent, takingasin-
informationasalreadymentionedinSection1.9. gle electron from a non-radical. The non-radical
must then have an unpaired electron left behind.
Example:hydroxylradicaloxidizesthesedativedrug
2.2 Howdofreeradicalsreact? promethazine(PR)toaradicalcation
Iftwofreeradicalsmeet,theycanjointheirunpaired PR+OH •→PR •++OH–
electronstoformacovalentbond.Thus,atomichydro-
4. AradicalmayabstractahydrogenatomfromaC–H
genformsdiatomichydrogen:
(orN–H)bond.AsH•hasonlyoneelectron,anun-
H • +H •→H pairedelectronmustbeleftonthecarbon(ornitro-
2
gen).Example:OH•abstractsH•fromahydrocarbon
Amorebiologically-relevantexampleisthefastreac- side-chainofafattyacidresidue(Section5.11.4).
tionofnitricoxide(NO•)andO •–toformanon-radical
2
product,peroxynitrite:2
NO
•
+O
•–→ONOO–(peroxynitrite)
2
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 86 ---

REDOX CHEMISTRY: THE ESSENTIALS 31
Table2.1 Nomenclatureofreactivespecies.
Freeradicals Non-radicals
Reactiveoxygenspecies(ROS) Reactiveoxygenspecies(ROS)
Superoxide,O •
2
– Hydrogenperoxide,H2O2
Hydroxyl,OH• Hypobromousacid,HOBra,b
Hydroperoxyl,HO • Hypochlorousacid,HOClb
2
Carbonate,
•
CO •
3
– Singletoxygen,O2 1(cid:6)g
Peroxyl,RO Organicperoxides,ROOH
2
Alkoxyl,RO• Peroxynitrite,ONOO–c
Carbondioxide,CO •
2
– Peroxynitrate,O2NOO–c
SingletO2 1(cid:7)g+ Peroxynitrousacid,ONOOHc
Peroxynitricacid,O2NOOHc
Nitrosoperoxycarbonate,ONOOCO–
2
Peroxomonocarbonate,HOOCO–
2
Reactivechlorinespecies(RCS) Reactivechlorinespecies(RCS)
Atomicchlorine,Cl• Hypochlorousacid,HOClb
Nitrylchloride,NO2Cld
Nitrosylchloride,NOCld
Chloramines
Chlorinegas,Cl2
Brominechloride,BrCla
Chlorinedioxide,ClO2
Reactivebrominespecies(RBS) Reactivebrominespecies(RBS)
Atomicbromine,Br• Hypobromousacid,HOBrb
Brominegas,Br2
Brominechloride,BrCl
Reactivenitrogenspecies(RNS) Reactivenitrogenspecies(RNS)
Nitricoxide,NO• Nitrousacid,HNO2
Nitrogendioxide,NO • Nitrosylcation,NO+
Nitrateradical,NO • 2 Nitroxylanion,NO–
3
Dinitrogentetroxide,N2O4
Dinitrogentrioxide,N2O3
Peroxynitrite,ONOO–c
Peroxynitrate,O2NOO–c
Peroxynitrousacid,ONOOHc
Peroxynitricacid,O2NOOHc
Nitronium(nitryl)cation,NO+
2
Alkylperoxynitrites,ROONO
Alkylperoxynitrates,RO2ONO
Nitrylchloride,NO2Cl
Peroxyacetylnitrate,CH3C(O)OONOe
2
‘Reactiveoxygenspecies’isacollectivetermforagentsmorereactivethanO2itself(Section1.9)andincludesboth
oxygenradicalsandcertainnon-radicalsthatareoxidizingagentsand/orareeasilyconvertedintoradicals(such
asHOCl,HOBr,ONOO–,H2O2).PeroxynitriteandH2O2arefrequentlyerroneouslydescribedintheliteratureas
freeradicals,forexample.AlloxygenradicalsareROS,butnotallROSareoxygenradicals.Remember
ofcoursethatO2isitselfaradical!(Fig.1.14).‘Reactivenitrogenspecies’isasimilarcollectivetermthatincludes
• •
N H su 2 O c O h 2 a a , s n N d R O O N • • 2 O , , 2 a N , n O d a • 3 s O , w • 2 R – e O ll r • e a , a s H c n t O o f C n a l - s , r t a H d w O i i c B t a h r l , s fe C s w u O c • 3 h m – o a , s l C ec H O u N • 2 le – O s , 2 , N w a O h n • 2 e d , re N O a 2 N s O O O 4 O H . – • ‘R , e r C e a l a c • c t , i t v s B e r f ’ • a i s , s t N n w o O i t t + 2 h a , l a w a l n a m d y o s s O a t 3 n e h v a e a p r v p y e t r h o i i n p n t r g e ia . r t m S e p e t d e e c i r a i m e te s :
reactivities.
aHOBrandBrClcouldalsoberegardedasRBS. bHOClandHOBrareoftenincludedasROS.
cONOO–,O2NOO–,O2NOOH,andONOOHareoftenincludedasROS.
dNO2ClandNOClcanalsoberegardedasRNS. eAnoxidizingspeciesformedinpollutedair.

--- Page 87 ---

32 FREE RADICALS IN BIOLOGY AND MEDICINE
2.3 Radicalchemistry:thermodynamics The measured voltage is given a negative value. If a
versuskinetics copper rod/1M Cu2+ solution is connected to the
hydrogen electrode, electrons flow the other way,
Classicalthermodynamicsdealswiththepossibilityof
thatis
chemicalreactionsoccurring:aretheypossibleorim-
possible?Areactionisthermodynamicallypossibleif (cid:4) (cid:5)
its free energy change, (cid:6)G, is negative. If a reaction
Cu2++2e–→Cu Cu2+isreduced
ispossible,howfastdoesitoccur?Thisistheareaof H →2H++2e–(H isoxidized)
2 2
chemicalkinetics;athermodynamicallypossiblereac-
tion may be very slow, or not occur at all. Catalysts Net:Cu2++H →Cu+2H+
2
such as enzymes can only speed up thermodynamic-
allypossiblereactions.
Themeasuredvoltageisgivenapositivevalue.These
Applicationofthermodynamicstolivingorganisms
voltages are called standard reduction potentials,
is fraught with difficulty, however, since numerical
values of thermodynamic parameters such as (cid:6)G in symbolized by E◦. Sometimes they are called elec-
trodepotentials.AsystemwithanegativeE◦ should
the chemical literature often refer to reaction condi-
reduce (i.e. donate electrons to) one that has a posi-
tions inappropriate to living organisms. In addition,
tiveE◦.Thus,ifweconnecttheCu/Cu2+half-celltothe
biochemical reactions are closely inter-linked; for ex-
Zn/Zn2+half-cell,thelattershouldreducetheformer,
ample, an ‘impossible’ reaction can be coupled to a
i.e.thepredictedreactionis
possibleonesothatthecombinationisfeasible,e.g.by
rapidlyremovingthereactionproductsofthe‘impos-
sible’reaction. Zn → Zn2++2e–(zincisoxidized)
(cid:4) (cid:5)
Cu2++2e–→Cu Cu2+isreduced
2.3.1 Redoxchemistry
A frequently used parameter in understanding the Net: Zn+Cu2+→Zn2++Cu
chemistry of reactive species (RS) is reduction po-
Inlivingsystems,redox-activebiomoleculesarenot
tential, a thermodynamic quantity which determines
separatedbyelectricwiresandsaltbridgesintohalf-
the feasibility and direction of oxidation and reduc-
cells. Nevertheless, the same principle applies: a sys-
tionreactions.Forexample,acompoundissaidtobe
tem with a negative E◦ should reduce a system with
autoxidizable if it can be oxidized by O , a process
2 a less negative, zero, or positive E◦. To illustrate this
often called autoxidation (Section 1.10.2). Reduction
consider Table 2.2, a list of values for some biologic-
potentialscanbeusedtoattempttopredictwhichcom-
allyrelevantspecies,inascendingorder(thenumbers
pounds should or should not be autoxidizable. Even
are corrected for pH so as to be the value at pH
whenautoxidationisthermodynamicallypossible,its
7.0, often writte(cid:6)n as(cid:7)E◦(cid:4)).3 Top of the list is the hy-
rateisusuallyslow(Section1.10.2).
The reference standard for reduction potentials is drated electron e– aq , formed by radiolysis of water
thestandardhydrogenelectrode,aplatinumelectrode (Section2.3.3.1).Thisshouldreduceeverythingelsebe-
dippedinaonemolarsolutionofH+ionsandexposed lowit,e.g.hydratedelectronsarethermodynamically
topurehydrogen(H )gasatoneatmospherepressure capableofreducingparaquattoparaquatradical,fer-
2
at25◦C.Areversiblereactionoccurs: ric EDTA to ferrous EDTA, and O
2
to O •
2
–. Bottom of
thelistisOH•.Thisisthermodynamicallycapableof
1/2H
2
(cid:2)H++e–
oxidizingeverythingelseonthelist,thatis,everything
Ifthiselectrodesystemisconnectedtoasystemcon- elseshoulddonateelectronstoOH•.
taining a zinc rod in a one molar solution of Zn2+
ThedatainTable2.2canbeusedtopredictthedirec-
ions,electronsflowfromtheZn/Zn2+half-cellintothe
tionsofreactionsawayfromtheseextremes.Thusthe
hydrogenelectrode.Thustheoverallreactionis
ascorbate/ascorbylradicalsystemshouldbeabletore-
Zn→Zn2++2e–(zincisoxidized)a duce α-tocopheryl radical to α-tocopherol. Ubiquinol
(cid:4) (cid:5)
should do the same. Some reactions are, by contrast,
2H++2e–→H H+isreduced
2 thermodynamically impossible (‘unlikely’ is a more
Net:Zn+2H+→Zn2++H
2
realisticterm—seethecaveatsbelow).ThusO •
2
–isun-
likelytoreduceferrictransferrintoferroustransferrin
a For definitions of oxidation and reduction please see
(E◦(cid:4)=–0.4V),butitistheoreticallycapableofreducing
Table1.2.
ferricironinferritintoFe2+(E◦(cid:4)=–0.19V).

--- Page 88 ---

REDOX CHEMISTRY: THE ESSENTIALS 33
Table2.2 Somebiologicallyrelevantstandardreductionpotentials. involvedinareaction,pHisimportant.Althoughthe
valuesinTable2.2aremostlycorrectedtopH7,pHin
Couple Standard
livingorganismscanvarywidely,from<2inthegas-
reduction
tricjuiceto8inthestromaofilluminatedchloroplasts
potential(V)
(Section7.8).Thus‘real’reductionpotentialsinvivocan
Highly H2O/hydratedelectron(e–
aq
) –2.84 differenormouslyfromstandardvalues.Temperature
reducing is often different from 25 ◦C, especially in mammals.
CO2/CO •
2
– –1.80 TocorrectE◦valuesfortheeffectsofconcentrationand
O2,H+/HO •
2
–0.46 temperature(T)theNernstequationisused
Paraquat/paraquat•– –0.45 ‘effectivereductionpotential(cid:4)
Fe(III)-transferrin/Fe2+-transferrin –0.40(pH7.3)
O2/O • 2 – –0.35 =Eo+ RT log [oxidizedform]
NAD+,H+/NADH –0.32 nF 10[reducedform]
F FA e( D II , I) 2 -f H e + rri / ti F n A / D fe H r 2 ritin,Fe2+ – – 0 0 . . 1 1 9 8 A second caveat is that E◦ values predict what is
Dehydroascorbate/ascorbate•– –0.17 feasible, but not what necessarily occurs. An impos-
Fe(III)-EDTA/Fe2+-EDTA –0.12 sible reaction should never occur, but a feasible one
Ubiquinone,H+/ubisemiquinone –0.04 mightnoteither.Ratesofreactiondependupontem-
Fe(III)-ADP/Fe2+-ADP ~0.10 perature and concentration of reactants, and reacting
Fe(III)-citrate/Fe2+-citrate ~0.10 moleculesneedtohaveacertainenergywhentheycol-
Ubisemiquinone,H+/ubiquinol 0.20
lidetobreakthefirstbondsandgetthereactiongoing.
Ferricytochromec/ferrocytochromec 0.26
ascorbate•–,H+/ascorbate– 0.28 Ifthisrequiredactivationenergyishigh,thereaction
H2O2,H+/H2O,OH• 0.32 canbeslowormaynotoccuratall.
αT•,H+/αTH(α-tocopherol) 0.50
HU•–,H+/UH–(urate) 0.59 2.3.1.2 Thermodynamicsofoxygenreduction
RO • ,H+/ROO 2 H(peroxyl) ~0.77–1.44a
R O H S O • 2 • – 2 • 2 , – / , 2 R H H S + – + / / ( H H cy 2 2 s O O te 2 2 ine) 0 1 0 . . . 9 0 9 4 6 2 I th n e a E qu ◦(cid:4) e f o o u r s th so e l 4 u O e t – io + r n e , d 4 O u H 2 c + t i i s + o a n n 4 t e o e – x w → ce a l t l 2 e e H r nt O oxidizingagent;
RO•,H+/ROH(aliphaticalkoxyl) ~1.60 2 2
(resultsvariable) is about 0.8 V. Thus thermodynamically, the human
CO
•–,H+/HCO–
1.78
3 3 body should be rapidly oxidized by O in the air.
2
Highly OH•,H+/H2O 2.31 Fortunately,thereisalargeactivationenergyfor this
oxidizing
process! In crematoria, bodies are heated to a high
enough temperature to overcome this, and will then
Datalargelyfromref3,andarecorrectedtopH7.0unlessotherwisestated,i.e.
theyareE◦(cid:4) valuesratherthanE◦ values.Valuesquotedindifferentpapers burn fiercely. The mitochondrial electron-transport
canvarysomewhat.Foreachcouple,theoxidizedspeciesisontheleftandthe chain (Section 1.10.4) is a gradient of reduction po-
reducedspeciesontheright. tentialfromnegativetopositive:forexample,–0.32V
aForexample,thevalueforCCl3OO•,H+/CCl3OOHis1.19V. (NAD+/NADH), –0.18 V (FAD/FADH
2
), and 0.26 V
(oxidized/reducedcytochromec).
Direct 4e– oxidations by O probably never hap-
2
pen,whateverthermodynamicssays.ReactionsofO
2
2.3.1.1 Caveats
usuallyproceedinsingleelectronsteps,forreasonsex-
DonotgettooexcitedbythepredictivevalueofE◦,E◦(cid:4), plainedinSection1.8.ConversionofO toO •– seems
2 2
or other thermodynamic parameters. First, reaction toneedquitepowerfulreducingsystems
conditionsmakeabigdifference.Considerthehalf-cell
Zn/Zn2+:theE◦referstoasolutionwith1MZn2+ions. O 2 +e–→O • 2 – Eo(cid:4) = – 0.35V
At lower Zn2+ concentrations, the electron-donating
However, O concentration is an important variable:
2
capacitywillrise,astheequilibrium
this value refers to 1 atm of O (as does the value
2
Zn(cid:2)Zn2++2e– of +0.8 V for O 2 /2H 2 O).3 At lower (physiological)
O levels,thereductionpotentialwillrise(i.e.become
2
shifts to the right. At higher Zn2+ concentrations, lessnegative).Fora1MconcentrationofO ,thevalue
2
the electron-donating capacity falls. If protons are risestoabout–0.16V,anditwillrisefurtheratlower

--- Page 89 ---

34 FREE RADICALS IN BIOLOGY AND MEDICINE
O levels,evenbecomingpositiveatthelowintracellu- In the rate law R = k [A], the rate of reaction de-
2 1
larO levelsinvivo(Fig.1.4).Thus,ifthelevelofO
•–is
pendsonlyonthefirstpoweroftheconcentrationof
2 2
10–10MandthatofO is10–5M,thevalueis+136mV. A;anotherwayofsayingthisisthatthereactionisfirst
2
Someoftheseelectrodepotentialshaverecentlybeen orderwithrespecttoA.Therateconstantk iscalled
1
revisedslightly,buttheconclusionsareunaffected.4 a first-order rate constant, with units s–1. Now con-
MostoftheoxidizingpowerofO doesnotbecome sideranotherreactioninwhichtherearetwodifferent
2
availableuntilthethirdelectronreduction,generating reactants,forexample
OH•.TheE◦(cid:4)valuesareapproximately
A+B→products
O • 2 –+e–+2H+(cid:2)H 2 O 2 +0.94V Thistypeofequationoftenrepresentsthereactionof
afreeradical(A•)orotherreactivespecieswithsome
H O + e– + H+ (cid:2) H O +OH • +0.39V
2 2 2 othermolecule(B),anditusuallyfollowstheratelaw
OH • + e– + H+ (cid:2) H 2 O +2.31V R to = A• k , 2 [ f A ir • s ] t [B o ] r . d T er he w r it e h ac r t e io sp n e i c s t f t i o rs B t , o a r n d d er s w ec i o th nd re o s r p d e e c r t
overall;k isasecond-orderrateconstant,withunits
2
dm3mol–1s–1(M–1s–1).
2.3.2 Reactionratesandrateconstants
As an example of the information that can be
Therateofathermodynamicallypossiblereactionde- gleanedfromrateconstants,letuslookattheforma-
pendsontemperature,activationenergy,andconcen- tionofOH• fromH 2 O 2 inthepresenceofFe2+ orCu+
trationofthestartingmaterials(reactants). Ratescan ions,
bemeasuredbyfollowinglossofreactants,orforma- H O +Fe2+→Fe(III)+OH–+OH •
2 2
tionofproducts.Reactionrateistheamountofproduct
k =76M–1s–1(Fentonreaction)
formed in unit time, or the amount of reactant used 2
upinunittime.Ofcoursetheserateswillonlybethe
same if 1 mole of reactant forms 1 mole of product. H 2 O 2 +Cu+→Cu2++OH–+OH •
Timeisusuallyquotedinseconds(s)andtheamountin k =4.7×103M–1s–1
2
moles(mol).Totakeasimpleexample,suppose1mol
IfequalconcentrationsofH O aremixedwithequal
of compound A in 1 dm3 of solution is reacting to 2 2
concentrations of Fe2+ or Cu+, the initial rate of OH•
formanothercompound,B.Supposefurtherthatafter
formation with Cu+ will be greater by a factor of
onesecond,0.01molofAhavebeenconvertedintoB.
4.7×103/76,or61.8.Valuesoftherateconstantcanbe
The reaction rate (R) can then be expressed either as
applied to see how quickly a reaction might occur in
0.01molofBformedperdm3persecond,oras0.01mol
vivo.Forexample,intracellularconcentrationsofH O
ofAusedupper1dm3persecond. 2 2
andFe2+areusuallyverylow.Letusassumethatthey
Themathematicalrelationshipbetweenreactionrate
areinthe10–7 MrangeforH O (Section2.6.2.1)and
andreactantconcentrationiscalledtheratelaw.Inthis 2 2
themicromolar(10–6M)rangeforFe2+(Sections3.22.1,
case it is likely that R is proportional to the concen-
3.22.5,and5.3.3)andthattheFe2+ ischelatedtoATP
tration of A, expressed in molar (mol/dm3) terms.
(Table 2.3). If 10–7 M H O comes into contact with 1
This is mathematically equivalent to saying that R μMFe2+-ATP,howmuc 2 h 2 OH• radicalwillbeformed
is equal to the concentration of A multiplied by a
at37◦C?Theratelawis:
constant, the rate constant for the reaction. Thus the (cid:2) (cid:3)
rate law is R=k 1 [A], where k 1 is the rate constant R=k 1 [H 2 O 2 ] Fe2+–ATP
and [A] means the molar concentration of A. Once =1.6×104(10–7)(10–6)
the reaction has started, A is used up, [A] falls, and
=1.6 × 10–9moldm–3s–1
so R will fall. Hence rate measurements are often
made in the first few seconds of a reaction so that This seems a tiny figure, but remember that one
theconcentrationofreactantshasnotchangedsignifi- mole of a substance contains 6.023 × 1023 molecules
cantly from that originally present (so-called initial (Avogadro’s number). Hence the number of OH•
rate measurements). Rate constants, and hence rates formedperdm3persecondis9.6×1014—muchmore
ofreaction,increasewithtemperature(Table2.3gives impressive! If the cell volume is 10–12 to 10–11 dm3
anexample),soshouldbequotedforaspecifiedtem- (averagevolumesforalivercell)thismeansapproxi-
perature;butsometimestheyarenotinthefreeradical mately 1000 to 10,000 OH• formed per cell every
literature. second. Of course, as the reaction proceeds, Fe2+ and

--- Page 90 ---

REDOX CHEMISTRY: THE ESSENTIALS 35
Table2.3 Rateconstantsforreactionsofsomephysiologicalironchelateswithvariousperoxides.
Chelate Peroxide k(M–1s–1)
25◦C 37◦C
Fe2+-ATP H2O2 6.7×103 1.6×104
t-Butylhydroperoxide 1.3×103 2.7×103
Cumenehydroperoxide 3.1×103 6.5×103
Fe2+-citrate H2O2 4.9×103 Notdetermined
t-Butylhydroperoxide 1.8×103 3.4×103
Cumenehydroperoxide 2.2×103 4.2×103
DataabstractedfromFEBSLett.275,114,1990.
H O willbeusedupandtherateofOH• production H O ∗→H • +OH •
2 2 2
willfall,unlesstheyarecontinuouslyreplenished(as
Within the same time scale H O+ also reacts to
indeed they tend to be in vivo). Thus, even reactions 2
giveOH•
with low rate constants (such as the Fenton reaction)
can be biologically important if they produce highly H O++H O→H O++OH •
2 2 3
reactiveproducts.
Electrons become surrounded by clusters of water
moleculeswithin10–12to10–11 s.Thesehydratedelec-
2.3.3 Measuringreactionratesandrate
trons are powerful reducing agents (Table 2.2) and
constants are written as e– where ‘aq’ is an abbreviation for
aq
‘aqueous’.Hencethreedifferentradicalsareproduced
ManyreactionsofRSarefastandsospecialtechniques
on ‘pulsing’ an aqueous solution: H•, OH•, and e– .
are required to measure their rates. These include aq
Initially, these radicals form in clusters called spurs,
pulseradiolysisandstoppedflow.
micro-regionsofhighradicalconcentration.Radicalre-
2.3.3.1 Pulseradiolysis combinationswithinspurs,whichproduceH O and
2 2
Pulseradiolysis5ofsolutionsallowsdirectobservation H 2 ,areoverin10–8 s,andafterwardsthedistribution
ofradicalsisessentiallyhomogeneousinthesolution.5
of reactions of RS and can also be used to determ-
Can we select a particular radical to react with X?
ine pK values and reduction potentials. The com-
a
Yeswecan.Iftheaqueoussolutionissaturatedwithni-
pound (X) to be studied is dissolved (often in water,
trousoxide(N O)gasbeforepulsing,e– areremoved
sometimes in organic solvents) and placed in a reac- 2 aq
andconvertedintoOH•.
tion cell. Radicals are formed in the cell by a rapid
(10–6–10–10s)‘pulse’ofhighenergyelectrons,e.g.from e– +N O+H+→N +OH •
aq 2 2
a linear accelerator, and they attack X. The result-
ingX-derivedradicalsaremonitoredovertime.Since Bycontrast,ifthesolutionissaturatedwithO 2 andalso
manyradicalsabsorblightorfluoresceatwavelengths contains sodium formate (HCOONa), the following
different from their parent compound, the progress reactionsoccur
of the reaction can be followed by changes in the e– +O →O •–
aq 2 2
absorbance/fluorescencespectra.Electronspinreson-
ance(ESR)(Section6.2)canalsobeused. H • +HCOO–→H 2 +CO • 2 –
What radicals can be formed to attack X? During OH • +HCOO–→H O+CO •–
radiolysisofdiluteaqueoussolutions,mostoftheen- 2 2
ergy is absorbed by water to produce ionization and The carbon dioxide radical is powerfully reducing
excitationwithin10–16s: (Table2.2)andconvertsO 2 tomoreO • 2 –
2H 2 O→H 2 O++e–+H 2 O ∗ CO • 2 –+O 2 →O • 2 –+CO 2
wheree– representsanelectronandH O*anexcited- Thus relatively ‘clean’ sources of OH• or O •– can be
2 2
state water molecule. H O* undergoes homolytic fis- produced,sothattheyandtheirreactionswithXcan
2
sionin10–14to10–13s: bestudied.

--- Page 91 ---

36 FREE RADICALS IN BIOLOGY AND MEDICINE
Pulseradiolysishasbeenveryusefulininvestigating 2.4 Transitionmetals:biocatalyticfree
theratesandmechanismsofreactionsofOH•andO •– radicals
2
withbiologicalmolecules,andalsothemechanismsof
action of the superoxide dismutase (SOD) enzymes5 Most of the metals in the first row of the d-block in
the periodic table contain unpaired electrons in their
(Section 3.5). As well as direct observations of ab-
atomsand/orionsandarethusfreeradicals;oneex-
sorbance, fluorescence, or ESR spectra, ‘competition
ceptioniszinc(Table2.4).Indeed,itisappropriateto
methods’may be usedto measurereaction rates. For
example, OH• reacts with thiocyanate ion (SCN–) to classify most transition metal ions as radicals, since
manyoftheirbiologicaleffects,whetherbeneficialor
give a radical anion that absorbs light strongly at
around500nm,(SCN)•– deleterious(Table2.4),involvetheabilitytoacceptor
2
donatesingleelectrons,sincethesingle-electrontrans-
OH • +SCN–→(HOSCN) •–→OH–+SCN • fers they promote can overcome the spin restriction
SCN • +SCN–(cid:2)(SCN)•– ondirectreactionofO 2 withnon-radicals.Thereduc-
2 tionpotentialsoftransitionmetalionsdependonthe
Ifanothercompound(X)thatreactswithOH•isadded, ligands to the metal, and thus can be altered in dif-
it will intercept some of the OH•, and the absorb- ferent enzymes to allow the same metal to catalyse
ancechangedueto(SCN)•–formationwillbesmaller. different reactions. The danger is that, unless their
2
Knowing the concentrations of SCN– and X, and the availability is carefully controlled, transition metals
rateconstantsfortheabovereactions,therateconstant will catalyse unwanted free-radical reactions such
forreactionbetweenXandOH•canbecalculated. as autoxidations (Section 1.10.2) and OH• formation
Pulse radiolysis can be used to study many types (Section2.4.4).
ofradical,includingsemiquinones(Section2.5.3.5)and
theascorbylradical(Section4.2).Forexample,ascorbyl
2.4.1 Iron
radical can be generated in pulse radiolysis by re-
ducing dehydroascorbate with e– or by oxidizing
aq Iron has two common oxidation states in which the
ascorbatewithOH•:
electronconfigurationsare:
ascorbate–+OH •→OH–+ascorbate •
orwithanotheroxidizingradicalsuchasBr
•–,formed
2
byaddingbromide(Br–)ions,
OH • +2Br–→OH–+Br •–
2
2.3.3.2 Stopped-flowmethods
Stopped-flowmethods5–8aresometimesusedtostudy
Iron (IV), (V), and (VI) species also exist. For ex-
RS,especiallywhenthereactionratesaretooslowtobe
ample, ferryl (iron (IV)) species are involved in the
measuredconvenientlybypulseradiolysis,yettoofast
mechanisms of action of catalases, peroxidases, and
to be measured by standard biochemical techniques.
cytochromesP450(Sections1.4.1,3.17,and3.19.3).
Solutionsofthecompoundstobereactedareplacedin
Insolutioninthepresenceofair,iron’smoststable
separatesyringes,connectedtoaquartzreactioncell. oxidationstateisFe(III),whereasFe2+saltsareweakly
To startthereaction,theplungersare pushed sothat
reducing,andferrylorferratecompoundsarepower-
thesyringecontentsareforcedsimultaneouslyintothe fuloxidizingagents.IfasolutionofanFe2+salt,suchas
reactioncell,wheretheymixandreact.Absorbance(or
ferroussulphate(FeSO ),isleftexposedtoair,itslowly
4
other)changescanbemeasuredandrecordedandre- oxidizestotheiron(III)state.TheFe2+undergoesone-
actionratescalculated.Forexample,asolutionofO
•–
(asitspotassiumsalt,K+O • 2 –)inanorganicsolventca 2 n e re le d c u tr c o e n d9 o t x o id O a • t – ion,andO 2 dissolvedinthesolutionis
2
beplacedinonesyringeandmixedwithacompound
inaqueoussolutionfromtheother,tomeasuretherate Fe2++O (cid:2)[Fe2+–O (cid:2)Fe(III)–O •–](cid:2)Fe(III)+O •–
2 2 2 2
ofreaction.Stopped-flowhasbeenusedtostudyreac- Intermediatecomplexes
tionsofseveralspecies,includinghypochlorousacid,6
peroxynitrite,andpotassiumferrate,anFe(VI)species The rate of oxidation of Fe2+ is markedly affected by
(K FeO ).7 ligandsbindingtoit.InFe2+,allfive3dorbitalshave
2 4

--- Page 92 ---

REDOX CHEMISTRY: THE ESSENTIALS 37
Table2.4 Biologicalimportanceofsomed-blockelements.
Metal Biochemicalsignificance Cross-references
Copper(Cu) EssentialindietforenzymessuchasEC-SOD,CuZnSOD,cytochromeoxidase, Sections2.4.2and3.22.2
lysyloxidase,dopamine-β-hydroxylase,andcaeruloplasmin.About80mgtotal
Cuinadulthumans(highestconcentrationsinliverandbrain).Bothexcessand
deficiencyofCucancauseoxidativestress,althoughCutoxicityinvolvesseveral
additionalmechanisms.
Zinc(Zn) Non-transitionelement,fixedoxidationnumberof2(Zn2+);2–3gpresentin Sections 9.16.12 and 10.17,
adulthumanbody(anamountsecondonlytoiron).OftensuggestedthatZn alsoseeFreeRadic.Biol.Med.
canactasanantioxidantbydisplacingironionsfromtheirbindingsitesand 53,1748,2012.
inhibiting iron-dependent oxidative damage. Essential in diet; found in RNA
polymerase,carbonicanhydrase,CuZnSOD,glyoxalaseI,EC-SOD,‘zincfingers’.
Toxicinexcess,especiallytoneurons.
Vanadium(V) Essentialinanimaldietandpossiblysoinhumans(suspected,butnotproven,to Section9.16.9
beinvolvedinregulationofglucosemetabolism).VanadateinhibitstheATPase
enzyme,whichexchangesNa+andK+ionsacrosscellmembranesandmayalso
affectproteinkinaseandphosphataseenzymes.
Chromium(Cr) Possibly essential in human diet, suggested to be involved in regulation of Section9.16.4
glucosemetabolism.ChromatesdamageDNA.
Manganese(Mn) Essential in diet. Needed for MnSOD, arginase, also activates a number of Sections7.8.2and9.5.6
hydrolase and carboxylase enzymes. Toxic in excess: in brain can cause a
Parkinsonian-typesyndrome.Playsakeyroleinphotosynthesis.
Iron(Fe) Essential in diet: deficiency causes anaemia. Commonest transition metal in Sections2.4.1and3.22.1
humanbody(about4–5gpresent).Neededforhaemoglobin,myoglobin,cyc-
looxygenases,cytochromes,manyhydroxylase/oxidaseenzymes,ribonucleotide
reductase,aconitase,succinatedehydrogenase,catalase,andmanyothers.Both
ironexcessandirondeficiencycancauseoxidativestress.
Cobalt(Co) EssentialinvitaminB12.CobaltionscancauseDNAdamage. Sections8.2and9.16.5
Nickel(Ni) Possiblyessentialinanimals,requirementinhumansnotestablished.Carcino- Section3.5.5
genicinexcess.Foundinureaseinplantcellsandbacteria(includingH.pylori)
andinseveralbacterialenzymes,suchasE.coliglyoxalase1,andsomebacterial
hydrogenases and carbon monoxide dehydrogenase. Some nickel-containing
SODenzymesexist.
Tungsten(W) Noreportsofinvolvementinanimalmetabolism.Caninhibitxanthineoxidase Section10.6.3
whenadministeredtoanimals,byreplacingessentialmolybdenum(J.Biol.Inorg.
Chem.1,292,1996;J.Biol.Chem.278,47285,2003).Tungsten-containing
enzymesreportedinseveralanaerobicbacteria.
Molybdenum(Mo) Essentialintraceamountsinhumandietforsomeflavinmetalloenzymes,e.g. Section1.10.1
xanthinedehydrogenase,aldehydeoxidase,andsulphiteoxidase.
the same energy and the electron configuration fol- tooxidize.Thisstateispresentinoxyhaemoglobinand
lows Hund’s rule as explained in the appendix. The oxymyoglobin.Bycontrast,Fe2+inthedeoxy-proteins
iron has four unpaired electrons and is said to be in isinthehigh-spinstate.
the high-spin state. Surrounding the Fe2+ with lig-
ands can alter the energy levels of some of the 3d
orbitals;iftheenergydifferencesbetweendifferent3d
2.4.2 Copper
orbitalsaresufficient,theelectronscanpairupintothe
lower-energyorbitals.TheFe2+istheninalow-spin Copper has two common oxidation numbers, copper
state,withnounpairedelectrons,andismoredifficult (I)andcopper(II),asshownbelow.

--- Page 93 ---

38 FREE RADICALS IN BIOLOGY AND MEDICINE
Copper (I) readily undergoes self-reaction if it when bound to phosphate and carbonate but not
accumulates. to citrate or pyrophosphate; also see Table 11.5).10
Thesereactionsarephysiologicallyimportantinsome
Cu++Cu+→Cu+Cu2+ bacteria (Section 3.8.2). In contrast with Fe2+ and
Cu+,unchelatedMn2+ appearsnottoreactwithH O
Theone-electrondifferencebetweenCu+andCu2+,or 2 2
to form OH• at a measurable rate.11 However, in
Cu2+ and Cu(III), allows copper to promote radical
HCO–-containingbuffer,Mn2+ plusH O canoxidize
reactions.Underappropriateconditions,forexample, 3 2 2
copperionsinteractrapidly8withO •– LDL and amino acids.12 Manganese is essential in
2
Cu2+ + O •–→Cu++O k=(5–8)×109M–1s–1
2 2
H++Cu++HO •→Cu2++H O k≈109M–1s–1
2 2 2
O •–+Cu++H O→Cu2++OH–+HO– k≈109M–1s–1
2 2 2
Net:O
•–+O •–+2H+→H
O +O
2 2 2 2 2
Thecopper,bychangingitsoxidationnumber,iscata-
lysingtheconversionoftwoO •– radicalsandtwoH+ the human diet, but too much can be neurotoxic
2 (Section9.5.6).
ionstoH O andO ,i.e.itiscatalysingthedismuta-
2 2 2
tionofO
•–
(Section2.5.3).Severalcopperionchelates
2
withbiologicalmoleculeshavebeenfoundtodothis 2.4.4 TheFentonreaction
(Section11.5.4).
Fenton chemistry is the prime example of dam-
aging free-radical reactions catalysed by transition
2.4.3 Manganese metals.13,14AmixtureofH O andanFe2+saltoxidizes
2 2
many different organic molecules, as first reported
ManganeseismoststableinaqueoussolutionasMn2+;
byDr.Fentonin1876,usingtartaricacid.Althoughthe
oxidizingspeciessuchasMn(III),Mn(IV),andMn(VII) majorityofevidencefavoursOH•astheprimarydam-
alsoexist.Mn2+caninteractwithO •–
2 agingspecies,otherreactivespeciesmaybegenerated
Mn2++O •–→MnOO+
onthepathwaytoOH•formation.14,15
2
2MnOO++2H+→2Mn2++H 2 O 2 +O 2 Fe2++H 2 O 2 →intermediateoxidizingspecies(??)
→Fe(III)+OH • +OH–
Like copper, Mn2+ is thus capable of catalysing the
dismutationofO • 2 – toH 2 O 2 ,toanextentconsiderably The Fenton reaction is thermodynamically favoured
affected by the ligands bound to it (e.g. it works since E◦(cid:4) for H O /OH• is ~0.32 V, whereas E◦(cid:4) for
2 2

--- Page 94 ---

REDOX CHEMISTRY: THE ESSENTIALS 39
aqueous iron ions at pH 7.0 is ~0.11 V, although this Fentonreagents,butsomeEDTAisdestroyedduring
valueisaffectedbytheligandtothemetal(Table2.5). thereaction.14
WhetheranyreactivespeciesotherthanOH•isindeed Thereismuchconfusionintheliteratureaboutche-
formedduringFentonchemistryisuncertain;although latorsas‘inhibitors’or‘promoters’ofFentonchemis-
Fe(IV)speciesareoftensuggested,thereisnocompel- try.Fromsimplechemicalprinciples,anironchelator
lingevidencefortheirexistenceinFe2+–H O systems thataffectstheobservedrateofOH• productionfrom
2 2
(although they do form when haem-iron reacts with amixtureofironionsandH O coulddosoby:
2 2
H O ;Sections3.17and3.19.3).Ferrylcouldconceiv-
2 2 (a) alteringthereductionpotentialofironionstofa-
ablybetheintermediateoxidizingspeciesindicatedin
vour(e.g.EDTA)ordisfavouroxidationbyH O
theaboveequation. 2 2
(Table2.5);
Iron(III) attached to some ligands can react further
(b) blockingaccessofH O totheiron;
withH O ,althoughthisisusuallyslowerthanthere- 2 2
actiono
2
fH
2
O withFe2+attachedtothesameligands.
(c) promoting oxidation of Fe2+ to Fe(III), which is
Generation 2 of 2 OH• by mixturesof certain Fe(III)che- l
‘b
es
u
s
rs
r
t
e
’
a
o
c
f
ti
O
ve •– w
p
i
r
t
o
h
d
H
uc
2
t
O
io
2
n
;t
(
h
e.
i
g
s
.
w
fo
il
r
l
d
r
e
e
s
s
f
u
e
l
r
t
r
i
i
n
ox
a
am
sh
in
o
e
rt
;
lates (e.g. ferric EDTA) and H O appears to involve 2
O •–,sinceitisinhibitedbySOD 2 .16 2 Theexactchemistry Section11.6.1)
2
leadingtoO •–andOH • formationisunclear. chelate–Fe2++O →chelate–Fe(III)+O •–
2 2 2
ManymorereactionsarepossibleinFentonsystems,
(d) intercepting OH• before it can escape from the
including
vicinityoftheironchelate,aprocessthatdepends
OH • +Fe2+→Fe(III)+OH– on the geometry of the ligand–iron complex and
therateofreactionoftheligandwithOH•;
OH • +H 2 O 2 →H 2 O+H++O • 2 – (e) interceptingOH• precursors(suchastheputative
ferrylintermediate);
Which reactions occur depends on the experimental
(f) if the chelator is in excess over the iron, some of
conditions, especially pH and the concentrations of theunboundchelatorcouldscavengeOH• infree
H O and Fe2+. If nothing else is added for OH• to
2 2 solution;
attack,itwillreactwithH
2
O
2
oroxidizeFe2+toFe(III)
(g) keepingironionsinsolutionathigherconcentra-
(k ≈3.5×108M–1s–1).Thus,highconcentrationofFe2+
2 tionsthanintheabsenceofthechelator;
or H O can decrease the yield of OH•. The overall
2 2 (h) anycombinationoftheaboveactions.
reaction, unless some other reagent is added, is an
iron-catalyseddecompositionofH O Theseprinciplesareimportantinthedesignofchela-
2 2
tors for therapeutic use and are discussed further in
2H O −−Fe−s−a→lt O +2H O Section11.6.
2 2 2 2
catalyst
Added organic molecules are attacked by the OH•, 2.4.6 ReactionofcopperionswithH 2 O 2
generating radicals that can undergo further reac- ThismayalsobeasignificantsourceofOH•invivo
tions, often including oxidizing or reducing the iron
ions. Cu++H O →Cu2++OH • +OH–
2 2
Copperionsbindavidlytomanybiologicalmolecules,
whichwill‘target’OH• tothebindingsite,makingit
2.4.5 IronchelatorsandFentonchemistry:
difficult to scavenge by any added OH• scavengers.
speedituporslowitdown?
Thus,failureofOH• scavengerstoinhibitdamageby
The rate constant for reaction of Fe2+ with H O is Cu/H O systems cannot be used as evidence that
2 2 2 2
<102 M–1s–1, but larger when the iron is attached to OH• isnotcausingthedamage.Forexample,Cuions
certain ligands (Table 2.3) including ATP, citrate, and promote H O -dependent damage to the Na+, K+-
2 2
oxalate.15,17 Ligandscanalsofacilitatethereactionby ATPaseiontransporteratthespecificsitestowhichthe
keepingFe2+ insolution,preventingitfromoxidizing copperbinds.18 AnothersuggestionisthatCu+ reacts
toFe(III)andprecipitating.However,ligandscanalso withH O ,nottogiveOH•,butinsteadanoxo-copper
2 2
scavengeOH•;theligand,beingatahighlocalconcen- oxidizingspeciesinwhichthecopperisintheCu(III)
tration, is an easy target for attack by newly formed state.However,Cu(III)couldalsoresultfromreaction
OH•. For example, iron–EDTA chelates are excellent ofCu2+ withOH•.Themajorityofevidencesuggests

--- Page 95 ---

40 FREE RADICALS IN BIOLOGY AND MEDICINE
Table2.5 Somestandardreductionpotentialsforironchelatorsin 2. Fromhypochlorousacid6reactingwithO •–:
2
relationtointeractionwithsuperoxide3.
HOCl+O •–→O +Cl–+OH •
Couple E◦(cid:3)(V) 2 2
k=7.5×106M–1s–1at25◦C
O2/O •
2
– –0.35
HOCl can also react with Fe2+ and certain iron
Likelyreductions
chelates, such as ferrocyanide and Fe2+-citrate, to
Fe(III)-(1,10phenanthroline)3/Fe2+-(1,10phenanthroline)3 +1.15
generate a species that can hydroxylate aromatic
Fe(III)-cytochromec/Fe2+-cytochromec +0.26
compounds.Thesimplestexplanationwouldbe
Fe(III)-EDTA/Fe2+-EDTA +0.12
Fe(III)/Fe2+(aq) +0.11
Fe2+-chelate+HOCl→Fe(III)–chelate
Fe(III)-citrate/Fe2+-citrate +0.1
Fe(III)-ADP/Fe2+-ADP +0.1 +OH • +Cl–
Fe(III)-DETAPAC/Fe2+-DETAPAC +0.03 k=1.3×104M–1s–1at25◦C
Fe(III)-ferritin/Fe2+-ferritin –0.19
Unlikelyreductions However,theRSproducedhasbeensuggested(but
Fe(III)-transferrin/Fe2+-transferrin –0.40 not established) to be a higher oxidation state of
Fe(III)-desferrioxamine/Fe2+-desferrioxamine –0.45
iron6insteadofOH•.
3. Ultrasound.22 Sonication of aqueous solutions pro-
Remember that thesearethermodynamicdata;reactant concentrationsand duces OH•. How? Ultrasound causes formation,
rates of reaction must be considered. Thus Fe(III)-EDTA is reduced by O•
2
–
growth,andcollapseofgasbubbles,aneventcalled
muchfasterthanisFe(III)-DETAPAC,eventhoughbothreductionsarethermo-
acousticcavitation.Transientcavitationslead,upon
dynamically favourable (J.Am.Chem.Soc. 130, 1727, 2008). DETAPAC,
diethylenetriaminepenta-aceticacid.Also,rememberthattheE ◦(cid:4) forO 2/O•
2
– collapse, to ‘hot spots’ in which temperatures of
isgivenforoneatmosphereO2(Section2.3.1.2). several thousand degrees and pressures of hun-
dreds of atmospheres coexist, causing homolytic
fissionofH OtoH•andOH•.Unlikeradiolysis,hy-
2
thatOH• isaproductofCu/H 2 O 2 systems,although drated electrons are not normally produced. Does
possiblynottheonlyoxidizingspeciesformed.19,20 thishappenduringtheuseofultrasoundinmedical
diagnosticimaging?Formationofradicalsbyultra-
sonicationofhumanamnioticfluidinvitrohasbeen
2.5 Chemistryofotherbiologically demonstrated,23 butthelevelsformedinvivoseem
importantradicals tobeinsufficienttocauseconcern.Hydroxylradical
formation during cataract removal by phacoemul-
2.5.1 Hydroxylradical
sification (use of an ultrasonic probe to break up
2.5.1.1 Generation thelenswithintheeye,followedbyaspiration)has
alsobeenreported,althoughtheuseofhyaluronic
Hydroxyl radical8,21 can be produced by reaction of
acid-containingfluidsmayminimizeanybiological
metal ions with H O , or by UV-induced homolytic
2 2 impact,24 sincehyaluronicacidisapowerfulscav-
fissionoftheO–ObondinH 2 O 2 engerofOH•.
Kidney stones can be fragmented by shock wave
H–O–O–H
−U→V
2OH
•
lithotripsy techniques, using rapid sonic pulses.
Inthelaboratory,steady-stategenerationofOH•from Studies in humans suggest that oxidative damage
can occur during this procedure, but it may not
H O can be carried out using a low-wavelength UV
2 2
be clinically significant.25 Sonication of lipids in
(approximately 254 nm) source. Hydroxyl radicals
the preparation of liposomes for studies of lipid
can also be generated from ozone and peroxynitrite
peroxidation (Section 5.11) is also likely to lead to
(Sections2.6.5and2.6.1).Othersourcesinclude:
generationoffreeradicalsthatcauselipidoxidation.
1. Ionizingradiation.Sincethemajorconstituentofliv- 4. Decompositionof N-hydroxythiopyridoneshasbeen
ingcellsiswater,exposuretohigh-energyradiation suggested as a simple laboratory source of OH•,
such as γ-rays will result in OH• production by althoughthereactionalsoproducesasulphurrad-
homolyticfissionofwater.Hydroxylradicalsarere- ical(Fig.2.1),whosereactivitymustbeconsidered.
sponsible for much of the damage done to living N-hydroxypyridonesareanalternative,producing
organismsbyionizingradiation(Section9.20). OH• andanalkoxylradical(Fig.2.1b).Someofthe

--- Page 96 ---

REDOX CHEMISTRY: THE ESSENTIALS 41
(a) Figure2.1 FormationofOH•from
hv + OH(cid:129) (a)N-hydroxy-2-thiopyridoneand
· (b)N-hydroxy-2-pyridone.AdaptedfromAnal.
N S N S Biochem.206,309,1992bycourtesyofDrT.A.
DixandAcademicPress.Thecompoundsrelease
OH OH•onexposuretovisiblelight.Athiylradicalis
alsoproduced.Ifthe–OHgroupisreplacedby
–OR,thenalkoxyl(RO•)radicalscanbe
(b) generated(FreeRad.Biol.Med.24,234,1998).
N-hydroxy-4-thiopyridoneshavealsobeenused.
hv
N-hydroxy-2-pyridone(J.Am.Chem.Soc.118,
N O N O · + OH(cid:129) 10124,1996;Meth.Enzymol.300,194,1999),
generatesaromaticalkoxylinsteadofaromatic
OH thiylradicals.
OH• canbeinterceptedbythearomaticringofthe In aqueous solution, OH• has a nondescript ab-
moleculeitself. sorbance spectrum, with a weak absorbance peak at
5. Production from quinones. Quinones and semiquin- 230nm.Itionizesatveryalkaline,biologicallyirrelev-
ones can generate OH• from H O by redox ant,pHvalues:
2 2
reactions involving iron ions (Section 10.16.2).
OH •(cid:2)O–+H+ pK ≈12
Inaddition,ithasbeenshownthattetrachloro-1,4- a
benzoquinone(TCBQ), IftwoOH•radicalsmeet,theycanformH O :
2 2
OH • +OH •→H O k=5×109M–1s–1
2 2
Althoughthisreactionhasahighrateconstantandoc-
curs in spurs during radiolysis (Section 2.3.3.1), it is
unlikelytooccurinvivobecausethesteady-statecon-
centrationofOH•iseffectivelyzero.AssoonasOH•is
a metabolite of the carcinogenic wood preserva-
formed,itreactsveryquicklywithmoleculesinitsim-
tive pentachlorophenol (Section 9.3.2), can gen-
mediatevicinity(Table2.6).Hydroxylradicalcanalso
erate OH• from H 2 O 2 by metal ion-independent abstractH• fromwater,propagatingitselfinaqueous
reactions.26Themechanisminvolvesformationofa
solution,28
peroxideintermediatethatcleaveshomolyticallyto
releaseOH•. H
2
O+OH •→OH • +H
2
O
RateconstantsforOH• reactionshavemainlybeen
2.5.1.2 Chemistry8,21 determinedbypulseradiolysis,althoughothermeth-
ods exist (Section 6.3). The values are almost always
In the upper atmosphere, OH• exists in the gaseous veryhigh(Table2.6);indeed,OH•isthemostreactive
state and plays an important role in oxidizing many oxygen radical known, with a highly positive reduc-
non-CO 2 greenhousegases(e.g.CH 4 )andvariousair tionpotential(Table2.2).Forexample,scientistshave
pollutants.Indeed,OH• hasbeencalled‘themostim- sometimes studied OH• reactions in solutions con-
portantchemicalcleansingagentoftheatmosphere’.27
tainingTris,Tricine,orHEPESbuffers.Unfortunately,
Itcanbeformed,amongotherreactions,byphotolysis OH• attacksthemrapidlyandbuffer-derivedradicals
ofatmosphericnitrousacidandofozone, areproduced,oneend-productofOH•attack29onTris
beingformaldehyde.Laboratorybuffersarefrequently
HNO 2 →OH • +NO • thought of as inert, but they can participate in many
O
−−U−V−→O+O freeradicalreactions,ascantheCO 2 /HCO 3 –dissolved
3 2 inthem(e.g.Section2.5.2).
O+H O→2OH • ReactionsofOH•areofthreemaintypes:hydrogen
2
abstraction,addition,and electrontransfer.Remem-
ber that reaction of a free radical with a non-radical
andalsowhenO reactswithalkenes(Fig.2.15). produces a different radical. Let’s illustrate this with
3

--- Page 97 ---

42 FREE RADICALS IN BIOLOGY AND MEDICINE
Table2.6 Some second-order rate constants for reactions of the Mannitol 2.7×109
hydroxylradical. Methanol 4.7×108
Compoundtested Rateconstant(M–1s–1) Methionine 5.1×109
Nicotinicacid 6.3×108
Fe2+ 3.5×108
Phenol 4.2×109
H2O2 4.5×107
Phenylalanine 3.5×109
Adenine 3.0×109
Propan-1-ol 1.5×109
Adenosine 2.5×109
Pyridoxalphosphate 1.6×109
Albumin >1010
AMP 1.8×109 Ribonuclease 1.9×1010
Arginine 2.1×109 Ribose 1.2×109
Ascorbicacid 7.2×109 Thiourea 4.7×109
Benzene 3.2×109 Thymine 3.1×109
Benzoicacid 4.3×109 Trisbuffer 1.1×109
Butan-1-ol(n-butanol) 2.2×109 Tricinebuffer 1.6×109
Butylatedhydroxyanisole 6×109 Tryptophan 8.5×109
Butylatedhydroxytoluene 6×109 Uracil 3.1×109
Catalase 2.6×1011 Urea <7.0×105
Citricacid 3.0×107 ValuesmostlytakenfromInt.J.Appl.Radiat.Isotopes18,493,1967;some
Cysteine 7.9×109 fromAnal.Biochem.165,215,1987,andweremeasuredatvariouspHval-
ues.ThevalueformannitolisfromFreeRadic.Res.Commun.4,259,1998and
Cystine 2.0×109 thoseforHEPES,TRIS,andTricinebuffersfromFEBSLett.199,92,1986.Note
thatOH• reactswithalmostallbiomoleculessorapidlythatoftenthereac-
Cytidine 2.0×109 •
tionislimitedonlybytherateatwhichOH contactsthemoleculeinsolution
Cytosine 2.9×109 (adiffusion-controlledrate).Ureaisarareexception:itsrateconstantislow
forareactionwithOH•butstillhighwhencomparedwiththatofmanyother
Deoxyribose 3.1×109 reactions(e.g.Fentonreactions:Table2.3).Acompendiumofrateconstantsfor
Desferrioxamine 1.3×1010
reactionsofOH•andseveralotherRScanbeaccessedontheNISTdatabase
(http://kinetics.nist.gov/solution/welcome.jsp).
Dimethylsulphoxide 3.5×109
EDTA 2.8×109 OH•, using its reaction with ethanol as an example.
Ethanol 7.2×108 The OH• abstracts H• and instantly combines with it
Formate 3.5×109 toformwater,leavingbehindanunpairedelectronon
thecarbontogenerateahydroxyethylradical,
Glucose 1.0×109
Glutamicacid 7.9×109
Glutathione 8.8×109
Glycylgycine 7.8×107
Glycyltyrosine 5.6×109
Hydroxyethyl radicals contribute to ethanol tox-
Guanine 1.0×1010
icity (Section 9.8.1) and deterioration of wines
Haemoglobin 3.6×1010 (Section9.8.1),andarepresentattheactivesitesofcer-
HEPESbuffer 5.1×109 tainenzymes(Section8.3.1).Oncecarbonradicalsare
formed,theyoftenreactwithO
Histidine 3.0×109 2
•
Hydrogen(H2) 4.2×107 CH
3
CHOH+O
2
→•O
2
CH
3
CHOH
Hydroxyproline 2.1×108 peroxylradical
Lactateion 4.8×109 or(ifO 2 levelsarelow),theycanreactwitheachother,
Lecithin 5.0×108 formingacovalentbondandanon-radical,

--- Page 98 ---

REDOX CHEMISTRY: THE ESSENTIALS 43
• •
CH CHOH+CH CHOH→CH CHOH ortyrosine,
3 3 3
| tyr–OH+CO •–→Tyr–O • +HCO– k=4.5×107M–1s–1
3 3
CH CHOH
3
or NAD(P)H (Section 2.6.1), and it can oxidize as-
Reaction of OH• with aromatic compounds often corbate, methionine, and guanine. Carbonate rad-
proceedsbyaddition.Forexample,OH•addstoguan-
ical is also involved in the ‘peroxidase’ reactions of
ineinDNAtoformaradical(Section5.8.2.1).Similarly, CuZnSOD (Section 3.5.1.6). Overall, however, CO •–
OH•canaddontodoublebonds,
is less damaging to proteins, lipids, and DNA tha
3
n
is OH•. More work is needed to ascertain the contri-
butionofCO •–tooxidativedamageinvivo.
3
Anotherspeciesofpossiblebiologicalinterestisper-
oxomonocarbonate,HCO–,reversiblyformed32 when
4
An example is the reaction of OH• with thymine; H 2 O 2 interactswithHCO– 3 (orCO 2 ),
the thymine radical undergoes further reactions, e.g. H O +HCO–(cid:2)H O+HOOCO–
2 2 3 2 2
withO (Fig.5.13b).
2 Itcanbereduced(e.g.byCu+)toreleaseCO •–,
Hydroxylradicalscantakepartinelectron-transfer 3
reactions,e.g.withhalideions, HOOCO–+Cu+→Cu2++CO •–+OH–
2 3
Cl–+OH •→Cl • +OH– HCO– has been proposed to be involved in the in-
Cl • +Cl–→Cl •– activa 4 tionofCuZnSODbyH O (Section3.5.1.6),and
2 2 2
alsoofcertainotherenzymes,suchasproteintyrosine
andwithnitrite,
phosphatases(Section5.5.4)
NO–+OH •→NO • +OH–
2 2
2.5.3 Superoxideradical
Superoxide5,8,21 is far less reactive than OH•, indeed
2.5.2 Carbonateradical
it does not react with most biological molecules in
ReactionofOH• withcarbonateorbicarbonateisalso aqueoussolution.Itdoesreactquickly,however,with
important;carbonateradicals30 areformed.Hencethe several other radicals, such as NO• (Section 2.5.6.2),
CO /HCO– content of reaction mixtures is an im- iron–sulphurclustersincertainenzymes(Section3.9),
2 3
portant (yet often overlooked) parameter in affecting and some phenoxyl radicals, such as that formed by
oxidative damage. The rate constants are lower than abstractinghydrogenfromthe–OHgroupoftyrosine
formostreactionsofOH•.Nevertheless,HCO– levels (k = 1.5×109M–1s–1).33 Atyrosinehydroperoxidere-
3
in vivo are high (e.g. 25 mM HCO– in blood plasma) sults,whichcanthenundergocyclizationandlossof
3
makingreactionfeasible, theperoxidegroup(Fig.2.2A).‘Repair’ofthetyrosine
radicalcanalsooccur,
CO2–+OH •→CO •–+OH– k=2×108M–1s–1
HC 3 O– 3 +OH •→H 2 3 O+CO • 3 – k=1×107M–1s–1 tyr–O • +O • 2 –+H+→Tyr–OH+O 2
Tyrosine
CarbonateradicalisalsoproducedwhenONOO– re-
acts with CO (Section 2.6.1) and when Mn2+ reacts Superoxidealsoreactswithcobalamin(Fig.8.2).
withH 2 O 2 in 2 thepresenceofHCO– 3 andCO 2 .12 Itcan ThereactivityofO • 2 – isinfluencedbysolvent,tem-
perature,andpH.ThepK ofthereaction
bemadeinthelaboratorybythedecompositionofaco- a
baltcomplex,[Co(NH 3 ) 4 CO 3 ]+,inducedbyUVlight.31 HO •(cid:2)H++O •–
2 2
Carbonate radicals absorb light at around 600 nm,
•
is approximately 4.8. Table 2.2 reveals that HO (hy-
making it easy to monitor their levels in reaction 2
droperoxyl)radicalisamorepowerfulreducingagent
mixtures.
than O •– (E◦(cid:4) values of –0.46 and –0.35 V, respect-
Carbonate radical is a powerful one-electron oxi- 2
dizing agent (E◦(cid:4) = 1.78V) and oxidizes a range of ively). Although at the pH of most body tissues the
ratio of [O
•–]/[HO •
] will be large (100/1 at pH 6.8,
biomolecules,includinghyaluronicacid.Forexample, 2 2
•
itcanabstractH•fromcysteine, 1000/1atpH7.8),thegreaterreactivityofHO
2
andits
unchargednature,whichmightallowittocrossmem-
cys–SH+CO •–→HCO–+cysS • k=4.6×107M–1s–1 branesmorereadilythanthechargedO •–,suggestthat
3 3 2

--- Page 99 ---

44 FREE RADICALS IN BIOLOGY AND MEDICINE
(a)
H 2 N R H 2 N R
O
(cid:129)–
+ O
(1) O O 2 O
O
TyrO(cid:129) I
HO
(2)
O NH R
O
O
HO II
(3) Nu
O NH R
+ NuOH
O
OH III
(4) GSH
O NH R
O
OH
IV
SG
(b) O(cid:129) O O O
(cid:129) (cid:129)
(cid:129)
R R R R
OH OH
R R

--- Page 100 ---

REDOX CHEMISTRY: THE ESSENTIALS 45
(cid:3)
Figure2.2 A.ProposedmechanismfortheformationoftheTyr-hydroxideGSHadduct.(1)AdditionofsuperoxidetoTyrosyl(tyrosinephenoxyl)
radicalsresultsintheformationofhydroperoxidespecies(I).Theschemeshowstheadditionattheparaposition,whichispreferredovertheortho
position.(2)additionoftheTyraminonitrogengivesabicyclichydroperoxidederivative(II).(3)Reductionofthehydroperoxidespeciesbya
nucleophile(Nu)*givesthecorrespondingalcohol.(4)AdditionofGSHtotheα-βunsaturatedcarbonylgroupofIIIgivesIV.AdaptedfromJ.Biol.
Chem.287,26068,2012,bycourtesyofDrsChristineWinterbournandAndrewDasandtheAmericanSocietyforBiochemistryandMolecular
Biology.*TermisdefinedinSection2.5.3.6.
B.Cross-linkingoftyrosineresidues(seeAminoAcids25,227,2003).Thetyrosylradicalhasvariousresonancestructures(upperdiagram)andcan
cross-linkindifferentways,formingseveralbityrosines.Ristheside-chainoftheaminoacid.Thelowerdiagramshows3,3(cid:4)-bityrosine,
sometimescalledortho,ortho-bityrosineordityrosine(countingthe–OHgroupontyrosineasposition4).Thiscompoundhasanintense
fluorescenceataround420nmwhenexcitedat315nm(alkalinesolutions)or284nm(acidicsolutions).Bityrosinecross-linksarefoundinproteins
fromthecuticleofC.elegansandcertaininsects,someyeastandfungalcellwalls,thefertilizationenvelopeofthesea-urchin(Section8.5),and
thethyroidgland(Section8.10.2).AnyradicalreactiveenoughtoabstractH•fromtyrosineresiduesinproteinsmayleadtobityrosineformation.
ithasthepotentialtocausedamage.However,thishas (iv) PulseradiolysisgeneratesO
•–;itcanbedetected
2
not been convincingly demonstrated to be important byitsUV-absorbance(maximalabsorptionaround
invivotodate.AlthoughO
•–doesnotingeneralcross
245nm;forHO
•
225nm)oritsESRspectrum.
2 2
membranes, it can pass through the anion exchange (v) Enzymes and photochemical reactions are often
proteinspresentintheplasmamembranesofseveral used to generate O
•–.
Mixtures of xanthine or
2
cells,includingerythrocytesandsomelungcells(Sec- hypoxanthine with XO are widely used in bio-
tions7.3and7.5).Theseproteinsmayalsobepresent logical laboratories, but this enzyme also makes
insubcellularcompartments,suchasendosomes,34 to H O ;somepointstoconsiderinitsusearelisted
2 2
facilitatesignallingbyO
•–(Section5.5).
inFig.1.10.Xanthineoxidasepreparationsandla-
2
boratorybuffersarefrequentlycontaminatedwith
2.5.3.1 Makingsuperoxideinthelaboratory iron compounds, meaning that OH• radicals can
Variousmethodsareavailable:5,8,21,35–37 be made in reaction mixtures containing this en-
zymeanditssubstrates,
(i) Oxygen may be reduced electrochemically in an
Fe(III)+O
•–→Fe2++O
organic solvent such as dimethylsulphoxide or 2 2
acetonitrile. H O +Fe2+→Fe(III)+OH • +OH–
2 2
(ii) Tetraalkylammonium superoxides such as tet-
ramethylammonium superoxide ((CH ) N+O •–), Thispairofreactionsaddsupto
3 4 2
o (( r CH ) tr P im hN et + h O yl • p –) h , en ca y n lam be mo d n is iu so m lved s i u n pe o r r o g x a id ni e c , H 2 O 2 +O • 2 –−F−e−ca−ta−ly→st OH • +OH–+O 2
3 3 2
solvents. and is often called the superoxide-assisted (or
(iii) Potassium metal can be burned in oxygen to driven)Fentonreaction.Manypublishedpapers
formtheioniccompoundpotassiumsuperoxide, have attributed effects of the xanthine/XO sys-
K+O •–, although usually it is far from pure. This temtoO •–,whentheyareinfactduetoH O or
2 2 2 2
salt is slightly soluble in organic solvents and toOH•.Thiscanbeavoidedbyaddingsufficient
its solubility can be increased by the addition of catalasetoremoveallH O generated,whichwill
2 2
crown ethers, such as dicyclohexyl-18-crown-6 stopOH•production.
(Fig. 2.3), cyclic molecules which bind K+. They (vi) SomeazocompoundsdecomposetogenerateO •–,
2
are soluble in organic solvents and so ‘drag into
solution’ the central K+ ion, together with its as- X – N=N–Y→X • +N 2 +Y •
sociated O •–. The reaction of O •– with another X • (Y • )+O →X+(Y+)+O •–
2 2 2 2
compoundaddedtotheorganicsolventcanbeob-
One example is SOTS, di(4-carboxybenzyl) hy-
served,ortheKO -containingorganicsolventcan
2
ponitrite,
be mixed with an aqueous solution of the com-
pound,forexampleinstopped-flowexperiments
(Section 2.3.3.2). Superoxide dissolved in organic
solvents is stable if water is kept away, but dis-
appearsrapidlybydismutation(Section2.5.3.2)if Itsdecompositioninwaterat37◦C,pH7(half-life
moisturefromtheairisallowedin. ~82min)givesasteadysourceofO
•–.
2

--- Page 101 ---

46 FREE RADICALS IN BIOLOGY AND MEDICINE
CH 2 CH 2 Superoxide can also act as an oxidizing agent, e.g.
CH 2 O CH 2 with dopamine, adrenalin (Section 3.5.6), and ascor-
bate(AH ),
2
CH 2 CH 2 CH O K+ O CH CH 2 CH 2 AH 2 +O • 2 –→A •–+H 2 O 2
CH 2 CH CH CH 2 The rate constant for the above reaction has been
CH 2 O O CH 2 quotedas2.7×105M–1s–1at25◦CandpH7.4.Super-
oxidedoesnotdirectlyoxidizeNADPHorNADH,but
CH 2 O CH 2 itcaninteractwithNADHboundtotheactivesiteof
CH CH
2 2 the enzyme lactate dehydrogenase (LDH) to form an
Figure2.3 Structureofdicyclohexyl-18-crown-6.TheK+ionfitsinto
NAD•radical,
thecentral‘hole’. LDH–NADH+O •–+H+ →LDH–NAD • +H O
2 2 2
UnlikeO •–, HO • canoxidizeNADHdirectly(k =1.8×
2.5.3.2 Reactionsofsuperoxide8,21 105M–1s– 2 1)toNA 2 D•. 2
The rapid disappearance of O • 2 – in aqueous solution Asmentionedearlier,however,O • 2 –inaqueoussolu-
is due to the dismutation reaction. Dismutation is a tionatpH7.4ispoorlyreactive,e.g.itsratesofreaction
chemicalreactioninwhichthesamespeciesisbothoxi- with DNA, lipids, amino acids, and most other bio-
dized and reduced. In this case, one O •– is oxidized molecules are low, or zero. For example, its reaction
2
(toO )andanotherisreduced(toH O ).Theoverall with GSH proceeds, if at all, with a rate constant38
reacti 2 onis 2 2 ≤200M–1s–1. Biological damage by O • 2 – is highly se-
lective and usually involves its reaction with other
O • 2 –+O • 2 –+2H+→H 2 O 2 +O 2 radicals, such as NO• or iron ions in iron–sulphur
proteins (Section 3.9). It also reacts with HOCl and
However,therateconstantforthisreactionaswritten
chloramines(Section2.6.3).
isclosetozero.Bycontrast,thereaction
HO
•
+O
•–+H+→H
O +O
2.5.3.3 Superoxide–ironinteractions8,13,16,17
2 2 2 2 2
WorkinBielski’slaboratoryestablishedthefollowing
has k 2 =9.7 × 107M–1s–1. Hence dismutation under rateconstantsforreactionofO • 2 –orHO • 2 withaqueous
physiological conditions usually proceeds by proton- ironsalts:
a O t • io –. n D o i f sm O • 2 u – ta fo ti l o lo n w i e s d th b u y s r m ea o c s ti t o r n ap of id H a O t • 2 th w e it a h ci a d n i o c th p e H r Fe2++HO • 2 +H+→Fe(III)+H 2 O 2 1.2×106M–1s–1
2
values needed to protonate O •– and slows down at Fe2++O •–+H+→Fe(III)+HO– 1×107M–1s–1
2 2 2
morealkalinepHvalues.Anymoleculethatreactswith Fe(III)+O •–→Fe2++O 1.5×108M–1s–1
O •–inaqueoussolutionwillbecompetingwiththedis- 2 2
2
mutationreaction,andanyaqueoussystemgenerating ThusO •–canbothreduceFe(III)andoxidizeFe2+.The
2
O • 2 –willproduceH 2 O 2 ,unlessalltheO • 2 –isintercepted reductionmayproceedthroughintermediates,suchas
bysomeothermolecule. perferryl,
Superoxideinaqueoussolutioncanactasareducing
Fe(III)+O •–(cid:2)[Fe2+–O ↔Fe(III)–O •–](cid:2)Fe2++O
agent,e.g.itdonatesanelectrontocytochromec, 2 2 2 2
cytc(Fe(III))+O •–→O +cytc(Fe2+) The above rate constants can be changed by binding
2 2 ligandstotheiron.Forexample,Fe(III)boundtoEDTA
and to the chloroplast copper-containing protein isstillreducedbyO • 2 –(k 2 =1.3×106M–1s–1atpH7),
plastocyanin(Section7.8),
Fe(III)–EDTA+O
•–(cid:2)(intermediatecomplexes)
2
plastocyanin(Cu2+)+O •
2
– →O
2
+plastocyanin(Cu+) (cid:2)Fe2+–EDTA+O
2
Superoxidereducestheyellowdyenitrobluetetrazo- whereas Fe(III) attached to transferrin, lactoferrin, or
lium(NBT2+)toproducetheblueproductformazan, desferrioxamineisnot,aspredictedbytherelativere-
althoughthereactionmechanismiscomplex(Fig.2.4). duction potentials (Tables 2.2 and 2.5). Reduction of
ReductionsofcytochromecandNBT2+byO •–areused Fe(III)chelatesofcitrate,ADP,andDETAPACbyO •–is
2 2
inassaysofSOD(Section3.5.6). possible(Table2.5)buttherateconstantsappearfairly

--- Page 102 ---

REDOX CHEMISTRY: THE ESSENTIALS 47
(R )
1
C N
N + N NO 2 (R 2 )
N
· N N R R N N
OCH (R ) O – 2 2
3 3 2 R 1 C C R 1
OCH 3 (R 3 ) O 2 N N R 3 R 3 N + N
k ~ 6×104 M–1s–1 Tetrazolinyl
radical
N × 2
+
N N NO 2 (R 2 ) H
C N N N R 2 R 2 N N
R 1 C C R 1
(R 1 ) N N R 3 R 3 N N
+
NBT2+ Monoformazan
Further
reduction
H H
N N R R N N
2 2
R 1 C C R 1
N N R R N N
3 3
Diformazan
Figure2.4 ReductionofNBT2+byO •–.Nitrobluetetrazolium(NBT)isaditetrazoliumsaltwhichcanbereducedtodiformazanbyadditionoffour
electrons,withformationofintermedia 2 tefreeradicals.ThetetrazolinylradicalintermediatescanalsoreactwithO2toformO •
2
–.Hence,highO2
concentrationsdepressformazanproductionfromO2 •–plusNBT2+.NBT2+shouldnotbeusedasaspecificdetectorofO2 •–inbiologicalsystems,
sinceitsreductiontoaradicalbyothermechanisms(e.g.byenzymessuchasglucoseoxidaseorthioredoxinreductase)canleadtoO2 •–formation.
TheCO2 •–radicalcanalsogenerateformazanfromNBT2+(J.Phys.Chem.84,830,1980;Arch.Biochem.Biophys.318,408,1995;FreeRadic.
Biol.Med.31,1287,2001).
low(e.g.6×103 M–1s–1forFe(III)–DETAPAC).Super- to Fe2+ and the Fe2+-EDTA reacts with H O to form
2 2
oxide, produced in sunlit natural waters by photo- OH•. Too much ascorbate can decrease the yield of
chemicalreactionsinvolvingdissolvedorganicmatter, OH•byscavengingit(rateconstant>109M–1s–1).
helps maintain some dissolved iron as Fe2+, and can
alsointeractwithdissolvedcopperions.37Superoxide
2.5.3.5 Semiquinonesandquinones
produced by the marine bacterium Roseobacter sp.
Superoxidecanreducequinonesandoxidizediphen-
Azwk-3bappearstobeinvolvedintheoxidationofsol-
ols, and semiquinones can often reduce O to O
•–
ubleMn2+intoinsolublemanganeseoxidedepositsin 2 2
(Fig. 2.5). Essentially these are reversible reactions.
theocean.39
However, dismutation of O
•–
in aqueous solution fa-
2
vours reaction of semiquinones with O by remov-
2
2.5.3.4 ReductantsandFentonchemistry ing O •–. Thus adding SOD can inhibit semiquinone-
2
Superoxide can accelerate OH• production by the dependentreactionsbycausingtheequilibrium
Fenton reaction (Section 2.5.3.1). Other reducing
agents,suchasascorbate,candothesame:theUden- semiquinone+O 2 (cid:2)quinone+O • 2 –
friendsystemforhydroxylatingaromaticcompounds
isamixtureofFe(III)–EDTA,H
2
O
2
,andascorbate.As- to move to the right. Examples are given in Sec-
corbatestimulatesOH•generationbyrecyclingFe(III) tions9.5.3and9.5.8.

--- Page 103 ---

48 FREE RADICALS IN BIOLOGY AND MEDICINE
Reduction of a quinone Lithium-superoxide(Li+O •–)isformedandthenreacts
2
·
O O further to produce lithium peroxide, Li 2 O 2 . However
theO
•–
canreadilyattackthebatteryelectrolytes(e.g.
·- 2
+ O 2 + O 2 alkylcarbonates).
Superoxide in organic solvents usually only acts
O O– as an oxidizing agent towards compounds that can
donate H+ ions, such as ascorbate, catechol, and α-
Oxidation of a diphenol tocopherol. The O • 2 – robs them of a proton, and then
furtherreactionsoccur.Inaqueoussolution,however,
OH ·- O– O •– does not react with α-tocopherol at a signific-
+ O 2 + H 2 O 2 an 2 trate.
OH O ·
2.5.4 Peroxylandalkoxylradicals
Figure2.5 ReactionofO
•–withquinonesanddiphenols.Some
quinonescanbereducedto
2
semiquinonesbyO
•–andsomediphenols
2.5.4.1 Chemistry
2
o i b .e x e . i n d s z i e z o e m q d u iq i t n u o o in s n e o e m n ( e r iq a s u t c e i a n c n o o n r n e e s d s t . u a R n ce e t a ~ O c 1 2 ti 0 o t 9 o ns M O a • 2 – r – 1 e . s o – A 1 f b t ) e ; o n b ve e r : e lo v r w e e d r : s u o ib c x t l i e i d o , a n ti o o f nof P go er o o d x o y x l i ( d R iz O i • 2 n ) g a a n g d en a t l s k , o a x s y t l he (R y O ha •) ve ra h d i i g c h a l l y s - a p r o e si u ti s v u e a E ll ◦ y (cid:4)
catechol(rateconstant~109M–1s–1).Foradetailedreview,seeFree values(Table2.2).IndeedHO •
2
,protonatedO •
2
–,canbe
Radic.Biol.Med.49,919,2010.Oftenreactionsreachequilibrium, regardedasthesimplestperoxylradical.Forexample,
thepositionofequilibriumbeingdependentonthequinoneor RO • radicals oxidize ascorbate and NADH, the latter
diphenolandaffectedbythedismutationofO • 2 –(inaqueoussolution). lead 2 ingtoO • 2 –formationinthepresenceofO 2
RO • +NADH→RO H+NAD •
2 2
2.5.3.6 Superoxideinhydrophobic
environments8,40 NAD • +O
2
→NAD++O •
2
k=109M–1s–1
WhenO •– isdissolvedinorganicsolvents,itbecomes Alkoxyl and RO • radicals can abstract H• from
2 2
much fiercer, chemically, than it is in water. Its abil- other molecules, a reaction important in lipid
itiestoactasabase(H+acceptor)andareducingagent peroxidation (Section 5.11). Some RO • , such as
2
areincreased.Forexample,itcanreducedissolvedsul- α-hydroxyalkyperoxylradicals,breakdowntoliberate
phurdioxide(SO 2 )gasinorganicsolventsbutnotin O • 2 –. For example, when glucose reacts with OH•, six
aqueoussolution, differentRO • radicalsareformed,sinceH•abstraction
2
SO 2 +O • 2 –→O 2 + SO • 2 – b of y t O he H se •c e a li n m o i c n c a u te ra O t • a – n r y ap o i f d t l h y e , sixcarbonatoms.43Five
2
Also, if protons are not available, dismutation is pre-
vented and the O • 2 – persists longer. In addition, it R1 O
acts as a much better nucleophile, an agent that at-
tacksacentreofpositivechargeinanothermolecule. R C O(cid:129) 2 R C R+H++O(cid:129) 2 –
Thus O
•–
can attack esters, leading to displacement
2 OH
of the alcohol and formation of a carboxylic acid.
Indeed,O
•–inorganicmediacanevennucleophilically
2 Peroxylradicalscanalsoreactwitheachother,bythe
displace chloride ion from chlorinated hydrocarbons
RussellmechanismtogeneratesingletO (1O ),
such as chloroform, tetrachloromethane (CCl ), hexa- 2 2
4
chlorobenzene (C Cl ), and polychlorobiphenyls; im-
6 6
portantenvironmentaltoxins.40,41 Forexample,inthe CHOO(cid:129) + CHOO(cid:129) CHOH + C O + 1O2
caseofCCl thereaction
4
Atetraoxideintermediate,
CCl +O •–→CCl O • +Cl–
4 2 3 2
is followed by further displacements of Cl–. By con- C O O O O C
trast,thenucleophilicityofO
•–
inaqueoussolutionis
2
low, in part because dismutation decreases its levels maybeinvolved.
andalsobecausehydrationofO
•–decreasesitscharge
Aromaticalkoxylandperoxylradicalstendtobeless
2
density.ThisfiercereactivityofO •–innonpolarenvir- reactivethanaliphaticones,sinceelectronsaredelocal-
2
onmentsisillustratedinsomelithium-ionbatteries.42 izedintothebenzenering.Forexample,whentyrosine

--- Page 104 ---

REDOX CHEMISTRY: THE ESSENTIALS 49
phenoxylradical(TyrO•)isgeneratedinbiologicalsys- react with some biological molecules, including
tems,itoftencross-linkstogivebityrosine(Fig.2.2B), albumin–SHgroups,47 soitisessentialtoensurethat
although it can also react with O
•–
(Fig. 2.2A). Tyr- sufficientO ispresenttoallowtheircompleteconver-
2 2
•
osyl radical can also react with ascorbate, and thiols siontoRO .TheperoxylradicalfromAAPHisposi-
2
suchascysteineorGSH,convertingthelattertothiyl tively charged, whereas many biologically occurring
radicals,44 peroxylradicalsarenegativelycharged(e.g.fattyacid
tyr-O • +R-SH→Tyr-OH+RS • peroxyls) or neutral, although some amino acid per-
oxylscanbepositive.Chargeinfluencesreactivity:for
k=2×106M–1s–1 forGSH example,inonestudyAAPH-derivedperoxylradicals
tyr-O • +AscH→Tyr-OH+Asc•– couldcleavedouble-strandedplasmidDNA,whereas
the negative and neutral peroxyl radicals examined
k=4.4×108M–1s–1
did not.48 Peroxyl radicals from azo initiators can in-
Inaddition,GSHadductscanform(Fig.2.2A).Tyrosyl ducelipidperoxidationanddamageproteins,e.g.they
radicals are widely used in biology, e.g. in ribonuc- inactivate the enzyme lysozyme.49 Indeed, they are
leotide reductase (Section 8.2), photosynthesis (Sec- usedintheTRAPassaytoassessantioxidantactivity
tion7.8),andprostaglandinbiosynthesis(Section8.12). (Section6.17.3).
Trichloromethylperoxyl radical50 is formed from
2.5.4.2 GenerationofRO2 • /RO • radicals CCl
4
in vivo (Section 9.2) and when O •
2
– attacks CCl
4
inorganicsolvents(Section2.5.3.6).Itcanbegenerated
Carbon-centredradicalsusuallyreactquicklywithO
2
(rateconstantsoften>109M–1s–1)toformRO • radicals. inthelaboratorybyradiolysisofanaqueousmixture
2
ofpropan-2-olandtetrachloromethane(CCl ),
Decomposition of organic peroxides (ROOH) gener- 4
atesbothRO • andRO•,andthelattercanalsobepro-
2
duced by substituted N-hydroxypyridones (Fig. 2.1). e– +CCl →CCl • +Cl–
aq 4 3
Most peroxides are stable at room temperature, but
•
they can be decomposed by heating, exposure to UV OH • +CH CHOHCH →CH COHCH +H O
3 3 3 3 2
light(insomecases),orbyadditionoftransitionmetal
•
ions,suchasiron, CH COHCH +CCl →CH COCH +H+
3 3 4 3 3
ROOH+Fe(III)→RO • +Fe2++H+ +CCl • +Cl–
2 3
ROOH+Fe2+→RO • +OH–+Fe(III) CCl • +O →CCl O •
3 2 3 2
These reactions are important in iron ion-stimulated
lipid peroxidation (Section 5.11.6), but protein per-
oxides are decomposed by metal ions as well (Sec-
CH CH
3 3
tion 5.13) to give protein radicals. Lipid peroxides
mightalsoreactwithHO • toformRO • , HN C C N N C C NH· 2HCl
2 2 azo
HO • 2 +ROOH→RO • 2 +H 2 O 2 H 2 N CH 3 group CH 3 NH 2
andsomehalogenatedquinoneshavebeenreportedto CH CH CH CH
decomposehydroperoxidestoRO•radicals.45 3 3 3 3
Azo initiators46 can be used in the laboratory, and H 3 C CH CH 2 C N N C CH 2 CHCH 3
in vivo after administration to animals, to generate CN CN
RO • radicals (and O •– radicals37). Whereas AAPH
2 2
(Fig. 2.6) is water-soluble, AMVN is hydrophobic CH CH
N 3 3 N
and can enter membranes to generate radicals in
the lipid phase. These compounds decompose at a C N N C · 2HCl
temperature-controlled rate to give carbon-centred NH HN
CH CH
radicals(R•), 3 3
R–N=N–R→N +2R • Figure2.6 Structureofthe‘azoinitiators’2,2(cid:4)-azobis(2-amidino-
2 propane)dihydrochloride(AAPH,top),2,2(cid:4)-azobis(2,4-dimethyl-
whichthenreactrapidlywithO togiveRO
•
radicals.
valeronitrile)(AMVN,middle),and2,2(cid:4)-azobis[2-(2-imidazolin-2-yl)
2 2
However, the carbon-centred radicals can themselves propane]dihydrochloride(AIPH,bottom).

--- Page 105 ---

50 FREE RADICALS IN BIOLOGY AND MEDICINE
It is very oxidizing (E ◦(cid:4) =1.19V) and reacts rapidly 2.5.5.2 Reactions
withmanybiomolecules(Section9.2). It is often assumed that RS• radicals are essentially
inertanddisappearbydimerization,e.g.forthegluta-
thionethiylradical,
2.5.5 Sulphurradicals1,43,44
GS • +GS •→GSSG k= 1.5 × 109M–1s–1
In vivo, thiols (especially reduced glutathione, GSH)
mostly act as antioxidants (Section 3.10). Evidence is This is unlikely in vivo because steady-state levels of
emerging that hydrogen sulphide (H S), essentially RS• arenormallylowandsotheywouldrarelymeet.
2
hydrogenthiol,H–SH,isasignallingmoleculeinvivo, Lefttoitself,theGS•radicalundergoesanintramolecu-
butitisprobablynotusuallypresentathighenough lar transfer reaction: the electron is transferred from
levelstoexertantioxidantproperties.21 thesulphurontotheα-carbonofthecysteineresidue
However,thiolscangeneratefreeradicals. (Fig.3.9)andsometimestoothercarbons.52 Thismay
not happen in vivo because the GS• is more likely to
2.5.5.1 Formation reactrapidlywithglutathione,presentincellsatmil-
limolarlevels(Section3.10).ThepK oftheGSHthiol
a
Thiyl radicals are formed when thiols react with
groupisaround9
carbon-centredradicals,
GSH(cid:2)GS–+H+
and so it is only a few per cent ionized at pH 7.4.
Nevertheless,anyavailableGS–canreactfastwithGS•,
withtransitionmetalions,orwithseveraloxygenrad-
icals,includingOH•,RO•,CO • 3 –,RO • 2 ,and(atamuch GS • +GS–→GSSG •– k=8×108M–1s–1
lowerrate38)O •–.Forexample,
2
Unlike the oxidizing GS• radical (reduction poten-
RSH+OH •→RS • +H O tial ~0.9 V), GSSG•– is powerfully reducing (E◦(cid:4) for
2 GSSG/GSSG•– is about –1.5 V). Thus it can reduce
RSH+RO •→RS • +ROOH metalions,aswellasformO •–fromO ,
2 2 2
RSH+Fe(III)→RS • +Fe2++H+ GSSG •–+O →GSSG+O •– k=5×108M–1s–1
2 2
RSH+Cu2+→RS • +Cu++H+ AscorbatealsoremovesRS•radicals,
AscH–+RS •→RSH+Asc•–
Theycanalsoformbythehomolyticfissionofdisulph-
ides,includingdisulphidebondsinproteins, k≈5×108M–1s–1(forGS • )
ascanNADHandNADPH,
cysteine–S–S–cysteine→cysteine–S • + • S–cysteine
RS • +NAD(P)H→RS–+NAD(P) • + H+
Human fingernails are composed largely of k= 2.3×108M–1s–1
α-keratin, a protein rich in disulphide bonds, and
which,ifO ispresent,islikelytobefollowedby
sulphur-centred radicals can be produced simply by 2
cutting fingernails.51 Indeed, grinding of proteins, NAD(P) • +O →NAD(P)++O •– k=1.9×109M–1s–1
2 2
especially at low temperature, is well-known to gen-
erate free radicals, and this can be a problem in the Cysteinethiylradicals(CysS•)arequitereactive:they
food industry, e.g. in flour milling. Sulphur, carbon, canabstracthydrogenfromlinoleic,linolenic,andara-
and(inthepresenceofO ),RO • radicalscanresult.51 chidonicacids,withrateconstantsof106to107M–1s–1,
2 2
Thiylradicalsalsoformwhenthiolsreactwithnitro- initiatingfattyacidperoxidation.Similarly,cysteamine
•
gen dioxide NO ), tyrosyl radicals, or peroxynitrite thiylradicalsarecapableofabstractinghydrogenfrom
2
(Section 2.6.1), and during the oxidation of thiols by theDNAbasethymine(k=1.2×104M–1s–1)andcyst-
peroxidases(Section3.19.3).Thedamagingactionsof einethiylradicalsfromdeoxyribose(2.7×104M–1s–1).
several toxins on animals may involve thiyl radicals Alternative fates of thiyl radicals are very fast re-
(Section7.5). action (k > 109 M–1s–1) with NO• (Section 2.5.6) and
2

--- Page 106 ---

REDOX CHEMISTRY: THE ESSENTIALS 51
formation of peroxyl radicals by reaction with techniquestoidentifysulphurradicalsinsuchsystems
O ,e.g. (Section6.2.7).Thethiolhomocysteinemaybetoxicto
2
vascularendotheliumviafree-radicalgeneration(Sec-
GS • +O 2 →GSOO • k≈3×107M–1s–1 tion 4.7), and oxysulphur radicals contribute to the
toxiceffectsofSO (Section7.9.3).Onabrighternote,
2
Thiyl peroxyl radicals are unstable and rapidly form
however,thiolredoxchemistryplaysanessentialrole
other species. For example, RSOO• radicals derived
inthecontrolofcellularredoxstateandofH O levels
2 2
from GSH, cysteine, or the drug penicillamine (Sec-
invivo(Section3.10).
tion10.11)canreactwithmorethioltoproducesulph-
inylradical(RSO•),orisomerizetosulphonylradical
(RSO • ), which then reacts with O to give RSO OO•, 2.5.5.3 Artefactsinvolvingsulphur
2 2 2
compounds
sulphonylperoxyl.Hence,end-productsofGSHoxi-
dationbyROSunderaerobicconditionsincludeGSSG, Thiols are unstable in commonly used cell culture
sulphenic acid (GSOH), and sulphonic acid (GSO H) media,54oxidizingtoproduceradicalsandH O .Some
3 2 2
(Fig. 2.7). It follows that oxidizing thiols generate a scientists incubate cells with thiols to study ‘redox
series of potentially cytotoxic oxygen, sulphur, and regulation’,withoutconsideringwhatishappeningto
oxysulphur radicals. Indeed, it was shown decades theminthemedium.Bothcopperandironionsaccel-
ago53 that mixtures of cysteine and copper ions are erate cysteine oxidation; copper far more effectively.
toxic to mammalian cells, and later work used ESR However, somewhat paradoxically, copper-catalysed
R SOH
sulphenic acid
O
thiolate ion
O R S O O• R S–
H O + H+
2 2
R S• O R S– R S S R'
sulphinyl radical sulphonylperoxyl radical thiolate ion disulfide
R-SOH H+
sulphenic ROS
acid
R-SH O 2
R‘SH
sulphenic acid
O O ROS ROS R‘SOH O
2
R S• R S• R-SH R SOH R S S R'
thiyl radical thiol sulphenic acid Thiosulphinate
O ROS
sulphonyl radical
•NO O
nitric oxide R S ROS
R S NO (not a direct
reaction) OH O
nitrosothiol
sulphinic acid
R S S R'
ROS
GSH
O
thiosulphonate
O
GSNO
R-SH
nitrosoglutathione R S OH
thiol
O
sulphonic acid
Figure2.7 Generationofvariousreactivesulphurspeciesfromthiols.Adaptedfromref1bycourtesyofDrAJSlusarenkoandElsevier.

--- Page 107 ---

52 FREE RADICALS IN BIOLOGY AND MEDICINE
oxidation of cysteine is slowed down by the simultan- likelytobecorrect,59meaningthatanyNO–formedin
eouspresenceoftracesofiron.55 vivoshouldprotonatetoHNO.HNOrapidlydimerizes
andthenformsnitrousoxide,N O,
2
2.5.5.4 Theperilsofdithiothreitol,thiourea,and
N-acetylcysteine56 2HNO→[HONNOH]→N 2 O+H 2 O
A recent high-throughput screen of >700,000 com- Hencenitroxylisareactiveshort-livedspecies.Inadd-
pounds to identify inhibitors of caspase-8 (Sec- ition,NO–canreactwithO 2 togiveperoxynitrite,
tion5.4.2)produceda1%hitrate.However,about85% NO–+O →ONOO–
2
of the inhibitors were false positives; compounds in-
hibitedtheenzymeartefactuallybecausetheyreacted
oxidizethiolssuchasGSH(k>105M–1s–1),
withdithiothreitol(‘Cleland’sreagent’) GSH+HNO→ GSNHOH
HO––CH––CH 2 ––SH GSNHOH+GSH→ NH 2 OH+GSSG
|
and combine with NO• to give hyponitrite radical,
HO––CH––CH ––SH
2 ONNO•–. The physiological significance (if any) of
NO–/HNO is unclear, although there have been sev-
a dithiol present in the assay medium. The reactions
eralsuggestionsthatdrugsgeneratingitmightbeuse-
generated H O , which readily inactivates caspases
2 2 fulintreatingcardiovasculardiseases.59 Afrequently
(Section5.4.2).Similarerrorshavebeenfoundinsome
usedsourceofHNOisAngeli’ssalt,58thesodiumsalt
otherscreensinwhichthetargetproteinbeingusedis
oftrioxodinitrate,
susceptible to oxidative damage (as indeed are most
O–
proteins). Ironically, the DTT is usually added in an 2Na+
attempt to stabilize protein-SH groups. However, like N+ O–
other thiols, DTT oxidizes rapidly if transition metal –O N
ions are present, forming a range of radicals. Thi- whichdecomposesrapidlyatroomtemperature,
ols can cause artefactually high results in the protein N O2–+H+→HNO+NO–
carbonyl assay, for example57. DTT can also impair 2 3 2
protein folding in the ER (Section 5.6). Please also HNO is also formed when nitrosothiols react with
note that N-acetylcysteine is widely used as an ‘anti- ascorbate(Box4.1).
oxidant’, although it has many other effects on cells Onexposuretoair,NO•reactswithO 2 toformnitro-
(Section11.5.9.2).Thioureaiswidelyusedasaspecific
gendioxide,afarmorereactivefreeradicalthanNO•
‘OH• scavenger’: it is not (Section 6.3.2) and its use (Section9.12.2).Theoverallreactionis
inthiswayhascausedseveralmisinterpretations(e.g. 2NO • +O →2NO •
Section9.17). 2 2
anditfollowsathird-orderratelaw,
2.5.6 Nitricoxide R=k[NO]2[O 2] k~ 8.4×106M–2s–1at37 ◦ C
2.5.6.1 Basicchemistry2,21,58 Essentially the same rate law applies to the reaction
of NO• and O in solution. This law has important
Nitric oxide (officially called nitrogen monoxide) is biological impl 2 ications, in that the rate of NO• oxi-
a 2 m m o co r M e lo s u o a r l t l u e 2 b s 0 s le ◦ g C in a , s o a , r b m g o a o u n d t ic e 1 r . s a 6 o t l e m v ly e M n s t o s a . l t u H 3 b 7 e l n e ◦ c C i e n ) N a w O n a d • te c ( r a li n k (u e c p r O o t s 2 o s ) d tr a a t t i i o o n n. d T e h p e en h d a s lf- u li p fe on of th 1 e μ s M qua N r O e • of is th s e ev N er O al • m co i n n c u e t n es -
inair-saturatedsolutionsanddoubleswitheach50%
membranes and diffuse readily between and within decreaseinNO• concentration.Physiologicallevelsof
cells.Nitricoxideisafreeradical,sinceithasanun- NO•maybeinthe1to10nMrangeorevenlower(ex-
pairedelectroninaπ*2pantibondingorbital,andwith
ceptwheniNOSispresent;Section2.5.6.4),andinvivo
interesting properties, e.g. it does not dimerize read-
O concentrationsarealsolow(Fig.1.4).Thus,ifreac-
ily. If the unpaired electron is removed, nitrosonium tio 2 nofNO•withO toformNO •wereitsonlyfatein
cation,NO+,isproduced.One-electronreductiongives
vivo,thelifetimeofN
2
O•wouldbe
2
hours.Theoxidation
nitroxylanion,NO–,whichcanalsoexistasaproton-
ofNO•dissolvedinaqueoussolutionproducesmainly
atedform,HNO.Therehasbeenconsiderabledebatein
nitrite(NO–);theoverallreactionis
theliteratureonthepK ofHNO,withvaluesranging 2
a
from4.7to11.4.However,thehighervaluesseemmore 4NO • +O +2H O→4H++4NO–
2 2 2

--- Page 108 ---

REDOX CHEMISTRY: THE ESSENTIALS 53
andmaybethesumofthereactions orperoxylradicals,
2NO • +O →2NO • RO • 2 +NO •→ROONO k>109M–1s–1
2 2
NO
•
+NO
•→N
O (additionoftworadicals)
andcombinewithtyrosylradicals,thelatterprobably
2 2 3 byareversibleadditionreaction.
N O +H O→2NO–+2H+ The literature on the free radical reactions of NO•
2 3 2 2
has largely focused on its reaction with O
•–
to give
2
ReactionofNO• withO canproceedfasterinhydro- peroxynitrite.2 Otherpotentiallydeleteriouseffectsof
2
phobic environments, such as the interior of mem- NO• include its ability to inhibit cytochrome oxidase
branesandlipoproteins,becausebothNO•andO can (Section2.5.6.5)andribonucleotidereductase;thelatter
2
concentratethere.58 byreactingwithatyrosylradicalessentialforcatalytic
function(Table2.7;Section8.2).Nevertheless,theabil-
2.5.6.2 Nitricoxideasafreeradical
ityofNO•toreactquicklywithfreeradicals(Table2.7)
scavenger2,21,58,60 may be beneficial overall in vivo. Thus the ability to
scavengeRO • meansthatNO• cansometimesinhibit
Nitric oxide is low down on the ‘reactivity scale’ of 2
lipidperoxidation.Nitricoxidealsodecreasesthepro-
free radicals, and reacts slowly, if at all, with most
oxidant properties of haem proteins in the presence
biological molecules, including thiols (k < 1 M–1s–1
ofperoxides(Section3.22.3),reactingwithbothhaem
at pH 7.4). To generate thionitrites (more commonly
ferrylspecies,
callednitrosothiols)fromthiols,NO• mustfirstform
ONOO–, or a higher oxide of nitrogen such as N O . Fe(IV)=O+NO •→Fe(III)+NO–
2 3 2
Bycontrast,NO•ishighlyreactivewithotherfreerad-
icals(Table2.7).ThusNO•canreactwiththiylradicals, a
d
n
e
d
cre
a
a
m
se
in
O
o
H
a
•
ci
f
d
or
r
m
ad
at
ic
io
a
n
ls,
f
6
r
1
om
an
H
d i
O
t ca
(T
n
a
b
b
i
l
n
e
d
2.7
to
).
Fe2+ to
2 2
RS
•
+NO
•→
nitrosothiol 2.5.6.3 Physiologicalroles
scavengeOH•, Nitric oxide has multiple, important physiological
roles21,58,62,63 inthebrain,penis,vascularsystem,and
NO • +OH •→HNO k >1010M–1s–1 almosteverywhereelseinthebody.Manyofitsphysio-
2 logical effects arise from its binding to Fe2+-haem
groupsintheenzymeguanylatecyclase.Forexample,
NO•synthesizedinthevascularendothelialcellsthat
linetheinteriorofbloodvesselspresumablydiffusesin
Table2.7 Somerateconstantsforreactionofnitricoxide
withotherfreeradicals60 alldirections,butsomeofitwillreachtheunderlying
smooth muscle, bind to guanylate cyclase, and acti-
Radical Rateconstant(M–1s–1) vateit.Asaresult,morecyclicGMPismade,which
lowers intracellular free Ca2+ and relaxes the muscle,
Superoxide/HO • >109
2 dilating the vessel and lowering the blood pressure.
Peroxyl >109 OtherimportantsignallingrolesofNO•maybemedi-
Tyrosyl >109 atedbyS-nitrosylationofcysteineresiduesonproteins.
Thephysiologicalroleofthesereactionsisnotyetfully
Tryptophanyl >109
established(Table2.8,legend).
Hydroxyethyl >109 NO• has been implicated in multiple physiological
Hydroxyl >109 processes,yetexcessproductionofNO•maycausecell
e–(aq) >1010
injury.CellinjurybyNO•canbedirect(e.g.inhibition
H• >1010 ofribonucleotidereductaseorcytochromeoxidase,as
already mentioned), or it can involve conversion of
GS• >109* NO•intootherreactivenitrogenspecies,suchasN O
2 3
orONOO–(Section2.6.1).
NitricoxidecanalsobindtovariousFe2+-chelates(e.g.Fe2+-NTA,
Fe2+-citrate)todecreasetheirreactivitywithperoxides,includinglipid
2.5.6.4 Synthesisofnitricoxide
peroxides,andH2O2intheFentonreaction(J.Biol.Inorg.Chem.10,
732,2005;J.Biol.Chem.289,19917,2014). Most NO• is synthesized21,58,62,63 in vivo in animals
*ValuefromFreeRadic.Biol.Med.44,2013,2008. by the nitric oxide synthase (NOS) enzymes. There

--- Page 109 ---

54 FREE RADICALS IN BIOLOGY AND MEDICINE
Table2.8 Sometermsthatarefrequentlyconfused. and liver cells after treatment with endotoxinb or
certain cytokines (Section 5.7). The iNOS enzymes
Nitrosylation TheattachmentofanNO(nitroso)groupto
bindcalmodulintightlyandtheiractivityisessentially
athiol(S-nitrosylation)orametal.Usually Ca2+-independent. They catalyse rapid NO• gener-
reversible.
ation,generatingmuchhigherlocalizedconcentrations
Nitration Attachment of a –NO2 (nitro) group to a
thannormal,perhapsashighasthemicromolarrange.
compound.Usuallynoteasilyreversible.
Another rate-limiting factor for NOS can be the con-
Variousreactivenitrogenspecies(RNS)canoxidize,nitrate,and/ornitrosylate centrationofO 2 ;K m valuesforeNOS,iNOS,andnNOS
proteins,lipids,andDNA.Nitricoxiderarelyreactsdirectlywith–SHgroups; havebeenquotedas4,135,and400μMrespectively,65
u ex su am all p y le N , O e + xp , o N s 2 u O re 3, o N fc O el • 2 ls ,o to rO ex N c O es O s – N a O re • n c e a e n de c d au to se ge co n v e a ra le te nt n m itr o o d so ifi t c h a io ti l o s. n Fo o r f a th lt e h l o i u te g r h at t u h r e e r .6 e 6 i R s e s g o u m la e t v io a n ri b at y io O nin lev re e p ls or c t o e u d ld va b l e ue r s el i e n -
–SHgroupsonproteinsanddamagetoiron–sulphurproteinsinmitochondria. 2
However,theseeffectsareprobablyduetoNO • -derivedoxidationproductsra- vantinseveraltissues(Fig.1.4),66 butislesslikelyto
therthanNO•itself.Indeedthismaybetrueofmanyallegedcellulareffectsof besointhevascularendothelium,whichisexposedto
NO•,whichisoftenappliedatunphysiologicallyhighlevelsinlaboratorystudies,
muchhigherO levelsthantheK ofeNOS(Fig.1.4)
s e o xc t e h s a s t N it O s • ox i i n d c a l t u i d o e n i t n o h m ib o it r i e o - n re o a f ct r i i v b e on N u O cle • 2 ot a id n e d r N e 2 d O uc 3 ta is se ra a p n id d . c D y i t r o e c c h t r e o f m fe e ct o s x o i- f The iNOS en 2 zyme does not al m ways have to be in-
dase.Nitrosylationofspecificproteinsinvivoisfavouredby(i)theirproximity duced;itispresentinnormalepitheliumintherespira-
toNOSenzymesand(ii)thepresenceofhighlyreactivecysteine–SHgroupson
torytractandnasalsinuses,perhapstoreleaseNO•as
theproteins.Over100differentproteinscanbecomeS-nitrosylatedinvivoand anantibacterialmechanism.67ExcessNO•production,
theresultingchangesintheirpropertiesarefrequentlysuggestedtobeimport-
often(butnotalways)involvingiNOS,occursinvari-
antsignallingevents(ref21andBiochim.Biophys.Acta.180,736,2012;J.Mol.
Med.90,233,2012).S-Nitrosylationmayalsoprotectlabile–SHgroupsunder ousdiseases.Inratsandmice,phagocytes(especially
somecircumstances(Nat.Med.19,753,2013).S-Nitrosothiolsreactreadilywith
macrophages)areprolificproducersofNO•duringin-
•
ascorbate(Box4.1).MitochondriallytargetedNO donorshavebeensynthesized flammation,buthumanphagocytesaremorereluctant
(Section11.5.12).S-Nitrosothiolscanberemovedbydenitrosylatingenzymes, togenerateNO•,atleastinvitro,andmayrequirepro-
suchastheNADH-dependentS-nitrosoglutathionereductase.Lackofthis
enzymeinmicecausesmyopathy,suggestingthattoomanynitrosothiolscanbe
longedexposuretocytokines.69PlantsalsomakeNO•,
deleterious(Antioxid.RedoxSignal.21,570,2014). butexactlyhowisuncertain.
Animal NOS enzymes are monooxygenases; they
generate NO• and another amino acid, L-citrulline,
are three types of NOS: neuronal NOS (sometimes f N ro O m Sa L r - e ar s g u i p n p in li e ed an b d y1 O .5 2. N T A h D e P e H lec m tr o o l n e s cu r l e e q s u p i e re r d NO by •
called nNOS or NOS1) was originally identified in
produced. NOS enzymes contain several cofactors:
nervous system tissues. It is also important in some
FAD, FMN, tetrahydrobiopterin (BH ), and haem, all
other tissues, including skeletal muscle, where the 4
compounds whose reduced forms can autoxidize to
NO• it produces helps to regulate contraction. Endo- make O •– (Section 1.10.2). Zn2+ is also present. The
thelial NOS (eNOS, NOS3) is expressed constitu- 2
haemcentresresemblethoseofCYPs;likeCYPs,NOS
tively in endothelial cells and synthesizes the NO• enzymes can bind NO• and this decreases their en-
needed for regulation of blood pressure. Nitric oxide
zyme activity. The NOS enzymes can even generate
f
a
r
s
o
a
m
n
v
en
as
d
c
o
u
t
l
h
a
e
r
li
e
u
n
m
do
-d
th
e
e
r
l
i
i
v
u
e
m
dr
w
el
a
a
s
xi
o
n
r
g
ig
f
i
a
n
c
a
t
l
o
ly
r(
i
E
d
D
en
R
ti
F
f
)
ie
,
d
a
O •
2
– if L-arginine is present and BH
4
levels are low
(Table1.3).69ThiscanhappenifBH becomesoxidized
‘factor’thatrelaxesbloodvessels.TheeNOSandnNOS 4
and/or if its synthesis, or its regeneration from di-
enzymes require Ca2+ and the calmodulin proteins
hydrobiopterin (BH ), are impaired. Ascorbate plays
for their action, so that the normally low intracellu- 2
a key role in maintaining BH levels in vivo; Box
lar‘free’Ca2+levelwithincells(Section5.3.2)restricts 4
4.1). Superoxide can trigger the oxidation of BH to
their activity. Although it is a constitutive enzyme,
BH , which in turn can release more O
•–,
mak
4
ing
the activity of eNOS in endothelium can be altered thin 2 gsworse.TheO •– caninterceptNO• to 2 formper-
byvariousmodifications,especiallyphosphorylation, 2
oxynitrite,whichcandamageNOSbyoxidizingBH
which usually increases NO• production. Thus H 2 O 2 to the radical BH • —see Box 4.1); it can also oxidize 4
cansometimesstimulateNO• synthesisbyincreasing 3
phosphorylation.64
b Endotoxinisaconstituentoflipopolysaccharides(LPS),
At sites of inflammation, an ‘extra’ NOS is of-
complexglycolipidsfoundintheoutermembraneofGram-
ten present, called inducible NOS (iNOS, NOS2). negative bacteria. Endotoxin is recognized as a PAMP
This enzyme was first identified in macrophages (Section8.7.1)andtriggersaninflammatoryresponse.

--- Page 110 ---

REDOX CHEMISTRY: THE ESSENTIALS 55
the haem. The BH oxidation can lead to uncoupling Nitric oxide can also interact with peroxidases,71
4
or inactivation of the enzyme. eNOS can also un- being oxidized in the presence of H O to NO–. For
2 2 2
dergo glutathionylation, again favouring uncoupling example, myeloperoxidase can oxidize NO• to NO–,
2
(Section 3.11). Uncoupling of eNOS by these various andthenoxidizeNO–furthertoNO • .Nitricoxidecan
2 2
mechanisms contributes to vascular dysfunction in bind to and inhibit CYPs; indeed, the loss of CYPs
atherosclerosisandsomeotherdiseases.69 observed during incubation of liver cells in culture
The activity of NOS is also affected in vivo (Section 1.11) may involve over-production of NO•
by the presence of circulating NOS inhibitors; duringcellisolation.72 Nitricoxideisalsooxidizedto
NG,NGdimethyl-L-arginine (sometimes called asym- NO– byoxycytoglobinandoxymyoglobin(whichcan
3
metrical dimethylarginine or ADMA), and NG- thereforehelptoprotectagainstexcessNO•inorgans
monomethyl-L-arginine (L-NMMA). The inhibitor containingthem,suchastheheart),anditcompetively
L-NMMAwasusedforyearsinthelaboratorybefore inhibits binding of O to cytochrome oxidase and so
2
it was realized that it is present in vivo (Figure 2.8). candecreasemitochondrialelectrontransportandATP
Excess levels of these agents (especially ADMA) can production,74 which can happen during ischaemia-
contributetohypertensionandatherosclerosis.70 reperfusion (Section 10.6.4.5). Prolonged inhibition of
cytochrome oxidase can increase O
•–
formation from
2
2.5.6.5 RemovalofNO•invivo58 theelectrontransportchain,allowingONOO–toform
MuchoftheNO• generatedinthevascularsystemis and damage the mitochondria (Section 2.6.1.4). Cyto-
chromeoxidasecanalsooxidizeNO•intoNO–.There
eventuallyremovedbyinteractionwithhaemoglobin. 2
Nitric oxide forms complexes with Fe2+ and ferrous is an ongoing debate about whether mitochondria
contain a special form of NOS (mitochondrial NOS,
compounds(aprocesscallednitrosylation,Table2.8),
mtNOS),butthedataareinconclusive.
includingdeoxyhaemoglobin,
HbFe2++NO •(cid:2)HbFe2+NO
2.5.6.6 Nitrateandnitrite:inertend-productsor
physiologicallyimportantsourcesofNO•?58,75,76
Nitric oxide also reacts with oxyhaemoglobin, oxi-
dizing it to methaemoglobin (HbFe(III)) and forming Nitrates are found in many foods, especially veget-
nitrate (k > 107M–1s–1). As a result, once NO• has ables, to an extent depending on such factors as soil
entered an erythrocyte, its half-life is <1 μsec. The compositionandfertilizeruse.Whenconsumed,some
rate of permeation of NO• into erythrocytes limits ofthenitrateisreducedtoNO– byoralandintestinal
2
its reaction with oxyhaemoglobin and it has been bacteria.BothNO–andNO–canprobablybeabsorbed
2 3
estimated that the half-life of NO• in whole blood is bytheintestine.
about1.8msec.FreeoxyhaemoglobinscavengesNO• Indeed, nitrites and nitrates have been used since
much faster and as a result can cause problems, for ancient times (and still are) as preserving and cur-
example in the brain (Section 10.18). Caeruloplasmin ing agents for meats, especially bacon, sausages, and
mayplaysomeroleintheconversionofNO• toNO– tinnedmeats.Nitritesinhibitthegrowthofmanybac-
2
in plasma (Section 3.22.2). Scavenging of NO• may teria in foods, particularly the anaerobe Clostridium
be a key function of flavohaemoglobins in bacteria botulinum, which causes botulism, a potentially le-
(Section1.3.1). thaltypeoffoodpoisoning.AnotheruseofNO– isto
2
CH 3 CH3 CH 3
NH NH 2 NH NH NH N
C C C
NH NH NH
CH 2 CH 2 CH 2
CH 2 CH 2 CH 2
CH 2 CH 2 CH 2 Figure2.8 StructuresofL-arginineand
CH CH CH endogenousmethylarginines,
NGmonomethyl-L-arginine(L-NMMA)and
H2N COOH H 2 N COOH H2N COOH NGNGdimethylarginine(ADMA),bothNOS
ARGININE L-NMMA ADMA inhibitors.

--- Page 111 ---

56 FREE RADICALS IN BIOLOGY AND MEDICINE
makemeatlookbetter;meattendstodarkenincolour XOR should be deleterious, whereas they are often
because the Fe2+-haem in myoglobin oxidizes to give beneficial,asdiscussedinSection10.6).75Nevertheless,
dull-redmetmyoglobin.Nitricoxidebindstomyoglo- severalstudieshaveshownthatinfusionofNO– into
2
bintogivethered(betterlooking!)nitrosylmyoglobin, animalsorhumanvolunteerscausesvasodilation,and
slowingoxidation.77 itisevenpossiblethatsomeofthehealth-promotingef-
One concern about the use of nitrites is that dur- fectsofvegetables(Section4.1;Table4.5)areduetothe
ing cooking or in the stomach they might react NO–/NO–present.Perhapsconsistentwiththis,when
2 3
withsecondaryaminesinfoodtogeneratenitrosam- hypertensive Sprague–Dawley rats were treated with
ines, a class of compounds that can be carcinogenic NO–, the levels of urinary isoprostanes and 8OHdG
3
(Section10.15), (good biomarkers of oxidative damage, discussed in
Chapter6)decreased,indicativeofanantioxidantef-
R NH+HNO →R –N–N=O+H O
2 2 2 2 fectinvivo.79Shouldn’tthencuredmeatsbeprotective
nitrosamine
also?Perhaps,unlikevegetables,thebadeffectsofthe
The stomach contents are acidic (often as low as meatoutweighthepotentiallygoodeffectsoftheNO–.
2
pH2)anddietaryNO–willformnitrousacid(HNO ) Nitric oxide can also be generated from NO– in skin
2 2 2
whichdecomposestooxidesofnitrogensuchasN O . (Section7.13).
2 3
InadditiontoNO– fromthediet,thesalivaryglands Hence NO– is not merely an end-product of NO•
2 2
take up NO– from plasma and excrete it into saliva, oxidation—itseemstohavemetabolicrolesinitsown
3
where some of it is reduced to NO– by oral bacteria. right.Inaddition,NO–reactswithhypochlorousacid,
2 2
Average salivary NO– levels in fasting subjects have anditispossiblethatitcouldprotectagainstdamage
2
been reported as 100 μM or more. Generation of ox- bythisspeciesatsitesofinflammationifenoughNO–
2
idesofnitrogenfromHNO hasbeenproposedtobe accumulates.80
2
anantibacterialandgastroprotectivemechanisminthe
stomach.YetnitrousacidcandamageDNA;itspoten-
2.5.6.7 Nitricoxidedonors
tial gastric carcinogenicity has been debated but has
Nitrite may be an important NO• donorin vivo (Sec-
notbeenclearlyestablished.
Blood plasma NO– levels in humans on a diet low
tion2.5.6.6),butmanyothersexist.62Nitrovasodilators
3
in NO– have been reported at around 30 μM, al- havebeenusedformorethanacenturyastreatment
3
for diseases with abnormal vasoconstriction (e.g. an-
though they rise rapidly after intake of nitrate or
gina pectoris; Section 10.6.4.1), and sometimes (e.g.
nitrite-rich foods. This basal level presumably results
from the oxidation of endogenously produced NO•. amyl nitrite) as recreational drugs. They act largely
Nitrateiseventuallyexcretedinurine.LevelsofNO– or entirely as NO• donors. These drugs include or-
2
in plasma are much lower (0.15–1.0 μM) and it has ganic nitrates and nitrites (e.g. nitroglycerin and
amylnitrite),inorganicnitrosocompounds(e.g.nitro-
been proposed that they reflect short-term rates of
endothelial NO• synthesis.78 Whereas oxyhaemoglo- prusside),sydnoniminessuchaslinsidomine(some-
bin/myoglobin can oxidize NO– to NO–, a reaction times called SIN-1), and nitrosothiols (Table 2.9; Figs
2 3
2.9 and 2.10). Many of these compounds are used as
that can cause problems in babies (Section 1.10.3),
deoxyhaemoglobin/myoglobin can reduce NO– to NO• donorsinlaboratoryexperiments,butinassess-
2
NO• (for the former, the rate is maximal when about ing their effects it is important to understand what
else they generate, even cyanide ions in the case of
halfthehaemoglobinexistsinthedeoxyform),
sodium nitroprusside (Table 2.10)! A popular experi-
NO–+HbFe2++H+→NO • +HbFe(III)+OH– mentalNO•donorisS-nitroso-N-acetylpenicillamine
2
methaemoglobin (SNAP).
HowdonitrosothiolspeciesgenerateNO•?Homo-
and it has been suggested that this promotes vaso-
lyticfissionwouldyieldthiylradical,
dilation when O levels are falling (e.g. for myoglo-
2
bin in the heart), conditions which could hinder the
O -dependentNOSenzymes.Ofcourse,deoxyhaemo- RSNO →RS • +NO •
2
globin will also bind the resulting NO• avidly! Ni-
triteenterserythrocytesreadily,probablythroughthe but,infact,decompositionofmanyRSNOiscatalysed
band3channel(Section7.4).Xanthinedehydrogenase bytransitionmetalions,especiallycopper,orislight-
and aldehyde oxidase can also convert NO– to NO• dependent(Table2.10),andavarietyofend-products
2
(Section1.10.1)invitroandthismaybefeasibleinvivo result. Never assume that a cellular effect of an NO•
(althoughifitwereveryimportanttheninhibitorsof donorisadirecteffectofNO•.

--- Page 112 ---

REDOX CHEMISTRY: THE ESSENTIALS 57
Table2.9 Somecommonlyusednitricoxidedonors.
Typeofcompound Examples Comments
Metalnitrosylcomplexes Sodiumnitroprusside(SNP) Nitricoxideformsoneoftheligandstoiron.Sodiumnitro-
Na2Fe(CN)5NO prussideiswidelyusedinpharmacologybutitisnotalways
Rutheniumnitrosylpentachloride(RNP) clearhowitmakesNO•:thiscaninvolvephotochemicalde-
K2Ru(Cl)5NO compositionorreductivebreakdown,
[Fe(CN)5NO]2–−−e−–→[Fe(CN)5]3–+NO •
Nitroprussidebreakdownreleasescyanideionsanditsbreak-
down products may promote Fenton chemistry (FreeRadic.
Biol.Med.24,1065,1998).
S-Nitrosothiols(thionitrites)R–S–N=O Nitrosocysteine(half-lifeinseconds), Generated by reaction of several RNS (but not NO• dir-
GSNO(t1/2 ≈160h) ectly)withthiols.Severalnitrosothiols(e.g.nitroso-albuminor
S-Nitroso-N-acetyl-DL-penicillamine, GSNO)arefoundinvivo(Fig.2.9,legend).Decompositionof
SNAP(t1/2 ≈1h). nitrosothiolsisacceleratedbylight,transitionmetalions(es-
peciallycopper),andreducingagents,
2RSNO−C−u−io→ns
RSSR+2NO
•
orlight
Thiylradicalsareoftenproducedduringthereactions.
Transnitrosationreactionscanalsooccurbetweenthiols,
RSNO+R(cid:4)S–(cid:2)RS–+R(cid:4)SNO
includingproteinthiols,e.g.onalbumin.
SIN-1 ComplexdecompositionmechanismthatgeneratesbothO
•–
2
andNO•,thereforelikelytoproduceONOO–.Breakdownac-
celeratedbylight.Activemetaboliteoftheanti-anginadrug
molsidomine.
Organicnitrates/nitrites Isosorbidedinitrate Usedinmedicineand/orasrecreationaldrugsformanyyears.
Nitroglycerine Reduction(e.g.bymitochondrialaldehydedehydrogenasein
(glyceroltrinitrateester) thecaseofnitroglycerine;Proc.Natl.Acad.Sci.102,12159,
Amylnitrite 2005)releasesNO•,producingvasodilation.SomeGSHtrans-
[(CH3)2 CH(CH2)2 –O–N=O] ferases(Section3.15.2)catalysereactionoforganicnitrites
withRSHtogivenitrosothiols.Organicnitratesbecomeless
effectiveonprolongedtherapy(nitrate tolerance),apro-
cesswhichmayinvolveincreasedvascularO
•–productionand
2
possiblyONOO-(J.Biol.Chem.282,792,2007).
NONOates.Containthe[N(O)NO]– DETA:R1=R2=H2NCH2CH2, GenerateNO• atvariableratesdependingonthestructure.
functionalgroup t1/2 ≈20hat37◦C. t1/2 valuesvaryaccordingtoreactionconditions:thevalues
+ givenareonlyillustrative.Thosecommonlyusedonesthatgive
S R PA p 2 e P = r A m : H i R n 2 1 e N : = ( R C 1 H C 2 H = ) 3 3 H C , 2 H t N 1 2 / ( C 2 C H = H 2 2 3 , ) 9 3N m H in 2 . (CH2)4, s C l H ow (C s H t 3 e ) a 2 d ; y R fl 2 u = xe (C s H of 2 N )3 O (N • H in 2 c ) lu a d n e d N N O O C C - - 5 18 (t1 [D /2 E ≈ TA 9 N 3 O m N in O , a R t 1 e] = ).
R2=H2N(CH2)3 ,t1/2=15min.
MAHMA:R1=CH3NH2(CH2)6 ,
R2=CH3,t1/2=1–2min
Continued

--- Page 113 ---

58 FREE RADICALS IN BIOLOGY AND MEDICINE
Table2.9 (Continued)
Typeofcompound Examples Comments
NO•-releasingpolymers VariousNO•-releasingagents FreeRadic.Biol.Med.37, 926, 2004 and 49, 530, 2010;
(e.g.NONOates)embeddedina Chem.Soc.Rev.39,2903,2010;J.Pharm.Exp.Ther.314,
matrix,e.g.ofsiliconerubber, 1117,2005;ACSChem.Biol.8,2493,2013.
PVC,orpolyurethanes,or
PEG–nitrosoalbumin.
Nanoparticlecarrierscanbe
used.Severalagentsthat
releaseNO•inresponsetolight
havebeendeveloped.
Formoredetails,seeCurr.Med.Chem.17,61,2010andref62.ManycompoundshavebeenusedtogenerateNO•forchemicalorpharmacologicalstudies;some
areusedasNO•donorsinvivo.OftenthemechanismofNO•generationisunclearandisinfluencedbyreactionconditions.Onemustbeawareofwhatelsecanbe
generated(e.g.CN–orRS • )bysomeNO • donors.SeveraldrugsinwhichNO–orNO2–groupsarelinkedtootherpharmacologicalagentshavebeendesigned,such
asnitro-aspirin(NCX-4016),nitrosocaptopril,NO–ferulicacid,andNO-histaminereceptorantagonists.62
CONHCH COO– point out that NO• and its oxidation products can
2
+ interactwithoxygen-derivedspeciesinseveralways.
ON–SCH 2 CH NH 3 For example, mixtures of HOCl and NO– can form
2
NHCOCH 2 CH 2 CH nitryl chloride, NO 2 Cl.82 Thisis a reactiveoxidizing,
COO– nitrating and chlorinating agent in vitro, although its
S-Nitrosoglutathione importanceinvivoisunclear.Hydrogenperoxideand
(GSNO) NO• exertsynergisticeffectsinsomesystems.Forex-
ample, H O and NO• can increase or decrease each
2 2
other’s cytotoxicity to cultured cells,83 depending on
COO– the cell type, the NO• donor used, reagent concen-
ON–SCH CH
trations,andwhethercellswerepre-exposedtoNO•.
2
Totakeoneexample,inductionofapoptosisbyH O in
2 2
NH +
3 bovineaorticendothelialcellsrequiresuptakeofiron
S-Nitroso-L-cysteine ionsfromthemediumandsubsequentFentonchem-
(CySNO) istry.Nitricoxidedecreasedthetoxicitybydecreasing
ironuptake.84
Nevertheless, most attention has been given to
CH 3 COO– peroxynitrite (officially called oxoperoxonitrate (1-)),
which can be formed from NO– and O (Sec-
ON–SCCHNHCOCH 2
3
tion2.5.6.1)or,morecommonly,bythecombinationof
CH
3
NO•andO •
2
–,
S-Nitroso-N-acetyl-DL-penicillamine
(SNAP) NO • +O • 2 –→ONOO– k ~4–16×109M–1s–1
Figure2.9 Somenitrosothiols.Lowlevelsofnitrosothiolsarefound
inthebloodstream,(includingnitrosoalbumin)andintissues,mostly Theabovereactionhasagreaterrateconstantthanre-
asproteinnitrosothiols.Somehavesuggestedthattheyactas actionofNO•withhaemcompounds(k<108M–1s–1),
‘reservoirs’ofNO•.
orevenreactionofO
•–
withSOD(Section3.5).Com-
2
bination of NO• and O •– is important, for at least
2
two reasons. First, it means that NO• and O •– an-
2.6 Chemistryofbiologicallyimportant 2
tagonize each other’s biological actions. It has been
non-radicals known for decades that NO•-mediated effects can be
enhancedbyaddingSOD.Thiswasfirstdemonstrated
2.6.1 Peroxynitrite
in bioassays of EDRF: adding SOD slowed the rate
Since we have just reviewed NO•, it seems logical to of loss of the relaxing factor. The bioassay systems
lookatperoxynitrite2,81next.Beforewedo,weshould musthavebeenproducingO •–,whichcombinedwith
2

--- Page 114 ---

REDOX CHEMISTRY: THE ESSENTIALS 59
O N N
NH
N
O
SIN-1
OH–
Figure2.10 ThestructureofSIN-1.
O N N CH CN ONOO– O N N CH 2 CN S O I N N O -1 O g – e g n e e n ra e t r e a s tio O n • 2 , – t a h n o d ug N h O t • to ,l b e e ad b i y ng th t e o
mechanismshown.SIN-1Ccanreactwith
N O
SIN-1C ONOOH,givingarangeofproductsthathave
SIN-1A
biologicaleffectsinsomesystems.Thepresence
O 2 ofbicarbonateaffectsthechemistryof
decompositionandthetoxicspeciesformed
(Oxid.Med.Cell.Longev.10,ArticleID326731,
NO(cid:129) O 2 (cid:129)– 2012).Henceneverassumethataneffectof
SIN-1isnecessarilyaneffectofONOO–(Free
CH 2 CN CH 2 CN Radic.Biol.Med.35,662,2003).Some
O N+ N O (cid:129)N+ N biologicaloxidizingagentscanpromotethe
formationofNO•ratherthanONOO–from
N O
SIN-1bycatalysingdirectoxidationofSIN-1A
SIN-1 cation radical (Arch.Biochem.Biophys.361,331,1999).
Table2.10 Somemethodsforlaboratorypreparationofperoxynitrite.
Method Basisofmethod Comments
SimultaneousgenerationofO •–andNO• Generate fluxes of O •– and NO• that SIN-1isoftenused,butHCO–canaffecttheresults
2 2 3
combinetoeffectasteadyrateofONOO– (Fig 2.10). Alternatively, mix spermine NONOate
production.Thismaybeabettermodel (Table 2.11) and the O
•–
generator SOTS (Sec-
2
for biological ONOO– generation than tion 2.5.3.1). NO• donors have been mixed with
bolusaddition of ONOO–, although the xanthine/xanthine oxidase, but urate produced by
complexity of the generation systems theenzymescavengesONOOH.Stopped-flowmix-
mustbeconsidered. ing of KO2 (dissolved in DMSO) and spermine
NONOatehasalsobeenused(J.Biol.Chem275,
32460, 2000). Tetramethylammonium superoxide
can be reacted in liquid ammonia with NO• to
give tetramethylammonium peroxynitrite, and the
tetramethylammonium exchanged for Li+ or Na+
on a column. Some NO– is still present (Chem.
2
Res. Toxicol. 21, 2257, 2008). Use of Hepes
and other Good’s buffers should be avoided as
ONOO–/ONOOH reacts with them (J.Biol.Chem.
273,12716,1998).
ReactionofH2O2withHNO2,madefrom HOONO has a t1/2 of ~1 s but can be Currently the most popular method. Product con-
NaNO2andHCl stabilizedbyrapidlyaddingexcessNaOH. taminated with Cl–, NO–
2
, NaOH, and H2O2.
‘Decomposed control’ often made by adding so-
lution to phosphate (or other) buffer at pH 7.4;
ONOO– protonates to ONOOH and decomposes
withinseconds,whereasotherproductsremain.Al-
ternatively,H2O2mayberemovedusingmanganese
dioxide(MnO2),althoughwithlossofsomeONOO–
andcontaminationbymetalions.
Continued

--- Page 115 ---

60 FREE RADICALS IN BIOLOGY AND MEDICINE
Table2.10 (Continued)
Method Basisofmethod Comments
Hydroxylaminemethod NH2OHinalkaliplusEDTAorDETAPAC H2O2 also produced. Some NO–
2
, alkali and NH2OH
isbubbledwithO2andoxidizedtoNO–, remainascontaminants.
whichreactswithO2togiveONOO–,
NH2OH+OH–+O2 →H2O2+NO–+H2O
IrradiationofNO–
3
Exposure of NaNO3 or KNO3 to short- Pooryield(~0.3%),someNO–
2
alsoformed.HighNO–
3
wavelengthUVlightcausessomeisomer- levelsremain.
izationtoperoxynitrite,(J.Am.Chem.Soc
125,15571,2003).
Ozone/azidesystem N–
3
+2O3 →ONOO–+N2O+O2+O2 Solutionsarelessalkalinethantheabovemethodsand
SolutionofsodiumazidebubbledwithO3 containlittle,ifany,H2O2,butpresenceofunreacted
at0–4◦Cinweaklyalkalinesolution. azidecanbeaproblemsinceitinhibitsmanyenzymes.
ReactionofH2O2withalkylnitrites H2O2 in alkali reacts with RONO An alcohol (ROH) contaminates the reaction mixture.
(e.g.isoamylnitrite), OneapproachtoavoidthisistomixalkalineH2O2with
H2O2+OH–+RONO→ awater-insoluble(e.g.isoamyl)nitrite;ONOO–staysin
ONOO–+ROH+H2O theaqueousphasewhereasisoamylalcoholremainsin
theorganicphaseandcanbeseparated.Lowcontam-
inationbyNO–
2
andH2O2,ifH2O2andalkylnitriteare
usedinequimolaramounts.(Anal.Biochem.354,165,
2006).
ReactionofNO•withpotassium GaseousNO•ispassedoversolidKO2, Productcanbeextractedintoalkalinesolution,butdis-
superoxide KO2+ NO •→ K+ONOO– mutationofunreactedKO2cangeneratesomeH2O2.
ReactionofO • 2 –withnitrosothiols R O S • 2 N – O + + NO O • • 2 – → → O R N S O H O + – NO • +O2 S th u e p n er r o e x a i c d t e sw slo it w h l a y n d o e th c e o r m O p • o – s . es Se R e S J N . O Bio t l o .C N h O em • . w 2 h 7 ic 3 h ,
2
7828,1998.
PhotocontrollableONOO–generator PNAPisexposedtoUVlightandgener-
atesNO•andO •–,whichformONOO–. FromJ.Am.Chem.Soc.134,2563,2012.
2
Forreferencessee2,Meth.Enzymol.233,299,1994and269,285,1996,Prog.Inorg.Chem.41,599,1994andChem.Res.Toxicol.21,2227,2008.
some of the NO•. Adding SOD removed O •– and so nitration of lipids, DNA strand breakage, nitration,
2
raisedtheNO• level.Invivo,excessO •– productionin and deamination of DNA bases (especially guanine;
2
or close to vascular endothelium can cause vasocon- Section 5.8.2.9), nitration of aromatic amino acid res-
striction,andexcessO
•–
isindeedinvolvedinhyper- idues in proteins and oxidation of cysteine (which
2
tension (Section 8.10.4). Similarly, if an injury system can lead to release of Zn2+ from zinc-thiolate lig-
is O •–-dependent, NO• can protect by removing O •–. ands), methionine (to methionine sulphoxide), and
2 2
Superoxidecanbegeneratedincellculturemediaby other residues. The most studied reaction in proteins
a variety of mechanisms (Section 1.11). If this occurs, has been conversion of tyrosine to 3-nitrotyrosine,86
then the availability of NO• from added NO donors buttryptophanandphenylalaninecanalsobenitrated.
canbediminished,andONOO–isalsoformed.85 Haemoglobin is rapidly oxidized to methaemoglobin
ThesecondreasonisthatONOO– isformed.Add- byONOO–,andotherhaemproteins(e.g.cytochrome
ition of ONOO– to cells, tissues, or body fluids c) are also oxidized. The methaemoglobin can then
leads to depletion of antioxidants, oxidation, and reactfurtherwithONOO–.

--- Page 116 ---

REDOX CHEMISTRY: THE ESSENTIALS 61
Nitration of tyrosine residues (not nitrosylation or 2.6.1.1 Howdoesperoxynitritecausedamage?2,81
nitrotyrosylation,asissometimeserroneouslywritten Peroxynitrite anion (ONOO–) is fairly unreactive and
in the literature; see Table 2.8) is widely used as
solutions of it in alkali are stable for weeks if kept
a biomarker of ONOO– generation in vivo and has
frozen.Indeed,peroxynitriteisusuallysynthesizedin
been observed in a range of human diseases,86 al-
thelaboratorybyreactingnitritewithH O atlowpH
2 2
though it is not a specific biomarker for ONOO–;
(Table2.10),
other nitrating species exist (Section 6.6.2). Nitration
often leads to enzyme inactivation and to interfer-
ence with signal transduction. This is, in part, be- NO–+H+→HONO(nitrousacid)
2
cause nitration decreases the pK of the tyrosine
a
–OH group from about 10 to 7.5, causing consider- HONO+H 2 O 2 →HOONO+H 2 O
able ionization at pH 7.4 and rendering the tyrosine
more hydrophilic. Manganese-containing superoxide
dismutase (MnSOD; Section 3.5.2) is susceptible to and immediately stabilizing the ONOO– by adding
nitration,causingitsinactivation,whichhasbeenob- excess sodium hydroxide. These solutions can be
served in vivo in several pathological conditions.87 standardized by using the absorbance of ONOO– at
Nitration of tyrosines might block phosphorylation 302 nm in alkali (ε = 16,770M–1cm–1). However, be
by certain tyrosine kinases. Other protein targets at-
awarethatthe‘ONOO–’obtainediscontaminatedwith
tackable upon ONOO– addition include xenobiotic- NO– 2 , NO– 3 ,andH 2 O 2 ,aswellasexcessalkali,causing
metabolizing enzymes such as N-acetyltransferases, largepHrisesifaddedtopoorlybufferedsolutionsand
CYPs,andglutathione-S-transferases,thecochlearpro- tissueirritationifinjectedintoanimals.Apopularcon-
teinLmo4(Section7.12),neurofilamentproteins,cyc-
trolexperimentistocomparetheeffectoftheONOO–
looxygenases, prostacylin synthase,88 albumin, iNOS, preparationwiththatof‘decomposed’ONOO– (Table
succinylCoA: 3-ketoacid coenzyme A transferase, de- 2.10). However, the possibility that two agents could
smin (a filamentous protein in muscle), carbonic an- beinvolvedincausingdamagemustnotbeforgotten
hydrase, mitochondrial proteins (including some in (e.g. a cytotoxic effect could involve both H 2 O 2 and
complex I)89, HDL (Section 10.3.9), collagen (e.g. in ONOO–). Problems also exist with other laboratory
arthritis, Section 10.11), and caeruloplasmin,90 which methodsofmakingONOO–(Table2.10).
releasescopperionswhentreatedwithONOO–.Add- BywhatmechanismdoesadditionofONOO–cause
itionofONOO– toratneuronsinculturecausedtox- damage to biomolecules? First, ONOO– reacts with
icity due to intracellular Zn2+ release, probably from CO 2 (k 2 ~5×104M–1s–1 at 37 oC) to form an adduct,
metallothionein (Section 3.23.2). Fibrinogen is a pro- nitrosoperoxycarbonate,O=NOOCO 2 –.Thisprobably
teinimportantinblood-clotting;itsnitratedformhas accounts for many of the reactions attributed to
been detected in the plasma of patients with heart ONOOH, such as nitration of tyrosine and guanine.
disease and appears to promote clot formation more Animal cells and body fluids have high concentra-
readilythannormal.91 tionsofCO 2 /HCO– 3 (e.g.approximately1mMCO 2 and
Proteomic techniques (nitroproteomics) have been 25mMHCO– 3 inhumanbloodplasma),makingreac-
used to identify which proteins are nitrated in vari- tionwithCO 2 perhapsalikelyfateofatleastsomeof
ousdiseasedoragedtissuesorinorganismsexposed
theONOO–generatedinvivo.Nitrosoperoxycarbonate
to oxides of nitrogen (Section 6.6). Several factors af- maysplitharmlesslytoNO– 3 andCO 2 orundergoho-
fectwhichproteinsarenitrated,includingtheircellular molyticfissiontogenerateNO • 2 andCO • 3 –radicals.The
abundance,proximitytothesystemsgeneratingRNS
approximatestoichiometryisquotedin81as
(e.g. iNOS), and how reactive/exposed a particular
tyrosineresidueiswithintheprotein,andwhatother
residuessurroundit.86 HighlevelsofCO 2 /HCO– 3 can ONOO–+ CO 2 →ONOOCO– 2
facilitatenitration(Section2.6.1.1). →0.35(CO •–+NO • )+0.65(CO +NO–)
3 2 2 3
Tyrosine nitration is not always the cause of en-
zymeinactivationbyONOO–(indeed,inafewcasesit
canactivateenzymes!),92sinceONOO–additionmodi- Both CO •– (Section 2.5.2) and NO • are reactive rad-
3 2
fies several other amino acid residues, e.g. histidine icals.Forexample,CO •– playsaroleintheoxidation
3
onCuZnSOD(Section2.6.1.1).Inactivationsofseveral ofNAD(P)H,inducedbyaddingONOO–,resultingin
enzymesbyONOO–resultfrom–SHgroupoxidation. O •–formation,93
2

--- Page 117 ---

62 FREE RADICALS IN BIOLOGY AND MEDICINE
CO •–+NADH→NAD • +HCO– inactivatetheenzyme(unlikethecaseofMnSOD),ra-
3 3
k=1.4×109M–1s–1 ther, damage to histidine does.96 By contrast, human
CuZnSODlacksthistyrosineresidueandisnotasub-
NAD • +O →NAD++O •– strate for nitration, although it can be nitrated (and
2 2
k=1.9×109M–1s–1 oxidized)onitssingletryptophanresidue.97Similarly,
MnSOD catalyses its own nitration involving redox
Nitrosoperoxycarbonate is less bactericidal than reactionswiththeactivesitemanganeseions.87
ONOO–; indeed, blocking CO production (by in-
2
hibiting the enzyme urease) in Helicobacter pylori 2.6.1.2 Toxicityofnitrotyrosineandnitrated
aggravates the toxicity of ONOO– to this organism proteins?
(Section10.13.2).
Nitrotyrosineaddedtocertaincellsathighconcentra-
Second, any ONOO– that does not react with CO
2 tions can be toxic, e.g. by undergoing redox cycling
orothermoleculesrapidlyprotonatestoperoxynitrous
(Section9.19),byinterferingwithsignaltransduction
acid(HO–O–N=O;pK ~6.8)andrearranges,forming
a orbybecomingincorporatedintothemicrotubulepro-
nitrateasthemajorend-product,plussomeNO–.Add-
2 tein tubulin and distorting the cytoskeleton.98 How-
itionofONOO– toaromaticcompoundsleadstoboth
ever,levelsoffreenitrotyrosineinvivoareverylow,in
hydroxylationandnitration.94ProbablysomeONOOH
undergoeshomolyticfissiontogenerateOH•andNO • . partbecauseitcanberapidlymetabolized(Section6.6),
2 sothephysiologicalsignificanceofthistoxicityisun-
However these radicals are generated close to each
certain. Nitrated proteins can sometimes trigger an
other(‘caged’)andcanrecombinequickly,
immune response,99 a possible contribution to auto-
ONOOH→ [OH • + NO • ]→ NO–+ H+ immunity and cell damage (e.g. in atherosclerotic le-
2 3 sions and in Parkinson disease (nitrated α-synuclein)
making it hard to detect much OH• experimentally. [Sections10.3.5and10.20]).Nitratedproteinsarefound
Hence,thecontributionofOH•tothebiologicaldam- in pollen (Section 7.7) and may be allergenic. Nitra-
agecausedbyadditionofONOO– maybesmall.Per- tionofMnSODmayevencontributetocausingchronic
oxynitrous acid is much more reactive than ONOO–, pain(Section10.24).Notmuchisknownaboutthefate
butitsimpactislimitedbyitsfastdecompositionand ofnitratedproteinsinvivo;theymaybedegradedby
byremovalofONOO– byCO .Howeveroneimport- theproteasomesystem(Section5.14.3.2)andpossibly
2
ant target of ONOO–/ONOOH in vivo may be the metabolized by denitrase enzyme systems,100 whose
peroxiredoxins(Section3.13.2.1). biochemistryremainstobeelucidated.
Whydoesformingnitrosoperoxycarbonateenhance
tyrosine nitration? Carbonate radical derived from it 2.6.1.3 Nitricoxide,superoxide,peroxynitrite,
readily oxidizes tyrosine to tyrosyl radical, which re- andnitratedlipids:abalance
•
acts rapidly with the NO 2 simultaneously produced. Just as O •– reacts rapidly with NO•, it can react with
Of course, several other reactive species can convert • 2
tyrosine to tyr-O•, which will become nitrotyrosine NO 2 ,givingperoxynitrate
•
if NO 2 is around; one reason why nitration is not a O •–+NO •→O NOO–
specific marker of ONOO– generation (Section 6.6.2). 2 2 2
NO• can also react reversibly with tyr-O• to give
a species to which little attention has been paid but
nitrosotyrosine.
whichmaywellbeinjurious.Itmayalsobegenerated
Addition of certain metal chelates, such as Fe(III)-
during the decomposition of ONOO– at neutral pH,
EDTAorevencopper-zinccontainingsuperoxidedis-
andprotonatetoperoxynitricacid,O NOOH.
mutase (CuZnSOD; Section 3.5.1), increases the yield 2
Nitricoxideisbeneficialinmanyways:forexample
of aromatic nitration products from ONOO–. This is
it deters phagocyte adherence to vascular endothe-
probablybypromotingheterolyticfissionofONOOH
lium, and platelet aggregation. The presence of ex-
tonitroniumion(NO+),agoodnitratingspecies,
2 cess NO• can sometimes inhibit damage by ONOO–.
ONOOH→NO+
2
+OH– For example, whereas equal fluxes of O •
2
– and NO•
can form ONOO– and stimulate lipid peroxidation, a
For example, bovine CuZnSOD can be nitrated on high ratio of NO• to O •– can decrease peroxidation
2
tyr108 by ONOO– addition, and can promote the ni- becauseoftheabilityofNO•toscavengeperoxylrad-
tration of adjacent proteins.95 This nitration does not icals (Table 2.7). Such reactions yield nitro, nitroso,

--- Page 118 ---

REDOX CHEMISTRY: THE ESSENTIALS 63
and nitrated lipid adducts, whose biological signifi- and its products are, collectively, powerfully oxidiz-
cance is attracting increasing attention. Some, e.g. ni- ing and nitrating, they often react directly with spin
tratedlinoleicacid,candecomposetoregenerateNO• traps (Section 6.2) and ‘scavengers’ of OH•, such
and form lipid radicals (perhaps a homolytic fission as thiourea.106 For example, in one study, an inhib-
reaction), the NO• then causing vasodilation. Nitroli- itor of caspase-1 blocked the toxicity of SIN-1 to rat
noleate has been detected in human plasma and red neurons in culture. However, the cell death was not
bloodcellmembranesandhasbeenshowntosuppress apoptotic; the inhibitor simply scavenged the toxic
human neutrophil O •– formation in vitro, suggesting ONOO–-derivedspecies.107SomePARPinhibitors,e.g.
2
that it might be anti-inflammatory. It may also bind 3-aminobenzamide(Section5.2.5),canexertthesame
and activate the PPARγ receptor (Section 10.3.4). Ni- non-specific effects, and probably many other com-
trated derivatives of linolenic, arachidonic, and other pounds do so as well. Always watch out for direct
fatty acids have also been detected in human body scavenging of RS by so-called ‘selective’ inhibitors
fluids101,102 and may have various biological effects, of various cell injury pathways, since many of these
whichalsoappeartobeanti-inflammatoryoverall(e.g. inhibitorsareredoxactive.
theycanactivatetheheatshock[Section5.6]andNrf2
[Section 5.5.8] responses, and nitro-oleic acid can in-
2.6.2 Hydrogenperoxide
hibitxanthineoxidase).Thereisgrowinginterestinni-
tratedlipidsaspotentialtherapeuticagentse.g.against Hydrogen peroxide (H O ) is a classic example of a
2 2
adriamycincardiotoxicity(Section11.5.11).Production ROS that is not very reactive. Indeed, its limited and
of nitrated fatty acids probably involves reaction of selective reactivity allows its use as a signalling mo-
•
NO with lipid radicals. However, the levels of ni- lecule (Section 5.5 and ref64), although it is toxic to
2
trated lipids reported in plasma by different groups manycelltypesathigherlevels.Indeed,productionof
are variable and more accurate methods to measure highlevelsofH
2
O
2
byL-aminoacidoxidasescontrib-
them are required.102 Conjugated linoleic acids can utes to the toxicity of some snake venoms,108 certain
alsobenitratedinvivo(Section6.15.4.2);indeed,their fishsecretions,108 andtotheantibacterialactionofthe
metabolitescanbedetectedinhumanurine.101 mucusofthegiantsnailAchatinafulicaFérussac.109The
weakantisepticactivityofhoney,usedinwoundtreat-
2.6.1.4 Canperoxynitritebeantioxidant? mentsinceancienttimes,ispartlyduetotheformation
In normal blood vessels, the NO • /O •– ratio experi- of H 2 O 2 ,110 although honey contains other antimicro-
2 bialagents,suchasmethylglyoxal(Section3.15.1)and
enced by the vascular endothelial cells is probably
propolis,aresincollectedfromtrees(Section4.5.4).
high. Lowering that ratio might favour pro-oxidant
(via ONOO–) rather than antioxidant effects of NO•. Of special interest in this context are the Manuka
honeys.TheManukatreegrowsinNewZealandand
Nevertheless, addition of ONOO– to thiols or ur-
ate leads to reactions103 that regenerate some NO•. Australia, and bees collect nectar from the Manuka
flower (Leptospermum scoparium) to make Manuka
In other words, under certain circumstances ONOO–
honey. This has a characteristic flavour and colour,
formationcouldbeamechanismforremovingexcess
O •– by NO•, provided that the damaging ONOO– is with high antimicrobial properties. As with other
2 honeys, methylgloxal and H O contribute to its
swiftlyremovedbyantioxidants,whichreturnsomeof 2 2
itasNO•. antimicrobial properties. However, the antimicrobial
Bycontrast,exposureofmitochondriatoexcessNO• propertiesofManuka,eveninthepresenceofcatalase,
areconsiderablyhigherthanotherhoneys.Thisadd-
inhibits cytochrome oxidase (Section 2.5.6.5), and the
itionalantimicrobialactivityhasbeencalledthe‘UMF’
back-up of electrons in the electron transport chain
can result in more O
•–.
Peroxynitrite can form, and
(uniqueManukafactor).
2
damagethemitochondria.ComplexI104andmitochon-
2.6.2.1 ProductionofH2O2
drialcreatinekinase105arepotentialtargets.Remember
SeveralenzymesinadditiontoL-aminoacidoxidases
also that ONOO– can lead to uncoupling of eNOS
generate H O , including xanthine, urate, copropor-
(Section2.5.6.4). 2 2
phyrinogenIII,glucose,lysyl(Section10.14.8.7),mono-
amine(Section10.17.5),andD-aminoacidoxidases,as
2.6.1.5 Morethingstobewareof
well as SOD. In addition, ascorbate, thiols, and some
Table 2.10 summarizes some things to bear in mind flavonoids and other polyphenols oxidize in com-
whenusing‘peroxynitritepreparations’.SinceONOO– monly used cell culture media to generate H O , an
2 2

--- Page 119 ---

64 FREE RADICALS IN BIOLOGY AND MEDICINE
artefactthathasledtosomemisinterpretationsabout mM levels. However, H O is capable of inactivating
2 2
theireffectsoncells.54,112SuperoxideandH O canalso a few enzymes directly, usually by oxidation of –SH
2 2
beproducedincellculturemediabyphotochemicalre- groupsessentialforcatalysis.Theseincludetheperox-
actions,usuallyinvolvingriboflavininthemedium.113 iredoxins(Section3.13),theglycolyticenzymeG3PDH
Low levels of H O and other peroxides are wide- (Fig. 1.7), chloroplast fructose bisphosphatase (Sec-
2 2
spreadintheenvironment,includinginrainwaterand tion 7.8), some protein phosphatases (Section 5.5.4),
seawaterandfreshlyabradedmetals.114,115Peroxidesin andthecaspasesinvolvedinapoptosis(Section5.4.2).
detergentscandamageproteins.116 Infact,H O reactsonlyslowly(k <5M–1s–1)with–SH
2 2 2
Hydrogen peroxide is continually produced in groups.Reactionwiththeionized(thiolate,S–)formis
many,ifnotall,tissuesinvivo,andstudiesonperfused faster(rateconstantstillonly18–26M–1s–1though),but
rat liver suggest steady-state intracellular concentra- inthesetargetproteinsthereactivethiolateisusually
tions of 10–7 to 10–8 M (Fig. 6.8). Mitochondria are surrounded by other amino acid residues that fur-
significant contributors to cellular H O generation, theracceleratereactionwithH O .Asulphenicacidis
2 2 2 2
both by enzymes such as monoamine oxidases (Sec- produced,
tion 10.17) and by dismutation of O
•–
from the elec-
2 RS–+H O +H+→RSOH+H O
tron transport chain. Mitochondria can also consume 2 2 2
H 2 O 2 (Section3.20.1),andsteady-statelevelsofH 2 O 2 Hydrogenperoxidecanalsooxidizecertainketo-acids
in Drosophila mitochondria were estimated as close suchaspyruvate(Section3.25.2).
to200nM(Section6.11.1). Hydrogenperoxidecan be Inspiteofitspoorreactivity,H O canbecytotoxic
2 2
detected in exhaled air (Section 6.15.9) and in urine and at high concentrations is often used as a disin-
(urinarylevelsareveryvariable—usually<10μM,but
fectant. Hydrogen peroxide generation by pathogens
sometimes>100μM).117Drinkingcoffeeraisesurinary
can injure animals. As examples, H O produced by
2 2
H 2 O 2 levels; the compound hydroxyhydroquinone an enzyme that oxidizes glycerol-3-phosphate in the
(Section4.5.3)isabsorbedfromthecoffee,re-excreted, pathogenMycoplasmapneumoniaecanattackepithelial
andrapidlyoxidizesintheurinetoproduceO • 2 – and cells in the trachea122 and H 2 O 2 produced by Strepto-
H
2
O
2
.117 E.coligrowingexponentiallyonglucosehas coccuspneumoniaecanworsenmeningitis.123Somebac-
been estimated to generate about 14 μM H 2 O 2 every teria produce H 2 O 2 to deter the growth of others,
second;moreifO 2 levelsareraised.118 e.g. in biofilms (Section 1.10.9). Indeed, certain bac-
terial strains are especially sensitive to H O , as is
2 2
2.6.2.2 ChemistryofH2O2 the worm C. elegans,124 whereas others are more res-
Hydrogenperoxidemixesreadilywithwaterandcan istant. There is a similar variability in the sensitivity
diffuse within and between cells in vivo. Diffusion is of different eukaryotic cells to H O . The results are
2 2
rapidbutnotcompletelyfree,andisinfluencedbythe influenced by how H O is delivered to cells: many
2 2
membranelipidcomposition.Forexample,adaptation scientists use bolus addition, but most of the H O
2 2
of yeast to H O involves changes in plasma mem- isdegradedwithinminutesbycatalaseandotheren-
2 2
brane lipid composition and organization that slow zymes (Section 3.20). Slow, steady H O generation
2 2
downentryofH O .119 (e.g.usingglucoseplusaglucoseoxidaseenzyme)is
2 2
Physiologists recognized decades ago that water more physiological. Many constituents of cell culture
crosses cell membranes much faster than can be ex- media can affect H O toxicity to cells, one of these
2 2
plainedbysimplediffusionofsuchapolarmolecule. beinghistidine(Section3.25.7).
Althoughsomewaterdoesappeartodiffuseacrossthe Although some cellular damage by H O is direct,
2 2
lipidbilayer,muchappearstopassthroughmembrane such as inactivation of G3PDH and peroxiredoxins,
water channels, the aquaporins. Certain aquaporins additionofH O tocellsandtissuesfrequentlyleadsto
2 2
alsoallowH O tocross;somehavecalledthemperox- lipid,DNA,RNA,andproteinoxidation,despiteitsin-
2 2
iporins.Theycanbefoundinplasmamembranesand abilitytoreactwiththesemolecules.Usually,theH O
2 2
innermitochondrialmembranes,forexample.120Simi- crossescellmembranesandreactswithiron,andpos-
larly, H O can enter Salmonella typhimurium through siblycopper,ionstoformmoredamagingspecies,most
2 2
themembraneporinOmpD,andoneresponseofthis likely OH•. Indeed, OH• accounts for most or all of
organismtoH O istodecreasetheporinlevel.121 thedamagedonetoDNAinH O -treatedrespiratory
2 2 2 2
H O is poorly reactive with most biomolecules. tractcells,andprobablymostothercellsaswell.13,125
2 2
For example, no oxidation occurs when DNA, lipids, The metal ions needed to convert H O to OH• may
2 2
or most proteins are incubated with H O , even at bepresentonDNAalready,ormaybeliberatedfrom
2 2

--- Page 120 ---

REDOX CHEMISTRY: THE ESSENTIALS 65
metalloproteins by oxidative stress, or released from quantitiesinthelungandothertissues).Fromtheliver
damaged organelles, such as lysosomes (Section 3.9). itisreleasedintoextracellularfluids,whereitservesto
Sometimes, exposing cells to H O can increase inhibitseveralproteolyticenzymes,includingelastase.
2 2
O
•–
production, by activating NADPH oxidases Elastase hydrolyses elastin and if uncontrolled can
2
(Section8.10).126 do severe damage, especially in the lung. An inborn
deficiency in α -antiproteinase in humans can cause
1
the disease emphysema, in which the elastic fibres
2.6.3 Hypohalousacidsandtheirderivatives
inthelungaredestroyedandgasexchangeimpaired
Let us start with hypochlorous acid (HOCl), pro- because the lung cannot expand and contract prop-
ducedbytheenzymemyeloperoxidase(MPO),which erly. In addition, the mutant protein can aggregate
can also oxidize Br– to hypobromous acid, HOBr in the ER of lung and liver, causing damage by ER
(Section8.7.5), stress (Section 5.6). The aggregates in lung can also
promote neutrophil recruitment. Hypochlorous acid
H O
+Cl–−−−M−P−O−→HOCl+OH–
2 2 rapidly(Table2.11)attacksamethionineresidueonthe
H O +Br–−−M−P→O HOBr+ OH– α 1 -antiproteinase, forming methionine sulphoxide.
2 2
Thisisacommonlyformedproductfrommethionine
HOClisaweakacid,pK a approximately7.6.Henceit residues exposed to HOCl (or to HOBr), although it
isabout50%ionizedatpH7.4, isnottheonlyone.Anotherisdehydromethionine,a
HOCl(cid:2)H++OCl– cyclicmolecule,129
By contrast, the pKa of HOBr is about 8.7, so the CH 2
protonatedformpredominatesatpH7.4.Hypochlor- O CH 2
ite (OCl–) absorbs light at 292 nm (molar extinction C CH
coefficient ε = 350 dm3 mol–1cm–1) and so concen- –O N
S+
trations of HOCl can easily be determined by add- H CH 3
ing alkali and reading the absorbance, or by adding
acid and reading the absorbance of HOCl at 235 nm Peroxynitrite also inactivates α -antiproteinase, again
1
(ε=100dm3mol–1cm–1). Studies with HOCl are fa- by attacking methionine.130 Surfactant proteins may
cilitated by the ease with which it can be made in also sometimes be targets of HOCl (Section 7.3).
the laboratory, by simple acidification of solutions Thrombomodulin,131 a glycoprotein in endothelial
of sodium hypochlorite (Na+OCl–), a constituent of cells that regulates the blood coagulation pathway
many bleaches. Hypochlorous acid readily decom- by modifying the action of thrombin, is also inacti-
posestoliberatechlorine(Cl )gas,areactionfavoured vated by HOCl, again by attack on methionine, and
2
atlowpH, α -macroglobulin can also be attacked (Table 8.2).
2
Of course, whether α -antiproteinase, thrombomod-
HOCl+H++Cl–(cid:2)Cl +H O 1
2 2 ulin,oranyoftheothermyriadofproteinsthatcanbe
ThetoxicityofCl isconsideredinSection9.11. oxidizedbyHOClareitsmajortargetsinvivodepends
2
Althoughitsimportanceinbacterialkillingbypha- on what else is around them, since HOCl is readily
gocytesisuncertain(Section8.7.5),HOClhasattracted scavengedbyantioxidantssuchasGSH,ascorbate,and
attentionbecauseofitshighreactivity(Table2.11)and albumin(Sections3.10,3.23.3.5,and4.2).
ability to damage biomolecules, both directly and by HOClcancauseside-chaindamage,fragmentation,
decomposing to form chlorine. It is a powerful two- andaggregationofproteinsbymultiplereactions,not
electronoxidizingagent.HOClcancrossmembranes, only oxidation of cysteine and methionine residues,
causing damage to membrane proteins and lipids on butalsoreactionwithside-chain–NH groupstogive
2
itspassageand,ifanysurvivestoenterthecytoplasm, chloramines(Section2.6.3.1).132Metalionsheldinpro-
tointracellularconstituents.Forexample,additionof teinsbythiolate(S–)ligandscanbereleasedafterHOCl
HOCltobacteriasuchasE.coliinhibitsATPsynthesis treatment;forexampleZn2+islostfromNOSenzymes
bydamagingelectrontransportchaincomponentsand and from metallothionein.133,134 HOCl and HOBr can
theATPsynthase.127 attacktheproteincoresofextracellularglycoproteins,
In animal systems, HOCl can attack many targets, disrupting the extracellular matrix;135 indeed, many
e.g. it can inactivate128 α -antiproteinase within proteoglycans bind MPO strongly (Section 8.9), tar-
1
seconds. α -Antiproteinase, formerly called α - geting damage to themselves. HOCl also oxidizes
1 1
antitrypsin, is produced mostly in the liver (smaller NAD(P)Handlipidsanditcandestroyhaemproteins,

--- Page 121 ---

66 FREE RADICALS IN BIOLOGY AND MEDICINE
Table2.11 Somerateconstantsforreactionsofhypochlorousacid. HOCl or HOBr overall, but they can (almost select-
ively) oxidize –SH groups, and can, like HOCl it-
Compound pH K(M–1s–1)at22or25◦C self, release Zn2+ from thiolate ligands in proteins.134
Monochlorodimedona 5.0 7×106 Thiocyanateisareadysubstrateforperoxidases,also
formingHOSCN/OSCN–. Thisissometimesa useful
NADH 7.5 2×105
antibacterialmechanism(Section3.19.2)butcancause
Taurine 7.0 4.8×105 problemsaswell(Section10.3.9).
GSHb 7.4 1.2×108
Cysteine 7.4 3.6×108 2.6.3.1 Chlorhydrins,chloramines,andhydroxyl
radicalfromHOCl
H2S 7.4 2×109
HowdoesHOClattacklipids?Itcanaddacrossdouble
N-Acetylcysteine 7.4 2.9×107
bonds in unsaturated fatty acid residuesin phospho-
Ascorbate 7.4 ~6×106 lipidsoresterifiedtocholesterol,
Methionine 7.4 3.4×107
Ferrocyanide,Fe(CN)4– 7.0 ~220
6
Fe2+ ~4 1.7×104
Fe(II)-citrate 5.0 1.3×104
to give chlorohydrins. Similar products (bromo-
Superoxide 5.0 7.5×106
hydrins) are formed with HOBr. Reaction of HOCl
withO
•–orFe2+generatesOH•oraspecieswithcom-
Datamostlyfromref6,alsoseeFreeRadic.Biol.Med.73,60,2014.HOClis 2
apowerfultwo-electronoxidizingagent;E◦(cid:4)forthecoupleHOCl/H2O,Cl–is parable reactivity; Fenton reported a long time ago
about1.1V.Oxidations/chlorinationscausedbyHOCladditiontobiomolecules thattheH O inhisFe2+/H O /tartaricacidsystem
2 2 2 2
arenotnecessarilyduetoHOClitself;itcandecomposetogiveCl2. (Section2.5.1.1)couldbereplacedby‘chlorinewater’.
a This compound, full name 1,1-dimethyl-4-chloro-3,5-cyclo- Indeed,E.colimutantswithelevatedintracellulariron
hexanedione, is chlorinated by HOCl; the resulting rise in absorbance
arehypersensitivetoHOCl(Section3.7.1).
at290nmissometimesusedtoassayHOClproductionbymyeloperoxidase.
b Reaction of GSH with HOCl gives a mixture of products, including Taurine (2-aminoethanesulphonic acid) is present
GSSG, GSO2Cl, GSO2SG (glutathione thiosulphonate), and a glutathione at high levels in many mammalian tissues as an
sulphonamide. end-productofthemetabolismofsulphur-containing
amino acids (Section 8.7.5). It reacts with HOCl to
generatetaurinechloramines,
releasing‘free’ironions.136ItcanalsochlorinateDNA
and RNA bases (especially pyrimidines)137 and tyro- R–NH 2 +HOCl→RNHCl+H 2 O
sineresiduesinproteins(generating3-chlorotyrosine
which can also inactivate α -antiproteinase. Chlor-
and 3,5-dichlorotyrosine). Nitration and chlorin- 1
amineswereinitiallyidentifiedas‘long-livedoxidants’
ation of HDL, apparently MPO-catalysed, seem to
generated by reaction of HOCl with body fluids.128
be important pathological events in atherosclerosis
Similar products are formed by HOCl from amino
(Sections10.3.5.1and10.3.9).Nevertheless,HOClcan
groupsonproteins,lipids,DNA,RNA,andaminosug-
sometimesbeanti-inflammatory(Section5.5.6.1)!
ars found in proteoglycans. Hypobromous acid can
Hypochlorousacidcanalsoparticipateinformation
similarly formbromamines, RNHBr. Both HOCl and
ofsingletO (Section2.6.4)andofnitrylchloride.82 In
2
chloramineshavebeenreportedtointerferewithDNA
addition,HOClandHOBroxidizethiocyanate(SCN–)
repairincells.ChloraminescanreactwithO
•–toprod-
tohypothiocyanite,138OSCN–, 2
ucenitrogen-centredradicals,
HOCl+SCN–→Cl–+OSCN–+H+ RNHCl+O •–→RNH • +Cl–+O
2 2
SCN–ispresentatmillimolarlevelsinsaliva,milk,and andthepresenceofO •–increases132damagetoproteins
2
tear fluids, and at up to 100 μM in plasma (smokers and proteoglycans by HOCl. Chloramines can oxid-
have elevated levels, up to 500 μM).138 The reaction izethiols,ascorbate,andmethionine,butmoreslowly
is rapid, especially for HOBr (k ~ 2.3 ×109M–1s–1). than does HOCl (rate constants <103 M–1s–1) Reac-
.
OSCN– and its protonated form (hypothiocyanous tionsofhistidinechloraminesaresomewhatfasterthan
acid, HOSCN, pKa ~5.3) are much less reactive than most,althoughstillslower139thanthoseofHOCl.

--- Page 122 ---

REDOX CHEMISTRY: THE ESSENTIALS 67
2.6.3.2 Atomicchlorine140 inculturetohigh-intensityvisiblelightleadstodam-
Chlorineatoms(Cl•)canbeformedintheupperatmos- age,especiallytothemitochondria,whicharerichin
haemproteinsandflavoproteins.Haem-containingen-
phere by several mechanisms, although their signifi-
zymessuchascatalasearealsoinactivated.Cellculture
cance in vivo is uncertain. Rate constants for reaction
of Cl• with hydrocarbons are very high, comparable mediafrequentlycontainriboflavin,whichaggravates
to those of OH•. The reactions usually proceed by theseeffects,sincetheintensityoflightinginmanyla-
boratories is sufficient to allow flavin-sensitized 1O
hydrogenatomabstraction. 2
formation.113,143
2.6.4 Singletoxygen21,141 2.6.4.2 TypeIandIIreactions
TwosingletstatesofO 2 exist(Fig.1.14).Sincethespin Not all photosensitization damage need involve 1O 2 ;
restrictionthatslowsreactionofO withnon-radicals theexcitedstateofthephotosensitizercansometimes
2
isremoved,bothsingletoxygensaremuchmorereact- causedirectdamage(saidtooccurbyatypeImechan-
ivethanground-stateO 2 andcandirectlyoxidizemany ism,whereasthatcausedby1O 2 isdescribedasatype
biomolecules,includingnucleicacids,lipids,andpro- II mechanism). Type I reactions sometimes involve
teins.The1(cid:7)g+staterapidlydecaystothe1(cid:6)gstate,so productionoffreeradicalswhenthetripletstatesens-
onlythelatterisusuallyconsideredinbiologicalsys- itizeroxidizesthesubstrate.TypeIandIImechanisms
tems.Hencereferencesto‘singletO ’inthisbookrefer mayoperatesimultaneouslyandtheirrelativeimport-
2
tothe1(cid:6)gstate.Notethat1(cid:6)gO isnotafreeradical ance depends on the target molecule, the efficiency
2
(Fig.1.14). of energy transfer from the sensitizer to O 2 , and the
SingletO 2 insolutioncantransferitsexcitationen- O 2 concentration.Thus,illuminationofseveralphoto-
ergy to the solvent, so its lifetime is affected by the sensitizers,includingporphyrinsandacridinedyes,in
solventused,e.g.itisgreaterinsomeorganicsolvents
aqueoussolutionproducesOH•andO •
2
–inadditionto
orindeuteriumoxide(D 2 O)thanitisinwater. 1O 2 .Anotherexample,titaniumoxidecanreadilyox-
idizeorganicmaterialsinthelight,andnotonly1O is
2
2.6.4.1 SingletO2fromphotosensitization involved but also other ROS,144 including OH•. Thus
neverassumethat1O istheonlyspeciesresponsible
Singlet O can be produced by the Russell mechan- 2
2 fordamageobservedinphotochemicalsystems.
ism (Section 2.5.4.1), but is more often generated by
photosensitizationreactions.Ifcertainmoleculesare
2.6.4.3 Biologicaldamagebyphotosensitization
illuminatedwithlightofthecorrectwavelength,they
absorb it and the energy raises the molecule into an Photosensitizationreactionsinvolving1O areimport-
2
excitedsingletstate.Thisshiftsrapidlytoanexcited ant in vivo, especially in skin (Section 7.13), plants
triplet state that transfers energy to an adjacent O (Section 7.8), and the eye (Section 7.10). Illumination
2
molecule,convertingittoasingletstatewhilstthepho- ofmilk,cheese,orbeercancausedevelopmentof‘off-
tosensitizerreturnstoitsgroundstate.Popularsensi- flavours’ as the riboflavin and other photosensitizers
tizers of 1O formation in the laboratory include the presentgenerate1O andcausethedegradationofpro-
2 2
dyes acridine orange, methylene blue, rose Bengal, teins, lipids, or other molecules to unpleasant tasting
andtoluidineblue,butmanynaturalbiomoleculesare products.145
sensitizers,includingvitaminB (riboflavin)anditsde- Several diseases can lead to excessive singlet O
2 2
rivatives FMN and FAD, hypocrellins A and B (Fig formation.Forexample,theporphyrias142 (atermde-
2.11), chlorophylls a and b (Section 7.8), the bile pig- rived from porphuros, Greek for purple) are caused
mentbilirubin,andvariousporphyrins,bothfreeand by defects in the biosynthesis of haem (Fig. 2.12).
boundtoproteins(Figs2.12and2.13).141,142 In some, porphyrins accumulate in the skin, expos-
The 1O produced on illumination of photosensit- ure of which to light causes eruptions, scarring, and
2
izerscanalsoattackthephotosensitizeritself.Hence, thickening(Fig.2.13).Theseverityofthedamagede-
illuminatedsolutionsofflavinslosetheirorangecolour pendsuponwhichporphyrinisaccumulatedandthus
and chlorophylls their green colour as they are at- differsindifferenttypesofporphyria.Oralβ-carotene,
tacked(photobleaching).Reactionsofthistypecause asingletO quencher(Section4.4),canoffersomepro-
2
the dyes in clothes and curtains, the paint on cars, tection.Evenhealthyskincanbeexposedto1O from
2
andthecoloursinsometattoos(Section7.13)tofade small amounts of porphyrins generated by bacteria
when exposed to sunlight. Indeed, exposure of cells (Section7.13).

--- Page 123 ---

68 FREE RADICALS IN BIOLOGY AND MEDICINE
(a) (d)
5 CH I I
HC CH –O O O
HC C O
O O
8 I I
COOH COOH
(b) Cl CO–
CH 2 CH 2 CH 2 CH 2 2
H 3 C HCCH 3 CH 2CH 2 CH 3CH 3 CH Cl Cl
Cl
O NH CH NH CH NH CH NH O
2
(e)
(c) (CH 3 ) 2 N S N+(CH 3 ) 2 Cl–
CH CH
3 3
H 3 C CH 3 CH C CH C C H N
CH CH CH CH O
CH
3
(f)
O HO
OCH
3
CH O
3
CH 3 O CH 3
COCH
3
OCH
3
O HO
Figure2.11 Somecompoundsthatsensitizeformationof1O2whenilluminatedwithlightofthecorrectwavelength.(a)Psoralen,(b)bilirubin,
(c)all-transretinal,amoleculeimportantinvision(Section7.10),(d)roseBengal,(e)methyleneblue,chloridesalt,(f)hypocrellinB.Hypocrellins
areproducedbyaparasiticfungusfoundinChina,Hypocrellabambuase.Otherplant-derivedphotosensitizersareshowninFig.7.15.
Severalclinicallyuseddrugsarecapableofsensitiz- Photosensitization reactions are also important in
ing1O formation,146includingsomeanti-depressants, veterinary medicine.147 Digestion of chlorophyll in
2
anti-fungals, anti-malarials, tetracycline, and fluoro- ruminantsformsthepigmentformerlycalledphyllo-
quinolone antibiotics (Section 9.17), and certain non- erythrin (now called phytoporphyrin), which is ab-
steroidal anti-inflammatory drugs, such as carpro- sorbed from the gut and excreted in the bile. Any
fen. There are two types of damage. A phototoxic liver malfunction (e.g. due to hepatotoxins in the
reaction is due to direct formation of singlet O , plants grazed) hinders excretion, allowing phytopor-
2
and sometimes other ROS, giving a sunburn-type phyrin to enter the blood and deposit in the tissues.
reaction. Photoallergy involves the immune system: Whentheanimalsareexposedtosunlightthepigment
the drug is oxidized and the products bind to pro- in the skin causes damage that results in redden-
teins to form conjugates that trigger an immune re- ingandswelling.Similarly,sporidesmin,producedby
sponse, as illustrated by the terpene limonene (Sec- thefungusPithomyceschartarumgrowingonpastures,
tion 7.13.1.1). Upon subsequent re-exposure to the causes damage to the bile ducts in animals that con-
agent, an allergic response occurs. Certain herbi- sume it, leading to light-dependent protoporphyrin-
cides damage plants by increasing 1O formation mediated facial eczema.148 Buckwheat synthesizes a
2
(Section7.9). compound that sensitizes 1O formation, and thus is
2

--- Page 124 ---

REDOX CHEMISTRY: THE ESSENTIALS 69
(a) COOH HOOC COOH P A (b) Aminolaevulinic acid
A P
CH C 2 H2 Deh A yd LA ratase N Dea P m BG inase HO N N H HH H N N Doss porphyria
O C H2N H P A Porphobilinogen
CH2 Porphobilinogen A P
(PBG) Acute intermittent porphyria
H2N Preuroporphyrinogen
δ–Aminolaevulinic
acid (ALA) Preuroporphyrinogen
Cosynthase
Congenital erythropoietic porphyria
P CH3 P A
CH3
NHHN
P
Uroporphyrinogen
A
NHHN
P Uroporphyrinogen lll
NHHN Decarboxylase NHHN Porphyria cutanea tarda
CH3 CH3 P A
P P A P Coproporphyrinogen
Coproporphyrinogen lll Uroporphyrinogen lll
Hereditary coproporphyria
Copro’gen
oxidase Protoporphyrinogen
CH2
CH3
CH2
CH3
CH2
CH3
Variegate porphyria
CH3 NHHN CH2Proto’gen CH 3 N HN CH2 Ferro- CH3 N Fel N l CH2 Protoporphyrin IX
NHHN oxidase N HN chelatase N N
CH3 CH3 CH3 CH3 CH3 CH3
Erythropoietic protoporphyria
P P P P P P= propionic acid group,
Protoporphyrinogen Protoporphyrin Haem
–(CH2)2COOH
Haem
Figure2.12 Biosynthesisofhaem.Eightstepsareinvolved(includingthesynthesisofALA).Differentporphyriasresultfrominbornerrorsin
differentenzymes.Forexample,hereditarycoproporphyria,congenitalerythropoieticporphyria,andvariegateporphyriaare
frequentlyassociatedwithskinlesions.Inporphyriacutaneatarda,uroporphyrinogendecarboxylaseactivityisdecreasedandskinlesionsare
common.Thisdiseaseisnotalwaysinherited:itcanresultfromexposuretocertaintoxins(Section9.3.2).Lossofferrochelataseactivityalsoleads
toskindamage,duetoprotoporphyrinIXaccumulation.FromTrendsBiochem.Sci.21,229,1996,bycourtesyofDrMartinWarrenandhis
colleaguesandElsevier,alsoseeref142.δ-Aminolaevulinicacid(ALA),whichaccumulatesinacuteintermittentporphyriaandalsoinlead
poisoning(Section9.16.8)isanautoxidizablemolecule;ratschronicallytreatedwithitshowedincreasedlevelsof8OHGinliverDNA
(Carcinogenesis15,2241,1994).
toxictofarmanimals.149 ThesameistrueofStJohn’s The soluble diglucuronide is excreted into bile. Pre-
wort, a plant that produces the sensitizer hypericin mature babies often have insufficient glucuronyl
(Fig.7.15). transferase in the liver, so that the lipid-soluble bili-
rubin accumulates in the blood, and deposits in
2.6.4.4 Usesofphotosensitization tissues with a high lipid content, especially brain,
where it can cause neuronal damage. The jaundice
Photochemical effects are sometimes useful. A well-
can be ameliorated by careful exposure of the ba-
establishedcaseisthetreatmentofthejaundicesome-
bies to blue light from a sunlamp. This causes a
times developed by premature infants.150 The yellow
light-inducedrearrangement(photoisomerization) of
colour is due to accumulation of bilirubin (Fig. 2.11)
the structure of bilirubin to give water-soluble prod-
in the skin. This compound arises from the break-
ucts that don’t enter the brain as readily and can be
down of haem and travels in the blood attached to
excreted.150
albumin, which can bind two molecules of bilirubin
Anotherexampleofthemedicalrelevanceofphoto-
per molecule of protein. The liver takes up biluru-
sensitizationistheuseofpsoralens(Fig.2.11),power-
binandconvertsitintoawater-solubleproductusing
ful photosensitizers produced by some plants (e.g.
the enzyme uridine diphosphoglucuronyl transfer-
celery), to treat the skin disease psoriasis. Treatment
ase,whichcatalysesthereaction,
consists of the combined application of ultraviolet
bilirubin+2UDP–glucuronicacid
light and a psoralen, and is often referred to as
→bilirubindiglucuronide+2UDP PUVAtherapy(psoralenultravioletA).Thistherapyis

--- Page 125 ---

70 FREE RADICALS IN BIOLOGY AND MEDICINE
Figure2.13(colourplate2) Skinlesionsinsomeporphyrias.A:Cutaneoussymptomsinvariegateporphyria,hereditarycoproporphyria,and
porphyriacutaneatarda;blistersandbullae(arrow).B–D:Clinicalpresentationofcongenitalerythropoieticporphyria(Günther’sdisease),the
mostfrequentoftherecessiveporphyrias.Severepresentationinadults(B);severepresentationinanewbornbefore(C)and2yearsafter(D)bone
marrowtransplantation.ItarisesfromadeficiencyofuroporphyrinogenIIIsynthase.Mostpatientshaveseverephotosensitivity,leadingtobullae,
scarring,andeventuallydisfigurementofthelight-exposedpartsofthebodysuchashands,ears,nose,andeyelids.AdaptedfromLancet,375,
924,2010,bycourtesyofProfessorJCDeybachandElsevier.
helpfulinpsoriasis,butthereisdebateaboutitssafety, (photodynamictherapy).Suchmethodsareunderde-
e.g. whether it increases the risk of developing skin velopment for cancer treatment, especially for skin
cancer.151 cancers and for oesophageal and some types of lung
Athirdexample—someporphyrinsaretakenupby cancer, in which the tumour can be illuminated with
malignanttumours.152AfterinjectionofthedrugHPD light from a flexible fibre-optic tube. Both OH• and
(haematoporphyrinderivative)intopatients,porphy- 1O appear to be involved in HPD-mediated tumour
2
rinsareaccumulatedbythetumour,enablingitsdetec- damage. The HPD preparation is a complex mixture
tion by observing fluorescence. Irradiation with light of porphyrins and, more recently, a simpler mixture
of the correct wavelength to excite the porphyrins (Photofrin II) enriched in the tumour-localizing frac-
can lead to 1O formation that damages the tumour tionshasbeenemployed.Hypocrellins(Fig.2.11)and
2

--- Page 126 ---

REDOX CHEMISTRY: THE ESSENTIALS 71
severalothercompoundshavealsobeentested,includ- proteinisKillerRed®,aderivativeofgreenfluorescent
ingsensitizersboundtonanoparticlesorothercarriers, protein(Section8.6.1).156
including BODIPY (Section 6.15.12) or to monoclonal
antibodiesdirectedagainstthetargetcells.Yetanother
2.6.4.6 Reactionsofsingletoxygen141
approach is to supply ALA or its esters (Fig. 2.12)—
this leads to a transient build-up of protoporphyrin Singlet O 2 interacts with other molecules in essen-
IX,whichespeciallyaffectstumourtissuessincetheir tiallytwoways:itcanchemicallyoxidizethem,and/or
ferrochelatase activities seem lower than normal.152 it can transfer its excitation energy to them, return-
Photodynamictherapyhasalsobeenusedinthetreat- ing to the ground state while the other molecule en-
mentofmaculardegeneration(Section7.10). tersanexcitedstate.Thelatterphenomenoniscalled
quenching of singlet O and is a key function of ca-
2
2.6.4.5 OthersourcesofsingletO2 rotenoids in chloroplasts, for example (Section 7.8.4).
Anothersystemusedtogenerate1O 2 inthelaboratory Moleculesusedinthelaboratoryas‘singletO 2 quench-
isamixtureofH O andhypochlorite,
ers/scavengers’includeβ-carotene,histidine,DABCO,
2 2
azide, and diphenylisobenzofuran. Sometimes both
OCl–+H 2 O 2 →Cl–+H 2 O+1O 2 quenchingandchemicalreactionsoccurwiththesame
molecule (Fig. 2.14). The reactions of singlet O with
The singlet O arises from the H O . Hypobromite 2
2 2 2 lipids and DNA are considered in detail in Sec-
(OBr–)reactssimilarly.SmallamountsofsingletO can
2 tions5.11.8.1and5.8.2.4respectively.Proteinsareread-
alsoariseduringthebreakdownofperoxynitrateand
ily attacked, including oxidation of cys, trp, his, met,
peroxynitrite,153andinreactionsofO (Section2.6.5).
3 andtyrresidues(Fig.2.14)
A ‘clean’ method of producing 1O without other
2 SingletO reactsrapidlywith compoundscontain-
ROSisthedecompositionofaromaticendoperoxides, 2
ing carbon–carbon double bonds. Molecules contain-
such as the substituted naphthalene endoperoxides.
ing two double bonds separated by a single bond
DependingontheRgroup,thesecanbewater-soluble
(known as conjugated double bonds) often react to
orhydrophobic,
giveendoperoxides,
Generationof1O inthiswayhasbeenusedtoassess
2 Diphenylisobenzofuran reacts in this way (Fig. 2.14).
its effects on antioxidants in human blood plasma.154
If one double bond is present, the ene-reaction can
Exposure of plasma to a water-soluble 1O gener-
2 occur—the 1O adds and the double bond changes
ator led to depletion of ascorbate, urate, protein –SH 2
position,
groups and bilirubin, but not of α-tocopherol or β-
carotene.Lipid-soluble1O generatorsledtofasterloss
2
of bilirubin, protein thiols, ubiquinol, and ascorbate,
but lower rates of urate degradation. A singlet O -
2
generating fluorescent flavoprotein (miniSOGc) has
beendescribed.Itcanbeselectivelyexpressedindif-
ferentcelltypesinanorganism,killingthetargetcells
uponillumination,thusallowinginvestigationofthat
Ifthereisanelectron-donatingatom,suchasNorS,
cell’sroleinvivo.MiniSOGhasbeenusedtoablatecells
adjacenttothedoublebond,1O maycausedioxetane
inC.elegans,forexample.155Analternativephototoxic 2
formation.Dioxetanesareunstableanddecomposeto
givecompoundscontainingcarbonylgroups,Trypto-
c SOG–singletO2generator. phanisanexample(Fig.2.14).

--- Page 127 ---

72 FREE RADICALS IN BIOLOGY AND MEDICINE
Compound Structure Comments
Guanine in DNA Forms unstable endoperoxide; opening of the ring can
eventually form 8OHdG. 1O can then oxidize 8OHdG further
2
(Section 5.8.2.11)
O O
N N
HN HN
R R
1O
HN N N 2 N N
2 HN
2
R R O
Guanosine O
8OHdG and
other products
Methionine N + H Forms methionine sulphoxide
3
CH 3 SCH 2 CH 2 CH O– N + H 3
COO–
CHSCHCHCH
3+ 2 2
COO–
+ Reactions not fully characterized: both cystine and cysteic acid
Cysteine NH 3 (RSO 3 H) are formed. Cystine can react further with 1O 2.
HSCHCH (R—SH)
2 COO– N + H 3 N + H 3 N + H 3
HC-CH 2 -S-S-CH 2 -CH SO3H-CH 2 CH
COO– COO– COO–
Cystine Cysteic acid
Histidine N + H Probably reacts to give an endoperoxide
3
N CHCHCOO– R
2
N
N
N
H
H
O O
which decomposes to a complex mixture of products
Tryptophan Reacts by several mechanisms, including an ene-reaction to
CH 2 CHCOO– give initially
OOH
NH
N + 3
H R
N
(R is the side-chain) and also formation of a dioxetane
Figure2.14 (Continued)

--- Page 128 ---

REDOX CHEMISTRY: THE ESSENTIALS 73
Compound Structure Comments
R
O
O
N
H
which decomposes to N-formylknurenine, itself a
photosensitizer of 1O formation
2
+
O NH
3
CCHCHCOO–
2
NHCHO
DABCO CH CH Quencher
2 2
(1,4-diazabicyclooctane)
N
H 2 C N CH 2
CH 2 CH 2
Azide ion N– Mostly quenching
3
α-Tocopherol See Fig. 4.3 Mostly quenching but some
chemical reaction to give
OOH CH
O 3
R
O
which decomposes to various
products including
α-tocopherylquinone
(R is the side chain); also see Fig. 4.3.
HO CH 3
O C
R
CH
O C 2
H
2
Figure2.14 (Continued)

--- Page 129 ---

74 FREE RADICALS IN BIOLOGY AND MEDICINE
Compound Structure Comments
Cholesterol Major product is the 5α-hydroperoxide
CH
8 17
CH
3
CH
8 17
CH 3 CH 3
CH
3
HO
HO
OOH
but some 6α and 6β-OOH can
form. Cholesterol can be used
to detect 1O.
β-Carotene
HC
2
H 3 C CH 3 CH 3 CH 3 3 M (co o m st p ly l e q x u ) e c n h c e h m in ic g a , l s r o e m ac e tions
(Section 4.4).
H 3 C CH 3
CH 3 3
Ascorbate Produces unstable hydroperoxides
R O R O R O
O O + O
1O H
H 2 H
HO OH HOO OH O O HO OOH
Fast reaction (k ~ 3 x 108 M–1s–1); HO is produced,
2 2 2
Photochem. Photobiol. 82, 1634, 2006)
Diphenylisobenzofuran Endoperoxide formation accompanied by loss of absorbance at
415 nm
CH
6 5
O
O O
O
CH
6 5
Figure2.14 ReactionsofsingletO2withvariousbiomolecules,antioxidants,and‘singletquenchers/scavengers’.Calculationsbasedonreaction
rateconstantssuggestthatmost1O2generatedinvivowillreactwithaminoacidresiduesonproteins.Proteinperoxidesthusformedcanthen
decomposeintofreeradicalstopropagatedamage(Section5.13).

--- Page 130 ---

REDOX CHEMISTRY: THE ESSENTIALS 75
2.6.5 Ozone,aradicalornot? Cl • +O →O +CIO
3 2
Ozone is a triatomic gas, poorly soluble in water.
It has a characteristic pungent smell and causes irri- Chlorine monoxide (ClO) in the atmosphere can fur-
tation to the respiratory tract and eyes etc. Indeed, therreactwithHO • andNO • ,
2 2
its name derives from the Greek ozein, ‘to smell’.
The two oxygen–oxygen bonds in O 3 are of equal ClO+HO • 2 →HOCl+O 2
length and intermediate in structure between O–O
ClO+NO
•→ClONO
andO=Obonds.However,someauthorshaveargued 2 2
that O has a degree of free-radical character, i.e.
3 However, O is a nuisance if formed in the lower
3
O O
atmosphere. It can arise by photochemical reactions
(cid:129)O O(cid:129) rather than O O, although the birad- between oxides of nitrogen and hydrocarbons; mo-
icalformmayonlybeasmallcontributortotheoverall tor vehicle exhausts are a good source of the neces-
structure.157 sary gas mixture. Millions of people in the world
Ozone performs an essential ‘antioxidant’ function are regularly exposed to O above the ‘safe’ levels
3
inthehigherlevelsoftheatmospherebyscreeningout (Section9.12.1).
UVC light. It is produced there by the photodissoci- Ozoneisapowerfuloxidizingagent.Forexample,it
ation of O 2 into oxygen atoms, which then combine canadddirectlyacrossdoublebondsinlipidstogener-
withO 2 .Concernoverthecommercialuseoffluorin- ateozonides,whichcandecomposetocytotoxicalde-
ated hydrocarbons because they may deplete the O 3 hydes and other products, including OH• (Fig. 2.15).
layerledtotheirphasingoutinmanycountries.Free Indeed, this is an important mechanism for removal
radicals are involved yet again! Homolytic photodis- ofunsaturatedhydrocarbonsintheupperatmosphere.
sociation of chlorofluorocarbon gases such as CF 2 Cl 2 Ozone also oxidizes GSH, ascorbate, and proteins,
and CFCl 3 produces chorine radicals in the atmos- attacking–SH,tyrosine,tryptophan,histidine,andme-
phere,whichreactrapidlywithozone(andalsowith thionineresidues,amongothers.158Evenlaboratoryair
organiccompounds,Section2.6.3.2), levels of O can sometimes be sufficient159 to oxidize
3
O
O O
O(cid:129) O–
O
3
C C C C C(cid:129) O C O + C = O
+
Resonance structure
carbonyl
compound
decomposition
Acids
recombination
Carbonyls
OH(cid:129) radicals
O
C C
O O
Figure2.15 Ozonecanaddacrossdoublebondstogiveacyclic1,2,3-trioxolanespecies.Theserapidlydecomposebyhomolyticbondfissionto
giveacarbonylmoleculeandacarbonyloxidereactiveintermediatewithsomeradicalcharacter(Criegeeintermediates).Intheabsenceof
othermoleculestoreactwith,productrecombinationcanoccurtogiveCriegeeozonides,whichcandecomposetoformradicals,carbonyl
compounds,andH2O2.Forexample,theC9aldehydenonanalarisesfromozonationofoleicacid,heptanalfrompalmitoleicacid,andhexanal
fromarachidonicacid.HydroxylradicalformedfromthebreakdownofCriegeeintermediatescansometimesparticipateinfurtheroxidation
reactions.SeeScience,355,178,2012;Chem.Soc.Rev.37,699,2008.

--- Page 131 ---

76 FREE RADICALS IN BIOLOGY AND MEDICINE
proteinsduringtheirpreparationforanalysisbymass cysteine,albumin,methionine,uricacid,orGSSG)has
spectrometry! Both lipids and proteins (e.g. in sur- beenshown161toproducesome1O ,whichcouldthen
2
factant) may be targets of direct attack by O in the causefurtheroxidations,ascouldtheOH• andH O
3 2 2
respiratorytract(Section9.12).Inaqueoussolution,O producedwhenO reactswithlipids(Fig.2.15).
3 3
decomposestoformsomeOH•,butthisisaslowre- Ozone can also facilitate the nitration of proteins:
action in vitro at physiological pH (only favoured at itoxidizestyrosineresiduestotyrosylradicalswhich
•
highly alkaline pH). Nevertheless, aromatic hydrox- then combine rapidly with NO (Sections 6.6.2 and
2
ylation techniques (Section 6.3.1) have detected OH• 9.12.1).162 Ozonation has sometimes been used as an
formationinratsorhumansbreathingozone.160Reac- alternativetochlorinationforthesterilizationofdrink-
tionofO withseveralbiomolecules(NADH,NADPH, ingwater,sinceO ishighlybactericidal.
3 3

--- Page 132 ---

CHAPTER 3
Antioxidant defences
synthesized invivo
Livingorganismsareexposedtomuchmoresevereoxidationthanisfoodinarefrigerator.Nevertheless,
theydonotbecomeranciduntilthey,intheirturn,becomefood.
GrahamBurtonandKeithIngold
3.1 Introduction to be a protective antioxidant (Sections 7.3 and 9.12).
By contrast, urate provides little protection against
Oxygen is poisonous; aerobes survive in its presence
damagetobloodplasmaconstituentsbyhypochlorous
onlybecausetheycontainantioxidantdefences.Anti-
acid(HOCl).IftheRSisthesamebutadifferentdam-
oxidantscanbesynthesizedinvivoortakeninfromthe
agetargetismeasured,differentanswersresult.Forex-
environment,e.g.indiet(Chapter4).Defencesagainst
ample,exposureofhumanbloodplasmatogas-phase
awiderangeofreactivespecies(Chapter2)areneeded.
cigarettesmokecausesperoxidationofplasmalipids,
Inthischapterweusethetermreactivespecies(RS)
whichisinhibitedbyascorbate.Bycontrast,ascorbate
to encompass ROS, RNS, and reactive halogen and
doesnotprotectagainstdamagetoplasmaproteinsby
sulphurspecies.
cigarettesmoke,asmeasuredbythecarbonylassay.3
Toencompassthesevariouscomplexities,thethird
3.2 Whatisanantioxidant? editionofthisbookproposedabroaddefinitionofan
antioxidant as any substance that, when present at
Antioxidant is a term widely used but surprisingly
lowconcentrationscomparedwiththoseofanoxidiz-
difficulttodefineclearly.Foodtechnologistsuseanti-
ablesubstrate,significantlydelaysorpreventsoxida-
oxidantstoinhibitlipidperoxidationinfoods,sothey
tionofthatsubstrate.Thetermoxidizablesubstrate
oftendefineanantioxidantasagoodinhibitoroflipid
includeseveryorganicandmanyinorganicmolecules
peroxidation. Museum curators use ‘antioxidants’ to
foundinvivo.Thisdefinitionwaschosentoemphasize
preservetheirexhibits.1Industryuses‘antioxidants’to
the importance of the damage target studied and the
control polymerization in the manufacture of rubber,
source of RS used when antioxidant action is exam-
plastics,andpaint,toprotectoilsagainstdeterioration,
ined. It is also imperfect, like us all. For example,
andfortheprotectionofclearplasticsagainstultravio-
plasma albumin may bind copper and protect low
let light.2 All these groups have their own views on
density lipoproteins (LDL) against oxidative damage
whatisa‘goodantioxidant’.
(Section 3.23.3.5), but here the albumin is in consid-
What about living organisms? When RS are gener-
erablemolarexcessovertheLDL.Thedefinitiondoes
atedinvivo,manyantioxidantscomeintoplay.Their
nottakeintoaccountchaperones,repairsystems,orin-
relativeimportancedependsupon:
hibitors of RS generation. Thus we now simplify the
definition to any substance that delays, prevents, or
• which RS is generated, in what amounts and over
removesoxidativedamagetoatargetmolecule.There
whattime-course
is no universal ‘best’ antioxidant, as illustrated by
• howandwhereitisgenerated
the cigarette smoke/plasma experiments mentioned
• whattargetofdamagebyRSismeasured.
above; different antioxidants react with different RS
Forexample,whenhumanbodyfluidsareexposedto at variable rates, act in various locations, and protect
•
ozone (O 3 ) or nitrogen dioxide (NO 2 ), urate appears differentmoleculartargets.
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 133 ---

78 FREE RADICALS IN BIOLOGY AND MEDICINE
3.3 Antioxidantdefences:general exposure of organisms to greater levels of RS and
principles to some cytokines (Section 5.7), and they can be
affected by genetic polymorphisms (Section 5.10.9).
Antioxidantdefencestrategiescaninclude
Exercise is a powerful antioxidant, in part by rais-
ing the levels of antioxidant defence mechanisms!
(a) agents that catalytically remove RS, such as
(Section7.14).
the superoxide dismutase (SOD) and catalase
Antioxidantdefencesarenot100%effective,asillus-
enzymes;
tratedbythefactthatoxidativedamagetoDNA,pro-
(b) agents that control RS formation, e.g. uncoupling
teins,lipids,andothermoleculescanbedemonstrated
proteins or the assembly of electron carriers into
inlivingsystemsunderambientO .Henceeven21%
complexesthatdisfavourescapeofelectronstoO 2
2
O istoxic(Table5.1).Whyaretheynottotallyeffect-
(Section1.10).Thiscategoryincludesproteinsthat 2
ive? We suffer from continual generation of OH• in
minimize the availability of such pro-oxidants as
vivo,whichreactswithwhateveritcontactsfirst,andis
ironions,copperions,orhaem.Examplesaretrans-
thusverydifficulttoprotectagainst(Sections2.5and
ferrins,albumin,haptoglobins,haemopexin,haem
9.20). Another reason may be because some RS are
oxygenases,andmetallothionein;
useful(e.g.asmessengers;discussedindetailinChap-
(c) agentsthatprotectbiomoleculesagainstoxidative
ter5),sothechallengehasbeentoevolveantioxidant
damagebyothermechanisms.Examplesarechap-
defences that allow these useful roles whilst minim-
erones (Section 5.6), proteins that coat DNA, or
izing damage. The oxidative damage we suffer has
enzymesthatdeterminePUFAlevelsinmitochon-
toberepairedorthedamagedbiomoleculesreplaced.
drialmembranes(Table11.2);
Some authors classify the repair systems needed to
(d) physical ‘quenchers’ of RS, e.g. of singlet O by
2
copewithdamagedmolecules(e.g.torepairDNA,re-
carotenoids(Section2.6.4);
assemble[Fe–S]clustersinenzymes(Section3.9),orto
(e) the replacement of molecules sensitive to oxida-
degrade damaged lipids and proteins) as antioxidant
tive damage by molecules that are resistant, e.g.
defences. Others consider the two as separate, but in
fumaraseCofE.coli(Section1.6);
anycaseantioxidantdefencesandrepairprocessesare
(f) ‘sacrificial agents’ that preferentially react with
intimatelylinked.
RS and stop them attacking more important bio-
molecules; examples are GSH, α-tocopherol, as-
corbate, urate, albumin, and plasmalogens (Sec- 3.4 Thesimplestantioxidantdefence:
tion5.12.8.1); minimizeexposuretooxygen
(g) reaction of RS with biomolecules to give prod-
ucts that are cytoprotective, e.g. nitro-fatty acids Some mobile organisms avoid O 2 toxicity by swim-
(Section 2.6) and some end-products of lipid per- mingawayfromregionswithhighO 2 levels.Inseveral
oxidation(Section5.12); bacteria,includingSalmonellatyphimuriumandE.coli,
(h) Compartmentalization. One example is keeping thereisanintracellular‘redoxsensor’whichmeasures
ironionsawayfromH O (Section3.22.4).Break- theredoxstateoftherespiratorychainandtransmits
2 2
down of normal cellular structure (e.g. by homo- asignaltotheflagellaeinvolvedinswimming.4 Simi-
genization) rapidly accelerates oxidative damage lar adaptations were to evolve cytochrome oxidases
because metal ions are released (Section 10.17). that work fast even at low pO 2 and do not release
A second example is that yeasts and bacteria ex- ROS,allowingintramitochondrialpO 2 tobekeptlow
posedtoexternalH O canadapttotakeinlessof (Section 1.10.4). This need to use the minimum in-
2 2
thismolecule(Section2.6.2). tracorporealO 2 levelsthatminimizeoxidativedamage
yet permit aerobic respiration may have been one
Thelevelsandcompositionofantioxidantdefences forcedrivingtheevolutionofmulticellularity(Fig.1.4).
differ from tissue to tissue, cell type to cell type Insects,forexample,seemtoopenandshuttheirspir-
(possibly even from cell to cell of the same type in aclestomaintainalowconstantinternalpO ,subject
2
a given tissue), and in different subcellular organ- to the need to allow CO to escape.5 Food manu-
2
elles. They can also vary with time of day e.g. GSH facturers exploit this technique when they seal foods
(Section 3.10) and peroxiredoxins (Section 3.13.2.3). undernitrogenorinvacuumpacks,orcoatthemwith
Extracellular fluids have different protective mech- wax.Themigrationof‘antioxidants’fromplasticfood
anisms from the intracellular environment (Section wrappings into the packaged food has caused some
3.23). Antioxidant defences are often increased after concern.6

--- Page 134 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 79
3.4.1 Protectingnitrogenases 3.5 Antioxidantdefenceenzymes:
superoxidedismutases(SODs)
We saw in Chapter 1 that most nitrogenase enzymes
areinactivatedbyO 2 ,yetnotallN 2 -fixingspeciesare ThediscoveryofSODs14,15providedmuchofthebasis
strict anaerobes. C. pasteurianum is, it simply avoids forourcurrentunderstandingofantioxidantdefence,
O 2 (Section1.2).SeveralaerotolerantN 2 -fixingbacteria sinceitledtothepostulationofthesuperoxidetheory
surround themselves with a thick capsule to restrict ofO toxicityandtherealizationthatoxygenradicals
2
theentryofO 2 ;thisstrategyof‘antioxidantdefence’is areimportantbiologicalproducts.Indeed,NickLane16
alsousedbycertainstreptococci(Section8.9.6).There statedthat‘thediscoveryandnamingofSODisinthe
are multiple other strategies. Just to list a few, some opinionofmanythemostimportantdiscoveryofmod-
photosyntheticN 2 -fixingorganismslocatetheirnitro- ern biology never to win the Nobel Prize’. Hencewe
genase in specialized, thick-walled, O 2 -resistant cells willconsiderSODsfirst.
knownasheterocysts.7SomecyanobacteriafixN only
2
atnight;bycontrastTrichodesmiumfixesN duringthe
2
day, but slows down photosynthesis to decrease O 3.5.1 Copper–zincSOD14,15
2
levels.7 The bacterium Gluconacetobacter diazotrophicus
In1938,MannandKeilinisolatedablue-greenprotein
isastrictaerobe,butwhenitneedstofixN itrapidly
2 containingcopper(haemocuprein)frombovineblood.
raisesitsantioxidantdefencelevels.8InAzotobacter,an
Other proteins of this type were later isolated, such
electrontransportsystemintheplasmamembraneis
ascerebrocupreinfrombrainandhepatocupreinfrom
thought to scavenge O and keep the cytoplasm an-
2 liver.Itwasnotuntil1969thatMcCordandFridovich
oxic; if it is overwhelmed by O , the nitrogenase is
2 reported that the erythrocyte protein is able to re-
converted into an active but O 2 -tolerant complex by moveO •– catalytically.In1970,itwasdiscoveredthat
bindingwithaprotectiveprotein.9Intherootnodules 2
theerythrocyteproteincontainszincaswellascopper
ofleguminousplantsthataresymbioticwithN -fixing
2 i.e.itfunctionsasacopper-andzinc-containingsuper-
bacteria, an O -binding protein (leghaemoglobin)
2 oxide dismutase enzyme (CuZnSOD). Figure 3.1 il-
helps to control the O concentration and protect
2 lustrates this using the technique of pulse radiolysis
the N -fixing system of the bacteria in the nodule
2 (Section2.3.3.1).TheSODenzymesarehighlyefficient
(Section7.8.11).
in catalytic removal of O
•–.
However, they can pro-
2
moteafewotherreactions,includingthenitrationof
tyrosineresiduesbyONOO–(Section2.6.1.1).
3.4.2 Stemcells
The CuZnSODs are unusually stable enzymes.
Severalpaperssuggestthatadultandembryonicstem InpurifyingCuZnSODfromerythrocytes,thecellsare
cells are exceptionally rich in antioxidant defences, lysed and haemoglobin removed by treatment with
whose levels decrease as the cells differentiate.10,11 chloroform and ethanol, followed by centrifugation.
Haematopoietic stem cells may reside in hypoxic The enzyme enters the organic phase, from which it
niches in the bone marrow (Section 6.2.2), perhaps can be precipitated by addition of cold acetone and
to slow down damage by ROS.11 In the laboratory, thenfurtherpurified.Notmanyenzymeswilltolerate
stemcellfunctionispreservedbetteratphysiological suchprocedures.MostCuZnSODsarefairlyresistant
O levels than in cells exposed to 21% O , which to heating, attack by proteinases, and denaturation
2 2
show increased mutation rates.12 Exposure to appro- by such reagents as guanidinium chloride, sodium
priate levels of ROS (including ROS generated by dodecylsulphate(SDS),andurea.
the cells themselves, e.g. from NADPH oxidase en-
3.5.1.1 CuZnSODineukaryotesandprokaryotes
zymes [Section 8.10]) can affect the proliferation and
differentiation of stem cells into different cell types, CuZnSODs are present in almost all eukaryotic cells.
and ROS may be an important mechanism of con- Inanimalcells,mostCuZnSODislocatedinthecyto-
trolling stem cell fate in vivo.13 Too many ROS will sol, but some appears present in lysosomes, nucleus,
impairtheirfunction,asmayhappeninageingtissues andthespacebetweeninnerandoutermitochondrial
(Section11.4.1). membranes. Peroxisomes have also been reported to
Letusnowexaminesomeantioxidantsystems,bear- containCuZnSOD.14,17
inginmindtwoquestions;(i)whatcantheydo?and CuZnSODswereoriginallythoughttoberareinpro-
(ii)whatevidenceexiststhattheydoitinvivoandthat karyoticcells,butexamplesoftheirpresencesoonac-
thisroleisimportant? cumulated.ThefirsttobediscoveredwasaCuZnSOD

--- Page 135 ---

80 FREE RADICALS IN BIOLOGY AND MEDICINE
A
10 B
C
0
NOITPROSBA
%
100 μs
Figure3.1 ThecatalyticactionofCuZnSODdemonstratedbypulseradiolysis.TheoscilloscopeshowsthedecayatpH8.8ofO
•–radical(initial
concentration32μM)measuredbythelossofitsabsorbanceat250nm.TraceA,spontaneousdismutationofO •–;traceC,plu 2 s2μMofSOD;
2
traceB,asfortraceCbutSODboiledfor5mintodestroyenzymeactivity.DatafromBiochim.Biophys.Acta268,605,1972,bycourtesyof
ProfessorG.RotilioandElsevier.
intheluminescentbacteriumPhotobacteriumleiognathi. in Section 3.23.3.2. Bacterial CuZnSODs are also usu-
This organism exists in a symbiotic relationship with allydimerswithoneCupersubunit,althoughsome,
theponyfish,occupyingaspecialglandandimparting includingtheE.colienzyme,aremonomers.
a characteristic luminescence to the fish. It was ini- TheCuZnSODsfunctiontoacceleratethedismutation
tiallysuggestedthatthebacteriumobtainedthegene ofO
•–(Fig.3.1),
2
foritsCuZnSODbygenetransferfromitshostfish,but
this is doubtful.14 Indeed, CuZnSODs occur in many O •–+O •–+2H+ →H O +O (ground-state)
2 2 2 2 2
otherbacteria,includingNeisseria,Caulobacter,Legion-
ella,Brucella,Salmonella,andHaemophilusspecies,and
Whereastheoverallrateconstantfortheuncatalysed
in Mycobacterium tuberculosis.18 Often (e.g. in E. coli)
dismutationofO
•–
dependsonpH(Section2.5.3)and
theCuZnSODislocatedintheperiplasmicspace(the is about 5 × 105 2 M–1s–1 at pH 7.0, the reaction cata-
space between the bacterial cell wall and cell mem-
lysed by bovine erythrocyte CuZnSOD (the enzyme
brane).Itmayhelptodefendagainstexternalsources
mostcommonlystudied)isalmostindependentofpH
of RS, such as activated phagocytes, and against any
O • 2 – generated in the periplasmic space itself. In Hae- i o n f t O he •– ra w n i g th e5 th .3 e to ac 9 t . i 5 v , e an si d te th is er a a t te le c a o s n t s 1 t . a 5 n × tf 1 o 0 r 9 re M ac –1 ti s o –1 n ,
mophilusducreyi,whichcausesthesexuallytransmitted 2
over three orders of magnitude greater. Also, non-
diseasechancroid,theCuZnSODhashaemboundtoit
enzymicdismutationrequiresO
•–
andHO
•
tocollide
(Section3.22.3). 2 2
(Section2.5.3),whichisdifficultgiventheirlowintra-
cellular concentrations (10–9–10–10 M). Superoxide is
3.5.1.2 CatalyticabilityofCuZnSOD more likely to collide with SOD, which is present in
CuZnSODsfromeukaryotesusuallyhaverelativemo- manycellsat~10–5Mconcentrations.14
lecularmassesofabout32,000andcontaintwoprotein ThecopperionsinCuZnSODscatalysedismutation
subunits, each of which has an active site containing byundergoingalternateoxidationandreduction,
onecopperandonezincionandanintramoleculardi-
sulphidebond(betweencys57and-146inthehuman enzyme-Cu2++O •–→enzyme-Cu++O
2 2
enzyme).HumanandbovineCuZnSODalsohavetwo enzyme-Cu++O •–+2H+→enzyme-Cu2++H O
freecysteine–SHgroups(cys6and-111inthehuman 2 2 2
enzyme). A different type of CuZnSOD, extracellular
Netreaction:O
•–+O •–+2H+→H
O +O
SOD(EC-SOD),sometimescalledSOD3,isconsidered 2 2 2 2 2

--- Page 136 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 81
Ionsofmostothertransitionmetals,includingironand COO–
manganese,cannotreplacethecopperofCuZnSODto
yieldafunctionalenzyme.TheZn2+doesnotfunction CH CH
2
in the catalytic cycle but helps stabilize the enzyme.
NH +
Indeed, the M. tuberculosis enzyme seems not to con- 3
tain zinc and yet dismutes O
•–
efficiently, but is less
C CH
2
thermostablethanmostCuZnSODs.18 Inanimalcells, N NH
a metallochaperone known as CCS (copper chaper- C
H
oneforSOD),deliverscopperionstotheapoenzyme
(metal-free enzyme) whilst facilitating correct disul-
Figure3.2 Structureoftheaminoacidhistidine.Theringstructureis
phide bridge formation in the SOD molecule.19 CCS knownastheimidazoleringandcontainstwonitrogenatoms.Each
is widely expressed in eukaryotes and has consider- hasfiveelectronsinitsoutermostshell,threeofwhicharebeingused
able structural similarity to CuZnSOD. Knockout of incovalentbonding.Theremainingtwoconstitutealonepair
CCSinyeastortheplantArabidopsisthalianaabolishes (explainedintheAppendix)andcanactasligandstometalionssuch
CuZnSOD activity. However, in animals some activ- asthecopperinCuZnSOD.
ityremains;apparentlythereisasecondarypathway
involving Cu delivery by GSH. Indeed, C.elegans ap-
ofthesepositivelychargedaminoacidside-chainsde-
parently does not require CCS at all.20 No chaperone
creasesenzymeactivity,andhighionicstrengthdoes
appearstoberequiredforZn2+tobindtotheenzymes.
thesame,astheybothinterferewiththiselectrostatic
3.5.1.3 CuZnSODstructure15,19 facilitationofO • 2 – dismutation.VariantsofSODhave
beendevelopedinthelaboratorythatworkfasterthan
Thecompleteaminoacidsequences(and,increasingly,
the wild-type enzyme by enhancing this mechanism
the three-dimensional structures) of CuZnSOD from
(Fig.3.4d).
multiple plants and animals have been determined
and, in general, are very similar. The first detailed 3.5.1.4 InhibitorsofCuZnSOD
structuredeterminedwasforbovineerythrocyteSOD.
Cyanideisapowerful,albeitnon-specific,inhibitorof
Each of the two subunits is primarily composed of
CuZnSODs. They are also inactivated on incubation
eight antiparallel strands of β-pleated sheet structure
withdiethyldithiocarbamate(DDTC),
that form a flattened cylinder, plus ‘loops’. The cop-
perionisheldattheactivesitebyinteractionwiththe
nitrogensintheimidazoleringstructures(Fig.3.2)of
fourhistidineresidues(numbers44,46,61,and118in
the amino acid sequence), whereas the Zn2+ ion is acompoundthatbindstocopperandremovesitfrom
bridgedtothecopperbyinteractionwiththeimidazole theactivesites.Itisalsoametaboliteofthedrug di-
ofHis61,anditalsointeractswithHis69andHis78and sulphiram, used to deter alcohol consumption. Note
the carboxyl group of Asp81. Histidine 61 (His63 in that DDTC administered to animals will lead to in-
thehumanenzyme),whichinteractswithbothmetals, hibition of aldehyde dehydrogenase (Section 9.8.1.1)
maybeinvolvedinsupplyingtheprotonsneededfor andwillalsobemetabolizedtothetoxincarbondisul-
dismutation. Human CuZnSOD shows similar struc- phide,CS .
2
ture: it is a dimeric enzyme with ellipsoidal dimen- Diethyldithiocarbamate has been used to inhibit
sions of about 30×40 × 70 Å. Each subunit contains CuZnSOD in cells and whole animals. For example,
153aminoacidresiduesplusonezincandonecopper 3 h after its injection into mice, the SOD activity of
ion (Fig. 3.3). In dimeric prokaryotic CuZnSODs the blood had decreased by 86%, that of liver by 71%,
structureisbroadlysimilar,buttheloopregionsdiffer and that of brain by 48%.21 However, use DDTC
andtheinteractionsholdingthetwosubunitstogether with caution; apart from the other effects mentioned
aregenerallylessstrong. above, it inhibits several copper-containing enzymes
InCuZnSODs,muchofthesurfaceofeachsubunit and also xanthine oxidase, and its copper complex
is negatively charged, repelling O •–, except for posi- can inhibit the proteasome.22,23 As a thiol, DDTC
2
tivelycharged‘tracks’thatleadintotheactivesite(Fig. canexertdirectantioxidantproperties,formRS• rad-
3.4).Similararrangementsexistinthemanganeseand icals, chelate metals, and inhibit apoptosis in some
iron(butnotnickel)SODs.Hence,O
•–approachingthe
cells. Hence its effects in vivo can be hard to inter-
2
enzyme is ‘guided’ into the active site. Modification pret. 2-Methoxyoestradiol has been claimed in some

--- Page 137 ---

82 FREE RADICALS IN BIOLOGY AND MEDICINE
Figure3.3(colourplate3) HumanCuZnSODβ-structureframework(blue)andloopregions,alongwithconformationallyimportantside
chains.Theα-carbonbackboneisshownasaribboncolouredtohighlightthevariousloops.Criticalside-chainsthatformmultipleside-chain–
main-chainhydrogenbondsareshowninball-and-stickrepresentation,labelledbyresiduenumberandtheone-letteraminoacidcode,and
colour-codedtomatchtheloopstheystabilize:Gln22forthepurpleinsertionloopII,His43forthelight-blueGreek-keyconnection(loopIII);
Ser59andArg143fortheyellowdisulphidesubloop(IV);Asn65andArg79forthegoldZn-ligandsubloop(IV);Ser111andArg115forthegreen
Greek-keyloop(VI);andAsn86,Asn131andSer134fortheredelectrostaticloop(VII).MetalligandsHis48,His120,andAsp83alsomakeside-
chaintomain-chainhydrogenbondstotheloopregions.Thecopperligands(His46,His48,His63,andHis210)formdistortedsquare-planar
geometry,whilethezincligands(His63,His71,His80,andAsp83)aretetrahedral.Thecopperandzincarelinkeddirectlybythebridging
histidine(His63)andindirectlybytheside-chaincarboxylateofburiedAsp124,whichhydrogenbondstobothacopper-andazinc-ligating
histidine.PhotographbycourtesyofDrsJohnTainerandElizabethGetzoffandtheAmericanNationalAcademyofSciences;seeProc.Natl.Acad.
USA89,6109,1992.
studies to inhibit SOD, but probably does not.24 An- as a consequence of attack on the SOD protein by
other molecule that can inhibit CuZnSOD is ATN- proteolyticenzymespresentintheextract.Partialloss
224, choline tetrathiomolybdate, which has been in of metal ions increases the net negative charge and
clinical trials for cancer chemotherapy (although it can also cause multiple bands. As mentioned earlier,
wasn’t effective).25 Again, however, it is probably someCuZnSODscontaincysteine-SHgroupsthatcan
nonspecific. cross-linkandaggregatetheenzyme,aswellasform-
ingmixeddisulphides(Section3.11)withotherthiols,
includingGSHandcysteine.26
3.5.1.5 IsoenzymesofCuZnSOD
Nevertheless, purification of the different enzymes
SOD activity can be visualized by gel electrophoresis has confirmed the existence of true isoenzymes of
(Fig. 3.5), and inhibition by cyanide used to identify CuZnSOD in multiple species, including maize, Ar-
CuZnSOD. Electrophoresis of tissue extracts, or even abidopsis, and Drosophila. Indeed a variant of human
ofpurifiedSODenzymes,oftenshowsthepresenceof CuZnSOD was reported in the 1980s from North-
multiple bands. Be cautious in attributing such mul- ern Sweden and Finland.27 Most of the population is
tiple bands to SOD isoenzymes since they can arise homozygous for ‘normal’ SOD, but there are some

--- Page 138 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 83
(a) (b)
(c) (d)
Figure3.4(colourplate4) NetworkofhumanSODresiduesinvolvedinelectrostaticrecognitionofsuperoxide:Glu132,Glu133,Lys136,and
Thr137.Thecolour-codeis:red,mostnegative;yellow,negative;green,neutral;lightblue,positive;blue,mostpositive.Copper(gold)andzinc
(blue)ionsareshownasspheres.TheSODenzymeshown,andusedasacontrolforconstructionofelectrostaticmutants,isthedoublemutant
Cys6→Ala,Cys111→Ser.Thismutantmaintainstheactivityandrate-versus-pHprofileofwild-typehumanSODbutismorestable.
(a)SuperimposedcopiesoftheSODactivesite.Dottedlines(upperright)showhydrogenbondslinkingside-chainsofelectrostaticallyimportant
residues:Thr137(green,centre)toGlu133(red,topcentre),toLys136(blue,upperright),toGlu132(red,upperright).Allotherresiduesare
showncolour-codedbysubunit,andappearwhitewheresuperimposed.(b)Overviewofmutatedresiduesintheelectrostaticloopandtheir
structuralrelationshiptotheactivesiteandoverallβ-barrelproteinfold(blueribbonfollowingpolypeptidechain)inonesubunitoftheSOD
homodimer.Electrostaticallyimportantside-chainsGlu132,Glu133,Lys136,andThr137(colouredandorientedasinpanel(a)formahydrogen-
bondingnetwork(ball-and-stickmodelswithdashedhydrogenbonds)onthesolvent-exposedhelicalturnoftheelectrostaticloopoverhangingthe
active-sitechannel(upperright).ThishelixisorientatedsothatitsC-terminalcarbonyloxygenatomsandhelicaldipolestabilizeandarestabilized
byzincbinding.Side-chainsofcopperandzincligandsandofactive-siteArg143areshownaslines.(c)Cross-sectionoftheactivesitechannelfor
wild-typehumanSOD,withcolour-codedmolecularsurfacedotsandarrowsindicatingthedirectionoftheelectrostaticforceonthenegativecharge
ofO
•–.(d)Correspondingviewfor(Glu133→Gln)mutatedSOD.NeutralizingnegativelychargedGlubyconvertingittounchargedglutamine
incre
2
asesthereactionratebyguidingO
•–moredirectlydownwardtothecatalyticcopperion.PhotographsbycourtesyofDrsJohnTainer,Elizabeth
2
Getzoff,andNaturePublishingGroup;seeNature358,347,1992.

--- Page 139 ---

84 FREE RADICALS IN BIOLOGY AND MEDICINE
1 2 3
a b c d a b c d a b c d
Figure3.5 VisualizationofSODonpolyacrylamidegels.Afterelectrophoresis,thegelissoakedinasolutionofnitrobluetetrazolium(NBT)and
exposedtoanO
•–generatingsystem.SuperoxidereducesNBTtotheblue-colouredformazan(Section2.5.3)andsothegelturnsblue,except
whereSODactiv
2
ityislocated.TheenzymeremovesO
•–,preventsformazanproduction,andawhite‘achromaticband’isdetected(Anal.Biochem.
2
44,276,1971).Theshowsthepatternobtainedafterelectrophoresisofextractsfrom(a)brain,(b)heart,(c)liver,and(d)lungof(1)rat,(2)mouse,
(3)chicken.Upperpanel,nocyanideadded.Lowerpanel,2mMCN–ionspresent,whichinhibitCuZnSODs.FromBiochim.Biophys.Acta556,32,
1979,bycourtesyoftheauthorsandElsevier,Amsterdam,alsoseeNat.Protoc.5,51,2010.Theactivitytetrazoliumoxidase,previously
extensivelystudiedbygeneticists,isactuallySOD(Arch.Biochem.Biophys.159,798,1973).Howeverbecautious;severalotherproteinsreact
withO
•–,includingsomecopperandironproteins(e.g.caeruloplasmin[Section3.22.2]andhaemperoxidases[Section3.19]).Thesereactionsare
notcat
2
alytic,buttheproteins,ifpresentathighlevels,caninterceptsufficientO
•–toproduceachromaticbands.
2
heterozygotes with both forms of the enzyme and a ThusCuZnSODinthepresenceofmMlevelsofH O
2 2
few homozygotes for the variant form. This mutant cangenerateOH•,oraspeciesthatresemblesit(pos-
SOD has been detected in several other countries, siblyCu(III);Section2.4.6)atitsactivesite.Mixturesof
includingIran,Canada,Belgium,France,Russia,Aus- SODandH O cancatalyseoxidationofseveralsub-
2 2
•
tralia, Turkey, and the UK, but interestingly not in stratesinvitro,includingazide,urate,nitrite(toNO ),
2
Iceland. The term SOD-2 was originally used to de- ABTS (Section 6.17.3), and the spin-trap DMPO (Sec-
scribe this mutant form, but is now more generally tion6.2).AdditionofCO /HCO–increasestheratesof
2 3
employed in the literature as a synonym for MnSOD manyoftheseoxidations,probablybyformingcarbon-
(Section3.5.2).ThemutantisnowcalledD90A;amu- ateradical(CO •–)byreactionofCO with‘OH•’atthe
3 2
tation in codon 90 causes aspartate to be replaced activesite,
by alanine. Originally thought to be harmless, it E–Cu2+···OH • + CO →E–Cu2++ CO •++ OH–
2 2
was later discovered that subjects homozygous for
the mutation are likely to develop the disease ALS CO 2 •++OH–→ CO • 3 –+H+
(Section10.22.1).
followedbyescapeofCO
•–fromtheenzymetooxidize
3
thesubstrate.CO
•+isthecarbondioxidecationradical.
2
3.5.1.6 Pro-oxidanteffectsofCuZnSOD?15,28,29 Another suggestion is that CO 2 reacts with H 2 O 2 in
solutiontoformperoxomonocarbonate(Section2.5.2),
S
C
u
u
p
Z
e
n
r
S
o
O
xi
D
de(cid:4)
k
rea
>
c
1
ts
0
r
9
a
M
pi
–
d
1s
ly
–1
w(cid:5)
.
i
T
th
he
th
re
e
a
a
c
c
t
t
i
i
o
v
n
e
p
s
r
it
o
e
d
c
u
o
c
p
t
p
H
er
O
of
whichthenforms CO • 3 –afterreductionbyE-Cu+,
2 2 2
(intheHO–
2
form)canalsoreactwiththecopper,but E–Cu++HOOCO–
2
→E–Cu2++CO •
3
–+OH–
much more slowly. The reaction rate increases as the
Inanycase,theCuZnSODproteinisdamagedduring
pHrises,sincethepKaofH O is11.9,
2 2
incubationwithhighH O levels,sufferingoxidation
2 2
of amino acid residues (e.g. active-site histidine to 2-
E–Cu2++HO–
2
→E–Cu++O •
2
–+H+
oxohistidineby‘OH•’andoxidationoftryptophanby
E–Cu++HO–+H+→E–Cu2+···OH • +OH– CO •–) and aggregation. Pro-oxidant copper ions can
2 3

--- Page 140 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 85
alsobereleased;someofthembindtotheSODprotein Therelativeamountsof MnSODandCuZnSODin
surfaceandtargetfurtheroxidativedamagethere. animalsdependonthetissueandspecies;oneobvious
variablebetweentissuesisthenumberofmitochondria
present.Mammalianerythrocytes(withnomitochon-
3.5.2 ManganeseSOD14,15,30
dria) contain no MnSOD, but it forms about 10% of
total SOD activity in rat liver. For bacteria and fungi
The first SOD to be isolated from E. coli was entirely
(and maybe green plants) growth conditions make
unlikeCuZnSOD.Itwaspinkratherthanblue-green,
not inhibited by CN– or DDTC, had a relative mo- a difference. Thus in a normal growth medium, the
fungus Dactylium dendroides contains 80% of its SOD
lecular mass of 40,000 rather than 32,000, was inacti-
activity as CuZnSOD and 20% as MnSOD. However,
vatedbytreatmentwithchloroformplusethanol(and
ifitscoppersupplyisrestricted,moreMnSODissyn-
hence did not survive the typical purification meth-
thesized to maintain the total cellular SOD activity
ods for CuZnSOD), and contained manganese at its
approximately constant. This ‘extra’ MnSOD appears
activesite,asMn(III)inthe‘resting’enzyme.Almost
inthecytosol.33Dietcanalsomakeadifference,e.g.the
allmanganese-containingSODsaremorelabiletode-
amountofdietaryMnaffectedtheactivityofMnSOD
naturationbyheat,organicsolvents,ordetergentsthan
intheheartsofchickens.34
CuZnSODs,althoughmore-stableMnSODshavebeen
isolatedfromthermophilicbacteria.30
Inspiteofthesedifferences,MnSODscatalyseessen- 3.5.2.2 RegulationofMnSODactivity
tiallythesamereactionasCuZnSODs.Inthe‘resting’ A polymorphism in the mitochondrial ‘targeting se-
enzyme OH– is bound to the Mn, and the reaction quence’ for MnSOD has been described in humans,
mechanismcanbewrittenas where position 16 can be either alanine or valine.
The relative frequency of the ala-encoding allele var-
Mn(III)SOD-OH–+O •–+H+→Mn2+SOD(H O)+O
2 2 2 ies from 0.13 to 0.50 depending on population, and
Mn2+SOD(H O)+O •–+H+→Mn(III)SOD-OH– individualscanbeval/valorala/alahomozygotes,or
2 2
ala/valheterozygotes.Ithasbeensuggestedthatthis
+H O
2 2
polymorphism affects mitochondrial uptake and ac-
AtpH7.0theratesofO •– dismutationforCuZnSOD tivityofMnSOD,butdespiteseveralepidemiological
2
andMnSODaresimilar,but,unlikemanyCuZnSODs, studiesnoclearlinktohumandiseasehasemerged.35
the rates for MnSODs decrease as the pH rises (e.g. However,theactivityofMnSODcanberegulatedby
for the E. coli enzymes, the rate constant at pH 7.8 is acetylation of lysine residues (acetylation decreases
1.8×109,but0.33×109M–1s–1atpH10.2). activity;deacetylationincreasesit),oneofthemechan-
Superoxide can also react ‘non-productively’ with ismsbywhichsirtuinsinfluencecellmetabolism(Sec-
the enzyme to form an inactive complex, tion11.4.1).MnSODlevelschangerapidlyinresponse
Mn(III)SOD(H O)-O2–, and so the enzyme becomes to external stresses, e.g. they increase in response to
2 2
lessefficientathighO •– levelsinvitro,althoughthese severalcytokinesandgrowthfactors(Section5.7)and
2
levels are probably unphysiological. This reaction is are also affected by p53 (Section 10.14.6).36 In other
more prominent in animal than in bacterial MnSODs words,MnSODlevelsareveryresponsivetochanges
(e.g. see Section 9.20.1.1). The complex eventually incellphysiology.
breaksdowntoreleaseH O andreformtheactiveMn
2 2
(III)SOD. 3.5.2.3 StructureofMnSOD
The MnSODs from higher organisms usually contain
3.5.2.1 WhereisMnSODfound?
four protein subunits and have either one (e.g. hu-
MnSODs are widespread in bacteria, plants, and ani- man liver MnSOD) or half an ion (i.e. two subunits
mals. In most animal tissues and yeast, MnSOD shareoneMn)ofMnpersubunit.Figure3.6showsthe
is largely (and usually entirely) located in the subunitstructureofhumanMnSODasdeterminedby
mitochondria,14althoughtheyeastCandidaalbicansex- X-raycrystallography.Bycontrast,most,butnotall,of
presses a cytoplasmic MnSOD under certain growth thebacterialenzymeshavetwosubunits,mostlywith
conditions.31Otherexceptionsaresomecrustaceathat oneMnpermolecule.RemovalofMnfromtheactive
usethecopper-containingproteinhaemocyaninforO sitecauseslossofcatalyticactivity;theMncannotusu-
2
transport.Forexample,thebluecrabCallinectessapidus ally be replaced by iron (even though it binds in the
containsMnSODinbothmitochondriaandcytosol,but activesite)oranyothermetaliontoyieldafunctional
noCuZnSOD.32 enzyme.

--- Page 141 ---

86 FREE RADICALS IN BIOLOGY AND MEDICINE
(a)
(b)
Figure3.6(colourplate5) StructureofhumanMnSOD.Manganeseionsareshownaslightpinkspheres.(a)MnSODsubunitcolouredto
emphasizesecondarystructureandorganization.TheN-terminaldomain(bottom)ismadeupofanN-terminalloop(blue)andtwolongα-helices
(α1andα2)showninpurple.TheC-terminalα/βdomain(top)iscomposedoffiveα-helices(α3–α7)showninblue,andthreeβ-strands
(β1–β3),inyellow.Themanganeseliesbetweenthetwodomains.MnSODsubunitshaveapproximatedimensions40×47×49Å.(b)Activesite
geometryofMnSOD.Thefivemanganeseligandsaredrawninaball-and-stickrepresentation.Aminoacidsfrombothdomainscontributetothe
activesite,His26inα1andHis74inα2fromtheN-terminaldomainandAsp159inβ3andHis163fromtheC-terminaldomain.Thefifth
co-ordinationsiteisoccupiedbyawatermolecule(bluesphere).ThefouractivesitesoftheMnSODtetrameraregroupedinpairsacrossthedimer
interfaces,withresiduesGlu162andTyr166fromonesubunitcontributingtotheactivesiteoftheneighbouringsubunit.Photographsbycourtesy
ofDrsJohnTainerandElizabethGetzoff,andCellPress(seeCell71,107,1992).MnSODalsoshowselectrostaticfacilitation,regulatedby
acetylationoflysineresidues(FreeRadic.Biol.Med.53,828,2012).
3.5.3 IronandcambialisticSODs14,15,30 In E. coli, both FeSOD and MnSOD are found in the
cytoplasm.14
Four SOD enzymes can be purified from E. coli, FeSODs usually contain two protein subunits, al-
including MnSOD and the periplasmic CuZnSOD. thoughsometetramericenzymeshavebeendescribed
A third SOD was found to be an iron-containing di- andsomedimericenzymescanassociatetoformtetra-
mer(FeSOD),andsimilarenzymeswerelaterfoundin mers under certain conditions (e.g. the FeSOD from
many other bacteria, algae, trypanosomes, yeast, and Sulpholobus acidocaldarius). The dimeric enzymes usu-
higher plants, but not in animals. The fourth E. coli allycontainoneortwoironionspermolecule.Theiron
SOD is a hybrid enzyme containing subunits of the in‘resting’FeSODsisFe(III)andoscillatesbetweenthe
manganese and iron enzymes in the same molecule. Fe(III)andFe2+statesduringcatalysis,

--- Page 142 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 87
Fe(III)–enzyme+O • 2 –→Fe2+–enzyme+O 2 The similarity of mitochondrial MnSOD to bacterial
Fe2+–enzyme+O •–+2H+→Fe(III)–enzyme+H O SODsisconsistentwiththeendosymbiotictheoryfor
2 2 2 theoriginofmitochondria(Section1.3).
Netreaction: O
•–+O •–+2H+→H
O +O
2 2 2 2 2 3.5.5 Nickel-containingSODs15
LikeMnSODs,FeSODsshowdecreasedcatalyticactiv- SeveralStreptomycesspecies,andsomecyanobacteria,
ityaspHrisesandarenotinhibitedbyCN–.
havebeenreportedtocontainSODswithnickelatthe
TheaminoacidsequencesandstructuresofFeSODs
activesite. Theseare usually tetramericor hexameric
are similar to those of MnSODs (both types of en-
enzymes,andstructurallydifferentfromtheotherSOD
zymearecloselyrelatedinevolutionaryterms;Section types. The metal oscillates between Ni2+ and Ni(III)
3.5.4), whichhelps toexplain why a hybridSOD can
duringcatalysis.
occur in E. coli. In spite of this structural similarity,
MnSODsandFeSODsareusuallyonlyeffectivewith
3.5.6 AssayingSOD40,41
thecorrectmetalattheactivesite.Asexceptionstothis
rule,SODsfromseveralbacteria,includingBacteroides
One can measure SOD protein levels and/or en-
fragilis,Sinorhizobiummeliloti,Streptococcusmutans,and
zyme activity. Immunological methods for detecting
Propionibacterium shermanii, appear to be active with
CuZnSOD and MnSOD have been developed; since
either (or both) metals present and are often called
these enzymes are structurally different, the anti-
cambialisticSODs.37AcambialisticSODhasalsobeen
bodies do not cross-react. Of course this measures
isolatedfromseedsofthecamphortree,Cinnamomum
protein,whichneednotnecessarilybeenzymicallyac-
camphora.38
tive. There is a high level of MnSOD and CuZnSOD
AfewspecieshavebeenreportedtocontainSODs
activity in liver in humans (Table 3.1) and other
withbothFeandZn,FeZnSOD.Streptomycescoelicolor
animals.
isoneexample.39
Direct determination of SOD activity can be car-
ried out by pulse radiolysis (Section 2.3.3.1; Fig. 3.1),
3.5.3.1 DistributionofFeSODs
which has been useful in studying the mechanism
Some bacteria contain either FeSOD or MnSOD, of enzyme action.15 Similarly, the loss of the ultra-
whereasotherscontainboth(e.g.E.coli).Forexample, violet absorbance of O •– when KO is added to an
2 2
Bacilluscereus containsonlyFeSOD,B.subtilis,Deino- aqueous solution can be observed, by stopped-flow
coccus radiodurans (Section 9.20.1.1), and Streptococcus techniques(Section2.3.3.2)orinaspectrophotometer.
sanguis only MnSOD. Mycobacterium tuberculosis and ThismethodcanonlybeusedatalkalinepH,whenthe
PhotobacteriumleiognathicontainFeSODinadditionto rateofnon-enzymicO •–dismutationislow,anditwill
2
CuZnSOD. One must not be too dogmatic, because underestimatetheactivityofFeSODorMnSODinre-
growth conditions (e.g. the supply of metals in the lationtothatofCuZnSOD,sinceFeSODandMnSOD
growthmedium)canhaveamajoreffect.GrowthofE. arelessactiveathighpH(Section3.5.2).Appropriate
coliunderanaerobicconditionsforseveralgenerations correctionfactorsmustbeused.
causeslossofMnSOD,butFeSODremains,apparently However, most laboratories use indirect assay
to aid survival on reintroduction of O 2 until MnSOD methods for SOD activity, in which O • 2 – is generated
canbesynthesized.14
andreactswithadetector.SODremovesO
•–andstops
2
itsreactionwiththedetector.Intheiroriginalworkon
erythrocyteSOD,McCordandFridovichusedthistype
3.5.4 EvolutionofSODs
ofassay;O
•–
wasgeneratedbyamixtureofxanthine
2
TheaminoacidsequencesofMnSODs,whetherfrom oxidase(XO)andxanthine,anddetectedbyitsability
animals, plants, or bacteria, are similar to each other toreducecytochromec,whichcausesariseinabsorb-
and unrelated to the CuZnSOD sequences.14 It has anceat550nm.AddingSODremovesO •–andinhibits
2
been argued that FeSODs are the most ancient SODs theabsorbancechange.OneunitofSODactivitywas
in evolutionary terms, evolving in response to rising defined as the amount that inhibits cytochrome c re-
O levels and making use of readily available Fe2+ duction by 50% under their assay conditions. Hence
2
(Section 1.1). As Fe2+ levels fell, MnSODs evolved units of SOD activity quoted in the literature bear
from FeSODs. CuZnSODs seem to have evolved no relation to quoted units for other enzymes (1 en-
independently, also in response to rising O levels.30 zyme unit is often defined as that amount catalysing
2

--- Page 143 ---

88 FREE RADICALS IN BIOLOGY AND MEDICINE
Table3.1 RepresentativedataforSODlevelsinhumantissues.
Tissue CuZnSODa CuZnSODactivityb MnSODactivityb
(μg/mgprotein) (units/gwetwt) (units/gwetwt)
Cerebralgreymatter 3.7 ND ND
Liver 4.71 106,900 2260
Erythrocytes 0.52c – 0
Renalcortex 1.93 24,800 1510
Thyroid 0.38 10,700 276
Testis 2.16 ND ND
Cardiacmuscle 1.82 ND ND
Pancreas 0.39 8630 778
Lung 0.47 7500 86
Thoracicaorta – 7040 86
aAnimmunologicalmethodwasusedwhichmeasurestheenzymeprotein.DataabstractedfromClin.Chim.Acta36,
125,1973.
bEnzymeactivitydeterminedbytheKO2methodathighpH,whichhaslowsensitivityforMnSOD.DatafromBio-
chem.J.222,649,1984andArterio.Thromb.Vasc.Biol.15,2032,1995.Resultswereobtainedfromsubjectswho
haddiedafteraccidents.ExtracellularSOD(EC-SOD)levelsinhumanthoracicaortawere~6440units/g;themeanfor
othertissuesis63–1260,ascomparedwithameanof7500–30,200forCuZnSOD.
cErythrocytevaluepermilligramofhaemoglobin.
NDnotdetermined.
transformationof1μmolofsubstrateperminute)and formazan, has some advantages over NBT (Table
valueswillbedifferentforeachdifferentSODassay. 3.2,legend).TheabilityofO
•–tooxidizeNADHinthe
2
One problem with indirect assays of SOD is that presence of lactate dehydrogenase (Section 2.5.3) has
a false SOD activity can be registered by any agent also been used. Luminol and lucigenin emit light
that inhibits O
•–
generation, e.g. by inhibiting XO. when exposed to O
•–
and other ROS and have often
2 2
One advantage of using XO is that this artefact can been used as detector molecules, but the chemistry
(and should!) be checked for by measuring enzyme involvediscomplexandtheirvalidityissuspect(Sec-
activity (e.g. as the production of uric acid). Many tion 6.12.4). Inhibition of autoxidation reactions has
tissue extracts contain cytochrome oxidase, which alsobeenused(Table3.2);oneproblemisthattissueex-
oxidizesreducedcytochromecandinterfereswiththe tractscancontaintransitionmetalionsthataccelerate
assay.Modificationofcytochromecbyattachmentof autoxidations.
acetyl groups to some of its amino acid side-chains Each method has its problems and no single as-
prevents it from being a substrate for cytochrome say is suitable for all systems. In some assays, it
oxidase but still allows reaction with O
•–.
Hydrogen is difficult to check for artefactual effects of a pu-
2
peroxide produced directly by XO (Section 1.10) and tative O
•–
scavenger on the rate of O
•–
generation.
2 2
by O
•–
dismutation can slowly re-oxidize reduced Our laboratory routinely uses inhibition of NBT or
2
cytochromecandreactwithcontaminatingmetalions XTTreductionbyaxanthine-XOsystemtoassaySOD
toproduceOH•.Topreventthis,catalasecanbeadded in cell or tissue extracts. Although this avoids prob-
to the reaction mixture. It is essential to ensure that lems with cytochrome oxidase, it must be remem-
any commercial catalase used is not contaminated bered that the reaction of NBT with O
•–
is complex
2
withSOD(itoftenis!):commercialcytochromecalso (Section2.5.3).
oftencontainstracesofSOD. Whatever assay is used, it should first be cali-
DetectormoleculesforO
•–
otherthancytochromec bratedwithpureSOD.AknownamountofSODen-
2
canbeused(Table3.2).Forexample,NBTisreduced zyme,addedtotheextractbeingexamined,shouldbe
by O
•–
to a dark blue formazan, and adrenalin is quantitatively detected on subsequent assay (internal
2
oxidizedbyO
•–toapinkproduct,adrenochrome.The
calibration).Oneshouldthinkcarefullyaboutpossible
2
compound XTT, which forms a water-soluble artefacts interfering with O
•–
generation or O
•–
2 2

--- Page 144 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 89
Table3.2 SomeoftheindirectmethodsusedtomeasureSODactivity.
Sourceofsuperoxide Detectorofsuperoxide Reactionmeasureda
Xanthine–xanthineoxidase Cytochromec Reduction,(cid:6)A
Nitrobluetetrazolium,NBTb Reduction,(cid:6)A
Luminol,luciferin Lightemission
Adrenalin Oxidation,(cid:6)A
NADH+lactatedehydrogenase Oxidation,(cid:6)Aat340nm
Hydroxylaminec Nitriteformation
(colorimetricmethod)
Spintraps ESRsignal(Section6.2)
Autoxidationreactions Adrenalind Oxidation,(cid:6)A
Sulphite O2uptake
Pyrogallol/pyrogallolred O2uptakeor(cid:6)A
6-Hydroxydopamine Oxidation,(cid:6)A
DirectlyaddedK+O– – LossofO •–,(cid:6)AinUV
2 2
NBT Reduction,(cid:6)A
Cytochromec Reduction,(cid:6)A
Tetranitromethane Reduction,(cid:6)A
Illuminatedflavinse NBT Reduction,(cid:6)A;O2uptake(SODaccelerates)
Dianisidine Oxidation,(cid:6)A(‘positive’assay)f
NADH+phenazinemethosulphateg NBT Reduction,(cid:6)A
a(cid:6)A:reactionresultsinameasurableabsorbancechange.
bHighO2concentrationscandecreaseNBTreductionbyO •
2
–(Fig.2.4)andformazancanbelostfromsolutionbyprecipitationinthereactionmixture.Tetrazolium
saltsthatgeneratewater-solubleformazanshavebeendeveloped,e.g.sulphonatedproductssuchas2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-
5-carboxanilide(XTT);
NO2
CH3O SO3 Na+
O NN SO3
NH C
N
+N NO2
CH3O
XTTisalsonotdirectlyreducedbyglucoseorxanthineoxidases(Fig.2.4),althoughsomeE.colienzymescanreduceitdirectly(Anal.Biochem.310,186,2002).
cHydroxylamineitselfreactsslowly,ifatall,withO •–,andnitriteformationmayrequireOH • .Thusthechemistryofthisassayiscomplex.
2
dTheseandmanyothercompoundsoxidizeinsolutionandproduceO •–.Onceformed,O •–participatesintheoxidationoffurthermolecules,sothatadditionof
2 2
SODslowstheobservedratesofoxidation.Theratesoftheseoxidationsareusuallyacceleratedbytransitionmetalions,andthiscancauseproblemsintheassayof
crudeextractscontainingsuchionsunlessmetal-ionchelatorsareadded.Eventhen,somemetalchelatesarestillredox-active(Section2.5.3).Reducingagentssuchas
ascorbatecaninterfereby‘recycling’radicalsbacktotheoriginalcompoundandpreventingchromogenformation.
eIlluminationofariboflavinsolutioninthepresenceofeitherEDTAormethioninecausesreductionoftheflavin.ItthenreoxidizesandsimultaneouslyreducesO2to
O •
2
–,whichisallowedtoreactwithadetectormoleculesuchasNBT.AddingSODinhibitsformazanproduction.Flavinphotochemistryiscomplex,however,and1O2is
alsoproduced.
fAsolutioncontainingriboflavinandthedetectormoleculeortho-dianisidineisilluminated,whereuponthedetectorisslowlyoxidized,accompaniedbyanabsorbance
changeat460nm.AdditionofSODincreasestherateofdianisidineoxidationbecauseitremovesO
•–,whichinteractswithanintermediatedianisidineradicaland
2
decreasesthenetrateofoxidation.Theassayiscalled‘positive’becauseadditionoftheSODcausestheabsorbancechangetoincreaseinsteadofdecrease.Atalkaline
pHvalues,SODacceleratestheoxidationofhaematoxylin,astainusedbyhistologists.ThisreactionhasalsobeenproposedasapositiveassayforSOD.
gNotrecommended;seeJ.Am.Chem.Soc.104,1666,1982.
detection.40–43 For example, pamoic acid and 2- 3.5.6.1 Distinguishingbetweendifferenttypes
methoxyoestradiolappearedtoinhibitSODactivityin ofSOD14,15,40
indirectassays,butwereinfactinterferingwiththeas-
says.Reducingagentsintissueextractscanreactwith The CuZnSODs and NiSODs are inhibited by CN–,
certaindetectormolecules;thisisaparticularproblem whereas FeSOD and MnSOD are not. Inhibition by
in autoxidation-based assays (Table 3.2 legend) and CN– can thus be used to identify CuZnSOD activity
with cytochrome c, which is easily reduced by ascor- inassaysofanimalorplanttissuehomogenatesoron
bateandthiols.Manylaboratoriesnowusecommercial polyacrylamide gels (e.g. Fig. 3.5). Millimolar levels
kitstomeasureSOD.Ifyoudo,pleasethinkaboutthe are required, and one must check for effects on pH
chemistryoftheassayandpotentialartefactsinitsuse. (solutions of KCN and NaCN are alkaline) and on

--- Page 145 ---

90 FREE RADICALS IN BIOLOGY AND MEDICINE
cytochrome c, which reacts with CN–. Cyanide does essentialintermediateindopamine,adrenalin,orDHF
notaffecttheXTTassay.43 oxidation,andsoSODinhibitsthatoxidation.Thusany
WhereasCuZnSOD,NiSOD,andFeSODareinacti- product of oxidation could be causing the damage, not
vatedonexposuretohighlevelsofH O ,MnSODis necessarilyO
•–.
2 2 2
not.ThusincubatingacellextractwithH O willinac- Finally, be aware that contamination of SOD pre-
2 2
tivateFeSOD,CuZnSODandNiSODbutnotMnSOD. parationswithendotoxincanaffecttheiractionswhen
injectedintoanimals(Sections3.7.5and11.5.3).
3.5.7 UsingSODenzymestoimplicate
superoxide 3.6 Superoxidereductases
The specificity of SOD for O •– is often used to estab- Several anaerobic and microaerophilic bacteria, in-
2
lish the involvement of O •– in biological processes; cludingTreponemapallidum,Desulphoarculusbaarsi,and
2
if SOD inhibits the process it is assumed that O •– Pyrococcus furiosus (and even the protozoan Giardia
2
is involved. Although SOD under most reaction con- intestinalis, which cause the unpleasant intestinal
ditions can indeed be regarded14,15 as specific for diseases giardiasis in humans and lacks ‘regular’
catalytic removal of O •–, the SOD proteins (like any SOD) are able to eliminate O •– using superoxide
2 2
other protein) can react directly with some RS, such reductases (SOR).15,47 These are non-haem-iron-
as OH•, RO • 2 ,RO•, HOCl,ONOOH,and1O 2 . Thus if containing proteins that can reduce O • 2 – to H 2 O 2 (i.e.
a large amount of SOD is added to a system produ- whereas SODs can have different metals, SORs have
cingtheaboveRS,anartefactualinhibitionofdamage onlyiron),
due to direct scavenging might result. Controls with
heat-denaturedSOD(Fig.3.1),otherproteins(e.g.al- 2H++E—Fe2++O • 2 –→E—Fe(III)+H 2 O 2
bumin) in equimolar amounts, or SOD apoenzyme
shouldthusbe performed.Asimilar pointapplies to Theoxidized(ferric)SORproteinsarethenre-reduced
the use of other enzymes, such as catalase, to impli- by a cellular electron donor (X). Hence the overall
cate H O involvement in an observed reaction; any reactionis
2 2
protein at high concentrations can act as a ‘general’
scavengerofRS. O • 2 –+2H++X→H 2 O 2 +X (OX)
Inhibitions by SOD must also be interpreted with
Thus SORs only reduce O
•–,
whereas SODs both oxi-
cautioninsystemscontainingquinonesandsemiquin- 2
dizeandreduceit.Hence,unlikeSODsSORsproduce
ones. Many semiquinones react reversibly with O
2
noO ,anobviousadvantageforananaerobe,although
(Section2.5.3.5), 2
theH O hastobedealtwith,ofcourse.However,their
2 2
semiquinone+O (cid:2)quinone + O •– catalyticefficiencyislessthanthatof‘real’SODs.SORs
2 2
canbeclassifiedintotwomaintypes:one-FeSORand
Theequilibriumtendstomovetotherightbecauseof two-Fe SORs, although other types exist. The former
non-enzymicdismutationofO
•–.AdditionofSOD,by
aresometimescallednelaredoxins(fromtheSanskrit
2
removingO
•–faster,decreasesthesteady-stateconcen-
word nela, blue). The electron donors for O
•–
reduc-
2 2
trationofsemiquinone.Henceareactioncausedbythe tion by SORs are often NADH or NADPH, passing
semiquinonemightbemistakenlyattributedtoO
•–
as electrons via various carrier proteins, such as rub-
2
aresultoftheinhibitionbyaddedSOD.Oneexample redoxin. Superoxide reductase can even remove O
•–
2
isprovidedbyearlystudiesonvitaminK-dependent whenintroducedintoeukaryoticcells.46
carboxylationofglutamicacidresiduesbyenzymesin GenomicstudiessuggestthatSORsmaybepresent
theendoplasmicreticulum.AddingSODinhibits,but in all anaerobic bacteria. Presumably, they allow O -
2
by removing semiquinone;O
•–
is not involvedin the intolerantbacteriatosurvivetransientexposuretoO
2 2
carboxylation.44 and consequent O •– production, especially as many
2
AsimilarartefactcanariseusingO
•–-generatingsys-
anaerobes lack SOD (e.g. Treponema pallidum has no
2
tems.Frequently,anautoxidizablecompound,suchas SOD, catalase, or peroxidase). A few anaerobes con-
adrenalin,dopamine,ordihydroxyfumarate(DHF),45 tainbothSORandSOD,usuallyFeSOD.Forexample,
isaddedtoacell/tissueandcausesdamage.Adding DesulphovibriovulgariscontainsacytoplasmicSORand
SOD inhibits the damage, a result often interpreted a periplasmic SOD.47 In others, such as Bacteroides
to mean that it is caused by O
•–.
However, O
•–
is an fragilis,SODappearsonlyifO ispresent.
2 2 2

--- Page 146 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 91
3.7 Superoxidedismutases:evidencefor yeast in which the electron transport chain was also
theirroleinvivo? absent (Rho◦ state) were more resistant, consistent
with the view that electron transport is an important
ThediscoveryofSODledtothesuperoxidetheoryof sourceofO •– invivo.55 S.cerevisiaelackingCuZnSOD
oxygen toxicity, which proposes that O
•–
is a major
2
2 isalsohypersensitivetoO 2 andwillnotgrowaerob-
factor in O toxicity and that SODs are an important
2 ically unless supplemented with leucine, lysine, and
defenceagainstit.14Dotheavailabledatasupportthis
methionine.15 Addingantioxidants,suchasascorbate
theory?Yestheydo,letusbrieflyreviewtheevidence. or GSH, overcame this requirement.56 The need for
lysine and leucine arises by O
•–-dependent
inacti-
2
vation of [Fe-S] cluster enzymes involved in their
3.7.1 Geneknockoutinbacteriaandyeasts
biosynthesis.15Whenyeastwasscreenedformutations
E. coli has two main SODs, FeSOD and MnSOD (the conferringhypersensitivitytohyperoxia,almostallthe
periplasmicCuZnSODcontributesonlyalittletototal mutantsfoundwerealsosensitivetotheO • 2 –generator
SOD activity). Farr et al.48 inactivated the genes en- paraquat (Section 9.4), suggesting that O • 2 – is a major
coding MnSOD and FeSOD in E. coli, generating a contributortohyperoxiadamage.53Genesrequiredfor
bacterium,initiallythoughttohavenoSOD(wenow O 2 toleranceinyeastincludenotonlythoseencoding
know that periplasmic CuZnSOD was still present). CuZnSODandMnSOD,butalsogenesencodingCCS,
The resulting mutant would not grow aerobically on andCu2+transporters,tohelpmaintainSODactivity.53
aminimalglucosemedium.Growthcouldberestored
by removing O , restoring SOD to the cells by intro-
2
ducing a gene coding for any SOD (even mamma-
3.7.2 Transgenicanimals
lian CuZnSOD), or enriching the growth medium of
the bacteria with amino acids. This is reminiscent With transgenic animal technology, it is possible to
of the observation that certain amino acids dimin- ‘knockout’orover-expressgenes.Forexample,mice
ish the growth-inhibiting effects of hyperbaric O on expressingthehumanCuZnSODgeneandcontaining
2
E. coli (Fig. 1.12). Even with this supplementation, humanCuZnSODproteininvarioustissueshavebeen
theSOD-deficientmutantgrewslowly;itsmembranes produced.ThehumanCuZnSODispresentinaddition
were leaky to certain ions, it was more sensitive to tothemouseCuZnSOD,raisingtotalCuZnSODactiv-
damage by increased O or by H O , and it showed ity.SuchmiceshowincreasedresistancetoO toxicity
2 2 2 2
elevated mutation rates during aerobic (but not an- and to other ROS-generating toxins, consistent with
aerobic)growthonrich media.Additionof DDTCto the superoxide theory of O toxicity, but they are ab-
2
inhibit periplasmic CuZnSOD inhibited growth even normalinseveralways57 (Box3.1).Miceoverexpress-
on a rich medium.49 The steady-state level of O •– in ing human MnSOD in the lung have been generated
2
aerobicE.coliinthelog-phas(cid:4)eofgrowthhasb(cid:5)eenes- (without affecting CuZnSOD, catalase, or glutathione
timatedat20to40picomolar 1pM = 10–12M ,rising peroxidaseactivities)andfoundtobesomewhatmore
toabout300pMinthedoublemutant.14 ThusanO •– resistant to lung damage by hyperoxia than are nor-
2
concentrationofafewhundredpicomolarissufficient malmice.59TransgenicstrainsofthefruitflyDrosophila
to lead to both DNA damage (resulting in mutation) overexpressingbovineCuZnSODweremoreresistant
and impairment of metabolic activity, and O
•–
must tohyperoxiaandtoparaquat(Section9.4)thancontrol
2
somehowcontributetoH O toxicity.Thereasonsare flies.Bycontrast, DrosophilialackingCuZnSODshow
2 2
examinedinSection3.9. decreasedlifespan,increasedO toxicity,andinfertil-
2
Similarstudieshavebeencarriedoutonotherorgan- ity. The effectsof CuZnSODor MnSODdeficiencyin
isms;herearesomeexamples.Pseudomonasaeruginosa DrosophilacanbeamelioratedbyloweringO levels.60
2
lacking Mn- and FeSOD grows poorly under aerobic More-dramatic data come from animals lacking
conditions.50 Removing SODs from Bacillus anthra- MnSOD. In one study,61 MnSOD-knockout mice
cis, the causative agent of anthrax, greatly decreases mostly died within ten days after birth, with cardiac
its virulence,51 as does deletion of the gene encod- abnormalities(Fig.3.7),fataccumulationinliverand
ing MnSOD in Listeria monocytogenes.52 Inactivating skeletal muscle, and metabolic acidosis. Severe mito-
the gene encoding MnSOD in Saccharomyces cerevisiae chondrialdamageintheheartand,toalesserextent,in
makes it hypersensitive to O .53 Expression of E. coli othertissueswasevidencedbydecreasesincomplexI,
2
FeSOD in the yeast mitochondria (but not in yeast succinatedehydrogenaseandaconitaseactivities(Fig.
cytosol)offeredprotection.54Indeed,MnSOD-deficient 3.7), and rises in oxidative damage to mitochondrial

--- Page 147 ---

92 FREE RADICALS IN BIOLOGY AND MEDICINE
Box3.1 ConsequencesofoverexpressingCuZnSODinmice(andsomecomparisons
withCuZnSODknockoutmice).
(1) TransgenicmicewithelevatedlevelsofCuZnSOD: (i) show no protection (and possible aggravation of
(a) aremoreresistantthancontrolstoO toxicityunder damage) against noise-induced hearing loss, al-
2
somebutnotallexperimentalconditions; though CuZnSOD-knockout mice are more suscep-
(b) are more resistant than controls to certain tox- tibletothis,andage-relatedcochlearhaircelllossis
ins (Chapter 9), e.g. ozone, alloxan, MPTP, NMDA increasedinknockoutmice(Section7.12);
receptor agonists (Section 10.17.4), methamphet- (j) haveeyelensesmoresusceptibletophotochemical
amine, methylenedioxyamphetamine, methylenedi- damageinvitro;
oxymethylamphetamine, 3-nitropropionic acid, 6- (k) show less damage after traumatic brain injury in
hydroxydopamine,andtoairwaychangesproduced somestudies.
bycertainallergens; (2) Diabeticmiceshowlessrenalinjury.Pregnantdiabetic
(c) suffermorebraininfarctionaftercerebralischaemia– animalsshowlessfoetaldamagebyelevatedglucose.
reperfusion(inyoungmice),butlessinadultmice; (3) Peritoneal macrophages show decreased microbicidal
adult CuZnSOD-knockout mice suffer greater dam- capacityandincreasedabilitytoproducecytokinesand
age; matrixmetalloproteinases.
(d) stillshowO -inducedretinopathy(whenexposedto (4) Midbrainneuronsfromtransgenicpupssurvivebetterin
2
90%O duringthefirstfivedaysoflife); culture.
2
(e) show abnormal neuromuscular junctions in the (5) Isolated hearts are less susceptible to ischaemia–
tongue, altered serotonin metabolism, impaired reperfusion injury in some model systems, as is intes-
functionofthehippocampusinoldrats,decreased tine invivo.Less rejection observed after hearts from
proteasome activity in the brain cortex, premature CuZnSOD-overexpressingmicearetransplanted.
involutionofthethymus,increasedsensitivitytomal- (6) Improved vascular function in old animals, in some
aria infection, a tendency to irregular heartbeats, studies.
and increased angiogenesis in response to growth
factors; Datasummarizedfrommultiplepublications,toonumer-
(f) showimpairedmemory(Section10.17.5); oustolist.Variationinresultsbetweenlaboratoriescan
(g) may show some of the other neurological defects occurbecauseofthegeneticbackgroundofthemousestrain
characteristicofDownsyndrome; used58 andtheextentoftheoverexpressionofCuZnSOD
(h) showlesscolonicinflammationaftertreatmentwith (moreisnotnecessarilymoreprotective).Therearealso
dextransodiumsulphate; differencesbetweenmaleandfemaletransgenicanimals.
DNA, consistent with an essential role of MnSOD MnSOD-knockout mice are also more susceptible
inmaintainingnormalmitochondrialfunction.62Even tohyperoxia.65
SOD2 (+/–) heterozygous mice, which at first seem However, some laboratories have reported less se-
normal,showincreasedmitochondrialoxidativedam- vere, although still serious, pathologies in MnSOD–
age as they age,63 as well as increased nuclear oxi- mice. Indeed, the phenotype is very much affected
dative DNA damage and elevated cancer rates (Sec- by the genetic background of the mice.58 One such
tion10.14).ThoseanimalscompletelylackingMnSOD modifier may be the level of nicotinamide nucleo-
that manage to survive longer than ten days soon tide transhydrogenase (Section 1.3.5). Low levels
succumbtoavarietyofpathologies,includingsevere worsen the MnSOD–/– phenotype (perhaps because
anaemiaandneurodegeneration.62Theyalsoshowret- less NADPH is generated for mitochondrial antioxi-
inal defects (Section 7.10.2.2). Treatment of MnSOD– dantdefences?).66
micewith‘SODmimetics’(Section11.5.4)keepsthem It is also possible to inactivate a gene in selected
alive longer, whereupon they suffer even more ret- tissues rather than in the whole animal.58 Selective
inaldamageandbraindegeneration,probablybecause knockoutofMnSODintheheartsofmiceledtomito-
the mimetics used did not enter the brain. Indeed, chondrial abnormalities and progressive congestive
scavengersthatcouldenterthebrainwereprotective.64 heartfailureafterabouteightweeksoflifeandallmice

--- Page 148 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 93
Figure3.7(colourplate6) AppearanceandhistopathologyofMnSOD-deficientmice.(a)MnSOD–/–(bottom)and+/+(top)mice,6daysold.
Notethesmallersizeandyellowtingeofthemutantanimal.(b)Transversesectionof+/+(left)and–/–(right)heartsshowingleft(LV)andright
ventricles(RV).Theleftventricularcavityof–/–miceisenlarged,andthewallisthinner.(c)Haematoxylinandeosin-stained,paraffin-embedded,
sectionsoftheventriclesof+/+(left)and–/–(right)miceshowingfibrousthickeningoftheendocardium(arrows)in–/–mice,100×.
(d)Succinatedehydrogenase(SDH)staininginfrozensectionsof+/+(left)and–/–(right)hearts,showingthelackofSDHactivityinthe–/–heart,
400×.(e)Cytochromecoxidase(COX)staininginfrozensectionsof+/+(left)and–/–(right)heartsshowingcomparablelevelsofCOX,400×.
(f)OilRedOstainforthedetectionoflipiddepositsinfrozensectionsofliverfrom+/+(left)and–/–(right)mice,400×.Adramaticincreasein
thenumberoflipidvesiclesispresentin–/–liver.Originalmagnificationsareindicated.ReprintedfromNat.Genet.11,376,1995,bycourtesyof
ProfessorC.J.EpsteinandNaturePublishers.
weredeadby22weeks.67LossofMnSODinconnective F -isoprostanes (F IsoPs)*, and of 8OHG* in DNA.
2 2-
tissue decreased the lifespan of mice and accelerated Protein carbonyl* levels increase in older animals,
theappearanceofageing-relatedphenotypes,suchas carbonic anhydrase III (Section 11.4.2) becoming es-
osteoporosisandskinatrophy.68 pecially oxidized. Urinary F -IsoPs excretion also
2
Mice lacking CuZnSOD have also been obtained; increases.15,70,71Caloricrestrictioncanamelioratesome
the phenotype is again affected by their genetic of the phenotype of older CuZnSOD– mice (Sec-
background.69 When young they appear normal (al- tion 11.4.1). On the bright side, these mice are more
though they are more sensitive to several toxins, in- resistant to the heptotoxicity of acetaminophen, for
cludingparaquatandethanol),butastheyage,neuro- reasonsexplainedinSection9.10.
logical damage, loss of retinal cells (Section 7.10.2.2),
musclewasting,bonethinning,anaemia,skinatrophy, 3.7.2.1 Caveatsabouttransgenicanimals
dysfunction of the lacrimal glands, hearing loss, and
Be circumspect in interpreting data from transgenic
cancers (especially liver cancer) develop at an ac-
animal experiments. Knockout or overexpression of
celerated rate. The mice have reproductive problems
andshowimpairedvascularreactivityanddecreased
lifespan. From as early as 3 months of age, their
*Foradiscussionofthesebiomarkersofoxidativedamage
liversshowfataccumulation,plusincreasedlevelsof pleaseseeChapter6.

--- Page 149 ---

94 FREE RADICALS IN BIOLOGY AND MEDICINE
any gene in the early embryo is likely to lead to a pureO aremoreresistanttothetoxiceffectsofhigh-
2
hostofcompensatorychangesinotherantioxidantde- pressureO thanarecellsgrownunderair.Similarly,
2
fences, or other protective mechanisms (e.g. altering onecanincreasetheMnSODactivityofE.coli (upto
targets to better resist oxidative stress). For example, about 7% of total cell protein!) by incubating it with
CuZnSOD– mice show increased metallothionein compoundsthatincreaseintracellularO •– generation,
2
(Section3.23.2)geneexpressionintheliverandmuscle, such as streptonigrin, paraquat, juglone, menadione,
perhaps to improve metal ion sequestration.72 Also, andpyocyanin(Sections9.4,9.5,9.6and9.17).Strains
knockout mice are kept in a laboratory under warm, ofE.coliwithelevatedSODactivityareresistantboth
protected, well-fed conditions. A knockout that is le- to the toxic effects of these compounds, and to O
2
thal in the wild might have a relatively mild (or no) toxicity. Elevated O and many O
•–
generating com-
2 2
apparent phenotype under these conditions. A strik- poundsofteninduceH O -degradingenzymesaswell.
2 2
ingexampleisprovidedbyp66Shc:lossofthegenein Similar experiments correlating SOD activity with
laboratory animals increases lifespan; whereas in the O exposurehavebeencarriedoutinplants,animals,
2
wild it has the opposite effect! (Sections 11.3.1.1 and and other bacteria. For example, the O produced by
2
11.4.1).Thusitcouldbeamistaketointerpretthemild thephotosyntheticactivityofsymbioticalgaeincreases
phenotype of CuZnSOD– mice early in life as mean- SODactivityintheiranimalhost,theseaanemoneAn-
ing a limited importance for this enzyme. Yet, even thopleuraelegantissima.Anemonesthatcontainsymbi-
laboratory-bredmicecannotadapttoalackofMnSOD, oticalgaehavemoreSODandcatalasethananemones
indicativeofitsessentialroleinvivo. whichdonot.Hencethefoodprovidedtotheanem-
one by the photosynthetic ‘guest’ has to be balanced
against the cost of increasing antioxidant defences in
3.7.3 RNAinterference
thehost.74
Some laboratories have used antisense oligonucleo-
tidesorRNAinterferencetoexaminetheroleofSOD.
3.7.5 SODandoxygentoxicity
Forexample,RNAinterference-mediatedsilencingof
inanimals14,65,75,76
MnSOD expression in Drosophila shortened lifespan
and caused loss of mitochondrial aconitase and suc- Adult rats placed in pure O rapidly develop lung
2
cinatedehydrogenaseactivities,73whereasRNAinter- damageandoftendieafter60to72h,withincreased
ference against CuZnSOD promoted senescence in oxidativedamageinthelungs(Section7.3).However,
culturedhumanfibroblasts(Section11.3.5.1).Onead- if rats are exposed to somewhat lower O concentra-
2
vantage of such methods is that they can examine tions (e.g. 85% for 7 days) they can adapt to survive
short-term effects of changes in antioxidant enzyme for longer when subsequently exposed to 100% O .
2
activities, without the adaptations possible in trans- This adaptation is correlated with increased SOD ac-
genicanimals(Section3.7.2.1).Agoodexamplecomes tivity in the lung. Transgenic studies also support a
from C.elegans: knockout of the gene encoding the protective role for SOD, since mice overexpressing
antioxidant peroxiredoxin-3 (Section 3.13) shows no MnSOD or CuZnSOD show increased O tolerance
2
phenotype, but knockdown shows an immediate im- under certain experimental conditions (Section 3.7.2),
pairment of reproductive capacity. The worms had whereas MnSOD– mice are more sensitive to hyper-
time to adapt to the knockout but not to the knock- oxia.However,aco-ordinatedincreaseinseveralanti-
down(Section11.4.5.1).Asimilarexamplecomesfrom oxidantdefences(includingGSH,catalase,glutathione
EC-SOD,asdiscussedinSection3.23.3.2. peroxidase and reductase, HO-1, peroxiredoxins, and
chaperones)isessentialtoobtainmaximumprotection.
Indeed,injectionofliposomescontainingSODintorats
3.7.4 Inductionexperiments
has limited protective effects against O toxicity, but
2
Much evidence other than that from molecular gen- including catalase gives more protection.77 Levels of
eticapproachessupportstheimportantroleofSODs. various cytochromes P450 in the lung also influence
ExposureoforganismstoelevatedO 2 should,accord- response of rodents to O 2 toxicity,78 and the genetic
ing to the superoxide theory of O 2 toxicity, cause background,sex(e.g.femaleratsareusuallylesssen-
them to form more O
•–
in vivo and this might lead sitivethanmales),79 anddietofrodentscaninfluence
2
to synthesis of more SOD as an adaptive response. howtheyrespondtohyperoxia.Adaptationofratsto
Data support this.14 For example, exposing E. coli ozone exposure also involves rises in antioxidant de-
to elevated O 2 increases its MnSOD activity. As the fencesinthelungandconfersresistancetoO 2 toxicity
superoxidetheorywouldpredict,E.coligrownunder (Section9.12.1).Indeed,briefpre-exposureofanimals

--- Page 150 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 95
tohyperbaricO (e.g.2.5atmfor1heachdayforsev- that appear to lack SOD. Mycoplasma pneumoniae83
2
eral days) can diminish the lung damage caused by containsO
•–-generatingsystems,butneitherSOD,nor
2
subsequent prolonged hyperoxia (Section 10.18.3 and catalaseactivities.AfewLeptospirastrains84havebeen
ref80).ThisphenomenoniscalledhyperbaricO pre- reportedasSOD-negativealthoughearlyreportsthat
2
conditioning. thegonococcus(Neisseriagonorrhoeae)isSOD-negative
Newborn rats, mice, and rabbits appear more re- havenotbeenconfirmed.85 Gonococciarealsoexcep-
sistant to O toxicity than adults, apparently because tionally rich in other antioxidant defence enzymes.85
2
theSODandotherantioxidantactivitiesoftheirlungs N. gonorrhoeae colonizes human mucous membranes
are increased and maintained more effectively under and provokes a strong neutrophil response, although
highO thaninadults(anotherpossibilityisthatneo- neutrophils are not good at killing it. Exposure of N.
2
natalcellsmakelessO
•–thanadultcells).Bycontrast,
gonorrhoeaetoH O orneutrophilsproducesafurther
2 2 2
newbornhamstersandguineapigs(andprobablyhu- riseincatalaselevels.86
mans)arenobetterthanadultsatincreasingdefences, Ifiron-catalysedOH•formationisamajorcontribu-
and they are equally susceptible to hyperoxia, if not tor to the toxicity of O
•–
in bacteria (Section 3.9.2.2),
2
moreso.Ifinductionofantioxidantdefenceenzymes it follows that protection could be achieved by the
is prevented (e.g. by injection of protein synthesis efficientremovalofeitherO
•–
orH O ,orbyironse-
2 2 2
inhibitors), newborn rats become highly sensitive to questrationinnon-redox-activeforms.Allthreearenot
hyperoxia.Newbornratskeptinpathogen-freeenvir- necessarily required. This is one possible explanation
onmentshave lowerSOD activitiesin lung than nor- for the rare ‘aerobes without SOD’. There are other
mal,andtheyaremoresensitivetoO toxicity.Indeed, explanations,however.Letusexamineone.
2
treatment of adult rats with low levels of endotoxin
(Section 2.5.6.4) enhances their resistance to O tox-
2 3.8.2 ManganesecanreplaceSOD
icity.Thisisanexampleofendotoxintolerance,which
isinpartrelatedtoincreasedsynthesisofantioxidant Several aerotolerant strains of Lactobacillaceae con-
defences in the lung (and elsewhere!). Be careful— tainSOD,butsome,suchasLactobacill(cid:4)usplan(cid:5)tarum,do
commercial SOD and catalase can be contaminated not. It accumulates manganese ions Mn2+ from its
withendotoxin(Sections10.10.2.1and11.5.3).Thishas growthmediumtoaninternalconcentrationof25mM
ledtosomeerroneousconclusionsabouttheeffectsof or more.87 If this is prevented by removing external
administration of these enzymes; the endotoxin was manganese,L.plantarumwillnotgrowinthepresence
theactiveingredient! ofO .SincechelatesofMn2+ withsomebiomolecules
2
can react with O
•–
(Section 2.4.3; Table 11.5), it has
2
been suggested that these chelates catalyse O
•–
re-
3.7.6 SODandhibernation 2
movalinvivo.L.plantarumalsopossessesamanganese-
HibernatinganimalsshowdecreasedO consumption containing, H O -degrading enzyme (Section 3.17.6).
2 2 2
andbodytemperature.YetactivitiesofSODandcer- IndeedBorreliaburgdorferi,thecausativeagentofLyme
tain other antioxidant defences in some tissues are disease, has evolved to do without iron at all, and
higherthannormal.Thismaybeinpreparationforthe manganeseisessentialtoit.88
intensemetabolicactivity(accompaniedbyrapidROS Manganesemighthelpotherorganismsaswell.For
production) that occurs during awakening.81 It may example,E.coliSOD– mutantsgrowbetteriftheme-
alsomaintainviabilitybyslowingaccumulationofoxi- dium is enriched with manganese ions,89 and such
dativedamageduringthehypothermiaitself,whenthe a medium also enhances the resistance of N. gonor-
scopetorepairsuchdamageislimited.82 rhoeaetooxidativestress.85MutantsofS.cerevisiaelack-
ingCuZnSODcanbe‘rescued’bymutationsinother
genes, such as the BSD (bypass SOD deficiency)90
3.8 Thesuperoxidetheoryofoxygen
genes. One of these encodes a transport protein, mu-
toxicity:variationsandanomalies
tationofwhichallowsthecellstoaccumulatemanga-
3.8.1 AnaerobeswithSODandaerobes nese. If extracellular Mn2+ is removed, the ‘rescue’ is
inoperative,consistentwithaO
•–
scavengingrolefor
withoutSOD 2
manganeseions.
Some anaerobes contain SOD and many have SOR One feature presumably(cid:8)making it possible to use
(Section 3.6), presumably to help them survive tran- manganese to remove O •– H O is that Mn2+ ions
2 2 2
sient O 2 exposure. More interesting in relation to the do not catalyse OH• formation from H 2 O 2 (Sec-
superoxide theory of O 2 toxicity are aerobic bacteria tions2.4.3and5.5.2).PerhapsMncanalsoout-compete

--- Page 151 ---

96 FREE RADICALS IN BIOLOGY AND MEDICINE
‘redox active’ iron for binding to sensitive cellular rateconstantsforreactionsoftheseenzymeswithO
•–
2
targets.91 Indeed the pentose phosphate pathway en- are 106 to 107 M–1s–1, whereas with O they are 102
2
zymeribulose-phosphate3-epimeraseinE.colihasan to 103 M–1s–1. Thus amino acid biosynthesis and en-
activesiteFe2+ionthatisreadilyattackedbyH O .Mn ergy metabolism in the Krebs cycle are major targets
2 2
canreplacetheiron,renderingtheenzymeresistantto ofdamagebyO
•–.Inactivationiscausedbyoxidation
2
H O butstillcatalyticallyactive.91 ofthecluster,leadingtoreleaseofiron,whichcanthen
2 2
promoteFentonchemistry(Section3.9.2.2),
3.9 Whyissuperoxidecytotoxic? [4Fe–4S]2++O •–+2H+→[4Fe–4S]3++H O
2 2 2
3.9.1 DirectdamagebysuperoxideorHO
•
?
[4Fe–4S]3+→[3Fe–4S]++Fe2+
2
Fe2++H O →Fe(III) + OH • + OH–
The evidence reviewed above shows that SOD is im- 2 2
portantinvivo.SinceSODusesO
•–asitsonlysubstrate
2 The oxidized enzymes can be ‘repaired’ in vivo by
mostorallofthetime,itfollowsthatO
•–isdamaging
2 reassembling the iron clusters. Indeed, even the low
invivo.However,despiteits‘super’name,O • 2 – isrela- basallevelsofO •–inE.coli(Section3.7.1)damagethese
tively unreactive in aqueous solution (Section 2.5.3). 2
enzymes,andactivityismaintainedbyconstantlyre-
UnliketheindiscriminatelyreactiveOH•,itcannotat-
pairingthem.IfO
•–levelsrise,asintheSOD-mutants,
tack DNA, lipids, or most proteins. So why is O •– a 2
2 inactivation rates accelerate, repair cannot keep up,
problem?
andmetabolicpathwaysareinhibited.91 Similardam-
Superoxide can decrease the activity of other anti-
agetoFe–Sclusters(e.g.inaconitase)mayoccurinS.
oxidantdefenceenzymes,suchascatalaseandgluta-
cerevisiaedeficientinCuZnSODorMnSOD.15,92Super-
thione peroxidase (Section 3.21.1). Any O
•–
produced
2 oxide can also interfere with E. coli transketolase, a
inthehydrophobicmembraneinteriorcouldconceiv-
key enzyme in the pentose phosphate pathway (Sec-
ably be damaging, since O
•–
is highly reactive in or-
2 tion 3.10.2.1). It oxidizes the dihydroxyethyl reaction
ganicsolvents(Section2.5.3).Theprotonatedformof
intermediateattheactivesite,inhibitingtheenzyme.93
O
•–,HO •
,ismorereactivethanO
•–,and(unlikeO •–)
2 2 2 2 Mammalian aconitase also has an [Fe-S] cluster
can initiate peroxidation of fatty acids (Section 2.5.3). and can be inactivated94 by O •– (this has been made
TracesofHO • 2 existinequilibriumwithO • 2 –atphysio- the basis of an assay for O •–; 2 Section 6.4.1). Indeed,
logicalpH,andthepHclosetosomemembranesur- 2
levelsof‘labileiron’werehigherinmitochondriafrom
•
faces may be more acidic, possibly favouring HO
2 MnSOD+/– heterozygousmicethaninnormalmice.94
•
formation. The uncharged HO should more readily
crossmembranesthanO • 2 –.Muc 2 hO • 2 –generatedwithin T di h r u ec s t ,a d s a i m n a E g . e co b l y i,e O n • e – r i g n y a m ni e m ta a b ls o , li a sm vie c w an s b u e p a po ta r r t g ed et b o y f
cells comes from membrane-bound systems (e.g. the 2
thelossofenzymeactivitiesinMnSOD-knockoutmice
electron transport chains of mitochondria and endo-
(Fig.3.7).Anotherpossibletargetisribonucleotidere-
•
plasmic reticulum), and so HO formed close to the
2 ductase,essentialtoprovidingtheprecursorsofDNA
membrane (or O
•–
within it) might cause damage.
2 (Section 8.2). This enzyme is inactivated by free rad-
However,thereisasyetnoclearevidencethatO
•–
or
2 icalsthatquenchitsactive-sitetyrosineradical.Nitric
•
HO 2 mediate significant direct membrane lipid dam- oxide is one example (Section 8.2) and O •– may be
ageinvivo. 2
another.95
What about proteins? The highly selective re-
Some mammalian creatine kinases have been
activity of O • 2 – does include the ability to damage reported96 to be inactivated by O •–, as has cal-
some important proteins. In E. coli, several enzymes 2
cineurin, a protein involved in signal transduction
can be attacked: examples are 6-phosphogluconate
(Section5.5.4.3).
dehydratase, ribulose-phosphate 3-epimerase (Sec-
tion 3.8.2), aconitase, fumarase, and dihydroxyacid
dehydratase.91 Dihydroxyacid dehydratase, which 3.9.2 Cytotoxicityofsuperoxide-derivedspecies
catalysesthethirdstepinthebiosynthesisofbranched-
chainaminoacids,containsa[4Fe–4S]2+clusteratits 3.9.2.1 Hydrogenperoxideandperoxynitrite
activesite,whichisdamageduponexposuretoO
•–(or,
Aswellascausingdirectdamage,O
•–canbecytotoxic
2 2
much moreslowly, to O ). E. coliaconitase, fumarase by generating other RS. Dismutation of O
•–
(spon-
2 2
A, and fumarase B enzymes contain similar clusters taneousorSOD-catalysed)generatesH O ,butH O
2 2 2 2
andarealsoinactivatedbyO andO
•–;second-order
is poorly reactive at physiological levels, although
2 2

--- Page 152 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 97
it can attack some enzymes directly (Section 2.6.2). and
Amorecytotoxicspeciesisperoxynitrite,whichgen-
eratesarangeofnoxiousspeciesunderphysiological Cu2++O • 2 –−−−→Cu++O 2
conditions (Section 2.6.1). For example, addition of
ONOO– inactivates creatine kinase more efficiently96 Cu++H 2 O 2 −−−→Cu2++OH • +OH–
thandoesO
•–.
2
Net: O
•–+H
O
−−m−e−ta→l
O +OH
•
+OH
•
3.9.2.2 Hydroxylradical 2 2 2 2
catalyst
Many early studies showing the ability of O
•–-
2 (superoxide driven Fenton-type chemistry) can occur
generating systems to kill cells and damage biomol-
invitro,isO
•–likelytobethereductantofthemetalsin
eculesinvitrofoundthatprotectionwasachievednot 2
only by adding SOD, but also by catalase and ‘OH• vivo?Probablynot,sinceitsconcentrationislow.Other
possiblereductantspresentathigherlevelsincludeas-
scavengers’(suchasmannitol,formate,thiourea,and
corbate,quinonesandsemiquinones,cysteine,reduced
dimethylsulphoxide [DMSO]).97 At first, it was sug-
gestedthatO •–andH O reactdirectlytoformOH•, flavins/flavoproteins,andNAD(P)H.98–100Instead,the
2 2 2 roleofO •– ismorethatofprovidingthenecessaryiron,
H 2 O 2 +O • 2 –→O 2 +OH • +OH– forexamp 2 le,byreleasingitfromFe–Sclustersorfrom
ferritin(Section3.22.4.2).Superoxidecanalsoliberate
TheabovereactionwaspostulatedbyF.Haberandhis
metal ions indirectly, via ONOO–. Exposing them to
colleaguesintheearly1930s,andhasbecomeknown
peroxynitritedisplacesironfromFe–Sproteinsandde-
as the Haber–Weiss reaction. However, the rate con-
gradescaeruloplasmintoreleasecopper(Section2.6.1).
stant for it in aqueous solution is at or close to zero.
Nevertheless, OH• formation can be accounted for if Manipulations of the intracellular iron content of
bacteriarevealitsimportanceinpromotingoxidative
the Haber–Weiss reaction is catalysed by transition
damage. Studies on Staphylococcus aureus many years
metals,
ago showed that raised intracellular iron levels in-
oxidizedmetalcomplex+O • 2 –−−−→ c p r e e r a m se e d ab s le us O ce H p • ti s b c i a li v ty en t g o er k s i o ll f i f n e g red by pr H ot 2 e O ct 2 i , on an .1 d 01 T ce h l i l s -
reducedmetalcomplex+O
2 is also true of other bacteria, e.g. the iron content of
reducedmetalcomplex+H O −−−→ Francisellatularensis,thecausativeagentoftularaemia,
2 2 determines its susceptibility to H O .102 E. coli has a
OH • +OH–+oxidizedmetalcomplex high-affinity iron uptake system, 2 enc 2 oded by several
genes whose transcription is decreased if cell iron
Net: O •–+H O −−m−e−ta→l O +OH • +OH– contentishigh.103IroncanbetakenupasFe(III)bound
2 2 2 catalyst 2 to siderophores (bacterially produced iron-chelating
agents),ordirectlyasFe2+.Uptakeisregulatedbythe
Hydroxyl radical formation is facilitated in vitro be- fur(ferricuptakeregulator)gene.Theproteinencoded
cause iron ions contaminate many biochemical re- byfurcanbindFe2+ andthenattachestoaDNAbase
agents; Table 3.3 shows some examples. Chromium sequence(theironbox)foundinthepromoterregions
(Cr2+),nickel(Ni2+),cobalt(Co2+),titanium(Ti3+),and of many genes regulated by iron, blocking the tran-
vanadium(vanadyl)canparticipateinOH•formation, scriptionofsome(e.g.theirontransporter)andenhan-
whichmaybeinvolvedintheirtoxicity(Section9.16). cingthatofothers.Geneswithironboxesincludenot
However,mostattentionhasfocusedonironandcop- only the iron uptake system but also those encoding
per as potential mediators of OH• generationin vivo, MnSODandhydroperoxidasesIandII(Section3.19).
and in the 1980s the authors proposed97 that iron- IncreasesinO • 2 –andH 2 O 2 raisefurexpression,presum-
dependent OH• generation occurs in vivo and is an ablyhelpingtostop‘free’ironrisingtoohigh.E.coli
important mediator of oxidative damage. However, mutants defective in fur accumulate excess iron and
althoughthereactions becomehypersensitivetoH 2 O 2 ,especiallyifMnSOD
and FeSOD are also absent. Hydroxyl radical gener-
Fe(III)+O • 2 –→Fe2++O 2 ation and oxidative DNA damage occur.104 A double
Fe2++H O →OH • +OH–+Fe(III) mutant, defective in both fur and DNA repair, is not
2 2

--- Page 153 ---

98 FREE RADICALS IN BIOLOGY AND MEDICINE
viable under aerobic conditions. It can be ‘rescued’ systemsandFe2+ transporters(Section3.22.1).Forex-
by addition of an iron chelator (ferrozine), further ample, in cardiac myocytes, some Ca2+ channels can
mutationsinterferingwithironuptake,overexpression alsotransportiron(Section3.22.5.4).Externallyadded
of a bacterial ferritin, increasing SOD activity, or by SODdoesnotusuallyprotectmammaliancellsagainst
adding the OH• scavengers DMSO or thiourea. Fur the toxicity of H O , but it can do so if allowed to
2 2
mutantsarealsohypersensitivetohypochlorousacid, enterthecells,orisoverexpressedinthem,106 consist-
suggestingthatreactionofthisspecieswithiron(Sec- entwitharoleforO
•–.Permeantironchelators,such
2
tion 2.6.3) might sometimes be significant in vivo.103 as o-phenanthroline, frequently also protect. Hydro-
However,inE.colistressedbyexcessO
•–
generation, gen peroxide added to animal cells causes oxidative
2
Feisnottotallybad;some‘labileFe’isessentialtoal- damage to several biomolecules, including DNA. Yet
low reassembly of the Fe–S clusters and recovery of neitherO
•–
norH O damagesDNA.Analysisofthe
2 2 2
metabolicactivity. pattern of damage to DNA bases (Section 5.8.2.1) re-
Considerable evidence supports a role of OH• and veals that OH• is the culprit.107 Presumably H O
2 2
O
•–
inthetoxicityofH O toeukaryoticcells;indeed, crosses the plasma membrane (Section 2.6.2), pene-
2 2 2
nitric oxidecan amelioratedamage by H O in some tratesthenucleus,andinteractswithtransitionmetal
2 2
cellsbydecreasingtheirironcontent(Section2.5.6.2), ionsboundtoDNAtoformOH•.Thesemetalsmight
and yeast lacking SOD also shows elevated levels normally be bound to DNA, and/or metals released
of ‘free’ iron.15,105 Fluorescent probes for ‘free’ iron from metalloproteins by O •– or H O could attach to
2 2 2
have shown its increased availability in mammalian DNA,makingitatargetofdamage.
cellssubjectedtooxidativestress(Section5.3.3).How- Hydroxylradicals,oncegenerated,reactwithDNA
ever, do note that the iron content of reagents (Table or whatever else is in their immediate vicinity. The
3.3),especiallythecell(orbacterial!)culturemedium, lower reactivity of O
•–
and H O means that these
2 2 2
is an important variable; iron in cell culture media species can diffuse away from their sites of forma-
can be transferrin-bound, present as contamination tion, leading to iron ion release and OH• generation
in inorganic form, and/or added deliberately, e.g. inanypartofthecellwhereasensitivemetalloprotein
Fe(III) as ferric nitrate is added to Dulbecco’s modi- islocated.97,98Hence,theprecisebiomoleculardamage
fied Eagle’s medium (Section 1.11). Cells can take up donebyO
•–
orH O isinfluencedbytheavailability
2 2 2
notonlytransferrin-boundironbutalso‘free’ironions, and distribution of metal ions, whether released by
by a mechanism involving plasma membrane redox O
•–
or available from other sources. The binding of
2
Table3.3 Ironcontaminationoflaboratoryreagentsandbiomedicalfluids.
Solutionanalysed Ironconcentration
Hydrochloricacid,5.8M 1–2μMa
Salinebuffer(67.5mMNa2HPO4+4mMKCladjustedtopH7.4withHCl)
Fresh 10μMa
Old(storedinlaboratoryforseveralweeksinflaskcoveredwithParafilm) 18μMa
EDTA,50mM 8μMa
Sodiumformate,0.5M 9μMa
Urea,0.5M 6μMa
Thiourea,0.5M 3μMa
Ascorbicacid,20mM 4μMa
Albuminsolutionsforclinicaluse 15–32μmol/mmolofalbuminb
UniversityofWisconsinorganpreservationfluid(usedforpreservationofheartandliverbefore 1.9±0.4μMc
transplantation)
Intralipidinfusionforprematurebabies 0–0.6μMc
aMeasuredbyatomicabsorption.
bSamplesfromsixdifferentmanufacturers;alsopresentwere1–7.9μmolcopperand2.8–12.1μmolvanadiumpermmolalbumin(J.Pharm.Sci.81,611,1992).
cMeasuredbythebleomycinassay(Fig.5.6andTransplantation62,1046,1996).

--- Page 154 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 99
H O OH(cid:129)
2 2
Fe-S cluster Inactivation of Fe-S
enzymes enzymes
Ferritin Metabolic impairment
NADH* Fe release
NO(cid:129)
ONOO– Cu or Fe
release
HO
2
Enzyme inactivation
DNA damage
Lipid peroxidation
Other cytotoxic actions
EDIXOREPUS
Direct enzyme inactivation
Dismutation
(non-enzymic or SOD)
Direct reactions
(cid:129)
Lipid peroxidation?
Other direct damage?
Figure3.8 Mechanismsofsuperoxide-dependentdamagetobiomolecules:asummary.*Catalysedbylactatedehydrogenase.
metalionstobiomoleculessuchasDNAmakessuch is a radioprotective agent (Section 9.20), may some-
moleculesareadytargetofoxidativedamageby site times be involved in supplying copper to CuZnSOD
specificOH• generation,i.e.OH• isgeneratedatthe (Section3.5.1.3),andisacofactorforseveralenzymes,
metal-bindingsiteandcauseslocalizeddestruction. including glutathione peroxidases (Section 3.14),
Figure 3.8 summarizes the various mechanisms of glutathione transferases (Section 3.15.2), glyoxalases
O
•–toxicity.NotethatSODgeneratesH
O ,whichcan (Section3.15.1),andenzymesinvolvedinleukotriene
2 2 2
be removed in vivo by multiple mechanisms. Before synthesis (Section 8.12). Glutathione plays a key role
consideringthemindetail,letusexamineglutathione, in protein folding (Section 3.12) and the degradation
akeyredoxagentandantioxidantdefenceinvivo. of proteins with disulphide bonds, such as insulin
(the first step in insulin breakdown is cleavage of
disulphide bridges linking the two peptide chains).
3.10 Glutathioneinmetabolism
AuniqueroleofGSHisseeninthefreshwatercoelen-
andcellularredoxstate108
terate Hydra, which recognizes wounded prey by the
releaseofGSHfromdamagedcells.TheGSHbindsto
Glutathione is a tripeptide (Fig. 3.9) present at mM
specificreceptors,leadingtotentaclecontractionsand
concentrations(Table3.4)ineukaryoticandmanypro-
mouthopeninginthehungrypredator.113
karyotic cells. When first described (in around 1888),
Because intracellular GSH levels are high, the
glutathione was given the romantic name philothion,
GSSG/2GSHcouple(Fig.3.9)isamajorcontributorto
‘loveofsulphur’.b
the‘redoxstate’ofthecell.Ifweassume10mMtotal
Glutathione is involved in many aspects of cell
glutathioneinthecytosolwith99%GSHand1%GSSG,
function,includingascorbatemetabolism(Section4.2),
the reduction potential is approximately –250 mV.108
maintaining communication between cells through
ThevaluedependsbothontheGSH/GSSGratioand
gap junctions,112 and preventing protein -SH groups
onthetotalconcentrationofglutathione.Forexample
fromoxidizingandcross-linking.Reducedglutathione
ifthisis1mMwith1%asGSSG,thepotentialrisesto
about–220mV.Itisabout–180mVintheER,where
b FrederickGowland-Hopkins.BiochemJ.115,286,1921. GSH/GSSG ratios are lower (Table 3.4, legend), and

--- Page 155 ---

100 FREE RADICALS IN BIOLOGY AND MEDICINE
O O–
C
Gly
H C* H
N H
Gly Gly
O C
H C* CH SH
2
N H Cys Cys S S Cys
O C
CH
2 Glu Glu
CH Oxidized glutathione
2
+H N C* H Glu
3
C
O O–
Reduced glutathione
Figure3.9 Structuresofreduced(GSH)andoxidized(GSSG)glutathione.GSHisatripeptide(glutamicacid–cysteine–glycine).InGSSG,twoGSH
moleculesjointogetherasthe–SHgroupsofcysteineoxidizetoformadisulphidebridge.IntheGS•radicaltheunpairedelectrononsulphurcan
migratetogivecarbon-centredradicals(*)atglu,cys,orgly(Section2.5.5.2),alsoseeChem.Res.Toxicol.25,1842,2012).Inhomoglu-
tathione,theglycineresidueisreplacedbyapeptidebondinvolvingthe–COOHgroupofcysteineandthe–NH2groupofβ-alanine,giving
glu-cys-CONHCH2CH2COO–.
differentagain(morenegative,about–330mV)inthe NADPH (Section 3.10.2). Reaction of GSH with
mitochondrial matrix, because pH is higher than in ONOO– leads to formation of some nitrosothiol
the cytoplasm due to the proton gradient. In human (GSNO), which can decompose to regenerateNO•.108
plasma, the potential is about –140 mV. Of course, Hence GSH can, to some extent, ‘recycle’ ONOO– to
there are many other redox couples in the cell; NO•.Italsochelatescopperionsandcandiminish114
examples include NAD+/NADH, cysteine/cystine, theirabilitytogenerateOH•fromH O .
2 2
ascorbate/dehydroascorbate, reduced and oxidized
thioredoxins(Section3.13.1),andNADP+/NADPH.108 3.10.2 Glutathionereductase
The ratios of reduced to oxidized glutathione in nor-
3.10.1 GSHasadirectantioxidant mal cells are high (Table 3.4). Although some yeasts
and higher plants have been reported to store GSSG
Invitro,GSHcanreactwithOH•,HOCl,ONOO–,RO•,
invacuolestosequesteritfromthecytoplasm,115 itis
RO
•
, CO
•–,
NO
•
, toxic aldehydes such as HNE (Sec-
2 3 2 usually thought that the ratio is kept high by rapid
tion5.12.5)andmethylgloxal(Section3.15.1),carbon-
conversion of GSSG back to GSH by the glutathione
centredradicals,and1O ,butnotO •– (oratleast,not
2 2 reductaseenzymes,whichcatalysethereaction,
very rapidly with O
•–).
Since GSH is present at mM
intracellular concentr 2 ations (Table 3.4), scavenging of GSSG + NADPH + H+→ 2GSH + NADP+
these RS (even OH•) is feasible in vivo. Indeed, the
Animal glutathione reductases often contain two
radioprotectiveeffectofGSHmayinvolveOH• scav- subunits,116 each with FAD at its active site. NADPH
enging (Section 9.20.1). Reaction with RS can often
reduces the FAD, which then passes its electrons
generate thiyl (GS•) radicals, and in turn O •– (Sec-
2 onto a disulphide bridge in the active site. The two
tion2.5.5),
–SH groups so formed then interact with GSSG
GS
•G→S–
GSSG
•–→O2GSSG+O •– and reduce it to 2GSH, reforming the protein di-
2 sulphide. Glutathione reductase can be inhibited in
TheO
•–canberemovedbySOD,andtheGSSGrecon-
vitro and in vivo by BCNU, N,N-bis(2-chloroethyl)-
2
verted to GSH by glutathione reductase, consuming N-nitrosourea, although this reactive compound is

--- Page 156 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 101
Table3.4 Glutathioneinvariousorganisms—someexamples. not specific.117 2-Acetylamino-3-[4-(2-acetylamino-
2-carboxyethylsulphanylthiocarbonylamino)phenyl-
Systemstudied GSHaconcentration Normal
thiocarbamoylsulphanyl]propionic acid) (2-AAPA)
GSH/GSSGbratio
has been reported as a more specific irreversible
Spinach 3.0mM >10/1 inhibitor,117
chloroplasts
Rat
Liver 7–8mM >100/1
Erythrocyte 2mM >100/1
Heart 2mM >100/1
Lung 2mM >100/1
Lens 6–10mM >100/1
Surprisingly perhaps, glutathione reductase is not
Kidney 4mM >100/1
present in Drosophila or the Anopheles mosquito (Sec-
Brain 2mM >100/1
tion3.13.1).
Skeletalmuscle 1mM >100/1
Bloodplasma 20–30μM ~5/1 3.10.2.1 SourcesofNADPH
Adiposetissue 3.2mg/106cells >100/1 How is the NADPH for glutathione reductase pro-
vided? By several mechanisms,118 a major one be-
Human ing the pentose phosphate pathway (PPP).118,119 The
Liver 4mmol/gwetwt >100/1
first enzyme is glucose-6-phosphate dehydrogenase
Kidney 2μmol/g >100/1 (G6PDH),catalysingthereaction
Lens 6–10mM >100/1 glucose6-phosphate + NADP+→
Erythrocytes 240μg/mlblood >100/1
6-phosphogluconate + NADPH +H+
Wholebloodc ~1mM >100/1
Bloodplasmac 1–3μM varies followedby6-phosphogluconatedehydrogenase,
Alveolarliningfluid 40–200μM(Section7.3) varies(usually>10/1) 6-phosphogluconate + NADP+→
E.coli CO + NADPH +H++ ribulose5-phosphate
2
Aerobicallygrown 27μmol/gd >10/1
Anaerobically 7μmol/g The rate of the PPP is affected by the supply of
grown
NADP+;astheactionofglutathionereductaselowers
the NADPH/NADP+ ratio, the pathway speeds up
Datacompiledfromawiderangeofpublications. to replace NADPH. Indeed, fibroblasts deficient in
aWheneverpossible,concentrationsareexpressedasmillimolarbutthiscannot G6PDH show premature senescence in culture, ac-
alwaysbecalculatedfrompublisheddata.TheseGSHlevelsmustnotbetaken companiedbyincreasedoxidativedamage,120 andde-
tooliterally,sincethey(i)declinewithage(Section11.4.3),(ii)aredifferentat
ficiency of this enzyme has clinical consequences in
differenttimesofdayinanimals,andatdifferentpointsofthegrowthcyclein
bacteriaandfungi,(iii)inanimaltissues(especiallyliver),decreaseonstarvation, humans(Sections3.10.4and7.4.5).Ofcourse,remem-
(iv)areaffectedbyphysicalactivity(orthelackofit),(v)varybetweenthediffer- berthatcellsinculturearesubjecttooxidativestress,
entcelltypespresentintissues,and(vi)maydependonthegenderandgenetic whichusesupGSHandsoacceleratestheG6PDHre-
backgroundoftheanimal(FreeRadic.Biol.Med.71,157,2014).
action(Section1.11).Micewithabnormallylowlevels
bGSH:GSSGratiosvaryindifferentsubcellularcompartments:lowerratioshave
of G6PDH in the heart show aggravated injury after
beenestimatedfortheinterioroftheER,whereproteinfoldinganddisulphide
bondformationtakeplace(Section3.12).108,109BeawarethatGSHcanreadily ischaemia–reperfusion(Section10.6.4.1).
oxidizeduringpreparationofsubcellularfractionsforanalysis.109 NADPHhasmanyotherrolesinmetabolism.Itcan
c Concentrations of cysteine and cystine in plasma are significantly higher help to make ROS, as a substrate of the NADPH
(7–10μMand80–90μM,respectivelyinhumans).110AlmostallGSHinblood
oxidase enzymes (Sections 8.7, 8.10, 8.11), and is
isinthecells,especiallyerythrocytes.GSHisveryeasilyoxidizedtoGSSGduring
analysisofextracellularfluids108andduringisolationofmitochondria(J.Biol. required to drive fatty acid biosynthesis, NADPH-
Chem.285,39646,2010). cytochrome P450 reductase (Section 1.10.7), dihydro-
d3.5mMinloggrowth:6.6mMinstationaryphase. folate reductase, and NOS enzymes (Section 2.5.6.4).

--- Page 157 ---

102 FREE RADICALS IN BIOLOGY AND MEDICINE
Another source of NADPH, especially in mitochon- only small amounts (if any) are absorbed intact by
dria (Fig. 1.7), but also in cytosol to some extent, is thegut;mostishydrolysedtoaminoacids,whichare
the enzyme NADP+-dependent isocitrate dehydro- thenabsorbed.γ-Glutamylcysteinesynthetaseisfeed-
genase,whichcanbeatargetofdamagebyRS.121The backinhibitedbyGSH(competitivelywithglutamate)
nicotinamidenucleotidetranshydrogenasemayalsobe anddoesnotappearsubstrate-saturatedatnormalcel-
importantinprovidingNADPHinmitochondria(Sec- lular cysteine levels, so that increased cysteine often
tions1.3.5).122Anothersourceismalicenzyme,which promotes GSH synthesis.126,128 Variations in cysteine
catalyses the conversion of malate to CO and pyru- levels might account for the effects of starvation and
2
vate, accompanied by reduction of NAD+ or NADP+ refeeding on GSH levels, for example (Table 3.4, le-
toNAD(P)H.Somemycobacteria(e.g.M.tuberculosis) gend).Inpatientswithsevereburns,metabolicdisturb-
have a G6PDH that does not use NADPH but trans- ances may decrease glycine availability to an extent
ferselectronsinsteadtoaflavin-likeacceptor,F .F thatlimitsGSHsynthesis.126 Indeed,13C-labelledgly-
420 420
may also help to protect the bacterium against toxic cine has been used to measure GSH synthesis rates
semiquinones/quinones.123 in vivo (Section 6.16.4). In several bacteria (e.g. Lis-
teriamonocytogenes,Pasteurellamultocida),GSHsynthe-
sisinvolvesasingleprotein(GshF)thatcatalysesboth
3.10.3 Glutathionebiosynthesis
theγ-glutamylcysteineligaseandtheGSHsynthetase
anddegradation124
reactions.129
Glutathione is synthesized in the cytoplasm of all Glutamylcysteinesynthetasecanbeinhibitedbybu-
animal cells, the liver being the most active organ. thionine sulphoximine (BSO), which is widely used
Mitochondria contain about 10 to 20% of total cellu- in experiments to deplete cellular GSH. It has the
lar GSH (depending on the number of mitochondria structure
in the tissue) yet cannot synthesize it and must ac-
quire GSHfrom thecytoplasm. Itpasses throughthe
outermitochondrialmembranesandisthenimported
by transporters (thought to be the dicarboxylate and
2-oxoglutarate carriers, although this has been chal- Treating isolated cells or whole organisms with BSO
lenged)intheinnermembrane.125 Thematrixpoolof is not usually lethal but it seriously perturbs normal
GSHinmitochondriaisnotinreadyequilibriumwith function(e.g.causingosteonecrosis,vascularoxidative
thecytosolicpool,whereastheinter-membranespace stress, and hypertension in rats,130,131 and increased
pool is, since the outer mitochondrial membrane is oxidative DNA damage in several rabbit tissues132),
morepermeable.ThecellnucleusisalsorichinGSH. and substantial falls in GSH levels make organisms
Glutamate cysteine ligase (often called γ- moresusceptibletoionizingradiationandtomanytox-
glutamylcysteine synthetase, γGCS) catalyses the ins (Chapter 9). It is much more difficult to deplete
first,andrate-limitingstep,inGSHsynthesis, mitochondrialGSHbyusingBSOthancytosolicGSH.
L-glutamate + L–cysteine + ATP → VerysevereGSHdepletion,affectingthemitochondrial
pool, leads to mitochondrial damage, and is lethal in
L–γ–glutamylcysteine + ADP +P i newborn animals because of multiple organ damage
(e.g.tokidney,liver,lung,brain,andeye).133
and the dipeptide product is converted to GSH by
Reduced glutathione is in a constant state of turn-
glutathionesynthetase,
over;itshalf-lifehasbeenestimatedas4daysinhuman
L-γ-glutamycysteine + glycine + ATP → erythrocytes and 3 h in rat liver. Turnover in several
cell types, including red blood cells, myocytes, astro-
GSH + ADP+P
i
cytes,andendothelialcellscaninvolveexportofGSSG
Cellscanmakethenecessarycysteinefrommethionine by an ATP-dependent process, involving multi-drug
(Fig. 4.13), or they can take it up from the surround- resistance-associated protein one (MRP1),134 present
ing fluids. Some take up cysteine as such, others the in a wide range of tissues. Liver constantly secretes
disulphide form, cystine, which they reduce to cyst- GSHintobileandintoplasma(mostlyviamulti-drug
eineinsidethecell.Cysteineandcystineusedifferent resistance-associated protein 2). The plasma pool
transporters, but the latter also transports glutamate. providessubstratesforGSHsynthesisinothertissues;
Hence,highextracellularglutamatelevelscandecrease liver is the main source of plasma GSH.135 However,
GSH levels in some cell types by slowing entry of mammalian cells are inefficient at taking up GSH
cystine.126,127Glutathioneispresentinmanyfoods,but and the enzyme γ-glutamyl transpeptidase, γGGT

--- Page 158 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 103
(sometimescalledγ-glutamyltransferase)stepsinto is an experimentally used, powerful (but sadly not
help.Thisenzymeislocatedontheplasmamembrane specific e.g. it inhibits enzymes involved in produc-
with its active site facing outwards, and acts on tion of CTP in animals and bacteria)136 inhibitor of
extracellular GSH to transfer the glutamate residue γGGT,firstisolatedasafermentationproductofStrep-
onto other amino acids such as cystine, methionine, tomyces sviceus. γ-Glutamyltranspeptidase is also in-
andglutamine, volvedinmetabolismofglutathione–xenobioticconju-
gates (Section 3.15.2) and in leukotriene biosynthesis
GSH + aminoacid →γ-glutamylaminoacid
(Section8.12).
+cysteinyl-glycine In summary, plasma GSH turns over rapidly (half
time is a few minutes); it originates largely from the
The cys-gly dipeptide can then be hydrolysed by
liverandismetabolizedbyγGGTinothertissues.Kid-
dipeptidases on the plasma membrane, and the cyst-
neyisespeciallyrichinγGGT,butlungandintestine
eineand/orglycinetakenupintothecelltomakemore
GSH.133 Theγ-glutamylaminoacidsarealsotakenup alsohavehighlevels.
and convertedto 5-oxoproline and then to glutamate
(Fig.3.10).K m valuesofthetranspeptidaseforGSHare 3.10.4 DefectsinGSHmetabolism:humansand
intheμMrange,similartoGSHlevelsinplasma(Table
otherorganisms111,126,133
3.4).Acivicin,
Humanswithinborndeficienciesofγ-GCS(veryrare),
N O O GSH synthetase (less rare), glutathione reductase,
CI γGGT, and 5-oxoprolinase have been reported. Such
H OH individualsoftenexhibitatendencytohaemolysisand
NH 2 neurologicaldefects,withvariablephenotypesamong
individuals. Usually, however, there is some residual
RCHCOOH
NH
2
amino acid
e
γ-glutamyl-cysteinyl-glycine
R (glutathione)
CONHCHCOOH
(CH )
22
CH SH ADP+P
CHNH 2 2 i
COOH H 2 NCHCO NHCH 2 COOH b
γ-glutamyl-amino acid cysteinyl-glycine ATP
c f H 2 NCHCOOH CH 2 SH
glycine
CO NHCHCOOH
RCHCOOH CH SH
2 (CH 2 ) 2 γ-glutamyl-cysteine
NH H NCHCOOH
2 2 CHNH
cysteine 2
amino acid
COOH
ADP+Pi
H COOH a
O N COOH d (CH 2 ) 2 ATP
H CHNH
2
COOH
5-oxoproline glutamic acid
ATP ADP
+Pi
Figure3.10 Glutathionesynthesisandmetabolism:(a)Glutamylcysteinesynthetase;(b)glutathionesynthetase;(c)γ-glutamylcyclotransferase;
(d)oxoprolinase;(e)γ-glutamyltranspeptidase;(f)dipeptidases(includingleucineaminopeptidase).DiagrambycourtesyofthelateProfessorAlton
MeisterandtheAmericanSocietyforBiochemistryandMolecularBiology.

--- Page 159 ---

104 FREE RADICALS IN BIOLOGY AND MEDICINE
enzyme activity; a knockout of γ-GCS in mice, lead- levels. They suffered growth retardation, developed
ing to very low GSH levels, is embryonic lethal, and cataracts, and most died between 10 to 18 weeks of
selective knockout of γ-GCS activity in mouse liver age,illustratingtheimportanceofthisenzymeinmain-
causedrapidonsetofliverdysfunctionleadingtoliver tainingtissueGSHlevelsinmice.MitochondrialGSH
failure.137Somepatientswithglutathionereductasede- levels were subnormal and mitochondria damaged.
ficiencyexhibitearlycataractformation;cataractsare Mice are not men, however; patients with γGGT de-
alsoobservedinnewbornmicetreatedwithbuthionine ficiency show normal cellular GSH levels, although
sulphoximine.InpatientswithsevereGSHsynthetase plasmaGSHiselevatedandGSHisexcretedinurine.
deficiency (5-oxoprolinuria) affecting several tissues, Mostseemtosufferfewilleffects,althoughsomeshow
there is decreased feedback inhibition of γ-GCS and abnormalitiesinthecentralnervoussystem.
thus increased synthesis of γ-glutamylcysteine. Since Mutant bacteria lacking enzymes involved in GSH
the latter is a good substrate of γ-glutamyl cyclo- synthesisaregenerallyviable(atleastunderlaboratory
transferase (Fig. 3.10), 5-oxoproline is overproduced, conditions),butareoften(notalways)moresensitive
leading to life-threatening acidosis and damage to to damage by radiation, peroxides, and some other
the brain and nervous system. In a milder form of toxins. Many bacteria, including E. coli, Streptococcus
GSH synthetase deficiency, apparently affecting only mutans, Streptococcus pneumoniae, and Haemophilus in-
the erythrocytes, the genetic defect leads to synthe- fluenzae,havetransportersthatenablethemtotakeup
sisofanunstableenzyme.Turnoverofthisactivebut GSHfromthemedium.138 However,GSH-deficientE.
unstable enzyme compensates for the defect in most colihavemembranesleakyforK+ andcannotgrowin
cells, but not in the erythrocytes, since they do not low-potassium media.139 Glutathione deficiency may
synthesize protein. Several other diseases have been also impair reassembly of the [Fe–S] clusters in en-
associatedwithchangesinGSHlevels,butthecontri- zymesafterinactivationbyO
•–(Section3.9.1).Several
2
butionsmadebythistothediseasepathologyareoften yeasts require GSH; knockout of γ-GCS has been re-
uncertain(Table3.5). portedinsome(e.g.S.cerevisiae),butnotallyeasts,to
Knockout mice lacking γGGT showed elevated produceorganismsunabletogrowunlessGSHorits
levelsofplasmaandurinaryGSHbutdecreasedtissue precursorsareaddedtothemedium.140
Table3.5 SomehumandiseaseswithreporteddecreasesinGSH.
Disease Tissue/bodyfluid GSH(%ofnormal)a FurtherdiscussioninSection
AIDS Variablereports 10.25.1
ARDS Alveolarliningfluid <10 10.8
Alcoholicliverdisease Liver 38–66 9.8.1
Blood 64
Non-alcoholicliverdisease Liver 63 9.8.1
Blood 51–66
Schizophrenia CSF/brain 48-73 10.23
Alcoholics Lungliningfluid 14 9.8.1
Idiopathicpulmonaryfibrosis Lungliningfluid 23 11.5.9.2
Kwashiorkor Bloodb 50 5.1.1
Parkinsondisease Substantianigra 60–72 10.20
Wilsondisease Liver 13 3.22.5.5
Diabetes Nerve,someothertissues Variable 10.5
ChangesofGSHwithagealsooccur(Section11.4.3).ARDS,acuterespiratorydistresssyndrome;ND,notdetermined.AdaptedfromLifeSci,51,1083,1992by
courtesyofProfessorA.Wendelandthepublishers.AlsoseeMol.Asp.Med.30,42,2009andref111.
aThesepercentagesareveryapproximate. bProbablyduetoinsufficientcysteinebecauseoflackofdietaryprotein.

--- Page 160 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 105
3.11 Glutathionylation:pathological RNScanleadtoS-nitrosylation,alsoeasilyreversible
orprotective?124 (Section2.5.6)thatcanleadtoS-thiolyation,
IntracellularfreeglutathioneislargelypresentasGSH
protein–SNO+GS–→protein–SSG+NO–
(Table3.4),butsomeofitexistsas‘mixeddisulphides’
Yetanotherrouteinvolvestwo-electronoxidationofa
withothercompoundscontaining–SHgroups.These
thioltoasulphenicacid(RSOH),followedby
canincludecysteine,coenzymeA,and–SHresiduesof
severalproteins,sometimesincludingCuZnSOD(Sec- protein–SOH + GS–→ protein–SSG + OH–
tion 3.5.1.5). If R–SH is used to represent the other
SometimesglutathionylationisacceleratedbyGSTen-
thiols, then the mixed disulphides have the general
zymes(Section3.15.2.1).
formula
The GSS–protein can remain as such, or react
with another thiolate group (on the same or a dif-
ferent protein) to give inter- or intra-protein disul-
phides. Indeed, incubation of several enzymes and
Some may have biological effects. For example, a co- other proteins with GSSG in vitro impairs their ac-
enzyme A–glutathione adduct was reported to be a tivity, by forming mixed disulphides. Examples in-
powerfulvasoconstrictor141andacysteine–glutathione clude adenylate cyclase, histone H3, Na+,K+-ATPase
disulphideisamatingsignalinthepolychaeteNereis (e.g.Sections5.3.1and8.10.4),isocitratedehydrogen-
succinea.142 Mixed disulphides involving GSH and ase,G3PDH,mitochondrialuncouplingproteins(Sec-
cystineoralbuminarealsopresentinplasma.110 tion 1.10.6), Ca2+ channels (Section 5.3.2.2), enolase,
Thiolgroupsareoftenessentialforproteinfunction andphosphofructokinase.S-Glutathionylationcanfa-
andthetotallevelofprotein–SHincellsmayapproach cilitate the uncoupling of eNOS (Section 2.5.6.4).144
orexceedthatofGSH,especiallyinmitochondria;in- FormationofexcessGSSGinmitochondriacangluta-
deed some have argued that they are, collectively, a thionylate several mitochondrial proteins, including
majorcellantioxidant.143Ofcourse,onehastobalance UCP2 and 3 and components of complex I, resulting
theirabilitytoscavengeRSagainstanydamagedone inincreasedO
•–formation.145Beaware,however,that
2
to cell function by their oxidation. Similarly, plasma oxidationofGSHandartefactualglutathionylationcan
albumincontributes300to500μM–SHgroupsandis occur during isolation of mitochondria and other or-
themajorcomponentof‘total–SHgroups’inplasma; ganelles if precautions are not taken.109,145 GSSG can
levelsofGSHandotherthiolsaresmallbycomparison inhibit protein synthesis in animal cells, and accu-
(Table3.4).ProteinthiolgroupscanreactwithGSSGto mulation of GSSG was suggested to account for this
formmixeddisulphides(aprocessthathasbeencalled inhibitioninwater-deprivedmosses.146
protein-S-glutathionylation).GSSGreactsmuchfaster Inafewcasesglutathionylationactivatesanenzyme,
with protein thiolate ions than with unionized –SH examples being 12-lipoxygenase, carbonic anhydrase
groups, and the susceptibility of protein cysteine–SH (Section 11.4.2), and certain calcium channels (Sec-
residuestothisdependsontheirpKa(inturnaffected tion 5.3.2). Indeed, injection of GSSG into the brains
by their environment within the protein) as well as of mice caused injury, apparently involving gluta-
theiraccessibility, thionylation and activation of 12-lipoxygenase.147 In
other cases it has no effect on activity, e.g. human
GSSG + protein –S–→ GSS-protein + GS–
CuZnSODactivityisnotaffectedbyglutathionylation,
Significant falls in cell GSH/GSSG ratio are neces- althoughtheenzymebecomesalittlelessstable.
saryfortheabovereactiontooccurinvivowithmost Mixeddisulphidesofglutathionewithproteinsand
proteins,butsometimesthisdoeshappen(e.g.inmi- other thiols accumulate in tissues subjected to oxida-
tochondriaorERsubjectedtosevereoxidativestress). tive stress, in both mitochondria and cytosol. These
More usually, however, glutathionylation occurs by apparently damaging actions of GSSG may explain
othermechanisms.Thesecanincludereactionsofthiyl why cells keep intracellular GSSG levels low (Table
radicals, 3.4) under normal conditions (by using glutathione
reductase and/or storage in vacuoles, in the case of
protein–SH−−−a−tta−ck−−by−→protein–S •
yeastandsomehigherplants115),andwhysomecells
reactivespecies
protein–S • +GSH→protein–S–S •–G export GSSG when under oxidative stress.134 Indeed,
GSSGcanbeusedtoenhancecancerchemotherapyby
protein–S–S •–G+O 2 →protein–SSG+O • 2 – promotingoxidativestress(Section10.16).

--- Page 161 ---

106 FREE RADICALS IN BIOLOGY AND MEDICINE
However, are GSSG and glutathionylation bad? E-FAD+2RSH → RSSR+E-FADH 2
Theycanbe:uncouplingeNOSprobablyisn’tgood.144 E-FADH +O → E-FAD+H O
2 2 2 2
But not always: glutathionylation can sometimes be
regarded as protective. GSSG has been reported to which could itself conceivably contribute to protein–
enhance mitochondrial fusion, an early response to SH oxidation. ER contains NADPH oxidase enzymes
cellular stress that may protect against apoptosis.148 andCYPs,alsoabletoproducesomeROSinvivo(Sec-
Glutathionylation is readily reversible; it may serve tions 1.10.7, 5.4.2, and 8.10). Fortunately, the ER can
toprotectprotein–SHgroupsfromfurtheroxidations easilydisposeofunwantedH O (Section3.13.2).The
2 2
(e.g.conversionofRS• orRSOHspeciesto sulphinic GSH/GSSG ratio is lower within the ER than in the
and sulphonic acids, RSO 2 H and RSO 3 H, which are rest of the cell (exactly how much lower is uncer-
hardertorepair[Section3.13.2.2],orformationofpro- tain, since GSH can oxidize readily during isolation
teincross-links)whenthecellisunderoxidativestress, of microsomes),109 presumably to give an optimum
allowingtheirlaterregenerationusingGSHwhennor- redoxstatefordisulphidebridgeformation.Glutathi-
malredoxbalancehasbeenrestored.Reversiblegluta- onemadeinthecytosolhastobeimportedintotheER
thionylationisinvolvedinredoxsignallinganditcan lumen,itcannotbesynthesizedthere.
affectcellmorphologybymodulatingthepropertiesof PDIenzymesalsohavedehydroascorbatereductase
cytoskeletal proteins such as actin.124 S-Nitrosylation activity and are involved in the action of prolyl hy-
(Table 2.8) may also sometimes be protective (Sec- droxylase (Section 4.2), an ascorbate-dependent en-
tion11.5.12). zymethathydroxylatesprolineresiduesduringcolla-
Deglutathionylation is accelerated by the glut- gensynthesis.Prolylhydroxylaseisatetrameroftwo
aredoxinproteins.Glutaredoxin,sometimescalledthi- α-andβ-subunits,thelatterbeingidenticaltoPDIand
oltransferase, wasoriginallydiscoveredasacofactor involvedininteractionwithascorbate.
ofribonucleotidereductaseinE.coli(Section8.2),but E.coliandotherbacteriahaveadisulphidebondma-
waslaterfoundtobepresentinmanyorganisms.Glut- chinerythatsimilarlyassistsoxidativeproteinfolding
aredoxinsarefoundinmanypartsofthecellandcan (Fig.3.11).Themitochondrialintermembranespaceis
bereduceddirectlybyGSH.Theyareinvolvedincata- also a site of disulphide bridge formation, involved
lysingthiol–disulphideinterchange,butcanalsorepair intheimportofproteinsfromthecytosol.Themech-
glutathionylatedproteins.Hence,whencellshavesuf- anisminvolvedresemblestheDsbsystemofbacteria,
feredexcessproteinglutathionylationduetooxidative again consistent with endosymbiotic theories of the
stress,glutaredoxincanstepintohelprestorethingsto originofmitochondria(Section3.5.4).151
normal.149 Theyareespeciallyimportantinmitochon-
dria,sincetheseorganellesseemunabletoexpelGSSG.
Glutaredoxins also have dehydroascorbate reductase 3.13 Peroxiredoxins:leadersinperoxide
activity,149 metabolism
2GSH+dehydroascorbate(cid:2)GSSG +ascorbate H O is produced by SOD and multiple other en-
2 2
zymes (Section 2.6.2). Its reactivity is limited, but its
levels must be carefully controlled, in part to deter
3.12 Protein-disulphideisomerase Fenton chemistry. H O plays important roles in sig-
2 2
nal transduction and so the activities of the enzymes
Duringfoldingofnewlysynthesizedproteins,thecor-
that remove it must be carefully modulated to allow
rect –SH residues must join up to form the right di-
H O to transiently accumulate, send its signal, and
sulphidebridges.Chaperonesarepresentwithincells 2 2
thenreturntonormallevels.Theperoxiredoxinsplay
to assist generally with protein folding (Section 5.6).
keyrolesinthis,soweshallconsiderthemfirst.
Protein-disulphide isomerase (PDI)150 enzymes, lo-
catedinthelumenoftheERatconcentrationscloseto
mM,catalysetheformationofnewdisulphidebridges
3.13.1 Introducingthioredoxins,cofactorsof
andtherearrangementsofincorrectones,byredoxex- peroxiredoxins140,152,153
change with disulphides at the PDI active sites. The
PDI is then re-oxidized by GSSG, or (more often) Thioredoxins are polypeptides of relative molecular
byEro(‘endoplasmicreticulumoxidoreductase’)pro- mass about 12,000, found in both prokaryotes and
teins. These are flavoenzymes that re-oxidize PDI at eukaryotes and widely distributed in mammalian
theexpenseofO ,producingH O , cells. Indeed, a ‘redox atlas of the mouse’ has been
2 2 2

--- Page 162 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 107
published, showing the widespread distribution of mediatethiol–disulphideexchangebetweenaprotein
glutaredoxins, thioredoxins, and peroxiredoxins in dithiol and another protein disulphide. Features of
tissuesofthisanimal.154Severaldifferentthioredoxins the thioredoxin structure are seen in several related
havebeendescribed,examplesbeingthecytosolicTrx1 proteins including glutaredoxin (Section 3.11), gluta-
andthemitochondrialTrx2.Thioredoxinsareinvolved thioneperoxidasesandtransferases,andPDI(Section
in chloroplast redox regulation (Section 7.8) and 3.12),wherethethioredoxin-likedomainsformtheac-
act as reducing agents for ribonucleotide reductase tive site. All these proteins may have evolved from
(Section 8.2) and methionine sulphoxide reductases, a common ‘thiol-binding protein’ ancestor (Fig. 3.11).
enzymes that repair oxidative damage to methionine Selenite(SeO2–)canbindto–SHgroupsonthioredoxin
3
residues in proteins (Section 5.14.1). In Drosophila andinhibititsfunction.156
and Anopheles mosquitoes, glutathione reductase is Oxidizedthioredoxinsarereducedinvivoinanimals
absentandthioredoxinisusedtoregenerateGSHfrom bythioredoxinreductaseenzymes,whichcontainsel-
GSSG.155 eniumattheiractivesites(asselenocysteine)andFAD
Reducedthioredoxinscontaintwokey–SHgroups, (Fig.3.12)andshowsimilaritiestoglutathionereduc-
whichformadisulphideinoxidizedthioredoxin.They tases, including use of NADPH (contrast this with
undergoredoxreactionswithmultipleproteins, glutaredoxin,whichisreduceddirectlybyGSH),
thioredoxin–(SH) +protein–S (cid:2) thioredoxin-S +NADPH+H+→
2 2 2
thioredoxin–S +protein–(SH) NADP++thioredoxin-(SH)
2 2 2
Thioredoxins bind to target proteins and, via inter- However, some chloroplast thioredoxin reductase
mediate formation of a mixed disulphide, reduce the enzymes use ferredoxin as an electron donor (Sec-
proteindisulphidebridgewhilstoxidizingthemselves. tion 7.8). Thioredoxin reductase can also reduce PDI
The E
◦(cid:4)
of thioredoxins is about –0.27 V, indicating and thus achieve an NADPH-dependent reduction
their high reducing potential. Thioredoxins can also of the disulphide bridges of such proteins as insulin.
Figure3.11(colourplate7) Somemembersofthethioredoxinsuperfamily.152(a)Thethioredoxin‘fold’containsabout80residuesand
involvesafour-strandedβ-sheet(β1–4)andflankingα-helices(α1–3).AnN-terminalβ1α1β2motifislinkedtoaC-terminalβ3β4α3motifbya
loopofresiduesalsocontainingahelix(α2).(b)Structuralcomparisonoffiveproteinstoshowthepresenceofthioredoxinfolds(ingreen).The
proteinDsbAispresentintheperiplasmicspaceofE.coliandinvolvedinthefoldingofproteinsexportedfromthecytoplasm.Theatomsthat
interactwiththecysteineresiduesofasubstrateareshownascolouredballs;yellowisasulphuratomofthemoreN-terminalcysteinein
thioredoxin,DsbA,andglutaredoxin,pinkistheselenocysteineresidueofbovineerythrocyteGPxandredthetyrosinehydroxylofratlivermuclass
GST.AdaptedfromStructure3,245,1995bycourtesyofDrJ.L.Martinandthepublishers.

--- Page 163 ---

108 FREE RADICALS IN BIOLOGY AND MEDICINE
1-Chloro-2,4-dinitrobenzene (CDNB), a substrate of the –SH group, catalysed by certain GST enzymes
GSTs (Section 3.15.2), is an inhibitor of thioredoxin (Section3.15.2).
reductase. It alkylates a key –SH residue, blocking There is growing evidence that peroxiredoxins are
reactivitywiththioredoxinandconvertingtheenzyme themostimportantperoxide-removingsystemsinani-
to a O •–-producing NADPH oxidase.157 Curcumin mals.Theiractivitiescanberapidlymodified,byboth
2
does the same (Section 4.5.3). Some gold-containing phosphorylation and oxidation. Peroxiredoxin pro-
compounds,formerlyusedinthetreatmentofrheuma- teins often constitute 0.1 to 0.8% of the total soluble
toid arthritis, can also inhibit thioredoxin reductase proteinofmammaliancells.Atleastsixdifferenttypes
(Section10.11.5). are known, designated as prx1, prx2 etc. The prx2 to
Cells contain an endogenous regulator of -4formsaretypical2-cysperoxiredoxins,prx5isatyp-
thioredoxin, namely thioredoxin interacting pro- ical2-cys,andprx6belongstothe1-cysclass.Theprx3
tein,asmall(38aminoacidresidues)protein.Itforms form occurs only in mitochondria, whereas Prx1, -2,
a mixed disulphide with thioredoxin and blocks its and -6 are largely cytosolic. The prx4 form is found
activity,153 an event especially important in diabetes in the ER (where it helps to dispose of H O gener-
2 2
(Section10.5.4). atedbyEroenzymes;Section3.12)andextracellularly,
prx5inbothmitochondriaandperoxisomes.Prx6also
3.13.2 Theperoxiredoxinsthemselves140,152,158 has an additional catalytic activity: it can act as a
phospholipase A , an activity favoured at a lower
2
Peroxiredoxins are a family of enzymes that reduce pH (pH optimum ~4) than is the peroxidase activity.
H 2 O 2 andorganicperoxides(Figure3.12).Peroxiredox- Prx6 may play a key role in lung, protecting against
insarehomodimersandcontainnoprostheticgroups: peroxides and also turning over lung phospholipids
the redox reactions involve only cysteine residues at (Section7.3.2).
theactivesites.Thereareatleastthreeclasses:thetyp- Peroxiredoxins are widely distributed, not only in
ical2-cys(themostcommon),theatypical2-cys,and animals,butalsoinplantsandbacteria.153,158,159Thus,
the1-cysperoxiredoxins.Inallcases,theperoxideoxi- the alkyl hydroperoxide reductase (AhpR) systems
dizes an –SH group on the peroxiredoxin to cysteine of bacteria such as E.coli and Salmonella typhimurium,
sulphenicacid,cys–SOH.Theenvironmentoftheac- whichuseNAD(P)Htoreducethymine,linoleicacid,
tive site raises the pK a of cys-SH from about 8.6 to andcumenehydroperoxidestoalcohols,involveatyp-
about 5–6 (i.e. almost entirely cys– at pH 7.4), and a ical 2-cys peroxiredoxin as one of their two subunits
hydrogenbondingnetworkfurtherfacilitatesreaction (AhpC); the other (AhpF) is a flavoprotein that me-
with H 2 O 2 to raise the rate constant to about 105– diates the electron supply from NAD(P)H. In some
108 M-1s-1 . In the 2-cys enzymes, this sulphenic acid bacteria,e.g.Helicobacterpylori¸theAhpCispresentbut
reacts with another –SH on the protein to give a di- the role of AhpF is replaced by other systems, such
sulphidethatisthenreducedbythioredoxinreductase as thioredoxin/thioredoxin reductase. Indeed, perox-
(Fig. 3.12). In typical 2-cys enzymes, the second thiol iredoxins have an ancient evolutionary origin, com-
isontheothersubunit,inatypical2-cys,onthesame ing into being at about the same time as SODs.160
subunit. In 1-cys peroxiredoxins, GSH regenerates Several pathogenic bacteria, including Vibrio cholerae,
ROOH HS (TPx) SH TR SH TR-FAD NADPH+H+
HS 2 SH SH
RO + H HS (TPx) 2 S TR S TR-FADH 2 NADP+
H O HS S S
2
Figure3.12 Two-cysperoxiredoxinsarethioredoxin-dependentperoxidereductases(TPx).Trx,thioredoxin;TR,thioredoxinreductase.
AdaptedfromJ.Biol.Chem.269,27670,1994,bycourtesyofDrsSueGooRheeandHoZoonChaeandtheAmericanSocietyforBiochemistry
andMolecularBiology.

--- Page 164 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 109
contain hybrid proteins with both peroxiredoxin and berecoveredlater,bydeglutathionylationcatalysedby
glutaredoxindomains. glutaredoxinand,tosomeextent,sulphiredoxin.158
Not all is wonderful about peroxiredoxins, how-
3.13.2.1 Reactionwithperoxynitrite140,158,161
ever:theirreleasefromdamagedcellscanhelptrigger
Peroxiredoxins react quite rapidly with ONOO–, e.g. inflammation, i.e. they can act as damage-associated
the rate constant for prx2 is about 7 x 107 M-1s-1 at molecularpatterns(DAMPs:Section8.7).Thishasbeen
pH7.4.Thecys-S– reducesONOOHinatwo-electron seenintheresponseofmicetoO 3 (Section9.12.1)and
manner, inanimalmodelsofstroke(Section10.18.3).Ofcourse,
DAMPsareavitalpartofourdefencenetworkagainst
ONOO–+H++Pr-S–→NO–+Pr-SOH
2 pathogens (Section 8.7), so maybe it’s not so bad
Theserateconstantsandthehighlevelsofprxenzymes afterall.
insomebiologicalsystems(e.g.erythrocytes)mightal-
lowthemtoout-competeCO /HCO–(Section2.6.1)for 3.13.2.3 Circadianrhythms
2 3
ONOO– andremoveONOO– atphysiologicallysigni- Many organisms exhibit regular cycles in metabol-
ficantrates. ism, physiology, and behaviour over a 24 h period
(circadianrhythms,160fromtheLatincircadiem,‘about
3.13.2.2 Hyperoxidation aday’),evenwhenisolatedfromexternalstimuli.The
Thecysteine–sulphenicacidformofeukaryotic2-Cys mechanismsachievingthisvarybetweenspecies.The
prxcansometimesreactwithasecondH O molecule redoxstate(reduced/(hyper)oxidized)ofperoxiredox-
2 2
duringitscatalyticcycleandbecomefurtheroxidized insinanimals(includinghumans),insects,plants,al-
to cysteine sulphinic acid, cys-SO H, which cannot gae,andbacteriaalsovariesovera24hperiod,even
2
be reduced by thioredoxin. The proteins are thereby in erythrocytes (Section 7.4). Levels of other antioxi-
inactivated and can then aggregate into a decamer dants(suchasGSH;Table3.4)maydothesame.Isthis
(10 subunits) or even more (e.g. with prx3 a dodeca- related to (circadian?) changes in ROS generation?
mer[12subunits]forms).Thisaggregationsometimes Perhaps,butwedon’treallyknowyet.
allows the protein to gain chaperone properties. For
the2-cysperoxiredoxins,reactivationofthesulphinic 3.14 Antioxidantdefenceenzymes:
acid form by reconversion to cys-SOH is achieved theglutathioneperoxidasefamily162
by the protein sulphiredoxin, which can draw redu-
cing power from either GSH or reduced thioredoxin, Glutathioneperoxidases(GPx)removeH O byredu-
2 2
andalsorequiresATP.Indeed,sulphiredoxinlevelsof- cingittoH OcoupledwithoxidationofGSH,
2
ten increase in cells subjected to oxidative stress.158
H O + 2GSH → GSSG + 2H O
Sulphiredoxins can also accelerate deglutathionyla- 2 2 2
tion of many proteins, especially peroxiredoxins, but AGPxenzymewasfirstdiscovered(inanimaltissues)
seemlessimportantoverallindoingthisthanarethe in1957;GPxarelesscommoninplantsorbacteria.In-
glutaredoxins.124 There are several reports that over- deed, GPx enzymes are widely distributed in animal
oxidized Prx enzymes accumulate in aged cells and tissuesandaremostlyspecificforGSHasahydrogen
tissues (Section 11.4.3), and some researchers have donor.Theycanbeinhibitedbymercaptosuccinate,
measuredthemasa‘biomarker’ofoxidativedamage
COOH
(Section6.16.6).Prokaryotic2-cysprxenzymesdonot
|
appear to undergo such oxidations and it has been
CH
suggested that the enzymes have evolvedduring eu- 2
|
karyotic evolution to allow inactivation to facilitate
CHSH
the signalling role of H O (Section 5.5.4). Consistent
2 2
|
with this view, prx3 (the mitochondrial enzyme) is
COOH
moreresistanttohyperoxidationthancytoplasmicprx
enzymes.161 and by certain other thiols, such as mercaptopropi-
Thioredoxin and peroxiredoxins can also form onylglycine(Section11.5.9.3).GPXenzymescanacton
mixed disulphides with glutathione under oxidative peroxidesotherthanH O .Forexample,theycatalyse
2 2
stress(Section3.11).Againthisinactivatestheirfunc- GSH-dependent reduction of fatty acid hydroperox-
tion,butitcouldalsoservetoprotectperoxiredoxins ides and various synthetic hydroperoxides such as
againstoxidationtocys-SO H,sothattheiractivitycan cumeneandt-butylhydroperoxides(Section5.11.8.3),
2

--- Page 165 ---

110 FREE RADICALS IN BIOLOGY AND MEDICINE
whichareoftenusedassubstratestoassaytheenzyme atitsactivesite.However,GPx4isanexception,being
invitro.Theperoxidegroupisreducedtoanalcohol. a monomer of relative molecular mass 19,000, with
one Se. Selenium (discovered in 1817 by Jöns Jacob
Berzelius and named after the Greek goddess of the
3.14.1 Afamilyofenzymes162
moonSelene)isanelementingroupVIoftheperiodic
Several types of GPx exist. One is the ‘classical’ (first table(Fig.A1),andresemblessulphurinitschemistry,
discovered) enzyme, often now called GPx1. It is althoughtheEarth’scrustcontainsaboutathousand-
mostly present in animal cell cytosol, and to some fold less Se than it does sulphur. Se is present at the
extentinnucleus,mitochondria,andperoxisomes(in active sites of GPx enzymes as selenocysteine, cyst-
some cells). Mammalian blood plasma contains low eine in which the sulphur atom is replaced by Se
levels of a different form, PGPx (often called GPx3), (R-SeH). The presence of Se lowers the pK a (~8.3 for
aglycoprotein.GPx3isalsofoundinotherextracellu- –SH,5.2for–SeH)andsofavoursionizationtoSe–.Sel-
lar fluids such as milk, seminal fluid, amniotic fluid, enocysteineisencodedintheGPxgenesasTGA(UGA
aqueoushumoroftheeye,andlungliningfluid,and in mRNA), also a stop codon. To prevent reading as
originates mainly from the kidney. Whether it func- ‘stop’,aselenocysteineinsertionsequencemustbepre-
tionsasaGPxinplasmaisuncertainbecauseofthelow sentdownstreamoftheUGA.Selenocysteinetransfer
levels of GSH: plasma GSH levels are μM (Table 3.4) RNA is first loaded with serine, which is then con-
buttheK oftheenzymeforGSHisinthemMrange. verted into selenocysteine, the Se being donated by
m
ItmayworkbetterinalveolarliningfluidwhereGSH selenophosphate.
levelsarehigher(Table3.4;Section7.3).TheGPx3en- DuringcatalysisbyGPx,theselenol(GPx-Se–)reacts
zymescanalsousethioredoxinasasubstrate,butthere withperoxidetogiveaselenenicacid(GPx-SeOH),
isnotalotofthisinplasmaeither.
GPx-Se–+ ROOH +H+→ ROH +GPx-SeOH
AnothertypeofGPxisfoundinthecellsliningthe
gastrointestinaltract.Intestinalglutathioneperoxidase Glutathionethenbinds,followedby
(GI-GPx, often called GPx2) may serve to metabol-
ize peroxides in ingested food lipids, as well as any GPx-SeOH-GSH→H 2 O + GPx-Se-SG
generatedduringlipidperoxidationintheintestineit-
ThesecondGSHbinds,followedby
self(Section7.2).HumanlivercontainsGPx2,aswell
as GPx1 and GPx4, a fourth member of the family. GPx-Se-SG-GSH → GPx-SeH-GSSG →
GPx4,oftencalledphospholipidhydroperoxidegluta-
GPx-Se–+ H++ GSSG
thioneperoxidase(PHGPx)canreducenotonlyH O
2 2
and synthetic organic peroxides, but also fatty acid Traces of Se are essential in the diet of animals,
andcholesterolhydroperoxidesthatarestillesterified. oneimportantrolebeingtoprovideselenocysteinefor
Bycontrast,GPx1andGPx2donotactoncholesterol the GPx family. When rodents are Se-deprived, GPx
peroxides, and GPx3 hydrolyses them only slowly. activity falls. However, Se plays many other meta-
In other words, GPx4 can act upon peroxidized fatty bolicroles.Itisaconstituentofthioredoxinreductase
acidresidueswithinmembranesandlipoproteins,re- (Section 3.13.1) and some methionine sulphoxide re-
ducing them to alcohols. It is found in many tissues ductases (Section 5.14.1). In thyroid hormone biosyn-
and subcellular compartments and is less specific for thesis(Section8.10.2),Seisanessentialcomponentof
GSHasareductantthantheotherGPxenzymes. iodothyronine-5(cid:4)-deiodinaseenzymes,whichconvert
Ingeneral,GPx4activityintissuesislowerthanthat thyroxine(T4)tothemorebiologicallyactivehormone
ofGPx1.Testisisanexception,withhighGPx4;thisen- 3,3(cid:4),5-triiodothyronine (T3). Several other selenopro-
zymeplaysakeyroleinspermmaturationbycatalys- teins are present in vivo. For example, most Se in
ingoxidationofproteinthiolgroupsinthespermhead. the plasma of humans and other animals resides on
TheGPx4endsupincorporatedintothespermcapsule selenoprotein P (P for plasma), a glycoselenoprotein
inaninactiveform(Section7.11).AGPx5enzymehas (ten selenocysteines per molecule) produced by the
beendescribed,inepididymis(Section7.11). liver. It acts as a carrier of Se to tissues such as the
testisandbrainandhasbeensuggestedtohaveanti-
3.14.2 Theroleofselenium162,163 oxidant properties itself, possibly by reducing phos-
pholipid hydroperoxides in a GPx-like manner with
TheGPx1,2,and3enzymescontainfourproteinsub- thioredoxinastheelectrondonor.164SelenoproteinW,
units, each of which bears an atom of selenium (Se) anintracellularproteinfoundinmanytissues,alsohas

--- Page 166 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 111
antioxidantpropertiesinsomecellculturesystems,but
whetheritactsinthiswayinvivoisuncertain.164
SomeenzymeswithGPxactivitythatdonotcontain
Se have also been discovered; they are more com-
mon in plants and bacteria than in animals but they
do occur in the latter (e.g. GPx7 and -8 in animals).
In general, they are less active as GPx enzymes than
theselenoproteins.GPx7and-8havebeensuggested
tobeinvolvedinproteinfoldingintheER;152,162 they
assistprx4toremoveH O generatedbyEroproteins
2 2
(Section 3.13.2) and may then help to re-oxidize PDI
enzymes.
3.14.3 WatchingGPxinaction
Figure3.13showsGSSGreleasewhenH O atincreas- 2 2
ingconcentrationsisinfusedintoaperfusedratliver:
the‘saturation’ofGSSGreleaseisprobablyrelatedto
0.15
0.10
0.05
0.000
0 1 2
Hydroperoxide infused (μ mol min–1 g –1 liver)
)revil
1–
g
1–nim
lom
μ(
esaeler
edihplusid
enoihtatulG
the increased action of catalase in removing H O at
2 2
higherconcentrations(Section3.17and3.20).
3.14.4 ConsequencesofGPx
deficiency162,164,165
RodentslackingGPx1areviable,fertile,anddevelop
normally(indeed,nakedmoleratsappeartolackthe
enzyme completely; Section 11.2), but they are more
susceptibletocertaintoxinssuchasparaquat,O ,and
3
the anthracyclines, and to ‘insults’ such as hyperoxia
(e.g.aggravatedretinaldamageinmiceexposedtoex-
cess O )166 or ischaemia–reperfusion. They may also
2
developmoreseverecataractswithagethandocontrol
mice (Section 7.10.2.2), as well as vascular dysfunc-
tion. Since several other types of GPx exist in vivo as
wellasotherperoxide-removingsystems,suchasthe
peroxiredoxins,thislimitedphenotypeisperhapspre-
dictable. In addition, ability to survive in the warm,
well-fed laboratory environment is not necessarily to
be interpreted as ability to survive in the stresses of
thewild.
By contrast, a dual knockout of the genes en-
coding GPx1 and GPx2 predisposed mice to intes-
tinal inflammation (involving O
•–
production by an
2
NADPH oxidase; Section 8.10.1) and cancer (knock-
out of GPx2 alone produced no phenotype, but can
lead to rises in GPx1 activity, possibly masking any
phenotype),162 andknockoutofPHGPx(GPx4)isem-
bryoniclethal.162 KnockoutofGPx3inmice,oritsab-
senceinhumansforgeneticreasons,leadstoagreater
tendency to thrombosis and more brain injury after
ischaemia–reperfusion.167 Knockout of both MnSOD
and GPx1 in mice led to increased oxidative damage
and the mice were more prone to develop cancer as
they aged;168 and falls in GPx3 seem to be involved
in obesity (Section 10.4). However, too much GPx1 is
alsonotgood:overexpressioninmiceleadstoinsulin
resistance(Section10.5).
3.15 Otherenzymesusingglutathione
3.15.1 Glyoxalases169
3
Methylglyoxal (CH COCHO) is produced by non-
3
enzymic reactions (Section 10.5) from glyceraldehyde
Figure3.13 ReleaseofGSSGfromanisolatedperfusedliverduring 3-phosphate and dihydroxyacetone phosphate (inter-
infusionofH2O2,includedintheperfusionmediumattheconcentra-
mediates of glycolysis), from acetone by CYP2E1
tionstated(opentriangles).Theclosedcirclesshowtheresultswhen
(Section 9.8), and during lipid peroxidation. It is
anorganichydroperoxidewasinfusedinstead,whereGSTscan
also present in many foods, including honeys
contribute(Section3.15.2.2).DiagrambycourtesyofProfessor
HelmutSies(seeAngew.Chem.Int.Ed.13,706,1974andEur.J. (Section 2.6.2). Its fast removal in vivo is essential
Biochem.89,113,1978). because it reacts rapidly with DNA and proteins,

--- Page 167 ---

112 FREE RADICALS IN BIOLOGY AND MEDICINE
including covalent binding to cysteine, arginine, and concentrations,impairingtheantioxidantdefencecap-
lysine residues to help generate advanced glyca- acityoftheliver.
tion end-products (Section 10.5). It can also cause Usually,conjugationwithGSHisthefirststepinde-
pain (Section 10.24). Methylglyoxal reacts (non- toxifyinganunwantedmolecule.Sometimes,however,
enzymically) with GSH and the complex is oxidized theresultingproductsarealsodamaging.Forexample,
by the glyoxalase 1 enzyme into S-lactoylglutathione GSHconjugatesofseveralhalogenatedhydrocarbons,
(CH CHOHCOSG).S-lactoylglutathioneishydrolysed includingdibromo-anddichloroethane,causekidney
3
by glyoxalase 2 into D-lactate (note not L-lactate; Fig damage.
1.7), regenerating GSH. Glyoxalases –1 and –2 are The most widely used substrate to assay GST ac-
found in most living organisms. Glyoxalase 1 in ani- tivityis1-chloro-2,4-dinitrobenzene(CDNB),whichis
malsandyeastsrequiresboundZn2+ foritsfunction, conjugated with GSH to give S-(2,4-dinitrophenyl)-
whereasbacterialenzymesoftenuseothermetals. glutathione,whoseformationisassayedspectrophoto-
Glyoxal, CHO-CHO, a simpler but still highly re- metrically.157 It also inhibits thioredoxin reductase,
activealdehydeproducedduringglucosedegradation however(Section3.13.1).
and common in foods, is also a substrate for gly-
oxalase 1. Glyoxalase 1 seems to be important for 3.15.2.1 SubclassesofGST171
wound healing (Section 11.4.3) and in anxiety syn-
Eukaryotes have multiple cytosolic and membrane-
dromes(Section10.23),andinprotectingplantsagainst
bound (e.g. in mitochondria and the ER) GST isoen-
damage by the sugars that they make (Section 7.8.3).
zymes, with distinct substrate specificities. Some of
Extra glyoxalase 1 and –2 introduced into the brains
the ER enzymes are involved in eicosanoid synthesis
of gerbils using a tat protein carrier (Section 11.5.3),
(Section8.12).SeveralGSTsappeartoserveaddition-
caused the animals to be less sensitive to cerebral
ischaemia–reperfusion.170 allyasintracellularcarrierproteinsforhaem,bilirubin,
bilepigments,thyroidhormones,andsteroids,which
bindnon-enzymicallytoGSTs.CytosolicGSTsaredi-
3.15.2 TheglutathioneS-transferase mers of subunits encoded by multiple gene families,
superfamily171 atleastseveninanimals(alpha,zeta,mu,pi,omega,
sigma, and theta). The two subunits can be identical,
Glutathioneisalsoinvolvedinthemetabolismofxeno-
forexampleadimeroftype1musubunitsiswritten
biotics (‘foreign compounds’) such as drugs and en-
as GST M1-1. Subunits in the dimer can be different,
vironmentalpollutants.Thisinvolvesconjugationwith
but always come from the same family; for example,
GSH, catalysed by glutathione S-transferase (GST)
aheterodimeroftype1and2alphasubunitsisA1-2.
enzymes,
Similarly,Pdenotespi,Kkappa,andTtheta.Forex-
RX + GSH → RSG + HX ample, human liver contains GSTs A1-1, A1-2, and
A2-2,amongmanyothers.GSTPenzymescanacceler-
For example, maize leaves contain an enzyme which atetheglutathionylationofselectedproteins,andthe
detoxifiestheherbicideatrazinebycombiningitwith omega class GST GSTO1-1 can reverseglutathionyla-
GSH.Someoftheherbicidesafeners,compoundsthat tion,buttheimportanceofthesereactionsinvivoisas
protectcropsfrominjurybycertainherbicides,actin yetuncertain.173
partbyraisingGSHandGSTlevelsintheplant.172 The alpha, mu, and pi class enzymes are the most
Liver is especially rich in GST enzymes and the abundantinmammals,andlevelsareoftenincreased
glutathioneconjugatesareoftenexcretedintobileus- byexposureoftheanimaltoxenobiotics(Section5.5.8).
ingATP-dependent‘effluxpumps’,someofwhichare Humangenepolymorphismsthatdecreasetheactivity
also involved in export of GSSG from liver (Section ofcertainGSTs(especiallytheGSTM1nullgenotype,
3.10.3). Adducts can be degraded by γGGT to re- whichabolishesGSTM1activity)havebeenclaimedto
moveglutamateandglycine;thecysteineconjugateis beassociatedwithincreasedriskofcardiovasculardis-
then acetylated to form a N-acetylcysteine conjugate easeandsomeformsofcancer,andtomakehumans
(mercapturic acid) which can be excreted in the ur- moresusceptibletoozone(Section9.12.1).Thesepoly-
ine.CompoundsmetabolizedbyGSTenzymesinani- morphismscanaffecttheresponseofpatientstocancer
malsincludechloroform,adriamycin,BCNU,organic chemotherapy.
nitrates, bromobenzene, aflatoxin, DDT, naphthalene, InmanyGSTsatyrosineresidueisimportantinGSH
andparacetamol(Section9.10).Thepresenceoflarge binding and exposure to ONOO– can inactivate the
amountsofsuchxenobioticscandecreasehepaticGSH proteins,inpartbycausingtyrosinenitration.174

--- Page 168 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 113
3.15.2.2 GSTsandlipidperoxidation NH O
2 H H
Some GSTs show a GPx-like activity with organic HO N N
N
hydroperoxides, which was formerly called non- H
O O O
selenium glutathione peroxidase activity. They cata- S
lyse reaction of organic peroxides (but not of H O )
2 2 S HN
with GSH to form GSSG and alcohols. Perfused O O H O
livers from rats fed a Se-deficient diet release no N
HO N N
GSSG when H O is infused, but do so when tert-
2 2 H H
butylhydroperoxide is infused, indicating that the
NH2 O
GSTs can function in whole organs (Fig. 3.13). The
OH
significance of most GSTs as peroxide-metabolizing
O
systemsinvivoisuncertain.Theycan,however,cause HO
confusionifsyntheticorganichydroperoxidesareused HO
toassay‘GPx’inbiologicalmaterial.Forexample,cu- NH
HS O
mene hydroperoxide will detect both ‘real’ GPx and COOH
someofthetransferases.ThusitisbettertouseH 2 O 2 H2N O COOH
asasubstratetoassayGPx.
However,certainGSTsmaybeimportantprotectors
against lipid peroxidation. Some (e.g. GST A1-1 and H3C O
A1-2) show PHGPx-like activity on membrane- H O
N
associatedlipidperoxides,aswellasonisolatedfatty H
OH
acidhydroperoxides.Some(e.g.GSTA4-4)canmeta- HS N OH
bolize toxic end-products of lipid peroxidation, such HO H O CH OH
as4-hydroxynonenal(HNE;Section5.12.5.3)andA /J HO O 2
2 2 HO
isoprostanes(Section5.12.3).MicelackingGSTA4had HO
increased levels of HNE in the liver, consistent with OH
such a role in vivo.175 In general, however, knockout
Figure3.14 Structuresoftrypanothionedisulphide(top),bacillithiol
ofindividualGSTsinanimalsproducesamildornull
(middle),andmycothiol(bottom).
phenotype, probably because the activities of other
GSTsoftenincreasetocompensate.Someomega-class
alternative to GSH (Fig. 3.14); indeed they have
GSTshavedehydroascorbatereductaseactivity.
evolved glyoxalases that use mycothiol instead of
GSH. Mycothiol’s oxidized form can be reduced at
3.16 Othersulphur-containing
the expense of NADPH by a flavoprotein reductase
compoundsandantioxidantdefence176
enzyme.Mycobacteriaalsocontainergothioneine(Sec-
tion3.16.2;Fig.3.15).Severalspecies,includingBacillus
Reduced glutathione plays key metabolic roles in
subtilis and S. aureus contain high levels of bacillith-
animals, plants, and some bacteria; several bac-
iol(Fig.3.14),whichhelptoprotectagainstoxidative
teria can import it from their surroundings (Sec-
stress.176,180 Sea-urchin eggs contain ovothiol C, ap-
tion 3.10.4). In contrast, many prokaryotes do not
parently to scavenge H O (Section 8.5). Entamoeba
produce GSH but contain other sulphur-containing 2 2
histolytica,thecauseofamoebiasis,lacksGSHandac-
compounds that fulfil similar roles. For example,
γ-glutamylcysteine is a major thiol in halobacteria. cumulates cysteine instead.181 Just as proteins might
be glutathionylated if GSH is present, they can also
Borrelia burgdorferi uses coenzyme A to replace GSH,
be S-bacillithiolated or mycothiolated in the relevant
as do S. aureus and Bacillus anthracis. Chromatium
organisms. γ-Glutamylcysteine is also reactive with
gracile likes glutathione amide (-CONH instead of
2 protein-SHgroups(Section6.16.5).
COO– on the C terminal glycine).177 Homogluta-
thione (γ-glutamylcysteinylalanine; Fig. 3.9) accumu-
lates in certain higher plants, especially legumes.178
3.16.1 Trypanothione:anantioxidantdefencein
Some mycobacteria (including M. tuberculosis) and
someparasites181,182
Streptomycetes produce a cysteine derivative, 2-(N-
acetylcysteinyl)amido-2-deoxy α-D-glucopyranosyl- Some parasitic protozoa, such as Crithidia fascicu-
myo-inositol (mycothiol),176,179 apparently as an lata or Trypanosoma brucei, lack glutathione reductase,

--- Page 169 ---

114 FREE RADICALS IN BIOLOGY AND MEDICINE
9–11
6 N(CH 3 ) 3 + N(CH 3 ) 3 +
H H
5 4
* CH2
H
C COO– CH
2 H
C COO–
HN1 3NH 7 8 HN N
2
C
S SH
Figure3.15 Structureofthethiol(right)andthione(left)formsofergothioneine.ThethionepredominatesatpH7.4.∗Ahydroxylated
ergothioneinewithanextra-OHatposition6hasbeenisolatedfromthemushroomLyophyllumconnatum(Biosci.Biotechnol.Biochem.69,
357,2005).
catalase,thioredoxinreductase,orselenoproteinGPx, The system has four components. Tryparedoxin per-
butcontaintrypanothione,twoglutathionemolecules oxidases(2-cysperoxiredoxins:Section3.13.2)remove
covalently linked to the polyamine spermidine (Fig. peroxides and oxidize the protein tryparedoxin. This
3.14).Trypanothioneplaysakeyroleinparasitemetab- is re-reduced by trypanothione, the oxidized form of
olism(Fig.3.16)andformspartofasystemforremov- which is regenerated at the expense of NADPH by
ingH O andorganicperoxidesthatmaybeespecially a flavoprotein trypanothione reductase that resem-
2 2
importanttotheseparasites,sincetheycontainH O - bles glutathione reductase. Many parasites contain
2 2
generatingenzymes,includingSODs(usuallyFeSOD). additionalperoxiredoxins,andsometimesovothiolA
metals, drugs,
oxoaldehydes
R(cid:129) RH
S(cid:129) S
T(SH) 2 -complexes: T(SH) T
detoxification, 2 SH S(cid:129)–
extrusion
NADP+
TryR
deoxy-
TXN
ribonucleotides ox NADPH
O
RR TS 2 2
ribonucleotides
TXN red O 2 (cid:129)–
TXNPx 2 GSH
GPx-I GSSG ROOH
ROH ROOH
+ dhAsc Asc GPx-I
H O GPx-II
2
APx
H 2 O H 2 O 2 ROH + H 2 O
Figure3.16 Trypanothione-dependentreactions.Trypanothioneismaintainedinitsreducedform[T(SH)2]byNADPH,inareactioncatalysedby
trypanothionereductase(TryR).T(SH)2candirectlyreducenotonlytryparedoxin(TXN),butalsodehydroascorbate(dhAsc)toascorbate(Asc),and
GSSGtoGSH.T(SH)2participatesinthesynthesisofdeoxyribonucleotidesanddecompositionofperoxides.T(SH)2canadditionallyinteractdirectly
withvariouselectrophilesindetoxificationofoxoaldehydes(e.g.itreplacesGSHintheglyoxalasereaction),metals,anddrugs.T(SH)2canalso
reactwithfreeradicals(R•)inscavengingand/orrepairreactionsthatleadtothetransientformationoftrypanothionethiylradical.Thissulphur-
centredradicalisexpectedtoreadilycombinewiththevicinalthioltoyieldatrypanothionedisulphideanionradical,agoodreductant,thatforms
trypanothionedisulphide(TS2)withtheconcomitantformationofsecondaryradicals,includingO •
2
–(Section2.5.5).RR,ribonucleotidereductase;
ROOH,hydroperoxides;A,one-electronoxidant;TXNPx,tryparedoxinperoxidase;GPx-I,GPx-II,glutathioneperoxidase-liketryparedoxin
peroxidasesIandII;APx,ascorbate-dependentperoxidase.FigureadaptedfromFreeRadic.Biol.Med.45,733,2008,courtesyofDr.RafaelRadi
andElsevier.

--- Page 170 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 115
(Section 8.5.2), as well as ascorbate peroxidases (Sec- or ergothioneine synthesis alone; further consistent
tion 3.19.6), the dehydroascorbate being reduced by with the view that they have overlapping antioxi-
trypanothione back to ascorbate (Fig. 3.16). Non- dant properties.185 Some fish (e.g. tuna, mackerel,
selenium GPx enzymes are also present. They play swordfish)containselenoneine,aSeanalogueofergo-
some role in removing lipid peroxides, and may also thioneine(–SeHreplaces–SH),againwithantioxidant
use tryparedoxin as a reductant. Tryparedoxin per- properties in vitro. Why these fish accumulate it is
oxidases might also help to remove ONOO– (Section unclear.186
3.13.2.1).Euglenagracilis,Treponemapallidum,andEnt-
amoeba histolytica also contain trypanothione and its
3.17 Antioxidantdefenceenzymes:
reductase.
catalases159,187,188
Compoundsthatinterferewiththesesystemsshould
beusefulintreatingdiseasescausedbyparasites,such Ingeneral,H O canberemovedbytwotypesofen-
2 2
as African sleeping sickness (T. brucei), Chagas’ dis- zyme.PeroxidasesdestroyH O byusingittooxidize
2 2
ease(T.cruzi),andleishmaniasis.Trivalentarsenicals anothersubstrate(writtenSH below),
2
(R-As = O) and trivalent antimonials (Sb(III)) inhibit
SH + H O → S + 2H O
trypanothionereductase,andsomequinonesandnitro 2 2 2 2
compoundsinteractwiththisenzymetogenerateROS The GPx enzymes and peroxiredoxins are examples
andexertcytotoxiceffects(Section9.19.1). (Section3.13and3.14),buttherearemanymore(Sec-
tion 3.19). By contrast, the catalases catalyse direct
3.16.2 Ergothioneine176,183,184 decompositionofH 2 O 2 toground-stateO 2 ,
2H O → 2H O + O
Ergothioneine, which exists in equilibrium between 2 2 2 2
thiolandthioneforms(Fig.3.15),wasfirstdiscovered Mostaerobescontaincatalase,althoughafewdonot,
inClavicepspurpurea(theergotfungus).Itspendsmost suchasBacilluspopilliae,Mycoplasmapneumoniae,83 the
ofitstimeinthethioneformandasaresultisfairlyre- green alga Euglena, and several parasitic organisms
sistanttooxidation.Earlyworkdetectedergothioneine (e.g. the liver fluke; also see Section 3.16.1). But re-
inhumanandotheranimaltissuesandsuggestedthat member that the growth medium can have an effect,
itarosefromdietaryplantmaterial,especiallycertain e.g. Enterococcus faecalis can only make catalase if it
types of mushroom. Apparently it can only be made issuppliedwithhaem,whichitcannotsynthesize.153
bycertainfungi,plusafewbacteria(Actinomycetales, Someanaerobicbacteria,suchasPropionibacteriumsher-
e.g.Mycobacteriumsp)andcyanobacteria.Itspresence manii, contain catalase, but many do not. In animals,
inhuman,rat,andotheranimaltissueshasbeencon- catalaseispresentinallorgans,butespeciallyconcen-
firmed by LC-MS, HPLC, and nuclear magnetic res- trated in liver. Catalase in erythrocytes helps protect
onancetechniques,andthegenesencodingaspecific them against H O generated by dismutation of O •–
2 2 2
membrane transporter for it (OCTN1) are highly ex- from haemoglobin autoxidation (Section 7.4). Since
pressed in some cells, such as monocytes, intestine, H O crossesmembranesfairlyreadily(Section2.6.2),
2 2
kidney,andtrachea.Expressionofthistransporteral- erythrocytes(andothercellsinblood)canprotectother
lows uptake of ergothioneine from the intestine and tissues against extracellular H O by ‘absorbing’ and
2 2
itsdeliveryintospecifictissues.Plantsobtainitfrom destroying it.189 This can also happen in cell culture;
thesoil. H O released by some cells can be catabolized by
2 2
Thefunctionofergothioneineisunknown.Invitro,it others, especially at high cell densities (Section 1.11).
formsstablecomplexeswithironandcopperions,and Brain,heart,andskeletalmusclehavelowerlevelsof
reacts rapidly with HOCl, singlet O 2 , ONOO–, OH•, catalase,overall,althoughtheactivityvariesbetween
RO•,RO • ,andhaemferrylspecies(butnotwithO •–), cell types. Several plants, maize being an example,
2 2
so it is widely thought to exert antioxidant effects, have multiple catalases, encoded by several genes
although limited direct evidence exists to confirm (Section7.8.6.2).
this view in vivo. Nevertheless, mycobacteria unable
to synthesize mycothiol make more ergothioneine
3.17.1 Catalasestructure187
instead, consistent with an antioxidant role. Indeed,
knockout of the ability to synthesize both makes Animalcatalasescontainfoursubunits,eachofwhich
mycobacteriafar moresensitivetodamageby added has Fe(III)-haem at its active site. Each subunit of
organic peroxides than knockout of either mycothiol bovine liver catalase consists of a large antiparallel

--- Page 171 ---

116 FREE RADICALS IN BIOLOGY AND MEDICINE
β-pleated sheet domain with helical insertions, fol- and levels increase if H O is added, whereas H O
2 2 2 2
lowedbyasmallerdomaincontainingfourα-helices. does not induce HPII in E. coli. HPI enzymes are
Thehaemgroupisburiedatleast20Åbelowthemo- present in many other bacteria, including M. tubercu-
lecularsurface,onlyaccessiblebyachannellinedwith losis (the only catalase present). By contrast, Pseudo-
hydrophobic residues. Ligands to the haem iron are monas aeruginosa has three different catalases (Kat A,
provided by Tyr357 (358 in human catalase), His74, KatB,KatE),butnocatalase–peroxidase.193
andAsp147.Buryingthehaemsinnon-polarpockets,
connectedtothesurfacebynarrowchannels,prevents 3.17.2 Thereactionmechanismofcatalase194
most molecules other than H O from gaining access
2 2
(Fig. 3.17 shows this for human catalase). Each sub- Catalase, like SOD, catalyses a dismutation reaction:
unit usually has one molecule of NADPH bound to one H 2 O 2 is reduced to H 2 O and the other oxi-
it.Dissociationofcatalaseintoitssubunits,whicheas- dizedtoO 2 ,
ilyoccursonstorage,freeze-drying,orexposureofthe
catalase-Fe(III)+H O
−→k1
compoundI+H O
enzymetoacidoralkali,causeslossofactivity.Com- 2 2 2
mercial catalase preparations can sometimes be con-
compoundI+H O
−→k2
catalase-Fe(III)+H O +O
2 2 2 2
taminated with these partial denaturation products,
as well as with SOD, arginases, epoxide hydrolases,
Net2H O −→2H O+O
antioxidant ‘stabilizers’ such as thymol (Section 4.5; 2 2 2 2
Fig. 4.7), and even with endotoxin.190,191 This should
be borne in mind when using commercial catalase Forratlivercatalase,therateconstants,k 1 andk 2 ,have
as a ‘probe’ for the involvement of H O in a reac- been quoted as 1.7×107 M–1s–1 and 2.6×107 M–1s–1,
2 2
tion,especiallyinwholeanimals.Suchcontamination respectively at 20–22 oC. Formation of compound I
has caused errors in studies of chromate toxicity192 leads to changes in the absorbance spectrum of cata-
and anti-inflammatory actions191 of ‘catalase’, for lase (Fig. 3.18), which have been used to assess rates
example. ofH 2 O 2 productioninperfusedorgans(Section6.11).
E. coli has two catalases,159 one of which (known IncompoundI,theironhasbeenoxidizedfromFe(III)
as hydroperoxidase II, HPII) is a tetramer with one to a nominal valency of Fe(V). In fact, an Fe(IV)
haempersubunit(butwithoutboundNADPH).Itis oxoporphyrin-cation radical, (haem•+), is formed, i.e.
encoded by the katE gene. By contrast, hydroperoxi- the Fe(III) becomes Fe(IV)O and the extra oxidizing
daseI(HPI),encodedbythekatGgene,isatetramer capacity is ‘parked’ by one-electron oxidation of the
withbothcatalaseandperoxidaseactivities,i.e.itisa haem. A similar intermediate is formed in the bac-
bifunctionalcatalase–peroxidase.TheHPIenzymeis terial catalase-peroxidases. Compound I receives two
present under both aerobic and anaerobic conditions electronsfromH 2 O 2 tore-formferriccatalase.
(a) (b)
His75 Phe153
water
Arg112
Asn148
TTrrpp118866
PPhhee115544 VVaall VV 11 aa 11 11 66 7744 haem
PPhhee115533
Arg365
Tyr358 Arg354
TTyyrr335588
Figure3.17(colourplate8) Activesiteofhumancatalase.(a)A~25Åtunnelleadsfromtheenzymesurfacetothehaemintheactivesite
andformsahydrophobicconstriction2–3Åwide,immediatelyabovetheactivesite,whichiscriticalfortheselectivityforH2O2.Side-chains
makingupthehydrophobictunnelandtheTyr358ligandaredisplayedingreen.Backboneshowninwhite.(b)Thepentaco-ordinatediron-haem
(red)intheactivesiteisaccessibleatthedistalsidetoperoxidesandsmallmoleculesatthebottomofthehydrophobictunnelthatendswitha
watermoleculeboundbytheproteinside-chains(green),His75andAsn148.Thereactivityofthehaemironistunedbyelectrondonationbythe
Tyr358ligand,andneutralizationofthehaemcarboxylatechargebyArg72,Arg112,andArg365.AdaptedfromJ.Mol.Biol.296,295,2000,by
courtesyofDrJohnTainerandElsevier.

--- Page 172 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 117
0.08
0.06
0.04
0.4 0.02
0 0
360
Wavelength (nm) Wavelength (nm)
ecnabrosbA
ecnabrosbA
Catalase
Catalase
+H O
2 2
1.2
Catalase
0.8
Catalase
+H O 2 2
Figure3.18 Absorbancespectraofpurifiedrat
livercatalaseandcatalasecompoundI.Thelarge
absorbanceofcatalasearound400nmisknown
400 440 480 600 640 680 astheSoretband,afeatureofmosthaem
proteins.
Catalase compound II can be produced by one- or heart (with lower levels). Similarly, for a given
electron reduction of compound I and is an inactive concentration of catalase, the initial rate of H O re-
2 2
Fe(IV) species, catalase-(haem)Fe(IV)O, without the movalwillbeproportionaltotheH
2
O
2
concentration.
porphyrin radical. The necessary electron may arise Asaresult,thespecificactivities(μmolH O decom-
2 2
fromtheproteinitself,e.g.fromtyrosine,thusgenerat- posed/min/mgprotein)quotedbymanufacturersfor
ingatyrosylradical,orfromanexternalelectrondonor theircatalasepreparationsaremeaninglessunlessthey
such as ferricyanide or O
•–.
One role of the bound describeexactlyhowtheassaywasdone.
2
NADPH may be to help maintain enzyme activity
byactingas a preferredelectrondonortocompound 3.17.3 Catalaseinhibitors187,195
I if H O supply is limited, so hindering formation
2 2
of amino acid radicals. NADPH may also reconvert Catalasecanbeinhibitedbyazide,cyanide,peroxyni-
compoundIItoactivecatalase.187 trite, and HOCl, but these are non-specific. A more
It is difficult to saturate catalase with H O —its usefulinhibitorisaminotriazole,
2 2
maximumvelocity(V )forthedestructionofH O
max 2 2
is enormous. However, the equations on p116 show
thatcompleteremovalofH O requirestheimpactof
2 2
twoH O moleculesuponasinglecatalaseactivesite,
2 2
whichbecomeslesslikelyasH O concentrationsfall.
2 2
The amount of compound I present in a mixture of
catalaseandH O dependsontheirrelativeconcentra-
2 2 whichinhibitscatalaseinvivo.Itactuallyinhibitscom-
tionsandonk andk .Chanceetal.194 calculatedthat
1 2 pound I, so aminotriazole will only affect catalase
atallreasonableconcentrations,therateofremovalof
when H O is present. It acts by modifying a histi-
H O isgivenbytheequation 2 2
2 2 dineligandtothehaem(His74inthebovineenzyme).
(cid:4) (cid:5) (cid:2) (cid:3)
Theobservationthataminotriazoleinhibitscatalasein
MolesH O used 1–1s–1 =2k [H O ] compoundI
2 2 2 2 2 whole animals or plants confirms that H O is pro-
2 2
=2k 1[H
2
O 2][freecatalase] ducedinvivo.
Thus if the concentration of H 2 O 2 is fixed, the ini- 3.17.4 Peroxidaticactivityofcatalase187,194
tial rate of its removal will be proportional to the
concentration of catalase present, and hence will be Mammalian catalases can also catalyse peroxidase-
higher in liver (rich in catalase) than in, say, brain type reactions, to an extent restricted by accessibility

--- Page 173 ---

118 FREE RADICALS IN BIOLOGY AND MEDICINE
of substrates to the haem (Fig. 3.17). Compound I donateelectronstotheelectrontransportchain,butin
canparticipateintheoxidationofmethanol(CH OH) peroxisomestheyreactwithO togiveH O .Itseems
3 2 2 2
and ethanol (CH CH OH) in vivo to their corres- logical(althoughsimplelogicissometimesmisleading
3 2
pondingaldehydes,HCHO(formaldehyde,sometimes in the free radical field!) to believe that these H O -
2 2
called methanal) and CH CHO (acetaldehyde, some- producing enzymes have evolved to colocate in an
3
times called ethanal), but propanols or butanols are organelle with high capacity to destroy H O . This
2 2
much poorer substrates (Section 9.8). Formic acid view is supported by mutations affecting the peroxi-
(HCOOH) can be oxidized to CO by compound I somal targeting sequence of catalase, so that it stays
2
and nitrite (NO–) to nitrate. Nitric oxide reversibly in the cytoplasm and does not enter peroxisomes.
2
binds to the haems of catalase, causing modest de- In its absence, H O produced in peroxisomes dam-
2 2
creasesinenzymeactivity.CatalasecanalsouseH O agesthem,fattyacidsarenotproperlydegraded,and
2 2
to slowly oxidize196 NO• to NO–, and on to NO–. severe symptoms result.200 Some CuZnSOD (Section
2 3
Catalase has additionally been suggested to oxidize 3.5.1.1) and prx5 (Section 3.13.2) may also be present
elementalmercury(Hg)absorbedintothehumanbody inperoxisomes,althoughthecontributionofthelatter
toHg2+ions.197 toH O removalisuncertain.Nevertheless,thereare
2 2
The presence of peroxidatic substrates for cata- suggestionsthatevenundernormalconditionsH O
2 2
lase in vivo will decrease the concentration of com- cansometimesescapedegradationinperoxisomesand
pound I, causing more free catalase to be formed. enterthecytosol,possibly for redox-signallingtonu-
Thisisanothervariabletobeconsideredinassessing cleusandmitochondria.199,201
how quickly catalase removes H O in vivo. Separ- Mitochondria (at least in skeletal muscle and
2 2
atedcatalasesubunitsshowlittlecatalaseactivity,but liver),202 chloroplasts,andtheERcontainlittle,ifany,
have peroxidase activity on a wider range of sub- catalase. Hence any H O produced by these organ-
2 2
strates, including NADH, because the haem is more ellesinvivocannotbedisposedofbycatalase,unless
accessible. H O were to diffuse out of them to the peroxi-
2 2
The drug cyanamide (H NC≡N) is converted in somes.Isolatedsubcellularfractions,especiallymicro-
2
vivo into a product (possibly nitroxyl anion; Sec- somesandmitochondria,maybeheavilycontaminated
tion2.5.6)thatinhibitsaldehydedehydrogenase(Sec- withcatalasereleasedfromperoxisomes,however.Al-
tion 9.8.1.1). Consumption of ethanol after taking thoughmuchofthecatalaseinhomogenatesofanimal
cyanamidecausesethanalaccumulationandunpleas- and plant tissues is not organelle-associated, this is
ant symptoms, and so cyanamide administration has generallythoughttobeduetoruptureofperoxisomes,
been used to deter alcohol consumption in patients, which are fragile organelles, during homogenization.
as has disulphiram (Section 3.5.1.4). It has been sug- However,somenon-peroxisomalcatalasemayoccurin
gested that catalase is responsible for oxidizing cy- theliversofafewanimals,suchasguineapigs203and
anamide to the product that inhibits aldehyde de- extra-peroxisomalcatalaselevelshavebeenreportedto
hydrogenase;duringthisoxidation,thecatalaseloses riseinothermammaliantissuesastheyage.199,200 By
activity.198 contrast with other tissues, mitochondria in rat heart
docontainsomecatalase,inthematrix.202
S.cerevisiaecontainstwocatalases,one(catalaseA)
3.17.5 Subcellularlocationofcatalase:
inperoxisomesandtheother(catalaseT)inthecytosol,
theperoxisome194,199
asdoesthenematodeC.elegans.
The catalase activity of animal (except for erythro-
cytes)andplantcellsislargelyorcompletelylocated
3.17.6 Manganese-containingcatalases
in subcellular organelles bounded by a single mem-
brane,theperoxisomes.Peroxisomesalsocontainsev- Several microorganisms contain Mn-catalases,87,188
eral enzymes that generate H O , such as glycollate H O -degrading enzymes insensitive to inhibition by
2 2 2 2
oxidase, urate oxidase (absent in primates; Section azide or cyanide and without haem, although they
3.25.6),andtheflavoproteindehydrogenasesinvolved are far less common than haem catalases. They are
inβ-oxidationoffattyacids,ametabolicpathwaythat sometimes called pseudocatalases. For example, the
operates in both mitochondria and peroxisomes in Lactobacillus plantarum Mn-catalase has six subunits,
mostanimaltissues.Peroxisomesplayakeyroleinde- eachofwhichcontainsadi-manganeseactivesite,the
gradinglong-chainfattyacidsinthebrain,forexample metalbeingintheMn(III)state.TheMncyclesbetween
(Section 10.17.5). In mitochondria these flavoproteins Mn(III)andMn2+duringcatalysis,

--- Page 174 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 119
2H++ Mn2+-Mn2++H 2 O 2 → Thediseaseaniridiaisassociatedwithanincreased
incidenceofmentalretardationandofthetypeofcan-
Mn(III)-Mn(III)+2H O
2
cerknownasWilms’tumour.Aniridiaresultsfroma
H 2 O 2 + Mn(III)-Mn(III)→Mn2+-Mn2++O 2 +2H+ deletiononchromosome11andalsoleadstodecreased
catalaseactivity.Whetherthisdecreasecontributesto
Mnplaysakeyroleinthesurvivalofseveralbacteria thesymptomsofaniridiaisunknown.209
(Section3.8.2).
3.18 NADHoxidases
NADHoxidasesarewidespreadinnatureandperform
3.17.7 Doescatalasematter?Acatalasaemia
various roles, e.g. electron transport across plasma
The gene encoding catalase in humans is located on membranes(Section1.10.8).Manybacteria(examples
chromosome 11, and mutations in it can result in being Streptococcus mutans, Streptococcus pneumoniae,
acatalasaemia.204Intheoriginaldescriptionofthiscon- and Lactobacillus lactis) contain flavoprotein enzymes
ditioninJapantherewasaseveredeficiencyofcatalase that oxidize NADH and reduce O 2 to H 2 O, or some-
activity,buttheonlyobservableclinicalproblemwas times to H 2 O 2 (e.g. in Enterococcus faecium).210–213 It
anincreasedincidenceofgumdisease(Takahara’sdis- is often suggested that the H 2 O-producing enzymes
ease). Splicing mutations, or a deletion in exon 4 of act in anaerobes as ‘O 2 -scavenging’ systems, remov-
the catalase gene, have been identified in different ing O 2 , and preventing O 2 toxicity at the expense of
Japanesepatients.Anotherseriesofmutationswasde- cellular reducing equivalents. Indeed, their knockout
scribed in Switzerland and results in an active but often renders bacteria more sensitive213 to low levels
unstableenzyme,leadingtovariabledecreasesincata- of O 2 . However, one must bear in mind that NADH
laseactivityindifferenttissues;noclinicaleffectsare oxidase activities assayed in crude bacterial extracts
apparent. Similarly, transgenic mice lacking catalase couldbelongtoavarietyofenzymesystems.Forex-
grownormallyandshownoobviousabnormalities,205 ample, flavoprotein NADH oxidases, reported from
although they are more prone to injury by H O - Amphibacillus xylanus and many other bacteria, are
2 2
generating toxins (including alloxan and adriamycin; probably part of an AHPR system, and serve to con-
Sections9.7.1and10.16),andmaybemoresusceptible sume H 2 O 2 when the peroxiredoxin-like component
to ischaemia–reperfusion and to cancer development (Section3.13.2)isadded.212
as they age.205,206 Drosophila mutants with lowered
catalasearealsoviable,unlessactivityisdecreasedto 3.19 Antioxidantdefenceenzymes:
<2%ofnormal,207butC.elegansneedsitsperoxisomal
anassortmentofotherperoxidases
catalase (Section 11.3.1). Studies in Hungary showed
noclinicaleffectsofacatalasaemia,butsuggestedthat Peroxidases other than those already described are
it is a risk factor for development of diabetes (Sec- widespreadinlivingorganisms.Letusexamineafew.
tion 10.5).204 A polymorphism (C→T substitution) in
the promoter region of the catalase gene may also
3.19.1 Cytochromecperoxidase:another
influence the enzyme activity in humans.208 By con-
specificperoxidase159,194,214
trast, overexpressing catalase in animal mitochondria
(whereitisnotnormallypresent)hasbeenreportedto The haem-containing enzyme cytochrome c peroxid-
extendlifespan(Section11.4.5). ase (CCP) is found in some bacteria (e.g. N. gonor-
Inactivatingcatalasegenesinbacteriaoryeastshas, rhoeae and P. aeruginosa), fungi (e.g. Cryptococcus neo-
in general, fewer striking effects than deleting SOD formans),andbetweentheinnerandoutermembranes
orperoxiredoxingenes(oneexceptionisP.aeruginosa, ofS.cerevisiaemitochondria,whichcontainnocatalase
whereKatAisrequiredforvirulence).193Thisislikely
(which is present in cytosol and peroxisomes in this
duetothepresenceofotherH 2 O 2 -removingenzymes. yeast).
Inaddition,someH 2 O 2 cansimplydiffuseoutofthe CCPreactsrapidlywithH 2 O 2 toformanenzyme–
celltothemedium.However,thecellsusuallybecome substratecomplex,whichhasanabsorbancemaximum
moresensitivetoaddedH 2 O 2 orH 2 O 2 -generatingtox- at419nm,whereasthatofthefreeenzymeisat407nm.
ins,whichcouldmakethemhypersensitivetophago- Hydrogen peroxide performs two-electron oxidation:
cytic killing (Section 8.7.4) in vivo. Catalase-deficient the haem Fe(III) is oxidized to a Fe(IV) state and
plantsareconsideredinSection7.8.6. thereisone-electronoxidationofatryptophanresidue

--- Page 175 ---

120 FREE RADICALS IN BIOLOGY AND MEDICINE
(Trp191)intheactivesitetoaradical.Twomolecules 3.19.3 Horseradishperoxidase
of reduced cytochrome c (Fe2+) are then oxidized to
One of the most studied non-specific peroxidases is
theFe(III)formandtheenzymereturnstoitsresting
horseradish peroxidase (HRP),215 obtained from the
state. An electron from the first cytochrome c neu-
horseradishplant(Armoraciarusticana).Severaldiffer-
tralizes the tryptophan radical, leaving compound II
ent forms exist, each containing bound carbohydrate
(still a ferryl haem species), and the second electron
andCa2+ ions,butallhavebroadsubstratespecificity.
reformstheFe(III)enzyme.Undersomeexperimental
For example, HRPs will oxidize guaiacol, pyrogallol,
conditions the reverse can happen: the ferryl is re-
CN–, I–, Br–, NADH, thiol compounds, and phenols.
duced first. Spectrophotometric measurement of the
OxidationsbyHRP,andprobablybymostothernon-
CCPenzyme–substratecomplexhasbeenusedtoas-
specific peroxidases, usually occur by the following
sayH O (Section6.11).
2 2 reactions,inwhichSH isthesubstrate:
2
peroxidase+H O → compoundI
3.19.2 ‘Non-specific’peroxidases 2 2
compoundI+SH →SH • +compoundII+H+
Plants and bacteria often harbour haem-containing 2
peroxidasesthatcanuseH 2 O 2 tooxidizeabroadrange compoundII+SH →SH • +peroxidase+H+
ofsubstrates,e.g.theE.coliHPI(Section3.17.1).‘Non- 2
specific’ peroxidases214,215 are usually assayed in cell Thehaemironin‘resting’peroxidaseisFe(III).Hydro-
extractsusingartificialsubstrates,whichareoxidized genperoxidereactswithittogivecompoundI,which
inthepresenceofH O togivecolouredorfluorescent containsironintheFe(IV)oxidationstate(perhapsas
2 2
products. Often the true substrates of these peroxi- Fe(IV)=O),theextraoxidizingcapacitybeingaccom-
dases in vivo have not been identified. Such artificial modated by one-electron oxidation of the haem to a
substrates include guaiacol (a phenol produced by
radicalcation(haem•+).Thetwoelectronsarereplaced
certainmillipedes,possiblyasadefencesystem;struc- intwoone-electronsteps,ineachofwhichasubstrate
tureshowninFig.4.7),216 benzidine(Fig.10.20),and moleculeformsaradical,SH•.Henceperoxidase–H 2 O 2
o-dianisidine. mixtures have been used to generate free radicals in
‘Non-specific’ peroxidases are also present in ani- the laboratory from almost every compound under
mals,althoughtheirfunctionstendtobebetterknown the sun. Compound II is the intermediate state; the
thaninplants.Thusmyeloperoxidase(MPO)ispartof haem iron is still ferryl but the haem•+ radical has
the antibacterial mechanism of phagocytic cells (Sec- been neutralized by receiving an electron from the
tion 8.7.5) and thyroid peroxidase helps to make the substrate.
thyroid hormones (Section 8.10.2). Lactoperoxidase The substrate-derived radicals have several fates.
(LPO) is found in milk, respiratory tract mucus, and Theymightundergodisproportionation,onereducing
saliva.Itmayhaveanantibacterialrole,since(among theothertoSH 2 whilstoxidizingitselftoS,
many other substrates) LPO can oxidize thiocyanate
SH
•
+ SH
•→
S + SH
(SCN–)ions,foundinbothmilkandsaliva,intohypo- 2
thiocyanite(OSCN–).Thisistoxictoseveralbacteria, Theymightlinktogether;forexample,tyrosinephen-
includingE.coli,Streptococci,Salmonellatyphimurium, oxyl radicals can produce bityrosine (Fig. 2.2). Some
and Pseudomonas aeruginosa (Section 10.9). It is also SH•radicalscanreactwithO 2 ,
produced when HOCl or MPO oxidize SCN– (Sec- SH • +O →S+O •–+H+
tion2.6.3).Lactoperoxidasemaybeoneofthefactorsin 2 2
milkthatprotectbabiesagainstinfectionsofthegastro- SuperoxidecangiveH 2 O 2 bydismutation,
intestinaltract.TheH 2 O 2 thatitneedstooxidizeSCN– O •–+O •–+2H+→H O +O
canarisefromcertainotherbacteria(e.g.Streptococcus 2 2 2 2 2
sanguis) which excrete H O into their surroundings, Thus, when HRP is oxidizing a substrate whose rad-
2 2
andfromNADPHoxidasesonmucosalsurfaces(Sec- icalreducesO 2 toO • 2 –,onlytraceamountsofH 2 O 2 are
tion8.10.1).217Hydrogenperoxideisalsooftenpresent needed.Forexample,oxidationofNADHbyHRPoc-
in beverages (Section 2.6.2). Vascular peroxidases218 curs without addition of H 2 O 2 , since traces of H 2 O 2
havebeendetectedintheheartandvascularsystems arepresentinNADHsolutionsduetoautoxidation.219
ofhumansandotheranimals.Theirroleisdiscussed
TheHRP-mediatedNADHoxidationgeneratesNAD•
inSection8.7.5.6. radicalandO
•–,
2

--- Page 176 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 121
compoundI+NADH→compoundII+NAD • +H O
2
compoundII+NADH→peroxidase+NAD • +H O
2
2NAD • +2O →2NAD++2O •–
2 2
2O
•–+2H+→H
O +O (dismutation)
2 2 2 2
overallreaction: 2NADH+O +2H+→2NAD++2H O
2 2
NAD•radicalscanalsoformadimer, 3.19.4 Whydoplantshavesomuchperoxidase?
NAD • + NAD •→(NAD) Deposition of lignin in plant cell walls involves
2
the polymerization of phenols; they are oxidized by
b(cid:4)ut this rea(cid:5)ction has a lower rate constant
peroxidasesboundtothecellwallsintophenoxylrad-
3× (cid:4)107M–1s–1 than th(cid:5)e reaction of NAD• with
icals,whichpolymerizetoformlignin(Section8.5.3).
O k =1.0×109M–1s–1 . NADH oxidation is an
2 2 Lignin destruction by fungi also involves peroxi-
example of the oxidase reactions of peroxidase, as
dases(Section8.5.3).Peroxidasesareinvolvedinfruit
compared with its ‘normal’ reactions in which equal
ripening, defence reactions against pathogens (Sec-
amounts of SH and H O are used up and no O is
2 2 2 2 tion 8.11.2), and metabolism of plant hormones, such
consumed.
asauxin.
Several non-specific peroxidases (including HRP)
canoxidizethiolsintothiylradicalsinthepresenceof
H O .Forexample, 3.19.5 Chloroperoxidase
2 2
andbromoperoxidase221,222
H O + 2GSH → 2H O + 2GS •
2 2 2
Chloroperoxidase was first isolated from the fun-
These radicals can then participate in several reac-
gus Caldariomyces fumago. It contains haem, catalyses
tions that result in O uptake. For example, for GS•
2 theusual‘non-specific’peroxidasereactions,andcan
(Section2.5.5),
showcatalaseactivityundercertainconditions.Inadd-
GS • + GS– →GSSG •– ition,itaddshalogenatomstoarangeofsubstratesin
the presence of H O and Cl–, Br–, or I–. If SH is the
GSSG •–+O 2 → GSSG+O • 2 – substrateandX–th 2 eh 2 alide,thereactionis
GS • +O 2 → GSO • 2 substrate-H + X–+H 2 O 2 +H+→ substrate-X+2H 2 O
Anotheroxidasereactionofperoxidaseisitsactionon For example, tyrosine can be converted to chloro-,
2-nitropropane (CH 3 CH(NO 2 )CH 3 ),220 a compound bromo-, or iodotyrosine depending on the halide
used as a solvent (e.g. in inks, paints, and varnishes) ion added. H O reacts with the enzyme to gener-
2 2
andalsofoundincigarettesmoke;a‘standard’USfil- ate compound I, a haem (IV) cation radical, which
terlesscigarettegeneratessmokecontainingabout1μg
then oxidizes Cl–, forming an unstable complex that
of 2-nitropropane. Peroxidases use traces of H 2 O 2 to some groups have suggested can decompose to re-
initiatenitropropaneoxidation,generatingintermedi- leaseHOCl.
ate radicals that reduce O 2 to O • 2 –. Superoxide then Many marine organisms are rich in halogen-
participatesincontinuedoxidation. ated compounds (possibly produced as antimicrobial
SuperoxidecanreactwithHRPtogenerateoxyper- agents) and contain similar enzymes. In some cases
oxidase,orcompoundIII, only one halide is a substrate. For example, a bro-
enzyme-Fe(III)+O
•–→enzyme(Fe2+–O
)
moperoxidase has been isolated from several marine
2 2 organisms. Bromoperoxidases from a few fungi, sev-
OxyperoxidaseoxidizesNADHonlyslowly,anditsac- eral marine algae (e.g. the brown alga Ascophyllum
cumulation during the reaction slows down the rate nodosum), and the lichen Xanthoria parietina contain
ofNADHoxidation.219CompoundIIIdecaysspontan- vanadium (as vanadate) at the active site, instead of
eously,butslowly,toreleaseO
•–.
haem, as do some chloroperoxidases. H O binds to
2 2 2

--- Page 177 ---

122 FREE RADICALS IN BIOLOGY AND MEDICINE
thevanadate,andthenreactswithhalide,apparently 3.20.1 Peroxisomesandmitochondria194,199,201
againtoproduceahypohalousacid.
Catalase seems to be the key enzyme for H O re-
2 2
movalinperoxisomes.Theprx5presentmightcontrib-
3.19.6 Ascorbateperoxidase214 ute, but if it does, the nature of its electron donor is
unclear. Mitochondria usually lack catalase; although
Chloroplasts (Section 7.8.6), green algae, some para-
there is some in rat heart (and some reports suggest
sites (Fig. 3.16), and cyanobacteria contain ascor-
liver also) mitochondria, its contribution to H O re-
2 2
bate peroxidase enzymes, which catalyse the overall movalappearssmall.202Hydrogenperoxideproduced
reaction
elsewhereinthecellcouldsometimesdiffuseintoper-
ascorbate + H O → 2H O + dehydroascorbate oxisomes(oracrosstheplasmamembraneintothesur-
2 2 2 roundings)forremoval.Onefascinatingsuggestion225
They are haem proteins with some structural resem-
isthatanimalsevolvedtomovesomeβ-oxidationout
blancetoCCP(Section3.19.1),butoperateby‘classical’ of mitochondria in order to diminish mitochondrial
peroxidase mechanisms, i.e. they form ascorbyl rad- O
•–generation,bydecreasingthenumberofelectrons
2
ical, which then disproportionates into ascorbate and fed into the flavoproteins in the electron transport
dehydroascorbate(DHA).Theycanalsooxidizeother
chain.Theβ-oxidationwasplacedinperoxisomesto-
substratessuchaspyrogallolorguaiacol.CompoundI gether with catalase to destroy all the H 2 O 2 . A fur-
isagainaFe(IV)-haemcationradical. ther suggestion is that neurons use glucose/lactate
WhenincubatedwithH O intheabsenceofascor- ratherthanfattyacidsasenergysubstratestominim-
2 2
bate,ascorbateperoxidaseisinactivated,apparentlyby
izeβ-oxidationbecauseoftheirsensitivitytooxidative
reactionofcompoundIwithH O tocausedestruction damage.225
2 2
ofthehaemring.223 Animal mitochondria contain GSH, some GST
enzymes, glutaredoxin, thioredoxin, glutathione
reductase, thioredoxin reductase, GPx1, GPx4, and
3.19.7 Peroxidase‘mimetics’
peroxiredoxins; these organelles generate and release
Myoglobin, haemoglobin, and complexes of haemo- H 2 O 2 , but they can also catabolize added H 2 O 2 .
globin with haptoglobins (Section 3.23.3.4) can show Mitochondrial H 2 O 2 has been suggested to be a
redox-signal to the nucleus (Section 5.5.5), yet how
peroxidaseactivitiesinvitrowhensuppliedwithH O
2 2
can mitochondria release it when so many H O-
andasuitableelectrondonor.Theperoxidaseproper- 2
catabolizing enzymes are present? There are some
ties of haemoglobin form the basis of one diagnostic
testforcolonicbleedingasapossibleindicatorofcan- ideas(Section5.5.5),butwedon’treallyknow.Calcu-
cer(faecaloccultbloodtest).Thetestisquitesensitive lations based upon rate constants and concentrations
butnotveryspecific.Forexample,itcanpickupperox- suggeststronglythatprx3isthemajorH 2 O 2 scavenger
idasesoriginatingfromthediet,suchasfrompartially in the mitochondrial matrix.226 Gpx1 is present at a
digestedplants.224 much lower concentration in mitochondria and thus
seemstobelessimportant.Indeed,inDrosophilathere
is no mitochondrial GPx and knockout of the genes
3.20 Makingsenseofitall.Whatfits encoding mitochondrial peroxiredoxins greatly de-
whereinperoxidemetabolism? creasedlifespan,whichwasincidentallynotrecovered
byover-expressingcatalaseinthemitochondria.227
So far in this chapter, we have described several
antioxidant defence systems, but how do they work
together and co-ordinate? Low levels of H O con-
2 2 3.20.2 Erythrocytes,lung,andyeast
tribute to redox regulation and signal transduction
(Section5.5),sohowdoesthecellarrangeitsperoxide- Red blood cells generate H O (Section 7.4) and
2 2
metabolizingenzymestoallowthis?Wefirstexamine many early papers discussed the relative import-
these questions in the context of peroxide-removing ance of catalase and GPx in removing it. The gen-
systems, and then expand to the broader antioxidant eral conclusion was that catalase is more important
defencenetwork(Section3.21).Thesolutionsvarybe- at high fluxes of H O (e.g. when H O or H O -
2 2 2 2 2 2
tweenorganelles,cells,tissues,andorganisms,aswe producing toxins are added), whereas GPx1 deals
shallillustratewitharangeofexamplesfromanimals with lower ‘physiological’ levels of H O generation.
2 2
tobacteria.Finally,weexaminewhereSefitsin. Yet, GPx1-knockout mice do not show haemolysis,

--- Page 178 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 123
normuchotherpathologyexceptunderstresscondi- 3.20.4 Bacteria153,159
tions(Section3.14.4).Bycontrast,knockoutofprx1in
Imlayetal159recentlyposedthequestion‘whydobac-
mice causes shortened lifespan due to early devel- .
teria use so many enzymes to scavenge H O ?’ The
opment of both cancers and severe haemolytic an- 2 2
E.coli AhpC seems critical in keeping basal levels of
aemia. Anaemia is also seen in prx2 knockouts.
H O low, but if the organism is exposed to higher
Hence peroxiredoxins play a key role in erythro- 2 2
levels,thecatalasesmaybemoreimportant(especially
cyte antioxidant defence, both during erythropoiesis
astheirlevelscanbeincreasedbytheoxyRsystem:Sec-
and in mature red cells, at least in older mice.140,158
tion 5.5.2), since the activity of AHPR is saturated at
This is further discussed in Section 7.4. Similarly,
low H O levelsand the supply of NADH may limit
whereas knockout of Gpx1 in mice had little effect 2 2
its action. The same holds true in Brucella abortus,231
on O toxicity, knockout of prx6 markedly increased
2 andprobablymanyotherbacteria. E.coliandseveral
lung damage and decreased survival on exposure
otherbacteriahaveperiplasmic‘thiolperoxidases’re-
to 100% O . Overexpression of prx6 diminished O
2 2 semblingatypical2-cys-peroxiredoxins,andseemingly
toxicity.228
importantinmetabolizingorganicperoxides,although
S. cerevisiae lacking peroxiredoxins shows an en-
somecanalsoutilizeH O .
hancedmutationrateandismorereadilydamagedby 2 2
H O orONOO–,yetthisyeastcantoleratelossofits
2 2
two catalases.229 Yeast lacking peroxiredoxins has in- 3.20.5 Seleniumdeficiency:reinterpretation
creased contents of GSH and glutathione reductase, ofanoldparadigm163,164
suggesting an attempt at compensation. Indeed,
these yeasts were hypersensitive to GSH-depleting Selenium (Se) deficiency in animals produces a var-
agents.229 ietyofdiseases.Theseincludewhitemuscledisease,
amusclewastingsyndrome(mink,horses,pigs,cattle,
sheep), mulberry heart disease (pigs), and infertility
3.20.3 Allowingredoxsignalling?
(many species). The effects of Se deficiency can often
Mammalian peroxiredoxins are slower at catalysing (although not always) be overcome by giving excess
H O removalthanGPx,althoughthelargeamounts α-tocopherol, and vice versa.232 Rats fed diets lacking
pr 2 ese 2 nt(tensorhundredsofμMinsometissues)and Se and α-tocopherol showed elevated plasma levels
their low K m for H 2 O 2 (<20 μM) can compensate for of F 2 -IsoPs.233 Similarly, guinea pigs deficient in Se
this. Some are readily inactivated by H O .140,158 In- andvitaminCshowedincreasedlipidperoxidationin
2 2
deed,inactivatedperoxiredoxinsaccumulateinmany muscle.234 Single nutrient deficiencies had much less
cells subjected to severe oxidative stresses, such as effect, in general, on the animals or on their levels
treatment with high levels of H O . It seems likely of oxidative stress biomarkers.233,234 By contrast, ad-
2 2
thatatlowphysiologicalH O concentrations,perox- ministering extra dietary Se to humans with normal
2 2
iredoxinsdisposeofmostH O generatedinsidecells. plasmalevelsdidnotalteroxidativedamagelevels,as
2 2
However,whenthecellsensesextraH 2 O 2 (e.g.atasite measuredbyplasmaF 2 -IsoPsorproteincarbonyls.235
ofinflammation),andaresponseisrequiredtoallow
3.20.5.1 Humanseleniumdeficiency163
geneexpressionbyredoxregulation,theperoxiredox-
ins are partially inactivated by sulphinic acid forma- The importance of Se in the human diet was appre-
tion (and sometimes by glutathionylation as well) to ciatedfullyafterthediscoveryofaSe-responsivede-
allowsomeH O toactontranscriptionfactors.140,158 generative heart disease, Keshan disease. Symptoms
2 2
AftertheextraH O hasdoneitsjob,theinactiveforms includedwastingandenlargementoftheheart,heart
2 2
ofperoxiredoxinsarere-activatedusingsulphiredoxin rhythmdisruptions,andeventualcardiacarrestinse-
(Section 3.13) and the H O level declines to nor- verecases.Thenamecomesfromanepisodein1935in
2 2
mal.Peroxidemetabolismisalsoinfluencedbyphos- which 57 out of 286 inhabitants of a village in Ke-
phorylation and dephosphorylation, itself subject to shan in Heilongjiang province in China died of the
cellular redox regulation (Section 5.5). Prx1 can be disease. Epidemiological studies showed that the in-
phosphorylatedbytyrosineandserine/threoninekin- cidenceofKeshandiseasewascorrelatedwiththatof
ases, which decreases peroxiredoxin activity.230 By animaldiseasesalreadyknowntoberelatedtoSede-
contrast, GPx1 and catalase are phosphorylated by ficiency.BothKeshandiseaseandtheanimaldiseases
the c-Abl and arg kinases, which activates them could be prevented by administration of small doses
(Section5.5). of sodium selenite (Na SeO ). In all affected areas,
2 3

--- Page 179 ---

124 FREE RADICALS IN BIOLOGY AND MEDICINE
Seconcentrationsinfoodstuffswerefoundtobelow. and a ‘garlic breath’ smell due to dimethylselenide,
Whole-bloodSelevelsinmanycountriesfallintothe (CH ) Se. Se-accumulating plants such as Astragalus
3 2
1 to 3 μM range, but levels in subjects with Keshan (milkvetch)speciescanpoisoncattle(leadingtoblind
disease were much lower. Measurements of total Se staggersandalkalidisease),andareaparticularnuis-
andGPxactivityinwholebloodfromNewZealanders ancetofarmersincertainpartsoftheworld.238Indeed,
showedagoodcorrelationbetweenthesetwoparam- in 1295 the explorer Marco Polo described a disease
eters at total blood Se concentrations up to 1.3 μM, of horses that sounds exactly like Se toxicity. Se poi-
butnotathigherlevels.Itseemsfromthisandother soning has been reported in patients who consumed
datathatabout1μMisthe‘thresholdfigure’atwhich Se-containingsupplementstogreatexcess.
GPx(atleastinblood)reachesmaximumactivity.This Se deficiency has sometimes been claimed to ac-
enzyme is the most responsive to Se withdrawal in company protein–calorie malnutrition or prolonged
animal experiments (Section 3.14), suggesting that it intravenousfeeding,butreportsareofteninconclusive.
maybeagoodmarkerofSestatusintheaboverange. Residents of low-Se areas in Finland or New Zea-
Indeed, when animals are Se-deprived, GPx1 activity land appear to suffer no obvious ill-effects, although
fallsmuchfasterthanGPx2and-4activities,consistent they may well eat, of course, some foods that were
withtheviewthatthelatteraremoreimportantinvivo growninareasofhigherSe.Nevertheless,suggestions
(Section3.14). remainthatlowbloodSemightpredisposetocardio-
AnabnormallylowSeintakeappearstobethema- vasculardisease,cancer,orcomplicationsofpregnancy
jor factor leading to Keshan disease, but not the sole (Section7.11.6).
cause.Forexample,Keshandiseasewasnotendemic
inalllow-SeareasofChinaandseasonalvariationsin 3.20.5.2 Seleniumdeficiencyandantioxidant
diseaseincidencedidnotseemtobecausedbychanges defences
inSe(orα-tocopherol)intake.Onefactorpredisposing
In thinking about how Se relates to antioxidant
to cardiomyopathy may be infection with Coxsackie defence,162–164 most emphasis was initially placed on
viruses.FeedingmiceaSe-deficientdiet(orknocking GPx1. Howeverthe other GPx proteinsmay be more
outGPx1)favouredselectionandreplicationofadam- important in vivo (Section 3.14.4). Se is required for
agingviralsubtypeintheheartafterinoculationofthe thioredoxin reductase, which plays key roles in per-
animalswithanormallybenignstrain.236
oxide metabolism (Section 3.13). It is also needed by
Se deficiency has also been implicated in Kashin– methionine sulphoxide reductase B (Section 5.14.1).
Beck disease237 (named after the Russian scientists SelenoproteinsPandWmightalsohavesomeantioxi-
who first described it), a disabling joint disease seen danteffects(Section3.14.2).TheroleofGPx4insperm
inchildreninNorthernChina,NorthKorea,andEast maturation(Section3.14.4)helpstoexplainwhySede-
Siberia. Administration of sodium selenite and α- ficiencyimpairsreproductioninratsandhumans,al-
tocopherolduringtheearlystagesofthediseaseseems thoughtestisalsorequiresanadditionalselenoprotein,
beneficial. The geographical distribution of Kashin– SEPP1.
Beckdiseaseresembles(butisnotidenticalwith)that Some cell culture media have low Se levels (Sec-
ofKeshandisease,andiodinedeficiencyalsoplaysa tion1.11),whichcanaffecttheredoxbehaviourofcells
role,sincebothiodineandSeareinvolvedinthyroid andtheirresponsestostress.239
hormone metabolism (Section 8.10.2). Another factor
maybethelevelofmycotoxinsinfood.
3.21 Furtherco-operation
AstudyofbloodSelevelsinChinaledscientiststo
concludethataminimumadequatedietaryintakefor
3.21.1 Superoxidedismutasesand
humans is about 30 μg. Normal daily intakes in ad-
peroxide-metabolizingenzymes
vanced countries are in the range 30 to 200 μg/day
andrecommendeddietaryallowancesareusually50to Section3.20consideredhowdifferentH O -removing
2 2
70 μg. Se intakes and blood levels have fallen in the systems might co-operate, but they must in turn co-
UKoverrecentyearsduetodietarychanges(e.g.less operatewithotherdefencesystemssuchastheSODsto
use of flour from Se-rich wheat imported from the achieveabalanced,coordinated,andresponsiveanti-
USA),butwhetherthismattersornotisunclear.Lar- oxidant defence network. A simple illustration: lipo-
ger intakes of Se (>500 μg/day) can produce toxic somes containing both catalase and SOD protect rats
effects:anearlysignofexcessSeintakeisdeformation againstO toxicitybetterthanliposomescontainingei-
2
and loss of fingernails, toenails, and sometimes hair, therenzymealone.77Furtherevidenceforco-operation

--- Page 180 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 125
is provided by numerous experiments carried out in aboutoneinevery1000babies.Itresultsfromthepres-
differentlaboratories.Toquoteoneexample,transfec- enceofanextracopyofallorpartofchromosome21,
tionofageneencodingCuZnSODintomouseepider- which leads to increased production of many of the
mal cells raised CuZnSOD levels and sensitized them proteins encoded by genes on this chromosome. One
todamageuponincubationwithamixtureofxanthine is CuZnSOD; 1.5 times the normal CuZnSOD activ-
andXO,whereascombinedtransfectionwithgenesen- ityisfoundincellsfromtrisomy21patients.Indeed,
codingCuZnSODpluscatalaseorGPx1renderedthe cells from DS patients are less readily damaged by
cellsequallyormoreresistanttodamage.240 M.pneumoniae.83
Theneedforco-operationmayinpartbedrivenby IsDSrelatedtotheriseinCuZnSOD?Thisquestion
thefactthatRScandamageindividualantioxidanten- has been examined using transgenic mice (Box 3.1).
zymes.Forexample,ifnotremovedbySODs,O
•–can
Animals have been obtained with 1.6- to 6-fold more
2
partiallyinhibitcatalase;thereaction241 SODactivity,especiallyinthebrain.Risesinbraincata-
laseactivity(butnotinGPx)werealsoobserved.The
enzyme–Fe(III)+O • 2 –(cid:2)enzyme–Fe2+–O 2 miceappearmorphologicallynormalandaremorere-
sistanttoseveraltoxins(Box3.1).However,abnormal
generates a ferroxycatalase that does not rapidly de-
neuromuscularjunctionswerereportedinthetongue,
compose H O . In addition, O
•–
can reduce catalase
2 2 2 apparentlysimilartothosefoundintonguemusclesof
compound I to compound II, again poorly active in
trisomy21patients.Themicealsoshowedabnormal-
degrading H O (Section 3.17.2). Mycoplasma pneu-
2 2 ities in serotonin metabolism comparable with those
moniae, which infects the human respiratory tract,
reportedinpatients.However,theydidnotshowthe
maydecreasethecatalaseactivityofrespiratorytract
changes in dorsal root ganglia that are found in pa-
cellsbythismechanism.83 InH.pylorilackingAHPR,
tients;henceonlysomeoftheneurologicalchangesin
organic peroxides accumulated and partially inacti-
trisomy21occurinthemice.
vated catalase.159 In another example, mice lacking
Thus the contribution of elevated CuZnSOD to DS
CuZnSOD showed decreases in GPx1 activity in the
is uncertain and changes in the levels of other gene
liver,242duetopartialconversionoftheselenocysteine
productsmaybemoreimportant.Nevertheless,some
todehydroalanine,whichlacksSe,
(butnotall)studieshavereportedincreasedoxidative
damage, e.g. elevated F –IsoPs, 8OHdG, and allan-
CH Se CH 2
2 2
toin (Section 6.13) levels, in DS patients.243–246 Cere-
NH CH CO NH C CO bralcortexfromDSpatientswasfoundatautopsyto
containelevatedlevelsofseveralHNE-modifiedpro-
This conversion is also observed in red blood cells teins, oxidized RNA, and nitrated proteins.246,247 The
incubated with 1 mM H 2 O 2 (Section 7.4), i.e. both gene encoding amyloid precursor protein is present
O • 2 – and H 2 O 2 seem able to attack GPx if allowed to onchromosome21andincreasedAβproduction(Sec-
accumulate.242
tion10.21)couldcontributetobrainoxidativedamage
Inaddition,SODsdiminishONOO– formationand andtheelevatedriskofADinDSpatients.Inspiteof
someperoxiredoxinsscavengethisspecies;iflefttoit- this, administration of ascorbate, α-tocopherol, lipoic
self,ONOO–caninactivateMnSOD,someCuZnSODs,
acid, or other ‘antioxidants’ to DS patients has dem-
catalase, and GPx enzymes. Similarly, if H O is not
2 2 onstrated no convincing clinical benefit in studies to
quickly removed, it can inactivate CuZnSOD and date.244 Thiscouldbebecausebrainlevelsofantioxi-
FeSOD.
dants were not raised, and/or because these agents
areineffectiveatdecreasingoxidativedamageinvivo
(Chapter4).
3.21.2 Downsyndrome243,244
Animbalanceofantioxidantdefencesmaybeimport- 3.22 Antioxidantdefence:sequestration
antintrisomy21,oftencalledDownorDown’ssyn-
ofmetalions
drome(DS),afterthephysicianJohnLangdonDown,
who described it in 1866. The syndrome is character- Iron and copper are essential in almost all aerobes
ized by variable degrees of mental retardation, mor- as cofactors of proteins involved in respiration, O
2
phologicalabnormalities,andanincreasedriskofde- transport,NO•formation,andantioxidantdefence.Yet
velopingAlzheimerdisease(AD).Downsyndromeis ions of these metals are potentially dangerous pro-
themostcommonchromosomalabnormality,affecting oxidants (Table 3.6). It is not only ‘free’ metal ions

--- Page 181 ---

126 FREE RADICALS IN BIOLOGY AND MEDICINE
Table3.6 Roleoftransitionmetalionsinconvertingless-reactivetomore-reactivespecies.97,98
Startingagent More-reactivespecies Metalinvolved Comment
producedonadditionof
metalions
H2O2(±O •
2
–) OH•(andpossiblyreactive Fe/Cu/Co/Ni/Cr/V(notMnorZn) Iron-andcopper-ion-dependent
oxo-metalspecies) conversionofH2O2toOH•.Alsosee
Section9.16.
HOCl OH• Fe Fe2+reactswithHOCltoformOH•ora
similarspecies(Section2.6.3).
Lipidperoxides Peroxylradicals,alkoxylradicals, Fe/Cu/severalothers Sections5.11.6and9.16.
cytotoxicaldehydes
Thiols(R-SH) O •
2
–,oxysulphurradicals,H2O2, Fe/Cu/severalothers Section2.5.5.
RS•,OH•
NAD(P)H NAD(P)•,O •
2
–,OH • Fe/Cu NAD(P)•radicalsreduceO2togiveO •
2
–;
copperisespeciallygoodatpromoting
NAD(P)Hoxidation.
Ascorbicacid OH•,possiblyO •
2
–,H2O2, Fe,especiallyCu Oxidationofascorbateproduces
semidehydroascorbateradical cytotoxicspecies(Section4.2).
Alloxan,adrenalin,DOPA, OH•,O •–,carbon-centredor Fe,Cu,Mn,oftenothermetals ‘Autoxidations’dependonthepresence
2
dopamine,dihydroxyfumarate, otherradicals(e.g.semiquinones) oftransitionmetalions(Section1.10.2).
tetrahydrofolates, derivedfromthetoxin AlsoseeSection9.16.
tetrahydrobiopterin,
6-hydroxydopamine,other
‘autoxidizable’compounds
(includingsomeplant
polyphenols)
Peroxynitrite(ONOO–) NO+ Fe/Cu Transitionmetalionsandsome
2
metalloproteins(includingSOD)
acceleratenitrationofaromatic
compounds,byfacilitatingconversionof
ONOO–toNO+(Section2.6).
2
thatcanpromoteoxidativedamage;haemandcertain will lead to either deficiency or overload, both with
haemproteinscandosoaswell(Section3.22.3).Hence deleteriousconsequences(e.g.irondeficiencyingrow-
organismsmusthandlemetalsverycarefully. ing children can impair mental development; Sec-
tion10.18.1andref249).Ithasbeenestimatedthatmore
3.22.1 Ironmetabolism248 than 500 million people in the world are iron de-
ficient (although be cautious in equating low blood
Thebodyofanaverageadulthumanmale(ifthereis ironorhaemoglobinlevelstodietaryirondeficiency—
suchathing!)containsabout4.5gofiron,mostofitin chronicinfection/inflammationcanalsocauseit;Sec-
haemoglobin. Liver (~1 g, mostly in ferritin), skeletal tion 10.11.6) and several million are iron-overloaded.
muscle (~300 mg, mostly in myoglobin), and macro- Ironislostfromthebodyinsweat,faeces(bylossof
phages(~600mgintotal)areimportantirondepots.He unabsorbed iron, and of iron in cells shed from the
absorbs1to2mgofironperdayfromthedietandloses lining of the gut), urine, and blood (especially men-
thesameamountwheninironbalance.Premenopausal strual bleeding in women), and small amounts seem
womenusuallyhavelessbodyironcontentbecauseof tobeexcretedbythelungintomucus(Section7.3)and
menstruation. will be lost if the mucus is expectorated. When body
Sincetotalplasmaironturnoverissome35mg/day, iron stores are sufficient, intestinal iron uptake de-
efficient mechanisms to regulate body iron content creases (Section 3.22.5). Foods such as wheat flour
mustexist.Evenslightdisturbancesofironmetabolism and breakfast cereals are fortified with iron in many

--- Page 182 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 127
countries;sometimes,infantformulasandsomewean- lung cells; Section 7.3). Exit of iron from the gut to
ingfoodsarealso. the plasma is facilitated by hephaestin, a copper-
InorganicironinfoodisusuallyintheFe(III)state, containing protein; it has been known for decades
the most stable oxidation state for iron. Agents that thatcopperdeficiencyimpairsironuptake.Hephaestin
solubilizeandreduceFe(III),suchastheascorbateand promotesoxidationofFe2+ toFe(III)forloadingonto
hydrochloric acid present in the gastric juice, facilit- transferrin;thisisfurtherdiscussedinSection3.22.2.3.
ate iron absorption. Indeed, gastric juice has higher ThenameisderivedfromHephaestus,theGreekgodof
ascorbate levels than plasma. Many dietary compo- fireandmetalworkers.
nentsinfluenceironuptake.Forexample,phyticacid
3.22.1.1 Transferrin
(inositolhexaphosphate),
Someoftheironabsorbedfromhaemorinorganiciron
inthedietisretainedinthegutmucosalcellswithin
ferritin and other proteins and is lost in the faeces
whenthesecellsareshed.Therestentersthecircula-
tionboundtotransferrin,248 aidedbyferroportinand
hephaestin.Transferrinalsoacceptsiron(estimatedto
presentincereals,nuts,andlegumes,chelatesironvia be 20–25 mg/day) released by macrophages as they
itsphosphategroupsandslowsitsabsorption.Haem destroy aged red blood cells. This occurs mostly in
ironisabsorbedbyadifferentpathway:haemreleased the spleen, but also in liver (Kupffer cells) and bone
byproteolysisofhaemoproteinsinthegutistakenup marrow.
(exactlyhowisuncertain)andtheironremovedfrom Most transferrin-bound iron is used by the bone
itinthemucosalcellsbytheactionofhaemoxygenase marrowtomakeabout200billionnewredbloodcells
(Section 3.24). A greater percentage of dietary haem per day, and the rest by other body cells. Circulat-
iron is absorbed than for non-haem iron, and haem ing transferrin only contains about 3 mg of the total
iron uptake is not affected by dietary iron-binding body iron, but it’s a busy protein, turning over its
agents such as phytates. Excess intake of meats rich ironabout10timesdaily.Transferrinisaglycoprotein
in haem, so that unabsorbed haem enters the faeces, (relativemolecularmass79,000),mostlysynthesizedin
has been suggested to contribute to the development the liver. It has N-terminal and C-terminal domains,
ofcoloncancer,andperhapssomeothercancersaswell eachofwhichtightlybindsoneFe(III)atpH7.4.Two
(Sections7.2.1and10.14.3).250 monoferric forms of transferrin can therefore exist,
Themainsiteofironuptakeistheduodenum,and with iron bound to the N-terminal or the C-terminal
dietary iron is presented to it in three forms: Fe(III), domain. Tight binding of Fe(III) to either domain re-
Fe2+ (reduction of some Fe(III) by ascorbate in the quiresthepresenceofcarbonateion(CO2–).Inhealthy
3
stomach),andhaem.Ferrousironistakenupbyadiva- people, plasma transferrin is usually no more than
lentmetaliontransportercalledNramp2(alsoknown 20 to 30% loaded with iron. Hence human and other
asDCT1orDMT1).Itcanadditionallytransportman- animalbloodplasmashaveconsiderableiron-binding
ganese,zinc,copper,cobalt,and(lessdesirably)lead, capacity and theircontentof ‘free’ iron ions is essen-
cadmium,andnickelions.Theduodenalmucosahan- tially zero. The affinity of transferrin for iron at pH
dlesFe(III)usingaferricreductasesystem,involving 7.4 is high (stability constant ~1022), slightly more so
ab-typecytochrome(duodenalcytochromeb;DcytB) fortheC-terminaldomainthanfortheN-terminal.The
onthecellsurface,andprobablyusingNADPHasan strengthofbindingdecreasesatlowerpH.
electron donor. Iron(III) is thus converted to Fe2+ for Transferrin can bind several metal ions other than
uptakebyNramp2.Reductaseactivityisincreasedin Fe(III),althoughwithloweraffinity,includingalumin-
hypoxiaorirondeficiency,bothofwhichincreaseiron ium(Al(III)[Section9.16.11]).
uptake;duodenalascorbatealsorises.251
3.22.1.2 Otheriron-bindingproteins252,253
Iron must then be released from the gut mucosa
to the blood, although some will be stored as fer- Aproteinsimilartotransferrin,lactoferrin,isfoundin
ritin(Section3.22.1.4)withinthemucosalcells.Serosal saliva,vaginalmucus,seminalfluid,tears,bile,nasal
release of iron involves the protein ferroportin, en- secretions,milk(moreinhumanmilkthancow’smilk),
coded by the IREG1 (iron-regulated transporter-1) and other secretory fluids and is released by neutro-
gene.Ferroportinalsoplaysaroleinironexportfrom phils during inflammation (Section 8.7). Lactoferrin
macrophages and several other cell types (including alsobindstwoFe(III)permolecule,butholdsitmore

--- Page 183 ---

128 FREE RADICALS IN BIOLOGY AND MEDICINE
tightly at low pH than does transferrin. Lactoferrin such as calcein green (Fig. 3.19) have demonstrated
may have several roles in vivo: it binds to DNA and itspresence.Calceinbluemayalsobeused,254 ascan
may influence gene transcription, has various effects Iron Probe 1257 (Fig. 3.19). The LIP may exist bound
on cells of the immune system, and may be an anti- toligandssuchasproteins,citrate,ATP,GTP,inositol
bacterialfactor,e.g.inhumanbreastmilk.Itisfurther phosphates, and other phosphate esters, possibly in-
discussedinSection11.6.2. cludingphosphategroupsinphospholipidsandDNA.
Manysimilariron-bindingproteinsareknown.Egg- Using calceins, an average LIP of 0.35 μM in human
whitecontainsovotransferrin(sometimescalledcon- erythroleukaemiacellsinculturewascalculated.Add-
albumin).Melanomacellscanexpressamelanotrans- itionofFe2+tothecellsraisedthisvalue,butitreturned
ferrin.Uteroferrinisapurpleprotein,synthesizedin tonormalwithin30to60min.AdditionofH O ortert-
2 2
large amounts by the uterus of pigs and a few other butylhydroperoxidealsoraisedthelevel,andittook
species. The colour arises from an active site where longer(60–90min)toreturntonormal.Poolsinother
ironisco-ordinatedwithtyrosine.Uteroferrincanalso cellsseemtobeinthe0.1to2μMrange.
act as a phosphatase enzyme, belonging to the type Do bear in mind that these are cells in culture
5 (tartrate-resistant) acid phosphatase class. In hu- and their LIP size may not reflect those of cells in
mans,thistypeofenzymeisfoundinosteoclasts(cells vivo.Inaddition,calceinsmeasure‘calcein-chelatable’
that destroy the matrix of bone and cartilage: Sec- iron: they can only bind iron that they come into
tion8.10.8)andserumlevelsincreaseindiseaseswhere contact with. For example, they may not enter lyso-
boneresorptionisenhanced. somes,whichcontainironreleasedbythedegradation
of endocytosed proteins and organelles.255 There is
3.22.1.3 Ironwithincells248,254–256 some evidence that lysosomes (and endosomes) can
Cellsneedingiron(especiallyerythroidprecursors)ex- export Fe2+, via the TRPML1 channel in the mem-
presstransferrinreceptorsontheirsurface;themore brane; defects in this channel can cause disease (Sec-
irontheywant,themorereceptorstheymake.Recep- tion10.23.3).258 Indeed,laserscanningmicroscopyus-
tors bind diferric plasma transferrin; the complex is ing Phen green (Fig 3.19) identified ‘labile iron’ in
internalizedbyendocytosisandentersthecytoplasm nucleus, cytosol, mitochondria, and the lysosomal–
inavacuole.Thecontentsofthisendosomeareacid- endosome system, the nucleus having the highest
ifiedtoaboutpH5.5bytheactionofanH+-pumping level.259 Mitochondria have been reported to take up
ATPase; this low pH weakens iron binding to trans- ironionsrapidly,usingthemtomakehaemandFe–S
ferrin. The iron is then removed, reduced to Fe2+ (by proteins;thesynthesisofhaem(Section2.6.4)isfinal-
an NADPH-dependent ferrireductase called Steap3), ized in the mitochondria and some of it must then
and transported out of the endosome by DMT1 to be exported to the rest of the cell. Mitochondria also
formthelabileironpool,LIP.Theiron-freetransfer- possessaniron-ionexporter,ABCB8intheinnermem-
rin(apotransferrin)isejectedfromthecellforre-use. brane; deleting it in the hearts of mice led to iron
AtpH7.4,thetransferrinreceptorhasamuchhigher overloadandcardiomyopathy.260 ATP-dependentup-
affinityforiron-loadedtransferrinthanfortheapopro- take systems for iron-citrate and iron-ATP have been
tein,enablingittocollecttheiron-bearingproteinfrom reported in microsomes and nuclei, although there
theplasma.Thisorderofaffinitiesisreversedatacidic mayalsobedirectirondeliverytomitochondriafrom
pH,sokeepingtheapotransferrinonthereceptorfor endosomesinerythroidcells.
ejectionfromthecell.Twodifferenttransferrinrecep-
torsexist,TfR1andTfR2.TfR1-mediatedendocytosis
3.22.1.4 Ferritin
is the usual pathway of iron uptake by body cells in
vivo;TfR2isinvolvedinregulationofironmetabolism Mostintracellularironisstoredinferritin.248,261Mam-
(Section3.22.5).Theliverandmanyothercells(e.g.car- malian ferritins consist of a hollow protein shell, 12–
diacmyocytes)canalsotakeup‘lowmolecularmass’ 13 nm outside diameter (7–8 nm inside diameter),
iron chelates, such as Fe–citrate,254,256 should they be composedof24subunits,eachwitharelativemolecu-
around;whichisnotusuallythecaseintheplasmaof larmassofabout20,000.Theshellsurroundsaniron
healthyanimals. core that can hold up to 4500 iron ions, but usually
TheLIPisatransitpoolthatreceivesironfromtrans- has fewer. Traces of other metals can be present, in-
ferrinandsuppliesitforthesynthesisofferroproteins. cluding copper. Most ferritin is intracellular, some in
The location and chemical nature of the LIP in cells mitochondriabutthemajorityinthecytosol.Someis
andorganellesisunclear,butfluorescentironchelators presentinblood,andplasmaferritinlevelisoftenused

--- Page 184 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 129
(b)
μ M C A in
5
60000
3
ΔF
1
50000
200
Time (s)
SIH
GLAC
)UA(
ecnecseroulF
gnidaol
llec
retfa
)UA(
ecnecseroulF
(a) HOOC COOH O– O O
CH 2 CH 2 CH O O O CH
HOOC N N COOH Cl Cl 2 3
CH 2 CH 2 CH 2 CH 2 C O– N O
O– O O O
CH
2
C O N N COOH
COO– NH N CH 2
2 K+
Iron Probe 1
Calcein green N N
Phen Green S K
70000
added cal
400 600
Figure3.19 Probesforthedetectionof‘labile’iron.(a)Structuresofcalceingreen(CALG),phengreenSK,andIronProbe1.(b)TheCALG
methodformeasuringthelabileironpool(LIP).CellsareloadedwiththeacetomethoxyderivativeofCALG(CALG-AM),whichisnon-fluorescent
andmembranepermeable.Uponentrytocells,CALG-AMishydrolysedtogiveCALG,whosefluorescenceisquencheduponbindingofiron.Anti-
CALGantibodiesareaddedtoensurethatfluorescenceisintracellular.Thecell-permeantironchelatorSIH(Section11.6)restoresfluorescence((cid:6)F)
bytakingironawayfromCALG.Otherpermeantchelatorscanalsobeused,suchasdeferiprone.Thefigureshowsarepresentativeexperiment.
CALG-boundironconcentrationisgivenby[CALG-Fe]=[CALG]tot ∗(cid:6)F,where[CALG]isobtainedfromacalibrationcurve(inset).KnowingtheK
d
ofironbindingtoCALG,itispossibletocomputetheconcentrationofCALG-detectablefreeiron.AdaptedfromFreeRadic.Biol.Med.33,1037,
2002,bycourtesyofProfessorZ.I.CabantchikandElsevier.Fluorescentchelatorsbasedonhydroxypyridones(Section11.6)havealsobeen
developedtoaccesstheendosomal/lysosomalcompartments(J.Pharm.Sci.98,2212,2009);alsoseeJ.Med.Chem.51,4539,2008.Ironprobe
1bindsFe2+withasubstantialincrease(ratherthanadecrease)influorescence.257Othersuch‘turnon’fluorescentprobeshavebeendescribed,
e.g.RhoNox-1(FreeRadic.Res.48,990,2014).
clinicallyasanapproximateindexofbodyironstores L-subunits than those in heart and brain, whereas
(e.g.Section11.4.10). mitochondrial ferritins are rich in H-type subunits.
Mammalianferritinscontaintwosubunittypes(H- By contrast, plant and bacterial ferritins are usually
and L-chains), of similar size and about 50% amino homo-polymers of H-type subunits. E. coli produces
acid sequence identity. Ferritins vary widely in H/L three ferritin-like proteins; bacterial ferritin (24 sub-
ratios, and ratios often change in various diseases. units),bacterioferritin(24subunits,butalsocontains
In general, ferritins in liver and spleen are richer in 12haems),andDps(12subunits).LevelsofDps(DNA

--- Page 185 ---

130 FREE RADICALS IN BIOLOGY AND MEDICINE
binding protein from starved cells) increase under 3.22.1.5 Regulationofcellularironbalance
stress conditions. These 12-subunit bacterial proteins, Iron homeostasis is regulated256 at the levels of the
sometimescalledminiferritins,servetoprotectDNA
organism (Section 3.22.5.2) and the cell. For example,
against damage by H O in several bacteria, includ-
2 2 thesynthesisoftransferrinreceptorsandferritinsub-
ing E. coli and Streptococcus suis. They oxidize and
unitsiscarefullyco-ordinatedinmammaliancells.This
store Fe2+, and also bind to the DNA262 and shield
involves cytoplasmic iron-regulatory proteins (IRPs)
it from attack by OH•. Such proteins may have had
which bind to iron-responsive (or regulatory) elem-
an early evolutionary origin,263 since Fenton chemis-
ents(IREs),specialbasesequencesintheuntranslated
try was probably common in the ‘pre-oxygen’ world
regionofthemRNAsencodingferritinHandLsub-
(Section1.1.1).
units and transferrin-1 receptors. When cellular iron
Iron enters ferritins as Fe2+, which is oxidized to
levels are too low, IRPs bind to IREs. This stabilizes
Fe(III) and deposited in the core as an insoluble hy-
transferrin-1receptormRNA,sothatmoretransferrin
drated ferric oxide. The loading is facilitated by a
is made to facilitate iron uptake. By contrast, it pre-
chaperone protein, PCBP1 protein, which binds Fe2+
vents translation of ferritin mRNA so that less iron
andhandsitovertoferritin.264 PCBP1mayalsohelp
is stored and more stays in the LIP for use in the
todeliverirontotheprolylhydroxylasesthatregulate
synthesisofiron-containingproteins.Whenthereisex-
HIF-1α (Section 1.3.2). The mechanism of iron oxida-
cesscellulariron,thereversehappens:mRNAforthe
tion as it enters ferritin is incompletely understood;
transferrin-1 receptor is rapidly degraded and more
the H–chains have an iron-binding site and can oxi-
ferritinismade.
dize Fe2+ to Fe(III), the ferroxidase activity, whereas
Howdoesthiswork?TheIRP-1proteinisidentical
the L-subunits facilitate iron nucleation and storage.
to a cytosolic form of the enzyme aconitase (acon-
The first step seems to be formation of a diferric
itase also occurs in mitochondria, in the Krebs cycle,
peroxide,
Fig. 1.7). IRP-1 has aconitase activity when its [4Fe–
2Fe2++O
2
→ Fe(III)–O–O–Fe(III) 4S]clusterispresent,butactsasanIRPwhenironis
low and the cluster disassembles; switching between
Thisrapidlyconvertsintoadi-Fe(III)Oproduct,which these forms depends on cellular iron status. Muta-
istheprecursorofthestoredirondeposits.265
tionsinactivatingtheIREinmRNAencodingferritin
AtlowfluxesofironintoferritinH 2 O 2 isproducedon L-subunitsleadtoelevatedplasmaferritinlevelsand
theH-chains, cataract in humans; the latter may be due to depos-
Fe(III)–O–O–Fe(III)+H
2
O → Fe(III)–O–Fe(III)+H
2
O
2
itionofferritinaggregatesinthelens.266 AnotherIRP,
IRP-2, without aconitase activity, is found in mam-
whereas at high fluxes, Fe2+ oxidation by H 2 O 2 oc- malian cells. It is synthesized when iron is low and,
curs on the surface of the growing core, minimizing whennolongerrequired,itisremovedbyproteasomal
net H 2 O 2 formation. Tyrosyl radicals and OH• have degradation (Section 5.14.3.2) after hydroxylation by
beendetectedfromferritinduringironloading,butare a2-oxoglutarate-dependentdioxygenase.Knockoutof
(fortunately)notstoichiometricallyproducedasFe2+is the IRP-2 gene in mice produces anaemia, iron ac-
oxidized.Theoverallreactionis265 cumulation in the brain, and neurodegeneration; so
2Fe2++O + (H O)x+3→ Fe O (H O)x+ 4H++ H O IRP-2seemstobeimportant.
2 2 2 3 2 2 2
Iron–sulphur clusters are sensitive to oxidizing
CellularferritinlevelsaffecttheLIP.Forexampleover- agents (Section 3.9) and so it is not surprising that
expression of ferritin in cells decreases the amount several ROS, RCS, and RNS can influence IRP ac-
of calcein-detectable iron (Fig. 3.19), and decreasing tion and hence iron metabolism in cells in culture.
ferritinraisesLIPsize. Theimportanceofthisinvivoisuncertain.Cytokines
Howcellsreleaseironfromferritinisuncertain; in such as IL-2 and TNF-α (Section 5.7) increase ferritin
vitro, it can be released (as Fe2+) by several reducing synthesis in several cell types, by promoting tran-
agents,includingascorbate,thiols,urate,O
•–,andre-
scription of the gene encoding the H-subunits. The
2
ducedflavins.Ironentersandleavesthroughchannels; IRPsalsoregulatethesynthesisofseveralotheriron-
it can also be released when ferritin is taken up into containingproteins,includingmitochondrialaconitase
lysosomesanddegraded.Ferritincanbeconvertedin andδ-aminolaevulinatesynthetase,anenzymeneeded
lysosomes into an insoluble product, haemosiderin, for haem synthesis (Section 2.6.4). Binding of IRPs
probably by proteolytic attack, and some iron can be blocks translation of the mRNA encoding the latter
exportedfromlysosomes.258 enzymeandthusdecreaseshaemproduction.

--- Page 186 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 131
Thecellularironlevelmustfindabalancebetween CopperdeliveredbyCtr1bindstotransportproteins,
supplyingenoughironformetabolicrequirementsand the copper chaperones, one of which (CCS, Section
theriskofacceleratedoxidativedamage.Toolittleiron 3.5.1.3) delivers copper to CuZnSOD, another to the
candecreasetheactivityofessentialproteinssuchas Golgi apparatus for insertion into exported proteins,
ribonucleotidereductaseandmitochondrialFe–Spro- and yet another (COX17) takes copper to mitochon-
teins. Indeed, incubation of cells with iron chelators driaforincorporationintocytochromeoxidase.Excess
for long periods can lead to apoptosis. Not only iron copper in the liver is excreted into the bile. Some
overload but also iron deficiency can cause oxidative intracellularcoppermayexistboundtoGSH,provid-
stress; both involve increased ROS production. Iron ing an additional source of Cu to CuZnSOD (Section
deficiency impairs mitochondrial electron transport, 3.5.1.3).Metallothioneinsalsoplayaroleincopperse-
promoting electron leakage, and can also lower cata- questration(Section3.23.2),asmayprionproteinsand
lase activity.266,267 A patient lacking ferritin L-chains, amyloidprecursorproteinsinthebrain(Section10.21).
sothatherferritinconsistedonlyofH-chains,showed Another important protein is caeruloplasmin
neurological and muscular disorders associated with (‘blue substance from plasma’), mostly made in the
increasedoxidativedamage:thelackofL-chainsmay liver. Caeruloplasmin, relative molecular mass about
leadtoexcessincorporationofironionsintoferritin.266 132,000, is then secreted into plasma. It contains six
tightly bound copper ions and often a seventh, less
well bound. A membrane-bound form of caerulo-
3.22.2 Coppermetabolism268
plasmin, attached to glycosylphosphatidylinositol,
Copperionsarepowerfulcatalystsofoxidativedam- is synthesized in some other tissues, including brain
age (Table 3.6), sometimes more effective than iron (Section10.17.6).
ions,e.g.incausingascorbateoxidation(Section4.2),
oxidative DNA damage (Section 5.8.2), and peroxid-
3.22.2.2 Aphantomcopperpool?
ation of LDL (Section 10.3.5). Hence organisms must
handle copper ions carefully, keeping most or all Human blood plasma normally contains 200 to
of them tightly protein-bound. Key Cu-containing 400mg/dm3ofcaeruloplasmin,accountingfor90%or
proteins include SOD1, EC-SOD (Section 3.23.3.2), more of total plasma copper. The rest is bound to al-
and cytochrome oxidase. Not only excess copper buminandtranscuprein.Inaddition,a‘lowmolecular
but also copper deprivation can increase oxidative mass’poolboundtohistidineorsmallpeptidesisoften
stress, the latter by decreasing SOD and cytochrome claimedtoexist.Invitro,coppercanberemovedfrom
oxidase activities and increasing mitochondrial O
•–
suchaminoacidchelatesbythemetal-bindingagento-
2
production.269 phenanthroline.270 However,ifmammalianplasmais
An ‘average’ adult human contains about 80 mg incubatedwithphenanthroline,nochelatablecopperis
copper and absorbs about 1 mg/day, both from diet- detected,whichimpliesthattheamountsofthesenon-
ary copper and from ‘recycled’ copper, i.e. copper caeruloplasmin copper chelates in plasma are small.
released by the liver into bile (Section 3.22.2.1). Cop- Chromatography,dialysis,orlow-temperaturestorage
perismainlyabsorbedintheduodenum.Notallthe ofplasmaorserumleadtoreleaseofcopperfromcaer-
copper entering gut mucosal cells enters the blood: uloplasmin, which may account for reports of ‘non-
some is stored in these cells and lost from the body caeruloplasmin copper’ in earlier studies.270 Copper
whentheyareshed.Therestentersthebloodbound releasein‘aged’plasmaappearstooccurbytheaction
to transcuprein (identical to α -macroglobulin in hu- of a plasma metalloproteinase on caeruloplasmin.271
2
mans; Table 8.2) and to albumin; each albumin mo- Adding ONOO– to caeruloplasmin also releases cop-
leculehasonehighaffinitybindingsiteforcopperplus perions(Section2.6.1).
anumberofweakerbindingsites.
3.22.2.1 Caeruloplasminandcopper 3.22.2.3 Caeruloplasminasanoxidase272
chaperones268
Caeruloplasmin has ferroxidase activity; it oxidizes
Copperistakenupbytheduodenum,liver,andother Fe2+ to Fe(III). Its physiological importance is illus-
organsthroughtheCtr1transporterandentersthecell tratedbypatientswithacaeruloplasminaemia,273who
in the Cu+ form (it is not clear how it is reduced). carry mutations in the gene encoding it. They show
Ctr1 can also transport silver (Ag+) ions and allows lowplasmairon,elevatedserumferritin,andelevated
entryoftheanti-cancerdrugcis-platin(Section10.16). irondepositioninthebrain(accompaniedbyincreased

--- Page 187 ---

132 FREE RADICALS IN BIOLOGY AND MEDICINE
lipid peroxidation), liver, and other tissues. Patho- activity.276 It thus may help to inhibit the activity of
logical consequences include diabetes, retinal degen- anyMPOpresentinplasma.Inaddition,caeruloplas-
eration, and neurological abnormalities. Mice lacking minmayhelptoconvertNO•toNO–inbloodplasma,
2
caeruloplasmindevelopadisorderresemblingParkin- althoughtheimportanceofthisisunclear.277
son disease (Section 10.19.1). Why do these defects
occur? Caeruloplasmin ferroxidase activity is needed
3.22.3 Haemandhaemproteins:powerful
for export of iron ions from liver, astrocytes (Sec-
tion 10.17.6.11), other tissues, and macrophages, and
pro-oxidants278
fortheircorrectbindingtotransferrin.Inthegut;this
Haemoglobinandmyoglobinarenormallyintracellu-
roleisplayedbyhephaestin(Section3.22.1),hencecop-
larproteinsinredcellsandmusclesrespectively.Both
peruptakethroughthegutisnormalinmicelacking
undergo slow oxidation to form O
•–
and Fe(III) pro-
caeruloplasmin. 2
tein(Section1.10.3),andbothcancausedamagewhen
Ferroussaltsspontaneouslyoxidizeatphysiological
mixed with H O , which readily penetrates to the
pH,toproduceO •–,H O ,andOH•, 2 2
2 2 2 haemcentres.Suchdamagecanoccurinvivoanddur-
Fe2++O →Fe(III)+O •– ingmeatprocessing,thelattercausinglipidoxidation,
2 2
‘off-flavours’, and ‘greening’ of the meat when ‘ac-
2O
•–+2H+→H
O +O
2 2 2 2 tivated’ haem proteins react with sulphur-containing
Fe2++H O →Fe(III)+OH • +OH– compoundsinthemeat.279
2 2
When haemoglobin or myoglobin are exposed to
By contrast, caeruloplasmin-catalysed Fe2+ oxidation excess (≥ 10:1 molar ratio) H O or lipid peroxides,
2 2
does not: four Fe2+ are oxidized and one O 2 is re- theFe2+isoxidizedandtheproteinsdegraded,releas-
ducedto2H O.Thesameistrueofhephaestin(Section
2 ing both haem and iron ions; the latter from haem
3.22.1). However, the loosely bound seventh copper ring breakdown.278,280,281 Haem and iron so released
of caeruloplasmin has been suggested to be capable
can stimulate lipid peroxidation, and iron ions can
of catalysing oxidation of LDL and contributing to form OH• from H O . At lower H O :protein ratios
2 2 2 2
atherosclerosis, although this is controversial (Sec-
(e.g.1:1),haemoglobinandmyoglobinaremostlycon-
tion10.3.5.2).271
vertedtohaemferrylspecies.Aminoacidradicalsare
The ferroxidase activity of caeruloplasmin is in-
also generated: tyrosine and tryptophan peroxyl rad-
hibited by azide and is often called ferroxidase I, to icals (Trp/TyrOO•) and histidinyl radicals have been
distinguishitfromotherferroxidases.Inhumans,caer-
identified,
uloplasminaccountsforalmostallplasmaferroxidase
activity, whereas in some other animals, such as rab- haemFe(III)protein+H 2 O 2 →
bits, plasma additionally contains an azide-resistant haem[Fe(IV)=O]protein•+H O
ferroxidase, ferroxidase II.272,274 Decreases in ferroxi- 2
daseactivityinthefaceofunchangedorraisedcaerulo- Cross-links between haem and tyrosine can also
plasmin protein levels have been observed in several form.278,281,282
human diseases, including ARDS, Parkinson disease Both ferryl and amino acid radicals can stimulate
(Section 10.20), and rheumatoid arthritis, but their peroxidation of lipids and oxidize other molecules,
physiological significance is uncertain. Of course, if including thiols, urate, and certain proteins, to form
caeruloplasminlosttoomuchferroxidaseactivitythis secondary radicals, such as urate radical and RS•.
could impair iron release from tissues, as has been When added to lipids or lipoproteins, haem proteins
suggestedtooccurinParkinsondisease(Table10.12). in the absence of added H O can stimulate peroxid-
2 2
ation, probably by promoting the decomposition of
3.22.2.4 Caeruloplasminasaperoxidase
pre-existing traces of lipid peroxides in the lipids to
CaeruloplasmincanremoveH O andlipidperoxides alkoxyl and peroxyl radicals (Section 5.11.6.1). Free
2 2
invitrointhepresenceofGSH;thiscouldbeimportant iron ions and haemoglobin can even synergize to ac-
inlungliningfluidswhereGSHlevelsarehigh(Table celerate oxidative damage in the vascular system.283
3.4),275butisunlikelytooccuratthelowplasmaGSH Myoglobin/H O canalsooxidizetheanticancerdrug
2 2
levels.Indeed,lungsynthesizessomecaeruloplasmin doxorubicinintheheart(Section10.16.2).
andsecretesitintotheliningfluid. Hencehaem,haemoglobin,andmyoglobinoutside
Caeruloplasmin can also bind to MPO, inhibiting their normal location are potentially damaging mol-
HOClformationwithoutblockingitsownferroxidase ecules. Indeed, haem is carefully sequestered within

--- Page 188 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 133
cells, employing a series of haem-binding proteins, (Sections 9.6 and 10.9). Iron-overloaded subjects are
including GSTs (Section 3.15.2.1). A haem export more prone to infection by a range of organisms,
mechanism is also essential in erythrocyte precursor including Vibrio vulnificus and Listeria monocytogenes.
cells (Section 3.23.3.4). This pro-oxidant potential of Chronic inflammation can markedly lower plasma
haemandhaemproteins,togetherwiththerapidscav- iron levels, leading to an apparent anaemia (Sections
engingofNO•byhaemoglobin,posesproblemsinthe 3.22.5.2and10.11.6).Alotoftheironisretainedwithin
design of haemoglobin-based blood substitutes.278,284 macrophages(Section3.22.5.2),sothe‘ironsequestra-
Similarly, myoglobin released as a result of severe tion’doesn’tworkwellforbacteriathatresidewithin
muscle injury can lead to kidney failure, involving macrophages,suchasS.typhimurium,Chlamydia,M.tu-
oxidative damage (including lipid peroxidation) pro- berculosis, and Legionella.293 Too much iron sequestra-
moted by myoglobin with haem–tyrosine cross-links, tionisalsoriskyinchildren(Section10.18.1).
haem itself, and released iron.278,281,285 Haem can fa- Mammals have evolved to fight back; siderocalins
cilitateapoptosisinducedbyTNF-α,anditstoxicityis (siderophore-binding lipocalins) are secreted by sev-
importantinsepsis,atleastinamousemodel.286 eralcelltypes(especiallyneutrophilsrespondingtoin-
When treated with H O , cytochrome c also fection)andbindsiderophores,stoppingthembinding
2 2
generates free radicals and can oxidize various to bacterial receptors and also helping to internalize
molecules.287,288 Pro-oxidant actions of cytochrome c themandliberatingtheirontheycarryforhostuse.294
canoccurduringapoptosis(Section5.4.2).Cytochrome
ccanalsobedegradedbyexcessH O ,withhaemand 3.22.4.2 Diminishingfree-radical
2 2
ironionrelease,ascancytochromesP450.Forexample, reactions97,98,295
kidney damage induced by cis-platin administration
Anotherreasonforsequesteringmetalionsistodimin-
toratsappearedtoinvolveironreleasefromCYPs.289
ishtheirpro-oxidantability(Table3.6).Manipulations
Theenzymemyeloperoxidasecanbedegradedbyits
of the iron content of S. aureus, E. coli, and mamma-
product,hypochlorousacid,causingironreleasefrom
liancellsthatdemonstratethisabilitywerediscussed
thehaem(Section8.7.5.1).
inSection3.9;multipleadditionalstudieshaveshown
Toolittlehaemisalsobad:cellularhaemdeficiency,
thatthetoxicityofH O ororganicperoxidestobacter-
2 2
likethatofironorcopper,canleadtooxidativestress
ial,animal,andplantcellsisincreasedbyraisingtheir
byincreasingmitochondrialO •– production.290 Hence
2 ironcontent,anddecreasedbythepresenceofchelat-
cells must carefully regulate their haem content, bal-
ingagentssuchasphenanthroline,ordesferrioxamine.
ancing synthesis, incorporation into haemoproteins,
Indeed, in some studiesthe size of the LIP of animal
degradation by haem oxygenases (Section 3.24), im-
cellshascorrelatedwithcellularsensitivitytodamage
port,andexport.ThebindingofhaemtoCuZnSODin by peroxides.254 In E. coli lacking H O -metabolizing
2 2
H.ducreyi(Section3.5.1.1)hasalsobeensuggestedasa enzymes, (AhpR, Kat G, Kat E), intracellular OH•
protectivemechanism,controllingcellular‘free’haem formation was detectable even with <1 μM H O .
2 2
contentintheorganism.291
Ironchelatorsreversedthepoorgrowthandelevated
DNA damage seen in these mutants under aerobic
3.22.4 Metalionsequestration:whydoit? conditions.296 Injection of ferric salts bound to the
chelating agent nitrilotriacetate (NTA) into animals
3.22.4.1 Keepingmicro-organismsatbay
causes severe tissue injury, increases oxidative dam-
Why do organisms take such care in the handling age to lipids, proteins, and DNA, and induces renal
of iron, copper, and other transition metal ions? One cancer(Section10.14.12),297inpartbecauseferric–NTA
answeristhatitdetersinfection.292 Almostallmicro- ishighlyeffectiveatgeneratingOH• fromH O .This
2 2
organisms need iron and copper for survival and chelatorhasbeenusedindetergentsandisemployed
growth,althoughafew(e.g.Borreliaburgdorferi)have inthelaboratorytoprepareiron-loadedtransferrin.
evolved to do without iron.88 Restricting metal ion Butareprotein-boundmetalionslesseffectivepro-
availabilityinbodyfluids(andrestrictingitevenmore oxidants than ‘unchelated’ metals or chelates of iron
duringtheacutephaseresponse;Section5.7.4)isthus with such molecules as citrate and ADP? In general,
an antibacterial mechanism. Indeed, some bacteria yes,withafewexceptions,haemoglobinandmyoglo-
have evolved mechanisms to circumvent this. They bin among them (Section 3.22.3). Iron in uteroferrin
synthesize powerful iron chelators (siderophores), andotherpurpleacidphosphataseshasbeenreported
able to take iron from transferrin. Others cleave togenerateOH• fromH O .298 However,inperform-
2 2
transferrin, an example being Pseudomonas aeruginosa ing such experiments it is essential to check that the

--- Page 189 ---

134 FREE RADICALS IN BIOLOGY AND MEDICINE
proteinsremainintact.Forexample,earlyreportsthat transferrin is injected.302 Atransferrinaemia, a rare
haemoglobinconvertsH O toOH• wereduetodeg- hereditarydisorder,producessimilareffectsinhumans
2 2
radationoftheproteinandironionreleaseinthereac- andistreatedbyinfusionsofplasma.302
tionmixture.280Thefollowinghavebeenestablished:
3.22.5.1 Ironoverload:diet-derived
(a) Iron correctly bound within the two iron-binding
OnceironhasenteredthebodyfromtheGItract,there
sitesoflactoferrinortransferrinwillnotstimulate
autoxidations, react with O
•–
or H O , or decom-
appearstobenospecificphysiologicalmechanismsfor
2 2 2 disposingofit,unlessonecountsmenstrualbleeding
poselipidperoxidesatpH7.4.295,299
andsweating.Thisinabilitytodisposeofexcessironis
(b) Iron in the ferritin cores is insoluble and not pro-
illustratedinironoverload.Transientironoverloadoc-
oxidant.However,itcanbemobilizedbyreducing
agents,includingO
•–.Nevertheless,theamountof cursinseveraldiseases(Chapter10)andinpremature
O
•–-mobilizable
iron
2
in ferritin is a low percent-
andsomefull-termbabies(Table5.2).Acutesevereiron
ag
2
eofthetotalironcontent;whetherO
•–
releases
overloadcanbecausedbyingestionoflargequantities
2 of iron salts, usually by children who eat ‘iron tab-
iron from the core or merely liberates iron still
lets’(containingferroussalts)meantfortheirparents.
within the channels or loosely bound to the pro-
Thereisvomiting,gastrointestinalbleeding,andsevere
teinsurface,isuncertain.98,300 Commercialferritin
shock,requiringurgenttreatmentwithdesferrioxam-
preparationsareoftenpartiallydegradedandthus
ine. Excess iron salts, particularly as Fe2+, generate
easiertomobilizeironfrom,sotheycanbeartefac-
OH•, degrade the protective layer of gastrointestinal
tuallypro-oxidantinlaboratoryexperiments.Hae-
mucus,301anddamagethecellsunderneath.Somezoo
mosiderinironislessavailablethanthatinferritin,
animals, includingmynah birds, bottlenosedolphins,
essentiallybecausehaemosiderinisinsoluble,soits
Californiansealions,pandas,andtheblackrhinoceros
formation could be an ‘antioxidant’ strategy.300 A
(Diceros bicornis) are sensitive to diet-induced iron
comparablestrategyisusedbythemalarialpara-
overload.303,304Thesespeciesmayhaveefficientuptake
site, which packs haem into insoluble haemozoin
systemsforiron,becausetheirdietaryironcontentin
(Section7.6).
thewildislow,whereaszoofeedmayhavetoomuch
(c) Copperionsattachedtoalbumincanstillreactwith
H O .However,theOH•producedisabsorbedby iron.Luckily,mosthumansdonotdevelopoverloadat
2 2 highdietaryironintakesbecauseoftheefficiencyofthe
the protein. Albumin binds copper and prevents
regulatorymechanismsthatdecreaseironuptakefrom
it from associating with lipoproteins and mem-
branes. If O
•–
or H O were produced in plasma
thegutwhenthebodyisreplete.
2 2 2 Amoreslowlydevelopingironoverloadofdietary
(e.g. from activated phagocytic cells) they might
originhasbeendescribedinseveralpartsofAfricaand
still react with copper, but this would damage
isrelatedbothtodrinkingacidicbeeroutofironpots
thealbumin.Sinceplasmaalbuminlevelsarehigh
andtoageneticpredispositiontoironoverload.305
and its turnover rapid, this is unlikely to matter
much. Albumin has thus been called a sacrificial 3.22.5.2 Ironoverload:genetic256
antioxidant.295
Perhapsthebest-studiediron-overloadconditionsare
the inherited diseases collectively known as haemo-
chromatosis. In these conditions, the normal down-
3.22.5 Metalionsequestration:whenitgoes
regulationofintestinalironuptakewhenthebodyhas
wrong
enough does not happen. Indeed, iron uptake is ac-
Therearerepeated(butcontroversial)suggestionsthat celerated, so that too much dietary iron is absorbed
levels of body iron stores help determine oxidative (absorption of cobalt, lead, manganese, and zincions
damage rates (Section 11.4.10). However, the import- may also be increased). The time taken for clinically
anceofmetalionsequestrationinhumansisdramat- significant iron overload to develop in most cases
ically illustrated by the pathology of iron overload of haemochromatosis is often 40 or more years, and
andcopperoverload diseases.Forexample,amouse depends to some extent on diet and gender, men be-
strain that synthesizes transferrin at less than 1% of ing more prone than women. In many subjects iron
the normal rate has been described. Gastrointestinal overload may never develop to an extent that causes
ironabsorptionisincreased,lowmolecularmassiron symptoms.
chelates are present in plasma, and iron accumulates When overload occurs, the iron-binding capacity
in many tissues. The mice die soon after birth unless of plasma transferrin can be exceeded, so that ‘labile

--- Page 190 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 135
iron’,oftenintheseconditionscallednon-transferrin- increased iron uptake from the gut and iron release
bound iron (NTBI), is present.254 This is not an ideal from macrophages (this release involves caeruloplas-
term, since ferritin iron in plasma is obviously non- min;Section3.22.2.3).Hepcidinproductionisnormally
transferrinboundbutprobablynotveryredox-active decreased by anaemia or hypoxia but raised by in-
(Section 3.22.4). At least some, and perhaps all, of creased iron content (e.g. in liver and plasma) and
what is usually meant by NTBI is bound to plasma byinflammation,thelatterleadingtothe‘anaemiaof
citrate,306 although other organic acids and albumin chronic inflammation’ (Section 10.11.6). Hence body
may also bind some iron. The liver takes up NTBI ironstoreshaveanegativeregulatoryeffectontheef-
rapidly(Section3.21.1.3),andotherorgans(e.g.heart) ficiency of iron absorption: normally only 10 to 15%
can also absorb some. Liver has a high capacity to of non-haem iron is absorbed but this increases in
store iron, initially mostly in ferritin, some of which irondeficiency.Micelackinghepcidinshowironover-
ispartially degradedin lysosomesintohaemosiderin load; indeed iron-overloaded haemochromatosis pa-
(Section3.22.1.4),whoseformationhasbeensuggested tients show abnormally low hepcidin levels. Control
to be an attempt to safely sequester the extra iron.300 of hepatic hepcidin production involves HFE, TfR2,
However,thereisalimittothecapacityoflivertostore transferrin,andtheproteinhaemojuvelin,amongoth-
ironsafely,andtoomuchwilldamageit. ers,andinborndefectsinanyofthemaffecthepcidin
The pathology resulting from iron overload can be production.308
devastating.Itincludesliverfibrosisandcirrhosis,in- Mutationsinthegeneencodinghepcidincauseafew
creasedriskoflivercancer,muscleweakness,malaise, cases of severe juvenile haemochromatosis, although
weightloss,damagetothegonads,skinpigmentation, most are due to other mutations, e.g. in the gene en-
diabetes (pancreatic β-cells are injured), cardiac mal- coding haemojuvelin (HFE2). Haemochromatosis can
functions,andachronicjointinflammationresembling also result from mutations in the gene encoding fer-
rheumatoid arthritis. Haemochromatosis is not rare: roportin (type 4 haemochromatosis), rendering this
theprevalenceofthehomozygousstateinAustralian, proteinresistanttoregulationbyhepcidin.
American,andseveralEuropeanpopulationshasbeen
estimated as 0.3 to 0.5%. The heterozygote frequency 3.22.5.3 Thalassaemias309,310
isabout10%,makingthisthecommonestgeneticdis- Ironoverloadcanalsoresultfrommedicaltreatmentof
orderamongCaucasians.IncidenceislowerinAsian, otherdiseases.Forexample,thethalassaemias(named
African,orHispanicpopulations.307 fromaGreekwordmeaning‘thesea’)arefairlycom-
Type 1 haemochromatosis, the commonest form, mongeneticconditionsinwhichtherateofsynthesis
results from mutations in the HFE (human gene for ofahaemoglobinchainisdiminished,theprefixα-or
haemochromatosis)geneonchromosome6.Themost β-thalassaemia being used to identify the chain syn-
frequentmutationchangesacysteineresidueatposi- thesizedabnormallyslowly.Theotherchaincanthen
tion282totyrosineintheHFEprotein,andmayhave accumulateandcauseoxidativedamage(especiallyα-
originated by chance in a Viking (or Celtic) ancestor chain accumulation), shortening erythrocyte lifespan.
inNorthernEuropesome2000yearsago.307 Juvenile Thalassaemia major (sometimes called Cooley’s an-
haemochromatosis(onsetofironoverloadbeforeage aemia,afterDrThomasCooley,whofirstdescribedit
30; sometimes called type 2 haemochromatosis) and in 1925) and thalassaemia minor refer to the homo-
neonatal haemochromatosis also exist, but are rarer zygousandheterozygousstates,respectively.Subjects
and are due to different mutations. In the latter, chil- heterozygous for thalassaemia may have a selective
dren are born with hepatic iron overload and liver advantageincertainpopulations(Section7.6).
damage,andrequiretransplantationtosurvive.Muta- Untreated patients with thalassaemia major die
tionsinthegeneencodingTfR2 arealsoa rarecause young,butcanbekeptalivebyregularbloodtransfu-
(type 3 haemochromatosis); clinically they resemble sions.Sinceeachunitofbloodcontainsabout200mg
thetype1form. of iron, the patients become iron-overloaded, lead-
A key player in these events is hepcidin, a 25- ing to saturation of transferrin and often the appear-
amino-acid peptide secreted into blood by the liver. ance of NTBI in the blood. Abnormal erythropoiesis
Hepcidin binds to ferroportin and promotes its deg- also ‘sends a signal’ (lowered hepcidin levels) to the
radation by the proteasome. This slows iron export gut to increase iron uptake. For both of these reas-
from the gut into the plasma and keeps iron within ons,ironaccumulatesintissues,especiallyintheliver
macrophagesandothercells.Conversely,lowhepcidin and spleen, with some in the heart. Since the heart
leads to elevated ferroportin levels, which promote is sensitive to iron (Section 10.16.2 and ref260), many

--- Page 191 ---

136 FREE RADICALS IN BIOLOGY AND MEDICINE
thalassaemicpatientssuffercardiacmalfunctions.Fer- of lysosomal membranes caused by excessive catab-
ric haem also circulates in the plasma and can exert olism of ferritin within them; this lysosomal damage
pro-oxidanteffects,forexampletoLDL.311 Prolonged might be a consequence of lipid peroxidation stimu-
iron overload may impair the microbicidal functions latedbyreleasedironions.Infusionofironcompounds
of phagocytes, predisposing (as does the iron over- inthetreatmentofvariousdiseases(e.g.renalfailure
load itself) to infections.312 Similar problems arise in or rheumatoid arthritis) can overload transferrin and
thetreatmentofotherchronicanaemiasbytransfusion. resultinformationofNTBIinplasma,leadingtooxida-
Bothhaemochromatosisandthalassaemiascauseage- tivedamage,andseveralauthorshaveurgedcaution
dependent thinning of bone, which may result from intheirclinicaluse(refs98,319;Section10.11.6).Methods
increasedboneresorptionduetoiron-relatedoxidative forthemeasurementofplasmaNTBIareconsideredin
damage.313 Section5.3.3.1.Ofcourse,labileironproducedtransi-
Treatment of iron overload resulting from haemo- entlymaynotalwaysbebad,e.g.itcanpromoteischae-
chromatosis is usually by blood-letting (phlebotomy, micpreconditioning(Section10.6.6).Whenchronically
sometimescalledvenesection),whereasdesferrioxam- presentinthecirculation,itis,however,badnews.
ineisadministeredtotransfusedthalassaemicpatients
in an effort to slow or prevent the accumulation of 3.22.5.5 Copperoverload320
ironinthebody.Desferrioxamineanditsironchelate ThetoxicityofexcesscopperisillustratedbyWilson
ferrioxamine are rapidly excreted, in both urine and disease, an inherited recessive disorder often charac-
bile, so removing iron from the body. Desferrioxam- terized by low plasma caeruloplasmin levels. Wilson
inecannotbegivenbymouth(requiringsubcutaneous disease occurs worldwidewith a prevalence of up to
orintravenousinfusion)anditpenetratesonlyslowly 1 in 30,000. Copper is deposited in the liver, kidney,
into cells. Hence orally active chelators have been cornea,andbrain,thelastcausingdamagethatleadsto
developed(Section11.6). lackofcoordination,tremors,andprogressivemental
retardation.
3.22.5.4 Non-transferrin-boundiron:
Itseemslikely(butisnotfullyproven)thatcopper-
isitpro-oxidant?98,254
stimulated free-radical reactions are involved in the
The NTBI found in the plasma of iron-overloaded pathology of Wilson disease. Plasma levels of as-
haemochromatosisorthalassaemiapatientswillstimu- corbate, α-tocopherol, and urate are subnormal, and
latelipidperoxidation,andOH•formationfromH O increased levels of products of urate oxidation (Sec-
2 2
in vitro, which suggests that the pathology of iron tion6.13),DNAdamage,andlipidperoxidationhave
overloadmightberelatedtoincreasedoxidativedam- been detected in patients.321,322 Treatment involves
age. The sensitivity of the heart to even modest iron a copper-restricted diet and use of chelating agents,
loading260 might be explained by its relatively poor such as penicillamine, tetrathiomolybdate, or tri-
protectionagainstROS:cardiaccatalaseactivityislow entine(Table11.8),thatpromotecopperexcretion.Oral
and activities of SOD and GPx are only moderate. administration of zinc salts may also help, by inter-
Otherexamplesofthesensitivityofthehearttooxida- feringwiththeintestinalabsorptionofcopperandby
tive damage include the cardiomyopathy induced by raisinglevelsofmetallothionein(Section3.23.2),which
doxorubicin (Section 10.16.2) and the heart lesions in can store copper. In addition, Zn2+ ions might com-
Keshandisease(Section3.20.5.1).L-typeCa2+channels petewithcoppertopreventitsbindingtotargetsites
intheheartmaybeonerouteofentryforNTBI.The ofdamagebyRS(Table2.4).
pancreatic β-cells are often sensitive to iron and fre- ThedefectivegeneinWilsondiseaseisonchromo-
quentlydamagedinhaemochromatosis(Section9.7). some 13 and encodes a Cu2+-transporting ATPase
Evidenceconsistentwiththis‘radicalhypothesis’of enzyme, ATP7B; the gene is strongly expressed in
damageinducedbyironoverloadhasbeenobtained. liver but also in brain, cornea, spleen, and kidney.
Forexample,iron-overloadedpatientsshowincreased The ATP7B transporter helps to deliver copper to
levelsoflipidperoxidation(e.g. asF -IsoPsandLDL newly synthesized proteins in the Golgi apparatus;
2
or HDL oxidation) in plasma,315 elevated urinary F - lowplasmacaeruloplasmininWilsondiseasepatients
2
IsoPs, protein carbonyls (e.g. in islet cells), urinary is secondary to a defect in this delivery. The activ-
8OHdGand8OHG316(Section6.14),andetheno-DNA ityofEC-SOD(Section3.23.3.2)mayalsobeaffected.
adducts317(Section5.12),aswellassubnormalplasma ATP7Bisadditionallyinvolvedincopperexportfrom
levelsofcoenzymeQ,α-tocopherol,andvitaminC.318 liver into bile; impairment of this aggravates copper
Anadditionalmechanismofdamageisthelabilization accumulation.

--- Page 192 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 137
TheLong–EvansCinnamon(LEC)rathasasimilar arrangement. Binding of Cu+ is tighter than that of
mutationandaccumulatescopperintheliver,spontan- Cu2+andappearstoinvolvethreethiolateligands.The
eously developing hepatitis. This is accompanied by MTcontentoftissuescanbeincreasedbyinjectionor
increased levels of etheno-DNA adducts,323 8OHdG, oraladministrationofCd,Cu,orZnsalts,andsynthe-
and other DNA oxidation products324 and elevated sis of MTs is also increased by several hormones, in-
OH•formation.325 cludingglucocorticoids,glucagon,andadrenalin,and
by IL-1 produced during inflammation (Section 5.7).
Proposed functions of MTs include storage of heavy
3.23 Metalionsandantioxidantdefence: metalsinanon-toxicform,regulationofcellularcop-
comparingintracellularandextracellular perandzincmetabolism,andcontroloftheabsorption
strategies295 ofthesemetalsbythegut.Forexample,culturedmam-
malian cells that cannot make MTs are sensitive to
3.23.1 Theintracellularenvironment:metals injurybyCd2+ions,whereascellsoverproducingthese
andoxidativedamage proteinsareresistanttoCd2+.
Metallothioneinsmightalsoactasantioxidantsun-
Withincells,ironisinconstanttransitbetweentheLIP,
der some circumstances. Sequestration of ‘catalytic’
ferritin,andotheriron-containingproteins.Oxidative
copperwilldiminishRSgeneration,andthehighcon-
stress frequently leads to higher levels of ‘catalytic’
tentof–SHgroupsinMTsmakesthemexcellentscav-
iron(andpossibly‘catalytic’copper).Thishelpstoex- engersofONOO–,HOCl,singletO ,andOH•radicals,
2
plain why cells rely heavily on enzymes that remove
althoughthefateoftheresultingsulphur-centredrad-
O • 2 – (SODs) and peroxides (catalases, peroxiredoxins, icalsmustbeconsidered.Forexample,reactionofOH•
theGPxfamily)fortheirantioxidantdefence;itisim-
withMTcangenerateathiylradicalthatreactswithan
portanttominimizelevelsofO
•–andH
O beforethey
2 2 2 adjacentthiolateontheprotein,
comeintocontactwithtransitionmetalionsandgen-
erate more-damaging species (Table 3.6). In addition, RS • +RS–→RSSR •–→O2RSSR+O •–
excessironisstored(relativelysafely)inferritin(Sec- 2
tion3.22.4.2).Nevertheless,H 2 O 2 cannotbeeliminated orcombineswithO 2 togiveathiylperoxylradical,
becauseitisusedinsignaltransduction(Section5.5.4).
Hencesomemetal-ion-dependentoxidativedamageis RS • + O 2 → RSOO •
probablyinevitableandisdealtwithbyrepairsystems.
Metallothionein-enriched cells are generally more re-
sistanttodamagebyRS,consistentwithanantioxidant
role.326,327 However, knockout mice defective in MT-I
3.23.2 Metallothioneins
and-IIappearednormal,includingunalteredlevelsof
Metallothioneins,326 lowmolecularmass(about6500) oxidativedamage,buttheyweremoresensitivetolung
proteins encoded by genes on chromosome16 in hu- damagebyO andcellsfromthemwerealsomoresen-
3
mans,alsocontributetosafesegregationofmetalions. sitivetodamagebyCd2+,tert-butylhydroperoxide,or
They are found in all living organisms, e.g. they are paraquat.Hencethe‘antioxidant’roleofMT-Iand-II
presentinthecytosolandnucleusofeukaryoticcells, may be limited in normal animals, but could be im-
especiallyinliver,kidney,andgut.Twoisoforms,MT-I portant in situations of severe oxidative stress.326–329
andMT-II,arefoundinallanimaltissues,andathird Metallothioneinlevelsriseinbraininresponsetocold
isoform,MT-III,inbrain(aswellasMT-Iand-II)and, injury, and MT-I and -II knockout mice showed an
to a lesser extent, kidney, testis, and prostate gland. aggravatedinflammatoryresponsetosuchinjury.Sur-
Afourth,MT-IV,alsoexists. prisinglyperhaps,micelackingthebrainMT-IIIwere
Metallothioneinsarerichinsulphur(23–33%ofthe notmoresusceptible,althoughoverexpressionofthis
amino acid residues are cysteine). They are there- proteininthebrainhasbeenshowntobeprotectivein
foresignificantcontributorstototalcellularthiolcon- some other neuronal injury models.330 Increasing the
tent. Each MT molecule can bind five to seven ions levels of MT in pancreatic β-cells can increase their
of metals such as zinc (Zn2+), silver (Ag+), copper survivalwhentransplantedintoanimals.328
(Cu+),cadmium(Cd2+),andmercury(Hg2+).Binding Plants also contain metallothioneins to sequester
isachievedbyassociationofcysteine–SHgroupswith metalsand(probably)aidantioxidantdefence.Inadd-
themetalion;forexample,Cd2+andZn2+arelinkedto ition,someplantscontainsmall,cysteine-richproteins.
fourcysteinethiolateligands(Cys-S–)inatetrahedral They consist of repetitive γ-glutamylcysteine units

--- Page 193 ---

138 FREE RADICALS IN BIOLOGY AND MEDICINE
andaresynthesizedfromGSH.Thesephytochelatins and H O might (like NO•) eventually diffuse into
2 2
bind metal ions (Cd, Zn, Cu) and might also act as erythrocytesformetabolism(Table3.7).Indeed,H O
2 2
antioxidants.331 candiffuseintoandoutofanycell.However,forthese
thingstohappen,itisimportantthatO
•–andH
O are
2 2 2
stopped from forming OH•. This is achieved by the
3.23.3 Extracellularantioxidantdefence295
tight sequestration of iron (especially by transferrin)
Antioxidants in the extracellular fluids of multicellu- andcopper(byalbuminandtranscuprein),whichalso
larorganismshelptoprotectthecellswithwhichthey detersoxidationofplasmaascorbateandotherbiomol-
areincontact,e.g.seminalplasmahelpsdefendsperm- ecules.Lactoferrinmayadditionallycontributetoiron
atozoaagainstROSgeneratedbyphagocytesinsemen ion sequestration and minimizing oxidative damage,
(Section 7.11.2). They also protect constituents of the anditssecretionbyneutrophilsatsitesofinflammation
aqueousphaseofthefluids(e.g.surfactantinlunglin- may be for this purpose (Section 8.7). Any Fe2+ ions
ing fluids), as well as those of the lipid phase of the releasedintoplasmafromcelllysiswillbeassistedin
fluids,e.g.plasmalipoproteins. bindingtotransferrin(orlactoferrin)bytheferroxidase
activityofcaeruloplasmin(Section3.22.2).
3.23.3.1 Lowantioxidantdefenceenzymesand
Metal-binding antioxidant defence may be weaker
limitedmetalionavailability in some other extracellular fluids. Thus human CSF
Inanimals,onedifferencefromtheintracellularenvir- containslittletransferrin,albumin,orcaeruloplasmin
onmentisthatlevelsof‘free’ironandcopperarelow anditstransferrinisatorclosetoironsaturation(Sec-
orabsentundernormalconditionsinplasmaandmost tion10.17.5).Synovialfluidhaslowerconcentrationsof
other extracellular fluids (Section 3.22.4.2). A second albumin,transferrin,andcaeruloplasminthanplasma
is that extracellular fluids generally contain little or (Section10.11).Thefluidsthatlinetherespiratorytract
nocatalase.Thetracesofcatalasesometimesdetected havealowproteincontent(mainlyalbumin,butsome
may have leaked from cells, since slight haemolysis transferrin),butcancontain‘free’iron(Section7.3).
iscommonduringcentrifugationofbloodforprepar-
3.23.3.2 Extracellularsuperoxidedismutase
ationofplasma.Theremaybeatleastoneexception:
an old report that catalase is present in human and Of the limited SOD activity present in extracellular
other animal oviductal fluids and may help protect fluids, some is CuZnSOD and some MnSOD. Both
thespermtransientlyresidingthere.332Themucuslin- might arise, at least in part, by leakage of enzymes
ing the respiratory and gastrointestinal tracts (Table fromdamagedcells.However,mostextracellularfluid
3.7) may contain catalases, peroxiredoxins, and other SODactivitybelongstoadifferenttypeofCuZnSOD,
peroxidasescontributedbylysisofshedcells;indeed calledextracellularSOD(EC-SOD)333,334,oftencalled
damage to underlying cells may ‘automatically’ in- SOD3. Plasma EC-SOD levels show a large interspe-
creasetheantioxidantdefenceofextracellularfluidsby cies variation. For example rabbits, rats, mice, and
releasingGSH,ascorbate,SODs,GPx,thioredoxin,and guinea pigs have levels one or two orders of magni-
peroxiredoxins.295,301 tudegreaterthanpigs,dogs,andhumans.EC-SODis
LevelsofGSH,SOD,andGPxarealsogenerallylow synthesizedandsecretedbysmoothmusclecellsand
inextracellularfluids,exceptthatthefluidliningthe fibroblasts, especially in the vascular system. Copper
lowerpartoftherespiratorytracthashighGSHlevels isdonatedtoitbyacopperchaperoneknownasAtox1
(Table3.4).AlthoughthereisaplasmaGPx,itsrolein (‘antioxidant1’).
vivoisuncertainsinceitssubstratesarepresentonlyat Extracellular SOD has a higher relative molecular
lowlevels(Section3.14.1).Celldamagecouldincrease mass (about 135,000) than CuZnSOD and is a tetra-
substratelevels,ofcourse. meric glycoprotein, each subunit containing one Cu
In spite of these low levels of antioxidant defence ion and one Zn ion. Like SOD1, EC-SOD can be in-
enzymes, O •– and H O are constantly generated in activated by CN– or by excess H O . The subunit
2 2 2 2 2
bloodbyactivatedphagocytes,xanthineoxidase,and structure and mechanism of O
•–
dismutation closely
2
other mechanisms. Sometimes these RS act as use- resemblethoseofSOD1anditseemslikelythattheEC-
ful signals, e.g. low localized levels of H O may SODgeneevolvedbyaduplicationoftheSOD1gene,
2 2
facilitatecellproliferation(Section5.2.1),NO• synthe- followed by various modifications. There are several
sis (Section 2.5.6.4), the aggregation of platelets (Sec- isoformsofEC-SOD(A,B,andC);BandCbindtohep-
tion 8.10.7), and adherence of phagocytes to vascular arin,CmoretightlythanB.InA,theheparin-binding
endothelium(Section8.7.3).Inwholeblood,excessO
•–
domainsattheCterminalregionsofallfoursubunits
2

--- Page 194 ---

ANTIOXIDANT
DEFENCES
SYNTHESIZEDINVIVO
139
Table3.7 Extracellularantioxidantdefences.295
Defence Modeofaction Comments
Transferrin,lactoferrin Bindironandstopitspro-oxidantactivity. TheseproteinsarenoteasilydamagedbyH2O2,HOCl,ONOO–,orlipid
peroxides;onlyreleaseironionsatacidicpH.
Caeruloplasmin CatalyticallyoxidizesFe2+toFe(III)withoutreleaseofoxygenradical Acute-phaseprotein,plasmalevelsriseindisease(Section5.7.4).
intermediates.ReactsstoichiometricallywithO
•–;reportsofgreater
O
•–-scavengingactivitymaybeduetocontami 2
nationwithEC-SOD;see
2
FreeRadic.Biol.Med.2,255,1988).Inactivatesmyeloperoxidase.
Erythrocytes CantakeupO •
2
–andH2O2formetabolismby H2O2generatedinbloodcouldsimilarlydiffuseintoplatelets,phagocytes,
SOD/catalase/GPx1/peroxiredoxins189andNO•foroxidationby endothelialcells,etc.formetabolism.
haemoglobin,whichcanalsoconvertNO–
2
toNO•whenO2levelsarelow.
Albumin Bindscoppertightlyandironweakly.Presentathighconcentrationsin Liversynthesisandplasmaconcentrationdropduringillness,the‘negative
plasma.Possiblesacrificialantioxidant;rapidlyscavengesseveralROS acute-phaseresponse’(Section5.7.4).
includingHOClandONOOH.Provideshigh–SHlevelinplasma.Bindshaem
andPUFAs,canhelpprotectPUFAsagainstoxidation.Carriesbilirubin.
Haptoglobin/haemopexin Bindfreehaemoglobin/haemanddecreasetheirpro-oxidantability. Acute-phaseproteins.Haptoglobinalsosuggestedtohavechaperone
activity (Section5.7.4;J.Biol.Chem.288,32326,2013).
Urate InhibitslipidperoxidationandscavengesRS. Canalsobindironandcopperions.Urateradicalispotentiallydamaging,
butcanberemovedbyascorbate.ReactionofuratewithONOO–produces
someNO•.
EC-SOD ScavengessomeO
•–.
Section3.23.3.2.
2
ExtracellularGPx Roleunclear,possiblyinvolvedinbloodcoagulation. Sections3.14.1and3.14.4.
α-Tocopherol Lipid-solublechain-breakingantioxidant. Section4.3.Importantinprotectinglipoproteinsagainstoxidation.
CoenzymeQalsopresentinlipoproteins,insmalleramounts(Section10.3).
Glucose ScavengerofOH•radical;rateconstantcomparablewiththatofmannitol, Normalplasmaconcentrationaround4.5mM,greaterafter
butcanexertpro-oxidanteffectsbyglycationofproteins(Section10.5). carbohydrate-containingmeals.
Bilirubin Postulatedantioxidant. Hasantioxidantpropertiesbutisalsoasensitizerof1O2production,andits
oxidationproductsmaybevasoactive.Possiblyneuroprotectiveatlow
levels,buttoomuchisneurotoxic(Section3.25.1).
Mucus(insurfacelayerofcellsin Mucusanditscontents(e.g.themucusglycoproteins(mucins)and Thecellularglycocalyxcanalsobesubjecttooxidativeattack,butthismight
respiratoryandgastrointestinaltracts) componentsfromlysedcells)canrapidlyscavengeHOCl,OH•andONOOH protecttheunderlyingcellmembrane(e.g.Am.J.Physiol.304,G57,2013).
toprotecttheunderlyingtissue.301MucussecretionisstimulatedbyROS
(Sections7.3.2and9.13.3).

--- Page 195 ---

140 FREE RADICALS IN BIOLOGY AND MEDICINE
are removedby intracellular proteolysisbefore secre- 3.23.3.3 OtherextracellularSODs
tionoftheenzyme,inBfromonlysomeofthesubunits
Several parasites, examples being Taenia, Trichinella,
andinCfromnoneofthem. Theheparin-bindingdo-
Leishmania, Schistosoma, and Ascaris species, secrete
main allows EC-SOD to bind to glycosaminoglycans,
SOD1(andsometimesotherantioxidantproteinssuch
and the protein fibulin 5 (which is closely associ-
as FeSOD and peroxiredoxins) onto their surfaces,
atedwithelastin)alsohelpstobindEC-SODtoblood
presumably to protect them against damage by host
vessels. phagocytes.14,337 FungisuchasCandidaalbicansattach
Asaresult,mostEC-SODinvivo(>90%)isbound
proteins similar to SOD1 to their external surfaces,
to the tissue interstitium and to cell surfaces, largely
to protect them against attack by phagocytes. One
by association with glycoproteins, especially in lung,
of these SODs (SOD5) contains copper but not zinc
cartilage(Section10.11.1),kidney,uterus,andarterial ions.338
walls. For example, human thoracic aorta has fairly
low SOD1 activity, but a comparable level of EC-
3.23.3.4 Bindinghaem
SOD (Table 3.1). This is unlike most tissues, where
CuZnSOD is the major contributor to total SOD (it’s
andhaemoglobin291,295,339,340
in a different place of course!). Injection of heparin Haemandhaemproteins,potentialpro-oxidants(Sec-
into animals produces a rise in plasma EC-SOD, by tion 3.22.3), are often released from damaged cells,
displacingtheenzymesfromthematrix. such as lysed erythrocytes. Indeed, injected haem or
Extracellular SOD may serve to minimize inter- erythrocytelysatearepro-inflammatoryinanimals341
action of O •
2
– and NO• to form ONOO–, especially andhaemmaycontributetothepathologyofsepsis.286
insituationssuchashypertensionwhenvascularO •
2
– Inerythropoiesis,ahaemexportprotein(FLVCR)isre-
production is increased (Section 8.10.4). Indeed, in- quiredtomaintainthecorrecthaemlevelsandprotect
creasedNO• levelsmayhelptotriggerincreasedEC- thecellsagainstdamage;thisproteinisalsofoundin
SOD biosynthesis. Transgenic mice lacking EC-SOD macrophagesinthereticuloendothelialsystemsandin
appear normal but they developed more lung dam- severalothertissues.342
ageanddiedfasterwhenexposedtopureO 2 ,showed Fortunately, plasma contains the haemoglobin-
greater lung inflammation when exposed to 1.5 ppm binding haptoglobin proteins (from the Greek
ozone,hadaggravatedjointinflammationincollagen- haptein, to bind), as well as a haem-binding protein
inducedarthritis(Section10.11),andimpairedangio- (haemopexin). Binding of haemoglobin to hapto-
genesis in some animal models. Be cautious though, globins, or of haem to haemopexin, decreases their
it has been claimed that EC-SOD may have anti- effectiveness in stimulating lipid peroxidation. The
inflammatoryeffectsunrelatedtoO • 2 –-scavenging(Sec- haemoglobin–haptoglobinorhaem–haemopexincom-
tions 8.9.4 and 10.11.4). Extracellular SOD knockout plexes are then removed from the circulation.
micealsodisplaymildlyimpairedlearningandmem- Macrophagesinliverandspleenplayakeyroleinup-
ory functions under certain experimental situations takeanddegradationofthehaemoglobin–haptoglobin
(althoughtheeffectsvariedwithanimalage),andmore complex,whichbindstotheCD163receptor(aclassB
braindamageaftercerebralischaemia.334,335However, scavengerreceptor;Section10.3.4)onthesecells.Itis
too much EC-SOD can also impair memory (Sec- internalized, the protein degraded in lysosomes, and
tion5.5.10). the haem broken down by haem oxygenase (Section
Of course, knockout animals may have adapted to 3.24).Thehaem–haemopexincomplexistakenupby
the loss of EC-SOD (Section 3.7.2.1) so as to show the liver via the CD91 receptor and then degraded.
a limited or no phenotype under normal conditions. Haemopexin must also cope with haem exported
Consistentwiththis,acutereductionofEC-SODlevels duringerythropoiesis,aspreviouslymentioned.
inadultmiceproducedsignsofO 2 toxicityeveninam- Haptoglobinisanacutephaseprotein(Section5.7.4),
bientair.336 Ahumanpolymorphism(2–6%ofadults) mainly synthesized in the liver but also in the lung
is known in which a single base substitution causes andafewothertissues.Itisinitiallysynthesizedasa
an arg → gly transition in EC-SOD, affects heparin singlepolypeptidechain,whichisthencleavedintoα
binding, and elevates plasma EC-SOD level, presum- andβchainslinkedbydisulphidebonds.Thegeneen-
ablyalsodecreasingtissuelevels.Therearenoobvious codingitonchromosome16(inhumans)has2alleles
physiological consequences, although increased risks (1or2),givingrisetohomozygous(1-1,2-2)orhetero-
ofacutelunginjuryduringinfectionandofischaemic zygous(2-1)genotypes.The2alleleencodesalonger
heartdiseasehavebeensuggested. protein, with the result that the finished haptoglobin

--- Page 196 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 141
has longer α chains. Haptoglobin 1-1 is a tetramer of attack by RS, including methionine and histidine. In-
two α and two β subunits, connected by disulphide deed, HOCl-modified albumin has been detected in
bonds,whereastheHp2-2and2-1typescanformmore human atherosclerotic lesions (Section 10.3.5.1). Al-
disulphidebonds,leadingtomultimericproteinsinthe bumin can additionally react with aldehydes gen-
circulation. The distribution of these alleles varies in erated during lipid peroxidation, such as HNE
differentcountries.Toillustrate,inCaucasianstheap- (Section5.12.5).
proximatefrequenciesofHp1-1,Hp2-1,andHp2-2are Rats unable to synthesize albumin show increased
about15,50,and35%,whereasinHanChinesetheyare levels of plasma cholesterol ester hydroperoxides
9,35,and55%,i.e.the2-2formismorecommon.Hp1- and decreased levels of ascorbate and ubiquinol.348
1 is better in vitro at inhibiting haemoglobin-induced In dialysis patients or subjects with advanced liver
lipid peroxidation than are Hp2-1 or Hp2-2, and it is disease, plasma albumin showed decreased levels
cleared more rapidly from the circulation. Indeed, it of –SH groups and increased levels of bityrosine
has been suggested that the presence of Hp2-2 is a and protein carbonyls (biomarkers of oxidative pro-
risk factor for cardiovascular disease in diabetic pa- tein damage; Section 6.16). Considerable oxidation of
tients(Section10.3.5.1),andmayinfluenceresponseto albumin–SH groups has also been reported in sep-
administrationofascorbate(Section4.2). sis and acute respiratory distress syndrome (ARDS)
Haptoglobin- or haemopexin-knockout mice seem patients (Section 10.8). Exercise has also been re-
normal, but suffer worse renal damage and oxida- ported to cause transient albumin oxidation (Sec-
tive stress during haemolysis than do controls.343 tion7.14.1).An‘ischaemia-modified’albumin,appar-
After acute haemolysis, haemopexin levels increased entlyarisingfromoxidativedamage,hasbeendetected
in haptoglobin-null mice, and haptoglobin increased in the plasma of patients with a range of diseases
inhaemopexin-lackingmice.Doubleknockoutsagain (Section6.16.7).349
appearednormal,butdevelopedspleenenlargement, All these observations are consistent with an anti-
liver inflammation, and fibrosis after a haemolytic oxidantroleforalbumin,althoughtherearealsosug-
event.344 Plasma α -microglobulin, a member of the gestions that oxidized albumin (including albumin
1
lipocalin protein family, can also bind haem, as can treated with HOCl or HOBr) may be toxic to vas-
albumin.345 cular endothelium and could provoke phagocyte RS
production.347,350,351 Fatty acids attached to it might
3.23.3.5 Albumin110,295,346,347 also oxidize to produce cytotoxic products. Oxidized
Albumin hasmultipleroles,e.g. itmaintainsosmotic albuminisprobablyremovedbyphagocytesandendo-
pressureandtransportsbilirubin(Section3.24.1),hor- thelialcellsusingscavengerreceptors(Section10.3.4).
mones,andfattyacidsintheblood.However,itcould Afewcases(<100todate)ofhumananalbuminaemia
also be an important extracellular antioxidant (Table (lessthanonepermillionbirths)duetomutationsin
3.7).Itbindshaem(lessstronglythanhaemopexinand thegeneonchromosome4thatencodesalbuminhave
doesnotpreventhaem’spro-oxidantactionsaseffect- been reported. As in the rat, analbuminaemia is not
ively,butitisingreatmolarexcessoverhaemopexin life-threatening but parameters of oxidative damage
soitscontributioncouldbesignificant).Albuminalso havenotbeenstudied.Levelsofseveralotherplasma
binds copper ions, protecting more important targets proteinsareelevatedinthiscondition.
(e.g. LDL) against damage. Albumin contains an ex-
3.23.3.6 Artefactswithalbumin
posed cysteine –SH group (position 34 in the human
protein),contributingupto500μMto‘totalplasmathi- Studies of antioxidant (or toxic) effects of albumin in
ols’.Somestudiessuggestthatupto30%ofthisexists cellcultureorinvivomustbearinmindthatcommer-
as mixed disulphides with GSH, cysteine, or homo- cialalbuminpreparationsareoftenpartiallyoxidized
cysteine,andpossiblyasmallamountisnitrosylated. at Cys34 (to sulphenic, sulphinic, or sulphonic res-
Albumin–SHreactsquicklywithONOOH,NO
•
,CO
•–,
idues), aggregated (e.g. by disulphide cross-linking)
2 3
HOCl, chloramines, RO • , and RO•, and slowly with andcontaminatedwithendotoxinandmetalssuchas
2
H O . Given its high concentration, albumin may be iron,copper,andvanadium.352 Sometimestransferrin
2 2
a major ‘sink’ for HOCl, HOBr, ONOO–, and pos- contaminationispresent.353Nevertheless,infusionsof
sibly H O generated in plasma. The pK of the –SH albumin have been used for over 50 years for main-
2 2 a
groupisabout8.0andtheresultingconsiderableion- tainingplasmavolumeandtotreathypoalbuminaemia
izationatpH7.4facilitatesreactionwithH O .Other and hyperbilirubinaemia. The clinical benefit of al-
2 2
amino acid residues on albumin are also subject to bumin infusion in sepsis, stroke, or ARDS patients

--- Page 197 ---

142 FREE RADICALS IN BIOLOGY AND MEDICINE
(Section 10.8) continues to be debated, especially if cellsoftheliverandinthebonemarrowandspleen,
oxidizedalbuminreallyistoxic.352 tobreakdownhaemfromtheprocessingofworn-out
red blood cells. Humans, or knockout mice lacking
3.24 Haemoxygenase354 HO-1,showanaemiaandtissueironaccumulation,as
wellaslowplasmabilirubin,indicativeofthekeyrole
Haem oxygenase (HO) enzymes are found in almost of HO-1 in iron metabolism. Carbon monoxide plays
allspeciesandcatalysethebreakdownofhaemtobili- some roles as a signalling molecule, not only in the
verdin,releasingironionsandcarbonmonoxide(Fig. carotid body but elsewhere in the body, e.g. in liver
3.20). This widespread distribution suggests that the andbrain.
needtodegradeunwantedhaemaroseearlyinevolu- Haem oxygenase enzymes remove a pro-oxidant
tion.Biliverdinisconvertedtobilirubinbytheenzyme (haem)whilstgeneratingapotentialantioxidant(bili-
biliverdinreductaseinthecytosol.Threeisoformsof rubin) and another pro-oxidant (iron ions), so we
HOhavebeencharacterizedinanimals(includinghu- are not quite sure whether to classify them as
mans); one is a constitutive isoform (HO-2) present antioxidants.295Howeverinmostanimalstudies,they
normally in several tissues, mostly in the ER. In the seem to be. For example, the brains of mice lacking
carotid body (Section 1.3.2), HO-2 is involved in O HO-2showedincreasedlevelsofHNE,anend-product
2
sensing; it degrades haem and forms CO that keeps of lipid peroxidation.356 Mice lacking HO-1 are more
K+channelsopen.Inhypoxia,COformationslows,K+ susceptible to inflammation and hypoxia (which in-
channelscloseandtriggeranalarmsignalforthebody ducesHO-1innormalanimals),butparadoxicallythey
thatincreasesrespirationrates.355 sufferedlesslungdamagewhenexposedtopureO
2
.357
Another form of HO is a ‘stress-inducible’ isoform Studies on several cell types, including endothelial
(HO-1), identical to the heat shock protein, Hsp32 and skin cells, show that induction of HO-1 by ex-
(Section 5.6). Its levels are increased by a wide range posing them to haem is accompanied by a rise in
of stimuli in various cell types, including free haem, ferritin; if this is prevented, exposure of the cells to
certain metal ions, hypoxia, H 2 O 2 , heat shock, and haem sensitizes them to H 2 O 2 . Hence HO must co-
selected cytokines (Sections 5.6 and 5.7). In addition, operate with systems to sequester the released iron
HO-1isnormallypresentathighlevelsintheKupffer inordertoachievecellprotection.Normally,theiron
M V
O 2 CO,Fe Biliverdin
N M V M Ce Ce M M V
M M
N Fe N
Ce V Haem
N oxygenase O N H N H N H N H O
NADPH
Ce M
Biliverdin
Haem
reductase
NADP+
M V M Ce Ce M M V
O N N N N O
H H H H H
Bilirubin
Figure3.20 Haemdegradationbyhaemoxygenases.AdaptedfromAm.J.Respir.Cell.Mol.Biol.15,9,1996,bycourtesyofDrAugustineChoi
andthepublishers.Haemoxygenaseenzymesaremixedfunctionoxidasesthatusehaemasbothsubstrateandprostheticgroup.NADPH-
cytochromeP450reductasereducestheactivesite-haemtoFe2+,whichthenbindsO2.TheFe2+–O2complexthengeneratestheoxidizingspecies,
aferricperoxide(Arch.Biochem.Biophys.544,87,2014).V,vinylgroup;M,methylgroup;Ce,propionylgroup.

--- Page 198 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 143
released by HO activity acts through the IRPs (Sec- proteinssuchasmyoglobin,catalase,andcytochromes.
tion 3.22.1.5) to increase ferritin synthesis. Studies on Over 270 mg of bilirubin is produced daily in the
transplanted hearts and blood vessel grafts showed averageadulthuman.
that increasing levels of HO-1 in the organ or vessel Bilirubin is insoluble in water at physiological pH
improve outcome, but the protection could be mim- and binds tightly to albumin in a 1:1 stoichiometry.
icked by brief exposure to CO, apparently because Thisbindingpreventsuptakebyextra-hepatictissues,
CO suppresses phagocyte infiltration/activation and particularlylipid-richorganssuchasthebrain,anddir-
fibroblast proliferation. In addition, when CO binds ectsbilirubintotheliver.Therethealbumin–bilirubin
to the haem groups of haemoproteins, their degrad- complex dissociates, bilirubin enters the hepatocyte
ationbyoxidativedamageisslowed.Insomesystems, through a carrier protein and binds to cytosolic pro-
bilirubin and/or biliverdin might contribute to pro- teins, mainly GSTs. Bilirubin undergoes conjugation
tection(Section3.25.1).354,358 InductionofHO-1inthe in the ER with glucuronic acid, forming mono- and
lung plays a role in hyperbaric O preconditioning diglucuronides which are water-soluble and excreted
2
(Section3.7.5).80 in the bile. Impaired conjugation leads to jaundice in
Haem oxygenases can be inhibited by zinc or tin prematurebabies(Section2.6.4).
protoporphyrin,widelyusedtostudytheroleofHO. In vitro, bilirubin can scavenge several RS, includ-
For example, pretreatment of rats with haemoglobin ingONOOH,RO • ,RO•,andsingletO Bilirubinhas
2 2.
toinduceHO-1decreasedthelethalityofsubsequent been proposed to be converted to biliverdin under
endotoxintreatment,buttinprotoporphyrinprevented oxidative stress, which can be recycled by biliverdin
this.359 However, these agents are not specific. For reductase(Fig.3.20).360 However,theexistenceofthis
example,tinprotoporphyrincandecreasecaspaseac- bilirubin–biliverdincyclehasbeenchallenged;358 bili-
tivitiesandinhibitapoptosis(Section5.4.2). rubin is more likely to be degraded to a range of
oxidation products, the biopyrrins (Section 6.13).361
Bilirubin bound to albumin can protect albumin it-
3.25 Antioxidantprotection
selfandalbumin-boundfattyacidsagainstfree-radical
bylow-molecular-massagents damage.
synthesizedinvivo Suggestions that bilirubin is an important anti-
oxidant in vivo were initially based on experiments
Several small molecules are thought to be important showing protective effects in cultured cells, but sev-
antioxidants. Some are made in vivo (such as GSH), eral animal studies have since been published. For
others obtained from the diet. The latter are con- example,bilirubinadministrationdecreasesoxidative
sidered in Chapter 4, but let us consider some of the damage and tissue injury in rats with experimental
former here. Compounds in this category discussed autoimmuneencephalitis,andinvariousanimalmod-
elsewhere in this book include taurine and hypo- els of organ transplantation and graft rejection.358,362
taurine(Section8.7.5),plasmalogens(Section5.12.8.1), Urinaryexcretionofbilirubinoxidationproductswas
coelenterazine and coelenteramine (Section 8.6), and reported to be elevated in septic patients, and after
tryptophan-derivedproducts(Section8.4.2) myocardial ischaemia–reperfusion in rats, consistent
withanantioxidantrole.361,363 Severalstudiessuggest
that low serum bilirubin levels are associated with
3.25.1 Bilirubin354,356,358
increased risk of coronary heart and respiratory dis-
Since we have just described HO, let’s first look at eases,atheroscleroticvasculardisease,andstroke,but
its product, bilirubin (Fig. 3.20). Biliverdin is blue- whyisuncertain.358 Isitbilirubinitself,orisitslevel
green, whereas bilirubin is bright yellow. Hence the merely an index of too little (cytoprotective) HO ac-
colour of a bruise changes from reddish brown (ex- tivity, or both perhaps? The former is suggested by
travascularhaemoglobin),throughgreenishtoyellow theobservationthatpatientswithGilbertsyndrome,
asthetissueheals.Biliverdinreductaseisnotpresent who have higher blood bilirubin levels than normal,
inbirds,reptiles,andamphibians,sotheyexcretebili- alsohavebetterendothelialfunctionandlowerlevels
verdin instead. About 80% of the bilirubin produced of serum malondialdehyde (MDA), serum MDA-
inmammalsarisesfromHO-dependentcatabolismof modified LDL, and urinary 8OHdG excretion than
haemoglobinfromsenescentredbloodcells,byreticu- controls.364
loendothelialcellsin thespleen,liver,andbonemar- Do not forget, however, that bilirubin can sensitize
row. The rest comes from breakdown of other haem formation of singlet O 2 in the presence of light, and

--- Page 199 ---

144 FREE RADICALS IN BIOLOGY AND MEDICINE
high levelsin prematurebabies aretoxictothebrain aswouldbeexpectedsinceitcontainsaphenolic–OH
and other tissues (Section 2.6.4), e.g. it can suppress group which in melatonin is blocked by methylation
immunecellfunction.362 Lowerlevelsmaybeprotect- (Fig.3.21).372
ive,however(Section7.11.8.4).Oxidativedegradation Nevertheless, there are several reports of benefits
of bilirubin can produce potentially toxic vasocon- of melatonin administration in oxidative stress situ-
stricting compounds, which have been detected in ationssuchasischaemia–reperfusionandintransgenic
CSFfrompatientsaftersubarachnoidhaemorrhage,365 miceoverexpressingAPP(Section10.21),371plussome
andadministeringbilirubintomicesensitizedthemto ‘noeffect’reports.373Melatoninseemsunlikelytoexert
injurybygammaradiation.366 directantioxidanteffectsinanimals,andmayinstead
actbyincreasingthelevelsofantioxidantdefenceen-
zymes,suchasGPxandγ-GCS,aswellasdecreasing
3.25.2 α-Ketoacids
productionofcytokinesandiNOS.
Several keto acids, including pyruvate, glyoxylate
(OHC.COOH), and α-ketoglutarate react non-
3.25.4 Lipoicacid
enzymically with H O and act as ‘H O scavengers’
2 2 2 2
when they are added at mM levels to cell cul- Lipoic acid, 1,2-dithiolane-3-pentanoic acid (some-
ture media.367 They can also scavenge HOCl and timescalledthiocticacid),374isanessentialcomponent
ONOOH, at least in vitro. Indeed, decarboxylation of (as the R-stereoisomer of its amide form, lipoamide)
α-ketoglutarate has been used as an assay for H 2 O 2 of the pyruvate and α-ketoglutarate dehydrogenase
(Section 6.11). Whether RS scavenging by keto acids multi-enzymecomplexes(Fig.1.7).Itissynthesizedin
occurs in vivo in animals is uncertain. Pyruvate is mitochondria,butcanalsobeabsorbedfromthegut.
an important metabolic substrate for the early hu- Both the oxidized (disulphide) and reduced (dithiol;
man embryo and might also act as an antioxidant to Fig.3.21)formsoflipoicacidshowantioxidantproper-
some extent (Section 7.11.5). Indeed, in 1987, it was tiesinvitro;theycanscavengeRO • ,HOCI,CO •–,NO • ,
2 3 2
proposed that cells under oxidative stress release OH•, and ONOOH, and bind iron and copper ions,
pyruvate to act as an extracellular H 2 O 2 scavenger368 decreasingtheirpro-oxidantpotential.
and HepG2 cells have been reported to increase Withareductionpotential(E◦(cid:4))of–0.32V,dihydrol-
α-ketoglutarate production in culture, possibly for ipoate (DHLA) is a powerful reducing agent. Thus
the same reason.369 Similarly, Pseudomonas fluorescens it can reduce GSSG to GSH, dehydroascorbate to as-
exposed to H 2 O 2 altered its metabolism to generate corbate,andα-tocopherylradicaltoα-tocopherol,the
more α-ketoglutarate.370 There has been interest in latterbothdirectlyandviaascorbate(Section4.3).In-
using ethyl pyruvate or salicylate–pyruvate esters as deed,administrationoflipoicacidreversessomeofthe
cytoprotectiveagents(Section11.8). effects produced by α-tocopherol deficiency in mice,
anddecreasedtheincidenceofcataractinmicetreated
3.25.3 Melatonin371 withBSOtoinhibitGSHsynthesis.Invivo,lipoicacid
is converted to DHLA by lipoamide dehydrogenase
Mostmelatoninisproducedbythepinealglandatthe enzymesattheexpenseofNADHorNADPH.Gluta-
baseofthebrain,butsmallamountsaremadeinsome thione and thioredoxin reductases may also act on
othertissues.Italsooccursinsomefoods,anexample lipoicacid.
beingwalnuts.Melatoninregulatescircadianrhythms, Levelsof‘free’lipoicacid/DHLAinanimaltissues
andhasbeenpopularizedasacurefor‘jetlag’.Itarises andbodyfluidsarelow,soitisunlikelytobeanim-
bymethylationandacetylationofserotonin(Fig.3.21); portantendogenousantioxidant.However,itsrangeof
bloodlevelsofmelatoninarelowduringthedayand antioxidant properties and ability to regenerate other
increase at night as its pineal synthesis accelerates. naturallyoccurringantioxidantshaveledtoattempts
Melatonin shows modest antioxidant activity in vitro to use it as a therapeutic antioxidant, e.g. to treat
(probablybydonationofhydrogenbytheNHgroup) diabeticneuropathy(Section10.24and11.5.9).Indeed,
andcaninhibitmyeloperoxidase,butonlyatconcen- lipoateisfoundinmanydietary‘antioxidant’supple-
trations some orders of magnitude higher than those ments on the market and has even been speculated
presentinvivo(whichare<1nM).Itsprecursor,sero- tobean‘antiageing’molecule,atleastindilapidated
tonin, is a better lipid peroxidation inhibitor in vitro, rats(Section11.4.5).Lipoicacidisprotectiveinvarious

--- Page 200 ---

OH
CH
3
HO
17β–Oestradiol
CH O
3
RO(cid:129)
2 + RO H
2
H+
(cid:129)O
Phenoxyl
HO
radical
17β–Oestrone
CH
3 OH
OH
HO
17β–Oestriol
HO H 3 CO
CH CH NH CH CH NHCOCH
2 2 2 2 2 3
N N
H H
Serotonin Melatonin
S S SH SH
CH *CH
2H+,2e–
CH CH
2 2
CH CH CH CH CH COOH CH CH CH CH CH COOH
2 2 2 2 2 2 2 2 2 2
Lipoic acid Dihydrolipoic acid
O COOH
H
C (β a -a rn la o n s y in l- e L-histidine) H 2 NCH 2 CH 2 CNHCHCH 2 N
N
O COOH
H
Homocarnosine H 2 N(CH 2 ) 3 CNHCHCH 2 N
(γ-amino butyryl-L-histidine)
N
O COOH
CH
3
Anserine H 2 NCH 2 CH 2 CNHCHCH 2 N
(β-alanyl-3-methyl-L-histidine)
N
O
OCH
Mycosporine–glycine 3
CH
2
HO NH
HO
CH
2
CO H
2
Figure3.21 Structuresofsomeputativeantioxidants.Inlipoamidethe–COOHgroupbecomes–CONH2.Themetabolismofoestrogensisshown
inFig.10.20.∗Representsthechiralcentreinlipoicacid.

--- Page 201 ---

146 FREE RADICALS IN BIOLOGY AND MEDICINE
animal models, e.g. of ischaemia–reperfusion: it may consistent with the view that CoQ can exert antioxi-
act by direct scavenging of RS, by raising levels of dant effects in at least some organisms.379 It could
ascorbateorbyinteractingwiththeNrf2system(Sec- decrease lipid oxidation in the aortas of rabbits, for
tion 5.5.8) to raise levels of GSH. The R-stereoisomer example (Section 10.6.5). Some scientists have sug-
oflipoicacidalsoseemstopromoteglucoseuptakeby gested that the ratio of ubiquinol to ubiquinone in
muscleandpossiblybrain. humanplasmamaybeanindexofoxidativestress,al-
Ofcourse,theuseofthiolsasantioxidantsshouldbe thoughcaremustbetakeninmeasuringthisbecause
undertakenwithconsiderationofthethiylandoxysul- ubiquinol readily oxidizes in vitro, and more work
phur radicals that can be produced (Section 2.5.5). is required to validate this approach.380 Coenzyme Q
In addition, large doses of lipoate in rats raised the administration appears to have a limited degree of
levelsofserumhomocysteine,375anagenttoxictovas- benefitinpatientswithdiabetes381 andcertainneuro-
cular endothelium (Section 4.7). Lipoic acid has add- degenerativediseases(Section10.17.6.7),althoughitis
itionaleffects:highdosesinratslowerfoodintakeand uncertainifthisisduetoantioxidantor‘mitochondria-
body weight, by increasing the activity of the AMP- protecting’effects,both,orneither.
activated protein kinase (AMPK) enzyme in muscle
but lowering it in hypothalamus. It also has a mild
analgesiceffect,duetoitsabilitytoblockvariousion
3.25.6 Uricacid
channels.376 Hence,neverassumethatanyeffectsthat
lipoatehasareduetoantioxidantmechanisms. Uricacidisproducedfromhypoxanthineandxanthine
byXOandXDHenzymes(Section1.10.1).Atphysio-
logical pH almost all uric acid is ionized to urate,382
3.25.5 CoenzymeQ
bearingasinglenegativecharge,sincethepK ofuric
a
Coenzyme Q377 is essential in mitochondrial electron acid is around 5.7. Hence we call it urate from now
transport (Fig. 1.7), undergoing oxidation and reduc- on. Urate has limited solubility in water: excess pro-
tion via a free-radical intermediate, ubisemiquinone duction in vivo can lead to crystallization from body
(CoQH•). It is also found in other cell membranes fluids.
and in lipoproteins. In vitro, ubiquinol (CoQH 2 ) can In most species, the H 2 O 2 -producing peroxisomal
•
scavengeRO radicalsandinhibitlipidperoxidation, enzyme urate oxidase converts urate to allantoin,
2
RO • +CoQH →RO H+CoQH • which is further converted to allantoate and then
2 2 2 gloxylateplusurea,allproductsmuchmoresolublein
For example, the ubiquinol content of LDL affects waterthanisurate(Fig.3.22).However,humansand
their resistance to peroxidation (Section 10.3.8). Ubi- otherprimateslackafunctionalurateoxidasegene;a
quinolcanregenerateα-tocopherolfromitsradicalin similar DNA sequence is present in the human gen-
lipoproteinsandmembranes, ome, but a stop codon is present in one of the exons
α-Toc • + CoQH → CoQH • +α-TocH andthedefectivegeneisnottranscribed.Urateoxidase
2 activityisthusabsentandurateaccumulatesinblood
•
The rate constant for scavenging of RO by CoQH plasmatohighconcentrations,usually0.2to0.4mM.
2 2
is about one-tenth that of α-tocopherol. It follows Urateisalsopresentintracellularlyandinotherhuman
that tocopherol recycling is probably more important bodyfluidsincludingmilk,respiratorytractliningflu-
•
than direct scavenging of RO by CoQH , since the ids, saliva, synovial fluid, and tear fluid, usually at
2 2
α-tocopherolandcoenzymeQlevelsinmostcellmem- lowerlevelsthanplasma(e.g.100–200μMinsaliva).
branes (but not in LDL; Section 10.3.8.2) are broadly Releaseofuratefromdamagedcellsleadingtoforma-
comparable. tionofsodiumuratecrystalsisoneofthefactorsthat
Thecontributionofubiquinoltoantioxidantdefence help to provoke an immune response.383 This is well
in vivo is uncertain. It may be especially important illustratedingout,adiseaseoftentreatedwithallopur-
in mitochondria, where the electron transport chain inol(Fig.1.10).Theexcruciatinglypainfulcharacterof
can easily reoxidize/re-reduce CoQH•. The enzyme attacksofgouthasbeenrecognizedsinceancienttimes
DT-diaphorase(Section9.5.4)canalsoreduceCoQto andafflicted(tonamebutafew)theRomanemperor
CoQH ,ascanthioredoxinreductase.378Nevertheless, Claudius,HenryVIII,andBenjaminFranklin.Indeed,
2
a CoQ-deficientstrain of S. cerevisiae was abnormally urate oxidase ‘knockout’ mice show elevated plasma
sensitivetodamagebyoxidationproductsofPUFAs, urateanddevelopkidneystones.384

--- Page 202 ---

Adenine and guanine
Hypoxanthine, Xanthine
Oxidation (XDH, XO)
O
H
HN N
O
–O N N
H
Urate
O
Oxidation (Urate oxidase) 2
HO
2 2
O OH
H
C N
HN
RS O–
O N N
us HIU
o
ne
o
nta
HIU hydrolase
s p H2O
–OOC OH
H
–OOC OH
H
H2N N H
2
N N
O O
O N N O N N
H H
us OHCU
o
nta
ne
CO
2
OHCU decarboxylase
o
p
s
O H
Racemic allantoin H 2 N N
O
O N N
H H H
Hydrolysis S-(+)-Allantoin RS
Allantoin
RS RS
HOOC H N O HO N OH
N NH N NH
HOOC-CH(-NH-CO-NH 2 ) 2 O OH O H N O
Allantoic acid Oxonic acid Cyanuric acid O + H 2 N-C-NH 2
Hydrolysis O NH Urea
Parabanic acid
O
HN-C-NH HOOC-CHO
2 2
Non-enzymic degradation
Urea Glyoxylic acid
O O
Oxidation (enzymic)
HN-C-NH-C-COOH
2
HOOC-COOH
Oxaluric acid
Oxalic acid
Figure3.22 Pathwaysofuricacidformationanddegradation,bothenzymicandnon-enzymic.Urateisformedbyenzyme-catalysedbreakdownof
unwantedpurinesandisreleasedintotheblood.Oxidationbyurateoxidaseinitiallyforms5-hydroxyisourate(HIU),whichthenspontaneously
formsallantoin;thisreactioncanalsobecatalysedbyenzymes.HIUmaycauselivercancerinmiceifallowedtoaccumulate(Proc.Natl.Acad.Sci.
USA.107,16625,2010).Someurateisexcretedinurine,butthekidneysreabsorbmuchofitandreturnittotheblood(Nature415,393,2002).
DiagramsadaptedbycourtesyofDrH.KaurandDrRPercudani(alsoseeNatureChem.Biol.2,144,2006;Org.Biomol.Chem.9,5149,2011and
Chem.Biol.Interac.73,235,1990).XDH,xanthinedehydrogenase;XO,xanthineoxidase;RS,reactivespecies,OHCU,2-oxo-4-hydroxy-4-carboxy-
5-ureidoimidazoline.

--- Page 203 ---

148 FREE RADICALS IN BIOLOGY AND MEDICINE
Losing urate oxidase is obviously risky, given the were infused with a urate oxidase preparation, their
propensity of urate to produce stones and cause urate levels were substantially lowered, but F -IsoP
2
inflammation. Various explanations have been pro- levelsdidnotdrop,nordidplasmaproteincarbonyls
posed,includingaputativeroleofurateinimproved change.388 Doesthiscastdoubtonthehypothesisthat
regulation of blood pressure or in fat storage during urateisanimportantantioxidantinvivo?Maybe,but
timesoffoodshortage.385 In1981,Amesetal.386 poin- infused urate oxidase will generate H O during its
2 2
tedoutthaturateisapowerfulscavengerofRSinvitro, action,apossibleconfoundingfactor.Uratemayalso
proposedthatitfunctionsasabiologicalantioxidant, beusedasanantioxidantininsects(Section7.6).
and further suggested that loss of urate oxidase was Reaction of urate with Cu2+, haem proteins plus
advantageoustoprimates,sinceitsimultaneouslyre- H O ,RO • ,OH•,ONOO–,tyrosyl,andtryptophan
2 2 2
movedasourceofH O (urateoxidase)andallowed radicals generates urate radical, as mentioned
2 2
apowerfulantioxidanttoaccumulate.Indeed,several above.382,389 This is not a very reactive radical but
RS,suchasOH•andRO • ,oxidizeurateintoafreerad- not necessarily innocuous either, since it has been
2
ical, which also bears a single negative charge at pH shown in vitro to lead to inactivation of some pro-
7.4,sinceitspK is3.1.Theunpairedelectronisdelocal- teins, such as α -antiproteinase.390 This may not be a
a 1
izedoverthepurinering,givingaresonance-stabilized significant problem in vivo however; inactivation of
radicalwhichdoesnotreactrapidlywithO toforma α -antiproteinase can be prevented by the simultan-
2 1
peroxylradical.382UrateisapowerfulscavengerofO eouspresenceofascorbate.390 Thereductionpotential
3
•
andNO andmayhelptoprotecttherespiratorytract of the urate/urate radical system at pH 7 is 0.59 V,
2
againsttheseoxidizingairpollutants(Section7.3).Ur- which is considerably higher than that of ascorbate
ateisasubstrateforoxidationbyhaemprotein/H O (E◦(cid:4)=–0.28V). Hence ascorbate would be expected to
2 2
systems such as myoglobin/haemoglobin/H O or reduce the urate radical, and this has been demon-
2 2
MPO(Section6.13),andmightbeabletoprotectother strated experimentally (second-order rate constant
biomoleculesagainstoxidativedamagebybeingpref- ~106M–1s–1).Urateradicalcanalsobereducedinvitro
erentiallyoxidized.Uratealsoprotectsproteinsagainst byseveralflavonoids(rateconstants~106 M–1s–1)and
nitration on addition of ONOO–; its reaction with reacts rapidly (k = 8 × 108 M–1s–1) with O •– to form
2
ONOO– is complex and produces some nitroso com- a peroxide that may then break down to regenerate
poundsthatdecomposetoreleaseNO•plustriuret,387 urateandO .391,392
2
Therehavebeensuggestionsthathighplasmalevels
ofurateareriskfactorsforcardiovasculardiseaseand
stroke, or alternatively that they are protective, e.g.
•
triuret carbonyl radical (-NH-C =O), and aminocar- againststrokeorParkinsondisease(Section10.20).In-
bonylradical. deed, in one population of patients with stroke there
wasaU-shapedassociation:thosewithurate<280μM
or>410μMhadworseoutcomes.393Infusionofurate
hasneuroprotectiveeffectsinsomeanimalmodels,ap-
Triuretcanbedetectedinhumanurine(Section6.13). parently by scavenging394 ONOO–-derived products.
Urate can also chelate metal ions: it binds iron and Indeed,infusionofurateintohumansdecreasedrises
copper ions in forms apparently poorly reactive in inF 2 –IsoPscausedbysevereexercise(Section7.14),al-
catalysing free-radical reactions, although it can also thoughtheseresultshavebeenquestioned395 because
reduce Cu2+ to Cu+ and stimulate LDL oxidation in of the use of an ELISA assay rather than mass spec-
vitro(Section10.3.8). trometry(Section6.15.6)tomeasureF 2 -IsoPs.Indeed,
The high levels of urate in vivo make a role in urate (infusion of one gram into the bloodstream) is
scavenging some RS feasible. This is supported by inclinicaltrialforthetreatmentofstroke,theURICO-
observations that levels of products of urate degrad- ICTUSstudy.396
ation by RS, especially allantoin (Fig. 3.22), increase
inconditionsassociatedwithoxidativestress,suchas 3.25.7 Histidine-containingdipeptides397,398
Wilson disease, Down syndrome, haemochromatosis,
rheumatoidarthritis,prematurebirth,andinintensive Manymammaliantissues,especiallymuscleandbrain,
exercise (also see Section 6.13). However, patients contain mM concentrations of dipeptides, composed
sufferinggouthadelevatedplasmaF -IsoPlevels(this of histidine attached to another amino acid (Fig.
2
couldbeinflammation-related,ofcourse).Whenthey 3.21).TheyincludeL-carnosine,homocarnosine,and

--- Page 204 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 149
anserine. In humans, pigs, and turkeys, carnosine is Enzymes(carnosinases)thathydrolysethesedipep-
more common than anserine, whereas the reverse is tides are present in various tissues.397,409 Some are
trueforchickensandrabbits(don’taskuswhy;no-one just ‘general dipeptidases’, but others may be more
knows!). Carnosine levels in rat and human muscles specific.409 Ithasbeensuggestedthatgeneticvariants
decline with age (Section 11.4). Humans can absorb in these enzymes, helping to raise plasma carnosine
carnosineandtheotherdipeptidesfrommeat(theori- levels,mayprotectagainstdiabeticnephropathy,and
ginofitsname)inthediet(chickenbreastextractisa variations in carnosine levels have been linked to
goodsourceofcarnosineandanserine)aswellasmake various other diseases. Better evidence is required
itthemselves.399 to confirm these associations.410 D-carnosine, a much
In vitro, these dipeptides can exert antioxidant poorer substrate for carnosinases, has been proposed
effects.397,398,400 For example, the imidazole ring che- fortherapeuticuse(Section11.5.6).
lates copper ions and can prevent copper-dependent
oxidative damage. They are weak inhibitors of lipid 3.25.8 Trehalose(α-D-glucopyranosyl-(1→1)-α-
peroxidation;claimsofgreaterinhibitoryeffectsareof- D-glucopyranoside)411
tenduetotheabilityofthesecompoundstointerfere
Some bacteria, insects (e.g. Anopheles gambiae), yeasts
with measurement of lipid peroxidation by the TBA
(including S. cerevisiae and Candida albicans), brine
test (Section 6.15.8).400 Contamination of commercial
shrimp(Section8.5.2),andafewplants(e.g.the‘resur-
carnosinepreparationswithhydrazine,apowerfulre-
rectionplants’)accumulatethedisaccharidetrehalose,
ducingagentthatreactsrapidlywithaldehydes,may
also have led to overestimation of carnosine’s anti-
oxidanteffects.401Ironically,histidylhydrazideisnow
being tested as a therapeutic agent (Section 11.5.6).
Nevertheless,thepurifieddipeptidesareabletoscav-
•
enge RO and singlet O . They also react with cyto-
2 2
toxicend-productsoflipidperoxidation,suchasHNE
andacrolein,398 someoftheproductsofreactionwith
carnosinebeingexcretedinmouseandhumanurine.402
They react with HOCl to form chloramines, which
have much lower reactivity than does HOCl itself or onexposuretoenvironmentalstresses(e.g.heat,des-
histidine chloramines (Section 2.6.3).403 Indeed, histi- sication),apparentlytoprotectproteinsandotherbio-
dine alone promotes404 iron ion-dependent lipid per- molecules against denaturation and aggregation. The
oxidation in vitro and enhances the toxicity of H O bond between the two glucose units of trehalose is
2 2
to mammalian cells in culture;405 the latter perhaps verystable.Inaddition,attheveryhighconcentrations
because histidine can form a hydrogen-bonded che- that accumulate in vivo (up to 500 mM), trehalose
latestructurewithH O .406 Sincethesedipeptidesdo may exert radical-scavenging (e.g. OH•) properties.
2 2
not exert such ‘pro-oxidant’ effects, they may repre- Indeed,trehalosehasbeenusedasaprotectiveagent
sent ‘safer’ ways of accumulating histidine at high for biological specimens undergoing electron micros-
levels for use as an intracellular buffer (the histidine copy. Consistent with this ‘antioxidant’ role, yeast
imidazole ring has a pK of about 6) and, perhaps, cells unable to make trehalose are hypersensitive to
a
copper ion chelator.400 One exception: both histidine oxidativeproteindamageonexposuretoH 2 O 2 .
andthedipeptidescanaggravateOH•productionfrom Trehalose is not made in animals, but its admin-
H O bynickelions(Section9.16.3).Anothersugges- istration in high doses to rodents in the drinking
2 2
tion is that these dipeptides help to protect proteins waterappearstostimulatetherateofautophagy(Sec-
against glycation, since carnosine is rapidly glycated tion 5.14.3.1). Indeed, protective effects of trehalose
uponincubationwithhighlevelsofglucose(orother havebeenreportedinseveralanimalmodelsofneuro-
sugars) in vitro.398 Carnosine also protects proteins degenerativedisease(e.g.Section10.23.2).
against damage by methylglyoxal (Section 3.15.1).398
Raising the muscle content of carnosine in human 3.25.9 Melanins:hair,skin,corals,fungi,
volunteers by feeding β-alanine has been claimed to andfish412,413
improve exercise performance, although perhaps by
counteringacidosisratherthanbyaffectingoxidative Melanins (from the Greek word melanos, ‘dark’) are
damage.407,408 pigments,foundthroughouttheanimalkingdomand

--- Page 205 ---

150 FREE RADICALS IN BIOLOGY AND MEDICINE
insomefungi,thatareformedbyoxidationandpoly- andthenoxidizeL-DOPA(Fig.3.23).Assemblyofmel-
merizationoftyrosine.Inhumanstheyareespecially anin occurs upon a scaffold of the Pmel17 protein,
importantintheskin,hair,andeye(Sections7.10and whichalsosequestersthereactiveintermediatestopro-
7.13).Melaninsaremadeinmelanosomes(Fig.3.23). tectotherpartsofthecell.414Tyrosinehydroxylaseen-
The first steps are catalysed by tyrosinases, copper- zymes,iron-containingproteins,assistinL-DOPAfor-
containing enzymes that convert tyrosine to L-DOPA mation. The end-products of polymerization contain
Tyrosinase
COOH O COOH
HO NH 2 O O NH 2
2
Tyrosine Dopaquinone (DQ)
+ Cysteine
– Cysteine
Tyrosinase
O 2 HO HO COOH HOOC
H H O O NH C 2 OOH HO N H COOH H2 H N O S NH2 + H 2 N HO S COOH
Cyclodopa NH
Dopa HOOC HO 2
O 5-S-Cysteinyldopa 2-S-Cysteinyldopa
COOH (5-S-CD) (2-S-CD)
–O N+ DQ
H
Dopachrome
Dopachrome tautomerase Dopa
(Tyrp2) HOOC
O COOH H 2 N S
NH + O COOH
O 2
CO H 2 N S O NH 2
HO 2 HO HOOC CD-quinones
COOH
HO N HO N
H H
HO COOH (HOOC)
S
5,6-Dihydroxyindole 5,6-Dihydroxyindole-2-
NH N COOH
(DHI) carboxylic acid (DHICA) N 2 +
S NH
(HOOC) HO 2
O O
2 2 1,4-Benzothiazine Intermediates
DQ
Tyrp1 (DHICA oxidase)
Dopa (O)
or Tyrosinase
Eumelanin Pheomelanin
Figure3.23 Biosynthesisofmelanin.Thecomplexreactionpathwaysinvolvebothenzyme-catalysedandnon-enzymicreactions.Melaninis
producedbyorganellescalledmelanosomesinspecializedcellscalledmelanocytes.Melanosomescanremaininthesecells,orbetransferredto
othercells.Thefirststepineumelanogenesis,aftertheproductionofdopaquinone(DQ),involvesitsspontaneouscyclizationtoproducecyclodopa,
whichthenrapidlyundergoesaredoxreactionwithanotherDQmoleculetoproduceonemoleculeeachofDOPAchromeandDOPA.DOPAchrome
thenspontaneouslydecomposesbydecarboxylationatneutralpHtoform5,6-dihydroxyindole(DHI)and5,6-dihydroxyindole-2-carboxylicacid
(DHICA),ina70:1ratio.However,inthepresenceofanenzymespecificallyproducedinmelanocytestermedDOPAchrometautomerase(DCT),
alsoknownasTYR-relatedprotein-2(Tyrp2),DOPAchromeundergoestautomerizationtoproduceDHICA.TheratioofDHICAtoDHIinnatural
eumelaninsisthusdeterminedbytheactivityofDCT.Finally,DHIandDHICAarefurtheroxidizedandpolymerizedtoformeumelanins.DQ,the
branchpointbetweeneumelaninandpheomelanin,canalsoreactwithcysteine.Variousmutationscanleadtoalbinism;sufferersareproneto
photochemicaldamagetotheskinandshowimpairedeyefunction.Forexample,mutationsthatinactivatetyrosinaseresultinabsenceofmelanin
inskin,eye,andhair(HumanMutation13,19,1999).DiagramandtextadaptedfromPhotochem.Photobiol.84,582,2008andExpertRev.
Dermatol.6,97,2011,bycourtesyofDrShosukeItoandTheAmericanSocietyofPhotobiology,DrVincentJ.Hearing,andExpertReviewsLtd.
TYR,tyrosinase.

--- Page 206 ---

ANTIOXIDANT DEFENCES SYNTHESIZEDINVIVO 151
high concentrations of o-quinone (oxidizing) and o- organisms.Theymayplayseveralmetabolicroles,in
hydroquinone(reducing)groups,aswellassemiquin- additiontoUVphotoprotection.419,420
ones,andmanyunpairedelectrons.Henceonecanre-
gardmelaninsaslargefreeradicals;indeed,theyhave 3.26 Antioxidantdefence:aquestion
astrongESRsignal.Themovementofunpairedelec-
ofsex
tronsbetweendifferentenergylevelshelpsmelanins,
especially the brown or black eumelanins, to absorb Inalladvancedcountrieswomenlivelongerthanmen,
visible and ultraviolet light. Illumination of melanins on average. The same is true of many, but not all,
generates O
•–
within the molecule, but this is usu- animal species. Multiple explanations have been ad-
2
allyquicklyscavenged;O
•–
canreducemelaninquin- vanced, some of which involve antioxidant defences.
2
ones to semiquinones, and oxidize hydroquinones, Thusincertaininterventionstudieswithdietaryanti-
alsotosemiquinones(Section2.5.3.5).Hence,overall, oxidants, women showed less benefit than men (Sec-
eumelanins can act as ‘sinks’ for O
•–
and other rad- tion4.6),suggestingbetterantioxidantstatus.Female
2
icals (OH•, RO • etc.). Melanins also bind transition rodents are less sensitive to hyperoxic lung injury
2
andothermetalions;forexample,thebindingofiron than males.79 Levels of oxidative damage products,
ionstoneuromelaninisrelevanttoParkinsondisease 8OHdG and F -IsoPs, are reported as lower in wo-
2
(Section10.20). men in some (not all) studies.421,422 IsoP levels were
The red-brown or yellow pigment found in the also lower after brain injury in females,423 and it has
skin and hair of fair-skinned, red-headed humans is evenbeenclaimedthatoxidativestresslevelsarenega-
pheomelanin, which appears less good as a radical tively correlated with the physical attractiveness of
scavenger and can even sensitize skin cells to oxida- men (to women).424 Testosterone aggravates O tox-
2
tive damage and promote the development of mel- icityandcastratedmaleslivelonger(ordoesitjustfeel
anomas under certain circumstances.415 On exposure like longer?); although castration increases free rad-
of pheomelanin to strong light it is degraded, and ical production in the prostate gland (Section 8.10) it
formationofRO • 2 andsingletO 2 occurs.416Pheomelan- decreases it elsewhere in the body.425 Women show
ins contain cysteine, which reacts with dopaquinone lowerbodyironstoresuntilafterthemenopause(Sec-
togivecysteinylDOPAs(Fig.3.23).Thusthesupply tion 11.4.10); in one large study, premenopausal wo-
of GSH/cysteine in the melanocyte helps determine men excreted less 8OHdG in urine than men, but
whetherpheomelaninsoreumelaninsform.Totakean postmenopausalfemalesexcretedmore.422Femaleani-
example,inhibitionofGSHsynthesisbyBSOingreat malshaveshownlessdamagetovarioustissues(e.g.
tits (Parus major) led to larger black breast stripes.417 brainandheart)afterischaemia–reperfusionthanmale
Sequestrationofmetalionsbymelaninscouldconceiv- animals,andadministrationof17β-oestradiolisneuro-
ably contribute to antioxidant defence, but the metal protectiveinanimals,perhapsbydecreasingNADPH
ionsareprobablystillredox-activeandcoulddamage oxidaseactivity,426whichisintimatelyinvolvedinthe
the melanin itself if, e.g. H 2 O 2 were present. Indeed, outcomeofstroke(Section10.18.3).
the‘pro-oxidant’effectofilluminatedpheomelaninin The female sex hormones oestradiol, oestrone, and
vitroseemedtoinvolveironionsboundtoit.416 oestriolcaninhibitlipidperoxidation(includingLDL
High levels of melanin contribute to the resistance peroxidation)invitro,becausetheypossessphenolic–
of some pigmented fungi and of the cancer melan- OHgroupsandcanactaschain-breakingantioxidants
oma to ionizing radiation. For example, melanized (Fig. 3.21). In general, however, the concentrations
cellsofthepathogenicfungusCryptococcusneoformans of hormones needed to inhibit peroxidation in vitro
aremoreresistanttokillingbyRSthannon-melanized are in the μM range, much larger than the physio-
cells.418 Overall, however, the physiological import- logical(pM)range.Inaddition,thephenoxylradicals
anceofmelaninsasantioxidants(apartfromtheir‘sun- producedduringantioxidantactivity(Fig.3.21)arere-
screen’roleinskinandeyesofcourse!)isuncertain. activeandcapableofdamagingproteinsandDNA427
Severalmarineorganisms(includingcoralsandcer- (againperhapsunlikelytoberelevantatphysiological
tainfish)appeartoprotectthemselvesagainstUVlight levels, although it could contribute to the cancers in-
byusingUV-absorbingmycosporine-likeaminoacids ducedinrodentsbytreatmentwithhighlevelsofthese
such as mycosporine glycine (Fig. 3.21). These are hormones [Section 10.15.1.1]). The synthetic oestro-
synthesizedbysomebacteria,fungi,andalgae,andin- gendiethylstilboestrolisapowerfulinhibitoroflipid
gestedandaccumulatedbysomefishandothermarine peroxidationatμMconcentrationsinvitro,althoughit

--- Page 207 ---

152 FREE RADICALS IN BIOLOGY AND MEDICINE
iscarcinogenicinhumans,427,428i.e.goodantioxidants In ovariectomized animals there is considerable
invitro arenotnecessarilygoodforyou! bone loss, apparently related to decreased antioxi-
Oestrogens at physiological levels may not act as dantdefencesandincreasedROS,promotingbonere-
direct antioxidants, but instead by decreasing ROS absorption(Section8.10.8).ThusROScouldcontribute
production and raising the levels of antioxidant en- toosteoporosis,thebone-thinningdiseasethatplagues
zymes.ThusmitochondrialH O productionappears manyelderlyladiesandsomemen.430Short-termhor-
2 2
lowerinfemalethaninmalerats,butisincreasedby mone replacement therapy decreased levels of lipid
removal of the ovaries (ovariectomy).429 Female rats peroxidation,asmeasuredbyF -IsoPs,inhumanvo-
2
also show higher levels of some antioxidant defence lunteers,althoughitslong-termeffects(e.g.increased
enzymes, such as MnSOD and GPx1.429 By contrast, cancerrisk)427continuetobeasubjectofdebate.How-
some assays reveal a lower total plasma antioxidant ever,oestrogensandtheir‘antioxidant’effectscannot
capacity in human females, although the physio- bethewholestory,becauseinsomeanimalsthereisno
logical significance of this parameter is uncertain differenceinlongevitydespitehigheroestrogenlevels
(Section6.17.3). infemales.

--- Page 208 ---

CHAPTER 4
Antioxidants from the diet
Sometimesscientificprogressisnotbasedonadiscoveryorthegenerationofnewdatabutonachange
ofviewpointthatallowsonetoseeasetofalreadyexistingdatainanewlight.
MichaelReth
4.1 Introduction human populations is related to lower all-cause
mortality.1,3,4
Thatfoodandhealthareintimatelylinkedisanancient Fruitsandvegetablesareimportantsourcesofmany
concept: in 400 BC the physician Hippocrates wrote, nutrients,fibre,andotheragents,yetattentioniscom-
‘letfoodbeyourmedicineandmedicinebeyourfood’ monlyfocusedontheantioxidantstheycontainasthe
(he liked giving apples and dates to his patients!). likelyagentsprotectiveagainsttheabovediseases.The
In particular, it is widely believed that diets rich in viewthatdiet-derivedantioxidantsaccountforthepro-
fruitsandvegetablesplayakeyroleintheprevention tectiveeffectsoffruitsandvegetablesaroselargelyfrom
of human disease, hence the ‘five a day’ campaigns epidemiological studies showing inverse correlations
in many countries. Indeed, a recent comprehensive ofbloodantioxidantlevels(ordietaryantioxidantin-
review1 concluded that there is convincing evidence takes)withtheriskofdeveloping(or,insomestudies,
thatincreasingtheconsumptionofvegetablesandfruit dyingfrom)variousdiseases.However,attemptstoval-
reducestheriskofourdevelopinghypertension,cor- idateacause–consequencerelationshipbyintervention
onary heart disease, and stroke. It further concluded studies(supplementingsubjectswithantioxidantsand
thatitislikelythattheriskofcanceringeneral(some observingeffectsondiseaseoutcome)haveproduced
specific cancers more than others e.g. stomach rather confusionratherthanenlightenment.Also,evenifan
thanbreast)decreaseswithincreasedconsumptionof ‘antioxidant’isfoundtopreventadisease,itmustnot
vegetablesandfruit.Inaddition,thereisevidencethat beassumedthatitdoessobyanantioxidantmechan-
anincreasedconsumptionofvegetablesandfruitmay ism. For example, flavonoids in red wine, chocolate,
preventbodyweightgain.Asobesityisakeyriskfac- andcocoahavebeensuggestedtobebeneficialtothe
torfortype2diabetesmellitusandalsoassociatedwith vascularsystem,butflavonoidscanexertbiologicalef-
oxidative damage (Section 10.4),2 an increased con- fectsotherthanantioxidantones(Section4.5).Similarly,
sumption of vegetables and fruit might therefore in- thejuryisstilloutonwhetherornotbeneficialeffects
directlyreducetheincidenceofthiscondition.1 Apart ofmoderatewinedrinkingaredueonlytothealcohol
from this, there is little evidence that increased con- rather than to the polyphenols (Sections 4.5 and 9.8).
sumptionoffruitsandvegetablesdecreasestheriskof Inaddition,manyothernutrientsaffectoxidativedam-
type2diabetes.1Thereissomeevidencethatincreasing age and antioxidant defences, e.g. a high fat diet can
theconsumptionofvegetablesandfruitlowerstherisk promoteliverdamageandatherosclerosisinsomeindi-
of certain eye diseases, dementia, and osteoporosis. viduals.WeexaminealltheseconceptslaterinChapter
Likewise,currentdataonasthma,chronicobstructive 4, but let us begin by describing the molecules most
pulmonarydisease,andrheumatoidarthritisindicate commonlyidentifiedaskeydiet-derivedantioxidants.
that an increase in vegetable and fruit consumption Infact,properantioxidantdefencerequiresmanynu-
may contribute to the prevention of these diseases.1 trientsnotcommonlyidentifiedas‘antioxidants’,i.e.a
Overall, higher fruit and vegetable consumption by balancednutritiousdietisrequired(Table4.1).
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 209 ---

154 FREE RADICALS IN BIOLOGY AND MEDICINE
Table4.1 Diet,oxidativedamage,andantioxidantdefenceinhumans.
Typeoflink Constituent Neededfor
‘Antioxidantnutrients’ VitaminC(Section4.2),vitaminE(Sec- Regulatingoxidativedamage,othermetabolicprocesses.
tion 4.3), carotenoids (Section 4.4),
flavonoids and other phenols (Section
4.5), possibly ergothioneine, histidine-
containingdipeptidesandcoenzymeQ
(Section3.25)
Agentsindirectlyinfluencing Fe Catalase,peroxidases,preventionofhypoxia(O2transportby
antioxidantdefences/oxidative haemoglobin,O2sensing,O2storagebymyoglobin),nitricox-
damage idesynthases(antioxidantpropertiesofNO•,Section2.5.6).
Both Fe deficiency and Fe overload can promote oxidative
damage(Sections3.22.1.5and3.22.5.1).
Mn MnSOD.
Cu CuZnSOD,EC-SOD,caeruloplasmin,hephaestin.
Both Cu deficiency and Cu overload cause oxidative stress
(Sections3.22.2and3.22.5.5).
Zn CuZnSOD, EC-SOD, NOS, metallothionein, glyoxalase, mem-
brane stabilization, displacement of Fe2+ from sites of pro-
oxidant action (replacing it by non-pro-oxidant Zn2+), com-
ponent of some transcription factors, p53, endonuclease IV.
Zn2+ can be toxic in excess, including neurotoxicity (Sec-
tions9.16.12,10.18.3.1,10.18.4,and10.21.3).
Mg Cofactorformultipleenzymes(e.g.inpentosephosphatepath-
way).Magnesiumdeficiencyinanimalscausesinflammation,
increasesoxidativedamage,anddecreasesGSHlevelsinsev-
eraltissues(e.g.Cardiovasc.Res.31,677,1996;FreeRadic.
Res.41,981,2007;IntJ.Clin.Exp.Med.4,103,2011).
Aminoacids/proteins Synthesisofantioxidantdefenceenzymes,metalbindingpro-
teins,albumin(as‘sacrificialantioxidant’;Section3.23.3.5),
GSH,e.g.dietaryproteinintakecanaffectratesofsynthesis
ofGSH(Am.J.Clin.Nutr.80,107,2004).β-alanineisapre-
cursorofcarnosine,whichcanitselfbeabsorbedfromthediet
(Sections3.25.7and7.14.1.1).
Riboflavin Glutathionereductase(FADcofactor)andmanyotherflavopro-
teins,e.g.essentialforcorrectmitochondrialelectrontransport
andfattyacidoxidation.
Thiamine Key component of pyruvate and α-ketoglutarate dehydro-
genases. Also used in transketolase, an enzyme in the
pentosephosphatepathway;thispathwaysuppliesNADPHfor
the glutathione and thioredoxin systems (Section 3.10.2.1).
Thiamine deficiency in animals causes neuronal and cardiac
damage accompanied by oxidative stress (Neurobiol.Aging
30, 1587, 2009; Neurochem.Int.62, 796, 2013; Am.J.
Physiol.298, H2039, 2010), and accumulation of methyl-
glyoxal (FEBSLett.579, 5596, 2005). Excess alcohol con-
sumptioncanlowerthiaminelevelsandcausebraindamage
(Wernicke’sencephalopathy)partlyduetooxidativestress;
Metab.BrainRes.28,387,2013.
Selenium GPxenzymes,thioredoxinreductases,methioninesulphoxide
reductases, selenoprotein P, other selenoproteins. Excess Se
canbedeleterious(Section3.20.5).

--- Page 210 ---

ANTIOXIDANTS FROM THE DIET 155
Table4.1 (Continued)
Typeoflink Constituent Neededfor
Nicotinamide/Nicotinicacid(niacin)- NAD+,NADP+,NADPH,NADH:energymetabolism,Ca2+storage,defence
vitaminB3 against infection (e.g. by NADPH oxidases), repair of DNA, PARP (Sec-
tion5.2.5),glutathioneandthioredoxinreductases,aldehydereductases,
maintainingcatalasefunction(Section3.17),regulatessirtuinswhichcanin
turnaffectantioxidantdefencessuchasMnSOD(Section11.4).Somestudies
suggestbeneficialeffectsofincreasedintake(e.g.J.Appl.Physiol.116,156,
2014),butaddinglargeamountsofnicotinamidetothedietsofratsimpaired
glucosetoleranceandinsulinsensitivityandincreasedlevelsofoxidative
damage(Br.J.Nutr.110,2156,2013).Highdosescausea‘flushreaction’in
humans,markedcutaneousvasodilation,duetoanactiononTRPV1channels
(Section10.24).
Folicacid,vitaminB6(pyridoxine) Minimizelevelsofplasmahomocysteine—ariskfactorforcardiovascular
disease.InvolvedinBH4metabolism,toolittleBH4cancauseNOSuncoupling
(Section2.5.6).
VitaminA SeeSection5.12.6.
VitaminD Deficiencysuggestedtocauseoxidativestress(J.Pediat.161,848,2012;
FreeRadic.Biol.Med.65,324,2013).
Inducersofantioxidantdefences Agentsthatincreaseexpressionofgenesencodingantioxidantand/orother
defencesystems(Section5.5.8).
Polyunsaturatedfattyacids Essentialinthehumandiet.Rapidlyoxidizeinvitro(e.g.infoods)butmay,
overall,decreaseoxidativedamageinvivo(Table4.5).
Totalcaloricintake Caloricrestrictioncanimproveantioxidantdefenceandlowerlevelsofoxi-
dativedamage(Section11.4);2highfatdietsandobesitycanraiselevelsof
oxidativedamage(Sections9.8and10.4).
Ethanol Lowlevelsmaybebeneficial:excessintakedamagesmanybodytissues,and
oxidativedamagecontributestothis(Section9.8).
AlsoseeTable4.5.
4.2 Ascorbicacid(vitaminC)5-8 during evolution, and so need ascorbate in the diet.
Gulonolactoneoxidasecatalysesthereaction,
Ascorbicacidisawhitecrystallinesolid,verysoluble
inwater.Itwasfirstisolatedfromadrenalglands,cab-
bages,lemons,andorangesasan‘acidiccarbohydrate’
L-gulono-γ-lactone+O
2
→ L-ascorbate+H
2
O
2
bySzent-Györgyiin1928.Hisfirstpaperdescribingit
wasrejectedbytheBiochemicalJournalbecausetheedi- ItispresentintheliverERinmammals,andsometimes
tordidnotlikethesuggestednameignose(from‘Idon’t inothertissuesaswell.NotethatH O isproduced,so
2 2
know’ and –ose for carbohydrate). Godnose was also thathighratesofascorbatesynthesisinanimalscould,
unacceptable,andeventuallytheyagreedonthename paradoxically, impose oxidative stress.9 By contrast,
hexuronic acid. Good dietary sources of vitamin C in- theterminalstepofascorbatesynthesisinplantsdoes
cludeoranges,lemons,guava,berries,mango,broccoli, notmakeH O (Section7.8.7).Anextensivelymutated
2 2
andpeppers. andinactiveformoftheL-gulonolactoneoxidasegene
Ascorbic acid has two ionizable –OH groups ispresentinthegenomeofhumansandtheotherspe-
(Fig.4.1).SincepK a1 is4.25andpK a2 isover11.5,the ciesmentionedabove.Inabilitytomakeascorbate(like
monoanionisfavouredatphysiologicalpH.Hencewe thelackofurateoxidase;Section3.25.6)isauniversal
usethenameascorbatefromnowon.Plantsandmost inbornerrorofmetabolisminhumans.
animals can synthesize ascorbate starting from glu- Ascorbateinanimalsisacofactorforatleasteight
cose,buthumans,otherprimates,guineapigs,teleost enzymes, of which the best known are the prolyl
fish(e.g.zebrafish),andfruitbatslosttheenzymere- and lysyl hydroxylases involved in collagen biosyn-
quiredfortheterminalstep(L-gulonolactoneoxidase) thesis, and the prolyl and asparagine hydroxylases

--- Page 211 ---

156 FREE RADICALS IN BIOLOGY AND MEDICINE
OH OH OH
HO 6 CH C 5 2 H -O 4 3 O 2 1 OH O - + e e –, – , - H + + H+ HO CH C 2 H O O (cid:129) O O + -e e – – HO CH C 2 H O O O O
Ascorbate Ascorbate radical Dehydroascorbate
(Asc(cid:129)–)
COOH
CHO C O
Several breakdown products O C -CO 2 C O
(e.g. 2-furoic acid, 3-hydroxy-2- H C OH H C OH
pyrone, oxalate, threonate)
HO C H HO C H
CH 2 OH CH 2 OH
Xylosone 2,3-Diketo-L-gulonic acid
Figure4.1 Structureofascorbateanditsoxidationanddegradationproducts.AtphysiologicalpHtheacidformislargelyionized(ascorbate)
sincethepKa1ofascorbicacidis4.25.Diketogulonatereadilyspontaneouslydegradestoamixtureofspecies,includingoxalate,thefour-carbon
sugarthreonate,andthe5-carbonxylosone,see5,6andBiochem.J.440,375,2011;Anal.Biochem.265,238,1998.ThepHandotherreaction
conditionsinfluencetheproductsformed.Someyeasts(e.g.S.cerevisiae,C.albicans)andfungioftencontainD-erythroascorbate,inwhichthe
side-chainis–CH2OHratherthan–CHOHCH2OH.Ithassimilarbiochemicalpropertiestoascorbate;theterminalstepinitssynthesisalsoinvolves
anH2O2-producingenzyme,D-arabinono-1,4-lactoneoxidase(Mol.Microbiol.30,895,1998).
thatcontributetoO sensing(Section1.3.2).Allcontain vividdescriptionofthediseaseandafurtherindication
2
ironionsattheiractivesites.Collagensynthesizedin thatplantscouldhelp:7
theabsenceofascorbateisinsufficientlyhydroxylated
anddoesnotformfibresproperly,givingrisetopoor Here a sharp, cold wind blows that must carry pestilence
wound healing and fragility of blood vessels. Ascor- withit,especiallyinpersonswornoutandfatiguedwiththe
hardshipsofthenavigation.Thefirstsymptomispaininthe
bateisalsorequiredbythecopper-containingenzyme
dopamine-β-hydroxylase, which converts dopamine whole body that makes it sensitive to touch; purple spots
begin to cover the body, especially from the waist down;
into noradrenalin. Two enzymes in the biosynthesis
thenthegumsbecomesoswollenthattheteethcannotbe
of carnitine, a cofactor important in fat metabolism,
broughttogetherandtheycanonlydrinkandfinally,theydie
requireascorbate.Otherascorbate-requiringenzymes allofasudden,whiletalking.Fortunately,thesealldiedafter
are involved in tyrosine metabolism and in the add- havingconfessedandreceivedextremeunction.Noordinary
itionofamidegroupstopeptidehormonestostabilize medicinesgaveanyreliefinthisdisease.
them. But,whilesomeofthepatientswerestillsurviving,anap-
Deficiency of ascorbate in the human diet causes parentmiracleoccurredandtheVirginMary,towhomthey
scurvy,anoldEnglishwordformerlyappliedtosome- hadbeenpraying,cametotheirrelief.Whilesomeofthesol-
one in a very scruffy condition.7 In 1536, the French dierswereashoreburyingtheirdead,onetookinhismouth
with some difficulty what the natives called a ‘jocoistle’ or
explorerJacquesCartiervividlydescribedthisdisease,
‘mancaniilla’,thelocallyeatenfruitofacactustree,andhe
which afflicted all but ten of the 110 men aboard his
felt that it had a good flavor and helped his condition, so
ships wintering in the frozen St Lawrence river: ‘The
thatheatemore,andtheyallbegantoeatthemandbring
victims’ weakened limbs became swollen and discol- thembackonboardsothat,afteranothertwoweeks,they
oured,whilsttheirputridgumsbledprofusely’.Nearly wereallhealed.
30 years later, the Dutch physician Ronsseus advised
thatsailorsconsumeorangestopreventscurvybutnot In 1639, one of England’s leading physicians,
manypeoplelistened.In1602therewasanevenmore John Woodall, recommended lemon juice as an

--- Page 212 ---

ANTIOXIDANTS FROM THE DIET 157
antiscorbutic. James Lind, a Scottish naval surgeon, importantingettingascorbateintotissues(exceptred
wasthefirstmaninmedicalhistorytoconductacon- blood cells; Section 7.4.3). For example, mice lacking
trolledclinicaltrial;inMay1747,hetestedavarietyof SVCT2havedecreasedlevelsofascorbateinmanytis-
reputedremedieson12scorbuticsailors.Twoofthem sues and die quickly after birth, with brain damage
were restricted to a control diet, but the others were (Section10.17.6.5).Muchintestinaluptakeofascorbate
additionally given one of the substances under trial. isNa+-dependent,probablymostlyviaSVCT1,butits
Thetwoseamenwhowereprovidedtwoorangesand oxidation product dehydroascorbate (DHA, Fig. 4.1)
a lemon each day made a speedy recovery. The only canalsobeabsorbed.HenceDHAinfoodscanactasa
otherstoshowanysignsofrecoverywerethosewho sourceofvitaminCforthebody,beingreducedwithin
hadbeengiven1.1litresofciderdaily(ciderismade thegutcellstoascorbatefordeliverytoplasma.Uptake
fromapples;applesareamediocresourceofvitaminC ofDHAinseveralcelltypesoccursthroughsomeofthe
anditreadilyoxidizesinsolution).Lindobservedno glucose transport systems (e.g. GLUT1, GLUT3, and
improvementintheconditionofthosewhohadbeen GLUT4);glucosethuscompeteswithDHAuptakein
given25mlofoilofvitriol(dilutesulphuricacid),vin- thesecells.
egar(18mlthreetimesdaily),seawater(halfapint), SVCT1 is also important in reabsorption of ascor-
orthecontroldiet. batebythekidneyafterultrafiltrationofplasma,i.e.it
Lind’s conclusions were acted upon by Captain playsakeyroleinwholebodyascorbatehomeostasis
James Cook on his second voyage round the world. anddeterminingplasmalevelsbyparticipatinginin-
Although Cook was at sea for three years, not a sin- testinaluptakeandrenalreabsorption.Polymorphisms
gle member of his crew died from scurvy, thanks to inthegene(SLC23A1)encodingSCVT1canaltertrans-
adequate provision of lemon juice, fresh fruit, and porterfunctionandthusleadtovariationsinascorbate
vegetables.Surprisingly,itwasnotuntil1795thatthe levelsinhumanplasma,whichmayinturninfluence
BritishAdmiraltyagreedtoLind’sdemandsforaregu- theriskofdevelopingcertaindiseases.8Therearealso
lar issue of lemon juice on British ships. The effect suggestions that haptoglobin polymorphisms can in-
was dramatic; in 1780, 1457 cases of scurvy were ad- fluenceplasmavitaminClevels,theHp2-2phenotype
mittedtoHaslarNavalHospital,butonlytwoadmis- (Section3.23.3.4)givingthelowestlevels.8Polymorph-
sionstookplacebetween1806and1810.Unfortunately, isms in the gene (SLC23A2) encoding SVCT2 can af-
lemonjuicewassoonreplacedbycheaperlimejuicein fect ascorbate entry into tissues, and may predispose
amoney-savingexerciserathertypicalofBritishgov- to glaucoma.8 Similarly, low activities of certain GST
ernments throughout the ages; hence English sailors enzymes seem to predispose to lower plasma vita-
were often nicknamed ‘limeys’. Scurvy returned and min C levels if the dietary intake is limited, perhaps
ittookoveracenturytorealizethatthelimejuiceused related to their dehydroascorbate reductase activity
hadonlyaboutone-quarteroftheantiscorbuticactiv- (Section 3.15.2).8 Little is known about the subcellu-
ityofthelemonjuice.Indeed,scurvywascommonin lardistributionandmovementofascorbate,although
Irelandinthegreatpotatofamineof1845;potatoesare mitochondria contain SVCT2 and also appear able to
notrichinascorbatebuttheycanbecomeasignificant takeupandreduceDHA,probablyviaaglucosetrans-
dietarysourceiflargeamountsareeaten.7 porterintheinnermembrane.Itisnotclearwhatstops
ascorbatefromsimplyreducingcytochromecorother
4.2.1 Ascorbateasanantioxidant5,6 cytochromesinvivo,however.
Themoststrikingchemicalpropertyofascorbateis
Ascorbate-dependentperoxidasesareimportantH 2 O 2 - itsactionasareducingagent,asillustratedbyitsabil-
removing systems in plants and some other spe- ity to reduce Fe(III) to Fe2+ to facilitate iron uptake
cies (Section 3.19.6), and ascorbate is capable of ex- intheduodenum(Section3.22.1),tomaintaintetrahy-
erting a multiplicity of direct antioxidant effects, at drobiopterin(BH )levels,andtoreducenitrosothiols
4
least in vitro (Box 4.1). Mammalian cells accumulate (Box4.1).Thisisalsohowitmaintainstheactivityof
ascorbate from body fluids against a concentration lysyl,asparagine,andprolylhydroxylases;ironatthe
gradient, coupled to uptake of Na+, using two simi- activesitemustbeintheFe2+ stateforhydroxylation
lartransportershighly-selectiveforascorbate,SVCT1 to occur and if the Fe2+ oxidizes to Fe(III), the ascor-
(sodium-vitaminCtransporter1)andSVCT2,oneor bate can reduce it back and re-activate the enzymes.
bothofwhicharefoundinmosttissues.8 Theformer Table 2.2 shows that the reduction potential of ascor-
hasahighermaximumvelocitybutloweraffinityfor bateplacesitclosetothebottomofthe‘peckingorder’
ascorbatethanthelatter.SVCT2seemstobethemore for oxidizing species, i.e. it is capable of reducing

--- Page 213 ---

158 FREE RADICALS IN BIOLOGY AND MEDICINE
Box4.1 Potentialmechanismsofantioxidantactionofascorbate
• ScavengesO •– andHO • (rateconstant>105 M–1s–1 at RSNO + asc– →RSH + NOasc– (nitrosoascorbate)
2 2
pH7.4).
• Scavenges OH• (rate constant >109 M–1s–1). This may NOasc–thendecomposestoproducenitroxyl,HNO(Sec-
notbeimportantinvivosincerateconstantsforreaction tion2.5.6).
ofOH•withmanyothermolecules,presentatcomparable • Infusion or oral administration of gram doses has
orhigherconcentrationsthanascorbate,aresimilarlyhigh been shown in some, but not all, studies to improve
(Section2.5.1). (cid:4) (cid:5) endothelium-dependentvasodilationinpatientswithvas-
•
• Scavengeswater-solubleperoxyl RO radicals;lipophilic culardysfunction,possiblybyscavengingROSand/orby
2
ascorbateestershavebeendevelopedforuseinfoodsand preservingtetrahydrobiopterin(BH4)foreNOS,andthus
cosmeticsandcanscavengelipid-solubleRO • radicalsand maintainingNO• levels(Section2.5.6.4).Duringtheen-
2
protectskin(Section7.13). zymecycleBH4 donatesanelectrontoeNOSandforms
• Scavengesthiyl,andoxysulphurradicals(Section2.5.5). thetrihydrobiopterinradical(BH 3 •),whichisreduced
• A substrate for ascorbate peroxidases, enzymes essen- backtoBH 4 byascorbate(k~1.7×105M–1s–1).Ifthis
tial for H O removal in chloroplasts, and some other does not happen, BH • converts to inactive BH (An-
2 2 3 2
organisms(Section3.19.6). tioxid.RedoxSignal.19, 2068, 2013; FreeRadic.Biol.
• PreventsdamagebyradicalsarisingbyattackofOH• or Med.32,203,2002).Indeed,BH4 levelswerelowerin
•
RO uponurate,probablybyreactingwithurateradicals guinea pigs on a diet poor in vitamin C (Nutr.Res.33,
2
(Section3.25.6). 859,2013).VitaminCsupplementshavebeenshownto
• Scavenges HOCl, chloramines, singlet O 2 , ONOOH, and decreasebloodpressureinsome,butnotall,humanstud-
nitrosating agents (Sections 2.6.1, 2.6.3, and 2.6.4) al- ies (Am.J.Clin.Nutr.95, 1079, 2012), but the effects
thoughitsabilitytopreventgastricnitrosationreactions may be different depending on the status of other nu-
invivois uncertain. Albumin may be a more important trients,suchasnicotinamide(J.Appl.Physiol.116,156,
scavengerofHOClthanascorbateinplasma(Chem.Res. 2014).
Toxicol.22,801,2009)becauseofitshigherconcentra- • Protects plasma lipids against peroxidation induced by
tion. activatedneutrophilsandAAPH-derivedperoxylradicals.
• Inhibits lipid peroxidation induced by haemoglobin—or • Protectsmembranesandlipoproteinsagainstlipidperox-
myoglobin—H O mixtures;reducesthehaemFe(IV)spe- idationinducedbycigarettesmoke(Section9.13).
2 2
cies back to the Fe2+ state, preventing ferryl-dependent • ScavengesO 3 andNO • 2 ;probablyprotectslungliningflu-
oxidationsandhaembreakdown(Section3.22.3). idsagainstinhaledoxidizingairpollutants(Section9.12).
• Co-operates with vitamin E; regenerates α-tocopherol • Inhibits oxidative damage by scavenging radicals gener-
fromα-tocopherylradicalsinmembranesandlipoproteins atedfromcertaindrugs(e.g.phenylbutazone).
(Section4.2.2). • Protects against phagocyte adhesion to endothelium in-
• Scavengesnitroxideradicals(Section6.2). ducedbyoxidizedLDL.
• Releases NO• from nitrosothiols, possibly regulates ni- • CanreactwithacroleinorHNEinvitrobutnotclearifthis
trosothiollevelsinvivo(Antioxid.RedoxSignal.17,937, happensinvivo(Proc.Natl.Acad.Sci.USA104,14543,
2012). 2007).
more-reactive species such as OH•, O•–, and urate antioxidanteffects: a reactive species (RS) interacts
2
radical. Donation of one electron by ascorbate gives with ascorbate and a much less reactive (ascorbyl)
the semidehydroascorbate (SDA), sometimes called radicalisformed(Box4.1).
ascorbyl, or ascorbate, radical (Fig. 4.1), which can Left to itself, ascorbyl undergoes slow dispropor-
be further oxidized to give DHA. Ascorbyl radical tionation,regeneratingsomeascorbate,
is not very reactive, being neither strongly oxidizing
2Asc
•–+H+(cid:2)DHA+AscH–
nor strongly reducing, nor does it seem to reduce
O 2 to O• 2 – at a high rate (if at all). The poor reactiv- Dehydroascorbate is unstable and breaks down to a
ity of ascorbyl is the essence of many of ascorbate’s mixture of products (Fig. 4.1). Aqueous solutions of

--- Page 214 ---

ANTIOXIDANTS FROM THE DIET 159
ascorbate are fairly stable at pH 7.4 unless transition malondialdehyde) in several tissues, including the
metalionsarepresent,whichcatalyseitsrapidoxida- brain;14chronicvitaminCdeficiencydidnotraiseoxi-
tion.Coppersaltsareexcellentcatalysts—ifyouwant dative damage levels in the brains of guinea pigs;15
plentyofvitaminCfromvegetables,donotcookthem andincreasesinoxidativedamagelevelsinthebrains
in copper pans! Copper- and iron-induced oxidation or livers of mice lacking gulonolactone oxidase were
ofascorbateproduceH O andOH•;themultiplelit- limited.16Theeffectsofascorbatedepletioncanalsobe
2 2
erature reports of the ability of ascorbate to degrade studiedinamutantratstrainthatcannotmakeascor-
DNAanddamagevariousanimalcellsinculture,in- bate.TheODSratwasdiscoveredinthelaboratoriesof
cludingcancercells,canprobablybeattributedtothe theJapanesepharmaceuticalcompanyShionogi&Co,
formationofH O andotherspeciescatalysedbytran- as suffering from osteogenic disorders when fed the
2 2
sitionmetalionsinthereactionsolutionsorcellculture usualratchow;hencethenameOsteogenicDisorder
media10 (Section1.11).Ascorbatecanbestabilizedby Shionogi (ODS) rat. Ascorbate intake (in the range
conversion to sulphate forms (found in some marine 150–900mg/kgdiet)doesnotalterlevelsoflipidper-
organisms), or by phosphorylation: ascorbate phos- oxidationinODSrats.Onlywhenthereisaverylow
phates and ascorbate glucosides have been used as ascorbateintakecanantioxidanteffectsofextradietary
‘non-autoxidizable’deliveryvehiclesforvitaminCin ascorbatebeconvincinglydemonstratedinODSrats.17
severalcellculturestudies. Hence, ‘normal’ ascorbate levels may be sufficient
But is ascorbate an antioxidant in vivo? The levels todecreaseoxidativedamageinhumansbythemax-
that are present in vivo (30–90 μM in human plasma; imum amount achievableby ascorbate. Nevertheless,
higher in CSF, aqueous humour of the eye, seminal do remember that a significant percentage of the
fluid, gastric juice, and lung lining fluid: millimolar world’spopulationismalnourished,eveninadvanced
intracellular levels in many cell types)8 are certainly countries,andmayhaveinsufficientvitaminC.Deple-
sufficienttobecapableofexertingantioxidanteffects tionsofascorbatecanoccurinsickpeople,forexample
(Box4.1).However,directevidencethatascorbateacts intheintensivecareunitorwithkidneyfailure.There
asanantioxidantinvivoislimited.Areview11fromthe is(limited)clinicalevidencethatimprovingvitaminC
LinusPaulinginstitutein1999concludedthatattempts statusinsuchpatientsisbeneficial(Section10.1).18Co-
to demonstrate antioxidant effects in vivo in humans deficiencies in other nutrients (e.g. selenium or vita-
usingbiomarkersofoxidativedamage(suchasDNA minE)aggravatetheeffectsofvitaminCdeficiencyin
baseoxidationproductsorF -isoprostanes[F -IsoPs]) animalsandprobablyalsoinhumans.Polymorphisms
2 2
hadnotgivenconsistentpositiveeffects,andmostof in genes affecting ascorbate transport may increase
the better-designed studies were negative. Few data dietary requirements in certain individuals.8 Admin-
have since been published to challenge that conclu- istration of ascorbate plus α-tocopherol was reported
sion,e.g.nodecreasesinF -IsoPor8OHdGlevelswere todecreaseurinary8OHdGexcretioninHIV-positive
2
observed when extra ascorbate was administered to subjectstreatedwithAZT(Section10.25.3).
human volunteers.12,13 Claimed vasculo-protective or Rapidoxidationofascorbatecanoccurinvivoatsites
anti-hypertensiveeffectsofascorbate(Box4.1)arevari- ofoxidativestress.Forexample,itisoxidizedtoDHA
ablebetweenlaboratoriesandinanycasecouldbedue insynovialfluidintheknee-jointsofpatientswithac-
to the preservation of BH for NOS (Box 4.1), rather tiverheumatoidarthritis,inthelungsofpatientswith
4
thantodirectantioxidanteffects. ARDS(Sections10.8and10.11),andinsubjectsoncar-
It may be that ascorbate levels in healthy subjects diopulmonarybypass(Section10.6.4.8),presumablyas
on a diet rich in fruits and vegetables are sufficient it acts to scavenge RS. Measurement of ascorbyl rad-
toexertmaximumantioxidanteffectsalready,sothat ical by ESR has been used as an index of oxidative
supplements give no further benefit. This is illus- stressinseveralsystems(Section6.2).Ascorbatelevels
trated by studies on human sperm: 60 mg ascorbate are decreased in cigarette smokers and in diabetics
perdayseemedsufficienttonormalizetheelevations (Sections9.13and10.5).
in 8OHG levels in sperm DNA that were observed
in subjects on an ascorbate-poor diet (Section 7.11.2;
4.2.2 ‘Recycling’ofascorbate6
Table7.4).Resultsinanimalssupportthisview.Only
mice severely deficient in ascorbate (because they Ascorbate/DHAconcentrationratiosarehighinmam-
lacked SCVT2) showed increased levels of biomark- malian body fluids and tissues during health; almost
ers of oxidative stress (isoketals, F 2 - and F 4 -IsoPs, no DHA is present. Oxidation of ascorbate in body

--- Page 215 ---

160 FREE RADICALS IN BIOLOGY AND MEDICINE
fluids usually leads to its depletion, probably by the Fe(III)–EDTA+ascorbate→ Fe2+–EDTA+SDA
reactions
Fe2+–EDTA+H O →Fe(III)–EDTA+OH•+OH–
2 2
ascorbate−R−S−a−tt−a→ck
SDAradical
Ascorbate/Cu2+ mixtures inactivate many enzymes,
2SDA−d−is−p−ro−po−r−tio−n−at−i→on
ascorbate+DHA probablybyformationofOH•and/oroxo-copperspe-
DHA−r−ap−id−−no−n−-e−nz−y−m→ic
multipleproducts
cies (Section 2.4), and iron salt/ascorbate mixtures
breakdown havebeenusedfordecadesinvitrotoinducelipidper-
oxidationandotheroxidativedamage(Section5.11.6).
Inaddition,erythrocytes,neutrophils,andsomeother
Instillation of ascorbate plus iron or copper ions into
cells take up DHA and convert it back to (intracellu- the stomach of animals was reported to lead to OH•
lar)ascorbate.Mosttissuespossessenzymesthatcon-
generation,21 and the mixture of metal ions and as-
vertascorbylradicalorDHAbacktoascorbateatthe
corbate in some vitamin pills has been claimed to
expenseofGSHorofNADH.TheseincludeNADH- generate OH• as the pills dissolve.22 Pro-oxidant ef-
semidehydroascorbate reductase, a flavoprotein pre-
fects of ascorbate are a problem in the food industry
sent in the ER and outer mitochondrial membrane,
and in the design of fluids for parenteral nutrition
and dehydroascorbate reductase activities. However,
(Section7.11.8.5).Evendissolvingascorbatetabletsin
theidentityofdehydroascorbatereductasesasunique tap water can generate OH• if, as is often the case,
enzymes is uncertain since several proteins involved
transitionmetalionsarepresent.23
in thiol–disulphide interchange, including PDI (Sec-
Are these pro-oxidant effects physiologically rele-
tion 3.12), omega-class GSTs (Section 3.15), and glut-
vant? In vitro pro-oxidant effects are not unique to
aredoxin (Sections 3.11) can act as DHA reductases.
ascorbate; they can be demonstrated with several re-
Forexample,a‘DHAreductase’purifiedfromhuman
ducingagentsinthepresenceoftransitionmetalions,
neutrophils was found to be glutaredoxin. In para- including α-tocopherol (Section 4.3), GSH and other
sites,trypanothione(Section3.16.1)canreducedehyd-
thiols, NAD(P)H, urate, and several plant polyphe-
roascorbate.Plasmamembraneredoxsystemscanalso
nols (Section 4.5.3). Thus if ascorbate’s pro-oxidant
reduceextracellularascorbate(Section1.10.8).
effectsarerelevantinvivo,pro-oxidanteffectsofthese
There is evidence that GSH and ascorbate interact
otherreductantsmightalsobeexpectedtooccur.The
in vivo.6 Severe GSH depletion in newborn rats and
keyquestionistheavailabilityof‘catalytic’transition
guinea pigs is lethal, but death can be prevented by
metal ions. Iron and copper ions in most extracel-
high doses of ascorbate (although not by DHA). The
lular fluids are largely sequestered in forms unable
onset of scurvy in guinea pigs fed a diet low in as-
to catalyse free-radical reactions (Section 3.23.3), so
corbate is delayed by administering GSH precursors.
thatthepro-oxidantpropertiesofascorbate(andother
In mice, lowering GSH levels by administering BSO
biologicalreducingagents)wouldbelimited.Incon-
(Section 3.10) increases ascorbate synthesis, and infu-
trast,cellshavelabileintracellular‘pools’ofiron(Sec-
sion of the enzyme ascorbate oxidase into mice de-
tion3.22.1.3).Ifthesecomeintocontactwithascorbate,
creasedliverGSHlevels:loweringGSHlevelsbyBSO
pro-oxidant effects could conceivably occur. Whether
enhanced the fall in plasma ascorbate caused by as-
theydoornotisstillanopenquestion,theymaywell
corbate oxidase.19 In a human study, concentrations
becarefullycompartmentalized.
of ascorbate and GSH in lymphocytes were found to
Do we learn anything by looking at patients with
correlate:bothdecliningwithage.20 Therewasalsoa
iron overload, e.g. in thalassaemia or haemochroma-
seasonalvariationinascorbateconcentration,andad-
tosis(Section3.22.5)?Plasmaascorbatelevelsinsuch
ministration of ascorbate to subjects with the lowest
patients are often subnormal.24–26 There are a few
plasmalevelsofthisvitaminraisedlymphocyteGSH
published‘casereports’whichsaythatgivingvitamin
levels.20
C to iron-overloaded subjects without administration
of desferrioxamine can produce deleterious clinical
4.2.3 Pro-oxidanteffectsofascorbate5,10,12 effects, although other studies did not find this.
The data are inconclusive, although, to be on the
In vitro, vitamin C can also exert pro-oxidant proper- safe side, haemochromatosis patients are often cau-
ties. The classic Udenfriend system for making OH• tionednottotakehigh-doseascorbatesupplements.24
in the laboratory consists of ferric-EDTA, H O , and Supplementing sickle cell anaemia or thalassaemia
2 2
ascorbate.Ascorbatereducestheiron, patients with ascorbate plus vitamin E increased the

--- Page 216 ---

ANTIOXIDANTS FROM THE DIET 161
risk of haemolysis.25 Indeed, transient iron overload obtainablefromadietwithfiveservingsoffruitsand
inhaemodialysispatientscausedbyinjectionsofiron vegetables)issufficienttosaturatecellsandbodyflu-
complexes led to increased plasma levels of F -IsoPs idswithascorbate;anyexcessisexcreted.31 However,
2
and ascorbyl radical.27 Another concern is whether heavy smokers need more vitamin C (Section 9.13).
excessintakeofascorbatecouldpredisposetokidney Thepopularbeliefthathighdosesofascorbateprotect
stoneformationbyincreasingoxalatelevels(Fig.4.1); against the common cold has been difficult to verify
there is some (albeit limited) clinical evidence that it incontrolledstudies.32Sotakeascorbatesupplements
could.28 if you believe in them; it probably does little harm,
Injurytohumantissuescanliberatetransitionmetal if not necessarily any good. Be aware, however, that
ions (Fig. 10.1). Could the pro-oxidant effects of as- ascorbic acid is quite acidic, whereas the sodium salt
corbate become relevant here? Evidence that ascor- will deliver a lot of Na+ if gram quantities are con-
bate can sometimes aggravate damage by CCl or sumed.Sincebodylevelsofascorbatereachsaturation
4
paraquatinanimalsisconsistentwiththisview(Sec- at quite low intake levels,31 taking gram quantities
tion 9.2). The authors have hypothesized29 that the merelygenerates‘expensiveurine’.
decline in ascorbate at sites of tissue injury occurs
because: (i) ascorbate scavenges RS and may recycle 4.3 VitaminE33-35
α-tocopherol; (ii) the resulting DHA is taken up by
cells to maintain intracellular ascorbate; and (iii) as- 4.3.1 Itsphysiologicalrole
corbate removal from the extracellular environment
VitaminEisoftensaidtobethemostimportant(but
minimizes its potential pro-oxidant interactions with
not the only) inhibitor of lipid peroxidation in vivo.
metal ions released by tissue damage. Thus one can It has also been used as an antioxidant in plastics.36
speculate that giving lots of ascorbate to sick people
However,aswithvitaminC,evidenceforanantioxid-
maynotbeagoodthing,anideasupportedbysome
anteffectofvitaminEsupplementsinwell-nourished
epidemiologicalstudiesindiabetes(Section10.5).An-
humansislimited.Forexample,largeoraldosesover
other frequently asked question is whether ascorbate
longperiods(greaterthan2000mg/dayformorethan
couldfavourexcessuptakeofironintothebody,since
eight weeks or, in one study, 200 mg/day for one
Fe(III)reductiontoFe2+byascorbatefacilitatesironup-
year)arerequiredtodecreaseperoxidationinhumans
take in the duodenum (Section 3.22.1). There is little (measuredaslevelsofF -IsoPs).37–39Itisevenpossible
2
evidencetosupportthisviewinhealthysubjects;iron
that these changes are due to increased metabolism
uptake is carefully regulated whatever the ascorbate of F -IsoPs rather than their decreased formation.40
2
intake(Section3.22.1).However,theissueneedstobe
In addition, vitamin E has been frequently proposed
addressedinironoverload.
to have non-antioxidant roles in metabolism (Sec-
Weconcludethat,althoughtheinvivoevidencefor tion4.3.9).41Thereislimitedevidencefromsomeclin-
major antioxidant effects of ascorbate is not compel-
icalstudiesthathigh-dosevitaminEcandecreasepain
ling,thatformetalion-dependentpro-oxidanteffects
inpatients(Section10.24).
is even more sparse. However, potentially damaging
effectsofascorbatecanoccurinotherways.Ascorbate
4.3.2 WhatisvitaminE?
canglycateproteins,forexample30 andthismightbe
importantintheeye(Section7.10). ‘Vitamin E’ was the term first used to refer to a fat-
soluble ‘factor’, discovered in 1922 to be essential in
the diet of rats to permit normal reproduction. Later
4.2.4 Takingascorbatesupplements?
work showed that vitamin E is essential to other
Thereislittleconvincingevidenceformuchtoxicityof animals:42,43 lack of it causes a variety of symptoms,
gramdosesofascorbateinhealthyhumans(although including sterility in male rats, dogs, cocks, rabbits,
it can increase urinary oxalate in some subjects and and monkeys, haemolysis in rats and chicks, muscu-
might increase the risk of kidney stone formation),28 lar degeneration in rabbits, guinea pigs, crocodiles,
but there is no compelling evidence of benefit either. snakes,lizards,elephants,monkeys,ducks,mice,and
There are also suggestions that consuming antioxi- mink,‘white-muscledisease’inlambs,flamingos,and
dantscannegatethebeneficialeffectsofexercise(Sec- calves,yellowfatdiseaseinkittens,anddegeneration
tion7.14.1.1).Ascorbateisultrafilteredandreabsorbed of the cerebellum in chicks. Low dietary intake of
inthekidney,buttheactiveuptakesystemhaslimited vitamin E increases the sensitivity of laboratory ani-
capacitysothatanintakeofabout200mgdaily(easily mals to certain toxins or to tissue insults such as

--- Page 217 ---

162 FREE RADICALS IN BIOLOGY AND MEDICINE
ischaemia–reperfusion (Sections 10.18.3.2 and ref44). α-TocH+LO •→α-Toc • +LO H
2 2
Short-termabsenceofvitaminEfromthehumandiet
are about 6×103 to 7×106 M–1s–1, several orders of
does not cause overt disease, although long-term ab-
•
senceisdevastating(Section4.3.8).42,45Dietarysources magnitude faster than those for reaction of LO 2 with
lipids.35 There appears to be little or no difference
of vitamin E include wheat-germ, vegetable oils and
in antioxidant activity in vitro between the different
foodscontainingthem(e.g.somemargarines),nuts(es-
pecially almonds and hazelnuts),46 grains, and green
tocopherolsandtocotrienols.TheaToc•radicaliscap-
able of reacting rapidly (k ~ 108 M-1s-1) with another
leafyvegetables.
peroxylradicaltogivenon-radicalproducts,
LO • +αToc •→αTocOOL
4.3.3 ChemistryofvitaminE33–35,46 2
Hence one molecule of α-tocopherol is, in principle,
Eight naturally occurring substances have been
capable of terminating two peroxidation chains (i.e.
reported to exert vitamin E activity in the rat repro-
it is a chain-breaking antioxidant). Further products
duction test: RRR-α-, -β-, -γ-, and -δ-tocopherols, include α-substituted tocopherones and epoxy (hy-
and RRR-α-, -β-, -γ-, and -δ-tocotrienols, although
droperoxy) tocopherones; the former readily hydro-
some of the work in the older literature may have
lyse to tocopherylquinone (Fig. 4.3) and the latter to
been confounded by the use of impure fractions
epoxyquinones.Thephysiologicalsignificanceofthese
(e.g. α-tocopherol contamination in γ-tocopherol
productsisuncertain.Tocopherolsalsoquenchandre-
preparations)a Indeed, the name ‘tocopherol’ comes
actwithsingletO (Fig.2.14)andmighthelptoprotect
2
from the Greek words tokos (childbirth) and phero
chloroplastandretinalmembranesagainstthisspecies
(to bring forth). Each tocopherol has three asymmet-
(Sections7.7and7.10.2).
ric carbon atoms, giving eight optical isomers. The α-Tocopherol is fat-soluble and therefore concen-
most effective form in animals is RRR-α-tocopherol,
trates in the interior of membranes and in lipopro-
formerly called d-α-tocopherol (Fig. 4.2). Plants and teins. The hydrophobic phytol chain of α-tocopherol
their oils often contain a mixture of tocopherols; for
anchors the molecule in the membrane, positioning
exampleinsoy,corn,walnut,andrapeseedoils,there
thechromanolringcontainingtheradical-scavenging
is more γ-tocopherol than α-tocopherol. By contrast,
phenolic –OH group exactly where it needs to be.
almondandsunfloweroilhavemostlyα-tocopherol.46
Forexample,mitochondrialmembranescontainabout
Palm oil is rich in tocotrienols (about 75% of their one molecule of α-tocopherol per 2100 molecules of
total vitamin E; only about 14% is α-tocopherol).47
phospholipid,butlevelsarehigherinthechloroplast
The terms ‘α-tocopherol’ and ‘vitamin E’ tend to
thylakoid membrane (Section 7.8.8) and in the outer
be used interchangeably in the literature, although
segmentmembranesoftheretinalrods(Section7.10.2),
the other tocopherols and tocotrienols have some
both of which are at special risk of peroxidation in
‘vitamin E activity’ in animal bioassays. It is worth vivo.Whetherα-tocopherolisevenlyspreadthrough-
bearing in mind that α-tocopherol supplements can
outthemembrane,orconcentratesincertainareas(e.g.
be RRR-α-tocopherol or dl-α-tocopherol (sometimes
lipidrafts:Section5.11.2.2),isuncertain.Insomecold-
called all-rac-α-tocopherol), which contains about
waterfish(e.g.salmon)amarine-derivedtocopherol
12.5% of the RRR-form, together with seven other (MDT)ispresentaswellasα-tocopherol;MDThasthe
isomersthatarelessbiologicallyactive(Section4.3.6).
samestructureexceptfora=CH insteadofoneofthe
Supplements of ‘mixed tocopherols’ (α, β, γ, δ) can 2
–CH groupsattheendoftheside-chain.Thismayal-
3
also be purchased. It is surprising how many papers
lowincreasedmobilitywithinthemembraneandthus
have been published in which humans or other ani-
increased antioxidant efficiency at low temperatures.
mals were administered extra ‘vitamin E’, without
The MDT seems to be acquired by the fish from the
specifyingexactlywhatwasgiven. planktontheyeat.48
Tocopherolsandtocotrienolsinhibitlipidperoxida-
•
tionbecausetheyscavengelipidperoxylradicals(LO )
2
muchfasterthantheseradicalscanreactwithadjacent 4.3.4 Recyclingofα-tocopherylradicals33,35
fattyacidside-chainsorwithmembraneproteins.Rate
During its action as a chain-breaking antioxidant,
constantsforthereaction
α-tocopherol forms a radical. Can this be converted
backtoα-tocopherol?Suchsynergybetweenvitamins
a ProfessorMaretTraber,personalcommunication. E and C was first suggested by A.L. Tappel in 1968.

--- Page 218 ---

ANTIOXIDANTS FROM THE DIET 163
(a)
CH 3 CH 3
HO H 3 C O
H 3 C CH 3 O CH 3 HCH 3 HCH 3 CH C 3 H 3 H O 3 C CH 3 O CH 3 HCH 3 HCH 3 CH C 3 H 3
RRR-α–Tocopherol RRR-α–Tocopheryl acetate
O CH
3
HO O
O
CH
3
H 3 C CH O CH 3 HCH 3 H CH 3 CH 3
3
RRR-α–Tocopheryl succinate
(b) Tocopherols
R α-T: R =R =CH
1 1 2 3
HO β-T: R =CH , R =H
1 3 2
CH 3 γ-T: R 1 =H, R 2 =CH 3
R 2 CH O CH 3 HCH 3 HCH 3 CH 3 δ-T: R 1 =R 2 =H
3
(c) Tocotrienol structure
R
1
HO α-T: R1=R2=CH3
β-T: R1=CH3, R2=H
CH
R 2 CH 3 O CH 3 CH 3 CH 3 CH 3 3 δ γ - - T T : : R R 1 1 = = H R , 2 R = 2 H =CH3
(d) γ–CEHC
HO
CH CH COOH
2 2
H 3 C O CH 3
CH
3
Figure4.2 VitaminEandsomeofitsderivatives.(a)Structuresof‘naturalvitaminE’(RRR-α-tocopherol)anditsesterswithaceticacid(RRR-α-
tocopherylacetate)andsuccinicacid(RRR-α-tocopherylsuccinate).TheestersareoftenusedincommercialvitaminEpreparationsbecausethey
aremorestableonstorage,butarerapidlyhydrolysedbyesterasesinthegut.Consumptionoftheacetate,forexample,usuallygivesapproximately
thesameplasmalevelsasunesterifiedα-tocopherol(e.g.Lipids23,834,1988).FromToleranceandSafetyofVitaminE,byH.KappusandA.T.
Diplock,bycourtesyoftheseauthorsandtheVitaminEResearchandInformationService.Tocopherylacetateisnotcommoninnature,butmaybe
secretedbythesquashbeetle,Epilachnavariestis,duringits‘defenceresponse’,asacarrierforanirritantchemical(Experientia52,616,1996).
(b)Diagrammaticrepresentationofthestructuresofα-,β-,γ-,andδ-tocopherols.Allthetocopherolshaveachromanolringstructureanda
phytolside-chainwhichanchorstheminthemembrane.(c)Structuresofthetocotrienols,whichhavethreedoublebondsinthehydrophobic
side-chain.Side-chainnomenclatureasforthetocopherols.(d)Structureofγ-CEHC,aproductofγ–tocopheroldegradation.Thechromanolring
(anditsantioxidantproperties)arestillintact.

--- Page 219 ---

164 FREE RADICALS IN BIOLOGY AND MEDICINE
designated R below
CH 3 CH 3
HO minor degradation HO CH
pathway 3
H 3 C O C C H H 2 3 (high intakes only) H 3 C O C C H H 3 2 (CH 2 CH 2 CH CH 2 ) 3 H
CH 3 CH 2 CH 3
COOH
lipid OO
α – CEHC
lipid OOH
Singlet O 1Δg
2
O (also quenching)
R
O CH
3
α–Tocopheryl radical
Intermediate
structure
OOH CH 3 OO O H CH 3
R R
O O
Tocopherylquinone
Figure4.3 Structureoftocopherolandsomeofitsoxidationproducts.Tocopherylradicalisanaromaticalkoxylradical(sometimescalled
tocopheroxylradical).Itmaybeconvertedbacktotocopherolorcanundergofurtheroxidation(e.g.totocopherylquinone)byaseriesof
reactions.Tracesofα-tocopherylquinonearefoundinanimal(includinghuman)tissues;itismetabolizedbyreductiontothehydroquinone(which
hasantioxidantpropertiesinvitro;Proc.Natl.Acad.Sci.USA94,7885,1997).Whenhighdosesofα-tocopherolareconsumedsomecanbe
degradedbyhepaticcytochromesP450toα-CEHC(2,5,7,8-tetramethyl-2-(2(cid:4)-carboxyethyl)-6-hydroxychroman),theringstructure(and
antioxidantactivity)beingretained.54Tocopherolsarepowerfulscavengersof1O2,buthavealsobeenreportedtophotosensitizeitsgeneration
whenilluminatedat308nm(FreeRadic.Res.40,333,2006).
Pulseradiolysis(Section2.3.3.1)studiesconfirmedthat inbothCandEdevelopedprogressiveparalysisand
ascorbatereducesα-tocopherylradicaltoα-tocopherol increased lipid peroxidation in the brain, effects not
with a reasonable rate constant (~3×105 M–1s–1 in seen with either deficiency alone.50 Feeding guinea
membrane bilayers), and this reaction has since been pigs,fish,orODSrats(Section4.2.1)onaC-deficient
showntooccurinisolatedmembranes,bloodplasma diet decreases tissue α-tocopherol levels,17,51 and the
(Fig. 6.1), cultured cells, and lipoproteins. How- fasterturnoverofα-tocopherolintheplasmaofcigar-
ever, studies using deuterated α-tocopherol adminis- ettesmokersisnormalizedbygivingextravitaminC
tered to guinea pigs gave no evidence of recycling (Section9.13.3).Overall,therefore,thebalanceofevi-
by ascorbate.49 In one human study,37 administra- dencesuggeststhatvitaminCcanrecycleα-tocopheryl
tion of 200 mg/day of RRR-α-tocopherol decreased radicalinvivo.
lipid peroxidation (measured as serum F -IsoPs) by Ubiquinol can also recycle the α-tocopheryl rad-
2
17%, but adding 500 mg vitamin C had no ex- ical in some experimental systems (Section 3.25.5),
tra effect, nor did the C itself affect F -IsoPs levels althoughwithalowerrateconstantthanforascorbate;
2
(maybe the subjects had enough ascorbate already). as can some flavonoids (Section 4.5) and GSH. It is
Nevertheless, other evidence supports an interaction generally felt that the ascorbate-dependent recycling
in vivo. For example, weanling guinea pigs deficient system is the most important in vivo. Ubiquinol may

--- Page 220 ---

ANTIOXIDANTS FROM THE DIET 165
onlybeimportantinmembraneswhereitispresentin of vitamin E enter the body in chylomicrons. Some
substantial amounts, such as the inner mitochondrial dietary fat is thus required for vitamin E uptake, but
membrane(Section1.10.4). only a small amount seems sufficient (Fig. 4.4). The
GI tract appears not to discriminate between the dif-
4.3.5 Pro-oxidanteffectsofα-tocopherol? ferentformsofvitaminEforuptake.However,levels
ofRRR-α-tocopherolarehigherinplasmabecausethe
TocopherolscanreduceFe(III)toFe2+andCu2+toCu+, liverincorporatesitselectivelyintotheverylowdens-
and so can exert pro-oxidant effects in vitro. Indeed, itylipoproteins(VLDLs)thatitsecretesintotheblood.
thisiron-reducingabilitywasthebasisofsomeolder Liver secretion of VLDL is an important contributor
colorimetricmethodstomeasuretocopherols.Inadd- to maintaining plasma RRR-α-tocopherol levels. The
ition,theα-Toc• radicalhassomecapacitytoabstract VLDLscontainlipidsthatoriginatedfromthediet(by
hydrogenfromPUFAs, uptakeofchylomicronremnantparticlesbytheliver),
aswellaslipidsmadebytheliveritself.
α-Toc • +LH→L • +α-TocH
How does liver achieve this selectivity? A hepatic
However, the rate constants are in the range 1–10 × α-tocopherol transfer protein (α-TTP) preferentially
10–2 M–1s–1, several orders of magnitude lower than picksRRR-α-tocopheroltoincorporateintoVLDL.This
therateconstantsforreactionofperoxylradicalswith protein is important; mutations in the gene encoding
PUFAs.35Nevertheless,ifα-Toc•isgeneratedinalipid it (at least 20 different types are known) cause the
system in the absence of RO • (e.g. if copper ions autosomalrecessiveneurodegenerativediseaseataxia
2
areaddedtoatocopherol-containinglipid),itcanact with isolated vitamin E deficiency (AVED). ‘Ataxia’
as a weak promoter of lipid oxidation (tocopherol- means loss of voluntary muscle control, resulting in
mediated peroxidation). This phenomenon has been lackofbalanceandcoordination.AVEDpatientshave
observed in the food industry and in studies of the an impaired ability to incorporate α-tocopherol into
oxidation of LDL (Section 10.3.8). Addition of excess VLDL. As a result, their plasma tocopherol levels
α-tocopherol to lipid emulsions used for intravenous decrease rapidly after consumption (Table 4.2) lead-
infusion was also reported in one study to acceler- ing to neuropathy and neurodegeneration, resulting
ate peroxidation of the lipids,52 presumably because inataxia.AfterAVEDpatientsconsumeα-tocopherol,
no co-reductants were present. The poor availability peak blood levels are reached within 6 h (faster than
of‘catalytic’metalions(Section3.22)shoulddiminish the normal 11–14 h), but drop swiftly, indicative of
thelikelihoodofsuchoccurrencesinvivo.However,we the importance of the liver α-TTP system in main-
should not dismiss their relevance entirely, e.g. dl-α- taining plasma levels. Their α-tocopherol is rapidly
tocopherylacetate(400IUdaily)administrationraised degraded to α-CEHC (Fig. 4.3) which is excreted in
plasmaF -IsoPlevelsinsmokersonahigh-fatdiet.53 urineaftermetabolism,e.g.sulphationorglucuronid-
2
High intakes of tocopherols in adults are gener- ation. In other words, binding to α-TTP also slows
allythoughttoshowlittletoxicity,althoughtheycan α-tocopherol degradation. Knockout mice lacking α-
affect blood coagulation by interfering with the ac- TTP similarly develop neurological symptoms after
tion of vitamin K (further discussed in Fig. 9.4), and about one year. They also show retinal degener-
this might predispose to haemorrhagic stroke (Sec- ation, since α-tocopherol is an important antioxidant
tion4.6.4).54 in the eye (Section 7.10.2.2). Pregnant α-TTP– mice
show severe placental malformations and their em-
4.3.6 ProcessingofdietaryvitaminE33–35,46,54,55 bryos die in utero unless high doses of α-tocopherol
are given. α-TTP is also found in astrocytes in the
If large oral doses of α-tocopherol are taken, much brainandmayhelptosupplyα-tocopheroltoneurons
fails to be absorbed and is excreted in the faeces. (Section10.17.6.6).
Usually 25 to 80% of the α-tocopherol in diets is Tissues acquire various tocopherols from chylo-
absorbed, mostly in the mid-gastrointestinal tract, al- microns,andα-tocopherolfromVLDL,LDL,andother
though there are considerable inter-individual vari- lipoproteins. During conversion of VLDL to LDL in
ationsintheplasmalevelsachievedfromagivenoral thecirculation,partoftheRRR-α-tocopherolremains
dose.55,56Thesemaybedue,atleastinpart,togenetic in the LDL, but some is transferred to HDL; LDL
polymorphisms.Also,thevitaminEinsomefoodsis and HDL can exchange tocopherol, assisted by the
morebioavailablethanothers(e.g.pastacanbeabet- plasmaphospholipidtransferprotein(Fig.4.4).RRR-
ter source than seeds!).55 Being fat-soluble, all forms α-tocopherol taken up by cells from lipoproteins is

--- Page 221 ---

166 FREE RADICALS IN BIOLOGY AND MEDICINE
(a)
CHYLOMICRONS
RRR,
SRR,
γ–
LPL
RRR, SRR,
γ–
RRR, fatty acids
SRR,
INTESTINE apo E
γ–
LIVER REMNANTS
RRR,
HDL SRR,
γ–
Excess Surface
LPL,
HTGL RRR,
VLDL SRR, LDL
γ–
Vitamin E transport during chylomicron catabolism
(b) CHYLOMICRONS
RRR,
SRR,
α,
γ–
LPL
RRR, SRR,
RRR,
γ–
SRR, fatty acids
INTESTINE α, apo E
γ–
LIVER REMNANTS
γ–,SRR
HDL RRR,
γ–, Excess Surface
SRR,
?
LPL,
BILE
HTGL,
RRR, γ–,SRR,
VLDL LDL
α RRR,
α–Tocopherol transport during VLDL catabolism

--- Page 222 ---

ANTIOXIDANTS FROM THE DIET 167
(cid:3)
Figure4.4 HumanlipoproteinmetabolisminrelationtothatofvitaminE.Lipoproteinsareplasmalipidtransportvehicleswithahydrophobic
core(containingtriglycerideandcholesterolester)andasurfacepermittinginteractionwithaqueousenvironmentsandusuallycontaining
cholesterol,phospholipid,andproteins.Thefourmajorclassesarechylomicrons(CL),verylowdensitylipoproteins(VLDL),lowdensity
lipoproteins(LDL),andhighdensitylipoproteins(HDLs).(a)ThetransfersoftocopherolsduringCLcatabolism.Theintestineabsorbsand
processesdietarylipidsandsecretesCLthatcarryvariousformsofvitaminE(RRR-andSRR-α-tocopherols,β-,γ-,andδ-tocopherols,tocotrienols,
etc.)intothelymph,fromwheretheyeventuallyenterthebloodstream.Fatdigestionrequiresbile;defectsinbilesecretionimpairabsorptionoffats
andfat-solublevitamins.Chylomicronsarehydrolysedinthecirculationbyalipoproteinlipase(LPL)enzymeonthesurfaceofcapillaries,andthe
fattyacidsandtocopherolstransfertotissues.TheCLremnantscantransfertocopherolstoHDLandcanacquireapolipoproteinE(apoE),aprotein
whichdirectstheCLremnantstotheliver.TocopherolsinHDLcantransfertoothercirculatinglipoproteins,suchasLDLandVLDL(transferto
circulatingVLDLisnotshown).(b)TheeventsfollowinghepaticuptakeofCLremnants.TheliversecreteslipidsinnascentVLDL.Thehepatic
α-tocopheroltransferproteinpreferentiallytransfersRRR-α-tocopheroltoVLDL.Otherformsofα-tocopherol(suchasSRR-α-tocopherol)are
passedintobileandsotheirlifetimeinthebloodisshorterthanthatofRRR-α-tocopherol.OnceVLDLissecretedinthecirculation,bothLPLand
hepatictriglyceridelipase(HTGL)participateinitsconversiontoLDL.OnlyabouthalfoftheVLDLisconvertedtoLDL;theremainderistakenupby
theliver(notshown).DuringtriglyceridehydrolysisbyLPLandHTGL,tocopherolcanbetransferredtoHDL,inamanneranalogoustotransfer
duringCLcatabolism(transfernotshown).ThesecretionofRRR-α-tocopherolinnascentVLDLbythelivermaintainsplasmatocopherol
concentrations;theexchangeoftocopherolsbetweenlipoproteinsdeterminestheamountsinindividuallipoproteins.Plasmalevelsofα-tocopherol
peakatabout11–14hafterconsumption.Hyperlipidaemia(J.Nutr.135,58,2005),otherdysfunctionsoflipidmetabolism,andAVEDcanimpair
tocopheroldeliverytotissues.DiagramandtextbycourtesyofDrsHerbertKaydenandMaretG.TraberandtheJournalofLipidResearch.
distributedtoorganelles(especiallythemitochondria) retained, whereas the other tocopherols/tocotrienols
by intracellular transfer proteins. The brain receives arehandledmorelikexenobioticsandaremetabolized
moreα-tocopherolfromVLDL/HDLthanitdoesfrom andexcreted.54
chylomicrons(Fig.4.4)andsoisespeciallyaffectedin In vitro, γ-tocopherol is a better scavenger of RNS
AVED. Intracellular trafficking of α-tocopherol is not suchasONOO–thanα-tocopherol,butitishardtoim-
completely understood, but Fig. 4.5 summarizes our aginehowitmightdothisinvivoatsuchalowplasma
currentknowledgefortheliver.54 level,unlessitisactingwithinmembranes.Neverthe-
The α-TTP recognizes other forms of vitamin E, to less,5-nitro-γ-tocopherolhasbeendetectedinhuman
a limited extent. Compared with RRR-α-tocopherol, atheroscleroticplaqueandplasma,andlevelsareele-
itsrelativeaffinityforSRR-α-tocopherolisabout11%, vated in patients with heart disease; a contributing
γ-tocopherol is 9%, β- about 38%, and α-tocotrienol factor may be that nitrated γ-tocopherol is less well
about 9%. Consuming a lot of α-tocopherol thus de- degradedtoγ-CEHC.57ScavengingofRNSmightalso
creasesplasmalevelsofothertocopherols,bycompeti- beimportantinplants(Section7.8.8)andinthecolon,
tionforbindingtoα-TTP. where higher levels of γ-tocopherol are present (Sec-
tion7.2.2).Thereareclaimsthatγ-tocopherolcanhave
4.3.7 Thefateofγ-tocopherol46 anti-inflammatory effects in animals, but also papers
showingtheopposite.58
Stereoisomersofα-tocopherolotherthantheRRRform
are not efficiently selected by α-TTP and their turn-
over in plasma is fast, as they are discarded intobile 4.3.8 α-Tocopheroldeficiency33,42,45,46
(Fig. 4.2). Gamma tocopherol is degraded by cyto-
chromes P450 (mostly CYP4F2) to 2,7,8-trimethyl-2- Supplementing well-nourished humans with α-
(2(cid:4)-carboxyethyl)-6-hydroxy-chroman (γ-CEHC) (Fig. tocopherol has little or no effect on rates of lipid
4.2), which is excreted in human urine after conjuga- peroxidation (at least as measured by F -IsoPs), but
2
tione.g.withglycine,taurine,sulphate,orglucuronic what can be learned by examining deficiency states?
acid. γ-CEHC can act as a natriuretic factor, pro- Many of the signs of α-tocopherol deficiency in ani-
moting Na+ excretion in the urine. Tocotrienols and malsarepartiallyorcompletelyalleviatedbyfeeding
α-tocopherol can be metabolized by a similar route, syntheticchain-breakingantioxidants(e.g.ethoxyquin
but the latter only when high doses are given or orpromethazine),orbyraisingtheseleniumcontentof
in AVED (Fig. 4.2); CYP4F2 acts only slowly on α- thediet(Section3.20.5).Itiswellknowntoveterinary
tocopherol. Because of its rapid metabolism, plasma practitioners, zoo-keepers, and farmers that feeding
γ-tocopherol levels rarely exceed the low μM range unsaturatedfatstoanimalsincreasestheirrequirement
evenwhensupplementsofitaretaken.Inotherwords forα-tocopherol.Forexample,feedingfishoiltohens
RRR-α-tocopherol is recognized as a vitamin and to increase the content of PUFAs in eggs resulted in

--- Page 223 ---

168 FREE RADICALS IN BIOLOGY AND MEDICINE
Table4.2 Representativehumanbloodα-tocopherollevelsinhealth sensitive to the toxic effects of pure O , exhale more
2
anddisease. hydrocarbon gases (Section 6.15.9), and accumulate
fluorescentpigments(Section11.4.7)incertaintissues
Subjects Totaltocopherol(μM)
morerapidlythannormal,especiallyiftheyarefeda
Healthyadultsandchildren 20–35
dietrichinPUFAs.Lackofα-tocopherolinthedietsof
(2–12years)*& rodentspromotesaccumulationofsenescentcellanti-
Terminfants 6–7 gen,adamagedcell-surfaceproteinindicativeof‘old’
cells (Section 7.4). Nevertheless, tocopherol-deficient
AVEDpatients(non- <5
supplemented) animals survive. It requires a combined deficiency of
both α-tocopherol and vitamin C to produce mortal-
Kwashiorkor 7
ityinweanlingguineapigs,forexample,accompanied
Gastrointestinaldiseases
byincreasedlevelsofF -IsoPsintissuesandplasma.50
-cholestaticliverdisease <2 2
In other animal studies, deficiencies of both selen-
-Abetalipoproteinaemia <2
iumandα-tocopherolarerequiredtocausesignificant
Haemolyticanaemias
-β-thalassaemiamajor 10 morbidity and often the animals still survive.60 Of
course,thismightsometimesbebecauselevelsofother
-thalassaemiaintermedia 5
-sickle-cellanaemia 4.5–20(dependson antioxidants, such as peroxiredoxins and ubiquinol,
numberoftransfusions; areincreasedtocompensate.63
Br.J.Haematol.114, Although a short-term lack of α-tocopherol in the
917,2001). human diet does not produce symptoms, it does in-
Glucose-6-phosphatedehydrogenase 12 crease susceptibility of membranes to peroxidation, as
deficiency revealed by an increased rate of haemolysis when
erythrocytes are treated with H O in vitro (peroxide
2 2
*‘Normal’valuesvaryamongdifferentpopulationsandtheabovedataareonly stresshaemolysistest;Section7.4.3).Severedepletion
illustrative.Becausetocopheroliscarriedbylipoproteins,theplasmalipidcontent of α-tocopherol (Table 4.2) in humans can occur as
influencestheplasmatocopherollevel.Henceplasmaα-tocopherollevelsare
a result of impaired fat absorption by the gut, after
bestexpressedasaratiowithtotalplasmalipidsorcholesterol(theusualrange
is4.5–6.0μmolα-tocopherolpermillimolecholesterol).Forexample,ithasbeen prolonged intravenous feeding, or as a result of an
suggestedthatsomeoralloftheapparentα-tocopheroldepletioninARDSand inborn error in metabolism such as AVED. Another
someotherdiseases(Chapter10)isduetolowerplasmalipids(Clin.Chim.Acta example,inpatientssufferingfromabetalipoprotein-
409,41,2009).TherequirementforvitaminEincreaseswhenmorePUFAsare
aemia,adefectinthemicrosomaltriglyceridetransfer
consumed,atleastinanimals.Attemptshavebeenmadetospecifyanoptimal
ratioofdietaryRRR-α-tocopheroltoPUFAs,butthishasnotbeencompletely protein (which facilitates exchange of triglycerides,
satisfactoryforhumans.WhentheprimaryPUFAinthedietislinoleicacid,asin cholesterolesters,andphospholipids),hindersassem-
mostUSdiets,aratioofapproximately0.4mgRRR-α-tocopherolto1gofPUFA
bly of chylomicrons, VLDLs, and LDL, and impairs
hasbeensuggestedasadequateforadulthumans.Asintakesofvegetableoils
delivery of vitamin E to plasma. Untreated patients
increase,vitaminEintakeincreasesaswell,becausetheoilscontainit,provided
thattheyhavenotdeterioratedtocausevitaminEoxidation.Databycourtesy
withabetalipoproteinaemiahavenegligibleplasmaα-
oftheVitaminEResearchandInformationService,alsoseeNutrition13,450, tocopherolandeventuallydevelopneuronaldamage,
1997andAm.J.Clin.Nutr.93,368,2011.
retinaldegeneration,andabnormallyshapederythro-
&Forcomparison,plasmalevelsinzoofelines(cheetah,fishingcat,lion,etc.)
cytes (acanthocytes). Neurological and retinal dis-
werealsoaround20μM(J.Nutr.133,160,2003).
ordershavesometimesbeenobservedinpatientswith
congenital defects that impair bile production, again
increased peroxidation in the egg lipids unless more relatedtoimpairedfatabsorption.Thiscanbeamelior-
vitamin E was included in the diet.59 Feeding extra atedbyadministeringlargeoraldosesofα-tocopherol
α-tocopherol to animals, such as pigs, chickens, and (sufficient to ensure some uptake by the gut), some-
cows, increases the stability of their meat against times as the water-soluble tocopheryl polyethylene
rancidityonstorage(Section11.5). glycol(Section11.5.6).64
Tissuesamplesfromα-tocopherol-deficientanimals Newbornbabieshavelowconcentrationsofplasma
show evidence of more peroxidation (e.g. as falls α-tocopherol(Table4.2),especiallyifbornprematurely.
in PUFA levels, elevated levels of F 2 -IsoPs60-62 or, Their erythrocytes are more susceptible to lipid per-
lessconvincingly[Section6.15.8],asTBA-reactivema- oxidation in vitro, although this does not normally
terial), and tissue homogenates or subcellular frac- cause a clinical problem. α-Tocopherol might also
tionsfromsuchanimalsperoxidizefasterthannormal help to protect against retinopathy of prematurity
when incubated in vitro. Deficient animals are more (Section1.5.2.1).

--- Page 224 ---

ANTIOXIDANTS FROM THE DIET 169
Lycopene 3 5 7 9 11 1315 13' 9' 5' 1'
12 4 6 8 10 12 1415
17 16 18' 3'
β-Carotene (all trans) 13' 9' 1'
1
9 13
3 5 16' 17'
18
α-Carotene
β-Cryptoxanthin
HO
OH
Zeaxanthin
HO
OH
Lutein
HO
Echinenone
O
O
Canthaxanthin
O O
OH Figure4.5 Structuresofseveralcarotenoids
foundinplantsandanimals.Thetransforms
Astaxanthin
areshown.StructuresbycourtesyofProfessors
HO
O CatherineRice-EvansandNormanKrinsky.
4.3.9 VitaminE:onlyanantioxidant, matrixmetalloproteinase-19.Onepointtoconsideris
orsomethingelseaswell?33,34,41,46 thatcellculturemediaoftencontainlittleα-tocopherol
(orascorbate;Section1.11),sothatsomecelllinesbe-
γ-Tocopherol metabolites may have physiological ef- ginwithabnormallylowlevelsoftheseantioxidants.65
fects other than antioxidant ones (Section 4.3.7). Some studies suggest a mild anti-inflammatory ef-
The same might be true for α-tocopherol, but this fect of high-dose α-tocopherol in humans.46 Another
is not firmly established. Studies on cells in cul- suggestion, based on studies of cells in culture,
ture reveal that physiological levels of α-tocopherol, is that α-tocopherol facilitates repair of membranes
but in general not other tocopherols, can de- after injury.66 Nevertheless, there are examples of α-
crease the activities of several enzymes, including tocopherol exerting anti-atherosclerotic effects in ani-
5-lipoxygenase, NADPH oxidases, protein kinase C, mals withoutaffecting levelsof lipid oxidation prod-
cyclooxygenase-2, and phospholipase A
2
. These can ucts(Section10.3.7);inonehumanstudy,γ-tocopherol
lead to inhibitory effects on cell proliferation (e.g. improved vascular function but did not alter F -IsoP
2
in smooth muscle cells), platelet aggregation, and levels(Section9.13.3).
monocyteadhesion/O•–production.α-Tocopherolalso α-Tocopheryl succinate (Fig. 4.2) has some un-
2
modulates the expression of several genes, including usual properties: it inhibits proliferation or pro-
thoseencodingtropomyosin,scavengerreceptors,and motesapoptosisofseveraltumourcelllines,whereas

--- Page 225 ---

170 FREE RADICALS IN BIOLOGY AND MEDICINE
α-tocopheroldoesnot.Itsusetotreatcancerisunder raw tomatoes are rich in lycopene, but little is ab-
evaluation. How α-tocopheryl succinate works at the sorbed. More is taken up from cooked tomatoes or
molecularlevelisuncertain,anddifferentmechanisms tomatopaste,e.g.onpizzas.Thereisalsoconsiderable
havebeenproposedindifferentcelllines.Onesugges- person-to-personvariationinabsorption.
tion is that it increases mitochondrial O•– production
2
to trigger apoptosis.67 Several other derivatives of α-
tocopherol(e.g.α-tocopheryloxyaceticacid,wherethe
4.4.1 Carotenoidchemistry
–OH group is replaced by –OCH COOH) have been
2
suggested to have similar properties.67 γ-Tocopherol Carotenoids have long chains of alternating double
wasalsoreportedtoinduceapoptosisinprostatecan- andsinglebonds(Fig.4.5).Thisallowsextensiveelec-
cercellsbyinterferingwiththesphingolipidpathway tron delocalization, causing carotenoids to absorb in
(Section5.4).Tocotrienolshavebeensuggestedtoex- the UV and visible ranges, the latter generating their
ertanticancereffects(basedoncellcultureandanimal beautiful colours. The basic skeleton of carotenoids
model studies) and to inhibit hydroxymethylglutaryl has40carbonatoms(althoughsomehavefewer)and
co-enzyme A reductase, the first enzyme in choles- can be modified by cyclization at one or both ends,
terol biosynthesis.68 More experiments are needed to by reducing certain double bonds, or by addition of
establishthephysiologicalrelevanceoftheseclaims.69 oxygen-containingfunctionalgroups(Fig.4.6).Carot-
Use of tocotrienols in the treatment of liver disease enoidsthatcontainoneormoreoxygensareknownas
and stroke has been proposed, although any benefi- xanthophylls,theparenthydrocarbonsascarotenes.
cial effects that they may have could be unrelated to Carotenoids are usually known by their trivial
antioxidantproperties.70,71 names, although a semi-systematic scheme has been
devised based on the stem name carotene, preceded
4.4 Carotenoids72 by two Greek-letter prefixes that indicate the end-
groups present (Fig. 4.6). Thus β-carotene should be
Carotenoids, of which the first to be isolated (in called β, β-carotene, α-carotene is β,ε-carotene, and
1831)wasfromcarrots(hencethename!),areagroup zeaxanthinisβ,β-carotene-3,3(cid:4)-diol.Inprinciple,each
ofcolouredpigments(usuallyyellow,red,ororange) doublebondinacarotenoidcouldexistascisortrans
thatarewidespreadinplants(Figs4.5and4.6).They geometricisomers,buttransformsaremorecommon
are also found in some animals (e.g. goldfish, sal- in nature, presumably because the most stable form
mon,birdplumage,andlobsters)andcertainbacteria of long polyunsaturated chains is usually a linear,
(e.g. Staphylococcus aureus; Section 8.7.4.12) and fungi trans,extendedconformation.Cisbondskinkthechain
(e.g. N. crassa). Hundreds of carotenoids have been andgreatlymodifytheoverallmolecularshape.Some
described. Carotenoids originating from the diet are cis isomers do occur, however, including several cis
foundinthetissuesofseveralanimals,includingfer- isomers of lycopene, and 9-cis-β-carotene. However,
rets,gerbils,andhumans,butnotinmanyotherani- the human gut prefers to absorb all trans-β-carotene.
mals (e.g. rodents, sheep, hares, or elephants). Either Heatingoftomatoesisomerizessomeofthelycopene
they are not absorbed and/or they are completely fromall-transtoseveralcisisomers;bothcisandtrans
broken down in the GI tract. In humans, most carot- forms can be absorbed and are present in human
enoids are found in adipose tissue (80–85% of total plasmaandtissues(e.g.prostategland).Thebiological
body amount) and liver (8–12%), but the concentra- significance of isomerization is unknown. Lycopene
tionishighestinthecorpusluteumoftheovaryand is also metabolized into polar products, which are
intheadrenalgland.Luteinandzeaxanthin(Fig.4.5) excretedinurine.73
are present in the macula of the eye (Section 7.10.4). As would be expected from their structures, carot-
Tissueandplasmacarotenoidlevelsvarywithdiet:hu- enoidsareveryhydrophobicandcompletelyinsoluble
manplasmalevelsareusuallyinthemicromolarrange inwater.Thiscausesaproblemincellculturestudies—
(e.g. lycopene, 0.5–1.0 μM; β-carotene, 0.2–0.6 μM; howtodeliverthemtothecells?Oftenorganicsolvents
α-carotene,0.05–0.1μM;lutein,~0.3μM). such as tetrahydrofuran are used, but at the fairly
Theamountsof dietary carotenoidsabsorbed from low solvent levels which cells can tolerate, there is
thehumanGItractarevariableanddependonwhat likely to be some carotenoid precipitation in the cul-
food mixtures are eaten (some dietary fat is required turemedium.Carotenoidsinbloodarelocatedinthe
for carotenoid uptake) and on how the food is pro- circulatinglipoproteins.Intissuestheyoccurwithinfat
cessed.Absorptionisusuallyincomplete.Forexample, stores,inthehydrophobicinteriorofmembranes,and

--- Page 226 ---

ANTIOXIDANTS FROM THE DIET 171
17 18 17 16 17 16
R
1 3 5 R 2 1 6 2 1 6 R
16 2 4 6 3 3
4 5 18 5 18
4
ψ
β ε
17 16 16
16 CH R
2 1 6 R 17 1 6 5 2 18 17 2 1 6 R
3 4 5 18 2 3 4 3 4 5 18
γ
κ φ
16
17 2 1
R Figure4.6 Somedifferentend-groupsfoundin
6
3 naturalcarotenoids.Forexample,β-carotenehas
5 twoβ-groups,α-carotenehasoneβ-andone
18 4 ε-group.DiagramfromFASEBJ.9,1551,1995,
χ bycourtesyofDrGeorgeBrittonandthepublishers.
boundtohydrophobicdomainsofcertainproteins.The chylomicrons (whether specific uptake proteins are
carotenoidswithpolargroups(e.g.xanthophylls)may also involved is unclear, as yet), and they are dis-
sometimeslocateataqueous/lipidinterfaces. tributedtotissuesbyuptakebothfromchylomicrons
(involving lipoprotein lipase) and from lipoproteins
(VLDL,HDL,andLDL).Theliver(andpossiblysome
4.4.2 Metabolicrolesofcarotenoids72 othertissues)canalsoconvertβ-caroteneintoretinol.74
Theirbest-establishedroleinhumansisasaprecursor Birdsfrequentlyusecarotenoids(aswellasmelan-
ofthefat-solublevitaminvitaminA,sometimescalled ins, porphyrins etc.) to colour themselves, often in
retinol.VitaminAisessentialforcellgrowthanddif- sexualornamentation.Oneamusingsuggestionisthat
ferentiation, and in vision (Section 7.10); vitamin A having plenty of unoxidized carotenoid (and hence
deficiencyisamajorcauseofblindnessintheworld. bright colours) is a sign of low oxidative stress and
Over50carotenoids(notincludinglutein,zeaxanthin,
hencefitnessasapotentialmate.75However,arecarot-
orlycopene)cangeneratevitaminA,butthemostim- enoidssuchgoodantioxidantsinvivo?
portantisβ-carotene.Indeed,inhumanseatinglargely
plant-baseddiets,carotenoidsarethemajorsourceof
4.4.3 CarotenoidsandvitaminAas
vitamin A. A variable percentage (estimated as 35– antioxidants?76,77
88%) of dietary β-carotene is absorbed, mostly in the
duodenum.β-caroteneiscleavedtotwomoleculesof Carotenoidsaregoodantioxidantsinsomesituations.
thealdehyderetinalbyaβ-carotenemonooxygenase The carotenoid staphyloxanthin may act as an anti-
enzyme(BCMO1)intheduodenalmucosalcells,and oxidant in S. aureus (Section 8.7.4.12). In plants, ca-
theretinalthenreducedtoretinol.74Thisenzymealso rotenoids play a key antioxidant role, helping both
actsonafewothercarotenoids,toeventuallyproduce to quench singlet O and to deter its formation dur-
2
retinol.Enzymelevelsdropwhenthebodyisreplete ing photosynthesis (Section 7.8.5). Indeed, β-carotene
with retinol, so that high doses of β-carotene do not administrationisprotectiveagainstlight-inducedskin
cause excess vitamin A accumulation. A second en- damageinporphyriapatients(Section2.6.4).Sunlight
zyme with a broader substrate specificity (BCDO2) depletes lycopene in skin, consistent with some pro-
exists, but seems less important overall than BCMO1 tective role of this carotenoid against UV damage.78
in vivo.74 Undegraded carotenoids enter the body in The overall importance of this protective effect of

--- Page 227 ---

172 FREE RADICALS IN BIOLOGY AND MEDICINE
carotenoids in skin (better to use a sunscreen!), eye orbyadditionreactions,
(Section 7.10.4), and other tissues is uncertain. Lyco-
Car+RO
•→[Car–OOR] •
pene appears to be the best singlet O quencher in 2
2
organic solvents in vitro, although all the carotenoids Additionproductscouldinterceptanotherradical,or
areverygood. reactwithO togiveaperoxylradical,
Invitro studieshaveshownthatβ-carotenecanin- 2
hibit peroxidation of lipid systems at low O 2 levels, [Car-OOR] • +R1O• 2 →R1-OOCar-OOR
butnotathighO concentration.However,β-carotene ↓
2
was reported not to protect LDL against peroxida- decompositionproducts
tion, whatever the O 2 concentration.79 Nevertheless, [Car-OOR] • +O
2
→[OO-Car-OOR] •
carotenoids are capable of scavenging some RS (Sec-
tion4.4.3.1)andmightdosoincysticfibrosispatients Thiylradicalscanaddtocarotenoids(k 2 forGS• ~2×
(Section 10.9.1). Vitamin A can also scavenge RS (as 108M–1s–1),
wouldbeexpectedfromitsdouble-bondstructure;Sec- RS • +Car→[Car–SR] •
tion5.12.6),butnodataexistsupportinganantioxidant
roleinvivo.Indeed,studies(again invitro)havesug- possibly followed by O addition to give a peroxyl
2
gestedpro-oxidanteffectsofhighlevelsofretinol.For radical,
example,itincreasedlevelsofoxidativeDNAdamage
inSertolicellsinculture80 andadministrationofhigh [Car–SR] • +O 2 (cid:2)[RS–Car–OO] •
dosestopregnantratsincreasedoxidativedamagein Carotenoids also react with OH• (as does everything
thefoetallung.81 Indeed,highdosesofvitaminAare
elseofcourse!),
probablyteratogenicinhumans.
OH • +CarH→Car • +H O
2
4.4.3.1 Docarotenoidsreactwithradicals?
The carbon-centred (Car•) radicals formed by the
Yestheydo:suchreactionscanbestudiedbypulsera-
abovereactionsarestabilizedbyextensiveelectronde-
diolysis(Section2.3.3.1), becausethecarotenoidsand
localization. Hence reaction with O to give peroxyl
theirradicalsabsorblightstrongly.Withoxidizingrad- 2
radicals,
icals, electron transfer can occur. For example, when
nitrogendioxidereactswithβ-carotene(writtenCaror Car • +O (cid:2)CarO •
2 2
CarHbelow)aradicalcationresults.Similarreactions
occurwithCCl O•andRSO • , is slow. The Car• could add to another radical, for
3 2 2
example,
NO • +Car→Car •++NO– k ~1×108M–1s–1
2 2 2
Car
•
+RO
•→Car–OOR(non-radicalproduct)
PossiblefatesofCar•+includedismutation, 2
Whereas reaction of carotenoids with RO • and OH•
2Car
•+(cid:2)Car+Car2+ 2
could inhibit lipid peroxidation, radicals such as
andreactionwithascorbate(assumingthatCar•+ was [OO–Car–OOR]•, and CarO 2 • could propagate lipid
peroxidation by abstracting hydrogen. Hence it
presentnearamembraneorlipoproteinsurfacetoin-
is easy to see why O concentration affects the
teractwithreductantsintheaqueousphase),thiols,or 2
antioxidant/pro-oxidant properties of carotenoids in
eventyrosine,
lipidsystemsinvitro.Anotherfactortobeconsideredis
Car•++Asc– →Car+Asc•–
thedifferentsolventsinwhichtheabovereactionshave
Car•++RSH→RS•+H++Car beenstudied,whichcanalterthereactionmechanism.
The rate constants for reaction of carotenoids with
Car•++TyrOH→TyrO•+H++Car
these various radicals are high, at first glance sug-
Peroxylradicalscanreactwithcarotenoidsbyelectron gesting that carotenoids in membranes and lipopro-
transfer, teins might be capable of reacting with them in vivo.
Whetherornotsuchreactionswouldprotectthesur-
H++RO •
2
+Car→Car •++ROOH
roundingPUFAsandproteinsdependslargelyonthe
reactivities of the various carotenoid-derivedradicals
byhydrogenabstraction,
that can be formed, and on the O level. Animal
2
CarH+RO •→Car • +ROOH membranes usually contain more α-tocopherol and
2

--- Page 228 ---

ANTIOXIDANTS FROM THE DIET 173
ubiquinol than carotenoids, so it is hard to envis- of carotenoids is reacted with radicals, LC•+ can ‘re-
age much contribution by carotenoids as free-radical pair’ any other Car•+ radicals and so the lycopene is
scavengers.Interactionsofα-tocopherolwithcaroten- preferentially oxidized.76 Whether this occurs in vivo
oids have been suggested to occur, but rather than isuncertain.Lycopeneaccumulatesinseveralhuman
carotenoids converting α-tocopheryl radical back to tissues,includingtestisandprostategland.Some(in-
α-tocopherol,thereversereaction, conclusive) epidemiological studies suggest that con-
sumption of tomato products might lower risk of
Car •++αTOH→Car+α-TO • +H+ prostate cancer (Section 4.6.7) and administration of
tomatosaucewasreportedtodecreaselevelsofoxida-
seems preferred, at least under some reaction condi-
tiveDNAdamage,bothinwhitecellsandinprostate
tions.
biopsiesofhumanvolunteers.87 Remember,however,
Ingeneral,withafewexceptions(e.g.Section10.9.1),
that lycopene and/or products derived from it (even
administrationofcarotenoidshaslittleornoeffecton
if they work!) might act by mechanisms other than
levels of biomarkers of oxidative damage in humans
antioxidant action, e.g. by promoting gap junctional
oranimals.Thus,theiroverallradicalscavengingabil-
communicationorinterferingwiththeproproliferative
ityinvivoseemslimited.However,thisdoesnotmean
effectsofandrogensandgrowthfactorsbymodulating
thattheyareunimportant;theycouldexertbeneficial
signaltransductionpathways.82
effectsbyothermechanisms,regulatingcell–cellcom-
municationorgeneexpression,forexample.Caroten-
oids, or sometimes their oxidation products, such as 4.5 Flavonoidsandotherphenols88,89
2,7,11-trimethyltetradecahexaene-1,14-dialfromlyco-
A phenol is any compound that contains an –OH
penebreakdown),82canfacilitatecell–cellcommunica-
groupattachedtoabenzenering.Monophenolshave
tionviagapjunctions(bystimulatingsynthesisofthe
one such aromatic –OH group, diphenols two, and
connexinproteins;Section5.2.4).Increasedcommuni-
polyphenols more than two. Plants contain a huge
cationdecreasesgrowthoftransformedcellsinculture.
rangeofphenols,includingthetocopherolsandtoco-
The relevance of these effects in vivo is uncertain, al-
though volatile products of β-carotene degradation trienols(monophenols).Themonophenolthymol(Fig.
4.7) is often used as an antiseptic and antioxidant in
may act as ‘stress signals’ in plants (Section 7.8.4).
commercialenzymesuspensions(e.g.ofcatalase;Sec-
Some carotenoids have been suggested to exert anti-
tion 3.17) and can exert effects that have sometimes
atheroscleroticeffects(Section10.3.8.2).
beenmistakenlyattributedtothecatalase.
Almostallphenolsexertadegreeofantioxidantac-
4.4.3.2 Stabilityofcarotenoids
tivityinsomeassayoranotherinvitro,ofteninhibiting
Purecarotenoids,evenassolids,aresusceptibletooxi-
lipid peroxidation by acting as peroxyl radical scav-
dation and can break down to a complex mixture of
engersthatstopthechainreaction(Sections4.4.3and
products, as evidenced by loss of their characteristic
5.11.5). In addition, phenols often scavenge other RS,
colours(bleaching).Sometimestheoxidationproducts such as OH•, NO • , N O , ONOOH, and HOCl, and
2 2 3
(particularlyepoxidesandhighly-reactivealdehydes)
can slow down peroxidation induced by haem pro-
show cytotoxic effects in vitro83 and may activate the
teinsplusH O ,byscavengingtheferrylradical(Sec-
2 2
Nrf2system,whichispotentiallybeneficialofcourse tion 3.22.3). Somephenolscan reactwith O•–, mostly
(Section5.5.8).84Thelikelypresenceofoxidationprod-
thedi-andpolyphenols(Section2.5.3).90Phe
2
nolswith
uctsincarotenoidpreparations(theycanalsobegen-
two adjacent –OH groups, or other chelating struc-
erated in vivo non-enzymically or by enzymes such
tures, can bind transition metal ions (especially iron
as BCDO2 or lipoxygenase [Section 8.11.3]) is a fac-
and copper), often in forms poorly active in promot-
tor to be considered by those who wish to consume ing free-radical reactions; this chelating ability can
carotenoidsupplements,ortoexaminetheeffectsofca-
sometimeshinderuptakeofmetalionsfromthediet.
rotenoidsoncellsinculture.83,85Indeed,thehalf-lifeof
Many plant polyphenols are excellent antioxidants
lycopeneincellculturemediahasbeenstatedasonly
whenassayedinvitro.Mostattentionhasbeengivento
twohours.86
theflavonoidssuchasquercetin,foundinhighlevels
in onion, wine, teas, and many other plant products;
4.4.3.3 Theinterestingcaseoflycopene
Fig.4.8).Thenumberofphenolic–OHgroupsandtheir
Thelycopeneradicalcation(LC•+)isthemoststrongly relativepositionsarekeydeterminantsofantioxidant
reducing of all the carotenoids. Hence if a mixture activityinvitro.

--- Page 229 ---

COOH CH
2
CH CH CHO CH CH CH 3 CH 2 CH 2 OH
2
OH OH
OH OCH 3 OCH 3 CH OH
OH OH OH H 3 C CH 3
Caffeic acid Vanillin Eugenol Thymol Hydroxytyrosol
OH CH OH CH
3 3 COH OH OH CHO
HO H O O C CH CH 3 O HO C CH CH 3 HO OH
O HO CH 3 H 3 C OH
CH CH
H 3 C CH 3 H 3 C CH 3 H 3 C CH 3 H 3 C CH 3
Carnosic acid Carnosol Gossypol
OH
OH O COOH HO O+
OCH 3 HO CH C CH
CH O CH 2 OH
OH
HO OH OH
Guaiacol Rosmarinic acid Pelargonidin
(an anthocyanin)
OH
HO O HO O
CH
HO CH
O OH O
OH OH OH
Resveratrol Daidzein Genistein
O O
OH
OH H 3 CO CH C C CH OCH 3
CH CH 2 CH
HO OH
Hydrox
O
yh
H
ydroquinone
Curcumin H3C COOH
O
O
H 3 CO C CH CH 3
HO
COOH CH3 CH3
HO CH C 2 H CH 3 H 3 CO OO CH3 CH3
HO O
HO CH CHCOCH
3 HOOC O O H3C CH3
OCH
3
OH HO OH
OH
Cinnamophilin Dehydrozingerone Glycyrrhizin
Figure4.7 Structuresofsomeplantphenols.Theisoflavones,suchasgenisteinanddaidzein,haveaweakantioestrogen-likeactivity,and
contributetotheabilityofcertainplants(eateninexcess)tointerferewithreproductioninanimals.Resveratrolexistsincisandtransforms;the
latterisshownasitisthemorecommonisomer.

--- Page 230 ---

ANTIOXIDANTS FROM THE DIET 175
Hydroxylation pattern
Generic structure Flavonoid
2’ 3’ 4’ 5’ 3 5 6 7 8
Flavane 3’
2’ B 4’
O 5’
8 6’ Catechins (cid:129) (cid:129) (cid:129) (cid:129) (cid:129)
7 A C 2 Meciadonol (cid:129) (cid:129) Methoxy (cid:129) (cid:129)
6 3
5 4
Flavanone
O Taxifolin (cid:129) (cid:129) (cid:129) (cid:129) (cid:129)
Naringenin (cid:129) (cid:129) (cid:129)
Naringin (cid:129) (cid:129) Rhamno-
glucoside
O
Flavone
O
Luteolin (cid:129) (cid:129) (cid:129) (cid:129)
Apigenin (cid:129) (cid:129) (cid:129)
O
Flavonol Quercetin (cid:129) (cid:129) (cid:129) (cid:129) (cid:129)
Myricetin (cid:129) (cid:129) (cid:129) (cid:129) (cid:129) (cid:129)
O Gossypetin (cid:129) (cid:129) (cid:129) (cid:129) (cid:129) (cid:129)
Fisetin (cid:129) (cid:129) (cid:129) (cid:129)
Cirsiliol (cid:129) (cid:129) H (cid:129) Methoxy
OH Morin (cid:129) (cid:129) (cid:129) (cid:129) (cid:129)
Kaempferol (cid:129) (cid:129) (cid:129) (cid:129)
O
Galangin (cid:129) (cid:129) (cid:129)
Baicalein H (cid:129) (cid:129) (cid:129)
Rutin (cid:129) (cid:129) Rutinose (cid:129) (cid:129)
Quercitrin (cid:129) (cid:129) Rhamnose (cid:129) (cid:129)
Gossypin (cid:129) (cid:129) (cid:129) (cid:129) (cid:129) Glycoside
Figure4.8 Structureandhydroxylationpatternofsomemembersoftheflavonoidfamily.TakenfromFoodChem.Toxicol.33,1061,1995,
bycourtesyofDrJoeFormicaandElsevier.Thefamilymembersincludeflavones,3-hydroxyflavones(flavonols),catechins(flavanols),anthocyanins,
isoflavones,andflavanones.Theflavonoidcorestructurecontainsthreerings(A,C,B):variationsinringCandtypeofsubstituentsproducethe
differentmembersoftheflavonoidfamily.
4.5.1 Phenolsinthediet89,91
fromtheleavesoftheplantCamelliasinensisforalmost
Thehumandietisrichinphenols.Forexample,soy- 50centuries,isanimportantsourceofdietaryphenols
bean contains tocopherols, isoflavones (e.g. genistein tomanypeople.Greenteaisrichincatechins,whereas
and daidzein), and caffeic acid (Fig. 4.7). Taxifolin blackteahasfewerbutadditionallycontainscomplex
(Fig.4.7)occursinpeanuts.Resveratrol(thetransform; polymers called theaflavins and thearubigins. These
Fig. 4.7) is found in several plants and is often pre- are formed by oxidation of catechins by the enzyme
sent at low levels in wine, being produced in the phenolase during preparation of the leaves for tea
grapesasadefenceagenttoxictofungi(Section8.11). manufacture.Ingreenteamanufacturingthisenzyme
Curcumin gives the yellow colour to the curry spice isinactivatedbysteamingtheleaves.Catechin,epicat-
turmeric, obtained from the roots of the plant Cur- echin,andepigallocatechingallatearealsosignificant
cuma longa. Sesame seed oil contains sesamol, esters contributors to the total antioxidant activity of red
of caffeic acid (Fig. 4.7) are present in several plants, wine(Section6.17.3).Cottonseedoilcontainsayellow
and green teas are rich in catechins (Fig. 4.9), which polyphenol,gossypol(Fig.4.7),whichhasspermicidal
contribute much of their in vitro antioxidant activity effects and has undergone (unsuccessful due to side-
(Section6.17.3).Tea,abeveragethathasbeenprepared effects)clinicaltrialsasamalecontraceptive.

--- Page 231 ---

176 FREE RADICALS IN BIOLOGY AND MEDICINE
OH OH
OH OH
CO H
2
OH O OH O
OH
OH OH
OH OH
OH OH
OH
gallic acid catechin epigallocatechin
OH OH
OH OH
OH O OH O
OH
O C O O C O
OH OH
OH OH OH OH
OH OH
epicatechin gallate epigallocatechin gallate
Figure4.9 Structureofgallicacidandthecatechins.AdaptedfromFreeRadic.Biol.Med.20,933,1996,bycourtesyofProfessorC.Rice-Evans
andElsevier,Amsterdam.
Herbs and spices have been used for centuries to (givingrutin)or,moreusually,toglucose.Forexample,
preservefoodsandwerevaluabletradingcommodit- onion contains quercetin 4(cid:4) glucoside and quercetin
ies; in the book of Exodus in the Old Testament it is 3,4(cid:4)-diglucoside. Most flavonoids in plants are glyc-
stated that spices were added to oil to keep it fresh. osylated,exceptforthecatechins.
Theyarerichsourcesofantioxidants:extractsofsage,
4.5.1.1 Dohumansandotheranimalsabsorb
rosemary,redpeppers,chilli,tarragon,ginger,thyme,
and oregano inhibit lipid peroxidation, largely due
phenols?91
to the phenols present. These include carnosic acid Yes but not completely, the amount absorbed var-
androsmarinicacidinrosemary,dehydrozingeronein ies between animal species and individuals and de-
ginger,andphenolicacidamidesinblackpepper.Oilof pends on the compound. For example, in humans,
clovescontainseugenol(Fig.4.7),sometimesaddedto anthocyaninsarelesswellabsorbedthanquercetinor
dentalmaterialsasananalgesicandantiseptic.Wood catechins.Glycosidesareusuallyhydrolysedbyintes-
smokecontainsvariousphenols,suchasguaiacol(Fig. tinalglycosidaseenzymes(especiallylactasephlorizin
4.7), that can inhibit lipid peroxidation in smoked hydrolase),andsomeoftheresultingphenolsareab-
foods and is widely used to assay peroxidases (Sec- sorbed. Unabsorbed phenols enter the colon, where
tion3.19.2).Olivescontainhydroxytyrosol(Fig.4.7). polyphenols are extensively metabolized by the gut
Phenols are often present in plants as conjugates flora to monophenols and other products, some of
with sugars (glycosides). Thus quercetin can be whichcanenterthecirculation.Thosephenolsthatare
attached to rhamnose to give quercitrin or rutinose absorbedarerapidlymetabolizedbymethylationand

--- Page 232 ---

ANTIOXIDANTS FROM THE DIET 177
glucuronidationof–OHgroups,inthegutitselfandin flavonoidscanrecycletheα-tocopherylradical,which
theliver.Theliveralsocatalysessulphationofphenols. could conceivably contribute to antioxidant effects in
Forexample,when[14C-]quercetinwasadministered LDL,100butascorbatemaybemorelikelytodothisin
tohumans,about36to53%wasabsorbed;18to27% vivobecauseitispresentatmuchhigherconcentrations
of the radioactivity appeared in urine, but <5% in thanareflavonoids(Section4.3.4).Teetotallersmaybe
faeces. The majority was detected as exhaled 14CO , pleasedtolearnthatphenolsintea,grapejuice,cocoa,
2
indicativeofextensivedegradation.92Plasmalevelsof darkchocolate,andmanyotherfoodsalsoinhibitLDL
unconjugated polyphenols rarely exceed 1 μM, even oxidationinvitro;wineisnotessential.
in subjects consuminglarge amounts in thediet, and Second, an epidemiological study in the Nether-
levels of ‘free’ quercetin in human plasma are virtu- lands (the Zutphen study) suggested an inverse cor-
ally zero; most is present as glucuronides and some relation between the incidence of coronary heart dis-
assulphates.91Similarly,plasmalevelsofresveratrolin ease and stroke and the dietary intake of flavonoids
winedrinkersareverylow(Section11.3.4). (especially the flavanol quercetin), which originated
Dietary flavonoid intake in the USA and Denmark mostly from tea, fruits (e.g. apples) and vegetables
has been estimated as ~20 to 25 mg/day, and total (e.g. onions) in the population examined. Since then
polyphenolintakecanbeover100mg/dayinsubjects severalotherepidemiologicalstudieshaveconfirmed
consumingdietsrichinfruitsandvegetables.91,93,94In similarassociations,andextendedthemtocorrelations
Asiancountries,consumptionofsoyamaydeliverup of intake with better endothelial function and less
to20to40mgisoflavonesdaily.Subjectswhodrinka cognitivedecline,althoughafewstudieshavenotde-
lotofcoffeemayingest0.5to0.8gofhydroxycinnam- tectedacorrelation.94LiketheUSAandDenmark,total
atesperday. dailyflavonoidconsumptionintheNetherlandsises-
timatedasatleast23mg,ofwhichabout16mg/day
is quercetin, more than the average daily intake of
α-tocopherol(7–10mg).
4.5.2 Arephenolsantioxidants
Itwaswidelyassumedthattheseapparentbeneficial
invivo?89,91,95,96
effects were due to antioxidant actions of flavonoids.
Within plants, some phenols are important biosyn- Sincethen,manystudieshaveusedbiomarkersofoxi-
thetic precursors (e.g. caffeic acid for lignin; Sec- dativedamage,suchasF 2 -IsoPsand8OHdG,toseeif
tion8.5.3).Others(e.g.thered/blueanthocyanins)can flavonoidsexertantioxidanteffectsinvivoinhumans
actasphotoprotectantsinplantsexposedtohighlight andotheranimals.Someapparentantioxidanteffects
intensity.97Theanthocyanins,plustheyellowaurones (lowering the levels of these biomarkers) have been
and chalcones, may attract pollinating insects. In the found,e.g.inseveralstudiesinvolvinggreentea,soy,
centralvacuolesofleavesbothphenolsandperoxidase dark chocolate, cocoa, dealcoholized wine, garlic ex-
maybepresent.AnyH O intheleafthatescapescon- tracts, blackcurrant and grape juices, and with some
2 2
sumptionelsewherecandiffuseintothevacuoleandbe involvingindividualphenols,suchashydroxytyrosol
consumedasacosubstrateintheoxidationofphenols or quercetin.95,101,102 Of course, a protective effect of
by peroxidase. Ascorbate in the vacuole may recycle flavonoid-richfoodsorbeveragesshouldnotnecessar-
theoxidizedphenols.98 ily be interpreted as a protective effect of flavonoids.
Aredietaryphenolsantioxidantinthehumanbody? For example, the ability of green or black tea to de-
Vitamin E is (Section 4.3), but what about the oth- creasetheincidenceofUV-inducedskincancerinhair-
ers?Twoobservationshighlightedthisquestion.First, lessmiceturnedouttobeduetothecaffeinepresent.103
phenols in red wine were found to inhibit LDL oxi- However,therearemanynegativereports,inwhich
dation in vitro, and it was suggested that they could administration of pure phenols or flavonoid-rich
exert cardioprotective effects by limiting LDL oxida- foods, has failed to lower the levels of biomarkers of
tioninvivo.99 Thiswasproposedasanexplanationof oxidativedamage(Section4.6.3.1andrefs95,104).Since
the lower incidence of heart disease in certain areas plasma levels of unconjugated flavonoids rarely ex-
of France despite the high prevalence there of risk
ceed1μMandthemetabolitestendtohaveloweranti-
factors, such as smoking and high fat intake (the oxidantactivitybecauseoftheblockingof–OHgroups
French paradox). Alcohol alone, however, has cardi- by methylation, sulphation, or glucuronidation, it
oprotectiveeffects(atmoderateintakes)andthedebate seems difficult to imagine a powerful antioxid-
continuesastowhetherwinehasanyadditionalbene- ant effect in vivo given the high levels of other
fit due to its flavonoid content (Section 9.8). Some antioxidants present. Nevertheless, greater levels of

--- Page 233 ---

178 FREE RADICALS IN BIOLOGY AND MEDICINE
phenolsexistinthestomach,smallintestine,andcolon 4.5.3 Pro-oxidanteffectsofphenols?
and could conceivably exert antioxidant, and other,
protectiveeffectsthere(Section7.2.2).Asecondpoint Di-andpolyphenolscanoftenchelatetransitionmetal
to consider is that the levels of some biomarkers of ions, but the chelates are not always redox-inactive;
oxidative damage, such as F -IsoPs, seem to change sometimesmixturesofmetalsandphenolscanstimu-
2
when fasted people are re-fed, even if the food does lateoxidativedamagetoDNAorproteinsinvitro(but
not contain antioxidants,105–107 and falls in biomarker notusuallytolipids,sincethechain-breakingantiox-
levels could be misinterpreted as antioxidant effects. idant effect predominates). As we have already com-
Forexample,levelsofplasmaoxidizedLDLorurinary mentedforvitaminsCandE(Sections4.2.3and4.3.5),
8OHdGdecreasedwhensubjectsweregivenoliveoil, the physiological relevance of these effects is uncer-
but oillowin antioxidantswasjust as effective.107,108 tain,althoughO -andironion-dependentoxidationof
2
Champagneconsumptionimprovedvascularfunction phenolscontributestoaromadevelopmentinwines.115
inonehumanstudy,butfakechampagne(withoutthe Severalstudieshaveshowncytostaticorcytotoxicef-
phenols) did so also, although to a lesser degree.109 fectsofflavonoidsoncellsinculture,andafewhave
Hence, appropriate controls are essential in feeding demonstratedantitumoureffectsofadministeringhigh
experiments. levelstoanimalmodelsofcarcinogenesis.89,96,116Many
oftheclaimedcellulareffectsareartefacts:polyphenols
4.5.2.1 Morethanantioxidants89,91,96,110 rapidlyoxidizeincommonlyusedcellculturemedia,
Flavonoidsarenotonlyantioxidants:theyhavemany generating both H 2 O 2 and quinones/semiquinones
other effects in vitro. Thus some can inhibit telomer- that can injure cells.117 Phenols also oxidize at high
ase (Section 11.3.5), protein glycation, XO, the pro- temperatures; for example this produces levels of
teasome, COX-1 and -2 (Section 8.12), lipoxygenases H 2 O 2 in instant coffee that are >100 μM and in teas
(Section 8.12), topoisomerase-1 (Section 10.16.2), and >50μM.118 Asaresult,thesebeveragesappearmuta-
matrix metalloproteinases (Table 8.2). Genistein and genicinsomebacterialtestsystemsthataresensitive
daidzeinhaveananti-oestrogenaction,whichislikely toH 2 O 2 .Drinkingcoffeeevenleadstoelevatedexcre-
to be more important than their limited antioxidant tion of H 2 O 2 in the urine, since some of the autoxid-
ability. Flavonoids can modulate signal transduc- izable compounds, such as benzenetriol (sometimes
tion mechanisms, including protein kinases, platelet- called hydroxyhydroquinone; Fig. 4.7) are absorbed,
derived growth factor (PDGF) receptor, AP-1, and re-excreted,andcontinuetogenerateH 2 O 2 intheurine
NF-κB (Section 5.5.6). Resveratrol and related com- (Section2.6.2).118 Thereisnoevidencethatsuchlevels
pounds can activate the sirtuins (Section 11.3.4). ofH 2 O 2 causeharm:nosignificantdeleteriouseffects
InapoE-knockoutmice,severalpolyphenolsdecreased of coffee drinking have been revealed in numerous
both atherosclerosis and F -IsoP levels in the lesions. epidemiological studies and the balance of evidence
2
YetepicatechindecreasedF -IsoPsbuthadnoeffecton suggestsbenefitratherthanharmfromgreenandblack
2
lesion size, suggestive of protection by certain phen- teas.Otherphenolsthathaveshownanticancereffects
olsviaanon-antioxidantmechanism.101Humanaortic in animal models include resveratrol and curcumin
atherosclerotic lesions have been reported to contain (Fig. 4.7).116 However, curcumin inhibits thioredoxin
someboundquercetinandcatechins.111 reductase,causingittobecomeanNADPH-dependent
Do remember, however, that plasma levels of fla- ROS-generatingenzyme(Section3.13.1andref119)and
vonoids are low and may not be sufficient to exert itsoxidationproducts,butnotcurcuminitself,canin-
these effects in vivo in humans; the activities of their hibittopoisomerase.119AOfcourse,pro-oxidantsmight
metabolites may be of more relevance. For example, sometimeshaveananti-cancereffect(Section10.16)as
3’-O-methyl-epicatechin was a much better inhibitor wellasdefendingtheorganismbyleadingtoactivation
of endothelial cell NADPH oxidase activity than epi- ofNrf2(Section5.5.8).
catechin itself.112 Nevertheless, all the above actions Moreresearchisneededtoassessthephysiological
are feasible at the levels present in the gut.95 For ex- importance of plant phenols as anti- or pro-oxidants
ample,ingestionofgreenteapartiallyinhibitedCOX in vivo. Possible biological effects of any flavonoid-
in human rectal mucosa.113 In addition, there is evi- derivedradicalsgeneratedduringantioxidantactivity
dence that consumption of blackcurrant juice, cocoa, must also be considered; this might help to explain
and dark chocolate can improve vascular function someofthesideeffectsofgossypolandeugenol.Both
in the short term in humans. How this happens is inhibit lipid peroxidation in vitro, but their resulting
uncertain.102,114 radicals can damage other molecular targets such as

--- Page 234 ---

ANTIOXIDANTS FROM THE DIET 179
DNA (again in vitro). Quercetin oxidation produces (Section2.6.2)haveoftenbeenusedinherbalmedicine,
quinonesthatconjugatewithGSHandcandepleteit and contain many phenolic and other plant-derived
in cultured cells (Fig. 4.10), although quercetin (and compounds, including caffeic acid phenethyl ester
probably other flavonoid-derived) phenoxyl radicals (Section5.5.6).RootsoftheplantPolygonumcapsidatum,
canbereducedbacktoquercetinbyascorbate,invitro used extensively in traditional Chinese medicine, are
atleast. richinresveratrol.
Never assume, however, that natural products are
4.5.4 Herbalmedicine120 safe to consume just because they are natural.
Examples of noxious agents produced by plants
There is considerable interest in the development of include cyanide and aflatoxin (Section 10.15).
flavonoids, other polyphenols, and their derivatives Nordihydroguairetic acid (Table 11.7), a powerful
fortherapeuticuse,e.g.asanti-inflammatory,antican- inhibitor of lipoxygenase-catalysed and non-enzymic
cer,anti-ischaemic,andanti-thromboticagents.96,116,119 lipidoxidation,isolatedfromthecreosotebushLarrea
An extract of the maidenhair tree Ginkgo biloba has divaricata, is no longer used as a food preservative
beenused‘toimprovememory’forthousandsofyears because of adverse toxicological reports. An extract
(Sections4.6.8and10.17.6.10). oftheplantCratoxylumcochinchinense,isolatedonthe
Kampo medicines are traditional in Japan; they basisofitspowerfulantioxidantactivity,turnedoutto
are extracts of multiple herbs and contain a complex becytotoxic.121 Flavonoidsincreaseddamageinmouse
mixture of phenols and other compounds, includ- autoimmuneencephalomyelitis,amodelformultiple
ing glycyrrhizin (Fig. 4.7) from roots of the licorice sclerosis122 and high doses of green tea extract can
plant, Glycyrrhiza glabra. Extracts of propolis, a res- cause liver damage in humans, possibly involving
inous substance used by bees in hive construction GSH depletion (Fig. 4.10).123 Nevertheless, curcumin
OH
OH O
OH O
HO O O(cid:129)
HO O
OH
OH O OH
OH O
Semiquinone radical quercetin o-quinone
OH OH
OH
O O O
O O HO O HO O
O O
O
OH OH O OH OH O
quercetin p-quinone methide I quercetin p-quinone methide II quercetin p-quinone methide III
GSH
OH OH
OH OH
SG
HO O HO O
+
SG OH OH
OH O OH O
6-glutathionyl quercetin 8-glutathionyl quercetin
Figure4.10 Quercetinandsomeofitsoxidationproducts.OxidationofthecatecholstructureintheBringinitiallyformsasemiquinoneradical,
whichcanthenformaquinone,whichhasseveralisomericforms.ThiscanreactwithGSHtogive6-or8-glutathionyl-quercetins(FreeRadic.Biol.
Med.51,2118,2011).AdaptedfromFreeRadic.Res.36,103S,2002,bycourtesyofProfessorIvonneM.C.M.RietjensandTaylorandFrancisLtd.

--- Page 235 ---

180 FREE RADICALS IN BIOLOGY AND MEDICINE
administration decreased124 oxidative damage and basisofthepresenceorabsenceofaparticulardisease.
brain pathology in a transgenic mouse model of Controls are randomly selected and can be matched
Alzheimerdisease,andseveralpaperssuggestneuro- for other criteria (e.g. age, sex, and smoking status).
protective effects of flavonoids and flavonoid-rich Thecase-controldesignisverysuitableforthestudyof
foods.110 Don’t assume that these are necessarily uncommondiseases.However,thereisastrongpossi-
mediated by antioxidant effects, however, especially bilityofrecallbiasasthesubjectstrytorememberwhat
astheamountsofflavonoidsthatcanenterthehuman theyate,didetc.inthepast.Associationsbetweenthe
brain seem very low. They could act by improving disease and a dietary factor are usually expressed as
vascular function and hence blood flow to the brain, anoddsratio(casecontrolstudies)orasrelativerisk
or even by affecting the bacterial composition of the (cohortstudies).Table4.3showsexamples.
colon.125 Nestedcase-controlstudiesarecase-controlstudies
using patients from (‘nested in’) a cohort study, who
4.6 Dietaryantioxidants:insightsfrom develop a particular disease. Exposures measured as
epidemiology91,94,126,127 partofthecohortstudyarecomparedbetweenpatients
and controls from the same cohort. For example, the
Epidemiology is the science that explores the distri- Honolulu heart study examined 8006 Hawaiian men
bution and determinants of disease in populations.
whoseα-tocopherolintakewasassessedatenrolment,
Its methods were first applied to epidemic diseases and followed them to see who developed coronary
such as smallpox and cholera, hence the name. One heart disease. A nested case-control study of 84 of
early example was the discovery that cholera inci- thesesubjectswhodevelopedParkinsondisease(PD)
denceisrelatedtoconsumptionofwaterfromspecific showed that, by comparison with 336 age-matched
(contaminated)sources. controlsfromthesamecohort,thereappearedtobeno
Epidemiologicalstudiesmaybedescriptive(e.g.cor-
relationshipofdietaryα-tocopherolintaketotherisk
relatingtheincidenceofadiseasetoaparticularhabit ofdevelopingPD.128
ordiet)orexperimental(e.g.takingadietarysupple- Manyepidemiologicalstudieshaveexaminedanti-
mentandseeingwhathappenstodiseaseincidence). oxidants,butletuslookfirstatsomeoftheearlyones
Manycountriesconductregularsurveysoffoodcon- thatsuggestedtheirimportanceasdisease-preventing
sumption patterns, nutritional status indicators, and agents. There are marked differences in cardiovascu-
incidenceofvariousdiseases(cross-sectionalstudies). lar disease incidence in different European countries:
Epidemiologists use these data in attempts to relate ingeneral,theincidenceishighinthenorth(e.g.Fin-
diseaseincidencetodietindifferentcountries(cross- landandScotland)andlowinthesouth(e.g.southern
cultural studies), within regions of the same coun- Italy). If populations are standardized to correct for
try, or over time (longitudinal studies)—looking for knownriskfactors,suchaselevatedplasmacholesterol
changesindiseaseincidenceandattemptingtorelate or smoking, there is an approximate inverse correla-
them to changes in diet. For example, one can com- tion between coronary events and lipid-standardized
paretheincidenceofmyocardialinfarction(Fig.4.11) plasma α-tocopherol (Fig. 4.11). Data from this and
orstomachcancerbetweendifferentcountries,andcan other studies allowed calculation129 of plasma anti-
also observe what happens to incidence rates when oxidant levels apparently associated with low risk of
people move between countries (migration studies). cardiovascular disease (Table 4.3). Similarly, the Zut-
Incohortstudies,subjectsareidentifiedonthebasisof phenelderlystudy94examinedriskfactorsforchronic
theirexposuretothefactorofinterestandfollowedto diseaseinelderlymen,andfoundadecreasedriskof
examinetheirdiseasestatus.Cohortstudiesareoften mortalityfromheartdiseaseinsubjectswithelevated
prospective,healthysubjectsbeingfollowedforwards flavanol (Fig. 4.8) intake, even after correction for in-
intime.Forexample,plasmaantioxidantlevelsordiet-
takesofvitaminC,α-tocopherol,andβ-carotene(Table
aryantioxidantintakemightbemeasuredatthestart 4.3).Nocleareffectsofflavonoidintakeoncancerrisk
of the study and subsequent disease appearance in wereobservedinthis(orlater)studies.).
thesubjectsexamined.Cohortstudieshavetheadvan- The Nurses’ Health Study, a prospective cohort
tageoffollowingthetemporalsequenceofthedisease study, began in 1976 in the USA with 121,700 fe-
pathogenesisandarelessproneto‘recallbias’onthe male nurses. In 1980, 87,245 nurses aged 34 to 59,
partoftheparticipants,sincethe‘exposure’datawere free of detectable cardiovascular disease, completed
collected before the onset of the disease of interest. dietary questionnaires that attempted to assess their
In case-control studies subjects are recruited on the consumptionofarangeofantioxidants.Ateightyears’

--- Page 236 ---

ANTIOXIDANTS FROM THE DIET 181
North Europe
High Finland
Scotland
Northern Ireland
Denmark
Medium Germany
Israel
Switzerland
Italy
France
Spain
Low
South Europe
Decreasing incidence of heart disease mortality
North Europe
High Finland
Scotland
Northern Ireland
Denmark
Medium Germany
Israel
Switzerland
Figure4.11 Across-culturalstudy:mortalitydue
Italy
France
toheartdisease(top)andplasmaα-tocopherol
Spain levels(below)indifferentEuropeancountries.
Low DiagramadaptedfromAm.J.Clin.Nutr.53,3265,
South Europe
1991,bycourtesyofthepublishersandDr
Increasing level of plasma vitamin E (lipid standardised) FredGey.
Table4.3 Relationshipbetweenriskofcoronaryheartdisease(CHD)andplasmaconcentrations/intakesofcertain‘antioxidants’.
Antioxidant Concentration(μM)associatedwith
ModerateriskofCHDa LowerriskofCHDa
Carotene(mostlyβ-carotene) <0.3 >0.4–0.6
α-Tocopherol <24 >27–28
α-Tocopherol;cholesterolratio(μmol/mmol) <4.1 >4.8–5.6
Ascorbate <24 >35–60
Daily flavonol intake 19.1–29.9
(mg)b0–19
MortalityfromCHD(per1000person-years) 20.4 14.5
Relativeriskaftercorrectionforintakeoftotalenergy,saturatedfats,bloodpressure, 1.00 0.58
physicalactivity,weight,smoking,totalandHDLcholesterol
aModerateriskofCHD,>250deaths/106;lowerrisk,<130deaths/106.DataaretakenfromGey,KF(Bibl.Nutr.Diet.51,84,1994andref129).Similarly,inelderly
subjects(70–75years)therewasaninversecorrelationbetweenplasmaαplusβ-caroteneandmortalityfromcancerandcardiovasculardisease(Am.J.Clin.Nutr.82,
879,2005). bFromHertog,MGLetal.Lancet349,699,1997.

--- Page 237 ---

182 FREE RADICALS IN BIOLOGY AND MEDICINE
follow-up,437non-fatalheartattackshadoccurredas vascular disease (stroke plus cardiovascular disease)
wellas115deathsfromcoronarydisease.Thosenurses did not correlate with vitamin E intake, although
inthetop20%ofdietaryα-tocopherolintake(ascalcu- there was some inverse correlation with vitamin C
lated from the questionnaire) showed 23 to 50% less intake.131
heart disease after adjustment of the data to correct
for age and smoking.Women whotookα-tocopherol
4.6.1 Problemsofinterpretation
supplementsforshortperiodshadlittleapparentbene-
fit,butthosewhotookthemformorethantwoyears Thestudiesreviewedabovesuggestedtheimportance
hadarelativeriskofmajorcoronaryheartdiseaseof of antioxidants, yet they relied on measurements of
0.38 to 0.91, after adjustment for age, smoking, other diet and disease incidence, neither of which is easy
riskfactors,andintakeofotherantioxidantnutrients. toquantityaccurately.Thequalityofmedicalrecords
There was no relation to vitamin C intake, although and disease classifications varies between countries.
this was above 60 mg/day even in the lowest quin- Dietary intake is commonly measured using 24-hour
tileandisthereforeinconclusive(seeTable4.3andthe dietary recalls, keeping diaries of food intake over
commentinTable4.4). severaldays,orfood-frequencyquestionnaires.Food-
In 1986, the Health Professionals Study began; compositiontablescanthenbeusedtocalculatenutri-
39,910 US males (dentists, veterinary surgeons, phar- entintake.Allofthesemethodshavetheirproblems,
macists, opticians, osteopaths, and podiatrists) 40 to asonecaneasilyimagine,addedtowhichthereiscon-
75 years of age and free of obvious coronary dis- siderable inter-individual variation in the uptake of
ease,completedquestionnairesdesignedtoassesstheir dietaryα-tocopherolandcarotenoidsfromthegutby
intake of vitamin C, β-carotene, and α-tocopherol. humans(Sections4.3and4.4).Food-compositiontables
During four years of follow-up, 667 cases of coron- maybeinaccurate;thecompositionofafoodmayvary
ary disease were observed. After controlling for age between countries and regions and depends on how
and other risk factors, a lower risk for coronary dis- long it is stored. Bias in recording can alter risk esti-
ease was observed among men with calculated high mates(e.g.ifobesepeoplesystematicallyunder-record
α-tocopherol intakes. For men consuming more than their food intake whereas non-obese people do not).
60 International Units per day the relative risk was Also, diets can change over time, a problem in lon-
0.49 to 0.83, compared with those taking less than gitudinal studies. Too many of these uncertainties in
7.5unitsperday.Ascomparedwithmenwhodidnot assessmentofdiet,orofdiseaseincidence,willobscure
use α-tocopherol supplements, men who consumed anyrelationship.
at least 100 units per day for at least two years had Some studies measure ‘biomarkers’ of body anti-
a relative risk of 0.47 to 0.84 for coronary disease. oxidant levels, examples being white cell ascorbate,
Bycontrast,dietaryβ-caroteneintakewasnotassoci- plasma β-carotene, or levels of α-tocopherol in adi-
ated with a lower risk among those who had never pose tissue or erythrocytes. More studies are needed
smoked, but among smokers, high β-carotene intake ontherelationbetweendietaryintakeandsuchparam-
did appear associated with lower risk. A high intake eters.Forexample,concentrationsofα-tocopheroland
of vitamin C was not associated with a lower risk of vitaminCinplasmachangequicklyafteralterationsin
coronarydisease,butagainthiswas,onthewhole,a dietaryintake,whereasα-tocopherollevelsinadipose
well-nourishedpopulation. tissue do not. Unfortunately, plasma concentrations
However,inaEuropeanmulticentrestudy(EURA- of α-tocopherol correlate poorly with adipose tissue
MIC; European Community Multicentre Study on levels.132 Bycontrast,levelsofcarotenoidsintheskin
Antioxidants,MyocardialInfarctionandBreastCan- seemtocorrelatewellwithplasmalevels(Section7.13).
cer), α-tocopherol and β-carotene concentrations in However, the major problem with interpreting the
human adipose tissue were measured. There was studies is that correlation does not prove a cause–
no difference in α-tocopherol levels between people consequence relationship. For example, cross-cultural
who had had heart attacks and controls. Adipose studies show a relation between cardiovascular dis-
tissue α-tocopherol levels were used as a (putat- ease rates and the number of television sets or tele-
ively) more accurate measure of α-tocopherol status phonesperthousandmembersofthepopulation.This
than dietary questionnaires. Low β-carotene levels is(presumably!)notacause-and-effectrelationshipbut
were associated with a higher incidence of myocar- due to the fact that TV sets and telephones (and the
dial infarction, but only in patients who smoked.130 consumptionofdietarysupplements!)aremarkersof
Similarly, in a Japanese study, the incidence of increasing ‘prosperity’, which tends to be associated

--- Page 238 ---

ANTIOXIDANTS FROM THE DIET 183
Table4.4 Commonlyusedcriteriaforinferringcausationfromepidemiologicaldata.
Proposedcriterion Comment
Biologicalplausibility,i.e.therearephysiologicalreasonsfor Runstherisksofignoringphenomenawhich,atthetime,havenoobvious
expectingthecorrelation.Forexample,LDLoxidationisinvolved explanation,yetforwhichthestatisticalevidenceisequallystrong.Alsoruns
inatherosclerosisandinvitroisinhibitedbyα-tocopherol,soone theriskofassumingwhatyouaretryingtoprove.
wouldexpectα-tocopheroltohaveananti-atheroscleroticeffect.
Strengthofthecorrelation;strongrelationobservedconsist- Difficultiesincollectingreliabledatatendtoobscurerelationships(Section
entlyinseveralstudiesconductedbydifferentcountries. 4.6.1).Thusifthecorrelationisveryclear-cutitisdifficulttoexplainitaway,
e.g.thatbetweencigarettesmokingandlungcancer.
The effect is dose-responsive, e.g. the lower the intake of Anegativeresultcanoccurifthereisacorrelationonlyoveragivenrange
a given nutrient the higher the incidence of a particular dis- ofintakes.Forexample,60mgofvitaminCperdaymaybeenoughtogive
ease.Oftensubjectsaredividedintotertiles(groupsof33.3%), maximumprotectiveeffectagainstcardiovasculardisease(Table4.5).Astudy
quartiles(25%),orquintiles(20%)ofintake,bloodlevels,etc. ofvitaminCintakeversussuchdiseaseinacountrywithawell-nourished
population(averagevitaminCintakewellabove60mg/day)willnotshowa
relationship.
Trends in the population over time match changes in Anexampleisthealterationoflungcancerincidencewithchangesinsmoking
diseaseincidence. habitsinseveralcountries.
Noneofthesecriteriacanprovecausation.
withmorecardiovasculardisease.Severalcriteriaare some subjects, ameliorating this risk factor for car-
used to assess the strength of a correlation and its diovascular and Alzheimer (Section 10.21) diseases.
likelihood to be a cause–consequence relationship Fruitsandvegetablesaregoodsourcesoffolicacidand
(Table 4.4), but none of these can establish causality NO–; both may have beneficial cardiovascular effects
2
assuch. (Sections2.5.6.6and4.7).
It is widely agreed by nutritionists that diets rich Similarly,supposethatagroupofsubjectsconsumes
in vegetables and fruits (such as the ‘Mediterranean largeamountsofvitaminCandα-tocopherolandalso
diet’, also rich in fish, nuts, olive oil, wines etc.) are showslowerincidenceofheartdiseasethanaverage.
associated with lowered incidence of cardiovascular Doesthismeanthatthesevitaminspreventheartdis-
disease,stroke,andcertaintypesofcancer,especially ease?Notnecessarily,sinceconsumersofvitaminpills
lungandoral(Section4.1).1,3,4,133β-Caroteneisacom- mightbemoreinterestedintheirhealththanaverage,
mon constituent of plants. In humans, the higher the such that they exercise more and eat better. Indeed,
plasmaβ-carotene,thelowertherisk(onapopulation there is evidence that subjects who join nutrition tri-
basis)ofdevelopingcardiovasculardiseases,diabetes, als or use supplements are ‘healthier’ than average
and some forms of cancer (e.g. Table 4.3 and ref134). (‘selection bias’).137,138 Poor people suffer more dis-
Serum carotenoid levels also seem to correlate with easethanricherpeople,andpoorpeoplemaynotcare
better lung function in young adults.135 But does β- aboutorevenbeabletoaffordvitaminsupplements.
carotene itself protect against these conditions? Or is In the UK, USA, and probably elsewhere, the lowest
itsimplyamarkerofagooddiet?Thus,eatingmore social classes have the lowest plasma vitamin C and
plantswillraiseplasmaβ-carotenelevels,butitcould α-tocopherollevels,andpovertyisstronglylinkedto
be anything (or any combination of things) in the diseaseincidence.139
plantsthatistheprotectiveagent.136 Plantscontaina
hugerangeofpotentiallyprotectiveagents,somedir- 4.6.2 Thegoldstandardofinterventiontrials:
ectly so and others acting as mild toxins that raise hopeunfulfilled126,127,138,140
thelevelofantioxidantdefencesinvivo(Section5.5.8;
Table 4.5). For example, oltipraz and sulphoraphane Thebestwayaroundthe‘cause–consequence’conun-
(Table4.5andFig.4.12)mayhelptoincreaselevelsof drum is to conduct intervention trials. One could,
phaseIIenzymesbyactivatingtheNrf2system(Sec- for example, supplement a group of subjects with an
tion5.5.8).Afruit-andvegetable-richdietisoftenlow antioxidant and compare their fates with a matched
in fat and contains more polyunsaturated fats (PU- placebogroup.Theuseofaplacebo,ideallycompletely
FAs)thansaturatedfats,andhighsaturatedfatintake indistinguishablefromthetestcompound,allowsboth
is a risk factor for cardiovascular disease and some subjects and investigators to be unaware of who is
cancers. Such a diet may lower plasma cholesterol in receivingwhat(double-blinding).

--- Page 239 ---

184 FREE RADICALS IN BIOLOGY AND MEDICINE
Table4.5 Dietaryconstituentsinfruitsandvegetables:relationtopreventionofcancerandotherdiseases(notethattheseagentscanonlywork
iftheyarepresentattheappropriatesiteinvivoatsufficientconcentrations).
Class Examples
Antioxidant effects in stomach/small intes- VitaminCreactingwithnitrosaminesinstomach.γ-Tocopherols,carotenoids,flavonoids,and
tine/colon otherphenolsmightscavengeRSintheGltract(Section7.2).
Agentsinterferingwithmetabolicactivation InhibitorsofP450(e.g.constituentsofgrapefruitjuice,garlic,parsley,chillies,andseveralherbal
orpromotingmetabolicdeactivation,ofcar- medicines),a although some compounds found in plants increase CYP levels (Carcinogenesis
cinogens 21,1157,2000).Anexampleisglucoraphanin(4-methylsulphinylbutylglucosinolate),which
is found at high levels in broccoli and is hydrolysed to sulphoraphane upon chewing the
vegetable.Thisdisruptionexposestheglucosinolatetoahydrolaseenzyme,myrosinase(Car-
cinogenesis25, 61, 2004). Many compounds such as 1,2-dithiole-3-thiones (e.g. Oltipraz),
sulphoraphane,bβ-phenylethyl-isothiocyanate(PEITC),certainflavonoids,resveratrol,curcumin,
and rosemary extract) increase the levels of ‘phase II’ enzymes and raise GSH levels via the
Nrf2system(Section5.5.8).ThiscanhappenincellsoftheGltract(Section7.2)orinother
bodytissuesifenoughofthecompoundisabsorbed.Figure4.12showsthestructuresofsome
ofthesecompounds.
Thiosulphinates Onions,garlic,otherAlliumspecies.Cancausehaemolysisincows,sheep,cats,andhorsescon-
suminggarlicoronions.Allicin(diallylthiosulphinate;Fig.4.12)isresponsibleforthesmellof
freshgarlic.Decomposesonheatingtoarangeofmono-,di-,tri-,andtetrasulphidesthatcan
generateROSandsulphurradicalsoninteractionwithhaemoglobin.Lowdosesmaybebeneficial
byincreasingthelevelsofphaseIIenzymesviaNrf2(Section5.5.8).SeeChem.Res.Toxicol.25,
47,2012.
Lipoxygenase/COXinhibitors Resveratrol,flavonoids,otherphenoliccompounds.CaninhibittheseenzymesinGltractcells
andperhapsinotherbodytissuesifenoughofthecompoundisabsorbed.Salicylateispresentin
severalplantsandmaycontributetoinhibitingCOXenzymes(Br.J.Nutr.98,802,2007).
Nitrite CanformNO•invivo,protectingthevascularsystem(Section2.5.6.6).
Inhibitorsofcellproliferation/inductionof Resveratrol,severalflavonoidsincludinggreenteaphenolics,curcumin,allicin,PEITC.Several
apoptosisintumourcells suggestions(notwellsupported)thatgreen(andtoalesserextent,black)teaconsumptionhave
anti-cancereffects.Blackteaconsumptionwasreportedtobenegativelycorrelatedwiththe
incidenceofParkinsondiseaseorstrokebutunrelatedtocoloncancer(Carcinogenesis28,2143,
2007;Stroke40,1786,2009).
Phytoestrogens:modulatetheeffectsofnat- Isoflavonoids
uralhormones
Inhibitorsofmetastasis Flavonoids,e.g.byinhibitingmatrixmetalloproteinasesorproductionofVEGF.Carotenoids(or
theirbreakdownproducts)mayencouragecell–cellcommunicationintransformedcellsandslow
theirgrowth(Section4.4.3),ifenoughgettotherightplace.
Inhibitorsofangiogenesis Genistein(anisoflavonoid),epigallocatechingallate.
Fibre Increasedspeedofmovementoffaecesthroughcolon;dilutescarcinogensand/orslowstheir
formation.
Stimulationofimmuneresponse Carotenoids,e.g.β-caroteneandvitaminE.Variableresultsreportedoneffectsontheimmune
systeminhumans.
Caloricrestriction/lowfatintake Highfatdiets,highplasmacholesterol,andobesitypromoteoxidativedamage(Sections4.1
and10.4).2Dietsrichinfruitsandvegetablesoftenhavedecreasedfatandcaloriecontentand
tendtolowerplasmacholesterol.
Selenium Contentinplantsvariable;relatedtosoilcontent.Essentialindietinmoderation.Confusingand
conflictingdataonanti-cancereffectinhumans,butingeneralnoclearprotectiverole.
Phytoalexins Resveratrol(grapes,wines).Antioxidant,anti-inflammatory,inducephaseIIenzymes,levelsin
vivoarelowduetorapidmetabolismsooverallcontributionisunclear.
Ironchelators Ithasbeenspeculatedthathighbodyironstoresareariskfactorforcardiovasculardisease
andcancer.Phytates,otherorganicphosphates,flavonoidsmaydecreaseironuptakeinthegut
(Section3.22).

--- Page 240 ---

ANTIOXIDANTS FROM THE DIET 185
Table4.5 (Continued)
Down-regulatorsoftranscriptionfactors(e.g. Capsaicin(foundinCapsicumpeppers).Caffeicacidphenethylester(Proc.Natl.Acad.Sci.USA
NF-κB),intimatelyinvolvedindisease 93,9090,1996),resveratrol,sulphoraphane,curcumin.Couldactinthegutandelsewherein
thebodyifenoughcanbeabsorbed.
Folicacid Canlowerhomocysteinelevels(Section4.7).
Psoralens Celery,parsnips.Photosensitizersof1O2formation(Section2.6.4).
Foodreductones Coffee,soysauce.OxidizetogenerateH2O2,e.g.hydroxyhydroquinoneincoffee(Section4.5.3).
Proteasomeinhibitors Epigallocatechingallate,genistein,otherphenols,curcumin.
Receptorbinding Severalflavonoids,aswellasluteinandcurcumin,canbindtothearylhydrocarbonreceptorand
decreasethetoxicityofdioxin.
aCompoundsingrapefruitjuice(e.g.furanocoumarinssuchas6(cid:4),7(cid:4)-dihydroxybergamottin)canirreversiblyinhibitCYP3A4inthegutandthuscanincreasetheoral
bioavailabilityofseveraldrugs,sometimesproducingtoxicity(BMJ346,1,2013).
bSulphoraphane,1-isothiocyanato-4-(methylsulphinyl)butane,ispresentinbroccoliandisapowerfulinducerofquinonereductaseandotherphaseIIenzymes,butnot
ofCYPs.Oltiprazisfoundincruciferousvegetables.Dithiolthioneshavebeenreportedtoinducehaemoxygenaseandferritinwhenadministeredtoanimals.
1 2 3
S S SS O
N S S S CH 2 CH 2
N CH 3 S H 3 C CH 2 CH 2 N C S
4 5
Figure4.12 Structuresofsomeofthe
O
CH 2 CH 2 N C S compoundsmentionedinTable4.5:(1)oltipraz;
H 2 C CH S S CH CH 2 (2)1,2-dithiole-3-thione;(3)sulphoraphane;
CH 2 CH 2 (4)β-phenethylisothiocyanate;and(5)Allicin
(diallylthiosulphinate).
Intervention trials are the ‘gold standard’ of epi- Sadly,theinterventiontrialswithantioxidantshave
demiology:inprinciple,theywillgiveaclearanswer. yieldedamorassofconfusingdata(Tables4.6and4.7).
However,theyareexpensiveandproblemscanoccur Wewillshortlyexaminesomeindetailandseewhat
ifsubjectsdonotcomplywiththeregime(ideally,com- wentwrong,butletusfirstcommentonbiomarkers.
plianceshouldbemonitored,forexamplebymeasur-
ing blood levels of the administered substance), or if
4.6.3 Theneedforbiomarkers
baselineparametersdriftwithtime.Forexample,sup-
pose that over a five-year study testing the effects of One major problem is that any beneficial effects of
vitaminCsupplementsontheincidenceofcardiovas- antioxidantssuchasascorbate(Table4.3)mayonlybe
culardisease,averagedietaryintakesofvitaminCin exertedoveracertainrangeofintake.Ifmostorallof
thepopulationincrease.ThiscanhappenifvitaminCis thestudypopulationisalreadyreceivingthatamount
beingaddedtomorefoods,and/orifthereisageneral from diet, the trial may mistakenly conclude that the
driftinthepopulationtowardseatingmorevitaminC- antioxidantisuseless.Anothererroristhatalmostall
richfoodsbecauseofencouragementbypublichealth studies assumed that consuming more antioxidants
agencies.Thiswillminimizedifferencesbetweenthose woulddecreaseoxidativedamage,withoutmeasuring
receiving vitamin C supplements or placebo. Such such damage to prove that it did decrease.136,140 Yet
driftshaveindeedbeendescribedintheUSANational we now know that ‘antioxidants’ often do not de-
HealthandNutritionExaminationSurvey(NHANES); crease oxidative damage in humans in vivo. For ex-
studies in 2003–2004 on 7277 subjects showed higher ample,manystudiesshowlittleeffectofflavonoidson
serum vitamin C concentrations on average than in oxidativedamage(Section4.5.2),onlyverylowintakes
1988–1994, but about 7% of the subjects still showed of vitamin C are associated with rises in 8OHdG in
‘deficiency’levels.139 DNA (Section 4.2.1), and high-dose α-tocopherol is

--- Page 241 ---

186 FREE RADICALS IN BIOLOGY AND MEDICINE
Table4.6 Summaryofmajorantioxidantstudiesincardiovascularhealth.
Clinicaltrials Effects
Positiveresults
ATBC Marginaleffectofsupplementationwith50mg/dayofα-tocopherolformedianfollow-upof6.1yearsontheincidenceoffatal
coronaryheartdiseaseinmalesmokerswithnohistoryofmyocardialinfarction.
ASAP Significantretardationofprogressionofcommoncarotidatherosclerosisinmentakingtwicedaily91mg(136IU)ofd-α-
tocopheroland250mgofslow-releasevitaminCforthreeyears.Noeffectinwomenandlessatherosclerosisinhibitionby
individualvitamins.
CLAS Less carotid atherosclerosis progression among nonsmoking men after coronary artery bypass graft surgery was found for
highsupplementaryvitaminE(≥100IUperday)usewhencomparedwithlowvitaminEuse.NoeffectofvitaminEwith
colestipol/niacin,aswellasnoeffectofvitaminC(≥250mgperday)withcolestipol/niacinorplacebowasfound.
CHAOS Reductionofnon-fatalmyocardialinfarctioninpatientswithangiographicallyprovencoronaryatherosclerosiswithα-tocopherol
(capsulescontaining800IUdailyforfirst546patients;400IUdailyforremainder),butoddlya(non-significant)excessof
cardiovasculardeaths.
Fangetal. Retardation of the early progression of transplant-associated coronary arteriosclerosis after cardiac transplantation with
supplementationofvitaminC(500mg)plusvitaminE(400IU),eachtwicedaily.
IEISS Lowerinfarctsizeandoxidativestressinpatientswithsuspectedacutemyocardialinfarctiononcombinedtreatmentwithvitamin
A(50,000IU/day),vitaminC(1000mg/day),vitaminE(400mg/day),andβ-carotene(25mg/day).
SPACE Reductionofcompositecardiovasculardiseaseendpointsandmyocardialinfarctioninhaemodialysispatientswithprevalent
cardiovasculardiseasewith800IU/dayofvitaminEsupplementation.
WACS Marginallysignificantreductioninthecombinedoutcomeofmyocardialinfarction,stroke,coronaryrevascularization,orCVD
deathamongwomenwithpriorCVDwithvitaminE(600IUeveryotherday)treatment.Fewerstrokeswereexperiencedin
femaleswithahistoryofCVDorthreeormoreCVDriskfactorswithsupplementationofascorbicacid(500mg/d)andvitamin
E(600IUeveryotherday)for~9.4years.
Noeffect
ATBC Nopreventiveeffectinmalesmokerswithnohistoryofmyocardialinfarctionof20mg/dayofβ-caroteneonmajorcoronary
eventsandnoinfluenceof50mg/dayofα-tocopherolonnonfatalmyocardialinfarctionformedianfollow-upof6.1years.
Nosignificantdifferencesinthenumberofmajorcoronaryeventsinmalesmokerswithpreviousmyocardialinfarctionreceiving
50mg/dayofα-tocopheroland/or20mg/dayofβ-caroteneformedianfollow-upof5.3years.
CARET Nobenefitsinsmokers,formersmokersandworkersexposedtoasbestosfromcombinationof30mgofβ-caroteneperdayand
25,000IUofretinol(vitaminA)intheformofretinylpalmitateperdayfor~4.0years.
GISSI Nobenefitinpatientssurvivingrecent(≤3months)myocardialinfarctionfrom300mgdailyofvitaminE(α-tocopherol)
supplementation.
HATS NosignificantlyloweratherosclerosisprogressioninpatientswithcoronarydiseaseandlowplasmalevelsofHDLfromvitamins
E(d-α-tocopherol,400IUtwicedaily),C(500mgtwicedaily),andβ-carotene(12.5mgofnaturalβ-carotene)and50μgof
selenium.Benefitsfromsimvastatin–niacintreatmentweredecreasedbythe‘antioxidants’.
HOPE Noapparenteffectsinpatientsathighriskforcardiovasculareventsfrom400IUofvitaminEfor~4.5yearstreatment.
HPS Nosignificantreductionsinmortalityfromorincidenceofanytypeofvasculardisease,cancer,orothermajoroutcomeamong
adultswithcoronarydisease,otherocclusivearterialdisease,ordiabetesreceiving600mgofvitaminE,250mgofvitaminC,
and20mgofβ-carotenedailyforfiveyears.
MICRO-HOPE Noeffectoncardiovascularoutcomesornephropathyinmiddle-agedandelderlypeoplewithdiabetesandCVdiseaseand/or
additionalcoronaryriskfactor(s)fromdailyadministrationof400IUofvitaminEfor~4.5years.
MVP Nosignificantreductioninluminaldiameterreductionandrestenosisratespersegmentinpatientsafterangioplasty,receiving
30,000IUofβ-carotene,500mgofvitaminC,and700IUofvitaminE,allgiventwicedailyforfourweeksbeforeandsix
monthsafterangioplastywithextra2000IUofvitaminE12hbeforeangioplasty.Attenuationofbeneficialeffectsofprobucol.
PHS Noearlyorlatedifferencesintheoverallincidenceofcardiovasculardisease,malignantneoplasms,ordeathfromallcauses
amonghealthymenwithsupplementationof50mgofβ-caroteneonalternatedaysfor12years.
PPP Nobeneficialeffectsof300mg/dayofvitaminEinprimarypreventionofcardiovasculareventsinpeoplewithatleastonemajor
riskfactor.

--- Page 242 ---

ANTIOXIDANTS FROM THE DIET 187
Table4.6 (Continued)
SCPS Nosupportforastrongeffectinreducingmortalityfromcardiovasculardiseaseorothercausesof50mgperdayofβ-carotene
supplementationduringmedianfollow-upof8.2years.
SUVIMAX Nobeneficialeffectsoncarotidatherosclerosisandarterialstiffnessinapparentlyhealthypeoplefreeofsymptomaticchronic
diseasesgivenacombinationofdaily‘antioxidants’(120mgvitaminC,30mgvitaminE,6mgβ-carotene,100μgselenium,
and20mgzinc)supplementationforover7years.
VEAPS NoeffectoncarotidIMTprogressioninpeopleatlowriskforCVDof400IUdailyofvitaminE(dl-α-tocopherol)supplementation.
WACS Nooveralleffectonmyocardialinfarction,stroke,coronaryrevascularization,orCVDdeathconsideredsingleorcombinedin
femaleswithahistoryofCVDorthreeormoreCVDriskfactorsofascorbicacid(500mg/d),vitaminE(600IUeveryotherday),
orβ-carotene(50mgeveryotherday)for~9.4years.
WAVE Nocardiovascularbenefitinpostmenopausalwomenwithcoronarystenosisfrom400IUofvitaminEtwicedailyplus500mg
ofvitaminCtwicedaily.Potentialforharm.
Studiessuggestingharm(alsoseeref126)
ATBC Increasedriskoffatalcoronaryheartdiseaseinmalesmokerswithpreviousmyocardialinfarctionthatreceivedeither20mg/d
ofβ-caroteneorthecombinationof50mg/dofα-tocopheroland20mg/dofβ-caroteneformedianfollow-upof5.3years.
CARET Acombinationof30mgofβ-caroteneand25,000IUofretinol(vitaminA)intheformofretinylpalmitateperdayfor~4.0years
mayhavehadanadverseeffectontheincidenceoflungcancerandontheriskofdeathfromlungcancer,cardiovasculardisease,
andanycauseinsmokers,formersmokers,andworkersexposedtoasbestos.
WAVE Increasedriskofdeathinpostmenopausalwomenwithcoronarystenosisreceiving400IUofvitaminEtwicedailyplus500mg
ofvitaminCtwicedaily.
ATBC–Alpha-Tocopherol,Beta-CaroteneTrial;ASAP–AntioxidantSupplementationinAtherosclerosisPreventionStudy;CLAS–CholesterolLoweringAtherosclerosis
Study;CHAOS–CambridgeHeartAntioxidantStudy;IEISS–IndianExperimentofInfarctSurvivalStudy;SPACE–SecondaryPreventionwithAntioxidantsofCardiovas-
culardiseaseinEndstageRenalDisease;WACS–Women’sAntioxidantCardiovascularStudy;CARET–β-CaroteneandRetinolEfficacyTrial;GISSI–GruppoItaliano
perloStudiodellaSopravvivenzanell(cid:4)InfartoMiocardico;HATS–HDL-AtherosclerosisTreatmentStudy;HOPE–HeartOutcomesPreventionEvaluationStudy;HPS–
HeartProtectionStudy;IMT–Intima-mediathickness;MICRO-HOPE–Microalbuminuria,Cardiovascular,andRenalOutcomesintheHOPEstudy;MVP–MultiVitamins
andProbucolTrial;PHS–Physicians’HealthStudy;PPP–PrimaryPreventionProject;SCPS–SkinCancerPreventionStudy;SUVIMAX–SupplementationinVitamins
andMineralAntioxidantstrial;VEAPS–VitaminEAtherosclerosisPreventionStudy;WAVE–Women’sAngiographicVitaminandOestrogenTrial.AdaptedfromVasc.
Pharmacol.56,216,2012,bycourtesyofDrTomaszJ.GuzikandElsevierInc.
poorlyeffectiveatdecreasingplasmaF -IsoPlevelsin and meat-rich diets with higher ones.143 Does chan-
2
healthy humans (Section 4.3.8); nor did a mixture of gingdietaffectthelevels?Theevidencethatitcan,at
vitamins E and C plus β-carotene decrease levels of leastintheshortterm,isnotcompelling:whilesome
cholesteroloxidationproducts.141 StudiesinDenmark studieshaveshownthatantioxidant-richfoodsorbev-
showedthaturinaryexcretionof8OHdGwasnotde- eragescanloweroxidativedamagelevelsinvivo,many
creasedbysupplementingvolunteerswithβ-carotene, havenot,orhavegivenmixedmessages.102,106,140,144–147
vitaminC,α-tocopherol,orcoenzymeQ .142 Theau- Forexample,givingsmokers250gofblueberrieseach
10
thorsbelievethat,wheneverpossible,epidemiological day for three weeks decreased plasma levels of lipid
studiesoftheprotectiveeffectsofantioxidantsagainst peroxides,butnotofF -IsoPs,147anda‘Mediterranean
2
human disease should be accompanied by measure- diet’ did not decrease urinary F -IsoP excretion in
2
mentofbiomarkersofoxidativedamage,tocheckthat healthyhumans.148 Tomatopastedecreasedsomebio-
anantioxidanteffectwasactuallyachieved.Itmaybe markersofoxidativedamagebutnotothers,inhuman
onlythoseindividualswho,forgeneticorotherreas- volunteers.144
ons(e.g.beingtreatedforHIV;Section10.25.3),show The use of biomarkers has been criticized. First,
elevatedlevelsofoxidativestress,whorespond. thereislimitedevidencethatthecommonlyusedbio-
markersofoxidativedamagearecorrelatedwithlater
developmentofdisease,althoughdataconsistentwith
4.6.3.1 Dofruitsandvegetablesdecreasetherisk
a predictive effect of F -IsoP levels are accumulating
2
ofdiseasebyloweringoxidativedamage?
(Section 6.15.6). However, if they are not built into
Both genetics (Section 10.21.2) and dietary patterns interventiontrials,wewillneverknowiftheypredict
seemtoinfluenceF 2 -IsoPlevelsinhumanplasma;high ornot.Second,therearemethodologicalissues.How-
fruit/vegetable diets are associated with lower levels ever,wefeelthaturinary8OHdGandplasma/urinary

--- Page 243 ---

188 FREE RADICALS IN BIOLOGY AND MEDICINE
IsoPs(measuredbymassspectrometry),arenowgood an inhibition of atherosclerosis development in the
enough for general use (Sections 6.15.11 and 6.14.6). new hearts of transplant patients by administration
The use of biomarkers might also help government of vitamin C and α-tocopherol (Section 10.7.1). How-
agencies in setting recommended dietary allowances ever,theWAVE(Women’sAngiographicVitaminand
(RDAs)fortheantioxidantnutrients. Oestrogen Trial)152 study showed no benefit of an
α-tocopherol/vitaminCcombinationoncoronaryath-
erosclerosis; nor did 600 units of α-tocopherol daily
4.6.4 Cardiovascularinterventiontrials
for ten years decrease the incidence of heart disease
A wide range of studies has been carried out; some in 39,876 healthy women.153 Even worse, subjects on
are positive but overall the effects are disappoint- acombinationofα-tocopherol,vitaminC,β-carotene,
ing (Table 4.6). One of the earliest and most posi- selenium,niacin,andsimvastatin(aninhibitorofchol-
tivewastheCHAOS(CambridgeHeartAntioxidant) esterol biosynthesis) showed a 0.7% progression in
study (Table 4.6). 2002 patients with coronary ath- coronary artery stenosis; giving just niacin and sim-
erosclerosis were randomized to receive supplemen- vastatin alone produced 0.4% regression. Hence the
tary α-tocopherol or placebo, and were followed for antioxidantsupplementappearedtodiminishtheposi-
510 days.149 The α-tocopherol supplemented group tive effect of the niacin/simvastatin.154 The Women’s
showedalmost50%fewernon-fatalmyocardialinfarc- Health Study ran from 1992–2004, and 38,176 appar-
tions, but oddly no decrease (indeed it tended to in- ently healthy women in the USA were randomized
crease)infatalones.Sadly,almostallsubsequenttrials to receive 600 IU of α-tocopherol every other day or
havefailedtoconfirmtheseprotectiveeffectsofvita- placebo. After ten years of follow up, there was no
minEandindeedinsomeitshowsatrendtoincrease decreaseintheincidenceofdiabetes,cancer,orheart
morbidity.Forexample,theGISSIstudyinItalyexam- disease.155
ined11,324patientswhohadsurvivedarecentmyo- Hence,highdosevitaminEcannotberecommended
cardialinfarction.Itfoundthat1gof(n-3)polyunsat- as protective against cardiovascular disease, and it
uratedfattyacidsperday(asfishoil),butnot300units poses some risks (Table 4.6) e.g. it may increase the
ofdl-α-tocopherol,decreasedtheriskofasecondcar- riskofhaemorrhagic(butnotischaemic)stroke,prob-
diac event. The HOPE (Heart Outcomes Prevention ably because of its mild anticoagulant effect (Sec-
Evaluation) study was also ‘hopeless’; 400 units of tion 4.3.5).126,156 This conclusion is, in a sense, pre-
α-tocopherol daily failed to decrease cardiovascular dictable because the α-tocopherol probably did not
events (or cancer incidence) in 9541 subjects, at high decrease oxidative damage very much at the doses
risk because of pre-existing cardiovascular disease or given (Section 4.3.1), but in the absence of measure-
diabetes;nordiditdecreaseothercomplicationsinthe ments of oxidative damage (Section 4.6.3), one can-
diabeticsubjects.150 TheUKMedicalResearchCoun- not say if that was the reason for failure. Would
cil/BritishHeartFoundation(MRC/BHF)studyexam- vitamin E be more beneficial in people with higher
ined 20,536 adults with arterial disease or diabetes: levels of oxidative damage than usual? Some stud-
a mixture of α-tocopherol, vitamin C, and β-carotene ies with obese people suggest yes,157 also, sub-group
hadnobenefit.Wethinkitsafetoconcludethatmostor analysis of the HOPE study participants suggested
allpatientswithextensiveatherosclerosisdonotbene- that vitamin E might have decreased the incidence
fitfromα-tocopherol.VitaminCorβ-carotenesupple- of cardiovascular events in subjects with the hapto-
mentationalsoshownoconvincingevidenceofbenefit globin 2–2 phenotype, who seem more prone to de-
(Table4.6).126 velopdiabetesandcouldbeunderincreasedoxidative
However, this is not the same as saying that α- stress (Section 3.23.3.4). This view was supported by
tocopherol cannot prevent the development of athero- a further study on diabetic Hp2-2 individuals, who
sclerosis. Some trials have addressed this point and seem to gain benefits (decreased risk of cardiovascu-
appear more encouraging, but far from uniformly lar disease) from 400 units of d-α-tocopherol acetate
so. In the ASAP (Antioxidant Supplementation in daily.However,vitaminCwasnotbeneficial.158 Some
Atherosclerosis Prevention) study, a combination of have argued (but the supporting data are poor) that
slow-release vitamin C (250 mg twice daily) and the other tocopherols, especially γ-tocopherol, have
α-tocopherol (1361 U twice daily) decreased the pro- benefit, and high doses of α-tocopherol could cause
gression of carotid atherosclerosis in 256 men, but harmbydecreasingtheplasmalevelsofγ-tocopherol
not 264 women.151 A small trial (40 patients) showed (Section4.3.7).

--- Page 244 ---

ANTIOXIDANTS FROM THE DIET 189
4.6.5 Cancerpreventionbyantioxidants? subjectswhohasalreadysufferedone.However,after
threeyears,subjectsreceivingβ-caroteneshowedasig-
Thepictureisnobetterhere,assummarizedinTable
nificantlygreaterincidenceoflungcancerthancontrols
4.7.Again,anearlystudyraisedhope,whichwasthen
(relativerisk1.16),anincreasedriskofmyocardialin-
dashed.
farction,andan8%increaseintotalmortality.Onthe
ThecountyofLinxianinChinahasahighdeathrate
brightside,therewasadecreasedriskofprostatecan-
fromcanceroftheoesophagusandstomach.Inatrial
cers (sadly, an effect not convincingly confirmed in
of vitamin supplementation conducted from 1985 to
subsequent studies with α-tocopherol; indeed, some
1991, 29,584 adults (mostly non-smokers) aged 40 to
studiessuggestvitaminEenhancestheriskofprostate
68weregivenvarioussupplements,orplacebo.Itwas
found that a daily supplement containing 50 μg sel-
cancer).126,160
enium, 15 mg β-carotene, and 30 mg α-tocopherol Epidemiological studies show that high plasma
β-carotenelevelsareassociatedwithlowerriskoflung
producedabouta21%fallindeathfromstomachcan-
cancer (Table 4.3). The ATBC study suggests that β-
cer, 13% for all cancers, and about 9% fewer deaths
carotene itself is not the protective agent, and may
overallafterfiveyears,whereassupplementationwith
a mixture containing 120 mg vitamin C (plus 30 μg simplybea‘marker’ofadietrichinfruitsandveget-
ables.Indeed,eveninthisstudy,subjectswithahigh
of molybdenum!) did not. The effects were greater
intake of β-carotene from diet were less likely to de-
in younger subjects (<55 years old) Although the ef-
veloplungcancer,whatevertheyweresupplemented
fect on cancer mortality seems convincing, it is un-
with.162
certain which component(s) of the supplement was
Manysubjectswhohavesmokedfor36to37years
responsible.159 Other studies examining the effects of
are well on the way to developing various patholo-
seleniumsupplementsoncancerincidencehavegiven
gies,includinglungcancer,anditseemsunlikelytothe
variableresults,buthavenotestablishedaclearanti-
authorsthatβ-caroteneorα-tocopherolcouldreverse
cancer effect.126,160 Selenium deficiency may increase
this.Hencealogicalresultofthistrialwouldbe‘noef-
levelsofoxidativedamage,butgivingextraselenium
fect’,especiallyas β-carotenesupplementsareinany
to subjects with normal plasma levels did not alter
caseineffectiveindecreasingoxidativeDNAdamage
levels of F -IsoPs or protein carbonyls, an index of
2 inhumans(Section4.4).136,142 Indeed,thePhysicians’
oxidativeproteindamage(Section3.20.5).Bycontrast,
interventiontrials in other countries with β-carotene, Health Study in the USA138 examined the effect of
α-tocopherol,andvitaminC,aloneorincombination,
50mgβ-caroteneor325mgaspirinversusplaceboin
22,071malephysicians.Therewasnosignificanteffect
againstcancerhavegivendisappointingresults.There
(goodorbad)ofβ-caroteneoncardiovasculardisease
is no evidence of benefit, and in several studies, a
or cancer, but only 11% of the participants were cur-
suggestionofharm.126,127,160
rentsmokers.ThePhysicians’HealthStudyIIfound
no effect of vitamin E, vitamin C, or multivitamins
4.6.5.1 TheFinnishstudy
on cancer incidence, nor did a mixture of selenium
(α-tocopherol/β-carotene[ATBC]cancer (200μg/day)andvitaminE(400IU/dayofallrac-α-
preventionstudy)andCARET126,127
tocopheryl acetate) have any anti-cancer effect in the
TheATBCstudywasawake-upcalltotheenthusias- SELECT trial; indeed vitamin E seemed to increase
ticanduncriticalpromotersofhigh-dosesupplements. the risk of prostate cancer.160 In the Women’s Health
Unfortunately,ithasnotdeterredsomeofthemfrom Study, 50 mg β-carotene for two years (this part of
‘pushing’flavonoids,herbalextracts,carotenoidsother the trial was terminated early) also had no effect on
than β-carotene, and the like.161 The study began in cancerincidence,butagainonly13%weresmokers.155
Finland in 1985 and examined 29,133 male smokers
Nordidβ-caroteneaffectcancerriskintheskincancer
(age range 50–69 years, mean age 57 years) who had preventionstudy.163
smoked (on average) 20 cigarettes a day for 36 to
Whythendidβ-caroteneincreaselungcancerinthe
37years.Somereceived20mgofβ-caroteneperday, ATBCstudy?Suggestedexplanationsinclude:
others50mgofdl-α-tocopherol,someboth,andsome
placebo. They were followed for five to eight years 1. Arandomstatistical‘fluke’.Thisseemsunlikelybe-
andtheincidenceoflungcancernoted.α-Tocopherol cause the data are supported by other studies,126
had no significant effect on lung cancer, but (as in suchasAREDS2(Section7.10.5)andtheβ-carotene
CHAOS) tended to decrease the incidence of a sec- andRetinolEfficacyTrial(CARET).164 Thiswasa
ond non-fatal (but not fatal) myocardial infarction in double-blindtrialofsupplementalβ-caroteneplus

--- Page 245 ---

190 FREE RADICALS IN BIOLOGY AND MEDICINE
retinyl palmitate in 18,314 asbestos workers and and on all-cause mortality (relative risk 0.63), but no
smokers.Itwasterminatedtwoyearsearlybecause protectionagainstcardiovasculardisease.Indeed,the
lung cancer incidence appeared increased by up data suggest an increased risk of the skin cancer mel-
to 28% in the supplemented subjects. Of course, it anomainwomen.170 Agendereffectwasalsoseenin
couldhavebeentheretinol,theβ-carotene,orboth the ASAP trial (Section 4.6.4.1). Why might women
thatwereresponsible.Sincesupplementationofthe benefit less? They may have higher endogenous an-
subjectsceased,theirexcessriskhastendedtodis- tioxidant defences (Section 3.26) and also eat better
appear. The results of the Vitamins and Lifestyle and have higher baseline plasma antioxidant levels.
(VITAL)studyalsosuggestedthatconsumptionof Hence effects of supplements would be less likely to
largeamountsofβ-carotene,retinol,orluteinmight beseen.
predisposetodevelopmentoflungcancer.165 To confuse things a little more, in the Stockholm
2. β-Carotene at high doses could be toxic or could HeartEpidemiologyProgram(SHEEP),consumption
interactwithcigarettesmoketoproducetoxicprod- ofalow-dosemultivitaminsupplementwasassociated
ucts,orexertapro-proliferativeeffectonpromoted withalowerriskofmyocardialinfarctionforbothmen
cells. Data consistent with these mechanisms have and women,171 but another study (Physicians Health
beenobtainedinrats,A/Jmice,andferrets;163,166,167 StudyIIon14,641maledoctors)showednosignificant
ferrets have similar carotenoid metabolism to hu- benefitofmultivitaminsinloweringtheriskofcancer
mans. mortality.172 Overall,takingthedatatogether,thereis
3. The β-carotene may have been contaminated with onlylimitedevidenceofbenefitfrommultivitaminsin
breakdownproductsthataccelerateproliferationof thestudiesconductedtodate.171–174
promotedcells,sincecarotenoidsareunstable(Sec-
tion4.4.3.2).
4. Theβ-carotenecouldhaveinterferedwithuptakeof 4.6.7 Lycopene,othercarotenoids,andhuman
othercarotenoids(putativelymoreprotective)from disease
the diet. Data from CARET seem consistent with
As mentioned in Section 4.6.5.1, one explanation for
this; individuals on placebo who consumed more
possibledeleteriouseffectsofhighlevelsofasinglenu-
fruitsandvegetableshadalowerriskoflungcan-
trientisthattheyinterferewithuptakeofothersofthat
cer,butthiseffectwasnotseeninthesupplemented
class, e.g. β-carotene with the other carotenoids. But
subjects.164
isthereevidencethatothercarotenoidsarebeneficial?
Inanycase,thedatashowthatthebestwayofpro- Luteinandzeaxanthinhavebeenexaminedinrelation
tectingagainstsmoke-inducedpathologyistogiveup totheeye(Section7.10).Severalstudieshavefocused
smoking,ratherthantokeepsmokingandtakesupple- uponlycopene.Ahighlycopeneintakewassuggested
ments.Ifyoumustsmoke,neverconsumeβ-carotene toprotectagainstcardiovasculardisease,andagreater
supplements. mass of data suggests that high lycopene intakes or
plasmalevelsareinverselyassociatedwithriskofpros-
tate cancers. However intervention studies for either
4.6.6 Someraysofhopeandagenderbias diseasehavenotconfirmedbenefit.175,176Butbecareful
withlycopenesupplements;thiscarotenoidisveryun-
The SUVIMAX (Supplementation en Vitamines et
stableanditsoxidationproductsmaydotheopposite
MinerauxAntioxidants)168,169 studyexaminedtheef-
of what is intended (Section 4.4.3.2). Nor do supple-
fectsoflow-dosesupplementson7876Frenchwomen
mentswithotherantioxidantsseemprotectiveagainst
aged 35 to 60 and 5141 men aged 45 to 60, all ap-
prostatecancer(Table4.7).
parentlyhealthy,overseveralyears.Theyweregiven
either a placebo, or a pill containing 120 mg vita-
min C, 30 mg α-tocopherol, 6 mg β-carotene, 100 μg
4.6.8 Antioxidantsandneuroprotection;
of selenium, and 20 mg of zinc every day. These low
insightsfromepidemiology?
dosesofnutrientshadnosignificanteffectoncanceror
cardiovascular disease for the group as a whole, nor Several studies suggest an inverse relationship be-
did they lower blood lipids (in fact there was a ten- tween antioxidant intake and incidence of stroke
dency to raise them). However, for men only, there or neurodegenerative diseases. For example, in the
was a protective effect (relative risk 0.69) on cancer Shibata study, a cohort of Japanese subjects aged
incidence at several sites (e.g. lung, digestive tract) 40yearsorolderhadtheirplasmavitaminCmeasured

--- Page 246 ---

Table4.7 Clinicaltrialsofantioxidantsascancerpreventionagents(intent-to-treatresultseitherreportedorcalculatedfromthedataintheoriginalarticles).
Studyname, Interventionandprimaryoutcome Studypopulation References Cancersites RR(95%CI) Comparison
location
Physicians‘HealthStudy Intervention: 2×2 design of aspirin 22,071 healthy male physicians Cook etal., CancerCausesControl Allsites 1.0(0.9–1.0) β-carotenevsplacebo
(PHS),USA (325mg)andβ-carotene(50mgqOD) 40–82yearsofagefollowedforup 11,617–626;2000 Prostate 1.0(0.9–1.1) β-carotenevsplacebo
orbothvsplacebo to13years Colon 0.9(0.7–1.2) β-carotenevsplacebo
Primaryoutcome:CVDandtotalcancer Rectum 1.1(0.7–1.8) β-carotenevsplacebo
incidence Lung 0.9(0.7–1.2) β-carotenevsplacebo
Lymphoma 1.0(0.8–1.4) β-carotenevsplacebo
Leukaemia 0.8(0.5–1.2) β-carotenevsplacebo
Melanoma 0.9(0.6–1.2) β-carotenevsplacebo
Bladder 1.5(1.0–2.2) β-carotenevsplacebo
Brain 0.8(0.5–1.3) β-carotenevsplacebo
Pancreas 1.4(0.8–2.6) β-carotenevsplacebo
Stomach 0.9(0.5–1.8) β-carotenevsplacebo
Thyroidgland 9.5(2.2–40.7) β-carotenevsplacebo
Beta-Caroteneand Intervention:β-carotene(30mg)plusret- 18,314 adults at risk for lung Omennetal.,J.Natl.CancerInst.88, Lung 1.36(1.07–1.73) interventionvsplacebo
RetinolEfficacyTrial inol(25000IU)vsplacebo cancer: 14,254 smokers + 4060 1550–1559;1996
(CARET),USA Primaryoutcome:lungcancerincidence asbestos workers followed for
4years
Alpha-tocopheroland Intervention: 2 × 2 design; 50 mg of 29,133malesmokers50–69years ATBC Group,N.Engl.J.Med.330, Lung 0.98(0.81–1.19) α-tocopherolvsplacebo
beta-carotene(ATBC) α-tocopherol (50 mg), or β-carotene ofagefollowedfor5–8years 1029–1035; 1994 , Virtamo etal., 1.16(0.97–1.38) β-carotenevsplacebo
study,Finland (20mg),orbothversusplacebo JAMA290,476–485;2003 1.15(0.96–1.38) bothvsplacebo
Primaryoutcome:lungcancerincidence
Heinonenetal.,J.Natl.CancerInst. Prostate 0.64(0.44–0.94) α-tocopherolvsplacebo
90,440–446;1998 1.20(0.87–1.66) β-carotenevsplacebo
0.84(0.59–1.20) bothvsplacebo
Rautalahtietal.,Cancer13, Pancreas 0.96(0.56–1.67) α-tocopherolvsplacebo
617–623;2002 0.46(0.23–0.92) β-carotenevsplacebo
1.00(0.52–1.73) bothvsplacebo
Albanesetal.CancerCausesControl Colon/rectum 0.79(0.48–1.28) α-tocopherolvsplacebo
11,197–205;2000 1.06(0.68–1.66) β-carotenevsplacebo
0.82(0.50–1.32) bothvsplacebo
Continued

--- Page 247 ---

Table4.7 (Continued)
Studyname, Interventionandprimaryoutcome Studypopulation References Cancersites RR(95%CI) Comparison
location
Virtamoetal.,CancerCauses Urothelium(bladder, 1.27(0.83–1.96) α-tocopherolvs
Control11,933–939;2000, renalpelvis,ureter) 1.17(0.75–1.81) placebo
Virtamoetal.JAMA290, 1.14(0.73–1.78) β-carotenevsplacebo
476–485;2003. bothvsplacebo
Kidney(renalcell) 1.00(0.59–1.71) α-tocopherolvsplacebo
0.78(0.44–1.38) β-carotenevsplacebo
1.01(0.59–1.71) bothvsplacebo
Malilaetal.,CancerCauses Stomach 1.34(0.78–2.29) α-tocopherolvsplacebo
Control13,617–623;2002 1.55(0.92–2.62) β-carotenevsplacebo
1.38(0.81–2.36) bothvsplacebo
Wrightetal.Cancer109, Oralcavity/pharynx 0.84(0.42–1.66) α-tocopherolvsplacebo
891–898;2007 0.84(0.42–1.66) β-carotenevsplacebo
0.95(0.49–1.84) bothvsplacebo
Oesophagus 0.86(0.29–2.56) α-tocopherolvsplacebo
0.86(0.29–2.56) β-carotenevsplacebo
0.72(0.23–2.27) bothvsplacebo
Larynx 1.00(0.51–1.97) α-tocopherolvsplacebo
0.71(0.34–1.48) β-carotenevsplacebo
0.59(0.27–1.29) bothvsplacebo
LinxianStudy,China Intervention:4×2designwith8groups 29,584adultsaged40–69from Blotetal.,J.Natl.CancerInst. Oesophagus 0.97(0.81–1.17) AvsnoA
AB,AC,AD,BC,BD,CD,ABCD,or fourcommunesinLinxiancounty 85,1483–1492;1993,Qiao 0.90(0.75–1.08) BvsnoB
placebo.SupplementA:retinol followedfor6years etal. J.Natl.CancerInst.101, 1.06(0.88–1.28) CvsnoC
(5000IU),zinc(22.5mg).SupplementB: 507–518;2009 1.00(0.84–1.21) DvsnoD
riboflavin(3.2mg) Stomach 1.05(0.86–1.27) AvsnoA
SupplementC:Vit.C(120mg), 1.08(0.89–1.31) BvsnoB
molybdenum(30μg).SupplementD: 1.06(0.87–1.28) CvsnoC
β-carotene(15mg),selenium(50μg), 0.81(0.66–0.98) DvsnoD
α-tocopherol(30mg) Kamangaretal.Cancer Lung 0.82(0.59–1.14) AvsnoA
Primaryoutcome:gastricandesophageal Epidemiol.BiomarkersPrev.15, 1.16(0.84–1.60) BvsnoB
cancermortality 1562–1564;2006. 1.01(0.73–1.39) CvsnoC
0.98(0.71–1.35) DvsnoD
Quetal.J.Natl.CancerInst.99, Liver 1.19(0.87–1.64)* AvsnoA
1240–1247;2007 1.16(0.84–1.59)* BvsnoB
1.19(0.87–1.64)* CvsnoC
1.22(0.89–1.68)* DvsnoD

--- Page 248 ---

Table4.7 (Continued)
Studyname, Interventionandprimaryoutcome Studypopulation References Cancersites RR(95%CI) Comparison
location
Women’sHealth Intervention:2×2×2 design of vit. E 39,876 women aged 45 years Leeetal.J.Natl.CancerInst.91, Allsites 1.03(0.89–1.18) β-carotenevsplacebo
Study(WHS),USA (600 IU), β-carotene (50 mg), aspirin or older followed for 10 years; 2102–2106;1999
(100 mg): each alone, 3 mixtures of β-carotene was stopped after a Lee et al. JAMA 294, 56–65; 1.01(0.93–1.16) vit.Evsplacebo
2agents,andall3vsplacebo medianof2.1years 2005 Breast 1.00(0.90–1.12) vit.Evsplacebo
Primaryoutcome:CVD and total cancer Lung 1.09(0.83–1.44) vit.Evsplacebo
incidence Colon 1.00(0.77–1.31) vit.Evsplacebo
HeartOutcomes Intervention:vitamin E (400 IU) vs pla- HOPE: 9541 adults 55+ years of Lonnetal.JAMA293, Prostate 0.98(0.76–1.26) vit.Evsplacebo
PreventionEvaluation cebo age with CVD or diabetes fol- 1338–1347;2005 Lung 0.72(0.53–0.98) vit.Evsplacebo
(HOPE) and HOPE the Primaryoutcome:CVD and cancer inci- lowed for a mean of 4.5 years. Oralcavity/pharynx 0.50(0.24–1.18) vit.Evsplacebo
OngoingOutcomes dence HOPE-TOO: 7030 HOPE subjects Colon/rectum 1.22(0.86–1.73) vit.Evsplacebo
(HOPE-TOO)studies, followedfor7years. Breast 0.86(0.50–1.47) vit.Evsplacebo
International Melanoma 0.84(0.42–1.66) vit.Evsplacebo
Heart Protection Study Intervention:Vit.E(600mg)vit.(250mg) 20,536 adults of 40–80 years of HPS Group, Lancet 360, 23–33; Allsites 0.98(0.89–1.08) interventionvsplacebo
(HPS),UK andβ-carotene(20mg)vsplacebo agewithvasculardisease,ordia- 2002 Lung 1.13(0.91–1.42)* interventionvsplacebo
Primaryoutcome:CVDincidence betesfollowedfor5years. Stomach 1.32(0.91–1.90)* interventionvsplacebo
Prostate 0.90(0.72–1.13)* interventionvsplacebo
Supplémentationen Intervention: vit. C (120 mg), α- 13017adults(7876womenaged Hercbergetal.Arch.Intern.Med. Allsites 0.91(0.77–1.07)* interventionvsplacebo
VitaminesetMinéraux tocopherol(30mg),β-carotene(6mg), 35–60yearsand5141menaged 164,2335–2342;2006
Antioxydants selenium (100 μg), zinc (20 mg) vs 45–60 years) followed for a me- Meyer etal.Int.J.Cancer 116, Prostate 0.88(0.60–1.29) interventionvsplacebo
(SUVIMAX)study, placebo. dianof7.5years 182–186;2005
France Primaryoutcome:CVDandcancer
incidence
Women’s Antioxidant Intervention:2× 2×2designofvita- 7627 women at least 40 years Linetal.J.Natl.CancerInst.101, Allsites 1.11(0.95–1.30) anyvit.Cvsplacebo
Cardiovascular Study min C (500 mg/day), vit. E (600 IU), of age selected from 8171 parti- 14–23;2009 0.93(0.79–1.09) anyvit.Evsplacebo
(WASC),USA β-carotene (50 mg) each alone, 3 mix- cipants in the CVD study if they
turesof2agents,andall3vsplacebo. werecancer-free.Averagefollow-
Primaryoutcome:CVDincidence up9.4years
1.00(0.85–1.17) anyβ–carotenevs
placebo
Continued

--- Page 249 ---

Table4.7 (Continued)
Studyname, Interventionandprimaryoutcome Studypopulation References Cancersites RR(95%CI) Comparison
location
Breast 1.11(0.87–1.41) anyvitCvsplacebo
0.98(0.77–1.25) anyvit.Evsplacebo
1.01(0.79–1.30) anyβ-carotenevs
placebo
Lung 1.84(1.14–2.97) anyvit.Cvsplacebo
1.25(0.79–1.97) anyvit.Evsplacebo
1.26(0.80–1.99) anyβ-carotenevs
placebo
Colon/rectum 0.76(0.42–1.38) anyvit.Cvsplacebo
0.63(0.34–1.15) anyvit.Evsplacebo
1.32(0.73–2.39) anyβ-carotenevs
placebo
Physicians‘HealthStudy Intervention:2×2×2×2designof 14,641 male physicians aged Gaziano etal.JAMA 301, 52–62; Allsites 1.02(0.91–1.15) vit.Evsplacebo
II(PHSII),USA vitE(400IU)vitaminC(500mg),mul- 50 years or older, including 2009 1.00(0.89–1.12) vit.Cvsplacebo
tivitamin(CentrumSilver)andβ-carotene 1307menwithahistoryofprior 1.03(0.91–1.16) bothvsplacebo
(50mg)vsplacebo.Theβ-caroteneinter- cancer followed for a mean of Prostate 1.04(0.88–1.23) vit.Evsplacebo
ventionwasstoppedafter4years. 8years 1.10(0.93–1.30) vit.Cvsplacebo
Primaryoutcome:CVD and cancer inci- 0.97(0.82–1.15) bothvsplacebo
dence Colon/rectum 0.93(0.61–1.42) vit.Evsplacebo
0.93(0.61–1.41) vit.Cvsplacebo
0.73(0.47–1.14) bothvsplacebo
Lung 0.66(0.38–1.13) vit.Evsplacebo
0.71(0.42–1.22) vit.Cvsplacebo
0.84(0.51–1.40) bothvsplacebo
SeleniumandVitamin Intervention:2× 2designof selenium 35,533 men age 50 years or Lippman etal.JAMA 301, 39–51; Prostate 1.13(0.99–1.29)¶ vit.Evsplacebo
E Cancer Prevention (200μg),vitE(400IU),orbothvspla- olderwithserumPSA≤4ng/mL 2009 1.04(0.90–1.18)¶ seleniumvsplacebo
Trial(SELECT),USA cebo andnegativeDREfollowedfor7– 1.05(0.91–1.20)¶ bothvsplacebo
Primaryoutcome:prostatecancer 12years Lung 1.00(0.64–1.55)¶ vit.Evsplacebo
incidence 1.12(0.73–1.72)¶ seleniumvsplacebo
1.16(0.76–1.78)¶ bothvsplacebo
Colon/rectum 1.09(0.69–1.73)¶ vit.Evsplacebo
1.05(0.66–1.67)¶ seleniumvsplacebo
1.28(0.82–2.00)¶ bothvsplacebo
*Intent-to-treatRRcalculatedbasedondataprovidedintheoriginalarticle.
¶Indicates99%confidenceintervals.
ReproducedfromFreeRadic.Biol.Med.51,1068–1084,2011,bycourtesyofDrMichaelGoodmanandElsevierLimited.

--- Page 250 ---

ANTIOXIDANTS FROM THE DIET 195
in 1977 and were followed until 1997. Low plasma treatmentofAD(Section10.21.4).Thebalanceofpub-
vitamin C was found tobe a risk factor predictiveof lisheddataissuggestiveofamodestbenefit,although
stroke,177aswasalsoobservedinanotherJapaneseco- α-tocopherol did not help in mild cognitive impair-
hort,theJapanCollaborativeCohort.131Asimilarcor- ment (Section 10.21.4) or in Down syndrome (Sec-
relationwasalsoseeninastudyinNorfolk,UK,178and tion3.21.2).Itisalsoworthcommentingthatmemory
highvitaminCintakewasassociatedwithlowerstroke and cognition can be assessed in different ways, and
risk (especially in smokers) in the Rotterdam study, sometimestheresultsofinterventionsdifferaccording
astudyof7983subjectsaged55orover.179 However, tothetestsused!186,187
intheHealthProfessionalsStudy,dietaryintakesofα- Be cautious, however. It is difficult to alter levels
tocopherol,vitaminC,orβ-carotenewerenotrelated of α-tocopherol and vitamin C in the brain by chan-
to stroke incidence; indeed high-dose α-tocopherol gingplasmalevels(Section10.17.6).Also,supplements
supplementsseemedtoraisetheriskofhaemorrhagic could affect memory by improving vascular func-
stroke.131,156 Severalotherinterventionstudies(Heart tion or (in the case of high-dose α-tocopherol) be
ProtectionStudy,PhysiciansHealthStudyII,Women’s mildlyanti-inflammatory.Third,eveniftheyenterthe
AntioxidantCardiovascularStudy)alsofailedtofind braintheireffectsonoxidativedamagetheremightbe
protective effects of vitamin C supplements against limited. For example, α-tocopherol supplementation
stroke incidence.131 The basal levels of antioxidants in old mice increased its levels in the brain, but did
inthevarioussubjectsstudiedmaybeonefactorde- not decrease neuroprostanes, although F -IsoP levels
2
termining the effects of antioxidant supplements; in fell.188 Rememberalsothatcognitiveimpairmentmay
well-nourished populations supplements may not be lead to changes in diet, nor can people with cogni-
beneficialagainststroke.Anotherissueistheextentto tive impairment be relied upon to complete dietary
whichtheseantioxidantlevelsarereflectingintakeof questionnairesaccurately.
fruits and vegetables; good diets also protect against Studies with animals have been more positive, al-
stroke.180,181 thoughnotuniformlyso.110Feedingrats,mice,ordogs
What about Parkinson disease or dementia? Some withα-tocopherolamelioratedage-relateddeclinesin
(butnotall128)dataareconsistentwitharolefordiet- cognitive function (Section 10.21.7). Supplementation
aryvitaminE(butnotvitaminC)indecreasingtherisk ofthedietofratswithspinach,strawberries,orblue-
ofdevelopingPD.182Alzheimerdisease(AD)isassoci- berries (the last were the most effective) appeared to
ated with elevated levels of oxidative damage in the improveneuronalfunction,189althoughtheymightact
affectedbrainregions(Section10.21.4);182thepotential by improving vascular function and so maintaining
importanceofdietandlifestyleinADisillustratedby betterbloodflowtothebrain.190Wementionedearlier
theobservationthatcaloricrestrictiondecreasedbrain thatteadrinkingseemstobeprotective,althoughthere
proteinoxidativedamage(measuredascarbonyls)in are many constituents in teas, including H O ! (Sec-
2 2
micewithinafewweeks,andthiswasassociatedwith tion 4.5.3). Several, but not all, other studies suggest
improved sensorimotor co-ordination.183 Protein car- thatflavonoid-richdietspromotegoodcognitivefunc-
bonyl levels were also decreased in rat brain after a tion in later life,l91,192 although it is still uncertain to
programmeofregularexercise,184andepidemiological what extent polyphenols can enter the brain.125 One
studiessuggestthatregularexerciseisanegativerisk possiblyrelevantobservationisthatfeedingberryex-
factor for AD development (Section 10.21.7). What tractstomiceincreasesexpressionofthegeneencoding
about vitamin C, carotenoids, and vitamin E? Sev- γ-glutamylcysteinesynthetaseinthebrain,193suggest-
eral (but not all) epidemiological studies report that ive of effects on the Nrf2 systems, i.e. the blueberry
their intake or plasma levels, or in some cases brain constituentsmaybemildly‘pro-oxidant’.
levels(Section10.21.4),arecorrelatedwithbettercog- Ginkgobilobaextract(Section4.5.4)iswidelythought
nitive function, or negatively correlated with the risk tobebeneficialinimprovingcognitivefunction;some
of AD development.185,186 This was seen in the Rot- (but not all) clinical trials in the elderly support this
terdam study, for example (the effect was clearest in view, although the benefit (if any) is small.194 Given
these subjects who smoked). They are supported by therisingincidenceofADaspopulationsage,weneed
somestudiesclaimingthathighdosevitaminCand/or to pay much more attention to the extent to which
α-tocopherolimprovememoryinelderlysubjectsand changes in diet and exercise might delay its onset or
that high-dose α-tocopherol has some benefit in the ameliorateitssymptoms.

--- Page 251 ---

196 FREE RADICALS IN BIOLOGY AND MEDICINE
4.7 Otherdietaryconstituents that this happens in vivo is limited (Table 4.8). It is
andoxidativedamage even possible that some degree of PUFA oxidation is
beneficialbyactivatingtheNrf2system.196
The PUFA content of the diet affects cardiovascular Elevated plasma levels (above 15 μM) of the thiol
disease;(n-3)PUFAssuchaslinolenicacidandeicosa- homocysteine,
pentaenoic acid (EPA) decrease LDL levels and ten-
+NH
dencytothrombosisandappeartohavebeneficialef- 3
fects,althoughnotallstudieshavebeenpositive.195For HSCH CH CH COO–
2 2
example,intheGISSIstudy(n-3)PUFAsupplements
wereprotective,decreasingtheriskofsuddencardiac are a risk factor for stroke, AD, and cardiovascular
death (Section 4.6.4.1). Animal studies suggest that disease.Homocysteinearisesfromtheessentialamino
high intakes of PUFAs may increase dietary require- acid methionine. Homocysteine levels depend on the
ments for α-tocopherol (Section 4.3.8). The vitamin E activityofseveralenzymeswhichrequirevitaminsB6,
contentofvariousvegetableandfishoilsvarieswidely, B12 and folic acid (Fig. 4.13), such that inadequate
apointthatshouldbeconsidered.Anotherpointisthat intake of any of these vitamins can elevate plasma
PUFAsoxidizereadilyandsomeinterventionstudies homocysteine.Mutationsinthegenesencodingthese
mayhaveusedoxidizedpreparations:lipidoxidation enzymes can also lead to increases in homocysteine;
products can have a range of biological effects, from oneofthemostcommonisapolymorphisminthegene
injurioustoprotective(Section5.12).Docosahexaenoic encodingmethylenetetrahydrofolatereductasethatde-
acid (DHA) is very important to brain function and creases enzyme activity, and has the overall effect
brain developmentin babies (Section 10.21) and sup- of raising the folic acid intake required to maintain
plementsofithavebeensuggestedasbeneficialinAD normal plasma homocysteine levels. It has been sug-
(Section10.21.7),especiallyasproductsderivedfromit gested (but by no means proven) that homocysteine
canbeanti-inflammatory(Section8.12).AlthoughEPA damages vascular endothelium by causing oxidative
and DHA are highly peroxidizable in vitro, evidence stress.197Ifso,theeffectsofinadequateintakeofthese
Table4.8 Ifantioxidantscannotaffectoxidativedamageinhumanthenwhatdoes?
Parameteraffectingoxidativestress Suggestedstrategy
Obesity(Section10.4) Loseweight
Hyperglycaemia(Section10.5) Controlbloodglucoselevel
Excessivealcoholintake(Section9.8) Drinkless
Smoking(Section9.13) Don’tsmoke
HighplasmaLDLcholesterol(Section10.3) DecreaseLDLcholesterol
Bodyironlevels(Section11.4.10) Avoidironsupplementsunlessevidenceofanaemia;avoidmeat-richdiet
Certainfoods(Humans,e.g.darksoysauce,tomato)(cid:3) Eatdietrichinfruits,grains,andvegetables
Intake of polyunsaturated fatty acids (PUFAs)(cid:6) (docosahexaenoic Eatfishregularly
acid,possiblyeicosapentaenoicacid)(humans)
Lackofexercise(Section7.14) Exercisefrequentlyinmoderation
(cid:3)
Itisessentialtodoappropriatecontrolsintestingeffectsoffoods,becausetheconsumptionofanyfood(antioxidantornot)cansometimesalterlevelsofcertain
biomarkers(Section4.5.2).
(cid:6)
DespitethepropensityofPUFAstooxidiseinvitro,growingevidencesuggeststhattheyminimizeoxidativedamageinvivo(Ann.Med.45,455,2013;FreeRadic.
Biol.Med.47,622,2009;55,8,2013;57,201,2013;FreeRadic.Res.38,233,2004).
ThistableisadaptedfromTrendsPharmacol.Sci.32,125,2011,Nutr.Rev.,70,257,2012andref136withpermission.AlsoseeFreeRadic.Res.44,522,2010
(antioxidantsupplementsdidnotdecreaseoxidativestressinoverweightsubjectswhereasweightlossdid.2)

--- Page 252 ---

ANTIOXIDANTS FROM THE DIET 197
Diet
Tetrahydrofolate (THF)
METHIONINE
–CH donor for
3 REMETHYLATION
metabolic reactions
Methionine synthase (vit B )
12
HOMOCYSTEINE
N5-methyltetrahydrofolate
Cystathionine-β–synthase (vit B )
6
Cystathionine
Cystathionine-γ-lyase (vit B )
6
GSH Cysteine Taurine
H S
2
Figure4.13 Folatemetabolismandhomocysteineformation.Thisdiagramisconsiderablysimplified;severalintermediatestepsareomitted.
MethylenetetrahydrofolatereductaseisinvolvedintheregenerationofN5-methylTHFfromTHF.
B-vitamins are another illustration of how oxidative 4.8 Whatdoesitallmean?Whatshould
stress can result from deficiencies in nutrients that wepoormortalseat?
arenotgenerallyregardedasantioxidants(Table4.3).
For healthy subjects, there is little or no benefit from
Homocysteine is metabolized into a thioester, homo-
consuming high-dose supplements of single antioxi-
cysteinethiolactone,
dants.Indeed,highintakesofβ-carotenemaydecrease
NH body levels of other carotenoids, and high-dose α-
2
tocopherol that of other tocopherols; some of these
other carotenoids and tocopherols may be important
O
tohumanhealth(buthavenotbeenprovedtobeso).
S Maintaining a good intake of fruits and vegetables,
eating fish periodically (although mercury contamin-
that can modify protein residues and cause dam- ationisapossibleconcern202),avoidingtoomuchred
age, by a mechanism apparently involving thiyl rad- meat(Section3.22.3),203avoidingobesity(Section10.4),
ical formation.198 It can be hydrolysed by an en- and exercising moderately (Section 7.14), may be the
zymethatalsoactsontheanti-cancerdrugbleomycin best ways of minimizing oxidative damage. Indeed,
(Section10.16.3.1). F -IsoPlevelsaremoreaffectedbyplasmacholesterol
2
Lowintakesoffolateareassociatedwithincreased levels and obesity than they are by taking antioxi-
incidenceofcolorectalcancer,AD,andofneuraltube dants(Table4.8).Don’tsmoke,butifyouarealready
defects in unborn babies. Folate is required for the a tobacco addict, then all of the above dietary ad-
synthesisofthymine(theCH 3 -groupinthymineispro- vice, especially the fruits and vegetables, becomes
videdbyfolatemetabolism)andlowintakemaycause evenmoreimportant.Smokersshouldavoidhigh-dose
DNA damage by allowing mistaken incorporation of β-carotene, and probably high-dose α-tocopherol as
uracilinsteadofthymine.However,interventionstud- well,53 but should take more vitamin C and B vita-
iestoexaminethebenefitsoffolate,B6,orB12supple- mins(wesuggest500mgofCdailyandtwicetheRDA
mentationindecreasinghomocysteineandtheriskof of the B vitamins). Those whose religion (if any) al-
cardiovasculardisease,cancer,ordementiahavegiven lows it, may gain added benefit by drinking alcohol
unconvincingresults.131,199–201 inmoderation(Section9.8.1).Toomuchalcoholisnot

--- Page 253 ---

198 FREE RADICALS IN BIOLOGY AND MEDICINE
goodforyou,especiallyifcombinedwithabad(high plasmaascorbatein1214elderlysubjectsexamined204
fat,lowfruitsandvegetables)diet;ifyouover-indulge in the UK was <17 μM. This segment of the popu-
regularlyyoumaybenefitfromincreasingyourintake lation may be the only one that benefits, explaining
oftheBvitamins. why trials on well-nourished subjects (usually those
Is it worth taking a daily multivitamin/mineral who volunteer for studies) have often been nega-
pill? The SUVIMAX and ASAP studies reveal that tive. However, the data supporting benefits of mul-
you do not need high doses of supplements to gain tivitamin use are sparse (Section 4.6.6). A study in
benefit. It may be that in a large population, even Iowa suggested deleterious effects on total mortality
in advanced countries such as France, the USA, risk, especially for iron supplements,199 and in the
and the UK, and more so in rural China (e.g. in the SUVIMAXstudytherewasnoimprovementin‘health-
Linxian study), the bottom quintile or quartile is so relatedqualityoflife’.169Perhapsthinktwice(orthree
badly nourished that they are at or close to antioxid- times!) about even the multivitamins if you eat a
antnutrientdeficiency.139Indeed,thelowestquintileof gooddiet.

--- Page 254 ---

CHAPTER 5
Oxidative stress and redox
regulation: adaptation, damage,
repair, senescence, and death
Lifeispleasant.Deathispeaceful.It’sthetransitionthat’stroublesome.
IsaacAsimov
5.1 Introduction 5.1.1 Definingoxidativestressandoxidative
damage
In healthy aerobes, production of reactive species
(RS) is approximately balanced with antioxidant de- Whathappensifthisdelicatebalanceisupset,orrepair
fence systems. The balance is not perfect, however, orreplacementsystemsfail?HavingtoomanyRSinre-
sothatsomeRS-mediateddamageoccurscontinually lationtotheavailableantioxidantsisoftensaidtobea
(Table5.1).1 Inotherwords,antioxidantdefencescon- stateofoxidativestress.Althoughthistermiswidely
trol levels of RS rather than eliminate them, e.g. the used in the free-radical literature it is hard to define
OxyR system keeps H 2 O 2 levels in E. coli at about precisely.HelmutSies,whointroducedthetermfrom
0.2 μM (Section 5.5.2). Why is this? Several explan- thetitleofthebookheeditedin1985,OxidativeStress,
ations are possible. First, maintaining excess antioxi- defined it in 1991 in the introduction to the second
dantdefenceswouldhaveanenergycost—itcouldbe edition2asadisturbanceintheprooxidant–antioxidantbal-
energetically ‘cheaper’ to repair or replace damaged ance in favour of the former, leading to potential damage.
biomolecules. Second, antioxidants may be incapable HeandDeanJonesupdated3 thedefinitionin2007to
•
of intercepting some RS. For example, OH gener- ‘animbalancebetweenoxidantsandantioxidantsinfavorof
atedinvivo,e.g.byhomolyticfissionofwaterdueto theoxidants,leadingtoadisruptionofredoxsignallingand
our exposure to background levels of ionizing radi- control and/or molecular damage’, emphasizing the cen-
ation, will react with whatever it meets first. This is tralimportanceofdisruptingredoxsignalling.Several
almost impossible to stop, the damage simply has to relatedtermshavespunoff,suchas‘reductivestress’,
berepairedorthedamagedmoleculesreplaced. ‘nitrosativestress’etc.Thedamagethatcanarisefrom
Athird,andkey,factoristhatRSplayessentialroles oxidativestressisoftencalledoxidativedamage.We1
invivo.Everyoneisfamiliarwithregulationofcellular have defined this as the biomolecular damage caused by
processesbyphosphorylationanddephosphorylation attackofRSupontheconstituentsoflivingorganisms.In-
of enzymes and transcription factors, but scientists creasedlevelsofoxidativedamagecanresultnotonly
have realized in the past decades that regulation by from more oxidative stress, but also from failure of
oxidationandreduction(redoxregulation)isequally repairorreplacementsystems.
important. Not only that, the two systems cross-talk: Inprinciple,oxidativestresscanresultfrom:
theredoxstateofthecellinfluencesphosphorylation,
and vice versa (Section 5.5). The antioxidant defence 1. Diminishedantioxidants,e.g.mutationsdecreasing
network must minimize the levels of most RS whilst the levels of antioxidant defences, such as GSH
still permitting enough to remain for their essential orMnSOD.Depletionsofdietaryantioxidantsand
roles. other essential dietary constituents (e.g. copper,
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 255 ---

200 FREE RADICALS IN BIOLOGY AND MEDICINE
Table5.1 Evidencethatdamagebyreactivespecies(RS)occursinvivoevenunder‘normal’conditions.
Targetofdamage Evidence
DNA/RNA(Section6.14) Lowlevelsofproductsofoxidativedamagetopurines,pyrimidines,andsugarspresentinDNA/RNA
isolatedfromaerobiccells.Somebasedamageproductsexcretedinurine,arisingfromrepairofoxidative
damagetoDNA/RNAandtheirprecursorpools.
Protein(Section6.16) AttackofRSuponproteinsproducescarbonylsandotheraminoacidmodifications,whicharepresent
inhealthytissuesandbodyfluids.Nitrotyrosines,productsofattackontyrosinebyRNS,arepresentin
manynormalbodytissuesatlowlevels,asarechlorotyrosine,bityrosine,ortho-tyrosineetc.
Lipids(Section6.15) End-productsofperoxidation(e.g.isoprostanes,MDA,isofurans,isoketals,HNE-adducts)detectablein
‘normal’tissuesandbodyfluids.
Uricacid(Sections3.25.6and6.13) AttackedbyseveralRStogenerateallantoin,cyanuricacid,parabanicacid,oxonicacid,andotherprod-
ucts,whicharedetectableinhumanbodyfluids.Levelsincreaseinseveraldiseases.Onlyapplicableto
primates,whichlackurateoxidase.
Furtherdetailsmaybefoundinthischapter,inChapters6and10,andinref1.
iron,zinc,thiamine,nicotinamide,vitaminD,mag- 3. Cellinjury.Thisinvolvesdamagetosomeorallmo-
nesium)canalsoleadtooxidativestress(Table4.1). leculartargets:lipids,DNA,protein,carbohydrate,
For example, children with the protein deficiency etc.Suchdamagecansometimesbethetriggerlead-
disease kwashiorkor suffer oxidative stress (Sec- ingtoadaptation.Notalldamagecausedbyoxidative
tion 6.16.1), involving low GSH levels (insufficient stressisoxidativedamage:secondarydamagetobio-
sulphur-containing amino acids in the diet) and molecules can result from oxidative stress-related
the presence of ‘catalytic iron ions’ in body fluids changesin,forexample,ionlevels(e.g.risesinCa2+
(inability to make enough transferrin to bind iron leadingtoactivationofproteinases;Section5.3.2).
safely;Table5.2).Whethergivingthemantioxidants 4. Senescence.Thecellsurvivesbutcannolongerdiv-
wouldbeofbenefitisuncertain.4 ide(Section5.2.4).
and/or 5. Celldeath.Afterinjurythecellmay:(a)recoverfrom
2. IncreasedproductionofRS,e.g.byexposuretoele- theoxidativedamagebyrepairingitorreplacingthe
vated O , the presence of toxins that produce RS damagedmolecules;or(b)itmaysurvivewithper-
2
(Chapter9),orexcessiveactivationof‘natural’sys- sistent oxidative damage; or (c) oxidative damage,
temsproducingRS,e.g.inappropriateactivationof especiallytoDNA,maytriggerdeathbyapoptosis,
phagocytic cells in chronic inflammatory diseases necrosis,orcelldeathmechanismsintermediatebe-
(Section8.9). tweentheseextremes.
Letuselaborateontheaboveevents.
5.2 Consequencesofoxidativestress
Consequences of oxidative stress can include any, or 5.2.1 Proliferation
any combination of, the following, to an extent that
Low-level oxidative stress (e.g. by adding small
dependsonthecell/tissuebeingexaminedandthese-
amounts of H O or of aldehydes such as
verityandtime-courseoftheoxidativestress(Fig.5.1). 2 2
4-hydroxynonenal; Section 5.12.5.3) stimulates the
1. Increased proliferation. Many cells respond to mild proliferationofseveralcelltypesinculture.Figure5.2
oxidativestressbyproliferating(Fig.5.2andSection shows an early published example. Indeed, the cell
8.10.1giveexamples). culture environment is for many cells a low-level
2. Adaptationofthecellororganismbyupregulationof oxidativestress,whichmaybewhytheygrowsowell
defencesystems,whichmay:(a)completelyprotect incertainmedia(Section1.11).Thearrestofgrowthin-
againstdamage;(b)protectagainstdamagetosome ducedbycellconfluence(contactinhibition)haseven
extentbutnotcompletely;or(c)‘over-protect’—the been suggested to be related to a decrease in intra-
cell is then resistant to higher levels of oxidative cellular ROS and consequent loss of pro-proliferative
stressimposedsubsequently. stimuli.5 Pro-proliferative effects of RS facilitate

--- Page 256 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 201
Mild oxidative stress
Greater oxidative stress
Greater oxidative stress
Failure to
protect
Greater oxidative stress
Intense oxidative stress
noitadixo
gnisaercnI
Highly Resting cell
reduced Generally reduced (high concentration of
GSH, ascorbate etc).
Some more oxidized microenvironments, e.g.
in the ER and in lysosomes.
Proliferation stimulated
Activation of transcription factors
Oxidative damage levels rise. Adaptive response
Release of transition metal ions that Increasing levels of protective systems (e.g.
catalyse free-radical reactions is an early chaperones, antioxidant enzymes,
stage in oxidative damage. Some may haem oxygenase-1, ferritin to sequester iron)
bind to DNA, lipids and proteins to damage that render cell more resistant to subsequent
them by site-s·pecific OH • formation. insults. Cell cycle halts to allow repair of
DNA damage.
More oxidative damage—mitochondrial
damage (e.g. mitochondrial permeability
transition (Fig. 1.9), cytochrome c release)
or excessive DNA damage (via p53) halt the
cell cycle or initiate apoptosis.
Severe oxidative damage—mitochondrial
damage or excessive DNA damage (via p53)
often initiate apoptosis.
Survival of badly damaged cells or necrotic
Highly Shut-down of caspases and/or calpains by cell death, the latter releasing metal ions and
oxidized oxidation of their active site –SH groups. other toxins to spread injury to surrounding
cells.
Figure5.1 Howcellsrespondtooxidativestress.UpdatedfromLancet355,1179,2000,bycourtesyofthepublishers.Stimulationof
proliferationbylowlevelsofRSisassociatedwithincreasedphosphorylationofmultipleproteins(Section5.5.4).Thecellisgenerallyareducing
environment,especiallythemitochondriaandcytosol,butlesssointheERlumen(Section3.10),andprobablyinendosomesandlysosomes.
normalwoundhealing(Section7.13.3),butifinexcess One example of the role of ROS in proliferation is
theycancontributetoscleroderma(Section10.7.4),ath- stemcells.Theyarerichinantioxidants;levelsdecline
erosclerosis(abnormalproliferationofsmoothmuscle astheydifferentiate.Indeed,someROSareneededfor
cells;Section10.3),cancer(Section10.14),angiogenesis stemcelldifferentiation,althoughtoomuchoxidative
(Section 10.14), rheumatoid arthritis (Section 10.11), damagewillimpairit(Section3.4.2).
andtofibrosis(abnormalproliferationoffibroblasts)
generally,bothindiseases6 andinbleomycintoxicity
5.2.2 Adaptation
(Section10.16.3),forexample.DiminishingROSlevels
can decrease proliferation; for example, overexpres- Cells usually tolerate mild to moderate oxidative
sion of catalase in rat aortic smooth muscle cells stress, which often results in increased synthesis of
lowered H 2 O 2 levels and slowed their proliferation,7 antioxidant defences (and/or other defences such as
and fibroblasts or aortic endothelial cells from mice heat-shockproteins;Section5.6)inanattempttomin-
overexpressing catalase showed decreased growth imize damage and restore the oxidant/antioxidant
ratesinculture.8SometimesH 2 O 2 canincreasecellular balance. For example, if adult rats are gradually
activities of NADPH oxidases, leading to greater O
•–
acclimatized to elevated O concentrations, they can
2 2
generation(Section2.6.2). toleratepureO forlongerthancontrolrats,involving
2

--- Page 257 ---

202 FREE RADICALS IN BIOLOGY AND MEDICINE
3.0
1 μM
2.5 H 2 O 2 CONTROL (no added H O )
2 2
1.5
100 μM
H O 2 2
0.5
24 48 72 96
Time (h)
601
×
hsid/sllec
eviL
80% O , a level lethal to ‘normal’ HeLa cells.10 These
cell numbers 2
cells did not show elevated levels of SOD, catalase,
or GPx, and it was proposed that their increased O 2
tolerance is due to an alteration of targets normally vulnerabletooxidativedamage.Suchaphenomenon
occurswiththeenzymefumaraseinE.coli(Section1.6).
2.0 Another possibility is that the mitochondria in these
HeLa cells have ‘adapted’ to produce less O •–/H O ,
2 2 2
possibly by increasing cytochrome oxidase activity.
Similar adaptations may contribute to the longevity
ofbirds(Section11.2.2),anddecreasedmitochondrial
1.0 O •–/H O productionhasbeenreportedinDrosophila 2 2 2
selectedinthelaboratorytotolerate90–95%O .12
2
5.2.3 Migrationandadhesion13
Themovementofcellsandtheiradhesiontotheextra-
cellular matrix is essential during embryonic devel-
opment and tissue remodelling, and in the response
Figure5.2 TheeffectofH2O2ontheproliferationofbaby-hamster to injury and inflammation. Reactive oxygen species
kidneyfibroblastcells.Monolayerculturesweretreatedwith1 havelongbeenknowntoplaysomeroleinregulating
μMH2O2,whichstimulatedcelldivision,or100μMH2O2,which
levels of adhesion molecules (Section 8.7.3) and pro-
inhibitedit.DatafromFreeRadic.Res.29,121,1994,bycourtesyof
motingmetastasisofmalignantcells(Section10.14.8.7),
thelateProfessorRoyBurdonandHarwoodAcademicPress.Fora
butrecentstudieshavere-emphasizedtheirroleincell
morerecentexampleseeJ.Pharm.Exp.Ther.339,218,2011.
movement.Forexample,inthezebrafish,rapidH O
2 2
generationuponwounding(byaDUOXenzyme;Sec-
increasedsynthesisoflungantioxidants(Section3.7.5). tion 8.10) plays an essential role in attracting phago-
Anotherexampleof adaptation is seenin somecases cytes and in wound healing (Section 7.13.3). In cell
ofischaemicpreconditioning(Section10.6.6).Totake studies, ROS have been shown to regulate assembly
an example, a brief period of ischaemia in pig hearts anddis-assemblyoffilamentous(F)-actin,soaffecting
followed by reperfusion led to prolonged depres- cellgrowth,shapechanges,andmigration.15
sion of contractile function, an effect attenuated by
antioxidants.9 However, repeated brief periods of is-
5.2.4 Cellinjuryandsenescence
chaemia led to quicker return of contractile function
on reperfusion, an adaptive response not seen in the ‘Injury’ is a widely used, but vague, term. It can be
antioxidant-treatedanimals.Inotherwords,ROSpro- definedastheresultofachemicalorphysicalstimu-
ducedbyischaemia–reperfusioncauseddamagelead- lus,eitherinexcessorindeficiency,thattransientlyor
ingtodepressedcontractility,butalsoledtoaresponse permanently alters the homeostasis of the cell.16 The
protective against subsequent insult. In some cases, response to oxidative injury may be reversible; for a
mildoxidativestresscanelevatedefencessufficiently variable period the cell is in an altered redox state
toprotectcellsagainstmoresevereoxidativestressap- which does not lead to cell death and it then returns
pliedsubsequently.Forexample,exposureofE.colito to‘normal’.Eventstriggeredbythealteredredoxstate
low levels of H O can render it resistant to higher (e.g. increased expression of genes encoding antioxi-
2 2
levels(Section5.5.2).ProductionofROSduringexer- dantdefencesorheat-shockproteins,andlessexpres-
cise in animals can also lead to adaptation, a process sionofsomeothergenes,e.g.thoseencodingCYPs)17
that can be impaired by too many antioxidants (Sec- canpersistforawhileorevenpermanently.Moderate
tion7.14.1). levels of oxidative stress tend to halt cell prolifer-
Mechanismsofadaptationneednotalwaysinvolve ationtransiently,bytriggeringcellcyclecheckpoints
increased antioxidant defences. For example, by cul- (Section 10.14). Oxidative stress can also affect inter-
turing HeLa cells (a malignant cell line) at gradually cellularcommunicationthroughgapjunctions.These
increasingO concentrationsovera21-monthperiod,it aremembranechannelsthatdirectlyconnectthecyto-
2
waspossibletoobtaincellscapableofgrowingunder plasm of adjacent cells, allowing direct but carefully

--- Page 258 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 203
regulated passage of electrical signals and small mo- oxidativestressofthecultureprocess(Section11.3.5),
lecules,suchasCa2+,ATP,GSH,orinositolphosphates. butsenescenceisimportantinvivoincancerandage-
Gapjunctionsarisewhentwohemichannels,onefrom ing(Sections10.14.8and11.3.5).
each cell, join together. Hemichannels in a single cell
can also allow exchange of materials with the envir-
5.2.5 Poly(ADP–ribose)polymerase20,21
onment.Hemichannels/gapjunctionsaremadeupof
a family of proteins called connexins. For example, Excessive DNA strand breakage can lead to deple-
H 2 O 2 can impair inter-cell communication by influ- tion of cellular ATP and NAD+ levels. The latter oc-
encingratesofconnexinsynthesisand/ortheirphos- cursbecauseachromatin-boundenzyme,poly(ADP–
phorylationstate(increasedconnexinphosphorylation ribose) polymerase 1 (PARP-1) binds to damaged
can decrease communication overall, and also alter DNA, splits the NAD+ molecule, and transfers the
the types of molecule being exchanged).18 High Ca2+ ADP–ribose portion onto nuclear proteins, including
levelsalso decreaseconnexinfunction (probably use- histones, DNA polymerases, DNA ligases, p53, and
fullysinceonemaynotwishtospreadhighCa2+levels PARP-1 itself (automodification) (Fig. 5.3). This pro-
betweencells;Section5.3.2). cess has been called parylation. ADP-ribosylation of
Oxidative stress can damage many different bio- proteinsisimportant;underconditionsoflowtomod-
molecules. Often it is unclear which is the first tar- erateDNAdamage,itfacilitatesDNArepair(Section
get, both because injury mechanisms interact widely, 5.10.5)andpromotescellsurvival.Henceanimalslack-
and because the assays used to measure damage ing PARP-1 show genomic instability in response to
havevariablespecificitiesandsensitivities(Chapter6). DNAdamagingagentssuchasionizingradiation.The
Forexample,measurementofproteincarbonyls(Sec- PARP-1enzymealsoaidsremovalofoxidizednuclear
tion6.16.3)wouldnotdetectearlydamagetoproteins proteinsviatheproteasome(Section5.14.3).Afterre-
by oxidation of essential –SH groups. The initial tar- pair is complete, the poly(ADP)–ribose residues are
get of oxidative stress can vary depending on the removed by a poly(ADP)–ribose glycohydrolase en-
cell, the type of stress imposed, and its severity and zyme,whichisconstitutivelyactive.
time-course.Forexample,carbontetrachlorideseems However,excessiveactivationofPARP-1(i.e.ifthere
to injure cells primarily by promoting lipid peroxid- aretoomanyDNAstrandbreaks)candepletethecel-
ation (Section 9.2). By contrast, DNA is an important lular NAD+ pool, interferingwithATP synthesisand
earlytargetofdamagewhenH 2 O 2 isaddedtomany perhapsevenleadingtocelldeath.Thiscelldeathhas
mammaliancells(Section3.9). sometimesbeencalledasuicideresponse;sinceDNA
Senescence (from the Latin senescere, ‘to grow old’), repairisnoterror-freeacellwithextensivelydamaged
apermanentstateofnon-division(Section11.3.5)can DNA may ‘commitsuicide’ in the interestsof the or-
beinducedbyhighlevelsofRS.Forexample,human ganismtoavoidtheriskofbecomingcancerous.Forex-
fibroblastsexposedto100to300μMH 2 O 2 inculture ample,micelackingPARP-1showincreasedresistance
developedasenescentphenotype,19showingincreased to streptozotocin-induced diabetes, which is thought
levels of proteins that inhibit the cell cycle. Senes- tobeanexampleofthis‘lethalNAD+ depletion’(Sec-
cenceafterprolongedcellcultureisinpartduetothe tion9.7).Treatmentofcellswithnicotinamide,which
Nicotinamide adenine
ribose ribose Nuclear protein
PARP
phosphate phosphate Nicotinamide + ribose phosphate
phosphate Figure5.3 Thereactioncatalysedbypoly(ADP–ribose)
NAD+
polymerase-1(PARP-1).PARPsaresometimescalled
adenine-ribose poly(ADP–ribose)synthetasesorpoly(ADP–
ribose)transferases.ADP–riboseisusuallyattached
ribose
totheside-chaincarboxylgroupsofglutamateresidues
onthetargetproteins,andchainscanbemorethan
phosphate
200unitslong.Sometimesthechainsareattachedto
phosphate lysineoraspartateinsteadofglutamate.Severalother
PARPshavebeenidentified;e.g.PARP-1andPARP-2
adenine-ribose areinvolvedinspindleformationduringmitosis.

--- Page 259 ---

204 FREE RADICALS IN BIOLOGY AND MEDICINE
maintains NAD+ levels, can often delay or prevent levels in extracellular fluids. This enzyme contains
this cell death. Nicotinamide also affects the sirtuin catalyticallyessential–SHgroupsthataresusceptible
system(Section11.3.4),sodonotassumethataprotect- to oxidative attack, including site-specific OH• for-
iveeffectofnicotinamidealwaysoccursbyopposing mation (Section 2.4.6) and glutathionylation, which
PARP-1 action. The word parthanatos has been used decrease pump activity.23 Potassium, and sometimes
to describe cell death induced by excessive PARP ac- Na+,channelsarealsoaffectedbyRSandbyaldehydes
tivation,afterThanatos,thepersonificationofdeathin producedduringlipidperoxidation,suchasHNE(Sec-
Greekmythology.21 tion 5.12.5.3). For example, inhibition of an NADPH
SeveralagentsinhibitPARP-1,includingtheophyl- oxidase in the lungs of mice caused alveolar oedema
line,theobromine,and3-aminobenzamide.Anorally relatedtoexcessopeningofaNa+channel.24K+chan-
active inhibitor, Olaparib has been tested as an anti- nelsareessentialingenerationofelectricalactivityin
cancer agent, as have other PARP inhibitors.20 They neuronal and cardiac cells, but are also important in
seemtoactbyinterferingwiththerepairofDNAdam- a variety of other cell types, such as T-lymphocytes,
age, e.g. after irradiation or chemotherapy, or in can- vascularsmoothmusclecells,andepithelialcells.The
cercellslackingBRCA1or–2genes(Section10.14.4), effects of RS on K+ channels vary, depending on the
whichseemheavilyreliantonPARPtokeeptheirDNA channel and the RS used; sometimes a K+ channel is
intact.Theyhavealsobeentestedinanimalmodelsof opened,sometimesitsfunctionisinhibited.23,25–27 For
stroke,withsomepositiveresults.Becareful,however, example,oxidationandinactivationofaK+channelis
inusingPARPinhibitorsinvitro.Insomestudiesthey involvedinageinginC.elegans(Section11.4).Oxidation
inhibited ONOO–-induced cell death not by blocking ofmethionineresidues(Section5.14.1)alsomodulates
PARP,butsimplybyreactingdirectlywithONOO–or theactivityofseveralionchannels.28
itstoxicbreakdownproducts(Section2.6.1).
5.3.1.1 Cellvolumechanges
Alterationsofcellularionbalancecanproducechanges
5.3 Oxidativestresscauseschanges
in cell volume, which in turn affect cell function. For
incellularionmetabolism
example, generation of H O (e.g. by adding a sub-
2 2
5.3.1 Basicprinciples22 strateformonoamineoxidase)orinfusionoftert-butyl
hydroperoxideintoisolatedperfusedratliverleadsto
Reactive species can affect ion movements in several K+ release(duetoabnormalopeningofK+ channels)
ways,including and hepatocyte shrinkage. Shrinkage stimulates sev-
eralmetabolicevents,includingproteolysis,glycogen
1. Redoxregulationoftheexpressionofgenesencod-
breakdown,biliaryGSSGrelease,andureasynthesis.
ingionchannelproteins.
Itdecreasestherateofothers,suchasproteinsynthe-
2. Redox regulation of ion channel proteins them-
sis, lactate uptake, and actin polymerization.25 Cells
selvestomodulatetheirfunction,e.g.byoxidizing
exposedtohypotonicconditionsactivateplasmamem-
andreducingessentialthiolgroups,glutathionylat-
brane chloride channels in response to the swelling;
ingornitrosylatingthem(Section3.11),ornitrating
insomecelltypes,increasedROSproductionmaybe
tyrosineresidues.Someofthesemodifications(e.g.
the signal for opening.29 Hydrogen peroxide also af-
nitration) may lead to accelerated degradation of
fectstheNa+/H+exchangesystemandcanacidifythe
channelproteins,e.g.throughtheproteasome(Sec-
cytosol(Section5.4.2.2).
tion5.14.3.2).
3. Secondaryeffects,e.g.redoxregulatingtheactivity
ofoneionchannelcancauseopeningsorclosingsof 5.3.2 Calcium30
othersinresponsetocellularionimbalanceand/or
5.3.2.1 Keepingitlow
changesinmembranepotential.
Intracellular cytosolic ‘free’ Ca2+ levels are normally
Oxidative stress can damage proteins involved in low, around 0.1 μM (100 nM) or less. Total cell Ca2+
maintenance of essential ion gradients between cells is far greater, but most is safely sequestered within
andextracellularfluids.TheNa+,K+-ATPaseenzyme mitochondriaandtheER,orboundtocytoplasmicpro-
(often called the sodium pump) in the plasma mem- teins. Transient increases in free Ca2+ regulate many
braneusesenergyreleasedbyATPhydrolysistoexport physiological processes, including cell proliferation
Na+fromthecellandimportK+.Itthuskeepsintracel- and neurotransmitter release. Some extracellular sig-
lularK+highandintracellularNa+low,comparedwith nalling molecules bind to cell surface receptors and

--- Page 260 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 205
lead to release of Ca2+ from the ER, often by linking Ca2+ export to entry of extracellular Na+
stimulating synthesis of an intracellular messen- down its concentration gradient. The Na+ is then
ger derived from phosphatidylinositol, inositol 1,4,5- ejectedbytheNa+,K+-ATPase.
trisphosphate(IP ).Theinositolmoietycanbephos- 2. Uptake of Ca2+ into the ER lumen by an ATP-
3
phorylated at several of its –OH groups, to yield a dependentmechanism.
rangeofsecondmessengers(Section5.5.4.2).IP opens 3. Uptake of Ca2+ by mitochondria through a uni-
3
Ca2+ channels in the ER membrane and lets Ca2+ es- porter,drivenbytheenergyoftheprotongradient
cape into the cytosol. Agents that bind to ryanodine (Fig. 1.8). It is commonly believed that mitochon-
receptorsintheERcanalsoleadtoreleaseofCa2+from drial Ca2+ uptake is a ‘back-up’ system that op-
there.Thestretchingofmyocytes,anessentialprocess erates to prevent excessive elevations in cytosolic
in heart function, increases Ca2+ levels by activation Ca2+levels.Indeed,micelackingthemitochondrial
ofanNADPHoxidase,producingROSthatactupon Ca2+ uptake system showed impaired tolerance to
ryanodine receptors to increase release of Ca2+ from exercisebutoverallonlyamildphenotype.31
thesarcoplasmicreticulum(Fig.5.4).However,risesin 4. Binding of Ca2+ to proteins, e.g. calmodulins,
Ca2+ must be carefully modulated: uncontrolled rises Ca2+-bindingproteinsfoundinalleukaryoticcells.
canleadtocellinjuryanddeath. Calmodulins regulate many enzymes, includ-
LowintracellularCa2+ levelsaremaintainedbythe ing calcineurin (Section 5.5.4.3) and nitric oxide
concertedoperationofseveralsystems: synthases (Section 2.5.6), and multiple cellular
processes such as cytoskeletal assembly. Calm-
1. Plasma membrane ATP-dependent Ca2+-extrusion
odulins are rich in methionine residues, and are
systems(inmostcells).Incellswhichmakeextens-
thus a potential target of oxidative damage,28
ive use of Ca2+ signalling (e.g. muscle and nerve),
since methionine is easily oxidized by RS (Sec-
Na+ –Ca2+ exchange transporters are additionally
tion 5.14). Binding of Ca2+ to high-affinity binding
present. Extracellular Ca2+ levels are in the mM
sites on calmodulin causes a conformational
rangeinanimals,sotheseCa2+-exportsystemsneed
change which enables the calmodulin to bind
energytoexportCa2+ againstahighconcentration
to target proteins in the cell. These include the
gradient.EnergycomesfromATPhydrolysis,orby
A BEFORE STRETCH B AFTER STRETCH
Sarcolemma Sarcolemma
T-T SR T-T SR
gp91phox gp91phox
rac1
rac1
VGCC VGCC
ROS RyR2 RyR2
Ca2+
Figure5.4 (colourplate9)ROSsignallinglinksmechanicalstresstorisesinCa2+levels.Inheartmusclecells,transversetubule(T-T)
membranescontainvoltage-gatedCa2+channels(VGCC,green).InfluxofCa2+throughthechannelsgeneratessignalsthatopenRyR2channels
(blue)intheneighbouringsarcoplasmicreticulum(SR);theensuingCa2+releasepromotescellcontraction.TheT-Tmembranealsocontainsthe
NOX2subunitsp22phoxandgp91phox(red).Beforestretch(A),NOX2activity,productionofROS(reddots),andCa2+sparks(bluedots)arelow.
Amoderatestretch(B)causesanimmediateactivationofNOX2byrecruitingitsregulatorysubunits(p40phox,p47phox,p67phox,andrac1)tothe
T-Tmembraneviaamechanismthatrequiresintactmicrotubules.TheresultingincreaseinROSproductionsensitizesRyR2toactivationbyCa2+,
presumablybychangingRyR2redoxstate,causingaburstofCa2+sparks.Returningthecelltoitsinitiallengthreturnssignallingtoitsinitialstate.
ModifiedfromScience,333,1388,2011,bycourtesyofDrC.Hidalgoandthepublishers;alsoseeJ.Mol.CellCardiol.58,172,2013.

--- Page 261 ---

206 FREE RADICALS IN BIOLOGY AND MEDICINE
Ca2+-ATPase in the plasma membrane (activated alsoaffectedbyRSandthisplaysanimportantrolein
by calmodulin binding), and a family of thesensationofpain(Section10.25).
Ca2+/calmodulin-dependent protein kinases A common consequence of excessive (>5 μM)
which phosphorylate serines and threonines in rises in cytosolic Ca2+ levels is membrane blebbing
their substrate proteins, activating a wide range (Fig. 5.5), caused by disruption of the cytoskeleton.
of processes such as smooth muscle contraction, Polymerization and reorganization of actin are in-
catecholaminesynthesisincertainneurons,andthe volved in multiple cell functions and are controlled
breakdownofglycogeninmuscle. by a range of actin-binding proteins.15 Actin also as-
sociateswithmembrane-anchoringproteinslocatedin
5.3.2.2 OxidativestressraisesCa2+levels focal adhesion sites where the cell attaches to the
Oxidative stress dysregulates Ca2+ metabolism, gen- extracellular matrix. Signalling molecules such as fo-
erally causing a rise in intracellular ‘free’ Ca2+.30–32 caladhesionkinaseplayakeyroleintheirformation.
Membrane blebbing is usually associated with loss
This can contribute to the pro-proliferative effects of
of focal adhesions. Calcium ions can activate a fam-
low-leveloxidativestress,aswellastothecytotoxicef-
ily of proteinases (calpains; calcium-activated non-
fectsofhigherlevels.Reactivespeciescandamagethe
ERCa2+-uptakesystemandinterferewithCa2+ efflux lysosomal proteinases)35 that cleave actin-binding
proteinssuchasspectrin,eliminatingtheplasmamem-
through the plasma membrane, by leading to oxida-
brane‘anchorage’tothecytoskeletonandallowingit
tion of essential –SH groups on the transmembrane
to ‘bleb out’. Calpains are present in all mammalian
channelsand/orbyglutathionylation(Section3.11),or
cellsandperformseveralessentialfunctions,buttheir
sometimes nitrosylation. For example, glutathionyla-
tion of the Ca 1.2 Ca2+ channel occurs in ischaemic activityisnormallytightlyregulated.Over-activation
v
ofcalpainshasbeenimplicatedinmanydiseases,in-
human heart to a much greater extent than in nor-
cludingmusculardystrophyandAlzheimerdisease.36
malheartsamples:glutathionylationincreaseschannel
functionandraisescellularCa2+ levels.34 Inaddition, Oxidation of –SH groups on cytoskeletal proteins by
RS,andfallsinATP(neededformaintenanceofcyto-
oxidativestresscauseopeningofvariouschannelsin
theplasmamembranethatallowCa2+toenter,e.g.by skeletalintegrity),alsofacilitateblebbing.Calpainsare
cysteineproteinasesandcanthemselvesbesubjectto
decreasing the membrane potential and opening the
voltage-gatedCa2+channels.Thesechannelsmayalso oxidativedamage.
Anabnormalrisein‘free’Ca2+willstimulatetheac-
be subject to regulation by oxidation and reduction
tivities of eNOS and nNOS (Section 2.5.6) producing
of –SH groups, which may be important events con-
more NO • , which could lead to ONOO– formation if
tributingtocardiacarrhythmiasandmyocardialstun-
O
•–werealsobeingproduced.TheriseinCa2+canin-
ning (Section 10.6.4.1). In some cells, a rise in H 2 O 2
de
2
ed lead to a rise in O
•–
production; in certain cells
levels leads to opening of the TRPM2 (transient re- 2
containingXDH,activecalpainsconvertittoXO,gen-
ceptorpotentialmelastatin2)cationchannelsinthe
plasma membrane that let Ca2+ in.33 These channels, eratingmoreROS(Fig.1.10).Nitricoxideathighlevels
foundinmanytissues(includingbrain,β-cells,heart, canalsobedirectlytoxic,e.g.byinhibitingcytochrome
oxidase(Section2.5.6).
lung,phagocytes,eye,andvascularendothelium)are
non-selective, also transporting Na+ and K+, so de- Calcium ions additionally stimulate the activity of
phospholipase A , an enzyme which cleaves mem-
polarizing the membrane and letting in even more 2
Ca2+ by opening voltage-gated channels. Opening of brane phospholipids to release arachidonic acid for
TRPM2 channels requires NAD+, which is converted synthesis of prostaglandins and leukotrienes (Sec-
tion 8.12). Increased production of free fatty acids
to ADP–ribose that opens the channel; the effect of
and eicosanoids thus occurs when Ca2+ levels rise,
H O isthusindirect,mediatedbyADP–riboseforma-
2 2
as well as accumulation of the hydrolysis products
tionorrelatedmechanisms.TheADP–riboseproduced
of membrane lipids, which can cause disruption of
byPARP-1anditsglycohydrolase(Section5.2.5)may
membrane organization. Rises in Ca2+ also activate
account for some of the opening by RS. The normal
Ca2+-dependentendonucleasesinthenucleustocause
physiological function of these channels is uncertain;
DNA fragmentation, an event important in apop-
theymaybeinvolvedinregulatingphagocyteROSand
cytokineproductionandinsulinsecretionfromβ-cells. tosis(Section5.4.2).Transglutaminases,thecommon-
est being transglutaminase 2, can be activated by
However, their presence renders cells exceptionally
sensitivetosufferingrisesin‘free’Ca2+inresponseto Ca2+; they catalyse the cross-linking of proteins be-
tween side-chain amino groups of lysine residues
RS.TRPA1channels,amemberofthesamefamily,are

--- Page 262 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 207
(a) (b)
Figure5.5 Blebformation.(a)Hepatocytesweretreatedwithmenadione,whichcausesoxidativestress(Section9.5).Top:untreatedcell,
showingmicrovillussurfacestructure.Centre:afterexposureto200μMmenadionefor30min,showingmultipleblebs.Bottom:ahepatocyteata
laterstage,dominatedbyasingleblebwhichmaysoonrupture;theremainderoftheoriginalcell,withsmallerblebs,canbeseenatthebottomof
thephotograph.FromTrendsPharmacol.Sci.10,282,1989,bycourtesyofProfessorStenOrreniusandElsevierSciencePublishers.(b)Blebbingin
ratcardiacmyocytestreatedwithcumenehydroperoxidefor30min.Top:normalmyocytes.Bottom:myocytesaftertreatment.Photographby
courtesyofDrA.A.Noronha-Dutra.
and side-chain glutamine –CONH groups, to prod- death occurs. Death involving excessive rises in Ca2+
2
uce insoluble aggregates. They can also convert the maybeacommonfeatureofmultiplenoxiousstimuli,
–CONH groups in glutamine into –COOH, forming including intense oxidative stress and (ironically) O
2 2
glutamate.37Transglutaminasesplayseveralimportant deprivation.
roles in metabolism, but excess activation of them is
deleterious.37 5.3.2.3 Ca2+andmitochondria31
Ifblebbingproceedstosuchanextentthatblebrup- Excess Ca2+ can trigger the mitochondrial permeabil-
ture occurs without rapid resealing, the cell loses its ity transition (MPT) and collapse the membrane po-
ion gradients and is effectively dead. Its contents are tential (Fig 1.9, legend). The MPT requires elevated
released into the surrounding area, i.e. necrotic cell mitochondrial Ca2+ levels, often assisted by another

--- Page 263 ---

208 FREE RADICALS IN BIOLOGY AND MEDICINE
agent inducing oxidative stress; effective agents in- bind iron ions and alter rates of oxidative damage.
clude those oxidizing –SH groups, such as some or- For example, Quin-2 was one of the first fluorescent
ganic peroxides and ONOO–. As solutes (including ‘probes’ used to monitor intracellular Ca2+. Unfortu-
mitochondrialGSHandCa2+)escapefromthematrix nately,italsobindsironandtheferric-Quin2complex
through the pore, osmotic imbalance occurs and the can react38 with H O to form OH • . The inhibitor of
2 2
mitochondria swell. Pore opening can be blocked by mitochondrial Ca2+ import ruthenium red, contains
cyclosporin A, a drug used to prevent transplant re- ruthenium(RuIII)ionsthatcanalsoreactwithH O 39
2 2
•
jection. It acts by binding to cyclophilin D. The MPT toformOH .
haltsmitochondrialATPsynthesisandcanleadtocell
death by apoptosis (involving cytochrome c release
5.3.3.1 Demonstratingironmobilization
frommitochondria;Section5.4.2)ornecrosis.
The LIP size can be estimated by the calcein, iron
probe 1, and phen-green assays. Such assays only
5.3.3 Oxidativestressandtransitionmetalion measure iron that these probes can access, not neces-
mobilization sarilyalltheiron‘catalytic’forfreeradicalreactionsin
thecell(Section3.22.1.3).
OxidativestressinterferesnotonlywithCa2+butalso
What about the extracellular environment? Several
with iron and copper metabolism; its overall effect is
methods have been developed to measure ‘catalytic’
toincreasethelevelsofpotentiallypro-oxidantmetal
iron(oftencalled‘non-transferrin-boundiron’iniron
ions(Section3.22.1;Fig5.1).Mechanismsinclude:
overload diseases; Section 3.22.5.4) in body fluids.
In terms of physiological relevance, perhaps the best
1. Raisingextracellulariron.Celllysis,e.g.bytraumatic
istheaconitaseassay.40Reassemblyofironclustersin
injury or necrosis, releases metal ions (and also
aconitaserequiresasourceofiron.Themolecularform
haem/haem proteins: Section 3.22.3) into the sur-
ofthisironinbacterialandanimalcellsseemsequiva-
roundingenvironment.Asimpleillustrationisthat
lenttoironabletocatalysefreeradicalreactions.Thus
homogenates of tissues, especially brain, undergo
theabilitytorestoreactivitytoaconitaseisameasure
lipid peroxidation faster than intact tissues, and
ofthelevelsofsuchironinbodyfluids.
the peroxidation is inhibited by iron ion chelators
Another approach is the bleomycin assay.41 The
(Section10.17.5).
antibiotic bleomycin requires iron to degrade DNA
2. Increasingthesizeoftheintracellularlabileironpool,LIP
(Section 10.16.3). If other reagents are present in ex-
(Section3.22.1.3).Mechanismsinclude:
cess, the amount of DNA degradation is propor-
(a) superoxidereleasesironfromferritinandiron–
tional to the amount of iron that can be bound
sulphurproteins(Sections3.9.1and3.22.4);
by bleomycin (Fig. 5.6). Hence the assay measures
(b) peroxides release iron by degrading haem pro-
bleomycin-chelatable iron (BCI). Bleomycin has a
teins(Section3.22.3);
fairlylowaffinityforiron,andatpH7.4cannotremove
(c) peroxynitrite can attack iron–sulphur proteins,
• it from iron-containing proteins such as lactoferrin,
releasingiron;thereportedabilityofexcessNO
transferrin,ferritin,myoglobin,haemoglobin,orcata-
to damage mitochondrial Fe–S centres is prob-
ablymediated,atleastinpart,viaONOO–; lase.HencenoBCIispresentinfreshlypreparedserum
or plasma from healthy animals (Table 5.2), because
(d) increaseduptakeofiron,e.g.manycellsreadily
almost all iron is bound to transferrin, and the rest
takeup‘low-molecular-mass’iron,e.g.released
toferritin.SomeBCIis,however,presentinlunglin-
bycelllysis(Section3.9.2);
ing fluid, some sweat samples, and the plasma from
(e) aspecialcase,UVirradiationofskinincreasesits
patientswithiron-overload(Table5.2).
ironcontent(Section7.13).
Bleomycin-chelatableironappearstorepresentiron
(f) rupture of lysosomes, which can spill iron ions
ionsboundtolow-molecular-massagentssuchascit-
intothecytosol(Section3.22.1.3).
rate, or loosely bound to certain proteins, such as
Preincubating cells with permeant iron ion chelat- albumin.Studiesuponhumanbodyfluidsshowthat
ing agents can therefore decrease oxidative damage, the BCI level often (but not always) correlates with
andcellsdeficientinSODarehypersensitivetoinjury the ability of these fluids to stimulate free-radical
by H O (Section 3.9.2). It is ironic (forgive the pun) reactions.41,42Forexample,plasmasamplesfromiron-
2 2
that chelators designed to affect Ca2+ can sometimes overloadedpatientsstimulateperoxidationoflipidsin

--- Page 264 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 209
Biological sample
+ Bleomycin +c b o o n u t n a d in i i r n o g n loosely- Fe3+ + Ascorbate Fe2+ +O 2
+H O ‘Active oxygen’ species
2 2
degrades DNA with release
of base-propenals.
Malondialdehyde (MDA)
+Thiobarbituric acid
(TBA) –MDA (A 532 nm)
2
Figure5.6 Thebleomycinassay.ProductsofDNAdegradationbybleomycinincludebasepropenalsthatreact,onheatingwiththiobarbituricacid
(TBA)atlowpH,toformapinkTBA–malondialdehydeadduct.Theassayishighlysensitiveandreadilydetectstheironcontaminationpresentin
laboratoryreagentsandfluidsforbiomedicaluse(Table3.3).Ironcontaminationofreagentscanbepartiallyremovedbytreatingthemwith
Chelexresin,whichbindsbothironandcopperions.However,Chelexusuallymakesthesolutionalkaline,whichlimitsthetreatmentofmost
biologicalbuffers.Amoreeffectiveprocedure(FEBSLett.214,362,1987)toremoveironionsfrombuffersistousecolumnsordialysissacs
containingiron-bindingproteins,e.g.transferrinor(thecheaper)conalbumin.CarefulcontrolofpHinthebleomycinassayisessential(Meth.
Enzymol.233,82,1994).Amicrowellversionoftheassayhasbeendeveloped(Clin.Chem.48,307,2002).DNAdamagecanalternativelybe
measuredbythelossofabilitytoenhanceethidiumfluorescence(Clin.Chem.100,239,2001).
vitro(Section3.22.5.4),andBCIlevelswerecorrelated 5.3.4 Copper
with increased oxidative protein damage and the se-
verityofside-effectsinastudyofpatientswithacute Oxidative stress can also increase the availability of
lymphoblastic leukaemia undergoing chemotherapy copper. For example, caeruloplasmin is readily de-
(Table5.2).Thebleomycinassayhasalsobeenapplied graded by proteinases, or on exposure to ONOO–
totissuehomogenates;ifthetissueisfirstsubjectedto (Section 2.6.1), to release copper, although it is fairly
aninsult(e.g.ischaemia–reperfusion),thelevelsofBCI resistant to damage by peroxides. Copper ions are
measured in homogenates often increase (Table 5.2). releasedwhentissuesarehomogenized(Table5.3).
However,beawarethatreleasedironneednotalways Inhumanbloodplasma,mostorallcopperisbound
bebad,e.g.itcanparticipateinthe‘preconditioning’ to caeruloplasmin (Section 3.22.2). An assay for non-
of tissues after ischaemia: the increased ROS gener- caeruloplasmincopper,thephenanthrolineassay,has
ationleadstoincreasedlevelsofprotectivepathways been developed, again based on the ability of a che-
(Fig.5.1;Section10.6.6). lating agent, 1,10-phenanthroline (o-phenanthroline;
Other assays to measure ‘catalytic’ iron have been structureshowninTable11.8)todegradeDNAinthe
developed, also based on the chelation principle.43 presence of copper ions.45 Degradation of DNA by
Iron chelatable by bathophenanthroline disulphonate copper-phenanthrolinerequiresO andconversionof
2
(BPDS),desferrioxamine,ornitrilotriacetate(NTA)has Cu2+ to Cu+ by an added reducingagent. Thisis fol-
•
beenmeasuredinsomestudies,bychromogenforma- lowed by formation of OH that immediately attacks
tion (BPDS) or HPLC analysis of the iron complexes the DNA to release a product that can be detected
(NTA, desferrioxamine). For example, ischaemia– in the TBA test. If other reagents are in excess, the
reperfusionofrabbitkidneyspriortohomogenization techniquemeasurescopperthatisavailabletotheche-
increased the amount of desferrioxamine-chelatable lator, in other words phenanthroline-chelatable cop-
iron in the homogenates.44 Nitrilotriacetate and des- per(PCC). ReagentsaretreatedwithChelex(Fig.5.6
ferrioxamine are stronger iron-chelating agents than legend)toremovecontaminatingcopper,andazideis
bleomycin, and NTA in particular may be capable added to inactivate catalase (H O is involved in the
2 2
•
of removing iron from certain iron proteins (i.e. it OH formation).Thisassaydetectscopperboundtoal-
might overestimate ‘catalytic’ iron ion levels). When bumin and to amino acids such as histidine, but not
sixdifferentmethodswereappliedtoserumfromiron- copper on caeruloplasmin. Phenanthroline-chelatable
overloaded patients, six different answers were ob- copper has been found in numerous biological sam-
tained,reflectingtheuniquechemistryofeachassay.43 ples(Table5.3).Itisnotpresentinplasmafromhealthy
Thebleomycinmethodgavethelowestvalues. animals.

--- Page 265 ---

Table5.2 Concentrationsofbleomycin-chelatableiron(BCI)inbodyfluids.
Sample BCIconcentration Comments
Plasma/serum
Healthyhumansorotheranimals 0 Neverpresent;plasmaandserumhaveconsiderableiron-bindingactivityduetounsaturatedtransferrin.Reportedto
appeartransientlyinsomesubjectsexposedtohighO2partialpressureindivingatdepth(J.Nutr.139,90,2009).
Rheumatoidarthritis
(a)Plasma 0 Notpresentunlessarthritisiscausedbyiron-overload
(b)Synovialfluid 3.1±1.9μM About40%offluidsshowBCIifassayedatpH5.3(Biochem.J.245,415,1987).
Fulminantliverfailure(plasma) 2±2μM Possiblyaconsequenceofironreleasefromfailingliverand/oritsinabilitytomaketransferrin(FreeRadic.Res.20,139,
1994).
Chemotherapy
Acutelymphoblasticleukaemia,afterchemotherapy Upto1μM Transferrinsaturationinpatientspre-chemotherapyoftenhigherthannormal,BCIsometimesbutnotusuallypresent.
(plasma) Levelscorrelatedwithproteincarbonyllevels,liverdamage,andotherside-effects.Chemotherapycausesriseintotal
plasmairon;whentransferrinsaturationreaches100%,BCIappears(CancerLett.94,219,1995;Clin.Chem.48,307,
2002).
Patientstreatedwithcyclophosphamideandtotal 0.1–1.1μM Foundfor6–18daysinallpatientsstudied,withapeakonday4(Br.J.Haematol.113,836,2001;Clin.Chem.89,8,
bodyirradiationtokillbonemarrowcellsbefore 2013).Injectingtransferrindecreasedthelevels(Br.J.Haematol119,547,2002).
transplantation
Patientswithvariouscancersundergoing 10.6±6.6μM1–4days Nonepresentbeforetreatmentortwomonthsaftertreatment(Clin.Sci.106,475,2004).LevelsofBCIcorrelatedwith
chemotherapywithbleomycin/etoposide/cis–platin after treatment in 64% of severityofside-effects.
orotherregimes patients
Autoimmunediseases
Patientswithautoimmunediseasesadministered ~0.5μM Noneinuntreatedsubjects(KidneyInt.66,295,2004).
iron–sucrosetotreatanaemia,serum
Lungliningfluid(bronchoalveolarlavage)
(a)Normalcontrols 0.3±0.02μM LowlevelsofBCIappearpresentnormallyinBALfluid,whichhaslowtransferrinlevels.InsevereARDS,excessentryof
(b)ARDSpatients plasmaproteinssuchastransferrinduetodisruptionofalveolarpermeabilitybarriermaybindtheBCI(Biochem.
(i)Survivors 0.3±0.09μM Biophys.Res.Commun.220,1024,1996).
(ii)Non-survivors 0
ARDSpatientswithmultiorganfailure(plasma) 0.5±0.2μM Represented33%ofARDSpatientsinthisstudy(Thorax49,702,1994).
Cardiopulmonarybypass
Extracorporealbloodcirculation 0.3±0.9μM Perhapsreleasedduetodamagetobloodcellsorfromanoxic/reperfusedtissues(FEBSLett.328,103,1993;FreeRadic.
Res.21,53,1994;Ann.ThoracicSurg.60,1735,1995).
Ironoverload
Micedeficientintransferrinsynthesis(plasma) 16.0±5.0μM Micedieunlesstransferrinperiodicallyinjected(Biochim.Biophys.Acta1156,19,1992).
Patientswithironoverloadduetoidiopathic 4.3±6.7μM Atleastsomeoftheironisboundtocitrate(Section3.22.5.5).SomeBCIcanexistevenwhentransferrinnotcompletely
haemochromatosis(plasma) saturated(Blood72,1416,1988;J.Hepatol.32,727,2000).PlasmafromthalassaemiapatientscancontainBCI(Eur.
J.Clin.Invest.32,Suppl1,50,2002)

--- Page 266 ---

Umbilicalcordbloodplasma
Newbornfull-termbabies 0.3±0.6μMa Transferrinsaturationishighatbirthandmaygoover100%inafew,apparentlynormal,babies(FEBSLett.303,210,
1992).
Prematurebabies(plasma) ~2–5μMb FreeRadic.Res.16,285,1995.
Foetusesandbabieswithrhesushaemolyticdisease ~0–44μM Veryhighlevelsinmostcases.Higherinfoetuseswithcomplications(Br.J.Obst.Gyn.111,303,2004).
(plasma)
Kwashiorkor(plasma) 1.0–19.5μM BCIpresentin58%ofkwashiorkorpatients(Eur.J.Clin.Nutr.49,208,1995).
Humansweat 0.7±2.5μM BCImoreoftenpresentintrunksweatthanarmsweat(Clin.Chim.Acta145,267,1985).
4.6±3.0μM
Urine,kidneyreperfusioninjury
(a)Beforeischaemia–reperfusion 138±54pmol KidneyInt.34,474,1988.
(b)Afterischaemia–reperfusion 1249±506pmol
Homogenizedhumantissues
Cerebellum 26±5nmol/mgtissue FEBSLett.353,246,1994.
Substantianigra 51±27nmol/mgtissue FreeRadic.Res.23,465,1995.
Arterialwall 3±2.4μM
Bacteria(fivedifferentstrains) 0.003–1.046μmol/mg Biochem.Int.8,89,1984.
protein
aOnly6/25positive. bMostsamplespositive.
Pleaserememberthatcellculturemedia,biochemical,andclinicalreagentsarealliron-contaminated(Table3.3),whichmustbeallowedforinperformingtheaboveassays.

--- Page 267 ---

212 FREE RADICALS IN BIOLOGY AND MEDICINE
Table5.3 Phenanthroline-chelatablecopper(PCC)insomebiologicalmaterials.
Sample ConcentrationofPCC Comments
Healthyanimals(plasma/serum) 0 Neverdetectedinfreshsamples.Amountofnon-caeruloplasmin
copper<0.1μM.Detectedinstoredsamples,probablydueto
breakdownofcaeruloplasmin(Section3.22.2.2).
Wilsondisease,untreated(plasma) 2.7μM Pediat.Res.37,219,1995.Variablypresentinpatientstreatedwith
copper-chelatingagents.
Liverfailure(plasma) 1–2μM Maybeduetometalreleasefromfailingliverand/orcessationof
livercaeruloplasminsynthesis(FreeRadic.Res.20,139,1994).
Sweat,human
Arm 18.1±3.9μM Sweatalsocontainsiron(Table5.2)andmaybeanexcretoryroute
forbothmetals.Theirpresencefacilitatesbacterialgrowthinsweat
(ClinChim.Acta145,267,1985).
Trunk 27.0±3μM
Homogenizedhumanbraintissue
Cerebellum 21±10nmol/mgtissue Levelsofcopperreleasedontissuehomogenizationbroadly
comparablewiththoseofBCI(FEBSLett.353,246,1994;Free
Radic.Res.23,465,1995).
Substantianigra 53±18nmol/mgtissue
Arterialwall 4.9±2.8μM
Atheroscleroticmaterial
‘Gruel’fromadvancedlesions ~4.0μM Copperionsarepowerfulcatalystsoflow-densitylipoprotein(LDL)
oxidation,whichmaycontributetoatherosclerosis(Biochem.J.
286,901,1992;FEBSLett.368,513,1995).Atheroscleroticlesion
extractsstimulateinvitroLDLoxidation.
Endarterectomysamples 0.3±0.1nmol/mgprotein
Aneurysms 0.3±0.2nmol/mgprotein
The relationship of PCC to oxidative damage is be measured by a variety of assays, each of which
unclear.Copperboundtoalbuminorhistidineisstill needscarefulthoughtaboutwhatisreallybeingmeas-
redox-active, but the damage is largely directed to ured,asitoftenisn’tquitedeath!(Table5.4).
theligand.Thusif,forexample,thecoppermeasured It is frequently said that cell death occurs by es-
as PCC were bound to LDL (Section 10.3.8), DNA sentially two mechanisms, necrosis (from the Greek
(Section 5.8), or Na+, K+-ATPase (Section 2.4.6), it nekros, a corpse) and apoptosis (Fig 5.7). However,
couldbebiologicallysignificant,butifitwasattached death by mechanisms with features of both apop-
to albumin or histidine it might not matter. Overall, tosisandnecrosispathwaysisfrequentlyseen.Indeed,
there has been less interest in ‘catalytic’ copper as the words necroptosis, ‘programmed cell necrosis’,
opposed to ‘catalytic iron’ as a mediator of oxidative or ‘regulated necrosis’ have been used to describe
damageinvivo,butthiscertainlydoesnotmeanthat necrosis that is regulated by various signal transduc-
copperisunimportant. tionpathways(especiallythereceptorinteractingpro-
tein kinases) and often results when some proteins
involved in apoptosis are inactivated.46A A ferrop-
5.4 Consequencesofoxidativestress:cell
tosis pathway has been described, a non-apoptotic
death30,46
cell death pathway that involves ROS and intracellu-
lar labile iron.47 It can occur when cells are treated
5.4.1 Basicdefinitions
withtoxiccompoundsthatgenerateROSandrelease
Cellsexposedtosevereoxidativestressmaydie.Death Fe2+ ions. A pyroptosis cell death mechanism46A ex-
canresultfrommultipleoverlappingmechanismsand ists (From the Greek for ‘fire falling from the sky’)

--- Page 268 ---

Table5.4 Somemethodsusedtodetectcellcytotoxicityandcelldeath.a,b
Method Assayprinciple Limitations
Vitaldyes(e.g.trypanblue,propidiumiodide(PI), Cannotpenetrateintactplasmamembranebutstainthecytoplasm -
crystalviolet,Hoechst33258) ornucleusofcellswithdamagedplasmamembranes.Measureloss
ofplasmamembraneintegrity(typicalfornecrosis).ForPI,cellscan
befixedandstained,allowingcellcycleanalysisbyflowcytometryor
detectionofchromatincondensationduringapoptosis,by
fluorescencemicroscopy.
Tetrazoliumsalts(e.g.MTT,XTT) Reducedtocolouredproducts(formazans)onlybymetabolically ThereductionofMTT(3-(4,5dimethylthiazol-2-yl)-2,
activecells.Measureslossofmetabolicactivity,notnecessarily 5-diphenyltetrazoliumbromide)dependsonmitochondrialfunctionand
relatedtocelldeath. otherreducingsystems,butcanalsobeachievedextracellularlyby
electrontransportacrosstheplasmamembraneandperhapsbycertain
ROS(e.g.O
•–)(Biotechnol.Ann.Rev.11,127,2005).Alwayscheck
2
thatanyagentyouareaddingtotheculturemediumdoesnotdirectly
reduceMTTormodifyMTTreductionkinetics(PlantaMed.68,445,
2002;Biotechnol.Ann.Rev.11,127,2005;Cytotechnology52,189,
2006).SeveralenzymescanreduceMTT,includingiNOS(Diabetologia
47,2042,2004).
Alamarblue Cellpermeable,reducedbymetabolicallyactivecellstoafluorescent Highercelldensitymightresultintheover-reductionofAlamarblueinto
product.Measureslossofmetabolicactivity,notnecessarilyrelated thecolourlessandnon-fluorescenthydroresorufin.Thepossibilityof
tocelldeath. reactionbetweentestcompoundsandAlamarbluemustbeconsidered
(Meth.Mol.Biol.170,1,2011;Sensors12,12347,2012).
Releaseofenzymes(e.g.lactatedehydrogenase Releaseofenzymesfromcytosolorothersubcellularcompartments Incellculturestudies,releasedenzymescansometimesbeinactivated
(LDH),creatinekinase(CK), isduetoplasmamembranedamage(typicalfornecrosis).Usedin bycertainreactivespecies,examplesbeingHOCl,ONOO–,andsilver
glutamate-oxaloacetatetransaminase(GOT), diagnosticmedicinetoassessdamagetoliver(GOT,GPT),heart nanoparticles(Toxicol.Lett.225,422,2014),givinganunderestimation
glutamate-pyruvatetransaminase(GPT)) (LDH,CK),etc.Releasealsopossiblefromreversibleinjurybythe ofdamage.
‘pinchingoff’ofblebs,withtherestofthecellremainingviable.
Calcein–AM Cell-permeable,non-fluorescentcompound,de-esterifiedby Aschangesincalceinfluorescencearealsoroutinelyusedtodetect
intracellularesterasestogivethefluorescentdyecalcein. multi-drugresistanceproteinactivity,cellular‘free’ironlevelsandsome
Fluorescenceisproportionaltocellularesteraseactivityandcanbe RS(Drug.Metab.Dispo.s34,786,2006;Anal.Biochem.233,221,
usedtodeterminecellviability.Calcein–AMissuitableforstaining 1996;Histochem.CellBiol.122,499,2004),assaydatamustbe
viablecellsbecauseofitslowcytotoxicity.Usingcalcein–AMwith interpretedwithcaution.
cellimpermeableDNA-bindingfluorescentdyessuchasPIor
ethidiumhomodimer-1allowsdiscriminationbetweenviableand
dead/dyingcells;viablecellsstainwithgreenfluorescence(calcein
positive,PInegative),whereasdeadcellsstainwithredfluorescence
(calceinnegative,PIpositive).Dyingcellsshowamixtureofgreen
andredfluorescence.CanalsobeusedtomeasureMPT.
Continued

--- Page 269 ---

Table5.4 (Continued)
Method Assayprinciple Limitations
51Crrelease Cellsarepreloadedwith51Crbyincubationwithlabelledsodium Methodrequiresuseofradioactivity.Assayislimitedtotargetcells
chromate,whichbindstointracellularproteins.Radioactiveproteins whichspontaneouslylabelwith51Cr.Background51Crreleaseneedsto
releasedduetoplasmamembranedamage. beconsidered(J.Immunol.Meth.325,51,2007).
[3H]thymidinerelease Cellspreloadedwithtritiatedthymidine,incorporatedintoDNA. Methodrequiresuseofradioactivity.
RadioactiveDNAreleaseduetosevereplasmamembranedamage.
DNAladdering(Section5.4.2) Usuallytakenasevidenceofapoptosis. Methodprovidesinsufficientevidenceforapoptosiswhenperformed
alone:ladderpatternsmightalsobeproducedbyinternucleosomal
attackbyRS.Forexample,treatmentofHepG2cellswith
copper–phenanthrolinechelates,whichbindtoDNAandgenerateOH•,
gaveaDNAladder(Biochem.J.317,13,1996).
ATP Commonlymeasuredusingluciferin–luciferase.ThelevelsofATPin Thetemperature-sensitivityofluciferaserequiresaconstanttemperature
cellsgenerallyrelatetocellviabilitybutcanvaryformanyreasons. environmenttoachieveassayreproducibility.Thepossibilitythattest
Afterlossofmembraneintegrity,cellslosetheabilitytosynthesize compoundsinhibitluciferaseactivityneedstobeconsidered(Expert
ATP,endogenousATPasesdestroyATPandthelevelsofATPfall Opin.DrugDiscov.3,655,2008).FallsinATPdonotgiveinformation
rapidly. aboutcelldeathmode(Nat.Rev.DrugDisc.10,221,2011).
Cellreplicationstudies Measurerateofcellreplication(e.g.BrdUincorporation;Table6.8).
Ofcourse,cellsnolongerabletodivide,e.g.senescentcells,arenot
necessarilyirreversiblyinjured,i.e.thisisanindexofcytostasis,
ratherthancelldeath(Section5.2.4).
Caspaseactivation Usedasanindexofapoptosis(however,caspase-independent CaspasesareinactivatedbyseveralRS(H2O2,HOCl,ONOO–)andtheir
apoptosishasalsobeenobserved).Varioussubstrateshydrolysedto levelsmustbeinterpretedwithcaution(FEBSLett.517,229,2002).
fluorescentproductsarecommerciallyavailabletodetectcaspases. Also,thefactthatcaspasesparticipateinmanycellprocessesnotlinked
CaspaseactivationcanalsobedetectedbyWesternblotting. tocelldeathmustbeconsideredintheanalysisofcaspaseactivation
data(Nat.Rev.DrugDisc.10,221,2011).
Phosphatidylserinemembraneflipping(Annexin-V) CanbeusedinparallelwithPItodistinguishapoptoticfromnecrotic Non-apoptoticcellswithdamagedplasmamembranesmightexposePS
cells.Reliesonthetranslocationofphosphatidylserine(PS)fromthe toAnnexin-Vbinding.Similarly,healthyimmunecellscanbecome
inner(cytoplasmic)faceoftheplasmamembranetothecellsurface Annexin-VpositiveduetoingestionofPS-containingcellfragments(Exp
soonafterinductionofapoptosis.Annexin-Vhasastrongaffinityfor Oncol34,255,2012).
PSonthecellsurface,providingthebasisforastainingassay.
aOneofthesimplestmethods,oftennotused,issimplytolookunderthemicroscopeandexaminecellmorphology!
bDetectingthemechanismofcelldeathrequiresassessmentofseveralcytotoxicitymarkersintime-dependencystudies(Curr.Protoc.Pharmacol.56,12.8.1,2012).

--- Page 270 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 215
that has some features of necrosis and contributes to nucleosomestogivefragmentsofDNAthataremul-
lymphocyte death after HIV infection (Section 10.25), tiples of 180–200 base pairs. When these fragments
and ‘programmed cell senescence’ may occur during areseparatedbygelelectrophoresis,a‘ladder’isseen.
embryonicdevelopment.48 However,letusstickwith Otherfeaturesarethecollapseofcytoskeletalstructure,
apoptosisandnecrosisfornow. nuclear fragmentation, and eventual break-up of the
Necrosis and apoptosis result from many causes, entirecellintoapoptoticbodies,withoutruptureofor-
includingoxidativestress.Forexample,insomemam- ganellemembranes.Apoptoticbodiesareusuallypha-
malian cells, adding mM levels of H O can cause gocytosed, mostly by macrophages, a process called
2 2
necrosis, whereas lower levels can trigger apoptosis efferocytosis(fromtheLatineffero,totakeacorpseto
(Fig5.1).ActivationofTRPM2channelsbyH O and thegrave).Phagocytesusecell-surfacereceptorstorec-
2 2
consequentrisesinintracellularCa2+levelsoftenplay ognize‘eatme’signalsonthesurfaceofapoptoticcells,
a key role in determining the type of cell death (Sec- oneofwhichistheappearanceofphosphatidylserine
tion 5.3.2.2). During necrotic cell death, there is cell ontheouterleafletoftheplasmamembrane(Table5.4).
and organelle swelling, loss of integrity of mitochon- Bindingofphosphatidylserinetothereceptors(usually
drial, peroxisomal, and lysosomal membranes, and via ‘bridging proteins’) decreases macrophage pro-
eventual rupture of the plasma membrane, releasing duction of proinflammatory cytokines, and increases
cell contents into the surrounding area to affect adja- thatofanti-inflammatoryones.52 Ifefferocytosisfails,
centcells.ContentsincludeantioxidantssuchasSOD, inflammationmaynotresolveproperly(Section8.9).
catalase, or GSH, pro-oxidants such as haem, iron, Cell death is essential during embryonic develop-
andcopperions,andotherdamagingagents,suchas ment,forexampletoeliminatethymocytesthatrecog-
activated calpains (Section 5.3.2.2). Several constitu- nize‘self-antigens’,andunwantedcellsduringtissue
ents (DAMPs; Section 8.7.1) released from cells can remodelling. It is often then called programmed cell
provokeinflammation,includingperoxiredoxins(Sec- death (PCD), is usually induced by binding of lig-
tion 3.13) and especially the nuclear high mobility ands to specific receptors, and frequently occurs by
group1protein(HMGB1),namedforitshighmobil- apoptosis. Thus PCD and apoptosis are terms often
ity on polyacrylamide gel electrophoresis. Controlled used interchangeably, although cells can die during
release of this protein by certain cells plays a role in developmentbymechanismsotherthanapoptosis.
regulation of inflammation by promoting inflamma- The apoptotic machinery exists in all cells except
some formation (Section 8.7.1), but excessive release erythrocytes (even they can undergo death in an
can trigger life-threatening inflammatory responses. apoptosis-like manner, eryptosis; Section 7.5.4) and
HMGB1hasthreecysteineresidues,whoseoxidation can be triggered by a range of signals or by the re-
afterreleasecanaffecttheactionsofHMGB1,i.e.dif- moval of growth factors from the medium. Among
ferent oxidation states may have different biological insultsthattriggerapoptosisareinterferencewithen-
effects.49NecroptosiscanalsoreleaseDAMPs. ergymetabolism(e.g.inhibitionofmitochondrialelec-
tron transport), oxidative and other cellular stresses,
andtheDNA-damagingeffectsofsomedrugsusedin
5.4.2 Apoptosis
cancerchemotherapy.However,theseagentscanalso
Inapoptosis,thecell’sownintrinsic‘suicidemechan- cause necrosis, depending upon the cell type studied
ism’ is activated; apoptotic cells do not release their andthelevelofstressapplied(ingeneral,higherstress
contents and so apoptosis does not, in general, affect levels are more likely to favour necrosis). Apoptosis
surroundingcells.Inparticular,apoptoticcellsdonot plays a role in abnormal cell loss in certain diseases,
releaseHMGB1;itremainsboundtochromatin.Some- suchastheneurodegenerativediseasesandsomeviral
times,however,peroxidesgeneratedduringapoptosis infections. By contrast, failure of cells with damaged
canbereleasedtoalevelthatmightaffectsurrounding DNAtoundergoapoptosiscancontributetodevelop-
cells,50 andoxidizedlipidsmightevenactasantigens mentofmalignancy.Anoikis,apoptosisinducedwhen
toprovokeautoimmunity.51 cellsdetachfromthematrixsurroundingthem,isim-
In apoptosis the earliest visible changes are cell portant in deterring tumour invasion and metastasis
shrinkage and condensation, and fragmentation of (Section10.14).
chromatin (Fig. 5.7). This is usually associated with
5.4.2.1 Molecularmechanismsofapoptosis30,46
DNA double-strand breaks. High molecular weight
DNA, with histones attached, is cleaved by a Ourknowledgeofthemechanismsbywhichapoptosis
caspase-activatedDNAse(CAD)whichcutsbetween occurshasincreasedexponentiallyinthepastdecades.

--- Page 271 ---

216 FREE RADICALS IN BIOLOGY AND MEDICINE
Necrosis
Mitochondrial morphological Membrane breakdown
changes
Chromatin pattern conserved
Normal Reversible swelling Irreversible swelling Disintegration
Apoptosis
Mitochondrial morphology Intact membranes
preserved
DNA
fragments
Nuclear changes Apoptotic bodies
Normal Condensation (cell blebbing) Fragmentation
Necrosis Apoptosis
Morphological features
(cid:129) Loss of membrane integrity (cid:129) Membrane blebbing, but no loss of
integrity
(cid:129) Flocculation of chromatin (cid:129) Margination and condensation of nuclear
chromatin (pyknosis)
(cid:129) Swelling of the cell and lysis (cid:129) Cellular condensation (cell shrinkage)
(cid:129) No vesicle formation, complete lysis (cid:129) Formulation of membrane bound
vesicles (apoptotic bodies)
(cid:129) Disintegration (swelling) of organelles (cid:129) No disintegration of organelles;
organelles remain intact
Biochemical features
(cid:129) Loss of regulation of ion homeostasis (cid:129) Tightly regulated process involving
activation of enzymes
(cid:129) No energy requirement (passive process, (cid:129) Energy (ATP)-dependent (active
also occurs at 4˚C) process, does not occur at 4˚C)
(cid:129) Random digestion of DNA (Smear of (cid:129) Non-random mono- and
DNA after agarose gel electrophoresis) oligonucleosomal length fragmentation
of DNA (Ladder pattern after agarose
gel electrophoresis)
(cid:129) Postlytic DNA fragmentation (= late (cid:129) Prelytic DNA fragmentation (= early
event of death) event of death)
Significance
(cid:129) Death of cell group (cid:129) Death of single, individual cells, often
(cid:129) Evoked by non-physiological induced by physiological stimuli during
disturbances embryonic development and tissue remodelling
(cid:129) Release of cell contents (cid:129) Phagocytosis of apoptotic bodies by
adjacent cells, e.g. macrophages
(cid:129) Inflammatory response (cid:129) Limited or no inflammatory response
Figure5.7 Apoptosisandnecrosis:theessentialdifferences.AdaptedfromGuidetoCellProliferationandApoptosisMethods,bykindpermission
ofBoehringerMannheim.

--- Page 272 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 217
Weconfineourselvesheretotheminimuminformation necrotic cell death (by blocking NAD+ and ATP
requiredtounderstandhowapoptosisrelatestoreact- depletion), it rarely affects apoptosis.16 Cell death re-
ivespeciesandantioxidants. sembling apoptosis can sometimes involve activation
Apoptosisdependsontheactivationofafamilyof of calpains in addition to caspases, or occasionally
proteinaseswithessentialactive-sitecysteineresidues, instead of them, e.g. in neurons exposed to HOCl.53
the caspases. They cleave their protein substrates at Arangeofcaspaseandcalpaininhibitorsiscommer-
aspartateresidues,hencethenamecysteine-aspartyl- ciallyavailable,butmanyarenotspecific;inaddition,
specific proteases, abbreviated to caspases. Caspase zinc or tin metalloporphyrins, used to inhibit haem
activation can be triggered by at least four mechan- oxygenases (Section 3.24), can also inhibit caspases-3
isms.Oneisthebindingofexternalligandstodeathre- and -8.54 Note that caspase-1 activation is involved
ceptors,suchastumournecrosisfactor(TNF)receptors in inflammasome formation (Section 8.7.1) and in
(TNF is described in Section 5.7.1). Ligands to death pyroptosis.46A
receptors include members of the TNF family, such Asecondwayoftriggeringapoptosisinvolvesdir-
asTNF-αitself,Fas(fibroblastassociatedcellsurface ectactiononmitochondria.Thiscanoccurbyinitiating
ligand L, also known as CD95L), and TRAIL (TNF- the MPT (Fig. 1.9). MPT-induced swelling can lead
relatedapoptosis-inducingligand).Theybindtothe to release of factors from the inter-membrane space
death receptors (TNF-α receptor, Fas (CD95), TRAIL to the cytosol, including apoptosis-inducing factor
Receptors1and2).Bindingoftheligandscausesthere- (AIF),55 cytochrome c, and SMAC (alternative name
ceptorstoclustertogetherintrimers.Thecytoplasmic DIABLO) (Fig. 5.8). The last is a protein that binds
‘tails’ofthesereceptorsrecruitotheradaptorproteins andinhibitsendogenouscaspaseblockers(inhibitors
suchasFADDandTRADD(TNFreceptor-associated of apoptosis, IAP). The overall result is activation of
death domain). These carry a death-effector domain thecaspaseadaptorApaf-1(apoptoticproteinaseac-
(DED)thatbindsprocaspase-8andincorporatesitinto tivating factor 1) which binds ATP (hence apoptosis
the death-inducing-signalling complex (DISC). Pro- needs ATP) and cytochrome c to form a caspase-9-
caspase-8isactivatedandinturnactivatescaspases-3, activating complex, the apoptosome. Caspase-9 then
-6,and-7.TheactionofDNA-cleavingenzymeisnor- activates caspase-3, which can in turn cleave and ac-
mally blocked by an inhibitor, ICAD (inhibitor of tivateothercaspases,includingcaspase-8.AIFtranslo-
caspase-activatedDNAse),whichinhibitstheDNAse catestothenucleusandtriggerschromatincondensa-
activityandkeepstheenzymeinthecytoplasm.This tionandDNAdegradation,inacaspase-independent
ICADisdestroyedbycaspases-3and-7,allowingthe manner (it is not a nuclease itself, but recruits and
DNAsetotranslocatetothenucleusandcleaveDNA. activates others). The role of AIF in cell death execu-
Cellular mechanisms also exist to halt apoptosis. For tionvariesbetweencelltypes,butitseemsespecially
example, FLIP is a caspase-8 homologue that binds important in neurons. AIF is a flavoprotein resem-
toFADDbutdoesnotcausecaspase-8activation,and bling bacterial NADH oxidases and can produce O
•–
2
someheat-shockproteins(Section5.6)canalsoinhibit under appropriate assay conditions. This is probably
apoptosis. irrelevanttoitspro-apoptoticactivity,butinsometu-
Caspases are classified as initiator caspases mourcellsitmaybeimportantinsuppressingapoptosis
(caspases-2,-8,-9,and-10)andeffectorcaspases,such (Section5.4.2.2).56
as -3, -6, and -7. Activation of the initiator caspases SomemembersoftheBcl-2familyofproteinscan
(oftencaspase-8or-9)leadstoactivationoftheeffector also trigger mitochondria-dependent apoptosis. They
caspases, which put in motion the cellular events regulatetheoutermembranepermeabilityandhence
characteristic of apoptosis, including DNA fragmen- the release of pro-apoptotic factors. The family has
tation (activation of CAD after destruction of ICAD) over 30 members. Some suppress apoptosis (such as
and enzymes that cleave nuclear and cytoskeletal Bcl-2, Bcl-XL, Bcl-w, and Bcl-B), whereas others pro-
proteins, the latter resulting in blebbing. The hun- mote it, including Bax, Bak, Bad, and Bcl-Xs. The
dredsofproteinsthatarecleavedbycaspasesduring balance of these various proteins controls the like-
apoptosis include PARP-1 (cleavage inactivates it), lihood of mitochondria-mediated apoptosis. There is
theplasmamembraneCa2+-ATPase,andtheNa+-K+- anintimatelinkbetweencaspaseactivation(triggered
ATPase(eventscontributingtocellularCa2+overload), by any mechanism) and mitochondrial function. For
DNA repair enzymes, cell-cycle regulatory proteins, example, in some cells, caspase-8 cleaves the proap-
and some proteins involved in signal transduction. optoticproteinBid,whichmovestothemitochondria,
Whereas PARP inhibition often protects cells against andtriggerseventsthatfacilitatecytochromecrelease.

--- Page 273 ---

218 FREE RADICALS IN BIOLOGY AND MEDICINE
Ligands
External stresses
Cell stress
Death receptors
Plasma membrane
Internal stresses
Endoplasmic ER stress-
Death receptor BH3 proteins reticulum induced
pathway pathway
Bax/BAK
Caspase-8 Bid
Ca21
Mitochondria
Bax Bak
Cytochrome c bcl-2/bcl-x L
SMAC/DIABLO
Mitochondrial
pathway Release of proapoptotic
factors
Apaf-1/cyt c/procaspase-9
Apoptosome
Caspase-9
XIAP
Caspase-3
Apoptosis
Figure5.8 Molecularpathwaysleadingtoapoptosis.Thediagramshowsthreeofthepathwaysthatcanbeactivated.Thecell-surface-mediated
ordeath-receptorpathwayinvolvesthebindingofaligandtotheTNFfamilyofreceptors.Mitochondrialapoptosiscanbeinducedbystressesthat
activateBaxandBak.Theseproteinsthentranslocatetothemitochondrialmembraneleadingtoreleaseofapoptoticproteins.Theendoplasmic
reticulum(ER)pathwayisinducedbymisfoldedandaggregatedproteinsandotherstressesintheERthatleadtothereleaseofCa2+and
activationofthemitochondrialapoptosispathwayandER-associatedcaspases.BidisamemberoftheproapoptoticBH3subfamily.BaxandBak
areproapoptoticproteinscontainingmultiplebcl-2homologydomains.SMAC/DIABLOandcytcareamongtheapoptoticproteinshousedinthe
mitochondriathatarereleaseduponmitochondrialdamage.XIAPisamemberoftheinhibitorofapoptosisproteinfamily,whichinhibitsactivation
ofdownstreamcaspases.Abbreviations:Apaf-1,apoptoticproteinaseactivatingfactor-1;cytc,cytochromec;DIABLO,directinhibitorofapoptosis
protein(IAP)bindingproteinwithlowpI;SMAC,secondmitochondria-derivedactivatorofcaspases;XIAP,X-linkedinhibitorofapoptosis.TheIAPs
areinhibitorsofapoptosisproteins,whichareinactivatedbySMAC/DIABLO.AdaptedfromTrendsBiotechnol.22,174,2004,bycourtesyof
Dr.M.J.BetenbaughandElsevier.TheproteasomemayalsoplayarolebydegradingproapoptoticproteinssuchasSMAC/DIABLO;inturn,active
caspasesmayattacktheproteasomeandimpairitsactivity.
CaspasecleavageofasubunitofcomplexIplaysarole 5.4.2.2 Reactivespeciesandapoptosis30,46,60
inlossofmitochondrialmembranepotentialandO • 2 – Oxidative stress can cause apoptosis, e.g. by indu-
formationduringapoptosis.57
cing the MPT and causing release of proapoptotic
A third way of triggering apoptosis is to intro- factors(Figs1.9and5.8).Anotherpossiblemechanism
duceanagentthatdirectlyactivatescaspasesand/or is to trigger severe GSH depletion.60 Indeed, apop-
mitochondrial pro-apoptotic proteins. For example, totic cell death was observed in the skeletal muscles
tributyltinisthoughttotargetmitochondria,causing ofratstreatedwithBSO,aninhibitorofGSHsynthesis
swelling and cytochrome c release, but other mech- (Section 3.10.3).61 Oxidation of the anionic phosphol-
anisms may also be involved.58 Cytotoxic T cells ipid cardiolipin facilitates cytochrome c release from
and natural killer (NK) cells deliver a pore-forming mitochondria (since cytochromec is bound to the in-
protein (perforin) and a set of proteolytic enzymes nermitochondrialmembranebyassociationwiththis
(granzymes) into their target cells. Granzymes can phospholipid)andinturncytochromeccanpromote
cleavecaspase-3,Bid,andICAD(Fig.5.8).59 cardiolipinoxidation.62 Apoptosisinducedbyadding
The ER stress response can also lead to apoptosis taurine chloramine (highly selective for oxidation of
(Fig.5.8). thiolgroupsandmethionineresidues;Section2.6.3)to

--- Page 274 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 219
alymphomacelllineinvolvedoxidationof–SHgroups importantinradiation-inducedapoptosis,andinlung
and methionine residues in the actin-binding protein damageinCOPDpatients(Section9.13).
cofilin, which then detached from actin and trans- Nevertheless, ROS are not essential for apoptosis;
located to mitochondria to induce the MPT.63 Some apoptosis triggered by a range of insults can pro-
naturally-occurring toxins also cause apoptosis via ceed in the absence of O .72 Are RS always proap-
2
cofilinoxidation.64CleavageofAIFbycalpainsisalso optotic? No; in some cell types, they can prevent
accelerated when the IAF is oxidatively modified.65 apoptosis triggered by ligands to Fas/CD95 or by
OtheragentsthataffectF-actinassemblyaretheMical toxins affecting mitochondria.73 For example, in the
proteins;theybindtofilamentsanddisassemblethem melanomacelllineM14,decreasingO
•–levelsbyover-
2
in an NADPH-dependent process by oxidizing key expressingCuZnSODpromotedapoptosis,anddecreas-
methionine residues.66 In contrast, the caspases have ingCuZnSODlevelsinhibitedapoptosis.ElevatedO •–
2
exposed –SH groups and can be readily inactivated leads to a higher cytosolic pH that deters caspase
by H O , HOCl, OH • , ONOO–, and other RS. Thus activation.73Bycontrast,H O canpromoteapoptosis,
2 2 2 2
high levels of RS can delay or halt apoptosis. Cell notonlybydamagingmitochondria,butalsobylower-
death often continues, but switches to necrosis or ing the cytosolic pH, although it can also inactivate
necroptosis. caspases, as discussed above. Indeed, production of
Just as ROS can lead to apoptosis, apoptosis trig- H O by glucose oxidase has been suggested to be a
2 2
gered by other mechanisms (e.g. ligand binding to mechanism by which the silkworm, Bombyx mori¸de-
death receptors, anoikis) increases ROS generation. laysapoptosisoftheanteriorsilkglandsduringpupal
Releaseofcytochromec,andcaspase-dependentcleav- metamorphosis.74 The actions of O •– and H O on
2 2 2
age of complex I, disrupt the mitochondrial electron intracellularpHseemtoinvolveincreasingordecreas-
transportchain,causingmoreO •– formation.57,67 The ing respectively the activities of a plasma membrane
2
p66shc protein (Section 11.3.1.1) may be involved in Na+/H+exchangesystem.75Indeed,generationofROS
ROSproductionandcouldsometimesbeakeyplayer byanNADPHoxidasewasfoundtobeanantiapop-
ininducingMPT.68 Apoptoticcellsshowdecreasesin toticandproproliferativestimulusinpancreaticcancer
intracellular GSH levels, partly because it is released cell lines,75 and the ability of AIF to oxidize NADH
intothemedium.Thisoccursmostly,butnotentirely, and make O
•–
contributes to the viability of certain
2
through multidrug resistance protein transporters.60 carcinoma cell lines.56 Leporipoxviruses contain de-
Many proteins involved in apoptosis can undergo S- coyproteinsthatbindthecopperchaperoneforSOD
glutathionylation, including Fas and caspases (which (Section3.5.1)andcauseafallincellularSODlevels,
decreasestheiractivity),yetanotherfactortobecon- possiblytohelpsuppressapoptosisinvirallyinfected
sidered. Most work has been carried out on isolated cells.76 Indeed, several viruses produce proteins that
cells,sotheoverallimportanceofS-glutathionylation preventapoptosis.
asaregulatorymechanismforapoptosisinvivoisstill Nitric oxide in excess can trigger apoptosis, e.g.
uncertain.60,69 by forming ONOO– that attacks mitochondria and
Does this increased ROS production during apop- triggers the MPT. Another mechanism is to nitro-
tosiscontributetothecelldeath?Tosomeextentyes. sylateG3PDH,aglycolyticenzyme(Section1.7).This
There are cases where maintaining GSH levels halts modified cytosolic enzyme then migrates to the nu-
apoptosis (e.g. in cells treated with the drug etopos- cleus, accompanied by an E3 ligase enzyme (Sec-
ide), and others where it just slows it down.60 With- tion 5.14.3.3). Once there, this ligase promotes the
drawal of growth factors from the culture medium ubiquitin-dependent degradation of nuclear proteins
of many cells increases ROS production, and overex- andstartsapoptosis.77 Caspasesandmanyotherpro-
pression of antioxidant enzymes can delay (but not teinsinvolvedinapoptosiscanalsobenitrosylated,but
prevent)thesubsequentapoptosis.Theexternalization thephysiologicalsignificanceofthisisuncertain.77
of phosphatidylserine during apoptosis is facilitated
by its oxidation, a feature also promoting recogni-
tionofapoptosingcellsbymacrophages.70 Thefallin 5.5 Redoxregulation
GSH can sometimes contribute to apoptosis by acti-
5.5.1 Whatisitandhowdoesitwork?
vating sphingomyelinase enzymes, which hydrolyse
membrane sphingolipids (Section 5.11.2) to liberate Redoxreactionsplaykeyrolesinintracellularsignal-
ceramide.71Ceramidecantriggerapoptosis,inpartby ling(e.g.incontrollinghowacellrespondstoexternal
actinguponmitochondria.Ceramideseemsespecially hormonesandgrowthfactors,andincommunication

--- Page 275 ---

220 FREE RADICALS IN BIOLOGY AND MEDICINE
betweennucleus,mitochondria,andotherorganelles), to limit its own signal). The oxyR system of E. coli
intercellular signalling, and in regulation of the or- maintains a steady-state intracellular H O level of
2 2
ganandwhole-bodyresponsestostress.Someproteins about 0.2 μM over a wide range of growth condi-
aredirectlyredox-regulated(e.g.someionchannels,22 tions. Strains lacking oxyR show increased spontan-
p53[Section10.14.6],caspases,aconitase)whereasfor eous mutation rates, indicating its importance. OxyR
otherstheirlevelsarecontrolledbyalteringgenetran- also regulates the synthesis of the catalases KatA
scriptionusingredox-sensitivetranscriptionfactors. and KatB as well as ahpB and other antioxidants in
Thereareatleasttwoformsofredoxregulation.One P.aeruginosa79andofkatA,peroxiredoxin,glutathione
is the oxidation and reduction of –SH groups (either reductaseandothersinN.gonorrhoeae78.
singly, or sometimes in pairs to form a disulphide). WhataboutO
•–?ExcessO •–generationwithinE.coli
2 2
Thiolmodificationsalsoincludeglutathionylationand may increase H O levels and activate oxyR. The in-
2 2
nitrosylation. The second is the oxidation and reduc- creasedO
•–formationalsoleadstoincreasedtranscrip-
2
tionofironions,usuallyin[Fe–S]clusters.Thelatteris tion of almost a hundred additional genes, including
lesscommoninanimalcells,althoughtheresponseof those encoding MnSOD (but not FeSOD), a DNA re-
the IRPs toRS representsoneexample (Section3.22). pairenzyme(endonucleaseIV),fumaraseC,aconitase
Our most detailed knowledge of physiologically im- A, and G6PDH. Fumarase C and aconitase A seem
portantredoxregulationcomesfrombacteria,soletus tobe‘back-up’enzymesinsensitivetoinactivationby
startthere.PlantsareconsideredinSection8.11. O
•–
(Section1.6).The‘superoxidesignal’issensedby
2
theproteinencodedbythesoxRgene.80SoxRcontains
[2Fe–2S]clustersandisactiveonlywhentheyareina
fullyoxidized,diferricstate.OxidizedSoxRproteinac-
5.5.2 Bacterialredoxregulation:oxyR,soxRS
tivatestranscriptionofthesoxSgene,whoseproductin
andHOCl-sensitivetranscriptionfactors78
turnacceleratestranscriptionofthegenesencodingthe
Manybacteriarespondtomildoxidativestressbybe- aboveproteins.OxidizedSoxRisrapidlyre-reducedat
coming resistant to more severe oxidative stress. For theexpenseofNADPHviaaseriesofelectrontransfer
example, when E. coli, S. typhimurium or many other proteins,andsoxSproteinisdegradedbyproteinases,
bacteria are exposed to moderate levels of H O , the tostopthesignalling.81
2 2
synthesis of multiple proteins increases and the cells IncreasedO
•–generationinbacteriacanresultfrom
2
becomeresistanttodamagebyhigherlevelsofH 2 O 2 exposure to elevated O 2 levels or to chemicals that
(resistancetoHOClalsoincreases).Someofthesepro- produceO
•–(Sections9.4and9.5).Theextenttowhich
2
teinsareidenticaltothoseinducedbyheatshock(Sec- O
•–
itselfoxidizesSoxRinvivoisuncertain;anumber
2
tion5.6).S.typhimuriumcanalsoalteritsmembraneto of‘redoxcycling’agents(Sections9.4and9.5)suchas
decreaseentryofH 2 O 2 (Section2.6.2). paraquatandmenadionethatgenerateO • 2 – alsoseem
The levels of some of these proteins are controlled able to activate SoxR directly.81 The oxyR and soxRS
by the product of the oxyR gene. They include sev- systemscanalsobeactivatedbyexposureofE.colito
•
eralantioxidantdefences:hydroperoxidaseI(product excessNO .ItreactswiththeSoxR[2Fe–2S]centresto
ofthekatGgene);fur(whichcontrolsironuptake;Sec- displacesulphurandgeneratenitroso-iron-thiolcom-
tion 3.9.2); YaaA, which diminishes ‘free’ iron levels, plexes,whichhavesometranscriptionalactivity.82
alkyl hydroperoxide reductase (ahpCF gene); glut- B.subtilisandseveralotherbacteriauseadifferent
aredoxin(Section3.11),andglutathionereductase(gor mechanismtosenseH 2 O 2 ;theH 2 O 2 reactswithanFe2+
gene). If two critical –SH groups within the oxyR
inthePerRproteintoformOH•andconverthistidine
protein are oxidized to a disulphide by H O (a fast to2-oxohistidine.Theoxidizedproteincannolonger
2 2
reaction!),theoxidizedproteinactsasatranscription represstheexpressionofgenesencodingantioxidants,
factor,promotingexpressionofthesegenes.Dpspro- includingcatalase,alkylhydroperoxidereductase,and
ductionisalsoincreasedbyoxyR;DpsbindstoDNA a Dps-like protein,and sotheirlevelsrise.83 Theoxi-
and protects it against oxidative damage. Levels of a dized PerR then has to be degraded and replaced,
Mn2+importsystemalsorise(Section3.8.2). somewhatwastefulperhaps.PerRcanalsobindMn2+
How is the signal switched off so that the bacteria and in that form is much less sensitive to H 2 O 2 , an-
don’twasteproteinsyntheticcapacitywhenthethreat other example of the key role of Mn2+ in affecting
has gone? Simply, by reduction of the OxyR disul- cellular antioxidant defences (Section 3.8.2). In addi-
phide,probablyinvolvingglutaredoxin(whoselevels tion,inB.subtilis,theOhrRproteinsensesthepresence
are handily increased by the action of OxyR, helping of organic peroxides (e.g. linoleate hydroperoxide).

--- Page 276 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 221
They oxidize a cysteine residue to a sulphenic acid called Orp1) in which cysteine (rather than seleno-
which forms a mixed disulphide with cellular thiols cysteine) is present at the active site. The -SH is oxi-
(e.g. cysteine, CoA), generating a form that can no dized by peroxides to a sulphenic acid which then
longerbindtoDNA.ItsreleasefromDNAallowsthe reactswithacys-SHonYap1toformadisulphidebond
synthesisofathiolperoxidasethatcanmetabolizeor- withYap1,whichthenconvertstoaYap1intramolecu-
ganichydroperoxidestoalcohols.83 OhrRisrelatively lardisulphidebond.Reducedthioredoxincanreverse
insensitivetoH O ,butitcanreactwithHOCl.Both theseprocesses:indeedGpx3cancatalyseremovalof
2 2
OhrRandsoxRproteinshavebeenemployedinassays peroxidesusingreducedthioredoxinasasubstrate.87
tomeasureperoxidesincells(Section6.11). S. cerevisiae contains five peroxiredoxins: three in
E. coli also contains several transcription factors thecytosol,oneinthenucleus,andoneinmitochon-
(YjiE[nowrenamedHypT],RclR,andNemR)thatde- dria.Twoofthecytosolicforms(Prx1and2)alsohave
tect HOCl, although HOCl can also induce the SoxR chaperone-likeactivity(Section5.6).88
response as well as generate a chaperone in this bac-
terium (Section 5.6).84–86 HypT in cells exposed to
5.5.4 Redoxregulationinanimals:kinases
HOCl undergoes oxidation of methionine. The oxi-
andphosphatases89–91
dized product then activates the expression of genes
involved in cysteine synthesis and slows down ex- 5.5.4.1 Whatisitabout?
pressionofthoseinvolvedinironacquisition,whereas
Signal transduction describes the mechanisms by
NemRleadstoincreasedlevelsofglyoxalase1.
which cells sense and respond to their environment,
fromthedetectionofsomething(e.g.H O ,agrowth
2 2
5.5.3 Redoxregulationinyeast factor, a cytokine) to the transmission of informa-
tion via other molecules eventually to the nucleus,
AnaerobicallygrownS.cerevisiaerespondstotheintro-
where gene transcription responds and alters the be-
ductionofO byactivatingthebiosynthesisofhaem,
2
haviour of the cell. For example, binding of ligands
usingametabolicpathwaythathastwoO -dependent
2
tosomegrowthfactorreceptorsactivatesproteintyro-
enzymes (coproporphyrinogen III oxidase and proto-
sine kinase domains on these receptors, which then
porphyrinogenIXoxidase).Thehaemproducedbinds
phosphorylateandactivatesubsequentproteinsinthe
to and activates the transcription factor Hap1.86 This
signal cascade. In addition to intracellular signalling,
inturnacceleratestranscriptionofgenesencodingsev-
multicellularorganismsrequirecomplexintercellular,
eral antioxidants, including MnSOD, catalases, and
andinter-tissuesignallingnetworkstoorchestrateand
peroxiredoxins. Added haem activates Hap1 even in
co-ordinate the functions of different cells and or-
theabsenceofO ;thesynthesisofhaemisthesignal
2
gansinordertomaintainhomeostasis,defendagainst
thatO ispresent.
2
pathogens, repair injury, undergo development and
Asinbacteria,pretreatmentofS.cerevisiaewithmod-
erate levels of H O , organic peroxides, or O
•–- tissue remodelling, and deter malignancy. We now
2 2 2 knowthatnotonlyNO•butalsoH O ,andsometimes
generating systems causes it to become resistant to 2 2
otherROS,playkeyrolesinsignallinginvivo.Hence
higherlevels.OnegeneinvolvedisYaP1(whichresem-
the activity and location of systems generating ROS
blesthemammaliantranscriptionfactorAP-1;Section
(e.g. NADPH oxidases, mitochondrial electron trans-
5.5.7).TheYaP1protein(sometimeswrittenasYaP1p)
port)mustbecarefullycoordinatedwiththeenzymes
controls the expression of several genes involved in
thatremoveROStoallowthemtotransientlyaccumu-
the synthesis of stress proteins and antioxidants, in-
late,andtheexcesstoberemovedoncesufficientsignal
cluding GSH, thioredoxin, CuZnSOD, catalase, and
hasbeensent.Anexampleoftheimportanceofloca-
cytochrome c peroxidase. When cysteine residues in
tionisgiveninSection8.11.1.Manypapersandbooks
YaP1 areoxidizedtoadisulphidebridge,theprotein
have been written about kinases and phosphatases
migrates to the nucleus and increases gene expres-
and, as for apoptosis (Section 5.4.1), we present here
sion.Thisoccursbecauseoxidationleadstoconform-
onlytheminimuminformationneededtounderstand
ational changes that conceal YaP1’s nuclear export
howROSareinvolved.
signaldomain,whichnormallykeepsitoutofthenu-
cleus.YaP1playsasimilarroleinseveralotheryeasts
5.5.4.2 Proteinkinases89–91
andfungi.
The Yap1 protein is not directly oxidized by per- The mitogen-activated protein kinases (MAP kin-
oxides; other proteins are involved. One is a yeast ases) are a large family of enzymes that use ATP
glutathioneperoxidasehomologue(GPx3,sometimes to phosphorylate their protein targets on serine or

--- Page 277 ---

222 FREE RADICALS IN BIOLOGY AND MEDICINE
threonineresidues.Theyareinvolvedincellprolifer- inplantandanimalcells(Sections8.10and8.11)and
ation(hencetheirname;theymediatecellresponsesto can produce O
•–
in response to stresses (e.g. growth
2
mitogens), differentiation, and response to stress and factor deprivation in neurons), hormones (e.g. angio-
usuallyleadtoalterationsintranscriptionfactoractiv- tensin II in vascular smooth muscle cells), growth
ity to modulate gene expression. Three of the major factors, and cytokines. Rises in Ca2+ levels can also
subdivisions are the p38 kinases, the extracellular- increaseRS,byincreasingXOlevels(insomecells;Sec-
signal-relatedkinases(ERKkinases),suchasERK-1 tion 5.3.2), by activating DUOX enzymes (Table 5.5;
•
and ERK-2, and the c-Jun N-terminal kinases (JNK Section 8.10), or by stimulating NO production by
kinases). All are activated via overlapping signalling eNOSornNOS(Section5.3.2).
cascades involving other kinases that phosphorylate WehavealreadymentionedtheroleofIP inraising
3
them (e.g. MAP kinase kinase, and MAP kinase intracellular‘free’Ca2+ (Section5.3.2.1).IP isderived
3
kinasekinase).TheERKpathwayisimportantincell fromphosphorylatedformsoftheplasmamembrane
proliferationinresponsetogrowthfactors,thep38and phospholipid phosphatidylinositol (Fig. 5.17). Other
JNK pathways more so in the response of cells to phosphorylatedformsofinositol(e.g.phosphatidylin-
stressessuchascytokines,radiation,heatshock,mech- ositol3,4,5-triphosphate,PIP ),generatedbytheaction
3
anical stress, osmotic stress, and of course, oxidative of phosphoinositide-3-kinases (PI3-kinases), in turn
stress. activatephosphoinositide-dependentkinases(PDK)
All three subfamilies can be activated when cells thatphosphorylateandactivateAkt(sometimescalled
are exposed to RS. For example, addition of H O protein kinase B). Active Akt is a serine/ threo-
2 2
to JurkatT cells (a lymphocyte cell line) increased nine kinase that, like ERK, is important in response
the phosphorylation and activation of p38, ERK, and to hormones (e.g. insulin), growth factors, and oxi-
JNK.92 Ofcourse,whenH O isaddedtocells,itmay dative stress. For example, exposure of various cells
2 2
enter multiple parts of the cell, whereas H O gen- to H O increases phosphorylation of the epidermal
2 2 2 2
erationduringsignallingisusuallylocalized.Indeed, growth factor receptor (EGFR), which in turn acti-
adding bolus H O to cells is probably not a good vatesPI3KandhenceAkt.Aktpromotescellsurvival,
2 2
modelfortheeffectsofsteadyandlocalizedH O gen- e.g. by phosphorylating and decreasing the activity
2 2
erationinvivo.AdditionofONOO–toseveralcelltypes of proapoptotic factors such as Bad and caspase-9
canalsoactivateallthreeMAPkinasefamilymembers (Section5.4.1).
(thesamecaveatsapply).93Ontheotherhand,ONOO– ActivationofAktalsoleadstoincreasedphosphor-
can sometimes impair signalling by causing tyrosine ylationoftheforkheadtranscriptionfactorsofclassO
nitration(Section2.6.1).ActivationofkinasesbyRScan (FOXOs). ‘Forkhead’ refers to a ‘winged-helix’ struc-
lead(dependingonthecelltype,thelevelofRS,and tural motif that all these proteins have, and the O to
forhowlongtheRSispresent)toproliferation(e.g.low ‘other’,thatisFOXOproteinsaresomewhatstructur-
levelsofH O stimulatedproliferationofalveolartype allydifferentfromotherforkheadproteins.WhereasC.
2 2
II cells, involving ERK activation94), cytoprotection, elegansandDrosophilaonlyhaveoneFOXO,mammals
(e.g.inendothelialcellstreatedwithH O ,activation havefour:FOXO-1,-3a,–4,and–6.Phosphorylationof
2 2
ofERKwasprotectiveagainstmembraneblebbing95), FOXOs excludes them from the nucleus, so that they
increased expression of cytoprotective stress genes, cannot promote gene transcription. Active intranuc-
growtharrest,orapoptosis(Section5.4.1). learFOXOspromotecellcyclearrestandseveralother
Onegeneralguideline(over-simplisticbutstilluse- events (including increasing autophagy rates, prote-
ful) is that, in response to stress, ERK activation asomeactivity,andlevelsofantioxidantdefencessuch
tends to promote cell survival, whereas prolonged as catalase, SOD, GPx, and peroxiredoxins), yet can
JNK activation favours cell death, e.g. by apoptosis. paradoxicallysometimesleadtoapoptosise.g.byin-
Since both are often activated, the balance between creasingproductionofFasligand.Asusual,life’sabit
them is critical in determining cell fate. A further morecomplicated—phosphorylationofFOXO4atdif-
example, exposing vascular cells to shear stress can ferentsitesbyJNKtendstomakeitenterthenucleus,
increase the levels of antioxidant defence enzymes andH O leadstoJNKactivation.Thusthecellularre-
2 2
and NO• production. In some cells this is due to sponse to ROS involvesa balance between signalling
increased intracellular production of O
•–
and H O pathwaysthatcanswitchoff(Akt)andswitchon(JNK)
2 2 2
fromNADPHoxidaseenzymes,leadingtoactivation thenucleartranscriptionalactionofFOXOs.97 FOXOs
of p38 MAPK, which phosphorylates eNOS to raise canalsoberegulatedbyacetylation,andareintimately
NO• production.96 NADPH oxidases are widespread involvedinageing(Sections11.3.1.1and11.3.4).

--- Page 278 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 223
Table5.5 Someexamplesofstimulatoryeffectsofhormones,cytokines,andgrowthfactorsinvolvingreactiveoxygenspeciesinanimalcells.
ActivationofNF-κB/AP-1inresponsetoseveralstimuli(Section5.5).
Responseofcellstocytokines,especiallyTNF-α(Section5.7).
ROSgeneratedbyaNADPHoxidasearerequiredforendothelin-inducedproliferationinratcardiacfibroblasts(Mol.Pharmacol.69,1347,2006).
Epidermalgrowthfactor-inducedtyrosinephosphorylationinepidermoidcancercellsrequiresH2O2(J.Biol.Chem.272,217,1997).
AngiotensinIIraisesO
•–productioninbloodvesselsviaaNADPHoxidase(Section8.10.4)leadingtoincreasedbloodpressure.
2
ActivationofAktbyangiotensinIIinvascularsmoothmusclecellsinvolvesROS(J.Biol.Chem.274,22699,1999).
RisesinCa2+ininsulin-treatedmyotubesinvolveH2O2andaNADPHoxidase(J.Biol.Chem.284,2568,2009).
PDGFreceptor-inducedphosphorylationofERK,DNAsynthesisandmigrationinsmoothmusclecellsinvolvesH2O2andisblockedby
overexpressionofcatalase(Science270,296,1995).
ChanglivercellsoverexpressingGpx1showedlessEGRF-receptormediatedAktactivation:knockdownofGPx1increasedactivationbut
expressionofcatalasedecreaseditagain(J.Biol.Chem.284,11931,2009).
Insulin-treatedadipocytesandothercellsshowphosphataseinactivationinvolvingH2O2production;thismayinvolveO •
2
–producedbyaNADPH
oxidaseenzyme(Physiol.Rev.89,27,2009).
AdhesionofNIH-3T3fibroblastsgeneratesROSwhichpromotephosphorylationoffocaladhesionkinase(FAK)byinhibitingFAKtyrosine
phosphatase(J.Cell.Biol.161,933,2003).
DifferentiationofhumanendometrialstromalcellsintodecidualcellsuponexposuretocAMPrequiresROSfromNOX4(Endocrinol.152,730,
2011).
Basicfibroblastgrowthfactor(FGF-2)inductionofc-FosinchondrocytesandlungfibroblastsrequiresROS(Am.J.Physiol.279,L1005,2000).
SynthesisofTIMP–3bychondrocytesorofacontractileproteininsmoothmusclecellsinresponsetoTGF-β1involvesROS(FreeRad.Biol.Med.
37,196,2004;Arterio.Thromb.Vasc.Biol.25,341,2005).
CelldivisioninexplantedrataortasinresponsetocatecholaminesismediatedviaROS,probablybyactivationofaNADPHoxidase(Circ.Res.94,
37,2004).
ShearstressinducesgenerationofH2O2inhumanarteriolesinculture,whichmediatesflow-induceddilation(Circ.Res.93,573,2003).
Shearstressincreasedfluid-phaseendocytosisinbovineaorticendothelialcellsviaincreasedROSproductionbyaNADPHoxidase(FreeRadic.
Res.40,167,2006).
CyclicstretchoflamblungarterialsmoothmusclecellsincreasedTGF-β1,whichincreasedROSproductionviaaNADPHoxidase,leadingto
increasedVEGFsynthesis(Am.J.Physiol.289,L288,2005).
Nervegrowthfactor-induceddifferentiationofPC12cellsismediatedbyROS(J.Biol.Chem.275,13175,2000).
ExposureofmyocytestoIGF-1increasedROSproductionviaNOX4leadingtohypertrophy(Endocrinol.152,912,2011).
ExposureofvascularendothelialcellstoVEGFcausedROSproduction,leadingtophosphorylationofgapjunctionproteinsandaltered
permeability(J.Biol.Chem.284,25602,2009).
Endothelin-1activatesERK1/2,PKBandproteintyrosinekinase2invascularsmoothmusclecellsviaROS(FreeRadic.Biol.Med.37,208,2004).
InsulinincreasesO •
2
–productioninhumanskinfibroblastsviathePI3kinasepathwayandNADPH,leadingtoERK-1activation(Diabetes53,
1344,2004).
Thrombin-inducedmitogenesisinvascularsmoothmusclecellsinvolvesO
•–producedbyaNADPHoxidase(J.Biol.Chem.274,19814,1999).
2
ROSarerequiredforstimulationofVEGFsecretionbyhumanendometrialstromalcellsexposedtoretinoicacid(J.Physiol.589,863,2011).
BindingofantigentoreceptorsonaBlymphomacelllineraisedintracellularCa2+whichincreasedROSproduction(byactivatingaDUOX
enzyme;Section8.10)andthusinactivatedphosphatases(Cell121,281,2005).
TGF-β-inducedcytoskeletalalterationsinhumanumbilicalveinendothelialcellsorsmoothmusclecellsinvolveROSproducedbyaNADPHoxidase
(Am.J.Physiol.289,F816,2005;FreeRadic.Biol.Med.50,354,2011).
ExposureofculturedrenalmedullacellstohighosmoticpressureincreasedROSproductionandraisedCOX-2levels(J.Biol.Chem.280,34966,
2005).

--- Page 279 ---

224 FREE RADICALS IN BIOLOGY AND MEDICINE
ReleaseofIP fromphospho-phosphatidylinositols, andGpx1.101 Hencetheyplay adualrole,promoting
3
which also produces diacylglycerol (DAG), is cata- apoptosisinresponsetohighlevelsofH O ,butalso
2 2
lysed by phospholipases C, whose activity is stimu- allowingcellstoadapttolowerlevels.Phosphorylated
lated by a G-protein.aPhospholipase C-γ1 (PLC-γ1) catalaseistargetedforubiquitinationanddestruction
andPLC-γ2arecomponentsofanothergrowth-factor- by the proteasome (Section 5.14.3.2), however. Phos-
receptor-mediated signalling system that responds to phorylation(byadifferentmechanism)alsomodulates
oxidativestress,whereupontheybecomephosphoryl- activityoftheperoxiredoxins,butthistimedecreasing
ated. Phospholipase D, which hydrolyses phosphat- it. The importance of GPx and catalase phosphoryl-
idylcholinetophosphatidicacidandcholine,canalso ation in vivo is uncertain (although that of catalase
beactivatedbyH O insomecells.98 maybeimportantintheactionofendothelin;Section
2 2
Protein kinases C are another family of ser- 5.5.10),butthatofperoxiredoxinsmaybeveryimport-
ine/threonine kinases involved in regulation of cell ant.Indeed,thephosphorylationofPrx1isconfinedto
proliferation and response to stress. In their inactive Prx1moleculesclosetothemembranesitesinvolvedin
forms they are usually cytosolic, but upon activation assemblyofthemoleculesrequiredforsignalling.102
they move to other sites (e.g. the plasma membrane) Membersofthesrcfamilyofnon-receptortyrosine
to exert their effects. Most of them need Ca2+ and kinasesarecloselyinvolvedincytoskeletalreorganiza-
DAG, the second product of PLC action, for activity. tionincellssubjectedtostress,andintheregulationof
ThePKCscontaincysteine-richregionssusceptibleto vasculartoneandanoikis.Manystimulithatgenerate
oxidation(orglutathionylation),causinglossofactiv- ROSalsoleadtoincreasedphosphorylationbysrckin-
ity when high levels of RS are present. On the other ases,byinactivatingphosphatasesandpossiblyalsoby
hand,selectiveoxidationoftheN-terminalregulatory directlyoxidizingthesrcproteins.99
domain can stimulate PKC activity by removing the
requirementforDAG,whichnormallybindstothisdo- 5.5.4.3 HowdoRSmodulatesignalling?
maininthepresenceofCa2+toactivatePKC.Peroxides Some kinases are directly affected by RS, including
canalsoactivatePKCsbystimulatingtheirphosphor- PKC (Section 5.5.4.2), ATM (Section 5.10.8), protein
ylation.HencePKCsareanothertargetofredoxregu- kinase G (Section 5.5.10), src, the kinase domain of
lation, and this plays a role in several physiological theepidermalgrowthfactorreceptor(Section5.5.4.4),
systems(includingbloodpressureregulation;Section andpyruvatedehydrogenasekinase2[Fig.1.7]).More
5.5.10).90,99,100PKCsareintimatelyinvolvedinphago- often,however,RSincreasenetphosphorylationbyin-
cyteactivation(Section8.7),celladhesion,mitogenesis, hibiting dephosphorylation. Protein phosphatase en-
andregulationofapoptosis,amongotherprocesses. zymes are constantly active in cells, and function to
TheC-Ablandargtyrosinekinases(membersofthe rapidlyreverseproteinphosphorylationandlimitthe
Abelsonfamilyofkinases)arefoundinthecytoplasm extent and duration of signalling.91 Some are specific
of many cell types (i.e. they are not activated via re- forphosphotyrosine,someforser/thrphosphatesand
ceptors,soaresometimescallednon-receptortyrosine others (e.g. PTEN—phosphatase and tensin homo-
kinases).Theycanbeactivatedbyoxidativestress(e.g. loguedeletedonchromosome10)havebroaderspe-
added H 2 O 2 ) which promotes their phosphorylation cificity. Its major substrate in vivo seems to be PIP 3 .
byaPKC.Theiractivationcanpromoteapoptosisun- By hydrolysing PIP , PTEN opposes the activation
3
dercertainconditions.Theseactivatedkinasescanalso of the PI3K/Akt pathway. Inactivation of PTEN can
bind to, phosphorylate, and stimulate the activity of thus favour inappropriate cell survival via increased
someantioxidantdefenceenzymes,includingcatalase Akt phosphorylation. Indeed, PTEN knockout mice
arepronetodevelopcancer,andPTENisinactivated
in some human cancers. Prx1 can bind to PTEN and
a G-proteins(guaninenucleotidebindingproteins)arefre- decreaseitsactivity.91
quentlyfoundascellsurfacereceptorsthatrespondtohor- Phosphatase inactivation by RS usually occurs
mones,neurotransmitters,andothersignallingmolecules.G-
proteinsaremostlytrimersofα,β,andγ subunits,butsome by oxidation of essential cysteine residues to sul-
aremonomeric,thesmallGproteins.Bindingofaligandto phenicacids(cys-SOH).ROSabletoinactivateprotein
thereceptoractivatestheG-protein;itbindsGTPandGDP phosphatases include ONOO–, H O , organic per-
2 2
is displaced. The ‘switch’ is turned off when the G-protein oxides, HOCl, and chloramines; H O seems to be
2 2
hydrolysesitsboundGTPtoGDP.G-proteinscommonlyuse
eitherCa2+orcyclicAMPasintracellularsignallingmolecules. the commonest oxidant in vivo.103,104 Inactivation of
They are important in O • 2 – production by phagocytes and phosphatasesbyH 2 O 2 ispotentiatedbythepresence
severalothercelltypes(Section8.7). of CO 2 /HCO– 3 and has been suggested to involve

--- Page 280 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 225
peroxomonocarbonate (Section 2.5.2) formation.105 If tyrosine kinase activity. Some of it oxidizes adjacent
you are not careful, phosphatases can be inactivated phosphatase enzymes.107 Oneestablished mechanism
byH O generatedartefactuallyincellculturemedia forROSproductionisforligandbindingtostimulate
2 2
(Section 1.11)!106 Further reactions can occur, e.g. the PI3K pathway, which activates the small G pro-
whenproteintyrosinephosphataseIBisoxidized,the teinRac1,thatinturnactivatesanNADPHoxidase,107
sulphenicacidrapidlyreactswiththeamidenitrogen producing O
•–
and hence H O . The localized inacti-
2 2 2
ofanadjacentserineresiduetogiveasulphenylamide vationofperoxiredoxinsbyphosphorylationmayaid
(S–N) species; it was proposed that this occurs to theprocess.102Similarly,peroxiredoxinshelptomodu-
preventfurtheroxidationofthesulphenicacidtosul- latetheresponseofcellstoPDGFbycontrollingH O
2 2
phonic (–SO H) or sulphinic (–SO H) species, which levels;PDFGbindingtoitsreceptorsactivatesNADPH
3 2
aremoredifficulttoconvertbacktoanactivecysteine oxidases and raises H O levels.112 Aquaporins (Sec-
2 2
residue.107Inactivationofphosphatasescanalsooccur tion2.6.2)arefrequentlyinvolvedinmakingsurethe
byglutathionylation. H O gets to the right place to exert its signalling
2 2
In some other phosphatases such as PTEN, ROS function.113
inactivate not by cys–SOH formation but by causing
disulphide bridge formation.108 Another phosphatase
5.5.5 MitochondrialcommunicationbyROS?
sensitive to RS is calcineurin, a Ca2+/calmodulin-
dependent serine/threonine phosphatase particularly Althoughsomeconstituentsofthemitochondrialelec-
importantinbrain,heart,cartilage,andlymphocytes. tron transport chain are encoded in mitochondrial
Itsinactivationoccursbyoxidationofironionsatthe DNA,thegenesformostareinnuclearDNA.Hence
activesite,109andcanbemediatedbyO • 2 –. nuclearandmitochondrialgeneexpressionmustbeco-
OthermechanismsbywhichRSstimulatephosphor- ordinated, both normally and in response to stresses,
ylationexist.Forexamplethioredoxinbindstoandin- such as hypoxia. PGC-1α (peroxisome-proliferator-
activatesASK1,apoptosissignal-regulatingkinase-1. activated-receptor γ co-activator-1α) induces mito-
Oxidative stress causes the oxidation of thioredoxin chondrial biogenesis by activating various transcrip-
resulting in its dissociation from ASK1. This causes tion factors. Two especially important ones are
activationofASK1,whichcanthenleadtophosphoryl- nuclearrespiratoryfactors-1and-2,NRF1andNRF2,
ationandactivationofJNKandp38kinasesbyacting whichcontrolexpressionofthenucleargenesencoding
asaMAPkinasekinasekinase.103,110 mitochondrial proteins. Binding of NRF2 (sometimes
Howareoxidizedphosphatasesre-convertedtoac- called GA-binding protein, GA-BP) to DNA can be
tive forms? Our knowledge of this is limited but inhibited by ROS, apparently due to oxidation of es-
reducedthioredoxinprobablyplaysakeyrole.111 sential –SH groups,114 but whether this happens in
vivo is unknown. Oxidation is reversible by reduced
5.5.4.4 Reactivespeciesasmediators
thioredoxin.NRF1canalsobeactivatedasatranscrip-
oftheactionsofsignallingmolecules?
tionfactorbyphosphorylation,whichcanbefacilitated
Exposure of cells to RS activates a range of signal- bytheinactivationofphosphatasesbyH O .
2 2
lingpathways.Butwhatabout‘normal’signallingvia Mitochondrial O
•–/H
O production is often th-
2 2 2
binding of growth factors, cytokines (Table 5.7), and oughtofasanuisance,anunavoidableconsequenceof
hormones to receptors? Their binding initiates pro- electronleakageinthepresenceofO .Indeed,these-
2
teinphosphorylationandtriggerssignallingcascades. verephenotypeofMnSOD-knockoutmicerevealsthe
However,thereisconsiderableevidencethatH O is threatposedbytoomuchO
•–intheseorganelles(Sec-
2 2 2
also involved in the response of cells to these agents tion 3.7.2). However, another view is that variations
(Table 5.5), e.g. for FGF, EGF, TGF-β, PDGF, VEGF, inmitochondrialH O productionnotonlyaffectthe
2 2
andinsulin.90,91Thissuggeststhatligand-bindingand mitochondriathemselves(Fig.1.7legend),butalsoact
activation of receptor-linked protein kinases cannot as a signal that advises the cytoplasm and nucleus
produce enough phosphorylation to allow a full re- what the mitochondria are doing, leading to changes
sponse;transientinactivationofphosphatasesbyH O innucleargenetranscription(includinggenesforthose
2 2
mayalsoberequired. mitochondrialproteinsencodedinthenucleus)viaac-
How are the ROS produced? As an example, EGF tivationofMAPkinasesandothermechanisms.Isthis
binding to its receptor (EGFR) leads to H O gener- possible? It seems so. Addition of antimycin A to
2 2
ation.SomeoftheH O canoxidizeathiolgroup(to cultured cells to partially block mitochondrial elec-
2 2
a sulphenic acid) in the EGF receptor, increasing its tron transport increased both intracellular peroxide

--- Page 281 ---

226 FREE RADICALS IN BIOLOGY AND MEDICINE
levels and the transcription of nuclear genes encod- production.120 So mitochondrial ROS do seem to be
ingmitochondrialproteins;bothwereantagonizedby importantsignallingagentsafterall.
antioxidants.115 Mice partially defective in mitochon- WesawinSection1.3.3thatmitochondriaconstantly
drial MnSOD showed increased oxidative damage in fuse and divide, and this is another potential tar-
nuclearDNA(Section11.4.5.1),asdidmicelackingthe get of oxidative stress: mitochondrial fragmentation
Bmi1 protein, whose knockout increases mitochon- is also promoted and fusion decreased during apop-
drialO •–/H O production.116Thesedatasuggestthat tosis. In some cells (e.g. endothelial cells and myo-
2 2 2
ROSfrommitochondriacanreachthenucleus.MnSOD cytes),H O exposurecanpromotemitochondrialfrag-
2 2
activitycanbeinfluencedbyacetylation,whichcould mentation, which slowly reverses with time (unless
be a regulatory mechanism (Section 11.3.4). The in- enoughH O isaddedtocausecelldeath,ofcourse).121
2 2
crease in levels of antioxidants such as MnSOD in GSSG also affects the process, promoting mitochon-
responsetoTNF-α (Section5.5.6)maybeanotherex- drial fusion that might sometimes delay apoptosis
ampleofmitochondria-to-nucleussignallinginwhich (Section3.11)!
ROSareinvolved.MitochondrialO
•–
appearstocon-
2
tribute to ischaemic preconditioning (Section 10.6.6).
5.5.6 NF-κB
Another example comes from diabetes, in which in-
creasedmitochondrialO • 2 – andH 2 O 2 production(Sec- NF-κB122 isanassemblyofproteinsthatactivatesthe
tion 10.5) seem to be involved in insulin secretion in transcriptionofmultiplegenesinresponsetoavariety
isolatedβ-cells.117
ofstimuli.ItbelongstotheRelfamilyoftranscription
Incontrast,over-expressionofcatalaseinthemito- factors. Active NF-κB is usually a heterodimer, most
chondria of heart and skeletal muscle decreased oxi- oftencontainingproteinsofrelativemolecularmasses
dative damage there and increased lifespan in mice 50,000and65,000,referredtoasp50andp65.NF-κBis
(Section 11.4.5.1), implying that diminution of mito- presentinalmostallmammaliancellsandinmostof
chondrialROSproductioncouldbebeneficial.Hence themspendsmuchofitstimeinaninactive,cytoplas-
ifmitochondrialROSareuseful,thebalancemaybea mic form. Cytoplasmic retention and lack of activity
fineone,asisindeedsuggestedbytherelationshipof resultfrombindingofinhibitorysubunits,theIκBs,to
mitochondrial O • 2 –/H 2 O 2 production to lifespan (Sec- theheterodimer.Awiderangeofstimuli,suchasendo-
tion 11.4.8). Indeed, some overexpression of catalase toxin, hypoxia, mechanical stress, infection with vir-
seemsgood,buttoomuchmaybebad(Section11.4.8) uses(Section10.25),exposuretoUVlight,toxins(e.g.
Another question is how could the O •
2
–/H
2
O
2
pro- nickel,cobalt),γ-rays,orcertaincytokines(e.g.TNF-α;
ducedinmitochondriaescapethemitochondrial(Sec- Section5.7)leadtoactivationofNF-κB.Indeed,NF-κB
tion3.20.1)andcytosolicantioxidantdefencestoreach isactivatedinawiderangeofinflammatorydiseases,
thenucleus?Wedon’tknow.However,doremember fromgastritistorheumatoidarthritis(Chapter10).
thatmitochondriaareverymobilewithincellsandcon- Activation results when IκB dissociates from the
stantlymakingtransientcontactswitheachotherand complex,usuallycausedbyitsphosphorylationontwo
with other organelles, which could allow ROS trans- serine residues by the kinases IKKα and -β. These
fer, avoiding cytosolic antioxidants. Consistent with kinasesarethemselvesregulatedbyphosphorylation,
this, exposure of pulmonary artery endothelial cells althoughothermechanismscanbeinvolved,depend-
to hypoxia caused movements of mitochondria to- ing on the cell type and the NF-κB-activating signal
wards the nucleus and a rise in nuclear H
2
O
2
levels, (Fig.5.9).ThedissociatedIκBisthenubiquitinatedand
consistentwiththefrequently-suggestedroleofmito- degradedbytheproteasome(Section5.14.3.2).Theac-
chondrial ROS in promoting adaptation to low O
2
tiveNF-κBheterodimermovesintothenucleus,binds
levels(Section5.9.4and118).Mitochondriallytargeted to DNA, and increases expression of multiple genes,
antioxidants (Section 11.5.12) have proven to be use- including those encoding several cytokines (e.g. IL-2,
fultoolstostudyphysiologicalrolesofmitochondrial IL-6,IL-8,TNF-α),acutephaseproteins(Section5.7.4),
ROS. For example, they halted the differentiation of iNOS, growth factors, adhesion molecules, cyclooxy-
humanstemcellsintoadipocytes,aneffectreversedby genase 2, cytokine receptors, HIF-1α, and MnSOD.
additionofH
2
O
2
.ThemitochondrialROSinvolvedap- PromptresynthesisofIκB,alsopromotedbytheacti-
pearedtocomelargelyfromcomplexIII.119Evenmore vatedNF-κB,shutsdownthesignal;itbindstonuclear
impressively, these antioxidants prevented the devel- NF-κB and helps to push it back into the cytoplasm
opmentofinsulinresistanceinratsonahigh-fatdiet, (Fig.5.10).ActivationofNF-κBcanleadtoinflamma-
whichappearstocauseincreasedmitochondrialH 2 O 2 tion,cellinjury,andapoptosisandisinvolvedincancer

--- Page 282 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 227
PAMPs,
GFs IL-1 LPS, others
RTK IL1R TLR
MyD88 PI3K 88DyM FIRT PARIT MART
2FART
DDART DDART
5FART
TNF-α
TNFR
IRAK4
IRAK1
TRAF6 IRAK4 RIP1
IRAK1
Akt
TRAF6
Atypical pathway Canonical/typical or Alternative pathway
classical pathway
SYK TAK1 NIK1
NEMO
I
K K α IK Kβ
I
K K α IK Kβ
P P
P P P
Tyr42 Ser32 Ser36 P
lκB lκB Ser866 P
Ser870
RelB p100
p65 p50 p65 p50
p65 p50 RelB p52
Figure5.9 DifferentwaystoactivateNF-κB.Receptortyrosinekinases(RTK):upongrowthfactorbinding,RTKsassociateformingdimers,
areautophosphorylatedatmultipletyrosines,andrecruitadditionalsignallingproteins.Amongrecruitedproteinsisphosphatidyl-inositol-3-kinase
(PI3K).Intheatypicalpathway,PI3Kphosphorylatesspleentyrosinekinase(SYK),whichinturnphosphorylatesIκBatTyr42,thesignalforIκB
degradation.Alternatively,PI3K-activatedAktcantransducesignalsthroughthetypicalpathwaybydirectlyphosphorylatingIκBkinaseβ(IKKβ).
Interleukin-1receptor-1(IL-1R1):afterbindingofIL-1tothereceptor,MyD88israpidlyrecruitedandassociatestothereceptorviainteraction
ofToll/IL-1receptor(TIR)domainspresentinbothIL-1RandMyD88.IL-1R-associatedkinase1(IRAK1)andIRAK4arerecruitedtoMyD88,where
IRAK4phosphorylatesIRAK1,resultinginhyperphosphorylatedIRAK1byautophosphorylation.ThekinasesdissociatefromMyD88.
AnintermediatecytosoliccomplexcomposedoftheE3ligasepellino-1,IRAK1,IRAK2,andIRAK4isformed,whereasTNFreceptor
(TNFR)-associatedfactor6(TRAF6)becomesubiquitinated,whichservesasaplatformforTGFβ-activatedkinase(TAK1).Thesamecomplexis
formedinTLRsignalling(notshown).TAK1thenactivatesIKKβ.Toll-likereceptors(TLR):withtheexceptionofTLR3,allTLRs,likeIL-1R,
activateTAK1throughMyD88,activationofIRAK1byIRAK4,IRAK1autophosphorylation,andTRAF6recruitment.Inaddition,
Toll-receptor-associatedactivatorofinterferon(TRIF)-relatedadaptormolecule(TRAM),TRIF,andTIR-domain-containingadaptorprotein(TIRAP)
interactwiththereceptor.Ifthetypicalpathwayistaken,TRAF6activatesTAK1.Ifthesignalentersthealternativepathway,NIK1becomes
activated.NIK1directlyphosphorylatesIKKα,whichinitiatesproteolyticcleavageofp100,theprecursorofp52,byphosphorylationatSer866and
870.Finally,theRelB/p52heterodimercanenterthenucleus.TNFR:TNFbindingtoTNFR1triggerstheassociationoftheadapterprotein
TNFR1-associateddeathdomainprotein(TRADD)tothereceptor.Then,TRAF2,TRAF5,andthekinasereceptorinteractingprotein-1(RIP1)are
recruited.RIP1canactivateTAK1inthetypicalandNIKinthealternativepathway.FromAntioxid.RedoxSignal.15,2335,2011,bycourtesyof
theauthorsDrsR.Brigelius-FlohéandL.Flohé,andbythepublisherMaryAnnLiebert,Inc.

--- Page 283 ---

228 FREE RADICALS IN BIOLOGY AND MEDICINE
Activating
stimuli
LPS CYTO ROS
NIK
NFκB IκB
(+) feedback
(–) feedback
Protein
synthesis
IκB
TNF-α,
IL-1β
IL-10
Figure5.10 NF-κBregulationanditsinteractionwithsomecytokines.LPS,lipopolysaccharide;CYTO,proinflammatorycytokines;NIK,NF-κB
induciblekinase;IκB,inhibitoryprotein.FromBr.J.Anaesthesia90,221,2003,bycourtesyofDrsJ.Macdonald,N.R.Webster,andH.F.Galley,and
thepublishers.
development (Section 10.14.11), but paradoxically it insomecelltypesthisisachievedbyincreasingtran-
canalsocontributetotheresolutionofinflammation. scription of genes encoding IκB. Another agent that
NF-κB activation can also promote survival in sev- caninhibitNF-κBactivationincertaincellsisthenat-
eralcelltypes,bydisfavouringapoptosis.Forexample, urallyoccurringproductcaffeicacidphenethylester
thisisimportant(tothevirus!)invirallyinfectedcells (acomponentofpropolis;Section4.5),
(Section10.25).
Whether NF-κB activation is bad or good depends
onitsextent,time-course(toolongisusuallynotgood),
onwhatothertranscriptionfactorsareactivatedorde-
activatedatthesametime,andonwhatpanelofgenes
is switched on by NF-κB in the cell under consider- althoughitaffectsothertranscriptionfactorsaswell.123
ation. Agents that activate NF-κB frequently activate NF-κBisparticularlyimportantintheimmunesys-
other cell signalling pathways, such as JNK. There is
tem.ImagingofNF-κBactivity(Section6.10)inhealthy
considerable cross-talk between these various path- mice showed it to be low in most tissues, except for
ways,inwhichtheycanco-operate(e.g.Aktactivation lymph nodes, thymus, and Peyer’s patches in the in-
promotes IκB phosphorylation) or antagonize each testine (also part of the immune system). Injection
other’sactions,dependingonthecellsstudiedandthe of cytokines or endotoxin increased activity in many
signalapplied.99 Rememberalsothat,overall,inflam- organs.124
mationisusuallybeneficialtothebody.Indeed,most
NF-κB-activatedgenesareinvolvedinwhatappearsto 5.5.6.1 ROSornoROS?
beanearlydefencenetworkagainstinfectionorinjury. SincemanystimulithatactivateNF-κBalsocauseoxi-
Glucocorticoid hormones decrease NF-κB-activation; dativestress,PahlandBaeuerle125 proposedthatROS

--- Page 284 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 229
are a common second messenger system used by all enzymes.130 Indeed,activityofNF-κBmaysometimes
stimuli to activate NF-κB. Indeed, addition of micro- be greater in phagocytes from patients with chronic
molar amounts of H O , HOCl, or ONOO– to the granulomatousdiseaseorinmicelackingNOX2.131
2 2
culturemediumactivatesNF-κBinsome(butnotall)
celllines.ManydatahavebeenobtainedusingHeLa
andJurkatcells,bothmalignant(andthussomewhat 5.5.7 AP-1
abnormal)celllines.
The transcription factor AP-1 (activator protein 1)89
Further support for the concept came from ex-
alsosensesintracellularredoxstateandregulatesthe
periments with antioxidants; overexpression of thio-
expression of multiple genes involved in stress re-
redoxinorGPxinsomecellspreventedNF-κBactiva-
sponse, growth, and differentiation, and in response
tionandseveraladdedantioxidants(includingthiols,
to certain cytokines and growth factors. It is usually
catechols, and spin-traps) blocked the activation of
adimerofproteinsoftheFosandJunfamilies,most
NF-κB by any stimulus.125 However, one should be
commonly a c-Fos/c-Jun heterodimer. The activity of
carefulininterpretingtheeffectsofseveralwidelyused
AP-1iscontrolledbothbyregulatinghowmuchc-Fos
‘antioxidants’, because they can have other actions.
andc-Junthecellmakes,andbyphosphorylationofal-
For example, N-acetylcysteine (Section 11.5.9.2) is a
readysynthesizedfos/jun(e.g.byMAPkinases).The
redoxagentthatraisescellGSHlevels,butitcanalso
c-Fos and c-Jun proteins were originally described as
blockthebindingofTNF-α toitsreceptor.126 Pyrroli-
productsofproto-oncogenes(Section10.14.4).c-Junis
dinedithiocarbamatehasbeenusedasanantioxidant
phosphorylated by JNK, and c-Fos by the ERK path-
to study NF-κB, but it also chelates metals and can
way. Both phosphorylations can be influenced by RS
interfere with ubiquitination of IκB.126 Nevertheless,
viaphosphataseinactivation.
administrationofcatalasepreparations(galactosylated
Binding of AP-1 to DNA is redox-regulated by a
or mannosylated catalase) or overexpression of GPxs
mechanism involving cysteine residues in the DNA-
(Section5.5.10)decreasedNF-κBactivationininflamed
binding domain of Fos and Jun: oxidation decreases
mousetissues,soROSdoplaysomeroleinvivo.127
DNAbinding.Oxidationcanbereversedbyacellular
HowcouldRScauseIκBdissociationandNF-κBac-
redox/DNA-repairproteincalledRef-1(redoxeffector
tivation?ThetriggerforIκBdetachmentisphosphoryl-
factor1),whichisinturnreducedbythioredoxin.This
ation(Fig.5.9).Alikelymechanismthereforeinvolves
Ref-1activityislocatedonanAPendonucleaseprotein
decreasingphosphataseactivity(Section5.5.4.3).How-
involvedinDNArepair(Section5.10.3).Hencerepair
ever,it’smorecomplexthanthat.Asalwaysinredox
iscloselylinkedtoactivationoftranscriptionbyAP-1.
biology,thereisabalance.ActivationofNF-κBisone
step, but to achieve biological effects the activated
transcription factor must bind to DNA. Binding is
5.5.8 Theantioxidantresponseelement
modulated by phosphorylation and acetylation. It is
andNrf287,89,132
alsoaffectedbyredoxstate,beinginhibitedbyoxidiz-
ing agents (by oxidation or glutathionylation of thiol Antioxidant response elements (ARE) are DNA se-
groups),andpotentiatedbythiols,especiallyreduced quences to which Nrf1 and Nrf2 (nuclear factor
thioredoxin,whichmayplayakeyroleinkeepingNF- erythroid 2-related factors 1 or 2) proteins can bind.
κBreducedinthenucleus.89 Hencetheoveralleffects Most attention has been paid to Nrf2. Its binding
ofredoxstateuponNF-κB-mediatedgeneexpression
to AREs allows increased transcription of genes en-
can be variable. Too many RS may activate NF-κB, coding xenobiotic metabolizing enzymes, including
but they could inhibit binding of the active factor to NAD(P)H: quinone oxidoreductase 1 (Section 9.5.4),
DNA,andinthiscaseantioxidants(atacertainlevel) GST(Section3.15.2),UDP-glucuronyltransferases(Sec-
mightpromoteNF-κB-dependentgeneexpression.For
tion 2.6.4), CYP2A5, P-glycoprotein, and multidrug
example, overexpression of catalase increased the NF- resistanceassociatedproteins.Inaddition,Nrf2activa-
κB-dependentinductionofiNOSinrataorticsmooth
tionincreasestheexpressionofgenesencodingHO-1
muscle cells treated with a mixture of cytokines and (Section3.24)andantioxidantdefencessuchasGPx2,
endotoxin.128SuchactionsonNF-κBmaycontributeto
Prx1, thioredoxin, sulphiredoxin, thioredoxin reduc-
anti-inflammatoryactionsofROSundercertaincondi- tase, and γ-GCS; increased activity of γ-GCS raises
tions(Section8.9.4).129 Forexample,HOCl,atjustthe GSHlevels(Section3.10.3).Thesechangesaidmetab-
rightlevel,preventedNF-κBactivationinhumankera-
olismandremovalofxenobiotics,andalsorendercells
tinocytesandtheskinofmice,byinactivatingtheIKK moreresistanttooxidativestress.Proteasomefunction

--- Page 285 ---

230 FREE RADICALS IN BIOLOGY AND MEDICINE
may also be increased (Section 5.14.3.3). The name site, and an NF-κB-responsive site.134 Thus any, or
‘antioxidant response element’ arose from its role in any combination of, these transcription factors can
mediating the response to agents such as t-butyl hy- raisecellularGSHlevels.Reactivespeciescanactivate
droquinone, which has antioxidant properties in in Nrf2bydirectattackonKeap1,indirectattackbyend-
vitro assays. Ironically, Nrf2 is usually responding to products of lipid peroxidation, by stimulating PKC,
pro-oxidantsinvivo. and/orbyinactivatingphosphatasesandstimulating
How does the system work? Nrf2 is widely ex- netKeap1phosphorylationbythisandotherkinases.
pressed in animal tissues but it is kept in an inactive In general (to use a gross oversimplification), acti-
form, mostly in the cytosol, by binding to the Keap1 vations of the heat-shock response (Section 5.6), AP-
(kelch-like ECH-associated protein 1) protein, which 1, Nrf2, ERK, Akt, and NF-κB promote cell survival
alsopromotesitsrapiddegradationbytheproteasome. afteroxidativestress,whereasprolongedactivationsof
Manyxenobioticsbothinduceoxidativestressandare, JNK,p38,andp53(Section10.14.4)moreoftenleadto
orcanform,electrophiles,agentsthatreactwithsites apoptosis.
of high electron density on proteins, DNA, or lipids
(e.g.unsaturatedaldehydessuchasHNEformeddur-
5.5.10 Physiologicalsignificanceofredox
ing lipid peroxidation; Section 5.12.5.3). An increase
regulationinanimals
inoxidative/electrophilicstresscanactivatePKC(Sec-
tion 5.5.4.2). PKC then phosphorylates cytoplasmic Evidence that redox regulation is physiologically im-
Nrf2,causingittofallawayfromKeap1.TheNrf2then portantisstronginbacteria,yeasts(Sections5.5.2and
migratesintothenucleusandbindstotheARE.Some 5.5.3),andinplants(Section8.11).Whataboutanimals?
other kinases can also phosphorylate Nrf2 and free Many studies of redox regulation have been carried
it from Keap1. In addition, Keap1 is rich in cysteine out upon cells in culture (Table 5.5). Here one must
residues and its direct modification by RS and elec- becareful,becausecellcultureimposesoxidativestress
trophiles,includingcyclopentenonecompounds(Sec- (Section1.11).Itisthereforepossible,indeedlikely,that
tion 5.12.3), unsaturated aldehydes (Section 5.12.5), culturedcellsevolveandadapttouseROStooxidize
carotenoidoxidationproducts(Section4.4.3.2),taurine molecules and send signals that in the whole animal
chloramines (Section 11.5.1), and dietary xenobiotics are sent in other ways.135 For example, a signal nor-
such as sulphoraphane (Table 4.5) can stop the pro- mally sent by oxidation of –SH groups in a molecule
teasomal degradation of Nrf2 and cause it to accu- viaanetworkofthiol-containingproteinscanalsobe
mulate. Thus a better term for AREs is electrophile sent (artefactually) by direct thiol oxidation by a RS.
responseelements. Inthelasteditionofthisbook,wehighlightedtheneed
Mice lacking Nrf2 are highly susceptible to the to move away from studies of isolated cells towards
toxicity of xenobiotics such as paracetamol (Sec- wholeanimals.
tion 9.10) and benzopyrene (Section 10.15) and show How far have we got? A long way towards estab-
impairedliverregenerationafterinjurytothatorgan. lishing the role of RS in signalling in pathology, and
Several dietary constituents in addition to sulph- some way towards establishing their role in ‘normal’
oraphanecanactivateNrf2(Table4.5),anditsactiva- physiology.First,itisnowclearthatmanycellsinvivo
tion has been made a therapeutic target in the treat- containNADPHoxidasesthatproduceO •–/H O (Sec-
2 2 2
mentofsomediseaseswhereoxidativestressplaysa tion 8.10), consistent with a role for RS in vivo. The
prominent role (Section 11.5.11). Too much Nrf2 ac- properties of peroxiredoxins are also consistent with
tivity is not good, however; it can promote cancer aroleforROSinsignalling(Section3.13).Studieson
development (Section 10.16.1). Indeed, mice lacking NOX1-knockoutmiceandspontaneouslyhypertensive
Keap1 had constitutively active Nrf2 and died soon ratshaverevealedaroleforO •–inregulationofblood
2
afterbirth.133 pressure (Section 8.10.4). ROS mediate responses to
exercise (Section 7.14) and ischaemic preconditioning
(Section10.6.6),insomestudiesatleast.Micetreated
5.5.9 Co-operationandcombination
withcatalaseoroverexpressingGPx1andextracellular
The cellular response to oxidative, ‘electrophile’, or GPx127,136 showed less activation of NF-κB after liver
other stresses involves multiple signalling pathways, injuryorischaemia–reperfusion,consistentwithsome
whichcansynergizeorantagonizeeachotherindoz- roleforH O inthatactivation.GPx1-overexpressing
2 2
ens of ways. For example, the promoter of the gene mice respond poorly to heat, suggesting that H O
2 2
encoding γ-GCS contains an ARE, an AP-1 binding helpstotriggertheheatshockresponse(Section5.6).

--- Page 286 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 231
Mice with elevated SOD showed accelerated angio- H O .Exercisingmiceoverexpressingcatalasedidnot
2 2
genesisaftersubcutaneousinjectionofbasicfibroblast showelevatedeNOSactivity,consistentwithH O be-
2 2
growth factor (bFGF) and abnormally high produc- ing a physiological messenger.144 Hydrogen peroxide
tion of cytokines from macrophages during inflam- may also help to mediate muscle adaptations to ex-
mation,suggestingthatO •– helpstomodulateangio- ercise in rats,145 and ROS also seem to be involved
2
genesisandinflammationinvivo.137ROSproducedby inadaptationtoexerciseinhumans(Section7.14).139A
NADPH oxidases are important in limiting excessive InSection5.5.5wesawthatmitochondrialH O pro-
2 2
inflammation(Sections8.9and10.11).129 vides a link between dietary fat intake and insu-
However,thesearepathologicalsituations,indicat- lin resistance in rats: mitochondria isolated from the
ing that ROS help coordinate and control response muscles of humans on a high-fat diet also showed
to injury (undoubtedly an important thing to do!). greaterH O production,invitro.120 Furtherevidence
2 2
What about healthy animals? Mice overexpressing comesfromstudiesofboneturnover(Section8.10.8).
GPx1 showed mild hyperglycaemia, insulin resist- Hence evidence is growing that ROS are important
ance, and obesity, apparently associated with im- players in signalling in the healthy animal, but the
paired phosphorylation of insulin receptor in liver extent of their role as compared to other signalling
and Akt in liver and muscle. This supports a role mechanismsisasyetuncertain.
for H O in ‘normal’ insulin action in vivo (Sec-
2 2
tion10.5.2);indeed,micelackingGPx1hadincreased
insulin sensitivity, perhaps due to PTEN inactivation 5.5.11 Lessonsfromanamoeba
andincreasedPI3K/Aktsignalling.103Isletsfrommice
Aninterestingperspectiveonredoxsignallingispro-
deficient in NOX2 show abnormally large insulin se-
vided by the slime mould Dictyostelium discoideum,
cretion in response to glucose.138 Obesity, intimately
often called a ‘social amoeba’. It usually lives hap-
involved with the development of insulin resistance
pilyaloneandfeedsonbacteria,butwhenfoodruns
and type 2 diabetes, is also linked to oxidative stress
out the amoebae aggregate to form a ball that pro-
(Section10.4).
duces a ‘fruiting body’ containing spores. The ball
•
StudiesondogsshowedthatbothNO andH O are
2 2 trundlestoa‘better’locationandreleasesthespores,
involvedincontrollingvasodilatorresponsesincoron-
eachofwhichgerminatestogenerateafreshamoeba.
aryarteries,andH 2 O 2 producedbyvascularendothe- AttheonsetofaggregationthecellsreleaseO •–usinga
lium has been suggested to be a physiological vaso-
NADPH oxidase enzyme; if O
•–
levels are d
2
ecreased
dilatorinseveralanimals,includinghumans,perhaps
by O
•–
scavengers or overexpr
2
ession of SOD, aggre-
acting by opening Ca2+-activated K+ channels.139,139A gation 2 is inhibited.146 This use of O •– in an amoeba
Inmice,theH O canoxidizecys-SHresiduestoadi- 2
2 2 as it converts from unicellular to multicellular raises
sulphidebridgeonaproteinkinaseG,activatingitand
the possibility of whether the same thing happened
eventually leading to vasodilation, perhaps by phos-
during the evolution of multicellular organisms, i.e.
phorylation of ion channels. Excessive activation of
couldROS-dependentsignallingbeofancientorigin?
thiskinasecancontributetohypotensionduringsepsis
ROS are also involved in differentiation in the slime
(Section10.6.7).140 Micecontainingafullyactiveform
mouldPhysarumpolycephalumandthefungiNeurospora
of the enzyme but with a mutated cysteine residue,
crassa,Podosporaanserina,andAspergillusnidulans.Dif-
sothatH O couldnotaffectit,developedhyperten-
2 2 ferentiation appears to be accompanied by increased
sion, and blood vessels isolated from them were not
oxidativestress,andchangesinredoxstatemaybethe
responsivetoH 2 O 2 .140Indeed,catalase-overexpressing triggerfordifferentiation.147
mice show lower blood pressure, an effect reversed
bytreatmentwiththecatalaseinhibitoraminotriazole
(Section3.17.3).141Regulationofcatalasebyphosphor- 5.6 Heat-shockandrelated
ylation (Section 5.5.4.2) may also be involved in con- ‘stress-induced’proteins;cross-talk
trollingH 2 O 2 levels.142Bothknockoutandoverexpres- withROS148,149
sionofEC-SOD(Sections3.23.3.2and10.17.5)affected
hippocampalfunctioninmiceasmeasuredbybehav- When cells are subjected to oxidative stress, it is not
iouralstudies,leadingtothesuggestionthatO • 2 – may onlyantioxidantdefencesthatcanrise;levelsofmany
playaroleinhippocampus-dependentmemory.143Ex- other proteins increase as well, including some of
ercisetraininginmiceincreasedeNOSactivity,anef- theheat-shockproteins(Hsp).TheHspareclassified
fectalsoseeninvascularendothelialcellstreatedwith into seven major families, denoted by their relative

--- Page 287 ---

232 FREE RADICALS IN BIOLOGY AND MEDICINE
molecular mass (e.g. the Hsp70 family contains pro- thecell(Fig.5.11).Forexample,Hsp70andsomeother
teinsbetween68and77kDamolecularmass). Hspcanfacilitateclearanceofabnormalproteinsbythe
Heat-shock proteins were first identified by stud- proteasomesystem(Section5.14.3.3).Metallothioneins
ies of the response to heat, hence the name. After a (Section 3.23.2) and MnSOD (Section 3.5.2) can also
suddenincreaseintemperatureallcells,fromhumans beincludedinthegeneralcategoryofstressproteins,
to plants (Section 7.9.4) to microbes, increase expres- sincetheirlevelsincreaseinresponsetomanystresses.
sionofgenesencodingHsp.Investigatorssoonfound Many Hspactas chaperones, proteinsthataidthe
that cells also produce more Hsp when exposed to folding and translocation of other proteins and are
other stresses, including ischaemia–reperfusion, toxic normallypresentwithinthecell(Fig.5.11).Someuse
metals, oxidative stress, cytotoxic aldehydes such as energyfromATP(e.g.Hsp70,Hsp90)whereasothers
HNE, alcohol, and other xenobiotics, and thus began do not (e.g. Hsp27). As an illustration of the value
to refer to them by a more general name, stress pro- of Hsp, mice lacking Hsp70 could not recover prop-
teins. The purpose of Hsp is to protect normal cells erly after injury to skeletal muscle.150 Chaperones of
from protein misfolding and also to help them to re- the Hsp70 family act early in the life of a protein,
cover from stress/injury (Fig. 5.11). Errors in protein before it leaves the ribosome, to help it start fold-
synthesis, folding, and glycosylation are common in ingcorrectly,andthenhanditovertoHsp60tohelp
vivo,andoxidativeorotherdamagetoproteinsisin- with later stages of protein folding. In addition, the
volvedinmanydiseases(Chapter10;Section5.13).The release of Hsp70 from cells helps to coordinate the
Hsp are one of the mechanisms that maintain prote- inflammatory/immuneresponsetoinjury(e.g.Hspre-
ome stability (sometimes called proteostasis) within leasedbygliamayprotectneurons;Section10.17.6.12).
CHAPERONES
On-pathway
Unfolded state intermediates Native state
Mutations
Molecular chaperones
Off-pathway
Biosynthetic errors
Clearance intermediates
mechanisms
(proteasome, Energy deficits
Oligomers
autophagy)
Protein damage
Aggregates (oxidative, glycation,
Detoxifying enzymes
other mechanisms)
Ageing
PROTEOSTASIS
function dysfunction
Figure5.11 Proteostasisandproteomestability.Proteostasisrepresentsthebalancebetweenafunctionalanddysfunctionalcellularstateand
dependsonproductiveproteinfolding.Foldingintermediatescanbeon-pathway,oroff-pathwayandformoligomersandaggregates.Suppression
ofoff-pathwayintermediatesbychaperonesandclearancemechanismsisalsochallengedbyproteindamage,includingmutationsresultingin
abnormalproteinsthatmisfold,biosyntheticerrors,andoxidativedamage.Adaptedfrom148bycourtesyofDrR.MorimotoandColdSpringHarbor
LaboratoryPress.

--- Page 288 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 233
Cytoplasmic chaperones eventually ‘hand over’ pro- activity.Inresponsetostress,HSF-1isreleasedasthe
teins destined for organelles to the organellar chap- Hspsaredivertedtodealwithabnormalproteins.The
erones. A cytosolic chaperone is involved in the de- HSF-1 formsa trimerthatbindswith highaffinity to
livery of iron to ferritin (Section 3.22.1.4). A special heat-shockelements.TheextraHsp70madeasaresult
formofHsp70,BiP(togetherwithseveralotherchap- should(hopefully!)facilitatetherefolding(orremoval
erones such as calnexin and calcireticulin), helps to of)damagedproteins.HSF-1isalsoregulatedbyacet-
fold proteins within the ER to allow correct disul- ylation,whichdecreasesitsactivity.De-acetylationby
phidebondformationbyPDI(Section3.12).Disturb- sirtuins (Section 11.3.4) thus promotes the heat shock
ances in ER Ca2+ homeostasis, inhibitors of protein response.154
glycosylationintheER,oxidativedamagetoERpro- Theheatshockresponseenhancescellsurvivaland
teins (consequent on exposure to ROS or sometimes decreases oxidative damage, not only to proteins but
to oxidized lipids, e.g. cholesterol oxidation prod- alsotolipidsandDNA,underawidevarietyofstress
ucts), or accumulation of misfolded proteins trigger conditions.Thiscross-protectiveresponsetocellstress
anERstressresponse,sometimescalledtheunfolded issometimescalledhormesis,‘alittlestressisgoodbe-
protein response. This activates signalling pathways causeitmakesyoustronger.’Thetermcomesfroman
from the ER to the rest of the cell to decrease pro- ancientGreekwordhormaein,‘tosetinmotion,impel,
tein synthesis (to stop the problem getting worse). urgeon’.155 Forexample,Hsp70canantagonizeJNK-
They also lead to increased levels of BiP, other chap- mediatedapoptosis insomecells.Hsp 70 and27 can
erones, and PDI to remedy the situation, and help inhibit key parts of the apoptotic pathway, includ-
ejecttheproteinsfromtheERintothecytosolforubi- ingcaspaseactivation.55,56TheNrf2systemisanother
quination and degradation by the proteasome, or by exampleofhormesis(Section5.5.8).
autophagy (Section 5.14.3). Nevertheless, severe ER ExposureofE.colitoHOClcausesoxidativeunfold-
stress that cannot be remedied in this way can lead ing and activation of a normally inactive chaperone,
to apoptosis (Fig. 5.8).151 ER stress caused by addi- Hsp33,whichthenhelpstodeteraggregationofbac-
tionoftunicamycin,aninhibitorofproteinglycosyla- terial proteins after attack by HOCl.156 This is one
tion, seemed to involve activation of a NADPH oxi- exampleofaredox-regulatedchaperone.Anotherwe
dase(NOX4)presentinER,leadingtoincreasedROS havealreadymet:oxidationofcertainperoxiredoxins
production and inactivation of ER protein tyrosine inactivates their H O -scavenging activity, but con-
2 2
phosphatase.152 Dithiothreitol (Section 2.5.5.4) can in- vertsthemintooligomerswithchaperoneactivity(Sec-
duceERstressincellsbyimpairingdisulphidebridge tion3.13).156 Chaperoneactivityofperoxiredoxinscan
formation. bedecreasedbyglutathionylation:157theimportanceof
Many stress-inducing agents (especially RS!) cause thisinvivoisasyetuncertain.
proteindamage,andtheaccumulationofpartiallyde- Someplasmaproteinsmayhavelimitedchaperone-
natured or abnormally folded proteins triggers the like activity, an example being clusterin,158 which in
Hspresponse(Fig5.11). Interferencewithproteolysis vitrocanpreventaggregationofseveraldamagedpro-
(Section 5.14.3) can do the same. The action of oxi- teins, including albumin. Clusterin is also found in
dativestressindamagingproteinsprobablyaccounts otherfluids,suchasCSF,milk,ocularfluid,andsem-
foritsabilitytoinducesomeHsp,althoughadditional inalplasma.Clusterinisfoundinextracellularprotein
mechanisms are probably involved.149 Similarly, Hsp aggregates in several diseases, consistent with its ac-
induction by heat can involve ROS. Indeed, thermal tion(orattemptedaction!)asachaperoneinvitro.158α -
2
induction of Hsp70 in transgenic mice overexpress- Macroglobulin, a proteinase inhibitor (Table 8.2) may
ing GPx1 was subnormal, and the mice were less alsohelptopreventproteinaggregation.158 Haptoglo-
thermotolerant;153 the heat shock response of plants bin (Section 3.23.3) can also exert similar chaperone-
alsoinvolvesROS(Section7.9.4). like activity in vitro, in addition to its haemoglobin-
Hsp synthesis involves activation of heat-shock bindingaction(Table3.7).
transcriptionfactors(e.g.HSF-1),whichbindtoDNA CertainHsphaveotherroles.Thustheubiquitins,a
sequences (heat-shock elements) in the promoters of group of smaller (8500 molecular mass) Hsp, help to
genesencodingHsp,andincreasetheirtranscription. remove unwanted proteins via the proteasome (Sec-
In unstressed cells HSF-1 is present in the cytoplasm tion 5.14.3.2). Ubiquitin levels rise five- to sevenfold
and the nucleus (perhaps bound to Hsps such as after stress. The protein Hsp32 is identical to HO-1
Hsp70)asamonomericformthathasnoDNA-binding (Section3.24).

--- Page 289 ---

234 FREE RADICALS IN BIOLOGY AND MEDICINE
5.7 Cytokines,hormones, work,inpart,bycausingRSgenerationatspecificsites
andredox-regulationoftheorganism intheirtargetcells(Section5.5.4).
Another(overlapping)signallingmechanismispro-
Most of the redox regulation we have discussed so videdbythecytokines.Cytokineisalooselydefined
far has been at the cellular level. Can multicellular term that encompasses a wide range of polypeptides
organismsuseRStotransmitsignalsbetweencells?Ni- andglycoproteins.Theirpresenceisusuallytransient
tric oxide is a clear precedent, but can other RS be and strictly controlled. Most cytokines are secreted,
similarly used? For example, if a cell is stressed, can and act by binding to receptors on their target cells.
it release RS that cause damage to, or perhaps even Cytokines cross-talk; one cytokine affects the secre-
leadtoincreaseddefencesin,othercellsandtissues? tion and actions of others. When first discovered,
Yes it can; systemic acquired resistance in plants is cytokines were usually identified as products of sin-
a good example (Section 8.11) and oxidized lipids in gle cell types, for example monokines from mono-
apoptotic cells can influence a cell’s neighbours (Sec- cytes, lymphokines from lymphocytes, and interleu-
tion5.4.1.2).Reactivespecies,especiallyH O ,operate kins from leukocytes. The list expanded to include
2 2
over short distances at sites of inflammation to trig- interferons,TNFs,andchemokines(Table5.6).Itwas
gerchangesinadjacentcells,suchasincreasedlevels soon realized that cytokines have multiple cellular
of adhesion molecules, proliferation (Fig. 5.2), and sources,abroad(andoftenoverlapping)rangeofbio-
phagocytechemotaxis(Section8.7).Intercellularcom- logicalactivities,andsomeredundancyintheireffects;
munication also occurs through cell–cell contact (e.g. different cytokines often affect cells in the same way.
viagapjunctions),whichmayallowinformationtrans- Inaddition,mostcytokinesarepleiotropic,thatisthey
fer about oxidative stress, such as exchange of H O , exertdifferenteffectsondifferentcells.Ausefulana-
2 2
GSH,GSSG,orthioredoxin,forexample(Section5.2.4). logy is that cytokines are ‘words’ in the language of
Communication between the cells located in dif- cellular communication; words mean different things
ferent organs of complex organisms is unlikely to be dependingonwhatotherwordssurroundthem.
directly mediated by RS, since their lifetime is short. Cytokinesplaykeyrolesinnormalgrowthanddev-
Itispartlyachievedbyhormonessuchasinsulin,thy- elopment,inflammatoryandotherresponsestoinjury,
roidhormones,adrenalin,oestrogen,andtestosterone, andtissueremodellingandrepair(e.g.woundhealing,
which are secreted into the blood and affect many angiogenesis). A complex balance between different
celltypesindifferentways,frequentlyincludingalter- cytokinesregulatesthefinaloutcome.Thussomecyto-
ationsofantioxidantdefences.Often,thesehormones kines are commonly regarded as pro-inflammatory
Table5.6 Somecytokines.
Class Examples
Interleukins IL-1α,IL-1β,IL-2to-7,andIL-9to-18(andmaybemore!)
Chemokinesa Inman,thereareabout50chemokineswhichhavebeensub-dividedintofourseparatefamilies—CXC
(includingCXCL1-17),CC(includingCCL1-28),CX3C(includesfractalkine),andXC(includinglymphotactin),
basedonthearrangementofcysteineresidueswithinthemolecule.Examplesincludemonocyte
chemoattractantprotein1(MCP-1),monocyteinflammatoryproteins(MIP-1αand-1β);andRANTES
(regulation-upon-activation,normalT-cellexpressedandsecreted)
Interferons Interferonsα,β,andγ
Tumournecrosisfactors Cachectin(TNF-α),lymphotoxins(TNF-β 1,-β 2)
Colony-stimulatingfactors(CSFs) GranulocyteCSF,macrophageCSF,granulocyte-macrophageCSF(GM–CSF)
Transforminggrowthfactors TGF-α,TGF-β(severaltypes),activins
Growthfactors Epidermalgrowthfactor(EGF),fibroblastgrowthfactor(FGF),hepatocytegrowthfactor(HGF),insulin-like
growthfactor(ILGF),keratinocytegrowthfactor(KGF),platelet-derivedgrowthfactor(PDGF),vascular
endothelialgrowthfactor(VEGF)
Neurotrophicfactors Nervegrowthfactor(NGF);brain-derivedneurotrophicfactor(BDNF);ciliaryneurotrophicfactor(CNTF)
aChemotacticcytokines.

--- Page 290 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 235
(e.g. IL-1, IL-6, TNF-α) whereas others are, over- priming phagocyte (especially neutrophil) ROS pro-
all, ‘anti-inflammatory’ (e.g. IL-1 receptor antagonist, duction (Section 8.7.4.2) as well as increasing iNOS
IL-10).Itisimpossibletoreviewallthecytokineshere levels (Section 2.5.6). It is often portrayed as a ‘bad
andsowediscussonlyafewthatareparticularlyim- guy’, and indeed it probably is overall in endotoxic
plicated in oxidative stress. Indeed, proinflammatory shockandsomechronicinflammatorydiseases.How-
cytokinesareoftenproducedinresponsetooxidative ever, it also plays a key part in host defence re-
stress, and act, in part, by causing oxidative stress in sponses against injury and infection. For example,
their target cells. For example, several cytokines are transgenic ‘knockout’ mice lacking TNF receptors
producedbycellsiftheirNF-κBisactivated(e.g.TNF- show various abnormalities and are more sensitive to
α,IL-Iβ,IL-2,IL-6,IL-12),andinturnthiscanincrease braindamagebycertainneurotoxinsorbyischaemia–
NF-κB activation and cytokine production (Figs 5.9 reperfusion.161
and 5.10). By contrast, anti-inflammatory cytokines, ThebindingofTNF-αtoitsreceptorsincreasesoxi-
such as IL-10, suppress inflammation, in part by de- dativestressinitstargetcells.Itisapowerfulactivator
creasing ROS formation (Fig. 5.10). The presence of of NF-κB in many cell types, often (but by no means
pathogens or of damage-associated molecular pat- always)actingviaincreasedproductionofH O .Thus
2 2
terns(hostsignalsfrominjuredcells)actsviaprotein TNF-αisabitlikeNF-κB;usefulwhentransientlypre-
complexes (inflammasomes) to regulate production sent/activated, but not good if high levels/activities
ofpro-inflammatorycytokinessuchasIL-6andIL-18 are there all the time. In at least some cells treated
(discussed in more detail in Section 8.7.1). Many pa- with TNF-α, some or all of these ROS originate from
pershaveimplicatedROSininflammasomefunction, mitochondria, the rest from NADPH oxidases.162,163
buttheirpreciseroleisasyetunclear.159 ExcessiveactivationofROSproductionbyTNF-αcan
trigger cell death under certain conditions (e.g. via
prolonged JNK activation resulting from phosphat-
5.7.1 TNF-α
ase inactivation), but at lower levels can result in
Tumournecrosisfactoralpha(TNF-α),aproteinofre- cytoprotection (NF-κB activation plus transient JNK
lativemolecularmass17,000,canbesecretedbymany activation) related to increased levels of antioxidant,
celltypes,includingmonocytes,macrophages,B-and anti-apoptotic, and other defence proteins, including
T-lymphocytes,mastcells,neutrophils,andfibroblasts. ferritinH-chains,thioredoxins,metallothioneins,Hsp,
Itactsbybindingtotwodifferenttypesofcell-surface MnSOD in mitochondria, and sometimes uncoupling
receptors(TNFR1and–2).ThenameTNFcomesfrom proteins(Section1.10.6).TheriseinMnSODseemses-
itsinitialidentificationasafactorfoundintheserumof
sentialforcellularsurvivalafterTNF-αtreatmentand
miceinfectedwithBacillusCalmetteGuerin(aweak- is an example of how increased mitochondrial ROS
enedformoftheagentcausingtuberculosis)thatcould production (due to TNF-α) can lead to activation of
cause haemorrhage and necrosis in tumours trans- nucleargenes,162 inpartviaNF-κBandsometimesby
plantedintothesamemice.Over100yearsago,Coley JNK-mediated activation of FOXOs (Section 5.5.4.2).
inNewYorkobservedthatcancerpatientsrepeatedly
ThuspretreatmentofanimalswithlowlevelsofTNF-α
administered ‘bacterial broths’ could show haemor- (or endotoxin) can protect them against several sub-
rhagic necrosis of their tumours. Later work showed sequent insults, including radiation, some cytotoxic
that the active agent was endotoxin (Section 2.5.6.4),
drugs,andischaemia–reperfusion.ToomuchTNF-αor
whichstimulatesproductionofTNF-α.However,too endotoxinandyougetaverysickanimal—theusual
muchendotoxincausessevereinjury,endotoxicshock, redoxbalance!
andover-productionofTNF-αisinvolved.TNF-αwas
laterfoundtobeidenticalwithcachectin,a‘bodywast-
5.7.2 Interleukins
ing factor’ identified in seriously ill cancer patients.
It promotes mobilization of fat stores, and muscle Interleukin-1 exists in two forms, IL-1α and IL-1β,
cells treated with TNF-α show ROS-dependent NF- and is a key mediator of the response to injury and
κB activation and accelerated proteolysis of muscle infection. It is generally pro-inflammatory, leads to
proteins.160 NF-κB activation, and can be secreted by monocytes,
TNF-αisstronglypro-inflammatory,e.g.promoting lymphocytes,macrophages,fibroblasts,keratinocytes,
increases in adhesion molecules that favour phago- and endothelial cells, among other cell types. Bind-
cyte adherence to vascular endothelium, stimulat- ing of IL-1β to its receptor leads to increased cellu-
ing cartilage degradation and bone resorption, and lar ROS production involving activation of NADPH

--- Page 291 ---

236 FREE RADICALS IN BIOLOGY AND MEDICINE
oxidase.163IL-1β issecretedinaninactiveformwhich ROScanalsoincreaseTGF-βproductioninseveralcell
hastobecleavedbyproteases,especiallycaspase-1;the types,suchasmacrophagesandkeratinocytes.168
activation of procaspase-1 is mediated by inflamma-
somes (Section 8.7.1).159 Interleukin-1 is a major con-
tributor tofever (TNF-α also contributes),and excess 5.7.4 Theacute-phaseresponse
IL-1 has been implicated in tissue damage in several The acute-phase response169 was first recognized in
diseases. the1930s.PatientswithpneumoniacausedbyStrepto-
Interleukin-8isachemokine(Table5.6)importantin coccus pneumoniae were found to have a protein in
promotingmigration,adhesion,andactivationofneut- their plasma which bound to a polysaccharide (C-
rophils. It is produced by monocytes, smooth muscle polysaccharide)fromthebacterialcellwall.Thepro-
cells, endothelial cells, lymphocytes, fibroblasts, and teinwasthuscalledC-reactiveproteinorCRP.Bind-
keratinocytes. Again, overproductionhas been impli- ing is Ca2+-dependent. This rise in CRP is part of
catedinseveralchronicinflammatorydiseases.React- the acute-phase response, a ‘whole-body’ response
ivespeciescanstimulateproductionofIL-8andother of animals to infections and inflammation generally,
interleukinsbysomecelltypes(Section8.9.2). thatincludesfatigue,lipolysis,musclecatabolism,and
Interleukin-10, by contrast, can inhibit produc- fever. Biochemical alterations include increased syn-
tion of proinflammatory cytokines by a range of thesis of certain proteins by the liver (acute-phase
cell types, and acts to downregulate inflammation proteins; Table 5.7), decreased synthesis of albumin
(Fig.5.10).ItalsoinducesHO-1inarangeofcells.For bytheliver(oftenthuscalledanegativeacute-phase
exampleIL-10-mediatedprotectionagainstendotoxin- protein), decreases in plasma iron and zinc levels,
induced sepsis in mice was diminished by adminis- and negative nitrogen balance (i.e. more nitrogen is
tering an HO-1 inhibitor.164 One of the many effects excreted than taken in in the diet). Cytokines such
of ROS during inflammation can be to stimulate IL- as TNF-α, IL-1β, and especially IL-6 play key roles
10 formation;165 indeed ROS are both pro- and anti- in triggering the acute-phase response. Some acute-
inflammatoryinvivo!(Section8.9).Phagocytesthaten- phase proteins are involved in antioxidant defence
gulfapoptoticcellsreleasevariousfactorstodampen (Table5.7).‘Acute’signifiesthatmanyofthechanges
inflammation,IL-10beingoneofthem(Section5.4.2). occur within hours of the precipitating event. Many
In mice treated with paracetamol, damaged hepato- features of the acute-phase response are also present
cytesreleasedIL-11, whichactedonadjacenthepato- in chronic conditions, such as persistent infections,
cytes to induce their proliferation; this IL-11 produc- rheumatoidarthritis(Section10.11),andmanyformsof
tionseemedtoinvolveROS.166 cancer.
The acute-phase response differs from the heat-
5.7.3 Transforminggrowthfactorsβ shockresponseinthatithasevolvedonlyincomplex
multicellularorganisms.
TGF-βisamultifunctionalcytokinethatexistsindif-
ferentisoforms(TGF-β1,2,3)andregulatescellprolifer-
5.8 Mechanismsofdamagetocellular
ation,differentiation,andextracellularmatrixproduc-
targetsbyoxidativestress:DNA
tion.Itinhibitstheproliferationofsomecelltypes,but
promotesthatofothers,especiallyfibroblasts.Itplays
5.8.1 DNAstructure
akeyroleinpromotingtherestorationoftissues(cells
and matrix) during wound healing, but too much of Reactive species (RS) are involved in the develop-
it can lead to fibrosis (e.g. in lungs exposed to bleo- ment of cancer, both by direct effects on DNA and
mycin; Section 10.16.3.1). Its action in at least some by modulating signal transduction, cell proliferation,
cell types seems to involve mitochondrial O
•–
pro- senescence, and cell death (Section 10.14). Here we
2
duction (from complex III) and can be attenuated by focus on their ability to damage DNA directly, al-
mitochondriallytargetedantioxidants.167Activationof though indirect damage also occurs, e.g. by activa-
NADPHoxidaseenzymes(especiallyNOX4)mayalso tionofCa2+-dependentendonucleases(Section5.3.2.2).
play a role in some cells.167,168 In addition, ROS can Direct damage to DNA by RS can affect the purine
promoteTGF-βactions:allthreeisoformsaresecreted (adenine, guanine) or pyrimidine (cytosine, thymine)
inlatentformsthatcanbeactivateddirectlybyoxida- bases,and/orthe2-deoxyribosesugar.Anoverviewof
tionand/orbytheactionofmatrixmetalloproteinases, nomenclatureforDNAbases,nucleosidesandnucleo-
which is sometimes stimulated by ROS (Table 8.2).168 tidesispresentedinTable5.8.

--- Page 292 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 237
Table5.7 Someacute-phaseplasmaproteinsinhumans.169
Protein Typicalincreaseinconcentration Biologicalfunction
Caeruloplasmin 50% Ironmetabolism,antioxidantdefence
(Section3.22.2)
C3 50% Thirdcomponentofcomplement(Section8.7.2);
levelsofsomeothercomponentsalsorise
Antiproteinases(e.g. 2-to4-fold Inhibitproteolyticenzymes,suchaselastase
α-antiproteinase, (Table8.2).
α 2-macroglobulin)
Haptoglobin 2-to4-fold.ProductionincreasedbyIL-6.IL-6also Bindshaemoglobin;antioxidantdefence,some
raiseslevelsofCD163,theligandforthe chaperone-likeeffects(Sections3.23.3.4and5.6)
haptoglobin–haemoglobincomplex
Haemopexin LevelsincreasedbyIL-6andsomeothercytokines Bindshaem:antioxidantdefence(Section3.23.3.4)
C-reactiveprotein(CRP) 1000-foldormore(littlepresentnormally); TransgenicmiceoverexpressingCRPareresistantto
containsfiveidenticalsubunitsarrangedarounda endotoxin
central‘pore’
SerumamyloidAprotein(SAA) Several-hundred-fold Roleunclear,maypromotechemotaxisandtissue
repair.Cansometimesgiverisetoamyloidosis
(Section10.21.8)
SerumamyloidPprotein(SAP) - SuggestedtoactsimilarlytoCRP.
Coagulation proteins (fibrinogen, <10-fold —
prothrombin, plasminogen, factor
VIII)
Transferrin Negativeacutephaseresponseinanimals(levels Ironbinding,antioxidantdefence(Section3.22)
fall);reversemaybetrueinbirds
C-reactiveproteinisawidelyusedmarkerofinflammationwithvarioussuggestedfunctions,includingactingasanopsonin,bindingtopolysaccharideresidueson
bacteriaandfungitoactivatecomplement(Section8.7.2),andpromotephagocytosis.Studiesofitsfunctioncanbehamperedbythefactthatcommercialproductscan
containazideasapreservativeandendotoxinasacontaminant(J.Cardiovasc.Pharm.45,193,2005;Circ.Res.97,135,2005;Int.Immunol.18,871,2006).
Table5.8 DNAbases,nucleosides,andnucleotides;nomenclatureasexemplifiedbyguanine.
Name Compound
Guanine Apurinebase
Guanosine Guanineattachedtoribose,thecombinationofbaseplussugariscalledanucleoside
GMP Guanosinemonophosphate,anucleosidephosphate(ornucleotide)
2-Deoxyguanosine Anucleoside,guanineattachedto2-deoxyribose
8-Hydroxy-2(cid:4)-deoxyguanosine,8OHdG Anucleoside,8-hydroxyguanineattachedto2-deoxyribose
8-Hydroxyguanosine,8OHGua Anucleoside,8-hydroxyguanineattachedtoribose
GTP Guanosinetriphosphate(nucleosideplus3phosphategroups;nucleosidetriphosphate)
dGTP Deoxyguanosinetriphosphate
8OHdGTP 8-Hydroxy-2(cid:4)-deoxyguanosinetriphosphate
Similarnomenclatureappliestoadenine(base),2-deoxyadenosineoradenosine(nucleosideswithdeoxyriboseorriboserespectively),AMPordAMP
(nucleotides),ATPordATP(nucleosidetriphosphates),andtheothertwoDNAbases.

--- Page 293 ---

238 FREE RADICALS IN BIOLOGY AND MEDICINE
The backbone of DNA consists of 2-deoxyriboses to the 3(cid:4) -OH terminus of a pre-existing DNA chain,
linkedbyesterifyingthe–OHgrouponposition5of the primer. They will not copy single stranded DNA
one to that on position 3 of the next by a phos- unlessaprimerispresenttogivea‘starterpoint’for
phate group (a phosphodiester bond). The presence thesecondstrand.Indeed,inDNAreplicationashort
of multiple phosphate groups gives DNA a substan- RNA primer is used and later removed. DNA poly-
tial negative charge since phosphates are ionized at merases only catalyse formation of a phosphodiester
physiological pH. Hence DNA binds cations such as bondwhenthebaseontheincomingnucleotideforms
Na+andK+.Ironandcopperionsalsobindreadilyto the correct hydrogen bonds with (is complementary
DNA:theDNAbindingaffinityofFe2+hasbeencalcu- to)thebaseonthestrandbeingcopied;guaninewith
latedtobeabout5.4×104,Fe(III)about105,andCu2+ cytosine,andadeninewiththymine.Onceabasehas
asaround2×104,althoughthevaluesareaffectedby beeninserted,mostDNApolymerases‘double-check’
pH,ionicstrength,andthepresenceofotherchelators, it and excise it if it is wrong (the proofreading or
e.g.phosphate,inthebuffersused.170,171 Copperions error-checkingfunction).
bindespeciallywelltoguanine,andtoalesserextent, TheneedforanRNAprimercausesaproblem;the
adeninemoieties.Ironandcopper may beassociated newDNAmoleculewouldhaveanincomplete5(cid:4) end
with DNA inside the nucleus, but can also become andshouldgetshorterwitheveryroundofreplication.
spuriouslyboundtoitduringDNAisolation,sincecell This problem is avoided by having telomeres at the
homogenizationreadilyreleasesironandcopperions endsofchromosomes(Section11.3.5).
(Section5.3.3).
In the centre of the DNA double helix, adenine
5.8.2 DamagetoDNAbyreactivespecies172–174
hydrogenbondstothymine,andguaninetocytosine.
E.coliDNAcontains4.2millionbasepairsandformsa DNAisfairlystable,butdoesundergo‘spontaneous’
continuouscirclewhereashumannuclearDNA(about chemical decomposition, mainly by hydrolysis. Loss
3 × 109 base pairs per cell) is linear. In the nuclei of of purines (creating apurinic sites in the DNA) has
eukaryoticcells,DNAispackagedintochromosomes been estimated to occur 104 times per day in the hu-
(46inhumans),eachofwhichcontainsasinglelength mangenome.Cytosinecanslowlyloseitsaminogroup
ofdouble-helicalDNA.Thechromosomesarepaired: (deaminate)byhydrolysistogenerateuracil,whereas
oneineachpairisinheritedfromthemaleparentand 5-methylcytosineinDNAcandeaminatetothymine.175
theotherfromthefemale.Thereare22pairsofauto- SeveralRScauseDNAdamage,whichmaybemeas-
somes(genesonthemareautosomallyinherited)and ured as strand breakage and/or chemical modifica-
twosexchromosomes(carryingsex-linkedgenes).For tionstotheDNAbasesorto2-deoxyribose.DNAcan
example, in males a Y chromosome is inherited from also be modified by end-products of lipid peroxida-
the father and an X chromosome from the mother. tion (Section 5.12.5) and by glycation/glycoxidation
Proteins (histones) rich in basic amino acid residues (Section 10.5). DNA isolated from archaeological ma-
(which are positively charged at physiological pH) terials (sometimes called ancient DNA) is usually
helpinthepackagingofDNAinchromosomes;DNA fragmented,depurinated,deaminated,andoxidatively
is woundaround histonestoform nucleosomes. The damaged,makingitdifficulttoamplifybyPCR.176
complex of DNA with histones and other proteins is Which RS can damage DNA? Physiologically rel-
calledchromatin.Inprinciple,thedefaultstateofDNA evant levels of O •–, NO • , H O , or organic perox-
2 2 2
inchromosomesistobeassembledintonucleosomes. ides do not react at significant rates with any of the
Thenon-nucleosomalregionsareoftensitesatwhich DNA(orRNA)basesorwiththe2-deoxyribose(orri-
gene transcription is initiated and are maintained as bose). However,O •– andNO • can reactwithradicals
2
non-nucleosomal sites by transcription factors and formedonDNAafteritisattackedbymore-aggressive
otherproteins. RS.GuanineisthemostsusceptibleDNAbasetooxi-
DNA is replicated by DNA polymerases, en- dation.ThebiologicalsignificanceofdamagetoDNA
zymes that use 2-deoxyribonucleoside triphosphates by RS depends on the extent of damage, where the
(dATP, dGTP, dCTP, and dTTP; Table 5.8) to add 2- damageislocatedinthegenome,andhowfastitcan
deoxyribonucleotides,e.g. berepaired.
5.8.2.1 Hydroxylradical172,173
DNA+dATP→(DNA–A)+pyrophosphate
•
AsmightbeexpectedfromthehighreactivityofOH ,
(DNA–A)+dGTP→(DNA–A–G)+pyrophosphate exposureofDNA(orRNA)toitgeneratesamultitude

--- Page 294 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 239
O O O
OH OH
HN N C H + e–, + H HN N C H HN NH CHO
(cid:129)
HN N N reduction HN N NH HN N NH
2 2 2
DNA DNA DNA
2,6-diamino-4-hydroxy-5-
formamidopyrimidine
(FapyG)
β-fragmentation
O (cid:129) O O H
HN N OH oxidation HN N HN N
H OH O
H 2 N N N – e–, – H H 2 N N N H 2 N N N
DNA DNA DNA
C8-OH–adduct radical enol form keto form
8-hydroxyguanine (80HG)
Figure5.12 Guaninemodificationbyhydroxylradicals.AdditionofOH•toC-8ofguanineinDNAgeneratesaC8-OHadductradical(Remember
therule(Section2.2);whenaradicalreactswithanon-radical,anewradicalisformed).8-Hydroxyguanineradicalcanbeoxidized(losingone
electron)to8-hydroxyguanine,oritcanundergoringopeningandbereduced,eventuallygiving2,6-diamino-4-hydroxy-5-formamidopyrimidine
(FAPyG).ThustoassessradicalattackonC-8ofguanine,bothFAPyGand8-hydroxyguanineshouldbemeasured,sincereactionconditionscan
affecttheratiobetweenthem,i.e.thesameamountofOH•attackonguaninecanleadtodifferentlevelsofFAPyGand8-hydroxyguanine.Attack
ofOH•atotherpositionsuponguaninealsooccurs.FigurebycourtesyofProfessorMiralDizdaroglu.
ofproducts.Forexample,OH • canaddtoguanineat by OH•. Hence, the relative amounts of the various
positions 4, 5, 8, or (to a lesser extent) 2 in the pur- end-products obtained after DNA is exposed to OH•
ine ring. Addition to C-8 produces a C-8 OH-adduct willvarydependingonwhetherOH• isgeneratedby
radical that can be oxidized to 8-hydroxyguanine radiation or by metal ion–H O systems and, if the
2 2
(8OHG; Table 5.8 explains the nomenclature), or latter, which metal was used. For example, copper
undergoringopeningfollowedbyone-electronreduc- ions bind to GC-rich sequences in DNA; subsequent
tionandprotonation,togive2,6-diamino-4-hydroxy- reactionwithH O favoursformationofguaninedam-
2 2
5-formamidopyrimidine, usually abbreviated as FA- age products.177 The location of damage can also be
•
PyG(Fig.5.12).Similarly,OH canaddontoC-4,C-5, affected by charge transfer in DNA, guanine radical
orC-8,orC-2(muchlessfavoured)ofadenine. cations generated by loss of an electron apparently
•
PyrimidinesarealsoattackedbyOH togivemul- ‘migrating’tootherguaninesintheDNA.
tiple products. Thus, thymine can suffer addition of 2-Deoxyribose and ribose are fragmented by OH•,
OH • to the ring, or H • abstraction from the methyl yielding dozens of products.172,173 All positions are
group. The resulting radicals give rise to a variety of susceptible to hydrogen abstraction by OH•, form-
products including thymine glycols (5,6-dihydroxy- ing carbon-centred radicals. In the presence of O
2
6-hydrothymines), 5-hydroxy-5-methylhydantoin, 5- theseconvertrapidlytosugarperoxylradicals,which
formyluracil,and5-(hydroxymethyl)uracil(Fig.5.13). undergo a series of reactions, to yield a variety
Cytosine similarly forms several products, includ- of carbonyl products. Some sugar products remain
ing cytosine glycol, 5-hydroxycytosine, and 5,6- within DNA or constitute end groups of broken
dihydroxycytosine (Figs 5.14 and 5.15). Cytosine- DNAstrands,whereasothersarereleased.Likemany
derivedproductscanreadilydeaminateanddehydrate carbohydrates,2-deoxyribosebindsiron,whichmakes
togiverisetouracilglycol,5-hydroxyuracil,and5,6- it vulnerable to attack by OH• produced during
dihydroxyuracil.ThepresenceofO and/ortransition Fentonreactions.Indeed,releaseofmalondialdehyde
2
metal ions affects the rate and mechanism of the from 2-deoxyribose is the basis of an assay for OH•
radical reactions taking place after attack on DNA (Section6.3.3).

--- Page 295 ---

240 FREE RADICALS IN BIOLOGY AND MEDICINE
NH
2
(a)
H
N
OH
(cid:129)
NH 2 O N H
H H
N + (cid:129)OH C5-OH-adduct radical (87%)
O N H NH
H 2
H
N (cid:129)
Cytosine
OH
O N H
H
C6-OH-adduct radical (~10%)
O
CH
HN 3
OH
(cid:129)
O N H
H
5-OH-adduct radical (60%)
O
O
CH
HN 3 + (cid:129)OH HN (cid:129) CH 3
OH
O N H
H O N H
H
Thymine 6-OH-adduct radical (30%)
O
(cid:129)
HN CH 2 Figure5.13 (a)ReactionsofOH•with
pyrimidines.173Thepercentagesareapproximate.
O N H (b)Whathappensnext;somefatesofthethymine
H radicals.FromMutat.Res.567,1,2004,bycourtesyof
allyl radical (10%) DrsEvans,Dizdaroglu,andCooke,andElsevier.
At low O levels, the C5 radicals of 2-deoxyribose and promoter of Fenton chemistry (Section 3.22.4.2),
2
can survive long enough to add on to C8 on pur- increasedlevelsofthymine–tyrosinecross-linksinkid-
ineringsinthesamenucleoside,resultingincyclized ney chromatin.179 Some tandem lesions have been
products,8,5(cid:4)-cyclo-2(cid:4)-deoxyguanosine(cyclodG)and described, in which two adjacent bases are modified.
8,5(cid:4)-cyclo-2(cid:4)-deoxyadenosine (cyclodA) (Fig. 5.14). Sometimescovalentcross-linksformbetweenadjacent
Twostereoisomers(RandS)ofeachcanform.These DNA bases (e.g. guanine–cytosine) on the same (or
products are formed in vivo and excreted in human sometimestheopposite)strand.Theyoftenarisefrom
urine.173,178 attack by a single OH• followed by radical reactions
NuclearproteinscanbealsoattackedbyOH•.Pro- betweenadjacentbases.
teinradicalsmightcross-linkwithDNAbase-derived
5.8.2.2 Hydrogenperoxideandtherole
radicals if the two meet in chromatin, giving DNA-
oftransitionmetals174
protein cross-links that can interfere with chromatin
unfolding,DNArepair,replication,andtranscription. AdditionofH O tocellsusuallyproducesincreased
2 2
Alternatively,DNAbaseradicalscanattackaminoacid DNA strand breakage within minutes, accompanied
residues in proteins, e.g. the allyl radical of thymine byanincreaseinmodifiedDNAbases(Fig.5.15).RNA
(Fig. 5.13a) can attack tyrosine residues to form a canalsobeoxidized,sometimesmoresothanDNA,180
thymine–tyrosine cross-link. As an in vivo example, andincreasedRNAoxidationisfoundinseveraldis-
treatment of rats with ferric-NTA, a renal carcinogen eases(Chapter10).YetH O atphysiologicallevelsis
2 2

--- Page 296 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 241
(b) O O
CH 3 +O –e , – , – + O H – 2 , O + H or O CH 3
HN OH 2 2 2 HN OH
OH
O N H O N H
H H
C5-OH-adduct radical of thymine thymine glycol
O
H
+e–, +H+ HN OH
H
O N H
H
5-hydroxy-6-hydrothymine
O
CH O
3
HN +O , –O –, +H O HN
2 2 2
OH CH
O N H O N OH 3
H H
C6-OH-adduct radical of thymine 5-hydroxy-5-methyl-hydantoin
O
CH OH
2
HN
O O N H
HN CH 2 +O –e 2 , – , – + O H 2 – 2 , O + H o 2 r O 5-(hydr H oxymethyl)uracil
O
O N H
H CHO
HN
allyl radical
O N H
H
5-formyluracil Figure5.13 (Continued)
notchemicallycapableofdamagingDNAorRNAdir- proteins or copper-containing proteins (Section 5.3.3)
ectly.ThepatternofDNAdamage(risesinthelevelsof which may then bind to DNA, making it a target
multipleproductsfromallfourbases)indicatesattack of H O attack. Indeed, it was observed in human
2 2
byOH•.IfOH•isattackingDNA,itmustbeproduced lymphocytesthatthelevelof8OHGinDNAwasposi-
very close to it, since OH• is too reactive to diffuse tively correlated with that of the labile iron pool; the
fromitssiteofformation.ThelikelyculpritisFenton sizeofthispoolisknowntobeincreasedbyH O ad-
2 2
chemistry(Section3.9.2.2).IfFentonchemistrygener- dition (Section 3.22.1).181 In cultured cells, raising the
atesOH• inthenucleus,thentheironionsmustbein level of Fe2+ in the culture medium increases steady-
closeproximitytoDNA.Copper/H O reactionsmay state levels of oxidative DNA damage.182 The dam-
2 2
alsodamageDNA(Sections2.4and3.22.5). aging effects of H O on bacteria also involve metal
2 2
Are metals always bound to DNA in vivo? They ionreleaseandFenton-typechemistry(Section3.9.2.2).
mightbe;ironandcopperarepresentinthenucleus, Ironorcopperoverloaddiseasesarefrequentlyaccom-
but this does not mean that they are in a molecular paniedbyincreasedoxidativeDNAandRNAdamage
form that will cause OH• formation. Another possi- (Section3.22.5).
bility is that oxidative stress causes release of ‘free’ The presence of metal ions on DNA favours ‘site-
ironand/orcopperionswithinthecelle.g.from[Fe-S] specific’ OH• generation, leading to DNA damage

--- Page 297 ---

(a) O O O O
CH CH CHOH CHO O
3 3 2
HN OH HN OH HN HN HN
H OH CH
O N H O N H O N H O N H O N OH 3
H H H H H
5-hydroxy-6-hydro- thymine glycol 5-hydroxymethyl- 5-formyluracil 5-hydroxy-5-methyl-
thymine uracil hydantoin
NH2 NH2 NH2 NH2 O O
H OH OH H H OH
N OH N N N OH HN OH HN
O N H OH O N H O N OH O N H H O N H OH O N H
H H H H H H
cytosine glycol 5-hydroxycytosine 5,6-dihydroxycytosine 5-hydroxy-6-hydro- uracil glycol 5-hydroxyuracil
cytosine
O O O
OH H O O
HN HN OH HN HN
OH H H
O N O N H O N OH O N O
H H H H
5,6-dihydroxyuracil 5-hydroxy-6-hydrouracil 5-hydroxyhydantoin alloxan
NH
2
N
N
N NH 2 N N NH 2 NHCHO N NH 2 N HO N N
OH H
H N N H N NH2 HO N N H H O H
H H
H H
8-hydroxyadenine 4,6-diamino-5-form- 2-hydroxyadenine OH H
amidopyrimidine 8,5’-cyclo-2’-deoxyadenosine
O
N
NH
O O
HN N OH HN NHCHO HO N N NH2
H2N N N
H
H2N N NH2 H H O H
H H
8-hydroxyguanine 2,6-diamino-4-hydroxy- OH H
5-formamidopyrimidine 8,5’-cyclo-2’-deoxyguanosine
(b)
O O O O O O
HN Cl HN N HN N O N HN C H H3 HN H H
O N
H
H O N
H
N
H
H H N N
H
H H2N N N
H
H O N
H
H H O N
H
H H
5-chlorouracil xanthine hypoxanthine oxanine 5,6-dihydrothymine 5,6-dihydrouracil
H
O N
H H 2 2 N N O N O NH2 H 2 N NH O 2 N H N N H N H H2N HN O N N H N NO 2 H 2 N N H N O N H O H 2 N NH N H O H N H H N O
oxazolone 5-guanidino-4- 8-nitroguanine spiroiminodihydantoin guanidinohydantoin
nitroimidazole
Figure5.14 SomeoftheproductsresultingfromattackofRSuponDNAbases.173(a)ModifiedbasesthatcanbeformedbyOH•.
•
(b)5,6-DihydrothymineisaproductofattackofH orhydratedelectronsuponthymine.5,6-Dihydrouracilresultsfromthedeaminationof
5,6-dihydrocytosine,whichisformedbyattackofH•orhydratedelectronsuponcytosine.8-NitroguanineisformedonadditionofONOO–toDNA.
Xanthineandhypoxanthineresultfromdeaminationofguanineandadeninerespectively.5-ChlorouracilisachlorinatedbaseproducedwhenDNA
istreatedwithHOClandsubsequentlyhydrolysedwithacid;itprobablyresultsfrombreakdownoftheinitiallyformedchlorocytosineunderacidic
conditions(Chem.Res.Toxicol,10,1240,1997).FigurebycourtesyofProfessorMiralDizdaroglu.

--- Page 298 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 243
0.45
0.40
0.35
0.30
0.25
0.15
0.05
0.00
0 10 20 30 40 50
Incubation time (min)
)AND
gm/lomn(
lortnoc
revo
noitartnecnoc
ni
esaercnI
0.10
0.05
0.00
60 0 10 20 30 40 50
Incubation time (min)
)AND
gm/lomn(
lortnoc
revo
noitartnecnoc
ni
esaercnI
60
4
3
2
1
0
0 10 20 30 40 50
Incubation time (min)
)AND
gm/lomn(
lortnoc
revo
noitartnecnoc
ni
esaercnI
82
80
78
60
AND
dednarts-elbuoD
%
5-OH, Me-Hydantoin 5-OH, Me-Uracil
5-OH-Hydantoin Thymine glycol
(a) 5-OH-Uracil (b)
0.35
0.30
0.25
0.20
0.20 0.15
0.10
FAPy-Adenine
(c) (d)
8-OH-Adenine
2-OH-Adenine
FAPy-Guanine 88
8-OH-Guanine
86
84
0 10 20 30 40 50 60
Incubation time (min)
Figure5.15 RatesofrepairofoxidativeDNAbasedamage.Humanrespiratorytractepithelialcellsweretreatedwithanon-lethaldoseofH2O2
(100μM).Notetheformationofawiderangeofbaseoxidationproducts,characteristicofattackbyOH•,aswellastherapidonsetofrepairof
some(c)butnotall(a,b)basedamageproducts.Duringrepair,DNAstrandbreakage(d)continuestoincrease,sincerepairitselfinvolvesDNA
strandbreakage.DatabycourtesyofDrJeremySpencer.

--- Page 299 ---

244 FREE RADICALS IN BIOLOGY AND MEDICINE
that ‘OH• scavengers’ cannot protect against. Some betargetedbyOH•first.Hydroxylradicalforsuchex-
amino acids present in cell culture media, espe- perimentscanalsobegeneratedbyradiolysisofwater,
cially histidine, enhance DNA damage by H O . orphotolysisofH O (Section2.5.1).
2 2 2 2
Since this effect is usually decreased by metal ion
5.8.2.4 Singletoxygen187
chelators, it may involve metal ion binding (Sec-
tion 3.25.7). DNA-associated copper ions might also The singlet states of oxygen are far more limited in
react with certain phenols (e.g. 2-hydroxyoestradiol, theirattackonDNAthanisOH•.SingletO isineffi-
2
2-methoxyoestradiol,diethylstilboestrol,andL-DOPA) cientatproducingstrandbreakageandpreferentially
to produce RS and oxidized phenols. Such reactions attacks guanine, the easiest base to oxidize. Singlet
canformarangeofoxidativelyinducedDNAlesions O adds to the imidazole ring to give unstable en-
2
and phenol adducts to the DNA bases, which might doperoxidesthatgeneratevariousproductsincluding
contribute to the carcinogenicity of certain phenolic 8OHG(Fig2.14);thisisreadilyoxidizedfurtherby1O
2
compounds(Sections3.26and10.15.1.1).183 (Section5.8.2.11).
Therehavebeenseveralclaimsthattotalbodyiron
5.8.2.5 Carbonateradicalanion
stores in humans correlate with levels of oxidative
DNA damage, often measured as the urinary excre- Thisalsogenerates8OHGfromguanineinDNA.188
tion of 8OHdG (Section 6.14). There are also vari-
ous counterclaims.184,185 Of course, most iron in vivo 5.8.2.6 Peroxylandalkoxylradicals
is safely sequestered in non-redox-active forms (Sec- Peroxyl and alkoxyl radicals have limited ability to
tion3.22),sothattotalbodyironstoredoesnotneces- damageDNA.Somecanattackguaninetogive8OHG
sarily equate to ‘redox active iron’. This is discussed (which can subsequently be oxidized further: Section
furtherinSection11.4.10. 5.8.2.11), but most biologically important ones prob-
ablydonot(Section2.5.4).
5.8.2.3 Useofironandhydrogenperoxidefor 5.8.2.7 Hypohalousacids
oxidative‘footprinting’186
HOCl targets both pyrimidines and purines in DNA,
BindingoftranscriptionfactorstoDNAregulatesgene with chlorination of adenine (to 8-chloroadenine),
expressionandsoitisimportanttoidentifytheDNA guanine to 8-chloroguanine, cytosine to 5-chloro-
sequence to which a given protein binds. This can cytosine,aswellasformationofthymineglycol.189,190
beachievedby‘footprinting’.Inprinciple,theDNA– Hypobromous acid (HOBr) can lead to bromination
protein complex is treated with a DNA-degrading ofcytosineandadenineresidues.191 Chloraminesand
reagentsuchasadeoxyribonuclease.Theboundpro- bromamines (Section 2.6.3) formed by reaction of
tein protects the region of the DNA to which it is HOCl/HOBrwith–NH groupsontheDNAbasesare
2
attached, which can then be isolated and sequenced. involvedinformationofhalogenatedbases.190Chloro-
The high reactivity of OH• towards DNA has led to andbromo-cytosineshavebeendetectedinthelivers
thedevelopmentofalternativefootprintingmethods. ofratstreatedwithlipopolysaccharideandintheurine
In one, reaction of Fe2+-EDTA with H 2 O 2 is used to ofdiabeticpatients.192
produceOH•.Iron(II)-EDTAhasanegativechargeat
physiological pH, and so will not bind to DNA (also 5.8.2.8 Ozone
negatively charged). Any OH• produced by reaction Ozone can fragment DNA and oxidize bases (espe-
of Fe2+-EDTA with H 2 O 2 that escapes scavenging by cially guanine, cytosine, and thymine) both directly
theEDTAenter‘freesolution’andwillrandomlydam- and via formation of OH• in aqueous solution (Sec-
agesitesinDNA.Aboundproteinblocksthecleavage tion 2.6.5).193 It usually adds on across double bonds
of DNA by OH•, allowing identification of the base and generates ozonide intermediates that fragment
sequence to which it was bound. Since OH• has no andrearrange.
markedsequencepreference,itdoesnothavethespe-
cificityproblemsencounteredwithnucleaseenzymes. 5.8.2.9 Reactivenitrogenspecies189,194
ItisalsopossibletoattachFe2+-EDTAtocompounds
Exposure of DNA to N O or HNO (probably via
2 3 2
that intercalate into DNA at specific sites, allowing N O )candeaminateDNAbases,convertingcytosine
site-specificcleavagebyOH•.Someauthorshaveused
to
2
ur
3
acil, 5-methylcytosine to thymine, and adenine
similar ‘oxidative footprinting’ techniques to analyse to hypoxanthine. Guanine is converted to xanthine
RNA structure, protein structure, or protein–protein and oxanine (Fig. 5.14). Oxanine can cross-link to
interactions:themost‘accessible’partsofaproteinwill amino groups on nuclear proteins. Peroxynitrite

--- Page 300 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 245
(probably via its reaction products with CO /HCO–; DNA base damage (measured as levels of 8OHG)
2 3
Section 2.6.1) converts guanine into 8-nitroguanine is several-fold higher in mitochondrial DNA than in
(Fig 5.14), which is rapidly lost from DNA by spon- nuclear DNA. This seemed logical because of the
taneous depurination. A more stable end-product proximity of mitochondrial DNA to ROS generated
is 5-guanidino-4-nitroimidazole (Fig. 5.14). 8- duringelectrontransport,andthefactthatmitochon-
Hydroxyguanine is formed when ONOO– attacks drial DNA is not protected by histones. It was also
DNA,butitisrapidlyfurtheroxidizedbyONOO– to suggested that DNA repair in mitochondria is less
avarietyofproducts(Section5.8.2.11). rapid than in the nucleus and that oxidative damage
couldcontributetothedeletionsandothermutations
5.8.2.10 Ultravioletlight inmitochondrialDNAthatareknowntoaccumulate
with age. The mtDNA genome has no introns, so it
UVlightreadilydamagesDNA.First,UV-Ccancon-
vert H O to OH•. Second (and more importantly), has been argued that a random ‘hit’ by a RS is more
2 2
likely to damage a gene than it is for nuclear DNA.
UV leads to covalent cross-linking of adjacent pyr-
However,wenowknowthatmitochondriacanrepair
imidinestogivecyclobutanepyrimidinedimersand
at least some lesions rapidly (Section 5.10.7) and the
6–4photoproducts.Thisisdiscussedinmoredetailin
mtDNA is indeed coated with proteins in vivo.196 In
Section7.13.1.
addition,therearedifficultiesinaccuratelyquantitat-
ingoxidativedamageinmitochondrialDNA.Areview
5.8.2.11 Oxidationofoxidationproducts
byBeckmanandAmes197concludedthatthehugedis-
DNA base oxidation products are themselves subject
parity between published measurements of oxidative
tooxidation.Thisisespeciallytruefor8OHG,whichis
damage makes it difficult to conclude beyond rea-
farmoreeasilyoxidizablethanguanine.Forexample,
sonable doubt that mtDNA suffers greater oxidation
it can be oxidized by singlet O , O , chromium salts
2 3 thannuclearDNAinvivo.Inaddition,RSdonotnor-
(Section 9.16.4), NO
•
, CO
•–,
and HOCl, or on addi-
2 3 mallycausespecificdeletionsinDNA,butratherpoint
tion of ONOO–. Singlet O can oxidize it to cyanuric
2 mutations (Section 5.10.7) It may be that some base
and oxaluric acid, CO
•–
or singlet O to spiroim-
3 2 oxidation products cause mitochondrial DNA poly-
inodihydantoin (Fig. 5.14), and addition of ONOO– merase (polγ) to ‘slip’ on the DNA to generate dele-
generatesarangeofproductsincludingspiroiminodi-
tions,and/orthatoxidativedamagetothepolymerase
hydantoin, oxazolone, oxaluric, and cyanuric acids. diminishesitscapacityforaccuratereplication.174,198
The product distribution varies enormously depend-
ThehighO concentrationsgeneratedduringphoto-
ingonhowmuchandatwhatrateONOO–isadded.194 2
synthesis (Section 7.7) would be expected to favour
Thisoxidizabilityof8OHGraisesproblemsinitsuse
damage to chloroplast DNA, but limited information
asabiomarkerofoxidativeDNA/RNAdamage(Sec-
isavailableonthistopic.Plantnucleicontainenzymes
tion6.14).Becauseofitseasyoxidizability,8OHGad-
forDNArepairpathways,buttherateofrepairofUV-
ministered to animals has been shown to have some
inducedlesions(andprobablyofotherlesions)maybe
‘antioxidant’ properties, e.g. decreasing phagocyte slowerinthechloroplastthaninthenucleus.199
ROS production,195 although it is unlikely that these
arerelevantatthelowlevelsusuallyfoundinvivo.
5.9 ConsequencesofdamagetoDNA
andRNAbyreactivespecies
5.8.3 Damagetomitochondrial
andchloroplastDNA 5.9.1 Mutation200
In plants and animals, the genetic information en- DamagetoDNA(oxidativeorotherwise)usuallyhalts
coding the vast majority of proteins is encoded in DNAreplicationandcelldivision,untilrepairiscom-
nuclearDNA.However,chloroplasts(Section7.7)and plete (Section 10.14). Too much DNA damage can
mitochondria(Section1.10.5)containsomeDNAthat leadtocelldeathviap53-mediatedapoptosisand/or
encodesafewproteins. NAD+depletionviaPARP(Sections5.2.5and10.14.4).
Reactive species can damage mitochondrial and However,ifnotallbaseorsugarlesionsareremoved
chloroplastDNA;mitochondrialDNAdamage(espe- beforeDNAreplicationresumesorbegins,error-prone
ciallydeletions)hasbeensuggestedtobeimportantin translesional DNA synthesis (TDS) can occur. Poly-
several human diseases and in ageing. Indeed, great merases normally involved in DNA replication have
excitement was generated by reports that oxidative efficienterror-correctingmechanisms,butinTDSthey

--- Page 301 ---

246 FREE RADICALS IN BIOLOGY AND MEDICINE
aretransientlyreplacedbyotherswithlessfidelityun- One approach to examining the overall mutagenic
tilthelesionisbypassed(Fig.5.16),thusincreasingthe effectofbasechangesinDNAistoexposecellstoRS
mutationrate. andlookformutationsinthenuclearormitochondrial
Several modified DNA bases can mispair. For ex- genomesorintransfectedDNA.Forexample,inone
ample, whereas adenine pairs with thymine, its de- study201 aplasmidwastransfectedintomonkeycells.
amination product hypoxanthine can pair with cyto- ThecellsweretreatedwithH O andthenincubated
2 2
sine. Uracil pairs with adenine rather than guanine. to allowrepair and replicationof theplasmid, which
Thus RNS can lead to GC → AT and AT → GC was then isolated and sequenced. The mutations de-
transitionmutations.Forexample, tectedincludeddeletionsandbasesubstitutions.Such
studies have revealed that the distribution of muta-
tionsinducedbyRSisnotrandom;theyclusteratso-
calledhotspots.Thiscanbeaccountedforbyseveral
mechanisms,includingaccessibilityofDNAtotheRS
andtorepairenzymes(forexample,inter-nucleosomal
DNAismoreexposedthanDNAwithinnucleosomes),
the sequence around a particular base influencing its
oxidizability,andpatternsoftransitionmetalionbind-
ing. Similar studies have been done with ONOO–:
a range of mutations results, depending on how the
8-Nitroguanine residues in DNA can cause G→T
ONOO–isadded(bolusorslowsteadygeneration).194
transversions as well as spontaneously depurinate,
Another approach is to oxidatively modify the DNA
leaving an AP site that might lead to mutation. 5-
andthentransfectit.
Guanidino-4-nitroimidazole (Section 5.8.2.9) is also
Amongthemutationsidentifiedinsuchstudiesare
mutagenic,producingG→CtransversionsandG→A
CC→TTtransitions,202whichcanalsoarisefromdam-
andG→Ttransitions.
age by UV light (Section 7.13.1). However, the most
The presence of thymine glycol is a strong block commonchangesobservedareC→Ttransitions,and
to DNA replication, but it can lead to T → C G→CandG→Ttransversions.TheG→Tchanges
transition mutations (although most thymine gly-
ofteninvolve8OHGandFAPyG,e.g.incellsexposed
col pairs correctly with adenine). 5-Hydroxycytosine tosingletO ,G→Twasthemostcommonmutation,
2
and5-hydroxyuracilcanmispairwithadenine,giving
sincesingletO islargelyselectivefordamageatguan-
C → T transitions. 5-Hydroxymethyluracil mispairs 2
ine.However,noneoftheabovemutationsisunique
(againwithalowprobability)toguanine.8OHGcan
tooxidativedamage;theycanalsooccurasaresultof
cause GC → TA transversion mutations since it can
polymerase errors, spontaneous deamination of cyto-
hydrogenbondtoadenine,althoughmost8OHGpairs
sinetouracil(or5-methylcytosinetothymine),andthe
correctlywithcytosine,
misreplicationofcertainDNA–carcinogenadducts.
5.9.2 Slowingproteinsynthesis
OxidativemodificationofRNA,whichisextensivein
Some of the oxidation products of 8OHG (Section somediseases(Chapter10),leadstoerrorsintransla-
5.8.2.1), such as oxaluric acid, oxazalone, cyanuric tion(e.g.ifthelesionisbypassedbyRNApolymerase
acid,andspiroiminodihydantoinmaybemoremuta- andanincorrectbaseinserted)andimpairmentofpro-
genicthan8OHGitself.8-Hydroxyadeninehasalow tein synthesis, which can contribute to cell death in
probability of mispairing with guanine, but mostly it somecases.203
pairs correctly with thymine, and is less mutagenic
than8OHG.FAPyGalsomispairswithadenine,lead-
5.9.3 Misincorporation
ing to G → T transversions, and may even be more
mutagenicthan8OHGinsomecelltypes.FAPyAalso Nucleosides and nucleotides can be modified by RS
mispairs with adenine, resulting in A → T transver- prior to their incorporation into RNA or DNA, thus
sions. Some end-products of lipid peroxidation can introducing mutagenic lesions directly. This can hap-
alsobindtoDNAandcausemutations(Section5.12). penwith5-bromo-2-deoxycytidine,aproductofattack
Tandem lesions (Section 5.8.2.1) tend to block DNA of HOBr on a cytosine nucleoside,204 although most
replication. attentionhasbeenpaidto8OHG(Section5.10.2).

--- Page 302 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 247
5.9.4 Changesingeneexpression function,butdomakesomemistakes,and mismatch
repairisneededtoremovemispairedbases.Spontan-
A mutation in an exon might lead to an altered
eous depurinations/deaminations must be repaired,
protein. However, mutations in introns are not ne-
as must adducts of xenobiotics that find their way
cessarily innocuous, e.g. they could affect mRNA
onto DNA. One advantage of the DNA double helix
splicing. Mutations in promoter regions could af-
is that, if one strand is damaged, the information in
fect transcription factor binding and alter gene ex-
theotherstrandcanbeusedtohelptorepairitaccur-
pression, as has been demonstrated in the ageing
ately.Thusdouble-strandbreaksareintrinsicallymore
brain (Section 11.4.2.1) and in lung tissue from pa-
damaging because this information is not available.
tientswithCOPD(Section9.13.2).Asanotherexample,
In addition, in a double helix the DNA bases are
whenpulmonaryarteryendothelialcellswereexposed
less exposed to attack, and they undergo spontan-
to hypoxia, ROS-generating mitochondria clustered
eousdeamination/depurinationatlowerratesthanin
around the nucleus (Section 5.5.5),118 leading to in-
single-strandedDNA.
creased 8OHG levels in the promoter of the gene
encoding VEGF. This selective oxidation appeared to
enhance HIF-1α binding and the hypoxia response; 5.10.1 Reversingthechemicalchange
howitisachievedbytheH O arisingfromthemito-
chondria is as yet uncerta 2 in. 2 205 Other studies have Direct reversal of changes in DNA211 can sometimes
occur. Reducing agents, especially GSH, can some-
reportedthatreplacementofGby8OHGinpromoters
alters binding of AP-1 or NF-κB. Another possibility times‘repair’theinitialradicalsgeneratedbyattackof
someRSonDNA, preventingformationofoxidation
isthatoxidativebasedamagecanaltermethylationof
products (Section 9.20). E. coli and many other bac-
CpG,aneventthatusuallysuppressesgenetranscrip-
teria contain a DNA photolyase. This enzyme binds
tion. If so, aberrant gene expression or inappropriate
genesilencingmightresult.206 to pyrimidine (pyr) dimers in DNA, absorbs light in
thenear-UVandbluespectralregions,andusestheen-
ergytosplitthedimersbacktotheoriginalDNAbases.
5.9.5 Havingsex Photolyasescontaintwochromogens.OneisFADand
theotherdiffersaccordingtothesourceoftheenzyme
The multicellular green alga Volvox carteriusually re-
(in E. coli it is a folate derivative). The flavin ring is
producesasexually,butabnormallyhightemperatures
reduced(inalight-dependentprocessinvolvingtryp-
causeproductionofsexualinducer.Thisglycoprotein
tophan residues) to FADH– and the excited-state re-
actsonthereproductivecellssothatinthenextgen-
ducedflavinthentransfersanelectr(cid:2)ontothed(cid:3)imerto
eration both females (carrying eggs) and males (with • •–
generatearadicalpair(FADH plus pyr–pyr ).The
sperm)areproducedandsexualreproductionoccurs.
dimersplitsandtheelectronisreturnedtotheflavinto
The ‘heat stress’ appears to act by raising levels of regeneratethecatalyticallyactiveFADH–form.
ROS,whichtriggerthesexualresponse.207Theunicel-
Why such an enzyme is present in an organism
lularalgaChlamydomonasreinhardtiirespondssimilarly
whose normal habitat is the dark recesses of the an-
buttoadifferentstress,nitrogendeprivation.Wasthe
imal colon is an enigma. However, similar enzymes
needtocopewithoxidativeDNAdamageoneofthe
are found in many eukaryotes, including Drosophila,
driving forces for sexual reproduction to evolve?208
plants,thegoldfishCarassiusauratus,andsomemam-
It’saninterestinghypothesis,butofcourseDNAcan
mals (the opossum and the kangaroo rat; both mar-
be repaired even in asexual organisms. Oxidation of
supials), but not humans. In the absence of light, the
methionine residues in pheromones can also change
photolyasecanstillbindtopyrimidinedimersandit
the behaviour of certain protozoans from mitotic cell
may be that this facilitates repair by other mechan-
divisiontosexualreproduction(Section5.13.4).
isms. For example, E. coli DNA photolyase binds to
DNA cross-linked by cis-platin (an anticancer drug;
5.10 RepairofoxidativeDNA Section 10.16) and stimulates removal of the cross-
damage200,209,210 link by excision repair. Human proteins resembling
photolyaseshavebeenidentified(cryptochromes),but
DNA repair is essential to allow aerobes to survive actinsteadtoregulatecircadianrhythms.UV-induced
withoutexcessivemutation.DNAdamagebyRSisnot damage to the DNA of some bacterial spores is re-
theonlyproblem.ThepolymerasesthatreplicateDNA pairedbyaratherdifferenttypeofenzyme,although
show high fidelity because of their error-correcting againinvolvingfreeradicals(Section8.2.3).

--- Page 303 ---

248 FREE RADICALS IN BIOLOGY AND MEDICINE
5.10.2 Don’tletitin:sanitizationof on the transcribed strand of active genes to help to
thenucleotidepool212,213 remove mutagenic and ‘blocking’ (i.e. those that can
halt transcription) lesions, and is co-ordinated with
Just as DNA and RNA can be oxidized, so can
the action of the RNA polymerase transcribing the
their precursors. Some years ago, mutation of the
strand. Global genomic repair (GGR) addresses the
mutT gene in E. coli was found to increase the
remainder of the genome: nontranscribed DNA and
occurrence of AT → CG transversions. The MutT
thenon-templatestrandoftranscribedgenes.NERis
protein was later identified as an enzyme that acts
especiallyimportantinremovingUV-induceddamage
upon dGTP in which the guanine has been con-
inanimals,butitmayalsohelptoremoveoxidatively
verted to 8OHG (8OHdGTP). It prevents incorpor-
induced DNA lesions, such as cyclodG and cyclodA,
ationof8OHdGintoDNA,byhydrolysing8OHdGTP
whichcannotberemovedbybaseexcisionrepair(see
tothemonophosphate8OHdGMP.MutTalsoactson
below)becauseofthecovalentbondbetweenthebase
8-hydroxyguanosine triphosphate (8OHGTP), an oxi-
andsugarmoieties.Nucleotideexcisionrepairinmam-
dizedribonucleosideprecursorofRNA.Asimilaren-
mals begins with damage recognition (which in TCR
zyme,MTH1(mutThomologue1),sometimescalled
involvestheproteinsCSAandCSB,andinGGRother
NUDT1, occurs in mammalian (including human)
proteins,suchasXPC).Boththenrequireunwindingof
cells.Ithydrolyses8OHGTP,2OHATP,8OHATP,8-and
DNA by another protein complex (that includesXPB
2-OHdATPs,and8-chlorodGTP,aswellas8OHdGTP,
and XPD), and incision by enzymes, including XPF
and thus has a broader substrate specificity than
andXPG.AbnormalitiesinXPproteinscausethedis-
E.colimutT(whichdoesnotactonoxidizedadenine
easexeroderma pigmentosum, those in CSA or CSB,
derivatives). The 8OHdGMP produced cannot be re-
Cockaynesyndrome(Section5.10.8.2).
phosphorylatedandisfurtherhydrolysedto8OHdG,
In the second type of excision repair, the one used
which is excreted in urine in animals, including hu-
mostoftentoremovedamagebyRS,thedamagedbase
mans(Section6.14).ThedGTPpoolisthesmallestof
is removed directly (base excision repair, BER). En-
the DNA precursor pools and turns over rapidly—is
zymes called DNA glycosylases hydrolyse the bond
thisperhapsanotherstrategytominimizedamageto
linking the abnormal base to the sugar–phosphate
it? Suppression of MTH1 expression in human fibro-
backbone (Fig. 5.16), removing the base and leaving
blasts in culture led to rapid onset of senescence,214
an apurinic or apyrimidinic site (AP site) in DNA.
indicativeofthedamagethatcanbedoneifoxidized
Thesesitesaremutagenicandcanblocktranscription
nucleotidesareallowedtoenterDNAorRNA.
and DNA replication; they also arise by spontaneous
E. coli has a second enzyme that can remove
baselossinDNA,anddepurinationof8-nitroguanine.
8OHdGTP, GTP cyclohydrolase II. Human cells also
Someglycosylasesdealingwithmodifiedbasesarebi-
have MTH2 (NUDT15) which can degrade both
functional:aswellasremovingthebasetheycutthe
8OHdGTP and 8OHdGDP, and MTH3 (NUDT19)
DNAattheAPsite.Otherglycosylases(themonofunc-
which prefers to hydrolyse 8OHdGDP and 8OHGDP
tionalones)cannot,andcleavageisthenbyaseparate
rather than the triphosphates. These NUDT proteins
AP endonuclease enzyme. After cleavage, the ‘spare
areexamplesofnudix(nucleosidediphosphatelinked end’ is removed, a polymerase (usually polβ) inserts
to another moiety X) hydrolase proteins, over 20 of
thecorrectnucleotide,andtheDNAisthensealedby
whicharepresentinhumans.
a ligase (short-patch BER). Sometimes the gap is ex-
tendedbyfourtosevennucleotidesbeforefinalrepair
5.10.3 Cutitout:excision
and ligase action (long-patch BER). Short-patch BER
repair200,209,210,215,215A
is more common when dealing with modified bases,
In one type of excision repair (the only type used long-patchforspontaneousbaseloss.
forbulkylesionssuchaspyrimidinedimers,propan- HumanAPendonuclease-1(APE1)playsakeyrole
odeoxyguanosineadducts[Section5.12.5],andcertain in BER as an endonuclease and cleaner-up of ‘loose
carcinogenadducts)theDNAiscutsomedistanceon ends’, and also activates AP1 transcription factors
eithersideofthelesion,whichisthusremovedaspart (Section 5.5.7), a process involving a cysteine residue
of an oligonucleotide (Fig. 5.16). A DNA polymerase in its N-terminal half. Thus it is sometimes called
fills the gap (using information from the undamaged redoxeffectorfactor1(Ref1).Thisactivityalsopro-
strand) and a ligase seals the DNA. This process is
motesNF-κBbindingtoDNA(Section5.5.6)andcan
called nucleotide excision repair (NER), and occurs reduceoxidizedp53(Section10.14.6);thereducedstate
intwoforms.Transcription-coupledrepair(TCR)acts of APE1 is maintained by thioredoxin. Activation of

--- Page 304 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 249
(a) Damage tolerance
Replicative bypass
(c) Checkpoint
activation
Signal
DNA damage
transduction
(b) Damage repair
Mononucleotides Oligonucleotide Free base
fragment
Arrested
cell-cycle
progression
Nucleotide excision Base excision
Mismatch repair
repair repair
Unimodal incision
mechanism
Global genomic Transcription-coupled
repair repair
Figure5.16 ResponsestoDNAdamage.DNAdamage((cid:4))resultsineitherrepairortolerance.(a)Duringdamagetolerance,damagedsitesare
recognizedbythereplicationmachinerybeforetheycanberepaired,resultinginanarrestthatcanberelievedbyreplicativebypass(translesional
DNAsynthesis).(b)DNArepairinvolvestheexcisionofbasesandDNAresynthesiswhichrequiresdouble-strandedDNA.Mispairedbases,usually
generatedbymistakesduringDNAreplication,areexcisedassinglenucleotidesduringmismatchrepair.Adamagedbasecanbeexcisedasasingle
freebase(baseexcisionrepair)orasanoligonucleotidefragment(nucleotideexcisionrepair).Suchfragmentsaregeneratedbyincisionsflanking
eithersideofthedamagedbase.(c)Thecellhasanetworkofcomplexsignallingpathwaysthatarrestthecellcycleandmayultimatelyleadto
apoptosis.FromNature421,436,2003,bycourtesyofDrE.C.Friedbergandthepublishers.
PARP (Section 5.2.5) facilitates BER by causing accu- removalofuracilbyuracil–DNAglycosylase(amono-
mulationofXRCC1,ascaffoldproteinthatassociates functional glycosylase). Both are found in bacterial
withautomodifiedPARP-1andthenhelpsthevarious and animal (including human) cells. The OGG1 bi-
proteinsinvolvedinBER(suchasAPE1,DNAligase, functional glycosylase enzymes remove 8OHG and
andpolβ)toassemblecorrectly. FAPyG from DNA and are present in humans, other
ExamplesofBERincluderemovalofhypoxanthine animals,andplants.Thehumanenzyme(hOGG1)is
from DNA by hypoxanthine–DNA glycosylase and a bifunctional glycosylase that exists as nuclear and

--- Page 305 ---

250 FREE RADICALS IN BIOLOGY AND MEDICINE
mitochondrial isoforms. A genetic polymorphism at mispairs with adenine, mismatch repair removes the
codon 326 (Ser 326 to Cys) has been described; the A from the 8OHG:A pair. Overall, 8OHG is repaired
serine-containing form of the enzyme has been sug- fasterthanseveralotherbaselesions,atleastincertain
gested to be more active in removing 8OHG from humancelltypes(Fig.5.15),consistentwiththeview
DNA.TheNEILglycosylasesremovearangeofmodi- thatitisanimportantmutageniclesionthatcellsmust
fiedbasesfromDNAandareimportantinTCR.200For remove quickly. Of course, the same may be true for
example, NEIL1 and –3 mainly remove FAPyA and other lesions (e.g. FAPyG), that have been measured
FAPyGandsomepyrimidine-derivedlesionsandoxi- farlessoften.
dationproductsof8OHGfromDNA,butdonotacton
8OHGitself. 5.10.6 Repairofdouble-strandbreaks210
DNA repair enzymes have often been purified by
assaying their ability to act upon a single base le- Double-strand breaks can arise from generation of
sion.However,theyareoftenfoundtohaveabroader
multipleROSinonesite,e.g.clustersofOH•duringex-
specificity when tested against a range of lesions.215 posuretoionizingradiation.Theycanalsoarisefrom
Forexample,humanuracilglycosylasealsorecognizes attemptedrepairofbasedamagelesionsthatareclose
threeuracilderivativesgeneratedbyoxidativedamage toeachother.
to cytosine (5-hydroxyuracil, alloxan, and isodialuric Cells cope with DNA double-strand breaks in two
acid),whileE.coliendonucleaseIII(aglycosylasedes- ways. In homologous recombination (HR) repair,
piteitsname)releasesarangeofthymineandcytosine the DNA ends are trimmed in the 5’ → 3’ direction
oxidationproductsaswellasFAPyAfromDNA.This by nucleases and the 3’-single-stranded tails invade
enzymehasa[4Fe–4S]clusteratitsactivesite.AFAPy thedoublehelixofanundamagedhomologousDNA
glycosylasethatremovesFAPyA,FAPyG,and8OHG strand on a sister chromatid. DNA polymerase ex-
from DNA has been found in bacteria (e.g. in E. coli tends the strand using information from the intact
itiscalledFpgorMutM).E.colialsocontainsMutY,a chromatid. When extension is complete the two
glycosylasethatremovesadeninefromadenine:8OHG strands separate. The Rad proteins play key roles in
mispairs. A similar (monofunctional) adenine–DNA organizing homologous recombination, and the pro-
glycosylaseisfoundinanimalsandcalledhMYH(hu- tein kinase ATM (Section 5.10.8.2) is also important;
man MutY homologue), sometimes written as MYH when DNA damage occurs, ATM phosphorylates
orMUTYH.Itcanremove2-hydroxyadenineresidues many proteins, including p53. In non-homologous
from DNA and also adenine itself wrongly incorp- end joining (NHEJ), damaged bases and sugars are
orated adjacent to 8OHG, i.e. it is involved both in trimmed from the broken end, replaced (without the
excisionrepairandinmismatchrepair(Section5.10.4). benefitofanintactstrandastemplate),andresealing
occurs. This is error-prone, and small deletions often
occur. Severe errors can generate large abnormalities
5.10.4 Mismatchrepair
in DNA, visible on the chromosome (chromosomal
Nucleotide and base excision repair correct errors aberrations), or can lead to loss of chromosome
in DNA before replication, whereas mismatch repair portions. A key component of the non-homologous
actsafterreplicationtoremovewronglypairedbases systemistheKuprotein,whichisthefirstproteinthat
causedbypolymeraseerrorsormiscodinginducedby bindstodouble-strandbreaksandactsasanalignment
any DNA base modifications that were not removed. factor to assemble the subsequent proteins properly.
A protein complex, MutSα, ‘spots’ base mismatches One of these is a DNA-dependent protein kinase
suchasG/T,G/G,C/C,orA/C,andrecruitsanucle- that recognizes free DNA ends and phosphorylates
asetoexcisethemispairedbase. proteinsinvolvedintherepairprocess.WhetherHRor
NHEJisuseddependsonthetissueandthecellcycle
phasethatthecellisinwhentheDNAdamageoccurs
5.10.5 Repairof8-hydroxyguanine(8OHG)
(e.g. HR can only occur in S- and G2-phases when a
To see how various mechanisms integrate, let us ask sisterchromatidispresent).
how cells are protected against the mutagenicity of
8OHG. First, removing 8OHdGTP from the precur- 5.10.7 MitochondrialDNArepair200
sor pool deters its incorporation into DNA. Second,
BER, usually short-patch BER, is normally the major Untilfairlyrecentlyitwasthoughtthatrepairofdam-
removalpathof8OHGfromDNA.However,NERcan agetomtDNAisslowandinefficient.Thisisuntrue,
also remove it. Fourth, if 8OHG escapes repair and although our knowledge is less extensive than for

--- Page 306 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 251
nuclear DNA repair. The only DNA polymerase in DNA from them contains elevated levels of GC →
mitochondria, Polγ, serves for both replication and TA mutations. Simultaneous knockouts of two glyc-
repair.Short-patchBERoccursinmitochondria,andin- osylases (e.g. the glycosylases NEIL1 and NTH1 in
volvesseveralglycosylases,andinhumansMutYand mice) usually produce a much more obvious cancer-
OGG1arepresentinbothnucleusandmitochondria. pronephenotype,consistentwithsomedegreeofover-
8OHGappearstoberemovedfrommtDNAasrapidly lap of function in vivo.218 Such animals exhibit in-
as from nuclear DNA. In addition, MTH1 is present creasedlevelsofFAPyAandFAPyGinseveralorgans,
in mitochondria, to deter incorporation of 8OHdGTP but not 8OHG, consistent with the substrate specifi-
andotheroxidizedDNAprecursorsintomtDNA(Sec- cityofNEIL1andNTH1glycosylases.218 Bycontrast,
tion 5.10.2). Mitochondria are much less efficient at knockoutstudiesindicateanabsoluterequirementfor
NER, however, although mitochondrial fusion and APE1 and polβ for survival; homozygous knockouts
fission can help to remove damaged mitochondria die during embryonic development. Heterozygous
(Section1.3.3). APE+/APE–micesurvive,butshowelevatedlevelsof
oxidativeDNAdamage.219E.colilackingFpgorMutY
showincreasedspontaneousmutationrates,andrates
5.10.8 IsDNArepairimportant?200,212,213 are600-to1600-foldgreaterthannormalifbothgenes
are defective. E. coli lacking uracil DNA glycosylase
5.10.8.1 Bacteriatomice orMutTalsosuffermoremutations.Salmonellastrains
DNA isolated from aerobic microorganisms, plants, with defects in DNA repair are susceptible to dam-
and animals (including humans) contains low levels age by low concentrations of H 2 O 2 and less virulent
of oxidatively damaged bases (Table 5.1), suggest- tomice,confirmingthatDNAisanimportantdamage
ing that repair enzymes do not achieve complete re- targetofH 2 O 2 invivo.220
moval of modified bases. Damage recognition may
5.10.8.2 Micetomen
be the rate-limiting step in repair, since in humans
over 109 base pairs must be ‘probed’ for errors by SeveralhumandiseasesinvolvedefectsinDNArepair.
limited numbers of repair enzymes (e.g. only about Xeroderma pigmentosum, a rare condition in which
50,000 hOGG1 molecules per human cell)216 to locate theskinisseverelydamagedbysunlightandtherisk
whatarerare(<1in105bases)lesions.DefectsinDNA ofskincancerishigh,isusuallycausedbydefectsin
that is being replicated or transcribed are repaired NER,leadingtoinabilitytoremovepyrimidinedimers.
more rapidly (TCR) (Fig. 5.16). Consistent with this Error-pronepolymerasesbypasstheselesionsandmu-
limitationonDNArepairrates,thesteady-statelevels tations accumulate. At least seven different defects,
ofproductsofoxidativebasedamageincreaseinmany affecting different XP proteins (Section 5.10.3), have
diseases associated with increased RS production beenidentified.Theriskofsomeothercancersisalso
(Chapter10). elevated,andpatientscandevelopneurologicalsymp-
If DNA repair is important then interfering with toms, suggesting that the pathway is also important
it would be expected to cause problems. Indeed it inremovalofothermutageniclesions.Cockaynesyn-
does!SuppressionofMTH1incellsledtosenescence drome(Section5.10.3)ischaracterizedbyphotosensit-
(Section 5.10.2). Mice lacking MTH1 show increased ivity, growth retardation, and deficient neurological
mutation rates and an enhanced rate of spontaneous development (but interestingly no great increase in
tumourigenesis,especiallyinthelungandliver,asdo risk of cancer development); the defects in the CSA
micedeficientinmismatchrepair.Conversely,overex- or CSB proteins impair repair of pyrimidine dimers,
pressionofMTH1inmiceloweredlevelsofoxidative 8OHG,cyclodA,and8-hydroxyadenine.Inheritedmu-
damageandincreasedlifespanandpossiblyimproved tations in hMYH can lead to excessive colonic polyp
brain function.217 Knockout of NEIL1 increases can- formation and increased risk of colon cancer. Defects
cerrisksomewhat,butalsoproducesobesemicewith in mismatchrepair can cause Lynchsyndrome, early
themetabolicsyndrome—whyexactlyisuncertain,but onset colorectal cancer, plus increased risk of several
a link to increased mitochondrial DNA damage has othercancers.
beensuggested.218 MicelackingOGG1areviableand In severe combined immunodeficient (scid) mice
showsomeelevationsin8OHGinDNA,buthavemore and in patients suffering ataxia telangiectasia, there
limitedincreasesincancerdevelopment,e.g.theyde- aredefectsintherepairofdouble-strandbreaks.The
velop more skin cancer after UVB irradiation. Mice latter disease is characterized by a high incidence
without MUTYH show increased intestinal cancers; of cancers, hypersensitivity to ionizing radiation,

--- Page 307 ---

252 FREE RADICALS IN BIOLOGY AND MEDICINE
immunedeficiencies,ataxiaduetoneuronallossinthe in Section 5.10.2 that MTH1 can degrade 8OHGTP,
cerebellum, and telangiectasias (dilated and tortuous 2OHATP, and 8OHATP, as well as 8OHdGTP, al-
small blood vessels in the eyes, ears, and hands). thoughhowimportantthisisinvivoisuncertain.The
The mutation affects the ATM (ataxia telangiectasia enzymepolynucleotidephosphorylasemaypreferen-
mutated)genethatencodesaserine–threonineprotein tiallybindtooxidizedRNAandhelptoremoveitin
kinase (ATM) important in repair of double-strand E.coli,andpossiblyinanimalcells.226
breaks and in cell-cycle checkpoints (Section 10.14).
Without active ATM protein, the cell cycle often
proceedsdespitethepresenceofdamagedDNA.Both 5.11 Mechanismsofdamagetocellular
AT patients and ATM-knockout mice have elevated
targetsbyoxidativestress:lipid
levels of 8OHG in DNA and of lipid peroxidation,221
peroxidation227,228
apparentlybecauseATMalsohelpstomaintaincellu-
larlevelsofantioxidantdefencesystems,includingthe
5.11.1 Ahistoryofperoxidation:fromoils
pentosephosphatepathway.Indeed,ATMcanbedir-
andtextilestobreastimplants,fishmeal,
ectlyactivatedbyoxidationof–SHgroupstoproduce
andplasticwrapping
anactivedisulphide-linkeddimer.222Thus,whencells
areexposedtooxidizingconditionsthatcangenerate Lipid peroxidation was defined by A.L. Tappel, a
double-strand breaks (e.g. ionizing radiation), ATM famous early researcher in the field, as the oxidative
can be activated by both the double-strand breaks deterioration of polyunsaturated lipids. Polyunsaturated
and by direct oxidation, perhaps allowing a faster fattyacids(PUFAs)arethosethatcontaintwoormore
response. In mice, the neurobehavioural defects of carbon–carbon double bonds. Monounsaturated and
ATMdeficiencycanbediminishedbytreatmentwith even saturated lipids can also be oxidized; it’s just
EUK-189,an‘antioxidant’thatcrossestheblood–brain moredifficulttodoit.
barrier(Section11.5.4).221 Increasedoxidativestressin Oxygen-dependentdeterioration,leadingtorancid-
ATMknockoutmicealsodamagesthebonemarrow.221 ity,hasbeenrecognizedsinceantiquityasaproblem
Many of the effects of ATM deficiency were amelior- in the storage of fats and oils, and was often dealt
atedinmicethatwereoverexpressingcatalaseintheir withbyusingantioxidantspices(Section4.5).Rancid-
mitochondria.223
ity is even more relevant today with the popularity
of‘polyunsaturated’margarinesandcookingoils,and
5.10.9 Polymorphismsingenesencoding theimportanceofpaints,plastics,lacquers,waxes,and
rubber, all of which can undergo oxidative damage.
antioxidantandrepairenzymes
Even oils within breast implants can oxidize229 and
The above diseases illustrate the essentiality of DNA lipidperoxidationcontributestothedegradationofpa-
repair mechanisms, consistent with the inability of perandparchment.230Attemptstostudyoiloxidation
antioxidantdefencestopreventoxidativeDNAdam- began in the 1800s when de Saussure used a simple
age in vivo completely (Table 5.1). Polymorphisms mercurymanometertoshowthatalayerofwalnutoil
in OGG1 and other DNA repair systems have been onwaterunderwentslowoxidationovereightmonths,
suggested to be linked with various types of can- absorbingthreetimesitsownvolumeofair.Thisslow
cer, such as lung, prostate, and nasopharyngeal. phasewasfollowedbytendaysofrapidairabsorption,
In addition, polymorphisms in genes encoding GST, theoiltakingup60-timesitsownvolumeofair.During
haptoglobin (Section 3.23.3.4), MnSOD, catalase, γ- the next three months, the rate of air uptake grad-
glutamylcysteine synthetase, selenoprotein P, tocoph- ually diminished, so that the oil eventually took up
eroltransferprotein,carnosinase,eNOS,GPx3,GPx1, 145-times its original volume, becoming viscous and
and MPO (Section 10.15.1.1) have all been linked to evil-smelling.Commentingontheseexperiments,the
diseases.However,moreandlargerpopulationstudies famouschemistBerzelius(whoalsodiscoveredselen-
arerequiredtoconfirmtheseproposals.224,225 ium)suggestedthatoilautoxidationmightbeinvolved
inthespontaneousignitionofwoolafteritslubrication
5.10.10 DealingwithoxidativeRNAdamage203 withlinseedoil,acommoncauseoffiresintextilemills
atthattime.Indeed,shippingregulationsstillprescribe
RNA bases and ribose can also be oxidized. Since addition of antioxidants to transported fish meal, to
mRNA turns over rapidly, oxidized RNA is often as- avoidsimilarcombustion.231
sumed to be disposed of by this mechanism, and The sequence of chemical reactions which is now
littleisknownaboutrepairprocesses.Wecommented recognized as the ‘core’ of lipid peroxidation was

--- Page 308 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 253
worked out in detail by scientists at the British Rub- together away from water, together with polar parts
berProducers’Associationresearchlaboratoriesinthe thatliketoassociatewithwater.Inanimalcellmem-
1940s. The relevance of these reactions to biological branes the dominant lipids are phospholipids, esters
systemswasnotappreciateduntillater,however.Food basedonthealcoholglycerol(Figs5.17and5.18),the
scientistshavealsomadesubstantialcontributionsto commonest in animal cell membranes being lecithin
understanding lipid peroxidation; not only food but (phosphatidylcholine).Somemembranes,particularly
also its packaging (e.g. plastic films) can oxidatively plasma membranes, contain significant proportions
deteriorate, and antioxidants are needed to preserve of sphingolipids and cholesterol (Fig. 5.17). Mito-
bothofthem.232,233 chondrial inner membranes are rich in cardiolipin
(Fig.5.17);peroxidationofPUFAsinthislipidmaycon-
tributetoage-relateddeclineinmitochondrialfunction
5.11.2 Targetsofattack:membranelipids (Section11.4.2.1)andtothesequelaeoftraumaticbrain
andproteins injury (Section 10.18.4) and can facilitate cytochrome
c release during apoptosis (Section 5.4.1). Cardioli-
5.11.2.1 What’sinamembrane?
pins are also found in bacteria, and their presence in
The membranes that surround cells and organelles mitochondriaisconsistentwiththeendosymbioticthe-
containlargeamountsofPUFAside-chains(Table5.9). ory of mitochondrial origin (Section 1.3.4). The name
Wearethereforeatconstantriskofgoingrancid. comesfromthefactthatcardiolipinswerefirstisolated
Themajorconstituentsofbiologicalmembranesare frombovineheart.
lipid and protein, the amount of protein increasing The fatty-acid side-chains of membrane lipids in
withthenumberoffunctionsthatthemembraneper- animalcellshaveunbranchedcarbonchainsandcon-
forms. In the myelin sheath, which serves largely to tain even numbers of carbon atoms, usually 14 to 24
insulatenerveaxons,onlyabout20%ofthedryweight (Table 5.9), and the double bonds are cis configura-
ofthemembraneisprotein,butmostmembraneshave tion,causing‘kinks’inthestructure(Fig.5.18).Other
50% or more protein, and the inner mitochondrial organismshavedifferentlipidcompositions.Thecom-
and chloroplast thylakoid membranes are about 80% positionofbacterialandyeastmembranesdependson
protein. Some proteins are loosely attached to mem- thespecies,cultureconditions,andstageinthegrowth
branesurfaces(extrinsicproteins),butmostaretightly cycle.
attached(intrinsicproteins),beingeitherpartiallyem-
bedded in the membrane, located in the membrane
5.11.2.2 Membranestructure
interior,ortraversingthemembrane.Lipidperoxida-
tioninmostbiologicalmembranesisthusverylikely As the number of double bonds in a fatty acid in-
todamagemembraneproteinsaswellaslipids. creases, its melting point drops. For example, stearic
Membranelipidsaregenerallyamphipathic,thatis acid(18:0)issolidatroomtemperaturewhereaslino-
theycontainhydrophobicregionsthattendtocluster leic acid (18:2) is liquid. Since membrane lipids are
Table5.9 Somecommon,naturallyoccurringfattyacids.
Shorthandnamea Commonname Examplesofoccurrence
16:0 Palmiticacid Naturalfatsandoils,especiallypalmoil
18:0 Stearicacid Naturalfatsandoils,especiallybeeffat
18:1(n-9)b Oleicacid Naturalfatsandoils,especiallyoliveoilandcanolaoil
18:2(n-6) Linoleicacid Widespread,manyseedoils
18:3(n-3) α-Linolenicacid Plantleaves,someseedoils,e.g.soybean,rapeseed,canola,linseedoils
20:4(n-6) Arachidonicacid Animalmembranes
20:5(n-3) Eicosapentaenoicacid(EPA) Fishoils
22:6(n-3) Docosahexaenoicacid(DHA) Fishoils,mammalianbrain,retina
aNumberofcarbonsinchain:numberofdoublebonds.
bThenumberingsysteminparentheses(oftenusedinthenutritionalliterature)identifiesdoublebondsfromthemethyl,-CH3,endofthechain.Fornomenclaturein
thechemicalliteratureseeFig.5.18.

--- Page 309 ---

254 FREE RADICALS IN BIOLOGY AND MEDICINE
O
R C OCH 2
R C O CH O
1
+
O CH O P O CH CH N(CH )
2 2 2 33 Phosphatidylcholine
O– (lecithin)
Polar part
(choline phosphate)
O
R C OCH
2
R C O CH O
1
+
O CH O P O CH CH NH Phosphatidylethanolamine
2 2 2 3
O–
Polar part
(ethanolamine phosphate)
O O
R C OCH CH O C R
2 2 4
R C O CH O H O CH O C R
1 3
O CH O P O CH C CH O P O CH O
2 2 2 2
O– OH O–
Diphosphatidylglycerol
Polar part
Ceramide part
H H O
+ Sphingomyelin
H 3 C (CH 2 ) 12 CH CH C C CH 2 O P O CH 2 CH 2 N(CH 3 ) 3 (–OH group of ceramide can
OH NH O– alternatively be bonded to sugars to
give glycosphingolipids)
O C Polar part
R (choline phosphate)
1
CH
3
C H H C CH 2 CH 2 OCOR 2
CH 3 3 C C H H 2 H OH OH O CHOCOR 1
2 O P OCH
H H 2
CH
HC 3 OH H O–
CH 3 HO H
HO H OH
Polar Cholesterol Phosphatidylinositol
part (polar part is the inositol phosphate)
Figure5.17 Lipidmoleculesfoundinanimals.R1,R2,etc.representlong,hydrophobic,fatty-acidside-chains(forstructures,seeTable5.9and
Fig.5.18).Inmostlipidsthesearejoinedbyesterbondstothealcoholglycerol.Insphingomyelins,however,thefattyacidsareattachedtothe
–NH2groupofsphingosine(Fig.5.18).Allofthelipidmoleculesshowncontainapolar(hydrophilic)partthatcaninteractwithwater,butin
cholesterolthisisverysmall(onlyan–OHgroup)sothat,overall,cholesterolisveryhydrophobic.Diphosphatidyglycerol(cardiolipin)comprises
about20%ofthephospholipidsintheinnermitochondrialmembrane.Itishighlysusceptibletooxidationsinceitcontainsfourfatty-acid
side-chains,allofthemunsaturated.Theexactcompositionvariesbetweenspecies.Forexample,animaltissuescontainmostlylinoleicacid
residues,whereassomemarinebivalvescontainonlyDHAresidues(Chem.Phys.Lipids138,38,2005;Antioxid.RedoxSignal.20,1925,2014).

--- Page 310 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 255
H H H (CH 2 ) 7 COOH
C C C C
(CH 2 ) 7 (CH 2 ) 7 (CH 2 ) 7 H
CH 3 COOH CH 3
cis-oleic acid trans-oleic acid
CH 3 (CH 2 ) 4 CH 2 CH 2 (CH 2 ) 6 COOH
C C C C
H H H H
cis cis
Linoleic acid
CH 3 CH 2 CH 2 CH 2 CH 2 (CH 2 ) 6 COOH
C C C C C
H H H H H H
cis cis cis
Linolenic acid
CH 3 (CH 2 ) 4 CH 2 CH 2 CH 2 CH 2 (CH 2 ) 2 COOH
C C C C C C C C
H H H H H H H H
Arachidonic acid
Figure5.18 Fattyacidsandother‘building
blocks’ofbiologicallipids.Phosphorylated
H H inositolsplaykeyrolesinsignaltransduction
(Section5.3.2).Top:cis-andtrans-oleicacid
CH 2 OH H 3 C (CH 2 ) 12 CH CH C C CH 2 OH (C18:1).Adoublebondinacarbonchain
preventsrotationofthegroupsattachedto
CHOH Sphingosine OH NH 2 thecarbonatomsformingit,sothattheyare
forcedtostayononesideofthedoublebond
CH OH
2 ortheother,generatingtransandcis
Glycerol configurations.Notethekinkinthechainof
OH OH thecisform.Linoleicacid(C18)hastwo
doublebonds,atcarbons9and11(wherethe
H OH
H H carbonintheCOOHgroupiscountedas
HO
OH H
H
carbonnumber1).Linolenicacid(C18)has
doublebondsatcarbons9,12,and15.
H OH Arachidonicacid(C20)hasdoublebondsat
Inositol carbons5,8,11,and14.
amphipathic,onexposuretowatertheyaggregatewith bags of aqueous solution bounded by a lipid bi-
theirhydrophobicregionsclusteredtogetherandtheir layer.Liposomescanbesurroundedbyasinglebilayer
hydrophilicregionsincontactwithH O.Howthisis (unilamellar) or several bilayers (multilamellar), as
2
achieveddependsontherelativeamountsoflipidand shown in Fig. 5.19. The interior of liposomes con-
water.Whenphospholipidsareshakenorsonicatedin tainssomeoftheaqueoussolutioninwhichtheywere
aqueous solution they form micelles (Fig. 5.19), but made,sotheyareoftenusedas‘parcels’fortransport-
as more phospholipids are added liposomes result, ing drugs (including antioxidant enzymes) to target

--- Page 311 ---

256 FREE RADICALS IN BIOLOGY AND MEDICINE
tissues. Liposomes are frequently used in studies of signalling.BindingofeNOStocaveolinhasbeensug-
lipidperoxidation. gestedtoregulateitsactivity,forexample.
The lipid bilayer (Fig. 5.19) is the basic structure
of all cell and organelle membranes. In each half of
5.11.3 Targetsofattack:dietarylipids
the bilayer, protein and lipid molecules can diffuse
andlipoproteins
quickly—indeed a lipid molecule in one half of a bi-
layer can move from one end of the ‘average’ cell to
Dietary fats have to be digested, absorbed, and
the other in a few seconds. This membrane fluidity
transported around the body. They can be oxidized
is largely due to the presence of PUFA side-chains,
duringcookingandstorage,andpossiblyinthegastro-
which lower the melting point of the membrane in-
intestinal tract itself (Section 7.2). Lipoproteins in-
teriorsothatithasthechemicalnatureandviscosity
volved in fat transport may contain small amounts
of a light oil. Membrane fluidity is essential for the
of oxidized lipids from the diet and can undergo
properfunctioningofbiologicalmembranes,anddam-
further oxidation in vivo, contributing to atheroscler-
age to PUFA residues can decrease it. By contrast,
osis (Section 10.3). Fatty acids circulating in the
exchange of lipids between the two halves of the bi-
blood are also potential targets for oxidation; albu-
layerislessfrequent.Someauthorshavearguedthat
minandalbumin-boundbilirubinhelptoprotectthem
membrane lipids, especially cholesterol and sphingo-
(Sections3.23.3.5and3.25.1).
lipids,canclustertogetherinmembranestoformlipid
rafts, which help to bring proteins together for func-
tional purposes such as signalling (e.g. clusteringthe 5.11.4 Howdoeslipidperoxidationbegin?
constituents of NADPH oxidases together to activate
O •– production,andoftenalsoincludingthemolecu- Initiationoflipidperoxidationcanbecausedbyaddi-
2
lartargetsofthisO •–/H O ).234Caveolin-1andsimilar tionofanRStoalipidor,moreusually,byhydrogen
2 2 2
proteins are involved in formation of caveolae (‘lit- atomabstractionfromamethylene(–CH 2 –)groupby
tle caves’), small transient invaginations at the cell an RS. In both cases, a carbon radical results. For
•
surfacethatparticipateinendocytosisandsometimes example,OH canreactbyaddition,
PHOSPHOLIPID
(LECITHIN)
polar part
(choline phosphate)
H 2 O H 2 O more phospholipid H 2 O H 2 O H 2 O H 2 O
long hydrocarbon Micelle (spherical structure) Liposome
side-chains of (polar heads on outside, nonpolar Lipid bilayer
fatty acids hydrocarbon chains inside) (hydrophobic interior, polar
parts in contact with water)
(a) (b)
Figure5.19 Formationofalipidbilayeronmixingphospholipids(e.g.lecithin)withaqueoussolutions.Top:generalprinciples.Bottom:electron
micrographsofpreparationsof(a)unilamellarand(b)multilamellarliposomes.

--- Page 312 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 257
any water undergoing homolysis within the mem-
•
branewillgenerateOH notaccessibletoscavengers.
•
The rate constant for reaction of OH with artificial
lecithin bilayers has been measured236 as about 5 ×
orbyH•abstraction,
108M–1s–1. Sonication (e.g. in the preparation of lipo-
somes) can also generate radicals (Section 2.5.1) that
•
–CH –+OH •→–CH–+H O promote lipid oxidation. Exposure of cells to electric
2 2
fieldscancausetransientincreasesinpermeabilityof
The free-radical gas nitrogen dioxide (NO • ) can per- the plasma membrane, and this process of electro-
2
form similar reactions (Section 9.12.2) and there is porationisoftenusedtofacilitatetheintroductionof
considerable interest in the biology of nitrated lip- material,e.g.DNA,intocells.Electroporationincreases
ids(Section2.6.1.3).Bycontrast,thenon-radicalHOCl lipidperoxidation,andinturnoxidizedareasofmem-
is more likely to chlorinate lipids by addition across brane seem to be more sensitive to electroporation,
doublebonds(Section5.11.8.2),althoughchloramines showing higher permeability rises.237 Sonoporation
can form on –NH groups of some lipids. Singlet O (usingultrasoundtopermeabilizethemembrane)also
(Section5.11.8.1)a 2 ndozone(Section2.6.5)directlyox 2 - promoteslipidoxidation.238 NotethatOH • generated
idizelipids,thelatterformingozonides. outside a membrane will also attack extrinsic carbo-
The presence of a double bond weakens the bond hydratesandproteins(e.g.cellsurfaceglycoproteins)
energyoftheC–Hbondspresentontheadjacentcar- and‘headgroups’ofphospholipids.Indeed,oxidative
bon atom (the allylic hydrogens), especially if there damage to the glycocalyx, the delicate meshwork of
is a double bond on either side of the C–H bond glycoproteinsonthesurfacesofmostcells,canaffect
(Fig. 5.20), giving bis-allylic hydrogens. The reduc- cellfunctionandmaycontributetopathology,e.g.in
tion potential of a bis-allylic PUFA•/PUFA couple ischaemia–reperfusion.239
at pH 7 (E◦(cid:4)) has been estimated235 at about 0.6 V. By contrast to OH•, neither NO • nor O • 2 – is suffi-
Hence, OH • , HO • , RO•, and RO • radicals are (ther- cientlyreactivetoabstractH•fromlipids;inanycase,
modynamically at 2 least) capable 2 of oxidizing PUFAs the charge of O • 2 – tends to preclude it from entering
(see Table 2.3) at allylic hydrogens. The more double the lipid phase of membranes. Indeed, O • 2 – does not
bonds, the more oxidizable is the PUFA, at least in readilycrossbiologicalmembranes,exceptwherespe-
vitro,e.g.theoxidizabilityofDHAorEPA(Table5.9)in cific channels exist, nor does it appear to react with
vitroisseveraltimesgreaterthanthatoflinoleicacid. membrane constituents on its passage through such
•
One consequence of this is that fish-oil supplements, channels(Section2.5.3).However,HO 2 ismorereact-
•
widelyadvocatedbyhealth-foodstores,undergooxi- ive and can abstract H from some PUFAs, such as
dationeasilybecausetheycontainsubstantialamounts linoleic,linolenic,andarachidonicacids(rateconstants
ofthesePUFAs.Clinicaltrialsinvestigatingthealleged
1.2,1.7,and3.0×103M–1s–1respectively).240
benefits of fish-oil supplementation in various dis-
•
eases have often given conflicting results; one reason –CH –+HO
•→–CH–+H
O
2 2 2 2
may be the extent of oxidation of the preparation •
HO ,beinguncharged,shouldentermembranesmore
that was tested (Section 4.7). Replacement of hydro-
easi
2
ly than O
•–,
and thus HO
•
-dependent lipid per-
genatomsbydeuteriuminlipidscanslowoxidation 2 2 •
oxidation is possible. In addition, HO can stimulate
(Section11.8). 2
peroxidationbyreactionwithpreformedlipidhydrop-
Hydroxyl radical readily initiates peroxidation of
eroxidestogenerateperoxylradicals,240
fattyacids,lipoproteins,andmembranes.Henceirradi-
ation of biological material stimulates lipid peroxid- HO • +ROOH→RO • +H O
ation; this has been shown not only for membranes 2 2 2 2
•
and lipoproteins but also for food lipids (a problem However, there is as yet no evidence that HO is an
2
in attempts to sterilize or preserve food by irradi- importantinitiatoroflipidperoxidationinvivo.
ation).Radiation-inducedperoxidationisinhibitedto
•
some extent by scavengers of OH , such as manni-
5.11.5 Propagationoflipidperoxidation
tol and formate (Section 6.3.2), which will compete
•
with the lipids for any OH generated in ‘free solu- Carbonradicalscanstabilizethemselvesbymolecular
tion’. However, H 2 O crosses membranes readily and rearrangement to form conjugated dienes (Fig. 5.20).

--- Page 313 ---

258 FREE RADICALS IN BIOLOGY AND MEDICINE
Intrinsic
protein
Extrinsic
protein
Membrane bilayer
Intrinsic protein
(membrane spanning)
Initiation of Removal of H (can
peroxidation occur at several places
in the chain)
Molecular
Carbon-centred radicals
rearrangement
Direct
reaction
with
singlet
oxygen O2
Other
reactions
1. Oxidation of cholesterol
O2 2. Attack on membrane proteins
Lipid peroxyl H abstraction from 3. Reaction of two peroxyl radicals
radical adjacent membrane lipid to cause singlet oxygen
(1O2) formation
O2H Lipid hydroperoxide plus
a new carbon-centred
radical that continues the
chain reaction
Figure5.20 Idealizedrepresentationoftheinitiationandpropagationreactionsoflipidperoxidation.Theperoxidationofafattyacidwiththree
doublebondsisshown.
• •
Iftwocarbonradicalscollidewithinamembranethey radical, ROO (or RO ), sometimes shortened to per-
2
mightcross-linkthefatty-acidside-chains: oxyradical,
R • +O →ROO •
2
Of course, very low O concentrations might favour
2
self-reaction of carbon-centred radicals, or their reac-
tionswithothermembranecomponents,suchas–SH
However, a more likely fate of carbon radicals un-
groupsonproteins.HencetheO concentrationaffects
2
der aerobic conditions is to combine with O (Sec-
2 the pathway of peroxidation, for this and for other
tion 2.5.1), especially as O concentrates inside mem-
2 reasons,thatareexploredbelow(alsoseeSections4.4
branes(Section1.1.3).ReactionwithO givesaperoxyl
2 and10.3.8).

--- Page 314 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 259
Peroxyl radicals can abstract H• from an adjacent Thus, the addition of Fe2+ (or a ferric salt plus a
fatty-acidside-chain, reducingagent)toaperoxide-freeunsaturatedlipidin
the presence of O should initiate lipid peroxidation
2
viaOH•formation.Theresultingperoxidationshould
beinhibitablebyH O -removingenzymes,scavengers
2 2
of OH•, and chelating agents that bind iron ions and
preventtheirparticipationinfree-radicalreactions.244
This is the propagation stage of lipid peroxidation.
Indeed, all of these effects have been observed in
It forms new carbon radicals that can react with O
2 studies involving iron addition to dispersed lipid
to form new peroxyl radicals, and so the chain re-
systems (e.g. fatty acids solubilized by detergents)or
actionoflipidperoxidationcontinues(Fig.5.20).The
ultrapurelipids.
RO • combines with the H• that it abstracts to give a
2 However,mostscientists,includingtheauthors,find
lipidhydroperoxide(ROOH).Thisnameissometimes that when catalase or scavengers of OH• are added
shortened to lipid peroxide, although the latter term
to lipids (e.g. microsomes, lipoproteins, liposomes)
alsoincludescyclicperoxides(Fig.5.20),whichresult
undergoing peroxidation stimulated by addition of
whenaperoxylradicalattacksanotherdoublebondin
iron ions, there is no inhibition, despite the fact that
thesamefatty-acidresidue. OH• radicalscanbedetectedinthereactionmixtures.
A single initiation event thus has the potential to Formation of OH• is inhibited by H O -scavenging
2 2
generatemultiplelipidperoxidesbyachainreaction. enzymes.244 ItfollowsthattheOH• beingmadefrom
The initial H• abstraction from a PUFA can occur at
H O isnotrequiredfortheperoxidation.Onemight
2 2
different points on the carbon chain (Fig. 5.20). Thus arguethattheOH• formationis‘site-specific’,involv-
peroxidationoflinoleicacidgivestwohydroperoxides, ing iron ions bound to the membrane, so that OH•
thatoflinolenicacid,four.Peroxidationofarachidonic
reactsimmediatelywiththelipidsandisnotavailable
acidgivessixlipidhydroperoxides.Similarly,EPAcan
for scavenging. However, H O -removing enzymes
2 2
giveeighthydroperoxides,andDHAten.Allofthese
should still inhibit. The fact that they usually do not
productsareformedasracemicmixuresofopticaliso-
hasledtoproposalsthatinitiationoflipidperoxidation
mers,i.e.lipidperoxidationisnotstereospecific.Cyclic byironsaltsinthepresenceofO isnotduetoOH•,
2
andbicyclicperoxidescanalsoform(Figs5.21–5.24).
buttootherRS.Ferrylhasbeensuggested,butferryl
formation by reaction of Fe2+ with H O should still
2 2
requireH O .Perferrylcouldalsobeinvolved.Some
2 2
5.11.6 Transitionmetalsandlipid studiessuggestthatperferrylisinsufficientlyreactive
peroxidation241,242 toabstractH•ortoinsertoxygendirectlyintofattyacid
side-chains,245,246butincontrast,othershavedescribed
5.11.6.1 Iron
enzymes(e.g.myo-inositoloxygenase,isopenicillin-N-
Interpretations of studies on the role of iron in lipid synthase) that appear to use active site Fe(III)-O
•–
2
oxidationtendtobeconfusedbytheexperimentalcon- speciestobringabouttherequiredreactions.247 Stud-
ditionsusedbymanyscientists.Levelsof‘free’metal ies of the kinetics of microsomal or liposomal lipid
ionsinvivoarelow,effectivelyzeroinplasmaandlow peroxidation in the presence of Fe2+ and/or Fe(III)
μMintheLIPandintheplasmaofpatientswithiron salts led to proposals that initiation requires a triple
overloaddisease(Section3.22.1.3).Yetmanyscientists complex of Fe(III)/Fe(II)/O 2 , but this has not been
add50to100μMFe2+,Fe3+/ascorbateorFe2+ -ADP substantiated.
to their lipids to ‘initiate’ peroxidation in vitro, with Howdoweexplainthisconfusion?Itisnotonlythe
considerablesuccess.Howdoesthiswork? levels of iron used in many of these studies that are
High concentrations of Fe2+ take part in electron- unphysiological,butalsothestateofthelipids,inthat
transferreactionswithO toformOH•, theirperoxidecontentisoftenabnormallyhigh.Com-
2
merciallyavailablelipidsarecontaminatedwithperox-
Fe2++O (cid:2)(Fe2+–O ↔Fe(III)–O •–)(cid:2)Fe(III)–O •– ides,andsowillbeliposomesormicellesmadefrom
2 2 2 2 them. Sonication, often used to prepare liposomes,
perferryl
introducesmoreperoxides(Section5.11.4),asmaythe
2O • 2 –+2H+→H 2 O 2 +O 2 proceduresusedtoisolatelipoproteins(Section10.3.5).
Fe2++H O →Fe(III)+OH–+OH • When tissues are damaged, lipid peroxidation is fa-
2 2

--- Page 315 ---

260 FREE RADICALS IN BIOLOGY AND MEDICINE
CO H
2
CO H CO H CO H
2 2 2
O O O O
2 2 2 2
· ·
O O O O
CO 2 H CO 2 H CO H CO 2 H
2
·
O O
·
O O
O CO 2 H O CO 2 H O CO 2 H O CO 2 H
O O O O
O O O O
2 2 2 2
OOH OOH
O O CO 2 H O O CO 2 H O O CO 2 H O O CO 2 H
OOH OOH
[H] [H] [H] [H]
OH OH OH OH OH OH
CO 2 H CO H CO 2 H CO H
2 2
OH OH OH OH OH OH
5-Series 12-Series 8-Series 15-Series
HO HO
OH OH
COOH
COOH COOH COOH
HO HO
OH OH OH OH OH HO
PGF 2a 8-iso-PGF 2a 2,3-dinor-5,6-dihydro-15F 2t -IsoP 2,3-dinor-15F 2t -IsoP
Figure5.21 FormationofF2-isoprostanes(F2-IsoPs)fromarachidonicacid.243FreeradicalscanabstractH•atthreedifferentpositions.Four
ROO•radicalsareformedwhenO2reactswiththecarbon-centredradicals.TheROO•attackdoublebondsinthesamechaintocyclizethe
structure,abicyclicstructureformsbyinternalH•abstraction(Fig.5.21)andO2addsagaintothenewcarbonradicals.Reductiongivesfour
isomersidentifiedbythelocationofthe–OHgroupontheside-chain(5-,8-,12-,and15-).Forsimplicity,stereochemistryisnotindicatedbuteach
seriespotentiallyhas16stereoisomers,giving64isomersinall.ThesecompoundsarestructurallyisomericwithprostaglandinF2α,hencethename
‘isoprostane’.DiagrambycourtesyofDrsL.JacksonRobertsII,thelateJasonMorrow,andGingerMilne.
voured(Fig.10.1)andlipidperoxidesarealsoformed Lipid peroxides are fairly stable at body tempera-
enzymicallyininjuredtissuesbycyclooxygenaseand ture,buttheydecomposeinthepresenceoftransition
lipoxygenase enzymes (Section 8.12).248 Thus, mem- metal ions. Fe2+ and certain Fe2+–chelates react with
brane fractions isolated from disrupted cells are usu- lipidperoxidesinasimilarwaytotheirreactionwith
allyenrichedinlipidperoxides. H O , splitting the O–O bond. This produces RO•,
2 2

--- Page 316 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 261
O
OR
OH OH O Arachidonic acid
OR
O OR
Isoleukotriene
O O
OH
Isoprostane Endoperoxide
reduction
HO OR rearrangement OR
O
O O O
HO OH OH
F2-Isoprostane Isothromboxane
HO O
OR OR
site of GSH O O
adduction O OH HO OH
OR D2-Isoprostane E2-Isoprostane O OR
O site of GSH O
O OH sit w e i o t f h a p d r d o u te c i t n ion O OR O OR adduction OH
J2-Isoprostane amino group O O A2-Isoprostane
O O
OH OH
OR D2-Isoketal sit
w
e
i
o
t
f
h
a
p
d
r
d
o
u
te
c
i
t
n
ion E2-Isoketal
O
amino group
O
deoxy-J2-Isoprostane
Figure5.22 AnarrayofproductsfromtheIsoPpathwayoflipidperoxidation.243Thenon-enzymaticoxidationofarachidonicacidyieldsa
complexmixtureofproductsincludingisoleukotrienesandIsoPs.Duringthisoxidation,abicyclicendoperoxide(indicatedinthisfigureasIsoP
endoperoxide)isgeneratedfirst.F2-IsoPsareformedfromtheendoperoxideviareductionoftheperoxidering.D2-/E2-IsoPs,andtheir
cyclopentenonedehydrationproducts,resultfromrearrangementoftheendoperoxide.TheavailabilityofreducingagentssuchasGSHor
α-tocopherolcanaffecttheratioofF2-toD2/E2-IsoPs.CyclopentenoneIsoPs(includingA2-/J2-anddeoxy-J2-IsoPs)canconjugatewithcellular
thiols.Acyclicγ-ketoaldehydes(D2-IsoK,E2-IsoK),theisoketals(sometimescalledisolevuglandins),canalsobeformedfromtherearrangement
oftheIPendoperoxideandcanreadilyadductaminogroupsinproteins.FigurebycourtesyofDrGingerMilne,VanderbiltUniversity.
an alkoxyl radical (sometimes shortened to alkoxy 1.5×103M–1s–1),althoughtheligandstothemetalion
radical), affect these rates (e.g. Table 2.3). Reactions of Fe(III)
ROOH+Fe2+→Fe(III)+OH–+RO • withhydroperoxidesareusuallyslowerthanthoseof
Fe2+.Hence,therateoflipidperoxidationinthepres-
AlkoxylradicalscanabstractH•fromPUFAsandfrom ence of Fe(III) can be increased by adding reducing
peroxides, agents, such as ascorbate or thiols, because peroxide
decompositionisfaster.AnotherfactoristhatFe2+salts
RO • +L–H→ROH+L •
are more soluble at pH 7.4 than are Fe(III) salts. The
ROOH+RO
•→ROO •
+ROH ironionsinsomeredwinescanoxidizelipidsinscal-
lopstounpleasanttastingproducts:asaresult,some
Thesereactionscancontinuepropagationoflipidper-
redwinesdonotgowellwithseafood.249
oxidation.Alkoxylradicalscansometimesattacktheir
Peroxyl radicals are efficient stimulators of lipid
ownPUFAchain,producingepoxyradicals.
peroxidation. Thus when iron ions are added to
Iron(III)andcertain Fe(III)chelatescan decompose peroxide-rich lipids, RO • (and possibly RO•) account
peroxidestoperoxylradicals, forthestimulationofper 2 oxidation,andOH•,although
ROOH+Fe(III)→RO • +H++Fe2+ formed,isnotrequired.Yetanothercomplexityisthat
2
toomuchFe2+canscavengeradicals,
ReactionsofFe2+ withlipidhydroperoxidesarefaster
thanthereactionofFe2+withH O (k forFe2++H O RO • +Fe2++H+→Fe(III)+ROH
2 2 2 2 2
is about 76 M–1s–1; that for ROOH + Fe2+ is about RO • +Fe2++H+→Fe(III)+ROOH
2

--- Page 317 ---

262 FREE RADICALS IN BIOLOGY AND MEDICINE
Arachidonic acid
14 11 8 5 COOH
•
–H
COOH
•13 OH
COOH
O
HO
•11
COOH
OH
isofuran
•
O
O O O
COOH
COOH
12 •
oo
H RH high O 2
O •
R
O O O
COOH
12 • 8 COOH
Monocyclic peroxide
•
Internal H abstraction
(favoured at low O )
2
COOH
reaction with O 9
O 2 and reduction* O 11 •
Bicyclic endoperoxide
an F -isoprostane
2
O
2
hydrolysis or heat
+ other products
O O
MDA
Figure5.23 Formationoflipidhydroperoxidesandcyclicperoxidesfromarachidonicacid.243ThechemistryiscomplexbecauseabstractionofH•
canoccuratdifferentsites,C7,C10,orC13;tosimplify,weshowitonlyatC13.TheROO•radicalsformedcangeneratehydroperoxidesorcyclize
tomonocyclicperoxides.Theseresultwhenperoxylradicalsattackadoublebondinthesamechain.Monocyclicperoxidescanformbicyclic
structuresthatcangiverisetoIsoPs,orreactwithO2,eventuallyproducingisofurans.Unstableperoxidescandecomposetoaldehydessuchas
malondialdehyde(MDA).Evenproductscontainingbicyclicendoperoxideandcyclicperoxidegroupsinthesamemolecule
(dioxolane–isoprostanes)canbegenerated(J.Biol.Chem.279,3766,2004).O2concentrationaffectstherelativelevelsofIsoPsandother
products,asdolevelsofGSHandotherreducingagents.∗ByGSHandotherthiols.
andsotheratioofFe2+/LOOHisimportantindeter- lipid peroxidation release iron from the protein
miningtheperoxidationkinetics. (Section3.22.4.2).Myoglobin,haemoglobin,andcyto-
Many iron chelates can stimulate lipid peroxid- chromes can also stimulate peroxidation. These pro-
ation (Table 5.10). For some proteins, such as fer- teins react with lipid peroxides rather like their
ritin,stimulationoccursbecauseRSproducedduring reactions with H O , to release iron and haem
2 2

--- Page 318 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 263
DHA
C C
9 6
COOH
C
12
C C
15 18
OH OH
4 COOH
C
6
OH
OH OH OH
COOH 7 COOH
C 9 11
OH OH OH
OH OH OH
COOH 10 COOH
C 12 14
OH OH
OH
OH OH OH
COOH 13 COOH
C 15 17
OH OH OH
OH
COOH
C
18 20
OH OH
Figure5.24 Theneuroprostanes.AbstractionofH•fromC6,C9,C12,C15,orC18gives4-,7-,10-,11-,13-,14-,17-,and20-series
neuroprostanes,givingatotalof128isomers.The4-and20-seriesaremorecommonlyformedthantheothers.FromChem.Phys.Lipids128,
173,2004,bycourtesyofDrL.JacksonRobertsIIandElsevier.
(Section3.22.3), bothofwhichcandecomposeperox- 5.11.6.2 Copper
idestoRO • andRO•radicals.Theyalsoformferryland
2 Copper ions are powerful promoters of peroxide de-
aminoacidradicals,250e.g.
composition;e.g.Cu2+ isanexcellentcatalystofLDL
Met(III)Mb+ROOH→ Mb •+(IV) =O + ROH peroxidation(Section10.3.5).Likeiron,Cuactsmainly
bydecomposingperoxides,
Met(III)Mb+ROOH→ Mb(IV) =O + RO • + H+
The MB•+(IV)=O and MB•(IV)=O species can fur-
ROOH+Cu2+→Cu++RO •
2
+H+
theraccelerateperoxidation250 byabstractingH• from ROOH+Cu+→RO • +Cu2++OH–
PUFAs, ROOH+Cu2+→ Cu(III) +RO • +OH–
Mb •+(IV) = O+PUFA-H→ Mb(IV) =O+
PUFA • +H+ Thereactionratesdependontheligandstothecopper
ions.
Mb • (IV) =O+PUFA-H→ Mb(IV) =O + PUFA •
WhataboutO
•–?Itmightcontributetotheperoxida- 5.11.6.3 Othermetals
2
•
tionintwoways,firstviaHO (Section5.11.4).Second, Cobalt ions can decompose lipid peroxides, whereas
2
O •– can reduce Fe(III) to Fe2+, although its effects are Zn2+ and Mn2+ ions do not. Some other metal ions
2
complex because it is also capable of oxidizing Fe2+ cannot themselves stimulate lipid peroxidation, but
backtoFe(III)(Section2.5.3.3). appear to bind to lipids in a way that facilitates

--- Page 319 ---

264 FREE RADICALS IN BIOLOGY AND MEDICINE
Table5.10 PhysiologicalformsofironandtheirpossibleparticipationinRSformation.
Typeofiron Willitdecomposelipid CanitformOH•from
peroxidestoformalkoxyl H2O2byFenton
and/orperoxylradicals? chemistry?
Ironionsboundto
Phosphateesters(e.g.ADP,ATP) Yes Yes
Carbohydratesandorganicacids(e.g.citrate,picolinicacid,deoxyribose) Yes Yes
DNA Yes Yes
Membranelipids Yes Yes
Looselyboundtoproteins,e.g.albumin Yes Yes
Ironboundtoproteins
(i)Non-haemiron
Ferritin Probablynoa Noa
Haemosiderin Noa Noa
Lactoferrin Noa Noa
Transferrin Noa Noa
Tartrate-resistantacidphosphatased Yes(ifironisreleased) Yes(ifironisreleased)
(ii)Haemiron
Haemitself Yes Probablynoa
Haemoglobin Yes Yes(onlyifironisreleased)
Leghaemoglobin Yes Yes(onlyifironisreleased)
Myoglobin Yes Yes(onlyifironisreleased)
Cytochromec Yes Yes(onlyifironisreleased)
CytochromesP450 Yes,especiallyCYP2E1 Yes(onlyifironisreleased)
Catalase Weaklyb Noc
aUnlessironisreleasedfromitinthereactionmixture. bActivitymaybeduetopartialdegradationofcatalase:catalasesubunitsshowgreaterperoxidaseactivity.
cUnlessenzymeactivityislostandironisreleased. dSeeSections3.22.1.2and3.22.4.2.
iron-dependent lipid peroxidation under certain CYPs and their reductases contribute to microsomal
reaction conditions; examples are Al(III) and Pb2+ lipidperoxidation.
(Section9.16.11).
5.11.8 Accelerationoflipidperoxidationby
speciesotherthanoxygenradicals
5.11.7 Microsomallipidperoxidation
5.11.8.1 Singletoxygen253
Microsomal fractions prepared from plant or animal
tissues undergo rapid lipid peroxidation when incu- Unlike ground-state O 2 , singlet O1 2 (cid:6)g can react with
batedwithFe2+ salts,orFe(III)saltsplusascorbateor carbon–carbondoublebondsbyanenereactiontogive
NADPH. This has been a popular experimental sys- peroxides(Section2.6.4).Forexample,reactionofsing-
tem for decades.251 It is easy to use, but extremely letO 2 withthedoublebondbetweenC12andC13of
complex, in part because ‘microsomes’ are a hetero- linoleicacidgivestwohydroperoxides:
geneous collection of lipid vesicles and contain vari-
able amounts of endogenous antioxidants such as
α-tocopherol and coenzyme Q. In addition, isolated
microsomes may generate ROS much faster than the
ER does in vivo (Section 1.10.6). Often, iron is ad-
ded as chelates with ADP, pyrophosphate, or EDTA.
Duringmicrosomalperoxidation,cytochromesb and
5
P450areattacked,theirhaembeingdegraded.252 Car-
bon monoxide is one product. NADPH-cytochrome
P450 reductase can reduce some Fe(III) chelates, gen- 9-and10-Hydroperoxidesresultwhen1O
2
reactswith
eratingFe2+andstimulatingperoxidation.Henceboth the double bond between C9 and C10. Thus four

--- Page 320 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 265
productsresultwhenlinoleicacidisexposedtosing- Decomposition of these peroxides to alkoxyl or per-
let O . By contrast, free-radical peroxidation of lino- oxyl radicals accelerates the chain reaction of lipid
2
leate gives mainly, but not exclusively, the 9- and peroxidation.256 Decomposition is facilitated by ‘free’
13-hydroperoxides.Strictlyspeaking,singletO isnot metal ions and haem proteins, including haemoglo-
2
initiatingperoxidation;unlesstheperoxidesaredecom- bin, myoglobin, and CYPs (especially CYP2E1). For
posed(e.g.bymetalions)togiveperoxylandalkoxyl example,forFe2+,
radicals,achainreactionwillnotbegin.
H3C H3C
ThelifetimeofsingletO 2 inthehydrophobicinter- Fe2+ + H3C C OOH H3C C O (cid:129) + OH– + Fe(III)
iorofmembranesisgreaterthaninaqueoussolution
H3C H3C
(Section 2.6.4). Hence, illumination of lipids in the
tert-butyl hydroperoxide alkoxyl radical
presenceofsensitizersof1O formationinducesrapid
2
peroxideformation.Suchreactionsareimportantinthe
(cid:129)
eye(Section7.10),inmilkandcheese(Section2.6.4.3), O O H O
and in plants (Section 7.7). Cholesterol within mem- Fe2+ + CH3 C CH3 CH3 C CH3 + OH– + Fe(III)
branescanalsobeoxidizedby1O ,forexampletoits
2
5α-hydroperoxide. Singlet O 2 reacts with membrane cumene hydroperoxide alkoxyl radical
proteinsfasterthanitdoeswithlipids,onaverage(Fig.
Rate constants for the reactions of cumene and tert-
2.14, legend). However, a photosensitizer in a mem-
butylhydroperoxideswithFe2+-ATPareabout3.1×103
branecantargetthedamagetolipidsifitresidesina
and1.3×103M–1s–1respectively.
lipid-richdomain.
Cytochromes P450 can carry out both one-electron
Singlet oxygen can form during lipid peroxidation
and two-electron reductions of organic peroxides,257
andmightthencausemorelipidperoxideformation.
both synthetic peroxides as well as natural fatty-acid
A likely mechanism is the self-reaction of peroxyl
hydroperoxides.Thusforcumenehydroperoxide,one-
radicals (Section 2.5.4), which can be regarded as a
electron reduction of the O–O bond generates the al-
chainterminationreaction,sinceitremovestwoper-
koxylradical.Two-electronreductiongeneratescumyl
oxylradicals. SingletO formationmightaccountfor
2
alcohol (–OOH reduced to –OH) plus a CYP oxo-
someofthechemiluminescencethataccompanieslipid
iron species capable of substrate hydroxylation (Sec-
peroxidation(Section6.15.10),butundermostphysio-
tion 1.4.1), i.e. the peroxide (XOOH below) is being
logical/pathological(unlessphotochemicallyinduced)
used in place of the normal NADPH-dependent sys-
conditions,itscontributiontolipidperoxidationseems
• temthatdrivesP450,
likelytobesmall;theself-reactionofRO isunlikelyto
2
befavoureduntiltheyhaveaccumulatedtosignificant S+XOOH→SO+XOH
levelswithinthemembrane,thatis,untilperoxidation
isalreadyextensive. Thisissometimescalledtheperoxygenaseactivityof
P450s.
5.11.8.2 Reactivehalogenspecies
Cumene and tert-butyl hydroperoxides are widely
HOCl can add on across double bonds of phospho- used as model peroxides to impose oxidative stress
lipidstogivechlorohydrins(Section2.6.3),formchlor- uponcells,becausetheyareeasytoobtainpure.How
amineswithany–NH 2 residuespresent(e.g.onphos- fartheymimictheactionsofthelipidperoxidespro-
phatidylserineand–ethanolamine),andalsoreactwith ducedinvivois,however,uncertain.Nevertheless,they
plasmalogens(Sections5.12.8.1and10.3.5.1).Chlorin- can stimulate peroxidation in vivo, e.g. injection of
ated lipids have multiple effects on cells in culture, tBHP into mice raised the plasma levels of F -IsoPs
2
but their importance in vivo is as yet uncertain.254 (Section5.12.3).258
HOBr can react with lipids to give bromamines and
bromohydrins,evenfasterthandoesHOCl.255
5.12 Lipidperoxidationproducts:bad,
5.11.8.3 Addingorganicperoxidesorazo good,orindifferent?228
initiators
5.12.1 Generaleffects
Anotherwayofstimulatinglipidperoxidationinvitro
is to add azo initiators (Section 2.5.4) or artificial Theoveralleffectsoflipidperoxidationaretodecrease
organic hydroperoxides such as tert-butyl hydrop- membrane fluidity (since PUFAs are oxidized), make
eroxide or cumene hydroperoxide (e.g. Fig. 6.22). it easier for phospholipids to exchange between the

--- Page 321 ---

266 FREE RADICALS IN BIOLOGY AND MEDICINE
two halves of the bilayer, increase the ‘leakiness’ of stress(Section5.6).ThishappensduringCC1 toxicity,
4
the membrane to H O and to substances that do not forexample(Section9.2).
2
normally cross it, other than through specific chan- Peroxyl and alkoxyl radicals, aldehydes, and some
nels (e.g. Ca2+), and to damage membrane proteins, other end-products of peroxidation can damage re-
inactivatingreceptors,enzymes,transportproteinsetc. ceptors, enzymes such as glucose 6-phosphatase, the
Cross-linking of membrane proteins decreases their Ca2+-ATPase of the ER, the Na+, K+-ATPase, and K+
lateral and rotational mobility. Part of the reason for channels. Since K+ channels play an essential role
thesechangesisthatperoxylradicalsandperoxidesare in generation of electrical activity in nervous tissue
morepolarthantheinteriorofnormalmembranes,and and heart, damage to them can result in irregular-
sotendtodistortthestructureasthey‘seek’tobecloser itiesinheartbeat,anddeathofneurons(Section5.3.1).
towater.Thetermlipidwhiskerhasbeenusedtore- Within mitochondria, both matrix enzymes and con-
flectthetendencyoftheseoxidationproductstogather stituents of the electron-transport chain can be dam-
and project out at the membrane surface.259 Indeed, aged,ubiquinonedestroyed,andmitochondrialDNA
thisclusteringmayaidtheirrecognitionbyscavenger attacked. Lipid oxidation in foods can change the
receptors. Some authors have suggested that ‘lipid taste, alter the texture of food proteins, and destroy
rafts’ are artefacts created by light-mediated oxida- essential amino acids.232,262 Thus the ‘classical’ view
tionoflipidsduringtheirobservationbyfluorescence of lipid peroxidation is that it is a bad thing that
microscopy.260 we need to prevent. However, let us look in more
Rises in Ca2+ induced by oxidative stress can ac- depth at the biological properties of the products of
tivate phospholipase A , which releases arachidonic peroxidation.
2
acid from membrane phospholipids (Section 5.3.2.2);
thefreearachidonicacidmightthenundergolipidper-
5.12.2 Lipidhydroperoxides
oxidationandcanalsostimulateeicosanoidsynthesis, (ROOH)227,228,248,263
apathwaythatisitselfintimatelylinkedtolipidper-
oxidation (Section 8.12). The lysophospholipids that Oraladministrationoflargedosesofperoxidizedlip-
phospholipase A action leaves behind in the mem- ids to animals causes some injury, including heart
2
branehavemilddetergent-likeeffectsandcancontrib- damage in rats, ‘fatty liver’ in rats and rabbits, and
ute to membrane disorganization if they accumulate damage to the pancreatic β-cells or to the immune
in large amounts. Phospholipase A can also cleave system in mice. Spin-trapping has been used to de-
2
oxidized arachidonic acid residues from membranes tectlipid-derivedradicalsinsuchanimals(Section6.2).
and may show some degree of selectivity for them, Overall,however,theirtoxicityislow,andanimalscan
althoughitsdegreeof‘preference’isuncertain.261Per- tolerate moderate amounts of oxidized lipids in the
oxiredoxin6hasassociatedphospholipaseA activity diet,264 although pregnant animals might be more at
2
(Section 3.13), which may be especially important in risk.265 Typical intakes in the human diet are about
thelung(Section7.3). 1.5 mmol/day, which seems to pose little risk.266,267
Continued oxidation of fatty-acid side-chains, and Indeed, the toxicity to animals may not be due to
theirfragmentationtoproducealdehydesandhydro- lipidperoxidesatall,buttocarbonylsformedasthey
carbons (Section 5.12.5), will eventually lead to loss decomposeinthestomach.268
of membrane integrity. For example, rupture of lyso- Oxidized lipids can have effects on cells similar
somal membranes will spill hydrolytic enzymes and to those of H O (Section 5.2); low levels can stim-
2 2
ironionsintotherestofthecell.Peroxidationoferyth- ulate proliferation, higher levels block proliferation,
rocytemembranescausesthemtolosetheirabilityto andyethigheronesinduceapoptosisandnecrosis.269
changeshapeandsqueezethroughthesmallestcapil- Such events occur in atherosclerotic lesions (Sec-
laries (Section 7.4). Loss of viability of spermatozoa tion10.3)andmaybeinthegastrointestinaltract(Sec-
on prolonged incubation at 37◦C can involve lipid tion 7.2). Certain products of lipid peroxidation can
peroxidation(Section7.11),ascanthelossoftheger- have specific biological effects. For example, some
minatingabilityofseedsstoredunderpoorconditions mimictheactionsofplateletactivatingfactor(PAF,1-
(Section8.11.5).Insomebacteria,theDNAisclosetoor O-alkyl-2-acetyl-sn-glycero-3-phosphocholine), a pro-
attachedtothecellmembraneanditcanbedamaged inflammatory phospholipid that can be synthesized
during peroxidation. Damage to ER or Golgi appar- by several cell types, including leukocytes, platelets,
atus by peroxidation will decrease the ability of cells and endothelial cells. PAF exerts effects at concentra-
tofold,glycosylate,andexportproteins,leadingtoER tions in the 10–10M range: they include activation of

--- Page 322 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 267
phagocytes,plateletaggregation,andmarkedvascular (Section 6.15.6). They are prostaglandin-like com-
(e.g.hypotension)andbronchialeffects.AlthoughPAF poundsformedfromtheperoxidationofPUFAswith
is useful at physiological levels, its overproduction at least three double bonds, including linolenic acid
contributestotissueinjuryinseveraldiseases,includ- (1-series IsoPs, sometimes called phytoprostanes),
ingasthmaandischaemia–reperfusion.Oncesecreted, arachidonic acid (2-series IsoPs), EPA (3-series
PAF is rapidly destroyed by PAF acetylhydrolase,270 IsoPs), and DHA (4-series IsoPs, sometimes called
anenzymepresentwithinplasmalipoproteins(mostly neuroprostanes,NPs)(Figs.5.21to5.24).
LDL). Peroxidation of phosphatidylcholine can gen- IsoPsareusuallygeneratedinvivofromPUFAses-
erate fragments that bind to PAF receptors on tar- terified to phospholipids in membranes and plasma
get cells and exert PAF-like activity. Some of these lipoproteins(a differencefrom prostaglandins, which
phospholipid fragments are also substrates for PAF are usually generated by COX enzymes from free
acetylhydrolase.270 PUFAs). Increased formation of IsoPs is observed in
Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3- manysystemsundergoingoxidativestress,suchasin
phosphorylcholine (ox-PAPC) can stimulate cytokine multiple human diseases (Chapter 10) and after ex-
productioninendothelialcells,butontheotherhand posure to a range of toxins (Chapter 9), including in
it can inhibit activation of NF-κB by endotoxin and mice injected with tert-butylhydroperoxide, as men-
thussubsequentcytokineproduction,i.e.itcanbeanti- tioned earlier.258 F2-IsoPs were the first class to be
inflammatory under some circumstances. It can also discovered and are still the most studied. Sixty-four
enhancetheactivitiesoftightjunctions,improvingthe isomersexist.F -IsoPscanbereleasedfromlipidsby
2
endothelialcellbarrierfunction,andraisethelevelsof lipases, including PAF acetylhydrolase.270 Free IsoPs
HO-1inendothelialcells.Indeed,intraperitonealinjec- turn over rapidly; their half-life in human blood is
tion of ox-PAPC allowed mice that had been treated less than 20 minutes. They are both excreted (in part
withanormallylethaldoseofendotoxintosurvive.271 as conjugates with glucuronic acid)273 and metabol-
Basedonthis,therehaveevenbeenattemptstouseoxi- ized. For example 15-F
2t
-IsoP (8-iso PGF 2α) under-
dizedlipidsastherapeuticagents!(Section11.5.11)Sev- goes β-oxidation and reduction in humans to 2,3-
eralperoxides,andsometimesproductsderivedfrom dinor-5,6-dihydro-15-F -IsoP, which is also excreted
2t
them, e.g. HNE (Section 5.12.5.3), IsoPs, and cyclo- in urine; another metabolite is 2,3-dinor-15-F -IsoP
2t
pentanonecompounds(Section5.12.3)canactivatethe (Fig.5.21).
Nrf2 system (Section 5.5.8) and raise cellular antioxi- F -IsoPshavebiologicaleffects,e.g.15-F -IsoPand
2 2t
dant defences such as GSH and HO-1 e.g. oxidized its major metabolite 2,3-dinor-5,6-dihydro-15-F -IsoP,
2t
dietarylipidsmightdosomegoodbyraisingantioxi- are powerful vasoconstrictors. These molecules also
dantdefencesinintestinal(orliver)cells.272 Peroxides exertvasoactiveeffectsinthelung,274 actingasendo-
canalsoinactivatephosphotyrosinephosphatases,and thelial ‘contracting factors’. These biological effects
it is conceivable that localized inactivation could fa- are due to binding of F -IsoPs to eicosanoid recep-
2
cilitate redox signalling in membranes. Lipid oxida- tors,particularlythethromboxane(TP)receptor.Renal
tioncanalsofacilitatetheremovalofunwantedcells, vasoconstriction due to elevated F -IsoPs may con-
2
e.g. after apoptosis (Section 5.4). Some lipid oxida- tribute to the pathology of hepatorenal syndrome, a
tion products are recognized by the immune system usually fatal disorder in which kidney failure devel-
andantibodiescandevelopagainstthem(Sections10.3 opsinpatientswithsevereliverdisease.27515-F -IsoP
2t
and10.10). also promotes bone resorption, affects platelet aggre-
Hence, several lipid oxidation (and nitration: Sec- gation induced by ADP or collagen, may provoke
tion 2.6.1.3) products act as signalling molecules and proliferation of smooth muscle cells (e.g. during ath-
their actionsare notalways bad. More such roles are erosclerosisorairwayremodellingduringasthma)274,
beingdiscovereddaily. isinvolvedinthetoxicityofhighglucoselevelstoem-
bryos(Section7.11.7),andcanpromotefibrogenesisin
liver(Section9.8.1.5).
5.12.3 Isoprostanes,isoketals,
Other classes of IsoPs are also formed and
andcyclopentenonecompounds227,243
Figure 5.22 attempts to summarize these different
Isoprostanes (IsoPs) are important products of groups of molecules. The levels of O 2 and thiols
lipid peroxidation, and their measurement is the influence the relative amounts of the various prod-
best currently available assay of lipid peroxidation ucts generated. D- and E-ring IsoPs are formed by

--- Page 323 ---

268 FREE RADICALS IN BIOLOGY AND MEDICINE
rearrangement of the cyclic peroxide precursors. 15- molecules (phytoprostanes) have been described in
E -IsoP exerts vasoconstrictive effects similar to 15- plants(Section7.7).F -IsoPshavebeenmeasuredina
2t 3
F -IsoP.D/E-IsoPsarelesschemicallystablethanthe fewstudies(Sections6.15.6and11.4.8).
2t
F -IsoPs.Dehydrationofthesemoleculescangenerate
2
A- and J- (cyclopentenone) IsoPs, which are power-
5.12.4 Cholesteroloxidationproducts
ful electrophiles, highly reactive with –SH groups
(COPs)227,253,278
(Fig. 5.22) that can be cytotoxic. They may not be
all bad, however, since they can damp down the in- Cholesterolinmembranesandlipoproteinscanbeoxi-
flammatory response in several systems and activate dizedphotochemicallyandduringlipidperoxidation,
the heat shock and Nrf2 responses. Isoketals (also generating a mixture of products (Fig. 5.25). Cho-
referredtoasisolevuglandins)canformviarearrange- lesteryl esters can be oxidized on the ring and/or on
ment of the PGH 2 -like precursors: isoketals combine theesterifiedfattyacid(givinghydroperoxides,IsoPs
rapidlywith–NH 2 groupsandformadductswithly- etc.), and some of these COPs have been detected
sine residues on membrane proteins or –NH 2 groups in human plasma or tissue samples (Section 6.15.5;
onphosphatidylethanolamine.InitiallyaSchiffbaseis Chapter 10), e.g. from atherosclerotic lesions, and
formed,whichthendehydratestoapyrroleandreacts brain.Theymayalsoplayaroleinfattyliverdisease
withO 2 toformlactamandhydroxylactamstructures. (Section 9.8.1.6). Reaction of singlet O 2 with choles-
Proteincross-linkingcanalsoresult.Henceduetotheir terolyieldsprimarilythe5α-hydroperoxide(Fig.2.14).
electrophilicity, both isoketals and the cyclopenten- Bycontrast,oxidationoftheringcanoccurbyH• ab-
one IsoPs can damage membrane proteins in vivo, straction(e.g.byRO • orOH•),usuallyatcarbon-7be-
2
cross-linkingthelipidscontainingthemtomembrane causetheC–Hbondthereisrelativelyweak.Hydrogen
proteins.Isoketal–proteinadductshavebeendetected abstraction is followed by O addition to give hy-
2
at μM levels in human plasma as well as in tissues. droperoxycholesterolsthatarereducedinvivo(e.g.by
Isoketals have been implicated in pulmonary O
2
tox- PHGPx,Section3.14)to7α-and7β-hydroxycholesterol.
icity (Fig. 6.18) and in the pathology of hypertension Some7α-and7β-canalsoconvertto7-ketocholesterol,
(Section8.10.4). which eventually results in formation of cholesterol
InadditiontotheIsoPs,anotherclassofcompounds, epoxides. 7-α-Hydroxycholesterol can also be gener-
termed isofurans (IsoFs) due the presence of a tetra- ated by CYP7A1 action on cholesterol, however, and
hydrofuran ring in the structure, are formed when a so the 7β-form may be a more reliable biomarker of
monocyclicperoxideradical(Fig.5.23)reactswithO 2 . non-enzymiccholesteroloxidation.
At physiological O 2 levels, IsoPs are major products Reports on the cytotoxicity of COPs are conflict-
of lipid peroxidation, while in settings of hyperoxia, ing,possiblybecausemanystudieshaveusedcomplex
IsoFs can predominate (Section 6.15.6). In patients mixtures rather than single products. For example,
with severe sepsis, development of renal failure was oxidationproductsofcholesterolhavevariouslybeen
closely correlated with plasma levels of F 2 -IsoPs and claimedtostimulateortosuppressatherogenesis.Sev-
isofurans.276 eral studies on isolated cells show that COPs can
PUFAs having three or more double bonds can decrease cytokine production induced by endotoxin
be oxidized to yield IsoPs by the same mechanisms treatment,apparentlybydecreasingNF-κBactivation;
as arachidonic acid. Neuroprostanes, from DHA, are butothersreportpro-inflammatoryeffects.
formed in increased amounts in some neurodegen- Cholesterol can also be oxidized in foodstuffs, and
erative diseases (Section 10.19). Because DHA has someoftheCOPscanthenbeabsorbedbythegastro-
moredoublebonds,eightregioisomerscanbeformed intestinal tract.278 It can also be attacked by HOCl
(Fig. 5.24). In addition E 4 - and D 4 -NPs can form, (formingchlorohydinsandotherproducts),andbyO 3 ,
although at lower levels, as well as cyclopenten- which adds across the double bond. The trioxolane
one structures (A 4 /J 4 neuroprostanes), isoketal-like so generated decomposes into a range of products
compounds (neuroketals), and IsoFs (neurofurans). such as the secosterols. Plant sterols (phytosterols)
Similar products can form from EPA. F 2 -dihomo- also undergo oxidation to POPs (phytosterol oxida-
IsoPs can arise from adrenic acid, another PUFA tion products). Since phytosterols are now being ad-
found in the brain (C 22:4 , n-6).277 In animal research, dedtomanyfoodstuffsthepossiblebiologicalconse-
less attention has been given to the two classes of quencesoftheiroxidationproductsprobablydeserve
IsoPs that arise from linolenic acid, although these moreattention.278

--- Page 324 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 269
OH
HO
27-hydroxycholesterol
CYP27A1 HO OH
ROS
HO O 7α-hydroxycholesterol
7-ketocholesterol
ROS
*
HO
ROS
Cholesterol
ROS
HO OH LOOH
HO
O
7β-hydroxycholesterol Cholesterol-5β,6β-epoxide
HO O
Cholesterol-5α,6α-epoxide
Figure5.25 Someofthemajorcholesteroloxidationproducts(oxysterols)foundinvivo.Whereas27-hydroxycholesterolarisesenzymaticallyvia
theactionofcholesterol27-hydroxylase(CYP27A1),theotherspeciesareproductsofnon-enzymaticcholesteroloxidation.7α-and
7β-hydroxycholesteroland7-ketocholesterolaremorestableproducts,arisingfromtheprimarycholesteroloxidationproduct
7-hydroperoxycholesterol.AdaptedfromCurr.Opin.Lipidol.23,462,2012,bycourtesyofDrVesaOlkkonenandWoltersKluwerHealth.Alsosee
Chem.Phys.Lipids164,457,2011.In7-dehydrocholesterolanextradoublebondispresentat.*
7-Dehydrocholesterol is much more susceptible to ketones (e.g. butanones, pentanones, octanones), and
oxidation than cholesterol itself. In Smith–Lemli– hydrocarbons.281ThermalhomolysisoftheO–Obond
Opitz syndrome (SLOS), the reductase that converts yieldsradicals,thatcanattackotherPUFAs,
ittocholesterolisdefectiveand7-dehydrocholesterol
and its oxidation products accumulate. These may ROOH→RO • +OH •
contribute to the neurological deficits and congenital
Cleavage of aldehyde, hydrocarbon, or other frag-
malformationscharacteristicofthisdisorder.280
mentsfromperoxidizedlipidsstillleavesanoxidized
fragmentattachedtotheparentlipidbyanesterbond.
5.12.5 Decompositionproductsoflipid
5.12.5.1 Ethaneandpentane
peroxides:yetmorebioactiveproducts
Metalions(especiallyironandcopper)andhaempro-
Decomposition of lipid peroxides by metal ions or teinscancausehydrocarbonformationfromperoxides.
by heating (e.g. of oxidized cooking oils) generates Forexample,ifFe2+reactswithahydroperoxideonthe
a hugely complex mixture of products, including ep- fifthcarbonfromthemethylendofaPUFA,pentane
oxides, saturated aldehydes (e.g. hexanal), unsatur- can be produced. This can happen with linoleic and
ated aldehydes such as trans, trans-2,4-decadienal, arachidonicacids,

--- Page 325 ---

270 FREE RADICALS IN BIOLOGY AND MEDICINE
Malondialdehyde also reacts with DNA bases
(Fig. 5.27) and can introduce mutagenic lesions.
Guanineisapreferredtarget.IfDNApretreatedwith
MDAisexpressedinE.coli,aboutatenfoldincreasein
mutationfrequencyisobserved:G→Ttransversions,
A → G transitions, and C → T transitions are pre-
dominant, but some frameshifts and deletions occur.
SuchDNAisalsomutagenicinhumancells,causing
large insertions and deletions, as well as base-pair
substitutions.282,283
Malondialdehyde is rapidly metabolized in mam-
Ethane(C H )andethylene(ethene,H C=CH )gases maliantissues.Aldehydedehydrogenasesoxidizeitto
2 6 2 2
are produced in similar reactions from linolenic acid. malonicsemialdehyde,whichdecarboxylatestoacetal-
Formation of these gases has been used to measure dehyde,inturnoxidizedbyaldehydedehydrogenases
lipidperoxidation(Section6.15.9). toacetate.
5.12.5.3 4-Hydroxy-2-trans-nonenal(HNE),
5.12.5.2 Malondialdehyde194,281,282
acrolein,andotherunsaturated
Malondialdehyde(MDA),sometimescalledmalonal- aldehydes194,248,281,284,285
dehyde,wasafocusofattentioninlipidperoxidation
HNE is formed during the peroxidation of n-6 PU-
for years, because it was commonly thought that the
FAs, such as arachidonic acid. It is one of many un-
widelyusedthiobarbituricacid(TBA)assaymeasures
saturated aldehydes (alkenals) formed during lipid
freeMDA.Sadly,thisisnotquitetrue(Section6.15.8).
peroxidation; others include decadienal and trans-4-
Also, MDA toxicity was over-estimated; it is less
hydroxy-2-hexenal(HHE),whichisparticularlydam-
reactive than HNE (Section 5.12.5.3), and much less
aging to mitochondria. Indeed, HHE is the ultimate
so than the levuglandins (Section 8.12.7) or isoketals
toxicproductformedintheliverduringthemetabol-
(Section5.12.3).Nonetheless,itspotentialtoxicityand
ismofpyrrolizidinealkaloidssuchassenecionine,286
immunogenicity (i.e. MDA-protein conjugates can
which are found in several plants that can poison
provokeanimmuneresponse)inbiologicalsystemsis
livestock. Linoleic acid oxidation during the brew-
wellestablished.
ing of beer can generate trans-2-nonenal, excess of
Malondialdehyde arises largely from peroxidation
which (plus other aldehydes) leads to a stale, ‘card-
ofPUFAswithmorethantwodoublebonds,suchas
board’ flavour of the beer.287 The ‘fishy aftertaste’
linolenic,arachidonic,anddocosahexaenoicacids,of-
causedbyco-consumingseafoodandcertainredwines
tenviabicyclicendoperoxides(Fig.5.23),butsomeis
(Section 5.11.6.1) involves a range of volatile alde-
formed enzymatically during eicosanoid metabolism
hydes,includinghexanal,heptanal,nonanal,decanal,
(Fig. 8.22a). It exists in various forms, depending on
and heptadienal.249 The oxidized oils found in some
pH (Fig. 5.26). At physiological pH most ‘free’ MDA
breast implants (Section 5.11.1) were rich in MDA,
existsasanenolateanion,whichhaslowreactivityto-
andHNEwasalsopresent.229 Sometimestheflavours
wardsaminogroups.AspHfalls,reactivityincreases
that develop as a result of lipid oxidation and alde-
andproteinscanthenbeattackedbyMDA,resultingin
hydeformationaremorepleasant,e.g.intheageingof
modificationofseveralresidues(especiallylysine)and
Parmaham.288
formationofintra-andinter-molecularcross-links,

--- Page 326 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 271
H H
O C CH 2 C O HO CH CH CHO –O CH CH CHO
keto enol enolate
anion
H H
C H H C H
O C C C
H C O O
O H
H H
O O
cyclic form H C C C H
H
HO O
O
C
H
+MDA O OH
O O
H
O H HO C H H C H
HO C C C +MDA HO C C C C C H –H 2 O HO C C C C C H
H H H H H H H
O O
+MDA
–H O
2
O
O
H C H
HO C C C H
C C C C
H H H C H
O
Figure5.26 Structuresofmalondialdehyde(MDA)inaqueoussolution.Top:atneutraloralkalinepH,99%ofMDAistheenolateanionwhereas
atacidicpHitexistslargelyastheundissociatedenolform,β-hydroxyacrolein,inequilibriumwiththeketoform.Intramolecularhydrogenbonds
favourformationofacyclicstructure,whichcandimerize.Bottom:likemostaldehydes,MDAinaqueoussolutionispronetoaldolcondensations
whichproducedimers,trimers,andlargepolymers,manyofwhicharefluorescent(excitationat365–395nm,emissionat490nm).Abstracted
fromFreeRadic.Biol.Med.11,81,1991,bycourtesyofthelateProfessorHermannEsterbauerandElsevier.
Hydroxyalkenals owe their chemical reactivity to effectsatdifferent‘levels’ofadditione.g.tocellsincul-
three main features: the aldehyde group, the double ture;howmuchisactuallyfreeandhowmuchbound
bond, and the –OH group (Fig. 5.28). Their ability to to biomolecules? For example, HNE added to blood
react rapidly with thiol groups at physiological pH plasma (where GSH levels are low) rapidly binds to
accounts for much of their cytotoxicity. For example, –SH groups on albumin, a reaction which may serve
GSH reacts with HNE to form a saturated aldehyde, to protect more important proteins (Section 3.23.3.5).
followedbyanintramolecularrearrangementtoyield Within cells, GSH levels are high and much of any
afive-memberedring(Fig.5.28).Thiolgroupsonpro- HNEgeneratedprobablyreactswithit.Nevertheless,
teinsaswellasaminogroupsonDNAbases(Fig.5.27), fatty acid binding proteins, found in several tissues
proteins (e.g. on lysine residues; histidine can also (e.g.theeye;Section7.10.2.2),havealsobeensuggested
beattacked),andphospholipids(phosphatidylethano- to help absorb HNE and protect other cell constitu-
lamine and phosphatidylserine) can react with HNE. ents. Consistent with this, the one present in adipo-
However,levuglandinsandisoketalsreactevenfaster cytes is heavily adducted by HNE in obese mice.289
withproteinsthandoesHNE. Etheno-adductsformedbyHNEinDNA(Fig.5.27)are
When HNE is generated in vivo, it rapidly reacts mutagenicbutcanberemovedbyBERandNER(Sec-
withproteinsandotherbiomoleculescontaining–NH tion5.10.3).HNE–,MDA–andotheraldehyde–protein
2
or –SH groups and does not stay ‘free’; this is one adducts can act as antigens in vivo and provoke an
problem in assessing the biological significance of its immuneresponse,e.g.inatherosclerosis(Section10.3).

--- Page 327 ---

272 FREE RADICALS IN BIOLOGY AND MEDICINE
(a) (b) O N
O N
N
HN
N N N dR
N dR
CH N
N
C CH H
O
M1G N2-Oxopropenyl-dG
(c) (d) H3C
OH O
CH2
CH2
N
N CH2
CH2
H3C CH2 CH2 CH2 CH2 CH N N N HO CH CH OH O
H dR
OH N N
N N N
H dR
Figure5.27 ReactionofcytotoxicaldehydeswithDNAbases.194ThemajorproductofreactionofMDAwithguanineinDNAatphysiologicalpH
is(a)pyrimido[1,2-α]purine-10(3H)-one(M1G),shownasanucleosideM1dG(dR=deoxyribose).Thisproducthasbeenidentifiedinrodentand
humanDNAatlowlevels.M1GundergoesringopeningtoN2-oxopropenyl-dG(b)whenpositionedoppositeCindouble-strandedDNA(J.Am.
Chem.Soc.126,8237,2004).M1GcanalsobeformedinDNAfrombasepropenalsgeneratedbyoxidationoftheC4siteondeoxyribose,for
examplebyOH•,i.e.itisnotaspecificmarkerofMDAdamagetoDNA(J.Biol.Chem.283,15545,2008).Hydroxynonenalreactswithallfour
DNAbases,butGisapreferredtarget,anNH2groupaddingtothedoublebondofthealdehydetogive1,N2-propano-2’-deoxyguanosine
adducts(c).Acroleincangenerateasimilaradduct.Asubstituted1,N2-ethenodeoxyguanosine(d)isalsoformedinsmalleramountson
reactionwithHNE;itsformationisfavouredbythepresenceofhighlevelsofH2O2.Nucleotideexcisionrepairisneededtoremovetheseadducts
fromDNAsincetheyaremutagenic(FreeRadic.Res.46,442,2012).AdductsofDNAbaseswith4-oxononenaland4-oxohexenalhavealsobeen
reportedinhumantissues(Chem.Res.Toxicol.23,1442,2010).
TheeffectsofHNEoverawiderangeofconcentra- 3. 1μMorlower:mayrepresentbasallevelsofHNE
tionshavebeenstudiedoncellsinculture. inhealthytissues(althoughprobablyprotein-bound
ratherthanfree).Invitro,lowμMlevelsofHNEcan
1. 100 μM or above: toxic to most cell types, cause stimulatephagocytechemotaxisandtheactivitiesof
mitochondrialdamage,ERstress,andcelldeath(of- severalreceptorsandenzymes,includingphospho-
tennecrotic).Theselevelsaregenerallyabovethose lipase C, PDI, and protein kinase C. Indeed, HNE
thatcanoccurinvivoandthusoflimitedrelevance, can lead to increased synthesis of Hsp (including
althoughhighlevelsmightconceivablyaccumulate HO-1),andcanactviamodificationofKeap1toac-
invivoatlocalizedsitesofintenselipidoxidation. tivate Nrf2 (Section 5.5.8), thus elevating GST and
2. 2to20μM:inhibitDNAandproteinsynthesis,gen- γ-GCSactivitiesandGSHlevels.Hence,alowlevel
erally inhibit cell proliferation and toxic to many ofHNEcansometimesinduceresistancetohigher
cells (especially neurons, e.g. HNE has been im- levelsappliedsubsequently.Likemostproductsof
plicated in stroke and neurodegenerative diseases; lipidperoxidation,HNEcanbegood,bad,orindif-
Sections 10.17 to 10.21), may also inhibit nucle- ferentdependingontheamountpresent,howlong
otideexcisionrepair.Caninduceapoptosisinsome itistherefor,andthebiologicalsystembeingstud-
cells.CaninhibitPARP-1,chaperoneaction(e.g.of ied. One example, low levels of HNE have been
Hsp72),andcertainCYPs,forexampleCYP2E1and implicatedinliverfibrosis(Section9.8).
CYP1AI and the synthesis of tetrahydrobiopterin
insomeendothelialcells.SuchHNEconcentrations Cells can catabolize HNE. It can be reduced to an
maybeachievableinvivoduringoxidativestress. alcohol by aldose reductase, oxidized to a carboxylic

--- Page 328 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 273
Lipid peroxidation
Degradation Degradation
OH H
RCH OH Reduction Oxidation RCOOH
2
4-hydroxynonenol CH 3 (CH 2 ) 4 CH–CH=CH–C 4-hydroxy-2-
nonenoic acid
O
4-Hydroxy-2-nonenal (HNE)
GSH
non-enzymic,or –NH2
GST-catalysed binding
Michael addition
DNA adducts
H C(CH ) CH–CH–CH CHO
3 2 4 2
OH SG Protein adducts
Phospholipid adducts
(Addition of –NH2
to double bond, or Schiff
Cyclization base formation with–CHO
group)
GS
CH CH
2
H C (CH ) CH C H
3 24 O OH
HNE mercapturic acid conjugate
(potential urinary biomarker of bodily
HNE production; Section 6.15.7)
Figure5.28 Toxicityandmetabolismof4-hydroxynonenal.Notethattheexcretedmercapturicacidproductmayrepresentonlyaminorproduct
ofHNEmetabolism(FreeRadic.Biol.Med.70,78,2014).
acidbyaldehydedehydrogenases(Fig.5.28),orform pro-inflammatorystateandincreasedoxidativedam-
GSH conjugates, both nonenzymically and catalysed age(Section10.4).
bycertainGSTs,especiallyGSTA4-4.290Indeed,knock- The GSH conjugates are degraded to mercapturic
outofthegeneencodingGSTA4-4inmiceraisedtissue acidsandexcretedinurine.Aldehyde–thiolconjugates
HNElevelsandthemicedevelopedage-relatedobes- are in general much less toxic than the parent alde-
ityandeventualinsulinresistance.RaisingHNElevels hydes, although not always harmless: they may be
in C. elegans also increased fat accumulation.290 This somewhat toxic in their own right and/or act as a
mayberelevanttohumans,sinceHNElevelsinblood ‘reservoir’thatslowlyreleasesHNE.
and muscle of obese subjects are reported to be ele- Acrolein, H C=CHCHO, is formed during lipid
2
vated.Itisincreasinglyrealizedthatobesityinvolvesa peroxidationandreactsreadilywith–SHgroups,and

--- Page 329 ---

274 FREE RADICALS IN BIOLOGY AND MEDICINE
with –NH groups on proteins and DNA bases, es- 5.12.8 Lipidsasantioxidants?
2
pecially guanine. It can also combine with histidine.
A completely opposite view to the classic one that
Acroleinisneurotoxic(Section10.18.3)anditsreaction
lipidoxidationproductsareharmful(Section5.12.1)is
withDNAbasesisfasterthanthatofHNE.However,
thatPUFAsareantioxidants,abletoabsorbdamaging
acrolein does not only arise from lipid peroxidation;
RS and protect other biomolecules, and in the pro-
it is a product of oxidation of allyl alcohol by alde-
cessgenerate‘signallingmolecules’(aldehydes,cyclo-
hyde dehydrogenase (Section 9.8.2), of spermine by
pentanoneIsoPs,hydroperoxides,neuroprostanesetc.)
spermineoxidase(Section10.18.3),andfromoxidation
thatupregulatedefencesystemsandsometimesactas
of the amino acid threonine by the myeloperoxidase-
alarmsignals.Thetruthislikelytobesomewherebe-
H O–Cl–system(Section5.13.4.6).282Acrolein-derived
2 tweentheseextremes.However,theplasmogenshave
products are readily detected in rodent and human
alreadybeenproposedtobe‘antioxidants’.
urine(Section6.15.7).
5.12.8.1 Theplasmalogens293
5.12.6 Peroxidationofothermolecules Plasmalogensarecholine-orethanolamine-containing
phospholipidsthathaveanetherratherthananester
PUFAsarenottheonlymoleculesthatcontaindouble bond at C1 of theglycerolbackbone (Fig. 5.29). They
bonds and can be oxidized. Carotenoids can (Sec- are found in bacteria and animals, e.g. in the mem-
tion 4.4.3.2). Retinal can be oxidized in the eye (Sec- branesofredbloodcells,heart,sperm,andespecially
tion7.10).Theretinalprecursorretinol(vitaminA)can
undergoperoxidationanddegradation,291ascansome
antibiotics that contain double bonds (Section 9.17). +
Indeed, retinol at high levels may be pro-oxidant H 3 N O O –
(Section4.4.3). O P
O
O 3
2
5.12.7 Repairingoxidizedlipids? O 1
Formation of peroxides in the membrane causes re- O
arrangementasthesemore-polarspeciesmovetothe
surface (Section 5.12.1). They can then be cleaved by
phospholipaseA (PLaseA )inthepresenceofCa2+,
2 2
whereupon the released fatty-acid peroxides can be
acteduponbyGPx1.Alternatively,peroxidescanbere-
ducedtoalcohols(whicharealsopolarmolecules)by
PHGPx (Section 3.14). PAF acetylhydrolases (Section
5.12.2) can remove aldehyde residues from partially
oxidized phospholipids. Of course, most lipids turn
over rapidly in vivo and so oxidized ones (or the al-
coholproductsoftheirreduction)tendtobereplaced
quickly, which may be more important than ‘repair’
processes.
Whenphosphatidylcholinehydroperoxideisadded Plasmenyl-glycerophospholipid
tohumanplasma,itisreducedtothealcohol,despite Hexadec-1-enyl-2 arachidonoyl-sn-
thefactthatplasmaGPxhasalmostnoGSHavailable glycero-3-phosphoethanolamine
to it (Section 3.14). One enzyme contributing to loss
Figure5.29 Anexampleoftheplasmenylglycerol-based
ofthehydroperoxideislecithincholesterolacyltrans-
phospholipidsfoundinmembranes.Plasmenylspeciesarecommonly
ferase(LCAT),foundinHDL.Thisenzymereversibly
referredtoasplasmalogens,withacisdoublebondadjacenttothe
transfersfatty-acidside-chainsfromphospholipidsto
Oatomoftheetherlinkagetoglycerol.Plasmalogensformabout
cholesterol,generatingcholesterylestersforstoragein 15–20%oftotalphospholipidsinmanycellmembranesandareabout
theHDLcore.Itappearstoreducethephosphatidyl- 5%ofphospholipidsinhumanlipoproteins.FromChem.Res.Toxicol.
cholinehydroperoxidetoanalcohol,whilstgenerating 14,463,2001,bycourtesyofDrR.C.MurphyandtheAmerican
acholesterolesterhydroperoxide.292 ChemicalSociety,alsoseeCurr.Med.Chem.16,2021,2009.

--- Page 330 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 275
the brain (Section 10.17.6.9). Cells lacking them are peptide/proteinsamplesformassspectrometrycanbe
more rapidly killed by oxidative stresses, including affected by protein oxidation,295 sometimes even by
generation of singlet O by photosensitization. The ambient O levels (Section 2.6.5). Oxidation of food
2 3
doublebondnexttotheethergroup(Fig.5.29)appears proteins,ortheirmodificationbyend-productsoflipid
to be attacked especially rapidly by RS such as sing- peroxidation,canimpairfoodquality.232,296
let O , O , HOCl, and HOBr, perhaps thus ‘sparing’
2 3
othermembranelipids.Theproductsdecomposerap-
5.13.2 Howdoesproteindamageoccur?297
idlyintospeciesthatdonotappeartopropagatelipid
peroxidation.Peroxisomalenzymesareinvolvedinthe Damagetoproteinscanoccurbydirectattackofcertain
synthesisofplasmalogens,soitcanbeimpairedifthere radicals (OH• being the most reactive) or nonradical
aredefectsinperoxisomes. RS (e.g. HOCl, ONOOH), or by ‘secondary damage’
However,thecellularconsequencesofplasmalogen involving reaction with end-products of lipid perox-
oxidation(e.g.dotheyformreactivealdehydes?)need idation, such as isoketals, MDA, and HNE. Proteins
to be better understood before this can be truly de- canalsobedamagedbyglycation/glycoxidation(Sec-
scribedasanantioxidanteffect.Reactivechlorineand tion10.5).Someprotein‘damage’isreversible,suchas
brominespeciescanoxidizeandhalogenatemembrane disulphidebondgeneration,sulphenicacidformation
plasmalogens,producingchloro-andbromoaldehydes (Section3.13),methioninesulphoxideformation(Sec-
thathavebeensuggestedtobechemotacticagentsfor tion5.14.1),S-nitrosylation(Section2.5.6),destruction
phagocytes.254 ofFe–SclustersbyO •– (Section3.9),glutathionylation
2
(Section 3.11) and, possibly, nitration (Section 6.6.2).
Other damage, such as oxidation of amino acid side-
5.13 Mechanismsofdamagetocellular
chains or cleavage of the peptide backbone, may be
targetsbyoxidativestress:protein
irreversible,andtheproteinthenhastobedestroyed
damage
and replaced. Oxidative damage to DNA (via muta-
tion) and RNA (via mistranslation) can also result in
5.13.1 Doesproteindamagematter?
faultyproteins.
Oxidative protein damage occurs during X-ray crys- Increased oxidative protein damage levels in vivo
tallography (Section 9.20). It is also important in vivo havebeenassociatedwithmultiplediseases,including
becauseitcanimpairthefunctioningofreceptors,anti- cancer,sarcopenia,heartfailure,andautoimmunedis-
bodies, signal transduction proteins, enzymes, struc- orders (Chapter 10). In addition, oxidative stress can
tural,andtransportproteins.Forexample,hyperbaric prevent protein synthesis by targeting initiation fac-
O damage to E. coli involves inactivation of specific tors, such as initiation factor 2, which is inactivated
2
enzymes (Section 1.5). Protein damage can lead to byphosphorylationpromotedbyoxidativestress.For
secondary damage to other proteins and other bio- example, its inactivation plays a role in the ER stress
molecules, e.g. by raising Ca2+ levels and activating response(Section5.6).Thisresponsemayhelptode-
calpains, NOS, nucleases, or lipases (Section 5.3.2). crease bulk protein synthesis under oxidative stress
Oxidative damage to DNA repair enzymes can de- conditions, so as not to flood the cell with damaged
crease their activity, raise oxidative DNA damage proteins,andperhapsallowtimeforareprogramming
levels,andincreasemutationfrequency,whereasdam- of protein synthesis in favour of making heat shock
age to DNA polymerases may decrease their fidelity proteins, antioxidant enzymes etc.298 On the other
in replicating DNA. Oxidized or aldehyde-modified hand, oxidative protein damage can impair protein
proteins can be recognized as ‘foreign’ by the im- turnovermechanisms(Section5.14.3.2).
munesystem,triggeringantibodyformationandper- When cells are subjected to oxidative stress, prote-
hapsautoimmunity,e.g.inatherosclerosis,rheumatoid omic techniques reveal that often only a small num-
arthritis, lupus, and scleroderma (Chapter 10). In the berofproteinsareoxidativelydamaged,althoughthe
pharmaceuticalindustry,oxidationisaprobleminthe mechanismsofthisselectivityremainlargelyundeter-
handling and storage of protein/polypeptide drugs; mined.Forexample,inE.colitreatedwithH O alco-
2 2
methionine,cysteine,andtryptophanresiduesarepar- holdehydrogenase E,elongationfactor G,enolase,a
ticularly prone to oxidative damage. For example, heat shock protein, an outer membrane protein, and
Fe2+ ionsleachingfromstainlesssteelcanoxidatively oligopeptide-bindingproteinAweremajortargets.299
damage monoclonal antibodies during their prepar- InS.cerevisiae,H O treatmentdamagedmitochondrial
2 2
ation for therapeutic use.294 Even the preparation of enzymes,Hsp60,cytosolicfattyacidsynthase,G3PDH,

--- Page 331 ---

276 FREE RADICALS IN BIOLOGY AND MEDICINE
and peroxiredoxin.300 In skin fibroblasts treated with damages the amino acid residues at the binding site.
H O ,severalproteinsintheER(includingPDI;Sec- For example, iron ions bind to PerR (Section 5.5.2).
2 2
tion 3.12) were rapidly oxidized, triggering an ER Copper ions can bind to histidine residues on albu-
stress response.301 Some proteins accumulate much min(Section3.23.3.5),Na+,K+-ATPases(Section2.4.6),
greateroxidativedamageduringageingthantheaver- several other ion channels, and on apoprotein B of
age(Section11.4.2),aneffectalsoseeninbraintissue LDL (Section 10.3.5). Subsequent addition of H O
2 2
from patients with Alzheimer disease (Section 10.21). causesconversionofhistidineintheseproteinstovari-
Similarly,measurementofproteincarbonylsinhuman ousproducts,including2-oxohistidine(Fig.4.30).Like
plasmashowsthemtobemostlylocatedononlyafew H O , protein peroxides can damage enzymes with
2 2
proteins(Section6.16.3). susceptible–SHgroups,suchascaspases,G3PDH,and
some cathepsins. Unlike H O , protein peroxides are
2 2
5.13.3 Chemistryofproteindamage297 hard to remove, not being substrates for catalase or
GPxenzymes.302
Someradical-containingenzymesareattackedbyO , Whenaminoacidradicalsaregeneratedinaprotein,
2
formingperoxylradicalsthatfragmentandinactivate electronscan‘migrate’toandfromotherresidues,i.e.
the protein (Section 8.3). However, most proteins in thefinalproductsobservedneednotnecessarilyrep-
vivoare‘non-radicals’. resent the initial sites of RS attack upon the protein.
Attackofvariousreactivenitrogenandhalogenspe- For example, methionine radicals can oxidize tryp-
•
cies (e.g. ONOOH, NO , HOCl, HOBr, and NO Cl) tophan, and trytophan radicals can oxidize tyrosine.
2 2
upontyrosine(bothfreeandinproteins)leadstopro- Tyrosine-O• radicals can react with several antioxi-
ductionof3-nitro-,bromo-,chloro-,anddihalogenated dants(e.g.GSH,ascorbate)andalsowithO
•–
togive
2
tyrosines. Nitration of phenylalanine and tryptophan hydroperoxides(Fig.2.2).Thus,althoughO
•–rarelyre-
2
canalsooccur(Fig.5.30).AttackofOH• orsingletO acts directly with proteins, its presence can alter the
2
(Section2.6.4)uponproteinsgeneratesamultiplicityof distributionofproductsgeneratedbyexposuretomore
end-products.Thechemistryofoxidativeproteindam- reactive species such as OH•. For example, if Tyr-O•
ageisevenmorecomplexthanthatofDNA;insteadof is generated, O
•–
can decrease bityrosine formation;
2
fourbasesandonesugarthereare20ormoreamino reactionwithO
•–‘diverts’tyrosineradicalsanddimin-
2
acid residues, each capable of forming several oxi- ishestheircross-linkingbutgeneratesafurtherreact-
dation products. Peptide bonds can also be attacked, ivespecies.Proteinradicalscancombinetocross-link
e.g.H• canbeabstractedfromthembyOH•.Bycon- proteins, for example by bityrosine formation (Figs.
trast, H O , NO•, or O •– at physiological levels have 2.2and5.30),ordisulphidebridgeformation,orbythe
2 2 2
little or no direct effect on most proteins, although joiningoftwocarbon-centredradicals(aprocessonly
H 2 O 2 can oxidize certain easily oxidizable, accessible favouredatlowO 2 ).
–SHgroupsinselectedproteins,suchasG3PDH(Sec-
tion2.6.2),peroxiredoxins(Section3.13),andcaspases 5.13.4 Damagetospecificaminoacid
(Section5.4.2),andO • 2 –canattackFe–Sclustersinsome residues297
enzymes(Section3.9.2).
In the early 1900s, Dakin, Tappel, and their col- 5.13.4.1 Cysteineandmethionine
leagues showed that a wide variety of carbonyls and Thiol groups are easily oxidized by RS and by tran-
peroxidesisproducedinirradiatedproteinsolutions. sition metal ions, forming thiyl radicals, disulphides,
InitialOH•attackuponproteinsgeneratesfreeradicals
andfurtheroxidationproductssuchassulphenic,sul-
thatcombinewithO 2 togivealkoxylandperoxylrad- phinic, and sulphonic acids (Section 2.5.5). Similar
icals,bothofwhicharecapableofabstractingH• and products can be generated by two-electron oxidants
forming peroxides. Alkoxyl radicals can fragment by such as singlet oxygen, HOCl, and ONOOH. Expos-
β-scission (Section 5.12.5.1), releasing carbonyls from ureofenzymestotheseagentsoftenresultsinalossof
theproteins.Peroxidescanformonthepeptideback- activity, particularly for enzymes with essential cyst-
bone, and on the side-chains of amino acid residues. eine residues, although a gain of function has been
Amino acid peroxides, like lipid peroxides, are fairly described in the case of the pro-forms of certain ma-
stableatphysiologicaltemperaturebutcandecompose trixmetalloproteinases,whereoxidationcanresultin
to RO• and RO • 2 radicals on heating or if transition enzymeactivation(Table8.2).
metalionsareadded.Sincemanyproteinsbindmetal Methionine is readily oxidized by OH•, 1O ,
2
ions, especially iron and copper, their subsequent HOCl, HOBr, chloramines, and ONOOH to produce
exposure to H 2 O 2 generates OH• which selectively methionine sulphoxide, which can undergo further

--- Page 332 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 277
(slow) oxidation to the sulphone (Fig. 5.30). One- 5.13.4.5 Tyrosineandphenylalanine
electron oxidation (e.g. by OH•) to the sulphoxide
Tyrosine residues in proteins can be attacked by
proceedsviaasulphurradicalcation(metS•+)andsub- RNS, reactive halogen species, OH•, and RO • /RO•
2
sequent reaction with water. Methionine sulphoxide (Fig. 5.30). Attack of OH• can give rise to dityrosine,
ismorehydrophilicthanmethionine;thiscandisrupt
or hydroxylate tyrosine to dihydroxyphenylalanine
protein structure if buried residues try to move
(DOPA), although this product is easily further oxi-
to the surface. Methionine residues are often es-
dizedbyalmostanyROS,includingO
•–.Otheroxid-
2
sential for protein function and so oxidation of
antsgiverisetostablespeciesthatincorporateatoms
methionine decreases activity, e.g. it can inactivate
fromtheoriginaloxidant,resultinginspeciesthatcan
α -antiproteinase(Section2.6.3).Methionineoxidation
1 beusedasbiomarkers(e.g.3-chloroTyrfromHOCl,3-
does not always cause inactivation, however, e.g. its
bromoTyr from HOBr, and 3-nitroTyr from ONOOH)
oxidation in the pheromone secreted by the proto- (Section6.16).AttackofOH•uponphenylalaninegen-
zoan ciliate Euplotes raikovi changes the effect of the
erates intermediate radicals which can form ortho-,
pheromonefrompromotingmitosistoinducingsexual
para-,andmeta-tyrosinesaswellascross-links.Phenyl-
reproduction.303 Inpatientswithchronicrenalfailure,
alaninecanadditionallybeatargetofattackbyRNS,
vonWillebrandfactorcanbeoxidizedonmethionine
generatingnitrophenylalanines(Fig.5.30).
residues. This plasma glycoprotein helps platelets to
attach to sites of damage on blood vessels and be-
5.13.4.6 Valine,leucine,andotheraliphaticamino
gin the process of thrombus formation. Methionine
acids
oxidationpotentiatesitspro-thromboticaction.304
Hydroperoxides are readily formed when proteins
are exposed to OH•, including, in the case of valine,
5.13.4.2 Histidine
β-hydroperoxyvaline,(2S,3S)-γ-hydroperoxyvalineand
Damage to histidine residues in proteins often leads (2S,3R)-γ-hydroperoxyvaline. Similar species are
to inactivation of function, which can sometimes be
formed from attack on many other C–H bonds on
useful, e.g. in PerR (Section 5.5.2) but is more often
side-chains(e.g.ofLeu,Ile,Lys,Pro,Glu).Thesespecies
deleterious. Histidine reacts rapidly with OH• and
canbedecomposedbytransitionmetals(orUVlight)to
singletO ,formingseveralproducts,includingperox-
2 givefurtherradicals.
ides and 2-oxohistidine (Fig. 5.30). Histidine’s ability
tobindtransitionmetalionssuch asCu2+ makes ita
5.13.4.7 Hydroxy-aminoacids(serineand
significanttargetofoxidativedamage.
threonine)
5.13.4.3 Proline,lysine,andarginine These can react with OH• and some other species,
with carbonyl compounds being common prod-
Oxidationofprolineandarginineresiduescanleadto
ucts. HOCl and HOBr can oxidize them to al-
glutamatesemialdehyde,whereaslysinecanform2-
dehydes, e.g. L-serine to glycolaldehyde, and L-
aminoadipatesemialdehyde(Fig.5.30).
threonine to 2-hydroxypropanal and its oxidation
productacrolein.282,306
5.13.4.4 Tryptophan
Insummary,oxidativedamagetoproteinscanlead
Tryptophan residues are sensitive to damage by sev- todamagetospecificaminoacidresidues,formationof
eral ROS, including singlet O , RO • , RO•, OH•, newantigens,fragmentation,lossofenzymic(orother)
2 2
ONOOH,andHOCl.Ringhydroxylationornitration function,conformationalchangestoexposehydropho-
products, peroxyl radicals, peroxides, and eventually bic residues on the protein surface (normally buried
N-formylkynurenine andkynurenine, as fluorescent intheinteriorawayfromwater),andvariabledegrees
oxidation products, can form (Fig. 5.30). In mito- of aggregation, in part facilitated by the appearance
chondria isolated from normal human heart, N- of surface hydrophobic patches. This series of events
formylkynurenine was detected in multiple proteins, isbeautifullyillustratedinvariousneurodegenerative
especiallythoseofcomplexesIandV,suggestingon- diseases (Section 10.19) and in meat or fish under-
going oxidative damage to tryptophan residues in going deterioration after prolonged freezing.307 Heat
these organelles.305 In the case of photo-oxidative treatment of proteins to sterilize them can also cause
damage, some of these oxidation products may be oxidative damage. Protein damage, especially oxida-
more effective photosensitizers than the parent Trp tionofmethionineresidues,isalsocommonwhenmilk
(Section7.10). isheat-treated.308

--- Page 333 ---

278 FREE RADICALS IN BIOLOGY AND MEDICINE
R
Phenylalanine
R OH(cid:129) OH(cid:129) R
OH
ONOO–
R OH
ortho-Tyrosine meta-Tyrosine
NO
2
3-Nitrophenylalanine
R O(cid:129) O O O
RS
OH R R R R
Tyrosine Tyrosyl radical
R OH(cid:129) RNS R
HOCl HOBr
OH R NO
2
OH OH OH OH
DOPA 3-Nitrotyrosine
Cl (Br)
OH
3-Chloro(bromo)tyrosine
R R
+
3,3'-Bityrosine
R
(Br)Cl Cl(Br)
OH
3,5-Dichloro(bromo)tyrosine
COOH COOH
H 2 N C H H 2 N C H
N ROS NH +other products
N N O
H H
Histidine 2-Oxohistidine
Figure5.30 Someend-productsofoxidativedamagetoaminoacidresiduesinproteins.Onlyselectedproductsareshown;manyothersform,
anditislikelythatsomeremaintobeidentified.

--- Page 334 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 279
Ring-hydroxylated
products (2-, 4-,5-, 6-, 7- sites) COO–
+
H C NH3
OH(cid:129)
CH
COO– O2N N
+ H
H C NH3 RNS
6-Nitrotryptophan
N
CH
COOH
NH2
H ROS CO CH2 CH COCH2 CH COOH
Tryptophan
NH2
NHCHO H2O HCOOH NH2
N-Formylkynurenine Kynurenine
COOH COOH COOH
H2N C H H2N C H H2N C H
CH2 ROS / RNS
CH2 CH2
CH2 CH2 CH2
S S O O S O
CH3 CH3 CH3
Sulphoxide Sulphone
Methionine (2 stereoisomers)
R1 NH CH CO R2 R1 NH CH CO R2
NH2
CH2 CH2
C NH
CH2 oxidation CH2
NH2
CH2 CH OH
NH NH
C NH C NH
R1 NH CH CO R2
NH2 NH2
CH2
Arginine CH2
H C O
R1 N CH CO R2 R1 N CH CO R2 Glutamate semialdehyde
H2C CH2 oxidation CH CH2
CH2 HO CH2
Proline
NH CH CO NH CH CO
CH2 CH2
oxidation
CH2 CH2
CH2 CH2
CH2 C O
NH2 H
Lysine 2-Aminoadipate
semialdehyde
Figure5.30 (Continued)

--- Page 335 ---

280 FREE RADICALS IN BIOLOGY AND MEDICINE
5.14 Dealingwithoxidativeprotein carbonyls with age, despite the presence of MsrB en-
damage zymes; although it isn’t clear if their lifespan was
extended (Section 11.4.5). Mice lacking MsrB3 were
5.14.1 Repairofmethionineresidues309 deaf.313 All of these data indicate that methionine
sulphoxidereductasesareimportantenzymesinvivo;
Methionine sulphoxide reductases (Msr) play a key
they also help plant seeds to survive (Section 7.9.4).
role in this. Methionine sulphoxide has R- and S-
However,MsrAcancatalysethereversereaction,con-
stereoisomers (Fig. 5.30). E. coli, Neisseria gonorrhoeae,
vertingmethionineresiduestothesulphoxideinsome
and many other bacteria, protozoa, yeasts, higher
proteins(e.g.calmodulin).314Theinvivosignificanceof
plants,andmammalian(includinghuman)tissuescon-
thisisunclear,butitcouldbeamechanismtorevers-
tain enzymes that reduce methionine sulphoxide in
iblyoxidizemethionineresiduesandregulateprotein
peptides/proteinsbacktomethionineandcanthusre-
function.
activate proteins inhibited by methionine oxidation.
Both S- and R-specific reductases have been identi-
fied;MsrA(sometimescalledMsrS)isspecificforthe 5.14.2 Removal:spatialsegregation
S-isomerandMsrB(MsrR)fortheR-isomer.Inmam-
StudiesonmitosisinS.cerevisiaehaverevealedthatthe
mals, there is only one type of MsrA enzyme, but at
distribution of cellular materials during cell division
least three forms of MsrB exist, the commonest be-
isoftenunequal.Inparticular,oxidizedproteinssuch
ing MsrB1. For all of these enzymes, the reducing
as aconitase seem to be preferentially retained in the
power is supplied by thioredoxin (often replaced by
mothercell,whicheventuallybecomessenescent(Sec-
the synthetic dithiol dithiothreitol in laboratory as-
tion11.4.4),perhapsgivingthedaughtercellsabetter
says).Someoftheseenzymescanbeinhibitedbythe
chanceofsurvival.Asimilarphenomenonmayoccur
widely used organic solvent dimethylsulphoxide, so
becarefulwhenaddingthistocellsinculture.310 Me- inthegenerationofgermcellsandstemcellsinsome
organisms.315
thionine sulphoxide reductase A in animals has an
essential cysteine residue at its active site which is
oxidized by methionine sulphoxide and re-reduced 5.14.3 Removal:proteolysis
by thioredoxin. In some animal MsrB enzymes (e.g.
MsrB1),aselenocysteineplaysthesamerole.311Hence 5.14.3.1 Autophagy
selenium deficiency can promote oxidative protein Lysosomes(fromtheGreekfor‘digestivebody’)areor-
damage by interfering with MsrB activity. MsrB en- ganellesboundedbyasinglemembrane.Theyhavean
zymesarefoundinnucleus,cytosol,mitochondria,and acidicinternalpHandarerichinhydrolyticenzymes,
ER.Msrenzymesarealsoinvolvedinthemetabolism acting on a range of substrates (sulphatases, lipases,
ofthedrugSulindac(Fig.10.14). nucleases,phosphatases,glycosidasesetc.),especially
onproteinsandpeptides.Amajorfamilyoflysosomal
5.14.1.1 Amethioninecycle?28,309,311 proteinases is the cathepsins (the Greek Kathepsein
means‘digest’).Theyareclassifiedintoaspartate,cyst-
Ithasbeensuggestedthatmethionineresiduesonthe eine,andserine-dependentproteinases(Table8.2)and
surfaceofproteinscanactas‘sinks’forRS,sincethe usuallyfunctionbestatorclosetopH5.
resulting sulphoxide can readily be repaired, or even Whenaproteinisdamagedinvivo(e.g.byRS),itis
that reversible oxidation of methionine residues may often‘marked’forproteolyticremoval.Thisisessential
playaroleinredoxsignalling(alsoseethediscussion sinceaccumulationofproteinswithincorrectconform-
of Mical in Section 5.4.2.2). For example, methionine ationcancausecelldeath,especiallyifitoccursinthe
residues in HDL can help to metabolize organic hy- ER (Fig. 5.6). By contrast, heavily damaged proteins
droperoxides (Section 10.3.9), and the transcription may resist proteolytic attack and form aggregates, a
factor HypT (Section 5.5.2) in E.coli is activated by processwhichmaydecreasetheirtoxicitybysequester-
methionine oxidation, and switched off by the action ingthemininsolubleclumps.Smallproteinaggregates
ofmethioninesulphoxidereductase.Bacteriaoryeast can be transported on microtubules to join together
lackingMsrarehypersensitivetodamagebyH 2 O 2 or andformaggresomes,whichareassembledinthecell
RNS,whereasoverexpressionofMsrinDrosophilaex- atthecentrosome,andthentargetedtolysosomesfor
tendedlifespan.312Insomestudies,micelackingMsrA
destruction.
showneurologicalsymptoms,decreasedresistanceto Autophagy316,317 (from the Greek auto - self and
oxidativestress,andincreasedaccumulationofprotein phagy - to eat) refers to the role of lysosomes in

--- Page 336 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 281
handling unwanted cellular proteins, and is a pro- much of yourself!). One result of autophagy is that
cess highly conserved in all eukaryotes. Lysosomes lysosomesaccumulateironandothertransitionmetals
help to degrade aggresomes, as well as proteins internallyastheydigesttheproteinscontainingthem
takenintothecellbyendocytosis,andtheyalsotake (Section 3.22.1.3), and oxidized aggregated proteins
up some cytoplasmic proteins and organelles (per- canaccumulateinthemwithage(Section11.4.7).Dam-
oxisomes, mitochondria etc.) for destruction. Auto- age to lysosomes can cause cell death, by release of
phagy is often classified into three types. The first hydrolases and ‘catalytic’ transition metal ions into
is chaperone-mediated autophagy, where unwanted thecytoplasm.Thesugartrehalosecanpromoteauto-
proteins are delivered to lysosomes by a chaperone phagyinanimalcells(Sections3.25.8and10.23.2).
(suchasHspA8).Microautophagyreferstodirectup-
takeofcytoplasmicconstituentsbyinvaginationofthe
lysosomal membranes (e.g. during normal turnover 5.14.3.2 Lonproteinaseandtheproteasome320,321
ofcellconstituents).Thethirdis macroautophagy,in Another proteolytic system is the Lon proteinase,
which cytoplasmic constituents/organelles (or some- part of the mitochondrial and peroxisomal322 protein
timesinvadingmicro-organisms)becomeenclosedby qualitycontrolsystem.LonisanATP-stimulatedpro-
a double membrane to generate an autophagosome, teinasethatdegradesaconitase(inmitochondria),cata-
which is then delivered to the lysosomes. The term lase(in peroxisomes)andseveralotherproteinsafter
‘autophagy’ as commonly used refers to macroauto- they have become oxidized. It recognizes hydropho-
phagy.Mitophagy,macroautophagyofmitochondria, bic patches that appear on the surface of aconitase
is a key mechanism for removing damaged mito- afteroxidation.IfLonismissingfromperoxisomesin
chondria: oxidized biomolecules on the surfaces of thefungusPenicilliumchrysogenum,proteinaggregates
mitochondria(andperoxisomes)helptopromotetheir develop, a major component of which is catalase.323
recognition for clearance.318,319 There are several pro- Levels of Lon increase in cells subjected to stress, in-
posalsthatRSfrommitochondriaorelsewherecanact cludingoxidativestress,althoughtheefficiencyofthis
to increase the rate of autophagy (e.g. starvation ap- adaptation may decrease with age.324 An oxidized
pearstoincreasecellularH 2 O 2 andO • 2 – levels,which protein hydrolase has been proposed to be import-
facilitateautophagy),butthemechanismsinvolvedare ant in removing oxidized proteins in some tissues
unclear as yet.316 A key part may be the redox regu- (Section7.4.6).
lation of a cysteine protease essential for autophagy: However,mostattentionhasbeenpaidtotheprote-
ATG4(AuTophaGy). asome,acytoplasmicandnuclearsystemineukaryotic
This‘self-catabolism’ofautophagyhelpscellstosur- cellsthatremovesunwantedproteins.Wehavealready
vive during periods of nutrient deprivation or other metseveralofitstargets,includingI k B(Section5.5.6),
stress(e.g.pathogeninfection,ischaemia–reperfusion). HIF-1α (Section 1.3.2), phosphorylated catalase (Sec-
Autophagy occurs at low levels in all normal cells, tion5.5.4.2),IRP-2(Section3.22.1),andKeap1(Section
butitsrateincreasesduringstarvationorstress,bya 5.5.8).Italsoplaysakeyroleinremovingoxidatively
seriesofcomplexsignallingmechanisms.Theserine– damagedproteins.
threonineproteinkinasemTOR(mechanistictargetof Its core part is the 20S proteasome, named for its
rapamycin)isespeciallyimportant.mTORisfoundin sedimentationcoefficientwhenspuninanultracentri-
two structurally and functionally distinct complexes, fuge.Ithasarelativemolecularmassofabout700,000,
mTORC1 and mTORC2. mTORC1 senses when nu- and is a cylindrical structure made of a stack of four
trients are plentiful and acts to promote net protein rings, each containing seven protein subunits. The
synthesisandcellgrowthandtodecreaseautophagy. cylinder has three internal cavities: the central cavity
Henceitsinhibition(e.g.bytheantibioticrapamycin, containsproteolyticsitesandaccesstoitiscontrolled
sometimescalledsirolimus)promotesautophagyand by gates from the two outer cavities, too narrow to
can even increaselifespan in animals (Section 11.3.4). admit folded proteins. The chymotrypsin-like pro-
How did rapamycin get its name? It was first dis- teolyticsitescleaveproteinsadjacenttohydrophobic
covered as an antifungal agent produced by Strepto- amino acid residues (tyrosine or phenylalanine),
myceshygroscopicus.ThediscoverytookplaceonRapa the trypsin-like sites, after basic residues (arginine,
Nui, one of the Easter Islands in the South Pacific lysine), and the peptidylglutamyl sites, after acidic
Ocean.ThediscoveryofitsactiononTORcamelater. residues (aspartate, glutamate). In vivo, however,
Autophagy is usually a protective mechanism, but the 20S proteasome is often assembled into a larger
if over-activated it can cause cell death (eating too structure, the 26S proteasome; the 20S cylinder plus

--- Page 337 ---

282 FREE RADICALS IN BIOLOGY AND MEDICINE
additional groups of proteins (19S cap complexes) a painful peripheral neuropathy in which RS are in-
attachedateitherorbothends. volved(Section10.25).326Proteasomeinhibitorsinduce
oxidative stress in cells (sometimes promoting RNS
5.14.3.3 Anyroleforubiquitin?321 production327), and can cause apoptosis (hence their
The 26S proteasome recognizes many of its targets use in chemotherapy). Proteasome inhibition often
because they have been marked for degradation by leadstoaggresomeformationandincreasedlysosomal
attachment of ubiquitin, a 76 amino-acid member of activity, presumably an attempt to compensate. Thus
the heat-shock protein family (Section 5.6). Ubiqui- proteasomal inhibition can lead to increased rates of
tination(attachmentofmultipleubiquitinmolecules) autophagy.Paradoxically,however,addinglowlevels
is ATP-dependent. It is catalysed by a group of en- ofproteasomeinhibitorstocellscanproducecytopro-
zymes that first attach ubiquitin to lysine residues tectionbyincreasingproductionofHsp,HO-1,andof
on the target and then add more ubiquitins to lys- theproteasomeitself.328 Cellsoftenrespondtooxida-
ines on the attached ubiquitin. Usually, a chain of at tive stress (e.g. addition of ONOO–, H 2 O 2 , paraquat)
least four ubiquitins is needed for proteasomal deg- by increasing proteasome activity, a process which
radation.Ubiquitin-activatingenzymes(E1)useATP requiresNrf2.329,330
to activate ubiquitin, which is transferred to several Loweringproteasomalactivity(bychemicalinhibi-
ubiquitinconjugatingproteins(E2).Theseco-operate tors or antisense oligonucleotides) increases levels of
withhundredsofubiquitinligases(E3),eachofwhich oxidizedproteinsincells,indicatingthattheirdegrad-
recognizes ‘destruction signals’ on its target protein ationproceedsviathissystem.Thenuclearproteasome
andattachesubiquitin.TheseE3enzymesarelargely may help to remove oxidized nuclear proteins, and
responsibleforthespecificityoftargetingproteinsfor PARP-1 activation appears to enhance its function.331
degradation. Various deubiquitinating enzymes can However,theroleofubiquitinationisuncertain;itap-
removeubiquitinresiduesandrescueproteins.Ifthis pearsthatthe20Sproteasomeissufficienttodegrade
doesnothappen,thecapstructuresrecognizethepoly- oxidizedproteins.How?Possiblyitrecognizespartial
ubiquitinatedprotein,unfoldit,andfeeditslowlyinto unfolding of oxidized proteins to expose hydropho-
theproteolyticcoreusingenergyfromATPhydrolysis. bicsurfacepatchesthatsomehow‘open’thegatesand
Onceinside,itishydrolysedintoshortpeptides.Sim- allow the oxidized proteins to enter in the absence
ultaneously, polyubiquitin is removed, disassembled of ubiquitin. It is important to remove such proteins
backintomonomersbyenzymes,includingubiquitin quickly, as the hydrophobic patches can allow aggre-
C-terminal hydrolase (UCHL1), and the monomeric gation, which deters proteasomal degradation: auto-
ubiquitin made available for re-use. The 26S prote- phagy then has to step in. Non-ubiquitin-dependent
asome thus catalyses an ATP-dependent degradation proteasomal degradation is not without precedent,
ofubiquitinatedproteins.The20Sproteasomewillnot since the 26S proteasome can degrade a few proteins
attackubiquitinatedproteins;recognitionrequiresthe (e.g. p21, thymidylate synthase, and ornithine de-
19Scapcomplexes.Thereareseveralsuggestionsthat carboxylase) without ubiquitination being necessary.
ubiquitinatingandde-ubiquitinatingenzymesoreven Another possibility is that Hsp such as Hsp90 recog-
the proteasome itself may be redox-regulated in vivo nizeoxidizedproteins(e.g.calmodulinwithoxidized
(e.g.byglutathionylation),butevidencetosupportthis methionine residues) and deliver them to the 20S
islimitedatpresent.325 proteasome.325 It has also been proposed that in cells
Severalinhibitorsoftheproteasomeareknown.For subjectedtooxidativestress,Hsp70canhelptodisas-
exampletheStreptomycesmetabolitelactacystininacti- semblethe26Sproteasome,releasingthe20Sformto
vatestheproteasomeandiscytotoxictodividingcells dealwithincreasedlevelsofoxidizedproteins.332
byinterferingwithcyclin-dependentregulationofthe One exception (perhaps one of several) to the gen-
cellcycle(Section10.14).Otherinhibitorsincludeepox- eralization that ubiquitin is not required to remove
omycin, aclacinomycin A, and MG132 (a synthetic oxidized proteins, is IRP-2, whose oxidized form is
inhibitor). Proteasome inhibitors such as bortezomib degradedbytheproteasome(Section3.22.1).
(Velcade®) are used in cancer chemotherapy (e.g. for
5.14.3.4 Clogginguptheproteasome
multiple myeloma). However, if proteasome inhibi-
tors could enter the brain they might be neurotoxic; Proteasomeactivitydeclineswithage,promotingaccu-
indeed defects in the brain’s ubiquitin–proteasome mulationofabnormalproteins(Section11.4.4).Inaddi-
systemareobservedinAlzheimerandParkinsondis- tion,someoxidativelydamagedproteinsappeartoin-
eases (Section 10.19). Indeed, bortezomib can cause hibitproteasomefunction,ratherthanbeingdegraded

--- Page 338 ---

OXIDATIVE STRESS AND REDOX REGULATION: ADAPTATION, DAMAGE, REPAIR, SENESCENCE, AND DEATH 283
byit.TheseincludeHNE-modifiedproteins325andpro- inaccurate replication by damaged polymerases,
teins modified by isoketals; a single isoketal adduct and cleavage by nucleases activated by a rise in
sloweddegradationbyabout50%.333Thus,theseend- intracellular free Ca2+. Different antioxidants are
products of lipid oxidation could lead to further cell needed to protect against these various events, and
dysfunctionviaimpairedproteasomeactivity. there is no universal single ‘marker’ of oxidative
stress, as we explore in Chapter 6. For example,
5.15 Summary:oxidativestress failuretofindlipidperoxidationdoesnotruleoutthe
andcellinjury occurrence of oxidative stress: damage to DNA and
proteinsisoftenanimportantinjuriousevent.Failure
Oxidativestresscanproduceinjurybymultiplepath- of a chain-breaking antioxidant such as α-tocopherol
waysthatoverlapandinteractincomplexways.Letus to protect is also inconclusive, for the same reason.
illustratewithDNA.DNAcansufferdirectoxidative Sometimes, the only evidence that oxidative stress
damage,e.g.byONOO–,HOCl,orOH•,indirectdam-
has occurred in vivo may be increases in antioxidant
age by binding of end-products of lipid peroxidation defence and/or other protective systems, indicating
such as HNE and MDA, failure of repair because of that the cell has responded and counteracted the
oxidativedamagetopolymerasesandrepairenzymes, damage.

--- Page 339 ---

CHAPTER 6
Measurement of reactive species
Itisdifficulttofindablackcatinadarkroom,especiallyifthereisnocat.
AnoldChinesesaying
6.1 Introduction 6.1.2 Fingerprinting:thebiomarkerconcept2,3
Reactive species (RS) play essential roles in vivo Analternativetotrappingisfingerprinting(onecould
(Chapters5and8)butarealsoinvolvedinmanydis- also call it footprinting). Such methods measure not
eases (Chapters 7 and 10), in the actions of several the RS themselves but the damage that they cause.
toxins(Chapter9),andintheageingprocess(Chapter IfanRSattacksabiologicalmoleculetoleaveaunique
11).Amajorprobleminascertainingtheirimportance chemical‘fingerprint’,thenthepresenceofthatfinger-
isthattheseevanescentspeciesaredifficulttomeasure. print(i.e.theoxidativedamagethatitcauses)canbe
Howcanweapproachthis?Therearebothdirectand usedtoinferthattheRShadbeengenerated.Suchbio-
indirectways. markers of oxidative damage can then be employed
to investigate effects of antioxidants or other agents
onoxidativedamage,hopefullyleadingtoexperimen-
6.1.1 Trapping
tallyverifiablepredictionsofthelikelyeffectsofthese
Theonlytechniquethatcanobservefreeradicalsdir- compoundsonoxidativestress-relateddiseases.Since
ectlyandspecificallyiselectronspinresonance(ESR), the methods currently available for the direct meas-
sometimes called electron paramagnetic resonance urement of RS are of limited applicability to humans
(EPR).1 ThistechniqueistooinsensitivetodetectO •– (discussed below), most human studies focus on the
2
and OH • directly in living systems. One approach to measurementofoxidativedamagebiomarkers.Thisis
this difficulty has been trapping, in which a reactive to some extent logical, since it is the damage caused
radicalisallowedtoreactwithatrapmoleculetogive byRSthatmattersratherthanthetotalamountofRS
one or more stable products, which are then meas- generated. For example, if OH• are generated within
ured.Mentionoftrappingusuallybringstomindthe acell,manymayreactwithunimportanttargets.The
technique of spin trapping, in which the radical re- fraction that reacts with DNA, with key proteins, or
acts with a spin trap to form a more stable radical, with lipids (initiating lipid peroxidation) may be the
which accumulates to a level that does permit detec- mostimportant.
tionbyESR.However,therearemanyothertrapping Table6.1summarizesthecharacteristicsofanideal
methods,asweshallseelater.Onefundamentalpoint biomarkerofoxidativedamage.Validationofbiomark-
to appreciate is that traps perturb the system under in- ersrequirestwodifferentsteps.Oneisanalyticalval-
vestigation. For example, let us suppose that damage idation,includingdevelopmentofprocedures,setting
in a biological system is caused by OH • . Adding a of reference intervals and values, analysis of refer-
molecule that traps OH • should decrease the dam- ence material in different laboratories, elimination of
age, provided that enough OH • is trapped. Indeed, methodologicalartefacts,andgeneralqualitycontrol.
spin traps and other trapping molecules have often Thesecond,morefundamental,istodemonstratethat
been shown to inhibit oxidative damage in cells and changes in biomarkers do reflect the later develop-
sometimes in vivo. In some cases, this has been a mentofpathologyorovertdisease.Nocurrentlyused
starting point to design therapeutic antioxidants (e.g. biomarker of oxidative damage has yet fulfilled this
Section11.5.5). secondcriterion;thenecessaryexperimentshaverarely
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 340 ---

MEASUREMENT OF REACTIVE SPECIES 285
Table6.1 Criteriaforan‘ideal’biomarkerofoxidativedamage. Thefundamentalequationis
A. Fundamentalcriterion
(cid:6)E=hγ =gβH
Thebiomarkerpredictsthelaterdevelopmentofpathologyor where(cid:6)Ecorrespondstotheenergyofabsorbedradi-
overtdisease.
ation(theenergygapbetweenthetwoenergylevelsof
B. Technicalcriteria
theelectron),hisPlanck’sconstant,γ isthefrequency
i. Thebiomarkershoulddetectamajorpart,oratleastafixed
of applied electromagnetic radiation, H the applied
percentage,oftotaloxidativedamagetothetarget fieldstrengthandβisaconstant,theBöhrmagneton.
moleculeinvivo.
Thevalueofg(thesplittingfactor)forafreeelectronis
ii. Itmustemployvalidatedmeasurementtechnology,
preferablysimpletouse(ifachievable). 2.00232andmostbiologicallyimportantradicalshave
iii. Theresultoftheassaymustbeaccurate,i.e.givethecorrect valuesclosetothis.Iftheaboveequationisobeyed,an
answerfortheamountofbiomarkerpresent. absorptionspectrumresults.Forasingleelectronthis
iv. Thecoefficientofvariationbetweendifferentassaysofthe canberepresentedinastylizedwayas
samesampleshouldbeverysmallincomparisonwiththe
differencesbetweensubjectsortheeffectofexperimental
manipulations(e.g.antioxidantsupplementation)upona
subject,i.e.theprecision(‘reproducibility’)oftheassay
shouldbehigh. but, if presented as its first derivative by an ESR
v. Itmustnotbeconfoundedbydietorotherphysiological machineitappearsas
factors.
vi. Itshouldbestableonstorage,notbeinglost,orformed
artefactually,instoredsamples.
vii. Forhumanuse,itispreferableifitcanbemeasuredineasily
obtainablesamples,e.g.blood,urine,saliva,skin,ormuscle
biopsy.
Someatomicnuclei,suchasthoseofhydrogenand
nitrogen,alsobehavelikesmallmagnetsandwillalign
either parallel or antiparallel to the applied magnetic
beenattempted.Itisunfortunatethatbiomarkerswere
field. Thus in a hydrogen atom the single unpaired
neverbuiltintohumaninterventiontrialswithantioxi-
electron will be exposed to two different magnetic
dants; they could have been of value in interpreting
fields: the one applied plus that from the nucleus, or
the confusing and conflicting results (Section 4.6.3).
the one applied minus that from the nucleus. Thus
Nocurrentlyavailablebiomarkerofoxidativedamage
there will be two energy absorptions and the ESR
meetsallpartsofcriteria(B)inTable6.1,butsomeare
spectrumappearsas
closerthanothers.
6.2 ESRandspintrapping1,4
6.2.1 WhatisESR?
Iftheunpairedelectronisclosetotwoidenticalhydro-
ESRisanon-destructivespectroscopictechniquethat gens, each can be aligned in the same way with the
detects unpaired electrons and so is specific for free appliedfield,inoppositeways,oroneinthesameway
radicals.Anunpairedelectroncanhaveaspinofeither andoneopposite,thatis
+1/2 or –1/2 and behaves as a small magnet. If ex-
posedtoanexternalmagneticfield,itcanalignitself
either parallel or antiparallel (in opposition) to that
field.Itthuscreatestwopossibleenergylevels,which
vary with the magnetic field strength. If electromag-
neticradiationofthecorrectenergyisapplied,itwillbe
absorbedandusedtomovetheelectronfromthelower
energyleveltotheupperone.Thusanabsorptionspec-
trum is obtained, usually in the microwave region of
theelectromagneticspectrum.ESRspectrometersdis-
play first-derivative spectra, which show the rate of givingathree-linespectruminwhichtheintensitiesare
changeofabsorbance. intheratio1:2:1,

--- Page 341 ---

286 FREE RADICALS IN BIOLOGY AND MEDICINE
ThenumberoflinesintheESRspectrumofaradical
is called the hyperfine structure and can be large in
radicalscontainingmanynuclei.Aradicalcanbeiden-
tifiedfromitsESRspectrumbylookingatthegvalue,
hyperfine structure, and line shape. For example,
•
Forexample,inthemethylradical(CH )theunpaired Fig. 6.1 shows the ESR spectra of the ascorbyl and
3
electron on the carbon is close to three identical hy- α-tocopheryl radicals. In spin trapping experiments
drogens.Thefieldofeachhydrogennucleuscanalign (Section 6.2.3) hyperfine splitting can be decreased if
withoragainsttheappliedmagneticfield,anda‘tree’ required,andsensitivityofdetectionincreased,byus-
diagramcanbeusedtopredictthespectrum, ingisotopicallylabelledtraps.ThusreplacingaHatom
withdeuteriumusuallyabolishesdoubletprotonsplit-
tings,andusing15Ninsteadof14Ngivedoubletrather
thantripletsplitting.
ESR is sufficiently sensitive to detect species such
asascorbyl,α-tocopheryl,sometransitionmetalions,
melanin (Section 3.25.9), and ubisemiquinone (UQ•-)
radicalsinbiologicalmaterial,aswellasradicalspro-
duced by the mechanical disruption of fingernails,
which therefore consists of four lines with intensity
bone, cartilage, and tooth enamel (Section 2.5.5), and
ratios1:3:3:1,or in cigarette smoke (Fig. 9.12). For example, UQ•- can
be detected by ESR in biopsies of human skeletal
muscleafterexercise.5 However,asmentionedearlier,
ESR is insufficiently sensitive to detect O
•–
and OH
•
.
2
3460 3475 3490
Gauss
60 700
50 600
40 500
30 400
20 300
10 200
0 25 50 75 100 125
)Mn(
(cid:129)OT
Time (min)
-
)Mn(
(cid:129)A
(a)
Figure6.1 ESRspectraofascorbylandα-tocopherylfree
radicals.Bloodplasmawasincubatedwithhypoxanthine
andxanthineoxidase(HX/XO),whichgeneratesO
•–and
2
H2O2.Ascorbylradicallevelswereinitiallylow(<20nM).
UponaddingHX/XO,theyroserapidlybutthenfellas
ascorbatewasdepleted(b).Notuntilascorbatehadalmost
disappeareddidthevitaminEradicalappear,consistent
(b) - witha‘recycling’ofthisradicalbyascorbate(Section
A(cid:129)
4.3.4).(a)Top:ascorbylfreeradicalspectrummeasuredat
TO(cid:129) 1.5minafteraddingHX/XO.Bottom:tocopherylfree
radicalmeasuredat70min.Undertheseexperimental
conditions,approximatelytentimesmoretocopheryl
radicalisneededtoproduceanESRsignalabovethenoise
level,largelybecauseithasabroadseven-linespectrum
whereasascorbylradicalisanarrowdoublet.Datafrom
FreeRadic.Biol.Med.14,649,1993,bycourtesyof
DrGaryBuettnerandElsevier.Ascorbylradicalhasbeen
detectedinmanybiologicalsystems,e.g.iniron-
overloadedanimalsorthosetreatedwithparaquat
(Section9.4).

--- Page 342 ---

MEASUREMENT OF REACTIVE SPECIES 287
Oneapproachistogeneratesuchradicalsinafrozen, wasthefirststablefreeradicaldescribed,byGomberg
transparentsolidmatrixwhichpreventsthemfromcol- in1900.TritylprobescanalsobeusedtomeasureO
•–
2
lidingandundergoingreaction.In1969,sucha‘rapid (Section6.4.3).
freezing’ ESR technique enabled the first identifica-
tion of O
•–
production by an enzyme-catalysed reac-
tion (XO 2 and xanthine).6 However, freeze-quenching 6.2.3 Spintrapping1,4,8
techniques are rarely used in biology; spin trapping In this technique, a short-lived radical reacts with a
(Section6.2.3)ismorecommon. trap to produce a long-lived radical. Reaction of ni-
X-band ESR is used in most studies, with an ap- troso (R–NO) compounds with short-lived radicals
plied field frequency of about 9–10 GHz (gigahertz). canproducelonger-livednitroxide(sometimescalled
Atthisfrequency,samplepenetrationbytheradiation aminoxyl)radicals,
is limited and only small samples can be examined.
Lower frequencies can be used for bigger samples,
suchaswholeorgansorliveanimals.ForexampleL-
bandESRspectroscopyuses1–2GHzorevenlower,
and it has been possible to image nitroxide radicals
(Section 6.2.3) administered to whole animals and to
demonstrate their rapid reduction to ESR-silent spe-
cies(Section6.2.6).1However,useoflowerfrequencies
decreases sensitivity. These techniques can be paired Theirstabilityisassociatedwithelectrondelocalization
withotherimagingmodalities,e.g.magneticresonance betweenthenitrogenandoxygenatoms,
imaging (MRI), to map both the organs of an an-
imal(MRI)andthefreeradicals,enablingapproximate
localizationoftheradicals.7–9
Nitronetrapsalsoproducenitroxideradicals,
6.2.2 Measurementofoxygen
MultiplemethodsareavailabletomeasureO levels.10
2
For example, the emissive triplet state of platinum
porphyrin-coumarin-343 is highly sensitive to pO ,
2
and this agent was used to confirm that mouse bone
marrow, despite its high blood flow, has a pO <
2
32mmHg,allowingittoharbourstemcellsin‘hyp-
oxicniches’(Section3.4.2).11 Oxygen,beingparamag- The ESR spectra of nitroxides have a main triplet
netic,canaffecttheESRspectraofotherparamagnetic (1:1:1) splitting due to interaction of the unpaired
species.Insomecases,thiscanbeusedtoassesscel- electronwiththenitrogenofthenitroxidegroup.Sec-
lular and organ O 2 levels, by the method of ESR ondary splittings arise from magnetic nuclei in the
oximetry.Suitabledetectorsincludetriphenylmethyl trapped radical and sometimes from other magnetic
(trityl)-basedradicalsandcertainparticulatesthatpos- nuclei in the spin trap. In nitroso traps, the radical
sess unpaired electrons (e.g. lithium phthalocyanine detected adds directly to the nitrogen, whereas with
crystals,Indiaink).ThelatteroftenshowasingleESR nitrones it adds to the adjacent carbon. With nitroso
linewhoseshapeisbroadenedbythepresenceofO 2 to traps the trapped radical thus more easily influences
anextentdependingonpO 2 .Ifsmallenough,theycan the ESR spectrum and usually generates hyperfine
betakenupbyendocytosisandreportonintracellular splittings,whereaswithnitronetrapsthespectratend
O 2 concentrations.12 Several trityl probes are used in to be broadly similar whatever the radical trapped.
vivoascontrastagentsinMRI.Indeed,triphenylmethyl However, nitroso compounds often give less stable
radical, adducts than nitrones, especially when oxygen rad-
icals are trapped, and they tend to be more toxic
to animals and cells. Hence nitrones are more com-
monly used. Table 6.2 shows some of the trapping
moleculesthathavebeenemployed;DMPOandPBN
(e.g. Section 11.5.5) are widely used and DEPMPO

--- Page 343 ---

288 FREE RADICALS IN BIOLOGY AND MEDICINE
(Fig. 6.3) is increasingly popular. For example, PBN presence of impurities in commercial spin trap pre-
wasusedtodetectaminocarbonylradicalwhenurate parations (e.g. DMPO, DEPMPO) that can influence
wasincubatedwithONOO–(Section3.25.6). results.4,13Yetanotherfactortobeconsiderediswhere
The ‘ideal’ trap should react rapidly and specific- the trap will localize in a biological system; for ex-
allywiththeradicalonewishestodetect,toproduce ample, PBN is much more hydrophobic than DMPO
a product that is chemically stable, not metabolized (Table6.2).
by living systems, and has a unique ESR spectrum. NitricoxidehasbeenmeasuredinvivobyESR,us-
Nocurrentlyavailabletrapsatisfiesallofthesecriteria ingvarioustraps(Section6.5),butsomespintrapsmay
(Section 6.2.6), and another area of concern is the alsobesourcesofNO•(Fig.6.2,legend).
Table6.2 Aselectionofthe‘spintraps’thathavebeenusedinbiologicalsystems.
Name Abbreviation Structure
tert-Nitrosobutane(nitroso-tert-butane) tNB(NtB)
α-Phenyl-tert-butylnitrone PBN
2,2,6,6-Tetramethylpiperidine TEMPb
(TEMPD)
5,5-Dimethylpyrroline-N-oxide DMPO
5-Diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide DEPMPO
5-Ethoxycarbonyl-5-methyl-1-pyrroline-N-oxidea EMPO
tert-Butylnitrosobenzene BNB
O–
α-(4-Pyridyl-1-oxide)-N-tert-butylnitrone 4-POBN CH N+ C(CH3)3
N+
O–

--- Page 344 ---

MEASUREMENT OF REACTIVE SPECIES 289
Table6.2 (Continued)
Name Abbreviation Structure
5-(2,2-Dimethyl-1,3-propoxycyclophosphoryl)-5- CYPMPO
methyl-1-pyrrolineN-oxide
3,5-Dibromo-4-nitroso-benzenesulphonicacid DBNBS
1,1,3-Trimethyl-isoindoleN-oxide TMINO CH
3
N + O–
H 3 C CH 3
Azulenylnitrone AZN
Spintrapsvaryintheirhydrophobicity;forexample,DMPO(octanol:waterpartitioncoefficient0.08)orPOBN(0.09)arelessusefulintrappingradicalswithinmembranes
orlipoproteinsthanPBN(partitioncoefficient10.4).Lipophilicitycanbeincreasedbyaddinghydrophobicside-chainstotraps.ForexamplethemethylgrouponDEPMPO
canbereplacedbyaPhCH2CH2–group(togiveDEPPEPO)ora–CH3onDMPObyatert-butoxycarbonylgroup(togiveBMPO).VariousDEPMOderivativesinwhich
theside-chainsarereplacedbycyclicmoietieshavebeensynthesized(Bioorg.Med.Chem.19,2218,2011)andarereportedtohaveimprovedtrappingproperties(Free
Radic.Res.43,668,2009),e.g.CYPMPO.AlsoseeFreeRadic.Biol.Med.67,150,2014.
aEMPOhasbeenreportedtogivesimplerEPRadductsthanDEPMPO,althoughitsO•–adductislessstablethanthatofDEPMPO,butstillfive-timesmorestable
thanthatwithDMPO.VariousstructuralmodificationscanincreasethestabilityoftheO•2 –adducts.POBNandDMPOhavebeenusedtodetectOH•
andhydroxyethyl
2
radicalsarisingfromFentonreactionsinwine(J.Agric.FoodChem.57,4359,2009).Et–ethylgroup.
bTEMPcansometimesreactwithexcitedstatesofphotosensitizers,over-estimating1O2production(FreeRadic.Biol.Med.77,64,2014).
6.2.4 DMPO,DEPMO,andPBN1,4 adductismorestable.However,thespectraobtained
are complex and need to be interpreted with cau-
SpintrappingisoftenusedtodetectO • 2 – andOH • in tion (Fig 6.3). Other traps with better properties than
biological systems. For example, DMPO reacts with DMPO have also been synthesized (Table 6.2). A dif-
bothOH • andO • 2 –toformproductswithdifferentESR ferent strategy is to use DMPO, but to employ OH •
spectra (Fig. 6.2). The rate constants for the reactions scavengers (e.g. ethanol) to verify the source of the
areverydifferent,however,at<20M-1s-1 forO • 2 – and DMPO–OHadduct.IftheDMPO–OHsignalisdueto
>109 M-1s-1 for OH • . Thus at equal concentrations of trapping of OH • by DMPO, then addition of excess
radicals,OH • istrappedmuchfasterthanO • 2 –.Hence ethanol should abolish it, because ethanol scavenges
efficient trapping of O • 2 – requires high DMPO con- OH • andwillcompetewithDMPOforit.Inaddition,
centrations. Unfortunately, the product of reaction of reactionofethanolwithOH • producesahydroxyethyl
DMPOwithO • 2 – (DMPO–OOH)isunstable(half-time radical (Fig. 5.2), which reacts with DMPO to give a
about1min)anddecomposestogiveseveralproducts, newradicalwithadifferentESRspectrum.Thisspec-
includingDMPO–OH,thesameproductgeneratedby trumshouldappearastheDMPO–OHsignalislost.
directreactionwithOH•(Fig.6.2).
Spin trapping has often been used in vivo. For
There are several solutions to this problem. One is example, PBN can detect radicals involved in liver
r to at u e s c e o D n E st P a M nt P s O co , m w p hi a c r h ab r l e e ac t t o sw D i M th P O O • 2 – b a u n t d w O h H os • e w O it • 2 h – d bu am tt a h g e e a b d y du C c C t 1 d 4 ec (S o e m ct p i o o s n es 9. q 2 u ). ic P k B ly N a r n e d ac s t o s w DM ith PO OH or •

--- Page 345 ---

290 FREE RADICALS IN BIOLOGY AND MEDICINE
CH CH
H C 2 2
3 OH(cid:129)
C CC H
+ radical
N
H C
3
O–
DMPO
CH CH
H C 2 2
3
H
C C
·
O 2 – radical H 3 C N OH
mposition O(cid:129)
deco DMPO—OH
CH CH
H C 2 2
3 H
C C
N
H C OOH
3
O(cid:129)
DMPO OOH
(cid:129)
DMPO CH 3 CHOH · H 3 C CH 2 CH 2
(from ethanol + OH ) H
C C
H C N CH CH 3
3
O(cid:129) OH
Figure6.2 ReactionsofDMPOwithO
•–,OH •
,andhydroxyethylradicals.TheESRspectraoftheDMPO–OHandDMPO–OOHadductsareshown
2
diagrammaticallytoillustratethekeydifferencesbetweenthem.DMPOcanalsoreactfairlyrapidly(k~2.5×106M-1s-1)withcarbonateradical
toproduceDMPO-OH(FreeRadic.Biol.Med.43,1523,2007;Biochem.J.417,341.2009)ThespectrumoftheDMPO–OOHadducthas12lines
andresultsfromcomplexinteractions(J.Org.Chem.70,1198,2005).SpectrabycourtesyofDrPaulTordoandtheAmericanChemicalSociety.
IthasalsobeensuggestedthattheO
•–adductsofDMPO,EMPO,andDEPMPOcandecomposetoreleaseNO•(Org.Biomol.Chem.3,3220,
2
2005;NitricOxide25,309,2011).
•
DEPMPOarebettertrapsforOH .Spintrapssuchas allowthetraptocompetewithendogenousmolecules
DEPMPO can be attached to triphenylphosphonium forareactivefreeradical).However,trapscanbeused
compounds(Section11.5.12)todirectthemintomito- on human (or other animal) body fluids and tissue
chondria,hopefullydetectingfreeradicalsthere. samples (e.g. muscle biopsies). For example, PBN is
abletodetectfreeradicalswhenitisaddedtocoron-
arysinusblooddrawnduringopenheartsurgery.14Of
6.2.5 Exvivotrappinginhumans
•
course, highly reactive radicals such as OH will not
•
SpintrapssuchasPBN,DMPO,DEPMPO,EMPO,and survive to be detected in ex vivo material, since OH
POBNaresufficientlynon-toxicforshort-termusein reacts instantly with whatever is in its immediate vi-
experimentalanimals,4 butcannotbeadministeredto cinity.Trappingwithinexvivosamplesusuallydetects
humansbecauseofunknowntoxicityatthehighlevels secondaryradicalsresultingfromattackofhighlyre-
•
thatarerequiredforradicaltrappinginvivo(inorderto active species (OH , ONOOH etc.) on biomolecules.

--- Page 346 ---

MEASUREMENT OF REACTIVE SPECIES 291
Spin-trap Free radicals Spin-adducts EPR spectra
2 mT
O O
H CH CO H CH CO
3 2 P 3 2 P H
H 3 CH 2 CO + H + OH(cid:129) H 3 CH 2 CO
H 3 C N H 3 C N OH
O– O(cid:129)
EPR “silent”
O
H CH CO
3 2 P H
+ O(cid:129) 2 – H 3 CH 2 CO H 3 C N OOH
O(cid:129)
O
H CH CO
3 2 P H
+ H(cid:129) H 3 CH 2 CO
H 3 C N H
O(cid:129)
O
H CH CO
3 2 P H
+ NO(cid:129) 2 H 3 CH 2 CO
H 3 C N ONO
O(cid:129)
O
H CH CO
3 2 P H
+ CO(cid:129) 2 – H 3 CH 2 CO
H 3 C N CO 2 –
O(cid:129)
O
H CH CO
3 2 P H
+ GS(cid:129) H 3 CH 2 CO
H 3 C N SG
O(cid:129)
Figure6.3 DEPMPOtrappingavarietyofphysiologicallyrelevantfreeradicals–OH • ,O •–,H•,CO •–,NO • ,andGS•.Eachadductshowsa
2 2 2
distinctiveEPRsignal.FromCrit.Rev.Clin.Lab.Sci.48,114,2011,withpermissionofDrIvanSpasojevic´andInformaHealthcare.
Suchsecondaryradicalscanincludeprotein-andlipid- radicals. Hence trapped radicals can be artefacts
derivedradicals.Forexample,POBNisagoodtrapfor ofsolventextraction.15
lipid-derived carbon-centred radicals. An example of
theuseofexvivotrappinginanimalscanbefoundin
6.2.6 Cautionsintheuseofspintraps1,4,13
Section10.9.
The ability of spin traps to react with organic-
Nitroxideradicalsareredox-active;theycanberevers-
solvent-derived radicals should be borne in mind
iblyreducedtohydroxylamines,
when tissues or body fluids are treated with such
solvents to extract lipophilic radicals for ESR stud-
H++e–+R-N–O •(cid:2)R–N–OH
ies. For example, chloroform/methanol mixtures are oroxidizedtooxoammoniumcations,
widely used to extract lipids, but methanol is eas-
ily oxidized by several RS, generating •CH 2 OH R–N–O •(cid:2)–R–N + =O+e–

--- Page 347 ---

292 FREE RADICALS IN BIOLOGY AND MEDICINE
both of which are ESR-silent (i.e. give no ESR spec-
trum) since there is no longer an unpaired elec- 10 G
tron. Indeed, cyclic hydroxylamines have also been
used as probes for RS, which can oxidize them
back to nitroxide radicals and an ESR signal ap- A
pears. An example is 1-acetoxy-3-carbamoyl-2,2,5,5-
tetramethylpyrrolidine,
B
C
Thisishydrolysedbycellularesterasestoexposethe
NOH group, which can then react with free radicals
Figure6.4 ReductionoftheDMPO–OHspinadducttoanESR-silent
to generate a nitroxide, 3-carbamoyl-proxyl, or 3-CP.
speciesbyascorbate.Hydroxylradicalwasgeneratedbyreactionof
It has been used to detect ROS production in ro- Fe(III)–EDTAwithH2O2.(A)Withoutascorbate,(B)with0.66mM
dentsbyfollowingtheappearanceofanESRsignal.16 ascorbate,(C)acrystalofsolidascorbateaddedafterthespectrahad
A similar probe, bis(1-hydroxy-2,2,6,6-tetramethyl-4- formed.Unpublisheddataofoneoftheauthors(J.M.C.G.)with
piperidinyl)-decandioate, LindsayMaidt,GemmaBrueggemann,andPaulMcCay.Caution
shouldthereforebeemployedwhenattemptingtousespintrapping
tostudythereactionsofreducingagentswithradicals;itisessential
toshowthatthereductantdoesnotsimplyreducethetrap–radical
adduct.Forexample,thethiol-containingdrugcaptoprilreduces
DMPO–OHtoanESR-silentspecies,whichmayhaveledto
overestimatesofcaptopril’sabilitytoscavengeROS(FreeRadic.Res.
24,391,1996).
hasbeenusedtomeasureradicalsinhumanbloodand
tissue samples.17 Cyclic hydroxylamines react faster HOClandONOOH,producingavarietyofproducts,
withO •–(k ~103–104M-1s-1)thandoesDMPO,andso includingradicaladducts.
2 2
lowerlevelsarerequired,4,18 buttheycanbeoxidized Some traps are rapidly metabolized in vivo. Both
by multiple agents (including peroxidase enzymes in PBNandDMPObindtocytochromesP450,andPBN
somecases)andsospecificityisaproblem. can be oxidized in P450-dependent reactions (Sec-
Nitroxide radical adducts of several spin traps are tion 11.5.5). PBN and DMPO can also enhance anti-
easily reduced by cellular reducing agents, such as oxidant defences in some cell types by activating the
ascorbate (Fig. 6.4), constituents of microsomal and
Nrf2system(Section5.5.8).21
mitochondrial electron transport chains, and even by
O • 2 –, and so their signals rapidly disappear in vivo, 6.2.7 Trappingthiylradicals22
as can be measured by L-band ESR.8 They can also
be quenched by direct addition of carbon-centred Spintrappingcanbeusedtodetectmanyradicals,in-
radicals in lipids. Indeed, O •– reacts faster with the cludingRS•(Fig.6.3).ThusDMPOreactswithseveral
2
DMPO–OOHadduct(rateconstant>106 M–1s–1)than RS•radicalswithahighrateconstant,~108M–1s–1.The
DMPO reacts with O •–. Haem ferryl species (Sec- DMPO adduct of the glutathione thiyl radical, GS•,
2
tion 3.22.3) can oxidize nitroxides, again with loss of superficiallyresemblesDMPO–OH,givingafour-line
the ESR signal.19 Caution should also be employed spectrum.However,theintensitypatternisusually1:
in using DMPO to trap OH
•
/O
•–
in photochemical 1:1:1ratherthan1:2:2:1.ThetrapPBNcanalso
2
systems, since DMPO reacts with singlet O to give intercept thiyl radicals but forms less-characteristic
2
•
products that include DMPO–OH and DMPO/HO spectra than does DMPO. DEPMPO is also useful in
2
adducts.20 Spin traps can often be oxidized by trappingRS•(Fig.6.3).

--- Page 348 ---

MEASUREMENT OF REACTIVE SPECIES 293
6.2.8 SpintrappingwithoutESR?4,9,19
Spin traps can be used to detect radicals on pro-
teins or DNA, the trap attaching to the protein- or
DNA-boundradical.Iftheadductisthenoxidizedto
stabilize the linkage, the traps remain attached cova-
Twosuchradicalscanjointogethertogiveadimer,that
lentlyatthepointwheretheradicaloriginallyformed.
maylosewatertoformbiphenyl,
Such adducts can be detected simply and sensitively
(farmoresensitivelythanbyESR)usingantibodiesdir-
ectedagainstDMPO–proteinorDMPO–DNAadducts.
Alternatively, protein mass spectrometry or DNA se-
quencing can be used to identify the site of DMPO
Hydroxycyclohexadienyl radical can alternatively be
attachment.Immunospintrappingcanhelpavoidone
oxidizedtophenol,
problem in the detection of protein radicals by spin
trapping/ESR, namely their tendency to give broad
spectra that convey only limited information. It has
beenusedinanimalstreatedwithtoxinsorsubjected
toischaemia–reperfusion(Section11.5.5)todetectpro-
teinthiylradicalsinvolvedintheglutathionylationof
mitochondrialcomplexI,23 andtoexaminethemech-
anism of the reaction of CuZnSOD with H O (Sec-
2 2
and can also disproportionate, one hydroxycyclohex-
tion3.5.1.6).ItcanbecombinedwithMRItechniques
to help to localize the radicals.9 When mice were fed adienylradicalbeingoxidizedtophenolandtheother
onahigh-fatdiet,immunospintrappingdetectedin-
reducedtobenzene.ThepresenceofO
2
,Fe(III),orCu2+
tendstoincreasetheyieldofhydroxylationproducts.
creased levels of free radicals in muscle, liver, and
kidney.24 Hencetheamountsofthesevariousend-productsob-
•
tainedfromattackofagivenamountofOH uponben-
Anotherapproachistousetrapsthatchangecolour.
zenevarydependingonreactionconditions.Ifsubsti-
Azulenyl nitrone (Table 6.2) is green, but its nitrox-
•
tutedbenzenesareattackedbyOH ,reactionsbecome
ide is purple, and breaks down to generate a red
evenmorecomplex.Foraromaticcarboxylicacids,de-
aldehyde.Theseproductscan be separatedby HPLC
and observed spectrophotometrically.25 Azulenyl ni- carboxylationisfavouredatlowpHintheabsenceof
metalions,whereashydroxylatedproductformationis
tronesareprotectiveagainstischaemia–reperfusionin
favouredifmetalionsarepresent.
animal studies (Section 11.5.5). Finally, HPLC can be
Decarboxylation of benzoic acid, labelled with 14C
combinedwithESRand/ormassspectrometrytoiden-
•
in the carboxyl group, has been used to detect OH
tify all the products formed when a trap is added to
in biological systems.29 The assay is sensitive, since
a biological system, whether they give ESR signals
ornot.26 small amounts of 14CO 2 can be trapped and meas-
uredaccuratelybyscintillationcounting.Benzoatesare
often added to foods as preservatives, and their de-
6.3 Othertrappingmethods, carboxylationbyOH • cangeneratetracesofbenzene.29
An alternative approach is to use benzoic acid la-
asexemplifiedbyhydroxylradical
belled with 13C in the carboxyl group and measure
trapping productionof13CO bymassspectrometry.30However,
2
6.3.1 Aromatichydroxylation27,28 decarboxylationseemstobeaminorreactionpathway
under physiological conditions, and so only a small
• •
Oxidationofaromaticcompoundsbymetalion–H O fractionoftheOH willbemeasured.Also,someRO
2 2 2
mixtureshasbeenknownforover100yearsand,since radicalsappeartobeabletodecarboxylatebenzoate.30
thepioneeringworkofMerzandWatersin1949,has Hence,hydroxylatedaromaticproductsarepreferable
•
generatedanenormouschemicalliterature.Inthecase tomeasuretodetectOH .
•
of the simplest aromatic compound, benzene, OH Usually, hydroxylated products are separated by
addition produces a hydroxycyclohexadienyl radical gas chromatography (GC) or HPLC and measured
(whenaradicaladdstoanon-radical,theadductmust by electrochemical detection, fluorescence spectra,
bearadical), or mass spectrometry. Suitable non-toxic aromatic

--- Page 349 ---

294 FREE RADICALS IN BIOLOGY AND MEDICINE
OH
R OH
OH CO 2 (~11%)
o-Tyrosine
Catechol
R R CO 2 H CO 2 H
OH OH
m-Tyrosine (~49%)
OH OH
Salicylate 2,3–Dihydroxybenzoate
Phenylalanine R
CO H
2
p-Tyrosine OH
(~40%)
HO
OH
2,5–Dihydroxybenzoate
•
Figure6.5 ProductsofthereactionofOH witharomaticcompounds.Atypicalpercentagedistributionofsalicylatehydroxylationproductsis
•
shown,butratiosofend-productsvarydependingonreactionconditions.RememberthattheinitialproductsofOH attackonaromaticringsare
freeradicals,thatcanhavevariablefatesdependingonwhatelseispresent(e.g.transitionmetalions)inthereactionmixture.
•
‘detectors’ must be chosen for use in biological thatcanscavengeOH .Giventhatallbiologicalmol-
•
systems. Salicylate (2-hydroxybenzoate) is popular; ecules react quickly with OH , it seems unlikely that
•
attack of OH upon it produces two dihydroxylated atrap(whetheraromaticoraspintrap)canintercept
•
products (2,3- and 2,5-dihydroxybenzoates), together morethanasmallpercentageofanyOH generatedin
with small amounts of the decarboxylation product vivo.Themethodalsoassumesthatanyhydroxylated
catechol (Fig. 6.5). 4-Hydroxybenzoic acid can also productisnotmetabolizedbyenzymesorfurtheroxi-
be used, forming 3,4-dihydroxybenzoate. Attack dized by ROS. For example, dihydroxybenzoates are
•
of OH upon phenylalanine produces three di- rapidlymetabolizedinperfusedliver,sothatsalicylate
•
hydroxylated products: 2-hydroxyphenylalanine isnotagooddetectorofOH inthisorgan.Theycan
(o-tyrosine), 3-hydroxyphenylalanine (m-tyrosine), alsobeoxidizedbyONOOHandHOCl.Ontheother
and 4-hydroxyphenylalanine (p-tyrosine), but p- hand,salicylateworkswellinisolatedrodentheart.31
tyrosine is also formed from phenylalanine by the Both salicylate and phenylalanine (Fig. 6.6) have
•
enzyme phenylalanine hydroxylase. Both D- and been used as ‘traps’ for the generation of OH in
•
L-isomers of phenylalanine react with OH equally vivo. Thus, 2,3-dihydroxybenzoate (2,3-DHB; Fig. 6.5)
fast, but the D-isomer is not a substrate for phenyl- does not appear to be an enzyme-produced metab-
alanine hydroxylase. Theoretically, therefore, D-phe olite of salicylate in animals, whereas 2,5-DHB can
•
would be the better trap for OH in vivo, although be generated from salicylate by CYPs, i.e. 2,3-DHB
one potential drawback is that it is a substrate for is the preferred product to measure. For example,
D-amino acid oxidase enzymes, which can generate hydroxylation of salicylate to 2,3-DHB was used to
•
H O (Section2.6.2). showOH generationinthelungsofanimalsbreath-
2 2
ing silicate dusts (Section 9.15) or in the brains of
6.3.1.1 Aromatichydroxylationinvivo
animals exposed to certain toxins, such as MDMA
•
IfanaromaticcompoundreactswithOH toformhy- (Section 9.9) or arsenic (Section 9.16.2). It was also
droxylated products that can be accurately measured used to detect OH• production in copper-overloaded
inbiologicalmaterial,andoneormoreoftheseprod- LECrats(Section3.22.5.5).Similarly,o-andm-tyrosines
uctsisnotidenticaltoenzyme-producedhydroxylated do not appear to be formed enzymically in humans.
products,thenformationofthe‘unnatural’product(s) Low levels of o-tyrosine have been reported in hu-
can conceivably be used to assess OH • formation in man urine;32 this o-tyrosine could originate from diet
vivo.Successinsuchstudiesrequiresthatthearomatic (Section 6.16.1) or from oxidative damage. Levels
•
‘trap’ be present at sites of OH generation, at con- of o-tyrosine rose in the urine of pigs subjected
centrationssufficienttocompetewithothermolecules to hypoxia-reoxygenation (Section 7.11.8.1). Salicylate

--- Page 350 ---

MEASUREMENT OF REACTIVE SPECIES 295
• •
and phenylalanine have been used to measure OH detect OH formation in saliva (Section 9.13.6) and
formation in body fluids from patients with rheuma- in hearts during myocardial stunning (Fig. 6.6). Sev-
toid arthritis (Section 10.11) and in humans exposed eralotherhumanstudieshaveusedsalicylatetodetect
•
to ozone (Section 2.6.5). Phenylalanine was used to OH in vivo, with some success. Examples include
400
300
200
100
0
esaeler
laidracoyM
)g/nim/lomn(
enisoryt-o
§
** Group I (n=12)
Group II (n=5)
Group III (n=7)
** **
*
*
*
B Occl 2′ 3′ 4′ 5′ 10′ 20′ 30′ 1h 2h 3h
Reperfusion
esaeler
laidracoyM
)g/nim/lomn(
enisoryt-m
(a)
* P <0.05 ** P <0.01 vs Group III
P <0.05 vs Group II
**
*
1′
(b) 320
**§
240
180 * * P <0.05 ** P <0.01 vs Group III
P <0.05 § P <0.01 vs Group II
*
**§
80
*
0
B Occl 1′ 2′ 3′ 4′ 5′ 10′ 20′ 30′ 1h 2h 3h
Reperfusion
•
Figure6.6 UseofphenylalaninehydroxylationtomeasureOH productionaftermyocardialischaemia–reperfusioninvivo.Ifpartofthe
myocardiumofanopen-chestanaesthetizeddogismadeischaemicforabriefperiod(tooshorttokillthetissue),subsequentreperfusiondoesnot
causeimmediatereturnofcontractilefunction.Thismyocardialstunningphenomenoncanbeattenuatedbyseveralantioxidants.The
•
involvementofOH wasconfirmedusingphenylalanine(Fig.6.5).AnimalswerepreloadedwithL-phenylalanine.Noo-orm-tyrosineswere
detectedinthecirculationsincethesearenotnormalmetabolitesofL-phenylalanine(unlikep-tyrosine,producedbytheenzymephenylalanine
hydroxylase).However,o-andm-tyrosine,(a)and(b)respectively,wereproducedbytheheartafterischaemia–reperfusion(groupIanimals,o).
Theamountsformedweredecreasedbyantioxidants,includingmercaptopropionylglycine(groupII,•)andamixtureofSOD,catalase,and
desferrioxamine(groupIII,(cid:4))butnotbyinhibitorsofNOS,i.e.NO•(and,byimplication,ONOO–)werenotinvolvedintheOH • generation.Data
adaptedfromCirc.Res.73,534,1993,bycourtesyofDrRobertoBolliandthepublishers.

--- Page 351 ---

296 FREE RADICALS IN BIOLOGY AND MEDICINE
•
studies on diabetes, alcoholism, radiation exposure be ineffective when OH is not generated in ‘free
(Section9.20),andmyocardialinfarction.27Phenylalan- solution’ but is formed upon a biological target, for
•
ine hydroxylation was used to detect OH formation example when iron or copper ions bind to a carbo-
inthecolonofrats33andendogenouslevelsofprotein- hydrate, protein, lipid, or nucleic acid that is then
boundortho-ormeta-tyrosineshavealsobeenusedto exposed to H O . Reaction of OH• with the target is
2 2
•
implicateOH formationinvivo(Section6.16). favoured over reaction with a scavenger in free solu-
Some plants (e.g. fescue grasses) produce tion. This principle is illustrated by the deoxyribose
m-tyrosine, which appears to be a toxic agent when assay (Section 6.3.3) and the coumarin hydroxylation
•
addedtocellsathighlevelsandhasbeenspeculated assay (Table 6.4). In addition, many OH scavengers
to be produced as a ‘natural herbicide’ that attacks are non-specific. For example, the widely used thio-
adjacent species.34 The production of m-tyrosine by ureaanddimethylthioureaalsoreactwithO •–,H O ,
2 2 2
cancer cells has been reported, allegedly related to HOCl, and ONOO–, and they chelate metal ions.38
theirproductionofOH • .35 Several oxysulphur radicals can react with formate
•
However,beawarethatsomeRSotherthanOH can and ethanol (Section 9.12.3). Dimethylsulphoxideis a
hydroxylatearomaticcompounds.SingletO hydrox- substrate for methionine sulphoxide reductases (Sec-
2
ylatesphenolandaniline(to4-hydroxyaniline).Italso tion 5.14.1). Mannitol can protect cells by preventing
attackssalicylate,36 butproduces2,5-DHBratherthan swelling(Section10.6.4)andmayhaveotherbiological
2,3-DHB.Myeloperoxidase(Section8.7.5)canconvert effectsaswell.39
salicylate to 2-5-DHB. These are further reasons why
measurementof2,3-DHB ispreferableasan indexof 6.3.3 Thedeoxyriboseassay40
OH • generation. Addition of ONOO– to salicylate or
•
phenylalanine at pH 7.4 can generate hydroxylation Attack of OH on 2-deoxyribose produces a range of
productsidenticaltothoseinFig.6.5,mostlikelydue products (Section 5.8.2). On heating at low pH, some
•
togenerationofOH fromdecompositionofONOOH ofthemdecomposetoformmalondialdehyde(MDA),
(Section 2.6). Addition of ONOO– (unlike OH • ) add- which can be detected by adding thiobarbituric acid
itionally generates nitration products from salicylate (TBA) to give a pink (TBA) –MDA chromogen. De-
2
andphenylalanine.37 oxyribosecanthusbeusedtodetectOH • production,
althoughitisunclearwhetherornotsomeotherROS
candegradedeoxyribose.
6.3.2 Useofhydroxylradicalscavengers
•
Inhibition upon addition of OH scavengers is of-
6.3.4 Measurementofrateconstants
•
ten used as evidence that OH is responsible for a forOH • reactions40
particular reaction (e.g. Table 6.3). In simple chem-
ical systems this often works well, but in biological The definitive technique for studying the rate and
systems it is fraught with danger. Scavengers can mechanismofcompoundsreactingwithOH • ispulse
Table6.3 Formationandscavengingofhydroxylradicalsduringtheoxidationofxanthinebyxanthineoxidaseinthepresenceofan
ironchelate.
Reagentadded(eachat5mM RateconstantforreactionwithOH• Percentageinhibitionofhydroxylation
finalconcentration) (M–1S –1)
None – 0
Mannitol 2.7×109 37
Sodiumformate 3.5×109 52
Thiourea 4.7×109 76
Urea <7.0×105 0
L E e x t p t e . r 9 im 2, en 3 t 2 s 1 w ,1 e 9 re 78 ca ). rr T i h e e d O ou H ta • t f p o H rm 7 e . d 4 w u a si s n d g e O tec H te • d g b e y n m er e a a te su d ri b n y g r s e a a l c ic t y io la n te of hy O d • 2 ro – xy a l n a d tio H n 2 . O H 2 yd ( r f o ro x m ylr o a x d i i d c a a t l i s o t n ha o t f e x s a c n a t p h e in r e ea b c y ti X o O n ) w w it i h th iro fe n r – ri E c D E T D A TA an ( d FE t B h S e
otherreagentspresent(e.g.xanthine)areequally‘available’tothesalicylateandtootheraddedscavengersofOH•
.Hencetheamountofhydroxylation
canbedecreasedbyadding‘OH• scavengers’.Thefasterthese‘scavengers’reactwithOH•
,themoretheyinhibitformationofhydroxylatedproducts.

--- Page 352 ---

MEASUREMENT
OF
REACTIVE
SPECIES
297
Table6.4 Somemethodsforthedetectionofhydroxylradicals.
Method Principleofmethod Comments
Hydroxylationofantipyrine Metabolized invivo in humans to 3-hydroxymethyl UsedtostudyOH • productionduringexerciseandintermittent
•
and 4-hydroxylated products. Attack by OH gives claudication(FreeRadic.Res35,435,2001;Metabolism50,
ortho-and meta-hydroxylation on the benzene ring: 1484,2001).Notwidelyused.
apparentlythesearenotnormalmetabolites.
•
Hydroxylationofterephthalicacid(benzene1,4-dicarboxylicacid) Non-fluorescent; hydroxylated by OH at position Onlyoneisomerisformed.Sensitivemethod,buttodatenot
•
marked*tofluorescent2-hydroxy-terephthalate(exci- widelyused,althoughhasbeenemployedtodetectOH inthe
tation326nm,emission432nm). brain(J.Appl.Physiol.98,2304,2005;J.Neurochem.105,
738,2008).
•
Hydroxylationofphthalichydrazide Non-fluorescent, forms fluorescent 3-hydroxylated Used to study OH in fungal degradation of wood
products(Anal.Chem.83,261,2011). (Holzforschung51,557,1997).
•
Hydroxylationofphenethylpolyacrylate Ahighmolecularweightpolymer,cannotbetakenup UsedtodetectOH producedbybrownrotfungi(FEBSLett.
bycells. 531,483,2002).
Conversionofmethional(CH3SCH2CH2CHO)andrelated MeasurementofethylenebyGC. NotspecificforOH • ;oxidizedbyRO •
2
,decomposingONOO–
compounds(methionineor2-keto-4-methylthiobutanoicacid, and some peroxidase enzymes (Section 8.5.3); confirmatory
•
CH3SCH2CH2COCOOH)intoethylene(ethene)gas(H2C=CH2) evidenceforroleofOH required.
Coumarinfluorescence Coumarin-3-carboxylicacid(CCA) Thisprobehasbeencovalentlylinkedtovariousbiomolecules
•
andfluorescencechangesusedtomeasurelocalizedOH gen-
•
eration(Int.J.Rad.Biol.63,445,1993).Forexample,OH
generation by copper ions bound to DNA could not be de-
creased by adding DMSO, methanol, or ethanol, but could
ishydroxylatedatposition7(*)toafluorescentproduct be by histidine (which chelates copper). This is typical of a
(FreeRadic.Res.46,861,2012). ‘site-specific’reaction(FreeRadic.Biol.Med.18,669,1995).
Continued

--- Page 353 ---

298
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table6.4 (Continued)
Method Principleofmethod Comments
Conversionofcaffeineto8-oxocaffeine Caffeineishydroxylatedatposition8;productanalysed Formation of 8-oxocaffeine from endogenous caffeine has
byHPLCwithelectrochemicaldetection. beenusedtomeasurefreeradicalgenerationduringroasting
HH 33 CC NN OO 6 NN 7 CCHH 33 HH 33 CC NN OO 6 NN 7 CCHH 33 andbrewingofcoffee(J.Agr.FoodChem.43,1332,1995).
8 OO
OO NN NN OO NN NNHH
CCHH CCHH
33 33
• •
Dimethylsulphoxide(DMSO)method Hydroxyl radicals react with DMSO, generating, in a NotspecificforOH ;confirmatoryevidenceforroleofOH re-
complex set of reactions, methane gas, measured by quired.Babbsetal.(FreeRad.Biol.Med.6,493,1989)have
gaschromatography(Biochemistry20,6006,1981),or suggestedthatoxidationofDMSOtoCH3SO2H,methanesul-
formaldehyde,measuredcolorimetrically. phinicacid(measuredcolorimetricallyorbyHPLC)isameans
( • C C H H 3 3 )2 + SO O + 2 → OH • CH → 3OO CH • 3SO2H + •CH3 o ra f d d ic e a te ls ct (A in n g a O l. H C • he in m v . iv 6 o 9 . , A 4 n 2 o 9 t 5 h , e 1 r 9 a 9 p 7 p ) r . o L a e c v h el i s s o to fO tr 2 ap w t il h l e af C fe H c • 3 t
2CH3OO • → HCHO + CH3OH + O2 theamountsofthevariousend-productssinceO2reactswith
• • C C H H 3 3 + + C (C H H 3 3 S ) O 2 S 2 O H → → C C H H 4 4 + + H C 3 H S 3 O SO CH • 2• 2 CH • 3 radicals.
•
Benzoatefluorescence Reaction of benzoic acid with OH gives 3- and 4- Sensitivemethod(Biochem.J.243,709,1987);confirmatory
•
hydroxybenzoates, which are fluorescent at 407 nm evidenceforroleofOH required.
whenexcitedat305nm.4-Hydroxybenzoateitselfcan
also be used, forming 3,4-dihydroxybenzoate, meas-
ured by HPLC, GC-MS, LC-MS, or microfluidic chip
(Anal.Biochem.241,67,1996;Analyst139,3416,
2014).
Oxidationof1,3,5-trimethylbenzene(TMB) LossofTMBinairisattributedtothepresenceofOH • . UsedtomeasureOH • inindoorandoutdoorair.AssumesTMB
•
isspecificforreactionwithOH (Env.Sci.Technol.31,3719,
1997;44,6269,2010).

--- Page 354 ---

MEASUREMENT OF REACTIVE SPECIES 299
radiolysis(Section2.3.3.1),butsuchfacilitiesarescarce (DHE) and lucigenin, are widely employed to de-
and so many laboratories use other methods. For ex- tect O
•–,
as examined in detail in Section 6.12, but
2
•
ample, an OH -generating system can be incubated their chemistry is complex, although conversion of
with DMPO and the ESR signal of DMPO-OH ob- DHE to 2-hydroxyethidium is a useful assay. A ‘yel-
served. An added OH
•
scavenger competes with low fluorescent protein’ has been developedas a O
•–
2
•
DMPO for OH and decreases the ESR signal; a sensor, although its specificity has been questioned
competition plot allows a rate constant to be calcu- (Section6.10).
lated.Thedeoxyriboseassaycanalsobeused;OH
•
is Often,O
•–ismeasuredbyitsabilitytoreducecyto-
2
generatedbyamixtureofascorbate,H O ,andferric chrome c or nitroblue tetrazolium (NBT). The former
2 2
•
EDTA.AnyOH notscavengedbytheiron–EDTAor reactionissimple,
•
o sc t a h v er en re g a e c r t c a o n m ts p a e tt t a e c s k w s i t t h h e d d e e o o x x y y r r ib ib o o s s e e f . o A r n th a e d O d H ed • , O a H nd cytochromec–Fe(III)+O • 2 –→O 2 +cytochromec–Fe2+
inhibitsgenerationofMDA.Acompetitionplotcanbe However, many other substances reduce cytochrome
•
usedtocalculatetherateconstantforOH scavenging. c (especially ascorbate and thiols) and interfere with
These and similar methods require several O •–determination,soitisessentialtoshowthatthere-
2
controls:40 ductionisinhibitedbySODbeforeassumingthatO •–
2
iscausingit.Inaddition,cytochromeoxidaseincells
1. Checkthatthesubstanceundertestdoesnotinter-
• •
andtissuescanre-oxidizeFe2+-cytochromec.Nitroblue
fere with OH formation. For example, if OH is
tetrazoliumislessoftenreducedbyothercellularre-
madebyFentonchemistry,doesthesubstancescav-
ductants, but the chemistry of chromogen formation
enge H 2 O 2 or bind iron ions? The deoxyribose iscomplex,andO •–canbegeneratedduringthis(Fig.
assay avoids the latter by pre-binding the iron 2
2.4).Thus,additionofNBTtoabiologicalsystemnot
toEDTA.
makingO
•–butabletoreduceNBTcancreateanarte-
2. Check that the substance does not interfere with factualO • 2 – generation.UsingXTT(Table3.2)issome-
measurementofproducts.Forexample,doesitre- 2
what better. Superoxide can also oxidize molecules
ducetheDMPO–OHadducttoanESR-silentspecies
suchasadrenalinorpyrogalloltochromophores,are-
(Fig.6.4)?Inthedeoxyriboseassay,doesitinterfere
actionsometimesusedtodetectO
•–(Table3.2).Again
with the TBA test, or generate a false chromogen 2
• there are problems: once adrenalin or pyrogallol has
whenitreactswithOH ?
begunoxidizing(whetherornotoxidationwasstarted
IfEDTAisomittedfromthedeoxyriboseassay,some byO
•–),O •–
isgeneratedandoxidizesmoreadrenalin
2 2
of the iron binds to deoxyribose.40 The bound iron orpyrogallol.Thusitisdifficulttorelateadrenochrome
ionsappeartoparticipateinFentonchemistry,butthe formationtotherateofO
•–
generationbythesystem
2
•
OH immediatelyattacksdeoxyribose.Hydroxylrad- undertest.
icalscavengers(suchasHepes,methanol,orethanol), AnotherdetectormoleculesometimesusedisTiron
at moderate concentrations, do not inhibit this site- (1,2-dihydroxybenzene-3,5-disulphonate),
specificdeoxyribosedegradation.Theonlysubstances
that do inhibit are those that chelate iron ions well
enoughtoremovethemfromdeoxyribose.
6.3.5 Othertrappingmethodsfor
hydroxylradical
•
MultipleotherdetectormoleculesforOH havebeen
described, each with its own advantages and draw- Likemanydiphenols(Section2.5.3.5),Tironreactswith
backs.Table6.4listsseveralofthem. O
•–
to give a semiquinone, which can be measured
2
by ESR. For example, tiron semiquinone formation
has been used to measure O
•–
production by chloro-
6.4 Detectionofsuperoxide 2
plasts. One problem is that diphenols are oxidized
Methods used to detect O •– overlap with those by many systems, including peroxidases and RO •
used to assay SOD (Section 2 3.5.6). Spin trapping radicals,soconfirmatoryevidenceisneededthatO • 2 –
2
and cyclic hydroxylamines can be useful (Section isbeingdetected.42TironalsochelatesCa2+,andprob-
6.2).18,41 Fluorescentprobes,suchasdihydroethidium ablyothermetals.43 EveninhibitionsbySODmustbe

--- Page 355 ---

300 FREE RADICALS IN BIOLOGY AND MEDICINE
interpreted with caution in systems containing semi- byXOinaccurate.HPLCdeterminationofurate,or
quinones(Section2.5.3.5). measurementofO uptakebyXO,arealternatives.
2
Superoxide electrodes have been described.44,45 2. Checkthatthesubstanceundertestdoesnotdirectly
Somemeasurereductionofboundcytochromec;usu- reducecytochromecorNBT.
ally SOD addition is used to show that reduction is 3. Consider the possibility that a radical formed by
O
•–-mediated.
Others electrochemically detect H O attackofO
•–onasubstancecoulditselfreducecyto-
2 2 2 2
fromdismutationofO
•–
bySODattachedtotheelec- chromecorNBT.Thisisoftenrevealedasdeviation
2
trode. Obviously, H O from other sources can affect from linear competition kinetics at high scavenger
2 2
them. Cytochrome c-based sensors are also subject concentrations.
to interference by H O , which reacts with this pro-
2 2
tein (Section 3.22.3). Hence these electrodes have not
becomewidelyused. 6.4.3 Triphenylradical-basedprobes47
Theseprobesshowwell-definedESRspectra,sensitive
6.4.1 Theaconitaseassayforsuperoxide
topO (Section6.2.2).SomecanalsoreactwithO
•–,to
2 2
Superoxide displaces iron from the [4Fe–4S]2+ clus- causelossoftheESRsignal.Oneofthem,TAMOXO63,
ter of aconitase, causing loss of enzyme activity. The
rate constant for reaction is about 2×107 M–1s–1 at
25 ◦C, from which it was calculated that in SOD-
deficient E. coli the O
•–
concentration was ~300 pM,
2
ascomparedwith20to40pMinnormalE.coli(Sec-
tion 3.7.1). The assay has also been used to calcu-
lateintra-mitochondrialO
•–
levelsinanimalcells.For
2
example, antimycin A addition (to inhibit mitochon-
drialelectrontransport)increasedO • 2 – from~6pMto reactswithO • 2 –(and/orwithHO • 2 inequilibriumwith
~15pMinratfibroblasts.46 O •–)witharateconstantof3.1×103M–1s–1,butisnot
2
The aconitase assay is sensitive and relevant to an reducedbyGSH,NADPH,orascorbate.Simultaneous
importantbiologicaleffectofO • 2 –.Oneproblemisthat observation of the line width (Section 6.2.2) and the
other RS (e.g. ONOO–, N 2 O 3 ) and the iron status of rateoflossoftheESRsignalcanbeusedtomeasure
the cell also affect aconitase activity. Indeed, restor- levelsofbothO •– andO .Theprobealsoreactswith
2 2
ation of aconitase activity has been used as an assay RO • radicals, apparently more slowly than with O •–,
2 2
for‘catalytic’ironions(Section5.3.3.1). butnotwithNO • .ReactionwithO •–/HO • canalsobe
2 2
followedbyafallinabsorbanceat464nm,accompan-
6.4.2 RateconstantsforreactionswithO •– iedbyariseat546nmduetoproductformation.
2
Perchlorotriphenylmethylradicalreactsevenfaster
These are ideally obtained by pulse radiolysis (Sec- withO •– (k >108 M-1s-1).Tetrathiatriarylmethylrad-
2 2
tion2.3.3.1).However,pulseradiolysisisunsuitablefor ical (CTO2-H) reacts with O •– to both lose its ESR
measuringmanyreactionsofO
•–
inaqueoussolution,
2
2 signal and change in colour from green to purple,
since the reaction rates are often lower than non-
allowing dual methods (ESR signal and absorbance
enzymic O •
2
– dismutation. Sometimes, simpler meth-
change)todetectO
•–.48
2
odsareadequate.Forexample,amixtureofhypoxan-
thine (or xanthine) and XO at pH 7.4 generates O
•–,
2
whichreactswithcytochromecandNBTwithknown 6.4.4 Histochemicaldetection
rate constants, 2.6 × 105 and 6 × 104 M–1s–1, respect-
ively.AnyaddedmoleculereactingwithO
•–decreases Histochemical methods4,49 to detect O •
2
– in tis-
2 sues have been described. For example, perfusion
the rates of cytochrome c or NBT reduction, and a
with tetrazolium salts can lead to microscopically
competitionplotallowscalculationofanapproximate
observableformazanprecipitationatsitesofO
•–
gen-
rateconstant.Essentialcontrols40areasfollows: 2
eration.Figure6.7showsananimalexampleandFig-
1. Check that the substance under test does not in- ures 7.12 and 8.18 plant examples. Another method
hibit O
•–
generation (e.g. by inhibiting XO). Many employs conversion of diaminobenzidine (DAB) to
2
compounds absorb strongly at 290 nm, making an insoluble product. Tissues or organs are perfused
spectrophotometricassessmentofurateproduction with DAB and Mn2+ ions. Superoxide oxidizes Mn2+

--- Page 356 ---

MEASUREMENT OF REACTIVE SPECIES 301
((aa)) (b)
(c) (d)
(e) (f)
(g)
Figure6.7(colourplate10) Toppanels:DetectionofO
•–andnitratedproteinsinvivo.Ratswereinjectedwithendotoxintocauseseptic
2
shock.TherewasanincreaseiniNOSinthelung.Stainingoflungsectionswithananti-nitrotyrosineantibodyshowedthepresenceofthismodified
aminoacid.Perfusionwithnitrobluetetrazoliumwasalsocarriedout;O
•–reducesittoblueformazan.Lungsfromuntreatedrats(a,c,e)or48h
2
afterendotoxaemia(b,d,f)wereperfusedwithaphorbolestertoactivatetherespiratoryburst(Section8.7)andwithnitrobluetetrazolium,and
fixed.Sectionswerethenstainedwithananti-nitrotyrosineantibody(c,d,e,f)orcontrolantiserum(a,b).(a)Nostaining;(b)formazanproduction
suggestiveofO
•–;(c,e)controlforanti-nitrotyrosinestaining;(d,f)Increasednitrotyrosineandformazaninendotoxaemicanimals.Magnification:
2
x1000(a,b,e,f)or×400(c,d).DatafromJ.Leuk.Biol.56,759,1994,bycourtesyofDrDebraLaskinandthepublishers.Bottompanel:
histochemicaldetectionofH2O2productioninahealing(3-day)inflammatoryskinlesioninarabbit.Theleukocytesinthecrustareactively
producingH2O2(shownbytheorange-browncolour).Newepitheliumisgrowingbeneaththecrust.Thetissuesectionwasfixedfor4hat4◦Cand
stainedwithDABfor5hat37◦C.PhotographfromJ.Leuk.Biol.56,436,1994,bycourtesyofDrArthurM.DannenbergJrandthepublishers.

--- Page 357 ---

302 FREE RADICALS IN BIOLOGY AND MEDICINE
toMn(III),whichinturnoxidizestheDAB.Thiscom- ONOO– oxidizes the dye dihydrorhodamine 123
pound can be used, under different reaction condi- (DHR123)intorhodamine123(Section6.12.2),which
tions,todetectH O (Fig.6.7,bottom). fluoresces at 536 nm when illuminated at 500 nm.53
2 2
Oxidation does not require metal ions and is not in-
•
hibited by OH scavengers, but can be inhibited60%
6.5 Detectionofnitricoxide4,50
by 100 mM HCO– (which reacts with ONOO–; Sec-
3
ManymethodshavebeendevelopedtomeasureNO • . tion 2.6.1). Oxidation of injected DHR 123 was ob-
Some are trapping methods, involving reactions of served in rats suffering from endotoxic or haemor-
NO • or its derivatives with spin traps, dyes, haem rhagic shock and was decreased by administration
compounds, other metal complexes, or ozone (Table of NOS inhibitors. However, DHR is not specific
6.5).AnalternativeapproachistoimplicateNO • ina as a ‘probe’ for ONOO– (Section 6.12.2). Peroxyni-
biological process if that process is blocked by NOS trite can also oxidize some of the boronate-based
inhibitors.However,NOSinhibitorsarenotnecessar- probes now being widely used to detect H 2 O 2 , and
ily specific; often they can scavenge OH • , HOCl, or some may end up being better ‘ONOO– detectors’
ONOOH, and so controls are needed (Table 6.5). Yet than‘H 2 O 2 detectors’(Section6.10).Otherfluorescent
anothertechniqueistoexamineend-productsofNO • , probesforONOO–areunderdevelopment,54including
themostcommonbeingNO– 2 (Table6.5).Forexample, HK-Green-2,-3and-4andPN 600 .
it has been suggested that plasma levels of NO– in
2
•
humans are a measure of vascular endothelial NO 6.6.2 Nitrationassays55
synthesis (Section 2.5.6).51 However, NO– is quickly
2
oxidizedtoNO–invivo(Section2.5.6). AdditionofONOO–leadstonitrationofaromaticcom-
3
Nitric oxide can oxidize to form such species as pounds, including tyrosine, tryptophan, and phenyl-
N O and can also react with O •– to give ONOO–. alanine.Mostattentionhasbeenpaidtotyrosine:both
2 3 2
All of these species can interfere with NO • detection thefreeaminoacidandtyrosineresidueswithinpro-
byvariousmethods(Table6.5).Forexample,whereas teins (e.g. SOD; Section 2.6.1) can be nitrated to give
NO • underaerobicconditionseventuallyformsNO–, 3-nitrotyrosine (3-NT). Nitrations by ONOO– are ac-
2
breakdown of ONOO– generates mostly nitrate, NO– celerated by some transition metal ions and metallo-
3
(Section2.6.1).ThusmeasuringonlyNO–inbiological proteins,includingCuZnSOD,MnSOD,andhorserad-
2
systems can underestimate the total amount of NO • ish peroxidase. Tyrosine does not react directly with
that was generated; both NO– and NO– should be ONOO–; it is first oxidized to tyrosyl radicals by RS
2 3
measured. generated from ONOO– (Section 2.6.1). The tyrosyl
•
radicals can react with NO to generate 3-NT. Al-
2
ternative fates of tyrosyl radical are to dimerize to
6.5.1 Calibration
bityrosine, or to react with O
•–,
GSH, or ascorbate
2
RegardlessofthemethodusedtomeasureNO • ,itwill (Section2.5.4).ThepresenceofCO 2 /HCO– 3 stimulates
need calibration. The direct methods (Table 6.5) can tyrosinenitration(Section2.6.1).
becalibratedusingNO • itself.Thismaybepurchased Nitrationoftyrosinecanbemeasuredspectrophoto-
asagas,generatedbyacidificationofnitrites,orpro- metrically(3-NTisyellowatalkalinepH),orbyamino
duced by the decomposition of ‘nitric oxide donors’, acidanalysisafterhydrolysisofmodifiedproteins.Li-
although their chemistry is complex and care must quid (or gas) chromatography/mass spectrometry or
be taken in interpreting results obtained with them HPLC with absorbance or electrochemical detection
(Table2.9). have also been used. HPLC analysis should be inter-
Severaltechniquestomeasurenitroxylarebeingde- preted with caution because some tissues, especially
veloped,althoughmoreworkisrequiredbeforethey brain, contain compounds56 that coelute with 3-NT
canbeappliedtobiologicalsystems.52 (also see Section 10.22.2). Electrochemical detection
(whichhashighsensitivity)iseasierifthenitrotyrosine
inbiologicalsamplesisfirstreducedtoaminotyrosine,
6.6 Detectionofperoxynitrite
whichisoxidizedatmuchlowervoltages,byaddition
ofthestrongreducingagentdithionite.
6.6.1 Probesforperoxynitrite
An alternative approach is the use of polyclonal
Generation of ONOO– by cells and tissues has or monoclonal antibodies directed against nitrated
been assessed using several reagents. For example, proteins. Although less quantitative than the above

--- Page 358 ---

MEASUREMENT
OF
REACTIVE
SPECIES
303
Table6.5 Somemethodsforthedetectionofnitricoxide.
Methods Principleofmethod Comments
A.Directmethods
• •
Lightemission ReactionofNO withO3produceslight,viaexcited-stateni- Sensitive(nMrange).Measuresonlygas-phaseNO .Poten-
•
trogendioxide tialinterferencebyotherlight-emittingsystems.NO mustbe
N N O O • 2 + (e O xc 3 ite → d)→ O2+ NO N • 2 O + • 2 li ( g e h x t cited) d an is a p l l y a s c is e , d e f . r g o . m by th fl e u b sh io in lo g gi w ca it l h m N a 2 te , r s ia o l m in e t t o im t e h s e t g ra a n s s p fe h r a i s s e n f o o t r
quantitative.
• •
NO electrodes Multipletypes(Chem.Soc.Rev.39,1925,2010).Forexample, UsedtostudyNO exhalationinhumans,anddemonstrate
•
inporphyrinicsensorsNO bindstoametallo-porphyrin(P) elevatedlevelsinasthma(Thorax51,233,1996),~10nM
adsorbedontoananodeandisoxidizedelectrochemically,e.g. sensitivity.Easytouse,butseveralreportsofinterferenceby
foranickel(P) ascorbate,catecholaminesandNO–.Insertionofaporphyrinic
Ni(P) + NO • → Ni(P)NO → Ni(P)NO++e– probeintoahandveinwasusedto 2 detectNO • invivoin1995
•
Metallophthalocyanineelectrodescanalsobeused. (Lancet346,153,1995).SeveralreportsthatNO electrodes
areunreliable(e.g.NitricOxide21,92,2009).
Haemoglobintrapping Nitricoxidereactswithoxyhaemoglobin,eventuallyconverting Sensitivity:~μM.Simpletoperform.Myoglobincanalsobe
ittomethaemoglobin,(cid:6)Aismeasured. used.Interferencecanoccurwithotheroxidizingagents,e.g.
ONOO–causingthesameoxidation.Haemoglobinadditionof-
•
ten used to bind NO and block its effects in experimental
•
systems,asacheckthateffectsareduetoNO .
Spintrapping4 Varioustrapsavailable,including Formation of ESR-detectable nitrosylhaemoglobin in blood
• Haemoglobin (ESR changes are an alternative to (cid:6)A and tissues can be used as an index of NO • produc-
measurement) tion,e.g.inischaemia–reperfusionoforgans.InjectedFe2+–
•Otherhaemproteins(Fe2+state) dithiocarbamateshavebeenusedtodetectNO • inanimals
•Fe2+-dithiocarbamates(diethyldithiocarbamateoftenused) with septic shock (Bull.Exp.Biol.Med.141, 211, 2006).
•Fe2+-thiosulphate Nitrosothiolate ligand signals, probably involving non-haem
NitricoxideisagoodligandtoFe2+ionsandthenitrosylcom- iron–sulphur proteins, have been detected by ESR in NO • -
plexesproducedhavecharacteristicESRspectra(e.g.HbNO, exposedcellsandtissues.
NOFe[DTC]2,Fe[S2O3]2[NO]2).SomeoralloftheseFe2+–traps
•
canreactwithH2O2toformOH andtheresultingferricform
canbereducedbacktoFe2+byascorbateorGSH(FreeRadic.
Biol.Med.39,1581,2005),i.e.theirchemistryiscomplex.
Continued

--- Page 359 ---

304
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table6.5 (Continued)
Methods Principleofmethod Comments
•
AttemptstouseDMPOtotrapNO havegivenequivocalre- Reduction of nitroxides to ESR-silent species by ascorbate,
sults. Indeed, some traps can release NO
•
(Fig. 6.2). More GSH, and sometimes O
•–
(Fig. 6.4) can be a problem in
2
successhasbeenobtainedwithnitronylnitroxides,agroup biologicalsystems(e.g.Free.Radic.Res.26,7,1997).
oforganiccompoundscontainingbothnitroneandnitroxide
groups(FreeRadic.Res.46,1004,2012).Nitronylnitroxides
•
reactwithNO togiveiminonitroxides,detectablebyESRsince
theyhavedifferentESRspectra.TheNNOcarboxy-PTIO(J.
Clin.Biochem.Nutr.47, 1, 2010) has been used to detect
• andalsoantagonizetheactionofNO inbiologicalsystems.
Nitronyl nitroxides have also been used as radioprotective
agents (Biochimie95, 1574, 2013; Section 9.20.1). Chelo-
tropicagents,suchas7,7,8,8-tetramethyl-o-quinodimethane,
• •
havealsobeenusedtodetectNO .TheybindNO togenerate
anitroxideradical,detectablebyESR(J.Am.Chem.Soc.116,
2767,1994).
4,5-Diaminofluoresceindiacetate(DAF-2-diacetate)andre- Entercellsandtheacetylgroupremovedbyesterases.Canac- SeeNitricOxide9,217,2003andFreeRadic.Biol.Med.39,
latedcompounds(e.g.DAF-2-FM,afluorinatedderivative). cumulatetomMintracellularlevels.ReactwithNO+orN2O3 327,2005.Detectionlimit~5nM.CanalsoreactwithONOO–
•
produced by NO oxidation to form a fluorescent product, andperoxidase–H2O2systems.Interferencebyascorbateand
•
HO O O i.e.theydonotdetectNO directly.Canbeusedtoidentify dehydroascorbatereported.
•
individualNO -producingcellsintissueslices.
F F
COOH
NH
2
NHCH
3
Fluorescentnaptho[2,3-d]imidazolderivativesorseminaptho- ReactwithCu2+toformnon-fluorescentcompoundsthathave Inorg.Chem.50,9385,2011;Chem.Eur.J.18,12388,2012;
fluoresceinscaffolds beenusedtoimageNO • incellsbyreductionofCu2+.Appear TrendsBiochem.Sci.38,556,2013.
•
todetectNO directly.
•
Diaminoanthroquinone Purple dye oxidized by NO-derived species (e.g. N2O3) to Can be used to detect sites of NO production in tissues.
insolubleredfluorescentproduct. ProbablyoxidizedbyseveralRNS(NitricOxide9,217,2003).

--- Page 360 ---

MEASUREMENT
OF
REACTIVE
SPECIES
305
Table6.5 (Continued)
Methods Principleofmethod Comments
MitochondriallytargetedNO•probes FluorescentprobesattachedtoTPP(Section11.5.12)totarget Anal.Chem.85,7026,2013
themtomitochondria.
B.Indirectmethods
NO–measurement OxidationofNO • generatesmostlyNO– Sensitivity:μM.NO–invivoisrapidlyoxidizedtoNO–.NO–
2 4NO • +O2+2H2O→4NO–
2
+ 4H+ 2 canbedetectedin 2 theassaybyusingnitratereducta 3 seen 3 -
In the Griess reaction NO– reacts with sulphanilamide in zymesorchemicalreducingagentstoconvertittoNO–.Nitrate
2 2
an acidic solution ofN-(1-naphthyl)ethylenediamine to give andNO–canalsocomefromdiet(Section2.5.6).Thusinone
2
acolouredazoproduct((cid:6)Aat548nm).Fluorimetry:reac- humanstudy,basalplasmaNO–was29±1μMandroseto
3
tionofNO–with2,3-diaminonaphthaleneformsafluorescent 205μM2hafterintakeofNO–-richfood.RangesofNO–and
2 3 2
product,3,3-naphthotriazole. NO–inplasmasamplesarequotedas1.3–13μMand4.0–
3
45.3μMinhealthypeople(Clin.Chem.41,892,1995).They
canalsobemeasuredinurine.Highascorbatelevelscaninter-
ferewiththeassay.InhaledNO • islargelyconvertedtoNO–
3
inhumans.GC-MSmethodstomeasureNO–/NO– havealso
2 3
beendeveloped.Oxidesofnitrogeninpollutedaircansome-
timesdissolveinsamplesbeinganalysedandgivefalsely-high
results(Anal.Biochem.397,126,2010).
Measurementofotheroxidationproducts Basedonformationofmore-reactivespeciesonthepathway Allsimplespectrophotometricmethods.Potentialinterference
fromNO • toNO–
2
inpresenceofO2.ThusoxidizingNO • con- fromotherRNS,e.g.ONOO–orNO •
2
.
vertsferrocyanidetoferricyanide((cid:6)Aat420nm)andthedye
ABTStothecolouredABTS•+((cid:6)Aat660nm).Nitrosationof
sulphanilamidegeneratesacolouredazodye.
•
UseofNOSinhibitors Canuse‘general’inhibitorsofallNOSisoformsorinhibitorsse- Subjecttosuitablecontrols,canprovideevidencethatNO (or
•
lectiveforaparticulartype.Theformeraregenerallyanalogues speciesderivedfromit)areinvolved.However,NO canarise
of the NOS substrate L-arginine, such as N-monomethyl- byreactionsnotinvolvingNOS,e.g.fromNO–
2
(Section2.5.6).
L-arginine (L-NMMA) or N-nitro-L-arginine methyl es-
ter (L-NAME). Essential controls include showing that the
D-isomersdonotinhibit(e.g.bothL-andD-formsarepower-
•
fulOH scavengers;Br.J.Pharmacol.122,1702,1997)and
thatinhibitionisreversedbyaddingexcessL-arginine.More-
selectiveinhibitorsincludeaminoguanidine(iNOS)andN-(1-
(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide(Eur.
J.Med.Chem.55,94,2012).
AdaptedfromTable1,p.278,AnalysisofFreeRadicalReactionsinBiologicalSystems(Favieretal.eds),Birkhauser-Verlag,Basle,1995,bycourtesyofDrM.Fontecaveandthepublishers.
AlsoseeCurr.Opin.Chem.Biol.14,43,2010andAnal.Chem.85,1957,2013.

--- Page 361 ---

306 FREE RADICALS IN BIOLOGY AND MEDICINE
approaches, these methods have the advantage that achieved in vivo when peroxidases oxidize tyrosine
theypermitthelocalizationofnitratedproteinsintis- and NO–, or when O •– and NO • react together, will
2 2
sues(Fig.6.7).Essentialcontrolsincludeshowingthat depend on their relative ratios, the surrounding anti-
theantibodybindingisblockedbyauthentic3-NT(or oxidantlevels,thepresenceofmetals/metalloproteins,
nitratedpeptides/proteins)and/orbytreatmentofthe the CO /HCO– levels and the ratio at which various
2 3
sample with dithionite. Proteomic techniques (nitro- nitrated proteins are ‘denitrated’ or degraded (Sec-
proteomics)havebeenusedtoidentifywhichproteins tion2.6.1.2).Tosummarize,observationofnitrationin
arenitratedincellsandtissues.57Forexample,nitrated vivoshouldnotbeequatedwithformationofONOO–;
MnSOD was detected in rejected kidney transplants itismoreageneralassayofRNS,andnitrationlevels
(Section 10.7.2), nitrated β-enolase, and creatine kin- are not a quantitative measure of RNS. Ozone can
ase in the skeletal muscles of old rats,58 and several also facilitate protein nitration by oxidizing tyrosine
nitratedproteins(includingβ-actin,α-enolase,andtri- residues(Section2.6.5).
osephosphateisomerase)inthebrainsofpatientswith
Alzheimerdisease(Section10.21).Selectivityofnitra- 6.6.2.2 Accuracyofnitrationassays?65
tioncanbeexplainedbyseveralfactors,includingthe Theformationofnitrotyrosinehasbeenobservedina
relativeabundanceoftheprotein,itsproximitytothe widerangeofinjuredtissues,althoughdifferentanti-
RNS-generatingsystems,theamountoftyrosineitcon- bodies,andsometimesthesameantibodiesindifferent
tains, the environment and location of those tyrosine laboratories, give different results for the intensity of
residues,andthepresenceofmetalcentresthatfacili- 3-NT staining. Some were reported to also detect ni-
tatenitration.59Massspectrometrycanbeemployedto trotryptophan residues.57 Chemical measurement of
identifyspecificsitesofnitrationwithinaprotein.An- nitrotyrosine in body fluids and tissues has been a
otherapproachistoreducethe3-NTtoaminotyrosine, controversial area, with claimed levels varying over
whichisthenconjugatedwithafluorescentprobethat twoordersofmagnitude.Thebestmethodsarebased
allowsvisualizationincellsortissues.60 on mass spectrometry. It is essential to avoid expos-
ure of biological material to low pH during sample
6.6.2.1 Specificityforperoxynitrite?61
workup,storage(evenfreezingphosphate-containing
Is 3-NT specific as a marker for ONOO–? Nitric ox- samplescancauselowpHtodevelop),andtheassay
ide does not nitrate aromatic compounds. Nitrogen procedure:atlowpHtracesofNO– presentcanform
2
dioxidecannitratetyrosineinvitroandinanimalsex- nitrating species via HNO and cause artefactual ni-
2
posedtohighlevelsofthistoxicgas,butappearsless tration. Addition of deuterated tyrosine can be used
efficient as a nitrating agent than ONOO–, probably tocheckforthis:thereshouldbenodeuterated3-NT
becauseitisnotasgoodatconvertingtyrosinetotyr- (easilydistinguishedfromnormalnitrotyrosineinthe
osyl radical. Mixtures of NO– and HOCl can nitrate massspectrometer)inbiologicalmaterials.66,67 Levels
2
tyrosine,apparentlybytheintermediateformationof of free- and protein-bound 3-NT in human blood
nitrylchloride(nitroniumchloride),NO Cl.However, plasmafromhealthysubjectsareinthelownanomolar
2
when NO– and HOCl were added together to cells range, and it is barely detectable (≤10 nM) in hu-
2
or cell lysates, no nitration was observed,62 perhaps manurine.67Nitrotyrosineismetabolizedto3-nitro-4-
because HOCl reacts faster with other cell constitu- hydroxyphenylacetate(NHPA)inanimals,whichhas
entsthanitdoeswithNO–.Myeloperoxidase(MPO), sometimes been measured in urine as an estimate of
2
eosinophilperoxidase(EPO),andseveralotherperox- 3-NTproductioninvivo.However,some(andperhaps
idases can oxidize NO– in the presence of H O to a most) urinary NHPA arises by other mechanisms,68
2 2 2
•
nitratingspecies,presumablyNO .Theycanalsooxid- makingtheassayquestionable.
2
izetyrosinetotyrosylradical.IfNO–issimultaneously Nevertheless, provided that artefacts are avoided,
2
•
present,theenzymescanconvertittoNO ,whichre- measurement of 3-NT by robust chemical methods is
2
acts with tyrosyl, and 3-NT is formed. For example, a useful biomarker of protein damage by RNS and
EPO-dependent nitration appears to occur in the air- howitisaffectedbyantioxidantorotherinterventions.
ways of asthmatic patients.63 Consumption of NO • For example, treatment with statins decreased nitro-,
by MPO, and associated nitration of such extracellu- chloro-, and ortho-tyrosine levels in the plasma of
larproteinsasfibronectin,maycontributetovascular hypercholesterolaemic patients,69 consistent with the
dysfunctionduringinflammation.64 view that hypercholesterolaemia is accompanied by
Nitrogendioxideisalsoscavengedbyascorbateand oxidative stress (Section 10.3). Antibodies that recog-
GSH (Section 9.12.2). Hence the amount of nitration nizenitrotyrosinehavebeendetectedinplasmafrom

--- Page 362 ---

MEASUREMENT OF REACTIVE SPECIES 307
patients with several diseases, including acute lung analysisofortho-,meta-,bromo-,chloro-,andnitrotyr-
injury(Table10.4)andcardiovasculardisease.70 osines have been developed,32,69 as have antibodies
directedagainstbromo-orchlorotyrosine,whichhave
been used to stain these residues in several tissues
6.7 Detectionofreactivehalogen
from humans and other animals. It is important to
species71
check the antibodies for specificity; for example, do
they recognize other halogenated tyrosines? One im-
Hypochlorousacidisapowerfuloxidizingandchlor-
portant tip: hydrolysisof proteins in HCl can lead to
inatingagent(Section2.6.3).Itcanevendestroy3-NT,
artefactualtyrosinechlorination—avoidit.Glutathione
andsoitsformationatsitesofinflammationcouldlead
to underestimation of tyrosine nitration.72 Similarly, sulphonamide(Sections3.10and6.16.4)anddehydro-
additionofONOOHcancauselossofchlorotyrosine.72 methionine(Section2.6.3)havealsobeensuggestedas
potentialbiomarkersofHOClandHOBrattackupon
Several assays for HOCl have been described, but
GSHandmethionineresiduesrespectively;sulphona-
of course the detector molecules have to compete
mide formation is much faster with HOCl than with
with multiple biomolecules for any HOCl gener-
HOBr. Chlorinated lipids, arising from HOCl attack
ated.Quenchingofgreenfluorescentproteinhasbeen
upon several lipids (including plasmalogens), have
used to measure HOCl in phagocytic vacuoles (Sec-
been measured (Section 5.12.8.1). Chlorotyrosine can
tion8.7.5.4).Thetaurineassayisbasedonconversion
be oxidized to 3-chloro-4-hydroxyphenylacetate and
oftaurinebyHOCltoachloramine,
to several dechlorinated metabolites (e.g. 4-hydroxy-
Taurine–NH + HOCl → taurine–NHCI + H O phenylacetate)invivo,andendothelialcellshavebeen
2 2
reportedtoconvertchloro-andnitrotyrosinestosulph-
The chloramine is then measured by allowing it atedadducts.74
to oxidize 3,3’,5,5’-tetramethylbenzidine (TMB) to a
Halogenated tyrosines are natural constituents of
chromogen in the presence of iodide (I–) as a cata-
some structural proteins in marine invertebrates and
lyst. HOBr also reacts with taurine, and the result-
insects.Forexamplechloro-anddichloro-tyrosineoc-
ing bromamine can oxidize TMB, but does not re-
cur in the cuticle of the desert locust Schistocerca
quire I–, allowing distinction of HOCl and HOBr gregaria.75
production (run the assay with and without I–). Di-
hydrorhodamine is also oxidized by taurine chlor-
amines, when I– is present, into rhodamine. Chlor- 6.8 Detectionofsingletoxygen76–79
ination of monochlorodimedon to dichlorodimedon,
6.8.1 Directdetection
with loss of absorbance at 290 nm, has been used
to assay HOCl production by MPO (Section 2.6.3). Decayof1O yieldstwotypesoflightemission:aweak
2
Various fluorescent probes have been developed that monomolemissionat1270nmandadimolemission
appear to detect HOCl from myeloperoxidase or iso- resulting from collision of two 1O molecules, which
2
latedphagocytes(HOCloxidizestheprobetounmask produces light at 630 and 701 nm. The 1270 nm (in-
a fluorescent moiety), but their usefulness in vivo is frared) emission has been much used to study 1O 2
unclear.71,73 chemistry, whereas the dimol emission wavelengths
Exposure of free or protein-associated tyrosine to arepronetointerferencebyotherlight-emittingreac-
HOCl leads to production of some 3-chlorotyrosine tions. The mere production of light does not impli-
and 3,5-dichlorotyrosine (Fig. 5.30), which have been cate 1O 2 unless the correct emission spectrum can be
suggested as biomarkers of HOCl generation. Simi- demonstrated.This is because many otherRS-related
larly,HOBrbrominatestyrosine.However,NO Clalso processes produce light, including Fenton reactions,
2
chlorinatestyrosine,sosimultaneousmeasurementof reactionsofhaemproteinswithH 2 O 2 ,andthedecom-
nitrated and chlorinated products (e.g. by HPLC or position of dioxetanes, which produce excited-state
MS after hydrolysis of proteins) can be useful in dis- carbonylsthatemitlightastheyreturntotheground
tinguishingeffectsofONOO–(nitration),HOCl(chlor- state(Section2.6.4).
ination), and NO Cl (both). Tyrosine chlorination is
2
not a quantitative measure of the amounts of HOCl
6.8.2 Useofscavengersandtraps
orNO Clgenerated;thesespeciesreactwithmultiple
2
othertargets(ascorbate,thiocyanate,GSHetc.),whose Scientists have often relied on ‘singlet-O scav-
2
levels will determine how much tyrosine modifica- engers’ and quenchers to implicate 1O in bio-
2
tion occurs in vivo. Mass spectrometric methods for logicalsystems.PopularcompoundsincludeDABCO,

--- Page 363 ---

308 FREE RADICALS IN BIOLOGY AND MEDICINE
diphenylisobenzofuran, histidine, and azide (Section Forexample,oxidationofdiphenylanthracenebound
2.6.4). Addition of these should inhibit a reaction de- toglassbeadswasusedtoinvestigate1O production
2
pendenton1O .If,whenaddedathighconcentrations, by phagocytes after engulfment of the beads into the
2
theydonotinhibit,onecanusuallyconcludethat1O phagocytic vacuole.81 In reverse, decomposition of
2
isnotrequiredforthatreaction.Iftheydoinhibit,this endoperoxides can be a source of 1O (Section 2.6.4).
2
doesnotprovearolefor1O ,becausethesecompounds SomespintrapscandetectsingletO ,suchas2,2,6,6-
2 2
arenotspecificfor1O .Forexample,theyallreactwith tetramethylpiperidine (TEMP), 4-hydroxyTEMP, and
2
OH • , often with a greater rate constant (usually >109 2,2,6,6-tetramethyl-4-piperidone (TEMPD), which are
M–1S–1)thanforreactionwith1O
2
.Forexample,azide converted to nitroxides when they react with 1O
2
• •
reactswithOH togiveareactiveazideradical,N , (Table 6.2). As already commented on for other
3
spin traps (Section 6.2.3), their commercial forms
N– + OH • → N • + OH– need further purification before use.79 Trans-1-
3 3 (2’-methoxyvinylpyrene)hasbeenusedtodetect1O ,
2
by formation of an endoperoxide that emits light as
β-Carotene (Section 4.4) and DABCO also react with it decomposes.82 It appears not to react with OH • ,
RO • 2 radicals80 and diphenylisobenzofuran can be a H 2 O 2 ,orO • 2 –,
ThisequationisreproducedbycourtesyofMolecularProbes
substrate for COX (Section 8.12.5). The products of Handbook,AGuidetoFluorescentProbesandLabelingTech-
reaction of certain fatty acids and of cholesterol with nologies,11thed.;MolecularProbes:Eugene,OR,USA,2010.
1O aredifferentfromthoseobtainedonreactionwith
2 A fluorescent probe, allegedly specific for singlet O ,
• 2
OH ,sotheirisolationandcharacterizationmayallow singlet O sensor green, is commercially available,
2
distinction.Forexample,observationofthe‘ene’prod- which reacts with 1O to give an endoperoxide with
uct, 5α-hydroperoxycholesterol, is considered reason- 2
a strong green fluorescence. Fig. 7.12A and B show
ablygoodevidencefor1O andhasbeenusedtodetect
2 examplesofitsuse.However,itshouldbeemployed
it in skin (Section 7.13). These approaches need skill
with caution, as the reaction product can itself sensi-
in analytical chemistry, however, and the use of 1O 2 tize1O formation.79Somefluorescentprobesthatlose
• 2
scavengers,likethatofspintrapsorOH scavengers,
fluorescencewhentheyreactwithsingletO havebeen
2
cannotberecommendedtothechemicallynaive. employed,e.g.DanePy,
Another trap that has been employed is 9,10-
diphenylanthracene(oritswater-solublederivatives),
towhichsingletO addstoformafluorescentendop-
2
eroxide,
was the first probe used to detect singlet O in
2
plants,althoughsingletO sensorgreenseemstowork
2
better.83

--- Page 364 ---

MEASUREMENT OF REACTIVE SPECIES 309
6.8.3 Deuteriumoxide(D O) 6.10 Changesingeneexpression:ROS
2
biosensors?86
Anotherapproach,oftenemployedinstudyingphoto-
dynamic effects, is to use D O. The lifetime of 1O is
2 2
Exposingcellstooxidativestressalterstheexpression
longer in D O than in H O by a factor of 10 or 15
2 2
ofmultiplegenesandthelevelsofmanyproteins.Sev-
(Section2.6.4).Thus,ifareactioninaqueoussolution
erallaboratorieshavelinkedthepromotersoftherele-
is dependent on 1O , carrying it out in D O instead
2 2
vantgenestoeasilydetectablemarkers.Forexample,
ofH Oshouldpotentiatethereaction.Theoretically,a
2
in many bioluminescent organisms light is produced
typeIreactionwouldbeunaffected.
bytheactionofaluciferaseenzymeonasubstrate(lu-
ciferin;Section8.6).Luciferasegenesarewidelyused
6.9 Studiesof‘generalized’light
as ‘reporter genes’ for activation of transcription, be-
emission(luminescence/fluorescence) cause transcription of the gene and translation of the
mRNAintoluciferaseproteinarereadilydetectedby
FollowingearlyresearchinEasternEurope,severalsci-
measuring light when a luciferin is added. For ex-
entistshaveusedphotomultipliersorluminometersto
ample,theE.coliMnSOD,katG(Section3.17),oroxyR
measure the light emitted by animal tissues, injured
gene promoters, or the yeast Yap1 response element
plants,wholeorgans,andorganismssuchasbacteria,
(Section 5.5.3) can be attached to a luciferase gene.
protozoa,orparasiticworms.84 Humanbreathshows
Any agent inducing gene expression via these pro-
low-levellightemission(about7000countsperlitreof
motersshouldleadtoluciferaseproduction.Becareful
breath per second), as do blood and plasma.84,85 The
though,luciferaseitselfcangeneratesomeROS.87One
lightemissionoccursintheUVandvisibleranges,but
useofsuchtechnologyistodevelopbacterial,yeastor
isfartoofainttoperceivewiththenakedeye.
animalcellline‘biosensors’,whichgeneratelightwhen
This low-level chemiluminescence often increases
exposedtoenvironmentaltoxinsthatemitROSand/or
in response to oxidative stress, such as elevated O
2 depleteantioxidantdefencesoractivatetheNrf2sys-
oradditionofROS-generatingagents.Lightcanarise
tem(Section5.5.8).88,89Anotheristheuseoftransgenic
frommanysources,includingreactionsofONOO–and micethatexpressluciferaseunderthecontrolofNF-κB
HOCl,lipoxygenaseaction,haemprotein/peroxidere-
(Section5.5.6),allowingdirectvisualizationoftheac-
actions,andFentonchemistry.OnesourceissingletO
2 tivityofthistranscriptionfactor.
bytheRussellmechanism(Section2.5.4),
Another marker is green fluorescent protein (Sec-
tion 8.6.1), which has the advantage that it is auto-
fluorescent and so does not require a substrate to be
added.Asmentionedearlier,lossofGFPfluorescence
hasbeenusedtomeasureHOClinphagocytes.More
Thecarbonylcompoundproducedmightalsobeinan recently, modified GFPs with two extra cysteine res-
excitedstateandemitlightasitdecaystotheground iduesclosetothechromophore(reduction-oxidation-
state.Otherpossiblesourcesoflightareself-reactionof sensitiveGFPvariants,roGFPs)havebeendeveloped
alkoxylradicalstogiveexcited-stateketones, that sense (measured using fluorescence microscopy)
the redox state of cells, in particular the redox po-
* tential of the GSSG/2GSH couple,86,90–92 and how it
canchangewithageorwhentoxinsareadministered.
roGFPscanbetargetedtodifferentorganelles,e.g.to
and the formation of dioxetanes by reaction of sing-
peroxisomes, nucleus, mitochondria, or ER, and the
let O with unsaturated fatty-acid side-chains (Sec-
2
resultingdataconfirmthattheERlumenis‘moreoxi-
tion2.5.4):dioxetanescandecomposetogiveexcited-
dized’thantherestofthecell.91However,theseprobes
statecarbonyls,
need glutaredoxin to function (either endogenous or
attached to the probe, giving Grx-1roGFP2), and the
glutathioneredoxpotentialisalsoaffectedbythetotal
glutathione concentration (Section 3.10), factors that
needtobeconsideredininterpretingthedata.86Thus,
Thepotentialofthemeasurementoflightemissionas roGFPs are not measuring ROS directly. A modified
anoninvasivetechniqueof‘general’ROSproduction, form of yellow fluorescent protein (cpYFP) has been
hasbeensuggestedbutnotyetrealized. developed that targets to the mitochondria and has

--- Page 365 ---

310 FREE RADICALS IN BIOLOGY AND MEDICINE
been claimed to measure O
•–
there, suggesting that Catalase is frequently used in assays of H O pro-
2 2 2
O
•–
is produced in bursts (‘superoxide flashes’, Sec- duction to check for specificity (Table 6.6). It can
2
tion1.10.4).Sadly,itprobablydoesn’tmeasureO
•–
at also detect H O directly; observation of the spec-
2 2 2
all.93YFPisamutantformofGFPwithanaminoacid tral intermediates of catalase has been used to as-
substitution that changes fluorescence emission from sess H O production in organs (Fig. 6.8). Catalase
2 2
greentoyellow. can use H O to oxidize methanol and formate (Sec-
2 2
tion3.17.4),andthishasbeenmadethebasisofvarious
assay systems, for example decarboxylation of 14C-
6.11 Detectionofhydrogenperoxide
labelled formate to 14CO . Catalase is inhibited by
2
aminotriazole, but only when H O is present (Sec-
H O isdifficulttomeasureaccuratelygivenitslowre- 2 2
2 2
tion3.17.3).Hencetheextentofinactivationofcatalase
activitywithmostorganiccompounds(Section2.6.2),
byaminotriazolehassometimesbeenusedtocalculate
but several methods have been developed, some of
H O production in cells and organs. Histochemical
which are summarized in Table 6.6. To be useful in 2 2
stainsforH O havebeendeveloped(Table6.6),often
biological systems the methods must be sensitive, 2 2
relyingontheabilityofperoxidasesinatissuetoox-
since rates of H O production by cells and organ-
2 2 idizesubstratessuchasDAB(3,3(cid:4)-diaminobenzidine)
elles are usually only in the nmol/min range (except
whenH O ispresent.Figure6.7,bottomphotograph,
foractivatedphagocytes).Steady-stateconcentrations 2 2
shows an example from animals and Figs 8.18 and
of H O in mammalian cells have been estimated
2 2
7.12B, examples from plants. Electrodes that detect
as maybe one nM, transiently rising to 500–700 nM
duringoxidativesignallingevents.86 Commonlyused H 2 O 2 have been constructed, but are rarely used by
biologists since reducing agents in biological sam-
assaysemploytheH O -dependentoxidationofsub-
2 2
ples can interfere with them. H O electrodes are of-
strates catalysed by horseradish peroxidase (HRP). 2 2
ten based around redox reactions of haem proteins,
Substrates include homovanillic acid or Amplex red
ferric hexacyanoferrate (Prussian blue), carbon nan-
(Table 6.6), which are oxidized to fluorescent prod-
otubes, or metal oxides.95,96 H O can also decarb-
ucts. The HRP-catalysed conversion of fluorescent 2 2
oxylateα-ketoacids(Table6.6andSection3.25.2),but
compounds such as scopoletin or resorufin to non-
other species (such as ONOO–) may be able to do so
fluorescent products has also been used, but the sen-
aswell.
sitivity is often lower since the intensity changes are
HydrogenperoxidehasbeendetectedatμMlevels
monitoredagainstabackgroundofhighfluorescence.
inhumanurineandarises,inpart,bytheautoxidation
HRP-basedassaysaretypicallyusedtomeasureextra-
of excreted compounds (Section 2.6.2).97 Smokers ex-
cellular H O production, since HRP does not enter
2 2
cretemore,onaverage(Section9.13.2).UrinaryH O
cells. It is essential to check that the reaction mixture 2 2
issimpletomeasure,butlevelsvarywidelywithtime
does not contain compounds that are substrates for
of day and between subjects, and it is uncertain to
HRP,thatcouldcompeteandcauseanartefactualin-
what extent urinary H O might be a ‘biomarker’ of
hibition. For example, ascorbate, many phenols, and 2 2
oxidativestress.95,97,98 Hydrogenperoxidecanalsobe
thiols are oxidized by HRP (Section 3.19.3), and can
measuredinexhaledair(Section6.15.9).
interfere with peroxidase-based assay systems. Inter-
ference by ascorbate was reported in the assay of
H 2 O 2 production by mitochondrial preparations, for 6.11.1 Fluorescent‘probes’forH O
2 2
example.46Suchacontrolisalsoessentialwhencheck-
ing for the H O -scavenging activity of compounds Several protein-based or low molecular mass probes
2 2
byusingHRPtomeasurethelossofH 2 O 2 :onemust for H 2 O 2 have been developed and used in cells to
checkthatthetestcompoundisnotitselfasubstratefor imagethesitesofH 2 O 2 productionandhowH 2 O 2 dif-
HRP, an inhibitor of peroxidase, or a compound that fuses. For example, HyPer is a H 2 O 2 -specific protein
scavenges radicals generated during oxidation of the sensorbasedonOxyR(Section5.5.2).18,83,86,92Acircu-
detectormolecule.SuperoxidedecreasesHRPactivity larlypermutedyellowfluorescentprotein(i.e.theori-
(formingcompoundIII;Section3.19.3)andmaycom- ginal–NH 2 and–COOHendsoftheYFParejoinedby
promisemeasurementofH 2 O 2 insystemsgenerating apolypeptidelinker)isattachedtotheH 2 O 2 -sensing
O •–.ThiscanbeavoidedbyaddingSOD.94Becauseof portion of E.coli oxyR. The excitation and emission
2
theinterferenceofintracellularreductants(e.g.gluta- spectraaresubstantiallyalteredwhenH 2 O 2 ispresent,
thione,ascorbate,NADH,NADPH)withHRP,assays because of the major conformational changes in Hy-
basedonitmaynotbeoptimalfordetectionofH O PerresultingfromoxidationofoxyR.HyPerhasbeen
2 2
incelllysates. used, for example, to demonstrate that wounding of

--- Page 366 ---

MEASUREMENT
OF
REACTIVE
SPECIES
311
Table6.6 SomemethodsformeasuringH2O2inbiologicalsystems.
Method Principleofthemethod Examplesofsystemstowhichithasbeenapplied
Observationofintracellularcatalase SeeFig.6.8 Bacteria,organs(perfusedandinsitu),organslices,homogenates.
compoundI
Oxidationof[14C]methanolor[14C] Seetext Difficulttouseinwholeanimalsasmethanolcanbeoxidizedby
formatebycatalasecompoundI alcoholdehydrogenaseandformatebyformatedehydrogenase
enzymes.
Cytochromecperoxidase OxidizesreducedcytochromecandisspecificforH2O2.Formsa Animalandplantmitochondria,protozoa,peroxisomes,microsomes
complexwithH2O2thatabsorbsat419nm (Biochem.J.128,617,1972).Assayoftendifficulttoapplyto
(Section3.19.1)whereasfreeenzymeabsorbsat407nm. biologicalsystemsbecauseothercytochromecreductases/oxidases
present.
Horseradishperoxidaseplussubstrates Animalandplantmitochondria,submitochondrialparticles,
phagocytes,protozoa,microsomes(J.Biochem.Biophys.Methods
18,297,1989;J.Bioeng.Biomemb.34,227,2004;Anal.Biochem.
253,162,1997),humanurine,breathcondensate(Eur.J.Clin.
Invest.33,274,2003;Anal.Chem.77,2862,2005).
Scopoletin(structureabove)isapopularsubstrate;othersinclude
homovanillicacid(3-methoxy-4-hydroxyphenylaceticacid;HVA)and
AmplexRed(N-acetyl-3,7-dihydroxyphenoxazine),
whichareoxidizedtofluorescentproducts(e.g.resorufinfrom
AmplexRedorafluorescentdimerfromHVA).
ExcesslightexposurecanconvertAmplexRedtoresorufininthe
absenceofperoxidase/H2O2(FreeRadic.Biol.Med.53,
1080,2012).
Continued

--- Page 367 ---

312
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table6.6 (Continued)
Method Principleofthemethod Examplesofsystemstowhichithasbeenapplied
O2-electrodemethod Addexcesscatalaseandmeasurereleaseofoxygen: Chloroplasts,mitochondria.Alsousedtostudyrateconstantsfor
2H2O2 → 2H2O + O2 reactionofcompoundswithH2O2,bymeasuringresidualH2O2.Not
verysensitivebutusefulinturbidsystems.UsedtomeasureH2O2in
humanurine(Biochem.Biophys.Res.Commun.262,205,1999).
H2O2electrode Usesmembrane-coatedPtmicroelectrode,μMsensitivity.Some‘O •
2
– Enzymes,neutrophils,othercells.Notverysensitive(FreeRadic.Biol.
electrodes’alsodetectH2O2(Section6.4) Med.31,894,2001),notwidelyused.
Inhibitionbycatalase IfareactionrequiresH2O2,thenitshouldbeinhibitedbycatalase. CatalaseslowatdestroyinglowconcentrationsofH2O2,soalarge
amountmustbeadded.OftenusedtoinvestigatetheroleofH2O2
inoxidativedamage.Controlswithinactiveenzymerequired.
CommercialcatalasesoftencontaminatedwithSOD,thymol(a
phenolicantioxidant),andendotoxin.Catalasepoorlyactiveatlow
orhighpH.
FOXassay SeeTable6.10fordetails. Simple,notverysensitive.CanmeasurebothH2O2andorganic
peroxides.
GSSGrelease Fig.3.13 Isolatedorgans.MeasuresGSHoxidation,notnecessarilyexclusively
duetoH2O2.
Aminotriazoleinhibitionofcatalase Seetext Fungi,variousbacteria,Mycoplasma,erythrocytes,otheranimal
tissues.
Decarboxylationofketoacids Glyoxylate,pyruvate,benzylformate,andα-ketoglutaratereact Eyelens,humanbodyfluids,peroxisomes(FreeRadicRes.Commun.
non-enzymicallywithH2O2.Useof14C-labelledsubstratespermits 5,359,1989;J.Am.Chem.Soc.133,3776,2011).
sensitivemeasurementof14CO2release.
Boronateprobes SeeSection6.11.1.Peroxide-mediatedconversionofboronatesto Microbial,plant,andmammalianculturedcells,flies(Acc.Chem.
phenols. Res.44,793,2011andMethodsEnzymol.526,19,2013).Control
experimentswithcatalaseandNOSinhibitorsmustbeperformedto
ruleoutcontributionsfromONOO–.
Histochemicalstainingmethods Severalexist,e.g.inplantsonemethodisbasedonoxidationof Plantslices(PlantPhysiol.Biochem.36,817,1998).Perfused
iodidetol2byH2O2,detectedbyformationofabluecomplexwith organs,cells,animaltissueslices(MethodsEnzymol.233,619,
starch.Moreofteninanimals,thetissueistreatedwith 1994).Wouldpresumablydetectotheroxidizingagentsaswellbutif
Fe2+-diethylenetriaminepenta-aceticacid.ThisisoxidizedbyH2O2 duetoH2O2catalaseshouldinhibit.
totheferricchelatewhichinturnoxidizesdiaminobenzidinetoan
insolublechromogen.

--- Page 368 ---

MEASUREMENT OF REACTIVE SPECIES 313
MeOH (mM)
noitcudeR-c
tyC
noitcudeR-NP
O
H-esalataC
noitcudeR-pF
2
2
63.5 30.0 8.62 60.0 7.2
4101.0
=
AΔ
11.0
=
AΔ
%5.21
=
Δ
%5.21
=
Δ
8 minutes
86.2 43.1 45.0 72.0 31.0 60.0 3.1 7.2 7.01 53.5 86.2 70.1 45.0 72.0 11.0
Glycollate Glycollate
EtOH (mM) (mM) (mM)
Figure6.8 ProductionofH2O2inratliverperfusedwithabicarbonate-salinesolutioncontaining2mML-lactateand0.3mMpyruvateat30◦C.
LightwasshonethroughaliverlobeandtheconcentrationofcatalasecompoundImeasuredbydual-wavelengthspectrophotometry.Thereisa
steadyconcentrationofcompoundIfromwhichtheendogenousrateofH2O2productioncanbecalculatedasbeingabout82nmolH2O2/min/gof
liver,inliversfromnormallyfedanimals.Inclusionofmethanol(MeOH)intheperfusionmediumdecreasescompoundIconcentrationbecause
MeOHisasubstratefortheperoxidaticactionofcatalase(Section3.17.4).Ethanol(EtOH)hasasimilareffect,butitalsocausesanincreased
reductionofpyridinenucleotides(PN)sinceitisamuchbettersubstratethanmethanolforthealcoholdehydrogenases,whichconvertNAD+to
NADH(Section9.8.1).Thereisalsosomereductionofflavoproteins(Fp).Infusionofglycollateraisesthesteady-stateconcentrationofcompoundI
becauseitisoxidizedintheperoxisomestoformH2O2byglycollateoxidase,
glycollate + O2 → glyoxylate+H2O2
Cyt-c,cytochromec.DatafromArch.Biochem.Biophys.154,117,1973,bycourtesyofProfessorBrittonChanceandAcademicPress.
thezebrafishtailproducesagradientofH O .mRNA glutathione redox potentials and H O concentration
2 2 2 2
encodingHyPerwasinjectedintothefishembryo,re- and how both changed with age.101 Similarly, Hy-
sultinginexpressionoftheproteinthroughoutthefish Per has been used to study ageing in C.elegans (Sec-
(Fig.6.9).HyPerhasalsobeenusedtodemonstratelo- tion11.4.2.1).92AYFP-baseddetectoroflipidperoxides
calizedH O productionin cellstreatedwithgrowth hasalsobeendesigned(Section6.15.12).
2 2
factorsandH O generationbyNOX4intheER.99,100 What about low molecular mass agents? H O can
2 2 2 2
HyPerappearstobespecificforH O ,butitsfluores- convertarylboronatestophenolsandthesereactions
2 2
cencecanbeaffectedbypHandthismustbecontrolled havebeenusedtodetectandimageH O withinliving
2 2
for.OxidizedHyPercanbereducedbycellularredu- systems.Inessence,afluorophoreislinkedtoaboro-
cingsystems(ashappenstooxyRinvivo;Section5.5.2). nateesterinaconformationthathasnofluorescence.
Perhaps thus it measures the balance between H O WhenH O ispresent,theboronateesterisconverted
2 2 2 2
levelsandredoxstateofthecell.Theseprobesarebe- to a phenol and the fluorescence is unleashed. Boro-
ingcontinuallyimproved(e.g.asHyper-2and-3and nateprobesentercellsreadilyandcanbetargetedto
HyPerRed). variousorganelles(Fig6.10).18,102Asexamples,peroxy
A similar H O detector has been generated by yellow 1 methyl ester was used to demonstrate that
2 2
fusing Orp1, a yeast thiol peroxidase, to roGFP2: some aquaporins, but not others, can allow H O to
2 2
H O oxidizes the Orp1 which then oxidizes the entercells,103andperoxyfluor6hasbeenusedtostudy
2 2
GFP.18,86,92,101 For example, Albrecht et al. gener- therolesofH O signallinginneuronalstemcellsand
2 2
atedtransgenicDrosophilacontainingroGFP2-Grx1or neurogenesis.102,104 Conversion of the mitochondria-
roGFP2-Orp1 targeted to either the cytosol or mito- targeted phenylboronate mito B to mito P by H O
2 2
chondrialmatrix,andtheywerethusabletoestimate (Fig 6.10) has been used to measure mitochondrial

--- Page 369 ---

314 FREE RADICALS IN BIOLOGY AND MEDICINE
(a) (b)
YFP YFP /YFP
500 500 420
1-cell stage 3 days after fertilization Cut tail fin
HyPer mRNA
YFP
420
YFP YFP /YFP
500 500 420
(c) (d)
3 min after wounding
YFP
420
YFP YFP /YFP
500 500 420
YFP 420
(e)
gnidnuow
retfa
nim
3
gnidnuow
retfa
nim
71
gnidnuow
retfa
nim
16
8.0
0.5
3 min after
wounding
snarT
2DERsD
Distance from wound
margin (μm)
19 min after 35 min after 51 min after 67 min after 83 min after 99 min after
wounding wounding wounding wounding wounding wounding
0.5 3.5
oitar
rePyH
oitar
rePyH
oitar
rePyH
Average arrival of first
leukocyte (+ – s.d.)
5.5 7 17 min after wounding
61 min after wounding
4.5 5
3.5 3
2.5 1
3 23 43 63 0 100 200 300
Time after wounding (min)
Figure6.9(colourplate11) (a)Experimentalprocedure.(b)HyPerimaginginaninjuredzebrafishlarva.[H2O2]isinferredfromthe
YFP500/YFP420excitationratioofHyPer.(c)Temporal[H2O2]profileina~10–30μmbroadregionofinterestalongthewoundmargin.Arrivalof
firstleukocyteatwound(solidredline)±s.d.(dashedredline)isshown,i.e.H2O2generationprecedesleukocyterecruitment.(d)[H2O2]line
profilenormaltothewoundmargin.(e)Imagingofleukocyterecruitmentand[H2O2].Colouredlinesaresuperimposedleukocytetracks.
Pseudo-colourcalibrationbars:HyPerratio(YFP500/YFP420).Scalebars:100μm.TheH2O2generationinvolvesaNADPHoxidaseenzymeofthe
DUOXtype(Section8.10).FromNature459,996,2009,bycourtesyofDrPhilippNiethammerandNaturePublishingGroup.
levels of H O in several systems, including cultured The same comment would apply to the fluorescent
2 2
cells,Drosophila,C.elegans,andmice.105In7-day-oldfe- proteins:howmuchoftheH O generatedtheyinter-
2 2
maleDrosophila,forexample,estimatedmitochondrial ceptisunclear(indeed,ifanyoftheagentsabsorbed
H O levelswerecloseto0.2μM,andtheyroseto~1.3 too much H O they could perturb the redox state
2 2 2 2
μMunder65%O . of the cell and interfere with H O -dependent cell
2 2 2
ThereactionofboronateswithH O isratherslow signalling!). One must also note that certain boron-
2 2
(k ~1 M-1s-1), and so they would not be expected to atescanbeoxidizedornitratedifONOO– ispresent.
2
compete efficiently with such enzymes as GPx and This reaction can proceed over 106 times faster106,107
peroxiredoxins.Hencetheyarelikelytobe intercept- than that with H O , generating the same major
2 2
ing only a small percentage of the H O generated. product. In many systems, however, H O levels are
2 2 2 2

--- Page 370 ---

MEASUREMENT OF REACTIVE SPECIES 315
Fluorescent probes
O
N
N O
O
H O
2 2
Ph +P
3 N O
N O O O O
O O
O
O O O
O O O
O
O
HO
HO
tnuoc
noi
O O
B
O COO–
O
PO1
O
B B
MitoPY1 PF6-AM
Mass spectrometric probes
MitoB
B P+ H 2 O 2 P+ MitoP
OH
MitoB MitoP M/Z ratio
Figure6.10 SomeprobestodetectH2O2.(a)TheconversionofboronatestophenolsbyH2O2hasbeenusedtocreateasuiteofnovel
fluorescentprobeswithvariousproperties,suchasred-shiftedemission(PeroxyOrange1,PO1),mitochondriallocalization(Mitochondria
PeroxyYellow1,MitoPY1),andenhancedsensitivitythroughcytosolictrappinggroups(Peroxyfluor-6acetoxymethylester,PF6-AM).These
compoundsentercellsreadily.(b)Amitochondria-targetedMSprobe,whichusestheconversionofaboronicacidtoaphenol,allowsratiometric
detectionandquantificationofH2O2invivobyanalysisoftheratiosbetweentheprotectedanddeprotectedformsoftheprobe,whichcanbe
measuredbymassspectrometry(masstocharge[m/z]ratio).AprobethatlocalizestocellnucleitomeasureH2O2hasalsobeendeveloped(Chem.
Biol.18,943,2011).AdaptedfromNat.Chem.Biol.7,504,2011,bycourtesyofDrChristopherChangandNaturePublishingGroup.
considerably higher than those of ONOO–, which coumarin-7-boronate, but far more slowly.106 The re-
can balance out rate differences. The careful use action of boronates with ONOO– leads to formation
of NOS inhibitors (Table 6.5) and H O scavengers of minor products, in addition to the major, phen-
2 2
can be useful in distinguishing detection of ONOO– olic product.107 This has been utilized to propose
from that of H O . Indeed, coumarin-7-boronate the use of a mitochondria-targeted phenylboronate
2 2
(o-MitoPhB(OH) ) for specific detection of ONOO–.
2
Theminor,nitratedproduct,o-MitoPhNO ,isformed
( b s o it r e o n o a f te O O by ONOO–, but not by H 2 O 2 , and therefo 2 re may be
(CBA), attachment) has been introduced to meas- used as a diagnostic product of ONOO– formation.
ure ONOO–: ONOO– displaces the boronate to give A circularly permuted GFP boronate probe has also
fluorescent7-hydroxycoumarin.H
2
O
2
alsoreactswith beendevelopedtodetectONOO–.

--- Page 371 ---

316 FREE RADICALS IN BIOLOGY AND MEDICINE
6.12 Othermethodstomeasurereactive
OH speciesinculturedcells:bewary
P+
ofDCFHDA!18,27,107,111
Apart from the fluorescent probes described above,
o-mito-PhOH
several other methods have been used to identify RS
(major product)
HO OH
B
P+
ONOO– in cells. Some of the most widely used are some of
the most questionable; precise chemical information
Br– onwhattheyreallymeasureislimited.Doremember,
NO ofcourse,thatcellcultureitselfcanraiseintracellular
o-mitoPhB(OH)
2
2 P+
ROSlevelsandthatmanycompoundscanoxidizein
Br– cell culture media to generate H
2
O
2
which can then
diffuseintocells(Section1.11).
(m o- i m no it r o p -P ro h d N u O c2t) Some simple guidelines can help in understand-
ingoxidativestress/oxidativedamageincellculture.
Hydrogen peroxide can cross cell membranes (Sec-
Another approach to detecting ONOO– is pyBor,108 tion2.6.2).Thuscatalaseaddedoutsidecellscanlower
boronate attached to pyrene. The fluorescence in- intracellular H 2 O 2 , by removing extracellular H 2 O 2
creases greatly when the boronate is oxidized and and establishing a concentration gradient that drains
displacedbyONOO–, H 2 O 2 outofthecell.Bycontrast,O • 2 – doesnotgener-
ally cross membranes, although it can do so through
protein channels in some cells (Section 2.5.3). Thus if
HO B OH OH externallyaddedSODisprotectiveagainstaneventin
cellculture,bewary;thiscouldindicateO
•–-generating
2
ONOO– reactions in the culture medium (i.e. extracellularly).
Similarly, neither the iron ion chelator desferrioxam-
ine(Section11.6.1)norGSHentercellseasily,soagain
pyrene-8-boronic acid 1-hydroxypyrene be wary if they have protective effects in short-term
cell culture experiments: this may suggest extracellu-
lar actions. For example, in one study, added GSH
AninterestingcombinationoftwoapproachesisPer- protectedcellsagainstdamagebydopaminebyreact-
oxyCagedLuciferin-1(PCL-1),aboronate-cagedfire- ingwithcytotoxicdopaminequinones/semiquinones
flyluciferin, generated in the cell culture medium.112 Given long
enough, however, everything can enter cells, includ-
ing desferrioxamine (into the lysosomal system; Sec-
N N COOH tion11.6.1)andSOD(byendocytosis).
Production of RS in cells can be measured by aro-
O S S maticcompoundsorspintraps,andoxidativedamage
HO B peroxy caged luciferin byassayingproductsofdamagetobiomolecules(Sec-
tions6.14–6.17).Spintrapshavebeenusedsuccessfully
OH
in many cell studies, since a wider range of traps at
higher concentrations can be used than is possible in
vivo.Again,beawareofthepossibilityofreductionof
H O displacestheboronatetoreleaseluciferin,which
2 2
spintrapadductstoESR-silentspeciesbynon-enzymic
generates light emission when luciferase is added.
antioxidants(suchasascorbate)andcellularenzymatic
The system was able to image H O production in
2 2
reducingsystems.
mice overexpressing firefly luciferase and to con-
firm that tumour xenografts showed increased H O
2 2
production.109 Thisprobealsoreactsmuchfasterwith
6.12.1 2’,7’-Dichlorodihydrofluorescein
ONOO–thanitdoeswithH O invitro.107
2 2 diacetate
Boronatesareoxidizedbyhypochlorite,witharate
constant about 200-fold higher than for reaction with This is widely used by many groups, often to meas-
H O , but this does not seem to interfere with the ureputative‘cellularperoxides’(Fig.6.11)or‘ROS’and
2 2
detectionofH O .110 papers using it frequently appear in leading journals
2 2

--- Page 372 ---

MEASUREMENT OF REACTIVE SPECIES 317
(Nature,Blood,andCellincluded!).Unfortunately,how- 45 min–1 h). Higher levelsof DCFHDA or high light
ever,DCFHDAdoesn’tmeasureperoxides.DCFHDA intensitiescancauseartefactualphotochemicaloxida-
enters cells and accumulates mostly in the cytosol, tiontofluorescentproductsthatcanbemistakenforRS
where it is deacetylated by esterases to dichlorodi- generation(Table6.7andFig.6.11).
hydrofluorescein(DCFH)andconvertedbyvariousRS One-electronoxidationofDCFHbyvariousradicals
into DCF, which can be visualized by fluorescence at orbyhaemproteinswillproduceintermediatephen-
around525nmwhenexcitedataround488nm. oxylradicalsthatcaninteractwithGSH,ascorbate,and
So what then does it measure? Neither peroxides NADHtocreatemorefreeradicals(Fig.6.11).DCFrad-
nor O
•–
oxidize DCFH rapidly, but RO
•
, RO
•
, NO
•
, ical can also reduce O to O
•–.
The extent to which
2 2 2 2 2
RS
•
, CO
•–,
and OH
•
radicals can, as can addition of these processes contribute to the signal is uncertain,
3
ONOO– (possibly via formation of NO • and CO •–) butisafurtherreasontoexercisecautionwheninter-
2 3
(Table 6.7). It follows that DCFHDA only detects cel- pretingDCFHDAdataandtokeepthelevelsusedlow.
lular peroxides efficiently if they are converted to CytochromeccanpromoteDCFHoxidation,sousing
radicals,suchasbytransitionmetalions(e.g.Fe2+ in DCFHDAtomeasureoxidativestressduringapoptosis
the labile iron pool; Section 3.22.1.3)113 or haem pro- shouldbeapproachedwithcaution;ariseincytosolic
teinssuchasMPO,otherperoxidases,orcytochromec. cytochromeclevelscouldgiveabiggersignalwithout
Thus,cellularlevelsofcatalyticiron/copperionsand anychangeinROSlevels.111Severalotheroxidants,in-
haemproteinsareessentialvariablestoconsiderwhen cludingchromium(V),candirectlyoxidizeDCFHand
interpretingstudiesusingDCFHDA.HenceDCFfluor- causeanartefactualsignal,andthepossibilityofdir-
escence is an assay of generalized RS production (or ectoxidationsmustbecheckedbeforeusingDCFHDA
mobilizationofmetalions/haemproteins)ratherthan tomeasureoxidativestressincellsexposedtotoxins.
of any particular RS, and it is not a direct assay for Variationincellularesterasecontentcouldconceivably
peroxides.Toavoidcytotoxicity,cellsshouldbeloaded affecttheuseofDCFHDAasaprobe,butthisissuehas
withDCFHDAatlowconcentrations(e.g.1–10μMfor notbeenexploredintheliterature.
Table6.7 Relativereactivityofvariousprobeswithdifferentspecies.
Reactivespecies HPF APF DCFH
OH
•a
730 1200 7400
ONOO–b 120 560 6600
Hypochloritec 6 3600 86
SingletO2 d 5 9 26
Superoxidee 8 6 67
H2O2 f 3 <1 190
NO
•g
6 <1 150
ROO•h 17 2 710
Photochemical oxi- <1 <1 2000
dationoftheprobei
StructuresandfullnamesoftheseprobesareshowninFigures6.12and6.13.Probes(final10μM;0.1%dimethylformamideasacosolvent)were
addedtosodiumphosphatebuffer(0.1M,pH7.4).ThefluorescenceintensitiesofHPF,APF,andDCFHweremeasuredatexcitationwavelengths490,
490,and500nmandfluorescenceemissionwavelengths515,515,and520nm,respectively.
a100μMofferrousperchlorate(II)and1mMofH2O2wereadded.
b3μM(final)ofONOO–wasadded.TheprobesareprobablyoxidizedbyspeciesderivedfromONOO–ratherthanbyONOO–itself.
c3μM(final)ofNaOClwasadded.APFcanalsodetectHOBr(J.Biol.Chem.287,27913,2012).
d100μMof3-(1,4-dihydro-1,4-epidioxy-1-naphthyl)propionicacidwasadded.
e100μMofKO2wasadded. f100μMofH2O2wasadded. g100μMof1-hydroxy-2-oxo-3-(3-aminopropyl)-3-methyl-1-triazenewasadded.
h100μMof2,2’-azobis(2-amidinopropane)dihydrochloridewasadded. iSolutionsofprobeswereplacedunderafluorescentlampfor2.5hours.
AdaptedfromJ.Biol.Chem.278,3170,2003,bycourtesyofProfessorTetsuoNaganoandtheAmericanSocietyofBiochemistryandMolecular
Biology.

--- Page 373 ---

318 FREE RADICALS IN BIOLOGY AND MEDICINE
GSSG + O 2 – DCF + A –
O
2
+ Ascorbate
(GSSG) –
GS– O O O
+ GSH + NADH
GS + DCF CI CI DCF + NAD
O
C
O– O
2
O –
2
HRP
O O
H 3 CCO O OCCH 3 HO O OH
uptake by cells
CI CI De-acetylation by CI CI
H C O esterases H C O
OH O–
DCFHDA 2’,7’-Dichlorodihydrofluorescein (DCFH)
Fe/H O (OH)
2 2
haem proteins
GS , CO3 – , NO2
–O O O–
HO O O
CI CI
CI CI O
C
C
O O-
O– O
2
– O
2
DCF H 2 O 2 DCF –
light
(DCF)*
Figure6.11 ConversionofDCFHDAtoafluorescentproduct.107,111Dichlorofluorescin(sometimeswrittenasdichlorofluorescein)diacetate,more
correctlycalled2’,7’-dichlorodihydrofluoresceindiacetate(DCFHDA),ishydrolysedbycellularesterasesto2’,7’-
dichlorodihydrofluorescein(DCFH),whoseoxidationbyseveralRS(Table6.7)formsfluorescentDCF(2’,7’-dichlorofluorescein)viaan
intermediateradical,DCF
•–.PeroxidasesorRScanconvertDCFHintoaphenoxylradicalthatcaninteractwithantioxidantssuchasascorbate
(AH–),reducingthephenoxylradicalandoxidizingascorbate,orwithGSH.GS • resultingfromthelatterreactioncanleadtoO •–generationand
D O C •
2
– F • ( – Se c c a t n io r n ed 3 u .1 c 3 e .4 O ) 2 .S to up O e • 2 r – o . xi T d h e e p p r h o e d n u o ce xy d l i r n ad th ic e a s l e ca re n a a ct ls io o n b s e w r i e ll c u yc n l d ed er b g y o N sp A o D n H ta , n p e r o o u d s uc o i r ng SO N D A - D ca • ta ra ly d z i e c d al, d w ism hi u ch ta r t e io a n ct t s o ra fo p r i m dly 2 H w 2O ith 2, O a 2 s t u o bs p t r r o a d te uce
foriron-orhaem-catalyzedDCFHoxidation.Adaptedfromref27bycourtesyoftheBritishSocietyofPharmacology.AlsoseeFreeRadic.Biol.Med.
41,657,2006.
The probes HPF and APF (Table 6.7; Fig. 6.12) Both are more stable to photochemical events than is
have been used by some groups. Both fluoresce after DCFHDA, and neither responds to 1O , O •–, H O ,
2 2 2 2
reaction with OH • , ONOO– and peroxidase-derived NO • , or RO • radicals. APF has been used together
2
species, but only APF emits light after exposure to withboronate-basedprobestodistinguishH O from
2 2
HOCl,althoughitisnotspecificforHOCl(Table6.7). HOCl in cells.110 Another approach has been to

--- Page 374 ---

MEASUREMENT OF REACTIVE SPECIES 319
XH
O O O RNS/ROS O O O-
C O O – X O C O O –
Almost non-fluorescent Strongly fluorescent
X = O; HPF
X = NH; APF CH 3
N+
NH O
2 NH O
2
N H
N H
N H N N H N+
O
Cl O CH
3
Luminol L-012 Lucigenin (bis-N-methylacridinum)
O
CH CH
2 3
CH H H H
N 3 CH C C C
CH O N C C C CH
3 H H H
HN
(CH ) COOH
27
2-Methyl-6-(4-methoxyphenyl)-3,7- cis-parinaric acid
dihydroimidazo[1,2,-α]pyrazin-3-one]
(MCLA)
HO
O
N N N
B
CH CH (CH )
F F 210 HN N
CH CH COOH
OH
Coelenterazine
4,4-difluoro-5-(4-phenyl-1,3,butadienyl)-
4-bora-3a,4a-diaza-s-indacene-3-
3-undecanoic acid (BODIPY®581/591 C11)
Figure6.12 Structuresofsomecommonprobesusedfordetectionofreactivespecies.HPFis2-[6-(4’-hydroxyl)phenoxy-3H-xanthen-3-on-9-yl]
benzoicacidandAPFis2-[6-(4’-amino)phenoxy-3H-xanthen-3-on-9-yl]benzoicacid.BODIPYisanabbreviationforborondipyrromethane.

--- Page 375 ---

320 FREE RADICALS IN BIOLOGY AND MEDICINE
use silica-coated 20–40 nm europium-doped nano- DNA, generating a strong red fluorescence. Its reac-
particles, Y Eu VO . These enter cells readily, and tion with O •– is fairly slow, however: k about 6 ×
0.6 0.4 4 2
can be photoreduced to the Eu2+ state by laser ra- 103 M-1s-1. Some other ROS (e.g. OH•, NO • , CO •–)
2 3
diation. They are re-oxidized to Eu(III) with restor- as well as haem proteins (e.g. haemoglobin, cyto-
ationoffluorescencebyROS,especiallyH O .Indeed, chrome c) can also oxidize it, but different products
2 2
they were used to measure the time course of ROS areformed,includingethidiumcation(E+)andseveral
(probably mostly H O ) production in cells treated dimers(HE-HE,HE-E+,E+-E+).Hence,formationof2-
2 2
withPDGF.114 hydroxyethidium seems specific for O •– under most
2
conditions.Nevertheless,DHEreadilyoxidizesspon-
6.12.2 Dihydrorhodamine123(DHR)18,53,107
taneously, and it can be oxidized by singlet O . The
2
• • major product of DHE oxidation in cells is ethidium,
ThiscompoundisusedtodetectseveralRS(OH ,NO ,
2
CO
•–,
peroxidase-derived species), but is poorly re-
which exhibits very similar spectroscopic properties
3
sponsivetoO
•–,H
O ,orNO
•
.Itsapparentresponse
to2-hydroxyethidium.However,ethidiumisnotpro-
toONOO–(Se 2 ction 2 6.6 2 .1)isduetoreactionwithprod- ducedbyO • 2 –.Therefore,forquantitationofO • 2 – using
ucts derived from ONOO–, such as CO •–, NO • , and DHE, the products need to be separated, and assays
3 2
possibly some OH• (Section 2.6.1). It is better than usingHPLCwithfluorescencedetectionhavebeende-
velopedtoquantify2-hydroxyethidium.Forexample,
DCFHDA at detecting HOCl. These various RS con-
thesteady-statelevelofO
•–
inthemitochondrialma-
vertDHRtorhodamine123(Fig.6.13),whichishighly 2
trix of rat skeletal muscle cells was measured by this
fluorescent at around 536 nm when excited at about
technique116 as ~3 pM (roughly comparable with the
500nm.AtphysiologicalpH,rhodamine123isalipo-
value obtained by the aconitase assay in a different
philiccationandtendstoaccumulateinmitochondria,
cell type; Section 6.4.1). HPLC-based analysis of HE-
driven by the mitochondrial inner membrane poten-
derived products allows determination of not only
tial. Athigh levels,rhodamine123 can sensitize mito-
2-hydroxyethidium, but also the other products (eth-
chondrial singlet O formation. Similarly to DCFH,
2
idium, dimers). Therefore, with the proper analytical
conversion of DHR into the fluorescent product in-
methods,theprobecanyieldmoreinformation117than
volves formation of a transient radical, which is able
toreduceoxygentoO
•–. justtheformationofO •
2
–.
2
DHE and other probes can be attached to tri-
phenylphosphonium residues to target them to
6.12.3 Dihydroethidium107,115
mitochondria,formingmito-HE,alsocalledMitoSOX
Dihydroethidium(DHE),sometimescalledhydroeth- Red. It reacts with O
•–
with a rate constant of
2
idine(HE),isfrequentlyusedasaprobeforO •–,being about 1.6 × 104 M-1s-1. Also, a cell-impermeable ana-
2
oxidizedtoafluorescentproduct,2-hydroxyethidium logue of DHE has been synthesized, called hydro-
(2-OH-E+;Fig.6.13),whichcanintercalateintonuclear propidine (or dihydropropidium)115, which detects
(a)
H 2 N O NH 2 H 2 N O NH 2 +
C RS C
H
C OCH3 C OCH3
O O
(b) OH
H 2 N NH 2 H 2 N NH 2
RS
H C N C N+
CH 2 CH 3 CH 2 CH 3 F 12 ig 3 u t r o e rh 6 o .1 da 3 m C in o e nv 1 e 2 r 3 sio a n nd of (b (a ) ) o d f i d h i y h d y r d o r r o h e o t d h a id m iu in m e
to2-hydroxyethidium.

--- Page 376 ---

MEASUREMENT OF REACTIVE SPECIES 321
extracellularO •–.BothMitoSOXRedandhydropropid- 6.12.5 Alternativeluminescentprobes
2
inedisplayverysimilarchemistrytodihydroethidium forsuperoxide
andcan,therefore,formO
•–-specificproducts.117
2 Alternative probes111 include coelenterazine (a lipo-
philic compound involved in light production in the
6.12.4 Luminol,lucigenin, aequorin system; Section 8.6), the luciferin analogue
andL-01218,27,53,107,111 MCLA (Fig. 6.12), and MCLA derivatives. However,
•
MCLA may also react with RO radicals, coelen-
Luminol and lucigenin (Fig. 6.12) are often used to • 2
terazine with RO and ONOOH or species derived
assess production of RS by activated phagocytes and 2
from it. Both MCLA and coelenterazine compounds
other cell types. The luminol analogue L-012 (Fig.
6.12) has been reported to be a more-sensitive O
•– arehighlyphotosensitive.
2
detectorthanluminolorDHEandhasbeenadminis-
tered to animals to detect ROS production at sites of 6.12.6 Effectsofreactivespeciesonother
inflammation.118 probes27
However,theuseofluminol(orL-012)todetectO
•–
2
is problematic. Neither reacts directly with O
•–,
they
Manyfluorescentprobesareavailabletodetectother
2
must first be oxidized (e.g. by OH
•
, NO
•
, CO
•–,
RS
•
,
cellular events, such as pH changes and ion move-
2 3
ments.SomeoftheseprobescanreactwithRS(HOCl,
HOCl, or peroxidases [including myeloperoxidase]
OH • ,1O , and ONOOH, or NO • , CO •–, and OH • de-
plus H 2 O 2 ). Peroxynitrite also oxidizes luminol, but 2 2 3
thismaybeviaNO
•
,CO
•–,andOH •
.Inallcases,the
rived from it, often being the culprits). Others can
2 3
resulting luminol or L-012 radicals react with O
•–
to
themselvesgenerateROSundercertaincircumstances,
2
including calcein and even MitoTracker Red, a dye
generatealight-emittingproduct.Unfortunately,simi-
thatstainsmitochondria.119Onemustbealertforthese
larly to DCFH- and DHR-derived radicals, luminol
or L-012 radicals can reduce O to generate O
•–,
so
effectswhenusingacombinationofprobesincells.
2 2
that the presence of luminol or L-012 plus an oxi-
dizing agent can lead to artefactual O
•–
generation. 6.13 Biomarkers:oxidationofbilirubin
2
Hence luminol or L-012 are questionable probes; any andofurate
oxidizing agent that can remove one electron from
themcancauselightemissioninhibitablebySOD,in Several RS react in characteristic ways with biomol-
which luminol or L-012 are both the source and the ecules. The products can be regarded as fingerprints
detectorofO
•–.
ofoxidativeattack,providedthattheyareunique,not
2
Lucigenin,adication(LC2+),isoftensaidtobemore generatedbynormalbiologicalprocessesororiginat-
specificforthedetectionofO
•–thanluminol,butagain
ing from diet. For example, some groups have used
2
itreactsonlyslowlywithO
•–,ifatall.Whereasluminol
ascorbylradical,measuredbyESR,asanindicatorof
2
needstobeoxidized,lucigeninmustfirstbereduced oxidative stress (Fig. 6.1). Others have used the ratio
tolucigenincationradical(LC•+).ThisreactswithO •– ofubiquinoltoubiquinoneinplasma(Section3.25.5).
2
togiveanunstabledioxetane,whichdecomposestoa Oxidationproductsofbilirubin(biopyrrins)havebeen
light-emitting species. Conversion of LC2+ to LC•+ is measured in human urinein severalconditionsasso-
notreadilyachievedbyO
•–,andusuallyinvolvesother
ciatedwithoxidativestress(Section3.25.1),including
2
cellularreducingsystems(e.g.XO,NOS,cytochromes atrialfibrillation120 and‘stress’itself.121 Theyarethus
P450,themitochondrialelectrontransportchain,orthe a possible biomarker of oxidative stress,120 although
phagocyte NADPH oxidase), introducing complexity notwidelystudied.Anotherapproach(applicableonly
ininterpretingresults.Evenworse,LC•+canreduceO toprimates)hasbeentodetectallantoin,arisingfrom
2
to O
•–,
so that addition of lucigenin can artefactually degradationofurate(Section3.25.1).Urateisoxidized
2
generatemoreO •–,byaredoxcyclingmechanism.The toallantoinbyarangeofRS,122andalsobymyeloper-
2
extent to which this artefact impairs accurate meas- oxidaseandlactoperoxidaseinthepresenceofH 2 O 2 .123
urement of O
•–
by lucigenin has been debated in the Allantoin can be measured in human plasma, urine,
2
literature,butinterferencedoesappeartobesignificant andotherbodyfluidsandlevelsareelevatedincon-
insomecellsystems,andthoseusinglucigeninought ditionsassociatedwithoxidativestress,suchasmen-
tobeawareofthepossibility.Similarlimitationsapply ingitis (Section 10.18.1), venous ulcers, vitiligo, cigar-
tothespectrophotometricprobeusedforO
•–,nitroblue
ettesmoking,diabetes,prematurebirth,ironoverload,
2
tetrazolium(NBT)(Section2.5.3). Downsyndrome,chronicheartfailure,exercise,andin

--- Page 377 ---

322 FREE RADICALS IN BIOLOGY AND MEDICINE
patientsundergoingchemotherapy(Section3.25.6and (Section 5.10) and so cannot be equated with oxida-
refs122,124,125). Allantoin levels rise in human muscle tive DNA damage. Fragmentation of 2-deoxyribose
duringexhaustiveexercise,presumablyduetooxida- generatesmultipleproducts.Probablymoreattention
tionofuratebyRS.Allantoinmeasurementmaybea needs to be paid to them, since they may contribute
promisingmethodforhumanuse,sincehumanurate to mutagenicity, both directly and via base propenal
levelsinvivoarehighanditreactswitharangeofRS. formation. Assays have been developed to detect
Allantoinisreadilyclearedfromtheplasmaandsoas them,126 but they are not commonly measured by
soonasoxidativestressdiminishesitslevelsfall.125 biologists.
Most attempts to ‘fingerprint’ oxidative damage to
DNAhavemeasuredmodifiedbases,mostcommonly
6.14 Biomarkers:oxidativeDNAdamage
8-hydroxy-2(cid:4)-deoxyguanosine,8OHdG(Table5.8dis-
6.14.1 DNAdamage:whymeasureit? cusses the nomenclature), following the introduction
of HPLC-based assays with sensitive electrochem-
OxidativeDNAdamageoccurscontinuallyinvivo,in
ical detection.127 8-Hydroxyguanine exhibits keto–
thatlowlevelsof8OHG(and,wheremeasured,other
enol tautomerism; the equilibrium favours the 6,8-
modified bases) have been detected in DNA isolated
diketo form, so some authors call it 8-oxo-7-hydro-
from the cells of every aerobe examined. The pres- 2(cid:4)-deoxyguanine, or 8oxoG (Fig. 6.15). However, we
enceofmultipleoxidizedpurineandpyrimidinebases
stickwith8OHG(or8OHdGforits2-deoxynucleoside
•
demonstrates that OH damages DNA in vivo (Sec-
form),forconsistency.Measurementof8OHGinDNA
•
tion3.9.2.2).IfOH isattackingDNA,itmustbemade
hasseveraladvantages.
very close to it. Background radiation may be one
sourceofOH•,andFentonchemistry(involvingmetal
1. AsensitiveHPLC-basedassayisavailable.
ionsboundtoDNA)another.Otherpotentialsources 2. It is formed in DNA by several RS, including 1O ,
of OH • include ONOO– (Section 2.6.1) and the reac- OH • ,CO •–,andsomeRO • radicals(Section5.8.2). 2
tionofO • 2 – withHOCl(Section2.6.3).However,when 3. It is a m 3 utagenic lesion 2 (Section 5.5.1); the mul-
HOCl or ONOO– are added to cells, OH • does not tiple mechanisms employed to remove it (Sec-
seem to contribute much to the DNA damage; direct tion 5.10.5) suggest that cells ‘perceive’ it to be a
reactionsofthesespecieswithDNApredominate(Sec- threateninglesionwhichmustbeclearedrapidly.
tion 5.8.2). Low levels of the DNA base deamination
products uracil, xanthine, and hypoxanthine are also Nevertheless, it must be appreciated that levels of
presentinDNAfromaerobes. 8OHGarenotaquantitativemarkerofDNAdamageby
Many laboratories attempt to measure damage to RS.First,8OHGisonlyaminorproductofattackon
DNA by RS. Why? It is widely accepted that such DNA by reactive nitrogen (e.g. ONOOH and nitrous
damage contributes significantly to cancer develop- acid) or chlorine (e.g. HOCl) species. Second, attack
•
ment (Section 10.14). In other words, oxidative DNA of singlet O or OH upon guanine generates other
2
damage may be a biomarker predictive (to some ex- products, such as FAPyG (Section 5.8.2). 8OHG and
tent) of cancer development later in life. If so, it can FAPyGareformedfromthesameC8-OH-adductrad-
be used to evaluate what the effects of diet, lifestyle, ical of guanine (Fig. 5.12), and the ratio of 8OHG to
andsupplementsmightbeoncancerincidence;agents FAPyG is affected by the redox state of the cell (e.g.
thatlowerlevelsofoxidativeDNAdamagemightbe it is decreased at low O concentrations) and by the
2
preventative. presence of transition metal ions. Hence, changes in
theamountof8OHGinDNAcanresultfromchanges
inredoxstateandtransitionmetalionavailability,not
6.14.2 CharacterizingDNAdamage:what
necessarily from changes in the rate of oxidative at-
tomeasure?
tack on DNA. In other words, the same amount of
Attack of RS on DNA can produce strand break- attack on DNA by RS could give different levels of
age, abasic sites, deoxyribose damage, modification 8OHG,dependingontheenvironment.Third,8OHG
of the purines and pyrimidines, DNA-DNA and is readily oxidized by RS, much faster than guanine
DNA-protein cross-links, and clustered lesions because its reduction potential (0.74 V) is lower than
(Section 5.8.2). Multiple methods exist to measure thatofguanine(1.29V).Thussomeauthorshaveadvo-
strand breaks (Table 6.8 and Fig. 6.14) and some to catedthat8OHGoxidationproducts(e.g.hydantoins)
detectabasicsites(Table6.8).However,strandbreak- be measured as well (Section 5.8.2.11), but this is not
age and abasic sites also occur during DNA repair widelydone.

--- Page 378 ---

MEASUREMENT OF REACTIVE SPECIES 323
Table6.8 SomeofthemethodsavailabletomeasurestrandbreakageinDNA.
Method Comment
[3H]thymidineincorporation Cellsareincubatedwithradioactive(tritiated)thymidine,whichisincorporatedintonuclearDNA.
Productionofradioactivefragmentsmeasured.Onlyusefulforproliferatingcellswhichcanincorporate
DNAprecursors.
IncorporationofBrdUa Non-radioactivealternativeto[3H]thymidine.IncorporatedintoDNA.Fragmentsdetectedusing
antibodiesagainstDNAcontainingBrdU.
Enzymaticlabellingtechniques FreeOHgroupscreatedbystrandbreakagearelabelledwithmodified(e.g.fluorescent)nucleotidesin
thepresenceofenzymes,e.g.terminaldeoxynucleotidyltransferase,TdT.Theincorporatedmodified
basesaredetectedfluorimetricallyorusingantibodies.ApopularmethodisTUNEL(TdT-mediated
dUTP-biotinnickend-labelling).Requirespermeabilizationofthecelltoallowenzymesin.
Gelelectrophoresis UsedtomeasureinternucleosomalDNAcleavage,e.g.duringapoptosis.
Cometassay Fig.6.14.
Alkalineelution Cellsarelysedaboveafilterandelutedbypassinganalkalinebufferthrough.ThehighpHunwindsthe
helixandthesmallerpiecespassthroughthefilterquickly.
Alkalineunwinding CellsarelysedandkeptathighpHforafixedtimetodenaturetheDNA.Unwindingbeginsfrom‘free
ends’soisfasterifstrandbreaksarepresent.Thesolutionisneutralizedandthefragmentsmeasured.
Bothelutionandunwindingtechniquescanbecombinedwithpreincubationofthecelllysateswith
endonuclease/glycosylaseenzymestoestimatetheoxidizedbasespresent(Fig.6.14).
UseofsupercoiledplasmidDNA Strandbreakagecauses‘relaxation’ofthesupercoilintoopencircleandlinearforms,measuredas
differentmigrationonagarosegelelectrophoresisorasincreasedfluorescenceduetomore
intercalationofethidiumbromideintherelaxedDNA.Ethidiumisaplanararomaticdyewhich
readilyintercalatesbetweenbasepairs,althoughthisisrestrictedinintactDNAbyitsresistanceto
distortion.
CellDNAfragmentationELISA Anantibody-basedtechniquewhichdetectshistone-coveredDNAfragmentsincellcytoplasm;often
usedtostudyapoptosis,whichgeneratesDNAfragmentsinsidecells.
Aldehydereactiveprobe(ARP; ARPreactswithaldehydegroupsintheopenringformoftheapurinic/apyrimidinic(AP)sitesof
N’-aminooxymethylcarbonylhydrazino- damagedDNA.AftertheadditionofARPreagent,APsitesaretaggedwithbiotinandquantifiedusing
D-biotin) anavidin–biotinassay(Section6.16.3)withcolorimetricdetectionusingperoxidaseoralkaline
phosphataseconjugates.HasalsobeenusedtomeasureM1dG(Fig.5.27);seeChem.Res.Toxicol.18,
51,2005.Abasicsitesanddeoxyribosedegradationproductscanalsobederivatizedandmeasuredby
massspectrometry(Anal.Biochem.343,84,2005;Chem.Res.Toxicol.19,300,2006).
a5-Bromo-2’-deoxyuridine.
MoststrandbreaksdetectedbythesetechniquesexistassuchintheDNA.Othersarecreatedduringthemeasurement,e.g.sugardamagecanbeconvertedintostrand
breakageonexposureofDNAtohighpHduringcertainassays(alkali-labilesites).Formoredetails,seeDidenko,VV(ed).DNADamageDetectionInSitu,ExVivo,
andInVivo:MethodsandProcotols,MethodsinMolecularBiology,682,2011,Springer.AlsoseeBjergbaek,L(ed)DNARepairProtocols,MethodsinMolecularBiology,
920,2012,Springer.
Althoughassayof8OHGisusefulandhasprovided ONOO– causes formation of 8-nitroguanine in DNA,
importantbiologicalinformation,itisintrinsicallyun- whereas HOCl generates several products including
reliable to measure a single product as an index of chlorocytosine (Section 5.8.2). Mass spectrometry can
oxidativeDNAdamage(thesamecommentappliesto distinguish these various products as well as detect
lipidandproteindamageaswell!).Abetterapproach andquantifythemandotherlesionssuchasbase–base
is to measure multiple products (Fig. 5.14), which andbase–aminoacidcross-links.
usually involves mass spectrometry linked to liquid
orgaschromatography.Suchapproachescanalsogive 6.14.3 CharacterizingDNAdamage:how
informationaboutthedamagingspecies.Forexample,
tomeasureit
•
thedistinctivefeatureofOH attackuponDNAisto
produce multiple products from all four DNA bases. There are in essence two types of measurement of
SeveralRNScandeaminatecytosinetouracil,guanine oxidative DNA damage. Steady-state damage, the
toxanthine,andadeninetohypoxanthine.Exposureto level measured in cellular DNA, reflects the balance

--- Page 379 ---

324 FREE RADICALS IN BIOLOGY AND MEDICINE
Figure6.14(colourplate12) Thecometassay.Humanlymphocytes(thecometassaycanbeappliedtoothercelltypesofcourse)beforeor
afterH2O2treatmentweresuspendedinagarosegelinbufferat37◦C andpipettedontoamicroscopeslideprecoatedwithagarose.Theagarose
wassetbyincubatingat4◦C,andtheslidesimmersedinlysissolutionat4◦C toremovecellularmembranes,proteins,etc.andleavebehindthe
DNA.Slideswerethenplacedinanelectrophoresistankcontaining0.3MNaOHand1mMNa2EDTAat4◦Cfor40minbeforeelectrophoresisin
thesamesolutionat25Vfor30minat4◦C.DNA,beingnegativelycharged,isattractedtotheanode.Thepresenceofbreaksallowssupercoiled
DNAtorelaxandmovetotheanodetoformatail(hencethenamecometassay),andthefractionofDNAinthetailreflectsthefrequencyof
breaks.TheslideswerewashedbeforestainingwithSybrGold.Thefigure(lefttoright)showscometswithincreasingextentsofDNAdamage.
Amodificationofthecometassaypermitsdetectionofoxidizedbasesinadditiontobreaks.Inthiscase,afterlysistheslidescanbewashedin
buffer,drained,andtheagarosecoveredwith50μlofbuffercontainingendonucleaseIII,FAPy-glycosylase(Fpg),orotherDNArepairenzymes,or
bufferonly,sealedwithacoverslip,andincubatedat37◦C.EndonucleaseIIIbreakstheDNAatsitescontainingoxidizedpyrimidines,and
FAPy-glycosylase(Fpg)at8OHG,FAPyG,andFAPyA.Alkalinetreatment,electrophoresis,andneutralizationarecarriedoutasbefore.Photograph
bycourtesyofDrAndrewCollins;alsoseeBiochim.Biophys.Acta1840,794,2014.
O O OH lessreliableandquantitativethanthosebasedonmass
HN N HN H N N H N spectrometry.130,131
OH O O
H2N N N H2N N N H2N N N Because urine contains thousands of compounds,
R R R sample preparation techniques are critical. Urinary
6-keto, 8-enol form 6,8-diketo form 6-enol, 8-keto form 8OHdG levels are usually standardized against cre-
(8OHG) (8oxoG)
atinine to allow for the degree of concentration of
Figure6.15 Keto–enoltautomerismof the urine.130 For example, in a study of 169 adults in
8-hydroxy-2’-deoxyguanosine.R,restofDNAmolecule. Denmark,132 theaverage8OHdGexcretionwas200to
300pmol/kgbodymassper24h,whichcorrespondsto
thenotinconsiderableaverageof140–200oxidatively-
between damage and repair. Hence a rise in its level induced modifications to the guanine in the DNA of
could be due to increased damage, decreased repair, eachcellofthehumanbodyeveryday.Furthermore,
orboth. 32 smokers in this study excreted, on average, 50%
Attempts have also been made to estimate the more 8OHdG than 53 non-smokers, suggestive of a
total oxidative DNA damage in vivo, by measur- 50% increased rate of oxidative DNA damage from
ing products of DNA repair that are excreted in smoking. Measurement of 8OHdG or other modified
urine. Several base damage products are present basesinurinegivesnoinformationabouttheirtissue
in mammalian urine, including 8OHG, 8OHdG, origin, although they can also be measured in fluids
thymine glycol, 8OHGua (8OH attached to ribose), from specific sites (e.g. saliva, synovial fluid, CSF) to
5-hydroxymethyluracil, 8-hydroxyadenine, 7-methyl- givemore‘local’information.
8-hydroxyguanine, and cyclodA and cyclodG What do measurements of urinary DNA bases
(Section5.8.2).127–129Theproductmostoftenmeasured mean? The level of 8OHdG in urine seems to be
is 8OHdG, usually by HPLC with electrochem- unaffectedbydiet,butsomeoftheotherproductsin
ical detection after concentration of the urine on urine (e.g. thymine glycol) could result from uptake
columns,127,128 although GC–MS and LC–MS-based of oxidized bases from the diet (e.g. after digestion
techniqueshavealsobeendescribed.Antibody-based of DNA damaged by cooking) and their excretion in
methods are also available, but in general, they are the urine.128 This remains to be explored; some (but

--- Page 380 ---

MEASUREMENT OF REACTIVE SPECIES 325
not all) studies have suggested that urinary 8OHG To measure oxidative DNA damage by most of
levelsareinfluencedbydiet.8-Hydroxyguaninecould thecurrentlyavailablemethods,onemustfirstisolate
inanycasecomefromrepairofRNA,DNA,orboth. DNA. The isolated DNA is then hydrolysed and the
The question of whether any 8OHdG is metabolized hydrolysate prepared for analysis of modified DNA
to other products in humans has not been fully ad- bases. During isolation and preparation for analysis,
dressed,althoughcurrentlyavailabledatasuggestthat DNAisexposedtoambientO (hyperoxiacompared
2
itisnot.Amoreworryingquestionisthesourceofthe with nuclear O levels) and to transition metal ions
2
8OHdG—doesitarisefromDNA,fromsanitizationof that can catalyse oxidative damage. Metals can be
the dGTP pool (Section 5.10.2), or both? The latter is presentascontaminantsinreagents(e.g.phenol)and
theobvioussource,becausebaseexcisionrepair(BER) equipment (e.g. dialysis membranes), and liberated
pathways(thepreferredrepairmechanismfor8OHG during homogenization of tissues prior to DNA ex-
in DNA; Section 5.10.5) liberate the free base 8OHG traction(Section5.3.3).Insomeanalyticalprocedures,
fromDNAandnotthenucleoside8OHdG.Neverthe- DNA is incubated for prolonged periods with nu-
less,pathwaysthatliberate8OHdGprobablyalsoexist cleases to liberate 8OHdG, or exposed to elevated
(e.g.nucleotideexcisionrepair:Section5.10.5)buttheir temperatures (e.g. in hydrolysis using formic acid).
contributionsneedbettercharacterization.128Similarly, Isolation, hydrolysis, and analysis all therefore have
8OHGua could come from the RNA precursor pool the potential to cause artefactual oxidation of DNA
(Section 5.10.2). In the case of cyclodG and cyclodA, (especially of guanine residues), raising the apparent
NER is the only repair mechanism utilized, because level of base oxidation products. If GC–MS is used,
of the 8,5’-covalent bond in these molecules. Thus, high-temperaturederivatizationinpreparationforGC
their origin is clear. Moreover, the availability of ac- can cause extensive DNA base oxidation unless con-
curate assays using LC–MS/MS, and their chemical ditions are rigorously controlled. If the steady-state
stabilitymakescyclodGandcyclodApotentialurinary level of 8OHG in cellular DNA is less than one per
biomarkersofoxidativeDNAdamage.129 105 guanines, as some propose, it is easy to see how
Inspiteoftheseissues,urinary8OHdG,8OHG,and oxidation of <0.01% of unmolested DNA bases can
8OHGuameasurementsarewidelyusedasanapproxi- invalidatethemeasurement.Manylaboratoriesarein-
mate index of how diet and lifestyle may influence vestigating better methods of isolating, hydrolysing,
‘whole-body’oxidativedamagetoDNAandRNAand and analysing cellular DNA. The unspoken criterion
their precursors. Comparable results seem to be ob- by which the results are usually judged seems to be
tainedwhether‘spot’urinesamplesor24-hcollections that the lower the level of oxidized bases in cellular
areused.131,133 DNAthatisobtained,themorelikelyitistobecorrect.
This seems logical because one would expect organ-
ismsto‘perceive’oxidativeDNAdamageasathreatto
6.14.4 Steady-statedamage:theartefact
theintegrityofthegenome,andsotominimizesteady-
problem134,135
stateconcentrationsofoxidizedDNAbasesusingtheir
Whereas there is some degree of agreement between plethora of DNA repair systems. However, there are
different laboratories on human urinary levels of manysurprisesinbiology;onemustattempttofindthe
8OHdG,agreementonthelevelsof8OHGinisolated realanswerastowhatthebackgroundlevelisrather
DNA is less good—values vary over some orders of thanmakeaprioriassumptions.
magnitude. It is even uncertain whether mtDNA is Assaysofdeaminationproductsarealsoveryprone
moreoxidizedthannuclearDNA(Section5.8.3).Pub- to artefacts, including acid-induced deamination and
lishedvaluesfornuclearDNArangefromlessthanone the widespread presence of deaminases in cells that
8OHGper106 guaninestoover20.a Whichiscorrect? canattackDNAduringitsisolation.Steady-statelevels
Possiblynoneofthem.Whatistheproblem? ofdeaminationproductsinDNAinvivoareprobably
nogreaterthanfor8OHG.136,137
a Comparisonsbetweenresultsfromdifferentlaboratories
maybeaidedbythefollowingconversionfactors(bycourtesy 6.14.5 Overcomingtheartefact134,135
ofDrMiralDizdaroglu).x8OHdG/105 2’-deoxyguanosines
is equal to (x/4.65) 8OHdG per 105 DNA bases (since Multiple approaches have been used. Many re-
about 21.5% of bases are guanine in mammalian DNA)
searchers avoid phenol in DNA extraction, since it
or to (x/30.8) nmol 8OHdG per mg of DNA. Similarly,
1 nmol of 8OHdG per mg of DNA is 143 8OHdG/105 2’- is often metal ion-contaminated and oxidizes to gen-
deoxyguanosinesor30.8/105DNAbases. erate ROS. Some add antioxidants or iron chelators

--- Page 381 ---

326 FREE RADICALS IN BIOLOGY AND MEDICINE
such as desferrioxamine to the extraction solutions, can be recognized by exogenously applied enzymes,
or even attempt to extract DNA under nitrogen. De- andtwoadjacentlesionsmayberecordedasasingle
rivatization for GC–MS can be performed at room strand break. Nevertheless, the comet assay is rapid,
temperatureinthepresenceofantioxidants,ortheun- easy to do, and uses only small amounts of material,
modified bases first removed by HPLC so that there although the numbers generated rely on semiquant-
isnothingtoartefactuallyoxidize.Onecanavoidde- itative assessments of the size of a ‘tail’ and there is
rivatization altogether and use LC–MS instead. DNA significantinter-observervariation.Attemptstostand-
canbedigestedwithrepairenzymestoremovemodi- ardize the methods between laboratories are making
fied bases, that can then be analysed by LC–MS or progress.
GC–MS, rather than digesting the whole DNA mol-
ecule.Ofcourse,thisassumesthattherepairenzymes
6.14.6 Interpretingtheresults:measureDNA
can remove all the lesions, which is uncertain. One
levelsorurinaryexcretion?Whatdothelevels
approach to evaluating work-up techniques is to use
mean?
DNA containing some [18O]-labelled 8OHdG, gener-
ated by exposing DNA to [18O]-singlet O 2 . The ratio Some studies have combined both types of measure-
of 818OHdG to 816OHdG in DNA during isolation ment. For example, administration of 2-nitropropane
should remain constant; if it falls, it suggests artefac- to rats led to elevated 8OHG levels in DNA. Levels
tual 8OHdG formation.135 8OH[15N 5 ]dG can also be subsequently decreased, accompanied by an increase
used. A Standard Reference Material (SRM2396) is inurinary8OHdGexcretion.138Cigarettesmokingcan
availablefromtheNationalInstituteofStandardsand raise both 8OHG levels in human cell DNA and
Technology, Gaithersburg, Maryland, USA, that con- 8OHdG urinary excretion rates (Section 9.13). Hence,
tains 13C-, 15N-, and deuterium-labelled analogues of bothnitropropaneandcigarettesmokeincreaseoxida-
thebaselesionsproducedbyoxidativeDNAdamage. tiveDNAdamageinvivo.Repair(atleastasindicated
Thesecompoundscanbeusedasinternalstandardsfor byurinary8OHdGexcretion)alsoincreases,butnotto
thequantitativemeasurementofcorrespondingDNA an extent that prevents a rise in the 8OHG levels in
productsbyGC–MSandLC–MSwithisotopedilution. DNA. Measurements of only 8OHdG excretion rates
should be interpreted with caution. For example, an
6.14.5.1 Thecometassay
agentthatincreases8OHdGexcretionmightbeinter-
AnotherapproachistobypasstheproblemsofDNA preted as ‘bad’ (seemingly increasing DNA damage),
isolationandpreparationandtrytomeasuredamage butmightinfactbe‘good’(ifitstimulatedrepairand
directlyincells.Immunostainingmethodsusinganti- thereforedecreasedsteady-state8OHGconcentrations
bodies against 8OHG or other oxidized DNA bases incellularDNA).Forexample,acceleratedmitophagy
haveprovedusefulinseveralstudies(Fig.6.16).Anal- of oxidized mitochondria would seem to be a good
ternative is the comet assay, single cell gel electro- thing,butitcanincreaseurinary8OHdGlevels.139
phoresis,whichisoftenemployedtostudyhowdiet- The ideal is thus to measure both cellular DNA
ary antioxidants might influence DNA damage. This damage levels and total damage (by urinary excre-
measuresDNAstrandbreaksand(athighpH)alkali tionrates).Ifonlyonemeasurementcanbemade,the
labile sites (Table 6.8; Fig. 6.14) The comet assay can steady-statelevelisarguablypreferable,becausemis-
also be modified to allow an assessment of oxidative codinginducedbymodifiedbasesispresumablywhat
base damage—the cells are lysed and the slides ex- determines the risk of mutation, and in turn the risk
posedtoDNA-repairenzymes.DNAiscleavedatsites ofcancerdevelopment.Therepairprocessitselfisnot
of base modification, producing more strand breaks. error-free, however (especially if translesional DNA
Hence a comparison of the comets before and after replicationoccurs;Fig5.16),anditcanintroducemuta-
enzymic treatment can estimate the oxidized bases tions,soitcouldbearguedthatagreater‘throughput’
present(Fig.6.14). ofDNAbaseoxidationisdeleteriousevenifitdoesnot
Thelevelsofoxidizedbasesmeasuredbythecomet resultinsignificantrisesinthesteady-stateconcentra-
assay in DNA are generally lower than those ob- tionsofDNAdamageproducts.
tainedbyHPLCorMStechniques.Isthecometassay TheproblemwithmeasuringcellularDNAdamage
morereliable,givingalowervaluebecauseartefactual isthatthemethodsarenotyetcompletelyrobust,al-
DNA oxidation is minimized? Or does the comet as- though getting better. Another problem (in humans)
say simply underestimate damage? It seems unlikely is the limited availability of tissues from which to
thatalltheoxidizedbasesintangledDNA(Fig.6.14) obtain DNA. Many studies are performed on DNA

--- Page 382 ---

MEASUREMENT OF REACTIVE SPECIES 327
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure6.16 Immunohistochemicaldetectionof8OHdGinDNAand4-hydroxy-2-nonenal(HNE)-modifiedproteinsinthekidneyofmaleWistar
ratstreatedwithferricnitrilotriacetate(Fe–NTA),acatalystofFentonchemistryandacarcinogen(Sections3.22.4.2and10.14.12).(a)Renalcortex
ofcontrolkidney.8OHdGinDNAwasvisualizedusingN45.1,amonoclonalantibody.Itcanalsodetect8OHGinRNA,albeittwoordersof
magnitudelesseffectivelythan8OHdG,butnototheroxidizedbases.Faintnuclearstainingofrenaltubularcellsisobserved(original
magnification,x164).(b)Renalcortex3hafterFe–NTAtreatment.Intensenuclearstainingofproximaltubularcellswithoutapparent
degenerationisseen.∗:Necrotictubules(originalmagnification,×164).(c)Renalcortex24haftertreatment.Approximatelyhalfoftheproximal
tubularcellsarenecrotic.Moderatenuclearstainingofbothproximalanddistaltubularcellsisseen(originalmagnification,×164).(dande)
Serialsections.Renalcortex1haftertreatmentimmunostainedwithN45.1andpolyclonalantibodyforHNE-modifiedproteins.Almostthesame
tubulesarestained.However,thedistributionisnuclearforN45.1andcytoplasmicforHNE-modifiedproteins.Whereas8OHdGinDNAisfound
onlyinmorphologicallylivecells,HNE-modifiedproteinsalsooccurinthenecrotizingdegeneratingcells(arrows:originalmagnification×164).
(f)Renalmedullaofcontrolkidney.Nuclearstainingisfoundinthecollectingductcells(originalmagnification×249).(g)Renalmedulla1hafter
Fe–NTAtreatment.IntensenuclearstainingofdescendingandascendinglimbsofHenle’sloopaswellascollectingductcellsisobserved(original
magnification×249).(h)Renalmedulla3haftertreatment.Nuclearstainingisslightlydecreasedcomparedwiththatof1h(original
magnification×249).(i)Glomerulus3haftertreatment(originalmagnification×398).NuclearstainingofBowman’scapsuleandsomeofthe
glomerularcellsaswellasproximaltubulesisobserved.Allimmunohistochemicalspecimensarewithoutnuclearcounterstaining.FromLab.Invest.
76,365,1997,bycourtesyofProfessorS.ToyokuniandNaturePublishingGroup.
isolated from lymphocytes (or sometimes total white for HPLC- or MS-based methods. Are we justified
cells)fromhumanblood.Mostgroupsprefertoisolate in assuming that changes in the amount of oxidative
lymphocytes, since total white cell DNA will include DNA damage in white blood cells caused by oxida-
amajorcontributionfromneutrophils.However,there tivestressarereflectedinthetissuesinwhichcancer
is no obvious reason why levels of oxidative DNA is most likely to develop later (e.g. breast, prostate,
damage in either cell type should reflect levels in rectum, and colon)? Are the basal amounts of oxida-
otherbodytissues.Sperm,buccalcells,placenta,and tive damage in all body tissues the same? More data
biopsies of muscle, skin (e.g. Section 9.16.2), colon, areneeded.Nevertheless,astudyindogsrevealedthat
andothertissuesareotherpotentialsourcesofDNA, exercise decreased 8OHG levels in DNA from colon
although biopsy samples often yield too little DNA and from lymphocytes, but not from other tissues.140

--- Page 383 ---

328 FREE RADICALS IN BIOLOGY AND MEDICINE
It is also encouraging to note that in smokers (Sec- How was this shown? The DNA was treated with
tion 9.13), diabetics (Section 10.5), and rheumatoid FAPy-glycosylase (Fpg) and AP-lyase. The first re-
arthritispatients(Section10.11),increased8OHdGcan moves8-OHpurinesandformamidopyrimidines,and
be detected in both DNA from white blood cells and the secondcreatesa break at theapurinic site, which
in urine. Elevated 8OHG levels were also observed, rendersitresistanttoamplificationbythepolymerase
not only in liver DNA, but also in DNA from leuko- chainreaction(PCR).Hence,DNAdamagetospecific
cytes in subjects with liver inflammation caused by sequences can be estimated by determining the ratio
hepatitis C virus.141,142 In rats fed high-fat diets, oxi- of intact PCR products in cleaved versus uncleaved
dativeDNAdamageincreasedinbothbloodcellsand DNA.Thesamepromoterswereselectivelydamaged
mammarygland(reviewedinref142). whenculturedhumanneuronsweretreatedwithiron
Finally,arethelevelsofDNAbasedamageproducts ions and H O , leading to decreased expression of
2 2
found in cells biologically significant? They probably the genes.148 A similar technique was used to show
are in terms of cancer development, as discussed in that oxidative DNA damage in H. pylori-infected hu-
detailinSection10.14.8.1. man gastric mucosa is unevenly distributed between
genes, being higher in those encoding p53 and TGF-
β receptor type II, for example.149 Another approach
6.14.7 Reactivenitrogenandchlorinespecies
is to cleave DNA into fragments and use antibodies
SeveralRNSdeaminateDNAbasesandassaysforthe toprecipitatethosecontainingspecificoxidativedam-
deaminationproducts(includinguracil,xanthine,and age products, followed by sequencing.150 Yet another
hypoxanthine) have been described.136,137 Peroxyni- istomap8OHdGdistributiononchromosomesusing
triteforms8-nitroguanine(8NG)inDNA;boththisand antibodytechniques;itisnotevenlydistributed.151We
5-guanidino-4-nitroimidazole(Fig.5.14) can bemeas- thusneedtocombinemoleculargeneticswithanalyt-
ured. For example, levels of both 8OHG and 8NG icalchemistrytolearnthetruesignificanceofoxidative
(measured using an antibody-based method) were DNA damage. Radicals generated on specific DNA
higherinDNAfromstomachcellsinpatientsinfected bases can also be detected by immuno-spin trapping
withH.pylori,orfromtheliversofpatientswithhepa- (Section6.2.8).152
titis C infections,143 and 8NG was increased in DNA
in the lungs of mice infected with an influenza virus 6.14.9 RNAoxidation153
(Section 10.25). 8-Nitroguanine is detectable in urine;
both cancer patients and cigarette smokers appear to ThereisincreasingevidencethatRNAoxidationcon-
excretemore.144,145 5-Chlorocytosinehasbeenusedas tributes to the pathology of human diseases such as
abiomarkerofdamagebyRCSatsitesofinflammation diabetes (Section 10.5) and so more interest is being
and8-chlorodGand8-bromodGarepresentinhuman takeninitsmeasurement.Moststudieshavemeasured
urine(Section5.8.2.7).146 8OHGua(8-hydroxyguanine-ribose)inisolatedRNA,
orurinaryexcretionof8OHGand8OHGua.Ofcourse,
8OHG in urine could arise, not only from RNA, but
6.14.8 Gene-specificoxidativedamage
alsofrombaseexcisionrepairofDNA,and8OHGua
Measurements of modified bases in DNA do not tell couldcomefromtheRNAprecursorpool.
us whether they are in telomeres, gene exons, pro-
moters, or introns, nor whether the genes containing 6.14.10 DNA–aldehydeadducts154
them are being transcribed or not. The telomeres are
GC-richandmaybesensitivetargetsofoxidativedam- Cytotoxic aldehydes are produced during lipid per-
agebecauseoftheguaninepresent(Section11.3.5).147 oxidation (Section 5.12.5) and are also widespread in
Damage to promoters may affect transcription factor the environment. For example, cigarette smoke con-
binding (Section 5.9.4). It is important to address the tainsmultiplealdehydes(Section9.13),asdodamaged
issue of localization; it is not only the level of oxida- plants (Section 8.11). If they reach DNA, aldehydes
tiveDNAdamage,butwhereitisinthegenomethat can bind to DNA bases (Fig. 5.27). Several assays to
determinesitsbiologicalimportance.Forexample,one measuresuchadductshavebeendescribed,oftenem-
study148 claimed that oxidative damage is markedly ploying GC–MS or HPLC–ECD after hydrolysis of
increasedinthepromoters(andtoalesserextentthe DNA,orimmunoassays,someofwhichcanbeapplied
exons)ofalimitednumberofgeneswhoseexpression towholecells.Forexample,M dG(Fig.5.27)hasbeen
1
isknowntodecreasewithageinhumanbraincortex. detectedinDNAfromhealthyanimals.Inonestudy,

--- Page 384 ---

MEASUREMENT OF REACTIVE SPECIES 329
DNA from healthy human liver contained between 6.15.2 Measurementofperoxidation
5–11M dGper107bases.155However,differentanalyt- andperoxidizability
1
icaltechniqueshavegivendifferentresults,suggesting
Lipidperoxidationisacomplexprocessthatoccursin
thatmorestandardizationofmethodologyisrequired.
multiplestages.Hencemanytechniquesareavailable
M dGandseveralotherDNAadductshavealsobeen
1
for measuring it. Each measures something different,
detectedinhumancolonicmucosaandthelevelswere
andnoonemethodisanaccurateandcompletemeas-
influencedbydiet.156M dGisremovedfromDNAby
1
ure of lipid peroxidation. In addition, a number of
nucleotideexcisionrepairandmetabolizedrapidlyto
studies have measured peroxidizability rather than
a6-oxoproduct,whichcanbedetectedinurineandis
peroxidation;theytakeacell,tissue,membrane,body
anotherpotentialbiomarker,albeitnotwidelyused.157
fluid, or lipoprotein, expose it to oxidative stress in
Reaction of HNE with DNA generates propano– and
vitro and measure the amount of lipid peroxidation
etheno–dGadducts(Fig.5.26),whichcanalsobemeas-
that results. One example is the erythrocyte peroxide
ured,e.g.inLECrats(Section3.22.5.5)andinchronic-
stress test (Table 6.9 ; Section 7.4). Another is the in-
allyinflamedhumantissues(Sections10.12–10.14).
cubation of lipoproteins with Cu2+ or AAPH in vitro,
However, there are caveats. M dG is not a specific
1
measuring the lag time before peroxidation acceler-
markerofdamagetoDNAbyMDA(Fig.5.27).Tissue
ates (Section 10.3.8). A third is the D-Roms test or
homogenatesundergoperoxidation(Sections5.3.3and
variants of it, such as the free oxygen radicals test
10.17.5), leading to possible artefactual modification
(FORT).159,160 Plasma is exposed to acidic pH to lib-
of DNA by aldehydes during the isolation process,
erate metals, which decompose peroxides and cause
which must be controlled for.155 Etheno–dG, etheno–
moreperoxidation.TheproductsaredetectedusingN,
dA,etheno–dC,anddG–MDAadductshavebeende-
N-diethyl-p-phenylenediamine.Thevaluesobtainedin
tected in human urine,158 but a possible origin from
theD-Romstestare250to300Carratelliunits(1unit
diethasnotbeenruledout.
correspondsto0.8mg/1ofH O )orabout5900μM,
2 2
very much greater than ‘real’ levels of peroxides in
6.15 Biomarkersoflipidperoxidation
plasma in vivo (Table 6.10). Hence we do not recom-
mendtheseassays.
Lipids can be oxidized, halogenated, or nitratedby a
rangeofRS(notincludingH O ,NO
•
,orO
•–,which The peroxidizability of a system is a complex par-
2 2 2 ameter determined by its fatty acid composition and
areunreactivewithlipids).SomeRSinitiatelipidper-
• • • antioxidantcontent,thetypeofoxidativestressused,
oxidation(e.g.OH ,RO ,NO )whereasothersoxidize
2 2 and the assay employed to measure lipid peroxida-
lipids and do not directly start a chain reaction (e.g.
tion.Itsbiologicalsignificanceisunclear;thefactthat
singlet O , O , HOCl). Techniques for measurement
2 3
a tissue or body fluid is more peroxidizable in vitro
of chlorinated and nitrated lipids have been devel-
under heavy oxidative stress does not mean that it
oped,andbotharedetectableinvivo(Sections5.8.2.7
is oxidizing faster in vivo. To use an analogy, build-
and2.6.1.3).
ing A may be able to resist an earthquake less well
than building B, but this does not mean that build-
6.15.1 Whymeasurelipidperoxidation? ing A is falling down. Let’s stick to measuring ‘real’
peroxidation.
Levels of certain end-products of peroxidation, espe-
ciallytheisoprostanes(IsoPs)andrelatedcompounds
(Section 5.12.3), are elevated in many human dis-
6.15.3 Lossofsubstrates
eases. Indeed, IsoPs are emerging as biomarkers of
the extent of disease and possibly, in cases such as Peroxidation causes loss of PUFAs, so a simple way
Alzheimer disease (AD) and cardiovascular disease to measure it (in principle) is to follow their dis-
(Sections 10.3 and 10.21), as indicators predictive of appearance (Table 6.9). The lipids are extracted from
laterdiseasedevelopmentand/ordiseaseprogression. the system under study and hydrolysed to release
Oxidation of lipids contributes to the actions of sev- fattyacids,whichcanthenbemeasuredbyHPLC,or
eraltoxins(Chapter9).Lipidperoxidationisacommon convertedintovolatileproducts(e.g.byformationof
reason for quality deterioration in processed foods, esterswithmethanol)andseparatedbyGC.Caremust
so food scientists are interested in spotting it early be taken to avoid peroxidation of fatty acids during
and controlling it. In addition, many end-products the hydrolysis and extraction procedures: a common
of peroxidation exert potent biological effects (Sec- practice is to carry out the procedures under N . In-
2
tions5.12and2.6.1.3). formation about which lipids are most affected can

--- Page 385 ---

330 FREE RADICALS IN BIOLOGY AND MEDICINE
Table6.9 Lossoffattyacidresiduesduringperoxidationofthehumanadultredbloodcellmembrane.
%oftotalfattyacidsinmembrane
No.ofcarbonatomsinfattyacid No.of Control AfterH2O2treatment
residue bondsinfattyacidresidue causinglipidperoxidation
16 0 21 21
18 0 14 14
18 1 12 11
18 2 10 8
20 4 15 5
22 4 5 2
22 6 6 0.5
Datafromoneoftheauthors(JMCG).ErythrocyteswerestressedbyincubationwithhighlevelsofH2O2inthepresenceofazidetoinhibitcatalase.
be gained by separating the different classes before
hydrolysis.
TheothersubstrateforperoxidationisO ,someas-
2
urement of O uptake is another index. De Saussure
2
used this method in his studies on oxidation of wal-
nut oil (Section 5.11.1). Today, rather than his simple
manometer, we use O electrodes. Most modern O
2 2
electrodesareClark-typearrangementswhichmeasure
1.0
dissolved O . Measuring O uptake does not require
2 2
sample preparation and is useful for complex matri-
ces(e.g.food)thatprecludetheuseofopticalmethods.
Onedisadvantageispoorsensitivity.
6.15.4 Measurementofintermediates
6.15.4.1 Radicals
SpintrapssuchasPBN,DMPOandPOBNcaninter-
ceptradicalintermediatesinthechainreactionandare
useful in mechanistic studies. The last is often used:
POBN is good at trapping carbon-centred radicals.
Trapsthat‘sit’atdifferentplacesinthemembranehave
beendevelopedtohelpdeterminewhereradicalsare
located.161Insomestudies,lipidconstituentsweresep-
arated by HPLC, subjected to ESR, and identified by
massspectrometry,togaindetailedinformationabout
which lipids hosted the radicals.162 Spin traps have
beenusedinwholeanimalstodetectcarbon-centred,
• •
RO andRO radicals,andtheycanbeaddedtobody
2
fluidsortissuebiopsiestodothesameSection6.2.5).
6.15.4.2 Dieneconjugates
Oxidation of PUFAs forms conjugated dienes
(Section 5.11.5) that absorb UV light maximally at
230–235nm (Fig. 6.17). Measurement of dienes is a
ecnabrosbA
C
B
A
0.0
210 230 250 270 290
λ (nm)
Figure6.17 Lipidperoxidationasfollowedbytheformationof
conjugateddienes.Theabsorbancespectrumofethyllinoleate(EL)is
showninlineA.LineBshowsELafteroxidationbyairat30◦Cfor
8h;andlineC,ELinwhichperoxidationwasspeededupbyadding
nitrogendioxide.The‘shoulder’ofUV-absorbanceinBandCisdueto
conjugateddieneformation.DatabycourtesyofProfessorWilliam
Pryor.

--- Page 386 ---

MEASUREMENT OF REACTIVE SPECIES 331
usefulindexofperoxidationinpurelipidsandisolated products (Figs 5.23 and 5.25). Cholesterol, like other
lipoproteins (Section 10.3.8), and has the advantage lipids, is easily oxidized during sample processing,
thatitmeasuresanearlystageinperoxidation.Diene and steps must be taken to prevent this.170 Methods
conjugation measurements can rarely be carried out forperoxidemeasurementcanbeclassifiedintothose
directly on tissues and body fluids because many that measure ‘total peroxides’ and those that attempt
other substances present absorb strongly in the UV. separationofdifferentperoxides(Table6.10),thebest
Extraction of lipids into organic solvents (e.g. chlo- beingthosethatemploymassspectrometricmethods
roform: methanol mixtures) before measurement is a to allow unequivocal identification of various lipid
commonapproachtothisproblem.Greatersensitivity oxidation products (Section 6.15.11 and Table 6.10).
forthedieneconjugationmethodcanbeachievedby The amount of peroxide present at a given time de-
applying second-derivative spectroscopy to sharpen pendsbothontherateofinitiationofperoxidationand
thepeaks,163 althoughthismethoddoesnotappearto on how quickly peroxides are decomposing to other
havebeenusedrecently. products (e.g. if transition metals are added, perox-
Although conjugated diene measurements work ideswilldecomposetocarbonylsandotherproducts)
well on isolated lipids and lipoproteins, their appli- oraremetabolized.Mostassaysreveallipidperoxide
cation to body fluids is problematic.164,165 Separation levels in human plasma to be in the low μM range
of the UV-absorbing ‘diene conjugate’ material from (Table6.10).OxidationofLDLisbelievedtocontribute
human body fluids revealed that most or all of it is to atherosclerosis (Section 10.3), so a variety of im-
an isomer of linoleic acid, octadeca-9 (cis), 11 (trans)- munoassays has been introduced to measure plasma
dienoicacid, ‘oxLDL’andtoinvestigateitsrelationshiptovascular
disease.171 Whatexactlythevariousmethodsmeasure
1 3 5 7 9 10 12 14 16 18 isuncertain:therearemanyepitopeson‘oxidizedLDL’
HOOC
anddifferentantibodypreparationsarelikelytogive
2 4 6 8 11 13 15 17
differentresults.
It probably originates from both diet (e.g. beef) and
6.15.6 Measurementofend-products:
microbial metabolism, involving bacteria in the gut,
isoprostanes(IsoPs),isofurans(IsoFs),
lung, or cervical mucus. It can also be present in the
calfserumusedincellculturemedia.166Itfollowsthat
andisoketals(IsoKs)3,169,172
applicationofdieneconjugationmethodstobodyflu-
The best currently available biomarker of lipid per-
ids,ortoextractsofthem,maynotreallybemeasuring
oxidation appears to be the IsoPs. Increased levels of
lipidperoxidation.Ofcourse,HPLCorGC–MScould
IsoPs in plasma and/or urine are observed in many
be used to separate the ‘real’ conjugated diene prod-
animal and human conditions associated with oxida-
ucts of lipid peroxidation from octadeca-9,11-dienoic
tive stress, whereas levels are lower in subjects with
acid,butthisisrarelydone.
chronicgranulomatousdisease,whosephagocyteROS
The above compound and several isomers of it,
production is impaired (Section 8.7.4.4). IsoPs have
knowncollectivelyasconjugatedlinoleicacids(CLA),
been used to study the effects of toxins (Chapter 9),
are sometimes consumed as health supplements be-
apoE genotype (Section 10.21.2), antioxidant supple-
causeofallegedanti-cancerandweight-reducingprop-
mentation,anddietarychangesonlipidperoxidation
erties(basedonanimalstudiesandofunprovenbene-
(Section 4.6.3.1). They have also helped to reveal a
fit in humans). However, administration of CLA to
genderdifferenceinoxidativedamage(Section3.26).
humans was observed to increase levels of lipid per-
Most work has been done on the F -IsoPs, which
2
oxidation,asmeasuredbyF -IsoPlevels.167 CLAscan
2 arise from arachidonic acid (Section 5.12.3). IsoPs
undergonitration;both9-nitroand11-nitro-octadeca-
are best measured by GC–MS or HPLC–MS tech-
9,11-dienoicacidsaredetectableatlowlevelsinhuman
niques, and several methods to measure them, ei-
urine.168
theralone,orsimultaneouslywithlevelsofperoxides
and COPs and sometimes prostaglandins, have been
6.15.5 Measurementofend-products: described.169,172–174 The sample ‘work-up’ techniques
peroxides169 requiredpriortoMScan,however,betedious.Correct
samplestorageisimportant:artefactuallipidoxidation
Lipid peroxidation generates both hydroperoxides andIsoPformationcanoccurintissuesandbodyflu-
and cyclic peroxides, as well as cholesterol oxidation ids on standing in the laboratory in ice, when frozen

--- Page 387 ---

332
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table6.10 Measurementofperoxidesinlipids.
Method Whatismeasured Remarks
A.‘Totalperoxide’measurements
Iodineliberation Allperoxides Oneoftheoldestmethods,sometimesusedinthefoodindustry;peroxidesoxidizeI–tol2.
ROOH + 2I– + 2H+ → I2 + ROH + H2O
InthepresenceofexcessI–thetri-iodideion(l3 –)formsandcanbemeasuredat358nm.BothH2O2and
proteinperoxidesalsooxidizeI–toI2,socontrolsareneeded.Peroxidelevelsinhumanplasmareportedas
2.1–4.6μM(Anal.Biochem.176,360,1989;Anal.Biochem.176,353,1989).
Methyleneblue Allperoxides Values in plasma reported as 8.6 ± 5.8 μM (Atherosclerosis 121, 193, 1996; Exp.Gerontol.22,
103,1987).
FOX(ferrousoxidationxylenolor- Allperoxides Simple,easytouse,workswellinvitro,canbeautomated.PeroxidesoxidizeFe2+ toFe(lll),detectedby
ange)assay xylenolorange((cid:6)Aat560nm).Detects3–5μM‘lipidperoxide’innormalhumanplasma.‘Amplification’
canoccurintheassaysincereactionofLOOHwithFe2+willgenerateLO•radicalsthatcouldpropagate
peroxidation.Antioxidantsareoftenaddedtotrytostopthis.SensitivitylowμMrange(Anal.Biochem.
220,403,1994).AlsodetectsH2O2(Table6.6)andproteinperoxides.Additionoftriphenylphosphine
reduceslipidperoxidesbutnotH2O2,andcatalasecanbeaddedtoremoveH2O2.Useofperchloricacid
toprecipitateproteinallowsdistinctionofproteinandlipidperoxides(Anal.Biochem.315,29,2003).Can
beinterferedwithbyreducingagentssuchasascorbate,whichcanreducetheFe(III)beforeitreactswith
xylenolorange.
Glutathioneperoxidase-1(GPx1) Fatty acid hydroperoxides (GPx1 does not act TheGPx1enzymereactswithH2O2andorganicperoxides,oxidizingGSHtoGSSG.Additionofglutathione
onesterifiedperoxidizedfattyacidswithinmem- reductaseandNADPHtoreduceGSSGbacktoGSHresultsinstoichiometricconsumptionofNADPH.Cannot
branesorlipoproteins) measureperoxideswithinmembranesunlessphospholipasesarefirstused;inprinciple,PHGPx(Section
3.14)couldbeusedtodothis.Peroxidelevelsinplasmaquotedasapprox.1μM(Chem.Res.Toxicol.2,
295,1989).
Cyclooxygenase(COX) Lipidhydroperoxides,possiblycyclicperoxides TherateatwhichCOXoxidizesarachidonicacidisincreasedbyaddinglipidperoxides(Section8.12.5).Thus
stimulationofCOXactivity(usuallyassayedasO2uptake)canbeusedtomeasureperoxidesinbiological
fluids(Anal.Biochem.145,192,1985;193,55,1991).Assayrelatesthepresenceofperoxidestooneof
theirpotentialbiologicalactions,stimulationofeicosanoidsynthesis.Humanplasmalevelsmeasuredare
~0.5μM.Valuesfor‘totalperoxide’dependtosomeextentuponwhichtypesarepresent,sincedifferent
peroxidesstimulateCOXtodifferentextents.
Diphenyl-1-pyrenylphosphine Allperoxides.Oxidationtothefluorescentoxide Lipophilic;canbeusedtomeasureperoxidesinoils,bodyfluids,membranes,andlipoproteins(FEBSLett.
(excitation353nm,emission380nm) 474,137,2000;Anal.Biochem.434,172,2013).Levelsinratplasmareportedas14.5±0.8μM;parallel
FOXassaygave4.9±0.4μM(Anal.Biochem.434,172,2013).Asimilarassayinwhichthiscompoundis
linkedtoa7-hydroxycoumarinmoietyhasbeendescribedasmoresensitive(Biorg.Med.Chem.13,1131,
2005).

--- Page 388 ---

MEASUREMENT
OF
REACTIVE
SPECIES
333
Table6.10 Measurementofperoxidesinlipids.
Method Whatismeasured Remarks
P P
O
+ ROOH + ROH
Similarprobesinclude3-perylenediphenylphosphine(Lipids41,295,2006).Theycanbeusedtoimage
peroxidesincells.
B.Peroxideassays:separationofproductsa
Haem degradation of peroxides Allperoxides(HPLCallowsseparationofphos- Haemandhaemproteinsdecomposelipidperoxidestoformradicalsthatreactwithisoluminoltoproduce
(afterHPLCseparation) pholipid,cholesterol,andcholesterolesterper- light. For example, microperoxidase, a haem-peptide produced by proteolytic degradation of cyto-
oxides) chromec,canbeused.TheHPLCmethodsmeasure~40nMlevelsofperoxidesinhumanbloodplasma
(e.g.Anal.Biochem.175,120,1988;Meth.Enzymol.233,319and324,1994),evenlowerinsome
studies(Lipids39,891,2004).Whythisislowerthaninotherassaysisunclear.Othersubstratesformi-
croperoxidase(e.g.ascorbate)mightcompetewithisoluminolandinterferewiththeassay,orperoxides
couldbedegradedonthecolumns(Curr.Med.Chem.19,2504,2012).IdentityofperoxidesafterHPLC
separationmustbeconfirmedchemicallyandnotbasedsimplyonretentiontime.Diodearraydetection,
atechniquewhichrecordstheabsorbancespectrumofeachpeak,isausefulvalidationmethod.Another
meansofdetectingperoxidesafterHPLCseparationistoreactthemwithdiphenyl-1-pyrenylphosphineto
generateafluorescentproduct(seeabove).Cholesterolesterscanalsobeoxidizedontheesterifiedfatty
acid;plasmacholesterolesterhydroperoxidesreportedas~0.2μMinhealthysubjects,risingto~13μM
inpatientswithliverfailure(Lipids40,515,2005).Probablyonly7β-hydroxycholesterolisausefulmarker
ofcholesterolringoxidationinvivo(Section5.12.4).
Massspectrometry-basedmethods Allperoxides(alsoaldehydes,isoprostanes,iso- ForGC–MSmethods,peroxidesareextracted,usuallyreduced(e.g.byborohydride)toalcohols,separatedby
furans,cholesterol/cholesterolesterperoxides) GC,andidentifiedbymassspectrometry(Lipids42,463,2007).Levelsof‘total’hydroxyfattyacidsusually
inlowμMrange.Severalmethodologicalvariationsexist(e.g.Meth.Enzymol.233,332,1994;Anal.
Biochem.198,104,1991;J.Chromatog.B823,37,2005).Controlsareneededtoshowthatthealcohols
werenotpresentinthesystembeforereduction,e.g.alcoholsaregeneratedbyGPxactivity.Lipidhydroxides
canbeabsorbedfromthedietandsosubjectsneedtofastbeforetheassay(FreeRadic.Biol.Med.32,
162,2002;Ann.Med.42,521,2010).SomeHPLC–MSmethodsnotrequiringreductionareavailableto
measureperoxidesandchlorohydrins(Biochem.Soc.Trans.39,1233,2011).Liquidchromatography–MS
basedassayscanidentifyawiderangeofoxidizedandnon-oxidizedlipidsinbiologicalmaterials,e.g.in
fattyliverdisease(J.LipidRes.51,3046,2010),afterirradiationoftissues(FreeRadic.Biol.Med.44,299,
2008),andafterbraininjury(Nat.Neurosci.15,1407,2012);alsoseeSection6.15.11.
aAlloftheassayslistedunderSectionAcouldalsobeappliedtoseparatedperoxides.

--- Page 389 ---

334 FREE RADICALS IN BIOLOGY AND MEDICINE
at –20 oC, and (more slowly) at –70 ◦C, unless anti- pericardialfluid,woundexudates,amnioticfluid,and
oxidants such as BHT are added.172–175 This is not a breathcondensate(Section6.15.9).Ideally,F -IsoPsand
2
problem with urine, since there is no lipid to oxid- their metabolites should be measured in both urine
ize. Haemolysis causes rapid oxidation of lipids and and plasma, as there are cases where they may not
F -IsoP generation in human plasma, so haemolysed alwaystellthesamestory.174,178 Forexample,ifthere
2
samplesshouldbeavoided.122Althoughimmunoassay is a sudden rise in oxidative lipid damage, plasma
kits for F –IsoPs are commercially available, their re- levelswillgoupbeforeurinaryones,astimeisneeded
2
liabilityhasbeenquestionedbyseveralauthors.172,176 to hydrolyse them from plasma lipids and excrete
SeveralextensivestudiesrelatingF -IsoPlevelstodiet, them.178ThepresenceofF -IsoPglucuronidesinurine
2 2
risk of disease, or genetic polymorphisms have been (Section 5.12.3) must also be considered; glucuroni-
published using such assays, but, sadly, the validity dase treatment raised the levels of free F -IsoPs
2
of the results is uncertain. F -IsoPs can be detected detected.
2
in foods, but they do not appear to pass through the AnotherpointtoponderisthatIsoPformationisin-
gutinsufficientquantitiestoaffectplasmaorurinary fluencedbyO concentration;themonocyclicperoxide
2
levels.177 precursors of IsoPs can alternatively react with O to
2
Even the F -IsoPs as commonly assayed by mass giveIsoFs(Fig.5.23).AtnormaltissueO levelsIsoPs
2 2
spectrometry are not ‘ideal’ biomarkers. Several iso- are major products, but this may not be the case in
merstendtocoeluteduringGC,sooftengroupsclaim- hyperoxia. For example, in mice exposed to pure O ,
2
ing to measure a single product (e.g. 8-iso-PGF 2α) are thelevelsofIsoFinthelungincreased,whereasthose
measuring a mixture. Sometimes the individual iso- ofF –IsoPsdidnot(Fig.6.18).Thisproblemcouldalso
2
mersresponddifferentlytodiseaseordietarychanges, affectmeasurementsincellculture,sincecellsareex-
whichisperhapsnotsurprisinggiventhecomplexity posed to 95% air/5% CO (Section 1.11). Studies on
2
ofthepathwaysbywhichtheyareformed(Figs5.21– brainslicesmayalsobeaffected;O readilydiffusesin
2
5.23).174,177,178 Fasting tends to increase urinary IsoP fromtheair.Undersuchcircumstances,measurement
levels177,179andsosamplesfromfastedsubjectsshould ofbothIsoFsandIsoPsisrecommended.172Othertypes
beregardedwithcaution.Whetherthisisduetorelease ofIsoPsshouldalsobeconsidered.F -IsoPprecursors
2
ofIsoPsfromfatstoresbyincreasedlipolysisand/or canrearrangetoD -/E -IsoPs,whichcansubsequently
2 2
toanoxidativestressassociatedwithfastingisuncer- dehydratetoA -/J -,orcyclopentenone,IsoPsthatare
2 2
tain.ChangesinF -IsoPsinsubjectsgivenlargedoses highly reactive with –SH groups. The precursors can
2
of vitamin E have been suggested to be due to their alsoformD -andE -IsoKs;IsoKsarehighlyreactive
2 2
altered metabolism rather than decreased formation withaminogroupsinproteins(Fig.5.22).IsoK-protein
(Section4.3.1). adductshavebeenmeasuredbyantibodymethodsin
Most IsoPs in tissues and plasma are esterified in human plasma at approximately 4 μM levels, higher
phospholids. In plasma, most seem to be present in in subjects with atherosclerosis.180 They can also be
HDL. Eventually they are hydrolysed to free IsoPs visualizedbyimmunostaining(Fig.6.18).
(mostly by platelet activating factor acetylhydrolase) AnotheradvantageofIsoPsasameasureofoxida-
whicharerapidlymetabolized,turningoverquickly.178 tivelipiddamageisthatdifferentPUFAsformdifferent
Thus a rise in plasma free IsoP levels could be due IsoPs (Section 5.12.3), which provides a mechanism
not only to increased formation, but also to acceler- forfollowingtheperoxidationofindividualPUFAsin
atedreleasefromlipidsand/ortoslowermetabolism vivo.IsoP‘biomarkers’,arisingfromdifferentPUFAs,
of the released IsoP. It is thus important for pub- shouldbehelpfulininvestigatingtheconsequencesof
lishedpaperstoidentifywhethertheymeasuredtotal eating diets rich in various PUFAs, whether any in-
IsoPs,freeIsoPs,orboth,inplasma.Measurementof creased peroxidation that results can be ameliorated
IsoPsinplasmaandurineis,ofcourse,a‘whole-body’ by antioxidants, and, if so, how much antioxidant is
measurement;itisnotalwaysclearwheretheycame needed. For example, supplementing mice with EPA
from. Urinary IsoPs presumably arise from all body increasedlevelsofF -IsoPsbutdecreasedlevelsofF -
3 2
tissues, including kidney. Ideally, both the F –IsoPs IsoPsintheheart.181F -IsoPshavealsobeenmeasured
2 3
andtheirmetabolites(Section5.12.3)suchas2,3-dinor- inC.elegans(Section11.4.8).IsoPmeasurementshave
5,6-dihydro-15-F -IsoP(whichisnotmadeinkidney) as yet given littleevidencethat EPA or DHA oxidize
2t
shouldbequantitatedinurine.IsoPscanalsobemeas- faster than arachidonic acid in healthy humans. In-
uredinfluidsdrawnfromspecificsites,suchasCSF, deed, the opposite might be true, although data are
synovialfluid,lunglavagefluid,seminalplasma,bile, limited(Table4.8).

--- Page 390 ---

MEASUREMENT OF REACTIVE SPECIES 335
(a) (b)
(c) (d)
Figure6.18(colourplate13) Exposureofmiceto>98%O2increasesthelevelsofisoketalsinairwaysandalveolarepithelium.
Formalin-fixed,paraffin-embeddedsectionsfromairwaysofmicebreathingeitherroomair(21%O2)or>98%O2for7hwerestainedwithan
antibodyraisedagainsta15E2-isoketalpeptideadduct.Thepresenceoftheantigenisindicatedbythebrown-colouredDABsubstrate.Sections
werecounterstainedwithhaematoxylin.(a)Low-magnificationphotomicrographoftheairwayepitheliumofamouseexposedtoroomair(bar=
50μM).Arrowpointstoepithelialcellsliningtheairway.(b)High-magnificationphotomicrographofthesameairway(bar=50μM).
(c)Low-magnificationphotomicrographoftheairwayepitheliumofamouseexposedto>98%O2for7h,showingimmunoreactiveairway
epithelialcellsandalveolarepithelialcells.(d)High-magnificationphotomicrographofthesameairway.Preadsorptionwithapeptidecontaining
isoketalablatedthestaining.FromFreeRadic.Biol.Med.36,1163,2004,bycourtesyofDrL.JacksonRobertsIIandElsevier.
6.15.7 Measurementofendproducts:aldehydes intovolatileproductsthatcanbeseparatedbyGCand
identifiedbyMS.ArangeofmethodstomeasureMDA
Many aldehydes and other carbonyls are generated and HNE has been described, the best being those
duringlipidperoxidation,includingmalondialdehyde employingmassspectrometry.184,185Nuclearmagnetic
(MDA)and4-hydroxynonenal(HNE)(Section5.12.5). resonance has been employed to measure aldehydes
For example, production of the saturated aldehyde andotherproductsinoxidizedoils,butitssensitivity
hexanal has been assayed as a measure of LDL ispoor.186
peroxidation182 and of the deterioration of dried Concentrationsof‘free’aldehydesinvivoareprob-
shrimp.183 The food industry has developed several ably low, because they readily conjugate to proteins
methods to detect these and other volatile products and other biomolecules (Section 5.12.5.3). This can
(123oftheminthecaseofdriedshrimp!)183infoodsas make their true levels difficult to assess, since the
earlyindicesofpotentialspoilagebyperoxidation.Al- abilityofthevariousHPLC-orGC-basedmethodsde-
dehydes can be reacted with dinitrophenylhydrazine scribed in the literature to detect all of the adducts
to give dinitrophenylhydrazones, which can be sep- formedisuncertain.Somemethodsuseprolongedin-
aratedbyHPLC.Alternatively,theycanbeconverted cubations to liberate bound aldehydes for analysis,

--- Page 391 ---

336 FREE RADICALS IN BIOLOGY AND MEDICINE
running the risk of artefactually increasing peroxid- theirmetabolitesasaputativemeasureofHNEforma-
ation in the sample during processing. Aldehyde– tion.ThusbothimmunoassaysandMS-basedmethods
protein conjugates are immunogenic and a range of havebeendescribedtomeasuretheurinarymetabolite
antibody-based methods is available to detect and 1,4-dihydroxynonene-mercapturic acid, arising from
visualizethem(e.g.Fig.6.16).Theantibodieshavevari- the reaction of HNE with GSH, although such me-
ablespecificity,however,e.g.antibodiesraisedagainst tabolites may represent only a small fraction of the
HNE-conjugated proteins may only recognize some HNE generated in vivo (Fig 5.28). Nevertheless, their
HNE–aminoacidresidueadducts(e.g.HNE–histidine levelsincreasedintheurineofratstreatedwithCCl
4
or HNE–lysine) and not others. As a result, different or BrCCl (Sections 9.2 and 9.3.1) or with ferric-NTA
3
antibodies can give different results when applied to (Section3.22.4.2).Levelsarealsoincreasedintheurine
tissuesorcells.187Aldehyde–DNAadductscanalsobe ofcigarettesmokers188andinsubjectsfedahaem-rich
measured(Section6.14.10). diet.189 However, remember that aldehydes can arise
Aldehydesarisebyperoxidedecomposition,which from diet, especially MDA (Section 6.15.8.4). There is
isoftenrestrictedinvivobythelowavailabilityofmetal considerable interest in acrolein as an agent causing
ions to decompose peroxides, rather than by the rate damageinstroke,190 althoughitcanarisebymechan-
ofperoxideformation.Further,MDA,HNE,andother isms other than lipid peroxidation (Sections 5.12.5.3).
aldehydes are metabolized by cells (Section 5.12.5.3). In vivo, acrolein can be metabolized by reaction with
Hence their levels as a measure of lipid peroxida- GSH, eventually yielding several products, including
tion should be interpreted with caution. It is also N-acetyl-S-3-hydroxypropylcysteine (3-HPMA; Fig.
possible to measure aldehyde–GSH conjugates and 6.19). This is excreted in the urine of rodents and
O
COOH COOH
CH C
H 2 N C H 3 N C H
CH 2 H CH 2
CH 2 CH 2 OH
CH 2 CH 2 CH 2
CH 2 O CH 2 O CH 2 O
N C C C N C C C N C C C
H H H
H H H H H H H H H
1 2 3
O
COOH
CH C
3
N C H
H CH
2
S
H H H COOH CH 2
O
C C C N CH CH 2
H
H C H CH 2
OH OH
4
5
Figure6.19 Someproductsfoundinurine.1,Nε-(2-propenal)lysine;2,Nα-acetyl-Nε-(2-propenal)lysine;3,N-(2-propenal)ethanolamine;
4,N-(2-propenal)serine;5,N-acetyl-S-3-hydroxypropylcysteine(3-Hydroxypropylmercapturicacid,HPMA).Thelysineadduct(1)anditsacetylated
form(2)arethemajorMDA-derivedproductsdetectedinratandhumanurine(FreeRadic.Res.40,1335,2006).Otherproductsarealsopresent
(FreeRadic.Biol.Med.46,1463,2009).Products1–4arisefromMDA-modifiedprotein.Product5arisesfromacrolein.

--- Page 392 ---

MEASUREMENT OF REACTIVE SPECIES 337
humans and has been proposed as a biomarker of In studying ‘MDA’ formed in this way, it is essential
acroleingenerationinvivo.190 Indeed,smokersexcrete toensurecompletehydrolysisofthesederivativesand
more(Section9.13.2). tobearinmindthatthesolutionwillcontainfourmol-
Proteomictechniqueshavebeenusedtoidentifythe eculesofethanol(ormethanol)permoleculeofMDA.
proteins to which aldehydes are bound in organelles Some reports of enzyme inhibition, genotoxicity, and
andtissues.Forexample,chemicallabellingcombined carcinogenicity of ‘MDA’ may have originated from
with mass spectrometry was used to show that rat thebiologicalactivitiesofpartiallyhydrolysedderiva-
heartmitochondriacontainproteinsmodifiedbyHNE, tivesoftheabovecompounds.Forexample,theabil-
acrolein, 4-oxo-2-nonenal, and 4-hydroxy-2-hexenal, ity of ‘MDA’ from tetraethoxypropane to inhibit XO
among others.191 Remember that tissue homogenates waspartlydue194tothepresenceofβ-ethoxyacrolein,
undergo rapid peroxidation (e.g. Section 10.17.5), so C H OCH = CHCHO. Malondialdehyde is still, of
2 5
it is essential to take precautions to avoid aldehyde course,anestablishedgenotoxin(Section5.12.5.2).
generationduringorganelleisolation. Sowhat’stheproblemwiththeTBAtest?Thereare
several,andasaresultsomehaveevencalledit‘that
bloodyassay’.
6.15.8 Thethiobarbituricacid(TBA)assay
The TBA assay192,193 is one of the oldest and most 6.15.8.1 Problem1:mostTBARS(TBA-reactive
frequentlyusedmethodsformeasuringperoxidation. substances)aregeneratedduringtheassay
Itcameoriginallyfromthefoodindustry,beingused Because the TBA assay is calibrated with MDA, the
todetectrancidity.It’samazinglyeasy:justheatsome results are often expressed as ‘MDA produced’, giv-
food,biologicalfluid,ortissuewithTBAinacidand ing the impression that the assay measures MDA in
apinkcolourdevelops.Anyonecandoit,andsothey the sample. Indeed, the molar extinction coefficient
have. Unfortunately, the simplicity of performing the of the (TBA) –MDA adduct (1.54 × 105 M–1cm–1 at
2
TBAassaybeliesitschemicalcomplexity. 532nm)isoftenusedtocalculatetheamountof‘MDA
ManypeoplestillbelievethattheTBAassaymeas- formed’. However, the amount of free MDA in most
uresMDAinasample.Smallamountsof‘free’MDA peroxidizing lipid systems is too low to give a sub-
are indeed formed during the peroxidation of most stantialcolouryield.Itwasshownaslongagoas1958,
membrane systems, especially microsomes. Malondi- in studies with peroxidizing fish oil, that 98% of the
aldehydereactsintheTBAtesttogenerateacoloured MDAthatreactsintheTBAassaywasnotoriginally
product,a(TBA) 2 –MDAadduct, presentinthesampleassayed,butwasformedbyde-
compositionoflipidperoxidesduringtheacidheating
stage of the assay. Peroxide decomposition generates
•
RO radicalsthatoxidizemorelipid,i.e.theTBAtest
2
amplifies peroxidation and subsequent MDA forma-
tion. Peroxide breakdown is accelerated by iron ions
inthesampleorintheassayreagents,andremovalof
such iron decreases the TBARS detected. Conversely,
antioxidants in the sample will decrease TBARS by
interferingwiththisamplification(Table6.11).Thiscan
leadtoerrorsinstudiesoftheactionofaddedantioxi-
Inacidsolution(TBA) 2 –MDAabsorbslightat532nm dantsormetal-chelatingagentsonlipidperoxidation:
and fluoresces at 553 nm, and is readily extractable they affect colour development in the TBA assay it-
into organic solvents such as butan-1-ol. Construc- self.Approachestoaddresstheseissueshaveincluded
tion of a calibration curve for the assay is compli- adding excess iron with the TBA reagents to maxi-
cated by the fact that MDA is unstable and must mizeperoxidation,or(perhapsmorelogically)adding
be prepared immediately before use by hydrolysing chain-breakingantioxidants(usuallyBHT)tosuppress
itsderivatives,1,1,3,3-tetramethoxypropaneor1,1,3,3- peroxidationduringtheassay(Table6.11).
tetraethoxypropane: It follows that the TBARS measured in a sample
willdifferaccordingtotheassayconditionsused.The
lack of specificity of the TBA assay when applied to
plasmaisexemplifiedbytheworkofLandsetal.;by
thecyclooxygenasemethod(Table6.10)theymeasured

--- Page 393 ---

338 FREE RADICALS IN BIOLOGY AND MEDICINE
Table6.11 VariabilityofresultsintheHPLC-basedTBAtestdependingonwhetherornotbutylatedhydroxytoluene(BHT)is
addedtothesamplewiththeTBAreagents.
Sample TBAreactivity(μMMDAequivalents)
BHTnotadded BHTadded
Freshhumanplasma
Healthysubjects 0.45±0.35(12)a 0.10±0.10(12)
Hyperlipidaemicsubjectsb 0.88±0.22(17) 0.61±0.25(17)
RatlivermicrosomesincubatedwithFeCl3/ascorbate
for5min 12.0±0.8(4) 5.8±0.9(4)
for20minc 14.7±1.0(4) 12.8±1.0(4)
anvaluesaregiveninparentheses.
bElevationofTBARSpersistsevenwhenexpressedperunitcholesterol.Hyperlipidaemiaisknowntobeassociatedwithincreasedlipidperoxidation
(Section10.3).
cBy20minperoxidationwasessentiallycomplete:notehowtheabsenceofBHTappearstoacceleratetherateofperoxidationasmeasuredby
TBARS.Thisisbecauseoffurtherperoxidationofthelipidsduringtheassay,whichisinhibitedbyBHT.Whenallthelipidshavebeenoxidizedthe
sameTBARSvalueswillresult.
DatafromFreeRadic.Res.Commun.19,51,1991.
aperoxidelevelofaround0.5μMinhumanplasma, humanbodyfluidswillalsomeasureMDAproduced
whereas expression of the results from a TBA assay enzymicallyduringeicosanoidsynthesis(Section8.12).
onthesamesamplesas‘peroxideequivalents’gavea
mean value of 38 μM. MDA can be determined dir- 6.15.8.4 UrinaryTBARS
ectlybyHPLCorGC–MSandbasallevelsoffreeMDA UrinaryTBARShassometimesbeenusedasanindex
in human plasma in most studies are far lower than of whole-body lipid peroxidation, e.g. in nutritional
valuesobtainedbytheTBAtest.184
studies.Unfortunatelytherearemajorproblems.First,
diet has an effect; much of the TBARS in urine seem
6.15.8.2 Problem2:falsechromogens
toarisefromlipidperoxidesoraldehydes(attachedto
SeveralcompoundsotherthanMDAreactintheTBA lysine and other amino acids) in ingested food, pre-
assay to give chromogens that absorb at, or close to, sumablygeneratedduringcooking,andtosomeextent
532 nm. They include streptomycin, sialic acid, and byperoxidationinthestomachitself(Section7.2).195,196
biliverdin. Measurement of TBARS at 532 nm could Forexample,adietrichincookedmeatincreasesurin-
thus include contributions from them. For example, ary TBARS excretion, to an extent depending on the
TBA tests on plasma from jaundiced patients can be temperature at which the meat was cooked.196,197 In-
confounded by bile pigments. However, fluorescence deed,askingsubjectstoeatlipid-poordietsortofast
measurements or examination of the full absorbance for24hcausedurinaryMDAlevelstodrop.177
spectra can often distinguish the products they form In any case, HPLC must be used to separate the
fromthe‘real’(TBA) –MDAadduct. real(TBA) –MDAadduct;muchTBARSinurineisnot
2 2
evenlipid-derivedandsomeoftherestarisesfromal-
6.15.8.3 Problem3:realchromogensbutnot dehydes other than MDA,198 although several MDA
fromlipids adductsareexcreted(Fig.6.19).
AnalternativeapproachtodealingwithProblem2isto
6.15.8.5 ShouldtheTBAassaybeabandoned?
separatethe(TBA) –MDAadductfromotherchromo-
2
gens before measurement, usually by HPLC. How- Itsuseisdecreasing,butitstillcanbeuseful:HPLC-
ever, exposure of several carbohydrates and amino based TBA assays eliminate much of the interference
•
acids to OH , produced by ionizing radiation or that plagues the simple TBA assay and are useful
metal-ion H O systems, yields products that give a ‘screening’ methods for examining large numbers of
2 2
genuine (TBA) –MDA adduct on heating with TBA. biological samples for elevated peroxidation, to pick
2
Theyinclude2-deoxyribose(Section6.3.3),DNAbase out those for more detailed study. The simple TBA
propenals,andproline.ApplicationoftheTBAassayto test in the presence of BHT (Table 6.11) is useful in

--- Page 394 ---

MEASUREMENT OF REACTIVE SPECIES 339
studying peroxidation of isolated lipids, liposomes, metabolizedintheliver,e.g.pentaneishydroxylated
cells,andsubcellularfractions.However,theTBAas- by certain CYPs to pentanol. Hence agents that al-
saycannotbeusedtocomparelevelsofperoxidation ter liver metabolism might affect pentane exhalation
betweentissueswithadifferentfattyacidcomposition, by altering its consumption by liver P450, and might
since MDA only originates from certain PUFAs (Sec- mistakenly be thought to be altering the rate of lipid
tion 5.12.5). We do not recommend urinary TBARS peroxidationinvivo.
measurementsuntilmoreworkisdonetoinvestigate Many GC columns used in the past did not sep-
whatthevariousassaysaremeasuring,andthecontri- aratepentanefromisoprene(2-methyl-1,3-butadiene),
butionofdiet.AcolorimetricassayforMDAandHNE a hydrocarbon present in large amounts in human
basedontheirreactionwith1-methyl-2-phenylindole breath, apparently a side-product of cholesterol
to produce a chromogen has been described.199 It biosynthesis.204 Thus several ‘breath pentane’ levels
seems to work reasonably well, although a detailed publishedintheearlierliteratureareartefactuallyhigh;
comparisonbetweenitandMDA/HNEmeasuredby healthy humans exhale only low (picomolar) levels
massspectrometryisneededforpropercalibration,as of pentane and other hydrocarbons. Given the prob-
theremaybediscrepancies.200 lem of pentane metabolism, perhaps ethane should
receive more attention. Care must also be taken in
experiments of this kind to control for hydrocarbon
6.15.9 Measurementofend-products:breath
production from the bacteria always present on the
analysis201,202
skin (and fur) and in the oral cavity and colon. The
Airexhaledbyhumansandotheranimalsconsistsof air in large cities is contaminated with hydrocarbons
agasphasecontainingO ,NO • ,N ,CO ,andalittle fromcombustionprocesses,e.g.inmotorvehiclesand
2 2 2
CO, plus a phase containing water vapour and aero- environmentaltobaccosmoke.Hydrocarbonspartition
solparticlesthatcanbecondensedwhenthebreathis into body fat stores and must first be flushed out by
cooled.F –IsoPs,HNE-modifiedproteins,arangeofal- breathing hydrocarbon-free air, before reliable meas-
2
dehydesincludingMDA,nitratedproteins,andH O urements can be made. Nevertheless, techniques to
2 2
have all been measured in exhaled breath conden- minimize these problems have been developed, and
sate and the levels reported to be elevated in several increased hydrocarbon exhalation with age, hyper-
diseases. The gas phase also contains a range of hy- oxia, smoking, scleroderma, RA (Table 10.6), some
drocarbons, including ethane, ethylene, and pentane lung diseases, and after heart (Section 10.7.1) or liver
(Section 5.12.5.1). Constituents of the gas phase pre- (Section10.7.3)surgeryhasbeendemonstratedinsev-
sumably originate from all over the body, whereas eralhumanstudies.205However,fewlaboratoriesnow
H O andoxidativedamagebiomarkersintheconden- measureexhaledhydrocarbonsasanassayoflipidper-
2 2
satemaycomelargelyfromtherespiratorytract.203 oxidation, in view of the questions raised above and
Ethaneisderivedfromperoxidationof(n-3)PUFAs theavailabilityofmorerobustassays(e.g.F 2 -IsoPs).
and pentane from (n-6) PUFAs (Section 5.12.5.1). The
latter PUFAs predominate in the human body, sug-
6.15.10 Measuringlipidperoxidation:light
gesting that pentane would be produced in greater
emission
amounts if all PUFAs peroxidize equally. Both gases
canbemeasuredbyGC;theexpiredbreathispassed ‘Low-levelchemiluminescence’hasbeenproposedas
through an adsorbent at low temperature to bind an index of oxidative stress (Section 6.9) and some
andconcentratethehydrocarbons,whicharethende- (but by no means all) of the light can come from
sorbedandassayed.However,hydrocarbonsareminor lipid peroxidation. Several groups have measured
end-productsofperoxidation,andtheirformationde- generation of fluorescent end-products as an index
pends on the presence of transition metal ions to de- of lipid peroxidation in foodstuffs, body fluids, and
compose peroxides. Hence an increased rate of gas tissues;206 the assay is sensitive but the chemistry is
productionmightreflectincreasedavailabilityofsuch complex.Fluorescenceisoftenthoughttoarisebyre-
metal ions, rather than increased initiation of perox- actionofcarbonylcompoundswithaminogroupson
idation. Formation of hydrocarbons is also affected proteins,phosphatidylserine,phosphatidylethanolam-
byO concentrations,beingfavouredatlowO .This ine, or even DNA and RNA bases. However, there
2 2
is probably because the carbon-centred radicals that are other mechanisms, sometimes completely differ-
leadtohydrocarbonproduction(e.g.thepentanerad- ent,e.g.indyingC.elegans(Section11.4.7).Aldehydes
ical; Section 5.12.5.1) can also react with O to form can polymerize into fluorescent products (Fig. 6.20).
2
peroxyl radicals. In addition, some hydrocarbons are Reaction of MDA with –NH groups at low pH
2

--- Page 395 ---

340 FREE RADICALS IN BIOLOGY AND MEDICINE
Lipid peroxides
accelerated by
Decomposition heat and metal
ions
Carbonyls
including MDA
OHC CH CHO
2
+R 1 NH 2 OHC CH 2 CHO
R N CH CH CHOH RNH 2 CH 2 CHO
1 Fluorescent MDA
OHC CH C
+R 2 NH 2 polymers
CHO
H
R
R 1 N CH CH CH NHR 2 OHC CHO
Aminoiminopropene Schiff base
N
R
Fluorescent
1,4-dihydropyridine-3,5-dicarbaldehyde
Figure6.20 Formationoffluorescentproductsduringlipidperoxidation.Malondialdehyde(MDA)cannotonlycondensewithitself,butalsowith
otheraldehydesformedduringperoxidation.
can generate fluorescent aminoiminopropene Schiff results and the reasons for the discrepant values ob-
bases,buttheircontributiontotheformationoffluor- tainedbysomeofthemethodsneedtobeelucidated.
escentproductsinperoxidizingmembranesisunclear, Measuring aldehydes and hydrocarbons has some
since MDA has limited reactivity at pH 7.4 (Sec- value, but if there is a shortage of metal ions to
tion5.12.5.2).Otheraldehydes,suchasHNE,maybe decompose lipid peroxides (and ‘catalytic’ metal ion
more important contributors. Even then, the role of levels are often low in vivo), there will be little for-
Schiffbaseshasbeenquestioned;dihydropyridinedi- mationofhydrocarbongases,carbonylcompounds,or
carbaldehydes(Fig.6.21)maybethemajorfluorescent theirfluorescentcomplexes.Lackofformationofthese
products formed.206 Fluorescent products have been products does not necessarily mean that there is no
measured in stroke patients as an index of oxidative peroxidation.Also,measuredlevelsofMDAandHNE
damage(Section10.18.3.1). varywidelybetweenlaboratoriesandmorevalidation
isneeded.Whatevermethodofmeasuringlipidperox-
idationischosen,oneshouldthinkclearlyaboutwhat
isbeingmeasuredandhowitrelatestotheoveralllipid
6.15.11 Whatisthebestmethodtomeasure
peroxidationprocess.
lipidperoxidationintissues,cells,andbody
Theareaoflipidomicsisnowcomingintoitsown:
fluids?
the use of LC–MS to quantitate a wide range of lip-
None is ideal, and all measure different things, but ids and their oxidation products, giving much more
some are preferable to others. On the basis of fairly chemical information about what is happening than
rigorouschemicalidentificationofproductsandbroad doassaysofanysinglelipidoxidationproduct.207One
general agreement between the values measured by example is the use of lipidomics to identify multiple
differentlaboratoriesinplasmaandurine,werecom- cardiolipin oxidation products after traumatic injury
mendmassspectrometricmeasurementoftheF –IsoPs tothebrainofrats.208 Othersincludeitsusetoexam-
2
(combinedwithmeasurementofisofuransundercer-
inelipidoxidationintheintestineofγ-irradiatedrats
tain circumstances). Peroxide assays are also poten- (Section 9.20) and in the lungs of mice exposed to
tially useful (Table 6.10) although diet can affect the pureO 2 .209

--- Page 396 ---

MEASUREMENT OF REACTIVE SPECIES 341
6.15.12 Visualizinglipidperoxidation (infree,protein-bound,orpeptideform)andshowing
thatthestainingisblocked(Fig.6.18,legend).
Severalstainingreagentsorantibodiescanallowvisu- In addition, several probes that partition into
alization of end-productions of lipid peroxidation in membranes have been introduced to measure
cells and tissues. Figure 6.16 shows one example, us- intra-membrane RS and lipid peroxidation. One is
ing an antibody against HNE. Figure 6.21 shows an- cis-parinaric acid (Fig. 6.12).210 When incorporated
other, based upon the fluorescence of conjugates of into lipids undergoing peroxidation, it is rapidly
naphthoic acid hydrazide with carbonyl groups. Fig- oxidized, losingits fluorescence(emission at 413 nm,
ure 6.18 shows a third: exposure of mice to >98% excitation324nm).Parinaricacidneedscarefulhand-
O causesformationofprotein-boundisoketalsinthe ling,becauseitissusceptibletonon-specificoxidation,
2
lung. It is essential when using antibody methods to and it should be stored in the dark under a N
2
checkforcross-reactivitywithotherproductsandfor atmosphere.Itcanbeaddedasthefreeacidorincorp-
non-specificityofstaining,e.g.byaddingtheantigen oratedintospecificphospholipids(parinaroyllipids)
(a)
(b)
Figure6.21(colourplate14) Imaging
ofoxidativestressbyconfocallaserscanning
microscopy.Sectionsofliverfromacontrol
rat(a)orarattreatedwithCCl4toinduce
lipidperoxidation(b)werestainedwith
3-hydroxy-2-naphthoicacidhydrazine
reagent,whichreactswithcarbonylstogive
afluorescentproduct.AdaptedfromAm.J.
Pathol.142,1353,1993,bycourtesyof
ProfessorsMarioComportiandA.Pompella,
andthepublishers.

--- Page 397 ---

342 FREE RADICALS IN BIOLOGY AND MEDICINE
and used to study their relative susceptibilities to Inaddition,ayellowfluorescentprotein(YFP)linked
oxidativedamagewithinmembranes.210,211 Diphenyl- to the protein OhrR, a transcriptional regulator con-
1-pyrenylphosphine (Table 6.10) or derivatives of it trollingthemetabolismoforganicperoxidesinbacteria
(suchasSpy-LHP,‘swallow-tailedperylenederivative (Section5.5.2),hasbeendesigned.213Whenoxidizedby
for detecting lipid hydroperoxides’) or Liperfluo212 organic peroxides, OhrR undergoes a conformational
have also been used to visualize peroxides in cells. changeandlightemissionfromtheYFPincreases.
(a)
(b)
(c)
(d)
0.5 10 20 30
Time (min)
% oxidized
0 50 100
Figure6.22(colourplate15) Serialimagesof(a)ratfibroblastsloadedwithC11-BODIPY581/591andexposedto80μM
cumenehydroperoxideand80nMhaemin.ThegreencolourindicatesRSattackontheprobe.(b)Thecellswerepreincubatedwithα-and
γ-tocopherolfor16hpriortoexposuretothecumenehydroperoxideandhaemin.In(c)and(d),thefractionofoxidizedC11-BODIPY581/591is
presented.Toobtainthisfractionthegreenfluorescenceisdividedbythetotalfluorescence(green+red).FromFEBSLett.453,278,1999by
courtesyofDrKarelWirtzandElsevier.

--- Page 398 ---

MEASUREMENT OF REACTIVE SPECIES 343
AnotherpopularprobeisC-11-BODIPY581/591 (Fig. Pleasebearinmindthatthepresenceofsuchprobes
6.12). Upon oxidation, its fluorescence shifts from mayaltertherate,andperhapsthemechanisticpath-
red to green, so that the green/(red + green) ratio way,oflipidperoxidation,becausetheytrapreaction
can be used as an estimate of membrane oxidation intermediates. The rate constant for reaction of C -
11
(Fig6.22).211 TheBODIPY581/591 moleculehasathree- BODIPY581/891withRO • radicalshasbeenestimatedto
2
ring structure centred on a boron atom. Attack of beabouttwoordersofmagnitudegreaterthanforre-
RS on the diene ‘linker’ alters electron delocaliza- actionoftheseradicalswithPUFAs,i.e.itisapreferred
tion between the two ring structures to cause the targetandthusmay‘over-report’lipidperoxidationas
•
colourchange.Useoftheratiohelpstodecreasevari- wellasperhapsslowingitdownbyinterceptingRO .
2
ations caused by heterogeneous probe distributions α-TocopherolsinhibitreactionofBODIPYwithRO • ,as
2
(cell thickness, uneven dye loading, compartmental- wouldbeexpected(Fig.6.23).
ization etc.). The BODIPY581/591 probe responds to a
range of RS (OH • , peroxyl, alkoxyl, ONOO–, NO • ),
2
but not to O
•–,
NO
•
, H O , singlet O , or hydroper-
6.16 Biomarkersofproteindamage
2 2 2 2
oxides. It may also detect tyrosyl radicals. Thus C-
byreactivespecies217,217A
11-BODIPY581/591 canbeusedtodetermineRSwithin
Proteins can be damaged by direct attack of certain
membranes.Whenaddedtocells,C-11-BODIPY581/591
RS, by the binding to them of end-products of lipid
entersmostmembranes,withnoapparentpreference
peroxidationsuchasHNEorisoketals,and/orbyglyc-
for any organelle,211 but it can be directed to spe-
ation/glycoxidation(Section10.5).Howcanoxidative
cific parts of the cell by suitable attachments (e.g. in
proteindamagebemeasured?
MitoPerOx, it is targeted to mitochondria).214 BOD-
IPY can also be attached to PUFAs to study their
oxidation in cells or to α-tocopherol to study per-
6.16.1 Damagebyreactiveoxygenspecies
oxyl radical formation, e.g. in mitochondria (Mito-
Bodipy-TOH).215 BODIPY probes, allegedly specific Analysing oxidative protein damage products is an
for O •–, ONOO–, NO • , or HOCl have also been order of magnitude more complex than dealing with
2
synthesized.216 DNA(20aminoacidresiduesaswellaspeptidebonds
CO –
2
NO
2
O N S S NO
2 2
COO– COO– S–
Ellman‘s reagent TNB
Figure6.23 Lossofthiolgroupsafteroxidativestress.
(a) (b)
Top:Ellman’sreagent,5,5’-dithiobis(2-nitrobenzoic
acid)(DTNB)iswidelyusedtomeasure–SHgroupsin
proteinsor‘total–SH’incells(thesumofGSH,cysteine,
protein–SH,andanyother–SHcompounds).
Thionitrobenzoate(TNB)absorbsstronglyat412nm
whenionized(pH≥8)(Arch.Biochem.Biophys.82,
70,1959).Bottom:visualizationofcellsurfaceprotein
–SHgroupsbyMPB-basedimmunofluorescence.
Confocallaserscanningfluorescenceimaging.(a)
Controlleukaemiacells,showingaringofprotein–SH
groupatthesurface.(b)Lossofsurfaceprotein–SH
followingexposuretoHNE.Bar:10μm.MPB;
3-(N-maleimidylpropionyl)biocytin.FromHistol.
Histopathol.15,173,2000,bycourtesyofProfessorA.
PompellaandJiménez-Godoypublishers,S.A.Murcia,
Spain.

--- Page 399 ---

344 FREE RADICALS IN BIOLOGY AND MEDICINE
canbeattackedascomparedwithfourbasesandone Bityrosine,easilydetectableinhumanandotheran-
sugar).Freeradicalattackonproteins(e.g.byOH•)can imal urines because of its intense fluorescence (Fig.
generateradicalsonaminoacidresidues.Thesemight 2.2), formed by RS attack on a wide range of pro-
cross-link, or alternatively react with O to give per- teins,andapparentlynotmetabolized,isabiomarker
2
oxyl radicals. Protein peroxyls may then abstract H•, that may be worth further development for human
formingmorefreeradicalsandconvertingthemselves use.3,174 For example, patients with sepsis showed
to protein peroxides which can in turn decompose increased urinary excretion of bityrosine, as did chil-
in complex ways, accelerated by heat or transition drenwithkwashiorkor,220adiseasebelievedtoinvolve
metalions,togenerateyetmoreradicals(Section5.13). oxidative stress (Section 5.1.1). Bityrosine is present
Thesituationwithtwo-electronoxidantssuchassing- normallyintheinsectcuticle,somefungalcellwalls,
let O is less complex, but it also results in multiple and the fertilization envelope of the sea urchin (Sec-
2
typesofdamageduetoformationofendo-andhydro- tion8.5.2).o-Tyrosinecanalsobedetectedinurine(Sec-
peroxides(Section2.6.4)whichcaninducesecondary tion5.13.4.5)andanimmunohistochemicalmethodto
oxidation by both radical and non-radical processes. detect bityrosine in human brain has been described,
Some of the methods used to study oxidative pro- butnotwidelyused.221
tein damage are summarized in Table 6.12. As with Proteins can be oxidized when food is cooked.
lipids and DNA, care must be taken to prevent oxi- Hence, oxidized amino acids (including bityrosine)
dativeproteindamageduringsamplehandling—this could conceivably be absorbed from the diet, which
canoccurduringhydrolysistoreleasemodifiedamino could confound their measurement in body fluids as
acidsforanalysis,aswellasinpreparationofthesam- putativebiomarkersofoxidativedamage.Thispossi-
ple for mass spectrometry, or even during MS itself bilityneedsfurtherstudy.
(Section5.13andref218).
Lossofthiolor–NH groups,oroftryptophanfluor-
2 6.16.2 Damagebyreactivehalogen
escence, and the carbonyl assay (Section 6.16.3), are
andnitrogenspecies
popularmethodsthatdonotrequiretheproteintobe
hydrolysed.Individualaminoacidoxidationproducts Proteinsarealsoattackedby reactivechlorine,brom-
thathavebeenmeasuredinvarioushumantissuesand ine, and nitrogen species, giving products such as 3-
often in foodstuffs include kynurenines (from tryp- chlorotyrosine, para-hydroxyphenylacetaldehyde, 3,5-
tophan), methionine sulphoxide, cysteine oxidation dichlorotyrosine,3-bromotyrosine,bromamines,chlor-
products, valine and leucine alcohols (hydroxides), amines,and3-nitrotyrosine(Section5.13.4),whichcan
L-DOPA(andquinonesfromfurtheroxidation),ortho- be detected by immunostaining or chemical analysis.
tyrosine,2-oxohistidine,glutamatesemialdehyde,and Chlorotyrosineshaveoftenbeenmeasuredasanindex
adipic semialdehyde. For example, ortho-tyrosine has of damage by RCS, although they are minor end-
beenmeasuredinhumanlensproteins(Section7.10.1). products of such damage. When HOCl and HOBr
Ortho- and bityrosines were measured in hair from reactwithproteins,HOBrbrominatestyrosineresidues
‘Alpineman’,Homotirolensis,219althoughwhetherthey morereadilythanHOClchlorinatesthem,sinceitre-
were formed during life or after death as a result of acts faster with tyrosine; in addition, HOBr is less
exposure of the body to sunlight or transition metals well scavenged by cysteine and methionine residues.
(a corroded copper axe was next to the body) is Hence if both halogenated tyrosines are measured,
unknown. Hydroperoxides, which can be generated their ratio should not be used to determine the rela-
on many side-chains and the peptide backbone, are tiveamounts of HOCland HOBr formed(HOBr will
poormarkersofproteindamageduetotheirinstabil- be over estimated).222 Reaction of HOCl and HOBr
ity, but reduction (e.g. using sodium borohydride) of withproteinaminegroups(e.g.onHis,Lys,andArg
hydroperoxides to stable alcohols can be a powerful residues)resultsintheformationofsemi-stablechlor-
method for MS studies due to their ease of detection aminesandbromamines(RNHClandRNHBrspecies),
by MS. DOPA has been quantified on proteins from whicharethemselvesoxidantsthatcaninducesecond-
multiple tissue samples, but the ready oxidation of ary oxidation via both radical and non-radical reac-
this species (Section 5.13.4.5) can confound quantifi- tions. These secondary reactions can confound prod-
cation.Measurementsofglutamateandaminoadipate uct analysis studies. 3-Nitrotyrosine is formed from
semialdehydes in human plasma proteins have been tyrosinebyarangeofRNS(Section6.6.2.1)andcanbe
usedtoassesstheeffectsofalterationsinantioxidant metabolizedinvariousways,includingsulphation,as
intakeonproteinoxidation(Section4.6.3.1). canchlorotyrosine.Nitro-,bromo-,andchlorotyrosines

--- Page 400 ---

Table6.12 Somemethodsforthedetectionandmeasurementofoxidativedamagetoproteins.
Method Reaction/detection Comments
A.Generalmethods
Aminoacidanalysis Proteinshydrolysedandaminoacidsseparatedandanalysed. Givesanoverallpatternofchanges;measureslossofaminoacids;candetect
nitrotyrosine,chlorotyrosine,2-oxohistidineetc.
Proteincarbonyls Section6.16.3
Proteinperoxides Severalmethods,includingiodometryandFOXassay. SeeTable6.10
ESRofproteinradicals Oftensignalsarebroadandgivelimitedstructuralinformation Canbeusefulundersomecircumstances.
MeasurementofDMPOadducts AsensitivealternativetoESRmeasurements Section6.2.8
Decreased levels of amino groups (e.g. after Fluorescamine:excitation390nm,emission475nm;O-phthalaldehyde: -
modificationoflysinesbyaldehydes) excitation340nm,emission450nm.
B.Specificchangestoindividualaminoacids
Cysteine Ellman’sreagent(Fig.6.23)Sulphenic,sulphonicacidsetc.byHPLC,LC–MS, Measuresavailablethiol(–SH)groups,buttherearemultiplerepair
(1)Lossof–SH(thiol)group andGC–MS(e.g.Biochim.Biophys.Acta1840,847,2014). mechanisms,bothmolecularandenzymatic,formostproductswiththe
(2)Formationofoxidationproducts exceptionofsulphonicacids(Section3.13.2.2).
Tryptophan
(1)Lossoffluorescence Fluorescencechanges:excitation280nm,emission342nm. Lossofthenativefluorescenceoftryptophan.Productssuchas
(2)Formationoftryptophanoxidationproducts AlteredfluorescencespectracomparedwithTrp.GC–MSandLC–MS. N-formylkynureninearefluorescent(AminoAcids3,184,1992;J.Agric.Food
Chem.58,3541,2010).AntibodiestoimmunostainN-formylkynureninehave
beendeveloped(Photochem.Photobiol.86,752,2010).
Tyrosine Bityrosine;HPLCseparationwithfluorescence,orECDdetection,GC–MS,or DOPAispresentnaturallyinsomeproteins(Mol.CellProteomics9,1199,
antibody-basedmethods.HydroxylationproductL-DOPAcanbemeasuredby 2010)andcanbeincorporatedintoproteinswhenadministeredtopatients
HPLC,MSetc. withParkinsondisease(J.Neurochem.98,1061,2006).
Methionine Oxidationtomethioninesulphoxideandsulphone(HPLC,LC–MS,GC–MS). Enzymescanrepairmethioninesulphoxideresidues(Section5.14.1)
Antibodymethodshavebeendescribedbutspecificityisquestionable.
Nitrationofproteins Antibodies,HPLCorGC–MS;usuallymeasuredontyrosine,butnitrationcan ProvidesevidenceofdamagebyRNS(Section6.6.2).
occuronphenylalanineandtryptophan.
Chlorination/brominationofproteins Chloro(bromo)tyrosine;HPLCorGC–MS.Antibodymethodshavebeen DetectsdamagebyRCS/RBS,suchasHOCl,HOBr,orNO2Cl(Section6.7),but
describedbutspecificityisquestionable(maydetectbromo-,dichloro-,or minorproduct,andhencemayunderestimatedamage.
dibromo-speciesaswell).
2-Oxohistidine HPLC,LC–MS.Alsodetectedincarbonylassay Canreactfurtherwithaminestogivecross-linksandhenceformationmaybe
underestimated.
•
Phenylalanine HydroxylatedbyOH toortho-,meta-,andpara-tyrosines;nitratedon Cross-linkedspeciescanalsobedetectedbyMS.
exposuretoONOOHandprobablysomeotherRNS.DetectedbyHPLC,GC–MS,
andLC–MS.
Valine/leucine/otheraliphaticside-chains Peroxidesortheirreductionproducts(alcohols,hydroxides)measuredbyHPLC, Biochem.J.324,41,1997
orLC–MS.
Arginine/proline Canbeoxidizedtoγ-glutamatesemialdehydewhichonreductionand HPLCorGC–MSmeasurement(FreeRadic.Biol.Med.21,65,1996).
hydrolysisforms5-hydroxy-2-aminovalericacid.

--- Page 401 ---

346 FREE RADICALS IN BIOLOGY AND MEDICINE
can be measured as the free amino acid or in pro- important to do so, because there is a considerable
teinsafterhydrolysis.Hereinliesapotentialforarte- variation in reported ‘baseline’ levels of protein car-
fact.HydrolysisofproteinsbyHClshouldbeavoided bonylsincellsandtissues,dependingonhowtheassay
if chlorotyrosine is to be measured. Traces of NO– isperformed.Forexample,reportedcarbonyllevelsfor
2
in biological samples can generate RNS upon ex- human brain cortex range from 1.5 to 6.4 nmol/mg
posure to acid that can artefactually nitrate tyrosine protein.227 By contrast, most groups seem to obtain
(Section6.6.2.2). broadly comparable values for protein carbonyls in
plasmafromhealthymammals,of0.4to1.0nmol/mg
protein.
6.16.3 Thecarbonylassay
Carbonyls can also be generated when aldehydes
Thecarbonylassay3,223,224 isoftenusedasa‘general’ such as HNE react with –SH and –NH 2 groups on
assayofoxidativeproteindamage.SeveralRS(includ- proteins(Fig5.12.5.2)andbyglycation/glycoxidation
ingOH • ,RO • ,O ,HOCl,ONOOH,andsingletO )ox- reactions (Section 10.5) and so the carbonyl assay is
2 3 2
idizeaminoacidresidues(Arg,His,Lys,Pro,Ser,Thr, notspecificfor‘direct’oxidativeproteindamage.Car-
Val, Leu, Ile) in proteins to form products containing bonylvaluescanalsobeconfoundedbythepresence
carbonylgroups.Forexample,OH • convertshistidine of glycoproteins and proteoglycans, due to the pres-
to 2-oxohistidine and singlet O converts tryptophan ence of native (reducing) sugars, or damaged sugar
2
toN-formylkynurenine(amongotherproducts).Glu- chains attached to the protein. It is also essential to
tamateandaminoadipicsemialdehydesaresignificant remove nucleic acids when analysing tissue protein
(~50%)contributorstoplasmaandtissueproteincar- carbonyls.Thedifferenttypesofcarbonylcanbedis-
bonyl levels. It should be noted, however, that the tinguishedinbodyfluidsandtissuesbymassspectro-
enzyme lysyl oxidase (Section 10.14.8.7) in connect- metricidentification.218
ivetissueoxidizesselectedlysineresiduesoncollagen The carbonyl assay as applied to tissues and body
andelastintoα-aminoadipic-δ-semialdehydetopermit fluids measures the ‘average’ extentof protein modi-
cross-linking.Hencethecarbonylassayshouldbeap- fication, a steady state between generation of modi-
pliedwithcautiontoconnectivetissues.Lysyloxidase fied proteins and their removal by proteolysis (Sec-
alsogeneratesH O .225 tion 5.14.3). It has also been suggested that ‘decar-
2 2
Carbonyls are easily measured after reaction with bonylation’mechanismsthatcanremovecarbonylres-
2,4-dinitrophenylhydrazine (DNPH) by the absorb- idues from proteins exist, but little is known about
ance of the adduct, or after its reduction by tritiated how this could work, except that thioredoxin may
sodiumborohydride(theincorporationofradioactive be involved.228 Separating and identifying oxidized
tritium into the protein being measured by scintilla- proteins by proteomic techniques often gives use-
tion counting) or by cytochemical techniques using ful information; sometimes only a small number of
anti-DNPHantibodies.Indeed,ausefulcommercialkit proteins accounts for most of the carbonyls (as is
(OxyblotTM)isavailable,althoughuseitwithcaution, also true when aldehyde adducts are measured, e.g.
asexplainedinref226(alsoseeSection2.5.5.4).Another Sections 3.21.2 and 10.21.4). For example, in human
approachistousehydrazidessuchasGirardPreagent plasmatreatedwithFe(III)/ascorbate,mostcarbonyls
or biotin hydrazide. The latter is popular; carbonyls werefoundonfibrinogen,althoughin‘normal’plasma
react withthehydrazinecomponentandcan then be a wider range of proteins (approximately 65) was
isolatedusingbiotin-bindingcolumnsoridentifiedon carbonylated.229Inthebrainsofsubjectswhodiedwith
gelsusingfluorescently-labelledavidin,aproteinthat Alzheimerdisease,onlyafewproteinswerehighlycar-
binds tightly to biotin. This technique is also used in bonylated(Section10.21.4).InHeLacellstreatedwith
theARPassaytodetectDNAstrandbreaks(Table6.8). H 2 O 2 , 210 carbonylated proteins containing 643 car-
Be aware that some carbonyls are released from pro- bonylationsiteswereidentified;44%ofsitesresulted
teinsbyfragmentation,andthesemaybelostduring from lysine oxidation to aminoadipic semialdehyde.
thewashingproceduresofthecarbonylassay.217 Additionally, 121 Arg, 121 Thr, and 117 Pro residues
Thecarbonylassayisusedwidelyandmanylabora- were oxidized.230 In patients suffering from cholan-
torieshavedevelopedindividualprotocolsforitsuse. giocarcinoma due to infection with liver fluke, only
Indeed,tissueorplasmacarbonyllevelsareelevatedin 14proteinswerehighlycarbonylatedinthemalignant
manydiseases.Sometimestheassayproceduresused tissue; the levels were higher in patients with poorer
are not specified precisely in published papers. It is prognosis.231

--- Page 402 ---

MEASUREMENT OF REACTIVE SPECIES 347
6.16.4 Glutathioneoxidationandsynthesis preparation is enough to artefactually raise plasma
GSHlevels.PlasmaGSHis,ofcourse,a‘transitpool’
GSH is easily measured by several methods; some
(Section 3.10) and changes in its level can be due to
arespecific(e.g.combinationwithmonobromobimane,
altered release by the liver, altered clearance by γ-
ortho-phthaldehyde, or dansyl chloride, followed by
glutamyl transpeptidase, as well as oxidation by RS.
HPLCseparationofthefluorescentGSH-adducts),and
Glutathionesulphonamide,
others not (e.g. Ellman’s reagent; Fig. 6.23).217,217A,232
TheoxidationofGSHtoGSSGandotherproductsin
cells, tissues, and body fluids has been widely used
as an index of ‘oxidative stress’, but it is essential
to prevent spontaneous oxidation of GSH during as-
say procedures, and some reported measurements of
plasmaGSH/GSSGratiosmaythusbeerroneous.3,233
In addition, GSH is easily released from red blood
cells by haemolysis; as these cells are rich in GSH oneoftheproductsgeneratedwhenGSHreactswith
even a small amount of haemolysis during plasma HOCl, has been measured in lung lining fluids and
Figure6.24(colourplate16)InvivoimagesoftissuesfromamouseintravenouslyinjectedwithaGSH-specificprobe(50μM)and
paracetamol(APAP;300mg/kg).Fluorescenceimagesofthe(A)liver,(B)kidney,(C)lung,and(D)spleendissectedfromamouseinjectedwith
probeonlyandamouseinjectedwiththeprobeafterbeingpreinjectedwithparacetamol.Thecyanine-basedprobehasthestructure
DiagramfromJ.Am.Chem.Soc.136,5351,2014,bycourtesyofDrsYoonJuyoungandRyuJi-Hwan,andtheAmericanChemicalSociety.

--- Page 403 ---

348 FREE RADICALS IN BIOLOGY AND MEDICINE
may be a sensitive marker of GSH oxidation by suggestthattherecanbedistinctivepatternsofexpres-
HOCl,unlikethesituationwithchlorotyrosinewhich sion of protein tyrosine phosphatases (PTPome) and
is formed slowly and is a minor target.234 Redox- theiroxidizedforms(oxPTPome)indifferentcelltypes
sensitive fluorescent proteins have been employed to (e.g.normalversusmalignant).239 Similarstudiescan
examine the glutathione redox status in cells. They bedonetomeasurenormal,oxidized(sulphenyl),and
canbetargetedtospecificorganellestoreportonthe hyperoxidized (sulphonyl) peroxiredoxins.240 Gluta-
GSH redox state there (Section 6.10). Low molecular thione adducts on proteins (glutathionylation: Sec-
mass probes to detect GSH in cells and in vivo have tion 3.11) can be detected with antibodies specific
beendeveloped(somebasedonBODIPY),andusedto for GSH,238 and methods to allow identification of
measure changes in GSH level. Figure 6.24 shows an proteins with S-nitrosylated thiol groups or me-
example. thionine sulphoxide residues (Table 6.12) have been
In vivo techniques for the measurement of rates of described.241,242
GSHsynthesishavebeendescribed;if[2-13C]glycine
is fed to animals (including humans) for a period,
13C-labelled GSH is produced and can be detected 6.16.7 Advancedoxidationproducts
in a magnetic resonance imaging scanner. Oxidative andmodifiedalbumin
stress in animals (e.g. in NASH [Section 9.8.1.6] or
Albumin is readily modified by various RS and may
CCl administration)causeschangesintherateofGSH
4 act as an antioxidant in vivo by being a preferred
synthesis.235
target for them (Section 3.23.3.5). Indeed, several
groups have measured oxidation of albumin’s –SH
6.16.5 γ-Glutamyltranspeptidase groupasanindexofoxidativestress,243 e.g.inARDS
(Section 10.8.1), liver failure,244 and in exercise (Sec-
This enzyme plays a key role in GSH metabolism
tion 7.14). In 1966, a spectrophotometric technique
(Section 3.10). It is present not only on cell surfaces,
was developed to identify advanced oxidation pro-
but also in plasma, and epidemiological studies sug-
tein products (AOPP) in the plasma of patients with
gest that plasma levels, even within the ‘normal’
kidneyfailure.AOPPseemtobeoxidizedaggregated
clinicalchemistryrange,arecorrelatedwithbiomark-
proteins, resulting from attack by HOCl and other
ers of inflammation (e.g. C-reactive protein) and oxi-
ROS, especially upon albumin and fibrinogen. AOPP
dative damage (e.g. F -IsoPs; oxLDL), with exposure
2 havesincebeendetectedinplasmafrompatientswith
to certain pollutants (e.g. lead, cadmium, and di-
severalotherdiseasese.g.liverfailure.245
oxin), and with the later development of cardiovas-
In addition, an ‘ischaemia-modified albumin’
cular disease.236 Why this should be so is not clear,
(IMA), detected by a colorimetric method, has been
although pro-oxidant effects of its product cysteinyl-
described in plasma from patients with myocardial
glycine(includingitsabilitytoS-thiolateproteins;‘S- infarction, stroke, kidney failure, or β-thalassaemia.
cysteinylglycylation’)havebeensuggested(butnotes-
ItseemstorepresentalbumininwhichtheN-terminus
tablished)tocontribute.237 HighγGTlevelscombined
hasbeenmodified,allegedlybyRS.246AOPPandIMA
withhighalcoholintakeseemtopredictincreasedrisk
probablyneedbetterchemicalcharacterizationbefore
ofstrokeandcancer(Section9.8.1).
their use as biomarkers of oxidative damage can be
recommended.
6.16.6 The‘thiol-ome’
Several proteomic methods have been developed to 6.17 ‘Indirect’approaches
investigate the distribution of –SH residues on cel-
Several indirect approaches have been used to impli-
lular proteins and how it is affected by oxidative
stress.217,217A,238 Caremustbe taken topreventspuri- cateRSinhumandisease.
ous oxidation during analysis. In addition, ‘probes’
that detect sulphenic acid residues have been intro-
6.17.1 Erythrocyteandplasmaenzymes
duced,oftenbasedontheirspecificreactionwith5,5-
dimethyl-1,3-cyclohexanedione (dimedone). Related Manygroupshavemeasuredthelevelsofantioxidant
to this, techniques that identify ‘normal’ and oxi- defenceenzymesinredbloodcellsorplasmaasanin-
dized(sulphonyl)proteintyrosinephosphatases(Sec- dexof‘oxidativestress’.PlasmalevelsofSODinclude
tion 5.5.4) in cells have been developed; the results EC-SOD (Section 3.23.3.2), but also SODs released by

--- Page 404 ---

MEASUREMENT OF REACTIVE SPECIES 349
celllysisduringmanipulationoftheblood,orfromin- duetolocalizedscavengingofRSinbloodvesselwalls
creasedlysisofcellsinvivoindiseasedtissuesorfrom byantioxidants,unlikemeasurementofbiomarkersof
muscleduringexercise.Itisthushardtodecidewhat oxidativedamageinplasmaorurine,whichreporton
plasmalevelsofantioxidantenzymesactuallymean. whole-body effects. The technique of flow-mediated
What about changes in erythrocyte antioxidant dilatation (sometimes written dilation), or FMD, of
levels? Human erythrocytes cannot synthesize pro- the brachial artery is popular. Brief ischaemia of the
teinsandtheirantioxidantenzymelevelsmaydropas forearm is induced by an inflatable cuff. When it is
they‘age’inthecirculation.Thus,changesinenzyme released, increased blood flow (reactive hyperaemia)
levelsaremorelikelytoreflectchangesintheratesof shouldincreaseNO•production,thevesselsdilate,and
red blood cell turnover rather than ‘oxidative stress’. this dilation is measured. Impaired FMD is an early
If turnover slows down, the circulating erythrocytes signofendothelialdysfunction.However,itmustnot
will be older on average and so levels of antioxidant beassumedthatanybeneficialeffectsofantioxidants
enzymesinthemwillappear tofall.Viceversa,ifan on FMD are necessarily due to RS scavenging. As-
intervention accelerates red cell removal or increases corbate can have a direct stimulating effect on eNOS
erythropoiesis, levels of antioxidants in red cells will activityby increasingendothelialtetrahydrobiopterin
seemtorise.Hence,interpretsuchdatawithcaution.27 levels, for example (Chapter 4, Box 1). Nevertheless,
FMD was increased in patients with chronic granu-
lomatous disease, whose O
•–
production is impaired,
2
6.17.2 Vascularreactivity247 suggesting that ROS do play a role (Section 8.7.4.4).
Bilirubin has also been suggested to improve endo-
Nitricoxideplaysakeyroleinvasodilation,butitsac-
tionisantagonizedbyO
•–(Section2.6.1).Somepapers thelial function (Section 3.25.1), measured using the
2 FMDtechnique.SeasonalvariationsinFMDisappar-
claimthathighdosesofinfusedororallyadministered
entlyhealthypeoplehavebeenreportedandsuggested
antioxidants(e.g.ascorbate)canscavengeROS,restore
• to be due to variations in vascular NADPH oxidase
NO bioavailability, and ameliorate human endothe-
activity.249
lialdysfunction,althoughotherreportsdonotconfirm
this.Thetimingofantioxidantadministrationandthe
stateofthevascularbed(healthy,mildlydiseased,or 6.17.3 Assaysoftotal(‘non-enzymic’)
severely diseased, which may in part depend on the antioxidantcapacity250,251
age of the subject) are likely to be critical variables
in explaining conflicting results.248 Hence, it is pos- Decreases in the levels of individual antioxidants
sible that examination of short-term vascular effects and/or generation of oxidation products from them
cangatherevidenceaboutimprovedNO• availability (e.g.ascorbylradical,biopyrrins,GSSG,allantoin)are
Table6.13 Totalantioxidantcapacityofhumanbloodplasma/serumbyvariousassays.
Method Typicalresults(μM) Reference
TRAP ~1000 Seetext
Enhancedchemiluminescence 829±77 Anal.Chim.Acta266,265,1992
ORAC ~1.1–3.1 FreeRadic.Res.33,S59,2000;
FreeRadic.Biol.Med.18,29,1995
ABTSassay ~2000 Usingpersulphate-basedassay:
FreeRadic.Res.38,831,2004
FRAP(ferricreducing 612–1634a Anal.Biochem.239,70,1996;
antioxidantpowerofplasma) (1.03±0.22)b×103 FreeRadic.Res.33,559,2000
Notethatdifferentassaysgivedifferentvalues,notsurprisinglybecausethechemistryofeachassayandthetime-courseoverwhichitisconductedaredifferent.Initial
reactionproductsof‘antioxidants’oftenundergofurtherreactionswithDPPH,ABTS,etc.Plasmaandserumdonotalwaysgiveidenticalresults.Theanticoagulantused
toprepareplasmacanaffectdeterminationofTAC,sinceheparinstabilizesplasmaagainstlossofTAConstandingbetterthanEDTAdoes(Ann.Clin.Biochem.36,104,
1999).ItisgenerallybesttoassayplasmasamplesimmediatelyforTAC.
aHealthyChineseadults.
bCaucasians.IngeneralTACvaluesarehigherinmalesthaninfemales(Ann.Clin.Biochem.36,104,1999;ArterioThromb.Vasc.Biol.21,1190,2001),although
malestendtohavehigheroxidativedamagelevelsbybiomarkerassays(Section3.26).

--- Page 405 ---

350
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table6.14 Someassaysfortotalantioxidantcapacity(TAC).
Method Principle Comments
•
TRAPassay Peroxidationofendogenousorexogenous(e.g.addedlinoleic CanmeasureO2uptakebyO2electrode,ordetectRO
2
directly,e.g.byluminol-enhanced
acid)lipidsinbodyfluidsonexposuretoazoinitiators. chemiluminescence,lossoftheESRsignalafterspintrapping(FreeRadic.Biol.Med.21,211,1996;
Anal.Biochem.386,167,2009),otherchemiluminescencemethods,orbleachingofpyrogallolred
(FreeRadic.Res.39,729,2005)orcrocin(J.Chromatogr.A1237,80,2012).Canalsouseproteinsas
•
targets,e.g.measureproteincarbonylformationorenzymeinactivationbyRO .Someauthorshave
2
usedLDLasatarget(e.g.Chem.Phys.Lipids164,42,2011).Other‘detectors’canbeusede.g.
DCFHDA,fluorescein,orBODIPY665/676(J.Agric.FoodChem.59,2235,2011;Curr.Opin.Clin.Nutr.
Metab.Care13,518,2010).
ORAC(oxygenradical β-PhycoerythrinisattackedbyRO • withlossoffluorescence. Phycoerythrinisaphotosyntheticproteinfoundinredalgae.Itcarries34covalentlylinkedopen-chain
2
absorbancecapacity) Usuallyusesemission565nm,excitation540nmandAAPH tetrapyrroleprostheticgroups,givingithighabsorbance(λ max372,497,566nm)andintense
assay togenerateRO •
2
.Antioxidantscausedecreasedfluorescence fluorescence(λ max578nm)(FASEBJ.2,2487,1988,FreeRad.Biol.Med.27,1173,1999).
loss.Thereactionisusuallytakentocompletionratherthan
allowedtorunforafixedtime(e.g.asintheABTSassay),or
onlyalagphasemeasured(e.g.asintheTRAPassay).
ABTSassay 2,2’-Azinobis(3-ethylbenzothiazoline6-sulphonate)is Rapidmethod,easilyautomated(RedoxReport2,161,1996),measurementathighλavoids
oxidizedtoanitrogen-centredradicalcation,ABTS•+(Fig. interferencefromabsorbanceofmostbiomolecules.CanbeappliedtoLDL.Bettertopre-formthe
6.25),whichabsorbsat660,734,and820nm.Oxidationof radicalusingpersulphate(FreeRad.Biol.Med.26,1231,1999);otherwisesomeantioxidants(e.g.
ABTStoABTS•+canbeachievedbymetmyoglobin/H2O2, ascorbate)caninterferewithitsgenerationbyperoxidaseormetmyoglobinsystemsbycompetingwith
horseradishperoxidase/H2O2,orsimplybyaddingMnO2or ABTSforoxidation.
persulphate.Antioxidantsdecolourizetheradical.
Galvinoxyl O-centredradical(Fig.6.24) ScavengingcanbemeasuredbylossofA432orlossoftheESRsignal(ActaBiochim.Polon.57,139,
2010).
DPPH 1,1-diphenyl-2-picrylhydrazyl(Fig.6.24),astable MeasurelossofabsorbanceoroftheESRsignal.Reactswithdifferentantioxidantsatdifferentrates
nitrogen-centredradical andbydifferentmechanisms,sohardtodosimplecomparisonof‘antioxidantcapacity’(J.Agric.Food
Chem.62,4251,2014).
FRAP(ferricreducing Measuresabilityofplasmaantioxidants(vitaminE,urate, Easilyautomated;simple.Assumesthatreducingabilityequatestofree-radicalscavengingcapacity
antioxidantpower) ascorbate,butnotalbumin)toreduceFe(III)chelatedwith (Anal.Biochem.239,70,1996).
2,4,6-tripyridyl-s-triazinetoFe2+atlowpH.Pretreatment
withascorbateoxidasecanbeusedtodeterminethe
contributionofascorbate.
SOAC(singletO2 Measuresabilityofcompoundstoquenchorscavengesinglet J.Agric.FoodChem.60,7905,2012.
absorptioncapacity) O2generatedbyendoperoxidedecompositionanddetected
using2,5-diphenyl-3,4-benzofuran(Section2.6.4.6).
CUPRACassay AbilitytoreduceCu2+-neocuproineorCu2+-bathocuproine FreeRadic.Res.39,949,2005;Anal.Biochem.423,36,2012.EquatesreducingcapacitytoTAC.
(cupricionreducing sulphonate
antioxidantcapacity)
ARACassay(Aroxyl Abilitytoscavengethe Followedbyabsorbancechange.J.Agric.FoodChem.61,10054,2013.
radicalabsorption 2,6-di-tert-butyl-4-(4’-methoxyphenyl)phenoxylradical
capacity)
Inmostoftheseassays,aradicalisgeneratedandscavengedbyantioxidants.Whentheantioxidantsareuseduptheradicalreactswithatargetmoleculetoproduceacolour,fluorescence,chemiluminescence,lossorgainofan
ESRsignal,orotherobservablechange.Electrochemicalmethods,basedontheoxidationofantioxidantsatelectrodes,havealsobeendeveloped(e.g.J.Agric.FoodChem.60,7836,2012).

--- Page 406 ---

MEASUREMENT OF REACTIVE SPECIES 351
•
frequentlymeasuredasanindexof‘oxidativestress’. these antioxidants have been depleted will the RO
2
However, antioxidant depletion does not necessarily radicalsattacklipids(lipidsinthefluid,orlipidsad-
equate to oxidative damage; it might simply signify dedtoit)tocauseperoxidation.Bymeasuringthelag
thatthedefencemechanismshaveremovedtheRSand periodbeforeonsetofperoxidation(e.g.byO uptake)
2
protectedthesystem. and calibrating the assay with a known antioxidant
•
Severalattemptshavebeenmadetoassessthetotal (usually Trolox whichcantraptwoRO ),avaluefor
2
antioxidantcapacity(TAC)ofbiologicalmaterials(e.g. TRAP can be obtained as the micromoles of peroxyl
bodyfluids)ratherthangoingtothetroubleofiden- radicals that can be trapped per litre of fluid. In hu-
tifyingwhat has happenedto each componentof the man plasma, TRAP values are around 103 μmol RO •
2
complex antioxidant defence network. Of course, it’s trapped/litre; major contributors to TRAP are urate
notreally‘total’.Theassaysusuallydonotdetectany (35–65%), plasma proteins (10–50%), ascorbate (up to
antioxidantenzymespresentandabetternamemaybe 24%),andvitaminE(5–10%)(Table6.13).Theknown
‘non-enzymaticantioxidantcapacity’.252 antioxidants do not account for all of the measured
The first TAC assay used was the TRAP (total TRAP, i.e. there is an ‘unidentified’ component. This
(peroxyl) radical trapping antioxidant parameter) couldbeduetoantioxidantsnotyetidentified,and/or
assay.253 A body fluid is incubated with AAPH tosynergybetweenantioxidantsduringtheassaysuch
(Section2.5.4),whichformsperoxylradicalsthatreact thattheyworkbetterincombinationthanindividually.
withsomeoftheantioxidantsinthefluid.Onlywhen ItisessentialtoensurethatO isnotdepletedduring
2
–O 3 S S S SO 3 –
C N N C
N N N
Et Et N•
ABTS λ max 342 nm O 2 N NO 2
–e– NO
2
DPPH
(diphenyl-p-picrylhydrazyl)
–O 3 S S S SO 3 –
C N N C
•+ CH
N N 3
HO
Et Et
λ max 417 nm CH 3
ABTS radical cation H 3 C O COOH
(absorbance peaks at 645, 734
CH
and 815 nm) 3
Trolox
(CH ) C (CH ) C
33 33
O CH O•
(CH ) C (CH ) C
33 33
Galvinoxyl
Figure6.25 Somecompoundsusedin‘totalantioxidantcapacityassays’.BothABTS•+andDPPHarenitrogen-centredradicals,whereas
galvinoxylisoxygen-centred.Trolox,usedtocalibratemanyassays,isawater-solubleformofα-tocopherol:thehydrophobicside-chainis
•
replacedbya–COOHgroup.OnemoleofTroloxcanscavengetwoRO radicals.WhereasABTSissolubleinaqueoussolutions,DPPHisdissolved
2
inethanol.

--- Page 407 ---

352 FREE RADICALS IN BIOLOGY AND MEDICINE
the TRAP assay, because the carbon-centred radicals foodsandbeveragesrarelytranslatesintoinvivoanti-
generatedfromAAPHcanthemselvesreactwithcer- oxidantactions(Chapter4).Forthisandotherreasons,
tainantioxidants(Section2.5.4). the US Agricultural Research Service no longer pub-
MultipleothermethodstomeasureTACexist.One lishesatableoftheORACvaluesoffoodstuffs(http://
•
is to use lipid-soluble RO generators (e.g. AMVN; ars.usda.gov/services/docs.htm?docid=15866).
2
Section 2.5.4), or other free radicals such as ABTS•+, Nevertheless,assaysofTACmaysometimesbeuse-
DPPH,orgalvinoxyl(Fig.6.25). Anotheristouseal- ful in getting a global picture of relative antioxidant
ternativedetectionmethodssuchasluminol-enhanced activitiesindifferentbodyfluidsandhowtheychange
chemiluminescence (Tables 6.13 and 6.14). In several in clinical conditions. Results should be interpreted
assays (e.g. ORAC, TRAP, ABTS), urate is a major inthelightofthechemistryoftheassay(Table6.14).
contributortothetotalantioxidantactivityofplasma Forexample,istheabilitytoreduceiron(asinFRAP)
or saliva. By contrast, human CSF has about four- or copper chelates (as in CUPRAC) equivalent to
fold higher ascorbate concentrations but lower ur- the ability to scavenge RO • or ABTS•+? Probably
2
ate concentrations than plasma, and so ascorbate is not. Changes in the levels of certain antioxidantscan
a more significant contributor to TRAP. Total CSF sometimes mislead; for example, rises in urate can
TRAP values are lower (~237 μM) than those in obscuredepletionsofascorbateorotherantioxidants.
plasma.254 Urate levels rise in many human diseases because of
Totalantioxidantcapacityassaysarefrequentlyused alterationsinpurinemetabolism,whichexplainswhy
tocomparetheinvitroantioxidantactivitiesofdiffer- somestudieshavedetectedincreasedplasmaTACin
ent molecules, foods, or beverages. Table 6.15 shows sickpeopleorpeoplewithlowphysicalfitness.255Sev-
anexampleusingABTS•+. eralscientistshaveusedTACdeterminationstoimply
that consuming various foods (e.g. chocolate, fruits,
6.17.3.1 Whatdochangesintotalantioxidant
vegetables) contributes specific phenolic antioxidants
capacitymean?
toplasmathatincreaseitsTAC.Often,however,eating
BearinmindthatDPPH,ABTS•+,galvinoxyl,andper- these foods transiently raises plasma urate levels,
oxyl radicals derived from AAPH and AMVN, are whichaccountsformostorallofthechanges.256 Sev-
non-physiologicalmolecules,sodonotover-interpret eralassaysshowagreaterplasmaTACinmalesthan
thesignificanceof‘scavenging’them.Itisalsoworth females (Section 3.26), perhaps due to higher urate
remembering that the in vitro antioxidant activity of levels.
Table6.15 UsingtheABTSassaytodeterminethecontributionofidentifiedconstituentstothetotalantioxidantactivityofredwineinvitro.
Antioxidant Concentrationin Contributionto
activityaofpure wine(mM) totalantioxidant
compound activity
Catechin 2.4±0.05 0.66 1.6
Epicatechin 2.5±0.02 0.28 0.7
Gallicacid 3.01±0.05 0.51 1.54
Cyanidin 4.42±0.12 0.01 0.04
Malvidin-3-glucoside 1.78±0.02 0.05 0.09
Rutin 2.42±0.12 0.01 0.02
Quercetin 4.72±0.10 0.02 0.09
Myricetin 3.72±0.28 0.03 0.09
Resveratrol 2.00±0.06 0.006 0.01
Caffeicacid 1.26±0.01 0.014 0.02
Totalcontributiontoantioxidantactivity 4.2
MeanTEACforredwines 16.7
a Expressed by comparison with Trolox as Trolox equivalent antioxidant capacity (TEAC). Note the high TAC of red wines and the large TAC ‘missing’
(16.7minus4.2).
DatabycourtesyofProfessorC.Rice-Evans(alsoseeFreeRadic.Biol.Med.20,933,1996).

--- Page 408 ---

MEASUREMENT OF REACTIVE SPECIES 353
Anotherproblemisthatbodyfluids,plantextracts, parallel in cells subjected to severe oxidative stress
and food contain a complex mixture of components (e.g.arisingfromadministrationofCCl ;Section9.2).
4
that react with radicals at different rates. Hence the Whyistherelittleornocorrelationbetweenlevelsof
timeoverwhichtheassayisconductedcaninfluence biomarkers in healthy tissues? For example, no cor-
theresults.Forexample,reactionofascorbateortrolox relationwasobservedbetweenlevelsofplasmaIsoPs
with ABTS•+ is complete within 1 to 2 min, but reac- andwhitecelloxidativeDNAdamageinhealthyhu-
tionofsoysaucewithitcontinuedforover50min.257 mansubjects.27Levelsof8OHGandotherbasedamage
Hence, assays that are allowed to run to completion products in DNA are a balance between the rate of
(e.g. ORAC) give different results from those run for oxidative DNA damage and the rate of DNA repair,
afixedtime(asABTSoftenis)orwherealagperiodis differentlesionsbeingremovedatdifferentrates(Fig.
measured. 5.15).IsoPs,onceformed,arehydrolysedfromlipids;
oncefree,theyaremetabolizedquickly.Oxidizedpro-
6.18 Isthereasinglebiomarkerof teinsaredegraded,oftenbytheproteasomesystem,or
oxidativestressoroxidativedamage?2,3 by autophagy, and appear to turn over more slowly.
Thus,evenifallbiomoleculesaredamaged,theextents
No, although (as might be expected) biomarkers andtimecoursesofchangeinthelevelsofbiomarkers
of damage to different molecules frequently rise in ofsuchdamagearelikelytobedifferent.

--- Page 409 ---

CHAPTER 7
Reactive species can pose special
problems needing special solutions:
some examples
It’sthefreeradicals,stupid!
ShinoNemotoandTorenFinkel
7.1 Introduction dietary lipids; e.g., a range of aldehydes can arise
from peroxidized cooking oils. Cooked foods of ani-
In Chapters 1 to 5 we described the problems faced
mal origin also contains F -isoprostanes (F -IsoPs),
by aerobes in coping with O , and the various ways 2 2
2 lipid hydroperoxides, oxidation products of choles-
in which they counter and repair oxidative damage.
terol (COPs), proteins and DNA, and Maillard com-
We have also seen a few ‘special cases’. For ex-
pounds (Sections 5.12.4 and 10.5.5). Oxidation prod-
ample,theswim-bladdersofsomedeep-seafish(Sec-
uctsofplantlipids(phytoprostanesandphytosterols;
tion1.5.2.3)musttoleratehighO partialpressures(the
2 Sections5.12.4and7.7)canalsobeingested.Wemay
effective O concentration at a depth of 3000 metres
2 consume millimoles of these various oxidation prod-
is 2500 times greater than ambient) yet the bladder
ucts per day.3 In addition, peroxidation can occur
remains undamaged. The fish as a whole cannot tol-
in the stomach, haem proteins being good catalysts.4
erate this pO , and so the bladder must be specially
2 Haem is fairly well absorbed (Section 3.22), but if
protected. How? We don’t know. Perhaps the blad-
a lot is consumed some can reach the colon and
der tissue has low metabolic activity and generates
exert pro-oxidant and pro-proliferative effects, and
few ROS; it does not seem to be especially enriched
may raise the risk of colon cancer (Section 10.14.3).
in antioxidant defences, in as far as they have been
Indeed, rats and humans fed a haem-rich diet ex-
studied.1
creted more 1,4-dihydroxynonane mercapturic acid,
In the present chapter we discuss several other
a biomarker of lipid peroxidation (Section 6.15.7), in
systems that have difficult problems of antioxidant
urine.5
defence.
The systemic toxicity of dietary lipid and protein
oxidation products seems fairly low (Section 5.12),
7.2 Thegastrointestinaltract2 probably because most are dealt with in the GI tract
anddonotentertheblood.3Nevertheless,sometrans-
7.2.1 Thethreatsitfaces
ferofaldehydes,lipidperoxides,andCOPsfromthe
The GI tract must absorb nutrients, and keep bac- GI tract to the circulation occurs (e.g. from cooked
teriaandbacterialproducts(e.g.endotoxin)outofthe meatsandfish;Section6.15.8.4).3,4,6However,thecells
body,byacombinationofbarrierandimmunological lining the GI tract will be exposed to the full force
defences. Damage to the GI tract, e.g. by ischaemia, of these agents. For example, chronic dietary expos-
can be life-threatening (Section 10.6.3). The GI tract uretooxidizedlipidsdecreasedmucosalcellturnover
must also cope with whatever we choose to eat and in rat small intestine, whereas lower levels might be
drink, including carcinogens, and pro-oxidants such pro-proliferative.3 DNA–aldehyde adducts are found
as ethanol (Section 9.8.1) and oxidation products in inhumancolonicmucosa(Section5.12.5).
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 410 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 355
Other sources of RS to which the mouth, oeso- 7.2.2 Defencesystems
phagus,andstomachareexposedinclude:
Food with a high content of oxidized biomolecules,
especially lipids, tastes rancid, and we reject it. The
1. Mixturesofironandascorbatefromfoodorsupple-
GI tract is lined by mucus, which in the colon helps
mentscancatalyselipidoxidationandpromoteOH•
to regulate the bacterial flora, but is also a powerful
generation,especiallyinthestomach.Diet-derived scavenger of RS such as OH• (Section 7.3; Table 3.7).
copper ions could also generate OH• and other
Indeed,itbecomesoxidativelydamagedafterhaemor-
RS from ascorbate. Indeed, gastric juice has high
rhagicshock,asithelpstoabsorbRS(Section10.6.2).
levels of ascorbate, to aid iron absorption (Section
The colonic contents are usually said to be anaerobic
3.22.1).
(although,ofcourse,thecellsofthecolonarenot).This
2. Nitrite in saliva and foods can be converted
may be fortunate, since exposure of faeces to air can
to HNO 2 by gastric acid, forming nitrosating causesubstantialOH•generation,probablyduetobac-
and DNA-deaminating species (Sections 2.5.6 and
terial H O production interacting with unabsorbed
2 2
10.15.3). transitionmetalions,12 especiallyiron.LevelsofOH•
3. High(>100μM)levelsofH O incertainbeverages,
2 2 productionwereincreasedbyfeedingvolunteersiron
especiallycoffee(Section2.6.2).Hydrogenperoxide
supplementsordietsrichinfatandlowinfibre.How-
isalsogeneratedbyoralbacteria(Section1.10.9).
ever, O at low and variable levels probably occurs
2
4. The presence in the diet of highly oxidizable pro-
frequently in the colon in vivo. Consistent with this,
oxidant phenolic compounds, such as hydroxyhy-
hydroxylatedPBNandD-phenylalanine,asbiomark-
droquinone(Section2.6.2).Sometimespro-oxidants ersforOH• formation(Section6.3.1.1),weredetected
are deliberately added to food, e.g. sulphite is
in the faeces of rats whose intestines were colonized
widelyusedasapreservativebutitcanbeoxidized withEnterococcusfaecalis,13 afacultativeanaerobethat
by transition metal ions and the NADPH oxidase
producesO
•–whenexposedtoO
.
system of intestinal lymphocytes7 to generate RS 2 2
Like all animal tissues, the cells of the GI tract
(Section9.12.3).
contain DNA repair enzymes, proteasomes that can
5. The intestine contains part of the immune system
remove oxidized proteins, methionine sulphoxide re-
and its resident phagocytes can respond to chal-
ductases, SODs, catalase, peroxiredoxins, GST and
lenge with antigens in food or bacteria to prod-
GPx, both GPx1 and the ‘intestinal form’, GPx2
uceRS.7
(Section3.14) being predominant, although some
6. OthercellsoftheGItractcanalsoreleaseRS.Forex-
GPx4 is also present in human small intestine and
ample,aO • 2 –-producingNADPHoxidasesystemis colon.3SomeoftheSODandtheGPx(GPx3)activities
foundincolonicepithelium(Section8.10.1).Asimi-
ofthesmallintestineandcolonappeartobelocatedat
larsystem,DUOX2,isfoundinsalivaryglandsand
theexternalcellsurface, possibly tohelp detoxifyRS
perhapsthroughouttheGItract,withsomespecies
from the food before they can enter the cell. In add-
differences in levels.8 These systems seem to exert
ition, the GPx enzymes within the GI tract cells may
antibacterial actions; adult Drosophila or zebrafish
removemostoftheperoxidespresentinabsorbedlip-
without active DUOX in the gut were more
idsbeforetheyentertheblood.Thegutisalsorichin
prone to die from infections after eating microbe-
GSTs, which can metabolize peroxides and cytotoxic
contaminatedfood,8andmicelackingactiveDUOX
aldehydes.Severaldietaryconstituents,includingsul-
enzymes were more susceptible to infection of the
phoraphane(Table4.5),canincreasethelevelsofGSTs,
stomach by Helicobacter.9 The O •–/H O produced
2 2 2 GPx2andotherantioxidantdefencesintheGItractvia
byNOX/DUOXsystemscouldactdirectlyagainst
theNrf2system(Section5.5.8).
unwanted bacteria (Section 8.10.1) and/or by sup-
plying H O to peroxidases, such as lactoperoxi-
2 2
7.2.2.1 Saliva
dase in saliva (Section 3.19). However, they also
have the potential to cause damage to the gut it- Salivacontainsperoxidaseactivity(Section3.19.2)and
self if generated in excess. There is a complex and H O addedtoitrapidlydisappears,probablybythe
2 2
poorly understood relationship between intestinal action of both peroxidases and catalase. Production
ROSgenerationandthepreservationofthenormal of thiocyanate oxidation products by salivary perox-
gutflora(Section8.10.1);10,11ROSseemtohelpcon- idase may be an important antibacterial mechanism
trolhuman–bacterialinteractionsintheGItract,just (Section3.19.2).Catalaseisliberatedintosalivaasthe
astheydoinplantrootnodules(Section7.8.11). buccal cells lining the oral cavity turn over and are

--- Page 411 ---

356 FREE RADICALS IN BIOLOGY AND MEDICINE
shed. The total antioxidant capacity (TAC) of saliva antioxidantsaredeliveredtotheGItract.Thestomach
(Section6.17.3)islowerthanthatofplasma;ascorbate probablyencountersthehighestlevels,buttherewill
levels are <10 μM and the major antioxidant present be substantial exposure of the small intestine, and
(as detected by TAC assays, that is) is urate.14 The manyflavonoidsandcarotenoidspassintothecolon.
TAC of saliva varies depending on which of the sal- HencescavengingofRSwithintheGItractisfeasible.
ivaryglandsitcamefrom.14Urateinswallowedsaliva Forexample,consumptionofredmeatbyratsorhu-
mayscavengesomeRNSinthestomach,butofcourse mans increased urinary or plasma malondialdehyde
salivaryNO–contributestoRNSformation.15 (MDA) levels (Section 6.15.8.4), but co-consumption
2
ofpolyphenol-richbeverages(redwineorcoffee)de-
creased these levels.4,17 As another example, nitrite
7.2.2.2 Antioxidantsfromdiet?2,4,16
from saliva and food forms nitrosating and DNA-
Foods and beverages deliver not only pro-oxidants, deaminatingspecies,butdamagebytheseinvitroisin-
but also a complex mixture of antioxidants to the GI hibitedbyflavonoidsatlevelssimilartothosethatcan
tract. Some of these are absorbed well, others not occurinthegastricjuice(Section10.15.3).18 Ascorbate
so well, but even the unabsorbed ones might exert may also offer some protection (Section 10.15.3). Un-
extracellular antioxidant protective effects in the GI absorbeddietaryironandhaementerthefaeces,where
tract. For example, flavonoids and some other phen- phyticacid(Section3.22.1)andphenolics,bychelating
olics are powerful scavengers of RS and inhibit lipid iron and scavenging RS (in the case of the phenols),
oxidation by haem proteins,4 but many in vitro stud- might help to alleviate pro-oxidant actions (Fig. 7.1).
iesshowingthishaveemployedconcentrationsmuch Flavonoidlevelsinhumanfaecalwatercanbeupto1
higher than are ever achieved in plasma or body tis- μM,andmuchhigherconcentrationsofmonophenols
sues (Section 4.5). A similar caveat applies about the (e.g.>100μMcaffeicacid)arepresent,mostlyproducts
physiological relevance of the ability of carotenoids ofbacterialdegradationofpolyphenols,butsomealso
to scavenge RS in vitro (Section 4.4). However, when fromdiet.16Asaninterestingcontrast,caterpillarsmay
foods or beverages rich in phenolics and/or caroten- ingest so many phenols that they oxidize in the gut,
oids are consumed, high (millimolar) levels of these catalysed by iron ions in the gut contents, and cause
SMALL
STOMACH COLON/RECTUM
INTESTINE
Duodenum Ileum Jejenum
High concentration of ascorbate in Vitamin C completely absorbeda Little vitamin C presenta
food and gastric juice
Carotenoids, tocopherols, tocotrienols, Vitamin E largely absorbeda,b Limited α–tocopherol presenta,b
flavonoids, other phenolics in food (if Some tocotrienols and β,γ,δ–tocopherols
Considerable amounts of unabsorbed
fruit/vegetable/grain–rich diets returned to GI tract in bile.
flavonoids, other phenolics, carotenoids,
consumed) can scavenge
tocotrienols, β,γ,δ–tocopherols (if diet
RNS from acidified nitrite rich in these compounds).
·
OH from reactions of Cu/Fe ions Some carotenoids cleaved to vitamin A Extensive metabolism of polyphenols by
with HO (e.g. in consumed colonic flora to generate simpler phenols
bevera 2 ge 2 sc) aided by ascorbate
Some carotenoids, flavonoids and other Scavenging/metal binding/other actions of
RO and RO 2 from dietary lipid phenolic compounds absorbed, but many phenols might exert external
peroxides or peroxidation in the are not protective effects on colonic/rectal
stomach epithelium. Oxidation products can activate
Some phenolics bind Fe2+ or Cu2+, the Nrf2 system.
to decrease their ability to generate
Inhibitions of LOX, COX–2, angiogenesis,
RS
lipid peroxidation, matrix metalloproteinases
Ferryl species from haem etc. by phenols (Section 4.5 )might also be
protein/peroxide interactions protective
Figure7.1 DietaryantioxidantsandtheGItract.aExceptwhensupplementsaretaken.Thisdiagramreferstonormaldietaryintake.bThereis
considerableintersubjectvariabilityintheefficiencyofGIuptakeofvitaminE(Section4.3).cMuchH2O2mayberemovedintheoralcavityby
saliva,andbyitsdiffusionintothebuccalandoesophagealepitheliumforrapidcatabolism.

--- Page 412 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 357
H O Ascorbate GSSG NADPH
2 2
1 2 3
H O Dehydro- GSH NADP+
2 ascorbate
Figure7.2 Theascorbate–glutathionecycleinchloroplasts.Enzymesinvolved:1,ascorbateperoxidase;2,dehydroascorbatereductase(reaction
2canalsooccurnon-enzymicallyathighpH—thepHofthestromaduringphotosynthesismayrisetoashighas8,duetoformationoftheproton
gradient);3,glutathionereductase.Thefirstproductofoxidationofascorbatebyascorbateperoxidaseissemidehydroascorbate(SDA);twoSDA
radicalscanundergodisproportionationtoformascorbateanddehydroascorbate.NAD(P)H-dependentandferredoxin-dependentmechanismsfor
reducingSDAalsoexistinchloroplasts(J.Exp.Bot.64,433,2013).Indeedmonodehydroascorbatereductases,FAD-containingenzymes,are
theonlytypeofenzymeknowntouseanorganicfreeradicalasasubstrate.TheypreferNADHtoNADPHasasourceofelectrons.Thecycleshown
abovehasbeencalledtheFoyer–Halliwell–Asadacycle,afterthenamesofthetwoscientistswhofirstproposeditandthethirdwhodidmuchto
establishevidenceforitsoccurrence.However,thisnamedoesnotrecognizethecontributionofGrodenandBeck,whodiscoveredascorbate
peroxidaseinchloroplasts.Thecyclealsooperatesinplantmitochondria(J.Biol.Chem.278,46869,2003),therootnodulesofleguminousplants
(Section7.8.11),andtheintestinesofsomeinsects(Section7.2.2.2).
damage.Someinsectsdealwiththisbysecretinghigh 7.3 Therespiratorytract
levels of ascorbate and GSH into the gut lumen and
7.3.1 Thechallenges
operating an ascorbate–glutathione cycle19 similar to
thatinplants(Fig.7.2). Thenasalpassages,trachea,bronchi,bronchioles,and
Of course, scavenging of various RS can generate alveoli are exposed to the full force of O in inhaled
2
oxidized, chlorinated, nitrosylated, or nitrated prod- air, unlike most body tissues (Fig. 1.4), yet alveolar
ucts from the polyphenols and certain other antioxi- type I cells are easily injured by too much O (Sec-
2
dants,productsthatcouldthemselveshavebiological tion1.5.2),whichcausesoxidativedamagetomultiple
effects, an area which is under-explored to date. Ni- biomolecules (e.g. Fig. 6.18), especially cardiolipin.21
trite and nitrate in the colon can be used as electron Asinothertissues,lipidoxidationproductsinlungcan
acceptorsbycertainbacteriasuchasE.coli,eventually bedeleteriousorbeneficial,dependingontheproduct
formingNO•andN 2 O.20 and its level (Section 5.12). Over an average human
The potential useful roles of ascorbate and vita- lifespan, about 3 × 108 litres of air (6 × 107 litres of
minEintheGItractmustnotbeoverlooked(Fig.7.1). O !) are breathed. The highest O levels exist in the
2 2
AscorbatecanscavengeRSanddecreasegastricnitro- upperrespiratorytract,andlevelsdecreasedeeperin
samine formation. After tocopherols and tocotrienols thelungasO isabsorbed.Therespiratorytractmust
2
are absorbed from the GI tract, α-tocopherol is pref- alsotoleratetoxicgasesintheinhaledair(Section9.12).
erentially selected by the liver for incorporation into Smokersinsulttheirownrespiratorytractsandthose
plasma lipoproteins, and some of the other tocoph- of the people around them with a complex mixture
erolsareexcretedinbileandreturnedtotheGItract of toxins (Section 9.13). The air is full of bacteria,
(Section4.3.6).Hence,highconcentrationsofδ-andγ-
viruses,fungalspores,plantpollen,andotherpartic-
tocopherolsandtocotrienolsarefoundinfaecalmatter ulates,someofwhicharedirectlyoxidizing(e.g.PM
10
ascomparedwithplasmalevels;16theymightbetaken andPM ;Section9.14)and/orcanprovokealveolar
2.5
up by colonic cells as well as exerting extracellular macrophages to release RS, and promote the recruit-
protective effects, e.g. γ-tocopherol scavenging RNS mentofneutrophilsandeosinophilstothelung,releas-
(Section4.3.7). ingfurtherRS(includingO •–,H O ,HOCl,andHOBr).
2 2 2
Protective effects of phenols, carotenoids etc. to Allergens/irritantsinpollencanincludenitratedpro-
the GI tract need not only be antioxidant; other teins (Section 9.12.2), phytoprostanes (Section 7.7),
mechanisms might be equally or more important and O •–/H O -producing NADPH oxidases.22 Over-
2 2 2
(Fig. 7.1). However, supplements of β-carotene, as- activation of eosinophils contributes to airway dam-
corbate, and α-tocopherol do not protect against the age in asthma, which is essentially a chronic inflam-
development of human GI cancers in well-nourished matory disease of the airways.23 Indeed, lung tissue
people(Section4.6). from patients with asthma shows increased levels of

--- Page 413 ---

358 FREE RADICALS IN BIOLOGY AND MEDICINE
bromotyrosine and possibly chlorotyrosine.24 Asth- sometimesdampeninflammationratherthanpromote
matic patients exhale more NO• (probably due to it(Section8.9).34
increasedlevelsofiNOS),showincreasedlevelsofpro- The fluids lining the respiratory tract contain mo-
teinnitrationinlungliningfluids(catalasebeingoneof lecules essential to lung function. Excessive elastase
thenitratedenzymes;itisalsochlorinatedandsuffers activitycanerodeelasticfibresandinterferewithlung
oxidationof–SHgroups,allreactionswhichinhibitits expansionandcontraction,leadingtoemphysema.Yet
activity),25 and lower GSH levels in respiratory tract theα -antiproteinase(Section2.6.3)inlungliningflu-
1
lining fluids (in some studies). They also have more idsthatnormallyinhibitselastaseisreadilyinactivated
H O intheirbreathcondensate,26 andproducemore by ONOO– and HOCl. Thesurfactant that maintains
2 2
F -IsoPs(levelsinbreathcondensate,plasma,andur- alveolar function (Section 1.5.2) can also be a target
2
ineareelevated).23Aswellasbeingbiomarkersofoxi- of oxidative damage, losing its ability to lower sur-
dativestress,certainIsoPsmaydirectlyaffectairway facetension.Thelipidcomponentofsurfactant(mainly
smooth muscle, contributing to the airway remodel- the saturated lipid dipalmitoylphosphatidylcholine)
ling that occurs as asthma develops.23 The oxidative isfairlyresistanttoROS,buttheproteinspresentcan
stress in asthma may also involve increased activity bedamaged35,36 byHOClandONOO–.Indeed,nitra-
of NADPH oxidases, especially NOX4.27 Indeed, the tionofsurfactantproteinsisobservedinratsexposed
airways of mice overexpressing CuZnSOD are less to hyperoxia.35 In spite of the presence of some iron-
sensitive to allergens (Box 3.1), and SOD levels are binding proteins (Section 7.3.2), low levels of ‘labile
reported to be lower in the asthmatic lung.28,29 Para- iron’,measuredbytheaconitaseassay(Section5.3.3.1),
doxically,however,CuZnSODinpollencansometimes have been detected in alveolar lining fluids.37 The
actasanallergen.30 role (if any) of this iron is uncertain: it might be a
ThereisaconstantproductionofNO•inthehealthy methodofcontrollinglungcellironlevelsbyexcreting
respiratory tract, due to constitutive expression of it (probably via ferroportin; Section 3.22.1) for even-
iNOSintheepithelium,probablyasadefencemech- tualclearancefromtherespiratorytractinthemucus.
anism against pathogens.31 In addition, fibroblasts, However,this‘free’ironcouldalsobepro-oxidant.
pulmonaryendothelial,andsmoothmusclecellscon-
tain NADPH oxidases (mostly the NOX4 type; Sec-
7.3.2 Defendingtherespiratorytract
tion8.10).DUOXenzymes(Section8.10)arealsopre-
sentinairwayandalveolarepithelialcells,andlevels The cells of the respiratory system have the usual
mayincreaseaftercytokinetreatment.Theseenzymes intracellular antioxidant defence and repair systems,
may normally function to help to regulate pulmon- including CuZnSOD, MnSOD, GPxs, catalase, perox-
aryvesseltone,stemcellfunction(Section3.4.2),and iredoxins (Prx6 [Section 3.13] seems especially im-
to aid defence of the respiratory tract, e.g. by pro- portant),ascorbate,methioninesulphoxidereductases,
viding H
2
O
2
for lactoperoxidase (Section 3.19.2) and GSH,andα-tocopherol.Nrf2playsanimportantrole
stimulatingmucussecretionorcytokineproductionby in regulating antioxidant defences in the respiratory
ROS-dependent mechanisms (Sections 9.6 and 9.13.3; tract.38Inspiteofthesedefences,evenasmallriseinO
2
Table3.7).27,32However,excessiveO • 2 –productionmay levelscancauseoxidativestress;merelybreathing28%
contribute to asthma by scavenging this NO• and O (7%abovenormal)for1h(avaluetoolowtocause
2
forming ONOO–, and possibly by leading to abnor- clinicalsymptoms)increasedtheamountsofIsoPsin
mal contractility of airway smooth muscle as well exhaledair.39
as proliferation of airway smooth muscle cells (Sec- There are also extracellular antioxidant defences.
tion 5.2.1).27 Indeed, protein nitration (including ni- Theupperrespiratorytractiscoatedwithaconstantly
tration of catalase, as mentioned above, but also of renewed mucus layer, which helps to trap bacteria,
MnSOD) is increased in asthma.29 H 2 O 2 is normally particulates, and iron ions, and remove them as the
present in breath condensate (Section 6.15.9) and a mucusispropelledupwardsbythebeatingofcilia.40
significant part originates from NADPH oxidases.26 The major component of mucus is a proteoglycan
NADPHoxidaseandDUOXenzymesmayalsobein- (‘mucin’); a protein core with many carbohydrate
volved in pulmonary O 2 toxicity (e.g. see Fig. 8.16). side-chains attached. It has a high content of cyst-
Of course, never assume that ROS are always bad; eine and disulphide bridges, which contribute to its
nitrosothiols formed by reaction of ONOO– with viscosity.Themucuslayeralsocontainsmaterials(lip-
GSH may be protective to the lung,33 and products ids, carbohydrates, proteins, DNA) originating from
of NADPH oxidase activation, such as H 2 O 2 , can death and lysis of underlying epithelial cells during

--- Page 414 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 359
their normal turnover. Hence, as a whole, the mu- severaltransporters,includingthecysticfibrosistrans-
cus layer is a powerful scavenger of OH•, ONOOH, membraneconductanceregulator(CFTR)protein(Sec-
and HOCl, and may also absorb40 some O and NO • tion 10.9).41 GSH is a powerful scavenger of several
3 2
(see also Table 3.7). Stimuli that promote mucus se- reactive species, including ONOO– and HOCl (Sec-
cretion often act by increasing ROS production (Sec- tion 3.10.1). One product of its reaction with HOCl,
tions9.6and9.13.3). glutathione sulphonamide (Section 6.16.4), has been
Levels of antioxidants in respiratory tract lining measured in tracheal aspirates of premature babies
fluids differ from those in blood plasma and vary (Section7.11.8.2).42 GSHturnsoverrapidly,beingde-
between species (e.g. rat has higher ascorbate levels gradedbyγ-glutamyltransferases(GGT)andthecyst-
than humans). Tables 7.1 and 7.2 show some values eine absorbed by the underlying cells to make more
for humans. The most striking feature is that GSH GSH,someofwhichisexported.Indeed,administra-
levels are much higher than in plasma; GSH secre- tion of the GGT inhibitor acivicin (Section 3.10.3) to
tionintothefluidsfromtheunderlyingcellsinvolves miceincreasesGSHlevelsintherespiratorytractlin-
ing fluids.43 Urate and albumin levels in human re-
spiratorytractliningfluidsarelowerthaninplasma,
Table7.1 Approximate values for the concentrations of non- and ascorbate about the same. Ascorbate and GSH
enzymaticantioxidantsinhumanplasmaandlungliningfluid. canhelptoprotectα 1 -antiproteinaseagainstinactiva-
tion by HOCl and ONOOH; mice lacking ascorbate
Antioxidant Concentration(μM) hadlowerlungcollagenlevelsandrapidlydeveloped
emphysema.44
Plasma Liningfluid
Antioxidant defence enzymes (including EC-SOD)
Ascorbate 20–100 40–100 are present in respiratory tract lining fluids at low
GSH <5 40–200 levels, and mice lacking EC-SOD are more sensitive
to hyperoxia (Section 3.23.3.2). However, lung injury
Urate 160–450 90–250
byO orothertoxicgasescanallowleakageofplasma
α-Tocopherol 25 2.5 2
constituents into the lining fluid, replenishing ascor-
β-Carotene 0.4 Trace bate, urate, and α-tocopherol, and raising levels of
Albumin–SH 500 70 albumin,perhapsthusaugmentingextracellularanti-
oxidantdefences,sincealbuminhasantioxidantprop-
Valuesareapproximatebecauselungliningfluidissampledbywashingoutthe erties (Section 3.23.3.5). Hence albumin transudation,
lung(bronchoalveolarlavage).Thiscausesconsiderableandvariabledilu-
often used as a marker of lung injury (e.g. as meas-
tions,andthecalculationsusedtoobtainvaluesforthe‘undiluted’fluidinvivo
makeseveralassumptionsandapproximations.Otherantioxidantsinlunglin- urements of raised albumin levels in lung lavage
ingfluidsincludelowlevelsoftransferrin,caeruloplasmin,lactoferrin,EC–SOD, fluid after pollutant exposure) may in some ways be
catalase,andextracellularGPx.Antioxidantlevelsdifferindifferentpartsofthe beneficial40
respiratorytract,e.g.alveolarliningfluidhasmoreGSHthanfluidliningtheup-
perrespiratorytract(Table7.2).
DataabstractedfromEnviron.HealthPerspect.106(Suppl.5),1246,1998,by 7.3.3 Asthmaandantioxidants
courtesyofProfessorCarrollCrossandthepublishers.
Epidemiological studies show that the incidence and
Table7.2 Approximate concentrations of some antioxidants in severity of asthma correlate with low levels of
humannasalliningfluidcomparedwithlungliningfluids. plasmaantioxidants,thedatabeingespeciallyclearfor
ascorbate.45 Doesthechronicinflammationofasthma
Antioxidant Concentration(μM)
useupantioxidants,orisalowintakeapredisposing
factor? If it is, is the benefit really due to the anti-
Nasalliningfluid Lungliningfluid
oxidants and/or to other constituents of antioxidant-
Ascorbicacid 2–20 40–100 richfoods?Woulddietaryantioxidantsupplementsor
Urate 20–250 90–250 agents that increase GSH levels45,46 help? In spite of
the many papers published in this area, the answers
Glutathione 0–15 40–200
tothesequestionsareasyetunclear.Oftentwoissues
Albumin–SH 10 70
aremixedtogether:theasthmaitselfandtheaggravat-
ingeffectsofairpollutantssuchasO onitssymptoms.
DataabstractedfromEnviron.HealthPerspect.106(Suppl.5),1246,1998, 3
by courtesy of Professor Carroll Cross and the publishers. The values are Thusitispossiblethatantioxidantsupplementsmight
approximate,forthereasonsgiveninthelegendtoTable7.1. modulatethelatterbutnottheformer.47

--- Page 415 ---

360 FREE RADICALS IN BIOLOGY AND MEDICINE
Human intervention studies generally suggest that 1. AconstantfluxofO
•–fromoxyhaemoglobin.About
2
supplementationwithantioxidantsconfersminimal,if 3–4% of oxyhaemoglobin is estimated to undergo
any, clinical benefit in adults with asthma, although oxidation every day.51 Complete oxidation should
dietsrichinfruitsandvegetablesmayhavebenefit.48 thus occur in 33–34 days and the cell would be
It has even been suggested that antioxidants might unabletocarryO .OxidationisacceleratedbyNO–
2 2
possiblyadverselyinfluencethedevelopmentofchild- (Section2.5.6).
hoodasthmaandatopicsensitizationbyaffectingthe 2. Carryinghighconcentrationsofapro-oxidanthaem
firstinteractionsbetweentheneonatalimmunesystem protein (Section 3.22.3) and its attached O inside
2
andallergens.Somestudieshavereportedpotentially amembranerichinPUFAside-chains.Erythrocyte
beneficial associations between intake of certain anti- membranes are about 44% lipid and 49% protein;
oxidantsandchildhoodasthma,andafewothers,the the rest is carbohydrate. Pro-oxidant reactions of
opposite. However, the exact nature of the relation- haemoglobin, as well as its ability to bind NO•,
ships and the potential for therapeutic intervention have caused side-effects in the clinical testing of
remainunclear.Inanycase,wedonotknowtowhat cross-linkedhaemoglobinsas‘bloodsubstitutes’.52
extent antioxidant concentrations in the respiratory 3. Erythrocyte cytoplasm may contain low molecu-
tractliningfluidsincreasewithdietaryintake:forex- lar mass ‘catalytic’ iron in amounts increasing
amplethecorrelationofascorbatelevelsinthesefluids with age,53 presumably arising from haemoglobin
withplasmaascorbatelevelsispoor.49,50 breakdown.
4. Repeated deformation and consequent physical
stress upon red cell membranes as these cells
7.4 Erythrocytes
squeeze through tiny capillaries at 37 ◦C. Deform-
Red blood cells (also known as erythrocytes) are bi- ation can aggravate the effects of any lipid per-
concave discs averaging about 7.7 μm in diameter. oxidation in causing leakage of ions across the
In humans, they lack a nucleus, mitochondria, and membrane.54
otherorganelles.Theiraveragelifespaninthehuman 5. No ability to synthesize new proteins (e.g. ferritin
bloodstreamisaround120daysandabout200billion tosequesteriron)orlipidstoreplaceoxidizedones.
new ones are produced per day. Each travels about Lacking mitochondria, red blood cells rely on gly-
400kmduringitslifespan. colysistomakeATP,whichisconsumedmostlyin
Erythrocyte cytoplasm is rich in protein, of which iontransport(especiallyNa+,K+-ATPase)andGSH
about33%ishaemoglobin(upto280millionmolecules synthesis. Of course, with no mitochondria, red
pererythrocyte).Hence,thethiolgroupsonthehaemo- bloodcellsdon’thavetoworryaboutmitochondrial
globinbetachains(β-93)areasignificantcontributorto O •–/H O production!
2 2 2
thetotal‘thiolpool’oferythrocytecytoplasm,almost
equaltothatofGSH.Adultmaleshave14to16.5gof
7.4.2 Solutions:antioxidantdefenceenzymes
haemoglobin per 100 ml of blood, and females 12 to
15g/100ml. ErythrocytescontainalotofCuZnSOD;indeed,thebo-
Astheerythrocytepassesthroughthelungcapillar- vineerythrocyteenzymewasthefirstCuZnSODtobe
ies,thefourhaemgroupsofhaemoglobinbindO
2
.The purified(Section3.5.1).ThisSODhasbeenestimated55
haemironindeoxyhaemoglobinisintheFe2+state,but tokeepintra-erythrocyteO •–levelsataround10–13M.
2
whenO 2 attaches,thereissomeelectrondelocalization NoMnSODispresent(nomitochondria).Micelacking
(Sections 1.3.1 and 1.10.3). Every so often a molecule CuZnSODshowavarietyofsymptoms(Section3.7.2),
ofoxyhaemoglobinreleasesO
•–,awatermoleculeora
including accelerated ageing of red blood cells and
2
hydroxylionreplacingtheO
2
, somedegreeofanaemia.56
haem–Fe2+–O → O •– + haem–Fe(III) TheCuZnSODconvertsO • 2 –toH 2 O 2 ,someofwhich
2 2 can be removed by catalase and GPx1 (Fig. 7.3), the
The Fe(III) product, methaemoglobin, cannot bind only GPx present. The relative importance of these
oxygen. twoenzymesincatabolizingH O mayvarybetween
2 2
species; the conventional view for years, although
periodically challenged, was that GPx1 is more im-
7.4.1 Whatproblemsdoerythrocytesface?
portantatlow(physiological)fluxesofH O ,whereas
2 2
Erythrocytes must keep their membranes intact for catalase, with its higher K for H O , becomes im-
m 2 2
longperiodsinthefaceof: portantathigherH O levels(Section3.20.2).Indeed,
2 2

--- Page 416 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 361
Oxyhaemoglobin
1/2 O + H O
O 2 CAT 2 2
SOD Peroxiredoxins
Haemoglobin Superoxide H 2 O 2 H 2 O
MR GSH
Methaemoglobin GPx H O
2
GR
NADH
NAD+
NADP+
(via thioredoxin and
(NADPH) (NADP+) GSSG thioredoxin reductase)
PPP
NADPH
Figure7.3 Protectionoferythrocytesagainstoxidativedamage.MR,methaemoglobinreductases;SOD,CuZnsuperoxidedismutase;CAT,
catalase;GPx,glutathioneperoxidase;GR,glutathionereductase;PPP,pentosephosphatepathway(firstenzyme:glucose6-phosphate
dehydrogenase).PeroxiredoxinsarethemajorpathwayofH2O2removal,andtheiractivityrequiresthioredoxinandthioredoxinreductaseinthe
erythrocyte.
erythrocytes can act as sinks for extracellular H O scavenge ONOO– (Section 3.13.2.1). However, perox-
2 2
andO
•–
generatedintheblood,i.e.theyare‘antioxi- iredoxinmaybeoverwhelmedifredcellsareexposed
2
dants’forthebloodasawhole(Table3.7).Superoxide to high levels of external H O ; GPx1 and catalase
2 2
crosses their membranes easily because the erythro- then becoming more important.59 The redox state of
cytehasananionchannelthroughwhichitcanmove. erythrocyteperoxiredoxinshasbeenreportedtovary
Thischannel(band3protein)isinvolvedinbothan- on a circadian cycle (Section 3.13.2.3), but the signifi-
choring the cytoskeleton to the membrane and as an canceofthisisuncertain.
iontransporter.ItnormallyexchangesHCO – forCl–, The NADPH needed for glutathione and thiore-
3
butO •– canalsopassthroughit,ascanNO–.Indeed, doxinreductasesisprovidedbythepentosephosphate
2 2
similar anion exchange proteins are found in sev- pathway (Section 3.10.2.1), which also supplies
eral tissues, including lung.57 Even ONOO– can get NADPH for a methaemoglobin reductase enzyme
through red blood cell membranes, probably via the that converts methaemoglobin to ferrous haemoglo-
sameprotein.58Onceinside,ONOO–/ONOOHcanre- bin,topermitcontinuedO transport.However,most
2
act with erythrocyte GSH and with oxyhaemoglobin, methaemoglobin reductase activity in erythrocytes
yieldingNO–,methaemoglobin,someH O (probably is NADH-dependent, using an enzyme system con-
3 2 2
viaO
•–dismutation),andsomeferrylhaemoglobin.58
taining FAD and cytochrome b . Mutations affecting
2 5
However, the GPx/catalase debate in the past was the reductase system can cause hereditary meth-
missing a key factor, the peroxiredoxins (Section aemoglobinaemia, accompanied by mild cyanosis.
3.20.2).Erythrocyteproblemsarerarelyseeninknock- There are two types of mutation, one affecting only
out mice lacking GPx1 or catalase, or indeed in hu- the erythrocyte enzyme and the other affecting all
manacatalasaemicsubjects.Bycontrast,micelacking tissues.Inthesecondtype,neurodegenerationoccurs
peroxiredoxins gradually develop severe haemolytic in addition to erythrocyte abnormalities, one reason
anaemia, preceded and accompanied by protein oxi- beingthattheenzymeisrequiredfordesaturationand
dation, haemoglobin instability, inclusion body for- elongationoffattyacidsintissues.60,61
mation, shortened erythrocyte lifespan, anaemia, and GSHlevelsinerythrocytesdeclinewithageandthe
spleen enlargement. Hence peroxiredoxins and their cytoplasmbecomesmoreoxidized.Thiswaselegantly
companions (thioredoxin and thioredoxin reductase) demonstratedinmiceexpressingaroGFP2probe(Sec-
playanimportantrole(Fig.7.3)inbothdevelopingand tion6.11)intheirerythrocytes.62
mature erythrocytes. Indeed, Prx2 has been stated to
be the third most abundant protein (after haemoglo-
7.4.3 Solutions:diet-derivedantioxidants
bin and carbonic anhydrase) in red blood cells, with
levels of 0.24 mM or more being quoted.55,59 Other Erythrocytemembranescontainα-tocopherol.Indeed,
peroxiredoxinsarealsopresent,atlowerlevels.These anearlysignofinadequateα-tocopherolintakeisthe
variousH O -removalsystemskeepinternallevelsof increasedlysisofisolatedredbloodcells(haemolysis)
2 2
H O down to about 10–11 M. Prx enzymes can also when they are treated with millimolar (grossly
2 2

--- Page 417 ---

362 FREE RADICALS IN BIOLOGY AND MEDICINE
unphysiological) levels of H O in the presence of a andtendstoprecipitateintheerythrocyte,interfering
2 2
catalase inhibitor (azide): the peroxide stress haem- with its deformability and creating sickle-shaped
olysis test. Haemoglobin oxidation plays an import- cells (hence the name of the disease). The sickled
ant role in the haemolysis60 and the membrane lip- cells can block capillaries, causing tissue ischaemia–
ids undergo extensive peroxidation (Table 6.9) Older reperfusion (Section10.6), accompanied by increased
erythrocytes in human blood contain a higher ra- productionofROSandRNS.67 Theyhaemolyseread-
tio of α-tocopherol to arachidonic acid residues than ilyandaremarkedfordestruction,leadingtoanaemia.
do younger ones, because the lipid content of the Sickle-cell patients show elevated plasma XO activ-
membrane decreases with age, whereas α tocopherol ity, which generates O •–, leading to production of
2
remainsapproximatelyconstant.63 ONOO–, and worsens the problem.67 Levels of GSH
α-Tocopheryl radical is probably recycled to in sickle-cell erythrocytes are sub-normal and there
α-tocopherol in the membrane by cytoplasmic (or isanaccumulation68 ofascorbateoxidationproducts,
perhaps even extracellular) ascorbate. Ascorbate con- such as diketogulonate (Section 4.2). The fall in GSH
centrationsinsidehumanandmouseredcellsseemto isduetoincreasedconsumption;indeedGSHsynthe-
beapproximately60%ofplasmalevels.64TheNADH– sisratesappeartobeincreasedinredbloodcellsfrom
cytochromeb reductasecanalsorecycleα-tocopheryl adultswithsickle-celldisease.69
5
radical, in vitro at least. Dehydroascorbate (DHA) Unstable haemoglobins tend to precipitate on the
in the erythrocyte cytoplasm can be converted to erythrocytemembraneandmaygenerateferrylspecies
ascorbate by GSH-dependent dehydroascorbate re- and release haem and iron ions (Section 3.22.3), set-
ductase activity, probably due to glutaredoxin and tingthesceneforsite-specificfree-radicalreactionsthat
thioredoxin reductases (Section 4.2.2). Erythrocytes promoteGSHdepletion,lipidperoxidation,anddam-
can take up DHA from plasma (using GLUT1 trans- agetomembraneproteins,decreasing‘deformability’
porters) and convert it to ascorbate, but they appear even more.70 Mutant haemoglobins may also impose
to lack Na+-dependent vitamin C transporters which oxidative stress on red cells by autoxidizing to prod-
are lost during erythropoiesis.64,65 Erythrocytes can uce O •– faster than normal haemoglobin. Infections
2
alsoreducesomeextracellularelectronacceptors,such can initiate haemolytic crises in carriers of unstable
as ferricyanide or ferricytochrome c, by the action of haemoglobins, possibly due to their faster oxidation
a transmembrane redox system. Electrons can come anddenaturationduringtheelevatedbodytemperat-
from NAD(P)H or from ascorbate in the erythrocyte uresinfever.71Acceleratedoxidationisalsoaproblem
cytosol. The function of this system is uncertain; one with the isolated α-or β-chains that accumulate in
suggestion is that it participates in reducing ascorbyl thalassaemic patients (Section 3.22.5.3). Indeed, there
radicalgeneratedinplasma.66 has to be careful co-ordination of α- and β-subunit
synthesis when haemoglobin is being made in red
cell precursors. An α-haemoglobin stabilizing pro-
7.4.4 Erythrocyteperoxidationinhealth
tein (AHSP) transiently holds α-subunits (which are
anddisease
morepronetooxidationthanβ-subunits),diminishes
Redcellsfromhealthysubjectsdonotreadilyundergo their reactivity with H 2 O 2 , and prevents haem loss
lipid peroxidation. In the peroxide stress haemoly- andprecipitation.KnockoutofAHSPinmiceimpairs
sis test, extensive peroxidation can be measured erythropoiesis and produces red cells with increased
(Table6.9),ascanthegenerationofoxidativelymodi- oxidationlevelsandshortenedlifespan.72
fiedandcross-linkedmembraneproteins,butthistest
7.4.4.1 Problemsinbloodtransfusion
is a physiologically-irrelevant insult. Peroxidation of
erythrocytes can also be induced in vitro by adding The management of haemorrhage by transfusion of
high levels of organic hydroperoxides, such as tert- blood or packed red cells has been a mainstay of
butyl,orlinoleicacidhydroperoxides. modern medicine for decades, but there is a grow-
Lipid peroxidation levels are increased in erythro- ingrealizationthatitdoesnotalwaysimproveclinical
cytes from patients with several diseases, includ- outcome and may sometimes have deleterious side-
ingthalassaemia(Section3.22.5.3)andsickle-cellan- effects.Onecontributingfactormaybewhathappens
aemia.67 Sickle-cell anaemia is an inherited defect whenbloodorredcellsarestoredforprolongedperi-
in which a glutamate residue at position 6 in the ods. They develop increased fragility, decreased de-
haemoglobinβ-chainsisreplacedbyvaline.Thepro- formability, and increased tendency to haemolyse on
tein still binds O , but its deoxy form is unstable storage and after transfusion into the patient. Such
2

--- Page 418 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 363
cellsseemtoscavengeNO• andNO–fasterthanfresh Drugs that trigger haemolysis in G6PDH-deficient
2
cells,73theirGSHandascorbatelevelsdrop,and‘free’ patients include the antimalarials primaquine and
ironlevelsincrease.74 Peroxiredoxinsmayalsoaggre- pamaquine (Table 7.3), involving ROS production.
gateintoformswithalesserabilitytoremoveH O .75 Indeed,theblackwaterfeverobservedinsometroops
2 2
Someofthecellsundergomorphologicalchangesand givenprophylacticantimalarialsduringWorldWarII
throw off microvesicles containing haemoglobin,73,74 was probably related to G6PDH deficiency. The term
which can rapidly scavenge NO•. In guinea pigs, co- ‘blackwater’ refers to the urinary discoloration pro-
infusionofhaptoglobin(Section3.23.3.4)wasfoundto duced by excretion of haemoglobin and its degrad-
ameliorate the effects of transfusion of ‘old’ blood.74 ationproductsreleasedfromlysederythrocytes,which
Perhapsthismightbeusefulinhumansalso,butithas probably also exerted pro-oxidant effects in vivo that
notbeentestedasfarasweknow. worsenedthedisease.52
Blood transfusion can also lead to iron over-
load in thalassaemic patients and premature babies
7.4.6 Solutions:destruction
(Section7.11.8).
Erythrocytes can degrade oxidized haemoglobin and
other abnormal proteins (e.g. H O -inactivated
2 2
7.4.5 Glucose-6-phosphatedehydrogenase CuZnSOD), apparently by the 20S proteasome.81 For
(G6PDH)deficiency70,76 haemoglobin, this ‘solution’ may be a problem if too
many iron ions are released (Section 7.4.1, point 3).
Almost400millionpeople,principallyintropicaland
An oxidized protein hydrolase enzyme that can
Mediterranean areas, have an inborn defect in the
remove damaged (oxidized, glycated) membrane
geneontheXchromosomethatencodesG6PDH,the
proteins in red blood cells has been described but
firstenzymeof thepentosephosphate pathway (Sec-
its physiological significance is unknown. It appears
tion 3.10.2.1). Indeed, G6PDH deficiency is the com-
identical to acylamino acid releasing enzyme (acyl-
monest human inborn error of metabolism. Different
peptide hydrolase), an exopeptidase that hydrolyses
mutations cause variable decreases in enzyme activ-
the peptide bond between an N-terminal acylated
ity in erythrocytes and elsewhere; rarely or never is
aminoacidandthesubsequentaminoacidresidue.82
all activity lost. Indeed, complete loss may be em-
Aprotectiveroleofthisenzymeinremovingoxidized
bryonic lethal. Often the mutations cause enzyme in-
proteinshasalsobeensuggestedinplantsandfish.82
stability, which affects erythrocytes most because of
Senescent erythrocytes are removed from the cir-
their long lifespan and inability to replace proteins.
culation and the iron in haemoglobin is recycled
SevereG6PDHdeficiencycanimpairO
•–andNO•pro-
2 (Section3.22).Asenescentcellantigen(SCA)appears
duction by phagocytes, perhaps explaining increased
on the surface of old cells, binds immunoglobulin G,
susceptibilitytoinfectionsseeninsomepatients.77Hu-
andisthenrecognizedbytheKupffercellsintheliver
mansarenotaloneinthisproblem;asanexample,the
and macrophages in the spleen, using ‘scavenger’
African black rhinoceros can suffer from G6PDH de-
receptors.62,83 In vitamin E-deficient animals, SCA
ficiency, sometimes accounting for episodic, massive
appears earlier than usual. This antigen arises by
haemolysisinzooanimals.78
damagetotheband3protein.83Damagetothisprotein
Deficiency of G6PDH can increase levels of oxida-
in other tissues (e.g. brain and lymphocytes) also
tive damage in the erythrocyte membranes, but not
generatesSCA.
usuallyenoughtocausesymptomsunlesstherateof
RSproductioninerythrocytesisincreased,ashappens
7.5 Erythrocytesastargetsfortoxins
on exposure to certain drugs and toxins (Table 7.3).
If H O production exceeds the capacity of the re-
2 2 7.5.1 Hydrazines
sidualenzymetogenerateNADPH,GSH/GSSGratios
fall and haemolysis may result, leading to anaemia Several agents cause haemolysis, including excess
and jaundice.79 African-American patients with mild NO–. Two of the most studied are phenylhy-
2
G6PDHdeficiencyhaveatendencytoworseoutcome drazine and acetylphenylhydrazine.62,84,85 Injecting
aftersevereinjury,presumablyduetoloweredability these compounds into animals leads to haemolysis,
to tolerate injury-related ROS production, and it has and the bone marrow responds by putting immature
been suggested (but not firmly established) that low erythrocytesintothecirculation.Indeedreticulocytes,
levelsofG6PDHmaypredisposetothedevelopment erythrocyte precursors, can be obtained for study by
ofcardiovasculardisease.80 injectinganimalswithphenylhydrazineandremoving

--- Page 419 ---

364 FREE RADICALS IN BIOLOGY AND MEDICINE
Table7.3 Inborndeficienciesoferythrocyteenzymesinrelationtodrugandtoxin-inducedhaemolysis.
Abnormality Prevalence Usualclinicalfeature Examplesofdrugsinducing
haemolysis
Glucose-6-phosphate Commoninpatientsintropicalor SomeRBCdamageisoften Favabeans,furazolidone,
dehydrogenasedeficiency Mediterraneanareasortheir detectedinlaboratorytestsbut nitrofurantoin,dapsone,
(X-linked,recessive) descendents,e.g.inAfrican severehaemolysisisrareinvivo. rasburicase(axanthineoxidase
Americans. Somepatientsshowincreased preparation),nitrofurazone,
susceptibilitytoinfections,but pamaquine,primaquine,
mostdonot. sulphonamides(DrugSafety33,
713,2010;Am.J.Trop.Med.Hyg.
77,779,2007).Sepsismayalso
provokeerythrocytedamage(Am.
J.Physiol.286,H2118,2004).
Primaquinemaycausedamageby
itsconversioninvivoto
5-hydroxyprimaquine,whichis
readilyoxidizedinredcells(Eur.J.
Med.Chem.44,937,2009).
Glutathioneperoxidase Rare Usuallynone,occasionallysevere Sulphonamides,nitrofurantoin
(GPx1)deficiency haemolysis,infertility.
Glutathionereductasedeficiency Veryrare,butlackofriboflavinin Oftennone,sometimessevere Sulphonamides
thedietcanalsodecreasethe haemolysis,sometimesearly
activity(enzymehasFADatits cataract.
activesites).BCNUisapowerful
inhibitorofglutathionereductase
andcancauseerythrocyte
damage.
Abnormalhaemoglobins(e.g.Hb Rare Oftensomehaemolysisseen Sulphonamides
Torino,HbShepherd’sBush,Hb relatedtoproteininstability;drug
Peterborough,HbZurich) administrationcancausea
haemolyticcrisis.
Methaemoglobinreductase Rare Canbesevere,dependsontype Benzenederivatives,NO–,
2
deficiency(autosomalrecessive) (Section7.4.2). antimalarials
DataaremostlytakenfromthearticlebyGaetani,GFandLuzzatto,L(1980)inPseudo-allergicReactions.InvolvementofDrugsandChemicals,Vol.2(Dukor,Petal.,
eds),SKarger,Basle,Switzerland.Alsoseeref79andBlood120,4123,2012.
reticulocyte-richbloodseveraldayslater.Theanimals However, the damage done by phenylhydrazine to
sufferincreasedoxidativedamage,however.84,85 erythrocytesisnotpreventedbySOD.51,84Methaemo-
Phenylhydrazineanditsderivativesslowlyoxidize globin, acting as a peroxidase, oxidizes phenylhy-
in aqueous solution to form O
•–
and H O , a reac- drazineinthepresenceofH O .Oxyhaemoglobinalso
2 2 2 2 2
tioncatalysedbytransitionmetalions.Thefirststages oxidizes phenylhydrazine, but H O is not required.
2 2
can probably be represented by the equations below, Theseoxidaseandperoxidasereactionsofhaemoglo-
in which Mn+ represents the metal ions and Ph the binformseveralradicals:
benzenering(Fig.7.4).Anitrogen-centredphenylhy-
drazineradical86isformed,
Ph—NH—NH
−h−a−em−o−g−lo−b→in
Ph— N
•
—NH
2 2
•
Ph—NH—NH 2 +Mn+→H++Ph—N—NH 2 +M(n–1)+ −h−a−em−o−g−lo−b→in PhN=NH
PhN==NH+O → Ph • (phenylradical)+O •–
whichthenreactswithO , 2 2
2
+N +H+
• 2
Ph—N—NH 2 +O 2 → H++O • 2 –+PhN==NH (viaPhN==N • ,phenyldiazineradical)
AdditionofSODslowsdownoxidation. Ph
•−H−+−a−bs−tr−ac−ti→on
Ph—H(benzene)

--- Page 420 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 365
CONHNH
NH * H N NH 2
2 2 2
Hydrazine
N
NHNH
2 Isoniazid
SO
2
CH
3
Phenylhydrazine CONHNH CH
CH
NH 2 * O 3
Dapsone
NHNHCCH N
3
Iproniazid
NH *
2
Acetylphenylhydrazine NHNH
2
CH N
SO 3
2
NH H C NHNH 2 N
CH 3 Hydralazine
N
Isopropylhydrazine
O
CH
3
Sulphamethoxazole S S + 2GSH GSSG + 2 SH
Diphenyldisulphide Thiophenol
Figure7.4 Structuresofsomehydrazineandhydroxylamine-containingdrugs.*These–NH2groupscanbeconvertedtohydroxylamines
(–NHOH)invivo.
Henceend-productsoftheoxidationincludebenzene side-effects, and prolonged use can produce auto-
andnitrogen.Themostdamagingspeciesseemstobe immunity (lupus- and rheumatoid arthritis-like syn-
phenyldiazineradical,whichcandenaturehaemoglo- dromes) (Section 10.10.1). Hydralazine is oxidized
bintoformintracellularprecipitates(Heinzbodies),as by haem proteins and transition metal ions to form
wellasdepositsonthecytoskeletonandplasmamem- O
•–,
H O , and nitrogen-centred radicals, which may
2 2 2
brane,causingeventualhaemolysis.Thehaemgroup participate in the side-effects. The antituberculosis
isconvertedintoagreenproduct;bothcleavageofthe drug isoniazid (isonicotinic acid hydrazide) and the
ringandcovalentbindingofphenylradicalstoitoccur. antidepressant iproniazid (Fig. 7.4) can similarly be
Someofthedenaturationproductsofhaemoglobin,as oxidized,86,87andtheproductsagainmightcontribute
well as released iron, might catalyse OH• formation. to their side-effects (including a risk of autoimmun-
Indeed,whenmouseerythrocytesareincubatedwith ity).Indeed,oxidationofisoniazidbyaM.tuberculosis
phenylhydrazine,thereisarapidreleaseof‘catalytic’ catalase–peroxidaseenzyme(KatG)toanisonicotinyl
iron.53 Micelackinghaptoglobinshowincreasedmor- acylradicalcontributestoitsantituberculareffect;the
talityandkidneydamage(accompaniedbyincreased radical reacts with NAD+ to form a product that in-
renal lipid peroxidation and 8OHG levels in DNA) hibitsanessentialmetabolicpathwayinthebacterium,
after treatment with phenylhydrazine, indicative of a andmutationsalteringthestructureofKatGcanresult
roleforhaemoglobininthetoxicity.85 inisoniazidresistance.87Iproniazidcanbemetabolized
Hydrazine derivatives are widely used in indus- inthelivertothehepatotoxicandhaemolyticisopro-
try, as rocket fuels, and in medicine. Many can be pylhydrazine(Fig.7.4),andspintrappingwithDMPO
oxidized, not only by haemoglobin but also by cyto- (Section6.2.4)hasbeenusedtoidentifyhaemoglobin
chromes P450. For example, hydralazine has been thiylradicalsinthebloodofiproniazid-treatedrats.88
used to treat high blood pressure, but has several Anantioxidantusedintherubberindustrytoprevent

--- Page 421 ---

366 FREE RADICALS IN BIOLOGY AND MEDICINE
‘perishing’ of the rubber, N-isopropyl-N(cid:4)-phenyl-p- 7.5.3 Favism79,92
phenylenediamine, can cause contact dermatitis and
Many so-called ‘haemolytic agents’ have only minor
alsooxidationanddenaturationofhaemoglobin(both
effects when small doses are given to healthy people
free and in erythrocytes) about 40 times faster than
oranimals.Greatereffectscanbeseeninpatientswith
phenylhydrazine,51 a beautiful illustration of the fact
inborndefectsinerythrocytedefencemechanisms.For
that antioxidants designed by chemists are not al-
example, patients with G6PDH deficiency show lit-
waysantioxidantsinbiologicalsystems!Onabrighter
tle or no haemolysis normally, but it can be induced
note,hydrazinesaregoodscavengersofcarbonylcom-
(often severely), by some drugs (Table 7.3) and by
pounds (Section 3.25.7), an example being the use
certainfoodssuchasthebroadbean,Viciafaba.Vicia-
of2,4-dinitrophenylhydrazinetomeasureproteincar-
inducedhaemolysis,aconditionknownasfavism,is
bonyls(Section6.16.3).
common in certain Mediterranean countries such as
Hydroxylamine, NH OH, and its derivatives are
2 SardiniaandGreece,intheMiddleEast,andinpartsof
used industrially, but can lead to haemolysis by
southeastAsia.ItsdistributionfollowsthatofG6PDH
oxidizing haemoglobin and causing free radical
deficiency,butnotallpatientsdeficientintheenzyme
formation.86,89 Similar reactions contribute to aniline
aresensitivetothebean.
toxicity (Section 9.5.8). Some drugs, such as sulpha-
Soon after ingesting the bean, the erythrocytes of
methoxazole and dapsone, are metabolized to hy-
susceptible patients show a rapid fall in NADPH/
droxylaminesthatmaycontributetotheirside-effects
NADP+ratiosandGSHlevels.ThechemicalsinV.faba
(Fig.7.4).86,90
responsible for this are the pyrimidine derivatives,
vicineandconvicine,whicharepresentatabout0.5%
of the total weight of the bean. They are hydrolysed
7.5.2 Sulphur-containinghaemolyticdrugs91 byβ-glucosidaseenzymestogive‘aglycone’products
(Fig. 7.5) that react rapidly with O to form both
Diphenyldisulphideadministeredorallytoratscauses 2
H O and quinones, leading to GH depletion, H O
haemolysis. It can be reduced by GSH to thiophenol 2 2 2 2
generation,haemoglobinoxidation,andsometimesan
(Fig. 7.4), which is oxidized by oxyhaemoglobin to
formmethaemoglobin,RS•radicals,O •–,andH O ;all increaseinthe‘catalytic’ironpool.53,79
2 2 2
ofthesespeciesprobablycontributetoitshaemolytic
action. Garlic contains sulphur compounds that can 7.5.4 Erythrocyteapoptosis93
causehaemolysiswheningestedbyanimals,butthey
canbebeneficialinsmalleramountsbyactivatingthe Red blood cells cannot undergo ‘classical’ apoptosis
Nrf2system(Table4.5).Thedisulphidegliotoxinim- as they have no nuclei or mitochondria. However,
pairscellfunctionbycyclingbetweendisulphideand they can undergo something resembling it, marked
dithiolstates(Section8.9.6). byshrinkage,blebbing,andphospholipidscrambling
O O
O HO
sugar NH β–glucosidase NH
H 2 N N NH 2 H 2 N N NH 2
Vicine Divicine
O O
O HO
sugar NH β–glucosidase NH Figure7.5 Compoundscausingfavism.The
aglyconesderivedfromhydrolysisofconvicineand
H 2 N N O H 2 N N O vicinefromViciafabaseedscanundergoredox
H H cyclingfromdiphenoltoquinoneform.The
aglyconeofconvicineiscalledisouramil,thatof
Convicine Isouramil vicineiscalleddivicine.

--- Page 422 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 367
inthemembranetoexposephosphatidylserineatthe 7.6.1 Malaria,oxidativestress,andanancient
cellsurface.Thisprocess,callederyptosis,involvesex- Chineseherb
cessiverisesinintracellularCa2+ levelsandceramide
The prevalence of G6PDH deficiency, thalassaemia,
(Section5.4.2)formation.Eryptosiscanbetriggeredby
andsickle-cellanaemiaincertainpartsoftheworldhas
certaintoxinsandoccursatincreasedlevelsinpatients
with sickle-cell anaemia, β-thalassaemia, G6DPH de- beensuggestedtoberelatedtotheirabilitytoprotect
humansagainstmalaria.70,99Thisassociationseemsto
ficiency, and sepsis, among other conditions. The
havearisenbynaturalselection,especiallyasmanyfa-
mechanism appears to involve increased opening of
talitiesfrommalariaoccurinchildren.Ifchildrenhave
Ca2+ channelsintheplasmamembranewhenthered
these inherited conditions in malaria-infested areas,
cellsareexposedtostress,especiallysevereoxidative
they are more likely to survive to a reproductive age
stress.
andpassonthegene.DeficiencyofG6PDHintheblack
rhinoceros78mayhavesimilaradvantagesinthewild.
Malariaiscausedbyinfectionwithprotozoanpara-
7.6 Bloodthirstyparasites:problems sites of the Plasmodium genus. Several species infect
forthemandforus humans,butP.falciparumisthemostvirulent.World-
wide, malaria infects hundreds of millions of people,
Several blood-dwelling parasites, including Plasmo- stillcausesmorethan650,000deathsperyear,andthe
dium (Section 7.6.1), Schistosoma, and Angiostrongylus, problem of resistance to therapies is growing.99 Mal-
digestsubstantialquantitiesofhaemoglobintoobtain aria is transmitted by the bite of an infected female
amino acids, but at the same time releasing haem Anophelesmosquito,whereupontheparasitesenterthe
andironions.Degradationoccursinalysosome-type subcutaneous tissue or a blood vessel, migrate to the
digestivevacuole.Howdotheparasitesprotectthem- liver,developwithinhepatocytes,andeventuallyleave
selves against these pro-oxidants? One suggestion to infect erythrocytes, wherein they degrade haemo-
is that, when dwelling in O 2 -rich blood, they switch globin, proliferate, and release progeny to infect new
their metabolism to glycolysis, avoiding O • 2 –/H 2 O 2 redbloodcells.Infectedredbloodcellsadheretovas-
production by stopping aerobic respiration.94 Some, cular endothelium and impair blood flow. If another
including Plasmodium, lack haem oxygenase. They mosquito sucks blood from the infected person, the
oxidize the haem to haematin and convert that to a infectioncanbespread.
dark-brown insoluble aggregate (haemozoin, some- Plasmodium must undergo a complex developmen-
times called malaria pigment) that is safely kept talcycleinthemosquito’ssalivaryglandsandmidgut,
insidethedigestivevacuole.Haemozoinismadeupof and has to escape the gut’s defence systems. Some
multipleunitsofhaematindimers.Itisnotcompletely Anophelesstrainsblocktheparasites’lifecyclebylys-
redox-inactive,butlesspro-oxidantthanhaemitself.95 ingitorbysequesteringitinthemidgut.Thisinvolves
Theantimalarialschloroquineandquinacrine(struc- bindingofamosquitocomplementprotein(TEP1)that
tures shown in Fig. 10.14) interfere with haemozoin tagstheparasitefordestructionbylysis,orbymelan-
formation and have been suggested to cause a toxic otic encapsulation. Melanotic encapsulation requires
build-up of haem that kills the malaria parasite by the oxidation of tyrosine to melanin (a process in-
excessiveoxidativedamage.96 volving ROS generated by a DUOX enzyme), which
Bloodsuckinginsectscanhaveadditionalproblems: cross-links proteins into a capsule assembled around
they sometimes consume several times their own theparasite.100Sadly,otherAnophelesstrainsdon’tuse
weightinbloodanddigestitrapidly,loadingthegut ROSinthisusefulfashionandasaresulttheytransmit
withhaemandiron.Thereisarapidincreaseinferritin malariatohumans.
intheguttocopewiththis,andintheinsectRhodnius WhydoG6PDHdeficiency,thalassaemia,andsickle-
prolixus(animportantvectorofTrypanosomacruzi)hae- cellanaemiaprotectagainstmalaria?Perhapssickling
mozoinisalsoproducedthere.Haemalsoaccelerates of infected cells kills the parasite, and/or the ab-
uratesynthesisinthisinsect,perhapsasanantioxidant normal haemoglobin cannot be digested properly by
defence.97 Xanthurenicacid,aproductoftryptophan the parasite. More likely, its RS yet again! Malaria-
breakdown,hasbeensuggestedtoplayasimilaranti- infectederythrocytesseemtobeunderoxidativestress,
oxidantroleinthegutofAedesaegypti,theinsectvector showingsignificantlipidoxidation,70increasedprotein
ofyellowfeveranddengue.98 oxidation,101 andlowGSH/GSSGratios.102 Indeed,in

--- Page 423 ---

368 FREE RADICALS IN BIOLOGY AND MEDICINE
vitro studies show that Plasmodium is readily dam- free haem to accumulate. Indeed, malaria-infected
aged by systems generating RS, by lipid peroxides, subjectssuffersystemicoxidativestress.105
orbycytotoxicaldehydes.P.falciparumcansynthesize Could this sensitivity of the malaria parasite and
FeSOD, GSH, GST, glyoxalase, glutathione reductase, of the red cell it inhabits lead to useful therapies?
andthioredoxin-dependentperoxideremovalsystems Consistent with this, inhibiting GSH synthesis with
(severalperoxiredoxins),butoverallitsantioxidantac- buthionine sulphoximine deterred the development
tivity seems limited,103 e.g. it lacks catalase and GPx. of P. falciparum in human red cells. Unlike normal
Ittriestomakeupby‘stealing’someantioxidantsfrom red cells, malaria-infected cells rapidly leak glutathi-
theredbloodcell,includingperoxiredoxin-2,catalase, one, so it must be continually replaced.106 Indeed,
andCuZnSOD.103Ofcourse,thismightrenderthered anti-malarial agents under development include in-
cellevenmoresensitivetoclearanceoreryptosis!102 hibitors of parasite glutathione reductase, of GST en-
If malaria-infected red cells are under oxidative zymes, of thioredoxin reductase, and of haemozoin
stress,thenincreasingsuchstress,e.g.bythepresence formation.96,102 Depletion of α-tocopherol in mice in-
ofabnormalhaemoglobins,mightkilltheparasite.In- creased their resistance to cerebral malaria.104 Injec-
deed,theparasitepossessesaG6PDHenzyme,butits tionofalloxan(aROS-producingagent;Section9.7.1),
activityseemsinsufficienttoprovidealltheNADPHit phenylhydrazine,divicine,ortert-butylhydroperoxide
needsformetabolismandantioxidantdefence,which into malaria-infected mice killed the parasites.107,108
may further explain why subjects deficient in this The effects of alloxan or divicine were overcome
enzyme resist malaria. Increased formation of SCA by pretreatment of the mice with desferrioxamine,
(Section7.4.6)bythecombinedpro-oxidanteffectsof suggesting that ROS produced by these agents in-
parasitaemia and abnormal haemoglobin or G6PDH teract with iron (from haem degradation?) to kill
deficiencyshouldaccelerateclearanceofinfectedcells, the parasite.107 Fluoromenadione, which generates
although abnormally high rates of phagocytosis of O
•–
and depletes GSH, is one example of a ‘pro-
2
erythrocytes by macrophages in the reticuloendothe- oxidant’ anti-malarial drug under development (Sec-
lialsystemcanimpairmacrophagefunction(probably tion9.5.3).96Anantimalarialagentalreadywidelyused
byiron-dependentoxidativedamage),andalsoleadto clinically may also act by imposing oxidative stress.
anaemia.104 Inaddition,lysisofinfectedredcellscan ItwasfirstfoundinaplantusedintraditionalChinese
release haem and haemoglobin into the circulation, medicine(Fig.7.6).Thiscompound,calledqinghaosu
depletinghaptoglobinandhaemopexin,andallowing orartemisinin,isasesquiterpeneendoperoxide.109
4
H C(cid:129)
H H 2 H
4
4 (cid:129)
H 3 C 3 O O O H Iron (Fe3 H + 3 ) C O O H O H or (Fe3+ O ) O H
O 10 O O O
CH 3 CH 3 CH 3
Artemisinin O C4 radical O seco-C4 radical O
Figure7.6 Structureofartemisinin.ThisdrugwasfirstisolatedfromArtemisiaannua(sweetwormwood),anancientChineseherb(quinghao,the
‘blue-green’herb)usedfortreatmentofmalaria.Writtendescriptionsoftheuseofquinghaodatebackto168BC.Theactionofartemisinin
appearstoinvolveinteractionwithhaemand/orfreeironionstocleavetheperoxidebridge,leadingtohaemmodificationandthegenerationof
radicalsthatattacktheparasite(Proc.Natl.Acad.Sci.USA108,11405,2011).OneimportanttargetappearstobeaparasiteCa2+–ATPasethat
maybeinvolvedinregulatingCa2+levels.109Artemisininmayalsointerferewithhaemozoinformation.109Artemether(amethylether)and
artesunate(asodiumsuccinylsalt)arewidelyused.Syntheticcompoundswithasimilarendoperoxidebridgearebeingevaluatedasantimalarials
(e.g.seeNature430,900,2004;Br.J.Clin.Pharmacol.75,524,2012;Curr.Med.Chem.18,3889,2011).FromNature424,887,2003,by
courtesyofDrR.G.Ridleyandthepublishers.

--- Page 424 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 369
Althoughchelatingagentscan,undersomeexperi- Several oxalate oxidases are manganese-containing
mental conditions, protect malaria parasites against proteinsandsome,suchastheproteingermin,found
oxidative damage,107 they can also suppress parasite intheapoplast(thespacebetweentheleafcuticleand
growth, by depriving them of iron. Growth of P. fal- thewallsofthecellsbelowit)showMnSODactivityin
ciparum in isolated human erythrocytes is completely vitro.TheoverallsignificanceofthisMnSODactivityin
inhibited by only 30μM desferrioxamine. However, vivoisuncertain,112 althoughitplaysaroleindefend-
this agent has not proved useful clinically, although ingfloralnectar(Section8.11.2).Amineoxidasesacton
thereissomeinterestinthepossibletherapeuticeffects aminessuchasputrescineandspermidine,whichplay
ofotherironchelators.109Desferrioxaminecaninterfere importantrolesinplantgrowthanddevelopmentand
withtheanti-malarialactionofartemisin,sinceironis areinvolvedintheresponsetopathogens.Manyplant
involved(Fig.7.6).109 amine oxidase enzymes contain copper and catalyse
Several other protozoan parasites are sensitive to thereaction
RS, a concept being exploited in drug design.96 Tryp-
anosoma brucei, for example, cannot synthesize haem RCH 2 NH 2 +H 2 O + O 2 → H 2 O 2 +NH 3 +RCHO
and lacks catalase. It can be killed by increasing
Other amine oxidases are FAD-containing but also
intracellular ROS levels, e.g. by adding menadione
generateH O .113
(Section 9.5). The trypanothione/trypanothione re- 2 2
PlantsuseperoxidesandotherRS(includingNO•)
ductase system (Section 3.16.1) is another target for
forredoxsignallinganddefence(Section8.11)andex-
drug intervention.106 Several ROS-producing nitro-
pose themselves to high levels of these agents. Basal
compounds(Section9.19)haveantiparasiteaction.
levels of H O and lipid hydroperoxides in plant tis-
2 2
suescanbemuchhigherthaninanimals.114,115 Plants
do not contain arachidonic acid, nor prostaglandins
7.7 Theproblemsofplants
derived from it. The lack of arachidonic acid also
Weneedplants:theysupplyuswithlife-givingO 2 ,as means that plants do not make F 2 -IsoPs. However,
wellastheessentialvitaminsEandC,andtheuseful non-enzymic oxidation of linolenic acid (the major
carotenoidsandflavonoids.Dietsrichinplantsareas- PUFAinplants)cangenerateotherisoprostanes,such
sociatedwithlowerriskofseveraldiseases(Chapter4). as the phytoprostanes (Figs 7.7 and 7.8).114 They
However, as they produce O , plants expose them- have been detected in all plants analysed, often at
2
selvestointenseoxidativestress.Splittingwaterwith- high levels. Phytoprostane levels increase dramatic-
outdestroyingyourselfisafearsomelydifficultprocess ally when plants are dried and stored, and they can
(Section7.8.2)sincewaterissostable;onereasonwhy bepresentinoxidized,plant-derivedcookingoilsand
thereissomuchofitonplanetEarth. inpollen.SimilarlytootherIsoPs,phytoprostanescan
PlantsalsohaveothersourcesofRS.Plantmitochon- formD 1 -,E 1 -,andF 1 -ringcompounds.TheD 1 -andE 1 -
dria generate O •–, mainly from complexes I and III. dinorisoprostanescandehydrateandrearrangetoJ 1 -,
2
However,therateappearstobekeptlow,bothbyun- deoxyJ 1 -,A 1 -,andB 1 -phytoprostanes(Fig.7.8).Little
couplingproteins(Section1.10.6)andbyanalternative isknownasyetabouttheirbiologicaleffects,butthey
oxidase system, a separate electron transport system maybeinvolvedinregulatingplantdefenceresponses
thatoperateswhenthemainoneisover-reducedorin- (Section8.11).
hibitedandconveyselectronsdirectlyfromubiquinol
toO ,reducingittoH O.110Levelsofplantuncoupling
2 2 7.8 Thekeytolife:photosynthetic
proteinsmay,liketheanimalones(Section1.10.6),be
increased111 when O •– levels rise. Several oxidase en- oxygenproduction
2
zymesinplantsgenerateH 2 O 2 ,includingperoxidases Chloroplastsintheleavesofhigherplantsarebounded
(Section 3.19) and sometimes NADPH oxidases (Sec- by an outer envelope, consisting of two membranes
tion 8.11) as well as amine, glycollate (Section 7.8.3), (Fig. 7.9). The envelope encloses the stroma, contain-
andoxalateoxidases;thelastuseO 2 tooxidizeoxalate ingacomplexinternalmembranestructure.Thestro-
toCO 2 , mal aqueous phase contains a high concentration of
proteins, many of which are the enzymes needed to
C(cid:9) OOH convert CO 2 into carbohydrate by the Calvin cycle,
(cid:9) + O −−→H O + 2CO a metabolic pathway requiring ATP and NADPH.
2 2 2 2
COOH Thefirstenzymeinthiscycle(ribulosebisphosphate

--- Page 425 ---

370 FREE RADICALS IN BIOLOGY AND MEDICINE
α-Linolenic acid γ-Linolenic acid
COOH
COOH
–H –H
O 2 O–O O R O 2 O R
R R O R O R
R R
OO
+H +H
O COOH O COOH
O O
16 13
OOH OOH
16-G -Dinor isoprostanes 13-G -Dinor isoprostanes
1 1
G -Phytoprostanes (type I) G -Dinor isoprostanes (type III)
1 1
& &
O O
O O COOH
9 COOH 6
OOH OOH
9-G -Dinor isoprostanes 9-G -Dinor isoprostanes
1 1
G -Phytoprostanes (type II) G -Dinor isoprostanes (type IV)
1 1
Figure7.7 G1-dinorisoprostanesinplantsandmammals.Autoxidationandcyclizationofα-linolenicacid(C18:3ω3)andγ-linolenicacid
(C18:3ω6)yieldstructurallydifferentG1-dinorisoprostaneswhichcanbeclassifiedwithrespecttothelocationoftheside-chainhydroxylgroupas
16-,9-,13-,and6-G1-dinorisoprostanesorwithreferencetotheω-carbonastypesI–IVG1-dinorisoprostanes.Sinceα-linolenateisamajor
unsaturatedfattyacidsinplantsandmuchlessimportantinanimals,thetypesIandIIdinorisoprostaneshavebeentermedphytoprostanes.
AdaptedfromChem.Phys.Lipids128,135,2004,bycourtesyofDrMartinMuellerandElsevier,plusadvicefromDrGingerMilne.
carboxylase;‘Rubisco’) catalyses reaction of the five- are encoded in the nucleus and imported when
carbon sugar ribulose 1,5-bisphosphate with CO to required.116 Indeed, over 90% of chloroplast proteins
2
formtwomoleculesofphosphoglycerate. areencodedintheplantnucleus.Amongtheproteins
Theinternalmembranestructureofchloroplastshas encodedinthechloroplastgenomearetheD1andD2
twodistinctfeatures,regionsofcloselystackedmem- proteinsofphotosystemII(Section7.8.2),andthelarge
branes (grana thylakoids) interconnected by a three- subunitofRubisco.
dimensionalnetworkofmembranes,thestromathyla-
koids.Bothcontainphotosyntheticpigments(chloro-
7.8.1 Trappingoflightenergy
phyllsaandb,greenpigmentsthatabsorblightinthe
blue and red regions of the spectrum) together with Absorptionoflightbychlorophyllcauseselectronsto
carotenesandxanthophylls(yellowpigmentsabsorb- move to higher energy states (excited singlet states).
ingbluelight;Section4.4).Thethylakoidsproducethe Theexcitationenergycanbelostbyre-emissionoflight
NADPHand,bytheprocessofphotophosphorylation to give fluorescence; it can be lost as heat (thermal
(involvinggenerationofaprotongradient[Fig.7.10]), energy dissipation), or it can be transferred to an-
theATPneededfortheCalvincycleandotherchloro- other molecule, for example an adjacent chlorophyll,
plastmetabolicactivities. thefirstmoleculereturningtothegroundstate,whilst
Chloroplasts contain DNA which encodes sev- thesecondbecomesexcited.Thechloroplastcarefully
eral proteins found in the thylakoid membranes, controlsthedistributionofenergybetweenthesethree
whereasmoststromalandtheotherthylakoidproteins processes.117

--- Page 426 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 371
O R
O R’
OOH
G
HO O HO
R R R
R’ R’ R’
O OH HO OH HO OH
D E F
O
R R PHYTO- Figure7.8 Thephytoprostanepathwayin
PROSTANES plants.G1-phytoprostanesrapidlydecomposein
R’ R’ aqueoussolution.Non-enzymaticorenzymatic
reductionofbothperoxygroupsyieldsstable
O OH HO OH type I
J A R = C 7 H 14 COOH F th 1 e -p e h n y d to o p p r e o r s o t x a id n e es g . r I o n u c p on a t n r d as r t e , d r u ea ct r i r o a n ng o e f m th e e ntof
R’ = C H
2 5 side-chainhydroperoxygroupof
G1-phytoprostanesyieldsD1-and
type II
O E1-phytoprostaneswhichmay
R = C H
R R 2 5 dehydrate/isomerizetoJ1-and
R’ = C H COOH
7 14 deoxy-J1-phytoprostanes,orA1-and
R’ R’ B1-phytoprostanes,respectively.FromChem.
O Phys.Lipids128,135,2004,bycourtesy
OH
d-J B ofDrMartinMuellerandElsevier.
Special molecules of chlorophylla in the thylakoid can help control the distribution of energy between
membranes (reaction centre chlorophylls) can, PSIandPSII.118
when excited, lose an electron to a neighbouring Electrons ejected from the P680 chlorophyll of
electron acceptor (A), producing a radical pair PSII pass to a phaeophytin a molecule and then
(chlorophyll•+A•–). This initial charge separation is to acceptors Q and Q , which are plastoquinone
A B
the key reaction of photosynthesis. Light energy molecules (Fig. 7.10). Electrons then pass ‘down’
absorbed by other chlorophyll a or b molecules in (i.e. to more positive reduction potentials) an elec-
the thylakoid membrane can be transferred to the tron transport chain that contains several compo-
reaction-centre chlorophylls, each of which is associ- nents, including ‘free’ plastoquinone, plastocyanin,
ated with light-harvesting arrays of other pigment and a cytochrome b–f complex, eventually enter-
molecules that channel energy to it.117 Two differ- ing PSI to replace the electrons lost on excitation
ent types of reaction centre contain two different of the P700 chlorophyll. Electrons ejected from PSI
forms of chlorophyll, known as P700 and P680, each are transferred to chlorophyll, phylloquinone, and
served by light-harvesting systems. The complexes then to an iron–sulphur cluster. They then pass
containing P700 are called photosystems I (PSI) and to other iron–sulphur proteins bound to the mem-
thosecontainingP680,photosystemsII(PSII).Stroma branes, and after that to a soluble [2Fe–2S] iron–
thylakoidsarerichinPSI,whereasthestackedmem- sulphur protein, ferredoxin. Reduced ferredoxin, in
branesareenrichedinPSII.Structuralchangesinthe thepresenceofareductaseenzyme,convertsNADP+
light-harvesting complexes, involving protein phos- to NADPH (Fig. 7.10). It also reduces thioredoxin
phorylation controlled by kinases and phosphatases, (Section7.8.6).

--- Page 427 ---

372 FREE RADICALS IN BIOLOGY AND MEDICINE
–CHO in chlorophyll b
CH
2
HC CH 3
H C I II CH CH
3 2 3
N N
Mg2+
H C N N
3
IV III CH 3
H
H V
H
O C O
C
O O O
CH
3
H C
3
H C
3
H
3
Figure7.9 Top:electronmicrographofachloroplast.Bottom:structureofchlorophyllsaandb.

--- Page 428 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 373
Stroma
Lumen
Photosystem II
–1.6
–1 ps
–1.2
40–200 ps
15–200 ns
–0.8 200–500 ns 2 NADPH 10 ps < 1–125 μs –0.4 hv –1ms
200 ps 2 NADP+ 0.0 100–600 μs
1 ms
1–20 ms 0.4 hv < 1 ms 200 μs
2 H 2 O50 μs–1.5 ms
0.8
O 2 20 ns–35 μs
+
4 H+
)stlov(
E m
2 HO 2
Cytochrome bf Photosystem I ATP synthase
6
1.2
1.6
mn
4
hv
hv
NADP+ CF 1
NADPH
LHCII 2 H+ 2 H+ FeS Fd
Q A Q B FNR
PQ
Pheo PQH 2 PQH 2 Cyt A 1
A P680 PQ 0
Y PQH 2 FeS
Z P700
Mn
4 Cyt f
PC
4 H+
FC 0
ATP 3 H+ ADP + P i
H+
3 H+
ICHL ICHL b 6
PC
4 H+
955b
tyC
Y
D
O 2
(a)
P
700*
A 0
Photosystem II A
1 F P 680° x F AB Fd Pheo FNR Cyt bf
6 Q Complex A Q B
PQ
FeS Cyt f PC P 700
Photosystem I
Mn
4
Y
Z
P 680
(b)
Figure7.10 (colourplate17)(a)Schematicrepresentationofproteincomplexesandcofactorsinvolvedinthelinearelectrontransportandthe
protontransportofphotosynthesisinhigherplants.(b)TheZschemeshowingtheenergeticsofoxygenicphotosyntheticelectrontransport.The
verticalscaleshowstheequilibriummidpointredoxpotential(Em)oftheelectrontransportcomponents.Approximateelectrontransfertimesare
shownforseveralreactions.Lookingatthecomponentsfromthebottomleftofthediagrams:Mn4,tetranuclearmanganese–oxygen–calcium
cluster(Fig.7.11);Yz,tyrosine-161ontheD1protein;P680,primaryelectrondonorofphotosystemII;P680∗,excitedelectronicstateofP680;
Pheo,phaeophytin;QA,atightlyboundplastoquinone;QB,aplastoquinonethatbindsandunbindsfromphotosystemII;PQ,apoolofmobile
plastoquinonemolecules;themiddleboxrepresentsaproteincomplexcontainingtwomoleculesofcytochromeb6(Cytb6;onlyoneisshown),an
iron–sulphurprotein(FeS;knownastheRieskeFeSprotein),andacytochromef(Cytf);PC,plastocyanin;P700,reactioncentrechlorophyllaof
photosystemI;P700∗,excitedelectronicstateofP700;A0,aspecialchlorophyllamolecule;A1,vitaminK;FX,FA,FB,iron–sulphurcentres;F
d
,
ferredoxin;FNR,ferredoxin–NADP+reductase.(a)shows,inaddition,LHC-IandLHC-II,light-harvestingcomplexesofphotosystemsIandII,
respectively,andtheATPsynthasewithcouplingfactors(CF0andCF1).Electrontransportcreatesaprotongradientacrossthethylakoid
membrane:movementofH+backviatheATPsynthaseprovidestheenergytodriveATPsynthesis(photophosphorylation).Fromhttp://www.els.net
[doi:10.1002/9780470015902.a0000669.pub2],bycourtesyofGovindjee,JanFKern,JohannesMessinger,JohnWhitmarsh,andJohnWiley&
Sons,Ltd.

--- Page 429 ---

374 FREE RADICALS IN BIOLOGY AND MEDICINE
7.8.2 Thewatersplittingmechanism:aradical 1. TheirinternalO concentrationinthelightwillbe
2
processandthereasonforthisbook119 greater than 21%, because O is produced by PSII,
2
soO toxicitycanbeaproblem.
2
The electrons ejected from PSII reaction centres leave
2. Ifthelightenergyabsorbedbythechloroplastisnot
behind chlorophyll radical cations (P •+) that have
680 transferredefficientlytothereactioncentrechloro-
a large positive reduction potential (greater than one
phylls, or lost as heat or fluorescence, intersystem
volt). Electrons are replaced by the electrons arising
crossingofthesingletstatetothetripletstatemay
from water oxidation, leading to O evolution. The
2 occur.Thetripletstatecan,inturn,transferenergy
chemistryofbiologicalwateroxidationiscomplexand
to O to form singlet O , a powerful oxidant for
2 2
involves a cluster of four manganese ions and one
chloroplastPUFAsandproteins,aswellaschloro-
Ca2+ ion, CaMn O (H O) , that converts two water
4 5 2 4 phyll itself. Studies on the green plant Arabidopsis
moleculestooneO ,4H+,andfourelectrons(Fig.7.11).
2 thaliana revealed that singlet O production is not
The radical P •+ oxidizes a tyrosine residue (Y ; 2
680 z onlydirectlydamagingbutcanalsoinducechanges
Fig.7.10)ontheD1protein,oneofthetwomajorpro-
ingeneexpressionthatleadtocelldeath,although
teinconstituentsofthePSIIreactioncentre(theother
it can sometimes alternatively act as a redox sig-
is D2) to a tyrosyl radical, which in turn extracts an
nal to increase antioxidant defences.121 Singlet O
2
electronfromthecluster.Thisclusteraccumulatesfour
productionisespeciallyprominentinPSII.
oxidizing equivalents and enters increasingly higher
3. Lipids in the chloroplast envelope and thylakoids
oxidation states (sometimes called theS ,S ,S , and
1 2 3 containahighpercentageofPUFAresidues(mostly
S states)beforewaterissplittoO .Mostoftheseox-
4 2 linolenate and linoleate), and are thus susceptible
idations occur on Mn, converting it from Mn(III) to
toperoxidation,andoxidationbysingletO .Meas-
2
Mn(IV). The water-splitting state S may involve an
4 urementsofspecificproductsofPUFAoxidationby
oxyl(O
•–)radicalintermediate.
singlet O have shown that this is a major source
2
of ‘basal’ lipid oxidation in photosynthesizing Ar-
abidopsisleaves,forexample.122
7.8.3 Whatproblemsdogreenleavesface?
Unlike humans, plants cannot go indoors if the
Green leaves, and especially their chloroplasts, are sun gets too hot, and they have to cope with
pronetooxidativedamageforseveralreasons.120 any light that they are exposed to (although some
H
N
N
H
O Figure7.11 TheCaMn4O5(H2O)4clusterin
photosystemIIresemblesadistortedchair,withan
H O asymmetriccubanestructure.TheCa2+andthreeMnions
H OH occupyfourcornersandfouroxygenatomsformtheother
H O fourcornersofthecubane-likestructure.AnotherMnion
O H Ca O O O islocatedoutsidethecubaneandislinkedtotwoMnions
O Mn1 withinthecubanebyoneoxygenofthecubaneandthe
N NH fifthoxygenbyadi-μ-oxobridge.Thelocationof
OH
O 2 O substratewatermoleculesisveryimportantfor
O
understandingthemechanismofwateroxidation.Four
Mn4 Mn2
watermoleculeshavebeendetectedinthe
H 2 O O O O O CaMn4O5(H2O)4 clusterofthewateroxidizingcomplex.
Twowatermoleculesarecoordinatedtothemanganese
O ionlocatedoutsidethecubaneandtwowatermolecules
Mn3
arecoordinatedtotheCa2+ions.Fromref119,bycourtesy
O
O ofDrMohammadMahdiNajafpourandElsevier.

--- Page 430 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 375
speciescanadjusttheangleoftheirleavestomin- The damaged D1 protein can be degraded by
imize exposure). If too much energy is absorbed proteinasesandreplaced,butifdamageistoofast
in relation to the demand for NADPH, NADPH forreplacementtokeepup,inhibitionofphotosyn-
mayaccumulate,theelectrontransportchainslows thesis(photoinhibition)willoccur.Degradationin-
down,andthereaction-centrechlorophyllsmaynot volves a zinc-dependent ATP-requiring proteinase
be able to dispose of all their excitation energy. known as FtSH.124 Photoinhibition involves other
Hence,singletO formationandconsequentoxida- processesaswell;toomuchlightmaydirectlydam-
2
tive damage to chlorophyll, PUFAs, and proteins agetheCaMn O cluster,accumulationofthehighly
4 5
(especiallytheD1proteinsinPSII)shouldincrease. oxidizingP •+canalsodamagePSII,andexcessive
680
Indeed increased 1O formation has been directly ROSformationcaninhibitsynthesisofnewD1pro-
2
demonstrated in plants using spin traps for 1O , teinbyslowingchloroplastproteinsynthesis.Inthe
2
and the fluorescent probe singlet O sensor green cyanobacteriumSynechocystis,andpossiblyinother
2
(Section6.8;Fig.7.12).123 species,thedecreasedrateofproteinsynthesismay
Figure7.12 (colourplate18)A.TheeffectofDCMUonsingletO2sensorgreen(SOSG)fluorescenceinArabidopsisleaves.Leaveswere
infiltratedwithSOSG,paintedwithDCMU(200μM)orwater(control)andexposedtolight.ImagesofSOSGfluorescenceweretakenafter30,60,
and90min.After90min,theleaveswereplacedinthedarkandthenimagedagain12hlater(12hindark+DCMU).Animageofacontrolleaf
thathasbeenkeptinthedarkfor12hisalsoshown.B.SOSGfluorescenceinArabidopsisleavestreatedwithparaquat.Leavesweregrown,
infiltratedwithSOSG,andpaintedwithparaquat(100μM)orwater(control)andthenthetophalvesoftheleaveswereexposedtolight.Some
leaveswereinfiltratedwith5mM3,3’-diaminobenzidene(DAB)or6mMnitrobluetetrazolium(NB)todetectH2O2orO •
2
–respectively.Figures
fromref123,bycourtesyofProfessorNeilR.BakerandOxfordUniversityPress.

--- Page 431 ---

376 FREE RADICALS IN BIOLOGY AND MEDICINE
be due to oxidation of thiol groups on elongation 5. Superoxide formed in chloroplasts can dismutate
factorGtoinhibititsfunctions,125areactionrevers- to H O non-enzymically or by the action of SOD
2 2
ible by reduced thioredoxin. Even under ‘normal’ (Section7.8.6.1).Unfortunately,H O inactivatesat
2 2
lightconditions,thePSIIreactioncentremayhave least two Calvin cycle enzymes, fructose bisphos-
toberebuilttwoorthreetimesperhour. phataseandsedoheptulosebisphosphatase,appar-
4. The electron transport chain of chloroplasts can entlybyoxidizingthiolgroupsessentialforcatalytic
‘leak electrons to O and form O •–, a reaction activity.120
2 2
favoured by high O levels. Isolated illuminated 6. HydrogenperoxidecanformOH•byFentonchem-
2
thylakoids slowly take up O in the absence of istry, but little is known about the availability of
2
added electron acceptors, a process first observed metal ions ‘catalytic’ for free radical reactions in
by A.H. Mehler,and often calledthe Mehler reac- chloroplasts(Section7.8.9).Severaliron-containing
tion.126 OnesourceofO •– isthereductionofO to proteins in chloroplasts (e.g. cytochromes) could
2 2
O
•–
by the electron acceptors of PSI. Addition of conceivably be damaged by excess H O , with re-
2 2 2
ferredoxinincreasesO uptake,sinceitisrapidlyre- leaseof‘catalytic’ironions,althoughferredoxinis
2
ducedby PSI andreducedferredoxincan, in turn, resistanttoH O .Chloroplastsoftencontainferritin
2 2
reduceO (Fig.7.13), (phytoferritin) from which O
•–
could conceivably
2 2
Fd +O →O •–+Fd mobilizesomeiron.
red 2 2 ox 7. Oxygen has a direct effect on Rubisco. The inter-
In vivo, however, reduced ferredoxin passes elec- mediate formed when it acts on ribulose bisphos-
trons on to NADP+ via ferredoxin–NADP+ re- phate can react not only with CO 2 , but also with
ductase. If the supply of NADP+ is limited, the O 2 (Fig. 7.14). Instead of forming two molecules
rate of electron flow along pathway C (Fig. 7.12) ofphosphoglycerate,thisoxygenaseactivityofthe
shouldbedecreased,andmoreO •– mightbemade enzymeformsonephosphoglycerateandonephos-
2
byroutesBandA.Superoxidecanalsoresultfrom phoglycollate. The latter is hydrolysed to glycol-
direct reduction of O by the electron acceptors of late and further metabolized by a series of reac-
2
PSII(reducedphaeophytinorQ ). tions known as photorespiration. The first step is
A
glycollateoxidase,aperoxisomalenzymethatgen-
eratesH O ,
2 2
PSI C(cid:9) H 2 OH C(cid:9) HO
(cid:9) + O 2 −−→ (cid:9) + H 2 O 2
COOH COOH
glyoxylate
O Ferredoxin
2
Ifthecatalaseinperoxisomesfailstoremoveallthe
H O , glyoxylate can react non-enzymically with
2 2
O
·-
Reduced ferredoxin H 2 O 2 , being oxidized to formate. This may hap-
Route A 2 : Direct NADP+ pen in planta under some circumstances. Usually
reduction of Ferredoxin O 2 glyoxylateisfurthermetabolizedenzymically,even-
oxygen NADP+
·- tuallyformingCO .Asaresultofphotorespiration,
NADPH –reductase O 2
2 CO previously fixed into the Calvin cycle is re-
2
Route B: Reduction
Route C: Formation leasedandhastoberefixed,usingmoreenergy.
of oxygen by reduced
of NADPH.
ferredoxin or the Fortunately, the affinity of the carboxylase for
reductase enzyme CO is so much greater than for O that carboxyl-
2 2
Calvin ation is favoured, even at 21% O 2 and 0.04% CO 2 ,
cycle normalairlevels.However,ifO iselevatedand/or
2
CO depleted, CO fixation into the Calvin cycle
2 2
is decreased and CO loss by photorespiration in-
Figure7.13 RoutesofelectronflowfromreducedphotosystemI 2
(PSI).ReducedferredoxinreducesO2toO •
2
–aswellaspassing creases. At some O 2 /CO 2 ratio, a point is reached
electronsontoNADP+.TheelectronacceptorsofphotosystemIcan at which the leaf no longer achieves net CO 2 fix-
themselvesslowlyreduceO2toO • 2 –.Electronsmightalsoescapefrom ation, so plant growth stops. At higher O 2 /CO 2
theferredoxin–NADP+reductaseenzyme. ratios there can be net loss of carbon from the

--- Page 432 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 377
CO
2
CH 2 O P CH 2 O P CH 2 O P CH 2 O P
C O C O– HO C CO– HOOC C OH
2
H C OH C OH C O H
+
H C OH H C OH H C OH COOH
CH 2 O P CH 2 O P CH 2 O P H C OH
Ribulose 1,5- Enediol 2-Carboxy-3-keto- CH 2 O P
bisphosphate intermediate arabinitol-1,5-bisphosphate
O
2
*
CH 2 O P
H O O C O– CH 2 O P COO–
C O C + H C OH
H C OH O O–
CH 2 O P
CH 2 O P Phosphoglycollate 3 - Phosphoglycerate
Figure7.14 Oxygenaseandcarboxylaseactivitiesofribulosebisphosphatecarboxylase,thefirstenzymeoftheCalvincycle.Theperoxyketone(∗)
hasbeenreportedtodecomposeinaminorsidereactiontogenerateH2O2(FEBSLett.571,124,2004).
plant as photorespiration exceeds CO fixation, a ‘photodynamicinsecticide’.Plantscanphotosensit-
2
lethalsituationifcontinuedfortoolong.Thissitu- ize themselvesif not careful, or can be attacked in
ationmaybeapproachedevenatnormalairlevels thesameway.Forexample,Cercosporafungiattacka
in warm conditions (35 oC), because increasing rangeofcropsbyproducingcercosporin(Fig.7.15).
temperature decreases carboxylation rates relative This generates singlet O and other ROS in the
2
to oxygenation. To overcome this problem, some presence of light to damage plant cell walls and
plants(e.g.maize)haveevolvedC4photosynthesis, allow fungal entry. The fungus itself is resistant
in which oxygenation is suppressed by concen- to cercosporin and other photosensitizers; why is
trating CO in the vicinity of Rubisco. Because unknown,althougharoleforfungalpyridoxal(vita-
2
C4 photosynthesisallows plants growing in warm minB )asa1O scavengerhasbeensuggested.122,130
6 2
environmentstobemoreproductive,thereismuch
interestingeneticallyengineeringthispathwayinto
importantcropspeciessuchasrice.Rubiscoisalso 7.8.4 Solutions:minimizingtheproblem120,130
afrequenttargetofoxidativedamageinplants,as
judgedbyproteincarbonylformation.127 We described photorespiration as a problem, but it
8. Plantsmakealotofsugars,whichcanglycatepro- couldalsobeasolution;itmayhelptoensurethatun-
teins (Section 10.5.5; a plant version of diabetes derstressconditions(e.g.drought,hightemperature,
perhaps!).Indeed,highlevelsofmethylglyoxal,de- highlightintensity)someCO 2 (fromphotorespiration)
rivedfrom3-phosphoglycerate,havebeenreported isalwaysavailable,causingademandforNADPHand
inchloroplasts.128 preventing over-reduction of the electron transport
9. Many higher plants produce photosensitizers, of- chain. Phosphorylation can not only alter the align-
ten to deter pathogens.129 For example, marigolds mentofthelight-harvestingcomplexes(Section7.8.1),
produce α-terthienyl (Fig. 7.15), apparently as a but can also help to alter electron transport from its

--- Page 433 ---

378 FREE RADICALS IN BIOLOGY AND MEDICINE
OH O
OCH
3
O CH CHOHCH
2 3
H C
2
CH CHOHCH
O 2 3 S S S
α-Terthienyl
OCH
3
OH O
Cercosporin
OH O OH
HO CH 3
HO CH
3
Hypericin
OH O OH
Figure7.15 Structuresofsomeplant-derivedphotosensitizers.DiagramfromActiveOxygeninChemistry,Vol.2,1995,bycourtesyofDrChris
FooteandBlackieAcademicandProfessionalPublishers.
normalmode,producingO ,tooneofacyclicelectron have been suggested to act as ‘stress signals’. The
2
flowaroundPSI,maintainingATPproductionbutnot Dunaliella group of green algae accumulates large
generatingNADPH.Cyclicelectronflowisbelievedto amounts of β-carotene, both all-trans and 9-cis-β-
limitO •–and,possibly,singletO production.118,130 carotene,apparentlytoprotectagainstphotodamage.
2 2
Carotenoids have important antioxidant roles in Indeed, this alga has been used as a source of β-
chloroplasts.First,theyquenchsingletO rapidly(Sec- carotenefordietary‘nutritionalsupplements’.133
2
tion 4.4). Second, they can absorb energy from the
chlorophylltripletstatesthatwouldotherwiseleadto 7.8.5 Thexanthophyllcycle117,121
singlet O formation.121 Lutein and zeaxanthin (Sec-
2
tion 7.8.5) are especially important, being intimately Thiscycle(Fig.7.16),whichoccursinalllandplants,
involved in the efficient transition of light-harvesting functionstoraisethelevelofzeaxanthinwhenneeded.
complexesfroman‘energytransfertoreactioncentres’ Under low light or otherwise unstressful conditions,
modetoan‘energydissipation’mode.117,120,131Hence, zeaxanthinlevelsarelow;itisconvertedtoviolaxan-
illuminationofmutantplantsunabletosynthesizeca- thin, which does not dissipate energy well. Epoxida-
rotenoids causes rapid bleaching of chlorophylls and tion of zeaxanthin to violaxanthin, via the intermedi-
destructionofchloroplastmembranes.Similardestruc- ate antheraxanthin, is an O 2 -dependent reaction that
tiveeffectsareseeninnormalplantsifcarotenoidbio- occurs in the thylakoids under both light and dark
synthesisisinhibitedbycertainherbicides,including conditions. When there is excess light, the sequence
aminotriazole(alsoacatalaseinhibitor;Section3.17.3), isreversed;de-epoxidationisanascorbate-dependent
pyriclor, and norflurazon (Section 7.9). Exposure of process that occurs only in the light, apparently be-
Arabidopsis to high light intensity causes release of causethede-epoxidaseenzymeislocatedontheinner
volatile products of β-carotene degradation,132 which sideofthethylakoidmembraneandonlyfunctionsat

--- Page 434 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 379
OH
O
O
HO Violaxanthin
OH
O
Antheraxanthin
HO
OH
HO
noitadixopxE
De-expoxidation
½ O
2
½ O
2
Zeaxanthin
Figure7.16 Thexanthophyllcycle.
the low pH generated there when a proton gradient ascorbatemightcontribute(Section7.8.7).Chloroplasts
(Fig.7.10,legend)isestablishedacrossthemembrane. usually contain CuZnSOD, some of which is bound
The accessibility of violaxanthin to the de-epoxidase to the thylakoids, and the rest free in the stroma, at
also appears to be increased by light-dependent con- concentrations up to 30 μM. Plants often also have
formational changes in the membrane. Zeaxanthin one or more cytosolic (and sometimes peroxisomal)
facilitates energy dissipation (Section 7.8.4) and can CuZnSODs. Copper is delivered to these proteins by
quench both 1O and chlorophyll excited states and a copper chaperone (Section 3.5.1). Leaf FeSOD, pre-
2
itmaybestrategicallylocatedinthethylakoidstodo sent in some plants (e.g. Brassica campestris, tomato,
this. It then rapidly loses the energy as heat. Zeax- Ginkgo biloba, three isoforms in Arabidopsis thaliana
anthincanalsoinhibitlipidperoxidationinchloroplast leaves) is usually largely or entirely located in the
membranes.MutantsofthegreenalgaChlamydomonas chloroplast,whereasMnSODappearsnottobepresent
or of Arabidopsis121,134 lacking both lutein and zeax- in higher plant chloroplasts. However, it plays a key
anthin underwent extensive lipid oxidation and loss role in mitochondria; knockdown of MnSOD activity
ofphotosyntheticcapacityathighlightintensities.The leadstoaconitaseinhibitionandadysfunctionalKrebs
lack of either carotenoid alone impaired growth, but cycle.136
wasnotlethal.134
7.8.6.2 Removalofhydrogenperoxide
7.8.6 Solutions:antioxidantdefenceenzymes Most of the H O produced by illuminated chloro-
2 2
control,butdonoteliminate,reactivespecies plastsseemstoarisefromO
•–.LikeotherCuZnSODs
2
(Section 3.5.1), the chloroplast enzyme is slowly
7.8.6.1 Superoxidedismutases135
inactivated on prolonged exposure to H O , and
2 2
Superoxide is capable of reducing plastocyanin (Sec- FeSOD is even more sensitive (Section 3.5.3). Some
tion 2.5.3) and chloroplast cytochromes, but the sig- CalvincycleenzymesarerapidlyinactivatedbyH O
2 2
nificanceofthisinvivoisuncertain.MostO
•–
formed (Section7.8.3).Thusitisessentialthatthechloroplast
2
in plants is probably disposed of by SODs, although controlsH O levels.
2 2

--- Page 435 ---

380 FREE RADICALS IN BIOLOGY AND MEDICINE
How does it do this? Catalase is not present; leaf it is also found in the cytosol and in other plant
catalase is largely or entirely located in peroxisomes organelles.127 Oxidized ascorbate can be regenerated
andhelpsdisposeoftheH O generatedbyglycollate by GSH (in the ascorbate–glutathione cycle) or by
2 2
oxidase. This role is illustrated by the properties of NAD(P)H or reduced ferredoxin (Fig. 7.2). Lower-
Arabidopsisor barleymutantsdeficientin leafperoxi- ing 2-cys peroxiredoxin levels in Arabidopsis led to
somalcatalase;theydonotgrowwellatlowCO levels marked increases in protein carbonyl levels, des-
2
(favouring photorespiration), but grow normally at pite(apparentlycompensatory)increasesinascorbate
high CO .137,138 Most plants have multiple isoforms peroxidase,140indicatingthegreaterimportanceofPrx
2
ofcatalasearisingfromthreedifferentgenes.138 Plant inprotectingagainstoxidativedamage.
catalases are haem proteins resembling the animal
7.8.6.3 Redoxsignallinginplants
enzymes.
ThechloroplastlacksselenoproteinGPxactivity(in- Although it is important to minimize H O levels
2 2
deed selenoprotein GPx enzymes are rare or absent in chloroplasts, plants in general accumulate higher
in plants). In some plants, GPx-like activity has been levelsofperoxidesthananimals(Section7.7),bothfor
identified in chloroplasts and cytoplasm, and genes defenceandredoxsignalling.Examplesofthelatterin-
similar to those that encode GPxs in animals occur cludesignallingtothenucleustocontrolexpressionof
in several plant genomes e.g. eight (the AtGPX1-8 genesencodingchloroplastproteins.Forexample,ROS
genes)havebeenidentifiedintheArabidopsisthaliana areinvolvedinsignallingtoincreasethesynthesisof
genome.139 Plant GPxs have cysteine rather than sel- carotenoidsinthefungusNeurosporacrassawhenitis
enocysteine at the active sites, which decreases their exposedtolight.142Indeed,theexpressionofmanynu-
catalyticactivityascomparedwithselenoproteinGPx clearandchloroplastgenesinplantsseemstoberedox-
enzymes. Indeed, most or all of the plant enzymes regulated.118 Asmentionedearlier,1O cansometimes
2
may prefer thioredoxinrather than GSHas theredu- triggercelldeathinplants,butalternatively(e.g.inAr-
cing substrate.139 Glutathione-S-transferases, present abidopsisandthegreenalgaChlamydomonasreinhardtii)
in many plants, can reduce organic hydroperoxides, it can induce increased levels of antioxidant defence
butthephysiologicalsignificanceofthisisuncertain. enzymes that increase resistance to singlet O ,121 as
2
Plants are rich in glutaredoxins and thioredoxins: in- maysomeβ-caroteneoxidationproducts.132Thephos-
deedthioredoxinsplayakeyroleinredoxregulation phorylation/dephosphorylationofthylakoidproteins
of enzyme activity in the chloroplast, especially fruc- thatregulatesenergytransferisalsoredox-regulated,
toseandsedoheptulosebisphosphatases.Forexample, althoughthedetailsareunclear.118
reduced thioredoxin can help to restore their activ-
ity after damage by H 2 O 2 .120 Oxidized thioredoxin 7.8.7 Ascorbateandglutathione120,127
in chloroplasts is re-reduced by both ferredoxin- and
NADPH-dependentsystems.Glyoxalasesareveryim- The chloroplast stroma contains mM levels of GSH,
portant in plants, to remove methylglyoxal and pre- andascorbateatconcentrationsupto25mM.Thera-
vent‘plantdiabetes’.128 tios of reduced to oxidized forms (GSH/GSSG and
Plant peroxiredoxins play a key role in peroxide ascorbate/dehydroascorbate) are normally high un-
removal.140 For example, the Arabidopsis genome has derbothlightanddarkconditions.GSH/GSSGratios
ten genes encoding Prx. Four types of enzyme have are kept high by the action of glutathione reductase,
beenidentified,1-cys,2-cys,Prx5,andPrxQ.Thelast and possibly by temporary sequestration of GSSG in
appearsnottobefoundinanimalsandisamonomeric vacuoles(Section3.10.2).
protein.The2-cysformsseemtobethemostimportant Ascorbate and GSH might act as RS scavengers in
inchloroplaststoaidinremovalofH O andpossibly chloroplasts,e.g.themillimolarascorbatelevelscould
of organic peroxides, and some or 2 all 2 of them are contributetoremovalofO • 2 – (Section4.2.1).Asinani-
thylakoid-bound. PrxQ is also found bound to thyla- mals,GSHisinvolvedinarangeofprocessesinplants,
koids,butseemstoplayalesserrole.Whetheroxida- including cell differentiation, detoxification of xeno-
tionofPrxplaysaroleinmodulatingH O signalling biotics(e.g.herbicides),andflowering.Itcanalsolead
2 2
inplants(asitdoesinanimals)isasyetuncertain,but toproteinglutathionylationifthechloroplastisunder
itseemslikelysincesulphiredoxinispresent.141 oxidativestress,reversiblebyglutaredoxin.Rubiscois
AnadditionalH O -metabolizingenzymeisascor- onetarget.However,glutathionylationcouldserveas
2 2
bate peroxidase (Section 3.19.6). In chloroplasts it is aprotectivemechanismforenzymeswithlabilethiol
present in both stromal and thylakoid-bound forms; groupsperhaps(Section3.11).

--- Page 436 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 381
Glutathione synthesis in higher plants occurs by a tocopheryl radicals). It may help to scavenge singlet
two-stage mechanism similar to that in animals (Sec- O aswell,althoughitisprobablylessimportantthan
2
tion 3.10.3). Some plants (e.g. legumes) have evolved thecarotenoids.Forexample,α-tocopheroldeficiency
modified enzymes that synthesize other thiols, such did not affect growth of Arabidopsis under normal
as homoglutathione (Fig. 3.9). The enzyme synthes- lightconditionswhereascarotenoiddeficiencycauses
izing this in soybean, for example, resembles human problems.145However,levelsofzeaxanthin,ascorbate,
glutathione synthetase, but uses β-alanine instead of and GSH in the α-tocopherol-deficientplant were in-
glycineasasubstrate.143Insomeplantsserinereplaces creased,presumably tohelpcompensate.Indeed, Ar-
glycine,togivehydroxymethyl-glutathione.143 Plants abidopsis plants lacking α-tocopherol were more sen-
alsocontainmetallothioneinsandphytochelatins(Sec- sitive to photoinhibition at high light intensities, ap-
tion3.23.2andref143). parently due to slower repair of D1.146 In Chlamy-
Apartfromsomedryseeds,ascorbateispresentin domonas treated with the herbicide pyrazolynate to
allpartsofplants,includingtheapoplast.144 Themil- block α-tocopherol biosynthesis, illumination caused
limolarlevelsintheapoplastmayhelptoremoveoxi- acceleratedlossof α-tocopherol,D1protein,andPSII
dizingtoxinssuchasNO • andO beforetheyreachthe activity.147 Arabidopsis mutants lacking violaxanthin
2 3
underlyingleafcells.Asinanimals,ascorbateinplants de-epoxidaseaccumulatedmoreα-tocopherol,further
is involved in several metabolic processes important illustrating the likelihood of cross-compensation be-
incellgrowthanddifferentiation,includinghydroxyl- tween antioxidant defence systems when one is
ation of proline in cell wall proteins, and it is a pre- missing.145
cursorofoxalateandtartrateinsomeplants,144aswell γ-Tocopherolsmayalsohelpplantstoresistdamage
•
as participating in the xanthophyll cycle (Fig. 7.16). byRNSsuchasNO frompollutedair(Section7.9.3)
2
Ascorbate synthesis is accelerated upon light expos- anditispossible,althoughnotproven,thattheyhave
ure of plants. Ascorbate oxidases, copper-containing additionalmetabolicroles.148 Tocotrienolsareamajor
enzymes that convert ascorbate to SDA whilst redu- componentofvitaminEinseedsofseveralplants,such
cing O to H O, are found in many plant tissues. asrice,oats,wheat,andpalm.Ofcourse,‘vitaminE’is
2 2
Theyhaveusuallybeenisolatedfromfruitsandveget- amisnomerforplantssincetheycanmakeit!
ables(squash,melon,cucumber,pumpkinetc.),where The reduced form of plastoquinone (plastoquinol)
theyaremainlyassociatedwithcellwalls.Theirfunc- can, like ubiquinol (Section 3.25.5), scavenge peroxyl
tion is uncertain, although a role in promoting cell radicals and inhibit lipid peroxidation in vitro.149,150
wallgrowthhasbeenpostulated.144However,insome Indeed, mitochondrially targeted antioxidants based
plants(suchastobacco)ascorbateoxidasecanbepre- on it have been designed (Section 11.5.12). It can
sentintheapoplast,andmayhelptoregulateascorbate alsoquenchsingletO .146 Whetherthesereactionsare
2
levelsthere. important in planta is uncertain. Some plastoquinol
Whereasthelaststepofascorbatesynthesisinani- canbeconvertedintoplastochromanolandhydroxy-
malsgeneratesH O (Section4.2),thatinhigherplants plastochromanol,
2 2
usually does not. Although several pathways exist,
mostascorbatearisesfromapathwayinwhichGDP- (HO)
OH
D-mannose is converted via GDP-L-galactose into L-
galactono-1,4-lactone. This is oxidized to L-ascorbate
byL-galactono-1,4-lactonedehydrogenase,locatedon O 7 H
the outer side of the inner mitochondrial membrane
anddonatingelectronstocytochromec.Thisenzyme
canbeinhibitedbythealkaloidlycorine.144 which may act as singlet O 2 scavengers (probably a
back-up to the carotenoids)150 and inhibitors of lipid
peroxidation.
7.8.8 Planttocopherols
Whereasnon-greenplanttissuescontainamixtureof
7.8.9 Solutions:sequesteringtransition
tocopherols, γ-tocopherol often predominating (Sec-
metalions151
tion4.3),thechloroplastenvelopeandthylakoidmem-
branes are enriched in α-tocopherol (indeed it is Plantsabsorbmetals,includingironandcopperions,
synthesizedinthechloroplast).Ithelpstoinhibitlipid fromthesoilandincorporatethemintomanyessential
peroxidation (ascorbate could presumably regenerate proteins. During the transport between tissues, cells,

--- Page 437 ---

382 FREE RADICALS IN BIOLOGY AND MEDICINE
and within cells, care must be taken that the redox controlled!)ROSproduction(e.g.byNADPHoxidases;
abilityofthesemetalionsdoesnotcauseexcessiveoxi- Section8.11.1)seemsinvolvedintheonsetofthesym-
dativedamage.Weknowfarlessaboutthisinplants biosis, during infection of the roots by the necessary
thanwedoinanimals,exceptthatferriccitrate,which bacteria. The leghaemoglobin present in nodules (a
haslimited(butnotzero)redoxactivity,appearstobe monomeric haem protein resembling myoglobin) has
amajortransportformfromrootstoleaves. a high affinity for O and keeps O levels low (prob-
2 2
Nearly 90% of the iron in green plants is in the ably ≤ 1 μM) to protect N fixation. Should O or
2 2
chloroplasts.Theseorganellescontainferritinsresem- H O levelsrise,leghaemoglobinisapotentialthreat
2 2
blinganimalferritins,whicharealsopresentinother becauseitcanoxidizetogenerateO
•–
aswellasreact
2
partsoftheplant.Knockoutofgenesencodingferritin withH O togiveferrylspeciesand/ortoreleaseiron
2 2
raisesoxidativestresslevelsinArabidopsis,indicating ions (Section 3.22.3). Nodules are rich in antioxidant
their important role. Some iron may be stored in the defences, including catalase, GSH, CuZnSOD, perox-
central vacuole of leaves. Plants also contain metal- iredoxins,MnSOD,sometimesFeSOD,GST,phytoche-
lothioneins,whichmayhelptosequestercopper and latins, metallothionein, ascorbate, thioredoxins, and
zincionsanddiminishoxidativedamageundersome (sometimes) homoglutathione (Section 3.9) and they
circumstances.152 Arabidopsis thylakoids also contain operatetheascorbate–glutathionecycle(Fig.7.2).They
a lipocalin protein (Section 3.22.4.1); plants lacking alsocontainferritin.
thisshowedhigherlevelsoflipidperoxidationwhen Eventually, nodules undergo senescence, as do we
exposedtohighlightstressatlowtemperature.153 all.Nitrogenfixationdecreases,someantioxidantde-
fences decline, leghaemoglobin degrades, ‘catalytic’
iron levels rise, and oxidative damage increases (at
7.8.10 Solutions:repairandreplacement
least in soybean nodules, although maybe not in all
A large part of chloroplast protein synthesis in the otherplantnodules).Moreworkisneededtoelucidate
lightisdevotedtoreplacingtheD1proteininphoto- theexactsequenceofevents.161
systemII,asmentionedearlier.DNArepairenzymes
are present in chloroplasts, the most important being
photolyases that cleave UV-induced pyrimidine di-
7.9 Plantsastargetsforstressandtoxins
mers(Section5.10.1),sinceDNAdamagebyUVlight
isamajorthreattoplants.154 Leafcytosol(e.g.inAra-
7.9.1 Inhibitionofelectrontransportand
bidopsis)containsanenzymethathydrolyses8OHGTP
carotenoidsynthesis118,121
and8OHdGTP,presumably‘sanitizingthenucleotide
pool’ (Section 5.10.2).155 Chaperones in chloroplasts Many herbicides, e.g. diuron (DCMU) and atrazine
assist protein folding, including their refolding after (Fig. 7.17) bind to the D1 protein of photosystem II,
partial denaturation. Reduced thioredoxin can reacti- and inhibit chloroplast electron transport. This stops
vateseveralchloroplastenzymesinactivatedbyROS, light-dependent generation of ATP and NADPH and
such as the oxidized forms of fructose and sedohep- thus CO fixation. Carotenoid destruction, chloro-
2
tulose bisphosphatases.120 Methionine sulphoxide re- phyllbleaching,andmembranelipidoxidationresult,
ductases, MsrA and B, also thioredoxin-dependent, probably caused by excess singlet O resulting from
2
are present in chloroplasts and cytoplasm, presum- blocked energy dissipation. Indeed, this singlet O
2
ably to remove oxidized methionine residues, al- can be directly imaged (Fig. 7.12). Herbicide inhibi-
though not much is known about their importance tors of carotenoid biosynthesis have similar effects
as yet.156 Chloroplasts and other parts of the plant (Section7.8.4).
contain 20S and 26S proteasomes, plus a range of The diphenylether herbicides (e.g. oxyfluorfen;
otherproteinases,andarolefortheproteasomeinre- Fig.7.16)alsodamageplantsbygeneratingsingletO
2
movalofoxidizedproteinshasbeensuggested.157Lon andotherROS,resultinginlipidoxidationandother
proteinase (Section 5.14.3.2) is also present in plant oxidativedamage.Theyactinadifferentway,byin-
mitochondria.158 hibiting the enzyme protoporphyrinogen oxidase in
mitochondria and chloroplasts, which leads to accu-
7.8.11 Thespecialcaseoftherootnodule159,160 mulationofthephotosensitizerprotoporphyrinIX.162
Thiscouldberegardedasaplantversionofporphy-
Leguminous plants often use symbiotic bacteria in ria! These agents are even being explored for use in
rootnodulestofixnitrogen.Somedegreeof(carefully photodynamictherapy(Section2.6.4.4).162

--- Page 438 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 383
CI
R = C H
1 2 5
2Br– N N
CH
3
H N C + + C N H R 1 HN N NHR 2 R 2 = CH CH 3
2 2
Diquat (dibromide) Atrazine
NO
2
H 3 C N+ +N CH 3 2CI– F 3 C O NO 2
Paraquat (dichloride) Fluorodifen
CI CI OC H
2 5
CH
3
CI NHCON CF O NO
3 2
CH
3
DCMU Oxyfluorfen
Figure7.17 Structuresofsomeherbicides.
7.9.2 Bipyridylherbicides 7.9.2.1 Redoxcycling163
The bipyridyl herbicides paraquat and diquat are Many years ago, it was observed that the killing of
useful because they kill a range of weeds, but do green plants by paraquat or diquat is accelerated by
not accumulate in soil, being destroyed by various light, but slowed if O 2 levels are decreased by flush-
microorganisms.163 ‘Bipyridyl’ means that that the ing with nitrogen. Later work showed that paraquat
structurecontainstwopyridinerings,aromaticringsin and diquat can cross the chloroplast envelope. Once
whichacarbonatomisreplacedbynitrogen.Therings inside,theyacceptelectronsfromtheFe–Sproteinsas-
maybejoinedbytheirnumber-2carbonatoms,orby sociatedwithPSIandalsofromtheflavinattheactive
theirnumber-4carbonatoms(thenitrogencountingas siteofferredoxin–NADP+reductase(Fig.7.13),andare
atomnumber1),togive2,2(cid:4)-bipyridylor4,4(cid:4)-bipyridyl reduced to bipyridyl radicals. These radicals can be
respectively. The prime is used to indicate an atom identifiedinparaquat-treatedchloroplastsbytheirab-
in the second ring. In paraquat, a methyl group is sorbance or ESR spectra if O 2 is absent. When O 2 is
attached to each nitrogen; its full chemical name is present,however(asitusuallyisinchloroplasts!),the
1,1(cid:4)-dimethyl-4,4(cid:4)-bipyridylium ion (Fig. 7.17). In di- radicals disappear because they react rapidly with it.
quat, the two nitrogen atoms are joined by an ethyl- IfBP2+ isusedtorepresentabipyridylherbicide,the
enegroup,togive1,1(cid:4)-ethylene-2,2(cid:4)-bipyridyliumion. reactionsare
Paraquat is usually manufactured as a chloride salt,
diquatasabromide. BP2+−e−le−ct−ro−n−tr−an−sp−o→rt
BP
•+
4,4(cid:4)-Bipyridyl compounds form coloured products chain
upon reduction. Several such compounds, under the BP •++O 2 →BP2++O • 2 –
generalnameviologens,havebeenusedforthisreason
(k=7.7×108M–1s–1, forparaquat)
tostudyredoxreactions.Thusparaquatissometimes
called methyl viologen. The colour is produced by
one-electronreductiontoformaradicalthathasachar- Thustreatmentofilluminatedchloroplastswithpara-
acteristicESRspectrum,andabsorbsvisiblelight(λ
max
quat or diquat leads to a rapid uptake of O
2
, as they
isat603nmforparaquat).Theextraelectrondelocal- are continuously reduced and reoxidized to generate
izesoverbothringswithpartialneutralizationofthe O
•–
in a redox cycle. Hence bipyridyl herbicides are
2
positivechargeoneachnitrogenatom. examplesofredox-cyclingagents(Section9.5).

--- Page 439 ---

384 FREE RADICALS IN BIOLOGY AND MEDICINE
Much of the O •– will be converted into H O by oftobaccoplantsoverexpressingferritin,171andthein-
2 2 2
chloroplast SOD; indeed, both H O and O
•–
can creased lipid peroxidation seen when plants lacking
2 2 2
be imaged in paraquat-treated levels (Fig. 7.12B). chloroplastlipocalinwereexposedtoparaquat.153 In-
By contrast, little 1O is formed (Fig. 7.12B). H O deed, the DMSO method (Table 6.4) detected OH• in
2 2 2
is normally dealt with by peroxiredoxins and the paraquat-treatedplants.172
ascorbate–glutathione cycle. However, the former Paraquatanddiquatarealsotoxictonon-greenplant
are susceptible to oxidation and inactivation at high tissues.Forexample,theycausemembranedamagein
H O levels (Section 3.13.2). In paraquat-treated fungi such as Aspergillus niger. If this is due to redox
2 2
chloroplasts, the load of H O is such that GSH and cycling, how are the bipyridyl radicals formed? Sev-
2 2
ascorbate are quickly oxidized, inactivation of key eralflavoproteins,includingglutathionereductase,can
Calvin cycle enzymes occurs (Section 7.8.3, point 5), reduce paraquat and/or diquat; the herbicides take
and CO fixation stops.164 If ascorbate levels fall too electronsfromtheflavinring.Similarreactionscanac-
2
low,ascorbateperoxidasecanbeinactivatedbyH O countforthe(slowlydeveloping)toxicityofparaquat
2 2
(Section 3.19.6). An additional reason for inhibition toleavesinthedark.Indeed,transgenictobaccoplants
of CO fixation is that diversion of electrons to the expressing MnSOD in the chloroplast were more re-
2
herbicides decreases the supply of NADPH for the sistant to paraquat in the dark. However, increased
Calvincycle,andforglutathionereductase. resistance was also observed if MnSOD was overex-
InhibitionofCO fixationisfollowedbymembrane pressed in the mitochondria, suggesting that ‘dark’
2
damage,lipidperoxidation,andleakageofionsfrom paraquatreductioncaninvolveenzymes(e.g.glutathi-
the leaves. Electron microscopy reveals damage to onereductases)presentinbothorganelles.165
thylakoidsandeventuallyothermembranes,including A major disadvantage of bipyridyl herbicides is
themembranesurroundingthecentralvacuoleofthe that they can poison animals (including us!), an ac-
plant cell. This vacuole contains hydrolytic enzymes, tionalsomediatedbyROS.Wediscussthisfurtherin
andoftenaccumulatesorganicacidstoahighconcen- Section9.4.
tration, so release of its contents into the rest of the
cellwillpotentiatedamage.Paraquatalsocausesoxi-
7.9.3 Environmentalstress:airpollutants
dative DNA and protein damage.155,165 For example,
(ozone,sulphurdioxide,nitrogendioxide)
inparaquat-treatedpealeavestherewasrapidinacti-
vation of several mitochondrial proteins, especially Plants are constantly subject to environmental chal-
glycine decarboxylase, possibly by the action of end- lenges,suchasvariablelightintensity,fluctuatingtem-
productsofperoxidationsuchasHNE.165 peratures,differencesinwateravailabilityorsoilsalin-
ity,mechanicaldamage,andattackbypathogens.They
7.9.2.2 EvidencethatROSareimportant
also suffer damage from air pollutants. Worldwide,
inparaquattoxicity
ozone may cause more damage to crops and forests
Much evidence supports a role for O • 2 – and H 2 O 2 in thananyotherairpollutant.Todealwithallofthese
thedamagetoplantscausedbybipyridylherbicides. challenges,plantshaveevolvedmultipleoverlapping
PlantsoverexpressingCuZnSOD,otherformsofSOD, signallingandstressresponsemechanisms,almostall
orcatalase,aregenerallymoreresistanttoparaquat,166 of them involving ROS at some stage (Section 8.11).
as are Arabidopsis plants overexpressing ascorbate Take O for example. Exposure of plants to it causes
3
peroxidase167 or methionine sulphoxide reductase,168 direct oxidation of proteins and lipids, aldehyde for-
whereas plants lacking various antioxidant defence mation,andDNAdamage(Section2.6.5).Forexample,
enzymesaregenerallymoresensitive.139 levelsof8OHGinchloroplastDNArise173 ifbeansor
The protective effects of SODs, ascorbate peroxid- peasareexposedtohighlevelsofO .Ozonecantrigger
3
ase, or catalase suggest that O • 2 – and H 2 O 2 are both theplanthypersensitivityresponsetopathogens(Sec-
involved in paraquat toxicity. Is this via OH•? Prob- tion8.11),which,ifnotproperlycontrolled,cancause
ably;expressingafungalgeneintobaccochloroplasts seriousdamage.Iftheplantdoescontrolit,however,it
that raised the intra-chloroplast mannitol (a putative canparadoxicallyinducedefencesystemsthatleadto
OH• scavenger) concentration to ~100 mM rendered tolerance not only to O but also to other toxins and
3
theplantslesssensitivetoparaquat.169 Desferrioxam- to pathogens (Section 8.11). For example, limited ex-
ineprotectspea(Pisumsativum)leavesagainstdamage posuretoO caninduceresistancetotobaccomosaic
3
byparaquat,consistentwitharoleforiron.170 Sucha virusintobaccoplantsandtoPseudomonassyringaein
roleissupportedbytheincreasedparaquatresistance Arabidopsis.174

--- Page 440 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 385
Antioxidantsplayakeyroleintheabilityofplants 7.9.4 Environmentalstress:heat,cold,
to resist oxidizing air pollutants such as O and ni- anddrought
3
•
trogen dioxide (NO ). Developing tolerance to O
2 3
can involve increased synthesis of ascorbate, GSH, Exposureofleavestohighlightintensitiescausespho-
catalase,phenoliccompounds,methioninesulphoxide toinhibitioninvolvinglossofD1;photosynthesisslows
reductase, ascorbate peroxidase, and glutathione re- down and the chloroplast is damaged (Section 7.8.3).
ductase; indeed, tobacco plants low in catalase were High light intensity is often accompanied by heat
more sensitive to O , whereas they were more resist- and/ordroughtstress,andplantscanrespondbyrais-
3
ant if overexpressing MnSOD in the chloroplast. The inglevelsofheatshockproteins(includingHsp100,90,
first ‘line of defence’ may be ascorbate in the apo- 70,60,andsmallHspfamilies)183,184aswellasantioxi-
plast, since ascorbate reacts rapidly with O . Indeed,
dantdefencessuchasSOD,α-tocopherol,methionine
3
loweringapoplasticascorbatelevelsincreasedthesen- sulphoxide reductase, and the ascorbate–glutathione
sitivity of Arabidopsis and tobacco plants to O .175 In- cycle.184ROSplayanessentialroleassignallingagents
3
terestingly, different vtc mutants (for ‘vitamin C’) in to trigger the plant heat shock response e.g. the Ar-
Arabidopsisgenesencodingdifferentenzymesoftheas- abidopsis heat-shock transcription factors (HSF, Sec-
corbatebiosyntheticpathwayledtovariableincreases tion 5.6) act as sensors of increased H 2 O 2 produc-
in sensitivity to O , even though they lowered leaf tion at elevated temperatures.183 Isoprene production
3
ascorbate to about the same extent.176 Levels of leaf may also be somewhat protective. Plants can also be
antioxidantsvarywithleafageandalsoseasonally,176 stressed by exposure to high salt levels. Increasing
andsopollutionresistancecansimilarlyvary.Another ascorbate, SOD, α-tocopherol and other antioxidant
relevantcompoundmaybeisoprene(C H ;2-methyl- levelsmayhelptoprotect;184ROSarealsoinvolvedin
5 8
1,3-butadiene),whichisproducedinthechloroplasts triggeringthisresponse(Section8.11.1).
of several plants. Blocking its synthesis increasesleaf Attheotherextreme,manytemperateplantsshow
damagebyO .WhetheritscavengesO directlyorex- depressed photosynthesis after exposure to low tem-
3 3
ertsindirecteffectsisuncertain.177Isoprene,likemany perature for one or more days (chilling injury). This
alkenes,reactsquicklywithsingletO andO . probablyinitiallyinvolveschangesinmembranestruc-
2 3
Nitrogendioxideispro-oxidant(Section9.12.2)and ture as the lipids ‘freeze’ below their transition tem-
additionally contributes to the acid rain that is dev- perature. Fluidity is decreased and electrons cannot
astatingtreesinseveralcountries.Acidraindamages passproperlythroughtheirnormalpaths.Inaddition,
plantsbothbyitslowpH,andbyconvertinginsoluble decreasedactivityofCalvincycleenzymesatlowtem-
compoundsoftoxicmetalsinthesoil(e.g.aluminium) perature reduces the demand for NADPH. Chilling
into soluble metal ions that can be absorbed by the injury affects photosystem II via damage to D1, and
plant. Ascorbate and tocopherols help plants to res- ROSagainplayarole.Forexample,astrainofChlorella
istNO • .Thus,ascorbatereadilyreducesNO • toNO – resistanttochillinginjuryshowedgreaterSODactivity
2 2 2
(Section9.12.2),andγ-tocopherolcanreactwithNO • thandidasensitivestrain;increasingtheSODactivity
2
toformanitroadduct(5-nitro-γ-tocopherol).Theim- of Chlorella by pretreating it with paraquat conferred
portanceofthisinplantaisuncertain,178althoughgrain increased resistance to chilling.185 Transgenic tobacco
stored in silos can sometimes generate high levels of plantsexpressingpeaCuZnSODinthechloroplast(so
NO • thatmightbescavengedbyγ-tocopherol.179 raising total chloroplast CuZnSOD) are more resist-
2
Sulphur dioxide can damage plants. This toxic re- ant to chilling injury, as are transgenic cotton plants
ducinggasdissolvesinwatertoformsulphitesandbi- expressing MnSOD in the chloroplast. By contrast,
sulphites,whichcanoxidizetogenerateO •–,sulphur- antisense‘knockdown’ofcatalaseintomatoplantsin-
2
containing radicals, and H O (Section 9.12.3). Hence creased their susceptibility to chilling injury.186 Many
2 2
antioxidants help to protect against SO toxicity. For plants can respond to low temperatures by activat-
2
example,growthofthealgaChlorellainthepresenceof ing mechanisms that enhance their ability to resist
sulphiteraisedSODlevelsandrendereditmoreresist- chilling or freezing (cold acclimation). This process
anttoparaquat.180Similarly,aparaquat-resistantstrain involves H
2
O
2
production (Section 8.11.1). Hence in-
ofConyzaboriensis(withelevatedSOD)ismoretoler- creasingantioxidantlevelscanhelpplantsresiststress,
ant to SO than the wild type, whereas the vtc1 mu- butincreasingthemtoomuchmightimpairadaptive
2
tantsofArabidopsisaremoresensitive.181Poplarplants responses(justlikeinanimals!).
with increased GSH levels are also more resistant182 Water deprivation also induces oxidative stress in
toSO . plants,frequentlyloweringSH/disulphideratiosand
2

--- Page 441 ---

386 FREE RADICALS IN BIOLOGY AND MEDICINE
increasing oxidativeprotein damage (although gluta- (zooxanthellae) within their cytoplasm; the zooxan-
thionylation can sometimes protect proteins). Water thellaephotosynthesizeandprovidenutrientsfortheir
loss in the presence of excess light accelerates pho- hostandreceiveprotectionfromherbivoresinreturn.
toinhibition. Once antioxidants such as GSH are se- However,thehostmustsuffertheO production.Both
2
verely depleted on prolonged desiccation, the plant partners have antioxidant defence systems adequate
may be unable to recover.187 In some species, there forthe‘normal’environment.IfUVexposureand/or
is an adaptive response to water deprivation involv- temperaturerisetoofar,excessRScanbemade,which
ingincreasedenergydissipationandsometimesraised canresultincoralbleaching,photoinhibition,oreven
levels of antioxidants such as SOD, thioredoxin, α- deathofthesymbiontanddegradationofitsphotosyn-
tocopherol, carotenoids, and ascorbate peroxidase.188 theticpigmentswithconsequentcolourloss.Damage
This response occurs, at least in part, as a result of tothehostresults,bothbyoxidativestressandbylack
increased H O production.189 Indeed, transgenic al- of nutrients.194 Often, the coral attempts to resist the
2 2
falfa (Medicago sativa) plants overexpressing MnSOD stress by synthesizing mycosporine-like amino acids
tolerated water deficit better,190 as did tobacco plants (Section3.25.9).
overexpressing catalase. Chilling or water stress in Overgrowthofcertainunicellularmarineorganisms,
pea plants causes lipid peroxidation and inactivation causedbyexcessnutrientsduetowaterpollution,can
of mitochondrial glycine decarboxylase,165 an effect leadtothedeathoffish.Theorganismsproducetoxins
resemblingthatofparaquattreatment(Section7.9.2.1). thatattackthegills,causingthefishtodieofanoxia.
The ability of many seeds to resist drying for One of these toxins (although probably not a major
long periods can involveaccumulation of high levels contributor) appears to be H O and/or other ROS;
2 2
of certain sugars, thioredoxin, and other protect- thishasbeendemonstratedinthetoxicredtideplank-
ive proteins.191 Tocopherols, plastochromanol (Sec- tons Chattonella marina and Karenia mikimotoi, which
tion 7.8.8), and methionine sulphoxide reductases havekilledmanyfisharoundJapan.195
A and B are also important in facilitating seed
longevity,192,193sincedeteriorationofseedsduringpro-
7.10 Theeye
longed storage involves oxidative damage to lipids
andproteins.191 Indeed,vitaminEdeficiencyinseeds Theeye(Fig.7.18)combinesproblemsofthelung(the
leads to elevated levels of phytoprostanes and other corneaisexposedto21%O ),erythrocytes(long-lived
2
lipid oxidation products, plus greatly decreased seed proteinsinthelens),andchloroplasts(theriskofdam-
longevity.148,191,193YetsomeROSareuseful—theyplay
age by too much light). We have already described
aroleinseedgermination(Section8.11.15);theusual retinopathy of prematurity (ROP) in premature ba-
redoxbalance! bies (Section 1.5.2.1), but problems also arise at the
Paradoxically, not only drought but also waterlog- otherendoftheagespectrum.Oneismaculardegen-
ging can cause oxidative stress in plants. Submerged eration(Section7.10.5).Anotheriscataract,definedas
partsofplantsmaybecomehypoxic,andhypoxicsig- a clinically significant opacity of the lens. These two
nalling (to increase the levels of proteins needed for conditionsaccountformostcasesofadultblindnessin
survivalatlowO 2 ,suchasalcoholdehydrogenaseand theworld.
Hsps)involvesH 2 O 2 (fromNADPHoxidaseenzymes The outward-facing side of the lens is covered by
and possibly some from mitochondria) in plants.183 a layer of highly metabolically active epithelial cells
Uponre-exposuretotheairan‘ischaemia–reperfusion thatundergodivision,elongation,anddevelopmentto
damage’ (Section 10.6) involving excess ROS produc- formthelensfibres,whichsynthesizethemajorpro-
tion can also occur (Section 10.6).183 ROS are also teins of the lens, the crystallins.196 These account for
involved in the adaptive response of plants to high about90%ofthesolubleproteinofthelensfibresand
salinity(Section8.11.1). therearethreemainclasses(α-,β-,andγ-crystallins)in
mammalianeyes.Newlyformedfibrespushtheolder
onestowardsthecentreofthelenstoformthelensnu-
7.9.5 Coralreefbleachingandtoxicalgal cleus.Newfibreproductionisrapidinyounganimals,
but soon decreases to a low constant level for the re-
blooms:examplesofplant-dependentoxidative
mainder of the lifespan. Thus the inner region of the
stress?
lensistheoldestpart.Thenucleus,mitochondria,and
Production of RS is contributing to the degradation otherorganellesarelostduringfibrematurationasthe
of the world’s coral reefs. Many coral reef inver- fibresbecomemoretransparent,sothatfullydifferen-
tebrates accommodate endosymbiotic dinoflagellates tiatedlensfibres,whichcomprisealargeproportionof

--- Page 442 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 387
Rectus muscle Sclera
Conjunctiva Choroid
Iris
Retina
Cornea
Aqueous Optic
humour nerve
Pupil Blind spot
Lens
Fovea
Suspensory
ligament
Vitreous
Ciliary humour
body
Ciliary
muscle
Figure7.18 Structureofthemammalianeye.Thescleraisatoughfibrouscoat,enclosingthechoroidlayercontainingbloodvesselsthat
supplyfoodandO2totheeye.Thechoroidishighlypigmentedwithmelanin.Theaqueoushumourisawateryfluidwhereasthevitreous
humourismorejelly-like.Pressureofthesefluidsoutwardsonthescleramaintainstheshapeoftheeye.Anymarkedvariationinthepressureof
thehumourscanalterbloodflowintheeye.Forexampleocularhypertension(toomuchpressure)canrestrictbloodflowandcauseischaemic
damage(Section10.6.8);glaucomaisagroupofdiseasesinwhichthisoccursandhasbeenassociatedwithincreasedoxidativedamageto
proteins,lipids,andDNAandproteinnitration(Exp.EyeRes.87,409,2008;FreeRadic.Biol.Med.45,367,2008;Prog.RetinalEyeRes.25,490,
2006)anddamagetotheopticnerveandretina.Anothercontributortoglaucoma(andtoretinaldamagebyischaemia–reperfusion)istherelease
ofexcessglutamateandsubsequentexcitotoxicity(Section10.17.4).Thecornea,lens,andconjunctivaobtainnutrientsandO2bydiffusionfrom
theaqueoushumour—theycontainnobloodvessels.Thelensissuspendedinpositionbyligamentsandcoveredbyacollagenouscapsule.The
retinacontainsneuronsspecializedtorecognizelight.Thesephotoreceptorsareoftwotypes,rodsandcones.Thelight-absorbingmaterialisan
aldehyde,11-cis-retinal,attachedtospecificproteinscalledopsins,suchasrhodopsininrodsorcone-opsinsincones.Uponexposuretolight,
11-cis-retinalisomerizestoall-trans-retinal,fallsofftheprotein,andmustthenbereconvertedtothiscisform(Fig.7.19).11-cis-Retinalis
synthesizedfromvitaminA.Onlytheconesaresensitivetocolouredlight,buttherodsaremoreresponsivetodimlight(hencethediminished
perceptionofcolouraslightintensitydecreases).Themacularregion(maculainLatinmeans‘spot’or‘stain’),about6mmdiameterinhumans,
istheareaofgreatestvisualacuity.Itsurroundsthefovea,adepressioninthemiddleoftheretina,highlyenrichedincones.Inhumansandother
primates,themacularregionisyellowbecauseluteinandzeaxanthinarepresent.
thelensinadultanimals,cannolongersynthesizepro- tryptophan derivatives may be protective; Section
teinstoreplacedamagedones,althoughthelensfibre 7.10.2.1). Lens crystallins turn over only slowly,
protein concentration (around 400 mg/ml) is among sodamageaccumulates.Theirnormalorganization
the highest in the body. The lens epithelium actively maintains the transparency of the lens: denatur-
transportsNa+ outofthelens,andK+ intoit,usinga ation, oxidation, and aggregation decrease trans-
Na+,K+-ATPaseenzyme.197 parency. To some extent, α-crystallin can act as
a ‘chaperone’ (Section 5.6), helping to protect the
othercrystallinsfromthermalinsultandoxidative
7.10.1 Whatproblemsdoestheeyeface? cross-linking.Glycationandoxidation(e.g.onme-
thionine residues) can favour protein aggregation
1. Thecorneaisexposedtothe21%O 2 ofambientair, anddiminishchaperoneactivity.196,199,200
andtoanyatmosphericpollutantsandirritants. Hence diabetes,200 prolonged exposure to sun-
2. The lens contains photosensitizers of singlet O 2 light, other UV sources, or ionizing radiation are
formation, and too much light can thus lead to risk factors for cataract. Indeed, proteins isolated
oxidation and cross-linking of lens proteins, aided from cataractous lenses contain elevated amounts
by the high protein concentration in the lens. of oxidative damage products, including methio-
For example, UV light degrades tryptophan to N- ninesulphoxide,tryptophandegradationproducts,
formylkynurenine (Fig. 5.30), which can sensitize meta-tyrosine, ortho-tyrosine, L-DOPA, and leucine
singlet O 2 formation198 (by contrast, some other hydroxide.201 Cataractous lenses show elevated

--- Page 443 ---

388 FREE RADICALS IN BIOLOGY AND MEDICINE
H O but decreased GSH levels, and lipid perox- levelsincreaseafterlightexposure.211 Oneproduct
2 2
ide levels are increased in the aqueous humour of of DHA oxidation, 4-hydroxy-7-oxohept-5-enoic
cataractpatients.197,202,203 acid,canreactwithprotein-NH groupstoform2-
2
3. Thevitreoushumour(Fig.7.18)containshyaluronic (ω-carboxyethyl)pyrrole adducts (CEP adducts).206
acid. This can be depolymerized by OH•, causing Unfortunately, the ‘visual pigment’ rhodopsin and
lossofviscosity(Section10.11).NormalH O levels itsproductA2E(Fig.7.19) readilysensitizeforma-
2 2
intheeyehavebeenestimatedbysomeauthorsat tionofsingletO ,andphotoreceptoroutersegments
2
20 to 30 μM, but other scientists have challenged containrhodopsinalongsidethehighestDHAlevel
the validity of the assays used, and the possibility of any cell in the human body.212 Hence, expos-
of post mortem H O generation in eyes must not ure of isolated retinas or animal eyes to high light
2 2
beignored.Amorerealisticvaluemaybearound1 intensitiesinduces rapid lipid oxidation.213 Retinal
μMnormally,higherincataract.202,203Nevertheless, proteins and nucleic acids can also be oxidatively
even these levels of H O can generate sufficient damaged, both by peroxidation products such as
2 2
OH•tocausedamageifmetalsarepresenttoallow HNE and by direct photooxidative damage. One
Fentonchemistry.Indeed,introductionofironions importanttargetisABCA4(previouslydenotedas
or haem proteins into the eye leads to retinal and ABCR), a transporter involved in the recycling of
lens damage (sometimes sufficient to cause blind- all-trans-retinal(Fig.7.19).214
ness); this can happen as a result of penetration
by iron objects or by haemorrhage.204 The poten- Lipidperoxidelevelsarealsoincreasedintheretina
afterexposureofanimalstoelevatedO ortoionizing
tial of iron to cause damage is further illustrated 2
radiation.PBNderivatives(Section11.5.5),synthesized
inmicelackingcaeruloplasminorhephaestin,both
asputativeantioxidants,havebeenreportedtoprotect
of which are important for retinal iron homeosta-
against light-induced retinal degeneration in animal
sis (Section 3.22.1); they suffer retinal iron over-
load followed by retinal degeneration.205 Iron ion models; but this may not be by antioxidant action.215
Thesensitivityoftheretinatooxidativedamagemay
availability in the eye may also increase as a re-
be further illustrated in retinitis pigmentosa (RP), a
sult of tissue damage, as in maculas undergoing
degeneration204,206andincataractouslenses.204 groupofinheriteddiseasesinwhichrodcellsdiepre-
maturely, followed by loss of cone cells. It has been
4. Lensepithelialcellsarereadilydamagedbyperox-
speculated that loss of rod cells causes less O con-
ides, (H O , lipid peroxides, cholesterol oxidation 2
2 2
sumptionintheretina,withaconsequentriseinpO
products) showing DNA strand breakage and ab- 2
normalitiesofiontransport,e.g.damagetotheNa+, toalevelthatcandamagecones.Consistentwiththis,
K+-ATPase.197,202,207 in mouse models of RP, 8OHG levels in DNA and
protein carbonyl levels were increased in the nuclei
5. TheretinahasahighrateofO uptakebecauseof
2
ofretinalcells.OverexpressionoftheDNA-protective
theintenseenergydemandforbothneurotransmis-
enzyme hMTH1 (Section 5.10.2) in the mice slowed
sion and the synthesis and recycling of molecules
the rate of photoreceptor loss, indicating the import-
involvedinvision(Fig.7.19).Itssteady-statepO is
2
ance of oxidative DNA damage.216 Vitreous samples
higher than most body tissues, 40–60 mmHg, and
from RP patients showed higher 8OHdG levels, con-
evenbriefischaemiacanleadtoirreversiblevision
sistent with a human relevance for DNA damage in
damage. However, a high rate of O uptake may
2
thisdisease.216Administeringmixturesofantioxidants
equate to a high rate of ROS production. Neuro-
orazinc-desferrioxaminechelatehasbeenreportedto
globin(Section1.3.1)ispresentathighlevelsinthe
slowretinaldegenerationinthesemousemodels.217
mammalianretina,probablyhelpingtomaintainO
2
supplyiflevelsstartfalling.208 Doremember,however,thatDHAisnotallbad;RPE
(like many cells) can convert it into neuroprotectins
6. Thelipidspresentinthemembranesofretinalrods
(Section 8.12) that can decrease the rate of apoptosis
and cones (Fig. 7.18) contain a high percentage
inducedbyoxidativestress.212,218
of PUFA side-chains, especially of docosahexaen-
oicacid(DHA),andarethushighlysusceptibleto
7.10.1.1 Maculardegeneration,lipofuscin,
peroxidation. F -IsoPs are present in an esterified
2
form in human retina209 and aqueous humour,210 andsingletoxygen
althoughF 4 -IsoPsdonotappeartohavebeenmeas- Age-related macular degeneration (AMD), deterior-
ured.7-Ketocholesterol(Section5.12.4)isnormally ation of the retina around the macular region, is the
present in retinal pigment epithelium (RPE), and leadingcauseofpermanentblindnessintheelderlyin

--- Page 444 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 389
(a) + opsin
O HN
11cRE
CH2OC–R
rhodopsin(11c
C
R
H
AL)
hv
LRAT 11cREH CHO apo-opsin metarhodopsin II
11cRAL
NADH
NAD+ (transfer from discs
facilitated by ABCA4)
11cROL
CH2OH
11cRDH5 CHO
(inhibited by isotretinoin) atRAL
isomerase
& Rpe65 NADPH atRDH
O
NADP+
CH2OC–R CH2OH CH2OH
atRE LRAT atROL atROL
RPE cell rod outer segment
(b) CHO O
O C R1
+ a O tRAL O C R1 1 HN O O P – OHOO O C R2
O P O
HO
O
H2N O–
O
C R2
phosphatid
N
yl
-
e
re
th
ti
a
n
n
y
o
li
l
d
a
e
m
n
i
e
n
-
e (N-ret-PE)
phosphatidylethanolamine +
CHO
atRAL
2
3
+ O + O
N O O P O HO O C R1 N O O P O HO O C R1
A2PE (430 nm) O– C R2 A2PE-H (500 nm) O– C R2
O 2 O
4
+ phosphatidic acid
O
O
5 O
O
+ (singlet oxygen) O O O O +
N N
OH O OH
A2E (435 nm) A2E nonaoxirane
Figure7.19 (a)Thenormalvisualcyclemediatingrhodopsinregeneration.Absorptionoflight(hv)byrhodopsininarodoutersegmentdisk
inducesphotoisomerizationofthe11-cis-retinal(11cRAL)chromophore,yieldingactivatedmetarhodopsinII.Afterseveralseconds,metarhodopsin
IIformsapo-rhodopsinandfreeall-trans-retinal(atRAL).TheABCA4transporteracceleratesremovalofatRALfromtheinteriorofoutersegment
discstothecytoplasm.TheatRAListhenreducedtoall-trans-retinol(atROL;vitaminA)byall-trans-retinoldehydrogenases(atRDH).TheatROLis
releasedfromtheoutersegmentandtakenupbyanadjacentRPEcell,whereitisesterifiedbylecithin-retinolacyltransferase(LRAT)toforman
ester,atRE,whichthenundergoeshydrolysis-isomerizationto11-cis-retinol(11cROL).IsomerizationiseffectedbyanisomerasethatusesatREas
asubstrate,inconjunctionwiththeRpe65protein(retinalpigmentepithelialproteinabout65kDainsize).The11cROLisoxidizedby11cRDH(a
dehydrogenase)toform11cRALagain.11cROLmayalsoserveasasubstrateforLRATtoform11-cis-retinylesters.Thefinalstepisrecombination
of11cRALwithaporhodopsinintheoutersegmenttoformanewmoleculeofrhodopsin.(b)Whenitgoeswrong:synthesisofA2E.Newly
releasedatRALcondensesreversiblywithphosphatidylethanolaminetoN-ret-PE(step1).Sometimes,asecondmoleculeofatRALwillcondense
withN-ret-PEtoformA2PE-H2(step2),whichabsorbslightmaximallyat500nm.WithintheacidicandoxidizingenvironmentofRPE
phagolysosomes,A2PE-H2isconvertedtoA2PE(λ max=430nm)(step3).HydrolysisofthephosphateesteryieldsA2E(λ max=435nm)and
phosphatidicacid(step4).DoublebondsalongthepolyenechainsofA2EmayreactwithsingletO2toformaseriesofonetonine(nineisshown)
oxiranes(step5).Abbreviations:RPE,retinalpigmentepithelium;N-ret-PE,N-retinylidene-phosphatidylethanolamine;A2E,N-retinylidene-
N-retinylethanolamine;A2PE-H2,dihydro-N-retinylidene-N-retinyl-phosphatidylethanolamine.FromProc.Natl.Acad.Sci.101,5928,2004,by
courtesyofDrG.H.TravisandtheUSNationalAcademyofSciences.AlsoseePhotochem.Photobiol.88,1320,2012.Otherfluorophoresand
oxidativeformsofA2E,suchasepoxides,peroxy-,orfurano-derivatives,andperhapsA2Eisomers,canalsoform(VisionRes.50,729,2010;J.
Biol.Chem.278,18207,2003;280,3972,2005).

--- Page 445 ---

390 FREE RADICALS IN BIOLOGY AND MEDICINE
advanced countries. Patients with AMD initially pre- humanstodevelopAMD.Formationofoxidizedlip-
sentwithdrusen,sub-retinaldepositscontainingpro- ids and cholesterol oxidation products may facilitate
teinandlipid,bothoftenoxidizedtosomeextent.More retinal damage by promoting recruitment of macro-
advanced macular degeneration can involve a ‘dry’ phagesandincreasinglevelsofVEGF,thelatterlead-
form,inwhichthereislossofmacula,ora‘wet’form ing to abnormal blood vessel proliferation.209,212 In-
withexcessivegrowthofbloodvesselsinthechoroid deed,injectionofpreformedlipidperoxidesintoeyes
andtheirpenetrationintotheretina.Thesevesselscan caused choroidal neovascularization, a feature of the
leakandcreateablisteroffluidundertheretina. ‘wet’ form of macular degeneration.213 CEP-adducts
The RPE supplies the retina with O and nutrients may also promote abnormal angiogenesis. Mice lack-
2
(whichpassthroughitfromthecapillaries)andphago- ing Nrf2 suffer age-related retinal degeneration and
cytoseswornoutphotoreceptormembranes(including havebeenusedasan(approximate)modelforAMD.220
any oxidized lipids, nucleic acids, and proteins they Treatment of ‘wet’ AMD involves intra-ocular in-
contain), which are shed daily and replaced. Indeed, jection of agents that decrease VEGF levels, al-
RPE cells may be the most active phagocytes in the though photodynamic therapy has been used to
healthyhumanbody.AhealthyRPEisessentialforop- deter blood vessel proliferation, often employing
timalphotoreceptorfunction.However,theRPEoften Verteporfin(sometimescalledVisudyne),amodified
accumulates a yellow pigment (lipofuscin) with age. benzoporphyrin.221
Itsformationbeginswhenall-trans-retinalreactsnon-
enzymicallywithphosphatidylethanolaminefollowed
by further reactions, including oxidation, to generate 7.10.2 Protectingtheeye
productsthatcauselight-dependentinjurytotheRPE
bypromotingoxidativedamageandlysosomaldesta- 7.10.2.1 Screening,prevention,andcrying
bilization(Fig.7.19).Theseeventsoccurinthephoto- No blood vessels enter the lens; it derives food and
receptor outer segments if all-trans-retinal is formed O bydiffusionanditsinternalO levelsarelow(es-
2 2
faster than it can be recycled to 11-cis-retinol (i.e. at timatedas9–10mmHginthelensnucleus).206 Hence
high light levels). The final product (N-retinylidene- intra-lens O levels are low, which perhaps helps to
2
N-retinylethanolamine,orA2E)accumulatesinlyso- minimizesingletO formationandoxidativedamage;
2
somesoftheRPEafterphagocytosisofrod/conemem- thiscanexplainwhyraisingO levelspredisposesto
2
branes,formingamajorcomponentoflipofuscin.CEP cataract.202 Rapid narrowing of the iris at high light
adducts are also present.206 Oxidative damage to the intensityhelpstoprotecttheretina.Asforthecornea,
ABCA4proteinmakesthingsworse,214aconceptillus- it has no blood vessels either, but its external surface
trated by patients with Stargardt disease. They have isbathedintearfluid,whichcontainsascorbate,urate,
adefectiveABCA4,accumulatepigmentintheRPEat mucin, and several proteins.222 These can help to
an early age, and suffer accelerated onset of macular absorb such pollutants as O , NO • , cigarette smoke,
3 2
degeneration.TheA2Echromogennotonlysensitizes andSO .Proteinsinthecorneacanabsorbsubstantial
2
singlet O 2 formation, but can also react with it to amounts of UV light, especially aldehyde dehydro-
formotherproductsthatmaybecytotoxictoRPEcells genase type 3A1, a so-called ‘corneal crystallin’ that
(Fig.7.19,legend). has broad specificity for reduction of aldehydes,
Degeneration of the RPE leads to the death of its including end-products of lipid peroxidation such as
associated rods and cones. The defective RPE can HNE.223
nolongerabsorb waste products,resultinginfurther Lactoferrin in tear fluid (present in most animals,
drusen formation in the retina. As mentioned above, although in the rabbit transferrin replaces it)224 has
they contain oxidized proteins and lipoproteins, but a low degree of ion saturation normally and so can
also a range of other products, including comple- chelateironinnon-redox-activeforms(Section3.23.3).
mentandAβ (Section10.21).Hencethepathologyof The protein lipocalin can bind not only iron com-
maculardegenerationinvolvesbothoxidativedamage plexed to bacterial siderophores (Section 3.22.4), but
andthecomplementsystem.Onecontributiontothis alsolipidperoxides,includingF -IsoPs.225 Anyirrita-
2
is the ability of oxidized and CEP-modified proteins tion increases tear flow, to wash away the offending
(e.g. in drusen) to provoke an immune response and agentandreplenishtheantioxidantsupply.Hencehu-
sometimestoactivatetheNLRP3inflammasome(Sec- man tears are powerful inhibitors of iron-dependent
tion 5.7).219 Indeed, certain genetic variants affecting free-radical reactions (so don’t cry over failed free-
thefunctionofthecomplementsystemcanpredispose radicalexperiments:itwillmakethingsworse).226

--- Page 446 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 391
Thelacrimalglandsthatproducetearsbecomeless to protect the thiol groups of crystallins, preventing
efficient with age and studies on animals show that them from aggregating to form opaque clusters. In-
levelsofoxidativedamagewithinthemincrease.These deed,injectionofbuthioninesulphoximine,toinhibit
changesareacceleratedinmicelackingCuZnSOD.227 GSHsynthesis(Section3.10.3),intonewbornratsand
Insufficient tear formation can lead to dry eye, with mice causes them to develop cataract, an effect also
increasedlevelsofoxidativedamagemarkerssuchas seen in mice lacking γ-glutamyl transpeptidase (Sec-
HNEand8OHdGinthecornea.228 Elevatedlevelsof tion3.10.4).OxidativestresscancauseS-thiolationof
oxidativedamagetothecorneaanddecreasedcorneal lensproteins,whichifnottooseverecanbereversed
antioxidant levels have also been observed in Fuch by glutaredoxin.235 The GSH/GSSG ratio is normally
endothelial corneal dystrophy, a progressive disease kept high in the eye by glutathione reductase, which
characterized by corneal apoptosis that can lead to obtainsNADPHfromthepentosephosphatepathway.
blindness. One of the proteins oxidatively damaged Glaucoma(definedinthelegendtoFig.7.17)decreases
is DJ-1 (Section 10.20.5). The cause of the disease is the supply of glucose to the lens, interferes with the
unknown.229 pentosephosphatepathway,andsorestrictsNADPH
Various tryptophan metabolites accumulate to supply.Glutathionereductaseactivityandlevelsofthe
millimolar levels in the human lens, including two enzymes needed to synthesise GSH in the lens
kynurenine, 3-hydroxykynurenine, 4-(2-amino-3- have also been reported to decrease with age, and
hydroxyphenyl)-4-oxobutanoicacidO-glucoside,and GSH/GSSGconcentrationratiostofall.196Anotherfac-
3-hydroxykynurenine glucoside, and can help to tormaybelossoftheabilitytoconvertmethionineto
absorb UV light.230 They are synthesized from tryp- the GSH precursor cysteine.239 As mentioned earlier,
tophan in the lens epithelium and then diffuse into micelackingNrf2developretinaldeteriorationasthey
the rest of the lens. However, some laboratory data age, possibly due to the role of Nrf2 in maintaining
suggestthattheycandirectlyphotochemicallyoxidize GSHlevels.220
ascorbate(notvia1O production),sotheiroverallrole Superoxide dismutase is present in all eye tissues,
2
invivoisuncertain.231,232MelaninispresentintheRPE mostly CuZnSOD, although the RPE has especially
and choroid (Fig 7.17); it can absorb some UV light highlevelsofmitochondrialMnSOD.206,240Itsprotect-
andmayhelptoscavenge1O .Melaninmayalsobind ive role is illustrated by the observation that knock-
2
zincions,whichhavebeensuggestedtocontribute(in downofretinalMnSODlevelsusingribozymetechnol-
awayasyetundefined)tomaintainingRPEfunction. ogyinmiceledtoRPEdamagewithaccumulationof
Consistentwithaprotectiveroleformelanin,albinism A2EandofnitratedandCEP-modifiedproteins.240 In
(Section3.25.9)isassociatedwithpoorervision.233 transgenic mice lacking MnSOD, photoreceptor layer
depth and optic nerve cross-sectional area were de-
7.10.2.2 Antioxidantsintheeye creased,implyingthatabsenceofMnSODaccelerates
Cornealepithelialcellscontaintheusualcomplement celldeathinthesepartsoftheeye.241 Inmicelacking
of antioxidants, including ascorbate, GSH, SOD, and CuZnSODthechangesweremoresubtle,butincreased
H O -removing enzymes.222,234 Glutathione peroxid- retinalcelllossandoxidativedamagewereobservable
2 2
ase, peroxiredoxins,235 and catalase are present in all inolderanimals.242Copper–zincSODsaresusceptible
parts of the eye but, as in other cells (Section 3.13), toinactivationbyglycation(e.g.indiabetes243)andby
highlevelsofH 2 O 2 caninactivateocularperoxiredox- H 2 O 2 . Indeed, feeding aminotriazole to rabbits raises
ins. Mice lacking GPx1 seem to develop more severe H 2 O 2 concentration in the lens, induces cataract, and
cataract as they age than controls, suggesting some causes a decrease in lens CuZnSOD activity. Hence,
role of GPx in peroxide removal.236 Glutathione S- as usual, SOD has to work alongside enzymes that
transferases are also present in the eye; their contri- removeH 2 O 2 .197
bution to aldehyde and lipid peroxide metabolism is Rod outer segments and RPE are rich in α-
unclear,butmightbesignificant.237Ferritinispresent; tocopherol244 - cell damage and lipofuscin accumu-
inadditiontoitsusualroleinironionsequestration, lation in the RPE are accelerated in animals lacking
it has been postulated to help protect DNA from UV tocopherol transfer protein (Section 4.3.6), indicative
damage.222,238 of α-tocopherol’s protective role. Indeed, deficien-
The concentration of GSH in the lens of several cies of selenium and α-tocopherol in the diet of rats
mammals is as high as in the liver, being at espe- cause loss of PUFAs and accumulation of fluores-
cially high levels in the lens epithelium, although cent products in the RPE,244 whereas feeding extra
levels are lower in the lens nucleus.197 GSH helps α-tocopherol decreases the severity of the cataracts

--- Page 447 ---

392 FREE RADICALS IN BIOLOGY AND MEDICINE
Table7.4 Levelsofα-tocopherolandascorbateinretinafromadulthumansorprematurebabies.
Sourceofretina α-Tocopherol Ascorbate
nmol/mgDNA nmol/cm2retina nmol/mgDNA nmol/cm2retina
Prematurebabies(vascularregion)a,b 1.4±1.1 0.47±0.32 244±38 71.3±15.2
Matureretinasc(centralregion) 10.9±6.0 3.04±1.34 162±33 38.3±8.8
aLevelsofα-tocopherolbutnotvitaminCwerelowerinavascularregions. b22–33weeks’gestation. c13samples,agerange1monthto73years.
DataabstractedfromInvest.Ophthalmol.Vis.Sci.29,22,1988,bycourtesyofDrR.E.Andersonandthepublishers.
caused by aminotriazole administration to rabbits. changes resembling those seen in old human lens.248
In premature babies, ocular α-tocopherol levels are We have already seen that damage to ocular tissues
subnormal (a factor predisposing to ROP) (Table can increase iron availability (Section 7.10.1). Indeed,
7.4). A fatty-acid binding protein (Section 5.12.5.3) is administration of the iron chelator deferiprone (Sec-
also present in RPE and may help to protect against tion11.6)inthewatersupplywasreportedtoprotect
damage by HNE, since mice lacking it showed more againstlight-inducedretinaldamageinmice.250Expos-
HNEintheRPE.245 ureofrodentstohighlightintensitiesincreaseslevels
Ascorbateispresent,notonlyintearfluid,butalsoat ofHO-Iintheretina,250,251presumablyanantioxidant
highconcentrationsinthelens,cornea,RPE,andaque- response (removal of haem, formation of biliverdin,
ous and vitreous humours of human, monkey, and but also creation of ‘free’ iron that is normally coun-
manyotheranimals(e.g.1to2mMinhumanlensand teractedbyraisingferritinlevels).Bleedingintheeye
aqueoushumour).246 Cornealepithelialcellshavethe can also lead to elevated HO-1 levels. In the healthy
highestlevels.Unlikethesituationwithα-tocopherol, eye, iron-dependent damage may be minimized by
premature babies have higher retinal ascorbate levels the presence of transferrin in aqueous and vitreous
(Table7.4).Ascorbateinthecorneamighthelptoab- humours.252 Melanin might also bind some iron and
sorbUVlight.Consistentwiththis,nocturnalanimals render it less redox-active (Section 3.25.9). The retina
(e.g.lynx,domesticcat,rat)havelowerascorbatecon- containsferritin(asdoesthecornea),metallothioneins,
centrationsintheeye.247 Ascorbate’sabilitytorecycle and the haem-binding protein haemopexin, whereas
α-tocopherylradical,interactwithGSH,andscavenge the photoreceptor cells express haptoglobin.253 RPE
O •–,singletO ,OH•,andotherROSmayalsobeim- cells can bind and internalize the haem–haemopexin
2 2
portantintheeye.Forexample,placingguineapigson complex, subsequently raising their levels of HO-1,
adietlowinvitaminCforseveralmonthsdecreased metallothionein-1andferritin.254Metallothioneinsalso
notonlyretinalascorbatelevelsbutalsothoseofGSH seemprotective;micelackingMT-3intheretinawere
and α-tocopherol.248 Indeed, polymorphisms that af- more sensitive to light-induced retinal degeneration,
fect SVCT2 function and lower ascorbate levels may butnotthoselackingMTs-1and-2;255loweringferritin
predisposetoglaucoma(Section4.2.1). levelsalsoincreaseddamage.251
Ontheotherhand,ithasbeensuggestedthatlight-
induced degradation of ascorbate in the aqueous hu-
mourmaybeasourceofH O .Onceithasstartedtoox- 7.10.2.4 Repairofdamage
2 2
idize,ascorbatecancause‘glycation-type’reactionson Methionine sulphoxide reductases are present in the
proteins, including crystallins.231,232 Epidemiological lens and retina and function (in co-operation with
data are inconclusive as to whether the overall effect thioredoxin)torepairoxidizedmethionineresidues.256
ofconsuminghigh-doseascorbatesupplementsonthe For example, they can restore α-crystallin chaperone
eyeisbeneficial,neutral,orharmful.249 activitylostuponmethionineresidueoxidation.199Par-
tially oxidized crystallins can be degraded in lens
7.10.2.3 Sequestrationofmetalions
epithelial cells by the proteasome, but highly oxi-
Lipocalin and lactoferrin in tears can bind iron (Sec- dized/crosslinkedproteinscannolongerbedegraded
tion 7.10.2.1), but what about inside the eye? As- and so accumulate.257 The ubiquitin–proteasome sys-
corbate can be a pro-oxidant if mixed with transi- temisalsoimportantintheretina.257Proteasomeactiv-
tionmetalions.Indeed,incubationofcrystallinswith itymaydecreasewithage,anotherfactorpredisposing
ascorbate plus iron ions in vitro produces oxidative to accumulation of oxidized proteins, and some of

--- Page 448 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 393
thisdeclinemayinvolveoxidativedamage.256,257Auto- higher macular levels of these carotenoids see better,
phagy can help to remove protein aggregates, but its e.g.patientswithcysticfibrosis(Section10.9)showlow
efficiencyintheeyemayalsodeclinewithage.258 serumandmacularlevelsofluteinandzeaxanthin,but
seemtoseenormally.265
The Chinese frequently use in cooking a small
7.10.3 Toxins,inflammationandtheeye red berry, Lycium barbarum (wolfberry), thought
to be good for the eyes. It has been shown to
Diquat (Section 7.9.2) causes cataract in rats, appar-
entlybyproducingO
•–andH
O afteritsreductionto
be rich in zeaxanthin—a coincidence or something
2 2 2 meaningful?268 Foods rich in lutein include spinach,
a bipyridyl radical by lens enzymes, including gluta-
kale,broccoli,peas,andBrusselssprouts,whereasfor
thione reductase.259 Paraquat (Section 7.9.2) splashed
zeaxanthin eat egg yolk, corn, orange peppers, and
into the eyes can cause severe damage to the cornea,
again likely to involve O •– production.260 Excessive honeydew melon. Canthaxanthin (Fig. 4.5) was once
2 usedasanoralskin-tanningagent;unfortunatelyitcan
exposuretocigarettesmokecancauseoxidativedam-
entertheeyeandevencrystallizethereiftoomuchis
agetothecorneaandlacrimalglands261 andsmoking
taken.Henceitisnowbannedinmanycountries.
is a risk factor for macular degeneration: the hydro-
quinonepresentincigarettesmoke(Section9.13.2)has
been suggested262 to damage the RPE. Inflammation 7.10.5 Antioxidants,cataractandmacular
of the eye induced by infection or irritation can in- degeneration
crease production of ROS and of NO•, resulting in
ONOO– formation.Indeed,nitrationandinactivation Epidemiologicalstudieshaveattemptedtorelateanti-
oxidant intake, or blood antioxidant levels, to the in-
of MnSOD were observed in the eyes of rats with
cidence of cataract or macular degeneration. Several
endotoxin-inducedinflammation.263
have suggestedthat high intakesof ascorbate, lutein,
or zeaxanthin are associated with lower risk of both
7.10.4 Ocularcarotenoids:aChineseherbgood conditions, but the conclusions are tentative, in part
because of the limitations associated with interpret-
fortheeyes?
ingepidemiologicaldata,aswellasfailuretoconsider
β-Caroteneandseveralothercarotenoidsareimport- polymorphismsaffectingvitaminC,andpossiblyvita-
anttovisionbecausetheyareprecursorsofvitaminA, minE,levels(Sections4.2,4.3,and4.6).Theresultsof
which in turn yields the chromophore of rhodopsin intervention studies have been variable, some claim-
(Fig.7.19).Carotenoidsmightalsoplaydirectprotect- ingdecreasedriskofcataractormaculardegeneration
iveroles(aslightabsorbersand/or1O 2 quenchers)in after supplementation with mixtures of antioxidants,
theeyesofsomespecies.264 Forexample,inthecom- andothersnot.269,270Forexample,theAge-RelatedEye
pound eye of the housefly, a carotenoid is present in DiseaseStudy(AREDS)reportedthatinelderly(55–
large amounts (four to ten molecules per rhodopsin). 80 years old) subjects, a daily supplement of 500 mg
Carotenoid has also been reported in the lateral eye vitamin C, 400 units α-tocopherol (sadly the dl-form
of the horseshoe crab Limulus. The corneas of puffer wasused),80mgzinc(plus2mgcopper,sincehigh-
fish are clear in the dark but become yellow in the dose zinc can impair copper absorption), and 15 mg
light,owingtothemigrationofcarotenoidpigmentin ofβ-carotenedecreasedtheprogressionofmacularde-
chromatophorecells.264 generationinsubjectssufferingitsearlyorintermedi-
What about humans? The macula of primates is atestages.Bothzincaloneandtheantioxidantmixture
enrichedinsomecarotenoids,especiallylutein,meso- showedpositiveeffects,butthecombinationwasmore
zeaxanthin, and zeaxanthin.265,266 Their role in the effective; there was some variation in response be-
eye is uncertain; they might act as blue-light filters tween subjects depending on their genetic make-up.
and/or singlet O
2
and RO •
2
scavengers. Such roles Itisnotclearwhyβ-carotenewasused,sinceitdoes
are feasible, since their macular levels can be hun- notappeartoentertheeye,anditmayhaveincreased
dredsofmicromolar.265However,therearelargeinter- the incidence of lung cancer in former smokers.271 In
individual variations in levels in humans, probably addition, high doses may decrease intestinal uptake
dependentondietaryintake;ocularlevelsofluteinand ofluteinandzeaxanthin.However,addingluteinand
zeaxanthinriseifmorearepresentinthediet,whereas zeaxanthintothemix(theAREDS2study)didnotim-
cigarette smoking tends to lower the levels.267 There provetheoutcome.271Also,80mgofzincdailyisalot
is no compelling evidence to date that persons with (althoughtheoxideused,ZnO,maynothavehadhigh

--- Page 449 ---

394 FREE RADICALS IN BIOLOGY AND MEDICINE
bioavailability). Copper was supplied as CuO—it is their O •– production.277 Oxidative stress also causes
2
alsounclearhowwellthiscanbeabsorbed.Thezinc± rises in intracellular free Ca2+ (Section 5.3.2), deple-
antioxidantsupplementsshowednoeffectsoncataract tions of ATP (interfering with sperm motility), and
developmentinthesubjects.Thevariablebutoverall damage to sperm DNA, forming 8OHG and other
disappointingresultsobtainedwithantioxidants270,271 lesions. Several studies suggest that high levels of
mayrelatetothegenerallypoorabilityoftheseagents 8OHGinspermnuclearDNAcorrelatewithpoorfer-
to alter oxidative damage levels in vivo, as discussed tility, and antioxidant administration to infertile men
in Chapter 4, rather than to a lack of importance of hasgivensuggestive,butnotcompelling,evidenceof
oxidativedamageineyediseases. benefit.278
Seminal fluid can generate ROS. The major source
appears to be neutrophils, present in the ejaculate.
7.11 Reproductionandoxidativestress
An additional source of RS is the sperm themselves,
All aspects of sexual reproduction, from sperm and which appear to generate O
•–,
although there is dis-
2
egg production, sex itself (Section 5.9.5), fertilization, agreement about how much they make. Superoxide
embryonicdevelopment,normalpregnancy,complica- productioncanarisefrommitochondria(mostlyfrom
tions of pregnancy, birth, and the first weeks of life complex1),butmayalsoinvolveanNADPHoxidase
(indeedalloflife!)involveRS,andcanbeaffectedifthe system containing NOX5 (Section 8.10).279 Low-level
balanceofRSandantioxidantdefence/repairsystems O
•–generationhasbeenproposedtoplayanimportant
2
goesawry.Forexample,indragonflies,redoxreactions roleinnormalspermfunction;itmaycontributetoca-
modulatethenuptialcolourchange(yellowtobright pacitation,280acollectivetermforthechangesinsperm
red)associatedwithsexualmaturity.272Letusexamine physiology,neededtoachievesuccessfulfertilization,
somemammalianexamples. thatoccurastheypassthroughthefemalereproduct-
ive tract. These changes include development of the
hyperactivated movement needed to achieve pene-
7.11.1 Pre-conception:spermatozoaface
tration of the membrane that surrounds the oocyte;
problems273
there is an increase in the volume of the mitochon-
The first indication that oxidative stress could affect driaandtherateofoxidativephosphorylation.Ithas
spermcamein1943,whenitwasobservedthathuman beensuggestedthatthisputsthespermmtDNAatrisk
spermrapidlylosemotilitywhenincubatedunderele- of oxidative damage, perhaps explaining why sperm
vatedO ,andthataddingcatalaseofferssomeprotec- mitochondria are degraded after fertilization, and in-
2
tion.Indeed,spermarehighlysusceptibletooxidative heritance of mtDNA is solely maternal (R.J. Aitken,
damage.Antioxidantsintheseminalplasmanormally personalcommunicationandref281).ROSalsocontrib-
helptoprotectthem(Section7.11.2),butthewashing utetotheacrosomereaction,amembranefusionevent
of sperm (e.g. in preparation for in vitro fertilization) involvingtheouteracrosomalandplasmamembranes
canremovethisprotection,andleadtooxidativedam- ofthesperm.280 Theacrosomereactioncausesrelease
agetospermDNA,lipids,andproteins,274especiallyif of the acrosomal contents, including proteinases that
thewashingandresuspensionfluidsarecontaminated arethoughttofacilitatepassageofthespermintothe
with transition metal ions (as they usually are). At- egg.ROSmayfacilitatethesevariouseventsbyincreas-
temptshavebeenmadetocounterthisbyaddingche- ing net protein phosphorylation (Section 5.5.4).277,280
latingagentsand/orantioxidantstowashingfluids.275 LowlevelsofONOO–canalsopromotecapacitation.280
Peroxidationcanbefurtheracceleratedbyprolonged Hence, there is the usual fine balance: some RS are
storageoffrozensperm,orrepeatedfreeze–thawing.276 helpfultosperm,buttoomanyarebad;theycandam-
Why are sperm prone to oxidative damage? Their age sperm directly and also impair spermatogenesis.
lipids are rich in PUFA side-chains: almost 50% are ROS (at just the right level) participate in the self-
DHA residues and there are also high levels of renewal of spermatogonial stem cells in the testis (at
arachidonate. This high content of PUFAs gives the least in mice),282 a process needed to ensure sperm
spermplasmamembraneconsiderablefluidity,needed production throughout life; but too many ROS can
for it to participate in the membrane fusion events doharm.
associated with fertilization. In peroxidized sperm, Spermproductionrequiresthetestestobeatalower
fluidity decreases and the capacity to fertilize is di- temperaturethantherestofthebody;warmingthem
minished.End-productsoflipidperoxidation,suchas upimpairsspermproduction.Superoxide/H 2 O 2 may
HNE, can damage sperm mitochondria and increase contributetothiseffect,sincemicelackingCuZnSOD

--- Page 450 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 395
or peroxiredoxin 4 in the testis show elevated heat- Table7.5 Dietaryascorbateintake,seminalplasmaascorbatelevels
inducedspermdeath.283Indeed,developingspermare and 8-hydroxy-2(cid:4)-deoxyguanosine (8OHdG) in DNA of sperm from
humanvolunteers.
verysensitivetooxidativestressandtheSertolicells
aroundthemhelptoprotect.273
Ascorbate Seminalplasma 8OHdG
intake ascorbate(μM) (fmol/mgDNA)
7.11.2 Spermatozoa:thesolutions273 (mg/day)
Baseline 250 399±55 34.0±2.4
Spermhavefairlylowantioxidantdefencessincethey
divest most of their cytoplasm just before they are Depletion 5 203±72 66.9±8.5
released from the germinal epithelium. In addition, Marginal 10or20 115±25 84.4±22.3
the antioxidants are concentrated in the midpiece of Repletion 60or250 422±100 53.8±16.8
the sperm, leaving the large expanse of membrane
that overlies the head and tail less well-protected. Humanvolunteersweremaintainedoncontrolleddietssupplementedwithvari-
Nevertheless, sperm contain SOD, the peroxiredoxin ousamountsofascorbate.Dietaryascorbatewasdecreasedfrom250mg/dayto
5mg/day,andthenrepletedafter28days.
system,catalase,plasmalogens(Section5.12.8.1),gluta-
DataabstractedfromProc.Natl.Acad.Sci.USA88,11003,1991,bycourtesy
thione reductase, and GSH, as well as ascorbate and
ofProfessorBruceAmesandtheUSNationalAcademyofSciences.
α-tocopherol.Alloftheseantioxidantsplayanimport-
ant role in maintaining sperm viability; for example,
plasma (Table 7.5). Hypotaurine (Section 8.7.5.1) is
sperm from mice lacking CuZnSOD show impaired
presentandmighthelptoscavengeseveralRS,includ-
fertilizationability.284Spermatozoaandtheepididymis
ingHOCl.273Thelevelsof8OHGinspermDNAwere
also contain GPx1, –3, –4, and –5, the last being se-
found to be inversely correlated with seminal fluid
creted into the epididymal lumen to help protect the
ascorbatelevels(Table7.5).
sperm.285,286GPx5hascysteineattheactivesiterather
thanselenocysteine,usesthioredoxinratherthanGSH
asareductant,andmaybelessimportantinhumans 7.11.3 Spermatozoaastargetsfortoxins273,291
thaninrodents.286Thesperm-associatedGPx4playsa
keyroleinassemblyofthesperm(Section3.14). The testis is a site of intense cell division and relies
Nrf2playsakeyroleinmaintainingantioxidantde- heavilyonribonucleosidediphosphatereductaseand
fencesinthereproductivetract.Micelackingitshowed thioredoxin (Section 8.2). Hence it is susceptible to
damage to the seminiferous tubules, leading to im- agentsthattargetdividingcells.Spermatozoaareread-
paired sperm production, accompanied by increased ilydamagedduringinflammationofthereproductive
lipidperoxidationandfallsinthelevelsofGST,GSH, tract,e.g.byRSgeneratedbyactivatedphagocytes.Ex-
GPx,andotherantioxidantdefences.287 Indeed,ithas cessivedamagecanleadtoinfertility.Cigarettesmoke
beenclaimedthatmenwithlowspermmobilityshow (Section9.13)canalsodamagespermDNAandseveral
decreased Nrf2 mRNA in their semen.288 Sperm con- agents that impair sperm production have been sug-
tain the ubiquitin–proteasome system, which plays gested to act by imposing oxidative stress. Examples
a role in fertilization, but whether it can remove are cyclophosphamide, endotoxin, ionizing radiation,
oxidized proteins is as yet unclear.289 However, toluene,Aroclor1254,andmethylparathion.
sperm have limited biosynthetic capacity, making
it difficult to replace any molecules that undergo
7.11.4 Thefemalestory
damage.
Giventhemodestantioxidantdefencesofsperm,the Asfortheothersex,ROSplayaroleinallaspectsof
seminalplasmaisimportantinprotectingthemagainst reproduction, including ovulation; H O is involved
2 2
damage by external ROS, e.g. generated by phago- in the signalling triggered by luteinizing hormone,
cytesintheejaculate.ThisfluidcontainsSOD(mostly whichstimulatesovulation.292Theovariescontainthe
CuZnSOD,someEC–SOD),catalase,iron-bindingpro- usualcomplementofantioxidantdefences:SOD,ascor-
teins (lactoferrin and transferrin), urate, GPX (mostly bate, GSH, GPx, peroxiredoxins etc.293 However, too
GPX3),GSTs,variablelevelsofGSH(e.g.0.5–2μMin many ROS are bad; female mice lacking CuZnSOD
humans),290 ergothioneine (again the levels vary be- show decreased fertility due to defects in the cor-
tween species: they are much higher in boar, horse, pusluteumandimpairedprogesteroneproduction.294
donkey,mole,andhedgehogthaninhumans),290 and Some agents that impair ovulation have been sug-
higher levels of ascorbate (up to 400 μM) than in gested to act, at least in part, by increasing oxidative

--- Page 451 ---

396 FREE RADICALS IN BIOLOGY AND MEDICINE
stress. They include chromate, methoxyclor, ionizing removal of oxidized proteins.295 Eggs and embryos
radiation,andcyclophosphamide.293 containawiderangeofantioxidantdefences,includ-
ingascorbate,α-tocopherol,SOD,GSH,GPX,theper-
oxiredoxin system,292 catalase, and metallothionein.
7.11.5 Problemsoftheembryo
Oocyte GSH levels must be kept high for fertiliza-
Duringthepreimplantationperiodpriortoestablish- tiontosucceedandforembryonicdevelopmenttothe
ment of pregnancy (about seven days in humans), blastocyststage.293
thefertilizedeggspendsaboutthreedaysintheovi- Mouseeggsculturedinvitrooftenceasedivisionat
duct and the rest in the uterus. Cell division usually the two-cell stage, a phenomenon called the two-cell
givesatwo-cell,four-cell,andthenupto16-cellstage block. It can be overcome by placing the cells back
(Fig.7.20).Compactionofthecellsoccursataboutthe intotheoviduct,orbyincubatinginculturemediacon-
eight-to16-cellstage;theyflattendownupononean- tainingEDTAandglutaminebutlackingglucose.The
other, becoming wedge-shaped rather than spherical. two-cell block is representative of a series of ‘blocks’
Eventuallyamatureblastocystisformed,consistingof that occur if one attempts to grow fertilized eggs in
anouterlayerofcells(trophectoderm)surroundinga culture. Thus a four- to eight-cell block is often seen
fluid-filledcavity(theblastocoel)containingacluster forhumanandcoweggs,andaneight-to16-cellblock
ofcells,theinnercellmass.Theembryoproperarises for sheep and goat eggs. Pyruvate is the preferred
fromsomeofthelattercells,whereastheremainderof metabolic substrate of the early stages of embryonic
theinnercellmassandthetrophectodermgiveriseto development, with glucose uptake increasing as the
extra-embryonicstructuressuchastheplacenta. blastocystisformed.
Preimplantationdevelopmentisinitiallycontrolled Severalpapershavesuggestedthatoxidativestress
bymRNAfromtheegg:expressionoftheembryonic is involved in the ‘cell blocks’, especially if eggs are
genome begins at the four- to eight-cell stage in hu- keptunder21%O orexposedtooxidizedmineraloils
2
mans,butatthetwo-cellstageinmice.Theubiquitin– duringthecultureprocess,296ortometalionscontam-
proteasome system plays a key role in growth and inatingthemedium.297Exposuretoairishyperoxicfor
development of the embryo, probably including the ovasinceO levelsintheuterusandoviductarequite
2
5-7 days, depending on species
Blastocoel
cavity
Trophectoderm
Inner Cell Mass
(cid:129)Differentiation
(cid:129)Fertilisation (cid:129)Cell division (cid:129)Genome of (cid:129)Cell-cell (cid:129)Protein synthesis
by mitosis; the embryo junctions (cid:129)Na+,K+-ATPase becomes
Increased activated begin to
active
cell number form (cid:129)Growth
(cid:129)Preparation for implantation
Cell number
Figure7.20 Embryonicdevelopmentinhumans.DiagramfromBiochem.Soc.Trans.41,664,2013,bycourtesyofDrRogerG.Sturmeyandthe
BiochemicalSociety.

--- Page 452 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 397
low,around15mmHg.298TheuseoflowerO tensions HumanplacentashavelowO tension(<20mmHg)
2 2
or the addition of antioxidants (including catalase, andlowantioxidantlevelsforaboutthefirsttenweeks
transferrin,SOD,thioredoxin,orevenwholeerythro- ofgestation.Oxygenlevelsrisetoabout50mmHgat
cytes,whichcanabsorbO
•–andH
O ;Table3.7)have 11to14weeksasthematernalintra-placentalcircula-
2 2 2
beenreportedtofacilitateembryonicdevelopmentin tionbecomesfullyestablished.Justatthattime,there
vitro.299Indeed,embryosfrommicelackingCuZnSOD isa‘burst’ofROSproduction,whichisaccompanied
arrested completely at the two-cell stage under 21% byincreasedsynthesisofantioxidantenzymessuchas
O
2
, but lowering the O
2
level to 1% allowed them to CuZnSOD,GPX,andMnSOD.Theoriginofthisburst
developfurther.300Pyruvatecouldconceivablybeact- is uncertain, but mitochondrial ROS production ap-
ing as a H O scavenger (Section 3.25.2) as well as a pearstocontribute.Theburstleadstooxidativedam-
2 2
nutrient. age,butdespitethis,seemstobephysiologicallyuseful
Asusual,however,thereisevidencethatROS(e.g. inpromotingremodellingoftheplacenta(e.g.lossof
generatedbyNADPHoxidaseenzymes)mayplayuse- certainvilli),althoughitcancausedamageiftoolarge
fulroles,e.g.bypromotingapoptosisofunwantedcells and/or prolonged. Hence, placental ROS production
duringembryonicdevelopmentandinfacilitatingthe and antioxidant defences must be in proper balance
implantationoftheembryo.301Thus,embryonicdevel- forsuccessfulpregnancy.301 Forexample,knockoutof
opmentmayneedjusttherightlevelofROS,bothtoo prx3 in mice leads to frequent stillbirths.307 Indeed,
manyandtoofewbeingdeleterious.Thiscouldhelp low dietary intakes of Se have been suggested to in-
toexplainwhyover50%offertilizedhumaneggsap- creasetheriskofhumanmiscarriage,butthedataare
pear not to survive past the early embryonic stages, inconclusive.308
evenintheprotectiveenvironmentofthereproductive Abnormally early onset of the full maternal circu-
tract. lation in the placenta is associated with many mis-
Oviductal lining fluid has a low O concentration carriages, and oxidative stress may contribute. In-
2
andmaycontainseveralantioxidants,includingSOD, deed,levelsoflipidperoxidesand3-nitrotyrosineare
ascorbate, hypotaurine, and GPX,293 but its antioxi- elevated in placentas from miscarriages.298 However,
dant defences have not been fully characterized, nor markersofoxidativedamagesuchaschlorinatedand
havethoseofuterinefluidsortheamnioticfluidthat nitrated proteins, and lipid oxidation products (in-
surrounds and protects the foetus. The limited data cludingHNE)arealsopresent,tovariableextents,in
availablesuggestthatantioxidantlevelsarelow.302In- thehealthyplacenta.298,309,310 Nitricoxideplaysarole
deed, amniotic fluid has been suggested to contain in maintaining normal placental blood flow, but its
non-protein-boundiron.303 presence means that there is a risk of ONOO– for-
mation if O
•–
levels are raised. As in other tissues
2
(Section 3.23.3.2), placental EC–SOD is involved in
7.11.6 Problemsofpregnancy:normal
regulatingtheO
•–/NO•
interaction.Insummary,oxi-
andabnormalO levels298 2
2 dativestressis a feature not onlyof pregnanciesthat
Theplacentaisthekeymaternal–foetalconnection;it go wrong, but also normal pregnancy. Indeed, preg-
provides protection and immunity to the foetus and nantwomenshowelevatedlevelsofplasmaF 2 -IsoPs
deliversO ,hormones,andnutrientsfromthemother andurinary8OHdG.304,311
2
tothebaby,thelastcategoryincludingiron,copper,as- Disruptions of placental blood flow later in preg-
corbate,cysteine/cystineneededforGSHandprotein nancy can cause pre-eclampsia, the leading cause
synthesis,andRRR-α-tocopherol.Placentaltransferof of maternal death in advanced countries and a ma-
thelastisfairlyslow,whichresultsinlowerlevelsofα- jor cause of maternal morbidity and foetal growth
tocopherolinbabiesthaninadults.304,305Nevertheless restriction. It affects up to 5% of pregnancies in
it is important; placentas of mice lacking tocopherol developed countries, and more in developing ones.
transferproteinareabnormal,andtheembryosdieat Impaired blood flow through the placenta causes
aboutthetimewhenplacentaldevelopmentandfunc- severe foetal and placental hypoxia and release of
tionstartandpresumablyO levelsrisesomewhat.305 pre-eclamptic factors into the systemic circulation,
2
Indeed, vitamin E was first recognized as a ‘factor’ including cytokines, anti-angiogenic factors, and
needed for normal reproduction in rats (Section 4.3). remnants of apoptotic cells. Some of these factors
The human placenta synthesizes ‘extracellular’ GPX promotevasoconstrictionandhypertension,aswellas
(GPX3)andsecretesitintothematernalcirculation,306 a severe inflammatory response involving neutrophil
butthesignificanceofthisisunclear. and platelet activation (including neutrophil NETs

--- Page 453 ---

398 FREE RADICALS IN BIOLOGY AND MEDICINE
production, Section 8.7.4.11) in the maternal vascular elevated F -IsoP levels in urine and peritoneal fluid)
2
system.Thebabymustbedeliveredassoonaspossible in women with this disease, plus a report that sup-
toreversethesyndrome,evenifitistooprematureto plements of vitamins E and C can diminish pain in
survive. affectedwomen.319Sometimesendometrioticcystsde-
Supplementationof‘atrisk’womenwith400units/ velopfromendometriosisintheovary,andareatrisk
day of α-tocopherol plus 1 g/day of vitamin C was of developing intoovarian cancers. These cysts accu-
claimedinearlystudiestodecreasethenumberswho mulate iron from retained menstrual blood, some of
developed pre-eclampsia. Sadly, these results have which can catalyse oxidative damage, which might
proveddifficulttoconfirm,perhapsbecausetheinitial predisposetocancerdevelopment.320
study was small and underpowered, and/or because
vitamins E and C did not affect levels of placental
oxidative damage (Sections 4.2 and 4.3).298 There are
7.11.7 Theembryo/foetusasatarget
even suggestions of harm from antioxidant supple-
fortoxins321
mentsinpregnantwomen.312 Indeed,attemptsindif-
ferent laboratories to demonstrate systemic oxidative Theincreasedriskoffoetalmalformationsobservedin
stressinpre-eclampsiabymeasuringsuchbiomarkers motherswithpoorlycontrolleddiabetesmayinvolve
as plasma F 2 -IsoPs have given variable and incon- oxidativestress,perhapsincludingtoxiceffectsofF 2 -
clusive results.313,314 For example, one study showed IsoPsontheembryo.322 Indeed,inductionofdiabetes
plasma F 2 -IsoPs to be higher in healthy pregnant (by streptozotocin treatment; Section 9.7) in pregnant
women than in non-pregnant controls, but not fur- mice produced embryonic malformations, but fewer
ther increased in pre-eclampsia.314 Another showed wereseeniftheembryosoverexpressedCuZnSOD.323
no change in plasma F 2 -IsoPs but rises in isofurans Diabetesincreasestheriskofpre-eclampsia,butsup-
(Sections5.12.3)andF 4 -IsoPsinplasmafromwomen plementsofvitaminsEandCdidnothelp.324 Hyper-
with pre-eclampsia.313 Urinary levels of triuret (Sec- cholesterolaemiainmotherscanleadtoatherosclerosis
tion3.25.6)wereelevatedinhealthypregnantwomen infoetalarteries(Section10.3).
as compared with controls, and slightly further ele- Exposure of pregnant females to certain xenobiot-
vatedinpre-eclampticsubjects,suggestiveofincreased ics can cause embryonic death, lethal foetal malfor-
ONOO-formationinbothconditions.315 mations, or birth defects (teratogenesis). Several ter-
Althoughithasbeenhardtoconvincinglydemon- atogens have been suggested to act, in whole or
strate elevated systemic oxidative stress in pre- in part, by imposing oxidative stress. They include
eclampsia, increased oxidative damage to DNA (as the anticonvulsant phenytoin (diphenylhydantoin,
8OHG),lipids(e.g.asHNEandF 2 -IsoPformation)and Dilantin), excess ethanol (Section 9.8.1), hydroxyurea
proteins,including3-nitrotyrosineformation,hasbeen (Section8.2.2),andpossiblycocaine(Section9.9).For
shown in the pre-eclamptic placenta.298,299,316 F 2 -IsoP example,pregnantacatalasaemicmiceormicelacking
levelswerereportedaselevatedintheamnioticfluid, G6PDHshowedgreaterlossofthefoetusthancontrols
andthiswassuggestedtocontributetofoetalgrowth whentreatedwithphenytoin.325,326 Thalidomide,no-
retardation.317 Presumably such localized oxidative toriousforcausingbirthdefects,hasananti-angiogenic
damageisnotalwaysreflectedinplasmabiomarkers. effect and causes severe foetal hypoxia; a role for
SourcesofROSinthedamagedplacentamayinclude ROS in its effects has been claimed but not fully
XO produced as a result of ischaemia–reperfusion, substantiated.327
dysfunctional mitochondria, and an NADPH oxidase Fortunately, the maternal drug-detoxification sys-
system.298,316,318 Excessive oxidative stress in the pla- tems (CYPs, glucuronidation, GSTs etc.) and the bar-
centacanimpairitsfunction(e.g.bycausingERstress; rier action of the placenta do an excellent job in
Section 5.6) and may help to trigger release of pre- protecting the embryo against most potential insults.
eclampticfactorsintothecirculation. Of course, CYPs can convert a few chemicals (in-
cludingparacetamol,benzopyrene,phenytoin,andco-
caine) to more reactive forms, but levels of CYPs in
7.11.6.1 Endometriosis298
the placenta and foetus are low, maybe for this rea-
Thisdisorderischaracterizedbythepresenceofendo- son.Nevertheless,animalstudiessuggestthatcigarette
metrial tissue outside the uterus, e.g. in the pelvis, smokingandalcoholconsumptionbythemothercan
and can cause pain and infertility. There have been elevate oxidative damage levels in the foetus (Sec-
severalreportsofincreasedoxidativedamage(e.g.as tions9.8.1and9.13).

--- Page 454 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 399
7.11.8 Birth arteriosus closes, pulmonary vascular resistance
normally falls simultaneously to allow blood to flow
7.11.8.1 Acoldhyperoxicshock
easily through the breathing lungs. Sometimes this
Birthinvolveshypoxia–reoxygenationcomplicatedby fails to occur properly, lung resistance remains high,
a fall in temperature and an interruption of the nu- and persistent pulmonary hypertension ofthe new-
trient supply until feeding is established. Newborns born results. Studies on animals suggest that this
faceasuddentransitionfromawarm,fluid-filleden- can involve excess O •– production by lung NADPH
2
vironmenttoacooler,air-breathingenvironment,with oxidases.335TheO •–decreasesNO•levelsandONOO–
2
exposureofthelungtoO 2 concentrationsmuchgreater is generated. Oxidative damage by similar mechan-
thanthoseexperiencedinutero.Often,severehypoxia isms is also involved in pulmonary hypertension in
occursduringbirthitself(uterinecontractionsimpair adults, and in the pathological remodelling of the
bloodflowthroughtheplacenta),makingtheeventual lung vasculature and of the heart that can result.336
exposure to 21% O 2 even more of a shock. We have The rise in O 2 affects other tissues in the newborn
alreadymentionedthatresuscitationofnon-breathing animal as well, e.g. it induces heart muscle cells to
newborn babies may be better done with air than stop proliferating (at least in mice); ROS are again
withO 2 (Section1.5.2.2).Indeed,resuscitationofhyp- involved.337
oxic newborn piglets with O 2 increased their urinary Newborn babies have low activities of methaemo-
excretion of 8OHdG and ortho-tyrosine, indicative of globin reductase338 in erythrocytes, and so are thus
increasedoxidativedamage.328
more prone to develop problems when exposed to
Preparations for birth occur in the later stages of agents that can oxidize haemoglobin, such as nitrite
development in utero and include increased levels of (Sections1.10.3and2.5.6).
EC–SOD,otherSODs,GSH,catalase,GPX,andperox-
iredoxins in the lung. Nrf2 is intimately involved in
this adaptation.38 There are marked inter-species dif- 7.11.8.2 Prematurity
ferencesinthetime-courseandextentofthesechanges Prematurebabiesfacespecialproblems:improvements
in antioxidants329,329A and so one must be wary of inneonatalcarehaveincreasedtheirsurvivalrate,but
extrapolatingstudiesonotheranimalstohumans,es- they often require respiratory support (with expos-
peciallyasratandmouselungsdonothavealveoliat ure to elevated O ) for many weeks. They are thus
2
birth,unlikehumanlungs.Inhumanlung,someanti- facing atmospheric and supra-atmospheric O levels
2
oxidants appear early in gestation (e.g. MnSOD and without fully developed antioxidant systems.329,329A
CuZnSOD),whereasothers(e.g.catalase,thioredoxin) PlasmaF -IsoPsarehigherthanadultvaluesinnormal
2
not until the last few weeks of pregnancy.329 Even term babies, and even higher in premature babies.332
so, newborn babies show increased plasma levels of Placental esterified F -IsoPs are also higher for pre-
2
F -IsoPsandgreaterurinary8OHdGand8OHGexcre- mature births.339 Exposure of premature babies to
2
tion,indicativeofsomedegreeofoxidativestress.330–333 excess O contributes to the development of retinop-
2
The levels gradually decrease with age from 1 to athy of prematurity (ROP; Section 1.5.2.1) and brain
11years(approximately).333 damage,includinghaemorrhage(releasingpotentially
Increased ROS production at birth may trigger pro-oxidant haemoglobin) and periventricular leuk-
importantadaptations.Inutero,thebabyisnotbreath- omalacia, localized damage to the precursor cells of
ing and blood bypasses the pulmonary circulation oligodendrocytes. A role for ROS in this damage has
through a foetal artery, the ductus arteriosus. This beenproposed,sincebrainF -IsoPsareelevatedinthe
2
rapidly closes at birth, first by vasoconstriction. affected regions, and IsoPs are toxic to the precursor
Within a few days, cell migration into the lumen cells.340,341 Oligodendrocytes form the myelin sheath
makes the closure irreversible. How does this artery (Section 10.17), and undermyelination resulting from
know when to close? Rising O and falling levels damagetotheirprecursorscanimpairbrainfunction.
2
of prostaglandin E are key signals. How is the Anotherproblemofprematurebabiesisbronchop-
2
O sensed? One suggestion is that a ‘redox sensor’ ulmonarydysplasia(BPD);BPDinvolveslunginjury
2
(probably mitochondria) responds to elevated O by andfibrosisandisasignificantcauseofmorbidityand
2
generating extra O
•–
and H O ; and the latter blocks mortalityinprematurebabies.BPDisaccompaniedby
2 2 2
K+ channels,depolarizes the membrane, opens Ca2+ increased oxidative damage, evidenced by increased
channels, and causes vasoconstriction.334 F -IsoPs allantoin/uric acid ratios (Section 6.13), protein car-
2
might facilitate vasoconstriction.332 As the ductus bonyls, glutathione sulphonamide (Section 6.16.4),

--- Page 455 ---

400 FREE RADICALS IN BIOLOGY AND MEDICINE
lipidperoxidation,andurinary8OHdGexcretion.42,342 workisneededtoconfirmthisandexplorethemech-
The immature lung is deficient not only in certain anismsbehindit.
antioxidants,329,329A but also in surfactant, and what Healthy newborn animals of several species are
surfactant there is can be damaged by RS (Section more tolerant to hyperoxia than adults, because they
7.3.1).Syntheticsurfactants(oftenmoreresistanttooxi- can rapidly induce lung antioxidant defences. There
dative damage than natural surfactant) have found is no evidence that this is the case in humans, sadly.
some role in the treatment of BPD.343 Even in chil- Administrationofhighdosesofsteroidstowomenat
drenwhoapparentlyrecoverfromBPD,thelungsmay riskofprematuredeliveryhasbeentriedinanattempt
be abnormally sensitive to insults (e.g. allergens, in- toacceleratelungmaturationinthefoetus,including
fluenza viruses, drugs that trigger fibrosis, such as increasesinsurfactantandantioxidantdefences.351
bleomycin[Section10.16.3]),laterinlife.344
Some authors have grouped ROP, BPD, and brain 7.11.8.4 Ironmetabolisminthenewborn
damagetogetherasdifferentmanifestationsofoxygen- Plasma ferritin levels, and the percentage saturation
radicaldiseasesofprematurity.345 of transferrin with iron, are higher in newborn ba-
bies than in adults. In about 40% of low birthweight
7.11.8.3 Antioxidantsandbabies
(<1.5 kg)prematurebabies, andin asmallerpercent-
Babies, especially premature ones, have low levels of ageofapparentlyhealthyfull-termbabies,transferrin
α-tocopherol in plasma and tissues (Table 7.5); the issaturatedandnon-transferrinboundiron(NTBI)is
low levels in erythrocytes can predispose to haem- present in the plasma. In vitro studies show that this
olysis (Section 4.3). Tissue and plasma α-tocopherol ironiscapableofcatalysingOH• generationandper-
levels rise rapidly after birth as it is taken in from oxidation of lipids, including surfactant lipids.352,353
milk;theearliestbreastmilk(colostrum)isespecially BloodtransfusionscanincreaseNTBIlevels,possibly
enriched in α-tocopherol and coenzyme Q.346 Plasma helpingtoexplainwhytheyareariskfactorforthede-
levelsofvitaminCinbabiesaregenerallyhigherthan velopmentofROPandBDP.354 Inaddition,NTBIwas
in adults, but fall after a few days. Levels of plasma found more often in babies who had experienced as-
caeruloplasmin(andthusferroxidaseIactivity),albu- phyxiaatbirth,especiallysointhosewhodeveloped
min, and α1-antiproteinase tend to be lower than in neurologicalimpairment,andNTBIlevelsinCSFwere
adults,whereasplasmaXOishigher;anyhypoxiawill correlatedwiththedegreeofimpairment.355,356 There
increase plasma hypoxanthine levels and potentiate were also elevations in ortho-and meta-tyrosine levels
ROSgeneration.347 Severalstudieshaveexaminedthe (suggestive of OH• production; Section 6.3.1) and in
potential beneficial effects of allopurinol administra- F -IsoPsinCSFfromthesedamagedbabies.356
2
tiontoO -deprivedorprematurebabiesortomothers Why should there be more iron at birth? The foe-
2
whose foetuses are at risk of hypoxia, but the results tus receives iron from the mother, especially during
are inconclusive. Of course, ROS generated by XO the last three months in utero. About 80% of foetal
couldpotentiallyhavebeneficialaswellasdeleterious iron is in haemoglobin, much of the rest in ferritin.
effects.318 Birthisassociatedwithavirtualcessationofredblood
Severalpapershavereportedthatantioxidantscan cell formation that persists for at least six weeks.
decrease lung injury induced by exposing prema- Henceironisnotusedupinerythropoiesiswhilstred
ture animals of various species to elevated O . For blood cell degradation continues. Neonatal erythro-
2
example, protections were seen using intraperiton- cytes differ from those of adults:357 they are larger,
ealGSHinrabbits,intraperitonealN-acetylcysteinein presentinhighernumbersperunitvolumeofblood,
guinea pigs, AEOL 10113 (Section 11.5.4) in baboons, and contain predominantly haemoglobin F. Haemo-
and intratracheal recombinant human CuZnSOD in globin F, like adult haemoglobin, is a tetramer but
piglets. However, attempts to use antioxidants thera- theβ chainsarereplacedbyγchains(i.e.α γ rather
2 2
peuticallyinhumaninfantshavebeendisappointing: than α β ). Haemoglobin F has a higher affinity for
2 2
neither N-acetylcysteine (aiming to raise lung GSH O under physiological conditions, optimizing trans-
2
levels) nor recombinant human CuZnSOD being ef- fer of O from the maternal to the foetal circulation.
2
fective in preventing, or decreasing the severity of, Neonatal erythrocytes are more susceptible to oxida-
BPD.348,349TheSOD-treatedinfantsalsoshowednofall tivestress330,357thanadultonesandtheyproducemore
inincidenceofROPorbrainhaemorrhage.However, O
•–/H
O ,duebothtoagreatercontentofhaemoglo-
2 2 2
atageoneyear,theydidshowfewerlungproblems;349 binpercellandtohigherautoxidationratesofhaemo-
andasuggestionoflessROP(Section1.5.2.1);350 more globin F. α-Tocopherol (both on a micromolar basis

--- Page 456 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 401
Low oxygen Birth High oxygen
Oxidative stress
Low antioxidants Low antioxidants
1 Wrong red blood cells for high pO Removal of
2 Increased
2 Wrong haemoglobin inappropriate
haemolysis
3 Too many red blood cells erythrocytes
Bilirubin (physiological jaundice)
—antioxidant ?
Figure7.21 Oxidativestress:isitamechanismfordestructionoffoetalerythrocytes?
andperunitlipid),GPX1,catalase,methaemoglobinre- mother may lead to problems in the foetus, perhaps
ductase,andCuZnSODarealllowerinneonatalthan rendering the baby more sensitive to the ‘oxidative
inadulterythrocytes.357 stress’ of birth. Anaemia in children can lead to im-
It is possible that the increased oxidative suscep- pairedmentaldevelopment.Hencematernalirondefi-
tibility of neonatal erythrocytes contributes to their ciencyshouldbeavoidedduringpregnancy,although
rapid destruction (Fig. 7.21). One result is increased thewidespreaduseofironsupplementsforpregnant
plasmabilirubinlevels.Althoughhighbilirubinlevels womeninadvancedcountriesmaybeunnecessary.361
aretoxic,moremoderate‘physiologicaljaundice’may An adequate supply of PUFAs, especially DHA, is
bebeneficialifbilirubinactsasanantioxidant,ashas neededfordevelopmentofthebrainandnervoussys-
beensuggested(Section3.25.1). tem. Infants have some capacity to synthesize DHA
fromlinolenicacidbutmayneedmorefromthediet.
7.11.8.5 Parenteralnutrition Supplementation of infant formulas with DHA must
Parenteralnutritionhasbeenusedinthemanagement takeintoaccounttheeaseofperoxidationofthisand
of low-birth-weight babies for years, but the lipids otherPUFAs,especiallyifsimultaneousironfortifica-
presentintheinfusionscansometimesbepartiallyoxi- tion is attempted. Breast milk is better; it is a good
dizedandcontainaldehydesandlipidperoxides,not
sourceofα-tocopherolandPUFAsandcontainslittle,
goodifthereis‘catalytic’ironintheplasma.Thefluids if any, ‘catalytic’ iron because of the lactoferrin pre-
can also be iron-contaminatedthemselves(Table 3.3). sent.Indeed,breast-fedpre-termbabiesshowedlower
Theaminoacid/vitamin/mineralmixtures(especially urinary excretion of 8OHdG and ortho-tyrosine than
those containing ascorbate) that are often added to
formula-fedones.362
infusions can generate H O on exposure to light.358
2 2
Indeed, urinary levels of H O were elevated in ba-
2 2 7.12 Theear
biesinfusedwithsuchmixtures.359Prolongedparental
nutrition has been associated with oxidative stress in The cochlea of the ear, like the retina, is a highly
adultsinsomestudies.360
specialized neuronal tissue. Age-related loss of hear-
ing is one of the most common sensory dysfunc-
7.11.8.6 Antioxidants,PUFAsandiron
tions in adults, and several studies measuring bio-
Optimal development of the brain and nervous sys- markers of oxidative damage suggest that ROS may
tem in children requires an adequate dietary intake be involved.363 Consistent with this, mice lacking
ofallmajornutrients,includingantioxidantvitamins, CuZnSODlosehearingfasterwithage,althoughover-
copper,iron,proteins,andPUFAs.Nutritionalantioxi- expressionofthisenzymehasnobenefit(andmaybe
dantdeficiency(ordietsexcessivelyrichinfat)inthe deleterious)inslowingage-relatedhearingloss.363–365

--- Page 457 ---

402 FREE RADICALS IN BIOLOGY AND MEDICINE
MicelackingMsrB3(Section5.14.1.1)aredeaf,andde- encoding pendrin, an ion exchange protein. Studies
fectsinthegeneencodingthisenzymehavealsobeen on a mouse model of the disease suggest that oxida-
implicated in causing deafness in humans.366 Caloric tivedamageisinvolvedinthepathology,buttheexact
restriction can delay age-related hearing loss in ani- mechanismisnotclear.374
mals,bymechanismsthatincludedecreasingoxidative
damage(Section11.4.1).
Excessive noise accelerates hearing loss, and ROS 7.13 Theskin
haveagainbeenimplicated.367 Loudnoisemaycause
Skinisthelargestorganinthehumanbody.Mamma-
directmechanicaldamagetothecochlea,but inadd-
lianskinhastwomajorlayers,dermisandepidermis.
ition produces hypoxia due to decreased blood flow.
Below them is the hypodermis, rich in adipocytes.
When flow returns to normal, a reperfusion injury
may occur, leading to formation of O •– and OH• Thedermiscontainsseveralcelltypes,especiallyfibro-
2 blasts, embedded in a fibrous network of connective
radicals and increased lipid peroxidation, as meas-
tissuecontainingproteoglycans,elastin,andcollagen.
ured by F -IsoP levels.368 ROS may elevate intracel-
2 Unlike the dermis, the epidermis has no blood ves-
lular Ca2+ levels, that can lead to increased glutam-
sels. Where it meets the dermis is a layer of actively
ate release and excitotoxicity (Section 10.17.4) in the
dividing cells; cells from this layer (keratinocytes)
cochlea.367IsoPsmayworsentheproblembyinducing
migrateupwardsintheepidermisandundergodiffer-
vasoconstriction.368Noise-inducedhearinglossinvari-
entiation,intheprocessofkeratinization,sometimes
ousanimalmodelscanbedecreasedbyadministering
called cornification. The uppermost layer of the epi-
desferrioxamine,edaravone(Section11.5.8),coenzyme
dermis (stratum corneum) represents the final stage
Q,theGPxmimeticEbselen(Section11.5.10),orbyrais-
of this process and consists of dead anucleate cells
ingGSHlevelsbysupplyingN-acetylcysteineorgluta-
(corneocytes) embedded in a keratin- and lipid-rich
thioneesters.369,370Variousspintraps,suchasPBNand
matrix,formingabarrier.Keratinisrichindisulphide
4-hydroxy-PBN are also effective in some animals,369
bridges;itsdegradationbydermatophytes,fungithat
although it should not be assumed that their benefi-
cause several skin diseases, has been suggested to
cial effects are necessarily due to antioxidant action
involve excretion of sulphite (SO2–) by the fungi, fol-
(Section 11.5.5). Whether antioxidants would benefit 3
lowedbythesulphitolysisreaction(Section9.12.3).375
noise-exposed humans is as yet uncertain. Reactive
Transglutaminases (Section 5.3.2) are important in
speciesmayalsobeinvolvedineardamagesecondary
cross-linking proteins and maintaining the skin bar-
topneumococcalmeningitis(Section10.18.1).
rier during corneocyte formation.376 Corneocytes are
Studiesofmicewithdefectsinbalanceshowedthat
oneofthegenesinvolvedencodesaO
•–-generatingen- constantly shed and are a significant contributor to
2 household dust. They provide food for house dust
zyme,NOX3(Section8.10),levelsofwhicharehigher
mites,towhichmanypeopleareallergic.
i g n es t t h s e t i h n a n t e O r • e – ar m t a h y an p i l n ay ot a he ro r l t e is i s n ue d s e . v I e ts lo p p r m es e e n n t ce of su th g e - KeratinocytescanproducelowlevelsofO • 2 – bythe
2 action of NADPH oxidase (often involving NOX1),
normalear,371i.e.ROSarebothbadandgood,asusual,
whichseemtoplayaroleintheregulationofcellpro-
explainingwhytoomuchSODmightdoharm.365
liferation, e.g. after injury to the skin (Section 7.13.3),
Several toxins that can impair hearing are thought
andmayhaveantibacterialactions(Fig.7.22legend).377
to act, in part at least, by causing oxidative stress.
NADPH oxidases are also present in skin fibroblasts
One such agent, cis-platin (Section 10.16), seems to
increase O •– production by NOX3367,372 and results
andmelanocytes.378Nitricoxideplaysimportantroles
2 intheskin,e.g.inregulatingbloodflow,hairgrowth,
in the nitration and inactivation of the cochlear pro-
and wound healing. eNOS is present in the blood
tein Lmo4.372 Indeed, hearing impairment can be a
vessels,nNOSinkeratinocytesandmelanocytes,and
problem in patients taking platinum-based drugs for
iNOSfrequentlyappearsduringinflammation.Nitric
cancer chemotherapy. Another drug that can affect
oxide can also be generated non-enzymically during
hearing is the aminoglycoside antibiotic gentamicin
UVexposureoftheskin(Section7.13.1.2).379
(Section9.17.3).Bothdrugsseemtoactbyaccelerating
apoptosisinouterhaircells,viaROS-dependentmech-
anisms. Indeed, the mitochondrially targeted antioxi-
7.13.1 Whatproblemsdoestheskinface?
dant SkQR1 (Section 11.5.12) was reported to protect
againstgentamicin-inducedhearingloss.373 Theskin,likethelungandcornea,isdirectlyexposed
Pendred syndrome, the most frequent form of in- to atmospheric O , although the strateum corneum
2
heriteddeafness,iscausedbyamutationinthegene may hinder O diffusion to the lower layers to some
2

--- Page 458 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 403
Figure7.22 FluorescenceofPropionibacteriumacnes-derivedcoproporphyrinIIIonhumanskinasseenunderUVlight.Thistechniquehasbeen
usedtomonitorthedistributionofP.acnes,abacteriummoreprevalentinacnepatients.PhotographfromBiochem.Biophys.Res.Commun.223,
578,1996,bycourtesyofDrKumiArakaneandAcademicPress.Acnehassometimesbeentreatedbycarefulexposuretobluelight(405–420nm),
whereuponP.acnescanphotosensitizeanddamageitselfwithitsowncoproporphyrinIII(J.Cosmet.LaserTher.13,308,2011).SinceP.acnes
contributestoinflammation,thiscandiminishtheseverityofacne.ProductionofO
•–bykeratinocytesmaybeinvolvedinregulatingP.acneslevels
2
(PLoSPathogens5,e1000527,2009).
degree. The skin plays a role in heat exchange; in response to some carcinogenic hydrocarbons (Sec-
vasodilationtoloseheatandvasoconstrictiontocon- tion 10.14.3). Retinoic acid, widely used in the treat-
serveitintheinterestsofthewholebodycandeliver ment of skin diseases, decreases CYP1A1 levels, an
too much or too little O to the skin itself, poten- effectwhichcontributestoitschemopreventativeeffect
2
tially causing problems. Skin must also put up with inskincancermodels.382
air pollutants, deodorants (e.g. many antiperspirants Letusexamineafewoftheseinsultsinmoredetail.
are acidic and contain aluminium salts), other ap-
pliedchemicals(e.g.insuncreams,lotions,cosmetics,
7.13.1.1 Photosensitization
greases, soaps, shower gels, shampoos, oils), indus-
trialchemicals(whichcanincludeorganicperoxides), Theskinisatriskofphoto-oxidativedamage,byboth
agents injected during cosmetic surgery, water-borne type I reactions (Section 2.6.4) and by generation of
toxins (e.g. chlorine, dissolved metal ions), UV light, singlet O 2 , OH•, H 2 O 2 , and other ROS. Photosensit-
otherradiation,productsfromskinbacteria(Fig.7.22), izers are found in some cosmetics, and as ingested
and fungi (e.g. fungal MnSOD can provoke an im- photosensitizing drugs that reach the skin, includ-
mune response in subjects with dermatitis, who may ing some phenothiazines (used as tranquillizers), as
then develop an autoimmune reaction to their own well as fluoroquinolone and tetracycline antibiotics
MnSOD380), and chemicals secreted in sweat. For ex- (Sections 2.6.4.3 and 9.17). The skin also contains
ample,sweatcontainstransitionmetalionscapableof endogenousphotosensitizers,includingflavoproteins,
catalysingfree-radicalreactionsandpromotingbacter- haemproteins,andpyridinoline,acompoundpresent
ial growth (Table 5.2). The skin bacteria constitute a in the cross-links of collagen.383 Some people con-
complexmixedflorathatinteractswithskininmany sume preparations of St. John’s wort (Hypericum hir-
ways, including playing a key role in the production sutum)totreatdepression.Donotconsumetoomuch
of odours in sweat that can attract biting insects381 andsunbathe,however;thisplantproduceshypericin
and in producing nitrite (Section 7.13.1.2). Skin re- (Fig.7.13),aphotosensitizer,andtheskindamagewill
sponds to many xenobiotics by increasing its content makeyouevenmoredepressed.Thisdamagingeffect
ofcytochromesP450.Forexample,CYP1A1levelsrise ofSt.John’swortwasrecognizedoveracenturyago

--- Page 459 ---

404 FREE RADICALS IN BIOLOGY AND MEDICINE
by Arab herdsmen, who avoided it by painting their Whereas UV-B is much more damaging to skin than
white horses with henna or grazed only black sheep UV-A if equal exposures are carried out; the deeper
onpasturescontainingthisplant. penetrationofUV-Aanditsfargreaterabundancein
Celery and parsnips are among the plants that sunlightmeanthatitisalsoasignificantcontributorto
contain psoralens; some patients undergoing photo- damage.
dynamic therapy (Section 2.6.4) have suffered severe IncontrastwithX-raysandγ-rays,UVlightdoesnot
skin damage, apparently by the additive effects of deposit sufficient energy in water molecules to frag-
the dietary psoralens with those given during the ment them. However, if H O is available, UV-B can
2 2
therapy.384 Porphyria (Section 2.6.2) patients can suf- leadtoOH•generation,
fer increased photooxidative damage, as do animals
consumingthetoxinsporidesmin(Section2.6.4.3).Pro- H O −−U−V−→OH • +OH •
2 2
pionibacterium acnes, a normal inhabitant of the skin,
producescoproporphyrin(Fig.7.22).Severalinksused andOH• candamageDNAdirectly.Moresignificant
in tattoos are photosensitizers that can damage the thanthisistheabsorptionofUV-Bbythymineorcyto-
skin,andoftenalsothetattoowillfadewithtimeupon sine, creating excited states that can react with water
exposuretosunlight(aprocessacceleratedwhenlasers toformpyrimidinehydrates(minorproducts),orwith
areusedtoremovetattoos).385 anadjacentpyrimidinetoproducecross-links(thefa-
In addition, some chemicals can react with skin vouredprocess;Fig.7.23).UV-Aismuchlesseffective
proteins to create adducts that provoke an immune at damaging DNA directly (Fig. 7.23, legend), but it
response, leading to allergic contact dermatitis. One can lead to ROS production (singlet O , H O ) that
2 2 2
example is the terpene limonene, often used in fra- canincreaseDNAdamage,generatingproductssuch
grances; it has little effect itself but readily oxidizes as8OHGintheDNA.Somestudiessuggestthatsun-
to peroxides that modify proteins to create powerful light passing through the skin can even cause DNA
contactallergens.386Thisisanexampleofphotoallergy damage in white cells circulating through skin capil-
(Section2.6.4.3). laries(perhapscontributingtotheimmunosuppressive
effects of UV light),389 but the greatest damage is
7.13.1.2 Ultravioletlight
withintheskincells,includingdamagetodermalmito-
The biggest problem that the skin (and eyes) face chondrial DNA; UV exposure leads to more deletion
is light exposure, especially UV light. Exposure to mutations.390 Ultraviolet light also leads to oxidation
sunlight is a risk factor for skin cancers (basal cell ofskinlipids;generationofaldehydessuchasacrolein
carcinoma, squamous cell carcinoma, and malignant and HNE from peroxides can damage proteins and
melanoma) in humans, and a major contributor to DNA,contributingtophotoageing.387,388
theageingofskin.Skinphoto-ageingisaccompanied DNAdamagebytheseandothermechanismscon-
by wrinkling, loss of elasticity, increased skin fragil- tributestocancerinducedbyUV;indeedhumans(or
ity,accumulationofproteinoxidationandchlorination mice)391 with defects in DNA repair are often more
products,lipidoxidationproducts,andslowerwound pronetoskincancer(Section5.10.8).Cytosinedimers
healing.387,388 are more mutagenic than thymine dimers and can
In the UV region of the solar spectrum, it is only cause CC→TT tandem double-base transition muta-
UV-A(320–400nm)andsomeUV-B(290–320nm)that tions in DNA. Mutations in the tumour suppressor
reach the surface of the Earth. Fortunately, the more gene p53 (Section 10.14.4) are often important events
damaging UV-C (100–290 nm) is filtered out. (The inskincancerdevelopment.Indeed,doubletransition
wavelengthboundariesbetweenUV-A,-B,and-Care mutations are much more common in mutated p53
somewhatarbitraryandvaryslightlyindifferentpub- genesfromskincancersthanincancersfrominternal
lications). The major barrier to UV-C (and largely to organs,revealingtheroleofsunlight.392
UV-B) is the ozone layer in the stratosphere. Deple- Ultraviolet-A or -B can lead to activation (some-
tionofthislayerwillresultinmoreUV-Breachingthe times via peroxides or singlet O as signalling
2
Earth,withacorrespondingincreaseinphotochemical molecules)393,394 of a wide range of transcription fac-
damagetobothaquatic(e.g.fish,amphibians)andter- tors in skin cells, including AP-1 and NF-κB. This
restrial organisms, including plants and humans. Up can increase production of matrix metalloproteinases
to 10% of UV-B light falling on the skin can pene- (Table 8.2) that can degrade collagen and other
tratetheepidermistoreachthedermis.Ultraviolet-A connective tissue components, contributing to photo-
has greater penetration (e.g. about 20% at 365 nm). ageing. Levels of cytokines and iNOS also increase,

--- Page 460 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 405
(1) NH 2 NH 2 O
N C C + H hv +H 2 O N C C H H –NH 2 H N C C H
O C N C H –H 2 O O C N C O H H –H 2 O O C N C H
O
(2) O O O
CH 3 H 3 C CH 3 CH 3
HN NH HN OH HN OH
5 5 5 H
6 6 6 N O N O
O N
OO N N O O N 4 H
H
5 N N
H C
H C 3
3
A B C
Figure7.23 ExamplesofdamagetoDNAbyUVlight.(1)ReversibleadditionofH2Otocytosineisshown,withthepossibilityofdeaminationto
uracil.(2)Twotypesofpyrimidinedimers;(A)thecyclobutanepyrimidinedimers,formedbyphotoadditionbetweenthecarbon–carbon
doublebondsinadjacentpyrimidines.ThesecanforminDNAexposedtoUV-AorUV-B.(B)thepyrimidine(6–4)pyrimidonedimers
(sometimesreferredtoasthe6–4photoproducts).TheseareformedbyphotoadditionofthecarbonylgroupatC4(ortheaminogroupwhen
cytosineisinvolved)ofonepyrimidinetoacarbon–carbondoublebondofanotherwithsubsequentorientationtoaring-openedstructure.These
formonlyinDNAexposedtoUV-B.TheyinturncanabsorbUVlightandisomerizewiththeformationofacovalentbondbetweenN3andC6to
theDewarvalenceisomers(C)(Photochem.Photobiol.88,1048,2012).Thyminecyclobutanedimers(A)arethemainlesionsinUV-exposed
DNA,butcyclobutanedimersatCCandCTsequencesareconsideredmoremutagenicbecausetheyarelessrapidlyrepaired.Thecyclobutane
pyrimidinedimersappeartocontributemoretocancerriskandinflammationthanthe6–4photoproducts(Curr.Biol.15,105,2005).Cytosine
withinbipyrimidinephotoproductsundergoesaccelerateddeaminationtouracil(A).Thymidinedimers,presumablyarisingfromnucleotideexcision
repair(Section5.10.3)havebeendetectedinincreasedamountsinurineaftersubjectswereexposedtosunlight(J.Invest.Dermatol.117,263,
2001;CancerEpidemiol.Biomark.Prev.14,2868,2005).
causing excess NO• production and ONOO– gener- increases the non-haem iron content of the skin; in-
ation.Asmentionedearlier,NO•canalsobegenerated creases in iron with age and sun exposure are also
non-enzymicallyfromNO–andnitroso-compoundsin observedinhumanskin.Topicalapplicationofcertain
2
the skin.379 Sweat contains up to 40 μM NO–, which ironionchelators(e.g.1,10-phenanthroline)totheskin
3
is constantly reduced to NO– by skin bacteria. Rapid ofhairlessmiceappearedtodelaytheonsetofUV-B-
2
evaporationofsweatdepositsNO–ontheskin,where induceddamage,butthisdoesnotappeartohavebeen
2
it can be broken down by UV light, especially as the testedinhumans.395
skinsurfaceisoftenacidic(pH~5),379
7.13.1.3 Inflammation
NO– 2 + hv→ [NO– 2 ] ∗−−−H− + → NO • +OH • Damage to skin by photosensitization, UV-light, or
other mechanisms causes an inflammatory response,
ThisNO•maybeprotective(e.g.inhibitinglipidperox- including recruitment and activation of lymphocytes
idation)andcanperhapsactasa“bridge”untiliNOS andneutrophilsthatmakeROS,andthereleaseofcyto-
levelsareraised,butnotethatOH•isalsoproducedin kinessuchasIL-1andTNF-αbyphagocytesandskin
theabovereactions. cells. Hydrolysis of phospholipids to liberate arachi-
Liberation of iron ions in photodamaged skin may donic acid, and the subsequent production of pros-
also contribute to oxidative damage (e.g. promoting taglandins and leukotrienes play key roles, as does
lipidperoxidationandOH•formationfromH O )and iNOS production. The skin is affected in many auto-
2 2
helpingintheactivationoftranscriptionfactors.393,394 immunediseases(Section10.10).Severalskindiseases
This iron arises from several sources, including cell involve inflammation, including acne (Fig. 7.22) and
necrosis,activationofHO-1(Section7.13.2),anddam- psoriasis. The latter affects up to 2% of the popula-
age to lysosomes, releasing proteinases that degrade tionofadvancedcountriesandischaracterizedbyin-
ferritin as well as intra-lysosomal iron ions. Indeed, creasedkeratinocyteproliferationandabnormalkerat-
chronicexposureofhairlessmicetolowlevelsofUV-B inocytedifferentiation;TNF-αandIFN-γareimportant

--- Page 461 ---

406 FREE RADICALS IN BIOLOGY AND MEDICINE
contributors to the pathology of psoriasis.396 Hyalur- isconstantlyreplacedbysecretionsfromthesebaceous
onic acid (HA) is present in skin matrix and also glands.404Theepidermiscontainstrans-urocanicacid,
widelyusedincosmeticsandcosmeticsurgery.How-
ever, small HA fragments are pro-inflammatory, act-
ingasDAMPs(Sections8.7.1and10.11.3).HOClwas
reported to be anti-inflammatory in mouse skin, by
deterringactivationofNF-κB(Section5.5.6.1).
Dapsone (Fig. 7.4) is used to treat several skin
diseases. It is metabolized to a hydroxylamine (and a breakdown product of filaggrin, a histidine-rich
possibly to nitroxide radicals) in vivo (Section 7.5.1), protein in the stratum corneum. Urocanate may ab-
although the contribution of these to its therapeutic sorb some UV light, dissipating the energy as it
effectsisuncertain.397 isomerizes to the cis form.387 Skin also contains
7-dehydrocholesterol, which can be photoconverted
7.13.1.4 Airpollutants
(mostlybyUV-B)to1,25-dihydroxyvitaminD ,which
3
Exposure to O 3 causes oxidation of proteins and lip- then forms vitamin D 3. This process is an important
•
ids in the stratum corneum, whereas excess NO can source of vitamin D in humans, as well as using up
2
nitratethem.Indeed,reactionsofO 3 withhumanskin someUV-Bofcourse.
lipidsareasourceofatmosphericvolatilecarbonyls.398 Sunlight induces the synthesis of melanin, which
Cysteine-rich proteins (Section 7.13.2) and other anti- hasabroadabsorbancespectrumthatrangesthrough
oxidantsinthestratumcorneumcan,tosomeextent, theUV-B,UV-A,andvisibleranges.Melaninismade
absorbthesetoxicgasesandprotectdeeperskincells in melanocytes in the epidermis and hair follicles,
(Section 7.13.2), but in the process the proteins are whichthentransferittokeratinocytesandtohair.Eu-
damaged.399Ofcourse,corneocytesareregularlyshed, melanin is protective against photodamage but this
butifdamageisexcessive,theskin’sbarrierfunction is not always true of pheomelanin (Section 3.25.9).
can be impaired. Smoking accelerates skin ageing, in Inthediseasevitiligothereispatchydepigmentation
part by promoting oxidative damage and activation oftheskinduetolossofmelanocytesfromtheepider-
ofmatrixmetalloproteinases.400 Glycationofcollagen mis (probably due to autoimmune attack), decreased
andotherproteinscanalsodamageskin.401 catalaseactivity,andaccumulationofperoxides,allan-
toin(anoxidationproductofurate;Section6.13),and
methionine sulphoxide, although the relationship of
7.13.2 Protectingtheskin
these events to the origin of the disease is unclear.405
The best solution to UV is avoidance; stay out of Skincontainscarotenoidswhoselevelsapproximately
the sun or use a sun block. Sadly, some constituents correlate with blood levels, especiallyβ-carotene and
of sun creams (such as titanium dioxide, TiO ) can lycopene(Section4.4.3).Lycopeneisrapidlydegraded
2
themselves generate 1O and OH• upon illumination inskinexposedtosunlight;itsoverallphotoprotective
2
(Section 2.6.4.1).402 Tocopherols, vitamin C (often as effectisnotlargebutmaybeuseful.406 Someauthors
hydrophobic esters such as ascorbyl palmitate), and have explored lipoic acid (Section 3.25.4) as a skin-
flavonoids are now being added as protective agents protective antioxidant. However, it is rapidly broken
toskincreams.Theirabilitytopenetratedeepintothe downbyUVlight.407
skin is limited, and a better way of raising antioxi- Keratinocytes and skin fibroblasts contain mil-
dant levels in the skin is to consume more of them limolar levels of GSH, the usual complement of anti-
in the diet. However, the results of the SUVIMAX oxidantdefenceenzymes(includingSODs,GPx,cata-
study have cautioned us that supplements are not lase, glyoxalases, and peroxiredoxins), α-tocopherol,
alwaysbeneficialinprotectingagainstskincancer(Sec- ascorbate (involved in skin collagen synthesis), and
tion4.6.6).α-Tocopherolinskinsurfacelipidssecreted repair systems; the proteasome,408 autophagy,409 and
by the sebaceous glands absorbs some UV-B, but is DNA repair enzymes (especially nucleotide excision
photo-oxidized to a range of products, including an repair;Section5.10.3). However,repairofpyrimidine
α-tocopherol dihydroxydimer and a spirodimer, in dimers in human skin seems fairly slow, taking 48 h
whichtwotocopherolmoleculesjointogetherandtheir or more after their formation.410 Indeed, the levels
–OHgroupsarebothoxidizedtoquinones.403Skinsur- of thymine dimers in human urine seem to correl-
facelipidsincludesqualene,whichcanabsorbUVlight ate with exposure to UV irradiation (at least in the
andreactwithO andbesimultaneouslyoxidized,but Swedishlifeguardsstudied!).410Theskinalsocontains
3

--- Page 462 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 407
8OHdGTPase, which ‘sanitizes’ the DNA precursor cansometimeshelp;409 ifitdoesn’t,theycanaccumu-
pool (Section 5.10.2). Keratinocytes possess the ergo- lateandimpairskinfunctions.Proteasomeactivityin
thioneine transporter (Section 3.16.2) and can take skinseemstodeclinewithage,perhapscontributingto
up this compound if it is present.411 Mice lacking thephotoageingphenomenon.408Inaddition,accumu-
CuZnSODshowacceleratedskinageing,whichcanbe lationofHNE-modifiedproteinsduringUVexposure
amelioratedtosomeextentbyapplicationofascorbyl- mayinhibittheproteasome(Section5.14.3.4).408
2-phosphate6-palmitate,avehicletodeliverascorbate
totheskin.412MnSOD+/–micealsoshowedaccelerated
7.13.3 Woundsandburns
skinageingandinflammation.413
In general, keratinocytes are more resistant than The skin can suffer cuts, abrasions, and burns, and
most animal cells to killing by H 2 O 2 , organic perox- the resulting cell death and breakdown of red blood
ides,orperoxynitrite.393,399 Inmice,levelsofcatalase, cells can release haem and iron, generating a pro-
GPX, glutathione reductase, α-tocopherol, ascorbate, oxidant environment around the wound.419 Is this
andGSHarereportedtobehigherinepidermisthan bad? Not necessarily; O •–/H O may play important
2 2 2
indermis.414 Ascorbate,GSH,SOD,catalase,andubi- rolesinwoundhealing.First,theyandotherROSare
quinol levels fall in both dermis and epidermis in produced by activated phagocytes to deter infection
UV-exposed murine skin, and ascorbyl radicals can (Section8.7);andhaemaccumulationmayaidphago-
be detected.414,415 The stratum corneum also contains cyte recruitment.419,420 Second, ROS are themselves
someantioxidants,especiallyα-tocopherol,ascorbate,
involvedinphagocyterecruitment(Section8.7.3),For
GSH, and urate, the last being a good scavenger example, injury to zebrafish led to formation of a
of O 3 .40 In addition, cysteine-rich proteins there (the gradientofH 2 O 2 thatpromotedneutrophilattraction
small proline-rich proteins) can help to absorb O 3 , to the site of injury (Fig. 6.9). Third, after wound-
singletO 2 ,andotherhighlyreactiveROS.399 Metallo- ingthebloodcoagulationcascadebeginsandplatelets
thioneins(Section3.23.2)mayalsobeimportant;mice aggregate, which involves O •–/H O (Section 8.10.7).
2 2 2
lacking MT-1 and MT-2 were more sensitive to UV- Thrombinreleasedbythecoagulationcascadecanin-
inducedskininjuryandmetallothioneinlevelsrisein creaseNADPHoxidaseactivityinvascularendothelial
keratinocytesandfibroblastsafterexposuretoUV-B.416 andsomeothercelltypes.Fourth,ROScanaidhealing,
Mice lacking Nrf2 show increased skin damage on bypromotingkeratinocyteandfibroblastproliferation,
exposuretoUV-B,probablybecauseoffailuretomain- andbyincreasingtheproductionofVEGFbykeratino-
tain or raise GSH levels.417 Increases in Nrf2 activity cytes(rememberthatbothcelltypescontainNADPH
in UVA-exposed skin may, in part be triggered by oxidase).420,421Indeed,amputationofpartofthetailof
accumulation of lipid oxidation products.409 Indeed, Xenopus tadpoles led to generation of H O that was
2 2
fumarateestersthatactivateNrf2(Section11.5.11)have necessaryfortailregeneration.422Collagensynthesisis
beenusedtotreatpsoriasis.However,asobservedin accompanied by H O production; lysyl oxidase pro-
2 2
othertissues(Section5.5.8),toomuchNrf2activation ducesH O asitcatalysescollagencross-linking.423Of
2 2
canbeinjurioustokeratinocytes.418 course,toomuchfibroblastproliferationcanproduce
Inskinfibroblasts,UV-Ainducessynthesisofheat- excessivescarring.
shock proteins, including HO-1.393 Keratinocytes are SomeauthorshavereportedthatascorbateandGSH
unusualinthattheyexpressHsp72constitutively,al- aredepletedinwounds,perhapstoallowtheROSlee-
though levels rise under UV light. By contrast, kera- waytoact.424 Bycontrast,othersreportthatlevelsof
tinocyteshavehigherbasallevelsofhaemoxygenase peroxiredoxin,HO-1,SOD,GPX1,PHGPx,andcatalase
(HO-2), but little inducible (HO-1) activity.393 Given are increased in proliferating keratinocytes of injured
that skin fibroblasts are covered by the epidermis, it mouseskin,425andmicelackingCuZnSOD426orglyox-
seems reasonable that they would have an inducible alase1(Section11.4.3)showimpairedwoundhealing.
response to UV, whereas the poor keratinocytes are Whetherapplyingantioxidantstoawoundwouldpro-
directly‘inthefiringline’andmayneedtokeepHO moteorimpairhealingisaquestionthatdeservesmore
aroundallthetime.RememberthatHO-1alsoliberates study,andtheanswermaydependonthewound.421
iron,whichcouldbeaproblemifthereisinsufficient Forexample,woundhealingisslowerindiabeticmice;
co-inductionofferritintosequesterit. therapy with genes encoding eNOS or MnSOD ac-
Damagedproteinsintheepidermiscanbedegraded celerated healing, suggesting that a correct ratio of
by the proteasome system,408 provided that aggrega- NO• to O •– is important.427 In some ulcers, the bal-
2
tion has not gone too far, in which case autophagy ance might be too far in favour of the ROS, so that

--- Page 463 ---

408 FREE RADICALS IN BIOLOGY AND MEDICINE
theyarecausingharm.428Indeedwounddressingscon- 7.14.1 Exercise,lackofexerciseandoxidative
taining desferrioxamine have been developed, in an damage
attempttodecreaseiron-dependentoxidativedamage
Does exercise increase oxidative damage? Before an-
in wounds.429 Remember, however, that iron is es-
swering that, let us step back a little to remind our-
sential for cell proliferation, so chelation must not be
selves that lack of exercise does. Obesity, related to
overdone.
too much food and lack of exercise, is associated
Burns also result in DAMP release, phagocyte ac-
withoxidativestress(Section10.4).Incagedmice,in-
tivation, iNOS induction, protein nitration, oxidative
activity led to increased NADPH oxidase-dependent
damage to the skin and, in extensive burns, severe
endothelial O
•–
production and consequent vascular
shockandARDS(Section10.8),aswellasheartdam- 2
dysfunction.438Anevenmorestrikingexampleispro-
age. Increased levels of XO in plasma (detected in
vided by disuse atrophy. Immobilization of animals
both rodents and humans) may contribute.430,431 In-
causes muscle wasting, accompanied by increases in
deed, administration of SOD or allopurinol to mice
muscle protein carbonyls, oxidative damage to nu-
before severe thermal skin injury increased their sur-
cleicacids,‘catalytic’iron,andOH• production.439,440
vival times.432 Burn-induced cardiac injury seems to
As the actress Helen Hayes said, ‘if you rest, you
involveimpairedhandlingofintracellularCa2+,caused
rust’.Inrats,amitochondriallytargeted‘antioxidant’
by oxidative damage to ryanodine receptors in the
(SS31) decreased muscle wasting arising from limb
sarcoplasmicreticulum.433
immobilization,441suggestingaroleformitochondrial
As is the case for wounds, the value of using anti-
O
•–/H
O (we have already cautioned that SS31 can
oxidants in burn treatment is an open question, al- 2 2 2
have other modes of action). Similar problems of
though some animal studies have suggested some
musclewastingoccurinastronautsinspaceflightand
benefit of liposomally encapsulated SOD,434 ascor-
in patients mechanically ventilated (atrophy of the
bate, or the antioxidant raxofelast (Table 11.5.6).435
diaphragm).439 Oxidative damage (e.g. measured as
Severeburninjuryinterfereswithmitochondrialfunc-
elevatedlevelsofproteincarbonyls)hasalsobeenim-
tionanddecreasesATPproduction.Superoxide/H O
2 2
plicatedindisuseatrophyandage-associatedmuscle
may contribute to this effect, since a mitochondrially
wasting (sarcopenia) in humans.442,443 In some stud-
targeted‘antioxidant’(SS-31)improvedmitochondrial
ies,levelsofplasmaproteincarbonylscorrelateclosely
function/ATPproductioninburnedmice.436However,
withthedegreeoffrailtyofthesubjects.444
remember that SS-31 can have other modes of action
Sobacktothequestion‘doesexercisecauseoxida-
(Section 11.5.12). Burn injury resulting from fires is,
tivedamage’?Exercisetoanextentthatcausessevere
of course, complicated by the toxic effects of smoke
muscledamagedoes.Aslongagoas1982itwasfound
inhalation(Section9.13.7).
that severe, forced physical exercise in rats results
in muscle damage, seen as a decrease in mitochon-
drialrespiratorycontrol,lossofstructuralintegrityof
7.14 Skeletalmuscle:isexerciseacause sarcoplasmic reticulum, and increased levels of lipid
oforaprotectionagainstoxidative
peroxidation.445α-Tocopherol-deficientratshadmark-
stress?437 edlylowerendurancecapacityforexercise.Laterwork
showedincreasedproteincarbonylsand‘catalytic’iron
It is often said that about 1 to 5% of the O taken in levelsinthemuscle.Protectionagainstoxidativedam-
2
byaerobesformsROS.Duringexercise,bodilyO con- age was offered by careful endurance training; such
2
sumptioncanincreasebyasmuchas10-to15-fold,and trainingincreasedtheactivitiesofantioxidantenzymes
O uptakeintheactiveskeletalmusclemaygoup100- suchasGPX,glutathionereductase,catalase,andSOD
2
foldormore.IfthesamepercentageforROSformation inratheartandskeletalmuscle.446
holdstrue,exerciseshouldleadtoalargeincreasein Similarly, in humans, vigorous prolonged exercise,
totalbodyROSburden,andanevenlargerincreasein especially in untrained individuals, produces muscle
theworkingmuscles.Thiswouldbeexpectedtocause damage,demonstrablehistologicallyorbymeasuring
muscle oxidative damage. Yet levels of antioxidant release of myoglobin or of muscle enzymes (such as
enzymes in muscle are only modest. Skeletal muscle creatinekinase)intothecirculation.Prolongedstrenu-
generates NO• (from eNOS and nNOS), which could ous exercise (e.g. running a marathon) increases the
formONOO–ifO •–productioniselevated. number of circulating neutrophils, activates some of
2

--- Page 464 ---

REACTIVE SPECIES CAN POSE SPECIAL PROBLEMS NEEDING SPECIAL SOLUTIONS: SOME EXAMPLES 409
them, and can produce some features of an acute- Insummary,excessiveexercisecausesmuscledam-
phaseresponse(Section5.7.4),suchasfallsinplasma age, and injured tissues are likely to show elevated
zincandironlevels,risesinIL-1,IL-6,TNF-α,andC- oxidative damage secondary to the injury (Fig. 10.1).
reactiveprotein,andmildfever.447Itcanalso(insevere Thus, the extent of muscle damage may be one fac-
cases) increase gut permeability, allowing endotoxin tor determining whether or not elevated lipid, DNA,
to enter the circulation and potentiate inflammatory orproteinoxidationcanbedetectedinexercisinghu-
changes.Butmusclereadilyadaptstomoremoderate mans.AnotherfactoristhatmusclesproduceROSfor
exercise;elevatedtemperatureinexercisingmusclecan usefulpurposes,includingfacilitatingtheiradaptation
triggertheheat-shockresponseandexercisecanraise to increased usage. Indeed, mitochondrially targeted
SOD,GPx1,andcatalaselevelsinhumanmuscle.448–450 antioxidants (Section 11.5.2) delayed differentiation
Regularmoderateexerciseimprovesvascularfunction; of myoblasts into muscle cells in culture.463 Skeletal
induction of antioxidant enzymes and of NO• syn- muscle sarcoplasmic reticulum contains an NADPH
thesis (eNOS) are involved451 and there is evidence oxidase, and ROS-dependent activations of NF-κB,
from mice that H O plays a role in this adaptation AP-1,andheat-shockfactor(Section5.6)seemtoplay
2 2
(Section5.5.10).Indeed,regularmoderateexercisecan a key role in adaptation to exercise, which includes
have an anti-inflammatory effect overall and it helps elevations in antioxidant enzymes, eNOS, and heat-
topreservevascularandmusclefunctionintheelderly shockproteins.450,464–466SourcesofO •–inmuscleother
2
(Section11.4.2).452 thanNADPHoxidasesmayincludemitochondriaand
Dozensofpapershaveclaimedincreasedoxidative xanthineoxidase,465 thelastprobablybeingmoreim-
damagedetectableinplasma,urine,ormusclebiopsies portant in rodent muscle than in humans. However,
after exercise in humans, but many have used unre- toomuchROSproducedinthemuscleduringsevere
liablebiomarkerssuchasTBARSordieneconjugates exercisemightbebad,generatingONOO–andcausing
(Section 6.15). Nevertheless, there are data showing injury. Indeed, mice with sub-normal MnSOD levels
risesin levelsofbetterbiomarkers,suchasallantoin, showed reduced exercise endurance.449 It’s the usual
F -IsoPs, and increased oxidation of albumin-SH ROS/antioxidant balance; some ROS are useful and
2
groups.453–457 It has been suggested that urate may toomanyareproblematic.
be beneficial by intercepting some ROS.458 Strenuous
(but not moderate) exercise in humans or dogs457,459 7.14.1.1 Antioxidantsupplementsandexercise
increased urinary excretion of 8OHdG; this could Is antioxidant supplementation of athletes beneficial,
reflectmoreDNAdamage(abadthing)oractivation either in minimizing oxidative damage secondary to
ofDNArepairprocesses(agoodthing;Section6.14.6). vigorous exercise or in accelerating healing of dam-
This question was addressed in the dogs; levels of aged tissues? The results of human studies, over-
8OHdG in lymphocytes and colon decreased after all, suggest that beneficial effects are small or non-
exercise, consistent with increased repair.459 Indeed, existent.N-acetylcysteineadministrationwasclaimed
moderateexerciseincreasedtheexpressionofmRNA todecreasemusclefatigueinhumans.467α-Tocopherol
encoding hMTH1 (Section 5.10) in leukocytes of administration might increase recovery after injury,
sedentaryhumans.460 possibly (as a few, but by no means all studies
However, other studies have not found signifi- have suggested)453 by modulating the inflammatory
cant increases in the levels of oxidative damage bio- response. However, in several (but by no means
markers after exercise in humans, and some data all)468 studies, antioxidant administration has wors-
have shown decreases (e.g. in F 2 -IsoPs). Why? First, ened some parameters of muscle damage448 or pre-
the extent of any rise may depend on the intensity ventedadaptationtoexercise.450,464Thusinonestudy,
and type of exercise.460–462 Second, oxidative dam- administrationofacombinedsupplementofvitamins
age that occurs locally (in the muscles) may not al- E and C to healthy males diminished both the bene-
ways be reflected in the plasma. Third, prolonged ficial effect of exercise on insulin sensitivity and the
vigorous exercise alters plasma volume; this must rise in CuZnSOD, MnSOD, and GPx1 in muscle in-
be corrected for in attempts to assess the signifi- duced by the exercise.450 In another, mitochondrial
cance of change in concentrations of antioxidants or biogenesisaftereightweeks’exercisetraininginmen
oxidative damage biomarkers in plasma. Finally, the was slowed by vitamin C administration;464 levels of
age of the subjects studied is important—muscles in ascorbate in human skeletal muscle rise rapidly if
the elderly may be more prone to oxidative damage extraisconsumed.469 Resveratroladministration(Sec-
(Section11.4.2). tion 4.5.1) was also reported to diminish the positive

--- Page 465 ---

410 FREE RADICALS IN BIOLOGY AND MEDICINE
effectsofexercisetraininginhumans.470 Howexactly glucosetoleranceandloweredrisksofobesity,hyper-
theseantioxidantsareworkingtodecreasetheadapta- tension,dementia,diabetes,andcertaininfections(by
tionisuncertain.468 contrast,hard-trainingathletesaremoresusceptibleto
One factor to consider is the starting antioxidant certaininfections,inpartbecauselymphocytenumbers
levels of the subjects studied—if it were subnormal transiently decline).471 Exercise might even increase
then a benefit might be more likely to be seen. Ele- neurogenesis in the brain and delay the onset of de-
vatingmusclecarnosinelevelsbyfeedingβ-alanineto mentia and related conditions (Section 10.21.7) in the
humansappearstoimprovetolerancetoenduranceex- elderly.472AsGeorgeBernardShawsaid‘Wedon’tstop
ercise(Section3.25.7)butthisisnotnecessarilydueto playing because we grow old; we grow old because
anantioxidantmechanism,e.g.itmayhelptoprevent we stop playing’. The extent to which the benefits of
afallinpH.Anotherfactorisage;intheelderly(espe- moderateexerciseareexplainedbyincreasedlevelsof
ciallyifunfit)theROS/antioxidantbalanceinmuscle antioxidantdefencesystemsinvascularendothelium,
is shifted in favour of the ROS, and perhaps then skeletal muscle, heart, and elsewhere is unknown.
antioxidantsmightsometimesbebeneficial,although TheymightalsoinvolvedecreasedO
•–
productionin
2
moderateexerciseisprobablybetter(Section11.4.2). mitochondria,e.g.byupregulationofuncouplingpro-
teins or simply by accelerating electron transport by
increasingtheADPsupply:mitochondriatendtomake
7.14.2 Exercise,healthandfreeradicals
lessO
•–
whentheelectrontransportchainisrunning
2
Regular physical activity in humans has positive ef- fast.Regularmoderateexercisealsoincreasesvascular
fects,includingimprovedcardiovascularfunctionand
endothelialNO•production.461

--- Page 466 ---

CHAPTER 8
Reactive species can be useful: some
more examples
Naturedoesnothinguselessly
Aristotle
8.1 Introduction prokaryotes, whereas the other classes are found
mostly in prokaryotes. All three classes use a thiyl
Wehavealreadyencounteredseveralexamplesofre- (-S•) radical to attack the ribose, but generate it in
activespecies(RS)servingusefulpurposes,including
differentways.
ferryl at the active sites of cytochromes P450 (Sec-
In aerobicallygrown E. coliand in animal cellsthe
tion1.4.1)andhaemperoxidases(Section3.19),water
class I enzymes have two homodimeric subunits, α
splittingduringphotosynthesis(Section7.8.2),thefla- 2
andβ .Theα dimeriscalledproteinR1andcontains
vinandpyrimidineradicalsinDNAphotolyase(Sec- 2 2
the active sites, whereas protein R2 is the β dimer.
tion 5.10.1), the tryptophan radical in cytochrome c 2
EachsubunitofR2containstwoFe(III)ionsconnected
peroxidase(Section3.19.1),themultiplephysiological
roles of NO• (Section 2.5.6), and the involvement of byoxygen.TheR2dimergivesanESRsignalthatarises
from a tyrosine phenoxyl radical, derived by loss of
H O in signalling (Section 5.5). In Chapter 8, we
2 2 a proton and electron from a tyrosine residue in the
examinemoresuchcasesindetail.
protein.Tyrosylradicalsarestablein‘resting’RNR,be-
ing buried inside the tertiary structure. The presence
8.2 Radicalenzymes:ribonucleotide ofTyr-O• iscloselylinkedtothepresenceofiron;the
reductaseanditscolleagues1
radicalislostonremovalofironfromtheenzyme.Itre-
formsonincubationofR2withFe2+ (orFe(III)plusa
First, let us consider a few more enzymes that use
reducingagent)inthepresenceofoxygen.Oncepre-
active-sitefreeradicalstobringabouttheirreactions.
sent on R2, the two Fe2+ ions are oxidized by O to
In general, enzymes use such radicals to remove 2
createthediferriccentreandformTyr-O•.Theoverall
hydrogen atoms from unreactive positions in sub-
reactionis
strates. This is chemically difficult, and the enzymes
mustcontroltheradicalscarefullytopreventdamage
tothemselves.
Deoxyribonucleotides, the precursors of DNA, are
made from ribonucleoside diphosphates by ribonuc-
leoside diphosphate reductase enzymes, sometimes
called ribonucleotide reductases and often abbrevi-
atedtoRNR.Theyreplacethe–OHgroupatposition The electron required can be supplied from exter-
2 on ribose by hydrogen, generating 2-deoxyribose nal sources (e.g. Fe2+) or from within the protein
(Fig.8.1). itself.
Substrate binding and reduction occur on R1. The
R2 tyrosyl radicals act as chain initiators, but do
8.2.1 Theenzymemechanism
not come near the substrate. Instead, an electron-
At least three classes of RNR are known. Class I transferprocessoccursthroughtheprotein,eventually
RNRs are found in almost all eukaryotes and some reachingtheactivesites,whichcontainthreecysteine
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 467 ---

412 FREE RADICALS IN BIOLOGY AND MEDICINE
NADPH NADP+
Thioredoxin
reductase
Thioredoxin Thioredoxin
SH SH S S
O O O O
5´
Base CH OPOP OH Base CH OPOP OH
2 2
O Ribonucleoside O
2´ 3´ O–O– diphosphate O–O–
reductase
OH OH H OH
Ribonucleoside 5´-diphosphate Deoxyribonucleoside 5´–diphosphate
Glutaredoxin Glutaredoxin
SH SH S S
GSSG GSH
GSSG
reductase
NADPH NADP+
Figure8.1 ReductionofribonucleosidediphosphatesbyclassIribonucleotidereductases.Thioredoxinisthemajorelectrondonor.Glutaredoxin
cansupplyreducingpowerinE.coliandpossiblyinanimalcells,butisgenerallythoughttobelessimportantinvivo.
residues. One is transiently converted into a thiyl proliferation),inactivatesclassIRNRsbyreducingthe
radical, which abstracts H• from the ribose, initially tyrosyl radical.2 Hydroxyurea is sometimes used in
at position 3 on the sugar ring, to generate a sub- cancerchemotherapyandinthetreatmentofsickle-cell
strate radical. The other two cysteines reduce and anaemia.InE.coli,RNRinhibitionbyhydroxyurealed
help to rearrange this transient sugar radical, so that toincreasedironionuptakebythecells,followedby
the –OH is lost from position 2. They are oxidized Fentonchemistry3togenerateOH•.
to a disulphide, which is then reduced, usually by High levels of O •– and NO• can inactivate RNRs
2
thioredoxin (Fig. 8.1). Thiyl radical is only generated byreactingwithTyr-O• (Sections2.5.3and2.5.6).Re-
whenthesubstrateisinplace,andsubstratecanonly action of tyrosyl radicals with O
•–
can form several
2
bind when the enzyme is in the reduced form, so species(Fig.2.2),whereaswithNO•anitroso-tyrosine
that the sugar radical can be immediately reduced. species is formed. By contrast, addition of ONOO–
In mutant enzymes lacking one of the reducing cyst- causes loss of the tyrosine radical, inactivates RNR,
eines, the sugar radical forms but then the substrate and nitrates the tyrosine,2 possibly by addition of
•
degrades. NO . In the R2 component of RNR from Chlamydia
2
In some class 1 RNRs the diferric oxygen cluster trachomatis (class IV RNR) the tyrosine is replaced
is replaced by a dimanganese-tyrosyl radical clus- by phenylalanine, which cannot generate a phenoxyl
ter (e.g. E. coli has one as a ‘back-up’ enzyme), or radical since the ring has no –OH group. Instead a
a Mn(IV)Fe(III) cluster, and a reductant other than Mn(IV)/Fe(III) cluster acts as the radical source.4 It
thioredoxin/glutaredoxinisused has been hypothesized that this variant mechanism
protects the enzyme from inactivation by NO• and
thus helps it to survive our antibacterial defences
8.2.2 InhibitorsofRNRs
(Section8.9.6).
Depletion of cellular iron (e.g. by incubation
Hydroxyurea, , a widely used inhibitor with iron chelators such as desferrioxamine; Sec-
of RNRs (and hence of DNA synthesis and cell tion11.6.1)canalsoinhibitRNR.

--- Page 468 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 413
8.2.3 ClassIIIribonucleotidereductases Cobalamin radicals are used by a handful of other
andother‘sonsofSAM’enzymes1,5–8 enzymes, including methylmalonyl-CoA mutase,
which converts methylmalonyl coenzyme A to suc-
Under anaerobic conditions, E. coli uses a different
cinyl coenzyme A, a reaction important in bacterial
RNR, in which a [4Fe-4S] cluster is used to form
fatty-acid metabolism. Others include ethanolamine
a radical from S-adenosylmethionine (SAM). SAM
ammonia-lyase,lysine-2,3-aminomutase,dioldehyd-
binds to the enzyme and undergoes one-electron re-
ratase, and an enzyme involved in the biosynthesis
duction,causingittofragmentintoa5(cid:4)-deoxyadenosyl
of gentamicin (Section 9.17.3). The cobalamin rad-
radical and methionine. The former abstracts hydro- icals abstract H• from substrates. The substrate
gen from a glycine residue to form a glycyl radical.
radicals rearrange to product radicals, which then
The glycyl radical then generates the thiyl radical regenerate the 5(cid:4)-adenosyl radical and form the
neededtoattackthesubstrate.Thisonlyworkswhen
product(Fig.8.2).
O is absent; O reacts rapidly with glycyl radicals
2 2
to cause enzyme inactivation (Section 8.3). Class III
enzymes use formate as a hydrogen donor rather
8.3 Pyruvate–formatelyase:asimilar
than thioredoxin or glutaredoxin, the formate being
mechanism11
oxidizedtoCO .
2
Another ‘radical SAM’ enzyme is the O -
2 The enzyme pyruvate–formate lyase (PFL) is found
independent coproporphyrinogen III oxidase
in many anaerobic bacteria, including anaerobically
(Section 1.3.1). An iron cluster cleaves SAM, lead-
grownE.coli.ItconvertspyruvatetoacetylSCoA,
ing to oxidation of the propionate side-chain on
coproporphyrinogen III (Fig. 2.12). Other such en-
CH COCOOH+HSCoA(cid:2)CH COSCoA
zymes include biotin synthase and lipoate synthase 3 3
(enzymes which insert sulphur into ring structures), +formate
enzymesinvolvedinmethanegenerationbybacteria,9
and an enzyme involved in the post-translational A glycyl radical on the enzyme is required for activ-
modification of a histidine residue on elongation ity. This is generated by an activating enzyme, PFL-
factor2,aproteinessentialtoallowproteinsynthesis.5 activase,a‘radicalSAM’proteinwhichusesreduced
Almost 3000 ‘radical SAM’ enzymes may exist, cata- flavodoxin (an iron–sulphur protein) to supply elec-
lysingover40differentreactiontypes;7 theyallusea trons.TheSAMiscleavedto5(cid:4)-deoxyadenosylradical,
[4Fe-4S]clustertocleaveSAMtothe5`-deoxyadenosyl whichabstractshydrogenfromGly734onthePFLpro-
radicalthatabstractsH•fromthesubstratetostartthe tein. The Gly• radical in turn causes thiyl radicals to
reaction.Anotherexample,damagetoDNAinspores formandattackthepyruvate.OxygeninactivatesPFL
ofBacillussubtilisbyUVlightisrepairedbyaradical withinseconds;aperoxylradicalforms,
SAMenzyme(sporephotoproductlyase;SPL)rather
than the usual photolyases, which involve different
radicals(Section5.10.1).10 SPLactiondoesnotrequire
light.
8.2.4 ClassIIribonucleotidereductasesand
othercobalaminradicalenzymes1,6,8 followed by fragmentation of the backbone between
serine-733andtheglycine,leavinganoxalyl(HOOC–
ClassIIRNRsalsouseadeoxyadenosylradicaltoform CO–NH–)residue.
the thiyl radical, but are not inactivated by O and
2
use thioredoxin or glutaredoxin as electron donors.
The source of the 5(cid:4)-deoxyadenosyl radical is differ-
8.3.1 Pyruvate–ferredoxinoxidoreductase
ent, namely, adenosylcobalamin. Cobalamin, other-
wise known as vitamin B , consists of a corrin ring Another type of pyruvate-metabolizing enzyme used
12
with a central cobalt ion. The radical is formed by byanaerobicbacteriaandsomeparasiticprotozoa(e.g.
homolytic cleavage of the fairly weak bond between Giardialamblia)ispyruvate–ferredoxinoxidoreductase
thecobaltandthe–CH groupinadenosylcobalamin (PFOR),12 which catalyses a reversible reaction that
2
(Fig.8.2). providesacetylSCoA,

--- Page 469 ---

414 FREE RADICALS IN BIOLOGY AND MEDICINE
(a) OH OH (b) AdoCH-B AdoCH(cid:129)+ B
2 12 2 12r
N
5'CH O N N X H H X
2
C C C C
N NH 1 2 Overall reaction 1 2
33NH
2
O34 40 NH
2 O39
2 AdoCH(cid:129)
2
AdoCH(cid:129)
2
2 2 8 9 O NH 2 2 2 0 5 CH 3 2 1 3 A N 4 2 3 1 5C 5 H 22 3 N 6B 7 9 8 CH 3 36 N O H 44 2 45 AdoCH 3 C X 1 C (cid:129) 2 C (cid:129) 1 C X 2 AdoCH 3
CH 3 Co 10
62NH 2 18 1 1 9 7 D 1 N 6 24 15 23N 14C 1 1 1 3 12 C C H H 3 4 4 6 7
63O 54CH 3 CH 3 53 3 O51 O
58O 56 NH 2 52 (c) H H O H C CoA
59NH 38N CH 3 C C C H
N HOOC CH 2 CoA HOOC CH 2
CH OH CH 3 Succinyl-CoA (2R)-Methylmalonyl-CoA
3 O
–O O
P
O
O
OH
Figure8.2 VitaminB12(adenosylcobalamin)anditsderivatives.Coiscobalt,atransitionmetal.Thecorrinringhasfournitrogenatoms
co-ordinatedtocobalt.Thefifthco-ordinationpositionisusedtoattachaderivativeofdimethylbenzimidazolewhichisalsoattachedtoaside-
chainofthecorrinring.Thesixthco-ordinationpositionofthecobaltcanbeoccupiedbyseveralligands,includingcyanide,togive
cyanocobalamin(cyanideisintroducedduringtheisolationprocedureandisnotpresentinvivo).Thecobaltatomincobalamincanhavea+1,
+2,or+3oxidationstate.Inhydroxycobalamin,OH–occupiesthesixthco-ordinationpositionandthecobaltisintheCo(III)state.Thisform,
calledB12a,isreducedbyaflavoproteinenzymetoB12r(Co2+),whichisreducedbyasecondflavoproteintogiveB12s(Co+).NADPHisthedonor
inbothcases.B12sisthesubstrateforareactionwithATPthatyields5(cid:4)-deoxyadenosylcobalamin(structureshownin(a)).Thismoleculeis
almostuniqueinlivingorganismsinhavingacarbon–metalbond(CH2–Co).Impairedabsorptionofcobalaminfromthehumandietresultsin
perniciousanaemia.Cobalamin2+canalsobereducedtocobalamin+byO •
2
–;thereactionisquitefast(k2~3.8×108M–1s–1 ;Chem.
Biochem.Commun.14,1081,213)(b)MechanismofB12-dependentrearrangements.Ado-CH2-B12is5(cid:4)-deoxyadenosylcobalamin:Ado-CH2and
Ado-CH3arerespectivelythe5(cid:4)-deoxyadenosylradicaland5(cid:4)-deoxyadenosine.Xisthetransferredgroup.(c)Anexampleof(b):therearrangement
reactioncatalysedbymethylmalonyl-CoAmutase.Thethioestergroup(O=C–CoA)isthegroupthatmigrates.FromStructure4,339,1996,by
courtesyofDrPhilipEvansandCurrentBiologyLtd.
HSCoA+pyruvate+2ferredoxin (cid:2) 8.4 Assortedoxidases
ox
acetylSCoA+CO 2 +2ferredoxin red +2H+ 8.4.1 Galactoseoxidase
Galactoseoxidase(GO),13anexampleofa‘radicalcop-
These enzymes contain Fe–S clusters and thiamine
peroxidase’,isamonomericproteincontainingasin-
pyrophosphate (TPP). The reaction mechanism in-
glecopperion.Itisreleasedextracellularlybyvarious
volves hydroxyethyl radicals attached to the TPP
Fusariumspeciesandcertainotherfungiandcatalyses
•
(CH –COH–TPP)andpossiblysulphurradicalsfrom atwo-electronoxidationofthe–CH OHgroupongal-
3 2
the coenzyme A (•SCoA). Hydroxyethyl radicals are actoseto–CHO,O beingreducedtoH O .IntheCu2+
2 2 2
also involved in the mechanism of action of several (oxidized)formofGO,thecopperisligandedtotwo
other2-oxoacidoxidoreductases,andinthepyruvate histidineresidues,andtotyr495andtyr272.Thetyr
oxidaseenzymeofL.plantarum,whichconvertspyru- 272iscovalentlybondedtothesulphurofcys-228to
vate to acetyl phosphate, CO , and H O . They add- formacysteinyl–tyrosine,inwhichthetyrosineispre-
2 2 2
itionally play a role in the metabolism of ethanol in sentasatyrosylradical.Ofthetwoelectronsabstracted
animals(Section9.8.1). from the substrate, one quenches the tyrosyl radical

--- Page 470 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 415
andtheotherreducesthecoppertoCu+.Oxygenthen ‘Non-specific’peroxidasescontributetoH O removal
2 2
reoxidizestheenzymetogiveCu2+andregeneratethe in bacteria and plants, as well as being involved in
tyr-O•radical. other metabolic processes. In animals, non-specific
Galactoseoxidaseisinitiallyproducedasaprecur- peroxidasesarelesscommonthaninplantsorbacteria,
sorproteinwithoutthecysteinyl–tyrosinebutcontain- butexamplesincludemyeloperoxidase(Section8.7.5),
inganextra41aminoacidsattheN-terminus.Partof peroxidasins (Section 8.7.5.6), thyroid peroxidase
thisleadersequenceisremovedintheendoplasmicre- (Section 8.10.2), and lactoperoxidase (Section 3.19.2).
ticulum(ER)duringpreparationforsecretion,andthe Letuslookatsomemore.
rest during activation of the enzyme by Cu+ and O ,
2
whichcanoccurintheERorGolgiapparatus,oreven
8.5.1 An‘antimolestation’spray16
outsidethecell.Duringactivation,thetyr–cysbondis
created,thetyr-O• radicalformed,andtherestofthe The ability of peroxidases to oxidize phenols into
N-terminalpeptidecleavedoff.Theprecisechemistry quinones in the presence of H O is made use of
2 2
oftheseeventsremainstobeelucidated. by bombardier beetles, which attack their enemies
by spraying them with hot, quinone-containing fluid
(Fig. 8.4). A sac near the insect’s ‘ejection mechan-
8.4.2 Indoleamineandtryptophan ism’ contains a 25% aqueous solution of H O plus
2 2
dioxygenases14 10% hydroquinone, and the spray is generated when
the contents of the sac are pushed into a reaction
Indoleamine 2,3-dioxygenases (IDO), haem-
chamber containing catalase and peroxidase. The hy-
containing enzymes, insert oxygen into the ring
droquinonesareexplosivelyoxidizedtosemiquinones
structures of tryptophan and some of its derivatives,
andquinones,andpartoftheH O isdecomposedto
2 2
such as 5-hydroxytryptophan and tryptamine. Two
O bycatalase.Theseeventscausethetemperatureto
2
forms exist, IDO1 and IDO2. They catalyse the first riseupto80◦Candthepressuretobuildup,driving
step in the kynurenine pathway, the major catabolic
ejectionofthehotspraytoscareoffwhateverdisturbed
route for tryptophan in mammals (Fig. 8.3). The
thebeetle.
enzymemustbeintheFe2+formtobindO andattack
2
thesubstrate;thereactionisinitiatedbyattackofaO
•–
2
radical attached to Fe(III) at the enzyme’s active site 8.5.2 Seaurchinsandbrineshrimp
ontheC –C bondoftryptophanorrelatedmolecules.
2 3 Upon fertilization, eggs of the sea urchin Strongylo-
A similar mechanism is used by tryptophan dioxy-
centrotus purpuratus rapidly form a ‘fertilization en-
genase, which is specific for tryptophan (Table 1.3).
velope’, to block further sperm from entering and to
The enzymes, when purified in the laboratory, are
protectthedevelopingembryo.Envelopeformationis
inactive ferric forms. They also sometimes undergo
oxidationduringthecatalyticcycletoreleaseO
•–
and
aidedbycross-linkingoftyrosineresidues.Cross-link
2 formationrequiresaperoxidasereleasedfromtheegg,
again produce the inactive ferric form. Re-activation
ovoperoxidase, which catalyses H O -dependent for-
of IDO can be achieved in vitro by various chemical 2 2
reducingagents,includingO
•–.However,invivoferric mationoftyrosylradicals.Fertilizationisaccompanied
2 by a ‘burst of O uptake by a DUOX enzyme (Sec-
IDOisprobablyreduced15bycytochromeb . 2
5 tion8.10),Udx1(urchinDUOX1),whichgeneratesthe
LevelsofIDOinmanytissuesincreaseinresponse
necessary H O .17,18 This enzyme also plays a role in
to infections and other pathological situations. En- 2 2
developmentofthefertilizedegg.
zyme synthesis is usually promoted by the cytokine
Any toxic effects of H O produced at fertilization
interferon-γ, and is thought to be a defence and im- 2 2
may be minimized both by the action of the usual
munomodulatoryresponse.Itmodifiestheimmunere-
H O -removingenzymesandbyovothiolC(Fig.8.5),
sponsebothbygeneratingkynurenineandbyaltering 2 2
athiolpresentatmillimolarlevelsinseaurchineggs.
tryptophanlevels.
The histidine ring facilitates ionization of the –SH
group to increase its reactivity with H O . Oxidized
2 2
ovothiol may be regenerated by reaction with GSH.
8.5 Usefulperoxidases
Ovothiolsarealsopresentinothermarineorganisms
Glutathione-,ascorbate-,thioredoxin-dependent,and andsomeparasites(Fig.8.5).
cytochrome c peroxidases are important H O - A rather different use of H O is seen in the
2 2 2 2
removing enzymes (all reviewed in Chapter 3). brine shrimp Artemia, an important source of fish

--- Page 471 ---

416 FREE RADICALS IN BIOLOGY AND MEDICINE
CH CH COOH
2
NH
2 Serotonin
N
H
L-Tryptophan
Tryptophan 2,3-dioxygenase Indoleamine 2,3-dioxygenases
(TDO) (IDO)
CO CH CH COOH
2
NH
2
N CHO
H
N-formylkynurenine
Formidase
OH
Kynurenine CO CH CH COOH
2
aminotransferase
NH
2
Kynureninase
N COOH NH
2
Kynurenic acid L-Kynurenine COOH
3- Hkyn monooxygenase NH
2
Anthranilic acid
Kynurenine CO CH CH COOH
OH 2
aminotransferase
NH
2
NH
2
N COOH OH
OH 3-Hydroxykynurenine
Xanthurenic acid
Kynureninase
COOH
NH
2
OH
3-Hydroxyanthranilic acid
3-Hydroxyanthranilic acid
3,4-dioxygenase
COOH Non- COOH Picolinate
enzymatic carboxylase
N COOH OHC OHC
HOOC NH 2 HOOC NH 2
Quinolinic acid 2-Amino-3-carboxy Non-
-muconate semialdehyde enzymatic
Quinolinate
phosphoribosyl
transferase CO + HO
2 2
N COOH
NAD+ Picolinic acid
Figure8.3 Thekynureninepathwayoftryptophanbreakdown.FromRedoxRep.4,199,1999,bycourtesyofDrsShaneThomasandRoland
Stocker,andManeypublishers.TheTDOenzymecatalysesthesamereactionasIDOsbutismainlyfoundinliver.Quinolinicacidcanactasan
excitotoxininthebrain(Section10.17.4;Neurotoxicology34,189,2013).

--- Page 472 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 417
Figure8.4 Abombardierbeetleinaction.From
Proc.Natl.Acad.Sci.USA96,9705,1999.
Copyright(1999)NationalAcademyofSciences,
U.S.A.
CH 3 H CH 3 CH 3
H 2 N C CH 2 N CH 3 N C CH 2 N (CH 3 ) 2 N C CH 2 N
HO 2 C H HO 2 C H HO 2 C H
HS N HS N HS N
A B C
Figure8.5 Structureofovothiols,thio-histidinederivatives.OvothiolCandrelatedcompoundshavebeendetectedinseaurchinsandother
marineinvertebrates.OvothiolsAandBhavebeenfoundintheeggsoftroutandsalmon.OvothiolAhasalsobeenfoundintheparasitesCrithidia
fasciculataandLeishmaniadonovani,andinT.cruziandT.brucei,althoughthetrypanothionepathway(Section3.16.1)maybemoreimportantto
theseparasitesinremovingperoxides(Antioxid.RedoxSignal.17,583,2012).DiagramadaptedfromBiochemistry29,1953,1990,bycourtesy
ofDrPaulHopkinsandthepublishers.
food. When subjected to stress, females release fewer (amajorconstituentofwood)andcellulose.Thewood
swimming larvae and more cysts, in which develop- becomespalerasligninisdestroyed,hencethe‘white’
mentishalted.Thecystsareresistanttoenvironmental name.Brownrotfungimainlyattackcellulose,leaving
stress,inpartbecauseoftheirthickshellandbecause aresidueofbrownish,partiallyoxidizedlignin.
they accumulate trehalose (Section 3.25.8) and heat-
shock proteins. H 2 O 2 may be involved in prompting 8.5.3.1 Makinglignin
the cysts to resume normal development when con-
ditions improve.19 This action seems to involve NO• Lignin arises from the oxidation and polymerization
and possibly OH•, but the details have yet to be of p-coumaryl, coniferyl, and sinapyl alcohols, syn-
thesized from phenylalanine and tyrosine and then
elucidated.
exported across the plasma membrane into the plant
cellwall.Theiroxidationtothephenoxylradicalsthat
8.5.3 Makinganddegradinglignin20,21 polymerize (Fig. 8.6) is usually achieved by perox-
idase enzymes. Laccases, copper-containing enzymes
WoodisoneofNature’stoughestsubstances,andcan thatuseO tocatalyseone-electronoxidationofphen-
2
last for centuries. Yet some fungi have managed to olstosemiquinones,alsoparticipateinligninsynthesis
harness the power of RS to break wood apart. One insomespecies.ThesourceoftheH O neededbycell
2 2
typeisthewhiterotfungi,whichdegradebothlignin wallperoxidasesisnotentirelyclear,butthereissome

--- Page 473 ---

418 FREE RADICALS IN BIOLOGY AND MEDICINE
+NH
3
+NH
3
CHCH CH CHCOO– CHCH
2 2
COO– COO–
1
OH
L-Phenylalanine trans Cinnamic acid L-Tyrosine
2
5 3
CH CHCOO–
2-Hydroxycinnamic acid
(o – Coumaric acid)
OH
4-Hydroxycinnamic acid
Coumarins (p – Coumaric acid)
Coumarin glycosides
4
CH CHCOO– CH CHCOO– CH CHCOO–
6
–
H 3 CO OH OCH 3 OH OCH 3 OH OH
Sinapic acid Ferulic acid 3 4 Dihydroxycinnamic acid
(caffeic acid)
ArCH CHCOS CoA
Lignans
Chalcones Neoflavonoids
Styrylpyrones
Other flavonoids
and isoflavonoids
CH CHCH 2 OH CH CHCH 2 OH CH CHCH 2 OH
OCH 3 H 3 CO OCH 3
OH OH OH
p - Coumaryl alcohol Coniferyl alcohol Sinapyl alcohol
Cell-wall peroxidases
HO
2 2 Figure8.6 Anoutlineofthebiosynthetic
pathwaysofphenylpropanoidcompounds
R OCH
3 inplants.Enzymesinvolved:1,
OCH
3 phenylalanineammonialyase;2,tyrosine
ammonialyase;3,cinnamatehydroxylase;
4,p-coumaratehydroxylase;5,o-
coumaratehydroxylase;6,caffeicacid
O(cid:129) CH 2 OH methyltransferase.Enzymescatalysingthe
Veratryl alcohol laterstepsinthepathwaysarenotshown
(3,4-dimethoxybenzyl alcohol) indetail.AdaptedfromChloroplast
Metabolism,2ndedition,OxfordUniversity
Cross-linking and
polymerization Press,1984.

--- Page 474 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 419
evidencethattheycanoxidizeNADHtogenerateO
•–,
a haem-containing glycoprotein that resembles HRP
2
and H O (Section 3.19.2). Another (and likely more (Section 3.19.3), in that it has compound I and
2 2
important) source may be NADPH oxidase enzymes II states and a less-active compound III. Lignin
(Section 8.11.1).22,23 Diamine oxidase enzymes (Sec- peroxidase catalyses H O -dependent oxidation of
2 2
tion 7.7)24 might sometimes contribute H O as well. veratryl alcohol (Fig. 8.7), a metabolite of the fun-
2 2
Thepolymerizationmaynotbecompletelyrandom;it gus. Oxidation forms a reactive radical cation (VA•+)
hasbeenproposedtobe‘guided’bydirigentproteins which diffuses into the wood and attacks the lig-
inthecellwall(fromLatindirigere,toalignorguide) nin. The peroxidase may additionally directly oxid-
thatbindtheradicalsandonlyallowthemtocouplein ize surface phenolic residues in the wood, generat-
certainways.25 ingotherradicalstopropagatedepolymerization.Un-
like HRP, the lignin peroxidase of P. chrysosporium
8.5.3.2 Breakinglignindown20,21,26 uses a tryptophan (trp171) radical cation during its
catalytic cycle, which is able to oxidize veratyl al-
Some wood-destroying fungi release both H 2 O 2 and cohol. This radical is generated from a Fe(IV)=O
peroxidases extracellularly to aid lignin degrad- Porphyrin•+ intermediate (compound I) by intramo-
ation. For example, the white rot fungus Phanero- lecularelectrontransfer,i.e.thespeciesoxidizingVAis
chaete chrysosporium can oxidize 60 to 70% of lignin Fe(IV)=OTrp-171•.
to CO 2 and water, leaving the rest as small frag- The second group of peroxidases, also haem en-
ments. This fungus produces at least two types of zymes,oxidizesMn2+ toMn(III)ina‘classical’perox-
extracellular peroxidase. One is lignin peroxidase, idasereactionsequence(Section3.19.2):
(a) OH (b) Protein-bound (c) OH
R molecular oxygen
2
O
O H+
O CH 2 O R 3 O H O Tyr184
R N N N N Carbanion O O R 3 H
1
N CH 2 R 1 N R 2 N N
H R
HO 2
Histidyl side chain R 1 N R 2
Coelenterazine Hydroperoxide
O
(f) (e) (d)
CO 2 O O O
O(cid:129) R 3 O R 3 O R 3
N N N N N N
R N R R N R R N R
1 2 1 2 1 2
Excited enolate anion Dioxetanone
Figure8.7 Possiblechemicalreactionsunderlyingbioluminescenceofaequorin.(a)Distortionofthegroundstateofcoelenterazinebythe
aequorinproteinleadstotheformationofareactivecarbanion.(b)Thecarbanionattacksprotein-boundO2,leadingtothehydroperoxide
(c),whichisstabilizedprimarilybyhydrogenbondingtoatyrosineresidueatposition184.(d)BindingofCa2+toaequorininducesa
conformationalchangewhichallowsattackbythehydroperoxideaniononthereactivecarbonyl,leadingtotransientformationofanunstable
dioxetanone(e).ThisundergoesscissiontoCO2andanenolateanion(f)inanexcitedstate,whichreturnstothegroundstatebyemissionofa
photonofbluelight.FromNature405,291,2000,bycourtesyofDrFranklynG.Prendergastandthepublishers.AlsoseeNature405,372,2000.

--- Page 475 ---

420 FREE RADICALS IN BIOLOGY AND MEDICINE
peroxidase+H
2
O
2
→ compoundI techniqueshavebeenusedtodetectOH•arisingfrom
compoundI+Mn2+ →compoundII+Mn(III) theactionofbrownrotfungi(Table6.4).
compoundII+Mn2+ →peroxidase+Mn(III)
8.6 Lightproduction
TheMn(III)bindstoanorganicacid,suchastartrate
In many bioluminescent systems, light is produced
or oxalate, and the chelate is then believed to attack
when an enzyme (a luciferase) acts on a low-
the lignin. In essence, both types of enzyme prod-
molecular-mass substrate (a luciferin) to generate an
uce ‘reactive species’ (VA•+ or Mn (III)–chelates) that
excited state, which produces light as it decays. Per-
diffuse away from the peroxidase and attack lignin.
hapsthebeststudiedisthefireflysystem,wherealuci-
Some fungi, for example Bjerkandera adusta, produce
ferasecatalysesareactionbetweenluciferinandATPto
versatileperoxidasesthatcanoxidizebothveratrylal-
generateanexcitedstateofoxyluciferinthatemitslight
coholandMn2+,gettingthebestofbothmechanisms.
asitdecaystothegroundstate.28 Sometimestheluci-
Atryptophanradicalisinvolvedinthecatalysis.26
ferinitselfisaprotein,e.g.intherock-boringmollusk
From where do these various peroxidases obtain
Pholasdactylus(thecommonpiddock),whichsquirtsa
their H O ? Several sources. One is an aryl alcohol
2 2 blueluminoussecretionifitisdisturbed.P.dactyluslu-
oxidase.Anotherisasecretedglyoxaloxidase,which
ciferin can be inducedtoemitlightwhen exposedto
oxidizesseveralaldehydestoacids,includingglyoxal several systems generating ROS, such as Fe2+ in the
and methylglyoxal. Glyoxal oxidase converts glyoxal
presenceofO ,oramixtureofXOandhypoxanthine.
2
tooxalateandcontainscopperandacysteinyl–tyrosine
Indeed,lightemissionfromP.dactylusluciferin(often
residue at its active site, like galactose oxidase (Sec-
calledpholasin)hasbeenusedasasensitivemethod
tion8.4.1).Anextracellularcellobiosedehydrogenase to detect ROS production by activated phagocytes.29
enzymeattackscelluloseinthewood,usingquinones
Bioluminescent marine scale worms also contain a
and metal chelates as electron acceptors. However, it
protein (polynoidin) that emits light when exposed
cansometimesbehaveasacellobioseoxidase,gener- toROS.30
atingO
•–
andH O .Inaddition,intracellularglucose
2 2 2 TheP.dactylusluciferaseisaglycoproteinwithper-
oxidase enzymes can generate H O , which diffuses
2 2 oxidaseactivity,butitcontainscopperionsratherthan
outofthefungus.
haem.Similarly,luciferasefromtheearthwormDiplo-
cardia longa (a luminescent earthworm several inches
8.5.3.3 Aroleforhydroxylradical?21,26,27 long found in Georgia, USA) contains copper and
exertsperoxidaseactivity.31
Intheearlydaysofresearchintolignindegradationby
whiterotfungi,itwassuggestedthatfreeOH•radicals
wereinvolved,becauseOH•‘traps’suchasmethional
8.6.1 Greenfluorescentprotein:another
and 4-methylthio-2-oxobutyrate (Table 6.4) were oxi-
exampleofautocatalyticoxidation
dizedtoethylene.However,thesecompoundscanbe
oxidizeddirectlybyperoxidases,anillustrationofthe LightproductionbythejellyfishAequoreavictoriaalso
potentialartefactsintheiruseasOH• detectors.Nev- involves oxidation reactions. When this organism is
ertheless,someOH• canbeformedwhenH O reacts disturbed, its intracellular Ca2+ levels rise and cause
2 2
with transition metals in the wood; metal ions such emissionofbluelightbytheproteinaequorin(widely
asFe(III)canbereducedbothbycellobiosedehydro- used in the laboratory as a Ca2+ detector). The chro-
genaseandbysemiquinonesgeneratedduringlignin magen in the protein iscoelenterazine; light produc-
oxidation. tionfromitinvolvesformationofhydroperoxideand
Hydroxyl radicals seem to play a greater role in dioxetaneintermediates(Fig.8.7).Coelenterazinehas
wooddegradationbybrownrotfungi(e.g.Gloeophyl- beenusedtodetectO
•–(Section6.12.5)andbothitand
2
lumtrabeum)thatdonotproducelignin-degradingen- its oxidation product coelenteramine have been sug-
zymes.Theyreleaseoxalicacid,whichbindsironions gestedtoactasantioxidants32inmarineorganismsby
togivechelatesthatreactwithH O togiveOH•.Oxal- scavengingO •–andotherRS.
2 2 2
atecanbeoxidizedbyOH•toCO •–,whichreducesO The blue light produced by aequorin is absorbed
2 2
toO
•–
(Section2.3.3.1).Somebrownrotfungi(includ- by another jellyfish protein, green fluorescent pro-
2
ingGloeophyllum)alsosecretehydroquinonestohelpto tein (GFP),33 which then emits a bright green flash.
keepironinthereducedstate.Aromatichydroxylation When first synthesized, GFP rapidly generates its

--- Page 476 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 421
own chromogen: a serine–tyrosine–glycine sequ- certaincells.ThesePRRincludetheToll-likereceptors
ence (residues 65–67) in the protein undergoes (TLR)andtheNod-likereceptors.Forexample,TLR4
autocatalytic cyclization, dehydration, and oxida- recognizeslipopolysaccharide.PRRactivationleadsto
tion by O to produce a chromophore, para-hydro- theassemblyoflargemulti-proteincomplexes,inflam-
2
xybenzylideneimidazolidinone.GFPandsimilarpro- masomes(Section5.7),thatinduceformationofactive
teins have been used to make ‘probes’ that respond caspase-1,whichthenleadstoproductionofIL-1βand
to cellular redox state or H O levels by changes in IL-18;thesecytokineshelptoorchestrateboththein-
2 2
fluorescence (Section 6.11), and a GFP-like red fluor- nateandadaptiveimmuneresponsestothepathogen
escent protein has been used to generate singlet O aswellastheprocessofinflammationitself.35Thereare
2
(Section2.6.4.5). several different types of inflammasome, depending
onwhichinflammatoryreceptorsarestimulated.One
ofthemoststudiedisthattriggeredbyactivationofthe
8.7 Phagocytosis34
Nod-like receptor NLRP3, which responds to a wide
rangeofactivators.TheroleofROSininflammasome
8.7.1 Settingthescene
formationisconsideredinSection8.9.4.
Defenceagainstpathogensisessentialtohumansur- Which cells respond to DAMPs and PAMPs? The
vival. Our immune defences can be broadly div- initialrecognitionofinfectionismediatedby‘cellular
ided into two types, which overlap and interact. In- sentinels’ such as macrophages, dendritic cells (Sec-
nate immunity (the immediate ‘hard wired’ robust tion 8.8), and epithelial cells when they are exposed
response to invaders) has evolved to recognize the to DAMPs and PAMPs at the site of tissue injury.
presence of invariant molecular structures such as These cells are at the front line of host defence, and
polysaccharides (e.g. lipopolysaccharide) and nucleic macrophagescanthemselveskillmicroorganisms,but
acidsexpressedbybroadclassesofpathogens.These oftencannotcopealone.The‘cellularsentinels’,once
structures are called pathogen-associated molecular activated, assemble inflammasomes and secrete mul-
patterns (PAMPs). Acquired immunity (‘learned im- tipleinflammatorymediators,especiallycytokinesand
munity’) relies on the ability of lymphocytes to rec- chemokines, but also eicosanoids, ROS, and protein-
ognizestrainand/orspecies-specificproteinantigens ases. Some of these agents signal endothelial cells to
expressed by pathogens, and respond by triggering upregulateadhesionmoleculesandbegintherecruit-
cellular (CD8+ cytotoxic T-cells and CD4+ T helper ment of other cells to help deal with the infection,
cells: Table 8.1) and antibody (B cells: Table 8.1) re- namely neutrophils and, later, monocytes. Recruited
sponses. Acquired immunity establishes an immuno- phagocytes can contribute to DAMP formation, e.g.
logicalmemory,whichleadstoamuchfasterresponse neutrophilscanreleasetheS100proteins.36
ifthepathogenappearsagain.
Anyinjury,byinfectionorotherwise,thatdamages 8.7.2 Neutrophils,monocytes,
cellscanreleasealarmins(dangersignals),oftencalled andmacrophages34
damage associated molecular patterns (DAMPs).
These host-derived agents can be modified biomol- The phagocyte killing mechanism is usually the first
ecules.Examplesincludefragmentedhyaluronicacid, thing that comes to mind when scientists are asked
certain products of lipid oxidation (e.g. from car- to name ‘useful’ roles for RS. In the late 1800s, the
diolipin, phosphatidylcholine or phosphatidylserine), Russian scientist Metchnikoff first reported the en-
HNE-orMDA-modifiedproteins,carboxyethylpyrrole gulfmentofbacteriabycellsfromthebloodstreamof
(Section 7.10.1) or fragments of mitochondrial pro- animals.Thisprocessiscalledphagocytosis—thecells
teins and DNA; mitochondria contain molecules that ‘flow around’ the foreign particle and enclose it in a
resemblebacterialones(Section1.3.4)suchasformyl- plasma membrane vesicle, which is then internalized
methioninethatisusedtoinitiateproteinsynthesisin (Fig.8.8).
both bacteria and mitochondria. DAMPs can also be Most of the phagocytes in the human bloodstream
‘normal’hostcellmolecules,suchasATP,heat-shock are neutrophils (Table 8.1), which have a multilobed
proteins, sodium urate crystals, cholesterol crystals, nucleus (hence they are called polymorphonuclear
peroxiredoxins(Section3.13),orHMGB1liberateddur- cells) and several different types of cytoplasmic
ing necrosis or pyroptosis (Section 5.4). DAMPs and granules (Fig. 8.8). The primary or azurophil gran-
PAMPsbindtopatternrecognitionreceptors(PRR)in ulescontaintheenzymesmyeloperoxidase(MPO)and

--- Page 477 ---

422 FREE RADICALS IN BIOLOGY AND MEDICINE
Table8.1 Cellsinhumanblood
Typeofcell Cells/μlblood Function
Erythrocytes 5×106 TransportO2 andCO2,regulatepH,catabolizeNO•,NO–
2
,andpossiblyH2O2 andO •
2
–
(Table3.7).
Whitebloodcells(leuko-
cytes)
Neutrophils 2500–7500 Innatedefenceagainstbacteria.Recruitedtositesoftissueinjury.Phagocytosis;secretion
ofmicrobicidalagents,formationofneutrophilextracellulartraps(NETs).Mostcommon
whitecellinhumanblood(50–60%oftotal),butnotinrodentblood(15–20%inrats
andmice)
Eosinophils 40–500 Anti-parasitedefence.Degranulationandsecretionofcationiccytotoxicproteins(includ-
ingmajorbasicproteinandeosinophilperoxidase);mediateallergicandhypersensitivity
responses.
Basophils 0–100 Hypersensitivityreactions;releasehistamineandothervasoactivepeptides
Mononuclearcells
Monocytes 200–800 Precursors of macrophages. Recruited to sites of infection/inflammation. Phagocytosis;
cytokinesecretion;andantigenpresentation.
Lymphocytes
Bcells ~200–400 Antibodysecretiona
Tcells ~1000 Killvirus-infectedcells(CD8);coordinateactivitiesofotherleukocytes(CD4).
Naturalkiller(NK)cells ~100 Innatedefenceagainstviralinfections.Cytotoxicactivityagainstvirus-infectedcellsand
somecancercells.
Platelets ~3×105 Bloodcoagulationandwoundrepair.
Theimmunecellsfoundinbloodcanbedividedintothoseinvolvedinrapidinnateprotectionagainstinvadingpathogensversusthoselinkedtoslower,highlyspecific
adaptiveresponses.Neutrophilsareabundantpolymorphonuclearphagocytesthatplayacriticalroleininnatedefences.Theyarerecruitedinlargenumberstositesof
infectionwheretheirprincipalroleistokillinvadingpathogens.Monocytesaremononuclearphagocytesthatalsomigratetositesofinfection,wheretheydifferentiate
intophagocyticmacrophagesandsecretecytokines.Onekeyroleistoaidtherecruitmentofotherleukocytesintotheinfectedsite.Eosinophilsdifferfromneutrophilsin
havinglargercytoplasmicgranulesandoftenanucleuswithonlytwolobes.Anabnormallyhighcontentofwhitecellsintheblood(>11,000/μl)iscalledleukocytosis,
whilstadecreasebelow4000/μlistermedleukopaenia,orsinceneutrophilsconstituteahighproportionofwhitecellsinhumans,neutropaenia.Mosteosinophils
resideinthetissuesratherthancirculatingintheblood.Allofthesecelltypes,andredbloodcells,derivefromthesamehaematopoieticstemcellsinthebone
marrow.
a BandTlymphocytesarecomponentsoftheadaptiveresponsetopathogens.TheprincipalfunctionofBlymphocytesistosynthesizeandsecreteantibodies
(immunoglobulins).WhenBcellsarestimulatedbyencounteringaforeignantigen,theyundergoseveralcyclesofcelldivisionandthendifferentiatewiththeaid
ofCD4T-helperlymphocytesintospecializedantibody-secretingplasmacells,ormemorycellsthatgobackintothecirculation.EachBcellcarriesonitssurface
immunoglobulinmoleculeswithdifferentantigen-bindingsites.Theseactasreceptorsforantigenandthesecretedimmunoglobulinhasthesameantigenbindingsite
(specificity)asthemembrane-boundimmunoglobulin.EachBcellwilldividetoproduceacloneofdaughtercells,allproducingthesameimmunoglobulin.Sincemany
proteinantigensencodemultipletargetmoieties(termedepitopes)againstwhichB-cellscanmakeantibodies,theserumofanimmunizedanimalwillcontainamixture
oftheantibodiesproducedbymanyclones;polyclonalantiserum.(Amonoclonalantibodyisproducedwhenalymphocyteisfusedwithanimmortalizedcancer
cell,producingasingleclonewhichsecretesmonospecificantibody.)
Tlymphocytescanbedividedfunctionallyintothosethatcoordinateandaidotherimmunefunctions(CD4Tcells)andthosethatdirectlytargetandkillinfectedcells
andtissues(CD8Tcells).CD4Tcellsco-ordinateadaptiveimmuneresponses.Forexample,differenttypesofCD4cellsproducegrowthanddifferentiationfactorsthat
shapetheformandscaleofBandotherTcellresponses,activatemacrophages,orsuppresstheimmuneresponse.CD8Tcellfunctioninvolvestherecognitionofhost
cellsinwhichpathogenssuchasvirusesarereplicatingthemselves.CD8Tcellsdestroytheseinfectedcellsbydirectcontacte.g.engagingdeathreceptors,and/orbythe
secretionoftoxicgranulescontainingcytotoxicproteins(suchaspore-formingperforinanddisintegraseenzymesincludinggranzymeB)thatinitiatecaspaseactivation
andapoptosis(Section5.4.2).
lysozyme, several proteinases (e.g. cathepsin G and enzymes, including gelatinase (Table 8.2) are housed
elastase; Table 8.2), and a number of granular cat- withintheso-calledtertiarygranules.Neutrophilsare
ionic proteins. The specific or secondary granules madeinthebonemarrow,circulateinthebloodfora
containaproteinthatbindsvitaminB (cobalophilin), short time (less than a day) and the ‘aged’ ones un-
12
the enzymes lysozyme and collagenase, and lactofer- dergoapoptosisandareremovedbymacrophagesin
rin,aniron-bindingprotein(Section3.22.1.2). Several theliver,spleen,andbonemarrow.

--- Page 478 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 423
Figure8.8 Aneutrophilasseenundertheelectronmicroscope.Thecellisphagocytosingopsonizedlatexbeads(thewhitecircles).Someare
beingtakenupbythecellflowingaroundthemandothersarealreadypresentinternallyinvacuoles(×18,000).Photographbycourtesyof
ProfessorAnthonySegal.
When animal tissues are injured (e.g. by infecting As they enter the inflamed area, neutrophils often
organisms,sterileinjury,ortheoccurrenceofnecrotic stop on the endothelial cells lining the blood vessels,
cell death; Section 8.7.1), an acute inflammatory re- a phenomenon known as pavementing or margina-
sponsedevelops,characterizedbyswelling(oedema), tion.Eveninthenormalcirculation,someneutrophils
warmth, pain, reddening, and partial immobilization loosely and transiently adhere to the vessel wall and
(Fig. 8.9 ). Thereisincreasedsynthesisofprostaglan- rollalongit.However,neutrophilsatsitesofinflamma-
dinsandleukotrienes(Section8.12),contributingtothe tionadherefirmly,pushoutpseudopodia,andsqueeze
swellingandpain.Thearteriolesinandaroundthein- through the gaps between endothelial cells, crossing
juredarearelax,sothatthecapillarynetworkbecomes the vessel wall and entering the inflamed area (Figs
engorgedwithblood(hencetheheatandredness).The 8.9 and 8.10), in a process called diapedesis. Some
permeabilityofthebloodvesselwallsincreasessothat neutrophils may even pass through endothelial cells.
more fluid leaks out, causing the oedema. Platelets Migration is induced by chemotactic factors formed
and plasma proteins enter the inflamed area. Plate- intheinflamedarea.Theseincludebacterialproducts
lets become activated by contact with collagen in the (DAMPs)suchasN-formyl-peptides,andhost-derived
extracellular matrix (Section 8.10.7). Hageman factor material such as products of complement activation,
(factorXII),aplasmaprotein,triggersvariousproteo- leukotrieneB (LTB ; Section 8.12), platelet-activating
4 4
lyticcascades,includingcoagulationandactivationof factor (PAF; Section 5.12.2), and chemokines. PAF is
asetofproteinsfoundinplasma,knowncollectively rapidlysynthesizedbyendothelialcellsafterexposure
as complement.37 Complement activation facilitates to histamine, thrombin, or leukotrienes. In general,
killingofbacteria(Section8.7.3.2). the α-chemokines, including IL-8, act on neutrophils

--- Page 479 ---

424 FREE RADICALS IN BIOLOGY AND MEDICINE
Table8.2 Animalproteinasesaandantiproteinasesandtheirresponsetoreactivespecies:asummary.
Typeof Comments EffectsofROSonthe
Proteinase proteinases/proteinaseinhibitors
Serineatactivesite Inhibitedbyorganophosphates:endogenousinhibitorsinclude Serine proteinases generally fairly resistant to RS, but
(serineproteinase) α 1-antiproteinase (formerly called α 1-antitrypsin) and α 1- α 1-AP can be inactivated on exposure to OH•, HOCl,
antichymotrypsin; often called serpins (serine proteinase in- ONOO–,orRO • ,andcathepsinGbyHOCl(J.Biol.Chem.
2
hibitors).Examplesofserineproteinasesareelastase,granzyme 280,29311,2005).
B, trypsin, thrombin, chymotrypsin, cathepsin G, and tryptase
(Section8.8).
Cysteine at active Inhibitedby–SHmodifyingreagentsandleupeptin.Endogen- Most (including caspases) are readily inactivated on
site ous inhibitorsinclude cystatinsand α 2-macroglobulins (which addition of several RS, including H2O2, HOCl, and
inhibitarangeofproteinasesincludingelastase).Examplesare ONOO–. α 2-Macroglobulin can be inactivated on ex-
cathepsinsB,H,L,andS.Caspasesplaykeyrolesinapoptosis posure to HOCl or ONOO–. Reaction with HOCl has
(Section5.4.2). beensuggestedtoconferchaperonepropertiesonα 2-
macroglobulin(Proc.Natl.Acad.Sci.USA111,E2081,
2014). This protein also transports copper in plasma,
sometimes then called transcuprein (Section 3.22.2;
J.Nutr.Biochem.18,597,2007).
Asparticacidat Inhibitedbypepstatin.ExamplesarecathepsinsDandE,rennin ProbablyfairlyresistanttoRS.
activesite andpepsin.
Metalloproteinases
Metalionsatactive Examplesarematrixmetalloproteinases(MMPs)andAdis- Complex effects; RS (especially HOCl) can both activ-
site integrin and metalloproteinases (ADAMs). MMPs are a atetheproenzymesandinhibittheactivatedproteinases
family of at least 24 zinc-containing enzymes responsible for (e.g.J.Biol.Chem.278,28408,2003),aswellasinacti-
turnover and remodelling of the extracellular matrix. They in- vatingantiproteinasessuchasTIMP(J.Biol.Chem.282,
cludecollagenases(MMP-1,-8,-13),gelatinases(MMP-2, 31826,2007).SomeRSmaypromoteincreasedexpres-
-9),matrilysin(MMP-7),stromelysins(MMP-3,-10,-11)and sion of genes encoding MMP, e.g. in vascular smooth
macrophage elastase (MMP-12). Most are secreted as la- muscle cells (e.g. Circ.Res.92, e80, 2003, J.Vasc.
tent proenzymes, requiring proteolytic (or other) activation Res.49,242,2012),skin(Section7.13)andastrocytes
(Am.J.Physiol.303,H919,2012).Endogenousinhibitorsin- (J.Neuroinflamm.9, 110, 2012). Expression of genes
clude α 2-macroglobulin and tissue inhibitors of metallo- encodingMMPsisfrequentlyincreasedbycytokines,and
proteinases (TIMPs). ADAMs are also zinc-containing and ROSareofteninvolvedinthemechanism(Section5.7).
usuallymembrane-bound,cleavingtheextracellulardomainsof
membrane-bound proteins (‘ectodomain shedding’) (Develop-
ment139,3693,2012).Substratesincludeadhesionmolecules,
cytokines,chemokines,growthfactors,andreceptors.
Ca2+-dependent Section5.3.2.
cysteineproteinases
(calpains)
a‘Proteinase’and‘protease’tendtobeusedinterchangeablyintheliterature—wehavestandardizedontheformerinthisbook.Cathepsinsareimportantproteinases
inlysosomes(Section5.14.3.1).
whereas the β-chemokines act on monocytes and Similar kinases are found in human neutrophils and
macrophages (Section 5.7). Some agents (IL-1, IL-6, so ROS probably influence chemotaxis in these cells
TNF-α,LTB ,GM-CSF;Table5.6)candelayorsuppress as well,41,42 although H O is certainly not the only
4 2 2
neutrophilapoptosisatasiteofinflammation.38 mediator of neutrophil attraction. In addition, too
In zebrafish, H O plays a key role in attracting much H O can impair neutrophil function, e.g. by
2 2 2 2
neutrophils to a site of tissue injury (Fig. 6.9).39,40 promotingglutathionylationofactintoanextentthat
The H O is recognized by a neutrophil kinase en- impairsmotility(Section8.9.3).41
2 2
zymeknownasLyn,whichphosphorylatesitselfwhen At a later stage of inflammation, monocytes (Table
H O is present and promotes directional migration. 8.1) leave the circulation and enter the inflamed
2 2

--- Page 480 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 425
Hypoxia or
(a) Microbial ‘Sterile’ Reperfusion
infection Trauma injury
PAMPs Endogenous chemical
(e.g. microbial peptides Mediators (DAMPs;
and endotoxins) LTB
4
and C
5a
)
Neutrophil ROS and hydrolytic
enzymes
Complete Incomplete (‘frustrated’)
phagocytosis phagocytosis
Acute inf lammation
Rubor, calor, tumour and dolor
(cid:129) Vasoconstriction: thromboxane A
2
and cysteinyl leukotrienes
(cid:129) Vasodilation : prostaglandin I, prostaglandin E,
1
prostaglandin E and prostaglandin D
2 2
(cid:129) Vascular permeability: cysteinyl leukotrienes
(cid:129) Chemotaxis , adhesion: leukotriene B
4
and lipoxin A
4
Prostaglandins and Prostaglandin E
2
and
leukotrienes prostaglandin D
2
Chronic Resolution
inflammation (cid:129)Lipoxins (and aspirin-
triggered lipoxins)
(cid:129)Resolvins (E-series
and D-series)
Fibrosis
(cid:129)Protectins
OH
(b)
HO OH
COOH OH HO
OH COOH
Lipoxin A
4 Resolvin E1
HO
COOH
OH
OH COOH
HO
OH
Resolvin D1 Protectin D1

--- Page 481 ---

426 FREE RADICALS IN BIOLOGY AND MEDICINE
(cid:3)
Figure8.9(colourplate19) Decisionpathsinacuteinflammation:resolutionorchronicinflammationandtherolesofendogenouschemical
mediators.(a)Microbialinvasionofthehost,injuryfromoutsideorthelossofbarrierfunction(e.g.inthegut)initiatesthereleaseofDAMPs(such
asmicrobialpeptidesandendotoxins)andendogenouschemicalmediatorsthatleadtoleukocyterecruitmentandenhancedantimicrobial
activities.Microorganismstakenupbyphagocytosiscanbekilledinthephagosome.Sometimes,neutrophilphagolysosomalvacuolecontents(such
asROS,hydrolyticenzymes,andothergranulecontents)canbereleasedextracellularly,whichhasvariouspossibleeffects(Section8.9).Sterile(e.g.
surgical)traumaandischaemia–reperfusioninjuryalsoactivatethereleaseofDAMPsandeventuallyothermediators,suchasleukotrieneB4,
prostaglandinE2,andC5a.Thesemediatorsaidvasodilation,vascularpermeability,andchemotaxis.Thecardinalsignsofinflammation,rubor
(redness),calor(heat),tumour(swelling),anddolor(pain),weredescribedbytheRomanphysicianCelsusinthefirstcentury.Theoutcomesof
acuteinflammation—resolution,chronicity,orfibrosis—areinfluencedbymanyfactors,suchasthetypeorsiteofinjury,andthehostresponse.
There-establishmentofnormalhomeostasis(resolution)isacarefullyregulatedprogramme.ProstaglandinE2andprostaglandinD2,forexample,
stimulatethegradualswitchingofarachidonicacid-derivedlipidsfromleukotrieneB4productiontolipoxinA4productionandthentheswitchingof
lipidmediatorfamiliestoproduceanti-inflammatoryandpro-resolutionlipidmediators,suchasE-seriesandD-seriesresolvinsandprotectins
(Section8.12).Thesefamiliesofpro-resolutionmoleculesfunctionintheresolutionofinflammationbyactivatingmultiplemechanismstopromote
homeostasis.Specificlipoxinsandmembersoftheresolvinandprotectinfamiliesprovidepotentsignalsthatselectivelystopneutrophiland
eosinophilinfiltration,stimulatenon-phlogisticrecruitmentofmonocytes(thatis,withoutthemelaboratingpro-inflammatorymediators),activate
macrophagephagocytosisofmicroorganismsandapoptoticcells(e.g.neutrophils),increasetheexitofphagocytesfromtheinflamedsitethrough
thelymphatics,andstimulatetheexpressionofmoleculesinvolvedinantimicrobialdefence.Bycontrast,prostaglandinsandleukotrienesare
generallypro-inflammatory.Usingcyclooxygenasesandlipoxygenases,leukocytesrapidlybiosynthesizetheselipidmediatorsfrommembrane-
derivedarachidonicacidwithinsecondstominutesofacutechallenge.Asinflammationproceeds,theneutrophilsinconfinedexudatesstop
producingchemoattractants(suchasleukotrieneB4)andwithinhoursbegintoconvertarachidonicacidintoprotectivelipoxins,therebyhelpingto
terminateinflammationandpromoteresolution.Incontainedexudatesincertaininflamedtissuesandinflammatorydiseases,bothprostaglandin
E2andprostaglandinD2havepro-inflammatoryactivities,buteachcanpromoteaswitchintheexpressionofbiosyntheticenzymesbyinfiltrating
neutrophilsthatchangestheirphenotypetoapro-resolutionphenotype—aprocessknownaslipid-mediatorclassswitching.Alternatively,chronic
inflammationcanresultfrommediatorssuchaspro-inflammatoryprostaglandins,andleukotrienescanamplifythisprocess.Fibrosiscanoccur
wheninflammatoryinjurycausessubstantialtissuedestruction;connectivetissuereplacementoccursandresultsinlossoftissuefunction.(b)The
chemicalstructuresofpro-resolutionmediatorslipoxinA4,resolvinE1,resolvinD1,andprotectinD1.
area. These cells are less mobile and phagocytic play a key role in its resolution. Indeed, cells of
then neutrophils, but once in the inflamed area the monocyte-macrophage type can play many roles.
they undergo differentiation into macrophages. This Dependingonthecytokinesandotherfactorsaround
involvesincreases in their content of lysosomal en- them,theycandevelopM1orM2phenotypes.Inthe
zymes,metabolicactivity,motility,andphagocyticand first, there is substantial production of ROS and pro-
microbicidal capacity. Macrophages, a name derived inflammatory cytokines such as TNF-α, IL-12, and
fromtwoGreekworks—macros(big)andphagos(eater), IL-23, and strong microbicidal capacity.43 By con-
are present normally (resident macrophages) in the trast, M2 macrophages are more involved in tis-
lymphnodesandspleen,andasscatteredcellsinmany sue remodelling and immune regulation and prod-
otherorgans,includingbrain,bone,mammarygland, uce fewer ROS or cytokines (Fig. 8.9). The cytokines
andperitoneum.Theyhelptomaintaintissuehomeo- thatareproducedtendtobemoreanti-inflammatory,
stasis by phagocytosis of apoptotic cells and necrotic and immune-modulating, such as IL-10. In reality,
cellular(orother)debris(Fig.8.9),buttheyarealsoa M1andM2aretheextremesofabroadspectrum,and
keycomponentofourfrontlinedefenceagainstpatho- phrasessuchas‘M2-like’or‘M1-like’areoftenusedto
gens(Section8.7.1).Forexample,thealveolarmacro- describe various macrophage/monocyte phenotypes.
phageslieonthealveolarwalls,andhelptodefendthe During the normal response to tissue injury or infec-
lungagainstinhaledbacteriaandotherparticles(Fig. tion, M1 macrophages help to initiate inflammation,
8.11).TheKupffercells,whichformpartofthelining whereas the M2 phenotype is more important in the
oftheliversinusoids,aremacrophages,asareretinal repairphase(Fig.8.9).43Inchronicinflammation,how-
pigmentepithelialcells(Section7.10).Thetermmono- ever,theM2phenotypeismoreprominent.
nuclearphagocytesystemisoftenusedtoencompass Macrophagesphagocytosenotonlymicroorganisms
bloodmonocytes,theirbonemarrowprecursors,and but also host cells, such as erythrocytes and apop-
tissuemacrophages. totic neutrophils. They can also ingest large amounts
Bothresidentand(lateron)monocyte-derivedmac- of insoluble material and retain it for months or
rophages contribute to inflammation but they also years(Fig.8.11). Uptakeoftoomanyerythrocytesby

--- Page 482 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 427
Vessel Lumen
2 3 2 3 11
1 Draining
Lymph node
4
Ti
i
s
n
s
j
u
u
e ry 6 9
5 9
7
12
8 10
M1 M2 Mres
Productive phase Transition phase Resolving phase
- Production of inflammatory mediators (1) - PMN and monocyte recruitment (2,3) - M2 Mres transition (10)
- Vessel permeability - PMN and macrophage effector function (5) - Production of resolution mediators:-
- Vasodilation - PMN apoptosis (6) - ‘Find-me’ and ‘eat-me’ Lipoxins, resolvins, protections, IL-10 etc. by
- Blood flow signals on apoptotic PMN Mres (9)
- Oedema - Efferocytosis (7) - Lymphocyte repopulation (11)
- Beginning of leukocyte recruitment (2,3) - M1 M2 transition (8) - Macrophages apoptosis or lymphatic
- Monocytes Macrophages (4) - M2 production of anti-inflammatory drainage (12)
- PMN and macrophage effector function (5) molecules (IL-10 and TGF-β)
eussit
demaflnI
(c)
ux
fl
n
e i
ocyt
k u
e L
Figure8.9(colourplate19) (Continued)(c)Anorchestratedseriesofeventsinasuccessfulself-resolvingacuteinflammatoryprocess.Tissue
injury(sterileorfollowinginfection)(Fig.8.9a)leadstorecognitionofmolecularpatterns(DAMPsandPAMPs)byresidentcells(tissue
macrophages,dendriticcells,andepithelialcells)thatrapidlyproduceseveralpro-inflammatorymediators(1).Inthisso-calledproductivephaseof
inflammation,mediatorsactbypromotingvasodilationandconsequentincreaseoflocalbloodflow,andmodifyingendothelialwallpermeability.
Theseeventsareaccompaniedbyhyperaemiaandexudationofplasmaproteinsandfluid(oedema).Endothelialcellsarealsoactivatedtoexpress
celladhesionmolecules(selectinsandintegrins)andtopresentchemoattractantmediatorswhichwillallowtheattractionandextravasationof
leukocytes(2–4).Polymorphonuclearleukocytes(mainlyneutrophils)arethefirstcellsthatextravasateintoinflamedtissues(2)followedby
mononuclearcells(3).Withprogressionoftheinflammatoryresponse,thereisintenseleukocyteinfluxintoinflamedtissue.Thesecellscanbe
activatedandbecomeanimportantsourceofarangeofmediators,includinggrowthfactors,cytokines,chemokines,lipidmediators,andROS(5),
whichwillallowinfiltratingleukocytestoperformtheireffectorfunctionsintissues.Inthetransitionphaseofinflammation,despitetheintense
leukocyteaccumulation,PMNsundertheactionofpro-resolvingsignals(mediatedbypro-resolvingmediatorsanddecreasedlevelsofsurvival
modifyingagents)startundergoingapoptosis(6)followedbyphagocytosisbytissuemacrophages(efferocytosis)(7).Thisprocessinvolvesseveral
signalsthatleadtoattraction,binding,andremovalofapoptoticcellsbymacrophages.Duringefferocytosis,macrophagephenotypesswitchfrom
M1toM2(8).M2(orM2-like)macrophagesarehighlyefferocyticandproduceanti-inflammatorymolecules(suchasIL-10andTGF-β)and
pro-resolvingmediators(9).SuchmediatorshavethepotentialtoinhibitadditionalPMNrecruitment,intensifymonocytemigration,andamplify
efferocytosis.M2macrophagesthenswitchtoMresolution(Mres)phenotype(10),whichdisplayreducedphagocytosis,but,instead,produce
anti-fibroticandanti-oxidantproteinsthatlimittissuedamageandfibrosis.Suchevents,pavethewaytotheresolutionphaseofinflammation.The
increasedproductionofpro-resolvingmediators,anti-inflammatoryandanti-fibroticagentsbyresolutionmacrophages(Mres),lymphocyte
repopulations(11)andlymphnodedrainageorapoptosisofmacrophages(12)closetheinflammatoryprocessandrestoretissuehomeostasis.
Figures(a)and(b)areadaptedfromNat.Rev.Immunol.8,349,2008,bycourtesyofDrCharlesN.SerhanandNaturePublishingGroup.Figure(c)
isadaptedfromPharm.Ther.139,189,2013,bycomplimentsofDrMauroM.TeixeiraandElsevierInc.
macrophages can depress their function, possibly by proteins (adhesion molecules) on both phagocyte
haem-and/oriron-dependentoxidativedamage.44 and vascular endothelial cell surfaces (Fig. 8.10).
As Metchnikoff said in 1893, ‘next to leukocytes, the
8.7.3 Phagocyterecruitment,adhesion, vessels and their endothelial lining play the most
activation,anddisappearance important role in inflammation’. Varying the levels
8.7.3.1 Gettingtotherightplace45,46 of adhesion molecules (e.g. in response to different
cytokines)determineswhichphagocytesarerecruited
Recruitment of phagocytes to sites of tissue in- and how tightly they stick. Agents that increase
jury/inflammation involves interactions between levels of adhesion molecules on endothelial cells

--- Page 483 ---

428 FREE RADICALS IN BIOLOGY AND MEDICINE
Figure8.10(colourplate20) Theneutrophilrecruitmentcascade;thesequentialstepsofneutrophilrecruitmentfromthevasculaturetothe
tissue.Twopossiblemethodsoftransmigrationareshown:paracellular(betweenendothelialcells;(a)andtranscellular(throughendothelialcells;
(b).Majorgroupsofadhesionmoleculesaremarked.Rollingismostlyselectin-dependent,whereasadhesion,crawling,andtransmigrationdepend
onintegrininteractions.Chemokinesliningtheluminalpartoftheendotheliumactivaterollingneutrophils,thusinducingconformationalchanges
ofneutrophilsurfaceintegrinsandallowingforsubsequentevents.Crawlingneutrophilsfollowthechemokinegradientalongtheendothelium,
whichguidesthemtothepreferentialsitesoftransmigration.Theintravitalmicroscopyimageshowsaskinpostcapillaryvenulewithneutrophils
labelledinred(phycoerythrinantibodyconjugate,10μg).MouseskinwasinfectedwithStaphylococcusaureusandtheimagewastakentwo
hourslater.Itcapturedneutrophilsatdifferentstagesofmigration:freelycirculatingcells,rollingcellsextendingtethers,adheringneutrophils,and
thecellsthatextravasatedoutofthebloodvessel.From[45]bycourtesyofDrPaulKubesandNaturePublishingGroup.
include TNF-α, IL-1, endotoxin, histamine, thrombin, A transient phagocyte contact with the endothe-
leukotrienes, and H O . Agents increasing the num- lium (rolling along the vessel wall for a short time)
2 2
bers of adhesion molecules on phagocyte surfaces isusuallymediatedbyamemberoftheselectinfam-
include IL-8, TNF-α, endotoxin, PAF, and leukotri- ily (Fig. 8.10). Selectins are cell-surface proteins that
enes. Hypoxia also increases expression of adhesion have a carbohydrate-binding (lectin) domain on the
molecules on both phagocytes and endothelium, a endofaprotein‘stalk’extendingoutfromthecellsur-
process involved in ischaemia–reperfusion injury face.L-Selectin(CD62L)a isexpressedbyphagocytes
(Section 10.6). HIF-1 (Section 1.3.2) plays a role; mice andbindsglycoproteinsontheendothelialcellsurface
whose phagocytes lack HIF-1α show a decreased
inflammatory response, perhaps because HIF-1 is
a CD stands for ‘cluster of differentiation’: a cell surface
needed for phagocytes to generate sufficient ATP by
markerthatisrecognizedbyaparticulargroupofmonoclonal
glycolysisinhypoxicregionsofinjuredtissues.
antibodiesisgivenaCDnumber.

--- Page 484 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 429
Figure8.11 Pulmonarymacrophagesfromthelungsof
healthyvolunteers.A,C,andEarefromnon-smokers,and
B,D,andFfromsmokers.AandBarelightmicrographs.
Thecellsvaryfrom15to50μmindiameter.CandDare
electronmicrographs(×6175);andEandFarescanning
electronmicrographswhichshowthesurfaceofthecells.
Largenumbersofvesiclesarepresent.Cigarettesmoke
causesmarkedchangesinthecells,whichcontain
characteristic‘smokers’inclusions’,theseinclude
‘needle-like’or‘fibre-like’structures.Theseneedle-like
structuresconsistofkaolinite,analuminiumsilicate
presentincigarettesmokethatthemacrophagescan
engulf.Cigarettesmokingincreasesthenumberofalveolar
macrophages(Section9.13).Photographsbycourtesyof
ProfessorW.G.Hocking.
thatareexpressedatsitesofinflammation.P-Selectin cells, whereas integrin α β binds to vascular cell
4 1
(CD62P) and E-selectin (CD62E) on the endothelial adhesionmolecule1(VCAM-1).
cell surface bind to carbohydrate on specific glycol- Migration of phagocytes between endothelial cells
ipidsorglycoproteinsonneutrophils.E-Selectinlevels involves adhesion molecules as well, including
areincreasedbyelevatedgeneexpressioninresponse platelet–endothelial cell adhesion molecule 1
tocytokines(e.g.TNF-α andIL-1),whereasP-selectin (PECAM-1),presentonbothendothelialcellsatinter-
is stored in cytoplasmic granules, from which it is cellular junctions and on phagocytes. It enables the
translocatedtotheplasmamembranewhenneeded. phagocytes to interact with the endothelial cells as
Thisinitialselectin-mediated‘loose’bindingallows they pass through the junctions. Production of RS by
a phagocyte to monitor the local environment; if it phagocytes(Section8.7.4)mustbecarefullyregulated
senses chemotactic factors it sticks more tightly to astheypass,tominimizeendothelialdamage.Adhe-
the endothelium and flattens out (Fig. 8.10). The sionusuallydetersRSproduction(althoughsomeROS
chemotacticfactorsbindtoreceptorsthatactivatein- areneededtocausenecessarychangesinendothelial
tegrin proteins on the phagocyte surface to change function),47 butthiscanbeover-riddenbyhighlevels
shape in preparation for binding to endothelial cell ofTNF-α,GM-CSF,andPAF,whichcanthuspromote
ligands.Forexample,lymphocytefunctionantigen1 endothelialdamage.48
(LFA-1)onneutrophilsbindstointercellularadhesion Matrix metalloproteinases, especially matrilysin
molecules 1 and 2 (ICAM-1 and -2) on endothelial (MMP-7; Table 8.2) can affect phagocyte migration.

--- Page 485 ---

430 FREE RADICALS IN BIOLOGY AND MEDICINE
They can digest matrix to facilitate movement, but (Fig. 8.9). The vessel walls regain their normal per-
can also limit inflammation by degrading some of meability. The emigrated neutrophils die (usually by
thechemokines.49 Sometimestheyhavemorespecific apoptosis).Inpart,thisisduetoafallinthelevelsof
roles. For example, in mice injected with bleomycin thosecytokinesthatacttosuppressneutrophilapop-
(Section10.16.3.1)thereisinflammationofthelunglin- tosis,butitmayalsoinvolvedamagetotheneutrophil
ingcells.Neutrophilscrossthecapillarywallsandthe bytheROSithasgenerated.41 Theapoptoticcellsare
lung epithelium, and enter the alveoli. In mice lack- phagocytosed by macrophages (this process is some-
ing MMP-7, the neutrophils leave the blood vessels times called efferocytosis [Section 5.4.2]) which rec-
butdonotcrosstheepithelium.Theinjuredepithelial ognizeexternalizedphosphatidylserineasan‘eatme’
cells secrete a chemokine, which binds to the extra- signal.Phosphatidylserineoxidationontheneutrophil
cellular matrix. The matrix is digested by MMP-7 to surfacefacilitatesthis.Efferocytosisalsocausesmacro-
release the chemokine, attracting the neutrophils to phagestoreleaseanti-inflammatorycytokinessuchas
cross.50 IL-10andTGF-β.Thus,asstatedearlier,macrophages
are usually pro-inflammatory at the outset of inflam-
8.7.3.2 Whatmustneutrophilsdo?45,46
mation, but become anti-inflammatory as it resolves.
Three things: recognize foreign organisms, engulf ROS also play a role in modulating inflammation
them, and kill them. The fluid leaking into the (Section8.9.4).
inflamed area often contains antibodies that can If there was loss of tissue (e.g. in a wound), re-
bind to microorganisms. Neutrophils have surface pair takes place, involving collagen synthesis and
receptors that recognize N-formyl peptides (e.g. N- fibroblast proliferation (and O • 2 –/H 2 O 2 as well; Sec-
formylmethionylleucylphenylalanine; fmet-leu-phe) tion 7.13.3). During phagocytic activity, neutrophils
from bacteria, PAF, LTB , lipopolysaccharide (TLR andmacrophagesreleaselysosomalenzymesintothe
4 4
receptor), immunoglobulin G, the C3b component surrounding fluid, where they contribute to the di-
of reacted complement,37 and many other ‘danger gestion of inflammatory debris, including DAMPs.
signals’. The complement system plays a key role There is a switch away from the production of pro-
both in allowing recognition of foreign material by inflammatory leukotrienes and prostaglandins to the
phagocytes (binding to C3b receptors) and in killing formation of anti-inflammatory ones, such as lipox-
microorganisms directly by forming a membrane at- ins (Fig. 8.9). Their actions include diminishing the
tackcomplexthatopensporesinthemicroorganisms’ production of ROS by monocytes entering the site of
cellmembranesandcausestheirrapiddeath. inflammation and stimulating efferocytosis. Another
Coating of microorganisms with host-derived pro- important group of anti-inflammatory agents gener-
teins,knowncollectivelyasopsonins,enablesneutro- ated in the resolution phase is the resolvins (Section
phils and macrophages to recognize them, although 8.12). Lipoxins, resolvins, and related mediators de-
a few pathogens have coats that can be recognized ter neutrophil recruitment and minimize the produc-
directly. Once the foreign organisms have been en- tion of pro-inflammatory cytokines.52 Nitrated lipids
gulfed, various cytoplasmic granules fuse with, and have also been suggested to be anti-inflammatory
empty their contents into, the vacuole containing the (Section2.6.1.3).
engulfed particle (the phagocytic vacuole or phago- If the pathogen is not completely eliminated, or
some). The engulfed particles are then killed and, thetissueinjurycontinues,orsomethinggoeswrong
if possible, digested within the phagocytic vacuole. with the normal mechanisms promoting resolution
Oncethefirstcohortofneutrophilsispresent,theyre- of inflammation (e.g. DAMPs persist or efferocytosis
leaseextrachemotactic(probablyincludingH O 39–42) fails and neutrophils undergoing apoptosis are not
2 2
factors to bring in more. One of these is myeloper- promptly engulfed, so that they proceed to necrosis
oxidase (MPO; Section 8.7.5), which binds to the in- and release DAMPs such as HMGB1 and S100 pro-
tegrin CD11b/CD18 on endothelium and acts as a teins), non-resolving (‘chronic’) inflammation38 can
chemoattractant.51 result.Bacterialikelytocausechronicinflammationin-
After the invading organisms have been destroyed cludeH.pylori,Treponemapallidum,andM.tuberculosis.
(or,ifinjurywascausedbyanothermechanism,after Some toxins cause chronic inflammation, e.g. chronic
the insult ceases) there is usually reversal of the lung inflammation can result from inhalation of sil-
inflammatorychanges.Residentmacrophagesandre- icadustorsilicatefibres(Section9.15).Excessfibrous
cruited ones (from monocytes) play key roles in this tissue produced during chronic inflammation causes

--- Page 486 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 431
NADPH
2O 2 NADPH O 2
O
·–
NADP+
2
2O
2
·– NADP+
outside inside
A foreign particle The oxidase complex The particle, when engulfed, is
touches the membrane is assembled as the wrapped up in a superoxide -
and phagocytosis phagocytic vacuole generating piece of membrane.
begins forms Other vesicles in the phagocyte
cytoplasm then fuse with the
phagocytic vesicle.
Figure8.12 Aschematicrepresentationoftherespiratoryburst.TheengulfedparticlesareexposedtoafluxofO
•–insidethephagocyticvacuole.
2
Activationoftheoxidaseinvolvestranslocationofproteinsfromthecytosoltotheplasmamembrane.
lossoffunction.Chronicinflammatorylesionsarerich name,sincetheextraO uptakeisnotduetoincreased
2
inmacrophages,severalofwhichmayfusetogetherto mitochondrial respiration, e.g. it is not prevented by
givegiantcellswithmultiplenuclei.Thefunctionof inhibitors of mitochondrial electron transport. The
giantcellsisnotclear,buttheyretainsomephagocytic increaseinO uptakeduringtherespiratoryburstcan
2
ability.43,53 One important factor influencing suscep- be10to20timesthe‘resting’O consumptionofneu-
2
tibility to infection, the time course and severity of trophils.AsO uptakeincreases,sodoesconsumption
2
infection,andtheriskofdevelopingchronicinflamma- of glucose by phagocytes, largely due to activation
tion is the relative amounts of proinflammatory (e.g. of the pentose phosphate pathway (Section 3.10.2.1).
TNF-α) and anti-inflammatory (e.g. IL-10) cytokines The respiratory burst can be triggered by opsonized
producedinresponsetotissuedamage.Thisistosome microorganisms,opsonizedzymosan(apreparationof
extentgeneticallydetermined.54Non-resolvinginflam- yeastcellwallsusedinthelaboratorytoactivatepha-
mationcontributestothepathologyofmanydiseases, gocytes)andseveralchemicals.Theseincludephorbol
asdiscussedinChapter10. esters such as phorbol myristate acetate (PMA) (Fig.
10.16), aluminium fluoride, peptide ‘mimics’ of parts
of certain bacterial proteins (such as fmet-leu-phe),
8.7.4 Howdophagocyteskill?46,55–57 unsaturatedfattyacids,andconcanavalinA,alectin.
There is considerable person-to-person variation in
8.7.4.1 Phagocytesshowarespiratoryburst
the extent and time course of O uptake by neutro-
2
Moststudiesonthebiochemistryofphagocytosishave phils isolated from human blood and activated in
beencarriedoutonneutrophils,feweronmonocytes, vitro, and activation can occur during the isolation
eosinophils,andmacrophages.Studiesonthelastare procedures.46,58 Neutrophilresponsivenessalsovaries
often done on alveolar macrophages since they can when these cells are obtained from the same person
be readily obtained from humans (by washing them atdifferenttimes.Thesizeanddurationofneutrophil
out of the lungs in the technique of bronchoalveolar responsiveness depend on the repertoire of receptors
lavage). engagedatanyonetime.46
Resting neutrophils consume little O 2 , since they Similarly,thesizeoftherespiratoryburstshownby
rely mainly on glycolysis for ATP production and macrophages depends on how, and from which tis-
are rich in stored glycogen. Their limited reliance sue site, they are obtained. Resident macrophages in
on oxidative phosphorylation allows them to exert healthytissuestendnottobeveryactiveinO uptake
2
antibacterial actions in hypoxic regions. By contrast, and need prior exposure to DAMPs/PAMPs before
macrophages possess more mitochondria, rely more theycanmountavigorousrespiratoryburst.Thisisof-
on oxidative phosphorylation, and hence consume tenachievedexperimentallybyinfectinganimalswith
more O 2 . At the onset of phagocytosis, however, all microorganismssuchasthetuberculosisbacillusorby
four types of phagocyte show a marked increase in injectingirritatingmaterialssuchasthioglycollate.The
O 2 uptake,calledtherespiratoryburst.Thisisabad antibacterial behaviour of the macrophages obtained

--- Page 487 ---

432 FREE RADICALS IN BIOLOGY AND MEDICINE
by these different procedures is variable and papers The NADPH oxidase complex contains a b-type
concerning, for example, the relative importance of cytochrome(cytb )withasufficientlylowreduction
558
ROS or RNS in killing by macrophages should be potentialtobeabletoreduceO toO
•–.Itisadimer,
2 2
read with this in mind. In addition, rodent and hu- with a large β subunit (gp91phox) that contains FAD
man phagocytes differ in many ways, so be wary of and a smaller α (p22phox) subunit.b Usually, less than
extrapolation from one to the other.59 Several cyto- 30% of neutrophil cytochrome b is present in the
558
kinesaffectmacrophageRSproduction;macrophages plasmamembrane;therestislocatedinsecretoryve-
are also a rich source of cytokines, such as IL-1, siclesandspecificgranules,whichcansupplymoreof
IL-6,IL-10,andTNF-α.Macrophagessecretehundreds ittotheplasmamembraneuponactivationofthere-
of other substances as well, including eicosanoids, spiratoryburst.ActivationoftheneutrophilNADPH
proteinases (e.g. collagenase and macrophage elas- oxidase requires several proteins normally present in
tase, an enzyme that has properties very different thecytosolof‘resting’neutrophils,especiallyp47phox,
from neutrophil elastase and is not inhibited by α - p67phox,p40phox,andrac2.Theytranslocatetothemem-
1
antiproteinase),growthfactors,enzymeinhibitors(e.g. braneandhelptoassembletheactivecomplex,aided
α-macroglobulin;Table8.2),somecomponentsofcom- byphosphorylationofp47.Thesuppressionofneutro-
plement,angiogenesisfactors,andPAF. philO
•–productionthatusuallyhappensasthesecells
2
passthroughtheendothelium(Section8.7.3.1)occurs
bymodulationofrac2activity.48
8.7.4.2 Primingoftherespiratoryburst46,55,60
Oncetheactivecomplexisassembled,theelectron
Phagocytescanbe‘primed’bypriorexposuretolow transport system shown below operates. Its compo-
levels of a stimulus: primed cells produce a more nents are arranged vectorially so that electrons pass
vigorous respiratory burst on exposure to a second across the phagocyte plasma membrane from the
stimulus. They are more ‘ready to go’ and have en- NADPH-oxidizingsiteonthecytoplasmicfacetothe
hanced levels of adhesion molecules and receptors. O -reducingsiteonthesurface(Fig.8.12).Theresult-
2
Priming agents include interferon γ, PAF, IL-8, GM- ingO •– isgeneratedinthenarrowspacebetweenthe
2
CSF(Table5.6),TNF-α,LTB ,andendotoxin.Theprim- membrane of the phagosome and the ingested par-
4
ing agents themselves (at in vivo levels) often induce ticle, and has been estimated to reach concentrations
someO •–production,butnotafullburst. of up to 20 μM.56 NADPH-dependent O •– formation
2 2
can be inhibited by diphenylene iodonium and re-
latedcompounds,althoughtheyarenotspecific(Fig.
8.7.4.3 Therespiratoryburstmakes
8.13) and better inhibitors are under development
superoxide34,46,55,56
(Section11.7).
Oxygen uptake during the respiratory burst is due The signal transduction pathways leading to
to activation of an enzyme complex in that part of activationoftheoxidasebyphysiologicalstimulicon-
the plasma membrane that initially contacts the for- tainmembranereceptors,asmallGproteinc (Rac2in
eignbodyandlaterformsthephagocyticvacuole.The human neutrophils, usually Rac1 in monocytes
activatedcomplexoxidizesNADPH(largelyprovided and macrophages), a phosphatidylinositol-specific
bythepentosephosphatepathwayinthecytosol), phospholipase C, and a protein kinase C (PKC)
into NADP+, releasing two electrons that are used to
reduce2O to2O
•–(Fig.8.12),
2 2 b Phoxdenotesphagocyteoxidase,pmeansprotein,andgp
glycoprotein.
NADPH+2O 2 →NADP++H++2O • 2 – c ForanexplanationofGproteinspleaseseeSection5.5.4.2.

--- Page 488 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 433
8.7.4.4 Superoxideisrequiredtokillsome
bacteria
TheK forO oftheactivatedoxidasecomplexinrat
I m 2
+ andhumanneutrophilsiswithintherangeofO con-
2
centrationsinbodyfluids(K forhumancellsis~10
m
Figure8.13 Structureofdiphenyleneiodonium(DPI).Thisand μM),andsotheamountofO •–producedislikelytobe
relatedcompoundsinhibitO • 2 –productionbythephagocyteNADPH affectedbyO concentration. 2 63,64
2
oxidaseandotherNOX/DUOXenzymes.Diphenyleneiodonium
If the respiratory burst of neutrophils is prevented
interceptsanelectronfromtheflavinandisconvertedtoaradical,
byplacingthemunderN ,theirkillingofmanybac-
whichthenformsanadductwiththeflavin,haem,oraminoacid 2
residuestoinactivatetheprotein(Biochem.J.290,41,1993;J.Biol. terial strains is not impaired. Many of these bacteria
Chem.277,19402,2002).However,DPIisfarfromspecific, are anaerobes, and the neutrophil would not be ex-
inhibitingseveralotherflavoproteinsaswell(e.g.NOS,cytochrome pectedtorelyonanO -dependentkillingmechanism
2
P450reductase,XO,aldehydeoxidase,andmitochondrialNADH–CoQ forspeciesthatitislikelytoencounteronlyatlowO .
2
oxidoreductase).Itmayalsodirectlyinhibitcytokineproduction.61
Theirkillingispresumablyachievedbythecontentsof
Another‘pre-inhibitor’isapocyninwhichisconvertedtotheactive
thevariousgranulesastheyemptyintothephagocytic
agentbymyeloperoxidase(Section11.7;Fig.11.5)andsowillnot
vacuole.46 Forexample,theenzymelysozymedigests
workincellslackingthisenzyme;itisalsonon-specific(Hypertension,
cell wall constituents of various bacteria, especially
51,211,2008;Arterio.Thromb.Vasc.Biol.33,2187,2013).
Gram-positivestrains.Severalofthegranularconstitu-
entshavebactericidalactivity,e.g.byactingasprotein-
asesorbyopening‘channels’acrossbacterialcellmem-
(Section 5.5.4.2). The Rac proteins are cytosolic and branesanddissipatingiongradients.Examplesofthe
upon activation of the respiratory burst they bind latter are the defensin and cathelicidin peptides.46,65
GTPandmigratetotheplasmamembranetofacilitate Many antimicrobial peptides/proteins also have im-
activation,byinteractingwithp67phox.Phosphoinosit- munomodulatory functions, e.g. stimulating neutro-
ides produced when fmet-leu-phe, LTB etc. bind to phil chemotaxis, deterring apoptosis, and promoting
4
G-protein coupled receptors play an important role cytokine production.46 Lactoferrin binds iron essen-
in the actin remodelling and other events necessary tialforthegrowthofbacteria,andhasbeenreported
for phagocytosis, and participate in the activation of to kill a few bacterial strains directly. Elastase and
PKC, leading to phosphorylation of many proteins, cathepsinGcanhelptokill,asevidencedbytheobser-
including p47phox (on serine). Once H O generation vationthataddingproteinaseinhibitorscansometimes
2 2
starts, it can facilitate this process by inactivating decreasebacterialkillingbyphagocytes.57
neutrophil phosphatases, such as PTEN.34 Phosphor- Nevertheless, the killing of other bacterial strains
ylationbyPKC(severalotherkinasesalsocontribute) by neutrophils is decreased under anaerobic condi-
promotes translocation of p47phox to the membrane tions. Indeed, patients suffering from chronic granu-
and contributes to activation of the oxidase. Priming lomatous disease (CGD), a collective term given to
(Section8.7.4.2) involvespartial phosphorylationand inherited conditions in which phagocytosis is nor-
translocationofsubunitstotheplasmamembrane,so mal but the respiratory burst is severely sub-normal
thattheneutrophilis‘readytofire’. orabsent,showpersistentandmultipleinfectionsby
Receptor-dependent oxidase activation is normally someofthesebacteria(Table8.3).CGDpatientshave
shortlived;theoxidaserapidly‘switchesoff’,inpart been reported to have lower platelet and urinary F 2 -
duetodephosphorylationofp47phox.Phorbolmyristate IsoPlevels,66,67indicatingthatsomelipidperoxidation
acetate stimulates the respiratory burst by activating in vivo involves phagocyte-generated ROS. Subjects
PKCdirectly;hencetheresultingphagocyteresponse also showed greater flow-mediated dilation, indica-
is Ca2+-independent and much more prolonged, and tive of greater NO• bioavailability in blood vessels
maybenon-physiologicalinotherwaysalso.62Thusbe (Section6.17.2),67andlesscarotidatherosclerosis.67A
careful not to over-interpret the physiological signifi- The symptoms of CGD show that O
•–
production
2
cance of effects of PMA-activated phagocytes. There is essential for killing some bacteria. Why? Before
is still debate over the precise sequence of events in attempting to answer that, it is worth mentioning
activationandtherolesofdifferentreceptorsandkin- that sometimes other sources of ROS contribute to
ases,whichvarydependingonthetypeofphagocyte, killing. For example, a trypanocidal protein isolated
the species it came from,59 and the stimulus used to fromplasmaofCapebuffalo(Synceruscaffer)inKenya
activate. turnedouttobexanthineoxidase,68andthetoxicagent

--- Page 489 ---

434 FREE RADICALS IN BIOLOGY AND MEDICINE
Table8.3 Chronicgranulomatousdisease.
Incidence 1in200,000to250,000(noapparentethnicdifferences).
Male:femaleratio 6:1(duetopredominanceofX-linkedform;nogenderdifferenceinautosomalforms).
Inheritance ~65%X-linked(defectivegp91phoxintheb-typecytochrome);restmostlyautosomalrecessive;defectsingp22phoxof
b-typecytochrome,orinp47phox,p40phox,p67phox,orrac2.
Carrierstate SeeninX-linkedCGDinmothersandsisters,usuallyasymptomatic.
Ageofonset Congenital,firstsymptomsusuallyat<1yearofage(80%),rarelyadultonset.
Clinicalmanifestations a.Recurrentbacterialandfungalinfections;
b.Sequelaeofchronicinflammation(failuretothrive,anaemia,enlargedspleen,etc.);
c.Granulomaformation,sometimestoanextentthatcancauseobstructionintheoesophagus,ureter,orelsewhere.
d.Increasedriskofdevelopinginflammatoryboweldisease.
Diagnosis AbsenceofO •
2
–andH2O2productionbyactivatedphagocytes,e.g.failuretodetectblueformazanproductionfromNBT
(Section2.5.3)underthemicroscope.
Organinvolvementa a.Lung(80%)—pneumonia(Staphylococcusaureus,Aspergillus)abscess,chronicchanges;
b.Lymphnodes(75%)—suppurativelymphadenitis(S.aureus),adenopathy;
c.Skin(65%)—infectiousdermatitis,abscesses;
d.Liver(40%)—abscess(Staphylococcusaureus);
e.Bone(30%)—osteomyelitis(Serratiamarcesens);
f.Gastrointestinaltract(30%);
g.Sepsisandmeningitis(20%);
h.Genitourinary(10%)
Prognosis Variable:deathininfancytomiddleageifinadequatelytreated.SurvivalisstronglyrelatedtohowmuchphagocyteROS
productionremains(N.Engl.J.Med.363,2600,2010).
Treatment Prophylacticantibiotics,anti-inflammatoryagents(e.g.steroids),haematopoieticstemcelltransplantation.
CGDiscausedbyimpairedphagocyteO•–production.Differentdefectsexist,e.g.patientswithX-linkedCGDhaveadefectivegp91phoxandsotheb-typecytochrome
2
doesn’tworkproperly.Non-X-linkedCGDcanresultfromotherproteinsintheb-typecytochromeorinvolvedinassemblingtheactiveNADPHoxidase.Adaptedfrom
CurrentClinicalTopicsinInfectiousDisease6,138,1985,bycourtesyofthelateProfessorBernieBabiorandthepublishers.Otherorganismsthatcancauseproblems
inCGDpatientsincludePseudomonasandBurkholderiacepacia.TheproblemsinCGDinvolvebothfailuretokillpathogensanddysregulationoftheimmuneresponse.
MicelackingNOX2,andpossiblyhumanCGDpatients,havemilddefectsinlearningandmemory(Section10.17.5).
aTransgenicmicelackingphagocyteoxidaseconstituentsalsoshowincreasedsusceptibilitytoS.aureus,Aspergillus,BurkholderiaandListeriamonocytogenesinfections
(J.Immunol.158,5581,1997;Infect.Immun.68,2374,2000)anddysregulatedinflammation.Forexample.Aspergillushyphaeadministeredinthetracheaproduced
mildinflammationinnormalmicebutseverepersistentinflammationinknockoutmice(J.Exp.Med.2,207,1997).
wasH O .Uponinfection,bloodhypoxanthinelevels reactive, but no evidence has yet been obtained that
2 2
risewhereascatalaseactivitydeclines,allowingH O this is important in vivo. Several microorganisms are
2 2
to accumulate and attack the parasite. In knockout quickly killed by H O , formed from O
•–
by non-
2 2 2
mice lacking active phagocyte oxidase, removal of enzymic or SOD-catalysed dismutation. Unlike O
•–,
2
Burkholderiawasdecreased;clearanceofthisorganism H O can cross bacterial envelopes and membranes.
2 2
was further decreased by injecting allopurinol,69 It can be toxic to bacteria by causing damage dir-
suggestinganancillaryroleforXO.Intherabbitfish ectly, and/or by forming OH• within the bacterium.
(Siganus oramin), plasma L-amino acid oxidase may For example, increasing the intracellular iron content
playasimilarantibacterialrole.70 ofbacteriasensitizesthemtoH O (Section3.9.2.2).In-
2 2
deed,dimethylsulphoxide,ascavengerofOH•thatcan
8.7.4.5 Sohowdoessuperoxidekill?ViaH2O2?
penetrate into cells, partially protects Staphylococcus
It is unlikely, given its limited reactivity in aque- aureus against killing by human neutrophils. During
ous solution and general inability to cross mem- theseexperiments,theformationofmethane,aproduct
branes,thatO •– itselfkillsmicroorganisms.HO • (Sec- ofthereactionbetweendimethylsulphoxideandOH•
2 2
tion 2.5.3) might be able to penetrate and is more (Table 6.4), was observed.71 The variable sensitivities

--- Page 490 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 435
ofdifferentbacteriatoH O areprobablyduetotheir by reacting with O •– and generating ONOO– which
2 2 2
different levels of H O -metabolizing systems, their leads to damage to iron–sulphur proteins, essential
2 2
varying ability to raise these levels quickly (e.g. via –SHgroups,andmanyothertargets(Sections2.5.6and
oxyR; Section 5.5.2), and to the different intracellular 2.6.1).Indeed,micelackingiNOSaremoresusceptible
availabilitiesoftransitionmetalions,whichcansome- tocertainpathogens(Table2.11).ThusiNOSinduction
timesbeaffectedbythemediausedtogrowthemin andtherespiratoryburstofphagocytesrepresentboth
thelaboratory. parallel and overlapping (via ONOO–) defences. In-
deed, knockout mice lacking both gp91phox and iNOS
8.7.4.6 Viahydroxylradical?
died of spontaneous infections unless reared under
Although bacterial killing by H O often involves pathogen-freeconditions.73Butexercisecautionwhen
2 2
intracellular OH• formation, killing by converting interpretingdatafromknockoutmicethatseemmore
H O into OH• in the phagosome is intrinsically un- susceptibletoinfection.Alwaysask‘whatdidtheani-
2 2
likely; extracellular OH• would probably attack the malsdieof’?Wasitoverwhelmingproliferationofthe
bacterial cell wall or host phagosomal proteins, and invader? Or a badly dysregulated immune response
couldnottargetdamagetothepathogen. that killed the animal (Section 8.9.4)? Sometimes it’s
Nevertheless, several scientists have detected OH• notclear.
insuspensionsofactivatedneutrophilsusingarange One must be somewhat sceptical about the rele-
of techniques, including deoxyribose degradation, vance of pathogen killing by RNS to humans, since
benzoate decarboxylation, oxidation of methional to itisdifficulttopersuadehumanneutrophils(oreven
ethene gas, and spin trapping (Sections 6.2 and 6.3). macrophages) to make NO• in vitro, whereas rodent
How does it arise? Some may be artefactual. When cells are prolific NO• producers.74 Engulfed bacteria
neutrophilsareisolated,theyareseparatedfromtheir inthephagosomeofhumanneutrophilswerereported
normal environment and suspended in laboratory tobechlorinatedbutnotnitrated,suggestinglittleex-
buffers, most or all of which are iron contaminated posure to RNS.75 Nitric oxide generation by rodent
(Table 3.3). Neutrophil-derived O
•–
and H O can re- phagocytes mostly involves increased production of
2 2 2
actwithsuchirontoformOH•.Lactoferrinissecreted iNOSinresponsetocytokines,andhumanphagocytes
into the phagocytic vacuole of activated neutrophils, can indeed express iNOS if given the right cytokine
andalsoreleasedbythesecells.Itsaffinityforironis mixture,76 e.g. in the lungs of patients infected with
high,theboundironisnotredoxactive,andlactoferrin tuberculosis.77Indeed,RNSproduction(asassessedby
needs to be at a pH below 3 for the iron to be ren- NO–/NO–levels,ornitrotyrosineproduction),ismark-
2 3
deredlabile(Section3.23.1.2).Lactoferrinsecretionby edly elevated in many human diseases (Chapter 10),
neutrophilsmaythushelptominimizeiron-dependent
showingthatthereisincreasedNO•generationinvivo.
OH• generation, by binding any available iron ions Hence,althoughONOO– isbactericidalandvirucidal
atsitesofinflammation.Itmayalsodelayneutrophil invitro, itsimportancein killing invivoinhumans is
apoptosis.72 notyetclear.
Activated neutrophils make both O
•–
and hypo-
2
chlorous acid (Section 8.7.5); interaction of these spe-
cies(Section2.6.3)couldalsoexplainOH• formation. 8.7.4.9 Byfacilitatingtheactionofother
microbicidalagents?56
Justtoremindyou,thereactionis
HOCl +O •– → O +OH • +CI– Micedeficientinneutrophilelastaseand/orcathepsin
2 2 G(Table8.2)showimpairedkillingofsomebacterial
species, even though O
•–
production by their neutro-
8.7.4.7 ViasingletO2?
phils isnormal. For exa
2
mple, human neutrophilsuse
SingletO canarisefromHOCl;weconsideritsimport- these proteinases rather than ROS to kill Streptococ-
2
ance(apparentlynotverygreat)inSection8.7.5.3. cus pneumoniae. Elastase is also involved in NETosis
(Section 8.7.4.11). Superoxide consumes H+ as it dis-
8.7.4.8 Viaperoxynitrite?
mutatesinthephagocyticvacuole,raisingthepH.This
Rat, mouse, and some other animal neutrophils and helps to facilitate the action of proteinases from the
macrophages (especially if primed) readily generate cationicgranules.Inthismechanism,O
•–
andspecies
2
NO•.Nitricoxideatmicromolarlevelscankillcertain derivedfromithavenodirectkillingrole;theysimply
bacteria and parasitic protozoa, both directly (e.g. by help to create the environment for the proteinases to
inhibiting respiratory chain function) and indirectly, operate.

--- Page 491 ---

436 FREE RADICALS IN BIOLOGY AND MEDICINE
8.7.4.10 Interferencewithquorumsensing78 macrophages and was less virulent in mice.82 Other
examples can be found in Sections 3.7.1 and 3.8.1.
Some bacteria (e.g. S. aureus) and mixtures of bac-
Staphylococcus aureus, a particular problem in CGD
teriacommunicatewitheachotherbysecretingsmall
patients(Table8.3),issonamedbecauseofitsgolden-
molecules.Whenthelevelsofthesereachathreshold
yellowcolour,duetothecarotenoid,staphyloxanthin.
indicativeofthenecessary‘quorum’ofbacteria,they
This may have some antioxidant action. Blocking ca-
triggerchangesinbacterialgeneexpressionthatresult
rotenoid synthesis enhances killing by phagocytes,
inincreasedvirulence.Thequorumsensingmolecules
whereas expressing carotenoids in the normally non-
of S. aureus can be inactivated in vitro on addition
of HOCl or ONOO–. Bacterial virulence was greater pigmented S. pyogenes conferred resistance to killing,
andincreasedvirulence.83
in mice treated with N-acetylmethionine to scavenge
HOCl and ONOO–, suggesting that this mechanism There are many other papers showing that micro-
organismswithdisabledantioxidantdefencesaremore
is relevant in vivo. Indeed, mice deficient in NADPH
sensitivetophagocytickilling.Collectivelytheyshow
oxidase or (to a lesser extent) MPO, were unable to
that ROS play an important role. They can also help
suppressquorumsensingproperly.
to suppress quorum sensing. We need more experi-
8.7.4.11 ByNETsformation46 ments to dissect out the various contributions of all
the killing pathways described above, using a range
NETs (neutrophil extracellular traps) are strands of
ofmicroorganismsandphagocytesfromdifferentspe-
DNA releasedfromneutrophilsintothesurrounding
cies.Therelativeimportanceofkillingmechanismsis
environmentuponneutrophilactivationbybacteria(or likelytodifferbetweenspecies59andforeachmicroor-
PMA).Multipleproteinsareattachedtothem,includ-
ganism that the phagocyte encounters. For example,
inghistones,elastase,MPO,andgranuleantimicrobial
humanneutrophilscontainmoreantibacterialproteins
proteins.NETsmaybeamechanismtocapturemicro- thanmousecells.51
organismsandstopthemspreading,directantimicro-
bial proteins (including histones, which can damage
some bacteria) to them, and (presumably) kill them.
8.7.5 Myeloperoxidase(MPO)51,56
Theproteinasescandamagethebacteriadirectly(Sec-
tion 8.7.4.9) and also help to degrade cytokines and 8.7.5.1 Hypochlorousacidproduction
chemokines (Section 8.7.3.1). NET formation in most
Once the phagocytic vacuole begins to form, other
systems requires the respiratory burst and the con-
granulesintheneutrophilcytoplasmfusewithitand
certedactionofelastaseandMPOinpromotingchro-
deliverarangeofmolecules,includingMPO.Thisen-
matin decondensation.79 NETosis is most commonly
zymecomprises2to5%oftotalneutrophilproteinand
associated with neutrophil lysis, but can also occur
up to 25% of protein in the phagocytic vacuole. It is
by non-lytic secretions from the neutrophil. NETosis
also present in monocytes but not usually in macro-
andneutrophilnecrosis(releasingHMGB1)arefurther
phages.MPOisalsofoundinleukaemiccelllines(e.g.
examplesofneutrophilsreleasingDAMPs.
HL60),whichisworthbearinginmindwhensuchcell
linesareexaminedfortheirsensitivitytoRS.Peroxide-
8.7.4.12 Fittingittogether
induced apoptosis in HL-60 cells may, for example,
Isthemainfunctionoftherespiratorybursttocreate involveHOCl.84
optimumconditionsforproteinasestooperate(Section Myeloperoxidase was first purified in 1941 from
8.7.4.9)? Probably not; evidence indicates that phago- large volumes of pus and named verdoperoxidase,
cytesdouseH O ,HOCl,(andsometimesONOO– or meaning a ‘green peroxidase’. Indeed, it is MPO that
2 2
intra-bacterialOH•)topromotedirectkillingofsome gives pus and other infected body fluids their green
organisms.Forexample,amutantofE.colidefectivein tinge. MPO is a highly cationic haem-containing en-
the oxyR system (Section 5.5.2) was more susceptible zyme that shows ‘non-specific’ peroxidase activity
toneutrophilkilling.IndeedgenesregulatedbyoxyR (Section 3.19.2), being able to oxidize a wide range
arestronglyexpresseduponphagocytosisofE.coliby of substrates, including urate (Section 3.25.6) and sa-
normal, but not CGD, neutrophils.80 H. pylori unable licylate (Section 6.3.1). MPO contains four subunits,
torepairDNAdamageproperlywerehighlysensitive two each of molecular weights ~60 and 15 kilo-
tokillingeitherbyROSorbyactivatedmacrophages, daltons respectively. These subunits are formed by
and were less infectious in mice.81 S. typhimurium post-translationalcleavageofan88-kilodaltonprotein.
lacking periplasmic CuZnSOD survived less well in The haem is covalently linked to the protein by two

--- Page 492 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 437
ester bonds (with glutamate and aspartate residues) neutrophilandevenhigher(perhapsmillimolar)inthe
andasulphurbond(toamethionineresidue). phagosome. Both MPO and HOCl (Section 2.6.3) can
In the presence of H O , and chloride or iodide oxidizeSCN–intohypothiocyanite,OSCN–,whichalso
2 2
ions,MPOkillsmanybacteriaandfungiinvitro.Since hasantibacterialeffects.MPOcanitselfbeinactivated
much more Cl– than I– is present in the phagocyte bytoomuchHOCl(orH O );aminoacidresiduesand
2 2
cytoplasm and in extracellular fluids, it is generally the haem are attacked, the latter leading to iron ion
thought that MPO kills by oxidizing Cl– into hypo- release.88
chlorousacid,HOCl.TheenzymecanalsooxidizeBr– Hypochlorousacidcanreactwithaminogroupson
tohypobromousacid, biomolecules to produce chloramines, which are also
goodbactericidalagentsbutingeneralarelessreactive
H 2 O 2
+Cl–(Br–)−M−P→O
HOCl(HOBr)+H 2 O withhostbiomolecules(Section2.6.3),89
although neutrophils form much less HOBr than RCH NH +HOCl→RCH NHCl+H O
2 2 2 2
HOCl.Hypochlorousacidishighlyreactive,abletoox-
idize(directlyorviachlorinegas)manybiomolecules
Chloraminescanslowlydecomposetoaldehydesand
(Section 2.6.3). Bacterial targets include cysteine, me-
ammonia, which can react with HOCl to generate
thionine, and other residues on membrane transport monochloramine, NH Cl, which readily enters cells
2
proteins, ATP-generating proteins, and iron–sulphur andisagoodmicrobicidalagent,
proteins.DNAmayalsobechlorinatedtosomeextent
(Section 5.8.2.7).85 Indeed, killing of S. aureus by iso- NH++HOCl→NH Cl+H O+H+
4 2 2
latedhumanneutrophilscouldbedecreasedbyMPO
inhibitors and was slower in MPO-deficient neutro- ChloraminescanreactfurtherwithHOCltogenerate
phils. A popular MPO inhibitor is 4-aminobenzoic dichloramines.
acid hydrazide, which is oxidized by MPO into a OnecommonaminereactivewithHOClis taurine
radical that inactivates the enzyme,86 although other (2-aminoethanesulphonic acid), present in plasma,
inhibitorsarebeingdeveloped(Section11.7).Isoniazid neutrophils, other phagocytes, and several other tis-
(Section7.5)isalsooxidizedbyMPOintoproductsthat sues (e.g. heart, retina, and nerves). It was first iso-
inhibittheenzyme,areactionwhichhasthepotential lated from the bile of the ox, Bos taurus, hence the
tointerferewithuseofthisdrugtotreattuberculosis.87 name.Taurineisanend-productofthemetabolismof
Whenneutrophilsareactivated,30%ormoreofthe sulphur-containing amino acids (Fig. 8.14) and intra-
H O they produce (via O
•–
dismutation) is used by cellular concentrations in human neutrophils have
2 2 2
MPOtomakeHOCl.IndeediftheHOClwereallowed been estimated as 10 to 50 mM.89 Proposals that the
to accumulate (which it doesn’t, since it is so react- biologicalroleoftaurineistoactasadirectantioxid-
ive),itcouldreachconcentrations>50μMaroundthe antareunlikelytobetrue,sinceitisapoorantioxidant
CH SO– HOCI CH SO–
2 3 2 3
+
CH NH CH NHCl
2 3 2
Taurine Taurine chloramine
Non–enzymic Enzymic
RS (including Hypotaurine
OH(cid:129) , HOCI, ONOO-, NO(cid:129), CO(cid:129)− ) dehydrogenase
2 3
Hypotaurine CH SO–
2 2
+
CH NH
2 3
Cysteine
Figure8.14 StructureoftaurineanditsreactionproductionwithHOClandotherRS.TaurineisoneproductofattackofcertainROSon
hypotaurine(alsoseeBiochem.J.389,233,2005).Taurinechloraminescanbreakdowntosulphoacetaldehyde,–SO3CH2CHO(Biochem.J.
330,939,1998;AminoAcids22,145,2002).

--- Page 493 ---

438 FREE RADICALS IN BIOLOGY AND MEDICINE
eveninvitro,90 andtaurinechloraminescanstilloxid- and reversibly with O •– to form an ‘oxyferrous’ en-
2
izesomebiomolecules.Itsprecursorhypotaurineisa zyme,compoundIII,
muchbetterantioxidant,90andmaycontributetoanti-
MPO–Fe(III)+O •– (cid:2) enzyme-Fe2+–O
oxidantdefenceinphagocytes,andinthereproductive 2 2
system(Section7.11).
SuperoxidecanalsoreactwithcompoundI,reducing
8.7.5.2 TheMPOreactionmechanism56 ittocompoundIIplusO 2 .HenceMPOcanhavebotha
superoxidedismutase(Fig.8.14D)anda‘superoxidase’
Oxidation of CI–, Br–, or SCN– by MPO occurs by
activity(Fig.8.14C),usingH O tooxidizeO
•–toO
.
2 2 2 2
compoundIformation,e.g.
The extent to which these various reactions oc-
MPO–Fe(III)haem
−H−2−O→2
compoundI
cur in the phagocytic vacuole has yet to be estab-
lished. They are all affected by pH, and their com-
(Fe(IV)haem-Pr•+)
plexity means that the enzyme’s behaviour is hard
CompoundI + Cl–(Br–) → OCl–(OBr–) to predict under biological conditions. For example,
HOCl formation consumes Cl–, and more must be
+Fe(III) –MPO(twoelectronoxidation)
transported in for ongoing HOCl production. Phago-
Compound I can also oxidize tyrosine, ascorbate, somal Cl– concentrations have been estimated to be
NO–, urate, and serotonin in one-electron processes about 70 μM. If the Cl– level drops too much, then
(the 2 peroxidase activity of MPO). The compound II O • 2 – (~20 μM) might become a preferred reactant
produced is insufficiently oxidizing to convert Cl– to forMPO.
HOCl,soitisessentiallyinactiveinthatroleuntilan
‘easier’electrondonor(suchasascorbateorserotonin)
8.7.5.3 SingletO2fromMPO?55
comes along, that it can oxidize and re-form active Hypochlorous acid reacts with O •– to give OH• and
2
MPO. Compound II can also oxidize polyphenols with H O (at alkaline pH) to form singlet O (Sec-
2 2 2
such as epicatechin. Hydrogen peroxide can convert tion2.6.4).However,thelatterreactionisslowatpH
compoundIbacktoferricMPOwithO release.Thus 7.4andtheamountofsingletO madebyneutrophils
2 2
under certain circumstances MPO has catalase-like is unclear and probably small. In addition, HOCl re-
activity(Fig.8.15). actsfasterwithmanyotherbiomoleculesthanitdoes
Myeloperoxidase,likehorseradishperoxidase(Sec- with H O . Attempts to measure 1O using ‘probes’
2 2 2
tion3.19.3),reactsquickly(rateconstant 2×106M–1s–1) for this species have been frustrated by the fact that
(A) Chlorination (B) Peroxidation
–OCI Cl–
Figure8.15 ThecomplexityofMPO.The
FeIII O=FeIV (cid:129)+ FeIII H 2 O 2 O=FeIV (cid:129)+ differentcatalyticcyclesofMPOareshown.
Ferric MPO H 2 O 2 Compound I Ferric MPO Compound I ( w A it ) h In th t e he fe c r h ri l c or e i n n z a y t m io e n t c o yc f l o e rm H2 C O o 2 m re p a o c u t n s dI,
O
2
R– R(cid:129) RH a
ha
F
e
e
m
IV
-c
in
a
t
t
e
io
r
n
m
r
e
a
d
d
ia
ic
t
a
e
l.
c
T
o
h
n
i
t
s
a
o
in
x
i
i
n
d
g
iz
a
esCl–and
O 2 O=FeIV R(cid:129) RH O=FeIV R(cid:129) Br–toproducehypohalousacids.Itcanalso
Compound II Compound II oxidizethiocyanate.(B)Peroxidationof
organicsubstrates(RH),suchasurateand
(E) Catalase tyrosine,occurswhentheyareoxidizedby
O 2 H 2 O 2 C fre o e m r p a o d u ic n a d ls I ( a R n • d ). C (C om )I p n o t u h n e d s I u I p to er p o r x o id d a u s c e e
(cid:129)+ (C) Superoxidase cycle,O •–isthesubstrateforCompoundI
FeIII O=FeIV
andCom
2
poundII.(D)MPOdismutatesO
•–
Ferric MPO H 2 O 2 Compound I FeIII H 2 O 2 O=FeIV (cid:129)+ whenthisradicalreactswithferricMPOa 2 nd
(D) Superoxide dismutase Ferric MPO Compound I CompoundIII.(E)MPOactsasacatalase
whenH2O2actsasatwo-electronoxidant
H 2 O 2 O 2 + 2H+ O 2 O 2 f f o o r r f C e o rr m ic p M ou P n O d a I. n A d d a a t p w te o d -e f l r e o c m tro A n nt r i e o d x u id c . tant
O 2 O=FeIV O 2 RedoxSignal.18,642,2013,bycourtesy
FeIII O 2 :FeIII Compound II ofDrTonyKettleandMaryAnnLiebert
Ferric MPO O 2 Compound III publishers.

--- Page 494 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 439
HOCl oxidizes a number of them directly, including (e.g.byglucose-glucoseoxidaseorD-aminoacidoxi-
DABCO, 2,5-diphenylfuran, histidine,andβ-carotene dase)toneutrophilsfromCGDpatientsrestoreskilling
(Section 6.8). Nevertheless, some 1O was detected ofsomebacteria,includingS.aureus.56,92 Onestudy94
2
in activated neutrophils and macrophages (how it examinedthefateofE.coliengulfedbyhumanneutro-
was formed in the latter is uncertain) using a 9,10- phils. The bacterial envelope was quickly perforated
diphenylanthracene probe (Section 6.8). By contrast, and bacterial enzymes inactivated. Perforation was
other studies using 14C-labelled cholesterol as a trap slowerinneutrophilsfrompatientswithCGD.How-
of1O detectedlittlesingletO .SingletO production ever,neutrophilsfromMPO-deficientpatientsshowed
2 2 2
maybemoresignificantineosinophils(Section8.8). a normal rate of perforation, but a lower rate of en-
zymeinactivation.ThusHOClfromMPOmighthelp
8.7.5.4 TheenigmaofMPO todestroybacteriaaftertheyhavebeendamaged,but
MeasurementofHOCllevelswithinE.coliorS.aureus doesnot,atleastinthiscase,appeartoberesponsible
using GFP (the protein present within the bacteria for the initial damage. E. coli internalized by human
after transfection of the GFP-encoding gene loses neutrophilsshowedamarkedincreaseintheircontent
fluorescenceonexposuretoHOCl)showedthat,after of 3-chlorotyrosine, a biomarker for RCS, that par-
phagocytosisbyhumanneutrophils,thebacteriawere alleled killing,75 but correlation does not, of course,
exposedtolevelsofHOClthatshouldbesufficientto imply causation. Intra-phagosomal chlorination has
killsomeofthem.91 Severalothermethodshavebeen alsobeenobservedinneutrophilscontainingotherbac-
usedtodemonstratesubstantialHOClproductionby teria, including S. aureus and Pseudomonas aeruginosa.
neutrophils. Given that HOCl in vitro is a powerful Ofcourse,hostproteins95 inthephagosomewillalso
antibacterial,antifungal,andantiviralagent,andthat beattackedbyHOCl,anddorememberthatchlorotyr-
MPOisinvolvedinNETsformation(Section8.7.4.11), osineisonlyoneofmanyproducts(andlikelyaminor
then mustn’t MPO be an essential phagocyte killing one) generated by reaction of HOCl with biomol-
mechanism? ecules(Section2.6.3).Chlorinatedlipidshavealsobeen
Apparentlynot;humanswithinborndeficienciesof detected in activated neutrophils (Section 2.6.3 and
MPOshowonlyminordecreasesinresistancetoinfec- 5.12.8.1),buttheirsignificanceinkillingisuncertain.
tion,implyingthatMPOislessimportant51inbacterial
killingthanisO
•–.However,occasionalincreasedsus- 8.7.5.5 NitrationbyMPO
2
ceptibilitytoCandidainfectionhasbeennoted;MPO- MPO catalyses co-oxidation of tyrosine and NO– to
2
knockout mice are also more susceptible to Candida form nitrotyrosine, apparently a significant pathway
(aswellasKlebsiellaandCryptococcusneoformans)infec- for generation of this compound in tissues in vivo
tions.SeveraldifferentmutationsinthehumanMPO (Section 6.6.2), although little nitration seems to hap-
gene have been identified. Indeed, MPO deficiency pen in the human neutrophil phagosome, as already
is a common defect in humans (about 1 in 2000– mentioned.75 NitricoxidecaninhibitMPOactivityby
4000 people).51 Polymorphisms in the gene promoter binding(reversibly)totheFe(III)–haem.56Ontheother
regionthatalterMPOlevelshavealsobeendescribed, hand,itcanbeoxidizedbycompoundsIandII(ascan
and suggested (without strong evidence as yet) to NO–)andsorecycleMPOintoaformactiveinHOCl
2
affectsusceptibilitytolungandsomeothercancers. production.96 Thus MPO can consume NO• in blood
OverallMPO-deficienthumansseemtohavefewer vesselwalls(Section8.9.1).
problems than MPO-deficient mice.51 This could be
8.7.5.6 Peroxidasins
becausethereisoftenresidualMPOactivity,orthathu-
mancellshavemoreantibacterialproteinsthanmouse Peroxidasinsareproteinsthatcontainahaemperoxid-
ones,asmentionedearlier,andmayhavealesserneed asesegment,resemblingthatoflactoperoxidase,plus
for MPO.51 Indeed, neutrophils from patients with a immunoglobulin-likeandleucine-richrepeatdomains.
completelackofMPOwerereportednottoformNETs, In the human genome, at least two different peroxi-
whichalsoraisesasecondaryquestionofhowessential dasinsareencoded,oftencalledvascularperoxidase-1
NETsareforbacterialkilling.93 (VPO1) and cardiac peroxidase (VPO2), because of
So where does MPO fit in? In CGD patients, pha- their high expressions in blood vessels or heart re-
gocytesdonotmakeO
•–
andsonoH O isprovided spectively. VPO1 is also found in other tissues such
2 2 2
forMPO,i.e.thereisatripledefect(noO
•–,H
O ,or as lung, spleen, and pancreas, and appears essen-
2 2 2
HOCl).ROSproductionbyseveralothercelltypesis tial for correct development of the eyes in mice and
also impaired (Section 8.10). Indeed, supplying H O humans. Like MPO, VPO1 can catalyse oxidation of
2 2

--- Page 495 ---

440 FREE RADICALS IN BIOLOGY AND MEDICINE
Cl– to HOCl, and Br– to HOBr.97 It can also oxidize key role of monocytes is to generate macrophages
and cross-link tyrosine residues. Another role of per- to help progress, and eventually resolve, inflamma-
oxidasinsistogeneratesulphilimine(S=N)bondsthat tion(Section8.7.2),buttheycanalsodifferentiateinto
arefoundintypeIVcollageninbasementmembranes dendriticcells.101Eosinophils,macrophages,basophils,
(bonds between the sulphur of methionine and ly- and mast cells can, like neutrophils, produce extra-
sine or hydroxylysine nitrogens): localized HOBr (or cellularDNAtraps,whoseformationusuallyrequires
to a lesser extent HOCl) formation by peroxidasin in NADPHoxidaseactivity.103
thebasementmembranecausesthesebondstoform.98 Mosteosinophilsarefoundintissues,especiallythe
These reactions are very important: basement mem- bonemarrowandintestinalmucosa.Theirnumbersin
branes (BM) are sheet-like structures that underlie blood are usually low (Table 8.1), but increase in al-
epithelia and endothelia, and surround muscle, per- lergic conditions, such as asthma and hay fever, and
ipheralnerve,andadiposetissue,providingstructural duringinfestationsbysomeparasites.Eosinophilsare
and signalling support to maintain cellular function. importantindefenceagainstparasites,whichtheycan
BMs compartmentalize tissues, act as a filtration bar- damage by producing ROS. Further damage is pro-
rier, provide stimuli for cell growth, migration, and duced by release of both an eosinophil peroxidase
differentiation,andtheyareimportantconstituentsof (EPO),andofvariouscytotoxicproteins,includingma-
stemcellniches.LossofintegrityofBMisassociated jor basic protein-1 (MBP-1) and eosinophil cationic
with developmental defects, and pathologies such as protein(ECP),thatarestoredinmultiplegranulesin
altered cancer progression, metastasis, and increased the eosinophil cytoplasm.104 Whereas activated neu-
susceptibility to autoimmune diseases. Collagen type trophils usually engulf their target and direct toxins
IVisakeyproteininbasementmembranes.98 into the phagocytic vacuole, eosinophils release their
toxins onto the surface (since their parasite target is
8.7.5.7 Otherdefensiveperoxidases usuallytoolargetophagocytose);MBPandECPhelp
topermeabilizethepathogen’smembranes.Eosinophil
Some Anopheles strains cannot transmit malaria be-
peroxidasehasacatalyticmechanismsimilartoMPO,
cause they ‘seal up’ the parasites in the gut (Sec-
except that it prefers bromide (Br–) as a substrate102
tion7.6).Anophelesstephensigoesonebetter;itinduces
andsogeneratesHOBr,despitethefactthatCl–levels
bothNOSandaperoxidaseinthegut,thelatterusing
in body fluids are much greater (140 mM Cl– versus
RNSfromtheformertocatalysenitrationandinacti-
vation of the parasite.99 The Hawaiian bobtail squid 20–100 μM Br–). Indeed, bromotyrosine has been de-
tectedintheairwaysandsputumofasthmaticpatients
Euprymna scolopes contains an MPO-like enzyme that
(Section7.3.3).EPOcanalsooxidizeSCN– toOSCN–.
makesHOCl.Itmayuseittoregulatesymbioticasso-
Both HOBr and HOCl can react with H O to form
ciationswithitspartner,theluminousbacteriumVibrio 2 2
fischeri.100 The squid feeds the bacteria, and in return singletO 2,
theygeneratelightthatmasksthesquid’ssilhouetteas
itpursuesitsprey. HOBr+H 2 O 2 →HBr+H 2 O+1O 2
8.7.5.8 Fittingittogether(part2) The reaction with HOBr is faster, and HOBr is less
quicklyremovedbyotherbiomolecules(Section2.6.3),
InSection8.9weattempttosummarizethebiological
so production of 1O by eosinophils may be greater
significance of ROS production by phagocytes. Be- 2
thanbyneutrophils,althoughitscontribution,ifany,
fore doing that, let us examine some other types of
to pathogen killing remains uncertain.105,106 Eosino-
phagocytesinmoredetail.
phil peroxidase can also convert tyrosine and NO–
2
intonitrotyrosine,andthesecellscannitratetheirown
8.8 Otherphagocytes:similarbut proteins,includingECP.107 However,humanEPOde-
ficiency, like that of MPO, appears asymptomatic,108
different
althoughfewstudieshavebeendone.
FormationofO
•–
byarespiratoryburstcanoccurnot Basophils and mast cells present in connective tis-
2
only in neutrophils but also in macrophages (includ- sue are rich in histamine, and both cell types can be
ingmicrogliainthebrain,osteoclastsofbone,andthe activated by allergens which combine with immuno-
Kupffer cells of liver), eosinophils, monocytes, baso- globulinE(IgE)boundtotheirsurface.Suchactivation
phils,dendriticcells,andmastcells.Ingeneral,these leads to release of several mediators, including O
•–,
2
burstsaresmallerthanthoseofneutrophils.101,102One histamine, and 5-hydroxytryptamine (serotonin), and

--- Page 496 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 441
the ROS production may help to regulate the pro- vitro, favouring proteolytic action. Whereas elastase
inflammatoryresponseofmastcells.109Histamineand withinneutrophilsismicrobicidal(Section8.7.4.9),re-
serotonincontributetothesymptomsobservedwhen leased elastase can hydrolyse connective tissue com-
patientswithallergiesareexposedtotheallergenthat ponents such as elastin and collagen; over-activity of
theirboundIgErecognizes,suchaspolleninthecase extracellularelastasecontributestothetissuedamage
of hay fever, or the house dust mite in many cases in emphysema (Sections 2.6.3 and 7.3.1), and prob-
of asthma. Histamine has variable effects on phago- ablyalsoinacuterespiratorydistresssyndrome(Sec-
cyte O
•–
generation, depending on its concentration. tion10.8),andcertainskindiseases,suchaspsoriasis.
2
Atphysiologicallevels,itmaydecreaseROSproduc- Elastase was also reported to cleave receptors on the
tionbymacrophagesandneutrophils.110Releaseofthe surfaceofmacrophages,thusinterferingwithphago-
serineproteinasetryptasebymastcellsisthoughttobe cytosisofapoptoticneutrophils.116
involvedinallergy;MPOinhibitsthisenzyme.111 Dotheseinactivationsofantiproteinaseshappenin
Dendriticcellsarespecializedcellsthatpresentpep- vivo? It depends on what else is present. Hypochlor-
tidesderivedfrompathogensorinfectedcellsasanti- ous acid or ONOO– added to plasma tend not to
genstoT-cells.Thisprocess,called‘cross-presentation’, damagetheantiproteinasesbecausetheyreactprefer-
requires the original protein antigen to pass through entially with albumin, present at 50 to 60 mg/ml (as
endosomes or phagosomes for proteolysis. NADPH comparedwith1–3mg/mlforα -antiproteinase).117In
1
oxidaseactivityseemstoplayaroleinantigenpresent- some other biological fluids (e.g. cerebrospinal, syn-
ation,perhapsbycontrollingthepHofthephagosome ovial,orlungliningfluids)albuminconcentrationsare
toallowjusttherightdegreeofproteolysis.112NADPH lower, and attack is conceivable. For example, inacti-
oxidase in dendritic cells also generates O •–, but its vatedchlorinatedα -macroglobulinhasbeenfoundin
2 2
activityisonlyafewpercentofthatinneutrophils. inflamed human rheumatoid joints.118 Ascorbate can
also scavenge ONOOH and HOCl, and the concen-
trations present in extracellular fluids (40–100 μM in
8.9 Whatdophagocyte-derivedreactive plasma,alveolarliningfluid,andsynovialfluid,more
species(RS)dotothehost? inCSF)canprotectα -antiproteinaseagainstthesespe-
1
cies, at least until the ascorbate has been depleted.119
Phagocyte-derived RS, proteinases, cationic proteins,
Ascorbate also reacts with MPO, but its effects on
MPO, NETs etc., are important in killing pathogens, HOClproductionarecomplex.56Itcanbeoxidizedby
buttheycanaffectthehostaswell,especiallyifneutro-
compoundII,regeneratingcompoundI,andaccelerat-
philphagocytosisisincomplete(frustratedphagocyt-
ingHOClproduction.Butitalsoactsasacompeting
osis;Fig.8.9).Untilrecently,emphasishasbeenplaced substratewithCl– forcompoundI(althoughitslevels
onthedamagingeffectofRS,butthereisanincreas- are much lower than those of Cl–) and it directly
ing realization that they also play a role in helping
scavenges HOCl. GSH, present at high levels in al-
inflammationresolve.113–115Indeed,inflammationusu-
veolarliningfluid,canscavengeHOClandONOOH
allysubsidesandthetissueheals—inotherwords,the andprotectα -antiproteinase.Alloftheseantioxidants
1
benefitofremovingtheinvadingorganismoutweighs
willtendtolimitthedamagedonetoantiproteinases
anytissuedamage,whichcansimplyberepaired.Yet
byHOCl.
duringchronicinflammation thereis extensivetissue
Ifleftunscavenged,HOClmightadditionallyfavour
damage and often an increased risk of cancer. Is this
proteolysisbyactivatingtwoenzymesthatcanbere-
duetoRS?
leasedfromneutrophilsinalatentform—collagenase
(which digests native type I collagen) and gelatinase
(which attacks denatured collagen and native types
8.9.1 ExtracellularRS:whatcantheydo?93
IV and V collagen; Table 8.2). It’s not that simple,
NETs can activate platelets—thus promoting blood however; HOCl can inactivate matrilysin and several
coagulation—anddamageendothelialcells,eventsim- other neutrophil enzymes, including lysozyme and
portantinseveralconditions,includingpre-eclampsia MPO itself, as well as destroying certain cytokines
(Section7.11.6).ReleasedMPOcanconsumeNO•,ni- anddecreasingtheactivityofsomeDAMPsbyoxidiz-
tratetyrosineresidues,andreactwithH O andCl–to ing them, examples being HMGB (Section 5.4.1) and
2 2
formextracellularHOCl.AdditionofHOCl,ONOO–, theS100proteins.36,120,121 Proteinasescanalsodestroy
orchloraminessuchastaurinechloraminesinactivates cytokines.122PeroxynitritecanconvertMPOtotheless
α -antiproteinase and α -macroglobulin (Table 8.2) in activecompoundII(Section8.7.5.2).
1 2

--- Page 497 ---

442 FREE RADICALS IN BIOLOGY AND MEDICINE
Thustheoveralltissue-damagingeffectsofreleased phagocyteandtherebydecreaseitsproductionof O
•–
2
MPO, HOCl, and ONOO– at sites of inflammation andcytokines(Section8.9.3).Wehavealreadyseenthis
are difficult to predict and may be minor. However, in the case of NF-κB activation (Section 5.5.6). React-
MPO bound to basement membranes or endothelial ivespeciesalsointeractwiththeeicosanoidpathway,
cellsurfacesmaytargetdamagethere(Section8.9.4). whoseproductsinfluencephagocytefunctioninmany
ways(Section8.12).
There are further checks and balances; increased
8.9.2 Signalling
blood flow rapidly replenishes α -antiproteinase and
1
Reactivespeciesreleasedatsitesofinflammationplay antioxidantssuchasascorbateandalbuminatsitesof
important roles in signalling. They can increase the inflammation. Erythrocytes and other cells can ‘soak
activity of MMPs (Table 8.2) and stimulate fibroblast up’ H 2 O 2 needed by MPO (Table 3.7). Concentra-
proliferationfortissueregeneration,bothdirectly(Sec- tionsofseveralacute-phaseantioxidantproteins(e.g.
tion 5.2.1) and/or as intermediates in the action of haptoglobin, caeruloplasmin) increase during inflam-
cytokines (although too much proliferation can re- mation(Section5.7.4);oneofthemiscaeruloplasmin,
sult in fibrosis). For example, Fig. 6.7 shows the which can inhibit MPO (Section 3.22.2.4).51 Albumin
presence of H O in a healing wound, not prevent- can also bind MPO, directing damage by HOCl onto
2 2
ing (and possibly accelerating) the healing process. itself and sparing other targets.51 The nucleoside ad-
H O facilitates not only phagocyte recruitment (Sec- enosine (adenine-ribose) is released by a variety of
2 2
tion 8.7.2) but also their adherence to endothelium, normal cells at low levels and by stimulated/injured
by increasing the levels of adhesion molecules such cellsathigherlevels(includingendothelium,platelets,
as P-selectin, ICAM-1, PECAM-1, and VCAM-1. Ac- and neutrophils). At low levels adenosine promotes
tivation of their synthesis by ROS or by cytokines neutrophilchemotaxisandphagocytosis,butaslevels
(which sometimes occurs via ROS; Section 5.7) often rise, it decreases them, by binding to different types
involvesNF-κB(Section5.5.6).H O canalsoincrease ofreceptor.130 Theneutrophilisthusbothasourceof
2 2
endothelial permeability.123 By contrast, NO• (at low adenosineandarespondertoit.
levels)candecreaseexpressionofadhesionmolecules
and deter phagocyte adherence, in part by decreas-
8.9.3 Damagetothephagocyte
ingNF-κBactivation.123Superoxidemodulatesthisby
removingtheprotectiveNO•andformingONOO–,po- Reactivespeciescandamagethephagocytesgenerat-
tentiallymoredamaging,butnotnecessarilyalwaysso ingthem.Indeed,oxidationofmethionineresiduesto
(Section2.6.1.4). thesulphoxide,DNAstrandbreakage,glutathionyla-
RSmayinfluencecytokine/chemokineproduction, tionofproteinssuchasactin(Section8.7.2),andDNA
but literature data are confusing and contradictory. baseoxidationanddeamination(ifNO•isbeingmade)
For example, RS were reported to stimulate synthe- occur within activated phagocytes.131,132 The DNA
sis of the chemokine MIP-1α by macrophages, and damage probably reflects diffusion of H O (or NO•)
2 2
of the pro-inflammatory cytokine IL-8 by fibroblasts from the phagosome to the nucleus to form OH• or
and epithelial cells.124,125 By contrast, ROS seem to RNSclosetoDNA.HOClattacksneutrophilproteins
impairIL-8productionbyhumanneutrophils;neutro- aseasilyasitcanbacterialtargets(Section8.7.5.4).95
phils from CGD patients produced more.113 Taurine Damage to neutrophils usually matters little since
chloramine was reported to decrease IL-8 production theycanbereplacedrapidly,anditmayevenbebene-
by rat neutrophils by interfering with activation of ficialincontrollingtheiractivitiesaslongastheycan
NF-κB,126 whereas addition of μM levels of ONOO– be safely disposed of after their apoptosis (Section
increased production of IL-6 and TNF-α by human 8.7.3.2). As indicated earlier, GM-CSF and other fac-
monocytes by activating NF-κB.127 Several aldehyde torsat sitesofinflammation deter apoptosis, but this
end-productsoflipidperoxidation,includingHNE,are can be over-ridden by high levels of RS, which trig-
chemotacticagentsforneutrophils,128andchemotactic ger apoptosis. Phagocytes do have some antioxidant
aldehydesareproducedwhenHOClandHOBroxid- defences,however.TheycontainCuZnSOD,aMnSOD
izeaminoacidsorlipids.129Butaldehydesreactrapidly in the mitochondria, catalase, methionine sulphoxide
with proteins such as albumin to form adducts, per- reductase,peroxiredoxins,andGPx,togetherwithas-
hapsleavinglittlebehindtoinfluencephagocytes.The corbate and GSH at millimolar concentrations.133,134
effects of any aldehydes or ROS on phagocytes are Activated phagocytes show higher rates of GSH
likelytobebiphasic;toohighalevelwilldamagethe turnover. Indeed, neutrophils deficientin glutathione

--- Page 498 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 443
reductase activity135 (or severely deficient in glucose- system,leadingtoaccumulation,aggregation,andac-
6-phosphate dehydrogenase; Section 7.4.5) show im- tivationofneutrophilsandmonocytesinthelung.This
pairedbacterialkilling. causeddamagebyinterferingwithbloodflow,andby
Reactivespeciescanhavevariableeffectsonthere- producingRS.Evenmodernkidneydialysismethods
spiratoryburst,sometimespromotingit.Forexample, causesomephagocyteactivationandplasmaantioxid-
additionoflowlevelsofONOO– orH O caninhibit antdepletion.141 Somestudieshavetriedtominimize
2 2
protein phosphatases and increase net phosphoryl- this using membranes coated with α-tocopherol, but
ation, associated with increased neutrophil adhesion, reports of clinical benefit range from substantial to
andactivationofNADPHoxidase.136Bycontrast,pro- zero.141,142Reactivespeciesareinvolvedintherejection
ductionofRSathigherlevelsbyphagocytescanimpair oftransplantedorgans,aprocessinvolvingchronicin-
both their own function as well as the proliferative flammation(Section10.7).Thepotentialfordamageby
response of T-lymphocytes to mitogens or antigens. excessRS/proteinasesisdramaticallyillustratedbythe
T-Lymphocytesplaykeyrolesininflammation(Table abilityofactivatedphagocytestocorrodemedicalim-
8.1);theycanproduce O
•–/H
O themselves(Section plants, a process which can damage such devices as
2 2 2
8.10.5),butcanundergoapoptosisifRSlevelsaretoo heart valves and joint prostheses if inflammation de-
high.137 Thiscouldbegoodifitdampsdowninflam- velopsaroundthem.143,144This‘foreignbodyresponse’
mation (Section 8.9.4), or bad if it happens too much isessentiallyasterileacutetochronicinflammation.
andcausesimmunosuppression.Therearereportsthat In the link between persistent inflammation and
humanmonocytesaremoresensitivetoROSthanneu- disease development, much attention has focused on
trophilsordendriticcells,beingpoorerinantioxidant MPO.145 It can facilitate neutrophil recruitment and
defencesandDNArepairsystems.138,139Oxidizedlip- delay neutrophil apoptosis at sites of inflammation
idscaneitherincreaseordecrease(dependingonthe (Section 8.7.3.2). Being a cationic protein, MPO read-
lipidoxidationproductanditsconcentration)phago- ily binds to anionic sites, including endothelial cell
cyte functions; e.g. they can diminish the activity of glycosaminoglycans in blood vessel walls and base-
dendriticcellsinantigenpresentation.140Theseeffects ment membranes (Section 8.10.6). Here it can oxid-
can again be good or bad, depending on degree. In- ize, chlorinate, and (if NO– is present) nitrate pro-
2
deed, lipid oxidation products accelerate engulfment teins such as extracellular matrix glycoproteins, and
ofapoptoticneutrophils,ausefulprocessinresolving possibly initiate lipid peroxidation and deplete nitric
inflammation(Section8.7.3.2). oxide.146,147 Antibodies that develop against released
To summarize, the complex mixture of cell types MPO (or other released neutrophil granule proteins)
producingRS,proteinases,cationicproteins,cytokines, can also contribute to chronic inflammation, espe-
andotherfactorsatsitesofinflammationcouldtheor- cially in blood vessels and kidney (Section 8.10.6).
eticallyresultinalmostanypossibleoutcome.Never- ManypaperssuggestaroleforMPOinvascular(Sec-
theless, tissue ‘damage’ by RS seems limited during tion10.3.5.1),renal(Section8.10.6),andneurodegener-
the ‘normal’ acute inflammatory response. So what ative (Sections 10.20 and 10.21) diseases145 and MPO
goeswrongwhentheinflammationdoesnotgoaway? inhibitorsare sometimesprotectivein animal models
Persistent stimulus (e.g. continual PAMP or DAMP (e.g.ofCOPDinducedbysmoking[Section9.13]).In-
production), the wrong mixture of cytokines, or inef- deed, when MPO-knockout mice were injected with
fectiveefferocytosisperhaps.Butsometimestoomany thioglycollate followed by zymosan to induce peri-
RS,oreventoofewRS.Letusseehow. tonitis, they showed less formation of F -IsoPs and
2
nitrotyrosine than control mice.146 The ability of hep-
arin to displace MPO from its binding sites in tis-
8.9.4 RS:promotersorsuppressorsofchronic
sues has been suggested as an anti-inflammatory
inflammation?
mechanism;147 heparin also displaces EC-SOD, how-
Persistent inflammation contributes to the pathology ever, maybe not such a good thing (Section 3.23.3.2).
ofmanydiseases,fromatherosclerosistoobesityand Becautious,however,beforeconcludingthatMPOis
cancer (Chapter 10). Silica and asbestos provoke per- alwaysabaddie;MPO-knockoutmiceshowedgreater
sistent phagocyte activation (Section 9.15) leading to lunginjuryafterbonemarrowtransplantation,148more
serious lung damage. In 1968, it was discovered that braindamageafterischaemia–reperfusion,149 andless
within the first few minutes of blood dialysis, leuk- atherosclerosis in some studies, but not all (Sec-
opaenia (Table 8.1) occurs. Contact of plasma with tion 10.2). Indeed, HOCl can decrease dendritic cell
cellophane in the dialyser activated the complement function,sometimesdampingdownanover-exuberant

--- Page 499 ---

444 FREE RADICALS IN BIOLOGY AND MEDICINE
inflammatory response.150 In addition, several re- apparently related to elevated cytokine production,
portssuggestthattaurinechloramineis,overall,anti- during collagen-induced arthritis.156 However, EC-
inflammatory(Section5.5.6.1andref115). SOD may have anti-inflammatory effects unrelated
DowelearnanythingbystudyingCGDpatientsor to O
•–
scavenging, so be careful in interpreting such
2
mice lacking NADPH oxidase? Both are more prone effects.157
to infection. In addition, inflammation is dysregu-
lated and chronic, suggesting that ROS have some
role in deterring persistence of inflammation.113–115 8.9.5 Whatdoesitallmean?AreRSboth
Indeed, the granulomas in CGD patients are often pro-andanti-inflammatory?
found to be sterile, i.e. forming without the presence
As Hazlitt said, ‘When a thing ceases to be a subject
of bacteria.115 Phagocytosis-inducedneutrophil apop-
of controversy, it ceases to be a subject of interest.’
tosis is also slower in CGD. Indeed, joint inflamma-
Lifeiscomplex.Evolutiondoesnotretainthingsthat
tion induced by intra-articular injection of zymosan
overalldo harm(or at least did harmunder thecon-
in mice was more severe if phagocyte NADPH oxi-
ditionsinwhichhumansevolved,whicharedifferent
daseactivitywasknockedout.Thiswasaccompanied
fromthoseunderwhichwelivenow158).Thusinflam-
by greater osteoclast activity and increased synovial
mation,anditsassociatedRSproduction,isbeneficial
expression of TNF-α, IL-1, and matrix metallopro-
overallinprotectingusagainstpathogens.Butaretoo
teinases. In this case, the RS seemed to damp down
many RS bad or good? Bad, because they can con-
inflammation(e.g.bycausingT-lymphocyteapoptosis)
tributetocancerandotherdiseases(Chapter10).This
rather than aggravate it.114,115 Similarly, mice lacking
maynotmattertoevolution—bettertohavearobust
active NADPH oxidase showed greater gastric dam-
immune response that kills pathogens and stops you
agebyH.pylori(Section10.13.2)andmorelunginjury
dyingyoungfrominfectionsbeforeyouhavechildren;
bycigarettesmoke(Section9.13.2),whereasmiceover-
ifitgivesyoucancerlateinlife(afteryourreproductive
expressingCuZnSODshowedincreasedintestinalin-
years),whocares?Evolutiondoesn’t.
flammationinamodelofinflammatoryboweldisease
Theliteratureiscomplexandconfusing.Theauthors
(Section 10.12). Mice lacking both NADPH oxidase
usethreeguidelinesintryingtomakesenseofit.
andiNOSdiedafterexposuretoCandidaalbicans,but
apparently because of an excessive and abnormal in- 1. Becarefulingeneralizingfromstudiesoftheeffects
flammatoryresponseratherthananinabilitytokillthis of agents produced by isolated activated phago-
fungus.152 cytes, separated from complex biological environ-
SeveralpapershaveclaimedaroleforROSinpro- ments (Section 8.9.3), especially if they are being
moting inflammasome assembly. The ROS might ori- activatedbyPMA,whichgivesanabnormallylarge
ginate from mitochondria or from NADPH oxidase respiratoryburst.
enzymes.153 However, monocytes from CGD patients 2. Be even more careful in extrapolating data from a
showed a greater inflammasome response to urate singlemodel(oneanimalspecies,onebacteriumor
crystals,61andthecurrentfeelingisthatmitochondrial otherchallenge,onetypeofinflammationdamage
ROSaremoreimportant.153Ratsandmicewithalower measuredforoneperiodonly)todrawconclusions
capacitytoproduceROSduetopolymorphismsinthe aboutwhatisorisnotimportanttotheorganismas
gene(Ncf1)thatencodesp47phoxdevelopamore-severe awhole.
arthritis related to excessive T-cell function (Section 3. Rememberthatlaboratoryanimalsareinaverypro-
8.10.4),154 anditisevenpossiblethatwhilesomeROS tected (warm, well-fed etc.) environment; the con-
promoteinflammasomeassembly,toomanyROScan sequencesofknockoutsoroverexpressionofgenes
deterit.61,153 maybeverydifferentinthewild(Section3.7.2.1).
When mice lacking active phagocyte NADPH oxi-
dase were challenged with E. coli to induce sepsis,
theyshowedincreasedrecruitmentofneutrophilsinto
8.9.6 Defeatingthedefences:bacterial
the lung and decreased bacterial clearance as com-
andfungalavoidancestrategies159
pared with controls, associated with elevated levels
ofthechemoattractantMIP-2.155However,othermod- Theinflammatory/immuneresponseimposesastrong
elsoflunginjuryinthesemicegavedifferingresults, selective pressure on pathogens to develop mechan-
the loss of NADPH oxidase making things worse.113 ismstoavoidorresistit.Manysuchmechanismshave
Mice lacking EC-SOD suffered worse tissue damage, evolved. Several bacterial strains swim away from

--- Page 500 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 445
environmentscontainingH O ,HOCl,orchloramines, conceivably protect against H O -dependent intra-
2 2 2 2
which may help them to evade phagocytosis.160 An- cellular OH• formation.163 Anaplasma phagocytophilum
otherstrategytoresistphagocytickillingistoproduce suppressestherespiratoryburstbyblockingnotonly
toxins that impair phagocytosis. One example is the assembly of the oxidase but also the transcription of
disulphidegliotoxin,producedbyseveralpathogenic genes encoding gp91phox and rac2, and it even man-
fungi, including Aspergillus fumigatus. The oxidized ages to multiply in neutrophils.167 H. pylori seems to
(disulphideform)ofgliotoxin, alterassemblyoftheNADPHoxidasesothatmost O
•–
2
is released extracellularly instead of into the phago-
cyticvacuole;168 itisalsorichinantioxidantdefences
O
(Section10.13.2).
Sometimes infectious organisms place antioxidant
N S S N proteinsintheperiplasmicspace(includingE.coli;Sec-
tion 3.7.1) or even extracellularly. Thus several para-
OH
O sites (Section 3.23.3.3), fungi (e.g. Candida albicans),
CH
2
OH andM.tuberculosislocateantioxidantenzymesaround
themselves,169 and SOD is present in the outermost
is taken up by animal cells, reduced by GSH, and layersofthesporesofBacillusanthracis,thecausative
then rapidly re-oxidizes, causing cellular GSH de- agentofanthrax.170
pletion and damaging the neutrophil by disrupting
actininthecytoskeleton.161 Anotherexample,Legion-
ella monocytogenes secretes agents that open pores in 8.10 NADPHoxidasesinothercell
thephagosomemembraneandallowtheorganismto types18,171,172
escape to the cytoplasm, where it can still replicate.
Other strategies include rapid induction of bacterial Until fairly recently, it was commonly believed that
heat-shockproteins(e.g.inSalmonellaandM.tubercu- only phagocytes produce RS ‘deliberately’, and that
losis),highendogenouslevelsofantioxidantdefences RSreleasebyothercellswasadeleterious‘accidentof
(e.g. SOD in Mycobacterium leprae and M. tuberculosis, chemistry’,aresponsetoinjuryortoxinexposure,or
mycothiolinM.tuberculosisorcatalaseandmethionine evenanartefactofusingluminolorlucigenintomeas-
sulphoxidereductaseinN.gonorrhoeae;Section3.8.1), ure O •–(Section6.12.4).WenowknowthatNAD(P)H
2
and/or an ability to rapidly raise antioxidant levels oxidasesystemsproducing O •–/H O arewidespread;
2 2 2
as soon as RS are sensed (e.g. by OxyR or similar many organs and tissues contain several of them, in-
systems; Section 5.5.2). Repair systems, especially for cluding blood vessel walls (Section 8.10.4) and the
DNA,andflavohaemoglobinsthatcanscavengeRNS respiratory tract (Fig. 8.16). ROS production by these
(Sections 1.3.1) can also be important. Siderophores systemsisoftenregulateddifferentlyfromthatofthe
(Section3.22.4.1)cansometimesinhibitFentonchem- phagocyteoxidaseanddoesnotrespondtothesame
istryandprotectsomebacteriaandfungiagainstOH•
stimuli.DPIinhibitsmostorallNADPHoxidases,but
formation.162 noteitslackofspecificity(Fig.8.12).
Otherstrategiesusedbyvariousorganismsinclude ThetermNOXisusuallyusedtodescribethecata-
surrounding themselves with capsules that not only lytic subunits of NADPH oxidases (i.e. the part that
hinder recognition of the organism by the phagocyte produces O •– or H O ; e.g. gp91phox is called NOX2),
2 2 2
but can also absorb RS (P. aeruginosa and the fungus but increasingly as an abbreviation for NADPH oxi-
Cryptococcus neoformans163 are examples); production dases themselves. The O •–/H O generated by these
2 2 2
of haem oxygenase to destroy the haem that phago- systems play important physiological roles but they
cytes require to make the b-type cytochrome;164 the canalsodoharm,andseveralNADPHoxidaseinhibi-
replacement of NO•-sensitive ribonucleotide reduc- torsarebeingdeveloped(Section11.7.4)tocontrolthis.
tase by a resistant one (Section 8.2.2); the secretion Wehavealreadyseenatleastelevenexamplesofbio-
of enzymes that degrade NETs;165 and the produc- logically important NADPH oxidases in addition to
tionofphosphatasesthatreversethephosphorylation phagocytes; in skin (Section 7.13), ear (Section 7.12),
needed to activate the respiratory burst.166 Cryptococ- spermatozoa (Section 7.11), stem cells (Section 3.4.2),
cusneoformansalsoproducesmelaninasanantioxidant heartmuscle(Fig.5.4),thecarotidbody(Section1.3.2),
(Section 3.25.9) as well as high levels of intracellu- sea urchins (Section 8.5.2), lung (Section 7.3 and Fig.
lar mannitol; as an OH• scavenger the latter could 8.16),zebrafish(Fig.6.9),adiposetissue(Table5.5),and

--- Page 501 ---

446 FREE RADICALS IN BIOLOGY AND MEDICINE
Airway epithelium (DUOX1/2, NOX2)
Beneficial role: Defence against infection
in airways and alveoli
Potential deleterious role: Mucus metaplasia,
chronic epithelial wound response and inflammation
Dendritic cells (NOX2)
Antigen processing, Airway smooth muscle (NOX4)
inflammasome signalling Beneficial role: Helps control pulmonary vessel tone
Potential deleterious role: Smooth muscle
hyperplasia, airway hyper-responsiveness
(e.g. in asthma)
Lymphocytes (NOX2, DUOX1)
Beneficial role: T and B cell signalling
and proliferation
Potential deleterious role:
Participation in chronic
inflammation Neutrophils/Eosinophils (NOX2)
Beneficial role: Pathogen killing,
regulation of apoptosis
Potential deleterious role: Pro-inflammatory
signalling, extracellular oxidative injury
Pulmonary fibroblasts (NOX4)
Beneficial role: Regulation of
proliferation and differentiation
Potential deleterious role: Fibrosis
Figure8.16(colourplate21) NADPHoxidasesinthelung:benefitsandpotentialdeleteriousroles(e.g.inasthma).AdaptedfromBiochim.
Biophys.Acta1810,1035,2011,bycourtesyofDrA.vanderVlietandElsevier.AlsoseeAm.J.Physiol.302,H2166,2012;Antioxid.Redox
Signal.11,2453,2009.Excessactivationoftheseenzymescanalsocontributetolungdamageinhyperoxia(Antioxid.RedoxSignal.21,
1803,2014).
the GI tract (Section 7.2). They are also involved in earandseemstobeimportantindevelopmentofoto-
the sensation of pain (Section 10.24). Even the hum- liths,thecalcifiedparticlesinthevestibularlabyrinth
bleslimemouldcontainsanNADPHoxidase,tohelp ofvertebrates.Indeed,micelackingNOX3haveprob-
ittosocialize.173Indeed,NOXesappearedearlyineu- lems with balance (Section 7.12). In other cases NOX
karyoticevolution,e.g.insectscontainhaemocytesto appear and/or become active (e.g. due to assembly
help to defend against infection, and they produce withtheregulatoryproteinsintoafunctionalNADPH
O •– by mechanisms similar to those of mammalian oxidase) in response to cytokines (especially TNF-α
2
phagocytes.174Likezebrafishneutrophils(Fig.6.9;Sec- and IL-1, e.g. treatment of airway smooth muscle
tion 8.7.2), Drosophila haemocytes can be attracted by cells with TNF-α increased O •– production by acti-
2
H O tositesoftissueinjury.174 vating an NADPH oxidase176), growth factors (e.g.
2 2
TheNADPHoxidasefamilycontainsatleastseven PDGF, TGF-β, VEGF), hormones (e.g. angiotensin II;
catalyticsubunits,namelyNOX1–5andDUOX1and2 Section 8.10.4), AGE-proteins (Section 10.5.5), or cell
(gp91phox is now called NOX2, as mentioned earlier). injury by toxins (e.g. oxLDL; Section 10.3), or mech-
The activities of NOX1–3 are usually controlled by anical damage. For example, castration of rats led to
interaction with regulatory proteins such as NOXO1, increased levels of NOX1, NOX2, and NOX4 in the
p47phox, p67phox, p40phox, and rac. NOX4 seems consti- prostate.Thiswasaccompaniedbydecreasedlevelsof
tutivelyactivealthoughitneedsp22phox,anditslevels SOD and H O -metabolizing enzymes and increased
2 2
may be controlled by the extent of expression of the oxidative damage. All of these events contributed to
gene encoding it. Whereas NOX1, 2, and 3 generate apoptosisandprostateshrinkage177andwerepartially
O •–, NOX4 reportedly produces mostly H O ,175 al- amelioratedbytestosteroneadministration.Thuscas-
2 2 2
thoughthishasbeendisputedbysome.Someauthors tration increases ROS in the prostate; by contrast, it
writeNOXandDUOXincapitals,aswedohere,others decreases pulmonary O toxicity (Section 3.26). De-
2
in lower case. Sometimes NOX are present at a spe- priving neurons in culture of growth factors leads
cificdevelopmentalstage.ForexampleNOX3isfound to NADPH oxidase activation and subsequent ROS-
in some foetal tissues and may play a role in signal- dependent apoptosis,178 but NOX often play useful
lingduringdevelopment.Itisalsofoundintheinner rolesinthebraininvivo(Section10.17.5).Hypoxiacan

--- Page 502 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 447
increaselevelsofNOXintheretina,andtheROSpro- especiallycolon.Italsooccursinseveralothertissues
duced may contribute to excessive VEGF production (e.g. prostate, uterus, vascular smooth muscle, blood
and thus to ROP (Section 1.6).179 Hydrogen perox- vessels).NOX1associateswithotherproteins(NOXO1
ide itself can also increase the activity of some NOX and NOXA1, which replace p47phox and p67phox) to
in some cell types. Sometimes there are species dif- formafunctionalNADPHoxidasethatgenerates O
•–
2
ferences, e.g. NOX5 is found in humans but not in eveninnormalcoloncells.Itsphysiologicalfunctions
rodents.171 Earlydescriptionsofproductionof O •– by maybetogenerate O •– aspartofabacterialsensing–
2 2
nuclearmembranes(Section1.10.8)wereprobablydue responsesystem,181 aswellastoaidtheproliferation
tothepresenceofNOX4.180 of intestinal stem cells during repair of damage to
Some NOXes (e.g. NOX1, NOX3, NOX4) structur- the GI tract and during growth and development.183
ally resemble NOX2 (gp91phox), in that they contain Interest in NOX1 was raised in relation to carcino-
a core catalytic unit with an NADPH-binding site genesis when it was reported that overexpression of
plus FAD within a dehydrogenase domain that is NOX1inNIH-3T3fibroblasts,followedbytheirintro-
linked to a transmembrane domain containing two ductionintomice,causedtheformationofhighlyvas-
haemgroups.NOX5issimilar,buthasanextraamino cularizedtumours;coexpressionofcatalaseprevented
acid sequence (calmodulin-like domain), that makes the effect. However, these experiments proved diffi-
its activity Ca2+-dependent; unlike NOX1, 2, or 3, it culttoreproduce.Forexample,ifNOX4isexpressed
does not require p22phox or regulatory subunits for in NIH-3T3 cells, it does not promote proliferation,
activation.NOX5isprominentintestis,spermatozoa, rather senescence. In other words, different types of
spleen,andlymphnodesbutalsofoundinothersites, NOX expressed at different levels in different parts
e.g.bloodvessels. of the cell may have variable effects, as one expects
The DUOX1 and DUOX2 families are Ca2+- fromRS!Nevertheless,theileocolitisobservedinmice
dependent and contain N-terminal peroxidase lacking GPx1 and -2 (Section 3.14.4) was not seen in
domains that can use H O arising from the ac- the absence of NOX1 activity, i.e. it seemed to need
2 2
tion of the oxidase domains, hence the name DUOX ROS production.184 But is NOX1 increased in human
for dual oxidase. They provide H O for thyroid coloncancer?Insome,yes(e.g.intumourswithaK-
2 2
hormone synthesis (Section 8.10.2) but are found in ras [Section 10.14.4.1] activating mutation),185,186 and
many other places, including placenta, brain, and studies on cancer cell lines suggest that ROS from
testis. The chemotactic H O in wounded Drosophila NOX1 may promote cell migration.185,187 Some sym-
2 2
is generated by a DUOX enzyme.174 DUOX enzymes biotic lactobacilli may increase O •– production by
2
can produce H O in salivary ducts, and on tracheal, NOX1,188 andROSseemtobeintimatelyinvolvedin
2 2
gut mucosal, and bronchial epithelial cell surfaces, regulatinghuman–bacterialinteractionsintheGItract
probablyforantibacterialactions. (Section7.2).189
LetuslookatsomeNOXinmoredetail.
8.10.2 Thyroidhormonesynthesis188
8.10.1 Thegastrointestinalandrespiratory
tracts171 Formationofthyroidhormonesrequiresiodinationof
tyrosine residues in the protein thyroglobulin, and
ADUOX2isfoundintheGItract,whereitmayfunc- coupling of the iodinated tyrosines to form iodo-
tion in mucosal immunity and homeostasis, and in thyronines (Fig. 8.17). Both processes are catalysed
mosquitoes it can help to control malarial parasites by thyroid peroxidase (TPO), an enzyme located
(Section 7.6). The fairly low levels of ROS generated in the apical membrane of thyroid epithelial cells.
bytheseenzymesinthegutandrespiratorytractmay Itcatalysesatwo-electronoxidationofiodideion(I–),
help to trigger bacterial avoidance reactions (i.e. the probably to form iodonium ion (I+), which iodin-
bacteriadonotsettleonthemucosa)ratherthanbeing ates the tyrosines. This produces mono-iodotyrosine
directly anti-bacterial.181 Indeed, the respiratory sys- and di-iodotyrosine residues on the protein. TPO
tem has a wide range of NOX enzymes, performing then catalyses one-electron oxidation of these iodin-
severalfunctions,assummarizedinFig.8.16.Interfer- ated residues to tyrosyl radicals which combine to
encewiththemcanpredisposetoinfections,e.g.with form dimers (T3, T4; Fig. 8.17). The H O that TPO
2 2
influenzavirus.182 requires is generated by two DUOX enzymes co-
NOX1(previouslycalledMOX1,mitogenicoxidase localized with TPO, of which DUOX2 seems to be
1) is present in the epithelium of the intestine, the more important. Indeed, they used to be called

--- Page 503 ---

448 FREE RADICALS IN BIOLOGY AND MEDICINE
I I
H
–OOC C CH O OH Figure8.17 Structureofthethyroidhormones.Theyact
2
onmanycelltypesbybindingtoreceptorsandaffecting
NH 3 + genetranscription.Thyroxine(T4)isgeneratedby
I
degradationofthyroglobulinandcanbede-iodinatedin
a fourth
iodine is severaltissues,includingthyroiditself,to
Tri-iodothyronine present here 3,3’,5-tri-iodothyronine(T3).T3canalsobereleased
(T3) in thyroxine (T4) directlybythyroglobulinbreakdown.
THOX-1 and-2 (thyroid oxidase), although DUOX cuticle;H O resultingfromtheactionoftheNADPH
2 2
enzymes occur in many other tissues. Mutations in oxidasedomainisusedbytheperoxidasedomainand
DUOX2areonecauseofcongenitalhypothyroidism, byanadditionalperoxidase(MoLT7)tocatalysecross-
themostcommoncongenitalendocrinedisorder. linkingoftyrosineresidues.TheroleofCe-DUOX2is
A balance must be struck in vivo to allow thyroid asyetunknown.
peroxidase enough H O to work, yet prevent dam-
2 2
agetothethyroidglandbyexcessH O ,especiallyto
2 2 8.10.4 Bloodvesselwallsandtheregulationof
DNA.190 Peroxiredoxins and GPx enzymes help with
bloodpressure171
this;theco-localizationofTPOandDUOX2mayalso
minimizeH 2 O 2 diffusionintotherestofthecell.The All major cell types in blood vessel walls (endothe-
iodinatedthyroglobulinisthendegradedinlysosomes lial cells, smooth muscle cells, and fibroblasts) are
toreleaseT3andT4(Fig.8.17). able to release O •– and H O . First, endothelial cells.
2 2 2
Thyroxine(T4)andtri-iodothyronine(T3)arephen- Several sources contribute to their extracellular ROS
ols(Fig.8.17).Assuch,theyshowchain-breakinganti- release,includingmitochondriaand(undercertaincir-
oxidant activity in vitro, including increasing the ‘lag cumstances) uncoupled eNOS (Table 1.3). Xanthine
period’ of oxidation of isolated LDL (Section 10.3.5). oxidase,whichcanbindtoendothelialcellsurfaces,193
However, the levels needed to achieve such effects generates O •–andH O (Fig.1.10).Inaddition,NOX1,
2 2 2
are greater than physiological. Hence the biological 2, 4, and 5can bepresent,asare p47phox,p22phox,and
significance of their ‘antioxidant activity’ is uncer- p67phox.
tain,especiallyasbothcompoundsarealmostentirely The physiological significance of extracellular vas-
protein-boundinplasma. cularendothelial O •–productionisuncertain;O •–and
2 2
NO• may antagonize each other’s actions as part
8.10.2.1 Iodideasanantioxidant191
of a normal vasoregulatory mechanism, a view sup-
Iodide ion is essential for thyroid function; 70–80% ported by the fact that NOX1-knockout mice have
of the total body content of up to 20mg I– resides decreased blood pressure (less O •– leading to more
2
in the thyroid gland. Iodine has also been suggested NO•). Of course, if O •–/NO • interact, the resulting
2
to play an antioxidant role in kelps (brown algae of ONOO– wouldhavetobedisposedofsafely.Itisstill
theLaminarialesfamily),andinafewotheralgalspe- unclear if endothelial cells make O •– all the time in
2
cies. It accumulates to high levels (50 mM or more) vivooronlyafterischaemia–reperfusion,vascularage-
in the kelps and may help them to cope with pollu- ing, shear stress, other insults, or exposure to certain
tantssuchasO 3 ;theiodineproducedbyI–oxidationis hormones or to cytokines. Be careful; the stresses of
released to the atmosphere. Iodide is easily oxidized cell isolation and culture can sometimes artefactually
to I 2 ; indeed this is the basis of an assay for perox- increase NADPH oxidase activities. Since NOX4 has
ides (Table 6.10) and iodine was first isolated from been suggested to release H O rather than O •–, it
2 2 2
kelpashes,in1811.Thegoitre-preventingeffectsofsea- would then not antagonize NO• and could even (via
weeds were known to Hippocrates, and even to the H O Section 5.5.10) increase eNOS activity. Hence
2 2;
ChineseemperorShen-Nungasearlyas300BC. some authors have called NOX4 the ‘good vascular
oxidase’.194 However, too much NOX4 activity might
8.10.3 C.elegans17,18,192 sometimesbebadinthebrain(Section10.18.3).
Vascular smooth muscle cells and fibroblasts also
ThisnematodecontainstwogenesthatencodeDUOX contain NOX1, 2, 4, and 5, p22phox, p67phox, rac, and
proteins. One of them, Ce-DUOX1, stabilizes the p47phox.Forboththesecelltypes,aswellasendothelial

--- Page 504 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 449
cells,therearetissueandspeciesdifferencesbetween (Section7.14).198 Theseratsmayinadditionsufferex-
theNOXformspresent.Subcellularlocationsmayalso cessproductionof O
•–inthepartsofthebrain(e.g.the
2
bedifferent,e.g.NOX1and4maybeindifferentsites rostralventrolateralmedulla)involvedincontrolling
within vascular smooth muscle cells, presumably in- bloodpressure,anotherreasonforthehypertension,199
dicativeofdifferentfunctions.Fibroblastsandsmooth and the kidney is involved as well (Section 8.10.6).
musclecellscanrespondtoROSbyproliferation(Sec- Mitochondrial O
•–
productionmayalsocontributeto
2
tion5.2.1),causinghypertrophyofthevesselwall.The hypertension resulting from infusing angiotensin II
cytokineTGF-β(Section5.7.3)canacceleratefibroblast into animals.200 By contrast, antioxidants have given
proliferation,andthrombin(Section8.10.7)stimulates variable (often no) effects in loweringblood pressure
smoothmusclecellproliferation;ROSgeneratedfrom when administered to human hypertensive patients
NOX1areinvolvedinbothprocesses.171,195 (perhapsbecausetheydon’tdecreaseoxidativestress
Theconceptthat O
•–playsaroleinnormalvasoreg-
much; Chapter 4), and F -IsoP levels are elevated in
2 2
ulationisfurtherstrengthenedbytheobservationthat only some patients. Nevertheless, both F -IsoPs and
2
angiotensinIIdstimulates O •–productionbyallthree isoketals have been implicated in the pathology of
2
celltypes,inpartbybindingtoreceptorsandleading murineandhumanhypertension.201Dorememberthat
toincreasedphosphorylationofp47phox andassembly H O arisingfrom O •–(orfromNOX4)canhavevaso-
2 2 2
ofactiveNADPHoxidase.DecreasingNOXactivityin dilatoryeffects(Section5.5.10)!
animals by knockout, siRNA, or inhibitors decreases Hypertension can not only result from excess ROS
the hypertensive effect of angiotensin II. NOX1, 2, but can itself cause more O
•–
formation; inappropri-
2
and4allseemtobeimportantintheresponse,butdata atemechanicalstressonvesselsincreasesNOXlevels,
ontheirexactrolesareconfusing;171oneeventthatmay andROSareinvolvedinthevascularremodellingthat
alsobeimportantisinactivationoftheNa+,K+-ATPase results.195ExcessROS(especiallyONOO–)leadtofalls
byglutathionylation(Section5.3.1).196ExcessROSpro- in tetrahydrobiopterin and O •– production by eNOS
2
duction contributes to hypertension; indeed, admin- (Table1.3).Cardiacremodellinginresponsetoelevated
istration of extra angiotensin II to animals increases bloodpressurealsoinvolvesROS(Section10.6.4.6).
plasma levelsofF -IsoPs, indicativeofincreasedoxi-
2
dative stress. Studies in mice suggest that O
•–
from
2 8.10.5 Lymphocytes34,202
variousNADPHoxidaseenzymesisalsoinvolvedin
angiogenesisstimulatedbyVEGFatsitesoftissuein- B-lymphocytes contain all the NADPH oxidase com-
jury(seealsoSection1.5.2.1).Angiogenesis(probably ponentsfoundinneutrophils,butsome10-to30-fold
likeeverythingelse!)requiressomeROS,buttoomany less abundant. The system can be activated by PMA
willinhibitit.197 and is defective in CGD patients. Inhibition of it im-
Vascular O
•–productionbyNADPHoxidasesisin-
pairs B-cell activation and differentiation. DUOX1 is
2
creasedinspontaneouslyhypertensiverats(SHR),a additionally present, but its physiological role is un-
strainwhosebloodpressurebecomesabnormallyhigh clear. T-lymphocytes also produce ROS, some from
after four to five weeks of age.171,197 Transfer of the DUOX1, during antigen-induced expansion, prob-
geneencodingEC-SODtovesselwallsusingviralvec- ably for signalling purposes, and to facilitate their
tors(Section11.5.3),administrationofheparin-binding migration.137,203,204InbothT-andB-cells,theabilityof
SOD that attaches to vessel walls (Section 11.5.3), or H O toinactivatephosphatasesisimportantinthese
2 2
other O
•–scavengers,orofcocktailsofnutritionalanti-
processes; the H O released outside T-cells can re-
2 2 2
oxidants, decreases the animals’ blood pressure and enter through aquaporin channels (Section 2.6.2.2) to
thelevelsofnitrotyrosineinthevesselwalls,suggest- dothis.204 However,bothTandBcellscanbeinjured
ing that the excess O •– decreases NO• levels, gener- bytoomanyROS;indeed,oneofthemechanismsby
2
ates ONOO–, and raises blood pressure. Exercise is whichROScanregulateinflammationisbydampen-
alsobeneficialintheseanimals(andinhumans!),per- ingover-exuberantT-cellactivity(Section8.9.4).
haps in part by increasing antioxidant enzyme levels
8.10.6 Renalfunctionandoxygensensing205
d AngiotensinII,apeptidewhichaffectsmanybodytissues The kidneys consume about 10% of basal O uptake
2
andraisesbloodpressure,isproducedfromangiotensinIby
inhumans,playingkeyrolesintheremovalofwastes
the action of angiotensin converting enzyme, ACE. Inhibi-
torsofACE,suchascaptoprilandenalapril,arewidelyused (filtering the whole plasma volume over 50 times
clinically. each day), osmoregulation, and the control of blood

--- Page 505 ---

450 FREE RADICALS IN BIOLOGY AND MEDICINE
pressure. Like skin (Section 7.13), kidney receives far (Section8.10.3).Ifthereistoomuch O
•–,ONOO–
can
2
morebloodthanitneedsforitsownmetabolism(~20– form;indeed,infusionofangiotensinIIintoratsledto
25% of cardiac output) to drive glomerular filtration. nitrationandinactivationofrenalMnSOD.213 Theur-
Unfortunately,kidneyisareadytargetofdamageby othelial cells that line the bladder can also produce
excessive RS generation. For example, kidney injury H O , via NOX4 and/or DUOX1. Perhaps this con-
2 2
by gentamicin (Section 9.17.3) and myoglobin (Sec- tributestotheH O presentinurine(Section2.6.2).214
2 2
tion3.22.3)involvesROS.F -IsoPscanconstrictrenal Kidneycanalsobedamagedbycontrastmediaanda
2
bloodvessels;particularlyworrying,sinceplasmaF - roleforROShasbeensuggested(Section11.5.9.2).
2
IsoPlevelsandseveralotherbiomarkersofoxidative Oxygen sensing by the whole organism involves
damage(e.g.proteincarbonyls,ischaemia-modifiedal- the carotid body and the neuroepithelial cells (Sec-
bumin[Section6.16.6],HOCl-modifiedalbumin,HNE, tion 1.3.2). The action of the latter involves a NOX;
AGE products) are elevated in patients with chronic newbornmicelackinggp91phoxbreathefasterandmore
kidney disease on dialysis.206 Indeed, there is a sug- shallowlythancontrolmiceanddonotrespondprop-
gestion (in some but not all) studies207,208 of modest erlytohypoxia.215
benefitfromantioxidantsupplementsinsuchpatients.
Carbamylation of proteins resulting from excessive
8.10.7 Platelets216
urealevelsortheMPO-dependentoxidationofSCN–
canalsooccurindialysispatients(Section10.3.9)and Platelets are vital in stopping blood loss from in-
contributestotheirincreasedriskofatherosclerosis.209 jured vessels; they rapidly adhere to collagen ex-
Deposition of antigen–antibody complexes in the posed when the endothelium is disrupted, and form
glomerulicanleadtocomplementactivationandinfil- a ‘platelet plug’, assisted by von Willebrand factor
trationofneutrophils.Inaddition,themesangialcells, (Section5.13.4).Simultaneously,bloodcoagulationoc-
upto40%ofcellsintheglomeruli,210 canrespondto curstoformafibrin-richclot.Thetwopathwayscross-
complementactivationbysecretingeicosanoids,cyto- talk,e.g.thrombin,aserineproteinaseliberateddur-
kines, proteinases, and ROS. Accumulation of MPO, ing the blood coagulation cascade, promotes platelet
and resultant protein chlorination, are frequently ob- aggregation.Adhesionandaggregationofplateletsare
servedinrenalinflammation.Forexample,MPOand triggered by changes in surface adhesion molecules,
chlorinatedproteins(althoughthereissomequestion and by the release of pro-aggregatory mediators, in-
about the specificity of the antibodies used) appear cludingADP(releasedfromthe‘densegranules’ofthe
to colocalize in glomerular basement membranes in platelets),andthromboxaneA (Section8.12).Aggre-
2
humanmembranousglomerulonephritis.Thesemem- gationinvolvesthiol–disulphideexchangesinsurface
branes are easily damaged by HOCl. Antibodies that proteinsandmaybemodulatedbyplasmaGSH/GSSG
develop against circulating MPO and other neutro- ratios. Exposure of platelets to ROS potentiates ag-
philgranulecomponents,contributetorenalinjuryby gregation induced by thrombin or collagen. Indeed,
binding to the membranes and provoking phagocyte platelets themselves generate some O •– via NADPH
2
attack.211 oxidase activity, and the rate is increased by colla-
However, RS at more moderate levels help to reg- gen or thrombin. Hence, O •– and H O produced by
2 2 2
ulaterenalfunction.KidneycontainsNOX,especially platelets, or cells around them, may synergize with
NOX4,butalsosomeNOX2and-1.NOX4hassome- otherstimulitoregulateaggregation.66,216 TheseROS
timesbeencalledRENOX(renalNOX)becauseofits may also regulate thromboxane A production by
2
high expression in kidney, although it is now known platelets. Indeed, the platelets of mice lacking both
tobewidespreadinanimaltissues.TheROSproduced catalase and GPx1 were more responsive to collagen
bytheNOXenzymesmayhelptocontrolrenalblood and the animals showed increased thrombus forma-
flow(especiallyinthekidneymedulla),glucosetrans- tion after carotid artery injury.217 On the other hand,
port,andNa+uptakeintherenaltubules,amongother NO•producedbyplateletsduringaggregationcande-
events.212 Indeed,knockoutofgp91phox inmiceraised ter further aggregation, possibly in part by helping
renalbloodflowandloweredrenalvascularresistance. toscavenge O •–.Indeed,nitrationofplateletproteins
The balance of O • 2 – and NO• is extremely important (suggestiveofO 2 NOO–)hasbeendetectedduringplate-
andiftheactivityofNOXisincreased,e.g.byangio- letactivationbycollagen.218However,toomuchH O
2 2
tensinIIand/orhighsaltintake,renalvasoconstriction orONOO– candamageplatelets,andincreasedH O
2 2
canresult,contributingfurthertohypertension.Levels productionhasbeensuggestedtoaccountfortheele-
of renal NOX are abnormally high in the SHR rat vatedriskofthrombosisintheelderly(Section11.4.2).

--- Page 506 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 451
ROSseemalsotobeneededfortheproperdevelop- is required to elucidate their function in vivo (Sec-
mentofmegakaryocytes,theprecursorsofplatelets,in tion1.10.8).Somemaybeinvolvedinmetalionuptake
thebonemarrow.219 (Section3.22.1),othersinregeneratingNAD+ forgly-
colysis by reoxidizing NADH in cells with limited
mitochondrial function, and yet others in ascorbate
8.10.8 Boneformationanddegradation
metabolism(Section7.4).TheactivitiesofsomeNADH
Bone is created and remodelled as required by a oxidases increase with age.227 In certain cells, the
balanceofopposingreactions;digestionbyosteoclasts plasmamembraneNADH–ferricyanidereductasehas
(macrophagelineagecellsthatsecreteH+ ionstodis- been identified as VDAC1, a voltage-dependent an-
solvethemineralsinboneandproteinasestodegrade ionselectivechannel.228Thisproteinalsooccursinthe
thematrix),depositionofnewmatrixbyosteoblasts, outermitochondrialmembrane,whereitissometimes
and then matrix calcification. ROS are involved in calledporin1.
all three processes.220,221 Low concentrations of lipid
peroxidesorH O accelerateboneresorptionbyosteo-
2 2
8.11 Plantsusereactivespecies
clasts; by contrast osteoblasts and their precursors
cells are more readily damaged by ROS, also leading fordefenceandregulation
todecreasednetboneformation.Indeed,micelacking
PlantsgeneratehighlevelsofRSandoxidativedamage
CuZnSOD or peroxiredoxin 2 show decreased bone
products(e.g.phytoprostanes)andadequateantioxid-
mineral density, associated with impaired osteoblast
antdefencesarecrucialtothem(Sections7.7and7.8).
function.219–223 Iron overload has the same effect
Nevertheless, plants employ RS for useful purposes
(Section 3.22.5.2), whereas mice with mitochondrially
(including growth and development, differentiation,
targeted catalase in osteoclasts showed greater bone
and defence) just as often as animals do, if not more
density.223 High levels of plasma F -IsoPs in elderly
2
so. For example, overexpression of a GPx enzyme
men correlated with lower bone mineral density;224
(PHGPx)incitrusplantsinterferedwithplantgrowth
this,andsimilarstudiesinwomen,areindicativeofa
anddifferentiation.229Plantscanbeattackedbyatmos-
linkbetweenoxidativestressandosteoporosis.Indeed,
pheric pollutants (Section 7.9), herbivorous insects or
oestrogensmayhelptomaintainantioxidantlevelsin
animals,orsufferfromadverseenvironmentalcondi-
osteoblasts,astheydoinothertissues(Section3.26).225
tions(Section7.9).Theyprotectthemselvesbyarange
Both NOX2 and NOX4 are presentin osteoclastsand
the O
•–
produced is involved in bone resorption;
of mechanisms, including increasing antioxidant de-
2 fences (Section 7.9), transmission of airborne signals
indeed, knockout or inhibition of NOX4 increased
between plants (Section 7.8.4), stress responses, and
bone mass in mice.226 NOX enzymes may also be
productionofanti-predatormetabolites.Theseinclude
involvedinthedifferentiationofosteoblastprecursor
poisonous alkaloids, agents that inhibit digestion of
cellstomatureosteoblasts.220 Thus,asusual,whether
proteins by insects, ROS (whose production is often
ROS are beneficial or deleterious is a matter of the
neededfortheseotheradaptations),andphytoalexins.
levels present, their variation over time, and where
Phytoalexins are toxic agents synthesized rapidly at
theyaremade.
the site of attack by fungi or bacteria. We have al-
Excessive alcohol intake seems to be a risk factor
ready seen that some plants make photosensitizers,
forosteoporosis.Infemaleratschronicallydosedwith
suchashypericin,todeterattack(Section7.8.3).Some
ethanol, this seemed to involve increased levels of
photosensitizers are phytoalexins, made after attack,
NOX1,-2,and-4inthebone,promotingtheactionof
whereasothersarealwayspresent.230Phytoalexinsoc-
osteoclasts(Section9.8.1.5).
cur in the human diet, e.g. resveratrol in grapes and
wines (Section 4.5) and the indole glucosinolates in
8.10.9 Otherredoxsystems Brassicas(Table4.5).231
There are many descriptions in the literature of
NAD(P)H oxidoreductases in the plasma membranes 8.11.1 PlantNOXes18,232
of multiple cell types, including erythrocytes (Sec-
tion 7.4), adipocytes, and renal brush border mem- Homologues of animal NOXes have been identified
branes. These oxidases have often been identified in a widerangeofplants (ricewas thefirst), andare
by using artificial electron acceptors such as ferri- calledrespiratoryburstoxidasehomologues(RBOH
cyanide (Fe(CN)3–), or indophenol, and more work proteins).TheycontainhaemandFAD,andresemble
6

--- Page 507 ---

452 FREE RADICALS IN BIOLOGY AND MEDICINE
NOX5(Section8.10)inhavingextraN-terminalCa2+- response (Section 7.9.3). An early effect produced by
binding sites. Activation of RBOH proteins involves bothistherapidgenerationofROSatthecellsurface
Ca2+ ions, rac-type proteins, and phosphorylation re- by the plant oxidative burst (Fig. 8.18). Even chop-
actions.TheROSproducedcanthenfurtherraiseCa2+ ping lettuce237 generates H O ! The H O from the
2 2 2 2
levels.Inrice,nineRBOHproteinshavebeenreported plant oxidative burst helps to kill pathogens and the
sofar,whereasinArabidopsisthaliana(At)thereareat plantcellsharbouringthem,butitalsopromotesother
leasttenRBOHproteinswithdifferentfunctions.For events. These include the synthesis of phytoalexins,
example, AtRBOHC is involvedin the production of the strengthening of cell walls to ‘wall in’ or ‘wall
root hairs; the ROS it produces cause increased cyto- out’thepathogen(e.g.bycross-linkingofproteinsand
solic Ca2+ levels, needed for the tip of the hairs to more lignin synthesis),238 the programmed death of
continuegrowth. The roothairs of plants lacking At- cellsaheadoftheinvadertostopitspreading,andthe
RBOHCdonotelongate;additionofROS(attheright upregulationofdefences(includingGSTandGPxen-
level!)restoresgrowth,butinrandomdirections,since zymes)inothercellsthatrendertheplantresistantto
theROSarenolongerfocusedtotheroottip.Similarly, attack by a broad range of pathogens, sometimes for
AtRBOHDandAtRBOHFaidtheclosureofleafsto- weeksormonths(systemicacquiredresistance,SAR).
matainresponsetotheplanthormoneabscisicacid,by BothROS(sometimesincluding1O )239andmultiple
2
promotingfluxesofCa2+acrosstheplasmamembrane. hormones(especiallysalicylate,butalsoethyleneand
Other RBOHs facilitate growth of cells in the shoot, jasmonicacid;Fig.8.19)areinvolvedininitiatingand
root,orpollentube,allofwhichrequirechangesinthe controllingSARandcelldeath.240 Theactionsofsali-
rigidityofplantcellwallsthatinvolveROS.Evenplant cylate and jasmonate in protecting against pathogens
pollenscontainNOXenzymes,productionofROSby are complex, sometimes complementary, and some-
whichcancontributetotheirallergiceffectsinsensitive times antagonistic. For example, salicylate and ethyl-
subjects(Section7.3.1).NOXenzymesareinvolvedin enesensitizeplantcellstoapoptosisinducedbyROS.
lignin synthesis (Section 8.5.3.1), adaptation of plants This localized cell death limits the spread of the in-
to hypoxia (Section 7.9.4), establishment of symbiotic vading pathogen, but, to avoid too much damage to
legume-Rhizobium interactions in root nodule forma- the plant, jasmonic acid produced by dying cells ex-
tion (Section 7.8.11), and in regulating ion (e.g. Na+) ertsopposingeffectsandslowsthedeathofotherplant
transport.233IndeedA.thalianalackingAtRBOHFwere cells, in part by raising the levels of ascorbate and
hypersensitive to high salinity. H O generated by GSH.241 TheA.thalianavtcmutants(Section7.8.7)are
2 2
NOX(Section7.9.4)isinvolvedinacclimationtocold moresensitivetoO butlesssensitivetocertainpatho-
3
in several plants, including tomato.234 Hence NOXes gens, apparently because of increases in H O levels
2 2
areinvolvedinadaptiveresponsestoawiderangeof that promote salicylate synthesis.242 Another player
stressesinplants.232,235 is the phytoprostanes (Section 7.7), which can trig-
A rise in Ca2+ may also increase catalase activity ger increases in phytoalexin production as well as in
inplantsbycalmodulin-dependentreactions,presum- antioxidant and other ‘anti-stress’ defences in plant
ably to limit H O levels (by contrast animal or bac- cells.243,244Theymayalsoincreasesynthesisofphenyl-
2 2
terialcatalasesareunaffectedbyCa2+/calmodulin).236 alanineammonialyase,thefirstenzymeinligninbio-
Inactivation of plant peroxiredoxins by H O (Sec- synthesis (Section 8.5.3.1).244 Lipoxygenase-catalysed
2 2
tion 3.13.2.2) may additionally regulate H O signal- reactions(Section8.11.3)mayalsoparticipate.Roottips
2 2
linginplants. can carry out a NETs-like process, releasing DNA to
entrapinvadingorganisms.245
Production of ROS in the plant oxidative burst
8.11.2 Thehypersensitiveresponse231,235
can involve diamine oxidases (Section 7.7) and per-
Sometimes infection of an animal leads to abscess oxidases, but the major source is NADPH oxidases.
formation: microorganisms and phagocytes battle it For example, knockout of AtRBOHD in Arabidopsis
out in a walled-off area, stopping the pathogen from prevents extracellular ROS production in response to
spreading. An analogy in plants is the hypersensi- pathogens,asdoesdownregulationofNtRBOHDe in
tive response. It is triggered by signal molecules ori- tobacco. Just as some fungi that infect animals accu-
ginating from the invading organism (analogous to mulate mannitol, apparently to protect against ROS
PAMPs) or synthesized by the plant itself (analog-
oustoDAMPs)thatbindtoplantpatternrecognition
receptors. Ozone can also induce the hypersensitive e TobaccoisNicotianatabacum,henceNt.

--- Page 508 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 453
Figure8.18(colourplate22) ProductionofROSduringattackofthepowderymildewfungusBlumeriagraminisf.sp.hordei(Bgh)onbarley
(Hordeumvulgare).(A)H2O2accumulationinlatephaseI(12haftersporelanding).Startingfromitsconidium(C)thefungushasbuiltaprimary
germtubeandanappressorium(A).Barleyhasbuiltacellwallapposition(CWA)beneaththeprimarygermtubewhereH2O2accumulationis
visible(reddish-brownDABstaining);bar8μm.(B)H2O2accumulationphaseIIduringformationofCWAsbeneaththreefungalpenetration
attempts(arrows).(C)H2O2accumulationphaseIIIduringthehypersensitiveresponse(HR)ofMla12barley.Thefunguspenetratedsuccessfully
B (a g r h row fo ) rm an e d d t a ri p g e g n e e re tr d at w io h n ol p e e -c g e ( l P l P H2 ) O an 2 d a a cc h u a m u u s l t a o t r i i o u n m (3 in 0 it h ia a l f (H te I r ). sp O o • r – e a la c n cu d m in u g l ) a . t ( i D on )O is • 2 – ind ac ic c a u t m ed ul b a y tio d n ar p k h -b a l s u e e I N .O BT rig s i t n a a in ti i n n g g f ( r S o e m cti t o h n e 2 a . p 5 p .3 re ) s a s r o o r u iu n m d ,
thepenetrationsite.(E)O
•–accumulationphaseII.HR(UV-autofluo 2
rescenceimageintheleftcorner)ofanattacked(arrow)cellisaccompaniedby
O
•–accumulationinthen 2
eighbouringcell.O
•–isvisibleatthenucleusandalongtheanticlinalcellwall(arrowheads).(F)NBT–DABdouble
s m t 2 a e i s n o i p n h g y s ll h H ow R i i n n g M H l 2 a O 12 2a b c a c r u le m y. u D la a ti r o k n -b p lu h e as N e B I T I 2 I s a t n a d in O in • 2 g – in ac d c ic u a m te u s la O ti • o – n in ph t a is s s e ue II s a a s r s o o u c n ia d te d d ea w d it c h e a ll n st H h R at (a a s r t e e f r r is e k e ) o . f (G st , a H in ) . O C • 2 e – ll p s h im as m e e I d I i d a u te ri l n y g b m ef u o l r t e icell
2
collapse(asterisks)alsodonotshowNBTstaining.Blue-lightexcitationrevealsyellowautofluorescenceofdeadcells.FromPlanta216,891,
2003,bycourtesyofDrRalphHückelhovenandthepublishers.
fromphagocytes(Section8.9.6),somefungithatattack Agermin-type(Section7.7)enzyme248dismutates O •–
2
plants also make it, perhaps to help them deal with fromtheNOXintoH O .
2 2
plant-derived ROS.246 Nitric oxide and ONOO– have
also been suggested to be involved in the hypersen-
8.11.3 Plantlipoxygenases
sitive response, but exactly how they participate and
howNO•ismadearenotclear.247 Many plants contain lipoxygenases (LOXs),249 en-
Another example of the use of ROS in defence is zymesthatcatalysereactionofPUFAswithO 2 togive
floral nectar, secreted as a reward for pollinating in- 13-and/or9-hydroperoxides(Fig.8.20).ThefirstLOX
sects. It is rich in nutrients and in principle a good tobepurifiedwasfromsoybean.Itisnowknownas
substrate for bacterial growth. One deterrent against soybeanlipoxygenase1,sinceotherLOXswerelater
thisistheaccumulationofH O ,generatedbyglucose foundinthisplant.IthasapHoptimumof9andits
2 2
oxidaseandaNOX-typeenzymeresemblingRBOHD. preferredsubstrateislinoleicacid,uponwhichitacts

--- Page 509 ---

454 FREE RADICALS IN BIOLOGY AND MEDICINE
O CHCH (CH)COO–
28 Various aldehydes
HL HL
Traumatin
H 3 C CH 2 CH CH CH 2 CH CH CH 2 CH CH (CH 2 ) 7 COO– LOX H 3 C CH CH CH H C O H O CH CH CH CH CH (CH) COO–
2 2 2 27
Linolenic acid
13-Hydroperoxide
AOS
O
HC CH CH C C CH CH COO–
3 CH CH H CH (CH)
2 2 2 27
Allene oxide
AOS
O
CH 2 CH CH CH 2 CH
3
(CH)COO–
27
12-Oxophytodienoic acid
reduction,
β-oxidation
O
CH 2 CH CH CH 2 CH
3
CHCOO–
2
Jasmonic acid
Figure8.19 Someplantoxylipinsderivedfromlinolenicacid.Severalstepsintheconversionsareomittedforsimplicity.LOX,lipoxygenase;AOC,
alleneoxidecyclase;AOS,alleneoxidesynthase;HL,hydroperoxidelyase.Traumatincanarisebysimilarpathwaysfromlinoleicacid.Oxylipinscan
alsoformbythephytoprostanepathway.Intraumaticacidthealdehydeoftraumatinisoxidizedtoacarboxylgroup.Themethylesterof
jasmonicacidisoftenusedinperfumes.
RCH CHCH CH CHR´ Although some fungal manganese-containing LOX
2
are known, plant LOXs usually contain one (non-
haem)ironionpermolecule.ItmustbeintheFe(III)
OOH OOH statetoallowtheenzymestofunction.Lipoxygenases
abstractahydrogenatomfromaPUFAinastereospe-
RC
13
CHH CHCH CHR´ RCH CHCH CHC
9
HR´ cific manner, the Fe(III) becoming Fe2+ and a carbon-
13, L-hydroperoxide 9, D-hydroperoxide centred PUFA radical forming. Bond rearrangement
and O insertion follow to give a peroxyl radical.
2
Figure8.20 Plantlipoxygenasescatalysestereospecificperoxidation Iron(II)reducesthistoaperoxylanion(LOO–)which
offattyacidswithacis,cis-1,4-pentadienestructure.Forexample,
protonatestoaperoxide,andtheactiveFe(III)enzyme
linoleicacidmaybeconvertedinto13-L-or9-D-hydroperoxy
isregenerated.250
derivativesorboth,dependingontheenzyme.
The action of LOXs on PUFAs can produce a ‘co-
oxidation’ of other molecules such as thiols, carot-
toproducemostlythe13-L-hydroperoxide(Fig.8.20). enoids, and chlorophylls. This happens when the
OtherLOXshavedifferentpHoptima,substratespe- intermediate peroxyl radicals that are normally re-
cificity, and produce different ratios of products. For duced to hydroperoxides during the catalytic cycle
example,soybeanLOX2hasapHoptimumof6.8and instead attack the other molecules present. Indeed,
prefers arachidonic acid as a substrate, but will also LOXs are employed commercially to oxidize, and
convertlinoleicacidintoapproximatelyequalamounts thus bleach, wheat-flour carotenoids during bread
ofthe13-and9-hydroperoxides. making.251 Self-reaction of RO • 2 radicals could form

--- Page 510 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 455
singlet O (Section 2.6.4), which might also contrib- Membrane lipids
2
utetoco-oxidations.Nitricoxideproducedbyplants247
Hydrolases
mighthelptoregulateLOX,byscavengingintermedi-
ate RO • radicalsanddecreasingproductformation.252 Free fatty acids
2
Lipoxygenase (s)
Hydroperoxy acids
8.11.4 Theinjuryresponseandoxylipin
Cleavage enzyme (s)
signalling253,254
Carbonyl compounds
Many fruits, tubers, seeds, and leaves respond to Hydrocarbon gases
damage, notonlyby NADPH oxidaseactivation,but
also with additional cascades of reactions (Fig. 8.21). Figure8.21 Breakdownofmembranelipidsinducedbywounding
planttissues.Thevolatileproductsfromthe9-hydroperoxidesof
Hydrolytic enzymes can attack membrane lipids, re-
18:2and18:3fattyacidsarecis-3-nonenalandcis-3-,
leasingPUFAsandotherfattyacids.Linoleicandlino-
cis-6-nonadienalrespectively.Thesearethetwomaincomponents
lenic acids are the main PUFAs in plants, e.g. they
oftheodourofslicedcucumbers.The13-hydroperoxidesgive
representabout75%ofthetotalfatty-acidside-chains hexanalandcis-3-hexenal.Severaloftheunsaturatedaldehydes
in potato tuber lipids. The released PUFAs are acted arehighlyreactive;theycanexertantibacterialandantifungalactivity
uponbyLOXs,andtheresultinghydroperoxidescan andrepelinsects.
be cleaved, both non-enzymically in the presence of
metal ions and by the action of hydroperoxide ly- whichneedtobecontrolledbytheuseofantioxidants
ases, specialized cytochromes P450. Several products and/or LOX inhibitors. Lipoxygenases are inhibited
result,includingvolatilealdehydes(someofwhichare by several antioxidants, such as propyl gallate, cer-
highlybactericidal,orcandeterinsects),alcohols,and tain flavonoids, and nordihydroguiaretic acid. These
hydrocarbongases,suchasethaneandpentane.Cer- compounds may act by scavenging peroxyl radicals
tain volatile products can injure predators; and some formedduringthecatalyticcycleand/orbyreducing
ofthemcantriggerdefencesystemsinadjacentplants, Fe(III)-lipoxygenasestotheinactiveFe2+state.250
rendering them more resistant to the predator.254,255 ThereactionsequenceshowninFig.8.21intersects
A fascinating example is the ability of aldehydes with the hypersensitivity response (Fig. 8.18). Thus
to attract the wasp Cotesia glomerata, which attacks salicylicacidcaninhibitLOXanddecreaseformation
the caterpillars of the cabbage white butterfly and of jasmonic acid during the early stages of the re-
stopsthemeatingtheleaves.254Jasmonicacid(Section sponse,andsomeofthealdehydesgeneratedstimulate
8.11.2),traumatin,traumaticacid,andoxophytodien- phytoalexinsynthesis.
oicacidarealsoproducedfromhydroperoxides(Fig.
8.19). Traumatin and traumatic acid are growth pro-
8.11.5 Germinationandsenescence256
moters, whereas jasmonic acid and its methyl ester
are involved in plant hypersensitive responses (Sec- Numerous papers have shown that adding H O in
2 2
tion8.11.2). Alloftheseproducts(Fig.8.19)areoften moderateamountspromotesgerminationoftheseeds
describedasoxylipins,biologicallyactiveproductsof of several plants, and that ROS (especially H O ) are
2 2
PUFAoxidation. producedduringgerminationandcauseoxidationof
Some of the aldehydes produced have characteris- selected proteins. Sources of H O can include per-
2 2
tic smells that contribute to the aroma of damaged oxidases and oxalate oxidases, but NADPH oxidases
plant tissues, such as newly mown grass and sliced may well be the most important. For example, At-
cucumbers(legend,Fig.8.21).Forexample,theodour RBOHB is present in Arabidopsis seeds and mutation
of crushed green leaves is due to several products, of the gene encoding it impairs germination.232 Hor-
including2-hexenal(leafaldehyde),whichcanbere- mones affecting germination seem to act, at least in
ducedto3-hexenol(leafalcohol).Thesequenceshown part, by regulating ROS production. Mechanisms by
in Fig. 8.21 can be fast, e.g. over 30% of the lip- which ROS could contribute to germination include
ids in potato tuber slices are hydrolysed in less than looseningoftheseedcoat257andactivationofthepen-
15 min, even at 3 ◦C. Indeed, such oxidations of dis- tosephosphatepathway.ThelatterprovidesNADPH
ruptedplantmaterialgiverisetoproblemsofrancid- toreducethioredoxin,whichisimportantintheregu-
ity and ‘off flavours’, caused by peroxide and alde- lationofgerminationandintheantioxidantdefenceof
hyde formation during food processing and storage, seeds.Ofcourse,toomanyROScanbebad!Excessive

--- Page 511 ---

456 FREE RADICALS IN BIOLOGY AND MEDICINE
oxidativedamage,e.g.duringprolongedstorage,can and the protectins (e.g. neuroprotectin D1). These
lead to seed deterioration and failure to germinate. interact in a complex way to regulate physiological
Antioxidantsinseeds(includingmethioninesulphox- processes (e.g. maintaining the functions of vascular
idereductases)helptopreventthis(Section7.9.4).258,259 endothelium, gastric mucosa and kidney) as well as
Fruitgrowth,ripening,andsenescencealsoinvolve inflammation.
ROS. Fruit growth (like all plant growth) requires
cellexpansion,permittedbyalooseningofcellwalls
in which peroxidases, H O , and possibly even OH•, 8.12.2 Eicosanoids:prostaglandins
2 2
appear to be involved.257 Fruit ripening is usually andleukotrienes263,265
promotedbyethyleneandinvolvesincreasesinperox-
Prostaglandins, leukotrienes, and other related sub-
idaseactivityandaccumulationofoxidationproducts.
stances such as the thromboxanes and lipoxins, are
Forexample,aspearsripen,theconcentrationof–SH
oftencollectivelycalledeicosanoids,becausetheyare
groupsinthefruitdecreases,andthereisanaccumu-
usuallysynthesizedfromPUFAswith20carbonatoms
lationofH O andlipidperoxides.260
2 2
(eikosi is Greek for 20). The eicosanoids act as local
Senescenceisthefinalfateofeveryplantorganand
hormones, effective at low concentrations. They are
allows redistribution of nutrients (especially amino
synthesizedandreleasedfromcellsinresponsetostim-
acids) to growing parts of the plant. For green plant
uli,interactwithreceptorsonadjacenttargetcells,and
tissues, it is characterized by degradation of chloro-
arequicklydestroyed.Indeed,F -IsoPsareoftenpre-
phyll(whichmustbedonecarefully,sothatproducts 2
sent at higher levels and turn over more slowly than
abletophotosensitize1O formationdonotresult!),261
2
prostaglandinsinhumanbodyfluids.
proteins, lipids, nucleic acids, and cell walls. Chloro-
plastsarethefirstorganellestobreakdown,withrapid
degradation of Rubisco. Senescence can be speeded
8.12.3 Prostaglandinsandthromboxanes
up by treatments that stimulate formation of H O
2 2
withinthetissue(e.g. withabscisicacidor ethylene), Prostaglandinsandthromboxanes(sometimescollect-
andOH• maybeinvolvedincellwalldegradation.262 ively called prostanoids) arise from PUFAs by inser-
Thefluidityofplasmaandorganellarmembranesde- tion of O to form a ring structure (Fig. 8.22). The
2
creases in senescing plant tissues, and lipoxygenases term ‘prostaglandin’ was coined in the 1930s to de-
are often activated to facilitate membrane oxidation scribe compounds present in semen that could af-
anddegradation. fect blood pressure in animals and cause contraction
of smooth muscle. In fact, ‘prostaglandin’ is a mis-
nomer,becausetheyarisefromtheseminalvesicle,not
8.12 Animallipoxygenasesand
the prostate gland. The seminal vesicle is the richest
cyclooxygenases:stereospecificlipid
knownsourceofprostaglandin-synthesizingenzymes,
peroxidation263–265 and seminal fluid is the only biological material
in which prostaglandins accumulate to a substantial
Lipoxygenases play key roles in animals as well. For
level.However,everybodytissue(excepterythrocytes)
example, activation of one such enzyme initiates the
canmakethem.Thefirstprostaglandinstobeisolated
degradation of mitochondria that occurs as reticulo-
cytesmatureintoerythrocytes.266 were the stable species PGE 2 and PGF 2α (Fig. 8.22),
but later work identified unstable prostanoids such
as PGG , PGH , thromboxane A (TXA ), and PGI
2 2 2 2 2
(prostacyclin).
8.12.1 OxidationofPUFAsbyenzymes
Prostaglandins have a core structure of 20 carbon
The oxidation of PUFAs by enzymes generates a atoms containing a saturated five-membered (cyclo-
wide range of lipid oxidation products, some of pentane) ring. Different prostaglandins are distin-
which are pro-inflammatory (e.g. certain prostaglan- guished by the chemical nature and geometry of the
dins and leukotrienes) and others anti-inflammatory groupsattachedtothering;thesevariationsinchem-
(e.g. resolvins). Oxidation of arachidonic acid gener- ical structure affect biological activity. Prostaglandins
atesprostaglandins,leukotrienes,andlipoxins;oxida- aresynthesizedinvivofromfattyacidsthatcontaincis
tion of eicosapentaenoic acid generates several prod- doublebondsatpositions8,11,and14,especiallyara-
ucts including the resolvin E series; and oxidation of chidonicacid(eicosatetraenoicacid,cis doublebonds
docosahexaenoicacidcanproducetheresolvinDseries atpositions5,8,11,and14).

--- Page 512 ---

(a) 9 8
7 5 3 COO–
1
6 4 2
10
14 16 18 20
11 12
13 15 17 19
Prostanoic acid
9 1
COOH
20
12 15
Arachidonic acid
O , Cyclooxygenase (1)
2
O COOH
O
OOH
PGG (9, 11-endo-Peroxy-15-hydroperoxyprostaglandin)
2
O COOH
7 MDA+ COOH
O
2
OH 6 OH
OH
PGH 2 5 HHT
HOOC 4
OH
COOH
O
3 COOH
O O
COOH
OH OH
PGD 2 OH O TXA 2
OH
O H O
COOH PGF 2α 2
OH
9
HO
COOH
HO OH 11 15
OH PGI 2 HO O
PGE 2 H 2 O lla OH
O COOH TXB
2
HO
HO
OH
6-Keto-PGF 1α
Figure8.22 (a)Structureofthromboxanesandprostaglandinsderivedfromarachidonicacid(AA).Enzymesinvolved:1,prostaglandin
endoperoxidesynthases(cyclooxygenases)convertAAtoPGG2andthenreducetheperoxidetoanalcohol,givingPGH2.ThePGG2canalsobe
reducedtoPGH2byGPxplusGSH;2,3,Non-enzymicand/orcatalysedbyGSTs;4,prostaglandinendoperoxidereductase;5,prostacyclin
synthetase;6,7,prostaglandinendoperoxide:thromboxaneAisomerase(thromboxanesynthetase).(b)StructuresofthelevuglandinsLGD2and
LGE2formednon-enzymicallyfromPGH2,andofthecyclopentanoneprostaglandinsPGJ2and15d-PGJ2.

--- Page 513 ---

458 FREE RADICALS IN BIOLOGY AND MEDICINE
(b)
O
OHC
H C
3 COOH COOH
H C
OHC 3
OH O OH
LGE LGD
2 2
COOH COOH
O O
OH
15-deoxy- 12,14-PGJ
2 PGJ 2 Figure8.22 (Continued)
8.12.4 Prostaglandinsynthesis limitedtheclinicaluseofCOX-2inhibitors,however.
Some cytochromes P450 e.g. in vascular endothelium
The first step in eicosanoid formation is to provide
and platelets, can also oxidize arachidonic acid (Sec-
a fatty acid precursor. Release of arachidonic acid
tion1.1),generatingepoxyeicosatrienoicacids(EETs),
from phospholipids can occur by activation of a
HETEs (Section 8.12.9), and dihydroxyeicosatrienoic
phospholipase A , or from hydrolysis of DAG (Sec-
2 acids (DHETs). EETs may have anti-inflammatory
tions5.5.4).Hence,agentsincreasingintracellularfree
propertiesandcaninhibitplateletaggregation.
Ca2+ concentrations can increase eicosanoid produc-
tion, and lipase activities must thus be carefully con-
trolled in the cell. Once arachidonic acid is available,
thehaem-containingenzymecyclooxygenase1(some-
8.12.5 Regulationby‘peroxidetone’267
timescalledprostaglandinG/Hsynthase1)addsO to
2
formtheperoxidePGG 2 ,whichitthenreducestothe If PUFAs are treated with GSH and GPx to remove
alcoholPGH 2 .Cyclooxygenase1(COX-1)isconstitu- lipidperoxides,theyarenotimmediatelyoxidizedby
tivelypresentinalmostallmammaliantissues.Itcan COX-1;thereisalagperiodbeforeratesofoxidation
be inactivated by aspirin, which acts by acetylating reachmaximum.Thelagisshortenedorabolishedby
a serine residue at the active site. Aspirin also exerts adding PGG . Other peroxides are also effective, in-
2
other anti-inflammatory and anti-thrombotic effects cluding those formed by the action of LOX (Section
(Figs8.9and8.25,legend). 8.12.9)orbynon-enzymiclipidperoxidation.Commer-
A second type of cyclooxygenase, prostaglandin cially available arachidonic acid is usually contamin-
synthase 2 (cyclooxygenase 2, COX-2) can be found atedwithperoxidesatvariablelevels(Section5.11.6),
in many cells, but usually only after its synthesis is and different batches can therefore produce different
promoted by exposure to such agents as PAF, IL-1, initial rates of reaction when used in COX-1 assays
TNF-α, or endotoxin. However, some cells in brain, (Table6.10).Additionofcumenehydroperoxideorof
kidney,andafewothertissuesproduceCOX-2consti- ONOO–canalsoactivateCOX,ascanH O (although
2 2
tutively,andthisenzymeisimportantinpostnatalde- athigherconcentrations).Forexample,thespawning
velopment,especiallyforthekidney.LevelsofCOX-2 of abalones (marine snails) was induced by adding
increase at sites of inflammation and may be respon- 5 mM H O to their sea water, apparently by stimu-
2 2
sibleformuchoftheprostaglandinproductionthere; lationofprostaglandinsynthesis.268Peroxynitriteonly
whereasCOX-1seemstosynthesizetheprostaglandins worksoveralimitedconcentrationrangeastoomuch
needed for normal tissue function. Hence, selective will inactivate COX; it can also nitrate and inactivate
COX-2inhibitorshavebeenproposedtobeefficacious prostacyclinsynthase,whichcouldbedeleterious.269
in controlling inflammation without the side-effects Hence, there is a bell-shaped relationship be-
(e.g. renal damage and gastric ulceration) commonly tween lipid peroxidation, ONOO– production,
seen with drugs such as aspirin and indomethacin, and prostaglandin metabolism. Efficient removal
which inhibit both enzymes. Other side-effects have of peroxides and/or ONOO– by antioxidants, or

--- Page 514 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 459
ROOH* ROH
PGG
Haem–Fe(III) Haem(cid:129)+–Fe(IV)=O Haem–Fe(IV)=O 2
Tyr-OH Tyr-OH Tyr-O(cid:129)
2e–
COMPOUND I COMPOUND II
oxidation
Arachidonate–H
O Haem–Fe(IV)=O
Haem–Fe(IV)=O 2 Tyr-OH
Tyr-OH +
Arachidonate(cid:129) Arachidonate–OO(cid:129)
Oxidation of other
substrates
Suicide inactivation
of the enzyme
Figure8.23 Cyclooxygenasereactionmechanism.Noteitsresemblancetoperoxidasechemistry.The‘seedingperoxide’isreducedtoanalcohol
asitoxidizesthehaem-Fe(III)enzymetogiveaferrylspeciesplushaemcationradical(compoundI).Thecationradicalconvertsanadjacent
tyrosinetoTyr-O•(compoundII),whichabstractsH•fromarachidonicacid,followedbyO2bindingtotheresultingcarbon-centredradical
(arachidonate•).ThetyrosinedonatesH•,PGG2isreleasedandthecyclerepeats.Cyclooxygenasescanalsocatalyseperoxidase-typereactions,in
whichcompoundIacceptsoneelectronfromasubstratetogiveferrylhaemenzyme,whichcanthenacceptafurtherelectronfromanother
substratemoleculetorestoreferrichaem.AdaptedfromJ.Biol.Chem.271,33157,1996bycourtesyofDrWilliamSmithandthepublishers.
*ROOHdenotesPGG2orotherlipidperoxides.ROHdenotesPGH2orotherlipidalcohols.
prevention of their formation, will slow down pro- (Section5.11.6),i.e.thereiscross-talkbetweenenzymic
staglandin synthesis, at least until sufficient PGG is andnon-enzymiclipidperoxidation.
2
formedtoactivateCOX-1.Bycontrast,toomanylipid WhatdotheperoxidesdotoCOX?Theyconvertfer-
peroxides or too much ONOO– can inactivate COX. ric COX into an intermediate containing ferryl haem
Many years ago, it was suggested that the peroxide and Tyr-O• radical (Fig. 8.23); the latter then stereo-
toneofthecell(i.e.itscontentoflipidperoxides,de- specifically abstracts H• from arachidonic acid. The
terminedbythebalancebetweenperoxidegeneration PGG eventuallyproducedcan‘seed’theCOXfurther,
2
by enzymic and non-enzymic mechanisms, and the being converted to PGH . COX enzymes can oxid-
2
rateofperoxideremoval)cancontrolCOXactivityand ize certain other substrates that can access the active
hence prostaglandin synthesis. However, the supply site (Fig. 8.23). For example, during PGG oxidation
2
of arachidonic acid is probably the main regulatory in vitro, COXs can co-oxidize adrenalin, dopamine,
mechanism in normal cells, although peroxide tone methional (into ethene), and diphenylisobenzofuran
couldbeimportantoncePUFAshavebeenreleasedat (anotherexampleofthelackofspecificityofthiscom-
sitesofinflammation.PeroxidetoneaffectsCOX-1and pound as a ‘singlet O ’ scavenger; Section 6.8), activ-
2
COX-2differently;COX-2needslower‘seedingperox- ate several aromatic amines to mutagenic products,
ide’levels(estimatedas~2nMratherthan~20nMfor convert the carcinogen benzopyrene into a quinone
COX-1)andsomightbeabletofunctionundercondi- (Section10.15.1),oxidize13-cis-retinoicacid,thalidom-
tionswhereCOX-1activityisimpaired.267,270Itshould ide, or amphetamines (Section 9.9), cause the emis-
also be noted that peroxides formed enzymically by sion of light from luminol, and oxidize bisulphite
COXandLOXenzymescanbedecomposedtovarious ion(HSO–)intosulphite(SO •–)radical.270 Ifactivated,
3 3
radicals,e.g.byhaemproteinsorfreemetalions,that COX is not provided with a substrate to oxidize,
can then stimulate non-enzymic lipid peroxidation the ferryl and tyrosyl radicals can inactivate COX

--- Page 515 ---

460 FREE RADICALS IN BIOLOGY AND MEDICINE
itself. Thus, appropriate concentrations of phenols, 8.12.8 Prostacyclinsandthromboxanes
adrenalin,orothercosubstratesenhanceprostaglandin
The compounds PGG and PGH are usually rap-
synthesisinsomeexperimentalsystems,bypreventing 2 2
idly transformed into other products such as PGE ,
thisself-inactivation.Certainanti-inflammatorydrugs, 2
examples being sulindac and 5-aminosalicylate (Sec-
PGD
2
, PGF 2α, TXA
2
, and prostacyclin (Fig. 8.22a), to
anextentdependingonthetissue.Forexample,plate-
tion10.11.5),mightexertsomeoftheiractionsinvivo
letsformpredominantlyTXA and12-hydroxy-5,8,10-
byactingassubstratesforCOX. 2
heptadecatrienoic acid (HHT), whereas endothelial
cells generate predominantly prostacyclin, which di-
8.12.6 Prostaglandinsfromisoprostanes? lates blood vessels and inhibits platelet aggregation.
Cross-talkofthesystems271 ItsactionscomplementthoseofNO•butopposethose
ofTXA ,andtherelativeamountsoftheseandother
Some IsoPs are unstable and can undergo re- 2
molecules (which differ from species to species and
arrangement to produce prostaglandins, except that
bloodvesseltobloodvessel)helptocontrolplatelet–
(unlike COX products) these prostaglandins are non-
vesselwall interactionsand local blood flow. Aspirin
stereospecific. Thus 15-E -IsoP forms PGE , and 15-
2t 2 prolongs bleeding time after vessel injury by inhibit-
D -IsoP gives PGD . Indeed, racemic PGE and -D
2C 2 2 2 ingCOXanddecreasingTXA production,butitwill
havebeendetectedinanimaltissuesaswellasinurine 2
alsoinhibitPGI synthesis.Sinceinhibitionbyaspirin
fromhumansandotheranimals.Urinarylevelswere 2
is irreversible, the platelet (unable to synthesize pro-
upto10%ofthetotalprostaglandinsdetectedandeven
teins) cannot recover from COX inhibition, whereas
higherinanimalssubjectedtooxidativestress.Produc-
theendothelialcellrapidlyreplacesinactivatedCOX.
tionofprostaglandinsinthiswayshouldbeunaffected
Overall then, aspirin is anti-thrombotic. Aspirin also
byCOXinhibitors.
promoteslipoxinformation(Fig.8.25,legend).Prosta-
cyclin is unstable (half-life of minutes), decomposing
8.12.7 Levuglandins272
togive6-keto-PGF 1α (Fig.8.22).Prostacyclinhasmany
If PGH is not quickly metabolized, it can undergo other important effects, e.g. it helps to regulate fluid
2
ring cleavage to form ketoaldehydes (Fig. 8.22b), transportinthekidneyandgut,andgastricacidsecre-
levuglandinsE and-D (LGE ,LGD ).Thesehighly tion.Italsocontributestopainandswellingatsitesof
2 2 2 2
reactive molecules rapidly form adducts with amino inflammation.
groups on nucleic acids, lipids, or proteins, and can Just as reactive cyclopentenone isoprostanes
inactivateenzymes. can form (Section 5.12.3), so can cyclopentenone
9 5 COOH
20
11 15
hils Arachidonic acid
N e
utr o p
OH
P la
te
le ts
M
o
R n
o
R’ R cy te
R’ s
5-HETE
(—OOH group in 5-HPETE)
OH
12-HETE
( –OOH in 12-HPETE) R
R’
OH
15-HETE
(—OOH in 15-HPETE)
Figure8.24 Someproductsofarachidonicacidmetabolismbymammalianlipoxygenases.UntilrecentlyLOXenzymeswereclassifiedas15-,12-,
or5-LOXs,butsequencestudiesanddifferencesbetweenspecieshavecomplicatedthepicture.

--- Page 516 ---

REACTIVE SPECIES CAN BE USEFUL: SOME MORE EXAMPLES 461
Arachidonic acid
5-HPETE
epoxide group
O COOH
5
6
20
14
Leukotriene A
4
(LTA ) Glutathione transferase
4
GSH (glutamyl-cysteinyl-glycine)
Hydroxylase glu-cys-gly
OH
H OH S
COOH COOH
5 5
6
12
14
H OH Leukotriene C
4
Leukotriene B 4 (LTC 4 )
(LTB )
4
glu
Leukotriene D
4
(LTD )
4
gly
Leukotriene E
4
(LTE )
4
Figure8.25 Theleukotrienes.LeukotrieneA4(LTA4)isareactiveepoxide(fullname:5,6-epoxy-7,9,11,14-eicosatetraenoicacid)thatcaneven
formadductswithDNA(Arch.Biochem.Biophys.379,119,126,2000).ItcanbeconvertedenzymaticallyintoleukotrieneB4(LTB4;
(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-6,8,10,14-eicosatetraenoicacid)ornon-enzymicallytoother5,12-and5,6-dihydroxyacids.OnlyLTB4is
shown,forsimplicity.Alternatively,LTA4canbeconvertedbyGST-catalysedconjugationwithGSHintoLTC4,whichisexportedfromcells.
γ-GlutamyltranspeptidasethenactstoformLTD4andLTE4intheextracellularenvironmentbysuccessiveremovalofaminoacids.Inborndeficiencies
inγGTthusimpairLTD4andLTE4synthesis.AnothergroupofproductsisformedbyinitialoxygenationofarachidonicacidatC-15;forexample,
incubatingneutrophilswith15-HPETEgeneratesthelipoxins.Oxidationof5-HETEcanform5-oxo-ETE(5-oxo-6,8,11,14-eicosatetraenoic
acid),apowerfulchemoattractantforeosinophils,monocytes,andneutrophils(FreeRadic.Biol.Med.50,1297,2011).LipoxinsA4andB4deter
neutrophilentryintositesofinflammationand,ingeneral,exertanti-inflammatoryeffects.Inhibitionofprostaglandinsynthesisbyaspirinincells
containingCOX2canincreasethesynthesisofaclassoflipoxinsknownasaspirin-triggeredlipoxins.Amongotheractions,theycanpromote
productionofNO•andtheexpressionofHO-1inendothelialcells.
prostaglandins. Thus PGE can dehydrate to PGA , containing –SH groups. Cyclopentenone prosta-
2 2
which binds to –SH groups. For example, it rap- glandins (unless swiftly removed using GSH) can
idly conjugates with GSH, both nonenzymically damage proteins, including thioredoxin reductase
and catalysed by GST enzymes. Similarly, PGD and the proteasome.274 Damage to the latter will
2
can form PGJ and several other products (espe- impair cellular protein turnover. Hence levuglandins
2
cially 15d-PGJ ; 15-deoxy-(cid:6)12,14-prostaglandin J ; (Section 8.12.7) and cyclopentenone prostaglandins
2 2
Fig. 8.22b),273 which can again target biomolecules couldmediatetissueinjuryiftoomanyprostaglandins

--- Page 517 ---

462 FREE RADICALS IN BIOLOGY AND MEDICINE
are formed during inflammation. However, they can and pathological processes, including atherosclerosis
alsoinhibitNF-κBactivationandpromoteneutrophil (Section10.3.5.3).
apoptosis,275 as well as activating Nrf2, and overall Platelet LOX acts upon arachidonic acid to form
maybeanti-inflammatory. 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid (12-
Althoughadetaileddiscussionofthetissue-specific HPETE), a reactive unstable peroxide that can be
complexities of prostaglandin biosynthesis is not ne- reduced to the 12-hydroxy derivative (12-HETE). Re-
cessary for the aims of this book, it is worth saying duction involves GPx plus GSH; 12-HETE formation
a little about platelets and endothelial cells to under- isthusdecreasedintheplateletsofselenium-deficient
stand the relationship of the pathways to redox biol- animals. Lipoxygenases present in other tissues
ogy.ThromboxaneA isformeduponplateletactiva- introduce oxygen at different places in the carbon
2
tionandpromotestheiraggregation;itisalsoapotent chain (Fig. 8.24), e.g. formation of 12-HETE in skin,
vasoconstrictor.ThromboxaneA isunstable(half-life 5-HETE and 15-HETE in rabbit and human neu-
2
about20sunderphysiologicalconditions)andquickly trophils, plus various 5,12-DHETEs (stereoisomers
formsthestable,biologicallyinactivethromboxaneB of5,12-dihydroxy-6,8,10,14-eicosatetraenoicacids).Li-
2
(TXB ; Fig. 8.22). Thromboxane A is also produced poxygenases, like COXs, are affected by the ONOO–
2 2
by activated neutrophils. The enzyme thromboxane level and ‘peroxide tone’ of the cell; peroxides can
synthase (Fig. 8.22) cleaves PGH to HHT, produ- oxidizeanyinactiveFe2+ enzymethatformstoactive
2
cing malondialdehyde (MDA). Prostaglandin endop- Fe(III) enzyme. Several phenolic antioxidants (e.g.
eroxides decompose to MDA under the acid-heating someflavonoids)areLOXinhibitors.277
conditions of the TBA test. Hence, application of The HPETEs are precursors of the leukotrienes,
the TBA assay to tissues synthesizing prostaglandins whichdifferfromprostanoidsinthattheyhavenocyc-
might overestimate nonenzymic lipid peroxidation lopentanering.Insteadtheyhaveaconjugatedtriene
(Section6.15.8). structure (three double bonds separated from each
Nitric oxide also interacts with the eicosanoid other by single bonds). Figure 8.25 shows the leuko-
pathway.276 For example, NO• counteracts COX self- trienesthatarisefrom5-HPETE,butothersarisefrom
inactivation, and can also activate it by forming different HPETEs. Leukotriene A is an unstable re-
4
ONOO– (up to a point). Both LOX (Section 8.12.9) activeepoxidewhich,insometissues,isconvertedto
and COX enzymes can, in the presence of peroxides, leukotrieneB (LTB ),apowerfulchemotacticagentfor
4 4
oxidizeNO•,andplateletCOXmightbeasignificant neutrophilswhichalsopromotestherespiratoryburst.
‘sink’forNO•invivo.276 NeutrophilsthemselvesmakeLTB ,helpingtoattract
4
moreofthemtoasiteofinflammation.LeukotrienesC
4
and D increase vascular permeability. Macrophages
4
8.12.9 Leukotrienesandotherlipoxygenase produceLTB 4 andotherleukotrienes,asdomanyother
products celltypes,includingmastcells.Thesemediatorscon-
tribute to inflammation, e.g. the inflammation and
InSection8.11.3,wedescribedplantLOXenzymesas bronchial constriction seen in allergic asthma (along
initiators of ‘controlled lipid peroxidation’, a process with other mediators such as PGD , PAF, and hista-
2
known for almost a century. It took until 1974 to mine).LeukotrieneC (LTC )isformedbyconjugation
4 4
discoveraLOXenzymeinplatelets,andlaterinother ofleukotrieneA4(LTA )withGSH.Removalofaglu-
4
mammalian cells. Animal LOXs contain non-haem tamateresidueyieldsLTD ,whichisfurtherconverted
4
iron, they act by a mechanism similar to the plant to the less biologically active leukotriene E . Hence
4
enzymes, and are involved in many physiological GSHplaysakeyroleinremovingLTB .
4

--- Page 518 ---

CHAPTER 9
Reactive species can be poisonous:
their role in toxicology
Listofexamplesdonotadduptounderstanding.
CarlNathan
9.1 Introduction xenobioticsbyconvertingthemintomoleculesthatare
moresolubleinwaterandthuseasiertoexcrete.Me-
Nathan’s comment is particularly appropriate to this
tabolismofteninvolvestwotypesofprocess.PhaseI
chapter; hundreds of papers have demonstrated the
reactions add (or sometimes unmask) a polar func-
formation of free radicals and other reactive species
tional group onto the toxin. This is often done by
(RS) in cells, organs, or whole animals exposed to a
cytochromes P450 (CYPs), but sometimes other en-
range of toxic agents. Yet for only a few such agents
zymesareinvolved,suchasesterases(e.g.foraspirin,
hasakeyroleforRSincausingtheirtoxicitybeenes-
Fig. 9.1), monoamine oxidases, and alcohol dehydro-
tablished. We examine some of them in this chapter,
genases.CytochromeP450levelsvarywidelybetween
butfirstletuslookatgeneralprinciples.
tissues,theliverhavingthehighest.Substantiallevels
arealsofoundinadrenalgland,kidney,smallintestine,
9.1.1 Whatistoxicology? andvariouscellsintherespiratorytract,includingthe
Claracells(non-ciliatedbronchiolarepithelialcells).1
Toxicology is concerned with the mechanisms of PhaseIIreactionsinvolveconjugation;anendogen-
injury to living organisms by exogenous chemicals ous molecule is added to the phase I reaction prod-
(xenobiotics). Although endogenous molecules often uct, or sometimes directly to the xenobiotic. Ex-
causeinjuryifpresentinexcess(e.g.glucose,O • 2 – and amples of phase II reactions already discussed in
NO•),weusethetermtoxinsinthepresentchapterto
this book are conjugations with GSH catalysed by
mean exogenous injurious molecules. Modern medi- glutathionetransferases(Section3.15.2)andwithglu-
cine and agriculture use a range of toxins to control curonic acid, catalysed by glucuronyl transferases
unwantedorganisms(bacteria,fungi,insects,rodents, (Section 2.6.4.4). Other examples of phase II reac-
weeds, etc.). We are exposed to some toxins delib- tions are sulphation (addition of a sulphate group,
erately (e.g. therapeutic or recreational drugs) and catalysed by sulphotransferases), methylation (ad-
others because they are present in the environment. dition of a methyl group, usually originating from
The side-effects of some drugs may involve RS (Sec- S-adenosyl-methionine), acetylation (catalysed by N-
tion 10.10.1). Some toxins can cross the placenta and acetyltransferases), and glycine conjugation. For ex-
damagethefoetus(Section7.11.7).Plantsandbacteria ample, benzoic acid in the diet can be excreted in
synthesize many toxins that can injure humans, such humansasaconjugatewithglycine.Thefateofaspirin
as aflatoxins (Section 10.15.1) and photosensitizing (acetylsalicylicacid)inhumansillustrateshowadrug
agents(Section7.8.3). canbemetabolizedbyseveralpathways(Fig.9.1).
Geneticvariationsoftenaffectactivitiesofdrugme-
9.1.2 Principlesoftoxinmetabolism tabolizing enzymes, especially CYPs (Table 1.1) and
GSTs (Section 3.15.2). For example, the activity of
Most xenobiotics are metabolized by enzymes with CYP2D6 affects the metabolism of the antihypertens-
broad substrate specificity; in general, they detoxify ive drug debrisoquine. Most people are ‘extensive
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 519 ---

464 FREE RADICALS IN BIOLOGY AND MEDICINE
CO H
2
OCOCH
3
Aspirin
hydrolysis
CO H
2
OH
COOC 6 H 9 O 6 CO 2 H
OH
OH OH
Salicylic acid
OH
Salicylacylglucuronide 2,3-DHB
CO H CO H
2 2
OC 6 H 9 O 6 CO 2 OH
HO
Salicylphenolglucuronide 2,5-DHB
CONHCH 2 CO 2 H OH
OH OH
Salicyluric acid Catechol
Figure9.1 Metabolismofaspirin.Aspirininhibitscyclooxygenasesbyacetylatingthem(Section8.12).However,aspirinisrapidlydeacetylatedby
esteraseactioninvivo.MetabolismofsalicylatebyCYPsproduces2,5-dihydroxybenzoate.2,3-Dihydroxybenzoatedoesnotappeartobe
metabolicallyproducedandhasbeenusedasa‘biomarker’ofOH•production(Section6.3.1).DiagrambycourtesyofDrH.Kaur.
metabolizers’ but a few are ‘poor metabolizers’ be- photosensitizers (Section 2.6.4). By what gen-
causeoflowenzymeactivity.Exposuretosometoxins eral mechanisms could RS be involved? There are
affects the metabolism of others, for example barbit- several:
urates and ethanol can raise levels of certain CYPs
(Sections 1.4.1 and 9.8.1), whereas xenobiotics in the a. ThetoxinitselfisaRS,e.g.oxygen(adiradical),ni-
diet can inhibit them (Table 4.5). Hyperoxia can in- trogen dioxide (NO • ), or the peroxide artemisinin
2
crease CYP synthesis in animals.2 There is growing (Section7.6.1).
evidence for redox regulation of the activity of sev- b. ThetoxinismetabolizedtoaRS,e.g.carbontetra-
eral enzymes metabolizing toxins, as well as of the chloride(Section9.2).
expressionofthegenesencodingthem. c. Thetoxinundergoesredoxcycling,i.e.itisreduced
by a cellular system and the reduction product
is then reoxidized by O , producing O
•–
and re-
9.1.3 Howcanreactivespeciescontribute 2 2
generating the original compound. The cycle then
totoxicity?
repeats.Anexamplealreadydiscussedisparaquat
Reactive species have been suggested to be in- (Section7.9.2).
volved in the actions of many toxins. Examples d. The toxin interferes with antioxidant defences.
already discussed include haemolytic drugs (Sec- Many toxins are metabolized by conjugation with
tion 7.5), teratogenic agents (Section 7.11.7), and GSH; a large dose may deplete GSH and lead to

--- Page 520 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 465
secondary oxidative damage because the lowered mayalsoinhibitcommunicationbetweenadjacentcells
GSH levels lead to a failure to adequately remove (Section5.2.4).
endogenous RS. The liver supplies GSH to other Letusnowexaminetheactionsofsomexenobiotics,
body tissues (Section 3.10); hence a toxin dam- toseehowfartheclaimsthat‘free-radicalmechanisms’
aging the liver can lead to decreases in GSH areinvolvedcanbejustified.
levelselsewhere.
e. ThetoxinstimulatesendogenousgenerationofRS,
e.g. by affecting mitochondrial electron transport, 9.2 Carbontetrachloride5–8
inducingiNOSorCYP2E1(a‘leaky’formofP450;
This was the first xenobiotic shown to cause injury
Section 9.8.1.1), or by activating phagocytes. For
largelyorentirelybyRSproduction.Itisacolourless
example,inhibitorsofmitochondrialelectrontrans-
liquid, immisciblewithwater,used in industryas an
port(e.g.nitropropionicacid,MPP+,cyanide)injure
organicsolvent,e.g.asadegreaser.Itwasformerlyem-
cellsbyinterferingwithATPproduction.However,
ployed as a dry-cleaning agent, but this use is now
the ‘back-up’ of electrons they cause by slowing
electrontransportleadstoincreasedO
•–formation, banned in many countries because of hepatotoxicity.
2 Whenfirstintroducedintomedicalpractice(in1847),
whichaggravatesinjury.3Severalothertoxinstarget
CCl wasenthusiasticallypromotedasananaesthetic
mitochondria, sometimes inducing the mitochon- 4
(soonphasedoutinfavourofchloroformafterseveral
drial permeability transition (Fig. 1.9), and conse-
quentexcessiveO
•–production,whichmayleadto deathsduetoliverfailure)andasa(ratherdangerous!)
2 treatmentforliverfluke.
cytochromecreleaseandapoptosis(Section5.4.2).
Clofibrate(Section10.15.2.1)isoneexample.Expos-
ure of rats to methyl chloride (CH Cl), a widely
3 9.2.1 Carbontetrachloridesynthesis:
used industrial gas, causes an acute inflammation
afree-radicalchainreaction
of the epididymis and sperm defects, possibly be-
causeRSproducedduringtheinflammationdam- CCl canbegeneratedbyreactionofCl gaswithmeth-
4 2
agespermDNA.4 ane;oneofthefirstreactionsencounteredbyastudent
f. Some toxins and/or their metabolites can bind oforganicchemistry.ReactionofCH andCl requires
4 2
to biomolecules to create new antigens, provok- UVlight,whichprovidessufficientenergytocauseho-
ing an immune response, which will increase RS molytic fission of the covalent bond in Cl . A radical
2
production. chainreactionresults.
g. CellnecrosisinducedbytoxinscanreleasePAMPs Initiation:
that trigger inflammation and consequent RS pro-
duction(Section5.4). Cl → Cl • +Cl •
2
h. A combination of any or all of the above mechan-
isms,e.g.forcigarettesmoke(Section9.13). Propagationreactions:
‘Free-radicalreactions’havebeenimplicatedinthe Cl • +CH →CH • +HCl
4 3
actions of many toxins, but published reports often CH • +Cl →CH Cl+Cl •
take insufficient care to distinguish between cases in 3 2 3
whichRSformationcausesthetoxicity,andothersin Cl • +CH Cl→HCl+ •CH Cl
which RS formation is a later stage in the process of 3 2
cellinjuryorisperipheraltoit.Oxidativedamagepro- •CH 2 Cl+Cl 2 →CH 2 Cl 2 +Cl • ,etc
ceedsfasteronceatissueisinjured,evenifthedamage
wasnotstartedbyRS(Fig.10.1).Akeypoint:Thefact Terminationreactions:
thatatoxincanbedemonstratedtoformRSinvivo
CH
•
+Cl
•→CH
Cl
does not mean that RS cause the injury. Even when 3 3
increasedRSformationisanimportanttoxicmechan- CH • +CH •→C H (ethane)
3 3 2 6
ism,oneshouldask,whatarethekeymoleculartargets
ofoxidativedamage?Answeringthisquestionisoften Hence,CH issuccessivelyconvertedintochlorometh-
4
difficultbecausemechanismsofcellinjuryarecomplex ane (CH Cl, methyl chloride), dichloromethane (CH
3 2
andinter-related(Fig.9.2),anditishardtodisentan- Cl ),trichloromethane(CHCl ,chloroform),andCCl .
2 3 4
gle primary from secondary events. Oxidative stress Similarreactionsoccurwithbromine,butmoreslowly.

--- Page 521 ---

466 FREE RADICALS IN BIOLOGY AND MEDICINE
Direct
‘solvent’
CCl
4
injury to
membranes Metabolism, largely by
(at high doses endoplasmic reticulum
of CCl ).
4
CCl
3 O
2
Direct covalent
O CCl binding to
2 3
macromolecules
?
Direct covalent binding
to macromolecules (e.g.
inactivation of Initiation of lipid
cytochrome P-450). peroxidation by H
Favoured at low pO 2 abstraction
Damage to Ca2+–
Cytotoxic GSH
sequestration
aldehydes depletion
mechanisms
Direct covalent binding
to macromolecules
Rises in
intracellular Increased damage to proteins Rises in
‘catalytic‘ iron by calpains, phospholipase intracellular Ca2+
ions A2 activation, arachidonic
acid release
ONOO– NO synthesis
More lipid peroxidation by NOS increased
Figure9.2 MechanismsofhepatotoxicityofCCl4.Inorganicsolvents,O •
2
–canattackCCl4toproduceCCl3O •
2
andotherproducts
(Section2.5.3.6);whetherthiscontributestoCCl4hepatotoxicityisuncertain(seeJ.Biol.Chem.263,12224,1988).Nitricoxidemaycontributeto
• •
damagebyCCl4(Mol.Pharmacol.46,391,1994).TheCCl
3
andCCl3O
2
radicalsarecapableofformingadductstoDNAbases(e.g.cytosine),yet
CCl4seemsonlyweaklymutagenic.Metalions,xanthineoxidase,activatedcalpains,andDAMPsreleasedfromdyinghepatocytescancause
systemicdamage.
9.2.2 ToxicityofCCl 4 5–8 (Fig. 9.2). The nuclear membrane is attacked more
slowly. Eventually there is necrosis of hepatocytes in
ThelipidsolubilityofCCl allowsittocrosscellmem-
4
thecentralareasoftheliverlobes,andliverfibrosis.
branes, and any CCl ingested is distributed to all
4
AlthoughdamageinvivoinvolvestheER,CCl does
organs. However, its main toxic effects are shown on 4
notinjureitdirectly.Instead,itisconvertedtothedam-
theliver.Itcausesfataccumulationduetoablockagein
agingproduct(s)bytheP450system.Indeed,neonatal
exportofthelipoproteinsthatcarrylipidsawayfrom
animals have low CYP levels (Section 7.11.7) and are
the liver (Section 4.3.6). The hepatocyte endoplasmic
fairlyresistanttothehepatoxicityofCCl .Whenme-
reticulum (ER) becomes distorted, protein synthesis 4
tabolizedbyCYPs,CCl inducesrapidperoxidationof
slows down, and the activity of enzymes located in 4
ERlipidsaccompaniedbyenzymeinactivation,includ-
the ER, such as glucose-6-phosphatase, declines, as
doestheabilityoftheERtosequesterCa2+ ions(Sec- ingdestructionofCYPs(thusCCl 4 hepatotoxicitycan
tion5.3.2).Hence,risesinintracellular‘free’Ca2+occur self-limit sometimes). Fatty-acid side-chains attached

--- Page 522 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 467
to phosphatidylserine are especially prone to attack, Doesthislipidperoxidationcontributetothedam-
perhapsbecausethislipidisadjacenttoP450 invivo. age caused by CCl ? Yes it does—administration of
4
Pretreatmentofanimalswithphenobarbital,orother several antioxidants to animals (including prometha-
agents which raise CYP levels in liver, renders them zine,α-tocopherol,andpropylgallate)decreasesCCl
4
moresusceptibletoCCl . toxicityin parallel with decreasedlipid peroxidation.
4
Elevatedlipidperoxidationisreadilydemonstrable Conversely, α-tocopherol-deficient animals are more
invivoinanimalsgivenCCl ,shownhistochemicallyin susceptibletoCCl .
4 4
Fig.6.21.LevelsofF -isoprostanes(F -IsoPs)increase
2 2
upto50-foldintheliver,plasma,andurineofanimals
9.2.3 HowdoesCCl causedamage?
givenCCl ;theseincreasesarebiggerinratspretreated 4
4
withphenobarbital.LargerisesinliverIsoPlevelspre- ItismetabolizedbytheP450systemtogivetrichloro-
cedethoseinplasma;smallerrisesareseeninkidney, methylradical(CCl • ),acarbon-centredradicaldetect-
3
lung,andheart,andF 2 -IsoPscanbemeasuredinbile ablebyspintrappinginvivo(Fig.9.3).SeveralCYPsare
from CCl 4 -exposed rats. Levels of other products of involved,includingCYP2E1(Section9.8.1),
lipid peroxidation, such as HNE, MDA, and deoxy-
J 2 -isoprostanes also increase,5,9 and CCl 4 -treated rats CCl 4 −o−ne−-−e−le−ctr−o−n−re−du−c−ti→on • CCl 3 +Cl–
exhalemorepentaneandethane,againprobablyfrom
•
lipidperoxidation(Section5.12.5.1).MDA,HNE,mer- TheCCl radicalmightattackbiologicalmoleculesdir-
3
capturic acid conjugates (Section 6.15.7), and 8OHdG ectly, causing covalent modification (Fig. 9.2) and/or
levels in urine also increase. Indeed, the BOSS (Bio- by abstracting H• from membrane lipids to initiate
markers of Oxidative Stress)study used rats treated lipid peroxidation. Indeed, CCl 4 -treated rats exhale
with CCl to examine how well different biomarkers chloroform vapour, conceivably produced by com-
4
coulddetectoxidativestress.5 bination of CCl • with H• abstracted from a lipid.
3
((aa))
in vivo
CCl intragastric
4
(b) –CCl
4
–CCl intragastric
4
(c) +CCl in extract
4 Figure9.3 Trappingoftrichloromethylradicalbythespin
trapPBN.FromFreeRadicals:APracticalApproach(Punchard,
N.A.andKelly,F.J.,eds),p.19,IRLPress,Oxford,bycourtesy
ofProfessorR.P.MasonandOxfordUniversityPress.(a)ESR
20 Gauss
spectrumofachloroform/methanolextractofliverfromarat
1hafteradministrationof0.8ml/kgCCl4(intragastric)and
70mg/kgPBN(intraperitoneal).(b)ESRspectrumofthe
H O extractofliverfromacontrolratgivenonlythePBN.(c)Asin
+ (b),butliverwashomogenizedinachloroform/methanol
CH N C(CH 3 ) 3 Cl 3 C C N C(CH 3 ) 3 mixturetowhich25μlofCCl4/goflivertissuehadbeen
O– added;thisisanessentialcontroltocheckforradical
+ CCl formationduringsolventextraction.PBNcanalsotrapthe
3 carbondioxideradical,CO •
2
–,inliverstreatedwithCCl4
Nitroxyl radical (J.Pharm.Exp.Ther.33,351,1988).

--- Page 523 ---

468 FREE RADICALS IN BIOLOGY AND MEDICINE
Hexachloroethane, another product of CCl metabol- which can react with GSH and protein thiols or be
4
ism,couldarisebythereaction furthermetabolizedtobromophenol.Nevertheless,the
CCl
•
+CCl
•→Cl
CCCl
antioxidantTroloxC(Section6.17.3)offeredsomepro-
3 3 3 3 tectionagainstlivernecrosisinducedbytoxicdosesof
Promethazinedecreasesperoxidationinlivercellsand bromobenzeneinmice,anddesferrioxaminewasalso
preventslossofglucose6-phosphataseactivity,butnot protective.ItmaybethatGSHdepletionandrisesin
that of CYPs. Probably CYPs are attacked directly by Ca2+duetodamageofCa2+-sequesteringsystemslead
CCl • orotherradicalsderivedfromit,whereasthein- to‘secondary’RSproduction.12
3
activation of glucose-6-phosphatase is brought about Halothane,2-bromo-2-chloro-1,1,1-trifluoroethane,
byproductsoflipidperoxidation.
•
However,CCl mayonlypersisttocausedamagein
3
hypoxic regions of the liver; like most C• radicals, it
reactsrapidlywithO ,
2
CCl • +O →CCl O • k =3.3×109M–1s–1
3 2 3 2 2
issometimesstillusedasaninhaledanaestheticgas,al-
Theproduct,trichloromethylperoxylradical,ishighly
thoughwithdecreasingfrequency.Itisgenerallysafe,
reactive(Section2.5.4);thepresenceofchlorineinthe
although about 20% of patients exposed to it show
side-chainincreasestheoxidizingcapacitybeyondthat
• mildliverdysfunction,asdetectedbylaboratorytests
ofmostperoxylradicals.Indeed,CCl O reactsrapidly
3 2 (halothanehepatitistypeI).Aboutonein35,000pa-
witharachidonicacid(k =7.3×106M–1s–1),linolenic
2 tients given halothane shows severe liver damage,
acid (k =7.3×106M–1s–1), thiol compounds, and the
2 leadingtonecrosisandliverfailure(halothanehepa-
tyrosineandtryptophanresiduesofproteins.
titis type II). Re-anaesthesia of patients previously
Essentially therefore, CCl causes hepatic damage
4 exposed to halothane can produce severe liver dam-
by initiating lipid peroxidation via its metabolism to
ageinagreaternumberofcases(aboutonein3700).
radicals.Subsequentdamagingeventsincluderisesin
Increased levels of F -IsoPs have been observed in
intracellularCa2+,GSHdepletion,andironionrelease 2
humansandanimalsexposedtohalothane,13andvari-
(Fig.9.2).Ascorbate-deficient(SMP30)micewereless
ous radicals can be spin trapped by PBN when halo-
sensitive to CCl , consistent with pro-oxidant inter-
4 thaneisincubatedwithlivermicrosomesplusNADPH
actionsofascorbateandironionsinvivo.10Liverinjury
in vitro. However, the major mechanism of toxicity
byCCl (indeedprobablybyanymechanism)canre-
4 is by the binding of products of halothane metabol-
leaseDAMPsandprovokeactivationofmacrophages
ism to proteins, to form trifluoroacetylated proteins,
(Kupffer cells) resident in this organ. Cytokine pro-
whichappeartoprovokeasevereimmuneresponsein
duction and recruitment of neutrophils from the cir-
susceptible individuals.14 Halothane has largely been
culation will then occur; production of RS by both
supersededbysaferanaestheticagents,suchassevo-
typesofphagocytecontributestoliverinjurybyCCl .
4 flurane,
End-productsoflipidperoxidation,suchasHNEand
F -IsoPs, can promote fibrosis in the damaged liver
2
(Section9.8.1).Superoxidemayalsobeinvolved,since
heparin-SOD(Section11.5.3)canprotectmiceagainst
CCl -inducedliverfibrosis.11
4
9.3 Otherhalogenatedhydrocarbons andisoflurane,
Since the role of free radicals in CCl toxicity is well
4
established, it has often been proposed that they are
involvedinthetoxicityofotherhalogenatedhydrocar-
bons.Forsome,suchas1,2-dibromoethane(ethylene
dibromide), halothane, trichloroethylene, perchloro-
ethylene (Cl C=CCl ), bromobenzene (C H Br), and Administrationoftheseagentstoanimalscanprotect
2 2 6 5
vinyl chloride, the evidence is not compelling. For the heart against subsequent damage by ischaemia–
example,thetoxicityofbromobenzeneislargelyasso- reperfusion, and ROS are involved in this ‘precondi-
ciatedwithP450-dependentformationofanepoxide, tioning’(Section10.6.6).

--- Page 524 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 469
9.3.1 Chloroformand cancer in some strains of mice and rats. The major
bromotrichloromethane7,15 metaboliteofPCP,tetrachlorohydroquinone(TCHQ),
Chloroformwasthefirstanaesthetictobewidelyem-
ployed in surgery, introduced by Sir James Young
Simpson in 1847. It is no longer used as an anaes-
thetic, but is still widely employed in industry as a
solvent, and small amounts are sometimes added to
cough mixtures and mouth washes. Traces of CHCl can form mutagenic adducts with DNA and may be
3
cancontaminatechlorinateddrinkingwater. thetoxicspecies.Severalstudieshaveshownincreased
Trichloromethane may be less harmful than CCl levelsof8OHGinDNAfromtheliversofanimalsfed
4
because it induces lipid peroxidation much less ef- PCP, and TCHQ exposure can increase 8OHG in the
fectively, possibly because the energy required to DNAofisolatedcellsandtheliversofmice.18,19Ithas
•
produce CCl from CHCl is greater than for CCl . thus been proposed that oxidative stress, perhaps in-
3 3 4
Consistent with this argument, compounds in which volving O
•–
formation during oxidation of TCHQ (a
2
homolytic fission is easier, such as bromotrichloro- diphenol)toasemiquinoneandontotetrachloroben-
methane (BrCCl ) induce peroxidation faster than zoquinone (TCBQ), causes additional oxidative DNA
3
CCl (Table 9.1) and also stimulate lipid peroxid- damage that leads to cancer. Further work is needed
4
ation in vivo (as revealed by increases in urinary tosupportthishypothesis,sincerisesin8OHGlevels
levels of F -IsoPs, MDA, and HNE-mercapturic acid in DNA may be a common feature of most or all
2
conjugates).16 Nevertheless, liver damage is still a carcinogenic agents (Section 10.15) rather than evi-
significant problem in humans exposed to excessive dencethatRSaremajorplayersinthecarcinogenicity.
chloroform and several deaths from liver failure oc- Nevertheless, TCBQ might be able to form DNA ad-
curredintheearlydaysofchloroformanaesthesia.The ductsitselfandcanalsoreactwithH 2 O 2 toformOH•
toxicity again involves metabolism by the P450 sys- (Section2.5.1.1).
tem, and agents raising CYP levels potentiate CHCl Otherenvironmentalcontaminantsthatmightcause
3
toxicity. oxidativestressincludethechlorinateddioxinTCDD
Administration of BrCCl (Table 9.1) to rats pro- (2,3,7,8-tetrachlorodibenzo-p-dioxin),
3
duced a different toxicity: damage to the Clara cells
ofthelung,17 apparentlybylipidperoxidation.Asal-
readymentioned,ClaracellsarerichinCYPs.
9.3.2 Pentachlorophenolandrelated a carcinogen that is more effective in female than in
environmentalpollutants male rats. Its toxicity involves binding to an intra-
cellularreceptorprotein(thearylhydrocarbonrecep-
Pentachlorophenol (PCP) is used as a wood preser- tor,AHR)andsubsequentlyalteringthetranscription
vative, herbicide, and insecticide, but can cause liver of multiple genes (including genes encoding several
CYPs). Giving high doses of TCCD to animals can
increase mitochondrial ROS production (exactly how
Table9.1 Lipidperoxidationinducedbyhalogenatedhydrocarbons.
is uncertain), lipid peroxidation, and oxidative DNA
Homolyticfission Energyneeded Relativerate damage in tissues. There is a relationship between
reaction forhomolytic oflipid TCCD toxicity and iron; iron-deficient animals show
bondfission peroxidation(%) lessinjury.19Increasedlevelsof8OHGweredetectedin
(kcal/mol)
DNAfromtheliversoffemaleratschronicallytreated
CCl4 →Cl • +•CCl3 68 100 with TCCD: elevations were less marked in ovariec-
CHCl3 →H • +•CCl3 90 7 t
is
om
un
iz
c
e
le
d
ar
r
;
a
o
ts
n
.2
e
0
p
T
o
h
s
e
sib
si
i
g
li
n
ty
ifi
i
c
s
a
t
n
h
c
a
e
tr
o
a
f
is
t
i
h
n
e
g
se
C
o
Y
b
P
se
le
r
v
v
e
a
l
t
s
io
i
n
n
s
-
BrCCl3 →Br•+•CCl3 49 3650 creasesthemetabolismofoestrogentocatecholoestro-
gens,whichcanoxidativelydamageDNAundercer-
PeroxidationinratlivermicrosomesinthepresenceofNADPHwasmeasuredby
taincircumstances(Sections3.26,5.8.2.2,and10.15.1.1).
theTBARSassay.ResultsareexpressedrelativetotheeffectofCCl4.
DataselectedfromBiochem.J.123,805,1971,bycourtesyofthelateProfessor Thefungicidehexachlorobenzenecausesliverdam-
T.F.Slater. age and interferes with haem biosynthesis, leading

--- Page 525 ---

470 FREE RADICALS IN BIOLOGY AND MEDICINE
to a syndrome of liver damage and photosensitiv- attempts. Bipyridyl herbicides can also be absorbed
itycalledporphyriacutaneatarda.Boththeinherited slowlythroughtheskin.
version of this disease and the hexachlorobenzene- Oral intake of paraquat initially causes local
induceddiseaseareaggravatedbyironoverloadand effects—irritation of the mouth, throat, and oeso-
are associated with inhibition of the hepatic uropor- phagus,andsometimesvomitinganddiarrhoea.For-
phyrinogen decarboxylase enzyme (Fig. 2.12). TCCD tunately,gutabsorptionofbipyridylherbicidesisslow,
canhavesimilareffects.19 andlifemayoftenbesavedbywashingoutthestom-
achandintestinesrepeatedlywithsalinesolutionsor
suspensions of clays that absorb the herbicides (e.g.
9.4 Redox-cyclingtoxins:bipyridyl
bentoniteorfuller’searth).Dialysisofbloodcanalso
herbicides
beemployed.
Themajororganaffectedbyparaquatinanimalsis
9.4.1 Toxicitytobacteria
thelung,butothertissuesaredamagedalso,suchas
Thetoxicityofbipyridylherbicidestoplantsinvolves kidney(thisdamageimpairsparaquatexcretion).The
redox cycling (Section 7.9.2). So does their toxicity type I cells that line the alveoli (Section 1.5.2) begin
to bacteria and animals. Low concentrations (0.1–1.0 to swell and are eventually destroyed, leading to oe-
μM) of paraquat halt the growth of E. coli (a bac- dema,capillarycongestion,andinflammation.TypeII
teriostatic effect), whereas higher (>100 μM) concen- cells(Section1.5.2)arealsoinjuredandsurfactantsyn-
trations can kill.21 Paraquat is taken up by E. coli thesisdecreases.Oedemaandlossofsurfactanthinder
andrapidlyreducedtoabipyridylradical,whichcan gasexchange.Deathcanresulte.g.ifthereisexcessive
be detected by its absorbance or ESR spectrum un- lungfibrosis.
der anaerobic conditions. Reduction is catalysed by
severalenzymes,includingthioredoxinreductaseand
9.4.3 Whyisparaquattoxictothelung?25
NADP+: ferredoxin oxidoreductase.22 In the presence
of O 2 , paraquat radical disappears, and O • 2 – is gener- The answer is simple; first, lung has a high pO 2 .
ated.AdditionofparaquattoaerobicallygrownE.coli Second, several lung cell types actively accumu-
inducesrapidsynthesisofMnSOD,thesameenzyme late paraquat, taking it up against a concentra-
induced by elevated O 2 (Section 3.7.4). E. coli whose tion gradient.26 The diamino compound putrescine
SODactivityisincreasedbyparaquatpretreatmentare (H N+(CH ) N+H ) blocks this uptake in isolated rat
3 2 4 3
more resistant to elevated O 2 . Vice versa, cells with lung slices, because paraquat ‘rides on’ a diamine
raisedSODduetopreviousexposuretohyperoxiaor transporter.Othertissues,includingliverandkidney,
to transfection with SOD genes, are more resistant to are damaged by paraquat, but more slowly, because
paraquat,confirmingtheimportanceofO • 2 –inthetox- theydonotconcentrateit.Bycontrast,althoughlarge
icity. If increased production of MnSOD by E. coli is dosesofdiquataffectthelung,itisnotthemajortarget
prevented, either by adding puromycin (an inhibitor tissue(intestinesandliveroftensuffermore),andmice
of protein synthesis) or by a poor growth medium, lacking Nrf2 are more sensitive to diquat because of
then the toxicity of paraquat increases, as would be loweredabilitytomaintainGSHlevels.27 The‘target-
predicted. ing’ofparaquattolungbyactivetransportmeansthat
Damage to E. coli by paraquat probably involves poisoningcanalsooccurbyinhalingparaquatdroplets
O • 2 –-dependentdamageto[Fe–S]clusterenzymes(Sec- fromcropspraying.
tion 3.9.2); released iron contributes to damage by Microsomal fractions from lung (and most other
promotingFentonchemistry.23 Someparaquatradical animal tissues) reduce paraquat in the presence of
can leak out of the bacteria and generate O • 2 – in the NADPH, and the paraquat radical then reacts with
growthmedium.24 O to form O •–. Reduction is achieved by NADPH–
2 2
cytochrome P450 reductase, since antibody directed
9.4.2 Toxicitytoanimals25 against this enzyme inhibits paraquat reduction by
microsomes in vitro. Mitochondrial enzymes and
A major problem in the agricultural use of para- VDAC1 (Section 8.10.9) can also reduce paraquat.28
quat and diquat is that they are poisonous to most Indeed, intravenous injection of paraquat into rats
animals, including humans. There have been many causes a rapid activation of the pentose phosphate
casesofchildrendrinkingparaquatcarelesslystoredin pathway in lung, presumably as SOD converts O
•–
2
soft-drinkbottles,anditissometimesusedinsuicide to H O and NADPH is consumed by glutathione
2 2

--- Page 526 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 471
and thioredoxin reductases. NADPH is also required P450 reductase (which is widely distributed) and/
for the biosynthesis of fatty acids (needed to re- or other flavoproteins, such as glutathione reductase;
place damaged lipids and to make surfactant), so reductionbythisenzymemightaccountforthehaem-
thatfattyacidsynthesisisdecreasedintheparaquat- olysissometimesseeninparaquat-poisonedhumans.
treated lung. There is an accumulation of ‘mixed di- Paraquat is neurotoxic if it enters the brain, with a
sulphides’ formed between protein –SH groups and limiteddegreeofselectivityforcellsinthesubstantia
GSSG.29 Oxidative protein damage, lipid peroxid- nigra(Section10.20.3).
ation, oxidation of ascorbate to ascorbyl radical,30
Fenton chemistry, and oxidative DNA damage all
9.5 Redox-cyclingtoxins:diphenols,
contribute to paraquat toxicity. Indeed, measure-
quinones,andrelatedmolecules
mentsofintra-mitochondrialH O levelsinDrosophila
2 2
showedthemtobemorethandoubledafterparaquat
Many quinones exist in the environment (Fig. 9.4);
administration.31
examples we have already met include TCHQ (Sec-
In the absence of O , PQ•+ can reduce Fe(III) che-
2 tion9.3.2),ubiquinone(Fig.1.8D),andplastoquinone
latestoFe2+.Thusitcanreductivelymobilizeironfrom
(Section7.8).Indeed,quinonescontributetothemedi-
ferritin,32 althoughtherelevanceofthesereactionsin
cinal properties of rhubarb, senna, and several other
the lung, where O is abundant, are uncertain. The
2 plants. Some quinones are used to repel predators,
powerful reducing ability of PQ•+ (Eo(cid:4)~ –0.45 V) has
as in the bombardier beetle (Section 8.5.1), or to de-
causedproblemsinusingdesferrioxaminetostudythe
ter competitors, for example the walnut tree (Fig. 9.4
roleofironinparaquattoxicity;theironisnotrendered
legend).Quinonesarepresentincigarettesmoke(Sec-
redox-inactive if PQ•+ is around. Some authors have
tion 9.13) and are used in cancer chemotherapy (Sec-
reportedprotectiveeffects(e.g.Section10.2),butoth-
tion10.16.2)andasantibiotics(Section9.17.2).Howdo
ers have claimed an aggravation of paraquat toxicity
quinonesinteractwithRS?
bydesferrioxamine.33Nevertheless,releasedirondoes
playaroleinparaquattoxicity.
Cellular injury by paraquat raises intracellular free 9.5.1 InteractionwithO andsuperoxide
2
Ca2+ levels, which could increase NO• and ONOO–
Superoxide can exist in equilibrium with diphenols
production and the activity of calpains that can con-
and quinones, with the intermediacy of semiquinone
vert xanthine dehydrogenase to XO (Section 5.3.2).
radicals(Section2.5.3.5).Hencediphenol/quinonesys-
Indeed,therearereportsthatrisesinXOactivitycon-
tributetolungdamagebyparaquatinhumans34 and tems can act as scavengers of O • 2 – or generators of
O
•–,
depending on the position of equilibrium and
thatNOSinhibitorsoffersomeprotectionagainstlung 2
damageinparaquat-treatedanimals.25However,NOS thepH,sincethedegreeofprotonationaffectsthere-
enzymes can reduce paraquat to PQ•+, an alternative ductionpotentials.37,38Forexample,plumbagin,mena-
dione, and juglone (Fig. 9.4), are redox-cycling quin-
explanation of why NOS inhibitors might offer some
protection.25 onesthat,likeparaquat,readilygenerateO • 2 –,andare
powerful inducers of MnSOD activity in E. coli via
The damaging effects of paraquat to bacteria or
activationoftheSoxRsystem(Section5.5.2).Diphen-
animals are potentiated at high O concentrations,
2
ols/semiquinonescanalsoreactwithperoxylradicals;
consistentwithakeyroleforreactionofparaquatrad-
indeed, both ubiquinol (in mitochondria and LDL)
ical with O . Indeed, overexpressing SOD in animal
2
andplastoquinol(inchloroplasts)havebeensuggested
cells usually decreases the toxicity of paraquat to
to act as antioxidants protecting against lipid perox-
them. Pretreatment of adult rats with endotoxin in-
idation (Sections 3.25.5 and 7.8.8). Unlike the other
creases catalase, SOD, G6PDH, and GPx activities in
molecules mentioned here, their semiquinone forms
the lung; such rats are resistant both to elevated O
(Section 3.7.5) and to paraquat.35 Selenium-deficien 2 t do not appear to generate O • 2 – at a significant rate
during the normal functioning of mitochondria and
rats are more sensitive to paraquat, which suggests
chloroplasts.
thatthioredoxinreductaseand/orGPxenzymespro-
tect,presumablybyfacilitatingH O removal.Indeed,
2 2
micelackingperoxiredoxin6arealsohypersensitiveto
9.5.2 Interactionwithmetals
paraquat.36
The toxicity of bipyridyl herbicides to tissues
Semiquinones(SQ•–)rarely,ifever,reactdirectlywith
other than the lung is probably also mediated H 2 O 2 to give OH•. However, they can reduce iron
by redox cycling, involving NADPH–cytochrome ionstoFe2+

--- Page 527 ---

472 FREE RADICALS IN BIOLOGY AND MEDICINE
O
CH
3
CH
3
CH –CH C (CH CH CH CH ) H
2 2 2 2n
O CH
3
Vitamin K
1
O
CH
3
CH
3
(CH –CH C CH ) H
2 2n
O
Vitamin K
2
OH OH
CH
2
O O O O
Dicoumarol
(Vitamin Kantagonist)
O
(* - CH F in fluoromenadione)
CH * 2
3 (=C in the quinone methide formed
after reduction and loss of HF.
Quinone methides react rapidly
O with -SH groups)
Menadione (vitamin K )
O 3
OH
Lawsone
O
O
Juglone
OH O
O
CH
3
Plumbagin
OH O
O
OH
Lapachol
CH CH C(CH )
2 32
O

--- Page 528 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 473
(cid:3)
Figure9.4 Somequinones.VitaminsK(fromtheGermanKoagulationsvitamin)arecofactorsrequiredbyenzymes(γ-carboxyglutamyl
carboxylases)thatattachcarboxylgroupstoglutamateresiduesinsomeoftheproteinsinvolvedinbloodcoagulation.DifferentformsofvitaminK
exist;thephylloquinoneorK1form(n=3intheside-chain)derivesfromplantsandthemenaquinone(K2)series(n=4–13intheside-chain)
mostlyfrombacteria,includingsomegutbacteria(Br.J.Nutr.110,1357,2013).DicoumarolantagonizesvitaminKactionandinterfereswith
bloodcoagulation;itisfoundinsweetclover,whichcancausehaemorrhagicdiseaseinanimals.Highdosesofα-tocopherolmightalsoantagonize
vitaminKaction(Section4.3.5).Menadioneisasyntheticcompoundlackingtheisoprenoidside-chain,butstillshowsvitaminKactivityinanimal
tests;hencethename‘vitaminK3’.Lawsoneisacolouredpigmentfoundinhenna,apastemadefromleavesofLawsoniainermisthathasbeen
usedtodyehairsinceancienttimes.Jugloneisexudedbytherootsofwalnut(Juglansregia)trees,possiblytodetergerminationofotherplant
seedsinthevicinityofthetree.Lapacholisfoundinthewoodofseveraltreesandhasbeenclaimedtohaveantimalarialandanticanceractivities.
PlumbaginisfoundinblackwalnutandinrootsofthemedicinalplantPlumbagozeylanicaandithasbeensuggestedthatplumbaginmightbe
usefultotreatovariancancer(Mol.Carcinogen.52,392,2013).
SQ
•–+Fe(III)→Fe2++Q
byredoxcycling,
andtheFentonreactioncanthenoccur
Q−1−e–−re−du−c−ti→on
SQ
•–
Fe2++H O →Fe(III)+OH • +OH– SQ •–+O 2 →Q+O • 2 –
2 2
One example is menadione (Fig. 9.4), which can
Net:SQ •–+H O −F−e−ca−ta−ly→st OH • +OH–+Q
2 2 cause haemolysis, especially in erythrocytes deficient
in G6PDH (Section 7.5). Reaction of menadione with
Thisisasemiquinone-drivenFentonreaction,analo-
oxyhaemoglobincausesoxidationandprecipitationof
goustoO •
2
–-drivenFentonchemistry(Section3.9.2.2). theprotein.Asemiquinone(SQ•-)isformed,
If the SQ•– reduces O to O •– an additional set of
reactionsis 2 2 Hb(Fe2+)O 2 +Q(cid:2)Hb[Fe(III)]+O 2 +SQ •–
methaemoglobin
SQ •–+O →Q+O •–
2 2 that can either re-reduce methaemoglobin or convert
O • 2 –+Fe(III)→Fe2++O 2 O 2 to O • 2 –. Addition of SOD accelerates methaemo-
globin formation, presumably by dismuting O
•–
and
2
Diphenols can also often reduce transition metal thusalteringtheequilibrium(Section2.5.3.5)tofavour
ions, for example hydroquinone (Fig. 9.5) reduces reactionofSQ•– withO ,ratherthanwithmethaemo-
2
Cu2+toCu+.
globin.Inaddition,menadionecanadddirectlytothe
β93cysteine–SHgroupsonhaemoglobin40toformthe
adduct
9.5.3 Mechanismsoftoxicity
Quinones can be toxic to aerobes by at least two
mechanisms.38 First, they or their semiquinones may
react with GSH and protein –SH groups (ubiquinone
andplastoquinonedonot).ReactionwithGSHcanbe
non-enzymicand/orcatalysedbyGSTenzymes,and
GSHdepletionmayresult.Inaddition,theconjugates Menadione-treated red blood cells can undergo
withGSHarenotalwaysbenign.Conjugatesofhydro- eryptosis(Section7.5.4).41
quinonewithGSHcausekidneydamage,forexample. In hepatocytes, high concentrations of menadione
Theyareexportedfromtheliver,metabolizedbyrenal depleteGSH,increaseformationofO
•–andH
O ,and
2 2 2
γ-glutamyltranspeptidase (Section 3.10.3) and the re- cause membrane blebbing, associated with increased
sulting cysteine conjugates taken up by kidney cells intracellularfreeCa2+levels(Section5.3.2).Menadione
to cause oxidative stress and damage to the renal alsocausesDNAdamage,butthisseemslargelydueto
proximaltubules.38,39 theactivationofCa2+-dependentnucleasesratherthan
Second, quinones can be reduced by enzymes, tooxidativedamage,sincerisesin8OHGwerenotob-
including mitochondrial complex I, NADPH- served in DNA from menadione-treated hepatocytes,
cytochrome P450 reductase, and NADH-cytochrome despite extensive DNA strand breakage.42 Fluorom-
b reductase in the endoplasmic reticulum, followed enadione derivatives (Fig 9.4) have been examined
5

--- Page 529 ---

474 FREE RADICALS IN BIOLOGY AND MEDICINE
COOH COOH
CH CHNH CH CHNH
2 2 2 2
OH O
OH O
3,4-Dihydroxyphenylalanine DOPA quinone
(DOPA)
CH CH NH CHOHCH NH CHOHCH NHCH
2 2 2 2 2 2 3
OH OH OH
OH OH OH
Dopamine Noradrenalin Adrenalin
CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2
HO HO O
OH O O
OH O OH
6-Hydroxydopamine ...ortho-quinone ...para-quinone
COOH
CH 2 CNH 2 CH 2 CH 2 NH 2 CHOHCH 2 NHCH(CH 3 ) 2
H N
2
CH
3 Figure9.5 Derivativesofphenylalanine.
Compoundswiththecatecholring
OH OH OH
structureplusanaminogroupareoften
OH OH OH calledcatecholamines,examplesbeing
Methyldopa 6-Aminodopamine Isoproterenol dopamineandnoradrenalin.
as anti-malarial agents; they are reduced by gluta- with other human tissues, whereas rat liver is a rich
thione reductase to eventually produce O •– and a sourceofit.46NQO1containsFAD,islargelypresentin
2
quinonemethide(Fig.9.4),bothofwhicharetoxicto thecellcytosol,andusedtobecalledDT-diaphorase.
Plasmodium.43,44 It can be inhibited by the anticoagulant dicoumarol
(Fig. 9.4). This enzyme reduces not only quinones
(includingmenadione,ubiquinone,and‘natural’vita-
9.5.4 Quinonereductase
mins K), but also some artificial electron acceptors
As mentioned earlier, several enzymes can catalyse suchastetrazoliumsalts.Itcanalsoreducetocopherol
one-electron reduction of quinones into semiquin- quinone,atleastinvitro.
ones and promote redox cycling, including glutathi- What is QR for? It may help to maintain coen-
one reductase and thioredoxin reductase. Sometimes zyme Q in the reduced (ubiquinol) form.47 Another
these enzymes are inactivated as a result.44,45 How- role could be to decrease formation of O •– in vivo
2
ever, many tissues contain enzymes which catalyse a by removing quinones, preventing their reduction
two-electronreductionofquinonesintohydroquinones to semiquinones by other enzyme systems. Hence
at the expense of NADH or NADPH;46 NAD(P)H: NQO1 is often regarded as a phase II detoxifica-
quinoneoxidoreductases,NQO,oftenabbreviatedto tion system. For example, menadione is reduced and
‘quinonereductase(QR)’.ThemostimportantisNQO the product conjugated with glucuronic acid and ex-
type 1 (NQO1), a flavoprotein. For some reason, its creted. Consistent with this, ‘knockout’ mice lack-
levels in human liver are low (or zero) as compared ing NQO1 show bone marrow abnormalities and

--- Page 530 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 475
elevatedlevelsofoxidativeDNAdamageinliverand Manganism in its later stages superficially resem-
kidney,plusincreasedsusceptibilitytomenadionetox- bles PD clinically, although the most extensive brain
icity.Quinonereductasegeneexpressionisunderthe damage is to the striatum and globus pallidus, and
control of the antioxidant response element and so lesstothesubstantianigra,themainsiteofcelldeath
its levels are increased by several xenobiotics (Sec- in PD (Section 10.20). The symptoms of manganism
tion 5.5.8). Three types of hydroquinones result from mayinvolveloweredlevelsofL-DOPA/dopamine,but
QR action: stable ones, autoxidizable ones that can ROSandsemiquinones/quinonesmayalsocontribute,
generateROS,andonesthatquicklyrearrangetopo- and F -IsoP levels in brain are elevated in mice in-
2
tentiallydamagingelectrophiles,asinthecaseofmi- jectedwithMnCl .50,51Anotherexampleofmanganese
2
tomycin C (Section 10.16.2). QR also helps to protect toxicity is the PD-like syndrome reported in Eastern
againstbenzenetoxicity(Section9.5.8). Europe amongst drug abusers who inject methcath-
inone,‘Russiancocktail’.Itismadebyoxidizingephe-
9.5.5 Catecholoestrogens38,48 drine with potassium permanganate (KMnO 4 ), and
sufficient Mn2+ remains in the preparation to cause
Oestrogens have been speculated to be antioxidants neurotoxicity.52 Similarly, large doses of adrenalin,
(Section3.26),butthisactionisnotestablishedinvivo. noradrenalin, or the synthetic catechol isoproterenol
Indeed,excessiveexposuretooestrogensmaypromote (Fig.9.6)canproducean‘infarct-like’necrosisofheart
cancer development e.g. in breast and endometrium muscle in animals, apparently involving oxidative
(Section 10.15.1.1). Several mechanisms are involved; damage.53 Oxidation products of α-methyl-DOPA, a
one of them may be the formation and oxidation drug used to lower blood pressure in humans, have
of catechol metabolites. Oestrone and oestradiol (Fig. beensuggestedtocontributetotheliverdamageitcan
3.21) can be converted by CYPs into 2-hydroxy and sometimescause.
4-hydroxycatechol derivatives which, if not rapidly Insects provide an interesting example of a useful
metabolized, can oxidize to give quinones and semi- rolefordopamineoxidation.54Duringformationofthe
quinones(Fig.10.20).Thesecouldbothredox-cycleand hard exoskeleton, N-acetyldopamine is converted to
formadductswithDNAbases,especiallyadenineand 1,2-dehydro-N-acetyldopamine, which is oxidized by
guanine(Section10.15.1.1). a tyrosinase enzyme, to give products that cross-link
proteinstotoughenthecuticle.
9.5.6 Substituteddihydroxyphenylalanines
and‘manganesemadness’ 9.5.7 Neurotoxicityof6-hydroxydopamine55
Diphenols derived from phenylalanine (Fig. 9.5) Oxidations of adrenalin, L-DOPA, dopamine, and
play important physiological roles, but can also noradrenalin are probably slow in vivo, both be-
oxidize.Forexample,oxidationofthehormoneadren- cause SOD is present to remove O
•–
and break the
2
alin, the neurotransmitter dopamine and its pre- ‘chainreaction’ofautoxidation(Section3.5.6)andbe-
cursor L-DOPA, and the hormone/neurotransmitter causeconcentrationsof‘catalytic’transitionmetalsare
noradrenalin produce O
•–
and H O and various low.Bycontrast,6-hydroxydopamine (6-OHDA)and
2 2 2
quinones/semiquinones.49 Indeed, adrenalin oxida- 6-aminodopamine (Fig. 9.5) oxidize much faster, al-
tioncanbeusedtoassaySOD(Section3.5.6).Oxidation though traces of metal ions are still needed. Again,
of these diphenols is accelerated by transition metal semiquinonesandquinonesareformed(Fig.9.5shows
ions,whosepresencemayalsoleadtoOH•formation. the two quinones that are produced by 6-OHDA),
Quinones and semiquinones can attack protein –SH togetherwithH O ,O
•–,andOH•.Superoxidepartici-
2 2 2
groups and deplete GSH; such reactions seem to oc- patesintheoxidationoffurthermoleculesof6-OHDA
cur in the brains of patients with Parkinson disease andhenceadditionofSODdecreasestheobservedoxi-
(PD) (Section 10.20), for example.49 Indeed, exposure dationrate.Indeed,overexpressionofCuZnSODpro-
ofanimalsorhumanstoexcessmanganesesaltspro- tectsisolatedneuronsagainstdamageby6-OHDA56
motesrapiddopamineoxidationinthebrainandcan When injected into the brains of animals (it can-
causemanganism(formerlycalledlocuramanganica), notcrosstheblood–brainbarriersosystemicinjection
a disease that has been observed in miners of man- doesnotwork),6-OHDAcausesrapidandfairlyspe-
ganeseoresinpartsofnorthernChile,andlessoften cificdamagetocatecholaminenerveterminals.Hence,
inAustraliaandTaiwan.Itcanalsooccurinwelders it is widely used as a research tool to investigate the
exposedtoMn-containingfumes.50 physiological roles of such terminals (Section 10.20).

--- Page 531 ---

476 FREE RADICALS IN BIOLOGY AND MEDICINE
OH O
OH
OH OH
OH
OH
OH
OH O
Benzene Phenol Catechol Benzenetriol Hydroquinone p-Benzoquinone
–2e– –2e– –2e–
NH NHOH N O NO
2 2
Aniline Phenylhydroxylamine Nitrosobenzene Nitrobenzene
Figure9.6 Benzeneanditsmetabolites.ConversionofbenzenetophenolandhydroquinoneiscatalysedbyCYPs,largelyintheliver.Thebottom
diagram(metabolismofaniline)isbycourtesyofProfessorRonMason.
Theselectiveactionisprobablyduetotheselectiveup- ofONOO– contributestobenzenetoxicity,bycausing
takeof6-OHDAbycatecholamineneurons,followed protein nitration and generating nitrobenzenes in the
by increased intra-neuronal formation of ROS, semi- bonemarrow.61
quinones,andquinones.Thismechanismissupported Quinone reductase converts benzoquinone back to
bytheobservationthatthebrainsofmiceoverexpress- hydroquinone; indeed a polymorphism of the gene
ingMnSOD(butnotEC-SOD)werelessdamagedby encoding NQO1 which abolishes enzyme activity
6-OHDA.57 The spin trap DMPO (Section 6.2.4) can has been suggested as a risk factor for benzene
also protect animals against damage by 6-OHDA,58 carcinogenicity.60
probablybytrappingOH•.
9.5.9 Toxic-oilsyndromeandanewSociety62
9.5.8 Benzeneanditsderivatives38
In 1981, a new disease was reported in Spain, the
Thearomatichydrocarbonbenzene,awidelyusedin- toxic-oilsyndromeorSpanishcooking-oilsyndrome.
dustrial solvent and fuel additive, can damage most Attheheightoftheepidemicmorethan20,000people
tissuesifingestedinsufficientquantity;includingthe incentralandnorth-westSpainwereaffected,ofwhom
liverandbrain.However,thebonemarrowisparticu- 11,000requiredhospitalizationandover800eventually
larly vulnerable, and excessexposureto benzene is a died. The symptoms of the disease in its acute stage
riskfactorfordevelopmentofacutemyelogenousleu- were respiratory distress, fever, headache, itching,
kaemia.Severalstudieshavereportedelevatedlevels nausea and, sometimes, muscular pains and neuro-
of8OHGinDNAfrombloodlymphocytes,or8OHdG logical disorders. Lung damage caused most of the
intheurineofbenzene-exposedworkers.59,60 early deaths. When followed up later, about 10% of
Benzene toxicity involves its conversion by CYPs patients had developed muscle wasting and weak-
(especially CYP2E1) to benzene oxide that can give ness, and another 49% had suffered some muscular
rise to various phenols (phenol, catechol, hydroquin- or neurological impairment. Sufferers from the dis-
one, and 1,2,4-benzenetriol). These can undergo oxi- ease were found to have consumed ‘olive oil’ sold
dation to quinones and semiquinones (Fig. 9.6), per- by door-to-door salesmen. Analysis showed that the
hapsacceleratedbythehighlevelsofmyeloperoxidase oilinquestionhadneverseenanolivetree,andwas
(MPO) present in bone marrow. Adding CuZnSOD basically oil obtained from seeds of the rape plant,
accelerates oxidation of hydroquinone to the more Brassicanapus.
toxicbenzoquinone,whichiscapableofformingDNA Rapeseed oil imported into Spain was at that time
adducts;SODremovesO
•–,sodrivingtheequilibrium
treated with aniline (Fig. 9.6) to deter its consump-
2
betweentheintermediatesemiquinoneradicalandO tion. Aniline is widely used in the manufacture of
2
to the right.37 It has been suggested that formation explosives, dyestuffs, and other chemicals. Excess

--- Page 532 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 477
exposure produces haemolytic anaemia and damage CH 3
to the spleen, accompanied by splenic fibrosis with
N
increased lipid peroxidation and oxidative protein
damage.63 This is probably because some damaged
N
erythrocytesaretakenupbythespleen,whichthusac-
cumulatesnotonlyanilineanditsmetabolitesbutalso O
excess iron. Damage to red blood cells by aniline ap-
ProductionofO
•–bypyocyaninappearstoaccountfor
pearstoinvolveitsmetabolitephenylhydroxylamine 2
its toxicity to E. coli (low levels raise MnSOD levels
(Fig.9.6),whichisoxidizedbyoxyhaemoglobintogive
inthisbacterium)anditappearstocontributetolung
nitrosobenzeneandmethaemoglobin.Nitrosobenzene
damageinpatientswithP.aeruginosainfection.Oneof
isthenreducedbymethaemoglobinreductase(ornon-
its actions on the lung is to cause mucus hypersecre-
enzymically) back to phenylhydroxylamine, which
tion;itapparentlyactsbyincreasingROSproduction
oxidizes more oxyhaemoglobin in a cyclic manner.64
inlungepithelialcellsasasignallingmechanism.65An-
Anilinecanalsobeoxidizedtoarangeofproducts,in-
otherfactormaybetheabilityofpyocyanintointerfere
cludingphenylradical,byMPO.64However,although
withthefunctionofDUOXenzymesintherespiratory
aniline might have made some contribution to toxic-
tract (Section 8.10.1); DUOX seems to be a protective
oil syndrome, the symptoms are different from those
factoragainstinfectionbyP.aeruginosa.65
of aniline poisoning. It appears that attempts had
P. aeruginosa secretes an elastase that can cleave
been made to remove aniline from the rapeseed oil.
lactoferrin and transferrin to release iron. It also re-
Duringthis‘purification’,aniline-derivedtoxinswere
leases siderophores that bind Fe(III) and promote its
formed.
uptakeintothebacterium.Ironboundtosomeofthese,
Onegoodthingtocomeoutofthetoxic-oilaffairwas
especiallypyochelinandpyoverdine,appearscapable
thatitledtothesettingup,largelythroughtheefforts
of catalysing OH• formation from H O ; hence the
ofRobinWillsonandthelateTrevorSlater,oftheSoci- 2 2
combination of a siderophore and pyocyanin is more
etyforFreeRadicalResearch(SFRR),intheUK.From
cytotoxicthaneitheragentalone.66
the seed they planted has grown a network of inter-
national societies with thousands of members: SFRR
Europe,SFRRAfrica,SFRRIndia,SFRRASEAN,SFRR 9.7 Diabetogenicdrugs
Asia,SFRRAustralasia,andSFRRAmerica(TheSoci-
ety for Free Radical Biology and Medicine, SFRBM), 9.7.1 Alloxan
plus at least five journals, Free Radical Research (offi-
Anotherredox-cyclingtoxinisalloxan;injectingitinto
cialjournalofSFRREurope),RedoxReport,Antioxidants
animalscausesdegenerationoftheβ-cellsintheislets
andRedoxSignaling,RedoxBiology,andFreeRadicalBiol-
of Langerhans of the pancreas. Since these cells syn-
ogyandMedicine(officialjournalofSFRBM).Ironically,
thesize insulin, alloxan causes diabetes. Two-electron
however,thereislittleevidencethatfreeradicalsand
reduction of alloxan gives dialuric acid (Fig. 9.7), a
oxidativedamagehadanythingtodowiththetoxicity
cytotoxic pyrimidine whose structure resembles that
oftheadulteratedoil.
ofthehaemolyticagentsdivicineandisouramil(Sec-
tion7.5.3),althoughalloxanisnotahaemolyticagent.
An intermediate radical, formed by one-electron re-
9.6 Redox-cyclingagents:toxinsderived duction of alloxan (or one-electron oxidation of di-
aluricacid),alsoexists.67Dialuricacidisunstableand
fromPseudomonasaeruginosa
readily oxidizes back to alloxan, accompanied by re-
Pseudomonas aeruginosa, a Gram-negative bacterium, duction of O to O
•–.
Its oxidation is accelerated by
2 2
can cause pneumonia in immunocompromised pa- transition metal ions, which often also catalyse OH•
tients and often chronically infects the respira- formation. Alloxan is additionally very reactive with
tory tract of patients with cystic fibrosis (Sec- –SHgroups, undergoingredoxcyclingandoxidizing
tion10.9).ManyP.aeruginosastrainssecretepyocyanin -SHgroupsonproteins.
(5-methyl-1-hydroxyphenazine), apparently to regu- Any body tissue that can take up and reduce al-
late biofilm formation. Pyocyanin is a redox-cycling loxanwillbeatriskofoxidativestress(anditcanpass
agentwiththestructure through the glucose transporter GLUT2), so why are

--- Page 533 ---

478 FREE RADICALS IN BIOLOGY AND MEDICINE
O O
Thetoxiceffectsofalloxanonrodentβ-cellscanbe
–2e– decreased69byaddingSOD,catalase,OH• scavengers
HN NH HN NH (includingmannitolanddimethylsulphoxide),oriron
–2e–
chelatorssuchasDETAPAC.DNAstrandbreakage,ac-
O O O O companiedbyactivationofPARP-1(Section5.2.5)isa
keyeventincellinjury.Itmayresultfromgenerationof
O OH OH•bytransitionmetalsboundtoDNA(Fig.9.8).In-
Alloxan Dialuric acid
deed,highbodyironstoresandironoverloadarerisk
factors for diabetes development (Sections 3.22.5 and
CH OH 10.5.1), and islets contain the iron transporter DMT1
2
(Section3.22.1).75
H C O H Are observations upon isolated β-cells relevant in
H
C OH H C1 vivo? Probably. Injection of CuZnSOD (attached to a
OH C C OH high-molecular-mass polymer to reduce its clearance
by the kidneys) into mice protected them against the
H NH diabetesnormallyinducedbyasubsequentinjectionof
C O alloxan,asdidtheironchelatorDETAPAC.69,76EDTA,
which(unlikeDETAPAC)allowsrapidO
•–-dependent
N 2
reductionofironboundtoit,wasnotprotective.ICRF-
H 3 C NO 187(Section10.16.2)and1,10-phenanthrolinealsopro-
tect against alloxan toxicity in animals, presumably
Streptozotocin
by chelating iron ions.77,78 Transgenic mice overex-
Figure9.7 Diabetogenicagents.Theαformofstreptozotocin pressing CuZnSOD in islets were more resistant to
(N-methylnitrosocarbamoylglucosamine)isshown;intheβformthe alloxanthancontrols,79 andmicedeficientincatalase
arrangementofthe–Hand–OHgroupsoncarbon1isreversed.The orvitaminEweremoresensitive.76,80
drugisnormallyamixtureofαandβforms. As with paraquat (Section 9.4.3), there are conflict-
ingreportsontheabilityofdesferrioxaminetoprotect
animalsagainstalloxan.Somescientistsreportedpro-
theisletsatarget?Acombinationoffactors.First,they tective effects in short-term experiments, but others
arerichinGLUT-2.Second,activitiesofantioxidantde- findthatdesferrioxamineaggravatesalloxan-induced
fence enzymes in islets are modest, perhaps because diabetesinvivo.76 ThespintrapPBNcanprotectmice
ROSplayaroleininsulinsignalling(Section10.5.2).68 againstalloxan-induceddiabetes,possiblybytrapping
Isolatedrodentβ-cellsreducealloxantodialuricacidat alloxanradicals,81butrememberthatPBNhasmultiple
ahighrate:reductionmayinvolveGSH,thioredoxin, biologicaleffects(Section11.5.5).
and/or glutaredoxin.69 In addition, islet cells contain
the TRPM2 cation channel (Section 5.3.2.2), which is
9.7.2 Streptozotocin
important in insulin secretion. However, its presence
means that islets are susceptible to excessive rises in Althoughitisnotaredox-cyclingagent,itisconveni-
intracellularfreeCa2+whenexposedtoRS.70Lastly,the enttodiscusshereanotherdrugoftenusedtoinduce
enzymeglucokinase,whichplaysakeypartininsulin diabetesinanimals.Streptozotocin(Fig.9.7)isanitro-
secretion, can be inactivated by –SH modification by sourea compound produced by Streptomyces achromo-
alloxan. genes.ItpassesthroughGLUT-2channelsandinduces
It is worth noting that human islet cells are less DNAstrandbreakageinβ-cells,probablybydirectat-
sensitive to oxidative damage (e.g. by alloxan) than tackonDNA(Fig.9.8).However,RScouldplaysome
the commonly used rodent cells, perhaps because roleinstreptozotocinaction,sincemicewithincreased
they have higher levels of SOD, catalase, heat-shock levels of MnSOD and catalase in their islets showed
proteins, and DNA-repair enzymes and possibly less less damage by this agent,82 as did mice lacking
GLUT-2.71,72However,levelsofGPxmaybelow73(in- the iron transporter DMT1.75 Raising metallothionein
deed,toomuchGPxcaninterferewithisletfunction; levels is also protective (Section 11.6.2). How the RS
Section 10.5). Chick islets are different yet again,74 so mightbeproducedisasyetunclear.
beware of species differences when interpreting data Knockout mice lacking PARP-1 are resistant to the
fromexperimentsonisolatedislets. diabetogenic action of streptozotocin. Inhibitors of

--- Page 534 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 479
Alloxan
O 2 (cid:129)–, H 2 O 2 protein damage, lipid
peroxidation
metals
DNA
OH(cid:129) Streptozotocin
damage
(direct attack by
methylnitrosourea group)
poly (ADP-ribose) polymerase
inhibitor present
Poly (ADP-ribose) polymerase NAD+ maintained
NAD+ DNA repair slowed
β-cell function protected
β-cell function
cell death
Risk of
Insulin-deficient
oncogenesis
diabetes
Figure9.8 Mechanismsofthediabetogenicactionsofstreptozotocinandalloxan.AdaptedfromBioEssays,2,19,1985,bycourtesyof
ProfessorH.Okamotoandthepublishers.InhibitorsofPARP-1thatprotectagainsttheseagentsincludebenzamide,3-aminobenzamide,and
theophylline.TheeffectsofexcessNO•onisletcellsmayalsoinvolveDNAdamage.KnockoutmicelackingPARP-1areresistanttostreptozotocin
(NatureMed.5,314,1999).
PARP are also protective, but treatment of rats with andsomeenterstheblood.83 Itisalsopresentinripe
both streptozotocin and PARP-1 inhibitors was re- fruits.83 Ethanolissolubleinwaterandmanyorganic
ported to lead to the development of tumours of the solvents. Hence it crosses cell membranes readily, in-
β-cells(insulinomas)inafewanimals.Thisisconsist- cluding the blood–brain barrier. One beneficial effect
ent with the concept of lethal NAD+ depletion (Sec- that it has, apart from some social ones, is to par-
tion5.2.5);PARP-1activationleadingtosevereNAD+ tiallyprotectanimalsagainstalloxan-induceddiabetes.
depletionmayhelptheorganismbykillingcellswith Itmaydothis(atthehighconcentrationsusedinthe
excessivelevelsofDNAdamage,sominimizingtheoc- studies)84byscavengingOH•toformthelessreactive
currenceofharmfulmutations(Fig.9.8).Lowcatalase hydroxyethylradical:
activityhasbeensuggestedtopre-disposehumansto
•
developingdiabetes(Section3.17.7). CH CH OH + OH •→CH CHOH + H O
3 2 3 2
This reaction is used in spin-trapping experiments
9.8 Alcohols
(Section 6.2.4). Indeed, spin traps such as PBN and
POBNhavebeenusedtodetecthydroxyethylradical
9.8.1 Ethanol
inoxidizedwine85andinvivoinethanol-dosedrats.86
Many of us drink some ethanol (ethyl alcohol) in al- Hydroxyethyl radicals generated in wine or beer can
coholic drinks, and even teetotallers are exposed to readily reactwith thephenoliccompoundspresent;85
it because traces are formed by human gut bacteria theycanalsoreactwiththiols,ifpresent.87

--- Page 535 ---

480 FREE RADICALS IN BIOLOGY AND MEDICINE
9.8.1.1 EthanolmetabolismandCYP2E186,88,89
Inanimals,mostethanolismetabolizedintheliverby
alcohol dehydrogenase (ADH) enzymes, to form the
aldehydeethanal(acetaldehyde),
causes the same symptoms, and has been used to
CH 3 CH 2 OH + NAD+→ NADH + H+ + CH 3 CHO treat alcoholism. It is rapidly converted in vivo into
diethyldithiocarbamate (a CuZnSOD inhibitor; Sec-
Ethanalismoretoxicthanethanolandmustberapidly tion3.5.1.4),whichisfurthermetabolizedintoasulph-
metabolized by aldehyde dehydrogenases in mito- oxide that inhibits aldehyde dehydrogenase.91 Cyan-
chondria, amide can also be metabolized to an aldehyde de-
H O + CH CHO + NAD+→ NADH +H+ hydrogenaseinhibitor(Section3.17.4).
2 3 HighintakesofalcoholshiftcellularNAD+/NADH
+CH COOH
3 ratios in favour of the reduced state in both cytosol
acetic (ethanoic) acid and mitochondria; this may help to promote abnor-
mal fat accumulation in the liver (Fig. 9.9). Indeed,
alcohol-relateddiseasesareasignificantcauseofmor-
Polymorphismsofaldehydedehydrogenasegenesthat bidityandmortalityinmostcountries.Thecommonest
produceenzymeswithlessactivitycauseimpairedtol- is alcoholic liver disease, which has various stages.
eranceofalcohol,sometimesmanifestedasnauseaand Manyheavydrinkersdevelopfattyliver,oftenasymp-
aflushreactiononalcoholconsumption,90thataredue tomatic.Someofthemprogresstohepatitisandeven-
to acetaldehyde accumulation. Administration of the tuallytohepaticfibrosis(cirrhosis).Upto15%ofthe
drugdisulphiram(Antabuse®), lastgroupmaygoontodeveloplivercancer.Excessive
Damage to gut, increase
Ethanol
Portal Vein Endotoxin
in gut permeability
activate via Toll-like receptors
Hepatocyte ROS/RNS
Redox shift Cytokines
NADH/NAD+ Prostaglandins
Kupffer cell
Oxidative stress
Antioxidants
Lipotoxicity
ER stress
Mitochondrial damage
DAMP release ROS/RNS
(Necrosis) Cytokines (especially TNF-α, also TGF-β1)
Prostaglandins
Acetaldehyde
LPO products
ROS/RNS cytokines
Stellate cell Extracellular
matrix protein
(especially collagen)
Vitamin A stores
Smooth muscle α–actin
Proliferation Fibrosis
Figure9.9 Effectsofalcoholontheliver.Chronicalcoholconsumptiontriggersaseriesofeventsinhepatocytes,Kupffercells,andhepaticstellate
cellsthatarebelievedtoplayimportantrolesintheinitiationandprogressionofalcohol-inducedliverinjury.AdaptedfromFreeRadic.Res.37,
585,2003,bycourtesyofDrS.M.BaileyandTaylorandFrancis.FataccumulationinresponsetoethanolistriggeredbyrisesintheNADH/NAD+
ratio,bydecreasingthelevelofperoxisomeproliferator-activatedreceptor-α(PPARα),atranscriptionfactorwhichincreaseslevelsof
enzymesinvolvedinfattyacidtransportandβ-oxidation(decreasedlevelspromoteincreasesinstoredfat;seealsoSection10.15.2.1),andby
stimulationoflipogenesisbyactivatingsterolregulatoryelementbindingprotein1(SREBP-1),atranscriptionfactorthatleadstohigher
activitiesofenzymesinvolvedincholesterol,fattyacid,andtriglyceridesynthesis(FreeRadic.Biol.Med.65,952,2013andref89).LPO–lipid
peroxidation.

--- Page 536 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 481
alcohol intake also increases the risk of developing beneficialtothecardiovascularsystem.Multiplemech-
cancersin othertissues,includingthemouth,larynx, anisms account for this, including increased plasma
oesophagus, liver, breast, and colon. The ability of HDL levels, decreased plasma fibrinogen, and in-
acetaldehydetobindtoDNAandproducemutagenic creased NO• synthesis by the vascular endothelium.
adductsisasignificantcontributortothisrisk;subjects Other possible effects include antithrombotic actions
lowinaldehydedehydrogenaseactivitywhodrinkap- andischaemicpreconditioning(Section10.6.6).95There
peartobeatincreasedriskofoesophagealandpossibly maybeextrabenefitsfromredwinesbecauseoftheir
other cancers.90 Indeed, high levels of acetaldehyde flavonoid content (Section 4.5), although this has not
can be present in saliva, due to oxidation of ethanol been clearly established; it may be the alcohol that
byoralbacteria.Acetaldehydecanbeproducedinthe exertsmostorallofthecardioprotectiveeffect.95 Epi-
colon from ethanol by the action of colonic bacteria, demiological studies plotting cardiovascular disease
andmightcontributetocolonicdamage(andperhaps incidenceagainstalcoholintakeoftenshowaJ-shaped
to colon cancer) resulting from excessive drinking.90 curve:asmalltomoderateethanolintakeisgoodand
Alcohol abuse is also a risk factor for pancreatitis excess(>35drinksperweek)increasesincidence.Ac-
(Section10.13.1)andosteoporosis(Section8.10.8). ceptableintakeshavebeenquotedas21unitsperweek
Smaller amounts of ethanol can be oxidized by in men and 14 in women (less in pregnant woman).
theperoxidaticactionofcatalaseinperoxisomes(Sec- One unit (10 g) of alcohol is contained in about 1 oz
tion3.17.4)andbycertainCYPs.Catalasealsooxidizes of whisky, one glass of wine, or half a pint of beer.
the ‘anti-alcohol’ drug cyanamide (Section 3.17.4). However,apregnantwomanwhodrinksisexposing
Manyyearsago,amicrosomalethanoloxidizingsys- thefoetustoalcohol,sinceitcrossestheplacentaread-
tem(MEOS)wasidentified;itwasobservedthatliver ily. Indeed, the foetal alcohol syndrome (FAS) that
microsomes can oxidize ethanol (and some other al- can arise in the babies of mothers who drink to ex-
cohols,includingbutanol)andthatratesofoxidation cess is characterized by growth retardation, damage
were increased in microsomes from animals chronic- to the nervous system (often accompanied by im-
ally exposed to ethanol. We now know that repeated pairedcognitivefunction),andfacialaberrations,such
exposuretoethanolinducessynthesisofCYP2E1,the as eye abnormalities.96 In part, the ethanol may act
ethanol-inducible cytochrome P450, in hepatocytes by interfering with the normal function of glutam-
andKupffercells.88Micelackingthisaremuchlesssus- ateinpromotingsynapseformationinthedeveloping
ceptibletoliverdamagebyethanol.92CYP2E1doesn’t brain, probably by inhibiting the NMDA receptors
onlyoxidizeethanoltoacetaldehyde;itactsonmany (Section10.17.4).96,97
othersubstrates,includingacetone,butanol,pentanol, Frequent intake of large amounts of ethanol by
aniline,paracetamol,benzene,pentane,halothane,iso- humans damages many tissues, especially the liver.
flurane, chloroform, cocaine, and CCl . Several xeno- Alcohol-induced liver disease is characterized by fat
4
biotics that are metabolized by CYP2E1 to more re- accumulation, inflammation, and necrotic death of
active products can thus exert toxic effects at lower hepatocytes (releasing DAMPs, so promoting inflam-
levels than usual in chronic alcohol consumers; ex- mation)anditcanprogresstocirrhosis(Section9.8.1.1;
amplesareparacetamol(Section9.10)andcocaine(Sec- Fig. 9.9). Inflammation involves both hepatic resi-
tion 9.9). CYP2E1 is present in various regions of the dent macrophages (Kupffer cells) and lymphocytes
brain and levels can be increased by ethanol expos- and neutrophils recruited from the circulation. Pro-
ure(Section10.17.5);itmaybeamoreimportantroute duction of ROS (via NADPH oxidase) and TNF-α by
ofalcoholmetabolismthere,sincebrainhasonlylow Kupffer cells play an important role; indeed, in mice
levels of ADH.93 Alcohol can decrease glucose con- deficientinTNF-αreceptors,alcohol-inducedliverin-
sumptionbythebrain,withincreasedusageofacetate juryisdecreased.88,89Hepaticironoverloadiscommon
asanenergysubstrate.94 in patients with alcoholic liver diseases and the ef-
CytochromeP4502E1levelsarealsoelevatedindia- fects of alcohol are worsened if there is pre-existing
betes and obesity, and its levels can be increased by ironoverload,e.g.duetohaemochromatosis.98Chronic
severalsolventsotherthanethanol,includingacetone, alcoholism frequently causes cognitive impairment,
benzene,CHCl ,anddimethylsulphoxide. possiblyinvolvingsuppressionofneurogenesisinthe
3
hippocampus99 and it can damage the intestine, al-
9.8.1.2 Ethanoltoxicity88,89 lowing endotoxins to enter the body (Fig. 9.9). It can
Ethanol is remarkably non-toxic to animals at mil- alsolowerthiaminelevelsinthebrain,addingtothe
limolar levels, and moderate intakes may even be damage(Table4.1).

--- Page 537 ---

482 FREE RADICALS IN BIOLOGY AND MEDICINE
9.8.1.3 DoesethanolincreaseRS present in blood from patients with alcoholic liver
formation?86,88,89 disease. There is some suggestion that CYP2E1 is
‘leakier’thanotherP450isoforms;duringitsoperation
In many countries it is illegal to drive a motor ve-
significantamountsofO
•–
andH O maybereleased
hiclewithabloodethanolconcentrationgreaterthan 2 2 2
(Fig.1.11).Indeed,overexpressingCYP2E1invarious
80mgper100ml,correspondingtoaconcentrationof
mousetissuesleadstoelevatedoxidativedamage.88,105
approximately 17.4 mM. Some heavy drinkers reach
Yet another source may be acetaldehyde. This is
levels of 300 mg per 100 ml of blood, or 65.2 mM.
mainly metabolized by aldehyde dehydrogenases in
Thesehugeconcentrations(hugebycomparisonwith
liver, but some might be acted upon by aldehyde
toxiclevelsofalmostanyotherxenobiotic)havebeen
oxidase,106 which produces O •– (Table 1.3). In ad-
showninanimalstoaffectantioxidantprotectivesys- 2
dition, CYP2E1 and XO can oxidize acetaldehyde,
tems and cause oxidative damage. Infusion of large
the latter producing O
•–
and H O . Indeed, the
dosesofethanolintoanimalsdecreasedtheSODactiv- 2 2 2
XO/dehydrogenase ratio can sometimes increase in
ityofcertaintissuesinsomestudies.Incontrast,some
the liver of ethanol-treated rodents.106 However, the
otherscientistshavereportedincreasesinSODactivity
affinity of XO for ethanal is low, so that xanthine
inanimalstreatedwithethanolforprolongedperiods,
andhypoxanthinemaywellout-competeacetaldehyde
possiblyreflectingadaptation.
as substrates in vivo. Acetaldehyde not only reacts
Both large doses of ethanol, and smaller doses
with DNA (Section 9.8.1.1) but also (reversibly) with
given repeatedly, increase lipid peroxidation in the
GSH (another contributor to a fall in GSH concen-
plasma and livers of animals and humans, as meas-
trations) and with protein –SH and NH groups, e.g.
ured by increases in conjugated dienes and, more 2
on albumin and in mitochondrial proteins. Some of
convincingly (Section 6.15), as rises in ethane exhala-
theseadductsmightprovokeanimmuneresponse.In-
tion, phosphatidylcholine hydroperoxides, HNE, and
F -IsoPs.100LargedosesofethanoldecreaseGSHlevels deed, protein adducts containing both acetaldehyde
2
andMDAhavebeendetectedinanimalsandhumans,
in several animal tissues, including liver, brain, and
andalcoholicswithadvancedliverdiseasefrequently
kidney; GSH depletion can promote oxidative stress.
have circulating antibodies that recognize aldehyde–
Decreases in GSH levels in lung lining fluids in hu-
man alcoholics have also been observed.101 Alcohol protein adducts or oxidized phospholipids.107 Acet-
aldehyde might even help to convert dopamine
abuse interferes with methionine metabolism in the
and serotonin in the brain (including the foetal
liver,slowingitsconversiontoS-adenosylmethionine
brainsinsidepregnantrats)intoneurotoxicproducts,
by the methionine adenosyltransferase (MAT) en-
such as tetrahydroisoquinolines and tetrahydro-β-
zyme and resulting in less cysteine production. This
carbolines (Section 10.20.3).49,108,109 Other potentially
contributes to the drop in GSH. Oxidative stress can
toxic products generated from ethanol include fatty
directlydamageMAT,whichhasseveralcysteineres-
idues essential to its function.102 Foetal brain tissues acid ethyl esters, which have been suggested to be
neurotoxic.
often show increased levels of oxidative damage to
Withdrawalofethanolfromneurons‘adapted’toits
DNA,proteins,andlipidsafterthemothershavebeen
presenceinculturecanalso,paradoxically,causedam-
dosed with ethanol, suggesting that oxidative dam-
agethatmayinvolveRS.Indeed,increasedlipidper-
age might contribute to the foetal alcohol syndrome.
oxidation(asF -neuroprostanelevels)wasobservedin
Theembryomaytrytoadapt,e.g.usingtheNrf2sys- 4
tem to increase GSH levels.95,103 Finally, the ability thebrainsofethanol-fedratswhenadministrationwas
stopped.110
of chronic ethanol consumption to decrease plasma
testosterone levels in males has been suggested to
9.8.1.5 Doesoxidativedamageexplainethanol
involve increased oxidative damage in the pituitary
gland.104
toxicity?88,89
We have seen that excess ethanol consumption is ac-
9.8.1.4 Howdoesethanolcauseoxidative
companiedbyGSHdepletionandincreasedoxidative
stress?86,88,89
damage.Doesthisaccountforethanoltoxicitytohu-
One possibility is that increased mitochondrial mans?Somecontributionseemslikely,buthowmuch
NADH/NAD+ratiospromoteO •–formation(Fig.9.9), is uncertain. Analysing the role of RS in tissue dam-
2
somewhat analogous to the situation in diabetes age in human alcoholics can be made difficult by
(Section10.5).Hydroxyethylradicalsgeneratedduring the fact that their diet is often inadequate, lacking
metabolism of ethanol by CYP2E1 can form adducts enough α-tocopherol, selenium, B vitamins, or PU-
with proteins; antibodies against such adducts are FAs and sometimes too rich in saturated fats. Heavy

--- Page 538 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 483
drinkersareoftencigarettesmokers,compoundingthe 9.8.1.7 Therapeuticoptions?
pathologyoftwodifferenttoxicagents.Theeffectsof
To summarize, important sources of RS in alcohol-
ethanol in causing fatty liver may be largely due to
inducedliverdamageincludemitochondria,CYP2E1,
alteredNADH/NAD+ratiosandchangesingenetran- Kupffercellsandotherphagocytes,TNF-α,andendo-
scription(Fig.9.9).Nevertheless,micelackinggastric
toxinfromthegut.Ironoverloadinthedamagedliver
parietalcellMnSODshowedgreaterstomachdamage
mayaggravateoxidativeinjury,assumingthattheac-
byethanol,111 andmicelackingCuZnSOD,orcatalase
cumulated iron is able to catalyse oxidative damage.
and Gpx-1, or peroxiredoxin-1 show enhanced liver
GSHdepletioncanfacilitateoxidativedamage;indeed,
damageafteralcoholadministration,accompaniedby
experimentallyloweringhepaticGSHlevelsinmiceby
risesinthelevelsofproteincarbonyls,aldehydesde- decreasingγ-glutamylcysteinesynthetaselevelsledto
rived from lipid peroxidation, and 3-nitrotyrosine.112
fataccumulationandeventualhepatocytenecrosisand
All of these data suggest key roles for ROS/RNS. liverfailure.124
Indeed, mice over-expressing MnSOD were more re-
So would antioxidants ameliorate the toxicity of
sistanttoliverdamagebyethanol,113 aswereratsad-
ethanol?Severalstudieshaveattemptedtousethemto
ministered the ‘mitochondrially targeted antioxidant’
treat liver damage/fibrosis due to alcohol, or NASH.
MitoQ(Section11.5.12).114 Some studies with high-dose α-tocopherol reported
Alcohol-inducedliverfibrosisseemscloselyassoci-
improvements,butothersfoundnoeffect(doremem-
atedwithlipidperoxidation.Fibrogenesisintheliver berthatα-tocopherolisoftenineffectiveatdecreasing
is mediated by hepatic stellate cells (Fig. 9.9). After oxidative damage).125–127 Effects of N-acetylcysteine
insulttotheliverbyethanol,othertoxins,orviralin- were similarly modest.116,128 The drug pentoxifylline
fection, they can become activated to proliferate and
has been suggested to be beneficial, perhaps by de-
produce collagen. Both 4-HNE and F 2 -IsoPs appear creasingratesoflipidperoxidation.121 Silymarin,iso-
to be profibrogenic stimuli for stellate cells and O
•–
2 latedfromthemilkthistleSilybummarianum,hasbeen
mayalsocontribute(Fig.9.9).100,115–117Oxidativestress
claimed to be beneficial against liver damage in hu-
probably also contributes to ethanol-induced cogni-
mans in some (but not all) studies, and is effective
tiveimpairment,thefoetalalcoholsyndrome,andthe in animals.129 Whether any benefit it has is due to
damagetotheintestinalmucosathatallowsendotoxin
antioxidant, or other, actions remains to be determ-
entrytothecirculation(Fig.9.9).118 Heartdamageby
ined. Silymarin is a mixture of phenolic compounds,
alcohol may also involve increased NADPH oxidase
includingsilybin(sometimescalledsilibinin),
activityandoxidativedamage.119
9.8.1.6 Otherliverdiseases
ROScanalsobeinvolvedinliverdiseasesnotrelated
toalcoholconsumption.Non-alcoholicfattyliverdis-
ease(NAFLD),excesshepaticfataccumulationinthe
absence of excess alcohol intake or other liver dis- 9.8.2 Allylalcoholandacrolein130
ease,isincreasinglycommoninthe‘advanced’world.
NAFLD is closely associated with the metabolic syn- Alcohol dehydrogenase is not specific for ethanol;
dromeandtype2diabetes(Section10.5).NAFLDcan othersubstratesincludemethanol(CH OH),oxidized
3
progress into the more serious non-alcoholic steato- to formaldehyde (HCHO), and allyl alcohol, to ac-
hepatitis (NASH), liver inflammation and degener- rolein. Allyl acetate, allyl alcohol, and acrolein are
ation involving fatty infiltration of hepatocytes. It is used in the manufacture of plastics, detergents, and
associatedwithobesityandhigh-fatdiets,andcanlead some pharmaceuticals. We have already met acrolein
to fibrosis that can progress to cirrhosis and/or liver asatoxicunsaturatedaldehydeproducedduringlipid
cancer. Levels of 8OHG in DNA, lipid peroxides (in- peroxidation (Section 5.12.5.3). Indeed, feeding allyl
cluding cholesterol oxidation products),120 HNE, and alcohol to animals produces liver necrosis, prevent-
iron in the liver are all elevated in NASH, and iron ablebysupplyingthealcoholdehydrogenaseinhibitor
overloaddiseasesorGSHdepletionacceleratethepro- pyrazole. Acrolein is also found in automobile ex-
gressionofNAFLD.121,122 Nrf2isalsoactivated.123Al- haustgases,overheatedcookingoils,cigarettesmoke
cohol consumption can also worsen hepatitis due to (Section9.13),andasametaboliteofcyclophospham-
viralinfections,e.g.withhepatitisC. ide,131adrugusedincancertreatment.Acroleincanbe

--- Page 539 ---

484 FREE RADICALS IN BIOLOGY AND MEDICINE
convertedbyaldehydedehydrogenasestoacrylicacid, convertedtoα-methyldopamine(Fig.9.10).Bothmay
butitalsoreactsrapidlywiththiols(largelybyMichael cause oxidative stress by quinone formation and/or
additiontothedoublebond;Section5.12.5.3),causing redox cycling; nitrotyrosine formation and neuronal
GSHdepletion,andproteinmodification.Highlevels damage induced by methamphetamine were attenu-
ofacroleinalsocausereleaseofironionsfromcellular atedinnNOS-knockoutmice,139 suggestingarolefor
ironstores.132 RNS as well. α-Methyldopamine readily oxidizes to
generate ROS and quinones/semiquinones that bind
9.9 Otherrecreationaldrugs to protein –SH groups and deplete GSH; their GSH
conjugates may be precursors of other neurotoxic
Somehavecalledethanol‘theworld’smostcommonly agents.38ProstaglandinHsynthase(Section8.12)may
used psychoactive drug’, but there are many others. alsobeabletooxidizeMDMAandMDAinvivo.140
Likeethanol,cocaine(Fig.9.10)candamagebothadult What about cannabis (Cannabis sativa)? Smoking
and foetus.133 It is metabolized in the liver, mainly anything causes harm (Section 9.13) and cannabis
by hydrolysis by esterases (detoxification), but about smoke is rich in polycyclic aromatic hydrocarbons,
10% can be acted upon by CYPs in various tissues acetaldehyde, and multiple other toxins.141 However,
(includingheartandbrain)togivenorcocaine(theN- there are proposals that some constituents of can-
oxidationpathway),andN-hydroxy-norcocaine.The nabis, such as the cannabinoids, could be antioxi-
latter can form a nitroxide radical that may gener- dants under certain circumstances. For example, (cid:7)9-
ate O
•–
by redox cycling as well as being directly tetrahydrocannabinol and the non-psychoactive can-
2
damaging to biomolecules, possibly by producing a nabinoid cannabidiol (Fig. 9.10) have been variously
+
nitrosonium(N=O)electrophile.133 reported to protect neurons in culture against excito-
Do RS contribute to damage by cocaine? Obser- toxicity and rats against diabetic cardiomyopathy, or
vations that administration of the GSH precursor 2- against brain damage induced by administration of
oxothiazolidine-4-carboxylate (Section 11.5.9.1) or the amphetamineor6-hydroxydopamine.142-144Cannabid-
spintrapPBN(Section6.2.4)decreasedembryodam- iolcouldalsoprotectratsagainstliverdamagecaused
age in pregnant mice given cocaine, and that MitoQ byexcessethanoladministration.145Antioxidantmech-
(Section 11.5.12) prevented cardiac damage in adult anisms, presumably due to the phenolic structures
rats treated with cocaine, suggest that they do.133,134 (Fig 9.10) have been suggested to account for these
Thefoetotoxicityofcocainemayinvolvenotonlydir- protective effects.142–145 However, cytotoxic effects of
ectdamage,butalsococaine-inducedvasoconstriction cannabidiol have also been reportedin some studies,
(itselfpossiblymediatedviaROSgeneration)thatcan e.g.tooligodendrocytesinculture.146
subjecttheembryotoischaemia–reperfusion.135
Other popular drugs are methamphetamine
(‘speed’) and its derivatives, including 3,4- 9.10 Paracetamol(acetaminophen)
methylenedioxymethylamphetamine (MDMA), so- andnaphthalene,glutathione-depleting
metimescalledecstasy.MDMAcausesanabnormally
toxins
large release of 5-hydroxytryptamine (5-HT) from
neurons,followedbyprolongeddepletionof5-HTand Paracetamol (called acetaminophen in the USA) is a
damage to serotonergic nerve terminals and axons. mild painkiller; unlike aspirin and other COX-1 in-
TheneurotoxicityofMDMAorofmethamphetamine hibitors,it does notirritatethestomach. Paracetamol
isdiminishedinmiceoverexpressingCuZnSOD,sug- is safe in the recommended dosage, but overdoses
gestingthatO •– isinvolved.136 Indeed,increasedOH• (frequentlyinsuicideattempts)damagetheliverand
2
formationhasbeendetectedinthebrainsofMDMA- kidneys.Theliverdamagecausedbyexcessparaceta-
treated animals,137 using the salicylate hydroxylation molislife-threateningandoftencanonlybedealtwith
technique (Section 6.3.1). The hyperthermia caused by transplantation. Ethyl paracetamol, phenacetin, is
by ecstasy may also accelerate ROS production in nolongermarketedasapainkillerbecauseoftherisk
the brain. Administration of methamphetamine to ofkidneydamage.
pregnant mice increased the levels of 8OHG in DNA Paracetamol is mostly metabolized by sulphation
from the foetal liver and brain and led to impaired and glucuronidation, but is also a substrate for sev-
motorcoordinationafterbirth.138 eral CYPs, especially CYP2E1. Oxidation by CYPs is
Ecstasy is demethylated by CYPs to 3,4- usuallyaminorpathwayinparacetamolmetabolism.
methylenedioxyamphetamine (MDA) and then Paracetamoloverdosagesaturatesthesulphationand

--- Page 540 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 485
CH —CH—CH
2 3
NH—CH
3
Methamphetamine
O CH 2 —CH—NH—CH 3
CH
3
O
3,4-Methylenedioxymethamphetamine (MDMA)
O CH 2 —CH—NH 2
CH
3
O
3,4-Methylenedioxyamphetamine
HO CH NH
2 2
CH
HO CH 3
α-Methyldopamine
CH O H O OH O
3
N CH 3 N CH 3 N CH 3
O O O
O O O
O O O
Cocaine Norcocaine N-hydroxy-norcocaine
CH
3
OH
H H 3 3 C C O CH 2 CH 2 CH 2 CH 2 CH 3
Δ9-Tetrahydrocannabinol (THC)
CH
3
OH
H 2 C C HO CH 2 CH 2 CH 2 CH 2 CH 3
CH
3
Cannabidiol (CBD)
Figure9.10 Structuresofsome‘recreationaldrugs’.

--- Page 541 ---

486 FREE RADICALS IN BIOLOGY AND MEDICINE
O O O O
NHCCH 3 NHCCH 3 NHCCH 3 NCCH 3
NO
2
OCH 2 CH 3 OH OH O
Phenacetin Paracetamol 3-Nitroparacetamol N-Acetyl- Naphthalene
(4-ethoxyacetanilide) (4-hydroxyacetanilide) p-benzoquinoneimine
Figure9.11 Structuresofphenacetin,paracetamol,itsnitratedandquinoneiminederivatives,andofnaphthalene.
glucuronidation pathways and the CYP pathway Paracetamol-induced lipid peroxidation has been
becomes more prominent. Indeed, ‘knockout’ mice demonstrated in the livers of animals, but there is
lackingCYP2E1arelesssensitivetoparacetamoltox- onlylimitedevidencethatperoxidationcontributesto
icity. The action of CYPs on paracetamol produces paracetamolhepatotoxicity.151Forexample,onlysmall
a reactive quinoneimine (Fig. 9.11), which can bind increases in F -IsoPs were observed in the plasma
2
to protein –SH groups as well as to GSH; the latter of rats given hepatotoxic doses of paracetamol. More
reaction occurs both spontaneously and is catalysed likely, the extensive GSH depletion and tissue injury
by GST enzymes.147 Figure 6.24 illustrates this fast caused by paracetamol lead to secondary lipid per-
dropinGSHlevels.ConjugationwithGSHandsubse- oxidation and other free-radical reactions. A rise in
quentmercapturicacidformation(Section3.15.2)help free Ca2+ can activate calpains and stimulate pro-
to detoxify paracetamol, although the paracetamol– duction of NO•, and hence of ONOO–. This results
cysteine conjugate may be toxic to the kidney at in protein nitration (including nitration of MnSOD
highlevels.148Paracetamoloverdosageleadstoexcess and several other mitochondrial proteins)149 and ni-
quinoneimine formation and severe GSH depletion tration of paracetamol itself, to 3-nitroparacetamol
in the liver. GSH depletion leaves the quinoneimine (Fig. 9.11).152 Unusually, CuZnSOD does not help!
freetoattackproteins,includingPDI,glutaminesyn- Mice deficient in it were less sensitive to paraceta-
thetase, the Ca2+-ATPase of the endoplasmic reticu- molhepatotoxicityandless3-nitrotyrosinewasformed
lum,theCa2+exportsystemoftheplasmamembrane, in the liver, consistent with the ability of this en-
and mitochondrial proteins.147,149 A rise in intracel- zyme to promote ONOO–-dependent nitration (Sec-
lular free Ca2+ results, and contributes to hepatocyte tion 2.6.1.1) and with an important role for nitra-
death. Activation of Kupffer cells and neutrophil re- tion in paracetamol hepatotoxicity.149,153 In addition,
cruitment resulting from the release of DAMPs from plasmaofpatientswithparacetamol-inducedliverfail-
necrosing hepatocytes make matters worse. In ad- urecontains‘catalytic’ironandcopperionsthatmight
dition, calpains released from damaged hepatocytes helptopromoteoxidativedamage.154 Onegoodthing
can injure other liver cells, and also cause systemic aboutparacetamol;itisanefficientscavengerofHOCl
damage.150 andasubstrateforMPO,andcaninhibitmyoglobin-
Sulphur-containing compounds, such as N- dependent lipid peroxidation and renal damage
acetylcysteine or methionine, can protect the liver inmice.155
against paracetamol if administered early enough. Thecarcinogenicenvironmentalpollutantnaphtha-
Theyactbybeingmetabolizedtocysteineandmain- lene (Fig. 9.11) targets the Clara cells of the lung in
taining intracellular GSH, and N-acetylcysteine may mice,probablybecausetheyarerichintheCYP2F2en-
directlyscavengethequinoneimineaswell.Alcoholics zymethatinitiateitsconversiontoreactivemetabolites
are more vulnerable to paracetamol because of de- (epoxides,diols,andquinones,thatcanredoxcycle).1
creasedGSHandelevatedCYP2EI.Thisdoesnotoccur The quinones also combine with GSH. Depletion of
when alcohol is in the body (since ethanol competes GSH contributes to naphthalene cytotoxicity, allow-
with paracetamol for metabolism by CYP2E1), but ingquinonestoattack–SHgroupsonkeyproteins.156
whenalcoholistemporarilyavoidedyettheCYP2E1is Naphthaleneismuchlesscarcinogenic(ifatall)inrats
stillpresent(e.g.takinghighdosesofparacetamolto andhumansthanitisinmice,duetolowerlevelsof
treatthe‘morningafterthebinge’symptoms). theCYPsthatcanmetabolizeit.

--- Page 542 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 487
9.11 Chlorinegas157 fabrics and clothing; all of these reactions generate
volatile aldehydes and other products,161 as does re-
Chlorine, a yellowish-green choking poisonous gas,
actionofO withhumanskinlipids.162 Ozoneattacks
3
is a widely used industrial chemical and popular as proteins(Section2.6.5)andcangenerate1O andOH•.
a means of water disinfection, so we are exposed 2
Both lipids and proteins in surfactant163,164 and else-
to low levels of it in drinking water and swimming
where in the respiratory tract may be targets of at-
pools. If too much chlorine is inhaled, severe lung
tackbyO .O canalsofacilitatenitrationofproteins
damage results. Chlorine is itself directly oxidizing 3 3
(Sections2.6.5and9.12.2).
andcanformhypochlorousacid,alsohighlyreactive
Millions of people worldwide are exposed to O
(Section2.6.3)togetherwithHCl,astrongacidthatin- 3
levelsabovethe1998USANationalAmbientAirQual-
stantlyionizesandcreatesalowpHthatirritatesthe
ityStandard(NAAQS)of0.12 ppm(120 ppb)for1h
respiratorytract,
exposure,and0.075ppmaveragedover8hexposure.
Cl + H O (cid:2) HOCl+H++Cl– Lung damage is both by direct oxidative damage, as
2 2
wellasbyinducinga‘sterile’inflammation,involving
Exposure of concentrated NaOCl-based bleaches to DAMPrelease(oneoftheDAMPsisperoxiredoxin1,
acidcanalsoliberatesubstantialquantitiesofCl 2 ,by another, fragmented hyaluronic acid), leading to ac-
forcingtheabovereactioninthereversedirection. tivation of alveolar macrophages and recruitment of
In animals, administration of several antioxidants neutrophils to the lung.165,166 Ozone levels as low as
has been reported to ameliorate Cl 2 toxicity: they in- 0.5ppmcancauselungdamage(especiallylossofcili-
clude ascorbate, GSH, N-acetylcysteine, AEOL10150 ated cells and type I alveolar cells) in a few hours.
(Section 11.5.4), and desferrioxamine. All of these Somephotocopyingmachineshaveevenbeenreported
agentsprobablyreactdirectlywithCl 2 and/orHOCl to produce detectable amounts of O 3 (in addition to
(Section2.6.3),helpingtoprotectthelung.Desferriox- fine particles and volatile organic compounds), al-
aminemayadditionallyprotectbychelating‘catalytic’ though whether the amounts are sufficient to be a
ironionsreleasedbylunginjury.157–159 humanhealthriskisuncertain.167Ozonemayalsoag-
gravate asthma in susceptible subjects (Section 7.3.3),
9.12 Airpollutants160 especially those with low dietary intake of antioxi-
dantsand/orthosecarryingtheGSTM1nullallele.168
Thereismuchinterestinthedeleterioushealtheffects However, studies of the correlations between poly-
ofairpollution.Toputthisintoperspective,remember morphismsofantioxidantenzymesandsusceptibility
thatO
2
isafree-radicalgas,whoseappearanceinthe toairpollutionareasyetinconclusive.169
atmosphere(Section1.1)hasbeencalled‘theworstcase Fortunately,constituentsoftherespiratorytractlin-
ofairpollutionevertooccuronEarth’,althoughinthe ingfluidsprobablyabsorbmostoralloftheO thatwe
3
longtermitdidmoregoodthanbadoverall!Wewill breathe in. These fluids contain ascorbate, GSH, and
nowconsidersomeotherpollutants,bearinginmind urate(Tables7.1and7.2)whichactasO scavengers,
3
thatthedamagecausedbyinhaledgaseoustoxinsmay e.g. GSH is oxidized to several products, including
bemediatednotonlybythetoxinsthemselves,butalso the sulphonate.170 Urate may be the most important
byproductsoftheirreactionswithconstituentsofthe scavenger because of its fast reaction with O and
3
respiratorytractliningfluids.Thisisespeciallytruefor high concentration in the lining fluids.171,172, Indeed,
O 3 ,soweconsideritfirst. breathingO 3 raiseslevelsoftheurateoxidationprod-
uctallantoin(Section6.13)inthelungliningfluidsof
human volunteers.173 Any O not scavenged by anti-
9.12.1 Ozone 3
oxidantsintheliningfluidscanreactwithliningfluid
Ozone performs an essential ‘antioxidant’ role in the lipids, proteins, and other constituents to form prod-
higher levels of the atmosphere by screening out UV ucts(e.g.cytotoxicaldehydes)thatcancausedamage
light (Section 1.1), but is a nuisance if formed at to the underlying cells.160,174 Ozone can also activate
lower levels, e.g. by photochemical reactions (Sec- TRPA1 channels in the respiratory tract, which can
tion 2.6.5). It readily damages plants, eyes, and skin causepain(Section10.24).
as well as the respiratory tract (Sections 2.6.5, 7.3, Ozonedoesnotinitiatelipidperoxidation,butfree
and 7.9.3). Ozone adds across double bonds in lip- radicals emanating from the products of its reactions
ids to generate ozonides, which can decompose to withPUFAs(Fig.2.15)might.Indeed,ariseinF 2 -IsoPs
cytotoxicaldehydes(Fig.2.15).Itcanevenreactwith was detected175 in the lung lining fluids of hamsters

--- Page 543 ---

488 FREE RADICALS IN BIOLOGY AND MEDICINE
exposedto1–3ppmO for6h,andF -IsoPsinbreath theradicalresultsfromphotolysis(bysunlight)orOH•
2 2
condensate(Section6.15.9)wereincreasedinhumans oxidation of several volatile compounds, including
exposed to 0.4 ppm O for 2 h.176 Several studies acetaldehyde,methylglyoxal,andacetone.183
3
•
have claimed decreased O -induced lung damage in Inmostlargecities,themainsourceofNO inout-
3 2
subjects supplementedwithα-tocopheroland/or vit- doorairisvehicleexhaustemissions.TheNAAQSfor
amin C, although others deny this.160,168 Of course, NO • in the USA is a one-hour exposure of 0.1 ppm
2
dietary supplements do not always raise antioxidant and an annual average of 0.053 ppm, a figure regu-
levelsintherespiratorytractliningfluids(Section7.3). larlyexceededinseveralcities.InLondoninDecember
•
Repeated exposure of animals to O can lead to 1991, air NO levels reached an all-time UK high of
3 2
adaptation (tolerance); subsequent exposures to O 0.42 ppm, and even in 2014 London still regularly
3
•
causelesslungdamage.Increasedlevelsofascorbatein exceedsEuropeanUnionlimitvaluesforNO .Nitro-
2
lungliningfluidsmaycontributetoadaptationinmice gen dioxide is also found in indoor air (levels can
and rats,178 as also may arise in lung cell antioxidant exceed1ppm),beingproducedbygascookers,wood-
enzymeactivities.Indeed,adaptationofratstoO ren- burningstoves,coalfires,keroseneheaters,andcigar-
3
dersthemmoreresistant179 toelevatedO .Plantscan ettesmoking(Section9.13).Exposuretohigherlevels
2
•
alsoadapttoO ,makingthemmoreresistanttoother of NO can occur in acetylene welding, explosives
3 2
insultsintheprocess(Section7.9). manufacturing, military activities, and in grain silos
(Section7.9.3).
Healthy humans appear to tolerate short-term ex-
9.12.2 Nitrogendioxide160,180 •
posure to up to about 4 ppm NO without obvious
2
Thetoxic,brown,irritatinggasnitrogendioxide(NO • ) acutelunginjury,butasthmaticsubjectscanbeaffected
2
isanintermediateinnitrationoftyrosineinthepres- bylevels<0.3ppm.LevelsabovetheNAAQSmaypre-
enceofONOO–orMPO(Sections2.6.1and8.7.5),but disposetorespiratoryillnesses,especiallyinchildren.
•
alsooccursintheairaroundus.Duringcombustionof In animals, levels of NO 2 in the 1 ppm range can in-
organicmaterial,nitrogenreactswithO togiveoxides creasesusceptibilitytoinfectionswithsuchorganisms
2
ofnitrogen,includingNO•andNO • .Thebrownfumes as Staphylococcus aureus, probably by interfering with
2
of NO • were first described in 1670 by the alchemist thenormaldefencefunctionsofalveolarmacrophages.
2
Clark,whocalledthevapours‘theflyingdragon’,but Indeed,alveolarmacrophagesobtainedfromhumans
•
itwasPriestley(thediscovererofO 2 )whowasthefirst exposedto2ppmNO 2 for4hwhilstperforminginter-
topreparepureNO • .LikeNO•,NO • isafreeradical mittentexercisehadimpairedphagocyticactivityand
inwhichtheunpaire 2 delectronisdelo 2 calizedbetween decreasedO • 2 –production.184
oxygenandnitrogenatoms,butNO • 2 isfarmorereact- Higher levels of NO • 2 (≥ 3–4 ppm) and/or more
ivethanNO•.NitricoxidecanformNO • byreaction prolonged exposures cause demonstrable lung dam-
2
withO (Section2.5.6)orwithozone.Ifsufficientlevels age, both by direct injury to cells (especially to type
2
ofO andNO • arepresentintheatmosphere,181 they I alveolar cells) and possibly also by inactivating
canf 3 ormnitra 2 teradical,NO • ,apowerfullyoxidizing α 1 -antiproteinase and α 2 -macroglobulin (Table 8.2),
3
andnitratingspecies, thuspromotingelastase-dependenthydrolysisoflung
•
elastin. Surfactant can be attacked by NO , nitrat-
NO • 2 +O 3 →NO • 3 +O 2 ingitsproteinsandimpairingalveolarexpan 2 sionand
contraction.163 Loss of alveolar structures, microscop-
•
Nitrate radical and NO can join together to give
2 ically similar to emphysema, has been observed in
dinitrogen pentoxide, N 2 O 5 . Nitrate radical may ac- animalsexposedtohighlevelsofNO • (e.g.20ppmfor
count for the presence of nitrated proteins in pollen 2 •
30days),butwhetherairpollutionlevelsofNO area
particles,182buttherecouldalsobeacontributionfrom 2
riskfactorforhumanemphysemaisuncertain.
peroxyacetylnitrate,
9.12.2.1 Nitrogendioxideasafree
radical180,181,185
Nitrogendioxidedissolvesinwatertogivenitricacid,
anotherconstituentofpollutedair.Itisformedbythe
astrongacid,irritatingtotherespiratorytract,anda
O
cause of damage to plants by ‘acid rain’. N O also
(cid:129) • 2 5
reactionofacetylperoxylradical CH 3 COO withNO 2 ; contributestonitricacidformation,

--- Page 544 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 489
2NO • 2 +H 2 O→HNO 3 +HNO 2 Nitrogen dioxide can react with itself, the two un-
nitricacid nitrousacid pairedelectronsformingacovalentbond,
HNO 3 →H++NO– 3 NO • 2 +NO • 2 (cid:2)N 2 O 4
HNO (cid:2)H++NO– dinitrogentetroxide
2 2
Like NO•, NO • reacts rapidly (rate constants >109
Nitrous acid is a weak acid, but can lead to nitrosa- M–1s–1) with o 2 ther free radicals, e.g. with NO •
mineformationanddeaminationofDNAbases,both
to give N O , with O
•–
to form peroxynitrate
3
potentiallymutagenic.Overall,however,thereislittle 2 5 2
•
(k~5×109M–1s–1),
evidencethatNO atusualatmosphericlevelsiscar-
2
cinogenicinanimals.Nitrogendioxidecannitrosylate NO • +O •–→OONOO–
2 2
andnitrateproteins,andinitiatelipidperoxidationby
abstractinghydrogen, and with alkoxyl and peroxyl radicals185 (e.g. tyrosyl
radical,formingnitrotyrosine),
LH+NO • 2 →L • +HNO 2 RO • +NO •→ROONO
2
andbyadditionreactions, RO • 2 +NO • 2 →RO 2 ONO
NO Such reactions could modulate lipid peroxidation,
2
(cid:129) (cid:129) and generate biologically active nitrated lipids (Sec-
C C +NO C C
2 tion 2.6.1.3), but little attention has yet been paid to
the possible importance of OONOO–, ROONO, and
Both reactions generate carbon-centred radicals that RO ONOinvivo.
2
combine with O to give peroxyl radicals and propa-
2
gate peroxidation. However, the former mechanism
(H• abstraction) seems to be preferred186 at low NO • 9.12.3 Sulphurdioxide
2
levels. Lipid peroxidation has been observed (e.g. as Sulphur dioxide (SO ), a colourless, choking gas
2
increasedethaneexhalation)inthelungsofanimalsex- formedbythecombustionoffuelscontainingsulphur
•
posedtoppmlevelsofNO 2 andinhumanbodyfluids (e.g. low-grade coals), is another common air pollut-
•
exposedtoNO 2 . ant, although becoming less important in developed
countries. The NAAQS is 0.075 ppm daily maximum
9.12.2.2 Antioxidantsandnitrogendioxide185,187 concentrationaveragedoverthreeyears,andalevelof
AscorbatereducesNO • toNO–.Thereactionratecon- 0.5ppmnottobeexceededmorethanonceperyear.
stantisquitehigh,abou 2 t3–6× 2 107M–1s–1.Tocopherols UnlikeO 3 andNO • 2 ,SO 2 isareducingratherthanan
can react directly with NO • (especially γ-tocopherol; oxidizingagent.Itcontainsnounpairedelectrons,and
2
Section 4.3.7) as well as inhibit lipid peroxidation in- thusisnotafreeradical.Sulphurdioxidedissolvesin
duced by NO • . Indeed, supplementation of humans watertoreversiblyformsulphiteandbisulphiteions,
2
withascorbateandα-tocopherolpriortoNO • exposure producinganacidicsolutionthatconstrictstheupper
2
has been reported as protective in several studies,177 airwaysifSO 2 isbreathedin;asthmaticsmaybemore
whereas α-tocopherol deficiency in rats, or ascorbate susceptibletothis,
deficiencyinguineapigs,aggravatedlungdamageby SO +H O(cid:2)H SO
NO • .Uratecanalsoscavenge160 NO • (k~107 M–1s–1); 2 2 2 3
2 2
sulphurousacid
levelsofurateandascorbateinlungliningfluidsfell
rapidly188 in hum • ans breathing 2 ppm NO • 2 . Urate is H 2 SO 3 (cid:2)H++HSO– 3
oxidized by NO to urate radical, which can be re-
2 bisulphiteion
cycledbyascorbate(Section3.25.6).Oxidationofthiols
byNO • isslowunlesstheyareintheirionizedform, HSO–(cid:2)H++ SO2–
2 3 3
sulphiteion
NO • +GS–(cid:2)NO–+GS •
2 2
Humans are additionally exposed to sulphite be-
Nevertheless,theamountofthiolatepresentatpH7.4 cause it is used as a preservative in some drug pre-
allowsGSHtoscavengeNO • witharateconstant187of parations, wines (there can be millimolar levels in
2
about2×107M–1s–1. white wines),189 and several foods, both as sulphites

--- Page 545 ---

490 FREE RADICALS IN BIOLOGY AND MEDICINE
and metabisulphites (e.g. Na S O ). Sulphite is also Humaninbornerrorsthatresultininactivesulphite
2 2 5
generatedinvivoduringthemetabolismofmethionine oxidaseleadtodeathatafewmonthsofagewithmul-
andcysteine.Usuallyitisoxidizedtosulphate(SO2–) tipledefects,includingneurodegeneration.Accumula-
4
bythemitochondrialmolybdenum-containingenzyme tionofsulphitecouldleadtofreeradicalformationin
sulphiteoxidase,whichusescytochromecasanelec- the brain, which might contribute. In addition, SO2–
3
tron acceptor, and is present in several tissues, liver at high levels can inhibit several important enzymes,
havingespeciallyhighlevels.190HighlevelsofSO2–can includingglutamatedehydrogenase.190
3
cleavedisulphidebridges,forexampleinalbumin,by
thesulphitolysisreaction,
9.13 Toxicityofmixtures:‘real’air
R–S–S–R+ SO2–→RS–SO–+RS–
3 3 pollution,cigarettesmoke,andother
toxicsmokes
Whether this occurs in vivo is uncertain, although it
mighthappeninskinattackedbyfungi(Section7.13). •
AlthoughwehaveconsideredO ,SO ,andNO sep-
SulphitescanalsooxidizetogenerateROS,whichare 3 2 2
arately,wemustrememberthatpollutedaircontains
involvedinthetoxicityofSO toplants(Section7.9.3).
2 amixtureoftoxins,andinteractionsbetweenthemcan
Indeed,theearliestuseofSODtoinvestigateareaction • •
aggravate[e.g.thereactionofO andNO toformNO
mechanismwasastudyoftheroleofO •– insulphite 3 2 3
2 (Section9.12.2)]orsometimesevendiminish,toxicity.
oxidation.191
Indeed,theurinary8OHdGexcretionratesofagroup
Peroxidases, COX-1, activated phagocytes,192
of elderly subjects were dependent on, their over-
ONOO–, and transition metal ions can bring about allexposuretoO ,NO • andatmosphericparticles.194
one-electron oxidation of SO2– to sulphite radical 3 2
(sulphur trioxide anion radica
3
l), SO
•–,
which can be
The strenuous pollution control activities used dur-
3 ing the 2008 Beijing Olympics provided an excellent
spin trapped using DMPO or DEPMPO (Section 6.2).
opportunity to compare the effects of high air pollu-
Indeed,sulphitestimulatestheperoxidationofPUFA
tiononnon-smokeryoungadultsbeforetheOlympics,
emulsions, microsomes, and lipid extracts from rat
lowerpollutionduringthem,andhigherlevelsagain
lungs, possibly by the interaction of SO
•–
(and/or
3 aftertheOlympicshadfinished.195TheirF -IsoPlevels
2
speciesderivedfromit)withpreformedlipidhydrop-
in exhaled breath condensate and urinary 8OHdG
eroxides and/or by abstraction of hydrogen atoms.
levels faithfully reflected the degree of pollution
As well as SO
•–,
SO
•–
(sulphate anion radical) and
3 4 exposure.195
SO
•–
(peroxomonosulphate radical anion) can form
5 One of the most complex mixtures is tobacco
during sulphite oxidation.193 The latter is a peroxyl
radicalformedbyreactionofSO
•–withO
,
smoke.196 Smoking predisposes to emphysema, bron-
3 2 chitis,maculardegeneration(Section7.10.3),pneumo-
SO •– + O →–O SOO • k>109M–1S–1 nia, lung cancer, and several other cancers (includ-
3 2 3 ingmouth,larynx,kidney,urinarytract,oesophagus,
It can react with more SO2– to continue sulphite pancreas, liver, stomach, colon, cervix), atheroscler-
3
oxidation, osis, and many other diseases. It damages the vas-
cularendothelium,facilitatesplateletaggregationand
SO2–+–O SOO •→SO •–+SO2– k>107M–1s–1 blood coagulation, and causes vasoconstriction. Ma-
3 3 4 4
SO •– + SO2–→SO2–+SO •– k>2×109M–1S–1 ternal smoking can injure the foetus both by dam-
4 3 4 3 agingtheplacentaanddirectly,e.g.nicotinecancross
the placenta and impair lung development. On the
Theoverallresultisoxidationofsulphitetosulphate,
otherhand,tobaccousers(smokers,tobaccochewers,
O +2SO2–→ 2SO2– snuff takers) are at lower risk of developing Parkin-
2 3 4
son disease (Section 10.20). However, to put this ‘ad-
Sulphate radical and SO
•–
are highly reactive; SO
•–
vantage’ into perspective, one can quote the 1989 US
5 4
can even oxidize the ‘OH• scavengers’ ethanol and SurgeonGeneral’sreport:‘In1985[intheUSA]smok-
formate, and SO
•–
can oxidize several biomolecules, ing accounted for 87% of lung cancer deaths, 82%
3
including methionine, tryptophan, and β-carotene.193 of deaths from chronic obstructive pulmonary dis-
ExcessSO mightthusleadtolungdamage(orplant ease, 21% of coronary heart disease deaths and 18%
2
damage; Section 7.9.3) by radical reactions as well as of stroke deaths’. About one third of cancer cases in
bylowpH. Europe and North America are related to smoking

--- Page 546 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 491
(Section 10.15). The rest of the world has similar of incomplete trapping or fast decomposition of the
problems. The effects of smoking on the risk of de- spin adducts. Filtration of the smoke may also affect
veloping Alzheimer disease are unclear: there seems theradicalspresent.198 Smokecanbedrawnasfaras
overalltobeamodestincreaseinrisk.197
(a)
9.13.1 Chemistryoftobaccosmoke
Cigarettesmokeisacomplexmixtureoftoxicagents,
some of which are free radicals, others free radical-
generating agents, and yet others, agents that react
withanddepleteGSH(Table9.2).Smokecanbesep-
arated by filters into gas and particulate (sometimes
calledtar)phases,eachwithdifferentchemistry.Over-
all,thegasphaseisoxidizingandtheparticulatephase
weaklyreducing.Bothcontainfreeradicals.
Onegramoftarcontainsabout1017 ESR-detectable (b)
radicals of several different types: many of them are
stable,persistingforhours(Fig.9.12).Oneprominent
type is semiquinones, undergoing redox interconver-
sions with quinones and hydroquinones to generate
O •– and H O . These ROS can be converted to OH•
2 2 2
by Fenton or Fenton-type chemistry; cigarette smoke
containsarangeofmetals(Table9.2)andithasbeen (c)
estimated that >1 μg of iron is inhaled per pack of
cigarettessmoked.Inaddition,‘catalytic’ironisavail-
able normally in the respiratory tract lining fluids
(Section7.3).Lungmacrophagesandrespiratorytract
lining fluids in smokers have elevated iron contents,
andsmokemaybecapableofreleasingironfromfer-
ritininthesefluids.Cellsdamagedbycigarettesmoke
10 G
mayalsoreleaseiron.
Radicals in gas-phase cigarette smoke have much
shorter lifetimes than those in the tar and are usu-
Figure9.12 Detectionofradicalsincigarettesmokebyelectronspin
allystudiedbyspintrapping(e.g.Fig.9.12c).Thegas
resonance.(a)ESRsignalfromaglass-woolfilteraftersmokefrom
phasecontainsover1015 radicalsperpuff(notcount-
fourcigaretteshasbeendrawnthroughit.(b)ESRsignalfroma
ing NO•; see below). They include alkoxyl, peroxyl glass-fibrefilteraftersmokefromfourcigaretteshasbeendrawn
and,toalesserextent,carbon-centredradicals.Upto throughit.(c)ESRspectrumoftheadduct(s)formedbythetrappingof
22nmolofradicalspercigarettecanbetrapped.This radicalsincigarettesmokewithPBNinbenzene.Spectrabycourtesy
isanunderestimate;manycannotbedetectedbecause ofProfessorW.A.Pryor.
Table9.2 Someconstituentsofcigarettesmoke.
Phase Examplesofconstituents
Gas Nitrogen,ammonia(NH3),carbonmonoxide(CO),CO2,NO•,NO •
2
,H2S,methane,hydrogencyanide(HCN),volatilealdehydes
(e.g.ethanal,formaldehyde,acrolein,crotonaldehyde,CH3CH=CHCHO),benzene,toluene,acetone,vinylchloride,unsaturated
hydrocarbons(e.g.butadiene,isoprene),methylamine,nitropropane(Section3.19.3).
Particulate Tar,nicotine,metals(e.g.cadmium,lead,aluminium,nickel,iron,manganese,chromium,arsenic),phenols/semiquinones/quinones,
carcinogenichydrocarbons(e.g.benzopyrene,benzanthracene,chrysene),othercarcinogens(e.g.nitrosamines),fattyacids.
‘Cigarettesmokeconsistsoftarryparticlessuspendedinacomplexmixtureofbothorganicandinorganicgasesandcontainsabout700differentknownchemicals’(Am.
Rev.Resp.Dis.136,1058,1987).Over70ofthesearecarcinogens,aidedbyseveraltumourpromoters.Thetopofaburningcigarettereachestemperaturesofupto
◦
900 C,facilitatinghomolyticbondcleavagetogenerateradicals.AlsoseeMassSpec.Rev.33,183,2014.

--- Page 547 ---

492 FREE RADICALS IN BIOLOGY AND MEDICINE
180 cm down a glass tube without a significant de- whitebloodcells,lung,andspermofsmokers;59,196
creaseintotalradicalconcentration,whichhasfright- excretion of 8-nitroguanine and 8OHdG in urine
eningimplicationsforwhathappensintherespiratory is also elevated.201 Levels of MDA–DNA adducts
tractsofsmokers. are also increased in lung tissue.202 Smokers have
Since the radicals have short lifetimes, this steady beenreportedtoexcretemoreH O inurine203and
2 2
level means that they must be constantly produced. to have elevated F -IsoP levels in CSF and F -IsoP
2 4
Freshcigarettesmokecontainshighconcentrationsof levelsinbraincortex.204
NO• (~300–400 ppm) and NO • ; the latter can react 2. Aldehydes(Table9.2),especiallyacrolein,otherun-
2
with unsaturated hydrocarbons (such as isoprene) in saturated aldehydes, acetaldehyde, and formalde-
thesmoke.Nitratesareaddedtocigarettestoimprove hyde,canformadductswithDNAbases.Theyalso
burning properties and these are a major source of deplete GSH and modify protein –SH and –NH
2
theoxidesofnitrogen.Radical-generatingreactionsin- groups,anexamplebeinginionchannelsinvolved
cludeheat-inducedhomolyticfissionofcarbon–carbon in coughing.205 The ‘total aldehydes’ generated by
bonds(Table9.2)aswellasthereactions smoking one cigarette, if completely dissolved in
RH+NO
•→R •
+HNO
the lung lining fluid, would reach levels of 2 to
2 2 3 mM. For example, smokers excrete higher levels
of(3-hydroxypropyl)mercapturicacid,ametabolite
ofacrolein(Section6.15.7),thannon-smokers.206
3. Thehydroquinones/quinonesinthetarphasemay
leachoutintolungliningfluids,diffuseacrosscell
R • +O 2 →RO • 2 membranes, and undergo both extracellular and
intracellular (e.g. in vascular endothelium207 and
Asteady-statelevelofradicalsisquicklyestablished.
ReactionofoxidesofnitrogenwithO • 2 –generatedfrom r c e y t c i l n in al g p to igm ge e n n e t ra e t p e it s h e e m liu iq m ui ; n S o e n c e t s io , n O • 7 – .1 a 0 n .3 d ) H red O ox .
thetarphasemightalsooccur, 2 2 2
In general, cigarette smoking seems to diminish
O •–+NO •→ONOO– endothelialNO• production,increaseNADPHoxi-
2
peroxynitrite daseactivity,andfacilitate208generationofONOO–.
O •–+NO •→O NOO– 4. Cigarette smoke is pro-inflammatory and irritant
2 2 2 and can activate alveolar macrophages to produce
peroxynitrate O •–, H O , and sometimes NO• from iNOS. Dam-
2 2 2
aswellas age to respiratory tract cells by smoke will also
RO • +NO •→ROONO release DAMPs. Lung inflammation involves re-
2
cruitment to, and retention of, neutrophils in the
RO • 2 +NO • 2 →ROONO 2 lung;activationofneutrophilswilladditionallygen-
erateHOCl.Indeed,smokersshowelevatedlevels
of3-chlorotyrosineinplasmaandurine.209Thenico-
9.13.2 Mechanismsofdamagebycigarette tineincigarettesmokehasbeensuggestedinsome
smoke196 (but by no means all) studies to ‘prime’ neutro-
phils to produce an increased respiratory burst in
Injury by cigarette smoke occurs by multiple mech- response to stimuli210 and nicotine can also react
anisms, including direct toxic effects of HCN, CO, with HOCl to produce chloramines.211 However,
aldehydes,andcarcinogens(Table9.2).Wefocushere
toomuchsmokingcandepressphagocytefunction
onthedamagethatinvolvesRS.
(e.g.byoxidationofmacrophageproteinsorlipids)
1. PeroxylandOH•radicalsandRNS(NO • ,ONOOH, andincreasetheriskofinfectionoftherespiratory
2
OONOOH)causedirectdamage,oxidizingandni-
tract.212Itcanalsoimpairtheabilityofmacrophages
trating proteins, lipids, and DNA bases. Plasma, to phagocytose bacteria or apoptotic neutrophils
urine, and (in some studies) breath condensate (Section8.7.3.2),thusimpedingtheresolutionofin-
from cigarette smokers show elevated levels of flammation. Knockout of NOX2 in mice actually
IsoPs.196,199 Urinary levels of IsoP metabolites and enhanced susceptibility to cigarette smoke-induced
ofetheno-guanineadducts(Section5.12.5)arealso lung inflammation and emphysema,213 consistent
elevated.199,200 In multiple studies, levelsof 8OHG withotherreportsthatROScansometimesdiminish
havebeenfoundtobeincreasedinDNAfromthe chronic inflammation (Section 8.9.4). Hence don’t

--- Page 548 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 493
assumethatphagocyte-derivedROSintherespira- in fat and ethanol, compounding the pro-oxidant
torytractofsmokersarealwaysbad. effectsofcigarettesmoke.
5. Bothsurfactant(bybothproteinandlipiddamage)
Some smokersare nowswitchingto electroniccig-
and antiproteinases can be inactivated on expos-
arettes as a ‘safer’ alternative. They do not contain
ure to RS from cigarette smoke and/or activated
phagocytes,includingNO • ,ROONO ,ONOO–,and thecarcinogenspresentinnormalcigarettesmoke,but
2 2 theyare by nomeanssafe; constituentsof thesmoke
HOCl. Indeed, smoking predisposes to the devel-
can include ethylene glycol, formaldehyde, acetalde-
opment of emphysema, in part via a localized
inactivation of α -antiproteinase and other anti- hyde,andpropionaldehyde.221
1
proteinases within the lung. This allows elastase
released from neutrophils and macrophages to re-
9.13.3 Howdoestherespiratorytractdefend
mainactive.Inappropriateapoptosisoflungcellsby
itself?196
theceramidepathway(Section5.4.2),perhapsacti-
vated by GSH depletion, may also be involved in Thebestdefenceagainstcigarettesmokingisnottodo
emphysema, and cigarette smoking increases lung it. However, the antioxidants in respiratory tract lin-
ceramidelevels.214 ing fluids offer some protection (Tables 7.1 and 7.2).
Thetermchronicobstructivepulmonarydisease Forexample,theGSHpresenttherecanhelptoremove
(COPD) is often used to encompass emphysema, aldehydes,RO • ,OH•,HOCl,ONOOH,andNO • .Con-
2 2
excessmucussecretion,andinflammationoftheair- stituentsoftherespiratorytractmucusmayscavenge
ways. Cigarette smoking is the primary risk factor some HOCl, RO • , OH•, and RNS (Table 3.7), as well
2
forCOPD,althoughonlyaminorityofsmokersde- as binding particulates and helping to remove them
velopsthefull-blownsyndrome.177N-acetylcysteine fromthelungbyitsmucociliaryclearance.Ofcourse,
(Section11.5.9.2),otherthiols,andagentsthatactiv- if the mucus is swallowed, particulates can be de-
ateNrf2,suchassulphoraphane(raisingthelevels liveredtotheGItract(Section9.14.1)! Asscavenging
ofsuchdefencesasGSHandquinonereductase)are occurs, the mucus is degraded, but it is continually
beingexaminedtotreatCOPD,sincepatientsshow replenishedbythemucus-secretingcellsoftherespira-
increased levels of oxidative damage to lipids and tory tract. Irritation of these cells by any mechanism
proteins.215–217N-acetylcysteineseemstohavesome (including smoking) causes increased mucus produc-
(limited)degreeofbenefit,perhapsinpartbecause tion,bymechanismsinvolvingROS-dependentsignal-
it is a mucolytic agent.216 COPD lung tissue also ling. For example, ROS can activate the transcription
showselevatedlevelsofoxidativeDNAdamage,es- factor AP-1 (Section 5.5.7), leading to increased ex-
peciallyinmtDNAandinthepromoterofthegene pression of the gene encoding mucin MUC5AC, a
encodingVEGF.218 COPDcancontinuetoprogress major airway mucin.222 The binding of benzopyrene
evenifthepatientstopssmoking. to the aryl hydrocarbon receptor (Section 9.3.2) can
6. Theactionofcarcinogensincigarettesmoke,suchas also increase mucus secretion,again by a mechanism
benzopyrene,mayinvolveRS(Section10.15).How involvingROS.223
muchoftheincreasedcancerriskfromsmokingis Ascorbate and urate in the lining fluids are also
duetodirectactionofcarcinogensandhowmuch protective;theyreactrapidlywithNO • andRO • ,and
2 2
to oxidative DNA damage is uncertain—probably ascorbate may also ‘recycle’ α-tocopherol. Consump-
thetwoaresynergistic.Althoughascorbatesupple- tion of extra ascorbate by smokers has been shown
ments have sometimes been reported to decrease in some224 but not other225 studies to decrease their
F 2 -IsoPlevelsinsmokers(Section9.13.3),neitheras- plasma F 2 -IsoP levels. Indeed, smokers ‘turn over’
corbate,α-tocopherol,norβ-carotenehadanyeffect
ascorbate faster than non-smokers, and the recom-
on urinary 8OHdG excretion,196,219 implying that mendeddailyallowancesofascorbateintheUKand
they would be unlikely to help much in prevent- USA are set at higher levels for smokers. There is
ingcancer,asisindeedthecase(Section4.6).More little evidence that α-tocopherol supplements lower
worryingly, high dietary levels of vitamin C and F -IsoPlevelsinsmokers226 andsomesuggestionthat
2
α-tocopherol accelerated the development of pren- they can increase levels in smokers on a diet sup-
eoplastic lesions in guinea pigs forced to breathe plemented with PUFAs.227 Nevertheless, smokers do
cigarettesmoke.220 show increased turnover of RRR-α-tocopherol, espe-
7. Smokingisoftenassociatedwithapoordiet,lack- cially if their plasma vitamin C levels are low, and
ingplant-derivedantioxidantsandexcessivelyrich consuming extra vitamin C normalizes the turnover

--- Page 549 ---

494 FREE RADICALS IN BIOLOGY AND MEDICINE
rate.225 Smokers also have increased plasma levels of Smokers also have higher levels of thiocyanate
5-nitro-γ-tocopherol(Section4.3.7),andotherdataalso (SCN–), a product of cyanide detoxification, in their
suggest accelerated turnover of γ-tocopherol.228 This body fluids. Thiocyanate is a favoured substrate for
accelerated turnover was again decreased by ascor- MPO. This could conceivably diminish damage by
batesupplementation.228 However,γ-tocopherolsup- decreasing generation of HOCl by MPO in vivo (Sec-
plements failed to lower urinary F -IsoP levels in tion8.7.5),237 althoughtoxicproductssuchascyanate
2
smokers,althoughtheydidimprovevascularendothe- canalsoresultfromexcessSCN–levels(Section10.3.9).
lialfunction.229 In addition, induction of haem oxygenase-1 in the
Decreases in vitamin C and α-tocopherol, and in- lungsofsmokersmayoffersomedegreeofprotection
creasedlipidperoxidation,couldconceivablycontrib- againstcigarettesmoking.238
ute to the increased atherosclerosis seen in smokers.
In addition, smokers have lower plasma HDL levels,
9.13.5 Environmentaltobaccosmoke(ETS)
which may relate to the ability of cigarette smoke
(probably via aldehydes) to inhibit the enzyme ETS is unpleasant and irritating to many people, but
lecithin–cholesterol acyltransferase (LCAT),230 that doesitcauseharm?Agrowingbodyofevidencesug-
catalysestheformationofcholesterylestersinHDL. geststhattheansweris‘yes,tosomeextent’.Indeed,
some animal studies suggest that fresh ‘sidestream’
smokemaybemoretoxicthanmainstreamsmoke,and
9.13.4 Adaptation196,231 exposureofpregnantratstoETSraisedlevelsof8OHG
in DNA from foetal liver, kidney, and brain, as well
The respiratory tract antioxidant defence system can asfromorgansofthemother.239Somestudiesshowed
adapt to cigarette smoke. Smoking stimulates mu- that humans exposed to ETS have lower plasma as-
cus production (Section 9.13.3). Activation of Nrf2 corbate,higherurinaryexcretionof8OHdG,andele-
(e.g. by reaction of cigarette smoke constituents with vatedurinaryorplasmaF -IsoPs,andtheIsoPlevels
2
thiols on Keap1; Section 5.5.8) increases levels of γ- were decreased by ascorbate supplementation.240,241
glutamylcysteinesynthetase,therate-limitingenzyme F 2 -IsoP levels were found to be elevated in the ur-
of GSH synthesis, as well as of peroxiredoxins and ine of infants whose mothers smoked242 and ascor-
sulphiredoxins.232,233 Nrf2 activation may also im- bate supplementation was reported to improve lung
prove bacterial clearance by alveolar macrophages in function in the newborn infants of mothers who
COPD patients.234 Probably as a result of Nrf2 acti- smoked.243 Moreworkisneededtoascertainthecon-
vation, GSH levels in lung lining fluid and alveolar tributionofoxidativedamagetothedeleteriouseffects
cells are often increased in smokers, although prob- ofETS.
ably transiently depleted during the act of smoking.
The CFTR protein (Section 10.9) plays a key role
9.13.6 Othertobaccousage
in GSH export to the lining fluids.235 Unfortunately,
the Nrf2 response may diminish with age, making Otherusesoftobacco,whichincludesnufftakingand
the elderly more susceptible (Section 11.4.3) to dam- tobacco chewing, are again associated with oral and
agebycigarettesmoke.GenesencodingGPx2,GPx3, upperdigestive/respiratorytractcancer.Thechewing
glutathionereductase,thioredoxinreductase,GST,and of betel quid, sometimes with tobacco, is popular in
G6PDH are also expressed to a higher degree in the certain parts of the world (e.g. Papua New Guinea,
airwayepitheliumofsmokersascomparedwithnon- India, and Taiwan) and has been associated with in-
smokers.231ActivitiesofDNArepairenzymesmayalso creased incidence of oral cancer, possibly related to
increaseinsmokers,althoughusuallynotsufficiently the delivery of both carcinogens and of RS to the
to prevent rises in 8OHG in DNA.236 Susceptibility mouth.244Twoingredientsofbetelquid,arecanutand
of smokers to lung cancer probably depends on the catechu, oxidize at high pH (provided by the slaked
relative activities of the CYPs that activate carcino- lime,Ca(OH) ,oftenaddedtothepreparationchewed)
2
gens, levels of antioxidant and detoxifying systems togiveO •–,H O ,andOH•,especiallyasarecanutis
2 2 2
(such as quinone reductases and GSTs), and the effi- richincopperions.FormationofOH•hasbeendemon-
ciencyofDNArepair.Allofthesesystemsareinduced, stratedbyaddingphenylalaninetothebetelquidand
to varying extents, by the ‘xenobiotic exposure’ of measuringthegenerationofortho-andmeta-tyrosines
smoking. (Section6.3.1).245

--- Page 550 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 495
9.13.7 Othersmokes,fumes,anddusts (Section 11.5.8) offered some protection against acute
lung damage after smoke inhalation.258 The possible
Manyothertypesofsmokes,fumes,anddustscanin-
useofantioxidantstotreatsmoke-exposedpatientsis
jurehumans.Forexample,cookingsmokecancontain
anareaworthyoffurtherinvestigation,sincesomany
cytotoxicagents,includingaldehydes(e.g.trans,trans-
people die from smoke exposure, and there is some
2,4-decadienal), that have been hypothesized to con- humanevidencethatoxidativestresscontributes.259,260
tributetolunginjuryandlatercancerdevelopment.246
Welding fumes are complex mixtures of gases (in-
9.14 Dieselexhaustandairborne
cluding CO, CO , NO•, O ) and metal salts that can
2 3 particulates181,261,262
provoke oxidative damage.247,248 Oil fly ash (a par-
ticulate air pollutant arising from combustion of fuel
Diesel exhaust is rich in CO, volatile organic com-
oil),249 coal fly ash, metal dusts, and soot may also
poundssuchasbenzene,and(ofcourse)freeradicals,
causemetal-dependentfree-radicalformationandoxi-
includingoxidesof nitrogen.Indeed,older dieselve-
dativedamage.Forexample,oilflyash249 cancontain
hiclescanemit30to100timesmoreparticulatesthan
Fe, Ni, V, Ti, Cr, and Mn salts, as well as SiO . Coal
2 petrol-enginedcars.Theparticlescontainsalts(mainly
andcoaldustscontainstablecarbon-centredradicals,
ammoniumsulphateandnitrate)pluscarbonparticu-
up to 1019 per gram, immobilized in the carbon ma-
lates, to which are adsorbed carcinogenic polycyc-
trix;ESRcanevendetecttheminlungtissuefromcoal
lic aromatic hydrocarbons, nitro-aromatics, and other
miners.250 Coals contain iron, the presence of which
toxins, including redox-active iron, as well as poly-
is one factor determining the ability of coal dusts to
phenols that can redox-cycle to generate both ROS
causelunginjuryinminers.250,251 Flyashfromwaste
andsemiquinones/quinones.Othermetalsoftenpre-
incineratorscontainsnotonlyfreeradicals,metals,and
sent include vanadium, copper, chromium, alumin-
carcinogenicaromatichydrocarbons,butalsochlorin-
ium,nickel,andtitanium.Thoseparticleswithadiam-
atedtoxinssuchaspolychlorinateddibenzo-p-dioxins eter of less than 2.5 μm (called PM particles) rep-
2.5
andpolychlorinateddibenzofurans,whichmightcon-
resentaparticularthreatbecausetheypenetratedeep
tributetooxidativedamage(Section9.3.2).Evendust
into the lungs, settle there, and generate ROS (in-
fromphotocopiershasbeensuggestedtobepotentially cludingOH•).262,263 OthersourcesofPM includeoil
2.5
toxic.167,252
refineries, burning peat, coal-burning power plants,
Many people die in fires, most often as a result
coke ovens and fires generally, e.g. wildfires. PM
2.5
ofsmokeinhalation.Thiscausesseverelungdamage
can activate phagocytes, a process involving prod-
within minutes, sometimes leading to death days or
uctsoflipidoxidation,resultingininflammationand
weeks later, often by acute respiratory distress syn- moreoxidativestress.261Theseparticlesaremutagenic
drome(Section10.8).Neurologicaldeficitscanoccurin
andcarcinogenicincellandanimalmodels,andsev-
survivors,perhapsrelatedtoincreasedoxidativedam-
eral studies have shown increased levels of 8OHG
ageinthebrain.253 Smokefromburningbuildingsin-
in DNA from lung tissues after exposing animals to
cludescontributionsfromwood,cellulose,paint,poly- dieselexhaust.264 Datasuggestthatdieselexhaustin-
styrene,polythene,otherplastics,andrubberandhas
creasestheriskofdevelopinglungcancer,andpossibly
several chemical similarities to cigarette smoke: CO, bladder cancer, in humans.265 Indeed, several studies
aldehydes,oxidesofnitrogen,ESR-detectablefreerad-
revealincreasedratesofurinary8OHdGexcretionand
icals, HCN (from nitrogen-containing polymers such elevated lipid peroxidation in humans264 exposed to
as nylon), and particulates are all present.254 In addi-
PM . These observations have triggered massive ef-
2.5
tion, the combustion of halogenated plastics (such as
fortstodevelopcleaner-burningdieselenginesandto
polyvinylchloride)generatesHCl,Cl ,andphosgene.
2 eliminateparticlesfromtheexhaustasfaraspossible,
One system often used to model smoke injury is
withsomesuccess.
theexposureofsheeptosmokefromburningcotton.
As in the case of cigarette smoke, the lung can re-
Reports have appeared that the resulting lung injury
spond to diesel extract and other smokes by raising
canbeamelioratedwithaerosolscontainingdimethyl-
thelevelsofdefencesystemssuchasGSH.However,
sulphoxide,α-tocopherol,ordesferrioxamineattached
PM can aggravate asthma and COPD in humans
2.5
to a starch polymer255 or by the metalloporphyrin
and increase the risk of cardiovascular disease, al-
WW-85,256 suggested to act as scavenger of ONOO–.
though more studies of the role of RS in this, and
Another such agent, INO-4885, was also reported to
the prospects for effective antioxidant intervention,
be protective.257 In rabbits, the antioxidant U-75412E arerequired.261,266Highlyredox-activeultrafine(nano)

--- Page 551 ---

496 FREE RADICALS IN BIOLOGY AND MEDICINE
particulatesfromengineexhausts(<100nm)orother differentlaboratoriesandusingdifferentcelllinesand
smokes/fumes can cross membranes of lung cells, culturemediaarequitevariable,andmayinpart,re-
damage subcellular organelles such as mitochondria, latetohowthenanoparticlesbehaveinthecellculture
andevenenterthebloodstreamandbedistributedto medium(e.g.iftheyaggregateandlosesometoxicity),
other tissues. There is increasing concern about their andtothelevelsofmetalsaltstheycontain(e.g.carbon
potentialtocauseharm,especiallygiventheapparent nanotubes can be contaminated with metals arising
abilityofsomeofthemtoenterthebrainandtrigger fromthecatalystsusedduringtheirsynthesis,andthis
inflammation,byactivatingmicroglia.267 playsaroleintheirtoxicitytomice).277Itisalsoessen-
tialtocheckthattheparticlesarenotinterferingwith
theassaysusedtomeasuretoxicity/cellviability;they
9.14.1 Nanoparticles
sometimesdo(Table5.4andref278).
Nanotechnology has been defined (http://www.
nano.gov/)as‘theunderstandingandcontrolofmat-
9.15 Toxicityofasbestosandsilica
ter at the nanoscale, at dimensions between ~1 and
100 nm, in which unique phenomena enable novel Continuing our description of toxic effects of par-
applications’. Nanomaterials are becoming increas- ticulates, we now consider silicon-containing agents.
ingly popular. Examples are carbon nanotubes used Silicon is the second most abundant element in the
inmultipleproducts,graphenenanoparticles,ironox- Earth’scrust,oftenpresentassilicondioxide(silica),
ide(Fe O orFe O )nanoparticlesforimagingstudies SiO , e.g. in sand and quartz. Many other minerals
3 4 2 3 2
(e.g. as MRI contrast agents) or magnetic data stor- contain silicate ion, SiO2–, examples being the vari-
4
age, and silver nanoparticles in clothing, detergents, ous forms of asbestos, until recently widely used in
and deodorants. Indeed, some nanoparticles are be- buildingsbecauseoftheirheatresistance,easeofma-
ing developed as antioxidants (Section 11.5). Others nipulation, and durability. Excess exposure to silica
are generated ‘accidentally’, e.g. during printing and dustcausesacuteandchronicinflammatorylungdam-
photocopying252andintheenvironment(Section9.14). age (silicosis).279,280 There is also concern about the
The large surface area of nanoparticles gives them increasingindustrialuseofsilicananoparticles.
unusual properties. For example, the silver ion Ag+ Inhalation of asbestos fibres for prolonged periods
doesnotformOH•fromH O ,butsilvernanoparticles causesnotonlyinflammationandlungfibrosisbutalso
2 2
appear to at low pH;268 exactly how is uncertain. In- two types of cancer, diffuse malignant mesothelioma
deed, it has been proposed that this OH• contributes (a cancer very rare in subjects not exposed to asbes-
to the antibacterial and antifungal activity of silver tos)andbronchogeniccarcinoma.Asbestosandseveral
nanoparticles.269 As mentioned above, nanoparticles othersilicatescontainiron,someofwhichisinaform
cancrosscellmembranesreadily(e.g.byendocytosis thatcanstimulateOH• formation,lipidperoxidation,
orpinocytosis)andenterthebrain267andothertissues. and oxidative DNA damage. Iron may sometimes be
Thus, ultrafine carbon particles accelerated allergen- an integral part of the silicate crystal structure, for
induced lung inflammation in mice;270 carbon nano- example in the amosite, [Fe-Mg] [Si O ](OH) , and
7 8 22 2
tubes can activate neutrophils (and can themselves crocidolite,Na Fe3+Fe2+[Si O ](OH) ,formsofasbes-
2 2 3 8 22 2
be attacked and degraded by HOCl from neutrophil tos.Alternatively,ironmaybepresentonthesurface,
MPO);271andseveralanimalstudiesshowthatgastro- aswithchrysotileasbestos(Mg [Si O ](OH) ),where
3 2 5 4
intestinalexposuretoTiO nanoparticles,carbonnano- varyingamountsofMg2+canbereplacedbyiron.281
2
tubes, fullerene C etc. can increase oxidative DNA Alveolar macrophages phagocytose asbestos fibres
60
damage in several tissues, including bone marrow, or silica particles in a certain size range (e.g. asbes-
lung, and liver.272 Even injection of gold (normally a tos fibres longer than 8 μm and less than 0.36 μm
veryinertmetal)nanoparticlesraisedlevelsofoxida- diameter for rats), and the resulting NOX2-derived
tivedamageinthebrainsofrats.273 O •–andH O participateiniron-dependentradicalre-
2 2 2
Chemicalandcellculturestudiesrevealthattheiron actions that contribute to phagosome destabilization
at the surface of iron oxide nanoparticles is a potent andinflammasomeactivation.281–283Macrophagesthen
catalystofFentonchemistry.274Theseandothernano- releaseelastase, IL-1βand otherproinflammatory cy-
materials(TiO ,nano-cobalt,carbonblack,silver,gold, tokines. Death of the macrophage liberates DAMPs,
2
C fullerenes) can increase oxidative damage when whichpromotefurtherinflammasomeformation,and
60
added to cells in culture.272,275,276 However, the re- also frees the toxic particles to be taken up by more
sults of cytotoxicity studies of nanoparticles between macrophages in a vicious cycle. Indeed, EC-SOD in

--- Page 552 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 497
mice can help to protect against asbestos toxicity284 Let us briefly review, for selected metals, the data
(but remember that EC-SOD may exert effects other availableabouttheroleofoxidativestressinthedam-
than antioxidant ones; Section 8.9.4) and transfection age that they cause, beginning with those where the
of a gene encoding MnSOD into tracheal epithelial evidenceisbetterthanaverage.Thisisespeciallytrue
cellsmakesthemmoreresistanttothetoxiceffectsof forarsenic.
crocidolite.285 Several papers show that workers ex-
posedtoasbestos excretemore8OHdGin urine, and 9.16.2 Arsenic
pro-proliferative effects of ROS may contribute to fi-
Arsenic,287,288 an element in group V of the periodic
brosis,bothdirectlyandbyincreasingtheproduction
of TGF-β (Sections 5.2.1 and 5.7.3), and to eventual table, is not quite a metal, but we will consider it
anyway.Ithastwomajoroxidationstates,As(III)and
cancerdevelopment.59,283
As(V).Itiswidespreadintheenvironment,e.g.insoil,
Redoxreactionsalsoparticipateinthedeleteriousef-
groundwater, and river water, fortunately usually at
fects of silica; quartz is more toxic to the lung when
concentrations below 0.1 ppm. Sadly, higher arsenic
freshly ground, and both silicon radicals and Fenton
levels can occur in ground water in several counties,
chemistry(fromtracesofironinthesilica)maycontrib-
including some parts of Taiwan, China, Bangladesh,
ute.Indeed,thesalicylatehydroxylationtechniquede-
tectedOH• generationinthelungsofanimalsbreath- India,andArgentina.Industrialexposurecanalsooc-
cur, e.g. arsenic is used as a wood preservative, in
ingsilicatedusts.286Whensilicaisfractured,breakage
non-ferrous metal production, and in the electronics
of the covalent bonds produces free radicals by ho-
molyticcleavage(SiO•,Si•),aswellasions(Si+,SiO–) industry(e.g.galliumarsenide).
AfteritsdiscoveryintheMiddleAges,arsenic(usu-
fromheterolyticfission.Oxygencombineswithsome
ally as arsenic trioxide, As O ) became one of the
of these species to generate ‘surface bound ROS’, in- 2 3
cluding Si+–O •–, SiO • , and SiO • . CO can also bind mostpopularpoisonsfordisposingofrodents,aswell
to form SiCOO 2 •. The 2 se radicals 3 decay 2 with time, but as unwanted rivals and spouses. A dose of 200 to
250 mg is usually lethal, but tolerance occurs upon
tracesarestillpresentinagedsilicadusts.Theyappear
repeatedexposuretolowerdoses,possiblyinvolving
tosynergizewithROSfromactivatedmacrophagesto
increasedlevelsofmetallothionein.Thistolerancehas
causelungdamage.279,280
confoundedpoisonersthroughouthistory.Thetrioxide
hasfoundanewuseasatreatmentforacutepromye-
9.16 Toxicityofmetals287,288 locyticleukaemia,289 andarsenicalshavebeenusedto
killtrypanosomes(Section3.16.1).
9.16.1 Causeorconsequence?
Long-term exposure to excess arsenic in drinking
Thecontributionofoxidativedamagetotheeffectsof water causes a variety of problems, including skin
iron, manganese, and copper has already been con- thickening and pigmentation. Arsenic is carcinogenic
sidered(e.g.Sections3.22.5and9.5.6),ashastherole (e.g. high levels in drinking water can raise the inci-
ofmetalsinpotentiatingthetoxicityofasbestos,die- denceoflung,liver,bladder,skin,andkidneycancers)
selexhaust,cigarettesmoke,weldingfumes,coaldust, andppmlevelsmaypredisposetoatherosclerosis.Ar-
silica,andotherashes,smokes,anddusts. senate (AsO3–) can be taken up by cells in mistake
4
IncreasedROSgenerationhasoftenbeensuggested forphosphateandaffectssignaltransductionsystems.
to contribute to the toxicity of lead, cobalt, mercury, Someofitisreducedtoarsenite(AsO3–),whichismore
3
beryllium, nickel, cadmium, molybdenum, tin, titan- reactiveandcanbindto–SHgroupsonGSHandcellu-
ium, vanadium, chromium, and aluminium salts, as larproteins,andmayalsobeabletotargetKeap1and
well as selenium and arsenic. For many of these ele- activate the Nrf2 system, raising GSH levels, appar-
ments,theevidencethatoxidativestressisaprimary ently as a protective mechanism.290 Indeed the anti-
cause of their toxicity is not convincing. Often, in- dotedevelopedtooneofthefirsttoxicgasesusedin
creased lipid peroxidation was demonstrated in cells chemical warfare (the arsenical lewisite) is a dithiol,
exposed to high levels of metal ions in culture, or in Britishanti-Lewisite(2,3-dimercapto-1-propanol).Ar-
tissuesfromanimalspoisonedbymetals(oftenatab- senitemayalsointerferewithDNArepairmechanisms
surdlyhighlevels,irrelevanttohumanexposure).Such andmethylation;indeedarseniccanitselfformmethyl
peroxidationmaybeaconsequenceoftissueinjurye.g. and dimethyl derivatives, which may act as tumour
via inflammatory ROS production (caused by release promoters.Studiesoncellsincultureshowthatarsenic
ofDAMPsfromnecroticcells)and/orGSHdepletion, treatmentincreasesoxidativedamage,bycausingGSH
ratherthananearlycontributortometaltoxicity. depletion and possibly by increasing mitochondrial

--- Page 553 ---

498 FREE RADICALS IN BIOLOGY AND MEDICINE
freeradicalproductionandincreasingNAD(P)Hoxi- Complexes of Ni2+ with nuclear proteins can gener-
dase activity. Indeed, NOX2 is involved in the toxic ateOH•;incubationofchromatinwithNi2+andH O
2 2
effectsofarsenicontheliverofmice.291Consistentwith leadstoDNAbasemodificationscharacteristicofOH•
a role for increased oxidative damage in the toxic ef- attack.295Thesebasemodificationsarealsoobservedin
fectsofarsenic,arsenic-exposedratsorhumansshow DNAfromtheliversandkidneysofratsinjectedwith
elevatedurinary8OHdGexcretionratesandincreased nickelcompounds.295Toxicdosesofnickeladditionally
levels of 8OHG in DNA from several tissues. For ex- inducelipidperoxidationandproteincarbonylforma-
ample,DNAfromarsenic-relatedskincancersshowed tioninanimals.Henceitiswidelythoughtthatoxida-
higher 8OHG levels than DNA from skin cancers of tive DNA damage is involved in nickel genotoxicity,
other origins.292 Re-oxidation of arsenite to arsenate although the evidence is not conclusive. In addition,
leads to H O production, and OH• was measured nickelcaninhibitsomeDNArepairenzymes.
2 2
in the brains of arsenite-treated rats using salicylate
hydroxylation.293
9.16.4 Chromium
However, it is difficult to piece together from the
currentliteraturetheexactroleplayedbyROSinthe Chromium287,288(namedfromtheGreekwordchroma,
toxicityandcarcinogenicityofarsenic;increasedlevels colour,sincemanyofitscompoundsarebrightlycol-
of 8OHG in DNA occur with most, if not all, car- oured)hasbeensuggested(butnotfullyestablished)
cinogens (Section 10.15). Indeed, the ability of As 2 O 3 tobeessentialinthedietofhumansandotheranimals
to cause apoptosis in leukaemia cells involves RS tofacilitateglucosemetabolism.Hencesupplementsof
production,andsomeantioxidantscandelayarsenic- chromiumpicolinatearesoldwidely,butdoubtshave
inducedcelldeath.289Thus,patientsbeingtreatedwith beenraisedabouttheirsafety.296 Chromiumhasmul-
arsenicshouldprobablyavoidtakingantioxidants!In- tipleoxidationstates;Cr(VI),Cr(V),Cr(II),andCr(III);
terestingly,thesyntheticantioxidantTroloxpotentiated thelastisthemoststableanditcanbindtotransferrin.
As 2 O 3 toxicity to tumour cells in culture and in a Examplesofeacharesodiumchromate(Na 2 CrO 4 )and
mousemodel.289 dichromate (Na Cr O ), both Cr(VI) species, and the
2 2 7
chlorides CrCl , CrCl , and CrCl . Chromium(V) can
5 3 2
reactwithH O toformOH•,
9.16.3 Nickel 2 2
Cr(V)+H O →Cr(VI)+OH–+OH •
The transition element nickel287,288 has principal oxi- 2 2
dationstatesofNi2+ andNi(III).Itisusedbyseveral andCr(VI)canbereducedbacktoCr(V)byascorbate,
organismsasanenzymecofactor,forexampleinurea- GSH (forming GS•), O •–, and other cellular reducing
2
hydrolysingenzymes(ureases)inplantsandbacteria, systems.AscorbatemayfirstreduceCr(VI)toCr(IV),
andinNiSODs(Section3.5.5).Itiswidelyusedindus- which then disproportionates to Cr(V) and Cr(III).
trially, e.g. to make stainless steel, other alloys, and Cr(IV) can also form OH• from H O , as can Cr(III),
2 2
coinage. Inhalation of nickel-containing particulates althoughthereactionforCr(III)isslower.
(e.g.nickelsubsulphide,Ni S ,ortheoxide,NiO)can Chromates apparently enter cells via the sulphate
3 2
leadtolunginflammationandfibrosisandevennasal orphosphatetransportsystems.Theyaretoxic,muta-
or lung cancer, as has been seen in miners of nickel genic,andcarcinogenicinhumansandotheranimals;
ores and refinery workers. Cells appear to phagocyt- lung and nasal cancers have developed in workers
ose those particles, and some of the Ni2+ ends up in exposed to excess Cr(VI), e.g. in the manufacture of
the nucleus. Nickel compounds can also act as skin chrome steel or in chrome plating. It is possible (but
allergensinsensitivesubjects. not proven in vivo) that reduction to Cr(V) followed
HydratedNi2+ionsreactslowly,ifatall,withH O byOH•generationcausesoxidativeDNAdamagethat
2 2
to form OH•, nor are they efficient at decomposing contributes to carcinogenicity; ROS could also pro-
organic peroxides. However, chelation of the Ni2+ to mote signalling mechanisms that facilitate malignant
proteinsandpeptides(includingthe‘antioxidants’an- transformation.297 Indeed, there is some suggestion
serine and carnosine; Section 3.25.7) alters the reduc- that workers exposed to Cr excrete more 8OHdG in
tionpotentialtofacilitateOH•generationandorganic urine.Inthepresenceofascorbate,chromium(VI)can
peroxidedecomposition,294 form 8OHG in isolated DNA, but then oxidizes the
8OHdGtospiroiminodihydantoin(Section5.8.2.11).298
Ni2+-chelate+H O →Ni(III)-chelate+OH • +OH–
2 2 Chromatescanalsoinactivatethioredoxinreductase,at
Ni2+-chelate+ROOH→Ni(III)-chelate+RO • +OH– leastinvitro.299

--- Page 554 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 499
Chromium- and nickel-induced oxidative stress intoariverusedtosupplywaterfortheirrigationof
probablycontributetothetoxicityofcigarettesmoke riceforhumanconsumption.Apartfromthesecases,
(Table 9.2), welding fumes, and PM generally cigarette smoking is the major source of cadmium
2.5
(Section9.14). in adults. There are several suggestions (but not a
lot of hard data) that oxidative stress plays a role in
cadmiumtoxicityandcarcinogenicity.However,Cd2+
9.16.5 Cobalt
doesnotreactwithH O toformOH•.Nevertheless,
2 2
Cobalt287,288,300isatransitionmetalwithprincipaloxi- itdoesbindto–SHgroupsandcancauseGSHdeple-
dationstatesofCo2+ andCo(III).Itiswidelyusedin tion. Administration of cadmium compounds to ani-
the hard-metal industry, its salts as colouring agents mals rapidly induces metallothionein synthesis (Sec-
forceramics(e.g.cobaltbluedyes)andglass,andthe tion 3.23.2), but sadly Cd-containing metallothionein
radioactiveisotopecobalt-60inradiotherapy.Cobaltis canbedegradedinthekidneytoreliberateCd2+,con-
toxic(especiallytotheheart;indeedcardiomyopathy tributingtoitsrenaltoxicity.303 Likecobaltandnickel,
wasseeninthe1960samongheavybeerdrinkersafter cadmium can interfere with DNA repair, especially
brewerieshadaddedCo2+saltstobeertostabilizethe mismatch repair. Zinc administration was able to de-
foam!). It is suspected to be carcinogenic to humans, creaselipidperoxidationobserveduponfeedingCd2+
and is so in animals when given in large quantities. toanimals.304
Co(II) can also ‘mimic hypoxia’ by inhibiting pro-
line hydroxylase (Section 1.3.2), leading to increased
9.16.7 Mercury
erythropoietin production. Indeed, it was previously
used to treat anaemia associated with renal failure. Mercury305(commonoxidationstatesHg+andHg2+)is
However,traceamountsofcobalt,intheformofvit- wellknowntobetoxictohumansandotheranimals.
aminB 12 ,areneededinthehumandiet(Section8.2). Thiswasdramaticallyillustratedin1956byMinamata
Reaction of Co2+ with H 2 O 2 produces a ‘react- disease,anoutbreakofpoisoningbymethylmercury
ive species’ that can degrade 2-deoxyribose and hy- (CH Hg+) ingested from fish and shellfish from the
3
droxylate phenol and salicylate (to 2,3- and 2,5- MinamataBayareaoftheShiranuiSeaaroundKyushu
dihydroxybenzoates).Thesimplestexplanationwould Island,Japan.Themarinelifehadbeencontaminated
beformationofOH•,
by mercury salts discharged in waste water from a
Co2++H O →Co(III)+OH • +OH– chemicalplant,whichwereconvertedtomethylmer-
2 2 cury by aquatic microorganisms. Fish and shellfish
but it has not yet proved possible to convincingly died, as did local cats (who ate seafood scraps), and
demonstrate this reaction in vitro.301 Instead, an oxy- manypeople;pathologicalfindingsincludeddamage
cobaltcomplexmayformthatcan(amongotherreac- tothecortex,cerebellum,andperipheralnerves.There
tions)oxidizeCO 2 /HCO– 3 intoCO • 3 –radical.302 Never- wasasignificantincreaseinthebirthofchildrenwith
theless,incubationofchromatinwithCo2+ andH 2 O 2 , cerebral palsy. Organic mercurials such as CH 3 Hg+
orinjectionofCo2+intorats,ledtoapatternofoxida- arefairlylipophilicandcrossthegastrointestinalepi-
tiveDNAbasedamagecharacteristicofOH•attack,295
thelium and the blood–brain barrier. Mercury occurs
i.e.OH•maybetheculpritafterall!ItmaybethatCo2+
naturallyinsomegeologicaldeposits,e.g.coalmining
(likeNi2+)doesnotitselfformOH•fromH 2 O 2 ,butthat andcoalburningcanreleaseitintotheenvironment.
certain Co2+ chelates with biomolecules can. In addi- The mechanism of CH Hg+ neurotoxicity is un-
3
tion,cobaltmayinhibitsomeDNArepairenzymes. known, but there are several suggestions that both
oxidativestress(possiblyasaresultofmitochondrial
damage)andincreasein‘free’Ca2+levelsareinvolved.
9.16.6 Cadmium
CH Hg+andHg2+ionsbindavidlyto–SHgroupsand
3
Cadmium,287,288 most common oxidation state Cd2+, caninhibitproteinswithessential–SHgroupsandde-
iswidelyusedinthemanufactureofbatteries,alloys, plete GSH, which might contribute to damage. They
and pigments, but is toxic (especially to the kidney), canalsobindtoselenols(moretightlythantothiols)
and carcinogenic to the lung, kidney, prostate, and andmightthusdecreasetheactivityofselenoproteins,
pancreas. Toxicity can arise from inhalation of Cd- such as GPx and thioredoxin reductase. Low concen-
containingfumesinfactories.InJapan,Itai-itaidisease trations of CH Hg+ were reported to stimulate O •–
3 2
(severecadmiumpoisoning)occurredinhumanswhen productionbyhumanneutrophils,astrocytes,andmi-
cadmium compounds were discharged from a mine croglia. Mercury(II) ions can displace Cu+ ions from

--- Page 555 ---

500 FREE RADICALS IN BIOLOGY AND MEDICINE
metallothioneininvitro,whichmightpotentiateoxida- (in decreasing order of oxidation state) sodium van-
tivedamageifitoccurredinvivo.Excessexposureto adate Na VO , the vanadyl ion VO2+, and the van-
3 4
mercuryhasbeenreportedtoleadtoelevatedurinary adiumchlorides,VCl andVCl .Vanadiumoccursin
3 2
8OHdGexcretioninhumans.306 some peroxidase enzymes (Section 3.19.5) and traces
have been suggested (but not proven) to be essential
in animal diets, apparently to aid glucose metabol-
9.16.8 Lead287,288,307,308
ism.VanadateinhibitsATPaseenzymes,includingthe
Humanscanbeexposedtoleadfromvehicleexhausts plasmamembraneNa+,K+–ATPase.Indeed,commer-
(althoughleadasafueladditivehasbeenphasedout cialATPsamplescanbecontaminatedwithvanadium
in many countries), lead-based paints (now banned (thusconfusingassaysofATPase),ascanpreparations
in most countries), handling of lead-acid batteries, ofalbumin.311 Vanadatealsoinhibitsphosphotyrosine
finecrystalglass(containingPbO),andcontamination phosphatasesandthuspotentiatesphosphorylationof
of food, medicines (especially Ayurvedic ones), and proteintyrosineresiduesincells,facilitatingsignalling
drinking water (e.g. from lead pipes). Lead is also (Section5.5.4).312
widely used as a shield against radiation. Lead was Vanadate is reduced to V(IV) by ascorbate, GSH,
a particular problem in Ancient Rome, arising both other thiols, and certain sugars. Vanadium (IV) can
fromthewatersupplyanddrinkingfromleadcups.309 reduceO
2
toO •
2
–,
Theuseofcosmeticscontaining‘whitelead’(PbCO 3 ) V(IV)+O (cid:2) O •– + V(V)
addedtotheburden. 2 2
Lead has two common oxidation states, Pb2+ and generateOH • fromH 2 O 2 ,
Pb(IV). Too much lead can cause hypertension, is V(IV)+ H O → V(V)+OH–+ OH •
neurotoxic, and damages many systems, including 2 2
red blood cells, the immune system, and the kidney. anddecomposelipidperoxides,
In children, blood lead concentrations in the micro- LOOH + V(IV) → V(V)+OH–+ LO •
molarrangemaybesufficienttoimpairdevelopment
of the nervous system, in part by interfering with Hencevanadiumsaltsarecapableofpromotingoxida-
theactionofNMDAreceptors(Section10.17.4).Other tive damage. Indeed, scientists using them to inhibit
mechanisms of lead toxicity include inhibition of δ- phosphatases in studies of signal transduction must
aminolaevulinic acid dehydratase (the first step in not ignore their potential to cause oxidative stress,312
haembiosynthesis;Fig.2.12),leadingtoaccumulation sinceROSalsoinhibitphosphatases(Section5.5.4).
ofδ-aminolaevulinicacid.Pb2+ionscanaccelerateoxi- It is possible (but not proven) that oxidative stress
dation of oxyhaemoglobin to methaemoglobin (with contributes to the toxic effects of excess vanadium,
increasedformationofO •–),combinerapidlywith–SH whichhavebeenobservedinminersofvanadiumores
2
groupsonproteinsand,athighconcentrations,cause andworkersinsomeotherindustries.
GSH depletion. Lead also alters Ca2+ homoeostasis,
perhaps interfering with Ca2+-dependent neurotrans-
9.16.10 Titanium
mitter release in the brain. Indeed, Pb2+ can enter
cells by passing through Ca2+ channels. In rats, lead- Titanium is widely regarded as an inert metal, hence
inducedhypertensionwasamelioratedbyfeedingex- its frequent use in medical implants. Similarly, titan-
tra α-tocopherol in the diet, suggesting that ROS are ium dioxide (TiO 2 ) particles are often used as ‘inert’
involved.Therearealsosuggestions,needingfurther controls when studying the effects of other particu-
confirmation,thatleadisariskfactorforthedevelop- lates,althoughtheycanactasphotosensitizersinsome
mentofAlzheimerdisease.310 sun blocks (Section 7.13.1) and TiO nanoparticles
2
have shown some cytotoxicity in cell cultures (Sec-
9.16.9 Vanadium
tion 9.14.1). A mixture of titanium(III) and H
2
O
2
has
beenusedfordecades301asalaboratorysourceofOH•,
The transition element vanadium287 (named after Va- Ti(III)+ H O → Ti(IV)+ OH • + OH–
2 2
nadis, the Norse goddess of beauty) is widely used
in industry (e.g. as a steel additive) and can con- Reactive species have been hypothesized to be in-
tribute to the pro-oxidant effects of particulates (Sec- volved in the ability of titanium implants (e.g. hip
tion 9.14). It exists in several oxidation states, e.g. replacements) to cause inflammation in surrounding
V(V), V(IV), V(III), and V(II). Examples of each are tissues;attheinterfaceofimplantandbone,phagocyte

--- Page 556 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 501
activationcanoccurtoproduceRS,whichcancontrib- Whyarehighlevelsofaluminiumneurotoxic?There
utetolooseningoftheimplant.313 areseveralhypotheses.Theyincludeinterferencewith
Ca2+ uptakemechanisms,inactivationofG6PDH(un-
likely), and inhibition of dihydropteridine reduc-
9.16.11 Aluminium
tase, an enzyme that catalyses NADPH-dependent
Aluminium307,314 is the most abundant metal in the reduction of dihydrobiopterin to tetrahydrobiopterin,
Earth’scrust(~8%),andthethirdmostabundantelem- a cofactor required for biosynthesis of tyrosine (the
ent(afteroxygenandsilicon).Humansarefrequently evidenceisweak).AnotherideaisthatAlimposesoxi-
exposed to it; it is slowly leached from aluminium dativestress.Aluminium(III)ionsdonotusuallystim-
cookware and cans, ingested from water (aluminium ulatefree-radicalreactions,becauseoftheirfixedoxi-
sulphateissometimesusedinwaterpurification)and dationnumber.However,ifperoxidationinliposomes,
otherbeveragessuchasteaandmanyprocessedfoods, erythrocytes, synaptosomes, myelin, LDL, or micro-
sprayed on skin as an ‘antiperspirant’, injected as a somesisstimulatedbyaddingFe2+ ions,thepresence
constituent of some vaccine preparations, and con- of Al3+ increases the peroxidation rate.314,315 Indeed,
sumedinantacidscontainingthehydroxideAl(OH) . administrationof Al(III) to Drosophila caused iron ac-
3
Itcontaminatessolutionsusedforparenteralnutrition cumulationandneurodegeneration,andironchelators
as well as many laboratory reagents, including ATP hadsomeprotectiveeffectagainstthetoxicity.316Itmay
andalbumin.311Ifitentersthebody,itcanbeexcreted bethatAl3+ionsbindtomembranesandcauseasub-
insweatandinurine. tle rearrangement of membrane lipids that aids iron-
Aluminiumhasafixedoxidationnumberof3,and dependentlipidperoxidation.315Lead(II)andNi2+can
aluminium salts can release the hydrated Al3+ ion, dothesameinvitro.315Yetanothersuggestion314isthat
Al(H O) 3+,inaqueoussolution.Onlysmallamounts aluminium forms a pro-oxidant complex with super-
2 6
of Al3+ exist in aqueous solution, except at low pH; oxide,AlO 2 •2+.Theimportanceofoxidativedamagein
aluminiumsaltsatpH7.4rapidlyhydrolyseandform producingencephalopathyisuncertain,althoughfeed-
sparingly soluble polyhydroxide species. The gastro- ingadietenrichedinAldidincreaseF 2 -IsoPlevelsin
intestinal tract does not readily take up aluminium. thebrainsofmice.317 Similarly,thetoxicityof Al3+ to
Nevertheless,highdosesofAl(OH) administeredor- rootsoftobaccoplantsinvolvedaldehydesgenerated
3
ally to rats or to humans (e.g. as antacids) do raise bylipidperoxidation.318
tissue and urine aluminium levels. It has been sug- Aluminium-based adjuvants (from adiuvare, the
gestedthatinhaledaluminiumcompounds(e.g.from Latinverb‘toaid’)arewidelyusedinhumanvaccin-
deodorants) might enter sensory neurons of the ol- ation, to potentiate the activity of the antigens. This
factory epithelium and pass into the brain, but how may be because the Al causes local cell damage, the
significant this is, is uncertain. Some organic acids, release of DAMPs, and inflammasome assembly, re-
suchascitrate,bindAl3+andaccelerateitsuptakefrom sulting in phagocyte recruitment and more effective
the gastrointestinal tract. Absorbed Al3+ can bind to antigenpresentation.319 Thisisaccompaniedbymore
transferrin,entercellsviathetransferrinreceptor,and ROSofcourse!
be deposited in ferritin. Aluminium can be a major
problem for plants, especially when mobilized from
9.16.12 Zinc
soils or sediments by exposure to low pH. Similarly,
acidificationofwaterandsubsequentAl3+releasecan Zinc287,288 is essential to animals (needed for over
killfish. 300 enzymes, including several antioxidant defences
Aluminium’s potential toxicity to humans was not and almost 2000 transcription factors, and especially
appreciateduntiltheearly1970s,soonafterthedevel- important for correctfunctioning of the immune sys-
opmentofhaemodialysisprocedurestotreatpatients tem) and may exert antioxidant properties under
withkidneydisease.Manydialysispatientsdeveloped somecircumstancese.g.byincreasingmetallothionein
a neurological syndrome, dialysis encephalopathy, levels304 and/orantagonizingthepro-oxidantactions
whichwaseventuallyshowntobecausedbyaccumu- of Fe2+ (Tables 2.4 and 4.1). Indeed, Zn-deficient ani-
lation of high concentrations of aluminium (derived malsshowincreasedlevelsofoxidativedamage.How-
fromAl-contaminateddialysisfluids)inthebrain.Dia- ever,Zn2+intakesfarabovetheRDAaretoxic.Inpar-
lysisencephalopathyisaccompaniedbyanaemiaand ticular, excess Zn2+ can damage neurons. Levels of
bone demineralization, leading to increased risk of intracellularandextracellular‘free’Zn2+ inbrainand
fracture. other tissues are normally low, perhaps <1 nM, but

--- Page 557 ---

502 FREE RADICALS IN BIOLOGY AND MEDICINE
extracellularlevelsinbrainhavebeenreportedtorise topoisomerase)suchasclinafloxacin,enoxacin,spar-
significantly during excitotoxicity (Section 10.18.3.1). floxacin, lomefloxacin, ciprofloxacin, and ofloxa-
This ‘free’ Zn2+ can then be taken up by and accu- cin.327 Indeed, excessive intake of photosensitizing
mulatewithinpostsynapticneurons,damagingthem. antibioticsbypatientsmaybeariskfactorfordevel-
Zinc can also be rendered ‘available’ by other mech- opingskincancer.328
anisms. For example, exposure of rat neurons to a Tetracyclineschelateironandcopperions,andthe
ONOO–-generating system caused a rise in intracel- chelates with the last two metals can generate OH•
lular ‘free’ Zn2+ levels, and the accompanying apop- fromH O invitro.Thismightsometimesberelevant
2 2
tosiswasdecreasedbyZn2+-chelators.320 Presumably, invivo,asmanybacteriacontain‘catalytic’intracellular
addition of ONOO– leads to release of Zn2+ from iron.329–331Ontheotherhand,tetracyclinesarepower-
transcription factors with ‘zinc fingers’, and/or from ful scavengers of HOCl and ONOOH, and there are
metallothioneins (Section 2.6.1). HOCl can also liber- reportsfromanimalmodelsofstrokeandneurodegen-
ate Zn2+ from metallothionein (Section 2.6.3). There erativediseasesthattheydecreaseROSproductionby
are various, but conflicting, reports that zinc supple- phagocytes (including microglia), suppress increases
mentsmaydecreaseoxidativedamageinhumans,but in iNOS, COX-2, and IL-1 levels, and inhibit matrix
this may only happen if zinc intake was previously metalloproteinases. Minocycline(Fig. 9.13) seems es-
sub-normal.321,322However,thereisaneedforcaution pecially effective and is being studied as a potential
withsupplements,giventhepotentialneurotoxicityof neuroprotectiveagentinstroke,andinneurodegener-
excessZn2+. ative diseases such as ALS (Section 10.22) and Hun-
In cell culture studies, antioxidants often protect tingtondisease(Section10.23.2).332
againstZn2+-inducedtoxicity.However,Zn2+doesnot Hence,neverassumethataneffectexertedbyanan-
itself promote free radical reactions. Instead, it may tibioticinvivoisnecessarilymediatedbyantibacterial
damage mitochondria to increase ROS production, action.Antioxidanteffectscouldmodulateinflamma-
and/or increase the activity of NADPH oxidase in tion, and anti-inflammatory effects should decrease
neurons.323 oxidative damage. Vice versa, pro-oxidant effects of
antibioticscouldaidthekillingofbacteria(sometimes
calledaphago-mimeticeffect).333Recentclaimsthata
9.17 Antibiotics
widerangeofbactericidalantibioticsgenerateOH•as
Antibiotics are substances produced by living organ- part of their bacterial killing mechanism are still un-
ismsthathaltthegrowthof,andsometimeskill,fungi, derintensivedebate.334–336 Someauthorsweremisled
bacteria, or other microorganisms. Antibiotics can be becausetheywerenotawareofthenon-specificityof
targetsofoxidativedamage,causesuchdamageor,in
thioureaasa‘OH•scavenger’(Section6.3.2).
somecases,exertantioxidanteffects.
As an example of the first, the polyene antifungal
9.17.2 Quinoneantibiotics
antibiotics (such as amphotericins A or B and can-
dicidin) bind to ergosterol in the membranes of fun- Many anti-cancer antibiotics are quinones that can
galcellsandcausemembranepermeabilization.Their redox cycle to produce O •–, semiquinones, and H O
2 2 2
highly polyunsaturated structures (Fig. 9.13) make in vivo. An example is streptonigrin, produced by
thempronetooxidizewiththeformationofperoxides, Streptomyces flocculus. It was one of the first quinone
alkoxyl/ peroxyl radicals, and cytotoxic aldehydes. antibioticswhoseactioninvivowasshowntoinvolve
As a result, they can deteriorate on storage.324 In- ROS,butisnowrarelyusedclinicallybecauseofside-
deed,ithasbeensuggestedthattheir‘antibiotic’effects effects. Its toxic action on E. coli requires O and is
2
maysometimesinvolveoxidationproducts.325Thean-
decreasedifSODactivityisraised.Similarly,treating
tifungalmiconazole(Fig.9.13)hasbeensuggestedto E.coli with low levels of it can raise MnSOD levels.
work both by inhibiting ergosterol synthesis and by Thequinonepartofstreptonigrin(Fig.9.13)isreduced
causingoxidativestressinthefungus.326
bybacterialenzymestoasemiquinoneformthatthen
reduces O to O
•–.
Elevated intrabacterial iron levels
2 2
enhancethebactericidalactionofstreptonigrin,appar-
9.17.1 Tetracyclinesaspro-andantioxidants
entlyviaOH•formation.330Forexample,killingofthe
The tetracyclines (Fig. 9.13) act by inhibiting ribo- gonococcus by streptonigrin depended on the avail-
somefunctioninbacteria,buttheyarealsosensitizers abilityofirontopromoteFenton-typereactions330and
of singlet O 2 formation, as are the quinolone Borreliaburgdorferi,whichlacksiron(Section3.22.4.1),
antibiotics (which inhibit bacterial DNA gyrase and isresistanttostreptonigrin.337

--- Page 558 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 503
(a)
O
H CO
3
N COOH O OH
H 2 N N
O + e–
H 2 N CH 3 + H+
HO
O O(cid:129)
–quinone – semiquinone
H CO
3
OCH
3
(b) O OH O OH (c) OH O OH O
OH
CONH
H NOC 2
2
OH
OH
HO H H
H R R N N
N(CH 3 ) 2 R 4 3 2 R 1 H 3 C CH 3 H 3 C CH 3
(d)
OH
O
H 3 C H 2 N
HN O
HO
NH
H C HO 2
3
O O
H 2 N NH 2
Figure9.13 Structuresofsomeantibacterialagents.(a)Streptonigrin.(b)Tetracycline:R1=H,R2=OH,R3=CH3,R4=H;oxytetracycline:
R1=H,R2=OH,R3=CH3,R4=OH;chlortetracycline:R1=Cl,R2=OH,R3=CH3,R4=H;doxycycline:R1=H,R2=H,R3=CH3,R4=OH.
(c)Minocycline.(d)GentamicinC1a.(e)Thepolyeneantibiotics.(f)Miconazole.
9.17.3 Aminoglycosidenephrotoxicity a cobalamin-dependent ‘radical SAM’ enzyme (Sec-
tion8.2.4)isinvolvedingentamicinbiosynthesis.340
Reactive species may also be involved in the side-
effects produced by several antibiotics, especially the
anti-cancer ones (Section 10.16). Another example,
9.18 Stress
aminoglycoside antibiotics such as gentamicin (Fig.
9.13) can damage the kidneys, accompanied by in- Many people suffer, or claim to suffer, from ‘stress’
creasedlipidperoxidation.Gentamicinbindsironions ofvariouskinds.Long-term‘stress’impairsthefunc-
to form a chelate that is a potent catalyst of lipid tioning of the nervous, endocrine, and immune sys-
peroxidation, and damage to renal mitochondria by tems,andseveralpapershavesuggestedaroleforRS
gentamicin may lead to iron ion release and forma- in causing this. In some animal models,341,342 stress
tion of this chelate.338 Indeed, desferrioxamine de- caused by immobilization of the animal is associated
creases gentamicin-induced kidney damage in rats, withincreasesinoxidativedamagetolipids,proteins,
and the mitochondrially targeted antioxidant SkQR1 and DNA in the brain. Increased NO• production,
(Section11.5.12)couldprotectratsagainstgentamicin- mitochondrialdysfunction,andO •–/H O production
2 2 2
induced renal failure.339 The ototoxicity of gentami- by accelerated oxidation of dopamine and tetrahy-
cin may also involve ROS (Section 7.12). Ironically, drobiopterinmaybeinvolved.Treatmentwithcertain

--- Page 559 ---

504 FREE RADICALS IN BIOLOGY AND MEDICINE
(e) OH
O OH
HO O O O OH OH OH O O
O OH
O O
HO OH
NH NH
2 2
Candicidin
OH O
O OH OH HO OH OH OH CH 3
HO
H C O OH
3 O O
H 3 C O NH 2
OH
HO CH
3
Amphotericin A
In amphotericin B, there is a double bond here
(f) Cl
Cl
O
N
N
Cl Cl
Figure9.13 (Continued)
glucocorticoid hormones, whose levels are increased urinary 8OHGua and 8OHdG levels in a cohort of
bystress(e.g.cortisolinhumans)mimickedseveralof elderlyhumans.345 Inanotherstudy,stressedmothers
these changes. However, it is unclear how well these of chronically ill children showed increased levels of
animalrestraintmodelsreflecthumanstress.Another urinaryF -IsoPsandacceleratedtelomerelossinwhite
2
model is sleep deprivation in animals, which may blood cells,346 although other studies have not found
increaseoxidativedamageinthebrain.343 arelationbetweendepressionandtelomerelength.347
Nevertheless,somestudiesdosuggestthatthelevel Much more work needs to be done to establish the
of stress/depression in patients correlates with ele- exact contribution of RS to stress, remembering that
vated levels of 8OHdG in serum, urine, or DNA stressed/depressedpeoplehaveabnormaldietaryand
from white blood cells, or with increased urinary ex- other lifestyle behaviours that could affect oxidative
cretion of biopyrrins (Sections 3.25.1 and 6.13), or damage levels. Alterations in glyoxalase activity and
with levels of F -IsoPs in plasma or urine.344 For ex- GSH levels have been proposed to play some role in
2
ample, urinary cortisol levels were correlated with depression/anxiety/stress(Sections3.15.1and10.23).

--- Page 560 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 505
9.19 Nitroandazocompounds348,349 9.19.2 Furtherreductionofnitroradicals
Several compounds containing nitro groups are used IntheabsenceofO 2 ,nitroradicalscanundergofurther
therapeutically,e.g.inthetreatmentofParkinsondis- reduction(e.g.byGSH),ordisproportionation,toform
ease (tolcapone, entacapone; Fig. 10.31), as vasodila- nitroso(RNO)compounds,
tors (e.g. nitroglycerin), or as COX-2 inhibitors, as 2RNO •–+ 2H+→ R – N = O + RNO +H O
in the case of nimesulide (Fig. 9.14). Toxicity can 2 2 2
occur from overdoses, or side-effects, of therapeutic RNO •–+ GSH → R – N = O +GS • +OH–
2
nitro compounds, and from over-exposure to nitro
Nitroso compounds might be further reduced to hy-
compounds used in industry, such as 2-nitropropane
droxylamines(RNHOH)oreventoamines,RNH .The
2
(Section 3.19.3). The manufacture and use of explo-
extentofreduction,andwhichproductistheultimate
sives has provided many cases of toxicity of nitro
toxin,dependsuponthenitrocompoundadministered
compounds.
andtheorganismstudied,
(cid:129)
9.19.1 Nitroradicalsandredoxcycling
Theantibacterialdrugnitrofurantoin(Fig.9.14),some- One-electron reduction of nitroso compounds gives
timesusedtotreaturinarytractinfections,canproduce nitroxideradicals,
lungdamage.Itstoxicitybothtobacteriaandtolung
may involve redox cycling. The drug is reduced (e.g.
(cid:129)
byNADPH–cytochromeP450reductaseinlungER),
RNO 2 −1→e– RNO • 2 – asdoesone-electronoxidationofhydroxylamines,
followed by reoxidation of the nitro radical to prod-
uceO
•–,
2
RNO •–+ O → RNO + O •–
2 2 2 2 Viceversa,nitroxidescanbereducedtohydroxylam-
Nitrofurantoin is one of the agents that can induce ines by ascorbate, thiols, and various enzymes. Ni-
haemolysis in patients with G6PDH deficiency (Sec- troxideradicalsarealsogeneratedbyadditionoffree
tion7.4.5),againlikelybyoxidativemechanisms. radicalstonitronesandnitrosocompounds;remember
Reduction of nitro compounds to RNO •– can also yourspintrappingchemistry(Section6.2).
2
be achieved by mitochondria, xanthine, and alde- Forseveralnitrocompounds,thereductionproducts
hyde oxidases, and, in some cases, by glutathione (RNO, RNH 2 etc.) are more cytotoxic than is O • 2 –, so
reductase. For example, reduction of trinitrotolu- thatthecompoundscausemoredamageintheabsence
ene by enzymes in the lens has been proposed to of O 2 than under aerobic conditions. For example,
account for the propensity of this compound to
metronidazole(Flagyl®;Fig.9.14)isusedtotreatinfec-
produce cataract,350 and nitrated metabolites may tionscausedbyanaerobicbacteriaandprotozoa,such
contribute to the toxicity of benzene (Section 9.5.8). as the human intestinal parasites Giardia lamblia and
Fish, crabs, and mussels contain enzymes that can Entamoebahistolytica,whicharedamagedbyitsreduc-
reduce nitro compounds, and oxidative stress may tionproducts.Sometimes,however,O • 2 –canplayapart
beinvolvedindamagetoaquaticorganismsbynitro
inthetoxicityofmetronidazole,e.g.toH.pylori.352
compounds in polluted waters.351 Redox-cycling and
nitroso compound (Section 9.19.2) formation seem 9.19.3 Azocompounds
to account for the toxicity of nitrofurazone (Fig.
9.14) and other nitro-compounds (e.g. nifurtimox, Azo compounds353 contain the –N = N– group and
benznidazole)43 to Trypanosoma cruzi (Section 3.16.1). arewidelyusedinthepharmaceutical,food,andcos-
Some dinitrohalobenzenes (e.g. CDNB) interact meticindustries,e.g.asdyesinplasticsandfabricsand
with thioredoxin reductase to cause O •– formation astheyellowdye tartrazine, whichhasbeenusedto
2
(Section3.13.1). colourfoods.TheazocompoundsAAPHandAMVN

--- Page 561 ---

506 FREE RADICALS IN BIOLOGY AND MEDICINE
OH
R N
4
R Misonidazole R : CH CHCH OCH
2 1 2 2 3
R N R : NO
5 2 2
R , R : H
4 5
R
1
Metronidazole R : CH CH OH
1 2 2
R : CH
2 3
R : H
4
R : NO
5 2
O
O N O
2
CH N N O Furazolidone
OH O
O 2 N CHCHNHCCHCl 2 Chloramphenicol
CH OH
2
O
NH
CH N N Nitrofurantoin
O N O
2
O
O
Nitrofurazone
CH NNHCNH
O N O 2
2
O 2 N O
Nimesulide
NH
SO CH
2 3
O–
N
+ N
+ Tirapazamine
N NH 2
O–
Figure9.14 Somenitrocompoundsusedinthetreatmentofdisease.Furazolidoneandnitrofurazoneareantibacterialagentsusedin
veterinarymedicine:theirtoxicitytobacteriamayinvolveRS.Theantibioticchloramphenicolactsagainstarangeofbacteria,butitsuseis
restrictedsinceitcanaffectthebonemarrowtosometimesproducesevereandirreversibleanaemia.Bonemarrowdamagemayinvolvereduction
ofthenitrogrouptonitrosochloramphenicol,aswellasoxidationoftheside-chainbyCYPstogeneratereactivespeciesthatformadductswith
proteins.

--- Page 562 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 507
•
are used as sources of RO radicals (Section 2.5.4.2), of products, and cross-links with nuclear proteins.
2
SOTS is an azo compound used to make O
•–
(Sec- Double-strand breaks are especially important dam-
2
tion2.5.3.1),andthedrugsulphasalazineisyetanother age events because their repair can be error prone
azocompound(Fig.10.14). (Section 5.10.6). In addition, radiation tends to prod-
Ingestedazocompoundsareoftenrapidlyreduced uce ‘clusters’ of DNA damage: two or more adjacent
anddegradedbygutflora.Inanimalcells,theycanbe lesions that interfere with repair of each other.354 In
reducedbyNADPH–cytochromeP450reductase,XO, patients undergoing radiotherapy, increased levels of
and several other enzymes to generate an azo anion 8OHdG in lymphocyte DNA and in urine have been
freeradical,capableofreducingO toO •–, observedinsomestudies,356but,perhapssurprisingly,
2 2
noriseinF -IsoPsinurineorplasmaseemtooccur.357
R–N = N–R’−1→e– [R–N–N–R’]•– At higher r 2 adiation doses lipid peroxidation does in-
[R–N–N–R’]•–+O −→ R–N=N–R’+O •– crease; lipidomics (Section 6.15.11) has been used to
2 2
identify peroxidized lipids in the intestine of irradi-
Further reduction yields hydrazines, R–NH–NH–R, ated mice,358 and peroxidation of mitochondrial car-
whosetoxicitycanalsoinvolveRS(Section7.5.1).The diolipin,catalysedbycytochromec,isalsoimportant
azo compound arsenazo III has been used to meas- (indeed,mitochondriallytargetedinhibitorsoftheper-
ureCa2+ movementsbecauseitchangescolourwhen oxidase action of cytochrome c were radioprotective
Ca2+bindstoit.However,arsenazoIIIcanbereduced in mice).359 Proteins can also be damaged, leading to
bycytosolicenzymes,mitochondria,andmicrosomes, protein radical formation. Indeed, radiation-induced
leadingtoO
•–generationbytheabovereactions.Oxi-
cataractinvolvesoxidativeproteindamageandcross-
2
dative stress alters Ca2+ homoeostasis (Section 5.3.2), linking of lens proteins that decreases transparency
sothatthis‘Ca2+probe’canendupalteringwhatitis (Section7.10.1).Oxidativedamagetobiomoleculesby
tryingtomeasure.353 OH• and ‘stray’ electrons may also occur during X-
ray crystallography, damaging the structure that the
9.20 Ionizingradiation354
techniqueistryingtovisualize.360
RadiationdoseismeasuredinGrays,onegraybeing
Iftheenergyofaphotonexceedstheenergyneededto anabsorbeddoseofonejouleperkilogram.AGrayis
displace an electron from a non-radical, it may cause alargedose:humansexposedto3to6Graysofion-
ionization of that molecule, knocking out the elec- izing radiation have a 50% chance of dying within a
tron and leaving a radical cation (X•+) behind. For few weeks, from damage to the gastrointestinal sys-
example,guaninecanformaguanine•+cationradical. tem and bone marrow (especially the haematopoietic
VisibleandUVlightareinsufficientlyenergetictoion- stemcells).Atdosesatorabove1Gray,radiationsick-
izemostbiomolecules,butγ-rays,X-rays,high-energy nessbeginstooccur,manifestedasnausea,vomiting,
electrons (β-particles), high-energy neutrons, and α- fatigue, fever, diarrhoea, and other symptoms. Sub-
particles (He2+ ions) can. These are often collectively jects who survive are more prone to sterility, some
calledionizingradiation. forms of cancer, and cataract. There may be no ‘safe
Whenionizingradiationpassesthroughabiological dose’ofionizingradiation;evenverylowdosesmay
system, energy is not deposited uniformly along its increase cancer risk.361 However, others argue for a
path, but in small packages; these spurs have differ- ‘hormeticeffect’(Section5.6)—exposuretolowdoses
ent sizes and may contain several excited molecules, raises defence mechanisms and offers some protec-
ions, and electrons. For example, in water exposed tion against radiation, or other toxins, administered
toγ-raysthereisbothionizationandexcitation(Sec- subsequently.362Neurogenesisinthebrainisregulated
tion2.3.3.1)toformH•,OH•,andhydratedelectrons. byROS(Section10.17.5)butcanbeshutdownifROS
Theseproductscanrecombinewitheachotherwithin levelsrisetoohigh.Thisisoneconsequenceofexpos-
aspur(e.g.2OH• formingH O ),ordiffuseintothe ureofthebraintoionizingradiation,andaparticular
2 2
bulk water. A significant part of the initial damage problem in using radiotherapy to target intra-cranial
donetocellsbyionizingradiationisduetoOH•.In- tumours.363
deed,salicylatehydroxylationhasbeenusedtodetect
OH• in various organs of X-irradiated mice.355 DNA 9.20.1 Theoxygeneffect364,365
is a particularly important target of attack by OH•,
suffering double- and single-strand breaks, deoxyri- Thedamagingeffectsofionizingradiationoncellsare
bosedamage,basemodificationtoformamultiplicity aggravated by the presence of O , by a factor (the
2

--- Page 563 ---

508 FREE RADICALS IN BIOLOGY AND MEDICINE
oxygenenhancementratio)of2-to3.5-fold.Thiswas Radiation can damage mitochondria, causing more
discoveredin1912,whenDr.Swartznoticedthataskin electron leakage to O . Superoxide might aggravate
2
reactionproducedonhisforearmbyaradiumsource injury by forming H O and by promoting metal ion
2 2
wasdecreasedifthesourcewaspressedintotheskin release (Section 3.9.2). Indeed, tissue damage by ra-
soastointerruptbloodflow.365Thisoxygeneffectcan diation can often increase the availability of ‘cata-
involveseveralmechanisms.AttackofOH•andother lytic’ transition metal ions in vivo; this has been
reactiveradicalsuponbiomoleculesoftenproceedsby demonstrated (as a rise in plasma non-transferrin-
H• abstraction. The resulting radicals (designated R• bound iron)367 in patients exposed to radiation, to
below) can sometimes be repaired by reaction with ablatethebonemarrowpriortotransplantationwith
GSHorascorbicacid,e.g. normal marrow. This iron may arise from injured
R • +GSH→RH+GS • o ly r so d s y o i m ng es) c 3 e 68 ll , s an (e d .g / . or re b le y as t e he o a f ct ir io o n n o fr f o O m •– d o a n ma ir g o e n d -
2
Itwasproposedmanyyearsagobyradiobiologists354 containing proteins. Elevated intracellular iron levels
that O ‘fixes’ the damage by forming other radicals aggravate radiation damage in both bacteria and
2
that cannot regenerate the original compound. For animalcells.368
example, A role for superoxide in radiation damage is sup-
ported by many experiments. For example, overex-
R • +O → RO • (peroxylradical)
2 2 pressionofMnSODrendersanimalcellsmoreresistant
RO • + GSH → RO H + GS • toradiation,andtreatmentofmicewithgenesencod-
2 2
ingMnSOD(Section11.5.3.1)hasdecreaseddamageby
(oxidizedbiomolecule)
radiation in several studies.369 Injection of CuZnSOD
Indeed, GSH plays an important role in protecting orMnSODintomicehasbeenreportedinsomestud-
against ionizing radiation, and treatment of organ- ies (but not others) to diminish mortality after X-
ismswithbuthioninesulphoximine(Section3.10.3)to irradiation. The effects depend on the time and dose
inhibit GSH synthesis increases their radiosensitivity. of SOD administered, and on the intensity of radi-
Reduced glutathione, its precursors, and other thiol ation used. The mechanism behind them remains to
compounds (such as cysteamine, HSCH 2 CH 2 NH 2 , be established, but could be by diminishing the in-
PrC-210, lipoic acid and mercaptopropionylglycine; flammatoryresponse.Irradiationleadstoactivationof
Section11.5.9.3),havebeenexaminedasradioprotect- transcription factors (partly by ROS production), in-
orsin animals.GSHmay beradioprotectivenotonly creasedcytokineproduction,risesinNADPHoxidase
by ‘repair’ reactions (shown above), but also by pro- activities, increased expression of COX-2 and iNOS
viding a substrate for GPx enzymes and possibly by genes,ONOO–formation,fibrosis,andoftencelldeath
scavenging OH• radicals directly, since GSH is pre- bynecrosisorapoptosis.Necroticcelldeathcanrelease
sentatmMlevelsincells(Section3.10.1).Inaddition, DAMPs to trigger inflammation, spreading damage
•
thiols react with RO 2 radicals, preventing them from beyond the initially injured cells. Oxidized lipids or
propagatingchainreactions.However,thereactivityof theirbreakdownproducts(suchasHNE)releasedfrom
the sulphur radicals produced should not be ignored irradiatedcellscancontributetospreadingtheinjury.
(Section2.5.5).Nitronylnitroxides(Table6.5)havealso When interpreting some of the earlier studies, how-
beenexploredasradioprotectiveagents.366
ever, do bear in mind the possible contamination of
SODwithendotoxin(Sections3.7.5and11.5.3).Some
9.20.1.1 Aroleforsuperoxide?364,365
Mn-containing porphyrins (Section 11.5.4) may also
IfO 2 ispresent,thehydratedelectronsformedbyion- protectagainstradiation-induceddamageinmiceboth
izing radiation can reduce it to O •
2
– (Section 2.3.3.1). byscavengingROSandbyinhibitinginflammation.370
In addition (although quantitatively less important), Apoptosisinducedbyionizingradiationfrequentlyin-
some peroxyl radicals formed by attack of OH• on volves the ceramide pathway.371 How much, overall,
biomolecules can decompose to give O • 2 –, e.g. for α- mightO • 2 – contributetooxygenenhancementofradi-
hydroxyalkylperoxylradicalsformedfromglucose, ation damage? Maybe a lot in animals. Not much in
E. coli, mutants lacking FeSOD and MnSOD showed
normalO enhancementratios.372
2
Some bacteria are highly radioresistant: they re-
pair DNA double-strand breaks exceptionally well,

--- Page 564 ---

REACTIVE SPECIES CAN BE POISONOUS: THEIR ROLE IN TOXICOLOGY 509
have high levels of SOD, and/or accumulate intra- The first HCS to be identified was metronidazole
cellular Mn2+ to scavenge O •– (Section 3.8.2). The (Fig. 9.14). Exposing animal cells in culture to metro-
2
most radioresistant organism discovered is Deino- nidazoleincreasedtheirsusceptibilitytoionizingradi-
coccus (from the Greek deinos, ‘strange’) radiodur- ationunderanaerobicconditions,andexperimentson
ans, isolated from canned meat that had been ex- tumour-bearing animals confirmed this effect in vivo,
posed to 4000 Gy!373 It is rich in carotenoids and although high doses were required. Research to find
MnSOD and it also accumulates Mn2+ to high levels. betterHCScontinued,misonidazole(Fig.9.14)being
Its MnSOD is more efficient than human or E.coli one candidate. It had little clinical success, however,
MnSOD in removing O
•–
generated at high levels andthefocusshiftedtofindingdrugsthataredirectly
2
(Section 3.5.2).374 Why it needs such radioresistance toxictohypoxiccells.TheantibioticmitomycinC(Sec-
is unknown; it is not exposed to much radiation in tion10.16)showslimitedselectivityforhypoxiccells.
its normal environment.373 Bdelloid rotifers are also Tirapazamine378 appearedinsomestudiestobemore
enormously resistant to desiccation and ionizing ra- promising,e.g. incervicalandheadandneckcancer,
diation; high antioxidant levels are again probably andalsoincombinationwithotherchemotherapeutic
involved.375 agents such as cis-platin. It is an N-oxide rather than
anitrocompound(Fig.9.14).Tirapazamineisreduced
byseveralcellularsystemstoafreeradicalthatreacts
9.20.2 Antioxidantsandradiotherapy
withO toregeneratetirapazamineandproduceO
•–.
2 2
Should patients undergoing radiotherapy take anti- If no O 2 is around, the reactive radical persists and
oxidants to protect against collateral damage to nor- damagesDNAbases.354
mal tissues? Or would they simply be protecting the
tumour? In one study of head and neck cancer, pa- 9.20.4 Foodirradiation379
tientsweregivenα-tocopherol(400units/day)andβ-
carotene(30mg/day)duringradiotherapyandforup Treatmentoffoodstuffswithionizingradiation(high-
tothreeyearslater.Therewasatendencytohaveless energy electrons, γ-rays, or X-rays) is an accepted
severeacuteadverseeffectsduringtreatmentinthetest methodforsterilization,killinginsects,orpreventing
groupascomparedwiththeplacebogroup.Unfortu- germination and ripening. In many countries, laws
nately, the test group also showed a trend for cancer govern the types of food that may be irradiated, and
recurrenceratestobehigher,especiallyinsmokers.376 the dose of radiation used. Their enforcement re-
Hence,onthebasisofcurrentdata,weseenocasefor quiresmethodstodetectirradiatedfoodandquantitate
patientsundergoingradiotherapytoconsumeantioxi- theradiationdose.Theavailabletechniquesresemble
dantsupplements.377 Antioxidantsupplementsmight those used to detect oxidative damage in living or-
perhaps be of more use to astronauts; in space they ganisms (Chapter 6). For example, most irradiated
are exposed to ionizing radiation, including protons, spices and some other foodstuffs give more chemilu-
helium ions, and high atomic number/high energy minescencewhenaddedtoalkalineluminolsolutions
particles.365 thandounirradiatedcontrolsamples.Boneandcalci-
fiedcuticle(e.g.inchickens,crustacea,andsomefish)
develop long-lived ESR signals upon irradiation be-
9.20.3 Hypoxiccellsensitizers
causetheradicalsaretrappedinasolidmatrix.(Bone
TheO effectcausesproblemsinthetreatmentofma- graftsareoftensterilizedbyradiationandsimilarlyde-
2
lignant tumours by radiotherapy. As tumours grow, veloplong-livedradicals,includingCO
•–andCO •–.)380
2 3
areas within them become hypoxic, resist radiation Food scientists may measure end-products of lipid
treatment, and serve as ‘nuclei’ for subsequent re- peroxidation(e.g.volatilehydrocarbonsoraldehydes,
growth. There has therefore been interest in therap- TBARS,peroxides,IsoPs),DNAdamageproducts(e.g.
ies combining increased O exposure with radiation, strandbreaks,thymineglycol,8OHdG),andoxidized
2
and also in various drugs that, like O , make hyp- amino acid residues, (ortho-tyrosine, formylkynuren-
2
oxic cells more sensitive to ionizing radiation. Such ine, bityrosine, 2-oxohistidine). As yet, however, no
drugs are collectively known as hypoxic-cell sensi- singlemethodtodetectirradiationisapplicabletoall
tizers (HCS).349,354 Another approach is to try to in- foods, just as there is no single ‘best’ method for de-
activate HIFs (Section 1.3.2), whose activation allows tecting oxidative damage in vivo, as we discussed in
tumourstosurvivehypoxia. Chapter6.

--- Page 565 ---

510 FREE RADICALS IN BIOLOGY AND MEDICINE
9.21 Summaryandconclusion predispose the cell to secondary oxidative stress, as
well as triggering inflammation, events which may
For some toxins (e.g. ionizing radiation, paraquat, addtotheoveralltoxiceffects.Foryetothers,RSmay
and CCl 4 ), RS generation is the major, if not the playnorolewhatsoever.Thisbringsusbacktowhat
only, mechanism by which they cause damage. For we wrote at the beginning of Chapter 9, the demon-
others, such as redox-cycling quinones and nitro strationofoxidativestressinducedbyatoxin,orthe
compounds, it may be a significant contributor. For trappingofatoxin-derivedRS,arenotsufficientevi-
others, RS may play a minor role. Several toxins dence to conclude that these RS are important in the
(e.g. metals, paracetamol) can deplete GSH and thus toxicity.

--- Page 566 ---

CHAPTER 10
Reactive species in disease: friends
or foes?
Livingmatterhasadarkside.Itfightsalostbattleagainstitsownfragilityandendsupscorched.
G.Schatz
10.1 Settingthescene 10.2 Doesoxidativestressmatter?
Thebiomedicalliteratureisfullofclaimsthatfreerad- Yes it does. Some disorders are probably caused by
icals and other reactive species (RS) are involved in oxidativestress;cancercansometimesbe,forexample
humandiseases.1,2Theyhavebeenimplicatedinover (Section10.14.8).Manyofthebiologicalconsequences
200disorders,rangingfromrheumatoidarthritis,Rett ofexcessradiationexposureareduetooxidativedam-
syndrome, and haemorrhagic shock, through cardio- age(Section9.20).Thesymptomsproducedbychronic
myopathy and cystic fibrosis to intestinal ischaemia, dietarydeficiencyofvitaminE(Section4.3)areprob-
AIDS, and even male-pattern baldness.3 In the last ably mediated by oxidative stress. However, in most
edition of this book, we gave a list of these diseases. diseases, oxidative stress is a consequence and not a
We have deleted it now because it is difficult to find cause of the disease. Tissue damage leads to release
any disease in which RS have not been implicated. of DAMPs (Section 8.7.1) and formation of increased
Asearlyas1984,wepointedout4thatthiswiderange amountsofputative‘injurymediators’,suchaspros-
ofdisordersrevealsthatincreasedRSformationisnot taglandins,leukotrienes,cytokinesand,ofcourse,RS.
somethingunusual,andthatitprobablyaccompanies Allofthesehave,atvarioustimes,beensuggestedto
tissueinjuryinmost,ifnotall,humandiseases.Why? playimportantrolesintissueinjury(Fig.10.1).
Simply because any form of tissue injury (even sur- If then, in most human diseases, more RS are pro-
gical operations5 or inserting a microelectrode into a ducedasaconsequenceoftissueinjury,dotheymake
cell)raisesRSformation.Reasonsforthisaresummar- asignificantcontributiontothediseasepathology,oris
ized in Fig. 10.1 and include liberation of ‘catalytic’ theirformationoflittleornoconsequence?Orisiteven
transitionmetalionsandhaemproteins,tissueinjury beneficial,forexample,intriggeringrapidadaptivere-
releasing DAMPs (Section 8.7.1) that can lead to re- sponses or modulating inflammation (Section 8.9.4)?
cruitment and activation of phagocytes, damage to Theanswerprobablydiffersindifferentdiseases(Fig.
mitochondria causing increased leakage of electrons 10.2)andmayevendifferfrompatienttopatient(de-
fromtheelectrontransportchain,6anddecreaseinthe pending,forexample,onhis/herantioxidantdefence
levels of antioxidants such as ascorbate, plasma thi- levelsorcytokineproduction)andatdifferentstagesof
ols (e.g. the albumin–SH group),7 and cellular GSH. thedisease. For example,theoutcomeofstroke(Sec-
Anancillarymechanismisthattheantioxidantnutri- tion 10.18.3) may be worse in subjects who initially
entstatusofsickpeoplemaybecompromised.Thus, hadlowlevelsofantioxidantssuchasα-tocopherolin
AIDSpatientsmayabsorbnutrientspoorly,8 andvery thebrain(Section10.18.3.2).Tissueinjuryaftertrauma
sick patients may not eat at all. Patients in intensive maybegreaterinsubjectslowinG6PDHactivity(Sec-
careorafterlungtransplantation(Section10.8)orcar- tion 7.4.5). When vitamin C was administeredto rats
diopulmonarybypass(Section10.6.4.8)oftenshowlow priortoparaquattreatmenttherewaslesslungdam-
plasma ascorbate—would it be beneficial to correct age. However, when it was administered at a time
this? Some studies suggest yes, and others no,9–11 so of extensive lung damage, it increased damage. This
moreworkremainstobedone. effect was likely mediated by ascorbate’s interaction
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 567 ---

512 FREE RADICALS IN BIOLOGY AND MEDICINE
Phagocyte activation and recruitment by DAMPs and
INJURY PAMPs (leading to increased production of O–, H O ,
2 2 2
NO , HOCl, ONOO–).
Ischaemia-reperfusion
Heat Raised intracellular Ca2+, stimulating calpains, Ca2+
Trauma dependent nucleases and Ca2+/calmodulin-dependent
Freezing nitric oxide synthases, giving more NO and increased risk of
Exercise to excess* ONOO– formation. Phospholipase A activation by Ca2+
2
Toxins releases arachidonic acid, a substrate for
Radiation prostaglandin/leukotriene synthesis and for non-enzymic
Infection lipid peroxidation. Released calpains and other toxins can
injure other cells/tissues.
Arachidonic acid release, enzymic peroxide formation (by
activation of lipoxygenase, cyclooxygenase enzymes). OXIDATIVE
Decomposition of enzyme-formed and non-enzymically STRESS
formed peroxides to peroxyl/alkoxyl radicals can spread
damage to lipids/proteins/DNA.
Metal ion release from storage sites (Fe2+, Cu2+) raising
intracelluar levels and stimulating conversion of H O to
2 2
OH , lipid peroxide breakdown to RO /RO , and
2
'autoxidation' reactions. Release of metal ions from
damaged cells can cause similar pro-oxidant effects in the
extracellular environment.
Haem protein release (myoglobin, haemoglobin,
cytochromes); haem proteins react with peroxides to
stimulate free radical damage and (if peroxide is in excess)
to release Fe2+ and haem, both of which can decompose
peroxides to RO and RO . Haem proteins can scavenge
2
NO and thereby diminish its antioxidant effects.
Interference with antioxidant defence systems (e.g. decreases
in intracellular or extracellular levels of GSH or ascorbate).
Conversion of xanthine dehydrogenase to XO in certain
tissues, release of XO from damaged cells to cause
systemic damage (e.g. binding to vascular endothelium),
increased hypoxanthine levels due to perturbed energy
metabolism.
Mitochondrial damage, increased leakage of electrons to
form O –, cytochrome c release.
2
Figure10.1 Someofthereasonswhytissueinjurycausesoxidativestress.Forexample,merelyplacingamicrodialysisprobeinamuscleincreased
productionofOH•andO •–,andthesystemtookatleast30minforROSproductiontoreturnto‘normal’(FreeRadic.Biol.Med.39,1460,2005;
2
Anal.Chem.80,9635,2008).IncreasedROSformationwasalsoobservedwhenfibroblastswerepuncturedwithapipette,andduring
electroporation(Section5.11.4;Arch.Biochem.Biophys.527,55,2012)*Toanextentthatcausestissuedamage/inflammation(Section7.14).
with released iron ions, since it was ameliorated by necroticfibres.Hyperactivityapparentlyledtomuscle
desferrioxamineadministration.12 Totakeanotherex- damageandlipidperoxidation,whichcontributedto
ample, inhibition of acetylcholinesterase in muscle, furthermuscleinjury.13
by organophosphate administration, delays clearance In many diseases, RS may not be major players in
of the neurotransmitter acetylcholine, leading to ex- tissueinjury.Forexample,increasedoxidativedamage
cessive contractions, muscle damage, and sometimes (e.g.aselevatedproteincarbonylsorF -IsoPlevels)has
2
necrosis.RisesinF -isoprostanes(F -IsoPs)inthedam- beendemonstratedinthedamagedmusclesofpatients
2 2
agedmusclewereblockedbytheantioxidantU78517F with various types of muscular dystrophy. This may
(Section 11.5.8), which also decreased the number of beaconsequenceofthetissuedamage,makinglimited

--- Page 568 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 513
Tissue injury
Oxidative damage
Induction of Early stage in
antioxidant and tissue injury
other defence/ Late stage in tissue
repair systems injury, accompanying
(e.g. heat shock cell death
proteins,
proteasome,
autophagy,
haem oxygenase). Necrotic death of some cells Induction of defence
Modulation of spreads damage to others systems inadequate or
inflammation, e.g. e.g. by Fe/Cu/haem protein release, non-existent. Oxidative
by decreasing T- and triggers inflammation (e.g. by damage to biomolecules
lymphocyte DAMP release), causing more RS causes impairment of cell
activity formation. Release of peroxides function; may lead to
from apoptosing cells may antigen formation and
sometimes affect surrounding an immune response.
cells. Increased activity
Neutralization of of NADPH oxidases
oxidative stress. (not always deleterious)
Sometimes
superprotection
of the tissue
No adverse contribution of Aggravates disease.
‘oxidative damage’ to disease Potential therapeutic
pathology. RS can sometimes be benefit from antioxidant
beneficial (e.g. in ischemic intervention, provided
preconditioning, adaptation that the antioxidants are
to exercise and sometimes effective in decreasing
regulating inflammation). oxidative damage
Antioxidant interventions to the important
fail to give benefit biomolecular targets.
and could conceivably be
deleterious.
Figure10.2 Whatisthesignificanceofoxidativestressindisease?AdaptedfromTrendsPharmacol.Sci.32,125,2011,withpermissionfrom
Elsevier.
(orno)furthercontributiontodamage.Hence,antioxi- withtheassumptionthatsuchrisesmeanthatoxida-
dantshavenotbeenfoundtobebeneficialintreating tive damage is important. This is not to criticize the
humanmusculardystrophies,althoughtheyhaveex- field unduly: exactly the same is true for the hun-
ertedgreaterprotectiveeffectsinvariousmousemod- dreds of papers that implicate NO•, prostaglandins,
els of these diseases.14,15 Do bear in mind, of course, leukotrienes, cytokines etc. as major players just be-
that ‘antioxidants’ may well not decrease oxidative cause the levels are increased—the fact that there is
damageeffectivelyinhumans(Chapter4).Thereisa more of something in a disease does not prove it is
plethoraofpapersmeasuringproteincarbonyls,lipid important.
peroxidesetc.insamplesoftissuesorbodyfluidsfrom Another factor to consider is how cells respond to
patientswithvariousdiseasesandshowingelevations, oxidativestress(Fig.10.2).InSection5.2weexamined

--- Page 569 ---

514 FREE RADICALS IN BIOLOGY AND MEDICINE
Table10.1 Cellularresponsestooxidativestressinhumandiseases.
Response(takenfrom Examplesofpossibleeffects
Section5.2)
Good Bad
Increasedproliferation Woundhealing Fibrosis
Increasedlevelsofdefences Resistancetofurtherinjury(e.g.ischaemic Persistenceofabnormalcells(e.g.malignantcells,
(chaperones,antioxidants,etc.) preconditioning;Section10.6.6),salvageoftissue damagedcardiomyocyteswithabnormalelectrical
activitypredisposingtoarrhythmias)
Increasedactivityoftranscription Phagocyterecruitmentandactivation,increased Survivalofunwantedcells.Overproductionof
factors(Nrf2,NF-κBetc.) productionofNO•andcytokinesasdefences NO•/cytokines/ROScausingtissuedamage(e.g.in
againstinfection;increasedsynthesisofGSHand chronicinflammation)
otherantioxidants
Necroticcelldeath DAMPreleasecan‘trigger’theinflammatory Lossofessentialcells(e.g.excitotoxicityinstroke;
response,signallingaproblemandrecruitingthe Section10.18.3).Releaseof‘catalytic’metalsand
resourcestodealwithit otherpotentiallytoxicagentscanaggravate
damageandpromotemoreinflammation
Apoptosis EliminatescellswithexcessiveDNAdamage,avoids Lossofessentialcells(e.g.inneurodegenerative
malignancy disease).Releaseofperoxidesfromapoptosing
cellscandamageadjacentcells.
Senescence Cellsdonotdividesocannotbecomemalignant Senescentcellscanprovideanenvironment
favouringmalignancy(Section10.14.1)
varioustypesofresponse.Table10.1liststhemagain, a role in furthering tissue injury in several diseases.
withcommentsonhowtheyarerelevanttodiseaseand Wehavealreadyconsideredtheexamplesofporphyria
howtheycanbebothgoodandbad,dependingonthe (Section 2.6.4), α-tocopherol deficiency (Section 4.3),
circumstances. COPD (Section 9.13), hypertension (Section 8.10.4),
drug-induced haemolytic disease (Section 7.5), cata-
10.2.1 Establishingimportance ractandmaculardegeneration(Section7.10),malaria
(Section 7.6) and iron overload (Section 3.22.5.1).
In order to show that RS are important in a par- Other possible examples are retinopathy of
ticular disease, it is necessary to fulfil the criteria prematurity (Section 1.5.2.1) and Wilson disease
listed in Table 10.2, using appropriate traps and/or (Section3.22.5.5).
biomarkers (Fig. 10.3). Although oxidative stress Let us examine some other diseases in detail, to
may often be a secondary event, the appropriate use evaluate the contributions of RS to their origin and
of such techniques has revealed that it does play progression.
Table10.2 Criteriaforimplicatingreactivespecies(RS)asasignificantmechanismoftissueinjuryinhumandisease.
1. TheRS(ortheoxidativedamagecaused)shouldbedemonstrableatthesiteofinjury.
2. Thetime-courseofformationoftheRS(oroftheoxidativedamagecaused)shouldbeconsistentwiththetime-courseoftissueinjury,preceding
oraccompanyingit.
3. DirectapplicationoftheRSoverarelevanttime-course(point2above)tothetissueatconcentrationswithintherangefoundinvivoshould
reproducethetissueinjuryandoxidativedamageobserved.
4. RemovingtheRSorinhibitingitsformationshoulddiminishthetissueinjurytoanextentrelatedtothedegreeofinhibitionoftheoxidative
damage.
Point4isworthafurthercomment;thefactthatanantioxidantdiminishestissueinjurydoesnotprovethatRSareimportant,sincemanyantioxidantsexertadditional
biologicaleffects(Section11.5).Onemustmeasurethefallinoxidativedamageandrelateittotheprotectiveeffect.Viceversa,anumberofdrugsdevelopedtotarget
othermediatorsofinjurymayadditionallyexertantioxidantactionsinvivo(Section11.5).
Wecouldreplace‘RS’intheabovetablebyNO • ,TNF-α,IL-6etc.;thesamecriteriahavetobefulfilledtoshowtheimportanceofanyputativemediatorofinjury.

--- Page 570 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 515
Antioxidant (AOX) depletion
Does not prove oxidative
damage, only that the defence
system is working
Total AOX capacity, depletion of
specific AOX, measurement of
AOX-derived species, e.g.
ascorbate radical, urate or
bilirubin oxidation products
Induction of AOX enzymes
Does not prove oxidative
damage, only that the
defence system is responding
Biomarkers of oxidative damage
Suggest that oxidative damage
has occurred but rises in
cell/tissue levels of biomarkers
could reflect not only more
damage but also decreased
repair or clearance
peroxides MDA, HNE and other
Lipid cholesterol oxidation products aldehydes
halogenated/nitrated lipids isoprostanes and related
products
oxidized/nitrated/deaminated/chlorinated/brominated bases in cells and urine;
DNA
aldehyde/DNA base adducts in cells and urine; deoxyribose breakdown products
–SH oxidation
Protein carbonyl formation
aldehyde adducts
oxidation products of tyr, trp, his, met, lys, leu, ileu, val, cys, pro, phe, ser, thr
nitrated/chlorinated/brominated tyrosine, trp, phe
protein peroxides/hydroxides
RS trapping
Spin traps
Aromatic probes (e.g. salicylate, phenylalanine), other
detectors
RS formation does not equate to RS importance. If RS
are important and the traps are efficient, the traps
should protect against tissue injury.
Figure10.3 Some‘biomarkers’ofoxidativestressorreactivespecies(RS)thatcanbeusedtostudydisease.Thereisafulldiscussionof
biomarkersinChapter6;herewerevisitthekeypointsinrelationtotheirapplicationandtotheinterpretationofresults.

--- Page 571 ---

516 FREE RADICALS IN BIOLOGY AND MEDICINE
10.3 Atherosclerosis arise largely from macrophages, but sometimes from
smoothmusclecells.Fattystreakscandevelopintofi-
10.3.1 Whatisatherosclerosis?16
brous plaques, approximately round, raised lesions,
Cardiovascular disease is a major cause of death usually off-white in colour and often a centimetre or
worldwide. Most heart attacks (myocardial infarc- so in diameter, partially obstructing the vascular lu-
tions)andmanycasesoflocalizedcerebralischaemia men. A typical fibrous plaque consists of a fibrous
(stroke)aresecondarytotheconditionofatheroscler- cap (composed mostly of smooth muscle cells and
osis,adiseaseofarteriesthatischaracterizedbyalocal dense connective tissue containing collagen, elastin,
thickeningofthevesselwallthatdevelopsintheinner and proteoglycans) covering an area rich in macro-
coat (tunica intima) (Fig. 10.4). The clinical effects of phages,smoothmusclecells,andTlymphocytes.Often
atherosclerosisare often most evidentwhen it occurs there is a deeper necrotic core, which contains deb-
in the coronary, carotid, femoral, and iliac arteries or ris from dead cells, extracellular lipid deposits, and
theaorta. cholesterolcrystals. Complicated plaquesarefibrous
Anearlystageofatherosclerosisisthefattystreak. plaquesthathavebeenalteredbynecrosis,calciumde-
These are slightly raised, yellow, narrow, longitudin- position,bleeding(leadingtoironaccumulation),and
allylyingareas.Theyarecharacterizedbythepresence thrombosis. Intra-plaque haemorrhage can accelerate
offoamcells(Fig.10.4),lipid-ladendistortedcellsthat lesiondevelopment.17
Figure10.4 Advancedatherosclerosis.Top:anatherosclerosed
andthrombosedhumancoronaryarteryobtainedduringnecropsy.
Bottom:sectionthroughalesion.Notethelipid-ladenfoamcells.
BycourtesyofDrM.J.MitchinsonandtheUpjohnCompany.

--- Page 572 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 517
Plaquescancauseproblemsbylimitingbloodflow focusedattentionontheroleofcholesterolinpromot-
to a region of an organ, such as the heart or brain. ing atherosclerosis. Indeed, later work showed that
A stroke or myocardial infarction occurs when the peoplewithhighbloodLDLcholesteroldevelopath-
lumen of an essential artery becomes completely oc- erosclerosis at an accelerated rate, and that lowering
cluded, usually by a thrombus forming at the site of elevated cholesterol levels (e.g. by blocking its syn-
a plaque. Thrombus formation is often triggered by thesis by the liver using the statin family of drugs)
plaquerupture,exposingthebloodtoproductssuchas decreasestheincidenceofmyocardialinfarction.One
tissuefactor(Fig.10.5a).Henceitisnotonlythepres- of the earliest responses induced by hypercholester-
ence of plaque that matters; its stability (tendency to olaemia is increased levels of VCAM-1 in the endo-
rupture)isakeyfactorinrelationtohumanmorbid- thelium, promoting attachment of lymphocytes and
ity/mortality,beingaffectedbyfibrouscapthickness, monocytes (Fig. 10.5). Cholesterol crystals can act
thedegreeofinflammation,andthesizeofthenecrotic as DAMPs, causing inflammasome formation within
core.Plaquedisruptionoccursmostfrequentlywhere macrophagesinthelesionandfurtheringlesiondevel-
thefibrouscapisthinnestandmostheavilyinfiltrated opment,andhypercholesterolaemiaincreasesNADPH
by foam cells; macrophage-derived proteinases (e.g. oxidaseactivityinbloodvesselwalls.18
collagenases,gelatinases,stromelysin,metalloelastase, LDL enter the arterial wall both by transport in
andmatrilysin;Table8.2)areinvolved. vesicles through endothelial cells, and by diffusion
throughtheintercellularmatrix.Theamountentering
dependsonboththeplasmaLDLlevelandthearter-
10.3.2 Predictorsofatherosclerosis16
ial wall permeability. LDL accumulation is facilitated
Atherosclerosis is accelerated by several factors, in- ifLDLthathaveenteredcanbindtoproteoglycansin
cludingelevatedplasmalowdensitylipoprotein(LDL) thevesselwall,promotingtheirretentionthere.Ifthey
levels,smoking(Section9.13),diabetes(Section10.5), undergooxidation/aggregation(seebelow),retention
andhypertension(Section8.10.4),allconditionsassoci- isfurtherpromoted.
atedwithoxidativestressandimpairmentofvascular Other errors in fat metabolism also predispose to
endothelialfunction.Anotherimportantcontributoris atherosclerosis,anexamplebeingtypeIIIhyperlipo-
inflammation; phagocyte recruitment occurs early in proteinaemia, araredisorderinwhichplasmalevels
atherosclerosisdevelopment(Fig.10.5)andinflamma- ofcholesterolandtriglyceridearemarkedlyelevated.
tionalsopromotesthrombosis.Indeed,atherosclerosis ThediseaseisassociatedwithapolipoproteinE(apoE)
canberegardedasachronicinflammatoryconditionof or with receptors for it. Apolipoprotein E is a com-
bloodvesselwalls.16,18HighbloodlevelsofC-reactive ponentofchylomicronsandVLDLandfunctionsasa
protein (CRP) (Section 5.7.4) and of myeloperoxidase ligandforuptakeof‘remnantparticles’,derivedfrom
(MPO;Sections8.7.5and10.3.5.1)areassociatedwith VLDLandchylomicrons,bytheliver(Fig.4.4).Inhu-
increasedriskofcardiovascularevents;CRPmayhave manstherearethreecommonisoformsofapoE:apoE2,
directpro-atheroscleroticeffects,assuggestedinsome apoE3,andapoE4(alsoseeSection10.21.2).Theydif-
studies,butmayalsosimplybeamarkerofongoing ferfromeachotherbysingleamino-acidsubstitutions
inflammation.16,19,20 atresidues112and158intheprotein.TheapoE2form,
Blood lipids play a key role. In well-fed popula- withcysteineresiduesatbothpositions,isassociated
tions,atherosclerosisbeginsinthefirstdecadeoflife. withimpairedbindingtotheapoEreceptorsandpre-
Fatty streaks have even been reported in the foetus, disposestotypeIIIhyperlipoproteinaemia.Transgenic
to an extent increasing with maternal plasma choles- ‘knockout’ C57BL/6J mice lacking apoE show accel-
terol levels.21 LDL are key players in fat metabolism; erated atherosclerosis on a normal diet (even faster
theyareproducedfromvery-low-densitylipoproteins on a high-cholesterol diet), and are frequently used
(VLDL)inthecirculation(Fig.4.4)andarerichinchol- as a model (somewhat abnormal) of human athero-
esterolanditsesters.LDLhelptosupplycholesterolto sclerosis. ‘Normal’ mice are resistant to diet-induced
tissuesbybindingtocellsurfacereceptorsandbeing atherosclerosis,whereasrabbitsrapidlydevelopiton
internalized. ahigh-cholesteroldiet.
Inthediseasefamilialhypercholesterolaemia,LDL
receptors are defective or absent, so that blood LDL 10.3.3 Whatinitiatesatherosclerosis?16
(andhencecholesterol)levelsbecomeveryhigh.Ath-
erosclerosisisaccelerated,andmyocardialinfarctions Atherosclerosisbeginswithimpairmentofthefunction
canoccurasearlyas2yearsofage.Theseobservations of the vascular endothelium. In the average human

--- Page 573 ---

518 FREE RADICALS IN BIOLOGY AND MEDICINE
(a)
Blood monocyte Monocyte
adhered to Arterial
epithelium lumen
Monocyte
migrating
Dying
into intima
macrophage
Monocyte becoming
intimal macrophage
Macrophage Apoptotic
Adhesion foam cell bodies
molecule
VCAM-1 Tissue
factor
CCR2
Arterial ROS
intima MCP-1 Scavenger Cytokines
receptor Lipid
M-CSF droplets MMPs
Modified
lipoprotein
particle
(b)
T lymphocyte Endothelium
Arterial
lumen
Tissue factor
MMPs
Macrophage or
other antigen-
presenting cell
Arterial CXCR3
intima Cytokines
CD 154 CD 40
IP-10
Mig I-TAC TH1 IL-1 γ
IFN-
Antigen TH2 TNF
receptor Antigens
(Ox-LDL etc) IL-10
IL-4
adult, the vascular endothelium consists of over 1013 andbranchpointsofarteries,apparentlybecausenor-
cells and weighs about 1 kg.22 Damaging events in- mal blood flow can be turbulent and shear stress is
clude infection of the vessel wall (herpes viruses, lowandvariable.Highbloodpressurecanmakethis
cytomegalovirus,andChlamydiaareamongtheagents worse.24 Incontrast,arterialregionsexposedtomod-
implicated), and exposure to blood-borne toxins, in- erate prolonged shear stress are protected. Moderate
cluding both xenobiotics (e.g. from cigarette smoke) shear stress increases endothelial eNOS activity and
and elevated levels of normal metabolites, such as levels of antioxidant defence enzymes, an adaptation
glucose.Repeatedconsumptionofmealsrichincarbo- that seems to be triggered by a carefully regulated
hydrates and fat may cause postprandial oxidative ROS production by NADPH oxidases (Table 5.5 ex-
stress and transient impairment of endothelial func- amples 16–18 and ref24). This contributes to the car-
tion, marked by a decrease23 in levels of bioavailable diovascular benefits of regular exercise. Disturbed
NO•. Atherosclerotic plaques are not randomly dis- flow/hypertensiondrasticallyincreaseO •–/H O pro-
2 2 2
tributed, but tend to form at the inner curvatures duction and can cause harm.24 It’s the usual redox

--- Page 574 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 519
(cid:3)
Figure10.5 (a)Anoutlineofstepsintherecruitmentofmononuclearphagocytestothenascentatheroscleroticplaqueandtheirrolesinthe
matureatheroma.Thestepsaredepictedinanapproximatetimesequencefromlefttoright.Normalarterialendotheliumdoesnotengagein
prolongedcontactwithcirculatingneutrophilsormonocytes,butwhenendothelialcellsundergoinflammatoryactivation,theyincreaseexpression
ofadhesionmolecules(Section8.7.3).Formonocyterecruitment,vascularcelladhesionmolecule-1(VCAM-1)andICAM-1playmajorroles.Once
adherenttotheactivatedendothelium,themonocytemovesbetweenendothelialcellstopenetrateintothetunicaintima,theinnermostlayerof
thearterialwall.Thisdirectedmigrationrequiresachemoattractantgradient.Variouschemokinesparticipate,particularlyinteractionofmonocyte
chemoattractantprotein-1(MCP-1)withitsreceptorCCR2.Onceresidentintheintima,themonocytesacquirecharacteristicsof
macrophages;themacrophageisakeyplayerinatherosclerosisanditscomplications.ManyofthemareoftheM1(pro-inflammatory)phenotype
(Section8.7.2),secretingcytokinessuchasIL-1βandTNF-α,althoughM2typemacrophagesarealsopresentinatheroscleroticlesions.18Inthe
atheroma,themacrophagesexpressscavengerreceptorsthatbindinternalizedlipoproteinparticlesmodifiedbyoxidationand/orglycation.These
processesgiverisetothefoamcell,ahallmarkofthearteriallesion(Fig.10.4).FoamcellssecreteRSandpro-inflammatorycytokinesthatamplify
thelocalinflammatoryresponseinthelesion.Inearlyatherosclerosis,apoptosingmacrophagesaremostlyphagocytosed,e.g.byM2-type
macrophages.Asthediseaseprogresses,thisbecomeslessefficientandapoptoticmacrophagesaccumulate,someprogressingtonecrosis.
Atheromaformationalsoinvolvestherecruitmentandproliferationofsmoothmusclecellsfromthetunicamedia(middlelayerofthearterywall)to
formthefibrouscap,astheysecreteanextracellularmatrixrichincollagenandelastin.Theactivatedmononuclearphagocytehasakeyroleinthe
thromboticcomplicationsofatherosclerosisbyproducingmatrixmetalloproteinases(MMPs),whichcandegradetheextracellularmatrixthatlends
strengthtotheplaque’sfibrouscap.Iftheplaquerupturesasaconsequence,itpermitsthebloodtocontactanothermacrophageproduct,the
potentpro-coagulantproteintissuefactor.Productionofthisbymonocyte/macrophagesisincreaseduponexposuretooxidizedLDL(J.Clin.
Invest.122,558,2012).Manymacrophagescongregateinacentralcoreinthetypicalatheroscleroticplaque.Macrophagescandieinthis
location,henceproducingthe‘necroticcore’oftheatheroscleroticlesion.(b)TherolesofTlymphocytesinatherogenesis.Similarlytomonocytes,
lymphocytesentertheintimafacilitatedbybindingtoadhesionmolecules,includingVCAM-1,inresponsetochemoattractantsselectivefor
lymphocytes.Knownchemoattractantsincludeatrioofinterferon-γ (IFN-γ)-induciblechemokinesoftheCXCfamilyincludinginducible
protein-10(IP-10),monokineinducedbyIFN-γ (Mig),andIFN-inducibleT-cellα-chemoattractant(I-TAC).Thesechemokinesbindtochemokine
receptorCXCR3expressedbyTcellsintheatheroscleroticlesion.Onceresidentinthearterialintima,theTcellmayencounterantigenssuchas
oxidizedLDL(Ox-LDL),heat-shockproteinssuchasHsp60and,insomecases,microbialantigens(Section10.3.3).Uponactivationbyengagement
ofthereceptorwithantigen,theTcellcanproducecytokinesthatinfluencethebehaviourofothercellspresentintheatheroma.Productionof
thesemediatorsprovidesanamplificationloopresultingfromcross-talkbetweenthecellofacquiredimmunity(theTlymphocyte)andthe
mononuclearphagocyte.Withintheatheroma,helperTcellscanpolarizeintothosesecretinggenerallypro-inflammatorycytokines(knownas
TH1cells)andthosesecretingpredominantlyanti-inflammatorycytokines(denotedTH2cells).AdaptedfromNature420,868,2002,bycourtesy
ofDrPeterLibbyandElsevier,alsosee16.
balance—some ROS are good, but too many, as in possess some receptors for ‘normal’ LDL, but LDL
hypertension (Section 8.10.4), hypercholesterolaemia, whoselipidshavebeenoxidizedisrecognizedbydif-
or disordered blood flow (the wrong kind of stress!), ferentreceptors.Theywerefirstidentifiedasreceptors
endupcausingendothelialdamage. thatboundchemicallyacetylatedLDL(theacetyl-LDL
EndothelialinjurycanincreasepermeabilitytoLDL receptors), but are now usually called scavenger re-
andalsoraiseslevelsofadhesionmolecules.Thisac- ceptors.25–27 At least eight types (A–H) of scavenger
tivation of the endothelium promotes the attachment receptor are known. Particularly important ones in-
of monocytes from the circulation, which enter the cludescavengerreceptorsA(SRAIandII)andCD36,
vesselwallanddifferentiateintomacrophages.Macro- a member of the class B family of scavenger recep-
phagesoftheM1phenotype(Section8.7.2;Fig.10.5)in tors(anothermemberisCD163;Section3.23.3.4).The
the vessel wall can generate active inflammasomes,18 A and B class scavenger receptors recognize several
secrete cytokines that amplify the local inflammatory ligands, including specific classes of lipid oxidation
response, and release matrix metalloproteinases that products. For example CD36 can recognize multiple
can damage the fibrous cap and weaken the plaque. ligands,oneofthembeingoxidizedphosphatidylcho-
Lymphocytesalsoenterthevesselwall(Fig.10.5)and lineresiduesthathaveacarbonylmoietyonthefatty
somecanthenrespondtoantigens(includingoxidized acid at position 2 of the glycerol backbone. Uptake
lipids)toproduceantibodies. of oxidized LDL (oxLDL) causes lipids to accumu-
late in droplets in the macrophage cytoplasm, and
10.3.4 LDLoxidationandthefoamcell16,18,25 foamcellsmayeventuallyresult.Akeyfactorpromot-
ing the transition of monocytes to macrophages and
LDL entering the vessel wall undergo oxidation foam cells is macrophage colony-stimulating factor,
(exactly how we will consider shortly). Macrophages MCSF,whichincreasesSRAexpressionandcytokine

--- Page 575 ---

520 FREE RADICALS IN BIOLOGY AND MEDICINE
production. Foam cells show increased expression Bycontrast,prostacyclin,resolvins,andpossiblycyc-
ofgenesencodingMCP-1,matrixmetalloproteinases, lopentenone prostaglandins (Section 8.12) could help
severalcytokines,and15-lipoxygenase. toprotecttheendothelium.
OxLDListhoughttobeimportantinatherosclerosis Although uptake ofoxLDLby macrophagesmight
in several ways. It may lead to increased expression be regarded as a ‘defence mechanism’ to protect the
of adhesion molecules such as VCAM-1 and ICAM-1 endothelium, it imposes an oxidative stress on the
intheendothelium,promotingmonocyterecruitment. macrophage to which it can respond, e.g. by synthe-
ItmayactivateNF-κBandotherredox-sensitivetran- sizing more chaperones and raising its GSH levels.32
scription factors; activated NF-κB can be detected in Eventually,however,somefoamcellssuccumbtothe
smooth muscle cells, macrophages, and endothelial oxidation load, poisoning themselves with ingested
cellswithinatheroscleroticlesions,butnotusuallyin oxidized lipids and dying by apoptosis or necrosis;
normalvesselwall.28 Dependingonitsdegreeofoxi- the latter helping to form the ‘necrotic core’ of ad-
dation,oxLDLcanbechemotacticformonocytesand vancedatheroscleroticlesions(Fig.10.5).TheDAMPs
T-cells,mitogenicforsmoothmusclecellsandmacro- (includingcholesterolcrystals)releasedbynecrosiscan
phages,andaccelerateproductionofMCP-1andMCSF furtheraggravateinflammation.
by endothelial and smooth muscle cells. Exposure of Similarly, excess uptake of oxLDL by endothelial
endothelialcellsinculturetooxLDLalsoincreasesthe cellscaninjureorkillthem(oftenbytriggeringapop-
activity of a O
•–-producing
NADPH oxidase (Section tosis),sodisruptingtheendothelium.Onecounterbal-
2
10.3.5).AswithotherROS(Section5.5.6),NF-κBshows ancing factor may be that oxLDL can activate Nrf2
abiphasicresponse;althoughlowlevelsofoxLDLcan (Section 5.5.8) in endothelial and other cells, raising
lead to activation, high levels can suppress binding levels of ‘defence’ systems such as GSH and HO-1.
oftheactivatedtranscriptionfactortoDNA.29Indeed, Another counterbalancing factor is the peroxisome
LDLintheearlystagesofoxidation(so-calledminim- proliferator-activated receptor γ (PPARγ), so-called
allymodifiedLDL)maybethemostdamaging;once because it is activated by peroxisome proliferator
ithasoxidizedfurther,itisrecognizedbythemacro- drugs (Section 10.15.2.1). This receptor is essential in
phagescavengerreceptors,takenupbythesecells,and animals for the development of adipose tissue and
removed from contact with the vascular endothelial for correct glucose homeostasis, and is the target of
cells. What is meant by ‘early’ and ‘minimally modi- several drugs (the thiazolidinediones) that decrease
fied’ varies from laboratory to laboratory i.e. these tissueinsulinresistanceintype2diabetes.Thereceptor
termsaresomewhatarbitrary. ishighlyexpressedinfoamcellsinatheroscleroticle-
Endothelial cells can also take up oxidized LDL sions; ligands to PPARγ decrease atherosclerosis in
via a receptor (LOX-1; lectin-like oxidized LDL LDL-receptor-deficient mice, suggesting that PPARγ
receptor-1),differentfromthescavengerreceptorson activation has some anti-atherosclerotic effect.33 Con-
macrophages.26 Its levels in healthy endothelium are stituents of oxLDL can activate this receptor, which
lowbutincreasewhenoxLDLispresent,orinthepres- wouldpresumablybeabeneficialeffectinvivo.34Other
ence of cytokines such as IL-1β and TNF-α.25–27 The members of the PPAR family, such as PPARα might
LOX-1 receptor recognizes a range of LDL modifica- alsobeinvolved.
tions in addition to lipid oxidation, including modi- Thus oxLDL might do both good things and bad
fication by aldehydes or by HOCl. Its expression is things in the vessel wall. Which predominate? The
increased by hypertension, diabetes, and hyperchol- pioneering oxidative modification hypothesis intro-
esterolaemiaandlevelsareelevatedinatherosclerotic duced by Steinberg et al.35 states that LDL oxidation
lesions. isakeycontributortothedevelopmentofatheroscler-
Lipid peroxides can accelerate cyclooxygenase osis, i.e. that overall the oxidation products are bad.
(COX)-andlipoxygenase-catalysedreactionsinendo- Beforereviewingtheevidenceforandagainstthiscon-
thelium, phagocytes, and in any platelets present, cept, let us ask how LDL might be oxidized in the
leading to enhanced formation of eicosanoids (Sec- vesselwall.
tion 8.12.4). Indeed, cyclooxygenase-2 is present in
humanatheroscleroticlesions,andPGE mayincrease
2 10.3.5 MechanismsofLDLoxidation16,18,35
metalloproteinaseexpressioninmacrophages.30 IsoPs
generatedfromarachidonicacidresiduesinLDLcould Activated monocytes and macrophages produce O •–,
2
alsocontributetodysfunctionofthevesselwall,e.g.by H O , and possibly NO• (the last less often in hu-
2 2
promoting vasoconstriction or platelet aggregation.31 mansthaninrodents;Section8.7.4.8).Otherpotential

--- Page 576 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 521
sources of ROS in the vessel wall are mitochondria, MPO can bind readily to LDL and several studies
COXandlipoxygenaseenzymes,NADPHoxidases,36 suggestthatplasmaMPOlevelscorrelatewithcardio-
MPO, and XO. The last two bind readily to vascu- vasculardisease.53–55MPOcancatalysetyrosinenitra-
lar endothelium and are present in human athero- tion(Section6.6.2.1),andHOClproducedbyMPOcan
sclerotic lesions.37 ‘Uncoupled’ eNOS (Table 1.3) can deplete antioxidants (especially ascorbate and thiols)
make ROS as well. Both hypercholesterolaemia and andattackLDLdirectly.ItoxidizesapoproteinB,espe-
oxLDL can increase NADPH oxidase activity in vas- ciallyoncysteine,convertsmethionineresiduestothe
cularendothelium,18,38andhypercholesterolaemicpa- sulphoxide,formschloraminesfrom–NH groupson
2
tientsshowincreasedoxidativestress,asrevealedby LDLproteinandlipid,andconvertsPUFAside-chains
higherF -IsoPlevels.39 and cholesterol into chlorohydrins and chlorinated
2
However, O •–, H O , or NO• cannot directly ox- sterols.56 Plasmalogens in LDL (Section 5.12.8.1) are
2 2 2
idize LDL. Indeed, NO• tends to inhibit LDL per- particularlysensitivetooxidationbyHOCl,generating
oxidation, probably by scavenging peroxyl radicals chlorinated aldehydes, some of which might be able
(Section 2.5.6.2), and is generally thought to be anti- toinjureendothelialcells.56Hypochlorousacid-treated
atherosclerotic.40 Nitric oxide also deters thrombosis, LDLarerecognizedbyCD36scavengerreceptors25and
phagocyte adhesion to endothelium, and NF-κB acti- promoteplateletaggregation,perhapscontributingto
vation.EndothelialNO• productioninatherosclerotic thrombusformationafterplaquerupture.57MPObinds
lesions appears subnormal, perhaps due to its con- tightly to the basement membranes (basement mem-
sumption by O •– (with ONOO– formation) and to branes are described in Section 8.7.5.6) of vascular
2
impairmentofeNOSactivity.41Indeedthehallmarkof endothelialcells(andothercelltypes)and,inthepres-
endothelialfunctionisimpairedbioavailabilityofNO•. enceofH O ,cancatalyseHOClformation,NO• de-
2 2
•
Anotherfactortoconsideristhatlevelsofthe‘natural’ pletion,NO formation,andproteinnitration.Indeed,
2
NOS inhibitor ADMA (Section 2.5.6) can be elevated HOCl-modified LDL, HDL, and albumin have been
inatherosclerotichumans,andsuchhigherlevelsarea detected,58andHOClgenerationdirectlyimaged,59in
riskfactorforcardiovasculardisease.42 human atherosclerotic lesions. It has been suggested,
Nevertheless, H O and O
•–
may play some roles but not firmly established, that subjects with a poly-
2 2 2
in the initiation and/or progression of atheroscler- morphisminthepromoterregionoftheMPOgenethat
osis.Forexample,humanswithlowerNOX2activity leadstodecreasedactivityshowalowerincidenceof
had lower urinary F -IsoPs, improved vascular func- heartdisease.54
2
tionandlesscarotidatherosclerosis(Section8.7.4.4).43 But hold on for a minute; LDL receptor-deficient
Overexpressionofcatalase,GPx(insomestudies,not mice that also lack MPO are not protected against
others), or peroxiredoxins in apoE-deficient mice de- atherosclerosis—in fact it is increased.60 However,
creases atherosclerosis development, whereas knock- over-expression of human MPO in mice does accel-
out of the genes encoding such antioxidant enzymes erate atherosclerosis,61 an MPO inhibitor (INV-315)
accelerates it.44–46 Indeed, over-oxidized peroxiredox- was reported to decrease atherosclerosis in apoE-
ins have been detected in human atherosclerotic knockout mice (although it might have been act-
lesions.47 ing by other mechanisms),62 and ROS, RNS, and
RCS do form in human atherosclerotic lesions, as
10.3.5.1 Reactivenitrogenandchlorine
evidenced by elevated levels of such biomarkers
species48,49
as bityrosine, 3-chlorotyrosine, 5-chlorouracil, chloro-
Unlike O •– or NO•, ONOOH readily oxidizes LDL.50 aldehydes,3-nitrotyrosine,nitratedγ-tocopherol(Sec-
2
AnotherroleforRNSincardiovasculardiseasemaybe tion 4.3.7), ortho- and meta-tyrosine (putative bio-
inthenitrationoffibrinogen,aprocesswhichcanac- markers of OH• generation; Section 5.3.1), and
celeratethrombusformation.Indeed,plasmalevelsof other amino acid oxidation products.53,58,63,64 One
nitratedfibrinogenareincreasedinpatientswithcor- especially important target of nitration/chlorination
onary artery disease.51 Nitrated proteins are present in atherosclerosis is apolipoprotein A-1 in HDL
insomehumanatheroscleroticlesions,andcanbeim- (Section10.3.9).20
munogenic; increased circulating levels of antibodies
10.3.5.2 Metalions
recognizing3-nitrotyrosinehavebeendetectedinsub-
jectswithcoronaryarterydisease.52Dorememberthat Macrophages, vascular endothelial cells, smooth
nitratedproteinscanarisebymechanismsotherthan musclecells,andlymphocytescauseoxidationofLDL
attackbyONOO–(Section6.6.2.2),suchasMPO. whenincubatedwithitinvitro.LDLoxidationbyallof

--- Page 577 ---

522 FREE RADICALS IN BIOLOGY AND MEDICINE
thesecelltypesinvitrorequirestracesofironorcopper endothelium (re-endothelialization), yet another pos-
ions, and is stimulated by certain thiol compounds. sibleprotectivemechanism.73
Is this an artefact of cell culture (Section 1.11) or The gene on chromosome 16 that encodes human
physiologically relevant? We don’t really know. In- haptoglobin is polymorphic. Hence there are three
jury to vascular endothelium in vivo might liberate haptoglobinphenotypes,1–1,1–2,and2–2.Undercer-
‘catalytic’ metal ions (Fig. 10.1), and caeruloplasmin tain reaction conditions in vitro, the 1-1- form is a
entering the vessel wall could conceivably degrade betterinhibitorofhaemoglobin-inducedlipidperoxid-
(after attack by ONOOH perhaps) to release copper ation than the 2–2 form, and haemoglobin bound to
ions.37 Peroxides in LDL might liberate haem or iron the 1–1 form is more rapidly cleared from the circu-
ionsfromhaemproteins(Section3.22.3),especiallyif lation(Section3.23.3.4).Thereareseveralsuggestions
bleeding delivers ‘free’ haemoglobin.17 Indeed, iron thatthe2–2phenotypeincreasestheriskofatheroscler-
and copper ions ‘catalytic’ for free radical reactions osis,e.g.indiabetes.Whydiabetes?Thishaptoglobin
havebeendetectedinadvancedhumanatherosclerotic seemslessgoodatblockingthepro-oxidantactivityof
lesions and can also be released by injury of normal glycatedhaemoglobins.74Theassociationofhaptoglo-
vesselwalls(Table5.3and37,65).Copperionsarepro- bin2–2genotypewithincreasedriskofcardiovascular
atherosclerotic when administered to some animals66 disease, especially in diabetic patients, may thus be
and the copper ion chelator tetrathiomolybdate is related to increased iron accumulation and oxidative
anti-atheroscleroticincertainanimalmodels.67 damageinhumanatheroscleroticlesions.74
Metal ions could accelerate lipid oxidation by pro- Tosummarize,thereissomeevidencethathaemand
motingOH• formationand/orbydecomposinglipid ironionsarepro-atheroscleroticinvivo,andthatHO-1
peroxides to peroxyl and alkoxyl radicals; haem also is anti-atherosclerotic. Evidence for a role of copper
facilitatesperoxidedecomposition.Even‘normal’cir- ionsorcaeruloplasmininatherosclerosisisevenmore
culatingLDLoftencontaintracesofperoxides(Section limited.Dorememberthatatherosclerosisindifferent
10.3.8).Inaddition,theintactcaeruloplasminmolecule animalmodelsmaybeverydifferentinitsoriginand
might be able to oxidize LDL (Section 3.22.2.3), al- progression.
thoughmoreevidenceisrequiredtosubstantiatethis.
If it can, rises in plasma caeruloplasmin levels in
10.3.5.3 Lipoxygenases
the acute-phase response (Section 5.7.4) might con-
tributetothepro-atherogeniceffectsofinflammation. Dual specificity 12/15-lipoxygenases (LOX)49,75 that
However, could free copper ions persist in the ves- can oxidize fatty acid side-chains in LDL have been
sel wall? Albumin and many other proteins avidly detected in animal atherosclerotic lesions. Peroxide
bind copper ions and decrease their pro-oxidant ef- decomposition to radicals can then cause further
fect, as do negatively charged proteoglycans. Indeed, (non-enzymic)peroxidation.Knockoutof12-/15-LOX
LDL bound to glycosaminoglycans are resistant68 to in mice lacking apoE decreased atherosclerosis in
oxidationbyCu2+. some studies but not others, and inhibition of 15-
Whataboutiron?Studiesondevelopingatheroscler- LOX in rabbits by an (allegedly) specific inhibitor
oticlesionsincholesterol-fedrabbitsshowedthemto lacking antioxidant properties (PD146176), also de-
beenrichediniron(butnotincopper),anddecreasing creased atherosclerosis.76 The importance of LOX en-
this iron accumulation in rabbits by using desferri- zymes to human atherosclerosis is uncertain; also
oxamine (or venesection) delayed the appearance of remember that mice, rabbits, and humans have dif-
atherosclerosis.69However,atleastsomeoftheironin ferent types of LOX. Analysis of stereospecificity
lesions is present in ferritin,70 which is not very pro- suggests that lipid oxidation products in human le-
oxidant(Section3.22.4.2).Haemoxygenase(HO-1)in sionsdonotariseenzymically,77,78 althoughthisdoes
lesions could be a potential source of iron, but haem not rule out a ‘seeding’ role for lipoxygenases in
isitselfapowerfulpro-oxidantforLDL,71sotheover- LDL oxidation (i.e. they start it and it then con-
alleffectofHO-1couldbeanti-atherosclerotic.Indeed, tinuesnon-enzymically).Lipoxygenases,especially5-
inhibition of HO-1 in animals often accelerates ath- LOX(whichhasbeendetectedinhumanatheroscler-
erosclerosis development,72,73 although this may not otic lesions), might also contribute to atherosclerosis
necessarilybeduetohaemremovalsincetheCOpro- by synthesizing leukotrienes (especially LTB ) that
4
duced by HO-1 might play some anti-atherosclerotic worsen the ‘inflammatory state’ of the vessel wall
role.HO-1alsopromotesrepairofdamagedvascular (Section8.12).

--- Page 578 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 523
10.3.5.4 Summingitup:whichpro-oxidant(s) patients with coronary artery disease.82 Some COPs
oxidizeLDLinvivo? aretoxictoarterialsmoothmuscleandvascularendo-
thelialcellsandtomonocyte/macrophagesinculture,
The extents of elevation of biomarkers of oxi-
promoting apoptosis. The significance of this in vivo
dative/nitrative/chlorinative damage measured in
is uncertain, since mixtures of oxidation products re-
human atherosclerotic lesions are variable between
sembling those found in lesions do not seem to be
laboratories.Wecannotsayatthemomentwhichspe-
cies (metals, ONOO–, other RNS, HOCl, LOX) is the especiallycytotoxic,andsomepapershavedescribed
effectsofoxysterolsindecreasingmacrophagecytokine
most important initiator of LDL oxidation in vivo.
production.83
In fact, given the complexity of lesions, they could
all be important in different regions and/or at dif-
ferent stages of lesion development in different spe-
10.3.7 Doesevidencesupportthe‘oxidative
cies. Indeed, it is possible that no two lesions have
modificationhypothesis’of
exactlythesamepatternofoxidativedamage.Forex-
ample, in diabetes-induced atherosclerosis, OH• may
atherosclerosis?16,18,35,46
be more important than HOCl or ONOO– (Section This hypothesis states that oxidation of LDL in ves-
10.5.7). Remember also that the presence of LOX or sel walls is a significant contributor to atheroscler-
biomarkersofoxidation,nitration,andchlorinationis osis development. Doubt has been cast on this con-
notevidencethattheseprocessesareimportant.Nev- cept by the failure of several intervention trials with
ertheless, it is suggestive that plasma 3-nitrotyrosine nutritional antioxidants (especially α-tocopherol) to
levels (and antibodies against nitrated proteins)52 are delaythedevelopmentofcardiovasculardisease(Sec-
increased in subjects with coronary artery disease, tion4.6).Indeed,therearesomesuggestionsofharm,
and3-NTlevelsdropwhenpatientsaregivenstatins e.g. vitamin E and C administration may antagon-
to lower cholesterol.79 It is also possible that ath- ize the protective effects of statins.84 However, this
erosclerosis development in mice is more dependent by itself does not prove the hypothesis wrong, given
on LOX and less so on MPO than in humans.16,60 thepoor(orzero)abilityofdiet-derivedantioxidants
Indeed, MPO is more abundant in human athero- to decrease oxidative damage in the human body
sclerotic lesions (and in human neutrophils!) than in (Chapter4).
mouseones,further illustratingthelimitedrelevance Whatcanwebesureof?First,oxidizedlipidispre-
of murine models of disease to the human situation. sentinhumanandotheranimalatheroscleroticlesions;
Indeed, even when mice are ‘forced’ to develop ath- ithasbeendetectedasCOPs,lipidhydroperoxidesand
erosclerosisbyapoEknockoutorothermanipulations, hydroxides, F -IsoPs, and decomposition products of
2
they rarely go on to suffer plaque disruption and lipidperoxides(such as 4-HNE, acrolein,andMDA).
thrombosis. ElevatedplasmaorurinaryF -IsoPlevelsarepredict-
2
iveofvasculardiseaseinsome,butnotall,studies.53,85
10.3.6 OtheraspectsoftheinvolvementofRS Lipid oxidation occurs despite the fact that the le-
sionscontainα-tocopherol(ofcourse,theperoxidation
inatherosclerosis
maybehappeninginregionsoflowvitaminE).86 In-
Matrix metalloproteinases can be activated by HOCl creasedoxidativeproteinandDNAdamage,thelatter
andotherRS,whichcouldcontributetoplaquerupture usually measured as 8OHG or etheno-DNA adducts,
(Table 8.2). Some products of LDL oxidation are pro- is also observed in endothelial and smooth muscle
coagulant80andmayplayaroleinpromotingcalcifica- cells and macrophages in atherosclerotic lesions,87
tioninadvancedlesions.81Somelipidoxidationprod- but its significance is unclear. It may be another re-
uctscanpromotetheconversionofsmoothmusclecells flection of the fact that RS production and uptake
intoosteoclastsinthevesselwalls(aninterestingcon- of oxidized LDL (oxLDL) cause oxidative stress in
trasttotheabilityofRStodecreasecalcificationinthe thesecells.
skeleton; Section 8.10.8). Oxidation products of chol- OxidationofLDLmostlyoccursinthemicroenvir-
esterol (COPs) might also be involved in atheroscler- onmentofthebloodvesselwallandnotinthecircu-
osis,sincecholesterolisoxidizedtomultipleproducts latingblood.Nevertheless,several(butnotall)reports
in oxidizing LDL. Indeed, cholesterol ester peroxides suggest that plasma LDL isolated from people with
andhydroxides(thelatterpresumablyreductionprod- extensiveatherosclerosisshowsamilddegreeofoxida-
uctsoftheperoxides)arepresentinadvancedhuman tionandthattheplasmalevelofoxLDL(whichisnot
lesions78 and levels are elevated in the plasma of easytomeasure,sinceoxLDLisamixtureofdifferent

--- Page 579 ---

524 FREE RADICALS IN BIOLOGY AND MEDICINE
species and different antibodies recognise different sometimes worked in animals. Probucol was initially
epitopesandsowillgivedifferentresults)appearsto introducedasadrugtolowerbloodcholesterollevels
predict cardiovascular events.53,80 Of course, oxLDL in humans, although now rarely used, but it is also
mightescapefromthevesselwallbackintothecircu- a chain-breaking antioxidant. Its major metabolite in
lation.ThusplasmaoxLDLlevelsmightbeamarkerof rabbits, a bis-phenol (Fig. 10.6), also has antioxidant
atherosclerosis progression. However, please remem- properties. The anti-atherogenic effect of probucol in
berthattheLDLfromsuchpatientsmighthavelower rabbits is greater than expected from its cholesterol-
antioxidant levels and tend to undergo more arte- loweringability,anobservationinitiallytakentosug-
factual peroxidation during isolation (Section 10.3.8). gest that its antioxidant activity might contribute.
OxidizedLDLis,inanycase,rapidlyclearedfromthe Similarly, butylated hydroxytoluene (BHT) has been
circulation, mostly by uptake by hepatic endothelial showntobeantiatheroscleroticinafewanimalstudies,
andKupffercellsusingscavengerreceptors.88 despitethefactthathigh-doseBHTraisesplasmalipid
Second,antibodiesthatrecognizeoxLDLarefound levelsinanimals.93
inplasmafromatheroscleroticpatients.Theantibodies However, never assume that ‘antioxidants’ are
recognizearangeofepitopesinoxLDL,includingal- working as such without measuring biomarkers of
dehydes (e.g. MDA) and specific oxidized lipids.27,89 oxidative damage to prove it. Thus in rabbits, bis-
Theplasma antibodytitrehas been reportedinsome phenoladministrationdecreasedlipidoxidationinthe
(but not all) studies to correlate with progression lesions but not the development of atherosclerosis,
of atherosclerosis.89,90 Does production of such anti- whereas probucol slowed both. Hence probucol’s ac-
bodiesaffectthetime-courseofhumanatherosclerosis? tions are not necessarily mediated by inhibiting lipid
Severalanimalexperimentssuggestthatitcould,e.g. peroxidation.Probucolmayexertadditionaleffects(es-
immunizationofmiceorrabbitslackingLDLreceptors pecially HO-1 induction) dependent on its disulphur
with MDA-treated LDL led to high plasma antibody structure,73whichisabsentfrombis-phenol.Similarly,
levels,andlessatherosclerosis.91Similarly,administra- inapoE-knockoutmice,variouspolyphenolsdecrease
tionofantibodiesrecognizingmouseoxLDLdecreased atherosclerosisbutnotthelevelsofF -IsoPsinlesions
2
atherosclerosisinLDLreceptor-deficientmice.89These or plasma, again suggestive of an anti-atherosclerotic
datasuggestthatneutralizationofoxidationproducts effectdifferentfrominhibitinglipidperoxidation,such
might sometimes be anti-atherosclerotic, from which as increasing HO-1 levels or improving the bioavail-
it follows that they do contribute to atherosclerosis. ability of NO•.94 In the human VEAPS (Vitamin E
However, depending on the model, both anti- and Atherosclerosis Prevention Study), 400 IU of dl-α-
pro-atherogenicimmuneresponsesmightoccur.92 Do tocopherol per day for three years decreased plasma
rememberofcoursethatsomelipidoxidationproducts oxLDL levels but had no effect on carotid artery
maybebeneficial(Sections5.12and11.5.11),sobinding atherosclerosis.95Infact,amoreeffective‘antioxidant’
thembyantibodiesmaynothelp! approachmaybetolowerelevatedplasmacholesterol
The third line of evidence often quoted to sup- levels using statins. As mentioned earlier, hypercho-
port the theory is that several ‘antioxidants’ decrease lesterolaemicpatientsshowelevatedplasmalevelsof
the extent and/or progression rate of atherosclerosis F -IsoPs(evenwhencorrectedfortheirhigherlipids).
2
in animals. One of the most effective73 is probucol Levelsdropafterstatintreatment,asdoplasmalevels
(Fig.10.6),butα-tocopherol,lazaroids(Section11.5.8), of chloro-, nitro-, and bityrosines.79 Statins seem to
flavonoids, and flavonoid-rich plant extracts have decrease the activity of endothelial NADPH oxidases
(CH 3 ) 3 C C(CH 3 ) 3 (CH 3 ) 3 C C(CH 3 ) 3
CH
3
HO S C S OH HO OH
CH
3
(CH 3 ) 3 C C(CH 3 ) 3 (CH 3 ) 3 C C(CH 3 ) 3
Figure10.6 Structureofprobucol,4,4(cid:4)-[(1-methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol],(left)andoneofitsmetabolites,
bis-phenol(right).Thephenolic–OHgroupsconferchain-breakingantioxidantactivity.AGI-1067,asuccinateesterofprobucol,wastestedin
humansbutnotfoundtobebeneficialinpreventinglatercardiovasculareventsinpatientswhohadalreadysufferedanacutecoronarysyndrome
(Lancet371,1761,2008).

--- Page 580 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 525
and the expression of adhesion molecules on the many laboratories in the past (less so recently) have
endothelialsurface(Section11.5.1andref96),aswellas examined the sensitivity of LDL to oxidation in vitro
increaseeNOSlevels,andantioxidantsmightactually andhowitisalteredbyadministrationofantioxidants
interferewiththeseprotectiveactions. toanimalsorhumanvolunteerspriortoLDLisolation.
Insummary,theoxidationhypothesis,asoriginally Whatdothesestudiestellus?Probablynotalot.
formulated,isindoubt;ifonecaninhibitlipidoxida- UsuallyLDLareisolatedfromplasmabyaprocess
tionbutnotlesionprogressionthisarguesagainstakey involving lengthy centrifugations. It is usually oxi-
roleoftheformerinthelatter.Indeed,arecentreview16 dizedbyincubation100,101 withCu2+,e.g.ascopper(II)
stated‘oxidationunproventoboosthumanatherogen- sulphate,CuSO .Manyinvestigatorsmeasurethelag
4
esis’. Nevertheless, administration of α-tocopherol to phaseorlagperiod,thetimetakenbeforeperoxidation
apoE-deficient mice in one study decreased both F - of the Cu2+-exposed LDL begins to accelerate. Other
2
IsoP levels and the development of atherosclerosis,97 parameters measured include the slope of the ‘accel-
although in another98, α-tocopherol, or its synthetic eration’ phase and levels of oxidation products (Fig.
analogue BO-563 (Section 11.5.6), decreased athero- 10.7). Factors affecting LDL resistance to oxidation in
sclerosiswithoutalteringlevelsofF -IsoPsorcholes- vitroinclude:
2
terol ester hydroperoxides in the vessel wall. Severe
1. Fattyacidcomposition.Agreaterproportionofsat-
deficiencies of vitamin E accelerate atherosclerosis in
uratedandmonounsaturatedfattyacidside-chains
apoE-deficient mice,98,99 but possibly by mechanisms
increases oxidation resistance. For example, LDL
other than accelerating lipid peroxidation. Of course,
isolatedfromhumansorotheranimalsfedondiets
‘lack of importance of lipid oxidation’, even if true,
enrichedinoleicacidweremoreresistanttooxida-
doesnotequateto‘lackofimportanceofRS’;theydo
tioninvitro.Thereverseistrueonfeedingdiets102
manythingsinatheroscleroticlesions(Section10.3.6).
containingalotofPUFAs.
2. The concentration of Cu2+. For Cu2+concentrations
10.3.8 ChemistryofLDLoxidation:isinvitro
intheμMrangethelagphasedecreaseswithCu2+
LDLoxidationarelevantmodel?46,100 concentrationuptoamaximum.The‘active’Cu2+is
thatwhichbindstohistidineresiduesonapoprotein
Onepredictionoftheoxidationhypothesisisthatthe B.103 Atlower,andlikelytobemorephysiological,
lower the resistance of LDL to oxidation, the greater Cu2+ concentrations (up to 0.1 μM) the kinetics
thechancethattheywillbecomeoxidizedintheves- can change (Fig. 10.7) and the lag period may not
selwallsand contributetotheatherosclerosis.Hence beseen.101
TBARS
Incubation time (h)
stinu
yrartibrA
1 2 3
1.0
Dienes
1.0 0.8
Fluorescence
ΔA 0.6
Vit. E 234
0.4
0.5
0.2
0.0
0 15 30 45
Peroxides Time, hours
5 10 15
Figure10.7 Sequenceofeventsduringcopperion-stimulatedoxidationofLDLinvitro.Usually,α-tocopherolisfirstconsumedandthe‘peroxide
pool’isfilled,whereuponperoxidationaccelerates.Peroxidationcanbemeasuredasformationofconjugateddienesat234nm,fluorescenceat
430nmwithexcitationat360nm,formationoflipidhydroperoxides,IsoPs,COPs,orproductionofthiobarbituricacid-reactivesubstances(TBARS),
althoughTBARSformationisnotagoodindexofLDLoxidation.Period1(top)isthelagphase,period2isthepropagationphase.Inphase3,
peroxidesdecomposetoaldehydesandotherproducts.DataprovidedbycourtesyofthelateProfessorDrHermannEsterbauer.Thesekinetics
areseenatμMCu2+concentrations,buttheycanbealteredatlowerCu2+levels101—seetheFigureontheright.Here0.03μMCu2+wasused;
notethesloweroxidationbuttheabsenceofalagperiod.

--- Page 581 ---

526 FREE RADICALS IN BIOLOGY AND MEDICINE
3. TheO concentration.104Incubationsareusuallycar- 4. Cellmembranesmightbeabletotransferperoxides
2
ried out under ambient O (21%), whereas pO intoLDLpassingbythemintheblood.108Theextent
2 2
in blood vessel walls may be as low as 2.5% O . towhichthisoccursinvivoisuncertain.
2
AtlowerpO ,therateofLDLperoxidationislower.
2
Oxygenlevelscanfallrapidlyininvitrostudiesof
10.3.8.2 AntioxidantsandLDLoxidation100
LDLoxidation,butarerarelymonitored.105
4. The content of antioxidants. Dietary supplementa- The‘average’LDLparticleisapproximatelyspherical
tionwithagentsthatinterceptlipidperoxylradicals, with a diameter of 19–25 nm and a relative molecu-
suchasα-tocopherolorprobucol,usuallyincreases larmassbetween1.8and2.8million.Itscomposition
the length of the lag phase in LDL subsequently is shown in Table 10.3. In order to allow these in-
isolatedfromtheplasma. soluble lipids to travel in an aqueous solution (the
5. The lipid peroxide content of the LDL. Copper blood plasma), the core is wrapped in a monolayer
ions appear to act largely or entirely by decom- containingphospholipidmolecules,mainlyphosphat-
posing peroxides in the LDL to chain-propagating idylcholine,withtheirpolarheadgroupsorientedto-
radicals,106 ward the aqueous phase. Apoprotein B is embedded
in this outer layer. Antioxidants are present in both
LOOH+Cu2+→LO • +Cu++H+
2 coreandphospholipidcoat,themostabundantbeing
LOOH+Cu+→LO • +Cu2++OH– α-tocopherol(Table10.3).
Cu2++LOOH→LO • +Cu(III)+OH– During the lag period, α-tocopherol is lost, as are
severalotherconstituents(Fig.10.8).Thelengthofthe
Peroxide decomposition forms multiple carbonyl lag period depends on several factors, including the
compounds, including MDA and HNE, which can chemicalnatureoftheoxidizingspeciesandtheoxid-
modify apoB, as can LO• and LO • radicals. Modi- anttoLDLratioused,theautocatalyticnatureoflipid
2
•
ficationofapoBcanchangethemobilityofLDLon peroxidationasRO levelsbuildup(Section5.11.5),the
2
electrophoreticgels,andthisissometimesusedas ‘seedingperoxide’contentofLDL,andtheinhibitory
anindexofoxidation. effect of α-tocopherol, plus some contribution from
6. The assay used to measure LDL oxidation. As ex- otherantioxidants.Tocopherolsreactmuchfasterwith
pectedfromthecomplexityofperoxidation,differ- peroxylradicalsthandoPUFAs(Section4.3),
entassaysgivedifferentresults(Fig.10.7).
TocH+LO
•→Toc •
+LO H
2 2
10.3.8.1 Theroleof‘seedingperoxides’ The tocopheryl radical (Toc•) has a weak capacity to
Ingeneral,thelargertheperoxidecontentinLDL,the abstracthydrogenfromPUFAs,butisfarlessreactive
•
greateristherateofCu2+-stimulatedoxidation.Levels thanLO
2
radicals.Indeed,ifLDLareisolatedfromsub-
ofperoxidesinLDLisolatedfromdifferentindividuals jects who have consumed α-tocopherol supplements,
varyalot.Wheredotheycomefrom?Thereareseveral the lag period after Cu2+ exposure of the LDL under
possibilities. appropriate reaction conditions (Fig. 10.7) is usually
significantlyincreased.95,100Thusinonestudysubjects
1. Some may be artefactually introduced by in vitro consumed RRR-α-tocopherol for 21 days.109 The oxi-
peroxidation during the prolonged centrifugation dation resistance of LDL isolated from their plasma
proceduresusedtoisolateLDL. increased,onaverage,to118%,156%,135%,and175%
2. Somemayarisefromperoxidesindietaryfats(Sec- of control for doses of 150, 225, 800, or 1200 IU/day,
tion 7.2). The extent of absorption of peroxidized respectively (1 IU = 0.67 mg RRR-α-tocopherol). Six
lipids from the diet has been investigated in sev- daysaftertheα-tocopherolsupplementswerestopped,
erallaboratories,withconflictinganswers.Thegut LDL resistance to Cu2+-mediated oxidation, and its
iseffectiveatdetoxifyinglipidperoxides,butsmall α-tocopherol content, had returned to normal. These
amountsprobablygetthroughwithinchylomicrons, percentage increases are very variable, depending on
especially if a diet rich in cooked fatty foods is the subject and the reaction conditions used for LDL
consumed.107
oxidation.
3. SomeperoxidescanforminLDLinvivoduetoits TocopherylradicalscanbeconvertedbacktoTocHif
oxidationbyRSand/orlipoxygenases,eitherasthe ascorbateisaddedtotheLDLsuspension,
LDLcirculatesinthebloodorwithinthevesselwall,
followedbyitsescapebackintothecirculation. Toc • + ascorbate → TocH + semidehydroascorbate

--- Page 582 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 527
Table10.3 Compositionofhumanlow-densitylipoprotein(LDL).a
Constituent Averageamount Constituent Averageamount
(molecules/LDL (molecules/LDL
particle) particle)
Totallipids Antioxidants
Phospholipids 700 α-Tocopherol 3–14
Phosphatidylcholine 450 γ-Tocopherol 0.50
Triglycerides 170 Ubiquinol-10 0.10–0.30b
Freecholesterol 600
Cholesterolester(mostlycholesterollinoleate) 1600
Fatty-acidesters Carotenoids
Palmitic 693 β-Carotene 0.30
Palmitoleic 44 α-Carotene 0.12
Stearic 143 Lycopene 0.16
Oleic 454 Luteinandzeaxanthin 0.04
Linoleic 1101 Phytofluene 0.05
Arachidonic 153
Docosahexaenoic 29
TotalPUFAesters 1282
aDataabstractedfromseveralpublicationsofthelateProfessorDrHermannEsterbauer.100Thenumbersmustnotbetakentooliterally,sincetheLDLcompositionin
anygivenindividualdependsagreatdealondietandthereisarangeofLDLsizesandbuoyancies(Section10.3.8.6).
bUbiquinoliseasilyoxidizedduringisolation,andthetruevaluemaybeupto0.5molecules/LDLparticle(RolandStocker,personalcommunication,1993).
Added ascorbate delays the onset of LDL peroxid- butthiswasineffectiveindecreasingatherosclerosisin
ation even when it is started by adding Cu2+ (Fig. apoE-knockoutmice.111
10.9), an apparent exception to the general rule that LDLcontainseveralcarotenoids,whicharelostdur-
Cu2+/ascorbatemixturesstimulateoxidativedamage. ing the lag period (Fig. 10.8). The amounts present
In fact, oxidative damage may be occurring, but not dependondiet,butinnocaseisthereevenapproach-
to the lipid. Incubation of LDL with Cu2+ and as- ing one molecule per LDL particle on average (Table
corbate led to conversion of histidine residues on 10.3),suggestingthatanyantioxidanteffectswouldbe
apo-B to 2-oxohistidine, presumably by site-specific limitedatbest.Indeed,raisingtheβ-carotenecontent
RS formation. Oxo-histidine binds Cu2+ less effect- ofLDLdoesnotusuallyincreasetheirresistancetooxi-
ively, so that less Cu2+ remains associated with the dationinvitro,104 norareluteinorlycopeneanymore
LDL particle.103 Ascorbate can also recycle probucol- effective.112However,someauthorshavereportedpro-
derived phenoxyl radicals in LDL treated with tectiveeffectsofconsumingsupplementsoflutein,or
probucol.110 luteinpluslycopeneagainstcarotidatherosclerosisde-
LDL contain ubiquinol (Table 10.3), another poten- velopmentinhumans.113 Animalstudiessuggestthat
tialchain-breakingantioxidant(Section3.25.5).When astaxanthinmightalsobebeneficial.114
LDL are oxidized, ubiquinol disappears faster than Flavonoids and other phenols can protect LDL
tocopherols, probably because it recycles tocopheryl againstperoxidationinvitro,andithasbeensuggested
radicals, that phenols in red wine, cocoa, nuts, and chocolate
mightexertanti-atherogeniceffects.Indeed,adminis-
CoQH 2 + Toc • →CoQ • + TocH + H+ trationofphenolsdecreasedatherosclerosisinseveral
animal models, but apparently by mechanisms other
However, the ubiquinol content of LDL is small— thanactingaschain-breakingantioxidants.94 Whether
only up to 50% of LDL particles contain it. Con- flavonoids could be significant antioxidants for LDL
sumptionofcoenzymeQ 10 supplementscanraisethe in vivo is uncertain, given the low levels of the free
amount of ubiquinol-10 in LDL to a limited extent, moleculesinhumanplasma(Section4.5).

--- Page 583 ---

528 FREE RADICALS IN BIOLOGY AND MEDICINE
Table10.4 Evidenceforoxidativestress*inARDSpatients.Forreferences(exceptwherecitedinthetable)pleaseseerefs7,376,377.
Observation Comments
Oxidizedα 1-antiproteinasefoundinlunglavagefluid Methionineresidueoxidized,presumablybyHOCl,ONOOH,chloraminesetc.
ElevatedH2O2 ElevatedH2O2levelsinexhaledairandurine.
ElevatedF2-IsoPsinbreathcondensate Isoprostanesmaynotonlybebiomarkersoflipidperoxidationbutmayhave
pathologicaleffects,sincesomearepowerfulconstrictorsofairwaysmooth
muscle.OtherevidenceoflipidoxidationincludesincreasedplasmaHNE.
Diminishedlevelsofascorbateinbodyfluidsa AscorbatecanbeoxidizedbyRSandtheDHAtakenupbyactivatedneutrophils.
Nutritioninverysickpeopleisalsocompromised.Somestudiessuggestthatthe
riskofdevelopingARDSinsurgicalpatientsmightbediminishedbyadministering
ascorbateandα-tocopherolbutthedataarenotcompelling.
Reportsofdecreasedα-tocopherol Dataconflicting:itisessentialtostandardizeα-tocopherollevelsagainstlipid
beforecomparisonbecauselipidlevelsinbodyfluidschangeinARDS,e.g.
cholesterollevelscanfallsharply.
Oxidation/chlorinationofproteinsinplasmaandlung Lossof–SHgroups,increasedlevelsofproteincarbonylsandofchloro-and
liningfluid.Nitrotyrosine(NT)formation ortho-tyrosine.Therehavebeenquestionsaboutthespecificityofsomeofthe
antibodiesthathavebeenusedtodetectchlorotyrosine.Immunostainingoflungs
fromARDSpatientsrevealednitrotyrosine,scarcelydetectableinnormallung.
PlasmaNTlevelsalsoincreased;plasmaproteinsmodifiedbynitrationinclude
caeruloplasmin,transferrin,andα 1-antiproteinase(Am.J.Physiol.278,L961,
2000).Somecirculatingantibodiesrecognizenitratedproteins(Am.J.Resp.
CellMol.Biol.36,152,2007).SurfactantcanbedamagedonexposuretoHOCl
orONOO–(Section7.3.1).
Increasedlevelsofhaemoxygenaseinthelung Oftenquotedasevidenceofoxidativestress,butprobablycytoprotective
(Section3.24).
Diminishedcaeruloplasmin‘ferroxidase’activity Plasmacaeruloplasminproteinlevelsoftenelevated(acutephaseresponse;
Section5.7.4),alsoinlungliningfluid(increasedleakagefromplasma)but
ferroxidaseactivityperunitproteinisdecreased.Couldbeduetoincreased
releaseofproteinases,sincecaeruloplasminissensitivetoproteolyticdamage,
and/ortodamageonexposuretoONOO–(Am.J.Physiol.278,L961,2000).
Lossofplasma–SHgroups Normallevels≈500μM;canfallto~300μMinARDSpatients.
DecreasedGSHlevelsinlungfluids Levelsinalveolarliningfluidare~20μM,muchlowerthannormal.Levelsof
GSSGelevated(Am.Rev.Resp.Dis.148,1174,1993).
Increasedxanthineoxidase Xanthineoxidasemaybereleasedfromotherinjuredtissuestocausedamageto
lungbybindingtocellsurfaces.Levelsofplasmahypoxanthineincrease
(Am.J.Resp.CareMed.155,479,1997).
IncreasedlevelsofangiotensinII CouldpromoteROSproduction(Section8.10.4);Nature436,112,2005.
aOften<5μmMinplasma;controlvalueswere~50μM.
*TheoxidativestressmeasuredcouldbeduenotonlytotheARDS,butalsotoitscauses(trauma,sepsis,etc.)andtoO2administration.
10.3.8.3 Pro-oxidanteffectsofantioxidants46 α-tocopherol is usually present with co-reductants
(especially ascorbate) which recycle the α-tocopheryl
Tocopherolsarereducingagents,abletoconvertFe(III)
to Fe2+ or Cu2+ to Cu+. Reaction of α-tocopherol radical.
with Cu2+ or Fe(III) generates the tocopheryl rad- Severalotherantioxidantscanexertpro-oxidantef-
fectsinCu2+-inducedLDLoxidationinvitro.Thiscan
ical, which can react with PUFAs at a low rate (Sec-
happenwithascorbate(whenoxidationhasproceeded
tion4.3.5).Thustocopherolscanacceleratemetal-ion-
far enough to deplete α-tocopherol), urate, and some
dependentoxidativedamage(i.e.actaspro-oxidants)
to LDL under certain reaction conditions, since Cu+
flavonoids.115,116Theyareprobablyagainactingbyre-
and Fe2+ decompose peroxides more quickly than
ducingCu2+toCu+,butthephysiologicalrelevanceis
Fe(III)andCu2+.Thismaynotberelevantinvivosince alsouncertain.

--- Page 584 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 529
0.50
0.40
0.30
0.20
0.10
0.00
0 10 20 30 40 50 60
Time (min)
LDL
ni
gniniamer
%
mn
432
ecnabrosbA
100
β-Carotene
80 Lutein/zeaxanthin
60
40 Lycopene
Cryptoxanthin
γ-Tocopherol
20
α-Tocopherol
0 Figure10.8 Sequenceoflossofantioxidantsduringthe
lagphaseofhumanLDLoxidationcatalysedbyCu2+.Data
bycourtesyofthelateProfessorDrHermannEsterbauer.100
Ascorbate
noitadixorep
fo
tnuomA
0.0 2.5 μM 5.0 μM Figure10.9 EffectofascorbateonLDLperoxidation.
Afterisolationfromhumanplasma,LDLwereexposedto
Cu2+.Ascorbatedelayedtheonsetofperoxidation,the
lengthofthelagperiodrisingwithincreasing
concentrations.DiagramfromFreeRadic.Res.Commun.6,
1 2 3 67,1989,bycourtesyofthelateProfessorDrHermann
Incubation time (h) EsterbauerandHarwoodAcademicPublishers.
10.3.8.4 Relevanceofthemodel seemsomewhatprotectiveagainstcardiovasculardis-
easeinvivo,byarangeofmechanisms(Table4.8and
Whydidwesay‘notalot’atthebeginningofthissec-
tion?Cu2+-dependentLDLoxidationinvitrohasbeen
ref118).
widelyused,butevidencethatcopperionsparticipate
in LDL oxidation in vivo is sparse (Section 10.3.5.2). 10.3.8.5 Anartefactofeating?
Whereasα-tocopherolmustbedepletedforrapidLDL One study119 showed that consumption of olive oil,
oxidation to occur in vitro (Fig. 9.8), LDL oxidation whichisrichinantioxidantphenolssuchashydroxy-
productsco-existwithα-tocopherolinlesions(although
tyrosol (Section 4.5.2), increased the lag period when
ofcoursetheymightbedistributeddifferently).Thus subsequently-isolated LDL were exposed to Cu2+.
α-tocopheroldepletionisnotnecessaryforoxidationto
However,thesameeffectwasseenifthephenolswere
occurinvivo.86Inanycase,α-tocopherolisnotveryef-
absentfromtheoil.Inotherwords,thelagperiodof
fectiveinprotectingLDLagainstdamagebyHOClor LDLoxidationmightbeincreasedbyconsumptionof
ONOO–;ascorbateisbetter.117 Hencesomelaborator- anyfood.Howthisoccursisuncertain,butthesedata
ieshaveexaminedoxidationandantioxidantdepletion addanotherquestionmarktotherelevanceofstudies
in isolated LDL exposed to HOCl, ONOO–, haem, ofexvivoLDLoxidation.
or haem proteins. For example, adding ONOO– to When LDL were isolated from humans at differ-
LDLdepletestheirlevelsofα-andγ-tocopherolsand
ent times of the year, the content of oxidized lip-
carotenoids.50 Others have used less physiologically ids present was different, causing variations120 in the
relevantsystems,suchasUVlightorsyntheticperoxyl lag phase after exposure to Cu2+. This seasonal ef-
radicalsderivedfromAAPH,AMVN,orrelatedcom- fect must also be considered when examining the ef-
pounds(Section5.11.8.3).Finally,ahighPUFAcontent fects of long-term dietary supplementations on LDL
accelerates LDL oxidationin vitro, but PUFAs overall oxidizability.

--- Page 585 ---

530 FREE RADICALS IN BIOLOGY AND MEDICINE
10.3.8.6 SubclassesofLDL toPON-1.Therelatedenzymeparaoxonase-3inHDL
mayalsocontribute.ThePAFacetylhydrolaseenzyme
AnotherimportantfactoristhatnotallLDLparticles
(sometimes called lipoprotein-associated phospholip-
are the same; they have a wide range of sizes and
ase A ) is found in both HDL and LDL and helps to
densitiesandaresometimesgroupedintofourclasses 2
removePAF,apotentmediatorofinflammation(Sec-
(LDL-Ito-IV)basedondensity,fromthelargest(most
tion 5.12.2). It can also hydrolyse peroxidized fatty
buoyant)tothesmallest(mostdense).Thesmalldense
acidsarisingfromphospholipidsduringoxidationof
LDL(sdLDL)seemtobemuchmoreatherogenicthan
LDL or HDL. Peroxidation of phospholipid-bound
‘average’ LDL; they may penetrate into vessel walls
morereadily,andhavelowerantioxidantlevels.121 fatty acid, followed by fragmentation to release an
aldehyde, leaves behind a substrate for PAF, which
removes the oxidized ‘residue’ to give a lysophos-
pholipid.LikeLDL,HDLinplasmaconsistofseveral
10.3.9 Theroleofhigh-density
types that vary in shape, size, density, and apolipo-
lipoproteins(HDL)
proteincomposition.EachHDLsubtypemayexertthe
HDL122 are usually anti-atherogenic;they removeex- protectiveeffectsdescribedabovetodifferentextents.
cess cholesterol from cells (including macrophages ParaoxonasesareCa2+-dependentesterases,origin-
and foam cells) within peripheral tissues, and trans- ally discovered by their ability to hydrolyse organo-
port it to the liver (reverse cholesterol transport) for phosphate and aromatic carboxylic acid esters, com-
uptake by scavenger receptors there, such as SRB1. poundsthatarewidelyusedasinsecticidesandhave
Like LDL, HDL have a hydrophobic core containing been employed as nerve gases in chemical warfare.
triglycerides and cholesterol esters surrounded by a Examples are sarin (released by terrorists into the
monolayer of phospholipids containing some choles- Tokyosubwaysystemin1995)andsoman.Thename
terol, although the protein-to-lipid ratio is higher in ‘paraoxonase’arisesfromtheuseofparaoxon,atoxic
HDLthanLDL.Severalproteinsareembeddedinthe organophosphate, to assay the enzyme. The ‘puri-
HDL coat, the major ones being apolipoproteins A1 fied’ PON-1 enzyme has been claimed to hydrolyse
(about70%oftotalprotein)and-A2(apoA1,apoA2). phospholipid oxidation products (e.g. phospholipid-
The beneficial cardiovascular effects of moderate in- boundIsoPsandaldehydes)andcholesterolesteroxi-
takesofethanolandofPUFAshavebeensuggestedto dation products derived from arachidonic or linoleic
involve rises in blood HDL levels. High doses of the acidresiduesinvitro.PON-1hasalsobeenclaimedto
vitaminnicotinamidealsoraiseHDLlevels,butcause reducelipidhydroperoxidestohydroxides.However,
variousside-effectsthatlimittheiruse.16 Theenzyme therehavebeensuggestionsthattheseeffectsof‘puri-
lecithin–cholesterolacyltransferase(LCAT)esterifies fied’PON-1wereduetocontaminationwithotheren-
free cholesterol entering HDL, facilitating storage as zymes or antioxidants.124,125 Nevertheless, ‘knockout’
cholesterol esters in the core. Indeed, transgenic ani- mice lacking PON-1 develop more atherosclerosis on
mals overexpressing the gene encoding LCAT show ahigh-fatdiet.124 PON-1canhydrolysehomocysteine
higher plasma HDL levels and are more resistant to thiolactoneandmighthelptoprotectagainstthevas-
diet-induced atherosclerosis.123 Inactivation of LCAT, cular toxicity of homocysteine (Section 4.7). You may
e.g.byconstituentsofcigarettesmoke(Section9.13.3), be amused to know that ostrich HDL does not con-
canthusbepro-atherogenic. tainPON-1,unlikethemammalianHDLs.ThePON-1
The anti-atherogenic actions of HDL do not stop genehasseveralpolymorphisms,someofwhichinflu-
at removing cholesterol. HDL also exerts anti- enceactivity.TwomajorformsofPON-1exist:ahigh
inflammatory properties and can remove peroxides activity (towards paraoxon) form, and a low activity
fromLDL.122 Indeed,incubationofoxLDLwithHDL forminwhicharginineatposition192isreplacedby
in vitro can prevent some of the cytotoxic effects of glutamine.WhetherpossessionofaparticularPON-1
the former. Peroxidized lipids can transfer from LDL phenotypeaffectsatherosclerosisisunclear.124
toHDL,promotedbyacholesterylestertransferpro- LikeLDL,HDLissubjecttoattackbyLOXenzymes
tein. They can then react with methionine residues
andRS,includingOH•,HOCl,andONOOH.Indeed,
on apoA1 (oxidizing them to methionine sulphox- in vitro, HDL seem more easily oxidized than LDL,
idewhilstreducingthehydroperoxidetoanalcohol). in part because of lower contents of α-tocopherol
Inadditiontheymaybedegradedbytwoenzymesin andotherantioxidants,andvariousassayshavebeen
HLD,plateletactivatingfactoracetylhydrolase(PAF developed to measure ‘oxHDL’ in human plasma.126
acetylhydrolase)andparaoxonase-1,oftenabbreviated Whereas ‘normal’ HDL has anti-inflammatory

--- Page 586 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 531
properties,HDLisolatedfrompatientswithcardiovas- for humans is how important it is in lesion progres-
culardiseaseordiabetesmayexerttheopposite,thatis sion, how it is initiated, why some lesions develop
pro-inflammatory,effects.16,48,122Thisappearstorelate andothersdonot,andhowlipidoxidationmightbe
to a high content of oxidation products (including modulated(ifitall)byantioxidants.Indeed,howcan
MDA) in the HDL and to damage tothe HDL by RS oxidation occur in vessel walls in the face of all the
generatedbyMPO.Indeed,nitrationandchlorination antioxidants that must diffuse into the wall from the
ofcertaintyrosineresiduesonapoA1inplasmaHDL plasma, and what contribution (if any) does caerulo-
is increased in subjects with cardiovascular disease, plasmin make to LDL oxidation in vivo? We have a
anddecreasestheabilityofHDLtoremovecholesterol lot more work to do! There also needs to be greater
fromvesselwalls.Theseeffectsmayberelevantinvivo, awarenessthatdifferentanimalmodelsmayhavedif-
sincetheamountsofnitratedandchlorinatedHDLare ferent mechanisms of atherosclerosis, not all relevant
increasedinhumanatheroscleroticlesions.16,48,127,128 tohumans.
ThiocyanateisalsoagoodsubstrateforMPO,gener-
atingmostlyHOSCN(Section8.10.6).However,cyan- 10.4 Obesityanditsopposite130–132
ate (OCN–) produced during oxidation of OCN– by
MPOcanmodifyHDL,carbamylatinglysineresidues Obesity is a risk factor for the development of mul-
toproducehomocitrulline(theside-chain–NH 2 ofly- tiple human diseases, especially cardiovascular dis-
sineisconvertedtoNHCONH 2 ).HOSCNcanalsoox- ease, type 2 diabetes, and some (but not all) cancers
idizetryptophanresidues.Indeed,HDLcarbamylation (e.g. uterus, liver, gall bladder, kidney, colon, cervix,
andhomocitrullinehavebeendetectedinhumanath- thyroid). Female obesity is associated with increased
erosclerotic lesions.127 Cyanate can also be produced complications of pregnancy and might even lead to
by a slow isomerization of urea, e.g. in patients with mild impairments in cognitive development in the
renalimpairment(Section8.10.6).Damagebycyanate child. The major causes of obesity are increased food
to HDL and to vascular endothelium seems to con- intakeand/orlimitedphysicalactivity,butotherrisk
tributetotheincreasedatherosclerosisinpatientswith factors have been postulated, including the composi-
chronicrenaldisease(Section8.10.6). tionofthegutfloraandexposuretocertainenviron-
mentalchemicals.
10.3.10 Lipoprotein(a)122,129 Obesityisassociatedwithincreasedlevelsofoxida-
tive damage to lipids (e.g. elevated plasma levels of
This species is found in humans, some other prim- F -IsoPsandisofurans,andincreasedurinarylevelsof
2
ates,and(oddly!)intheEuropeanhedgehog,butnot F -IsoPs) and proteins (e.g. protein carbonyls in adi-
2
inlaboratoryanimalscommonlyusedtostudyathero- pose tissue proteins and in some other tissues, e.g.
sclerosis, such as mice and rabbits. It resembles LDL skeletalmuscle).Thisriseinproteincarbonyllevelsin
butcontainsanadditionalglycoprotein,apo(a),linked adiposetissueisaccompaniedbyadecreaseintheac-
to apoB by a disulphide bridge. There are multiple tivityofGST-A4,anenzymeespeciallyeffectiveinre-
apo(a) isoforms. Increased plasma levels of lipopro- movingHNEandotheraldehydes(Sections3.15.2and
tein(a)areanadditionalriskfactorforatherosclerosis 5.12.5.3). Indeed, levels of HNE are elevated in adi-
and it is present in atherosclerotic lesions. Like LDL, posetissueinobesity,andHNEitselfhasbeenreported
lipoprotein(a) can be oxidized to a form recognized to promote further fat storage in adipose tissue (Sec-
by scavenger receptors, and it may also be able to tion5.12.5.3).Levelsofperoxiredoxin-3(Prx3)arealso
collect and retain oxidized phospholipids from cells decreased in adipose tissue from obese mice and hu-
or other lipoproteins, possibly aggravating their pro- mans, and Prx3-knockout mice had greater amounts
oxidant effect. The structure of apo(a) resembles that ofadiposetissue.133 Afallinlevelsoftheglutathione
ofplasminogen,theprecursoroftheenzymeplasmin peroxidase GPx3 may also occur in adipose tissue in
thatdissolvesfibrininbloodclots.Thusanothereffect obesity.134HoweverROSarenotallbad;theyplayim-
of apo(a) could be to antagonize plasminogen action portantrolesinadiposetissueformation(e.g.bypro-
andfavourbloodcoagulation. motingdifferentiationofadiposetissuestemcells)and
function,andNADPHoxidaseenzymesareinvolved
intheresponseoffatcellstoinsulin(Section10.5.2).
10.3.11 Unansweredquestions
Why does obesity lead to oxidative stress? First,
The evidence that lipid oxidation occurs in athero- obesity-inducing diets could contribute. In animals,
sclerotic lesions is clear-cut. What remains unclear high fat diets lead to oxidative stress, damage to

--- Page 587 ---

532 FREE RADICALS IN BIOLOGY AND MEDICINE
liverandotherorgans(Section9.8.1.6),andincreased and fat metabolism in several tissues. Leptin at nor-
atherosclerosis.135,136 This may also be true (per- mallevelshelpscontrolbodyweight,butatelevated
haps to a lesser degree) in humans; fat-rich diets levels has various effects on other tissues, including
cantransientlyimpairvascularendothelialfunction,23 causing oxidative stress in endothelial cells and pro-
may increase mitochondrial H O production,137 and motingatherosclerosis,whereasadiponectinisthought
2 2
raise levels of urinary F -IsoPs and muscle pro- tobeanti-inflammatoryoverall.140
2
tein carbonyls.136 Immuno spin trapping detected in- Excessive leanness may also have its problems. In-
creased levels of free radicals in muscle, liver, and deed, an increased risk of some types of cancer (e.g.
kidneyinmicefedafat-richdiet(Section6.2.8). lungandoesophagealcancer)inleanindividualshas
Asecondreasonfortheassociationofobesitywith been described in Japan. The authors reported that
oxidative stress is that white adipose tissue, long amongmalesmokerstherewasaninverseassociation
thought of as an inert depot of triglyceride, in fact ofBMItourinarylevelsof8OHdG,especiallyinlight
releases pro-inflammatory cytokines, including IL-1β, smokers.141 Inverse correlations of lung cancer inci-
IL-6, monocyte chemoattractant protein-1 (MCP-1), dence with BMI were reported for male and female
and TNF-α. Thus, when accumulated to excess, adi- smokersinaFrenchcohort.142 Whatexactlythesere-
pose tissue promotes a low-grade inflammation in sults mean is not clear, but similar ones have been
the body.131 Indeed, adipose tissue contains not only reportedinothercountries.
fat-storing adipocytes, but also endothelial cells, pre- Doesconsumingantioxidantsupplementsdecrease
adipocytes, macrophages, and other cell types. The oxidativestressinobesepeople?Somestudiessuggest
pro-inflammatorycytokinesarereleasednotonlyfrom yes,manyno,butimprovementsindietandlifestyle
adipocytes and macrophages, but also from mono- canhelp,ascanlosingweight.143–146
cytes and other immune cells that infiltrate adipose
tissues in obesity. Most macrophages in adipose tis-
10.5 Diabetes
sue from obese mice and humans are of the pro-
inflammatory M1 phenotype, whereas in lean people Diabetes mellitus (the Latin word mellitus means
they tend more towards M2, anti-inflammatory (Sec- ‘honey-sweet’ and refers to the taste of diabetic ur-
tion 8.7.2; Fig. 8.9).131 One trigger of the increased ine) is a disease marked by elevated blood glucose
cytokineproductionmaybeactivationofNF-κB,due
(hyperglycaemia) andurinaryglucoseexcretion.Itis
toROSgeneratedbyincreasedlevelsofNADPHoxi- causedbyfaultyproductionof,ortissueresponseto,
dase, which have been reported in adipose tissue in insulin.Insulinsignallingisakeypartoftheregulation
obese animals.138 Indeed, experimentally raising vas- ofmetabolism,itsactioninvolvesROSanditisintim-
cularNADPHoxidaseinmicepromotedobesitywhen ately linked to ageing (Section 11.3). One of insulin’s
the animals were given a high-fat diet.138 Elevated majorrolesistoregulatebloodglucoselevelsbyfacili-
cytokine levels may then promote further ROS pro- tatingitsentryintomuscleandadiposetissuewhilst
ductionina‘viciouscycle’,againinvolvingactivation decreasingglucoseproductionbytheliver.Insulinalso
of NF-κB (Section 5.5.6). However, as already stated, regulatesfatandaminoacidmetabolism.
ROSfromNADPHoxidasesplayrolesinnormaladi- Complicationsofpoorlycontrolleddiabetesinclude
posetissuemetabolism(Section10.5),soit’samatter accelerated atherosclerosis, impaired wound healing,
ofdegree,asusual. microvasculardiseaseoftheeyecausingbleedingand
Adipose tissue secretes some unique cytokines retinal degeneration (diabetic retinopathy), cataract,
(adipokines), such as leptin and adiponectin, that kidney damage leading to renal failure, and damage
help to regulate metabolism. Leptin acts on the cen- toperipheralnerves(peripheralneuropathy).Retina,
tralnervoussystemtodecreaseappetiteandfacilitate kidney,renalglomerularcells,andneuronsarefreely
energyhomeostasis,socontrollingweight.Theeffects permeabletoglucoseandarethusexposedtothefull
of leptin in the hypothalamus of the brain may be force of hyperglycaemia. By contrast, in the absence
mediated by ROS production,139 so (yet again) ROS of insulin (or in failure to respond to it) muscle, adi-
are not all bad in obesity! In obesity, there is lep- pose tissue, and many other tissues do not take up
tin resistance; it no longer works as well to promote glucose well, minimizing damage to themselves but
decreased food intake, perhaps because there are in- contributingtoelevatedplasmaglucoselevels.
sufficient ROS in the hypothalamus.139 More leptin is In the most common form of diabetes (type 2 or
thereforemadeasaresponse.Bycontrastadiponectin non-insulin-dependentdiabetes)bloodinsulinlevels
levels fall in obesity; it functions to regulate glucose are normal or elevated, yet tissue response to it is

--- Page 588 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 533
subnormal; there is said to beinsulin resistance. For riskisaffectedbypolymorphismsinnumerousgenes
example,muscleandadiposetissueshowimpairedre- affectinginnateandadaptiveimmunity,β-cellfunction
sponses, taking up less glucose. Liver also responds andrateofapoptosis.147
poorlytoinsulin,continuingtoproduceglucosedes- In some animals that develop diabetes spontan-
pite the elevated plasma levels. The β-cells react to eously,suchasthenon-obese-diabetic(NOD)mouse
hyperglycaemia by releasing more insulin, but even- and the biobreeding (BB) rat, a role for ROS has
tually there is β-cell exhaustion and death, in part been established. In these animals, there is an auto-
due to oxidative stress caused by hyperglycaemia immune attack on the β-cells, and RS (especially
(Section10.5.4). ONOO–)148 generatedbytheattackingphagocytesare
Type2diabetesisseenmostofteninadults,andrisk involved in islet cell killing. Indeed, α-tocopherol,
factorsincludeobesityandlackofexercise,aswellasa SOD, thioredoxin, the ‘antioxidant’ EUK-8 (Sec-
dietrichinfatorcaloriesgenerally.Therearealsosome tion 11.5.4), and desferrioxamine have been reported
geneticdispositions.Type2diabetesisoftenpreceded todelaytheonsetofdiabetesinNODmice,149,150 and
by the metabolic syndrome, a cluster of metabolic N-acetylcysteineoradesferrioxamineconjugatewere
abnormalities (low plasma HDL, elevated levels of effectiveintheBBrat(Section11.6.1andref151).Dietary
LDL[especiallysdLDL;Section10.3.8.6]121,hyperten- ironrestrictionoradministrationofanorallybioavail-
sion, high plasma triglycerides, mild hyperglycaemia ableironchelatoralsodelayedthedevelopmentofdia-
due to insulin resistance) usually associated with ab- betesintheob/obleptin–/–mouse,whichcannotmake
dominal obesity; we have already seen that obesity leptin due to a spontaneously arising gene mutation,
itself causes oxidative stress (Section 10.4). Sadly, in andisgrosslyobese.152Desferrioxaminealsodecreased
advancedcountries,type2diabetesisnotonlybecom- urinary8OHdGexcretionandadiposetissuemassin
ingmorefrequent,butalsoincreasinglyappearingin thediabeticKKAymousemodel.153
children.Asyet,however,mostchildhooddiabetesis Type 1 diabetes in humans is also a chronic pro-
Type 1, in which insulin secretion is impaired or ab- gressive autoimmune disorder involving cytokines,
sentbecauseofdamagetothepancreaticisletcellsthat T-cells that target the β-cells, neutrophil recruitment,
secretethishormone. and DAMPs released from dying β-cells; the contri-
The complications of diabetes correlate with the bution of RS is uncertain but probably significant.
extent and time period of blood glucose elevation, Iron-overload predisposes to diabetes and worsens
so it is widely thought that excessive glucose is the effects of ROS-generating toxins on β-cells (Sec-
a major cause of tissue injury. In addition, blood tions 3.22.5 and 9.7.1) and there are repeated sugges-
LDL, sdLDL, free fatty acids, VLDL, and lipopro- tionsthathighbodyironstoresareariskfactorfortype
tein(a) levels are increased in diabetes, whereas HDL 2diabetes.154Antioxidantsmayfindaroleinhelpingto
and PON-1 tend to be lowered. These changes also protectisolatedhumanisletsforuseintransplantation
contribute to pathology, especially to the accelerated fromtheoxidativestressofcellhandling.155
atherosclerosis.
10.5.2 ROSinnormalinsulinfunctionand
10.5.1 Canoxidativestresscausediabetes? insulinresistance156,157
Somediabetogenicagents(e.g.alloxan)actbyimpos- ROSplaykeyrolesintheactionofinsulinonitstarget
ing severe oxidative stress on the β-cell (Section 9.7), tissues.Insulinbindstotheα-subunitofcell-surfacere-
butwhetheroxidativestresscontributestotheorigin ceptorsandthisleadstotyrosinephosphorylationon
of human diabetes is unclear. There is some genetic the β-subunit. The activated receptor then phosphor-
predisposition to diabetes, which is clearest in the ylates insulin receptor substrates (IRSs) such as IRS-
1–2% of cases inherited in a simple autosomal dom- 1 to trigger signalling cascades, including Akt (Sec-
inantmanner(maturityonsetdiabetesoftheyoung, tions5.5.4and5.5.10)phosphorylation.Insulinbinding
MODY).147 Genes found to be defective in differ- to its receptors also leads to H O production via
2 2
ent MODY patients include those encoding the en- NADPH oxidases in the target cells (e.g. adipocytes,
zymeglucokinase(whichconvertsglucosetoglucose muscle).TheH O facilitatesphosphorylation(e.g.of
2 2
6-phosphate) and the gene transcription factor HNF- the insulin receptor β-chain and IRSs) by inhibiting
1α (hepatic nuclearfactor-1α).Inheriteddecreasesin phosphataseenzymes.
catalaseactivityhavebeensuggestedtopredisposeto A question often asked is why the pancreatic β-
diabetes (Section 3.17.7). In addition, type 2 diabetes cell is not better provided with antioxidant defences

--- Page 589 ---

534 FREE RADICALS IN BIOLOGY AND MEDICINE
(Section 9.7). One answer is that ROS are important O
•–/H
O formation to just the right level; in its ab-
2 2 2
in insulin secretion. Islets contain NOX, including sencetoomanyROSmaybemade.163
NOX2andNOX4.Indeed,micelackingNOX4,present
also in adipocytes and several other cell types (Sec-
10.5.3 Oxidativestressindiabetic
tion8.10),showedincreasedadiposity,fattyliver,and
patients156,164
accelerated development of insulin resistance when
placed on a high fat diet.158 By contrast, excessive Oxidative stress contributes to diabetes, and diabetes
oxidative stress can impair insulin signalling in fat, thencausesoxidativestress.LevelsofplasmaF -IsoPs,
2
muscle, or liver by multiple mechanisms, including oxLDL,lipidperoxides(evenifvaluesarecorrectedfor
the inappropriate activation of serine/threonine kin- elevatedplasmalipids),andproteincarbonylsareof-
ases that distort the normal insulin signalling cas- tenfoundtobeelevatedindiabeticpatients.Diabetics
cades. Indeed, mice lacking CuZnSOD showed de- excretemore8OHGuaand8OHdGinurineandhave
creased plasma insulin levels, reduced β-cell mass, elevated levels of several DNA base oxidation prod-
andhyperglycaemia,whereasknockoutofGPx1pro- uctsintheirwhitecells.164–166Indeed,urinaryexcretion
ducedmuchsmallereffects.159Oxidativestresscanalso ratesof8OHGua(butsurprisinglynot8OHdG)were
promoteinsulinresistancebyraisingthelevelsofpro- strongly associated with risk of death in newly diag-
inflammatorycytokinessuchasTNF-αandIL-6;they nosed type 2 diabetics.165 Some studies have found
cannegativelyaffectinsulinsignalling,e.g.byactivat- noelevationsinbiomarkersofoxidativedamage,but
ingJNK(Section5.5.4),leadingtothephosphorylation many diabetics today have their plasma glucose and
ofIRS-1atinhibitorysites. lipidlevelswellcontrolled,diminishingthesourcesof
Again we have the typical redox balance: antioxi- oxidativestress.
dantseffectiveindecreasingelevatedlevelsofoxida- What about antioxidant levels? There is disagree-
tivestressmightimproveinsulinresistance,butifthey mentastowhetherplasmaα-tocopherollevelsindia-
are too effective they might worsen it by interfering betic patients are low (one must correct for elevated
withnormalinsulinsignallingorsecretion.Indeed,an lipids, and diabetics are often on low fat diets which
earlycluetothiswasthatmicelackingGPx1showed could affect vitamin E uptake), but most researchers
lessinsulinresistancethancontrolswhengivenahigh findthatplasmavitaminClevelsaresubnormal167and
fatdiet,whereasmiceoverexpressingGPx1developed thereareseveralreportsofloweredGSHlevelsinvari-
type 2 diabetes faster. Indeed, there are suggestions oustissues,inpartduetodecreasedGSHsynthesis.168
that selenium supplements could increase the risk of LoweredGSHlevelscanpredisposediabeticstoinfec-
humans developing type 2 diabetes,160 or that anti- tionbyBurkholderiapseudomallei.169
oxidant supplements might interfere with the effects Oxidativestressprobablycontributes,bothdirectly
of exercise in improving tissue insulin sensitivity.161 and via glycation (Section 10.5.5), to the accelerated
Thevariableresultsobtainedwithvariousknockouts atherosclerosis, renal damage, neuropathy, impaired
or overexpression of antioxidant enzymes in rodents woundhealing(Section11.4.3andref170),cataract,and
confirmtheviewthatROScanbegoodorbadindia- retinopathythatcanariseindiabeticpatients.Forex-
betes,dependingontheirlevel,time-course,andsiteof ample, overexpression of MnSOD decreased retinal
generation.159,162 damageinhyperglycaemicmice,171 andincreasedtis-
Themechanismofglucose-stimulatedinsulinsecre- suelevelsofNOX4indiabeteshavebeenproposedto
tion in β-cells and the role of ROS in it are not yet contributetotheretinopathyandrenaldamage.172,173
fullyunderstood.157Glucoseentersthecellsfreelyand Indeed,inhibitorsofNADPHoxidasearebeingtested
israpidlyphosphorylatedbyglucokinaseandmetab- clinicallytopreventtissuedamageindiabeticpatients
olizedbyglycolysisandtheKrebscycle,raisingATP (Section 11.7.4). Maternal diabetes increases the in-
levels (Fig. 1.7). This leads to closure of K ATP chan- cidence of foetal abnormalities; a role for oxidative
nels(ATP-sensitiveK+channels),depolarizationofthe stress in this is suggested by the observation that
plasmamembrane,andrisesinintracellularfreeCa2+ transgenicmouseembryosoverexpressingCuZnSOD
(this rise may be one of the steps facilitated by ROS) showed fewer malformations than controls when ex-
that eventually lead to insulin release. The nicotina- posedtohyperglycaemiacausedbyadministrationof
midenucleotidetranshydrogenase(Section1.3.5)plays streptozotocin to their mothers (Section 7.11.5). In rat
akeyrole,sincemicelackingthisshowedimpairedin- embryos, the oxidative stress appeared to impair the
sulinsecretion.Itmayhelptoregulatemitochondrial expressionofgenesrequiredforneuraltubeclosure.174

--- Page 590 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 535
10.5.4 Howdoestheoxidativestress InactivationofaconitasebyO •–(Section3.9)couldalso
2
originate?156,157 contributetometabolicdysfunction.182
Most of the evidence implicating glucose-induced
One possible source is elevated plasma lipids lead-
mitochondrial O
•–
formation in the deleterious ef-
ing to increased lipid oxidation by peroxisomal β- 2
fects of hyperglycaemia has come from studies on
oxidation, which generates H O .175 As mentioned
2 2 isolated cells. Is it relevant in vivo? A lot of evi-
earlier, diets rich in fat increase mitochondrial O
•–
2 denceis consistentwith its importance. For example,
production in skeletal muscle of rats and humans.137
in diabetic patients, acute rises in plasma glucose
Treatmentofratswithamitochondriallytargetedanti-
are accompanied by rapid elevations in plasma F -
2
oxidant,oroverexpressionofcatalaseinmusclemito-
IsoPs.183 Eveninhealthysubjects,transienthypergly-
chondria,decreasedthedevelopmentofinsulinresist-
caemiacanincreaseplasmaF -IsoPlevelsanddecrease
2
anceonsuchdiets,implyingaroleforH O ininsulin
2 2 endothelium-dependent vascular relaxation,23 which
resistance.137 Exposureofβ-cellstohighlevelsoffree
is significantly impaired in diabetics. The hypergly-
fatty acids can diminish insulin secretion (ROS have
caemiaassociatedwithmyocardialinfarction(Section
againbeenimplicated)175,176andelevatedplasmaLDL
10.6.4.1)canalsopromoteoxidativestress.Ofcourse,
levelspromoteatherosclerosis.
thesedatadonotprovethattheROSoriginatedfrom
However, most attention has focused on hyper-
mitochondria.Isletcellsthemselvescanbeoxidatively
glycaemia as a cause of oxidative stress. Indeed in-
damagedbyhyperglycaemia,decreasingtranscription
cubation of many cell types (including β-cells and
of the genes encoding insulin, and aggravating the
neurons) with elevated glucose levels causes in-
diabetes.184 Increasedsynthesisofisletamyloidpoly-
creased ROS production, the key event apparently
peptide, a precursor of insulin, and its glycosylation
being disruption of mitochondrial function176,177 to in β-cells chronically exposed to excess glucose can
releasemoreO
•–.Thishasbeenproposedtooccurbe-
2 lead to ER stress and an unfolded protein response.
cause excess glucose metabolism generates too much
In part this is due to the ability of the glycosylated
NADH, overloads the electron transport chain, and
peptidetoformanamyloid-typestructure,whichmay
promoteselectronleakage;p66shc(Sections5.4.2.2and
itselfpromoteROSgeneration.176Anothermechanism
11.3.1.1) may be involved in the increased mitochon-
may be the induction of uncoupling protein 2 (Sec-
drialO
•–production.177,178
2 tion 1.10.6) in the islet mitochondria, causing falls in
ExcessROSgeneratedasaresultofhyperglycaemia
ATPthatimpairinsulinsecretion.
can cause damage by several mechanisms, including
Anothersourceofoxidativedamageresultsfromthe
stimulationofproteinkinaseC(PKC)activity,leading
reaction of sugars with –NH groups. Let us exam-
toincreasedactivityofNOXandp66shc.Activationof 2
inehow.
PKCcanbeachievedbothdirectlybyROSandbecause
hyperglycaemia promotes the synthesis177,179 of the
PKC activator DAG, diacylglycerol (Section 5.5.4.2),
10.5.5 Non-enzymaticglycation
as explained in Section 10.5.5. The accumulation of andglycoxidation185,186
fructose-6-phosphate from accelerated glycolysis can
increase formation of glucosamine-6-phosphate, and Glucoseinsolutionisaringstructure,inequilibrium
henceUDP-N-acetylglucosamine.Thisisusedbyvari- withasmallamountofanopen-chainaldehydeform.
ous enzymes to post-translationally modify proteins, Aldehydes can combine with –NH groups, modify-
2
decreasinginsulinsignallingandpromotingH O pro- ing DNA bases, proteins, and aminolipids such as
2 2
duction. Another factor may be that hyperglycaemia phosphatidylethanolamine,inaprocessreferredtoas
depressesROSscavengingbythethioredoxinsystem. non-enzymicglycation (Fig.10.10).Glycationofpro-
It increasesthe levelsof thioredoxin-interacting pro- teinsisthefirststepinthe‘browningprocess’,known
tein(TXNIP)inseveraltissues(includinghumankid- as Maillard browning. It is named after Professor
ney and heart); this protein binds to thioredoxin and Louis Camille Maillard, who in 1912 began to eluci-
blocksitsredox-activecysteineresiduesandhenceits date the chemistry behind the colours formed upon
function(Section3.13.1).180 Insympatheticneuronsin heating mixtures of reducing sugars and amines. In-
culture, hyperglycaemia-induced excessive ROS pro- deed,thegolden-browncolours(andsomeelementsof
duction led to oxidation of –SH groups and inacti- the taste) of cooked foods are due to Maillard prod-
vation of nicotinic acetylcholine receptors, a possible ucts.Maillardchemistrycangeneratepleasantaromas,
contribution to neuropathy if it occurs in vivo.181 suchasthoseassociatedwithroastedcoffee.However,

--- Page 591 ---

536 FREE RADICALS IN BIOLOGY AND MEDICINE
mutagenic heterocyclic amines can be formed by turnover rate, such as collagen in connective tissues
Maillard chemistry in meats and fish. Several phen- and lens crystallins (Section 7.10). Glycation is faster
olicantioxidants,includingcatechins,BHT,andBHA, atelevatedglucose,occurringintheseandmanyother
decrease formation of these mutagenic products.187 proteinsindiabeticpatients.Indeed,glycatedhaemo-
Whether dietary Maillard products can be absorbed globinlevelsareusedasanindexofhowwellblood
and contribute to tissue damage is still a subject of glucosehasbeencontrolledoverthepreviousmonthor
debate.188 so.Glycationstartswhenareducingsugar(commonly
Glycation in vivo is slow at physiological glucose glucose) reacts with an amino group on a protein
levels, tending mostly to affect proteins with a low (aminolipidsandnucleicacidscanalsobeglycated)to
(a) OHO
R C C H (aldehyde form of glucose)
H
reversible protein NH 2 group (DNA, aminolipids can also react)
OHOH
R C C NH protein
H H
H 2 O H 2 O
OH OH
R C C N protein R C C NH protein
H H H
Schiff base
O
R C CH NH protein (Amadori product)
2
(b) LYS NH LYS ARG
H C O CH C 2 O CH N 2 H O N NH
CH OH CH OH N
HO CH CH OH Lysine HO CH CH OH HO CH CH HO N+ LYS Arginine HO N LYS
CH 2 CH CH 2 CH CH C 2 HO HO
HO OH HO OH O O
Glucose Amadori 1,4-Dideoxy Glucosepane
Product 5,6-glucosone
Figure10.10 (a)Reactionofglucosewithproteins(otherreducingsugarscanreactsimilarly)togenerateadvancedglycationend-products.
(b)Formationofacross-linkedarginine/lysinecomplex(glucosepane)byglucose.FromJ.Biol.Chem.280,12310,2005,bycourtesyofthe
AmericanSocietyforBiochemistryandMolecularBiologyandProfessorVincentMonnier.Glucosepaneisamajornon-oxidativeadvancedglycation
product(AGE)incollagen(J.Biol.Chem.280,12310,2005)andalsofoundinoldhumanlenses.Ascorbate-derivedAGEsarealsoprominentin
lens(Section7.10.2).Glucose–lysinedimercross-linkinghasalsobeendescribed(AminoAcids40,167,2011;FreeRadic.Biol.Med.49,
847,2010).

--- Page 592 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 537
formaSchiffbase,whichcanrearrangeintoAmadori thetriosephosphatescanconverttomethylglyoxal,a
products(Fig.10.10)andeventuallygenerateavariety furthersourceofthismolecule.185,191
ofderivativescalledadvancedglycationend-products Sugars themselves can oxidize, catalysed by traces
(AGE)suchasglucosepane(Fig.10.10).Forexample, of iron and copper ions, to produce O •–, H O , OH•,
2 2 2
glycated haemoglobin (HbA ) contains a glucose andcarbonylsthatparticipateinglycation(Figs10.10
1C
Amadori product attached to the N-terminal valine and 10.11). Ascorbate can do the same. Hence oxida-
oftheβ-chain.Glucosepaneformationinvolveslysine tivestresscancontributetoAGEformation(Fig.10.11)
andargininecross-linkingandisespeciallyprominent andthewordglycoxidationisoftenusedtodescribe
incollagenintheelderlyandevenmoresoindiabet- thepathwaysinvolved,whichleadtotheformationof
ics.GlucosealsoglycatesCuZnSODintheerythrocyte, multipleend-productssuchascarboxymethyl-lysine,
decreasingitsactivity;thismayaccountforthelower carboxyethyl-lysine, and pentosidine, a fluorescent
SODactivityreportedinthebloodofsomediabetics.189 cross-link between lysine and arginine residues (Fig.
BothCuZnSODandcaeruloplasmincanfragmentafter 10.11). The glyoxalase system (Section 3.15.1) is thus
glycation,toreleasepro-oxidantcopperions.190 importantincontrollingAGEformationinvivo,191 but
In addition to the non-oxidativeformation of AGE will be compromised if GSH levels are low, as they
such as glucosepane, Amadori products can frag- can be in diabetes. Indeed, overexpression of glyox-
ment on exposure to ROS to give reactive carbonyls alase1decreasedrenaldamagecausedbydiabetesin
suchasglyoxal(CHO.CHO)andmethylglyoxal(Sec- mice.192 OxidationofAmadoriproductsandsugarsis
tion3.15.1).Theseoxoaldehydesarefastreactingglyc- importantindiabetes,becausebothROSandglucose
ating agents191 that attack multiple biomolecules, in- levelsareelevated.
cluding DNA and the guanidino group of arginine Accumulation of non-oxidatively or oxidatively-
residues(whichareoftencriticaltoproteinfunction). generatedAGEonproteinsisaccompaniedbybrown-
Increased ROS production in diabetes decreases the ing(theequivalentofthebrowningofcookedfoods),
activity of glyceraldehyde-3-phosphate dehydrogen- increasedfluorescence,andcross-linking.Formationof
ase (G3PDH; Fig. 1.7), allowing triose phosphates to AGEproteinsfromglucoseusuallyoccursoverperiods
accumulate for ready conversion into DAG (Section ofmonthstoyears,whereasglyoxalandmethylglyoxal
10.5.4). Inactivation of G3PDH seems to involve its can glycate rapidly if allowed to accumulate (e.g. by
ADP-ribosylationbyPARP-1(Section5.2.5).185Someof impairment of the glyoxalase system). Hence glyoxal
glycation
Glycated
protein
Glucose oxidation AGE
oxidation Reactive
carbonyls
Lysine
O
Figure10.11 Glycoxidation.Aswellasthe
NH CH C N+ non-oxidativeformationofAGE(Fig.10.10),the
HN
combinationofglycationandoxidationcanresultin
(CH)
24 theirformation.Glucosecanbeoxidizedtoform
HN N
NH carbonylssuchasglyoxalandmethylglyoxal,orglycated
CH proteinscanthemselvesbeoxidized.
2 Nε-Carboxymethyl-lysineandpentosidinehave
COOH Arginine beenidentifiedasproductsthatarisebyglycoxidation,
Carboxymethyl-lysine Pentosidine buttherearemanyothers.

--- Page 593 ---

538 FREE RADICALS IN BIOLOGY AND MEDICINE
and methylglyoxal are significant contributors to the interactionspromotecellularactivationandformation
intracellularglycationofproteins,lipids,andDNAin of pro-inflammatory cytokines, and as a result AGE
diabetes. Indeed, a mitochondrially targeted ‘probe’ promoteinflammation.
has been used to detect their increased formation in
mitochondriaincellsincultureandindiabeticmice.193 10.5.5.1 ReversingAGEing?186,195
AGEformationcanimpairthefunctionofenzymes, Aminoguanidine,
structuralproteins,receptors,andtranscriptionfactors.
For example, accumulation of AGE in collagen de-
creases the elasticity of connective tissue (impairing
blood vessel function), and damages basement mem-
branes, e.g. in the kidney as a contributor to diabetic a hydrazine compound that reacts with dicarbonyls,
nephropathy.Indiabeticpatients,AGEarepresentin has been tested in diabetic patients; its ability to
many tissues, on circulating LDL, and in atheroscler- decrease AGE formation might retard the develop-
oticlesions. mentofkidney,eye,bloodvessel,andnervedamage.
Once formed, AGE proteins cause more oxida- Pyridoxamine,
tivestress.Glycationofproteinsinthemitochondrial
electron transport chain can impair normal electron
flow194 and promote ‘leakage’ to form O •–. Binding
2
of glucose to the amino groups on both apoB and
on lipids in LDL facilitates LDL oxidation. In add-
ition, AGE are toxic to many cell types185 and pro-
inflammatory: they can lead to increased formation
of tissue factor (promoting blood coagulation; Fig. a compound related to vitamin B 6 (pyridoxine) has
10.5), and of the pro-inflammatory cytokines TNF- a similar action, as may carnosine (Section 3.25.7).
α, IL-1, and IL-6 in various cell types. For example, Other agents, such as ALT-711 (alagebrium), have
exposure of endothelial cells to AGE activates NF- been described that appear to dissolve AGE struc-
κB, increases adhesion molecule (including VCAM- tures and can decrease the AGE content of tissues.
1)production,NADPHoxidaseandCOX-2activities, The copper ion chelator triethylenetetramine (TETA
and may decrease GSH and eNOS levels. In other ortrientine,Table11.8)wasreportedtoimprovecar-
words, the endothelium undergoes inflammatory ac- diac function in diabetic patients and experimental
tivation. This occurs in addition to the direct dele- animals, consistent with a role for copper ions in
terious effects of high glucose on vascular endothe- AGEformation;copperionchelationmightalsocon-
lium. Proteins bearing AGE have been implicated in tribute to the action of alagebrium.196,197 Agents that
the excessive proliferation of blood vessels that oc- increase glyoxalase 1 levels are being developed to
cursindiabeticretinopathy(e.g.bypromotingVEGF helppreventglyoxal-andmethylglyoxal-inducedAGE
synthesis). formation.198RAGEantagonistsarealsounderinvest-
HowdoAGEcausethisdamage?Manycelltypes, igation.Theclinicalvalueoftheaboveagentsis,asyet,
including monocyte/macrophages, T-lymphocytes, uncertain.
andendothelialcells,recognizeAGEusingcell-surface
receptors,RAGE(ReceptorsforAGE),thataredistinct
10.5.6 Othermechanismsofglucose
from the scavenger receptors. The RAGE in athero-
toxicity173,174
sclerotic lesions are involved in several processes,
including monocyte migration and activation in Aldosereductase,anenzymefoundinseveralmam-
responsetoAGE.Inaddition,severalscavengerrecep- malian tissues (including lens and retina), has been
tors,includingSR-A,CD36,andLOX-1recognizeAGE proposedtocontributetothedevelopmentofdiabetic
proteins.Normally,RAGEmayenablemacrophagesto cataract.Itconvertsglucosetothepolyalcoholsorbitol
recognizeandengulfglycosylatedcells,suchasAGE- byreducingthealdehydegroup,
modified erythrocytes. RAGE receptors bind several
other ligands, including β-amyloid and HMGB1, a RCHO + NADPH + H+→ RCH 2 OH + NADP+
promoter of inflammation (Section 5.4).185 RAGE is Itcanalsoreduceglyceraldehyde-3-phosphate.Hyper-
thus one of the pattern recognition receptors of the glycaemiaraisesintracellularglucoselevelsandaccel-
innate immune system (Section 8.7.1); RAGE–ligand erates enzyme action. Inhibitors of aldose reductase

--- Page 594 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 539
can delay the onset of diabetic complications in ani- ‘normal’ atherosclerosed subjects.207 We have already
mals,buthavenotgivenconvincingresultsinhumans. commented on the complexity and variability of ath-
Whyabnormalactivityofaldosereductaseshouldbe erosclerotic lesions (Section 10.3.5.4). Oxidative stress
toxicisunknown;suggestionsincludetheoxidationof may also contribute to neuropathy and retinopathy,
sorbitolbyNAD+-dependentenzymestofructose,fur- as discussed earlier. Indeed, in the Zucker diabetic
ther raising NADH levels. Fructose is an even better fat (ZDF) rat, a model of the metabolic syndrome,
glycatingagentthanglucose!Inaddition,highaldose developmentofrenaldamagewasdelayedbythe‘an-
reductase activity may consume the NADPH needed tioxidant’ ebselen,208 although this agent has several
bythioredoxinandglutathionereductases,somaking modesofaction(Section11.5.10).
tissuesmorevulnerabletooxidativedamage.
10.5.7.1 Doantioxidantsupplementshelp
10.5.7 Asummary:howimportantisoxidative diabeticpatients?
stressindiabetes? Intervention trials with high-dose α-tocopherol gave
littleornoevidenceofbenefitindiabetes,209 although
Insomestudies,elevatedlipidperoxidationhasbeen
itisuncleartowhatextentlipidperoxidationwasde-
demonstratedinmetabolicsyndromeandinearlydia-
creased by the interventions (probably little, if at all;
betes. Hence it is not always a consequence of tissue
Section4.3andref210).Lipoicacid(Section3.25.4)has
injury from diabetic complications.132,199,200 Similarly,
been suggested, but not convincingly established, to
inonestudy,patientswithhigherurinaryexcretionof
decreasetheseverityofdiabeticneuropathybymain-
8OHdG later developed more severe nephropathy.201
taining GSH levels and/or by its direct antioxidant
High plasma levels of 2-aminoadipic acid (AA) were
properties.209 However,lipoicacidadministrationim-
reportedtobeariskfactorforthedevelopmentofdia-
proved endothelial function in subjects with meta-
betes in normal subjects.202 This compound can arise
bolic syndrome, but did not decrease their plasma
fromoxidativedamagetoproteins(Section6.16.1),and
F -IsoPlevels,suggestiveofbenefitbynon-antioxidant
2
indeeditslevelswereincreasedintheskinofdiabetic
mechanisms.209,211
patients,203althoughwhetherAAinplasmaoriginates
Since ascorbate levels are subnormal in diabet-
fromoxidativedamageisuncertain.202
ics, would they benefit from taking ascorbate sup-
However, other studies have not found elevations
plements? Ascorbate has antioxidant properties, but
in biomarkers of oxidative damage in subjects with
it can also glycate proteins (Section 7.10.2 and Fig.
themetabolicsyndromeorearlydiabetes,suggesting
10.10).Oneepidemiologicalstudysuggestedthathigh
thatoxidativestress(asrevealedbycertainbiomarkers
ascorbate intake in subjects who had been diabetic
at least) rises only as diabetes progresses.204 One fac-
for many years was associated with increased risk of
toraccountingforthediscrepancymaybethedegree
complications.212Moreworkisneededbeforeclear-cut
of obesity and hypercholesterolaemia, both of which
conclusionscanbedrawn.Oxidativestressindiabetes
increase oxidative stress and are common in diabet-
isprobablybestcontrolledbycarefullymonitoringand
ics.Anotherfactoristhatbloodlipidsandglucoseare
controllingplasmaglucoseandlipid(especiallyLDL)
better controlled in many patients than they were in
levels,moderateexercise,andbycorrectingobesityby
thepast,decreasingtheoxidativestressresultingfrom
eatingfewercalorie-richfoods.
hyperglycaemiaandhyperlipidaemia.
Oxidative stress probably contributes, via LDL
oxidation and AGE/RAGE interactions, to the ac- 10.6 Ischaemia–reperfusion213
celerated progression of atherosclerosis in diabetics.
Measurementsofproteinmodificationproductsinath- We have already considered the roles of hypoxia–
erosclerotic lesions from diabetic monkeys suggested reperfusion in birth and in sickle-cell anaemia (Sec-
that OH• rather than ONOO– was important; levels tion 7.11.8.1 and 7.4.4). Let us now examine other
of o-tyrosine, m-tyrosine, and bityrosine were raised, examplesofthisphenomenon.Damagetotheheartor
but 3-nitrotyrosine was not.205 In contrast, elevated brain by restricting the supply of blood (ischaemia),
levels of nitrotyrosine and nitrated prostacyclin syn- causingashortageofO (hypoxia)andnutrients,isa
2
thase were observed in atherosclerotic carotid arter- major cause of death worldwide. Rupture of an ath-
ies from diabetic patients,206 although just to confuse erosclerotic lesion, followed by thrombosis and the
you,inyetanotherstudylevelsofF -IsoPsincarotid blockage of an essential coronary or cerebral artery,
2
artery lesions were lower in diabetic patients then in is the usual cause (Section 10.3). Impairment of the

--- Page 595 ---

540 FREE RADICALS IN BIOLOGY AND MEDICINE
blood supply to a tissue also slows the removal of of ATP eventually fall, AMP levels increase, and the
metabolicwasteproducts. cells’ normal ion gradients are disrupted as the ATP
Ischaemic tissues survive for a variable time, de- supplyfails.TheAMPformedisdegraded,hypoxan-
pendingonwhattissueitis,thespeciesitisfrom,the thine accumulates (Fig. 10.12), and intracellular Ca2+
ageoftheanimal,andhowmuchbloodflowremains. levelsrise,activatingCa2+-stimulatedproteinasesand
Thusskeletalmuscleisfairlyresistanttoischaemicin- phospholipases (providing fatty acid substrates for
jury, whereas the brain is far more sensitive. Many eicosanoidsynthesis)andnitricoxidesynthases(ifpre-
tissues can adapt to cope with some degree of O sent). Of course, O is a substrate for COX and NOS
2 2
deprivation(Section1.3.2).However,anymammalian enzymes and so complete O deprivation will block
2
tissuerenderedischaemicforasufficientperiodwillbe NO•andeicosanoidformation.
irreversiblyinjured.TissuesrespondtoO deprivation
2
in several ways. Early responses usually include in-
10.6.1 Reoxygenationinjury213
creasedratesofglycogendegradationandglycolysisto
maintainATPlevels,leadingtolactateproductionand If the period of ischaemia is not long enough to in-
acidosis. However, if ischaemia is prolonged, levels jurethetissueirreversibly,muchofitcanbesalvaged
Deprivation of
Xanthine dehydrogenase
oxygen
Oxidation of
–SH groups
and/or
ATP ADP AMP adenosine proteolysis
(Ca2+–stimulated
proteinases)
Inosine
Hypoxanthine Xanthine oxidase
Reperfusion
restores
O
2
–
O , xanthine, urate, HO
2 2 2
Fe, Cu ion Ischaemic tissue injury
release Reperfusion tissue injury
OH
Figure10.12 Aproposedmechanismfortissueinjuryuponreoxygenationofischaemicorhypoxictissues.ModifiedfromJ.M.McCordFed.Proc.
46,2402,1987.Theenzymethatconvertsadenosinetoinosineisadenosinedeaminase.Adenosineisavasodilator,decreasesphagocyteRS
production,modulatestheactivityofnumerousothercelltypes,andmayhelptoprotectcellsagainstsomeoftheconsequencesofischaemia–
reperfusion(Section8.9.2).

--- Page 596 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 541
by restoring the blood supply, thus reintroducing O transfers electrons not to O , but to NAD+, as it oxi-
2 2
andnutrientsandclearingmetabolicwasteproducts. dizes xanthine or hypoxanthine into urate. When tis-
In this situation, reperfusion is obviously beneficial. sues are damaged, some XDH can be converted to
However, it was shown in the early 1980s that re- XO (Fig. 10.12) by oxidation of –SH groups or by
introduction of O to an ischaemic tissue can cause limited proteolysis. Proteolytic cleavage of surface-
2
an additional insult to the tissue (reoxygenation in- exposedloopsintheproteincausesaconformational
jury)thatis,inpart,mediatedbyaburstofO
•–/H
O changearoundtheFADbindingsitethatblocksaccess
2 2 2
production.Therelativeimportanceofreoxygenation to NAD+ and allows electrons to pass to O . Oxi-
2
(oftencalledreperfusion)injurydependsonthetime dation of –SH groups may form a disulphide bond
andseverityofischaemia.Ifthisissufficientlylong,the that leads to similar changes.215 Depletion of ATP
tissueisirreversiblyinjuredandwilldie,sothatreoxy- in hypoxic tissue causes hypoxanthine accumulation.
genationinjuryaddslittleornothingtothedamage,at This hypoxanthine can be oxidized by XO when the
leasttothattissue.Nevertheless,reperfusionofadead tissue is reoxygenated, causing rapid generation of
ordyingtissuecanreleasetoxicagentsintothelymph O
•–andH
O .Transitionmetalionscanthenpromote
2 2 2
or blood to cause problems to other organs. These OH•formation(Fig.10.12).
products can include xanthine oxidase (XO; Section Xanthine oxidase can also contribute to systemic
10.6.2), biologically active oxidized lipids (e.g. IsoPs, injury,e.g.inMODS.Itbindsreadilytovascularglyco-
PAF-likeproducts[Section5.12.2]),DAMPs,and‘cata- saminoglycansandgeneratesO
•–/H
O thatcaninjure
2 2 2
lytic’transitionmetalions.DAMPreleasecanleadtoa vascularendothelium.216EvenifXDHisreleasedfrom
‘sterileinflammation’. damaged tissues, it is rapidly converted to XO in
Suchreleaseoftoxinsmaycontributetomultipleor- plasma.215 IfXObindstoendotheliumandmetalions
gandysfunctionsyndrome(MODS),aleadingcause areavailable,theOH• generatedcanhelptodegrade
ofdeathinverysickpatients.MODScanresultfrom theendothelialglycocalyx,amongotherdamagingef-
several events, including major trauma, overwhelm- fects. HOCl and ONOO– can also lead to damage to
ing infection, and ischaemia/reoxygenation of intes- glycosaminglycansintheglycocalyx(Table3.7).217
tine, liver, or skeletal muscle. In particular, damage
to the gut can allow bacteria and bacterial prod-
10.6.3 Intestinal
ucts (e.g. endotoxin) into the circulation, and some
ischaemia–reoxygenation213,218,219
groups have called the gut ‘the motor of multior-
gan failure’. MODS is characterized by a release of Intestinal ischaemia–reperfusion injury in humans is
‘stresshormones’,suchascatecholaminesandcortisol, associated with high morbidity and mortality; inter-
and by a systemic inflammation (systemic inflam- ruptions to the blood supply of the gut can occur in
matory response syndrome, SIRS) with overproduc- haemorrhagic or septic shock (Section 10.6.7), throm-
tion of pro-inflammatory cytokines, complement ac- bosis, strangulated hernias, and torsions of the intes-
tivation, and mitochondrial dysfunction with falls in tine.Impairmentsofbloodflowcansometimesoccur
ATP. Some studies have suggested limited benefit of duringlaparascopicsurgery.5Afterthebrain,thegutis
N-acetylcysteineadministrationindecreasingtheinci- themostsensitivebodyorgan;ischaemiareadilydam-
denceofMODSinpatients,butmosthavenot.214 ages the gut lining, especially the cells at the tips of
However,iftheperiodofischaemiaisshort,there- the villi, and reperfusion aggravates damage. Even a
oxygenationinjurycomponentmaybecomeimportant brief period of gut ischaemia can disrupt the mucus
and the amount of tissue damage can be decreased layer,andinjurethevilli,allowingbacteria,endotoxin,
by including antioxidants in the reoxygenation fluid. andotherPAMPstoenterthebodyandcontributeto
What length of time is ‘short’ depends on the tissue MODS(Section10.6.1).
andthedegreeofO 2 deprivation.Theremayalsobea Indeed,theearliestevidencesupportingthescheme
‘burst’ofNO•(withthepotentialtoreactwithO •
2
–and
inFig.10.12camefromstudiesuponintestine.Partial
formONOO–)andeicosanoidproductionwhenO 2 is occlusion of the artery supplying blood to a segment
restored. ofcatsmallintestine,followedbyreperfusion,causes
histologicallyobservabledamagetothetissueandin-
creases intestinal vascular permeability. Intravenous
10.6.2 Aroleforxanthineoxidase?
administrationofSOD,ororaladministrationofallo-
Almostallofthexanthine-oxidizingactivityinhealthy purinol (to inhibit XO) to the cats before reperfusion
animal tissues is the dehydrogenase (XDH), which decreaseddamage,andinfusionofhypoxanthineplus

--- Page 597 ---

542 FREE RADICALS IN BIOLOGY AND MEDICINE
XOintothearterialsupplyofasegmentofnormalcat or pretreatmentof themwith antibodiesthat prevent
intestinemimickedthedamage,aneffectthatwasde- neutrophiladherencetoendothelium,hasdiminished
creasedbySOD,OH• scavengers,ordesferrioxamine. reoxygenation injury to intestine and other tissues in
Iron ions able to catalyse OH• production could ori- someanimalstudies.
ginatefromseveralsources(Section10.6.4.4).Intestinal
ischaemia in cats results in accumulation of hypo-
xanthine, which disappears quickly on reperfusion, 10.6.4 Cardiacischaemia–reoxygenation213,223
and both lipid peroxidation (indeed, some products
of peroxidation, such as F -IsoPs, can contribute to 10.6.4.1 Thephenomenon
2
the injury)219 and GSSG formation can be measured ThemodelinFig.10.12soonattractedtheattentionof
in the reperfused intestine. It has also been reported cardiologists.Advancedcoronaryatherosclerosisoften
thatSODordesferrioxamineadministrationdiminish leadstoanginapectoris,chestpainuponexertiondue
the mortality consequent upon gut ischaemia in rats. tomyocardialischaemia.Completeocclusionofacor-
Dobearinmind,however,thatironionchelationcan onary artery (usually due to plaque rupture; Section
alsoactivatetheHIFsystem(Section11.6.1)soastoin- 10.3.1) produces myocardial infarction (MI; severe is-
creasetolerancetohypoxia.Pterinaldehyde(2-amino- chaemic injury to heart muscle). MI is a major cause
4-hydroxypteridine-6-carboxaldehyde),apowerfulXO of death, and thrombolytictherapy is widelyused to
inhibitor that can contaminate commercial prepar- dissolvebloodclotsandpromotereperfusion.Indeed,
ationsofthevitaminfolicacid(Fig.1.10),alsooffered oneinterestingdebateiswhetherMIpatientsshouldbe
protection.Feedinganimalswithtungstencompounds given oxygen (Section 1.5.2.2). Heart muscle can sur-
decreasestissueXDHactivity;intestinefromratspre- vive up to 60 to 90 min of ischaemia, depending on
treated in this way showed less reoxygenation injury theanimal.Acutemyocardialinfarctioninhumansis
after hypoxia than segments from normal rats. The sometimes accompanied by hyperglycaemia, another
tungstenworksbybeingincorporatedintoXOinstead potentialsourceofROSproduction.224
ofmolybdenum,producinganinactiveenzyme.220 After short periods of ischaemia, reoxygenation of
ThemodelinFig.10.12thusexplainsmanyaspects isolated perfused animal hearts has been shown to
ofintestinalischaemia–reoxygenationinsomeanimals. produce additional tissue damage that is diminished
Rat, human, and cat intestine are rich in XDH, al- by adding MnSOD, CuZnSOD, catalase, spin traps
thoughitsimportancetohumanshasbeenquestioned such as PBN, ‘scavengers of OH•’ such as dimethyl-
becausetheXDHtoXOconversionseemsveryslow.221 sulphoxide or mannitol, desferrioxamine, or allopur-
However,XOisnottheonlysourceofROSinreoxy- inoltothereperfusionfluids.Inaddition,heartsfrom
genatedintestine(orothertissues)anditmaynotbe transgenicanimalsoverexpressingvariousantioxidant
themajorsourceinhumans.221Mitochondriadamaged enzymes(e.g.catalase,EC-SOD,MnSOD,GPx1)show
byischaemiaseemto‘leak’moreelectronsthanusual less reperfusion injury, whereas hearts from animals
fromtheirelectrontransportchain,formingmoreO • 2 – lackingvariousantioxidantenzymes,orG6PDH,show
(especiallyfromcomplexI)whenO 2 isrestored.6 The more.225–229 Figure 3.7 shows a stark example of the
mitochondrial permeability transition can occur, trig- cardiacdamagedonebylackofMnSODinmice.One
geredbyCa2+ overloadandROS,depletingATPand point worth making—studies showing protection by
increasingO • 2 – production(Fig.1.9).Excessintramito- mannitol should not assume that it is acting as an
chondrial O •– can interfere with energy metabolism OH•scavenger.230Deleteriouscellvolumechangescan
2
by inactivating enzymes such as aconitase, simultan- occur in response to ischaemia and/or reperfusion,
eouslyreleasingiron.222Reactivespeciescanarisefrom and mannitol may help to prevent these by exerting
inflammationduetoDAMPreleasefromdyingcells, osmoticeffects.
involving phagocytes present within, and recruited The manifestations of cardiac reoxygenation injury
to, the reperfused intestine. Reperfused tissues can varyaccordingtospecies,ageoftheanimal(oldones
release leukotriene B 4 , PAF, and other chemoattract- generally do worse), and experimental protocol. Pro-
antsforneutrophils,andincreaselevelsofendothelial longed ischaemia will lead to myocardial cell death
adhesion molecules by signalling pathways that in- and infarct formation. By contrast, reoxygenation of
volveROS(Section8.9.2).Neutrophilsadheretoendo- isolated rat hearts after brief ischaemia can produce
thelium and may activate to generate products (O • 2 –, irregularcontractions(arrhythmias).230 Thisphenom-
H 2 O 2 , HOCl, chloramines, eicosanoids, elastase) that enon is also potentially life threatening; sudden car-
worseninjury.Indeed,neutrophildepletionofanimals, diac death in humans often results from ventricular

--- Page 598 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 543
arrhythmias such as fibrillation or tachycardia, and (the chest is opened, a coronary artery partially or
atrialfibrillationalsocausessignificantmorbidity,e.g. completelyoccluded,andtheblockageremovedafter
aftercardiacsurgery.Reoxygenationafter15to20min variousperiods)severalstudiesshowedthatpretreat-
ischaemia can result in delayed return of contract- mentofanimalswithSODpluscatalase,orallopurinol,
ilefunction(myocardialstunning)inpig,rabbit,and decreased the amount of tissue death (size of the in-
doghearts.231Thestunnedmyocardiumdoesnotcon- farction)producedbyprolonged(≥60min)occlusion,
tract,butisnotirreversiblyinjuredandwilleventually followedbyreoxygenation.Thismodelhasalsobeen
recovernormalfunction(hourstodayslater).Themo- used to show the involvement of OH• in myocardial
lecular mechanism of stunning is unclear; its rapid stunningresultingfromashorter(10–15mins)period
onsetandtheprotectiveeffectsofthiolcompoundsin ofischaemiafollowedbyreoxygenation(Fig.6.6).231
somestudieshaveledtosuggestionsthatOH•oxidizes Theextentofprotectionbyantioxidantshasvaried
–SH groups on membrane ion-transport systems that widelyindifferentexperiments,especiallyinstudiesof
areessentialformaintainingmembranepotentialand infarctsize,themostcontroversialarea.Atleastthree
keepingintracellularCa2+low.231 reasonsaccountforthis.
Normalheartfunctiondependsonperiodic‘waves’
1. The importance of reoxygenation injury as a frac-
ofelectricalactivitytostimulatethecardiomyocytesto
tionoftotaltissuedamagedeclinesastheischaemic
contractinanorderedsequence,soitiseasytoenvis-
periodincreases.Inexperimentswithprolongedis-
age how disruptions of membrane ion transport (e.g.
chaemia, so much tissue injury may be done by
elevatedCa2+)couldprovokestunningorarrhythmias.
IonchannelscanbedamagedbyOH•,ONOOH,alde- deprivationofO 2 andnutrientsthatreperfusionin-
juryaddslittleandantioxidantsareunlikelytooffer
hydessuchasHNE,orisoketals,thelasttworesulting
muchprotection.Indogheart,forexample,coron-
from lipid peroxidation (Section 5.3). If the channels
aryocclusionforlessthanabout20mincanleadto
have easily oxidizable –SH groups, H O might also
2 2
stunningonreperfusion,butrarelyanyinfarct.Oc-
attack them. Oxidative stress can cause excessive ac-
clusion for more than 4 h followed by reperfusion
tivationofthecalcium-calmodulindependentkinase
givesaninfarctaboutthesamesizeasthatresulting
II(CaMKII)enzyme,whichleadstoabnormalbehav-
frompermanentocclusion(i.e.damageismaximum
iourofionchannels,dysfunctionalheartbeating,and
andcannotbefurtherincreased).231
increased mortality after MI. Activation involves oxi-
2. In ‘whole-animal’ studies (e.g. using open-chest
dationofmethionineresiduesbyROS;indeed,levelsof
pigs or dogs), the extent of O -deprivation during
oxidizedCaMKIIareincreasedintheatriaofpatients 2
arterialocclusioncanvaryconsiderablybecauseof
with atrial fibrillation.232 This enzyme is also acti-
collateralvessels.
vatedasaconsequenceofprolongedhyperglycaemia
3. Some of the antioxidants used show bell-shaped
in diabetes,233,234 and administration of mitoTEMPO
dose–responsecurves.Forexample,instudiesupon
(Section11.5.12)todiabeticmicedecreasedtheactiva-
arrhythmiasinisolatedratheartsafterabriefperiod
tion and improved heart function. Calcium overload
of ischaemia, there is an optimal concentration of
canactivatecalpains(Section5.3.2)andcauseproteo-
SODforprotection,andhigherorlowerconcentra-
lytic damage to myofibrils; the time taken to repair
tionsgivesmallerprotectiveeffects.230 Thereasons
thisdamagemaycontributetothedelayedrecoveryof
remaintobeestablished.Forexample,adeleterious
functioninstunning.231
effectofimpuritiesinsomeoftheantioxidantsstud-
10.6.4.2 Importanceofthemodelused ied (e.g. endotoxin or Cu2+ in CuZnSOD prepar-
ations)mightbecomesignificantathighantioxidant
Many studies showing protective effects of antioxi-
concentrations.OritcouldsimplybethatsomeROS
dants have used hearts isolated from animals (mice,
areusefulandtoomanybad,afamiliarstory.
rats,rabbits,dogsetc.)andperfusedwithbuffersolu-
tions.Thesestudiesareeasytocontrolandstandard- Otherstudieshaveused‘conscious’dog,rabbit,or
ize,butthebufferslackalltheantioxidantsnormally pig models in an attempt to eliminate possible con-
presentintheblood,sotheeffectsofantioxidantsad- founding effects of anaesthesia, surgical trauma, and
dedtothebuffermaybegreaterthantheywouldbe mechanical ventilation.231 Probes that record myocar-
in vivo. In addition, buffers are usually contaminated dial function and a hydraulic coronary ‘balloon oc-
withtransitionmetalions,aggravatingOH•formation. cluder’ are implanted into an anaesthetized animal,
Alternatively,studiescanbeperformedwithorgansin whichisthenallowedtorecover.Switchingontheoc-
situ. For example, in ‘open-chest’ anaesthetized dogs cluderintheawakeanimalforashortperiod,followed

--- Page 599 ---

544 FREE RADICALS IN BIOLOGY AND MEDICINE
by reperfusion, produces myocardial stunning which reperfusion,230,231 but they are important after longer
can be attenuated by thiol compounds and desfer- ischaemicperiods.213 Thus,depletinganimalsofneu-
rioxamine. Spin adducts from pre-administered PBN trophils,orinjectingthemwithantibodiesthatprevent
(Section6.2.5)canalsobedetectedintheanimal’scor- neutrophiladherencetoendothelium,beforeperform-
onary venous blood after hypoxia–reperfusion. Both ing ischaemia–reperfusion has decreased infarct size
the extent of the stunning and the amounts of PBN insomestudies,andtherearesuggestionsthatHOCl
adducts detected are lower in ‘conscious’ than in fromMPOcouldpromoteatrialfibrillation.241 Activa-
‘open-chest’dogs,butthestunningphenomenonisstill tionofcomplementduringischaemia–reperfusioncan
evident.231 helptoprovokeneutrophilstoreleasemoreROS.Neu-
trophiladherencetovascularendotheliumispromoted
10.6.4.3 Therelevanceofxanthine by ROS (Section 8.7.3) and may contribute to the no-
oxidase213,215,235,236
reflowphenomenon,theinabilitytoreperfuseareasof
Multiplereportsthatantioxidantsandallopurinolpro- previouslyischaemictissue,oftenthoughttobedueto
tectagainstcardiacischaemia–reoxygenationinjuryin plugging of capillaries, both by swelling of damaged
variousanimalssupporttherelevanceofthemodelin endothelialcellsandbyneutrophiladherence.Theac-
Fig. 10.12. However, all is not clear-cut. Rat, mouse, tionsofMPOandthetoxiceffectsofF 2 -IsoPsformed
guinea pig, and dog heart contain XDH, but its rate during oxidative damage (Section 5.12.3)219,242 might
ofproteolyticconversiontoXOduringischaemiacan alsocontributetothisphenomenon.
be slow and variable. Of course, the basal level of
XO could still lead to extra ROS generation because
10.6.4.4 Therelevanceoftransitionmetals
of increased hypoxanthine. Unfortunately, rabbit and
porcine hearts have been reported to contain little, if IfOH• isformedinthereoxygenatedheartbyFenton
any,XO.Ifso,howcanoneexplaintheprotectiveef- chemistry(Fig.10.12),thenasourceoftransitionmetal
fectsofallopurinolintheseanimalsreportedbyseveral ions must be identified (not neglecting the contam-
groups? It might prevent the depletion of purine nu- ination of buffers by them in studies with isolated
cleotidesthatcanbeusedassubstratesforresynthesis hearts).Theirimportanceissuggestedbythegenerally
ofATPonreoxygenation.223 Thereappearstobelittle protective effects of iron chelators (such as desferri-
XOinhumanhearts,althoughhigherlevelshavebeen oxamine) on ischaemia–reoxygenation-induced dam-
reportedinhumanheartsthatarefailing. age in animals, and the fact that hearts isolated from
Other sources of RS may also be important, as al- iron-overloadedanimalsaremoresusceptibletoreoxy-
ready discussed for intestine (Section 10.6.3). Mito- genation injury.243,244 One study on humans with MI
chondria are more ‘leaky’ after a period of ischae- foundthatdesferrioxamineadministrationatreperfu-
mia and the MPT can occur; prolonged opening of sion decreased plasma F -IsoP levels but not infarct
2
the pore and a drop in ATP levels can lead to cell size,243 whereas other studies have shown some clin-
death,237whereastransientopeningmayleadtoadap- icalbenefit(Section10.6.4.7).Remember,however,that
tive responses (Section 10.6.6). Mitochondrial cardi- desferrioxamine can scavenge ROS directly and also
olipin may be one target of oxidative damage in activateHIF(Section11.6.1),soneverassumethatitis
the heart. Indeed, cyclosporin (a MPT inhibitor; Fig. actingbychelatingironions.
1.9)hasbeentestedinhumanMIpatients,butitsvalue Iron and copper244 ions might become more avail-
isuncertain.238SomeO •–mightarisefromcytochromes able because of their release as a result of cell in-
2
P450 in the heart, although their levels are generally jury caused by ischaemia and/or reperfusion. Iron
low.239 However,cardiaclevelsofCYP2E1riseincer- can also arise from bleeding (and subsequent deg-
tain human heart diseases and in excessive alcohol radation of haemoglobin), or the action of O
•–
on
2
consumption, potentially raising the contribution of iron-containing proteins such as aconitase222 and fer-
CYPs to O •– generation.239 NADPH oxidases in the ritin (Section 3.22.4.2). In heart, another source could
2
heart probably also play a role.240 They are normally bemyoglobin.ExposureofmyoglobintoexcessH O
2 2
presenttohelpregulatecardiacfunction(e.g.Fig.5.4), causesliberationofhaemandironions.245Myoglobin–
but if over-activated they can produce too much O
•–
H O mixturesalsoexertpro-oxidanteffectsbyferryl
2 2 2
andcauseproblems. formation (Section 3.22.3). Indeed, MI patients with
Sterile inflammation is another source of ROS. elevatedlevelsofplasma‘catalytic’iron,asmeasured
Neutrophils play little role in the arrhythmias and bythebleomycinassay(Section5.3.3),showedaworse
stunning seen after brief ischaemia followed by prognosis.246

--- Page 600 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 545
10.6.4.5 Nitricoxide:goodorbad?247 that mitochondrially targeted ‘antioxidants’ such as
TheroleofNO•andONOO–inischaemia–reperfusion SS31mightbeusefultotreatheartfailure,255butthese
injuryisunclear.ManypapersimplythatNO•isgood agentsmayactbymechanismsotherthanantioxidant
action(Section11.5.12).
(hencetheuseofnitrovasodilators;Table2.9),yetsev-
eralsaythatitisbad.Nitricoxidewillincreaseblood
flow,scavengeO
•–(helpfulonlyaslongastheONOO–
2 10.6.4.7 Clinicalrelevance
producedcanberemoved),deterneutrophiladherence
toendothelium,removeferrylmyoglobinbyreacting Sinceoxidativestressisinvolvedinthecommonrisk
with it, and deter platelet aggregation. Nitric oxide factors for coronary heart disease (diabetes, hyper-
playsaroleinpreconditioning(Section10.6.6).Bycon- tension, cigarette smoking, obesity, hypercholesterol-
trast,ONOOHcaninactivateCa2+pumpsintheheart, aemia), it is not surprising to find that patients with
impairingcontractility,andincreasedproteinnitration heartdiseaseshowelevatedF 2 -IsoPlevels.256 Indeed,
hasbeenobservedinfailinghumanhearts248andafter elevated levels of F 2 -IsoPs seem to be both an indi-
ischaemia–reperfusion in some animal studies. Nitric cator and a risk factor for coronary heart disease.85
oxide competes with O for binding to cytochrome SeveralstudiessuggestthatplasmalevelsofMPOor
2
oxidase,andsocouldfurtherdiminishmitochondrial of oxidative damage biomarkers such as 8OHdG, F 2 -
ATPproductionwhenO levelsarelowinischaemic IsoPs,oroxLDLpredictpooroutcomeinpatientswith
2
tissues.249 Ofcourse,lowO mightalsodecreaseNOS chronic heart disease. Do note that several of these
2
activity, as it is O -dependent. Nevertheless, nitrated studieshaveusedantibody-basedtechniquestomeas-
2
lipidshavebeensuggestedtobecardioprotective.250 ure the biomarkers. The validity of these methods is
not always clear; read the methodology section care-
fully when evaluating the paper (Sections 6.14.3 and
10.6.4.6 Heartfailure 6.15.6).However,othershaveusedrobustmethods.85
Chronichighbloodpressure,other‘overloadstresses’ The protective effects of antioxidants against
or attempted ‘adaptations’ of the heart to impaired ischaemia–reperfusion in isolated hearts and various
function after a MI can lead to hypertrophy of the animal models cannot be doubted, although their
ventricles and sometimes eventual heart failure. Sev- abilitytoinfluenceinfarctsizeafterprolongedischae-
eralpapers(includingsomehumanstudies)240suggest miaisdebatable.However,aretheseeffectsclinically
thatexcessROSproduction(frommitochondria,NOS, relevant? In many human myocardial infarctions,
and NADPH oxidase enzymes, especially NOX2 and occlusion of a coronary artery may be maintained
4, the major NOX enzymes found in the heart) con- for so long that ischaemic injury is the sole cause of
tributestotheabnormalremodellingoftheventricular tissue death; reoxygenation injury being irrelevant
wall.36,251MechanismsbywhichROSachievethiscan (exceptwhenreleasedtoxinscausesystemicdamage).
includestimulatingproliferationofcardiacfibroblasts However, the early use of agents (such as strepto-
(Section5.2.1),activationofmatrixmetalloproteinases kinase or tissue plasminogen activator) to dissolve
(Table 8.2),252 and oxidative damage to proteins in- thrombiiscommonplace,andthrombolysissometimes
volvedinthecontractilemechanism.Bycontrast,more occurs spontaneously. Several (but not all) studies
modest levels of ROS play valuable roles in the car- have shown that thrombolysis in humans is accom-
diac remodelling and angiogenesis that occur in sur- paniedbyincreasedoxidativedamage,e.g.aselevated
vivors of myocardial infarction. The literature on the plasma F -IsoP levels.243,256–258 Combined use of an
2
roleofNADPHoxidasesintheheartisconfusedand antioxidant and a thrombolytic agent might thus be
confusing, especially on whether NOX4 is a goodie predicted to give enhanced benefit. However, results
or a baddie. Indeed, normal cardiac function (Fig. ofclinicaltrialsusinghumanrecombinantCuZnSOD,
5.4), the differentiation of myocytes from stem cells N-acetylcysteine,allopurinol,ordesferrioxaminehave
and their normal growth and development, require beengenerallyinconclusive,althoughthereislimited
ROS.251 In addition, the beneficial effects of exercise evidence of modest benefit with allopurinol, which
on the heart may involve ROS production leading may also have a degree of benefit in treating heart
to Nrf2 activation and a rise in antioxidant defences failure,236,257–259 presumably because failing hearts
(Section 7.14).253 Similarly, aldehydes such as HNE containsomeXO.236 Thrombolysisisgenerallyaslow
generated by lipid peroxidation during ischaemia– process,ratherthananabruptreoxygenation,perhaps
reperfusioninheartcancausedamage,butalsoleadto mitigating ROS formation. Indeed, less damage is
cytoprotection.254Someanimalstudieshavesuggested seen if cardiac reperfusion is carried out for several

--- Page 601 ---

546 FREE RADICALS IN BIOLOGY AND MEDICINE
brief periods before full reperfusion; this has been Probucolmightbeexertingantioxidanteffects,butits
calledpost-conditioning.260 other actions in raising HO-1 levels and promoting
repair of damage to the endothelium seem more im-
10.6.4.8 Cardiopulmonarybypass portant(Section10.3.7).73Restenosisisassociatedwith
Inopen-heartsurgery,patientsareoftenplaced‘onby- increasesinNADPHoxidaseactivity,andconsequent
pass’,thebloodbeingdivertedfromtheheartthrough production of O
•–,
in the vessel wall, especially in
2
anoxygenationsystem.Prolongeduseofoxygenators smoothmusclecellsandfibroblasts.HenceO
•–islikely
2
can lead to damage to erythrocytes, a fall in plasma tocontributetotheirproliferation(Section5.2.1).270In-
ascorbatelevels(withincreasedascorbatefreeradical deed, NADPH oxidase inhibitors have been reported
formation),261 complement activation, phagocyte ad- to decrease restenosis in animal models, as did gene
herencetoendothelium,andreleaseof‘catalytic’iron therapy to raise EC-SOD levels in the vessel walls,
and copper ions,262,263 potentially causing increases and stents that release NO• are being explored.226,270
in oxidative damage that have indeed been reported Thecontributionoflipidperoxidationtorestenosisis
in some (but not all)264 studies. Indeed, desferriox- uncertain;forexample,inrabbits,coenzymeQsupple-
amine administration immediately after anaesthesia mentationdecreasedlipidoxidationbutdidnotdelay
improvedcardiacfunctioninahumanstudy.265These restenosisafterballoon-injuryoftheaorta.271
problemscanbeespeciallysignificantinbabies,since An alternative treatment for coronary atheroscler-
theirplasmatransferrinsaturationtendstobegreater osis is bypass grafting. Again, accelerated athero-
thanadults(Section7.11.8.4).Thereisnowanincreas- sclerosis/fibrosis can occur in the grafted vessels,
ingtendency,whenpossible,toperformsurgeryonthe thought to involve increased activities of NADPH
beatingheart(‘offpump’),inanattempttominimize oxidase.272 Endothelial injury, perhaps caused by
suchproblems.262 mechanical damage and hypoxia (e.g. during the
preparation and placement of the vessel), followed
by reoxygenation, might contribute.273 Some short-
10.6.5 Angioplasty,restenosis,andbypass
termanimalstudieshavesuggestedthatantioxidants
grafting
(e.g. desferrioxamine–manganese and lazaroids; Sec-
Another relevant area is the reopening of partially tion11.5.8)mightexertprotectiveeffects.274,275
atherosclerosedarteriesbyangioplasty.Inballoonan-
gioplasty, a coronary artery is completely occluded 10.6.6 Ischaemicpreconditioning223,276–278
when the balloon is inflated to ‘squash’ the athero-
scleroticlesions.Abruptreperfusionoccursuponbal- Short periods (a few minutes) of myocardial ischae-
loondeflation,whenbloodflowsthroughthe‘cleared’ miacanproducetissuechangesthatresultindecreased
artery. Usually the short duration of the occlusion sensitivity to a subsequent ischaemic event, perhaps
(1–2min)precludessignificantreoxygenationinjuryto analogous to a ‘vaccination’ against more extensive
the heart, although elevations in blood F -IsoP levels insult.Similarphenomenaareseeninothertissues,in-
2
mayoccurinpatients,andsomestudiessuggestthat cludingbrain,retina,gut,muscle,andskin.Thereare
allopurinoladministrationdecreasesthis.266 Coronary two phases of protection: a transient one that occurs
artery constriction, attenuated by SOD administra- withinminutesbutdisappearswithinhours,andade-
tion,wasobservedindogsafterballoonangioplasty.267 layed phase that takes hours to appear but can then
Presumably, excess O
•–
generation resulting from re- last for days. For example, if dog hearts are precon-
2
oxygenation of the vascular endothelium transiently ditioned by several 5-min periods of coronary artery
decreasednetNO• production.The‘squashing’ofthe occlusion, a subsequent 40-min reocclusion results in
atherosclerotic lesions may liberate transition metal infarctsupto75%smallerthanincontrols.Theeffects
ionsandoxLDLintothecirculation.268 ofpreconditioningcanalsobeobservedagainststun-
A more important problem is the high incidence ningandarrhythmias,andmayhaveclinicalrelevance
(>50%ofcases)ofrestenosisafterangioplasty.269 This inanginapectoris(Section10.6.4.1).Inthisdisease,ex-
involves endothelial damage caused by the balloon, ercisecancausetheheart’sO 2 requirementstoexceed
andbyanystentsplacedtokeepthevesselopen,lead- itsbloodsupply,causingacutechestpain,yetthisre-
ing to excessive proliferation of smooth muscle cells petitive brief ischaemia may, paradoxically, decrease
andfibroblasts.Highdosesofprobucoldecreasethese- thepatient’sriskofinfarction.
verityofrestenosissomewhatinanimals,269 although Themechanismofpreconditioningisintensivelyde-
its benefit to patients is uncertain (Fig. 10.6, legend). bated and not well understood. Adenosine released

--- Page 602 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 547
fromischaemicmyocytesisinvolved(Fig.10.12)inthe several mechanisms, including actions on adenosine
earlyphase.Itbindstoreceptors,stimulatesphospho- receptors, increasing NO• production, and causing
lipase activity, raises DAG levels, activates protein ROS-dependent PKC activation.285 Some anaesthet-
kinaseC(Section5.5.4),andpromotesitstranslocation ics, such as sevoflurane, isoflurane (Section 9.3), and
to the plasma membrane. During subsequent ischae- propofol(Section11.5.7)arecardioprotectiveinanimal
mia,thePKCalreadyonthemembranecanberapidly studies. ROS and RNS have been implicated, seem-
activatedbyDAG.PKCactivationiscardioprotective ingly again in part by effects on the ATP-dependent
byseveralmechanisms.Forexample,itleadstophos- K+ channels.286 Indeed, the mitochondrially targeted
phorylation and activation of ATP-sensitive K+ chan- ‘antioxidant’mitotempol(Section11.5.12) couldabol-
nels in plasma membrane and mitochondria, which ishmyocardialpreconditioningbyisofluraneinrats.287
seems to exert tissue-protective effects. For example, Carbon monoxide (at the right level!) can promote
ithasbeensuggestedthatopeningofamitochondrial preconditioning(Section10.6.9).
inner membrane ATP-dependent K+ channel, which Recently,theconceptofremotepreconditioninghas
allows K+ to enter the matrix, increases mitochon- been developed; brief ischaemic injury to one organ
drial ROS production and triggers signalling path- can lead to increased resistance of another part of
ways, leading to cardioprotection.279 ROS themselves thesameorgan,orevenadifferentorgan.Thusbrief
mayalsohelptoopenthechannel.OncethePKChas ischaemia of arm or leg muscles has been reported
leftthemembraneandgonebacktoitsnormallocation, to raise the tolerance of the heart to more exten-
theprotectiveeffectdisappears.Otherkinasesarealso siveischaemia–reperfusionsubsequently.278,288 Natur-
involved. Reactive species produced during reperfu- ally,thereisconsiderableclinicalinterestintheconcept
sioncanactivatePKCandotherkinases(Section5.5.4), (e.g.forcardiacprotectionbeforecardiacsurgery)since
and, in cases where this is important, the precon- arms and legs are easily accessible. How remote pre-
ditioning is abolished by antioxidants.280 Ischaemic conditioning is supposed to work is unknown, but
preconditioning may also involve intermittent brief releaseofmediatorssuchasadenosinefromthemuscle
MPT pore openings, leading to elevated O •–/H O maybeinvolved.238,288
2 2 2
production.237 Increased NO• production may also
help, e.g. by leading to S-nitrosylation, which transi-
ently protects –SH groups on key mitochondrial pro-
10.6.7 Shock-andsepsis-related
teins (especially in complex I) against damage by ex-
ischaemia–reoxygenation
cess ROS during subsequent ischemia–reperfusion.281
Indeed, mitochondrially targeted NO• donors (e.g. Severebleedingcausesarapidfallinbloodpressure.
mitoSNO; Section 11.5.12) have proved to be pro- Thisplacesmanytissuesatrisk,sinceitresultsinhypo-
tective in some animal studies of cardiac reperfusion perfusionwithblood.Whenbloodvolumeisrestored,
injury.281,282 a ‘shock’ syndrome (haemorrhagic shock) can result,
Delayed preconditioning involves changes in gene to which reperfusion injury and other sources of RS
expressionandproteinsynthesis,includingHO-1,an- (e.g.activatedphagocytes)cancontribute.289Stomach,
tioxidantdefence enzymes such as MnSOD, and also brain,intestine,kidney,andpancreasareamongtheor-
Hsps and (in some animals) COX-1. In addition, in- gansthatcanbeaffected,and,asalreadycommented,
creasedferritinsynthesis,triggeredbyariseinlabile intestinaldamagecanallowbacteriaandendotoxinto
iron in the preconditioning phase, may help to pro- enter the body and promote inflammation, which is
tect by binding iron ions released during subsequent furtheraggravatedbythereleaseofDAMPsfromdam-
insults,283aneventalsoseenintheeye(Section10.6.8). agedtissues.ROSplayimportantrolesintheseevents,
Nitricoxide(fromeNOSand,inpart,producedbyin- sincepretreatmentofanimalswithallopurinol,lipoic
creased expression of the gene encoding iNOS) and acid,orSODbeforehaemorrhagicshockhasbeenre-
other ROS, help to mediate these changes by activat- ported to minimize damage to various tissues.290,291
ingtranscriptionfactors,probablyagainviaactivation Administrationofallopurinolanddesferrioxaminein-
of PKC and other kinases,282 Myocardial ischaemia– creased survival in dogs subjected to severe haemor-
reperfusiondecreasesproteasomeactivity,andprecon- rhagicshock,thelattersuggestiveofaroleforironion
ditioningcanhelptopreserveit,tofacilitateremoval release,aneventthathasindeedbeendemonstratedin
ofdamagedproteinsthatcanimpaircontractility.284 someanimalstudies.291,292
Pre-exposure to ethanol can also protect the Shock can also be induced after substantial tissue
heart and intestine against ischaemia–reperfusion by injury e.g. in severe crush injury or extensive burns

--- Page 603 ---

548 FREE RADICALS IN BIOLOGY AND MEDICINE
(Section 7.13.3), and it can result from sepsis. Sepsis whether correcting this would be beneficial or not is
is a progressive and dysregulated inflammatory re- uncertain.9–11 Nevertheless, there is growing interest
sponse to overwhelming infection, associated with in the use of mitochondrially targeted antioxidants
impairedorganperfusionandmultipleorgandysfunc- (Section11.5.12)insepsis.303
tion. Sepsis is often said (although this is somewhat
ofanoversimplification)toconsistoftwophases;sys- 10.6.7.1 Aneurysm
temicinflammatoryresponsesyndrome(SIRS;Section
Onecauseofhaemorrhagicshockistheruptureofaor-
10.6.1),followedbyacompensatoryanti-inflammatory
ticaneurysms,causingmassivebleeding.Aneurysms
response syndrome (CARS) that facilitates growth of
inthebrainmayalsoruptureandleadtohaemorrhagic
the infecting organisms. In other words, both exces-
stroke(Section10.18.3).Aneurysmsarisebystructural
sive and insufficient inflammatory response occur in
deterioration of the blood vessel wall, leading to its
sepsis.293Haemolysisandreleaseofhaemoglobinmay
dilationtoforma‘ballooningout’.Akeyfactoristhe
contributetothepathologyofsepsis.294 Septicshock
excess activity of matrix metalloproteinases (MMPs;
(severe sepsis plus hypotension) leads to inadequate
Table 8.2), linked to inflammation of the vessel wall,
perfusion of many organs. Endothelial permeability
andithasbeensuggestedthatROSgeneratedbysev-
increases, resulting in plasma extravasation and oe-
dema.ThereismarkedoverproductionofO
•–insepsis eralmechanisms,especiallyNADPHoxidases,304 play
2 aroleintheincreasedMMPactivity.Forexample,the
(from activated phagocytes, other NADPH oxidases,
mitochondria,andpossiblyXO)andofNO•,largelyin- ‘antioxidant’edaravone(Section11.5.8),orknockoutof
p47phox,decreasedthesizeofcerebralaneurysmsina
volving increased iNOS expression in various organs
mousemodel.305TheMMPsgraduallydegradeelastin
in response to cytokines. Hence ONOO– production
andcollageninthevesselwall,soweakeningit.306
also occurs and scavengers of this species have been
reported as protective in several animal models of
sepsis.295 Mitochondrial ATP production is impaired,
inpartbytheinhibitoryeffectsofNO•oncytochrome 10.6.8 Theeye
oxidase. Plasma levels of F 2 -IsoPs and isofurans in TheretinarequiresasubstantialO 2 supply(aidedby
septic patients are elevated, and the former were thepresenceofneuroglobin;Section7.10)andisvery
higher in patients who later developed liver or kid- sensitivetoO deprivation.Itcanbecomehypoxicas
2
neyfailure.296Oxidativeinactivationofproteinkinase a resultof atherosclerosisof ocular bloodvessels(es-
G (Section 5.5.2) during sepsis may contribute to the peciallyindiabetes),maculardegeneration,traumatic
hypotension.297 damage to the retinal pigment epithelium, vascular
Treatment of septic shock includes antibiotics and occlusion by sickled red blood cells in patients with
administration of adrenalin or noradrenalin to main- sickle-cell anaemia, and in retinopathy of prematur-
tain blood pressure. However, response to these cat- ity(Section1.5.2.1).Risesinintra-ocularpressure(e.g.
echolaminesisoftenlimited,andithasbeensuggested inglaucoma)canalsodecreasebloodflowandcause
that this is due to their oxidation295,298 by O • 2 – or oxidative damage (Fig. 7.18). In animals, it has been
ONOOH.MimeticsofSOD(Section11.5.4),SODitself, shown that reperfusion of ischaemic retina leads to
and several other antioxidants, including ascorbate,10 ROSproduction;forexample,OH•wasidentified307by
have been tested in animal models of sepsis, where the salicylate method (Section 6.3.1). Increased levels
theyareoftenprotective.295Sadly,thosetestedinsepsis of MnSOD were protective against the damage done
patients have given variable but generally unimpres- by elevated intra-ocular pressure followed by reper-
siveresults;298theymightworkbestinthemostsevere fusion in a rat model, and mice lacking NOX2 also
cases(wheredeleteriouseffectsofROSoutweighbene- showed less damage,308,309 suggesting that ROS from
ficial ones).299,300 One reason for the difference in ef- NADPH oxidases contribute to the injury and that
fectivenessmaybethatrodentshavebeenreportedto these enzymes could be possible targets to treat
respondtosevereinjuryinawayverydifferentfrom glaucoma.
humans, as judged by changes in gene transcription, Brief periods of ischaemia can produce precondi-
i.e.theyareapoormodelforhumans.301Theseconclu- tioningintheretina,renderingitabletobettertolerate
sionshavebeenchallenged,302butoneshouldalsonote more prolonged subsequent ischaemia–reperfusion.
thatlaboratoryanimalsaregenerallymoreresponsive Onefactorinvolvedinpreconditioningofratretinais
to antioxidants than are humans (Chapter 4). Sep- increasedferritinlevel,triggeredbyarisein‘catalytic’
ticpatientsshowsub-normalplasmaascorbatelevels; iron.310

--- Page 604 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 549
10.6.9 Chemicalischaemia–reperfusion:carbon However, severe and prolonged chilling of tissues
monoxidepoisoning can lead to hypoxia, and rewarming may create a
reoxygenation injury. Freezing and thawing is well
Carbonmonoxide,CO,isacolourless,odourless,taste-
knowntobiomedical(e.g.insperm;Section7.11)and
less gas produced by incomplete combustion of car-
foodscientists316asincreasingoxidativedamage.Thus,
bonorcarbon-containingmaterials.Itoccursinwood
ithasbeenhypothesizedthatRScontributetofrostbite
smoke,carexhausts,pollutedair,andcigarettesmoke
injury,althoughlittleevidencehasbeenprovidedfrom
(Section 9.13), and is generated in vivo by haem oxy-
the few studies conducted to date that antioxidants
genase (Section 3.24) and as a minor end-product of
suchasSODwouldbeprotectiveinhumans.317 Cold
lipidperoxidation(Section5.11.7).
exposureofcellscanincreasethesizeoftheirlabileiron
LowlevelsofCOareusefulinvivo(Section3.24)and
pools,sometimesfacilitatingoxidativedamage.318
appear to contribute to the ability of HO-1 to protect
Several organisms can tolerate freezing. For ex-
tissues against ischaemia–reperfusion. Indeed, vari-
ample, the North American red-sided garter snake
ous CO-releasing molecules (CO-RMs) have been
Thamnophis sirtalis parietalis can be frozen for several
synthesized for potential therapeutic use.311 For ex- hours at –2.5 ◦C, with about 50% of the body water
ample, exposure of mice to CO-RM-3, tricarbonyl-
as ice. It can also endure ischaemia (under N gas)
2
chloro(glycinato)ruthenium(II), produced a ‘late pre-
for up to two days. One survival strategy may be a
conditioning’effectintheheartinvolvingincreasesin
rapid increase in antioxidant defences at the onset of
thelevelsofcardioprotectiveenzymessuchasMnSOD,
freezing or anoxia.319 A related strategy seems to be
HO-1,andEC-SOD.312
used by the ground squirrel Citellus citellus, in which
However,highCOlevelsarepoisonous.Toxicityof
anincreaseintissueantioxidantdefencesisobserved
COlargelyresultsfromitsavidbindingtohaempro-
just before the onset of hibernation, presumably to
teins, especially haemoglobin. It out-competes O for
2 minimizeoxidativestressonreawakening.320
bindingbyafactorofabout220,andtheresultingcarb-
Manybiomedicalscientistsstudybiopsiesofvarious
oxyhaemoglobin dissociates only slowly. Coma can
humantissues,lookingforpatternsofgeneexpression
occur at carboxyhaemoglobin levels of >40% (levels
andotherevents.Whatisoftennotappreciatedisthat
in healthy non-smoking subjects are usually ≤ 0.7%)
thetissuesamplemaybecomehypoxic.Ifnotimmedi-
and lower levels can adversely affect organs that are
atelychilledorfrozen,itwillsufferwarmischaemia.
especiallysensitivetohypoxia,suchasthebrain.Cyto-
When it is chilled or frozen, cold ischaemia/freezing
chrome oxidase can also be inhibited and mitochon-
damagecanoccur.Alloftheseproducemajorchanges
drial ROS production from the ‘backed up’ electron
ingeneexpression.321
transportchainisincreased.
Treatment of CO poisoning is to remove the pa-
tientfromtheCOsourceandadministerpure(oreven 10.6.11 Sleepapnoea
hyperbaric) O . It is thus likely that tissue hypoxia–
2 Many humans suffer from this problem; their air-
reoxygenation occurs. Patients often appear to re-
ways become obstructed during sleep, creating hyp-
cover from CO poisoning only to display delayed
oxiathatthen(hopefully!)wakesthemup,whereupon
neurologicaleffects,towhichRSmightcontribute.In-
deed,increasedproductionofRS(includingOH• and normal breathing resumes and pO 2 rises (reoxygen-
ation). Their problems include not only fatigue due
ONOO–)andlipidperoxidationhavebeenreportedin
to interrupted sleep (which can lead to a low-level
thebrainsofanimalsafterCOexposure.313,314
chronicinflammatorystate),butalsoanincreasedrisk
of hypertension, myocardial infarction, and neuronal
death in the brain. ROS may be involved in these
10.6.10 Coldandfreezinginjury:theenigma
sequelae, for example by increases in the activity of
ofbiopsies
NADPH oxidases.322 Factors predisposing to apnoea
Cold-inducedvasoconstrictionintheskinisanimport- include hypertension and obesity, which can them-
antmechanismtoreduceheatloss—lowtemperature selvescauseoxidativestress.However,urinaryF -IsoP
2
enhancestheresponseofreceptorsonsmoothmuscle levelswereelevatedinsleepapnoeapatientswhowere
cellstonoradrenalin,facilitatingbloodvesselcontrac- not obese,323 consistent with the view that apnoea it-
tion. Increased mitochondrial generation of ROS has self can raise oxidative damage levels. In addition,
beensuggestedtobeinvolvedinthesignallingpath- the levels of some biomarkers of oxidative damage,
waysthatincreasereceptorsensitivity.315 including MDA and dityrosine, increase during the

--- Page 605 ---

550 FREE RADICALS IN BIOLOGY AND MEDICINE
apnoea period.324 Hypoxia due to living at high alti- 10.7.2 Kidney
tudes has also been suggested to increase oxidative
Human kidneys can only tolerate ischaemia for up
damage (e.g. as elevated urinary 8OHdG excretion),
particularlyduringexercise.325 to about 30 minutes; their function can thus be eas-
ily compromised, e.g. during septic or haemorrhagic
shock.Severalgroupshavereportedthatpretreatment
10.7 Organpreservation, ofwholeanimalsorisolatedkidneyswithSOD,cata-
lase, allopurinol, or desferrioxamine decreases reper-
transplantation,andreattachment
fusion injury after transplantation. Rodent kidney
ofseveredtissues278
contains XDH, although its irreversible (proteolytic)
conversion to XO in ischaemic tissues occurs only
10.7.1 Heart
slowly.331 There is much less XO in dog or human
The preservation of organs for transplantation, and kidney.264,332HencethemodelinFig.10.12isunlikely
the transplant surgery itself, can involve reperfusion toaccountforreperfusioninjuryinkidney.ROSfrom
injury. One aspect is cold hypoxia, the organ be- other sources are thus likely to be important, includ-
coming hypoxic when stored at low temperature in ingNADPHoxidasesandmitochondria;indeedmitoQ
a preservation fluid. Metabolism (and O 2 consump- (Section 11.5.12) delayed deterioration of pig kidneys
tion) are decreased at low temperature, but hypoxia duringcoldstorage.333
will still eventually occur. Another aspect is warm Intransplantedhumankidneysthathadbeensub-
hypoxia. This occurs both when the organ is inside jected to 25–28 h of cold storage, SOD infusion into
the body of the donor after death, and later when it the renal artery at implantation produced significant
is in the recipient after transplant, warming up but improvement in short-term renal function; the differ-
unperfused as its blood vessel connections are being encewaslessmarkedwithstoragetimesbelow25h.334
made. Once perfusion is established, any injured or Similar data have been published using allopurinol.
deadcellsinthetransplantedorgancanreleasetoxins, However,theclinicalimpactofsuchtherapyonrenal
such as XO or DAMPs, into the circulation, trigger- transplant surgery has been minor; the priority is
ing inflammation. In addition, the body may mount to obtain the freshest kidneys possible and improve
aninflammatory/immuneattackupontheorgan.Ifse- the preservation fluids, which often already contain
vere, this can cause eventual rejection, a process to allopurinol (Section 10.7.5). Interesting models per-
whichphagocyte-derivedRSmaycontribute.Indeed, hapsworthfurtherstudytoelucidatenovelprotective
onestudysuggestedthatthelevelofalkanesinexhaled mechanismsincludetheringedseal,Phocahispida.Dur-
air,abiomarkeroflipidperoxidation(Section6.15.9), ingprolongeddiving,bloodflowisredistributedtothe
can be used to identify patients rejecting their heart heartandnervoussystem,andthekidneyisseverely
transplants.326 vasoconstricted. The seal kidney, both in vivo and as
Newly transplanted hearts may suffer atheroscler- anisolatedorgan,ismuchmoretolerantofischaemia–
osisofthecoronaryvessels,aprocesstowhichthehost reperfusionthanotheranimalkidneys.Spermwhales
inflammatory–immune response contributes.327 One andsouthernelephantsealscanalsospendhoursun-
study of 40 patients indicated that supplementation derwater.Eventhehumblegoldfish(Carassiusauratus)
with500mgvitaminCplus400unitsofα-tocopherol is remarkably tolerantto anoxia.335 Whether elevated
for one year decreased atherosclerosis in heart trans- antioxidant defences account for the lack of damage
plantrecipients,butthiswasasmallstudythatneeds byhypoxiaintheseanimalsremainstobeestablished;
confirmation.328 Increasing the levels of CuZnSOD someevidencesuggestsyes.336
or HO-1 (e.g. by haemin treatment) in transplanted Transplantedkidneys(likealltransplantedorgans)
hearts decreased atherosclerosis and rejection in ani- arefrequentlyattackedbythehostimmunesystem327
mals;COaccountsforatleastpartoftheprotectiveef- and the RS so produced might contribute to trans-
fectofHO-1,e.g.bypromotingvasodilation,deterring plant rejection, e.g. by facilitating organ fibrosis. In-
phagocyte infiltration and decreasing thrombosis.329 deed,enhancedimmunostainingfornitrotyrosinehas
Carbonmonoxidemightalsobeusedtoprecondition beenmeasuredin‘rejected’humankidneytransplants.
the organ before transplant (Section 10.6.9). In add- OneofthenitratedtargetsisMnSOD.337 Exposureof
ition,bilirubinmightcontributetotheprotection.For thisenzymetoONOO– inactivatesit(Section2.6.1.1).
example,inratsgivenbilirubinorbiliverdintherewas Is this an early or late event? It’s hard to tell in
lessrestenosisafterballooninjury.330 humans, but in a rat model, increased amounts of

--- Page 606 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 551
mitochondrialnitratedMnSODwereobservedpriorto respond to DAMPs arising from cell death in the
renaldysfunction.337 ischemicliver,producingROSandcytokinesthathelp
Patientsawaitingkidneytransplantsaremaintained toattractneutrophils.RaisingthelevelsofMnSODin
bydialysis,aprocessthatitselfcausesoxidativestress mouselivermitochondriadecreasedbothliverdamage
andinflammation(Sections8.9.4and10.3.9)andpre- and the extent of activation of AP1 and NF-κB after
disposes to atherosclerosis. Renal damage can also hypoxia–reoxygenation, indicative of a role for mito-
resultfromrhabdomyolysis,involvingthepro-oxidant chondrial O •–/H O .349 Indeed, mitochondrially tar-
2 2 2
actionsofmyoglobin(Section3.22.3).Releaseof‘labile getedantioxidantssuchasmitoQ(Section11.5.12)have
iron’andhaemproteinsduringopenheartsurgerycan shown protective effects in mouse models of hepatic
alsosometimescauserenaldysfunction(acutekidney ischaemia–reperfusion.350
injury, AKI).262,338 Cis-platin, used in cancer chemo- TheroleofKupffercellscanbeinvestigatedbykill-
therapy,canalsodamagekidneybypromotingironion ingthemusinggadoliniumchloride,GdC1 ,although
3
releasethere.339 one must be cautious because this agent can exert
Likemanyorgans,kidneycanbepreconditionedby hepatoprotectiveeffectsbyothermechanisms,suchas
brief periods of ischaemia. This process can involve decreasingCYPlevels.351Endothelialcelldamageand
ROS and be interfered with by antioxidants, in some glycocalyx degradation (which can produce hyalur-
animalmodels.340 onicacidfragments,actingasDAMPs;Section8.7.1)217
at early stages of liver reoxygenation may involve
activation of Kupffer cells, whereas neutrophils may
10.7.3 Liverandpancreas341
contribute to later damage. Transplanted livers usu-
Liver ischemia can occur in septic or haemorrhagic allycomefromaccidentvictims,whohavesometimes
shockandalsoduringlivertransplantation(bothcold beendrinkingheavily,andsotheirfunctionmightbe
and warm hypoxia). During cold preservation, liver compromised by ethanol e.g. causing hepatic fat ac-
endothelialcellsandhepatocytescanbesensitizedto cumulation and high CYP2E1 levels (Section 9.8.1).
injurybyseveralmechanisms,includingrisesintheir Likemostorgans,livercanbepreconditionedbybrief
lowmolecularmassironpool(Section10.6.10),acceler- periodsofischaemia.ROSand‘catalytic’ironaidthis
atingdamagebyanyROSgeneratedafterthenewliver process.318,341,352
is perfused. For example, human liver transplant re- Pancreaticischaemia–reperfusioninjuryandthefail-
cipientshavebeenreportedtoexhalemoreethane(Sec- ureofpancreatictransplantsarealsoareaswhereROS
tion6.15.9)atthetimeoforganreperfusion342andliver seem to be involved,353 but more work is needed to
GSH levels drop rapidly at that time.343 Patients also establishtheirimportance.
showedincreasedurinaryF -IsoPexcretion.344Plasma
2
F -IsoPlevelswerealsoapredictorofliverorkidney
2 10.7.4 Limbs,digits,andsexorgans
failure in septic patients.296 Indeed, N-acetylcysteine
has been clinically tested as an agent to minimize Limb ischaemia can result from severe atheroscler-
hepaticischaemia–reperfusion,butreportedprotective osis,especiallyindiabeticswithpoorcontrolofblood
effectsaremodestatbest.341 glucose,whoshowacceleratedatherosclerosisandim-
Liver contains XDH, but this is only slowly con- paired development of collateral vessels. Thrombosis
vertedtoXOduringischaemia,althoughbothenzymes makesitworse.Inbadcases,gangreneoftheextrem-
(as well as ‘catalytic’ metal ions)345 can be released itiescandevelop.Narrowingoflegarteriescancause
into the blood from injured liver and contribute to intermittentclaudication;sufficientbloodreachesthe
extra-hepatic damage. In human liver, XDH is pre- muscles at rest, but exercise leads to ischaemia and
sentinhepatocytesandbileductepithelialcells,where severemusclepaininthecalves.Limbischaemiacan
it concentrates at the luminal surface. Indeed, the alsoresultfromarterialinjuryresultinginrapidblood
enzyme may be excreted into bile.346 Other sources loss, and (to a controlled extent) in the use of tour-
of oxidative stress in reperfused livers include dam- niquets to provide a ‘bloodless field’ for orthopaedic
aged mitochondria releasing more O
•–,
recruitment surgery.Modernsurgicaltechniquesforreattachment
2
and activation of neutrophils, O
•–/H
O production of severed digits, limbs, and even penises can result
2 2 2
from cytochromes P450, and activation of Kupffer in the reoxygenation of tissue that has been hypoxic
cells.347,348 Kupffer cells are strategically located in forhours.Prolongederectioncanalsocausepenileis-
the liver to intercept bacteria and bacterial products chaemia, and oxidative damage upon reperfusion.354
(PAMPs) from the portal blood. In addition, they Conversely, oxidative stress has been speculated to

--- Page 607 ---

552 FREE RADICALS IN BIOLOGY AND MEDICINE
be involved in erectile dysfunction (ED),355 which is show elevated oxidative damage, e.g. as elevated
likely to be the case, since ED is often consequential urinary 8OHdG and F -IsoP levels.365,366 Skin fibro-
2
todiabetesandatherosclerosis. blasts from scleroderma patients showed increased
Skeletal muscle is more resistant to ischaemic in- NADPH oxidase activity and released more O
•–
in
2
jury than most tissues, and ROS are involved in its culture,366 perhapsrelevanttotheirexcessiveprolifer-
normal function (Section 7.14). However, after some ationinvivo(Section5.2.1).However,theimportanceof
hoursofischaemia,anischaemia–reperfusioninjuryto ROSinsclerodermaremainstobeestablished;arethey
muscle can be demonstrated, and is greater in mice good,bad,orirrelevant?366,367Thesamequestionarises
lackingEC-SOD.356Forexample,experimentswithrat for the increased oxidative damage seen in Sjögren
hind limbs have demonstrated OH• formation dur- syndrome, an autoimmune disease mainly affecting
ing ischaemia–reperfusion using the technique of sa- thesalivaryandtearglands.368
licylate hydroxylation (Section 6.3.1), have observed
the presence of lipid-derived radicals that could be 10.7.5 Organpreservationfluids369,370
trappedbyPBNinbothmuscleandblood,andhave
shown some protective effects of SOD plus catalase As mentioned earlier, antioxidants are frequently ad-
against the injury.357 Levels of XO in pig or human ded to organ preservation fluids. Examples are man-
muscle are lower than in rat,358 although allopurinol nitol(althoughitsmajoractionmaybeasanosmotic
(possiblyactingbymechanismsotherthanXOinhib- agent that decreases cell swelling), GSH, and allo-
ition;Section10.6.4.3)wasclaimedsomeyearsagoto purinol. For example the widely used University of
be beneficial in decreasing lower limb swelling after Wisconsinpreservationfluidhasmillimolarlevelsof
legarterybypasssurgery.359Inpatientswithclaudica- addedGSH.However,bythetimethefluidisused,this
tion,OH•formationwasdemonstratedduringtherest islargelyorcompletelyoxidizedtoGSSG.345Thefluid
periodafterexercise(Table6.4andref360). alsocontainshighK+levels,1mMallopurinol,lactobi-
Limbs, digits, and penises are not just muscle of onicacid(aweakCa2+andironionchelator),5mMad-
course;thevascularendotheliumisfarmoresensitive enosine(whichmaysuppressphagocyteROSproduc-
todamagebyischaemia–reperfusionthanthemuscle. tion; Section 8.9.2), the trisaccharide sugar raffinose,
For example, 20 minutes of upper limb ischaemia in andhydroxyethylstarch.Thelasttwohelptodecrease
humanscausedendothelialdysfunction,aneffectde- cell swelling. Organs can be preserved for hours by
creasedinsubjectswithchronicgranulomatousdisease flushingwiththissolutionandstoringat0–5◦C.Some
(Table 8.3), indicative of a role for NOX2.361 Severe researchers have advocated supplementing this and
endothelial damage can lead to a ‘no reflow’ situ- otherorganpreservationfluidswithdesferrioxamine,
ationasneutrophilsadheretodamagedendothelium, otherthiols(e.g.bucillamine),PARP-1inhibitors,ora
or thrombosis occurs. Reperfusion of large areas of chimeric MnSOD that binds to vascular endothelium
damaged muscle (e.g. crushed legs) can cause sys- (Section 11.5.3), but none of these has found wide-
temic injury to which both complement activation spread use. Alternative preservation fluids include
and ROSappear tocontribute.Thelatter can involve Celsior, which also contains glutathione, lactobionic
release of XO, myoglobin (especially toxic to kid- acid,andmannitol,andHKT,histidine-tryptophan-α-
ney;Section3.22.3),andtransitionmetalionsintothe ketoglutarate;α-ketoglutaratemighthelptoscavenge
bloodstream.362 H O (Section3.25.2).
2 2
Dupuytrencontracture,adiseaseinwhichexcessive
fibrosiscausestendonsinthehandtoshortenabnor-
10.7.6 Otherexamples
mally and pull the fingers into a closed position, has
been suggested to involve ischaemia–reoxygenation. Oxidative damage may contribute to the death of is-
ElevatedlevelsofhypoxanthineandXOwerereported let cell grafts implanted to treat diabetes, (Section
inthepalmarfasciaandaroleforO •–inthecondition 10.5.1),150,371 ofneuronsinjectedintothebraintotreat
2
(by promoting fibroblast proliferation) has been pro- Parkinsondisease(Section10.20),ofstemcellsusedin
posedbutnotestablished.363Similarsuggestionshave attemptstorepairdamagedhearts,372andintherejec-
been made for Peyronie disease, excessive fibrosis tionofskingrafts.Forexample,therearereportsthat
withinthehumanpenisthatleadstocurvature,364and the ‘survival time’ of skin flaps (often used to repair
in scleroderma (often called systemic sclerosis, SSc), defectsresultingfromtraumaorsurgery)isincreased
anunpleasantdiseasecharacterizedbyfibrosisofthe by treatment with SOD, desferrioxamine, or allopur-
bloodvessels,skin,andorgans.Sclerodermapatients inol,orbyischaemicpreconditioning.373,374Indeed,we

--- Page 608 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 553
have already seen that stem cells need some ROS to Lungdamagecanalsoresultfromeventselsewhere
proliferateanddifferentiate,buttoomanyimpairtheir in the body, such as injury to the gut resulting in
function(Section3.4.2). sepsisandMODS(Section10.6.1).Indeed,ischaemia–
Whenvascularendotheliumisinjured,endothelial reperfusiondamagetotheliverofratsledtonitration
progenitor cells produced by the bone marrow mi- and inactivation of MnSOD in the lung.384 The acute
gratetothesiteofinjury,differentiateintoendothelial lung injury (ALI) associated with MODS varies from
cells, and help to repair the damage. Excessive ROS mild to very severe, the latter producing the acute
productioncanimpairtheirfunction.375 (sometimes called adult, although this term is less
popularnowbecausechildrencansufferthecondition)
respiratory distress syndrome (ARDS). ARDS is de-
10.8 Lungtransplants,shock, finedasseverehypoxiaresistanttoO 2 administration,
andARDS376,377 causedbypulmonaryoedemaresultingfromimpaired
alveolar-capillary barrier function. It can arise as a
In lung transplantation, ischaemia occurs during the complication of haemorrhagic shock, sepsis, bacterial
timetakentoremovelungsfromthedonor,theirpres- or viral pneumonia, severe pancreatitis, aspiration of
ervationfortransplantation,andtheperiodforwhich stomachcontentsintothelung,prolongedcardiopul-
they sit in the warm body of the recipient before be- monarybypass,orseveretrauma,suchasthatcaused
ing reperfused. Hence, addition of antioxidants (e.g. by burns and accidents. ARDS has a high morbidity
dimethylthiourea)tolungpreservationfluidshasbeen andmortality,leadingtodeathinupto40%ofcases.
advocated,andsupplyingcatalase(attachedtothead- Even today, mortality has decreased only modestly
hesionmoleculePECAM[Section8.7.3.1]toallowitto fromwhenARDSwasfirstdescribedin1967.
bindtopulmonaryendothelium)totheratlungdur- ARDSismarkedbyadramaticappearanceofneu-
ingcoldstoragewasreportedtodecreaseinjuryafter trophilsandneutrophil-derivedproductsinthelung,
transplantationandimprovegraftfunction.378Increas- involving increased levels of adhesion molecules on
ingthelevelsofHO-1alsoprotectsthelung,CObeing lung endothelial cells, production of cytokines by al-
acontributortotheprotectiveeffect.379 veolar macrophages, and other phagocytes, and acti-
Reperfusion of isolated animal lungs after ischae- vationofthecomplementsystem.Itiswidelyagreed
mialeadstoincreasedproductionofO •–andH O ,in (butnotnecessarilytrue)300thatRSfromactivatedpha-
2 2 2
partbyincreasedactivityofNADPHoxidaseenzymes gocytes are important mediators of the lung injury.
that normally generate some O •– in the lung for use- Indeed, the acute lung injury produced in rats after
2
fulpurposes(Fig.8.16).TheincreasedO •– production severe skin burns or injection of cobra-venom factor
2
depletesNO• andincreasesONOO– production.380 In (both causing complement activation and neutrophil
some animals, xanthine oxidase may be a source of infiltration into lung) can be minimized by treating
ROS, but its activity in human lung is low.381 Reoxy- the animals with SOD, catalase, desferrioxamine, or
genation injury can also occur when collapsed lungs apolactoferrin, and worsened by infusion of iron(III)
arere-expandedinvivo,andifpulmonaryvesselsare
salts,implyingthatiron-dependentformationofOH•
blockedbythrombithatthendissolve. is involved.385 Activated neutrophils produce HOCl
A major problem for transplanted human lungs is andsecreteelastase;lungelasticfibrescanbedegraded
inflammation,neutrophilinfiltration,infection,andfi- ifα 1 -antiproteinaseisinactivatedbyHOClorONOOH
brosis. Indeed, obliterative bronchiolitis, a fibropro- and these species can also damage surfactant. NETs
liferative disease that narrows the airways and com- formation(Section8.7.4.11)maycontributetothelung
promiseslungfunction,isamajorcauseoflong-term injury.
morbidityandmortalityafterlungtransplantation.Al- In ARDS, alveolar macrophages responding to
though it is likely to be an immune system-based DAMPsandPAMPsareanothersourceofRS,protein-
disease, iron accumulation and O •–/H O formation asessuchaselastase,andcytokines,promotingfurther
2 2 2
in the transplanted lung seem to play some role in neutrophil recruitment into the lung. Additional RS
its pathology.382 Lung transplant recipients were re- cancomefromlungmitochondriaandXO.Although,
ported to have low antioxidant (especially ascorbate) as mentioned earlier, normal human lung contains
levelsinserumandlungliningfluidsforatleastone little XO, circulating XO from other injured body tis-
year post-surgery;383 perhaps indicative of antioxid- sues can readily bind and remain within the lung.381
ant consumption by ongoing inflammation and RS Chronicalcoholabusepredisposeshumanstodevelop
production. ARDS upon injury; depletion of antioxidants such as

--- Page 609 ---

554 FREE RADICALS IN BIOLOGY AND MEDICINE
GSH and elevated ROS production from increased (sadly)demonstratedthatthiolsupplementationisof
activityofNADPHoxidaseseemtoplayarole.386 little benefit to most patients.214 In some studies (but
notothers),N-acetylcysteineadministrationappeared
to offer benefit in another condition affecting the
10.8.1 OxidativestressinARDS:doesitoccur
lung,idiopathicpulmonaryfibrosis(Section11.5.9.2).
anddoesitmatter?7
The complexity of ARDS and the large number of
NeitherneutrophilsnorROSshouldautomaticallybe mediatorsoftissueinjuryinvolved(complement,pro-
assumedtobethe‘bêtenoir’inARDS.Theyalsohave teinases, RS, cytokines, prostaglandins, leukotrienes,
beneficialeffects;combatingpulmonaryinfectionand lipoxins,resolvins)makeitperhapsunlikelythatany
releasinglactoferrin,whichcaninhibitiron-dependent single intervention will have a major clinical benefit.
oxidativedamage,300,387andROScanhelpdecreasein- In addition, it should be recognised that ARDS is a
flammation as well as promote it (Section 8.9.4) and blanket term for several closely-related conditions
may (in the right amount) diminish MMP activity provoked by different stimuli, and the exact roles
(Table8.2). playedbyneutrophilsandRSarelikelytodependon
SoareRSimportantcontributorstoARDS?Oxida- theincitingcondition(e.g.sepsis,trauma).ThusARDS
tivedamagecertainlyoccurs(Table10.4),butattempts can even develop in neutropaenic patients, i.e. it can
to target it as a therapeutic strategy have been dis- occur without significant neutrophil infiltration into
appointing. Oxidative stress can result from ARDS thelung.
itself,thecondition(s)thattriggeredARDS,andfrom
the elevated O 2 administered to patients to maintain 10.9 Cysticfibrosis390,391
bloodandtissuepO .Ithasevenbeensuggestedthat
2
theroutineclinicalpracticeofadministeringO could Cysticfibrosis(CF)isoneofthecommonestinherited
2
be bad because it interferes with tissue-protective re- human diseases among Caucasians (incidence about
sponses to hypoxia.388 Lung previously injured, e.g. 1 in 2500). It is due to an abnormality in a protein
by aspiration of gastric contents or infection, may be encodedbyageneonchromosome7.Approximately
more susceptible to O -induced damage. In addition, 2000mutationsareknown,butthemostcommonisa
2
prolonged mechanical ventilation has been proposed three-base-pairdeletionthateliminatesaphenylalan-
toincreaseoxidativedamageinlunganddiaphragm ine residue at position 508, giving a misfolded pro-
tissues, probably related to induction of inflamma- tein that instead of moving to the plasma membrane
tion secondary to physical stress of lung tissues and staysintheERandcausesERstress.Thisprotein,the
atrophyofdiaphragmaticmuscle,respectively.389Clin- cystic fibrosis transmembrane conductance regula-
ically there is often no choice, there has to be a tor(CFTR),couplesATPhydrolysiswithCl–transport
balance between delivering enough O to peripheral across epithelial surfaces. It has other physiological
2
tissues whilst minimizing ventilator-induced lung or functionsaswell,suchastransportofotheranions(e.g.
diaphragmdamage. ATP, HCO–, and thiocyanate)392 and GSH. Indeed, it
3
Plasma and tissue levels of several pro- contributestotheincreasedextracellularGSHlevelsin
inflammatory and pro-oxidant cytokines (Section thelungsofcigarettesmokers(Section9.13).Asmight
5.7) are elevated in septic patients at high risk for bepredictedtherefore,GSHlevelsinlungliningfluids
ARDS and in ARDS patients. Special attention has aresubnormalinCFpatients(Table10.5).
beenpaidtoTNF-α,whichincreasescellularO •–/H O The defect in CF impairs the movement of water
2 2 2
production. Yet TNF-α also induces antioxidant de- andelectrolytesacrossvariousepithelialsurfaces,most
fences, especially MnSOD (Section 5.7). TNF-α itself notably in the respiratory tract, but also in the liver,
is not therefore necessarily bad; it seems more the bileducts,pancreas,gastrointestinaltract,andskin(the
balance of pro-inflammatory (including TNF-α) and sweatexcretionsystem).Intherespiratorytractthere
anti-inflammatory(e.g.IL-10)cytokinesthatinfluences is decreased Cl– secretion and increased Na+ absorp-
outcome in sepsis and in ARDS. Indeed, therapies tion,resultingininadequatehydrationoftherespira-
directed at neutralizing TNF-α or other cytokines, or tory tract mucus. This makes it stickier and difficult
glucocorticoidsasanti-inflammatoryagents,havenot to clear, predisposing the CF patient to chronic lung
proved effective in ARDS. Similarly, the antioxidant infection.DNA-richNETsreleasedfromactivatedneu-
properties of N-acetylcysteine in vitro, together with trophils(Section8.7.4.11)contributetotheviscosity.393
the observed depletion of thiols in ARDS patients Chronic infection, and the ensuing overly exuberant
(Table 10.4), have led to clinical trials, which have inflammatory-immune responses, lead to progressive

--- Page 610 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 555
Table10.5 Evidenceconsistentwithincreasedoxidativestressincysticfibrosis.
ElevatedF2-IsoPsandDMPO-detectablefreeradicalsinbreathcondensate
Elevatedlevelsofplasmalipidperoxidationproducts,includingF2-IsoPsandCOPs
Increasedsusceptibilityoflipoproteinstooxidation
Increasedsusceptibilityoferythrocytestoperoxide-inducedhaemolysis
Elevatedbreathpentaneandethanelevels
Increasesinmyeloperoxidaselevelsinsputum
Increasedphagocyte-derived‘long-livedoxidants’(Section8.7.5)insputum
Increased‘catalytic’ironinsputumandrespiratorytractliningfluids
Evidenceofproteinoxidation(e.g.carbonyls,dityrosine),chlorination,bromination,andnitrationinsputumandbronchoalveolarlavagefluid
Increasedplasmaproteincarbonyls
DecreasedGSHlevelsinbronchoalveolarlavagefluid
Increasedamountsofpro-oxidantcytokines(e.g.TNF-α)
Increasedneutrophilandmonocytenumbersinlung
Decreasesinplasmaascorbateandα-tocopherol(insomebutnotallstudies)a
IncreasedoxidativedamagetoDNA(assayedbyurinary8OHdG)
Inactivationofα 1-antiproteinase
Increasedlevelsofiron,HO-1,andferritininthelung
IncreasedCOinexhaledair,presumablyfromtheHO-1butpossiblysomefromlipidperoxidation
Forreferencesnotcitedabove,seerefs390,391.
aItisimportanttostandardizetoplasmalipidswhenexpressingα-tocopherollevels(Table10.4).
lungdestructionandeventualrespiratoryfailure.Oxi- DNA,paradoxicallysometimeshelpingP.aeruginosato
dativestressappearstocontributetothisinjury(Table mutatefasterandacquireresistancetoantibiotics.396In
10.5),but,aswithARDS,itsclinicalsignificanceisun- mice infected with P. aeruginosa, treatment with allo-
certain. For example, elastase and ROS can increase purinolordesferrioxamine,ortheuseofmicelacking
mucus production (Section 9.13.3), normally a good NOX2,diminishedthelunginjury.Theextentoflung
thinginclearingbacteria,butnotsowhenthemucus injury was correlated with the level of lipid radicals
istooviscous,394 impairingbronchopulmonaryciliary inlungextracts,asdetectedusingthespintrapPOBN
clearanceandobstructingairways. (Section6.2).397
The commonest pathogen chronically infecting CF
patients is Pseudomonas aeruginosa, an organism rich 10.9.1 Cysticfibrosisandcarotenoids390
in antioxidant defences that releases cytotoxic sid-
erophores and redox-cycling agents that aggravate Cystic fibrosis patients have low plasma levels of β-
oxidative damage to the lung (Section 9.6). P. aeru- carotene(often~0.04μMasopposedtonormallevels
ginosa readily forms biofilms resistant to treatment. ofaround0.2–0.6μM),andofothercarotenoidssuchas
DecreasedtransportofthiocyanateintheCFlungim- lutein,zeaxanthin,lycopene,andα-carotene.Caroten-
pairs the activity of the lactoperoxidase-H O -SCN– oidlevelsinthemaculaoftheeye(Section7.10.2)are
2 2
antibacterialsystem(Section3.19.2),whichmayinturn also subnormal. The decreases seem not to be due
facilitatecolonizationbyP.aeruginosa.395Thisorganism to lower carotenoid intake or disordered fat absorp-
also produces an enzyme that can cleave transferrin tion and (at least for β-carotene) are greater in more
and lactoferrin to release iron (Section 9.6) and can severe disease. Is there increased turnover of carot-
secrete an extracellular polysaccharide (alginate) to enoids? If so, is it due to their acting as antioxi-
protectitselfagainstROS.P.aeruginosacanalsoinfect dants? Some studies suggest yes; for example, ad-
thelungsofARDSandimmunocompromisedpatients. ministration of β-carotene to children with CF was
Elevated lung ROS levels can damage the bacterial reportedtodecreaseplasmaTBARS(measuredusing

--- Page 611 ---

556 FREE RADICALS IN BIOLOGY AND MEDICINE
HPLC) from ~90 nM to ~70 nM (close to the val- is affected. For example, in Hashimoto thyroiditis
ues found in normal children).398 However, please infiltration of the thyroid gland by lymphocytes and
remember that carotenoids have other biological ac- phagocytes is accompanied by tissue damage and fi-
tions (Section 4.4). It would be good to measure brosis,andthepresenceofplasmaantibodiesagainst
carotenoid oxidation products in CF patients (to es- such thyroid constituents as thyroglobulin and thy-
tablish their putative antioxidant activity), and also roid peroxidase (Section 8.10.2).404 In some other
to carry out studies of carotenoid turnover in CF. autoimmune diseases, such as systemic lupus eryth-
In another study, supplementation of CF patients ematosus (SLE), scleroderma (Section 10.7.4), and
with a mixture of α-tocopherol, vitamin C, selen- autoimmune vasculitis, lesions are widespread and
ium, and retinol did not decrease plasma F -IsoPs, autoantibodies are present against many tissue con-
2
nor did it improve lung function.399 Several stud- stituents. SLE patients often have inflammation in
ies have tested N-acetylcysteine or inhaled GSH many organs, including skin, kidney, blood vessels,
in CF patients, but with little evidence of clinical and joints. Antibodies directed against constituents
improvement.390,400 of neutrophils or monocytes seem important in sev-
eral vascular autoimmune diseases, such asWegener
granulomatosis.MPOisonetarget.AnotherisPr3,a
10.10 Someautoimmunediseases
serineproteinasefoundintheazurophilicgranulesof
Theacuteinflammatoryresponseisessentialinhelp- neutrophils.403
ing to eliminate dangerous pathogens. Inflammation Lupus mainly affects young women. Patients are
isnormallyself-limitinganditsbenefitoutweighsany light-sensitive and in about 40% of cases develop a
tissue damage caused (Section 8.7). However, any- characteristic ‘butterfly’ rash across the cheeks and
thingcausingabnormallylargeand/orprolongedac- nosewhenexposedtosunlight.Amongthewiderange
tivation of the immune system has the potential to ofautoantibodiesproducedaresomedirectedagainst
cause severe injury. For example, infection by organ- catalase,CuZnSOD,DNA,RNA,erythrocytes,subcel-
isms that the host finds hard to eliminate can cause lular organelles, and plasma proteins.405 The kidney
problems;wehavejustseenthisforP.aeruginosa(Sec- lesionsinlupusareprobablyduetodepositionofim-
tion10.9).Otherexamplesincludeleprosyandtuber- munecomplexesonthebasementmembranesofglom-
culosis. Persistent inflammation also contributes to eruli,followedbycomplementactivation.Overlapping
asthma(Section7.3.3),cancer(Section10.14.11),obesity with lupus is antiphospholipid syndrome (APS), an
(Section 10.4), atherosclerosis (Section 10.3), diabetes autoimmunediseasecharacterizedbyawiderangeof
(Section 10.5), ischaemia–reperfusion (Section 10.6), circulatingantibodiesdirectedagainstphospholipids.
psoriasis(Section7.13.1),graftrejection(Section10.7), APScanoccurindependentlyofSLE(e.g.sometimesin
Alzheimerdisease(Section10.21), andMODS/ARDS womenwithfailureofpregnancy),27butoftenthetwo
(Sections10.6.1and10.8).Yetanotherexampleisgout, occur together. Several of the antibodies in APS and
where severe inflammation is triggered by precipita- SLEpatientsrecognizeoxidizedlipids,suchasoxLDL
tionofsodiumuratecrystalswithinjoints;thesecrys- or oxidized cardiolipin, attached to a phospholipid-
talsactasDAMPs(Section3.25.6)andleadtoinflam- binding protein found in plasma, β 2 -glycoprotein I
masome formation.401 Gout is treated with xanthine (sometimes called apolipoprotein H).27 This protein
oxidaseinhibitors,oftenallopurinol.Sometimesaur- can itself become oxidatively damaged, and its oxi-
ateoxidasepreparation,pegloticase,isused.Inmany dizedformsmayalsobepro-immunogenic.27 Patients
(or all) chronic inflammatory diseases, modified bio- withantiphospholipidantibodies(andotherlupuspa-
molecules(e.g.oxidizedlipidsorproteins,orproteins tients) show elevated plasma protein carbonyls and
modified by end-products of lipid oxidation such as increasedlipidperoxidation,measuredasMDA,HNE,
HNEorMDA)cantriggerimmuneresponses.402 This oxLDL,orF 2 -IsoPs.406,407PlasmaF 2 -IsoPlevelsinSLE
canworsendamage,butmaysometimesbebeneficial, patients were reported to correlate with tiredness, a
asinatherosclerosis(Section10.3).Antibodiescanalso commonside-effectofSLE.408Ithasbeenproposedthat
formagainst‘normal’proteinsinthewrongplace,such some of the anti-DNA antibodies in lupus arise from
asmyeloperoxidase.403 animmuneresponsetoproductsofoxidativedamage
Perhaps the most striking consequences of exces- toDNAornucleoproteins,409suchasthoseinNETsre-
sive phagocyte/lymphocyte action are seen in the leasedbyactivatedphagocytes(Section8.7.4.11).DNA
so-called autoimmune diseases, including multiple that had been exposed to a O • 2 –-generating system
sclerosis(Section10.18.2).Sometimes,onlyonetissue (hypoxanthineplusXO)ortoONOO–wasreportedto

--- Page 612 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 557
beantigenic409 wheninjectedintoanimals,theformer Nevertheless, injection of SOD or other antioxi-
possiblybecauseofO
•–-dependentgenerationofOH•.
dants can decrease inflammation in several animal
2
Oxidative modifications to 60kD Ro ribonucleopro- models of acute and chronic inflammation. For ex-
tein(e.g.byHNE)generateantigensandtheresulting ample,SODboundtoahigh-molecular-masspolymer
antibodies are frequently seen in lupus.402 Oxidized suchasFicolldecreasesinflammationinducedbyin-
mitochondrialDNAmayalsobepro-inflammatory(a jecting carrageenan, an irritating substance derived
DAMP),410 and SLE patients may have defects in the fromseaweed,intothefeetofrats.BothSODandcata-
repairof8OHGinDNA.411 lase showed inhibitory effects against inflammation
Notsurprisingly,APSandlupusarefrequentlyac- induced by the implantation of carrageenan-soaked
companiedbyincreasedatherosclerosis.Theabilityof sponges beneath the skin of rats. Nitric oxide, prob-
oxLDL/β2-glycoproteinIcomplexestopromotefoam ably via ONOO–, also contributes to this model of
cellformationmaycontribute.27 inflammation.416 Injection of a low-molecular mass
‘SODmimetic’,M40403(Fig.11.5)decreasedinflamma-
tion,nitrotyrosineformation,andpaininratsinjected
10.10.1 Adversedrugreactions
inahindpawwithcarrageenan,416but‘SODmimetics’
Several drugs can induce a condition resembling arenotspecificscavengersofO
•–(Section11.5.4).
2
lupus,includinghydralazine,isoniazid,chlorpromaz-
10.10.2.1 Artefactstowatchfor:contaminationof
ine,procainamide,and(muchlessfrequently)penicil-
lamine,α-methyl-DOPA,anddiphenylhydantoin.Me- commercialantioxidantsandoxidationonsample
storage
tabolitesof,orproductsformedbyattackofRSupon,
these drugs may bind to proteins to give products One criticism that can be levelled at many of the
that behave as ‘foreign antigens’, Myeloperoxidase- above animal experiments with antioxidant proteins
dependent oxidations are sometimes involved (Sec- isthelackofcontrols.ControlswithinactivatedSOD
tion 10.11.5), e.g. in the side-effects of clozapine, an andcatalaseareneededtoruleout‘nonspecific’anti-
anti-psychotic that can damage the bone marrow.412 inflammatory effects of proteins (Section 3.5.7), or of
Mitochondrialdamagealsoplaysaroleinsomeidio- contaminants within the enzyme preparations. These
syncraticdrugreactions.413 can include endotoxin417 and thymol, an antioxidant
preservativeinsomecommercialcatalasesolutions.418
Contamination of SOD with low levels of endotoxin
10.10.2 AreRSimportantmediators
could explain some of its reported anti-inflammatory
ofautoimmunediseases?
effects, since this agent can trigger a protective re-
Since oxidative damage levels are increased in the sponse involving a rise in the levels of antioxidant
autoimmune diseases, would antioxidants be useful enzymes(Section3.7.5).
therapies? These diseases generally have active and Anotherartefactcanaffectmeasurementsofoxida-
quiescentphases,whichmakesevaluationofmedical tivedamageinpatientmaterial.Bodyfluidsundergo
treatmentdifficult.Thisshouldbeborneinmindwhen lipid peroxidation on prolonged storage (even at –70
assessing the effectiveness of any therapy, including ◦C) or mishandling (e.g. repeated freeze–thawing),
theuseofantioxidants,inanystudyotherthanafully in part because of release of copper ions from
randomizeddouble-blindcontrolledclinicaltrialover caeruloplasmin.419 Several studies identifying ‘cyto-
a sufficient period. Most claims of benefit from, for toxic’ or ‘clastogenic’ factors in plasma or serum of
example SOD, have been based on short-term ‘open’ patients with various diseases have been led astray
studiesofsmallnumbersofpatients. bytheartefactualgenerationofperoxidationproducts.
Increased production of RS or levels of oxidative One cannot necessarily allow for this by using con-
damage do not, of course, prove their importance as trols of normal body fluids stored for the same time.
mediators of tissue injury (Fig. 10.2), and ROS can Plasmaandserumcontainantioxidantsthatlimitlipid
also sometimes dampen inflammation (Section 8.9.4). peroxidationonstorage;depletionoftheseprotective
Indeed, knockout of NOX2 in a lupus-prone mouse mechanisms and increased levels of caeruloplasmin
strainaggravatedthedisease,andhumanswithdimin- (Section 5.7.4) occur during many diseases, so that
ished phagocyte O •– production due to mutations in the plasma or serum is less stable on storage than
2
neutrophil cytosolic factor 2 (NCF2) seem less prone those from healthy subjects. Hence studies of oxida-
tolupus.414,415Thus,whetherantioxidantswouldhave tive damage should, whenever possible, be carried
benefitisunclear;theymightdoharm. outonfreshlydrawnorproperlystoredsamples.For

--- Page 613 ---

558 FREE RADICALS IN BIOLOGY AND MEDICINE
example,plasmaorserumsamplesstoredforlaterana- also an important autoantigen in RA; its modifica-
lysis of IsoPs (Section 6.15.6) must have antioxidants tionbyRS(OH•,HOCl,ONOOHetc.)canincreaseits
suchasBHTadded. antigenicity.430
As for many of the diseases we have already con-
10.10.2.2 Periodontaldisease:amissed
sidered, there is considerable evidence for increased
opportunity?420,421
oxidativedamageinRA(Table10.6).Butdoesitmatter
Inflammationofthegingivaisamajorcauseoftooth tothediseasepathology?
lossworldwide,andappearstobeduetoaninflamma-
tory/immuneresponsetodentalplaqueaccumulation
10.11.1 Thenormaljoint
around the gum margin. Given that increased oxi-
dative damage can be demonstrated in this region Innormalsynovialjoints,articularcartilagecoversthe
(although more work is needed with state-of-the-art bone ends and both are enclosed by a thin synovial
techniques)andthattopicalapplicationofantioxidants membrane,madeupofliningcellsthatfacethejoint
should be easy, it is surprising to the authors that cavity, plus overlying fatty and fibrous material. The
moreworkhasnotbeendoneinthisarea(thesameis lining cells (synoviocytes) are of at least two types:
alsotrueofchronicskininflammations,suchasacne: typeAcellsareessentiallyresidentmacrophagesand
Section 7.13). Nevertheless, one study did show that typeBcellsaresecretory,fibroblast-typecells.Thesyn-
M40403 (Fig. 11.5) decreased inflammation in a rat ovial lining synthesizes hyaluronic acid (Fig. 10.13)
modelofperiodontaldisease.422 Inbothsunburnand andsecretesitintothesynovialfluid(SF),whereitis
periodontal disease, increased ‘catalytic’ iron may be largely responsible for the viscosity of the fluid. The
involved(Section7.13.1.2andref423). synovialliningalsoactsasabarriertothefreemove-
mentofproteinsfromplasmaintothesynovialfluid.
10.11 Rheumatoidarthritis27,424,425 Themacrophage-likecellsmayfunctiontoengulfdeb-
risproducedasaresultof‘wearandtear’inthejoint.
Joint inflammation often accompanies autoimmune The volume of SF in healthy synovial joints is small,
diseases such as SLE, and can be a complication of onlyabout0.5mlinhumankneejoints.Itlubricatesthe
iron overload (Section 3.25), but some of the sever- joint, supplies nutrients to, and removes waste from,
est cases are due to rheumatoid arthritis (RA). RA thecartilage.
is characterized by chronic joint inflammation, espe- Articularcartilageisadensetissuecontainingcells
cially in the hands and legs, and is more frequent in (chondrocytes)embeddedinamatrixofcollagenfibres
females.T-andB-lymphocytesplayakeyrole,which and proteoglycans (mostly aggrecan). Cartilage does
has led to the proposal that RA is a persistent, cell- not contain blood vessels and receives O 2 by diffu-
mediatedimmuneresponsetoanunknownantigen.426 sionfromtheboneandSF,sothatcartilageO
2
levels
ThebloodplasmaandjointfluidofRApatientscontain are low. One of the essential nutrients it requires is
autoantibodies directed against several components. ascorbate,neededforcollagensynthesis(Section4.2).
One is immunoglobulin G (IgG), mostly against the Chondrocytes take up ascorbate in a Na+-dependent
Fc region of this protein. Something must cause IgG process(usingSVCT2)andconcentrateittomillimolar
to become antigenic in RA; this may be because the intracellular levels. They can also take up DHA, us-
carbohydrateside-chainsaredifferentand/orbecause ingglucosetransporters.432 Chondrocytescontainthe
IgG is damaged by RS (e.g. OH•) generated during usual complement of antioxidants, including perox-
theinflammationtocreatenewantigens.425,427,428 Ele- iredoxins,andcartilagehasahighlevelofEC-SODin
vatedlevelsofantibodiesdirectedagainstoxLDLare thematrix.433
often observed, and antibodies that recognize pep-
tidescontainingcitrullineresiduesarecommoninRA 10.11.2 TheRAjoint424,425
andusedtodiagnoseit.428 Citrullineisanaminoacid
produced by deamination of arginine residues and it The onset of RA is usually slow, appearing as pain,
may form on several proteins in RA, including filag- stiffness, and swelling of the joints. The synovial lin-
rin and vimentin. The action of MPO on SCN– can ing thickens and folds, there is growth of new blood
leadtoproductionofcyanate,whichcancarbamylate vessels, infiltration of lymphocytes, increased num-
proteins (converting lysine to homocitrulline; Section bers of macrophages, and proliferation of fibroblasts.
10.3.9), again forming autoantigens, which are fre- The permeability of the synovial lining rises, allow-
quently found in RA patients.429 Type II collagen is ing more proteins to enter the joint from the plasma.

--- Page 614 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 559
Table10.6 Evidenceforincreasedoxidativedamageinrheumatoiddisease.
Observation Comment
Increasedlevelsoflipidperoxidationproductsin ElevatedF2-IsoPsand4-HNE.Decreasedα-tocopherol(perunitlipid)inSFis
serumandsynovialfluid(SF) consistentwithlipidperoxidation,asarereportsof‘foamcells’containingoxidized
LDLinrheumatoidsynovium.LDLisolatedfromRASFshowedalteredelectrophoretic
mobilityconsistentwithoxidation.Highdosesofα-tocopherolwerereportedto
diminishpainbutnototherparametersofinflammationinRApatients(Ann.Rheum.
Dis.56,649,1997).
DepletionofascorbateinserumandSF Presumablyresultsfromoxidationofascorbateduringitsantioxidantaction.Activated
neutrophilstakeupDHArapidly.
DecreasedGSHinsynovialT-lymphocytes Mayresultfromoxidativestressorlymphocyteactivation(J.Immunol.158,1458,
1997).SynovialT-lymphocytesfrequentlystainpositiveforH2O2productionintheRA
joint(Arth.Rheum.52,2003,2005).
Increasedexhalationofpentane Putativeend-productoflipidperoxidation;FreeRadic.Res.Commun.5,101,1988
(Section6.15.9).
Increasedconcentrationsofurateoxidationproducts, End-productsofRSattackuponurate(Section6.13).
e.g.allantoin
ActivationofNF-κBinrheumatoidsynovia ProbablymediatedbyTNF-αandothercytokines,possiblybyROSassecond
messengers
Increaseinformationof2,3-DHBfromsalicylate 2,3-DHBisaproductofattackofOH•uponsalicylateinpatientstakinghigh-dose
aspirin(Section6.3.1).
Hyaluronicaciddegradation PatternofdegradationissuggestiveofOH•production.431
Formationof‘fluorescent’proteins Fluorescenceprobablycausedbyoxidativedamagetoproteins.Nitratedand
chlorinatedIgGfoundinRASF(J.Immunol.165,6532,2000).
Increasedsteady-statelevels(incellularDNA)and IndicativeofoxidativeDNAdamage.OxidizedmitochondrialDNAdetectedinplasma
increasedurinaryexcretionof8OHdG andsynovialfluidof>50%ofRApatients(Arth.Res.Ther.5,R234,2003).
Increasedlevelsofproteincarbonylsinsynovialfluid Indicativeofoxidativeproteindamage,butcouldalsoresultfrombindingofHNEand
otheraldehydestoproteins(Section6.16.3).Carbamylationbycyanatecanalso
occur.429
Nitrotyrosine 3-NitrotyrosinedetectedinSFandtissuesofRApatients,butnotcleariflevelsare
elevatedcomparedwithcontrolorOApatients.Serumlevelsofnitratedpeptides
derivedfromcollagenwerereportedtobeelevatedinbothOAandRA(Osteoarth.
Cartilage13,258,2005;Ann.Rheum.Dis.68,451,2009).Overallcontributionof
ONOO–toRAisunclear(Osteoarth.Cartilage21,151,2013).
Increasedinactivationofantiproteinases Synovialfluidα 2-macroglobulinshowsincreasedchlorinationandoxidation(as
carbonyls)andinactivationinRA(Arch.Biochem.Biophys.391,119,2001).This
proteinisknowntobeinactivatedbyHOCl,althoughwhenthishappensitmaygain
chaperoneproperties(Table8.2).Increasedlevelsofoxidizedα 1-antiproteinaseare
alsodetectedinplasma(Clin.Chim.Acta317,125,2002).
DamagetoHDL IncreasedlevelsofnitratedandchlorinatedHDLfoundinplasma(Ann.Rheum.Dis.
72,1725,2013).
IncreasedexpressionofNrf2 Apparentlyaresponsetooxidativestress.MicelackingNrf2showedworsejoint
damageinamousemodelofantibody-inducedarthritis(Ann.Rheum.Dis.70,844,
2011;Antioxid.RedoxSignal.15,889,2011).
Glycation Nε-carboxymethyllysinelevelsincreasedinsynovialtissue(Section10.5.5).Elevation
alsoseeninOApatients.
(cid:4)
Abbreviations:2,3-DHB,2,3-dihydroxybenzoate;HNE,hydroxynonenal;LDL,low-densitylipoprotein:8OHdG,8-hydroxy-2-deoxyguanosine;OA,osteoarthritis.
Forreferencesnotcitedinthetable,seerefs424,425.

--- Page 615 ---

560 FREE RADICALS IN BIOLOGY AND MEDICINE
COO– CH 2 OH COO– CH 2 OH
H H O H H O O H O H H O O
OH H H OH H H
HO H H H HO H
O O
H OH H NHCOCH 3 H OH H NHCOCH 3
GA NAG GA NAG
Figure10.13 Structureofhyaluronicacid.Hyaluronicacidisalongpolymerformedbyjoiningtogetheralternatelytwodifferentsugars:
glucuronicacid(GA)andN-acetylglucosamine(NAG).ThenegativechargeonthecarboxylgroupsofGAatphysiologicalpHcausesthemtorepel
eachother,sothatthemoleculeextendsoutinsolution.Hencesolutionsofhyaluronicacidareextremelyviscous.
Ironaccumulateswithinthesynovialcells,muchofit cartilage)bythegrowthoftheinflamedsynoviallin-
inferritinandhaemosiderin.TheprogressionofRAis ing over, and into, the cartilage. This ‘overgrowing’
variable; in some subjects it is mild and self-limiting, tissue is called pannus (from the Latin for ‘cloth’,
butinothersitleadstodestructionofthearticularcar- the pannus being said to resemble a reddish cloth
tilage,boneerosion,andimpairmentofjointfunction. spreading over the cartilage). Pannus is often vas-
Severe RA is also associated with accelerated athero- cularized and contains iron deposits, and most cells
sclerosis and cardiovascular disease. How do these in pannus are large and mononuclear, many having
eventshappen? fibroblastic features. Most of the macrophages arise
Bone is normally remodelled as required by a bal- from blood monocytes attracted by chemotactic fac-
ance of opposing reactions; digestion by osteoclasts torsproducedinthejoint.ThecytokineTNF-αsecreted
and deposition of new matrix by osteoblasts (Sec- by activated macrophages induces activation of NF-
tion8.10.8).Thisbalanceisalteredtofavournetbone κB in synoviocytes, leading to increased production
loss in severe RA. Why? Partly because of increased of IL-1, IL-8, IL-7, iNOS, COX-2, monocyte chemo-
osteoclast activity due to the expression (in response attractantprotein-1(MCP-1),andTNF-αitself,among
to cytokines such as IL-17) of the RANKL (receptor other products. IL-1, IL-17, and TNF-α promote car-
activatorofNF-κBligand)proteinonT-cellsandsyn- tilage/bone resorption. In addition TNF-α and other
oviocytesintherheumatoidjoint.Thisligandattaches cytokinesincreaseexpressionofadhesionmoleculesto
to the RANK (receptor activator of NF-κB) receptor facilitate phagocyte recruitment. The actions of TNF-
onosteoclasts,promotingtheirmaturationandactiva- α seem important in RA, since the drugs infliximab
tion.Reactivespeciesareinvolvedintheintracellular (Remicade®),adalimumab,andetanercept(allTNF-α
signalling(Section8.10.8).Inaddition,osteoblastsare bindingagents)areeffectiveindecreasingsymptoms,
readilydamagedonexposuretoRS,includingH O , andofteninducingremission,inRApatients.426
2 2
oxidized lipids, and ONOO–. By contrast, low con- The SF of the inflamed rheumatoid joint swarms
centrations of RS or oxidized lipids accelerate bone withneutrophils.Someareactivated,andtheSFthus
resorptionbyosteoclasts;thesecellsevenmakeROS, containsincreasedquantitiesoftheirproducts,includ-
usingaNOX4enzyme(Section8.10.8).Inotherwords, ing lysozyme, lactoferrin, prostaglandins, and NETs
apro-oxidantenvironmentfavoursboneloss. (some of which contain antigenic citrullinated pro-
Destruction of the cartilage matrix involves in- teins).Neutrophilsarealsopresentattheinterfaceof
creased activity of matrix metalloproteinases (MMPs; cartilageandpannus.ThevolumeofSFisincreasedin
Table 8.2), aided by inactivation of antiproteinases.434 theswolleninflamedrheumatoidjoint,butitsviscosity
In addition, chondrocytes can be damaged435 by ex- islowerthannormal,becausethehyaluronicacidpre-
posuretoONOO–andotherRS;H O readilyinhibits senthasaloweraveragemolecularmassthannormal.
2 2
cartilageproteoglycansynthesis,436 e.g.byinterfering The cartilage wear particles, produced by increased
with ATP synthesis, in part by inhibiting G3PDH in frictioninthejoints,mightalsoactivatephagocytesto
chondrocytes.Indeed,intra-articularinjectionofH O - makemattersworse.
2 2
generating systems causes severe joint damage in
animals.437ThelowascorbateconcentrationsinRASF
10.11.3 Howdoesincreasedoxidativedamage
(Table10.6)mighthindercollagenresynthesis,adding ariseinRA?424,425
totheproblem.
DamageintheRAjointusuallyoccursfromtheper- Interest in the role of oxidative damage in RA began
iphery (where the synovial lining meets the articular withtheseminalworkofJoeMcCord,whonotedthe

--- Page 616 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 561
decreasedviscosityof SF in RA patients and showed or GSH, and only traces of SOD activity (largely as
thatasimilardecreasecouldbeproducedbyexposing EC-SOD),soitisnotgoodatquenchingRS.
SF, or solutions of hyaluronic acid, to a system gen- AnotherproposedsourceofROSinRAishypoxia–
erating O •– (xanthine/XO). Later work showed that reperfusion.446 The K for O of neutrophil NADPH
2 m 2
this hyaluronate degradation in vitro is not caused oxidase enzymes is within the range of physiological
by O •–, but by OH• generated by O •–-driven Fenton O concentrations in body fluids (Section 8.7.4.4), so
2 2 2
chemistry.438 Therequiredironwasprobablycontam- that local O concentrations at sites of inflamma-
2
inating the reagents. Nevertheless, the chemical pat- tion should modulate ROS production. Tensing an
tern of damage to hyaluronate in RA synovial fluids inflamed rheumatoid knee joint can generate intra-
(as demonstrated using nuclear magnetic resonance) articularpressuresabovecapillaryperfusionpressure,
is consistent with OH• attack,431 although hyaluron- resulting in sharp drops in pO . Upon relaxing the
2
ate can also be degraded439 on exposure to HOCl or joint,theO levelgraduallyreturnstonormalandROS
2
ONOO–, and may additionally be secreted as abnor- may be generated. Some may come from XO, which
mally short chains by the dysfunctional synovium in has been identified in synovial membranes. Indeed,
RA.Hydroxylradicalisprobablygeneratedathigher hypoxanthine concentrations are elevated in SF from
ratesthancontrolsinRApatientsinvivo,asdetected RApatients.446
by aromatic hydroxylation of salicylate (Table 10.6).
Indeed,aspirationofRASFintosolutionsofphenyl-
10.11.4 DoesoxidativedamagematterinRA?
alanine or salicylate produces patterns of aromatic
hydroxylationconsistentwithOH•production.440
How far does the increased oxidative damage in RA
How might OH• arise in the joint? One possibility (Table10.6)contributetothechronicinflammationand
isreactionofO • 2 –withHOCl(Section2.6.3).Anotheris thecartilageandbonedestruction?Itseemslikelythat
fromONOO– (Section2.6.1),althoughtheimportance it could; we have already seen that iron overload or
ofONOO– inRA(asjudgedbynitrotyrosineproduc- intra-articular injections of H O -generating systems
2 2
tion) is unclear (Table 10.6). A third is Fenton-type damage joints and that loss of Nrf2 causes worse
chemistry;indeed‘catalytic’iron(butnotcopper)can jointdamageinmice(Table10.6).MPO-knockoutmice
bemeasuredinabout40%ofsynovialfluidsaspirated showedlessinflammationinamodelofarthritis.447A
frominflamedRAkneejoints.441 Thisironcouldarise further illustration of the potential pro-inflammatory
byreleasefromnecroticcells,byH 2 O 2 -mediateddeg- action of ROS may be provided by alkaptonuria,
radation of haemoglobin (liberated by microbleeding a disease caused by an inborn defect in homogen-
intheRAjoint),andbytheactionofO
•–
onsynovial tisate oxidase, an enzyme involved in the degrad-
2
fluidferritin.Indeed,ironionreleaseoccurswhenSF ation of tyrosine. Alkaptonuric patients accumulate
is exposed to O • 2 –, especially at acidic pH.442 Haem homogentisic acid, show pigmentation of cartilage
oxygenase might also play a role, since its levels are and connective tissue, and may gradually develop
increasedinsynovialtissuefromRApatients.443 severeinflammatoryarthritis,presumablyduetooxi-
OneobvioussourceofRSinRAisactivatedmacro- dation of homogentisic acid to generate ROS and
phagesandneutrophils,releasingO • 2 –,H 2 O 2 ,protein- quinones/semiquinones. Polymerization of the latter
ases, HOCl, eicosanoids, and NO• (by induction of mayaccountforthepigmentationobserved.448
iNOS).SeveralRS(e.g.OH•,HOCl,ONOOH)mightal-
However, all is not clear-cut. Early studies claim-
tertheantigenicbehaviourofimmunoglobulinG,col- ingthatintra-articularinjectionsofSODarebeneficial
lagentypeII,andotherproteins,producingmodified to patients were unconvincing449 and this line of re-
proteinsthatmightactivatephagocyticcells,provoke searchdoesnotappeartohavebeenpursued,although
antibody formation, and be pro-inflammatory.427,430 interest in other therapeutic uses of SODs in hu-
Somighthyaluronicaciddegradationproducts,some manscontinues(Section11.5.3).Reactivespeciescould
of which can act as DAMPs.444 Hypochlorous acid, even be beneficial!450–452 When mice lacking neutro-
ONOOH, and O • 2 – react with ascorbate, which may philNADPHoxidaseactivityweresubjectedtointra-
helptoexplainitslowlevelsinRAbodyfluids(Table articularinjectionofzymosan(anirritant-inducedin-
10.6).α 1 -Antiproteinase,α 2 -macroglobulin(Table8.2), flammation) or pre-treated with an antibody against
and other proteins (tissue inhibitors of metallopro- lysozyme followed by intra-articular injection of a
teinases, TIMPs)445 that normally antagonize the ac- modifiedlysozyme(animmune-complex-mediatedin-
tionofMMPscanbeinactivatedonexposuretoHOCl flammation), they showed an aggravated inflamma-
or ONOO–. Human SF contains little catalase, GPx, tory response. There was more cartilage and bone

--- Page 617 ---

562 FREE RADICALS IN BIOLOGY AND MEDICINE
erosion, and enhanced synovial expression of TNF-α, introducedacetylsalicylate(aspirin).Aspiriningested
IL1α,RANKL,andsomematrixmetalloproteinases.450 by humans is quickly hydrolysed to salicylate by es-
Consistent with this, increased severity of collagen- terasesinthedigestivetractandliver(Section9.1).Sa-
induced arthritis and autoimmunity, as well as some licylateinplantsisnotthereforourbenefit;itplayskey
spontaneous severe arthritis (in females), were ob- roles in helping plants to defend themselves against
served in rats and mice with mutations in the Ncf1 pathogens(Section8.11.2).
gene; these animals have decreased phagocyte ROS Several other non-steroidal anti-inflammatory
production because the gene encodes p47phox (Sec- drugs(NSAIDs)havebeendevelopedasCOXinhibi-
tion8.7.4).451HenceintheseanimalmodelsfewerROS tors; they include diclofenac sodium, indomethacin,
equatestomoreinflammation.Bycontrast,miceover- ibuprofen, phenylbutazone, piroxicam, and mefe-
expressing EC-SOD showed milder collagen-induced namic acid. Major side-effects of COX inhibitors are
arthritisthancontrols.453 However,increasedlevelsof gastrointestinal damage and renal injury. Some of
EC-SOD were also able to mitigate collagen-induced theseeffectshavebeensuggestedtoinvolveoxidative
inflammationinmicelackingNOX2,454suggestingthat damage.457 None of these drugs decreases cartilage
EC-SOD could exert anti-inflammatory effects other damageorboneerosioninRA,andsomemayenhance
thanbyscavengingNOX2-derivedO
•–.Asinathero-
it. Selective inhibitors of COX-2, an enzyme present
2
sclerosis, some oxidized lipids might be beneficial in invariouscellsintheRAjointasaresultofcytokine
RA, e.g. by antagonizing vascular leakage at sites of action, have also been examined. A popular agent
inflammation.455 is celecoxib (Celebrex®—Fig. 10.14). In principle, a
Thus the answer to the question posed at the be- COX-2 inhibitor should not produce the typical side-
ginning of this section is ‘RS are probably both good effects of a COX-1 inhibitor (Section 8.12). However,
and bad’. On the bad side they can damage proteins as COX-2 inhibitors have become more widely used
andcreateantigens;onthegoodside,the‘rightlevel’ they also turn out to have side-effects, especially on
ofRScanhelptonedowninflammation.LosingNrf2 theheart.
(Table10.6)maytipthebalancetoofartowardstheRS. Several thiol compounds have at some stage been
Oxidative stress may also contribute to the increased used to treat RA; they include penicillamine, usu-
risk of atherosclerosis/cardiovascular disease in RA ally administered as its disulphide, which is reduced
patients.456 to penicillamine in vivo (Fig. 10.14), bucillamine and
gold–thiol complexes such as aurothiomalate and
aurothioglucose. Several drugs developed for other
10.11.5 DrugstotreatRA:antioxidant,
diseases have found use in RA, such as the anti-
pro-oxidant,orneither? malarials chloroquine and hydroxychloroquine, and
sulphasalazine(Fig.10.14).Sulphasalazineconsistsof
Cyclooxygenase (COX) inhibitors, blocking prosta-
5-aminosalicylicacidlinkedbyanazo(–N=N–)bond
glandin production and hence decreasing pain and
to sulphapyridine. In vitro, millimolar levels inhibit
swelling, are still commonly used in the day-to-day
both lipoxygenase activity and prostaglandin biosyn-
treatment of RA, although the mainstay of treatment
thesis, although it is not clear if this accounts for the
isnowthecontroloflymphocyteproliferationbysuch
clinicalactionsofsulphasalazine.InRA,theeffective
agentsasmethotrexate(Section10.16),plustheuseof
anti-TNF-αagents.424,426 agentseemstobesulphasalazineitselforsulphapyrid-
ine,ratherthan5-aminosalicylate.458
The first COX inhibitor to be synthesized was as-
Doanyofthesedrugsactbymodulatingoxidative
pirin, a drug with a long history which still springs
damage? In principle, they could do this in several
surprises on us today, e.g. salicylate can promote the
ways.
synthesisofanti-inflammatorylipoxins(Section8.12).
EventheancientEgyptianswereawareoftheanalgesic 1. Anydrugthatinhibitsinflammation(byanymech-
effectsofanextractofwillowleaves.In1763,theRev- anism)mayleadtodecreasedproductionofRS,e.g.
erendEdmundStone,avicarinChippingNorton(Ox- by reducing the numbers of activated phagocytes.
fordshire,England),readareporttotheRoyalSociety CorticosteroidsdecreasephospholipaseA activity,
2
ontheanti-feveractionofwillowbarkandin1876the lowering arachidonic acid release and hence di-
Scottish physician Thomas MacLagan reported its ef- minishingeicosanoidformation.Theyalsodecrease
fectivenessinarthritis.Theactivecomponentwaslater levels of cytokines and iNOS. Naturally occurring
extractedandshowntobesalicylate(salixisLatinfor corticosteroids include cortisol, and synthetic ones
‘willow’)andin1899theBayerCompanyinGermany includeprednisoloneanddexamethasone.Steroids

--- Page 618 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 563
O STEROIDS
Cortisol (R1=OH; R11=H; R111=H;
CCHOH
R1 CH 3 O 2 H R111 C 1–2 saturated)
Prednisolone (R1=OH; R11=H; R111=H;
1 CCHH R11
33 C 1–2 unsaturated)
2
Dexamethasone (R1=OH; R11=F; R111=CH 3 ;
O C 1–2 unsaturated)
NON-STEROIDALS
COOH O COOH CH 2 COOH
OCCH OH F
3
CH
3
Aspirin Salicyclic acid Sulindac CH
(acetylsalicyclic acid) (2–hydroxybenzoic acid) (Clinoril®) O (* becomes SCH3 in sulindac
* S CH 3 sulphide, the active agent)
SONH SOCH
2 2 2 3
CHCOO–Na+
COOH 2 Cl N N
F 3 C O
NH NH
O
CF 3 Cl CH 3
Flufenamic acid Diclofenac sodium Celecoxib Rofecoxib
COOH C C H H 3 COOH O S O N CH 3 H 2 N N N CH 3
N
F OH CONH N N CH 2 N CONH
CHO
Di F flunisal 3 Naproxen O P H iroxicam NH 2 HOOCCH 2 CH 2 C COOH
Methotrexate H
CH
3
O C Cl O CHCOOH CH 3
N CH C (CH 3 ) 2 CHCH 2 CHCOOH
3
CH 3 O CH 2 COOH Ketoprofen Ibuprofen
Indomethacin
COOH O
OH
NH C NH
S
O N N N
H 3 C CH 3 N
CH(CH)CH O S CH 3
3 22 2 O O
Phenylbutazone Mefenamic acid Tenoxicam
(rarely used in
RA now)
Figure10.14 Structuresofsomedrugsusedinthetreatmentofinflammatorydiseases.Sulindacisapro-drug(asulphoxide)thatmustbe
reducedtosulindacsulphidetobeactive,probablybymethioninesulphoxidereductases(Section5.14.1;DrugMetab.Disp.39,1014,2011).
are effective drugs in RA, but side-effects limit and thiol compounds react rapidly with OH•. Is it
prolongeduseofhighdoses.Anti-TNF-αagentsare importantinvivo?Millimolarorhigherdruglevels
quiteeffectiveinRA,decreasinginflammation(and would be required to compete with biomolecules
henceprobablyoxidativedamage). (e.g. GSH, also at mM levels) for any OH• gener-
2. Drugs might scavenge RS. Most, if not all, anti- ated, and most drugs achieve nowhere near such
inflammatory drugs react quickly with OH• (rate concentrations in vivo. One exception is aspirin; in
constants5×109to1×1010M–1s–1).Thisispredict- aspirin-treatedRApatientssalicylateconcentrations
ablefromtheirstructures(Fig.10.14),sincearomatic inplasmaandsynovialfluidcanreachmillimolar.

--- Page 619 ---

564 FREE RADICALS IN BIOLOGY AND MEDICINE
THIOLS
COO–
(CH)C CHCOOH
32
(CH 3 ) 2 C SH C N H H C 2 OOH (CH 3 ) 2 C S S C N N H H H C 2 2 OOH Na2n Au S C C C O H H 2 O– n H 3 C H 3 C C SH O C H N CH C C O H O 2 H SH
Penicillamine Penicillamine disulphide Gold sodium thiomalate Bucillamine
ANTI-MALARIALS CH
3
NHCH(CH)N(CHCH)· 2HCl
Cl N 23 OC 2 H 32
3
Cl N
NHCH(CH)N(CHCH)
23 2 32
CH
3
Chloroquine Quinacrine hydrochloride
CH
3
Cl N HNCH(CH 2 ) 3 NH 2
N
CHCHOH
2 2
NHCH(CH 2 ) 3 N CH 3 O
CHCH
CH 2 3 Primaquine
3
Hydroxychloroquine
MISCELLANEOUS
COOH
COOH
OH
OH
H 2 N NH 2
5–Aminosalicylic acid 4–Aminosalicylic acid
HOOC
N N
HO N N SO 2 NH H 2 N SO 2 NH
Sulphasalazine (SASP) Sulphapyridine (SP)
HO O
O N
NN
O
S
Tetomilast (OPC-6535)
Figure10.14 (Continued)

--- Page 620 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 565
Indeed,levelsof2,3-dihydroxybenzoate,aproduct 10.11.6 Ironandrheumatoidarthritis
ofOH• attackonsalicylate,areelevatedinplasma
Rheumatoid arthritis is accompanied by changes in
from aspirin-treated RA patients.425 Many drugs
body iron metabolism. A rapid fall in the ‘total iron’
react with HOCl and ONOOH in vitro, but in
levelofplasmaattheonsetofdiseaseisfollowedbya
few cases is the reaction fast enough for scav-
dropinhaemoglobinandincreaseddepositionofiron
enging to be feasible at the drug concentrations
in the synovial membranes. The drop in blood iron
present in vivo. Feasible (which doesn’t mean that
is due to the inflammation; it is an example of the
they actually do it in vivo!) HOCl and ONOOH
anaemia of chronic inflammation (Section 3.22.4.1),
scavengersincludepenicillamineandgoldsodium
also seen in chronic infections and in patients with
thiomalate.425
cancer.461Attemptstoreversethis‘anaemia’bygiving
3. Drugs may chelate transition metal ions needed
oralironsaltstoRApatientsareusuallyineffective;it
for OH• generation and lipid peroxidation. Little
isnotduetoirondeficiency,buttoincreasedsynthesis
informationisavailableonwhetherthiscouldhap-
ofhepcidin.
penattherapeuticdruglevels,butitisfeasiblefor
Indeed, iron treatment can worsen the symptoms
salicylate.
of RA, e.g. by injection of iron dextran to treat ‘se-
4. DrugsmightdecreaseproductionofROSbyphago-
vere anaemia’. Although the side-effects are often
cytes.Therehavebeenseveralclaims,butfewcon-
attributed to the dextran, it may be the iron that
vincingdemonstrations,thatNSAIDsatlevelsthat
is at fault.462 Exacerbations of joint inflammation in
arepresentatsitesofinflammationcandothis.One
agentthatmaydecreaseneutrophilO
•–
production
RA patients treated with iron dextran occurred at
2 the same time that plasma transferrin became iron-
istetomilast(Section11.7.3andFig.10.14).
saturatedand‘catalytic’ironappearedinbodyfluids.
Consistent with this, iron-overloaded haemochroma-
tosispatientsfrequentlyshowjointinflammation(Sec-
Of course, if ROS have some anti-inflammatory
tion3.22.5),andbleedingintothejointsofhaemophil-
effects in RA (Section 10.11.4) then scavenging
iacpatientsisassociatedwithinflammationandjoint
too many of them might not be good. Indeed, damage.463 Indeed, injection of blood into the joints
certain drugs may exert the opposite (pro-oxidant) of animals can trigger inflammation.463 However the
effects. The gold-containing compound auranofin, S-
use of iron-chelating agents such as desferrioxamine
triethylphosphine gold(I)-2,3,4,6-tetra-O-acetyl-1-thio-
aspotentialanti-inflammatoryagentsinanimalmod-
β-D-glucopyranoside,usedinRAinthepast,wasre-
els of RA gave inconclusive results, and preliminary
ported to inhibit thioredoxinreductase and stimulate
studies in humans revealed little benefit and several
mitochondrialROSproductionatlevelsachievablein side-effects.464
vivo.459,460 Aurothioglucose also inhibits thioredoxin
reductase,aswellasGPx(athigherconcentrations).460
SomedrugsusedinthetreatmentofRAmightthem- 10.12 Inflammatoryboweldisease465,466
selves be converted into RS. For example, in vitro
studies show that radicals derived from penicillam- Reactive species may be involved in tissue injury in
ine, indomethacin, phenylbutazone, diclofenac, some theinflammatoryboweldiseases(IBDs)suchasCrohn
fenamic acids, and the aminosalicylate component of diseaseandulcerativecolitis.Theformerisarecurrent
sulphasalazine can inactivate α -antiproteinase, oxid- inflammation and ulceration of the whole digestive
1
ize ascorbic acid, and accelerate lipid peroxidation. tract,althoughitisoftenmostsevereinthelowerpart
Such radicals might form in vivo when drugs are of the ileum, and in the colon and rectum. In ulcera-
oxidized by MPO413 (e.g. diclofenac, indomethacin, tivecolitis,theulcerationandinflammationaffectthe
phenylbutazone), the peroxidase action of COX (e.g. mucosa of the colon and rectum only. In both con-
phenylbutazone),orbydirectreactionofthedrugwith ditions, autoantibodies to bowel constituents can be
RS (e.g. aminosalicylate, penicillamine). For example, foundinplasma.Patientssufferseverediarrhoea,pain,
thiyl(RS•)andmorereactive(RSO • andRSO•)radicals fever, weight loss, and are at increased risk of devel-
2
(Section2.5.5)formedwhenpenicillaminereactswith opingcolorectalcancer.Thesediseasesseemtoresult
RS could combine with proteins, alter their antigen- fromanabnormalimmuneresponsetothegutflorain
icity, and account for penicillamine’s ability to cause geneticallysusceptiblesubjects.
autoimmunityinRA(Section10.10.1).Theimportance As in the case of RA, the tissue injury and inflam-
ofthesevariousreactionsinvivoisasyetunclear. mation associated with IBDs involve the extensive

--- Page 621 ---

566 FREE RADICALS IN BIOLOGY AND MEDICINE
recruitmentandactivationofneutrophils,monocytes, lackingphagocyteNADPHoxidaseactivity(knockout
and lymphocytes, inflammasome formation, and the of p47phox), the inflammation was unchanged. How-
overproduction of cytokines (e.g. IL-1β, TNF-α), ever, in one471 (but not another)472 study in mice
eicosanoids,proteinasesandRS,includingHOCland overexpressingCuZnSODtheinflammationwasmore
ONOO–. There is marked activation of NF-κB in gut severe, hinting that O •– production might be neutral
2
epithelial cells and phagocytes. Hydrogen peroxide, or beneficial. In contrast, mice lacking Nrf2 showed
HOCl, and chloramines are capable of increasing the aggravated inflammation in this model, and various
permeabilityofthegutwallandpromotingelectrolyte administeredantioxidantsseembeneficial.467,473 Nev-
secretion,perhapscontributingtothediarrhoea.Bleed- ertheless,patientswithchronicgranulomatousdisease
ing is common in the inflamed gut and may provide frequently develop chronic colonic inflammation re-
a sourceof iron for OH• generation.In addition,fae- semblingCrohndisease,consistentwiththeviewthat
cesoftencontain‘catalytic’ironunabsorbedfromthe RScouldsometimeshavebeneficialeffects.474 Tetom-
diet(Section7.2.2).Immunocytochemicalevidencefor ilast, an inhibitor of phagocyte O
•–
production, has
2
formation of nitrotyrosine has been obtained in sev- been tested in IBD patients but the extent of its be-
eral animal models of IBD and in biopsies from pa- nefitisuncertain(Section11.7.3).Indeed,littlebenefit
tientswithulcerativecolitisandCrohndisease.Actin would be predicted if ROS are good things overall
isoneoftheproteinsnitrated.467 Intra-rectaladminis- inIBD.
trationofbolusONOO– toanimalsprovokesasevere
inflammation, consistent with its contributing to in-
10.12.1 Thesalazines
jury in IBDs.467 However, increased NO• production
in IBD patients must not be assumed to be all bad, One popular treatment for IBD is sulphasalazine
since NO• may depress phagocyte recruitment, e.g. (Fig.10.14);theactiveconstituentis5-aminosalicylate
by decreasing synthesis of adhesion molecules. In- (mesalazineormesalamine),generatedbyhydrolysis
creased levels of NO–/NO– arising from NO• in the ofsulphasalazinebycolonicbacteria.Indeed,boththis
2 3
gut may favour the growth of some bacteria, such andotheraminosalicylates,suchas4-aminosalicylate,
asE.coli.468 areusedtotreatIBD.Anti-TNF-αantibodiesandster-
Is the increased production of RS in IBD a ma- oidsareusedinseverecases.
jor contributor to tissue injury? The answer is as yet Aminosalicylates are powerful scavengers of OH•,
unclear, but evidence consistent with their import- ONOOH, and HOCl in vitro and may be able to de-
ance is provided by the observation that transgenic creaseNF-κBactivationinvivo.475 Sincetheyaccumu-
mice lacking both GPx1 and GPx2 (the two major late in the bowel to millimolar levels during therapy,
GPx types in colonic epithelium) show spontaneous scavenging of RS is feasible.475 Evidence consistent
colonic inflammation and cancer development.469 In withthisisprovidedbytheisolationfromfaecesofIBD
a mouse model of IBD, levels of GSH in the colon patientsofwhatappeartobeROS-generatedoxidation
droppedpriortoonsetofinflammation;preventionof products of 5-aminosalicylate.476 However, it is also
thisbyadministeringN-acetylcysteineslowedthede- possible that oxidation products of aminosalicylates
velopment of inflammation. Levels of GSH are also (e.g. iminoquinones and quinones) could cause dam-
sub-normalinthemucosaofIBDpatients.465 Patients age,e.g.byattackingproteins.477 Orareaminosalicyl-
with Crohn’s disease show elevated plasma F
2
-IsoP atesbeneficialbecausetheyincreaseoxidativedamage
levels; in one study these were decreased by admin- perhaps?
istration of vitamin C plus α-tocopherol, but it is not
clear if there was clinical benefit.470 The increased
10.12.2 Coeliacdisease
risk of cancer in ulcerative colitis may involve DNA
damagebyRS;indeed,levelsof8OHGandofetheno- Thisisanautoimmunedisorderofthesmallintestine
DNA adducts in DNA from the inflamed colon are triggeredasaresponsetocertaindietaryproteins,such
elevated.466 asglutenincereals.Asusual,theresultinginflamma-
Nevertheless, be cautious. A popular (although tioncausesincreasedROSproduction,loweredlevels
perhaps not that relevant to human IBD)301 animal of antioxidants (e.g. GSH) in the small intestine, and
model is to administer dextran sodium sulphate in increasedurinary8OHdGexcretion.RShavebeensug-
thediet:thissulphatedpolysaccharideinduceschronic gested to contribute to the intestinal damage,478 but
colon inflammation.467 When this was done to mice howmuchtheydoisasyetunclear.

--- Page 622 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 567
10.13 Inflammationofotherparts predisposition to ulcer formation, and elevated risk
ofthegastrointestinaltract of gastric cancer. Other Helicobacter species can be
found in the stomachs of different animals. Levels of
10.13.1 Pancreas479
lipid peroxidation, and of 8OHG and 8-nitroguanine
inDNA,areelevatedinthegastricmucosaofinfected
Pancreatitisisaninflammatorydiseasecausingintense
patients,andGSHlevelsaresubnormal,asareascor-
pain and destruction of pancreatic tissue. It can be
bate levels in the gastric fluid.483–485 The phagocyte
provokedbyseveralfactors,includingexcessalcohol,
infiltrationandRSformationmaybeattemptsbythe
obstructionofthepancreaticductbygallstones,orby
body to eradicate the bacterium, but sadly they are
a period of pancreatic ischaemia, e.g. after haemor-
rhagic shock. Cytokines, NF-κB activation, adhesion not successful (indeed, H. pylori turns them against
the host by altering assembly of the NADPH oxi-
molecules, phagocytes, and iNOS are involved, and
dase so that much of the O
•–
is directed away from
severepancreatitiscantriggerARDS.Indeed,F 2 -IsoP 2
H. pylori and released extracellularly; Section 8.9.6).
levels are increased in bile from patients with pan-
H. pylori is resistant to ROS, in part due to its high
creatitis and there are more etheno–DNA adducts in
contentofcatalases,peroxiredoxins,iron-bindingpro-
DNAfromtheinflamedpancreatictissue.Somestud-
teins, and methionine sulphoxide reductase.486,487 It
ies have shown that the injury induced by fatty-acid
contains the enzyme urease, which hydrolyses urea
infusion,ischaemia,orpartialductobstructioniniso-
andreleasesCO thatcancombinewithONOO–(Sec-
lated perfused animal pancreases can be diminished 2
byincludingantioxidantsinthemedium.480 Whether
tion2.6.1),decreasingONOO–’sbactericidalaction.488
The ammonia produced by urease helps to con-
RScontributesignificantlytopancreatitisisanimport-
trol pH in the microenvironment of the organism,
antissue,sincecurrenttreatmentsforitareinadequate.
and can also react with HOCl to give less-reactive
Someclinicaltrialssuggestedthatadministeringamix-
ture of ascorbate, selenium, β-carotene, α-tocopherol, monochloramine,NH 2 Cl.483
SoareRSdamaginginH.pyloriinfection?HostDNA
andmethioninetopatientscoulddecreasethesevere
is oxidatively damaged, including the p53 gene. This
pain associated with chronic pancreatitis. However
organismcanbeeradicatedbyantibiotictreatment,but
other studies have not confirmed this and overall
additionalsupplementsofvitaminCandα-tocopherol
there is little compelling evidence of clinical benefit
did not appear to add clinical benefit.489 Indeed, in
ofantioxidantsupplementstopatients;plusthereare
suggestionsthattheymightsometimesdoharm.479,481
micelackinggp91phox,gastricdamagebyH.pyloriwas
moresevere.Thiswasnotduetoanincreaseinbacterial
numbers,butrathertogreatertissueinjurybyneutro-
10.13.2 Oesophagusandstomach
philgranulecomponents.490Thisisyetmoreevidence
Reactive species have been suggested to be involved to reinforce the growing view that RS sometimes act
in inflammation of the oesophagus (e.g. after reflux todown-regulateinflammation.Indeed,CGDpatients
of acid and bile salts from the stomach and duo- canshowworsegastricdamagethannormalsubjects
denum due to weakness of the sphincter) and in wheninfectedwithH.pylori.491
gastric damage secondary to haemorrhagic shock or
inflammation.482Indeed,‘Barrett’soesophagus’dueto
10.13.3 Liver
refluxisariskfactorforcancerdevelopment.483Inthis
condition,normaloesophagealepitheliumisgradually Inflammationoftheliver(hepatitis)isamajorclinical
replacedbysecretoryepithelialcellsofatypeusually problem.Causesincludealcoholabuse(Section9.8.1),
foundwithinthestomach(thisisanexampleofmeta- infection with viruses such as hepatitis B or C or
plasia:onetypeofnormalcellisdisplacedbyanother parasites such as the liver fluke Opisthorchis (Section
typenotnormallypresentthere,althoughstillappar- 10.14.11), and exposure to toxins such as chlorinated
ently a normal cell). It can progress via hyperplasia hydrocarbons(Section9.2).SourcesofRSinhepatitis
(an excessive density of cells, although still normal include infiltrating neutrophils, activation of Kupffer
looking)toeventualcancerdevelopment. cells, and of other NADPH oxidase enzymes in hep-
ROSmayalsocontributetogastricinjuryinchronic atocytes. Iron accumulation often occurs in damaged
infection by Helicobacter pylori. This organism infects liver(especiallywithhepatitisCinfection),andseems
thestomachsofmanyoftheworld’spopulationand, to contribute to oxidative injury.492 Vice versa, oxida-
in a minority of cases, causes inflammation (with tivedamagemaycontributetotheironaccumulation,
neutrophil, lymphocyte, and monocyte infiltration), bydecreasingtheproductionofhepcidin.493

--- Page 623 ---

568 FREE RADICALS IN BIOLOGY AND MEDICINE
Hepatitisisariskfactorforthedevelopmentofliver NOX4 and infiltrating lymphocytes.500 Indeed, bile
cancer (Section 10.14.11). Indeed, increased levels of saltscanactivateNADPHoxidaseenzymesundercer-
8OHG and 8-nitroguanine are present in DNA from tain conditions.482 Chronic inflammation of the gall
the inflamed liver in hepatitis C patients,494 and sub- bladderisariskfactorforcancerdevelopmentthere,
jects infected with hepatitis B virus or Opisthorchis and levels of 8OHG are elevated in the DNA of the
excrete more etheno-DNA adducts in urine.495 In pa- inflamed tissue,501 as are levels of oxidized proteins
tients chronically infected with hepatitis C virus, ele- (Section6.16.3).
vatedlevelsof8OHGinliverDNAseemtobearisk
factor for the subsequent development of cancer;492
10.14 Oxidativestressandcancer:
consistentwiththis,micelackingCuZnSODshowele-
acomplexrelationship502–506
vated 8OHG levels in liver DNA and develop more
hepatomas.496 Plasma F 2 -IsoP levels are elevated in 10.14.1 Thecellcycle
hepatitispatients497andseveralstudieshaveexamined
theeffectsofadministeringα-tocopherolorotheranti- Most cells in an adult, multicellular animal are not
oxidants.Sadly,clinicalimprovementshavegenerally dividing and must receive mitogenic signals (e.g.
been minimal or absent.498,499 Of course, the antioxi- from platelet-derived growth factor (PDGF), epider-
dants may not have decreased the oxidative damage mal growth factor (EGF), insulin-like growth factor 1
(Chapter 4). Severe liver damage can elevate blood (IGF-1),fibroblastgrowthfactor(FGF),erythropoietin,
NH + concentrations, potentially toxic to the brain IL-2,orIL-3tostarttheprocess.Somegrowthfactors
4
(Table10.7). act on a range of cells (e.g. PDGF, FGF, EGF, IGF-1)
Inflammation of the bile ducts (e.g. as a result of whereas others are more selective. Cells will only re-
parasite infection or immunological attack) can inter- spond if they express receptors for the growth fac-
ferewithnormaldrainageofthebile,leadingtoliver tor,bindingtowhichactivatesintracellularsignalling
damage by the retained bile constituents, and even- mechanisms that lead to changes in gene expression
tual liver fibrosis. Both the initial ductal inflamma- and frequently involve ROS (Section 5.5.4). There are
tion and the subsequent liver damage (including the also agents that inhibit cell division, e.g. TGF-β often
fibrosis)havebeensuggestedtoinvolveRS,e.g.from does (Section 5.7.3) In adult humans, neurons do not
Table10.7 Someneurotoxicagentswhoseactionmayinvolveoxidativestress.
Typeofagent Examples Moreinformationin
Inhibitorsofenergy Cyanide,carbonmonoxide,iodoacetate,rotenone, ThischapterandTable4.1.
metabolism antimycinA,nitropropionicacid,malonicacid,MPP+,
ethanol(cancausethiaminedeficiencyandimpairglucose
metabolism).
Excitotoxicagents Kainate,quinolinate,domoicacid. Thischapter.
Metals Copper,lead,mercury,tin,aluminium,manganese,iron. ThischapterandSection9.16.
Organicsolvents Ethanol,toluene,n-hexane,pyridine ThischapterandSection9.8.
Agentsaffecting Buthioninesulphoximine(GSHdepletion),aminotriazole Thischapter,Chapter3,andSection9.8.1.
antioxidantdefences (catalaseinhibitor),chloropropionicacid(GSHdepletion),
mercaptosuccinate(GPxinhibition),ethanol
Freeradicalgenerators 6-hydroxydopamine,paraquat,ethanol,sulphite,CCl4, ThischapterandChapter9.
somecancerchemotherapeuticagents(e.g.anthracyclines,
proteasomeinhibitors).
Otheragents Cocaine,methamphetamine,ecstasy,heroin,haloperidol, Chapter9.
morphine,chlorpromazine,phenytoin
Ammonia Elevatedlevels(e.g.ininborndisordersoftheureacycle, Nat.Med.19,1643,2013;Hepatology,48,567,
orinliverfailure)areneurotoxicsinceNH3readilycrosses 2008;Metab.Brain.Dis.25,3,2010.
theblood-brainbarrier;increasesinextracellularK+levels
andoxidativedamagetoproteins,DNAandRNAmaybe
involvedintheneurotoxicity.

--- Page 624 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 569
divide at all, hepatocytes perhaps once a year or so, animal cells, one major checkpoint is in G ; entrance
1
whereassomeepithelialcellsintheintestinemaydiv- intoSisblockedifthegenomeisdamaged.DNArep-
ide twice daily as the intestinal lining is constantly lication during S itself can also be halted in response
renewed.Inculture,manycellssuppliedwithserumas toDNAdamage.AcheckpointinG canhaltentrance
2
asourceofgrowthfactorswillgrowuntilaconfluent into mitosis if DNA replication is not completed or
monolayer is obtained—in general, when cells touch theDNAstillhasunrepaireddamage.Thecheckpoint
each other, proliferation is inhibited. Both adhesion mechanismsbothhaltreplicationandhelptopromote
moleculesandgapjunctionalproteins(e.g.connexins; repairofDNAdamage.
Section5.2.4)areinvolvedinthiscontactinhibition. Proteins involved in the G checkpoint include
1
To produce a pair of genetically identical daugh- ATM(Sections5.10.6and5.10.8)andATR(‘ATMand
tercells,theDNAmustfirstbeaccuratelyreplicated. Rad-3related’).ATMrecognizesdouble-strandbreaks,
Celldivisionbeginswithmitosis(Mphase),thepro- whereasATRisactivatedbyUV-radiationandunrep-
cessofnucleardivision.Thenuclearenvelopebreaks licated DNA (stalled DNA replication). Both lead to
down,chromatincondensesintovisiblechromosomes, activationofcheckpointkinasesthatcanactivatep53
and the cellular microtubules form a mitotic spin- (Section10.14.4.2)byphosphorylation.Thep53protein
dle on which the chromosomes eventually separate. isalsoinvolvedintheG checkpoint.Themovement
2
In anaphase the chromosomes move to the poles of ofcellsfromG toScanalsobeblockedbylackofnu-
1
thespindleandreformintactnuclei,andthecellthen trientsorbyoxidativestress.Thelattereffectispartly
divides in two. In most cells M phase is short (often mediated by DNA damage induced by RS, but also
60minorless)bycomparisonwithinterphase,thegap involves FOXO transcription factors. If nutrients are
betweenMphases. missingand/orthereisoxidativestress,FOXOsaccu-
Replication of nuclear DNA occurs in the S phase mulateinthenucleus(Section5.5.4.2)andcanleadto
(S for ‘synthesis’) of interphase. Cells in S phase can increasedlevelsofcytostaticandpro-apoptoticfactors.
be recognized experimentally because they take up
DNA precursors, such as bromodeoxyuridine, a thy-
10.14.2 Tumours502
midineanaloguethatcanbedetectedinthenucleusby
antibody staining techniques (Table 6.8). The interval Thereare over3 ×1013 cellsin thehuman bodyand
betweencompletionofmitosisandthestartofanew about 1016 cell divisions per lifetime (~3 × 1011 per
roundofDNAsynthesisistheG
1
phase;theG
2
phase day)inthehumanbody,andabout1012inthemouse.
is the gap between finishing DNA synthesis and the The ‘spontaneous’ mutation rate due to errors made
onsetoftheMphase,whenthecellispreparingitself by DNA polymerases has been estimated as 10–6 per
formitosis(e.g.increasingitslevelsofbiomoleculesto gene per cell division. Hence each gene might have
ensure that each daughter cell receives a fair share). undergone1010mutationsinthehuman(106inmouse)
The G 1 and G 2 phases provide time for cell growth lifespan.Mechanismstorepairdamageandeliminate
andsynthesisofothercomponents,andforrepairing mutatedcellsarethusessential.
anyerrorsmadeinDNAreplication.CellsinG 1 ,ifnot Atumourmaybedefinedasanabnormallumpor
yetcommittedtoDNAreplication,canhalttheirpro- mass of tissue, the growth of which exceeds, and is
gressaroundthecellcycleandarethensaidtobein unco-ordinatedwith,thatofthenormaltissue,i.e.nor-
aresting,G o ,state.Withdrawalofgrowthfactorsfrom malintercellularcollaborationhasbrokendown.Most
proliferatingcellssendsthemintoG o . tumoursformdiscretemasses,butintheleukaemias
Control of the cell cycle needs many proteins; an (tumours of myeloid or lymphoid cells) the tumour
essential group is the cyclin-dependent protein kin- cellsspreadthroughthebonemarroworlymphoidtis-
ases (cdk), serine–threonine kinases whose ability to sues,andcirculateintheblood.Tumoursvarywidely
phosphorylatetheirtargetsisregulatedbyanotherim- in their growth rates. The most important classifica-
portantproteinclass,thecyclins.Differentcyclin/cdk tion is that of benign or malignant. Benign tumours
complexes are assembled and activated at different remainatthesiteoforigin.Whengrowinginasolidtis-
pointsinthecellcycle.Ubiquitinandtheproteasome sue,theyusuallybecomeenclosedinalayeroffibrous
(Section5.14.3.2)playkeyregulatoryrolesbydegrad- material, the capsule. Benign tumours rarely kill, un-
ingcyclins.Alsoimportantarecheckpointsatvarious lesstheypressonavitalstructureorsecreteabnormal
stagesofthecellcycle;thecellmusthavefulfilledcer- amountsofhormones.
taincriteria(e.g.DNAreplicationcompleted,acertain Most fatal tumours are malignant, or cancerous.
minimumsize),beforemovingontothenextstage.For They contain malignant cells in a matrix rich in

--- Page 625 ---

570 FREE RADICALS IN BIOLOGY AND MEDICINE
fibroblasts and cells of the host immune system colon(Section7.2.1).509Obesity(viainflammationand
(Section 10.14.8.7). Unlike benign tumours, the cells ROS perhaps; Section 10.4) is also a risk factor for
of malignant tumours invade locally (crossing the these cancers, whereas diets rich in fruits and veget-
basement membrane to invade the surrounding ablesareprotectiveagainstseveral(butnotall)types
stroma),andoftenalsopassthroughthebloodstream ofcancer(Section4.1).Somepeoplearemoresensitive
and/orlymphaticsystemtoformsecondarytumours to environmental or self-administered (e.g. cigarette
(metastases) at other sites. This involves release of smoke)carcinogensthanareothers,inpartduetodif-
the cell from the matrix, prevention of the apoptosis ferencesintherelativelevelsoftheirphaseIandphase
(anoikis; Section 5.4), that usually occurs when cells IIxenobioticmetabolizingenzymes(e.g.Section9.13).
detachfromtheirnormalenvironment,andmigration The environment of the tumour is also important;
through the tissue and vessel walls to enter the cir- e.g.areinflammatorycellspresent(inflammationcan
culation. Rates of growth and metastasis differ from promotetumourdevelopmentbutalsodamagemalig-
tumourtotumour;forexamplebasalcellcancerofthe nantcells),isintercellularcommunicationtakingplace,
skin(whicharisesfromkeratinocyteprecursors)rarely what are the levels of growth factors and hormones
metastasizes, whereas melanoma (which arises from that influence cell growth and proliferation, and can
pigment cells) frequently does. Cancers are classified thetumourgetanadequatebloodsupply?
accordingtothetissuesfromwhichtheyarose,e.g.car- The development of cancer usually takes years
cinomasarisefromepithelialcellsandsarcomasfrom and involves progressive tissue and cellular changes
connectivetissueormuscle. (Table10.8andFig.10.15).Forexample,colorectalcan-
Malignant transformation is accompanied by cersarecommonage-relatedcancersworldwide;they
changesincellmetabolism,inparticularanincreased arise from the epithelium lining the colon and rec-
rate of glycolysis and resulting lactate production tum. Often they are preceded by a benign tumour,
(Fig. 1.7). The pentose phosphate pathway (PPP) an adenoma, called a polyp. Colorectal cancer aris-
is activated, to produce NADPH to drive biosyn- inginsubjectswithulcerativecolitisseemstoinvolve
thetic reactions (e.g. DNA replication and fatty acid a gradual progression from inflamed colorectal epi-
synthesis) and perhaps to help modulate oxidative thelia showing hyperplasiab, to dysplasiab and even-
stress.507 Cancer cells are thus avid consumers of tualadenocarcinoma.
glucose.ThesechangesinglycolysisandPPPinvolve Studies of the action of carcinogens in mouse skin
severalmechanisms,includinginhibitionofpyruvate (painting the skin with carcinogenic hydrocarbons
kinase M2 by the oxidation of cysteine residue 358, such as benzopyrene or dimethylbenzanthracene;
apparentlybyH O .508 Section10.15)werethefirsttorevealthattwodistinct
2 2
stagesofcarcinogenesiscanbedefined,andlaterwork
10.14.3 Carcinogenesis502 identified a third stage (Table 10.8). This three-stage
modelapplies(withreservations)tomanycancers.
Theconversionofanormalcelltothemalignantstateis
calledcarcinogenesis,andagentsthatinduceitarecar- 10.14.3.1 Initiation
cinogens.Carcinogenesisisacomplex,multistagepro-
Initiation is caused by DNA alteration, such as reac-
cess;essentially,anabnormalcellisgeneratedandthen
tionofcarcinogenswithDNA.Themajorprotections
givesrisetoalargernumberofincreasinglyabnormal
againstinitiationarelimitingexposuretocarcinogens,
cellsasaresultofaseriesofmutations,celldivisions,
efficiencyofcarcinogendetoxificationbyphaseI/IIen-
andchangesinthepatternofgeneexpression.
zymes,DNArepair,elimination(e.g.byapoptosis)of
Factors predisposing to malignancy are both in-
cells with damaged DNA or sending such cells into
herited and environmental. For example, the risk of
senescence(Fig.10.15).
developing breast and ovarian cancers is affected by
Successful initiation requires not only DNA modi-
genetic predisposition (e.g. mutations in the genes,
ficationbutalsoatleastoneroundofDNAreplication
BRCA1a and BRCA2), the products of both of which
andcellproliferationtoallowthemutationtobe‘fixed’
areinvolvedinDNArepair.504 Cancerincidenceisaf-
in the DNA before repair can remove the mutagenic
fected by diet; for example, a high-calorie (especially
lesion. The cell proliferation may be occurring nor-
meat/fat-rich)dietisariskfactorforbreastandcolon
mallyinadividingtissue,couldbestimulatedbythe
cancer. Haem especially may be pro-oxidant in the
a Breastcancertype1susceptibilityprotein b ThesetermsareexplainedinSection10.13.2.

--- Page 626 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 571
Table10.8 Thestageofcarcinogenesis.
Stage Description
Initiation Characterizedbyirreversiblegeneticchanges.ExamplesofinitiatorsincludechemicalsthatreactdirectlywithDNA(canbe
endogenous,suchascertainRS[e.g.OH•]orxenobiotic).Singleinitiatedcellsarenotmorphologicallyrecognizable;mayhave
subtlephenotypicchangesaftermultiplication.
Promotion Usuallyreversibleprocessofgeneactivation;oftentheresultofactionofxenobioticsorendogenoussubstances;mayproducea
benigntumourfrominitiatedcells.Mayhaveseveralstages(earlyreversible,andlateirreversible).
Progression Conversionofbenigntomalignanttumours,usuallyaccompaniedbyfastergrowth,invasiveness,increasedgeneticinstability,
oftenmetastasis.Maybeassociatedwithfurtherirreversiblegeneticchange.Examplesincludeprogressionofbenignpapillomasto
squamouscellcarcinomainmouseskin,benigncolonpolypstoadenocarcinoma,andfocalbenignhepaticnodulestohepatoma.
AdaptedfromTable1inBlood76,655,1990,bycourtesyofProfessorS.A.Weitzmanandthepublishers.ConsideringthenumberofcelldivisionsanderrorsinDNA
replicationoverthehumanlifespan,itisperhapsremarkablethatonlyaboutone-thirdofhumansdevelopcancer.Thisisbecausecellscandie,haltproliferation,or
senesceateverystage(Fig.10.15).
Loss of cell
differentiation/
apoptosis/
Normal cell Potential senescence
controlled proliferation oncogenic
survival signals alteration 1
Loss of cell
differentiation/
apoptosis/
Retention of cell Potential senescence/
oncogenic hypoxia
continued proliferation
alteration 2
survival
Loss of cell
differentiation/
apoptosis/
senescence/
Retention of cell
Potential hypoxia/
continued proliferation oncogenic confinement
survival alteration 3
angiogenesis
Retention of cell
continued proliferation
survival
immortalization
angiogenesis
invasion
Figure10.15 Developmentofcancerismorecomplexthanthestraightforwardlinearaccumulationofoncogenicmutations.Potentially
oncogenicproliferativesignalsarecoupledtoavarietyofgrowth-inhibitoryprocesses,suchastheinductionofapoptosis,differentiation,or
senescence,eachofwhichrestrictssubsequentclonalexpansionandneoplasticevolution.Tumourprogressionoccursonlywherethesegrowth-
inhibitorymechanismsfailtoworkorarethwartedbycompensatorymutations.FromNature411,342,2001,bycourtesyofElsevierandDrsG.I.
EvanandK.H.Vousden.Alsoseerefs502,505.
initiator, or might occur secondarily because of the 10.14.3.2 Tumourpromoters
need to replace some cells killed by the carcinogen.
Initiationcanbefollowedbypromotion.Tumourpro-
Ofcourse,ifalltheinitiatedcellsarekilledtheprob-
moterscauseexpressionofthelatentphenotypeofini-
lemdisappears.Mosthumancancersarecarcinomas,
tiatedcells(Table10.8)byselectionandclonalexpan-
inpartbecauseepithelialcellsoftenproliferaterapidly
sion, promoting cell proliferation and/or decreasing
inthehealthyanimalandtheyarefrequentlyexposed
apoptosis.Manycarcinogens,inlargedoses,areboth
tocarcinogens,e.g.ininhaledairorfromdiet.

--- Page 627 ---

572 FREE RADICALS IN BIOLOGY AND MEDICINE
O because they often grow well in culture, but they
C (CH 2 ) 12 CH 3 are often not a good model of normal physiology
O (Section1.11).
O
18
H 3 C 12 13 O C CH 3
1 H H O 11 14 15 C 17 H 3 10.14.4 Genesandcancer502,504,505
H 3 C 2 10 9 8 H H 1 C 6 H 3 Changes in several types of genes play key roles in
3 4 7 cancer.Letusconsidersomeofthem.
5
O OH 6
CH 2 OH 10.14.4.1 Oncogenes
20
Oncogenes were first discovered by a virologist; the
Figure10.16 Structureofphorbolmyristateacetate(PMA).Itsfull resultofanencounterin1909betweenafarmerinLong
chemicalnameis12-O-tetradecanoylphorbol-13-acetate.
Island (USA) whose chickens were sick and the dis-
tinguishedresearcherPeytonRous.Severalvirusesin-
ducetumoursinanimals,e.g.theRoussarcomavirus
initiators and promoters. However, a dose of a carci-
(namedafterhim)wascausingsarcomasinthechick-
nogen too small to induce a tumour can lead to can-
ens.Frommanyofthesevirusesoncogeneswerethen
cerifsuppliedtogetherwithcertainnon-carcinogens,
identified,specificgenesthatcantransformcertainan-
theso-calledtumourpromoters.Forexample, croton
imal cells in culture into a malignant state when the
oil, a non-carcinogen, promotes the development of
virusinfectsthem.Roussarcomaviruscontainstheon-
cancer by sub-carcinogenic doses of the hydrocarbon
cogenesrc,aproteintyrosinekinase.Itwassoonfound
methylcholanthrene, but only if the oil is given with,
that normal mammalian cells contain genes (proto-
or after, the methylcholanthrene. Croton oil comes
oncogenes)thatresembletheviraloncogenes.Thusthe
from seeds of the plant Croton tiglium. Fractionation
normalcellularanalogueoftheviralsrc(v-src)geneis
oftheoilshowedthatthemostpowerfultumourpro-
c-src(sometimesjustwrittenassrc).
moterpresentisphorbolmyristateacetate(PMA,Fig.
Proto-oncogenes are frequently related to cell
10.16),acompoundfrequentlyusedtoinducethere-
growth. Often they encode growth factors, growth
spiratory burst in phagocytic cells (Section 8.7.4.1).
factor receptors, proteins involved in transferring the
Many tumour promoters, including PMA, are potent
growthsignalfromreceptorstothenucleus(e.g.pro-
inducersofinflammation,butnosinglemechanismex-
teinkinases),orproteinsinvolvedincontrolofthecell
plainstheactionofallthedifferentpromotingagents.
cycle,orcelldeath(Table10.9).Manyoncogeneshave
TCDD (Section 9.3.2) can act as a promoter in some
been identified by means other than the use of vir-
systems.
uses,forexamplebydirectidentificationinmalignant
Duringpromotion,thealteredDNAoftheinitiated
tumours or analysis of chromosomal abnormalities.
cellisrevealedbychangesintheexpressionofgenes
Examples are N-ras and bcl-2; the last is involved
that regulate cell differentiation and growth. Tumour
in suppressing apoptosis (Section 5.4.2). In essence,
promoters can produce changes in cell proliferation
oncogenesareactivatedproto-oncogenes,suchthatthe
andphenotypicexpression(Table10.8).Removalofthe
geneisalwaysexpressed,oratleastexpressedunder
promoter (at least in the early stages of promotion)
conditionswherethewild-typegeneisnot.Activation
often results in the tissue returning approximately to
canbebymutationoftheproto-oncogene,geneamp-
normal,althoughitwillstillbeinitiated.
lification, or chromosomal rearrangements that place
the gene in a region of the chromosome being exten-
10.14.3.3 Progression
sively transcribed, so that abnormally large amounts
The final stage of carcinogenesis is the development oftheproto-oncogeneproductaremade.Forexample,
of a premalignant lesion into a malignant one. This the oncogene erbB (Table 10.9) is a mutated form of
tumour progression involves additional changes in the EGF receptor that ‘sends a signal’ all the time.
DNA. Malignant (transformed) cells in culture lose Rasmutationsarecommoninhumancancers.Apoint
contact inhibition and can proliferate without attach- mutation results in diminished ability to hydrolyse
menttoasubstratum.Oftenthereisdown-regulation GTP(Table10.9).TheGTP-boundconformationisac-
of connexin synthesis and hence of communication tiveinsignaltransductionandtheGDP-conformation
through gap junctions. Many studies of cell and inactive (Section 5.5.4), so that loss of GTPase pro-
molecularbiologyareperformeduponmalignantcells motes excessive signalling. In the mouse skin cancer

--- Page 628 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 573
Table10.9 Someoncogenesoriginallyidentifiedintransformingviruses.
Oncogene Functionofgeneproduct Sourceofvirus Virus-inducedtumour
Src Tyrosinekinase Chicken Sarcoma
Abl Tyrosinekinase,involvedinsuppressingapoptosis(Section5.5.4) Mouse,cat Leukaemia,sarcoma
erb-B Tyrosinekinase:epidermalgrowthfactorreceptor Chicken Erythroleukaemia,fibrosarcoma
fos,jun FosandJunproteinsassociatetoformAP-1(Section5.5.7) Mouse,chicken Osteosarcoma,fibrosarcoma
Raf Proteinkinase(serine/threonine)activatedbyRas Mouse,chicken Sarcoma
Myc Transcriptionfactor;normallyactsinnucleusassignalforcell Chicken Myeloidleukaemia
proliferation
H-ras,K-ras GTP-bindingproteins;cyclebetweenactive(GTP-bound)andinactive Rat Sarcoma
(GDP-bound)states;hydrolysisofGTPstopsactivity(Section5.5.7)
v-rel Gene-regulatoryproteinrelatedtoNF-κB(Section5.5.6) Turkey Lymphomainspleenandliver
Sis Platelet-derivedgrowthfactorB-chain Monkey Sarcoma
Mosthumancancersarenotrelatedtoviralinfection,butsomeare,e.g.Burkittlymphoma(Epstein–Barrvirus)andadultT-cellleukaemia/lymphoma(human
T-cellleukaemiavirustypeI,HTLV-I).Ingeneral,viralinfectionalonedoesnotproducecancer—manyothereventsareinvolved.Thus<5%ofadultsinfectedwithHTLV-I
developleukaemia.DNAtumourvirusesoftenalsoencodeproteinsthatinactivatetumoursuppressorgenes.Sometimesvirusescanpredisposetocancerbyprovoking
inflammation,e.g.hepatitisBandC(Section10.25).
experiments(Section10.14.3),thecancersthatemerge theoncogenes’;thepresenceofactiveoncogenessuch
carrypoint-mutatedH-rasoncogenes,whichpromote as myc also activates p53 to halt replication or pro-
rapidproliferation. moteapoptosis.512ROScanbeinvolvedinthisprocess
(Section11.3.5).
Innormalcells,p53levelsarelow.Itissynthesized
10.14.4.2 Tumoursuppressor
constantlybutrapidlydegraded.Thisisfacilitatedby
genes502,505,507,510,511
MDM2, a protein that blocks the action of p53 as a
Anactiveoncogenehasbeencomparedtoacarwith transcription factor and facilitates its ubiquitination
a stuck accelerator—the car moves even if you take for destruction by the proteasome (Section 5.14.3.2).
yourfootoffit(footequalsgrowthsignal!).However, The presence of DNA damage or oncogenic signal-
thecarwillstillstopifthebrakeispressed.Mutations lingleadstostabilizationofp53againstdegradation.
intumoursuppressorgenesareanalogoustoafaulty Severalotherstimulicandothesame,includinghyp-
brake—theynolongerworktohaltproliferationofan oxia. How is this stabilization achieved? Phosphor-
abnormalcell.Themostimportanttumoursuppressor ylation is key to the recognition of DNA damage.
gene is p53, so called because the relative molecular For example, double-strand DNA breaks activate the
massofitsproteinproductis53,000.Itisthemostfre- ATM kinase, which then phosphorylates p53, which
quentlymutatedgeneinhumancancers.Thep53pro- prevents MDM2 from acting. ATM kinase can also
teinisatranscriptionfactorthatcansenseDNAdam- phosphorylateandinactivateMDM2.Single-stranded
age.Whenitdoes,ithaltsthecellcycleandfacilitates DNA,whichcanaccumulateifDNAreplicationstalls
DNA repair. Thus it has been called ‘guardian of the becauseabnormalbasesarepresent,cantriggertheac-
genome’.TheDNAdamagecanbecausedbyUVlight, tionofotherkinasesthatphosphorylatep53.Another
ionizing radiation, other sources of DNA-damaging means of regulation is by acetylation (Section 11.3.4).
ROS, or by DNA-modifying agents (carcinogens and Oncogenic signalling acts through the ARF (‘alterna-
chemotherapeuticagents).Ifp53perceivesthedamage tivereadingframe’)protein,whichagaininhibitsthe
tobetoosevere,itcanpromoteapoptosis,e.g.byin- functionofMDM2andthusstabilizesp53.
creasing the synthesis of pro-apoptotic proteins such Once it has accumulated, active p53 protein in-
asbax(Section5.4.2).Micelackingp53rapidlydevelop creases transcription of other genes, including p21
cancers(sarcomasandleukaemias).Humanswiththe (which encodes a cyclin kinase inhibitor), Gadd45
Li-Fraumeni syndrome, named after its discoverers, (growth arrest and DNA damage inducible), and
arealsocancer-prone,duetoinheritedmutationsinthe Mdm2, the gene encoding MDM2. Thus, p53 helps
geneencodingp53.p53hasanotherrole,‘policemanof to regulate its own level, which will fall due to the

--- Page 629 ---

574 FREE RADICALS IN BIOLOGY AND MEDICINE
action of MDM2 if the stimuli stabilizing p53 against inadditionalroundsofclonalexpansion.Inactivation
degradation (and phosphorylating MDM2) go away. ofstabilitygenescontributestothegrosschromosomal
Although p53 protein function is most often inacti- rearrangementsandlossesofpartsofchromosomes(or
vatedincancersbygenemutation,itsactivitycanalso sometimeswholechromosomes)inmalignantcells.
bediminishedbychangesingenesencodingproteins
thatinteractwithp53,includingmdm2. 10.14.4.4 Angiogenesisandcancer516
Other tumour suppressor genes exist. One is
A growing tumour needs a blood supply, and thus
APC (adenomatouspolyposiscoligene).Thedisease
angiogenesis is important to it. Angiogenesis in re-
familialadenomatouspolyposis,inwhichpolypde-
sponsetohypoxiainvolvesproductionofsuchagents
velopment occurs early in life and colon cancer al-
asVEGF,underthecontrolofHIF(Section1.3.2).Hyp-
most invariably develops, is associated with a defect
oxia also affects p53 (Section 10.14.4.2). HIF plays a
in APC.513 In addition, mutations in the gene en-
key role in many cancers, e.g. increasing the levels
coding PTEN are frequently found in cancers. Since
of glucose transporters to deliver (Section 1.3.2) the
PTEN hydrolyses PIP , its inactivation promotes ex-
3 increased glucose demanded by the cancer cell (Sec-
cessivesignallingbythePI3K/Aktpathway,514 which
tion10.14.2).AnothertumoursuppressorgeneisVHL,
promotescellsurvival(Section5.5.4).
which encodes the von Hippel–Lindau protein, an
10.14.4.3 Stabilitygenes
E3ubiquitinligase(Section5.14.3.2)thatcausesHIF-1α
tobedegradedinthepresenceofO .IftheVHLgene
2
StabilitygeneskeepDNA‘normal’,byrepairingdam-
ismutated,HIFisstabilizedandVEGFproductionac-
age to it or otherwise ensuring that cell division and
celerated.GermlinemutationsinVHLincreasetherisk
chromosomal segregation proceed accurately. When
ofcancer,especiallyinkidney,andareassociatedwith
stability genes malfunction, mutations in other genes
abnormalangiogenesis.
occurmoreoftenandtheriskofcreatinganoncogene
orinactivatingatumoursuppressorgeneisincreased.
For example, defects in DNA repair predispose to
10.14.5 Reactivespeciesandcarcinogenesis:
cancerdevelopment.Inxerodermapigmentosum,an basicconcepts503
inborn recessive defect in the ability to repair UV-
induced lesions in DNA (Section 5.10.8.2), there is a We have already mentioned RS several times in our
high risk of skin cancer on exposure to sunlight. Pa- brief description of the origin of cancer. Indeed, a
tients with Fanconi anaemia, a disorder caused by few moments thought will reveal that RS could be
mutationsinseveral(15ormore)genes,showanele- involved in all aspects of carcinogenesis; they can
vated level of 8OHG in DNA (Section 10.14.7) and be pro-proliferative (Section 5.2.1), induce senescence
anincreasedincidenceofmalignancies.515TheFanconi (Section 5.2.4), increase p53 activity by causing DNA
gene products are, collectively involved in the repair damage (Section 10.14.4.2), cause apoptosis, facilitate
ofDNAdouble-strandcross-links.Elevatedcancerrisk apoptosis triggered by other agents, suppress apop-
is also seen in Werner syndrome (Section 11.3.3) and tosis (Section 5.4.2.2), activate FOXOs (Section 5.5.4),
in ataxia telangiectasia, caused by mutation in the and recruit phagocytes (Section 8.7.3). Indeed, it was
ATMgeneencodingtheATMprotein(Section5.10.8.2). shownasfarbackas1985thatexposureofmouseem-
Cellsfromataxiatelangiectasiapatientsaredeficientin bryonic C3H/10T1/
2
fibroblasts to just the right level
checkpoint control; for example after irradiation they ofROS(fromX/XOoractivatedhumanneutrophils)
proceedintoSphasewithoutrepairingDNA. canleadtotransformation,517buttoomanyRScanhalt
Mutations in proto-oncogenes, tumour suppressor, replicationorcauseapoptosisorsenescence.Sowhich
or stability genes sometimes occur in the germline, predominatesincancer—goodorbadeffectsofRS?
givingahereditarypredispositiontocancer.Canceris One way to approach this question is to decrease
not guaranteed to develop, but the risk is increased antioxidant defences, and see what happens. The re-
because the cells have a ‘head start’ on the normal sults are clear-cut. Knockout mice lacking CuZnSOD
cell (one gene class defective, only two to go). Muta- have increased rates of liver cancer development
tions may also occur ‘randomly’ in a cell, to give a later in life (Section 3.7.2).496 Mice heterozygous for
sporadic tumour. Often, the first mutation creates an MnSOD (50% of normal mitochondrial levels) are
oncogeneandcausessomedegreeofclonalexpansion at increased risk of developing lymphomas, adeno-
thatstartsthewholeprocess(Table10.8).Subsequent carcinomas, and pituitary adenomas as they age.
mutationsinanyorallofthethreegeneclassesresult Knockout of two GPx enzymes (GPx1 and GPx2) in

--- Page 630 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 575
mice led to intestinal cancers,469 whereas elimination mutageniclesionsaccumulateaswell.However,some
of some of the peroxiredoxins promotes develop- dataareclear-cut.Humanandotheranimalcellscon-
ment of lymphomas, sarcomas, and adenomas (Sec- tain an enzyme (MTH1) that sanitizes the nucleotide
tions 3.14.4 and 3.20.2). Embryonic fibroblasts from pool.Micelackingthisenzymeshowanincreasedrate
micelackingperoxiredoxin-1showelevatedROSpro- of spontaneous tumorigenesis with age, especially in
duction, evidence of elevated c-myc expression, and thelung,stomach,andliver(Section5.10.8).
increasedsusceptibilitytotransformationbyrasover-
expression.Micelackingcatalasesometimesshowin-
10.14.6 p53andROS510,511
creasedincidenceof‘spontaneous’mammarytumours
(Section3.17.7).
Theactionsofp53areintimatelylinkedwithROS(Fig.
Defects in some of the enzymes that repair oxida-
10.17). First, the normal low cellular levels of active
tive DNA damage lead to increased levels of 8OHG
p53areinvolvedinmaintainingthecellularantioxid-
and other mutagenic bases in cellular DNA and are ant defence network, promoting the transcription of
associated with increased age-dependent cancer inci- genesencodingMnSOD,GPx1,catalase,andproteins
dence in animals (Section 5.10). This evidence is less that regenerate oxidized peroxiredoxins, among oth-
compelling, in general, than that provided by knock- ers.Second,ROScancauseDNAdamageandincrease
outofantioxidantdefenceenzymes,becausemanyof
p53activity.Third,higherlevelsofp53cancauseROS
theenzymesinvolvedinbaseandnucleotideexcision production by increasing the levels of the p66shc pro-
repair act on several lesions in DNA, not just oxida-
tein (Sections 5.4.2.2 and 11.3.1.1), of proline (Section
tive damage, and so it is possible that non-oxidative
10.14.8.2) and lysine (Section 10.14.8.7) oxidases, and
(a)
Normal p53
Antioxidant
ROS Prevention or repair
genes
p53 of mutations
No stress/mild
reversible damage
Normal cell growth
(b)
Normal p53
p53
p53
Elimination of cells
p53 Pro g -o e x n i e d s ant ROS with mutations
p53
Extended stress/
irreparable damage Cell death
(c)
Mutant p53
Accumulation
p53
of mutations
ROS
Tumorigenesis
Figure10.17(colourplate23) Thep53proteinhasbothpro-andantioxidantfunctions.(a)Intheabsenceofstressoraftermildstress,low
levelsofp53increasetheexpressionofseveralantioxidantgenes.p53alsofacilitatesDNArepair.(b)Greateractivationofp53aftersevereor
extendedstressleadstotheformationofROSbyseveralmechanisms,resultinginelevatedROSlevelsthatcancontributetohaltingthecellcycle,
ortosenescenceorapoptosis.Thesemechanismscontributetotumoursuppression.(c)Lossofp53functionincreasesintracellularlevelsofROS,
whichdamageDNAandincreasethemutationrate.Theinabilitytoactivatep53-inducedcytostasisorapoptosisinresponsetotheseoncogenic
alterationsultimatelyresultsinthedevelopmentofcancer.Thep53proteincanalsobeinactivatedbyoxidationofitscysteineresidues(Section
10.14.6).AdaptedfromNatureMedicine11,1278,2005,bycourtesyofElsevierandDrsKarimBensaadandKarenVousden.AlsoseeJ.Mol.
Med.89,237,2011.

--- Page 631 ---

576 FREE RADICALS IN BIOLOGY AND MEDICINE
by other mechanisms. These ROS contribute to the thioredoxinreductaseinhumanprostatecancer,524 al-
cytostatic and pro-apoptotic effect of p53. Some data though prx3 levels in the latter may be elevated.525
suggestthatp53atlowlevelscanincreaseNrf2activity, By contrast, levels of MnSOD in human cancers are
whereashighlevelsmaydotheopposite.518 frequently(e.g.inmesothelioma,neuroblastoma,mel-
The p53 protein itself can be subject to oxidative anoma,stomach,bladder,ovarian,andbreastcancer)
damage.Humanp53hastencysteineresidues,someof elevated.521 Indeed,highMnSODactivityseemstobe
whichareinvolvedinbindingaZn2+ ionrequiredfor associated with increased tumour invasion, metasta-
activity.Oxidationofp53inhibitsitsactionasatran- sis and a poor prognosis, in part perhaps because a
scriptionfactor.Forexample,p53canbeoxidizedand cellularredoximbalanceinducedbyMnSODoverex-
nitratedonadditionofONOO–,andnitratedp53was pressionincreasestheactivityofMMPs.526Theactivity
detected in human glioblastoma, a highly malignant of the sulphiredoxin/peroxiredoxin/thioredoxin sys-
brain cancer.519 Oxidized cysteines on p53 can be temmaybeincreasedinlungcancer,527 andwehave
re-reducedbyRef-1(Section5.10.3)orthethioredoxin alreadynotedthatthepentosephosphatepathwayis
system, restoring p53 activity.510 S-glutathionylation running faster in malignant cells.507 Some oncogenes
(Section 3.11) can also decrease p53 function, and havebeenreportedtoleadtoactivationofNrf2inma-
p53modifiedinthiswayhasbeendetectedinsomehu- lignant cells, causing a rise in antioxidant defences,
mancancers,butitssignificanceinvivoisunknown.520 includingHO-1.528
p53 is additionally involved in the regulation of glu- Probably what is important in vivo is not the level
cosemetabolism,e.g.itdecreasesglucose-6-phosphate of any one enzyme, but the balance of RS produc-
dehydrogenaseactivity.507Thusdecreasedp53activity tion, antioxidant defence, and the repair systems (es-
incancersfacilitatesacceleratedglycolysisandpentose pecially for DNA), including the ratio of SOD to
phosphatepathwayactivity(Section10.14.2). H O -consuming enzymes. In addition, data on anti-
2 2
oxidantenzymelevelsinbiopsyspecimensshouldbe
interpreted cautiously, given their heterogeneity. For
10.14.7 Changesinantioxidantdefences
example, areas within a tumour mass are often hyp-
incancer503
oxic (Section 9.20.3) which may decrease antioxidant
Are there changes in antioxidant defences in human levels. Indeed, in a rat breast cancer,529 SOD levels
cancers?Mitochondriafromseveralmalignantanimal were found to be about 54 μg/g tissue at the centre
tumours,andfrommanytumourcellsinculture,show
ofthetumour,but117μg/gattheedge.Exposureof
low MnSOD activity.521 Transfection of the MnSOD thetumour-bearingratstoelevatedO 2 concentrations
geneintocellscansuppressthemalignantphenotype
raisedbothvalues,to162and286μg/g,respectively.
in some (but notall) cell lines. Some authors suggest It is also important to measure enzyme activity and
that elevated MnSOD generates more H O , which not just gene expression or protein level. Increased
2 2
causesinhibitionofproliferation,sometimesinvolving mRNAdoesnotalwaysequatetomoreenzyme,and
p53activation.Consistentwiththis,overexpressionof inactivatedenzymes(e.g.inactivenitratedMnSODor
catalasecanoftenpreventtheeffectsofexcessMnSOD oxidized inactivated peroxiredoxins) can show up in
in cell lines. Low activities of CuZnSOD, catalase, protein measurements. As another example, loss of
and GPx are also sometimes reported in transformed SIRT could decrease MnSOD activity by increasing
celllines. its acetylation levels (Section 3.5.2.2), but not affect
Onemustbecautiouswhenexamininganythingin MnSODproteinlevels;thishasbeenreportedinbreast
tumourcellsgrowninculture,sincetheyhaveadapted cancer.530
to the culture process and may use signalling mech- TheincreasedriskofcancerinDownsyndrome(Sec-
anismsnotemployedinvivo(Sections1.11and5.5.10). tion3.21.2),Bloomsyndrome,mutationsinBRCA1or
Inaddition,celllinesoftenharbourchangesinp53(e.g. –2,ataxiatelangiectasia(Section5.10.8.2),andFanconi
itcanbeincreasedbythestressofcellculture)thatin- anaemia515 has prompted investigations of cellular
fluencelevelsofROSandantioxidants(Fig.10.17).522 antioxidant defences in these conditions, although
So what do direct measurements on malignant tis- in none of the last three do the primary gene
sue show? Results are variable, but in general there defects directly affect antioxidant defence. Never-
is no clear pattern of marked decreases in MnSOD theless, mice lacking the ATM protein show in-
or other antioxidant enzymes in freshly obtained hu- creased oxidative damage (Section 5.10.8.2) accom-
mancanceroustissue.Sometimeslevelsaredecreased, panied by rises in thioredoxin, MnSOD, CuZnSOD,
e.g. GPx7 in oesophageal cancers523 and GPx1 and andGSHinsometissues.531Indeed,administrationof

--- Page 632 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 577
N-acetylcysteine,Tempol(Section11.5.5), orEUK-189 a lifetime of attack by ROS, some produced by car-
(Section11.5.4)hasbeenreportedtoincreaselifespanin cinogens(Section10.15)andsomeendogenous.536Are
suchmice,presumablybyexertingantioxidantactivity. endogenous RS production and DNA damage large
N-acetylcysteine also decreased lymphoma incidence enoughtoaccountforage-dependentcancerdevelop-
in the mice.532 Loss of BRCA1 in ovarian cancer cells ment?The‘steady-state’levelsofproductsofoxidative
also appears to lead to increased ROS production.533 damagetoDNAbasesinnormalcellsvaryaccording
Cells from Fanconi patients are hypersensitive to O to the measurement method and between laborator-
2
and to ROS-generating agents in culture, and these ies, but an average value for all such lesions may be
patientsshowelevatedlevelsof8OHGintheirleuko- around 1 per 105 DNA bases, or more (Section 6.14).
cyte DNA.534 This increased sensitivity appears due, Enough to cause cancer? By comparison with the
inatleastsomeFApatients,todecreasedactivitiesof levels of carcinogen–DNA adducts that are detected
severalantioxidantdefenceenzymes,includingGPx1, in carcinogen-exposed cells, it could be (reviewed in
prx3,CuZnSOD,MnSOD,andcatalase,apparentlydue ref537).Forexample,levelsofbenzopyreneadductsin
toincreasedoxidativedamageinthepromotersofthe DNA from cancers taken from smokers range from
genes encoding them.534 Indeed, in addition to their 0.062 to 0.53 per 105 bases. In rat liver the levels of
role in DNA repair, several Fanconi gene products carcinogen–DNAadductsassociatedwitha50%inci-
are involved in redox reactions. For example, one of denceofhepatomarangedfrom0.053to2.083per105
them (FANCC) regulates microsomal electron trans- bases for a range of carcinogens. In mouse liver the
port,FANCJdecreasesexpressionofthegeneencoding respectivefigureswere0.812to5.543adductsper105
HO-1,andFANCGaffectstheexpressionofCYP2E1, bases for several carcinogens. Of course, one can al-
a‘leaky’CYP(Section9.8.1.1).YetotherFanconipro- ways debate the relative mutagenicity of carcinogen
teinsplayaroleinredox-dependentcellsignalling,for adducts versus ROS-derived DNA lesions. However,
example through Akt kinase (Section 5.5.4), whereas many of the latter are mutagenic (Section 5.9.1), they
FANCD1isnowknowntobeidenticalwithBRCA2. areformedinourDNAsinceconception,andthelevels
Of course, antioxidants are not the only defence present could have even more impact if damage is
mechanisms that cancer cells can utilize. Many show located in specific genes relevant to cancer, such as
increasedlevelsofheat-shockproteins,forexample.535 p53. In addition, several organic peroxides (e.g. ben-
zoyl peroxide) are tumour promoters in mouse skin;
their conversion into free radicals is thought to be
10.14.8 ROSandcancer503
involved.538
ThegeneknockoutstudiesreviewedinSection10.14.5
10.14.8.2 IsthereincreasedoxidativeDNA
revealthatlackofantioxidantdefenceorcertainDNA
damageincancer?
repair enzymes can lead to more cancer. How might
thishappen? Yes;moststudies(withafewexceptions)haveshown
increased levels of 8OHG in DNA from human and
10.14.8.1 DNAdamagebyRS otheranimaltumours,485,503,538–540whetherthetumours
This is the most commonly offered explanation. In- arisespontaneouslyorareinducedbycarcinogentreat-
deed, exposure to ionizing radiation has long been ment(evencarcinogenswhoseactiondoesnotappear
knowntocausecancer.Radiation-inducedcarcinogen- to involve ROS). Several of these studies show that
esisappearstoinvolveinitiation,promotion,activation higher 8OHG levels correlate with increased malig-
of proto-oncogenes, and inactivation of stability- and nancyandpoorersurvival.538–542 Insomecases,mass
tumour-suppressorgenes.Somegeneticdamagebyra- spectrometry has been used to reveal that the levels
diationoccursbydirectabsorptionofenergybyDNA, ofmultipleoxidativeDNAbasedamageproductsare
butmuchismediatedbyOH• (Section9.20).Inother elevated,indicativeofdamagebyOH•.
words,OH•couldbeinvolvedinallstagesofcarcino- Methodological caution is needed in such studies,
genesis;OH•radicalattackuponDNAgeneratesmul- since a biopsy sample may include not only tumour
tiple mutagenic purine, pyrimidine, and deoxyribose cells but also inflammatory cells (Section 10.14.11),
oxidationproducts(Section5.8.2.1). whichmaybeactivatedtodamagetheirownDNAand
Theincidenceofmostcancersriseswiththefourth henceraisebulk8OHGlevelsinDNAextractedfrom
or fifth power of age in animals, e.g. about 35% of thewholetissuesample.Nevertheless,theauthorsfeel
humans have cancer by age 85 (Fig. 10.18). It was thattheavailableevidenceoverallsupportsincreased
hypothesized as far back as 1980 that this is due to levels of oxidative DNA damage in many cancers,

--- Page 633 ---

578 FREE RADICALS IN BIOLOGY AND MEDICINE
30
20
10
0 1 2 20 40 60 80 100
Age (years)
)tnec
rep(
ksir
evitalumuC
Figure10.18 Thecumulativeriskofcancerasa
functionofageinhumans.Notethesharprisein
Rats Humans cancerincidenceinolderpeople.Apartfromafew
rarecancers(e.g.testicularcancer,leukaemias),
cancerisgenerallyadiseaseofoldage.Thesame
phenomenonoccurs,onashortertime-scale,inother
mammalssuchasmiceandrats.Atfirstsightthe
ratesseemshigh,buttheenormousnumberof
mutationsthatoccuroveralifetimecausedby
polymeraseerrors,spontaneousdeamination,and
depurinationofDNA,plustheactionsofRSand
exogenouscarcinogens,makesoneadmirethehigh
efficiencyofprotectivemechanisms(Fig.10.15)in
ensuringthatthemajorityofusdonotdevelop
cancer.FigurefromFreeRadic.Res.Commun.7,122,
1989,bycourtesyofProfessorBruceAmesand
HarwoodAcademicPress.
especially those related to inflammation (Section are not specific for attack by RS. For example, C→T
10.14.11). Several authors have proposed that malig- can result from deamination of 5-methylcytosine to
nant tumours are in a ‘pro-oxidant’ state, generating thymine.Bycontrast,tandemmutationsprovidegood
moreROS(e.g.fromincreasedmitochondrialO
•–
for- evidenceforUV-inducedDNAdamagetop53inskin
2
mationandbyNADPHoxidaseactivity)503,543–546 that cancers(Section7.13.1.2).
might contribute to genetic instability. The NADPH Nevertheless, it seems unlikely that the pro-cancer
oxidases that are thought to be involved seem to effects of RS are all due to elevated 8OHG levels in
varyfromcancertocancer,e.g.NOX1incoloncancer DNA,sincetherearesituationswhere8OHGlevelsin
andNOX4inmelanomaandglioblastoma.546Another DNA are elevated, but cancer rates do not increase.
source of ROS in some tumours might be proline OneisRA.548 InRApatients,thereisincreasedoxida-
oxidase, an H O -generating mitochondrial enzyme tivedamagetoDNA,lipids,andproteins(Table10.5)
2 2
thatconvertsprolinetopyrroline-5-carboxylate.547 Its butnocompellingevidencethatRApatientsdevelop
levels can be increased by high activities of p53 cancers (except perhaps lymphoma) at an increased
(Fig. 10.17). Lysyl oxidase might also play a role rate, at least not at the most intense site of oxidative
(Section10.14.8.7). stress, the inflamed joint. One hypothesis is that this
In principle, decreases in DNA repair rates might is because of the nature of the synovial cells. Syn-
also explain rises in levels of base damage products, ovium seems to be a hostileenvironmentfor tumour
but, paradoxically, data are conflicting on whether development, although it has been argued that the
activities of DNA repair enzymes in human cancers excessive synovial cell proliferation in RA resembles
are increased, decreased, or unchanged.503,539 Over- neoplastictransformationandmightberelatedtothe
all it seems that rates of oxidative DNA damage growth-promoting properties of ROS.424 An ancillary
are increased in malignancy and repair does not factormaybethatsomeNSAIDsusedtotreatRAhave
keepup. anti-cancer effects, decreasing the incidence of colo-
Dothevariousmutationsdetectedinmalignanttu- rectal and some other cancers. They may do this by
mours arise by oxidative DNA damage? Maybe, but inhibiting COX-2,548,549 whose levels are elevated in
wecan’tbesure.Mostattentionhasfocusedon8OHG, severalcancersandmayproduceproducts(e.g.PGE )
2
sinceitismutagenicandisproducedinDNAinsignifi- thatfacilitatetumourprogression.Aspirinmaybees-
cantamountsbyseveralRS.TheG→Ttransversions pecially effective, since it not only inhibits COX but
often seen in mutated cancer-related genes (e.g. p53) alsoleadstogenerationofanti-inflammatorylipoxins
could result from the mutagenic effect of 8OHdG. (Section8.12).
However,theycouldalsobegeneratedbycertaincar- Another exception is diabetes; it is associated with
cinogensandbyerrorsinthereplicationofDNAcon- some inflammation and is accompanied by increased
taining abasic sites. Oxidative damage could account oxidative DNA and RNA damage (Section 10.5),
for C → T and G →A transitions frequently seen in but again the evidence of a general increased can-
variouscancer-relatedgenes,butagainthesechanges cer risk is weak; the risks of several cancers seem

--- Page 634 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 579
slightly elevated but that of prostate cancer possibly deaminationproductsinhumancancers.485,559Thishas
decreased.550Psoriasisisanotherchronicinflammation rarelybeendone,however.
that does not seem to increase cancer risk.548 Some Nitric oxide and other RNS might play mul-
knockoutsofDNArepairenzymesraise8OHGlevelin tiple roles in cancer but their overall significance
DNA,butnotcancerincidence(Section5.10.8).Inadd- is unclear.559–561 Some RNS inhibit caspases, de-
ition,micechronicallyexposedtopotassiumbromate laying apoptosis. They can inhibit cytochrome oxi-
(KBrO )forayearshowedstrikinglyelevated8OHG dase and slow mitochondrial ATP formation (Section
3
levels in kidney DNA, but no increased cancer risk 10.6.4.5), impairing cell proliferation and slowing tu-
in any organ. The same results were obtained even mour growth. Indeed, that might be one reason for
if the mice were deficient in the DNA repair enzyme NO•productionbymacrophagesaroundatumour,al-
Ogg1(Section5.10.3).551 However,iftheylackedboth though cancer cells rely more on glycolysis anyway.
OGG1 and MUTYH, KBrO did increase the tumour Some of the anti-proliferative effects of RNS involve
3
incidence.552Nakedmoleratsshowelevatedoxidative activation of p53, indirectly (via causing DNA dam-
DNAdamage(Section11.4.1)butrarelydevelopcan- age) and directly by promoting phosphorylation,561
cer,aneffectseeminglyrelatedtotheirproductionofa althoughtoomanyRNScanoxidizeandinactivatep53
specialtypeofextracellularhyaluronan.553 (Section10.14.6).Often,iNOSinductionoccursaspart
ItisalsounclearwhereoxidativeDNAdamagefits oftheinflammatoryresponseassociatedwithtumours,
intothesequenceofeventsthatresultsincancer;stud- andformationofnitratingspeciessuchasONOO–,as
iesonprostatesuggestedthatitwaselevatedinbenign evidenced by the presence of nitrotyrosine, occurs.560
prostatichypertrophy554 (i.e.anearlyevent),whereas Reactive nitrogen species have been suggested (but
studiesoncoloncancerfound8OHGelevatedincar- not yet proven) to be especially important in caus-
cinomaDNAbutnotDNAfromadenoma.555Inmouth ingDNAdamage(measuredas8-nitroguanine[8-NG]
cancer, levels of 8OHG and 8-nitroguanine were ele- formation) in chronic inflammation induced by the
vated in DNA in both oral squamous cell carcinoma Opisthorchis parasites.485 Levels of 8-NG are also ele-
and in the pre-malignant lesion oral leukoplakia.485 vatedinthestomachofhumansinfectedwithH.pylori,
Yetinonestudyofbreastcancer8OHGlevelsfell(al- in human oral and cervical cancers, and in the colon
though HNE rose) as the cancer progressed, perhaps of mice with IBD.485,562 Patients with lung, rectal, or
relatingtoincreasesinDNArepairratesintheinvasive breast cancers excreted more 8-NG (and 8OHdG) in
lesionsstudied.556 urinethancontrols.562
RSneednotdamageDNAdirectlytofacilitatecan- What effects of RS other than oxidative damage
cer development. Oxidative damage to lipids and to mightcontributetocancerdevelopment?Several!Let
proteins(e.g.DNArepairenzymes)couldalsocontrib- uslookatsome.
ute(Fig.10.19).Forexample,severalcarbonylatedpro-
teinsoccurinhumancholangiocarcinomas;thehigher
10.14.8.4 Epigenetics,cellproliferation,
their levels the worse the prognosis (Section 6.16.3).
Levels of lipid peroxidation are decreased in some
andHIF-1α
cancers and tumour cell lines,557 but again this does Another possible mechanism is for RS to affect gene
notseemtobeageneralfeatureofhumanmalignant methylation,buttheliteratureisconfusing.Oxidative
tumours; several show increased amounts of perox- damage could potentially decrease methylation (e.g.
idation end-products, such as HNE.555,556 Indeed, in oxidized guanine residues can hinder methylation of
one study, acrolein levels in human prostate biopsies CpG islands), which might cause inappropriate gene
appearedpredictiveofcancerprogression.558 expression. On the other hand, some studies indic-
atethatH O canfavourgenemethylation.Increased
2 2
10.14.8.3 Aroleforreactivenitrogen
methylationcouldsilencegenesencodingantioxidant
andchlorinespecies defences563 (e.g. GPx7 in oesophageal cancer523), tu-
Wemustnotforgetthatthereismuchmoretooxidative mour suppressors, repair systems, or even NADPH
DNAdamagethan8OHG.N O ,HNO ,HOCl,HOBr, oxidase enzyme components.564 Overall, the signifi-
2 3 2
andONOOHcandamageDNA(andoxidize8OHdG!) cance of ROS to epigenetic modifications is as yet
tomutagenicproducts(Section5.8.2).Thuswemight unclear.
have a clearer picture of the role of DNA damage CellproliferationisessentialincancerandROS(in
by RS in cancer if we measured a range of DNA justtherightamounts!)canstimulateit(Section5.2.1).
oxidation, aldehyde-modification, halogenation, and A human example, O
•–
generated (by a NADPH
2

--- Page 635 ---

580 FREE RADICALS IN BIOLOGY AND MEDICINE
(a)
Structural alterations in the
DNA/chromatin
2
Conformational changes
1
Increased lipid peroxidation
Activation of carcinogens
3
Decreased efficiency of DNA
5 RS polymerase and DNA repair
4 enzymes by oxidative protein
damage or abnormal
DNA shape
Redox regulation of enzymes
and transcription factors
Stimulate cell growth
Suppress apoptosis
Promote metastasis
(b)
Changes in DNA/chromatin
Chemical changes in Changes in DNA/chromatin
bases/sugar/chromatin conformation
Enhancement Inaccurate
Incorrect Block in Inaccurate
of ‘hot spot’ gene
H-bonding replication replication
mutagenicity expression
Accelerated
base loss to ‘Error-prone’ Facilitation of
give AP bypass carcinogenesis
sites
Mutation
Figure10.19 Someofthewaysinwhichreactivespecies(RS)couldfacilitatecancerdevelopment.(a)1.DirectoxidativedamagetoDNA.2.
Aldehydeend-productsoflipidperoxidation(e.g.MDAandHNE)formmutagenicadductswithDNAbases.Forexample,M1-dG(Section5.12.5.3)
ispresentincolonicmucosa(CancerEpidemiol.Biomark.Prevent.11,207,2002).Radicals(RO•andRO2 •)formedduringperoxidationmightalso
attackDNA.3.Reactivespeciescanactivatecarcinogens,andsomethengeneratemoreRS(Section10.15).4.RScandamageproteins,e.g.DNA
repairenzymesandpolymerases,decreasingrepairefficiencyandincreasingtheerrorrateofreplication.5.Hydroxynonenalandsomeother
aldehydescanactivatetranscriptionfactorsandpromotecellproliferationatlowlevelsandtheoppositeathigherones(Section5.12.5.3).(b)How
RS-inducedchangesintheDNAcancausemutations.Anotherpossiblemechanism(notshown)isforRStoaffectgenemethylation(Section
10.14.8.4).UpdatedfromBiochem.J.401,1,2007,bycourtesyoftheBiochemicalSociety.

--- Page 636 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 581
oxidase) in malignant cells from acute myeloid leuk- by NADPH oxidases (e.g. in melanomas, which me-
aemiapatientsacceleratedtheirproliferation.565 tastasizerapidly564,571)and/orbymitochondria(some-
Several transcription factors are subject to redox times via p66shc).545 In addition, ROS and various
regulation, especially NF-κB and AP-1, but also cytokines might help suppress anoikis.568 To seed a
p21 and p53. Some papers have suggested that ROS new tumour, the circulating metastatic cell must ad-
(perhapsarisingfrommitochondriaandNADPHoxi- heresomewhere;upregulationofadhesionmolecules
daseenzymes)cancontributetomaintaininglevelsof isthusimportant.Thiscaninvolvereleaseofcytokines
HIF-1α in hypoxic tumour regions by decreasing the fromthemalignantcellsortheimmunecellssurround-
rate of its turnover.566 Of course, very low O will ingthem,whichcanincreaseROSproduction.
2
impairROSproduction. Would, therefore, a judicious use of antioxi-
dants have an anti-metastatic effect? Maybe, but
10.14.8.5 Intercellularcommunication567 the evidence is limited. Some animal studies in-
dicate that experimentally increasing the levels of
Communication through gap junctions is generally
peroxide-metabolizing enzymes in or around malig-
decreasedinmalignantcells,whichmayfacilitatepro-
nant cells injected into animals decreases their meta-
liferation. Oxidative stress (Section 5.2.4) and several
staticpotential.572 Indeed,theleveloflysyloxidase,a
tumour promoters (sometimes acting via oxidative
copper-containing H O -producing enzyme involved
stresse.g.bypromotingphosphorylationofconnexins) 2 2
in the cross-linking of collagen and elastin, was in-
decreasegap-junctionalcommunication.
creased in distant metastatic human breast cancer
10.14.8.6 Suppressingapoptosis568 tissues as compared with primary cancer tissues,
and levels were in both cases greater than in nor-
Certain tumour cell lines use ROS to deter apop- mal breast tissue.573 Higher levels not only prod-
tosis, by mechanisms involving suppression of cas-
uce more H O , but will increase the rigidity of
2 2
pase activity and changes in intracellular pH (Sec-
the matrix, which may facilitate metastasis, e.g. by
tion 5.4.2.2). As mentioned earlier, several ROS can promoting adhesion of metastatic cells.573 In mice,
inhibit PTEN, favouring cell survival by stimulating
weakly tumorigenic and non-metastatic cells became
theAktpathway.
malignant and invasive after co-implantation with
a gelatin sponge to induce inflammation, an effect
10.14.8.7 Metastasisandangiogenesis decreasedbyinstillingaSODpreparation.572Thepro-
Reactive species might contribute to metastasis,569 a metastaticeffectwasalsodiminishedifthemicelacked
multi-stage process involving escape of primary can- NADPH oxidase activity (reviewed in refs503,571).
cer cells from the tumour into blood and/or lymph, Inmice,decreasingprx2levelsenhancedmetastasisby
their transit and survival in the vascular/lymphatic melanomacells.574
system,andtheirultimatecolonizationofdistantsites. ROS (e.g. from lysyl oxidase or elsewhere)575 can
ConsistentwitharoleforROS,humanmetastaticpros- also promote angiogenesis, by increasing VEGF pro-
tatecancershowedhigherlevelsof8OHG,HNE,and ductionandbeinginvolvedinitsmechanismofaction.
3-nitrotyrosinethandidprimarycancer.570 Metastasis Of course, too many ROS can suppress angiogenesis,
involveschangesincancercellmorphologyintheso- ascanhappenindiabetes.
calledepithelial-mesenchymaltransition,548inwhich
10.14.8.8 Affectingstemcells576
tumour cells of epithelial origin undergo conversion
toamesenchymal-typestateassociatedwithincreased Thereisgrowingevidencethatpopulationsoftumour
cellmobility. initiating cells (TICs), sometimes called cancer stem
Metastasis is facilitated by the environment of cells, contribute to tumorigenicity, by reseeding tu-
the cancer cell, in particular its content of im- mour growth after the bulk of a tumour has been
mune/inflammatorycells.548 Degradationofextracel- destroyed by radiation or chemotherapy. These cells
lular matrix involves MMPs, some of which are se- seem to be resistant to ROS, perhaps for the reasons
creted in latent forms (by both tumour cells and that regular stem cells are (Section 3.4.2) and so can
phagocytes, especially macrophages) that can (some- resist radiotherapy or chemotherapy and later prolif-
times!)beactivatedbyRS(Table8.2).526,571MMPscan erate.Indeed,thesequenceofeventsleadingtocancer
alsoliberategrowthfactorsboundtomatrixconstitu- (Section10.14.3)maybeparticularlyimportant,atleast
ents.TheROSinvolvedinmetastasiscanbeproduced in some tumours (e.g. colon cancer), if it occurs in

--- Page 637 ---

582 FREE RADICALS IN BIOLOGY AND MEDICINE
stem cells resident within the tissue. ROS play key 10.14.11 Chronicinflammationandcancer:
rolesinstemcellfunction,buttoomanyROSimpair acloselinkbutisitduetoreactive
it(Section3.4.2). species?502,503,581,582
Inflammation is a well-known risk factor for can-
10.14.9 Cancerandcachexia
cer and inducing it is a major mechanism of action
Advancedmalignantdiseaseisaccompaniedbybody of tumour promoters. Agents and diseases causing
wasting,includinglossofmusclemass.Thiscachexia chronic inflammation predisposing to cancer include
(derived from the Greek words kakos [bad] and hexis asbestos(Section9.15),ulcerativecolitis(Section10.12),
[state]) can also accompany heart failure and severe pancreatitis (Section 10.13.1), oesophagitis, bile duct
chronic inflammation (e.g. advanced RA). Cytokines, inflammation(Section10.13.3),H.pyloriinfection(Sec-
especially TNF-α, play an important role, in part by tion 10.13.2), and infection with the parasite Schis-
inducing oxidative stress (Section 5.7) in the muscle tosoma haematobium, which produces chronic bladder
and damaging it. The mechanisms include increased inflammationwithincreasedriskofbladdercancer.485
oxidativedamagetomyofilamentproteinsandfaster In both Asia and Africa, hepatocellular carcinoma
proteolysisofmuscleproteins.Aroleforxanthineoxi- is commoner than in the West and is often associ-
dase in causing the damage has been suggested in ated with chronic infection and inflammation caused
animals,577andoxidativedamagemayalsocontribute by hepatitis B and -C viruses, or liver flukes of
tocachexiainhumancancerpatients.578 the Opisthorchis genus, e.g. O. viverrini.485,495 Indeed,
a transgenic mouse strain expressing a hepatitis B
virus protein in the liver (provoking an immune re-
10.14.10 Aremalignantcellstrulyunder
sponse)showedchronichepatitisandelevated8OHG
oxidativestress?503
levels in liver DNA, which preceded the develop-
The increased oxidative damage levels reported in ment of hepatoma.583 Where it has been measured,
some malignant cells and tumours could result from most or all of these inflammatory conditions in hu-
(i) moreRSformationwithunalteredantioxidantde- mans are accompanied by increased oxidative and
fences; (ii) unaltered RS formation with decreases in nitrativeDNAdamage.485,495,540,562 Indeed,micewith
antioxidant defences; (iii) failure to repair oxidative inactivatedGPxlandGPx2genesonlyshowincreased
damage, so that levels rise; or (iv) any combination intestinal cancer if gut bacteria are present to trigger
of the above. We have already seen that changes in inflammation.469
DNArepairandantioxidantenzymesarevariablebe- Just as inflammation can promote cancer
tween different tumours. Many authors have argued development, a tumour often induces an inflamma-
that cancer cells ‘deliberately’ increase ROS produc- toryresponse.Tumourmicroenvironmentsfrequently
tion to suppress apoptosis (Section 10.14.8.6), accel- contain cells of the immune system, including
erate proliferation, metastasis, and angiogenesis, and monocyte-derivedmacrophages,neutrophils,TandB
possibly to promote genetic instability (by increased lymphocytes,andmastcells,manysecretingcytokines
oxidative DNA damage), or as an immune evasion andchemokines.Indeedan‘inflammatorymicroenvir-
strategy(Section10.14.11).579 onment’ may be needed for tumours to progress.548
Indeed, many malignant cells produce high levels One example of this need for a supportive environ-
of H O in culture. But is this a cell culture artefact ment is that human chronic lymphocytic leukaemia
2 2
(Section1.11)ordomalignantcellsreallymakemore cellsaresuppliedwithGSHbybonemarrowstromal
ROS in vivo? Several experiments reveal that many cells.580 Tumours can secrete cytokines that recruit
of them do. One example is given in Section 6.11.1. phagocytes and lymphocytes. Expression of onco-
Another, acute myeloid or chronic lymphocytic leuk- genes(e.g.Ras,myc)isofteninvolvedinthiscytokine
aemia cells freshly taken from patients showed in- production.Necrosiswithinlargetumourscanrelease
creased O •– production.565,580 To summarize, sources DAMPstoactivatemacrophages.
2
ofROSinmalignantcellsmightincludelysyloxidase, Whether this immune response is good (helping
prolineoxidase,COX-2,sometimeslipoxygenases,in- to suppress tumour growth) or bad (e.g. facilitating
creased mitochondrial O •– production, and NADPH moremutationsinthetumourcellsand/orpromoting
2
oxidases. Much interest has been expressed in the metastasisbysecretingproteolyticenzymes)isuncer-
link between NADPH oxidase activities and human tain and may differ from tumour to tumour.584 Re-
cancer.546 memberalsothatROScandampdowninflammation

--- Page 638 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 583
(Section 8.9.4) and sometimes drive cells into sen- transferrinreceptorsanddecreasedferroportinlevels:
escence (Section 5.2.4). As mentioned earlier, excess low ferroportin seemed to be associated with worse
ROSproductionbytumourcellscouldbeanimmune clinical outcome, implying that the accumulated iron
evasion strategy (Section 10.14.10), impairing T-cell facilitatesbreastcancerdevelopment.591 Insomecan-
function.579 Thus phagocyte-derived ROS have been cers, including Hodgkin disease, breast cancer, and
suggestedtointerferewiththeT-cellimmuneresponse leukaemia,thelevelsofferritininthebloodaresignifi-
inpatientswithadvancedcancer.585Somestudiessug- cantlyincreased.590,592Chemotherapyorradiotherapy
gest that progression of carcinogenesis is associated canproduceasharpriseinpatients’‘totalbloodiron’
with a switch of macrophages from the M1 pheno- andplasmatransferrinsaturation,thelatteroftenap-
type (Section 8.7.2; Fig. 8.9) that has potential anti- proaching or reaching 100%, presumably as iron is
tumouractivity,totheM2type,withlesstumoricidal releasedfromdamagedmalignant(andnormal!)cells.
activity and a greater propensity to facilitate tissue Indeed, non-transferrin-bound iron can appear (Sec-
remodelling.548 tion 3.22.5.4).593 M1-type macrophages (Section 8.7.2;
Senescentcellscanbepresentinthetumourmicro- Fig.8.9)seemtosequesteriron,whereastheM2type
environment;theyarenotdividingbutnotnecessarily oftenseenintumours(Section10.14.11)maybemore
harmlesseither.Forexample,senescentfibroblastsse- pronetoreleaseit.594
creteMMPs,growthfactors,andcytokines.Thismight Can iron contributetocancer?Iron-dependentoxi-
contribute to tissue damage/local inflammation, cre- dativeDNAdamageseemstoaccountfortheincreased
ating an environment that favours the spread of ma- risk of hepatoma in iron-overloaded haemochroma-
lignantcells,andpromotescancer.586 Ithasevenbeen tosis patients (Section 3.22.5). Some iron compounds
suggested that oxidative damage to DNA (or its pre- are carcinogenic in animals,595 asbestos being one of
cursors) in senescent cells might generate mutations them(Section9.15).Indeed,theearliestreportofiron
that allow escape from senescenceto generatemalig- carcinogenicitywasin1940:miceexposedtoironox-
nantcells.587 ide dust developed lung tumours. In 1959, it was
Studiesinanimalsrevealthatprogressiontomalig- shownthatmultipleinjectionsofirondextranintorats
nancyfrequentlyinvolvesactivationofNF-κB.Under could produce tumours at the site of inoculation. In-
‘normal’conditionsor acuteinflammation,activation jectionofferricnitrilotriacetate(Section3.22.4.2)into
ofNF-κBistransient.Chronicactivationhelpstocreate ratsormicecausesincreasedlipidperoxidation,oxida-
a situation where cells progressively become resist- tiveDNAdamage(measuredas8OHdGinDNAand
anttoapoptosis,proliferate,andbegintoinvadeand in urine), a range of mutations (including deletions)
eventuallytransform.548,549Indeed,manyofthegenes and, eventually, renal cancers; the chelate is excreted
encodingproductsrelatedtoinflammationareunder inurine,andsothekidneyhashighexposuretoit.595
NF-κB control (COX-2, TNF, ILs etc.). NF-κB activa- TheDNAdamageisnotrandom,forexampletheras
tionmayalsoplayaroleinmetastasisandinraising oncogenes or p53 are not affected. Instead, two other
MnSODlevels.549HypoxiacanalsoleadtoNF-κBacti- tumoursuppressorgenes,p15andp16,areamongthe
vation,andthismaybeimportantinmanytumours.588 targets of oxidative damage.595 By contrast, p53 mu-
Anothertranscriptionfactorthatcouldplayanim- tationsaredetectedintheliversofhaemochromatosis
portantroleandperhapsisredox-regulatedisSTAT3, patients.596 Ironmayalsopromotelocalinvasionand
bymodulatingtheexpressionofgenesinvolvedincell metastasis, and it can aggravate the carcinogenicity
proliferation,metastasis,andangiogenesis.589 of some toxins, such as hexachlorobenzene or poly-
chlorinated biphenyls in mice (Section 9.3.2). There
are suggestions that high body iron stores predis-
10.14.12 Transitionmetalsandcancer
pose humans to develop cancer (Section 11.4.10).594
Malignantdiseaseproduceschangesinbodyironand Iron might even contribute to the increased risk of
copper distribution. In most cases, total plasma iron cancer in Fanconi anaemia592 and in endometriosis
levelsfallandcaeruloplasminrises.These‘acute-phase (Section7.11.6.1).
response’changes(Section5.7.4)areinducedbycyto- Copper can also promote cancer development,597
kinesfromthetumourand/orhostinflammatorycells. possibly in part by increasing ROS production
One suggestion590 is that they are a host’s attempt to damage DNA, and to promote migration and
to withhold iron from the tumour and slow down metastasis.596,598 For example, the LEC rat develops
its cell division. Indeed, human breast tumours ap- hepatitis and hepatoma, associated with increased
peartoaccumulateironduetoincreasednumbersof copper accumulation in the liver (Section 3.22.5.5).

--- Page 639 ---

584 FREE RADICALS IN BIOLOGY AND MEDICINE
Copper-inducedoxidativeDNAdamageislikelytobe Many carcinogens act by damaging DNA. The re-
involved,sinceLECratsshowelevatedliverlevelsof sulting carcinogen–DNA adducts lead to mutations
aldehyde–DNAadductsand8OHGinDNA,priorto thatactivateproto-oncogenes,inactivatetumoursup-
cancerdevelopment.599 pressor genes, and/or cause genetic instability. Some
carcinogens, such as N-methyl-N(cid:4)-nitrosoguanidine
(Fig. 10.20), modify DNA directly, for example by
10.15 Carcinogens:oxygenandothers
methylating guanine. Most have to be converted in
TheO thatsurroundsusisessentialtolife,yetcarcino- vivo into their active form, the ultimate carcinogen.
2
genic.Oxygenisnotadirectcarcinogen;itmustfirstbe Conversion of a procarcinogen to the ultimate car-
metabolized(toROS).Thesameistrueofmanyofthe cinogen can proceed in one or more steps. If more
molecules that are more usually regarded as carcino- thanonestepisrequired,theintermediatesarecalled
gens. They are metabolized to electrophiles, agents proximate carcinogens. The necessary metabolism is
thatseekareasofhighelectrondensity(includingthe sometimescarriedoutbygutbacteria.Oneexampleis
purine and pyrimidine bases of DNA). In 1775, the thehydrolysisofcycasin,atoxicconstituentofcycad
English surgeon Percival Pott reported that the inci- plants,totheproximatecarcinogenmethylazoxymeth-
denceofcancerofthescrotuminchimneysweepswas anol, which then decomposes to a DNA-damaging
correlatedwithdepositionofsootandtarinthescrotal product.602 More often, enzymes in the body are in-
creases.Laterworkshowedthatrepeatedapplication volved. Individual variations in carcinogen metabol-
ofcoaltartotheskinofanimalsproducesmalignant ismareinpartgeneticallydetermined,dependingon
tumours at the application site. Aromatic hydrocar- thelevelsofthevariousCYPsandphaseIIenzymes,
bonssuchasbenzo[α]pyrene(Fig.10.20),abbreviated as well as on rates of repair of DNA–carcinogen ad-
elsewhereinthisbooktobenzopyrene,wereisolated ducts.Thefirstexampleofmetabolicactivationtobe
fromcoaltarandshowntobecarcinogenic.Carcino- discoveredwastheconversionofthearomaticamine
genichydrocarbonsarepresentincombustedorganic derivative 2-acetylaminofluorene (Fig. 10.20) to an
matter,suchassoot,vehicleexhaustparticulates,and N-hydroxylatedproductbyCYPs.Thistypeofmetab-
cigarette tar600 (Sections 9.13 and 9.14) and in some olismiscommontoseveralaromaticamines,including
tattooinks.601 Inthelate1800s,theGermanphysician heterocyclic amines formed in cooked foods (Section
Rehnnoticedanassociationbetweenexposureofdye 10.5.5). The N-OH product can undergo several reac-
workers to aromatic amines such as benzidine (Fig. tions, including sulphation to give an N-O-sulphate
10.20)andthedevelopmentofbladdercancer.Notun- ester.Lossofsulphateproducesareactivenitrenium
tilthe1930swasitshownthatsomearomaticamines ion,whichcombineswithguanineresiduesinDNA.
causethiscancer. Benzopyrene also needs metabolic activation; the
Manynaturallyoccurringandman-madechemicals ultimate carcinogen is a 7,8-diol-9,10-epoxide (Fig.
are carcinogenic: examples we have already met in- 10.20). Cytochromes P450 (especially CYP1A1 and
clude arsenic (Section 9.16.2), benzene (Section 9.5.8), 1B1) convert benzopyrene into a 7,8-epoxide. This is
andasbestos(Section9.15).Ithasbeenestimatedthat acteduponbytheenzymeepoxidehydratasetoform
one-thirdormoreofcancercasesinEuropeandNorth adiol,whichisasubstrateforfurtherepoxidationby
America originate from exposure to carcinogens in P450. The 7,8-diol-9,10-epoxide combines with guan-
tobaccoproducts.600 ineinDNAandcauseG→Ttransversionmutations.
Epoxidation can occur at other positions on the ring,
although the products are less carcinogenic. Inducers
10.15.1 Carcinogenmetabolism
of CYPs, such as phenobarbital, can thus accelerate
Manycarcinogens,suchasbenzopyrene,arecomplete carcinogenesis due to benzopyrene. Aflatoxin B1, a
carcinogens,bothinitiatorsandpromotersofcarcino- powerfulhepatocarcinogen,isalsometabolizedtoan
genesis.Othersareinitiatorsonly(incompletecarcino- epoxide,whichbindstoguanine(Fig.10.20).Epoxides
gens) and produce malignant transformation only if can be detoxified by glutathione S-transferases (Sec-
a promoter is present. Low doses of a complete car- tion3.15.2),beingconvertedintoderivativeswhichare
cinogen,toosmalltoproducecancer,canbemadeto excreted.
dosobyatumourpromoter.Thebiologicaleffectsof
10.15.1.1 CarcinogenscanmakeRS
a carcinogen depend on the dose, the animal species
used,sometimesthesexoftheanimal,andthemode Insomecases,theDNA-attackingagentderivedfrom
ofcarcinogenadministration. a carcinogen may be a RS. For example, ROS may

--- Page 640 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 585
(a) AFLATOXIN B1
O O
O
A
O
O B
O OCH
3
2-ACETYLAMINOFLUORENE
NH COCH
3
NOH NOSO
3
– N+
nitrenium ion
DIMETHYLNITROSAMINE
H 3 C N N O Liver ER H 3 C N NO [ CH
3
+ ] + N2 + OH–
H 3 C NADPH, O2 H DNA
methylating agent
BENZOPYRENE
O
P450
Epoxide P450
10
hydratase
9 O HO HO
OH OH
8
7 -epoxide –7,8-diol –7,8-diol–9,10-epoxide
O
O
–7,8-dione
Figure10.20 Thestructureandmetabolismofsomecarcinogens.Benzopyreneismetabolizedtoarangeofmetabolites;onlyonepathwayis
shown,forsimplicity.
contribute to carcinogenesis induced by the admin- and are carried to the DNA, a sort of ‘Trojan horse’
istration of high doses of oestrogens to rodents and, mechanism.The4-hydroxycatecholseemstobemore
possibly,humans.Oestroneandoestradiolcanbecon- damaging than the 2-species.603,604 Excess oestradiol
vertedbyCYPsinto2-hydroxyand4-hydroxycatechol hasadditionallybeensuggestedtoincreasemitochon-
derivativeswhich,ifnotrapidlymetabolized,canox- drial O •–/H O production,605 although it may have
2 2 2
idize in the presence of metal ions (e.g. copper) or theoppositeeffectatphysiologicallevels(Section3.26).
oxidaseenzymestoformsemiquinonesandquinones Reactive species can also promote (or sometimes
that can bind to DNA bases (especially adenine and decrease!) DNA damage by other carcinogens. First,
guanine), as well as redox-cycle to generate ROS theycanleadtochangesintheactivitiesofdetoxifica-
(Sections 5.8.2.2 and 9.5.5). These DNA adducts are tion enzymes such as GST e.g. via activation of Nrf2
unstableandcanleadtodepurination.Ithasbeenpro- (Section 5.5.8). Second, cyclooxygenases (COX; Sec-
posedthatthequinonesbindtotheoestrogenreceptor tion 8.12.5), MPO,403 and lactoperoxidase can oxidize

--- Page 641 ---

586 FREE RADICALS IN BIOLOGY AND MEDICINE
(b) BENZANTHRACENE BENZIDINE
H 2 N NH 2
SAFROLE VINYL CHLORIDE
CH 2 O H C C H
O Cl H
1,2-DIMETHYLHYDRAZINE
CH 2 CH CH 2 CH 3 NH NH CH 3
N-METHYL-N’-NITROSOGUANIDINE
N O
CH 3 NH C NHNO 2
NH
O
O O
P450 HO
+
HO
HO HO OH
OESTRONE 2-HYDROXYOESTRONE 4-HYDROXYOESTRONE
[[OO]]
Oestradiol [O]
dehydrogenase O O
OH
O
O O
HO O
4-QUINONE
OESTRADIOL 2-QUINONE
Figure10.20 (Continued)

--- Page 642 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 587
several pro-carcinogens in vitro to yield RS. For ex- Severalcompounds,includingtrichloroethylene,some
ample,COX(whoselevelsoftenincreaseinmalignant drugs that lower blood lipid levels (e.g. clofibrate,
tumours, as COX2)548,549 and peroxidases can con- ciprofibrate, nafenopin, gemfibrozil), plasticizers
vert benzopyrene into 6-hydroxybenzopyrene, which (e.g. di-(2-ethylhexyl)phthalate), and phenoxyacetic
rapidlyoxidizesintoamixtureofquinones,withpro- acid herbicides (e.g. 2,4-dichlorophenoxyacetic acid),
ductionofO
•–.Benzopyrene7,8-diolneednotalways
produceliverenlargementwhenadministeredtoani-
2
undergoepoxidation;itcan beoxidizedby aldo-keto mals, accompanied by increases in the number of
reductaseenzymes,resultinginadione(Fig.10.20)that hepatic peroxisomes. Peroxisomes not only increase
isbothelectrophilicandredox-active,damagingDNA in number, but their balance of enzyme activities
bothdirectly(addingtoguanineandadenineresidues) changes. Thus the activity of the peroxisomal system
andviaROS(beingreducedbacktoacatecholthatthen for β-oxidationoffattyacids(whichgeneratesH O )
2 2
reoxidizes).606 Other substrates for theperoxidase ac- oftenincreasesmorethanthatofcatalase.Theseagents
tionofCOXincludebenzidine,2-aminofluorene,and sometimes also cause proliferation of hepatic ER and
2-naphthylamine.Oxidizinglipidswerereported607to itsassociatedCYPs,perhapsadditionalsourcesofO •–
2
convert benzopyrene into mutagenic products, prob- andH O (Section1.10.6).
2 2
ably by the action of peroxyl radicals. Oxidizing sul- Administering PP to rodents (but not humans for-
phite ions can also produce diol epoxides from the tunately!) increases the incidence of liver cancer, but
7,8-diol,perhapsbytheactionof•O SO– radical(Sec- neither they nor their metabolites react directly with
2 3
tion 9.12.3). Indeed, SO exposure has been reported DNA;thetermnon-genotoxiccarcinogenisoftenused
2
topromotethedevelopmentoflungcancerinanimals for agents of this type, whereas a genotoxic carcino-
treatedwithbenzopyrene.608 genisonewhereit(oritsmetabolites)damageDNA
The contributions of these various reactions to directly.Otherexamplesofnon-genotoxiccarcinogens
cancerdevelopmentisunclearasyet,althoughithas includeimmunesuppressors,agentsthatactivatehor-
been suggested that polymorphisms affecting MPO monereceptors,andsomephosphataseinhibitors.
activity influence the formation of DNA-carcinogen HowdoPPwork?TheybindtoPP-activatedrecep-
adducts in smokers.609 One such polymorphism is tors (PPARs; Fig. 9.9) and the complexes eventually
at position 463 in the promoter region; the presence translocate to the nucleus to induce changes in gene
of A produces less MPO gene transcription than if transcription,includingincreasedexpressionofgenes
G is present. Some papers suggest that the 463A encodingenzymesinvolvedinperoxisomalfattyacid
alleledecreasestheriskofsmoking-inducedtumours, oxidation.OnesuggestionisthattheexcessH O pro-
2 2
although data are controversial. Such effects could ductionisnotfullymetabolizedbythelimitedcatalase
relate to MPO-dependent metabolism of carcinogens, activitypresent,leaksoutoftheseorganelles,reaches
but might also of course involve modulation of the the nucleus, and causes oxidative DNA damage that
inflammationassociatedwithcancer. leadstocancer.Consistentwiththis,perfusionoflauric
acid,asubstrateforperoxisomalβ-oxidation,intoliv-
ers of fasted rats produced only small increases in
10.15.2 CarcinogensandoxidativeDNA
the efflux of GSSG (Fig. 3.13), presumably because
damage502,503,539,540,567
catalasedegradedtheH O .However,iftheratshad
2 2
Thedamage doneto DNA by mostcarcinogensdoes been pretreated with nafenopin, lauric acid infusion
not involve RS. Yet, increases in the levels of 8OHG did increase GSSG efflux, consistent with escape of
(andinotherbaseoxidationproducts,whentheyhave H 2 O 2 fromperoxisomes.OfcoursemoreGSSGmeans
beenmeasured)inDNAfromtheneoplastic,andoften thatH 2 O 2 isbeingmetabolizedbyGPx,whichisnot
the preneoplastic, lesions are common in carcinogen- evidencethatH 2 O 2 reachesthenucleus.So,doesoxi-
exposed tissue (Section 10.14.8.2). For example, sub- dativedamageinnuclearDNAincreaseafterexposing
jects exposed to aflatoxin excreted more 8OHdG in animals to PP? Some, but not all, studies say yes.
urine.610 HenceoxidativeDNAdamageisinvolvedin However,increasesinoxidativeDNAdamageareob-
carcinogenesis,whetherduetospontaneousmutation served generally in cancer and so their significance
(Section10.14.8)ortocarcinogenaction. mustnotbeover-interpreted.Clofibratealsoincreases
mitochondrial ROS production and 8OHG levels in
10.15.2.1 Peroxisomeproliferators mtDNAinmice.612
Reactive species have been particularly implicated Overall, in a court of law, RS would be acquitted
in the actions of peroxisome proliferators (PP).611 ofcausingperoxisomeproliferator-inducedcanceron

--- Page 643 ---

588 FREE RADICALS IN BIOLOGY AND MEDICINE
thebasisof‘notprovedbeyondreasonabledoubt.’Of agent nitrogen mustard was used in a patient with
course, acquittal does not equate to innocence. ROS lymphoma. One class of chemotherapeutic agents is
havealsobeensuggestedtocontributetothetoxicity the alkylating agents; they or their metabolites bind
of furan, a heterocyclic aromatic amine that causes to DNA, and modify it, interfering with replica-
liverandbileductcancerinrats;itsrisktohumansis tion and transcription. The nitrosourea carmustine
unclear,althoughitispresentinmanyfoodstuffs.613 (BCNU) additionally inhibits glutathione reductase
(Section3.10.2).Cytosinearabinosidecontainsanara-
binose sugar instead of ribose, and its incorporation
10.15.3 Carcinogenicreactivenitrogenspecies?
into DNA interferes with replication. Cis-platin (cis-
Nitrous acid and ONOO– can be produced in tu- diamminedichloroplatinum(II);Fig.10.21),whichwas
mours(Section10.14.11)andmightleadtoDNAdam- discovered as an ‘antibacterial agent’ that formed at
age. Reaction of secondary or tertiary amines with platinum electrodes, probably acts by cross-linking
HNO /N O produces N-nitrosamines (in the case guanineresiduesbetweentheDNAstrands,whereas
2 2 3
of a secondary amine, for example, N–H is replaced vincristine, vinblastine, and taxol (paclitaxel) inter-
byN–N=O).Nitrosaminesareformedinthestomach fere with mitotic spindle formation. DNA damage or
fromdietaryamines(Section7.2),andcanbegenerated stalledDNAreplicationwillactivatep53andhaltpro-
atsitesofinflammationwhenRNSfromactivatedpha- liferation;thustheeffectsofDNA-damagingdrugsare
gocytesreactwithamines.Nitrosaminesarefoundin oftendiminishedincancerswherenormalp53function
humanfaeces(levelsincreaseonahigh-meatdiet),614 hasbeenlost.
and tobacco smoke is a rich source of nitrosamines, Otheranticancerdrugsinterferewithmetabolicre-
some of which are ‘tobacco specific’ and established actions. Methotrexate (also used in the treatment of
carcinogens.600Nitrosaminesrequiremetabolicconver- RA)inhibitstheenzymedihydrofolatereductaseand
sion (involving CYPs) to agents that attack guanine preventstransferofmethylgroupsinseveralbiosyn-
(Fig. 10.20). Ascorbate,615 and possibly various other thetic reactions, including synthesis of thymine for
plant constituents (e.g. N-acetyl-S-allylcysteine and DNA. 5-Fluorouracil is an analogue of thymine and
certainflavonoids)614–616,maybescavengersofnitrosa- prevents DNA synthesis by inhibiting thymidylate
minesinvivo.One‘bioassay’forsuchreactionsinvivo synthetase. Hydroxyurea inhibits ribonucleoside di-
istofeednitrateplustheaminoacidproline;proline phosphate reductase (Section 8.2.2). Hormone antag-
isconvertedintothenon-carcinogenicnitrosoproline, onistssuchastamoxifenhavebeendevelopedtotreat
whichisexcretedinurine.Forexample,ascorbatede- cancerswhosegrowthdependsonsteroidhormones.
creasednitrosoprolineexcretioninhumansgivenNO– PARP inhibitors interfere with DNA repair in cancer
3
andproline.615 cells(Section5.2).Agentsthattargethypoxicregionsin
tumours, diminishing response to radiotherapy, have
beendeveloped(Section9.20.3).
10.16 Cancerchemotherapyandreactive
Manyanticanceragentsareproducedbylivingor-
oxygenspecies503
ganisms.Theyincludetheanthracyclines(Fig.10.21),
Cancer treatment by radiotherapy or chemotherapy other quinone-containing drugs (such as mitomy-
aimstokillmalignantcellswithaslittledamageaspos- cinsandstreptonigrin),somemetal-chelators(suchas
sibletonormalcells.However,allofthesetreatments tallysomycin and the bleomycins), and aureolic acid-
cause release of DAMPs from damaged host tissues based antibiotics (such as mithramycin, chromomy-
anddyingcancercells,promotinginflammation.This cins, and olivomycins). Another promising class of
inflammationmayaidthedrug’santi-cancereffects,or anticancerdrugsistheproteasomeinhibitors,which
under some circumstances it could promote tumour
bothdecreaseNF-κBactivationaswellasblockthecell
growth (Section 10.14.11).617 Surgery can also cause cyclebyhaltingtheubiquitin-dependentdegradation
DAMPreleaseastissuesareincisedanddamaged. ofcyclins(Sections5.14.3.2and10.14.1).
Inmalignanttumours,morecellsthanusualarediv- Of course, any normal cells undergoing division
idingandsoradiotherapyandmostchemotherapeutic (e.g.intheintestinalepithelium,hairfollicles,gonads,
agents are designed to interfere with cell division. andbonemarrow)willbedamagedbymostofthese
However, many cells in a large tumour are not div- agents. These and other side-effects limit the doses
idingverymuchandyettheseagentswork,soother ofradiationandchemotherapeuticagentsthatcanbe
factors must be involved.502 The first reported use of used. Agents that damage DNA are also potentially
chemotherapywasin1942,whentheDNA-modifying carcinogenicthemselvesandcanevencausemutations

--- Page 644 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 589
Group reduced to CHOH
in doxorubicinol
O OH O OH
COCH2OH COCH3
OH OH
O O
H3CO O OH H3CO O OH
O Group missing O
in idarubicin
H3C NH2 H3C NH2
OH OH
Conformation of this
-OH group is altered
in epirubicin
(a) (b)
OH
O C O O H CH2OCO(CH2)3CH3 H2N O 10 O O C C H O 3 NH2 2e- H2N OH 10 O O C C H O 3 NH2
1 reduction 1
H3CO O OH O H3C O N 3 2 NH H3C OH N 3 2 NH
O
C1, C10 strong
H3C NHCOCF3 electrophilic positions
OH
(d)
(c)
OH O NH(CH2)2NH(CH2)2OH
H3N Cl
Pt(II)
H3N Cl
H3N
Pt(II)
Cl OH O NH(CH2)2NH(CH2)2OH
Cl NH3
(e)
(f)
O
O O O O O
H 3 C N H3C N NHHNN CH3 Cu2+ H3C N N N N CH3
H C
3
O O S S S S
O
CH
3
Cu2+-chelate
(g) (h)
Figure10.21 Structuresofsomeantitumourdrugs.(a)Adriamycin(doxorubicin);(b)daunomycin(daunorubicin);(c)AD32(valrubicin);
(d)mitomycinC;(e)cis-diamminedichloroplatinum(II);thetrans-isomer(below,inbrackets)isnotaneffectiveantitumourdrug;cis-platinappears
toentercellsusingthecoppertransporterCtr1(CancerCell17,574,2010)(f)mitoxantrone;(g)piperlongumine;(h)elesclomol.

--- Page 645 ---

590 FREE RADICALS IN BIOLOGY AND MEDICINE
in the tumour cells that might sometimes enhance malignant cells ‘over the edge’ (Fig. 10.22), increas-
malignancy.618 For example, arsenic trioxide (As O ) ing oxidative damage to a point that the cell cannot
2 3
at high levels can be used to treat acute promyelo- cope and senesces or dies. Indeed, it was observed
cyticleukaemia,butAs O canalsobecarcinogenicby thathumanleukaemiacellswithhighROSlevelsare
2 3
RS-dependentmechanisms(Section9.16.2). more sensitive to injury by the oestrogen derivative
2-methoxyoestradiolthannormalcells.Thisagentap-
pears to increase oxidative stress in cells, although
10.16.1 Oxidativestressandchemotherapy503
exactlyhowisnotclear.625
Reactive species are often suggested to be involved DoesincreasedRSformationcontributetotheanti-
both in the mechanisms of action of (e.g. Sections tumour effects of chemotherapy and radiotherapy?
10.16.2, 10.16.3), and/or in the side-effects produced Certainly so in radiotherapy (Section 9.20), as well
by,severalanticancerdrugs,e.g.indamagetotheear as in photodynamic therapy (Section 2.6.4.4). Most
(Section 7.12) and kidney619 caused by cis-platin, and agents used in chemotherapy act in specific ways,
inmucositisinducedby5-fluorouracil.620Forexample, e.g. cytosine arabinoside, cis-platin, and methotrex-
patients treated with cis-platin and 5-fluorouracil ate, as explained earlier. Some other examples: iri-
showed increased urinary excretion of 8OHG and notecanandtheanthracyclinesactbyinhibitingtopoi-
8OHdG.621 The effects of taxol may involve RS, in somerases,farnesyltransferaseinhibitorsbyinterfering
addition to direct interference with mitosis.622 One with the action of small GTPases, adaphostin by in-
side-effect of certain drugs is chemobrain, impaired hibitingproteinkinases,andproteasomeinhibitorsby
cognitivefunctionafterchemotherapy.Severalstudies interfering with cell division. Yet many (and prob-
suggestthatchemobrainrelatestoincreasedoxidative ably all) of these agents also cause oxidative stress,
damage in the brain (measured as protein carbonyls whichhasoftenbeensuggestedtocontributetotheir
andHNEadducts),623eitherbecausesomeofthedrug side-effects but may also sometimes aid their anti-
entersthebraintocausedamageand/orthereisanin- cancer activity.503 Several other potential anti-cancer
ductionofinflammation,e.g.raisingcirculatingTNF-α agents under evaluation may act by increasing oxi-
levelsthataffectthebrainand/orblood–brainbarrier. dativestress,e.g.NOV-002(acomplexofGSSGwith
If malignant cells in vivo are under self-inflicted
cis-platin:Section11.5.11),β-lapachoneandmenadione
(and/orhostinflicted)oxidativestress,andthatstress (Section 9.5), piperlongumine,626 artesunate (used as
contributestomalignancy(Section10.14.10),thenanti- ananti-malarial[Section7.6]butmayalsohaveprom-
oxidantsthatareeffectiveatdecreasingoxidativedam- ise in chemotherapy), auranofin (Section 10.11.5)627,
ageinvivoorinhibitorsoflysylorprolineoxidasesor some‘SODmimetics’(Section11.5.4)andadenanthin
ofNADPHoxidases,624 mighthaveanti-cancereffects (aditerpenoidfromtheplantIsodonadenanthus),which
(e.g.byinhibitingmetastasis).Theoppositeapproach inhibits prx1 and -2, but probably is not specific.628
wouldbetostressmalignantcellsfurtherbyproviding Inhibitors of MTH1, preventing sanitization of the
agentsthatgenerateRSordepleteantioxidants.These DNA precursor pool (Section 5.10.2), are also be-
shouldhavelimitedeffectsonnormalcells(provided ing examined; they appear to overwhelm the DNA
that RS levels do not rise too high), but might, when of the cancer cell with oxidized bases.629 A cop-
added to their already elevated RS generation, push per ion chelator that inhibits CuZnSOD (ATN-224;
Net Cell Redox
Reducing Oxidizing
Potential
noitarefilorP
Figure10.22 Impactofcellredoxpotentialoncell
proliferation.Smallshiftsintheredoxpotentialtoward
oxidationcanincreasetheproliferativecapacityofmalignant
Normal Malignant cells(Fig.5.1).Incontrast,thehighlyoxidizingenvironment
createdbyradiationtherapyorsomechemotherapeuticdrugs
Radiation Therapy canbecytostatic/cytotoxic(Fig.5.1).FromFreeRadic.Biol.
Chemotherapeutics Med.36,718,2004,bycourtesyofDrsVLKinnula,JDCrapo,
andElsevier.AlsoseeNatureRev.DrugDisc.8,579,2008.
Ithasevenbeenspeculatedthathigh-doseascorbatecould
bepro-oxidanttotumourcellsinvivobygeneratingH2O2
(Sci.Transl.Med.6,222ra18,2014).Thep53proteinalso
influencestheredoxstateofthecell(Fig.10.17).

--- Page 646 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 591
Section3.5.1.4)hasalsobeentested,butwasnotvery 10.16.1) and consequent elevations in quinone reduc-
effective therapeutically.630 The drug elesclomol (Fig. tase(NQO1)activity.635
10.21) has been suggested to work by chelating cop- The role of ROS has been given greatest attention
perionsandtransportingthemintothemitochondria fortheanthracyclines,tetracyclicantibioticsproduced
of malignant cells to enhance oxidative damage. Its byvariousStreptomycesstrains.Thefour-ringstructure
clinicaleffectivenessisalsouncertain.631 is attached to a carbohydrate, removal of which usu-
If some or all anti-cancer drugs work, at least in allycauseslossofantitumouractivity.Anthracyclines
part,bycausingoxidativestress,thentumoursmight are widely used in the treatment of several cancers,
fight back by raising antioxidant defences, especially includingleukaemias,breastcancer,andHodgkindis-
GSH,whichisalsoinvolvedinthemetabolismofmul- ease. The best known are daunorubicin (sometimes
tipleanti-cancerdrugstoineffectiveproducts.Indeed, calleddaunomycin)anddoxorubicin(oftencalledad-
some tumour cells have increased Nrf2 activity, rais- riamycin).BothareproductsofStreptomycespeucetius.
ingHO-1,GSH,andGSTlevels.528,569Wehavealready Inboth,theattachedsugarisdaunosamine(Fig.10.21).
seenthathumanCLLcellsneedtoreceiveGSHfrom Howanthracyclinesworkisnotentirelyclear;mul-
theirenvironmentinvivo.580Henceseveralagentsthat tiplemechanismsseemtobeinvolved.Oncetheyhave
inhibit GSH synthesis or GST enzymes, or otherwise entered the nucleus (a process which may involve
affectGSHmetabolism,areinclinicaltrial.632 their binding to the proteasome, followed by move-
Let us explore some ROS-generating anticancer mentofthecomplexintothenucleusanditsdissoci-
agentsinmoredetail. ation), doxorubicin and daunorubicin can intercalate
betweenDNAbases,interferingwithDNAreplication
and RNA transcription. Probably their major antic-
10.16.2 Theanthracyclinesandother
ancer target is topoisomerase II, an ATP-dependent
quinones633,634
enzymeinvolvedinunwindingDNAfortranscription
Several antitumour antibiotics are quinones (Fig. and replication; it prevents knots and tangles form-
10.21). Hence redox cycling and/or reaction of semi- inginthedoublehelix.Todothis,ithastointroduce
quinones/quinones with –SH groups (Section 9.5) or transient double-strand breaks in the DNA (a rather
ironions(Section9.5.2)mightparticipateintheiranti- dangerous thing!). Anthracyclines (sometimes called
canceractivity. topoisomerase II poisons) stop the enzyme from re-
The first anti-tumour antibiotic whose action in sealing these breaks, and cell division halts. Other
vivo was demonstrated to involve ROS was strepto- mechanismsofanthracyclineactionmayincludepar-
nigrin (Section 9.17), no longer used clinically. An- tialinhibitionofproteasomefunction,andinterference
other is mitomycinC (Fig. 10.21). This drug, isolated withiontransport.Indeed,thedoxorubicinderivative
from Streptomyces caespitosus, is used, in combination AD32(N-trifluoroacetyladriamycin-14-valerate,valru-
with other agents, in the treatment of several can- bicin;Fig.10.21)willnotbindtoDNA,andyetisstill
cers. In vitro, it can be reduced by microsomal or anantitumouragent,althoughnotoftenused.636
nuclear electron-transport chains in the presence of What about ROS? Reduction of the quinone moi-
NADPH.Reductionformsasemiquinonethatcanre- etycan be achievedby NADPH-cytochromeP450 re-
actwithO toformO •–.NADPH-cytochromeP450re- ductase, XO, eNOS, the electron transport chain of
2 2
ductase converts mitomycin C under hypoxic con- the nuclear envelope, and the mitochondrial NADH-
ditions into reactive bis-electrophiles (Fig. 10.21) that dehydrogenase complex (simultaneously interfering
attack DNA directly, and cross-link the strands. Usu- with normal mitochondrial electron transport). Dam-
ally the cytotoxicity of mitomycin C is greater under age could then be caused by semiquinones and/or
hypoxic conditions, suggesting that its reductive ac- byROS.However,intercalationofanthracyclinesinto
tivation and resulting DNA cross-linking are more DNA prevents their reduction by enzymes (because
importantindamagingitstargetcellsthanisredoxcyc- of inaccessibility), and so it seems unlikely that ROS
ling. The action of mitomycin C against large ‘solid’ contribute a lot to the DNA damage (probably much
tumours, which often contain hypoxic areas (Sec- less than topoisomerase inhibition does). Of course,
tion 9.20.3), is consistent with this conclusion. Mito- someH 2 O 2 formedelsewhereinthecellbyredoxcyc-
mycinCcanalsobereducedbyNQO1(Section9.5.4);
lingmightdiffuseintothenucleus,generateOH•,and
two-electron reduction by this enzyme again forms contributetotheDNAdamage.
a DNA-damaging product. This may be relevant in Likeallanti-tumourdrugs,theanthracyclinesprod-
vivosincemanytumourshaveactivatedNrf2(Section uceside-effects,themostseriousbeingheartdamage.

--- Page 647 ---

592 FREE RADICALS IN BIOLOGY AND MEDICINE
Acutecardiotoxicitycanoccurwithinminutesofdrug cardiotoxicity, a more serious clinical problem, nor
administration, revealed as arrhythmias and electro- havevitaminEorN-acetylcysteinebeeneffectiveindi-
cardiographic changes. More serious than this is a minishingcardiotoxicityinpatients.633,634Inhibitionof
chronicirreversiblecongestiveheartfailure,whichbe- cardiactopoisomerase(Top26)mayalsobeinvolvedin
comes a significant problem once a certain amount thecardiotoxicityandseemsintimatelyrelatedtoROS
of anthracycline has been administered. This cardi- generation.640
otoxicity limits the total amounts of doxorubicin and
10.16.2.2 Ironandanthracyclines633,641
daunorubicin that can safely be given to cancer pa-
tients.Onepartialsolutionhasbeentouseepirubicin Iron contributes to anthracycline cardiotoxicity. In-
(Fig.10.21),whichexertscomparableanti-canceractiv- deed, doxorubicin can chelate several metal ions, in-
itybutismetabolizedfaster,allowinglargerdosesto cluding Fe2+ and Fe(III), and it can carry them into
begiven.Anotherhasbeentouseliposomalorother themitochondriaofcardiacmyocytes.642 Doxorubicin
formulationsofdoxorubicinthatdelivermoredrugto formsacomplexwithFe(III),inwhichthreedoxorubi-
thetumourandlesstotheheart. cin molecules associate with each Fe(III). A combin-
ationofdoxorubicinandiron,quelamycin,wasonce
10.16.2.1 Mechanismsofcardiotoxicity:redox
tested for anticancer activity but found to be highly
cyclingandothers633
toxic to heart and other tissues. The levels of several
Changes in Ca2+ handling may contribute to the car- DNA base oxidation products in blood cells are in-
diotoxic effects of adriamycin. Doxorubicinol, a ma- creased in patients given epirubicin or doxorubicin,
jor metabolite of doxorubicin formed by NADPH- consistentwithOH• formationinvivo,643 andpatients
dependent reduction of the side-chain keto group to treatedwithdoxorubicinpluscyclophosphamideoften
–CHOH by a carbonyl reductase enzyme, impairs (butnotalways)showelevatedlevelsofbiomarkersof
cardiacCa2+metabolism. oxidativedamage,includingF
2
-IsoPsandallantoinin
Whereas ROS may not contribute much to the urine(Section6.13).644
DNA-damaging effects of anthracyclines, they seem Would iron ion chelating agents therefore protect
to be more important in their cardiotoxicity, espe- against the cardiotoxicity? The compound ICRF-187
cially as several newer anthracycline analogues with (or dexrazoxane) has some cardioprotective action in
less cardiotoxicity (such as pixantrone or mitoxan- humansandotheranimalsandallowshigherdosesof
trone, which also act on topoisomerase II) appear to anthracyclinestobeused.Dexrazoxaneundergoestwo
undergo less redox cycling, although they still have enzyme-catalysed(or,moreslowly,non-enzymic)hy-
side-effects.637 Theanthracyclinesemiquinonecanox- drolysisstepstoformadiaciddiamide(ADR925)that
idizetoloseitssugar,givingatherapeuticallyinactive resembles EDTA (Fig. 10.23). Although ICRF-187 can
aglycone which can still, nevertheless, redox-cycle itself inhibit topoisomerase II, evidence suggests that
andmaypartitionintomitochondria,facilitatinglocal itactsadditionallybyironchelation,inparticularre-
ROS generation, cytochrome c release, and apoptosis movingironfrommitochondria.642Bothactivitiesmay
of cardiac myocytes. Indeed, doxorubicin cardiotox- accountforitstherapeuticeffects.
icity in mice is accompanied by cardiac protein ni- Where might the ‘catalytic’ iron in the heart come
tration and inactivation of creatine kinase, consistent from?Superoxidecanreleaseironfromaconitaseand
with ONOO– production.638 HNE-modified proteins ferritin(Sections3.9.2and3.22.4.2).Cancerchemother-
arealsopresent.639 apy can cause ‘non-transferrin-bound’ iron to appear
Why should heart be a target of damage? One inplasma(Section10.14.2),whichcanbetakenupby
possibility could be its modest levels of antioxid- cardiaccells(Section3.22.5.4).645
ant defences. Indeed, transgenic mice overexpressing Ferrylmyoglobin (Section 3.22.3) can oxidize
catalase,metallothionein,ormitochondrialMnSODin doxorubicin to several products, including
the heart are more resistant to the acute cardiotox- 3-methoxyphthalicacid,
icityofadriamycin.Treatmentsofanimalswithascor-
bate, ubiquinone, MnTE-2-PyP (Section 11.5.4), PBN,
α-tocopherol,probucol,orN-acetylcysteinehaveoften
shown protective effects against the acute toxicity of
doxorubicin.Ofcourse,someofthesescavengers(e.g.
thiols)mightreactdirectlywithsemiquinones.Ingen-
eral, however, they are less effective against chronic

--- Page 648 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 593
O
HN N CH CH COOH
2 2
CH N
O H C CH CONH
3 2 2
O
O HOOC CH
HN N CH 2 N CH 2 CH 2 COOH
2 H NOC CH CH N
O H C CH N NH 2 2 H 3 C CH 2 CONH 2
3
O
DEXRAZOXANE DIACID DIAMIDE (ADR 925)
(ADR 529)
O
HOOC CH 2 HOOC CH 2
N CH 2 N CH 2 CH 2 COOH
H 2 NOC CH 2 CH N NH HOOC CH 2 CH 2 N
H 3 C CH 2 COOH
O EDTA
Figure10.23 Two-stephydrolysisofdexrazoxanetoanEDTA-likediaciddiamide.FromPharmacol.Rev.56,185,2004,bycourtesyofDr
G.MinottiandtheAmericanSocietyforPharmacologyandExperimentalTherapeutics.
whichhasbeendetectedintheheartsofdoxorubicin- DNAbybleomycinforms,amongotherproducts,base
treated mice.646 Since this product appears non- propenals (base–CH = CH–CHO), which further de-
cardiotoxic, myoglobin may help to protect the heart composetoreleaseMDA.SinceMDAreactswithTBA
against damage by anthracyclines. Myeloperoxidase to give a chromogen, the TBA assay can be used to
can also oxidize anthracyclines to this and other followDNAbreakdownbybleomycin(Section5.3.3.1).
products, although the importance of this in vivo is Bleomycins are powerful chelators of transition
uncertain.647 metalions,bydonationofelectronsfromnitrogenand
fromacarbonylgroup(Fig.10.24).Indeed,transition-
10.16.3 Bleomycin648 metalionsareneededforbleomycintodegradeDNA.
Invitro,complexesofbleomycinswithFe2+,Cu+,Co2+,
Bleomycin is the collective name given to a family Mn2+, and vanadium(IV) can damage DNA, but iron
of glycopeptide antibiotics produced by Streptomyces ionsareprobablythemostimportantinvivo.AnFe2+-
verticillus.Theclinicalpreparationusuallyused,Blen- bleomycincomplexcapableofdegradingDNA(inthe
oxane,isamixtureofbleomycinsdifferingslightlyin presenceofO
2
)canbegeneratedbyaddingFe2+ salts
structure,bleomycinsA and(toalesserextent),B be- tobleomycinorbyreducingaFe(III)-bleomycincom-
2 2
ingthemajorcomponents(Fig.10.24).Bleomycinsare plex,e.g.withascorbate,GSH,orO
•–.Ferricbleomycin
2
activeagainstseveralhumancancers,includingHodg- willalsodegradeDNAifH 2 O 2 isadded;O 2 isnotthen
kindiseaseandcancerofthehead,neck,ortestis.They required.Inallcases,theDNA-degradingintermediate
bindtoDNA,especiallyadjacenttoguanineresidues, appearstobeanoxo-iron,probablyFe(III)-OOH,spe-
and cause single-strand, and some double-strand, cies. If bleomycin is incubated with Fe2+ under air in
breaks,haltingthecellcycleandsometimestriggering theabsenceofDNAthebleomycindestroysitself;itis
apoptosis. Breakdown of the deoxyribose residues in protectedbyadditionofDNA,whichthenbecomesthe

--- Page 649 ---

594 FREE RADICALS IN BIOLOGY AND MEDICINE
*
CONH NH
2 2
CH 2 N* CH
CH H CH CONH
2 2
CH
3
N N*
CH CH CH OH
3 3
H 2 N CO N * H CH CO NH CH CH CH CO NH CH CO
CH 3 CH N* OH NH
O NH CH
HO 2
O CH 2 OH CH 2
O
N S
HOCH O OH Z
2
HO N
O OH
CH 2 CH 2 CH 2 NH CO S
CONH
* 2 S+
HC CH
3 3
X
NH
NH (CH) NH C NH in B
24 2 2
Figure10.24 StructureofbleomycinA2.InbleomycinB2thesubstituentshownreplacespartXofbleomycinA2.Theasterisksdenotetheatoms
thatinteractwithtransition-metalions.Thephleomycinantibioticsdifferfromthebleomycinsintheabsenceofoneofthedoublebondsinthe
ringmarkedZ.Bleomycinisusuallysuppliedbythemanufacturersasasulphatesalt.
targetofattack.Sincethedamageisdirectlytargeted EC-SOD show more lung inflammation and fibrosis
to DNA, addition of catalase, SOD, or other antioxi- after bleomycin administration, whereas overexpres-
dants offers little or no protection. Indeed, ascorbate, sion of EC-SOD is protective,651 although remember
propyl gallate, and some other phenolic antioxidants thatEC-SODmayhaveotheractionsaswell(Section
make the damage worse in vitro by reducing Fe(III)- 10.11.4).Nevertheless,micelackingNOX4(ortreated
bleomycinbacktotheFe2+ state.649 DNAdegradation with inhibitors of it) showed less lung injury after
canbeinhibitedbypreventingironbindingtothebleo- bleomycin,652 and there are several reports that SOD
mycin,e.g.withEDTA,DETAPAC,desferrioxamine,or preparations (e.g. lecithinised SOD or heparin-SOD)
ICRF-187. administered to bleomycin-treated mice can decrease
lung fibrosis.653,654 Bleomycin-induced lung damage
10.16.3.1 Side-effectsofbleomycin648
in animals is increased by exposure to elevated O .
2
Amajorside-effectofbleomycinislungdamagelead- The lung may be a target because it has low activ-
ing to fibrosis. As usual, inflammasome activation is ities of bleomycin hydrolase, a cysteine proteinase
involved;matrilysin(matrixmetalloproteinase7)and which breaks down bleomycin into an inactive form.
other MMPs also play a role (Section 8.7.3.1). Ac- Thishydrolaseispresentinmostbodytissuesandits
tivation of phospholipase A (bleomycin toxicity is level in malignant tumours is one factor that affects
2
attenuated in mice lacking this enzyme)650 and over- theirsensitivitytobleomycin.655 Itcanalsohydrolyse
production of TGF-β (Section 5.7.3) by pulmonary homocysteinethiolactone(Section4.7).
macrophagesandalveolartypeIIcellsarealsoimport- A key factor relevant to bleomycin toxicity is the
ant.ExcessTGF-βpromotesfibrosis. availability of iron within the tissue. Thus intraven-
Lung damage by bleomycin may also involve ousinjectionofbleomycinintoratsproducesnolung
RS, which could contribute to fibroblast proliferation injury, yet simultaneous tracheal installation of fer-
(Section 5.2.1). Consistent with this, mice lacking ric ions led to marked bleomycin-dependent lung

--- Page 650 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 595
damage.656 However, attempts to use desferrioxam- explored in Section 11.2.2, is how and why caloric
ine to prevent bleomycin-induced lung fibrosis in restrictiondecreasescancerincidence.
animals have given negative or marginally positive Oneapparentexceptiontotheineffectivenessofan-
results,656,657 perhaps because desferrioxamine does tioxidantsupplementsinhumansissomeolderstud-
not penetrate easily into lung cells (Section 11.6.1). iesonoralleukoplakia,aprecancerousmouthlesion
The chelator ICRF-187 (Section 10.16.2.2) has been that can develop after excessive exposure to tobacco
claimed to be protective in some animal studies, but and alcohol and may progress to cancer. Levels of
notothers.Intraperitonealadministrationofnicotina- 8OHGand8-nitroguanineareelevatedintheabnormal
mide decreased bleomycin-induced lung damage in tissue.485 It was reported in 1993 that some of the le-
hamsters,658possiblybyactingasaprecursorofNAD+ sionsregressafteroraladministrationofα-tocopherol
andpreventing‘lethalNAD+ depletion’duetoPARP or β-carotene,666 but their effectiveness has not been
activation(Section5.2.5). established.666A
10.16.4 Shouldcancerpatientsconsume 10.17 Oxidativestressanddisorders
antioxidants? ofthenervoussystem:setting
thescene667,668
If,onthewhole,RSarebadthingsincancer,thenanti-
oxidants should have an anti-cancer effect, provided
10.17.1 Introductiontothebrain
that they can actually scavenge the damaging RS in
vivo.Indeed,protectiveeffectshavebeenobservedin Allaerobiccellssufferoxidativedamage,yetthemam-
some animal models. For example, increased dietary malian brain is often said to be especially sensitive.
intake of dl-α-tocopherol decreased liver tumour for- One reason is its high O 2 consumption; in adult hu-
mation in transgenic mice overexpressing c-myc and mans, the brain accounts for only a few percent of
TGF-α genes.659 Inatransgenicmousemodelofpros- bodyweight,butabout20%ofbasalO consumption
2
tate cancer, administration of a mixture of vitamin (Fig. 1.9). Hence it processes a lot of O 2 per unit tis-
E, selenium, and lycopene slowed cancer develop- sue mass. The discrepancy is even more striking in
ment,buttheseagentsseemineffectiveinhumans.660 youngchildren—muchsmallerbodiesbutnotpropor-
Lipoicaciddecreasedintestinalcancerincidenceinone tionately smaller brains. The other reasons we will
mousemodel,butstimulatedthegrowthrateofbreast examineshortly(Section10.17.5),butfirstletusmake
cancers in another!661 Transgenic mice carrying an somegeneralcommentstosetthescene.Figure10.25
oncogenicK-rasgeneshowedfasterprogressionoflung outlines the structure of the brain, covering the parts
cancerandincreasedmortalitywhenN-acetylcysteine dealtwithinthischapter.
and/or dl-α-tocopherol were added to the diet; ap- The adult human brain contains about 1011 to 1012
parently these ‘antioxidants’ decreased expression of nerve cells (neurons), which are supported and pro-
genes encoding endogenous antioxidant defences as tected by a much greater number of glial cells (glia
wellasp53.662 Antioxidantscouldconceivablyalsobe isderivedfromtheGreekfor‘glue’).Theneuron,the
beneficialinchemotherapy,sinceROSplayaroleinthe basic working unit of the brain, is a specialized cell
side-effects,butcouldbedamagingifROScontribute evolved to transmit information to other nerve cells
totheeffectivenessofthedrugs. (ortomuscleorglandcells).Neuronsconsistofacell
What about humans? The few good clinical tri- body, dendrites (short, branched extensions from the
als that have been conducted to date provide some, cellbody),anaxonthattransmitselectricalsignals(by
butnotcompelling,evidenceofbenefitfromantioxid- theopeningandclosingofspecificionchannels),and
antsupplementationincancerpatients.663,664However, a nerve terminal (Fig. 10.26). The neuronal cytoskel-
suchstudiesrarelyprovideevidencetoshowthatthe etonhelpstomaintaintheaxonstructureandfacilitates
supplements did decrease oxidative damage, and so transport of materials between the cell body and the
are inconclusive. By contrast, in patients undergoing nerve terminal, which can be a considerable distance
radiotherapythereisasuggestionofharmfromanti- away;axonlengthsvaryfrommmtoametre(e.g.in
oxidants(Section9.20.2).Gooddiet(lotsoffruit,grains, neurons from the brain to the toes). Hence damage
and vegetables) and some degree of exercise may be to cytoskeletal proteins (e.g. by oxidation or nitra-
more beneficial.665 Antioxidant supplements seem to tion) leads to neuronal dysfunction, sometimes to an
have little value in preventing cancer development extent that causes axonal degeneration and neuronal
in humans (Section 4.6.5). One fascinating question, death. Neurons with long axons must maintain large

--- Page 651 ---

596 FREE RADICALS IN BIOLOGY AND MEDICINE
(c) Caudate
(a) Putamen
Motor cortex Sensory cortex Nerve terminals
Frontal lobe
Parietal lobe
Occipital lobe
Temporal lobe
(b) Cerebrum
Thalamus
Hypothalamus
Cell body Substantia
1 Forebrain nigra
Amygdala
Hippocampus
2 Midbrain
Pons
3 Hindbrain Cerebellum Spinal cord
Medulla
oblongata
Figure10.25 Thebrain.(a)Cerebralcortex.Thisisdividedintofoursections:theoccipital,temporal,parietal,andfrontallobes.
Functionssuchasvision,hearing,andspeech,aredistributedinselectedregions(someregionsareassociatedwithmorethanonefunction).
(b)Majorinternalstructures.Theforebrain(1)iscreditedwiththehighestintellectualfunctions—thinking,planning,andproblem-solving.The
hippocampusisinvolvedinmemoryformationandconsolidation.Thethalamusservesasarelaystationforinformationcomingintothebrain.
Neuronsinthehypothalamusserveasrelaystationsforinternalregulatorysystemsbymonitoringinformationcominginfromtheautonomic
nervoussystemandcontrollingthebodythroughthosenervesandthepituitarygland.Ontheuppersurfaceofthemidbrain(2)aretwopairsof
smallhills,colliculi,collectionsofcellsthatrelaysensoryinformationfromsenseorganstothebrain.Thehindbrain(3)consistsoftheponsand
medullaoblongata,whichhelptocontrolrespirationandheartrhythms,andthecerebellum,whichhelpstocontrolmovement.Parts(a)and
(b)reproducedfromBrainFacts:APrimerontheBrainandNervousSystem(Carey,J,ed.2002)bypermissionoftheSocietyforNeuroscience,USA.
(c)Asectionthroughthehumanbraintoshowthecaudateandputamen,whichconstitutethestriatum.Asectionthroughthemidbrainshows
thesubstantianigra(SN).DopaminergicneuronswhosecellbodiesarelocatedintheSNsendprojectionsthatterminate,andreleasedopamine,
inthestriatum.Upondegenerationofthedopaminergicpathwaylessdopamineisreleasedintothestriatum.Striataldopaminedeficiencyresultsin
complexchangesinthebrain’smotorcircuitrythatleadtothemotordeficitscharacteristicofParkinsondisease(Section10.20).FromBioessays
24,308,2002,bycourtesyofDrR.BetarbetandWiley.
areasofmembrane,andtransportarangeofmaterials whereas an inhibitory neurotransmitter does the op-
(vesicles, proteins, etc.) from the cell body down the posite.Neuronsdonotdivide,anduntilfairlyrecently
axon to the terminal (anterograde transport), espe- itwasthoughtthatthenumberofneuronsisfixedbe-
cially as themajor site of protein synthesisis thecell forebirth.Thediscoveryofadultneuronalstemcells
body. Materials also move in the opposite direction hastransformedthisview,butitisunclearhowmany
(retrogradetransport).Transportofsomematerialsoc- new functional neurons they generate in the adult
cursquickly(50–200mm/day)andthatofothersmore brain.Neurogenesisseemsrestrictedtothehippocam-
slowly(0.1–3.0mm/day).Ifanaxonissevered,theseg- pus(andpossiblythestriatum)inhumansbutcanalso
mentbeyondthecutwilldegenerate;thisisanactive occurintheolfactorybulbinmostothermammals.669
processofself-destructioninvolvingtheproteasome. Hippocampalneurogenesisappearstobepromotedby
The nerve terminal forms part of a synapse, the exercisebutimpairedbybraininflammationandafter
sites for passage of signals between neurons or from irradiation,e.g.totreatbraintumours,670andseemsto
neuronstoothercells.Synapsescanbeexcitatoryorin- decreaseinagedanimals(Section11.2).
hibitory;theformerreleaseneurotransmittersthatde- There are several types of glial cell, includ-
polarizethemembranepotentialofthetargetneuron ing microglia, astrocytes (the most abundant), and
and make it more likely to fire an action potential, oligodendrocytes. The last synthesize and maintain

--- Page 652 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 597
Dendrites
Nucleus
Axon
Cell body
Myelin sheath
Node of
Ranvier
Axon
Nerve impulse
Veside
Direction
Synapse of impulse
Axon
terminals
Dendrite
of receiving
Neurotransmitters neuron
Receptor molecules
Figure10.26 Neurons:aneuronfiresbytransmittingelectricalsignals(actionpotentials)alongitsaxon.Whensignalsreachtheendofthe
axon,theytriggerthereleaseofneurotransmittersthatarenormallystoredinvesicles.Neurotransmittersbindtoreceptorsonthesurfacesof
adjacentneurons(orsometimesothercelltypes).Thepointofvirtualcontactisknownasthesynapse.ThenodesofRanvierinmyelinated
axonsacceleratetransmissionoftheactionpotential.AdaptedfromBrainFacts:APrimerontheBrainandNervousSystem(Carey,J,ed.2002)by
permissionoftheSocietyforNeuroscience,USA.
the myelin sheath, which insulates most axons (Fig. ‘sense’thestateoftheneuronsaroundthem.Inbrain
10.26).Astrocytesco-operateinthemetabolismof,and injury, microglia rapidly direct these processes to-
helptoprotect,neurons.Theyarealsopresentaround wardsthesiteofinjury.672 Microgliaarealsoinvolved
synapsesandnodesofRanvier(Fig.10.26).Afterbrain in removing apoptotic cells, regulating neurogenesis
injury or infection or in the neurodegenerative dis- and synaptic remodelling (astrocytes also play a role
eases, astrocytes become highly activated (‘reactive in this), and are frequently activated in response to
astrogliosis’). Peripheral immune cells do not usu- inflammatory stimuli and in neurodegenerative dis-
ally enter the healthy brain, and normal ‘immune eases, releasing cytokines (e.g. IL-1β, IL-6, TNF-α) as
surveillance’isprovidedbythemicroglia.671Theyarise wellaseicosanoids(fromCOX-2)andsometimesNO•
frommacrophagesduringbraindevelopmentandare (via iNOS). These products can kill pathogens, but
highly dynamic, frequently sending out processes to can also worsen damage after brain injury or during

--- Page 653 ---

598 FREE RADICALS IN BIOLOGY AND MEDICINE
sepsis, including decreasing the rate of neurogenesis. causedneurotoxicityinanimals(e.g.cattleintheUSA)
Likeotherhumanphagocytes(Section8.7.4.8),human and humans (in subjects in China who ate sugar-
microgliaarelessreadilyinducedtogenerateNO•than cane infected with such a fungus).678,679 Mitochon-
arerodentones.673 driaarehighlydynamicmobilefluctuatingstructures
The endothelium of the blood vessels in the brain in neurons (Section 1.3.3) and interference with their
is much less permeable to molecules than vascular constant fusion/fission by toxins or inherited defects
endothelia elsewhere in the body, although essential readilycausesneurodegeneration.676,680
molecules (such as glucose and ascorbate, using spe- Neuronsalsouseenergyinneurotransmittersecre-
cific transporters) and most lipid-soluble molecules tion;arrivalofanactionpotentialatthenerveterminal
(suchasethanol,otherorganicsolvents,andanaesthet- opens voltage-gated Ca2+ channels to allow Ca2+ in-
ics,viadiffusion)dopenetrate.Mostothermolecules flux, leading to release of neurotransmitter into the
are excluded from the brain by this so-called blood– synapsebyexocytosis.Eachsubgroupofneuronsisas-
brainbarrier.Theblood–brainbarrieralsoinvolvesthe sociated with a particular neurotransmitter or group
capillarybasementmembranes,cellscalledpericytes, of neurotransmitters. The released neurotransmitter
and the end-feet of astrocytes ensheathing the blood binds to receptors on the target neuron, muscle, or
vessels.674 gland cell. For example there are multiple types of
receptor for the neurotransmitter dopamine. Acetyl-
cholineisreleasedbyneuronsinterfacingwithvolun-
10.17.2 Energymetabolisminthebrain675
tarymuscle,forexampleinpromotingconstrictionof
Neurons use most of the O they take up in mito- blood vessels. Other neurotransmitters include sero-
2
chondria, to make the ATP needed to maintain ion tonin, noradrenalin, γ-aminobutyrate (GABA), gly-
gradients(highintracellularK+,lowNa+,lowCl–,very cine, and glutamate. Glutamate is stored in synaptic
low‘free’Ca2+),synthesizeandsecreteneurotransmit- vesiclesinneurons.Afterrelease,glutamatere-uptake
tersandforothermetabolicprocesses.Sodiuminflux ismostlybyastrocytes,whichconvertitintoglutam-
is needed to propagate action potentials; Na+ must ine(theside-chain–COOHbecomes–CONH 2 )bythe
then be pumped out of the neuron using Na+, K+- ATP-dependent enzyme glutamine synthetase. Glu-
ATPases. For example, a human cortical neuron can tamine is then released and taken up by neurons for
use about 4.7 billion ATP molecules per second.676 hydrolysis into glutamate for loading into synaptic
The human brain uses glucose (about 120 g per day, vesiclesreadyforthenextrelease.681
approximately 60% of the total body’s resting state Theinabilityofneuronstodividerendersthebrain
glucose utilization)677 for ATP production, relying on sensitivetolossoffunctionifneuronsdie.Fortunately,
glycolysis and the Krebs cycle. It can also utilize lac- manypartsofthebrainhaveconsiderableredundancy
tatefromthecirculation,whichitmustfirstconvertto and plasticity. Neurons in culture are prone to in-
pyruvateusingNAD+andlactatedehydrogenase(Fig. jury, often leading to necrosis or apoptosis, if treated
1.7).Lactateisreleasedasanend-productofglycolysis withtoxinsthatinterferewithenergymetabolism,ex-
in astrocytes and oligodendrocytes, and taken up by posed to RS such as ONOO– or H 2 O 2 , or if ‘growth
neurons;indeed,lactatemaybeasignificantmetabolic factors’ (better called neurotrophic factors) are with-
fuel of neurons in vivo. The brain is rapidly affected drawnfromtheculturemedium.Duringdevelopment
by interruptions of the glucose supply, since limited of the nervous system, several neurotrophic factors
glycogen is stored there (little in neurons, some in regulate proliferation of different neuronal progenit-
astrocytes).Hence,injectionofexcessinsulinproduces ors; they include nerve growth factor (NGF), brain-
hypoglycaemiccoma. derived neurotrophic factor (BDNF), ciliary neuro-
Its heavy reliance on oxidative phosphorylation trophicfactor,neurotrophins3,4,and5,andfibroblast
makes the brain vulnerable to interruptions of O growth factor. For example, BDNF seems to promote
2
supply.Similarly,inhibitorsofmitochondrialATPsyn- hippocampal-dependentmemory;somehumanscarry
thesis readily cause neuronal death (Table 10.7)678 by a variant form in which a valine at position 66 is
both ATP depletion and increased oxidative damage. replacedbymethionine.Ithasbeenclaimedtobeasso-
Examples include cyanide, 3-nitropropionic acid (an ciatedwithpoorermemoryandlearningperformance,
inhibitor of mitochondrial complex II, thus blocking atleastinsomecognitivetests.682Neuronsappeartobe
succinate dehydrogenase activity; Fig. 1.7), and rote- bothamajorsourceandakeytargetofactionofBDNF.
none(aninhibitorofcomplexI).3-Nitropropionicacid Alloftheseneurotrophicfactorsarecapableofprotect-
is produced by some fungi, exposure to which has ingneuronsincultureagainstvarioustypesofinjury.

--- Page 654 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 599
Thustheyarenotonly‘growthfactors’butalso‘sup- MPTP(Section10.20.3),andtoischaemia–reperfusion
port factors’. Often they act, in part, by increasing damage to the brain, implying that excess NO•
levelsofneuronalantioxidants. production contributes to injury in these situations.
Indeed,injectionof3-nitropropionate(Section10.17.2)
10.17.3 Glutamate,calcium,andnitricoxide orofmalonateintothebrainsofratsormiceleadsto
neuronaldeathinwhichNO• andONOO– appearto
Glutamate is often used as a neurotransmitter at ex- beinvolved.
citatory synapses in the brain, i.e. the second neuron Theendothelialcellsofbrainbloodvesselscontain
becomesmorepronetofireanactionpotential.Bycon- eNOS, which has an important vasodilatory role in
trast,glycineandGABAareinhibitoryneurotransmit- regulatingcerebralbloodflow.
ters. Glutamate released from one neuron binds to
NMDA,AMPA,andKAreceptorsonotherneurons.
10.17.4 Excitotoxicity
These receptors are named after agonists, molecules
used in the laboratory to activate them, namely N- The term excitotoxin was coined in the 1970s when
methyl-D-aspartate, α-amino-3-hydroxy-5-methyl-4- the ability of high levels of glutamate or aspartate
isoxazole-4-propionate, and kainic acid. The excita- to kill neurons was observed. Similar neurotoxicity
tory action of glutamate plays key roles in learning, can be produced by NMDA, AMPA, kainic acid, or
memory, and brain development, e.g. some of the domoicacid(aneurotoxinwhichbindstokainatere-
neurotoxicity of Pb2+ seems to be due to its abil- ceptors). Domoic acid is produced by the seaweed
ity to impair the functioning of NMDA receptors Digeneadomoi;eatingmusselscontaminatedwiththis
(Section9.16.8). toxin induces acute gastrointestinal symptoms fol-
Binding of glutamate to these various receptors lowed by neurological damage. Kainic acid was also
openscationchannelsanddepolarizesthemembrane first described as a product of a seaweed, Digenea
ofthetargetneuron(e.g.bindingtoAMPAreceptors simplex. High levels of quinolinic acid, a product of
allows in Na+), increasing the likelihood that it will the kynurenine pathway (Section 8.4.2), in the brain
fireanactionpotential.TheNMDAreceptorrequires can also cause excitotoxicity by binding to NMDA
membranedepolarizationaswellasglutamatebinding receptors.685
beforeitopenstoallowCa2+andNa+intothecell.Glu- Concentrations of glutamate in brain extracellular
tamatealsobindstoreceptorscoupledtoGTP-binding fluids are normally low (<1 μM). The death of cells
proteins(Section5.5.4),theso-calledmetabotropicglu- or collapse of normal ion gradients (e.g. due to se-
tamatereceptors.Bindingofglutamatetoalltypesof vereATPdepletionafterintroductionofmitochondrial
its receptors leads, directly or indirectly, to a rise in inhibitors, or O 2 deprivation) in neurons can cause
intracellularfreeCa2+.Calciumisanimportantsignal- massive glutamate release. It then binds to receptors
ling molecule in neurons (indeed in most or all cell on adjacent neurons, leading to excessive and pro-
types: Section 5.3.2), which therefore expend a lot of longed increases in intracellular free Ca2+ and Na+
ATP in maintaining low intracellular free Ca2+ levels within them. Neurons treated with excess glutamate
using transporters in the ER, plasma membrane, and or other excitotoxins swell rapidly and die, usually
mitochondria(Section5.3.2). by necrosis. Excessive increases in free intracellular
Nitric oxide is used as an intercellular messenger Ca2+levelsinterferewithmitochondrialfunction(Sec-
by neurons in the peripheral nervous system (e.g. in tion 5.3.2.3), cause overproduction of NO• by stimu-
regulation of penile erection and gut function) and lating nNOS activity (in nNOS-positive neurons, al-
by 1 to 2% of neurons in the brain (somewhat more though the NO• can then diffuse to adjacent cells in
in cerebellum). These neurons contain nNOS (neur- thebrain),andincreaseO • 2 –/H 2 O 2 generation,insome
onalNOS),whichisCa2+/calmodulin-regulated(Sec- animals(butprobablynothumans)bypromotingcon-
tion 2.5.6.4).683 Nitric oxide plays a role in the devel- versionofXDHtoXObyCa2+-stimulatedproteinases.
opment of synaptic plasticity—the strengthening or
ExcessNO•plusO •–cancauseONOO–formation,and
2
weakeningofsynapticconnections(andtheirrespons- in some cases mitochondrial MnSOD is nitrated and
ivity)betweenneurons,dependingonhowoftenthey inactivated.686 Rises in free Ca2+ also activate phos-
are used. This process is very important in the for- pholipases,increasingconcentrationsoffreefattyacids
mation and maintenance of long-term memory.683,684 andhenceeicosanoidproduction.687
Transgenic ‘knockout’ mice lacking nNOS show en- Hence studies of neurons or neuron-like cells in
largement of the stomach and behavioural changes, culture in different laboratories have shown vari-
but are more resistant to the toxicities of malonate able protective effects against excitotoxic damage
(asuccinatedehydrogenaseinhibitor),theneurotoxin upon adding inhibitors of NOS or of XO, or by a

--- Page 655 ---

600 FREE RADICALS IN BIOLOGY AND MEDICINE
variety of antioxidants, including overexpression of containtheTRPM2cationchannels,whichrapidly
CuZnSOD. nNOS-containing neurons are themselves allowCa2+inwhenROSsuchasH O arepresent
2 2
fairlyresistanttoexcitotoxicity,butcansometimesre- (Section5.3.2.2).693 Thismaybeimportantinmul-
spond to excess glutamate or NMDA by releasing tiple sclerosis, for example (Section 10.18.2). The
enoughNO• toinjureadjacentneurons.Themechan- actions of many other ion channels found in the
isms underlying resistance are uncertain, but one of brain can be modulated in various ways by ROS
themmaybeahighlevelofMnSOD.688 Excitotoxicity (e.g. ref694). Several receptors are prone to oxida-
canalsodamagetheear(Section7.12). tive damage, examples being NMDA receptors692
and the nicotinic acetylcholine receptors. The lat-
ter have an exposed cysteine residue, essential to
10.17.5 Whyshouldthebrainbeprone theirfunction,thatcanbeoxidized695 onaddition
tooxidativestress?ROSarebothuseful ofH O orONOO–.
2 2
anddeleterious667
2. The presence of excitotoxic amino acids (Section
10.17.4).Oxidativestresscandamageneuronsand
Itisoftensaidthatbrainandnervoustissueareprone
promote the release of glutamate, generating a
to oxidative stress. Neurons seem more susceptible
‘vicious cycle’ of events.696 Other relevant events
than glia. Oxidative stress can also occur in the cells
may include the ability of several RS (including
comprising the blood–brain barrier, and increase its
ONOO–) to decrease glutamate uptake by glial
permeability.Whyisbrainmoresensitive,apartfrom
cellsandtoinactivateglutaminesynthetase.
itshighO 2 uptake? 3. Neuronal mitochondria, like others, generate O •–
First, like all tissues, brain uses ROS for essential 2
(mostly from complex I).684 Levels of 8OHG, de-
activities, so must carefully control ROS production
letions, and point mutations increase with age in
and antioxidant defences to allow this. For example,
brainmitochondrialDNA(mtDNA),althoughthe
ROSinthebrainareinvolvedinregulatingbloodpres-
contributionofthistoage-relateddeclineinbrain
sure (Section 8.10.4), body mass (Section 10.4), and
functionisuncertain(Section11.4.1).
thesensationofpain(Section10.24).NADPHoxidases
4. Several neurotransmitters (not glycine or glu-
(NOX1, 2 and 4) are widespread in the brain, being
tamate) are autoxidizable molecules. Dopamine,
present in neurons, astrocytes, microglia, and vascu-
its precursor L-DOPA,697 serotonin, and norad-
larendothelialcells.689OtherrolesofROSmayinclude
renalin react with O to generate O
•–,
H O ,
controlofbloodflowandparticipationinthesignalling 2 2 2 2
and quinones/semiquinones. The last can de-
processesafteractivationofNMDAreceptors.684,689,690
plete GSH and bind to protein –SH groups.
Mice lacking NOX2 (and possibly human CGD pa-
Superoxide can react with noradrenalin, dopa-
tients; Table 8.3) have mild deficits in learning and
mine, and serotonin698,699 to initiate their oxida-
memory, so ROS may play a role there too e.g. by
tion, which then continues with production of
modulation of the function of NMDA receptors and
more ROS, quinones, etc. Dopamine–GSH con-
various ion channels. NADPH oxidases can promote
jugates are degraded by peptidase enzymes to
proliferationofstemcellsinthehippocampus;neuro-
produce dopamine–cysteine conjugates (e.g. 5S-
genesiswasimpairedinmicelackingNOX2.691During
cysteinyldopamine), which can be detected in
braindevelopment,neuronalstemcellswilleithercon-
several brain regions, and levels are elevated in
tinue proliferating or differentiate; the levels of ROS
Parkinsondisease(Section10.20).
help them to make that decision. Indeed, we have
5. The oxidation of neurotransmitters is accelerated
already seen that either excess or deficit of EC-SOD
notonlybyO
•–
butalsobytransitionmetalions,
in the brain can impair long-term potentiation (Sec- 2
such as manganese (Section 9.5.6) and iron. Iron
tion 3.23.3.2), and excess SOD1 can diminish NMDA
is found throughout the brain;700 important iron-
functionandimpairmemory.692
containing proteins include cytochromes, ferritin,
Otherreasonswhythebrainmaybeespeciallyprone
aconitases, non-haem-iron proteins in the mito-
tooxidativestressinclude:
chondrial electron transport chain, cytochromes
1. The high Ca2+ flux across neuronal membranes; P450,andthetyrosineandtryptophanhydroxylase
henceinterferencewithCa2+ sequestrationbyoxi- enzymes, which catalyse the first steps in the
dative stress and/or disruption of energy metab- synthesisofdopamineandserotoninrespectively.
olism produces especially rapid rises in intracel- There are about 60 mg of non-haem iron in the
lularfreeCa2+ inneurons.Someneuronsandglia ‘average’ adult human brain. Several brain areas

--- Page 656 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 601
(e.g. substantia nigra, caudate nucleus, putamen,
globus pallidus) have a high iron content, which
canbedetectedbymagneticresonanceimaging.701
Much iron in healthy brain is in ferritin, some
in haemosiderin. The iron content of the brain is
lowatbirthbutrapidlyincreasesinearlylifeand
levelsinsomepartsofthehumanbraincontinue
6
to increase with age (Section 11.4.10). Much of
theironresidesinoligodendrocytesandisneeded
for myelin synthesis. These cells express recep-
torsforferritinandappeartoobtainmostoftheir 5
iron from it.700 Hence, if insufficient dietary iron
is available to children there may be permanent
impairments of brain function (also see Section r = 0.92
4 slope=0.504
10.18.1).Transferrindeliversironacrosstheblood–
brain barrier, utilizing receptors located on the
brainmicrovasculature.700
However, there is a problem; damage to brain 3
readily releases ‘catalytic’ iron (and possibly cop-
per) ions capable of catalysing such reactions
as OH• formation from H 2 O 2 , lipid peroxidation 2 r = 0.82
slope=0.253
(Fig. 10.27), and autoxidation of neurotransmit-
ters. Injection of iron salts into the brains of ani-
mals can produce vascular damage, epilepsy-like
1
convulsions, dopamine depletion, and death of
neurons accompanied by lipid peroxidation, oxi-
dative damage, and OH• generation. ‘Catalytic’
ironreleasedbybraindamagecanpersistbecause 0
the cerebrospinal fluid (CSF) that surrounds the 10 20 30
Iron content (μg/g wet wt.)
brainandspinalcordhaslittleornoiron-binding
capacity. ‘Total iron’ values in CSF from normal
humanshavebeenreportedas0.29–1.12μM.The
transferrincontentis~0.24μM.Sinceonemoleof
transferrinbindstwomolesofironions,thesedata
suggestthatCSFtransferrinisoftenat,orcloseto,
iron saturation.667,700 ‘Free’ iron and copper ions
also have the potential to interfere with repair of
oxidativeDNAdamagebyNEILglycosylases(Sec-
tion 10.17.6.12). Fortunately, astrocytes can take
up some of this catalytic iron, to help to protect
neurons.702Ironaccumulationisacommonfeature
ofneurodegenerativediseases(Section10.19.1).
6. Neuronalmembranelipidscontainalotofhighly
polyunsaturated fatty acid side-chains, especially
docosahexaenoic (C ,n-3) acid (DHA) residues. 22:6
DHAplaysessentialrolesinbrainfunction.Nev-
ertheless, homogenization of brain tissue causes
rapid lipid peroxidation (Fig. 10.27), which can
be largely inhibited by iron ion-chelating agents
such as desferrioxamine, indicating its iron-
dependence. In addition, products of lipid per-
oxidationcaninjurethebrain.4-Hydroxynonenal
)nim
03/p
gm/ADM
selomm(
noitadixorep
dipiL
metS
sumalahtopyH
xetroC
supmacoppiH
*mutairtS
,mullebereC
Figure10.27 Peroxidationofbrainhomogenates.Regionsofrat
brainwerehomogenizedandtheironcontentandratesofTBARS
(Section6.15.8)formationmeasured.Theclosedcirclesrepresent
valuesobtainedfromhomogenatesincubatedunderairandthe
trianglesarethevaluesobtainedunder100%O2.Ironcontentand
rateofperoxidationarewell-correlated.Dataadaptedfrom
Neurochem.Res.10,397,1995,bycourtesyofProfessorRobertFloyd
andthepublishers.
(Section 5.12.5.3) is especially toxic to neurons,
e.g. by increasing Ca2+ levels, inactivating glu-
tamatetransporters,anddamagingneurofilament
proteins.703,704 4-Oxo-2-nonenalmaybeequallyor
more toxic.703 Isoprostanes may act as vasocon-
strictive agents in the brain705 and can damage
developingoligodendrocytesinprematurebabies
(Section 7.11.8.2). Cyclopentenone isoprostanes
andprostaglandins(Sections5.12.3and8.12.8)may
alsobeneurotoxic.706
The brain is rich in cholesterol; indeed brain
contains about 20–25% of total body cholesterol,

--- Page 657 ---

602 FREE RADICALS IN BIOLOGY AND MEDICINE
most of it in the myelin sheath. The blood–brain 9. Microglia can become activated to produce ROS,
barrier stops plasma cholesterol from entering or andcytokines(Section10.17.1).Inturn,suchcyto-
leavingthebrain;hencethebraincontrolscholes- kines can prime microglia to generate more ROS
terol levels by balancing its cholesterol synthesis upon activation and to increase the synthesis of
withcholesterolmetabolism(largelyinastrocytes) COX-2(andsometimesiNOSandhenceofNO•).
by CYPs to products that are released into the Cytokines can additionally be produced by acti-
blood,especially24-hydroxycholesterol.707Various vatedastrocytes,whichmayagainrespondtothem
cholesteroloxidationproductsresultingfromfree- byiNOSinduction.Thusmicrogliaandastrocytes
radicalattack(Section5.12.4)canbedetectedinthe aremajorplayersininflammatoryprocessesinthe
brain and have been suggested to be neurotoxic brain,whichareusuallyprotectivetoneurons,but
in various neurodegenerative diseases, including maysometimescausedamage(e.g.Section10.18).
Niemann–Pickdisease(Section10.23)andSmith– 10. CytochromesP450arepresentinbrain.713 Forex-
Lemli–Opitzsyndrome(Section5.12.4).707,708 ample,CYP2E1occursinhippocampus,substantia
7. BrainmetabolismgeneratesalotofH O ,notonly nigra,andtheblood–brainbarrier,andCYP2D6in
2 2
via SOD but also by other enzymes. Especially severalhumanbrainregions.AsCYPs,especially
important are monoamine oxidases,709,710 flavo- CYP2E1, can produce O •–/H O (Section 9.8.1.1),
2 2 2
proteinenzymeslocatedintheoutermitochondrial they are another potential source of oxidative
membranesofneuronsandglia.Theycatalysethe stress, although the magnitude of this may be
reaction small since brain P450 levels are low. However,
CYP2E1 metabolizes ethanol, acetone, halothane,
monoamine+O +H O→aldehyde+H O +NH
2 2 2 2 3 related anaesthetics, and organic solvents such
(RCH NH ) (RCHO)
2 2 as CC1 and CHC1 , and its levels may be in-
4 3
For example, dopamine is oxidized to 3,4- creased in human brain by ethanol consumption
dihydroxyphenylacetaldehyde,whichisthencon- andsmoking.714Thusitcouldcontributetosolvent
verted by an aldehyde dehydrogenase into neurotoxicity.BrainCYP2D6levelsareelevatedin
DOPAC (3,4-dihydroxyphenylacetic acid). Mono- human alcoholics;thisisoformmetabolizes many
amine oxidases exist in two forms (MAO-A drugsthatactonthenervoussystem,suchastri-
and -B). The former preferentially oxidizes hyd- cyclicantidepressantsandMAOinhibitors.713 Ex-
roxylated amines such as serotonin and cessalcoholconsumptioncanalsolowerthiamine
noradrenalin, whereas MAO-B prefers to act levelsinthebrain,causingneuronaldamagethat
on non-hydroxylated amines. Both can oxidize involvesROS(Table4.1).
dopamine. The ammonia generated is poten- 11. CertainRScan,bothdirectly(e.g.bydamagingthe
tiallyneurotoxic(Table10.7)andmustberapidly proteins involved in the tight junctions between
removed by several mechanisms, including con- cells,ordecreasingtheirsynthesis)and/orbyac-
version of glutamate to glutamine by glutamine tivatingMMPs,‘openup’theblood–brainbarrier,
synthetase. Clorgyline is a drug that inhibits allowing neurotoxins and inflammatory cells to
MAO-A, selegiline is selective for MAO-B, and enterthebrain(Section10.18).674,715,716 Suchdam-
pargylineinhibitsboth. age to the barrier occurs in stroke, trauma, and
8. Antioxidant defences in the brain are modest. neurodegenerative diseases, for example. Some-
Inparticular,catalaselevelsarelowinmostbrain timesitcanbeagoodthing(e.g.allowingincells
regions; levels are somewhat higher in hypothal- of the immune system that can help resolve in-
amusandsubstantianigrathanincortexorcere- flammation,aidinrepairandcleardeadcells)but
bellum. Brain catalase is located in peroxisomes sometimesitisbad,e.g.byleadingtooedemaor
and its activity in rat or mouse brain is rapidly excessiveinflammation.717
inhibited if aminotriazole is administered to the 12. Like many cells, neurons contain PARP-1, which
animals,showingthatthebraingeneratesH O in responds to DNA damage, can lead to ‘lethal
2 2
vivoandthatatleastsomeofitreachescatalase.709 NAD+depletion’(Section5.2.5),andisinvolvedin
Onekeyroleofperoxisomesinthebrainistode- opening TRPM2 channels (Section 5.3.2.2). NAD+
grade saturated long-chain (C27, C26) fatty acids maybeneuroprotective;NAD+ addedtoneurons
byβ-oxidation.711Theperoxidaticactionofcatalase canslowaxonaldegeneration,aneffectthatseems
seemstobethemajorrouteofethanolcatabolism to require the enzyme SIRT1 (Section 11.3.4).718
inthebrain(Section9.8.1.1andref712). Thisenzymemaycontributetotheneuroprotective

--- Page 658 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 603
effectsofcaloricrestrictioninsomeanimalmodels transplantation into other animals, and overexpres-
ofAlzheimerdisease.718 sionofCuZnSODinnormalneuronsdelaystheROS-
13. Although NADPH oxidases are usually useful in dependent apoptosis that is triggered by removal of
the brain, excessive increases in their activity can growth factors, or by addition of H O . By contrast,
2 2
causeharm.Thisseemstohappeninseveralneuro- decreasing CuZnSOD levels promotes apoptosis un-
degenerativediseases,andcanbetriggeredbyloss der these conditions. Nevertheless, overexpression of
of trophic support. Thus there is considerable in- CuZnSOD may contribute to the pathology of Down
terest in the possible therapeutic use of NADPH syndrome (Box 3.1) and can interfere with memory
oxidaseinhibitorsintheseconditions.689 (Section10.17.5),692i.e.toomuchisnotalwaysgood.
Mice lacking GPx1 show no evidence of brain ab-
normalities at 2 to 3 months of age, but the damage
10.17.6 Antioxidantdefencesinthebrain667 causedbyadministrationofmitochondrialtoxins(mal-
onate, MPTP, nitropropionic acid) is worse. It thus
10.17.6.1 Keepingoxygenlow
seemsthatlackofGPx1canbecompensatedfor(e.g.
One defence may be to keep brain pO as low as by the peroxiredoxin system) under normal condi-
2
possibleconsistentwithnormalfunction.LowO de- tions,butnotwhenmitochondrialtoxinsarepresent.725
2
creasesautoxidationreactions,mitochondrialO
•–pro-
Brain is a ‘privileged organ’ with respect to selen-
2
duction,andtherateofH O generationbyoxidases ium,efficientlyretainingitandmaintainingGPx1and
2 2
suchasMAO.Ofcourse,keepingpO lowhasadisad- thioredoxinreductaseactivities,evenunderconditions
2
vantage;itrendersthebrainhighly-sensitivetointer- ofseveredietaryseleniumdeficiency.SelenoproteinP
ruptionsoftheO supply.Thepresenceofneuroglobin (Section3.14.2)isimportantindeliveringseleniumto
2
(Section1.3.1)inneuronshasbeenhypothesizedtoas- thebrain;micelackingthisproteinoritsreceptorinthe
sist correct O delivery to mitochondria; this protein brainsuffersevereneurodegeneration.726
2
seemslesspro-oxidant719inthepresenceofH O than NADPHisessentialforglutathioneandthioredoxin
2 2
arehaemoglobinormyoglobin(Section3.22.3).How- reductases. Indeed, neurons appear to use glucose
ever,someauthorshavequestioneditsimportanceas preferentially for the pentose phosphate pathway ra-
aneuroprotectivemechanism.720 therthanforglycolysis(replacedbyutilizationoflac-
tatereleasedfromastrocytesandoligodendrocytes).727
10.17.6.2 Superoxidedismutases
RapidremovalofGSSGisessential,asitcanbeneuro-
andperoxide-removingenzymes toxic(Section3.11).
All parts of the nervous system contain CuZnSOD,
10.17.6.3 Glutathioneandergothioneine
MnSOD,GSH(atmillimolarintracellularlevels),GPx
enzymes, and the thioredoxin/peroxiredoxin system. It is generally thought that neuronal GSH levels are
The last seems particularly important in modulating lowerthaninglia,andthatgliaassistneuronsbyef-
ROSlevelstoalloweffectivesynaptictransmission.721 ficientlydegradingextracellularH O .Astrocytesap-
2 2
Indeed, knockout of Prx2 in mice, an enzyme prom- peartoreleaseGSH,whichisbrokendownbyγ-GGT
inentinthehippocampus,aggravatedage-dependent (Section 3.10.3) on their cell surface to produce cys–
decreases in long-term potentiation.722 The other Prx gly.Thisisfurtherdegradedbyanenzymepresenton
forms (Prx1–6) are also widespread in the brain.723 theneuronalmembraneandthecysteinetakenupby
Bear in mind, however, that Prx3 is a DAMP; its re- neuronsforconversiontoGSH.728Astrocytescantake
lease from injured cells can promote inflammation up cystine for reduction to cysteine for GSH synthe-
(Section10.18.3).ThebrainalsocontainsglutathioneS- sis,butthisuptakeisinexchangeforglutamaterelease
transferases;isoformsdifferbetweenneuronsandglia. (Section3.10.3),obviouslyaprocessthathastobecare-
Mitochondrial MnSOD is essential; mice lacking it fullymodulatedtoallowGSHlevelstobemaintained
suffer neurodegeneration after birth (Section 3.7.2), whilstavoidingpossibleexcitotoxicity.
marked by cell death (especially in the cortex and In general, glia appear less susceptible to RS (such
brainstem) and severe motor disturbances.724 No asONOO–)thanareneuronsandmoreabletoacceler-
such problems are seen in mice lacking CuZnSOD, ateGSHsynthesisunderstress.728 However,manyof
whereas mice overexpressing CuZnSOD are more re- theseconclusionsarebasedonstudiesofisolatedcells,
sistanttoischaemia–reperfusionandtocertainneuro- and the isolation process is itself a ‘stress’ that could
toxins (Box 3.1). Indeed, neurons from transgenic increase glial GSH levels (Section 1.11). For example,
mice overexpressing CuZnSOD survive longer after inastudyonratbrainusingantibodiestodetecttotal

--- Page 659 ---

604 FREE RADICALS IN BIOLOGY AND MEDICINE
glutathione, levels appeared higher in neurons than include involvement in dopamine hydroxylation and
glia. Injection of kainate depleted levels in neurons formation of the myelin sheath.736 Indeed, mice lack-
whilst raising those in astrocytes.729 The Nrf2 sys- ing SVCT2 show severely decreased ascorbate levels
temispresentinbrainandcanhelptoincreaseGSH in brain (and other tissues), indicating that it is the
(and other antioxidant) levels when needed.730 Ergo- mostimportanttransporterforascorbateentrytothe
thioneine (Section 3.16.2) is present in the brains of brain. These mice die within a few minutes of birth
animals,anditsOCTN1transporterisfoundinsome with respiratoryfailure and brain haemorrhage,737,738
brainregions,butlittleisknownaboutergothioneine’s i.e. ascorbate is essential in the lung and brain to
importancetohumans.731 copewith‘birthhyperoxia’(Section7.11.8.1).However,
SeveredepletionofGSHinmice,byadministration brain catecholamine levels were normal, suggesting
of buthionine sulphoximine (Section 3.10.3), causes that impairment of dopamine-β-hydroxylase activity
neuronal damage and mitochondrial degeneration, wasnotthemechanisminvolved.737Didthelackofcol-
perhaps indicative of the special importance of the lagencauseweakbloodvessels?Possiblynot738asskin
mitochondrial GSH pool. Paradoxically, excess cyst- hadnormalhydroxyprolinecontent(ofcourseskinis
eine can also be neurotoxic.732 Cysteine seems to be not brain!). Perhaps sudden oxidative stress at birth
weakly excitotoxic and can act synergistically with damagedthebloodvessels?
glutamate. In addition, cysteine readily oxidizes to However,ifironorcopperionsareavailable,forex-
form O
•–,
H O , and thiyl radicals (Section 2.5.5), al- ample in damaged brain (Fig. 10.27), ascorbate could
2 2 2
though the contribution of this to its neurotoxicity is conceivably stimulate oxidative damage. Haemoglo-
unknown.OverproductionofH Sfromcysteinemay bintoxicitymayinvolveitspro-oxidantactionsinthe
2
beanothermechanismofinjury.732Anotherinteresting presenceofperoxidesandalsoitsreleaseofhaemand
observationisthat,inrodents,activitiesofglutathione iron ions on decomposition. Unlike ascorbate’s pro-
reductaseandglyoxalase-1inbrainseemtobecorrel- oxidant effect with ‘free’ iron ions, ascorbate inhibits
ated with the level of anxiety.733 Whether this is true oxidative damage caused by haem protein/peroxide
ofhumansremainsuncertain(Section10.24).Thegly- mixtures(Section3.22.3).Henceitsneteffectsatsites
oxalase system seems more active in astrocytes than of tissue injury are hard to predict. For example, ad-
neurons.734 ministrationofascorbateorDHAtoanimalsdecreased
neuronal damage in some stroke models, suggesting
10.17.6.4 Protectingbrainmitochondria
thatoverall(atleastinthemodelsstudied)ascorbate
As in other tissues (Section 3.20.1), brain mitochon- isbeneficial.738
driacontainaplethoraofantioxidantdefencesystems,
GSH,MnSOD,andperoxiredoxinsbeingespeciallyim-
10.17.6.6 VitaminE667
portant.Inaddition,mitochondrialfissionandfusion
(Section1.3.3)seemtoplayaqualitycontrolrole,help- Tocopherols are important in the brain, especially α-
ing to segregate oxidatively damaged organelles for tocopherol (Section 4.3), which is the major form of
autophagy.676,680 vitamin E present. Analysis of brain tissue has gen-
erally shown much lower contents of tocotrienols or
10.17.6.5 Ascorbate667 β-, γ-, or δ-tocopherols, although they can be de-
Allanimalspeciesexaminedtodatehavehighascor- tected,andfeedingtocotrienolstohumansandanimals
bate levels in the brain. Ascorbate concentrations in raises brain levels.739 α-Tocopherol transfer protein
humanCSFarehigherthaninplasma(Section6.17.3), is found in astrocytes and may help to supply α-
and neurons and glia have active transport systems tocopheroltoneurons.Muchbrainα-tocopherolisde-
that concentrate ascorbate even more, to millimolar rivedfromHDL.Severeandprolongeddeprivationof
intracellularlevels,neuronsachievinghigherconcen- α-tocopherol,asoccursinfatmalabsorptionsyndrome
trations than glia. Neurons readily take up ascorbate or ataxia with isolated vitamin E deficiency (AVED),
viatheSVCT2transporter(Section4.2),whereasastro- produces neurodegeneration that probably involves
cytestakeupdehydroascorbate(DHA)andconvertit elevated levels of oxidative damage (Section 4.3.8).
to ascorbate intracellularly. Indeed, neurons may re- α-Tocopherol-deficient diets take a long time to sig-
lease DHA for ‘recycling’ to ascorbate by astrocytes. nificantlylowerbrainα-tocopherollevels;forexample,
AscorbatelevelsinCSFandbrainaremaintainedhigh, it is necessary to feed rats such a diet for a year in
evenwhentherearefallsinplasmalevels,suggestive ordertodecreasebrainlevelsto<3%ofcontrol.Simi-
ofascorbate’simportancethere.735Keymetabolicroles larly,ittakesmanyweekstoincreasetheα-tocopherol

--- Page 660 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 605
content of brain in adult mammals supplemented since plasmalogens form a significant proportion of
withthisvitamin. phospholipidsintheadulthumanbrain.744 However,
Hence,brainα-tocopherollevelsseemtightlyregu- theircontributiontoantioxidantdefenceisuncertain.
lated.Thispointisrelevantwhenassessingthethera- Thefirsttwostepsinplasmalogenbiosynthesisoccur
peuticeffectsofα-tocopherolsupplementationinclin- inperoxisomes.711
ical trials; large doses need to be given for long
periods to raise brain levels significantly. Levels of 10.17.6.10 Carotenoidsandflavonoids
α-tocopherol appear normal in the brains of centen-
Lutein, zeaxanthin, cryptoxanthin, β-carotene, and
arians,patientswithAlzheimerorParkinsondisease,
lycopenearepresentinlowamountsinhumanbrain,
or in foetuses with Down syndrome.740 High doses
of α-tocopherol have been reported in some stud- luteinbeingthecommonest.745 Brainlevelshavebeen
reported to correlate with cognitive function (Sec-
ies to improve cognitive function in aged rodents741
tion11.4.9).Thereisalsoevidencethatsomephenolics
andtoalimitedextentinAlzheimerpatients(Section
cancrosstheblood–brainbarrier,withseveralanimal
10.21.4). Studies on old dogs reported improvements
studiesclaimingthatmonophenolssuchasferulicacid
incognitionresultingfromexercise,environmentalen-
richment,anddietsrichinα-tocopherol,ascorbate(but and flavonoids such as epigallocatechin gallate, hes-
peritin, and naringenin can enter.746 In studies with
dogscanmaketheirown!),lipoicacid,andcarnitine.
carotenoids and phenolics (or any agent likely to be
Increases in brain BDNF levels may be involved.742
Three months’ supplementation with high-dose α- presentatonlylowlevels),itisessentialtowashout
residual compounds from the vascular system before
tocopherol delayed the loss of cognitive function in
extracting the tissue for analysis; levels of the above
micelackingPrx2.722Weanlingguineapigsdeficientin
bothascorbateandα-tocopherol(butnotα-tocopherol phenols within the brain itself seem low. Some (but
notother)reportssuggestaprotectiveeffectoforally
alone)developedprogressiveparalysisandincreased
administered Ginkgo biloba extracts against the devel-
lipidperoxidationinthebrain(Section4.3.4).
opment of dementia. Such effects (if real) are often
10.17.6.7 CoenzymeQ667 attributed to the flavonoids present, which include
myricetinandquercetin.747Micewhosedietsweresup-
Defects in the ability to synthesize ubiquinone cause
plementedwithGinkgodidshowchangesinneuronal
encephalopathy,andoraladministrationofcoenzyme
gene expression, suggesting that something had en-
Qtoratswasreportedtoincreaseitslevelsinthebrain
tered the brain. Flavonoids might also help the brain
and to protect against striatal damage caused by ad-
byimprovingvascularfunction(betterbloodflow)or
ministrationofmalonateor3-nitropropionicacid.Co-
by actingon thegut flora, sincethereis considerable
enzymeQadministrationprotectsagainstMPTPtox-
‘cross-talk’betweenthegutandthebrain:foodshave
icityinmice(Section10.20.3)andmayhave(limited)
major influences on brain function.746,748 The ‘antiox-
therapeutic benefit in Huntington disease (Section
idant’contentofthedietstronglyinfluencestheriskof
10.23.2), PD (Section 10.20.4), and Friedreich ataxia
developingbraindisorders(Section4.6.8).
(Section10.23.1).Neuroprotectiveeffectscouldinvolve
its electron transport action in mitochondria and/or
10.17.6.11 Metal-bindingandrelatedprotective
the antioxidant action of ubiquinol (CoQH ). In one
2 proteins667,700,749
study, the learning ability of old mice was improved
byfeedingamixtureofcoenzymeQandα-tocopherol,
Most caeruloplasmin is made in liver, but some is
butnotbyeitheragentalone.743 synthesizedinbrain.Thebrainform,mostlyinastro-
cytes, is anchored to glycosylphosphatidylinositol on
10.17.6.8 Histidine-containingdipeptides667
the plasma membrane. It associates with ferroportin
Carnosine, homocarnosine, and related compounds on the cell surface and promotes iron efflux from
arepresentathighlevelsinbrainandhavebeenpos- astrocytes.Indeed,humanacaeruloplasminaemiaisas-
tulated to exert antioxidant effects, e.g. by chelating sociated with degeneration of the retina and basal
transitionmetalionsandbindingcytotoxicaldehydes ganglia,ironaccumulationinastrocytes,andelevated
producedduringlipidperoxidation(Section3.25.7). lipidperoxidation(Section3.22.2.3).
Haptoglobin is present in CSF, although levels are
10.17.6.9 Plasmalogens low,750 andmayhelptobindhaemoglobinreleasedas
Thesehavebeensuggestedtoexertantioxidantproper- a result of bleeding. Haemopexin is present in vari-
ties(Section5.12.8.1).Sucharoleisfeasibleinthebrain, ous brain regions and the brains of mice lacking it

--- Page 661 ---

606 FREE RADICALS IN BIOLOGY AND MEDICINE
showincreasedironandTBARSlevels,suggestiveof Methionine sulphoxide reductases (MsrA and B;
anantioxidantroleviahaembinding.751 Section 5.14.1) are also found in brain. Mice lacking
Brain also contains metallothioneins, including a MsrA show a peculiar neurological phenotype, ‘tip-
‘brain-specific’metallothionein-IIIisoform,prominent toewalking’,andhaveelevateddopaminelevelsinthe
in astrocytes and present to a lesser extent in certain brain.759
neurons. Transgenic mice lacking metallothioneins I
and II (but oddly, not mice lacking metallothionein 10.17.6.13 Defenceoftheblood–brainbarrier667
III!)showedimpairedrepairofbraindamageaftercor-
Another important aspect in the maintenance of nor-
ticalinjury(Section3.23.2),althoughMT-IIIknockout
mal brain function is the antioxidant defence of the
miceweremoresensitivetoseizuresinducedbykainic
cells that make up the blood–brain barrier. Rat mi-
acid.Metallothioneinsaremajorstoresofintracellular
crovesselsarerichinGSH,GPx,glutathionereductase,
zinc and alterations in zinc metabolism may contrib-
andcatalasewhencomparedwiththerestofthebrain.
utetothepathologyofstrokeandneurodegenerative
Glutathioneappearsespeciallyimportantinmaintain-
diseases(Sections10.18.3.1,10.18.4,10.21.3,and752).
ing theintegrityof theblood–brain barrier, and GSH
Haem oxygenase is widespread in the brain; both
depletioncanhelptoopenupthebarrier.
constitutive(HO-2)andinducible(HO-1)formshave
been detected. Indeed, the CO it produces has some
role as a neurotransmitter. The levels of HO-1 often
10.18 Oxidativestressinischaemia,
increase after damage, e.g. in ischaemia–reperfusion,
inflammation,andtraumainthe
subarachnoidhaemorrhage,andAlzheimerdisease,as
discussedinSection10.18.4. nervoussystem
10.18.1 Inflammation:acommonfeature
10.17.6.12 Repairofoxidativedamage
Inflammation is a key player in most, if not all, hu-
Brain contains the ubiquitin–proteasome system to mandisorders,andthenervoussystemisnoexception.
degrade oxidatively-damaged and other abnormal Sepsiscanseverelydamagethebrain(septicenceph-
proteins, including oxidized glutamine synthetase. alopathy),760 and injury to the CNS (e.g. by stroke
Defectsinthissystem,orinlysosomalfunctionleading or trauma) is rapidly followed by inflammation. In-
todefectiveautophagy,playkeyrolesinneurodegen- flammation in the brain involves activation of glia to
erative disease (Sections 10.19, 10.20.4, 10.21.5, and produce RS and cytokines (including IL-1, IL-6, and
10.23.2). Chaperones that can help to prevent and TNF-α), and/or entry of endotoxin and/or periph-
resolveaggregationofmisfoldedproteinsarealsovery eralinflammatorycells(neutrophils,lymphocytesetc.).
importantinbrain,753 e.g.thereleaseofHsp70byglia Thelatterisfacilitatedbyincreasedlevelsofadhesion
canhelptoprotectneurons.754Indeed,overexpression molecules on the blood–brain barrier triggered by its
of Hsp70 reduces ischaemia–reperfusion injury in exposuretocytokines(especiallyIL-1andTNF-α)and
animalmodelsofstroke.755 RS.674,717 For example, injection of endotoxin into the
DNA repair and DNA precursor pool ‘sanitiza- brainsofmiceprovokedincreasesinthelevelsofboth
tion’ enzymes are present in nucleus and mitochon- F - and F -IsoPs.761 Endotoxin does not usually cross
2 4
driaandareimportantforneuronalfunction.Forex- theblood–brainbarrier,butcandosoifthebarrieris
ample, mice lacking MTH1 or OGG1 showed severe damaged (e.g. by trauma) or otherwise ‘opened up’
neurodegeneration after exposure to 3-nitropropionic (e.g.bycytokineexposure).
acid,756 lack of the ATM protein causes increased Animal studies have shown that administration of
oxidative damage and ataxia (Sections 5.10.8.2 and antioxidants(e.g.N-acetylcysteine,spintraps,desfer-
10.14.7), and the brains of mice lacking Ku70 (Sec- rioxamine,uricacid)canprotectagainstbraindamage
tion 5.10.6) showed elevated oxidative DNA damage resulting from bacterial meningitis, inflammation of
levels and cell death.757 The NEIL glycosylase en- the membrane that covers the brain. Oxidative and
zymes (Section 5.10.3) are readily inhibited by iron nitrative damage may occur first to the blood–brain
and copper ions, and the release of such ions from barrier (helping to damage it) and then spread into
injured brain might help to impede repair of oxi- the brain.762 Thus, in human meningitis, HNE and
dative DNA damage.758 Conversely, overexpression nitrotyrosine were detected in blood vessels in the
of MTH1 in mice seemed to improve brain function subarachnoidspace.Nitrotyrosineandallantoin(Sec-
(Section5.10.8.1). tion 6.13) levels rose in the CSF, and ascorbate levels

--- Page 662 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 607
fell.763 Pneumococcal meningitis can result in inflam- anti-inflammatory effect in MS under certain circum-
mationoftheinnerearandhearingloss,againpossibly stances (Sections 8.9.4 and 10.11.4). Some lipid oxi-
involvingoxidativedamage.762Severeinfectionsearly dation products might also be anti-inflammatory.774
inlifemightrestrictironavailabilityforoligodendro- However, in other circumstances, ROS make things
cyte maturation, causing long-term impairments of worsee.g.MPOinhibitorscanbeprotectiveinanimal
brainfunctioninchildren.764 modelsofMS775andCuZnSOD-deficientmiceshowed
increasedsusceptibilitytoautoimmuneencephalomy-
elitisinducedbyMOG.776
10.18.2 Multiplesclerosis765,766
What about humans? Dimethylfumarate (BG-12),
Multiple sclerosis (MS) is a chronic inflammatory which activates the Nrf2 system and raises levels
disease leading to myelin destruction, oligodendro- of GSH, HO-1, and other antioxidant systems (Sec-
cyte death, and axonal damage. The symptoms of tion 11.5.11) seems beneficial in MS.777 It’s all very
MSresultfromimpairednerveconductioncausedby confusing!
damage to the myelin sheath, apparently by an in-
flammatoryreactioninvolvingglialcells,aswellasT- 10.18.3 Braininjury:stroke778
lymphocytesandmacrophagesrecruited(thelatterini-
tiallyasmonocytes)fromthecirculationbyincreased There are two broad types of brain hypoxia. Global
levels of adhesion molecules on vascular endothelial hypoxia occurs when O supply to the whole brain
2
cells. TRPM4 cation channels may be involvedin the failsorisseverelylimited.Thiscanbeduetointerrup-
axonalinjuryinMS.767 tionofthebloodsupply(e.g.inmyocardialinfarction
MS is an autoimmune disease; suggested autoanti- or haemorrhagic shock) or other interruptions of O
2
gens include αβ-crystallin (a small heat-shock pro- delivery,asinasphyxiaorpoisoningbyCO.Hypoxia
tein found in oligodendrocytes and astrocytes in MS canalsooccurduringbirth(Section7.11.8.1).Cerebral
lesions), oxidized lipids, the enzyme transaldolase bloodflowinadulthumansisabout50mlper100g
(part of the pentose phosphate pathway), and sev- ofbrainpermin;flowsbelow18mlwillleadtoinjury,
eralmyelinproteins,includingmyelinbasicprotein, andO supplymustbere-establishedwithinminutes
2
myelin-associatedbasicglycoprotein,andmyelinoli- topreventneuronaldamage.
godendrocyte glycoprotein (MOG). Several myelin Hypoxiacanalsoresultfromlocal(sometimescalled
proteins cause autoimmune encephalomyelitis (in- focal)ischaemia,failureofthebloodsupplytopartof
flammationanddemyelinationinthecentralnervous the brain. This can occur by rupture of a blood ves-
system) when injected into animals.301 In these an- sel(haemorrhagicstroke)orthemorecommon(~85%)
imal models and in human MS lesions there is in- thromboticstrokeduetothrombusformation,usually
creasediNOSandcytokineproduction,higherlevelsof in an atherosclerosed vessel. The former is often due
MMPs,increasedoxidativedamagetolipids,proteins, toruptureofananeurysm(aneurismalsubarachnoid
and DNA, elevated iron levels, and more nitrotyr- haemorrhage), and has the additional problem that,
osine. In the animal models, some protection by N- aswithanybleedingintothebrain,intracranialpres-
acetylcysteineamide(Section11.5.9.2),catalase,BHA, sure rises because of the rigid skull and more brain
EUK-8(Section11.5.4),epigallocatechingallate,lipoic damageresults.Haemoglobinisalsoneurotoxic(Sec-
acid,oruratehasbeendemonstrated;768,769 uratewas tion3.22.3).667 Strokeisthethirdmostcommoncause
suggested to act by preventing damage by ONOO– of medically related deaths and the second leading
since it decreased nitrotyrosine levels.769 By contrast, causeofneurologicalmorbidity(afterAlzheimerdis-
flavonoids increased damage in a mouse model,770 ease) in the USA and Europe. It is the fourth most
and rats lacking the Ncf1 gene showed not only commoncauseofdeathinSingapore.Actionsthathelp
more aggressive collagen-induced arthritis (Section to prevent stroke include treatment of hypertension
10.11.4), but also more severe encephalomyelitis after andhypercholesterolaemia,andadietrichinfruitsand
injection of MOG.771 MOG-induced encephalomyeli- vegetables(Section4.7).
tis in mice was also decreased by the ‘pro-oxidant’ Inlocalischaemia,cellsintheischaemiczonearethe
adenanthin (Section 10.16.1).772 Guillain–Barré syn- mostrapidlydamaged.Cellsinthesurroundingarea
drome, a demyelinating disease of the nervous sys- (often called the ischaemic penumbra) that receive
tem, has also been suggested to involve impaired someO (butnotenough)fromotherbloodvesselsare
2
phagocyte O •– production.773 These data imply that alsoatrisk,butpotentiallyrescuableifO isrestored
2 2
phagocyte ROS production could have, overall, an quickly.Animalmodelshavebeendevelopedtomimic

--- Page 663 ---

608 FREE RADICALS IN BIOLOGY AND MEDICINE
both types of ischaemia. For example, ligation of the 10.17.4) raises Ca2+ and Na+ levels in other neurons;
carotid and vertebral arteries in rodents gives global ATPlevelsfallthereaswell,andthedamageperpetu-
ischaemia,whereasligationofthemid-cerebralartery ates.Cellswellingintheinjuredbrainduetoabnormal
isapopularfocalmodel. ion composition contributes to tissue oedema. Other
Global brain ischaemia for short periods damages relevant events include acidosis (accelerated lactate
onlycertaingroupsofneurons.Mostsensitivearethe production,andfailuretoclearmetabolicwasteprod-
so-called pyramidal neurons in the CA1 region of ucts, although there is some suggestion that low pH
the hippocampus. Other groups of neurons here and might be neuroprotective)783, release of haem/haem
elsewhere(e.g.inlayers3,5,and6ofthecerebralcor- proteinsand‘catalytic’ironfromnecroticcells,andac-
tex and in parts of the striatum, hypothalamus, and tivation of phospholipases A and C. Phospholipase
2
cerebellum) have intermediate sensitivities. By con- activationcausesrapidriseinarachidonicacidlevels
trast, the majority of neurons can tolerate 30 min or andexcessiveformationofeicosanoids,sinceCOX-2is
more of ischaemia (at least in animal studies). How- normallypresentinbrain(Fig.10.28).NeuronalNOS
ever,cerebralischaemialastingmorethanabout60min is Ca2+-dependent, so NO• production may rise ex-
produces tissue infarction in which all cells within cessively. Of course, eicosanoids, NO• or O •– cannot
2
the severely ischaemic region die. Necrotic cells re- formintheabsenceofO sinceitisrequiredtoprod-
2
lease DAMPs that promote inflammation, including ucethem,butinfactpO rarelyfallstozero,andthey
2
peroxiredoxins(Section3.13.2)andHMGB1.779 caneasilyformafterreperfusion.IncreasesinfreeCa2+
The brain displays ischaemic preconditioning; in levelsleadtoactivationofcalpains(Section5.3.2.2)—
various animal models, brief ischaemia can decrease one target of digestion by these proteinases may be
injury resulting from subsequent, more prolonged is- the Na+/Ca2+ exchange system, hindering cells from
chaemia.Ethanolandtheanaestheticsevoflurane(Sec- exporting Ca2+ and slowing the restoration of correct
tion 10.6.6) also have preconditioning effects on the ion gradients during reperfusion.782 Excess uptake of
brain under certain circumstances.286,780 Administra- Ca2+ by brain mitochondria can further impair ATP
tionoflow(controlled!)dosesof3-nitropropionicacid productionandcantriggertheMPT,raisingO
•–
pro-
2
can also induce tolerance against subsequent ischae- duction(Fig.1.9).
mia. Suggested mechanisms of ischaemic precondi- Ischaemia–reperfusion in mouse cortex produced
tioning in the brain include adenosine release, in- rises in the levels of several base oxidation prod-
creased synthesis of neurotrophic factors and Hsps, ucts in DNA, a pattern indicative of attack by
elevations in HIF-1α, and modulation of K+ channel OH• (Section 5.8.2.1).784 This DNA damage might
activity.277Briefpre-exposureofanimalstohyperbaric contribute to cell death. So might end-products of
O (e.g.2.5atmfor1heachdayforseveraldays)also lipid peroxidation such as HNE, oxononenal, IsoPs,
2
diminishesthedamagecausedbysubsequenttrauma and cyclopentenone IsoPs, as several of these spe-
or cerebral ischaemia (hyperbaric O precondition- cies are neurotoxic (Section 10.17.5) and their brain
2
ing), at least partly due to increases in the levels of levels rise in stroke.785 Another reactive aldehyde
antioxidantenzymes.781 that may contribute to damage in stroke is acrolein,
whichcanbeproducedduringlipidperoxidationand
10.18.3.1 Mediatorsofdamage also by oxidation of spermine by polyamine oxidase
The best way of treating brain ischaemia is to re- enzymes (Section 5.12.5.3).786 The spermine is oxi-
storebloodsupplyassoonaspossible.Inthrombotic dizedto3-aminopropanal,H 2 NCH 2 CH 2 CHO,which
stroke,rapidbutcautiousadministrationofthrombo- thenspontaneouslygeneratesacrolein.786Anotherpro-
lyticagentssuchasTPA(tissueplasminogenactivator) posed mediator of injury is Zn2+, essential for the
isoftenbeneficial,butisclearlynotsuitableforhaem- developmentandfunctionofthecentralnervoussys-
orrhagic stroke. Even when thrombolytic agents are tem, yet a neurotoxin at high levels (Section 9.16.12).
used,reoxygenationinjurymightoccurandcausead- Excitotoxicityduringischaemiahasbeensuggestedto
ded damage, especially in the ischaemic penumbra. cause sufficient Zn2+ release from stores in synaptic
Hence there has been much interest in attempts to vesicles to reach toxic extracellular levels in brain,787
developtherapiestocounterthis. althoughdoubthasbeenraisedsincesomeofthedyes
The most important event in ischaemic brain in- used to detect Zn2+ may be non-specific.788 Metallo-
jury appears to be failure of ATP synthesis, lead- thionein in brain (Section 10.17.6.11) is another pos-
ing to release of excessive amounts of glutamate sible source; it can release Zn2+ if attacked by RS
from neurons.782 The resulting excitotoxicity (Section (Section3.23.2).

--- Page 664 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 609
Ischaemia
Glutamate Reduction of oxygen and glucose supply, energy failure, bleeding, acidosis
release
ATP ATP
Glutamate receptor
activation Membrane depolarization
Haemoglobin, haem
DAG and Fe release
Ca2+
PKC
Mitochondrial
Protein phosphorylation Proteolysis Lipolysis Reoxygenation NOS activity damage, possible MPT
(if O level
(if ATP level allows) 2
allows)
Membrane Inflammatory
degradation mediators NAD+
(eicosanoids) depletion
Degradation of Reactive
the cytoskeleton oxygen species
Membrane and
vascular dysfunction
Phosphorylation and Changes in membrane PARP–1
inactivation of initiation receptor and ion blebbing Oxidative damage to activation
factors and changes in channel activities proteins, lipids, DNA
gene expression
ini D tia a t m io a n g e fa t c o t ors Cell death Fe release Caspase
Necrosis/apoptosis/ activation
Protein synthesis combined mechanisms
Oedema
Inflammation
(DAMP release)
Figure10.28 Mechanismsofcellinjuryinstroke.Duringischaemia,lessO2andglucosereachtheaffectedareaandATPlevelsfall.Thisandthe
depolarizationofmembranesleadtoincreasedintracellularfreeCa2+andreleaseofglutamate.Glutamatereceptorsarethenactivatedanda
furtherincreaseinCa2+occurs,todamaginglevels,withexcessiveCa2+-dependentproteolysisandlipolysis.Thereisalsoadecreaseinprotein
synthesisrates.Althoughreoxygenationisrequiredforrecovery,itresultsinthegenerationofRS.TogetherwithincreasedNOSactivityand
mitochondrialdamage,thiscanleadtocaspaseactivation,thereleaseofinflammatorymediators,andoxidativedamage,ultimatelyleadingtocell
death,whichcaninvolvenecrosisorapoptosisandoftenhasfeaturesofboth.ExtensivelymodifiedfromClin.Exp.Pharmacol.Physiol.31,397,
2004,bycourtesyofDrP.J.Crackandthepublishers,alsoseeCurr.Med.Chem.51,1,2008.DAG,diacylglycerol;PKC,proteinkinaseC;
MPT-mitochondrialpermeabilitytransition.
ThatRSplayaroleinischaemia–reperfusioninjury allantoin,andfluorescentend-productsoflipidperox-
is further illustrated by observations that transgenic idation (Section 6.15.10), are also elevated in human
animals overexpressing antioxidant proteins, such as strokepatients.791,792
MnSOD,CuZnSOD,GPX1,orthioredoxinareusually WheredoRScomefromintheinjuredbrain?Likely
more resistant to cerebral ischaemia–reperfusion and sources include increased electron leakage from the
traumatic injury, whereas mice lacking GPx1 or SOD mitochondrial electron transport chain, XO (in some
are often more sensitive. Too many antioxidants may animals, probably not humans),793 NADPH oxidases,
interfere with ischaemic preconditioning, however.789 and faster oxidation of neurotransmitters catalysed
Inseveralanimalmodelsofstroke,administeredanti- by released transition metal ions. Some studies of
oxidants(Section10.18.3.2)decreasetissueinjury,oxi- mice lacking NOX1, NOX2, or NOX4 enzymes have
dative lipid, DNA, and protein damage, and may reported smaller infarct sizes after stroke, but other
help to protect mitochondria (e.g. by preventing O •– resultsareconflicting.36,690
2
from inactivating aconitase) and thus maintain ATP Ischaemia–reperfusion also affects the blood–brain
levels and diminish the loss of ion gradients.790 Bio- barrier,causingincreasedleakinessandraisinglevels
markers of oxidative damage (e.g. F - and F -IsoPs, of adhesion molecules, hence recruiting lymphocytes
2 4

--- Page 665 ---

610 FREE RADICALS IN BIOLOGY AND MEDICINE
andneutrophils;RScandamagethebarrierbothdir- Section 11.5.8), and proteasome inhibitors. The last is
ectly and by activating MMPs.715 This inflammatory- somewhatparadoxicalbecauseproteasomeinhibitors
immuneresponsetotissueinjury/DAMPrelease,both can also be neurotoxic (Section 10.19); possibly in
by recruited cells and by the brain’s microglia, after the animals tested they dampened inflammation by
a stroke is presumably intended to help to repair tis- decreasingactivationofNF-κB.800Heat-shockproteins
sueinjury,717 butifitoccurstoexcessitcouldleadto may also be neuroprotective in animal models of
furtherdamageinvolvingROS,cytokines,proteinases stroke (Section 11.5.3). The efficacy of these various
etc.794 One mechanism of damage by neutrophils is treatments depends on the amount of agent admin-
bycreatinga‘noreflow’phenomenon(Section10.6.4). istered, for how long it is given, the animal species
Interestingly, though, mice deficient in receptors for used and its age and sex, the extent and duration
TNF-α (acytokineoftenpickedasthe‘badguy’dur- of ischaemia, the length of follow-up of the animals
inginflammation)showedincreasedneuronaldamage (some agents delay neuronal death rather than pre-
after focal cerebral ischaemia or injection of the ex- venting it, an effect easily missed in a short-term
citotoxinkainicacid.795Similarly,increasedproduction study), the baseline levels of brain antioxidants (e.g.
of NO• is not necessarily bad; it can decrease levels α-tocopherol-deficient animals suffer more damage
of adhesion molecules, improve blood flow (by vas- afterischaemia–reperfusion),801 andotherparameters
odilation)andinhibitlipidperoxidation.Microgliaand ofexperimentaldesign.
astrocytesseemtofacilitatetheremodellingofsynaptic Thefactthatthiswidevarietyofinterventionscan
connectionsafterstroke.671 workinanimalssuggeststhatcelldeathisnotdueto
asingleevent,buttomultipleeventsactinginparal-
10.18.3.2 Therapeuticinterventions?796 lel and/or synergistically (Fig. 10.28). Suggestions as
towhysomeneuronsaremorevulnerabletoischaemia
Onepossibletreatmentistolowerbraintemperature,
thanothers(Section10.18.3)includetheirlevelsofglu-
which slows falls in ATP, deleterious changes in ion
tamatereceptors,basallevelsofoxidativestress,ability
gradients,andlipidperoxidation.797Hypothermiahas
totakeupZn2+,andpropensitytosufferproteasomal
somereportedbenefitindecreasingneurologicaldam-
dysfunction and/or to undergo a rise in intracellu-
ageinpatientsresuscitatedaftercardiacarrest,andin
lar free Ca2+ (e.g. whether TRPM2 is present) and
traumatic brain injury, but it is difficult to apply to
mitochondrial damage.802 The ability to activate sig-
strokepatientsandhasseveralside-effects.
nalpathwaysthatpromoteneuronalsurvival,suchas
Manyagentshavebeenshowntodecreaseneuronal
the PI3-K/Akt pathway (Section 5.5.4) may also be
loss after brain ischaemia/reperfusion in animal
important.803
models, including Ca2+ blockers, docosahexaenoic
Sadly,noneoftheagentsmentionedabovethathave
acid, and Zn2+ chelators (such as DP-b99 [which
beentestedinhumanstrokepatientsgaveconvincing
also chelates Ca2+ and possibly other metals] and
N,N,N(cid:4),N(cid:4)-tetrakis(2-pyridylmethyl)ethylenediamine; evidence of clinical benefit, although studies on ur-
atearestillcontinuing.Inparticular,theearlypromise
TPEN).798,799 Inhibitors of nNOS, NOX4 or other
of NXY-059 was not fulfilled (Section 11.5.5). Unlike
NOXes, XO, PARP-1, and phospholipase A have
2 thehighly-controlledanimalmodels,humanstrokepa-
also worked, as have cyclosporin A, agents that
tientsvaryintheirdegreeofhypoxia,thetimeatwhich
prevent binding of glutamate to its receptors, and
‘antioxidants’ such as 17β-oestradiol, PEG-SOD,c theyappearinhospitalwithsymptoms,andthetime
α-tocotrienol, SOD mimetics (Section 11.5.4), urate, takentodiagnoseastroke.Hencetheycanbeatwidely
different points along the ‘cytotoxic chain of events’,
ebselen (Section 11.5.10), some plant phenols, albu-
and it would be naïve to expect a single agent to be-
min, N-acetylcysteine, Prx3, lipoic acid, minocycline,
nefit the majority of subjects. Studies of biomarkers
desferrioxamine, ICL670 (Section 11.6.2), ascorbate or
of oxidative damage (F - and F -IsoPs, allantoin) in
dehydroascorbate,738 carnosine (Section 3.25.7), lazar- 2 4
plasmaandurinefromstrokepatientsshowedthemto
oids (Section 11.5.8), stilbazulenyl nitrone, TEMPOL
beelevatedevenonfirstadmissiontohospital,i.e.the
(Section 11.5.5), edaravone (Section 11.5.8), PBN or
‘therapeuticwindow’inwhichinterventionwithanti-
related compounds such as NXY-059 (Section 11.5.8),
oxidantsmightbesuccessfulmayalreadyhavepassed
agents acting as both free radical scavengers and
inmanypatients.791
NMDA receptor antagonists (such as Neu2000;
Severalstudiessuggestthatdietaryantioxidantsdi-
minishtheriskofdevelopingstroke.Theevidenceis
c CuZnSODconjugatedtothepolymerpolyethyleneglycol. strongestforvitaminC,althoughcontroversial.There

--- Page 666 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 611
is no evidence that high-dose α-tocopherol adminis- ironionsreleasedbytheactionofHO.Transgenicmice
trationprotectshumansagainststroke,indeeditmay overexpressing HO-2 were less sensitive to traumatic
raise the risk of haemorrhagic stroke. On the other brain injury, probably due to increased ferritin syn-
hand,dietsrichinfruitsandvegetablesseemprotect- thesis secondary to the increased HO.813 By contrast,
ive:therearerepeatedsuggestions,butasyetnotmuch knockout of HO-1 led to less damage in a mouse in-
hardevidence,thatflavonoidscontributetothiseffect tracerebralhaemorrhagemodel.806 Bilirubinproduced
(Section4.6.8).Bycontrast,consumingtoomuchmeat by haem degradation might have some antioxidant
may increase stroke risk; a role for haem in this has activities, but its degradation can produce vasocon-
beenproposed.804 stricting compounds (Section 3.25.1). Carbon monox-
idefromHOactivitymightalsohaveprotectiveeffects.
Increasesincaeruloplasminlevelsintheinjuredspinal
10.18.4 Traumaticinjury805,806
cordmayalsoplayaprotectiverolebyoxidizingFe2+
Severetraumaticinjurytothebrainorspinalcordin- theretothelesspro-oxidantFe(III).814
volves both direct tissue damage (crushing, tearing, Soon after trauma, inflammatory/immune res-
bruising) and secondary damage involving many of ponses begin, involving cytokines, activation of tran-
the events that occur in stroke. These include release scription factors (e.g. NF-κB), activation of microglia,
of iron ions, Zn2+, and haemoglobin, increased NO• and recruitment of circulating phagocytes. Traumatic
andO •–production,proteinnitration(includingnitra- injury can directly damage the blood–brain barrier,
2
tion and inactivation of MnSOD), phospholipase and allowingentryintothebrainofagentsthatdonotnor-
calpainactivation,mitochondrialdysfunction,release mallycross.Theinflammatory-immuneresponseafter
offattyacids,lipidperoxidation(e.g.risesinF -and injury may be good, bad, or, more likely, both (as in
2
F -IsoPsandoxidationofmitochondrialcardiolipin807) the case of stroke). For example, mice lacking myel-
4
and rises in glutamate. For example, damage to the operoxidase showed better functional recovery after
ratspinalcordcausedextracellularironreleaseaccom- spinal cord injury.815 Yet opening of the blood-brain
panied by OH• formation.808 Indeed, ‘catalytic’ iron barriercanallowpotentiallyneuroprotectiveagentsin,
levels are elevated in the CSF of patients with intra- suchashaptoglobinandhaemopexinfromtheplasma
ventricularhaemorrhage.809Bloodvesselsrupturedby (Section3.23.3.4).
thetraumaleakblood,andthepartsofthebrainthey Manyagentstestedforthetreatmentofstrokehave
normally supply will become hypoxic. Bleeding and alsobeenshowntoimproveoutcomeinanimalmod-
oedema(duebothtocellswellingresultingfromdis- elsoftraumaticinjury.Theseincludedesferrioxamine,
turbedionbalanceandtoleakagefromdamagedblood PEG-CuZnSOD, bipyridyl, GSH, tirilizad, lipoic acid,
vessels)raiseintracranialpressure,whichcreatesmore PBN, tempol, agents that increase Nrf2 action, and
ischaemiaandfurtherdecreasesbloodflow.Thevaso- U83836E(Section11.5.8).805However,noneofthemhas
spasm that can occur some days after intra-cranial beenshowntohelppatientssufferingfromtraumatic
bleeding seems to involve oxidative damage, e.g. by braininjury.805
OH•production810andbyend-productsoflipidperox-
idationsuchasIsoPs.Forexample,F -IsoPlevelswere
2
higherintheCSFofpatientswithsubarachnoidhaem- 10.19 Oxidativestress
orrhage who suffered vasospasm that in those who andneurodegenerativediseases:some
didnot.809,811 BindingofNO• byhaemoglobinisalso generalconcepts667,700,749,800,816–819
involvedinthevasospasm.
Duringthefirstfewdaysafteranintracranialbleed, The various neurodegenerative diseases (diseases in
the released erythrocytes slowly haemolyse, releas- which neurons degenerate and die) have different
ing haemoglobin and haem. Glial cells gather at the symptoms,affectdifferentpartsofthebrainandner-
site, take up iron, and eventually store it as ferritin voussystem,andhavedifferentcauses.Beforeexam-
or haemosiderin. Much haemoglobin is converted to ining some of them individually, it is worth em-
bilirubinbyHObutpartundergoesnon-enzymicoxi- phasizing that they have a lot in common (Table
dationanddegradation.812Injuryorischaemiaincrease 10.10); the affected regions show impaired mitochon-
HO-1levels,especiallyinglia.HO-2,constitutivelyex- drial function, increased oxidative damage, defects
pressedinbrain,alsoplaysarole.IsHOgoodorbad? in the ubiquitin–proteasome and autophagy systems,
The answer may depend on how much haem needs the presence of abnormal, misfolded aggregated pro-
to be degraded and if the system can cope with the teins, changes in iron metabolism, involvement of

--- Page 667 ---

612
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table10.10 Commonfeaturesofthemajorneurodegenerativediseases.ReproducedwithpermissionfromJohnWiley&Sons.
Parkinsondisease Alzheimerdisease Amyotrophiclateralsclerosis Friedreichataxia Huntingtondisease Priondiseases
Mitochondrial ComplexI↓,αKGDH*↓ ComplexI,II,IV↓(some ComplexI,II,III,IV,V↓ Frataxinisamitochondrial ComplexesII,III,IV↓, Reportedinbrainsof
dysfunction studies),αKGDHa↓, (varyingreports) Fe–Sprotein;levelsof αKGDH*,aconitase↓ scrapie-infectedmice
Pyruvatedehydrogenase↓ complexesII,III,
andaconitase↓
Proteasome Specificgeneticdefectsin Proteasomeproteolytic Aggregatedubiquinatedinclusions Nodata Aggregates(seebelow) Accumulationof
dysfunction ubiquitin/proteasome activitiessubnormal seeninbothsporadicandgenetic includeproteasome ubiquitinatedproteins
(defectsin pathwaycauseinherited ALSbrainandspinalcord. subunitsandmayimpair observedinanimal
autophagyare PD.Proteasome Mutationsinthegeneencodingthe proteasomefunction modelsandCJDbrain
alsocommon) proteolyticactivities ubiquitin-likeproteinubiquilin2 suggestiveof
subnormalinsporadicPD (involvedinregulationof proteasome
degradationofubiquinated dysfunction823
proteins)areararecauseofFALS
(Nature477,211,
2011)Proteasomeactivitymaybe
decreasedbyaggregatesofmutant
SODsinFALSa.Experimentally
decreasingproteasomeactivityin
animalmodelsmayworsenthe
disease824
Abnormalprotein Lewybody Amyloidplaques, Arangeofaggregatesdescribed, Frataxinaggregates Aggregatescontaining Abnormalprotein
aggregates neurofibrillarytriangles oftencontainingubiquitin, huntingtin,ubiquitin, aggregates(Section
neurofilaments,dorfinbetc. heat-shockproteins,and 10.21.9)
Inmotorcortexandspinalmotor proteasomesubunits
neuronsCuZnSODisamajor
componentofaggregatesinFALSa.
causedbySOD1mutations
Changesiniron Moreironinsubstantia Ironinplaques Irondepositionindysfunctional ‘Catalytic’Felevelsmightbe Irondepositedinlesions Ironlevelsreportedas
metabolism nigra motorneurons elevatedduetoabnormal raisedinaffectedareas
frataxin.Irondepositsin
heart
Oxidativeand Section10.20 Section10.21 Section10.22 Section10.23.1 Section10.23.2 Section10.21.9
nitrativedamage
aαKGDH,α-ketoglutaratedehydrogenase.Theactivityofthisenzymeisfrequentlydecreasedinneurodegenerativediseases,possiblybyoxidativedamage(Mol.Cell.Neurosci.55,13,2013).FALSfamilialamyotrophiclateral
sclerosis;CJDCreutzfeldt–Jakobdisease.Adaptedfromref667.
bDorfinisanE3ubiquitinligase(Mol.Biol.Rep.39,10053,2012),alsofoundinLewybodies.

--- Page 668 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 613
excitotoxicityandinflammation,anddefectsinaxonal neuronal cell death, later involving the others
transport. Oxidative damage is usually manifested (Fig. 10.29). Thus damage to mitochondria (e.g.
as increases in lipid peroxidation end-products (e.g. byneurotoxinsthattargetthem[Section10.20.3]orby
HNE, F -, or F -IsoPs), DNA (and often RNA) base abnormal proteins such as mutant CuZnSODs or hy-
2 4
oxidation(usuallymeasuredas8OHdGor8OHGua), perphosphorylated tau; Sections 10.21 and 10.22) can
andproteindamageintheaffectedbrainregions.The impairATPproduction.Itcanalsoleadtogeneration
proteinaggregatesfrequentlycontainproteinsthatare of more ROS, causing oxidative stress that increases
nitrated, bear carbonyl residues, have attached alde- oxidativedamagetoDNA,RNA,lipids,andproteins.
hydessuchasHNEoracroleinand,sometimes,carry Oxidized and nitrated proteins are usually re-
AGE(Section10.5.5). moved by the proteasome (Section 5.14.3.2). Defect-
It seems likely that all these processes are inter- ive proteasome function allows abnormal proteins to
related. Perhaps any one of them could initiate accumulate and produces oxidative stress; potential
GENE DUPLICATION/
TRIPLICATION OXIDATIVE
STRESS
Too much NEUROTOXIC g e
a
normal protein PROTEASOME a m
MU
G
TA
EN
TI
E
ONS
A
P
b
r
n
o
o
te
rm
in
a
s
l
o ve
rlo
a
d
o v e rlo
a
I
d
NHIBITORS
dir
ect d
oa d
A
P
b
r
n
o
o
te
r
i
m
ns
al
pero
L
x
ip
id
id
ation
overl
HNE, other aldehydes,
inhibition isoketals etc
Proteasomal
Increased proteasome activity Dysfunction m in o h d i i b fi i o t e i v d o e n p r l r b o o y a t d e so in m s e A P b r n o o te rm in a s l M ac i t c i r v o a g ti l o ia n l
Upregulation of
Oxidative stre·ss
protective systems Increased NO
e.g. Hsp production Protein damage,
ONOO– formation
fa MITOCHONDRIAL Lipid peroxidation
ilu fa TOXINS
re
to
ilu
re
p
ro
te
c t
to
p ro
te
Mit
D
o
a
c
m
ho
a
n
g
d
e
rial
c
t
Oxidative stress
NEURONAL
(during apoptosis or
CELL DEATH
necrosis)
Figure10.29 Interplayofmitochondria,oxidativedamage,andtheproteasomeinneurodegeneration.AdaptedfromAntioxid.RedoxSignal.8,
2007,2006,bycourtesyofMaryAnnLiebert,Inc.Proteasomeinhibitioncansometimescausetransientneuroprotection(e.g.byraisingthelevels
ofheat-shockproteins;Section5.6).

--- Page 669 ---

614 FREE RADICALS IN BIOLOGY AND MEDICINE
Table10.11 Processesgeneratingabnormalproteinsinneurodegenerativediseases
Overexpressionofanormalgene,causingtoomuchnormalproteintobeproduced(e.g.triplicationoftheα-synucleingeneinsomefamilial
casesofPD)
Genemutations,producinganabnormalprotein
AberrantsplicingofmRNA,producinganabnormalprotein
Faultypost-translationalmodification,producinganabnormalprotein
Oxidationofaminoacidresiduesbyreactiveoxygenspecies
Nitrationand/oroxidationofaminoacidresiduesbyreactivenitrogenspecies
Halogenationand/oroxidationofaminoacidresiduesbyreactivechlorineorbrominespecies
Glycation/glycoxidation
Spontaneousdeaminationordeamidation
Modificationofaminoacidresiduesbyend-productsoflipidperoxidationsuchasHNE,otheraldehydes,andisoketals
Modificationofaminoacidresiduesbyend-productsoftheeicosanoidpathway,e.g.cyclopentenoneprostaglandins,levuglandins
Modificationofaminoacidresiduesbyquinonesorsemiquinonesproducedbyoxidationofneurotransmittersortheirprecursors(L-DOPA,
dopamine,serotonin,noradrenalin)
FromAntioxid.RedoxSignal.8,2007,2006,bycourtesyofMaryAnnLiebert,Inc.
mechanismsaccountingforthisincludeERstress(Sec- apoptosisresults.Thiscellcycleactivationseemstobe
tion 5.6), greater mitochondrial ROS production,820 associatedwitharesponsetoelevatedlevelsofDNA
and increases in the activity of nNOS, producing821 damage.822
moreNO•.Abnormalproteinsresultingfromgenemu-
tations could overload the proteasome (Table 10.11);
10.19.1 Theroleofiron
its activity tends to decrease with age in the brain,
as does that of autophagy (Section 11.4.4), making Where does iron fit into the story? A view often
neurons more vulnerable in older people. Extracellu- expressed is that its deposition is a late stage in
larproteinaggregatesmaystimulateRSformation,e.g. tissue injury, with the implication that it is unim-
by activating microglia. Finally, RS-producing agents portant. However, the pathologies of subarachnoid
could initiate neurodegeneration, since RS can dam- haemorrhage (Section 10.18.3) and of caeruloplas-
agemitochondria,causeariseinCa2+,andmayinhibit
min deficiency in humans (Section 3.22.2.3) and of
proteasome function directly (e.g. by oxidative or ni- mice lacking IRP2 (Section 3.22.1.5) clearly show
trativeinactivationofproteasomesubunits),orindir- the potential of haem and/or iron ions to cause
ectly(e.g.byinterferingwithubiquitination,orover- neuronal damage. Indeed, mice lacking caeruloplas-
loading the proteasome by creating more oxidatively min developed a PD-like disorder.825 Further evi-
modified proteins). In particular, HNE and isoketals dence; inborn errors in the gene encoding ferritin
(Section5.14.3.4)caninactivateproteasomehydrolytic L-chains are associated with abundant iron depos-
activities, and proteins modified by these agents are ition in the human brain accompanied by neurode-
poorsubstratesfortheproteasomeand‘clogitup’. generation (neuroferritinopathies). These disorders,
How do neurons die in these various diseases? and caeruloplasmin deficiency, belong to a group
Sometimes death occurs by necrosis, as is common of neurodegenerative diseases called Neurodegener-
in excitotoxicity. This releases DAMPs that promote ation with Brain Iron Accumulation (NBIA).700,749
inflammation.Sometimes,byapoptosis.Asmorestud- Anothermemberofthisgroupisajuvenile-onsetauto-
iesaredone,however,theroleof‘intermediate’types somalrecessiveseveremovementdisorder,previously
of cell death, with features of both, is becoming known as Hallevorden–Spatz syndrome, but now
moreprominent.Somestudiessuggestthatinmature calledpantothenatekinase-associatedneurodegener-
neurons one action of oxidative stress (at a certain ation(PKAN),orNBIA1,associatedwithirondepos-
level) is to increase the expression of genes encoding itionintheglobuspallidus.Thedefectivegeneencodes
cellcycleproteins,asiftheneuronwereabouttoenter pantothenatekinase,anenzymeinvolvedinthebio-
the cell cycle. Neurons cannot divide, however, and synthesisofcoenzymeA.Thefaultyenzymeleadsto

--- Page 670 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 615
cysteine accumulation, and it has been hypothesized disorderandthesecondmostcommonneurodegener-
thatapro-oxidantmixtureofironandcysteinemight ativedisease,afterAlzheimerdisease(AD).
contributetoneurodegeneration. PDinvolvesdeathofneuronsinthesubstantianigra
Theironcontentofmostbrainareasincreaseswith (SN) pars compacta (Fig. 10.25) in the upper part of
age, and iron, copper, and other metals promote the the brainstem; the word ‘nigra’ reflects the fact that
aggregationofseveralproteinsincludingα-synucleins theseneuronsarerichingranulescontainingtheblack
(Section 10.20) and β-amyloid (Section 10.21). Iron pigment neuromelanin.828 Cells also die in another
chelation could protect against the neurotoxicity of a part of the brain in PD, the locus coeruleus, leading
proteasomeinhibitor(Section10.20). to lowered noradrenalin levels. Neuromelanin arises
from dopamine oxidation to quinones and semiquin-
ones, followed by cross-linking. Like other melanins,
10.19.2 Areaggregatestoxic?
neuromelanin can be redox-active and binds metal
There has been intense debate about whether inclu- ions.Itcontainsresiduesderivedfromcysteinyldopa-
sion bodies or other protein aggregates (Table 10.10) mine and appears to be a ‘mixed-type melanin’, con-
are toxic to neurons. In general, it seems to be the taining some cysteine sulphurs (unlike eumelanins),
earlystagesofaggregateformation(e.g.ofhuntingtin, but not as much as in pheomelanins (Section 3.25.9).
α-synuclein, or β-amyloid) that are toxic rather than About20%ofneuromelaningranulecontentisisopren-
the final insoluble complexes. In fact, formation of oidlipids,especiallydolichols.828
the latter may be beneficial if it helps convert toxic PDisassociatedwiththeappearanceofLewybod-
oligomers to an insoluble form.816,826 Some cells han- iesintheresidualneuronsintheSNandseveralother
dleaggregatedproteinsbyusingmicrotubulestomove brain regions. Lewy bodies are electron-dense inclu-
them all to a single site in the cell, the aggresome, sionbodies,withanespeciallydensecorefromwhich
wheretheycansometimesbedealtwithbyuptakeinto filamentsradiate.Theyarefoundinabout10%of‘nor-
lysosomes (autophagy) and intra-lysosomal degrad- mal’personsabovetheageof60,inanotherdisorder,
ation (not always successful!). The autophagic mech- dementiawithLewybodies,andinabout15%ofAD
anismscanbeoverloadedandmayfailintheneuro- patients. Hence they are not specific to PD. A major
degenerative diseases,827 they also decline with age constituent of Lewy bodies is α-synuclein, a protein
(Section 11.4.4), as does proteasome function. Chap- that may have several functions and is widespread
erones help to delay the accumulation of protein ag- in the brain and especially enriched in presynaptic
gregatesby preventingmisfoldingand by promoting nerve terminals. Other proteins present include ubi-
autophagy,buteventuallytheyareoverwhelmed(Fig. quitin and neurofilaments. Synuclein in Lewy bodies
5.11). ROS may also help to promote autophagy, but isfrequentlyoxidized(e.g.onmethionine),phosphor-
their exactrole is unclear (Section 5.14.3.1). Trehalose ylated, ubiquitinated, nitrated, and contains HNE. α-
hashadbeneficialeffectsinvariousanimalmodelsof Synuclein has four tyrosine (and four methionine)
neurodegenerativedisease by decreasing aggregation residues and is rapidly nitrated upon exposure to
(Section10.23.2). ONOO–.
The symptoms of PD do not appear until enough
10.20 Parkinsondisease667,816–819 cells have died in the substantia nigra to impair
its function. Rather than the fully aggregated α-
Parkinsondisease(PD)wasfirstdescribedin1817as synuclein,itmaybetheoligomersgeneratedearlyin
the‘shakingpalsy’bytheEnglishphysicianJamesPar- theaggregationprocessthatarethemostcytotoxicto
kinson, but his essay on the topic was ignored for neurons:suggestedmechanismsincludeformingpores
almosthalfacenturyanditwasnotuntilthe1900sthat in neuronal plasma membranes, causing ER stress,
thediseasewasnamedafterhim.Itusuallyappearsin damaging mitochondria, and ‘seeding’ the aggrega-
middletooldage(rarelybefore50),oftenasarhythmic tion of more α-synuclein in a ‘prion like’ (Section
tremorin afootorhand,especiallywhenthelimbis 10.21.9)mechanism.829,830 Indeed,injectionoffibrillar
atrest.Asthediseasedevelops,patientshaveincreas- α-synuclein into the striatum of animals was suffi-
ing problems in controlling movement. Movement is cient to cause Lewy body pathology,830 and foetal
slow(bradykinesia),tremorbecomesmoreprominent, neuronstransplantedintoPDpatientscanshowLewy
initiationofmovementisdifficult(akinesia)andthere bodyformation,consistentwith‘hosttograftdisease
ismusclerigidity.PDisthemostcommonmovement propagation’.831

--- Page 671 ---

616 FREE RADICALS IN BIOLOGY AND MEDICINE
10.20.1 Geneticsorenvironment? Further attention was drawn to the ubiquitin–
proteasome system by the discovery of rare PD-
The great majority of PD cases aresporadic, i.e. they
causing mutations in the gene encoding ubiquitin
appear without obvious genetic cause. However,
carboxy-terminal hydrolase L1, UCHL1 (Fig. 10.30).
identification of rare inherited variants (at least eight
These mutations interfere with normal protein turn-
typestodate)hasgivenconsiderableinsightintodis-
over. Indeed, it was soon discovered that both
easepathology,revealingtheimportanceofdefective
UCHL1834andproteasome829,835activitiesintheSNare
protein clearance mechanisms and of mitochondria.
low, even in sporadic PD. Knockout of proteasomal
Severalgroupsofpatientswithautosomallyinherited
functioninmicecausesneurodegenerationaccompan-
dominant PD have mis-sense mutations in the gene
encoding α-synuclein, an observation that led to the
iedbyLewybodyformation.836Synucleinisnormally
turned over by the proteasome and by autophagy,827
discoveryofthisproteinintheLewybody.Thesemu-
tant α-synucleins have a much greater tendency to butnitratedandoxidizedsynucleinsarecatabolizedat
lowerrates.837
polymerize and aggregate than wild-type synuclein,
andaremorecytotoxic.
Someoftherarejuvenile(appearingbeforeage20) 10.20.2 Treatment
orearlyonset(beforeage40–50)PDcasesarecausedby
recessivemutationsinparkin,anenzymeinvolvedin AsFig10.25cshows,thesubstantianigrasendsnerve
ubiquitination,andfoundinLewybodies.Parkinisan fibrestothestriatum(meaning‘striped’);theterminals
E3ligase(Fig.10.30)witharangeofsubstrates,andit of these fibres secrete dopamine as a neurotransmit-
assistsintheremovalofdamagedmitochondria,inco- ter. Striatal neurons relay the message to the cortex,
operationwithPINK1(Section10.20.5).832,833Parkinis helping to control movement. The progressive death
richincysteineresidesandcanbeinactivatedinvitro of nigral cells mean that less dopamine is available.
byoxidationornitrosylation:thesignificanceofthisin HencePD patientsbenefitfromtherapytoreplaceit.
vivoisuncertain. Dopamine cannot cross the blood–brain barrier, but
Ubiquitin-activating enzyme (E1)
ATP
Monomeric Activated
ubiquitin ubiquitin
Ubiquitin carboxy-
terminal hydrolase
Ubiquitin-conjugating
(UCHL1 missense
enzyme (E2)
mutation causes
familial PD)
Polyubiquitin
chain Activated Abnormal/
damaged/mutant
ubiquitin/E2
proteins
Short
(α-synuclein
peptide
missense
fragments ATP mutations cause
26S proteasome familial PD)
Polyubiquitin-protein
(inhibited in sporadic PD) Ubiquitin ligase (E3)
conjugate
(parkin deletions and point
mutations cause juvenile PD)
Figure10.30(colourplate24) Defectsintheubiquitin-proteasomesysteminParkinsondisease.Thebluesectionshowsthenormal
ATP-dependentlabellingofunwantedproteinswithubiquitinmolecules(ubiquitination)asasignalforATP-dependentdegradationbythe26S
proteasomecomplex(proteolysis;redsection).Thegreensectionshowsrecoveryandrecyclingofubiquitinmoleculesthatarereleasedfrom
proteins.AlsodepictedarewaysinwhichpotentialdefectsinthesystemcausePD.TheUCHL1enzyme,oneofthemostabundantproteinsinbrain
(upto2%oftotalbrainprotein)releasesfreeubiquitinandallowsthecycletocontinue.Avarietyofdeletionandpointmutationsintheparkin
genecanleadtoPD.FromNatureRev.Neurosci.2,589,2001,bycourtesyofProfessorPeterJennerandNaturepublishers.

--- Page 672 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 617
L-DOPAcanandisdecarboxylatedtodopamineinthe contaminatedwithMPTPasaby-productofthesyn-
brain.Itisadministeredtogetherwithaninhibitorof thesis. Ironically, MPTP had been synthesized, tested
DOPA decarboxylase that does not cross the blood– (and fortunately discarded!) as an anti-PD drug by a
brainbarrier(e.g.benserazide,carbidopa)sothatitis majorpharmaceuticalcompanyinthelate1950s.
only decarboxylated in the CNS. The combination of MPTP can cross the human blood–brain barrier.
L-DOPAandcarbidopaiscalledSinemet®;Madopar® It enters astrocytes and is oxidized by MAO-B. Oxi-
isL-DOPAplusbenserazide. dationofMPTPinastrocytesproducesMPDP+,which
Treatment with L-DOPA can produce distressing thenformsMPP+(Fig.10.32).Thisisrecognizedbythe
side-effects and its efficacy diminishes with time. dopaminetransporterDAT,andsoMPP+ releasedby
Dopaminecanoxidizeinvivo(Table10.12)697 andme- glia is taken up by SN neurons, a process that may
tabolism of excess dopamine by MAO might prod- beacceleratedbyMPP+bindingtoneuromelaninafter
uce damaging levels of H O and contribute to fur- uptake.NeuronsintheSNarekilled,producingdopa-
2 2
ther neuronal death. Other treatments for PD exist. mine depletion, a rapid onset of parkinsonian symp-
One is to block dopamine metabolism, e.g. by in- toms, and formation of inclusion bodies containing
hibiting its methylation using inhibitors of catechol- α-synuclein.
O-methyltransferase (COMT) such as entacapone or How are neurons killed? α-Synuclein plays a role;
tolcapone, or by inhibiting MAO. Thus selegiline micelackingitdevelopnormally,butarelesssensitive
(deprenyl) is an inhibitor of MAO-B, which should toMPTP.829 Primarily,however,MPP+ accumulatesin
both preserve dopamine and decrease H O produc- mitochondriaandisapowerfulinhibitorofmitochon-
2 2
tion. L-Deprenyl (Fig. 10.31) is rapidly metabolized drialcomplexI(NADHdehydrogenase);neuronalcell
to (-)methamphetamine. Prolonged administration of deathmayresultfrominterferencewithATPproduc-
deprenyl to animals has been reported to increase tion.SecondaryconsequencesincludeariseinO
•–pro-
2
levels of CuZnSOD in the SN and, to a lesser extent, duction from the (inhibited) electron transport chain,
in other brain areas. Hence it could be neuroprotect- andelevationofCa2+ leadingtoincreasedproduction
ivebymechanismsadditionaltoMAO-Binhibition.838 ofNO•andthenofONOO–;MPTP-treatedmiceshow
Consistentwiththis, L-deprenylhasbeenreportedto elevated brain nitrotyrosine levels.848 Microglial acti-
protectneuronsagainstdamagebyseveraltoxinsand vationmayalsocontributetoproductionofNO• and
to raise neuronal GSH levels. Some COMT inhibitors other ROS,849 and a role for myeloperoxidase (MPO)
haveantioxidantpropertiesinvitro,ascanbepredicted innitrationhasbeensuggested.Indeed,nNOSinhibi-
from their phenolic structures (Fig. 10.31). Whether tors,orknockoutofMPOorofnNOS,decreaseMPTP
thesepropertiesareimportantinvivoisuncertain. neurotoxicityinanimals.MiceoverexpressingMnSOD
Yet another therapeutic approach is to use agents orCuZnSODarealsolesssensitivetoMPTP.Ironac-
that directly stimulate dopamine receptors, such as cumulation,andelevationsinCOX-2,alsoseemtobe
bromocriptine, pramipexole, ropinirole, and per- involvedinMPP+-inducedcelldeath.844
golide.Someofthesehaveagainbeensuggestedtoact, ThereissomestructuralresemblancebetweenMPTP
inpart,byraisingneuronalantioxidantdefences.839,840 (Fig.10.32),paraquat(Section9.4),andseveralotherin-
Variousagentswithmetalironchelatingabilityarealso dustrialchemicals.ThisraisedthepossibilitythatPDis
underevaluationtotreatPD(Section11.6). causedbytoxin(s)fromtheenvironment,andseveral
(inconclusive)epidemiologicalstudieshaveattempted
tolinkPDincidencetopesticide,herbicide,orinsect-
10.20.3 EnvironmentaltoxinsandPD845,846
icideexposure,drinkingwellwater,orlivinginrural
One important clue about possible causes of spor- areas.846 Toxinsfoundincycadplantsweresuggested
adic PD came from studies of drug abusers. In 1982, to cause a neurodegenerative disease with features
cliniciansathospitalsinCaliforniaweresurprisedby of both ALS (Section 10.22) and PD with dementia
a sudden influx of young patients with severe par- (ALS-parkinsonism-dementia complex) that used to
kinsonian symptoms. They were found to have used be common among the native Chamorro Indians on
‘synthetic heroin’ from a drug pusher, but unfortu- thePacificislandsGuamandRota.602,850Asimilarsyn-
nately it was contaminated with 1-methyl-4-phenyl- dromehasbeendescribedintheKiipeninsulaofJapan;
1,2,3,6-tetrahydropyridine (MPTP).847 A report pub- sufferers show elevated urinary 8OHdG excretion.851
lished in 1979 was then unearthed describing a However,cycadsarenotconsumedthere.Inaddition,
23-year-oldgraduatestudentwhodevelopedPDafter some(butnotall)animalstudiessuggestthatchronic
tryingtosynthesizethedrugDemerol,whichbecame exposure of animals to paraquat by i.p. injection can

--- Page 673 ---

618 FREE RADICALS IN BIOLOGY AND MEDICINE
Table10.12 EvidenceconsistentwithoxidativestressinParkinsondisease.
Observation Comments
Directevidence(measurementofincreasedoxidativedamageorotherbiomarkersofRSproduction)
Increasedlipidperoxidation MeasuredinSNasacrolein-orHNE-proteinadductsinLewybodies,andincreasedperoxides
(byHPLC/chemiluminescenceassays),alsorisesinisofurans(seeparagraphbelow).
NochangesinSNα-tocopherollevelsreportedoranybeneficialeffectofadministering
α-tocopherolinPD.Somedolicholinneuromelaninisoxidized,possiblybyreactionwith
peroxylradicals.828CSFlevelsofHNEareelevated,asareplasmalevelsofF2-andF4-IsoPs
and7β-hydroxycholesterol.841
IncreasedoxidativeDNAdamage Risesin8OHGreportedinmitochondrialand‘totalDNA’inSN;littleornoriseinotherDNA
baseoxidationordeaminationproducts,suggestingthattheriseisnotduetoattackofOH•or
ONOOHonDNA.DecreasedlevelsofFaPyGyetunchangedtotaloxidativedamagetoguanine
inDNAfromPDSNaresuggestiveofachangetoamoreoxidizingenvironment
(Section6.14.2),consistentwithariseinisofuransbutnotF2-IsoPs(Section6.15.6)inSN.
CouldtherebealocalriseinO2duetoreducedconsumptionofitasaresultofdefective
mitochondrialfunction?IncreasedoxidativedamagetoRNAalsoreported,andanincreasein
8OHdGTPaseinthemitochondriaofSNneuronsand8OHdGinCSFandurineofPDpatients.
MoremtDNAdeletionsdetectedinPDSNthaninage-matchedcontrols;controllevelsare
somewhatlessbutstillhigh(Neurobiol.Aging34,2231,2013).
Increasedproteindamage RiseinproteincarbonylsobservedinSNbutalsoinseveralotherbrainregionsofpatients,
includingthoseunaffectedinPD.SOD1isreportedtobeoxidizedinPDbrain(carbonyls,–SH
groupoxidation),butnotpresentinLewybodies(J.Biol.Chem.280,11648,2005).Damage
tocomplexIproteinsmaybeoxidative.842InactivatedUCHL1showselevatedlevelsof
carbonylsandmethioninesulphoxide.834DJ-1ismoreoxidizedinPDSN.
Increasedreactivenitrogenspecies LewybodiesinSNstainwithantibodiesagainstnitrotyrosine.ThiscouldbeduetoONOO–
fromNO•(iNOS)and/ortoMPO,sinceMPOispresentinhumanPDbrain403andinthebrains
ofmicetreatedwithMPTP.Indeed,knockoutofMPOdecreasesMPTPtoxicitytomice.
NitrosylationofperoxiredoxinshasbeensuggestedtodecreasetheiractivityinPD(Proc.Natl.
Acad.Sci.USA104,18742,2007).
Increasedlevelsofdopamineoxidationproducts Levelsofcysteinyl–DOPAand–dopamineincreasedinSN
Indirectevidence(evidencesuggestingeffectsof,orresponseto,oxidativestress)
FallinGSH,nomarkedriseinGSSG GSHdecreasesabout40%inSN,notinotherbrainregions.
IncreasedlevelsofNADPHoxidase(NOX-1)in SuggestiveofmoreROSproduction.843GlialNOX2levelsalsoincrease.689
SNneurons
Increasedironcontent700 SNzonacompacta(butnototherbrainregions)hashigherironlevelsinPD,apparentlywith
unalteredferritin.LevelsofironinSNincreasewithageeveninhealthypeople.Uncertain
whetherthisextraironis‘catalytic’forfreeradicalreactionsbutlevelsoftheFe2+transporter
DMT1areincreasedintheSN844andthereisalossofcaeruloplasminferroxidaseactivity
there,825possiblyduetooxidativedamage(J.Neurosci.31,18568,2011).NoincreaseinCu
orMndetectedbutZnmayincrease.SourceofexcessFeunknownbutincreasedexpressionof
receptorsforlactoferrinhasbeenreportedonneuronsandmicrovesselsinSN.Lactoferrinmay
alsobemadebyactivatedmicroglia.
Changesinantioxidantenzymes IncreasedlevelsofphosphorylatedPrx2.Phosphorylationmayleadtoinactivation
(Section3.20.3;Neuron55,37,2007).SmalldecreasesincatalaseandGPxreportedinSN
andotherbrainregionsbysome(notall)researchers.LevelsofmRNAforGPx1reportedas
subnormal.γ-Glutamyltranspeptidase(involvedindegradationandrecyclingofGSH)and
glutathionereductaselevelsmaybeelevated.NochangeinGSTorγ-glutamylcysteine
synthetase(therate-limitingenzymeinGSHsynthesis).Doremember,however,thedangersof
comparingdiseasedandhealthySNsinceneuronalandglialglutathionemetabolismare
different(Section10.17.6.3),andtherearefewerneuronsandmoregliaintheSNofPD
patients.

--- Page 674 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 619
Table10.12 (Continued)
Observation Comments
Otherevidenceconsistentwiththeconcept
Defectsinmitochondrialfunction DecreasedcomplexIactivityinSN,alsoinsomeperipheraltissues(e.g.inplateletsand
skeletalmuscle).CoenzymeQ10levelsreportedasdecreasedinplateletmitochondriainPD.
Increasedglycoxidation Impliesbothglycationandoxidation.
Elevatedserumuratelevelsasanegativerisk Hypothesizedtobeduetourateactingasanantioxidant(Curr.Neurol.Neurosci.Rep.12,
factorforPDinmales 367,2012).
Morehaemoxygenase-1 Occursinneurons(associatedwithLewybodies)andastrocytes.Increasecouldbetriggeredby
severalstressmechanisms.
ActivationofNF-κB Couldbeexplainedbyoxidativestress.
MoreCOX-2 FoundinParkinsonianSNandMPTP-treatedmice.COX-2suggestedtoparticipatein
dopamineoxidation.
SN,substantianigra;PD,Parkinsondisease.
Informationfromref667exceptwherespecificreferencesarequotedinthetableortext.
O O
CH 3 HO C HO CH C CH CH
C N 2 3
CH 2 C N CH 2 C CH CN CH 2 CH 3
H 3 C H HO CH 3 HO
NO NO
2 2
deprenyl tolcapone entacapone
Figure10.31 Thestructuresofdeprenyl(selegiline),tolcapone,andentacapone.Deprenylhasnodirectantioxidantabilitywhereastolcapone
andentacaponearecatecholsandthuscapableofscavengingROSandbindingmetalions.However,theirsemiquinone/quinoneoxidationproducts
couldconceivablybetoxic(Chem.Res.Tox.16,123,2003).
cause selective degeneration of the SN accompanied
by oxidative damage involving increases in neuronal
NOX1activityandproteinnitration,852althoughpara-
MAO-B 2e– quatisapoorcomplexIinhibitor.Paraquat’seffectsin
2e– oxidation oxidation causingneurodegenerationandoxidativedamagemay
beaggravatedifitiscoadministeredwithothertoxins,
N N+ N+
suchasthefungicidemaneb.853
However, PD is found throughout the world, sug-
CH 3 CH 3 CH 3 gestingthatifasingletoxinisresponsible,itmustbe
present universally. It seems more likely that several
MPTP MPDP+ MPP+
toxins can damage SN and predispose to PD in later
life.Oneistrichloroethylene.854 Anotherishexane,an
Figure10.32 MPTPmetabolism.MPTPisoxidizedtoMPDP+
(1-methyl-4-phenyl-2,3-dihydropyridineion)whichformsMPP+,the organicsolventusedinadhesives,varnishes,andfuels.
1-methyl-4-phenylpyridiniumion.Inhibitorsofmonoamineoxidase, Hexaneismetabolizedtoproducehexanol,hexanone,
suchaspargylineordeprenyl,diminishdamagebyMPTP.HowMPDP+ hexanediols, and 2, 5-hexanedione, a neurotoxin.854
isconvertedintoMPP+isnotcompletelyclear.Mitochondrial Yetanotherisatoxinfoundintheyellowstarthistle,
ubiquinonemightoxidizeit,simultaneouslyformingubiquinol(FEBS consumptionofwhichcancauseaPD-likesyndrome
Lett.461,196,1999). inhorses.855 Othersincludedeguelinandannonacin,

--- Page 675 ---

620 FREE RADICALS IN BIOLOGY AND MEDICINE
complex I inhibitors found in certain plants.845,850 In- 10.20.4 Theviciouscycle:proteasomal
deed, complex I inhibitors (including rotenone) may dysfunction,oxidativestress,andmitochondrial
be(worryinglyperhaps!)commoninnature.850Expos- defectsinPD667,816–819,835,845,846,862
ureofanimalstolowdosesofrotenoneoveraperiod
In addition to lowered proteasome activity, compari-
leadstonigrostriatalneurodegeneration.UnlikeMPTP,
sonofSNtissuefrompatientswhodiedwithPDwith
rotenonehasnoparticularselectivityforcelltypesand
tissuefromnormalcontrolsrevealsincreasedoxidative
seemstoeasilycrosstheblood–brainbarrierandenter
damage,moreiron,depletedGSH,defectivemitochon-
allpartsofthebrain;itsactionsimplythatSNneurons
areparticularlysusceptibletocomplexIinhibition.846 drialfunction,andmicroglialactivation(Table10.12).
Decreases in complex I activity have been found in
However, rotenone may not be specific as a complex
the SN (probably in both neurons and glia) but not
I inhibitor; evidence that it can activate NADPH oxi-
daseshasbeenpresented.856 TheChamorroswereex- in other brain regions. Since the decreases are spe-
cifictocomplexI(activitiesoftheothermitochondrial
posedtorotenonebecausetheyusedextractsofplants
electron-transportcomplexesseemunaltered),theyare
containingittoparalysefishtocatchthemmoreeasily
unlikely to be related to cell death, gliosis, or loss of
forfood,aprocedurenow(fortunately!)illegalonthe
mitochondria, and may involve oxidative damage to
islands.Substantianigraneuronsmaybeparticularly
sensitivetooxidativestresssincetheyuseL-typeCa2+
complexI.842
Defective mitochondria may generate more ROS
channelsintheplasmamembrane;theyseemproneto
developinghighintracellularCa2+levelsthatmaylead than usual, and ROS can further inhibit complex I.
tomitochondrialandotherdysfunction.857 DecreasesinATPlevelscouldinterferewithubiquitin-
ation and proteasome function863 (Fig. 10.30), further
Injection of the proteasome inhibitor lactacystin
impairing this system. Hence PD is an excellent ex-
into mouse or rat brain (in some laboratories but
ample of the ‘vicious cycle’ shown in Fig. 10.29. One
not confirmed in others) has produced SN degener-
ation,movementdisorders,andproteinaggregates.835 illustrationofthepotentialofmitochondrialdysfunc-
tiontocausePDisprovidedbytheMitoParkmouse.
Desferrioxamine gave some protection, suggesting
an involvement of iron.858 Proteasome inhibitors oc- It is generated by deleting the gene encoding mito-
chondrialtranscriptionfactorA,whichisessentialfor
cur naturally and, if some could enter the brain
maintaining mtDNA levels and mitochondrial func-
after consumption in the diet, PD could conceiv-
tion in dopaminergic neurons. Initially, the mice are
ably result. Investigators have also tried to iden-
normal,buttheygraduallydevelopaprogressiveloss
tify endogenous neurotoxins in the brain. One such
ofdopaminergicneuronsandaPD-likephenotype,re-
groupisthetetrahydroisoquinolines(e.g.N-methyl-
(R)Salsolinol)678 formedfromL-DOPA,anotheristhe sponsivetoL-DOPA.803,862 Asforhumans,some(but
tetrahydro-β-carbolines.859 Both can produce parkin- not all) clinical studies suggest that high-dose coen-
zyme Q has modest clinical benefit in PD patients,
sonian symptoms in animals after long-term treat-
perhaps by protecting mitochondria,862,864–866 but un-
ment and both are found at low levels in certain
fortunately the mitochondrially targeted version (Mi-
foods (e.g. cheese, chocolate powder, and wine) and
toQ;Section11.5.12)hasnodiscernibleclinicalbenefit,
their formation in the brain is encouraged by alco-
as far as it has been studied.866 The actions of α-
holconsumption(Section9.8.1.4).Theirimportanceis
synucleinonmitochondriamayincludepromotingthe
unclear.
release of endonuclease G, a mitochondrial nuclease
Ironically, despite its many deleterious effects, to-
that can trigger apoptosis when it enters the cytosol
bacco usage lessens the risk of developing PD (even
andtravelstothenucleus.867
when corrections are made for earlier death in
smokers).859,860 Possible explanations include raising Anothercontributortoneuronalcelldeathcouldbe
production of O •–, NO•, and cytokines by activated
brain GSH levels, an effect of nicotine in stimulating 2
glialcellsintheSN,althoughitsoverallimportanceis
dopamine release by dopamine neurons, and chem-
unclear.868Activationofmicrogliamightsometimesbe
icals in tobacco that inhibit MAO, but none is sup-
ported by strong evidence as yet.859,860 Another hy- provokedbyDAMPs,neuromelaninreleasedbydying
neurons,828orbynitratedα-synuclein.837
pothesisisthatsmokingraisesbrainCYP26levels;this
enzyme can metabolize several neurotoxins, includ-
Dopamineand L-DOPAreadilyoxidizeinvitro(es-
ing MPTP, isoquinoline, and β-carbolines.859 Coffee pecially in cell culture media!)869 to generate semi-
quinones, quinones, O
•–,
and H O , a process cata-
and tea drinking may also be protective against PD 2 2 2
development,861andaremuchsaferthansmoking! lyzed by transition metal ions.697 Does this happen

--- Page 676 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 621
in vivo? Probably; levels of products formed by con- of synuclein-containing inclusions result.829 Overex-
jugation of these quinones and semiquinones with pression of the wild-type gene has a similar effect;
GSH followed by cleavage of the glutathione side- indeed triplication of the gene encoding α-synuclein
chain, are elevated in SN in PD (Table 10.12). Dopa- (resulting from a chromosome abnormality) is a rare
mineoxidationbyMAOproducesnotonlyH O but causeoffamilialPD(Table10.11).Hencetoomuchnor-
2 2
also dihydroxyphenylacetaldehyde, which is poten- malα-synuclein,andanyofthemutantα-synucleins,is
tiallyneurotoxicifnotrapidlymetabolized;vulnerable bad(Fig.10.28).Cellstransfectedwithgenesencoding
neuronsintheSNmaybelessabletometabolizethis mutantα-synucleinsaremoresensitivetoapoptosisin-
compound.870 Dopamine has also been suggested to ducedbyarangeoftoxins,includingH O ,ironions,
2 2
delay aggregation of α-synuclein, potentially raising andHNE,andshowincreasedlevelsofoxidativedam-
the levels of toxic oligomeric forms.816 The effects of age and protein aggregate formation.872,873 Cell data
6-hydroxydopamine(Section9.5.7)illustratethepoten- ontheeffectsofoverexpressionofnormalα-synuclein
tialofsuchoxidationtocauseneuronaldeath.Damage are conflicting: in some studies it protected the cells
by6-hydroxydopamineispotentiatedbyironinjection against toxins, but in others it did not. There is vari-
or depletion of GSH (e.g. by intracerebral adminis- ation between different cell lines, and probably also
trationofbuthioninesulphoximine)anddecreasedto withthedegreeofoverexpressionachieved:highlevel
someextentbypretreatinganimalswithα-tocopherol overexpressionofanyproteinmightdisturbneuronal
or desferrioxamine. 6-Hydroxydopamine-induced le- metabolism (Fig. 10.28). Trehalose can help to pro-
sions in the rat striatum show increased iron levels, tect against α-synuclein toxicity in animals and cells
and6-hydroxydopaminehasalsobeenreportedtoin- (Section10.23.2).
hibit mitochondrial complex I. Indeed, in PD, where One approach that might distinguish cause from
most of the dopaminergic neurons have been lost, consequenceinhumanPDisbasedontheobservation
a rise in dopamine turnover in the remaining cells that abnormal numbers of Lewy bodies, and limited
wouldbeexpectedinthefaceofdecreasedGSHlevels neurodegeneration,aresometimesobservedintheSN
(Table10.12). ofsubjectswhodiedwithnoobservablePDsymptoms.
Someneurologistsproposethattheseindividualswere
10.20.4.1 Earlyorlate? inthepresymptomaticstagesofPD(andthuswould
A key question is whether the changes in mitochon- nothavebeentreatedwith L-DOPA).Itisimpossible
dria, oxidative damage, and the proteasome in PD tobesurebecausethisso-calledincidentalLewybody
occurearlyinneurodegenerationandcontributetoit, disease(ILBD)isonlydiagnosedpostmortem,soone
are a consequence of neurodegeneration, or an effect cannot follow up the subjects to see if PD develops
oftreatment(patientswhodiewithPDwilloftenhave later. However, if one accepts this interpretation, one
takenL-DOPAand/orotherdrugsforyears).Another can ask which potentially damaging events are still
point to consider when pondering the data in Table detected.835LoweredGSHlevelsareseenintheSNof
10.12 is that one is comparing a healthy SN with SN these subjects, but iron accumulation is not, and de-
in which >80% of the neurons have died and been creases in complex I activity are less apparent. This
replacedbyothercelltypes,suchasmicroglia. perhapssuggeststhatthefallinGSHisanearlyevent.
One way of attempting to distinguish cause from Buthowandwhy?
consequenceistoperformanimalexperiments.Forex-
ample, mice lacking a neuronal cysteine transporter
10.20.5 Summingitup;insightsfromPINK1
haddecreasedbrainGSHlevelsanddevelopedbehav-
andDJ-1
iouralabnormalitiesandbrainatrophy,butonlywhen
11monthsofageorolder.Theatrophywasaccompan- Another clue pointing to a key role for mitochondria
iedbyincreasedlevelsofHNEand3-nitrotyrosine.871 inPDisprovidedbytheobservationthatearly-onset
Falls in GSH can interfere with the ubiquitin system PD can be caused by mutations in the nuclear gene
and, if they occur in mitochondria, might potentiate encodingtheproteinPINK1(PTEN-inducedputative
mitochondrial damage, including loss of complex I kinase 1), a serine/threonine kinase that can help to
activity.842 protect neurons against apoptosis. PINK1 phosphor-
Transgenicstudieshavealsogivenvaluableinsights. ylates parkin, which then translocates to apparently
Ifthemutantsynucleinsassociatedwithsomecasesof abnormal mitochondria (perhaps detecting a low
familialPDareoverexpressedinthenigrostriatalareas membranepotential)andubiquitinatesselectedmito-
ofratsormonkeys,neurodegenerationandformation chondrial proteins. This modulates fission/fusion

--- Page 677 ---

622 FREE RADICALS IN BIOLOGY AND MEDICINE
(Section 1.3.3) and promotes export of oxidized mol- incidenceofADintheUSAmaybe30%orhigherin
eculesfrom,aswellasmitophagyof,thedysfunctional thoseaged90ormore.
mitochondria.819,832,833 In other words, PINK1 and In AD, several brain regions involved in learning
parkin work together in mitochondrial ‘quality and memory, such as the basal forebrain and hippo-
control’. campus, suffer synaptic damage and eventual major
These studies, as well as those with MPTP and neuronalloss.Full-blownADisoftenprecededbyam-
rotenonediscussedearlier,suggestthatPDcanbegin nestic mild cognitive impairment (MCI), in which
with mitochondrial dysfunction, whereas the studies memory function for age is abnormally poor, but the
using 6-hydroxydopamine show that oxidative stress subjectappearsnormalotherwise.Otherformsofde-
might initiate PD. The effects of mutations in the mentiaincludedementiawithLewybodies,andvas-
ubiquitin–proteasomesystem,togetherwiththefind- cular dementia, caused by impaired blood supply to
ingthatUCHL1activitiesaredecreasedeveninspor- the brain due to atherosclerosis. As we shall see, the
adicPD,revealthatfailuretoturnoverproteinsprop- distinctionbetweendifferenttypesofdementiaisnot
erly can initiate PD. Hence all the events shown in clear-cut.Forexample,vascularproblemscontributeto
Fig.10.28areimportantandinter-related.Forexample, AD (Section 10.21.3). Whereas smoking decreases the
the fall in UCHL1 activity in sporadic PD involves riskofPD,itseemstoraisethatofAD.878
oxidative damage, since the protein shows elevated Two pathological features of AD, first reported by
levelsofcarbonylsandmethioninesulphoxide.834Mice theGermanpsychiatristAloisAlzheimerin1906,are
lacking UCHL1 (the GAD, gracile axonal dystrophy the presence of neurofibrillary tangles and senile
mouse) show widespread neurodegeneration, forma- plaques in the brain (Fig. 10.33). Tangles are fibrous
tion of protein aggregates, and increased oxidative masses inside affected neurons. They consist of pairs
damage,874 further evidence that these events are of filaments, each about 10 nm in diameter, twisted
inter-related. around each other (paired helical filaments). They
Another clue comes from the DJ-1 protein. Several contain several proteins, the major one being tau (τ),
mutationsinthegeneencodingitcauseautosomalre- phosphorylatedtoanabnormallyhighextentandwith
cessivePD.DJ-1seemstoplayseveralroles,including attachedubiquitin.Tauisessentialforproperassembly
activatingtheNrf2system,acceleratingGSHsynthesis, ofmicrotubulestoenabletransportofcargo,including
and acting directly as an antioxidant (it has an eas- mitochondria and neurotransmitter vesicles, in both
ily oxidizable –SH residue that can form a sulphonic anterograde and retrograde directions in axons and
acid). DJ-1 is oxidized and translocates to mitochon- to maintain neuronal shape. Hyperphosphorylation
driaunderconditionsofoxidativestress.832Abnormal of tau disrupts these processes, so that microtubules
DJ-1proteinsmayaggregateandoverwhelmthepro- disassemble(therebystarvingsynapticregions).879Tau
teasome (Fig 10.28), and levels of oxidized DJ-1 are may also be required for normal neuronal iron me-
increased in PD SN.845 DJ-1 is an oncogene, and ele- tabolism, and the drop in levels of soluble tau may
vated expression is detected in several cancers, e.g. contribute to iron accumulation in the affected brain
breast, lung, and prostate. It may promote carcino- regionsinbothPDandAD.880
genesisbydecreasingp53levelsand/orbyincreasing Untilrecently,however,researchershavepaidmore
Nrf2activity.875 attentiontoplaquesthantotau.Senileplaques(some-
times called neuritic plaques) are extracellular local-
ized areas of degenerating and frequently swollen
10.21 Alzheimerdisease667,700,816,876,877 axons,neurites,andgliasurroundingacoreofaggre-
gated β-amyloid peptides (Aβ) with a β-sheet con-
10.21.1 Definitionandpathology
formation.Plaquesaremostcommonintheamygdala,
DementiaisdefinedbytheWorldHealthOrganization hippocampus,andcerebralcortex,butalsooccurelse-
as‘anacquiredglobalimpairmentofhighercognitive where in AD. Diffuse deposits of Aβ, often called
functions, including memory, the ability to deal with ‘diffuse’or‘preamyloid’plaques,notaccompaniedby
daily life, the performance of sensorimotor and so- neuritesorglia,alsooccur.Neurofibrillarytanglesand
cialfunctions,languagecommunication,andcontrolof plaques are found in young adults with Down syn-
emotionalreactions,withoutmarkedreductionofcon- drome(Section3.21.2)and,toamorelimitedextent,in
sciousness’.Sixpercentormoreofpeopleaged65and thenormallyageingbrain.However,intheADbrain
above in the world suffer from dementia, and in the
solubleAβisatleastfivetimeshigherthanincontrols,
WestmostofthesehaveAlzheimerdisease(AD).The
andprecipitatedAβmaybe100timeshigher.

--- Page 678 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 623
Cytoplasm
γ-secretase γ-secretase
Cell
membrane
p3 α-secretase
APP
β-secretase Aβ
Extracellular
β-APP
space
α-APP
Aβ generation
and aggregation
Oxidation Excitotoxicity inflammation Tau hyperphosphorylation
(glial activation)
Neuron
Senile plaque with microglial Neurofibrillary
activation tangles
Cell Cognitive
death and behavioural
abnormalities
Neuro-
transmitter
deficit
(especially
acetylcholine)
β-Amyloid (Aβ) is a family of peptides produced are encoded by a gene on chromosome 21 and form
bycleavageoflargerproteins(amyloidprecursorpro- a set of proteins varying from 695 to 770 amino acid
teins, APPs); APPs are transmembrane proteins, pre- residues long; APP695 is abundant in neurons. They
sentinmostcells,withashortintracellularCterminus are secreted by many cell types and several func-
andalongerextracellularNterminus.Inhumansthey tions have been ascribed to them; in neurons, they

--- Page 679 ---

624 FREE RADICALS IN BIOLOGY AND MEDICINE
(cid:3)
Figure10.33 PathogenesisofAlzheimerdisease(AD);theamyloidhypothesis.Theamyloidcascadeprogressesfromthegenerationofthe
β-amyloidpeptides(Aβ)fromtheamyloidprecursorprotein(APP),throughmultiplesecondarystepstoeventualneuronaldeath.TheAPPismade
intheERandpassesthroughtheGolgiapparatustoreachtheplasmamembrane,undergoingglycosylationandothermodificationsduringits
passage.Atthecellsurface,APPisattackedbyα-secretase(amemberoftheADAMfamilyofmetalloproteinases;Table8.2),whichcleavesinthe
middleoftheAβsequence,destroyingthatsequenceandreleasingsolubleAPPαintotheextracellularenvironment.Thismoleculeappears
neuroprotective(J.Neurochem.128,196,2014)andneuronaldamageinADmaybefacilitatedbecauseitslevelsarelower.Inhealthybrain,thisis
themajorrouteofAPPcleavage.UncleavedAPPcanberecycledbyendocytosisandeithercompletelydegradedorreturnedtothecellsurface.
β-Secretase,amembrane-boundaspartylproteinase,cleavesAPPattheN-terminusoftheAβsequence.ThetruncatedN-terminusisreleased,
whereasthecell-associatedC-terminuscanbecleavedbyγ-secretasetogiveAβ(lengthsfrom39–43aminoacids),ordegradedcompletely.The
γ-secretasecomplexcontainsatleastfourproteins,includingpresenilin-1,alsoanaspartylproteinase,andnicastrin.γ-Secretaseactson
severalothercellproteins,whichmayhinderattemptstouseitasatherapeutictargetinAD.TheAPPmutantsinfamilialADenhanceitscleavage
bythispathwayandstimulateAβformation.ModifiedfromN.Engl.J.Med.351,56,2004,bycourtesyofDrJ.L.Cummingsandthe
MassachusettsMedicalSociety.Levelsofβ-secretasemayincreaseinneuronswithmitochondrialdefects(J.Neurosci.25,10874,2005).
may facilitate survival and growth during brain de- Aβ 1→40 ratio.AfewluckypeoplehaveAPPmutations
velopment, as well as neuronal responses to excita- thatdotheopposite,andsotheyrarelydevelopAD.886
tory neurotransmitters. The normal turnover of APP Transgenicmiceoverexpressingoneofthepathological
involvesproteolyticprocessing(byα-secretase)tore- mutantAPPproteins(APP ;Lys670→Asn;Met671→
695
lease the N-terminal sequence and leave a fragment Leu,adualmutationfirstidentifiedinalargeSwed-
inthemembrane.Bycontrast,releaseofAβ involves ishfamilywithearlyonsetAD),seemnormalatbirth
γ-andβ-secretaseenzymes(Fig.10.33).Cholesterolis but by 9 to 10 months of age they develop behav-
intimatelyinvolvedinAPPcleavage.Indeed,inhibit- iouraldeficitsaccompaniedbybrainamyloidplaques.
ing cholesterol synthesis using statins seems to de- Suchtransgenicmiceareauseful(butnotideal)model
creasetheriskofAD,perhapsbyloweringAβ forma- of AD, i.e. they accumulate Aβ plaques and show
tion,by decreasing β-and γ-secretaseaction,and/or cognitivedysfunction,buttaupathologydoesnotap-
by antioxidant mechanisms (Section 11.5.1).881,882 In- pear.InDownsyndromethepresenceofthreecopies
deed, hypercholesterolemia may facilitate oxidative of chromosome21 may account for theearly appear-
damageinthebrain(Section11.5.1andrefs882,883). ance of AD-type pathology. Early onset AD can also
TheAβ peptidescanbe39to43aminoacidslong, resultfrommutationsinthegenesencodingpresenil-
depending on where APP is cleaved; most attention ins(PS1 andPS2),transmembraneproteinsinvolved
has been paid to Aβ , but Aβ is the common- in γ-secretase action and cellular Ca2+ metabolism
1-42 1–40
est. Aβ-Peptides made in the laboratory are initially (Fig.10.33).
soluble in water and non-toxic to neurons. They be- ThegeneencodingapoEislocatedonchromosome
comecytotoxiconincubation,aprocessrelatedtotheir 19 and has three alleles (Section 10.3.2). The most
aggregation. This probably involves traces of transi- common isoform, apoE3, is a 299 amino acid protein
tionmetalionsinlaboratoryreagentsandcellculture withonecysteineresidue,atposition112.Apoprotein
media. Oligomeric Aβ has been found within neur- E2 and apoE4 differ in that the former has an extra
onalprocessesandsynapsesandcandisruptsynaptic cysteine(replacinganarginine)at158,whereasthelat-
activity.884Senileplaquescontainmanyotherproteins ter has lost the cysteine at 112, which is replaced by
in addition to Aβ, including α -antichymotrypsin, arginine.SinceapoE4lackscysteine,itcannotformdi-
1
ubiquitin, acetylcholinesterase, proteoglycans, apoli- sulphide bonds with itself (to form homodimers) or
poproteinE(Section10.21.2),885andserumamyloidP. withotherproteins.PossessionoftheapoE4alleleisa
riskfactorfordevelopmentofAD;885itoccursinabout
25%oftheUSpopulation,whereas65–80%ofADpa-
10.21.2 GeneticsofAD
tientshaveatleastoneallele(onecopyofapoE4raises
Geneticsstronglyinfluencesthechanceofdeveloping theriskaboutfourfold,twocopiesuptotwelve-fold!).
AD. In some cases, a particular genetic trait almost Inthebrain,apoEismadebyastrocytes(littlecomes
guarantees that AD will develop. Such familial AD, from plasma) and synthesis increases after traumatic
withearlyonsetandrapidprogression,canbecaused injuryandinseveralneurodegenerativediseases.Itap-
byseveralmutations.Someareinthegeneonchromo- pears to be essential for neuronal and glial develop-
some21 thatencodesAPP, in regionswithinor close ment.APOEistheprimarycholesteroltransporterto
to that encoding the Aβ sequence. Their effect is to neurons in the brain, and cholesterol in turn affects
accelerate Aβ production, or increase the Aβ 1→42 to Aβ production, as mentioned earlier. ApoE4 is the

--- Page 680 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 625
leasteffectiveofthethreeallelesinpromotingnormal channels’byinsertionofthepeptidesintotheplasma
membrane lipid turnover and also seems to facilitate membrane), inhibit mitochondrial function (hyper-
Aβ depositionintoplaquesandbloodvesselwalls,as phosphorylated tau may also damage mitochondria),
well as tau phosphorylation.885 Plasma and CSF F - decrease the levels of proteins essential for synaptic
2
IsoP levels are also increased more in humans with function, and generate RS, leading to lipid peroxida-
cognitive decline who possess the apoE4 allele.887 By tion and cholesterol oxidation.891,892 All these events
contrast,theapoE2formisnegativelyassociatedwith arelinked,ofcourse(Fig.10.29).Indeed,theeffectsof
theriskofdevelopingAD. Aβ (orthe25–35fragmentofit)onneuronsincul-
1–42
turearepreventedbymanyantioxidants.TheAβ
25–35
fragment aggregates and develops neurotoxicity ex-
10.21.3 Mechanismsofneurodegeneration
ceptionallyrapidlyandisthusoftenusedinlaboratory
LikePD,ADshowsthewholeclusterofabnormalpro- experiments,althoughitisnotfoundinvivo.
teins,increasedoxidativedamage,elevatediron,mito- How can Aβ lead to RS production? First, it can
chondrialdysfunction,excitotoxicity,andneuroinflam- makeRSitself.Themethionineresidueatposition35is
mation(Table10.10;Fig.10.23).Evidenceofattempted essential for ROS generation by Aβ 1–42 , and copper
re-entry of neurons into the cell cycle (Section 10.19) ionspromotethereaction.Boundcopperinteractswith
has also been obtained. Most neuroscientists believe met35 to oxidize it to a radical that can initiate lipid
that the Aβ peptides are the culprits, although in- peroxidation,893
terestin tau is growing. Aβ is rapidly exportedfrom metS + Cu2+→ Cu++ metS •+
brain to plasma, or can be degraded by microglia or
theIDE(insulin-degradingenzyme,azinc-containing and eventually to the sulphoxide. Copper can also
proteinaseresponsibleforcatabolizinginsulinthatcan oxidize tyrosine residues on Aβ, and tyrosine rad-
alsoactonAβ).Structuresformedintheearlystagesof icalsthencross-linkAβ bybityrosineformation.Mix-
Aβ aggregationcausedamagetosynapses(manybe- tures of Aβ and Cu+ can cause oxidation of ascor-
lievethatsynapticfailure,followedbyneuronalloss, bate,L-DOPA,dopamine,orcholesterol,accompanied
isthekeyprocessindementia)andareneurotoxic.The by H O production and conversion of histidine in
2 2
formwith42aminoacids,Aβ ,istheworstandis Aβ to 2-oxohistidine. The cholesterol is oxidized to
1–42
themajorAβ presentinplaques,despitethefactthat 4-cholesten-3-one,levelsofwhichareincreasedinthe
much more Aβ is made in vivo. Once it has been ADbrain.894 Indeed,oneofthephysiologicalrolesof
1–40
released,furthermodificationscanoccurtoAβ ,in- APP may be to bind copper and regulate neuronal
1–42
cludinglossofaminoacidsfromtheNterminus,which coppermetabolism,sinceAPP-knockoutmiceshowin-
mayincreaseitsneurotoxicity.888 creasedcopperinliverandbrain.895 However,unlike
ThefinalaggregatedAβ inplaquesmaynolonger withAPP,theinteractionofAβ peptideswithcopper
be directly neurotoxic (i.e. plaque formation can be ionsisnotgood!APPmayaidironmetabolismaswell;
arguedasneuroprotectivebecauseithasprecipitated butexactlyhowisuncertain.896
thetoxic‘earlyaggregates’outofsolution),unlessof Second,asmentionedearlier,AβmaystimulateROS
course Aβ oligomers leach out of the plaques. How- productionbyglia.ItcanincreaseNADPHoxidaseac-
ever,theplaquemaycausefurtherinjurybyprovoking tivity in astrocytes, producing RS that could damage
a glial inflammatory response, in addition to which neurons.897Activatedmicrogliaandreactiveastrocytes
amyloid fibrils might act as DAMPs, promoting in- localize to plaques and complement is also present.
flammasomeformation.889Amyloidβisalsodeposited MicroglialactivationbyplaquesincreasesRSandcy-
inbloodvesselwallsinADandmayleadtoendothe- tokineproduction.689Ofcourse,activationofgliamay
lialdysfunction.Forexample,itcanleadtoincreased notbeallbad;671 itmaybeanattempttophagocytose
activitiesofNADPHoxidase,formingO •– thatantag- andsequesterAβ.Nevertheless,levelsofiNOS,12/15-
2
onizes NO•, generates ONOO–, and thus aggravates lipoxygenase,andCOX-2areallincreasedinAD,with
dementiabyimpairingbloodflow.Indeed,endothelial thepotentialtocauseharm.
function was better in APP-overexpressing mice that IsinflammationimportantinthepathologyofAD?
alsooverexpressedCuZnSOD.890 Chlorotyrosinelevelshavebeenclaimedtobeelevated
Why should ‘partially aggregated’ Aβ be neuro- intheADbrain,andimmunostainingforMPOdetects
toxic? This has been variously attributed to its abil- thisenzymeinsomemicroglia,plaques,andneurons.
ity to increase intracellular free Ca2+ (perhaps by By contrast, MPO is low or absent in the normal
opening TRPM2 channels and/or by forming ‘cation brain,403 although present in PD brain (Table 10.12).

--- Page 681 ---

626 FREE RADICALS IN BIOLOGY AND MEDICINE
WhyMPOappearsinPDandADisunknown.Regular inthelevelsof8OHGandotherDNAbaseoxidation
consumption of certain NSAIDs, such as indometh- products in both nuclear and mitochondrial DNA,
acinoribuprofen(butnotaspirin),hasbeensuggested increased mtDNA deletions, elevated 8OHGua (indi-
to correlate with lower risk of developing AD. Too cativeofRNAoxidation),proteincarbonyls,glutamic
manyprostaglandinscoulddamageneuronsbyform- andaminoadipicsemialdehydes,methioninesulphox-
ing levuglandins, for example.898 However, NSAIDs ide, nitrotyrosine, acrolein, 4-HNE, HHE, HO-1 and
might additionally affect APP processing and hence F -andF -IsoPsinaffectedbrainregionsinADhave
2 4
decrease Aβ production,899 so be cautious in assum- been reported by multiple research groups.667,903–907
ing that any effect they might have is necessarily Plaquesandpairedhelicalfilamentscontainoxidized
anti-inflammatory. andnitratedproteins,andCSFfromADpatientswas
Elevated levels of RAGE (Section 10.5.5) are found alsoreportedtocontainelevatedlevelsof8OHdG,as
on microglia, vascular endothelial cells, and neurons well as oxidized and nitrated proteins;900 as in PD,
in AD and might contribute to activation of the first UCH-L1isoxidizedintheADbrain.834 Oneoxidized
anddamagetothelasttwo,sinceinADAGEproteins protein associated with plaques is CuZnSOD.908
accumulate in CSF, plaques, and tangles.900 Indeed, Plaques contain copper and iron in forms capable of
type 2 diabetes is a risk factor for AD; high glucose facilitating oxidative damage;895,909 indeed, traces of
promotes AGE formation, high insulin may raise Aβ suchmetalsmaybeessentialforAβaggregationtooc-
levels by impairing its degradation,901 and Aβ seems curinvivo(astheyareforaggregationinvitro).Hence
tointerferewithnormalinsulinsignallinginthebrain. metalionchelatingagentssuchasthedrugclioquinol
Mitochondria, particularly synaptic mitochondria, (5-chloro-7-iodo-8-hydroxyquinoline), which binds
mayalsobeakeytargetofAβ.HowmightAβdamage iron, copper, and zinc ions, may have therapeutic
them? Causing oxidative damage is one mechanism. benefit,895 although concern has been expressed that
Aβ can also associate with a mitochondrial enzyme clioquinolitselfmightbesomewhatneurotoxic.Other
that catalyses oxidation of several alcohols and of 3- chelatorssuchasPBT2(PranaBiotechnologyLtd)are
hydroxyacylcoenzyme A. What this enzyme (called underclinicaltrialinAD,895
ABAD,theAβ-bindingalcoholdehydrogenase)does
in vivo is uncertain, but its levels rise in AD.818,884
Co-expressionofAβ andABADincellscausesmito- CI CI
chondrialROSproduction,cytotoxicityandlipidper- CH 3
oxidation;overexpressionofABADinAPP-transgenic
N
miceworsenedtheneurologicaldefects.Anotherpos- I N CI N CH
3
sibletargetofAβinmitochondriaisproteinsinvolved
OH OH
in the fission/fusion cycle; normal operation of this
cycle is essential to maintain neuronal mitochondrial clioquinol PBT2
function.892 Yet other targets may include cyclophilin
D(involvedinMPT;Fig.1.9)andVDAC1;interaction
of the latter with Aβ may interfere with transport of The copper chelator trientine (Section 3.22.5.5;
essential metabolites across the outer mitochondrial Table 11.8) decreased Aβ deposition, AGE accu-
membrane. Synaptic mitochondria may be especially mulation, and β-secretase activity in a transgenic
sensitive to Aβ because of higher levels of cyclo- AD mouse model.910 Zinc is also present in plaques
philinD.891 and levels of Zn2+ have been reported as elevated in
SoAβneurotoxicityinvitroinvolvesoxidativestress the affected brain regions in AD;787 although Zn2+ is
and mitochondrial dysfunction. Is this relevant in not redox-active, it can facilitate Aβ aggregation and
vivo? Most certainly; brain energy metabolism and Zn2+ canbereleasedfromdamagedneurons(Section
glucose utilization677 decline in AD and mitochon- 10.18.3.1). However, Zn2+ can compete with Fe2+ and
drial defects reported include decreased activities of Cu2+forbindingtoAβ anddecreaseitsneurotoxicity,
pyruvateandα-ketoglutaratedehydrogenases,andof although a high Zn/Cu ratio is required since Aβ
cytochromeoxidase(Table10.4),keyenzymesinATP preferentially binds copper. Hence overall, ‘free’
production.902 MicetransgenicforamutantAPPalso Zn2+ may be bad in AD. Various reports of elevated
showed lowered αKGDH activities. As for oxidative metallothionein levels in AD brain might thus reflect
stress,strongevidencesupportsitsroleinAD,stronger attemptstocompensate,bysequesteringZn2+andCu+
than for any other neurodegenerative disease. Rises perhaps.752

--- Page 682 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 627
10.21.4 OxidativedamageinAD:cause of excitotoxicity, and K+ transport.893,904 Proteomics
orconsequence? hasrevealedthatheavilyoxidizedproteinsinaffected
regions of the human AD brain include not only
Whydowethinkthatoxidativedamageisimportant UCHL1 and CuZnSOD, as already mentioned, but
inAD?First,thereisalotofit(Section10.21.3).Second, also creatine kinase, glyceraldehyde-3-phosphate de-
there is evidence that it occurs early in the disease hydrogenase, glutamine synthetase, and α-enolase (a
pathology. Lipid peroxidation, measured as F 2 -IsoPs glycolytic enzyme). In earlier studies, ‘total’ protein
in brain tissue or CSF, is already elevated in patients carbonyl levels and decreased glutamine synthetase
withMCI.903Aswellasbeingbiomarkersofoxidative levelsinvariousregionsofthebraininoldmicewere
damage, F 2 -IsoPs can have direct toxic effects, e.g. as found to correlate with impairment of cognitive and
vasoconstrictors (Sections 5.12.3 and 10.18.4). Neuro- motor functions,906 which is not surprising given the
prostanelevelsarealsoincreasedintheMCIbrain,and keymetabolicrolesoftheaboveenzymes.
levels tend to rise further as dementia progresses.903 Similarly, only certain proteins become heavily ni-
Brain protein carbonyls, oxidative DNA and RNA tratedintheADbrain,903includingα-enolase,β-actin,
damage,andHNEandironlevelsarealsoelevatedin and triosephosphate isomerase. Remarkably, mRNA
MCI, and GSH levels are sub-normal.911 By contrast, oxidationinADisalsoselective;onlycertainmRNAs
thebalanceofevidencesuggeststhatplasmaorurin- contain8OHGandothersareunaffected.907 Thesame
aryIsoPlevelsarenotincreasedinAD,i.e.thehigher maybetrueforDNA;asoneexample,oxidativedam-
levels in the CNS are not reflected systemically.903 age(measuredas8OHG)occursinthepromoterregion
A decrease in the level of the REST protein in the ofthegeneencodingp62anddecreasesgeneexpres-
AD brain may favour increased oxidative damage sion,loweringp62levels.916Normally,p62aidsaggre-
(Section11.3.1). someformationandautophagyofaggregatedproteins,
Third, high doses of α-tocopherol (2000 units per and lower levels of it should further impair removal
day) have been reported in two intervention trials to ofabnormalproteinsinAD.916 Evenproteinmodific-
produce a modest but significant delay in the pro- ationbyHNEisnotrandominAD:specificproteins
gressionofADsymptomsinhumans,although,sadly, attacked include α-enolase, nicastrin (a component
the same dose did not affect the progression of pa- of γ-secretase;Fig.10.33), glutaminesynthetase,LDL
tientswithMCItoAD.912Othertrialsareunderway.913 receptor-related protein 1 (LRP1, involved in export
Given that α-tocopherol enters the brain only slowly, of Aβ from the brain to the blood), and Prd6.917 An-
isnotefficientatdecreasinglipidperoxidationinhu- other target is tau; HNE inhibits dephosphorylation
mans(Section4.3),andappearsnottobedepletedin of the protein.918 These data indicate that damage
ADbrain,itsmodestpositiveeffectinADgiveshope by RS in AD is highly targeted, and require spe-
that antioxidants better designed to target the brain cificmolecularmechanisms,notunderstoodasyet,to
could have a significant therapeutic impact. Studies explainthem.
onhumanswithmildtomoderateADsuggestedthat Lastly, studies on transgenic animal models of AD
a combination of α-tocopherol and vitamin C (or α- confirmthatoxidativedamageisanearlyandimport-
tocopherol,E,andlipoicacid),butnotCoQ,decreases antevent.Forexampleinmiceoverexpressingmutant
CSFF 2 -IsoPsmoreeffectivelythanα-tocopherolalone, humanAPP,brainF 2 -IsoPformationprecededplaque
but the key question would be if this translates into deposition.919,920 Indeed, inhibition of F -IsoP forma-
2
therapeuticbenefit;itappearednotto.913–915Inelderly tionbyadministeringα-tocopherol(whichworksbet-
subjects,highplasmalevelsoftocopherolsandtocotri- ter as an antioxidant in mice than in men) delayed
enolscorrelatenegativelywiththeriskofdeveloping plaqueformationandcognitiveimpairment.921Knock-
AD, although this could of course be indicative of a out of the genes encoding CuZnSOD or MnSOD in
gooddietratherthanduetorealprotectiveeffectsof thesemiceacceleratedplaquedevelopmentandmem-
vitaminE(Section4.6.8).Highplasmaorbrainlevels ory loss.922 Oxidative damage in the mice requires
of some carotenoids are also related to better cogni- the met residue to be present at position 35 of Aβ
tive function, perhaps for the same reasons (also see (Section10.21.3), indicativeofitsimportanceincaus-
Section11.4.9).745 ing ROS generation in vivo,893 as explained earlier.
Fourth, the oxidative protein damage observed in InmiceexpressingdifferenthumanapoEalleles,brain
AD is not random, but selective and affects enzymes levels of F -IsoPs paralleled changes in Aβ levels.923
2
key to neuronal function, such as some of those in- Mitochondrially targeted catalase decreased Aβ pro-
volvedinproteinturnover,energymetabolism,control ductionand8OHGlevelsinDNAoftransgenicmice,

--- Page 683 ---

628 FREE RADICALS IN BIOLOGY AND MEDICINE
consistentwithakeyroleforROSandmitochondrial 10.21.6 Anoldredherring:aluminiuminAD
dysfunction.902 In C. elegans overexpressing Aβ ,
1–42 Interest in the role of aluminium arose from reports
rises in protein carbonyls preceded plaque forma-
that the cores of senile plaques are enriched in alu-
tion, whereas a modified Aβ lacking the methio-
1–42 miniumandsilicon.Unfortunately,thisturnedoutto
nine residue did not cause carbonyl formation.924 In
beanartefactcausedbycontaminationoftheplaques
mice overexpressing APP, deposition of Aβ in the
(whichbindmetalsavidly)byaluminiumcompounds
brain was paralleled by a rise in the levels of HNE,
in laboratory reagents.928 Aluminium causes enceph-
pentosidine, iron, and HO-1, as well as inactivation
alopathy(Section9.16.11),butnotAD-typepathology,
ofUCHL1.
and no increased incidence of AD has been ob-
Just as Aβ can increase oxidative stress, ROS can
servedinworkersexposedtohighaluminiumlevels.
increase Aβ production. Several studies on cells in
However, feeding aluminium compounds to APP-
culture suggest that exposure to H O or HNE can
2 2 overexpressingmice(butnotnormalmice)accelerated
increase β- and γ-secretase activities, and this has
plaque deposition and raised the levels of F -IsoPs
also been reported in the brains of animals subjected andAβinthebrain,effectspreventedbyα-toco 2 pherol
toischaemia–reperfusion.925,926Inaddition,IsoP-F 2αIII
supplementation.929 In vitro, aluminium(III) can ac-
can bind to the thromboxane A2-prostanoid receptor
celerate iron ion-dependent lipid peroxidation (Sec-
on neurons,stabilizemRNAencodingAPP, andthus
tion9.16.11)andsoithasthepotentialtoworsenAD
increaseAβproduction.927
ifitgetsintothebrain.Therearealsosuggestionsthat
Pb2+ exposurecouldpredisposetoAD,bypromoting
10.21.5 Impairmentofproteolysis oxidative damage (Section 9.16.8), raising APP levels
andacceleratingAβformation.930
As in PD, the proteasome is defective in AD, show-
ing lowered hydrolytic activities. One reason may
be the presence of UBB+1. This is an abnormal ubi-
10.21.7 Diet,lifestyle,andAD931
quitin carrying a 19-amino acid C-terminal exten-
sion that is found in affected neurons in AD and Several risk factors other than genetics, type 2 dia-
Downsyndrome,apparentlygeneratedbyerrorsdur- betes,andhypercholesterolaemiaappeartopredispose
ing transcription. This mutant ubiquitin cannot at- to AD, and may synergise with genetic factors. They
tach itself to an expanding polyubiquitin chain, and include low plasma levels of tocopherols, tocotrien-
also appears to inhibit the proteasome.818,874 In add- ols,andcertaincarotenoids(Sections4.6.8and10.21.4),
ition,HNE-modifiedandotherabnormalproteins(in- lowdietaryintakesoffolicacid,orofPUFAssuchas
cludingHNE-Aβ andhyperphosphorylatedtau)may DHA,loweducationlevel,littleexercise,highplasma
clog up the proteasome.874 UCH-L1 activities are de- homocysteine and repeated minor brain trauma, an
creased by oxidation,834 and the drop in p62 (Sec- example being chronic traumatic encephalopathy,
tion 10.21.4) does not help either.916 Indeed, there sometimescalleddementiapugilistica(‘punch-drunk
is evidence for impaired autophagy in AD, making syndrome’), e.g. in boxers. Repeated microhaemor-
it harder to remove aggregated proteins and dys- rhages and iron accumulation may contribute to the
functional mitochondria.827 Administration of trehal- increased risk in the last.932 Small strokes and defi-
ose has shown benefit in some animal models of AD ciencies in other nutrients, such as thiamine (e.g. in
(Section10.23.2). heavydrinkers),mightalsomakeADworse(Table4.1),
To summarize, AD appears to arise because of ac- although moderate alcohol consumption might be
cumulationofAβ,whichprobablyhappensbothdue
protective.
to impaired clearance and increased formation. Mu- Feeding aged rats or mice with ‘antioxidant-rich’
tations increasing Aβ formation (and possibly some blueberryextractshasimprovedcognitivefunctionin
delayingitsclearance)speedupADonset.TheAβ is some studies.933 Similarly, feeding old dogs ‘antiox-
neurotoxicbyseveralmechanisms,RSformationand idant nutrient’ mixtures (e.g. containing vitamin E,
mitochondrial damage being some of the most im- L-carnitine, lipoic acid, vitamin C, and often others
portant. Of course, in stating this, we are neglecting suchascurcuminorplantextracts)hasbeenreported
theimportanceoftau.Anotherareathatwehavenot todiminishage-relateddeclinesincognitivefunction
toucheduponisthepossibleroleofdefectsinthevari- and to decrease oxidative damage in the brain.934 Do
ous mechanisms by which Aβ is exported from the remember that dogs can synthesize their own ascor-
brain. bate! There is considerable interest in the possible

--- Page 684 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 629
protectiveroleofdietaryDHA,sincesomeofitsme- are useful, e.g. a β-sheet conformation of the protein
tabolites(Section8.12)maybeanti-inflammatory.935 Pmel17formsascaffoldtoaidthesynthesisofmelanin
However,animalstudiesoftenfailtopredictvalue inmelanosomes(Section3.25.9).
to humans: they have identified numerous potential Amyloid deposits form when soluble proteins
protective agents in stroke (Section 10.18.3), AD, and undergo structural changes that cause them to ag-
ALS (Section 10.22.1), few of which have shown be- gregate. Several rare, inherited types of severe amyl-
nefit in human clinical trials.913 Interventions that do oid deposition have been described,939,944 such as
seem beneficial in transgenic AD mice, old animals, familial amyloid polyneuropathy, caused by pro-
andagedhumansincludegooddiet,α-tocopherolad- aggregatory mutations in the gene encoding the
ministration,mentalstimulation,andexercise(alsosee protein transthyretin (which transports thyroxine in
Sections7.14.2and11.4.9).936 Exercise,betterdiet,and plasma).Patientsonlong-termkidneydialysiscansuf-
controlofriskfactors(e.g.highbloodpressureorele- ferdialysis-associatedamyloidosis,duetoaggregation
vated cholesterol) may already have helped to slow ofβ -microglobulin.
2
downtheriseintheincidenceofADintheUK.937Ex- The cytotoxicity of amyloid deposits may involve
ercise seems to increase levels of BDNF in the brain oxidative damage, as indicated by increases in the
and may mitigate loss of neurons in normal ageing levels of HNE and protein carbonyls around the
andearly neurodegenerativedisease, perhaps in part deposits.945 As with β-amyloid, it seems to be oligo-
bydecreasingoxidativedamage.938 mersratherthanthefullyinsolubleproteinsthatper-
Inspiteofthedeleteriousvasculareffectsofhomo- turbcellmetabolismandleadtoincreasedintracellular
cysteine, evidence for benefits of folate or vitamin Ca2+, oxidative stress, impaired mitochondrial func-
B supplementation in delaying the onset of AD in tion, and phagocyte activation.946 However, the few
humans is weak.931 Nevertheless, more complex nu- (very limited) studies that have been carried out to
tritionalsupplementssuchasSouvenaid(EPA,DHA, date suggest that antioxidants have little therapeutic
choline, phospholipids, UMP, vitamins E, C, B6, B12, benefit.944,947
folate,selenium)arebeingtestedinADpatients.931
10.21.9 Priondiseases948
10.21.8 Otheramyloiddiseases939
There are other examples of the toxicity of aggregat-
Amyloid deposits are found in several other condi- ing proteins. Scrapie, a neurodegenerative disease of
tions, including in the drusen in macular degener- goats and sheep, was first described some 250 years
ation (Section 7.10),940 in the β-cells in diabetes (Sec- ago. It presents with excitability, ataxia, itching, and
tion10.5.4),andinthemusclesinsporadicinclusion eventual paralysis and death. Its transmissibility was
bodymyositis.Thisisadegenerativemuscledisease accidentally demonstrated in 1937, when a flock of
seen in some elderly people, accompanied by amyl- sheep was inoculated with an extract of brain tissue
oid deposits, proteasome dysfunction, ER stress, and fromananimalthatturnedouttoharbourthedisease,
aggresome formation.941 ‘Amyloid’ is also deposited whichmanyofthesheepwentontodevelop.
intissuesinseveralotherdiseases,includingtubercu- In the 1950s, Australian administrators exploring
losis,syphilis,andrheumatoidarthritis.Itoftenarises newterritoriesinPapuaNewGuineadiscoveredapre-
fromproteolysisandaggregationofserumamyloidA, viouslyunknowntribe(theForé)inwhichdeathfrom
an acute phase protein (Section 5.7.4)942 whose levels thedisease kuru(‘toshiver’,intheirtriballanguage)
rise sharply during inflammation. In fact, the term wasoftenobserved,especiallyinwomenandchildren.
‘amyloid’isoftenusedlooselytorefertoanytissuede- Thelesionsofkuruinhumanbrainandofscrapiein
positofrigid,proteinaceousmaterial.Thenamemeans sheepbrainlooksimilar,andkuruwassoonshownto
‘starch-like’ (from the Latin amylum), a misnomer as involveanagentthatcouldbetransmittedtomonkeys.
it is protein, not carbohydrate. Amyloids show whit- Thehighkuruincidencewasattributedtocannibalism;
ish birefringence in unstained sections and a green womenandchildreneatingthebrainsofinfectedsub-
birefringenceunderpolarizedlightafterstainingwith jects.Themenweremorelikelytoeattheflesh,thus
Congo Red. Amyloid proteins adopt β-pleated sheet developing kuru less often. In the 1920s, Creutzfeldt
conformations (as in AD). Several other proteins can and Jakob described the human neurodegenerative
form amyloid (including the enzyme lysozyme and disease named after them as Creutzfeldt–Jakob dis-
certainimmunoglobulins)andevenoxidizedLDLcan ease (CJD), which usually occurs sporadically in late
form amyloid-like structures.943 Sometimes amyloids middle age and rapidly leads to dementia, ataxia,

--- Page 685 ---

630 FREE RADICALS IN BIOLOGY AND MEDICINE
tremor, other neurological dysfunctions, and death in the brain. Indeed, mice lacking PrPc showed in-
within1–2years. creasedbrainproteincarbonylsandMDAandgreater
Someyearsago,anepidemicofbovinespongiform braininfarctsafterischaemicinjury,perhapsrelatedto
encephalopathy (BSE) occurred in cattle in the UK; decreasedCuZnSOD.949
eating meat from animals infected by this ‘mad cow Fragments of PrPc (e.g. residues 121–231 or
disease’ apparently gave rise to a small number of 106–126) are toxic to cells (including neurons) in
atypical cases of CJD (variant CJD, vCJD) in young culture. As with Aβ, this may involve formation of
people.Morethan75casesofCJDhadpreviouslyoc- membrane ion channels and/or oxidative stress, in
curred in children given growth hormone prepared partduetoredoxreactionsofthepeptidewithcopper
fromhumanpituitaryglandsobtainedatautopsy;this or iron.950 Neurodegeneration in scrapie-infected
practicehasbeenabandonedsincesomeoftheglands mousebrainisaccompanied,andmaybeprecededby,
musthavecomefromcadaverswithunrecognizeddis- increased levels of iron, HO-1, HNE, glutamate, and
ease. Other cases occurred in patients who received aminoadipatesemialdehydes(markersofproteinoxi-
grafts of meningeal tissue, derived from donors with dation;Section6.16.3),F -IsoPsandnitrotyrosine.951,952
2
unsuspected disease, during neurosurgery. The vCJD EUK-8(Section11.5.4)hasbeenreportedtodelaydeath
caseshaveclinicalfeaturesclosertothoseofthegrowth inmiceinjectedwithprion.953LevelsofF -IsoPsinCSF,
2
hormonecases,andkuru,andlesssimilartosporadic and of HNE, AGE, RAGE, glutamate/aminoadipate
CJD. Spaces created in the brain by neuronal death semialdehydes and nitrotyrosine are also elevated in
createasponge-likeappearance,hencethenametrans- brainsamplesfromhumanCJDpatients.951,952
missiblespongiformencephalopathiesoftengivento Self-propagation of pathogenic proteins may be
thesediseases.Thereismarkedastrogliosis. morecommonthanhasbeensuspectedinneurodegen-
Scrapie, BSE, CJD, and kuru are all thought to be erativediseases,aswehavediscussedforα-synuclein
caused by prions (proteinaceous infectious particles). inPD(Section10.20).830,831ItmayevenbetrueforAD
Prion, a glycoprotein with 231 amino acid residues, (Section10.21).Indeed,amyloid-richextractsfromAD
is found in all mammals in many tissues, with levels brainscanaccelerateplaque formationwheninjected
highestinthebrain.Theproblemariseswhennormal intothebrainsofhealthyanimals.954
prion protein (PrPc) becomes converted to an abnor-
malform(PrPSc),scfor‘scrapie’.ThisdiffersfromPrPc
not in amino acid sequence, but only in conforma- 10.22 Amyotrophiclateral
tion, having adopted an abnormal β-sheet structure. sclerosis(ALS)667,955
The abnormal protein cannot be degraded and accu-
mulates, leading to neuronal dysfunction and death, Amyotrophiclateralsclerosisisadiseaseinwhichmo-
and can precipitate to give PrP-amyloid plaques that tor neurons in the brain and spinal cord degenerate.
may provoke glial activation. It has been speculated, Motor neuron dysfunction is accompanied by neur-
but not established in vivo, that oxidation of some ofilament abnormalities, ubiquitin-positive inclusion
of the methionine resides on PrPc may facilitate this bodies(Table10.10),andglialcellproliferation.‘Amyo-
conversion. trophic’ refers to the muscle wasting associated with
In‘sporadic’casesofCJDinelderlypeople,thiscon- thedisease.SynonymsforALSincludeLouGehrig’s
formationalchangeisprobablyarare,randomevent. disease (after the New York Yankees baseball player
However, several (also rare) inherited mutations in who ended his distinguished career in 1938 because
the PrPc gene that favour PrPSc formation, and thus he developed ALS), and, by common usage, motor
cause autosomal dominant prion disease, have been neuron disease (MND). Strictly, however, ALS refers
described.ContactwithPrPSc canalsotriggerthedis- tooneformofMND,sincesomeotherdiseasestarget
ease;ifitgainsaccesstoanormaltissue,italtersthe motorneurons.
conformationofthePrPctheretogeneratemorePrPSc. TheaverageageofonsetofALSismid-fifties;itbe-
This is probably what happened in BSE, vCJD, kuru ginsaspainlessmuscleweaknessandimpairedmuscle
and the growth hormone and surgical cases. Indeed, tone, leading to atrophy. Problems with speech and
micelackingPrPccannotbeinfectedwithscrapie,un- swallowingfollow.Thediseaseischronicandprogres-
like normal mice. Nevertheless, these knockout mice sive, often leading to death within a few years of its
showvariousabnormalities(insomestudies),indicat- appearance,usuallyofpneumoniaorrespiratoryfail-
ing a role for PrPc in vivo. One possibility is that it uresecondarytomuscleparalysis.Malesareaffected
helpstobindcopperandpreventitspro-oxidanteffects twiceasoftenasfemalesandtheaverageincidencein

--- Page 686 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 631
theUSAisabout2per100,000.Ninetypercentormore mutantenzymeinthepatientsispresentinothertis-
ofALScasesaresporadic,≤10%areinherited.Thelat- suesaswell?Thesimpleansweristhatwedon’tknow,
ter(familial)formsofALShaveanearliermeanageof althoughseveralclueshaveemerged.
onsetandmenandwomenseemequallyatrisk(unlike The mutant CuZnSODs are often (not always) less
sporadicALS). stableinvitrothannormalCuZnSODandtendtoag-
gregate, forming fibrils that could be toxic in vivo;
someauthorshaveevensuggestedaprion-likemech-
10.22.1 FamilialALS(FALS)andsuperoxide
anism (Section 10.21.9) of damage. The SODs might
dismutase956
misfold after release from the ribosome, or denature
SeveraldifferentmutationscauseFALS(e.g.someare morequicklythannormal invivotoreleaseZn2+ and
in genes encoding proteins involved in axonal trans- potentially pro-oxidant copper ions. Some are more
port),butabout10–15%ofFALScases(i.e.upto1.5%of susceptibletobreakdownwhenH 2 O 2 isadded,apro-
allALScases)havealterationsinthegeneonchromo- cess involving OH• generation (Section 3.5.1.6). Zinc
some 21 that encodes CuZnSOD. More than 160 mu- maybeeasilylostfromsome(butbynomeansall)of
tations in this gene have been identified in different theabnormalCuZnSODs,exposingtheactivesitecop-
patients.Theyaremostlymis-sensemutations,witha perions.Indeed,someofthemutantenzymescatalyse
few deletions, insertions, and C-terminal truncations. H 2 O 2 -dependent peroxidase-type reactions (e.g. oxi-
Somemutationsalteraminoacidresiduesatorcloseto dizingascorbateandthiols)andformnitratingspecies
themetalbindingsites,otherselsewhereintheprotein. from ONOO– at an increased rate (the zinc-depleted
Mostofthesemutantproteinshavedecreasedenzyme enzyme is especially good at this). Since CuZnSOD
activity,butrarelydoesitfallbelow40%ofnormal,and is present not only in cytosol but also in the mito-
somearefullyactive.Forexample,aGly→Alamuta- chondrialintermembranespace,atoxicproteincould
tion at position 93 decreases SOD activity by about lead to mitochondrial dysfunction, which has indeed
64%. The mutations are usually autosomal domin- beendescribedinALS(Table10.10).818 Mitochondrial
ant;oneexceptionistheD90Amutant(Asp90→Ala), degeneration is especially obvious in the transgenic
which predisposes to ALS development usually only mouse models, and appears to precede symptoms.
inhomozygoussubjects(Section3.5.1.5)andisalmost However,somedatasuggestthatSODwithoutmetals
fullyactiveasaSOD.957 canbeneurotoxic,castingdoubtontheimportanceof
Transgenicratsormiceoverexpressinggenesencod- metal-dependentredoxreactions.
ingsomeofthesemutantCuZnSODs(e.g.Gly93→Ala Sowhymotorneurons?Manyofthemcontainalot
orGly85→Arg)developmotorneurondegeneration, ofCuZnSODbecauseoftheirsize;thelargesthuman
the pathology and progression of which resemble motorneuronshaveaxonsofaroundametreinlength.
human ALS. By contrast, overexpression of normal AbnormalSODsmaybindtoneurofilaments,directing
human CuZnSOD in mice results in some patho- oxidativedamageandnitrationtoneurofilamentpro-
logicalchanges(includingneuromuscularimpairment; teins; interference with neurofilament formation and
Box 3.1) but slower, if any, neurodegeneration, al- functionmaybeaspecialprobleminmotorneurons.959
thoughitmaycausemoreneurodegenerationifithas TransportofCuZnSODfromthecellbodytotheend
becomeoxidizedand/ormisfolded.Sincerodentsex- of the axon appears to be by the slow mechanism
pressing mutant CuZnSODs also express their own (Section 10.17.1) and it is possible that denaturation,
CuZnSOD,theALSsyndrometheydevelopcannotbe aggregation, or association with neurofilaments oc-
due to a lack of superoxide-dismutating activity. The cur during its travels. Slow transport through long
greater the expression of the mutant transgene, the motor neurons may mean that CuZnSOD takes one
morequicklytheanimalsdevelopdisease.Hencethe to two years to reach the nerve terminus. Neurofil-
mutant CuZnSODs must have acquired a toxic prop- ament aggregation is a marked feature of ALS and
erty.Thisconceptissupportedbycellculturestudies; presumably impairs delivery of essential molecules
raising the CuZnSOD content of cells delays apop- andorganellesdowntheaxon.Inthetransgenicmice,
tosis induced by withdrawal of growth factors from decreasedaxonaltransportratesaredemonstrablewell
theculturemediumandincreasesresistancetoseveral beforeneurodegeneration.955 AbnormalSODsarede-
neurotoxins. However, mutant SODs render the cell graded by the proteasome and might ‘clog it up’,
moresensitivetoserumwithdrawal,HNE,orH O .958 causingdecreasedactivity.Indeed,targetedknockout
2 2
ButwhatisthiscytotoxicpropertyofmutantSODsand of proteasome function in mouse motor neurons led
whyshoulditbeconfinedtomotorneurons,sincethe todevelopmentofproteinaggregatesandanALS-like

--- Page 687 ---

632 FREE RADICALS IN BIOLOGY AND MEDICINE
syndrome.824 Anothersuggestedfactoristhatmutant mice, nitrated proteins found in the spinal cord in-
SODs bind to and damage mitochondria in motor cludeenolase,ATPsynthase,andactin;nitrationwas
neuronsbutnotothercells.818 observedbeforeappearanceofsymptoms.968Oxidized
However, there is more to it than just SOD be- proteins (bearing carbonyls) included CuZnSOD and
ing toxic to motor neurons. When gene expression UCHL1,yetagainalinktotheubiquitin–proteasome
in mice is targeted so that mutant SODs form only system.968 Motor neurons do not normally contain
inmotorneurons,earlyonsetdegenerationnolonger muchNOS,butmaydevelopiNOSwheninjured,and
occurs.HencethepresenceofamutantSODinamo- NO• couldoriginatefromastrocytesormicroglia.Ni-
tor neuron is a necessary but not a sufficient cause tratedHsp90hasbeensuggestedtobeselectivelytoxic
of ALS. It must also be present in other cell types to motor neurons, by an unknown mechanism.969 In-
around the neurons (in FALS, of course, it is present creases in the levels of COX-2, iron, and zinc in the
inallcelltypes)todrivediseaseprogression.Indeed, spinal cord of ALS patients have been demonstrated
removing the mutant gene from microglia or astro- andlevelsoftoxiccyclopentenoneprostaglandinsmay
cytes extends the lifespan of transgenic mice.955,960 alsorise.965
Whyshouldexpressioninseveralcelltypesbeneeded?
Motorneuronsdonotworkinisolation;theydepend 10.22.2.1 Therapies667,689,961,970
onglia,e.g.tosupplythemwithlactateandprecursors TransgenicmiceoverexpressingmutanthumanSODs
of GSH (Sections 10.17.2 and 10.17.6.3). Astrocytes are a popular tool to examine potential therapies for
withmutantCuZnSODmayhaveanexcessively‘pro- ALS.InhibitorsofnNOSorPARP-1hadlittleornoef-
inflammatory’ phenotype when activated, together fectonthecourseofdiseaseintransgenicmice,nordid
withdefectsinglutamateuptake;failuretoclearextra- restrictionofenergyintake.Bycontrast,administration
cellularglutamatewillpromoteexcitotoxicity.961Motor of coenzyme Q , polyamine-modified or putrescine-
10
neurons may be especially sensitive to excitotoxicity, modifiedcatalase,SS-31peptides(Section11.5.12),Mi-
sincetheyexpresshighlevelsofAMPAreceptorsand toQ(Section11.5.12),971 creatine(whichraisescreatine
may not be good at buffering high intracellular Ca2+ phosphatelevels),minocycline(Section9.17),thecop-
levels.962 Astrocyte production of NO• and ONOO– perchelatorstrientine,tetrathiomolybdate,orpenicil-
may be toxic to motor neurons in ALS,963 and glial lamine,theironchelatorsSIH(Section11.6.2),andM30
NOX2 levels are increased in the spinal cord of pa- (Section 11.6.2), carboxyfullerene (Section 11.5.3), tre-
tients;transgenicmicelackingNOX2livelonger.689 halose(Section10.23.2),the(unspecific)NOXinhibitor
Different SOD mutations are associated with dif- apocynin, EUK-8, EUK-134, and AEOL 10150 (Sec-
ferent rates of disease progression in FALS. One set tion11.5.4),thespintrapDMPO(Section6.2.4),tempol
of mutations (e.g. Ala4 → Val) is linked to rapidly (Section11.5.5),972α-tocopherol,lipoicacid,edaravone
progressive disease (death in about 1 year), another (Section 11.5.8), bromocriptine (Section 10.20.2), COX
set(e.g.Gly93→Ala)withaveragediseaseduration
inhibitors, the lipoxygenase inhibitor NDGA, and N-
(2–5 years) and yet another set (e.g. Leu126 → Ser, acetylcysteine have been reported to extend lifespan
His46 → Arg and D90A) with ‘benign’ progression in this model and/or to delay onset of the disease
(10yearssurvivalormore).Itwouldbeinterestingto to a limited extent. These data suggest that copper,
compare the cytotoxicity of the proteins encoded by iron,oxidativedamage,eicosanoidsanddefectiveen-
thesevariousmutants. ergy metabolism play important roles in the disease
pathology.Thedrugriluzole,whichinhibitsglutamate
releaseatpresynapticterminals,alsoextendslifespan
10.22.2 Oxidativedamageandexcitotoxicity
inALS667,959,961 in these mice. Indeed, riluzole is used in the treat-
ment of ALS and extends patient survival slightly,
Oxidative damage levels are increased in ALS pa- suggestingsomecontributionofexcitotoxicitytoALS
tients.Forexample,levelsofF -IsoPsand8OHdGin pathology.
2
CSF, plasma, and urine are elevated, and seem to in- However, no evidence for beneficial effects of
crease further as the disease progresses.964–966 Levels α-tocopherol, selegiline, coenzyme Q, minocycline,
of8OHGinDNA,proteincarbonyls,HNE,glycoxid- N-acetylcysteine, or an antioxidant cocktail has been
ationproducts,and3-nitrotyrosineareelevatedinALS obtainedinhumans,nordidadministrationof500mg
spinalcord(althoughreportsofelevatedfreenitrotyr- of α-tocopherol per day for 18 months improve out-
osine levels in CSF were probably artefacts because comeforpatientsonriluzoletherapy.667,970,973Whether
ofanalyticalproblems).967InSOD-1mutanttransgenic this is a failure of these agents to influence oxidative

--- Page 688 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 633
damageinpatients,oranindicationthatsuchdamage mightagainbeacontributionofthedrugsusedtotreat
islessimportanttodiseaseprogressioninhumansthan thisdisease;tardivedyskinesiaisaseriousside-effect
inSODtransgenicmice,isuncertain. of long-term antipsychotic use, and may involve oxi-
dativedamage.985Increasedoxidativedamagetomito-
chondrialproteinsanddecreasedcomplexIactivityin
10.23 Otherdiseasesofthebrain brain cortex have been reported in patients with bi-
polardisorder.986 N-acetylcysteineadministrationhas
andnervoussystem
been suggested to be beneficial in these various dis-
Oxidative damage has been suggested (but rarely orders,butitsvalueisnotfirmlyestablished.987
proven)tobeinvolvedinmanyotherdisordersofthe
CNS, even chronic fatigue syndrome!974 The list in-
10.23.1 Friedreichataxia749,988
cludesZellwegersyndrome,inwhichperoxisomesdo
not assemble properly,711 X-linked adrenoleukodys- Friedreich ataxia (FA), the most common hereditary
trophy, in which peroxisomes fail to oxidize long- ataxiad, has an incidence of about 1 in 50,000. Onset
chain fatty acids due to a defective transporter, and isusuallyafterage15.Inthepast,somecasesofAVED
Niemann–PickC1disease,involvingmutationsaffect- (whichrespondstotreatmentwithα-tocopherol;Sec-
ing proteins necessary for intracellular trafficking of tion4.3)weremistakenforFA(whichdoesnot).
cholesterol;cholesterolanditsoxidationproductsac- Friedreich ataxia is caused by mutations in a gene
cumulateinlysosomes.708 ThesymptomsofCharcot– on chromosome 9 that encodes a protein (frataxin)
Marie–Toothdiseasetype1A,aseveredemyelinating involved in mitochondrial iron metabolism. The mu-
disorder, were not improved by administering ascor- tations involve expansion of a trinucleotide (GAA)
batetopatients,althoughascorbateworkedinanimal repeatsequenceinintron1,theoveralleffectofwhich
models.975 Rett syndrome is caused by mutations in is to decrease transcription of the gene. Low frataxin
the gene encoding methyl-CpG binding protein-2, levels hinder the formation of Fe/S clusters in acon-
an important regulator of synaptic plasticity. It has a itaseandincomplexesI,II,andIII.Ithasalsobeensug-
complex and variable phenotype with some features gested,butnotestablished,thatthesefrataxinabnor-
of autism. Plasma levels of F 4 -neuroprostanes and malitiesleadtoariseintheintra-mitochondriallevel
F 2 -dihomo-IsoPs (oxidation products of adrenic acid: ofiron‘catalytic’forfreeradicalreactions.Theheartis
Section5.12.3)arehighlyelevatedevenearlyinthedis- alsorichinfrataxinandearlydeathofFApatientsof-
ease,suggestingthatlipidperoxidationcontributesto teninvolvescardiacproblems.Severalstudiessuggest
the pathology.976 Autism itself has been suggested to that the ‘antioxidant’ idebenone (Section 11.5.7) has
involve oxidative stress; increases in cerebellar levels limited therapeutic benefit in FA, consistent with a
of8OHGinDNA,3-nitrotyrosineand3-chlorotyrosine, roleforoxidativedamage.989 Indeed,insomebutnot
together with decreases in GSH levels have been allstudies,itdecreasedtheelevatedurinarylevelsof
reported in post-mortem brain samples977 and aut- 8OHdG reported in FA patients.990 Mixtures of coen-
istic children had higher urinary F 2 -IsoP levels.978 zyme Q and α-tocopherol are also reported as help-
The seizures in epilepsy involve excitotoxicity, which ful to patients. However, all of these agents improve
couldresultinGSHdepletionandincreasedoxidative cardiac function more than they do the neurological
damage.979
symptoms and their overall clinical effectiveness
Wehavealreadyseenthatalterationsinglyoxalase issmall.989
andGSHmaybeinvolvedindepressionandanxiety
andin‘stress’(Sections6.13,9.18,and10.17.6.3).733‘De-
pression’isamuch-misusedword,butsomeevidence 10.23.2 Huntingtondisease678,818,991,992
has been presented for decreased neurogenesis and
Huntington disease (HD; sometimes called Hunting-
elevated biomarkers of oxidative damage in patients
ton chorea) is an autosomal dominantly inherited
sufferingfromsevereclinicaldepression,e.g.increased
diseasecharacterizedbypsychiatricdisorders,demen-
F -IsoPlevelsinCSFandurine.980–982 Oxidativedam-
2 tia, and involuntary twitchings, writhings, and other
ageinallthesediseasescouldresultfromthedisease
movements. It is named after the physician George
itself, the effect of the drugs used to treat it, or per-
Huntington,whodescribeditin1872intheonlypaper
hapsalterationsinnutritionandlifestylecausedbythe
depression.983 Decreased brain GSH levels have also
beenreportedinpatientswithschizophrenia.984There d ThistermisdefinedinSection4.3.6.

--- Page 689 ---

634 FREE RADICALS IN BIOLOGY AND MEDICINE
he ever published (hence one breakthrough clinical butearlystagesofaggregation.Inaddition,N-terminal
paper can leave your name remembered forever!) fragments of huntingtin generated by proteolytic ac-
ChorearelatestotheLatinchoreusandtheGreekchoros, tion seem to be cytotoxic. Excitotoxicity is also an
having to do with dancing (referring to the abnor- important event in HD, perhaps related to elevated
mal movements). The symptoms are largely caused levelsofNMDAreceptorswhenthemutantproteinis
by degeneration of striatal neurons, accompanied by present.
astrocytosis, leading to atrophy of the caudate nu- Thesugartrehalose(Section3.25.8)diminishedthe
cleusandputamen. Thediseasedoesnotusually ap- toxicityofmutanthuntingtinincellsandmousemod-
pear before age 30 and can last for 20 years or more, els; it seems both to decrease aggregation of the mu-
withprogressivelyworseningsymptoms.Huntington tant protein and to accelerate rates of autophagy.994
graphically described this as ‘the hapless sufferer is It also decreased neurodegeneration in animals over-
but a quivering wreck of his former self’. The preva- expressing α-synuclein or tau protein, or mutant
lenceintheUSAandEuropehasbeenestimatedas4to CuZnSOD as an ALS model.994–996 Other drugs
10per100,000. that accelerated autophagy, such as rapamycin (Sec-
HD is caused by a defect in a gene on chromo- tion5.14.3.1),werealsoeffective.997
some 4, which encodes the protein huntingtin. Its Does oxidative damage contribute to HD? It prob-
function is unclear, although it could be involved in ably does. Elevated levels of 8OHG in DNA from
regulatingthebiosynthesisofcysteine,993thetransport striatal neurons, and increased neuronal NOX2 ac-
of the neurotrophic factor BDNF along microtubules, tivity, have been reported in some studies, as have
and the control of levels of NMDA receptors and of increased levels of F -IsoPs in patients’ CSF (but not
2
autophagy, among other processes. The gene encod- in their plasma or urine).991,998 Some of the oxida-
inghuntingtinisexpressedinmanytissues,especially tive DNA damage is located in the promoter of the
neurons, testis, lung, and ovary. Within the normal p62gene.AsinAD(Section10.21.4),thismayhinder
gene, the trinucleotide CAG occurs in sequences re- clearance of abnormal proteins.916 Elevated 8OHdG
peated 9 to 39 (mean 19) times and encodes a string levels, increased lipid peroxidation, nitrotyrosine for-
ofglutamineresiduesstartingneartheN-terminus(at mation, NOX2 levels, and mitochondrial dysfunction
position18)intheprotein.InHDtherepeatfrequency have also been reported in transgenic mouse models
is greater (range 36–121, mean 43) and, correspond- ofHD.Applicationofredoxproteomicstobrainsam-
ingly, the polyglutamine sequence is longer. Repeat ples from HD patients and transgenicmice has iden-
lengths of ≥ 40 make it likely that a subject with tified oxidative damage to several proteins involved
evenonecopyoftheabnormalgenewilldevelopHD. inenergymetabolism,includingα-enolase,aconitase,
Repeatlengthstendtoincreasefromgenerationtogen- and glyceraldehyde-3-phosphate dehydrogenase.999
eration so that the disease can become more severe The‘antioxidants’lipoicacidorBN82451(Fig.11.5)in-
insucceedinggenerations(geneticanticipation).Very creased survival and motor performance and slowed
high(>50)repeatlengthscanleadtoearlydiseaseonset neuronal death in the animals, as did coenzyme
(sometimes before age 30). The abnormal huntingtin Q, creatine, NADPH oxidase inhibitors (including
gainsatoxicfunction,relatedtotoomanyglutamine VAS2870; Section 11.7.4), clioquinol, cystamine, and
repeats.Onekeyquestioniswhythisaffectsonlyse- minocycline.689,991,998,1000
lectedpartsofthebrain,sincehuntingtinispresentin DefectsinenergymetabolismcanbedetectedinHD
manytissues.MiceexpressingtheN-terminalpartof patientsbyimagingtechniques(aswouldbepredicted
themutanthumangenedevelopprogressiveneurode- by the redox proteomics), and falls in complex II, III,
generationfromaboutsixweeksofage,991 confirming and aconitase activities are reported in post-mortem
thetoxicnatureoftheprotein. material, possibly because the abnormal huntingtin
Whydoeshavingextraglutaminesmakehuntingtin associates with and damages mitochondria. Indeed,
neurotoxic?Thedefectiveproteinshowsanabnormal injection of complex II inhibitors, such as nitropro-
propensitytoaggregateandforminclusionbodiesthat pionic acid or malonate, into animals causes striatal
contain ubiquitin and proteasome components and damage resembling that in HD, and complex II in-
mightimpairthefunctionoftheproteasome;aggrega- hibitioniswellknowntoincreasemitochondrialROS
tionmaybetheoriginofitstoxicity.Autophagyalso production.678,818 Theremaybesomebenefitofhigh-
seemstobedefectiveinHD.827Asseemsusual,itmay dosecoenzymeQinHDpatients,butidebenonewas
not be the final huntingtin aggregates that are toxic, noteffective.818,991

--- Page 690 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 635
10.23.3 Neuronalceroidlipofuscinoses1001 damageprobablyanother.Painisathird.Chronicpain
isanenormousclinicalproblem.Painfulstimuli(heat,
The neuronal ceroid lipofuscinoses (NCL) are
chemical,cold,mechanical)arerecognizedbyaspecial
autosomal, recessively inherited, progressive (and
class of neurons that transmit the nociceptive (pain)
eventually fatal) degenerative diseases that occur
signal to the dorsal horn of the spinal cord. There
worldwide in about 1 per 100,000 live births, but
the nociceptive signals are sorted and directed to the
morefrequentlyinScandinavia.Theyaffectprimarily
braintoproducethesensationofpain.Tissuedamage
the brain and retina. Some patients develop symp-
notonlycausespainitself,butcanincreasethesensi-
toms (dementia, seizures, visual loss) during infancy
tivity to pain from other stimuli (hyperalgesia) or to
(infantile NCL), others in early childhood (late in-
stimuli that are normally non-painful, such as touch
fantileNCL),othersinlatechildhood(juvenileNCL),
(allodynia).
andyetothersafteradolescence(adultNCL).Multiple
There have been several suggestions that pain in-
genemutationsaffectinglysosomalfunctioncanlead
volves such ROS as ONOO– and H O , as well as
to NCL. For example, infantile NCL is caused by an 2 2
sometimesend-productsoftheirreactionwithbiomol-
inherited defect in a lysosomal proteinase (palmitoyl
ecules, such as nitro-oleic acids.1003,1004 For example,
protein thioesterase 1), which removes fatty acids
carrageenan-induced hind paw inflammation in ro-
such as palmitate esterified to cysteine residues in
dentscausedpainwhichwasdiminishedbyinjection
lipoproteins.Ifthesefattyacidsarenotremoved,deg-
ofSOD,catalase,orTEMPOL(Section11.5.5),andag-
radationofthelipoproteinsinlysosomesisimpaired.
gravated by injecting H O .1005 The effect seemed to
Late-infantileNCLisalsocausedbyalysosomaldefect 2 2
involve activation of the non-selective cation chan-
(intripeptidylpeptidase1).
nel transient receptor potential vanilloid 1 (TRPV1)
Attention was focused on NCL by free radical re-
receptors on nociceptive neurons, also activatable by
searchers many years ago because the disease is ac-
the chilli compound capsaicin and by nicotinic acid
companied by accumulation of fluorescent pigments
(Table 4.1).1005,1006 In other cases the TRP ankyrin
resemblingthe‘agepigment’ceroid(Section11.4.7)in
1 (TRPA1) receptor, is involved (e.g. in inflamma-
the brain (especially in cortex and cerebellum) and
tion/paincausedbyinjectingmonosodiumuratecrys-
elsewhere.However,theoriginalassumptionthat‘age
tals into the hind paws of rats).1006,1007 Activation of
pigment’ is largely peroxidized lipid was mistaken,
TRPA1/TRPV1onadditionofH O orONOO–seems
and there is no clear evidence of increased oxidative 2 2
to be direct. Activation of TRPM2 can also promote
damage or defects in antioxidant protection in NCL
pain,buttheeffectofH O seemstobemediatedby
(nor, to be fair, has it been studied systematically). 2 2
ADP-ribose (Section 5.3.2.2).693 TRPA1 receptors can
However, glial cell activation is a common feature of
additionally be activated by a range of end-products
NCLs, so a contribution of RS is feasible, and the
of lipid peroxidation (including acrolein and HNE),
‘antioxidant’t-butylhydroxylaminedecreaseddisease
andbycyclopentenonecompounds(Section5.12.3),all
severity in a mouse model of infantile NCL (Sec-
of which oxidize or bind to cysteine residues to trig-
tion 11.5.5). The pigments are located within ‘storage
gerthesignal.1006,1008Inhaledozonecanalsoinactivate
bodies’originatingfromlysosomes.Inadult,juvenile,
thischannelintherespiratorytract.1006 Inmice,treat-
andlateinfantile(butnotinfantile)NCLmuchofthe
ment with methylglyoxal caused pain, apparently by
proteinwithinthesebodiesissubunitc,ahydrophobic
promoting the slow inactivation of a Na+ channel in
component of mitochondrialATP synthase. In NCLs,
pain-detecting nerves. Indeed, this may be relevant
lysosomes have difficulty in degrading the proteins
indiabetessincediabeticpatientswithhigherplasma
they receive from autophagy, so that abnormal lyso-
methyglyoxallevelssufferedmorepain.1009
somes accumulate. Defects in the TRPML1 channel,
ROS are involved in generating the sensation of
which exports Fe2+ from lysosomes (Section 3.22.1.3),
painnotonlyatthesitewherethepainoriginatesbut
canresultintherareneurodegenerativediseasemucol-
also in the central nervous system (spinal cord and
ipidosistypeIV,whichmayinvolveFe2+-dependent
rostral ventromedial medulla of the brain) where the
oxidativedamage.1002
‘painsignal’isprocessed.Indeed,elevatedspinalcord
ROSlevelsseemtoinducepaininrodents.Suggested
sources of ROS in pain-sensing events in the CNS
10.24 Pain
include NOX4 (e.g. in pain after nerve injury),1003 D-
Allhumandiseaseshavecertainthingsincommon,in- amino acid oxidase (e.g. in metastatic bone pain in
flammationbeingoneofthemandincreasedoxidative rats),1010 or mitochondria.1008 Microglial activation in

--- Page 691 ---

636 FREE RADICALS IN BIOLOGY AND MEDICINE
spinal cord can also contribute to pain, via ROS gen- example (Section 10.18.1). The same is true for vir-
eratedfromtheirNOX2activity.Peroxynitritearising uses.Theimmunedefencesofthehostcanrespondto
fromNO
•
andO
•–hasbeensuggested,onthebasisof
PAMPs (e.g. viral nucleic acids) and DAMPs to gen-
2
protectiveeffectsofporphyrin-based‘ONOO–decom- erate large amounts of ROS in a (usually successful)
positioncatalysts’inanimalmodels1004(Section11.5.4; attempttoeliminatethevirus,lateraidedbyantibody
Table11.6)tobeinvolvedinthepainprocessingofthe generation. For example, NO• inhibits replication of
rostral ventromedial medulla. Peroxynitrite addition manyvirusesincellsinculture,eitherdirectlyand/or
can nitrate and inactivate MnSOD, raising mitochon- bydamagingtheinfectedhostcellandpreventingthe
drial O •– levels.1011 Animal experiments suggest that virus from using it to replicate.1016 Some ROS (e.g.
2
ONOO– formation in the spinal cord may also be in- OH•),andRNS(e.g.HNO ,ONOOH,N O ),cancause
2 2 3
volvedinthedevelopmentoftolerancetotheanalgesic mutations in the viral genome, helping to inactivate
effectsofopiatessuchasmorphine1011 andintheper- the virus. An alternative possibility, however, is that
ipheral neuropathy and chronic pain that sometimes theycansometimescausemutationsthatfacilitateviral
result from treatment of cancer patients with oxali- evolution,anotherexampleoftheJanusnatureofRS.
platin, taxol, or the proteasome inhibitor bortezomib Mobilizationofthehostdefencesysteminvolvesac-
(Section5.14.3).1012 tivationofNF-κB,butthiscanbesubvertedbyviruses
Ofcourse,manyagentsotherthanROSareinvolved for their own advantage, since viral gene promoters
in pain generation, including peptides (e.g. bradyki- often contain NF-κB-binding sequences that promote
nin,substanceP),andprostaglandins[Section8.12]). transcription of viral genes.1016 The persistent activa-
By contrast, resolvins such as E1 and D1 can dimin- tion of NF-κB by some viruses, including those that
ish pain and inflammation (Section 8.12). The pain- causeacquiredimmunodeficiencysyndrome(AIDS),
promoting effects of bradykinin and substance P as hepatitisBandC,andinfluenza,mayalsohelptosup-
processedinthespinalcordandbrainmayalsoinvolve pressapoptosisofthehostcell.Withsomeinfections,
ROS.1008TRPMchannels,leukotrieneB (Section8.12), aswithchronicinflammations,anover-exuberantim-
4
and ROS have also been suggested to be involved in mune response can damage the host more than the
thesensationofitch.1013 infectingagente.g.itcanpromotecancerdevelopment.
Are ROS relevant to human pain? Possibly. High A striking example is HTLV-1, which causes adult
doses of vitamin E were reported to ease pain in T-cell leukaemia (Table 10.9). The viral tax protein
RA patients,1014 women with endometriosis (E plus leadstoexcessiveactivationofNF-κBandothertran-
C; Section 7.11.6.1), patients suffering chemotherapy- scription factors, which can facilitate malignancy.1017
induced peripheral neuropathy,1015 and in sufferers The hepatitis B virus X protein (HBx) and several
from pancreatitis, although data on the last two are hepatitisCvirusproteinsactsimilarly,increasingoxi-
conflicting (Section 10.13.1). Do remember, of course, dative damage and raising the risk of hepatocellular
that the vitamin E may not have affected oxidative carcinoma.1018 Infections by human papilloma virus
damage, a possible explanation for lack of effect in can also lead to cancer (cervical cancer) and oxida-
somestudies.RecombinanthumanSODwasreported tive/nitrative damage has been implicated.1019 An-
todecreasepenilepaininsubjectswithPeyroniedis- other example of damage to the host; infection of
ease (Section 10.7.4), although it did not improve the laboratorymicewithaninfluenzaviruscausedsignifi-
penilecurvature.364Lipoicacidisfrequentlysuggested cantmortalitythatcouldbedecreasedbyadminister-
to decrease peripheral neuropathy and related pain ingSOD(linkedtoapolymertoprolongitslifetimein
in diabetics, but this could be an effect on ion chan- the circulation), EUK-207 (Table 11.6), or allopurinol.
nels rather than an antioxidant effect (Section 3.25.4). Mortalitywasduetolungdamage,andinvolvedXO,
A greater investment in studies as to whether more- NO•,ONOO–,andNADPHoxidase(Section8.10.1)en-
effective antioxidants could relieve pain seems to be zymes in activated macrophages and in the airway
merited,giventhesufferingthatchronicpaincauses. epithelium.1020Increasedlevelsof8-nitroguaninewere
presentinthelungDNA.Thebraindamagethatcan
sometimesbecausedbyvirusessuchasmeaslesvirus,
10.25 Oxidativestressandviral HIV(Section10.25.1),rabies,andherpessimplextype
I,involvesRSandcytokines.1021Seleniumdeficiencyin
infections
mice allows a usually benign coxsackievirus to cause
Reactive species can contribute to the damage done heart damage (Section 3.20.5). Interestingly, hepatitis
by bacterial infections, bacterial meningitis being an BvirusactivatestheNrf2systeminhumanliver,but

--- Page 692 ---

REACTIVE SPECIES IN DISEASE: FRIENDS OR FOES? 637
hepatitis C virus does not.1022 Marburg virus, which eliminated (e.g. Pneumocystis carinii pneumonia), and
causesahaemorrhagicfeverwithahighmortalityrate full-blownAIDSappears.
inhumans,alsoactivatesNrf2;micelackingNrf2were Therapeutic agents used in triple combinations are
better at controlling infection by Marburg virus.1023 effective in controlling HIV infection, although they
Nrf2activationbythesevirusesmaythushelpinfected have side-effects. They include inhibitors of reverse
cells to survive attack by RS from the host immune transcriptase (e.g. azidodeoxythymidine (AZT), di-
system,1024 with the implication that administering deoxyinosine (ddI) and dideoxycytidine (ddC)), and
antioxidantsmightnotbebeneficial! inhibitorsoftheproteinaseenzymeusedbythevirus
InthecontextofRSandantioxidants,muchattention to cleave newly synthesized proteins into the forms
has been paid to the human immunodeficiency vir- neededforviralassembly.Examplesofproteinasein-
uses(HIV),thecausativeagentsofAIDS.Thesepatho- hibitorsareritonavir,indinavir,andsaquinavir.
gens,HIV-1and–2,belongtoafamilyofretroviruses
whose other members infect monkeys. The former is
10.25.1 Reactivespecies,antioxidants,andHIV
morepathogenictohumansthanHIV-2.TheHIVviral
particlescontainacapsidenclosingthesingle-stranded The presence of HIV in the brain can lead to neur-
RNAgenomeplusthreeviralenzymes:proteinase,re- onaldeathandglialproliferation,resultingincognitive
versetranscriptase,andintegrase.Reversetranscript- and motor defects. The most severe form of this is
asecopiesviralRNAintoDNA,whichintegrasethen calledAIDSdementiacomplex.Neurologicaldamage
incorporates into the host genome. The viral genome by HIV involves activation of astrocytes and micro-
contains genes that encode regulatory proteins. One glia,leadingtoincreasedproductionofTNF-α,IL-1β,
is Tat (transactivator of transcription); it encodes a othercytokines,iNOS,ROS,andeicosanoids,withele-
proteinthatactivatesgenetranscriptionfromtheviral vatedlevelsofHNE,8OHGinDNA,andnitrotyrosine
promoteraswellasNF-κBinthehostcell.Tatprotein inthebrain.1021,1025 Inaddition,gp120proteinistoxic
can be secreted from infected cells into the blood- to neurons; the toxicity requires glutamate and Ca+
stream.Thecapsidissurroundedbyamatrixprotein andisblockedbyagentsthatantagonizeglutamatere-
whichinturniscoveredbyanenvelopeconsistingof ceptors.HenceanexcitotoxicmechanisminvolvingRS
alipidbilayerthatcontainstheproteinsgp120(outer may contribute to neuronal death.1021,1025 Tat protein
envelopeprotein)andgp41(transmembrane). itselfistoxic,andcaninduceoxidativestressincells,
Infection with HIV results from intimate exposure possibly by raising NADPH oxidase activity,1026 al-
to the blood or other body fluids of an infected per- thoughtheexacteffectsmaydependonthecellculture
son.Itusuallyresultsinabriefillnessassociatedwith conditions.1027Withtheadventoftripletherapy,AIDS
a period of rapid viral replication. The virus infects dementia complex is decreasing in frequency, fortu-
andcausesdeathofCD4+T-lymphocytes;lymphocytes nately.TathasbeenusedtodeliverCuZnSOD,Hsps,
expressingthecell-surfaceantigenCD4.Somedieby andotherprotectiveproteinstocells(Section11.5.3).
apoptosis, others by pyroptosis (Section 5.4.1). These
lymphocytesareessentialtothefunctioningoftheim- 10.25.1.1 Changesinglutathione?
munesystemandthosepresentinthemucosalsurfaces Earlyindicationsthatoxidativestressmightbeimport-
exposedtoHIVareanearlytargetofdestruction.The antinHIVinfectioncamefrommeasurementsofGSH.
CD4+ glycoprotein is recognized by the HIV-1 enve- Plasma and lung lining fluids from HIV-infected pa-
lopeproteincomplex(viagp120)toallowthevirusto tientswerereportedtoshowdecreasedlevelsofGSH,
bindtoitstargetcells.OtherreceptorssuchasCCR5 cysteine,andcystine.Monocyteandlymphocytelevels
are needed for virus to enter; normally CCR5 binds of GSH were also claimed to be subnormal. The size
chemokines such as MIP-1α, MIP-1β, and RANTES ofthereportedfallsvariedbetweenlaboratories,with
(Table 5.6). Soon, the viral load falls and the patients some disagreement about whether or not there is a
become asymptomatic. This low apparent viral load fall in lymphocyte, plasma, or lung lining fluid GSH
results from an equilibrium between production of levels in asymptomatic HIV-positive patients rather
new virus and destruction of CD4+ T-lymphocytes. than in those with AIDS.1028,1029 In Rhesus macaque
Over many years, CD4+ cell numbers tend to fall as monkeys,plasmacysteineandintracellularGSHlevels
the ability of the immune system to replace them also fall two weeks after infection with simian im-
fails. When they fall below the minimum needed munodeficiencyvirus.1029 However,administrationof
for normal immune function, patients develop ‘op- N-acetylcysteinetoraiseGSHlevelsdoesnotseemto
portunistic’infectionswithorganismsnormallyeasily confermuch,ifany,clinicalbenefitinhumans,1030nor

--- Page 693 ---

638 FREE RADICALS IN BIOLOGY AND MEDICINE
didadministrationofotherantioxidants.1031 Thismay including herpes simplex type I, dengue, respira-
perhapsbeaspredicted,asdiscussedaboveinrelation tory syncytial virus (RSV), cytomegalovirus, murine
toHCVandMarburgviruses.Inaddition,theevidence Sindbis virus, hepatitis B or C viruses, and Epstein–
thatincreasedoxidativedamageoccursinasymptom- Barr virus (EBV). For example, respiratory syncytial
aticHIV-infectedsubjectsisnotcompelling.1032 virus, an important cause of respiratory tract infec-
The falls in GSH are most striking in patients tions in the young, stimulates the NADPH oxidase
with AIDS, where malnutrition due both to poor ap- activity of alveolar epithelial cells, elevates ROS gen-
petite and to impaired intestinal absorption of nu- eration,activatesNF-κB,andinactivatesproteinphos-
trients could contribute. Probably for these reasons, phatases, increasing net protein phosphorylation.1016
plasma concentrations of several vitamins and min- ElevatedlevelsofF -IsoPswerefoundinnasopharyn-
2
erals, including zinc, magnesium, selenium, vitamin gealsecretionsininfectedchildren,andlevelsseemed
B ,β-carotene,andothercarotenoids,arelowinsome tocorrelatewithseverityoftheinfection.Thisdoesn’t
12
AIDSpatients.Hencecorrectnutritionisanimportant prove that the ROS are bad of course, although they
partoftherapy.1031 could be.1020 Patients with infectious mononucleosis
causedbyEBVdevelopawiderangeofantibodiesbe-
cause of the extensiveB-cell activation caused by the
10.25.2 Redoxregulationofviralexpression
disease.OneofthemisdirectedagainstMnSODand
Studies on HIV-infected lymphocyte cell lines in cul- inhibitstheenzymeactivity.1034EBVinfectioncanpre-
turerevealthatimposingoxidativestress(e.g.byH O disposetodevelopmentofthecancerBurkittlymph-
2 2
or UV light) sometimes increases HIV gene expres- oma,whichmaybefacilitatedbyexcessiveoxidative
sion (often via increased NF-κB activation), whereas DNAdamage.1035
antioxidants diminish it. In human cells and tis-
sues, tat protein decreases GSH and MnSOD levels
10.25.3 Side-effectsoftherapy
and increases ROS production. The tat protein con-
tains multiple cysteine residues and is thus suscep- The first drug used to treat AIDS was AZT; it is still
tible to oxidation; oxidized tat will not promote viral used as part of drug combinations. Treatment with
gene expression. Thus a limited degree of oxidative AZTledtomitochondrialdamage(e.g.intheheart)in
stress could conceivably encourage HIV production about20%ofpatients,inpartbyinhibitingthemito-
(via more NF-κB activation), whereas high levels of chondrial DNA polymerase (pol-γ).1036 Elevations in
oxidative stress might deter it by oxidizing NF-κB 8OHdGlevelsinmtDNAinAZT-treatedanimals,and
(Section 5.5.6) and tat, and triggering lymphocyte increased urinary 8OHdG excretion in patients, have
apoptosis. Hence, as usual, the redox balance is all been reported. Indeed, mice with elevated MnSOD
important.1025,1026 Indeed, As O , which imposes oxi- or catalase levels showed less cardiac damage after
2 3
dativestress(Section9.16.2)hasbeenexaminedasan AZTtreatment.1037Excretionof8OHdGinAZT-treated
anti-viral agent in animals and cells.1033 In addition, patients can be decreased by oral supplements of
activation of NF-κB in the host cells may not be all α-tocopherolplusvitaminC.1036
bad;itleadstoincreasedsynthesisofseveralcytokines, One side-effect of triple therapy is to perturb lipid
including RANTES, a chemokine that can block HIV metabolism,causingabnormaldistributionofadipose
infectionofcells. tissues,e.g.lipoatrophyoftheface,arms,andlegsand
Inhibition of viral replication in cultured cells by anincreaseinabdominalvisceralfat.Patientswiththis
thiolsandsometimesother‘antioxidants’(e.g.BO-563; conditionwerereportedtohavehigherplasmaF -IsoP
2
Table11.7)hasbeenobservedforsomeotherviruses, levelsthanothersnotshowingthisside-effect.1038

--- Page 694 ---

CHAPTER 11
Ageing, nutrition, disease,
and therapy: a role for antioxidants?
Ageingseemstobetheonlyavailablewaytolivealonglife.
DFEAuber
11.1 Introduction ratsshowedlessERKactivation(byphosphorylation)
when exposed to EGF or to low (pro-proliferative)
Theincidenceofmanydiseases,includingcardiovas-
levelsofH O thandidhepatocytesfromyoungani-
cular and neurodegenerative diseases, osteoporosis, 2 2
mals;whereashigherlevelsofH O weremoredam-
macular degeneration, and osteoarthritis increases 2 2
agingtotheseoldercells.5Thuslossofsignaltransduc-
withage.Forexample,thecombinedincidenceofthe
tioncapacitywithage(eventhoughcellsmaystillhave
majorcancersincreasesapproximatelyproportionally
their surface receptors for mitogens, cytokines, etc.)
tothefourthorfifthpowerofage,bothinshort-lived
may sometimes involve loss of protein kinase activ-
species such as rats and mice and in humans (Fig.
ities.Inoldmice,thekidneysweremoresusceptibleto
10.18). Increased oxidative damage occurs in most, if
damagebyhaemoglobin,inpartduetoabluntedup-
not all, diseases (Chapter 10). Let us now examine
regulationofHO-2whencomparedwithyoungmice.6
whetheroxidativedamageisinvolvedinageingitself.
One of the many problems in studying ageing ex-
perimentallyisthedifficultyofseparatingageingfrom
age-related disease (indeed, it may be impossible).7,8
11.2 Theoriesofageing;thebasics
Mostoldanimals(includinghumans)haveovert(e.g.
‘Ageing’isaworddifficulttodefineprecisely.Inbroad hypertension, obesity) or subclinical (e.g. atheroscler-
terms, it can be described as a progressive decline osis, β-amyloid plaques) conditions that can increase
in the efficiency of physiological processes (not ne- oxidativedamagelevels.
cessarily all at the same rate) after the reproductive
phase of life, and an increase in mortality. The abil-
11.2.1 Generalprinciples
ity of cells and organisms to recover from an insult,
such as traumatic injury (or oxidative stress) also As an organism ages, its chance of death increases.
decreases with age. One example, the efficiency of Themaximumlifespanachievedtodateinhumansis
ischaemic preconditioning (Section 10.6.6) is dimin- 122years;theFrenchladyJeanneCalmentwasbornon
ishedinheartandbrainfromelderlyanimals,1andin February211875anddiedinAugust1997.Thelongest-
the arms of elderly humans.2 Indeed, oxidative dam- livedmaletodatewasShigechiyoIzumi,aJapanese,
age (measured as F -IsoP levels) was higher in older whodiedatage120.
2
thanyoungermalesafterischaemia–reperfusionofthe In many countries today (and, until recently, in all
forearm.3 Muscle atrophies with age (especially if lit- countries), few individuals reach their potential life-
tleexerciseistaken)andisslowertoregenerateafter spanbecauseofinfectiousdiseasesand/orpoornutri-
injury,andfracturestakelongertoheal.Inpart,these tion.Inadvancedcountries,suchdeathsarenowrare.
changes involve ‘ageing’ of stem cells within tissues, Thosefewpeoplewhodieundertheageof35usually
an example being decreased hippocampal neurogen- dosofromaccidents,certaininfectiousdiseasessuchas
esis in the elderly.4 However, other mechanisms are AIDS,orsuicide.Bycontrast,oldpeopleusuallydieof
also important. For example, hepatocytes from old cancer, cardiovascular or neurodegenerativediseases,
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 695 ---

640 FREE RADICALS IN BIOLOGY AND MEDICINE
stroke, or pneumonia, the last relating to an inabil- sometimesreferredtoas‘undernutritionwithoutmal-
ity to respond effectively to infection, tissue injury, nutrition’.Itproducessignificantincreasesinlifespan
or prolonged confinement in bed. Thus the average inseveralspecies,includinginsects,worms,mice,fish,
lifespan (or mean lifespan) of humans in ‘advanced’ dogs,cows,andrats.Thusthe‘average’mouseinthe
societiesisgreaterthanthatofless-developedones,but ‘average’laboratorylivesabout28months.Feedingit
the achievable lifespan is probably the same. The in- 53,31,or25%ofitsnormalcaloricintakeextendslife-
creaseinhumanlifeexpectancyinmanycountriesin spantoanaverageof33,45,or47months(asever,be
thepastdecadeshasbeenremarkable.AsKirkwood7,8 wary of extrapolation; it will not live forever if you
says‘youwokeupthismorningtowhatiseffectivelya don’t feed it at all). There are marked differences in
29-hourday:24hoursyouwillusenowandtheother the extent of the lifespan extension produced by dif-
5areputbyforlater’. ferentmousestrainsandbetweenindividualanimals,
however.15 Caloric restriction delays the appearance
ofcancers(bothspontaneousonesandthoseinduced
11.2.2 Whatfeaturesofageingmust
by administered carcinogens), slows age-related de-
theoriesexplain?7–12
cline in the immune system and brain function, and
Whatevertheoryisproposedtoexplainageing,itmust increasesthephysicalactivityofanimals,butdetersre-
account for several phenomena, one of which is the
production.ItevenattenuatesthedevelopmentofAβ
linktometabolicrate.Cold-bloodedanimals,suchas plaquesinAPP-transgenicmice,apparentlybyincreas-
insects and reptiles, live longer at lower temperat-
ingα-secretaseactivity,andenhancestissuesensitivity
ures. For example, the mean lifespan of Drosophila is to insulin, accompanied by a fall in plasma insulin
120 days at 10◦C, but only 14 days at 30◦C. Simi- levels.16Somestudieshaveproducedincreasesinlife-
larly,thenematodewormC.elegansliveslonger(and span by restricting the intake of only protein, or of
movesmoreslowly)ifthetemperatureisreduced.In- certainaminoacids(suchasmethionine),17ratherthan
sectsconsumemuchmoreO whenflyingthanatrest. total food intake—more research in this area is re-
2
Prevention of houseflies from flying, e.g. by confin- quired.Caloricrestrictionhasbeenproposedtobean
ing them in small bottles, increases their lifespan.13 evolutionary adaptation that diverts resources from
Formanyspecies,thereisanapproximateinversecor- reproduction to maintenance of the body, keeping it
relation between basal metabolic rates and lifespan. going so that reproduction can start again when the
In general, larger animals live longer and consume foodsupplyisrestored.
lessO perunitbodymassthandosmallerones.Cer-
2
11.2.2.2 Obesity,oxidativestress,andCR
tainanimalslivelongeronaveragethanpredictedby
thiscorrelation,includingpigeons,canaries,bats, na- Onemustnotforgetthatlaboratoryanimalsarekept
kedmolerats,andhumans.Someoftheseanomalies under conditions unrepresentative of nature. Animal
arediscussedlaterinthischapter.Remember,however, breeders may have selected for rodents that eat well
thatincreasedtemperatureandphysicalactivityhave and have large early litters (more animals to sell!), a
many effects on an animal’s physiology, and exercise trade-offforlongevityperhaps.Theirphysicalactivity
mayincreaselifespaninmammals(Section7.14)! isdecreasedbycaging,andfoodissuppliedadlibitum.
Asecondimportantfactorthatneedstobeexplained However,manyhumansliveessentiallythesameway
isstochasticity,thelargeandunpredictablevariability (little exercise, a lot of food)18 and obesity is a major
in the lifespans of individuals in a population; some health problem in many parts of the world. Obesity
deteriorateanddiefasterthanothers.Inhumans,this shortenslifespan,increasestheriskofmanydiseases,
is affected by diet, lifestyle, and genetics, but in la- and causes oxidative stress (Section 10.4). High-fat
boratoryorganismstheseareallstandardized;andyet (calorie-rich)dietshavebeenshowntoincreaselevels
variability remains. For example, some C. elegans age of oxidative damage in animal studies, and they can
poorly and die young, others hang on well past the aggravatethedeleteriouseffectsofsmokingandexcess
mean lifespan as the nematode equivalent of healthy ethanol consumption in humans. On the other hand,
centenarians!14 laboratoryanimalsliveinawarmprotectedenviron-
ment,whichmayhelptoconcealdeleteriouseffectsof
11.2.2.1 Caloricrestriction(CR)9 alteringvariousgenes.19
Another striking effect on lifespan is provided by SowouldhumansbenefitfromCR?Thosewhoover-
caloric restriction (eating fewer calories whilstmain- eatdobenefitfromeatingless,andcertainepidemio-
taining intake of essential vitamins and minerals), logical studies (e.g. ref20) suggest that some degree

--- Page 696 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 641
of CR would be beneficial. However, too little food overcrowding),C.eleganslarvaecanenteranalterna-
(≤ 1400 kcal/day) is also associated with increased tive developmental stage called dauer. Dauer larvae
mortality,21 although often such a diet may lack suf- are developmentally arrested, reproductively imma-
ficientvitaminsandminerals,unlike‘laboratory’CR. ture, do not eat, and do not appear to age much.
Nevertheless,thepotentialforbenefitisshownbyex- Theycansurviveforalongtimeuntilconditionsim-
periments on CR in Rhesus monkeys that began in prove,whereupontheyresumedevelopmentintothe
1987 at the National Institute of Aging (NIA) in the adult.
USA.Halfeatadlibitumandtherestreceive30%lessof Becauseoftheshortlifespanandwell-characterized
thesamediet.Dataareconsistentwithrodentstudies, structure and genetics of C. elegans, many scientists
in that CR-monkeys and rodents are smaller, mature have looked for genes that influence lifespan in this
later, have lower blood glucose and insulin levels, worm.Theyhavereapedarichharvest.Forexample,
and slightly lower body temperatures, yet increased some mutations in the age-1 gene slow muscle de-
daytime activity and lower risk of cancer. Is lifespan generation and can extend life expectancy by 40 to
in the monkeys increased? Not so far in these stud- 100% or even more in some cases; they do not af-
ies.ButinanothergroupofRhesusmonkeysstudied fectreproduction,andmovementisnormal.Thisisan
since1989attheWisconsinNationalPrimateResearch important control; in cold-blooded animals increased
Center in Madison USA, CR did appear to increase activity often shortens lifespan. Any change that al-
lifespan.22 tersO consumption(e.g.byincreasingordecreasing
2
activity)orfoodintake(e.g.leadingtoCR)couldprod-
uce indirect effects on lifespan, which might be mis-
11.3 Whattheoriesofageing
takenforidentificationofan‘ageinggene’.However,
exist?7–12,23–26
completeablationoffunctionalage-1doesdecreasefer-
tilitysubstantiallyandthelifespanisincreasedupto
Theories proposed to explain ageing fall into three
tenfold.27
general groups. There are genetic theories, in which
Mutations in the daf-2 gene also increase lifespan;
gene-controlled,programmed‘biologicalclocks’(Sec-
the DAF-2 protein resembles the mammalian recep-
tion 11.3.5) regulate growth, maturity, and old age;
tors that allow cells to respond to insulin or insulin-
neuroendocrine theories; and damage-accumulation
like growth factors (IGFs) (Figs 11.1 and 11.2). The
theories (Table 11.1). In fact, this distinction is artifi-
Daf2 gene product is involved in dauer formation;11
cial,becauseallofthesemechanismsareinvolvedand
harsh environmental conditions act, in part, by de-
interrelated.
creasing insulin/IGF signalling, whereas when food
isrestoredligandsarereleasedfromsecretorycellsin
thenervoussystemtoactivatethepathway.24 Ligand
11.3.1 Dogenesinfluenceageing?Thestory
binding to DAF-2 activates a kinase cascade involv-
ofC.elegans11,24–26
ingtheproteinencodedbyage-1.Theend-resultisto
Yestheydo;adatabaseexiststhatlistsalmost300genes phosphorylateatranscriptionfactor,DAF-16,whichis
linkedinsomewaytoageing<genomics.senescence.info/ thensequesteredinthecytoplasminaninactiveform
longevity/>.Mostevidenceforaroleofgeneshascome (Fig.11.2).TheDAF-16proteinisamemberofthefam-
from studies on Drosophila, yeast, and the nematode ilyofforkheadtranscriptionfactorsofclassO(FOXO),
wormC.elegans,althoughtherearesomerodentand which are stopped from working upon phosphoryl-
humandata. ation because they are excluded from the nucleus
C. elegans normally lives for about 20 to 25 days (Section5.5.4.2).Leftunphosphorylatedasaresultof
when food (bacteria such as E. coli) is abundant. mutationsinage-1ordaf-2,DAF-16proteinentersthe
At20◦C, it develops from embryo to sexual matur- nucleusandcausesthetranscriptionofgenesthatpro-
ity in about 3–4 days, lays most of its eggs in the mote longevity and resistance to stressors, including
next 3–4 days, and then survives for the rest of its heatandoxidativestress(Fig.11.1).Geneswhoseex-
lifespan with deteriorating function, such as muscle pressionisincreased28byactiveDAF-16includethose
wasting and deterioration of motor neurons, accom- encoding antioxidant defences (Section 11.4.1), anti-
paniedbyslowingmovement.C.elegansisahermaph- microbial proteins (C. elegans feeds on bacteria, but
rodite and reproduces primarily by self-fertilization, they can also damage its gut), heat-shock proteins
firstproducingsperm,andlatereggsforthespermto (Hsps),andmembersoftheubiquitin–proteasomesys-
fertilize. When threatened (e.g. by food restriction or tem.Bycontrast,DAF-16decreasesexpressionofgenes

--- Page 697 ---

642 FREE RADICALS IN BIOLOGY AND MEDICINE
Table11.1 Sometheoriesofageing.
Theory Summaryoftheoryasoriginallyproposed
Freeradical Randomcumulativedeleteriouseffectsoffreeradicalsproducedduringnormalaerobicmetabolism.
Cross-linkage Randomcross-linksofDNAandproteinsdisruptfunction.Overlapswithfree-radicaltheory.
Errorcatastrophe Cumulativerandomerrorsinproteinsynthesis,affectingproteinfunctionandgenetranscription.
Glycation GlycationofproteinsandothermoleculesleadstoAGEformation(Section10.5.5)anddisruptionofcellfunction.
Longevitydeterminants Ageingiscausedbytheproductsofcellularmetabolism,andtherateofageingisgovernedbyprotectionagainst
thesedamagingproducts.Overlapswithfree-radicaltheory.
Membranehypothesis Membranedamageleadstodecreasedeliminationofwasteproducts,decreasedproteinsynthesis,andlossof
waterfromthecytoplasmleadingtodecreasedenzymicactivities.Overlapswithfree-radicaltheory.
Inflammatoryhypothesis NF-κBandAP-1activitiesriseintissuesastheyageandcauseformationofmorecytokines,COX,prostaglandins,
andRSthatdamagetissues.Overlapswithfree-radicaltheory.
Cellsenescencehypothesis Progressiveaccumulationofsenescentcellscausesageingoftissues;senescenceofstemcellsimpairs
regenerativecapacityoftissues.
Neuroendocrine Changesinneuralfunctionandhormonescauseage-relatedphysiologicalchangesbyinterferingwith
co-operationbetweenorgansandimpairingtheresponsetoexternalstimuli.Sometheoriesalsoincorporate
changesintheimmunesystemproducedbyneuroendocrinealterations;thusasoneagestheimmunesystem
becauselessgoodatdealingwithinfectiousagentsbutmorelikelytocauseautoimmunity.
‘Hyperfunction’theories Earlyinlifethereisselectiontogrowandreproduceasfastaspossible,involvingrapidsynthesisofmany
biomolecules.Theremaybelessselectivepressuretostopmakingthem,whichcouldbedeleteriousatolderages.
OnesuggestedexampleisyolkproteininC.elegans,whichcontinuestobemadeandaccumulatesintheworm
evenwhenegglayingisfinished,perhapscausingdeleteriouseffects(Ann.Rev.Physiol.75,621,2013;Antioxid.
RedoxSignal.19,321,2013).
Multipledamage-accumulationtheorieshavebeenproposed,butaresimilarinthattheyassumesomeprogressiveaccumulationofdamagebecauserepairand
maintenancearealwayslessthanthoserequiredfor‘indefinite’survival.Evolutionhaslittle‘interest’inmaintainingthesomainthepostreproductiveyears(the
disposablesomatheory).7,8,10Faultymacromoleculescanaccumulatebothbygeneratingmoreofthem(e.g.bymoreerrorsingenetranscriptionormRNAtranslation,
and/orbydamagingmacromoleculesmore)and/orbyfailureofsystemsthatrepairordegradethem.Apopularideainitstimewastheerror–catastrophetheory,
introducedin1963.ItproposedthaterrorsintranscriptionofRNAanditstranslationintoproteineventuallyleadtoaccumulationofalterednon-functionalproteinsin
oldcells,reachinglevelsthatultimatelyleadtoan‘errorcatastrophe’offailuretofunction.However,althoughsomealterednon-functionalorlessactiveenzymeshave
beenisolatedfromagedcells,thereisnoevidenceforaccumulationofalteredproteinstoveryhigh(‘catastrophic’)concentrationsintissuesfromoldanimals,andonly
limitedevidencethatthefidelityoftranscriptionortranslationdecreaseswithage.Asimilarcriticismcanbemadeaboutthe‘membranehypothesis’;membranesarenot
fallingapartincellsfromoldanimals,andAGEproteinsarepresentbutnotathighlevels(exceptindiabetes).
encodingsomeotherproteins,includingvitellogenin incomplexIIoftheelectrontransportchain,whereas
(ayolkprotein)andINS-7(Fig.11.1). ctl-1codesforacytosoliccatalase.Mutationsineither
Another C. elegans gene whose mutation confers ofthesemayaggravateoxidativedamage.Mutantsin
increased lifespan and stress resistance is clk-1 (clk mev-1 show shortened lifespan, whereas ctl-1 muta-
for ‘clock’), which encodes a mitochondrial protein tionsarereportedtoshortenlifespaninsomestudies
involved in the synthesis of coenzyme Q. These mu- butnotothers.30 Incontrast,knockoutofperoxisomal
tantslackthenormalC.elegansCoQ (Fig.1.8,legend) catalase in C. elegans causes a drastic shortening of
9
and must obtain CoQ from the diet (E. coli contains lifespan.30
CoQ ). Themutationimpairs29 electrontransferfrom
8
11.3.1.1 Whataboutmammals?
complex I to complex III, but does not seem to af-
fectmetabolicactivitymuch.TheCoQ precursorthat Just as an insulin-like signalling pathway affects lon-
9
accumulates (demethoxyubiquinone) may even be a gevity in C. elegans, hormones and receptors do the
betterantioxidantthanCoQ . same in mammals (Fig. 11.2). Indeed, CR in animals
9
C.elegansmutationsthatshortenlifespanhavealso decreases insulin and IGF-1 levels. Unlike C. elegans,
been described,24 but one must be careful here; any which has one gene (daf-2) encoding an insulin/IGF-
mutation that makes an animal sick might shorten like receptor, animals have separate receptors for
its lifespan, and need not be affecting ageing per se. insulin and IGF-1, affecting multiple aspects of
The gene mev-1 encodes a subunit of cytochrome b metabolism.31 Binding of IGF-1 to its receptors is

--- Page 698 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 643
Figure11.1 AgeingversuslonglifeinC.elegans:thesignallingmoleculesinvolved.ThetranscriptionfactorDAF-16controlstheexpressionofa
batteryofgenesthataffectlifespan.Pro-longevitygenesincludethosethatencodeantioxidantenzymes,orheat-shockproteinsthatcanhelpto
restoremisfoldedproteinstotheircorrectconformations.Genesthatpromoteageingincludesomethatencodeyolkproteins,consistentwithalink
betweenageingandreproduction.Anotherpro-ageingproteinistheinsulin-likeINS-7,which,bybindingtotheinsulin/IGF-1receptor(DAF-2),
mayrepressDAF-16inthesameandothercells.ThissuggeststhepresenceofapositivefeedbackloopthatregulatesDAF-2activity.Arrows
indicateactivation;T-barsindicateinhibition.FromNature424,259,2003,bycourtesyofElsevierandDrsDavidGemsandJoshuaMcElwee.
Yeast Worms Flies Mice Humans
Growth hormone Growth hormone
Ligands Glucose Insulin/IGF-1-like Insulin/IGF-1-like IGF-1 IGF-1
Receptors Gpr1 DAF-2 INR IGF-1-receptor IGF-1-receptor
CHICO
G-proteins Ras2 Ras Ras
Second messengers Cyr1 (cAMP) AGE-1 (Ptdlns-3-Ps) PI3K (Ptdlns-3-Ps) PI3K (Ptdlns-3-Ps) PI3K (Ptdlns-3-Ps)
? ? ?
Serine/ PKA Akt/PKB Akt/PKB Akt/PKB Akt/PKB
Threonine-kinases
Stress resistance
transcription factors ? Msn2, Msn4 DAF-16 ? ? ?
Stress-resistance SOD, catalase, Hsps, SOD, catalase, Hsps, SOD, fat SOD, catalase, Hsps ?
proteins glycogen accumulation, ...? fat and glycogen accumulation, ...? fat accumulation, ...? fat accumulation
accumulation, ...?
? ? ?
(Growth) (Growth) (Growth) (Growth) (Growth)
Aging Aging Aging Aging/diseases ?
Figure11.2 Conservedregulationoflongevity.Inyeast,worms,andflies,thepartiallyconservedglucoseorinsulin/IGF-I-likepathwaysdecrease
antioxidantenzymesandheatshockproteins,reducetheaccumulationofglycogenorfat,andincreasegrowthandmortality.Mutationsthat
reducetheactivityofthesepathwaysextendlongevity.Inyeastandworms,theinductionofstress-resistancegenesisrequiredforlongevity
extension.Inmice,IGF-Iactivatessignaltransductionpathwaysanalogoustothelongevityregulatorypathwaysinlowereukaryotesandincreases
mortality.FromScience299,1342,2003,bycourtesyofthepublishersandDrValterD.Longo.FordetailsofthePI3kinaseandAktpathways,
consultSection5.5.4.

--- Page 699 ---

644 FREE RADICALS IN BIOLOGY AND MEDICINE
involved in the actions of several molecules control- mousestrainsshowabnormaldevelopmentofthepi-
ling energy metabolism, including growth hormone, tuitarygland,andhavelowlevelsofgrowthhormone,
insulin, IGF-2, leptin, and adrenal steroid hormones. whichinturnleadstolowlevelsofIGF(growthhor-
It also plays a key role in maintaining muscle mass. monenormallyincreasesIGF-1production).Theylive
CompletelyinactivatingtheIGF-1receptorislethalin longer, and develop cancer less frequently on aver-
mice,butheterozygousknockoutsseemtobenormal age. One example is the Ames dwarf mouse, which
andhavelivedupto30%longerthancontrolsinsome livesabout3yearsandhasadefectinapituitarytran-
studies(resultsareaffectedbythegeneticbackground scriptionfactor,leadingtoloweredsecretionofgrowth
oftheanimals),especiallyfemalemice.26,32Micewitha hormoneandinsulin.33,34Similareffects(lesscanceror
targeteddisruptionofthegeneencodinginsulinrecep- diabetes)havebeenreportedinpeoplewithmutations
torsinadiposetissue(butnotinliver;lossofthegene inthereceptorforgrowthhormone.33
therecausesdiabetes)havelifespanextendedbyabout Animals also have FOXOs resembling DAF-16.
18%(furtherevidencethatfatislinkedtoageing). FOXO1, FOXO3a, and FOXO4 are regulated by
TheIGFreceptorinanimalsworksthroughatleast hormones and growth factors via the PI3 kinase–
two signalling pathways, one of which involves two Akt pathway (Fig. 11.2; Section 5.5.4.2); when
formsoftheShcprotein,p66shc andp52shc.Whenac- unphosphorylated they enter the nucleus and
tive,p66shcincreasesROSproductioninmitochondria modulate the expression of genes affecting apop-
by several mechanisms (Sections 5.4.2.2, 10.14.6, and tosis,cellcyclearrest,differentiation,gluconeogenesis,
11.4.1). In mice with fewer IGF-1R receptors, p66shc fat breakdown, DNA repair, and antioxidant de-
is underphosphorylated and so less active. Indeed, fence. Exactly which genes are affected depends on
in some (but not other) studies, mutating p66shc has the cell type, the cell environment, and what other
extended the lifespan of laboratory mice and pro- transcriptionfactorsareactive.
moted resistance to oxidative stress and apoptosis Overactivityofp53(Section10.14.4.2)inmicemakes
(Section 11.4.1).19 However, don’t get too excited; it themappeartoagefaster(shortenedlifespan,hunch-
shortenedthelifespanofmicelivinginamorenatural backed spine, thinning of the skin, muscle atrophy,
environment.19 Several other mutations decreasing poorwoundhealing,andosteoporosis;Fig.11.3),pos-
hormoneproductioncanincreaselifespan;somedwarf sibly related to the role of this protein in promoting
Figure11.3 (colourplate25)Apparent
‘prematureageing’causedbyexcessiveactivityof
p53.Representative20-month-oldskinnedp53+/+
femalemouse(top)andage-andsex-matched
p53+/mmouse(bottom).Pronouncedlordokyphosis,
lossofbodymass,muscleatrophy,andlossof
adiposetissueisevidentinthep53+/mmouse.From
ref35bycourtesyofNaturePublishingGroupand
DrLawrenceA.Donehower.

--- Page 700 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 645
cellsenescence.35Indeed,p53-mediatedapoptosismay 11.3.2 Genesandhumanlongevity
require p66shc (Section 10.14.6). These mice are, how-
Ageingmightinvolvedeleteriouseffectsoftheexpres-
ever, less likely to develop cancer (given the role of
sionofgenesinlatelifethatconferbenefitinearlylife,
p53asatumour-suppressorgene)anddonotshowall
especially if they enhance reproductive success (e.g.
features of ageing; brain amyloid deposits, cataracts,
keepingyoualivetoreproduce).7,8,12Anabilitytorap-
andintestinalatrophyarenotincreased.Indeed,p53is
idly store fat in the body when food is available is
muchmorethanatumoursuppressorproteinandhas
remarkablyusefuliffoodisperiodicallyinshortsup-
complex interactions with the SIRT1 (Section 11.3.4),
ply,ashappenedduringhumanevolution.It’sanuis-
mTOR(Section11.3.4),andIGF-1pathways.Thereare
anceinmanycountriesnowthatfoodisfree-flowing.18
even suggestions that a polymorphism in the human
Genes that keep you alive when young so that you
p53 gene that places a proline residue in place of an
canreproduceandpassthemontothenextgeneration
arginineatresidue72oftheproteincanincreaselife-
willbeselectedforwhatevertheydoduringthepost-
span without elevated cancer risk, perhaps by being
reproductive years. The mutant gene responsible for
more effective in causing malignant cells to undergo
Huntingtondisease(Section10.23.2)hasbeenhypothe-
apoptosis.36
sizedtobeselectedforinthisway:43youngadultspos-
Microarray analysis and other omics technologies
sessingitmaybemorefertile.Similaradvantagesmay
(lipidomics, metagenomics, proteomics, metabolom-
come from thalassaemia (Section 3.22.5.3) and idio-
ics)havebeenusedbyvariousgroupstotrytounder-
pathic haemochromatosis (Section 3.22.5.2); the first
standwhathappensduringageing,butdatamustbe
helping to prevent early death from malaria and the
interpretedwithcaution.37 Forexample,inrathippo-
secondfacilitatingironuptake,whichmayfavoursur-
campus,ageingisassociatedwithincreasedexpression
vivalofmotherandbabyduringpregnancyifthefood
ofgenesencodingproteinsinvolvedininflammation,
supplyiserraticand/orlowiniron.Avigorousinflam-
cholesterol metabolism, and iron metabolism (among
matory response to kill pathogens is beneficial, even
others),whereasgenesencodingproteinsinvolvedin
if over-exuberant inflammation gives you cancer and
synapticplasticity,chaperones,andaproteasomesub-
cardiovasculardiseaseslaterinlife(post-reproductive
unit were less expressed.38 Broadly similar changes
years).18ArecentexamplecomesfromGhana.44
were seen in human frontal cortex.39 Skeletal muscle
This concept is strikingly illustrated by the Pacific
from old Rhesus monkeys also showed increased ex-
salmon.10 Itgrows,reproducesonce,andthendeteri-
pression of genes associated with inflammation and
oratesfastanddies—itvirtually‘fallsapart’.Sincethe
less of genes encoding mitochondrial enzymes, in-
chances of a Pacific salmon surviving to reproduce
cluding MnSOD.40 However, changes in the patterns
againaresmall,evolutiondidnotfavour‘holdingback
of gene expression in the brains of ageing mice,
resources’ for survival after reproduction. To quote10
men,andmacaquesshowsomesimilaritiesbutmany
‘therapiddeteriorationofPacificsalmonaftermating
differences.41 In the ‘normal’ ageing human brain,
is a natural byproduct of a life history that has been
levels of the transcription factor REST (repressor
geared by natural selection to stake everything on a
element 1-silencing transcription factor) increase in
single bout of reproduction. As soon as the signal to
neuronsinthecortexandhippocampus.RESTseems
reproduceistriggered,amassiveeffortismadetomo-
to be neuroprotective by increasing antioxidant and
bilizeallavailableresourcestomaximizereproductive
other defences. In AD, less REST is present, perhaps
success, even if this leaves the adult so severely de-
facilitatingneurodegeneration.42
pletedordamagedthatdeathensues’.Thedisposable
Thesegenomicandotheromicsdatadonotaddup
somatheory(Table11.1)arguesthatorganismsonlyin-
to a clear picture as yet. Please remember that gene
vestenoughresourcesinmaintenanceofthesomato
expression can change during tissue handling (Sec-
maximizereproduction.
tion 10.6.10), that different cells in a tissue are likely
to be expressing genes differentially (which can con-
fuse studies when DNA extracted from the whole
11.3.3 Prematurehumanageing34
tissue is examined), and that any changes identified
onmicroarraymustbefollowedupwithexperiments Thehumanprogeroid(‘prematureageing’)syndromes
demonstrating that increased gene expression gives (Hutchinson–Gilford syndrome and Werner syn-
rise to increased protein product, and (even more drome) provide striking evidence that some genes
fundamental) that that protein product is actually havemajoreffectsonageing(orwhatlookslikeage-
active.37 ing).Hutchinson–Gilfordsyndrome(sometimescalled

--- Page 701 ---

646 FREE RADICALS IN BIOLOGY AND MEDICINE
progeria)isarare,dominantlyinheriteddisease(one damage.47 Mice carrying mutations in the XPD gene
inevery4–8millionbirths).Newbornsappearnormal (Section 5.10.3), which also encodes a helicase, again
but at about 1 year old, severe growth retardation is showsignsofprematureageing.MutationsinXPDin
observed.Lossofhairandsubcutaneousfatmakethe humanscancausetrichothiodystrophy,characterized
skinappearold(Fig.11.4)andpigmented‘agespots’ bysome(butnotall,e.g.noincreasedcancerincidence)
are present. The subjects have an average weight of features of premature ageing. Different mutations in
~11–14 kg and a height of around 100 cm, as teen- thesamegenecanresultinxerodermapigmentosum
agers.Theyhavenormaltoaboveaverageintelligence (Section10.14.4.3).PatientswithCockaynesyndrome
but sadly many die by about 13 years, often due to (Section5.10.3)alsoshowsomefeaturesofaccelerated
heart failure or stroke, consequential on accelerated ageing;theaffectedgeneagainencodesahelicase.
atherosclerosis. The defective gene encodes (by al- However,theprogeroidsyndromesarenotfullyrep-
ternative splicing of mRNA) two structural proteins resentativeof‘acceleratedhumanageing’.Featuresof
in the nucleus, lamin A and lamin C. A defective normal ageing absent in progeria include increased
lamin A (sometimes called progerin) results; it even- frequencyofcancer,neurodegenerativedisease,catar-
tuallycausesnucleitocollapse,andthereisimpaired acts, and bone demineralization. Similarly, Werner
repair of DNA damage. Mice deficient in lamin A, syndromehasbeencalleda‘caricatureofageing’,al-
or in the proteinase involved in its formation, simi- thoughthereisanincreasedriskofcancerandcataract
larlyshow‘prematureageing’.Excessiveactivationof development.
p53triggeredbythenuclearabnormalities,45mayalso
contribute. Defects in lamin can occur randomly and
11.3.4 Mechanismsofcaloricrestriction;
spontaneouslyduringnormalageing.46
learningfromyeast9,48
Werner syndrome is a rare, autosomal-recessive
mutation in a gene on chromosome 8. Affected indi- HowdoesCRwork?Importantclueshavecomefrom
vidualsseemnormalduringchildhoodbutstopgrow- studieswiththeyeastS.cerevisiae.Itproducesprogeny
ing during their teens. Greying and whitening of the bybudding:leaving‘old’material(includingoxidized
hair occur at an early age, and the skin appears old proteins)49 in the mother cell. Eventually the mother
and scaly. Patients develop early cataracts, tumours, cellsbecomesenescent,usuallyafterabout20to25di-
bonedemineralization,anddiabetesandshowmuscle visions.ToquoteNemotoandFinkelfromNature429,
atrophy, poor wound healing, poor gonad develop- 149(2004),‘themiddle-agedyeastcellisslower,fatter
ment, and accelerated atherosclerosis. They usually andlessinterestedinreproduction’,ratherlikemany
die in their 40s from atherosclerosis-related condi- middle-agedhumans.Whenglucoseisplentiful,yeast
tions or cancer. The defective gene encodes an en- cellsbudrapidly,andthensenesce.Ifglucoseisrestric-
zyme with helicase and exonuclease activities that is ted, cell division slows, stress resistance mechanisms
essential for genome stability, facilitating unwinding are upregulated, lifespan extends, and reproduction
of the DNA double helix to allow transcription, rep- slows or ceases. These mechanisms allow the cell to
lication, and repair of damage, including oxidative surviveuntilfoodisplentifulagain,whereuponrepro-
ductionresumes.
The response to glucose involves protein kinases
(Fig. 11.2); if genes encoding them are mutated, div-
isionslowsandlifespanincreasesevenwhenglucose
is plentiful. This increase can be blocked by further
mutationsthatimpaireitherNAD+ productionorthe
activity of an NAD+-dependent histone deacetylase
enzyme called Sir2 (silent information regulator 2).
Thisenzymecleavesnicotinamidefromtheribosering
of NAD+ and attaches the acetyl group it takes from
the protein to the remainder of the NAD+ molecule
to form O-acetyl-ADP-ribose and a deacetylated pro-
tein.Despiteitsname,Sir2isnotspecificforhistones
and can remove acetyl groups from many other pro-
Figure11.4 (colourplate26)A6-year-oldgirlwithprogeria. teins.Over-expressionoftheSir2genedecreasesyeast
PhotobycourtesyofPLoSBiol3,e395,2005.
senescence even when glucose is plentiful, whereas

--- Page 702 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 647
its inactivation accelerates senescence. C. elegans has gamma coactivator 1-α) receptor. Nitric oxide from
a gene resembling Sir2, which encodes a component the rise in eNOS activity in CR further facilitates
oftheDAFpathway,beforeDAF-16.Whataboutani- mitochondrialbiogenesis.56 Sirtuinsmayalsohavean
mals? Present there as well. For example, SIRT1 is anti-inflammatoryeffect.9
a human deacetylase enzyme that closely resembles By what mechanism does CR affect the sirtuins?
the yeast and C. elegans proteins—it is one of at least NicotinamideandNADHinhibitthem.Inyeast,CRre-
seven human enzymes of this type, three of which lieves this by decreasing NADH levels (due to lesser
(SIRT3–5)arepresentinmitochondria.They(SIRT3es- glucose metabolism) and/or by increasing the levels
pecially) regulate the acetylation levels of multiple ofanenzyme(Pnc1)57thathydrolysesnicotinamideto
enzymes involved in mitochondrial metabolism, e.g. nicotinic acid, which can then be used to make more
promotingfatcatabolismduringCRbydeacetylating NAD+. The levels of NAD+ regulate sirtuin activity
andactivatingseveralenzymes.Theycanalsoremove in animal cells as well (e.g. consumption of NAD+
succinyl-, malonyl-, and long-chain fatty acyl groups byPARP[Section5.2.5]candecreasesirtuinactivity).
fromproteins. NAD+levelsinanimaltissuesfluctuateonacircadian
SIRT1hasseveralmetabolicroles,includingregulat- rhythm,andmaydecreasewithage,perhapsimpairing
ingliverglucosemetabolism.Indeed,Sir2-likeproteins sirtuin function.58 Would consuming extra nicotina-
(sirtuins) with deactylase activity seem to be present mide help us to age better? Maybe not; adding large
in all organisms, from E. coli to humans. The phen- amounts of nicotinamide to the diets of young male
olic compound resveratrol, found in red wine, (Fig. ratsimpairedglucosetoleranceandinsulinsensitivity
4.7) has been claimed to activate Sir2 and SIRT1 (al- andincreasedoxidativedamagelevels(Table4.1).
though conflicting data have been published).48,50–52 Another important mechanism of action of CR
Woulddrinkingwineincreasehumanlifespan?Prob- involves mTOR (Section 5.14.3.1), a conserved ser-
ably not; human plasma levels of resveratrol are low ine/threoninekinasefoundinalleukaryotes.12,59 One
in wine drinkers since there is rapid metabolism by of its roles (as mTORC1; Section 5.14.3.1) is to con-
sulphationandconjugationwithglucuronicacid.53But trol protein and lipid synthesis and cell growth in
console yourself; moderate wine intake may be good responsetotheavailabilityofaminoacids.Whennu-
foryouinotherways(Sections4.5and9.8.1)andbetter trientsareplentiful,mTORevokessignallingpathways
activators of SIRT (e.g. SRT1720) are under develop- that encourage cell growth and division. When nu-
ment, although beware that too much SIRT activity trients are in short supply, mTOR is less active and
mightnotalwaysbegoodforyou!54 ratesofproteinturnover(e.g.byautophagy)increase
The Sir2 and SIRT1 enzymes act on several sub- andcellgrowth/replicationareslowed.60 Autophagy
strates, including HIF-1α, HSF-1 (Section 5.6), some of proteins releases amino acids for biosynthesis of
DNA repair systems (e.g. Ku70; Section 5.10.6), and essentialnewproteins,butinparallel,itsincreasedac-
p53. p53 is stabilized by acetylation (which reduces tivityhelpstoclearmisfoldedorotherwiseabnormal
bindingtomdm2;Section10.14.4.2),andsodeacetyla- proteins.Indeed,treatmentwiththemTORC1inhibitor
tion of it decreases its pro-apoptotic activity.54 The rapamycinhasextendedlifespaninseveralorganisms
activityofanimalFOXOscanbedecreasedbyacetyl- including C. elegans and mice,60 although it modified
ation that is reversed by sirtuins, and sometimes only some of the effects of ageing in the mice.61 In-
this deacetylation can over-ride the nuclear exclu- sulin and insulin-like growth factors are important
sioneffectsofphosphorylation.55 Theoveralleffectof activators of TOR and lower levels of them will thus
SIRT1 may be to increase the ability of FOXOs and decreaseTORactivity.
p53 to induce cell cycle arrest and raise antioxidant
and other defences, but decrease their pro-apoptotic
11.3.5 Telomeresandcellular
effects.54,55 Sirtuins are involved in the neuroprotect-
senescence47,62,63
ive effects of CR in some animals e.g. by activating
α-secretase and decreasing Aβ formation, decreasing Telomeres are found at the ends of chromosomes in
microglialactivation,increasingthelevels9,48ofBDNF eukaryoticcells.Inmosteukaryotes,theycontainmul-
(Section 10.21.7), and promoting vascular endothelial tiple (several thousand in humans) DNA base repeat
function, e.g. by increasing eNOS activity. Caloric re- sequences (TTAGGG in humans) that are generated
strictioninratsincreasestissuelevelsofSIRT1,which byanRNA-containingenzyme,telomerase.TheRNA
promotes mitochondrial biogenesis by activating the provides a template for the addition of the repeat
PGC-1α (peroxisome proliferator activated receptor sequencestoDNA.Telomeraseactivityisregulatedby

--- Page 703 ---

648 FREE RADICALS IN BIOLOGY AND MEDICINE
aclusterofproteinsknownasshelterinthathelpsto cellswilldie,but‘immortal’cellsthatcontinuetogrow
protect the chromosome ends and decreases telomer- aresoonselected;mostsuchcellshavetelomeraseand
aseactivitywhenthecorrecttelomerelengthhasbeen donotundergotelomereshortening.Thusinactivation
obtained. oftelomeraseisoneapproachtocancertherapy.Genes
Whyaretelomeresneeded?DNApolymerasesuse affecting telomere length or the rate of telomere loss
the information in one DNA strand to make another. couldobviouslyinfluencetheageingprocessatthecel-
However,theyneedaprimer(usuallyRNA)tostartoff lularlevel.CellsfrompatientswithprogeriaorWerner
thenewstrand;itattachesatthe5(cid:4)endoftheDNAse- syndrome, for example, have pronounced shortening
quencebeingcopied.Withouttelomeres,therewould oftelomeres.TelomerasealsoactstoincreaseNF-κBac-
bealossofDNAateachroundofreplication;thepri- tivityincancercells;theyappeartobeco-conspirators
merisremovedfromthenewstrandandthesequence inpromotingmalignancy.67
of bases in the DNA to which it was bound will not
be present in the new DNA strand. Up to 200 base 11.3.5.1 Anartefactofcellculture?63,68,69
pairs are lost from telomeres at each chromosomal Issenescenceofcellsgrowninthelaboratoryrelevant
division.Telomeresalsoprotectthechromosomeends in vivo? Cell culture imposes oxidative stress (Sec-
fromdamageorfusion,helpingtomaintaingenomic tion1.11);indeed,growingcellsatlowpO increases
2
stability. Mice lacking telomerase eventually become the number of cell divisions they can undertake and
sterileandshowsomefeaturesofprematureageing. delayssenescence,whichiswellknowntobeonecon-
In 1961, it was reported that mammalian primary sequenceofoxidativestress(Section5.2.4).Oxidative
cells undergo only a certain number of cell divisions stresscausesDNAdamageandcanacceleratetheloss
when cultured in the laboratory. For example, fibro- of telomeres. It also increases lipid and protein dam-
blasts taken from a human foetus will divide only age;indeed,increasingproteasomeactivitycandelay
about50times.ThiswascalledtheHayflicklimit,after cellsenescence.64Some‘antioxidants’(e.g.N-tert-butyl
the pioneer in ageing biology who first described it. hydroxylamine:Section11.5.5)candelaysenescencein
Whenthelimitisreached,thecellsnolongerrespond cellculture.
tomitogensdespitethefactthatreceptorsforthemcan If senescence of cells in culture is promoted by
stillbepresent(althoughlevelsofthesereceptorsmay oxidative stress, it follows that telomeres are not a
sometimesalsofall)andaresaidtobeinsenescence(a fixed ‘molecular clock’ of ageing. Indeed, in cultured
terminal G 0 state of non-division; Section 5.2.4). Sen- mouseembryonicfibroblasts,oxidativestressappears
escent human cells have, on average, lost about half tobemoreimportantthantelomerelossasacauseof
of their telomeric length and show an accumulation senescence. For human fibroblasts, both are probably
ofoxidizedandubiquitinatedproteinsanddecreased involved. For example, decreasing CuZnSOD activ-
proteasomeactivity.64Hence,telomereshorteningwas ity in cultured human fibroblasts by RNA interfer-
suggestedtobea‘molecularclock’oftheageingpro- ence led to senescence70 involving activation of p53,
cess. Short telomeres have been proposed to trigger whereas overexpression of SOD delayed senescence
senescencebysignallingaDNAdamageresponseand andtelomereshortening.71Acceleratedtelomereshort-
haltingcellproliferationbymechanismsinvolvingp53, eningincellsfrompatientswithataxiatelangiectasia
p21,andsometimesp16.Senescenceisalsoaccelerated (Section 5.10.8.2) also appears to involve oxidative
(probably not via actions on telomeres) in cells over- stress,72 and decreasing MTH1 expression promoted
expressing oncogenes, as one mechanism deterring senescenceinfibroblastsinculture(Section5.10.2)The
cancer development (Section 10.14.4.2). For example, G-richnatureoftelomeresmaysensitizethemtooxida-
the ras oncogenes may accelerate ROS production to tivedamage,sinceGistheeasiestDNAbaseforRSto
an extent that elevates oxidative DNA damage, in- attack(Section5.8.2).OxidativedamagetoGcanalso
creases p53 activity (‘policeman of the oncogenes’; weaken the association of the shelterin proteins with
Section10.14.4.2),andtriggerssenescence.65,66 thetelomericDNA,73exposingittofurtherdamage.
Telomerase is absent from most cells (exceptions Nevertheless,theolderananimalfromwhichcells
include germline cells and bone marrow stem cells). are taken, the fewer cell divisions occur in culture,
In contrast, it is presentin many malignant tumours, suggestingsomerelationshipofsenescencewithage-
suggesting that telomere elongation is involved in ing. Senescence is also faster in cells from progeria
inappropriate cell replication and tumour growth. patients.34Increasedlevelsofa‘senescence-associated’
If cultured cells are exposed to certain viruses (e.g. β-galactosidaseenzyme—andtosomeextentelevated
Epstein–Barr virus, human papilloma virus), many p16 levels—are thought to be markers of senescence.

--- Page 704 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 649
Insome(butnotall)studiesβ-galactosidasehasbeen 2. Production of RS can be envisaged as the con-
detected in human skin, to an extent increasing with sequence of genes selected because they confer
age. It has also been reported in certain cells within benefitinearlylife,e.g.byfacilitatingsignaltrans-
atherosclerotic lesions, venous ulcers, tissues around duction. When humans first crowded together in
certain malignant tumours, arthritic joints, and pre- cities,infectiousdiseasewasamajorthreat.Phago-
malignant tissues from both human and mouse.68,69 cyteproductionofRSisbeneficialintheshortterm
Several authors have implicated senescence in age- bydecreasingtheriskofdeathfrominfectionsbe-
ing of the cardiovascular systems.62 Introduction of foreorduringthereproductiveyears.44 Evolution
telomerase into some cell lines in culture can delay doesn’tcareifoverexuberantRSproductiongives
senescence, diminish oxidative stress, and decrease youcancerdecadeslater.18
β-galactosidaseexpression,althoughonemustbecare- 3. Thetheorycanexplaintherelationbetweenmeta-
ful to check that antioxidant defences do not also bolicrate,O consumption,andlifespan.Ifafixed
2
change. Why β-galactosidase appears, and what it is percentage of the O consumed forms ROS, then
2
for,areuncertain.Inarapidlyageingmousemutant, the more O consumed per unit mass of tissue,
2
removalofsenescentcellsdelayedthedevelopmentof the more ROS will be made. Indeed, urinary ex-
ageing-associatedincreasesinsarcopeniaandcataract, cretionof8-hydroxyguanine(butsurprisinglyper-
and loss of adipose tissue, although lifespan was not haps,not8OHdG)wasreportedtocorrelatewith
increased.74 Senescencemaybeanimportanttumour- lifespanindifferentmammals,77andpreventionof
suppressive mechanism. But beware, senescent cells flightactivityinhousefliesdecreasedlevelsofoxi-
arenotnecessarilyharmless;theycansometimesfacil- dative damage to mitochondrial proteins.78 Cool-
itatecancerdevelopment(Section10.14.11). ing down cold blooded animals or stopping flies
fromflyingpresumablydecreasesROSproduction.
Becautioushowever,sometimeslowtemperature
11.4 Oxidativedamage:alinkbetween
acts to promote longevity via specific signalling
thetheoriesofageing?75,76 mechanisms, e.g. a cold-sensitive TRPA1 channel
(Section10.24)inC.elegans.79
11.4.1 Introductiontothefree-radicaltheory
ButsupposethatthepercentageofO thatforms
2
ofageing ROSis notfixed, but variable. Thentherewillbe
anomalies, but we often learn a lot by examin-
The free-radical theory of ageing was introduced in
ing ‘exceptions to the rule’. One is the ‘rat/bird
1956byDenhamHarman,whoproposedthatageing
paradox’.TotalO consumptionatrestishigherin
resultsfromrandomcumulativedeleteriousdamageto 2
pigeon and canarythan in rat, but theyhavedif-
tissuesbyfreeradicals.Insubsequentpapers,heand
ferentmeanlifespans:rat3years,pigeon35years,
others focused on mitochondria as both free-radical
canary 24 years. It turns out that mitochondria
generatorsandtargetsofdamage,andMiqueletal.76A
from avian tissues generate less O
•–
and H O
proposed a mitochondrial theory of ageing (progres- 2 2 2
sive damage to mitochondrial DNA, e.g. by OH•, in vitro than do rat mitochondria, providing a
possibleexplanationofthedifference.80 However,
leading to mitochondrial dysfunction that affects the
no differences in ROS production were detected
wholecell).WenowknowthatmanyRSarenotfree
inmitochondriaisolatedfromquails(short-lived)
radicals,sothatHarman’stheoryshouldperhapsbere-
and parrots (longer-lived),81 so this explanation
namedtheoxidativedamagetheoryofageingorthe
does not always apply. Even in the same spe-
RStheoryofageing.
cies, individuals vary. A positive association be-
Thetheoryhassomeimmediatelyattractivefeatures
tween metabolic intensity (food intake per gram
inrelationtoexplanationsofageing.
ofbodymass)andlifespanwasobservedinmice,
1. Reactivespeciesareproducedduringnormalme- but no relationship of lifespan to the actual body
tabolism, sometimes accidentally and sometimes mass. Mice with the highest metabolic intensity
for useful purposes. Antioxidant defences do not had greater O 2 consumption, but the inner mem-
removethemcompletely,sothatongoingoxidative branes of their skeletal muscle mitochondria had
damage to DNA, lipids, and proteins is detect- greaterprotonconductance,82presumablyleading
ableinaerobes(Table5.1),andcontributestomany tolesserROSformation(Section1.10.6).However,
age-relateddiseases(Chapter10). wecautionthereaderaboutcaveatsininterpreting

--- Page 705 ---

650 FREE RADICALS IN BIOLOGY AND MEDICINE
studies with isolated mitochondria, as elaborated decreasingsirtuinactivity.Levelsofmitochondrial
inpoint4below.83 H O -producing enzymes, such as monoamine
2 2
An especially interesting anomaly is the naked oxidase, may increase with age in certain tissues.
mole rat, Heterocephalus glaber. This ugly rodent Indeed,treatmentofratswiththeMAOinhibitor
(some have called them ‘saber tooth sausages’!), deprenyl(Section10.20.2)wasreportedtoincrease
which is neither a mole nor a rat but definitely lifespan and raise brain levels of CuZn-SOD.89
almost hairless (‘naked’), has a lifespan of up to Many studies have reported increased oxidation
31 years, much longer than most rats or mice. of mtDNA as compared with nuclear DNA, and
Mole rats appear to be healthy (e.g. cancer rarely thatlevelsof8OHdGinmtDNAincreasewithage.
develops and they are resistant to carcinogens) However, methodological problems render these
for most of that long lifespan with no appar- conclusions uncertain (Sections 1.10.4 and 5.8.3).
ent decline in mitochondrial function, but they Similarly, problems in assaying SOD make it un-
eventually develop signs of ageing. Their anti- clear as to whether or not mitochondrial SOD
oxidant levels appear to be average, in so far as activities fall with age.90 Certainly, mtDNA dele-
they have been studied, and levels of oxidative tionsandpointmutationsaccumulatewithage,91
damage to DNA (8OHdG in urine and tissues), but these are not necessarily caused by oxidative
lipids (MDA, F -IsoPs), and proteins (carbonyls) damage.92
2
are higher than other rodents in young animals, StudiesinmicerevealthepotentialofmtDNAde-
andtissueGSHandGPxlevelsarelower.84 How- fectstoproduceanageingphenotype.Whenmito-
ever,oxidativedamagelevelsinmoleratsdonot chondrialDNApolymeraseismutatedtoremove
rise with age, whereas they do in rats, mice etc. its error-correcting function, so that point muta-
Particularly-oxidisedproteinsinmoleratsinclude tions and deletions accumulate in the mtDNA,
Prx1 and the glycolytic enzyme triose phosphate the mice show some features of accelerated age-
isomerase,85whereasproteincarbonyllevelsinthe ing(shortenedlifespan,reducedsubcutaneousfat,
nucleus were lower.84 One clue to their peculiar- hairloss,osteoporosis,curvatureofthespine,de-
itiesmaybethatnakedmoleratshavedifficultyin creasedfertility,anddefectivestemcellfunction).91
maintaining body temperatures in the cold. They Theseeffectsweredecreasedbyforcedendurance
spend most of their time in burrows that main- exerciseoftheanimals,whichincreasedmitochon-
tainatemperaturehigherthanambient,butoften drial biogenesis and decreased levels of mtDNA
harbour low O levels, to which the animals are deletions.93Inthismodel,levelsofoxidativedam-
2
verytolerant(thenwhenyoukeeptheminthela- age to mitochondrial DNA did not increase, al-
boratoryunder‘normal’vivariumconditionsthey thoughoxidativestressmighthavecontributedto
can be hyperoxic!). Overall, these animals have a the stem cell defects91 and the cardiomyopathy,
low metabolic rate compared with rats and mice. since increasing catalase levels in the mitochon-
They also have high proteasome activities and a dria attenuated it.94 However, this model may be
lower membrane content of n-3 PUFAs such as oflimitedrelevancesincethelevelsofmtDNAle-
DHA, plus a greater proportion of monounsatu- sions in the mice are far above those observed in
rated fatty acids and arachidonate (related to the vivoin‘normal’ageinganimals.
high levels of F -IsoPs perhaps?).80,84,86 Another Nevertheless, microscopy and other data sug-
2
suggestion is that mole rat proteins lose activity gest that mitochondria do deteriorate in aged
lessreadilyuponoxidativedamagethandorator tissues76A,88,90 and imaging studies on elderly hu-
mouse proteins.85 The resistance of mole rats to mansshowthatmitochondrialmetabolism(e.g.the
cancermayinvolveanunusualextracellularmatrix rateoftheKrebscycle)decreaseswithageinsome
composition(Section10.14.8.2). organs,especiallybrain.95Mitochondriawithinthe
4. Mitochondria are well established as a source of same tissue in old animals can be heterogeneous
ROSineukaryoticcells,althoughthelevelofun- in their levels of oxidative damage and respira-
coupling proteins (Section 1.10.6) is an important tory chain activities.87,96 For example, in hearts
variable.82 Several studies suggest that the elec- from aged rats, only mitochondria between the
trontransportchainbecomesleakierwithage87,88 myofibrilshaveimpairedcomplexIIIandIVactiv-
and produces more O
•–.
This could impact on itiesandincreasedO
•–/H
O production,whereas
2 2 2 2
nuclear gene transcription (Section 5.5.5) as well mitochondria just beneath the plasma membrane
asalteringNAD+/NADHratios,possiblythereby were unaffected.87 In one study, increases in

--- Page 706 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 651
muscle mitochondrial O
•–/H
O production with bydeacetylation(Section3.5.2.2).Deacetylationof
2 2 2
ageseemedmuchmoreprominentinisolatedmi- FOXOs by SIRT-1, or impaired phosphorylation
tochondria than in permeabilized myofibres, in of them, increases their transcriptional activity
which the mitochondrial ‘network’ (Fig. 1.8) was and can help to raise cellular levels of antioxi-
more intact.83 Hence, one must be cautious in dants,againincludingMnSOD.Indeed,micelack-
drawing conclusions based on studies with iso- ingSIRT3showincreasedoxidativeDNAdamage,
lated mitochondria, which are essentially frag- which is not decreased by CR.48,108 SIRT3 seems
mentsofalargerwhole.Inanycase,mitochondria to be essential for maintaining the functionality
possessseveralcopiesoftheirmtDNAandaredes- ofstemcellswithage,inpartbydecreasingROS
troyedbymitophagyafterafewweeks,diminish- levels, and declines in SIRT3 levels with ageing
ingtheriskthattheywillfailcompletely,although can impair stem cell function and hence tissue
autophagy itself can be impaired in ageing ani- repair.109 In addition, the ability of CR to de-
mals(Section11.4.4).Theremayalsobedeclining creaseage-relatedhearinglossinanimalsrequires
ratesofmitochondrialbiogenesisandimpairedfis- SIRT3 activity, apparently by raising GSH levels
sion/fusionwithage.97,98Overall,acausativerole anddecreasingoxidativedamage.110CRinRhesus
for mtDNA mutations, whether caused by ROS monkeysslowedage-relatedironaccumulationin
or otherwise, in ageing has not been established, thebrain.111
although more general failures of mitochondrial 6. Thetheoryhelpstoexplainsomeobservationsin
functionmaybeimportant.91,94–100 C.elegans.Thelong-livedage-1anddaf-2mutants
5. The theory helps to explain how CR might haveelevatedantioxidantdefences(cytosolicand
work. Caloric restriction in rodents and mon- peroxisomal catalases, CuZnSOD, MnSOD) and
keys (in so far as the latter have been studied) increased resistance to agents inducing oxidative
decreases levels of oxidative damage to DNA, stress, such as paraquat. By contrast, mev-1 mu-
RNA, lipids, and proteins (including mitochon- tants make more ROS and lifespan is shortened.
drialproteins),101preventsdeclineinGSHlevels,76 ActiveDAF-16promotesthetranscriptionofmul-
and attenuates age-related decline in the activ- tiple genes, including those encoding catalases,
ity of repair systems, such as DNA repair and CuZnSOD and MnSOD. Do these changes con-
theproteasome.102,103Itevendecreasedage-related tribute to the increased longevity? They seem to,
sarcopenia and other age-related defects in mice sinceantisenseRNAsdirectedagainsttherelevant
lacking CuZnSOD.103 CR also decreases plasma genespreventedariseinenzymeactivityandde-
levels of glucose, IGF1, and insulin. Plasma as- creased the lifespan of daf-2 mutants28 (but do
corbate levels can fall, perhaps because ascorbate remember that other studies have shown no ef-
is made from glucose and this substrate may be fects of SOD deletions on lifespan in C. elegans
less available.104 Whether CR decreases oxidative [Section 11.4.5.1]). Mild heat shock also activates
damageinhumansisuncertain;resultshavebeen DAF-16,whichisinturnrequiredforthesynthe-
variable.77,77A sisofsomeHsps.Indeed,thelifespanofC.elegans
HowdoesthemechanismofCR(Section11.3.4) andfliesisextendedbytransientheatshock.Thisis
relatetooxidativedamage?CRseemstodecrease anexampleofhormesis(Section5.6)—alowlevel
mitochondrial O
•–/H
O generation and levels of a stress leads to subsequent protection against
2 2 2
of oxidative damage to mtDNA.102 Some studies biggerinsults.
on mitochondria suggest that this involves in- 7. Mutating p66shc in mice not only can extend life-
creased proton leaks across the inner membrane, span(Section11.3.1.1)butalsopromotesresistance
an effect reversed by infusing insulin into the to oxidative stress; these mice show lower levels
animals.105Howeverotherstudies,whileconfirm- of F -IsoPs, 8OHG in DNA and 3-nitrotyrosine,
2
ing decreased ROS production in CR animals, and are resistant to atherosclerosis induced by a
did not detect a rise in proton leak.106 Caloric high-fatdiet.112Normallyp66shcsuppressesFOXO
restriction of yeast also decreased mitochondrial activity by promoting phosphorylation. If p66shc
O
•–/H
O generation,althoughitraisedmitochon- no longer works, FOXO causes transcription of
2 2 2
drialrespirationrates.107 Activationofsirtuinsby antioxidant defence enzymes. Indeed, p66shc is
CRdecreasesmitochondrialROSlevels;SIRT3can required for oxidative stress-activated p53 to
deacetylateandactivateisocitratedehydrogenase, induce apoptosis; cells from mice lacking it are
whichhelpstoproduceNADPHtoaidremovalof resistanttoapoptosisinducedbyischaemia,with-
H O .Inaddition,SIRT3activatesMnSOD,again drawal of growth factors, or paraquat.112 P66shc
2 2

--- Page 707 ---

652 FREE RADICALS IN BIOLOGY AND MEDICINE
actsinvariouswaystoraiseROSlevels,including 10. Differences in RS production and antioxidant de-
thoseinmitochondria.19,112 fencemayhelptoexplaintherelationshipofgen-
8. Ames dwarf mice show low levels of oxidative dertolifespan(Section3.26).
DNA damage and protein carbonyls in liver and Inprinciple,howmightRSaffectlifespan?They
appeartoberesistanttooxidativestress.Increased could:
levels of GSH and higher activities of CuZnSOD, 1. causeoxidativedamagetoimportantmolecules,
GPx and catalase have been reported in several impairingcellfunction;
tissues.113 2. promote apoptosis or senescence in cells (es-
9. Inflammationbecomesdysregulatedwithage,re- pecially stem cells), leading to impaired tissue
sponding less effectively to pathogens but de- renewal;senescentcellsmightalsocontributeto
veloping a low-level chronic inflammatory state tissuedamage(Section10.14.11);
(inflammaging) as revealed by NF-κB activation 3. generate inappropriate cellular signalling, e.g.
andariseinplasmalevelsofCRP,IL-1,TNF-α,and activation of the insulin pathway. ROS have a
severalothercytokinesinageinghumans.114,115 In rangeofeffectsonkinasesandphosphatases,for
part this can be due to tissue deterioration caus- example(Section5.5.4);
ing DAMP release, inflammasome assembly, and 4. cause,orcontributeto,age-relateddiseases;
phagocyte activation.114 Of course, most (or all) 5. promote,orsuppress,inflammation;
age-related diseases have an inflammatory com- 6. exertahormeticeffect,raisinglevelsofantioxi-
ponent which will also contribute. Inflammation dantsandotherdefences;
in the brain (involving activated microglia) can 7. anycombinationof1–6. Hence,geneticorepi-
decrease neurogenesis and also impair secretion genetic changes that affect rates of ROS pro-
of gonadotrophin-releasing hormone by the hy- duction, levels of antioxidant defences, tar-
pothalamus.Lossofthishormonecouldpromote gets of damage or repair systems, could have
decline in the function of several tissues, includ- complex and interlinked effects on lifespan
ingskin,muscle,andbone.114 ROSlevelsincrease and healthspan (how long you live before de-
duringinflammation,althoughtheycanhaveboth veloping overt diseases), as summarized in
pro-andanti-inflammatoryactions(Section8.9.4). Table11.2.
Table11.2 Geneticorepigeneticchangesthatcouldaffectoxidativedamage.
System/factoraffectedby Examples
(epi)geneticregulation
Antioxidantdefence SOD,catalase,GPx,peroxiredoxins,haemoxygenases,sulphiredoxins,Nrf2.Enzymessynthesizingand
catabolizingGSH,ascorbate(non-primates),urate(non-primates),carnosineandsimilardipeptides,
bilirubin,biliverdin,etc.
Repairsystems Proteasome,Lonproteinase,autophagy,otherproteinases,DNArepair,PHGPx,enzymesthat
metabolizecytotoxicaldehydes(e.g.GSTs),chaperones,methioninesulphoxidereductases
Availabilityoftransition-metalions Transferrin,ferritin,caeruloplasmin,metallothionein,hephaestin,haemopexin,haptoglobin,Fe2+
‘catalytic’forfree-radicalreactions transporters,Cu2+-ATPases,lactoferrin,haemoxygenases
Targetsofoxidativedamage Alterationsinproteins,DNA,chromatin,membranes,lipoproteins,etc.thatmakeiteasierorharderfor
RStoattacksensitivetargets(e.g.fumarase;Section1.6);changesinDNAmethylation,protein
acetylation.Ithasbeensuggestedthatlonger-livedanimals(includingsomebirdsandtheshort-beaked
echidnaTachyglossusaculeatus)havealowerdegreeofunsaturationintheirmembranelipids,
especiallyinmitochondria,involvingchangesindesaturaseenzymeactivity(Exp.Gerontol.43,729,
2008andref80).
Uptakeorprocessingofdietary UptakeofvitaminsCandEandtheirdeliverytotissues,rateandtypeofcarotenoidcleavageingut,
antioxidants flavonoiduptakeandmetabolism,uptakeofcarnosineandsimilardipeptides.
Reactivespeciesproduction TypesofcytochromeP450,‘leakrates’frommitochondrialandERelectrontransportchains,activitiesof
NADPHoxidasesandotheroxidasesproducingO •
2
–and/orH2O2,myeloperoxidase,otherperoxidases.
Rateatwhichoxidativelydamaged P53,bcl-2,bax,p66shc,othergenesaffectingcellcycleandapoptosis/necrosis/senescence
cellsdie

--- Page 708 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 653
11.4.2 DoROSproductionandoxidative Older rats have been claimed to exhale more ethane
damageincreasewithage? and pentane than younger ones and to show higher
F -IsoPlevelsinplasma,liver,andkidney.131However,
2
Asmentionedintheprevioussection,thereisevidence increasesinF -orF -IsoPsandHNEwerenotobvious
4 2
from animal studies that mitochondrial O •–/H O innormalbrainfromoldratsorhumans.132Neverthe-
2 2 2
production rises with age.88 Indeed, the use of ra- less,levelsofF 2 -IsoPsintheCSFofhumanvolunteers
tiometric probes (Section 6.11.1) revealed increased increasewithage133andelevatedplasmaF 2 -IsoPshave
mitochondrial H O levels with age in Drosophila.:116 beenreportedinsome(butnotall)studiesonelderly
2 2
these increased levels were, interestingly, unaffected humans.134
by CR. Another factor may be increases in tissue Whataboutproteindamage?Levelsofnitratedpro-
levels of ROS-generating enzymes with age, such as teinsincreaseinthebrain,liver,andheartofsomeaged
xanthine oxidase,117 monoamine oxidase,89 urate oxi- miceandrats,andinskeletalmusclefromoldseden-
dase (not in primates of course),118 myeloperoxidase tary subjects (although not in subjects who exercised
(perhaps relating to ‘inflammaging’),119 and NADPH a lot).129 Certain proteins appear to be preferred tar-
oxidases. For example, increased O
•–/H
O produc- gets of nitration. In rat heart they include aldolase,
2 2 2
tion by platelet NADPH oxidase has been suggested α-enolase, creatine kinase, MnSOD, the Ca2+-ATPase
to account for the increased risk of thrombosis with ofthesarcoplasmicreticulum,andG3PDH.135,136C.el-
age.120 One particular site of increased age-related egans and Drosophila accumulate carbonylated pro-
O
•–/H
O production involving both mitochondrial teins with age and C. elegans also has raised levels
2 2 2
ROS generation and elevated activity of NADPH ox- of F 3 -IsoPs.137 Protein carbonyl levels are decreased
idases(e.g.NOX4)isthecardiovascularsystem,where in age-1 and daf-2 mutants, but increased in mev-1
increasedO •– productionhasbeenimplicatedinage- mutants or if daf-16 is knocked out.138 One target of
2
inducedhypertension,vascularhardening,andcardiac oxidative damage (we don’t know why) is vitello-
dysfunction.121–123 Indeed, endothelial dysfunction is genin (Section 11.3.1);139 maybe this relates to the
common in the elderly and several studies have re- hyperfunction theory of ageing (Table 11.1; it accu-
vealedthatbloodvesselsfromagedanimals(including mulates and oxidizes and this seems deleterious).
humans) make more O
•–
and show diminished bio- On the other hand, in honey bees, a vitellogenin has
2
availability of NO•. Not only increases in ROS pro- been suggested to exert antioxidant properties (soak-
duction but also declines in EC-SOD activity may ing up ROS perhaps?) and its accumulation seems
contribute.124 Indeed, in one study, orally adminis- to increase lifespan!140 Levels of protein carbonyls,
teredantioxidantsimprovedflow-mediatedvasodila- MDA, and HNE in the brains and other tissues of
tionin70yearolds,butworseneditin25yearolds,125 rodents and humans show a trend (sometimes not
suggesting that ROS production in arteries may be that clear-cut if one examines the data carefully) to
a good thing in the young but less so in the eld- rise with age and increased protein carbonyl levels
erly. Another site of increased O
•–
generation from in the brains of aged mice correlated with loss of
2
NADPH oxidases and/or mitochondria with age is cognitive function in the animals.141,142 Protein car-
skeletalmuscle,especiallyinsedentarypeople;oxida- bonyllevelsinsenescentfibroblastsareincreased,and
tivedamagetomuscleproteinsiselevatedinhuman those in fibroblasts cultured from patients with pro-
sarcopenia (Section 7.14.1) and the normal role that geriaorWernersyndromearestrikinglyelevated.141,142
controlled levels of ROS play in promoting muscle Thereisanage-dependentaccumulationofAGEprod-
regeneration no longer works properly.126,127 Exercise ucts in such human proteins as collagen and crys-
helps to preserve vascular and muscle function, hav- tallins, which have a slow turnover rate; their form-
ing the overall effect of diminishing the O
•–/H
O ation often involves both oxidation and glycation
2 2 2
productiontolevelswherebeneficialeffectsoutweigh (Section10.5.5).
deleteriousones.122,128,129 What about nucleic acids? Several studies showed
Measurements of biomarkers (discussed in Chap- increased 8OHG levels in DNA from ageing rodents,
ter6)intissuesfromhumansandotheranimalssug- especiallyinliver,kidney,brain,heart,andmuscle,al-
gestthat,ingeneral,‘global’oxidativedamage(i.e.that thoughthechangestendtobemodest(meanincrease
measuredinthetissueasawhole)doesincreasewith of49%).143RisesinotherDNAbasedamageproducts,
age,butonlymodestly.Forexample,rhesusmonkeys such as 8,5(cid:4)-cyclo-2(cid:4)-deoxyadenosine/guanosine (Sec-
showed higher levels of HNE-modified proteins in tion 5.8.2) have also been reported in ageing mouse
skeletalmusclewithage,aneffectattenuatedbyCR.130 tissues.144

--- Page 709 ---

654 FREE RADICALS IN BIOLOGY AND MEDICINE
11.4.2.1 Becautiouswithglobalbiomarkers Oxidative damage to a K+ channel, KCNB1 also in-
creases with age in the mouse brain.154 Falls in acon-
If elevated oxidative damage occurs only in certain
itase and adenine nucleotide translocase activities in
cells, organelles (e.g. mitochondria), or specific mol-
ageing flies will impair mitochondrial function.78,145
ecules, large changes in oxidative damage (or anti-
Some proteins that form parts of the pores in the
oxidant levels) at those sites may not be detected
animal nuclear envelope are long-lived and accumu-
because they are ‘swamped out’ by lack of change
late oxidative damage, which has been suggested
elsewhere if the whole organ, cell, or tissue is as-
to weaken the nuclear permeability barrier in aged
sayed with such biomarkers as HNE, IsoPs, 8OHG,
animals.155 This could perhaps allow entry of tran-
or protein carbonyls. For example in DNA from age-
scription factors that are normally excluded from the
ing human brain, levels of 8OHG rise modestly, but
nucleus, promoting inflammation. Oxidation of ry-
the rises were particularly marked in the promoters
anodine receptors may contribute to Ca2+ leak and
of several genes whose expression is decreased with
muscleweaknessorcardiacdysfunctioninageingrab-
age, such as some involved in synaptic transmission
andlong-termpotentiation,39andinthep62promoter bits and mice,156,157 and oxidation of –SH groups on
NMDAreceptorsmaycausedysfunctionintheageing
(Section 10.21.4). In houseflies, oxidative damage to
brain.158
twomitochondrialproteins,aconitaseandadeninenu-
Overall,therefore,thebalanceofevidencesupports
cleotide translocase, is particularly prominent with
age,78,145 whereasinmiceadifferentsetofmitochon- a rise in oxidative damage with age, although there
drial proteins is modified.101 In rodent tissues, the aresomecontradictorydata(e.g.levelsofF 2 -IsoPsand
MDA in naked mole rats are high throughout life,
proteincarbonicanhydraseIII seemstoundergoex-
not increasing with age.80,84); as mice age their levels
ceptionallyrapidoxidationandnitrationwithage,and
rise and catch up with the mole rat levels! Oxidative
falls in aconitase with age have also been observed
damageinthepromotersofessentialgenes,orinhibit-
in mitochondria from some rodent tissues. Carbonic
ing key proteins, or oxidizing important lipids (e.g.
anhydraseIIIisapeculiarprotein;itscarbonicanhyd-
cardiolipininmitochondria)maybethekeyevents,al-
raseactivityislowandknockoutofthegeneencoding
thoughthemechanismsbehindthisspecificityremain
it produces no phenotype in laboratory mice. It also
tobeelucidated.Inaddition,damagemaymattermore
undergoes glutathionylation (Section 3.11) with age
in some tissues (e.g. brain, skeletal muscle, kidney,
and is oxidized and nitrated even faster in the liv-
ers of mice lacking CuZnSOD.146 Is it functioning to heart)andcells(e.g.stemcells)thaninothers.
As an interesting aside, Stadman and Levine141,142
soak up ROS perhaps? Only a few proteins in aged
S.cerevisiaecellssufferheavyoxidativedamage;147the foundthatproteincarbonyllevelsincreasedwithage
sameistrueinthebrainsofageingnormalmice,148and inlaboratoryrats.Tenyearslater,theycouldnotrepeat
thisusingthesameratstrain,fromthesamesupplier,
human AD patients (Section 10.21.4). Age-dependent
fedonthesamediet.Oneclue,thenewbatchofrats
selective increases in cardiolipin oxidation in mito-
livedabout30%longer.
chondriahavebeenreported,andmayleadtodecline
incytochromeoxidaseactivityandthusmitochondrial
function.149Theuseoffluorescentbiosensorstomeas-
11.4.3 Istheriseinoxidativedamagedue
ureH O (Section6.11.1)inC.elegansrevealedthatits
2 2 tofailureofantioxidantprotectionwithage?
production increased as adult worms aged, was de-
creasedbyCR,andwasnotuniformacrossthevarious There are no marked falls in most antioxidant de-
cells, e.g. there were ‘hot spots’ of elevated H 2 O 2 in fences with age in human or other mammalian tis-
certain neurons.150 Levels were also high during lar- sues, and some increases have been reported. For
valdevelopment,suggestinganimportantroleforROS example α-tocopherol: PUFA ratios rise with age in
inthisprocess.151 Similarly,somecellsinageingDros- rattissuesandsomehumancells(e.g.erythrocytes)159
ophilahadhigherROSlevelsthanothers,e.g.mid-gut and SOD activities can increase in some tissues
enterocytes.152 of ageing animals whilst falling in others.160 Nev-
Theserisesinoxidativedamagetoselectedbiomol- ertheless, localized changes could have significant
eculescanhaveimportantfunctionalconsequences,as impact, e.g. age-related decline in EC-SOD activity
alreadyillustratedbyoxidativedamagetopromoters may impair the vascular system.124 Studies in yeast
in the ageing brain.39 Another example, in C. elegans and rats have suggested that hyperoxidized inacti-
age-related loss of sensory function may involve oxi- vated peroxiredoxins may accumulate with age, and
dativeinactivationofaspecificK+ channel,KVS-1.153 that a fall in sulphiredoxin levels may contribute

--- Page 710 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 655
to this.161 Such changes in Prx enzymes could 11.4.4 Isthereafailuretorepairoxidative
also contribute to dysfunctional signalling processes damagewithage?
with age, since prx play major roles in signalling
Autophagy seems to become less efficient in older
(Section5.5.4).
tissues,173 including the brain and the human and
ManyreportsindicatethatGSH/GSSGratios,espe-
mouse vascular systems.174 Lon proteinase (Sec-
cially in mitochondria, are lower in older C. elegans
tion5.14.3.2)activitiesinmuscleandliverfallwithage,
and in at least some tissues from old Drosophila and
as does its ability to increase in activity under stress
rodents, and that more protein–SSG adducts are pre-
conditions (Section 5.14.3.2).86 Proteasome activities
sent in the tissues.76,150 Falls in GSH could be due
alsodeclinewithageinseveralanimaltissues,includ-
to increased consumption of this thiol and/or to de-
creasedγ-GCSactivity;thelatterperhapsinpart76,162 ing brain, skin, muscle, lung, lens, heart, and liver,
aswellasinsenescentcellsandsomehumantissues
relatingtoimpairedNrf2activation.Indeed,inblood
(Section 11.3.5).86 The decline in proteasome activity
vessels and liver of old rats, Nrf2 levels are sub-
occurs by multiple mechanisms, including decreased
normal, which limits activation of the ARE system
transcription of the genes encoding proteasomal pro-
and hinders the normal rises in GSH, HO-1 etc. in
teins, elevated oxidative damage to proteasome sub-
response to stress.162,163 Caloric restriction appears
units, and a decline in Nrf2 activity; subunits of the
to attenuate falls in GSH.15,76,111 In elderly humans,
26S proteasome are one of several products of the
plasma GSH levels and GSH/GSSG ratios are re-
genesregulatedbyNrf2.64,86Inmice,thedeclineofLon
ported to decrease,164 but it is hard to know what
in liver was accompanied by increased levels of oxi-
this signifies—is it lesser release by the liver, more
dizedmitochondrialproteins,includingaconitase.86,175
rapid oxidation, or faster clearance (Section 3.10.3)?
Caloricrestrictionhasoftenbeenobservedtocounter-
Nevertheless,feedingelderlyhumanswithextracyst-
act these age-related declines in proteasome activity
eine (as N-acetylcysteine) and glycine was able to
and autophagy.176 Age-related changes in Lon, pro-
increase GSH synthesis and raise GSH levels in their
teasome, and autophagy, sometimes combined with
redbloodcells;plasmaF -IsoPlevelsalsodecreased.165
2 a sub-normal Hsp response,172 can facilitate protein
Carnosine (Section 3.25.7) levels are reported to de-
misfolding and aggregation, especially in brain.170,177
crease with age in human and rat skeletal muscles166
In Drosophila, decreases in proteasome function with
andglyoxalaseIactivitydeclinesinbraintissuefrom
ageweremoreprominentinsomaticcellstheninthe
elderly humans, facilitating accumulation of AGE
gonads,preservingthelatterforreproductionattheex-
proteins.167 A fall in glyoxalase 1 activity may also
penseoftherestofthebodyperhaps?178 Hence,there
help to account for poorer wound healing in aged
is considerable interest in agents that could increase
mice.168 Elderly humans seem to require more vit-
proteasome function or improve autophagy (e.g. tre-
amin C in their diets to maintain the same plasma
halose[Section3.25.8]orLi+),aspotentialanti-ageing
levels,possiblyduetoadropinSVCT1levels.169 As-
agents.179,180
corbatelevelsinlymphocytesmayalsofallwithage,
AsforDNA,apositivecorrelationbetweentheeffi-
correlated with a drop in GSH level (Section 4.22).
ciencyofDNArepairenzymes(includingPARP-1)and
So overall in the context of ageing, GSH might be
specieslongevityhasbeenclaimed,andlevelsofsome
theantioxidanttowatch,eventhoughthedeclinesare
of the enzymes that repair DNA have been reported
nothuge.
to decline in certain tissues (e.g. brain, retina) from
Loweredabilitytoraisedefences(GSH,heat-shock
old animals in several, but not all, studies.181,182 CR
proteins etc.) when required could help to account
has sometimes been reported to prevent these de-
fordiminishedresponsivenesstoinsultsintheelderly
clines. Conversely, overexpression of MTH1 in mice
(Section 11.2).129,162,163,170,171 For example, aged mice
increased their lifespan and improved brain function
wereunabletorapidlyraiseGSHlevelsinlunglining
(Section5.10.8.1).
fluid when exposed to cigarette smoke, and suffered
more lung inflammation and oxidative damage as a
result.163 ThesamemaybetrueofNF-κB,chronically
11.4.5 Testingthefree-radicaltheoryofageing:
activated in ageing and contributing to a low grade
alteringantioxidantlevels76
inflammatory state (Section 11.4.1)115 but showing an
impairedresponsetodangersignals.170Theheat-shock If oxidative damage to certain biomolecules contrib-
responsemayalsobedysregulatedinsometissuesin utes to ageing, then would antioxidants be effective
oldanimals.170,172 anti-ageingagents?Manystudieshaveexaminedtheir

--- Page 711 ---

656 FREE RADICALS IN BIOLOGY AND MEDICINE
effects on the longevity of various organisms. Thiol proteincarbonylsaswellasoxidationof–SHgroups
compounds(suchasN-acetylcysteine,glutathione,and in NMDA receptors in the brains of aged mice.193
mercaptoethylamine), ascorbate, chain-breaking lipid Often they do not, rendering a lack of effect incon-
soluble antioxidants such as BHT, α-tocopherol, and clusive.Inaddition,any‘antioxidant’thatdoeswork
Santoquin(ethoxyquin;Table11.7),andSODmimet- might do so by other mechanisms, for example res-
ics (Section 11.5.4) have often been used. Thus, some veratrolviathesirtuinpathway(Section11.3.4),PBN
studiesreportthatα-tocopherolprolongsthelifespan as an anti-inflammatory agent (Section 11.5.5) and
of Drosophila, C. elegans, and the rotifer Philodina in pro-oxidant action of ‘antioxidants’in growth media,
the laboratory, but others do not.183 Results with as- as just mentioned. Excessive dosing of animals with
corbate are equally confusing; various papers report an ‘antioxidant’ might decrease the rate of synthe-
increased,decreased,ornoeffectonlifespaninvarious sis or uptake of other antioxidants, so that the total
organisms.184 The ‘antioxidants’ EUK-134 and EUK-8 ‘tissue antioxidant potential’ remains unaltered. For
(Section 11.5.4) were reported (but not confirmed by example, feeding female rats a diet rich in BHT de-
others)185toextendthelifespanofC.elegans,although creasedliverα-tocopherolcontent,194 andadministra-
they didn’t work on houseflies,186 and the nitrone tion of dl-α-tocopherol or N-acetylcysteine decreased
LPBNAH(Section11.5.5)wasclaimedtomakePhilod- theexpressionofseveralgenesencodingantioxidants
ina live longer.187 Feeding CoQ to C. elegans also inmice.195Inmice,lipoicacidadministrationdownreg-
10
increasedlifespan.188 ulated the expression of genes encoding chaperones,
Unfortunately, the effects of administered antioxi- whilstcoenzymeQdecreasedtheexpressionofgenes
dantsonthelifespanofrodentsaresmallorzero.For encoding prx5 as well.189 Vice versa, inhibiting SOD
example, lipoic acid, NDGA (Table 11.7), PBN, ascor- orcatalaseinhousefliesusingdiethyldithiocarbamate
bate,orcoenzymeQhadnoeffect.184,189,190High-dose (Section 3.5.1.4) or aminotriazole (Section 3.17.3) led
α-tocopherolhasnoeffectonlifespaninmiceeither,191 to compensatory rises in the levels of some other
although it has sometimes been reported to diminish antioxidants.196
theirdeclineinimmuneresponsewithage.192 Claims Nevertheless, combinations of lipoic acid and N-
in the older literature that antioxidants such as mer- acetylcarnitinehavebeenreportedtodecrease8OHG
captoethylamine and Santoquin raise the lifespan of levels in DNA, and improve cognitive function in
mice by up to 18% were soon challenged. It appears old rats, although they didn’t help old beagles very
that some of the control animals did not live as long much.197,198 This mixture is sold as a health supple-
astheyshouldhavedone;perhapstheirdietwasbad ment, Juvenon®. Only time will tell if it has value to
ortheywerestressed,sothattheydiedearlier.Inadd- humans. Do remember of course that lipoic acid has
ition,betterhusbandryhasdecreasedriskofinfections. specific metabolic effects in addition to its antioxi-
Thus the antioxidants might have acted to diminish dantproperties(Section3.25.4);sodoesacetylcarnitine,
oxidative damage produced by poor diet, infections, whichseemstoexertanti-depressantactions.199 More
or environmental stress rather than increasing ‘real’ worryingly,itmaybepro-atherosclerotic.200
lifespan.190 If the supplements tasted bad, they could Much more striking effects on lifespan have been
have caused the animals to eat less and produced a claimed by using mitochondrially targeted antioxi-
degreeofCR,ascanhappenwithN-acetylcysteine.190 dants,suchasSkQ1(Section11.5.12).201 However,the
We have no idea what is the optimal diet for small more studies that are done the more confusing the
organisms such as Philodina. The antioxidant (e.g. α- picture becomes, and some of the ‘best’ effects of
tocopherol) content of laboratory animal diets is an- SkQ1 were observed in mice kept in poor environ-
other important variable, and has increased over the ments, so that death rates from infections were high.
pastthreedecades(Sections4.3.2and10.18.3.2).Add- Perhaps SkQ1 was preventing age-related decline in
ingagentssuchasascorbateorpolyphenolstogrowth theimmunesystem,sodecreasingdeathsfrominfec-
mediaforsmallorganismsmayhavetheoppositeef- tiousdisease.201
fect from what was intended, i.e. not an antioxidant
11.4.5.1 Transgenicorganisms:aconfusing
action,butapro-oxidantactionduetooxidationinthe
medium(Section1.11).
picture30,76,202,203
Another problem is that these animal studies as- Another approach to study the role of ROS in
sumed that antioxidants would decrease oxidative ageing is to genetically manipulate antioxidant de-
damage in healthy animals, without testing it. Some- fences and examine the effects on lifespan; such an
times they do, e.g. N-acetylcysteine decreased brain approach suggested that antioxidant enzymes are

--- Page 712 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 657
important in the lifespan extension of C. elegans daf- coenzyme Q synthesis, is essential for life. However,
2 mutants (Section 11.4.1) What about animals? Mice miceheterozygousforit(Mclk1+/-)showextendedlife-
lacking CuZnSOD suffer multiple age-related path- spaneventhoughthereisincreasedoxidativedamage
ologies (skin thinning, osteoporosis, cataract, muscle inmitochondria(proteincarbonyls)andloweredATP
atrophy, cancer, hearing loss etc.; Section 3.7.2) and production.207 Thisincreasedlifespanisaccompanied
have decreased lifespan, which can be extended by by lower plasma levels of F -IsoPs and of oxidative
2
CR.103,202However,rodentsoverexpressingCuZnSOD damage (carbonyls) to cytosolic proteins.207 All these
do not live longer (do not assume, of course, that data support the growing view that increased mito-
more CuZnSOD means less oxidative damage) (Sec- chondrialO
•–and/orH
O productioncansometimes
2 2 2
tions 3.21.1 and 3.21.2). What about MnSOD? Select- signal to increase longevity (mitohormesis).208–210 In-
ive deletion of MnSOD in the fibroblasts of mice deed, nicotinamide, metformin, and D-glucosamine
caused features of premature ageing, including skin were found to increase lifespan in C. elegans by rais-
atrophy,osteoporosis,andmusclewasting,aswellas ing O •–/H O production in mitochondria,211–213 and
2 2 2
decreasedlifespan.99‘Knockout’micelackingMnSOD the increased longevity of the C. elegans isp-1 and
inalltissuesdonotlivelongenoughforageingrates nuo-6 mutants, which affect mitochondrial electron
to be examined (Section 3.7.2) but, somewhat con- transport, also seems to involve increased O
•–/H
O
2 2 2
fusingly, laboratory mice heterozygous for defects in production.214
MnSOD have normal lifespans (even if they are also The subcellular location of the overexpressed anti-
engineered to lack GPx1 activity) despite increased oxidantisalsolikelytobeafactor(rememberthatin
levelsof8OHGinbothnuclearandmtDNA,impaired normal cells most CuZnSOD is not in mitochondria,
mitochondrial function, and greater risk of cancer whereasmostorallMnSODusuallyis!),sincethemost
development.202 important oxidative damage may affect only certain
Itis,ofcourse,essentialwheninterpretinganysuch targets(Section11.4.2.1).Indeed,overexpressionofhu-
datatocheckthatgeneknockouts(orover-expression) mancatalasetargetedtothemitochondriaofheartand
do not lead to secondary (adaptive) changes in other skeletalmuscleinmice(butnotDrosophila)increased
antioxidant defences, alterations in rates of ROS pro- lifespanmodestly(~18%),buttherewasnoeffectifthe
duction,ortobehaviouralchanges(e.g.impairedap- catalase was targeted to the nucleus or peroxisomes.
petite leading to CR) that can influence lifespan. For Themousemitochondriashowedlowerlevelsofpro-
example, knockout of Prx3 in C. elegans had no ap- teincarbonyls,andof8OHGinmtDNA,andseemed
parent phenotypic effect. This was probably due to better preserved structurally during ageing. Indeed,
adaptation,sinceknockdownusingsiRNAcausedan age-related decreases in cardiac and skeletal muscle
immediate decrease in fecundity.204 It must also be function were ameliorated in these animals.121 Don’t
shownthatthemanipulationdiddecreaseorincrease forget,however,thatcatalasenormallyresidesinper-
oxidative damage. For example, overexpressing SOD oxisomes,notmitochondria(Section3.17),anditisnot
to too great an extent may increase oxidative damage the best-suited enzyme to scavenge H O at physio-
2 2
(Section 3.21.1 and 3.21.2), whereas C. elegans lack- logical levels in mitochondria (Section 3.20.1). Hence
ingmitochondrialSODenzymesshowedonlymodest several questions remain to be answered about this
increases in oxidative damage levels.205 Indeed, sin- model.
gle, multiple, or total deletions of the various types Much transgenic work has been carried out on
ofSOD(twocytosolicCuZnSODs,twoEC-SODs,and Drosophila.Overexpressionofγ-glutamylcysteinesyn-
two mitochondrial MnSODs, SOD2 and SOD3) pre- thetase(γ-GCS),glucose-6-phosphatedehydrogenase,
sent in C. elegans did not shorten lifespan: strikingly, and prx2 or -5, increased lifespan.76 What about
lossofSOD2frommitochondriaincreasedsensitivity SOD? In one set of studies, global overexpression of
tooxidativestressbutatthesametimeincreasedmean CuZnSOD by 32 to 42% had little effect on lifespan
lifespan.However,theextentofincrease(ifany)inoxi- andtheabilitytowithstandoxidativestress,although
dativedamagelevelsintheseknockoutsremainstobe selectiveoverexpressioninmotorneurons(whichnor-
established.30,185,205,206 mally have low CuZnSOD levels in Drosophila) did
Geneticmanipulationsofyeast,C.elegansandDros- appear to increase longevity. Similarly, overexpress-
ophila that impair function of the mitochondrial elec- ing γ-GCS to increase GSH levels in neurons raised
tron transport chain and might thus be predicted to lifespanmorethandidglobalexpression.Globalover-
raiseO
•–production,seemtoincreaselifespan.Inmice,
expression of catalase alone did not affect lifespan in
2
thegeneMclk1,whichencodesanenzymeneededfor Drosophila. However, when genes encoding SOD and

--- Page 713 ---

658 FREE RADICALS IN BIOLOGY AND MEDICINE
catalasewerebothgloballyoverexpressed,lifespanof 11.4.7 Lipofuscinandceroid;fluorescent
Drosophila increased by up to one third.76 The nor- ‘redherrings’?221,222
malage-relatedlossofvigourwasdecreased,andthe
flies showed lower levels of protein carbonyls, and One of the earliest pieces of evidence put forward to
of 8OHG in DNA, and were more resistant to DNA supportthefree-radicaltheoryofageingwasthepres-
damagebyionizingradiation.These‘superflies’were ence in old tissues of age pigments, initially thought
more active than control flies and their calculated tobeaccumulatedend-productsoflipidperoxidation,
‘lifetimeO consumptionperunitbodymass’hadin- although we now know that they are more complex.
2
creased.However,subsequentrepeatsofthesestudies Lipofuscin accumulates, in amounts increasing with
gavemuchlessimpressiveresults. age, in senescent cells and in many tissues of hu-
The extent of overexpression of the antioxidant mans and other species, including rats, fungi, Dros-
(moreisnotnecessarilybetter)anditstissueandsub- ophila, houseflies, and even in very old naked mole
cellular location are likely to be critical variables in rats. It is especially prominent in post-mitotic cells.
explaining these different experimental results. For In houseflies, the lipofuscin content of muscles in-
example,alittlemoreprx4orγ-GCSinDrosophilain- creases with flight activity; flies that are more active
creasedlifespan,buthighlevelsdecreasedit.76,215An- liveforshortertimesandaccumulateitfaster.Thecyto-
othervariableisthelifespanofthecontrolorganisms— plasmoflargemotorneuronsofhumancentenarians
themostdramaticeffectsareusuallyfoundwhenthis may be more than 70% occupied by ‘age pigments’.
isrelativelyshort;whenitislonger,effectsofoverex- Don’tassumethatfluorescentpigmentsarenecessarily
pressingantioxidantstendtodisappear.76Forexample, lipofuscin,however:theyseemnottobeinC.elegans,
knockoutofmethioninesulphoxidereductaseA(Sec- forexample.223
tion5.14.1)decreasedlifespaninmiceinonestudybut Lipofuscinvariesincolourfromred,throughyellow,
notanother:inthefirstthecontrollifespanwasabnor- to dark-brown, and occurs intracellularly as granules
mallyshort.203 Thisisreminiscentoftheearlystudies 1 to 5 μm in diameter bounded by a single mem-
with antioxidants in rodents discussed at the begin- brane.Boththenumberandsizeofgranulesincrease
ning of this section—one wonders why control flies, withage.Manydifferentlipidsarepresentinlipofus-
rodents,andC.elegansindifferentlaboratorieslivefor cin, including triglyceride, phospholipids, and chol-
variabletimes. esterol, and an equally wide variety of proteins. For
Overall,transgenicexperimentsuponfliesorC.el- example,AGEproteinsarefrequentlyfound,andlipo-
egans cannot be said to validate the free-radical the- fuscinwithintheretinalpigmentepitheliumcontains
ory of ageing, but they do not convincingly refute large amounts of retinal derivatives (Section 7.10.1).
it either.12,59,197,216 They leave us wondering what to Lipofuscin granules are rich in metal ions such as
think! zinc,copperand,especially,iron.Theyseemtobethe
end-product of autophagy and lysosomal catabolism
ofunwantedcellularcomponents,includingdamaged
11.4.6 ‘Rapidlyageing’rodents
mitochondria. Oxidation may be accelerated in the
Severalsuchanimalshavebeenusedtostudyoxida- lysosomal environment by low pH and the presence
tivedamage.ExamplesincludetheOXYSrat(bredin of Fe2+ and other transition metal ions. Extraction of
Russia)andthesenescenceacceleratedmouse(SAM). lipofuscin granules with organic solvents solubilizes
These animals have shortened lifespan, age rapidly, part of them, and the resulting solution has fluores-
and several studies have shown elevated levels of cencecharacteristicssimilartothoseoftheconjugated
oxidative damage to RNA, DNA, lipids, and certain Schiffbases,dihydropyridinedicarbaldehydes,andal-
proteins (e.g. α-enolase), and decreased activities of dehyde polymers formed during lipid peroxidation
OGG1 (Section 5.10.3) in their tissues. Various ‘anti- (Section6.15.10).
oxidants’(e.g.PBN,lipoicacid)candecreaseoxidative Another pigment that superficially resembles lipo-
damageandslowneurocognitivedeclineinOXYSrats fuscin is ceroid, a term introduced in 1942 to de-
or SAM mice.217–219 CR also increases lifespan. SkQ1 scribelipofuscin-likematerialaccumulatinginvarious
(Section11.5.12)butnotN-acetylcysteineslowedage- diseases, such as NCL (Section 10.23.3). Like lipofus-
relateddeclineintheOXYSrat.220 However,arethese cin, ceroid originates from uptake of material into
micedemonstrating‘realageing’oraretheyjustsick lysosomes.Macrophagesincultureaccumulateceroid
animals?Wedon’tknowyet. when they are exposed to lipids rich in PUFAs, and

--- Page 714 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 659
ceroidwithinmacrophages,aswellasextracellularcer- However, exposure of C. elegans to high levels of the
oid(presumablyreleasedfromdeadcells)arepresent redox-cyclingcompoundjuglone(Section9.5)killedit,
in human atherosclerotic lesions. Ceroid/lipofuscin whereaslowerlevelsincreasedlifespan,seeminglyre-
deposition are promoted by several abnormalities of latedtoenhancedlevelsofGSHandHspandnuclear
fatmetabolism,includingabetalipoproteinaemia(Sec- translocation of DAF-16.225 Similarly, overexpression
tion 4.3.8). Presumably more lipid than usual is de- of catalase in mitochondria to too great an extent
gradedwithinlysosomesinsuchdiseases. might be deleterious rather than beneficial, by re-
Accumulation of intracellular age pigments is not moving too much H O perhaps.226 Remember that
2 2
evidencethatlipidperoxidationisimportantindisease as tissues deteriorate with age, more oxidative dam-
pathology, since peroxidation probably occurs within ageisalikelyconsequenceofdisorganizationandcell
thelysosomeandthesepigmentsarepresumablysafe death(Fig.10.1);risinglevelsofoxidativedamagebio-
aslongastheystaythere.However,iflysosomesare markers with age do not prove a cause–consequence
damaged,metalionsandlipofuscin-attachedperoxid- relationship. Another key question; C. elegans is gen-
izedlipidscanescape,causeoxidativecellinjury,and eticallyuniformandkeptinadefinedenvironmentin
interferewithproteasomefunction.224 thelaboratory.Inspiteofthistherearewidevariations
inthelongevityofindividualworms,consistentwith
anelementofrandomness(ofdamagebyfreeradicals
11.4.8 Istheoxidativedamagetheoryofageing
perhaps?)inageing.Yetoxidativedamageoftenaffects
ageingbadly?
specific molecular targets (Section 11.4.2.1); it doesn’t
Harman’s theory, expanded in the light of modern seem to be random. Why? More food for thought,
knowledge, has gained much credence because it fits an adult C. elegans has no dividing cells and so can
with many studies in C. elegans, Drosophila, and la- neverbeacompletemodelforhumanageing,14which
boratory rodents, and it forms a link between most involves not only damage to postmitotic cells (e.g.
or all of the other suggested theories (Table 11.1). neurons)butalsoimpairedcellproliferationintissues,
Many longevity-determining genes could be, directly especially of stem cells. A recent article227 identified
orindirectly,linkedtooxidativedamage(Table11.2). ninehallmarksofageing:namelygenomicinstability,
However, the studies on MnSOD+/- and Mclk1+/- telomereattrition,mitochondrialdysfunction,cellular
mice suggest that ROS production can be elevated senescence,epigeneticalterations,lossofproteostasis,
in mitochondria yet lifespan remain unaltered, or deregulatednutrientsensing,stemcellexhaustion,and
even increased. Indeed, the long-lived daf-2 mutant altered intercellular communication; perhaps we can
of C. elegans has elevated F -IsoP levels.137 The data addinflammagingasatenth.RSareinvolvedinallof
3
onnakedmoleratsandC.eleganslackingMnSODs185 theseprocesses.
suggest the same thing. It thus seems that increased
mitochondrial O
•–/H
O production need not cause
2 2 2 11.4.9 Howtolivealongtime
ageing, but might instead slow it down by signal-
ling to the rest of the cell to adapt (Section 11.4.5.1). There are now many centenarians in the world, and
For example, ROS have been suggested to stimulate somearethesubjectofintensestudy.Datasuggestthat
autophagy (Section 5.14.3.1)59 and they can promote humancentenariansgenerallydonotshowinsulinre-
ischaemic preconditioning (Section 10.6.6). So if ROS sistanceandtheircellscopebetterwithstressors.But
cause ageing, their target of damage is perhaps not dotheydie‘oldbuthealthy’?No,onestudyshowed
mitochondria. But why then does raising mitochon- that most die of age-related diseases, often cardio-
drial catalase in mice121 seem to delay some features vascular,althoughdeathsfromcancerseemedrare.228
of ageing? There must also be a limit; high ROS Oneexampleofastudyincludingcentenariansisthe
levels (or perhaps high levels for too long) cause InCHIANTI study of 986 Italians aged from 65 to
severe mitochondrial damage and early death, as il- 102 years. In general, risk of developing disability in
lustratedbythepathologyofanimalslackingMnSOD this and similar studies was lower in those subjects
(Section 3.7.2). Also, can CR really be acting by de- withhigherplasmalevelsofcarotenoids,probablydue
creasing mitochondrial O •–/H O production in vivo todietsricherinfruitsandvegetablesratherthanany
2 2 2
(Section11.4.1)? effectsofcarotenoidsthemselves.229,230 IntheGeorgia
SodotoomanyRSfortoolongcauseageingwhereas centenariansstudy,bettercognitivefunctionwascor-
lower levels of ROS production (perhaps transient) relatedwithhigherlevelsofluteinandzeaxanthinin
might slow it down? We cannot confidently say yes. thebrain(seealsoSection10.17.6.10).230,231

--- Page 715 ---

660 FREE RADICALS IN BIOLOGY AND MEDICINE
Apart from a diet rich in fruits, grains, and veget- defences in females (Section 3.26). There have been
ables, the intervention that seems most effective in severalattemptstocorrelatebodyironstores(usually
slowingage-relateddysfunctionincardiovascularand assessed as plasma ferritin levels) with the incidence
nervous systems and skeletal muscle and extending of cancer, diabetes, and cardiovascular disease, but
lifespaninhumans(estimateduptoaboutfiveyears) thedataareinconclusive240,241 andtheriskforcancer
is a moderate degree of exercise (Sections 7.14.2 and may be greatest if both iron stores and blood lip-
10.21.7),121,122,126,128,129 whereas smoking clearly de- ids are elevated.242 Iron does play a role in the early
creaseslifespan.Humanmuscleintheelderlyappears stagesofatherosclerosis,insomeanimalsatleast(Sec-
to generate more O
•–
when at rest, but there is less tion10.3.5),butmeasuringtotaltissueironorplasma
2
response to the usual actions of ROS in increasing ferritin can be misleading, for at least two reasons.
levels of protective factors such as Hsp and antioxi- First,elevatedbodyironstoresmayindicatehighcon-
dant defences. For example, the Nrf2 system doesn’t sumptionoffoodsrichinhaemiron,especiallycooked
work properly in old human skeletal muscle (Sec- meats.Suchadietisitselfariskfactorfordiseasessuch
tion 11.4.3).232 These changes can be attenuated by as stroke and certain cancers (Sections 7.2.1, 10.14.12,
moderateexercise.Exerciseinhumansandotherani- and10.18.3).Second,ironinferritinandotherproteins
mals also seems to slow down age-related vascular is relatively safe, having little pro-oxidant capacity
dysfunction,apparentlybyloweringNADPHoxidase (Sections3.22.4.2and5.8.2.2).
activities, increasing MnSOD and EC-SOD levels,233 Nevertheless,theincreasedironcontentofoldertis-
and increasing NO• bioavailability. It may also de- sues,whichmightalsoincreasethesizeofthe‘labile
creaseinflammation. iron pool’ (Section 3.22.1.3)243 may allow release of
Soifexerciseisagood‘anti-ageing’strategy,should morepro-oxidantironupontissuedamage,sothatoxi-
we supplement it with antioxidants? Certainly, eat dativedamagesecondarytotissueinjurycanbeaggra-
plenty of fruits, grains, and vegetables to get suffi- vated(Fig.10.1).Thereisevidenceconsistentwiththis
cientamountsofnutritionalantioxidants.Butbecare- in older patients with intracerebral haemorrhage;244
fulwithhigh-dosesupplements:theymaynegatethe high plasma ferritin was associated with poor out-
beneficial effects of exercise in the elderly,234 as they come.Severalstudieshaveshownthatoverexpression
havebeensometimesreportedtodoinyoungersub- ofmetallothioneincanmodestlyincreasethelifespan
jects (Section 7.14.1.1). Several papers have claimed ofmice,andtargetingittotheheartslowsage-related
effects of high-dose vitamin E in improving immune cardiac dysfunction (similarly to catalase); levels are
function,andhenceresistancetoinfectionintheeld- increased in dwarf mice and in rodents subjected to
erly,butthedataarecontroversial.235 CR.245 How this relates, if at all, to Zn2+ homeostasis
isuncertain.Highlevelsofoxidativedamageinnaked
molerats(andvampirebats!)havebeensuggestedto
11.4.10 Iron,ageing,anddisease:another
involvehighintracellularironcontents.84
gendergap
One manipulation that did shorten lifespan in
11.5 Antioxidantstotreatdisease
insects196 orC.elegans236 wastofeedthemextrairon;
indeed, iron accumulates in flies with age,196 as it Increased oxidative damage occurs in most, if not all
does in tissues of humans, other animals, and even diseases(Chapter10).Insome,itcontributestotissue
insenescentyeast.112,237 Caloricrestrictionmay,asal- injury, so that therapeutic interventions with antioxi-
ready mentioned, diminish this iron accumulation.111 dants should be beneficial, provided that the agents
Iron has always been a paradox; essential for life yet usedactuallygettotherightplaceanddecreaseoxida-
pro-oxidant in the wrong molecular form. Excess or tive damage there. A good ‘tissue antioxidant status’
‘mal-placed’ iron is intimately involved in many dis- may also help us resist the sequelae of trauma and
eases,aswereviewedinChapters3and10.Ofcourse, disease, since tissue injury leads to increased oxida-
thesedatadonotshowthatironaccumulationcauses tive stress. For example, the extent of tissue damage
ageing. after stroke or Aβ deposition may be lower in pa-
Women suffer fewer heart attacks than men un- tients who already have high antioxidant levels in
til after the menopause, one suggestion being that the brain. Open-heart surgery, organ transplantation,
menstrualbleedingkeepsbodyironstoreslow.238 For and stays in the intensive care unit can lead to falls
example, iron levels in some brain regions increase in plasma and/or tissue antioxidant levels. By ana-
withage,buttendtobehigherinmen.239Anotherfac- logy,researchinthelivestockindustryhasshownthat
tormaybelessRSproductionandgreaterantioxidant supplementation of farm animals with α-tocopherol

--- Page 716 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 661
improves the resistance of their meat to spoilage.246 removalofoxidativelydamagedmolecules,e.g.rapa-
Woulditdothesameforourmeat? mycin (Section 11.3.4) and peptides that activate the
20S proteasome.251 Even nitrite, as a donor of NO•
11.5.1 Therapeuticantioxidants247 (Section2.5.6.6)hasbeensuggestedasapossiblethera-
peuticagent.252
The therapeutic use of antioxidants may involve nat- Anyantioxidantproposedfortherapeuticusemust
urally occurring antioxidants (with or without struc- obviouslybenon-toxic,butotherquestionsshouldalso
turalmodifications)orsyntheticmolecules(Table11.3). beaddressed.Theyinclude:
In addition, some drugs already used clinically may
1. Whatbiomolecule(s)istheantioxidantdesignedto
exert part or all of their effects by antioxidant mech-
protect?Isthatbiomoleculeanimportanttargetof
anisms (Table 11.3), one example being aminosalicyl-
injury?Forexample,thereisnopointininhibiting
ates in the treatment of inflammatory bowel disease
lipidperoxidationifthecriticaloxidativedamageis
(Section 10.12.1) and another being various antibiot-
toDNAorproteins.
ics (Section 9.17). There is growing evidence that
2. Howdoestheantioxidantwork—byscavengingRS,
the statins may act, in part, by reducing oxidative
preventingtheirformation,increasingendogenous
stress.Correctionof hypercholesterolaemiashouldit-
defencesystemsoraidingrepairofdamage?
self decrease oxidative stress (Sections 10.3.2 and
3. If it acts by scavenging, can the resulting
10.21.1) but statins have additional effects, e.g. in
antioxidant-derived radicals cause damage? They
decreasingNADPHoxidaseactivitiesinbloodvessels
might be directly damaging, and/or reduce O
and platelets.233,248–250 Some agents accelerate the 2
Table11.3 Some‘antioxidants’availablefortherapeuticuse.
Categoryofcompound Example
Naturallyoccurring SOD(CuZnSOD,MnSOD,EC-SOD;recombinantorpurified),superoxidereductase,metallothioneins,
catalase,thioredoxin,peroxiredoxins,otherperoxidases,tocopherols,tocotrienols,coenzymeQ,lipoicacid,
vitaminC,adenosine,transferrin,lactoferrin,cysteine,GSH,histidine-containingdipeptides,pyridoxamine,
carotenoids,flavonoids,otherplantphenols(e.g.resveratrol,curcumin),desferrioxamine,other‘natural’
ironchelators,melatonin,coelenterazine,antibiotics,pyruvate,andotherketoacids,tetrahydrocannabinol,
mannitol,trehalose,cannabidiol,β-hydroxybutyrate,nitratedfattyacids,nitrite(NO–)
2
Synthetic Thiols(e.g.mercaptopropionylglycine,N-acetylcysteine),syntheticmetal-ionchelators(e.g.ICRF-187,
Exjade,hydroxypyridones),fullerenes,D-carnosine,inhibitorsofxanthine,MPO,orNADPHoxidases,other
inhibitorsofO
•–generationbyphagocytes,inhibitorsofmonoamineorD-aminoacidoxidases,a
2
lipid-solublechain-breakingantioxidants,modifiedcannabinols/cannabidiols,inhibitorsofphagocyte
adhesion,GSHdonors,SODmimetics,pyruvateesters,derivativesofvitaminsE,Corpolyphenols,
curcuminorresveratrolderivatives,coelenterazinederivatives,modifiedantibiotics,idebenone,NO•
donors,β-hydroxybutyrateesters
Alreadyinclinicaluseandmight Penicillamine,bbucillamine,baminosalicyatesb(aloneorascomponentsofsulphasalazine),pentoxifylline
haveantioxidantactivityinvivo (Section9.8.1.7),apomorphine,bselegiline,flupirtine,omeprazole,metformin,statins,
(butwerenotdevelopedas 4-hydroxytamoxifen,bACEinhibitors(e.g.quinapril,ramipril,captopril)orangiotensinIIreceptor
antioxidants) antagonists(e.g.losartan,candesartan,valsartan),ketoconazole,folicacid,tetracyclines,probucol,
propofol,isoflurane,sevoflurane,someβ-blockers(e.g.carvedilol,nebivolol,metoprolol),ccimetidine,
someCa2+channelblockers,cphenylbutazone,bparacetamol,aspirin,salicylate,nitecapone,btolcapone,b
entacapone,bidebenone,troglitazone,btacrolimus,agentsinducingweightloss,exercise
aE.g.totreatpain(J.Pharm.Exp.Ther.345,502,2013);Section10.24.
bCompoundswhichreactwithRStoformproductswiththepotentialtocausedamage.
cSeveralβ-blockers/Ca2+blockersinhibitperoxidationinvitro;itisuncertainiftheydosoinvivoatthetherapeuticlevelsnormallyachieved;theevidencefornebivolol
F F
O N O
H
OH OH
actinginthiswayisbetterthanaverage(FreeRadic.Biol.Med.65,47,2013;73,308,2014),butnotconclusive.

--- Page 717 ---

662
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.4 Someassaysusedforscreeningputativeantioxidantsinvitro.
Speciesscreened Assays Comments
Superoxide Superoxideisgenerated(e.g.byxanthine/xanthineoxidase)or Sections2.5.3and3.5.6
added(e.g.asKO2)andallowedtoreactwithadetector
molecule.Inhibitionofthereactionbya‘O
•–scavenger’is
2
measured.Pulseradiolysiscandirectlyobservereactionswith
O
•–,stoppedflowcanalsobeused(Section2.3.2).
2
Hydrogenperoxide ReactionwithH2O2ismeasured. MultiplemethodsavailabletomeasurelossofH2O2asthereactionproceeds(Section6.11).
SingletO2 Scavenging/quenchingof1O2ismeasured. Section6.8
Nitricoxide NO•isgenerated.Thereactionisfolloweddirectly,oras Section6.5
inhibitionofthereactionofNO•withatargetmolecule.
Hydroxylradical OH•isgeneratedandallowedtoreactwithatarget(e.g. Sections2.3.3.1,2.5.1,6.2,and6.3
salicylate,deoxyribose,oraspintrap).Inhibitionismeasured.
PulseradiolysiscandirectlyobservereactionswithOH•.
InhibitionofFentonchemistry EffectsonFe2+/H2O2-dependentdamagetotargetmolecules AntioxidantsthataffectOH•-dependentdamagecanactbyscavengingOH•and/orby
aremeasured. blockingOH•formation,byremovingitsprecursors(O •
2
–,H2O2,HOCI,etc.)and/orby
chelatingmetals.
Peroxylradical Reactionwithamodelperoxylradical(Section2.5.4),e.g. Peroxylradicalscavengingabilitydoesnotnecessarilyequatetoabilitytoinhibitlipid
•
AAPH-derivedradicalsortrichloromethylperoxyl(CCl3O
2
)is peroxidationinmembranesorlipoproteins;otherfactors(e.g.lipophilicityandinteraction
measured,ortheeffectsonlipidperoxidationareexamined withanyendogenousantioxidants)areimportant.Forexample,dihydrolipoicacidrecycles
directly. α-tocopherolradicalinmicrosomesbacktoα-tocopheroltoinhibitperoxidation(Biochem.
Biophys.Acta1001,256,1989).Hencewerecommenddirecttestingonbiological
membranesorlipoproteins.Nevertheless,studieswithmodelperoxylradicalsareusefulin
attemptingtooptimizeantioxidantactivityinthedesignofchain-breakingantioxidants.
Peroxynitrite Nitrationoftyrosine,inactivationofα 1-antiproteinase, Peroxynitritehascomplexchemistry;manyantioxidantsreactwithitsdecompositionproducts
oxidationsofABTS,pyrogallol,DCFHDA,or (CO •–,OH • ,NO • )ordirectwithONOOH;fewscavengeONOO–directly(Section2.6)
3 2
dihydrorhodamine123. Severalmetalloporphyins(Section11.5.4)areanexceptiontothisgeneralization.
Hypochlorousacid Oxidationofthionitrobenzoate;inactivationof Somemolecules(e.g.taurine)reactwithHOCl/OCl–togenerateproductsthatalsoinactivate
α 1-antiproteinase(Sections2.6.3and6.7). α 1-antiproteinase.
Totalantioxidantcapacity SeeSection6.17.3 Differentmethodsgivedifferentanswers.
Cell-basedstudies Various‘probes’ofcellularRScanbeused(Section6.12). Theantioxidantmustbeabletoenterthecell.Bewareofeffectsincellculturemedia
(Section1.11)
Whateverassayisused,onemustcheckforanyeffectsoftheputativeantioxidantontheassaysystem.Forexample,doesitinterferewithgenerationofRS(e.g.inhibitingXO)orreactwiththeend-productdetected(e.g.ascorbate
reducingDMPO-OHtoanESR-silentspecies;Fig.6.4).

--- Page 718 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 663
to O •–. It is advantageous if antioxidant-derived they can work as OH• scavengers in vivo since most
2
radicals do not react with O and can be ‘re- will never be present at levels remotely approaching
2
cycled’(e.g.byascorbateorGSH)toregeneratethe thoseofendogenousmoleculesthatreactatdiffusion-
antioxidant. controlledrateswithOH•,suchasmMlevelsofGSH
4. SomeRShaveusefulrolesinvivo.Couldtheantioxi- incells(Sections3.10.1and9.20.1),0.5mMalbuminin
dantinterferewiththem? plasma(rateconstant>1010M–1s–1)and4.5mMplasma
glucose(~109 M–1s–1).Theauthorsareunderwhelmed
Suppose that clinical trials show that the antioxi- when told ‘compound X is a good OH• scavenger,
dant is beneficial. What does this tell us? It could
soit’sapromisingantioxidant’.Our(usuallypolitely
mean that RS make a significant contribution to dis-
unspoken) thought is ‘tell us something that isn’t a
ease pathology. It could also mean that the antioxi- good OH• scavenger, it may be useful as a control
dant has beneficial pharmacological effects unrelated
substance’.
toitsantioxidantaction.Itisthusimportanttoaccom-
Evenanexcellentantioxidantinvitromaynotwork
pany clinical testing of a putative ‘antioxidant drug’
invivo.Forexample,itcouldberapidlyexcreted,me-
with measurements of oxidative damage biomarkers,
tabolizedtoinactiveproducts,ornotreachthecorrect
to show that any benefit is related to the ability to
site. In addition, some compounds that have limited
decreaseoxidativedamageinvivo.
(orzero)directantioxidantactivitymayexertantioxi-
dant actions in vivo by being metabolized to better
11.5.2 Approachestoantioxidant antioxidants,byinhibitinggenerationofRSand/orby
characterization247,253 increasing endogenous antioxidant defences. Selegil-
ine(Section10.20.2)andmelatonin(Section3.25.3)may
Afirststepinevaluatingputativetherapeuticantioxi- beexamplesofthelastmechanism.Someagents(e.g.
dantsistoestablishwhattheyarecapableofdoingin carnosineandpyridoxamine)maybindcytotoxicend-
chemicalterms.Abatteryofinvitroantioxidantchar- products of lipid peroxidation or block formation of
acterizationmethodshasbeendeveloped(Table11.4). AGEproteins(Sections3.25.7and10.5.5.1).
Twoimportant(butoftenforgotten)pointsarethat: Let us look at some examples of proposed thera-
peuticantioxidants.
1. Acompoundshouldbetestedatconcentrationsthat
areachievableinvivo.
2. In assaying antioxidants, one should employ bio- 11.5.3 Superoxidedismutases,catalases,
logicallyrelevantRS,andthinkcarefullyaboutwhat andnanoparticles
targetsofdamagetouse.Forexample,in‘screening’
Antioxidantenzymesavailablefortherapeuticusein-
agentsthatmightinhibitdamagebyperoxynitrite,
cluderecombinanthumanSODs(CuZnSOD,MnSOD,
theauthorsuseatleasttwotypesofassay,includ-
ing ability to prevent ONOO–-dependent tyrosine and EC-SOD) and catalase. But if these enzymes are
nitration,aswellasinactivationofα -antiproteinase injected into animals, they have short plasma half-
1
(α -AP) on addition of ONOO–. Because the as- lives. To avoid this problem, they can be encapsu-
1
latedintoinjectablehydrogels,orbiodegradablenano-
says do not measure the same aspects of the re-
activityofONOO–anditsdecompositionproducts, spheres, which then slowly release the enzymes.255
A variety of ‘longer-lasting’ SOD or catalase conju-
‘scavengers’ do not always behave in the same
way.Forexample,urateinhibitsONOO–-dependent gates is also available, including polyethylene glycol
tyrosinenitrationbutnotα -APinactivation.254 α - (PEG)-SOD, galactosylated or mannosylated catalase
1 1 (e.g. used to study NF-κB activation; Section 5.5.6.1),
AntiproteinaseisinactivatedbyawiderangeofRS
Ficoll–SOD, lecithinized SOD, polyamine-conjugated
and is useful for detecting damaging antioxidant-
derivedradicals.254 SOD, cationized SOD, genetically engineered SOD
polymers, SOD or catalase conjugated to fragments
Theresultsofinvitrotestscanbeusedtoevaluate of (or the entire) HIV–tat protein (which facilitates
the likelihood that a compound exerts direct antioxi- their uptake into cells, but note that full-length
danteffectsinvivo.ThusifyourcompoundneedsmM tat can be toxic; Section 10.25.1), pyran–SOD, hya-
levels to act as a good RS scavenger in vitro but can luronic acid–SOD, hexamethylenediamine–SOD, and
only be present at micromolar levels in vivo, throw albumin–SOD.256–261 For example, CuZnSOD-tat was
it away. Most (or all) putative antioxidants react rap- radioprotectiveinmice.257Tathasalsobeenusedtode-
idly with OH• in vitro and are often suggested for liverHsp,resultinginneuroprotectioninsomeanimal
use in vivo on this basis. However, it is unlikely that models of stroke.262 Some animal studies show that

--- Page 719 ---

664
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.5 SomeSODmimeticscontainingtransitionmetals.
Compound Comments References
Mn2+–polyphosphate,–lactate, SomecancatalyseO •–dismutation.Forexample,Mnphosphatewasreported Section3.8.2andref279
–succinateand–malate tohavek~106-107 2 M-1s-1.ImportantcatalystsofO •–dismutationinsome
2
bacteriathatdonothaveSODenzymes.
Desferal–Mn(III)andrelatedMn Agreencomplexformedbyreactionofdesferrioxaminewithmanganese Arch.Biochem.Biophys.310,341,1994.
complexes dioxide,MnO2(k~106M-1s-1).Hasantioxidanteffectsinbacteria.Shownin
variousanimalmodelstoprotectagainstvascularinjury,e.g.inendotoxic
shock.Rarelyusednow.
Coppercomplexes Cu2+(aq)andsomechelatesofitcatalyseO •
2
–dismutationatlowpHequally Biochem.Biophys.Res.Commun.81,576,1978;
ormorerapidlythanequimolaramountsofCuZnSOD.Cu2+islesseffectiveat Arch.Biochem.Biophys.203,830,1980;
physiologicalpHorwhenboundtoproteinssuchasalbumin.Some Biochim.Biophys.Acta745,37,1983;
copper–amino-acidcomplexes(e.g.withlysineorwithhistidine)arestillgood J.Med.Chem.27,1747,1984;
catalystsatpH7.4,asarecomplexesofcopperwith3,5-diisopropylsalicylate Arch.Biochem.Biophys.315,185,1994;
orindomethacin.Manyofthesecoppercomplexesareunstable,however,and J.Inorg.Biochem.60,133,1995
problemscanbecausedduetothereleaseofCu2+ions(e.g.ascatalystsof
O
•–dismutationorOH•formation).EDTAdecreasesorabolishesreactionof
O
2•–withcoppersaltsbuthasnoeffectonCuZnSOD.Severalcomplexes,e.g.
2
Cu(II)2(3,5-diisopropylsalicylate)4caninhibitotherenzymesystems,including
NOSandcytochromesP450.CuII(atsm)isbeingexaminedforhumanuse
(Table11.8).
Porphyrinstructures ExamplesareMnTE-2-PyP5+,MnTDE-2-ImP5+,MnTnHex-2-PyP5+, Section11.5.4
MnTnBuOE-2-PyP5+,FeTM-4-PyP5+(Fig.11.5).
Othermanganesecomplexes ModifiedEDTA-typestructureswitharomaticrings.EUK-series,M40403, Section11.5.4
M40401,SC-55858,SC-54417

--- Page 720 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 665
intravenous administration of PEG–SOD and PEG– claimed for fullerenes, spherical nanoparticles made
catalasedecreasesischaemia–reperfusioninjurytothe of 60 or more carbon atoms (Fig. 11.5). They show
brainorspinalcord;injurytothebloodbrainbarrier highreactivityforradicaladdition(‘radicalsponges’)
mayallowthemtoenterthedamagedtissue.Controls andpolyhydroxylatedorpolycarboxylatedformswith
with PEG alone are needed since PEG can itself be increased antioxidant activity have been synthesized
neuroprotective.263 PEG-catalase administration was and shown to have protective effects in various an-
showntoimproveinsulinresistanceinobesemice.264 imalmodels,e.g.inmonkeystreatedwithMPTP.269,272
SODswithheparin-bindingdomainshavebeendevel- Again,however,therearereportsofcytotoxicity.269,273
oped which (like EC-SOD) can bind to blood vessel Onekeyquestioniswhathappenstothenanoparticles
walls and have shown protection against bleomycin- aftertheiradministration.Particlesthatareexcretedor
induced lung fibrosis and the hepatotoxicity of CCl biodegraded should be employed; carbon nanotubes
4
in animals (Sections 9.2.3 and 10.16.3.1). An inter- can be degraded by phagocytes in reactions involv-
esting example is to fuse MnSOD with the heparin- ingMPO(Section9.14.1),forexample.274Variousdrug
binding domain of EC-SOD.265 SOD or catalase can deliverysystemsthatonlyunloadthedrugatsitesof
also be attached to antibodies recognizing adhesion oxidativestressarebeingdeveloped.Forexample,the
molecules (e.g. ICAM-1, PECAM-1) to target them to reactivityofboronateswithH O (Section6.11.1) has
2 2
inflamed vascular endothelium.256 Section 10.8 gives been used to design nanocapsules that release their
anexample. contentswhentheyencounterH O invivo.275
2 2
The involvementof ROS in cancer metastasis (Sec- Many older papers reported anti-inflammatory ef-
tion 10.14.8.7) has prompted studies of the effects fects of SOD, and some of catalase, in various ani-
of antioxidant enzymes. Thus injection of galacto- mals.Resultswerevariablebothwithin(e.g.different
sylated or PEG-modified catalase decreased metasta- enzymes of equal activity not having the same anti-
sis in mice.258 Some SOD conjugates that appear to inflammatory effect) and between laboratories. One
be able to cross the blood–brain barrier have been factor that may account for many of these problems
constructed.266 A cell-penetrating derivative of cata- is the frequent contamination of SOD and catalase
lasehasbeendevelopedwithanargininenonamerat preparations with endotoxin,276 which can itself be
its N-terminus and a high-efficiency peroxisome tar- protective(Section3.7.5).
geting sequence at the C-terminus. It can enter cells, AfewhumanstudieswithSODhaveshownprom-
quicklytargetstotheperoxisome,andhasshownpro- ise; administration of recombinant human CuZnSOD
tective effects against oxidative stress in various cell to premature babies decreased inflammation some-
systems.267 Other methods used to deliver antioxi- whatandthereweresignsofimprovementinclinical
dantenzymes(orotherantioxidantagents268)tocells outcome in later life (Section 7.11.8.3). SOD injec-
includeliposomes,albuminmicrocapsules,andnano- tiondecreasedpaininpatientswithPeyroniedisease
particlecarriers,includingcarbonnanotubes.269,270 (Section10.24).
In addition to the use of nanoparticles as carriers
forantioxidants,thelargesurfaceareaofmanynano- 11.5.3.1 Viralvectors
particlesgivesthemunusualproperties;insomecases An alternative approach is to deliver not the antioxi-
they are able to scavenge ROS directly and protect dant enzymes but the genes encoding them, e.g. by
cellsincultureagainstoxidativestress.Suchactivities using viral vectors such as adenovirus or retrovirus.
have been claimed for cerium oxide, gold, platinum, In one study, genes encoding MnSOD or CuZnSOD
Fe 3 O 4 ,andsilvernanoparticles,forexample.269,271Cer- attached to an adenoviral vector were injected into
ium (e.g. as the oxide CeO 2 ) can scavenge certain rats 3 days before bile duct ligation. The activity of
ROSbycyclingbetweenCe(III)andCe(IV)oxidation both enzymes increased in the liver, but the MnSOD
states,e.g. gene offered more protection against liver damage
causedbytheligationthanthatencodingCuZnSOD.277
Ce(IV)+O
•–(cid:2)
Ce(III)+O
2 2 There are also reports of radioprotective effects of
Ce(III)+O •–+2H+(cid:2) Ce(IV)+H O SOD genes (Section 9.20), and of protection against
2 2 2
ischaemia–reperfusion injury in the rat retina (Sec-
buthowgoldandsilverparticlescouldworkasROS tion10.6.8).TreatmentwitheNOSorMnSODgenesim-
scavengers is uncertain. Equally, there are a number provedwoundhealingindiabeticmice(Section7.13.3),
ofreportsoftoxicityofnanoparticles(Section9.14.1), and adenoviral delivery of the gene encoding 1-cys
which need to be evaluated before they are used peroxiredoxin to the lungs of mice protected against
therapeutically.Antioxidantpropertieshavealsobeen injurybypureO .278 Severalstudieshavealsoshown
2

--- Page 721 ---

666 FREE RADICALS IN BIOLOGY AND MEDICINE
protectiveeffectsofHO-1genedelivery.Useofadeno- SOD mimetics usually contain transition metal
viralvectorsalloweddeliveryofSODandcatalaseto ions. Examples include various Mn2+ and Mn(III)
the hippocampus of rats to examine their effect on chelates, and Cu2+ ions chelated to amino acids
learningandmemory(Sections5.5.10and10.17.5). or to anti-inflammatory drugs. However, many of
Of course, gene delivery methods are difficult to the ‘SOD-mimetic’ copper chelates described in the
useinacutesituations,andquestionspersistaboutthe early literature probably dissociate to release cop-
safetyofviralvectors. per ions in vivo (Table 11.5) which may lead to
the production of OH• radical, and there is now
little interest in their use. Research currently fo-
11.5.4 SODmimeticsandrelatedredox-active
cuses around iron or manganese porphyrins such
molecules279,280
as FeTM-4-PyP5+, MnTE-2-PyP5+ (AEOL10113; the
SOD mimetics are compounds that catalyse the dis- AEOLseriesisnamedafterAeolusPharmaceuticals),
mutationofO •– ataratehigherthanthatofO •– self- MnTnBuOE-2-PyP5+ (BMX-001; the name origin-
2 2
dismutation(k ~5×105M–1s–1),i.e.theycan(likeSOD ates from BioMimetix Pharmaceuticals), MnTDE-
2
enzymes)bothoxidizeandreduceO •–.Mostofthem 2-ImP5+ (AEOL10150), MnTnHex-2-PyP5+, Mn(III)
2
appear not to be catalysts of H O dismutation (i.e. salen derivatives such as EUK-8 and EUK-134
2 2
catalasemimetics),althoughsomecanuseH O toox- (EUK originates from the company Eukarion), and
2 2
idize other biomolecules in peroxidase-type reactions Mn(II) cyclic polyamines such as M40403 (Fig.
(e.g.GSHtoGS•). 11.5) that are able to catalyse the removal of O •
2
– to
N N
O
N N N
N N N
N N N N N N
HO
N
(cid:129)2HCl
N N N
O O
U83836E U101033E U104067F
SH SH
H H
SH N N H N NH
H N N 2 2
2 H
WR-1065 PrC-210 PrC-211
(S-phosphate on pro-drug) (OH)
n
SH O
H H
N N NH
OH HS 2
O NH
Mercaptopropionylglycine Mercaptoethylguanidine (MEG) O Polyhydroxylated C 60
O
N O
NH
Se Se OH
Ebselen BXT-51072 Apocynin
Figure11.5 Structuresofsomeantioxidantsmentionedinthetext.Corrolesareporphyrin-likecompoundsinwhichtwoofthepyrrolegroupsare
directlylinked,notbyabridgingcarbon.

--- Page 722 ---

F F O
N Cl N Cl O ONa F C OH
3
HN Mn NH N Mn N O S SH HN OH
H H H H F F
N N N N
Cl Cl
M40403 M40401 MESNA Neu2000
H
N C H
N+ 7 15 HN Cl NH HN Cl NH
OH
O–
O
HO OH OHO HN Mn NH HN Mn NH
OH
Cl Cl
O
HO O HN N N
OH OH H H
LPBNAH SC-55858 SC-54417
OH
ONO
2 O
S
HO
N NH N N N N
2
O(cid:129)
O(cid:129) O(cid:129) O(cid:129)
BN82451 3-Nitratomethyl-PROXYL TEMPO OXANO TEMPOL
(NMP) (4-hydroxy-TEMPO)
OH
SO 3 Na N O– HO O O O
N+
N N+ O 3
P
O– O O HO O O
NaOS OK
3
Edaravone CPI-1429 EPC-K1
NXY-059 (MCI-186), keto form
O–
N O
N+ N HO
O
HO O
N N N O
N
O
2HCl N N OH
PBN U78517F IAC
(bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl)decandioate)
N
O O— N O–
OH HN O N N N N
N N
N
CH 3 SO 3 H –O N
HO
O 2
OPC-14117 U74006F STAZN
Figure11.5 (Continued)

--- Page 723 ---

668 FREE RADICALS IN BIOLOGY AND MEDICINE
O
N
N N N N N N
+
N Fe N N Mn N Mn
+
N N N N O X O
R R
R=H, =EUK-8 (X=Cl);
FeTM-4-PyP5+ MnDiM-4-PyMAn-Corrole2+ R=OCH3, =EUK-134 (X=Cl);
N R=OCH2CH3, =EUK-189 (X=OAc);
MnTBAP3- MnTDE-2-ImP5+ MnTE-2-PyP5+ MnTnHex-2-PyP5+ MnTnBuOE-2-PyP5+
R
(AEOL 10150) (AEOL 10113) (BMX-001)
N N N
R Mn R R= COO–
N N N N N N
O
R
O OH O
O OH
O
O O
EPI-743 Idebenone
HO O
O N
N
O
S
Tetomilast
Figure11.5 (Continued)
various extents. Reaction of Mn complexes with O
•–
Unlikethe‘sheltered’catalyticsiteofSOD,themetal
2
usually involves a mechanism similar to that of centresinthesemoleculesaremore‘open’toundergo
MnSOD (Section 3.5.2), cycling between Mn(II) and redoxreactionswithawiderrangeofbiomolecules,to
Mn(III) states. Other ring structures, such as Mn(III) anextentmodulatedbytheligandsaroundthemetal.
biliverdin and its derivatives as well as corroles (Fig. Thismeansthattheycaninteractwithcellularreduc-
11.5),havealsobeenusedinplaceofporphyrins,but tantssuchasascorbateorGSH;sometimesthesereac-
catalyse O •– dismutation employing Mn(III)/Mn(IV) tions can generate H O and cause cytotoxicity.279–281
2 2 2
redox couples. The optimized Mn(III) corrole has a Indeed,SODmimeticsathighlevelscould(likeSODs)
highk(O
•–)of1.3×108M–1s–1.
generate excess H O if levels of H O -scavenging
2 2 2 2 2

--- Page 724 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 669
enzymeswereinsufficient.However,thesecompounds being pro-oxidant (Table 11.6), but also by increasing
have the advantage that they can penetrate to vari- the levels of HO-1.282 Some commercial samples of
ous degrees into cells and organelles, e.g. mitochon- MnTBAP3- (AEOL10201) have been reported to con-
dria,dependingontheirhydrophobicity.Forexample, tain contaminants (small Mn2+-chelates) that account
MnTnHex-2-PyP5+andMnTnBuOE-2-PyP5+(Fig.11.5) formost,ifnotall,oftheO •–scavengingactivity,279,283
2
can cross the blood–brain barrier, and accumulate in pureMnTBAP3-scavengesONOO–(k~105M–1s–1)far
mitochondria. better than it does O •–, k~103 M–1s–1. Since this is
2
The manganese(II) in cyclic polyamines such as more than two orders of magnitude lower than O
•–
2
SC–55858, SC–54417, M40401, and M40403 is bound self-dismutation,itwillnotbeaSODmimeticinvivo.
to ligands at five co-ordination points. These com- Weawaitwithinteresttheresultsoftheapplication
pounds can transfer electrons to and from O
•–
to oftheseagentstohumans.
2
catalyse its dismutation, with rate constants reaching
1.2×108M–1s–1forM40401.
11.5.5 Spintraps/nitroxides279,284
Most SOD mimetics are also capable of reacting
with other reactive species such as NO•, CO •–,NO • , Spintrapsareusedtodetectfreeradicalsinvivoand
3 2
and ONOO–, however. Hence do not regard any of in vitro (Section 6.2). If a spin trap intercepts a bio-
these metal complexes as specific scavengers of O
•–
in logically damaging radical in vivo, then it ought to
2
vivo. They are perhaps better described as modula- protect against injury. For example, DMPO protected
tors of the redox environment, sometimes antioxi- ratsagainsttheneurotoxicityof6-hydroxydopamine285
dantandperhapssometimespro-oxidant!Indeed,pro- andagainstischaemia–reperfusioninjurytoliver.286 If
oxidant effects could contribute to the anti-cancer ef- atrapdoesnotprotect,itcouldmeanthat
fects of some of these compounds in animal models
i. theradicalstrappedarenotimportantcontributors
(Table11.6).
todamage;
In the EUK series, the tetra-coordinated manga-
nese(III)canreactwithO •– andONOO–.Indeed,sev- ii. notenoughradicalistrappedforsignificantprotec-
2 tion;
eral of these compounds react faster with ONOO–
than does CO (although remember that CO /HCO– iii. Thetrap,itsmetabolites,and/orproductsofitsre-
2 2 3 actionwithfreeradicalscausedamagethemselves.
levelsarehighinvivo,raisingthequestionofwhether
iv. anycombinationofreasons1–3
these compounds could truly compete in vivo at the
levelsattainable).Forexample,MnTM-4-PyP5+ reacts The idea of using spin traps as therapeutic anti-
quickly with ONOO– [rate constant quoted as 1.2 × oxidants arose from studies showing that α-phenyl-
106 M–1s–1 at 37 ◦C), and with carbonate radical.280 tert-butylnitrone (PBN) could protect rats against
FeTM-4-PyP5+ reacts faster with ONOO–, ~ 5 × 107 death from shock induced by intestinal ischaemia–
M–1s–1. Similar reactivity was reported for MnTE-2- reperfusionorendotoxininjection.Laterworkshowed
PyP5+ and other Mn(III) N-substituted pyridylpor- that PBN can protect in other animal models, e.g. of
phyrins. The reduction of ONOO– can be rendered myocardial ischaemia–reperfusion, light-induced ret-
catalytic by coupling with GSH, ascorbate, O • 2 –, or inaldegeneration,hearttransplantrejection,andcere-
urate. The cycling involves the oxidation of either bral ischaemia–reperfusion. It was noted in the last
Mn(III) to oxoMn(IV) in a one-electron transfer, or experiments(ingerbils)thatPBNadministrationeven
of Mn(II) to oxoMn(IV) in a two-electron transfer. tooldcontrolgerbilsdecreasedlevelsofbrainprotein
•
One-electron transfer produces the reactive NO rad- carbonylsandappearedtoimprovecognitivefunction.
2
ical, while two-electron transfer produces NO–. The After injection into animals, PBN is rapidly taken up
2
latter is possible only with those metalloporphyrins by all tissues (including the brain); concentrations in
which are in vivo readily reduced to the Mn2+ oxi- gerbil brain are estimated to approach 0.5 mM after
dation state, such as MnTE-2-PyP5+ and MnTDE- injectionof150mgPBN/kgbodyweight.
2-ImP5+, and other analogues which have similar However, things are not so simple. In vitro char-
properties. acterization of PBN shows it to be a poor chain-
‘SODmimetics’havebeenshowntoprotectagainst breakingantioxidantorinhibitoroflipidperoxidation,
oxidative damage in a wide range of cell and an- so its mechanism of action may not be as a radical
imal model systems (Table 11.6). However, they may scavenger.284,287,288 Several traps, including PBN, can
also exert other effects in vivo, not only modulating have other metabolic effects, including metabolism
redoxstate,exertingperoxidaseactionandsometimes to generate NO• (Fig. 6.2, legend). PBN, POBN, and

--- Page 725 ---

670 FREE RADICALS IN BIOLOGY AND MEDICINE
Table11.6 Redox-activecatalytic‘antioxidants’∗areeffectiveinanimalmodelsofdiseases.Someexamples.
Modelsystem Speciesused Compoundfoundtobeprotective
Lung
Bleomycinfibrosis Mice AEOL10201
Radiationfibrosis Rats AEOL10113,MnTnHex-2-PyP5+,AEOL10150
Cigarettesmokeinjury Rats AEOL10150
Firesmokeinhalation Sheep INO-4885(Section9.13.7)
Antigen-inducedasthma Mice AEOL10113
Guineapigs M40403
Pulmonaryhypertension Mice AEOL10113
Haemorrhage-inducedinjury SOD3knock-outmice AEOL10150
Bronchopulmonarydysplasia Baboon AEOL10150
Carrageenan-inducedinflammation Rats M40403
Chlorinetoxicity Rodents AEOL10150
Influenzainfection Mice EUK-207(FreeRadic.Biol.Med.67,235,2014)
Cardiovascular
Splanchnicarteryocclusion Rats AEOL10217
Heartischaemia–reperfusion Rats M40403,EUK-8
Circulatoryshock Rats EUK-8,EUK-134,FeTM-4-PyP5+,AEOL10113,and
others
Nitratetolerance Rats AEOL10201
Interleukin-2-inducedhypotension Mice M40403
Endotoxin-inducedshock Rats M40401
EUK-8
Hypoxicpulmonaryvasoconstriction Mice EUK-8
Stenosisafterballooninjury Rats M40401
Anti-atherosclerotic ApoE-deficientmice Fecorroles;(gadoliniumcorroleusedasacontrol;
AngewChem.47,7856,2008)
Centralnervoussystem
Kainateinjury SOD2knockoutmice AEOL10201
Cerebralvasoconstriction Amyloid-overproducingtransgenicmice AEOL10201
Rats AEOL10201
Correctsneurobehaviouraldefects ATM-knockoutmice EUK-139
ALS MutantCuZnSODtransgenicmice EUK-8,EUK-134
AEOL10150
Spinalcordinjury Rats AEOL10201,AEOL10150,AEOL10113,MnTBAP3-
Mice AEOL10150
Stroke Rats MnTnHex-2-PyP5+,AEOL10113,AEOL10150
Subarachnoidhaemorrhage Mice MnTnHex-2-PyP5+
Paraquat-inducedneurodegeneration Mice EUK-134,EUK-189
Spongiformencephalopathy SOD2knockoutmice EUK-8,EUK-134
Ischaemia–reperfusion Rats AEOL10113
Mice AEOL10150
Gerbils M40401
Foetalrabbits MnTnHex-2-PyP5+
Rats MnTnHex-2-PyP5+

--- Page 726 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 671
Phencyclidineinjury Rats M40401
Hyperalgesia Rats M40403
Age-inducedcognitiveimpairment Mice EUK-189,EUK-207
Meningitis-inducedhearingloss Rats AEOL10150
Painrelief Rats AEOL10113,FeTM-4-PyP5+,MnTnHex-2-PyP5+
(Section10.24)
Liver
Acetaminopheninjury Mice AEOL10201
Fas-inducedinjury Mice AEOL10201
Ischaemia–reperfusion Rats AEOL10150
Non-alcoholicsteatohepatitis Rats EUK-8,EUK-134
Gastrointestinal
Aceticacid-inducedcolitis Rats AEOL11201
Trinitrobenzenesulphonic Rats M40403
acid-inducedcolitis
Cerulein-inducedpancreatitis Mice M40401
Radiationproctitis Rats AEOL10113
Renal
Gentamicininjury Rats M40403
Endotoxicity Mice AEOL10113
Ischaemia–reperfusion Rats EUK-134,MnTnHex-2-PyP5+
Endocrine
Diabetes NODmice AEOL10113,EUK-8,AEOL10150
Rats∗ AEOL10112
Joints
Collagen-inducedarthritis Rats M40403
Other
Peridontitis Rats M40403
Cancerradio-andchemosensitisation
Breast Mice AEOL10113
Glioma Mice BMX-001,MnTnHex-2-PyP5+
Lymphoma Cells AEOL10113,BMX-001
Radioprotectionofnormaltissue
Erectiledysfunction,prostate Rats AEOL10113,BMX-001
Wholebrain Mice BMX-001,MnTnHex-2-PyP5+
Breast Mice AEOL10113
Salivaryglandsandmucositis Mice BMX-001,AEOL10113
Eye Rats AEOL10113
Haematopoieticstemcells Mice AEOL10113
Wholebody Mice AEOL10112
*Neverassumetheyareactuallyactingasantioxidants,withoutevidence,assomeoftheiractionscanbepro-oxidant.Abbreviations:ATM,ataxiatelangiectasiamutated;
NOD,non-obesediabetic.
*Effectswerebeneficialordeleterious,dependingonwhetheradministeredattheonsetofdiabetes(streptozotocin-induced)orlater(RedoxBiol.1,457,2013).
AdaptedfromDrugDiscoveryToday9,559,2004,bycourtesyofthepublishersandDrBrianJ.DaywithsubstantialinputfromDr.InesBatinic-Haberle.Alsosee,279,280
Med.Princ.Prac.22,103,2013.Alsoseeforadetailedlistoftheirpotentialtherapeuticeffectsincentralnervoussysteminjuries,immunedisorders,andanticancerand
radioprotectiveeffects,allmanuscriptsoftheForumIssueonSODmimetics,Antioxid.Redox.Signal.20(15),2014.ThecompoundAEOL10201isMnTBAP,AEOL10110is
MnTM-4-PyP5+,AEOL10112isMnTM-2-PyP5+,AEOL10113isMnTE-2-PyP5+,andAEOL10150isMnTDE-2-ImP5+.Morelipophilicagentsthatmaycrosstheblood–
brainbarrier,suchasMnTnHex-2-PyP5+andMnTnBuOE-2-PyP5+(BMX-001)havebeendeveloped(Fig.11.5).AEOL10113isnowalsoknownasBMX-010.Alsosee
RedoxBiol.5,43,2015.

--- Page 727 ---

672 FREE RADICALS IN BIOLOGY AND MEDICINE
DMPObindtoCYPsandinhibitsomeoftheiroxidase Hydroxylamines, reduction products of nitrox-
activities289 and some of their radical adducts can be ides, can also act as antioxidants. One example is
metabolizedbyCYPs.290 Ratherthanbeingadirectly- IAC (Fig. 11.5), which has shown protective ef-
actingantioxidant,PBNmayprotectbydecreasingthe fects in animal models of colitis, Alzheimer disease,
expressionofgenesencodingiNOS,COX-2,andproin- and ischaemia–reperfusion.294 Indeed, N-t-butyl hy-
flammatory cytokines, whilst stimulating IL-10 pro- droxylamine, formed during the spontaneous de-
duction.NitronesmayalsoactivateNrf2andtherefore composition of PBN, is a better antioxidant in vitro
lead to increases in endogenous antioxidant defences than PBN itself.295 It crosses the blood–brain bar-
(Section6.2.6). rier, at least in mice, and was reported to have
Several derivatives of PBN have been developed neuroprotective effects in a mouse model of infantile
aspotentialtherapeuticagents,suchasCPI-1429and neuronalceroidlipofuscinosis(adiseasediscussedin
NXY-059,2,4-disulphophenyl-N-tert-butylnitrone,also Section10.23.3).295Nitroxideshavebeenusedasstabil-
calledCerovive® (Fig.11.5).Cerovive® wasshownto izers in plastics, and there is an old report that some
improveoutcomeinaprimatestrokemodelevenwhen disposableplasticsyringescancontaminatesolutions
it was administered as late as 4 h after ischemia, but insidethemwithnitroxides.296
sadly it did not exert significant protective effects in Nitroxideshaveradioprotectiveeffects(Section9.20)
clinical trials on human stroke patients. Again, it is andcandecreasetissuedamageinsomeanimalmodel
onlyaweakantioxidantinvitro288 andmaywork(in systems of ALS (Section 10.22.2.1), shock, ischaemia–
animal models) by the other mechanisms mentioned reperfusion, and inflammation, e.g. mouse models
above.Inanycase,itshydrophilicstructure(negative of colitis. TEMPO attached to nanoparticles was es-
charge)suggestsapoorabilitytocrosstheblood–brain pecially effective in the latter model.268 Nitroxides
barrier, unlike PBN. All may not be lost: there are have also been attached to PEG or heparin, to de-
suggestions that NXY-059 could be useful in chemo- liver them to blood vessel walls.297 However, they
therapy of glioma (it has been renamed as OKN-007 can also be toxic to some cell types. A compound
in those studies); how it gets to the glioma in vivo (3-nitratomethylPROXYL,Fig.11.5)thatisbothani-
is not clear if it cannot cross the blood–brain barrier. troxide and an NO• donor (from its nitro group) has
AnevenmorehydrophilicagentisLPBNAH,whereas beendeveloped.298 Mito-TEMPO(Section11.5.12)has
a more hydrophobic agent that is protective in some beentestedinsomeanimalmodels.
animalstrokemodelsisSTAZN,stilbazulenylnitrone
(Fig.11.5).291
11.5.6 VitaminsCandE,carnosine,
PBN is a nitrone and reacts with radicals to give a
andtheirderivatives
nitroxide (Section 6.2). Indeed, some nitroxides have
been proposed as antioxidants, such as OXANO, Prolonged deficiency of α-tocopherol causes neuro-
TEMPO, and TEMPOL (Fig. 11.5).292 However, they logical damage (Section 4.3), whereas its adminis-
react with O • 2 – with rate constants lower than that tration to premature babies may have some limited
of O • 2 – self-dismutation at physiological pH. In vivo, benefit (Section 1.5.2.1). However, attempts to use α-
nitroxidescanundergootherredoxreactions.Forex- tocopheroltotreatdiabetes,anthracycline-inducedcar-
ample, they can react with ONOO–, CO • 3 –, or NO • 2 . diotoxicity,cancer,Huntington,orParkinsondiseases,
They can also oxidize ascorbate, thiols, NAD(P)H, or have been disappointing, although there seems to be
Fe2+, and inhibit myeloperoxidase (Section 11.7.1).293 limited benefit in AD (Section 10.21). Remember that
Protonated superoxide (HO • 2 ), however, reacts rap- it takes a considerable time to raise the α-tocopherol
idly with nitroxides. Once nitroxides are oxidized content of tissues, especially brain, whereas oxida-
(e.g. by HO • 2 or ONOO–), the oxoammonium cations tive damage can often be fast (e.g. within minutes in
(RNO+)producedcanthenreactrapidlywithO • 2 –tore- some reoxygenation injury experiments). Tocopheryl
establishnitroxide,i.e.theseagentscouldconceivably polyethyleneglycolsuccinate(Table11.7)appearsto
removeO • 2 –andONOO–invivo, be more bioavailable and has been used to increase
RNO • + HO • + H+(cid:2)RNO+ + H O plasma α-tocopherol levels in patients with impaired
RNO+ + O •–(cid:2) 2 RNO • +O 2 2 fat absorption, but how quickly it raises tissue levels
2 2 is uncertain. A second reason for limited efficacy of
However, in view of their wide range of redox reac- vitamin E is that oxidative damage frequently occurs
tions,neverassumethatanyeffectstheyexertinvivo by mechanisms other than lipid peroxidation. Third,
areduetoantioxidantactivity. high-dose α-tocopherol does not, in any case, seem

--- Page 728 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 673
goodatinhibitinglipidperoxidationinhumans(Sec- also protects animals against adriamycin cardiotox-
tion 4.3). Various therapeutic effects of other tocoph- icity(Section10.16.2.1).Asuccinateesterofprobucol,
erolsandoftocotrienolshavebeensuggestedbutnot AGI-1067provedineffectiveinclinicaltrial(Fig.10.6).
yetestablishedinhumans(Section4.3.7). CoenzymeQ(CoQ)haslimitedbeneficialeffectsin
Several structural analogues of α-tocopherol, some human neurodegenerative diseases (Sections 10.20.4,
with improved antioxidant activity (as assayed in 10.23.1, and 10.23.2). These may or may not involve
vitro and/or tested in animals), have been described. antioxidant actions—the data are insufficient to de-
OneisNH-tocopherol(Table11.7).AnotherisBO-653 cide. The CoQ derivatives idebenone and EPI-743
(Table 11.7), which has shown anti-atherosclerotic ef- (Fig. 11.5) have also been used, with limited indica-
fectsin animalsand, unlikeprobucol (Section11.5.7), tions of positive effects, in some of these diseases as
does not lower HDL levels. However, it might also well as in subjects with inherited mitochondrial (e.g.
decrease proteasome activity.299 A water-soluble ana- MELAS, LHON; Section 1.10.4) disorders.306 In con-
logue of α-tocopherol, Trolox C, is widely used in trast, the phenolic antioxidant OPC-14117 (Fig. 11.5),
vitroasanantioxidant(e.g.Section6.17.3),a‘cardiose- althoughshowingsomebenefitinseveralanimalmod-
lective’ α-tocopherol analogue, MDL 74,405 has been elsofneurodegenerativedisease,didnothelppatients
developed(Table11.7),andvariousmoleculesinwhich withHuntingtondisease,nordidα-tocopherol.307The
Trolox or α-tocopherol are linked with NO•-donating compoundBN82451(Fig.11.5)wasalsoneuroprotect-
groups have been described.300 Few, if any, human iveinanimalmodels,butdoesnotappeartohavebeen
studies have been conducted for these compounds. testedinhumans.308
Troglitazone, an antidiabetic agent with antioxidant The chain-breaking antioxidants BHA and BHT
properties has been used on patients, although not (Table 11.7) are widely used in the food industry to
withoutproblems(Table11.7).Raxofelasthasbeenre- prevent rancidity. In spite of their low toxicity, they
portedtoimprovevascularendothelialdysfunctionin have not been explored much as therapeutic agents,
diabetes; it is hydrolysed to the antioxidant IRFI005 although comparable phenolic structures can be seen
in vivo (Table 11.7). Tocopheryl succinate has been in probucol and in many other agents tested in hu-
claimedtohaveanticancerproperties(Section4.3.9). mans(Table11.7).Butylatedhydroxytoluenecanalso
Various esters of ascorbic acid, such as ascorbyl increasetranscriptionofc-fosandc-jun,andinteracts
palmitate and 2-octadecylascorbate, have been syn- with the ARE to increase activities of defence en-
thesizedaslipophilicversionsofascorbate.Theyhave zymes (Section 5.5.8). BHA administration decreased
been used as food preservatives and tested as anti- lung damage in mice infected with respiratory syn-
oxidants in some animal models, but do not appear cytial virus,309 and BHT has been attached to carbon
to have attracted much interest for therapeutic use. nanotubestoenhancetheirantioxidantactivity.310Plas-
EPC-K1 (Fig. 11.7) is a combined phosphate ester of ticsoftencontainBHT,andtracescanleachoutfrom
vitamins E and C that has been reported as protect- ParafilmandPVCtubing,sometimestoanextentthat
iveinratmodelsofhepaticischaemia–reperfusionand can affect experiments (Section 1.1.3). Propofol, the
stroke.301 active ingredient of the anaesthetic Diprivan, resem-
L-carnosine may have some antioxidant properties blesBHT(Table11.7)andhasantioxidantactivitiesin
in vivo (Section 3.25.7) but is rapidly hydrolysed by vitroatlevelsclosetothosethatcanbepresentinvivo
carnosinases when administered. Some protective ef- duringanaesthesia.Whetheritsantioxidanteffectsare
fects of D-carnosine, which has equivalent antioxi- significantinvivoisuncertain.311
dant properties but is not a substrate for hydrolysis, Because of alleged toxicity problems of BHA and
have been reported in animal models of atheroscler- BHT(atabsurdlyhighdoses;Table11.7),attemptshave
osis, stroke, and spinal cord injury.302–304 Eye drops been made to replace them as food preservatives by
containingN-acetylcarnosinehavebeendevelopedfor ‘natural’phenoliccompoundssuchasflavonoids,hy-
potentialtreatmentofoculardisorders.305 droxytyrosol, or rosemary antioxidants. Much work
hasbeendoneonmixturesofphenolssuchasGinkgo
biloba extract (Sections 4.5.4, 4.6.8, and 10.17.6.10) for
11.5.7 CoenzymeQandsynthetic
dementia,orDaflon,amixtureofdiosmin(90%)and
chain-breakingantioxidants
hesperidin (10%) to treat vascular problems. Little
Probucolhasanti-atheroscleroticeffectsinvivoaswell harddataontheirclinicalefficacyexist.312Otherplant
as antioxidant properties in vitro, although the latter phenols of interest include silybin (Section 9.8.1.7)
do not explain the former (Section 10.3.7). Probucol and hydroxyethylrutosides (e.g. Table 11.8), esters

--- Page 729 ---

674
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.7 Somesyntheticchain-breakingantioxidants.
Compound Structure Comments
Syntheticchain-breakingantioxidantsrelatedtotocopherols
Trolox Water-solubleformofα-tocopherol;thehydrophobicside-chainisre-
placedbyahydrophilic–COOHgroup.Goodscavengerofperoxyland
alkoxylradicals,givingaTroloxradicalthatcanberecycledbyascor-
bate.Oftendoesnotworkwellasanantioxidantinmembranes–too
hydrophilictoenter.Usedasastandardinassaysoftotalantioxidant
capacity(Section6.17.3).
Tocopherolesters - Tocopherolesterifiedwithphosphateatthe–OHgroupor
γ-tocopherolesterifiedwithN-dimethylglycinate
[-OCOCH2N(CH3)2]havebeenusedinstudieswithskin(Bioorg.
Med.Chem.19,6348,2011).Botharemorehydrophilicthanα-or
γ-tocopherol.
Tocopherylpolyethyleneglycolsuccinate CH FDA-approvedaswatersolublesourceofvitaminEinsubjectswith
O 3
O O impairedfatabsorption.Alsousedasadrugstabilizer/emulsifier/
H n O O CH 3 a 1 b 5 s 6 o 7 r , p 2 ti 0 o 1 n 4 e ) n . hancer(Carbon45,2463,2007;Anal.Chem.86,
H C O C 16 H 33
3
CH
3
CH3 CH3 CH3
C16H33
CH3
TFA-12 Atocopherollong-chainfattyalcohol.ProtectiveagainstEAE
(Section10.18.2)inmice(J.Neurosci.33,11633,2013).May
decreaseactivationofmicroglia.
NH-tocopherol Increasedinvitroantioxidantactivitybyan–NHgrouptodonate
hydrogen(FEBSLett.586,711,2012).Thesameistrueof
NH-Trolox(seebelow).Analternativeapproachistoreplacethe
–OHgroupby–NH2givingtocopheraminesortocotrienamines
(Bioorg.Med.Chem.21,5039,2013).
NH-Trolox -

--- Page 730 ---

AGEING,
NUTRITION,
DISEASE,
AND
THERAPY:
A
ROLE
FOR
ANTIOXIDANTS?
675
Table11.7 (Continued)
Compound Structure Comments
TMG Water-solubleformsoftocopherol(Cardiovasc.Res.28,235,1994;
Dig.Dis.Sci.48,54,2003;FreeRadic.Biol.Med.26,858,1999;Br.
J.Haematol.117,699,2002;Biochimie93,1880,2011).The
compoundIRFI016,sometimescalledRaxofelast,wasreportedto
aidwoundhealing(Section7.13.3);IRFI005isitsdeacetylated
(antioxidant)form.PMCwasreportedtohaveantithromboticand
anti-atheroscleroticeffectsinmice(FreeRadic.Biol.Med.49,
881,2010).
PMC
IRFI005 InIRFI016the–OHmarked*is-OCOCH3.
CS-045(Troglitazone) Ananalogueofα-tocopherol;actsasahypoglycaemicagentby
mimickingorenhancingtheeffectofinsulin.MarketedasRezulinin
severalcountriesfordiabeticpatients,buthepatotoxicityhascaused
problems.Itsoxidationtoperoxylradicals,semiquinones,and
quinonesbyCYPsandperoxidases,leadingtoGSHdepletion,may
contribute(DrugMetab.Disp.39,2290,2011;Chem.Res.Toxicol.
24,1113,2011).
MDL74,405 Quaternaryammoniumcompound.Entersseveraltissueswhen
administeredtoanimalsbutmayconcentrateintheheart.Protective
inmyocardialischaemia–reperfusionmodelsinseveralanimals;also
againstmodelsofinflammatoryboweldiseaseinrodents.Related
compoundscontainingatertiaryaminefunctionhavebeentestedin
animalsasneuroprotectiveagents(Am.HeartJ.130,940,1995;
Cardiovasc.Res.28,235,1994).Norecentreportsofusage.
Continued

--- Page 731 ---

676
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.7 (Continued)
Compound Structure Comments
CX-659S Anti-inflammatoryinanimals(Eur.J.Pharmacol.438,189,2002),
e.g.againstcontacthypersensitivity.Notmuchusedrecently.
CR-6 ClaimedtoscavengeNO•.Protectiveinmodelsoffocalbrain
ischaemiainrats(J.CerebralBloodFloodMetab.30,638,2010).
Amore-lipophilicderivativeofit(BP3)wasreportedtoprotectrat
retinaagainstdamagebyhighlightintensityinvivo(Exp.EyeRes.
93,65,2011).
ETS-GS Combinationofα-tocopherol,GSH,andtaurine.Protectiveinvarious
animalmodelsofischaemia–reperfusionandinflammation
(Inflammation35,545,2012;J.Surg.Res.171,226,2011).
Asimilaragent,ESeroS-GS,hasbeenusedinwhichthetaurineis
replacedbyaserotoninmoiety(J.Surg.Res.176,220,2012).
BO-563 Lipophilicα-tocopherolanalogue.ReportedtosuppresshepatitisC
replication(J.Med.Virol.85,241,2013)andtolowerF2-IsoPlevels
invitaminE-deficientmice(Lipids42,463,2007).Apparentlyno
longerincommercialdevelopment.

--- Page 732 ---

AGEING,
NUTRITION,
DISEASE,
AND
THERAPY:
A
ROLE
FOR
ANTIOXIDANTS?
677
Table11.7 (Continued)
Compound Structure Comments
Othersyntheticchain-breakingantioxidants
Butylatedhydroxyanisole(BHA) Themajor(90%)constituent(3-tert-butyl-4-hydroxyanisole)of
commercialBHAisshown.Actsbyhydrogendonation.Oftenadded
tofoodsasapreservative.Generallyrecognizedassafe(GRAS)but
largedoses(≥1%ofdiet)depleteliverGSHandcauseforestomach
cancerinrats(Toxicol.Lett.37,251,1987;FoodChem.Tox.24,1
167,1986).Highdosescanantagonizetheactionofcarcinogensin
animals,byinducingphaseIIenzymes(Crit.Rev.Toxicol.15,109,
1985).MetabolizedinanimalsbyO-demethylationtothediphenol
tert-butylhydroquinone(TBHQ)followedbyglucuronidationand
sulphation.TBHQalsohasantioxidantpropertiesinvitro;canbe
oxidizedtoasemiquinoneradical,andontoaquinone
(tert-butylquinone).
Propofol(2,6-diisopropylphenol) Anaestheticandsedative,usedinhumans.
Butylatedhydroxytoluene(BHT) Oftenaddedtofoodsasapreservative;generallyrecognizedassafe
butveryhighdosescanantagonizeactionofvitaminKandcause
bleedinginanimals.
Propylgallate Fairlywater-soluble;goodinhibitoroflipidperoxidation;
lipoxygenaseinhibitor.BindsironionsandreducesFe(III)toFe2+.
Gallatesareveryoxidisable,e.g.gallicacidanditsestersreadily
oxidizeincellculturemediatogenerateH2O2.
Continued

--- Page 733 ---

678
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.7 (Continued)
Compound Structure Comments
Irganox3114 Widelyusedasanantioxidantinpolymers(Int.J.Pharmaceut.437,
89,2012).
Nordihydroguaiareticacid(NDGA) OccursnaturallyinresinousexudatesofLarreatridentata(American
creosotebush)andinsomeotherplants.Bindsironionsandreduces
Fe(III)toFe2+,powerfullipoxygenaseinhibitor.Sometoxicityto
animals(Section4.5.4).Suggestionsofpotentialanti-inflammatory
andanti-atheroscleroticactions,basedoncellandanimalstudies
(Lab.Invest.92,1777,2012;Biomol.Ther.20,463,2012;Med.Sci.
Monit.16,RA93,2010).
LY178002(R=H),LY256548(R=CH3) BHTderivativesthatareorallyactiveinanimalmodelsofrheumatoid
arthritisandcerebralischaemia–reperfusion.MayinhibitPLA2,
5-LOXandCOX(Ag.Act.27,300,1989;Stroke22,1048,1991).
Norecentreportsofuse.
ONO-3144 O OH Chain-breakingantioxidant;anti-inflammatoryandprotective
H 3 C againstcardiacreperfusioninjuryinanimalmodels(J.Cardiovasc.
NH+Cl–
3 Pharm.16,992,1990).Norecentreportsofuse.
HC C CH
3 3
CH
3

--- Page 734 ---

AGEING,
NUTRITION,
DISEASE,
AND
THERAPY:
A
ROLE
FOR
ANTIOXIDANTS?
679
Table11.7 (Continued)
Compound Structure Comments
Phenothiazine Inhibitslipidperoxidationinvitro.TheNHgroupdonates–Htoact
asachain-breakingantioxidantinoils,fuels,andcellsinculture(J.
Neurochem.110, 118, 2009). The properties of the resulting N•
radicalmustalsobeconsidered.Itmightreactwithanotherperoxyl
radical,
–N• +RO •
2
→–NO2R
togiveanon-radical,whichcouldsometimesbreakdown
–NO2R→–NO • +RO • .
Promethazine S
Inhibitslipidperoxidationinvitro;antihistamineandsedative.
N
CH
3
N
H C CH
3 3
N,N’-Diphenyl-p-phenylenediamine(DPPD) Sometimesusedforanimalstudiesofinvivolipidperoxidation.
Inhibitsvia–Hdonationfromthe–NHgroup.Aromaticaminesare
oftenusedasantioxidantsinthelubricantandpolymerindustries.
ThefateoftheN•radicalmustagainbeconsidered.
Ethoxyquin(Santoquin) Powerfulenzymeinducerinvivo.Usedinlongevityexperiments
(Section11.4.5),oftenaddedtopetfoodsandtofishmeal.Usedfor
seatransportoffishmealoverlongdistancestoreduceriskof
self-ignition(J.FoodProtect.74,1574,2011).Actsasantioxidant
viathe–NHgroup(againproducingN•).
Carvedilol Antihypertensivedrug.Moderateinhibitoroflipidperoxidationin
vitro,butitshydroxylatedmetabolite(–OHatpointX)SB211475is
morepotent(Eur.J.Pharm.251,237,1996).Itdecreasedlevelsof
HNEintheheartsofpatientswithdilatedcardiomyopathy
(Circulation105,2867,2002),buthadnoeffectonlevelsofurinary
F2-IsoPsinvolunteers(Eur.J.Clin.Pharmacol.60,83,2004).
SUN-8075 ClaimedtoblockNa+andCa2+channelsaswellastoexert
antioxidantproperties(J.Med.Chem.43,3372,2000).Reportedas
protectiveagainstlight-inducedretinaldamageinrats(Biol.Pharm.
Bull.37,424,2014).

--- Page 735 ---

680 FREE RADICALS IN BIOLOGY AND MEDICINE
of the flavonoid rutin.313 Indeed, several flavonoids to the brain or spinal cord. The most studied was
and derivatives of them are under investigation as U74006F (Freedox), sometimes called tirilazad
anti-inflammatory and anti-cancer agents and for the mesylate(Fig.11.5),whichunderwentseveralclinical
treatmentofvascularproblems,e.g.indiabetes,since trials for the treatment of stroke or traumatic injury
somemayinhibitproteinglycationandaldosereduc- tothenervoussystem.Sadly,therewasnoobservable
tase activity as well as exerting antioxidant effects.314 clinical benefit in the majority of cases and possible
Whenaddedtothedietofrats,the‘yellowcurryspice’ deleterious effects in stroke. Some studies suggested
curcumin(Section4.5.1)decreasedF -IsoPlevelsand modestbenefitincasesofsubarachnoidhaemorrhage
2
neuronal damage when the animals later had Aβ in- inmalebutnotfemalepatients,apparentlybecausefe-
fusedintothebrain.313 Curcuminalsoslowedplaque malesmetabolizethedrugfaster,buttheclinicalvalue
developmentinADtransgenicmice.313Similarly,green oftheeffectisuncertain.320,321 Thereisnocompelling
tea extract or epigallocatechin gallate (EGCG) have evidencethatlazaroidsexertantioxidantactioninvivo.
shown protective effects in animal models of various Tirilazad seems to accumulate in the blood–brain
diseases, e.g. EGCG diminished the neurotoxicity of barrier,perhapsprotectingthemicrovascularendothe-
MPP+inmice.315 lium, and its penetration into the brain is limited.
Of course, the safety of high doses of any plant An alternative is the pyrrolopyrimidines, such as
phenol should never be assumed just because it is a U101033EandU104067F(Fig.11.5),antioxidantswhich
naturalproduct,normustitbeassumedthatanybene- appear to enter the brain more readily.320 Yet an-
fit observed is due to antioxidant action. Indeed, the other agent that has attracted interest is U83836E
effectsofcurcuminandEGCGmentionedaboveprob- (Fig 11.5), which combines the chroman ring struc-
ablywerenot,oratleastnotcompletely.313,315,316They tureofα-tocopherolwithpartofthetirilazadstructure
couldevenbeactinginvivoasmildpro-oxidants,trig- andisamuchbetterchain-breakingantioxidantthan
geringanincreaseinthelevelsofantioxidantandother tirilazad.320
defencesystemssuchasHO-1.Thisisindeedlikelyfor Another drug being tested on stroke patients
EGCG,givenitspropensitytooxidize(Section1.11). is edaravone (Radicut®), 3-methyl-1-phenyl-2-
pyrazoline-5-one, with some suggestion of benefit
in clinical trials, both from edaravone alone and
11.5.8 Dualactionmoleculesandedaravone
in combination with thrombolytic agents.322,323 Its
Severalcompoundshavebeendesignedtohaveboth structure (Fig. 11.5) does not suggest a high anti-
antioxidantactivitiesandothertherapeuticproperties, oxidant activity, although keto-enol tautomerism
such as cholesterol-lowering activity, activation of may occur so that the structure shown in Fig. 11.5
sirtuins (Section 11.3.4), NO• donors,300 agonists of is in equilibrium with a monophenol with chain-
PPARα or γ receptors, antagonists of glutamate or breaking antioxidant activity.324 Edaravone has also
angiotensin II receptors, ion channel blockers (e.g. been suggested to be beneficial in animal models of
SUN-8075; Table 11.7), NSAIDs, anti-arrhythmic aneurysm (Section 10.6.7.1) and of cardiac and joint
agents such as lidocaine, and compounds that in- inflammation.Perhaps,likePBN,itsactionsaremore
hibit specific enzymes, such as tyrosinase, elastase, anti-inflammatorythandirectlyantioxidant.323
calpains, acetylcholinesterase (Section 11.6.2), lipoxy-
genase, thromboxane synthetase, COX-2, iNOS, or
11.5.9 Thiolcompounds
nNOS.317,318 For example, Neu2000 (Fig. 11.5) is an
NMDA antagonist and antioxidant derived from Thiols can scavenge several RS, but can also be cyto-
sulphasalazineandhasbeentestedinvariousanimal toxic,inpartbygeneratingsulphur-containingradicals
models of brain or spinal cord injury.319 Another ex- (Section 2.5.5). For example, penicillamine and bucil-
ampleisthelazaroids;theoriginalaimindeveloping lamine(Fig.10.14)mayexertside-effectsinrheumatoid
themasneuroprotectiveagentswastoaddantioxidant arthritispatientsbyformingsulphurradicalsthatbind
activity to a steroid nucleus, since high doses of to proteins and create new antigens (Section 10.11.5).
methylprednisolone were thought at the time to be Cysteine oxidizes much faster than either GSH orN-
effectiveindiminishingbrainlipidperoxidationafter acetylcysteine and is correspondingly more cytotoxic
traumaandimprovingclinicaloutcome.Thelazaroids invitro,andhomocysteinehasbeenproposedtoexert
inhibit iron-dependent lipid peroxidation in brain pro-oxidant effectsin vivo (Section 4.7). Nevertheless,
homogenates in vitro and exerted neuroprotective cysteine administration raised GSH levels in elderly
effects in various animal models of traumatic injury humans.165 Mixturesofcystineandselenomethionine

--- Page 736 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 681
(acombinationcalledF1)werereportedtodelayloss can be pro-oxidant (Section 3.11), an effect that has
ofmusclemassinageingmice.325 beenusedincancerchemotherapy(Section10.16.1).
11.5.9.1 Glutathione 11.5.9.2 N-Acetylcysteine
GSH is often suggested as potentially therapeutically N-Acetylcysteine(NAc)isusedasan‘antioxidant’in
useful,especiallyasitslevelstendtofallinagedani- manylaboratoryexperiments.Itcanprotectbyenter-
mals (Section 11.4.3). Other areas of interest include ingcellsandbeinghydrolysedtocysteine,aprecursor
the preservation of organs for transplantation (e.g. ofGSH.Additionally,NAccanitselfscavengeseveral
GSHisaddedtoUniversityofWisconsinsolution;Sec- RS(includingHOCl,ONOOH,RO • ,OH•,andH O ).
2 2 2
tion 10.7.5) and protection against tissue damage by Infact,NAchascomplexeffectsoncellredoxstateand
cytotoxic drugs such as cyclophosphamide. Aerosol- metabolism, leading to actions that may not involve
ized GSH solutions have been suggested as a means radicalscavenging(Section5.5.6.1andref335)soplease
of diminishing lung damage by RS (e.g. in cystic fi- donotequateNActo‘antioxidant’,assomanypapers
brosis)althoughwhentestedinasthmapatientsthey do. Clinically, NAc is effective in treating paraceta-
induced bronchoconstriction (not very beneficial!).326 moloverdosage(Section9.10)andithasbeenwidely
Rememberthatglutathioneisadicarboxylicacid(Fig. usedinhumansasamucolyticagent(Mucomist®)for
3.9), so the free acid dissolved in insufficiently buf- treatment of several respiratory disorders (e.g. BPD
feredsolutionwillhavealowpHandcouldbeirritant inbabies[Section7.11.8],ARDS[Section10.8],COPD
for that reason.Thesame commentabout acidityap- [Section 9.13.2], cystic fibrosis [Section 10.9], and in
plies to N-acetylcysteine. In general, the evidence for HIV [Section 10.25.1]); NAc has little toxicity but its
theirtherapeuticeffectivenessinasthmaandCFisvery therapeuticbenefitsintheseconditionsseemlimited,
limited.327 ifany.327,336–339
Glutathioneisnoteasilytakenupbycells.However, More positive clinical results (although not uni-
methyl, isopropyl, and ethyl monoesters (esterified formly so) have been obtained in the use of NAc to
on the glycine carboxyl group) have been described, decrease the risk of cardiovascular problems in pa-
which can cross membranes and be hydrolysed to tientswithkidneyfailure,aswellastheriskofkidney
GSH within the cell (Fig. 11.6). Of course, this damageinpatientswithrenaldysfunctionwhoaread-
also liberates equimolar amounts of the alcohol! ministeredradiocontrastmediabeforeradiography.340
Diethylesters (esterified on both the glycine carb- However, in one such study the protection occurred
oxyl group and the side-chain carboxyl group of without effect on urinary F -IsoP levels, possibly in-
2
the glutamate) have also been tested, and may be dicativeofanon-antioxidantprotectivemechanism.341
more efficient delivery systems than monoesters. L- Indeed, the protective effects of NAc in some an-
2-oxathiazolidine-4-carboxylate(OTC)canbehydro- imal models of stroke seemed to involve increases
lysed to cysteine in vivo, which can lead to increased in HIF-1 activity.342 NAc administration (in some but
GSHsynthesis(Fig.11.6).Hydrolysisrequirestheen- notallstudies)340,343 slowedlungdeteriorationinpa-
zyme 5-oxoprolinase. OTC has been tested in HIV- tientswithidiopathicpulmonaryfibrosis,aprogres-
infected subjects, with no apparent benefit.328 By siveandusuallyfataldisorderofunknownaetiology
contrast, it ameliorated allergen-induced airway in- that is characterized by fibrosis and remodelling of
jury in animal models of asthma, in part by de- thelungaccompaniedbyincreasedoxidativeandni-
creasingVEGFproduction,329 andimprovedendothe- trative damage, and an elevated risk of lung cancer
lial function in the brachial arteries of patients with development.344,345NAchasalsobeensuggestedtobe
atherosclerosis.330 A series of modified glutathiones usefulintreatingsomepsychiatricdisorders,including
(theUPFpeptides),morehydrophobicthanGSHitself, depressionandautism(Section10.23).
hasbeendescribedbutnotwidelyusedinvivo.They N-Acetylcysteine amide (AD4) has been reported
include UPF1 (4-methoxy-L-tyrosinyl-γ-L-glutamyl- to cross the blood–brain barrier, which NAc ap-
L-cysteinyl-glycine),UPF17(4-methoxy-L-tyrosinyl-α- pears not to, and it showed protective effects against
glutamyl-L-cysteinyl-glycine), and UPF51 (β-ala-his- MOG-induced autoimmune encephalomyelitis (Sec-
tyr(Me)-α-glu-cys-gly).331 Glutathione can also be tion10.18.2)andagainstMPTPtoxicityinrats.336NAc
attached to fatty acids (S-acylglutathione deriva- attached to dendrimers (synthetic biomimics of pro-
tives).332GSHcanalsobedeliveredusingchitosanco- teins that can deliver drugs across membranes) was
valentlyattachedtoitinahydrogel333orbyusinggold reported as beneficial in a model of cerebral palsy
nanoparticles.334 Remember that high levels of GSSG usingnewbornrabbits.346

--- Page 737 ---

682 FREE RADICALS IN BIOLOGY AND MEDICINE
O O O
+
GSH-ester H NCHCH CH CNHCHCNHCH C
3 2 2 2
O CH CH
C CH SH 2 3
2
O O–
glutathione monoethyl ester
O O O
+
H NCHCH CH CNHCHCNHCH C
3 2 2 2
O CH CH
C CH SH 2 3
2
O O CH CH
2 3
glutathione diethyl ester
O
O
NAC, NH CH CH
2 2
N-acetyl-L-cysteine H 3 C C HNCHCOO– S C S C O
CH 2 SH O OH
Erdosteine
S
OTC, L-2-oxo-
t 4 h -c ia a z rb o o li x d y in la e te O N H COO–
5-oxo-
prolinase
S CH 2 −CO 2 HS CH 2
COO– CHCOO– CHCOO–
+NH
3
+NH
3
L-cysteine
Figure11.6 SomeagentsthatcanincreaseGSHlevelsincells.FormoreinformationseeAdv.Pharmacol.38,65,1996.
11.5.9.3 Otherthiols Mercaptopropionylglycine(MPG)(Fig.11.5),some-
timescalledTiopronin,decreasesROSproductionand
Mercaptoethylguanidine(Fig.11.5)isapowerfulscav-
protects against ischaemia–reperfusion injury in sev-
engerofONOOHandHOClandinhibitsiNOS;ithas
eral animal models of myocardial stunning and in-
beneficial effects in several animal models of inflam-
farction (Fig. 6.6),351 but unfortunately, it can cause
mationbuthasnotbeenusedmuchrecently.347Lipoic
renal damage in humans and inhibits glutathione
acid (Section 3.25.4) can act as an antioxidant in vitro
peroxidases.334,334AAsinthecaseofNAc,342protective
and has been used in diabetes (Section 10.5.7.1); and actions of MPG via increases in HIF-1α activity have
ithasbeenattachedtoanacetylcholinesteraseinhibi-
been suggested.352 Finally, albumin has been claimed
tor to produce an agent that has been hypothesized
to have various therapeutic actions, perhaps in part
to be useful for AD.348 In rats, lipoate administration
due to the antioxidant actions of its –SH group (Sec-
slowed falls in GSH levels with age.162 Several struc-
tion 3.23.3.5). Indeed, various conjugated albumins,
turallymodifiedformsoflipoicacidwithimprovedin
including PEGylated albumin, have been developed
vitroantioxidantactivityhavebeendescribed,someof
forpotentialtherapeuticuse.353
whichcancrosstheblood–brainbarrier.349Erdosteine
(Fig. 11.6) has mucolytic properties and preliminary
11.5.9.4 Thiolsasradioprotectors
studiessuggestittohavesomeeffectivenessinCOPD
patients.350 Ergothioneine (Section 3.16.2) may also Many thiols have been tested for their ability to
meritmoreattentionasatherapeuticagent. protect cells and animals against ionizing radiation

--- Page 738 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 683
(Section 9.20). They include GSH, cysteine, bucillam- production.358 Some clinical studies have suggested
ine, cysteamine, British anti-Lewisite (Section 9.16.2), beneficialeffectsinpatientswithsubarachnoidhaem-
penicillamine, mesna (the sodium salt of 2- orrhageandstrokebuttheseremaintobeconfirmed.
mercaptoethanesulphonic acid; Fig. 11.5), and Inanycase,givenitsmixtureofproperties,itcannotbe
S-2-(3-aminopropylamino)ethylphosphorothioicacid, assumedthatanyprotectionbyebselenisnecessarily
aprodrug(amifostine)whichishydrolysedtothefree duetoantioxidantactions.Ithasalsobeensuggested
thiol (WR-1065; Fig. 11.5) in vivo, and has been used tobindtokeap1toactivatetheNrf2system.359Ebselen
to protect normal tissues during radiotherapy. ‘WR’ canalsobetoxictocertainbacteria,byinhibitingtheir
signifies that this radioprotector (like many others) thioredoxin reductase,360 and may have a range of
was developed at the Walter Reed Army Hospital otherpotentiallyusefulbiologicaleffects.357
in the USA.354 The net charge on a thiol affects its Other organoselenium compounds have also been
radioprotective effect; if this is negative it can be re- reported to possess GPx-like activity, including sev-
pelledbythenetnegativechargeofDNA.Compounds eral diselenides (containing –Se–Se– groupings), and
with fewer side effects, such as PrC-210 and PrC-211 BXT–51072 (Fig. 11.5), one of a group of compounds
(Fig.11.5),areunderdevelopment.355 which appear to exert greater protective effects than
ebselen against oxidative stress in cells in culture.359
Severalcompoundscontainingtheelementtellurium
(which,likesulphurandselenium,isingroupVIofthe
11.5.10 Glutathioneperoxidase
‘mimetics’356,357 periodic table) can scavenge peroxides and ONOOH
and show other antioxidant effects in vitro, although
Selenocysteine plays a key role at the active sites of they may well be toxic in vivo and so of little thera-
manyGPxenzymes(Section3.14.2),andattemptshave peuticuse.361,362
thus been made to design low-molecular-mass selen-
ium compounds with similar catalytic activity. The
11.5.11 ‘Pro-oxidants’andNrf2activators
first, introduced by Helmut Sies and his colleagues,
was ebselen (PZ51), 2-phenyl-1,2-benzisoselenazol-3 MildoxidativestresscantriggertheNrf2systemand
(2H)-one (Fig. 11.5). After reduction by GSH, ebselen thus increase levels of cytoprotective enzymes (Sec-
decomposes peroxides (including H O ) in a cata- tion 5.5.8). Several dietary agents also activate Nrf2,
2 2
lytic manner. Other thiols, including NAc, reduced including resveratrol, curcumin, and sulphoraphane
thioredoxin, and dihydrolipoate (DHLA) can replace (Table 4.5), which have been tested in various an-
GSH as cofactors, DHLA being especially effective. imalmodels,e.g.ofADandtraumaticbrainorspinal
Thioredoxin reductase can use NADPH to reduce cord injury. Some other ‘antioxidants’ also activate
ebselen, and thus ebselen has also been described as Nrf2,includingebselen(Section11.5.10)andPBN(Sec-
a ‘peroxiredoxin mimetic’. The commonly accepted tion 11.5.5). Agents specifically designed to activate
mechanism (although it has been challenged) is that Nrf2areunderintensivestudyfortheirpossibleeffi-
reduction of ebselen by the thiol opens the ring con- cacyinthetreatmentofCOPD,chronicrenaldisease,
taining the Se, converting it to –SeH (selenol). This psoriasis,andmultiplesclerosis(Section10.18.2).They
reactswiththeperoxide(ROOH),reducingittoROH include BG-12 (dimethylfumarate) and bardoxolone
and converting ebselen to a selenenic acid (–SeOH). methyl,atriterpenoidsynthesizedfromoleanolicacid,
ThisthenreactswithGSHtoforma–SeSGintermedi- present in the fruit and leaves of the olive tree. The
ate.AsecondGSHregeneratesthe–SeHandreleases former delivers fumarate, which leads to Nrf2 acti-
GSSG.Ebselenadditionallyhasdirectantioxidantac- vation (exactly how is uncertain), and is being used
tivities in vitro, for example scavenging HOCl, sing- in the treatment of psoriasis and multiple sclerosis
letO 2 ,ONOOH,andRO • 2 .Ebselenbindsto–SHgroups patients.363 The latter binds to specific cysteine res-
on proteins, and much of it in plasma is probably idues on keap1 (Section 5.5.8) but sadly has various
attachedtoalbumin–SHgroups. side-effects (e.g. increased cardiovascular pathology)
Ebselen hasshown protectiveeffects in severalan- thatmaypreventitsclinicaluse.Thesemightbedue,
imalmodelsofdisease,suchasischaemia–reperfusion, at least in part, to excessive activation of Nrf2, lead-
radiation injury, metabolic syndrome, and noise- ing to interference with normal cell physiology.364,365
induced hearing loss (Section 7.12), and its toxicity In addition, excessive activation of Nrf2 might pro-
appears to be low. As well as showing antioxidant motecancerprogression(Section10.16.1).Bardoxolone
activity, it can inhibit 5- and 15-lipoxygenases and methylalsoinhibitsNF-κBactivationbybindingtoa
NOS and may be able to decrease phagocyte O •– cysteineresidueinIκBkinase(Section5.5.6).
2

--- Page 739 ---

684 FREE RADICALS IN BIOLOGY AND MEDICINE
Certain products of lipid peroxidation can ex- insidenegativechargesoftheplasmamembraneand
ert anti-inflammatory and cytoprotective effects (Sec- innermitochondrialmembrane.Whenfedtoanimals,
tion 5.12.2), and agents modelled on some of them, theycanenteralltissues,includingthebrain.MitoQ
10
such as VB-201 (a structure based on a product of administered to rodents has shown protective effects
LDL oxidation) and LipoCardium (based on cyclo- in several models of disease, including ischaemia–
pentenone prostaglandins; Section 8.12.8) have ex- reperfusion injury, sepsis, hepatitis C infection, ALS
erted anti-inflammatory effects in some animal mod- (Section10.22.2.1),andAlzheimerdisease(APPtrans-
els. VB-201 and similar compounds have been called genicanimals).GivingtheanimalsCoQ orTPPinthe
10
lecinoxoids (lecithin-oxidized).366 ‘Pro-oxidants’ have dietisgenerallynotprotective.373Theclinicalutilityof
alsobeenreportedtofacilitatechemotherapybylower- theseagentsisuncertain;MitoQhadnoeffectagainst
ingthecellularthiol-disulphidestatus,i.e.NOV-002is PDbutexertedmodesthepatoprotectiveeffectsinpa-
acomplexofGSSGwithasmallamountofcis-platin tientswithhepatitisC.Also,donotassumethattheir
that seems to improve the anti-tumour action, and protectiveeffectsarenecessarilyrelatedtoantioxidant
decrease the side-effects of, anti-cancer drugs.367 Per- mechanisms.371,372
haps it aids their action by promoting oxidative stress The delivery of NO• to mitochondria (e.g. using
(Section10.16.1). Taurinechloramines,generatedasa Mito-SNO;Fig.11.7)isalsoprotectiveinseveralstress
result of HOCl production at sites of inflammation situations; nitrosylation of complex I inhibits its ac-
(Section 8.7.5.1), have also been reported to activate tivity but can protect it against oxidative damage,
Nrf2andexertcytoprotectiveactivity,368 andanagent whereas nitrosylation of cylophilin D may attenuate
that raises taurine levels (‘taurine donor’, ethane-β- theMPT(Section10.6.6).Mitochondriallytargetedin-
sultam) hasbeenproposedasapotentialtherapeutic hibitorsoftheperoxidaseactivityofcytochromechave
agent.369Nitratedfattyacids(Section2.6.1.3)mayalso been reported as radioprotective (Section 9.20). Tri-
have cytoprotective properties, e.g. nitro-oleic acid phenylphosphoniumandsimilarcompoundscanalso
protected against kidney damage by adriamycin in be used to deliver ROS-detecting molecules such as
mice.370 Even the SOD mimetics might sometimes be dihydroethidium,MitoB(Section6.11.1),Mito-Bodipy-
workingbypro-oxidantmechanisms(Section11.5.4)! tocopherol(Section6.15.12),oraspintrapsuchasDEP-
MPO (Section 6.2.4) to the mitochondria, or to target
tothemagentsthatinhibittheMPTdirectly(e.g.cyc-
11.5.12 Mitochondriallytargeted
losporin). Damaging agents, such as photosensitizers
antioxidants201,371,372
forphotodynamictherapy,canalsobetargeted,anda
Sincemitochondriaarethoughttobemajorsourcesof probetodetectglyoxals,importantglycatingagents,in
O •–/H O invivo,anddamagetothemcontributesto mitochondriahasbeensynthesized(Section10.5.5).
2 2 2
ageing and disease, antioxidants selectively targeted An alternative approach has been to deliver
totheseorganelles(e.g.catalase;Section11.4.5)could plastoquinone(Section7.8)tomitochondriausingTPP
be especially beneficial (although not necessarily so or other carriers (as in SkQMH 2 ; Fig. 11.7). Indeed,
if some degree of mitochondrial O •–/H O produc- a range of ‘Sk’ compounds based on plastoquinone
2 2 2
tion is useful; Sections 5.5.5 and 11.4.8). One ap- and plastoquinone derivatives has been developed
proach has been to link an antioxidant (such as a (Fig. 11.7). ‘Sk’ stands for Skulachev, whose research
thiol, α-tocopherol, nitrone/nitroxide, SOD mimetic groupinRussiadevelopedthesemolecules.Theyhave
[such as M4043], lipoic acid, ebselen, CoQ, or an been shown to be protective in various animal mod-
NO•donor)viahydrocarbonchainsofvariablelength elsoftraumaanddisease.Inparticular,theyappearto
to the phosphorus of the lipophilic compound tri- protectanimalsagainstinfection.201,372
phenylphosphonium (TPP), giving a triphenylphos- Yet another approach has been to synthesize pep-
phoniumcation(Ph) P+–R,whereRistheantioxidant. tide ‘antioxidants’ that can target mitochondria, such
3
Forexample,MitoTEMPOimprovedheartfunctionin as the Szeto–Schiller (SS) peptides.374 They have a
diabeticrats(Section10.6.4.1).However,nitroxidesare unique amino acid sequence that somehow allows
readily reduced by the electron transport chain (via them to cross cell membranes readily and accumu-
ubiquinol) to hydroxylamines, so it is uncertain how late in mitochondria. SS-02 (Dmt-Darg-phe-lys-NH 2 )
theymaybeprotecting.Mostworkhasbeendonewith andSS-31(D-arg-Dmt-lys-phe-NH 2 )peptidescontain
MitoQ (Fig.11.7). a dimethyltyrosine (Dmt) residue which is alleged to
10
TheseTPPadductsconcentrateinsidecellsandthen scavengeavarietyofROSinvivo(givenitsstructures,
furtherconcentrateintomitochondria,attractedbythe
itmightscavengeOH•,ONOOH,possiblyHOCland

--- Page 740 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 685
HN NH 2
NH
2
NH
H O H O
N N N SS-31
H 2 N O H O NH 2
OH
O
O +
+ P
H 3 CO P N O
Se
H CO
3
O
MitoQ 10 MitoPeroxidase
CH 3OH
O CH
3
O P + MitoSOD
CH 3 OH P + S
MitoQH
2
N
CH Cl
3 NH HN
HO
+ Mn
P
H 3 C O CH 3 NH Cl HN
CH
3
MitoE
2
NO
S
O
+ H
O N O P N P +
N
MitoTEMPOL H O MitoSNO
OH OH
H C CH
H C 3 3
3
H C P + H 3 C P +
3 OH
OH
SkQ1H 2 SkQ3H 2
OH OH
H 3 C H 3 C
+
H 3 C N + H 3 C P
OH OH
SkQ4MH
2 SkQ5H
2
Figure11.7 Somemitochondriallytargetedantioxidants.MitoE2istheradical-scavengingpartofα-tocopherolattachedtoTPPviaa2-carbon
link.MitoQisTPPattachedtoubiquinolviaa10-carbonlink.SkQ1H2isreducedplastoquinoneconjugatedtoTPPbya10-carbonlink,whereasin
SkQ5H2thelinkisonly5-carbons.Mitoperoxidaseisanebselenconjugate.MitoSODcontainsTPPattachedtoaMn-containingSODmimetic.

--- Page 741 ---

686 FREE RADICALS IN BIOLOGY AND MEDICINE
RO • /RO • , but probably not O •– or H O ) (Fig. 11.7). 2. BindingofmetalionstoXdoesnotstopOH•form-
2 2 2 2
These peptides have shown some effects in animal ation,buttheOH•formedatthebindingsitereacts
modelsofdisease(e.g.oxaliplatin-inducedpain,heart with X and does not escape into solution. For ex-
failure),374 but there is little evidence that they act ample,copperionsboundtoalbumincanstillform
by antioxidant mechanisms in vivo. They may act in OH•, but the protein absorbs it and is damaged.
other ways, e.g. SS-31 seems to decrease levels of AnotherexampleisOR10141(Table11.8).
the scavenger receptor CD36 and to bind to opioid 3. XscavengesOH• infreesolution,competingforit
receptors.374,375 Yet another approach is the XJB pep- with the ‘detector molecule’ being used to meas-
tides;theycontain4-amino-TEMPOattachedtoafrag- ureOH•.
ment of the antibiotic gramicidin, which targets to
To help to distinguish between these mechanisms,
mitochondrial membranes because it binds avidly to
onecananalysethefateofthechelatorinthereaction
cardiolipin.Antioxidantssuchastroloxhavealsobeen
mixture;itwillbemodifiedifitisreactingwithOH•.
attachedto‘mitochondria-penetratingpeptides’.376
Similarprinciplesapplytostudiesofeffectsofmetal-
One thing to bear in mind is that agents that util-
chelatingantioxidantsonlipidperoxidation.Chelators
izethemitochondrialmembranepotentialwilltendto
thatinhibitRSproductionareintrinsicallypreferable,
alterit.Ifthepotentialisdecreased,milduncoupling
sincethosethatscavengeRSaredestroyedasthereac-
mightoccur,whichitselftendstodecreasemitochon-
drialO
•–generation.HencecontrolswithTPPonlyare tionproceedsandmayproducetoxicchelator-derived
2 radicals.
essential.373 Indeed,uncouplerssuchasdinitrophenol
The first chelating agent reported to decrease
(DNP) attached to TPP have been developed; in one the rate of O •–-dependent OH• generation in vitro
suchmoleculetheDNPisonlyreleased(‘uncaged’)if 2
was DETAPAC (Table 11.8). It decreases OH• gen-
H O levelsarehigh.376 Ofcourse,toomuchuncoup-
2 2 eration because Fe(III)–DETAPAC is reduced only
lingwouldnotbegood!Ontheotherhand,damaged slowlybyO •– (Table2.5,legend).AnFe2+–DETAPAC
mitochondriaoftenhaveloweredmembranepotential, 2
complexstillreactswithH O toformOH•,however,
whichcoulddecreasethetargetingofantioxidantsto
and more powerful reduc
2
ing
2
agents than O
•–
(such
exactlythesemitochondriathatneedthem! 2
as paraquat radical) are able to reduce Fe(III)–
DETAPAC. Hence DETAPAC is not a general in-
11.6 Ironandcopperion hibitor of iron-dependent OH• generation. Phytic
chelators247,253,377 acid,o-phenanthroline,bathophenanthrolinesulphon-
ate,anddesferrioxaminearebetterinhibitorsofiron-
Several chelating agents (Table 11.8) and some metal ion-dependentformationofOH• fromO •– andH O .
2 2 2
chelates(Fig.11.5,Tables11.5and11.6)havebeenused Phyticacid(Section3.22.1)hasbeenusedasanantioxi-
in attempts to inhibit oxidative damage, not forget- dantinfoodstuffsandcouldconceivablybeprotective
tingofcoursethetherapeuticpotentialofhaemopexin in thecolon,by binding‘catalytic’iron ionsin faeces
and haptoglobins in protecting against damage by (Section 7.2). Several plant phenolics can bind tran-
haemandhaemproteins(Section3.23.3.4),orthevalue sition metal ions (Section 4.5), and this may be the
of raising HO-1 levels (Section 3.24). Examples of mechanism by which 7-monohydroxyethylrutoside
ironionchelatorsalreadydiscussedincludeICRF-187 (Table11.8)diminishesthecardiotoxicityofdoxorubi-
(Section 10.16.2) and clioquinol (Section 10.21.3). The cintomice.
wordchelatorderivesfromtheGreekchela,clawofa
crab. Chelators designed to prevent iron- or copper- 11.6.1 Desferrioxamine
ion-dependent oxidative damage can act by multiple
mechanisms.Considerasimpleobservation;addinga Desferrioxamine247,253 (DFO) is a naturally occurring
chelator(X)decreasestheamountofOH•thatisbeing chelatorproducedbyStreptomycespilosus.Itisapower-
producedbyametalion–H O mixture.HowmightX ful chelator of Fe(III) and, in the presence of physio-
2 2
dothis? logical buffer systems, it inhibits iron-ion-dependent
lipid peroxidation and conversion of H O to OH•
2 2
1. X could chelate metal ions and alter their reduc- (Table 11.9). Desferrioxamine is widely used for the
tion potential and/or accessibility in a way that preventionandtreatmentofironoverloadinpatients
stopsthemcatalysingOH• production,asdoesthe who have ingested toxic oral doses of iron salts, or
binding of iron ions to transferrin or lactoferrin who require multiple blood transfusions, e.g. to treat
(Section3.22.4.2). thalassaemia.LargedosesofDFOcanbeinjectedinto

--- Page 742 ---

AGEING,
NUTRITION,
DISEASE,
AND
THERAPY:
A
ROLE
FOR
ANTIOXIDANTS?
687
Table11.8 Somechelatingagents.
Chelatingagent Comments
Penicillamine UsefulinpromotingurinaryexcretionofcopperionsintreatmentofWilsondisease.AlsobindsFe2+
OH C CH
3 3
HO SH
NH
2
EDTA Chelatesseveralmetalions.Manganese–andcopper–EDTAchelatesareusuallylessredox-activethan
O
theunchelatedmetalions,whereaschelatesofEDTAwithFe2+orFe(III)stillreactwithH2O2orO •
2
–.
OftenEDTApromotesiron-dependentdamagebykeepingironionsinsolutioninaredox-activeform.
HO O
OH
However,Fe2+–EDTArapidlyoxidizestoFe(III)–EDTAatpH7.4,releasingO •
2
–
N
N Fe2+ –EDTA+O2 →Fe(III)–EDTA+O •
2
–
HO EDTAcaninhibit‘site-specific’damagebyremovingmetalionsfromatarget(e.g.DNA).EDTAinfusion
O OH intothebloodhasbeenusedinsomecountries(chelationtherapy)totreatpatientswithvascular
O problems,butitsvalueisuncertain.
DETAPAC Chelatesiron,copper,andothermetalions.Littleusedclinicallybecauseofside-effects,includingzinc
andmagnesiumdepletion,buthasbeenusedinvivotoremoveleadandplutonium,andsometimesto
O
removeironfromthalassaemicpatientswhocannottoleratedesferrioxamine.
HO
O NHO O
N
OH O
N
OHO
OH
Rhodotorulicacid Effectiveironchelatorinanimals.Boththisanddesferrioxamineareexamplesofsiderophores(from
theGreekwordsfor‘iron’and‘carrier’).Siderophoresareproducedbymicroorganismstochelate
O O
extracellularironandbringitintothecell.IronisusuallyboundasFe(III).Siderophoresareusually
OH
H C N NH hydroxamates(suchasdesferrioxamine)orphenols.M.tuberculosisproducestheexochelins,
3
OH HN N CH 3 lipid-solublesiderophores.
O O
Continued

--- Page 743 ---

688
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.8 (Continued)
Chelatingagent Comments
HBED Effectiveironchelatorinanimals.
OH
HOOC N
N COOH
OH
2-3-Dihydroxybenzoate Canbegivenorally.
COO–
OH
OH
Triethylenetetramine(TETA;Trientine) Copperionchelator.HasbeenusedinanimalsandhumanstodecreaseformationofAGEproducts
(Section10.5.5.1).AlsoseeCardiovasc.Diabetol.12,123,2013andDiabetologia52,715,2009.
H
N NH
H N N 2
2 H
DesferrioxamineB Alinearmoleculethat‘bendsround’tochelateFe(III)withsixligands(i.e.itisahexadentate
chelator)formingabright-redcomplex,ferrioxamine.Commerciallyavailableasdesferal
H N CONH CONH
2 (desferrioxamineBmethanesulphonate).Oftencalleddeferoxamine.
(CH ) (CH ) (CH ) (CH ) (CH ) CH
25 22 25 22 25 3
N C N C N C
OH O OH O OH O
PIH Effectiveironchelatorinanimals.Canbegivenorally.Analternativeissalicylaldehyde
isonicotinoylhydrazone(SIH),whichisusedinthecalceinassayforlabilecellularironpools
HO H
(Fig.3.19).
N
N C N H
N N
O
OH N C N
CH
3
O
OH
Boronate groups can be attached
here to generate an HO-activatable
2 2
“pro-chelator”, a technology also
applicable to other chelators.377

--- Page 744 ---

AGEING,
NUTRITION,
DISEASE,
AND
THERAPY:
A
ROLE
FOR
ANTIOXIDANTS?
689
Table11.8 (Continued)
Chelatingagent Comments
o-Phenanthroline(1,10-phenanthroline) GoodchelatorofCu2+ions(logstabilityconstant=6.3).AlsobindsFe2+(logstabilityconstant=
5.8)andZn2+.CanpreventH2O2-mediateddamagetoDNAinmammaliancells,probablybychelating
iron.However,aCu2+-phenanthrolinecomplexcanpromoteDNAdegradation(Section5.3.4).
N N
1,2-Dimethyl-3-hydroxy-pyridin-4-onea Oneofaseriesofchelators,the1-alkyl-3-hydroxy-2-methylpyrid-4-ones,whichcanbegiven
orallysincetheyareabsorbedfromtheGItract.Theyentertissuesmorereadilythandesferalandhave
O
shownpromiseinthetreatmentofthalassaemia.Theyarebidentate:threemoleculesareneededto
OH
coordinateoneironcompletely.
N
CH
3
CH
3
OR10141 Fe2+chelatedtothiscompoundcanreactwithH2O2tohydroxylatesite-specificallyonthearomatic
ringandtherebygenerateabetterironchelator(J.Med.Chem.43,1418,2000).X=co-ordinating
O MeO OMe O MeO OMe solvent.*Siteofhydroxylation
O OMe O OMe
N X H O
2 2 N O
N Fe X N Fe X
O
MeO MeO O
O
O
MeO OMe
MeO OMe
7-Monohydroxy-ethylrutoside EffectivenessinprotectingagainstcardiotoxicityinmiceiscomparabletothatofICRF-187
(Br.J.Pharmacol.115,1260,1995).Glu,glucose;Rha,rhamnose.
OH
HOCH 2 CH 2 O O
OH
O-Glu-Rha
OH O
Continued

--- Page 745 ---

690
FREE
RADICALS
IN
BIOLOGY
AND
MEDICINE
Table11.8 (Continued)
Chelatingagent Comments
Exjade(deferasirox) Atridentateligandusedintreatmentofthalassaemia.377
HO
OH N
N
N
COOH
LAP(oxidizedform) Derivativeoflipoicacid(FreeRadic.Biol.Med.34,1295,2003).Targetstolysosomesincells.
O
CH
3
C
N
N CH
H 3
S S
LAPreduced,atacidicpH
O CH
3
H C C N+ H
2 N
SH SH H CH 3
Diacetylbis(N(4)-methylthiosemicarbazonato)Cu(II),CuII(atsm) SODmimetic,reportedasbeneficialinanimalmodelsofALSandPD(J.Exp.Med.209,837,2012;J.
Biol.Chem.286,44035,2011).MayalsoscavengeONOOHorproductsderivedfromit.Crossesthe
H3C CH3 blood–brainbarrier,underinvestigationasaligandforPETimaginginhumans.
N N
N N
Cu
S S
HN NH
CH3 CH3
Abbreviations:HBED,N,N’-bis(2-hydroxybenzyl)ethylenediamine-N,N’-diaceticacid;EDTA,ethylenediaminetetra-aceticacid,DETAPAC,diethylenetriaminepenta-aceticacid;PIH,pyridoxalisonicotinoylhydrazone.Forfurtherdetails,
see317,377
aSometimescalledCP20,deferiproneorL1.InCP94both–CH3groupsarereplacedbyethylgroups.

--- Page 746 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 691
Table11.9 Propertiesofdesferrioxamine.
• PowerfulchelatorofFe(III)(stabilityconstant~1031).
• Chelatesseveralothermetalionswithstabilityconstantsseveralordersofmagnitudelower(e.g.AI(III),~1025;Cu2+,~1014;Zn2+,~1011);has
beenusedtoremovealuminiumfromdialysispatients(Section10.21.6).
• ReactsslowlywithO •
2
–orHO •
2
(k2~103M–1s–1)toformnitroxideradicalsthatcanoxidizeascorbate,GSH,andNAD(P)H.
• Substrateformyoglobin/H2O2systems,nitroxideradicalformsasferrylhaemisreduced.
• Moderatelygoodscavengerofperoxyl(RO • )radicalsinaqueoussolution,againanitroxide.
2
• Reactswithtyr-O•radical(k2~6.3×106M–1s–1),anitroxideagainresults.
• Reacts rapidly with OH• (k2~1010 M–1s–1); nitroxide radicals are again produced, so desferrioxamine is an excellent OH• scavenger;
ferrioxaminescavengesOH•withthesamerateconstant.
• D
an
o
d
es
N
n
O
o
• 2
t
r
r
a
e
d
a
i
c
c
t
a
d
ls
ir
(
e
k
c
2
tl
~
yw
7.
i
6
th
×
ON
1
O
06
O
M
–/O
–1
N
s
O
–1
O
)
H
.N
b
i
u
tr
t
o
c
x
a
id
n
e
p
p
r
r
o
o
t
d
e
u
ct
ce
a
d
ga
a
i
g
n
a
s
i
t
n
d
.
amagebythembyreactingquicklywithCO •
3
–(k2~1.7×109M–1s–1)
• Inhibitsiron-dependentlipidperoxidationandOH•generationfromH2O2inmostsystems;ferrioxaminedoesnotinhibit,soacontrolwiththis
substancecandistinguishprotectionbyironbindingfromprotectionbydirectscavengingofRS.
• AcceleratestheoxidationofFe2+solutions,bybindingtheresultingFe(III)moretightlythanitdoesFe2+;thisistheferroxidaseactionofDFO,
whichproducesO
•–:
2 Fe2+–DFO + O2 → Fe(III) –DFO + O •
2
–
• Penetratesonlyslowlyintomostanimalcells;mayenterbypinocytosisintolysosomes;poorlyabsorbedfromgutbutoraladministrationcould
conceivablybeusedtointerferewithironabsorption.
• CanraiselevelsofHIF1-αandpromoteacellular‘hypoxicresponse’.
Moststudieswithdesferrioxaminearecarriedoutwiththecommerciallyavailabledesferal(desferrioxamineBmethanesulphonate).
AdaptedfromFreeRadic.Biol.Med.7,645,1989;alsoseeFreeRadic.Biol.Med.36,471,2004andBiochim.Biophys.Acta1840,768,2014.
animals or humans; 50 mg/kg body weight per day oxidationbyRSwillgeneratenitroxideradicals,which
appears fairly safe in thalassaemic patients provided could oxidize other biomolecules such as GSH and
that they do not become iron deficient. Too much ascorbate.380However,thetoxicityofnitroxidesisgen-
DFOcanleadtoauditoryandvisualproblems,usually erallylowandtheyareoftenbeneficial(Section11.5.5).
reversible when the excess is withdrawn. Desferriox- Scavenging of RS by DFO may be of limited signifi-
amineishighly(butnotabsolutely;Table11.9)specific canceinvivo,becausetheconcentrationachieveddur-
forFe(III).TheFe(III)–DFOcomplex(ferrioxamine)is ingnormaltherapeuticuse(upto20μMplasmalevels
difficulttoreduce,notonlybyO
•–,butalsobymore
duringinfusion)isprobablytoolowforscavengingto
2
powerfulreductants(Table2.5).Inspiteofitshighsta- befeasible.
bilityconstantforFe(III)binding,DFOisinefficientat Because iron is essential for the function of an-
removing iron ions bound to transferrin or lactofer- imal cells, prolonged administration of any powerful
rin,whichmaybeadvantageoussinceironleftsafely iron-chelating agent to humans (others than patients
boundtotheseproteinsdoesnotstimulatefree-radical sufferingfromironoverload)willprobablycauseside-
reactions.Desferrioxamineistoohydrophilictocross effects.However,thisshouldnotprecludeuseofche-
cell membranes, and seems to enter cells by pinocyt- latorsinacutesituations(Table11.10).High-molecular-
osis, localizing in lysosomes.379 Its limited toxicity to mass forms of DFO have been described, in which it
humans and other animals has allowed it to be used is attached to polymers such as cellulose, PEG, dex-
in vivo to investigate the role of iron ions in disease tran, or hydroxyethyl starch. Conjugation of DFO to
(Table 11.9), and it has sometimes been added to or- thesepolymerswasreportednottodiminishitsFe(III)-
gan preservation fluids, e.g. for heart transplantation binding activity, but to decrease the toxicity of high
(Section10.7.5). doses and to increase circulating plasma half-life in
DesferrioxaminecanreactdirectlywithseveralRS, animals. They presumably enter cells by endocytosis
including RO
•
, tyrosyl radical, CO
•–,
NO
•
, O
•–
andendupinthelysosomes–thehydroxyethylstarch
2 3 2 2
(slowly),OH•,HOCl,andoxo–haemspeciesproduced remains there as it cannot be degraded by lysosomal
bymixinghaemproteinswithH O .Itdoesnotreact enzymes.381 These conjugates have been reported to
2 2
withONOO–,butcanbeattackedbyONOO–-derived be protective in several animal models of disease,
species such as CO
•–
and NO
•
(Table 11.9). Hence includingsepticshock,andtodelaytheonsetofdia-
3 2
it can inhibit damage caused by adding ONOO– to betes in spontaneously diabetic rats (‘biobreeding’;
biological systems. Since it is a hydroxamate, DFO’s Section 10.5).381,382 Do bear in mind that the carrier

--- Page 747 ---

692 FREE RADICALS IN BIOLOGY AND MEDICINE
Table11.10 Someanimalmodelsofoxidativestressinwhichdesferrioxamineisprotective.
Effectreported Comments
Decreasesneutrophil-mediatedacutelunginjuryinratsafter AmodelforsomeformsofARDS(Section10.8).
complementactivation.
Anti-inflammatoryinseveralacuteandacute-to-chronicmodelsof Notnecessarilyactingbyanantioxidantmechanism(Section11.6.1).
inflammation,includinganautoimmunediseasemodel(experimental
allergicencephalomyelitis)inrats(J.Neuroimmunol.17,127,1988).
Inhibitsthetoxicactionofalloxanandparaquat. Resultsvariable(Sections9.4and9.7).
DecreasesliverdamagebyCCl4. Section9.2
Protectiveagainstreoxygenationinjuryafterischaemiainmultiple Sections10.6and10.18
organs,includinglung,heart,kidney,gut,brain,andskin.Protective
againsthaemorrhagicshockinrodentsanddogs.Cardiacstudies
showprotectionagainstarrhythmiasandstunningandperhaps
decreasedinfarctsize.Effectscanbeantioxidant,and/orbythe
inductionofHIF1-α,whichcansometimescontributetoa
‘preconditioning’effect.378
Intranasaldesferrioxaminecounteredmemorydeficitsin Neurobiol.Aging34,562,2013.
APP-overexpressingmice,amodelofAD.
Decreasesantigen/antibody-inducedkidneydamageinrabbits DamagemaybeduetoO •
2
–andH2O2producedbyneutrophils,
reactingwithironionstoformOH•(KidneyInt.30,813,1986)
itself may sometimes be protective.263,383 However, actionsinvolvingironchelation.Itisnecessarytomeasure
there have been few examples of the use of DFO or biomarkersofoxidativedamageaswellasferrioxam-
itsconjugatestotreathumandisease,apartfromiron ineproductiontodemonstratethattheyare.
overloadofcourse,althoughitisunderevaluationfor
stroke.384
11.6.2 Otheriron-chelatingagents317,377,386,388
SinceDFOcaninhibitcellproliferation,it(andother
iron chelators) have been considered for use in can- Lactoferrin (Section 3.22.1.2) can be added to baby
cer chemotherapy.385,386 They may act by depleting foods to prevent possible pro-oxidant effects of iron
malignant cells of iron (so inhibiting iron-dependent fortification. It was also reported to decrease gastro-
enzymes such as ribonucleoside diphosphate reduc- intestinal damage by indomethacin in humans and
tase; Section 8.2) and also by altering levels of the to be beneficial in patients with sepsis.389,390 Both
cyclins and cdk2.385 Hence, if DFO is infused over lactoferrin and peptides derived from it (e.g. lacto-
several days, as has been done in some studies of ferricin) can exert antimicrobial effects and improve
itseffectsuponchronicinflammationorautoimmune immune responses.391 Metallothioneins might also
disease in animals, it is possible that any beneficial have potential; they can be delivered to cells, e.g.
effects it exerts could involve inhibition of the pro- Tat-metallothioneins administered to mice offered
liferation of inflammatory cells such as lymphocytes. protection against streptozotocin-induced diabetes.392
Desferrioxamine also increases the activity of HIF-1 Similarly, PEP-metallothionein III (PEP is a pro-
(Section 1.3.2) in many cell types, with subsequent tein transduction peptide) could protect gerbil brain
increased transcription of genes under the control of againstischaemia–reperfusion.393
thispathway(e.g.erythropoietin,glycolyticenzymes). TherearetwomajordrawbacksofDFOintreating
Similar effects are seen with several other iron chela- human iron overload diseases such as thalassaemia:
torsandseemtoinvolveremovalofironfromprolyl it is costly and is not absorbed by the GI tract and
hydroxylase,toinhibititsactivity(Section1.3.2).378,387 thereforemustbeadministeredbyintravenousorsub-
HIF-α activation may not be a good thing in cancer, cutaneous infusion. Hence there has been a search
however(Section9.20.3). for cheaper and orally active chelating agents. Some
BecauseofthesedifferentactionsofDFO,neveras- work was carried out with HBED, PIH, desferrith-
sumethatanyeffectsithasinvivoareduetoantioxidant iocin, and 2,3-dihydroxybenzoate, but most attention

--- Page 748 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 693
focused on the 3-hydroxypyrid-4-ones (Table 11.8). andM10,structureasbelowbuttheside-chainis
For example, 1,2-dimethyl-3-hydroxypyridin-4-one
+
(deferiprone, sometimes called L1 or ferriprox) has NH
3
undergone clinical trials in humans. It appears more HSCH CH CH COO–
toxicthanDFO,butstillclinicallyuseful.377,394 2 2
The apparent increased toxicity of hydroxypy- They have been suggested for use in PD, ALS, and
ridonescouldbeduetotheirchemistry.Anironioncan AD,andworkwellinvariousmousemodelsofthese
bindsixligands.Desferrioxamineisahexadentatelig- diseases.315,377,397 Combined MAO and acetylcholin-
and,i.e.itoccupiesallsixco-ordinationsites.TheDFO esteraseinhibitorswithironionchelatingabilityhave
‘wraps around’ the iron ion, encasing it in an enve- also been described,377 as have molecules combining
lopeoforganicmaterial.Incontrast,hydroxypyridones MAO-B inhibition, Cu2+ chelation, and ability to in-
occupy only two co-ordination sites (i.e. they are hibit Aβ aggregation.388 Chelators such as PBT2 are
bidentate ligands) and three hydroxypyridone mol- in clinical trial for AD patients (Section 10.21.3).
ecules are needed to chelate one Fe(III) completely. HuperzineA,
Upon dilution, 3:1 hydroxypyridone: iron ion com-
plexes might dissociate into 2:1 or 1:1 complexes,
H
leaving available co-ordination sites on the iron that N O
could allow catalysis of free-radical reactions.395 In
addition, hydroxypyridones can mobilize iron ions H N
2
fromtransferrin.394Thusonecouldenvisageascenario
in which ‘safely’ protein-bound iron could be mo- an acetylcholinesterase inhibitor derived from the
bilized and transferred to other sites in the body to ChinesefolkmedicineplantHuperziaserrata,mayalso
promote oxidative damage. Whether this contributes exertironionchelationactivity.ItisusedtotreatAD
totheside-effectsofL1isuncertain.394,395 inChina,butnotintheWest.398
Afeworallyactivetridentateligandshavebeende-
scribed. One is ICL670 (deferasirox, Exjade®) (Table 11.7 Inhibitorsofthegeneration
11.8) which is now in clinical use to treat iron over-
ofreactivespecies
load, including patients with Fanconi anaemia (Sec-
tion10.14.7).377,396Twomoleculesareneededtochelate Another approach to antioxidant protection is to in-
one Fe(III). Some authors have described ‘oxidative hibitRSformation.
stress-activatable’ iron chelators. For example, in the
presence of H O an Fe2+-chelate of OR10141 (Table
2 2 11.7.1 Xanthineoxidase(XO)inhibitors
11.8)undergoeshydroxylationonthearomaticringto
generateabetterironchelator.Hencethesecompounds These were discussed in Fig. 1.10, so we make only
mightbeabletochelateironionsatsitesofoxidative briefcommentshere.Manyanimalexperimentsshow
stress, and not in the body generally. The reactivity thatallopurinolprotectsagainstreoxygenationinjury
ofboronateswithH 2 O 2 (Section6.11.1)hasbeenused (Section10.6).Sinceallopurinoliswidelyusedtotreat
to generate compounds which are converted to SIH hyperuricaemia in humans, its toxicologicalprofile is
(Table11.8)orotherironorcopperchelatorsatsitesof well known and it is added to some organ preser-
H 2 O 2 accumulation.377Anotherinterestingcompound vationsolutions(Section10.7.5).AlthoughXOmakes
isLAP(Table11.8),aderivativeoflipoamidedesigned only limited contributions to RS generation in most
toaccumulatewithinlysosomes.Itcanprotectcellsin humantissues,itdoesoccuringut(Section10.6.2),ath-
cultureagainstthetoxiceffectsofH 2 O 2 .379 eroscleroticlesions(Section10.3),failinghumanhearts
Iron-chelatingabilitycanbe‘added’toanotherdrug, (Section10.6.4.3),thesynoviaofpatientswithrheuma-
suchasaMAOinhibitor.ExamplesareM30, toid arthritis (Section 10.11), the palmar fascia of pa-
tientswithDupuytrencontracture(Section10.7.4),and
the plasma of patients with sickle cell anaemia (Sec-
tion7.4.4)andARDS(Section10.8.1).Thetherapeutic
possibilitiesoftreatmentwithallopurinolorotherXO
inhibitors in these diseases have been discussed, but
not fully established clinically. Chapter 10 discusses
thisinmoredetail.

--- Page 749 ---

694 FREE RADICALS IN BIOLOGY AND MEDICINE
AswellasinhibitingXO,oxypurinol(themajorme- burstinisolatedneutrophils,butarenon-specific(Fig.
tabolite of allopurinol; Fig. 1.10) can scavenge HOCl 8.13). Apocynin (Fig. 11.5) is a plant phenol (from
in vitro, which might contribute to its protective ef- the plant Kurroa picroria) that is oxidized by MPO to
fects under certain circumstances,399 although no in a product that blocks assembly of the NADPH oxi-
vivoevidenceforthishasbeenobtained.Invitro,both dase.Henceonlyactivatedphagocytes(producingthe
allopurinolandoxypurinolreactrapidlywithOH•,but H O necessary for MPO action) are affected. Apo-
2 2
the concentrations achieved in vivo are probably too cynin has anti-inflammatory effect in animals, but
lowforthistobeasignificantmechanismofprotection. high levels are needed and it is probably also non-
An additional mechanismby which allopurinol, oxy- specific.404,405Aconjugateofapocyninandlipoicacid,
purinol,orotherXOinhibitorscouldprotectischaemic VPEI-100,wasreportedtoprotectagainstischaemia–
tissues is by preventing oxidation of hypoxanthine, reperfusion in rat brain.406 Tetomilast (Fig. 11.5),
so enhancing its salvage for reincorporation into ad- whichcaninhibitphagocyteO
•–
generation,isunder
2
enine nucleotides when the tissue is reoxygenated evaluation for the treatment of inflammatory bowel
(Section10.6.4.3). disease, although its benefits do not seem great.407
Tetrandrine,
11.7.2 Myeloperoxidaseinhibitors
Several inhibitors of MPO have been developed and
tested in various animal models. Examples are 2-
thioxanthines (although their specificity has been
questioned)400 and INV-315.401,402 As already men-
tioned, nitroxides can inhibit MPO-dependent HOCl
generation,byactingasalternativesubstratestochlor-
ideandtrappingtheenzyme293asthelessactiveMPO
compound II. Paracetamol can also act as a substrate
analkaloidfromrootsoftheplantStephaniatetrandra,
forMPOandinhibitHOClformation.403Doremember,
isusedinChinatotreatsilicosisinminers.Itprevents
however, that MPO is not always a ‘baddie’ (Sec- NF-κB activation and hence may act by decreasing
tions8.9.4and10.3.5.1).
theinductionofiNOSandCOX-2.Ithasshownpro-
tective effects in animal models of inflammation and
ischaemia–reperfusion injury but its clinical value is
11.7.3 Inhibitorsofphagocyteaction
uncertain.408
Generation of RS by phagocytes sometimes contrib-
utes to tissue injury. Hence inhibitors of phago-
11.7.4 NADPHoxidaseinhibitors
cyte recruitment can be useful. They include agents
that inhibit the production, or antagonize the action Several allegedly-selective inhibitors of NADPH
of, ‘pro-inflammatory’ cytokines (e.g. infliximab, Sec- oxidase enzymes have been developed (Table 11.11),
tion10.11),compoundsthatdecreaselevelsofadhesion e.g. for treatment of diabetic nephropathy, idiopathic
molecules, antibodies directed against adhesion mol- pulmonaryfibrosis,andpossibleuseinstroke,osteo-
ecules, or synthetic ‘decoy’ adhesion molecules that porosis (Section 8.10.8), vascular complications of
competewithphagocytesforbindingtoendothelium. diabetes, and metastatic cancer.404 Other potential
CompoundsinterferingwithphagocyteRSproduction therapeutic uses include HD (Section 10.23.2), heart
might also be useful—indeed, adenosine may act in failure (Section 10.6.4.6), and chronic pain (Sec-
thisway(Section8.9.2). tion10.24).Theinhibitorsincludepyrazolopyridines;
Several anti-inflammatory drugs have been hy- forexample4-methyl-2-phenyl-5(pyridin-3-ylmethyl)-
pothesized to decrease O
•–
formation by phagocytes 1H-pyrazole [4,3-c] pyridine-3,6(2H,5H)dione inhibits
2
(Section10.11.5), andsomeofthebeneficialeffectsof NOX4andNOX1,butlesssoNOX2.Otherinhibitors
ebselen(Section11.5.10)couldbeduetothis;Ebselen include tetrahydroindoles, peptides that interfere
seems able to inhibit NOX1 and NOX2.358 Diphen- with assembly of the phagocyte NADPH oxidase
ylene iodonium compounds inhibit the respiratory (e.g.gp91ds-Tat;theTatisthecellularinternalization

--- Page 750 ---

AGEING, NUTRITION, DISEASE, AND THERAPY: A ROLE FOR ANTIOXIDANTS? 695
Table11.11 SomeNADPHoxidaseinhibitors.
Name Structure Comments
GKT136901 Allegedly-selectiveNOX1andNOX4inhibitor,butmayalsoaffect
NOX5.Mechanismofactionnotdefined,butstructuralsimilaritywith
NADPHsuggeststhatitmayactasacompetitiveinhibitorwithNADPH.
GKTsignifiesthecompanyGenKyoTex.
GKT137831 Inclinicaltrialsfordiabeticnephropathyandidiopathicpulmonary
fibrosis.ActsonNOX1andNOX4.
ML171 AphenothiazinewithsomedegreeofselectivityforNOX1(IC50of
0.25μM)overotherNOX(IC50>3μM).
S17834 FlavonoidderivativeproposedtodirectlyinhibitNOXactivity,although
themechanismofactionisundefined.Anti-atheroscleroticinsome
animalmodels.Notmuchusedrecently.SdenotesthecompanyServier.
VAS2870 InhibitsNOX2and-4.Mayactbyreactingwith–SHgroups;maynotbe
specific(FreeRadic.Biol.Med.52,1897,2012).VASsignifiesthe
companyVasopharmGmbH.
VAS3947 AtriazolopyrimidinethatreducesNOX-derivedROSproductionin
severalcelllinesatlowmicromolarlevels,irrespectiveofthespecific
isoformsexpressed
AdaptedfromNat.Rev.DrugDiscov.10,453,2011,bycourtesyofDrGrantR.DrummondandNaturePublishingGroup.AlsoseeAntioxid.RedoxSignal.20,2741,2014.
TheactionsoftheseinhibitorsonDUOXenzymesalsoneedtobestudied.
signal [Section 11.5.3]), triazolopyrimidines (e.g. 11.8 Agentstowatch
VAS2870, VAS3947; Table 11.11) and siRNA dir-
Pyruvate and other keto acids can scavenge H O
ected against various NOX isoforms. Of course, 2 2
in vitro (Section 3.25.2). Indeed, administration of
NADPH oxidases are not always bad, so any in-
ethyl pyruvate or other pyruvate esters has shown
hibitors that make it to phase III clinical trials will
protective effects in several animal models of hu-
have to be used judiciously. The closest seems to
man disease, including sepsis, gastric cancer, hepatic
be GKT137831, a pyrazolopyridine NOX1 and -4
ischaemia–reperfusion, pancreatitis, and stroke. Their
inhibitor granted orphan drug status to treat idio-
clinicalvalue(notestablishedtodate)andmechanism
pathicpulmonaryfibrosis(Table11.11)andalsobeing
ofaction(H O scavenging,anti-inflammatoryeffects
tested in diabetic nephropathy patients.404 Statins 2 2
[e.g. by blocking the action of HMGB1; Section 5.4],
can also decrease vascular NADPH oxidase activity
Nrf2 activation, and/or alterations of metabolism)
(Section11.5.1).

--- Page 751 ---

696 FREE RADICALS IN BIOLOGY AND MEDICINE
remain to be established.409 PUFAs containing one H +OH •→H • +H O
2 2
or more deuterium atoms appear to be able to slow
the chain reaction of lipid peroxidation.410 Hydrogen but this is unlikely since the levels of H 2 achieved
gas (inhaled or administered orally as H -saturated in solution would probably not be high enough
2
water) has been reported to lessen damage in an- to compete with endogenous biomolecules for any
imal models of atherosclerosis, radiation damage, OH• generated, and the rate constant for the re-
ischaemia–reperfusion injury, and graft rejection, action is quite low (4.2 × 107 M–1s–1; Table 2.6).
among others.411 The suggested mechanism of action In any case the resulting H• is highly reactive with
isbyscavengingOH•, biomolecules.412

--- Page 752 ---

APPENDIX
Some basic chemistry
A1 Atomicstructure precisely,butonlytheregionofspacewhereitismost
Atoms consist of a positively charged nucleus sur- likelytobe.Theseregionsarecalledorbitals.Eachelec-
roundedbyoneormorenegativelychargedelectrons. troninanatomhasitsenergydefinedbyfourquantum
Thenucleuscontainstwotypesofparticleofapproxi- numbers.Thefirst,orprincipalquantumnumber(n),
matelyequalmass,thepositivelychargedprotonand defines the main energy level that the electron occu-
the uncharged neutron. By comparison with these pies.FortheK-shell,n =1;forL,n =2;forM,n =3;
particles,themassoftheelectronisnegligible,sothat andforN,n =4.Thesecond,orazimuthalquantum
virtuallyallofthemassoftheatomiscontributedbyits number (l), governs the shape of the orbital and has
nucleus.Theatomicnumberofanelementisthenum- valuesfromzeroupto(n–1).Whenl=0,theelectrons
berofprotonsinitsnucleus,themassnumberisthe are called ‘s’ electrons; when l = 1, they are ‘p’ elec-
numberofprotonsplusneutrons.Intheneutralatom, trons;l = 2,‘d’electrons;andl = 3gives‘f’electrons.
theatomicnumberalsoequalsthenumberofelectrons. Thethirdquantumnumberisthemagneticquantum
Thesimplestatomisthatofhydrogen,containingone number (m) and, for each value ofl, m has values of
proton (atomic number one, mass number one) and
l,(l–l),...,0,–1,...,...,–l.Finally,thefourthquan-
oneelectron.Allotherelementscontainneutronsinthe tumnumber,orspinquantumnumber,canonlyhave
nucleus. valuesof1/2or–1/2.TableA3showshowelectrons
Someelementsexistasisotopes,inwhichtheatoms withthesedifferentquantumnumbersfilltheelectron
containthesamenumberofprotonsandelectrons,but shells. Pauli’s principle states that ‘no two electrons
different numbers of neutrons. These isotopes can be canhavethesamefourquantumnumbers’.Sincethe
stable(e.g.15N)orunstable,theunstableonesunder- spin quantum number has only two possible values
going radioactive decay at various rates (e.g. 14C). (±1/2),itfollowsthatanorbitalcanholdamaximum
Inthisprocess,thenucleusoftheradioactiveisotope oftwoelectrons(TableA3).
changes,andanewelementforms.Carbon,hydrogen, Infillingtheavailableorbitalselectronsentertheor-
nitrogen, and oxygen exist almost exclusively as one bitalswiththelowestenergyfirst(Aufbauprinciple).
isotopicforminnature(TableA1),whereaschlorineis Theorderis
amixture.
1s2s2p3s3p4s3d4p5s4d5p6s4f5d6p7s5f
Electronsarenegativelycharged.Sincetheydonot
spiral into the positively charged nucleus, they must −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−→
possessenergytocounteractitsattractiveforce.Elec- Lowestenergy Highestenergy
trons exist in specific orbits, or ‘electron shells’, each
associatedwithaparticularenergylevel.The‘K’-shell TableA4givestheelectronicenergyconfigurations
electrons,lyingclosesttothenucleus,havethelowest of the elements with atomic numbers 1 to 32. When
energy, and the energy successively increases as one the elements are arranged in the periodic table
proceeds outwards to the so-called M- and N-shells. (FigureA1),elementswithsimilarelectronicarrange-
TheK-shellcanholdamaximumoftwoelectrons,the mentsfallintosimilargroups(verticalrows),e.g.the
L-shell,8,M-shell,18andN-shell,32.TableA2shows groupIIelementsallhavetwoelectronsintheirouter-
thelocationofelectronsineachoftheseshellsforthe most electron shell, and the group IV elements have
elementsuptoatomicnumber36. four. Since the 4s-orbital is of lower energy than the
Electronshavesomeofthepropertiesofaparticle, 3d-orbitals,theselatterorbitalsremainemptyuntilthe
and some of the properties of a wave. The position 4s-orbital is filled (e.g. see potassium and calcium in
of an electron at a given time cannot be specified TableA4).Insubsequentelementsthefive3d-orbitals
FreeRadicalsinBiologyandMedicine.FifthEdition.BarryHalliwellandJohnM.C.Gutteridge.
©BarryHalliwellandJohnM.C.Gutteridge2015.Publishedin2015byOxfordUniversityPress.

--- Page 753 ---

698 FREE RADICALS IN BIOLOGY AND MEDICINE
TableA1 Isotopesofsomecommonelements.
Element Isotope Numberof Numberof Comments
protonsin neutrons
nucleus innucleus
Chlorine 35Cl 17 18 Bothisotopesarestableandoccurnaturally,35Clbeingmore
17
37Cl 17 20 abundant.
17
Carbon 12C 6 6 Over90%ofnaturallyoccurringcarbonis12C.Smallamountsofthe
6 6
13C 6 7 radioactiveisotope1 6 4C areformedbythebombardmentof
6
14C 6 8
atmosphericCO2withcosmicrays(streamsofneutronsarisingfrom
6 outerspace).Thisisotopeundergoesslowradioactivedecay(50%
decayafter5600years).
Nitrogen 14N 7 7 15Nisastableisotopeofnitrogenoftenusedasa‘tracer’,
7
e.g.15NO–canbefedtohumanstostudyitsmetabolism.
15N 7 8 3
7
Oxygen 16O 8 8 Over90%ofnaturallyoccurringoxygenistheisotope16O.
8 8
17O 8 9
8
18O 8 10
8
Hydrogen 1H 1 0 Over99%ofhydrogenis1H.Deuterium(2H)isastableisotope,
1 1 1
2 1 3 H H 1 1 1 2 w ‘h h e e a r v e y a w s a tr t i e ti r u ’, m an (3 1 d H i ) s i u s s r e a d di i o n a d c e ti t v e e c . t D in e g u s te in r g iu le m tO ox 2 id (S e e i c s t k io n n ow 6. n 8. a 3 s ).
1
Thesuperscriptnumberontheleftofthesymbolfortheelementisthemassnumber,andthesubscripttheatomicnumber.
TableA2 Locationofelectronsinshellsfortheelementswithatomicnumbers1to36.
Atomicnumber Element Symbol ShellK ShellL ShellM ShellN
ofelement
1 Hydrogen H 1
2 Helium He 2
3 Lithium Li 2 1
4 Beryllium Be 2 2
5 Boron B 2 3
6 Carbon C 2 4
7 Nitrogen N 2 5
8 Oxygen O 2 6
9 Fluorine F 2 7
10 Neon Ne 2 8
11 Sodium Na 2 8 1
12 Magnesium Mg 2 8 2
13 Aluminium Al 2 8 3
14 Silicon Si 2 8 4
15 Phosphorus P 2 8 5
Continued

--- Page 754 ---

APPENDIX: SOME BASIC CHEMISTRY 699
TableA2 (Continued)
Atomicnumber Element Symbol ShellK ShellL ShellM ShellN
ofelement
16 Sulphur S 2 8 6
17 Chlorine Cl 2 8 7
18 Argon Ar 2 8 8
19 Potassium K 2 8 8 1
20 Calcium Ca 2 8 8 2
21 Scandium Sc 2 8 9 2
22 Titanium Ti 2 8 10 2
23 Vanadium V 2 8 11 2
24 Chromium Cr 2 8 13 1
25 Manganese Mn 2 8 13 2
26 Iron Fe 2 8 14 2
27 Cobalt Co 2 8 15 2
28 Nickel Ni 2 8 16 2
29 Copper Cu 2 8 18 1
30 Zinc Zn 2 8 18 2
31 Gallium Ga 2 8 18 3
32 Germanium Ge 2 8 18 4
33 Arsenic As 2 8 18 5
34 Selenium Se 2 8 18 6
35 Bromine Br 2 8 18 7
36 Krypton Kr 2 8 18 8
TableA3 Orbitalsavailableintheprincipalelectronshells.
Shell Principal Valueofl Electron Valueofm(magnetic Valueofs Maximumnumberof
quantum (azimuthal type quantumnumber) (spinquantum electronsinshell
number quantum number)
number)
K 1 0 s 0 ±1/2 2(1s–orbital)
(cid:10)
L 2 0 s 0 ±1/2 2(2s–orbital)
1 p 1,0,–1 ±1/2 3×2(three2p–orbitals) 8
⎫
M 3 0 s 0 ±1/2 2(3s–orbital) ⎬
1 p 1,0,–1 ±1/2 3×2(three2p–orbitals) 18
⎭
2 d 2,1,0,–1,–2 ±1/2 5×2(five3d–orbitals)
⎫
N 4 0
1 p
s 0
1,0,–1
±
±
1
1
/
/
2
2
2
3×
(4s
2
–
(
o
th
rb
re
it
e
al
4
)
p–orbitals)
⎪⎪⎬
2 d 2,1,0,–1,–2 ±1/2 5×2(five4d–orbitals) ⎪⎪⎭ 32
3 f 3,2,1,0,–1,–2,–3 7×2(seven4f–orbitals)

--- Page 755 ---

700 FREE RADICALS IN BIOLOGY AND MEDICINE
TableA4 Electronicconfigurationoftheelements.
Element Atomic Symbol Configuration Placeinperiodic
number table
Hydrogen 1 H 1s1 Uncertain
Helium 2 He 1s2 Group0(inertgases)
Lithium 3 Li 1s22s1 GroupI(alkalimetals)
Beryllium 4 Be 1s22s2 GroupII(alkaline-earth
metals)
Boron 5 B 1s22s22p1 GroupIII
Carbon 6 C 1s22s22p2 GroupIV
Nitrogen 7 N 1s22s22p3 GroupV
Oxygen 8 O 1s22s22p4 GroupVI
Fluorine 9 F 1s22s22p5 GroupVII(halogen
elements)
Neon 10 Ne 1s22s22p6 Group0
Sodium 11 Na 1s22s22p63s1 GroupI
Magnesium 12 Mg 1s22s22p63s2 GroupII
Aluminium 13 Al 1s22s22p63s23p1 GroupIII
Silicon 14 Si 1s22s22p63s23p2 GroupIV
Phosphorus 15 P 1s22s22p63s23p3 GroupV
Sulphur 16 S 1s22s22p63s23p4 GroupVI
Chlorine 17 Cl 1s22s22p63s23p5 GroupVII
Argon 18 Ar 1s22s22p63s23p6 Group0
Potassium 19 K 1s22s22p63s23p64s1 GroupI
Calcium 20 Ca 1s22s22p63s23p64s2 GroupII
Scandium 21 Sc 1s22s22p63s23p64s23d1 d-block
Titanium 22 Ti 1s22s22p63s23p64s23d2 d-block
Vanadium 23 V 1s22s22p63s23p64s23d3 d-block
Chromium 24 Cr 1s22s22p63s23p64s13d5 d-block
Manganese 25 Mn 1s22s22p63s23p64s23d5 d-block
Iron 26 Fe 1s22s22p63s23p64s23d6 d-block
Cobalt 27 Co 1s22s22p63s23p64s23d7 d-block
Nickel 28 Ni 1s22s22p63s23p64s23d8 d-block
Copper 29 Cu 1s22s22p63s23p64s13d10 d-block
Zinc 30 Zn 1s22s22p63s23p64s23d10 d-block
Gallium 31 Ga 1s22s22p63s23p64s23d104p1 GroupIII
Germanium 32 Ge 1s12s22p63s23p64s23d104p2 GroupIV

--- Page 756 ---

APPENDIX: SOME BASIC CHEMISTRY 701
Groups Groups
I II III IV V VI VII O
s–block
1 1 2
H H He
3 4 5 6 7 8 9 10
Li Be B C N O F Ne
11 12 13 14 15 16 17 18
Na Mg d–block A1 Si P S Cl Ar
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
K Ca Sc Ti V Cr Mn Fe Co Ni Cu Zn Ga Ge As Se Br Kr
37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54
Rb Sr Y Zr Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb Te I Xe
55 56 57 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86
Cs Ba La Hf Ta W Re Os Ir Pt Au Hg Ti Pb Bi Po At Rn
87 88 89
Fr Ra Ac p–block
Lanthanides f–block
58 59 60 61 62 63 64 65 66 67 68 69 70 71
Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu
90 91 92 93 94 95 96 97 98 99 100 101 102 103
Actinides Th Pa U Np Pu Am Cm Bk Cf Es Fm Md No Lr
FigureA1 Theperiodictable.
TableA5 Electronicconfigurationoftheelementsscandiumtozincinthefirstrowofthed-blockoftheperiodictable.
3d 4s
Scandium Ar ↑ ↑↓
Titanium Ar ↑ ↑ ↑↓
Vanadium Ar ↑ ↑ ↑ ↑↓
Chromium Ar ↑ ↑ ↑ ↑ ↑ ↑
Manganese Ar ↑ ↑ ↑ ↑ ↑ ↑↓
Iron Ar ↑↓ ↑ ↑ ↑ ↑ ↑↓
Cobalt Ar ↑↓ ↑↓ ↑ ↑ ↑ ↑↓
Nickel Ar ↑↓ ↑↓ ↑↓ ↑ ↑ ↑↓
Copper Ar ↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑
Zinc Ar ↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑↓
receiveelectrons,creatingthefirstrowofthed-block toscandiumandsubsequentelementsasfarasnickel,
intheperiodictable(FigureA1).Someofthesed-block although it is often extended to include the whole of
elements are transition elements, meaning elements thefirstrowofthed-block.
in which an inner shell of electrons is incomplete (in If orbitals of equal energy are available, for ex-
this case there are electrons in the fourth shell, but ample the three 2p-orbitals in the L-shell, or the five
all the d-orbitals of the third shell are not yet full). 3d-orbitalsintheM-shell(TableA3),eachisfilledwith
Thetermtransitionelement,asdefinedabove,applies one electron before any receives two (Hund’s rule).

--- Page 757 ---

702 FREE RADICALS IN BIOLOGY AND MEDICINE
Henceonecanfurtheranalysetheelectronicconfigur- but the loss of an electron leaves the atom with a
ationsinTableA4.Forexample,boronhastwo1s,two positivecharge,forminganionor,morespecifically,a
2s,andone2pelectrons.Three2p-orbitalsofequalen- cation(positivelychargedion).Forchlorine,configur-
ergyareavailable(TableA3),oftenwrittenas2p ,2p , ation1s22s22p63s23p5,acceptanceofoneelectrongives
x y
and2p .Ifwerepresenteachorbitalasaboxandan theargonelectronconfiguration1s22s22p63s23p6,and
z
electronasanarrow,boroncanberepresentedas producesanegativelychargedion(anion)Cl–.
InthecaseofagroupIIelementsuchasmagnesium,
itmustlosetwoelectronstogainaninertgaselectron
configuration.Thusoneatomofmagnesiumcanpro-
vide electrons for acceptance by two chlorine atoms,
Forthenextelement,carbon,theextraelectronenters
givingmagnesiumchlorideaformulaMgC1 ,
2
another2p-orbitalincompliancewithHund’srule,
Mg→Mg2++2e–
1s22s22p63s2 1s22s22p6
(neonconfiguration)
Andfornitrogen,
Anatomofoxygen,however,canaccepttwoelectrons
andcombinewithmagnesiumtoformanoxideMgO,
O+2e–→O2–
Furtherelectronswillnowbeginto‘pairup’tofillthe
2p-orbitals,forexampletheoxygenatom, 1s22s22p4 1s22s22p6
(neonconfiguration)
Once formed, anions and cations are held together
bytheattractionoftheiroppositecharges.Eachionwill
Table A5 uses the same ‘electrons-in-boxes’ notation exertaneffectoneachotherioninitsvicinity,andthese
for the elements in the first row of the d-block. Each forces cause the ions to pack together into an ionic
ofthefive3d-orbitalsreceivesoneelectron,beforeany crystallattice.Asanexample,incrystalsofNaCl,each
receivestwo. Na+ ionissurroundedbysixCl– ions,andviceversa.
Oncethelatticehasformed,itcannotbesaidthatany
A2 Bondingbetweenatoms oneNa+ion‘belongs’toanyoneCl–ion,norcan‘mol-
ecules’ofsodiumchloridebesaidtoexist.Theformula
Thedescriptionofchemicalbondingbelowisthesim-
ofanioniccompoundmerelyindicatestheratioofthe
plestpossibleneededtounderstandthisbook.
ionspresent.Alotofenergyisneededtodisruptallthe
A2.1 Ionicbonding electrostaticforcesbetweenthemanymillionsofions
inacrystalofanioniccompound,sosuchcompounds
Essentiallytwotypesofchemicalbondexist.Thefirst
areusuallysolidswithhighmelting-points.Ioniccom-
is ionic bonding, and occurs when electropositive
poundsaremostlysolubleinwater,andthesolutions
elementscombinewithelectronegativeones.Electro-
conduct electricity because of the presence of ions to
positiveelements,suchasthoseingroupsIandIIof
carrythecurrent.Thepropertiesofanioniccompound
theperiodictable(FigureA1),tendtolosetheirouter-
insolutionarethoseofitsconstituentions.
most electrons easily, whereas electronegative elem-
ents(groupVII,andoxygenandsulphuringroupVI)
A2.2 Covalentbonding
tendtoacceptextraelectrons.Bydoingso,bothgain
the electronic configuration of the inert gases, which This involves sharing a pair of electrons between the
seemstobeaparticularlystableconfigurationinview two bonded atoms. Usually each atom contributes
ofthelackofreactivityoftheseelements.Consider,for one electron to the shared pair, but in dative cova-
example,thecombinationofanatomofsodiumwith lentbonding,oneatomcontributesboth.Forexample,
one of chlorine. Sodium, an electropositive group I hydrogen usually occurs as covalently bonded di-
element,hastheelectronicconfiguration1s22s22p63s1. atomic molecules, H . If we represent the electron of
2
If a sodium atom loses one electron, it now has the eachhydrogenatombyacross(×)wecanwrite
configuration 1s22s22p6, that of the inert gas neon.
It is still sodium because its nucleus is unchanged, H×+ × H→H × ×H

--- Page 758 ---

APPENDIX: SOME BASIC CHEMISTRY 703
×
where × is the shared pair of electrons. Many other thebondingmolecularorbital.HenceH 2 ismuchmore
gaseouselements,includingoxygenandchlorine,ex- stablethantwoHatoms.
ist as covalently bonded diatomic molecules. For the P-typeatomicorbitalscanproducetwotypesofmo-
covalent compound ammonia, NH , let us represent lecular orbital (σ and π) by overlapping in different
3
the outermost electrons of the N as circles and those ways.Hence,fora2p-orbital(say2p )combiningwith
x
ofhydrogenasX, anotherone,therewillbetwobondingmolecularor-
bitals,σ2p andπ2p ,andtwoantibondingmolecular
x x
orbitals,σ*2p andπ*2p .Energyincreasesintheorder
x x
σ2p <π2p <π*2p <σ*2p
x x x x
Eachatomcontributesoneelectrontothebond.Am-
Withthisinmind,wecanconsiderbondingintwo
monia also undergoes dative covalent bonding using
more complex cases: the gases nitrogen and oxygen.
thesparepair(lonepair)ofelectronsonthenitrogen. The nitrogen atom has the configuration 1s22s22p3.
For example, it forms a covalent bond with a pro-
IftwoatomsjointoformN ,thefour1s-electrons(two
2
ton(H+).H+ isformedbylossofoneelectronfroma fromeachatom)fullyoccupyaσ1sbondingandaσ*1s
hydrogenatom,andsohasnoelectrons,
antibondingorbital,andsothereisnonetbonding.The
four 2s-electrons similarly occupy σ2s and σ*2s mo-
lecularorbitals,againnonetbonding.Sixelectronsare
left,locatedintwo2p ,two2p ,andtwo2p atomicor-
x y z
bitals.Iftheaxisofthebondbetweentheatomsistaken
to be that of the 2p orbitals, they can overlap along
x
thisaxistoproduceabondingσ2p molecularorbital
x
that can hold both electrons. The 2p and 2p atomic
y z
Onceformed,eachofthefourcovalentbondsinNH+ orbitalscannotoverlapalongtheiraxes,buttheycan
4 overlaplaterallytogivebondingπ2p andπ2p mo-
isindistinguishablefromtheothers. y z
lecularorbitals,eachofwhichholdstwoelectrons.The
Covalent compounds are usually gases, liquids, or
2pantibondingorbitalsarenotoccupied;andthenet
low-melting-pointsolidsatroomtemperature,because
resultisatriplecovalentbondN ≡ N;oneσ cova-
the forces of interaction between the molecules are
lentbondandtwoπcovalentbonds.TheN molecule
weak.Bycontrast,covalentbondsthemselvesareusu- 2
isthusfarmorestablethanindividualNatoms.
allystrongandhardtobreak.Covalentbonds,unlike
Theoxygenatom(configuration,1s22s22p4)hasone
ionicbonds, have definitedirectionsin space, and so
more electron, and so when O forms there are two
their length, and the angles between them, can be 2
moreelectronstoconsider.Thesemustoccupythenext
measured.
highest molecular orbital in terms of energy. In fact,
Orbitaltheory(SectionA1)alsoappliestocovalent
therearetwosuchorbitalsofequalenergy,π*2p and
compounds,thebondingelectronsoccupyingmolecu- y
π*2p .ByHund’srule,eachreceivesoneelectron.Since
larorbitalsformedbyinteractionoftheatomicorbitals z
the presence of two electrons in antibonding orbitals
inwhichtheywereoriginallylocated.Variouspossible
energetically cancels out one of the π2p bonding or-
interactionsproducemolecularorbitalsofdifferenten-
bitals,thetwooxygenatomsareeffectivelyjoinedbya
ergylevels,eachofwhichcanholdamaximumoftwo
doublebond,thatisO=O(alsoseeFig1.14).
electrons with opposite values of the spin quantum
The fluorine molecule contains two more electrons
number (Pauli’s principle). In the simplest case, H ,
2 than does O , and so the π*2p and π*2p orbitals
twopossiblemolecularorbitalscanformbyinteraction 2 y z
are both full. Since three bonding and two antibond-
of the 1s atomic orbitals of each H atom. The lowest
ing molecular orbitals are occupied, the F molecule
energyorbitalisthebondingmolecularorbital(often 2
writtenasσ1s)inwhichtheelectronismostlikelyto effectivelycontainsasinglebond,F–F.
befoundbetweenthetwonuclei.Thereisalsoanan-
tibondingmolecularorbital(writtenasσ*1s)ofhigher A2.3 Non-idealcharacterofbonds
energy in which there is little chance of finding an Thediscussionsofarhasimpliedanequalsharingof
electronbetweenthetwonuclei.Abondingmolecular thebondingelectronsbetweentwoatomsjoinedbya
orbitalismorestablethantheatomicorbitals,whereas covalent bond. However, this only occurs when both
anantibondingmolecularorbitalislessstable.Thetwo atoms have a similar attraction for the electrons, i.e.
electrons in H have opposite spin, and both occupy areequallyelectronegative.Thisisoftennotthecase.
2

--- Page 759 ---

704 FREE RADICALS IN BIOLOGY AND MEDICINE
Consider,forexample,thewatermolecule,whichcon- bond has six shared electrons (three pairs). The sim-
tains two oxygen–hydrogen covalent bonds. Oxygen plesthydrocarboncontainingadoublebondisthegas
ismoreelectronegativethanhydrogen,andsotakesa ethene,sometimescalledethylene,
slightlygreater‘share’ofthebondingelectrons,giving
itaslightnegativecharge(writtenasδ–).Thehydrogen
thushasaslightpositivecharge,
Etheneisproducedinseveralassaysforthedetection
ofhydroxylradicals(Table6.14).
Ethyne,sometimescalledacetylene,containsatriple
bond and has the structure H—C≡C—H. Organic
Thesechargesgivewatermanyofitsproperties.They
compoundscontainingcarbon–carbondoubleortriple
attractwatermoleculestoeachother,makingitharder
bondsaresaidtobeunsaturated,forexamplePUFAs
to separate them and so raising the boiling point of
(Section5.11.2).
waterto100◦Catnormalatmosphericpressure,
The organic liquid benzene has the formula C H .
6 6
Giventhatcarbonformsfourcovalentbonds,thestruc-
ture of benzene might be drawn as containing three
carbon–carbonsinglebonds,andthreedoublebonds,
thatis
These weak ionic bonds are called hydrogen bonds.
The δ+ and δ– charges also allow water to hydrate
ions;watermoleculesclusteraroundionsandhelpto
stabilizethem.
Theenergyreleasedwhenionsbecomehydratedhelps
toprovidetheenergyneededtodisruptthecrystallat- This structure cannot be correct, however, since
ticewhenioniccompoundsdissolveinwater.Insome benzene does not show the characteristic chemical
cases the energy of hydration is too small to disrupt reactions of compounds containing double bonds.
thelattice,resultinginanioniccompoundinsolublein A carbon–carbon single bond is normally 0.154 nm
water.
long(onenanometre,nm,is10–9metre),andacarbon–
carbondoublebond,0.134nm;yetallthebondlengths
A2.4 Hydrocarbonsandelectrondelocalization between the carbon atoms in benzene are equal at
Carbonhasfourelectronsinitsoutermostshell(Table 0.139nm,thatis,intermediatebetweenthedoubleand
A4),andnormallyformsfourcovalentbonds.Carbon single bond lengths. The six electrons, which should
atomscancovalentlybondtoeachothertoformlong haveformedthreedoublebonds,appeartobe‘spread
chains.Forexample,butanehasthestructure around’allsixbonds.Thisisoftendrawnas
Butaneisahydrocarbon,thatisitcontainsonlycarbon
and hydrogen. Two other hydrocarbon gases, ethane
and pentane, are released during lipid peroxidation
(Section5.12.5.1).Theyhavethestructures Compoundscontainingthebenzeneringorsimilar
ringstructuresarecalledaromaticcompounds.Delo-
calization of electrons over several bonds greatly in-
creasesthestabilityofamolecule.Otherexamplescan
beseeninhaemrings(Section1.10.3),whichshowex-
Carbonatomscanalsoformdoublecovalentbonds tensivedelocalizationofelectrons,andinseveralions
(written as ( ) and triple covalent bonds such as nitrate (NO–) and carbonate (CO2–). In each
3 3
(—C ≡ C—) with each other. A double bond con- casethenegativechargeisspreadbetweeneachofthe
sistsoffoursharedelectrons(twopairs),andatriple bonds,

--- Page 760 ---

APPENDIX: SOME BASIC CHEMISTRY 705
but‘physiologicalpH’rangesfrom<2inthestomach
to >8 in the stroma of illuminated chloroplasts. The
termpHisdefinedas
(cid:2) (cid:3)
pH=–log H+
10
(each O has, on average, one-third of the negative wherethesquarebracketsdenoteconcentration.Thus
charge).
purewaterat25◦Ccontains10–7moles/dm3ofH+ions
anditspHis7.Astemperaturerises,heterolyticfission
ofwater(Fig.1.13)isfavoured,[H+]risesandpHfalls,
sopurewaterat37◦Cisnotneutralbutslightlyacidic.
An acid may be (somewhat simplistically) defined
asadonorofhydrogenions.Strongacids(HCl,HNO ,
3
H SO )arecompletelyionizedwhenmixedwithwater
2 4
to give dilute aqueous solutions (but not as the pure
(each O has, on average, two-thirds of a negative acids, which are covalently bonded). However, most
charge). acids in living systems (e.g. HNO , HOCl, HO • , are
2 2
onlypartiallyionized(so-calledweakacids)andexist
A3 Molesandmolarity inanequilibrium:
Onemoleofasubstanceisitsrelativemolecularmass HA(cid:2)H++A–
acid
(‘molecular weight’) expressed in grams. Thus one
moleofhydrogen(H )is2g,onemoleofwater18g, A–istheconjugatebaseoftheweakacidHA;abaseis
2
andonemoleofsodiumhydroxide(NaOH)40g.One ahydrogenionacceptor.
moleofanycovalentlybondedsubstancecontainsthe Theaciddissociationconstant,K a ,istheratioofthe
samenumberofmolecules,6.023×1023 tobeprecise concentrations,
(Avogadro’snumber).Thus6.023×1023H molecules
2 [H+][A–]/[HA]
are found in 2 g of hydrogen, and 6.023×1023 water
moleculesin18gofwater.Onemoleoftheionicsolid atequilibrium.ThebiggerthevalueofK ,thestronger
a
NaOHwillcontain6.023×1023Na+ionsandthesame the acid. Values of K are affected by temperature.
a
numberofOH–ions. AnothertermoftenusedispK ,
a
Whereasmolesareamounts,molarityisaconcentra-
pK =–log K
tion.Solutionconcentrationsareusuallyexpressedin a 10 a
molartermsbecausethisrelatestotheactualnumber Thus,thehigherK ,thesmallerispK .
a a
ofionsormoleculespresentinthesolution.Amolar Mixtures of weak acids and their conjugate bases
solution has one mole of solute (the substance dis- formbuffersolutions;theirpHchangesonlyslightly
solved)presentin1dm3(or1litre)ofsolution.
whenacidoralkali(inmoderateamounts)areadded.
Onemillimole(1mmol)is10–3 moles.Thusamil- Theequationgoverningthebehaviourofbuffersis
limolar(1mM)solutionhas1mmolofsoluteperdm3. theHenderson–Hasselbalchequation:
Onemicromole(1μmol)is10–6 moles.Thusamicro-
molar(1μM)solutionhas1μmoleofsoluteperdm3. pH=pK a +log 10 [base]/[acid]
A1mMsolutionhas1μmolofsolutepercm3(ml).One
Thusifequalamountsofaweakacidanditsconjugate
nanomole (1 nmol) is 10–9 moles. Thus a nanomolar
basearemixed,thepHoftheresultingsolutionequals
(1nM)solutionhas1nmolofsoluteperdm3.A1μM
thepK oftheacid.IfextraH+ isadded,itisbuffered
a
solutionhas1nmolofsolutepercm3(ml).
bymovementoftheequilibrium
A4 pHandpK
HA(cid:2)H++A–
a
The pH of a solution is a measure of its acidity; towardstheleft;ifalkaliisadded,[H+]fallsanditisre-
pH 7.0 is neutral, pH <7 acidic, and pH >7 alkaline. placedbymovementofthereactiontowardstheright.
Most cells operate at pH values at or close to 7.4, Thisistheessenceofbufferaction.

--- Page 761 ---



--- Page 762 ---

References
Chapter1 15. Müller,Metal.(2012)Biochemistryandevolutionof
anaerobicenergymetabolismineukaryotes.Microbiol.
1. Abele,D(2002)Theradicallife-giver.Nature420,27.
Mol.Biol.Rev.76,444.
2. Canfield,DE(2014)Oxygen,afourbillionyearhistory.
PrincetonUniversityPress,NewJersey,USA.
16. Marquis, RE (1995) O2-metabolism, oxidative stress
and acid–base physiology of dental plaque biofilms.
3. Lane, N (2011) The evolution of oxidative stress. In:
J.Indust.Microbiol.15,198.
Principles of Free Radical Biomedicine. Volume 1. Nova
17. Morris,RLandSchmidt,TM(2013)Shallowbreathing:
SciencePublishersInc.,NewYork,USA.
4. Lyons,TW(2007)Oxygen’srisereduced.Nature448,
breathinglifeatlowO2.Nat.Rev.Microbiol.11,205.
18. Meehan, BM and Malamy, MH (2012) Fumarate re-
1005.
ductase is a major contributor to the generation of
5. Lyons,TWetal.(2014)TheriseofO2 inEarth’searly
ROSintheanaerobeBacteroidesfragilis.Microbiol.158,
oceanandatmosphere.Nature506,307.
539.
6. Latifi,Aetal.(2009)Oxidativestressincyanobacteria.
19. Mukhopadhyay,Aetal.(2007)Cell-wideresponsesto
FEMSMicrobiol.Rev.33,258.
7. Jeltsch,A(2013)O2,epigeneticsignaling,andtheevo- l
o
o
u
w
g
-
h
O
.J
2
.B
ex
ac
p
t
o
er
s
i
u
o
r
l.
e
1
i
8
n
9,
D
59
es
9
u
6
l
.
fovibrio vulgaris Hildenbor-
lutionofearlylife.TrendsBiochem.Sci.38,172.
20. Imlay, JA (2013) The molecular mechanisms and
8. Jiang,YYetal.(2010)HowdoesO2 risedriveevolu-
physiologicalconsequencesofoxidativestress:lessons
tion?CluesfromO2-dependentbiosynthesisofnuclear
fromamodelbacterium.Nat.Rev.Microbiol.11,443.
receptorligands.Biochem.Biophys.Res.Commun.391,
21. Ulrike,Betal.(2014)Myoglobinfunctionsintheheart.
1158.
FreeRadic.Biol.Med.73,252.
9. Payne, JL et al. (2009) Two-phase increase in the
22. Oleksiewicz, U et al. (2011) Cytoglobin: biochemical,
maximum size of life over 3.5 billion years reflects
functionalandclinicalperspectiveofthenewestmem-
biologicalinnovationandenvironmentalopportunity.
beroftheglobinfamily.Cell.Mol.LifeSci.68,3869.
Proc.Natl.Acad.Sci.USA106,24.
23. Forrester,MTandFoster,MW(2012)Protectionfrom
10. Hohmann-Marriott, MF and Blankenship, RE (2011)
nitrosative stress: a central role for microbial flavo-
Evolutionofphotosynthesis.Annu.Rev.PlantBiol.62,
hemoglobin.FreeRadic.Biol.Med.52,1620.
515.
11. Kaiser,Aetal.(2007)Increaseintrachealinvestment
24. Bunn, HF and Poyton, RO (1996) O2 sensing and
molecularadaptationtohypoxia.Physiol.Rev.76,839.
withbeetlesizesupportshypothesisofO2 limitation
25. Smalley,JWetal.(2000)TheperiodontalpathogenPor-
on insect gigantism. Proc. Natl. Acad. Sci. USA 104,
phyromonas gingivalis harnesses the chemistry of the
13198. μ-oxo bishaem of iron protoporphyrin IX to protect
12.
p
M
r
u
iv
n
a
n
ti
s
o
,
n
SE
in
a
g
n
l
d
as
A
sc
rt
u
h
l
u
tu
r,
re
P
v
G
es
(
s
2
e
0
l
0
s
2
f
)
a
S
ci
t
l
a
it
b
a
i
t
li
e
t
s
y
f
o
as
f
t
O
re
2
p
d
ro
e-
-
againstH2O2.FEMSMicrobiol.Lett.183,159.
duciblecelldeathtocorticalneuronsundersimulated
26. Semenza, GL (2014) O2 sensing, HIFs, and disease
pathophysiology.Annu.Rev.Pathol.9,47.
ischemia.Anal.Biochem.306,149.
13. Hill,SSetal.(2003)Plasticizers,antioxidants,andother
27. Kemp,PJandPeers,C(2009)Enzyme-linkedacuteO2
sensing in airway and arterial chemoreceptors. Adv.
contaminants found in air delivered by PCV tubing
Exp.Med.Biol.648,39.
used in respiratory therapy. Biomed. Chromatogr. 17,
28. Hamanaka,RBandChandel,NS(2009)Mitochondrial
250.
ROSregulatehypoxicsignaling.Curr.Opin.CellBiol.
14. Selby,Cetal.(1996)Inhibitionofsomaticembryomat-
21,894.
urationinSitkaspruce[Piceasitchensis(Bong.)Carr.]by
29. Picard,Metal.(2011)Mitochondria:isolation,structure
BHT,avolatileantioxidantreleasedbyparafilm.Plant
andfunction.J.Physiol.589,4413.
CellReports16,192.
707

--- Page 763 ---

708 REFERENCES
30. Kowald,AandKirkwoodTBL(2011)Evolutionofthe 51. Meyhoff,CSetal.(2012)RationaluseofO2inmedical
mitochondrialfusion-fissioncycleanditsroleinaging. diseaseandanesthesia.Curr.Opin.Anesthesiol.25,363.
Proc.Natl.Acad.Sci.USA108,10237. 52. Berenbrink,Metal.(2005)EvolutionofO2secretionin
31. Muramoto,Ketal.(2010)Bovinecytochromecoxidase fishesandtheemergenceofacomplexphysiological
structures enable O2 reduction with minimization of system.Science307,1752.
ROSandprovideaproton-pumpinggate.Proc.Natl. 53. Lehr, HA et al. (1999) Do vitamin E supplements in
Acad.Sci.USA107,7740. diets for laboratory animals jeopardize findings in
32. Friedman, JR and Nunnari, J (2014) Mitochondrial animalmodelsofdisease?FreeRadic.Biol.Med.26,472.
formandfunction.Nature505,335. 54. Haugaard, N (1968) Cellular mechanisms of O2 tox-
33. Meimaridou,Eetal.(2012)MutationsinNNTencod- icity.Physiol.Rev.48,311.
ing nicotinamide nucleotide transhydrogenase cause 55. Liochev,SIandFridovich,I(1993)Modulationofthe
familialglucocorticoiddeficiency.Nat.Genet.44,740. fumarases of E. coli in response to oxidative stress.
34. deGroot,HandLittauer,A(1989)Hypoxia,reactive Arch.Biochem.Biophys.301,379.
O2andcellinjury.FreeRadic.Biol.Med.6,541. 56. Morton RL et al. (1998) Loss of lung mitochondrial
35. Guengerich,FPandCheng,Q(2011)Orphansinthe aconitaseactivityduetohyperoxiainbronchopulmon-
human cytochrome P450 superfamily: approaches to arydysplasiainprimates.Am.J.Physiol.274,L127.
discoveringfunctionsandrelevanceinpharmacology. 57. Takumi,Setal.(2008)O2inducesmutationinastrict
Pharmacol.Rev.63,684. anaerobe, Prevotella melaninogenica. Free Radic. Biol.
36. Lai,WandShaik,S(2011)CanFe(III)-O
•–actasapo-
Med.44,1857.
2
tentialoxidantinP450cam?QM/MMinvestigationof 58. Chavko,Metal.(2003)Relationshipbetweenprotein
hydroxylation,epoxidation,andsulfoxidation.J.Am. nitrationandoxidationanddevelopmentofhyperoxic
Chem.Soc.133,5444. seizures.NitricOxide9,18.
37. Halliwell,B(1984)ChloroplastMetabolism.OxfordUni- 59. Gu, XL et al. (2003) Hyperoxia induces retinal vas-
versityPress,Oxford. cularendothelialcellapoptosisthroughformationof
38. Balentine,JD(1982)PathologyofO2Toxicity.Academic ONOO–.Am.J.Physiol.285,C546.
Press,NewYork. 60. Carnesecchi,Setal.(2009)NOX-1playsacrucialrole
39. Berner,RAetal.(2007)O2andevolution.Science316, in hyperoxia-induced acute lung injury in mice. Am.
557. J.Respir.Crit.CareMed.180,972.
40. Gray,JMetal.(2004)O2 sensationandsocialfeeding 61. Fukumoto,Jetal.(2013)NLRP3deletionprotectsfrom
mediatedbyaC.elegansguanylatecyclasehomologue. hyperoxia-induced acute lung injury. Am. J. Physiol.
Nature430,317. 305,C182.
41. Harrison,JFetal.(2010)AtmosphericO2levelandthe 62. Gröger,Metal.(2009)DNAdamageafterlong-term
evolutionofinsectbodysize.Proc.R.Soc.B.277,1937. repetitivehyperbaricO2exposure.J.Appl.Physiol.106,
42. Beerling, DJet al. (1998) The influence of carbonifer- 311.
ous palaeoatmospheres on plant function: an experi- 63. vonSonntag,C(1987)TheChemicalBasisofRadiation
mentalandmodellingassessment.Phil.Trans.R.Soc. Biology.Taylor&Francis,London.
353,131. 64. Krabicka, J et al. (2011) Profiling and characteriza-
43. Gilbert,DL(ed)(1981)O2andLivingProcesses:anInter- tion of flame radicals by combining spectroscopic
disciplinaryApproach.Springer,NewYork. imaging and neural network techniques. IEEE T.
44. Thom,SRetal.(2006)Stemcellmobilizationbyhyper- InstrumentationandMeasurement.60,1854.
baricO2.AmJ.Physiol.290,H1378. 65. Symons, MCR (1996) Radicals generated by bone
45. Demchenko,ITetal.(2011)Autonomicactivationlinks cuttingandfracture.FreeRadic.Biol.Med.20,831.
CNSO2toxicitytoacutecardiogenicpulmonaryinjury. 66. Molina, MDC and Anchordoquy, TJ (2008) Formu-
Am.J.Physiol.300,L102. lation strategies to minimize oxidative damage in
46. Deneke, SM and Fanburg, BL (1980) Normobaric O2 lyophilized lipid/DNA complexes during storage.
toxicityofthelung.N.Engl.J.Med.303,76. J.Pharm.Sci.97,5089.
47. Santos, G et al. (2006) Negative regulation of 67. Imlay, JA (2011) Redox pioneer: Professor Irwin
SOD-1promoterbythyroidhormone.Mol.Pharmacol. Fridovich.Antioxid.RedoxSignal.14,335.
70,793. 68. Harrison, R (2004) Physiological roles of XOR. Drug
48. Fu,Yetal.(2013)Testosteroneenhancestubuloglom- Metab.Rev.36,363.
erular feedback by increasing O
•–
production in the 69. Cantu-Medellin, N and Kelley, EE (2013) XOR-
2
maculadensa.Am.J.Physiol.304,R726. catalyzedreactionofNO– toNO • :insightsregarding
2
49. Tasman, W et al. (2006) ROP: the life of a lifetime where,whenandhow.NitricOxide34,19.
disease.Am.J.Ophthalmol.141,167. 70. Rifkind,JMetal.(2004)Redoxreactionsofhemoglobin.
50. Saugstad,OD(2012)Hyperoxiainthetermnewborn: Antioxid.RedoxSignal.6,657.
moreevidenceisstillneededforoptimalO2 therapy. 71. Aranda, R et al. (2009) Structural analysis of fish
ActaPaediatricaSuppl101,34. versus mammalian hemoglobins: effect of the heme

--- Page 764 ---

REFERENCES 709
pocketenvironmentonautooxidationandheminloss. (arNOX)proteinsasmembersoftheTM9superfamily
Proteins75,217. oftransmembraneproteins.Adv.Biol.Chem.3,187.
72. Winterbourn,CCetal.(1976)ReactionsinvolvingO
•–
89. Korshunov, S and Imlay, JA (2010) Two sources of
2
and normal and unstable haemoglobins. Biochem. J. endogenousH2O2inE.coli.Mol.Microbiol.75,1389.
155,493. 90. Stacy, A et al. (2014) Bacterial fight-and-flight re-
73. Bonaventura,Cetal.(1999)Internalelectrontransfer sponses enhance virulence in a polymicrobial
betweenhemesandCu(II)boundatcysteineβ93pro- infection.Proc.Natl.Acad.Sci.USA111,7819.
motesmethemoglobinreductionbyCO.J.Biol.Chem. 91. Boles,BRandSinghPK(2008)Endogenousoxidative
274,5499. stress produces diversity and adaptability in biofilm
74. Duncan, C et al. (1997) Protection against oral and communities.Proc.Natl.Acad.Sci.USA105,12503.
gastrointestinal diseases: importance of dietary NO– 92. Cˇáp, M et al. (2012) ROS in the signaling and adap-
3
intake, oral NO– reduction and enterosalivary NO– tation of multicellular microbial communities. Oxid.
3 3
circulation.Comp.Biochem.Physiol.118A,939. Med.Cell.Longev.2012,ArticleID976753.
75. Figueira,TRetal.(2013)Mitochondriaasasourceof 93. Carlsson, J et al. (1978) H2O2 and O •
2
– formation in
RONS:frommolecularmechanismstohumanhealth. anaerobic broth media exposed to atmospheric O2.
Antioxid.RedoxSignal.18,2029. Appl.Env.Microbiol.36,223.
76. Freeman, BA and Crapo, JD (1981) Hyperoxia in- 94. De Spiegeleer, P et al. (2004) Source of tryptone in
creases O2 radical production in rat lungs and lung growth medium affects oxidative stress in E.coli.
mitochondria.J.Biol.Chem.256,10986. J.Appl.Microbiol.97,124.
77. Park, JI et al. (1998) The cytoplasmic CuZnSOD of 95. Halliwell, B (2014) Cell culture, oxidative stress, and
S. cerevisiae is required for resistance to freeze–thaw antioxidants:avoidingpitfalls.Biomed.J.37,99.
stress.J.Biol.Chem.273,22921. 96. Du, L et al. (2004) Innate gender-based proclivity in
78. Giulivi,Cetal.(1999)Thesteady-stateconcentrations response to cytotoxicity and programmed cell death
of O2 radicals in mitochondria. In: ROS in Biological pathway.J.Biol.Chem.279,38563.
Systems.KluwerAcademic,PlenumPressPublishers, 97. Schaffer,Setal.(2014)VariabilityinAPOEgenotype
NewYork,USA. statusinhuman-derivedcelllines:acauseforconcern
79. Li, N et al. (2003) Mitochondrial complex I inhibi- incellculturestudies.GenesNutr.9,364.
tor rotenone induces apoptosis through enhancing 98. Barker,CWetal.(1994)Down-regulationofP4501A1
mitochondrialROSproduction.J.Biol.Chem.278,8516. and P4501A2 mRNA expression in isolated hep-
80. Wang,Xetal.(2012)O
•–
flashes:elementaleventsof atocytes by oxidative stress. J. Biol. Chem. 269,
2
mitochondrialROSsignalingintheheart.J.Mol.Cell. 3985.
Cardiol.52,940. 99. Jose,Cetal.(2013)Mitoplasticity:adaptationbiology
81. Barja, G (1999) Mitochondrial O2 radical generation of the mitochondrion to the cellular redox state in
and leak: sites of production in state 4 and 3, or- physiologyandcarcinogenesis.Antioxid.RedoxSignal.
gan specificity, and relation to aging and longevity. 18,808.
J.Bioenerg.Biomembr.31,347. 100. Ahn,WSandAntoniewicz,MR(2011)Metabolicflux
82. Starkov,AA(2013)Anupdateontheroleofmitochon- analysis of CHO cells at growth and non-growth
drial αKGDH in oxidative stress. Mol. Cell. Neurosci. phasesusingisotopictracersandmassspectrometry.
55,13. Metab.Eng.13,598.
83. Schwarzlander, M et al. (2014) The ‘mitoflash’ probe 101. Amps, K et al. (2011) Screening ethnically diverse
cpYFPdoesnotrespondtoO
•–.Nature514,E12.
humanembryonicstemcellsidentifiesachromosome
2
84. Minuz, P et al. (2012) Endothelial dysfunction and 20 minimal amplicon conferring growth advantage.
increased oxidative stress in mitochondrial diseases. Nat.Biotech.29,1132.
Clin.Sci.122,289. 102. O’Donnell-Tormey,Jetal.(1987)Secretionofpyruvate.
85. Schönfeld,PandWojtczak,L(2012)BATmitochondria An antioxidant defense of mammalian cells. J. Exp.
oxidizingfattyacidsgeneratehighlevelsofROSirre- Med.165,500.
spectiveoftheUCP-1activitystate.Biochim.Biophys. 103. Yan, H et al. (2010) The O2 tension modulates
Acta.1817,410. acetaminophen-inducedmitochondrialoxidantstress
86. Goeptar,ARetal.(1995)O2 andxenobioticreductase and cell injury in cultured hepatocytes. Toxicol. Sci.
activitiesofcytochromeP450.Crit.Rev.Toxicol.25,25. 117,515.
87. Dostalek, M et al. (2008) Development of oxidative 104. Carrera, S et al. (2010) Protection of cells in physio-
stress by CYP induction in rodents is selective for logical O2 tensions against DNA damage-induced
barbituratesandrelatedtolossofpyridinenucleotide- apoptosis.J.Biol.Chem.285,13658.
dependentprotectivesystems.J.Biol.Chem.283,17147. 105. Halliwell, B (2008) Are polyphenols antioxidants or
88. Tang, X et al. (2013) Molecular cloning and char- pro-oxidants?Whatdowelearnfromcellcultureand
acterization of human age-related NADH oxidase invivostudies?Arch.Biochem.Biophys.476,107.

--- Page 765 ---

710 REFERENCES
Chapter2 20. Johnson,GRetal.(1988)Reactionoftheaquacopper(I)
1. Grhulke,MCandSlusarenko,AJ(2012)Thebiologyof
ionwithH2O2.J.Chem.Soc.FaradayTrans1,84,501.
21. Fukuto, JM et al. (2012) Small molecule signaling
reactivesulfurspecies(RSS).PlantPhysiol.59,98.
agents:theintegratedchemistryandbiochemistryof
2. Koppenol,WHetal.(2012)Peroxynitrousacid:contro-
versyandconsensussurroundinganenigmaticoxid-
nitrogenoxides,oxidesofcarbon,O2,H2S,andtheir
derivedspecies.Chem.Res.Toxicol.25,769.
ant.DaltonTrans.41,13779.
22. Riesz, P et al. (1990) Sonochemistry of volatile and
3. Buettner,GR(1993)Thepeckingorderoffreeradicals
andantioxidants:lipidperoxidation,α-tocopheroland non-volatilesolutesinaqueoussolutions:eprandspin
trappingstudies.Ultrasonics28,295.
ascorbate.Arch.Biochem.Biophys.300,535.
23. Crum,LAetal.(1987)Freeradicalproductioninam-
4. Koppenol,WHetal.(2010)Electrodepotentialsofpar-
nioticfluidandbloodplasmabymedicalultrasound.
tiallyreducedO2species,fromO2toH2O.Free.Radic.
J.UltrasoundMed.6,643.
Biol.Med.49,317.
24. Murano,Netal.(2008)Cornealendothelialcelldam-
5. Abreu,IAandCabelli,DE(2010)SODs–areviewof
agebyfreeradicalsassociatedwithultrasoundoscilla-
the metal-associated mechanistic variations. Biochim.
tion.Arch.Ophthalmol.126,816.
Biophys.Acta1804,263.
25. Gulum,Metal.(2011)SpermDNAdamageandsem-
6. Folkes, LK et al. (1995) Kinetics and mechanisms of
inal oxidative status after shock-wave lithotripsy for
HOClreactions.Arch.Biochem.Biophys.323,120.
distalureteralstones.Fertil.Steril.96,1087.
7. Rush,JDetal.(1996)Reactionofferrate(VI)/ferrate •
(V)withH2O2 andO •
2
– –astopped-flowandpremix 26. Z
tw
h
o
u
-
,
st
B
e
Z
p
e
c
t
he
a
m
l.
i
(
l
2
u
0
m
12
in
)
e
U
sc
n
e
p
n
r
c
e
e
ce
p
d
r
e
o
n
d
t
u
e
c
d
ti
O
on
H
by
-d
p
ep
ol
e
y
n
h
d
a
e
l
n
o
t
-
pulseradiolysisstudy.FreeRadic.Res.24,187.
8. Bielski,BHJandCabelli,DE(1995)Chapter3.In:Foote,
genated quinoid carcinogens and H2O2. Proc. Natl.
Acad.Sci.USA109,16046.
9. C H S al e l t iw al e . l ( l e , d B s) (1 A 9 c 7 ti 8 v ) e O O • 2 2 –- in de C p h e e n m d i e st n r t y. fo B r la m c a k t i i e o , n Lo o n f d O o H n. • 27. R be o t h w re e r e , n F le a v n e d ls B o e f r t r r e o s p h o ei s m ph H eri ( c 20 O 0 H 6) • S r t a r d o i n c g als co a r n r d ela s t o i l o a n r
inthepresenceofFesalts.Itsroleindegradationof
hyaluronicacidbyaO
•–-generatingsystem.FEBSLett. UVradiation.Nature442,184.
2 28. Codorniu-Hernández, E and Kusalik, PG (2012) Mo-
96,238. •
bility mechanism of OH in aqueous solution via H
10. Barnese,Ketal.(2012)Biologicallyrelevantmechanism
for catalyticO
•–
removal by simpleMn compounds.
transfer.J.Am.Chem.Soc.134,532.
2 29. Schäcker,Metal.(1991)OxidationofTristo1-carbon
Proc.Natl.Acad.Sci.USA109,6892.
compounds in a radical-producing model system, in
11. Gutteridge, JM and Bannister, JV (1986) CuZn and
microsomes,inhepatocytesandinrats.FreeRadic.Res.
MnSODs inhibit deoxyribose degradation by the
O • 2 –-driven Fenton reaction at two different stages. 30. M Co e m d m in u a n s . , 1 D 1 B ,3 e 3 t 9 a . l.(2007)TheCO •–radicalandrelated
Biochem.J.234,225. 3
12. Liochev, SI and Fridovich, I (2004) CO2 mediates
o
25
x
5
id
.
antsderivedfromHCO3 - buffer.IUBMBLife59,
Mn(II)-catalyzeddecompositionofH2O2andperoxid- 31. Andrekopoulos, C et al. (2004) HCO •– enhances α-
ationreactions.Proc.Natl.Acad.Sci.USA101,12485. 3
synucleinoligomerizationandnitration:intermediacy
13. r H e a le ll v i a w n e t ll m ,B eta a l n i d on G -d u e tt p e e r n id d g e e n , t J O M H C • ( g 1 e 9 n 9 e 2 r ) a B ti i o o n lo . g A ic n a u ll p y - - ofCO • 3 –andNO • 2 .Biochem.J.378,435
32. Bakhmutova-Albert EV et al. (2010) Kinetics and
date.FEBSLett.307,108.
mechanisms of peroxymonocarbonate formation. In-
14. Walling, C (1998) Intermediates in the reactions of
org.Chem.49,11287.
Fentontypereagents.Acc.Chem.Res.31,155.
33. Möller, MT et al. (2012) O
•–
reaction with tyrosyl
15. Burkitt, MJ (2003) Chemical, biological, and medical 2
radicalsgeneratepara-hydroperoxyandpara-hydroxy
controversies surrounding the Fenton reaction. Prog.
derivativesoftyrosine.J.Am.Chem.Soc.134,16773.
React.Kinet.Mech.28,75.
16. Gutteridge, JMC (1990) O
•–-dependent
formation of
34. Oakley,FDetal.(2009)Signalingcomponentsofredox
• 2 active endosomes: the redoxosomes. Antioxid. Redox
OH fromFe(III)complexesandH2O2:anevaluation
Signal.11,1313.
of14ironchelators.FreeRadic.Res.Commun.9,119.
35. Konya,KGetal.(2000)Laserflashphotolysisstudies
17. Gutteridge, JMC et al. (1990) ADP-Fe as Fenton re-
onthefirstO
•–thermalsource.J.Am.Chem.Soc.122,
actant:radicalreactionsdetectedbyspintrapping,H 2
7518.
abstractionandaromatichydroxylation.Arch.Biochem.
36. Dietzel,PDCetal.(2004)TetraorganylammoniumO
•–
Biophys.277,422.
compounds: close to unperturbed O
•–
in the soli
2
d
18. Shimon,MBetal.(1998)SpecificCu2+-catalyzedoxi- 2
state.J.Am.Chem.Soc.126,4689.
dative cleavage of Na, K-ATPase at the extracellular
37. Heller,MLandCrootPL(2010)ApplicationofaO
•–
surface.J.Biol.Chem.273,51. 2
• thermal source (SOTS-1) for the determination and
19. Eberhardt, MK (1995) OH . Formation and some re-
actions used in its identification. Trends Org. Chem.
calibrationofO2 - fluxesinseawater.Anal.Chim.Acta
667,1.
5,115.

--- Page 766 ---

REFERENCES 711
38. Jones, CM et al. (2002) EPR spin trapping investiga- 57. Luo, S and Weh, NB (2009) Protein carbonylation:
tion into the kinetics of GSH oxidation by O
•–:
re- avoidingpitfallsinthe2,4-dinitrophenylhydrazineas-
2
evaluationoftherateconstant.FreeRadic.Biol.Med.32, say.RedoxRep.14,159.
982. 58. Toledo, JS Jr and Augusto, O (2012) Connecting the
•
39. Learman,DRetal.(2011)FormationofMnoxidesby chemicalandbiologicalpropertiesofNO .Chem.Res.
bacteriallygeneratedO
•–.Nat.Geosci.4,95.
Toxicol.25,975.
2
40. Sawyer,DTandValentine,JS(1981)HowsuperisO
•–?
59. Irvine,JCetal.(2008)Nitroxyl(HNO):theCinderella
2
•
Acc.Chem.Res.14,393. oftheNO story.TrendsPharmacol.Sci.29,601.
41. Sugimoto, H et al. (1987) Oxygenation of polychloro 60. Halliwell,Betal.(1999)NO • andONOO–.Theugly,
aromatichydrocarbonsbyO
•–inaproticmedia.J.Am.
theuglierandthenotsogood.FreeRadic.Res.31,651.
2
Chem.Soc.109,8081. 61. Gorbunov, NV et al. (1995) Reduction of ferrylmyo-
42. Black, R et al. (2012) Screening for O
•–reactivity
in globin and ferrylhemoglobin by NO
•
: a protective
2
Li-O2 batteries:effectonLi2O2/LiOHcrystallization. mechanismagainstferrylhemoprotein-inducedoxid-
J.Am.Chem.Soc.134,2902. ations.Biochemistry34,6689.
•
43. VonSonntag,C(1987)TheChemicalBasisofRadiation 62. Serafim,RAMetal.(2012)NO :stateoftheartindrug
Biology.TaylorandFrancis,London. design.Curr.Med.Chem.19,386.
•
44. Folkes,LKetal.(2011)Kineticsofreductionoftyr-O 63. Feng,C(2012)MechanismofNOSregulation:electron
radicalsbyGSH.Arch.Biochem.Biophys.506,242. transfer and interdomain interactions. Coord. Chem.
45. Zhu,BZetal.(2007)Mechanismofmetal-independent Rev.256,393.
decompositionoforganichydroperoxidesandforma- 64. Rafikov,Retal.(2011)eNOSactivationandNOfunc-
tionofalkoxylradicalsbyhalogenatedquinones.Proc. tion: structural motifs responsible for the posttrans-
Natl.Acad.Sci.USA104,3698. lational control of eNOS activity. J. Endocrinol. 210,
46. Morita, M et al. (2012) Fatty liver induced by free 271.
radicalsandlipidperoxidation.FreeRadic.Res.46,758. 65. Dweik,RA(2005)NO
•
,hypoxiaandO
•–;thegood,the
2
47. Soriani,Metal.(1994)Antioxidantpotentialofanaer- bad,andtheugly!Thorax60,265.
obichumanplasma:roleofserumalbuminandthiols 66. Robinson, MA et al. (2011) O2-dependent regulation
• •
asscavengersofC .Arch.Biochem.Biophys.312,180. ofNO productionbyiNOS.FreeRadic.Biol.Med.51,
48. Paul, T et al. (2000) Strand cleavage of supercoiled 1952.
DNAbywater-solubleRO
•
.Theoverlookedimport- 67. Pasto,Metal.(2001)Nasalpolyp-derivedO
•–:dose-
• 2 2
anceofRO charge.Biochemistry39,4129. dependent inhibition by NO and pathophysiological
2
49. Arenas,Aetal.(2012)Chemicalmodificationoflyso- implications.Am.J.Resp.Crit.CareMed.163,145.
zyme,G6PDH,andbovineeyelensproteinsinduced 68. Gross, TJ et al. (2014) Epigenetic silencing of the hu-
•
byRO radicals:roleofoxidizableaminoacidresidues. manNOS2gene:rethinkingtheroleofNOinhuman
2
Chem.Res.Toxicol.26,67. macrophageinflammatoryresponses.J.Immunol.192,
50. Aruoma,OIetal.(1995)Reactionofplant-derivedand 2326.
•
syntheticantioxidantswithCC13O
2
.FreeRadic.Res.22, 69. Roe,NDandRenJ(2012)NOSuncoupling:athera-
187. peutictargetincardiovasculardiseases.Vascul.Phar-
51. Symons,MCR(1996)Radicalsgeneratedbybonecut- macol.57,168.
tingandfracture.FreeRadic.Biol.Med.20,831. 70. Caplin,BandLeiper,J(2012)EndogenousNOSinhibi-
52. MozziconacciO,etal.(2012)IntramolecularHtransfer torsinthebiologyofdisease:markers,mediators,and
•
reactionsofthiylradicalsfromGSH:formationofC regulators?Arterioscler.Thromb.Vasc.Biol.32,1343.
•
atGlu,Cys,andGly.Chem.Res.Toxicol.25,1842. 71. Abu-Soud,HMandHazen,SL(2000)NO isaphysio-
53. Saez, G et al. (1982) The production of free radicals logical substrate for mammalian peroxidases. J. Biol.
duringtheautoxidationofcysteineandtheireffecton Chem.275,37524.
isolatedrathepatocytes.Biochim.Biophys.Acta719,24. 72. Vernia,Setal.(2001)Differentialsensitivityofrathep-
•
54. Long,LHandHalliwell,B(2001)Oxidationandgener- atocyteCYPisoformstoself-generatedNO .FEBSLett.
ationofH2O2bythiolcompoundsincommonlyused 488,59.
cellculturemedia.Biochem.Biophys.Res.Commun.268, 73. Liu,XPetal.(2013)DifferencesinO2-dependentNO
991. metabolismbycytoglobinandmyoglobinaccountfor
55. Munday,Retal.(2004)InhibitionofCu-catalyzedcyst- theirdifferingfunctionalroles.FEBSJ.280,3621.
•
eineoxidationbynMconcentrationsofFesalts.Free 74. Pearce, LL et al. (2002) The catabolic fate of NO .
Radic.Biol.Med.36,757. TheNO • oxidaseandONOO– reductaseactivitiesof
56. Johnston,PA(2011)Redoxcyclingcompoundsgener- cytochromeoxidase.J.Biol.Chem.277,13556.
ate H2O2 in HTS buffers containing strong reducing 75. Castiglione,Netal.(2012)NO–
2
andNO–
3
reductases:
reagents–realhitsorpromiscuousartifacts.Curr.Opin. frommolecularmechanismstosignificanceinhuman
Chem.Biol.15,174. healthanddisease.Antioxid.RedoxSignal.17,684.

--- Page 767 ---

712 REFERENCES
76. Lundberg,JOandWeitzberg,E(2013)BiologyofNOx 95. Crow, JP et al. (1997) SOD catalyzes nitration of tyr-
intheGItract.Gut62,616. osines by ONOO– in the rod and head domains of
•
77. Skibsted, LH (2011) NO and quality and safety of neurofilament-L.J.Neurochem.69,1945.
musclebasedfood.NitricOxide24,176. 96. Alvarez, B et al. (2004) Inactivation of human
78. Kevil,CGetal.(2011)InorganicNO–therapy:historical CuZnSODbyONOO-andformationofhistidinylrad-
2
perspectiveandfuturedirections.FreeRadic.Biol.Med. ical.FreeRadic.Biol.Med.37,813.
51,576. 97. Yamakura, F et al. (2005) Nitrated and oxidized
79. Carlström,Metal.(2011)DietaryNO–attenuatesoxi- products of a single tryptophan residue in hu-
3
dativestress,preventscardiacandrenalinjuries,and man CuZnSOD treated with either ONOO–-CO2 or
reducesbloodpressureinsalt-inducedhypertension. MPO-H2O2-NO–
2
.J.Biochem.138,57.
Cardiovasc.Res.89,574. 98. Eiserich, JP et al. (1999) Microtubule dysfunction
80. Whiteman, M et al. (2003) NO–-mediated protection byposttranslationalnitrotyrosinationofα-tubulin:A
2
•
against HOCl-induced chondrocyte toxicity: a novel NO -dependent mechanism of cellular injury. Proc.
•
cytoprotectiveroleofNO intheinflamedjoint?Arth- Natl.Acad.Sci.USA96,6365.
ritis.Rheum.48,3140. 99. Jones,LH(2012)Chemistryandbiologyofbiomolecule
81. Ferrer-Sueta,GandRadiR(2012)Chemicalbiologyof nitration.Chem.Biol.19,1086.
ONOO-: kinetics, diffusion, and radicals. ACS Chem. 100. Smallwood,HSetal.(2007)Identificationofadenitrase
Biol.4,161. activityagainstcalmodulininactivatedmacrophages
82. Eiserich, JP et al. (1996) Formation of nitrating and using high-field liquid chromatography–FTICR mass
chlorinating species by reaction of NO– with HOCl. spectrometry.Biochemistry.46,10498.
2
J.Biol.Chem.271,19199. 101. Trostchansky, A et al. (2013) Nitro-fatty acids: for-
•
83. Wink,DAetal.(1996)TheeffectofvariousNO -donor mation, redox signaling, and therapeutic potential.
agentsonH2O2-mediatedtoxicity.Arch.Biochem.Bio- Antioxid.RedoxSignal.19,1257.
phys.331,241. 102. Tsikas,Detal.(2011)Oxidizedandnitratedoleicacid
•
84. Kotamraju,Setal.(2003)NO inhibitsH2O2-induced inbiologicalsystems:analysisbyGC-MS/MSandLC-
transferrinreceptor-dependentapoptosisinendothe- MS/MS,andbiologicalsignificance.Biochim.Biophys.
lialcells:roleofubiquitin-proteasomepathway.Proc. Acta.1811,694.
Natl.Acad.Sci.USA100,10653. 103. Skinner, KA et al. (1998) Nitrosation of uric acid by
85. Keynes,RGetal.(2003)O •–-dependentconsumption ONOO–.FormationofavasoactiveNO • donor.J.Biol.
2
•
of NO in biological media may confound in vitro Chem.273,24491.
experiments.Biochem.J.369,399. 104. Murray,Jetal.(2003)Oxidativedamagetomitochon-
86. Radi,R(2013)Proteintyrosinenitration:biochemical drial complex I due to ONOO–. J. Biol. Chem. 278,
mechanismsandstructuralbasisoffunctionaleffects. 37223.
Acc.Chem.Res.46,550. 105. Stachowiak,Oetal.(1998)Mitochondrialcreatinekin-
87. Surmeli,NSetal.(2010)ONOO– mediatesactivesite aseisaprimetargetofONOO–inducedmodification
tyrosine nitration in MnSOD. Evidence of a role for andinactivation.J.Biol.Chem.273,16694.
CO
•–.J.Am.Chem.Soc.132,17174.
106. Whiteman, M and Halliwell, B (1997) Thiourea
3
88. He,Cetal.(2010)Enhancedtyrosinenitrationofpros- andDMTUinhibitONOO–-dependentdamage:non-
•
tacyclinsynthaseisassociatedwithincreasedinflam- specificityasOH scavengers.FreeRadic.Biol.Med.22,
mation in atherosclerotic carotid arteries from type 1309.
2diabeticpatients.Am.J.Pathol.176,2542. 107. Zhang, Y and Rosenberg, PA (2004) Caspase-1 and
89. Castro, L et al. (2011) Mitochondrial protein tyrosine PARPinhibitorsmayprotectagainstONOO–-induced
nitration.FreeRadic.Res.45,37. neurotoxicity independent of their enzyme inhibitor
90. Swain,JAetal.(1994)ONOO–releasesCufromcaer- activity.Eur.J.Neurosci.20,1727.
uloplasmin:implicationsforatherosclerosis.FEBSLett. 108. Puiffe,MLetal.(2013)Antibacterialpropertiesofthe
342,49. mammalianL-aminoacidoxidaseIL4I1.PLoSOne,8,
91. Martinez,Metal.(2012)Nitratedfibrinogenisabio- e54589.
marker of oxidative stress in venous thromboembol- 109. Ehara,Tetal.(2002)Antimicrobialactionofachacinis
ism.FreeRadic.Biol.Med.53,230. mediatedbyL-aminoacidoxidaseactivity.FEBSLett.
92. Ji,Yetal.(2006)Nitrationoftyrosine92mediatesthe 531,509.
activationofratmicrosomalGSTbyONOO–.J.Biol. 110. Kwakman,PHSandZaa,SAJ(2012)Antibacterialcom-
Chem.281,1986. ponentsofhoney.IUBMBLife64,48.
93. Goldstein, S and Czapski, G (2000) Reactivity of 111. Lu,Jetal.(2013)TheeffectofNewZealandkanuka,
ONOO– versussimultaneousgenerationof • NOand manuka and clover honeys on bacterial growth dy-
O
•–towardNADH.Chem.Res.Toxicol.13,736.
namics and cellular morphology varies according to
2
94. Kaur,Hetal.(1997)ONOO–-dependentaromatichy- thespecies.PLoSOne8,e55898.
droxylationandnitrationofsalicylateandphenylan- 112. Halliwell, B (2014) Cell culture, oxidative stress, and
•
ine.IsOH involved?FreeRadic.Res.26,71. antioxidants:avoidingpitfalls.Biomed.J.37,99.

--- Page 768 ---

REFERENCES 713
113. Mahns, A et al. (2003) Irradiation of cells with UVA 131. Glaser, CB et al. (1992) Oxidation of a specific me-
(320–400nm)inthepresenceofcellculturemedium thionine in thrombomodulin by activated neutrophil
elicitsbiologicaleffectsduetoextracellulargeneration products blocks cofactor activity. J. Clin. Invest. 90,
ofH2O2.FreeRadic.Res.37,391. 2565.
114. Daniels, V (1984) The Russell effect - a review of its 132. Hawkins, CL et al. (2002) O
•–
can act synergistically
2
possibleusesinconservationandthescientificexam- with OCl– to induce damage to proteins. FEBS Lett.
inationofmaterials.Stud.Conserv.29,57. 510,41.
115. King,DWetal.(2007)FlowinjectionanalysisofH2O2 133. Fliss, H and Menard, M (1991) HOCl-induced mo-
innaturalwatersusingacridinumesterchemilumines- bilization of Zn from metalloproteins. Arch. Biochem.
cence:methoddevelopmentandoptimizationusinga Biophys.287,175.
kineticmodel.Anal.Chem.79,4169. 134. Talib, J et al. (2014) The smoking-associated oxidant
116. Li, C et al. (2006) Identification of oxidized me- hypothiocyanousacidinduceseNOSdysfunction.Bio-
thionine sites in erythrocyte membrane protein by chem.J.457,89.
LC/electrosprayionizationMSpeptidemapping.Bio- 135. Rees, MD et al. (2010) MPO-derived oxidants select-
chemistry45,12117. ively disrupt the protein core of the heparin sulfate
117. Halliwell, B et al. (2004) Establishing biomarkers of proteoglycanperlecan.MatrixBiol.29,63.
oxidativestress.ThemeasurementofH2O2inhuman 136. Maitra,Detal.(2011)MechanismofHOCl-mediated
urine.Curr.Med.Chem.11,1085. hemedestructionandfreeironrelease.FreeRadic.Biol.
118. Mishra, S and Imlay, J (2012) Why do bacteria use Med.51,364.
so many enzymes to scavenge H2O2? Arch. Biochem. 137. Spencer,JPetal.(2000)NO–
2
-induceddeaminationand
Biophys.525,145. OCl–-inducedoxidationofDNAinintacthumanre-
119. Pedroso, Netal.(2009)Modulationofplasmamem- spiratorytractepithelialcells.FreeRad.Biol.Med.28,
brane lipid profile and microdomains by H2O2 in S. 1039.
cerevisiae.FreeRadic.Biol.Med.46,289. 138. Rayner,BS,Love,DT,andHawkins,CL(2014)Com-
120. Sies, H (2014) Role of metabolic H2O2 generation: parative reactivity of MPO-derived oxidants with
redoxsignallingandoxidativestress.J.Biol.Chem.289, mammaliancells.FreeRadic.Biol.Med.71,240.
8735. 139. Pattison,DIandDaviesMJ(2005)Kineticanalysisof
121. Calderón,ILetal.(2011)ResponseregulatorArcAof the role of histidine chloramines in HOCl mediated
SalmonellaentericserovarTyphimuriumdownregulates proteinoxidation.Biochemistry44,7378.
•
expression of OmpD, a porin facilitating uptake of 140. Ezell,MJetal.(2002)KineticsofreactionsofCl with
H2O2.Res.Microbiol.162,214. aseriesofalkenesat1atmand298K:structureand
122. Schmidl,SRetal.(2011)AtriggerenzymeinM.pneu- reactivity.Phys.Chem.Chem.Phys.4,5813.
moniae:impactoftheglycerophosphodiesteraseGlpQ 141. Foote, CS et al. (eds) (1995) Active O2 in Chemistry.
on virulence and gene expression. PLoS Pathogens 7, Blackie,London.
e1002263. 142. Puy,Hetal.(2010)Porphyrias.Lancet375,924.
123. Hoffmann,OMetal.(2007)BacterialH2O2contributes 143. Song,Jetal.(2012)Thephotocytotoxicityofdifferent
to cerebral hyperemia during early stages of experi- lightsonmammaliancellsininteriorlightingsystem.
mentalpneumococcalmeningitis.J.Cereb.BloodFlow J.Photochem.Photobiol.B117,13.
Metab.27,1792. 144. Fujishima,Aetal.(2008)TiO2 photocatalysisandre-
124. Jansen, WTM et al. (2002) H2O2-mediated killing of latedsurfacephenomena.Surf.Sci.Rep.63,515.
C.elegansbyStreptococcuspyogenes.Infect.Immun.70, 145. Andersen,CMetal.(2008)Wavelengthdependenceof
5202. light-inducedlipidoxidationandnaturallyoccurring
125. Spencer, JPE et al. (1995) DNA damage in human photosensitizersincheese.J.Agric.FoodChem.56,1611.
respiratorytractepithelialcells.FEBSLett.375,179. 146. Santoro,FAandLimHW(2011)Updateonphotoder-
126. Ghouleh, IA et al. (2013) Aquaporin 1, Nox1, and matoses.Semin.Cutan.Med.Surg.30,229.
Ask1mediateoxidant-inducedsmoothmusclecellhy- 147. Campbell,WMetal.(2010)Photodynamicchlorophyll
pertrophy.Cardiovasc.Res.97,134. ametabolites,includingphytoporphyrin(phylloeryth-
127. Hannum, DM et al. (1995) Subunit sites of oxidative rin),inthebloodofphotosensitivelivestock:overview
inactivation of E. coli F1-ATPase by HOCl. Biochem. andmeasurement.NZVet.J.58,146.
Biophys.Res.Commun.212,868. 148. Scheie, E et al. (2003) Spectrofluorometric analysis of
128. Weiss,SJ(1989)Tissuedestructionbyneutrophils.N. phylloerythrin(phytoporphyrin)inplasmaandtissues
Engl.JMed.320,365. fromsheepsufferingfromfacialeczema.NZVetJ.51,
129. Beal,JLetal.(2009)HOClreactswiththeN-terminal 104.
methioninesofproteinstogivedehydromethionine,a 149. TavcˇarBenkovic´,Eetal.(2014)Isolation,analysisand
potentialbiomarkerforneutrophil-inducedoxidative structures of phototoxic fagopyrins from buckwheat.
stress.Biochemistry48,11142. FoodChem.143,432.
130. Moreno,JJandPryor,WA(1992)Inactivationofα 1P 150. Mreihil,Ketal.(2010)Earlyisomerizationofbilirubinin
inhibitorbyONOO–.Chem.Res.Toxicol.5,425. phototherapyofneonataljaundice.Pediatr.Res.67,656.

--- Page 769 ---

714 REFERENCES
151. Archier, E et al. (2012) Carcinogenic risks of psor- 6. Dopico-García,MSetal.(2007)Antioxidantcontentof
alenUV-AtherapyandnarrowbandUV-Btherapyin and migration from commercial polyethylene, poly-
chronicplaquepsoriasis:asystemicliteraturereview. propylene,andPVCpackages.J.Agric.Food.Chem.55,
J.Eur.Acad.Dermatol.Venereol.Suppl.26,22. 3225.
152. Ogura, S et al. (2012) Improvement of tumor local- 7. Canfield,DE(2014)Oxygen,afourbillionyearhistory,
izationofphotosensitizersforphotodynamictherapy PrincetonUniversityPress.
anditsapplicationfortumordiagnosis.Curr.Top.Med. 8. Alquéres, SM et al. (2010) Antioxidant pathways are
Chem.12,176. up-regulatedduringbiologicalN2 fixationtoprevent
153. Miyamoto,Setal.(2009)Directevidenceof1O2 gen- ROS-inducednitrogenaseinhibitioninGluconacetobac-
erationfromperoxynitrate,adecompositionmodelof terdiazotrophicus.Arch.Microbiol.192,835.
ONOO–.DaltonTrans.2009,5720. 9. Oelze, J (2000) Respiratory protection of nitrogenase
154. Wagner,JRetal.(1993)Theoxidationofbloodplasma in Azotobacter species: is a widely held hypothesis
and LDL components by chemically generated 1O2. unequivocally supported by experimental evidence?
J.Biol.Chem.268,18502. FEMSMicrobiol.Rev.24,321.
155. Qi,YBetal.(2012)Photo-induciblecellablationinC. 10. Oh,Jetal.(2014)Stemcellaging:mechanisms,regu-
elegansusingthegeneticallyencoded1O2 generating lators and therapeutic opportunities. Nat. Med. 20,
proteinminiSOG.Proc.Natl.Acad.Sci.USA109,7499. 870.
156. Bulina, ME et al. (2006) Chromophore-assisted light 11. Urao,NandUshio-Fukai,M(2013)Redoxregulation
inactivation (CALI) using the phototoxic fluorescent ofstem/progenitorcellsandbonemarrowniche.Free
proteinKillerRed.Nat.Protoc.1,947. Radic.Biol.Med.54,26.
157. Miliordos,EandXantheas,SS(2014)Onthebonding 12. Estrada,JCetal.(2012)Cultureofhumanmesenchy-
natureofO3anditsS-substitutedanaloguesSO2,OS2, mal stem cells at low O2 tension improves growth
and S3: correlation between their biradical character andgeneticstabilitybyactivatingglycolysis.CellDeath
andmolecularproperties.J.Am.Chem.Soc.136,2808. Diff.19,743.
158. Lloyd, JA et al. (2006) Peptide ozonolysis: product 13. LeBelle,JEetal.(2011)Proliferativeneuralstemcells
structuresandrelativereactivitiesforoxidationoftyro- have high endogenous ROS levels that regulate self-
sineandhistidineresidues.J.Am.Soc.MassSpectrom. renewal and neurogenesis in a PI3K/Akt-dependent
17,1289. manner.CellStemCell8,5.
159. Cohen, SL (2006) O3 in ambient air as a source of 14. Fridovich,I(1995)SuperoxideradicalandSODs.Ann.
adventitious oxidation. A mass spectrometric study. Rev.Biochem.64,97.
Anal.Chem.78,4352. 15. Sheng,Yetal.(2014)SODsandSORs.Chem.Rev.114,
160. Frischer, Th et al. (1997) Aromatic hydroxylation in 3854.
nasallavagefluidfollowingambientO3exposure.Free 16. Lane,N(2002)Oxygen:themoleculethatmadetheworld.
Radic.Biol.Med.22,201. OxfordUniversityPress,NewYork.
161. Kanofsky, JR and Sima, PD (1993) 1O2 generation at 17. Okado-Matsumoto, A and Fridovich, I (2001) Sub-
gas-liquidinterfaces:asignificantartifactinthemeas- cellulardistributionofSODsinratliver.J.Biol.Chem.
urements of 1O2 yields from O3–biomolecule inter- 276,38388.
actions.Photochem.Photobiol.58,335. 18. D’Orazio,Metal.(2009)Thermalstabilityandredox
162. Shiraiwa,Metal.(2012)Multiphasechemicalkinetics properties of M. tuberculosis CuSOD. Arch. Biochem.
•
ofthenitrationofaerosolizedproteinbyO3andNO
2
. Biophys.486,119.
Environ.Sci.Technol.46,6672. 19. Banci, L et al. (2012) Human SOD (hSOD1) matur-
ation through interaction with human Cu chaperone
Chapter3 for SOD1 (hCCS). Proc. Natl. Acad. Sci. USA 109,
13555.
1. Daniels,V(1989)Oxidativedamageandthepreserva- 20. Leitch,JMetal.(2009)ActivationofCu,Zn-SODinthe
tion of organic artefacts. Free Radic. Res. Commun. 5, absenceofO2andtheCuchaperoneCCS.J.Biol.Chem.
213. 284,21863.
2. Scott,G(1993)AtmosphericOxidationandAntioxidants, 21. Heikkila,REetal.(1976)InvivoinhibitionofSODin
VolsI,II,andIII,Elsevier,Amsterdam. micebyDDTC.J.Biol.Chem.251,2182.
3. Reznick,AZetal.(1992)Modificationofplasmapro- 22. Kober,Tetal.(2003)DDTCinhibitsthecatalyticactiv-
teinsbycigarettesmokeasmeasuredbyproteincar- ityofXO.FEBSLett.551,99.
bonylformation.Biochem.J.286,607. 23. Skrott,ZandCvek,B(2012)DDTCcomplexwithCu:
4. Armitage, JP (1999) Bacterial tactic responses. Adv. themechanismofactionincancercells.Mini-Reviews
Microb.Physiol.41,229. Med.Chem.12,1184.
5. Contreras, HL and Bradley, TJ (2009) Metabolic rate 24. Kachadourian,Retal.(2001)2-Methoxyestradioldoes
controlsrespiratoryrateininsects.J.Exp.Biol.212,424. notinhibitSOD.Arch.Biochem.Biophys.392,349.

--- Page 770 ---

REFERENCES 715
25. Glasauer, A et al. (2014) Targeting SOD1 reduces ex- 43. Okado-Matsumoto,AandFridovich,I(2001)Assayof
perimental non-small-cell lung cancer. J. Clin. Invest. SOD:cautionsrelevanttotheuseofcytochromec,a
124,117. sulfonated tetrazolium, and CN–. Anal. Biochem.298,
26. Auclair, JR et al. (2013) Post-translational modifica- 337.
tionbycysteineprotectsCu/Zn-SODfromoxidative 44. Kanabus-Kaminska, JM and Girardot, JM (1984) In-
damage.Biochemistry52,6137. hibitionofvitaminK-dependentcarboxylasebymetal
27. Själander, A et al. (1995) The D90A mutation results ionsandmetalcomplexes:areassessment.Arch.Bio-
inapolymorphismofCu,ZnSODthatisprevalentin chem.Biophys.228,646.
northern Sweden and Finland. Hum. Mol. Genet. 4, 45. Halliwell,B(1977)GenerationofH2O2,O •
2
–andOH •
1105. duringtheoxidationofdihydroxyfumaricacidbyper-
28. Liochev,SI(2012)AstoryofCu,ZnSOD,peroxymono- oxidase.Biochem.J.163,441.
carbonate, and pseudo-second-order rate constants. 46. Im, YJ et al. (2009) Expression of Pyrococcus furiosus
FreeRadic.Biol.Med.53,1988. SOR in Arabidopsis enhances heat tolerance. Plant
29. Ramirez, DC et al. (2009) Cu, Zn-SOD-driven free Physiol.151,893.
radical modifications: Cu and CO
•–-initiated
protein 47. Fournier,Metal.(2004)AnewfunctionoftheDesulfo-
3
radicalchemistry.Biochem.J.417,341. vibriovulgarisHildenborough[Fe]hydrogenaseinthe
30. Bafana,Aetal.(2011)Thebasicandappliedaspectsof protectionagainstoxidativestress. J. Biol. Chem.279,
SOD.J.Mol.Catal.B-Enzym.68,129. 1787.
31. Lamarre,Cetal.(2001)C.albicansexpressesanunusual 48. Farr,SBetal.(1986)O2-dependentmutagenesisinE.
cytoplasmic MnSOD (SOD3 gene product) upon the colilackingSOD.Proc.Natl.Acad.SciUSA83,8268.
entry and during the stationary phase. J. Biol. Chem. 49. Benov, L and Fridovich, I (1996) Functional signifi-
276,43784. canceoftheCuZnSODinE.coli.Arch.Biochem.Biophys.
32. Brouwer, M et al. (2003) Replacement of a cytosolic 327,249.
CuZnSODbyanovelcytosolicMnSODincrustaceans 50. Hassett, DJet al. (1995) Pseudomonas aeruginosa, sodA
thatuseCu(haemocyanin)forO2transport.Biochem.J. andsodBmutantsdefectiveinMn-andFe-cofactored
374,219. SOD activity demonstrate the importance of the Fe-
33. Shatzman, AR and Kosman, DJ (1979) Biosynthesis cofactoredforminaerobicmetabolism.J.Bacteriol.177,
andcellulardistributionofthetwoSODsofDactylium 6330.
dendroides.J.Bacteriol.137,313. 51. Cybulski, RJ Jr et al. (2009) Four SODs contribute to
34. Li,Setal.(2010)DietaryMnmodulatesexpressionof Bacillus anthracis virulence and provide spores with
theMnSODgeneinchickens.J.Nutr.141,189. redundantprotectionfromoxidativestress.Infect.Im-
35. Li, H et al. (2005) MnSOD polymorphism, pre- mun.77,274.
diagnosticantioxidantstatus,andriskofclinicalsig- 52. Archambaud,Cetal.(2006)ControlofListeriaSODby
nificantprostatecancer.CancerRes.65,2498. phosphorylation.J.Biol.Chem.281,31812.
36. Cyr, AR et al. (2013) Regulation of SOD2 in cancer 53. Outten, CE et al. (2005) Cellular factors required for
byhistonemodificationsandCpGmethylation:clos- protectionfromhyperoxiatoxicityinS.cerevisiae.Bio-
ing the loop between redox biology and epigenetics. chem.J.388,93.
Antioxid.RedoxSignal.18,1946. 54. Balzan, R et al. (1995) E. coli FeSOD targeted to the
37. Gabbianelli,Retal.(1995)Metaluptakeofrecombin- mitochondria of yeast cells protects the cells against
antcambialisticSODfromPropionibacteriumshermanii oxidativestress.Proc.Natl.Acad.SciUSA92,4219.
isaffectedbygrowthconditionsofhostE.coli.cells. 55. Guidot,DMetal.(1993)Absenceofelectrontransport
◦
Biochem.Biophys.Res.Commun.216,841. (Rh state) restores growth of a MnSOD-deficient S.
38. Chen,HYetal.(2002)Structuralstudiesofaneukary- cerevisiaeinhyperoxia.J.Biol.Chem.268,26699.
oticcambialisticSODpurifiedfromthematureseeds 56. Zyracka,Eetal.(2005)Ascorbateabolishesauxotrophy
ofcamphortree.Arch.Biochem.Biophys.404,218. causedbythelackofSODinS.cerevisiae.Yeastcanbe
39. Kim,EJetal.(1998)Expressionandregulationofthe abiosensorforantioxidants.J.Biotechnol.115,271.
sodF gene encoding Fe- and Zn-containing SOD in 57. Peled-Kamar,Metal.(1997)Oxidativestressmediates
StreptomycescoelicolorMüller.J.Bact.180,2014. impairmentofmusclefunctionintransgenicmicewith
40. Bannister,JVandCalabrese,L(1987)AssaysforSOD. elevatedlevelofwild-typeCuZnSOD.Proc.Natl.Acad.
Meth.Biochem.Anal.32,279. Sci.USA94,3883.
41. Beyer, WF, Jr and Fridovich, I (1987) Assaying for 58. Marecki,JCetal.(2014)TheuseoftheCre/loxPsys-
SOD: some large consequences of minor changes in temtostudyoxidativestressintissue-specificMnSOD
conditions.Anal.Biochem.161,559. knockoutmodels.Antioxid.RedoxSignal.20,1655.
42. Hassan,HMetal.(1980)InhibitorsofSODs:acaution- 59. Ho,YSetal.(1998)Transgenicmodelsforthestudyof
arytale.Arch.Biochem.Biophys.199,349. lung antioxidant defense: enhanced MnSOD activity

--- Page 771 ---

716 REFERENCES
givespartialprotectiontoB6C3hybridmiceexposed 75. Gan Z et al. (2011) Differential responses of targeted
tohyperoxia.Am.J.Respir.CellMol.Biol.18,538. lung redox enzymes to rat exposure to 60 or 85%
60. Wicks,Setal.(2009)Hypoxiarescuesearlymortality oxygen.J.Appl.Physiol.111,95.
conferredbySODdeficiency.FreeRadic.Biol.Med.46, 76. Reddy,NMetal.(2009)DisruptionofNrf2impairsthe
176. resolutionofhyperoxia-inducedacutelunginjuryand
61. Lebovitz, RM et al. (1996) Neurodegeneration, myo- inflammationinmice.J.Immunol.182,7264.
cardial injury and perinatal death in mitochondrial 77. Turrens,JFetal.(1984)ProtectionagainstO2toxicityby
SOD-deficientmice.Proc.Natl.Acad.Sci.USA93,9782. intravenous injection of liposome-entrapped catalase
62. Hinerfeld, D et al. (2004) Endogenous mitochondrial andSOD.J.Clin.Invest.73,87.
oxidative stress: neurodegeneration, proteomic ana- 78. Lingappan, K et al. (2014) Mice deficientin the gene
lysis,specificrespiratorychaindefects,andefficacious for CYP1A1 are more susceptible than wild-type to
antioxidanttherapyinSOD2nullmice.J.Neurochem. hyperoxiclunginjury:evidenceforprotectiveroleof
88,657. CYP1A1againstoxidativestress.Toxicol.Sci.141,68.
63. Kokoszka,JEetal.(2001)Increasedmitochondrialoxi- 79. Lingappan, K et al. (2013) Sex-specific differences in
dative stress in the Sod2 (+/–) mouse results in the hyperoxiclunginjuryinmice:implicationsforacute
age-relateddeclineofmitochondrialfunctionculmin- and chronic lung disease in humans. Toxicol. Appl.
atinginincreasedapoptosis.Proc.Natl.Acad.SciUSA Pharmacol.272,281.
98,2278. 80. Feng, Y et al. (2015) Hyperbaric O2 preconditioning
64. Liang, LP et al. (2012) Mitochondrial oxidativestress protects lung against hyperoxic acute lung injury in
andepilepsyinSOD2deficientmice:attenuationbya rats via HO-1 induction. Biochem. Biophys. Res. Com-
lipophilicmetalloporphyrin.Neurobiol.Dis.45,1068. mun.456,549.
65. Asikainen, TM et al. (2002) Increased sensitivity of 81. Buzadzic, B et al. (1990) Antioxidant defenses in the
homozygous SOD 2 mutant mice to O2 toxicity. Free groundsquirrelCitelluscitellus.2.Theeffectofhiberna-
Radic.Biol.Med.32,175. tion.FreeRadic.Biol.Med.9,407.
66. KimAetal.(2010)Geneticmodifierofmitochondrial 82. Allan,MEandStorey,KB(2012)ExpressionofNF-κB
SOD-deficientmicedelaysheartfailureandprolongs anddownstreamantioxidantgenesinskeletalmuscle
survival.Mamm.Genome.21,534. ofhibernatinggroundsquirrels,Spermophilustridecem-
67. Koyama, H et al. (2013) Antioxidants improve the lineatus.CellBiochem.Funct.30,166.
phenotypesofdilatedcardiomyopathyandmusclefa- 83. Almagor,Metal.(1984)RoleofO
•–inhostcellinjury
2
tigueinmitochondrialSOD-deficientmice. Molecules inducedbyM.pneumoniaeinfection.Astudyinnormal
18,1383. andtrisomy21cells.J.Clin.Invest.73,842.
68. Treiber, N et al. (2011) Accelerated aging phenotype 84. Austin,FEetal.(1981)DistributionofSOD,catalase,
inmicewithconditionaldeficiencyformitochondrial and peroxidase activities among Treponema pallidum
SODintheconnectivetissue.AgingCell10,239. andotherspirochetes.Infect.Immun.33,372.
69. Sakellariou, GK et al. (2014) Neuron-specific expres- 85. Wu,HJetal.(2010)Mnregulationofvirulencefactors
sion of CuZnSOD prevents the loss of muscle mass andoxidativestressresistanceinNeisseriagonorrhoeae.
and function that occurs in homozygous CuZnSOD- J.Proteomics73,899.
knockoutmice.FASEBJ.28,1666. 86. Zheng, H et al. (1992) Regulation of catalase in N.
70. Didion, SP et al. (2002) Increased O
•–
and vascular gonorrhoeae.J.Clin.Invest.90,1000.
2
dysfunctioninCuZnSOD-deficientmice.Circ.Res.91, 87. Archibald,FS(1985)Mn:itsacquisitionbyandfunc-
938. tioninthelacticacidbacteria.CRCCrit.Rev.Microbiol.
71. Elchuri, S et al. (2005) CuZnSOD deficiency leads to 13,63.
persistentandwidespreadoxidativedamageandhep- 88. Aguirre,JDetal.(2013)AMn-richenvironmentsup-
atocarcinogenesislaterinlife.Oncogene24,367. portsSODactivityinaLymediseasepathogen,Borrelia
72. Ghoshal, K et al. (1999) Transcriptional induction burgdorferi.J.Biol.Chem.288,8468.
of metallothionein-I and -II genes in the livers of 89. Al-Maghrebi,Metal.(2002)Mnsupplementationre-
CuZnSODknockoutmice.Biochem.Biophys.Res.Com- lievesthephenotypicdeficitsseeninSOD-nullE.coli.
mun.264,735. Arch.Biochem.Biophys.402,104.
73. Kirby,Ketal.(2002)RNAinterference-mediatedsilen- 90. Reddi,ARetal.(2009)TheoverlappingrolesofMnand
cingofSOD2inDrosophilaleadstoearlyadult-onset Cu/ZnSODinoxidativestressprotection.FreeRadic.
mortality and elevated endogenous oxidative stress. Biol.Med.46,154.
Proc.Natl.Acad.Sci.USA99,16162. 91. Anjem, A and Imlay, JA (2012) Mononuclear Fe en-
74. Dykens, JA and Shick, JM (1984) Photobiology of zymesareprimarytargetsofH2O2stress.J.Biol.Chem.
thesymbioticseaanemone,Anthopleuraelegantissima: 287,15544.
defences against photodynamic effects, and seasonal 92. Wallace, MA et al. (2004) O
•–
inhibits 4Fe-4S cluster
2
photoacclimatization.Biol.Bull.167,683. enzymesinvolvedinaminoacidbiosynthesis.Cross-

--- Page 772 ---

REFERENCES 717
compartmentprotectionbyCuZn-SOD.J.Biol.Chem. 110. Turell,Letal.(2013)Thethiolpoolinhumanplasma:
279,32055. thecentralcontributionofalbumintoredoxprocesses.
93. Benov, L and Fridovich, I (1999) Why O
•–
imposes FreeRadic.Biol.Med.65,244.
2
an aromatic amino acid auxotrophy on E.coli. The 111. Ballatori,Netal.(2009)GSHdysregulationandtheeti-
transketolaseconnection.J.Biol.Chem.274,4202. ologyandprogressionofhumandisease.Biol.Chem.
94. Ibrahim,WHetal.(2013)MitochondrialO
•–mediates
390,191.
2
labileFelevel:evidencefromMnSOD-transgenicmice 112. Barhoumi,Retal.(1993)Concurrentanalysisofintra-
andheterozygousknockoutmiceandisolatedratliver cellularGSHcontentandgapjunctionalintercellular
mitochondria.FreeRadic.Biol.Med.65,143. communication.Cytometry14,747.
95. Gaudu,Petal.(1996)Theirreversibleinactivationof 113. Bellis, SL et al. (1994) Affinity purification of Hydra
RNRfromE.colibyO
•–.FEBSLett.387,137.
GSHbindingproteins.FEBSLett.354,320.
2
96. Wendt,Setal.(2003)DifferentialeffectsofONOO–on 114. Hanna,PMandMason,RP(1992)Directevidencefor
humanmitochondrialcreatinekinaseisoenzymes.In- inhibition of free radical formation from Cu(I) and
activation,octamerdestabilization,andidentification H2O2 by GSH and other potential ligands using the
ofinvolvedresidues.J.Biol.Chem.278,1125. EPR spin-trapping technique. Arch. Biochem. Biophys.
97. Halliwell, B and Gutteridge JMC (1984) O2 toxicity, 295,205.
O2 radicals,transitionmetalsanddisease.Biochem.J. 115. Morgan,Betal.(2013)MultipleGSSGremovalpath-
219,1. waysmediatecytosolicredoxhomeostasis.Nat.Chem.
98. Halliwell,BandGutteridge,JMC(1990)Roleof free Biol.9,119.
radicals and catalytic metal ions in human disease. 116. Thienne, R et al. (1981) 3D-structure of glutathione
Meth.Enzymol.186,1. reductaseat2Åresolution.J.Mol.Biol.152,763.
99. Woodmansee,ANandImlay,JA(2002)Reducedfla- 117. Seefeldt,Tetal.(2009)Characterizationofanoveldith-
vinspromoteoxidativeDNAdamageinnon-respiring iocarbamateglutathionereductaseinhibitoranditsuse
E.colibydeliveringelectronstointracellularfreeFe. asatooltomodulateintracellularglutathione.J.Biol.
J.Biol.Chem.277,34055. Chem.284,2729.
100. Park,SandImlayJA(2003)Highlevelsofintracellular 118. Fan, J et al. (2014) Quantitative flux analysis re-
cysteinepromoteoxidativeDNAdamagebydriving veals folate-dependent NADPH production. Nature
theFentonreaction.J.Bacteriol.185,1942. 510,298.
101. Repine,JEetal.(1981)H2O2killsS.aureusbyreacting 119. Stanton,RC(2012)Glucose-6-phosphatedehydrogen-
•
withstaphylococcalFetoformOH .J.Biol.Chem.256, ase,NADPH,andcellsurvival.IUBMBLife64,362.
7094. 120. Cheng,MLetal.(2004)G6PDH-deficientcellsshowan
102. Lindgren, H et al. (2011) Fe content differs between increasedpropensityforoxidant-inducedsenescence.
Francisellatularensissubspeciestularensisandsubspe- FreeRadic.Biol.Med.36,580.
ciesholarcticastrainsandcorrelatestotheirsusceptibil- 121. Maeng, O et al. (2004) Cytosolic NADP+-dependent
itytoH2O2-inducedkilling.Infect.Immun.79,1218. isocitrate dehydrogenase protects macrophages from
•
103. Touati,Detal.(1995)Lethaloxidativedamageandmu- LPS-inducedNO andROS.Biochim.Biophys.Acta317,
tagenesisaregeneratedbyironin(cid:6)furmutantsofE. 558.
coli:protectiveroleofSOD.J.Bacteriol.177,2305. 122. Ronchi, JA et al. (2013) A spontaneous mutation in
104. Nunoshiba,Tetal.(1999)RoleofFeandO
•–forgener-
thenicotinamidenucleotidetranshydrogenasegeneof
2
•
ationofOH ,oxidativeDNAlesions,andmutagenesis C57BL/6Jmiceresultsinmitochondrialredoxabnor-
inE.coli.J.Biol.Chem.274,34832. malities.FreeRadic.Biol.Med.63,446.
105. SrinivasanCetal.(2000)YeastlackingSODsshowele- 123. Gurumurthy,Metal.(2013)AnovelF420-dependent
vated levels of “free Fe” as measured by whole cell antioxidant mechanism protects Mycobacterium tuber-
EPR.J.Biol.Chem.275,29187. culosisagainstoxidativestressandbactericidalagents.
106. Kyle,MEetal.(1988)EndocytosisofSODisrequiredin Mol.Microbiol.87,744.
orderfortheenzymetoprotecthepatocytesfromthe 124. Xiong,Yetal.(2011)S-glutathionylation:frommolecu-
cytotoxicityofH2O2.J.Biol.Chem.263,3784. lar mechanisms to health outcomes. Antioxid. Redox
107. Spencer,JPetal.(1995)DNAstrandbreakageandbase Signal.15,233.
modification induced by H2O2 treatment of human 125. Marí, M et al. (2013) Mitochondrial GSH: features,
respiratorytractepithelialcells.FEBSLett.374,233. regulation and role in disease. Biochim. Biophys. Acta
108. Go, YM and Jones, DP (2013) Thiol/disulfide redox 1830,3317.
statesinsignalingandsensing.Crit.Rev.Biochem.Mol. 126. Wu,Getal.(2004)GSHmetabolismanditsimplica-
Biol.48,173. tionsforhealth.J.Nutr.134,489.
109. Dixon, BM et al. (2008) Assessment of ER glutathi- 127. Morris, G et al. (2014) The GSH system: a new
one redox status is confounded by extensive ex vivo drugtargetinneuroimmunedisorders.Mol.Neurobiol.
oxidation.Antioxid.Redox.Signal.10,963. 50,1059.

--- Page 773 ---

718 REFERENCES
128. Lyons, J et al. (2000) Blood GSH synthesis rates in 145. Garcia,Jetal.(2010)Regulationofmitochondrialgluta-
healthyadultsreceivingasulfuraminoacid-freediet. thione redox status and protein glutathionylation by
Proc.Natl.Acad.Sci.USA97,5071. respiratorysubstrates.J.Biol.Chem.285,39646.
129. Stout, J et al. (2012) GSH biosynthesis in bacteria by 146. Dhindsa,RS(1991)Droughtstress,enzymesofgluta-
bifunctionalGshFisdrivenbyamodularstructurefea- thionemetabolism,oxidationinjury,andproteinsyn-
turinganovelhybridATP-graspfold.J.Mol.Biol.416, thesisinTortularuralis.PlantPhysiol.95,648.
486. 147. Park,HAetal.(2009)GSSGinducesneuralcelldeath
130. Vaziri,NDetal.(2000)Inductionofoxidativestressby viaa12-LOXpathway.CellDeathDiffer.16,1167.
GSHdepletioncausesseverehypertensioninnormal 148. Ryan, MT and Stojanovski, D (2012) Mitofusins
rats.Hypertension36,142. ‘bridge’ the gap between oxidative stress and mito-
131. Ichiseki,Tetal.(2011)Osteonecrosisdevelopmentina chondrialhyperfusion.EMBOReports13,870.
novelratmodelcharacterizedbyasingleapplication 149. Ströher,EandMillar,AH(2012)Thebiologicalrolesof
ofoxidativestress.ArthritisRheum.63,2138. glutaredoxins.Biochem.J.446,333.
132. Gokce,Getal.(2009)GSHdepletionbyBSOinduces 150. Hatahet, F and Ruddock, LW (2009) Protein disul-
oxidativedamagetoDNAinorgansofrabbitsinvivo. fideisomerase:acriticalevaluationofitsfunctionin
Biochemistry48,4980. disulfide bond formation. Antioxid. Redox. Signal. 11,
133. Meister, A (1995) Mitochondrial changes associated 2807.
withGSHdeficiency.Biochim.Biophys.Acta1271,35. 151. Herrmann,JMandRiemer,J(2012)Mitochondrialdi-
134. Cole,SP(2014)Targetingmultidrugresistanceprotein sulfiderelay:redox-regulatedproteinimportintothe
1(MRP1,ABCC1):past,present,andfuture.Annu.Rev. intermembranespace.J.Biol.Chem.287,4426.
Pharmacol.Toxicol.54,95. 152. Lu,JandHolmgren,A(2014)Thethioredoxinsuper-
135. Ballatori,Netal.(2005)Molecularmechanismsofre- family in oxidative protein folding. Antioxid. Redox
ducedGSHtransport:roleofMRP/CFTR/ABCCand Signal.21,457.
OATP/SLC21Afamiliesofmembraneproteins.Toxicol. 153. Lu,JandHolmgren,A(2014)Thethioredoxinantioxi-
Appl.Pharmacol.204,238. dantsystem.FreeRadic.Biol.Med.66,75.
136. Carcamo,WJetal.(2011)Inductionofcytoplasmicrods 154. Godoy, JR et al. (2011) Redox atlas of the mouse;
andringsstructuresbyinhibitionoftheCTPandGTP immunohistochemical detection of glutaredoxin-,
synthetic pathway in mammalian cells. PLoS One 6, peroxiredoxin-, and thioredoxin-family proteins in
e29690. various tissues of the laboratory mouse. Biochim.
137. Chen,Yetal.(2013)GSHdefensemechanisminliver Biophys.Acta.1810,2.
injury:insightsfromanimalmodels.FoodChem.Toxicol. 155. Bauer,Hetal.(2013)Thioredoxinreductasefromthe
60,38. malaria mosquito Anopheles gambiae. Eur. J. Biochem.
138. Bachhawat,Aetal.(2013)GSHtransporters.Biochim. 270,4273.
Biophys.Acta1830,3154. 156. Björnstedt,Metal.(1995)Seleniteandselenodigluta-
139. Ferguson,GPandBooth,IR(1998)ImportanceofGSH thione:reactionswiththioredoxinsystems.Meth.En-
forgrowthandsurvivalofE.colicells:detoxification zymol.252,209.
ofmethylglyoxalandmaintenanceofintracellularK+. 157. Arnér,ESetal.(1995)1-Chloro-2,4-dinitrobenzeneisan
J.Bacteriol.180,4314. irreversibleinhibitorofhumanthioredoxinreductase.
140. Hanschmann,Eetal.(2013)Thioredoxins,glutaredox- J.Biol.Chem.270,3479.
ins,andperoxiredoxins–molecularmechanismsand 158. Jeong,Wetal.(2012)Roleofsulfiredoxinasaregulator
health significance: from cofactors to antioxidants to ofprxfunctionandregulationofitsexpression.Free
redoxsignaling.Antioxid.RedoxSignal.19,1539. Radic.Biol.Med.53,447.
141. vanderGiet,Metal.(2001)CoenzymeA-GSSGisa 159. Mishra, S and Imlay, J (2012) Why do bacteria use
potentmodulatorofangiotensinII-inducedvasocon- so many enzymes to scavenge H2O2? Arch. Biochem.
striction.Am.J.Hypertens.14,164. Biophys.525,145.
142. Ram, JL et al. (2008) Finding females: pheromone- 160. Edgar, RS et al. (2012) Peroxiredoxins are conserved
guidedreproductivetrackingbehaviorbymaleNereis markersofcircadianrhythms.Nature485,459.
succinea in the marine environment. J. Exp. Biol. 211, 161. Cox,AGetal.(2009)Mitochondrialprx3ismoreresili-
757. ent to hyperoxidation than cytoplasmic peroxiredox-
143. Requejo, R et al. (2010) Cysteine residues exposed ins.Biochem.J.421,51.
on protein surfaces are the dominant intramitochon- 162. Brigelius-Flohé,RandMaiorino,M(2013)Glutathione
drialthiolandmayprotectagainstoxidativedamage. peroxidases.Biochim.Biophys.Acta1830,3289.
FEBSJ.277,1465. 163. Rayman,MP(2012)Seleniumandhumanhealth.Lan-
144. Crabtree, MJ et al. (2013) Integrated redox sensor cet379,1256.
and effector functions for tetrahydrobiopterin- and 164. Steinbrenner,HandSies,H(2009)Protectionagainst
glutathionylation-dependenteNOSuncoupling.J.Biol. ROS by selenoproteins. Biochim. Biophys. Acta 1790,
Chem.288,561. 1478.

--- Page 774 ---

REFERENCES 719
165. Pouyet,LandCarrier,A(2010)Mutantmousemodels 184. Cheah,IKandHalliwell,B(2012)Ergothioneine;anti-
ofoxidativestress.TransgenicRes.19,155. oxidant potential, physiological function and role in
166. Tan,SMetal.(2013)LackoftheantioxidantGPx1ex- disease.Biochim.Biophys.Acta1822,784.
acerbatesROPinmice.Invest.Ophthalmol.Vis.Sci.54, 185. Emani,CSetal.(2013)Ergothioneineisasecretedanti-
555. oxidantinMycobacteriumsmegmatis.Antimicrob.Agents
167. Jin,RCetal.(2011)GPx-3deficiencypromotesplatelet- Chemother.57,3202.
dependentthrombosisinvitro.Circulation123,1963. 186. Yamashita,Tetal.(2013)SecontentinseafoodinJapan.
168. Zhang,Yetal.(2009)MicedeficientinbothMnSOD Nutrients5,388.
and GPx-1 have increased oxidative damage and a 187. Nicholls,P(2012)Classicalcatalase:ancientandmod-
greater incidence of pathology but no reduction in ern.Arch.Biochem.Biophys.525,95.
longevity.J.Gerontol.A.Biol.Sci.Med.Sci.64,1212. 188. Zamocky,Metal.(2008)Evolutionofcatalasesfrom
169. Rabbani,NandThornalley,PJ(2012)Methylglyoxal, bacteriatohumans.Antioxid.RedoxSignal.10,1527.
glyoxalase1andthedicarbonylproteome.AminoAcids 189. Winterbourn,CCandStern,A(1987)Humanredcells
42,1133. scavengeextracellularH2O2 andinhibitformationof
•
170. Shin, MJ et al. (2014) Tat-glyoxalase protein inhibits HOClandOH .J.Clin.Invest.80,1486.
againstischemicneuronalcelldamageandameliorates 190. Gauthier,KMetal.(2011)Solubleepoxidehydrolase
ischemicinjury.FreeRadic.Biol.Med.67,195. contaminationofspecificcatalasepreparationsinhibits
171. Mannervik,B(2012)FivedecadeswithGSHandthe epoxyeicosatrienoic acid vasodilation of rat renal ar-
GSTome.J.Biol.Chem.287,6072. terioles.Am.J.Physiol.301,F765.
172. Cummins, I et al. (2009) Safener responsiveness and 191. Gordon,T(1986)Purityofcatalasepreparations:con-
multipleherbicideresistanceintheweedblack-grass taminationbyendotoxinanditsroleintheinhibition
(Alopecurusmyosuroides).PlantBiotechnol.J.7,807. ofairwayinflammation.FreeRadic.Biol.Med.2,373.
173. Tew, KD et al. (2011) The role of GST-P in signaling 192. Borthiry,GRetal.(2007)ReductionofhexavalentCr
pathwaysandS-glutathionylationincancer.FreeRadic. byhumancytochromeb5:generationofOH • andO •
2
–.
Biol.Med.51,299. FreeRadic.Biol.Med.42,738.
•
174. Wong, PS et al. (2001) Inactivation of GSTs by NO - 193. Shin,DHetal.(2008)UnusualpropertiesofcatalaseA
derived oxidants: exploring a role for tyrosine nitra- (KatA)ofPseudomonasaeruginosaPA14areassociated
tion.Arch.Biochem.Biophys.394,216. with its biofilm peroxide resistance. J. Bacteriol. 190,
175. Raza,H(2011)DuallocalizationGSTinthecytosoland 2663.
mitochondria:implicationsinoxidativestress,toxicity 194. Chance,Betal.(1979)Hydroperoxidemetabolismin
anddisease.FEBSJ.278,4243. mammalianorgans.Physiol.Rev.59,527.
176. Fahey,RC(2013)Glutathioneanalogsinprokaryotes. 195. Darr, D and Fridovich, I (1986) Irreversible inacti-
Biochim.Biophys.Acta1830,3182. vation of catalase by 3-amino-1,2,4-triazole. Biochem.
177. Van Petegem, F et al. (2007)Understanding nicotina- Pharmacol.35,3642.
midedinucleotidecofactorandsubstratespecificityin 196. Brunelli,Letal.(2001)Modulationofcatalaseperoxid-
•
classIflavoproteindisulfideoxidoreductases:crystal- aticandcatalaticactivitybyNO .FreeRadic.Biol.Med.
lographic analysis of a glutathione amide reductase. 30,709.
J.Mol.Biol.374,883. 197. Ogata,Metal.(1987)ReductionofHg2+ ionandex-
178. CruzdeCarvalho,MHetal.(2010)Homoglutathione halationofHginacatalasemicandnormalmice.Arch.
synthetase and GSH synthetase in drought-stressed Environ.Health42,26.
cowpealeaves:expressionpatternsandaccumulation 198. Shoeman, DW et al. (2000) Reaction of HNO, an al-
of low-molecular-weight thiols. J. Plant Physiol. 167, dehyde dehydrogenase inhibitor, with NAc. Alcohol
480. 20,55.
179. Suttisansanee,UandHonek,JF(2011)Bacterialglyox- 199. Nordgren,MandFransen,M(2014)Peroxisomalme-
alaseenzymes.Semin.CellDev.Biol.22,285. tabolismandoxidativestress.Biochimie98,56.
180. VanLaer,Ketal.(2013)Low-molecular-weightthiols 200. Kawada,Yetal.(2004)Inhibitionofperoxisomalfunc-
inthiol-disulfideexchange.Antioxid.RedoxSignal.18, tions due to oxidative imbalance induced by mistar-
1642. geting of catalase to cytoplasm is restored by vita-
181. Krauth-Siegal, RL and Leroux, AE (2012) Low- min E treatment in skin fibroblasts from Zellweger
molecular-mass antioxidants in parasites. Antioxid. syndrome-likepatients.Mol.Genet.Metab.83,297.
RedoxSignal.17,583. 201. Ivashchenko, O et al. (2011) Intraperoxisomal redox
182. Gretes, MC et al. (2012) Peroxiredoxins in parasites. balanceinmammaliancells:oxidativestressandinter-
Antioxid.RedoxSignal.17,608. organellarcross-talk.Mol.Biol.Cell22,1440.
183. Gründemann,A(2012)Theergothioneinetransporter 202. Antunes,Fetal.(2002)Relativecontributionsofheart
controls and indicates ergothioneine activity – a re- mitochondriaGPxandcatalasetoH2O2detoxification
view.Prev.Med.54,571. ininvivoconditions.FreeRadic.Biol.Med.33,1260.

--- Page 775 ---

720 REFERENCES
203. Bulitta, C et al. (1996) Cytoplasmic and peroxisomal 222. Winter,JMandMoore,BS(2009)Exploringthechem-
catalases of the guinea pig liver: evidence for two istry and biology of V-dependent haloperoxidases.
distinctproteins.Biochim.Biophys.Acta1293,55. J.Biol.Chem.284,18577.
204. Góth, L and Nagy, T (2013) Inherited catalase defi- 223. Hiner,ANPetal.(2000)Kineticstudyoftheinactiva-
ciency:isitbenignorafactorinvariousagerelated tionofascorbateperoxidasebyH2O2.Biochem.J.348,
disorders?Mutat.Res.753,147. 321.
205. Ho,YSetal.(2004)Micelackingcatalasedevelopnor- 224. Wong,CKWetal.(2012)Thesensitivityandspecificity
mallybutshowdifferentialsensitivitytooxidanttissue ofguaiacandimmunochemicalfecaloccultbloodtests
injury.J.Biol.Chem.279,32804. for the detection of advanced colonic adenomas and
206. Ishii,K etal.(1996)Preventionofmammarytumori- cancer.Int.J.ColorectalDis.27,1657.
genesisinacatalasemicmicebyvitaminEsupplemen- 225. Speijer, D et al. (2014) How to deal with O2 radicals
tation.Jpn.J.CancerRes.87,680. stemming from mitochondrial fatty acid oxidation.
207. Mackey, WJ and Bewley, GC (1989) The genetics of Phil.Trans.R.Soc.B369,20130446.
catalaseinDrosophilamelanogaster:isolationandchar- 226. Cox,AGetal.(2010)Mitochondrialprxinvolvement
acterizationofacatalasemicmutants.Genetics122,643. inantioxidantdefenceandredoxsignalling.Biochem.J.
208. Ahn,Jetal.(2006)Associationsbetweencatalasephen- 425,313.
otype and genotype: modification by epidemiologic 227. Radyuk,SNetal.(2010)Mitochondrialprxarecritical
factors.CancerEpidemiol.Biomark.Prev.15,1217. forthemaintenanceofredoxstateandthesurvivalof
209. Niederfuhr, A et al. (1998) A sequence-ready 3-Mb adultDrosophila.FreeRadic.Biol.Med.49,1892.
PAC contig covering 16 breakpoints of the Wilms 228. Lien, YC et al. (2012) The roles of peroxidase and
tumor/anirida region of human chromosome 11p13. phospholipaseA2activitiesofprx6inprotectingpul-
Genomics53,155. monarymicrovascularendothelialcellsagainstperox-
210. Moy,TIetal.(2004)CytotoxicityofH2O2producedby idativestress.Antioxid.RedoxSignal.16,440.
E.faecium.Infect.Immun.72,4512. 229. Wong,CMetal.(2004)Peroxiredoxin-nullyeastcells
211. Baker,JLetal.(2014)StreptococcusmutansNADHoxi- arehypersensitivetooxidativestressandaregenomic-
dase lies at the intersection of overlapping regulons allyunstable.J.Biol.Chem.279,23207.
controlled by O2 and NAD+ levels. J. Bacteriol. 196, 230. Rawat,SJetal.(2013)ThetumoursuppressorMst1pro-
2166. moteschangesinthecellularredoxstatebyphosphor-
212. Nishiyama,Yetal.(2001)H2O2-formingNADHoxi- ylationandinactivationofprx1protein.J.Biol.Chem.
dase belonging to the peroxiredoxin oxidoreductase 288,8762.
family: existence and physiological role in bacteria. 231. Steele,KHetal.(2010)Comparativestudyoftheroles
J.Bacteriol.183,2431. ofAhpCandKatEasrespiratoryantioxidantsinBru-
213. Tachon, S et al. (2011) Identification of a conserved cellaabortus2308.J.Bacteriol.192,4912.
sequenceinflavoproteinsessentialforthecorrectcon- 232. Diplock, AT (1985) Fat-soluble Vitamins. Heineman,
formationandactivityoftheNADHoxidaseNoxEof London.
Lactococcuslactis.J.Bacteriol.193,3000. 233. Awad, JA et al. (1994) Detection and localization of
214. Zámocký, M et al. (2010) Evolution of structure and lipidperoxidationinSe-andvitaminE-deficientrats
functionofclassIperoxidases.Arch.Biochem.Biophys. usingF2-IPs.J.Nutr.124,810.
500,45. 234. Hill,KEetal.(2009)CombinedSeandvitaminCdefi-
215. Passardi, F et al. (2005) Peroxidases have more func- ciencycausescelldeathinguineapigskeletalmuscle.
tionsthanaSwissarmyknife.PlantCellRep.24,255. Nutr.Res.29,213.
216. Duffey,SSandBlum,MS(1977)Phenolandguaiacol: 235. Wu, J et al. (2009) Increased consumption of wheat
biosynthesis, detoxication and function in a polyde- biofortified with Se does not modify biomarkers of
smidmillipede,Oxidusgracilis.Insect.Biochem.7,57. cancer risk, oxidative stress, or immune function in
217. Conner,GEetal.(2002)LPOandH2O2metabolismin healthy Australian males. Environ. Mol. Mutagen. 50,
theairway.Am.J.Respir.Crit.CareMed.166,S57. 489.
218. ChengGetal.(2011)Vascularperoxidase-1israpidly 236. Beck, MA et al. (1998) GPx protects mice from viral-
secreted,circulatesinplasma,andsupportsdityrosine inducedmyocarditisFASEBJ.12,143.
cross-linkingreactions.FreeRadic.Biol.Med.51,1445. 237. Conrad, M and Schweizer, U (2010) Unveiling the
219. Halliwell, B (1978) Lignin synthesis: generation of molecular mechanisms behind Se-related diseases
H2O2andO •
2
–byHRPanditsstimulationbyMn2+and throughout knockout mouse studies. Antioxid. Redox
phenols.Planta140,81. Signal.12,851.
220. Porter, DJT and Bright HJ (1983) The mechanism of 238. Brown,TAandShrift,A(1982)Se:toxicityandtoler-
oxidation of nitroalkanes by HRP. J. Biol. Chem. 258, anceinhigherplants.Biol.Rev.57,59.
9913. 239. Karlenius,TCetal.(2011)TheSecontentofcellculture
221. Butler,AandSandy,M(2009)Mechanisticconsider- seruminfluencesredox-regulatedgeneexpression.Bi-
ationsofhalogenatingenzymes.Nature460,848. otechniques50,295.

--- Page 776 ---

REFERENCES 721
240. de Haan, JB et al. (1996) Elevation in the ratio of 259. Petrat,Fetal.(2001)Subcellulardistributionofchelat-
CuZnSODtoGPxactivityinducesfeaturesofcellular ableFe:alaserscanningmicroscopicstudyinisolated
senescenceandthiseffectismediatedbyH2O2.Hum. hepatocytesandliverendothelialcells.Biochem.J.356,
Mol.Genet.5,283. 61.
241. Lardinois,OM(1995)Reactionsofbovinelivercatalase 260. Ichikawa,Yetal.(2012)DisruptionofATP-bindingcas-
withO •
2
–andH2O2.FreeRadic.Res.22,251.234. sette B8 in mice leads to cardiomyopathy through a
242. Wang,SKetal.(2011)KnockoutofSOD1promotescon- decreaseinmitochondrialFeexport.Proc.Natl.Acad.
versionofselenocysteinetodehydroalanineinmurine Sci.USA109,4152.
hepaticGPX1protein.FreeRadic.Biol.Med.51,197. 261. Crichton,RRandDeclercq,JP(2010)X-raystructures
243. Pagano,GandCastello,G(2012)Oxidativestressand offerritinsandrelatedproteins.Biochim.Biophys.Acta
mitochondrial dysfunction in Down syndrome. Adv. 1800,706.
Exp.Med.Biol.724,291. 262. Chiancone,EandCeci,P(2010)Themultifacetedcap-
244. Lott, IT (2012) Antioxidants in Down syndrome. acityofDpsproteinstocombatbacterialstresscondi-
Biochim.Biophys.Acta1822,657. tions:detoxificationofFeandH2O2andDNAbinding.
245. Tolun, AA et al. (2012) Systemic oxidative stress, as Biochim.Biophys.Acta1800,798.
measured by urinary allantoin and F2-IsoPs, is not 263. Wiedenheft, B et al. (2005) An archaeal antioxidant:
increased in Down syndrome. Annals Epidemiol. 22, characterizationofaDps-likeproteinfromSulfolobus
892. solfataricus.Proc.Natl.Acad.Sci.USA102,10551.
246. Nunomura, A et al. (2000) Neuronal oxidative stress 264. Nandal,Aetal.(2011)ActivationoftheHIFprolylhy-
precedesAβdepositioninDownsyndrome.J.Neuro- droxylasebytheFechaperonesPCBP1andPCBP2.Cell
pathol.Exp.Neurol.59,1011. Metab.14,647.
247. Domenico,FDetal.(2014)Redoxproteomicsanalysis 265. Liu,X,andTheil,EC(2005)Ferritins:dynamicman-
ofHNE-modifiedproteinsinDownsyndromebrain: agementofbiologicalFeandO2chemistry.Acc.Chem.
cluesforunderstandingthedevelopmentofAD.Free Res.38,167.
Radic.Biol.Med.71,270. 266. Cozzi, A et al. (2013) Human L-ferritin deficiency
248. Sheftel,ADetal.(2012)ThelonghistoryofFeinthe is characterized by idiopathic generalized seizures
Universeandinhealthanddisease.Biochim.Biophys. and atypical restless leg syndrome. J. Exp. Med. 210,
Acta1820,161. 1779.
249. Fretham,SJBetal.(2011)TheroleofFeinlearningand 267. Walter, PB et al. (2002) Fe deficiency and Fe excess
memory.Adv.Nutr.2,112–121. damagemitochondriaandmitochondrialDNAinrats.
250. Jakszyn, P et al. (2012) Dietary intake of heme Fe Proc.Natl.Acad.Sci.USA99,2264.
and risk of gastric cancer in the European prospect- 268. Turski,MLandThiele,DJ(2009)NewrolesforCume-
iveinvestigationintocancerandnutritionstudy.Int. tabolism in cell proliferation, signaling, and disease.
J.Cancer130,2654. J.Biol.Chem.284,717.
251. Atanasova,BDetal.(2005)Duodenalascorbateandfer- 269. Ruiz, LM et al. (2014) Adaptive responses of mito-
ricreductaseinhumanFedeficiency.Am.J.Clin.Nutr. chondriatomildCudeprivationinvolveschangesin
81,130. morphology,OXPHOSremodelingandbioenergetics.
252. Padua,MBetal.(2012)ACP5(Uteroferrin):phylogeny J.Cell.Physiol.229,607.
of an ancient and conserved gene expressed in the 270. Gutteridge, JMC et al. (1985) The behaviour of caer-
endometriumofmammals.Biol.Reprod.86,123 uloplasmin in stored human extracellular fluids in
253. Brock,JH(2012)Lactoferrin–50yearson.Biochem.Cell relation to ferroxidase II activity, lipid peroxidation
Biol.90,245. and phenanthroline-detectable Cu. Biochem. J. 230,
254. Cabantchik,ZI(2014)LabileFeincellsandbodyflu- 517.
ids: physiology, pathology and pharmacology. Front. 271. Shukla,Netal.(2006)Doesoxidativestresschangecer-
Pharmacol.5,45. uloplasminfromaprotectivetoavasculopathicfactor?
255. Kurz,Tetal.(2011)TheroleoflysosomesinFemetab- Atherosclerosis187,238.
olismandrecycling.IntJ.Biochem.CellBiol.43,1686. 272. Gutteridge,JMCandStocks,J(1981)Caeruloplasmin:
256. Lawen,AandLane,DJ(2013)MammalianFehomeo- physiologicalandpathologicalperspectives.CRCCrit.
stasisinhealthanddisease:uptake,storage,transport, Rev.Clin.Lab.Sci.14,257.
andmolecularmechanismsofaction.Antioxid.Redox 273. Kono,S(2012)Aceruloplasminemia.Curr.DrugTargets
Signal.18,2473. 13,1190.
257. Au-Yeung,HY,etal.(2013)Molecularimagingoflabile 274. Evans, PJ et al. (1989) Non-caeruloplasmin Cu and
Fe(II)poolsinlivingcellswithaturn-onfluorescent ferroxidaseactivityinmammalianserum.FreeRadic.
probe.J.Am.Chem.Soc.135,15165. Res.Commun.7,55.
258. Coblentz, J et al. (2014) Loss of TRPML1 promotes 275. Park,YSetal.(1999)GPx-likeactivityofcaeruloplas-
production of ROS: is oxidative damage a factor in minasanimportantlungantioxidant.FEBSLett.458,
mucolipidosistypeIV?Biochem.J.457,361. 133.

--- Page 777 ---

722 REFERENCES
276. Sokolov,AVetal.(2010)Identificationandproperties 295. Halliwell,BandGutteridge,JMC(1990)Theantioxi-
ofcomplexesformedbyMPOwithlipoproteinsand dants of human extracellular fluids. Arch. Biochem.
ceruloplasmin.Chem.Phys.Lipids163,347. Biophys.280,1.
277. Vrancken, K et al. (2013) Role of ceruloplasmin in 296. Park, S et al. (2005) Substantial DNA damage from
NO metabolism in plasma of humans and sheep: a submicromolar intracellular H2O2 detected in Hpx–
comparisonofadultsandfetuses.Am.J.Physiol.305, mutants of E. coli. Proc. Natl. Acad. Sci. USA 102,
R1401. 9317.
278. Reeder,BJ(2010)Theredoxactivityofhemoglobins: 297. Toyokuni,Setal.(1995)TreatmentofWistarratswith
fromphysiologicfunctionstopathologicmechanisms. a renal carcinogen, Fe(III)NTA, causes DNA protein
Antioxid.RedoxSignal.13,1087. cross-linking between thymine and tyrosine in their
279. Libardi,SHetal.(2013)Reductionofferrylmyoglobin renalchromatin.Int.J.Cancer62,309.
byH2S.Kineticsinrelationtomeatgreening.J.Agric. 298. Halleen,JMetal.(1999)Intracellularfragmentationof
FoodChem.61,2883. boneresorptionproductsbyROSgeneratedbyosteo-
280. Gutteridge,JM(1986)FepromotersoftheFentonre- clastictartrate-resistantacidphosphatase.J.Biol.Chem.
action and lipid peroxidation can be released from 274,22907.
haemoglobinbyperoxides.FEBSLett.201,291. 299. Paul, T (2000) Effects of a prolonged O
•–
flux on
2
281. Richards, MP (2013) Redox reactions of myoglobin. transferrinandferritin.Arch.Biochem.Biophys.382,253.
Antioxid.RedoxSignal.18,2342. 300. O’Connell,MJetal.(1986)Haemosiderin-likeproper-
282. Lardinois, OM and Ortiz de Montellano, PR (2003) ties of free-radical-modified ferritin. Biochem. J. 240,
Intra-andintermoleculartransfersofproteinradicals 297.
inthereactionsofspermwhalemyoglobinwithH2O2. 301. Cross,CEetal.(1984)Antioxidantprotection:afunc-
J.Biol.Chem.278,36214. tion of tracheobronchial and gastrointestinal mucus.
283. Woollard, KJ et al. (2009) Erythrocyte hemolysis and Lancet1,1328.
hemoglobinoxidationpromoteFeCl3-inducedvascu- 302. Bartnikas, TB (2012) Known and potential roles of
larinjury.J.Biol.Chem.284,13110. transferrininFebiology.Biometals25,677.
284. Elmer,Jetal.(2012)Hemoglobin-basedO2carriersfor 303. Mete, A et al. (2005) Intestinal over-expression of Fe
hemorrhagicshock.Resuscitation83,285. transportersinducesFeoverloadinbirdsincaptivity.
285. Boutaud, O et al. (2010) Acetaminophen inhibits BloodCellsMol.Dis.34,151.
hemoprotein-catalyzedlipidperoxidationandattenu- 304. Mazzaro, LM et al. (2012) Fe indices in bottlenose
atesrhabdomyolysis-inducedrenalfailure.Proc.Natl. dolphins(Tursiopstruncates).Comp.Med.62,508.
Acad.Sci.USA107,2699. 305. Kew,MCandAsare,GA(2007)DietaryFeoverloadin
286. Larsen,Retal.(2010)Acentralroleforfreehemein theAfricanandhepatocellularcarcinoma.LiverInt.27,
the pathogenesis of severe sepsis. Sci. Transl. Med.2, 735.
51ra71. 306. Grootveld, M et al. (1989) NTBI in plasma or serum
287. YinHetal.(2012)Acetaminopheninhibitscytochrome frompatientswithidiopathichemochromatosis.J.Biol.
c redox cycling induced lipid peroxidation. Biochem. Chem.264,4417.
Biophys.Res.Commun.43,224. 307. Vaulont,Setal.(2005)Ofmiceandmen;theFeage.
288. Evans, PJ et al. (1994) Promotion of oxidative dam- J.Clin.Invest.115,2079.
age to AA and α 1-AP by anti-inflammatory drugs 308. Chen,JandEnns,CA(2012)Hereditaryhemochroma-
inthepresenceofthehaemproteinsmyoglobinand tosisandTfR2.Biochim.Biophys.Acta1820,256.
cytochromec.Biochem.Pharmacol.48,2173. 309. Fleming, RE and Ponka, P (2012) Iron overload in
289. Baliga, R (1998) Role of CYP as a source of catalytic humandisease.N.Engl.J.Med.366,348.
Feincisplatin-inducednephrotoxicity.KidneyInt.54, 310. Higgs,DR(2012)Thalassaemia.Lancet379,373.
1562. 311. Phumala, N et al. (2003) Hemin: a possible cause of
290. Atamna, H et al. (2001) Heme deficiency selectively oxidativestressinbloodcirculationinβ-thalassemia/
interrupts assembly of mitochondrial complex IV in hemoglobinEdisease.FreeRadic.Res.37,129.
humanfibroblasts.J.Biol.Chem.276,48410. 312. Amer,JandFibach,E(2005)Chronicoxidativestress
291. Negari, S et al. (2008) A role for Haemophilus ducreyi reducestherespiratoryburstresponseofneutrophils
Cu,ZnSODinresistancetohemetoxicity.Biometals21, fromβ-thalassaemiapatients.Br.J.Haematol.129,435.
249. 313. Hershko, C (2010) Fe, bone, and marrow. Blood 116,
292. Weinberg,EDandMiklossy,J(2008)Fewithholding:a 2405.
defenseagainstdisease.J.Alz.Dis.13,451. 314. Shan, H et al. (2013) Verapamil reverses cardiac Fe
293. Paradkar, PN et al. (2008) Fe depletion limits intra- overloadinstreptozocin-induceddiabeticrats.Naunyn
cellular bacterial growth in macrophages. Blood 112, SchmiedebergsArch.Pharmacol.386,645.
866. 315. Matayatsuk, C et al. (2007) Elevated F2-IsoPs in
294. Correnti,CandStrong,RK(2012)Mammaliansidero- thalassemicpatients.FreeRadic.Biol.Med.43,1649.
phores,siderophore-bindinglipocalins,andthelabile 316. Broedbaek, K et al. (2009) Urinary excretion of bio-
ironpool.J.Biol.Chem.287,13524. markers of oxidatively damaged DNA and RNA in

--- Page 778 ---

REFERENCES 723
hereditary hemochromatosis. Free Radic. Biol. Med. 335. Hu,Detal.(2006)Aging-dependentalterationsinsyn-
47,1230. apticplasticityandmemoryinmicethatoverexpress
317. Meerang, M et al. (2009) Accumulation of lipid EC-SOD.J.Neurosci.26,3933.
peroxidation-derived DNA lesions in Fe-overloaded 336. Gongora, MC et al. (2008) Loss of EC-SOD leads to
thalassemic mouse livers: comparison with levels in acutelungdamageinthepresenceofambientair.Am.
thelymphocytesofthalassemiapatients.Int.J.Cancer J.Pathol.173,915.
25,759. 337. Dzik,JM(2006)Moleculesreleasedbyhelminthpara-
318. De Luca, C et al. (1999) Blood antioxidant status sitesinvolvedinhostcolonization.ActaBiochim.Pol.
and urinary levels of catecholamine metabolites in 53,33.
β-thalassemia.FreeRadic.Res.30,453. 338. Gleason, JE et al. (2014) Candida albicans SOD5 rep-
319. Van Buren, P et al. (2012) Fe overdose: a contributor resents the prototype of an unprecedented class of
to adverse outcomes in randomized trials of anemia Cu-only SODs required for pathogen defense. Proc.
correctioninCKD.Int.Urol.Nephrol.44,499. Natl.Acad.Sci.USA111,5866.
320. Boal,Ak,andRosenzweig,AC(2009)Structuralbiol- 339. Nielsen,MJetal.(2010)Hemoglobinandhemescav-
ogyofCutrafficking.Chem.Rev.109,4760. engerreceptors.Antioxid.RedoxSignal.12,261.
321. Ogihara, H et al. (1995) Plasma Cu and antioxidant 340. Levy,APetal.(2010)Haptoglobin:basicandclinical
statusinWilson’sdisease.Pediat.Res.37,219. aspects.Antioxid.RedoxSignal.12,293.
322. Von Herbay, A et al. (1994) Low vitamin E content 341. Wagener, F et al. (2001) Heme is a potent inducer of
in plasma of patients with alcoholic liver disease, inflammationinmiceandiscounteractedbyHO.Blood
haemochromatosis and Wilson’s disease. J. Hepatol. 98,1802.
20,41. 342. Khan,AAandQuigley,JG(2011)Controlofintracellu-
323. Nair,Jetal.(2005)Apoptosisandage-dependentin- larhemelevels:hemetransportersandHOs.Biochim.
duction of nuclear and mitochondrial etheno-DNA Biophys.Acta1813,668.
adductsinLECrats:enhancedDNAdamagebydiet- 343. LimSKetal.(2001)Roleofhaptoglobininfreehemo-
ary curcumin upon Cu accumulation. Carcinogenesis globinmetabolism.RedoxRep.6,219.
26,1307. 344. Tolosano,Eetal.(2002)Enhancedsplenomegalyand
324. Wang, J et al. (2011) Quantification of oxidative severeliverinflammationinhaptoglobin/hemopexin
DNA lesions in tissues of LEC rats by capillary double-null mice after acute hemolysis. Blood 100,
high-performanceLC-tandemMScoupledwithstable 4201.
isotope-dilutionmethod.Anal.Chem.83,2201. 345. Larsson,Jetal.(2004)Thelipocalinα 1-microglobulin
325. Yamamoto,Hetal.(2001)Invivoevidenceforacceler- bindshemeindifferentspecies.Arch.Biochem.Biophys.
•
atedgenerationofOH inliverofLECratswithacute 432,196.
hepatitis.FreeRadic.Biol.Med.30,547. 346. Fanali, G et al. (2012) Human serum albumin: from
326. Santos,CRAetal.(2012)Neuroprotectiveandneurore- benchtobedside.Mol.AspectsMed.33,209.
generativepropertiesofmetallothioneins.IUBMBLife 347. Colombo,Getal.(2012)Redoxalbuminomics:oxidized
64,126. albumininhumandisease.Antioxid.RedoxSignal.17,
327. Inoue,Ketal.(2008)Roleofmetallothioneininlung 1515.
inflammation induced by O3 exposure in mice. Free 348. Yamamoto,Yetal.(1992)Comparisonofplasmalevels
Radic.Biol.Med.45,1714. oflipidhydroperoxidesandantioxidantsinhyperlip-
328. Li,Xetal.(2004)MTprotectsisletsfromhypoxiaand idemicNagaseanalbuminemicrats,Sprague-Dawley
extendsisletgraftsurvivalbyscavengingmostkinds ratsandhumans.Biochem.Biophys.Res.Commun.189,
ofROS.J.Biol.Chem.279,765. 518.
329. Conrad,CCetal.(2000)UsingMT–/–micetostudyMT 349. Sbarouni, E et al. (2011) Ischemia modified albumin
andoxidativestress.FreeRadic.Biol.Med.28,447. changes–reviewandclinicalimplications.Clin.Chem.
330. Carrasco,Jetal.(2003)RoleofMT-IIIfollowingCNS Lab.Med.49,177.
damage.Neurobiol.Dis.13,22. 350. Gorudko, IV et al. (2014) Hypohalous acid-modified
331. Rea,PA(2012)Phytochelatinsynthase:ofaproteasea human serum albumin induces neutrophil NADPH
peptidepolymerasemade.Physiol.Plant.145,154. oxidaseactivation,degranulation,andshapechange.
332. Lapointe,Setal.(1998)Bindingofabovineoviductal FreeRadic.Biol.Med.68,326.
fluidcatalasetomammalianspermatozoa.Biol.Reprod. 351. Kaiser, VL et al. (2005) Trauma–hemorrhagic shock
58,747. mesentericlymphfromratcontainsamodifiedformof
333. Antonyuk, SV et al. (2009) The structure of human albuminthatisimplicatedinendothelialcelltoxicity.
ECSODat1.7Aresolution:insightsintoheparinand Shock23,417.
collagenbinding.J.Mol.Biol.388,310. 352. Quinlan, GJ et al. (1998) Administration of albu-
334. Fukai,TandUshio-Fukai,M(2011)SODs:roleinredox min to patients with sepsis syndrome: a possible
signaling, vascular function, and diseases. Antioxid. beneficial role in plasma thiol repletion. Clin. Sci.
RedoxSignal.15,1583. 95,459.

--- Page 779 ---

724 REFERENCES
353. Gosriwatana, I et al. (1999) Quantification of non- 371. Reiter,RJetal.(2009)Reducingoxidative/nitrosative
transferrin-bound Fe in the presence of unsaturated stress: a newly-discovered genre for melatonin. Crit.
transferrin.Anal.Biochem.273,212. Rev.Biochem.Mol.Biol.44,175.
354. Calay, D and Mason, JC (2014) The multifunctional 372. Marshall,KAetal.(1996)Evaluationoftheantioxidant
roleandtherapeuticpotentialofHO-1inthevascular activityofmelatonininvitro.FreeRadic.Biol.Med.21,
endothelium.Antioxid.RedoxSignal.20,1789. 307.
355. Williams,SEJetal.(2004)HO-2isanO2 sensorfora 373. Quinn,Jetal.(2005)Chronicmelatonintherapyfails
Ca2+-sensitiveK+channel.Science306,2093. to alter amyloid burden or oxidative damage in old
356. Sedlak,TWetal.(2009)BilirubinandGSHhavecom- Tg2576mice:implicationsforclinicaltrials.BrainRes.
plementaryantioxidantandcytoprotectiveroles.Proc. 1037,209.
Natl.Acad.Sci.USA106,5171. 374. Shay, KP et al. (2009) Alpha-lipoic acid as a dietary
357. Dennery,PAetal.(2003)Resistancetohyperoxiawith supplement: molecular mechanisms and therapeutic
HO-1disruption:roleofFe.FreeRadic.Biol.Med.34, potential.Biochim.Biophys.Acta1790,1149.
124. 375. Stabler, SP et al. (2009) α-Lipoic acid induces ele-
358. Ryter, SW (2012) Bile pigments in pulmonary and vated S-adenosylhomocysteine and depletes SAM.
vasculardisease.Front.Pharmacol.3,39. FreeRadic.Biol.Med.47,1147.
359. Otterbein, L et al. (1995) Hemoglobin provides pro- 376. Lee,WYetal.(2009)Molecularmechanismsoflipoic
tectionagainstlethalendotoxemiainrats:theroleof acid modulation of T-type calcium channels in pain
HO-1.Am.J.Resp.Cell.Mol.Biol.13,595. pathway.J.Neurosci.29,9500.
360. Barañano,DEetal.(2002)Biliverdinreductase:amajor 377. Bentinger,Metal.(2010)CoenzymeQ–biosynthesis
physiologiccytoprotectant.Proc.Natl.Acad.Sci.USA andfunctions.Biochem.Biophys.Res.Commun.396,74.
99,16093. 378. Xia, L et al. (2003) The mammalian cytosolic selen-
361. Yamamoto,Metal.(2008)Biphasicelevationofbiliru- oenyzme thioredoxin reductase reduces ubiquinone.
binoxidationduringmyocardialischemiareperfusion. J.Biol.Chem.278,2141.
Circ.J.72,1520. 379. Do, TQ et al. (1996) Enhanced sensitivity of
362. Liu, Y et al. (2008) Bilirubin possesses powerful im- ubiquinone-deficient mutants of S. cerevisiae to
munomodulatoryactivityandsuppressesexperimen- productsofautoxidizedPUFAs.Proc.Natl.Acad.Sci.
tal autoimmune encephalomyelitis. J. Immunol. 181, USA93,7534.
1887. 380. Franke, AA et al. (2010) Coenzyme Q10 in human
363. Otani,Ketal.(2001)Increasedurinaryexcretionofbili- blood:nativelevelsanddeterminantsofoxidationdur-
rubin oxidative metabolites in septic patients: a new ing processing and storage. Free Radic. Biol. Med. 48,
markerforoxidativestressinvivo.J.Surg.Res.96,44. 1610.
364. Maruhashi, T et al. (2012) Hyperbilirubinemia, aug- 381. Hernández-Ojeda, J et al. (2012) The effect of ubi-
mentation of endothelial function, and decrease in quinone in diabetic polyneuropathy: a randomized
oxidative stress in Gilbert syndrome. Circulation 126, double-blindplacebo-controlledstudy.J.DiabetesCom-
598. plications26,352.
365. Pyne-Geithman,Getal.(2013)Roleofbilirubinoxida- 382. Simic, MG and Jovanovic, SV (1989) Antioxidation
tionproductsinthepathophysiologyofDINDfollow- mechanismsofuricacid.J.Am.Chem.Soc.111,5778.
ingSAH.ActaNeurochir.Suppl.115,267. 383. Rock,KLetal.(2013)Uricacidasadangersigningout
366. Khan,NMandPoduval,TB(2012)Bilirubinaugments anditscomorbidities.Nat.Rev.Rheumatol.9,13.
radiationinjuryandleadstoincreasedinfectionand 384. Wu,Xetal.(1994)Hyperuricaemiaanduratenephrop-
mortalityinmice:molecularmechanisms.FreeRadic. athyinurateoxidase-deficientmice.Proc.Natl.Acad.
Biol.Med.53,1152. Sci.USA91,742.
367. Long, LH and Halliwell, B (2011) Artefacts in cell 385. Johnson, RJ et al. (2009) Lessons from comparative
culture:α-kGcanscavengeH2O2generatedbyascor- physiology: could uric acid represent a physiologic
bateandepigallocatechingallateincellculturemedia. alarm signal gone awry in Western society?J. Comp.
Biochem.Biophys.Res.Commun.406,20. Physiol.B179,67.
368. O’Donnell-Tormey,Jetal.(1987)Secretionofpyruvate. 386. Ames,BNetal.(1981)Uricacidprovidesanantioxi-
An antioxidant defense of mammalian cells. J. Exp. dantdefenseinhumansagainstoxidant-andradical-
Med.165,500.210. caused aging and cancer. A hypothesis. Proc. Natl.
369. Mailloux, RJ et al. (2007) The TCA cycle, an ancient Acad.Sci.USA78,6858.
metabolicnetworkwithanoveltwist.PloSOne2,e690. 387. Gersch,Cetal.(2009)ReactionsofONOO– withuric
370. Lemire, J et al. (2010) Histidine is a source of the acid: formation of reactive intermediates, alkylated
antioxidant, α-kG, in Pseudomonas fluorescens chal- products and triuret, and in vivo production of tri-
lengedbyoxidativestress.FEMSMicrobiol.Lett.309, uret under conditions of oxidative stress. Nucleosides
170. NucleotidesNucleicAcids28,118.

--- Page 780 ---

REFERENCES 725
388. Hershfield,MSetal.(2010)Treatinggoutwithpeglot- cellsbyhistidineascomparedwithotheraminoacids.
icase,aPEGylatedurateoxidase,providesinsightinto Biochim.Biophys.Acta.796,226.
theimportanceofuricacidasanantioxidantinvivo. 405. Cantoni,Oetal.(1994)TheL-histidinemediateden-
Proc.Natl.Acad.Sci.USA107,14351. hancementofH2O2-inducedcytotoxicityisageneral
389. Domazou,ASetal.(2012)Fastrepairofproteinradicals responseinculturedmammaliancelllinesandisal-
byurate.FreeRadic.Biol.Med.52,1929. ways associated with the formation of DNA double
390. Whiteman, M and Halliwell, B (1996) Protection strandbreaks.FEBSLett.353,75.
againstONOO–-dependenttyrosinenitrationandα 1- 406. Schubert, J and Wilmer, JW (1991) Does H2O2 exist
antiproteinase inactivation by ascorbic acid. A com- “free”inbiologicalsystems?FreeRadic.Biol.Med.11,
parisonwithotherbiologicalantioxidants.FreeRadic. 545.
Res.25,275. 407. Bex, T et al. (2014) Muscle carnosine loading by
391. Santus, R et al. (2001) Redox reactions of the urate β-alanine supplementation is more pronounced in
radical/ urate couple with O
•–,
the tryptophan neu- trainedvs.untrainedmuscles.J.Appl.Physiol.116,204.
2
tralradicalandselectedflavonoidsinneutralaqueous 408. Smith-Ryan,AEetal.(2014)Theinfluenceofβ-alanine
solutions.FreeRadic.Res.35,129. supplementationonmarkersofexercise-inducedoxi-
392. Clausen, MR et al. (2010) Characterization of perox- dativestress.Appl.Physiol.Nutr.Metab.39,101.
idesformedbyriboflavinandlightexposureofmilk. 409. Vistoli,Getal.(2006)Homologymodelingofhuman
Detectionofuratehydroperoxideasanoveloxidation serum carnosinase, a potential medicinal target, and
product.J.Agric.Food.Chem.58,481. MD simulations of its allosteric activation by citrate.
393. Seet,RCSetal.(2010)Isuricacidprotectiveordele- J.Med.Chem.49,3269.
teriousinacuteischemicstroke?Aprospectivecohort 410. Alkhalaf,Aetal.(2010)Apolymorphisminthegene
study.Atherosclerosis209,215. encodingcarnosinase(CNDP1)asapredictorofmor-
394. Scott,GSetal.(2005)Uricacidprotectsagainstsecond- talityandprogressionfromnephropathytoend-stage
arydamageafterspinalcordinjury.Proc.Natl.Acad. renaldiseaseintype1diabetesmellitus. Diabetologia
Sci.USA102,3483. 53,2562.
395. McAnulty, SR et al. (2007) Effect of pharmacological 411. Ohtake,SandWang,J(2011)Trehalose:currentuseand
loweringofplasmaurateonexercise-inducedoxida- futureapplications.J.Pharm.Sci.100,2020
tivestress.Appl.Physiol.Nutr.Metab.32,1148. 412. Hearing,VJ(2011)Determinationofmelaninsynthetic
396. Schmidt, A et al. (2013) Emerging neuroprotective pathways.J.Invest.Dermatol.131,E8.
drugs for the treatment of acute ischaemic stroke. 413. Chiarelli-Neto,Oetal.(2011)Generationandsuppres-
ExpertOpin.EmergingDrugs18,109. sionof1O2 inhairbyphotosensitizationofmelanin.
397. Boldyrev, AA (2012) Carnosine: new concept for the FreeRadic.Biol.Med.51,1195.
functionofanoldmolecule.Biochemistry(Moscow)77, 414. Watt, B et al. (2013) PMEL: a pigment cell-specific
313. modelforfunctionalamyloidformation.PigmentCell
398. Hipkiss,AR(2009)Carnosineanditspossiblerolesin MelanomaRes.26,300.
nutritionandhealth.Adv.FoodNutr.Res.57,87. 415. Morgan,AM,Lo,J,andFisher,DE(2013)Howdoes
399. Kubomura, D et al. (2009) Intestinal absorption and pheomelanin synthesis contribute to melanomagen-
bloodclearanceofL-histidine-relatedcompoundsafter esis?Bioessays35,672.
ingestion of anserine in humans and comparison to 416. Takeuchi,Setal.(2004)MelaninactsasapotentUVB
anserine-containingdiets.J.Agric.FoodChem.57,1781. photosensitizertocauseanatypicalmodeofcelldeath
400. Aruoma, OI et al. (1989) Carnosine, homocarnosine inmurineskin.Proc.Natl.Acad.Sci.USA101,15076.
and anserine: could they act as antioxidants in vivo? 417. Galván, I and Alonso-Alvarez, C (2008) An intra-
Biochem.J.264,863. cellular antioxidant determines the expression of a
401. Decker,EAetal.(2000)Are-evaluationoftheantioxi- melanin-basedsignalinabird.PLoSOne3,e3335.
dantactivityofpurifiedcarnosine.Biochem.(Mosc.)65, 418. Eisenman,HCandCasadevall,A(2012)Synthesisand
766. assemblyoffungalmelanin.Appl.Microbiol.Biotechnol.
402. Baba, SP et al. (2013) Role of aldose reductase in the 93,931.
metabolism and detoxification of carnosine-acrolein 419. Rosie,NNandDove,S(2011)Mycosporine-likeamino
conjugates.J.Biol.Chem.288,28163. acidsfromcoraldinoflagellates.Appl.Environ.Micro-
403. Pattison,DIandDavies,MJ(2006)Evidenceforrapid biol.77,8478.
inter-andintramolecularCltransferreactionsofhista- 420. Balskus,EPandWalsh,CT(2010)Thegeneticandmo-
mineandcarnosinechloramines:implicationsforthe lecular basis for sunscreen biosynthesis in cyanobac-
prevention of HOCl-mediated damage. Biochemistry teria.Science329,1653.
45,8152. 421. Ide,Tetal.(2002)Greateroxidativestressinhealthy
404. Winkler,Petal.(1984)SelectivepromotionofFe2+ion- young men compared with premenopausal women.
dependentlipidperoxidationinEhrlichascitestumor Arterio.Thromb.Vasc.Biol.22,438.

--- Page 781 ---

726 REFERENCES
422. Nakano, M et al. (2003) Oxidative DNA damage 9. Braun,Letal.(1999)Inductionandperoxisomalap-
(8OHdG)andbodyFestatus:astudyof2507healthy pearance of gulonolactone oxidase upon clofibrate
people.FreeRadic.Biol.Med.35,826. treatmentinmouseliver.FEBSLett.458,359.
423. Bayir,Hetal.(2004)Markedgendereffectonlipidper- 10. Clement,MVetal.(2001)Theinvitrocytotoxicityof
oxidationafterseveretraumaticbraininjuryinadult ascorbate depends on the culture medium used to
patients.J.Neurotrauma21,1. performtheassayandinvolvesH2O2.Antiox.Redox
424. Gangestad,SWetal.(2010)Men’soxidativestress,fluc- Signal.3,157.
tuatingasymmetryandphysicalattractiveness.Anim. 11. McCall,MRandFrei,B(1999)Canantioxidantvita-
Behav.80,1005. mins materially reduce oxidative damage in hu-
425. Kim, J et al. (2006) Orchiectomy attenuates post- mans?FreeRadic.Biol.Med.26,1034.
ischemic oxidative stress and ischemia/reperfusion 12. Du,J etal.(2012)Ascorbicacid:chemistry,biology
injuryinmice.J.Biol.Chem.281,20349. and the treatment of cancer. Biochim. Biophys. Acta
426. Zhang,QG etal.(2009)Estrogenattenuatesischemic 1826,443.
oxidativedamageviaanestrogenreceptorα-mediated 13. Levine,Metal.(2001)Anewrecommendeddietary
inhibitionofNOXactivation.J.Neurosci.29,13823. allowance of vitamin C for healthy young women.
427. Okoh,Vetal.(2011)Estrogen-inducedROS-mediated Proc.Natl.Acad.Sci.USA98,9842.
signalingscontributetobreastcancer.Biochim.Biophys. 14. Harrison, FE et al. (2010) Low vitamin C and in-
Acta1815,115. creased oxidative stress and cell death in mice
428. Wiseman, H and Halliwell, B (1993) Carcinogenic thatlacktheNa+-dependentvitaminCtransporter
antioxidants: diethylstilboestrol, hexoestrol and 17α- SVCT2.FreeRadic.Biol.Med.49,821.
ethynyloestradiol.FEBSLett.322,159. 15. Tveden-Nybord,Petal.(2012)ChronicvitaminCde-
429. Viña,JandBorrás,C(2010)Womenlivelongerthan ficiencydoesnotaccelerateoxidativestressinageing
men:understandingmolecularmechanismsoffersop- brains of guinea pigs. Basic Clin Pharmacol. Toxicol.
portunities to intervene by using estrogenic com- 110,524.
pounds.AntioxidRedoxSignal.13,269. 16. Harrison,FEetal.(2010)VitaminCdistributionand
430. Grassi, F et al. (2007) Oxidative stress causes bone retentioninthemousebrain.BrainRes.1348,181.
lossinestrogen-deficientmicethroughenhancedbone 17. Kojo, S (2004) Vitamin C: basic metabolism and its
marrowdendriticcellactivation.Proc.Natl.Acad.Sci. functionasanindexofoxidativestress.Curr.Med.
USA104,15087. Chem.11,1041.
18. Reddell,LandCotton,BA(2012)Antioxidantsand
micronutrient supplementation in trauma patients.
Curr.Opin.Clin.Nutr.Metab.Care15,181.
Chapter4
19. Kasahara, E et al. (2009) Dynamic aspects of ascor-
1. Boeing, B et al. (2012) Critical review: vegetables bic acid metabolism in the circulation: analysis by
andfruitinthepreventionofchronicdiseases.Eur. ascorbateoxidasewithaprolongedinvivohalf-life.
J.Nutr.51,637. Biochem.J.421,293.
2. Buchowski,MSetal.(2012)Effectofmodestcaloric 20. Lenton,KJetal.(2003)VitaminCaugmentslymph-
restrictiononoxidativestressinwomen,arandom- ocyteGSHinsubjectswithascorbatedeficiency.Am.
izedtrial.PLoSOne7,e47079. J.Clin.Nutr.77,189.
3. Leenders, M et al. (2013) Fruit and vegetable con- 21. Kadiiska,MBetal.(1995)Fesupplementationgener-
•
sumptionandmortality:Europeanprospectivecon- atesOH invivo.J.Clin.Invest.96,1653.
sumptionandmortalityAm.J.Epidemiol.178,590. 22. Maskos, Z and Koppenol, WH (1991) Oxyradic-
4. Bellavia, A et al. (2013) Fruit and vegetable con- als and multivitamin tablets. Free Radic. Biol. Med.
sumption and all-cause mortality: a dose-response 11,609.
analysis.Am.J.Clin.Nutr.98,454. 23. Jansson, PJ et al. (2005) Fe prevents ascorbic acid
5. Bradshaw, MP et al. (2011) Ascorbic acid: a review (vitaminC)inducedH2O2accumulationinCucon-
ofitschemistryandreactivityinrelationtoawine taminateddrinkingwater.FreeRadic.Res.39,1233.
environment.Crit.Rev.FoodSci.Nutr.51,479. 24. Barton,JCetal.(1998)Managementofhemochroma-
6. Linster, CL and Van Schaftingen, E (2007) Vitamin tosis.Ann.Intern.Med.129(Suppl.11S),932.
C.Biosynthesis,recyclinganddegradationinmam- 25. Arruda, MM et al. (2013) Antioxidant vitamins C
mals.FEBSJ.274,1. andEsupplementationincreasesmarkersofhaem-
7. Carpenter, KJ (2012) The discovery of vitamin C. olysis in sickle cell anaemia patients: a random-
Ann.Nutr.Metab.61,259. ized, double-blind, placebo-controlled trial. Brit.
8. Michels,AJetal.(2013)Humangeneticvariationin- J.Haematol.160,688.
fluencesvitaminChomeostasisbyalteringvitamin 26. Allen, A et al. (2012) Methemoglobinemia and as-
Ctransportandantioxidantenzymefunction.Annu. corbate deficiency in hemoglobin E β thalassemia:
Rev.Nutr.33,45. metabolicandclinicalimplications.Blood120,2939.

--- Page 782 ---

REFERENCES 727
27. Conner,TAetal.(2012)Effectofintravenousvitamin andtheirroleindiseasepreventionandtherapy.Free
Concytokineactivationandoxidativestressinend- Radic.Biol.Med.72,76.
stagerenaldiseasepatientsreceivingintravenousFe 47. Sundram, K et al. (2003) Palm fruit chemistry and
sucrose.Biometals25,961. nutrition.AsiaPac.J.Clin.Nutr.12,355.
28. Fletcher,RH(2013)Theriskoftakingascorbicacid. 48. Fujisawa,Aetal.(2010)VitaminEprotectioninthe
JAMAIntern.Med.173,388. biochemicaladaptationofmarineorganismstocold-
29. Halliwell,BandGutteridgeJMC(1990)Theantioxi- water environments. Comp. Biochem. Physiol. B 157,
dants of human extracellular fluids. Arch. Biochem. 145.
Biophys.280,1. 49. Burton,GWetal.(1990)BiokineticsofdietaryRRR-
30. Fan, X et al. (2006) Vitamin C mediates chemical α-tocopherolinthemaleguinea-pigatthreedietary
agingoflenscrystallinsbytheMaillardreactionina levelsofvitaminCandtwolevelsofvitaminE.Lipids
humanizedmousemodel.Proc.Natl.Acad.Sci.USA 25,199.
103,16912. 50. Burk,RFetal.(2006)Acombineddeficiencyofvita-
31. Levine,Metal.(1996)VitaminCpharmacokinetics minsEandCcausessevereCNSdamageinguinea
inhealthyvolunteers:evidenceforarecommended pigs.J.Nutr.136,1576.
dietaryallowance.Proc.Natl.Acad.Sci.USA93,3704. 51. Sealey,WMandGatlinIII,DM.(2002)Dietaryvita-
32. Hemilä, H and Chalker, E (2013) Vitamin C for minCandvitaminEinteracttoinfluencegrowthand
preventingandtreatingthecommoncold.Cochrane tissue composition of juvenile hybrid striped bass
♀ ♂
DatabaseSyst.Rev.1,CD000980. (Moronechrysops xM.saxatilis )buthavelimited
33. Traber,MGandStevens,JF(2011)VitaminsCandE: effectsonimmuneresponses.J.Nutr.132,748.
beneficialeffectsfromamechanisticperspective.Free 52. Steger,PJKandMühlebach,SF(1998)Lipidperoxid-
Radic.Biol.Med.51,1000. ationofIVlipidemulsionsinTPNbags:theinfluence
34. Brigelius-Flohé,R(2009)VitaminE:theshrewwait- oftocopherols.Nutrition14,179.
ingtobetamed.FreeRadic.Biol.Med.46,543. 53. Weinberg,RBetal.(2001)Pro-oxidanteffectofvita-
35. Niki,E(2014)RoleofvitaminEasalipid-solubleper- minEincigarettesmokersconsumingahighpoly-
oxylradicalscavenger:invitroandinvivoevidence. unsaturated fat diet. Arterio. Thromb. Vasc. Biol. 21,
FreeRadic.Biol.Med.66,3. 1029.
36. Lerf,Retal.(2010)UseofvitaminEtoprotectcross- 54. Traber,MG(2013)Mechanismsforthepreventionof
linked UHMWPE from oxidation. Biomaterials 31, vitaminEexcess.J.LipidRes.54,2295.
3643. 55. Borel, P et al. (2013) Bioavailability of vitamin E in
37. Kaikkonen,Jetal.(2001)Supplementationwithvita- humans:anupdate.Nutr.Rev.71,319.
minEbutnotwithvitaminClowerslipidperoxida- 56. Zingg,Jetal.(2008)Geneticpolymorphismsasde-
tioninvivoinmildlyhypercholesterolemicmen.Free terminantsfordisease-preventiveeffectsofvitamin
Radic.Res.35,967. E.Nutr.Rev.66,406.
38. Meagher,EAetal.(2001)EffectsofvitaminEonlipid 57. Wu,JHYetal.(2005)Nitrationofγ-tocopherolpre-
peroxidationinhealthypersons.JAMA285,1178. ventsitsoxidativemetabolismbyHepG2cells.Free
39. Roberts,LJIIetal.(2007)Therelationshipbetween Radic.Biol.Med.39,483.
doseofvitaminEandsuppressionofoxidativestress 58. McCary, CA et al. (2011) Supplemental and highly
inhumans.FreeRadic.Biol.Med.43,1388. elevatedtocopheroldosesdifferentiallyregulateal-
40. Taylor, AW et al. (2008) Women and smokers have lergicinflammation:reversibilityofα-tocopheroland
elevatedurinaryF2-IsoPmetabolites:anovelextrac- γ-tocopherol’seffects.J.Immunol.186,3674.
tionandLC-MSmethodology.Lipids43,925. 59. Grune,Tetal.(2001)Enrichmentofeggswithn-3PU-
41. Zingg,JMandAzzi,A(2004)Non-antioxidantactiv- FAs:effectsofvitaminEsupplementation.Lipids36,
itiesofvitaminE.Curr.Med.Chem.11,1113. 833.
42. Diplock,AT(1985)Fatsolublevitamins:theirbiochem- 60. Awad, JA et al. (1994) Detection and localization
istryandapplications.Heinemann. of lipid peroxidation in selenium and vitamin E-
43. Dierenfeld, ES (1989) Vitamin E deficiency in zoo deficientratsusingF2-IsoPs.J.Nutr.124,810.
reptiles,birdsandungulates.J.ZooWildlifeMed.20,3. 61. Yoshida, Y et al. (2007) Evaluation of lipophilic
44. Willy,Cetal.(1995)ImpactofvitaminEsupplement antioxidant efficacy in vivo by the biomarkers hy-
instandardlaboratoryanimaldietonmicrovascular droxyoctadecadienoicacidandIsoP.Lipids42,463.
manisfestation of ischemia/reperfusion injury. Free 62. Lebold,KMetal.(2014)NovelLC-MSmethodshows
Radic.Biol.Med.19,919. that vitamin E deficiency depletes AA and DHA
45. Muller,DPRandGoss-Sampson,MA(1990)Neuro- in zebrafish (Danio rerio) embryos. Redox Biol. 2,
chemical,neurophysiologicalandneuropathological 105.
studiesinvitaminEdeficiency.Crit.Rev.Neurobiol.5, 63. Navarro, F et al. (1998) Vitamin E and Se de-
239. ficiency induces expression of the ubiquinone-
46. Jiang,Q(2014)NaturalformsofvitaminE:metab- dependent antioxidant system at the plasma mem-
olism, antioxidant, and anti-inflammation activities brane.FASEBJ.12,1665.

--- Page 783 ---

728 REFERENCES
64. Yan, A et al. (2007) Tocopheryl PEG succinate as 82. Ford, NA and Erdman, JW Jr (2012) Are lycopene
asafe,antioxidantsurfactantforprocessingcarbon metabolites metabolically active? Acta Biochim. Pol.
nanotubesandfullerenes.Carbon45,2463. 59,1.
65. Kelley, EE et al. (1995) Relative α-tocopherol defi- 83. Yeh, SL and Hu, ML (2001) Induction of oxidative
ciency in cultured cells: free radical-mediated lipid DNAdamageinhumanforeskinfibroblastHs68cells
peroxidation,lipidoxidizability,andcellularPUFA byoxidizedβ-caroteneandlycopene.FreeRadic.Res.
content.Arch.Biochem.Biophys.319,102. 35,203.
66. Howard,ACetal.(2011)Promotionofplasmamem- 84. Linnewiel,Ketal.(2009)Structureactivityrelation-
branerepairbyvitaminE.Nat.Commun.2,597. ship of carotenoid derivatives in activation of the
67. Angulo-Molina,Aetal.(2014)Theroleofα-TOSasa electrophile/ARE transcription system. Free Radic.
potentialanticanceragent.Nutr.Cancer66,167. Biol.Med.47,659.
68. Aggarwal,BBetal.(2010)Tocotrienols,thevitamin 85. Alija,AJetal.(2010)Cytotoxicityofβ-carotenecleav-
Eofthe21stcentury:itspotentialagainstcancerand ageproductsanditspreventionbyantioxidants.Acta
otherchronicdiseases.Biochem.Pharmacol.80,1613. Biochim.Pol.57,217.
69. O’Byrne. D et al. (2000) Studies of LDL oxidation 86. XuXetal.(1999)Solubilizationandstabilizationof
followingα-,γ-orδ-tocotrienylacetatesupplemen- carotenoids using micelles: delivery of lycopene to
tation of hypercholesterolemic humans. Free Radic. cellsinculture.Lipids34,1031.
Biol.Med.29,834. 87. Thapa,DandGhosh,R(2012)Antioxidantsforpros-
70. Patel,Vetal.(2012)Oraltocotrienolsaretransported tatecancerchemoprevention:challengesandoppor-
to human tissues and delay the progression of the tunities.Biochem.Pharmacol.83,1319.
model for end-stageliverdiseasescorein patients. 88. Rice-Evans,Cetal.(1996)Structure-antioxidantac-
J.Nutr.142,513. tivityrelationshipsofflavonoidsandphenolicacids.
71. Park, Han-A et al. (2011) Natural vitamin E α- FreeRadic.Biol.Med.20,933.
tocotrienolprotectsagainstischemicstrokebyinduc- 89. Chu,KOetal.(2014)Pro-oxidativeandantioxidative
tionofMRP1.Stroke42,2308. controlsandsignalingmodificationofpolyphenolic
72. CarotenoidsVolumes1A,1B,2,3,4,5,andhandbook. phytochemicals: contribution to health promotion
G. Britton, S. Liaaen-Jensen, and H. Pfander (eds). anddiseaseprevention?J.Agric.FoodChem.62,4026.
BirkhauserVerlag,2004. 90. Taubert, D et al. (2003) Reaction rate constants of
73. Ross, AB et al. (2011) Lycopene bioavailability and O
•–scavengingbyplantantioxidants.FreeRadic.Biol.
2
metabolism in humans: an accelerator mass spec- Med.35,1599.
trometrystudy.Am.J.Clin.Nutr.93,1263. 91. Del Rio, D et al. (2013) Dietary (poly)phenolics in
74. Lietz, G et al. (2012) Importance of β,β-carotene human health: structures, bioavailability, and evi-
15,15’-monooxygenase1(BCMO1)andβ,β-carotene denceofprotectiveeffectsagainstchronicdiseases.
9’,10’-dioxygenase 2 (BCDO2) in nutrition and Antioxid.RedoxSignal.18,1818.
health.Mol.Nutr.FoodRes.56,241. 92. Walle,Tetal.(2001)CO2 isthemajormetaboliteof
75. Garratt, M and Brooks, RC (2012) Oxidative stress quercetininhumans.J.Nutr.131,2648.
andcondition-dependentsexualsignals:morethan 93. Manach,Cetal.(2004)Polyphenols:foodsourcesand
justseeingred.Proc.R.Soc.B.279,3121. bioavailability.Am.J.Clin.Nutr.79,727.
76. Böhm,Fetal.(2012)Interactionsofdietarycaroten- 94. Wang X et al. (2014) Flavonoid intake and risk of
oidswithactivated1O2 andfreeradicals:potential CVD:asystematicreviewandmeta-analysisofpro-
effectsforhumanhealth.Mol.Nutr.FoodRes.56,205. spectivecohortstudies.Brit.J.Nutr.111,1.
77. Skibsted,LH(2012)Carotenoidsinantioxidantnet- 95. Halliwell, B et al. (2005) Health promotion by fla-
works.Colorantsorradicalscavengers?J.Agric.Food vonoids,tocopherols,tocotrienolsandotherphenols.
Chem.60,2409. Direct or indirect effects? Antioxidant or not? Am.
78. Stahl,WandSies,H(2012)Photoprotectionbydiet- J.Clin.Nutr.81(Suppl.),268S.
arycarotenoids:concept,mechanisms,evidenceand 96. Ravishankar,Detal.(2013)Flavonoidsasprospective
futuredevelopment.Mol.Nutr.Food.Res.56,287. compounds for anti-cancer therapy. Int. J. Biochem.
79. Hatta, A and Frei, B (1995) Oxidative modification CellBiol.45,2821.
and antioxidant protection of human LDL at high 97. Page, M et al. (2012) The influence of ascorbate on
andlowO2partialpressures.J.LipidRes.36,2383. anthocyaninaccumulationduringhighlightacclima-
80. Gelain,DPetal.(2006)RetinolinducestheERK1/2- tioninArabidopsisthaliana:furtherevidenceforredox
dependentphosphorylationofCREBthroughapath- controlofanthocyaninsynthesis.PlantCellEnviron.
way involving the generation of ROS in cultured 35,388.
Sertolicells.CellSignal.18,1685. 98. Agati,Getal.(2013)Functionalrolesofflavonoids
81. Pasquali, MAetal. (2010)VitaminA supplementa- inphotoprotection:newevidence,lessonsfromthe
tion to pregnant and breastfeeding female rats in- past.PlantPhysiol.Biochem.72,35.
ducesoxidativestressintheneonatallung.Reprod. 99. Frankel, EN et al. (1995) Principal phenolic phyto-
Toxicol.30,452. chemicals in selected California wines and their

--- Page 784 ---

REFERENCES 729
antioxidantactivityininhibitingoxidationofhuman 115. Ugliano, M (2013) O2 contribution to wine aroma
LDL.J.Agric.FoodChem.43,890. evolutionduringbottleaging.J.Agric.FoodChem.61,
100. Mukai,Ketal.(2005)Structure–activityrelationship 6125.
ofthetocopherol-regenerationreactionbycatechins. 116. Vinod, BS et al. (2013) Phytochemicals as chemo-
FreeRadic.Biol.Med.38,1243. sensitizers: from molecular mechanism to clinical
101. Loke, WM et al. (2010) Specific dietary polyphe- significance.Antioxid.RedoxSignal.18,1307.
nols attenuate atherosclerosis in apolipoprotein E- 117. Halliwell,B(2008)Arepolyphenolsantioxidantsor
knockout mice by alleviating inflammation and pro-oxidants?Whatdowelearnfromcellcultureand
endothelial dysfunction. Arterioscler. Thromb. Vasc. invivostudies?Arch.Biochem.Biophys.476,107.
Biol.30,749. 118. Halliwell,Betal.(2004)Establishingbiomarkersof
102. Khan, F et al. (2014) Lowering of oxidative stress oxidative stress. The measurement of H2O2 in hu-
improves endothelial function in healthy subjects manurine.Curr.Med.Chem.11,1085.
with habitually low intake of fruit and vegetables: 119. Cai, W et al. (2012) Curcumin targeting the
a randomized controlled trial of antioxidant- and thioredoxinsystemelevatesoxidativestressinHeLa
polyphenol-rich blackcurrant juice. Free Radic. Biol. cells.Toxicol.Appl.Pharmacol.262,341.
Med.72,232. 119A. Ketron, AC et al. (2013) Oxidative metabolites of
103. Lu, YP et al. (2001) Inhibitory effects of orally ad- curcuminpoisonhumantypeIItopoisomerases.Bio-
ministeredgreentea,blacktea,andcaffeineonskin chemistry.52,221.
carcinogenesisinmicepreviouslytreatedwithUVB 120. Packer,Letal.(2004)HerbalandTraditionalMedicine.
light(high-riskmice):relationshiptodecreasedtis- MolecularAspectsofHealth.MarcelDekker,NewYork,
suefat.CancerRes.61,5002. USA.
104. Shanely,RAetal.(2010)Quercetinsupplementation 121. Tang, SY et al. (2004) Mechanism of cell death in-
does not alter antioxidant status in humans. Free ducedbyanantioxidantextractofCratoxylumcoch-
Radic.Res.44,224. inchinense(YCT)inJurkatTcells:theroleofROSand
105. Lee,CYetal.(2006)Cautionsintheuseofbiomarkers Ca2+.FreeRadic.Biol.Med.36,1588.
ofoxidativedamage:thevascularandantioxidantef- 122. Verbeek,Retal.(2005)Oralflavonoidsdelayrecov-
fectsofdarksoysauceinhumans.Biochem.Biophys. eryfromexperimentalautoimmuneencephalomyeli-
Res.Commun.344,906. tisinmice.Biochem.Pharmacol.70,220.
106. Schrieks,ICetal.(2013)Effectofredwineconsump- 123. Salminen, WF et al. (2012) Green tea extract can
tiononbiomarkersofoxidativestress.AlcoholAlcohol potentiateacetaminophen-inducedhepatotoxicityin
48,153. mice.FoodChem.Toxicol.50,1439.
107. Vissers, MN et al. (2001) Effect of consumption of 124. Lim, GP et al. (2001) The curry spice curcumin re-
phenolsfromolivesandextravirginoliveoilonLDL ducesoxidativedamageandamyloidpathologyin
oxidizabilityinhealthyhumans.FreeRadic.Res.35, anAlzheimertransgenicmouse.J.Neurosci.21,8370.
619. 125. Schaffer, S and Halliwell B (2012) Do polyphenols
108. Machowetz,Aetal.(2007)Effectofoliveoilsonbio- enterthebrainanddoesitmatter?Sometheoretical
markers of oxidative DNA stress in Northern and andpracticalconsiderations.GenesNutr.7,99.
SouthernEuropeans.FASEBJ.21,45. 126. Bjelakovic,G,Nikolova,D,andGluud,C(2014)Anti-
109. Vauzour, D et al. (2010) Moderate champagne oxidantsupplementsandmortality.Curr.Opin.Clin.
consumption promotes an acute improvement in Nutr.Metab.Care17,40.
acute endothelial-independent vascular function in 127. Goodman, M et al. (2011) Clinical trials of antioxi-
healthyhumanvolunteers.Br.J.Nutr.103,1168. dantsascancerpreventionagents:past,present,and
110. Williams, RJ and Spencer, JPE (2012) Flavonoids, future.FreeRadic.Biol.Med.51,1068.
cognition, anddementia:actions,mechanisms,and 128. Morens,DMetal.(1996)Case-controlstudyofidio-
potential therapeutic utility for Alzheimer disease. pathicPDanddietaryvitaminEintake.Neurology46,
FreeRadic.Biol.Med.52,35. 1270.
111. Kawai,Y(2011)Immunochemicaldetectionoffood- 129. Gey, KF (1995) Ten-year retrospective on the anti-
derivedpolyphenolsintheaorta:macrophagesasa oxidant hypothesis of arteriosclerosis: threshold
major target underlying the anti-atherosclerotic ac- plasma level of antioxidant micronutrients related
tivityofpolyphenols.Biosci.Biotechnol.Biochem.75, to minimum cardiovascular risk. J. Nutr. Biochem.
609. 6,206.
112. Steffen, Y et al. (2008) Mono-O-methylated flavan- 130. Kardinaal, AF et al. (1993) Antioxidants in adi-
olsandotherflavonoidsasinhibitorsofendothelial pose tissue and risk of myocardial infarctions: the
NADPHoxidase.Arch.Biochem.Biophys.469,209. EURAMICstudy.Lancet342,1379.
113. August,DAetal.(1999)Ingestionofgreentearapidly 131. Hankey, GJ (2012) Vitamin supplementation and
decreasesprostaglandinE2levelsinrectalmucosain strokeprevention.Stroke43,2814.
humans.CancerEpidemiol.Biomark.Prev.8,709. 132. Su, LCJ et al. (1998) Differences between plasma
114. Katz,DLetal.(2011)Cocoaandchocolateinhuman and adipose tissue biomarkers of carotenoids and
healthanddisease.Antioxid.RedoxSignal.15,2779. tocopherols.CancerEpidemiol.Biomark.Prev.7,1043.

--- Page 785 ---

730 REFERENCES
133. Dauchet,Letal.(2009)Fruits,vegetablesandcoron- CambridgeHeartAntioxidantStudy(CHAOS)Lan-
aryheartdisease.Nat.Rev.Cardiol.6,599. cet347,781.
134. Perry,JRBetal.(2009)Circulatingβ-carotenelevels 150. Blum,Setal.(2010)TheeffectofvitaminEsupple-
andtype2diabetes–causeoreffect?Diabetologia52, mentationoncardiovascularriskindiabeticindivid-
2117. ualswithdifferenthaptoglobinphenotypes.Athero-
135. Thyagarajan, B et al. (2011) Serum carotenoid con- sclerosis211,25.
centrationspredictlungfunctionevolutioninyoung 151. Salonen,RMetal.(2003)Six-yeareffectofcombined
adults: the Coronary Artery Risk Development in vitaminCandEsupplementationonatherosclerotic
YoungAdults(CARDIA)study.Am.J.Clin.Nutr.94, progression:theASAPstudy.Circulation107,947.
1211. 152. Kelemen,Metal.(2005)Hormonetherapyandanti-
136. Halliwell,B(1999)Establishingthesignificanceand oxidantvitaminsdonotimproveendothelialvaso-
optimalintakeofdietaryantioxidants:thebiomarker dilatorfunctioninpostmenopausalwomanwithes-
concept.Nutr.Rev.57,104. tablishedcoronaryarterydisease:asubstudyofthe
137. Sesso,HDetal.(2002)Comparisonofbaselinechar- WAVEtrial.Atherosclerosis179,193.
acteristics and mortality experience of participants 153. Lee,IMetal.(2005)VitaminEintheprimarypreven-
and nonparticipants in a randomized clinical trial: tionofcardiovasculardiseaseandcancer.JAMA294,
thePhysicians’HealthStudy.Control.Clin.Trials23, 56.
686. 154. Brown,BGetal.(2001)Simvastatinandniacin,anti-
138. Bailey, RL et al. (2013) Why US adults use dietary oxidantvitamins,orthecombinationforthepreven-
supplements.JAMAIntern.Med.173,355. tionofcoronarydisease.N.Engl.J.Med.345,1583.
139. Schleicher,RLetal.(2009)SerumvitaminCandthe 155. Liu,Setal.(2006)VitaminEandriskoftype2dia-
prevalenceofvitaminCdeficiencyintheUSA:2003– betes in the Women’s Health Study randomized
2004 National Health and Nutrition Examination controlledtrial.Diabetes55,2856.
Survey(NHANES).Am.J.Clin.Nutr.90,1252. 156. Schürks,Metal.(2010)EffectsofvitaminEonstroke
140. Halliwell, B (2012) The antioxidant paradox: less subtypes: meta-analysis of randomized controlled
paradoxicalnow.Br.J.Clin.Pharmacol.75,637. trials.BMJ341,c5702.
141. Guardiola,Fetal.(2007)Lackofeffectoforalsupple- 157. Block,Getal.(2008)TheeffectofvitaminsCandEon
mentationwithantioxidantsonCOPconcentration biomarkersofoxidativestressdependsonbaseline
ofhumanplasma,asrevealedbyanimprovedGC level.FreeRadic.Biol.Med.45,377.
method.Anal.Bioanal.Chem.389,277. 158. Vardi, M et al. (2013) Vitamin E in the prevention
142. Priemé,Hetal.(1997)Noeffectofsupplementation ofcardiovasculardisease:theimportanceofproper
with vitamin E, ascorbic acid, or CoQ10 on oxida- patientselection.J.LipidRes.54,2307.
tiveDNAdamageestimatedby8OHdGexcretionin 159. Qiao YL et al. (2009) Total and cancer mortality
smokers.Am.J.Clin.Nutr.65,503. after supplementation with vitamins and minerals:
143. Meyer,KAetal.(2013)Dietarypatternsareassoci- follow-up of the Linxian general population nutri-
atedwithplasmaF2-IsoPsinanobservationalcohort tioninterventiontrial.J.Natl.CancerInst.101,507.
studyofadults.FreeRadic.Biol.Med.57,201. 160. Kristal,ARetal.(2014)BaselineSestatusandeffects
144. Lee,CYetal.(2009)Limitedantioxidanteffectafter of Se and vitamin E supplementation on prostate
consumption of a single dose of tomato sauce by cancerrisk.J.Natl.CancerInst.106,djt456.
youngmales,despiteariseinplasmalycopene.Free 161. Hercberg, S (2005) The history of β-carotene and
Radic.Res.43,622. cancers:fromobservationaltointerventionstudies.
145. Dragsead,LOetal.(2004)The6-a-daystudy:effects What lessons can be drawn for future research on
offruitandvegetablesonmarkersofoxidativestress polyphenols?Am.J.Clin.Nutr.81(Suppl.),218S.
and antioxidative defense in healthy nonsmokers. 162. Wright,MEetal.(2004)Developmentofacompre-
Am.J.Clin.Nutr.79,1060. hensivedietaryantioxidantindexandapplicationto
146. Crane,TEetal.(2011)Increasingthevegetableintake lung cancer risk in a cohort of male smokers. Am.
doseisassociatedwithariseinplasmacarotenoids J.Epidemiol.160,68.
without modifying oxidative stress or inflamma- 163. Duffield-Lillico,AJandBegg,CB(2004)Reflections
tioninoverweightorobesepostmenopausalwomen. onthelandmarkstudiesofβ-carotenesupplementa-
J.Nutr.141,1827. tion.J.Natl.Cancer.Inst.96,1729.
147. McAnulty, SR et al. (2005) Effect of daily fruit in- 164. Neuhouser,MLetal.(2003)Fruitsandvegetablesare
gestion on angiotensin converting enzyme activ- associated with lower lung cancer risk only in the
ity, blood pressure, and oxidative stress in chronic placebo arm of the β-carotene and retinol efficacy
smokers.FreeRadic.Res.39,1241. trial(CARET).CancerEpidemiol.Biomark.Prevent.12,
148. Ambring,Aetal.(2004)EffectsofaMediterranean- 350.
inspireddietonbloodlipids,vascularfunctionand 165. Satia, JA et al. (2009) Long-term use of β-carotene,
oxidativestressinhealthysubjects.Clin.Sci.106,519. retinol,lycopene,andluteinsupplementsandlung
149. Stephens, NG et al. (1996) Randomised controlled cancerrisk:resultsfromtheVITaminsAndLifestyle
trialofvitaminEinpatientswithcoronarydisease: (VITAL)study.Am.J.Epidemiol.169,815.

--- Page 786 ---

REFERENCES 731
166. Paolini, M et al. (2001) Induction of CYP enzymes 182. Miyake, Y et al. (2011) Dietary intake of antioxi-
and over-generation of O2 radicals in β-carotene dant vitamins and risk of Parkinson’s disease: a
supplementedrats.Carcinogenesis22,1483. case-controlstudyinJapan.Eur.J.Neurol.18,106.
167. Kim,JandKim,Y(2011)Animalsmodelsincarot- 183. Forster,MJetal.(2000)Reversibleeffectsoflong-term
enoidsresearchandlungcancerprevention.Transl. CRonproteinoxidativedamage.J.Gerontol.55,B522.
Oncol.4,271. 184. Radak,Zetal.(2001)Regularexerciseimprovescog-
168. Péneau,Setal.(2011)Fruitandvegetableintakeand nitivefunctionanddecreasesoxidativedamageinrat
cognitivefunctionintheSU.VI.MAX2prospective brain.Neurochem.Int.38,17.
study.Am.J.Clin.Nutr.94,1295. 185. Devore, EE et al. (2013) The association of antioxi-
169. Briancon,Setal.(2011)Long-termantioxidantsup- dantsandcognitionintheNurses’HealthStudy.Am.
plementation has no effect on health-related qual- J.Epidemiol.177,33.
ity of life: the randomized, double-blind, placebo- 186. Harrison,FE(2012)AcriticalreviewofvitaminCfor
controlled,primarypreventionSU.VI.MAXtrial.Int. thepreventionofage-relatedcognitivedeclineand
J.Epidemiol.40,1605. Alzheimer’sdisease.J.AlzheimersDis.29,711.
170. Ezzedine, K et al. (2010) Incidence of skin cancers 187. deJager,CAetal.(2014)Criteriaforvalidationand
during 5-year follow-up after stopping antioxidant selection of cognitive tests for investigating the ef-
vitaminsandmineralsupplementation.Eur.J.Cancer fectsoffoodsandnutrients.Nutr.Rev.72,162.
46,3316. 188. Reich,EEetal.(2001)InteractionsbetweenapoEgene
171. Holmquist,Cetal.(2003)Multivitaminsupplements anddietaryα-tocopherolinfluencecerebraloxidative
areinverselyassociatedwithriskofmyocardialin- damageinagedmice.J.Neurosci.21,5993.
farction in men and women-Stockholm heart epi- 189. Rendeiro,Cetal.(2012)Blueberrysupplementation
demiologyprogram(SHEEP).J.Nutr.133,2650. inducesspatialmemoryimprovementsandregion-
172. Gaziano,JMetal.(2012)Multivitaminsinthepreven- specific regulation of hippocampal BDNF mRNA
tionofcancerinmen.ThePhysicians’HealthStudy expression in young rats. Psychopharmacology 223,
IIrandomizedcontrolledtrial.JAMA308,1871. 319.
173. Myung,SKetal.(2013)Efficacyofvitaminandanti- 190. Rodriguez-Mateos,Aetal.(2013)Intakeandtimede-
oxidantsupplementsinpreventionofcardiovascular pendenceofblueberryflavonoid-inducedimprove-
disease:systematicreviewandmeta-analysisofran- ments in vascular function: a randomized, con-
domizedcontrolledtrials.BMJ346,f10. trolled, double-blind, crossover intervention study
174. Macpherson, H et al. (2013) Multivitamin- withmechanisticinsightsintobiologicalactivity.Am.
multimineral supplementation and mortality: a J.Clin.Nutr.98,1179.
meta-analysis of randomized controlled trials. Am. 191. Butchart,Cetal.(2011)Flavonoidintakeinrelation
J.Clin.Nutr.97,437. tocognitivefunctioninlaterlifeintheLothianBirth
175. Thies,Fetal.(2012)Effectofatomato-richdieton Cohort1936.Br.J.Nutr.106,141.
markersofcardiovasculardiseaseriskinmoderately 192. Devore, EE et al. (2012) Dietary intakes of berries
overweight,disease-free,middle-agedadults:aran- andflavonoidsinrelationtocognitivedecline.Ann.
domizedcontrolledtrial.Am.J.Clin.Nutr.95,1013. Neurol.72,135.
176. Ilic, D et al. (2011) Lycopene for the prevention 193. Carlsen,Hetal.(2003)Berryintakeincreasestheac-
of prostate cancer. Cochrane Database Syst Rev. 9, tivityoftheγ-GCSpromoterintransgenicreporter
CD008007. mice.J.Nutr.133,2137.
177. Yokoyama, T et al. (2000) Serum vitamin C con- 194. Schneider, LS (2008) Gingko biloba extract and pre-
centrationwasinverselyassociatedwithsubsequent ventingAD.JAMA300,2306.
20-yearincidenceofstrokeinaJapaneseruralcom- 195. Superko,HRetal.(2013)Omega-3fattyacidblood
munity.Stroke31,2287. levels:clinicalsignificanceandcontroversy.Circula-
178. Myint, PK et al. (2008) Plasma vitamin C concen- tion128,2154.
trations predict risk of incident stroke over 10 y 196. Zhang,Metal.(2014)Omega-3fattyacidsprotectthe
in 20649 participants of the European Prospective brainagainstischemicinjurybyactivatingNrf2and
InvestigationintoCancer-Norfolkprospectivepopu- upregulatingHO-1.J.Neurosci.34,1903.
lationstudy.Am.J.Clin.Nutr.87,64. 197. Steed,MMandTyagi,SC(2011)Mechanismsofcar-
179. Voko,Zetal.(2003)Dietaryantioxidantsandtherisk diovascular remodeling in hyperhomocysteinemia.
of ischemic stroke: the Rotterdam study. Neurology Antioxid.RedoxSignal.15,1927.
61,1273. 198. Jakubowski, H and Giowacki, R (2011) Chemical
180. Sherzai,Aetal.(2012)Stroke,foodgroups,anddiet- biologyofhomocysteinethiolactoneandrelatedme-
arypatterns:asystematicreview.Nutr.Rev.70,423. tabolites.Adv.Clin.Chem.55,81.
181. Larsson,SC,Virtamo,J,andWolk,A(2013)Totaland 199. Kristal,ARandLippman,SM(2009)Nutritionalpre-
specificfruitandvegetableconsumptionandriskof ventionofcancer:newdirectionsforanincreasingly
stroke:aprospectivestudy.Atherosclerosis227,147. complexchallenge.J.Natl.CancerInst.101,363.

--- Page 787 ---

732 REFERENCES
200. Mursu,Jetal.(2011)Dietarysupplementsandmor- 12. Zhao,HWetal.(2012)Doeshyperoxiaselectioncause
tality rate in older women. Arch. Intern. Med. 171, adaptivealterationsofmitochondrialelectrontrans-
1625. port chain activity leading to a reduction of O
•–
2
201. Hankey, GJ et al. (2013) Effect of B vitamins and production?Antioxid.RedoxSignal.16,1071.
loweringhomocysteineoncognitiveimpairmentin 13. Hurd,TRetal.(2012)Redoxregulationofcellmigra-
patients with previous stroke or transient ischemic tionandadhesion.TrendsCellBiol.22,107.
attack.Stroke44,2232. 14. Niethammer,Petal.(2009)Atissue-scalegradientof
202. Mahaffey,KRetal.(2011)Balancingthebenefitsofn- H2O2mediateswounddetectioninzebrafish.Nature
3PUFAsandtherisksofCH3Hgexposurefromfish 459,996.
consumption.Nutr.Rev.69,493. 15. Tochhawng,Letal.(2012)Redoxregulationofcancer
203. Figueiredo, JC et al. (2014) Genome-wide diet-gene cellmigrationandinvasion.Mitochondrion13,246.
interactionanalysesforriskofcolorectalcancer.PLoS 16. Nicotera,PandOrrenius,S(1994)Molecularmech-
Genetics10,e1004228. anismsoftoxiccelldeath;anoverview.Meth.Toxicol.
204. Fletcher, AE et al. (2003) Antioxidant vitamins and 1B,23[andotherarticlesinthisvolume].
mortalityinolderpersons:findingsfromthenutri- 17. Barouki, R and Morel, Y (2001) Repression of
tionadd-onstudytotheMRCtrialofassessmentand CYP1A1geneexpressionbyoxidativestress:mech-
managementofolderpeopleinthecommunity.Am. anisms and biological implications. Biochem. Phar-
J.Clin.Nutr.78,999. macol.61,511.
18. Lee,KMetal.(2009)Ascorbicacid6-palmitatesup-
presses gap-junctional intercellular communication
Chapter5
throughphosphorylationofconnexin43viaactiva-
1. Halliwell,BandWhiteman,M(2004)MeasuringRS tionoftheMEK-ERKpathway.Mutat.Res.660,51.
andoxidativedamageinvivoandincellculture:how 19. Chen,QMetal.(1998)MolecularanalysisofH2O2-
shouldyoudoitandwhatdotheresultsmean?Br. inducedsenescent-likegrowtharrestinnormalhu-
J.Pharmacol.142,231. manfibroblasts:p53andRbcontrolG1arrestbutnot
2. Sies,H(1991)OxidativeStressII.OxidantsandAntioxi- cellreplication.Biochem.J.332,43.
dants.AcademicPress,London. 20. Gibson,BAandKraus,WL(2012)Newinsightsinto
3. Sies, H and Jones, DP (2007) Encyclopaedia of Stress the molecular and cellular functions of poly(ADP-
(ed.GFink)45–48,Elsevier,SanDiego,CA. ribose)andPARPs.Nat.Rev.Mol.CellBiol.13,411.
4. Badaloo, AV and Marshall, KG (2014) Oxidative 21. David,KKetal.(2009)Parthanatos,amessengerof
stressinchildhoodsevereacutemalnutrition.In:Role death.Front.Biosci.14,1116.
ofOxidativeStressinChronicDiseases.EditedbyDi- 22. Matalon, S et al. (2003) Regulation of ion channel
chi, I, Breganó, JM, Simão, AM, Cecchini, R. CRC structure and function by reactive O2-N2 species.
Press. Am.J.Physiol.285,L1184.
5. Pani,Getal.(2000)Aredoxsignalingmechanismfor 23. Liu,CCetal.(2013)Redox-dependentregulationof
density-dependentinhibitionofcellgrowth.J.Biol. the Na+-K+ pump: new twists to an old target for
Chem.275,38891. treatmentofheartfailure.J.Mol.Cell.Cardiol.61,94.
6. Jiang, JX et al. (2012) Liver fibrosis and hepatocyte 24. Goodson,Petal.(2012)NADPHoxidaseregulatesal-
apoptosis are attenuated by GKT137831, a novel veolarepithelialNa+channelactivityandlungfluid
NOX4/NOX1inhibitorinvivo.FreeRadic.Biol.Med. balanceinvivoviaO
•–signaling.Am.J.Physiol.302,
2
53,289. L410.
7. Brown, MR et al. (1999) Overexpression of human 25. Schliess,FandHäussinger,D(2002)Thecellularhy-
catalase inhibits proliferation and promotes apop- drationstate:acriticaldeterminantforcelldeathand
tosisin vascularsmoothmusclecells. Circ. Res. 85, survival.Biol.Chem.383,577.
524. 26. Gamper,Netal.(2006)OxidativemodificationofM-
8. Onumah,OEetal.(2009)Overexpressionofcatalase typeK+ channelsasamechanismofcytoprotective
delaysG0/G1-toS-phasetransitionduringcellcycle neuronalsilencing.EMBOJ.25,4996.
progression in mouse aortic endothelial cells. Free 27. Vandenberg,JI(2010)Oxidativestressfine-tunesthe
Radic.Biol.Med.46,1658. danceofhERGK+channels.J.Physiol.588,2975.
9. Sun,JZetal.(1996)Evidenceforanessentialroleof 28. Cui,ZJetal.(2010)Modulatingproteinactivityand
ROS in the genesis of late preconditioning against cellular function by methionine residue oxidation.
myocardialstunninginconsciouspigs.J.Clin.Invest. AminoAcids43,505.
97,562. 29. Matsuda, JJ et al. (2010) Activation of swelling-
10. Gille,JJPandJoenje,H(1989)Chromosomalinstabil- activated Cl– current by TNF-α requires CIC-3-
ity and progressive loss of chromosomes in HeLa dependent endosomal reactive oxygen production.
cellsduringadaptationtohyperoxicgrowthcondi- J.Biol.Chem.285,22864.
tions.Mutat.Res.219,225. 30. Zhivotovsky,BandOrrenius,S(2011)Ca2+andcell
11. Campain,JLetal.(2007)Cytochromecoxidaseactiv- deathmechanisms:aperspectivefromthecelldeath
ityandO2tolerance.J.Biol.Chem.282,12430. community.CellCalcium50,211.

--- Page 788 ---

REFERENCES 733
31. Pan, X et al. (2013) The physiological role of mito- 49. Janko,Cetal.(2014)RedoxmodulationofHMGB1-
chondrial Ca2+ revealed by mice lacking the mito- relatedsignaling.Antioxid.RedoxSignal.20,1075.
chondrialCa2+uniporter.Nat.CellBiol.15,1464. 50. Thubagere, A and Reinhard, BM (2010)
32. Bogeski,Ietal.(2011)RedoxregulationofCa2+chan- Nanoparticle-inducedapoptosispropagatesthrough
nels:chemicalandphysiologicalaspects.CellCalcium H2O2-mediated bystander killing: insights from a
50,407. human intestinal epithelium in vitro model. ACS
33. Simon, F et al. (2013) Oxidative stress-modulated Nano4,3611.
TRPM ion channels in cell dysfunction and patho- 51. Bratton,DLandHenson,PM(2005)Autoimmunity
logicalconditionsinhumans.Cell.Signal.25,1614. and apoptosis: refusing to go quietly. Nature Med.
34. Tang,Hetal.(2011)Cav1.2calciumchannelisgluta- 11,26.
thionylatedduringoxidativestressinguineapigand 52. Züllig,SandHengartner,MO(2004)Ticklingmacro-
ischemichumanheart.FreeRadic.Biol.Med.51,1501. phages,aseriousbusiness.Science304,1123.
35. McClung, JM et al. (2009) Calpain-1 is required for 53. Yap, YW et al. (2006) HOCl induces apoptosis
H2O2-inducedmyotubeatrophy.Am.J.Physiol.296, of cultured cortical neurons through activation of
C363. calpainsandruptureoflysosomes.J.Neurochem.98,
36. Donkor, IO (2015) An updated patent review of 1597.
calpaininhibitors(2012–2014).ExpertOpin.Ther.Pa- 54. Blumenthal,SBetal.(2005)Metalloporphyrinsinacti-
tents25,17. vatecaspase-3and–8.FASEBJ.19,1272.
37. Eckert,RLetal.(2014)Transglutaminaseregulation 55. Sevrioukova, IF (2011) Apoptosis-inducing factor:
ofcellfunction.Physiol.Rev.94,383. structure, function, and redox regulation. Antioxid.
38. Sandstrom, BE et al. (1994) New roles for quin 2: RedoxSignal.14,2545.
powerful transition-metal ion chelator that inhibits 56. Urbano, A et al. (2005) AIF suppresses chemical
Cu-, but potentiates Fe-driven, Fenton-type reac- stress-induced apoptosis and maintains the trans-
tions.FreeRadic.Biol.Med.16,177. formedstateoftumourcells.EMBOJ.24,2815.
39. Meinicke,ARetal.(1996)TheCa2+sensorRuredcan 57. Ricci, JE et al. (2004) Disruption of mitochondrial
actasaFenton-typereagent.Arch.Biochem.Biophys. function during apoptosis is mediated by caspase
328,239. cleavage of the p75 subunit of complex I of the
40. Mumby, S et al. (1998) Reactive Fe species in bio- electrontransportchain.Cell117,773.
logicalfluidsactivatetheFe–Sclusterofaconitase. 58. Krug,HE(2012)Caspase-10isthekeyinitiatorcas-
Biochim.Biophys.Acta1380,102. pase involved in tributyltin-mediated apoptosis in
41. Gutteridge, JMC and Halliwell, B (1987) Radical- humanimmunecells.J.Toxicol.2012,ID395482.
promotingloosely-boundFeinbiologicalfluidsand 59. Aguiló, JI et al. (2010) Granzyme B of cytotoxic
thebleomycinassay.LifeChem.Rep.4,113. TcellsinducesextramitochondrialROSproduction
42. Esposito,BPetal.(2003)LabileplasmaFeinFeover- via caspase-dependent NADPH oxidase activation.
load: redox activity and susceptibility to chelation. Immunol.CellBiol.88,545.
Blood102,2670. 60. Circu,MLandAw,TY(2012)Glutathioneandmodu-
43. Jacobs,EMGetal.(2005)Resultsofaninternational lationofcellapoptosis.Biochim.Biophys.Acta1823,
round robin for the quantification of serum NTBI: 1767.
need for defining standardization and a clinically 61. Dam,ADetal.(2012)Elevatedskeletalmuscleapop-
relevantisoform.Anal.Biochem.341,241. totic signaling following GSH depletion. Apoptosis
44. Healing,Getal.(1990)IntracellularFeredistribution. 17,48.
Animportantdeterminantofreperfusiondamageto 62. Kapralov,AAetal.(2011)Topographyoftyrosineres-
rabbitkidneys.Biochem.Pharmacol.39,1239.30. iduesandtheirinvolvementinperoxidationofpoly-
45. Gutteridge, JM (1984) Cu-phenanthroline-induced unsaturatedcardiolipinincytochromec/cardiolipin
site-specific O2-radical damage to DNA. Detection peroxidase complexes. Biochim. Biophys. Acta 1808,
of loosely bound trace Cu in biological fluids. Bio- 2147.
chem.J.218,983. 63. Luo, S et al. (2014) Taurine chloramine-induced in-
46. Wu,CCandBratton,SB(2013)Regulationofthein- activationofcofilinproteinthroughmethionineoxi-
trinsic apoptosis pathway by ROS. Antioxid. Redox dation.FreeRadic.Biol.Med.75,84.
Signal.19,546. 64. Hsieh,YCetal.(2010)MethylantcinateAfromAntro-
46A. Pasparakis,MandVandenabeele,P(2015)Necrop- diacamphorateinducesapoptosisinhumanlivercan-
tosisanditsroleininflammation.Nature.517,311. cercellsthroughoxidant-mediatedcofilin-andbax-
47. Yang,WSetal.(2014)Regulationofferroptoticcancer triggeredmitochondrialpathway.Chem.Res.Toxicol.
celldeathbyGPX4.Cell156,317. 23,1256.
48. Muñoz-Espín,Detal.(2013)Programmedcellsenes- 65. Norberg,Eetal.(2010)Oxidativemodificationsensi-
cence during mammalian embryonic development. tizesmitochondrialAIFtocalpain-mediatedprocess-
Cell155,1104. ing.FreeRadic.Biol.Med.48,791.

--- Page 789 ---

734 REFERENCES
66. Giridharan, SS and Caplan S (2014) MICAL-family 84. Gray, MJ et al. (2013) NemR is a bleach-sensing
proteins: complex regulators of the actin cytoskel- transcriptionfactor.J.Biol.Chem.288,13789.
eton.Antioxid.Redox.Signal.20,2059. 85. Parker,BWetal.(2013)TheRclRproteinisareactive
67. Pasdois, P et al. (2011) The role of oxidized cyto- Cl2-specifictranscriptionfactorinE.coli.J.Biol.Chem.
chromecinregulatingmitochondrialROSproduc- 288,32574.
tionanditsperturbationinischaemia.Biochem.J.436, 86. Lee,HCandZhang,L(2009)Auniquemechanism
493. of chaperone action: heme regulation of Hap1 ac-
68. Pellegrini,MandBaldari,CT(2009)Apoptosisand tivity involves separate control of repression and
oxidativestress-relateddiseases:thep66Shcconnec- activation.ProteinPept.Lett.16,642.
tion.Curr.Mol.Med.9,392. 87. García-Santamarina, S et al. (2014) Reversible cyst-
69. Anathy, V et al. (2012) Redox-based regulation of eineoxidationinH2O2sensingandsignaltransduc-
apoptosis:S-glutathionylationasaregulatorymech- tion.Biochemistry53,2560.
anismtocontrolcelldeath.Antioxid.RedoxSignal.16, 88. Jang,HHetal.(2004)Twoenzymesinone:twoyeast
496. peroxiredoxins display oxidative stress-dependent
70. Tyurin,VAetal.(2014)Oxidativelymodifiedphos- switchingfromaperoxidasetoamolecularchaper-
phatidylserinesonthesurfaceofapoptoticcellsare onefunction.Cell117,625.
essential phagocytic ‘eat-me’ signals: cleavage and 89. Brigelius-Flohé, R and Flohé, L (2011) Basic prin-
inhibition of phagocytosis by Lp-PLA2. Cell Death ciplesandemergingconceptsintheredoxcontrolof
Diff.21,825. transcriptionfactors.Antioxid.RedoxSignal.15,2335.
71. Nikolova-Karakashian, MN and Reid MB (2011) 90. Truong,THandCarroll,KS(2013)Redoxregulation
Sphingolipid metabolism, oxidant signaling, and of protein kinases. Crit. Rev. Biochem. Mol. Biol. 48,
contractile function of skeletal muscle. Antioxid. 332.
RedoxSignal.15,2501. 91. Ray, PD et al. (2012) ROS homeostasis and redox
72. Jacobson, MD (1996) ROS and programmed cell regulationincellularsignaling.Cell.Signal.24,981.
death.TrendsBiochem.Sci.21,83. 92. Lee,KandEsselman,WJ(2002)InhibitionofPTPs
73. Loo, SYetal. (2012)NHE-1: apromisingtargetfor byH2O2 regulatestheactivationofdistinctMAPK
novelanti-cancertherapeutics.Curr.Pharm.Des.18, pathways.FreeRadic.Biol.Med.33,1121.
1372. 93. Klotz, LO et al. (2002) ONOO– signaling: receptor
74. Matsui,Hetal.(2011)Glucoseoxidasepreventspro- tyrosinekinasesandactivationofstress-responsive
grammed cell death of the silkworm anterior silk pathways.FreeRadic.Biol.Med.33,737.
glandthroughH2O2production.FEBSJ.278,776. 94. Sigaud,Setal.(2005)H2O2-inducedproliferationof
75. Vaquero,ECetal.(2004)ROSproducedbyNAD(P)H primaryalveolarepithelialcellsismediatedbyMAP
oxidaseinhibitapoptosisinpancreaticcancercells. kinases.Antioxid.RedoxSignal.7,6.
J.Biol.Chem.279,34643. 95. Houle, F et al. (2003) ERK mediates phosphoryl-
76. Teoh, ML et al. (2005) Tumorigenic poxviruses up- ationoftropomyosin-1topromotecytoskeletonre-
regulate intracellular O
•–
to inhibit apoptosis and modelinginresponsetooxidativestress:impacton
2
promotecellproliferation.J.Virol79,5799. membraneblebbing.Mol.Biol.Cell.14,1418.
77. Anand,PandStamler,JS(2012)Enzymaticmechan- 96. Bretón-Romero,Retal.(2012)CriticalroleofH2O2
ismsregulatingproteinS-nitrosylation:implications signalinginthesequentialactivationofp38MAPK
inhealthanddisease.J.Mol.Med.90,233. and eNOS in laminar shear stress. Free Radic. Biol.
78. Faulkner,MJandHelmann,JD(2011)Peroxidestress Med.52,1093.
elicitsadaptivechangeinbacterialmetalionhomeo- 97. Charitou, P and Burgering BM (2013) Forkhead
stasis.Antioxid.RedoxSignal.15,175. box(O)incontrolofROSandgenomicstabilitytoen-
79. Wei,Qetal.(2012)Globalregulationofgeneexpres- surehealthylifespan.Antioxid.RedoxSignal.19,1400.
sionbyOxyRinanimportanthumanopportunistic 98. WuMetal.(2010)ActivationofphospholipaseDin-
pathogen.NucleicAcidsRes.40,4320. volvedinbothinjuryandsurvivalinA549alveolar
80. Fujikawa,Metal.(2012)Directoxidationofthe[2Fe- epithelial cells exposed to H2O2. Toxicol. Lett. 196,
2S]clusterinSoxRproteinbyO
•–.J.Biol.Chem.287,
168.
2
25702. 99. Knock,GAandWard,JPT(2011)Redoxregulationof
81. Imlay, JA (2013) The molecular mechanisms and proteinkinasesasamodulatorofvascularfunction.
physiological consequences of oxidative stress: les- Antioxid.RedoxSignal.15,1531.
sonsfromamodelbacterium.Nat.Rev.Microbiol.11, 100. Giorgi,Cetal.(2010)Redoxcontrolofproteinkinase
443. C:cell-anddisease-specificaspects.Antioxid.Redox
82. Lo,FCetal.(2008)AstudyofNOtraffickingfrom Signal.13,1051.
dinitrosyl-ironcomplexestotherecombinantE.coli 101. Lei,XGetal.(2007)Metabolicregulationandfunc-
transcriptional factor SoxR. J. Biol. Inorg. Chem. 13, tionofGpx1.Annu.Rev.Nutr.27,41.
961. 102. Woo,HAetal.(2010)InactivationofperoxiredoxinI
83. Zuber, P (2009) Management of oxidative stress in byphosphorylationallowslocalizedH2O2accumu-
Bacillus.Annu.Rev.Microbiol.63,575. lationforcellsignaling.Cell140,517.

--- Page 790 ---

REFERENCES 735
103. Finkel,R(2011)SignaltransductionbyROS.J.Cell 121. Fan,Xetal.(2010)H2O2-inducedmitochondrialfrag-
Biol.194,7. mentationinC2C12 myocytes.FreeRadic.Biol.Med.
104. Forman,HJetal.(2010)SignalingfunctionsofROS. 49,1646.
Biochemistry49,835. 122. Oliveira-Marques,Vetal.(2009)RoleofH2O2inNF-
105. Zhou, H et al. (2011) The biological buffer κBactivation:frominducertomodulator.Antioxid.
HCO–
3
/CO2 potentiates H2O2-mediated inacti- RedoxSignal.11,2223.
vationofproteintyrosinephosphatases.J.Am.Chem. 123. Park, MH et al. (2013) Caffeic acid phenethyl ester
Soc.133,15803. downregulates phospholipase D1 via direct bind-
106. Kuban-Jankowska, A et al. (2011) Protein tyrosine ingandinhibitionofNF-κBtransactivation.Biochem.
phosphataseCD45asamolecularbiosensorofH2O2 Biophys.Res.Commun.442,1.
generation in cell culture media. Biochem. Biophys. 124. Carlsen, H et al. (2002) In vivo imaging of NF-κB
Res.Commun.415,270. activity.J.Immunol.168,1441.
107. Paulsen, CE et al. (2012) Peroxide-dependent 125. Pahl,HLandBaeuerle,PA(1994)O2andthecontrol
sulfenylation of the EGFR catalytic site enhances ofgeneexpression.BioEssays16,497.
kinaseactivity.Nat.Chem.Biol.8,57. 126. Hayakawa,Metal.(2003)EvidencethatROSdonot
108. Cho,SHetal.(2004)RedoxregulationofPTENand mediateNF-κBactivation.EMBOJ.22,3356.
proteintyrosinephosphatasesinH2O2-mediatedcell 127. Hyoudou, K etal. (2007)Analysisofin vivo NF-κB
signaling.FEBSLett.560,7. activationduringliverinflammationinmice:preven-
109. Musson, REA et al. (2012) Effects of arsenite and tionbycatalasedelivery.Mol.Pharmacol.71,446.
UVA-1radiationoncalcineurinsignaling.Mutat.Res. 128. Fries,DMetal.(2003)ExpressionofiNOSandintra-
75,32. cellularproteintyrosinenitrationinvascularsmooth
110. Lee,Setal.(2013)Thioredoxinandthioredoxintarget musclecells.J.Biol.Chem.278,22901.
proteins:frommolecularmechanismstofunctional 129. Han, W et al. (2013) NADPH oxidase limits
significance.Antioxid.RedoxSignal.18,1165. lipopolysaccharide-inducedlung inflammationand
111. Dagnell, M et al. (2013) Selective activation of oxi- injury in mice through reduction-oxidation regula-
dized PTP1B by the thioredoxin system modulates tionofNF-κBactivity.J.Immunol.190,4786.
PDGF-βreceptortyrosinekinasesignaling.Proc.Natl. 130. Leung,THetal.(2013)TopicalOCl–amelioratesNF-
Acad.Sci.USA110,13398. κB-mediatedskindiseasesinmice.J.Clin.Invest.123,
112. Choi,MHetal.(2005)RegulationofPDGFsignaling 5361.
andvascularremodelingbyperoxiredoxinII.Nature 131. Segal,BHetal.(2012)Regulationofinnateimmunity
435,347. byNADPHoxidase.FreeRadic.Biol.Med.53,72.
113. Bertolotti, M et al. (2013) Tyrosine kinase signal 132. Ma,QandHe,X(2012)Molecularbasisofelectro-
modulation:amatterofH2O2membranepermeabil- philicandoxidativedefense:promisesandperilsof
ity?Antioxid.RedoxSignal.19,1447. Nrf2.Pharmacol.Rev.64,1055.
114. Jornayvaz,FRandShulman,GI(2010)Regulationof 133. Suzuki,Tetal.(2013)Towardclinicalapplicationof
mitochondrialbiogenesis.EssaysBiochem.47,69. the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 34,
115. Suzuki,Hetal.(1998)IncreaseinintracellularH2O2 340.
and upregulation of a nuclear respiratory gene 134. Yao,KSetal.(1995)Evidenceforalteredregulation
evoked by impairment of mitochondrial electron ofγ-GCSgeneexpressionamongcisplatin-sensitive
transferinhumancells.Biochem.Biophys.Res.Com- and cisplatin-resistant human ovarian cancer cell
mun.249,542. lines.CancerRes.55,4367.
116. Liu,Jetal.(2009)Bmi1regulatesmitochondrialfunc- 135. Halliwell,B(1996)Freeradicals,proteinsandDNA:
tionandtheDNAdamageresponsepathway.Nature oxidativedamageversusredoxregulation.Biochem.
459,387. Soc.Trans.24,1023.
117. Affourtit, C et al. (2011) UCP2 attenuates glucose- 136. Ishibashi,Netal.(1999)Modulationofchemokineex-
stimulated insulin secretion in INS-1E insulinoma pressionduringischemia/reperfusionintransgenic
cellsbyloweringmitochondrialROS.FreeRadic.Biol. mice overproducing human GPx. J. Immunol. 163,
Med.50,609. 5666.
118. Al-Mehdi,ABetal.(2012)Perinuclearmitochondrial 137. Marikovsky, M et al. (2003) CuZnSOD plays im-
clustering creates an oxidant-rich nuclear domain portant role in immune response. J. Immunol. 170,
required for hypoxia-induced transcription. Science 2993.
Signal.5,ra47. 138. Li,Netal.(2012)NADPHoxidaseNOX2definesa
119. Tormos, KV et al. (2011) Mitochondrial complex III newantagonisticroleforROSandcAMP/PKAinthe
ROS regulate adipocyte differentiation. Cell Metab. regulationofinsulinsecretion.Diabetes61,2842.
14,537. 139. Shimokawa, H (2010) H2O2 as an endothelium-
120. Anderson,EJetal.(2009)MitochondrialH2O2emis- derived hyperpolarizing factor. Pflugers Arch. 459,
sion and cellular redox state link excess fat intake 915.
to insulin resistance in both rodents and humans. 139A. Durand, MJ et al. (2015) Acute exertion elicits
J.Clin.Invest.119,573. a H2O2-dependent vasodilator mechanism in the

--- Page 791 ---

736 REFERENCES
microvasculatureofexercise-trainedbutnotseden- 158. Wyatt,Aetal.(2009)Thechaperoneactionofclus-
taryadultsHypertension65,140. terinanditsputativeroleinqualitycontrolofextra-
140. Prysyazhna,Oetal.(2012)Singleatomsubstitution cellularproteinfolding.Adv.CancerRes.104,89.
inmouseproteinkinaseGeliminatesoxidantsensing 159. Haneklaus,Metal.(2013)Modulatorymechanisms
tocausehypertension.Nat.Med.18,286. controllingtheNLRP3inflammasomeininflamma-
141. Suvorava,Tetal.(2005)EndogenousvascularH2O2 tion:recentdevelopments.Curr.Opin.Immunol.25,1.
regulates arteriolar tension in vivo. Circulation 112, 160. Li,YPetal.(1998)Skeletalmusclemyocytesundergo
2487. proteinlossandROS-mediatedNF-κBactivationin
142. Rafikov,Retal.(2014)Endothelin-1stimulatescata- responsetoTNFα.FASEBJ.12,871.
laseactivitythroughthePKCδ-mediatedphosphor- 161. Montgomery,SLetal.(2011)AblationofTNF-RI/RII
ylationofserine167.FreeRadic.Biol.Med.67,255. expressioninAlzheimer’sdiseasemiceleadstoan
143. Zou,Yetal.(2012)ECSODisimportantforhippo- unexpectedenhancementofpathology.Am.J.Pathol.
campal neurogenesis and preservation of cognitive 179,2053.
functionsafterirradiation.Proc.Natl.Acad.Sci.USA 162. Hamanaka, RB and Chandel, NS (2010) Mitochon-
109,21522. drial ROS regulate cellular signaling and dictate
144. Lauer,Netal.(2005)CriticalinvolvementofH2O2 biologicaloutcomes.TrendsBiochem.Sci.35,505.
inexercise-inducedup-regulationofendothelialNO 163. Spencer, NY and Engelhardt, JF (2014) The basic
synthase.Cardiovasc.Res.65,254. biology of redoxosomes in cytokine-mediated sig-
145. Lee, S et al. (2011) Mitochondrial H2O2 generated naltransductionandimplicationsfordisease-specific
from electron transport chain complex I stimulates therapies.Biochemistry53,1551.
muscledifferentiation.CellResearch21,817. 164. Lee,TSandChau,LY(2002)HO-1mediatestheanti-
146. Lardy,Betal.(2005)NADPHoxidasehomologsare inflammatoryeffectofIL-10inmice.Nat.Med.8,240.
requiredfornormalcelldifferentiationandmorpho- 165. Deng, J et al. (2012) Protective role of ROS
genesisinDictyosteliumdiscoideum.Biochim.Biophys. in endotoxin-induced lung inflammation through
Acta1744,199. modulationofIL-10expression.J.Immunol.188,5734.
147. Tudzynski,Petal.(2012)ROSgenerationinfungal 166. Nishina,Tetal.(2012)Interleukin-11linksoxidative
developmentandpathogenesis.Curr.Opin.Microbiol. stressandcompensatoryproliferation.ScienceSignal.
15,653. 5,ra5.
148. Morimoto, RI (2012) The heat shock response: sys- 167. Jain,Metal.(2013)MitochondrialROSregulateTGF-
temsbiologyofproteotoxicstressinaginganddis- βsignaling.J.Biol.Chem.288,770.
ease.ColdSpringHarb.Symp.Quant.Biol.76,91. 168. Cheresh,Petal.(2013)Oxidativestressandpulmon-
149. Fittipaldi,Setal.(2014)Roleofexercise-inducedROS aryfibrosis.Biochim.Biophys.Acta1832,1028.
in the modulation of heat shock protein response. 169. Cray,C(2012)Acutephaseproteinsinanimals.Prog.
FreeRadic.Res.48,52. Mol.Biol.Transl.Sci.105,113.
150. Senf,SMetal.(2013)LossoftheinducibleHsp70de- 170. Sagripanti,Jetal.(1991)InteractionofCuwithDNA
laystheinflammatoryresponsetoskeletalmusclein- andantagonismbyothermetals.Toxicol.Appl.Phar-
juryandseverelyimpairsmuscleregeneration.PloS macol.110,477.
One8,e62687. 171. Ouameur, AA et al. (2005) A comparative study
151. Cao,SSandKaufman,RJ(2014)ERstressandoxi- ofFe(II)andFe(III)interactionswithDNAduplex:
dativestressincellfatedecisionandhumandisease. major and minor grooves bindings. DNA Cell Biol.
Antioxid.RedoxSignal.21,396. 24,394.
152. Wu,FRetal.(2010)Nox4-derivedH2O2mediatesER 172. von Sonntag, C (2006) Free-Radical-Induced DNA
signalingthroughlocalRasactivation.Mol.Cell.Biol. DamageanditsRepair.Springer,Basle.
30,3553. 173. Dizdaroglu,MandJaruga,P(2012)Mechanismsof
153. Mirochnitchenko, O et al. (1995) Thermosensitive freeradical-induceddamagetoDNA.FreeRadic.Res.
phenotypeoftransgenicmiceoverproducinghuman 46,382.
GPx.Proc.Natl.Acad.Sci.USA.92,8120. 174. Halliwell, B (1999) O2 and N2 are pro-carcinogens.
154. Westerheide,SDetal.(2009)Stress-inducibleregula- Damage to DNA by reactive oxygen, chlorine and
tionofHSF1bythedeacetylaseSIRT1.Science323, nitrogenspecies:measurement,mechanismandthe
1063. effectsofnutrition.Mutat.Res.443,37.
155. Martins,Ietal.(2011)Hormesis,celldeathandaging. 175. Barnes,DEandLindahl,T(2004)Repairandgenetic
Aging3,821. consequencesofendogenousDNAbasedamagein
156. Kumsta,CandJakob(2009)Redox-regulatedchaper- mammaliancells.Ann.Rev.Genet.38,445.
ones.Biochemistry48,4666. 176. Lamers,Retal.(2009)Postmortemmiscodinglesions
157. Park, JW et al. (2011) Glutathionylation of prx1 in- insequenceanalysisofhumanancientmitochondrial
duces decamers to dimers dissociation with con- DNA.J.Mol.Evol.68,40.
comitant loss of chaperone activity. Biochemistry 177. Rodriguez, M et al. (1995) Mapping of Cu/H2O2-
50,3204. induced DNA damage at nucleotide resolution in

--- Page 792 ---

REFERENCES 737
human genomic DNA by ligation-mediated PCR. 194. Lonkar, P and Dedon, PC (2011) Reactive species
J.Biol.Chem.270,17633. and DNA damage in chronic inflammation: recon-
(cid:4)
178. Jaruga, P et al. (2012) DNA damage products (5R) cilingchemicalmechanismsandbiologicalfates.Int.
(cid:4) (cid:4) (cid:4)
and (5S)-8,5-cyclo-2-deoxyadenosines as potential J.Cancer128,1999.
biomarkersinhumanurineforatherosclerosis.Bio- 195. Ko,SHetal.(2014)8OHdGamelioratesfeaturesof
chemistry51,1822. metabolicsyndromeinobesemice.Biochem.Biophys.
179. Toyokuni, S et al. (1995) Treatment of Wistar rats Res.Commun.443,610.
witharenalcarcinogen,FeNTA,causesDNA-protein 196. Wiesner,RJetal.(2006)MitochondrialDNAdamage
cross-linkingbetweenthymineandtyrosineintheir andtheagingprocess–factsandimaginations.Free
renalchromatin.Int.J.Cancer62,309. Radic.Res.40,1284.
180. Wu,JandLi,Z(2008)Humanpolynucleotidephos- 197. Beckman,KBandAmes,BN(1999)Endogenousoxi-
phorylasereducesoxidativeRNAdamageandpro- dativedamageofmtDNA.Mutat.Res.424,51.
tects HeLa cells against oxidative stress. Biochem. 198. Graziewicz,MAetal.(2002)ThemitochondrialDNA
Biophys.Res.Commun.372,288. polymeraseasatargetofoxidativedamage.Nucleic
181. Gackowski, D et al. (2002) The level of 8OHdG is AcidsRes.30,2817.
positivelycorrelatedwiththesizeofthelabileiron 199. Balestrazzi,Aetal.(2011)GenotoxicstressandDNA
poolinhumanlymphocytes.J.Biol.Inorg.Chem.7, repair in plants: emerging functions and tools for
548. improvingcropproductivity.PlantCellRep.30,287.
182. Zastawny,THetal.(1995)DNAbasemodifications 200. Hegde,ML etal.(2012)Oxidativegenomedamage
andmembranedamageinculturedmammaliancells anditsrepair:implicationsinagingandneurodegen-
treatedwithFe.FreeRadic.Biol.Med.18,1013. erativediseases.Mech.AgeingDev.133,157.
183. Li,YandTrush,MA(1994)ReactiveO2-dependent 201. Moraes,ECetal.(1990)MutagenesisbyH2O2treat-
DNAdamageresultingfromtheoxidationofphen- mentofmammaliancells:amolecularanalysis.Car-
olic compounds by a Cu-redox cycle mechanism. cinogenesis11,283.
CancerRes.54,1895S. 202. Newcomb, TG et al. (1999) Detection of tandem
184. Hori,Aetal.(2010)Bodyironstoreasapredictorof CC → TT mutations induced by O2 radicals using
oxidativeDNAdamageinhealthymenandwomen. mutation-specificPCR.Mutat.Res.427,21.
CancerSci.101,517. 203. Poulsen,HEetal.(2012)RNAmodificationsbyoxi-
185. Broedbaek, K et al. (2011) The association be- dation:anoveldiseasemechanism?FreeRadic.Biol.
tweenlow-gradeinflammation,ironstatusandnu- Med.52,1353.
cleic acid oxidation in the elderly. Free Radic. Res. 204. Henderson, JP et al. (2001) Bromination of
45,409. deoxycytidine by EPO: a mechanism for mutagen-
186. Jones,CDetal.(2011)Amicrofluidicdevicethatgen- esis by oxidative damage of nucleotide precursors.
•
eratesOH toprobethesolventaccessiblesurfaceof Proc.Natl.Acad.Sci.USA98,1631.
nucleicacids.LabChip11,3458. 205. Clark, DW et al. (2012) Promoter G-quadruplex se-
187. Ronsein, GE et al. (2012) Role of 1O2 in the oxi- quences are targets for base oxidation and strand
dative damage to biomolecules. In Oxidative Stress cleavageduringhypoxia-inducedtranscription.Free
in Aquatic Ecosystems (eds D. Abele, J. P. Vázquez- Radic.Biol.Med.53,51.
MedinaandT.Zenteno-Savín),JohnWiley&Sons, 206. O’Hagan, HM et al. (2011) Oxidative damage tar-
Ltd,Chichester,UK. getscomplexescontainingDNAmethyltransferases,
188. Lee, YA et al. (2007) Mechanisms of oxidation of SIRT1, and polycomb members to promoter CpG
guanineinDNAbyCO
•–,adecompositionproduct
islands.CancerCell20,606.
3
ofnitrosoperoxycarbonate.Chem.Eur.J.13,4571. 207. Nedelcu,AMetal.(2004)Sexasaresponsetooxi-
189. Spencer,JPEetal.(2000)NO–-induceddeamination dative stress: a twofold increase in cellular ROS
2
andHOCl-inducedoxidationofDNAinintacthu- activatessexgenes.Proc.R.Soc.Lond.B271,1591.
manrespiratorytractepithelialcells.FreeRadic.Biol. 208. Bernstein,C(1998)Sexmaybeasignificantfactorin
Med.28,1039. efficientrepairofendogenousoxidativeDNAdam-
190. Stanley, NR et al. (2010) Ability of HOCl and N- ageinthegermline.InDNAandFreeRadicals;Tech-
chloraminestochlorinateDNAanditsconstituents. nologies, Mechanisms and Applications. (eds Aruoma,
Chem.Res.Toxicol.23,1293. OIandHalliwell,B),OICAPress,p99.
191. Shen,Zetal.(2001)EPOcatalyzesbrominationoffree 209. Odell,IDetal.(2012)Rulesofengagementforbase
nucleosidesanddouble-strandedDNA.Biochemistry excisionrepairinchromatin.J.Cell.Physiol.228,258.
40,2041. 210. Aziz, K et al. (2012) Targeting DNA damage and
192. Asahi,Tetal.(2010)Chemicalandimmunochemical repair: embracing the pharmacological era for suc-
detectionof8-halogenateddeoxyguanosinesatearly cessfulcancertherapy.Pharmacol.Ther.133,334.
stageinflammation.J.Biol.Chem.285,9282. 211. Benjdia, A (2012) DNA photolyases and SP lyase:
193. Suzuki,Tetal.(2012)Effectsofhalidesonreaction structure and mechanism of light-dependent and
of nucleosides with ozone. Nucleosides Nucleotides independent DNA lyases. Curr. Opin. Struct. Biol.
NucleicAcid31,461. 22,711.

--- Page 793 ---

738 REFERENCES
212. Evans,MDetal.(2010)DNArepairandtheorigins 230. Strlicˇ, M et al. (2009) Material degradomics: on the
of urinary oxidized 2’-deoxyribonucleosides. Muta- smellofoldbooks.Anal.Chem.81,8617.
genesis25,433. 231. Bowes,PC(1954)Spontaneousheatingandignition
213. Takagi,Yetal.(2012)HumanMTH3(NUDT18)pro- offishmeal,FPAJ.27,285.
tein hydrolyses oxidised forms of guanosine and 232. Finley,JWetal.(2011)Antioxidantsinfoods:stateof
deoxyguanosine diphosphates. Comparison with thescienceimportanttothefoodindustry.J.Agric.
MTH1andMTH2.J.Biol.Chem.287,21541. FoodChem.59,6837.
214. Rai,Petal.(2009)Continuouseliminationofoxidized 233. Alin,Jetal.(2011)Microwaveheatingcausesrapid
nucleotidesisnecessarytopreventrapidonsetofcel- degradationofantioxidantsinpolypropylenepack-
lularsenescence.Proc.Natl.Acad.Sci.USA106,169. aging,leadingtogreatlyincreasedspecificmigration
215. Dizdaroglu,M(2005)Base-excisionrepairofoxida- tofoodstimulantsasshownbyESI-MSandGC-MS.
tiveDNAdamagebyDNAglycosylases.Mutat.Res. J.Agric.FoodChem.59,5418.
591,45. 234. Jin,Setal.(2011)Lipidraftredoxsignaling:molecu-
215A. Shan,JLetal.(2015)APE1promotesantioxidantcap- larmechanismsinhealthanddisease.Antioxid.Redox
acity by regulating Nrf2 function through a redox- Signal.15,1043.
dependentmechanism.FreeRadic.Biol.Med.78,11. 235. Koppenol, WH (1990) Oxyradical reactions: from
216. Banerjee, A et al. (2006) Structure of a DNA glyc- bond-dissociation energies to reduction potentials.
osylasesearchingforlesions.Science311,1153. FEBSLett.264,165.
217. Luca, GD et al. (2013) Prolonged lifespan with en- 236. Barber, DJW and Thomas, JK (1978) Reactions of
hanced exploratory behavior in mice overexpress- radicalswithlecithinbilayers.Radiat.Res.74,51.
ingtheoxidizednucleosidetriphosphatasehMTH1. 237. Vernier, PT et al. (2009) Electroporating fields tar-
AgingCell12,695. getoxidativelydamagedareasinthecellmembrane.
218. Chan,MKetal.(2009)Targeteddeletionofthegenes PLoSOne4,e7966.
encodingNTH1andNEIL1DNAN-glycosylasesre- 238. Leung,KSetal.(2014)Microbubble-mediatedsono-
veals the existence of novel carcinogenic oxidative porationamplifiedlipidperoxidationofJurkatcells.
damagetoDNA.DNARepair8,786. Chem.Phys.Lipids180,53.
219. Meira,LBetal.(2001)Heterozygosityforthemouse 239. vanGolen,RFetal.(2012)Mechanisticoverviewof
apexgeneresultsinphenotypesassociatedwithoxi- RS-induceddegradationoftheendothelialglycoca-
dativestress.CancerRes.61,5552. lyxduringhepaticischemia/reperfusioninjury.Free
220. Buchmeier,NAetal.(1995)DNArepairismoreim- Radic.Biol.Med.52,1382.
portantthancatalaseforSalmonellavirulenceinmice. 240. Aikens, J and Dix, JA (1991) Perhydroxyl radical
•
J.Clin.Invest.95,1047. (HOO ) initiated lipid peroxidation. J. Biol. Chem.
221. Chen, BPC et al. (2011) New insights into the roles 266,15091.
of ATM and DNA-PKcs in the cellular response to 241. Halliwell,BandGutteridge,JMC(1990)Roleoffree
oxidativestress.CancerLett.327,103 radicalsandcatalyticmetalionsinhumandisease:
222. Kerr,BAandByzova,TV(2012)Thedarksideofthe anoverview.Meth.Enzymol.186,1.
oxidativeforceinangiogenesis.Nat.Med.18,1184. 242. Cheng, Z and Li, Y (2007) What is responsible for
223. D’Souza, AD et al. (2013) Reducing mitochondrial theinitiatingchemistryofFe-mediatedlipidperox-
ROSimprovesdisease-relatedpathologyinamouse idation:anupdate.Chem.Rev.107,748.
modelofataxia-telangiectasia.Mol.Ther.21,42. 243. Milne, GL et al. (2015) The isoprostanes - 25 years
224. Crawford,Aetal.(2012)Relationshipsbetweensin- later.Biochim.Biophys.Acta1851,433.
gle nucleotide polymorphisms of antioxidant en- 244. Gutteridge, JMC (1982) The role of O
•–
and OH
•
2
zymesanddisease.Gene501,89. inphospholipidperoxidationcatalyzedbyFesalts.
225. Simonelli,Vetal.(2012)Genesusceptibilitytooxida- FEBSLett.150,454.
tivedamage:fromsinglenucleotidepolymorphisms 245. Lai,WandShaik,S(2011)Canferric-O
•–actasapo-
2
tofunction.Mutat.Res.731,1. tentialoxidantinP450cam?QM/MMinvestigationof
226. Wu,Jetal.(2009)Polynucleotidephosphorylasepro- hydroxylation,epoxidation,andsulfoxidation.J.Am.
tectsEscherichiacoliagainstoxidativestress.Biochem- Chem.Soc.133,5444.
istry48,2012. 246. Park, MJ et al. (2006) Reactivities of mononuclear
227. Niki, E (2014) Biomarkers of lipid peroxidation in non-hemeFeintermediatesincludingevidencethat
clinicalmaterial.Biochim.Biophys.Acta1840,809. Fe(III)-hydroperoxo species is a sluggish oxidant.
228. Davies,SSandGuo,L(2014)Lipidperoxidationgen- J.Am.Chem.Soc.128,2630.
erates biologically active phospholipids including 247. Ray, K et al. (2014) Status of reactive non-heme
oxidatively N-modified phospholipids. Chem. Phys. metal-O2 intermediates in chemical and enzymatic
Lipids181,1. reactions.J.Am.Chem.Soc.136,13942.
229. Williams,GMetal.(2009)Multicenterstudytoassess 248. Spiteller, G (2006) Peroxyl radicals: inductors of
potential hazards from exposure to lipid peroxid- neurodegenerativeandotherinflammatorydiseases.
ation products in soya bean oil from TrilucentTM Their origin and how they transform cholesterol,
breastimplants.Regul.Toxicol.Pharmacol.53,107. phospholipids, plasmalogens, PUFAs, sugars, and

--- Page 794 ---

REFERENCES 739
proteins into deleterious products. Free Radic. Biol. apossiblecontributoryfactortoatherosclerosis.Ath-
Med.41,362. erosclerosis119,261.
249. Tamura,Tetal.(2009)Feisanessentialcauseoffishy 267. Ottestad, I et al. (2012) Oxidised fish oil does not
aftertaste formation in wine and seafood pairing. influenceestablishedmarkersofoxidativestressin
J.Agric.FoodChem.57,8550. healthy human subjects: a randomized controlled
250. Richards,MP(2013)Redoxreactionsofmyoglobin. trial.Brit.J.Nutr.108,315.
Antioxid.RedoxSignal.18,2342. 268. Kanazawa,KandAshida,H(1998)Dietaryhydrop-
251. Sevanian,Aetal.(1990)Microsomallipidperoxida- eroxides of linoleic acid decompose to aldehydes
tion:theroleofNADPH-cytochromeP450reductase in stomach before being absorbed into the body.
andcytochromeP450.FreeRadic.Biol.Med.8,145. Biochim.Biophys.Acta.1393,349.
252. Schacter, BA et al. (1972) Hemoprotein catabolism 269. Tsunada,Setal.(2003)Chronicexposuretosubtoxic
duringstimulationofmicrosomallipidperoxidation. levelsofperoxidizedlipidssuppressesmucosalcell
Biochim.Biophys.Acta279,221. turnoverinratsmallintestineandreversalbyGSH.
253. Girotti, AW and Kriska, T (2004) Role of lipid hy- Dig.Dis.Sci.48,210.
droperoxidesinphoto-oxidativestresssignaling.An- 270. Stafforini, DM (2009) Biology of platelet-activating
tioxid.RedoxSignal.6,301. factor acetylhydrolase (PAF-AH, lipoprotein asso-
254. Greig, FH et al. (2012) Physiological effects of oxi- ciated phospholipase A2). Cardiovasc. Drugs Ther.
dized phospholipids and their cellular signaling 23,73.
mechanisms in inflammation. Free Radic. Biol. Med. 271. Oskolkova,OVetal.(2010)Oxidizedphospholipids
52,266. are more potent antagonists of lipopolysaccharide
255. Skaff,Oetal.(2007)KineticsofHOBr-mediatedoxi- thaninducersofinflammation.J.Immunol.185,7706.
dationoflipidcomponentsandantioxidants.Chem. 272. Varady,Jetal.(2012)Dietarymoderatelyoxidizedoil
Res.Toxicol.20,1980. activatestheNrf2signalingpathwayintheliverof
256. Hix, S et al. (2000) In vivo metabolism of tert-butyl pigs.LipidsHealthDis.11,31.
•
hydroperoxide to CH
3
radicals. EPR spin-trapping 273. Yan, Z et al. (2010) A significant proportion of F2-
andDNAmethylationstudies.Chem.Res.Toxicol.13, IsoPs in human urine are excreted as glucuronide
1056. conjugates.Anal.Biochem.403,126.
257. Hrycay,EGandBandiera,SM(2012)Themonooxy- 274. Janssen,LJ(2008)IsoPsandlungvascularpathology.
genase,peroxidase,andperoxygenasepropertiesof Am.J.Respir.CellMol.Biol.39,383.
cytochromeP450.Arch.Biochem.Biophys.522,71. 275. Moore, K (2004) IsoPs and the liver. Chem. Phys.
258. Janicka, M et al. (2013) LC-MS/MS determination Lipids128,125.
ofIsoPsinplasmasamplescollectedfrommiceex- 276. Ware,LBetal.(2011)Plasmabiomarkersofoxidant
posed to doxorubicin or tert-butyl hydroperoxide. stress and development of organ failure in severe
Int.J.Mol.Sci.14,6157. sepsis.Shock36,12.
259. Catalá,A(2012)Lipidperoxidationmodifiesthepic- 277. Durand, T et al. (2013) F2-dihomo-IsoPs and brain
tureofmembranesfromthe“fluidmosaicmodel”to white matter damage in stage 1 Rett syndrome.
the“lipidwhiskermodel”.Biochimie94,101. Biochimie95,86.
260. Ayuyan,AGandCohen,FS(2006)Lipidperoxides 278. Otaegui-Arrazola,Aetal.(2010)Oxysterols:aworld
promote large rafts: effects of excitation of probes toexplore.FoodChem.Toxicol.48,3289.
influorescencemicroscopyandelectrochemicalreac- 279. O’Callaghan, Y et al. (2014) Recent advances in
tionsduringvesicleformation.Biophys.J.91,2172. phytosteroloxidationproducts.Biochem.Biophys.Res.
261. Nigam, S and Schewe, T (2000)Phospholipase A2s Commun.446,786.
andlipidperoxidation.Biochim.Biophys.Acta.1488, 280. Korade,Zetal.(2014)Antioxidantsupplementation
167. amelioratesmoleculardeficitsinSmith-Lemli-Opitz
262. Choe,EandMin,DB(2006)Chemistryandreactions syndrome.Biol.Psychiatry75,215.
ofROSinfoods.Crit.Rev.FoodSci.Nutr.46,1. 281. Esterbauer,Hetal.(1991)Chemistryandbiochem-
263. Bochkov,VNetal.(2010)Generationandbiological istry of 4-HNE, MDA and related aldehydes. Free
activitiesofoxidizedphospholipids.Antioxid.Redox Radic.Biol.Med.11,81.
Signal.12,1009. 282. West,JDandMarnett,LJ(2006)Endogenousreactive
264. Billek,G(2000)Healthaspectsofthermooxidizedoils intermediatesasmodulatorsofcellsignalingandcell
andfats.Eur.J.LipidSci.Technol.102,587. death.Chem.Res.Toxicol.19,173.
265. Huang,CFetal.(2014)Oxidizedfryingoilanditspo- 283. Niedernhofer,LJetal.(2003)MDA,aproductoflipid
larfractionfedtopregnantmiceareteratogenicand peroxidation, is mutagenic in human cells. J. Biol.
alter mRNA expressions of vitamin A metabolism Chem.278,31426.
genesintheliverofdamsandtheirfetuses.J.Nutr. 284. Long, EK and Picklo MJ (2010) Trans-4-hydroxy-
Biochem.25,549. 2-hexenal, a product of n-3 fatty acid peroxida-
266. Wolff,SPandNourooz-Zadeh,J(1996)Hypothesis: tion: make some room HNE. Free Radic. Biol. Med.
UK consumption of dietary lipid hydroperoxides - 49,1.

--- Page 795 ---

740 REFERENCES
285. Dalleau,Setal.(2013)Celldeathanddiseasesrelated 304. De Filippis, V et al. (2012) Oxidation of Met1606 in
to oxidative stress: HNE in the balance. Cell Death vonWillebrandfactorisariskfactorforthrombotic
Diff.20,1615. and septic complications in chronic renal failure.
286. Segall,HJetal.(1985)Trans-4-HHE:areactivemeta- Biochem.J.442,423.
bolite from the macrocyclic pyrrolizidine alkaloid 305. Taylor,SWetal.(2003)Oxidativepost-translational
senecionine.Science229,472. modificationoftryptophanresiduesincardiacmito-
287. Baert,JJetal.(2012)Ontheoriginoffreeandbound chondrialproteins.J.Biol.Chem.278,19587.
staling aldehydes in beer. J. Agric. Food Chem. 60, 306. Anderson,MMetal.(1997)Humanneutrophilsem-
11449. ploytheMPO-H2O2-Cl-systemtoconverthydroxyl-
288. Koutina,Getal.(2012)Proteinandlipidoxidationin aminoacidsintoglycolaldehyde,2-hydroxypropanal,
Parmahamduringproduction.J.Agric.FoodChem. andacrolein.J.Clin.Invest.99,424.
60,9737. 307. Leygonie,Cetal.(2012)Impactoffreezingandthaw-
289. Hellberg, K et al. (2010) X-ray crystallographic ingonthequalityofmeat:review.MeatSci.91,93.
analysis of adipocyte fatty acid binding protein 308. Meyer,Betal.(2012)Distributionofproteinoxida-
(aP2)modifiedwith4-HNE.ProteinSci.19,1480. tionproductsintheproteomeofthermallyprocessed
290. Mattson,MP(2009)Rolesofthelipidperoxidation milk.J.Agric.FoodChem.60,7306.
product4-HNEinobesity,themetabolicsyndrome, 309. Kim,Getal.(2014)Methionineoxidationandreduc-
andassociatedvascularandneurodegenerativedis- tioninproteins.Biochim.Biophys.Acta1840,901.
orders.Exp.Gerontol.44,625. 310. Kwak, GH et al. (2010) DMSO elevates H2O2-
291. Fisher, D et al. (1972) Environmental effects on the mediatedcelldeathinS.cerevisiaebyinhibitingthe
autoxidationofretinol.Biochem.J.130,259. antioxidantfunctionofMSRA.BMBRep.43,622.
292. Kunnen,SandVanEck,M(2012)Lecithin:choles- 311. Kim,HY(2013)TheMSRsystem:Seutilizationand
terolacyltransferase:oldfriendorfoeinatheroscler- MSR enzymes and their functions. Antioxid. Redox
osis?J.LipidRes.53,1783. Signal.19,958.
293. Braverman,NEandMoser,AB(2012)Functionsof 312. Lim,Detal.(2012)MsrBintheERiscriticalforstress
plasmalogen lipids in health and disease. Biochim. resistanceandaginginDrosophila.Biochem.Biophys.
Biophys.Acta1822,1442. Res.Commun.419,20.
294. Yang,Yetal.(2014)Characterizationofoxidativecar- 313. Kwon,Tetal.(2014)MsrB3deficiencycauseshear-
bonylation on recombinant monoclonal antibodies. inglossduetostereociliadegenerationandapoptotic
Anal.Chem.86,4799. celldeathincochlearhaircells.HumanMol.Genet.23,
295. Kanev,ILetal.(2014)AreROSgeneratedinelectros- 1591.
prayatlowcurrents?Anal.Chem.86,1511. 314. Lim, JCet al. (2013)Stereospecificoxidation of cal-
296. Bekhit,AEetal.(2013)Oxidativeprocessesinmuscle modulinbymethioninesulfoxidereductaseA.Free
systemsandfreshmeat:sources,markers,andrem- Radic.Biol.Med.61,257.
edies.Comp.Rev.FoodSci.FoodSafety12,565. 315. Nyström,T(2012)Spatialproteinqualitycontroland
297. Morgan, PE et al. (2008) Separation, detection, theevolutionoflineage-specificageing.Phil.Trans.
and quantification of hydroperoxides formed at R.Soc.B366,71.
side-chain and backbone sites on amino acids, 316. Scherz-Shouval,RandElazar,Z(2011)Regulationof
peptides, and proteins. Free Radic. Biol. Med. autophagybyROS:physiologyandpathology.Trends
45,1279. Biochem.Sci.36,30.
298. Grant,CM(2011)RegulationoftranslationbyH2O2. 317. Parzych,KRandKlionsky,DJ(2014)Anoverviewof
Antioxid.RedoxSignal.15,191. autophagy:morphology,mechanism,andregulation.
299. Tamarit J et al. (1998) Identification of the major Antioxid.RedoxSignal.20,460.
oxidatively damaged proteins in E. coli exposed to 318. Chu, CT et al. (2013) Cardiolipin externalization to
oxidativestress.J.Biol.Chem.273,3027. theoutermitochondrialmembraneactsasanelim-
300. Cabiscol, E et al. (2000) Oxidative stress promotes inationsignalformitophagyinneuronalcells.Nat.
specificproteindamageinS.cerevisiae.J.Biol.Chem. CellBiol.15,1197.
275,27393. 319. Yoshimoto,Ketal.(2014)Organ-specificqualitycon-
301. vanderVliesDetal.(2002)ERresidentproteinsof trolofplantperoxisomesismediatedbyautophagy.
normalhumandermalfibroblastsarethemajortar- J.CellSci.127,1161.
getsforoxidativestressinducedbyH2O2.Biochem.J. 320. Luce, K et al. (2010) Mitochondrial protein quality
366,825. controlsystemsinaginganddisease.Adv.Exp.Med.
302. Morgan, PE et al. (2004) Protective mechanisms Biol.694,108.
againstpeptideandproteinperoxidesgeneratedby 321. Pickering, AM and Davies, KJ (2012) Degradation
1O2.FreeRadic.Biol.Med.36,484. of damaged proteins: the main function of the 20S
303. Alimenti,Cetal.(2012)Cellaging-inducedmethio- proteasome.Prog.Mol.Biol.Transl.Sci.109,227.
nineoxidationcausesanautocrinetoparacrineshift 322. Yokota,Setal.(2008)InductionofperoxisomalLon
of the pheromone activity in the protozoan ciliate, proteaseinratliverafterdi-(2-ethylhexyl)phthalate
Euplotesraikovi.Exp.CellRes.318,144. treatment.Histochem.CellBiol.129,73.

--- Page 796 ---

REFERENCES 741
323. Bartoszewska, M et al. (2012) Peroxisomal proteo- 6. Knowles,PFetal.(1969)ESRevidenceforenzymic
stasisinvolveaLonfamilyproteinthatfunctionsas reduction of O2 to a free radical: the O •
2
– ion. Bio-
proteaseandchaperone.J.Biol.Chem.287,27380. chem.J.111,53.
324. Ngo, JK et al. (2013) Upregulation of the mito- 7. Caia, GL et al. (2012) Organ specific mapping of
chondrial Lon protease allows adaptation to acute in vivo redox state in control and cigarette smoke-
oxidative stress but dysregulation is associated exposedmiceusingEPR/NMRco-imaging.J.Magn.
with chronic stress, disease, and aging. Redox Biol. Reson.216,21.
1,258. 8. Elas,Metal.(2012)Oxidativestressimaginginlive
325. Kriegenburg, F et al. (2011) Redox control of the animalswithtechniquesbasedonEPR.Radiat.Res.
ubiquitin-proteasomesystem:frommolecularmech- 177,514.
anisms to functional significance. Antioxid. Redox 9. Towner, RA et al. (2013) In vivo detection of free
Signal.15,2265. radicals using molecular MRI and immuno-spin
326. Meregalli, C et al. (2012) CR4056, a new analgesic trappinginamousemodelforALS.FreeRadic.Biol.
I2 ligand, is highly effective against bortezomib- Med.63,351.
induced painful neuropathy in rats. J. Pain Res. 5, 10. Dmitriev, RI and Papkovsky, DB (2012) Optical
151. probes and techniques for O2 measurement in live
327. Lee,MHetal.(2001)Effectofproteasomeinhibition cellsandtissue.Cell.Mol.LifeSci.69,2025.
on cellular oxidative damage, antioxidant defences 11. Spencer,JAetal.(2014)Directmeasurementoflocal
•
andNO production.J.Neurochem.78,32. O2concentrationinthebonemarrowofliveanimals.
328. Yew, EHJ et al. (2005) Proteasome inhibition by Nature508,269.
lactacystin in primary neuronal cells induces both 12. Bokko,AAetal.(2009)Trityl-basedEPRprobewith
potentially neuroprotective and pro-apoptotic tran- enhancedsensitivitytoO2.FreeRadic.Biol.Med.47,
scriptionalresponses:amicroarrayanalysis.J.Neuro- 654.
chem.94,943. 13. Jackson, SK et al. (2002) Detection and removal of
329. Pickering,AMetal.(2012)Nrf2-dependentinduction contaminating hydroxylamines from the spin trap
ofproteasomeandPa28αβregulatorarerequiredfor DEPMPO, and re-evaluation of its use to indicate
adaptiontooxidativestress.J.Biol.Chem.287,10021. nitroneradicalcationformationandSN1reactions.
330. Lee,CSetal.(2011)LossofnuclearfactorE2-related FreeRadic.Biol.Med.32,228.
•
factor1inthebrainleadstodysregulationofprote- 14. Tortolani,AJetal.(1993)DetectionofalkoxylandC
asomegeneexpressionandneurodegeneration.Proc. free radicals in coronary sinus blood from patients
Natl.Acad.Sci.USA108,8408. undergoing elective cardioplegia. Free Radic. Biol.
331. Bakondi, E et al. (2011) Age-related loss of stress- Med.14,421.
inducednuclearproteasomeactivationisduetolow 15. Connor,HDetal.(1994)NewROScausesformation
•
PARP-1activity.FreeRadic.Biol.Med.50,86. of C radical adducts in organic extracts of blood
332. Grune, T et al. (2011) HSP70 mediates dissociation followinglivertransplantation.FreeRadic.Biol.Med.
and reassociation of the 26S proteasome during 16,871.
adaptationtooxidativestress.FreeRadic.Biol.Med. 16. Okazaki, S et al. (2014) Redox evaluation in sepsis
51,1355. model mice by the in vivo ESR technique using
333. Davies,SS etal. (2004)Isoketals: highlyreactiveγ- acyl-protectedhydroxylamine.FreeRadic.Biol.Med.
ketoaldehydes formed from the H2-IsoP pathway. 68,72.
Chem.Phys.Lipids128,85. 17. Filosa, A et al. (2005) Quantitative evaluation of
oxidative stress status on peripheral blood in β-
thalassaemicpatientsbymeansofEPRspectroscopy.
Chapter6 Br.J.Haematol.131,135.
18. Dikalov,SIandHarrison,DG(2014)Methodsforde-
1. Han, JY et al. (2010) In vivo ESR: an effective new
tectionofmitochondrialandcellularROS.Antioxid.
tool for ROS/RNS measurement. Arch. Pharm. Res.
RedoxSignal.20,572.
33,1293.
19. Gomez-Mejiba, SE et al. (2014) Immuno-spin trap-
2. Halliwell,B(1999)Establishingthesignificanceand
ping from biochemistry to medicine: advances,
optimalintakeofdietaryantioxidants:thebiomarker
challenges, and pitfalls. Focus on protein-centered
concept.Nutr.Rev.57,104.
radicals.Biochim.Biophys.Acta1840,722.
3. Dalle-Donne,Letal.(2006)Biomarkersofoxidative •
20. Nishizawa, C et al. (2004) OH generation caused
damageinhumandisease.Clin.Chem.52,601.
4. Hawkins, CL and Davies, MJ (2014) Detection and
by the reaction of 1O2 with a spin trap, DMPO,
increases significantly in the presence of biological
characterizationofradicalsinbiologicalmaterialsus-
reductants.FreeRadic.Res.38,385.
ing EPR methodology. Biochim. Biophys. Acta 1840,
21. Das,Aetal.(2012)InhibitionofROS-inducedapop-
708.
tosis in endothelial cells by nitrone spin traps via
5. Bailey, DM et al. (2007) EPR evidence of exercise-
induction of phase II enzymes and suppression of
inducedfreeradicalaccumulationinhumanskeletal
mitochondria-dependent pro-apoptotic signaling.
muscle.FreeRadic.Res.41,182.
Biochem.Pharmacol.84,486.

--- Page 797 ---

742 REFERENCES
22. Stoyanovsky, DA et al. (2011) Assessment of 39. Shaltiel-Karyo, R et al. (2013) A blood-brain
thiyl radicals in biosystems: difficulties and new barrier (BBB) disrupter is also a potent a-
applications.Anal.Chem.83,6432. synuclein aggregation inhibitor. J. Biol. Chem. 288,
23. Kang,PTetal.(2012)Proteinthiylradicalmediates 17579.
S-glutathionylation of complex I. Free Radic. Biol. 40. Halliwell, B (1995) Antioxidant characterization.
Med.53,962. Methodology and mechanism. Biochem. Pharmacol.
24. Khoo,NKHetal.(2012)Obesity-inducedtissuefree 49,1341.
radicalgeneration:aninvivoimmune-spintrapping 41. Saito, K et al. (2009) Comparison of O
•–detection
2
study.FreeRadic.Biol.Med.52,2312. abilitiesofnewlydevelopedspintrapsintheliving
25. Althaus,JSetal.(1998)Azulenylnitrones:colorimet- cells.FreeRadic.Res.43,668.
ricdetectionofoxyradicalendproductsandneuro- 42. Kahn,V(1989)Tironasasubstrateforhorseradish
protection in the gerbil transient forebrain ische- peroxidase.Phytochemistry28,41.
mia/reperfusionmodel.FreeRadic.Biol.Med.24,738. 43. Ghosh,Metal.(2002)Tironexertseffectsunrelatedto
26. Qian,SYetal.(2005)Anovelprotocoltoidentifyand itsroleasascavengerofO
•–:effectsonCa2+binding
2
quantifyallspintrappedfreeradicalsfrominvitro and vascular responses. Can. J. Physiol. Pharmacol.
•
/ in vivo interaction of HO and DMSO: LC/ESR, 80,755.
LC/MS,anddualspintrappingcombinations.Free 44. Fujita,Metal.(2009)Invivoreal-timemeasurement
Radic.Biol.Med.38,125. of O
•–
radical with a novel electrochemical sensor.
2
27. Halliwell,BandWhiteman,M(2004)MeasuringRS FreeRadic.Biol.Med.47,1039.
and oxidative damage in vivo and in cell culture: 45. Cortina-Puig, M et al. (2010) Determination of the
howshouldyoudoitandwhatdotheresultsmean? antioxidants’abilitytoscavengefreeradicalsusing
BrJ.Pharmacol.142,231. biosensors.Adv.Exp.Med.Biol.698,222.
•
28. Freinbichler,Wetal.(2008)ThedetectionofOH in 46. Giulivi, C et al. (1999) The steady-state concentra-
vitro.J.Inorg.Biochem.102,1329. tions of O2 radicals in mitochondria. In: ROS in
29. Vinci, RM et al. (2011) Factors influencing benzene Biological Systems.KluwerAcademic, Plenum Press
formation from the decarboxylation of benzoate in Publishers,NewYork,USA.
liquidmodelsystems.J.Agric.FoodChem.59,12975. 47. Warwar,Netal.(2011)DetectionandimagingofO
•–
2
30. Lamrini, R et al. (1998) Oxidative decarboxylation in roots by an ESR spin-probe method. Biophys. J.
ofbenzoicacidbyperoxylradicals.FreeRadic.Biol. 101,1529.
Med.24,280. 48. Liu,Yetal.(2012)Tetrathiatriarylmethylradicalwith
•
31. Powell, SR (1994) Salicylate trapping of OH as a asinglearomaticHasahighlysensitiveandspecific
tool for studying post-ischemic oxidative injury in O
•–probe.FreeRadic.Biol.Med.53,2081.
2
theisolatedratheart.FreeRadic.Res.21,355. 49. Freitas, I et al. (2002) In situ detection of ROS and
•
32. Orhan,Hetal.(2004)Simultaneousdeterminationof NO productioninnormalandpathologicaltissues:
tyrosine,phenylalanineanddGoxidationproducts improvement by differential interference contrast.
byLC-MSasnon-invasivebiomarkersforoxidative Exp.Gerontol.37,591.
•
damage.J.Chromatogr.B799,245. 50. Coneski, PN and Schoenfisch, MH (2012) NO
33. Huycke,MMandMoore,DR(2002)Invivoproduc- release:partIII.Measurementandreporting.Chem.
•
tion of OH by Enterococcus faecalis colonizing the Soc.Rev.41,3753.
intestinal tract using aromatic hydroxylation. Free 51. Kleinbongard, P et al. (2003) Plasma NO– reflects
2
•
Radic.Biol.Med.33,818. constitutiveNO synthaseactivityinmammals.Free
34. Bertin, C et al. (2007) Grass roots chemistry: meta- Radic.Biol.Med.35,790.
tyrosine,anherbicidalnonproteinaminoacid.Proc. 52. Kawai, K et al. (2013) A reductant-resistant and
Natl.Acad.Sci.USA104,16964. metal-freefluorescentprobeforHNOapplicableto
35. Ruggiero,RAetal.(2012)Concomitanttumorresist- livingcells.J.Am.Chem.Soc.135,12690.
ance:theroleoftyrosineisomersinthemechanisms 53. Tarpey, MM et al. (2004) Methods for detection of
ofmetastasescontrol.CancerRes.72,1043. reactivemetabolitesofO2andN2:invitroandinvivo
36. Kalyanaraman,Betal.(1993)Formationof2,5-DHB considerations.Am.J.Physiol.289,R431.
during the reaction between 1O2 and salicylic 54. Chen, X et al. (2014) Pros and cons of current
acid. Analysis by ESR oximetry and HPLC with approaches for detecting ONOO– and their
electrochemicaldetection.J.Am.Chem.Soc.115,4007. applications.Biomed.J.37,120.
37. Ferger,Betal.(2001)6-hydroxydopamineincreases 55. Ryberg, H and Caidahl, K (2007) Chromatographic
thehydroxylationandnitrationofphenylalaninein and MS methods for quantitative determination
vivo:implicationofONOO–formation.J.Neurochem. of 3-nitrotyrosine in biological samples and their
78,509. application to human samples. J. Chromatogr. B
38. Whiteman, M and Halliwell, B (1997) Thiourea 851,160.
and DMTU inhibit ONOO–-dependent damage: 56. Kaur,Hetal.(1998)ArtefactsinHPLCdetectionof
•
non-specificity as OH scavengers. Free Radic. Biol. 3-nitrotyrosineinhumanbraintissue.J.Neurochem.
Med.22,1309. 70,2220.

--- Page 798 ---

REFERENCES 743
57. Feeney, MB and Schöneich, C (2013) Proteomic epithelialcells:roleofthehumanSULT1A3.Toxicol.
approaches to analyze protein tyrosine nitration. Appl.Pharmacol.251,104.
Antioxid.RedoxSignal.19,1247. 75. Andersen, SO (2004) Chlorinated tyrosine deriva-
58. Kanski,Jetal.(2003)Proteomicidentificationofage- tives in insect cuticle. Insect Biochem. Mol. Biol. 34,
dependent protein nitration in rat skeletal muscle. 1079.
FreeRadic.Biol.Med.35,1229. 76. Foote, CS and Clennan, EL (1995) Properties and
59. Ischiropoulos, H (2003) Biological selectivity and reactionsofsingletO2.In:ActiveOxygeninChemistry
functional aspects of protein tyrosine nitration. (Foote,CSetal.,eds),p.105.Blackie,London.
Biochem.Biophys.Res.Commun.305,776. 77. Ronsein,GEetal.(2012)Roleof1O2intheoxidative
60. Sharov,VSetal.(2012)Fluorogenictaggingofpro- damage to biomolecules. In: Oxidative Stress in
tein 3-nitrotyrosine with 4-(aminomethyl)benzene AquaticEcosystems,BlackwellPublishingLtd.
sulfonateintissues:ausefulalternativetoimmuno- 78. Nakamura,Ketal.(2011)Reevaluationofanalytical
histochemistryforfluorescencemicroscopyimaging methods for photogenerated 1O2. J. Clin. Biochem.
ofproteinnitration.FreeRadic.Biol.Med.53,1877. Nutr.49,87.
61. Halliwell,B(1997)Whatnitratestyrosine?FEBSLett. 79. Fischer, BB et al. (2013) Production, detection, and
411,157. signaling of 1O2 in photosynthetic organisms.
62. Whiteman,Metal.(2003)Lackoftyrosinenitration Antioxid.RedoxSignal.18,2145.
byHOClinthepresenceofphysiologicalconcentra- 80. Packer, JE et al. (1981) Free radicals and 1O2 scav-
tionsofNO2 –.ImplicationsfortheroleofNO2Clin engers:reactionofaperoxyradicalwithβ-carotene,
tyrosinenitrationinvivo.J.Biol.Chem.278,8380. diphenyl furan and DABCO. Biochem. Biophys. Res.
63. MacPherson,JCetal.(2001)Eosinophilsareamajor Commun.98,901.
•
source of NO -derived oxidants in severe asthma: 81. Steinbeck, MJ et al. (1993) Extracellular produc-
characterizationofpathwaysavailabletoeosinophils tion of 1O2 by stimulated macrophages quantified
forgeneratingRNS.J.Immunol.166,5763. using 9,10-diphenylanthracene and perylene in a
64. Eiserich, JP et al. (2002) MPO, a leukocyte-derived polystyrenefilm.J.Biol.Chem.268,15649.
•
vascularNO oxidase.Science296,2391. 82. Mori, H et al. (2010) Substituent effects of pterin
65. Tsikas, D (2010) Measurement of nitrotyrosine in derivativeson1O2 scavengingactivity.Biol.Pharm.
plasma by immunoassays is fraught with danger: Bull.33,905.
commercialavailabilityisnoguaranteeofanalytical 83. Swanson,SJetal.(2011)InvivoimagingofCa2+,pH
reliability.Clin.Chem.Lab.Med.48,141. and ROS using fluorescent probes in plants. Annu.
66. Frost,MTetal.(2000)Analysisoffreeandprotein- Rev.PlantBiol.62,273.
bound3-NTinhumanplasmabyaGC/MSmethod 84. Vladimirov, YA and Proskurnina, EV (2009) Free
thatavoidsnitrationartifacts.Biochem.J.345,453. radicals and cell chemiluminescence. Biochemistry
67. Tsikas, D et al. (2005) Determination of 3-NT in (Moscow)74,1545.
human urine at the basal state by GC-tandem MS 85. Williams, MD and Chance, B (1993) Spontaneous
and evaluation of the excretion after oral intake. chemiluminescence of human breath. J. Biol. Chem.
J.Chromatogr.B827,146. 258,3628.
68. Pannala,ASetal.(2006)pH-dependentnitrationof 86. Ezerin¸a, D et al. (2014) Imaging dynamic redox
para-hydroxyphenylacetic acid in the stomach. Free processes with genetically encoded probes. J. Mol.
Radic.Biol.Med.41,896. Cell.Cardiol.73,43.
69. Shishehbor, MH et al. (2003) Statins promote po- 87. Gonzalez-Flecha,BandDemple,B(1994)Intracellu-
tent systemic antioxidant effects through specific largenerationofO
•–asaby-productofVibrioharveyi
2
inflammatorypathways.Circulation108,426. luciferaseexpressedinE.coli.J.Bacteriol.176,2293.
70. Daiber,AandMünzel,T(2013)Increasedcirculating 88. Chen, Z et al. (2011) Enhanced bacterial biosensor
levels of 3-nitrotyrosine autoantibodies: marker for forfastandsensitivedetectionofoxidativelyDNA
ormakerofcardiovasculardisease?Circulation126, damagingagents.Anal.Chem.83,3248.
2371. 89. van der Linden, SC et al. (2014) Development of a
71. Kettle,AJetal.(2014)MeasuringCl2 bleachinbiol- panel of high-throughput reporter-gene assays to
ogyandmedicine.Biochim.Biophys.Acta1840,781. detectgenotoxicityandoxidativestress.Mutat.Res.
72. Whiteman, M and Spencer, JPE (2008) Loss of 760,23.
3-chlorotyrosinebyinflammatoryoxidants:implica- 90. Xu, X et al. (2012) A novel approach for in vivo
tionsfortheuseof3-chlorotyrosineasabiomarker measurement of mouse red cell redox status. Blood
invivo.Biochem.Biophys.Res.Commun.371,50. 118,3694.
73. Xu,Qetal.(2013)Ahighlyspecificfluorescentprobe 91. van Lith, M et al. (2011) Real-time monitoring of
for HOCl and its application in imaging microbe- redoxchangesinthemammalianER.J.Cell.Sci.124,
induced HOCl production. J. Am. Chem. Soc. 135, 2349.
9944. 92. Lukyanov,KAandBelousov,VV(2014)Genetically
74. Yasuda, S et al. (2011) Sulfation of chlorotyrosine encodedfluorescentredoxsensors.Biochim.Biophys.
and nitrotyrosine by human lung endothelial and Acta1840,745.

--- Page 799 ---

744 REFERENCES
93. Schwarzländer,Metal.(2014)The‘mitoflash’probe 112. Clement,MVetal.(2002)Thecytotoxicityofdopa-
cpYFPdoesnotrespondtoO
•–.Nature514,E12.
minemaybeanartifactofcellculture.J.Neurochem.
2
94. Kettle, AJ et al. (1994) Assays using HRP and 81,414.
phenolicsubstratesrequireSODforaccuratedeter- 113. Balcerczyk, A et al. (2007) Does the cellular la-
mination of H2O2 production by neutrophils. Free bile Fe pool participate in the oxidation of
(cid:4) (cid:4)
Radic.Biol.Med.17,161 2,7-dichlorodihydrofluorescein? Free Radic. Res.
95. Chatterjee,SandChen,S(2012)Functionalizationof 41,563.
carbon buckypaper for the sensitive determination 114. Bouzigues, CI et al. (2014) Regulation of the ROS
ofH2O2inhumanurine.Biosens.Bioelectron.35,302. responsedynamicsandorganizationtoPDGFmotile
96. Chen,Wetal.(2012)Recentadvancesinelectrochem- stimuli revealed by single nanoparticle imaging.
icalsensingforH2O2:areview.Analyst,137,49. Chem.Biol.21,647.
97. Halliwell,Betal.(2004)Establishingbiomarkersof 115. Michalski, R et al. (2013) Hydropropidine: a novel,
oxidativestress:themeasurementofH2O2inhuman cell-impermeant fluorogenic probe for detecting
urine.Curr.Med.Chem.11,1085. extracellularO
•–.FreeRadic.Biol.Med.54,135.
2
98. Sato, Y et al. (2012) Evaluation of urinary H2O2 as 116. Cu, X and Arriaga, EA (2010) Chemical cytometry
anoxidativestressbiomarkerinahealthyJapanese quantitatesO
•–levelsinthemitochondrialmatrixof
2
population.FreeRadic.Res.47,181. singlemyoblasts.Anal.Chem.82,6745.
99. Mishina,NMetal.(2011)DoescellularH2O2diffuse 117. Kalyanaraman,Betal.(2014)HPLC-basedmonitor-
oractlocally?Antioxid.RedoxSignal.14,1. ing of products formed from hydroethidine-based
100. Wu,Fetal.(2010)Nox-4derivedH2O2mediatesER fluorogenicprobes–theultimateapproachforintra-
signalingthroughlocalRasactivation.Mol.Cell.Biol. and extracellular O
•–
detection. Biochim. Biophys.
2
30,3553. Acta1840,739.
101. Albrecht,SCetal.(2011)InvivomappingofH2O2and 118. Han, W et al. (2012) Bioluminescence imaging of
oxidized glutathione reveals chemical and regional NADPHoxidaseactivityindifferentanimalmodels.
specificityofredoxhomeostasis.CellMetab.14,819. J.Vis.Exp.68,e3925.
102. Lin, VS et al. (2013) Boronate-based fluorescent 119. Chernyak, BV et al. (2006) Production of ROS in
probes: imaging H2O2 in living systems. Methods mitochondria of HeLa cells under oxidative stress.
Enzymol.526,19. Biochim.Biophys.Acta1757,525.
103. Miller, EW et al. (2010) Aquaporin-3 mediates 120. Toyama, K et al. (2013) Analysis of oxidative
H2O2 uptake to regulate downstream intracellular stress expressed by urinary levels of 8OHdG and
signaling.Proc.Natl.Acad.Sci.USA107,15681. biopyrrininatrialfibrillation:effectofsinusrhythm
104. Dickinson, BC et al. (2011) Nox2 redox signaling restoration.Int.J.Cardiol.168,80.
maintainsessentialcellpopulationsinthebrain.Nat. 121. Novo, S et al. (2012) Urinary biopyrrins: potential
Chem.Biol.7,106. biomarker for monitoring of the response to treat-
105. Logan, A et al. (2014) Using exomarkers to assess mentwithanxiolytics.BasicClin.Pharmacol.Toxicol.
mitochondrialRSinvivo.Biochim.Biophys.Acta1840, 111,206.
923. 122. Gruber, J et al. (2009) Allantoin in human plasma,
106. Zielonka,Jetal.(2012)Boronateprobesasdiagnos- serum, and nasal-lining fluids as a biomarker of
tic tools for real time monitoring of ONOO– and oxidativestress:avoidingartifactsand establishing
hydroperoxides.Chem.Res.Toxicol.25,1793. realinvivoconcentrations.Antioxid.RedoxSignal.11,
107. Kalyanaraman,Betal.(2012)MeasuringRONSwith 1767.
fluorescent probes: challenges and limitations. Free 123. Seidel,Aetal.(2014)UricacidandCNS–ascompet-
Radic.Biol.Med.52,1. ingsubstratesoflactoperoxidase.J.Biol.Chem.289,
108. Yu, F et al. (2012) A fluorescent probe directly de- 21937.
tects ONOO– based on boronate oxidation and its 124. Il’yasova, D et al. (2011) Individual responses to
applicationsforfluorescenceimaginginlivingcells. chemotherapy-induced oxidative stress. Breast
Analyst137,3740. CancerRes.Treat.125,583.
109. Van de Bittner, GC et al. (2010) In vivo imaging of 125. Seet,RCSetal.(2011)Biomarkersofoxidativedam-
H2O2 production ina murinetumormodel with a age in cigarette smokers: which biomarkers might
chemoselective bioluminescent reporter. Proc. Natl. reflect acute versus chronic oxidative stress? Free
Acad.Sci.USA107,21316. Radic.Biol.Med.50,1787.
110. Dickinson, BC et al. (2010) A palette of fluorescent 126. Chan, W et al. (2010) Quantification of the 2-
probes with varying emission colors for imaging deoxyribonolactone and nucleoside 5’-aldehyde
H2O2signalinginlivingcells.J.Am.Chem.Soc.132, products of 2-deoxyribose oxidation in DNA and
5906. cells by isotope-dilution gas chromatography mass
111. Wardman, P (2007) Fluorescent and luminescent spectrometry:differentialeffectsofγ-radiationand
probesformeasurementofoxidativeandnitrosative Fe2+-EDTA.J.Am.Chem.Soc.132,6145.
species in cells and tissues: progress, pitfalls, and 127. Nishimura, S (2011) 8-Hydroguanine: a base for
prospects.FreeRadic.Biol.Med.43,995. discovery.DNARepair10,1078.

--- Page 800 ---

REFERENCES 745
128. Evans, MD et al. (2010) DNA repair and the ori- 145. Li,MJetal.(2011)Capillaryelectrophoreticdetermin-
gins of urinary oxidized 2’-deoxyribonucleosides. ationofDNAdamagemarkers:contentof8-OHdG
Mutagenesis25,433. and8-NGinurine.J.Chromatogr.B879,3818.
(cid:4)
129. Jaruga,Petal.(2012)DNAdamageproducts(5R)- 146. Asahi, T et al. (2010) Chemical and immunochem-
(cid:4) (cid:4) (cid:4)
and (5S)-8,5-cyclo-2deoxyadenosines as potential ical detection of 8-halogenated dG at early stage
biomarkers in human urine for atherosclerosis. inflammation.J.Biol.Chem.285,9282.
Biochemistry51,1822. 147. O’Callaghan,Netal.(2011)AqPCR-basedassayto
130. Rossner,PJretal.(2013)Urinary8OHdGvaluesde- quantifyoxidizedguanineandotherFPG-sensitive
terminedbyamodifiedELISAimprovesagreement base lesions within telomeric DNA. BioTechniques
withHPLC-MS/MS.Biochem.Biophys.Res.Commun. 51,403
440,725. 148. Lu,Tetal.(2004)GeneregulationandDNAdamage
131. Barregard,Letal.(2013)Humanandmethodological intheageinghumanbrain.Nature429,883.
sourcesofvariabilityinthemeasurementofurinary 149. Choi, J et al. (2002) Gene-specific oxidative DNA
8OHdG.Antioxid.RedoxSignal.18,2377. damageinH.pylori-infectedhumangastricmucosa.
132. Loft, S and Poulsen, HE (1996) Cancer risk and Int.J.Cancer99,485.
oxidativeDNAdamageinman.J.Mol.Med.74,297. 150. Akatsuka, S and Toyokuni, S (2012) Genome-wide
133. Andreoli,Retal.(2010)Quantitativedetermination assessmentofoxidativelygeneratedDNAdamage.
of urinary 8OHdG, 8-oxo-7,8-dihydroguanine, 8- FreeRadic.Res.46,523.
oxo-7,8-dihydroguanosine, and their non-oxidized 151. Ohno, M et al. (2012) A genome-wide distribution
forms: daily concentration profile in healthy of 8-oxoG correlates with the preferred regions for
volunteers.Biomarkers15,221. recombinationandsinglenucleotidepolymorphism
134. Halliwell,B(2000)Whyandhowshouldwemeasure inthehumangenome.GenomeRes.16,567.
oxidativeDNAdamageinnutritionalstudies?How 152. Bhattacharjee,Setal.(2012)Detectionandimaging
farhavewecome?Am.J.Clin.Nutr.72,1082. ofthefreeradicalDNAincells–site-specificradical
135. Ravanat,JL(2012)Chromatographicmethodsforthe formation induced by Fenton chemistry and its
analysis of oxidatively damaged DNA. Free Radic. repairincellularDNAasseenbyESR,immune-spin
Res.46,479. trappingandconfocalmicroscopy.NucleicAcidsRes.
136. Lim,KSetal.(2006)Potentialartifactsinthemeas- 40,5477.
urementofDNAdeamination.FreeRadic.Biol.Med. 153. Poulsen, HE et al. (2012) RNA modifications by
40,1939. oxidation: a novel disease mechanism. Free Radic.
137. Taghizadeh, K et al. (2008) Quantification of DNA Biol.Med.52,1353.
damageproductsresultingfromdeamination,oxida- 154. Matsuda, T et al. (2013) Lipid peroxidation-
tionandreactionwithproductsoflipidperoxidation induced DNA adducts in human gastric mucosa.
by LC isotope dilution tandem MS. Nat. Protoc. 3, Carcinogenesis34,121.
1287. 155. Chaudhary,AKetal.(1994)Detectionofendogenous
138. Loft,Setal.(1998)Experimentalstudyofoxidative MDA-deoxyguanosine adducts in human liver.
DNAdamage.FreeRadic.Res.29,523. Science265,1580.
139. Cavallini, G et al. (2014) Effects of stimulation of 156. Leuratti, C et al. (2002) Detection of MDA–DNA
autophagyontheurinaryexcretionofbiomarkersof adducts in human colorectal mucosa: relationship
theoxidativestatus.AgingClin.Exp.Res.26,13. with diet and the presence of adenomas. Cancer
140. Kamura,Ketal.(1997)Effectofenduranceexercise Epidemiol.Biomark.Prev.11,267.
onthetissue8OHdGcontentindogs.FreeRadic.Res. 157. Otteneder,MBetal.(2006)Invivooxidativemetab-
26,253. olismofamajorperoxidation-derivedDNAadduct
141. Cardin, R et al. (2001) DNA oxidative damage M1dG.Proc.Natl.Acad.Sci.USA103,6665.
in leukocytes correlates with the severity of 158. Nair, J et al. (2010) High urinary excretion of lipid
HCV-related liver disease: validation in an open peroxidation-derivedDNAdamageinpatientswith
populationstudy.J.Hepatol.34,587. cancer-proneliverdiseases.Mutat.Res.683,23.
142. Halliwell,B(2002)Effectofdietoncancerdevelop- 159. Harma,MIandHarma,M(2006)TheFORTtest-a
ment: is oxidativeDNA damagea biomarker?Free noveloxidativestressmarkerorawell-knownmeas-
Radic.Biol.Med.32,968. ureofceruloplasminoxidaseactivity.Atherosclerosis
143. Kawanishi, S and Hiraku, Y (2006) Oxidative and 187,441.
nitrativeDNAdamageasbiomarkerforcarcinogen- 160. Kilk,Ketal.(2014)Assessmentofoxidativestressin
esiswithspecialreferencetoinflammation.Antioxid. serumbyd-ROMStest.FreeRadic.Res.48,883.
RedoxSignal.8,1047. 161. Hay,Aetal.(2005)DevelopmentofanewEPRspin
144. Sawa, T et al. (2006) Analysis of urinary 8NG, a trap,DOD-8Cforthetrappingoflipidradicalsata
markerofnitrativenucleicaciddamage,byHPLC- predetermineddepthwithinbiologicalmembranes.
ECD coupled with immunoaffinity purification: Arch.Biochem.Biophys.435,336.
association with cigarette smoking. Free Radic. Biol. 162. Qian, S et al. (2002) Characterization of the initial
Med.40,711. carbon-centeredpentadienylradicalandsubsequent

--- Page 801 ---

746 REFERENCES
radicalsinlipidperoxidation:identificationviaon- seriesisolevuglandininvitro.Chem.Res.Toxicol.17,
lineHPLC/ESRandMS.FreeRadic.Biol.Med.33,998. 613.
163. Banni, S et al. (1996) A novel approach to study 181. Gao, L et al. (2006) Formation of F-ring IsoP-like
linoleic acid autoxidation: importance of simultan- compounds(F3-IsoPs)invivofromEPA.J.Biol.Chem.
eous detection of the substrate and its derivative 281,14092.
oxidationproducts.FreeRadic.Res.25,43. 182. Frankel,ENetal.(1989)RapidheadspaceGCofhex-
164. Banni,Setal.(1996)Nodirectevidenceofincreased analasameasureoflipidperoxidationinbiological
lipidperoxidationinhemodialysispatients.Nephron. samples.Lipids24,976.
72,177. 183. Souza,HAandBragagnolo,N(2014)Newmethod
165. Thompson,SandSmith,MT(1985)Measurementof for the extraction of volatile lipid oxidation
thedieneconjugatedformoflinoleicacidinplasma products from shrimp by headspace-solid-phase
byHPLC:aquestionablenon-invasiveassayoffree microextraction-GC-MSandevaluationoftheeffect
radicalactivity?Chem.Biol.Interac.55,357. ofsaltinganddrying.J.Agric.FoodChem.62,590.
166. Park,YandPariza,MW(1998)Evidencethatcom- 184. Giera,Metal.(2012)RecentadvancementsintheLC-
mercial calf and horse sera can contain substantial and GC-based analysis of MDA: a brief overview.
amountsoftrans-10,cis-12CLA.Lipids33,817. Chromatographia75,433.
167. Dilzer, A and Park, Y (2012) Implication of conju- 185. Spickett,CM(2013)Thelipidperoxidationproduct
gatedlinoleicacid(CLA)inhumanhealth.Crit.Rev. 4-HNE: advances in chemistry and analysis. Redox
FoodSci.Nutr.52,488. Biol.1,145.
168. Salvatore, SR et al. (2013) Characterization and 186. Goicoechea, E and Guillen, MD (2010) Analysis of
quantificationofendogenousfattyacidnitroalkene hydroperoxides, aldehydes and epoxides by 1H
metabolitesinhumanurine.J.LipidRes.54,1998. NMR in sunflower oil oxidized at 70 and 100 oC.
169. Niki, E (2014) Biomarkers of lipid peroxidation in J.Agric.FoodChem.58,6234.
clinicalmaterial.Biochim.Biophys.Acta1840,809. 187. Weber,Detal.(2013)MeasurementofHNE-protein
170. Griffiths,WJetal.(2013)Methodsforoxysterolana- adducts in human plasma and serum by ELISA –
lysis: past, present and future. Biochem. Pharmacol. comparisonoftwoprimaryantibodies.RedoxBiol.1,
86,3. 226.
171. Ishigaki, Y et al. (2009) Circulating oxidized LDL: 188. Kuiper, HC et al. (2010) Quantification of mercap-
a biomarker and a pathogenic factor. Curr. Opin. turicacidconjugatesof4-HNEand4-oxo-2-nonenal
Lipidol.20,363. metabolitesinasmokingcessationstudy.FreeRadic.
172. Milne, GL et al. (2015) The isoprostanes - 25 years Biol.Med.48,65.
later.Biochim.Biophys.Acta1851,433. 189. Pierre,Fetal.(2012)Newmarkerofcoloncancerrisk
173. Yoshida, Y et al. (2008) Simultaneous measurement associated with heme intake: 1,4-dihydroxynonane
of F2-IsoP, hydroxyoctadecadienoic acid, hy- mercapturic acid. Cancer Epidemiol. Biomarkers Prev.
droxyeicosatetraenoicacid,andhydroxycholesterols 15,2274.
fromphysiologicalsamples.Anal.Biochem.379,105. 190. Zheng, L et al. (2013) Determination of urine 3-
174. Il’yasova, D et al. (2012) Urinary biomarkers of HPMA,astableacroleinmetaboliteinaratmodelof
oxidativestress.Clin.Chim.Acta413,1446. spinalcordinjury.J.Neurotrauma30,1334.
175. Barden, AE et al. (2014) Minimizing artifactual 191. Chavez,JDetal.(2011)Site-specificproteomicana-
elevationoflipidperoxidationproducts(F2-IsoPs)in lysisoflipoxidationadductsincardiacmitochondria
plasmaduringcollectionandstorage.Anal.Biochem. reveals chemical diversity of 2-alkenal adduction.
449C,129. J.Proteomics24,2417.
176. Klawitter, J et al. (2011) Quantification of 15-F2t- 192. Gutteridge, JMC and Quinlan, GJ (1983) MDA
IsoP in human plasma and urine: results from formationfromlipidperoxidesintheTBAtest:the
enzyme-linked immunoassay and LC/tandem MS role of lipid radicals, Fe salts, and metal chelators.
cannotbecompared.RapidCommun.MassSpectrom. J.Appl.Biochem.5,293.
25,463. 193. Onyango,ANandBaba,N(2010)Newhypotheses
177. Richelle,Metal.(1999)UrinaryIsoPexcretionisnot onthepathwaysofformationofMDAandisofurans.
confounded by the lipid content of the diet. FEBS FreeRadic.Biol.Med.49,1594.
Lett.459,259. 194. Cighetti,Getal.(1998)β-Ethoxyacroleincontamin-
178. Halliwell,BandLee,CYJ(2010)UsingIsoPsasbio- ationincreasesMDAinhibitionofmilkXOactivity.
markersofoxidativestress:somerarelyconsidered FreeRadic.Biol.Med.25,818.
issues.Antioxid.RedoxSignal.13,145. 195. Draper,HHetal.(2000)Urinaryaldehydesasindi-
179. Lee, CY et al. (2004) Rapid preparation of human catorsoflipidperoxidationinvivo.FreeRadic.Biol.
urineandplasmasamplesforanalysisofF2–IPsby Med.29,1071.
GC–MS.Biochem.Biophys.Res.Comm.320,696. 196. Li, Z et al. (2010) Antioxidant-rich spice added to
180. Poliakov,Eetal.(2004)Iso[7]LGD2-proteinadducts hamburgermeatduringcookingresultsinreduced
areabundantinvivoandfreeradical-inducedoxida- meat, plasma, and urine MDA concentrations. Am.
tionofanarachidonylphospholipidgeneratesthisD J.Clin.Nutr.91,1180.

--- Page 802 ---

REFERENCES 747
197. Brown, ED et al. (1995) Urinary MDA-equivalents within the inner mitochondrial membrane of live
during ingestion of meat cooked at high or low cells.J.Am.Chem.Soc.135,17135.
temperatures.Lipids30,1053. 216. Boens,Netal.(2012)Fluorescentindicatorsbasedon
198. Kosugi, H et al. (1993) Characteristics of the TBA BODIPY.Chem.Soc.Rev.41,1130.
reactivityofhumanurineasapossibleconsequence 217. Hawkins, CL et al. (2009) Quantification of protein
oflipidperoxidation.Lipids28,337. modification by oxidants. Free Radic. Biol. Med. 46,
199. Gérard-Monnier, D et al. (1998) Reactions of 965.
1-methyl-2-phenylindole with MDA and 4- 217A. Bachi, A et al. (2013) Redox proteomics: chem-
hydroxyalkenals. Analytical applications to a ical principles, methodological approaches and
colorimetric assay of lipid peroxidation.Chem. Res. biological/biomedicalpromises.Chem.Rev.113,596.
Toxicol.11,1176. 218. Thornalley,PGandRabbani,N(2014)Detectionof
200. Spirlandeli, AL et al. (2014) Plasma MDA as bio- oxidized and glycated proteins in clinical samples
markeroflipidperoxidation:effectsofacuteexercise. using MS – a user’s perspective. Biochim. Biophys.
Int.J.SportsMed.35,14. Acta1840,818.
201. Stolarek,Retal.(2010)BreathanalysisofH2O2asa 219. Lubec, G et al. (1994) Racemization and oxidation
diagnostictool.Clin.Chim.Acta.411,1849. studiesofhairproteininHomotirolensis.FASEBJ.8,
202. Gorham, KA et al. (2009) Ethane and n-pentane in 1166.
exhaledbreatharebiomarkersofexposurenoteffect. 220. Manary,MJetal.(2000)Increasedoxidativestressin
Biomarkers14,17. kwashiorkor.J.Pediatr.137,421.
203. Forteza, Retal. (2005)RegulatedH2O2 production 221. Kato,Tetal.(1998)Immunohistochemicaldetection
by Duox in human airway epithelial cells. Am. of dityrosine in lipofuscin pigments in the aged
J.Respir.CellMol.Biol.32,462. humanbrain.FEBSLett.439,231.
204. King, J et al. (2012) Breath isoprene: muscle dys- 222. Pattison,DIandDavies,MJ(2004)Kineticanalysis
trophy patients support the concept of a pool of of the reactions of HOBr with protein compo-
isoprene in the periphery of the human body. nents: implications for cellular damage and use of
Biochim.Biophys.Res.Commun.423,526. 3-bromotyrosine as a marker of oxidative stress.
205. Kanoh,Setal.(2005)Exhaledethane.Chest128,2387. Biochemistry43,4799.
206. Kikugawa, K and Beppu, M (1987) Involvement of 223. Yan, LJ and Forster, MJ (2011) Chemical probes
lipidoxidationproductsintheformationoffluores- for analysis of carbonylated proteins: a review.
centandcross-linkedproteins.Chem.Phys.Lipids44, J.Chromatogr.B879,1308.
277. 224. Møller, IM et al. (2011) Protein carbonylation and
207. Massey, KA and Nicolaou, A (2013) Lipidomics of metal-catalyzed protein oxidation in a cellular
oxidizedPUFAs.FreeRadic.Biol.Med.59,45. perspective.J.Proteomics74,2228.
208. Ji, J et al. (2012) Lipidomics identifies cardiolipin 225. Lucero,HAandKagan,HM(2006)Lysyloxidase:an
oxidationasamitochondrialtargetforredoxtherapy oxidativeenzymeandeffectorofcellfunction.Cell.
ofbraininjury.Nat.Neurosci.15,1407. Mol.LifeSci.63,2304.
209. Tyurina, YY et al. (2010) Oxidative lipidomics of 226. Luo, S and Wehr, NB (2009) Protein carbonylation:
hyperoxicacutelunginjury:MScharacterizationof avoidingpitfallsinthe2,4-DNPHassay.RedoxRep.
cardiolipin and phosphatidylserine peroxidation. 14,159.
Am.J.Physiol.299,L73. 227. Lyras, L et al. (1996) Oxidative damage and motor
210. Drummen,GPCetal.(1999)Validationoftheperox- neuronedisease.Difficultiesinthemeasurementof
idativeindicators,cis-parinaricacidandparinaroyl- proteincarbonylsinhumanbraintissue.FreeRadic.
phospholipids, in a model system and cultured Res.24,397.
cardiacmyocytes.Biochim.Biophys.Acta1436,370. 228. Wong, CM et al. (2013) Mechanism of protein
211. Gomes,Aetal.(2005)Fluorescenceprobesusedfor decarbonylation.FreeRadic.Biol.Med.65,1126.
detectionofROS.J.Biochem.Biophys.Methods65,45. 229. Madian, AG and Regnier, FE (2010) Profiling car-
212. Yamanaka,Ketal.(2012)Anovelfluorescentprobe bonylatedproteinsinhumanplasma.J.ProteomeRes.
withhighsensitivityandselectivedetectionoflipid 9,1330.
hydroperoxidesincells.RSCAdvances2,7894. 230. Bollineni, RC et al. (2014) Proteome-wide profiling
213. Zhao,BSetal.(2010)Ahighlyselectivefluorescent of carbonylated proteinsand carbonylation sitesin
probeforvisualizationoforganichydroperoxidesin HeLa cells under mild oxidative stress conditions.
livingcells.J.Am.Chem.Soc.132,17065. FreeRadic.Biol.Med.68,186.
214. Primer, TA et al. (2012) A ratiometric fluorescent 231. Thanan, R et al. (2012) Inflammation-induced pro-
probe for assessing mitochondrial phospholipid tein carbonylation contributes to poor prognosis
peroxidationwithinlivingcells.FreeRadic.Biol.Med. for cholangiocarcinoma. Free Radic. Biol. Med. 52,
53,544. 1465.
215. Krumova, K et al. (2013) Fluorogenic a-tocopherol 232. Winther,JRandThorpe,C(2014)Quantificationof
analogue for monitoring the antioxidant status thiolsanddisulfides.Biochim.Biophys.Acta1840,838.

--- Page 803 ---

748 REFERENCES
233. Giustarini, D et al. (2011) Detection of gluta- 252. Bartosz, G (2010) Non-enzymatic antioxidant cap-
thione in whole blood after stabilization with acityassays:limitationsofuseinbiomedicine.Free
N-ethylmaleimide.Anal.Biochem.415,81. Radic.Res.44,711.
234. Harwood, DT et al. (2009) Simultaneous determin- 253. Wayner,DDMetal.(1987)Therelativecontributions
ationofGSH,GSSGandglutathionesulphonamide of vitamin E, urate, ascorbate and proteins to the
incellsandphysiologicalfluidsbyisotopedilution TRAP activity of human blood plasma. Biochim.
LC-MS.J.Chromatogr.B877,3393. Biophys.Acta924,408.
235. Skamarauskas, JT et al. (2014) Noninvasive in vivo 254. Lönnrot, K et al. (1996) The effect of ascorbate and
magnetic resonance measures of GSH synthesis in ubiquinone supplementation on plasma and CSF
humanandratliverasanoxidativestressbiomarker. TAC.FreeRadic.Biol.Med.21,211.
Hepatology59,2321. 255. Chrzczanowicz, J et al. (2011) Physical activity and
236. Lee DH and Jacobs DR Jr (2009) Is serum γ-GT TACacrossanadultlifespanofmen.Med.Sci.Sports
a marker of exposure to various environmental Exerc.44,575.
pollutants?FreeRadic.Res.43,533. 256. Lotito, SB and Frei, B (2006) Consumption of
237. Drogan, D et al. (2010) Plasma γ-GT, cysteinyl- flavonoid-rich foods and increased plasma anti-
glycine, and oxLDL. Arterioscler. Thromb. Vasc. Biol. oxidant capacity in humans: cause, consequence,
30,2053. or epiphenomenon? Free Radic. Biol. Med. 41,
238. Held,JMandGibson,BW(2012)Regulatorycontrol 1727.
or oxidative damage? Proteomic approaches to 257. Long, LH et al. (2000) The antioxidant activities of
interrogate the role of cysteine oxidation status seasonings used in Asian cooking. Powerful anti-
in biological processes. Mol. Cell. Proteomics 11, oxidantactivityofdarksoysaucerevealedusingthe
R111.013037. ABTSassay.FreeRadic.Res.32,181.
239. Karisch,Retal.(2011)Globalproteomicassessment
of the classical protein-tyrosine phosphatome and Chapter7
‘redoxome’.Cell146,826.
240. Poynton, RA and Hampton, MB (2014) Perox- 1. Lemaire,Petal.(1993)Pro-oxidantandantioxidant
iredoxinsasbiomarkersofoxidativestress.Biochim. processesingasglandandothertissuesofcod(Gadus
Biophys.Acta1840,906. morhua).J.Comp.Physiol.163,477.
241. Bechtold, E and King, SB (2012) Chemical meth- 2. Halliwell,Betal.(2000)Thegastrointestinaltract:a
ods for the direct detection and labeling of majorsiteofantioxidantaction?FreeRadic.Res.33,
S-nitrosothiols.Antioxid.RedoxSignal.17,981. 819.
242. Ghesquière B et al. (2011) Redox proteomics of 3. Circu,MLandAwTY(2011)Redoxbiologyofthe
protein-bound methionine oxidation. Mol. Cell. intestine.FreeRadic.Res.45,1245.
Proteomics.10,M110.006866. 4. Gorelik, S et al. (2013) A rational approach to pre-
243. Anraku, M et al. (2013) Redox properties of serum vent postprandial modification of LDL by dietary
albumin.Biochim.Biophys.Acta1830,5465. polyphenols.J.Func.Food5,163.
244. Oettl, K et al. (2013) Oxidative albumin damage in 5. Pierre,Fetal.(2006)Newmarkerofcoloncancerrisk
chronic liver failure: relation to albumin binding associated with heme intake: 1,4-dihydroxynonane
capacity, liver dysfunction and survival. J. Hepatol. mercapturicacid.CancerEpidemiol.Biomark.Prev.15,
59,978. 2274.
245. Colombo, G et al. (2015) A central role of intermo- 6. Kawai,Ketal.(2010)DNAmodificationbythew-3
leculardityrosinecross-linkingoffibrinogeninhigh lipidperoxidation-derivedmutagen4-oxo-2-hexenal
molecularweightAOPPformation.Biochim.Biophys. invitroandtheiranalysisinmouseandhumanDNA.
Acta1850,1. Chem.Res.Toxicol.23,630.
246. Roy, D et al. (2012) Role of ROS on the formation 7. Chamulitrat,W(1999)ActivationoftheO • 2 –-gener-
ofthenoveldiagnosticmarkerischaemiamodified atingNADPHoxidaseofintestinallymphocytespro-
albumin.Heart92,113. duceshighlyreactivefreeradicalsfromsulfite.Free
247. Tousoulis, D et al. (2012) The role of NO • on Radic.Biol.Med.27,411.
endothelialfunction.Curr.Vas.Pharmacol.10,4. 8. Flores, MV et al. (2010) DUOX in the intestinal
248. Wray, DW et al. (2012) Acute reversal of endothe- epithelium of zebrafish larvae has anti-bacterial
lial dysfunction in the elderly after antioxidant properties. Biochem. Biophys. Res. Commun. 400,
consumption.Hypertension59,818. 164.
249. Konior,Aetal.(2014)NADPHoxidasesinvascular 9. Grasberger,Hetal.(2013)DUOXcontrolreleaseof
pathology.Antioxid.RedoxSignal.20,2794. H2O2bythegastricepitheliumtopreventHelicobac-
250. Huang,Detal.(2005)Thechemistrybehindantioxi- terfelisinfectionandinflammationinmice.Gastro-
dantcapacityassays.J.Agric.FoodChem.53,1841. enterology145,1045.
251. Pinchuk, I et al. (2012) Evaluation of antioxidants: 10. Patel, PH et al. (2013) Stimulating cROSstalk be-
scope, limitations and relevance of assays. Chem. tweencommensalbacteriaandintestinalstemcells.
Phys.Lipids165,638. EMBOJ.32,3009.

--- Page 804 ---

REFERENCES 749
11. Espey, MG (2013) Role of O2 gradients in shaping 28. Ghosh,Setal.(2013)Disulfidebondasaswitchfor
redoxrelationshipsbetweenthehumanintestineand CuZnSODactivityinasthma.Antioxid.RedoxSignal.
itsmicrobiota.FreeRadic.Biol.Med.55,130. 18,412.
12. Orozco,MNetal.(2010)Antioxidant-richoralsup- 29. Comhair,SAAetal.(2005)SODinactivationinpatho-
plementsattenuatetheeffectsoforalirononinsitu physiologyofasthmaticairwayremodelingandre-
oxidationsusceptibilityofhumanfeces.J.Nutr.140, activity.Am.J.Pathol.166,663.
1105. 30. Butteroni,Cetal.(2004)Cloningandexpressionof
13. Huycke,MMandMoore,DR(2002)Invivoproduc- theOleaeuropaeaallergenOlee5,thepollenCuZn-
•
tion of OH by Enterococcus faecalis colonizing the SOD.Int.Arch.AllergyImmunol.137,9.
•
intestinal tract using aromatic hydroxylation. Free 31. Xu,Wetal.(2006)RoleofepithelialNO inairway
Radic.Biol.Med.33,818. viralinfection.FreeRadic.Biol.Med.41,19.
14. Nagler,RMetal.(2002)Characterizationofthedif- 32. vanderVliet,A(2011)Noxenzymesinallergicair-
ferentiatedantioxidantprofileofhumansaliva.Free wayinflammation.Biochim.Biophys.Acta1810,1035.
Radic.Biol.Med.32,268. 33. Que, LG et al. (2005) Protection from experimen-
15. Pietraforte, D et al. (2006) Salivary uric acid at the talasthmabyanendogenousbronchodilator.Science
acidic pH of the stomach is the principal defense 308,1618.
againstNO–-derivedreactivespecies:sparingeffects 34. Segal,BHetal.(2010)NADPHoxidaselimitsinnate
2
ofchlorogenicacidandserumalbumin. FreeRadic. immuneresponsesinthelungsinmice.PLoSOne5,
Biol.Med.41,1753. e9631.
16. Halliwell,Betal.(2005)Healthpromotionbyflavon- 35. Crouch,ECetal.(2010)MPO-dependentinactivation
oids, tocopherols, tocotrienols, and other phenols: of surfactant protein D in vitro and in vivo. J. Biol.
direct or indirect effects? Antioxidant or not? Am. Chem.285,16757.
J.Clin.Nutr.81,268S. 36. Narasaraju, TA et al. (2003) Protein nitration in rat
17. Sirota, R et al. (2013) Coffee polyphenols protect lungsduringhyperoxiaexposure:apossibleroleof
humanplasmafrompostprandialcarbonyl modifi- MPO.Am.J.Physiol.285,L1037.
cations.Mol.Nutr.FoodRes.57,916. 37. Lagan,ALetal.(2008)Pathogenesisofthesystemic
18. Zhao, K et al. (2001) DNA damage by NO– and inflammatorysyndromeandacutelunginjury:role
2
ONOO–: protection by dietary phenols. Meth. En- ofFemobilizationanddecompartmentalization.Am.
zymol.335,296. J.Physiol.294,L161.
19. Barbehenn, RV et al. (2008) Linking phenolic oxi- 38. Cho,HYetal.(2012)TargeteddeletionofNrf2im-
dation in the midgut lumen with oxidative stress pairslungdevelopmentandoxidantinjuryinneo-
in the midgut tissues of a tree-feeding caterpillar natalmice.Antioxid.RedoxSignal.17,1066.
Malacosomadisstria(Lepidoptera:lasiocampidae)En- 39. Carpagnano, GE et al. (2004) Supplementary O2 in
viron.Entomol.37,1113. healthysubjectsandthosewithCOPDincreasesoxi-
20. Winter, SE et al. (2013) Host-derived NO– boosts dative stress and airway inflammation. Thorax 59,
3
growthofE.coliintheinflamedgut.Science339,708. 1016.
21. Tyurina, YY et al. (2010) Oxidative lipidomics of 40. Cross,CEetal.(1994)Oxidants,antioxidants,andre-
hyperoxic acute lung injury: mass spectrometric spiratorytractliningfluids.Environ.HealthPerspect.
characterizationofcardiolipinandphosphatidylser- 102(Suppl.10),185.
ineperoxidation.Am.J.Physiol.299,L73. 41. Gould,NSetal.(2012)CFTRistheprimaryknown
22. Wang,XLetal.(2009)NOXactivityinallergenicpol- apicalGSHtransporterinvolvedincigarettesmoke-
lengrainsofdifferentplantspecies.Biochem.Biophys. inducedadaptiveresponsesinthelung.FreeRadic.
Res.Commun.387,430. Biol.Med.52,1201.
23. Voynow, JA and Kummarapurugu, A (2011) IsoPs 42. Harwood,DTetal.(2011)Biomarkersofneutrophil-
andasthma.Biochim.Biophys.Acta1810,1091. mediated GSH and protein oxidation in tracheal
24. Jin, H et al. (2014) A halotyrosine antibody that aspiratesfrompreterminfants:associationwithbac-
detects increased protein modifications in asthma terialinfection.Pediatr.Res.69,28.
patients.J.Immunol.Methods403,17. 43. Joyce-Brady, M and Hiratake, J (2011) Inhibiting
25. Ghosh,Setal.(2006)Nitrotyrosineproteomesurvey GSH metabolism in lung lining fluid as a strategy
inasthmaidentifiesoxidativemechanismofcatalase toaugmentantioxidantdefense.Curr.Enzym.Inhib.
inactivation.J.Immunol.176,5587. 7,71.
26. Stolarek,Retal.(2010)BreathanalysisofH2O2asa 44. Koike, K et al. (2010) Complete lack of vitamin C
diagnostictool.Clin.Chim.Acta411,1849. intake generates pulmonary emphysema in SMP-
27. Sutcliffe,Aetal.(2012)IncreasedNOX4expression 30knockoutmice.Am.J.Physiol.298,L784.
mediatesintrinsicairwaysmoothmusclehypercon- 45. Nakamura,Ketal.(2013)Associationsofintakeof
tractility in asthma. Am. J. Respir. Crit. Care Med. antioxidantvitaminsandfattyacidswithasthmain
185,267. pre-schoolchildren.PublicHealthNutr.16,2040.

--- Page 805 ---

750 REFERENCES
46. Park,SJetal.(2012)L-2-oxothiazolidine-4-carboxylic usingthesametransportercomplex.Am.J.Physiol.
acidorα-lipoicacidattenuatesairwayremodeling: 306,C910.
involvementofNF-κB,Nrf2,andHIF.Int.J.Mol.Sci. 66. May,JMetal.(2004)Humanerythrocyterecyclingof
13,7915. ascorbicacid.J.Biol.Chem.279,14975.
47. Romieu,Ietal.(2002)Antioxidantsupplementation 67. George, A et al. (2013) Erythrocyte NOX activity
andlungfunctionsamongchildrenwithasthmaex- modulatedbyRacGTPases,PKC,andplasmacyto-
posedtohighlevelsofairpollutants.Am.J.Resp.Crit. kines contributes to oxidative stress in sickle cell
CareMed.166,703. disease.Blood121,2099.
48. Wood,LGetal.(2012)Manipulatingantioxidantin- 68. Darghouth,Detal.(2011)Pathophysiologyofsickle
take in asthma: a randomized controlled trial. Am. celldiseaseismirroredbytheredbloodcellmeta-
J.Clin.Nutr.96,534. bolome.Blood117,e57.
49. Behndig, AF et al. (2009) Augmentation of re- 69. Reid,Metal.(2006)Invivoratesoferythrocytegluta-
spiratorytractliningfluidascorbateconcentrations thione synthesis in adults with sickle cell disease.
throughsupplementationwithvitaminC.Inhal.Tox- Am.J.Physiol.291,E73.
icol.21,250. 70. vanZwieten,Retal.(2014)Inborndefectsintheanti-
50. Fuchs,D(2012)Antioxidantintakeandallergicdis- oxidantsystemsofhumanredbloodcells.FreeRadic.
ease.Clin.Exp.Allergy42,1420. Biol.Med.67,377.
51. Winterbourn,CC(1985)Free-radicalproductionand 71. Winterbourn, CC et al. (1981) Unstable haemoglo-
oxidative reactions of hemoglobin. Environ. Health bin haemolytic crises: contributions of pyrexia and
Perspect.64,321. neutrophiloxidants.Br.J.Haematol.49,111.
52. Reeder,BJ(2010)Theredoxactivityofhemoglobins: 72. Mollan,TLetal.(2010)Theroleofα-hemoglobinsta-
from physiologic functions to pathologic mechan- bilizingproteininredoxchemistry,denaturationand
isms.Antioxid.RedoxSignal.13,1087. hemoglobinassembly.Antioxid.RedoxSignal.12,219.
53. Comporti,Metal.(2002)Ferelease,oxidativestress 73. Stapley,Retal.(2012)Erythrocytestorageincreases
anderythrocyteageing.FreeRadic.Biol.Med.32,568. rate of NO and NO– scavenging: implications for
2
54. Ney,PAetal.(1990)Synergisticeffectsofoxidation transfusion-relatedtoxicity.Biochem.J.446,499.
anddeformationonerythrocytemonovalentcation 74. Baek,JHetal.(2012)Hemoglobin-drivenpathophysi-
leak.Blood75,1192. ology is an in vivo consequence of the red blood
55. Low,FMetal.(2008)Prx2andperoxidemetabolism cellstoragelesionthatcanbeattenuatedinguinea
intheerythrocyte.Antioxid.RedoxSignal.10,1621. pigs by haptoglobin therapy. J. Clin. Invest. 122,
56. Iuchi, Y et al. (2010) Implication of oxidative stress 1444.
asacauseofautoimmunehemolyticanemiainNZB 75. Harper,VMetal.(2015)Prx-2recyclingisinhibited
mice.FreeRadic.Biol.Med.48,935. duringerythrocytestorage.Antioxid.RedoxSignal.22,
57. Nozik-Grayck,Eetal.(2003)HCO–-dependentO •– 294.
3 2
release and pulmonary artery tone. Am. J. Physiol. 76. Stanton, RC (2012) G6PDH, NADPH, and cell sur-
285,H2327. vival.IUBMBLife64,362.
58. Metere,Aetal.(2009)ONOO– signalinginhuman 77. Tsai, KJ et al. (1998) Impaired production of NO • ,
erythrocytes: synergistic role of hemoglobin oxida- O •
2
–, and H2O2 in G6PDH-deficient granulocytes.
tion and band 3 tyrosine phosphorylation. Arch. FEBSLett.436,411.
Biochem.Biophys.484,173. 78. Paglia, DE (1993) Acute episodic hemolysis in the
59. Johnson, RM et al. (2010) The effects of disruption African black rhinoceros as an analogue of human
ofgenesforPrx2,GPx1,andcatalaseonerythrocyte G6PDHdeficiency.Am.J.Hematol.42,36.
oxidativemetabolism.FreeRadic.Biol.Med.48,519. 79. Ho,HYetal.(2014)G6PDH–beyondtherealmof
60. Clemens,MRandWaller,HD(1987)Lipidperoxida- redcellbiology.FreeRadic.Res.48,1028.
tioninerythrocytes.Chem.Phys.Lipids45,251. 80. Spolarics,Zetal.(2001)Increasedincidenceofsepsis
61. Siendones, E et al. (2014) Membrane-bound and altered monocyte functions in severely-injured
CYB5R3 is a common effector of nutritional and type A-G6PDH-deficient African American trauma
oxidativestressresponsethroughFOXO3aandNrf2. patients.Crit.CareMed.29,728.
Antioxid.RedoxSignal.21,1708. 81. Salo,DCetal.(1990)SODundergoesproteolysisand
62. Xu,Zetal.(2011)Anovelapproachforinvivomeas- fragmentationfollowingoxidativemodificationand
urement of mouse red cell redox status. Blood 118, inactivation.J.Biol.Chem.265,11919.
3694. 82. Gogliettino,Metal.(2014)Anovelclassofbifunc-
63. Burton,GWetal.(1986)VitaminEinyoungandold tionalacylpeptidehydrolases–potentialroleinthe
humanredbloodcells.Biochim.Biophys.Acta860,84. antioxidant defense systems of the Antarctic fish
64. Li,Hetal.(2012)VitaminCinmouseandhumanred Trematomusbernacchii.FEBSJ.281,401.
bloodcells:anHPLCassay.Anal.Biochem.426,109. 83. Bosman,GJetal.(2010)Comparativeproteomicsof
65. Sage,JMandCarruthers,A(2014)Humanerythro- erythrocyteageinginvivoandinvitro.J.Proteomics
cytes transport dehydroascorbic acid and sugars 73,396.

--- Page 806 ---

REFERENCES 751
84. McMillan,DCetal.(2005)Lipidsversusproteinsas 103. Muller, S (2004) Redox and antioxidant systems of
majortargetsofpro-oxidant,direct-actinghemolytic themalariaparasiteP.falciparum.Mol.Microbiol.53,
agents.Toxicol.Sci.88,274. 1291.
85. Lim, YK et al. (2000) Haptoglobin reduces renal 104. Cambos, M and Scorza, T (2011) Robust erythro-
oxidative DNA and tissue damage during phagocytosis leads to macrophage apoptosis via a
phenylhydrazine-induced hemolysis. Kidney Int. hemin-mediatedredoximbalance:roleinhemolytic
58,1033. disorders.J.Leukoc.Biol.89,159.
86. Sipe,HJJretal.(2004)Fast-flowEPRspectroscopic 105. Aguilar,Retal.(2014)Bloodoxidativestressmark-
observationoftheisoniazid,iproniazid,andphenyl- ersandP.falciparummalariainnon-immuneAfrican
hydrazine hydrazyl radicals. Chem. Res. Toxicol. 17, children.Brit.J.Haematol.164,438.
226. 106. Krauth-Siegel, RL and Leroux, AE (2012) Low-
87. Rickman,KAetal.(2013)Isoniazid:radical-induced molecular-mass antioxidants in parasites. Antioxid.
oxidation and reduction chemistry. Bioorg. Med. RedoxSignal.17,583.
Chem.Lett.23,3096. 107. Clark, IA et al. (1984) Radical-mediated damage to
88. Maples,KRetal.(1988)Invivorathemoglobinthiyl parasitesanderythrocytesinP.vinckeiinfectedmice
free radical formation following administration of after injection of t-butyl hydroperoxide. Clin. Exp.
phenylhydrazineandhydrazine-baseddrugs.Drug Immunol.56,524.
Metab.Disp.16,799. 108. Ghashghaeinia,Metal.(2010)TargetingGSHbydi-
89. Evelo, CT et al. (1998) Two mechanisms for toxic methylfumarate protects against experimental mal-
effectsofhydroxylaminesinhumanerythrocytes:in- ariabyenhancingerythrocytecellmembranescram-
volvementoffreeradicalsandriskofpotentiation. bling.Am.J.Physiol.299,C791.
BloodCellsMol.Dis.24,280. 109. Weinberg, ED and Moon, J (2009) Malaria and Fe:
90. Veggi, LM et al. (2008) Dapsone induces oxidative historyandreview.DrugMetab.Rev.41,644.
stressandimpairsantioxidantdefensesinratliver. 110. Dahal,Ketal.(2014)Mitochondrialalternativeoxi-
LifeSci.83,155. dase maintains respiration and preserves photo-
91. Munday,R(2012)Harmfulandbeneficialeffectsof synthetic capacity during moderate drought in. N.
organicmonosulfides,disulfides,andpolysulfidesin tabacum.PlantPhysiol.166,1560.
animalsandhumans.Chem.Res.Toxicol.25,47. 111. Møller,IMetal.(2007)Oxidativemodificationstocel-
92. Ray,HandGeorges,F(2010)Agenomicapproach lularcomponentsinplants.Annu.Rev.PlantBiol.58,
tonutritional,pharmacologicalandgeneticissuesof 459.
thefababean(Viciafaba).GMCrops1,99. 112. Woo,EJetal.(2000)GerminisaMncontainingho-
93. Lang, F et al. (2014) Oxidative stress and suicidal mohexamerwithoxalateoxidaseandSODactivities.
erythrocytedeath.Antioxid.RedoxSignal.21,138. NatureStruct.Biol.7,1036.
94. Oliveira,PLandOliveira,MF(2002)Vampires,Pas- 113. Moschou,PNandRoubelakis-Angelakis,KA(2011)
teurandROS.FEBSLett.525,3. Characterization, assay, and substrate specificity of
95. Oliveira,MFetal.(2002)Onthepro-oxidanteffects plantpolyamineoxidases.MethodsMolBiol.720,183.
ofhaemozoin.FEBSLett.512,139. 114. Karg,Ketal.(2007)Biologicallyactiveoxidizedlip-
96. Pal, C and Bandyopadhyay, U (2012) Redox-active ids(phytoprostanes)intheplantdietandparenteral
antiparasiticdrugs.Antioxid.RedoxSignal.17,555. lipidnutrition.FreeRadic.Res.41,25.
97. Graça-Souza, AV et al. (2006) Adaptations against 115. Queval, G et al. (2008) Why are literature data for
hemetoxicityinblood-feedingarthropods.InsectBio- H2O2contentssovariable?Adiscussionofpotential
chem.Mol.Biol.36,322. difficultiesinthequantitativeassayofleafextracts.
98. Lima, VL et al. (2012) The antioxidant role of xan- J.Exp.Bot.59,135.
thurenic acid in the Aedes aegypti midgut during 116. Xiong,ASetal.(2009)Geneduplication,transfer,and
digestionofabloodmeal.PLoSOne7,e38349. evolutioninthechloroplastgenome.Biotechnol.Adv.
99. Greenwood,BandOwusu-Agyei,S(2012)Malariain 27,340.
thepost-genomeera.Science338,49. 117. Jahns,PandHolzwarth,AR(2012)Theroleofxan-
100. Molina-Cruz,Aetal.(2008)ROSmodulateAnopheles thophyll cycle and of lutein in photoprotection of
gambiaeimmunityagainstbacteriaandPlasmodium. PSII.Biochim.Biophys.Acta1817,182.
J.Biol.Chem.283,3217. 118. Foyer,CHetal.(2012)Photosyntheticcontrolofelec-
101. Méndez, D et al. (2011) Stress response and cyto- trontransportandtheregulationofgeneexpression.
skeletalproteinsinvolvedinerythrocytemembrane J.Exp.Bot.63,1637.
remodelinguponP.falciparuminvasionaredifferen- 119. Najafpour,MMetal.(2012)Biologicalwateroxida-
tiallycarbonylatedinG6PDA-deficiency.FreeRadic. tion:lessonsfromNature.Biochim.Biophys.Acta1817,
Biol.Med.50,1305. 1110.
102. Goyal, M et al. (2012) Redox regulation in malaria: 120. Halliwell, B (1987) Oxidative damage, lipid perox-
currentconceptsandpharmacotherapeuticimplica- idation and antioxidant protection in chloroplasts.
tions.Curr.Med.Chem.19,1475. Chem.Phys.Lipids44,327.

--- Page 807 ---

752 REFERENCES
121. Fischer, BB et al. (2013) Production, detection, and 138. Mhamdi,Aetal.(2012)Plantcatalases:peroxisomal
signalingof1O2 inphotosyntheticorganisms.Anti- redoxguardians.Arch.Biochem.Biophys.525,181.
oxid.RedoxSignal.18,2145. 139. Gaber,Aetal.(2012)TheinvolvementofArabidopsis
122. Triantaphylidès,Cetal.(2008)SingletO2isthemajor GPX8inthesuppressionofoxidativedamageinthe
ROS involved in photooxidative damage to plants. nucleusandcytosol.PlantCellPhysiol.53,1596.
PlantPhysiol.148,960. 140. Dietz, KJ (2011) Peroxiredoxins in plants and cy-
123. Karonen,Metal.(2014)AtandemMSmethodof1O2 anobacteria.Antioxid.RedoxSignal.15,1129.
measurement.Photochem.Photobiol.90,965. 141. Iglesias-Baena,Ietal.(2011)Thedual-targetedplant
124. Yoshioka,MandYamamoto,Y(2011)Qualitycontrol sulfiredoxinretroreducesthesulfinicformofatypical
ofPSII:whereandhowdoesthedegradationofthe mitochondrialperoxiredoxin.PlantPhysiol.155,944.
D1proteinbyFtsHproteasesstartunderlightstress? 142. Iigusa, H et al. (2005) O2 and H2O2 enhance light-
–factsandhypotheses.J.Photochem.Photobiol.B104, induced carotenoid synthesis in Neurospora crassa.
229. FEBSLett.579,4012.
125. Nishiyama,Yetal.(2011)Proteinsynthesisisthepri- 143. Pivato,Metal.(2014)Low-molecular-weightthiolsin
mary target of ROS in the photoinhibition of PSII. plants:functionalandanalyticalimplications.Arch.
Physiol.Plant.142,35. Biochem.Biophys.560,83.
126. Borisova, MM et al. (2012) Photosynthetic electron 144. Hancock,RDandViola,R(2005)Biosynthesisandca-
flow to O2 and diffusion of H2O2 through the tabolismofL-ascorbicacidinplants.Crit.Rev.Plant
chloroplast envelope via aquaporins. Biochim. Bio- Sci.24,167.
phys.Acta1817,1314. 145. Kanwischer, M et al. (2005) Alterations in tocoph-
127. Foyer, CH and Noctor, G (2009) Redox regulation erolcyclaseactivityintransgenicandmutantplants
inphotosyntheticorganisms:signaling,acclimation, of Arabidopsis affect tocopherol content, tocopherol
andpracticalimplications.Antioxid.RedoxSignal.11, composition,andoxidativestress.PlantPhysiol.137,
861. 713.
128. Takagi,Detal.(2014)TheCalvincycleinevitablypro- 146. Murata,Netal.(2012)Themechanismofphotoinhib-
ducessugar-derivedreactivecarbonylmethylglyoxal itioninvivo:re-evaluationoftherolesofcatalase,α-
during photosynthesis: a potential cause of plant tocopherol,non-photochemicalquenching,andelec-
diabetes.PlantCellPhysiol.55,333. trontransport.Biochim.Biophys.Acta1817,1127.
129. Daub,MEetal.(2013)ROSinplantpathogenesis:the 147. Trebst,Aetal.(2002)Aspecificrolefortocopherol
role of perylenequinone photosensitizers. Antioxid. andofchemical1O2 quenchersinthemaintenance
RedoxSignal.19,970. ofPSIIstructureandfunctioninChlamydomonasrein-
130. Foyer,CHandShigeoka,S(2011)Understandingoxi- hardtii.FEBSLett.516,156.
dative stress and antioxidant functions to enhance 148. Falk, J and Munné-Bosch, S (2010) Tocochromanol
photosynthesis.PlantPhysiol.155,93. functionsinplants:antioxidationandbeyond.J.Exp.
131. Liu,Zetal.(2004)Crystalstructureofspinachmajor Bot.61,1549.
light-harvestingcomplexat2.72Å ´ resolution.Nature 149. Hundal, T et al. (1995) Antioxidant activity of re-
428,287. ducedplastoquinoneinchloroplastthylakoidmem-
132. Ramel,Fetal.(2012)Carotenoidoxidationproducts branes.Arch.Biochem.Biophys.324,117.
arestresssignalsthatmediategeneresponsesto1O2 150. Szyman´ska,Retal.(2014)Hydroxy-plastochromanol
inplants.Proc.Natl.Acad.Sci.USA109,5535.
andplastoquinone-Cas1O2productsduringphoto-
133. Fu, W et al. (2012) Enhancement of carotenoid bio- oxidative stress in Arabidopsis. Plant Cell Env. 37,
synthesis in the green microalga Dunaliella salina 1464.
with light-emitting diodes and adaptive laboratory 151. Palmer,CMandGuerinot,ML(2009)Facingthechal-
evolution.Appl.Microbiol.Biotechnol.97,2395. lengesofCu,FeandZnhomeostasisinplants.Nat.
134. Baroli, I et al. (2004) Photo-oxidative stress in Chem.Biol.5,333.
a xanthophyll-deficient mutant of Chlamydomonas. 152. Hassinen, VH et al. (2011) Plant metallothioneins –
J.Biol.Chem.279,6337. metalchelatorswithROSscavengingactivity?Plant
135. Pilon,Metal.(2011)Thebiogenesisandphysiological Biol.13,225.
functionofchloroplastSODs.Biochim.Biophys.Acta 153. Levesque-Tremblay,Getal.(2009)Thechloroplastic
1807,989. lipocalin AtCHL prevents lipid peroxidation and
136. Morgan,MJetal.(2008)DecreaseinMnSODleadsto protectsArabidopsisagainstoxidativestress.PlantJ.
reducedrootgrowthandaffectsTCAcyclefluxand 60,691.
mitochondrialredoxhomeostasis.PlantPhysiol.147, 154. Kimura,Setal.(2004)DNArepairinhigherplants;
101. photoreactivationisthemajorDNArepairpathway
137. Smith,IKetal.(1994)IncreasedlevelsofGSHina innon-proliferatingcellswhileexcisionrepair(NER
catalase-deficientmutantofbarley(Hordeumvulgare andBER)isactiveinproliferatingcells.NucleicAcids
L).PlantSci.Lett.37,29. Res.32,2760.

--- Page 808 ---

REFERENCES 753
155. Yoshimura, K et al. (2007) AtNUDX1, an 8oxoGTP 174. Bowler,CandFluhr,R(2000)TheroleofCa2+andac-
pyrophosphohydrolase, is responsible for eliminat- tivatedO2 assignalsforcontrollingcross-tolerance.
ing oxidized nucleotides in Arabidopsis. Plant Cell TrendsPlantSci.5,241.
Physiol.48,1438. 175. Sanmartin,Metal.(2003)Over-expressionofascor-
156. Tarrago, L et al. (2009) Protein-repairing MSRs in bate oxidase in the apoplast of transgenic tobacco
photosyntheticorganisms:geneorganization,reduc- resultsinalteredascorbateandGSHredoxstatesand
tionmechanisms,andphysiologicalroles.Mol.Plant increasedsensitivitytoO3.Planta216,918.
2,202. 176. Conklin,PL(2001)Recentadvancesintheroleand
157. Kurepa, J et al. (2009) Proteasome regulation, plant biosynthesis of ascorbic acid in plants. Plant Cell
growthandstresstolerance.PlantSignalBehav.4,924. Envir.24,383.
158. Rigas,Setal.(2009)RoleofLon1proteaseinpost- 177. Vickers,CEetal.(2009)Isoprenesynthesisprotects
germinativegrowthandmaintenanceofmitochon- transgenictobaccoplantsfromoxidativestress.Plant
drialfunctioninA.thaliana.NewPhytol.181,588. CellEnviron.32,520.
159. Puppo, A et al. (2013) H2O2 and NO: key regu- 178. Szyman´ska,RandKruk,J(2008)γ-Tocopheroldom-
lators of the legume – Rhizobium and mycorrhizal inates in young leaves of runner bean (Phaseolus
symbioses.Antioxid.RedoxSignal.18,2202. coccineus)underavarietyofgrowingconditions:the
160. Montiel,Jetal.(2012)APhaseolusvulgarisNOXgene possiblefunctionsofγ-tocopherol.Phytochemisty69,
isrequiredforrootinfectionbyrhizobia.PlantCell 2142.
Physiol.53,1751. 179. Lehnert, BE (1993) NO • and NO– toxicology. In:
2
161. Becana,Metal.(2010)Recentinsightsintoantioxi- Handbookofhazardousmaterials,SanDiego,Academic
dant defenses of legume root nodules. New Phytol. Press.
188,960. 180. Rabinowitch,HDandFridovich,I(1995)Growthof
162. Hao,GFetal.(2011)Structure-activityrelationships Chlorellasorokinianainthepresenceofsulfiteelevates
of diphenyl-ether as protoporphyrinogen oxidase cellcontentofSODandimpartsresistancetowards
inhibitors: insights from computation simulations. paraquat.Planta164,524.
J.Comput.AidedMol.Des.25,213. 181. Smirnoff, N (2000) Ascorbic acid: metabolism and
163. Calderbank, A (1968) The bipyridylium herbicides. functions of a multi-facetted molecule. Curr. Opin.
Adv.PestControlRes.8,127. PlantBiol.3,229.
164. Law,MYetal.(1983)Glutathioneandascorbicacid 182. Nakamura, M et al. (2009) Increased thiol biosyn-
inspinach(Spinaciaoleracea)chloroplasts.Theeffect thesis of transgenic poplar expressing a wheat O-
ofH2O2andofparaquat.Biochem.J.210,899. acetylserine(thiol) lyase enhances resistance to H2S
165. Taylor,NLetal.(2002)Environmentalstresscauses andSO2toxicity.PlantCellRep.28,313.
oxidativedamagetoplantmitochondrialeadingto 183. Pucciariello,Cetal.(2012)ROSsignalingascommon
inhibitionofglycinedecarboxylase.J.Biol.Chem.277, element in low O2 and heat stresses. Plant Physiol.
42663. Biochem.59,3.
166. Allen,RD(1995)Dissectionofoxidativestresstoler- 184. Gill,SSandTuteja,N(2010)ROSandantioxidantma-
anceusingtransgenicplants.PlantPhysiol.107,1049. chineryinabioticstresstoleranceincropplants.Plant
167. Murgia,Ietal.(2004)A.thalianaplantsover-expressing Physiol.Biochem.48,909.
thylakoidalascorbateperoxidaseshowincreasedre- 185. Wise, RR (1995) Chilling-enhanced photooxidation:
sistance to paraquat-induced photooxidative stress theproduction,actionandstudyofROSproduced
•
andtoNO -inducedcelldeath.PlantJ.38,940. duringchillinginthelight.Photosynth.Res.45,79.
168. Li,CWetal.(2012)Arabidopsisroot-abundantcyto- 186. Kerdnaimongkol,KandWoodson,WR(1999)Inhib-
solicMsrBgenesMsrB7andMsrB8areinvolvedin itionofcatalasebyantisenseRNAincreasessuscepti-
tolerance to oxidative stress. Plant Cell Physiol. 53, bilitytooxidativestressandchillinginjuryintrans-
1707. genictomatoplants.J.Amer.Soc.Hort.Sci.124,330.
169. Shen, B et al. (1997) Increased resistance to oxida- 187. Kranner,IandBirtic´,S(2005)Amodulatingrolefor
tivestressintransgenicplantsbytargetingmannitol antioxidants in desiccation tolerance. Integr. Comp.
biosynthesistochloroplasts.PlantPhysiol.113,1177. Biol.45,734.
170. Zer, H et al. (1994) The protective effect of desfer- 188. Munné-Bosch, S et al. (1999) Enhanced formation
rioxamineonparaquat-treatedpea(Pisumsativum). of α-tocopherol and highly oxidized abietane di-
Physiol.Plant.92,437. terpenes in water-stressed rosemary plants. Plant
171. VanWuytswinkel,Oetal.(1999)Fehomeostasisal- Physiol.121,1047.
terationintransgenictobaccooverexpressingferritin. 189. Yao,Yetal.(2013)Drought-inducedH2O2 accumu-
PlantJ.17,93. lation in subsidiary cells is involved in regulatory
•
172. Babbs, CF et al. (1989) Lethal OH production in signalingofstomatalclosureinmaizeleaves.Planta
paraquat-treatedplants.PlantPhysiol.90,1267. 238,217.
173. Floyd, RA et al. (1989) Increased 8OHdG content 190. McKersie, BD et al. (1996) Water-deficit tolerance
of chloroplast DNA from O3-treated plants. Plant and field performance of transgenic alfalfa over-
Physiol.91,644. expressingSOD.PlantPhysiol.111,1177.

--- Page 809 ---

754 REFERENCES
191. Terskikh, VV et al. (2008) Deterioration of western 209. Jamil,Jetal.(2012)Regulationof[3H]D-aspartatere-
redcedar(ThujaplicataDonnexD.Don)seeds:pro- lease by the 5-F2t-IsoP and its 5-epimer in isolated
teinoxidationandinvivoNMRmonitoringofstorage bovineretina.Neurochem.Res.37,574.
oils.J.Exp.Bot.59,765. 210. Koliakos, GC et al. (2003) 8-IsoP F2α and ascorbic
192. Châtelain,Eetal.(2013)Evidenceforparticipationof acidconcentrationintheaqueoushumourofpatients
theMsrrepairsysteminplantseedlongevity.Proc. withexfoliationsyndrome.Br.J.Ophthalmol.87,353.
Natl.Acad.Sci.USA110,3633. 211. Rodríguez, IR and Larrayoz, IM (2010) Cholesterol
193. Mène-Saffraneé, L et al. (2010) Plastochromanol- oxidationintheretina:implicationsof7KChforma-
8 and tocopherols are essential lipid-soluble anti- tioninchronicinflammationandage-relatedmacu-
oxidantsduringseeddesiccationandquiescencein lardegeneration.J.Lipid.Res.51,2847.
Arabidopsis.Proc.Natl.Acad.Sci.USA107,17815. 212. Mukherjee, PK et al. (2004) Neuroprotectin D1: a
194. Weis,VM(2008)CellularmechanismsofCnidarian DHA-deriveddocosatrieneprotectshumanRPEcells
bleaching: stress causes the collapse of symbiosis. fromoxidativestress.Proc.Natl.Acad.Sci.USA101,
J.Exp.Bot.211,3059. 8491.
195. Yamasaki, Y et al. (2004) Production of O
•–
and 213. Suzuki,Metal.(2012)Chronicphoto-oxidativestress
2
H2O2bytheredtidedinoflagellateKareniamikimotoi. and subsequent MCP-1 activation as causative fac-
J.Biosci.Bioeng.97,212. torsforage-relatedmaculardegeneration.J.CellSci.
196. Michael,RandBron,AJ(2011)Theageinglensand 125,2407.
cataract:amodelofnormalandpathologicalageing. 214. Sun,HandNathans,J(2001)ABCR,theATP-binding
Phil.Trans.R.Soc.B366,1278. cassettetransporterresponsibleforStargardtmacu-
197. Spector,A(1995)Oxidativestress-inducedcataract: lardystrophy,isanefficienttargetofall-trans-retinal-
mechanismofaction.FASEBJ.9,1173. mediated photooxidative damage in vitro. J. Biol.
198. Parker, NR et al. (2004) Protein-bound kynurenine Chem.276,11766.
isaphotosensitizerofoxidativedamage.FreeRadic. 215. Mandal,MNetal.(2011)PBNpreventslight-induced
Biol.Med.37,1479. degenerationoftheretinabyinhibitingRPE65pro-
199. Brennan,LAetal.(2009)MsrArestoresα-crystallin tein isomerohydrolase activity. J. Biol. Chem. 286,
chaperoneactivitylostupon methionineoxidation. 32491.
Biochim.Biophys.Acta1790,1665. 216. Murakami, Y et al. (2012) MutT homolog-1 attenu-
200. Linetsky,Metal.(2011)Determinationofdideoxy- atesoxidativeDNAdamageanddelaysphotorecep-
osone precursors of AGEs in human lens proteins. torcelldeathininheritedretinaldegeneration.Am.
Arch.Biochem.Biophys.514,16. J.Pathol.181,1378.
•
201. Molnár, GA et al. (2005) Accumulation of the OH 217. Obolensky, A et al. (2011) Zn-desferrioxamine at-
markersmeta-,ortho-tyrosineandDOPAincataract- tenuates retinal degeneration in the rd10 mouse
ous lenses is accompanied by a lower protein and modelofretinitispigmentosa.FreeRadic.Biol.Med.
phenylalaninecontentoftheH2O-solublephase.Free 51,1482.
Radic.Res.39,1359. 218. Serhan, CN et al. (2008) Resolving inflammation:
202. Beebe,DCetal.(2010)Oxidativedamageandthepre- dualanti-inflammatoryandpro-resolutionlipidme-
ventionofage-relatedcataracts.Ophthalmic.Res.44, diators.Nat.Rev.Immunol.8,349.
155. 219. Doyle, SLet al. (2012) NLRP3 has a protectiverole
203. Babizhayev,MA(2011)Mitochondriainduceoxida- inage-relatedmaculardegenerationthroughthein-
tive stress, generation of ROS and redox state un- ductionofIL-18bydrusencomponents.Nat.Med.18,
balance of the eye lens leading to human cataract 791.
formation:disruptionofredoxlensorganizationby 220. Zhao,Zetal.(2011)Age-relatedretinopathyinNRF2-
phospholipidhydroperoxidesasacommonbasisfor deficientmice.PLoSOne6,e19456.
cataractdisease.CellBiochem.Funct.29,183. 221. Ziemssen, F and Heimann, H (2012) Evaluation of
204. Loh,Aetal.(2009)Fehomeostasisandeyedisease. verteporfinpharmacokinetics–redefiningtheneed
Biochim.Biophys.Acta1790,637. of photosensitizers in ophthalmology. Expert Opin.
205. Hahn,Petal.(2004)Disruptionofceruloplasminand DrugMetab.Toxicol.8,1023.
hephaestininmicecausesretinalFeoverloadandret- 222. Saccà, SC et al. (2013) Environmental light and en-
inaldegenerationwithfeaturesofage-relatedmacular dogenousantioxidantsasthemaindeterminantsof
degeneration.Proc.Natl.Acad.Sci.USA101,13850. non-canceroculardiseases.Mutat.Res.752,153.
206. García-Castiñeiras S. (2010) Fe, the retina and the 223. Chen, Y et al. (2012) Ocular aldehyde dehydro-
lens:afocusedreview.Exp.EyeResearch90,664. genases:protectionagainstUVdamageandmainten-
207. Shoham,Aetal.(2008)Oxidativestressindiseasesof anceoftransparencyforvision.Prog.Retin.EyeRes.
thehumancornea.FreeRadic.Biol.Med.45,1047. 33,28.
208. Lechauve, C et al. (2013) Neuroglobin involvement 224. Boonstra,AandKijlstra,A(1984)Theidentification
invisualpathwaysthroughtheopticnerve.Biochim. oftransferrin,anFe-bindingproteininrabbittears.
Biophys.Acta1834,1772. Exp.EyeRes.38,561.

--- Page 810 ---

REFERENCES 755
225. Breusted, DA et al. (2005) The 1.8-A crystal struc- 244. Newsome,DAetal.(1994)AntioxidantsintheRPE.
ture of human tear lipocalin reveals an extended Prog.Ret.EyeRes.13,101.
branchedcavitywithcapacityformultipleligands. 245. Bennaars-Eiden,Aetal.(2002)Covalentmodification
J.Biol.Chem.280,484. ofepithelialfattyacid-bindingproteinby4-HNEin
•
226. Kuizenga,Aetal.(1987)InhibitionofOH formation vitroandinvivo.J.Biol.Chem.277,50693.
byhumantears.Invest.Ophthalmol.Vis.Sci.28,305. 246. Taylor,A(1993)Cataract:relationshipbetweennutri-
227. Kojima,Tetal.(2012)Age-relateddysfunctionofthe tionandoxidation.J.Am.Coll.Nutr.12,138.
lacrimalglandandoxidativestress.Am.J.Pathol.180, 247. Ringvold, A et al. (1998) Ascorbate in the corneal
1879. epitheliumofdiurnalandnocturnalspecies.Invest.
228. Makamura,Setal.(2007)Involvementofoxidative Ophthalmol.Vis.Sci.39,2774.
stress on corneal epithelial alterations in a blink- 248. Ohta,Yetal.(2002)Prolongedmarginalascorbicacid
suppresseddryeye.Invest.Ophthal.Vis.Sci.48,1552. deficiencyinducesoxidativestressinretinaofguinea
229. Bitar,MSetal.(2012)DeclineinDJ-1anddecreased pigs.Int.J.Vitam.Nutr.Res.72,63.
nuclear translocation of Nrf2 in Fuchs endothelial 249. Rautiainen,Setal.(2010)VitaminCsupplementsand
corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 53, the risk of age-related cataract: a population-based
5806. prospectivecohortstudyinwomen.Am.J.Clin.Nutr.
230. Tsentalovich,YPetal.(2011)Photochemicalproper- 91,487.
tiesofUVfiltermoleculesofthehumaneye.Invest. 250. Song,Detal.(2012)SystemicadministrationoftheFe
Ophthalmol.Vis.Sci.52,7687. chelator deferiprone protects against light-induced
231. Ortwerth, BJ et al. (2009) Tryptophan metabolites photoreceptordegenerationinthemouseretina.Free
from young human lenses and the photooxidation Radic.Biol.Med.53,64.
ofascorbicacidbyUVAlight.Invest.Ophthalmol.Vis. 251. Picard,Eetal.(2011)Light-inducedretinaldegener-
Sci.50,3311. ationcorrelateswithchangesinFemetabolismgene
232. Linetsky,Metal.(2014)UVAlight-excitedkynuren- expression,ferritinlevel,andaging.Invest.Ophthal-
ines oxidize ascorbate and modify lens proteins mol.Vis.Sci.52,1261.
throughtheformationofAGEproducts.J.Biol.Chem. 252. McGahan, MC and Fleischer, LN (1986) A micro-
289,17111. methodforthedeterminationofFe2+ andtotalFe-
233. Olusanya,Betal.(2012)Profileofpatientspresenting bindingcapacityinintraocularfluidsandplasmaus-
atalowvisionclinicinadevelopingcountry.BMC ing electrothermal atomic absorption spectroscopy.
Ophthalmol.12,31. Anal.Biochem.156,397.
234. Chen, Y et al. (2009) Antioxidant defenses in the 253. Chen, W et al. (1998) Expression of the protective
ocularsurface.Ocul.Surf.7,176. proteinshemopexinandhaptoglobinbycellsofthe
235. Lou, MF (2003) Redox regulation in the lens. Prog. neuralretina.Exp.EyeRes.67,83.
Retin.EyeRes.22,657. 254. Tolosano, E et al. (2010) Heme scavenging and the
236. Wolf,Netal.(2005)Age-relatedcataractprogression otherfacetsofhemopexin.Antioxid.RedoxSignal.12,
in five mouse models for antioxidant protection or 305.
hormonalinfluence.Exp.EyeRes.81,276. 255. Tsuruma,Ketal.(2012)MT-IIIdeficiencyexacerbates
237. Maeda,Aetal.(2005)MicrosomalGST1intheRPE: light-induced retinal degeneration. Invest. Ophthal-
protection against oxidative stress and a potential mol.Vis.Sci.53,7896.
roleinaging.Biochemistry44,480. 256. Brennan,LAandKantorow,M(2009)Mitochondrial
238. Nurminskaya, MV et al. (2009) Nuclear ferritin: a function and redox control in the aging eye: role
ferritoid-ferritin complex in corneal epithelial cells. of MsrA and other repair systems in cataract and
Invest.Ophthalmol.Vis.Sci.50,3655. maculardegenerations.Exp.EyeRes.88,195.
239. Sastre,Jetal.(2005)Age-associatedoxidativedam- 257. Shang,FandTaylor,A(2012)Roleoftheubiquitin-
ageleadstoabsenceofγ-cystathionaseinover50% proteasomeinproteinqualitycontrolandsignaling:
ofratlenses:relevanceincataractogenesis.FreeRadic. implicationinthepathogenesisofeyediseases.Prog.
Biol.Med.38,575. Mol.Biol.Transl.Sci.109,347.
240. Justilien, V et al. (2007) SOD2 knockdown mouse 258. Wang,Letal.(2014)p62providesdualcytoprotection
model of early AMD. Invest. Ophthalmol. Vis. Sci. againstoxidativestressintheRPE.Biochim.Biophys.
48,4407. Acta1843,1248.
241. Sandbach,JMetal.(2001)Ocularpathologyinmito- 259. Stancliffe, TC and Pirie, A (1971) The production
chondrialSOD(Sod2)-deficientmice.Invest.Ophthal- ofO
•–
radicalsinreactionsoftheherbicidediquat.
2
mol.Vis.Sci.42,2173. FEBSLett.17,297.
242. Yuki, K et al. (2011) Retinal ganglion cell loss in 260. Dong,Aetal.(2006)SOD1protectsretinalcellsfrom
SOD1deficiency.Invest.Ophthalmol.Vis.Sci.52,4143. oxidativedamage.J.Cell.Physiol.208,516.
243. Takata, I et al. (1996) Glycated CuZnSOD in rat 261. Higuchi,Aetal.(2011)Cornealdamageandlacrimal
lenses:evidenceforthepresenceoffragmentationin glanddysfunctioninasmokingratmodel.FreeRadic.
vivo.Biochem.Biophys.Res.Commun.219,243. Biol.Med.51,2210.

--- Page 811 ---

756 REFERENCES
262. Pons, M and Marin-Castan´o, ME (2011) Cigarette 281. Piomboni, P et al. (2012) The role of mitochondria
smoke-related hydroquinone dysregulates MCP-1, inenergyproductionforhumanspermmotility.Int.
VEGFandPEDFexpressioninretinalpigmentepi- J.Androl.35,109.
theliuminvitroandinvivo.PLoSOne6,e16722. 282. Morimoto,Hetal.(2013)ROSarerequiredformouse
263. Pittman,KMetal.(2002)NitrationofMnSODduring spermatogonialstemcellself-renewal.CellStemCell
ocularinflammation.Exp.EyeRes.74,463. 12,774.
264. Kirschfeld,K(1982)Carotenoidpigments:theirpos- 283. Iuchi,Yetal.(2009)Peroxiredoxin4knockoutresults
sible role in protecting against photo-oxidation in in elevated spermatogenic cell death via oxidative
eyesandphotoreceptorcells.Proc.R.Soc.Lond.BBiol. stress.Biochem.J.419,149.
Sci.216,71. 284. Tsunoda, S et al. (2012) Impaired fertilizing abil-
265. Shi, AJ et al. (2014) Macular pigment and macular ity of SOD1-deficient mouse sperm during in vivo
volumeineyesofpatientswithcysticfibrosis.Free fertilization.Biol.Reprod.87,121.
Radic.Res.48,740. 285. Noblanc, A et al. (2011) GPxs at work on epididy-
266. Kijlstra,Aetal.(2012)Lutein:morethanjustafilter mal spermatozoa: an example of the dual effect of
forbluelight.Prog.RetinalEyeRes.31,303. ROSonmammalianmalefertilizingability.J.Androl.
267. Kirby, ML et al. (2010) A central dip in the macu- 32,641.
larpigmentspatialprofileisassociatedwithageand 286. Taylor, A et al. (2013) Epididymal specific, Se-
smoking.Invest.Ophthalmol.Vis.Sci.51,6722. independent GPX5 protects cells from oxidative
268. Leung, I et al. (2001) Absorption and tissue distri- stress-induced lipid peroxidation and DNA muta-
butionofzeaxanthinandluteininrhesusmonkeys tion.HumanReprod.28,2332.
aftertakingFructuslycii(GouQiZi)extract.Invest. 287. Nakamura, BN et al. (2010) Knockout of the tran-
Ophthalmol.Vis.Sci.42,466. scriptionfactorNRF2disruptsspermatogenesisinan
269. Evans, JR and Lawrenson, JG (2012) Antioxidant age-dependentmanner.FreeRadic.Biol.Med.49,1368.
vitamin and mineral supplements for preventing 288. Chen, Ket al. (2012) Low NRF2 mRNA expression
age-relatedmaculardegeneration.CochraneDatabase inspermatozoafrommenwithlowspermmotility.
Syst.Rev.6:CD000253. TohokuJ.Exp.Med.228,259.
270. Grover,AKandSamson,SE(2014)Antioxidantsand 289. Sutovsky,P(2011)Spermproteasomeandfertiliza-
visionhealth:factsandfiction.Mol.CellBiochem.388, tion.Reproduction142,1.
173. 290. Nikodemus,Detal. (2012)Paramountlevelsofer-
271. Age-Related Eye Disease Study 2 Research Group gothioneine transporter SLC22A4 mRNA in boar
(2014)Lutein+zeaxanthinandomega-3fattyacids seminal vesicles and cross-species analysis of er-
for age-related macular degeneration. JAMA 309, gothioneine and glutathione in seminal plasma.
2005. J.Physiol.Pharmacol.62,411.
272. Futahashi,Retal.(2012)Redoxaltersyellowdragon- 291. Turner,TTandLysiak,JJ(2008)Oxidativestress:a
fliesintored.Proc.Natl.Acad.Sci.USA109,12626. commonfactorintesticulardysfunction.J.Androl.29,
273. Aitken,RJetal.(2012)ROSandspermfunction–in 488.
sicknessandinhealth.J.Androl.33,1096. 292. Park, JI et al. (2012) Periovulatory expression of
274. Aitken,RJetal.(2010)Analysisoftherelationships H2O2-induced sulfiredoxin and prx-2 in the rat
betweenoxidativestress,DNAdamageandsperm ovary:gonadotropinregulationandpotentialmodi-
vitalityinapatientpopulation:developmentofdiag- fication.Endocrinology153,5512.
nosticcriteria.HumanReprod.25,2415. 293. Devine,PJetal.(2012)RolesofROSandantioxidants
275. Sikka,SC(2004)Roleofoxidativestressandantioxi- inovariantoxicity.Biol.Reprod.86,1.
dantsinandrologyandassistedreproductivetechno- 294. Noda,Yetal.(2012)CuZnSODinsufficiencyimpairs
logy.J.Androl.25,5. progesterone secretion and fertility in female mice.
276. Partyka, A et al. (2011) Detection of lipid perox- Biol.Reprod.86,1.
idation in frozen-thawed avian spermatozoa using 295. Frediksson, Å et al. (2012) Effects of aging and
C11-BODIPY581/591.Theriogenology75,1623. reproduction on protein quality control in soma
277. Aitken,RJetal.(2012)Electrophilicaldehydesgen- and gametes of Drosophila melanogaster. Aging Cell
eratedbyspermmetabolismactivatemitochondrial 11,634.
ROSgenerationandapoptosisbytargetingSDHase. 296. Otsuki, J et al. (2009) Damage of embryo devel-
J.Biol.Chem.287,33048. opment caused by peroxidized mineral oil and its
278. Showell,MGetal.(2011)Antioxidantsformalesub- associationwithalbumininculture.Fertil.Steril.91,
fertility.CochraneDatabaseSyst.Rev.1,CD007411. 1745.
279. Cifuentes-Pagano, E et al. (2014) The quest for se- 297. Morbeck, DE (2014) Composition of protein sup-
lectiveNoxinhibitorsandtherapeutics:challenges, plementsusedforhumanembryoculture.J.Assist.
triumphsandpitfalls.Antioxid.RedoxSignal.20,2741. Reprodc.Genet.31,1703.
280. Aitken,RJandNixon,B(2013)Spermcapacitation: 298. Pereira,ACandMartel,F(2014)Oxidativestressin
a distant landscape glimpsed but unexplored. Mol. pregnancyandfertilitypathologies.CellBiol.Toxicol.
HumanReprod.19,785. 30,301.

--- Page 812 ---

REFERENCES 757
299. Takahashi,M(2012)Oxidativestressandredoxregu- 316. Shibata, E et al. (2003) Enhancement of mitochon-
lation on in vitro development of mammalian em- drial oxidative stress and up-regulation of antioxi-
bryos.J.Reprod.Dev.58,1. dant protein prx III/SP-22 in the mitochondria of
300. Kimura, N et al. (2010) Intrinsic oxidative stress humanpre-eclampticplacentae.Placenta24,698.
causes either 2-cell arrest or cell death depending 317. Wang, CN et al. (2011) Elevated amniotic fluid F2-
ondevelopmentalstageoftheembryosfromSOD1- IsoP:apotentialpredictivemarkerforpreeclampsia.
deficientmice.Mol.HumanReprod.16,441. FreeRadic.Biol.Med.50,1124.
301. Bevilacqua, E et al. (2012) NADPH oxidase as an 318. Herrera,EAetal.(2012)AroleforXOinthecontrolof
importantsourceofROSatthemousematernalfetal- fetalcardiovascularfunctioninlategestationsheep.
interface: putative biological roles. Reprod. Biomed. J.Physiol.590,1825.
Online25,31. 319. Santanam, N et al. (2012) Antioxidant supplemen-
302. Bogavac, M et al. (2012) Biomarkers of oxidative tation reduces endometriosis-related pelvic pain in
stress in amniotic fluid and complications in preg- humans.Transl.Res.161,189.
nancy.J.Matern.FetalNeonatalMed.25,104. 320. Yamaguchi, K et al. (2008) Contents of endometri-
303. Paffetti,Petal.(2006)Non-protein-boundFedetec- otic cysts, especially the high concentration of free
tioninsmallsamplesofbiologicalfluidsandtissues. Fe,areapossiblecauseofcarcinogenesisinthecysts
Biol.TraceElementRes.112,221. through the Fe-induced persistent oxidative stress.
304. Hung,THetal.(2010)Alongitudinalstudyofoxida- Clin.CancerRes.14,32.
tivestressandantioxidantstatusinwomenwithun- 321. Wells,PGetal.(2010)OxidativeDNAdamageand
complicated pregnancies throughout gestation. Re- repairinteratogenesisandneurodevelopmentaldef-
prod.Sci.17,401. icits.BirthDefectsResCEmbryoToday90,103.
305. Didenco,Setal.(2011)IncreasedvitaminEintakeis 322. Wentzel,PandEriksson,UJ(2002)8-Iso-PGF2α ad-
associatedwithhigherα-tocopherolconcentrationin ministration generates dysmorphogenesis and in-
the maternal circulation but higher α-carboxyethyl creased lipid peroxidation in rat embryos in vitro.
hydroxychroman concentration in the fetal circula- Teratology66,164.
tion.Am.J.Clin.Nutr.93,368. 323. Wang, F et al. (2013) SOD1 overexpression in mice
306. Avissar,Netal.(1994)Humanplacentamakesextra- abolishesmaternaldiabetes-inducedERstressindia-
cellularGPxandsecretesitintomaternalcirculation. beticembryopathy.Am.J.Obstet.Gynecol.209,345.e1.
Am.J.Physiol.267,E68 324. McCance,DRetal.(2010)VitaminsCandEforpre-
307. Li, L et al. (2008) Crucial role of prxIII in placental ventionofpre-eclampsiainwomenwithtype1dia-
antioxidantdefenseofmice.FEBSLett.582,2431. betes (DAPIT): a randomized placebo-controlled
308. Thomas,VVetal.(2013)MaternalhairSelevelsasa trial.Lancet376,259.
possiblelong-termnutritionalindicatorofrecurrent 325. Abramov,JPandWells,PG(2011)Embryoniccata-
pregnancyloss.BMCWomensHealth13,40. lase protects against endogenous and phenytoin-
309. Hammer,Aetal.(2001)MPO-dependentgeneration enhanced DNA oxidation and embryopathies in
of OCl–-modified proteins in human placental tis- acatalasemic and human catalase-expressing mice.
suesduringnormalpregnancy.Lab.Invest.81,543. FASEBJ.25,2188.
310. Hnat, MD et al. (2005) Hsp-70 and 4HNE adducts 326. Nicol,CJetal.(2000)Anembryoprotectiverolefor
in human placental villous tissue of normotens- G6PDHindevelopmentaloxidativestressandchem-
ive,preeclampticandintrauterinegrowthrestricted icalteratogenesis.FASEBJ.14,111.
pregnancies.Am.J.Obst.Gynecol.193,836. 327. Ito,Tetal.(2011)Teratogeniceffectsofthalidomide:
311. Palm,Metal.(2009)F2-IsoPs,tocopherolsandnor- molecularmechanisms.Cell.Mol.LifeSci.68,1569.
malpregnancy.FreeRadic.Res.43,546. 328. Solberg,Retal.(2007)Resuscitationofhypoxicnew-
312. Poston, L et al. (2006) Vitamin C and vitamin E bornpigletswithO2 inducesadose-dependentin-
in pregnant women at risk for pre-eclampsia (VIP creaseinmarkersofoxidation.Pediatr.Res.62,559.
trial): randomized placebo-controlled trial. Lancet 329. Kaarteenaho-Wilk,RandKinnula,VL(2004)Distri-
367,1145. butionofantioxidantenzymesindevelopinghuman
313. Barden, AE et al. (2012) Is there a role of isofur- lung,respiratorydistresssyndrome,andbronchop-
ansandneuroprostanesinpre-eclampsiaandnormal ulmonarydysplasia.J.Histochem.Cytochem.52,1231.
pregnancy?Antioxid.RedoxSignal.16,165. 329A. Berkelhamer, SK and Farrow, KN (2014) Develop-
314. Ishihara,Oetal.(2004)IsoPs,prostaglandinsandto- mentalregulationofantioxidantenzymesandtheir
copherols in pre-eclampsia, normal pregnancy and impact on neonatal lung disease. Antioxid. Redox
non-pregnancy.FreeRadic.Res.38,913. Signal.21,1837.
315. Gersch,Cetal.(2009)ReactionsofONOO–withuric 330. Rossi, V et al. (2006) Oxidative stress and autolo-
acid: formation of reactive intermediates, alkylated gousimmunoglobulinGbindingtoband3dimersin
products and triuret, and in vivo production of tri- newbornerythrocytes.FreeRadic.Biol.Med.40,907.
uretunderconditionsofoxidativestress.Nucleosides 331. Dziaman, T et al. (2007) Urinary excretion rate of
NucleotidesNucleicAcids28,118. 8-oxoGua and 8-oxodG and antioxidant vitamins

--- Page 813 ---

758 REFERENCES
level as a measure of oxidative status in healthy, 351. Gazzolo, D et al. (2013) Antenatal glucocorticoids
full-termnewborns.FreeRadic.Res.41,997. supplementationandCNSdevelopment.Curr.Drug
332. Chen, JX et al. (2012) IsoPs as physiological medi- Metab.14,160.
atorsoftransitiontonewbornlife:novelmechanisms 352. Moison,RMWetal.(1993)Inductionoflipidperoxid-
regulatingpatencyofthetermandpretermductus ationofpulmonarysurfactantbyplasmaofpreterm
arteriosus.Pediatr.Res.72,122. babies.Lancet341,79.
333. Tsukahara,H(2007)Biomarkersforoxidativestress: 353. Evans,PJetal.(1992)Bleomycin-detectableFeinthe
clinicalapplicationinpediatricmedicine.Curr.Med. plasma of premature and full-term neonates. FEBS
Chem.14,339. Lett.303,210.
334. Hong, Z et al. (2013) Role of Drp1-mediated mito- 354. Hirano, K et al. (2001) Blood transfusion increases
chondrial fission in O2 sensing and constriction of radicalpromotingnon-transferrinboundFeinpre-
theductusarteriosus.Circ.Res.112,802. terminfants.Arch.Dis.Child84,F188.
335. Wedgwood,Setal.(2012)Apocyninimprovesoxy- 355. Yu,Tetal.(2003)Effectofasphyxiaonnon-protein-
genationandincreaseseNOSinpersistentpulmonary boundFeandlipidperoxidationinnewborninfants.
hypertensionofthenewborn.Am.J.Physiol.302,L616. Dev.Med.ChildNeurol.45,24.
336. Wong,CMetal.(2013)ROSandantioxidantsinpul- 356. Ogihara,Tetal.(2003)Non-protein-boundtransition
•
monaryhypertension.Antioxid.RedoxSignal.18,1789. metals and OH generation in CSF of newborn in-
337. Puente, BN et al. (2014) The O2-rich postnatal en- fantswithhypoxicischemicencephalopathy.Pediatr.
vironment induces cardiomyocyte cell-cycle arrest Res.53,594.
throughDNAdamageresponse.Cell157,565. 357. Jain,SK(1989)Theneonatalerythrocyteanditsoxi-
338. Rechetzki,KFetal.(2012)Referencevaluesformeth- dativesusceptibility.Semin.Hematol.26,286.
emoglobinconcentrationsinchildren.Rev.Bras.Hem- 358. Nasef,Netal.(2011)Roleofascorbateinlungcel-
atol.Hemoter.34,14. lular toxicity mediated by light-exposed parenteral
339. Comporti, M et al. (2004) Plasma F2-IsoPs are ele- nutritionsolution.FreeRadic.Res.45,359.
vatedinnewbornsandinverselycorrelatedtoges- 359. Lavoie,Jetal.(2008)Influenceoflungoxidantand
tationalage.FreeRadic.Biol.Med.37,724. antioxidant status on alveolarization: role of light-
340. Belik,Jetal.(2010)IsoPsinfetalandneonatalhealth exposed total parenteral nutrition. Free Radic. Biol.
anddisease.FreeRadic.Biol.Med.48,177. Med.45,572.
341. Back,SAetal.(2005)Selectivevulnerabilityofpre- 360. Calder, PC et al. (2010) Lipid emulsions in par-
termwhite matterto oxidativedamage definedby enteral nutrition of intensive care patients: current
F2-IsoPs.Ann.Neurol.58,108. thinking and future directions. Intensive Care Med.
342. Tsukahara, H et al. (2004) Oxidative stress in 36,735.
neonates:evaluationusingspecificbiomarkers.Life 361. Haider, BA et al. (2013) Anaemia, prenatal Fe use,
Sci.75,933. andriskofadversepregnancyoutcomes:systematic
343. Merritt, TA et al. (1993) Reduction of the surface- reviewandmeta-analysis.BMJ346:f3443.
tension-loweringabilityofsurfactantafterexposure 362. Ledo,Aetal.(2009)Humanmilkenhancesantioxi-
•
toHOCl.Biochem.J.295,19. dant defenses against OH aggression in preterm
344. Yee, M et al. (2013) Neonatal hyperoxia increases infants.Am.J.Clin.Nutr.89,210.
sensitivityofadultmicetobleomycin-inducedlung 363. Jiang,Hetal.(2007)Oxidativeimbalanceintheaging
fibrosis.Am.J.Respir.CellMol.Biol.48,258. innerear.Neurobiol.Aging28,1605.
345. Sullivan,JL(1988)Fe,plasmaantioxidants,andthe 364. Coling,DEetal.(2003)EffectofSOD1overexpression
‘O2radicaldiseaseofprematurity’.Am.J.Dis.Child on age- and noise-related hearing loss. Free Radic.
142,1341. Biol.Med.34,873.
346. Quiles, JL et al. (2006) Coenzyme Q concentration 365. Endo, T et al. (2005) Elevation of SOD increases
andtotalantioxidantcapacityofhumanmilkatdif- acoustictraumafromnoiseexposure.FreeRadic.Biol.
ferentstagesoflactationinmothersofpretermand Med.38,492.
full-terminfants.FreeRadic.Res.40,199. 366. Ahmed, ZM et al. (2011) Functional null mutations
347. Karg,Eetal.(2001)FerroxidasesandXOinplasmaof ofMSRB3encodingMSRareassociatedwithhuman
healthynewborninfants.FreeRadic.Res.35,555. deafnessDFNB74.Am.J.HumanGenet.88,19.
348. Welty,SE(2003)AntioxidantsandoxidationsinBPD: 367. Poirrier,ALetal.(2010)Oxidativestressinthecoch-
therearenoeasyanswers.J.Pediatr.143,697. lea:anupdate.Curr.Med.Chem.17,3591.
349. McBride,JAetal.(2009)Economicevaluationofre- 368. Miller,JMetal.(2008)8-IsoP-F2α,aproductofnoise
combinanthumanCuZnSODadministeredatbirth exposure,reducesinnerearbloodflow.Audiol.Neu-
toprematureinfants.J.Perinatol.29,364. rootol.8,207.
350. Parad, RB et al. (2012) Reduction of retinopathy of 369. Choi,CHetal.(2014)Therapeuticeffectsoforallyad-
prematurity in extremely low gestational age new- ministeredantioxidantdrugsonacutenoise-induced
bornstreatedwithrecombinanthumanCu/ZnSOD. hearingloss.FreeRadic.Res.48,264.
Neonatal.102,139. 370. Dolgin,E(2012)Soundmedicine.Nat.Med.18,642.

--- Page 814 ---

REFERENCES 759
371. Rybak,LPetal.(2012)siRNA-mediatedknock-down 388. Ishitsuka,Yetal.(2012)Increasedhalogenatedtyro-
ofNOX3:therapyforhearingloss?Cell.Mol.LifeSci. sinelevelsareusefulmarkersofhumanskinageing,
69,2429. reflectingproteinsdenaturedbypastskininflamma-
372. Jamesdaniel, S et al. (2012) Cisplatin-induced oto- tion.Clin.Exp.Dermatol.37,252.
toxicityismediatedbynitroxidativemodificationof 389. Nair-Shalliker, V et al. (2012) Sunlight and vitamin
cochlearproteinscharacterizedbynitrationofLmo4. DaffectDNAdamage,celldivisionandcelldeathin
J.Biol.Chem.287,18674. humanlymphocytes:across-sectionalstudyinSouth
373. Jankauskas, SS et al. (2012) Mitochondria-targeted Australia.Mutagenesis27,609.
antioxidantSkQR1amelioratesgentamycin-induced 390. Janeko, N et al. (2012) Mitochondrial common
renalfailureandhearingloss.Biochemistry(Moscow) deletion mutation and extrinsic skin ageing in
77,666. German and Japanese women. Exp. Dermatol. 21
374. Singh, R and Wangemann, P (2008) Free radical Suppl1,26.
stress-mediated loss of Kcnj10 protein expression 391. Kunisada,Metal.(2005)8OHdGformationinduced
in stria vascularis contributes to deafness in Pen- bychronicUVBexposuremakesogg1knockoutmice
dred syndrome mouse model. Am. J. Physiol. 294, susceptible to skin carcinogenesis. Cancer Res. 65,
F139. 6006.
375. Grumbt,Metal.(2013)Keratindegradationbyderm- 392. Besaratinia,AandPfeifer,GP(2010)Applicationsof
atophytesreliesoncysteinedioxygenaseandasulfite the human p53 knock-in (Hupki) mouse model for
effluxpump.J.Invest.Dermatol.133,1550. humancarcinogentesting.FASEBJ.24,2612.
376. Bognar,Petal.(2014)Reducedinflammatorythresh- 393. Aroun,Aetal.(2012)Fe,oxidativestressandtheex-
oldindicatesskinbarrierdefectintransglutaminase ampleofsolarUVAradiation. Photochem.Photobiol.
3knockoutmice.J.Invest.Dermatol.134,105. Sci.11,118.
377. Kim, JS et al. (2011) Neuregulin induces HaCat 394. Reelfs,Oetal.(2004)UVAradiation-inducedimme-
keratinocytemigrationviaRac1-mediatedNADPH- diateFereleaseisakeymodulatoroftheactivationof
oxidaseactivation.J.Cell.Physiol.226,3014. NF-κBinhumanskinfibroblasts.J.Invest.Dermatol.
378. Stanley,Aetal.(2012)RhoGTPasesandNoxdepend- 122,1440.
ent ROS production in skin. Is there a connection? 395. Bissett,DLetal.(1991)ChronicUVradiation-induced
Histol.Histopathol.27,1395. increaseinskinFeandthephotoprotectiveeffectof
379. Suschek,CVetal.(2010)Non-enzymaticNOproduc- topically applied Fe chelators. Photochem. Photobiol.
tioninhumanskin:effectofUVAoncutaneousNO 54,215.
stores.NitricOxide22,120. 396. Zhou,Qetal.(2009)Oxidativestressinthepathogen-
380. Schmid-Grendelmeier, P et al. (2005) IgE-mediated esisofpsoriasis.FreeRadic.Biol.Med.47,891.
andTcell-mediatedauto-immunityagainstMnSOD 397. Vyas,PMetal.(2005)ROSgenerationanditsrolein
inatopicdermatitis.J.Allerg.Clin.Immunol.115,1068. the differential cytotoxicity of the arylhydroxylam-
381. Verhulst,NOetal.(2010)Chemicalecologyofinter- ine metabolites of sulfamethoxazole and dapsone
actionsbetweenhumanskinmicrobiotaandmosqui- innormalhumanepidermalkeratinocytes.Biochem.
toes.FEMSMicrobiol.Ecol.74,1. Pharmacol.70,275.
382. Du, L et al. (2006) Differentiation-specific factors 398. Wisthaler, A and Weschler, CJ (2010) Reactions of
modulateepidermalCYP1-4geneexpressioninhu- O3withhumanskinlipids:sourcesofcarbonyls,di-
manskininresponsetoretinoicacidandclassicaryl carbonyls,andhydroxycarbonylsinindoorair.Proc.
hydrocarbonreceptorligands.J.Pharmacol.Exp.Ther. Natl.Acad.Sci.USA107,6568.
319,1162. 399. Schäfer, M and Werner, S (2011) The cornified en-
383. Wondrak, GT et al. (2004) 3-Hydroxypyridine velope:afirstlineofdefenseagainstROS.J.Invest.
chromophoresareendogenoussensitizersofphoto- Dermatol.131,1409.
oxidative stress in human skin cells. J. Biol. Chem. 400. Ortiz, A and Grando, SA (2012) Smoking and the
279,30009. skin.Int.J.Dermatol.51,250.
384. Beattie,PEetal.(2007)Candietaryfuranocoumarinin- 401. Nowotny, K and Grune, T (2014) Degradation of
gestionenhancetheerythemalresponseduringhigh- oxidizedandglycoxidizedcollagen:roleofcollagen
doseUVA1therapy?J.Am.Acad.Dermatol.56,84. cross-linking.Arch.Biochem.Biophys.542,56.
385. Anderson,RR(2004)Sheddingsomelightontattoos? 402. Yih, JJ et al. (2012) Phototoxicity of nano TiO2 in
Photochem.Photobiol.80,155. HaCat keratinocytes – generation of ROS and cell
386. Johansson, S et al. (2008) Carbon- and O2-centered damage.Toxicol.Appl.Pharmacol.263,81.
radicalsareequallyimportanthaptensofallylichy- 403. Kramer-Stickland,Ketal.(1999)UV-B-Inducedpho-
droperoxides in allergic contact dermatitis. Chem. tooxidationofvitaminEinmouseskin.Chem.Res.
Res.Toxicol.21,1536. Toxicol.12,187.
387. Burke, KE (2010) Photoaging: the role of oxidative 404. Kostyuk, V et al. (2012) Photo-oxidation products
stress.GItal.Dermatol.Venereol.145,445. of skin surface squalene mediate metabolic and

--- Page 815 ---

760 REFERENCES
inflammatoryresponsestosolarUVinhumankera- 422. Love,NRetal.(2013)Amputation-inducedROSare
tinocytes.PLoSOne7,e44472. requiredforsuccessfulXenopustadpoletailregener-
405. Denat,Letal.(2014)Melanocytesasinstigatorsand ation.Nat.CellBiol.15,222.
victims of oxidative stress. J. Invest. Dermatol. 134, 423. Li, W et al. (2000) H2O2-mediated, lysyl-oxidase-
1512. dependent chemotaxis of vascular smooth muscle
406. Scarmo,Setal.(2010)Significantcorrelationsofder- cells.J.Cell.Biochem.78,550.
maltotalcarotenoidsanddermallycopenewiththeir 424. Shukla, A et al. (1997) Depletion of GSH, ascorbic
respectiveplasmalevelsinhealthyadults.Arch.Bio- acid,vitaminEandantioxidantdefenceenzymesin
chem.Biophys.504,34. ahealingcutaneouswound.FreeRadic.Res.26,93.
407. Matsugo, S et al. (2011) Photochemical stability of 425. Hanselmann,Cetal.(2001)HO-1:anovelplayerin
lipoicacidanditsimpactonskinageing.FreeRadic. cutaneous wound repair and psoriasis? Biochem. J.
Res.45,918. 353,459.
408. Bulteau,ALetal.(2002)Impairmentofproteasome 426. Iuchi,Yetal.(2010)Spontaneousskindamageand
functionuponUVA-andUVB-irradiationofhuman delayedwoundhealinginSOD1-deficientmice.Mol.
keratinocytes.FreeRadic.Biol.Med.32,1157. Cell.Biochem.341,181.
409. Zhao,Yetal.(2013)AutophagyisinducedbyUVA 427. Luo, JD et al. (2004) Gene therapy of eNOS and
and promotes removal of oxidized phospholipids MnSOD restores delayed wound healing in type
and protein aggregates in epidermal keratinocytes. 1diabeticmice.Circulation110,2484.
J.Invest.Dermatol.133,1629. 428. Wlaschek, M and Scharffetter-Kochanek, K (2005)
410. Liljendahl,TSetal.(2013)Urinarylevelsofthymine Oxidativestressinchronicvenouslegulcers.Wound
dimer as a biomarker of exposure to UV radiation Rep.Reg.13,452.
inhumansduringoutdooractivitiesinthesummer. 429. Taylor, JE et al. (2005) Extent of Fe pick-up in
Mutagenesis28,249. deferoxamine-coupled polyurethane materials for
411. Markova, NG et al. (2009) Skin cells and tissue are therapyofchronicwounds.Biomaterials26,6024.
capableofusingL-ergothioneineasanintegralcom- 430. Horton, JW (2003) Free radicals and lipid peroxid-
ponent of their antioxidant defense system. Free ation mediated injury in burn trauma: the role of
Radic.Biol.Med.46,1168. antioxidanttherapy.Toxicology189,75.
412. Murakami,Ketal.(2009)Skinatrophyincytoplas- 431. Ritter, C et al. (2003) Plasma oxidative parameters
mic SOD-deficient mice and its complete recovery and mortality in patients with severe burn injury.
usingavitaminCderivative.Biochem.Biophys.Res. IntensiveCareMed.29,1380.
Commun.382,457. 432. Saez,JCetal.(1984)O
•–
radicalinvolvementinthe
2
413. Scheurmann,Jetal.(2014)Micewithheterozygous pathogenesisofburnshock.Circ.Shock12,229.
deficiency of MnSOD (SOD2) have a skin immune 433. Jiang,Xetal.(2013)Polydatinprotectscardiacfunc-
systemwithfeaturesof‘inflamm-aging’.Arch.Der- tion against burn injury by inhibiting sarcoplasmic
matol.Res.306,143. reticulumCa2+leakbyreducingoxidativemodifica-
414. Polefka,TGetal.(2012)Cutaneousoxidativestress. tionofryanodinereceptors.FreeRadic.Biol.Med.60,
J.Cosmet.Dermatol.11,55. 292.
415. Shindo, Y et al. (1993) Antioxidant defense mech- 434. Vorauer-Uhl,Ketal.(2002)Reepithelializationofex-
anisms in murine epidermis and dermis and their perimentalscaldseffectedbytopicallyappliedSOD:
responsestoUVlight.JInvest.Dermatol.100,260. controlledanimalstudies.WoundRep.Reg.10,366.
416. McGee, HM et al. (2010) The two faces of metallo- 435. Bitto, A et al. (2007) Raxofelast, (±)5-(acetyloxy)-
thionein in carcinogenesis: photoprotection against 2-3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acid:
UVR-inducedcancerandpromotionoftumoursur- a new antioxidant to modulate the inflammatory
vival.Photochem.Photobiol.Sci.9,586. response during ischemia-reperfusion injury and
417. Kawachi,Yetal.(2008)AttenuationofUVB-induced impaired wound healing. Mini Rev. Med. Chem.
sunburnreactionandoxidativeDNAdamagewith 7,339.
noalterationsinUVB-inducedskincarcinogenesisin 436. Righi, V et al. (2013) Mitochondria-targeted anti-
Nrf2genedeficientmice.J.Invest.Dermatol.128,1773. oxidantpromotesrecoveryofskeletalmusclemito-
418. Schäfer,Metal.(2014)ActivationofNrf2inkeratino- chondrial function after burn trauma assessed by
cytes causes chloracne (MADISH)-like skin disease in vivo 31P NMR and EPR spectroscopy. FASEB J.
inmice.EMBOMol.Med.6,442. 27,2521.
419. Wagener, FA et al. (2010) The heme-HO system in 437. Nikolaidis,MGetal.(2012)Redoxbiologyofexer-
woundhealing;implicationsforscarformation.Curr. cise:anintegrativeandcomparativeconsiderationof
DrugTargets11,1571. someoverlookedissues.J.Exp.Biol.215,1615.
420. Sen,CKandRoy,S(2008)Redoxsignalsinwound 438. Durrant,JRetal.(2009)Voluntarywheelrunningre-
healing.Biochim.Biophys.Acta1780,1348. storesendothelialfunctioninconduitarteriesofold
421. Loo,AEKetal.(2012)EffectsofH2O2onwoundheal- mice:directevidenceforreducedoxidativestress,in-
inginmiceinrelationtooxidativedamage.PLoSOne creasedSODactivityanddown-regulationofNOX.
7,e49215. J.Physiol.587,3271.

--- Page 816 ---

REFERENCES 761
439. Pellegrino,MAetal.(2011)Redoxhomeostasis,oxi- 456. Lamprecht, M et al. (2008) Single bout of exer-
dative stress and disuse muscle atrophy. J. Physiol. ciseaffectalbuminredoxstateandcarbonylgroups
589,2147. on plasma protein of trained men in a workload-
440. Hofer,Tetal.(2008)IncreasedFecontentandRNA dependentmanner.J.Appl.Physiol.104,1611.
oxidativedamageinskeletalmusclewithagingand 457. Poulsen,HEetal.(1996)Extremeexerciseandoxida-
disuseatrophy.Exp.Gerontol.43,563. tiveDNAmodification.J.SportsSci.14,343.
441. Talbert,EEetal.(2013)Immobilization-inducedacti- 458. Waring,WSetal.(2003)Uricacidreducesexercise-
vationofkeyproteolyticsystemsinskeletalmuscles inducedoxidativestressinhealthyadults.Clin.Sci.
ispreventedbyamitochondria-targetedantioxidant. 105,425.
J.Appl.Physiol.115,529. 459. Okamura,Ketal.(1997)Effectofenduranceexercise
442. Howard, C et al. (2007) Oxidative protein damage onthetissue8OHdGcontentindogs.FreeRadic.Res.
is associated with poor grip strength among older 26,523.
women living in the community. J. Appl. Physiol. 460. Sato,Yetal.(2003)IncreaseofhumanMTH1andde-
103,17. crease of 8OHdG in leukocyte DNA by acute and
443. Agostini,Fetal.(2010)Effectsofinactivityonhuman chronic exercise in healthy male subjects. Biochem.
muscleGSHsynthesisbyadouble-tracerandsingle- Biophys.Res.Commun.305,333.
biopsyapproach.J.Physiol.588,5089. 461. Goto,Cetal.(2003)Effectofdifferentintensitiesof
444. Semba,RDetal.(2007)Oxidativestressandsevere exerciseonendothelium-dependentvasodilationin
walkingdisabilityamongolderwomen.Am.J.Med. humans.Circulation108,530.
120,1084. 462. Arikawa, AY et al. (2013) Aerobic training reduces
445. Davies, KJA et al. (1982) Free radicals and tissue systemicoxidativestressinyoungwomenwithele-
damageproducedbyexercise.Biochem.Biophys.Res. vatedF2-IsoPs.Contemp.Clin.Trials34,212.
Commun.107,1198. 463. Lee, S et al. (2011) Mitochondrial H2O2 generated
446. Witt, EF et al. (1992) Exercise, oxidative damage from electron transport chain complex I stimulates
andeffectsofantioxidantmanipulation.J.Nutr.122 muscledifferentiation.CellRes.21,817.
(3Suppl.),766. 464. Gomez-Cabrera,MCetal.(2008)Oraladministration
447. Smith,JAetal.(1990)Exercise,trainingandneutrophil of vitamin C decreases muscle mitochondrial bio-
microbicidalactivity.Int.J.SportsMed.11,179. genesis and hampers training-induced adaptations
448. Leeuwenburgh, C and Heinecke, JW (2001) Oxida- inenduranceperformance.Am.J.Clin.Nutr.87,142.
tive stress and antioxidants in exercise. Curr. Med. 465. Sakellariou, GK et al. (2014) Redefining the major
Chem.8,829. contributorstoO
•–productionincontractingskeletal
2
449. Kuwahara,Hetal.(2010)Oxidativestressinskeletal muscle. The role of NAD(P)H oxidases. Free Radic.
muscle causes severe disturbance of exercise activ- Res.48,12.
itywithoutmuscleatrophy.FreeRadic.Biol.Med.48, 466. Fittipaldi,Setal.(2014)Roleofexercise-inducedROS
1252. inthemodulationofHspresponse.FreeRadic.Res.
450. Ristow,Metal.(2009)Antioxidantspreventhealth- 48,52.
promoting effects of physical exercise in humans. 467. Reid, MB et al. (1994) N-Acetylcysteine inhibits
Proc.Natl.Acad.Sci.USA106,8665. musclefatigueinhumans.J.Clin.Invest.94,2468.
•
451. Xie,Wetal.(2012)EffectofexercisetrainingonNO 468. Cobley, JNetal.(2015)InfluenceofvitaminCand
and O •
2
–/H2O2 signaling pathways in collateral- vitaminEonredoxsignalling:implicationsforexer-
dependent porcine coronary arterioles. J. Appl. ciseadaptation.FreeRadic.Biol.Med.84,65.
Physiol.112,1546. 469. Carr,ACetal.(2013)Humanskeletalmuscleascor-
452. Glesson,Metal.(2011)Theanti-inflammatoryeffects bate is highly responsive to changes in vitamin C
ofexercise:mechanismsandimplicationsforthepre- intakeandplasmaconcentrations.Am.J.Clin.Nutr.
ventionandtreatmentofdisease.Nat.Rev.Immunol. 97,800.
11,607. 470. Gliemann,Letal.(2013)Resveratrolbluntsthepos-
453. Mastaloudis,Aetal.(2004)Antioxidantsupplemen- itive effects of exercise training on cardiovascular
tationpreventsexercise-inducedlipidperoxidation, healthinagedmen.J.Physiol.591,5047.
butnotinflammation,inultramarathonrunners.Free 471. Handschin, Cand Spiegelman,BM (2008)The role
Rad.Biol.Med.36,1329. ofexerciseandPGC1αininflammationandchronic
454. Nikolaidis,MGetal.(2011)F2-IsoPformation,meas- disease.Nature454,463.
urementandinterpretation:theroleofexercise.Prog. 472. Brown, BM et al. (2013) Multiple effects of phys-
LipidRes.50,89. ical activity on molecular and cognitive signs of
455. Hellsten,Yetal.(1997)Oxidationofurateinhuman brain aging: can exercise slow neurodegeneration
skeletalmuscleduringexercise.FreeRadic.Biol.Med. and delay Alzheimer’s disease? Mol. Psychiatry
22,169. 18,864.

--- Page 817 ---

762 REFERENCES
Chapter8 Artemia parthenogenetica embryos during H2O2 ex-
posure.Biometals24,1035.
1. Cotruvo, JA and Stubbe, J (2011) Class I ribonuc-
20. Goodell,Betal.(2003)WoodDeteriorationandPreser-
leotidereductases:metallocofactorassemblyandre-
vation.ACSSymposiumSeries845,AmericanChem-
pair in vitro and in vivo. Annu. Rev. Biochem. 80,
icalSociety,WashingtonDC,USA.
733.
21. Kersten,PandCullen,D(2014)Curadicaloxidases
2. Guittet,Oetal.(2000)ONOO–-mediatednitrationof
and related extracellular oxidoreductases of wood-
the stable free radical tyrosine residue of the RNR
decayAgaricomycetes.FungalGenet.Biol.72,124.
smallsubunit.Biochemistry39,4640.
• 22. Demmess,Letal.(2011)Cellwalldamage-induced
3. Davies,BWetal.(2009)HydroxyureainducesOH -
lignin biosynthesis is regulated by a ROS- and jas-
mediatedcelldeathinE.coli.Mol.Cell.36,845.
monic acid-dependent process in Arabidopsis. Plant
4. Voevodskaya,Netal.(2009)Redoxintermediatesof
Physiol.156,1364.
theMn-FesiteinsubunitR2ofChlamydiatrachomatis
23. O’Brien,JAetal.(2012)ROSandtheirroleinplant
ribonucleotidereductase.J.Biol.Chem.284,4555.
defenceandcellwallmetabolism.Planta236,765.
5. Zhang,Yetal.(2010)Diphthamidebiosynthesisre-
24. Su, G et al. (2005) Light promotes the synthesis of
quires an organic radical generated by an Fe-S en-
zyme.Nature465,891.
lignin through the production of H2O2 mediated
bydiamineoxidasesinsoybeanhypocotyls.J.Plant
6. Arcinas,AJ,Booker,SJ(2011)Radicalbreak-up,bliss-
Physiol.162,1297.
fulmake-up.Nat.Chem.Biol.7,133.
25. LiuCJ(2012)Decipheringtheenigmaoflignification:
7. Wang,Jetal.(2014)RecentadvancesinradicalSAM
precursor transport, oxidation, and the topochem-
enzymology:newstructuresandmechanisms.ACS
istryofligninassembly.Mol.Plant5,304.
Chem.Biol.9,1929.
26. Bugg, TD etal. (2011)Pathwaysfordegradationof
8. Marsh, EN and Meléndez GD. (2012) Adenosylco-
lignininbacteriaandfungi.Nat.Prod.Rep.28,1883.
balamin enzymes: theory and experiment begin to •
27. Kirk,TKetal.(1985)FreeOH isnotinvolvedinan
converge.Biochim.Biophys.Acta1824,1154.
importantreactionoflignindegradationbyPhanero-
9. Buckel,W(2013)Bacterialmethanogenesisproceeds
chaetechrysosporiumBurds.Biochem.J.226,455.
by a radical mechanism. Angew. Chem. Int. Ed. 52,
28. Vieira,Jetal.(2012)Advancesintheknowledgeof
8507.
light emission by firefly luciferin and oxyluciferin.
10. Benjdia, A (2012) DNA photolyases and SP lyase:
J.Photochem.Photobiol.B.117,33.
structureandmechanismoflight-dependentandin-
29. Kuse, M et al. (2008) Pholasin luminescence is en-
dependentDNAlyases. Curr.Opin. Struct.Biol. 22,
hancedbyadditionofdehydrocoelenterazine.Bioorg.
711.
Med.Chem.Lett.18,5657.
11. Shisler, KA and Broderick, JB (2014) Glycyl rad-
30. Bassot,JMandNicolas,MT(1995)Bioluminescence
ical activating enzymes: structure, mechanism, and
in scale-worm photosomes: the photoprotein poly-
substrateinteractions.Arch.Biochem.Biophys.546,64.
noidinisspecificforthedetectionofO
•–.Histochem.
12. Reed, GH et al. (2012) Radical reactions of TPP 2
CellBiol.104,199.
in 2-oxoacid oxidoreductases. Biochim. Biophys Acta
31. Rota,E(2009)Lightsontheground:ahistoricalsur-
1824,1291.
veyoflightproductionintheOligochaeta.In:Meyer-
13. Rokhsana,Detal.(2012)RoleoftheTyr-Cyscross-
Rochow,VB(ed),Bioluminescenceinfocus,Research
linktotheactivesitepropertiesofgalactoseoxidase.
Signpost,Trivandrum,Kerala,India,105.
Inorg.Chem.51,3513.
32. Janssens, BJ et al. (2002) Protection of peroxide-
14. Millet,ESetal.(2012)Heme-containingdioxygenases
treated fish erythrocytes by coelenterazine and
involvedintryptophanoxidation.Curr.Opin.Chem.
coelenteramine.FreeRadic.Res.36,967.
Biol.16,60.
15. Maghazal,GJetal.(2008)Cytochromeb5,notO •
2
–,is 33. T
ch
o
r
lb
o
e
m
rt
o
,
p
L
h
M
or
e
e
ta
e
l
m
.(2
is
0
s
1
io
2)
n
C
t
o
h
l
r
l
o
ap
u
s
g
e
h
a
t
n
o
d
p
r
o
e
l
c
o
o
g
v
ic
e
a
r
l
y
e
o
f
f
f
G
ec
F
ts
P
.
amajorreductantofindoleamine2,3-dioxygenasein
Acc.Chem.Res.45,171.
humancells.J.Biol.Chem.283,12014.
34. Nathan,CandCunningham-Bussel,A(2013)Beyond
16. James,Aetal.(2013)Amathematicalmodelofthe
oxidative stress: an immunologist’s guide to ROS.
defencemechanismofabombardierbeetle.J.R.Soc.
Nat.Rev.Immunol.13,349.
Interface10,20120801.
35. Strowig,Tetal.(2012)Inflammasomesinhealthand
17. Wong,JLandWessel,GM(2005)ROSandUdx1dur-
disease.Nature481,278.
ing early sea urchin development. Dev. Biol. 288,
36. Gomes,LHetal.(2013)S100A8andS100A9–oxidant
317.
scavengersininflammation.FreeRadic.Biol.Med.58,
18. Lambeth,JDandNeishAS(2014)Noxenzymesand
170.
newthinkingonreactiveO2:adouble-edgedsword
37. Renné,Tetal.(2012)InvivorolesoffactorXII.Blood
revisited.Annu.Rev.Pathol.9,119.
120,4296.
19. Veeramani, S and Baskaralingam, V (2011) Shell-
• 38. Nathan,CandDing,A(2010)Nonresolvinginflam-
bound Fe dependent NO synthesis in encysted
mation.Cell140,871.

--- Page 818 ---

REFERENCES 763
39. Yoo,SAetal.(2011)Lynisaredoxsensorthatmedi- 58. Fletcher,MPandSeligmann,BE(1986)PMNhetero-
atesleukocytewoundattractioninvivo.Nature480, geneity:long-termstabilityoffluorescentmembrane
109. potentialresponsestothechemoattractantf-met-leu-
40. Deng,Qetal.(2012)Distinctsignallingmechanisms phe in healthy adults and correlation with respira-
mediate neutrophil attraction to bacterial infection toryburstactivity.Blood68,611.
andtissueinjury.Cell.Microbiol.14,517. 59. Geering,Betal.(2013)Livinganddyingforinflam-
41. Sakai,Jetal.(2012)ROS-inducedactinglutathionyla- mation: neutrophils, eosinophils, basophils. Trends
tioncontrolsactindynamicsinneutrophils.Immunity Immunol.34,398.
37,1037. 60. Lamb, FS et al. (2012) Endotoxin priming of neu-
42. Hattori,Hetal.(2010)Small-moleculescreenidenti- trophilsrequiresendocytosisandNADPHoxidase-
fiesROSaskeyregulatorsofneutrophilchemotaxis. dependentendosomeROS.J.Biol.Chem.287,12395.
Proc.Natl.Acad.Sci.USA107,3546. 61. vandeVeerdonk,FLetal.(2010)ROS-independent
43. Sica,AandMantovani,A(2012)Macrophageplas- activation of the IL-1β inflammasome in cells from
ticityandpolarization:invivoveritas.J.Clin.Invest. patients with CGD. Proc. Natl. Acad. Sci. USA 107,
122,787. 3030.
44. Cambos, M and Scorza, T (2011) Robust erythro- 62. Parker,Hetal.(2012)RequirementsforNADPHoxi-
phagocytosis leads to macrophage apoptosis via a daseandMPOinNETformationdifferdepending
hemin-mediatedredoximbalance:roleinhemolytic onthestimulus.J.Leukoc.Biol.92,841.
disorders.J.Leukoc.Biol.89,159. 63. Edwards,SWandLloyd,D(1988)Therelationship
45. Kolackowska,EandKubes,P(2013)Neutrophilre- between O •
2
– generation, cytochrome b and O2 in
cruitmentandfunctioninhealthandinflammation. activatedneutrophils.FEBSLett.227,39.
Nat.Rev.Immunol.13,159. 64. Gabig,TGetal.(1979)EffectsofO2tensionandpH
46. Mayadas,TNetal.(2014)Themultifacetedfunctions ontherespiratoryburstofhumanneutrophils.Blood
ofneutrophils.Annu.Rev.Pathol.Mech.Dis.9,181. 53,1133.
47. Yuan,SYetal.(2012)Neutrophiltransmigration,fo- 65. Frasca, L and Lande, R (2012) Role of defensins
caladhesionkinaseandendothelialbarrierfunction. and cathelicidin LL37 in auto-immune and auto-
Microvas.Res.83,82. inflammatory diseases. Curr. Pharm. Biotechnol. 13,
48. Zhao, T and Bokoch, GM (2005) Critical role of 1882.
proline-rich tyrosine kinase 2 in reversion of the 66. Pignatelli,Petal.(2011)Inheritedhumangp91phoxde-
adhesion-mediated suppression of ROS generation ficiencyisassociatedwithimpairedIsoPformation
byhumanneutrophils.J.Immunol.174,8049. and platelet dysfunction. Arterioscler. Thromb. Vasc.
49. Manicone,AMetal.(2009)Matrilysin(MMP-7)regu- Biol.31,423
lates anti-inflammatory and antifibrotic pulmonary 67. Loffredo,Letal.(2013)DoesNOXdeficiencycause
dendritic cells that express CD103 (α e β 7-integrin). arterydilatationinhumans?Antioxid.RedoxSignal.
Am.J.Pathol.175,2319. 18,1491.
50. Shapiro,SD(2003)Mobilizingthearmy.Nature421, 67A. Sibley,CTetal.(2014)Assessmentofatherosclerosis
223. in chronic granulomatous disease. Circulation 130,
51. Arnhold,JandFlemmig,J(2010)HumanMPOinin- 2031.
nateandacquiredimmunity.Arch.Biochem.Biophys. 68. Namangala,B(2011)Contributionofinnateimmune
500,92. responses towards resistance to African trypano-
52. Weylandt,KTetal.(2012)Omega-3fattyacidsand someinfections.Scand.J.Immunol.75,5.
their lipid mediators: towards an understanding 69. Segal,BHetal.(2000)XOcontributestohostdefense
ofresolvingandprotectinformation.Prostaglandins againstBurkholderiacepaciainthep47phox–/– mouse
OtherLipidMediat.97,73. modelofCGD.Infect.Immun.68,2374.
53. McNally,AKandAnderson,JM(2011)Macrophage 70. Wang,Fetal.(2011)Theserumofrabbitfish(Siganus
fusion and multinucleated giant cells of inflamma- oramin)hasantimicrobialactivitytosomepathogenic
tion.Adv.Exp.Med.713,97. organismsandanovelserumL-aminoacidoxidase
54. Boef,AGCetal.(2012)Theinfluenceofgeneticvari- isisolated.FishShellfishImmunol.30,1095.
ationoninnateimmuneactivationinanenvironment 71. Repine,JEetal.(1981)H2O2killsS.aureusbyreact-
•
withhighinfectiouspressure.GenesImmun.13,103. ingwithstaphylococcalFetoformOH .J.Biol.Chem.
55. Hurst,JK(2012)Whatreallyhappensintheneutro- 256,7094.
philphagosome?FreeRadic.Biol.Med.53,508. 72. Francis, N et al. (2011) Lactoferrin inhibits neutro-
56. Winterbourn,CCandKettle,AJ(2012)Redoxreac- phil apoptosis via blockade of proximal apoptotic
tionsandmicrobialkillingintheneutrophilphago- signalingevents.Biochim.Biophys.Acta1813,1822.
some.Antioxid.RedoxSignal.18,642. 73. Nathan,CandShiloh,MU(2000)ReactiveO2andN2
57. Standish,AJandWeiser,JN(2009)Humanneutro- intermediatesintherelationshipbetweenmamma-
phils kill Streptococcus pneumoniae via serine prote- lianhostsandmicrobialpathogens.Proc.Natl.Acad.
ases.J.Immunol.183,2602. Sci.USA97,8841.

--- Page 819 ---

764 REFERENCES
74. Schneemann, M and Schoeden, G (2007) Macro- 92. Nakamura,Hetal.(2012)PEGylatedD-aminoacid
phagebiologyandimmunology:manisnotamouse. oxidaserestoresbactericidalactivityofneutrophilsin
J.Leuk.Biol.81,579. CGDviaOCl–.Exp.Biol.Med.237,703.
75. Rosen, H et al. (2002) Human neutrophils use the 93. Metzler,KDetal.(2011)MPOisrequiredforNETfor-
MPO-H2O2-Cl– systemtochlorinatebutnotnitrate mation:implicationsforinnateimmunity.Blood117,
bacterialproteinsduringphagocytosis.J.Biol.Chem. 953.
277,30463. 94. Hamers,MNetal.(1984)Kineticsandmechanismof
76. Wheeler,MAetal.(1997)Bacterialinfectioninduces thebactericidalactionofhumanneutrophilsagainst
NOSinhumanneutrophils.J.Clin.Invest.99,110. E.coli.Blood64,635.
77. Cunningham-Bussel,Aetal.(2013)NO–producedby 95. Chapman, ALP et al. (2002) Chlorination of bacter-
2
M.tuberculosisinhumanmacrophagesinphysiolo- ialandneutrophilproteinsduringphagocytosisand
gicO2impactsbacterialATPconsumptionandgene killingofS.aureus.J.Biol.Chem.277,9757.
expression.Proc.Natl.Acad.Sci.USA110,E4256. 96. Galijasevic,Setal.(2006)MPOmetabolizesCNS–in
•
78. Rothfork, JM et al. (2004) Inactivation of a bacter- areactiondrivenbyNO .Biochemistry45,1255.
ial virulence pheromone by phagocyte-derived ox- 97. Li,Hetal.(2012)Vascularperoxidase1catalyzesthe
idants: new role for the NADPH oxidase in host formationofhypohalousacids:characterizationofits
defense.Proc.Natl.Acad.Sci.USA101,13867. substrate specificity and enzymatic properties. Free
79. Liu,FCetal.(2014)RoleofNETsfollowinginjury. Radic.Biol.Med.53,1954.
Shock41,491. 98. Péterfi, Z and Geiszt,M (2014)Peroxidasins: novel
80. Staudinger,BJetal.(2002)mRNAexpressionprofiles playersintissuegenesis.TrendsBiochem.Sci.39,305.
forE.coliingestedbynormalandphagocyteoxidase- 99. Kumar, S et al. (2004) Inducible peroxidases medi-
deficienthumanneutrophils.J.Clin.Invest.110,1151. ate nitration of Anopheles midgut cells undergoing
81. O’Rourke,EJetal.(2003)PathogenDNAasatarget apoptosisinresponsetoPlasmodiuminvasion.J.Biol.
forhost-generatedoxidativestress:roleforrepairof Chem.279,53475.
bacterialDNAdamageinH.pyloricolonization.Proc. 100. Small,ALandMcFall-Ngai,MJ(1999)Halideperox-
Natl.Acad.Sci.USA100,2789. idaseintissuesthatinteractwithbacteriainthehost
82. DeGroote,MAetal.(1997)PeriplasmicSODprotects squidEuprymnascolopes.J.Cell.Biochem.72,445.
Salmonella from products of phagocyte NADPH- 101. Dale, DC et al. (2008) The phagocytes: neutrophils
oxidase and NOS. Proc. Natl. Acad. Sci. USA 94, andmonocytes.Blood112,935.
13997. 102. Wang, JG and Slungaard, A (2006) Role of EPO in
83. Liu,GYetal.(2005)S.aureusgoldenpigmentimpairs host defense and disease pathology. Arch. Biochem.
neutrophil killing and promotes virulence through Biophys.445,256.
itsantioxidantactivity.J.Exp.Med.202,209. 103. Yousefi,Setal.(2012)EosinophilextracellularDNA
84. Parker, A et al. (2011) Roles of O
•–and
MPO in traps:molecularmechanismsandpotentialrolesin
2
ascorbate oxidation in stimulated neutrophils and disease.Curr.Opin.Immunol.24,736.
H2O2-treated HL60 cells. Free Radic. Biol. Med. 51, 104. Rosenberg, HF et al. (2013) Eosinophils: changing
1399. perspectivesinhealthanddisease.Nat.Rev.Immunol.
85. Suquet,Cetal.(2010)ComparativestudyofHOCl- 13,9.
inflicteddamagetobacterialDNAexvivoandwithin 105. Tarr, M and Valenzeno, DP (2003) Singlet O2: the
cells.Arch.Biochem.Biophys.493,135. relevanceofextracellularproductionmechanismsto
86. Burner, U et al. (1999) Transient and steady-state oxidative stress in vivo. Photochem. Photobiol. Sci. 2,
kineticsoftheoxidationofsubstitutedbenzoicacid 355.
hydrazidesbyMPO.J.Biol.Chem.274,9494. 106. Kanofsky,JRetal.(1988)SingletO2 productionby
87. Forbes,LVetal.(2012)Isoniazidasasubstrateandin- humaneosinophils.J.Biol.Chem.263,9692.
hibitorofMPO;identificationofamineadductsand 107. Ulrich, M et al. (2008) Post-translational tyro-
the influence of SOD on their formation. Biochem. sine nitration of eosinophil granule toxins medi-
Pharmacol.84,949. ated by eosinophil peroxidase. J. Biol. Chem. 283,
88. Maitra,Detal.(2013)MPOactsasasourceoffreeFe 28629.
duringsteady-statecatalysisbyafeedbackinhibitory 108. Nakagawa,Tetal.(2001)Eosinophilicperoxidasede-
pathway.FreeRadic.Biol.Med.63,90. ficiency:identificationofapointmutation(D648N)
89. Learn,DBetal.(1990)Taurineandhypotaurinecon- andpredictionofstructuralchanges.Hum.Mutat.17,
tentofhumanleukocytes.J.Leuk.Biol.48,174. 235.
90. Aruoma, OI et al. (1988) The antioxidant action of 109. Inoue, T et al. (2008) ROS produced up- or down-
taurine,hypotaurineandtheirmetabolicprecursors. streamofCa2+influxregulatepro-inflammatoryme-
Biochem.J.256,251. diator release from mast cells: role of NOX and
91. Schwartz, J et al. (2009) Neutrophil bleaching of mitochondria.Biochim.Biophys.Acta.1783,789.
GFP-expressingstaphylococci:probingtheintrapha- 110. Cˇíž,MandLojek,A(2013)Modulationofneutrophil
gosomalfateofindividualbacteria.J.Immunol.183, oxidative burst via histamine receptors.Br. J. Phar-
2632. macol.170,17.

--- Page 820 ---

REFERENCES 765
111. Cregar,Letal.(1999)NeutrophilMPOisapotentand 129. Hazen, SL et al. (1998) Human neutrophils employ
selectiveinhibitorofmastcelltryptase.Arch.Biochem. theMPO-H2O2-Cl–systemtooxidizeα-aminoacids
Biophys.366,125. toafamilyofreactivealdehydes.J.Biol.Chem.273,
112. Mantegazza,AR etal. (2008)NADPHoxidasecon- 4997.
trolsphagosomalpHandantigencross-presentation 130. Barletta, KE et al. (2012) Regulation of neutrophil
inhumandendriticcells.Blood112,4712. functionbyadenosine.Arterioscler.Thromb.Vasc.Biol.
113. Segal,BHetal.(2012)Regulationofinnateimmunity 32,856.
byNADPHoxidase.FreeRadic.Biol.Med.53,72. 131. Fliss, H et al. (1983) Oxidation of methionine res-
114. Holmdahl,Retal.(2012)H2O2asanimmunological idues in proteins of activated human neutrophils.
transmitterregulatingautoreactiveTcells.Antioxid. Proc.Natl.Acad.Sci.USA80,7160.
•
RedoxSignal.18,1463. 132. deRojas-Walker,Tetal.(1995)NO inducesoxidative
115. Lam,GYandBrumell,JH(2010)Themanyrolesof damageinadditiontodeaminationinmacrophage
NOX2 -derived ROS in immunity. Semin. Immuno- DNA.Chem.Res.Toxicol.8,473.
pathol.32,415. 133. Pietarinen-Runtti,Petal.(2000)Expressionofanti-
116. Vandivier,RWetal.(2002)Elastase-mediatedphos- oxidantenzymesinhumaninflammatorycells.Am.
phatidylserine receptor cleavage impairs apoptotic J.Physiol.278,C118.
cell clearance in cystic fibrosis and bronchiectasis. 134. Ambruso, DR et al. (2012) Prx6 translocates to the
J.Clin.Invest.109,661. plasmamembraneduringneutrophilactivationand
117. Wasil,Metal.(1987)Theantioxidantactionofhu- is required for optimal NOX activity. Biochim. Bio-
manECfluids.Effectofhumanserumanditsprotein phys.Acta1823,306.
componentsontheinactivationofα 1-antiproteinase 135. Yan,Jetal.(2013)Glutathionereductaseisessential
byHOClandbyH2O2.Biochem.J.243,219. forhostdefenseagainstbacterialinfection.FreeRadic.
118. Wu,SMandPizzo,SV(2001)α 2-Macroglobulinfrom Biol.Med.61,320.
RAsynovialfluid:functionalanalysisdefinesarole 136. Lee,Cetal.(2000)Biphasicregulationofleukocyte
foroxidationininflammation.Arch.Biochem.Biophys. O •– generation by NO • and ONOO–. J. Biol. Chem.
2
391,119 275,38965.
119. Whiteman, M and Halliwell, B (1996) Protection 137. van der Veen, RC et al. (2000) O
•–
prevents NO
•
-
2
against ONOO–-dependent tyrosine nitration and mediatedsuppressionofhelperTlymphocytes:de-
α 1-antiproteinaseinactivationbyascorbicacid.Free creasedautoimmuneencephalomyelitisinNADPH
Radic.Res.25,275. oxidaseknockoutmice.J.Immunol.164,5177.
120. Lim, SY et al. (2011) Oxidative modifications 138. Van Brussel, I et al. (2012) Transcript and protein
of DAMPs suppress inflammation: the case for analysis reveals better survival skills of monocyte-
S100A8andS100A9.Antioxid.RedoxSignal.15,2235. deriveddendriticcellscomparedtomonocytesdur-
121. Venereau, E et al. (2012) Mutually exclusive redox ingoxidativestress.PLoSOne7,e43357.
formsofHMGB1promotecellrecruitmentorproin- 139. Bauer, M et al. (2012) Human monocytes undergo
flammatorycytokinerelease.J.Exp.Med.209,1519. excessive apoptosis following temozolomide ac-
122. Gresnigt,MSetal.(2012)Neutrophil-mediatedinhib- tivating the ATM/ATR pathway while dendritic
itionofproinflammatorycytokineresponses. J.Im- cells and macrophages are resistant. PLoS One, 7,
munol.189,4806. e39956.
123. Boueiz, A and Hassoun, PM (2009) Regulation of 140. Cao, W et al. (2014) Oxidized lipids block antigen
endothelialbarrierfunctionbyRONS.Microvasc.Res. cross-presentationbydendriticcellsincancer.J.Im-
77,26. munol.192,2920.
124. Steinhauser,MLetal.(1998)Macrophage/fibroblast 141. Takemoto,Yetal.(2011)Biocompatibilityofthedia-
coculture induces MIP1α production mediated lysismembrane.Contrib.Nephrol.168,139.
by ICAM-1 and oxygen radicals. J. Leuk. Biol. 142. Piroddi, M et al. (2012) Vitamin E as a functional
64,636. andbiocompatibilitymodifierofsynthetichemodia-
125. DeForge, LE et al. (1993) Regulation of IL-8 gene lyzer membranes: an overview of the literature on
expressionbyoxidantstress.J.Biol.Chem.268,25568. vitaminE-modifiedhemodialyzermembranes.Am.
126. Kanayama,Aetal.(2002)OxidationofIκBα atmet J.Nephrol.35,559.
45isonecauseoftaurinechloramines-inducedinhib- 143. Sutherland,Ketal.(1993)Degradationofbiomater-
itionofNF-κBactivation.J.Biol.Chem.277,24049. ialsbyphagocyte-derivedoxidants.J.Clin.Invest.92,
127. Matata,BMandGaliñanes,M(2002)ONOO– isan 2360.
essentialcomponentofcytokinesproductionmech- 144. Christian, AJ et al. (2014) The susceptibility of
anisminhumanmonocytesthroughmodulationof bioprosthetic heart valve leaflets to oxidation. Bio-
NF-κBDNAbindingactivity.J.Biol.Chem.277,2330. materials35,2097.
128. Curzio, M (1988) Interaction between neutrophils 145. Nussbaum,Cetal.(2013)MPO:aleukocyte-derived
and4-hydroxyalkenalsandconsequencesonneutro- protagonistofinflammationandcardiovasculardis-
philmotility.FreeRadic.Res.Commun.5,55. ease.Antioxid.RedoxSignal.18,692.

--- Page 821 ---

766 REFERENCES
146. Zhang,Retal.(2002)MPOfunctionsasamajoren- 162. Achard, ME et al. (2013) An antioxidant role for
zymaticcatalystforinitiationoflipidperoxidationat catecholate siderophores in Salmonella. Biochem. J.
sitesofinflammation.J.Biol.Chem.277,46116. 454,543.
147. Ruldolph, TK et al. (2010) Liberation of vessel ad- 163. García-Rodas, R and Zaragoza, O (2012) Catch me
herent MPO by enoxaparin improves endothelial if you can: phagocytosis and killing avoidance by
function.Int.J.Cardiol.140,42 Cryptococcusneoformans.FEMSImmunol.Med.Micro-
148. Milla, C et al. (2004) MPO deficiency enhances in- biol.64,147.
flammationafterallogenicmarrowtransplantation. 164. Pham,NKetal.(2005)Leishmaniapifanoiamastigotes
Am.J.Physiol.287,L706. avoid macrophage production of O
•–
by inducing
2
149. Takizawa,Setal.(2002)DeficiencyofMPOincreases hemedegradation.Infect.Immun.73,8322.
infarctvolumeandnitrotyrosineformationinmouse 165. Thammavongsa, V et al. (2013) S. aureus degrades
brain.J.Cereb.BloodFlowMetab.22,50. NETstopromoteimmunecelldeath.Science342,863.
150. Odobasic,Detal.(2013)NeutrophilMPOregulates 166. Mohapatra, NP et al. (2010) Francisella acid phos-
T-cell-driventissueinflammationinmicebyinhibit- phatases inactivate the NADPH oxidase in human
ingdendriticcellfunction.Blood121,4195. phagocytes.J.Immunol.184,5141.
151. Kim,CandCha,YN(2014)Taurinechloraminespro- 167. Carlyon,JAandFikrig,E(2006)Mechanismsofeva-
duced from taurine under inflammation provides sionofneutrophilkillingbyAnaplasmaphagocytophi-
anti-inflammatoryandcytoprotectiveeffects.Amino lum.Curr.Opin.Hematol.13,28.
Acids46,89. 168. Allen,LAHetal.(2005)H.pylori disruptsNADPH
152. Balish, E et al. (2005) Susceptibility of germfree oxidase targeting in human neutrophils to induce
phagocyteoxidase-andNOS2-deficientmice,defect- extracellularO
•–release.J.Immunol.174,3658.
2
iveintheproductionofreactivemetabolitesofboth 169. Raynaud, C et al. (1998) Extracellular enzyme ac-
O2 andN2,tomucosalandsystemiccandidiasisof tivitiespotentiallyinvolvedinthepathogenicityof
endogenousorigin.Infect.Immun.73,1313. M.tuberculosis.Microbiol.144,577.
153. Haneklaus,Metal.(2013)Modulatorymechanisms 170. Cybulski,RJJretal.(2009)FourSODscontributeto
controlling the NLRP3 inflammasome in inflam- Bacillusanthracisvirulenceandprovidesporeswith
mation: recent developments. Curr. Opin. Immunol. redundant protection from oxidative stress. Infect.
25,40. Immun.77,274.
154. Pizzolla, A et al. (2011) CD68-expressing cells can 171. Lassègue, B et al. (2012) Biochemistry, physiology,
primeTcellsandinitiateautoimmunearthritisinthe and pathophysiology of NADPH oxidases in the
absenceofROS.Eur.J.Immunol.41,403. cardiovascularsystem.Circ.Res.110,1364.
155. Gao,XPetal.(2002)RoleofNADPHoxidaseinthe 172. Suzuki,Netal.(2011)Respiratoryburstoxidases:the
mechanismoflungneutrophilsequestrationandmi- enginesofROSsignaling.Curr.Opin.PlantBiol.14,
crovessel injury induced by gram-negative sepsis: 691.
studiesinp47phox–/–andgp91phox–/–mice.J.Immunol. 173. Lardy, B et al. (2005) NADPH oxidase homologs
168,3974. are required for normal cell differentiation and
156. Ross, AD et al. (2004) Enhancement of collagen- morphogenesisinDictyosteliumdiscoideum.Biochim.
induced arthritis in mice genetically deficient in Biophys.Acta1744,199.
ECSOD.Arth.Rheum.50,3702. 174. Razzell,Wetal.(2013)Ca2+ flashesorchestratethe
157. Kelkka,Tetal.(2012)SOD-3limitscollagen-induced woundinflammatoryresponsethroughDUOXacti-
arthritisintheabsenceofphagocyteoxidativeburst. vationandH2O2release.Curr.Biol.23,424.
MediatorsInflamm.2012,730169. 175. Takac,Ietal.(2011)TheE-loopisinvolvedinH2O2
158. Halliwell,B(2004)Ageinganddisease:fromDarwin- formation by the NADPH oxidase Nox4. J. Biol.
ianmedicinetoantioxidants?Innovation4,12. Chem.286,13304.
159. Flannagan,RSetal.(2009)Antimicrobialmechanisms 176. Thabut,Getal.(2002)TNFαincreasesairwaysmooth
ofphagocytesandbacterialevasionstrategies.Nat. muscle oxidants production through a NADPH
Rev.Microbiol.7,355. oxidase-like system to enhance myosin light chain
160. Benov,LandFridovich,I(1996)E.coliexhibitsnega- phosphorylationandcontractility.J.Biol.Chem.277,
tive chemotaxis in gradients of H2O2, OCl-, and 22814.
N-chlorotaurine: products of the respiratory burst 177. Tam,NNCetal.(2003)Androgenicregulationofoxi-
of phagocytic cells. Proc. Natl. Acad. Sci. USA 93, dative stress in the rat prostate. Am. J. Pathol. 163,
4999. 2513.
161. Coméra,Cetal.(2007)GliotoxinfromAspergillusfu- 178. Tammariello, SP et al. (2000) NADPH oxidase con-
migatusaffectsphagocytosisandtheorganizationof tributesdirectlytooxidativestressandapoptosisin
theactincytoskeletonbydistinctsignalingpathways NGF-deprivedsympatheticneurons.J.Neurosci.20,
inhumanneutrophils.MicrobesInfect.9,47. RC53.

--- Page 822 ---

REFERENCES 767
179. Wilkinson-Berka, JL et al. (2014) NADPH oxidase, 197. Wilkinson-Berka,JLetal.(2013)ROS,Noxandangio-
NOX1,mediatesvascularinjuryinischemicretinop- tensin II in angiogenesis: implications for retinop-
athy.Antioxid.RedoxSignal.20,2726. athy.Clin.Sci.124,597.
180. Spencer,NYetal.(2011)Controlofhepaticnuclear 198. Briones,AMandTouyz,RM(2009)Moderateexer-
O
•–productionbyG6PDHandNOX4.J.Biol.Chem.
cisedecreasesinflammationandoxidativestressin
2
286,8977. hypertension:butwhatarethemechanisms?Hyper-
181. Allaoui, A et al. (2009) Dual oxidases and H2O2 tension54,1206.
in a complex dialogue between host mucosae and 199. Savalia, K et al. (2014) Neuronal uptake of nano-
bacteria.TrendsMol.Med.15,571. formulated SOD and attenuation of angiotensin II-
182. Strengeri,Metal.(2014)MucosalROSarerequired dependenthypertensionaftercentraladministration.
for antiviral response: role of Duox in influenza A FreeRadic.Biol.Med.73,299.
virusinfection.Antioxid.RedoxSignal.20,2695. 200. Dikalova, AE et al. (2010) Therapeutic targeting of
183. Jones, RM et al. (2013) Symbiotic lactobacilli stim- mitochondrial O
•–
in hypertension. Circ. Res. 107,
2
ulate gut epithelial proliferation via Nox-mediated 106.
generationofROS.EMBOJ.32,3017. 201. Kirabo,Aetal.(2014)DCisoketal-modifiedproteins
184. Esworthy,RSetal.(2014)Nox1causesileocolitisin activate T cells and promote hypertension. J. Clin.
micedeficientinGPx1and–2.FreeRadic.Biol.Med. Invest.124,4642.
68,315. 202. Yang,Yetal.(2013)ROSintheimmunesystem.Int.
185. Kamata,T(2009)RolesofNox1andotherNoxiso- Rev.Immunol.32,249.
formsincancerdevelopment.CancerSci.100,1382. 203. Kwon,Jetal.(2010)ThenonphagocyticNOXDuox1
186. Laurent, E et al. (2008) Nox1 is over-expressed in mediatesapositivefeedbackloopduringTcellre-
humancoloncancersandcorrelateswithactivating ceptorsignaling.SciSignal.3,ra59.
mutationsinK-Ras.Int.J.Cancer.123,100. 204. Hara-Chikuma, M et al. (2012) Chemokine-
187. Doroshow,JHetal.(2013)Effectsofiodonium-class dependent T cell migration requires
flavindehydrogenaseinhibitorsongrowth,ROSpro- aquaporin-3-mediated H2O2 uptake. J. Exp. Med.
duction, cell cycle progression, NOX1 levels, and 209,1743.
gene expression in human colon cancer cells and 205. Sedeek,Metal.(2013)NADPHoxidases,ROS,and
xenografts.FreeRadic.Biol.Med.57,162. the kidney: friend and foe. J. Am. Soc. Nephrol. 24,
188. DeDeken,Xetal.(2014)RolesofDUOX-mediated 1512.
H2O2 in metabolism, host defense, and signaling. 206. Tucker,PS etal.(2013)Clinicalandresearchmark-
Antioxid.RedoxSignal.20,2776. ers of oxidative stress in chronic kidney disease.
189. Alam, A et al. (2014) Redox signaling regulates Biomarkers18,103.
commensal-mediatedmucosalhomeostasisandres- 207. Jun,Metal.(2012)Antioxidantsforchronickidney
titutionandrequiresformylpeptidereceptor1.Mu- disease.CochraneDatabaseSystRev.10:CD008176.
cosalImmunol.7,645. 208. Himmelfarb,J etal.(2014)Provisionofantioxidant
190. Maier,Jetal.(2006)DNAdamageandspontaneous therapyinhemodialysis(PATH):arandomizedclin-
mutagenesisinthethyroidglandofratsandmice. icaltrial.J.Am.Soc.Nephrol.25,623.
Endocrinol.147,3391. 209. Hawkins,CL(2014)Roleofcyanateintheinduction
191. Küpper, FC et al. (2011) Commemorating two cen- of vascular dysfunction during uremia: more than
turiesofI–research:aninterdisciplinaryoverviewof proteincarbamylation?KidneyInt.86,875.
currentresearch.Angew.Chem.Int.Ed.50,11598. 210. Abboud,HE(2012)Mesangialcellbiology.Exp.Cell
192. Moribe, H et al. (2012) Tetraspanin is required for Res.318,979.
generationofROSbytheDUOXsysteminC.elegans. 211. Ooi, JD et al. (2012) The immunodominant MPO
PLoSGenetics8,e1002957. T-cell epitope induces local cell-mediated injury in
193. Malik, UZ et al. (2011) Febuxostat inhibition of anti-MPO glomerulonephritis. Proc. Natl. Acad. Sci.
endothelial-bound XO: implications for targeting USA109,E2615.
vascular ROS production. Free Radic. Biol. Med. 51, 212. Cowley, AW Jr (2008) Renal medullary oxidative
179. stress,pressure-natriuresis,andhypertension.Hyper-
194. Schröder, K et al. (2012) Nox4 is a protective ROS- tension52,777.
generatingvascularNADPHoxidase.Circ.Res.110, 213. Guo,Wetal.(2003)Quantitativeassessmentoftyro-
1217. sinenitrationofMnSODinangiotensinII-infusedrat
195. Matlung,HLetal.(2009)Shearstress,ROS,andarter- kidney.Am.J.Physiol.285,H1396.
ialstructureandfunction.Antioxid.RedoxSignal.11, 214. Shimada, K et al. (2011) ROS generation via
1699. NOX4anditsutilityinthecytologicaldiagnosisof
196. Liu,CCetal.(2013)Oxidativeinhibitionofthevas- urothelial carcinoma of the urinary bladder. BMC
cularNa+-K+pumpviaNOX-dependentβ 1-subunit Urology11,22.
glutathionylation: implications for angiotensin II- 215. Kazemian, P et al. (2001) Respiratory control in
inducedvasculardysfunction.FreeRadic.Biol.Med. neonatal mice with NOX deficiency. Respir. Physiol.
65,563. 126,89.

--- Page 823 ---

768 REFERENCES
216. Ferroni,Petal.(2012)Plateletfunctioninhealthand 234. Zhou, J et al. (2014) RBOH1-dependent H2O2 pro-
disease:frommolecularmechanism,redoxconsider- ductionandsubsequentactivationofMPK1/2play
ations to novel therapeutic opportunities. Antioxid. an important role in acclimation-induced cross-
Redox.Signal.17,1447. toleranceintomato.J.Exp.Biol.65,595.
217. Jang, JY et al. (2014) ROS play a critical role in 235. Baxter, A et al. (2014) ROS as key players in plant
collagen-inducedplateletactivationviaSHP-2oxida- stresssignalling.J.Exp.Bot.65,1229.
tion.Antioxid.RedoxSignal.20,2528. 236. Afiyanti, M and Chen JH (2014) Catalase activity
218. Sabetkar, M et al. (2008) The nitration of plate- is modulated by Ca2+ and calmodulin in detached
letvasodilator-stimulatedphosphoproteinfollowing matureleavesofsweetpotato.J.PlantPhysiol.171,
exposuretolowconcentrationsofH2O2.Platelets19, 35.
282. 237. Toivonen, PM et al. (2012) Modulation of wound-
219. Eliades, A et al. (2012) Oxidases and ROS during inducedH2O2anditsinfluenceonthefateofE.coli
haematopoiesis:afocusonmegakaryocytes.J.Cell. O157:H7incutlettucetissues.J.FoodProtect.75,2208.
Physiol.227,3355. 238. Denness,Letal.(2011)Cellwalldamage-inducedlig-
220. Mandal,CCetal.(2011)ROSderivedfromNox4me- ninbiosynthesisisregulatedbyaROSandjasmonic
diateBMP2genetranscriptionandosteoblastdiffer- acid-dependentprocessinArabidopsis.PlantPhysiol.
entiation.Biochem.J.433,393. 156,1364.
221. Kim, MS et al. (2010) RANKL-mediated ROS path- 239. Flors,Cetal.(2006)Imagingtheproductionof1O2
waythatinduceslonglastingCa2+oscillationsessen- in vivo using a new fluorescent sensor, 1O2 sensor
tialforosteoclastogenesis.J.Biol.Chem.285,6913. green®.J.Exp.Bot.57,1725.
222. Nojiri,Hetal.(2011)CytoplasmicO
•–
causesbone 240. Miller, G et al. (2009) The plant NADPH oxidase
2
fragilityowingtolow-turnoverosteoporosisandim- RBOHD mediates rapid systemic signaling in re-
pairedcollagencross-linking.J.BoneMiner.Res.26, sponsetodiversestimuli.Sci.Signal.2,ra45.
2682. 241. Thaler, JS et al. (2012) Evolution of jasmonate and
223. Bartell, SM et al. (2014) FoxO proteins restrain os- salicylatesignalcrosstalk.TrendsPlantSci.17,260.
teoclastogenesisandboneresorptionbyattenuating 242. Mukherjee,Metal.(2010)Ascorbicaciddeficiencyin
H2O2accumulation.Nat.Commun.5,3773. Arabidopsisinduces constitutive primingthat is de-
224. Östman,Betal.(2009)Oxidativestressandbonemin- pendentonH2O2,salicylicacid,andtheNPR1gene.
eral density in elderly men: antioxidant activity of Mol.PlantMicrobeInteract.23,340.
α-tocopherol.FreeRadic.Biol.Med.47,668. 243. Durand, T et al. (2011) IsoPs and phytoprostanes:
225. Manolagas,SC(2010)Fromestrogen-centrictoaging bioactivelipids.Biochimie93,52.
and oxidative stress: a revised perspective of the 244. Thoma, I et al. (2003) Cyclopentenone IsoPs in-
pathogenesisofosteoporosis.EndocrineRev.31,266. duced by ROS trigger defense gene activation and
226. Goettsch, C et al. (2013) NOX4 limits bone mass phytoalexinaccumulationinplants.PlantJ.34,363.
bypromotingosteoclastogenesis.J.Clin.Invest.123, 245. Wen,Fetal.(2009)ExtracellularDNAisrequiredfor
4731. roottipresistancetofungalinfection.PlantPhysiol.
227. Tang, X et al. (2013) Molecular cloning and char- 151,820.
acterization of human age-related NADH oxidase 246. Blackburn,Ketal.(2010)Data-independentLC/MSE
(arNOX)proteinsasmembersoftheTM9superfam- detection and quantification of the secreted Apium
ily of transmembrane proteins. Adv. Biol. Chem. 3, graveolens pathogen defense protein mannitol
187. dehydrogenase. Rapid Commun. Mass Spectrom.
228. Sabirov,RZandMerzlyak,PG(2012)Plasmalemmal 24,1009.
VDACcontroversiesandmaxi-anionchannelpuzzle. 247. Vandelle,EandDelledonne,M(2011)ONOO– for-
Biochim.Biphys.Acta1818,1570. mationandfunctioninplants.PlantSci.181,534.
229. Faltin, Z et al. (2010) GPx regulation of ROS level 248. Carter, C et al. (2007) Tobacco nectaries express
iscrucialforinvitroplantdifferentiation.PlantCell a novel NOX implicated in the defense of floral
Physiol.51,1151. reproductive tissues against microorganisms. Plant
230. Flors,CandNonell,S(2006)Lightand1O2inplant Physiol.143,389.
defenseagainstpathogens:phototoxicphenalenone 249. Andreou,AandFeussner,I(2009)Lipoxygenases–
phytoalexins.Acc.Chem.Res.39,293. structureandreactionmechanism.Phytochemistry70,
231. Ahuja,Ietal.(2012)Phytoalexinsindefenseagainst 1504.
pathogens.TrendsPlantSci.17,73. 250. Kemal,Cetal.(1987)Reductiveinactivationofsoy-
232. Marino, D et al. (2012) A burst of plant NADPH beanLOX-1bycatechols:apossiblemechanismfor
oxidases.TrendsPlantSci17,9. regulationofLOXactivity.Biochemistry26,7064.
233. Jiang,Cetal.(2012)ROS-mediatedvascularhomeo- 251. Leenhardt,Fetal.(2006)WheatLOXactivityinduces
static control of root-to-shoot soil Na+ delivery in greater loss of carotenoids than vitamin E during
Arabidopsis.EMBOJ.31,4359. breadmaking.J.Agric.FoodChem.54,1710.

--- Page 824 ---

REFERENCES 769
252. O’Donnell,VBetal.(1999)15-LOXcatalyticallycon- 270. Gonçalves,LLetal.(2009)PGHsynthase-1-catalyzed
•
sumes NO and impairs activation of guanylate bioactivationofneurotransmitters,theirprecursors,
cyclase.J.Biol.Chem.274,20083. and metabolites: oxidative DNA damage and elec-
253. Nakashima, A et al. (2013) Traumatin- and tronspinresonancespectroscopystudies.Chem.Res.
dinortraumatin-containing galactolipids in Toxicol.22,842.
Arabidopsis.J.Biol.Chem.288,26078. 271. Gao,Letal.(2003)FormationofprostaglandinsE2
254. Shiojiri,Ketal.(2012)Intermittentexposuretotraces andD2viatheIPpathway.J.Biol.Chem.278,28479.
ofgreenleafvolatilestriggersaplantresponse.Sci. 272. Zhang, M et al. (2011) Generation and detection of
Rep.2,378. levuglandinsandisolevuglandinsinvitroandinvivo.
255. Sugimoto,Ketal.(2014)Intakeandtransformation Molecules16,5333
toaglycosideof(Z)-3-hexenolfrominfestedneigh- 273. Hardy, KD et al. (2011) Nonenzymatic free radical-
bours reveals a mode of plant odor reception and catalyzed generation of 15-deoxy-(cid:6)12,14-PG2 J2-like
defense.Proc.Natl.Acad.Sci.USA111,7144. compounds(deoxy-J2-IsoPs)invivo.J.LipidRes.52,
256. El-Maarouf-Bouteau,HandBailly,C(2008)Oxida- 113.
tive signaling in seed germination and dormancy. 274. Mullally,JEetal.(2001)Cyclopentenoneprostaglan-
PlantSignal.Behav.3,175. dinsoftheJseriesinhibittheubiquitinisopeptidase
257. Müller,Ketal.(2009)Invivocellwalllooseningby activityoftheproteasomepathway.J.Biol.Chem.276,
•
OH duringcressseedgerminationandelongation 30366.
growth.PlantPhysiol.150,1855. 275. Serhan, CN et al. (2008) Resolving inflammation:
258. Châtelain, E et al. (2013) Evidence for participation dualanti-inflammatoryandpro-resolutionlipidme-
ofthemetSOreductaserepairsysteminplantseed diators.NatureRev.Immunol.8,349.
•
longevity.Proc.Natl.Acad.Sci.USA110,3633. 276. Kim, SF (2011) The role of NO in prostaglandin
259. Lee, YP et al. (2010) Tobacco seeds simultaneously biology;update.NitricOxide25,255.
over-expressingCuZnSODandascorbateperoxidase 277. Laughton,MJetal.(1991)Inhibitionofmammalian
display enhanced seed longevity and germination 5-LOX and COX by flavonoids and phenolic diet-
ratesunderstressconditions.J.Exp.Bot.61,2499. ary additives. Relationship to antioxidant activity
260. Brennan, T and Frenkel, C (1977) Involvement of andtoFeion-reducingability.Biochem.Pharmacol.42,
H2O2 intheregulationofsenescenceinpear.Plant 1673.
Physiol.59,411.
261. Kashiyama,Yetal.(2012)Ubiquityandquantitative
significance of detoxification catabolism of chloro-
Chapter9
phyllassociatedwithprotistanherbivory.Proc.Natl.
Acad.SciUSA109,17328. 1. Hukkanen, J et al. (2002) Expression and regulation
262. Khanna-Chopra, R (2012) Leaf senescence and abi- ofxenobiotic-metabolizingcytochromeP450(CYP)en-
oticstressesshareROS-mediatedchloroplastdegrad- zymesinhumanlung.Crit.Rev.Toxicol.32,391.
ation.Protoplasma249,469. 2. Couroucli,XIetal.(2011)Prenataladministrationofthe
263. Kuhn,Hetal.(2015)Mammalianlipoxygenasesand cytochromeP4501Ainducer,β-naphthoflavone(BNF),
theirbiologicalrelevance.Biochim.Biophys.Acta1851, attenuateshyperoxiclunginjuryinnewbornmice:im-
308. plicationsforBPDinprematureinfants.Toxicol.Appl.
264. Zhang, MJ and Spite, M (2012) Resolvins: anti- Pharmacol.256,83.
inflammatory and proresolving mediators derived 3. Mills,EMetal.(1996)CN–-inducedapoptosisandoxi-
from omega-3 polyunsaturated fatty acids. Annu. dativestressindifferentiatedPC12cells.J.Neurochem.
Rev.Nutr.32,203. 67,1039.
265. Ricciotti,EandFitzGerald,GA(2011)Prostaglandins 4. Chellman,GJetal.(1986)Roleofepididymalinflam-
andinflammation.Arterioscler.Thromb.Vasc.Biol.31, mationintheinductionofdominantlethalmutations
986. inFischer344ratspermbyCH3Cl.Proc.Natl.Acad.Sci.
266. Rai, G et al. (2010) Discovery of potent and select- USA83,8087.
iveinhibitorsofhumanreticulocyte15-LOX1.J.Med. 5. Kadiiska, MB et al. (2005) Biomarkers of oxidative
Chem.53,7392. stressstudyII.Areoxidationproductsoflipids,pro-
267. Smith,WL(2005)COX,peroxidetoneandtheallure teins,andDNAmarkersofCCl4poisoning?FreeRadic.
offishoil.Curr.Opin.CellBiol.17,174. Biol.Med.38,698.
268. Morse, DE et al. (1977) H2O2 induces spawning in 6. Basu, S (2003) CCl4-induced lipid peroxidation:
mollusks,withactivationofprostaglandinendoper- eicosanoidformationandtheirregulationbyantioxi-
oxidesynthetase.Science196,298. dantnutrients.Toxicology189,113.
269. Schildknecht, S and Ullrich, V (2009) ONOO– as 7. Plaa,GL(2000)Chlorinatedmethanesandliverinjury:
regulatorofvascularprostanoidsynthesis.Arch.Bio- highlights of the past 50 years. Ann. Rev. Pharmacol.
chem.Biophys.484,183. Toxiciol.40,43.

--- Page 825 ---

770 REFERENCES
•
8. Manibusan, MK et al. (2007) Postulated CCl4 mode 25. Morán, JM et al. (2010) NO in paraquat-mediated
of action: a review. J. Environ. Sci. Health C Environ. toxicity:areview.J.Biochem.Mol.Toxicol.24,402.
Carcinog.Ecotoxicol.Rev.25,185. 26. Smith, LL and Wyatt, I (1981) The accumulation of
9. Hardy, KD et al. (2011) Nonenzymatic free radical- putrescineintoslicesofratlungandbrainanditsre-
catalyzedgenerationof15-deoxy-(cid:6)12,14-prostaglandin lationship to the accumulation of paraquat. Biochem.
J2-like compounds (deoxy-J2-isoprostanes) in vivo. Pharmacol.30,1053.
J.LipidRes.52,113. 27. Wu, KC et al. (2012) Nrf2 protects against diquat-
10. Ki,MRetal.(2011)AscorbatepromotesCCl4-induced inducedliverandlunginjury.FreeRadic.Res.46,1220.
hepaticinjuryinSMP-30-deficientmicebyenhancing 28. Shimada,Hetal.(2009)Paraquattoxicityinducedby
inflammation.J.Nutr.Biochem.22,535. VDAC-1actsasanNADH-dependentoxidoreductase.
11. Liu, J et al. (2009) The preventive effects of heparin- J.Biol.Chem.284,28642.
SODonCCl4-inducedacuteliverfailureandhepatic 29. Keeling,PLandSmith,LL(1982)RelevanceofNADPH
fibrosisinmice.Mol.Cell.Biochem.327,219. depletionandmixeddisulphideformationinratlung
12. Casini,AFetal.(1987)Lipidperoxidation,proteinthi- tothemechanismofcelldamagefollowingparaquat
ols and Ca2+ homeostasis in bromobenzene-induced administration.Biochem.Pharmacol.31,3243.
liverdamage.Biochem.Pharmacol.36,3689. 30. Minakata,Ketal.(2000)Increaseinproductionofas-
13. Kharasch, ED et al. (2000) Human halothane me- corbateradicalintissuesofrattreatedwithparaquat.
tabolism, lipid peroxidation, and cytochrome FreeRadic.Res.33,179.
P(450)2A6 and P(450)3A4. Eur. J. Clin. Pharmacol. 55, 31. Cochemé, HM et al. (2011) Measurement of H2O2
853. withinlivingDrosophiladuringagingusingaratiomet-
14. Nguyen,Cetal.(2008)TrifluoroacetylatedIgG4anti- ricmassspectrometryprobetargetedtothemitochon-
bodiesinachildwithidiosyncraticacuteliverfailure drialmatrix.CellMetab.13,340.
after first exposure to halothane. J. Pediatr. Gastroen- 32. Thomas,CEandAust,SD(1986)Reductivereleaseof
terol.Nutr.47,199. Fefromferritinbycationfreeradicalsofparaquatand
15. Pohl,LR(1979)BiochemicaltoxicologyofCHCl3.Rev. otherbipyridyls.J.Biol.Chem.261,13064.
Biochem.Toxicol.1,79. 33. Burkitt, MJ et al. (1993) ESR spin-trapping investiga-
16. Guéraud, F et al. (2006) Enzyme immunoassay for tionintotheeffectsofparaquatanddesferrioxamine
•
a urinary metabolite of 4-HNE as a marker of lipid onOH generationduringacuteironpoisoning.Mol.
peroxidation.FreeRadic.Biol.Med.40,54. Pharmacol.43,257.
17. Lungarella, G et al. (1987) BrCCl3-induced damage 34. Zhang, J et al. (2011) The significance of serum XO
to bronchiolar Clara cells. Res. Comm. Chem. Pathol. andoxidationmarkersinacuteparaquatpoisoningin
Pharmacol.57,213. humans.Clin.Biochem.44,221.
18. Tasaki,Metal.(2013)OxidativeDNAdamageandin 35. Frank, L (1981) Prolonged survival after paraquat.
vivomutagenicitycausedbyROSgeneratedintheliv- Biochem.Pharmacol.30,2319.
ersofp53-proficientor–deficientgptdeltamicetreated 36. Wang,Yetal.(2006)Pr6gene-targetedmiceshowin-
withnon-genotoxichepatocarcinogens.J.Appl.Toxicol. creasedlunginjurywithparaquat-inducedoxidative
33,1433. stress.Antioxid.Redox.Signal.8,229.
19. Smith, AG and Elder, GH (2010) Complex gene- 37. Li,Yetal.(1996)RoleofCuZnSODinxenobioticactiva-
chemical interactions: hepatic uroporphyria as a tion.1.ChemicalreactionsinvolvedintheCuZnSOD-
paradigm.Chem.Res.Toxicol.23,712. accelerated oxidation of the benzene metabolite, 1,4-
20. Matés, JM et al. (2010) Roles of dioxins and heavy hydroquinone.J.Pharmacol.Exp.Ther.49,404.
metals in cancer and neurological diseases using 38. Bolten,JLetal.(2000)Roleofquinonesintoxicology.
ROS-mediated mechanisms.Free Radic. Biol. Med. 49, Chem.Res.Toxicol.13,135.
1328. 39. McGregor, D (2007) Hydroquinone: an evaluation of
21. Kitzler, J and Fridovich, I (1986) The effects of para- thehumanrisksfromitscarcinogenicandmutagenic
quatonE.coli:distinctionbetweenbacteriostasisand properties.Crit.Rev.Toxicol.37,887.
lethality.J.FreeRadic.Biol.Med.2,245. 40. Winterbourn, CC et al. (1979) The reaction of mena-
22. Liochev,SIetal.(1994)NADPH:ferredoxinoxidore- dionewithhaemoglobin.Biochem.J.179,665.
ductaseactsasaparaquatdiaphoraseandisamem- 41. Qadri, SM et al. (2009) Stimulation of ceramide for-
ber of the soxRS regulon. Proc. Natl. Acad. Sci. USA mationandsuicidalerythrocytedeathbyvitaminK3
91,1328. (menadione)Eur.J.Pharmacol.623,10.
23. Korbashi,Petal.(1986)Femediatesparaquattoxicity 42. Fischer-Nielsen, A et al. (1995) Menadione-induced
inE.coli.J.Biol.Chem.261,12472. DNAfragmentationwithout8OHdGformationiniso-
24. Hassan,HMandFridovich,I(1979)ParaquatandE. latedrathepatocytes.Biochem.Pharmacol.49,1469.
coli. Mechanism of production of extracellular O
•–.
43. Pal, C and Bandyopadhyay, U (2012) Redox-active
2
J.Biol.Chem.254,10846. antiparasiticdrugs.Antioxid.RedoxSignal.17,555.

--- Page 826 ---

REFERENCES 771
44. Lanfranchi,DAetal.(2012)Exploringthetrifluorom- acidoxidationandtheirmodulationbypolymorphic
enadione core as a template to design antimalarial xenobiotic metabolizing enzymes. Toxicol. Lett. 193,
redox-activeagentsinteractingwithglutathionereduc- 229.
tase.Org.Biomol.Chem.10,4795. 61. Chen, KM et al. (2005) Benzene increases protein-
45. Paz,MMetal.(2012)Anewmechanismofactionfor bound3-nitrotyrosineinbonemarrowofB6C3F1mice.
the anticancer drug mitomycin C: mechanism-based Chem.Biol.Interact.156,81.
inhibitionofthioredoxinreductase.Chem.Res.Toxicol. 62. de la Paz, MP et al. (2003) Neurologic outcomes of
25,1502. toxicoilsyndromepatients18yearsaftertheepidemic.
46. Siegel, D et al. (2012) NAD(P)H: quinone oxidore- Environ.HealthPerspect.111,1326.
ductase (NQO1) in the sensitivity and resistance to 63. Ciccoli,Letal.(1999)Hemolyticdrugsanilineanddap-
antitumorquinones.Biochem.Pharmacol.83,1033. soneinduceFereleaseinerythrocytesandincreasethe
47. El-Najjar, Net al. (2011) The chemical and biological freeFepoolinspleenandliver.Toxicol.Lett.110,57.
activities of quinones: overview and implications in 64. Siraki,AGetal.(2010)Investigatingthemechanismof
analyticaldetection.Phytochem.Rev.10,353. aromaticamine-inducedproteinfreeradicalformation
48. Okoh,Vetal.(2011)Estrogen-inducedROS-mediated byquantitativestructure-activityrelationships:impli-
signalingcontributetobreastcancer.Biochim.Biophys. cations for drug-induced agranulocytosis. Chem. Res.
Acta1815,115. Toxicol.23,880.
49. Napolitano,Aetal.(2011)Oxidationchemistryofcat- 65. Rada,BandLeto,TL(2012)Pyocyanineffectsonre-
echolamines and neuronal degeneration: an update. spiratoryepithelium:relevanceinP.aeruginosaairway
Curr.Med.Chem.18,1832. infections.TrendsMicrobiol.21,73.
50. Martinez-Finley,EJetal.(2013)Mnneurotoxicityand 66. Britigan, BE et al. (1997) Augmentation of oxidant
theroleofROS.FreeRadic.Biol.Med.62,65. injurytohumanpulmonaryepithelialbytheP.aeru-
51. Serra, PA et al. (2000) Mn increases L-DOPA auto- ginosasiderophorepyochelin.Infect.Immun.65,1071.
oxidation in the striatum of the freely moving rat: 67. Rosso,JAetal.(2009)Alloxan-dialuricacidcycling:a
potentialimplicationstoL-DOPAlong-termtherapyof complexredoxmechanism.FreeRadic.Res.43,93.
PD.Br.J.Pharmacol.130,937. 68. Lei,XGandVatamaniuk,MZ(2011)Twotalesofanti-
52. Stepens, A et al. (2008) A Parkinsonian syndrome in oxidant enzymes on β cells and diabetes. Antioxid.
methcathinone users and the role of Mn. N. Engl. RedoxSignal.14,489.
J.Med.358,1009. 69. Lenzen, S (2008) The mechanisms of alloxan- and
53. Mohamadin, AM et al. (2012) Lycopene attenuates streptozotocin-induceddiabetes.Diabetologia51,216.
oxidative stress and heart lysosomal damage in iso- 70. Uchida,KandTominaga,M(2011)TRPM2modulates
proterenolinducedcardiotoxicityinrats:abiochemical insulinsecretioninpancreaticβ-cells.Islets3,209.
study.Pathophysiology19,121. 71. Hadjivassiliou,Vetal.(1998)Insulinsecretion,DNA
54. Abebe, A et al. (2010) Reexamination of the mech- damage, and apoptosis in human and rat islets of
anisms of oxidative transformation of the insect LangerhansfollowingexposuretoNO • ,ONOO– and
cuticular sclerotizing precursor, 1,2-dehydro- cytokines.NitricOxide2,429.
N-acetyldopamine. Insect Biochem. Mol. Biol. 40, 72. McCulloch, LJ et al. (2011) GLUT2 (SLC2A2) is not
650. theprincipalglucosetransporterinhumanpancreatic
55. Blesa,Jetal.(2012)Classicandnewanimalmodelsof β cells: implications for understanding genetic asso-
PD.J.Biomed.Biotechnol.2012,ArticleID845618. ciation signals at this locus.Mol. Genet. Metabol.104,
56. Barkats,Metal.(2002)Neuronaltransferofthehuman 648.
CuZnSOD gene increasesthe resistanceof dopamin- 73. Tonooka,Netal.(2007)GPxproteinexpressionandac-
ergicneuronsto6-hydroxydopamine.J.Neurochem.82, tivityinhumanisletsisolatedfortransplantation.Clin.
101. Transplant.21,767.
57. Callio, J et al. (2005) MnSOD protects against 6- 74. Modak,MA etal. (2007)Differentialsusceptibilityof
hydroxydopamine injury in mouse brains. J. Biol. chickandmouseisletstostreptozotocinanditscorrel-
Chem.280,18536. ationwithisletantioxidantstatus.J.Comp.Physiol.B
58. Inden, M et al. (2012) Detoxification of 6- 177,247.
hydroxydopamine-induced dopaminergic neurode- 75. Hansem,JBetal.(2012)DMT1regulatesFe-mediated
generation by DMPO, a radical trapper, in ROSandpancreaticβ-cellfateinresponsetocytokines.
hemiparkinsonianrats.Biol.Pharm.Bull.35,1603. CellMetab.16,449.
59. Pilger,AandRüdiger,HW(2006)8OHdGasamarker 76. Kikumoto, Y et al. (2010) Sensitization to alloxan-
ofoxidativeDNAdamagerelatedtooccupationaland induced diabetes and pancreatic cell apoptosis in
environmental exposures. Int. Arch. Occup. Environ. acatalasemicmice.Biochim.Biophys.Acta1802,240.
Health80,1. 77. el-Hage,Aetal.(1986)Mechanismoftheprotectiveac-
60. Manini, P et al. (2010) Occupational exposure to low tivityofICRF-187againstalloxan-induceddiabetesin
levelsofbenzene:biomarkersofexposureandnucleic mice.Res.Commun.Chem.Pathol.Pharmacol.52,341.

--- Page 827 ---

772 REFERENCES
78. Eizirik, DL et al. (1986) 1,10 phenanthroline, a 97. Möykkynen,TandKorpi,ER(2012)Acuteeffectsof
metal chelator, protects against alloxan- but not ethanolonglutamatereceptors.BasicClin.Pharmacol.
streptozotocin-induceddiabetes.FreeRadic.Biol.Med. Toxicol.111,4.
2,189. 98. Harrison-Findik,DD(2007)Roleofalcoholintheregu-
79. Kubisch,HMetal.(1994)TransgenicCuZnSODmodu- lation of iron metabolism. World J. Gastroenterol. 13,
latessusceptibilitytotypeIdiabetes.Proc.Natl.Acad. 4925.
Sci.USA91,9956. 99. Anderson,MLetal.(2012)Moderatedrinking?Alco-
80. Kamimura, W et al. (2013) Effect of vitamin E on holconsumptionsignificantlydecreasesneurogenesis
alloxan-inducedmousediabetes.Clin.Biochem.46,795. intheadulthippocampus.Neuroscience224,202.
81. Ho,Eetal.(2000)PBNinhibitsNFκBactivationoffer- 100. Acquaviva,Aetal.(2013)Signalingpathwaysinvolved
ing protection against chemically induced diabetes. inIsoP-mediatedfibrogeniceffectsinrathepaticstel-
FreeRadic.Biol.Med.28,604. latecells.FreeRadic.Biol.Med.65,201.
82. Chen,Hetal.(2005)MnSODandcatalasetransgenes 101. Brown,LAetal.(2007)Glutathioneavailabilitymodu-
demonstrate that protection of islets from oxidative lates alveolar macrophage function in the chronic
stressdoesnotaltercytokinetoxicity.Diabetes54,1437. ethanol-fedrat.Am.J.Physiol.292,L824.
83. Hernández-Tobías,Aetal.(2011)Naturalalcoholex- 102. Pajares, MA et al. (2013) How are mammalian me-
posure:isethanolthemainsubstrateforADHasesin thionineadenosyltransferasesregulatedintheliver?A
animals?Chem.Biol.Interact.191,14. focusonredoxstress.FEBSLett.587,1711.
84. Katsumata,Ketal.(1994)Acuteandchroniceffectof 103. Chen, S (2012) Analysis of Nrf2-mediated transcrip-
ethanolontheoccurrenceofalloxandiabetesinrats. tionalinductionofantioxidantresponsesinearlyem-
Horm.Metab.Res.26,166. bryos.MethodsMol.Biol.889,277.
85. Kreitman,GYetal.(2013)Investigationofethylrad- 104. Fernández-Mateos, P et al. (2012) Discontinuous vs.
icalquenchingbyphenolicsandthiolsinmodelwine. continuousdrinkingofethanolinperipubertalrats:ef-
J.Agric.FoodChem.61,685. fect on 24-hour pattern of hypophyseal-gonadal axis
86. Navasumrit,Petal.(2000)Ethanol-inducedfreerad- activityandanteriorpituitaryoxidativestress.Neuro-
icals and hepatic DNA strand breaks are prevented endocrinology96,194.
in vivo by antioxidants: effects of acute and chronic 105. Zhang,Wetal.(2011)ExpressionofCYP2E1increases
ethanolexposure.Carcinogenesis21,93. oxidativestressandinducesapoptosisofcardiomyo-
87. de Almeida, NE, et al. (2013) Beer thiol-containing cytesintransgenicmice.FEBSJ.278,1484.
compounds and redox stability: kinetic study of 106. Shaw,SandJayatilleke,E(1990)Theroleofaldehyde
1-hydroxyethylradicalscavengingability.J.Agric.Food oxidaseinethanol-inducedhepaticlipidperoxidation
Chem.61,9444. intherat.Biochem.J.268,579.
88. Wu,DandCederbaum,AI(2009)Oxidativestressand 107. Vidali, M et al. (2007) Interplay between oxidative
alcoholicliverdisease.Semin.LiverDis.29,141. stress and immunity in the progression of alcohol-
89. Zhu, H et al. (2012) Oxidative stress and redox sig- mediatedliverinjury.TrendsMol.Med.14,63.
nalingmechanismsofalcoholicliverdisease:updated 108. Han, QP and Dryhurst, G (1996) Influence of
experimentalandclinicalevidence.J.Dig.Dis.13,133. GSH on the oxidation of 1-methyl-6-hydroxyl-1,2,3,
90. Seitz,HKandStickel,F(2007)Molecularmechanisms 4-tetrahydro-β -carboline:chemistryofpotentialrele-
ofalcohol-mediatedcarcinogenesis.Nat.Rev.Cancer7, vancetotheaddictiveandneurodegenerativeconse-
599. quencesofethanolabuse.J.Med.Chem.39,1494.
91. Brüning, A and Kast RE (2014) Oxidizing to death: 109. Mao, J et al. (2013) Increased levels of monoamine-
disulfiramforcancercellkilling.CellCycle13,1513. derivedneurotoxinsinfetalratbrainexposedtoetha-
92. Wang,Xetal.(2013)CYP2E1potentiatesethanolinduc- nol.Neurochem.Res.38,356.
tionofhypoxiaandHIF-1αinvivo.FreeRadic.Biol.Med. 110. Long, EK et al. (2010) Ethanol withdrawal increases
63,175. GSHadductsof4-hydroxy-2-hexenalbutnot4-HNE
93. Haorah,Jetal.(2008)Mechanismofalcohol-induced in the rat cerebral cortex. Free Radic. Biol. Med.
oxidative stress and neuronal injury. Free Radic. Biol. 48,384.
Med.45,1542. 111. Jones,MKetal.(2011)LossofparietalcellSODleads
94. Volkow, ND et al. (2013) Acute alcohol intoxication togastricoxidativestressandincreasedinjurysuscep-
decreases glucose metabolism but increases acetate tibilityinmice.Am.J.Physiol.301,G537.
uptakeinthehumanbrain.NeuroImage64,277. 112. Bae,SHetal.(2011)Concertedactionofsulfiredoxin
95. Nova,Eetal.(2012)Potentialhealthbenefitsofmod- andperoxiredoxinIprotectsagainstalcohol-induced
erate alcohol consumption: current perspectives in oxidativeinjuryinmouseliver.Hepatology53,945.
research.Proc.Nutr.Soc.71,307. 113. Larosche,Ietal.(2010)HepaticmitochondrialDNAde-
96. Brocardo, PS et al. (2011)The roleof oxidativestress pletionafteranalcoholbingeinmice:probableroleof
infetalalcoholspectrumdisorders.BrainRes.Rev.67, ONOO–andmodulationbyMnSOD.J.Pharmacol.Exp.
209. Ther.332,886.

--- Page 828 ---

REFERENCES 773
114. Chacko, BK et al. (2011) Mitochondria-targeted ubi- 132. Ferrali, M et al. (1990) Fe release and erythrocyte
quinone (MitoQ) decreases ethanol-dependent micro damageinallylalcoholintoxicationinmice.Biochem.
andmacrohepatosteatosis.Hepatology54,153. Pharmacol.40,1485.
115. DenHartog,Getal.(2014)O
•–radicalsactivatehepatic
133. Valente,MJetal.(2012)Contributionofoxidativeme-
2
stellatecellsafterentrythroughCl– channels:anew tabolismtococaine-inducedliverandkidneydamage.
targetinliverfibrosis.Eur.J.Pharmacol.724,140. Curr.Med.Chem.19,5601.
116. Singal, AK et al. (2011) Antioxidants as therapeutic 134. Vergeade, A et al. (2010) Mitochondrial impairment
agentsforliverdisease.LiverInt.31,1432. contributes to cocaine-induced cardiac dysfunction:
117. Poli, G (2014) A new biochemical effect of HNE: prevention by the targeted antioxidant MitoQ. Free
downregulation of TGFβ-dependent elastogenesis. Radic.Biol.Med.49,748.
FreeRadic.Biol.Med.71,437. 135. Zimmerman,EFetal.(1994)RoleofO2freeradicalsin
118. Elamin, E et al. (2012) Effects of ethanol and acetal- cocaine-inducedvasculardisruptioninmice.Teratology
dehyde on tight junction integrity: in vivo study in 49,192.
a three dimensional intestinal epithelial cell culture 136. Cadet,JLetal.(1995)O
•–radicalsmediatethebiochem-
2
model.PLoSOne7,e35008. icaleffectsofMDMA:evidencefromusingCuZnSOD
119. Tan,Yetal.(2012)AngiotensinIIplaysacriticalrolein transgenicmice.Synapse21,169.
alcohol-inducedcardiacnitrativedamage,celldeath, 137. Camarero,Jetal.(2002)Studies,usinginvivomicro-
remodeling,andcardiomyopathyinaproteinkinase dialysis,ontheeffectofthedopamineuptakeinhibitor
C/NOX-dependent manner. J. Am. Coll. Cardiol. 59, GBR 12909 on 3,4-MDMA (‘ecstasy’)-induced dopa-
1477. minereleaseandfreeradicalformationinthemouse
120. Serviddio, G et al. (2013) Oxysterols and redox sig- striatum.J.Neurochem.81,961.
nalinginthepathogenesisofnon-alcoholicfattyliver 138. Jeng,Wetal.(2005)Methamphetamine-enhancedem-
disease.FreeRadic.Res.47,881. bryonic oxidative DNA damage and neurodevelop-
121. Zein, CO et al. (2012) Pentoxifylline decreases oxi- mentaldeficits.FreeRadic.Biol.Med.39,317.
dized lipid products in nonalcoholic steatohepatitis: 139. Itzhak,YandAchat-Mendes,C(2004)Methampheta-
newevidenceonthepotentialtherapeuticmechanism. mineandMDMA(Ecstasy)neurotoxicity:‘ofmiceand
Hepatology56,1291. men’.IUBMBLife56,249.
122. Leclercq, IA (2012) Pro-oxidants or anti-oxidant de- 140. Jeng, W and Wells, PG (2010) Reduced MDMA
fenses? Which one to blame in non-alcoholic ste- (Ecstasy)-initiatedoxidativeDNAdamageandneuro-
atohepatitispathogenesis.J.Gastroenterol.Hepatol.27, degenerationinprostaglandinHsynthase-1knockout
1647. mice.ACSChem.Neurosci.1,366.
123. Takahashi,Yetal.(2014)Doeshepaticoxidativestress 141. Singh, R et al. (2009) Evaluation of the DNA dam-
enhance activation of Nrf2 in patients with nonalco- agingpotentialofcannabiscigarettesmokebythede-
holicsteatohepatitis?Antioxid.RedoxSignal.20,538. termination of the acetaldehyde derived N2-ethyl-2’-
124. Chen,Yetal.(2013)GSHdefensemechanisminliver deoxyguanosineadducts.Chem.Res.Toxicol.22,1181.
injury:insightsfromanimalmodels.FoodChem.Toxicol. 142. Valvassori, SS et al. (2011) Effects of cannabidiol
60,38. onamphetamine-inducedoxidativestressgeneration
125. Bjelakovic,Getal.(2011)Antioxidantsupplementsfor in an animal model of mania. J. Psychopharmacol.
liverdiseases.CochraneDatabaseSystRev.3:CD007749. 25,274.
126. Sanyal,AJetal.(2010)Pioglitazone,vitaminEorpla- 143. Lastres-Becker, I et al. (2005) Cannabinoids provide
cebofornonalcoholicsteatohepatitis.N.Engl.J.Med. neuroprotection against 6-hydroxydopamine toxicity
362,1675. in vivo and in vitro: relevance to PD. Neurobiol. Dis.
127. Lavine, JE et al. (2011) Effect of vitamin E or met- 19,96.
forminfortreatmentofnonalcoholicfattyliverdisease 144. Rajesh,Metal.(2010)Cannabidiolattenuatescardiac
inchildrenandadolescents.JAMA305,1659. dysfunction,oxidativestress,fibrosis,andinflamma-
128. Nguyen-Khac, E et al. (2011) Glucocorticoids plus tory and cell death signaling pathways in diabetic
N-acetylcysteineinseverealcoholichepatitis.N.Engl. cardiomyopathy.J.Am.Coll.Cardiol.56,2115.
J.Med.365,1781. 145. Yang, L et al. (2014) Cannabidiol protects liver from
129. Fried,MWetal.(2012)Effectofsilymarin(milkthistle) binge alcohol-induced steatosis by mechanisms in-
on liver disease in patients with chronic hepatitis C cludinginhibitionofoxidativestressandincreasein
unsuccessfullytreatedwithinterferontherapy.JAMA autophagy.FreeRadic.Biol.Med.68,260.
308,274. 146. Mato, S et al. (2010) Cannabidiol induces intracellu-
130. Auerbach,SSetal.(2008)Acomparative90-daytox- larcalciumelevationandcytotoxicityinoligodendro-
icitystudyofallylacetate,allylalcoholandacrolein. cytes.Glia58,1739.
Toxicology253,79. 147. McGill, MR et al. (2012) The mechanism underlying
131. Liu,Fetal.(2012)Thecyclophosphamidemetabolite, acetaminophen-inducedhepatotoxicityinhumansand
acrolein, induces cytoskeletal changes and oxidative mice involves mitochondrial damage and nuclear
stressinSertolicells.Mol.Biol.Rep.39,493. DNAfragmentation.J.Clin.Invest.122,1574.

--- Page 829 ---

774 REFERENCES
148. Stern,STetal.(2005)Contributionofacetaminophen- 164. Wynalda, KM and Murphy, RC (2010) Low-
cysteinetoacetaminophennephrotoxicityII.Possible concentration O3 reacts with plasmalogen gly-
involvement of the γ-glutamyl cycle. Toxicol. Appl. cerophosphoethanolamine lipids in lung surfactant.
Pharmacol.202,160. Chem.Res.Toxicol.23,108.
149. Abdelmegeed,MAetal.(2013)Robustproteinnitration 165. Yanagisawa, R et al. (2012) PrxI null mice exhibits
contributestoacetaminophen-inducedmitochondrial reducedacutelunginflammationfollowingO3expos-
dysfunctionandacuteliverinjury.FreeRadic.Biol.Med. ure.J.Biochem.152,595.
60,211. 166. Garantziotis,Setal.(2009)HyaluronanmediatesO3-
150. Mehendale, HM and Limaye, PB (2005) Calpain: a inducedairwayhyper-responsivenessinmice.J.Biol.
deathproteinthatmediatesprogressionofliverinjury. Chem.284,11309.
TrendsPharmacol.Sci.26,232. 167. Han,MDetal.(2011)Assessmentofthechargedaero-
151. Awad,JAandMorrow,JD(1995)ExcretionofF2-IsoPs solvalueincopycentres.Ind.Health49,107.
in bile; a novel index of hepatic lipid peroxidation. 168. Romieu, I et al. (2004) Genetic polymorphism of
Hepatology22,962. GSTM1 and antioxidant supplementation influence
152. Trettin, A et al. (2014) LC-MS/MS and GC-MS/MS lungfunctioninrelationtoO3 exposureinasthmatic
measurement of plasma and urine di-paracetamol childreninMexicocity.Thorax59,8.
and3-nitro-paracetamol:proof-of-conceptstudiesona 169. Minelli,Cetal.(2011)Interactiveeffectsofantioxidant
novelhumanmodelofoxidativestressbasedonoral genes and air pollution on respiratory function and
paracetamoladministration.J.Chromatogr.B959,71. airwaydisease:aHuGEreview.Am.J.Epidemiol.173,
153. Zhu,JHetal.(2008)RoleofCuZnSODincatalyzing 603.
nitrotyrosineformationinmurineliver.FreeRadic.Biol. 170. Enami, S et al. (2009) O3 oxidizes glutathione to a
Med.45,611. sulfonicacid.Chem.Res.Toxicol.22,35.
154. Evans,PJetal.(1994)Metalionscatalyticforfreerad- 171. Kermani, S et al. (2006) Kinetics of O3 reaction with
icalreactionsintheplasmaofpatientswithfulminant uric acid, ascorbic acid, and GSH at physiologically
hepaticfailure.FreeRadic.Res.20,139. relevantconditions.Arch.Biochem.Biophys.451,8.
155. Koelsch,Metal.(2010)Acetaminophen(paracetamol) 172. Behndig, AF et al. (2009) Antioxidant responses to
inhibits MPO-catalyzed oxidant production and bio- acuteO3challengeinthehealthyhumanairway.Inhal.
logical damage at therapeutically achievable concen- Toxicol.21,933.
trations.Biochem.Pharmacol.79,1156. 173. Gruber,Jetal.(2009)Allantoininhumanbodyfluidsas
156. Piccirillo,VJetal.(2012)Preliminaryevaluationofthe abiomarkerofoxidativestress;avoidingartifactsand
human relevance of respiratory tumors observed in establishingrealinvivoconcentrations.Antioxid.Redox
rodents exposed to naphthalene. Regul. Toxicol. Phar- Signal.11,1767.
macol.62,433. 174. Ballinger,CAetal.(2005)Antioxidant-mediatedaug-
157. Squadrito, GL et al. (2010) Elucidating mechanisms mentation of O3-induced membrane oxidation. Free
ofCltoxicity:reactionkinetics,thermodynamics,and Radic.Biol.Med.38,515.
physiologicalimplications.Am.J.Physiol.299,L289. 175. Long,NCetal.(2001)O3causeslipidperoxidationbut
158. Zarogiannis,SGetal.(2011)Ascorbateanddeferoxam- littleantioxidantdepletioninexercisingandnonexer-
ineadministrationafterCl2 exposuredecreasesmor- cisinghamsters.J.Appl.Physiol.91,1694.
talityandlunginjuryinmice.Am.J.Respir.CellMol. 176. Montuschi,Petal. (2002)O3-inducedincreaseinex-
Biol.45,386. haled 8-IP in healthy subjects is resistant to inhaled
159. McGovern,Tetal.(2011)AEOL10150:anovelthera- budesonide.FreeRadic.Biol.Med.33,1403.
peuticforrescuetreatmentaftertoxicgaslunginjury. 177. Zuo,Letal.(2014)Interrelatedroleofcigarettesmok-
FreeRadic.Biol.Med.50,602. ing,oxidativestress,andimmuneresponseinCOPD
160. Cross, CE et al. (2006) Combating oxidative stress at and corresponding treatments. Am. J. Physiol. 307,
respiratorytractbiosurfaces.FreeRadic.Biol.Med.40, L205.
1693. 178. Wiester,MJetal.(2000)O3adaptationinmiceandits
161. Coleman,BKetal.(2008)O3consumptionandvolatile associationwithascorbicacidinthelung.Inhal.Toxicol.
byproductformationfromsurfacereactionswithair- 12,577.
craftcabinmaterialsandclothingfabrics.Atmos.Env. 179. Jackson,RMandFrank,L(1984)O3-inducedtolerance
42,642. tohyperoxiainrats.Am.Rev.Resp.Dis.129,425.
162. Wisthaler,AandWeschler,CJ(2010)ReactionsofO3 180. Augusto,Oetal.(2002)NO •
2
andCO •
3
–:twoemerging
with human skin lipids: sources of carbonyls, dicar- radicalsinbiology.FreeRadic.Biol.Med.32,841.
bonyls,andhydroxycarbonylsinindoorair.Proc.Natl. 181. Finlayson-Pitts, BJ and Pitts Jr, JN (1997) Tropo-
Acad.Sci.USA107,6568. spheric air pollution: O3, airborne toxics, polycyc-
163. Matalon,Setal.(2009)Modificationofsurfactantpro- lic aromatic hydrocarbons, and particles. Science
tein D by reactive oxygen-nitrogen intermediates is 276,1045.
accompanied by loss of aggregating activity, in vitro 182. Franze,Tetal.(2005)Proteinnitrationbypollutedair.
andinvivo.FASEBJ.23,1415. Env.Sci.Technol.39,1673.

--- Page 830 ---

REFERENCES 775
183. Orlando,JJandTyndall,GS(2012)Laboratorystudies 201. Sawa, T et al. (2006) Analysis of urinary 8NG, a
oforganicperoxyradicalchemistry:anoverviewwith marker of nitrative nucleic acid damage, by HPLC-
emphasisonrecentissuesofatmosphericsignificance. ECDcoupledwithimmunoaffinitypurification:asso-
Chem.Soc.Rev.41,6294. ciationwithcigarettesmoking.FreeRadic.Biol.Med.40,
184. Devlin,RBetal.(1999)Inflammatoryresponseinhu- 711.
mansexposedto2.0ppmNO2.Inhal.Toxicol.11,89. 202. Munnia,Aetal.(2006)BronchialMDADNAadducts,
•
185. Huie,RE(1994)ThereactionkineticsofNO .Toxicology tobaccosmoke,andlungcancer.FreeRadic.Biol.Med.
2
89,193. 41,1499.
186. Pryor, WA and Lightsey, JW (1981) Mechanisms of 203. Campos, C et al. (2011) Urinary biomarkers of
•
NO reactions:initiationoflipidperoxidationandthe oxidative/nitrosativestressinhealthysmokers.Inhal.
2
productionofHNO2.Science214,435. Toxicol.23,148.
•
187. Ford, E et al. (2002) Kinetics of the reactions of NO 204. Sonnen,JAetal.(2009)Freeradicaldamagetocerebral
2
withGSH,cysteine,anduricacidatphysiologicalpH. cortexinAD,microvascularbraininjury,andsmoking.
FreeRadic.Biol.Med.32,1314. Ann.Neurol.65,226.
188. Kelly,FJetal.(1996)Antioxidantkineticsinlunglav- 205. Smit,LAetal.(2012)TRPgenes,smoking,occupational
•
agefluidfollowingexposureofhumanstoNO .Am. exposuresandcoughinadults.Respir.Res.13,26.
2
J.Resp.Crit.CareMed.154,1700. 206. Carmella, SG et al. (2007) Quantification of acrolein-
189. Mitsuhashi,Hetal.(2001)Issulfiteanantiatherogenic derived(3-hydroxypropyl)mercapturicacidinhuman
compoundinwine?Clin.Chem.47,1872. urinebyLC–atmosphericpressurechemicalionization
190. Zhang, X et al. (2004) A mechanism of SO2– neuro- tandem MS: effects of cigarette smoking. Chem. Res.
3
toxicity:directinhibitionofglutamatedehydrogenase. Toxicol.20,986.
J.Biol.Chem.279,43035. 207. Jaimes,EAetal(2004)Stablecompoundsofcigarette
191. McCord,JMandFridovich,I(1969)TheutilityofSOD smoke induce endothelial O
•–
production via NOX
2
in studying free radical reactions. J. Biol. Chem. 244, activation.Arterio.Thromb.Vasc.Biol.24,1031.
6056. 208. Peluffo, G et al. (2009) O
•–-mediated
inactivation of
2
192. Ranguelova,Ketal.(2013)Sulfite-mediatedoxidation NO • and ONOO– formation by tobacco smoke in
of MPO to a free radical: immune-spin trapping de- vascular endothelium: studies in cultured cells and
tection in human neutrophils. Free Radic. Biol. Med. smokers.Am.J.Physiol.296,H1781.
60,98. 209. Loke,WMetal.(2012)Productsof5-LOXandMPOac-
193. Mottley,CandMason,RP(1988)Sulfatefreeradical tivitiesareincreasedinyoungmalecigarettesmokers.
formationbytheperoxidationof(bi)sulfiteanditsre- FreeRadic.Res.46,1230.
action with OH
•
scavengers. Arch. Biochem. Biophys. 210. MatthewsJBetal.(2012)NeutrophilO
•–productionin
2
267,681. the presence of cigarette smoke extract, nicotine and
194. Ren,Cetal.(2011)Urinary8OHdGasabiomarkerof cotinine.J.Clin.Periodontol.39,626.
oxidativeDNAdamageinducedbyambientpollution 211. Salama, SA et al. (2013) Nicotine mediates HOCl-
intheNormativeAgeingStudy.Occup.Environ.Med. inducednuclearproteindamageinmammaliancells.
68,562. Inflammation37,785.
195. Huang, W et al. (2012) Inflammatory and oxidative 212. Bozinovski, S et al. (2011) Carbonylation caused by
stressresponsesofhealthyyoungadultstochangesin cigarette smoke extract is associated with defective
airqualityduringtheBeijingOlympics.Am.J.Respir. macrophageimmunity.Am.J.Respir.CellMol.Biol.45,
Crit.CareMed.186,1150. 229.
196. Halliwell, B and Poulsen, HE (eds) (2006) Cigarette 213. Yao,Hetal.(2008)GeneticablationofNOXenhances
Smoke and Oxidative Stress. Springer Verlag, Basle, susceptibilitytocigarettesmoke-inducedlunginflam-
Switzerland. mation and emphysema in mice. Am. J. Pathol. 172,
197. Moreno-Gonzalez,Ietal.(2013)Smokingexacerbates 1222.
amyloid pathology in a mouse model of AD. Nat. 214. Kamocki, K et al. (2013) RTP801 is required for
Commun.4,1495. ceramide-induced cell-specific death in the murine
198. Bartalis,Jetal.(2009)Carbon-centeredradicalsincig- lung.Am.J.Respir.CellMol.Biol.48,87.
arette smoke: acyl and alkylaminocarbonyl radicals. 215. Biswas, S et al. (2013) Pharmacological and dietary
Anal.Chem.81,631. antioxidanttherapiesforCOPD.Curr.Med.Chem.20,
199. Taylor,AWetal.(2008)Womenandsmokershaveele- 1496.
vatedurinaryF2-IsoPmetabolites:anovelextraction 216. Garber,K(2012)Aradicaltreatment.Nature489,S4.
andLC-MSmethodology.Lipids43,925. 217. Kirkham,PAetal.(2011)Oxidativestress-inducedanti-
200. Chen, HJ and Chiu, WL (2005) Association between bodiestocarbonyl-modifiedproteincorrelatewithse-
cigarette smoking and urinary excretion of 1, N2- verityofchronicobstructivepulmonarydisease.Am.
ethenoguanine measured by isotope dilution LC- J.Respir.Crit.CareMed.184,796.
electrospray ionization/ tandem MS. Chem. Res. Tox- 218. Pastukh,VMetal.(2011)OxidativeDNAdamagein
icol.18,1593. lung tissue from patients with COPD is clustered in

--- Page 831 ---

776 REFERENCES
functionally significant sequences. Int. J. Chron. Ob- smoke-induced adaptive responses in the lung. Free
struct.Pulmon.Dis.6,209. Radic.Biol.Med.52,1201.
219. Prieme, H et al. (1997) No effect of supplementation 236. Asami, S et al. (1996) Increase of a type of oxidative
withvitaminE,ascorbicacid,orcoenzymeQ10onoxi- DNAdamage,8OHGanditsrepairactivityinhuman
dativeDNAdamageestimatedby8OHdGexcretionin leukocytesbycigarettesmoking.CancerRes.56,2546.
smokers.Am.J.Clin.Nutr.65,503. 237. Talib, J et al. (2012) High plasma SCN– levels mod-
220. Fiala,ESetal.(2005)Inductionofpreneoplasticlungle- ulate protein damage induced by MPO and perturb
sionsinguineapigsbycigarettesmokeinhalationand measurementof3-chlorotyrosine.FreeRadic.Biol.Med.
theirexacerbationbyhighdietarylevelsofvitaminsC 53,20.
andE.Carcinogenesis26,605. 238. Dolinay,Tetal.(2012)HO-1/COasprotectivemedi-
221. Hutzler,Cetal.(2014)Chemicalhazardspresentinli- atorsincigarettesmoke-inducedlungcellinjuryand
quidsandvaporsofelectroniccigarettes.Arch.Toxicol. chronic obstructive pulmonary disease. Curr. Pharm.
88,1295. Biotechnol.13,769.
222. Gensch,Eetal.(2004)Tobaccosmokecontrolofmucin 239. Maciag,Aetal.(2003)Gestationstage-specificoxida-
productioninlungcellsrequiresO2radicalsAP-1and tiveDNAdamagefromsidestreamsmokeinpregnant
JNK.J.Biol.Chem.279,39085. ratsandtheirfetuses.Arch.Environ.Health.58,238.
223. Chiba,Tetal.(2011)Arylhydrocarbonreceptor(AhR) 240. Collier, AC and Pritsos, CA (2003) ETS in the work-
activationinairwayepithelialcellsinducesMUC5AC place:markersofexposure,polymorphicenzymesand
viaROSproduction.Pulm.Pharmacol.Ther.24,133. implicationsfordiseasestate.Chem.Biol.Interact.146,
224. Dietrich, M et al. (2002) Antioxidant supplementa- 211.
tiondecreaseslipidperoxidationbiomarkerF2-IsoPsin 241. Dietrich,Metal.(2003)VitaminCsupplementationde-
plasmaofsmokers.CancerEpidemiol.Biomark.Prevent. creasesoxidativestressbiomarkerF2-IsoPsinplasma
11,7. ofnonsmokersexposedtoETS.Nutr.Cancer45,176.
225. Bruno, RS et al. (2006) Faster plasma vitamin E dis- 242. Noakes,PSetal.(2007)Associationofmaternalsmok-
appearance in smokers is normalized by vitamin C ingwithincreasedinfantoxidativestressat3months
supplementation.FreeRadic.Biol.Med.40,689. ofage.Thorax62,714.
226. Patrignani,Petal.(2000)EffectsofvitaminEsupple- 243. McEvoy,CTetal.(2014)VitaminCsupplementation
mentationonF2-IsoPandthromboxanebiosynthesisin forpregnantsmokingwomenandpulmonaryfunction
healthycigarettesmokers.Circulation102,539. in their newborn infants: a randomized clinical trial.
227. Weinberg, RB et al. (2001) Pro-oxidant effect of vita- JAMA311,2074.
min E in cigarette smokers consuming a high poly- 244. Wong, RH et al. (2008) Sulfotransferase 1A1 and
unsaturatedfatdiet.Arterioscler.Thromb.Vasc.Biol.21, GSTP1geneticpolymorphismsmodulatethelevelsof
1029. urinary8OHdGinbetelquidchewers.Arch.Toxicol.82,
228. Bruno,RSandTraber,MG(2006)VitaminEbiokinet- 313.
•
ics,oxidativestressandcigarettesmoking.Pathophysi- 245. Chen, CL et al. (2002) OH formation and oxidative
ology13,143. DNA damage induced by areca quid in vivo. J. Tox.
229. Mah, E et al. (2013) γ-Tocopherol-rich supplementa- Environ.HealthA.65,327.
tionadditivelyimprovesvascularendothelialfunction 246. Pan, CH et al. (2008) Effects on Chinese restaurant
during smoking cessation. Free Radic. Biol. Med. 65, workersofexposuretocookingoilfumes:acautionary
1291. noteonurinary8OHdG.CancerEpidemiol.Biomarkers
230. Bielicki, JK et al. (1995) Cu and gas-phase cigarette Prev.17,3351.
smokeinhibitplasmaLCATactivitybydifferentmech- 247. Sriram,Ketal.(2010)Mitochondrialdysfunctionand
anisms.J.LipidRes.36,322. lossofPD-linkedproteinscontributetoneurotoxicity
231. Kinnula,VL(2005)Focusonantioxidantenzymesand ofMn-containingweldingfumes.FASEBJ.24,4989.
antioxidantstrategiesinsmokingrelatedairwaydis- 248. McNeilly,JDetal.(2005)Solubletransitionmetalsin
eases.Thorax60,693. welding fumes cause inflammation via activation of
232. Singh, A et al. (2009) Nrf2-dependent sulfiredoxin-1 NF-κBandAP-1.Toxicol.Lett.158,152.
expression protects against cigarette smoke-induced 249. Kadiiska, MB et al. (1997) In vivo evidence of free
oxidative stress in lungs. Free Radic. Biol. Med. radical formation in the rat lung after exposure to
46,376. an emission source air pollution particle. Chem. Res.
233. Müller, T and Hengstermann, A (2012) Nrf2: friend Toxicol.10,1104.
and foe in preventing cigarette smoking-dependent 250. Huang, X et al. (1999) Chemical reactivity of the C-
lungdisease.Chem.Res.Toxicol.21,1805. centeredfreeradicalsandFe2+incoals:roleofbioavail-
234. Harvey, CJ et al. (2011) Targeting Nrf2 signaling im- ableFe2+incoalworkers’pneumoconiosis.FreeRadic.
provesbacterialclearancebyalveolarmacrophagesin Res.30,439.
patientswithCOPDandinamousemodel.Sci.Transl. 251. Zhang,Qetal.(2002)RolesofbioavailableFeandCa
Med.3,78ra32. incoaldust-inducedoxidativestress:possibleimplica-
235. Gould, NS et al. (2012) CFTR is the primary tionsincoalworkers’lungdisease.FreeRadic.Res.36,
known apical GSH transporter involved in cigarette 285.

--- Page 832 ---

REFERENCES 777
252. Khatri,Metal.(2013)Nanoparticlesfromphotocopiers 269. Hwang,Ietal.(2012)Agnanoparticlesinduceapop-
induce oxidative stress and upper respiratory tract toticcelldeathinCandidaalbicansthroughtheincrease
•
inflammationinhealthyvolunteers.Nanotoxicology7, ofOH .FEBSJ.279,1327.
1014. 270. Alessandrini,Fetal.(2009)Roleofoxidativestressin
253. Lee, HM et al. (2011) Transgenic overexpression ultrafineparticle-inducedexacerbationofallergiclung
of neuroglobin attenuates formation of smoke- inflammation.AmJ.Respir.Crit.CareMed.179,984.
inhalation-inducedoxidativeDNAdamage,invivo,in 271. Kotchey,GPetal.(2013)Peroxidase-mediatedbiodeg-
themousebrain.FreeRadic.Biol.Med.51,2281. radationofcarbonnanotubesinvitroandinvivo.Adv.
254. Valavanidis, A et al. (2008) Persistent free radicals, DrugDeliv.Rev.65,1921.
heavymetalsandPAHsgeneratedinparticulatesoot 272. Møller,Petal.(2012)Oxidativestressgenerateddam-
emissions and residue ash from controlled combus- agetoDNAbygastrointestinalexposuretoinsoluble
tion of common types of plastic. J. Hazard. Mat. particles.Curr.Mol.Med.12,732.
156,277. 273. Siddiqi,NJetal.(2012)Identificationofpotentialbio-
255. La Londe, C et al. (1994) Aerosolized deferoxamine markers of Au nanoparticle toxicity in rat brains.
prevents lung and systemic injury caused by smoke J.Neuroinflammation9,123.
inhalation.J.Appl.Physiol.77,2057. 274. Cochran,DBetal.(2013)SuppressingFeoxidenano-
256. Hamahata,Aetal.(2012)AdministrationofaONOO– particletoxicitybyvasculartargetedantioxidantpoly-
decomposition catalyst into the bronchial artery at- mernanoparticles.Biomaterials34,9615.
tenuates pulmonary dysfunction after smoke inhal- 275. Møller, P et al. (2010) Role of oxidative damage in
ationandburninjuryinsheep.Shock38,543. toxicityofparticulates.FreeRadic.Res.44,1.
257. Lange,Metal.(2011)Beneficialpulmonaryeffectsofa 276. Xie,Hetal.(2011)Genotoxicityofmetalnanoparticles.
metalloporphyrinicONOO–decompositioncatalystin Rev.Environ.Health26,251.
burnandsmokeinhalationinjury.Am.J.Physiol.300, 277. Shvedova, AA et al. (2014) ESR evidence for in vivo
L167. formation of free radicals in tissue of mice exposed
258. Wang, S et al. (1999) Early alterations of lung injury to single-walled C nanotubes. Free Radic. Biol. Med.
following acute smoke exposure by 21-aminosteroid 73,154.
treatment.Toxicol.Pathol.27,334. 278. Guadagnini,Retal.(2015)Toxicityscreeningsofnan-
259. Barregard, L et al. (2006) Experimental exposure to omaterials:challengesduetointerferencewithassay
wood-smoke particles in healthy humans: effects on processesandcomponentsofclassicinvitrotest.Nano-
markersofinflammation,coagulation,andlipidper- toxicology.9Suppl1,13.
oxidation.Inhal.Toxicol.18,845. 279. Leung,CCetal.(2012)Silicosis.Lancet379,2008.
260. Kurmi,OPetal.(2013)Oxidativepotentialofsmoke 280. Hamilton,RFJretal.(2008)Silicabindingandtoxicity
from burning wood and mixed biomass fuels. Free inalveolarmacrophages.FreeRadic.Biol.Med.44,1246.
Radic.Res.47,829. 281. Jiang,Letal.(2012)Feoverloadsignatureinchrysotile-
261. Conklin, DJ (2011) Beware the air! Why particulate inducedmalignantmesothelioma.J.Pathol.228,366.
mattermatters.Circ.Res.108,644. 282. Dostert, C et al. (2008) Innate immune activation
262. Shiraiwa,Metal.(2012)Hazardouscomponentsand throughNalp3inflammasomesensingofasbestosand
health effects of atmospheric aerosol particles: ROS, silica.Science320,674.
soot, polycyclic aromatic compounds and allergenic 283. Murthy,Setal.(2009)ModulationofROSbyRac1or
proteins.FreeRadic.Res.46,927. catalase prevents asbestos-induced pulmonary fibro-
263. Ghio, AJ et al. (2008) Particulate matter in cigarette sis.Am.J.Physiol.297,L846.
smoke alters Fe homeostasis to produce a biological 284. Jun, S et al. (2011) Allele-specific effects of ecSOD
effect.Am.J.Respir.Crit.CareMed.178,1130. onasbestos-inducedfibroproliferativelungdiseasein
264. Møller,PandLoft,S(2010)OxidativedamagetoDNA mice.FreeRadic.Biol.Med.50,1288.
andlipidsasbiomarkersofexposuretoairpollution. 285. Mossman, BT et al. (1996) Transfection of a Mn-
Environ.HealthPerspect.118,1126. containingSODgeneintohamstertrachealepithelial
265. Scheepers,PTandVermeulen,RCH(2012)Dieselen- cells ameliorates asbestos-mediated cytotoxicity. Free
gine exhaust classified as a human lung carcinogen. Radic.Biol.Med.21,125.
•
How will this affect occupational exposures? Occup. 286. Schapira, RM et al. (1995) OH production and lung
Environ.Med.69,691. injuryintheratfollowingsilicaorTiO2instillationin
266. Mudway,ISetal.(2004)Aninvitroandinvivoinvesti- vivo.Am.J.Resp.CellMol.Biol.12,220.
gationoftheeffectsofdieselexhaustonhumanairway 287. Lee,JCetal.(2012)Oxidativestressandmetalcarcino-
lining fluid antioxidants. Arch. Biochem. Biophys. 423, genesis.FreeRadic.Biol.Med.53,742.
200. 288. Jomova, J and Valko, M (2011) Advances in metal-
267. Block,MLetal.(2012)Theoutdoorairpollutionand inducedoxidativestressandhumandisease.Toxicology
brainhealthworkshop.NeuroToxicol.33,972. 283,65.
268. He,WWetal.(2012)MechanismsofthepHdepend- 289. Diaz,Zetal.(2007)Troloxenhancestheanti-lymphoma
•
ent generation of OH and oxygen induced by Ag effectsofAs2O3,whileprotectingagainstlivertoxicity.
nanoparticles.Biomaterials33,7547. Leukemia21,2117.

--- Page 833 ---

778 REFERENCES
290. Lau, A et al. (2013) Arsenic-mediated activation of andserumredoxstatusinpersonsexposedtoHg.Clin.
theNrf2-Keap1antioxidantpathway.J.Biochem.Mol. Chem.51,759.
Toxicol.27,99. 307. Verstraeten, SV et al. (2008) Al and Pb: molecular
291. Straub,ACetal.(2008)As-stimulatedliversinusoidal mechanismsofbraintoxicity.Arch.Toxicol.82,789.
capillarization in mice requires NOX-generated O
•–.
308. Ahamed, M and Siddiqui, MKJ (2007) Low level Pb
2
J.Clin.Invest.118,3980. exposureandoxidativestress:currentopinions.Clin.
292. An, Y et al. (2004) Immunohistochemical analysis of Chim.Acta383,57.
oxidativeDNAdamageinAs-relatedhumanskinsam- 309. Delile,Hetal.(2014)PbinancientRome’scitywaters.
plesfromAs-contaminatedareaofChina.CancerLett. Proc.Natl.Acad.Sci.USA111,6594.
214,11. 310. Bakulski, KM et al. (2012) AD and environmen-
293. García-Chávez,Eetal.(2003)Arsenite-inducedforma- tal exposure to Pb: the epidemiologic evidence and
•
tionofOH inthestriatumofawakerats.BrainRes. potential role of epigenetics. Curr. Alzheimer Res.
976,82. 9,563.
294. Datta, AK et al. (1993) Effect of carnosine homo- 311. QuinlanGJetal.(1992)VandCuinclinicalalbuminso-
carnosineandanserineonhydroxylationoftheguan- lutionsandtheirpotentialtodamageproteinstructure.
(cid:4)
inemoietyin2-deoxyguanosine,DNAandnucleohis- J.Pharm.Sci.81,611.
tonewithH2O2inthepresenceofNi(II).Carcinogenesis 312. Krejsa, CM and Schieven, GL (1998) Impact of oxi-
14,417. dativestressonsignaltransductioncontrolbyphos-
295. Nackerdien,Zetal.(1991)Ni(II)-andCo(II)-dependent photyrosinephosphatases.Environ.HealthPerspect.106
damagebyH2O2totheDNAbasesinisolatedhuman (Suppl5),1179.
chromatin.CancerRes.51,5837. 313. Xie,Detal.(2013)SurfaceengineeringofTisubstrates
296. Golubnitschaja, O and Yeghiazaryan, K (2012) Opin- with chitosan-atorvastatin conjugate for reduced in-
ioncontroversytoCrpicolinatetherapy’ssafetyand flammation responses and improved cytocompatibil-
efficacy:ignoring‘anecdotes’ofcasereportsorrecog- ity.J.Biomed.Mater.Res.A101,2005.
nizing individual risks and new guidelines urgency 314. Ruipérez,Fetal.(2012)Pro-oxidantactivityofAl:pro-
to introduce innovation by predictive diagnostics? motingtheFentonreactionbyreducingFe(III)toFe(II).
EPMAJ.3,11. J.Inorg.Biochem.117,118.
297. Son, YK et al. (2013) ROS mediate Cr(VI)-induced 315. Quinlan, GJ et al. (1988) Action of Pb(II) and Al(III)
carcinogenesisthroughPI3K/AKT-dependentactiva- ions on Fe-stimulated lipid peroxidation in lipo-
tionofGSK-3β/β-cateninsignaling.Toxicol.Appl.Phar- somes,erythrocytesandratlivermicrosomalfractions.
macol.271,239. Biochim.Biophys.Acta962,196.
298. Slade, PG et al. (2005) Guanine-specific oxidation of 316. Wu,Zetal.(2012)Alinducesneurodegenerationand
double-stranded DNA by Cr(VI) and ascorbic acid itstoxicityarisesfromincreasedFeaccumulationand
formsspiroiminodihydantoinand8OHdG.Chem.Res. ROSproduction.Neurobiol.Aging33,199.e1.
Toxicol.18,1140. 317. Pratico, D et al. (2002) Al modulates brain amyloid-
299. Myers, CR (2012) The effects of Cr(VI) on the osisthroughoxidativestressinAPPtransgenicmice.
thioredoxinsystem:implicationsforredoxregulation. FASEBJ.16,1138.
FreeRadic.Biol.Med.52,2091. 318. Yin,Letal.(2010)Theinvolvementoflipidperoxide-
300. Simonsen, LO et al. (2012) Co metabolism and derivedaldehydesinAltoxicityoftobaccoroots.Plant
toxicology–abriefupdate.Sci.TotalEnviron.432,210. Physiol.152,1406.
•
301. Eberhardt, MK (1995) OH . Formation and some re- 319. Fierens,KandKool,M(2012)Themechanismofad-
actionsusedinitsidentification.TrendsOrg.Chem.5, juvanticityofAl-containingformulas.Curr.Pharm.Des.
115. 18,2305.
302. Liochev, SI and Fridovich, I (2005) The roles of CO2 320. Knoch,MEetal.(2008)Microgliainduceneurotoxicity
inCo-catalyzedperoxidations.Arch.Biochem.Biophys. viainterneuronalZn2+releaseandaK+currentsurge.
439,99. Glia56,89.
303. Onodera,Aetal.(2012)Roleofmegalinandthesol- 321. Seet, RC et al. (2011) Oral Zn supplementation does
uble form of its ligand RAP in Cd-metallothionein not improve oxidative stress or vascular function in
endocytosisandCd-metallothionein-inducednephro- patientswithtype2diabeteswithnormalZnlevels.
toxicityinvivo.Toxicol.Lett.212,91. Atherosclerosis219,231.
304. Rogalska, J et al. (2009) Enhanced Zn consumption 322. Brantley,MAJretal.(2012)Theshort-termeffectsof
preventsCd-inducedalterationinlipidmetabolismin antioxidant and Zn supplements on oxidative stress
malerats.Chem.Biol.Interact.177,142. biomarkerlevelsinplasma:apilotinvestigation.Am.
305. Farina, M et al. (2013) Metals, oxidative stress and J.Ophthalmol.153,1104.
neurodegeneration:afocusonFe,MnandHg.Neuro- 323. Kumar,Aetal.(2012)InvolvementofNOXandGSHin
chem.Int.62,575. Zn-induceddopaminergicneurodegenerationinrats:
306. Chen, C et al. (2005) Increased oxidative DNA dam- similaritywithparaquatneurotoxicity.BrainResearch
age, as assessed by urinary 8OHdG concentrations, 1438,48.

--- Page 834 ---

REFERENCES 779
324. Gutteridge, JMC et al. (1983) Free radical damage 343. Vollert, C et al. (2011) Exercise prevents sleep
to polyene antifungal antibiotics: changes in bio- derivation-associatedanxiety-likebehaviorinrats:po-
logical activity and TBA reactivity. J. Appl. Biochem. tentialroleofoxidativestressmechanisms.Behav.Brain
5,53. Res.224,233.
325. Mesa-Arango,ACetal.(2012)Itonlytakesonetodo 344. Rawdin,BSetal.(2012)Dysregulatedrelationshipof
manyjobs:amphotericinBasantifungalandimmun- inflammationandoxidativestressinmajordepression.
omodulatorydrug.Front.Microbiol.3,286. BrainBehav.Immun.31,143.
326. Bink,Aetal.(2011)SODsareinvolvedinCandidaalbic- 345. Joergensen, A et al. (2011) Association between urin-
ansbiofilmpersistenceagainstmiconazole.Antimicrob. ary excretion of cortisol and markers of oxidatively
AgentsChemotherapy55,4033. damaged DNA and RNA in humans. PLoS One 6,
327. Koker,EBetal.(2010)Real-timevisualizationofphoto- e20795.
chemically induced fluorescence of 8-halogenated 346. Epel,ESetal.(2004)Acceleratedtelomereshortening
quinolones:lomefloxacin,clinafloxacinandBay3118in inresponsetolifestress.Proc.Natl.Acad.Sci.USA101,
livehumanHaCaTkeratinocytes.Photochem.Photobiol. 17312.
86,792. 347. Shaffer,JAetal.(2012)Depressivesymptomsarenot
328. Makhzoumi,ZHandArron,ST(2013)Photosensitiz- associated with leukocyte telomere length: findings
ingagentsandtheriskofnon-melanomaskincancer: from the Nova Scotia Health Survey (NSHS95), a
apopulation-basedcase-controlstudy.J.Invest.Derma- population-basedstudy.PLoSOne7,e48318.
tol.133,1922. 348. Boelsterli, UA et al. (2006) Bioactivation and hepato-
329. Gutteridge, JM and Wilkins, S (1984) Non-protein- toxicity of nitroaromatic drugs. Curr. Drug Metab. 7,
bound Fe within bacterial cells and the action of 715.
bleomycin.Biochem.Int.8,89. 349. Biaglow,JEetal.(1986)Biochemistryofreductionof
330. Hassett,DJetal.(1987)Bacteriaformintracellularfree nitroheterocycles.Biochem.Pharmacol.35,77.
radicals in response to paraquat and streptonigrin: 350. Kumagai,Yetal.(2000)ζ-Crystallincatalyzesthere-
•
demonstrationofthepotencyofOH .J.Biol.Chem.262, ductive activation of 2,4,6-TNT to generate ROS: a
13404. proposed mechanism for the induction of cataracts.
331. Yeom,Jetal.(2010)Fehomeostasisaffectsantibiotic- FEBSLett.478,295.
mediated cell death in Pseudomonas species. J. Biol. 351. Hetherington,LHetal.(1996)Two-andone-electron
Chem.285,22689. dependent in vitro reductive metabolism of nitroaro-
332. Orsucci,Detal.(2012)Tetracyclinesandneuromuscu- maticsbyMytilusedulis,CarcinusmaenasandAsterias
lardisorders.Curr.Neuropharmacol.10,134. rubens.Comp.Biochem.Physiol.113C,231.
333. Gutteridge, JM et al. (1998) Phagomimetic action of 352. Olekhnovich, IN et al. (2014) Response to metro-
antimicrobialagents.FreeRadic.Res.28,1. nidazole and oxidative stress is mediated through
334. Keren,Ietal.(2013)Killingbybactericidalantibiotics homeostatic regulator HsrA (HP1043) in Helicobacter
doesnotdependonROS.Science339,1213. pylori.J.Bacteriol.196,729.
335. Fang, FC (2013) Antibiotic and ROS linkage ques- 353. Moreno, SNJ et al. (1985) Reduction of the metallo-
tioned.Nat.Biotechnol.31,415. chromicindicatorsarsenoazoIIIandantipyrylazoIIIto
336. Dwyer,DJetal.(2014)Antibioticsinduceredox-related theirfreeradicalmetabolitesbycytoplasmicenzymes.
physiologicalalterationsaspartoftheirlethality.Proc. FEBSLett.180,229.
Natl.Acad.Sci.USA111,E2100. 354. O’Neill,PandWardman,P(2009)Radiationchemistry
337. Troxell,B etal.(2012)Borreliaburgdorferi,apathogen comesfromradiationbiology.Int.J.Radiat.Biol.85,9.
•
thatlacksFe,encodesMnSODessentialforresistance 355. Ueno,Setal.(2006)EstimationofOH generationby
tostreptonigrin.J.Biol.Chem.287,19284. salicylatehydroxylationmethodinmultipleorgansof
338. Lesniak,Wetal.(2005)Ternarycomplexesofgentami- mice exposed to whole-body X-ray irradiation. Free
cinwithFeandlipidcatalyzeformationofROS.Chem. Radic.Res.40,944.
Res.Toxicol.18,357. 356. Tondel,Metal.(2005)Urinary8OHdGinBelarussian
339. Jankauskas,SSetal.(2012)Mitochondria-targetedanti- childrenrelatestourbanlivingratherthanradiation
oxidantSkQR1amelioratesgentamycin-inducedrenal doseaftertheChernobylaccident:apilotstudy.Arch.
failureandhearingloss.Biochemistry77,666. Environ.Contam.Toxicol.48,515.
(cid:4)
340. Kim,HJetal.(2013)GenK-catalyzedC-6 methylation 357. Lim,KHetal.(2010)Doesradiotherapyincreaseoxi-
inthebiosynthesisofgentamicin:isolationandchar- dative stress? A study with nasopharyngeal cancer
acterization of a cobalamin-dependent radical SAM patients revealing anomalies in IsoP measurements.
enzyme.J.Am.Chem.Soc.135,8093 FreeRadic.Res.44,1064.
341. Kim,STetal.(2005)Immobilizationstresscausesin- 358. Tyurina, YY et al. (2008) Oxidative lipidomics of
creases in THB, dopamine, and neuromelanin and γ-irradiation-inducedintestinalinjury.FreeRadic.Biol.
oxidativedamageinthenigrostriatalsystem.J.Neuro- Med.44,299.
chem.95,89. 359. Atkinson, J et al. (2011) A mitochondria-targeted in-
342. Seo,JSetal.(2012)NOXmediatesdepressivebehavior hibitorofcytochromecperoxidasemitigatesradiation-
inducedbychronicstressinmice.J.Neurosci.32,9690. induceddeath.Nat.Commun.2,497.

--- Page 835 ---

780 REFERENCES
360. Hersleth, HP and Andersson, KK (2011) How dif- dietaryantioxidantsandchemotherapyorradiother-
ferent oxidation states of crystalline myoglobin are apy.CancerInvest.29,655.
influencedbyX-rays.Biochim.Biophys.Acta1814,785. 378. Ghatage, P and Sabagh, H (2012) Is there a role for
361. Stone,R(2005)Russiancancerstudyaddstotheindict- tirapazamineinthetreatmentofcervicalcancer?Expert
mentoflow-doseradiation.Science310,959. Opin.DrugMetab.Toxicol.8,1589.
362. Szumiel,I(2012)Radiationhormesis:autophagyand 379. Arvanitoyannis,ISetal.(2009)Impactofirradiationon
othercellularmechanism.Int.J.Radiat.Biol.88,619. fishandseafoodshelflife:acomprehensivereviewof
363. Huang, TT et al. (2012) Oxidative stress and adult applicationsandirradiationdetection.Crit.Rev.Food
neurogenesis–effectsofradiationandSODdeficiency. Sci.Nutr.49,68.
Semin.CellDev.Biol.23,738. 380. Sadio, J et al. (2012) Carbon-centered radicals in
364. Wardman,P(2009)Theimportanceofradiationchem- γ-irradiated bone substituting biomaterials based on
istrytoradiationandfreeradicalbiology(The2008Sil- hydroxyapatite.J.Mater.Sci.Mat.Med.23,2061.
vanus Thompson Memorial Lecture). Brit. J. Radiol.
82,89.
Chapter10
365. Li,Metal.(2014)Healthrisksofspaceexploration:tar-
getedandnontargetedoxidativeinjurybyhigh-charge 1. Halliwell,Betal.(1992)Freeradicals,antioxidants
and high-energy particles. Antioxid. Redox Signal. 20, andhumandisease.Wherearewenow?J.Lab.Clin.
1501. Med.119,598.
366. Wang,Hetal.(2013)Synthesis,radioprotectiveactiv- 2. Firuzi,Oetal.(2011)Antioxidanttherapy:current
ityandpharmacokineticscharacteristicofanewstable status and future prospects. Curr. Med. Chem. 18,
nitronylnitroxylradical–NIT2011.Biochimie95,1574. 3871.
367. Dürken,Metal.(2000)Impairedplasmaanti-oxidative 3. Trüeb,R(2009)Oxidativestressinageingofhair.
defenseandincreasednontransferrin-boundFeduring Int.J.Trichology1,6.
high-dosechemotherapyandradiochemotherapypre- 4. Halliwell,BandGutteridge,JMC(1984)Lipidper-
cedingbonemarrowtransplantation.FreeRadic.Biol. oxidation,O2radicals,celldamageandantioxidant
Med.28,887. therapy.Lancet1,1396.
368. Persson,HL(2006)Radiation-inducedlysosomaliron 5. Arsalani-Zadeh, R et al. (2011) Oxidative stress in
reactivity: implications for radioprotective therapy. laparoscopicversusopenabdominalsurgery:asys-
IUBMBLife58,395. tematicreview.J.Surg.Res.169,e59.
369. Maier, P et al. (2011) Radioprotective gene therapy. 6. Solaini,GandHarris,DA(2005)Biochemicaldys-
ExpertOpin.Biol.Ther.11,1135. functioninheartmitochondriaexposedtoischae-
370. Gauter-Fleckenstein,Betal.(2010)Earlyandlatead- miaandreperfusion.Biochem.J.390,377.
ministrationofMnTE-2-PyP5+inmitigationandtreat- 7. Gutteridge,JMCandMitchell,J(1999)Redoximbal-
ment of radiation-induced lung damage. Free Radic. anceinthecriticallyill.Br.Med.Bull.55,49.
Biol.Med.48,1034. 8. Sepulveda,RTandWatson,RR(2002)Treatmentof
371. Kolesnick, R and Fuks, Z (2003) Radiation and antioxidantdeficienciesinAIDSpatients.Nutr.Res.
ceramide-inducedapoptosis.Oncogene22,5897. 22,27.
372. Misra, H and Fridovich, I (1976) SOD and the O2 9. Wang, Y et al. (2013) Effects of vitamin C and
enhancementofradiationlethality.Arch.Biochem.Bio- vitaminD administration on mood and distress
phys.176,577. in acutely hospitalized patients. Am. J. Clin. Nutr.
373. Slade, D and Radman, M (2011) Oxidative stress re- 98,705.
sistanceinDeinococcusradiodurans.Microbiol.Mol.Biol. 10. Manzanares,Wetal.(2013)Updateonantioxidant
Rev.75,133. micronutrientsinthecriticallyill.Curr.Opin.Clin.
374. Abreu, IA et al. (2008) The kinetic mechanism of Nutr.Metab.Care16,719.
Mn-containing SOD from Deinococcus radiodurans: a 11. Heyland,Detal.(2013)Arandomizedtrialofglu-
specialized enzyme for the elimination of high O
•–
tamineandantioxidantsincriticallyillpatients.N.
2
concentrations.Biochemistry47,2350. Engl.J.Med.368,1489.
375. Krisko, A et al. (2012) Extreme anti-oxidant protec- 12. Kang, SA et al. (1998) In vivo dual effects of
tionagainstionizingradiationinbdelloidrotifers.Proc. vitaminC on paraquat-induced lung damage: de-
Natl.Acad.Sci.USA109,2354. pendence on released metals from the damaged
376. Meyer,Fetal.(2008)Interactionbetweenantioxidant tissue.FreeRadic.Res.28,93.
vitaminsupplementationandcigarettesmokingdur- 13. Yang, ZP et al. (1996) Diisopropylphosphoro-
ing radiation therapy in relation to long-term effects fluoridate-inducedmusclehyperactivityassociated
onrecurrenceandmortality:arandomizedtrialamong withenhancedlipidperoxidationinvivo.Biochem.
headandneckcancerpatients.Int.J.Cancer122,1679. Pharmacol.52,357.
377. Nakayama,Aetal.(2011)Systematicreview:generat- 14. Lawler,JM(2011)Exacerbationofpathologybyoxi-
ingevidence-basedguidelinesontheconcurrentuseof dativestressinrespiratoryandlocomotormuscles

--- Page 836 ---

REFERENCES 781
withDuchennemusculardystrophy.J.Physiol.589, 32. Darley-Usmar,VandHalliwell,B(1996)Bloodrad-
2161. icals.Pharm.Res.13,649.
15. Renjini, R et al. (2012) Oxidative damage in mus- 33. Devchand, PR et al. (2004) Oxidative stress and
culardystrophycorrelateswiththeseverityofthe PPARs.Circ.Res.95,1137.
pathology:roleofGSHmetabolism.Neurochem.Res. 34. Davies, SS et al. (2001) Oxidized alkyl phospho-
37,885. lipidsarespecific,highaffinityPPARγligandsand
16. Libby, P et al. (2011) Progress and challenges in agonists.J.Biol.Chem.276,16015.
translating the biology of atherosclerosis. Nature 35. Steinberg,DandWitztum,JL(2010)OxidizedLDL
473,317. andatherosclerosis.Arterioscler.Thromb.Vasc.Biol.
17. Boyle, JJ (2012) Heme and haemoglobin direct 30,2311.
macrophage Mhem phenotype and counter foam 36. Lassègue, B et al. (2012) Biochemistry, physiology,
cellformationinareasofintraplaquehaemorrhage. andpathophysiologyofNOXsinthecardiovascular
Curr.Opin.Lipidol.23,453. system.Circ.Res.110,1364.
18. Moore,KJetal.(2013)Macrophagesinatheroscler- 37. Swain, J and Gutteridge, JMC (1995) Prooxidant
osis:adynamicbalance.Nat.Rev.Immunol.13,709. Fe and Cu, with ferroxidase and XO activities in
19. Zhang,Zetal.(2012)DoesCRPcontributetoath- humanatheroscleroticlesions.FEBSLett.368,513.
erothrombosisviaoxidant-mediatedreleaseofpro- 38. Martino, F et al. (2008) Oxidative stress is associ-
thromboticfactorsandactivationofplatelets?Front. atedwitharterialdysfunctionandenhancedintima-
Physiol.3,433. media thickness in children with hypercholester-
20. Shao,Betal.(2010)MPO:anoxidativepathwayfor olemia: the potential role of NOX. Pediatrics 122,
generating dysfunctional HDL. Chem. Res. Toxicol. e648.
23,447. 39. Reilly,MPetal.(1998)Increasedformationofdis-
21. Palinski,WandNapoli,C(2002)Thefetalorigins tinct F2-IsoPs in hypercholesterolemia. Circulation
of atherosclerosis: maternal hypercholesterolemia, 98,2822.
and cholesterol-lowering or antioxidant treatment 40. Allen,JDetal.(2012)NO– andNOmetabolismin
2
during pregnancy influence in utero program- peripheralarterydisease.NitricOxide26,217.
mingandpostnatalsusceptibilitytoatherogenesis. 41. Badimon,Letal.(2011)Updateonlipids,inflamma-
FASEBJ.16,1348. tion and atherothrombosis. Thromb. Haemost. 105,
22. Cines, DB et al. (1998) Endothelial cells in physi- S34.
ologyandinthepathophysiologyofvasculardis- 42. Sydow, K and Böger, RH (2012) ADMA and oxi-
orders.Blood91,3527. dative stress are responsible for endothelial dys-
23. Lacroix,Setal. (2012)Therole of oxidativestress functioninhyperhomocyst(e)inaemia:effectsofL-
inpostprandialendothelialdysfunction.Nutr.Res. arginineandBvitamins.Cardiovasc.Res.96,167.
Rev.25,288. 43. Violi, F et al. (2013) Reduced atherosclerotic bur-
24. Raaz, U et al. (2014) Hemodynamic regulation of den in subjects with genetically determined low
ROS: implications for vascular diseases. Antioxid. oxidativestress.Arterioscler.Thromb.Vasc.Biol.33,1.
RedoxSignal.20,914. 44. Guo,Xetal.(2012)OverexpressionofPrdx4attenu-
25. Goyal,Tetal.(2012)Currentconceptsoftheroleof ates atherosclerosis in apoE-knockout mice. Anti-
oxLDLreceptorsinatherosclerosis.Curr.Atheroscler. oxid.Redox.Signal.17,1362.
Rep.14,150. 45. Park, JG et al. (2011) Prdx2 deficiency exacerbates
26. Sawamura, T et al. (2012) LOX-1: a multiligand atherosclerosisinapoE-deficientmice.Circ.Res.109,
receptor at the crossroads of response to danger 739.
signals.Curr.Opin.Lipidol.23,439. 46. Lönn, ME et al. (2012) Actions of “antioxidants”
27. Levitan,Ietal.(2010)OxLDL:diversity,patternsof intheprotectionagainstatherosclerosis.FreeRadic.
recognition,andpathophysiology.Antioxid.Redox. Biol.Med.53,863.
Signal.13,39. 47. Kang, DH et al. (2013) Vascular injury involves
28. Brand,Ketal.(1997)RoleofNF-κBinatherogenesis. the overoxidation of prx type II and is recovered
Exp.Physiol.82,297. bytheperoxiredoxinactivitymimeticthatinduces
29. Robbesyn,Fetal.(2004)DualroleofoxLDLonthe re-endothelialization.Circulation128,834.
NF-κBsignalingpathway.FreeRadic.Res.38,541. 48. Shao,Betal.(2010)MPO:anoxidativepathwayfor
30. Cipollone,Fetal.(2004)BalancebetweenPGDsyn- generating dysfunctional HDL. Chem. Res. Toxicol.
thaseandPGEsynthaseisamajordeterminantof 23,447.
atheroscleroticplaqueinstabilityinhumans.Arterio. 49. Yoshida,HandKisugi,R(2010)MechanismsofLDL
Thromb.Vasc.Biol.24,1259. oxidation.Clin.Chim.Acta411,1875.
31. Praticò, D et al. (1997) Localization of distinct F2- 50. Pannala,ASetal.(1998)InteractionofONOO–with
IsoPs in human atherosclerotic lesions. J. Clin. In- carotenoidsandtocopherolswithinLDL.FEBSLett.
vest.100,2028. 423,297.

--- Page 837 ---

782 REFERENCES
51. Martinez,Metal.(2013)Functionalimpactofoxida- and atherosclerotic lesion development in
tive posttranslational modifications on fibrinogen apoE-deficientmice.Atherosclerosis223,306.
andfibrinclots.FreeRadic.Biol.Med.65,411. 68. Pentikäinen, MO et al. (2001) MPO and OCl–, but
52. Daiber,AandMünzel,T(2012)Increasedcirculat- notCuions,oxidizeheparin-boundLDLparticles
inglevelsof3-nitrotyrosineautoantibodies.Circula- and release them from heparin. Arterio. Thromb.
tion126,2371. Vasc.Biol.21,1902.
53. Strobel,NAetal.(2011)Oxidativestressbiomarkers 69. Ren,Metal.(2005)Fechelationinhibitsatheroscler-
aspredictorsofcardiovasculardisease.Int.J.Car- osislesiondevelopmentandreduceslesionFecon-
diol.147,191. centrationsinthecholesterol-fedrabbit.FreeRadic.
54. Haslacher, H et al. (2012) Plasma MPO level and Biol.Med.38,1206.
peripheral arterial disease. Eur. J. Clin. Invest. 42, 70. You,SAandWang,Q(2005)Ferritininatheroscler-
463. osis.Clin.Chim.Acta357,1.
55. Karakas, M et al. (2012) MPO is associated with 71. Jeney,Vetal.(2002)Pro-oxidantandcytotoxicef-
incident coronary heart disease independently of fectsofcirculatingheme.Blood100,879.
traditional risk factors: results from the MON- 72. Ishikawa, K et al. (2001) HO-1 inhibits atherogen-
ICA/KORAAugsburgstudy.J.Intern.Med.271,43. esisinWatanabeheritablehyperlipidemicrabbits.
56. Malle,Eetal.(2006)ModificationofLDLbyMPO- Circulation104,1831.
derived oxidants and reagent HOCl. Biochim. Bio- 73. Stocker,R(2009)Molecularmechanismsunderlying
phys.Acta1761,392. the antiatherosclerotic and antidiabetic effects of
57. Coleman, LG et al. (2004) LDL oxidized by HOCl probucol, succinobucol, and other probucol ana-
causesirreversibleplateletaggregationwhencom- logues.Curr.Opin.Lipidol.20,227.
binedwithlowlevelsofADP,thrombin,epineph- 74. Purushothaman,KRetal.(2012)Increasedexpres-
rine, or macrophage-derived chemokine (CCL22). sion of oxidation-specific epitopes and apoptosis
Blood104,380. are associated with haptoglobin genotype. J. Am.
58. Marsche, G et al. (2007) OCl–-modified al- Coll.Cardiol.60,112.
bumin colocalizes with RAGE in the artery 75. Merched,AJetal.(2008)Atherosclerosis:evidence
wall and promotes MCP-1 expression via the forimpairmentofresolutionofvascularinflamma-
RAGE-Erk1/2 MAP-kinase pathway. FASEB J. tiongovernedbyspecificlipidmediators.FASEBJ.
21,1145. 22,3595.
59. Shepherd, J et al. (2007) A fluorescent probe for 76. Sendobry, SM et al. (1997) Attenuation of diet-
the detection of MPO activity in atherosclerosis- induced atherosclerosis in rabbits with a highly
associatedmacrophages.Chem.Biol.14,1221. selective15-LOXinhibitorlackingsignificantanti-
60. Brennan,MLetal.(2001)Increasedatherosclerosis oxidantproperties.Br.J.Pharmacol.120,1199.
inMPO-deficientmice.J.Clin.Invest.107,419. 77. Waddington, EI et al. (2003) Fatty acid oxidation
61. Castellani,LWetal.(2006)Transgenicmiceexpress productions in human atherosclerotic plaque: an
human MPO – 463G/A alleles at atherosclerotic analysisofclinicalandhistopathologicalcorrelates.
lesions,developinghyperlipidemiaandobesityin Atherosclerosis167,111.
-463Gmales.J.LipidRes.47,1366. 78. Hutchins,PMetal.(2011)ElectrosprayMS/MSre-
62. Liu,Cetal.(2012)Effectsofanovelpharmacologic veals extensive and nonspecific oxidation of chol-
inhibitorofMPOinamouseatherosclerosismodel. esterolestersinhumanperipheralvascularlesions.
PLoSOne7,e50767. J.LipidRes.52,2070.
63. Thukkani, AK et al. (2003) Identification of α- 79. Shishehbor, MH et al. (2003) Association of ni-
chloro fatty aldehydes and unsaturated lysophos- trotyrosine levels with cardiovascular disease and
phatidylcholinemolecularspeciesinhumanathero- modulationbystatintherapy.JAMA289,1675.
scleroticlesions.Circulation108,3128. 80. Rota, S et al. (1998) Atherogenic lipoproteins sup-
64. Fu,Setal.(1998)Evidenceforrolesofradicalsin portassemblyoftheprothrombinasecomplexand
proteinoxidationinadvancedhumanatheroscler- thrombingeneration:modulationbyoxidationand
oticplaque.Biochem.J.333,519. vitaminE.Blood91,508.
65. Evans, PJ et al. (1995) Metal ion release from 81. Demer, L and Tintut, Y (2011) The roles of lipid
mechanically-disruptedhumanarterialwall.Impli- oxidationproductsandreceptoractivatorofNF-κB
cationsforthedevelopmentofatherosclerosis.Free signaling in atherosclerotic calcification. Circ. Res.
Radic.Res.23,465. 108,1482.
66. Völker, W et al. (1997) Cu-induced inflammatory 82. Rimner, A et al. (2005) Relevance and mechanism
reactions of rat carotid arteries mimic restenosis/ ofoxysterolstereospecificityincoronaryarterydis-
arteriosclerosis-like neointima formation. Athero- ease.FreeRadic.Biol.Med.38,535.
sclerosis130,29. 83. Olkkonen, VM (2012) Macrophage oxysterols and
67. Wei, H et al. (2012) Cu chelation by tetra- theirbindingproteins:rolesinatherosclerosis.Curr.
thiomolybdate inhibits vascular inflammation Opin.Lipidol.23,462.

--- Page 838 ---

REFERENCES 783
84. Brown, BG et al. (2001) Simvastatin and niacin, 100. Esterbauer,Hetal.(1992)Theroleoflipidperoxid-
antioxidant vitamins, or the combination for the ationandantioxidantsinoxidativemodificationof
prevention of coronary disease. N. Engl. J. Med. LDL.FreeRadic.Biol.Med.13,341.
345,1583. 101. Ziouzenkova,Oetal.(1998)Cucanpromoteoxida-
85. Davies,SSandRoberts,LJII(2011)F2-IsoPsasan tionofLDLbymarkedlydifferentmechanisms.Free
indicatorandriskfactorforcoronaryheartdisease. Radic.Biol.Med.24,607.
FreeRadic.Biol.Med.50,559. 102. Reaven,P(1996)TheroleofdietaryfatinLDLoxi-
86. Upston,JMetal.(2002)Oxidizedlipidaccumulates dationandatherosclerosis.Nutr.Metab.Cardiovasc.
in the presence of α-tocopherol in atherosclerosis. Dis.6,57.
Biochem.J.363,753. 103. Retsky, KL et al. (1999) Inhibition of Cu-induced
87. Malik,QandHerbert,KE(2012)Oxidativeandnon- LDL oxidation by vitamin C is associated with
oxidativeDNAdamageandcardiovasculardisease. decreased Cu-binding to LDL and 2-oxo-histidine
FreeRadic.Res.46,554. formation.FreeRadic.Biol.Med.26,90.
88. Horiuchi, S et al. (2003) Scavenger receptors for 104. Hatta,AandFrei,B(1995)Oxidativemodification
oxidizedandglycatedproteins.AminoAcids25,283. andantioxidantprotectionofhumanLDLathigh
89. Bochkov,VNetal.(2010)Generationandbiological andlowO2partialpressures.J.LipidRes.36,2383.
activitiesofoxidizedphospholipids.Antioxid.Redox 105. Raveh,Oetal.(2002)O2 availabilityasapossible
Signal.12,1009. limitingfactorinLDLoxidation.FreeRadic.Res.36,
90. Lahoute,Cetal.(2011)Adaptiveimmunityinath- 1109.
erosclerosis: mechanisms and future therapeutic 106. Burkitt,MJ(2001)Acriticaloverviewofthechem-
targets.Nat.Rev.Cardiol.8,348. istryofCu-dependentLDLoxidation:rolesoflipid
91. Nilsson,Jetal.(2003)Immunomodulationofathero- hydroperoxides, α-tocopherol, thiols, and cerulo-
sclerosis.Arterioscler.Thromb.Vasc.Biol.25,18. plasmin.Arch.Biochem.Biophys.394,117.
92. Björkbacka, H et al. (2013) Emerging biomarkers 107. Ahotupa,Metal.(2010)Lipoprotein-specifictrans-
and intervention targets for immune-modulation port of circulating lipid peroxides. Ann. Med. 42,
of atherosclerosis – a review of the experimental 521.
evidence.Atherosclerosis227,9. 108. Girotti,AW(2008)Translocationasameansofdis-
93. Freyschuss,Aetal.(2001)Ontheanti-atherogenic seminatinglipidhydroperoxide-inducedoxidative
effectoftheantioxidantBHTincholesterol-fedrab- damageandeffectoraction.FreeRadic.Biol.Med.44,
bits: inverse relation between serum triglycerides 956.
and atheromatous lesions. Biochim. Biophys. Acta 109. Esterbauer,Hetal.(1991)Effectofantioxidantson
1534,129. oxidativemodificationofLDL.Ann.Med.23,573.
94. Loke, WM et al. (2010) Specific dietary polyphe- 110. Kalyanaraman,Betal.(1992)Synergisticinteraction
nolsattenuateatherosclerosisinapolipoproteinE- betweentheprobucolphenoxylradicalandascorbic
knockout mice by alleviating inflammation and acidininhibitingtheoxidationofLDL.J.Biol.Chem.
endothelial dysfunction. Arterioscler. Throm. Vasc. 267,6789.
Biol.30,749. 111. Bräsen,JHetal.(2002)Comparisonoftheeffectsof
95. Hodis, HN et al. (2002) α-Tocopherol supplemen- α-tocopherol,ubiquinone-10andprobucolatthera-
tation in healthy individuals reduces LDL oxida- peutic doses on atherosclerosis in WHHL rabbits.
tion but not atherosclerosis:the vitaminE athero- Atherosclerosis163,249.
sclerosispreventionstudy(VEAPS).Circulation106, 112. Milde,Jetal.(2007)Synergisticeffectsofphenolics
1453. and carotenoids on human LDL oxidation. Mol.
96. Pignatelli, P et al. (2010) Atorvastatin inhibits Nutr.FoodRes.51,956.
gp91phox circulatinglevelsinpatientswithhyper- 113. Zou,ZYetal.(2014)Effectsofluteinandlycopene
cholesterolemia.Arterioscler.Thromb.Vasc.Biol. 30, oncarotidintima-mediathicknessinChinesesub-
360. jectswithsubclinicalatherosclerosis:arandomized,
97. Praticò,Detal.(2001)Lipidperoxidationinmouse double-blind placebo-controlled trial. Brit. J. Nutr.
modelsofatherosclerosis.TrendsCardiovasc.Med.11, 111,474.
112. 114. Fassett, RG and Coombes, JS (2012) Astaxanthin
98. Suarna, C et al. (2006) Protective effect of vitamin incardiovascularhealthanddisease.Molecules17,
E supplements on experimental atherosclerosis is 2030.
modestanddependsonpreexistingvitaminEde- 115. Patterson, RA et al. (2003) Prooxidant and anti-
ficiency.FreeRadic.Biol.Med.41,722. oxidant properties of human serum ultrafiltrates
99. Babaev, BR et al. (2010) Combined vitamin C and towardLDL:importantroleofuricacid.J.LipidRes.
vitaminEdeficiencyworsensearlyatherosclerosis 44,512
in apoE-deficient mice. Arterioscler. Thromb. Vasc. 116. Otero, P et al. (1997) Antioxidant and prooxidant
Biol.30,1751. effects of ascorbic acid, DHA and flavonoids on

--- Page 839 ---

784 REFERENCES
LDL submitted to different degrees of oxidation. 133. Huh, JY et al. (2012) Prx3 is a key molecule regu-
FreeRadic.Res.27,619. latingadipocyteoxidativestress,mitochondrialbio-
117. Carr,ACetal.(2000)VitaminCprotectsagainstand genesis,andadipokineexpression.Antioxid.Redox.
reversesspecificHOCl-andchloramine-dependent Signal.16,229.
modificationsofLDL.Biochem.J.346,491. 134. Lee, YS et al. (2008) Dysregulation of adipose
118. Penumetcha,Metal.(2012)Pretreatmentwithn-6 GPx3 in obesity contributes to local and systemic
PUFAprotectsagainstsubsequenthighfatdietin- oxidativestress.Mol.Endocrinol.22,2176.
duced atherosclerosis – potential role of oxidative 135. Nair, D et al. (2012) Adverse cognitive effects of
stress-induced antioxidant defense. Atherosclerosis high-fatdietinamurinemodelofsleepapneaare
220,53. mediatedbyNOXactivity.Neuroscience227,361.
119. Vissers, MN et al. (2001) Effect of consumption of 136. Samocha-Bonet,Detal.(2012)Overfeedingreduces
phenols from olives and extra virgin olive oil on insulin sensitivity and increases oxidative stress,
LDL oxidizability in healthy humans. Free Radic. withoutalteringmarkersofmitochondrialcontent
Res.35,619. andfunctioninhumans.PLoSOne7,e36320.
120. Riemersma, RA et al. (2003) Seasonal variation in 137. Anderson,EJetal.(2009)MitochondrialH2O2emis-
Cu-mediated LDL oxidation in vitro is related to sionandcellularredoxstatelinkexcessfatintake
varyingplasmaconcentrationofoxidizedlipidsin to insulin resistance in both rodents and humans.
summerandwinter.FreeRadic.Res.37,341. J.Clin.Invest.119,573.
121. Nikolic,Detal.(2013)Lipoproteinsubfractionsin 138. Youn,Jetal.(2014)Roleofvascularoxidativestress
metabolic syndrome and obesity: clinical signifi- in obesity and metabolic syndrome. Diabetes 63,
canceandtherapeuticapproaches.Nutrients5,928. 2344.
122. Navab,Metal.(2011)HDLandcardiovasculardis- 139. Rochford,JJetal.(2011)Settingthetone:ROSand
ease:atherogenicandatheroprotectivemechanisms. thecontrolofappetitivemelanocortinneurons.Cell
Nat.Rev.Cardiol.8,222. Metab.14,573.
123. Hoeg, JM et al. (1996) Overexpression of LCAT 140. Parola, M and Marra, F (2011) Adipokines and
intransgenicrabbitspreventsdiet-inducedathero- redoxsignaling:impactonfattyliverdisease.An-
sclerosis.Proc.Natl.Acad.Sci.USA93,11448. tioxid.RedoxSignal.15,461.
124. She,ZGetal.(2012)ThehumanPONgeneclusteras 141. Mizoue,Tetal.(2007)Bodymassindexandoxida-
atargetinthetreatmentofatherosclerosis.Antioxid. tiveDNAdamage:alongitudinalstudy.CancerSci.
RedoxSignal.16,597. 98,1254.
125. Connelly,PWetal.(2005)PON-1doesnotreduceor 142. Tarnaud,Cetal.(2012)Bodymassindexandlung
modifyoxidationofphospholipidsbyONOO–.Free cancerrisk:resultsfromtheICAREstudy,alarge,
Radic.Biol.Med.38,164. population-basedcase-controlstudy.CancerCauses
126. Francis,GA(2000)HDLoxidation:invitrosuscep- Control23,1113.
tibilityandpotentialinvivoconsequences.Biochim. 143. Dow,CAetal.(2013)Dailyconsumptionofgrape-
Biophys.Acta1483,217. fruit for 6 weeks reduces urine F2-IsoPs in over-
127. Hadfield, KA et al. (2013) MPO-derived oxidants weightadultswithhighbaselinevaluesbuthasno
modify apolipoprotein A-I and generate dysfunc- effectonplasmahigh-sensitivityCRPorsVCAM-1.
tional HDL: comparison of HOSCN with HOCl. J.Nutr.143,1586.
Biochem.J.449,531. 144. Guardiola, F et al. (2007) Lack of effect of oral
128. Shao, B et al. (2014) Humans with atherosclerosis supplementation with antioxidants on cholesterol
have impaired ABCA1 cholesterol efflux and en- oxidationproductconcentrationofhumanplasma,
hanced HDL oxidation by MPO. Circ. Res. 114, as revealed by an improved gas chromatography
1733. method.Anal.Bioanal.Chem.389,277.
129. Bergmark,Cetal.(2008)Anovelfunctionoflipo- 145. Block,Getal.(2008)TheeffectofvitaminsCand
protein [a] as a preferential carrier of oxidized E on biomarkers of oxidative stress depends on
phospholipids in human plasma. J. Lipid Res. 49, baselinelevel.FreeRadic.Biol.Med.45,377.
2230. 146. McAnulty, SR et al. (2005) Effect of daily fruit in-
130. Mattson,MP(2009)Rolesofthelipidperoxidation gestion on angiotensin converting enzyme activ-
product4-HNEinobesity,themetabolicsyndrome, ity,bloodpressure,andoxidativestressinchronic
andassociatedvascularandneurodegenerativedis- smokers.FreeRadic.Res.39,1241.
orders.Exp.Gerontol.44,625. 147. Kota,SKetal.(2012)Geneticsoftype2diabetesmel-
131. Dali-Youcef,Netal.(2012)Metabolicinflammation: litusandotherspecifictypesofdiabetes;itsrolein
connectingobesityandinsulinresistance.Ann.Med. treatmentmodalities.DiabetesMetab.Syndr.6,54.
45,242. 148. Piganelli,JDetal.(2002)Ametalloporphyrin-based
132. Bhaskaran,Ketal.(2014)Body-massindexandrisk SOD mimic inhibits adoptive transfer of auto-
of 22 specific cancers: a population-based cohort immune diabetes by a diabetogenic T-cell clone.
studyof5.24millionUKadults.Lancet384,755. Diabetes51,347.

--- Page 840 ---

REFERENCES 785
149. Bowman, MA et al. (1994) Prevention of diabetes 167. Shim,JEetal.(2010)VitaminCnutritureinnewly
in the NOD mouse: implications for therapeutic diagnoseddiabetes.J.Nutr.Sci.Vitaminol.56,217.
interventioninhumandisease.Immunol.Today15, 168. Sekhar, RV et al. (2011) GSH is diminished in pa-
115. tients with uncontrolled diabetes and restored by
150. Olcott, AP et al. (2004) A salen-Mn catalytic free dietarysupplementationwithcysteineandglycine.
radicalscavengerinhibitstype1diabetesandislet DiabetesCare34,162.
allograftrejection.Diabetes53,2574. 169. Gamage,AMetal.(2014)EffectoforalNAcsupple-
151. Bogdani,Metal.(2012)Biobreedingratisletsexhibit mentationintype2diabeticpatientsonintracellular
reducedanti-oxidativedefenseandNActreatment GSHcontentandinnateimmuneresponsetoBurk-
delaysType1diabetes.J.Endocrinol.216,111. holderiapseudomallei.MicrobesInfect.16,661.
152. Cooksey, RC et al. (2010) Dietary Fe restriction or 170. Marrotte,EJetal.(2010)MnSODexpressioninendo-
Fe chelation protects from diabetes and loss of β- thelialprogenitorcellsaccelerateswoundhealingin
cellfunctionintheobese(ob/oblep-/–)mouse.Am. diabeticmice.J.Clin.Invest.120,4207.
J.Physiol.298,E1236. 171. Kowluru, RA et al. (2006) Overexpression of
153. Tajima,Setal.(2012)Fereductionbydeferoxamine MnSODinmiceprotectstheretinafromdiabetes-
leadstoameliorationofadiposityviatheregulation induced oxidative stress. Free Radic. Biol. Med. 41,
ofoxidativestressandinflammationinobeseand 1191.
type2diabetesKKAymice.Am.J.Physiol.302,E77. 172. Wilkinson-Berka, JL et al. (2013) ROS, Nox and
154. Simcox,JAandMcClain,DA(2013)Feanddiabetes angiotensinIIinangiogenesis:implicationsforret-
risk.CellMetab.17,329. inopathy.Clin.Sci.124,597.
155. Monfared,SSetal.(2009)Islettransplantationand 173. Gorin, Y and Block, K (2013) Nox4 and diabetic
antioxidantmanagement:acomprehensivereview. nephropathy: with a friend like this, who needs
WorldJ.Gastroenterol.15,1153. enemies?FreeRadic.Biol.Med.61,130.
156. Gratas-Delamarche, A et al. (2014) Physical in- 174. Chang, TI et al. (2003) Oxidant regulation of
activity, insulin resistance, and the oxidative- geneexpressionandneuraltubedevelopment:in-
inflammatoryloop.FreeRadic.Res.48,93 sights gained from diabetic pregnancy on mo-
157. Bashan,Netal.(2009)Positiveandnegativeregu- lecular causes of neural tube defects. Diabetologia
lation of insulin signaling by RONS. Physiol. Rev. 46,538.
89,27. 175. Elsner,Metal.(2011)Peroxisome-generatedH2O2
158. Li, Y et al. (2012) Deficiency in the NOX4 predis- as important mediator of lipotoxicity in insulin-
poses towards diet-induced obesity. Int. J. Obesity producingcells.Diabetes60,200.
36,1503. 176. Acharya, JD and Ghaskadbi, SS (2010) Islets and
159. Lei,XGandVatamaniuk,MZetal.(2011)Twotales theirantioxidantdefense.Islets2,225.
of antioxidant enzymes on β cells and diabetes. 177. Giacco,FandBrownlee,M(2010)Oxidativestress
Antioxid.RedoxSignal.14,489. anddiabeticcomplications.Circ.Res.107,1058.
160. Pi, J et al. (2010) ROS signaling, oxidative stress 178. Paneni, F et al. (2012) Gene silencing of the
andNrf2inpancreaticβ-cellfunction.Toxicol.Appl. mitochondrial adaptor p66Shc suppresses vascular
Pharmacol.244,77. hyperglycemicmemory in diabetes. Circ. Res.111,
161. Ristow,Retal.(2009)Antioxidantspreventhealth- 278.
promoting effects of physical exercise in humans. 179. Rains,JLandJain,SK(2011)Oxidativestress,insu-
Proc.Natl.Acad.Sci.USA106,8665. linsignaling,anddiabetes.FreeRadic.Biol.Med.50,
162. Liu, Y et al. (2013) Oxidative damage associated 567.
with obesity is prevented by overexpression of 180. Connelly, KA et al. (2014) Impaired cardiac anti-
CuZn-orMn-SOD.Biochem.Biophys.Res.Commun. oxidantactivityindiabetes:humanandcorrelative
438,78. experimentalstudies.ActaDiabetol.51,771.
163. Freeman, H et al. (2006) Nicotinamide nucleotide 181. Campanucci,Vetal.(2010)Diabetesdepressessyn-
transhydrogenase:alinkbetweeninsulinsecretion, aptictransmissioninsympatheticgangliabyinacti-
glucose metabolism and oxidative stress. Biochem. vating nAChRs through a conserved intracellular
Soc.Trans.34,806. cysteineresidue.Neuron66,827.
164. Basu,S(2010)FattyacidoxidationandIsoPs:oxi- 182. James, AM et al. (2012) Mitochondrial oxidative
dative strain and oxidative stress. Prostaglandins stress and the metabolic syndrome. Trends Endo-
Leukot.Essent.FattyAcids82,219. crinol.Metabol.23,429.
165. Broedbaek,Ketal.(2013)Associationbetweenurin- 183. Monnier,Letal.(2006)Activationofoxidativestress
arymarkersofnucleicacidoxidationandmortality by acute glucose fluctuations compared with sus-
intype2diabetes.DiabetesCare36,669. tainedchronichyperglycemiainpatientswithtype
166. Rehman,Aetal.(1999)Increasedoxidativedamage 2diabetes.JAMA295,1681.
toallDNAbasesinpatientswithtype2diabetes 184. Sakuraba,Hetal.(2002)Reducedβ-cellmassand
mellitus.FEBSLett.448,120. expressionofoxidativestress-relatedDNAdamage

--- Page 841 ---

786 REFERENCES
in the islet of Japanese Type II diabetic patients. 204. Seet,RCetal.(2010)Markersofoxidativedamage
Diabetologia45,85. are not elevated in otherwise healthy individuals
185. Negre-Salvayre,Aetal.(2009)Hyperglycemiaand withthemetabolicsyndrome.DiabetesCare33,1140.
glycationindiabeticcomplications.Antioxid.Redox 205. Monnier,VM(2001)Transitionmetalsredox:reviv-
Signal.11,3071. inganoldplotfordiabeticvasculardisease.J.Clin.
186. Turco,SDandBasta,G(2012)AnupdateonAGE Invest.107,799.
andatherosclerosis.Biofactors38,266. 206. He, C et al. (2010) Enhanced tyrosine nitration
187. Puangsombat, K et al. (2011) Inhibitory activity of of prostacyclin synthase is associated with in-
Asianspeciesonheterocyclicaminesformationin creasedinflammationinatheroscleroticcarotidar-
cookedbeefpatties.J.FoodSci.76,T174. teries from type 2 diabetic patients. Am. J. Pathol.
188. Calder, PC et al. (2011) Dietary factors and low- 176,2542.
gradeinflammationinrelationtooverweightand 207. Stadler,Netal.(2012)Reducedmetalionconcentra-
obesity.Br.J.Nutr.106,S5. tionsinatheroscleroticplaquesfromsubjectswith
189. Yamakura, F and Kawasaki, H (2010) Post- type2diabetesmellitus.Atherosclerosis222,512.
translational modifications of SOD. Biochim. 208. Chander,PNetal.(2004)NephropathyinZDFrat
Biophys.Acta1804,318. isassociatedwithoxidativeandnitrosativestress:
190. Islam,KNetal.(1995)Fragmentationofceruloplas- preventionbychronictherapywithaONOO–scav-
min following non-enzymatic glycation reaction. engerebselen.J.Am.Soc.Nephrol.15,2391.
J.Biochem.118,1054. 209. Golbidi,Setal.(2011)Antioxidantsinthetreatment
191. Xue,Metal.(2011)Glyoxalaseinageing.Sem.Cell ofdiabetes.Curr.DiabetesRev.7,106.
Dev.Biol.22,293. 210. Rytter,Eetal.(2010)Supplementationwithacom-
192. Giacco, Fet al. (2014) Knockdown of glyoxalase 1 bination of antioxidants does not affect glycaemic
mimicsdiabeticnephropathyinnondiabeticmice. control, oxidative stress or inflammation in type
Diabetes63,291. 2diabetessubjects.FreeRadic.Res.44,1445.
193. Pun,PBetal.(2014)Amitochondria-targetedmass 211. Sola, S et al. (2005) Irbesartan and lipoic acid im-
spectrometryprobetodetectglyoxals:implications proveendothelialfunctionandreducemarkersof
fordiabetes.FreeRadic.Biol.Med.67,437. inflammation in the metabolic syndrome. Circula-
194. Pun,PBandMurphy,MP(2012)Pathologicalsig- tion111,343.
nificanceofmitochondrialglycation.Int.J.CellBiol. 212. Lee,DHetal.(2004)DoessupplementalvitaminC
2012,ArticleID843305. increasecardiovasculardiseaseriskinwomenwith
195. Engelen, L et al. (2012) Current therapeutic inter- diabetes?Am.J.Clin.Nutr.80,1194.
ventions in the glycation pathway: evidence from 213. Kalogeris, T et al. (2012) Cell biology of ische-
clinicalstudies.DiabetesObes.Metab.15,677. mia/reperfusioninjury.Int.Rev.CellMol.Biol.298,
196. Cooper,GJS(2012)SelectivedivalentCuchelation 229.
for the treatment of diabetes mellitus. Curr. Med. 214. Szakmany, T et al. (2012) NAc for sepsis and sys-
Chem.19,2828. temic inflammatory responses in adults. Cochrane
197. Thomas,MCetal.(2005)TheroleofAGEsandAGE DatabaseSystRev.9:CD006616.
inhibitors in diabetic cardiovascular disease. Curr. 215. Harrison,R(2002)StructureandfunctionofXOR:
DrugTargets6,453. wherearewenow?FreeRadic.Biol.Med.33,774.
198. Xue,Metal.(2012)Transcriptionalcontrolofgly- 216. Malik, UZ et al. (2011) Febuxostat inhibition of
oxalase 1 by Nrf2 provides a stress-responsive endothelial-bound XO: implications for targeting
defence against dicarbonyl glycation. Biochem. J. vascularROSproduction.FreeRadic.Biol.Med.51,
443,213. 179.
199. Davi,Getal.(2005)Lipidperoxidationindiabetes 217. van Golen, RF et al. (2014) The mechanisms and
mellitus.Antioxid.RedoxSignal.7,256. physiological relevance of glycocalyx degradation
200. Gopaul, NK et al. (2001) Oxidative stress could in hepatic ischemia/reperfusion injury. Antioxid.
precedeendothelialdysfunctionandinsulinresist- RedoxSignal.21,1098.
ance in Indian Mauritians with impaired glucose 218. Mallick, IH et al. (2004) Ischemia-reperfusion in-
metabolism.Diabetologia44,706.126. juryoftheintestineandprotectivestrategiesagainst
201. Hinokio,Yetal.(2002)Urinaryexcretionof8OHdG injury.Dig.Dis.Sci.49,1359.
asapredictorofthedevelopmentofdiabeticneph- 219. Wen,SHetal.(2014)Roleof15-F2t-IsoPinintestinal
ropathy.Diabetologia45,877. injury induced by intestinal ischemia/reperfusion
202. Wang,TJetal.(2013)2-Aminoadipicacidisabio- inrats.FreeRadic.Res.48,907.
markerfordiabetesrisk.J.Clin.Invest.123,4309. 220. Pitt, RM et al. (1991) A tungsten-supplemented
203. Sell,DRetal.(2007)2-Aminoadipicacidisamarker dietdeliveredbytransplacentalandbreast-feeding
ofproteincarbonyloxidationintheaginghuman lowers intestinal XO activity and affords cytopro-
skin: effects of diabetes, renal failure and sepsis. tectioninischemia-reperfusioninjurytothesmall
Biochem.J.404,269. intestine.J.Pediatr.Surg.26,930.

--- Page 842 ---

REFERENCES 787
221. Bianciardi,Petal.(2004)XORactivityinischemic 237. Penna,Cetal.(2013)Mitochondrialpathways,per-
humanandratintestine.FreeRadic.Res.38,919. meability transition pore, and redox signaling in
222. Powell,CSandJackson,RM(2003)Mitochondrial cardioprotection:therapeuticimplications.Antioxid.
complex I, aconitase, and succinate dehydrogen- RedoxSignal.18,556.
ase during hypoxia-reoxygenation: modulation of 238. Gerczuk,PZetal.(2012)Anupdateoncardiopro-
enzyme activities by MnSOD. Am. J. Physiol. 285, tection:areviewofthelatestadjunctivetherapies
L189. tolimitmyocardialinfarctionsizeinclinicaltrials.
223. Raedschelders,Ketal.(2012)Thecellularandmo- J.Am.Coll.Cardiol.59,969.
lecularoriginofROSgenerationduringmyocardial 239. Lu,Detal.(2012)KnockdownofCYP2E1inhibits
ischemiaandreperfusion.Pharmacol.Ther.133,230. oxidativestressandapoptosisinthecTnTR141Wdi-
224. Su, H et al. (2012) Acute hyperglycaemia en- latedcardiomyopathytransgenicmice.Hypertension
hancesoxidativestressandaggravatesmyocardial 60,81.
ischaemia/reperfusion injury: role of thioredoxin- 240. Braunersreuther, V et al. (2013) Role of NOX iso-
interactingprotein.J.Cell.Mol.Med.17,181. formsNOX1,NOX2andNOX4inmyocardialische-
225. Li, G et al. (1997) Catalase-overexpressing mia/reperfusioninjury.J.Mol.Cell.Cardiol.64,99.
transgenic mouse heart is resistant to 241. Rudolph,Vetal.(2010)MPOactsasaprofibrotic
ischemia-reperfusion injury. Am. J. Physiol. 273, mediatorofatrialfibrillation.Nat.Med.16,470.
H1090. 242. Benndorf, RA et al. (2008) IsoPs inhibit VEGF-
226. Levonen,ALetal.(2008)Antioxidantgenetherapy inducedendothelialcellmigration,tubeformation,
forcardiovasculardisease:currentstatusandfuture and cardiac vessel sprouting in vitro, as well as
perspectives.Circulation117,2142. angiogenesisinvivoviaactivationoftheTxA2 re-
227. Obal,Detal.(2012)Cardiomyocyte-restrictedover- ceptor:apotentiallinkbetweenoxidativestressand
•
expressionofEC-SODincreasesNO bioavailability impairedangiogenesis.Circ.Res.103,1037.
andreducesinfarctsizeafterischemia/reperfusion. 243. Chan, W et al. (2012) Effect of Fe chelation on
BasicRes.Cardiol.107,305. myocardialinfarctsizeandoxidativestressinST-
228. Jain, M et al. (2004) Increased myocardial dys- elevation-myocardial infarction. Cardiovasc. Interv.
functionafterischemia-reperfusioninmicelacking 5,270.
G6PDH.Circulation109,898. 244. Chevion, M et al. (1993) Cu and Fe are mobilized
229. Richters,Letal.(2011)Exercise-inducedadaptations followingmyocardialischemia:possiblepredictive
of cardiac redox homeostasis and remodeling in criteriafortissueinjury.Proc.Natl.Acad.Sci.USA
heterozygousSOD2-knockoutmice.J.Appl.Physiol. 90,1102.
111,1431. 245. Puppo, A and Halliwell, B (1988) Formation of
•
230. Bernier, M et al. (1989) Reperfusion arrhythmias: OH in biological systems. Does myoglobin stim-
•
dose-related protection by anti-free-radical inter- ulate OH formation from H2O2? Free Radic. Res.
ventions.Am.J.Physiol.256,H1344. Commun.4,415.
231. Bolli,RandMarbán(1999)Molecularandcellular 246. Steen,DLetal.(2013)Prognosticevaluationofcata-
mechanisms of myocardial stunning. Physiol. Rev. lyticFeinpatientswithacutecoronarysyndromes.
79,609. Clin.Cardiol.36,139.
232. Purohit,Aetal.(2013)OxidizedCa2+/calmodulin- 247. Calvert,JWandLefer,DJ(2010)Clinicaltranslation
dependentproteinkinaseIItriggersatrialfibrilla- ofNO– therapyforcardiovasculardiseases.Nitric
2
tion.Circulation128,1748. Oxide22,91.
233. Erickson, JR et al. (2013) Diabetic hyperglycaemia 248. Lokuta,AJetal.(2005)Increasednitrationofsarco-
activates CaMKII and arrhythmias by O-linked plasmic reticulum Ca2+-ATPase in human heart
glycosylation.Nature502,372. failure.Circulation111,988.
234. Luo, M et al. (2013) Diabetes increases mortality 249. Borutaite, V et al. (2013) In the eye of the storm:
after myocardial infarction by oxidizing CaMKII. mitochondrial damage during heart and brain is-
J.Clin.Invest.123,1262. chaemia.FEBSJ.280,4999.
235. Downey, JM et al. (1988) XO is not likely to be 250. Nadtochiy, SM et al. (2012) Nitroalkenes confer
a source of injurious free radicals in the ischemic acutecardioprotectionviaadeninenucleotidetrans-
human heart: a study of species differences. In: locase1.J.Biol.Chem.287,3573.
OxygenRadicalsinthePathophysiologyofHeartDis- 251. Burgoyne,JRetal.(2012)Redoxsignalingincardiac
ease,Singh,PK(ed),KluwerAcademicPublishers, physiologyandpathology.Circ.Res.111,1091.
Boston/Dordrecht/Lancaster. 252. Lovett, DH et al. (2013) N-Terminal truncated
236. deJong,JWetal.(1990)XORactivityinperfused intracellular MMP-2 induces cardiomyocyte hy-
hearts of various species, including humans. Circ. pertrophy,inflammationandsystolicheartfailure.
Res.67,770. PLoSOne8,e68154.

--- Page 843 ---

788 REFERENCES
253. Muthusamy, VR et al. (2012) Acute exercise stress 269. Juni, RP et al. (2013) Oxidative stress and patho-
activates Nrf2/ARE signaling and promotes anti- logicalchangesaftercoronaryarteryinterventions.
oxidantmechanismsinthemyocardium.FreeRadic. J.Am.Coll.Cardiol.61,1471.
Biol.Med.52,366. 270. Watt,Jetal.(2008)Pro-healingdrug-elutingstents:
254. Hill,BGandBhatnagar,A(2009)BeyondROS:alde- aroleofantioxidants.Clin.Sci.114,265.
hydesasarbitratorsofalarmandadaptation.Circ. 271. Choy, KJ et al. (2003) Coenzyme Q10 supplemen-
Res.105,1044. tationinhibitsaorticlipidoxidationbutfailstoat-
255. Maack,CandBöhm,M(2011)Targetingmitochon- tenuateintimalthickeninginballoon-injuredNew
drial oxidative stress in heart failure. J. Am. Coll. Zealandwhiterabbits.FreeRadic.Biol.Med.35,300.
Cardiol.58,83. 272. Eeaver,Hetal.(2012)Oxidativestressandveingraft
•
256. Cracowski,JL(2004)IsoPs:anemergingroleinvas- failure:afocusonNOX,NO andeicosanoids.Curr.
cular physiology and disease? Chem. Phys. Lipids Opin.Pharmacol.12,160.
128,75. 273. Coghlan, JG etal.(1994)Allopurinolpretreatment
257. Ahmed, Z and Tang WH (2012) Pharmacologic improvespostoperativerecoveryandreduceslipid
strategiestotargetoxidativestressinheartfailure. peroxidation in patients undergoing coronary ar-
Curr.HeartFailRep.9,14. terybypassgrafting.J.Thorac.Cardiovasc.Surg.107,
258. Braunersreuther, V and Jaquet, V (2012) ROS in 248.
myocardial reperfusion injury: from physiopatho- 274. Davies,MGetal.(1996)Lazaroidtherapy(methyl-
logytotherapeuticapproaches.Curr.Pharm.Biotech- aminochroman:U83836E)reducesveingraftintimal
nol.13,97. hyperplasia.J.Surg.Res.63,128.
259. Higgins,Petal.(2012)XOinhibitionforthetreat- 275. Godfried, SL and Deckelbaum, LI (1995) Nat-
mentofcardiovasculardisease:asystematicreview uralantioxidantsandrestenosisafterpercutaneous
andmeta-analysis.Cardiovas.Ther.30,217. trans-luminal coronary angioplasty. Am. Heart J.
260. Ovize,Metal.(2013)Myocardialconditioning:op- 129,203.
portunities for clinical translation. Circ. Res. 113, 276. Bolli, R et al. (2007) The late phase of precondi-
439. tioning and its natural clinical application – gene
261. Rodemeister,Setal.(2014)Massiveandlong-lasting therapy.HeartFail.Rev.12,189.
decrease in vitamin C plasma levels as a con- 277. Della-Morte,Detal.(2012)Geneticsandgenomics
sequenceofextracorporealcirculation.Nutrition30, of ischemic tolerance: focus on cardiac and cere-
673. bral ischemic preconditioning. Pharmacogenomics
262. Fontaine,Detal.(2009)Oxidativestressproduced 13,1741.
bycirculatingmicroparticlesinon-pumpbutnotin 278. Heusch,G(2015)Molecularbasisofcardioprotec-
off-pumpcoronarysurgery.ActaCardiol.64,715. tion.Signaltransductioninischemicpre-,post-,and
263. Hasse,Metal.(2010)Novelbiomarkers,oxidative remoteconditioning.Circ.Res.116,674.
stress, and the role of labile Fe toxicity in cardio- 279. Garlid,AOetal.(2013)MitochondrialROS:which
pulmonary bypass-associated acute kidney injury. ROS signals cardioprotection? Am. J. Physiol. 305,
J.Am.Coll.Cardiol.55,2024. H960.
264. de Vries, DK et al. (2013) Oxidative damage in 280. Tang, XL et al. (2002) Oxidant species trigger late
clinicalischemia/reperfusioninjury:areappraisal. preconditioning against myocardial stunning in
Antioxid.RedoxSignal.19,535. consciousrabbits.Am.J.Physiol.282,H281.
265. Paraskevaidis,Ietal.(2005)Deferoxamineinfusion 281. Chouchani,ETetal.(2013)CardioprotectionbyS-
duringcoronaryarterybypassgraftingameliorates nitrosation of a cysteine switch on mitochondrial
lipidperoxidationandprotectsagainstthemyocar- complexI.Nat.Med.19,753.
•
dium against reperfusion injury: immediate and 282. Schulz,RandFerdinandy,P(2013)DoesNO sig-
long-termsignificance.Eur.HeartJ.26,263. naling differ in pre- and post-conditioning? Im-
266. Guan,Wetal.(2003)Effectofallopurinolpretreat- portance of S-nitrosylation vs. protein kinase G
mentonfreeradicalgenerationafterprimarycor- activation.FreeRadic.Biol.Med.54,113.
onaryangioplastyforacutemyocardialinfarction. 283. Bulvik,BEetal.(2012)Cardiacprotectionbyprecon-
J.Cardiovasc.Pharmacol.41,699. ditioning is generated via an Fe-signal created by
267. Laurindo, FRM et al. (1991) Evidence for O
•–-
proteasomaldegradationofFeproteins.PLoSOne
2
dependentcoronaryarteryvasospasmafterangio- 7,e48947.
plastyinintactdogs.Circulation83,1705. 284. Divald,Aetal.(2010)Myocardialischemicprecon-
268. Tsimikas, S et al. (2004) Percutaneous coronary ditioningpreservespostischemicfunctionofthe26S
intervention results in acute increases in oxidized proteasomethroughdiminishedoxidativedamage
phospholipids and lipoprotein(a). Circulation 109, to 19S regulatory particle subunits. Circ. Res. 106,
3164. 1829.

--- Page 844 ---

REFERENCES 789
285. Miyamae,Metal.(2010)Cardioprotectionbyregu- 304. Guzik, B et al. (2013) Mechanisms of oxidative
larethanolconsumption:potentialmechanismsand stressinhumanaorticaneurysms–associationwith
clinicalapplication.Curr.DrugAbuseRev.3,39. clinicalriskfactorsforatherosclerosisanddisease
286. Álvarez,Petal.(2014)Cellularmechanismsagainst severity.Int.J.Cardiol.168,2389.
ischemiareperfusioninjuryinducedbytheuseof 305. Aoki,Tetal.(2009)ROSmodulategrowthofcere-
anestheticpharmacologicalagents.Chem.Biol.Inter- bralaneurysms:astudyusingthefreeradicalscav-
act.218,89. engeredaravoneandp47phox-/- mice.Lab.Invest.
287. Lamberts, RR et al. (2009) ROS-induced stimu- 89,730.
lation of 5’AMP-activated protein kinase medi- 306. Fernandez-Moure, JS et al. (2011) Biology of aor-
atessevoflurane-inducedcardioprotection.Circula- tic aneurysms and dissections. Methodist Debakey
tion120,S10. CardiovascJ.7,2.
•
288. Hausenloy,DJ(2013)Cardioprotectiontechniques: 307. Ophir,Aetal.(1993)OH generationinthecatret-
preconditioning,postconditioningandremotecon- inaduringreperfusionfollowingischemia.Exp.Eye
ditioning (basic science). Curr. Pharm. Des. 19, Res.57,351.
4544. 308. Liu,Yetal.(2012)Effectsofantioxidantgenether-
289. Akgür,FMetal.(2000)RoleofO
•–inhemorrhagic
apy on retinal neurons and oxidative stress in a
2
shock-inducedP-selectinexpression.Am.J.Physiol. model of retinal ischemia/reperfusion. Free Radic.
279,H791. Biol.Med.52,909.
290. Tharakan, B et al. (2008) α-Lipoic acid attenu- 309. Yokota, H et al. (2011) Neuroprotection from ret-
ates hemorrhagic shock-induced apoptotic signal- inalischemia/reperfusioninjurybyNOX2deletion.
ingandvascularhyperpermeability.Shock30,571. Invest.Ophthalmol.Vis.Sci.52,8123.
291. Sanan, S and Sharma, G (1986) Effect of desferri- 310. Obolensky,Aetal.(2008)Ischemicpreconditioning
oxamine mesylate (Desferal) in anesthetized dogs oftheratretina:protectiveroleofferritin.FreeRadic.
withclinicalhemorrhagicshock.Ind.J.Med.Res.83, Biol.Med.44,1286.
655. 311. Motterlini,RandForesti,R(2014)HO-1asatarget
292. Atkins,JLetal.(2011)FerrousFeisfoundinmes- fordrugdiscovery.Antioxid.RedoxSignal.20,1810.
entericlymphboundtoTIMP-1followinghemor- 312. Stein, AB et al. (2012) CO induces a late
rhage/resuscitation.Biometals24,279. preconditioning-mimetic cardioprotective and
293. Angus,DCandvanderPoll,T(2013)Severesepsis antiapoptoticmilieuinthemyocardiumJ.Mol.Cell.
andsepticshock.NEngl.J.Med.369,840. Cardiol.52,228.
294. Janz,DRetal.(2013)Associationbetweencell-free 313. Hettiarachchi,NTetal.(2012)ONOO–mediatesdis-
hemoglobin, acetaminophen, and mortality in pa- ruptionofCa2+homeostasisbyCOviaCa2+ATPase
tientswithsepsis:anobservationalstudy.Crit.Care degradation.Antioxid.RedoxSignal.17,744.
•
Med.41,784. 314. Hara,Setal.(2014)DifferentmechanismsofOH
295. Szabó, C and Módis, K (2010) Pathophysiological productionsusceptibletopurineP2receptorantag-
rolesofONOO–incirculatoryshock.Shock34,4. onistsbetweenCOpoisoningandexogenousATP
296. Ware,LBetal.(2011)Plasmabiomarkersofoxidant inratstriatum.FreeRadic.Res.48,1322.
stress and development of organ failure in severe 315. Bailey, SR et al. (2005) ROS from smooth muscle
sepsis.Shock36,12. mitochondria initiate cold-induced constriction of
297. Rudyk,Oetal.(2013)ProteinkinaseGoxidationisa cutaneousarteries.Am.J.Physiol.289,H243.
majorcauseofinjuryduringsepsis.Proc.Natl.Acad. 316. Leygonie,C,Britz,TJandHoffman,LC(2012)Im-
Sci.USA110,9909. pactoffreezingandthawingonthequalityofmeat:
298. Salvemini, D and Cuzzocrea, S (2002) Oxidative review.MeatSci.91,93.
stressinsepticshockanddisseminatedintravascu- 317. Muelleman,RLetal.(1997)Theuseofpegorgotein
larcoagulation.FreeRadic.Biol.Med.33,1173. in the treatment of frostbite. Wilderness Environ.
299. Cui,Xetal.(2004)Severityofsepsisalterstheef- Med.8,17.
fectsofO
•–inhibitioninaratsepsismodel.J.Appl.
318. Zieger, MA and Gupta, MP (2009) Hypothermic
2
Physiol.97,1349. preconditioningofendothelialcellsattenuatescold-
300. Whitmore, LC et al. (2014) NOX2 protects against inducedinjurybyaferritin-dependentprocess.Free
progressivelunginjuryandMODS.Am.J.Physiol. Radic.Biol.Med.46,680.
307,L71. 319. Hermes-Lima,MandStorey,KB(1993)Antioxidant
301. Webb,DR(2014)Animalmodelsofhumandisease: defensesinthetoleranceoffreezingandanoxiaby
inflammation.Biochem.Pharmacol.87,121. gartersnakes.Am.J.Physiol.265,R646.
302. Leslie,M(2014)Inflammationdebatereignites.Sci- 320. Buzadzic, B et al. (1990) Antioxidant defenses in
ence345,607. thegroundsquirrel,Citelluscitellus.2.Theeffectof
303. Patil,NKetal.(2014)Inactivationofrenalmitochon- hibernation.FreeRadic.Biol.Med.9,407.
drial respiratory complexes and MnSOD during 321. Ma, Y et al. (2012) Impact of warm ischemia on
sepsis:mitochondria-targetedantioxidantmitigates gene expression analysis in surgically removed
injury.Am.J.Physiol.306,F734. biosamples.Anal.Biochem.423,229.

--- Page 845 ---

790 REFERENCES
322. Lavie,LandLavie,P(2009)Molecularmechanisms 340. Kim,Jetal.(2010)ROSgeneratedbyrenalischemia
ofcardiovasculardiseaseinOSAHS:theoxidative and reperfusion trigger protection against subse-
stresslink.Eur.Respir.J.33,1467. quentrenalischemiaandreperfusioninjuryinmice.
323. Monneret, D et al. (2010) Association of urinary Am.J.Physiol.298,F158.
15-F2t-IsoPlevelwithO2 desaturationandcarotid 341. Jaeschke,HandWoolbright,B(2012)Currentstrat-
intima-media thickness in nonobese sleep apnea egiestominimizehepaticischemia-reperfusionin-
patients.FreeRadic.Biol.Med.48,619. jurybytargetingROS.Transplant.Rev.26,103.
324. Jordan, W et al. (2006) Evaluation of oxidative 342. Risby, TH et al. (1994) Evidence for free radical-
stressmeasurementsinobstructivesleepapneasyn- mediated lipid peroxidation at reperfusion of hu-
drome.J.NeuralTransm.113,239. manorthotopiclivertransplants.Surgery115,94.
325. Jefferson,JAetal.(2014)Increasedoxidativestress 343. Grezzana, TJM et al. (2004) Oxidative stress, hep-
ataltitude.Chest145,423. atocellularintegrity,andhepaticfunctionafterini-
326. Phillips, M et al. (2004) Heart allograft rejection: tial reperfusion in human hepatic transplantation.
detection with breath alkanes in low levels (the Transplant.Proc.36,843.
HARDBALL study). J. Heart Lung Transplant. 23, 344. Burke,Aetal.(2002)Aprospectiveanalysisofoxi-
701. dative stress and liver transplantation. Transplant-
327. Land,WG(2012)Emergingroleofinnateimmunity ation74,217.
inorgantransplantationpartIII:thequestfortrans- 345. Evans,PJetal.(1996)Catalyticmetalionsandthe
planttoleranceviapreventionofoxidativeallograft lossofGSHfromUniversityofWisconsinpreserva-
injury and its consequences. Transplantation Rev. tionsolution.Transplantation62,1046.
26,88. 346. Martin,HMetal.(2004)XORispresentinbileducts
328. Fang, JC et al. (2002) Effect of vitamins C and E ofnormalandcirrhoticliver.FreeRadic.Biol.Med.
onprogressionoftransplant-associatedarterioscler- 37,1214.
osis:arandomizedtrial.Lancet359,1108. 347. Shaik,IHandMehvar,R(2010)CYPinductionby
329. Wu, ML et al. (2011) HO-1 in inflammation and phenobarbitalexacerbateswarmhepaticischemia-
cardiovasculardisease.Am.J.Cardiovasc.Dis.1,150. reperfusioninjuryinratlivers.FreeRadic.Res.44,
330. Ollinger, R et al. (2005) Bilirubin. Circulation 112, 441.
1030. 348. Schemmer,Petal.(1999)Reperfusioninjuryinliv-
331. Cighetti,Getal.(1990)LackofconversionofXDHto ersduetogentleinsituorganmanipulationduring
XOduringwarmrenalischemia.FEBSLett.274,82. harvestinvolveshypoxiaandfreeradicals.J.Phar-
332. Kooij, A et al. (1992) Distribution of XOR activity macol.Exp.Ther.290,235.
inhumantissues–ahistochemicalandbiochemical 349. Zwacka, RM et al. (1998) Redox gene therapy for
study.VirchowsArchiv.CellPathol.63,17. ischemia/reperfusion injury of the liver reduces
333. Parajuli, N et al. (2012) MitoQ blunts mitochon- AP1andNFκBactivation.Nat.Med.4,698.
drialandrenaldamageduringcoldpreservationof 350. Mukhopadhyay,Petal.(2012)MitochondrialROS
porcinekidney.PLoSOne7,e48590. generation triggers inflammatory response and
334. Pollak, R et al. (1993) A randomized double-blind tissue injury associated with hepatic ischemia-
trialoftheuseofhumanrecombinantSODinrenal reperfusion: therapeutic potential of mitochondri-
transplantation.Transplantation55,57. allytargetedantioxidants.FreeRadic.Biol.Med.53,
335. vandenThillart,Getal.(1983)Anaerobicmetabol- 1123.
ismofgoldfish,Carassiusauratus(L.):ethanoland 351. Kiso,Ketal.(2012)TheroleofKupffercellsinCCl4
CO2 excretion rates and anoxia tolerance at 20, intoxicationinmice.Biol.Pharm.Bull.35,980.
10and5oC.Comp.Biochem.Physiol.76A,295. 352. Fernández,Vetal.(2012)Recentadvancesinliver
336. Zenteno-Savin,Tetal.(2012)Ischemia/reperfusion preconditioning: thyroid hormone, n-3 long-chain
in diving birds and mammals: how they avoid PUFAsandFe.WorldJ.Hepatol.4,119.
oxidativedamage.In:Oxidativestressinaquaticeco- 353. Neeff,HPetal.(2012)Bloodmodulatesthekinetics
systems, Ed. Abele, D, Vázquez-Medina, JP and of ROS release in pancreatic ischemia-reperfusion
Zenteno-Savin,T,BlackwellPublishingLtd. injury.Pancreas41,1105.
337. MacMillan-Crow, LA et al. (2001) Mitochondrial 354. Azadzoi, KM et al. (2009) Oxidative stress and
tyrosinenitrationprecedeschronicallograftneph- neurodegenerationinpenileischaemia.BJUInt.105,
ropathy.FreeRadic.Biol.Med.31,1603. 404.
338. Billings,FTIVetal.(2011)Postoperativeacutekid- 355. Meldrum,DRetal.(2011)Thelinkbetweenerect-
neyinjuryisassociatedwithhemoglobinemiaand ileandcardiovascularhealth:thecanaryinthecoal
an enhanced oxidative stress response. Free Radic. mine.Am.J.Cardiol.108,599.
Biol.Med.50,1480. 356. Park,JWetal.(2005)Skeletalmusclereperfusionin-
339. Shah,SVetal.(2011)TheroleofcatalyticFeinacute juryisenhancedinECSODknockoutmouse.Am.
kidneyinjury.Clin.J.Am.Soc.Nephrol.6,2329. J.Physiol.289,H181.

--- Page 846 ---

REFERENCES 791
357. Pattwell,Detal.(2003)Ischemiaandreperfusionof 375. Lin,CPetal.(2013)Endothelialprogenitorcelldys-
skeletalmuscleleadtotheappearanceofastable functionincardiovasculardiseases:roleofROSand
lipid free radical in the circulation. Am. J. Physiol. inflammation.BiomedRes.Int.2013,845037.
284,H2400. 376. Matthay, MA et al. (2012) The acute respiratory
358. Dorion, D et al. (1993) Role of XO in reperfusion distresssyndrome.J.Clin.Invest.122,2731.
injuryofischemicskeletalmusclesinthepigand 377. Den Hengst, WA et al. (2010) Lung ischemia-
human.J.Appl.Physiol.75,246. reperfusion injury: a molecular and clinical view
359. Soong,CVetal.(1994)Reductionoffreeradicalgen- on a complex pathophysiological process. Am.
eration minimizes lower limb swelling following J.Physiol.299,H1283.
femoropoplitealbypasssurgery.Eur.J.Vasc.Surg.8, 378. Kozower,BDetal.(2003)Immunotargetingofcata-
435. laseto thepulmonaryendothelium alleviatesoxi-
360. Wijnen, MHWA et al. (2001) Antioxidants reduce dativestressandreducesacutelungtransplantation
oxidativestressinclaudicants.J.Surg.Res.96,183. injury.Nat.Biotechnol.221,392.
361. Loukogeorgakis, SP et al. (2010) Role of NOX in 379. Thiemermann, C et al. (2001) Inhaled CO: deadly
endothelialischemia/reperfusioninjuryinhumans. gasornoveltherapeutic?Nat.Med.7,534.
Circulation121,2310. 380. Damico,Retal.(2012)Pulmonaryendothelialcell
362. Chiao, JJC et al. (1994) Fe delocalization occurs NOX.Am.J.Respir.CellMol.Biol.47,129.
during ischemia and persists on reoxygenation of 381. Kinnula,VLetal.(1997)AssessmentofXOinhu-
skeletalmuscle.J.Lab.Clin.Med.124,432. manlungandlungtransplantation.Eur.Respir.J.10,
363. Shih,BandBayat,A(2010)Scientificunderstand- 676.
•
ingandclinicalmanagementofDupuytrendisease. 382. Reid,Detal.(2001)FeoverloadandNO -derived
Nat.Rev.Rheumatol.6,715. oxidative stress following lung transplantation.
364. Abdel-Hamid, IA and Anis, T (2011) Peyronie’s J.HeartLungTransplant.20,840.
disease:perspectivesontherapeutictargets.Expert 383. Williams,Aetal.(1999)Compromisedantioxidant
Opin.Ther.Targets15,913. statusandpersistentoxidativestressinlungtrans-
365. Gabrielli, A et al. (2008) Oxidative stress and the plantrecipients.FreeRadic.Res.30,383.
pathogenesisofscleroderma:theMurrell’shypoth- 384. Gray,KDetal.(2004)PulmonaryMnSODisnitrated
esisrevisited.Semin.Immunopathol.30,329. followinghepaticischemia-reperfusion.Surg.Infect.
366. Sambo, P et al. (2001) Oxidative stress in sclero- 5,166.
derma.ArthritisRheum.44,2653. 385. Lagan,ALetal.(2008)Pathogenesisofthesystemic
367. Kavian,Netal.(2012)ROS-mediatedkillingofacti- inflammatorysyndromeandacutelunginjury:role
vatedfibroblastsbyAs2O3amelioratesfibrosisina of Fe mobilization and decompartmentalization.
murinemodelofsystemicsclerosis.ArthritisRheum. Am.J.Physiol.294,L161.
64,3430. 386. Wagner, MC et al. (2012) PPARγ ligands regulate
368. Pagano, G et al. (2013) Sjögren’s syndrome- NOX, eNOS, and barrier function in the lung fol-
associatedoxidativestressandmitochondrialdys- lowingchronicalcoholingestion.Alcohol.Clin.Exp.
function:prospectsforchemopreventiontrials.Free Res.36,197.
Radic.Res.47,71. 387. Zmijewski,JWetal.(2009)Antiinflammatoryeffects
369. Southard,JHandBelzer,FO(1995)Organpreserva- of H2O2 in neutrophil activation and acute lung
tion.Ann.Rev.Med.46,235. injury.Am.J.Respir.Crit.CareMed.179,694.
370. Rauen, U et al. (2007) Fe-dependent vs Fe- 388. Thiel, M et al. (2005) Oxygenation inhibits the
independent cold-induced injury to cultured rat physiological tissue-protecting mechanism and
hepatocytes:acomparativestudyinphysiological therebyexacerbatesacuteinflammatorylunginjury.
mediaandorganpreservationsolutions.Cryobiology PLoSBiol.3,e174.
54,77. 389. Kavazis, AN et al. (2009) Mechanical ventilation
371. Li, X et al. (2004) Metallothionein protects islets induces diaphragmatic mitochondrial dysfunction
from hypoxia and extends islet graft survival by andincreasedoxidantproduction.FreeRadic.Biol.
scavenging most kinds of ROS. J. Biol. Chem. 279, Med.46,842.
765. 390. Galli, F et al. (2012) Oxidative stress and antioxi-
372. Li, TS et al. (2011) Expansion of human cardiac danttherapyincysticfibrosis.Biochim.Biophys.Acta
stemcellsinphysiologicalO2improvescellproduc- 1822,690.
tion efficiency and potency for myocardial repair. 391. Reverri, EJ et al. (2014) Inflammation, oxidative
Cardiovasc.Res.89,157. stress, and cardiovascular disease risk factors in
373. Diaz,DDetal.(1992)Hematoma-inducedflapne- adultswithcysticfibrosis.FreeRadic.Biol.Med.76,
crosisandfreeradicalscavengers.ActaOtolaryngol. 261.
HeadNeckSurg.118,516. 392. Ballatori,Netal.(2005)Molecularmechanismsof
374. Wang, WZ et al. (2011) Update on ischemia- GSHtransport:roleoftheMRP/CFTR/ABCCand
reperfusion injury for the plastic surgeon: 2011. OATP/SLC21Afamiliesofmembraneproteins.Tox-
Plast.Reconstr.Surg.128,685e. icol.Appl.Pharmacol.204,238.

--- Page 847 ---

792 REFERENCES
393. Rada,Betal.(2013)Pyocyanin-enhancedNETfor- 412. Lobach,ARandUetrecht,J(2014)Involvementof
mationrequirestheNADPHoxidase.PLoSOne8, MPOandNADPHoxidaseinthecovalentbinding
e54205. of amodiaquine and clozapine to neutrophils: im-
394. Meyer,MLetal.(2012)NAD(PH)quinoneoxidore- plicationsfordrug-inducedagranulocytosis.Chem.
ductase1regulatesneutrophilelastase-inducedmu- Res.Toxicol.27,699.
couscellmetaplasia.Am.J.Physiol.303,L181. 413. Ng,Wetal.(2012)Animalmodelsofidiosyncratic
395. Lorentzen,Detal.(2011)Concentrationoftheanti- drugreactions.Adv.Pharmacol.63,81.
bacterial precursor CNS– in CF airway secretions. 414. Campbell,AMetal.(2012)NOXinhibitsthepatho-
FreeRadic.Biol.Med.50,1144. genesisofSLE.Sci.Transl.Med.4,157ra141.
396. Mandsberg, LF et al. (2009) Antibiotic resistance 415. Jacob, CO et al. (2012) Lupus-associated causal
in P. aeruginosa strains with increased mutation mutation in NCF2 brings unique insights to the
frequency due to inactivation of the DNA oxida- structure and function of NADPH oxidase. Proc.
tiverepairsystem.Antimicrob.AgentsChemother.53, Natl.Acad.Sci.USA109,E59.
2483. 416. Wang,ZQetal.(2004)Anewlyidentifiedrolefor
397. Sato, K et al. (2012) In vivo evidence of free rad- O
•–in
inflammatory pain. J. Pharmacol. Exp. Ther.
2
ical generation in the mouse lung after exposure 309,869.
to P. aeruginosa bacterium: an ESR spin-trapping 417. Iida, M and Saito, K (1999) Failure of endotoxin-
investigation.FreeRadic.Res.46,645. freeSODtoreducesomepawedemasandadjuvant
398. Lepage, G et al. (1996) Supplementation with ca- arthritisinrats.Inflamm.Res.48,63.
rotenoids corrects increased lipid peroxidation in 418. Flick,MRetal.(1988)Catalasepreventsincreased
childrenwithCF.Am.J.Clin.Nutr.64,87.245. lung vascular permeability during air emboli in
399. Wood, LG et al. (2003) Improved antioxidant and unanesthetizedsheep.J.Appl.Physiol.64,929.
fatty acid status of patients with CF after antioxi- 419. Gutteridge,JMCetal.(1995)Thebehaviourofcaer-
dant supplementation is linked to improved lung uloplasmininstoredhumanextracellularfluidsin
function.Am.J.Clin.Nutr.77,150. relationtoferroxidaseIIactivity,lipidperoxidation
400. Corti,Aetal.(2014)GSHinhalationtreatmentsin andphenanthroline-detectableCu.Biochem.J.230,
CF:theinterferenceofairwayγ-GT.Am.J.Respir. 517.
Crit.CareMed.189,233. 420. Halliwell, B (2000) Oral inflammation and RS: a
401. Rock,KLetal.(2013)Uricacidasadangersignal missedopportunity?OralDis.6,136.
ingoutanditscomorbidities.Nat.Rev.Rheumatol. 421. Iannitti,Tetal.(2012)Roleoffreeradicalsandanti-
9,13. oxidantdefencesinoralcavity-relatedpathologies.
402. Kurien, BT et al. (2011) Degree of modification of J.OralPathol.Med.41,649.
Ro60 by the lipid peroxidation by-product HNE 422. DiPaola,Retal.(2005)Reduceddevelopmentofex-
maydifferentiallyinduceSjögrensyndromeorSLE perimentalperiodontitisbytreatmentwithM40403,
inBALB/cmice.FreeRadic.Biol.Med.50,1222. aSODmimetic.Eur.J.Pharmacol.516,151.
403. vanderVeen,BSetal.(2009)MPO:molecularmech- 423. Goulet,Vetal.(2004)Cleavageofhumantransfer-
anisms of action and their relevance to human rinbyPorphyromonasgingivalisgingipainspromotes
•
healthanddisease.Antioxid.RedoxSignal.11,2899. growth and formation of OH . Infect. Immun. 72,
404. Burek, CL and Rose, NR (2008) Autoimmune 4351.
thyroiditisandROS.Autoimmun.Rev.7,530. 424. Philips, DC et al. (2010) Aberrant RONS gener-
405. Mansour,RBetal.(2008)Increasedlevelsofauto- ationinRA:causesandconsequencesforimmune
antibodiesagainstcatalaseandSODassociatedwith function,cellsurvival,andtherapeuticintervention.
oxidativestressinpatientswithRAandSLE.Scand. Antioxid.RedoxSignal.12,743.
•
J.Rheumatol.37,103. 425. Halliwell, B (1995) O2 radicals, NO and human
406. Morgan,PEetal.(2005)Increasedlevelsofserum inflammatory joint disease. Ann. Rheum. Dis. 54,
protein oxidation and correlation with disease ac- 505.
tivityinSLE.ArthritisRheum.52,2069. 426. Pavelka, K et al. (2012) Optimizing outcomes
407. Wang, G et al. (2010) Markers of oxidative and in RA patients with inadequate responses to
nitrosativestressinSLE.ArthritisRheum.62,2064. disease-modifying anti-rheumatic drugs. Rheuma-
408. Segal,BMetal.(2012)Oxidativestressandfatigue tology51,12.
•
inSLE.Lupus21,984. 427. Rasheed,Z(2008)OH damagedimmunoglobulin
409. Khan,MAetal.(2014)StudiesonONOO–-modified G in patients with RA: biochemical and immuno-
H1histone:implicationsinSLE.Biochimie97,104. logicalstudies.Clin.Biochem.41,663.
410. Collins, LV et al. (2004) Endogenously oxidized 428. Zhang,Wetal.(2014)Meta-analysis:diagnosticac-
mitochondrial DNA induces in vivo and in vitro curacyofanti-cycliccitrullinatedpeptide2antibody
inflammatoryresponses.J.Leuk.Biol.75,995. and anti-cyclic citrullinated peptide 3 antibody in
411. Davies, RC et al. (2012) Defective DNA double- RA.Clin.Chem.Lab.Med.52,779.
strand break repair in pediatric SLE. Arthritis 429. Shi, J et al. (2011) Autoantibodies recognizing car-
Rheum.64,568. bamylatedproteinsarepresentin seraof patients

--- Page 848 ---

REFERENCES 793
withRAandpredictjointdamage.Proc.Natl.Acad. 447. Odobasic, D et al. (2014) Endogenous MPO is a
Sci.USA108,17372. mediatorofjointinflammationanddamageinex-
430. Nissim, Aet al. (2005) Generation of neoantigenic perimentalarthritis.ArthritisRheumatol.66,907.
epitopesafterposttranslationalmodificationoftype 448. Braconi, D et al. (2012) Biochemical and prote-
II collagen by factors present within the inflamed omiccharacterizationofalkaptonuricchondrocytes.
joint.ArthritisRheum.52,3829. J.Cell.Physiol.227,3333.
431. Grootveld, M et al. (1991) Oxidative damage to 449. Greenwald, RA (1991) Therapeutic usages of O2
hyaluronate and glucose in synovial fluid during radical scavengers in human diseases: myths and
exercise of the inflamed rheumatoid joint. Detec- realities.FreeRadic.Res.Commun.12–13,531.
tion of abnormal low-molecular-mass metabolites 450. Lee, K et al. (2011) Spontaneous and aging-
byH-nmrspectroscopy.Biochem.J.273,459. dependent development of arthritis in NOX2 de-
432. McNulty, AL et al. (2005) DHA transport in hu- ficiencythroughaltereddifferentiationofCD11b+
manchondrocytesisregulatedbyhypoxiaandisa and Th/Treg cells. Proc. Natl. Acad. Sci. USA 108,
physiologicallyrelevantsourceofascorbicacidin 9548.
thejoint.ArthritisRheum.52,2676. 451. Gelderman,KAetal.(2007)Macrophagessuppress
433. Regan,Eetal.(2005)EC-SODandoxidantdamage Tcellresponsesandarthritisdevelopmentinmice
inosteoarthritis.ArthritisRheum.52,3479. byproducingROS.J.Clin.Invest.117,3020.
434. Wang, X et al. (2004) Overexpression of human 452. Lopes,Fetal.(2011)Resolutionofneutrophilicin-
MMP-12 enhances the development of inflamma- flammation by H2O2 in antigen-induced arthritis.
toryarthritisintransgenicrabbits.Am.J.Pathol.165, ArthritisRheum.63,2651.
1375. 453. Yu,DHetal.(2012)Over-expressionofEC-SODin
435. Whiteman, M et al. (2004) ONOO– mediates Ca- mousesynovialtissueattenuatestheinflammatory
dependent mitochondrial dysfunction and cell arthritis.Exp.Mol.Med.44,529.
deathviaactivationofcalpains.FASEBJ.18,1395. 454. Kelkka,Tetal.(2012)SOD-3limitscollagen-induced
436. Bates, EJ et al. (1985) Inhibition of proteoglycan arthritisintheabsenceofphagocyteoxidativeburst.
synthesisbyH2O2inculturedbovinearticularcar- MediatorsInflamm.2012,730469.
tilage.Biochim.Biophys.Acta838,221. 455. Fu, P and Birukov, KG (2009) Oxidized phospho-
437. Schalkwijk,Jetal.(1986)Anexperimentalmodelfor lipids in control of inflammation and endothelial
H2O2-induced tissue damage. Arthritis Rheum. 29, barrier.Transl.Res.153,166.
532. 456. Lopez-Pedrera,Cetal.(2012)Tocardiovasculardis-
438. Halliwell, B (1978) Superoxide-dependent forma- easeandbeyond:newtherapeuticperspectivesof
•
tionofOH inthepresenceofFesalts.Itsrolein statins in autoimmune diseases and cancer. Curr.
degradationofhyaluronicacidbyaO
•–generating
DrugTargets13,829.
2
system.FEBSLett.96,238. 457. Maity,Petal.(2009)Indomethacin,NSAID,devel-
439. Fuchs,BandSchiller,J(2014)Glycosaminoglycan opsgastropathyby inducing ROS-mediatedmito-
degradationbyselectedROS.Antioxid.RedoxSignal. chondrial pathology and associated apoptosis in
21,1044. gastricmucosa:anovelroleofmitochondrialacon-
•
440. Kaur,Hetal.(1996)OH generationbyrheumatoid itaseoxidation.J.Biol.Chem.284,3058.
blood and knee joint synovial fluid. Ann. Rheum. 458. Steiman, AG et al. (2013) Non-biologic disease-
Dis.55,915. modifying antirheumatic drugs (DMARDs) im-
441. Gutteridge, JM (1987) Bleomycin-detectable Fe in provepainininflammatoryarthritis(IA):asystemic
knee-jointsynovialfluidfromarthriticpatientsand literature review of randomized controlled trials.
itsrelationshiptotheextracellularantioxidantac- Rheumatol.Int.33,1105.
tivitiesofcaeruloplasmin,transferrinandlactofer- 459. Rigobello, MR et al. (2005) Effect of auranofin on
rin.Biochem.J.245,415. the mitochondrial generation of H2O2. Role of
442. Kawasaki, N et al. (1994) Determination of non- thioredoxinreductase.FreeRadic.Res.39,687.
protein-boundFeinhumansynovialfluidbyHPLC 460. Gromer,Setal.(1998)Humanplacentalthioredoxin
withECD.JChromatogr.B656,436. reductase.J.Biol.Chem.273,20096.
443. Kobayashi,Hetal.(2006)RegulatoryroleofHO-1in 461. Gangat, N and Wolanskyj, AP (2013) Anemia of
inflammationofRA.ArthritisRheum.54,1132. chronicdisease.Semin.Hematol.50,232.
444. Scheibner, KA et al. (2006) Hyaluronan fragments 462. Winyard, PG et al. (1987) Mechanism of exacer-
act as an endogenous danger signal by engaging bation of rheumatoid synovitis by total-dose-Fe-
TLR2.J.Immunol.177,1272. dextran infusion: in vivo demonstration of Fe-
445. Frears, ER et al. (1996) Inactivation of TIMP-1 by promotedoxidantstress.Lancet1,69.
ONOO–.FEBSLett.381,21. 463. Sen,Detal.(2012)NF-κBanditsassociatedpath-
446. Edmonds,SEetal.(1993)Animaginativeapproach ways are major molecular regulators of blood in-
tosynovitis-theroleofhypoxicreperfusiondamage duced joint damage in a murine of hemophilia.
inarthritis.J.Rheumatol.20(Suppl.37),26. J.Thromb.Haemost.11,293.

--- Page 849 ---

794 REFERENCES
464. Blake,DRetal.(1985)Cerebralandoculartoxicity 482. Hong,Jetal.(2010)Bileacidrefluxcontributesto
inducedbydesferrioxamine.Q.J.Med.219,345. developmentofesophagealadenocarcinomaviaac-
465. Circu,MLandAw,TY(2011)Redoxbiologyofthe tivation of phosphatidylinositol-specific phospho-
intestine.FreeRadic.Res.45,1245. lipase Cy2 and NADPH oxidase NOX5-S. Cancer
466. Mangerich,Aetal.(2013)Chemistrymeetsbiology Res.70,1247.
incolitis-associatedcarcinogenesis.FreeRadic.Res. 483. Kim, YJ et al. (2012) Oxidative stress in
47,958. inflammation-based gastrointestinal tract dis-
467. Seril,DNetal.(2003)Oxidativestressandulcerative eases:challengesandopportunities.J.Gastroenterol.
colitis-associatedcarcinogenesis:studiesinhumans Hepatol.27,1004.
andanimalmodels.Carcinogenesis24,353. 484. Park, DK et al. (2003) GSH levels in Helicobacter
468. Winter, SE et al. (2013) Host-derived NO– boosts pylori-infected gastric mucosa. Korean J. Gastroen-
3
growthofE.coliintheinflamedgut.Science339,708. terol.42,267.
469. Chu,FFetal.(2004)Bacteria-inducedintestinalcan- 485. Murata,Metal.(2012)Roleofnitrativeandoxida-
cer in mice with disrupted Gpx1 and Gpx2 genes. tiveDNAdamageininflammation-relatedcarcino-
CancerRes.64,962. genesis.J.Biomed.Biotechnol.2012,623019.
470. Aghdassi,Eetal.(2003)Antioxidantvitaminsup- 486. Wang,Getal.(2005)Oxidativestressdefensemech-
plementation in Crohn’s disease decreases oxi- anismstocounterFe-promotedDNAdamageinH.
dative stress: a randomized controlled trial. Am. pylori.FreeRadic.Res.39,1183.
J.Gastroenterol.98,348. 487. Alamuri,PandMaier,RJ(2004)MSRisanimport-
471. Krieglstein, CF et al. (2001) Regulation of murine antantioxidantenzymeinthegastricpathogenH.
intestinal inflammation by reactive metabolites of pylori.Mol.Microbiol.53,1397.
O2 andN:divergentrolesofO •
2
– andNO. J.Exp. 488. Juwahara,Hetal.(2000)H.pyloriureasesuppresses
Med.194,1207. bactericidalactivityofONOO–viaCO2production.
472. Kruidenier,Letal.(2003)Attenuatedmildcolonic Infect.Immun.68,4378.
inflammation and improved survival from severe 489. Everett, SM et al. (2002) Antioxidant vitamin sup-
Dss-colitisoftransgenicCuZnSODmice.FreeRadic. plements do not reduce ROS activity in H. pylori
Biol.Med.34,753. gastritisintheshortterm.Br.J.Nutr.87,3.
473. Khor,TOetal.(2006)Nrf2-deficientmicehavean 490. Keenan, JI et al. (2005) NOX involvement in the
increasedsusceptibilitytodextransulfatesodium- pathologyofH.pyloriinfection.FreeRadic.Biol.Med.
inducedcolitis.CancerRes.66,11580. 38,1188.
474. Muise,AMetal.(2012)NOXcomplexandIBDcan- 491. Shatynski,KEetal.(2012)DecreasedSTAT5phos-
didategenestudies:identificationofararevariant phorylation and GATA-3 expression in NOX2-
inNCF2thatresultsinreducedbindingtoRAC2. deficientTcells:roleinThelperdevelopment.Eur.
Gut61,1028. J.Immunol.42,3202.
475. Aruoma, OI et al. (1987) The scavenging of oxid- 492. Tanaka,Hetal.(2008)HepaticoxidativeDNAdam-
antsbysulphasalazineanditsmetabolites.Biochem. ageisassociatedwithincreasedriskforhepatocel-
Pharmacol.36,3739. lularcarcinomainchronichepatitisC.Br.J.Cancer.
476. Ahnfelt-Ronne, I et al. (1990) Clinical evidence 98,580.
supportingtheradicalscavengermechanismof5- 493. Fargion, S et al. (2011) Beyond hereditary hemo-
aminosalicylicacid.Gastroenterol.98,1162. chromatosis:newinsightsintotherelationshipbe-
477. Liu, ZC et al. (1995) Oxidation of 5-aminosalicylic tweenFeoverloadandchronicliverdiseases.Dig.
acid by HOCl to a reactive iminoquinone. Drug LiverDis.43,89.
Metab.Dispos.23,246. 494. Horiike, S et al. (2005) Accumulation of 8-
478. Ferretti, G et al. (2012) Celiac disease, inflamma- nitroguanine in the liver of patients with chronic
tionandoxidativedamage:anutrigeneticapproach. hepatitisC.J.Hepatol.43,403.
Nutrients4,243. 495. Nair,Jetal.(2010)Highurinaryexcretionoflipid
479. Armstrong,JAetal.(2013)Oxidativestressinacute peroxidation-derivedDNAdamageinpatientswith
pancreatitis:lostintranslation?FreeRadic.Res.47, cancer-proneliverdiseases.Mutat.Res.683,23.
917. 496. Elchuri, S et al. (2005) CuZnSOD deficiency leads
480. Sledzinski, M et al. (2013) Cerulein-induced acute topersistentandwidespreadoxidativedamageand
pancreatitisisassociatedwithc-JunNH2-terminal hepatocarcinogenesislaterinlife.Oncogene24,367.
kinase 1-dependent ferritin degradation and Fe- 497. Jain, SK et al. (2002) Oxidative stress in chronic
dependent free radicals formation. Pancreas 42, hepatitisC:notjustafeatureoflatestagedisease.
1070. J.Hepatol.36,805.
481. Pezzilli,R(2012)Antioxidantsforintractablepainin 498. Fried, MW et al. (2012) Effect of silymarin (milk
chronicpancreatitispatients.Istheendofthestory? thistle) on liver disease in patients with chronic
JOP13,461. hepatitis C unsuccessfully treated with interferon

--- Page 850 ---

REFERENCES 795
therapy:arandomizedcontrolledtrial.JAMA308, 519. Cobbs, CS et al. (2001) Evidence for ONOO–-
274. mediatedmodificationstop53inhumangliomas:
499. Bjelakovic,Getal.(2011)Antioxidantsupplements possible functional consequences. Arch. Biochem.
for liver diseases. Cochrane Database Syst Rev. 3, Biophys.394,167.
CD007749. 520. Yusuf,MAetal.(2010)Cys-141glutathionylationof
500. Sancho,Petal.(2012)NOX4mediatesstellatecell humanp53:studiesusingspecificpolyclonalanti-
activation and hepatocyte cell death during liver bodiesincancersamplesandcelllines.FreeRadic.
fibrosisdevelopment.PLoSOne7,e45285. Biol.Med.49,908.
501. Seki,Setal.(2002)Immunohistochemicaldetection 521. Holley, AK et al. (2012) MnSOD: beyond life and
of8OHdG,amarkerofoxidativeDNAdamage,in death.AminoAcids42,139.
humanchroniccholecystitis.Histopathol.40,531. 522. Millau,JFetal.(2010)p53functionsandcelllines:
502. Weinberg,RA(2014)TheBiologyofCancer,edn2, havewelearnedthelessonsfromthepast?Bioessays
GarlandScience,NewYork. 32,392.
503. Halliwell,B(2007)Oxidativestressandcancer:have 523. Peng, D et al. (2014) GPx7 has potential tumour
wemovedforward?Biochem.J.401,1. suppressorfunctionsthataresilencedbylocation-
504. Curtin, NJ (2012) DNA repair dysregulation from specific methylation in oesophageal adenocarcin-
cancerdrivertotherapeutictarget.Nat.Rev.Cancer oma.Gut63,540.
12,801. 524. Sampson, N et al. (2011) ROS signaling by
505. Muller,PAandVousden,KH(2013)p53mutations NOX4drivesfibroblast-to-myofibroblastdifferenti-
incancer.Nat.CellBiol.15,2. ation in the diseased prostatic stroma. Mol. Endo-
506. Caputo, F et al. (2012) Redox modulation of the crinol.25,503.
DNA damage response. Biochem. Pharmacol. 84, 525. Whitaker,HCetal.(2013)Prx3isoverexpressedin
1292. prostatecancerandpromotescancercellsurvivalby
507. Jiang, P et al. (2011) p53 regulates biosynthesis protectingcellsfromoxidativestress.Brit.J.Cancer.
through direct inactivation of G6PDH. Nat. Cell. 109,983.
Biol.13,310. 526. Radisky,DCandPrzybylo,JA(2008)MMP-induced
508. Grüning, NM and Ralser, M (2011) Sacrifice for fibrosis and malignancy in breast and lung. Proc.
survival.Nature480,190. Am.Thorac.Soc.5,316.
509. Gilsing,AMetal.(2013)DietaryhemeFeandthe 527. Wei, Q et al. (2011) Sulfiredoxin-peroxiredoxin
riskofcolorectalcancerwithspecificmutationsin IV axis promotes human lung cancer progres-
KRASandAPC.Carcinogenesis34,2757. sion through modulation of specific phosphok-
510. Maddocks,ODandVousden,KH(2011)Metabolic inase signaling. Proc. Natl. Acad. Sci. USA 108,
regulationbyp53.J.Mol.Med.89,237. 7004.
511. Zhuang, J et al. (2012) Metabolic regulation of O2 528. DeNicola, GM et al. (2011) Oncogene-induced
andredoxhomeostasisbyp53:lessonsfromevolu- Nrf2transcriptionpromotesROSdetoxificationand
tionarybiology.FreeRadic.Biol.Med.53,1279. tumorigenesis.Nature475,106.
512. Efeyan,AandSerrano,M(2007)p53:guardianof 529. Petkau, A et al. (1977) Modification of SOD in
the genome and policeman of the oncogenes. Cell ratmammarycarcinoma.Res.Comm.Chem.Pathol.
Cycle6,1006. Pharmacol.17,125.
513. Kastrinos,FandSyngal,S(2011)Inheritedcolorec- 530. Papa,Letal.(2014)SOD2toSOD1switchinbreast
talcancersyndromes.CancerJ.17,405. cancer.J.Biol.Chem.289,5412.
514. Silva, A et al. (2008) PTEN posttranslational in- 531. Chen, BP et al. (2012) New insights into the roles
activation and hyperactivation of the PI3K/Akt ofATMandDNA-PKcsinthecellularresponseto
pathwaysustainprimaryTcellleukemiaviability. oxidativestress.CancerLett.327,103.
J.Clin.Invest.118,3762. 532. Reliene, R and Schiestl, RH (2007) Antioxidants
515. Kottemann, MC and Smogorzewska, A (2013) suppresslymphomaandincreaselongevityinAtm-
FanconianaemiaandtherepairofWatsonandCrick deficientmice.J.Nutr.137,229S.
DNAcrosslinks.Nature493,356. 533. Martinez-Outschoorn, UE et al. (2012) Hereditary
516. Mamlouk, S and Wielockx, B (2013) HIFs as key ovariancancerandtwo-compartmenttumormetab-
regulatorsoftumorinflammation.Int.J.Cancer132, olism.CellCycle11,1.
2721. 534. Pagano, G et al. (2013) From clinical description,
517. Weitzman, SA et al. (1985) Phagocytes as carcino- to in vitro and animal studies, and backward to
gens: malignant transformation produced by hu- patients: oxidative stress and mitochondrial dys-
manneutrophils.Science227,1231. functioninFanconianemia.FreeRadic.Biol.Med.58,
518. Chen,Wetal.(2012)DoesNrf2contributetop53- 118.
mediatedcontrolofcellsurvivalanddeath?Anti- 535. Nahlel,Zetal.(2012)HSPsincancer:targetingthe
oxid.RedoxSignal.17,1670. ‘chaperones’.FutureMed.Chem.4,927.

--- Page 851 ---

796 REFERENCES
536. Totter, TR (1980) Spontaneous cancer and its pos- 556. Karihtala,Petal.(2011)Divergentbehaviourofoxi-
siblerelationshiptoO2metabolism.Proc.Natl.Acad. dativestressmarkers(8OHdG)and4-HNEinbreast
Sci.USA77,1763. carcinogenesis.Histopathology58,854.
537. Halliwell,B(2002)Effectofdietoncancerdevelop- 557. Biasi,Fetal.(2002)Associatedchangeoflipidper-
ment:isoxidativeDNAdamageabiomarker?Free oxidationandTGFβ1levelsinhumancoloncancer
Radic.Biol.Med.32,968. duringtumorprogression.Gut50,361.
538. Kensler, TW and Taffe, BG (1986) Free radicals in 558. Custovic,Zetal.(2010)Lipidperoxidationproduct
tumorpromotion.Adv.FreeRadic.Biol.Med.2,347. acroleinasapredictivebiomarkerofprostatecar-
539. Cooke, MS et al. (2003) Oxidative DNA damage: cinomarelapseafterradicalsurgery.FreeRadic.Res.
mechanisms, mutation and disease. FASEB J. 17, 44,497.
1195. 559. Mangerich, A et al. (2012) Infection-induced col-
540. Kryston,TBetal.(2011)Roleofoxidativestressand itis in mice causes dynamic and tissue-specific
DNAdamageinhumancarcinogenesis.Mutat.Res. changesinstressresponseandDNAdamagelead-
711,193. ingtocoloncancer.Proc.Natl.Acad.Sci.USA109,
541. Sheridan,Jetal.(2009)Nuclearoxidativedamage E1820.
•
correlateswithpoorsurvivalincolorectalcancer.Br. 560. Burke,Aetal.(2013)TheyinandyangofNO in
J.Cancer100,381. cancerprogression.Carcinogenesis34,503.
•
542. Dziaman,Tetal.(2014)8OHdGanduricacidaseffi- 561. Hofseth,LJetal.(2003)NO -inducedcellularstress
cientpredictorsofsurvivalincoloncancerpatients. and p53 activation in chronic inflammation. Proc.
Int.J.Cancer134,376. Natl.Acad.Sci.USA100,143.
543. Arbiser, JL et al. (2002) Reactive O2 generated by 562. Li, MJ et al. (2011) Capillary electrophoretic
Nox1 triggers the angiogenic switch. Proc. Natl. determination of DNA damage markers: con-
Acad.Sci.USA99,715. tent of 8OHdG in urine. J Chromatogr. B 879,
544. Lim,SDetal.(2005)IncreasedNox1andH2O2 in 3818.
prostatecancer.Prostate62,200. 563. Min,JYetal.(2010)Downregulationofcatalaseby
545. Chung, JS et al. (2012) Overexpression of ROSviahypermethylationofCpGislandIIonthe
Romo1 promotes production of ROS and in- catalasepromoter.FEBSLett.584,2427.
vasiveness of hepatic tumor cells. Gastroenterology 564. Hayes, P and Knaus, UG (2013) Balancing ROS
143,1084. intheepigenome:NOXastargetandperpetrator.
546. Meitzler, JL et al. (2014) NADPH oxidases: a per- Antioxid.RedoxSignal.18,1937.
spectiveonROSproductionintumorbiology.An- 565. Hole, PS et al. (2013) Overproduction of NOX-
tioxid.RedoxSignal.20,2873. derivedROSinAMLpromotesproliferationandis
547. Liu,Wetal.(2012)Prolineoxidasepromotestumor associatedwithdefectiveoxidativestresssignaling.
cellsurvivalinhypoxictumormicroenvironments. Blood122,3322.
CancerRes.72,3677. 566. Calvani, M et al. (2012) Time-dependent stabiliza-
548. Grivennikov, SI et al. (2010) Immunity, inflamma- tionofHIF-1αbydifferentintracellularsourcesof
tion,andcancer.Cell140,883. ROS.PLoSOne7,e38388.
549. Ben-Neriah, Y and Karin, M (2011) Inflammation 567. Klaunig, JE et al. (2011) Oxidative stress and oxi-
meetscancer,withNF-κBasthematchmaker.Nat. dativedamageinchemicalcarcinogenesis.Toxicol.
Immunol.12,715. Appl.Pharmacol.254,86.
550. Szablewski, L (2014) Diabetes mellitus: influences 568. Luo,Letal.(2012)RedoxcontrolofcytosolicAkt
oncancerrisk.DiabetesMetab.Res.Rev.30,543. phosphorylationinPTENnullcells.FreeRadic.Biol.
551. Arai,Tetal.(2006)Thestudyusingwild-typeand Med.53,1697.
Ogg1 knockout mice exposed to KBrO3 shows no 569. Reuter,Setal.(2010)Oxidativestress,inflammation,
tumorinductiondespiteanextensiveaccumulation and cancer: how are they linked? Free Radic. Biol.
of8OHGinkidneyDNA.Toxicology221,179. Med.49,1603.
552. Kidane,Detal.(2014)InterplaybetweenDNAre- 570. Oberley,TD(2002)Oxidativedamageandcancer.
pairandinflammation,andthelinktocancer.Crit. Am.J.Pathol.160,403.
Rev.Biochem.Mol.Biol.49,116. 571. Liu,Fetal.(2012)NOX-1overexpressionenhances
553. Tian, X et al. (2013) High-molecular-mass hyalur- invasion via MMP-2 and epithelial-mesenchymal
onan mediates the cancer resistance of the naked transitioninmelanomacells.J.Invest.Dermatol.132,
molerat.Nature499,346. 2033.
554. Olinski, R et al. (1995) DNA base modifications 572. Nishikawa, M et al. (2009) Catalase delivery for
andantioxidantenzymeactivitiesinhumanbenign inhibiting ROS-mediated tissue injury and tumor
prostatichyperplasia.FreeRadic.Biol.Med.18,807. metastasis.Adv.DrugDeliv.Rev.61,319.
555. Kondo,Setal.(1999)Persistentoxidativestressin 573. Levental,KRetal.(2009)Matrixcrosslinkingforces
human colorectal carcinoma, but not in adenoma. tumorprogressionbyenhancingintegrinsignaling.
FreeRadic.Biol.Med.27,401. Cell139,891.

--- Page 852 ---

REFERENCES 797
574. Lee,DJetal.(2013)Prx2repressesmelanomametas- 592. Alkhateeb, AA and Connor, JR(2013) The signifi-
tasisbyincreasingE-cadherin/β-catenincomplexes canceofferritinincancer:anti-oxidation,inflamma-
inadherensjunctions.CancerRes.73,4744. tionandtumorigenesis.Biochim.Biophys.Acta1836,
575. Baker,AMetal.(2012)Lysyloxidaseplaysacritical 245.
roleinendothelialcellstimulationtodrivetumor 593. Carmine,Tetal.(1995)PresenceofFecatalyticfor
angiogenesis.CancerRes.73,583. freeradicalreactionsinpatientsundergoingchemo-
576. Liang,RandGhaffari,S(2014)Stemcells,redoxsig- therapy:implicationsfortherapeuticmanagement.
naling,andstemcellaging.Antioxid.RedoxSignal. CancerLett.94,219.
20,1902. 594. Torti,SVandTorti,FM(2013)Feandcancer:more
577. Springer, J et al. (2012) Inhibition of XO reduces oretobemined.NatureRev.Cancer13,342.
wasting and improves outcome in a rat model of 595. Akatsuka, S et al. (2012) Fenton reaction induced
cancercachexia.Int.J.Cancer131,2187. cancer in wild type rats recapitulates genomic al-
578. Mantovani,Getal.(2012)Cachexiaandoxidative terations observed in human cancer. PLoS One 7,
stressincancer:aninnovativetherapeuticmanage- e43403.
ment.Curr.Pharm.Des.18,4813. 596. Hussain, SP et al. (2000) Increased p53 mutation
579. Aurelius, J et al. (2012) Monocytic AML cells load in nontumorous human liver of Wilson dis-
inactivate antileukemic lymphocytes: role of ease and hemochromatosis: oxyradical overload
NOX/gp91phox expression and the PARP-1/PAR diseases.Proc.Natl.Acad.Sci.USA97,12770.
pathwayofapoptosis.Blood119,5832. 597. Brady,DCetal.(2014)Cuisrequiredforoncogenic
580. Zhang,Wetal.(2012)Stromalcontrolofcystineme- BRAFsignallingandtumorigenesis.Nature509,492.
tabolism promotes cancer cell survival in chronic 598. MacDonald,Getal.(2014)MemoisaCu-dependent
lymphocyticleukaemia.Nat.Cell.Biol.14,276. redox protein with an essential role in migration
581. Sethi,Getal.(2012)Multifacetedlinkbetweencan- andmetastasis.Sci.Signal.7,ra56.
cerandinflammation.Biosci.Rep.32,1. 599. Marquez-Quinones,Aetal.(2010)HNE-proteinad-
582. Choi,Jetal.(2014)OxidativestressandhepaticNox ductsformationindifferentpre-carcinogenicstages
proteins in chronic hepatitis C and hepatocellular ofhepatitisinLECrats.FreeRadic.Res.44,119.
carcinoma.FreeRadic.Biol.Med.72,267. 600. Hecht, SS (2012) Lung carcinogenesis by cigarette
583. Hagen, TM et al. (1994) Extensive oxidative DNA smoke.Int.J.Cancer131,2724.
damage in hepatocytes of transgenic mice with 601. Regensburger, J et al. (2010) Tattoo inks contain
chronic active hepatitis destined to develop hep- polycyclicaromatichydrocarbonsthatadditionally
atocellularcarcinoma.Proc.Natl.Acad.Sci.USA91, generatedeleterious1O2.Exp.Dermatol.19,e275.
12808. 602. Kisby,GEandSpencer,PS(2011)Isneurodegenerat-
584. Zitvogel, L et al. (2012) Inflammasomes in car- ivediseasealong-latencyresponsetoearly-lifegen-
cinogenesisandanticancerimmuneresponses.Nat. otoxinexposure?Int.J.Environ.Res.PublicHealth8,
Immunol.13,343. 3889.
585. Schmielau,JandFinn,OJ(2001)Activatedgranulo- 603. Bolten,JLetal.(2000)Roleofquinonesintoxicology.
cytesandgranulocyte-derivedH2O2aretheunder- Chem.Res.Toxicol.13,135.
lying mechanisms of suppression of T-cell func- 604. Okoh, V et al. (2011) Estrogen-induced ROS-
tion in advanced cancer patients. Cancer Res. 61, mediated signaling contribute to breast cancer.
4756. Biochim.Biophys.Acta1815,115.
586. Muñoz-Espìn,DandSerrano,M(2014)Cellularsen- 605. Felty, Q et al. (2005) Estrogen-induced mitochon-
escence: from physiology to pathology. Nat. Mol. drial ROS as signal-transducing messengers. Bio-
Cell.Biol.15,482. chemistry44,6900.
587. Gosselin,Ketal.(2009)Senescence-associatedoxi- 606. Mangal,Detal.(2009)Analysisof8OHdGincellu-
dative DNA damage promotes the generation of larDNAduringoxidativestress.Chem.Res.Toxicol.
neoplasticcells.CancerRes.69,7917. 22,788.
588. Cummins, EP et al. (2006) Prolyl hydroxylase- 607. Gower,JD(1988)Arolefordietarylipidsandanti-
1 negatively regulates IKKβ, giving insight into oxidantsintheactivationofcarcinogens.FreeRadic.
hypoxia-induced NF-κB activity. Proc. Natl. Acad. Biol.Med.5,95.
Sci.USA103,18154. 608. Qin,GandMeng,Z(2010)Expressionofoncogenes
589. Li,Letal.(2010)Modulationofgeneexpressionand and tumor suppressor genes in lungs of rats ex-
tumorcellgrowthbyredoxmodificationofSTAT3. posedtoSO2andbenzo(a)pyrene.Inhal.Toxicol.22,
CancerRes.70,8222. 322.
590. Weinberg,ED(1996)TheroleofFeincancer.Eur. 609. Arslan,Setal.(2011)MPOG-463Apolymorphism
J.CancerPrev.5,19. and risk of lung and prostate cancer in a Turkish
591. Pinnix,ZKetal.(2010)FerroportinandFeregula- population.Mol.Med.Rep.4,87.
tioninbreastcancerprogressionandprognosis.Sci. 610. Peng,Tetal.(2007)Evaluationofoxidativestress
Transl.Med.2,56. inagroupofadolescentsexposedtoahighlevelof

--- Page 853 ---

798 REFERENCES
aflatoxinB1–amulti-centerandmulti-biomarker 628. Muchowicz, A et al. (2014) Adenanthin targets
study.Carcinogenesis28,2347. proteins involved in the regulation of disulphide
611. Penna, F et al. (2010) Cytotoxic properties of bonds.Biochem.Pharmacol.89,210.
clofibrateandotherperoxisomeproliferators:rele- 629. Dominissini,DandHe,C(2014)Damagepreven-
vance to cancer progression. Curr. Med. Chem. 17, tiontargeted.Nature508,191.
309. 630. Lin,Jetal.(2013)Anon-comparativerandomized
612. Qu,Betal.(2001)Mechanismofclofibratehepato- phaseIIstudyof2dosesofATN-224,aCuZnSOD
toxicity:mitochondrialdamageandoxidativestress inhibitor, in patients with biochemically recurrent
inhepatocytes.FreeRadic.Biol.Med.31,659. hormone-naïveprostatecancer.Urol.Oncol.31,581.
613. Moro, S et al. (2012) Furan in heat-treated foods: 631. O’Day.SJetal.(2013)FinalresultsofphaseIIISYM-
formation, exposure, toxicity, and aspects of risk METRY study: randomized, double-blind trial of
assessment.Mol.Nutr.FoodRes.56,1197. elesclomol plus paclitaxel versus paclitaxel alone
614. Holtrop, G et al. (2012) Diet composition is as- astreatmentforchemotherapy-naivepatientswith
sociated with endogenous formation of N-nitroso advancedmelanoma.J.Clin.Oncol.31,1211.
compoundsinobesemen.J.Nutr.142,1652. 632. Montero, AJ and Jassem, J (2011) Cellular redox
615. Cope, K et al. (2009) A GC-MS method for the pathwaysasatherapeutictargetinthetreatmentof
quantitation of N-nitrosoproline and N-acetyl-S- cancer.Drugs71,1385.
allylcysteineinhumanurine:applicationtoastudy 633. Šte˘rba, M et al. (2013) Oxidative stress, redox sig-
oftheeffectsofgarlicconsumptiononnitrosation. naling, and metal chelation in anthracycline car-
Anal.Biochem.394,243. diotoxicity and pharmacological cardioprotection.
616. Zhao, K et al. (2001) DNA damage by NO– and Antioxid.RedoxSignal.18,899.
2
ONOO–: protection by dietary phenols. Meth. En- 634. van Dalen, EC et al. (2011) Cardioprotective inter-
zymol.335,296. ventions for cancer patients receiving anthracyc-
617. Bruchard, M et al. (2013) Chemotherapy-triggered lines.CochraneDatabaseSyst.Rev.6,CD003917.
cathepsinBreleaseinmyeloid-derivedsuppressor 635. Siegel, D et al. (2012) NAD(P)H:quinone oxidore-
cells activates the Nlrp3 inflammasome and pro- ductase 1 (NQO1) in the sensitivity and resist-
motestumorgrowth.Nat.Med.19,57. ancetoantitumorquinones.Biochem.Pharmacol.83,
618. Johnson,BEetal.(2014)Mutationalanalysisreveals 1033.
theoriginandtherapy-drivenevolutionofrecurrent 636. Steinberg, GD et al. (2011) Factors affecting val-
glioma.Science343,189. rubicin response in patients with BCF-refractory
619. Shah,SVetal.(2011)TheroleofcatalyticFeinacute bladdercarcinomainsitu.Postgrad.Med.123,28.
kidneyinjury.Clin.J.Am.Soc.Nephrol.6,2329. 637. Salvatorelli,Eetal.(2013)Thenovelanthracenedi-
620. Yasuda, M et al. (2012) Potential role of NOX1 in one, pixantrone, lacks redox activity and inhibits
the pathogenesis of 5-fluorouracil-induced intes- doxorubicinolformationinhumanmyocardium:in-
tinalmucositisinmice.Am.J.Physiol.302,G1133. sighttoexplainthecardiacsafetyofpixantronein
621. Afzal, S et al. (2012) Oxidative damage to guan- doxorubicin-treatedpatients.J.Pharmacol.Exp.Ther.
inenucleosidesfollowingcombinationchemother- 344,467.
apy with 5-fluorouracil and oxaliplatin. Cancer 638. Mihm,MJetal.(2002)Intracellulardistributionof
Chemother.Pharmacol.69,301. ONOO– duringdoxorubicincardiomyopathy:evi-
622. Alexandre,Jetal.(2007)Novelactionofpaclitaxel denceforselectiveimpairmentofmyofibrillarcre-
against cancer cells: bystander effect mediated by atinekinase.Br.J.Pharmacol.135,581.
ROS.CancerRes.67,3512. 639. Zhao,Yetal.(2014)Redoxproteomicidentification
623. Keeney,JTetal.(2013)ApoA-I:insightsfromredox of HNE-bound mitochondrial proteins in cardiac
proteomicsforitsroleinneurodegeneration.Prote- tissuesrevealsa systemiceffecton energy metab-
omicsClin.Appl.7,109. olismafterdoxorubicintreatment.FreeRadic.Biol.
624. Weyemi, U et al. (2013) NOX and DUOXs as pu- Med.72,55.
tativetargetsforcancertherapy.AnticancerAgents 640. Zhang,Setal.(2012)Identificationofthemolecu-
Med.Chem.13,502. larbasisofdoxorubicin-inducedcardiotoxicity.Nat.
625. Kachadourian, R et al. (2001) 2-Methoxyestradiol Med.18,1639.
does not inhibit SOD. Arch. Biochem. Biophys. 392, 641. Cvetkovic´, RS and Scott, LJ (2005) Dexrazoxane.
349. Drugs65,1005.
626. Raj,Letal.(2011)Selectivekillingofcancercellsbya 642. Ichikawa,Yetal.(2014)Cardiotoxicityofdoxorubi-
smallmoleculetargetingthestressresponsetoROS. cinismediatedthroughmitochondrialFeaccumu-
Nature475,231. lation.J.Clin.Invest.124,617.
627. Fiskus, W et al. (2014) Auranofin induces lethal 643. Doroshow, JH et al. (2001) Oxidative DNA base
oxidationandERstressandexertspotentpreclin- modifications in peripheral blood mononuclear
icalactivityagainstchroniclymphocyticleukemia. cells of patients treated with high-dose infusional
CancerRes.74,2520. doxorubicin.Blood97,2839.

--- Page 854 ---

REFERENCES 799
644. Il’yasova, D et al. (2011) Individual responses to 661. Rossi, C et al. (2008) Intestinal tumour chemo-
chemotherapy-inducedoxidativestress.BreastCan- preventionwiththeantioxidantlipoicacidstimu-
cerRes.Treat.125,583. latesthegrowthofbreastcancer.Eur.J.Cancer44,
645. Kumfu, S et al. (2013) Ferric Fe uptake into car- 2696.
diomyocytes of β-thalassemic mice is not through 662. Sayin,VIetal.(2014)Antioxidantsacceleratelung
Ca2+channels.DrugChem.Toxicol.36,329. cancer progression in mice. Sci. Transl. Med. 6,
646. Menna, P et al. (2010) Anthracycline degradation 221ra15.
incardiomyocytes:ajourneytooxidativesurvival. 663. Nakayama,Aetal.(2011)Systematicreview:gener-
Chem.Res.Toxicol.23,6. atingevidence-basedguidelinesontheconcurrent
647. Reszka,KJetal.(2005)Inactivationofanthracyclines use of dietary antioxidants and chemotherapy or
bycellularperoxidase.CancerRes.65,6346. radiotherapy.CancerInvest.29,655.
648. Chen, J and Stubbe, J (2005) Bleomycins: towards 664. Block, KI et al. (2008) Impact of antioxidant sup-
bettertherapeutics.Nat.Rev.Cancer5,102. plementation on chemotherapeutic toxicity: a sys-
649. Gutteridge,JMCandFu,XC(1981)Enhancementof tematic review of the evidence from randomized
bleomycin-FefreeradicaldamagetoDNAbyanti- controlledtrials.Int.J.Cancer123,1227.
oxidantsandtheirinhibitionoflipidperoxidation. 665. Kwan,MLetal.(2011)Multivitaminuseandbreast
FEBSLett.123,71. canceroutcomesinwomenwithearly-stagebreast
650. Nagase, T et al. (2002) A pivotal role of cytosolic cancer: the life after cancer epidemiology study.
PLA2 in bleomycin-induced pulmonary fibrosis. BreastCancerRes.Treat.130,195.
Nat.Med.8,480. 666. Benner, SE et al. (1993) Regression of oral leuk-
651. VanRheen,Zetal.(2011)LungEC-SODoverexpres- oplakia with α-tocopherol: a community clinical
sionlessensbleomycin-inducedpulmonaryhyper- oncologyprogramchemopreventionstudy.J.Natl.
tensionandvascularremodeling.Am.J.Respir.Cell CancerInst.85,44.
Mol.Biol.44,500. 666A. Nagao, T et al. (2015) Treatment of oral leuko-
652. Jarma, ER et al. (2014) An inhibitor of NOX4 at- plakiawithalow-doseof β-caroteneandvitamin
tenuatesestablishedpulmonaryfibrosisinarodent Csupplements:arandomizedcontrolledtrial.Int.J.
diseasemodel.Am.J.Respir.CellMol.Biol.50,158. Cancer136,1708.
653. Tanaka,KIetal.(2012)EffectsoflecithinizedSOD 667. Halliwell, B (2006) Oxidative stress and neurode-
and/or pirfenidone against bleomycin-induced generation: where are we now? J. Neurochem. 97,
pulmonaryfibrosis.Chest142,1011. 1634.
654. Liu, J et al. (2009) Attenuation effects of heparin- 668. Lim, KL and Soong, TW (2012) The Brain Book,
SODconjugateonbleomycin-inducedlungfibrosis Department of Physiology, National University of
in vivo and radiation-induced inflammatory cyto- Singapore,Singapore.
kine expression in vitro. Biomed. Pharmacother. 63, 669. Ernst,Aetal.(2014)Neurogenesisinthestriatumof
484. theadulthumanbrain.Cell156,1072.
655. Borowczyk,Ketal.(2012)Metabolismandneuro- 670. Huang, TT (2012) Redox balance- and radiation-
toxicity of homocysteine thiolactone in mice: pro- mediatedalterationinhippocampalneurogenesis.
tectiveroleofbleomycinhydrolase.AminoAcids43, FreeRadic.Res.46,951.
1339. 671. Aguzzi, A et al. (2013) Microglia: scapegoat,
656. Hay,JGetal.(1987)TheeffectsofFeanddesferriox- saboteur,orsomethingelse?Science339,156.
amineonthelunginjuryproducedbyintravenous 672. Wake,Hetal.(2009)Restingmicrogliadirectlymon-
bleomycinandhyperoxia.FreeRadic.Res.Commun. itor the functional state of synapses in vivo and
4,109. determinethefateofischemicterminals.J.Neurosci.
657. Cross,CEetal.(1985)Deferoxamineinjectiondoes 29,3974.
notaffectbleomycin-inducedlungfibrosisinrats. 673. Smith, AM and Dragunow, M (2014) The human
J.Lab.Clin.Med.106,433. sideofmicroglia.TrendsNeurosci.37,125.
658. Wang, Q et al. (1991) Amelioration of bleomycin- 674. Obermeier, B et al. (2013) Development, mainten-
induced pulmonary fibrosis in hamsters by com- anceanddisruptionoftheblood-brainbarrier.Nat.
bined treatment with taurine and niacin. Biochem. Med.19,1584.
Pharmacol.42,1115. 675. Mergenthaler, P et al. (2013) Sugar for the brain:
659. Factor,VMetal.(2000)VitaminEreduceschromo- theroleofglucoseinphysiologicalandpathological
somaldamageandinhibitshepatictumorformation brainfunction.TrendsNeurosci.36,587.
inatransgenicmousemodel.Proc.Natl.Acad.Sci. 676. ShengZH(2014)Mitochondrialtraffickingandan-
USA97,2196. choringinneurons:newinsightandimplications.
660. Thapa, D and Ghost, R (2012) Antioxidants for J.CellBiol.204,1087.
prostate cancer chemoprevention: challenges and 677. Schubert, D (2005) Glucose metabolism and AD.
opportunities.Biochem.Pharmacol.83,1319. AgeingRes.Rev.4,240.

--- Page 855 ---

800 REFERENCES
678. Ayala, A et al. (2007) Mitochondrial toxins and 696. Dong,Yetal.(2012)Twofreeradicalpathwaysme-
neurodegenerativediseases.Front.Biosci.12,986. diate chemical hypoxia-induced glutamate release
679. Ubhi, K et al. (2009) Mitochondrial inhibitor 3- insynaptosomesfromtheprefrontalcortex.Biochim.
nitropropionic acid enhances oxidative modifica- Biophys.Acta1823,493.
tionofα-synucleininatransgenicmousemodelof 697. Chen, L et al. (2008) Unregulated cytosolic dopa-
multiplesystematrophy.J.Neurosci.Res.87,2728. minecausesneurodegenerationassociatedwithoxi-
680. Kageyama, Y et al. (2012) Mitochondrial division dativestressinmice.J.Neurosci.28,425.
ensuresthesurvivalofpostmitoticneuronsbysup- 698. Wrona, MZ and Dryhurst, G (1998) Oxidation of
pressingoxidativedamage.J.CellBiol.197,535. serotonin by O
•–radical:
implications to neurode-
2
681. Rothman, DL et al. (2011) 13C MRS studies of generative brain disorders. Chem. Res. Toxicol. 11,
neuroenergeticsandneurotransmittercyclinginhu- 639.
mans.NMRBiomed.24,943. 699. Napolitano,Aetal.(2011)Oxidationchemistryof
682. Gajewski,PDetal.(2012)TheMet-genotypeofthe catecholaminesandneuronaldegeneration:anup-
BDNFVal66Metpolymorphismisassociatedwith date.Curr.Med.Chem.18,1832.
reducedStroopinterferenceinelderly.Neuropsycho- 700. Singh, N et al. (2014) Brain Fe homeostasis: from
logia50,3554. molecularmechanismstoclinicalsignificanceand
683. Milton,VJandSweeney,ST(2012)Oxidativestress therapeuticopportunities.Antioxid.RedoxSignal.20,
in synapse development and function. Develop. 1324.
Neurobiol.72,100. 701. Jahanshad,Netal.(2013)Neuroimaging,nutrition,
684. Massaad,CAandKlann,E(2011)ROSintheregu- andFe-relatedgenes.Cell.Mol.LifeSci.70,4449.
lationofsynapticplasticityandmemory.Antioxid. 702. Pelizzoni, I et al. (2013) Fe uptake in quiescent
RedoxSignal.14,2013. and inflammation-activated astrocytes: a poten-
685. Wang, YR et al. (2013) Cathepsin L plays a role tiallyneuroprotectivecontrolofFeburden.Biochim.
in quinolinic acid-induced NF-κB activation and Biophys.Acta1832,1326.
excitotoxicity in rat striatal neurons. PLoS One 8, 703. Lin, D et al. (2005) 4-Oxo-2-nonenal is both more
e75702. neurotoxic and more protein reactive than 4HNE.
686. Muscoli, C et al. (2004) O
•–-mediated
nitration Chem.Res.Toxicol.18,1219.
2
of spinal MnSOD: a novel pathway in NMDA- 704. Mark, RJ et al. (1997) A role for 4-HNE, an alde-
mediatedhyperalgesia.Pain111,96. hydeproductoflipidperoxidation,indisruptionof
687. Phillis,JWandO’Regan,MH(2004)Apotentially ionhomeostasisandneuronaldeathinducedbyAβ.
critical role of phospholipases in CNS ischemic, J.Neurochem.68,225.
traumatic,andneurodegenerativedisorders.Brain 705. Hou, X et al. (2004) Isomer-specific contractile ef-
Res.Rev.44,13. fectsofaseriesofsyntheticF2-IsoPsonretinaland
688. Gonzalez-Zulueta,Metal.(1998)MnSODprotects cerebralmicrovasculature.FreeRadic.Biol.Med.36,
•
nNOS neurons from NMDA and NO -mediated 163.
neurotoxicity.J.Neurosci.18,2040. 706. Musiek, ES et al. (2006) Cyclopentenone IsoPs
689. Nayernia, Z et al. (2014) New insights on NOX are novel bioactive products of lipid oxidation
enzymesintheCNS.Antioxid.RedoxSignal.20,2815. whichenhanceneurodegeneration.J.Neurochem.97,
690. Drummon, GR et al. (2011) Combating oxidative 1301.
stressinvasculardisease:NOXastherapeutictar- 707. Jeitner, TM et al. (2011) Oxysterol derivatives of
gets.Nat.Rev.DrugDiscov.10,453. cholesterol in neurodegenerative disorders. Curr.
691. Dickinson, BC et al. (2011) Nox2 redox signaling Med.Chem.18,1515.
maintains essential cell populations in the brain. 708. Porter, FD et al. (2010) COPs are sensitive and
Nat.Chem.Biol.7,106. specificblood-basedbiomarkersforNiemann-Pick
692. Lee,Wetal.(2014)Roleofantioxidantenzymesin C1disease.Sci.Transl.Med.2,56ra81.
redox regulation of NMDA receptor function and 709. Sinet,PMetal.(1980)H2O2productionbyratbrain
memory in middle-aged rats. Neurobiol. Aging 35, invivo.J.Neurochem.34,1421.
1459. 710. Mousseau, DD and Baker, GB (2012) Recent de-
693. Nazirog˘lu,M(2011)TRPM2cationchannels,oxida- velopments in the regulation of MAO form and
tivestressandneurologicaldiseases:wherearewe function:isthecurrentmodelrestrictingourunder-
now?Neurochem.Res.36,355. standing of the breadth of contribution of MAO
694. Cotella, D et al. (2012) Toxic role of K+ channel tobrain[dys]function?Curr.TopicsMed.Chem.12,
oxidationinmammalianbrain.J.Neurosci.32,4133. 2163.
695. Krishnaswamy, A and Cooper, E (2012) ROS in- 711. Trompier,Detal.(2014)Brainperoxisomes.Biochi-
activate neuronal nicotinic acetylcholine receptors mie98,102.
throughahighlyconservedcysteineneartheintra- 712. Zimatkin, SM et al. (2006) Enzymatic mechanisms
cellularmouthofthechannel:implicationsfordis- ofethanoloxidationinthebrain.Alcohol.Clin.Exp.
easesthatinvolveoxidativestress.J.Physiol.590,39. Res.30,1500.

--- Page 856 ---

REFERENCES 801
713. Miksys, S and Tyndale, RF (2013) CYP-mediated 730. Gan, L and Johnson, JA (2013) Oxidative damage
drugmetabolisminthebrain.J.PsychiatryNeurosci. and the Nrf2-ARE pathway in neurodegenerative
38,152. diseases.Biochim.Biophys.Acta1842,1208.
714. Howard,LAetal.(2003)BrainCYP2E1isinduced 731. Nakamichi, N et al. (2012) Functional expression
by nicotine and ethanol in rat and is higher in of carnitine/organic cation transporter OCTN1 in
smokersandalcoholics.Br.J.Pharmacol.138,1376. mousebrainneurons:possibleinvolvementinneur-
715. Fraser, PA (2011) The role of free radical gener- onaldifferentiation.Neurochem.Int.61,1121.
ation in increasing cerebrovascular permeability. 732. Wong,PTHetal.(2006)Highplasmacyst(e)inelevel
FreeRadic.Biol.Med.51,967. mayindicatepoorclinicaloutcomeinacutestroke
716. Gu,Yetal.(2011)Interactionoffreeradicals,MMPs patients:possibleinvolvementofH2S.J.Neuropath.
andcaveolin-1impactsblood-brainbarrierperme- Exp.Neurol.65,109.
ability.Front.Biosci.S3,1216. 733. Vida,Cetal.(2014)Increaseofoxidationandinflam-
717. Schwartz, M and Baruch, K (2014) The resolution mationinnervousandimmunesystemswithaging
ofneuroinflammationinneurodegeneration:leuk- andanxiety.Curr.Pharm.Des.20,4656.
ocyterecruitmentviathechoroidplexus.EMBOJ. 734. Bélanger,Metal.(2011)Roleoftheglyoxalasesys-
33,7. teminastrocyte-mediatedneuroprotection.J.Neur-
718. Anekonda,TSandReddy,PH(2006)Neuronalpro- osci.31,18338.
tectionbysirtuinsinAD.J.Neurochem.96,305. 735. Terpstra,Metal.(2011)Noninvasivequantification
719. Lardinois,OMetal.(2008)Identificationofprotein ofhumanbrainantioxidantconcentrationafteran
radicals formed in the human neuroglobin-H2O2 intravenous bolus of vitamin C. NMR Biomed. 24,
reaction using immuno-spin trapping and mass 521.
spectrometry.Biochemistry47,10440. 736. Gess,Betal.(2011)Na+-dependentvitaminCtrans-
720. Hundahl, CA et al. (2013) Neuroglobin and cyto- porter 2 deficiency causes hypomyelination and
globinexpressioninthehumanbrain.BrainStruct. extracellular matrix defects in the peripheral ner-
Funct.218,603. voussystem.J.Neurosci.31,17180.
721. Papadia, S et al. (2008) Synaptic NMDA receptor 737. Bornstein,SRetal.(2003)Impairedadrenalcatechol-
activity boosts intrinsic antioxidant defenses. Nat. amine system function in mice with deficiency of
Neurosci.11,476. theascorbicacidtransporter(SVCT2).FASEBJ.17,
722. Kim, SU et al. (2011) Prx II preserves cognitive 1928.
functionagainstage-linkedhippocampaloxidative 738. Nualart,Fetal.(2014)VitaminCtransporters,recyc-
damage.Neurobiol.Aging32,1054. lingandthebystandereffectinthenervoussystem:
723. Goemaere, J and Knoops, B (2012) Prx distribu- SVCT2versusGluts.J.StemCellRes.Ther.4,209.
tion in the mouse brain with emphasis on neur- 739. Patel, V et al. (2012) Oral tocotrienols are trans-
onalpopulationsaffectedinneurodegenerativedis- portedtohumantissuesanddelaytheprogression
orders.J.Comp.Neurol.520,258. of the model for end-stage liver disease score in
724. Flynn, JM and Melov, S (2013) SOD2 in mito- patients.J.Nutr.142,513.
chondrialdysfunctionandneurodegeneration.Free 740. Muller, DP and Goss-Sampson, MA (1990)
Radic.Biol.Med.62,4. Neurochemical, neurophysiological and neuro-
725. Klivenyi, P et al. (2000) Mice deficient in cellu- pathological studies in vitamin E deficiency. Crit.
lar GPx show increased vulnerability to malon- Rev.Neurobiol.5,239.
ate, 3-nitro-propionic acid, and MPTP.J. Neurosci. 741. Martin,Aetal.(2002)RolesofvitaminsEandCon
20,1. neurodegenerativediseasesandcognitiveperform-
726. Burk, RF et al. (2014) Selenoprotein P and apoE ance.Nutr.Rev.60,308.
receptor-2 interact at the blood-brain barrier and 742. Fahnestock,Metal.(2012)BDNFincreaseswithbe-
also within the brain to maintain an essential haviouralenrichmentandanantioxidantdietinthe
Se pool that protects against neurodegeneration. ageddog.Neurobiol.Aging33,546.
FASEBJ.28,3579. 743. Mcdonald,SRetal.(2005)Concurrentadministra-
727. Herro-Mendez,Aetal.(2009)Thebioenergeticand tion of coenzyme Q10 and α-tocopherol improves
antioxidantstatusofneuronsiscontrolledbycon- learninginagedmice.FreeRadic.Biol.Med.38,729.
tinuousdegradationofakeyglycolyticenzymeby 744. Kuczynski, B and Reo, NV (2006) Evidence that
APC/C-Cdh1.Nat.CellBiol.11,747. plasmalogenisprotectiveagainstoxidativestressin
728. Fernandez-Fernandez, S et al. (2012) Antioxidant theratbrain.Neurochem.Res.31,639.
and bioenergetic coupling between neurons and 745. Johnson, EJ (2014) Role of lutein and zeaxanthin
astrocytes.Biochem.J.443,3. in visual and cognitive function throughout the
729. Ong,WYetal.(2000)ChangesinGSHinthehippo- lifespan.Nutr.Rev.72,605.
campusof ratsinjected with kainate: depletion in 746. Schaffer,SandHalliwell,B(2012)Dopolyphenols
neurons and upregulation in glia. Exp. Brain Res. enterthebrainanddoesitmatter?Sometheoretical
132,510. andpracticalconsiderations.GenesNutr.7,99.

--- Page 857 ---

802 REFERENCES
747. Gillette-Guyonnet, S et al. (2013) Nutrition and 765. Lee,DYetal.(2012)Mechanismsofoxidativedam-
neurodegeneration: epidemiological evidence and age in MS and neurodegenerative diseases: thera-
challengesforfutureresearch.Br.J.Clin.Pharmacol. peutic modulation via fumaric acid esters. Int.
75,738 J.Mol.Sci.13,11783.
748. Gómez-Pinilla, F (2008) Brain foods: the effects of 766. Haider, L et al. (2011) Oxidative damage in MS
nutrients on brain function. Nat. Rev. Neurosci. 9, lesions.Brain134,1914.
568. 767. Schattling,Betal.(2012)TRPM4cationchannelme-
749. Rouault,TA(2013)FemetabolismintheCNS:im- diates axonal and neuronal degeneration in EAE
plicationsforneurodegenerativediseases.Nat.Rev. andMS.Nat.Med.18,1805.
Neurosci.14,551. 768. Gilgun-Sherki,Y etal.(2005)Analysisofgeneex-
750. Zhao,Xetal.(2009)Neuroprotectiveroleofhapto- pressioninMOG-inducedEAEaftertreatmentwith
globin after intracerebral hemorrhage. J. Neurosci. anovelbrain-penetratingantioxidant.J.Mol.Neur-
29,15819. osci.27,125.
751. Morello,Netal.(2009)HaemopexinaffectsFedis- 769. Spitsin,SVetal.(2002)Comparisonofuricacidand
tribution and ferritin expression in mouse brain. ascorbicacidinprotectionagainstEAE.FreeRadic.
J.Cell.Mol.Med.13,4192. Biol.Med.33,1363.
752. Santos, CR et al. (2012) Neuroprotective and 770. Verbeek,Retal.(2005)Oralflavonoidsdelayrecov-
neuroregenerative properties of metallothioneins. eryfromEAEinSJLmice.Biochem.Pharmacol.70,
IUBMBLife64,126. 220.
753. Brown, IR (2007) HSPs and protection of the ner- 771. Hultqvist,Metal.(2004)Enhancedautoimmunity,
voussystem.Ann.N.Y.Acad.Sci.1113,147. arthritis,andencephalomyelitisinmicewithare-
754. Giffard, RG et al. (2013) The future of molecular duced oxidative burst due to an mutation in the
chaperonesandbeyond.J.Clin.Invest.123,3206. Ncf1gene.Proc.Natl.Acad.Sci.USA101,12646.
755. Qi,Detal.(2012)Hsp72inhibitsc-JunN-terminal 772. Yin, Q et al. (2013) Preventive and therapeutic ef-
kinase3signalingpathwayviaAkt1duringcerebral fects of adenanthin on EAE by inhibiting NF-κB
ischemia.J.Neurol.Sci.317,123. signaling.J.Immunol.191,2115.
756. Sheng,Zetal.(2012)8OHGcausesneurodegenera- 773. Mossberg,Netal.(2010)LeukocyteO2radicalpro-
tionduringMUTYH-mediatedDNAbaseexcision ductiondeterminesdiseaseseverityintherecurrent
repair.J.Clin.Invest.122,4344. Guillain-Barrésyndrome.J.Inflamm.7,40.
757. Narasimhaiah,Retal.(2005)Oxidativedamageand 774. Ho, PP et al. (2012) Identification of naturally oc-
defectiveDNArepairislinkedtoapoptosisofmi- curringfattyacidsofthemyelinsheaththatresolve
grating neurons and progenitors during cerebral neuroinflammation.Sci.Transl.Med.4,137ra73.
cortex development in Ku70-deficientmice. Cereb. 775. Forghani, R et al. (2012) Demyelinating diseases:
Cortex15,696. MPO as an imaging biomarker and therapeutic
758. Hegde,MLetal.(2011)Oxidativegenomedamage target.Radiology263,451.
anditsrepairinneurodegenerativediseases:func- 776. Massilamany, C et al. (2013) Cu-Zn SOD-deficient
tionoftransitionmetalsasadouble-edgedsword. miceshowincreasedsusceptibilitytoEAEinduced
J.Alz.Dis.24Suppl2,183. withMOG35-55.J.Neuroimmunol.256,19.
759. Ortiz,ANetal.(2011)Quantificationofreservepool 777. Fox,RJetal.(2014)BG-12(dimethylfumarate):are-
dopamine in MSRA null mice. Neuroscience 177, view of mechanism of action, efficacy, and safety.
223. Curr.Med.Res.Opin.30,251.
760. Dal-Pizzol, F et al. (2010) Oxidative mechanisms 778. Ladecola,CandAnrather,J(2011)Theimmunology
ofbraindysfunctionduringsepsis.Neurochem.Res. ofstroke:frommechanismstotranslation.Nat.Med.
35,1. 17,796.
761. Montine,TJetal.(2002)Neuronaloxidativedamage 779. Shichita,Tetal.(2012)Noveltherapeuticstrategies
from activated innate immunity is EP2 receptor- targeting innate immune responses and early in-
dependent.J.Neurochem.83,463. flammationafterstroke.J.Neurochem.123(suppl2),
762. Klein,Metal.(2006)Oxidativestressinpneumo- 29.
coccal meningitis: a future target for adjunctive 780. Krenz, M and Korthuis, RJ (2012) Moderate etha-
therapy.Prog.Neurobiol.80,269. nol ingestion and cardiovascular protection: from
763. Kastenbauer,Setal.(2002)Oxidativestressinbac- epidemiologicassociationstocellularmechanisms.
terialmeningitisinhumans.Neurology58,186. J.Mol.Cell.Cardiol.52,93.
764. Lieblein-Boff,JCetal.(2013)NeonatalE.coliinfec- 781. Li,Jetal.(2008)HyperbaricO2preconditioningin-
tion causes neuro-behavioural deficits associated ducestoleranceagainstbrainischemia-reperfusion
withhypomyelinationandneuronalsequestration injury by upregulation of antioxidant enzymes in
ofFe.J.Neurosci.33,16334. rats.BrainRes.1210,223.

--- Page 858 ---

REFERENCES 803
782. Choi,DW(2005)Cellulardefencesdestroyed.Na- 800. Caldeira, MV et al. (2014) Role of the ubiquitin-
ture433,696. proteasomesysteminbrainischemia:friendorfoe?
783. Khacho, M et al. (2014) Acidosis overrides O2 de- ProgressNeurobiol.112,50.
privation to maintain mitochondrial function and 801. van der Worp, HB et al. (1998) Dietary vitamin E
cellsurvival.Nat.Commun.5,3550. levels affect outcome of permanent focal cerebral
784. Liu, PK et al. (1996) Damage, repair and muta- ischemiainrats.Stroke29,1002.
genesis in nuclear genes after mouse forebrain 802. Asai,Aetal.(2002)Selectiveproteasomaldysfunc-
ischemia-reperfusion.J.Neurosci.16,6795. tioninthehippocampalCA1regionaftertransient
785. Zeiger,SLetal.(2009)Neurotoxiclipidperoxidation forebrain ischemia. J. Cereb. Blood Flow Metab. 22,
speciesformedbyischemicstrokeincreaseinjury. 705.
FreeRadic.Biol.Med.47,1422. 803. Zhang,Yetal.(2012)PTENdeletionenhancessur-
786. Saiki,Retal.(2011)Braininfarctioncorrelatesmore vival,neuriteoutgrowthandfunctionofdopamine
closelywithacroleinthanwithROS.Biochem.Bio- neurongraftstoMitoParkmice.Brain135,2736.
phys.Res.Commun.404,1044. 804. Kaluza, J et al. (2012) Red meat consumption and
787. Shuttleworth, CW and Weiss, JH (2011) Zn: new riskofstroke:ameta-analysisofprospectivestud-
cluestodiverserolesinbrainischemia.TrendsPhar- ies.Stroke43,2556.
macol.Sci.32,480. 805. Bains,MandHall,ED(2012)Antioxidanttherapies
788. Hawkins,BEetal.(2012)Fluorophilia:fluorophore- intraumaticbrainandspinalcordinjury.Biochim.
containing compounds adhere non-specifically to Biophys.Acta1822,675.
injuredneurons.BrainRes.1432,28. 806. Aronowski,JandZhao,X(2011)Molecularpatho-
789. Autherman, D et al. (2012) GPx overexpression physiology of cerebral hemorrhage: secondary
causesaberrantERKactivationinneonatalmouse braininjury.Stroke42,1781.
cortex after hypoxic preconditioning. Pediatr. Res. 807. Ji,Jetal.(2012)Lipidomicsidentifiescardiolipinoxi-
72,568. dationasamitochondrialtargetforredoxtherapy
790. Hurtado, O et al. (2003) Inhibition of glutam- ofbraininjury.Nat.Neurosci.15,1407.
ate release by delaying ATP fall accounts 808. Liu,Detal.(2003)SpinalcordinjuryincreasesFe
•
for neuroprotective effects of antioxidants in levels:catalyticproductionofOH .FreeRadic.Biol.
experimentalstroke.FASEBJ.17,2082. Med.34,64.
791. Seet,RCetal.(2011)Oxidativedamageinischemic 809. Chen,Zetal.(2011)RoleofFeinbraininjuryafter
stroke revealed using multiple biomarkers. Stroke intraventricularhemorrhage.Stroke42,465.
42,2326. 810. Macdonald,RLetal.(2004)Timecourseofproduc-
•
792. Llombart,Vetal.(2014)Fluorescentmolecularper- tionofOH aftersubarachnoidhemorrhageindogs.
oxidationproducts:aprognosticbiomarkerofearly LifeSci.75,979.
neurologic deterioration after thrombolysis. Stroke 811. Asaeda, M et al. (2005) A non-enzymatic derived
45,432. arachidonyl peroxide, 8-IP F2α, in CSF of patients
793. Linder,Netal.(1999)CellularexpressionofXOR with aneurysmal subarachnoid hemorrhage par-
proteininnormalhumantissues.Lab.Invest.79,967. ticipates in the pathogenesis of delayed cerebral
794. Neher,JJetal.(2013)Phagocytosisexecutesdelayed vasospasm.Neurosci.Lett.373,222.
neuronaldeathafterfocalbrainischemia.Proc.Natl. 812. Clark, JF et al. (2008) Chemical and biochemical
Acad.Sci.USA110,E4098. oxidationsinspinalfluidaftersubarachnoidhem-
795. Bruce,AJetal.(1996)Alteredneuronalandmicro- orrhage.Front.Biosci.13,1806.
glial responses to excitotoxic and ischemic brain 813. Chang,EFetal.(2003)HO-2protectsagainstlipid
injuryinmicelackingTNFreceptors.Nat.Med.2, peroxidation-mediatedcelllossandimpairedmotor
788. recoveryaftertraumaticbraininjury.J.Neurosci.23,
796. Sutherland,BAetal.(2012)Neuroprotectionforis- 3689.
chaemic stroke: translation from the bench to the 814. Rathore,KIetal.(2008)Ceruloplasminprotectsin-
bedside.Int.J.Stroke7,407. juredspinalcordfromFe-mediatedoxidativedam-
797. Ma, H et al. (2012) Therapeutic hypothermia as age.J.Neurosci.28,12736.
a neuroprotective strategy in neonatal hypoxic- 815. Kubota, K et al. (2012) MPO exacerbates second-
ischemic brain injury and traumatic brain injury. aryinjurybygeneratinghighlyROSandmediating
Curr.Mol.Med.12,1282. neutrophilrecruitmentinexperimentalspinalcord
798. Yeghiazaryan, M et al. (2014) DP-99b modulates injury.Spine37,1363.
MMPactivityandneuronalplasticity.PLoSOne9, 816. Jellinger,KA(2009)Recentadvancesinourunder-
e99789. standing of neurodegeneration. J. Neural Transm.
799. Zhao, Y et al. (2014) Chelating intracellularly ac- 116,1111.
cumulated Zn2+ decreased ischemic brain injury 817. Ischiropoulos,HandBeckman,JS(2003)Oxidative
throughreducingneuronalapoptoticdeath.Stroke stress and nitration in neurodegeneration: cause,
45,1139. effect,orassociation?J.Clin.Invest.111,163.

--- Page 859 ---

804 REFERENCES
818. Johri,AandBeal,MF(2012)Mitochondrialdysfunc- 836. Bedford,Letal.(2008)Depletionof26Sproteasomes
tion in neurodegenerative diseases. J. Pharmacol. inmousebrainneuronscausesneurodegeneration
Exp.Ther.342,619. and Lewy-like inclusions resembling human pale
819. Dennissen,FJetal.(2012)Theubiquitinproteasome bodies.J.Neurosci.28,8189.
system in neurodegenerative disease: culprit, ac- 837. Chavarría,CandSouza,JM(2013)Oxidationand
compliceorvitamin?Prog.Neurobiol.96,190. nitration of α-synuclein and their implications in
820. Sullivan,PGetal.(2004)Proteasomeinhibitional- neurodegenerativediseases.Arch.Biochem.Biophys.
ters neural mitochondrial homeostasis and mito- 533,25.
chondriaturnover.J.Biol.Chem.279,20699. 838. Subramanian,MVandJames,TJ(2010)Age-related
821. Lee,MHetal.(2001)Effectofproteasomeinhibition protective effect of deprenyl on changes in the
oncellularoxidativedamage,antioxidantdefences levels of diagnostic marker enzymes and antioxi-
•
andNO production.J.Neurochem.78,32. dantdefenseenzymesactivitiesincerebellartissue
822. Kawauchi,Tetal.(2013)Extra-cellcycleregulatory inWistarrats.CellStressChaperones15,743.
functions of cyclin-dependent kinases (CDK) and 839. Danzeisen,Retal.(2006)Targetedantioxidativeand
CDK inhibitor proteins contribute to brain devel- neuroprotectivepropertiesofthedopamineagonist
opmentandneurologicaldisorders.GenesCells18, pramipexoleanditsnondopaminergicenantiomer
176. SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-
823. Andreoletti, O et al. (2002) Astrocytes accumulate L-propylamino-benzathiazole dihydrochloride].
4-HNEadductsinmurinescrapieandhumanCJD. J.Pharmacol.Exp.Ther.316,189.
Neurobiol.Dis.11,386. 840. Iida,Metal.(1999)DopamineD2receptor-mediated
824. Tashiro,Yetal.(2012)Motorneuron-specificdisrup- antioxidantandneuroprotectiveeffectsofropinir-
tionofproteasomes,butnotautophagy,replicates ole,adopamineagonist.BrainRes.838,51.
ALS.J.Biol.Chem.287,42984. 841. Seet,RCetal.(2010)OxidativedamageinPD:meas-
825. Ayton, S et al. (2013) Ceruloplasmin dysfunction urementusingaccuratebiomarkers.FreeRadic.Biol.
and therapeutic potential for PD. Ann. Neurol. 73, Med.48,560.
554. 842. Danielson, SR et al. (2011) Quantitative mapping
826. Orr, HT (2004) Neuron protection agency. Nature ofreversiblemitochondrialcomplexIcysteineoxi-
431,747. dation in a PD mouse model. J. Biol. Chem. 286,
827. Ghavami,Setal.(2014)Autophagyandapoptosis 7601.
dysfunction in neurodegenerative disorders. Prog. 843. Cristóva¯o, AC et al. (2012) NOX1 mediates α-
Neurobiol.112,24. synucleinopathyinPD.J.Neurosci.32,14465.
828. Ward,WCetal.(2009)Neuromelaninsinvariousre- 844. Salazar,Jetal.(2008)DMT1contributestoneurode-
gionsofhumanbrainareassociatedwithnativeand generationinanimalmodelsofPD.Proc.Natl.Acad.
oxidized isoprenoid lipids. Arch. Biochem. Biophys. Sci.USA105,18578.
484,94. 845. Exner,Netal.(2012)Mitochondrialdysfunctionin
829. Kalia, LV et al. (2013) α-Synuclein oligomers and PD:molecularmechanismsandpathophysiological
clinicalimplicationsforPD.Ann.Neurol.73,155. consequences.EMBOJ.31,3038.
830. Recasens,Aetal.(2014)Lewybodyextractsfrom 846. Sanders,LHandGreenamyre,JT(2013)Oxidative
PDbrainstriggerα-synucleinpathologyandneuro- damagetomacromoleculesinhumanPDandthe
degenerationinmiceandmonkeys.Ann.Neurol.75, rotenonemodel.FreeRadic.Biol.Med.62,111.
351. 847. Przedborski,Setal.(2001)Theparkinsoniantoxin
831. Li,JYetal.(2008)Lewybodiesingraftedneurons MPTP:atechnicalreviewofitsutilityandsafety.
in subjects with PD suggest host-to-graft disease J.Neurochem.76,1265.
propagation.Nat.Med.14,501. 848. Pennathur,Setal.(1999)Massspectrometricquan-
(cid:4)
832. Hauser, DN and Hastings, TG (2013) Mito- tificationof3-NT,ortho-tyrosine,ando,o-dityrosine
chondrial dysfunction and oxidative stress in in brain tissue of MPTP-treated mice, a model of
PD and monogenic parkinsonism. Neurobiol. Dis. oxidativestressinPD.J.Biol.Chem.274,34621.
51,35. 849. Collins,LMetal.(2012)Contributionsofcentraland
833. McLelland,Getal.(2014)ParkinandPINK1func- systemic inflammation to the pathophysiology of
tion in a vesicular trafficking pathway regulating PD.Neuropharmacology62,2154.
mitochondrialqualitycontrol.EMBOJ.33,282. 850. Caparros-Lefebvre, D and Steele, J (2005) Atyp-
834. Choi, J et al. (2004) Oxidative modifications and icalparkinsonismonGuadeloupe,comparisonwith
down-regulation of UCHL1 associated with idio- theparkinsonism-dementiacomplexofGuam,and
pathicPDandAD.J.Biol.Chem.279,13256. environmental toxic hypotheses. Environ. Toxicol.
835. Dexter,DTandJenner,P(2013)PD:frompathology Pharmacol.19,407.
to molecular disease mechanisms. Free Radic. Biol. 851. Kihira,Tetal.(2013)Environmentalcharacteristics
Med.62,132. andoxidativestressofinhabitantsandpatientswith

--- Page 860 ---

REFERENCES 805
ALSinahigh-incidenceareaontheKiiPeninsula, 870. Liu,Getal.(2014)Aldehydedehydrogenase1de-
Japan.Intern.Med.52,1479. fines and protects a nigrostriatal dopaminergic
852. Cristóva˘o,ACetal.(2009)TheroleofNOX1-derived neuronsubpopulation.J.Clin.Invest.124,3032.
ROSinparaquat-mediateddopaminergiccelldeath. 871. Aoyama, K et al. (2006) Neuronal GSH defi-
Antioxid.RedoxSignal.11,2105. ciencyandage-dependentneurodegenerationinthe
853. Snyder,AMandConnor,JR(2009)Fe,thesubstantia EAAC1deficientmouse.Nat.Neurosci.9,119.
nigra and related neurological disorders. Biochim. 872. Lee,Metal.(2001)Effectoftheoverexpressionof
Biophys.Acta1790,606. wild-typeormutantalpha-synucleinoncellsuscep-
854. Lock, EA et al. (2013) Solvents and PD: a system- tibilitytoinsult.J.Neurochem.76,998.
atic review of toxicological and epidemiological 873. Li,WandLee,MK(2005)Antiapoptoticproperty
evidence.Toxicol.Appl.Pharmacol.266,345. of human α-synuclein in neuronal cell lines is as-
855. Chang,HTetal.(2012)Toxicequineparkinsonism: sociated with the inhibition of caspase-3 but not
an immunohistochemical study of 10 horses with caspase-9activity.J.Neurochem.93,1542.
nigropallidalencephalomalacia.Vet.Pathol.49,398. 874. van Tijin, P et al. (2008) The neuronal ubiquitin-
856. Pal, R et al. (2014) Rotenone induces neurotox- proteasome system: murine models and their
icitythroughRac1-dependentactivationofNOXin neurologicalphenotype.Prog.Neurobiol.85,176.
SHSY-5Ycells.FEBSLett.588,472. 875. Merikallio,Hetal.(2012)Nrf2andDJ1areprognos-
857. Goldberg,JAetal.(2012)Ca2+ entryinducesmito- ticfactorsinlungcancer.HumanPathol.43,577.
chondrialoxidantstressinvagalneuronsatriskin 876. Teich,AFandArancio,O(2012)Istheamyloidhy-
PD.Nat.Neurosci.15,1414. pothesisofADtherapeuticallyrelevant?Biochem.J.
858. Zhang, X et al. (2005) Neuroprotection by Fe che- 446,165.
lator against proteasome inhibitor-induced nigral 877. Querfurth,HWandLaFerla,FM(2010)Alzheimer
degeneration. Biochem. Biophys. Res. Commun. 333, disease.N.Engl.J.Med.362,329.
544. 878. Chang,CHetal.(2012)Smoking,death,andAD:a
859. Soto-Otero, R et al. (1998) Studies on the inter- caseofcompetingrisks.AlzheimerDis.Assoc.Disord.
action between 1,2,3,4-tetrahydro-β-carboline and 26,300.
cigarette smoke: a potential mechanism of neuro- 879. Spillantini, MG and Goedert, M (2013) Tau path-
protectionforPD.BrainRes.802,155. ologyandneurodegeneration.LancetNeurol.12,609.
860. Quik,Metal.(2012)Nicotineasapotentialneuro- 880. Lei,Petal.(2012)Taudeficiencyinducesparkinson-
protectiveagentforPD.Mov.Disord.27,947. ismwithdementiabyimpairingAPP-mediatedFe
861. Noyce,AJetal.(2012)Meta-analysisofearlynon- export.Nat.Med.18,291.
motorfeaturesandriskfactorsforPD.Ann.Neurol. 881. Ricciarelli,Retal.(2012)CholesterolandAD:astill
72,893. poorlyunderstoodcorrelation.IUBMBLife64,931.
862. Beal,MF(2010)PD:amodeldilemma.Nature66,S8. 882. Barone,Eetal.(2014)Statinsmorethancholesterol
863. Huang, Q et al. (2013) Negative regulation of 26S loweringagentsinAD:theirpleiotropicfunctions
proteasomestabilityviacalpain-mediatedcleavage aspotentialtherapeutictargets.Biochem.Pharmacol.
ofRpn10subunituponmitochondrialdysfunction 88,605.
inneurons.J.Biol.Chem.288,12161. 883. Ong,WYandHalliwell,B(2004)Fe,atherosclerosis,
864. Seet, RC et al. (2014) Does high-dose CoQ10 im- andneurodegeneration:akeyroleforcholesterolin
prove oxidative damage and clinical outcomes in promoting Fe-dependent oxidative damage? Ann.
PD?Antioxid.RedoxSignal.21,211. NYAcad.Sci.1012,51.
865. Beal MF et al. (2014) A randomized clinical trial 884. Bayer,TAandWirths,O(2011)IntraneuronalAβas
ofhigh-dosageCoQ10inearlyPD:noevidenceof atriggerforneuronloss:canthisbetranslatedinto
benefit.JAMANeurol.71,543. humanpathology?Biochem.Soc.Trans.39,857.
866. Jin, H et al. (2014) Mitochondria-targeted antioxi- 885. Liu,Cetal.(2013)ApolipoproteinEandAD:risk,
dants for treatment of PD: preclinical and clinical mechanismsandtherapy.Nat.Rev.Neurol.9,106.
outcomes.Biochim.Biophys.Acta1842,1282. 886. Hashimoto, Y and Matsuoka, M (2014) A muta-
867. Büttner, S et al. (2013) Endonuclease G mediates tionprotectiveagainstADrendersAPPincapable
α-synuclein cytotoxicity during PD. EMBO J. 32, ofmediatingneurotoxicity.J.Neurochem.130,291.
3041. 887. Duits,FHetal.(2013)Increaseincerebrospinalfluid
868. Liu, B and Hong, JS (2003) Role of microglia F2-IsoPs is related to cognitive decline in APOE
in inflammation-mediated neurodegenerative dis- ε4carriers.J.Alz.Dis.36,563.
eases: mechanisms and strategies for therapeutic 888. Bibl,Metal.(2012)Aminoterminallytruncatedand
intervention.J.Pharmacol.Exp.Ther.304,1. oxidized Aβ peptides in the CSF of AD patients.
869. Clement,MVetal.(2002)Thecytotoxicityofdopa- J.Alz.Dis.29,809.
minemaybeanartifactofcellculture.J.Neurochem. 889. Sheedy,FJetal.(2013)CD36coordinatesNLRP3in-
81,414. flammasomeactivationbyfacilitatingintracellular

--- Page 861 ---

806 REFERENCES
nucleation of soluble ligands into particulate lig- 907. Shan,Xetal.(2003)Theidentificationandcharac-
andsinsterileinflammation.Nat.Immunol.14,812. terizationofoxidizedRNAsinAD.J.Neurosci.23,
890. Park, L et al. (2005) NOX-derived ROS mediate 4913.
thecerebrovasculardysfunctioninducedbytheAβ 908. Choi,Jetal.(2005)Oxidativemodificationsandag-
peptide.J.Neurosci.25,1769. gregationofCuZnSODassociatedwithADandPD.
891. Reddy,PH(2013)Isthemitochondrialoutermem- J.Biol.Chem.280,11648.
braneproteinVDAC1atherapeutictargetforAD? 909. Rajendran R et al. (2009) A novel approach to the
Biochim.Biophys.Acta1832,67. identificationandquantitativeelementalanalysisof
892. DuBoff,Betal.(2013)Whysizematters–balancing amyloid deposits – insights into the pathology of
mitochondrialdynamicsinAD.TrendsNeurosci.36, AD.Biochem.Biophys.Res.Commun.382,91.
325. 910. Wang, CY et al. (2013) Trientine reduces BACE1
893. Swomley, AM et al. (2014) Aβ, oxidative stress activity and mitigates amyloidosis via the AGE/
in AD: evidence based on proteomics studies. RAGE/NF-κB pathway in a transgenic mouse
Biochim.Biophys.Acta1842,1248. modelofAD.Antioxid.RedoxSignal.19,2024.
894. Puglielli,Letal.(2005)ADβ-amyloidactivitymim- 911. Wang,Jetal.(2006)Increasedoxidativedamagein
icscholesteroloxidase.J.Clin.Invest.115,2556. nuclearandmtDNAinMCI.J.Neurochem.96,825.
895. Greenough,MAetal.(2012)Metaldyshomeostasis 912. Evans,DAetal.(2014)VitaminE,memantine,and
andoxidativestressinAD.Neurochem.Int.62,540. AD.JAMA311,29.
896. McCarthy,RCetal.(2014)sAPPmodulatesFeefflux 913. Mecocci, P and Polidori, MC (2012) Antioxidant
frombrainmicrovascularendothelialcellsbystabil- clinicaltrialsinmildcognitiveimpairmentandAD.
izingtheFe2+ exporterferroportin.EMBORep.15, Biochim.Biophys.Acta1822,631.
809. 914. Galasko,DRetal.(2012)AntioxidantsforAD:aran-
897. Abramov,AYetal.(2004)Aβpeptidesinducemito- domized clinical trial with CSF biomarkers meas-
chondrialdysfunctionandoxidativestressinastro- ures.Arch.Neurol.69,836.
cytes and death of neurons through activation of 915. Quinn,JFetal.(2004)Suppressionoflongitudinal
NOX.J.Neurosci.24,565. increaseinCSFF2-IsoPsinAD.J.Alz.Dis.6,93.
898. Zagol-Ikapitte,Ietal.(2005)PGH2-derivedadducts 916. Du,Yetal.(2009)Oxidativedamagetothepromoter
ofproteincorrelatewithADseverity.J.Neurochem. regionofSQSTM1/p62iscommontoneurodegen-
94,1140. erativedisease.Neurobiol.Dis.35,302.
899. Rubio-Perez, JM and Morillas-Ruiz, JM (2012) A 917. Owen, JB et al. (2010) Oxidative modification to
review:inflammatoryprocessinAD,roleofcyto- LDL receptor-related protein 1 in hippocampus
kines.ScientificWorldJournal2012,756357. from subjects with AD: implications for Aβ accu-
900. Ahmed, N et al. (2005) Protein glycation, oxida- mulation in AD brain. Free Radic. Biol. Med. 49,
tionandnitrationadductresiduesandfreeadducts 1798.
of CSF in AD and link to cognitive impairment. 918. Mattson, MP et al. (1997) 4-HNE, a product of
J.Neurochem.92,255. lipid peroxidation, inhibits dephosphorylation of
901. De Felice, FG (2013) AD and insulin resistance: themicrotubule-associatedproteintau.Neuroreport
translating basic science into clinical applications. 8,2275.
J.Clin.Invest.123,531. 919. Praticò,Detal.(2001)Increasedlipidperoxidation
902. Mao,Petal.(2012)Mitochondria-targetedcatalase precedes amyloid plaque formation in an animal
reducesabnormalAPPprocessing,Aβ production model of Alzheimer amyloidosis. J. Neurosci. 21,
andBACE1inamousemodelofAD:implications 4183.
for neuroprotection and lifespan extension. Hum. 920. Xie, H et al. (2013) Rapid cell death is preceded
Mol.Genet.21,2973. byamyloidplaque-mediatedoxidativestress.Proc.
903. Markesbery,WRetal.(2005)Lipidperoxidationis Natl.Acad.Sci.USA110,7904.
anearlyeventinthebraininamnesticMCI.Ann. 921. Conte,Vetal.(2004)VitaminEreducesamyloidosis
Neurol.58,730. andimprovescognitivefunctioninTg2576micefol-
904. Butterfield,DAetal.(2014)Redoxproteomicsana- lowingrepetitiveconcussivebraininjury.J.Neuro-
lysistodeciphertheneurobiologyofAlzheimer-like chem.90,758.
neurodegeneration: overlaps in Down syndrome 922. Murakami, K et al. (2011) SOD1 (CuZnSOD) defi-
andADbrain.Biochem.J.463,177. ciencydrivesAβproteinoligomerizationandmem-
905. Sultana,Retal.(2013)Lipidperoxidationtriggers orylossinmousemodelofAD.J.Biol.Chem.286,
neurodegeneration: a redox proteomics view into 44557.
theADbrain.FreeRadic.Biol.Med.62,157. 923. Yao,Jetal.(2004)Aging,genderandAPOEisotype
906. Smith,CDetal.(1991)Excessbrainproteinoxida- modulatemetabolismofAlzheimer’sAβ peptides
tionandenzymedysfunctioninnormalagingand andF2-IsoPsintheabsenceofdetectableamyloid
inAD.Proc.Natl.Acad.Sci.USA88,10540. deposits.J.Neurochem.90,1011.

--- Page 862 ---

REFERENCES 807
924. Drake,Jetal.(2003)Oxidativestressprecedesfibril- multifactorial ageing-related degenerative muscle
lardepositionofADamyloidβ-peptide(1–42)ina disease associated with proteasomal and lyso-
transgenicC.elegansmodel.Neurobiol.Aging24,415. somal inhibition, ER stress, and accumulation of
925. Tamagno, E et al. (2008) Oxidative stress acti- Aβ42 oligomers and phosphorylated tau. Presse
vates a positive feedback between the γ- and Med.40,e219.
β-secretase cleavages of the β-amyloid precursor 942. Takase, H et al. (2014) Effect of amino acid vari-
protein.J.Neurochem.104,683. ations in the central region of human SAA on
926. Gwon,Aetal.(2012)Oxidativelipidmodificationof theamyloidogenicproperties.Biochem.Biophys.Res.
nicastrinenhancesamyloidogenicγ-secretaseactiv- Commun.444,92.
ityinAD.AgingCell11,559. 943. Stewart, CR et al. (2005) Oxidation of LDL in-
927. Soper, JH et al. (2012) Brain-penetrant tetrahy- duces amyloid-like structures that are recognized
dronaphthalene thromboxane A2-prostanoid (TP) bymacrophages.Biochemistry44,9108.
receptor antagonists as prototype therapeutics for 944. Suhr, OB et al. (2001) Scavenger treatment of free
AD.ACSChem.Neurosci.3,928. radical injury in familial amyloidotic polyneurop-
928. Makjanic,Jetal.(1998)AbsenceofAlinneurofibril- athy: a study on Swedish transplanted and non-
larytanglesinAD.Neurosci.Lett.240,123. transplantedpatients.Scand.J.Clin.Lab.Invest.61,
929. Pratico, D et al. (2002) Al modulates brain amyl- 11.
oidosisthroughoxidativestressinAPPtransgenic 945. Ando, Y et al. (1997) Oxidative stress is found in
mice.FASEBJ.16,1138. amyloiddepositsinsystemicamyloidosis.Biochem.
930. Loef,Metal.(2011)PbandtheriskofADorcog- Biophys.Res.Commun.232,497.
nitivedecline:asystematicreview.ToxinReviews30, 946. Vilasi, A et al. (2013) Unraveling amyloid toxicity
103. pathway in NIH3T3 cells by a combined prote-
931. Gillette-Guyonnet, S et al. (2013) Nutrition and omicand1H-NMRmetabonomicapproach.J.Cell
neurodegeneration: epidemiological evidence and Physiol.228,1359.
challengesforfutureresearch.Br.J.Clin.Pharmacol. 947. Ando,Y(2003)Newtherapeuticapproachesforfa-
75,738. milialamyloidoticpolyneuropathy(FAP).Amyloid
932. Nisenbaum, EJet al. (2014) The presence and role 10(Suppl.1),55.
of Fe in mild traumatic brain injury: an imaging 948. Singh,Netal.(2010)Redoxcontrolofprionanddis-
perspective.J.Neurotrauma31,301. easepathogenesis.Antioxid.RedoxSignal.12,1271.
933. Rendeiro,Cetal.(2012)Flavonoidsasmodulators 949. Scheiber,IVetal.(2014)Metabolismandfunctions
ofmemoryandlearning:molecularinteractionsre- ofCuinbrain.ProgressNeurobiol.116,33.
sulting in behavioural effects. Proc. Nutr. Soc. 71, 950. Turnbull, S et al. (2003) Generation of H2O2 from
246. mutantformsoftheprionproteinfragmentPrP121–
934. Opii, WO et al. (2008) Proteomic identification of 131.Biochemistry42,7675.
brainproteinsinthecaninemodelofhumanaging 951. Pamplona,Retal.(2008)Increasedoxidation,gly-
followingalong-termtreatmentwithantioxidants coxidation, and lipoxidation of brain proteins in
andaprogramofbehavioralenrichment:relevance priondisease.FreeRadic.Biol.Med.45,1159.
toAD.Neurobiol.Aging29,51. 952. Minghetti, L et al. (2000) Increased brain synthe-
935. Bazan, NG (2009) Neuroprotectin D1-mediated sis of PGE2 and F2-IsoPs in human and experi-
anti-inflammatoryandsurvivalsignalinginstroke, mentaltransmissiblespongiformencephalopathies.
retinaldegenerations,andAD.J.LipidRes.50,S400. J.Neuropathol.Exp.Neurol.59,866.
936. Pang, TY and Hannan, AJ (2013) Enhancement 953. Brazier, MW et al. (2008) A MnSOD/catalase mi-
of cognitive function in models of brain disease meticextendssurvivalinamousemodelofhuman
throughenvironmentenrichmentandphysicalac- priondisease.FreeRadic.Biol.Med.45,184.
tivity.Neuropharmacology64,515. 954. Aguzzi,A(2014)ADunderstrain.Nature512,32.
937. Banerjee,S(2013)Goodnewsondementiapreva- 955. Ilieva,Hetal.(2009)Non-cellautonomoustoxicity
lence–wecanmakeadifference.Lancet382,1384. in neurodegenerative disorders: ALS and beyond.
938. Radak,Zetal.(2014)Theredox-associatedadaptive J.CellBiol.187,761.
response of brain to physical exercise. Free Radic. 956. Sheng, Yetal. (2014)SODs and SORs.Chem. Rev.
Res.48,84. 114,3854.
939. Pepys,MB(2006)Amyloidosis.Annu.Rev.Med.57, 957. Jonsson, PA et al. (2006) Motor neuron disease in
223. mice expressing the wild type-like D90A mutant
940. Sivak,JM(2013)Theagingeye:commondegenera- SOD-1.J.Neuropathol.Exp.Neurol.65,1126.
tivemechanismsbetweentheADbrainandretinal 958. Lee, M et al. (2001) Effect of overexpression of
disease.Invest.Opthalmol.Vis.Sci.54,871. wild-typeandmutantCuZnSODonoxidativestress
941. Askanas, V and Engel, WK (2011) Spor- andcelldeathinducedbyH2O2,4-HNEorserum
adic inclusion-body myositis: conformational deprivation: potentiation of injury by ALS-related

--- Page 863 ---

808 REFERENCES
mutantSODandprotectionbyBcl-2.J.Neurochem. 975. Lewis, RA et al. (2013) High-dosage ascorbic acid
78,209. treatmentinCharcot-Marie-ToothDiseaseType1A:
959. Chen,Hetal.(2014)ModelingALSwithiPSCsre- resultsofarandomized,double-masked,controlled
vealsthatmutantSOD1misregulatesneurofilament trial.JAMANeurol.70,981.
balanceinmotorneurons.CellStemCell14,796. 976. Durand,Tetal.(2013)F2-dihomo-IsoPsandbrain
960. Lino,MMetal.(2002)AccumulationofSOD1mu- white matter damage in stage 1 Rett syndrome.
tantsinpostnatalmotoneuronsdoesnotcausemo- Biochimie95,86.
toneuronpathologyormotoneurondisease.J.Neur- 977. Rose,Setal.(2012)Evidenceofoxidativedamage
osci.22,4825. andinflammationassociatedwithlowglutathione
961. Sorce,Setal.(2012)TargetingNOXenzymesinthe redoxstatusintheautismbrain.Transl.Psychiatry2,
CNS: therapeutic opportunities. Cell. Mol. Life Sci. e134.
69,2387. 978. Yao, Y et al. (2006) Altered vascular phenotype in
962. von Lewinski, F and Keller, BU (2005) Ca2+, mi- autism.Arch.Neurol.63,1161.
tochondriaandselectivemotoneuronvulnerability: 979. Shin, EJ et al. (2011) Role of oxidative stress in
implicationsforALS.TrendsNeurosci.28,494. epilepticseizures.Neurochem.Int.59,122.
963. Drechsel, DA et al. (2012) NO • -mediated oxida- 980. Pomara, N et al. (2012) Lower CSF Aβ peptides
tivedamageandtheprogressivedemiseofmotor and higher F2-IsoPs in cognitively intact elderly
neuronsinALS.Neurotox.Res.22,251. individuals with major depressive disorder. Am.
964. Bogdanov,Metal.(2000)Increasedoxidativedam- J.Psychiatry169,523.
agetoDNAinALSpatients.FreeRadic.Biol.Med. 981. Bergmann,OandFrisén,J(2013)Whyadultsneed
29,652. newbraincells.Science340,695.
965. Mitsumoto, H et al. (2008) Oxidative stress bio- 982. Chung, CP et al. (2013) Increased oxidative stress
markersinsporadicALS. Amyotroph.LateralScler. inpatientswithdepressionanditsrelationshipto
9,177. treatment.PsychiatryRes.206,213.
966. Montine,TJetal.(2005)F2-IsoPsinADandother 983. Maes, M et al. (2011) A review on the oxida-
neurodegenerativediseases.Antioxid.RedoxSignal. tive and nitrosative (O&NS) pathways in major
7,269. depression and their possible contribution to the
967. Ryberg,Hetal.(2004)CSFlevelsoffree3-NTare (neuro)degenerativeprocessesinthatillness.Prog.
notelevatedinthemajorityofpatientswithALSor Neuropsychopharmacol.Biol.Psychiatry35,676.
AD.Neurochem.Int.45,57. 984. Wu, JQ et al. (2013) Free radicals, antioxidant de-
968. Poon,HFetal.(2005)Redoxproteomicsanalysisof fense systems, and schizophrenia. Prog. Neuropsy-
oxidativelymodifiedproteinsinG93A-SOD1trans- chopharmacol.Biol.Psychiatry46,200.
genicmice-amodelofFALS.FreeRadic.Biol.Med. 985. Cho, CH and Lee HJ (2013) Oxidative stress and
39,453. tardivedyskinesia:pharmacogenicevidence.Prog.
969. Franco,MCetal.(2013)NitrationofHsp90induces Neuropsychopharmacol.Biol.Psychiatry46,207.
celldeath.Proc.Natl.Acad.Sci.USA110,E1102. 986. Andreazza, AC et al. (2013) Specific subcellular
970. Greek,RandHansen,LA(2013)Questionsregard- changesinoxidativestressinprefrontalcortexfrom
ing the predictive value of one evolved complex patients with bipolar disorder. J. Neurochem. 127,
adaptive system for a second: exemplified by the 552.
SOD1mouse.Prog.Biophys.Mol.Biol.113,231. 987. Berk,Metal.(2013)ThepromiseofN-acetylcysteine
971. Miquel, E et al. (2014) Neuroprotective effects of inneuropsychiatry.TrendsPharmacol.Sci.34,167.
the mitochondria-targeted antioxidant MitoQ in a 988. Vaubel, RA and Isaya, G (2013) Fe-S cluster syn-
model of inherited ALS. Free Radic. Biol. Med. 70, thesis, Fe homeostasis and oxidative stress in
204. Friedreichataxia.Mol.Cell.Neurosci.55,50.
972. Linares,Eetal.(2013)Tempolmoderatelyextends 989. Parkinson,MHetal.(2013)CoQ10andidebenone
survival in a hSOD1G93A ALS rat model by in- useinFriedreich’sataxia.J.Neurochem.126Suppl1,
hibiting neuronal cell loss, oxidative damage and 125.
levelsofnon-nativehSOD1G93Aforms.PLoSOne8, 990. DiProspero,NAetal.(2007)Neurologicaleffectsof
e55868. high-dose idebenone in patients with Friedreich’s
973. Graf,Metal.(2005)HighdosevitaminEtherapy ataxia:arandomized,placebo-controlledtrial.Lan-
in ALS as add-on therapy to riluzole: results of cetNeurol.6,878.
a placebo-controlled double-blind study. J. Neural 991. Johri,AandBeal,MF(2012)AntioxidantsinHD.
Trans.112,649. Biochim.Biophys.Acta1822,664.
974. Twisk,FN(2014)Thestatusofandfutureresearch 992. Muller,MandLeavitt,BR(2014)Fedysregulation
into Myalgic Encephalomyelitis and Chronic Fa- inHD.J.Neurochem.130,328.
tigue Syndrome: the need for accurate diagnosis, 993. Paul, BD et al. (2014) Cystathionine γ-lyase defi-
objectiveassessment,andacknowledgingbiological ciency mediatesneurodegeneration in HD. Nature
andclinicalsubgroups.Front.Physiol.5,109. 509,96.

--- Page 864 ---

REFERENCES 809
994. Sarkar, S et al. (2007) Trehalose, a novel mTOR- 1012. Janes, K et al. (2013) Bioenergetic deficits
independent autophagy enhancer, accelerates the in peripheral nerve sensory axons during
clearance of mutant huntingtin and α-synuclein. chemotherapy-induced neuropathic pain resulting
J.Biol.Chem.282,5641. fromONOO–-mediatedpost-translationalnitration
995. Castillo, K et al. (2013) Trehalose delays the pro- ofmitochondrialSOD.Pain154,2432.
gressionofALSbyenhancingautophagyinmoto- 1013. Fernandes,ESetal.(2013)O
•–generationandleuk-
2
neurons.Autophagy9,1308 ocyteaccumulation:keyelementsinthemediation
996. Schaeffer,Vetal.(2012)Stimulationofautophagy of LTB4-induced itch by TRP ankyrin 1 and TRP
reduces neurodegeneration in a mouse model of vanilloid1.FASEBJ.27,1664.
humantauopathy.Brain135,2169. 1014. Edmonds,SEetal.(1997)Putativeanalgesicactivity
997. Emanule, E (2014) Can trehalose prevent neuro- ofrepeatedoraldosesofvitaminEinthetreatment
degeneration? Insights from experimental studies. ofrheumatoidarthritis.Resultsofaprospectivepla-
Curr.DrugTargets15,551. cebo controlleddouble blind trial.Ann. Rheumatic
998. Reed, TT (2011) Lipid peroxidation and neurode- Dis.56,649.
generativedisease.FreeRadic.Biol.Med.51,1302. 1015. Eum,Setal.(2013)ProtectiveeffectsofvitaminE
999. Sorolla, MA et al. (2008) Proteomic and oxidative onchemotherapy-inducedperipheralneuropathy:a
stressanalysisinhumanbrainsamplesofHD.Free meta-analysisofrandomizedcontrolledtrials.Int.
Radic.Biol.Med.45,667. J.Vitam.Nutr.Res.83,101.
1000. Nguyen,Tetal.(2005)Clioquinoldown-regulates 1016. Garofalo,RPetal.(2013)Respiratorysyncytialvirus
mutanthuntingtinexpressioninvitroandmitigates infection: mechanisms of redox control and novel
pathologyinaHDmousemodel.Proc.Natl.Acad. therapeuticopportunities.Antioxid.RedoxSignal.18,
Sci.USA102,11840. 186.
1001. Kollman,Ketal.(2013)Cellbiologyandfunction 1017. Kinjo, T et al. (2010) Induction of ROS by human
ofNCL-relatedproteins.Biochim.Biophys.Acta1832, T-cell leukemia virus type 1 Tax correlates with
1866. DNAdamageandexpressionofcellularsenescence
1002. Coblentz,Jetal.(2014)LossofTRPML1promotes marker.J.Virol.84,5431.
productionofROS:isoxidativedamageafactorin 1018. Higgs,MRetal.(2014)‘Liverletdie’:oxidativeDNA
mucolipidosistypeIV?Biochem.J.457,361. damageandhepatotropicviruses.J.Gen.Virol.95,
1003. Kallenborn-Gerhardt,Wetal.(2013)NOXioussig- 991.
nalinginpainprocessing.Pharmacol.Ther.137,309. 1019. Hiraku,Yetal.(2007)NitrativeandoxidativeDNA
1004. Sheng,Hetal.(2014)Metalloporphyrinsasthera- damageincervicalintraepithelialneoplasiaassoci-
peutic catalytic oxidoreductants in central ner- atedwithhumanpapillomavirusinfection.Cancer
vous system disorders. Antioxid. Redox Signal. 20, Sci.98,964.
2437. 1020. Vlahos, R et al. (2012) Suppressing production of
1005. Keeble,JEetal.(2009)H2O2isanovelmediatorof ROSforinfluenzaAvirustherapy.TrendsPharmacol.
inflammatory hyperalgesia, acting via TRP vanil- Sci.33,3
loid 1-dependent and independent mechanisms. 1021. Valyi-Nagy, T and Dermody, TS (2005) Role of
Pain141,135. oxidativedamageinthepathogenesisofviralinfec-
1006. Kozai,Detal.(2014)RedoxregulationofTRPchan- tionsofthenervoussystem.Histol.Histopathol.20,
nels.Antioxid.RedoxSignal.21,971. 957.
1007. Trevisan, G et al. (2014) TRPA1 receptor stimu- 1022. Carvajal-Yepes,Metal.(2011)HepatitisCvirusim-
lation by H2O2 is critical to trigger hyperalgesia pairs the induction of cytoprotective Nrf2 target
and inflammation in a model of acute gout. Free genesbydelocalizationofsmallMafproteins.J.Biol.
Radic.Biol.Med.72,200. Chem.286,8941.
1008. Linley,JEetal.(2012)ROSaresecondmessengersof 1023. Page, A et al. (2014) Marburg virus hijacks Nrf2-
neurokininsignalinginperipheralsensoryneurons. dependent pathway by targeting Nrf2-negative
Proc.Natl.Acad.Sci.USA.109,e1578. regulatorKeap1.CellRep.6,1026.
1009. Bierhaus, A et al. (2012) Methylglyoxal modifica- 1024. Yamane,Detal.(2014)RegulationoftheHCVRNA
tionsofNav1.8facilitatesnociceptiveneuronfiring replicase by endogenous lipid peroxidation. Nat.
and causes hyperalgesia in diabetic neuropathy. Med.20,927.
Nat.Med.18,926. 1025. Nicolini, A et al. (2001) HIV-1 Tat protein induces
1010. Huang, JL et al. (2012) Contributions of spinal D- NF-κBactivationandoxidativestressinmicroglial
aminoacidoxidasetobonecancerpain.AminoAcids culturesbyindependentmechanisms.J.Neurochem.
43,1905. 79,713.
1011. Janes, K et al. (2012) Anti-O •– and anti-ONOO– 1026. Cota-Gomez, A et al. (2011) HIV-Tat increases ox-
2
strategiesinpainsuppression.Biochim.Biophys.Acta idantburdeninthelungsoftransgenicmice.Free
1822,815. Radic.Biol.Med.51,1697.

--- Page 865 ---

810 REFERENCES
1027. Tiede,LMetal.(2011)O2matters:tissuecultureO2 4. Liang,RandGhaffari,S(2014)Stemcells,redoxsig-
levels affect mitochondrial function and structure naling,andstemcellaging.Antioxid.RedoxSignal.20,
aswellasresponsestoHIVviroproteins.CellDeath 1902.
Dis.2,e246. 5. Li, J and Holbrook, NJ (2003) Common mechan-
1028. Morris,Detal.(2012)Unveilingthemechanismsfor isms for declines in oxidative stress tolerance and
decreasedglutathioneinindividualswithHIVin- proliferation with ageing. Free Radic. Biol. Med. 35,
fection.Clin.Dev.Immunol.2012,ArticleID734125. 292.
1029. Gross,Aetal.(1996)Elevatedhepaticγ-GCSactiv- 6. Nath, KA et al. (2013) Age sensitizes the kidney
ityandabnormalsulfatelevelsinliverandmuscle to heme protein-induced acute kidney injury. Am.
tissue may explain abnormal cysteine and GSH J.Physiol.304,F317.
levelsin SIV-infected rhesus macaques. AIDS Res. 7. Kirkwood TB (2008) A systematic look at an old
Hum.Retrovir.12,1639. problem.Nature451,644.
1030. Müller,Fetal.(2000)Virologicalandimmunological 8. KirkwoodTB(2005)Understandingtheoddscience
effectsofantioxidanttreatmentinpatientswithHIV ofaging.Cell120,437.
infection.Eur.J.Clin.Invest.30,905. 9. Chang,HCandGuarente,L(2014)SIRT1andother
1031. Nkengfack,GNetal.(2012)Effectsofantioxidants sirtuinsinmetabolism.TrendsEndocrinol.Metab.25,
on CD4 and viral load in HIV-infected women in 138.
sub-SaharanAfrica–dietarysupplementsvslocal 10. Kirkwood, TB and Melov, S (2011) On the
diet.Int.J.Vitam.Nutr.Res.82,63 programmed/non-programmed nature of ageing
1032. Redhage,LAetal.(2009)Clinicalfactorsassociated withinthelifehistory.Curr.Biol.21,R701.
withplasmaF2-IsoPlevelsinHIV-infectedadults. 11. Walker, DW et al. (2000) Evolution of lifespan in
HIVClin.Trials10,181. C.elegans.Nature405,296.
1033. Molin,Yetal.(2010)As2O3influencesviralreplica- 12. Blagosklonny, MV (2007) Paradoxes of aging. Cell
tionintargetorgansofcoxsackievirusB3-infected Cycle6,2997.
mice.MicrobesInfect.12,1027. 13. Ragland,SSandSohal,RS(1975)Ambienttemper-
1034. Dalpke,AHetal.(2003)Oxidativeinjurytoendo- ature, physical activity and aging in the housefly,
thelial cells due to EBV-induced autoantibodies Muscadomestica.Exp.Geront.10,279.
againstMnSOD.J.Med.Virol.71,408. 14. Sánchez-Blanco, A and Kim, SK (2011) Variable
1035. Kamranvar, SA and Masucci, MG (2011) The pathogenicitydeterminesindividuallifespaninC.el-
Epstein-Barrvirusnuclearantigen-1promotestelo- egans.PLoSGenet.7,e1002047.
meredysfunctionviainductionofoxidativestress. 15. Sohal,RSandForster,MJ(2014)Caloricrestriction
Leukemia25,1017. andtheagingprocess:acritique.FreeRadic.Biol.Med.
1036. delaAsunción,JGetal.(1998)AZTtreatmentin- 73,366.
ducesmolecularandultrastructuraloxidativedam- 16. Hursting,SDetal.(2003)CR,agingandcancerpre-
agetomusclemitochondria.J.Clin.Invest.102,4. vention: mechanisms of action and applicability to
1037. Kohler, JJ et al. (2009) Transgenic mitochondrial humans.Ann.Rev.Med.54,131.
SOD and mitochondrially targeted catalase pre- 17. Mirzaei,Hetal.(2014)Proteinandaminoacidrestric-
vents antiretroviral-induced oxidative stress and tion,aginganddisease:fromyeasttohumans.Trends
cardiomyopathy.Lab.Invest.89,782. Endocrinol.Metab.25,558.
1038. McComsey, GA and Morrow, JD (2003) Lipid 18. Halliwell,B(2004)Ageinganddisease:fromDarwin-
oxidative markers are significantly increased in ianmedicinetoantioxidants.Innovation4,13.
lipoatrophybutnotinsustainedasymptomatichy- 19. Giorgio,Metal.(2011)Thep66Shcknockoutmiceare
perlactatemia.J.Acquir.ImmuneDefic.Syndr.34,45. short lived under natural condition. Aging Cell 11,
162.
20. Willcox, BJ and Willcox, DC (2014) Caloric restric-
tion,caloricrestrictionmimetics,andhealthyaging
Chapter11
inOkinawa:controversiesandclinicalimplications.
1. Della-Morte, D et al. (2012) Genetics and genomics Curr.Opin.Clin.Nutr.Metab.Care17,51.
of ischemic tolerance: focus on cardiac and cere- 21. Willcox, BJ et al. (2004) How much should we eat?
bralischemicpreconditioning.Pharmacogenomics13, Theassociationbetweenenergyintakeandmortality
1741. ina36-yearfollow-upstudyofJapanese-American
2. van den Munckhof, I et al. (2013) Aging attenu- men.J.Gerontol.A59,789.
atestheprotectiveeffectofischemicpreconditioning 22. Colman, RJ et al. (2014) Caloric restriction reduces
against endothelial ischemia-reperfusion injury in age-related and all-cause mortality in rhesus mon-
humans.Am.J.Physiol.304,H1727. keys.Nat.Commun.5,3557.
3. Davies, SS et al. (2009) Ischemia/reperfusion un- 23. Finkel,TandHolbrook,NJ(2000)Oxidants,oxida-
veils impaired capacity of older adults to restrain tive stress and the biology of ageing. Nature 408,
oxidativeinsult.FreeRadic.Biol.Med.47,1014. 239.

--- Page 866 ---

REFERENCES 811
24. Lapierre, LR and Hansen, M (2012) Lessons from 44. Kuningas,Metal.(2009)Selectionforgeneticvari-
C. elegans: signaling pathways for longevity. Trends ation inducing pro-inflammatory responses under
Endocrinol.Metab.23,637. adverse environmental conditions in a Ghanaian
25. Partridge,LandGems,D(2006)Beyondtheevolu- population.PLoSOne4,e7795.
tionarytheoryofageing,fromfunctionalgenomics 45. Varela,Ietal.(2005)Acceleratedageinginmicedefi-
toevo-gero.TrendsEcol.Evol.21,334. cientinZmpste24proteaseislinkedtop53signalling
26. Kenyon,CJ(2010)Thegeneticsofageing.Nature464, activation.Nature437,564.
504. 46. Scaffidi, P and Misteli, T (2006) Lamin-A depend-
27. Ayyadevara, S et al. (2008) Remarkable longevity ent nuclear defects in human ageing. Science 312,
andstressresistanceofnematodePI3K-nullmutants. 1059.
AgingCell7,13. 47. Tchkonia,Tetal.(2013)Cellularsenescenceandthe
28. Murphy,CTetal.(2003)Genesthatactdownstream senescent secretory phenotype: therapeutic oppor-
of DAF-16 to influence the lifespan of C. elegans. tunities.J.Clin.Invest.123,966.
Nature424,277. 48. Guarente,L(2011)Sirtuins,aging,andmedicine.N.
29. Cristina, D et al. (2009) A regulated response to Engl.J.Med.364,2235.
impaired respiration slows behavioral rates and 49. Soares,Hetal.(2014)Cellularpolarityinaging:role
increases lifespan in C. elegans. PLoS Genetics 5, ofredoxregulationandnutrition.GenesNutr.9,371.
e1000450. 50. Hubbard, BP et al. (2013) Evidence for a common
30. Gems,DandDoonan,R(2009)Antioxidantdefense mechanismofSIRT1regulationbyallostericactivat-
andaginginC.elegans.CellCycle8,1681. ors.Science339,1216.
31. Tatar, M et al. (2003) The endocrine regulation of 51. Baur, JAetal. (2012)Are sirtuinsviable targetsfor
agingbyinsulin-likesignals.Science299,1346. improvinghealthspanandlifespan?Nat.Rev.Drug
32. Xu,Jetal.(2014)LongevityeffectofIGF-1R+/-muta- Discov.11,443.
tiondependsongeneticbackground-specificrecep- 52. Barger, JL et al. (2008) A low dose of dietary res-
toractivation.AgingCell13,19. veratrol partially mimics CR and retards aging
33. Guevara-Aguirre, J et al. (2011) Growth hormone parametersinmice.PLoSOne3,e2264.
receptordeficiencyisassociatedwithamajorreduc- 53. Walle,Tetal.(2004)Highabsorptionbutverylow
tioninpro-agingsignalling,cancer,anddiabetesin bioavailability of oral resveratrol in humans. Drug
humans.Sci.Transl.Med.3,70ra13. Metab.Dis.32,1377.
34. Burtner,CRandKennedy,BK(2010)Progeriasyn- 54. Bagul,PKandBanerjee,SK(2013)Insulinresistance,
dromesandageing:whatistheconnection?Nat.Rev. oxidative stress and cardiovascular complications:
Mol.CellBiol.11,567. roleofsirtuins.Curr.Pharm.Des.19,5663.
35. Tyner,SDetal.(2002)p53mutantmicethatdisplay 55. Massagué,J(2004)G1cell-cyclecontrolandcancer.
earlyageing-associatedphenotypes.Nature415,45. Nature432,298.
36. Ørsted, DD et al. (2007) Tumor suppressor p53 56. Martin-Montalvo, A and de Cabo, R (2013) Mito-
Arg72Propolymorphismandlongevity,cancersur- chondrialmetabolicreprogramminginducedbycal-
vival,andriskofcancerinthegeneralpopulation. orierestriction.Antioxid.RedoxSignal.19,310.
J.Exp.Med.204,1295. 57. McClure,JMetal.(2012)Isonicotinamideenhances
37. Valdes,AMetal.(2013)Omicstechnologiesandthe Sir2 protein-mediated silencing and longevity in
studyofhumanageing.Nat.Rev.Genetics14,601. yeast by raising intracellular NAD+ concentration.
38. Blalock, EM et al. (2003) Gene microarrays in hip- J.Biol.Chem.287,20957.
pocampalaging:statisticalprofilingidentifiesnovel 58. Verdin,E(2014)CouplingofNADmetabolism,sirtu-
processes correlated with cognitive impairment. insandlifespan.Nat.Med.20,25.
J.Neurosci.23,3807. 59. Blagosklonny, MV (2008) Aging: ROS or TOR. Cell
39. Lu,Tetal.(2004)GeneregulationandDNAdamage Cycle7,3344.
intheageinghumanbrain.Nature429,883. 60. Johnson,SCetal.(2013)mTORisakeymodulatorof
40. Kayo,Tetal.(2001)InfluencesofagingandCRonthe ageingandage-relateddisease.Nature493,338.
transcriptionalprofileofskeletalmusclefromrhesus 61. Leslie, M (2013) A putative antiaging drug takes a
monkeys.Proc.Natl.Acad.Sci.USA98,5093. stepfrommicetomen.Science342,789.
41. Loerch,PMetal.(2008)Evolutionoftheagingbrain 62. Muller, M (2009) Cellular senescence: molecular
transcriptomeandsynapticregulation.PLoSOne3, mechanisms,invivosignificance,andredoxconsid-
e3329. erations.Antioxid.RedoxSignal.11,59.
42. Lu,Tetal.(2014)RESTandstressresistanceinageing 63. vonZglinicki,T(2002)Oxidativestressshortenste-
andAD.Nature507,448. lomeres.TrendsBiochem.Sci.27,339
43. Eskenazi,BRetal.(2007)ADarwinianapproachto 64. Kapeta,Setal.(2010)Nrf2-mediatedproteasomeacti-
HD:subtlehealthbenefitsofaneurologicaldisorder. vationdelayssenescenceinhumanfibroblasts.J.Biol.
Med.Hypotheses69,1183. Chem.285,8171.

--- Page 867 ---

812 REFERENCES
65. Weyemi, U et al. (2012) ROS-generating NOX4 is a 81. Montgomery, MK et al. (2012) Does the oxidative
criticalmediatorinoncogenicH-Ras-inducedDNA stresstheoryofagingexplainlongevitydifferences
damage and subsequent senescence. Oncogene 31, inbirds?I.MitochondrialROSproduction.Exp.Ge-
1117. rontol.47,203.
66. Rai,Petal.(2011)Enhancedeliminationofoxidized 82. Speakman,JRetal.(2004)Uncoupledandsurviving:
guaninenucleotidesinhibitsoncogenicRAS-induced individualmicewithhighmetabolismhavegreater
DNAdamageandprematuresenescence.Oncogene mitochondrialuncouplingandlivelonger.AgingCell
30,1489. 3,87.
67. LowKCandTergaonkar,V(2013)Telomerase:cen- 83. Picard,Metal.(2010)Mitochondrialfunctionalim-
tralregulatorofallofthehallmarksofcancer.Trends pairmentwithagingisexaggeratedinisolatedmi-
Biochem.Sci.38,426. tochondria compared to permeabilized myofibers.
68. Toussaint,Oetal.(2010)ArtefactualeffectsofO2on AgingCell9,1032.
cellculturemodelsofcellularsenescenceandstem 84. Lewis,KNetal.(2013)Thenakedmole-ratresponse
cellbiology.J.Cell.Physiol.226,315. tooxidativestress:justdealwithit.Antioxid.Redox
69. Itahana,Ketal.(2004)Mechanismsofcellularsen- Signal.19,1388.
escence in human and mouse cells. Biogerontology 85. DeWaal,EMetal.(2013)Elevatedproteincarbonyla-
5,1. tionandoxidativestressdonotaffectproteinstruc-
70. Blander, G et al. (2003) SOD1 knock-down induces tureandfunctioninthelong-livingnaked-molerat:a
senescence in human fibroblasts. J. Biol. Chem. 278, proteomicapproach.Biochem.Biophys.Res.Commun.
38966. 434,815.
71. Serra,Vetal.(2003)EC-SODisamajorantioxidant 86. Baraibar,MAandFriguet,B(2012)Changesofthe
inhumanfibroblastsandslowstelomereshortening. proteasomalsystemduringtheagingprocess.Prog.
J.Biol.Chem.278,6824. Mol.Biol.Transl.Sci.109,249.
72. Barascu, A et al. (2012) Oxidative stress alters nu- 87. Moghaddas, S et al. (2003) Aging defect at the Qo
clearshapethroughlaminsdysregulation.Nucleus3, siteofcomplexIIIaugmentsoxyradicalproduction
411. inratheartinterfibrillarmitochondria.Arch.Biochem.
73. Wang, Z et al. (2010) Characterization of oxida- Biophys.414,59.
tive guanine damage and repair in mammalian te- 88. Pulliam,DAetal.(2013)Mitochondrialdysfunction
lomeres.PLoSGenetics6,e1000951. inagingandlongevity:acausalorprotectiverole?
74. vanDeursen,JM(2014)Theroleofsenescentcellsin Antioxid.RedoxSignal.19,1373.
ageing.Nature509,439. 89. Knoll,J(1988)Thestriataldopaminedependencyof
75. Harman,D(2009)Originand evolutionofthe free lifespaninmalerats.Mech.AgeingDev.46,237.
radicaltheoryofaging:abriefpersonalhistory,1954– 90. Navarro, A and Boveris, A (2004) Rat brain and
2009.Biogerontology10,773. livermitochondriadevelopoxidativestressandlose
76. Orr,WCetal.(2013)Involvementofredoxstatein enzymatic activities on aging. Am. J. Physiol. 287,
theagingofDrosophilamelanogaster.Antioxid.Redox R1244.
Signal.19,788. 91. Bratic,AandLarsson,N(2013)Theroleofmitochon-
76A. Miquel,Jetal.(1980)Mitochondrialroleincellaging. driainaging.J.Clin.Invest.123,951.
Exp.Geront.15,575. 92. Kennedy,SRetal.(2014)Ultra-sensitivesequencing
77. Loft, S et al. (2012) Urinary excretion of 8-oxo-7,8- revealsanage-relatedincreaseinsomaticmitochon-
dihydroguanineasbiomarkerofoxidativedamageto drialmutationsthatareinconsistentwithoxidative
DNA.Arch.Biochem.Biophys.518,142. damage.PLoSGenet.9,e1003794.
77A. Hofer,Tetal.(2008)Long-termeffectsofcaloricre- 93. Safdar, A et al. (2011) Endurance exercise rescues
striction or exercise on DNA and RNA oxidation progeroidagingandinducessystemicmitochondrial
levels in white blood cells and urine in humans. rejuvenation in mtDNA mutator mice. Proc. Natl.
Rejuv.Res.11,793. Acad.Sci.USA108,4135.
78. Yan,LJandSohal,RS(2000)Preventionofflightac- 94. Dai, DF et al. (2010) Age-dependent cardiomyop-
tivityprolongs the life span of the housefly, Musca athyinmitochondrialmutatormiceisattenuatedby
domestica, and attenuates the age-associated oxida- overexpressionofcatalasetargetedtomitochondria.
tivedamagetospecificmitochondrialproteins.Free AgingCell9,536.
Radic.Biol.Med.29,1143. 95. Boumezbeur,Fetal.(2010)Alteredbrainmitochon-
79. Xiao, R et al. (2013) A genetic program promotes drial metabolism in healthy aging as assessed by
C.eleganslongevityatcoldtemperaturesviaather- in vivomagneticresonance spectroscopy. J. Cerebral
mosensitiveTRPchannel.Cell152,806. BloodFlowMetab.30,211.
80. Pamplona, R and Barja, G (2011) An evolution- 96. Hagen,TMetal.(1997)Mitochondrialdecayinhep-
ary comparative scan for longevity-related oxida- atocytesfromoldrats:membranepotentialdeclines,
tive stress resistance mechanisms in homeotherms. heterogeneityandoxidantsincrease.Proc.Natl.Acad.
Biogerontology12,409. Sci.USA94,3064.

--- Page 868 ---

REFERENCES 813
97. Kowald, A and Kirkwood, TB (2011) Evolution of 115. Franceschi,CandCampisi,J(2014)Chronicinflam-
themitochondrialfusion-fissioncycleanditsrolein mation(inflammaging)anditspotentialcontribution
aging.Proc.Natl.Acad.Sci.USA108,10237. toage-associateddiseases.J.Gerontol.A.69,S4.
98. Kowald,Aetal.(2014)Mitochondrialmutationsand 116. Cochemé, HM et al. (2011) Measurement of H2O2
ageing:canmitochondrialdeletionmutantsaccumu- within living Drosophila during aging using a ra-
lateviaasizebasedreplicationadvantage?J.Theor. tiometric mass spectrometry probe targeted to the
Biol.340,111. mitochondrialmatrix.CellMetab.13,340.
99. Treiber,Netal.(2011)Acceleratedagingphenotype 117. Vida,Cetal.(2011)Theaged-relatedincreaseinXO
inmicewithconditionaldeficiencyformitochondrial expressionandactivityinseveraltissuesfrommice
SODintheconnectivetissue.AgingCell10,239. isnotshowninlong-livedanimals.Biogerontology12,
100. Vermulst,Metal.(2007)Mitochondrialpointmuta- 551.
tionsdonotlimitthenaturallifespanofmice.Nat. 118. Beier, K et al. (1993) The impact of aging on en-
Genet.39,540. zymeproteinsofratliverperoxisomes:quantitative
101. Li,XDetal.(2012)Effectsofageandcaloricrestric- analysis by immunoblotting and immunoelectron
tion on mitochondrial protein oxidative damage in microscopy.VirchowsArch.BCellPathol.63,139.
mice.Mech.AgeingDev.133,30. 119. Son,TGetal.(2005)AgingeffectonMPOinratkid-
102. Gredilla,RandBarja,G(2005)Minireview:therole ney and its modulation by calorie restriction. Free
of oxidative stress in relation to CR and longevity. Radic.Res.39,283.
Endocrinology146,3713. 120. Dayal, S et al. (2013) H2O2 promotes aging-related
103. Zhang, Yet al. (2013) Dietary restriction attenuates platelethyperactivationandthrombosis.Circulation
theacceleratedagingphenotypeofSod1-/-mice.Free 127,1308.
Radic.Biol.Med.60,300. 121. Dai,DFetal.(2012)Mitochondriaandcardiovascular
104. Rojas,Cetal.(1993)Relationshipbetweenlipidper- aging.Circ.Res.110,1109.
oxidation,fattyacidcomposition,andascorbicacid 122. Durrant,JRetal.(2009)Voluntarywheelrunningre-
in the liver during carbohydrate and CR in mice. storesendothelialfunctioninconduitarteriesofold
Arch.Biochem.Biophys.306,59. mice:directevidenceforreducedoxidativestress,in-
105. Ash, CE and Merry, BJ (2011) The molecular creasedSODactivityanddown-regulationofNOX.
basis by which dietary restricted feeding reduces J.Physiol.587,3271.
mitochondrial ROS generation. Mech. Ageing Dev. 123. ElAssar,Metal.(2013)Oxidativestressandvascular
132,43. inflammationinaging.FreeRadic.Biol.Med.65,380.
106. Hagopian,Ketal.(2005)Long-termCRreducespro- 124. Lund,DDetal.(2009)ProtectiveeffectofEC-SODon
tonleakandH2O2productioninlivermitochondria. endothelialfunctionduringaging.Am.J.Physiol.296,
Am.J.Physiol.288,E674. H1920.
107. Barros,MHetal.(2004)Higherrespiratoryactivity 125. Wray, DW et al. (2012) Acute reversal of endothe-
decreases mitochondrial ROS release and increases lialdysfunctionintheelderlyafterantioxidantcon-
lifespaninS.cerevisiae.J.Biol.Chem.279,49883. sumption.Hypertension59,818.
108. Newman, JC et al. (2012) Mitochondrial protein 126. Vasilaki, A and Jackson, MJ (2013) Role of ROS in
acylation and intermediary metabolism: regulation thedefectiveregenerationseeninagingmuscle.Free
by sirtuins and implications for metabolic disease. Radic.Biol.Med.65,317.
J.Biol.Chem.287,42436. 127. Howard, C et al. (2007) Oxidative protein damage
109. Brown,Ketal.(2013)SIRT3reversesaging-associated is associated with poor grip strength among older
degeneration.CellRep.3,319. women living in the community. J. Appl. Physiol.
110. Han,CandSomeya,S(2013)Maintaininggoodhear- 103,17.
ing:calorierestriction,Sirt3,andGSH.Exp.Gerontol. 128. Pierce, GL et al. (2011) Habitually exercising older
48,1091. men do not demonstrate age-associated vascular
111. Kastman,EKetal.(2010)Acalorie-restricteddietde- endothelialoxidativestress.AgingCell10,1032.
creasesbrainFeaccumulationandpreservesmotor 129. Cobley, JN et al. (2014) Lifelong training preserves
performanceinoldRhesusmonkeys.J.Neurosci.30, some redox-regulated adaptive responses after an
7940. acute exercise stimulus in aged human skeletal
112. Pani,GandGaleotti,T(2011)RoleofMnSODand muscle.FreeRadic.Biol.Med.70,23.
p66shc in mitochondrial response to p53. Antioxid. 130. Zainal,TAetal.(2000)CRofrhesusmonkeyslowers
RedoxSignal.15,1715. oxidative damage in skeletal muscle. FASEB J. 14,
113. Brown-Bord,HMandRokoczy,SG(2005)Glutathi- 1825.
one metabolism in long-living Ames dwarf mice. 131. Ward,WFetal.(2005)EffectsofageandCRonlipid
Exp.Gerontol.40,115. peroxidation:measurementofoxidativestressbyF2-
114. Youm, YH et al. (2013) Canonical Nlrp3 inflam- IsoPlevels.J.Gerontol.A60,874.
masome links systemic low-grade inflammation to 132. Youssef,JAetal.(2003)Age-dependent,graymatter-
functionaldeclineinaging.Cell.Metab.18,519. localized, brain-enhanced oxidative stress in male

--- Page 869 ---

814 REFERENCES
Fischer 344 rats: brain levels of F2-IsoPs and 150. Back,Petal.(2012)Exploringreal-timeinvivoredox
F4-neuroprostanes.FreeRadic.Biol.Med.34,1631. biology of developing and aging C. elegans. Free
133. Peskind,ERetal.(2014)Influenceoflifestylemodi- Radic.Biol.Med.52,850.
ficationsonage-relatedfreeradicalinjurytobrain. 151. Knoefler, D et al. (2012) Quantitative in vivo redox
JAMANeurol.71,1150. sensorsuncoveroxidativestressasanearlyeventin
134. Lee, CY et al. (2009) Different patterns of oxidized life.Mol.Cell.47,767.
lipidproductsinplasmaandurineofdenguefever, 152. Albrecht, SC et al. (2011) In vivo mapping of
stroke,andPDpatients:cautionsintheuseofbio- H2O2 and GSSG reveals chemical and regional
markersofoxidativestress.Antioxid.RedoxSignal.11, specificity of redox homeostasis. Cell Metab. 14,
407. 819.
135. Kanski, J et al. (2005) Proteomic identification of 153. Cai,SQandSesti,F(2009)OxidationofaK+ chan-
3-NT-containingratcardiacproteins:effectsofbio- nelcausesprogressivesensoryfunctionlossduring
logicalaging.Am.J.Physiol.288,H371. aging.Nat.Neurosci.12,611.
136. Knyushko,TVetal.(2005)3-Nitrotyrosinemodifica- 154. Cotella, D et al. (2012) Toxic role of K+ channel
tionofSERCA2aintheagingheart:adistinctsigna- oxidationinmammalianbrain.J.Neurosci.32,4133.
tureofthecellularredoxenvironment.Biochemistry 155. Toyama,BHandHetzer,MW(2013)Proteinhomeo-
44,13071. stasis: live long, won’t prosper. Nat. Rev. Mol. Cell
137. Labuschagne, CF et al. (2013) Quantification of in Biol.14,55.
vivooxidativedamageinC.elegansduringagingby 156. Andersson,DCetal.(2011)Ryanodinereceptoroxi-
endogenousF3-IsoPmeasurement.AgingCell12,214. dation causes intracellular Ca2+ leak and muscle
138. Ishii,Netal.(2002)Proteinoxidationduringaging weaknessinaging.CellMetab.14,196.
ofthenematodeC.elegans.FreeRadic.Biol.Med.33, 157. Cooper,LLetal.(2013)Redoxmodificationofryan-
1021. odinereceptorsbymitochondria-derivedROScon-
139. Goudeau, J and Aguilaniu, H (2010) Carbonylated tributestoaberrantCa2+ handlinginageingrabbit
proteins are eliminated during reproduction in C. hearts.J.Physiol.591,5895.
elegans.AgingCell9,991. 158. Kumar,AandFoster,TC(2013)Linkingredoxregu-
140. Havukainen,Hetal.(2013)Vitellogeninrecognizes lation of NMDAR synaptic function to cognitive
celldamagethroughmembranebindingandshields declineduringaging.J.Neurosci.33,15710.
livingcellsfromROS.J.Biol.Chem.288,28369. 159. vanderLoo,Betal.(2002)Cardiovascularagingis
141. Stadtman, ER and Berlett, BS (1998) Reactive O2- associated with vitamin E increase. Circulation 105,
mediated protein oxidation in aging and disease. 1635.
DrugMetab.Rev.30,225. 160. Carrillo,MCetal.(1992)Age-relatedchangesinanti-
142. Stadtman, ER and Levine, RL (2003) Free radical- oxidant enzyme activities are region and organ, as
mediated oxidation of free amino acids and amino wellassex,selectiveintherat.Mech.AgeingDev.65,
acidresiduesinproteins.AminoAcids25,207. 187.
143. Møller, P et al. (2010) Aging and oxidatively dam- 161. Nyström,Tetal.(2012)Peroxiredoxins,gerontogenes
agednuclearDNAinanimalorgans.FreeRadic.Biol. linkingagingtogenomeinstabilityandcancer.Genes
Med.48,1275. Dev.26,2001.
144. Wang, J et al. (2012) The oxidative DNA lesions 162. Shenvi,SVetal.(2012)Identificationofage-specific
(cid:4)
8,5-cyclopurinesaccumulatewithaginginatissue- Nrf2bindingtoanovelARElocusintheGclcpro-
specificmanner.AgingCell11,714. moter: a compensatory means for the loss of GSH
145. Yan, LJ and Sohal, RS (1988) Mitochondrial aden- syntheticcapacityintheagingratliver?AgingCell
ine nucleotide translocase is modified oxidatively 11,297.
duringaging.Proc.Natl.Acad.Sci.USA95,12896. 163. Gould, NS et al. (2010) Aging adversely affects the
146. Sakellariou,GKetal.(2011)RoleofO
•–-NO •
inter- CS-inducedGSHadaptiveresponseinthelung.Am.
2
actionsintheacceleratedage-relatedlossofmuscle J.Respir.Crit.CareMed.182,1114.
massinmicelackingCu,ZnSOD.AgingCell10,749. 164. Jones, DP et al. (2002) Redox analysis of human
147. Tamarit, J et al. (2012) Analysis of oxidative stress- plasma allows separation of pro-oxidant events of
inducedproteincarbonylationusingfluorescenthy- aging from decline in antioxidant defenses. Free
drazides.J.Proteomics75,3778. Radic.Biol.Med.33,1290.
148. Poon,HFetal.(2006)Quantitativeproteomicsana- 165. Sekhar, RV et al. (2011) Deficient synthesis of GSH
lysisofdifferentialproteinexpressionandoxidative underlies oxidative stress in aging and can be cor-
modificationofspecificproteinsinthebrainsofold rectedbydietarycysteineandglycinesupplementa-
mice.Neurobiol.Aging.27,1010. tion.Am.J.Clin.Nutr.94,847.
149. Petrosillo,Getal.(2013)Declineincytochromecoxi- 166. del Favero, S et al. (2012) β-alanine (CarnosynTM)
dase activity in rat-brain mitochondria with aging. supplementation in elderly subjects (60–80 years):
Roleofperoxidizedcardiolipinandbeneficialeffect effects on muscle carnosine content and physical
ofmelatonin.J.Bioenerg.Biomembr.45,431. capacity.AminoAcids43,49.

--- Page 870 ---

REFERENCES 815
167. Xue,Metal(2011)Glyoxalaseinageing.Semin.Cell 186. Orr, WC et al. (2003) Effects of overexpression of
Dev.Biol.22,293. CuZnandMnSODs,catalase,andthioredoxinreduc-
168. Fleming,THetal.(2013)Aging-dependentreduction tase genes on longevity in D. melanogaster. J. Biol.
inglyoxalase1delayswoundhealing.Gerontology59, Chem.278,26418.
427. 187. Poeggeler, B et al. (2005) Mitochondrial medi-
169. Wilson,JX(2005)RegulationofvitaminCtransport. cine: neuroprotection and life extension by the
Ann.Rev.Nutr.25,105. new amphiphilic nitrone LPBNAH acting as a
170. Calabrese, V et al. (2011) Hormesis, cellular stress highly potent antioxidant agent. J. Neurochem. 95,
response and vitagenes as critical determinants in 962.
agingandlongevity.Mol.AspectsMed.32,279. 188. Ishii,Netal.(2004)CoQ10canprolongC.eleganslife-
171. Landis,Getal.(2012)Geneexpressionchangesinre- spanbyloweringoxidativestress.Mech.AgeingDev.
sponse to aging compared to heat stress, oxidative 125,41.
stressandionizingradiationinD.melanogaster.Aging 189. Lee, CK et al. (2004) The impact of α-lipoic acid,
4,768. coenzyme Q10, and CR on life span and gene ex-
172. Carnemolla,Aetal.(2014)Contestingthedogmaof pression patterns in mice. Free Radic. Biol. Med. 36,
anage-relatedheatshockresponseimpairment:im- 1043.
plicationsforcardiac-specificage-relateddisorders. 190. Flurkey,Ketal.(2010)Lifeextensionbydietrestric-
HumanMol.Genet.23,3641. tion and N-acetyl-L-cysteine in genetically hetero-
173. Green, DR et al. (2011) Mitochondria and the geneousmice.J.Gerontol.A65,1275.
autophagy-inflammation-cell death axis in organis- 191. Lipman, RD et al. (1998) Disease incidence and
malaging.Science333,1109. longevity are unaltered by dietary antioxidant
174. LaRocca,TJetal.(2012)Translationalevidencethat supplementation initiated during middle age in
impaired autophagy contributes to arterial ageing. C57BL/6mice.Mech.AgeingDev.103,269.
J.Physiol.590,3305. 192. Enioutina,EYetal.(2000)Enhancementofcommon
175. Delaval, E et al. (2004) Age-related impairment of mucosalimmunityinagedmicefollowingtheirsup-
mitochondrialmatrixaconitaseandATP-stimulated plementationwithvariousantioxidants.Vaccine18,
proteaseinratliverandheart.Eur.J.Biochem.271, 2381.
4559. 193. Haxaire,Cetal.(2012)Reversalofage-relatedoxida-
176. Yang, F et al. (2014) mTOR and autophagy in nor- tivestresspreventshippocampalsynapticplasticity
mal brain aging and CR ameliorating age-related deficitsbyprotectingD-serine-dependentNMDAre-
cognitiondefects.Behav.BrainRes.264,82. ceptoractivation.AgingCell11,336.
177. Hagis,MCandYankner,BA(2010)Theagingstress 194. Simán,CMandEriksson,UJ(1996)EffectofBHTon
response.Mol.Cell40,333. α-tocopherol content in liver and adipose tissue of
178. Tsakiri, EN et al. (2013) Differential regulation of rats.Toxicol.Lett.87,103.
proteasomefunctionalityinreproductivevssomatic 195. Sayin, VI et al. (2014) Antioxidants accelerate lung
tissuesofDrosophiladuringagingoroxidativestress. cancer progression in mice. Sci. Transl. Med. 6,
FASEBJ.27,2407. 221ra15.
179. Chondrogianni,Netal.(2014)Proteasomeactivation 196. Sohal,RSetal.(1985)Feinducesoxidativestressand
delaysaginginvitroandinvivo.FreeRadic.Biol.Med. may alter the rate of aging in the housefly, Musca
71,303. domestica.Mech.AgeingDev.32,33.
180. Tam,ZYetal.(2014)EffectsofLi+onage-relatedde- 197. Gruber,Jetal.(2008)Themitochondrialfreeradical
cline in mitochondrial turnover and function in C. theoryofageing–wheredowestand?Front.Biosci.
elegans.J.Gerontol.A69,810. 13,6554.
181. Mikkelsen,Letal.(2009)Aginganddefenseagainst 198. Christie,Letal.(2009)Short-termsupplementation
generationof8OHdGinDNA.FreeRadic.Biol.Med. withacetyl-L-carnitineandlipoicacidaltersplasma
47,608. proteincarbonyllevelsbutdoesnotimprovecogni-
182. Hegde,ML etal.(2012)Oxidativegenomedamage tioninagedbeagles.Exp.Gerontol.44,752.
anditsrepair:implicationsinagingandneurodegen- 199. Nasca,Letal.(2013)L-acetylcarnitinecausesrapid
erativediseases.Mech.AgeingDev.133,157. anti-depressanteffectsthroughtheepigeneticinduc-
183. Zou,Setal.(2007)Comparativeapproachestofacil- tion of mGlu2 receptors. Proc. Natl. Acad. Sci. USA
itatethediscoveryofprolongevityinterventions:ef- 110,4804.
fectsoftocopherolsonlifespanofthreeinvertebrate 200. Koeth,RAetal.(2013)Intestinalmicrobiotametabol-
species.Mech.AgeingDev.128,222. ismofL-carnitine,anutrientinredmeat,promotes
184. Pallauf, K et al. (2013) Vitamin C and lifespan in atherosclerosis.Nat.Med.19,576.
modelorganisms.FoodChem.Toxicol.58,255. 201. Anisimov, VN et al. (2011) Effects of the
185. Back,Petal.(2012)ROSinagingC.elegans:damage mitochondria-targetedantioxidantSkQ1onlifespan
orsignaling?Oxid.Med.Cell.Longev.2012,608478. ofrodents.Aging3,1110.

--- Page 871 ---

816 REFERENCES
202. Muller,FL(2008)Doesoxidativestresslimitmouse 219. Morley, JE et al. (2012) The senescence accelerated
life span? From: Aging Medicine: oxidative stress in mouse(SAMP8)asamodelforoxidativestressand
aging:frommodelsystemstohumandiseases.Humana AD.Biochim.Biophys.Acta1822,650.
Press,NJ. 220. Skulachev, MV et al. (2011) Mitochondrial-targeted
203. Salmon, AB et al. (2010) Update on the oxidative plastoquinonederivatives.Effectonsenescenceand
stress theory of aging: does oxidative stress play a acuteage-relatedpathologies.Curr.DrugTargets12,
roleinagingorhealthyaging?FreeRadic.Biol.Med. 800.
48,642. 221. Kurz,Tetal.(2011)TheroleoflysosomesinFeme-
204. Manickaratnam, R et al. (2013) Repression of the tabolismandrecycling.Int.J.Biochem.CellBiol.43,
mitochondrial prdx antioxidant system does not 1686.
shorten lifespan but causes reduced fitness in 222. Sulzer, D et al. (2008) Neuronal pigmented auto-
C.elegans.FreeRadic.Biol.Med.63,381. phagicvacuoles:lipofuscin,neuromelanin,andcer-
205. Gruber,Jetal.(2011)Mitochondrialchangesinage- oidasmacroautophagicresponsesduringagingand
ingC.elegans–whatdowelearnfromSODknock- disease.J.Neurochem.106,24.
outs?PLoSOne6,e19444. 223. Coburn, C et al. (2013) Anthranilate fluorescence
206. VanRaamsdonk,JMandHekimi,S(2012)SODisdis- marks a Ca2+-propagated necrotic wave that pro-
pensablefornormalanimallifespan.Proc.Natl.Acad. motes organismal death in C.elegans. PLoS Biol. 11,
Sci.USA109,5785. e1001613.
207. Lapointe,JandHekimi,S(2008)Earlymitochondrial 224. Höhn, A et al. (2011) Lipofuscin inhibits the prote-
dysfunction in long-lived MCLK1+/– mice. J. Biol. asomebybindingtosurfacemotifs.FreeRadic.Biol.
Chem.283,26217. Med.50,585.
208. Schroeder,EAetal.(2013)Epigeneticsilencingme- 225. Heidler, T et al. (2010) C.elegans lifespan extension
diates mitochondria stress-induced longevity. Cell caused by treatment with an orally active ROS-
Metab.17,954. generator is dependent on DAF-16 and SIR-2.1.
209. Long, YC et al. (2014) The biochemistry and cell Biogerontol.11,183.
biology of aging: metabolic regulation through 226. Carley,ANandLewandowskiED(2014)Isthethera-
mitochondrial signalling. Am. J. Physiol. 306, peuticwindowformitochondrialROShalf-openor
E581. half-closed?Circ.Res.115,329.
210. Ristow, M (2014) Mitohormesis explains ROS- 227. López-Otín, C et al. (2013) The hallmarks of aging.
inducedhealthbenefits.Nat.Med.20,709. Cell153,1194.
211. Schmeisser,Ketal.(2013)Roleofsirtuinsinlifespan 228. Berzlanovich, AM et al. (2005) Do centenarians die
regulationislinkedtomethylationofnicotinamide. healthy?Anautopsystudy.J.Gerontol.A60,862.
Nat.Chem.Biol.9,693. 229. Talegawkar,SAetal.(2012)Ahigheradherencetoa
212. Weimer, S et al. (2014) D-Glucosamine supplemen- Mediterranean-styledietisinverselyassociatedwith
tationextendslifespanofnematodesandofageing the development of frailty in community-dwelling
mice.Nat.Commun.5,3563. elderlymenandwomen.J.Nutr.142,2161.
213. DeHaes,Wetal.(2014)Metforminpromoteslifespan 230. Johnson,EJetal.(2013)Relationshipbetweenserum
throughmitohormesisviatheperoxiredoxinPRDX- andbraincarotenoids,α-tocopherol,andretinolcon-
2.Proc.Natl.Acad.Sci.USA111,E2501. centrationsandcognitiveperformanceintheoldest
214. Yee,C,Yang,WandHekimi,S(2014)Theintrinsic oldfromtheGeorgiaCentenarianStudy.J.AgingRes.
apoptosis pathway mediates the pro-longevity re- 2013,ID951786.
sponsetomitochondrialROSinC.elegans.Cell157, 231. Johnson,EJ(2012)Apossibleroleforluteinandzeax-
897. anthinincognitivefunctionintheelderly.Am.J.Clin.
215. Radyuk, SV et al. (2013) The effect of prx4 on fly Nutr.96,1161S.
physiologyisacomplexinterplayofantioxidantand 232. Safdar, A et al. (2010) Dysfunctional Nrf2-Keap1
signalingfunctions.FASEBJ.27,1426. redoxsignalinginskeletalmuscleofthesedentary
216. Kirkwood,TBandKowald,A(2012)Thefree-radical old.FreeRadic.Biol.Med.49,1487.
theoryofageing–older,wiserandstillalive.Bioes- 233. Schramm,Aetal.(2012)TargetingNADPHoxidases
says34,692. invascularpharmacology.Vascul.Pharmacol.56,216.
217. Poon, HF et al. (2005) Proteomic analysis of spe- 234. Wray, DW et al. (2013) The paradox of oxidative
cific brain proteins in aged SAMP8 mice treated stressandexercisewithadvancingage.Exerc.Sport
with α-LA: implications for aging and age-related Sci.Rev.39,68.
neurodegenerative disorders. Neurochem. Int. 46, 235. Pae,Metal.(2012)Theroleofnutritioninenhancing
159. immunityinaging.AgingDis.3,91.
218. Stefanova, NA et al. (2014) Senescence-accelerated 236. Valentini, S et al. (2012) Manipulation of in vivo Fe
OXYSrats:amodelofage-relatedcognitivedecline levels can alter resistance to oxidative stress with-
withrelevancetoabnormalitiesinAD.CellCycle13, outaffectingageinginthenematodeC.elegans.Mech.
898. AgeingDev.133,282.

--- Page 872 ---

REFERENCES 817
237. Reverter-Branchat, G et al. (2004) Oxidative 254. Whiteman, M and Halliwell, B (1996) Protection
damage to specific proteins in replicative and against ONOO–-dependent tyrosine nitration and
chronological-aged S. cerevisiae. J. Biol. Chem. 279, α 1-antiproteinaseinactivationbyascorbicacid.Free
31983. Radic.Res.55,383.
238. Sullivan, JL (2003) Are menstruating women pro- 255. Li,Zetal.(2009)Injectable,highlyflexible,andther-
tected from heart disease because of, or in spite mosensitive hydrogels capable of delivering SOD.
of, estrogen? Relevance to the Fe hypothesis. Am. Biomacromolecules10,3306.
HeartJ.145,190. 256. Han,Jetal.(2012)Targetedinterceptionofsignaling
239. Ramos,Petal.(2014)Felevelsinthehumanbrain: ROSinthevascularendothelium.Ther.Deliv.3,263.
a post-mortem study of anatomical region differ- 257. Pan, J et al. (2012) Protective effect of recombinant
ences and age-related changes. J. Trace Elem. Med. protein SOD-TAT on radiation-induced lung injury
Biol.28,13. inmice.LifeSci.91,89.
240. Hunnicutt,Jetal.(2014)DietaryFeintakeandbody 258. Nishikawa,Metal.(2009)Catalasedeliveryforin-
Festoresareassociatedwithriskofcoronaryheart hibitingROS-mediatedtissueinjuryandtumorme-
diseaseinameta-analysisofprospectivecohortstud- tastasis.Adv.DrugDeliv.Rev.61,319.
ies.J.Nutr.144,359. 259. Kim, DW et al. (2009) Transduced human PEP-1-
241. Bao,Wetal.(2012)DietaryFeintake,bodyFestores, catalasefusionproteinattenuatesischemicneuronal
andtheriskoftype2diabetes:asystematicreview damage.FreeRadic.Biol.Med.47,941.
andmeta-analysis.BMCMed.10,119. 260. Bafana,Aetal.(2011)Thebasicandappliedaspects
242. Mainous III, AG et al. (2005) Fe, lipids, and risk ofSOD.J.Mol.CatalysisB68,129.
ofcancerintheFraminghamoffspringcohort.Am. 261. Savalia, K et al. (2014) Neuronal uptake of nano-
J.Epidemiol.161,1115. formulated SOD and attenuation of angiotensin
243. Doulias,PTetal.(2008)Flowcytometricestimation II-dependenthypertensionaftercentraladministra-
of‘labileFepool’inhumanwhitebloodcellsreveals tion.FreeRadic.Biol.Med.73,299.
apositiveassociationwithageing.FreeRadic.Res.42, 262. Doeppner,TRetal.(2013)TAT-Hsp70inducesneuro-
253. protection against stroke via anti-inflammatory ac-
244. DelaOssa,NPetal.(2010)Fe-relatedbraindamage tions providing appropriate cellular microenviron-
inpatientswithintracerebralhemorrhage.Stroke41, ment for transplantation of neural precursor cells.
810. J.Cereb.BloodFlowMetab.33,1778.
245. Swindell,WR(2011)Metallothioneinandthebiology 263. Baptiste, DC et al. (2009) Systemic PEG promotes
ofaging.AgeingRes.Rev.10,132. neurologicalrecoveryandtissuesparinginratsafter
246. Botsoglou,Eetal.(2012)Lipidandproteinoxidation cervicalspinalcordinjury.J.Neuropathol.Exp.Neurol.
ofα-linolenicacid-enrichedporkduringrefrigerated 68,661.
storageasinfluencedbydietsupplementationwith 264. Ikemura,Metal.(2010)Improvementofinsulinre-
oliveleaves(OleaeuropeaL.)orα-tocopherylacetate. sistancebyremovalofsystemicH2O2byPEGylated
MeatSci.92,525. catalaseinobesemice.Mol.Pharm.7,2069.
247. Halliwell,B(1991)Drugantioxidanteffects.Abasis 265. Clarke,MBetal.(2010)Sustainedlungactivityofa
fordrugselection?Drugs42,569. novel chimericprotein,SOD2/3, afterintratracheal
248. Margaritis, M et al (2014) Statins as regulators of administration.FreeRadic.Biol.Med.49,2032.
redoxstateinthevascularendothelium:beyondlipid 266. Tong,Jetal.(2013)ConjugatesofSOD1withamphi-
lowering.Antioxid.RedoxSignal.20,1198. philic poly(2-oxazoline) block copolymers for en-
249. Violi,FandPignatelli,P(2014)Statinsasregulators hanced brain delivery: synthesis, characterization
ofredoxsignalinginplatelets.Antioxid.RedoxSignal. andevaluationinvitroandinvivo.Mol.Pharmaceut.
20,1300. 10,360.
250. Barone,Eetal.(2014)Statinsmorethancholesterol 267. Giordano,CRandTerlecky,SR(2012)Peroxisomes,
loweringagentsinAD:theirpleiotrophicfunctions cellsenescence,andratesofaging.Biochim.Biophys.
aspotentialtherapeutictargets.Biochem.Pharmacol. Acta1822,1358.
88,605. 268. Nagasaki, Y (2012) Nitroxide radicals and nano-
251. Vechio,FHetal.(2014)Peptidesthatactivatethe20S particles: a partnership for nanomedicine radical
proteasomebygateopeningincreasedoxidizedpro- delivery.Therap.Deliv.3,165.
teinremovalandreducedproteinaggregation.Free 269. Gruber,Jetal.(2012)Mitochondria-targetedantioxi-
Radic.Biol.Med.67,304. dantsandmetabolicmodulatorsaspharmacological
252. Sindler,ALetal.(2014)InorganicNO– supplemen- interventionstoslowageing.Biotechnol.Adv.31,563.
2
tationforhealthyarterialaging.J.Appl.Physiol.116, 270. Lucente-Schultz,RMetal.(2009)Antioxidantsingle-
463. walledcarbonnanotubes.J.Am.Chem.Soc.131,3934.
253. Halliwell,B(1999)Food-derivedantioxidants,evalu- 271. He,W etal.(2013)IntrinsiccatalyticactivityofAu
atingtheirimportanceinfoodandinvivo.FoodSci. nanoparticles with respect to H2O2 decomposition
Agric.Chem.1,67. andO
•–scavenging.Biomaterials34,765.
2

--- Page 873 ---

818 REFERENCES
272. Dugan,LLetal.(2014)Carboxyfullereneneuropro- 288. Maples, KR et al. (2001) Comparison of the radical
tectionpostinjuryinParkinsoniannonhumanprim- trapping ability of PBN, S-PBN and NXY-059. Free
ates.Ann.Neurol.76,393. Radic.Res.34,417
273. Trpkovic, A et al. (2012) Toxicity of pristine versus 289. Knecht,KTandMason,RP(1993)Invivospintrap-
functionalized fullerenes: mechanisms of cell dam- ping of xenobiotic free radical metabolites. Arch.
ageandtheroleofoxidativestress.Arch.Toxicol.86, Biochem.Biophys.303,185.
1809. 290. Novakov,CPandStoyanovsky,DA(2002)Compara-
274. Kotchey, GP et al. (2013) Peroxidase-mediated bio- tivemetabolismofN-tert-butyl-N-[1-(1-oxy-pyridin-
degradationofCnanotubesinvitroandinvivo.Adv. 4-yl)-ethyl]- and N-tert-butyl-N-(1-phenyl-ethyl)-
DrugDeliv.Rev.65,1921. nitroxide by the cytochrome P450 monooxygenase
275. Joshi-Barr,Setal.(2014)Exploitingoxidativemicro- system.Chem.Res.Toxicol.15,749.
environmentsinthebodyastriggersfordrugdeliv- 291. Ley,JJetal.(2007)NeuroprotectiveeffectofSTAZN,
erysystems.Antioxid.RedoxSignal.21,730. a novel azulenyl nitrone antioxidant, in focal cere-
276. Kubota, Yetal. (2004)Significantcontaminationof bralischemiainrats:dose-responseandtherapeutic
SODsandcatalaseswithLPS-likesubstances.Toxicol. window.BrainRes.1180,101.
InVitro18,711. 292. Soule,BPetal.(2007)Thechemistryandbiologyof
277. Zhong, Z et al. (2002) Viral gene delivery of SOD nitroxidecompounds.FreeRadic.Biol.Med.42,1632.
attenuatesexperimentalcholestasis-inducedliverfi- 293. Kajer, TB et al. (2014) Inhibitor of MPO- and
brosisintherat.GeneTher.9,183. neutrophil-mediated oxidant production of tetra-
278. Wang,Yetal.(2004)Adenovirus-mediatedtransferof ethyl and tetramethyl nitroxides. Free Radic. Biol.
the1-cysperoxiredoxingenetomouselungprotects Med.70,96.
againsthyperoxicinjury.Am.J.Physiol.286,L1188. 294. Puoliväli, J et al. (2011) The radical scavenger IAC
279. Batinic´-Haberle,Ietal.(2014)SODtherapeutics:lat- decreasesmortality,enhancescognitivefunctionsin
estinsightsintotheirstructure-activityrelationships watermazeandreducesamyloidplaqueburdenin
andimpactuponthecellularredox-basedsignaling hAβPPtransgenicmice.J.Alz.Dis.27,499.
pathways.Antioxid.RedoxSignal.20,2372. 295. Sarkar,Cetal.(2013)Neuroprotectionandlifespan
280. Tovmasyan,Aetal.(2014)Simplebiologicalsystems extension in Ppt1-/- mice by NtBuHA: therapeutic
for assessing the activity of SOD mimics. Antioxid. implicationsforINCL.Nat.Neurosci.16,1608.
RedoxSignal.20,2416. 296. Buettner,GRandSharma,MK(1993)Thesyringeni-
281. Evans,MKetal.(2014)Mnporphyrinincombination troxide radical-part II. Free Radic. Res. Commun. 19,
with ascorbate acts as a pro-oxidant and mediates S227.
caspase-independent cancer cell death. Free Radic. 297. Kleschyov,ALetal.(2012)Heparin-polynitroxides:
Biol.Med.68,302. synthesis and preliminary evaluation as cardio-
282. Konorev, EA et al. (2002) Paradoxical effects of vascular EPR/MR imaging probes and extracellu-
metalloporphyrins on doxorubicin-induced apop- lar space-targeted antioxidants. Eur. J. Med. Chem.
tosis:scavengingofROSversusinductionofHO-1 58,265.
FreeRadic.Biol.Med.33,988. 298. Haj-Yehia,Aetal.(2000)Developmentof3-nitrato-
283. Batinic´-Haberle,Ietal.(2009)PureMnTBAPselect- methyl-proxyl (NMP): a novel, bifunctional SOD
ively scavenges ONOO– over O •–: comparison of mimic-NO • -donor.DrugDev.Res.50,528.
2
pure and commercial MnTBAP samples to MnTE- 299. Takabe,Wetal.(2006)Chemicalstructure-dependent
2-PyP in two models of oxidative stress injury, an geneexpressionofproteasomesubunitsviaregula-
SOD-specificE.colimodelandcarrageenan-induced tionoftheARE.FreeRadic.Res.40,21.
pleurisy.FreeRadic.Biol.Med.46,192. 300. López, GV et al. (2005) Design, synthesis, and bio-
284. Floyd, RA et al. (2013) Nitrone-based therapeutics logicalcharacterizationofpotentialantiatherogenic
•
forneurodegenerativediseases:theirusealoneorin NO releasingtocopherolanalogs.Bioorg.Med.Chem.
combinationwithlanthionines.FreeRadic.Biol.Med. 13,5787.
62,145. 301. Oishi, K et al. (2012) The vitamin E derivative,
285. Inden, M et al. (2012) Detoxification of 6- EPC-K1, suppresses inflammation during hepatic
hydroxydopamine-induced dopaminergic neurode- ischemia-reperfusion injury and exerts hepatopro-
generation by DMPO, a radical trapper, in tectiveeffectsinrats.J.Surg.Res.176,164.
hemiparkinsonianrats.Biol.Pharm.Bull.35,1603. 302. DiPaola,Retal.(2011)Administrationofcarnosine
286. Dogan, S et al. (2012) Measurement of intracellular inthetreatmentofacutespinalcordinjury.Biochem.
biomolecularoxidationinliverischemia-reperfusion Pharmacol.82,1478.
injury via immuno-spin trapping. Free Radic. Biol. 303. Bae,ONetal.(2013)Safetyandefficacyevaluationof
Med.53,406. carnosine,anendogenousneuroprotectiveagentfor
287. Mandal,MNetal.(2011)PBNpreventslight-induced ischemicstroke.Stroke44,205.
degenerationoftheretinabyinhibitingRPE65pro- 304. Barski, OA et al. (2013) Dietary carnosine prevents
tein isomerohydrolase activity. J. Biol. Chem. 286, early atherosclerotic lesion formation in apoE-null
32491. mice.Arterioscler.Thromb.Vasc.Biol.33,1162.

--- Page 874 ---

REFERENCES 819
305. Babizhayev, MA (2012) Bioactivation antioxidant in subarachnoid hemorrhage trials. J. Neurosurg.
and transglycating properties of N-acetylcarnosine 118,3.
autoinduction prodrug of a dipeptide L-carnosine 322. Feng, S et al. (2011) Edaravone for acute ischaemic
in mucoadhesive drug delivery eye-drop formula- stroke.CochraneDatabaseSyst.Rev.12,CD007230.
tion:powerfuleyehealthapplicationtechniqueand 323. Kikuchi, K et al. (2012) Beyond free radical scav-
therapeuticplatform.DrugTest.Analysis4,468. enging: beneficial effects of edaravone (Radicut) in
306. Kerr, DS (2013) Review of clinical trials for mito- variousdiseases.Exp.Therap.Med.3,3.
chondrialdisorders:1997–2012.Neurotherapeutics10, 324. Lin, M et al. (2007) Pulse radiolysis study on free
307. radical scavenger edaravone (3-methyl-1-phenyl-2-
307. Bonelli, RM and Beal MF (2012) Huntington’s dis- pyrazolin-5-one).J.Photochem.Photobiol.B89,36.
ease.Handb.Clin.Neurol.106,507. 325. Sinha-Hikim,Ietal.(2013)Long-termsupplementa-
308. Chabrier,PEandAuguet,M(2007)Pharmacological tionwithacystine-basedantioxidantdelayslossof
propertiesofBN82451:anovelmultitargetingneuro- musclemassinaging.J.Gerontol.A68,749.
protectiveagent.CNSDrugReviews13,317. 326. Marrades,RMetal.(1997)NebulizedGSHinduces
309. Castro,SMetal.(2006)Antioxidanttreatmentameli- bronchoconstriction in patients with mild asthma.
orates respiratory syncytial virus-induced disease Am.J.Respir.Crit.CareMed.156,425.
andlunginflammation.Am.J.Respir.Crit.CareMed. 327. Rahman,I(2012)Pharmacologicalantioxidantstrat-
174,1361. egiesastherapeuticinterventionsforCOPD.Biochim.
310. Lucente-Schultz,RMetal.(2009)Antioxidantsingle- Biophys.Acta1822,714.
walledcarbonnanotubes.J.Am.Chem.Soc.131,3934. 328. Raju,PAetal.(1994)GSHprecursorandantioxidant
311. Huang, Z et al. (2011) Synergy of isoflurane pre- activitiesofNAcandOTCcomparedininvitrostud-
conditioningandpropofolpostconditioningreduces iesofHIVreplication.AIDSRes.Hum.Retrovir.10,
myocardialreperfusioninjuryinpatients. Clin.Sci. 961.
121,57. 329. Park,SJetal.(2012)L-2-oxothiazolidine-4-carboxylic
312. Firuzi, O et al. (2011) Antioxidant therapy: current acidor α-lipoicacidattenuatesairwayremodeling:
status and future prospects. Curr. Med. Chem. 18, involvementofNF-κB,Nrf2,andHIF.Int.J.Mol.Sci.
3871. 13,7915.
313. Kim,Jetal.(2010)Naturallyoccurringphytochem- 330. Vita,JAetal.(1998)L-2-Oxothiazolidine-4-carboxylic
icals for the prevention of AD. J. Neurochem. 112, acid reverses endothelial dysfunction in patients
1415. with coronary artery disease. J. Clin. Invest. 101,
314. Wu,CHandYen,GC(2005)Inhibitoryeffectofnatur- 1408.
allyoccurringflavonoidsontheformationofAGEs. 331. Kazarjan, J et al. (2013) Separation of GSH and its
J.Agric.FoodChem.53,3167. novelanaloguesanddeterminationoftheirdissoci-
315. Avramovich-Tirosh, Y et al. (2007) Neurorescue ac- ationconstantsbycapillaryelectrophoresis.Electro-
tivity, APP regulation and Aβ reduction by novel phoresis34,1820.
multi-functional brain permeable Fe-chelating anti- 332. Cascella,R etal.(2014)S-linolenoylglutathionein-
oxidants, M-30 and green tea polyphenol, EGCG. take extends life-span and stress resistance via Sir-
Curr.AlzheimerRes.4,403. 2.1upregulationinC.elegans.FreeRadic.Biol.Med.
316. Mandel,Setal.(2004)Cellsignalingpathwaysinthe 73,127.
neuroprotectiveactionsofthegreenteapolyphenol 333. Li, J et al. (2013) A chitosan-glutathione based in-
(-)-EGCG: implications for neurodegenerative dis- jectablehydrogelforsuppressionofoxidativestress
eases.J.Neurochem.88,1555. damageincardiomyoctes.Biomaterials34,9071.
317. Jin, H et al. (2010) Multifunctional antioxidants for 334. Simpson,CAetal.(2013)Invivotoxicity,biodistribu-
thetreatmentofage-relateddiseases.J.Med.Chem. tion,andclearanceofglutathione-coatedgoldnano-
53,1117. particles.Nanomedicine9,257.
318. Randazzo,Jetal.(2011)Orallyactivemultifunctional 334A. Hall,MDetal.(2014)InhibitionofGPxmediatesthe
antioxidants are neuroprotective in a rat model of collateral sensitivity of multidrug-resistant cells to
light-inducedretinaldamage.PLoSOne6,e21926. tiopronin.J.Biol.Chem.289,21473.
319. Visavadiya,NPetal.(2013)Antioxidantpropertiesof 335. Parasassi,Tetal.(2010)Thiolredoxtransitionsincell
Neu2000onmitochondrialfreeradicalsandoxida- signaling:alessonfromNAc.ScientificWorldJournal
tivedamage.Toxicol.InVitro27,788. 10,1192.
320. Bains,MandHall,ED(2012)Antioxidanttherapies 336. Sunitha,Ketal.(2013)NAcamide:aderivativetoful-
in traumatic brain and spinal cord injury. Biochim. fillthepromisesofN-acetylcysteine.FreeRadic.Res.
Biophys.Acta1822,675. 47,357.
321. Ilodigwe,Detal.(2013)Slidingdichotomycompared 337. Szakmany, T et al. (2012) NAc for SIR response in
withfixeddichotomizationofordinaloutcomescales adults.CochraneDatabaseSyst.Rev.9,CD006616.

--- Page 875 ---

820 REFERENCES
338. Gould, NS and Day, BJ (2011) Targeting maladap- 355. Copp, RRet al. (2013) Radioprotective efficacy and
tiveglutathioneresponsesinlungdisease.Biochem. toxicityofanewfamilyofaminothiolanalogs.Int.
Pharmacol.81,187 J.Radiat.Biol.89,485.
339. Nash, EF et al. (2009) Nebulized and oral thiol de- 356. Mugesh, G (2013) GPx activity of ebselen and its
rivatives for pulmonary disease in cystic fibrosis. analogues: some insights into the complex chem-
CochraneDatabaseSyst.Rev.1,CD007168. icalmechanismsunderlyingtheantioxidantactivity.
340. Rushworth,GFandMegson,IL(2014)Existingand Curr.Chem.Biol.7,47.
potentialtherapeuticusesforNAc:theneedforcon- 357. Parnham,MJandSies,H(2013)Theearlyresearch
versiontointracellularGSHforantioxidantbenefits. anddevelopmentofebselen.Biochem.Pharmacol.86,
Pharmacol.Ther.141,150. 1248.
341. Efrati,Setal.(2003)TheeffectofNAconrenalfunc- 358. Smith, SM et al. (2012) Ebselen and congeners in-
tion, NO
•
, and oxidative stress after angiography. hibitNOX2-dependentO
•–generationbyinterrupt-
2
KidneyInt.64,2182. ingthebindingofregulatorysubunits.Chem.Biol.19,
342. Zhang, Z et al. (2014) HIF-1 contributes to NAc’s 752.
protectioninstroke.FreeRadic.Biol.Med.68,8. 359. Orian,LandToppo,S(2014)Organochalcogenper-
343. Martinez,FJetal.(2014)RandomizedtrialofNAcin oxidasemimeticsaspotentialdrugs:alongstoryofa
idiopathicpulmonaryfibrosis.N.Engl.J.Med.370, promisestillunfulfilled.FreeRadic.Biol.Med.66,65.
2093. 360. Lu,Jetal.(2013)Inhibitionofbacterialthioredoxin
344. Markart, P et al. (2009) Alveolar oxidative stress reductase:anantibioticmechanismtargetingbacteria
is associated with elevated levels of nonenzymatic lackingGSH.FASEBJ.27,1394.
low-molecular-weightantioxidantsinpatientswith 361. Sredni, B et al. (2007) Multifunctional Te molecule
differentformsofchronicfibrosinginterstitiallung protects and restores dopaminergic neurons in PD
disease.Antioxid.RedoxSignal.11,227. models.FASEBJ.21,1870.
345. Terasaki, Y et al. (2006) Guanine nitration in idio- 362. Comparsi,Betal.(2012)Diphenylditelluridetargets
pathic pulmonary fibrosis and its implication for brain selenoproteins in vivo: inhibition of cerebral
carcinogenesis.Am.J.Respir.Crit.CareMed.174,665. thioredoxin reductase and GPx in mice after acute
346. Kannan, S et al. (2012) Dendrimer-based postnatal exposure.Mol.CellBiochem.370,173.
therapyforneuroinflammationandcerebralpalsyin 363. Fox,Retal.(2014)BG-12(dimethylfumarate):are-
arabbitmodel.Sci.Transl.Med.4,130ra46. view of mechanism of action, efficacy, and safety.
347. Guven,Aetal.(2011)MEGattenuatescausticesopha- Curr.Med.Res.Opin.30,251.
gealinjuryinrats:aroleforscavengingofONOO–. 364. Zhang, DD (2013) Bardoxolone brings Nrf2-based
J.Pediatr.Surg.46,1746. therapiestolight.Antioxid.RedoxSignal.19,517.
348. Rosini,Metal.(2014)OxidativestressinAD:arewe 365. Xu, J et al. (2012) Enhanced Nrf2 activity worsens
connectingthedots?J.Med.Chem.57,2821. insulin resistance, impairs lipid accumulation in
349. Koufaki, M et al. (2009) Multifunctional lipoic acid adipose tissue, and increases hepatitis steatosis in
conjugates.Curr.Med.Chem.16,4728. leptin-deficientmice.Diabetes61,3208.
350. Moretti,Metal.(2004)Theeffectoflong-termtreat- 366. Feige,Eetal.(2013)Inhibitionofmonocytechemo-
mentwitherdosteinonCOPD:theEQUALIFEstudy. taxisbyVB-201,asmallmoleculelecinoxoid,hinders
DrugsExp.Clin.Res.30,143. atherosclerosisdevelopmentinApoE-/-mice.Athero-
351. Andreadou,Ietal.(2011)Investigatingtheeffectof sclerosis229,430.
antioxidanttreatmentontheprotectiveeffectofpre- 367. Montero, AJ et al. (2012) Phase 2 study of neoad-
conditioning in anesthetized rabbits. J. Cardiovasc. juvanttreatmentwithNOV-002incombinationwith
Pharmacol.58,609. doxorubicinandcyclophosphamidefollowedbydo-
352. Yum,Setal.(2014)N-(2-mercaptopropionyl)-glycine, cetaxelinpatientswithHER-2negativeclinicalstage
a diffusible antioxidant, activates HIF-1 by inhibit- II-IIIcbreastcancer.BreastCancerRes.Treat.132,215.
ingHIFprolylhydroxylase-2:implicationinameli- 368. Kang, IS and Kim, C (2013) Taurine chloramines
oration of rat colitis by the antioxidant. Biochem. administered in vivo increase NRF2-regulated anti-
Biophys.Res.Commun.443,1008. oxidant enzyme expression in murine peritoneal
353. Katsumi,Hetal.(2014)DevelopmentofPEGylated macrophages.Adv.Exp.Med.Biol.775,259.
serum albumin with multiple reduced thiols as a 369. Ward, RJ et al. (2011) Anti-inflammatory action of
long-circulatingscavengerofROSforthetreatment a taurine analogue, ethane β-sultam, in phagocytic
offulminanthepaticfailureinmice.FreeRadic.Biol. cells,invivoandinvitro.Biochem.Pharmacol.81,743.
Med.69,318. 370. Liu, S et al. (2013) Nitro-oleic acid protects against
354. Nair,CKKetal.(2001)Radioprotectorsinradiother- adriamycin-induced nephropathy in mice. Am.
apy.J.Radiat.Res.42,21. J.Physiol.305,F1533.

--- Page 876 ---

REFERENCES 821
371. Smith,RAetal.(2012)Mitochondrialpharmacology. antioxidant,metalchelation,andMAO-Binhibition
TrendsPharmacol.Sci.33,341. propertiesagainstAD.J.Med.Chem.55,8483.
372. Skulachev, VP (2013) Cationic antioxidants as a 389. Troost,FJetal.(2003)Recombinanthumanlactoferrin
powerfultoolagainstmitochondrialoxidativestress. ingestionattenuatesindomethacin-inducedenterop-
Biochim.Biophys.Res.Commun.441,275. athyinvivoinhealthyvolunteers.Eur.J.Clin.Nutr.
373. Ng, LF et al. (2014) The mitochondria-targeted 57,1579.
antioxidant MitoQ extends lifespan and improves 390. Li,Jetal.(2012)Determinationofbovinelactoferrin
healthspanofatransgenicC.elegans modelofAD. in infant formula by capillary electrophoresis with
FreeRadic.Biol.Med.71,390. ultravioletdetection.J.Chromatogr.A1244,178.
374. Szeto,HHandSchiller,PW(2011)Noveltherapies 391. Vogel,HJ(2012)Lactoferrin,abird’seyeview.Bio-
targetinginnermitochondrialmembrane–fromdis- chem.CellBiol.90,233.
coverytoclinicaldevelopment.Pharm.Res.28,2669. 392. Park,Letal.(2011)Tat-enhanceddeliveryofmetal-
375. Cho, S et al. (2007) A novel cell-permeable antioxi- lothioneincanpartiallypreventthedevelopmentof
dantpeptide,SS31,attenuatesischemicbraininjury diabetes.FreeRadic.Biol.Med.51,1666.
bydown-regulatingCD36.J.Biol.Chem.282,4634. 393. Sohn,EJ etal.(2012)PEP-1-metallothionein-IIIpro-
376. McQuaker, SJ et al. (2013) A prototypical small- tein ameliorates the oxidative stress-induced neur-
molecularmodulatoruncouplesmitochondriainre- onal cell death and brain ischemic insults. Biochim.
sponse to endogenous H2O2 production. ChemBio- Biophys.Acta1820,1647.
Chem.14,993. 394. Kontoghiorghe,CNetal.(2014)Antioxidanttarget-
377. Heli, H et al. (2011) Advances in Fe chelation: an ing by deferiprone in diseases related to oxidative
update.ExpertOpin.Ther.Patents21,819. damage.Front.Biosci.19,862.
378. Prass,Ketal.(2002)DFOinducesdelayedtolerance 395. Jirasomprasert,Tetal.(2009)Pharmaco/ferrokinetic-
againstcerebralischemiainvivoandinvitro.J.Cereb. related pro-oxidant activity of deferiprone in
BloodFlowMetab.22,520. β-thalassemia.FreeRadic.Res.43,485.
379. Kurz,Tetal.(2006)IntralysosomalFechelationpro- 396. Cappellini,MD(2005)Fe-chelatingtherapywiththe
tectsagainstoxidativestress-inducedcellulardam- neworalagentICL670(Exjade).BestPract.Res.Clin.
age.FEBSJ.273,3106. Haematol.18,289.
380. Davies, MJ et al. (1987) DFO (Desferal) and O
•–.
397. Kupershmidt,Letal.(2012)Thenovelmulti-target
2
Biochem.J.246,725. Fechelating-radicalscavengingcompoundM30pos-
381. Moch, D et al. (1995) Protective effects of hy- sesses beneficial effects on major hallmarks of AD.
droxyethylstarch-DFOinearlysepsis.Shock4,425. Antioxid.RedoxSignal.17,860.
382. Roza,AMetal.(1994)Hydroxyethylstarchdeferox- 398. Huang, XT et al. (2014) Reducing Fe in the brain:
amine,anovelFechelator,delaysdiabetesinBBrats. a novel pharmacologic mechanism of huperzine
J.Lab.Clin.Med.123,556. A in the treatment of AD. Neurobiol. Aging 35,
383. Strunden, MS et al. (2012) Glycocalyx degradation 1045.
causes microvascular perfusion failure in the ex 399. Grootveld, M et al. (1987) Action of uric acid, allo-
vivo perfused mouse lung: hydroxyethyl starch purinolandoxypurinolontheMPO-derivedoxidant
130/0.4pretreatmentattenuatesthisresponse.Shock HOCl.FreeRadic.Res.Commun.4,69.
38,559. 400. Ward, J et al. (2013) Mechanistic characterization
384. Ma,Jetal.(2012)Fechelatorsforacutestroke. Co- of a 2-thioxanthine MPO inhibitor and selectivity
chraneDatabaseSyst.Rev.9,CD009280. assessment utilizing click chemistry-activity-based
385. Merlot,AM etal. (2013)Novel chelatorsfor cancer proteinprofiling.Biochemistry52,9187.
treatment:wherearewenow?Antioxid.RedoxSignal. 401. Churg,Aetal.(2012)LateinterventionwithaMPO
18,973. inhibitor stops progression of experimental COPD.
386. Kalinowski,JSandRichardson,DR(2005)Theevolu- Am.J.Respir.Crit.CareMed.185,34.
tionofFechelatorsforthetreatmentofFeoverload 402. Liu,Cetal.(2012)Effectsofanovelpharmacologic
diseaseandcancer.Pharm.Rev.57,547. inhibitorofMPOinamouseatherosclerosismodel.
387. Zhao,YandRempe,DA(2011)Prophylacticneuro- PLoSOne7,e50767.
protectionagainststroke:low-dose,prolongedtreat- 403. Koelsch, M et al. (2010) Acetaminophen (paraceta-
ment with deferoxamine or deferasirox establishes mol)inhibitsMPO-catalyzedoxidantproductionand
prolonged neuroprotection independent of HIF- biologicaldamageattherapeuticallyachievablecon-
1function.J.CerebralBloodFlowMetab.31,1412. centrations.Biochem.Pharmacol.79,1156.
388. Huang, L et al. (2012) Multitarget-directed ben- 404. Kim,JAetal.(2011)NOXinhibitors:apatentreview.
zylideneindanone derivates: Aβ aggregation, ExpertOpin.Ther.Patents21,1147.

--- Page 877 ---

822 REFERENCES
405. Khanicheh,Eetal.(2013)Molecularimagingreveals 409. Kao,KKandFink,MP(2010)Thebiochemicalbasis
rapid reduction of endothelial activation in early fortheanti-inflammatoryandcytoprotectiveactions
atherosclerosiswithapocyninindependentofantiox- ofethylpyruvateandrelatedcompounds.Biochem.
idativeproperties.Arterioscler.Thromb.Vasc.Biol.33, Pharmacol.80,151.
2187. 410. Hill, S et al. (2012) Small amounts of isotope-
406. Connell, BJ et al. (2012) UPEI-100, a conjugate of reinforcedPUFAssuppresslipidautooxidation.Free
lipoicacidandapocynin,mediatesneuroprotection Radic.Biol.Med.53,893.
inaratmodelofischemia/reperfusion.Am.J.Physiol. 411. Ohta,S(2012)MolecularH2isanovelantioxidantto
302,R886. efficientlyreduceoxidativestresswithpotentialfor
407. Bickston, SJ et al. (2012) Tetomilast: new promise theimprovementofmitochondrialdiseases.Biochim.
forphosphodiesterase-4inhibitors.Expert.Opin.In- Biophys.Acta1820,586.
vestig.Drugs21,1845. 412. Penders,Jetal.(2014)ONOOHdoesnotreactwith
408. Chen, Y and Tseng, SH (2010) The potential of H2: potential benefits of H2 as an antioxidant by
•
tetrandrineagainstgliomas.Anti-CancerAgentsMed. selective reaction with OH . Free Radic. Biol. Med.
Chem.10,534. 75,191.

--- Page 878 ---

Index
Note:Themostextensivediscussionofatopicisindicatedinbold.‘Struc.’inparenthesesindicateswherethestructure
ofacompoundisshown.‘Def.’inparenthesesindicateswhereatermisdefined.
A α ε
N -acetyl-N -(2-propenal)lysine 336 acetylperoxylradical 488(struc.)
A2-isoprostanes 113,261(struc.),334 (struc.) acetylphenylhydrazine 363,365(struc.)
A4-neuroprostanes 368 N-acetyl-S-allylcysteine 588 acetylsalicyclicacid,seeaspirin
A1-phytoprostanes 369,371(struc.) N-acetyl-S-3-hydroxypropylcysteine acetylSCoA 10,12,413–414
Aβ,seeβ-amyloid 336(struc.) N-acetyltransferases 61,463
Aβ-bindingalcoholdehydrogenase acetylatedLDL 519 AchatinafulicaFérussac 63
(ABAD) 626 acetylation 85–86,144,222,226,229, achievablelifespan 640
2-AAPA 101(struc.) 233,463,573,576,647,652 achromatic 84
AAPH 49(struc.),158,329,350–352, seealsosirtuins acid 705(def.)
505,529,662 N-acetylcarnitine,inageing 656 dissociationconstant 705(def.)
abalones 458 acetylcholine 512,598,623 rain 385,488
ABCA4(ABCR)transporter 388–390 acetylcholinesterase 512,624,680, acidosis 10(def.),91,104,540,608–609
682,693 acivicin 103(struc.),359
ABCB8 128
N-acetylcysteine(NAc) 52,66,229, aclacinomycinA 282
Abelsonfamily 224
400,402,409,487,541,545,551, acne 403,405,558
abetalipoproteinaemia 168,659
577,606,655–656,661,680,682 aconitase 10,20,37,91,94,96,130,220,
abortiveoxygenreduction 17
(struc.),683 280–281,300,379,535,544,592,
abruptreoxygenation 545
acidity 681 600,612,633–634
abscisicacid 452,456
amide(AD4) 607,681 andageing 654–645
ABTS 84,305,351(struc.),662
andHIF 681 assayforiron 208,358
ABTSassay 349–350,352 andlifespan 656 assayforO •– 300,320
interferencebyascorbate 350 2
andNMDAreceptors 656 inHuntingtondisease 634
acaeruloplasminaemia 131,605
andproteincarbonyls 656 instroke 609
acanthocytes 168
artefactualcaloricrestriction 656 acousticcavitation 40
acatalasaemia 119,361,398 asan‘antioxidant’ 681–682 acridinedyes 67
acatalasaemicmice,seeknockoutmice; inAIDS 637 acrolein 149,158,270,272,273(struc.),
catalase inALS 632 277,336–337,483–484,491–492
accidentofchemistry 445 inARDS 554 inatherosclerosis 523
acetaldehyde 15,118,270,480–482, inchemotherapy 592,595 incancer 579
484,488,491–493 incysticfibrosis 556 inneurodegenerativediseases 613,
acetaminophen,seeparacetamol indiabetes 533 618,626
acetate 270,480–481 inIBD 566 inpain 635
acetone 16,24,79,111,481,488, inliverdisease 483 inskin 404
491,602 inparacetamoltoxicity 486 instroke 608
acetonitrile 45 inpsychiatricdisorders 633,681 inurine 274
1-acetoxy-3-carbamoyl-2,2,5,5- inrapidlyageingrodents 658 acrosomereaction 394
tetramethylpyrrolidine 292 insmokers 493 acrylicacid 484
(struc.) instroke 610 actin 106,202,204,206,219,306,424,
O-acetyl-ADP-ribose 646 non-antioxidanteffects 229 433,442,480,627,632
acetylphosphate 414 therapeuticuse 681–682 nitration 566
2-acetylaminofluorene 584,585 acetylene 16,488,704(struc.) Actinomycetales 115
(struc.),587 N-acetyldopamine 475 actionpotential 596–599
N-acetyl-p-benzoquinoneimine N-acetylglucosamine 560 activatingenzyme 413
486(struc.) N-acetylmethionine 436 activationenergy 33,34
823

--- Page 879 ---

824 INDEX
activins 234 adiposetissue/adipocytes 101,170, Age-RelatedEyeDiseaseStudy
acute 182,223,226,271,402,440, (AREDS,AREDS2) 189,393
inflammation,seeinflammation 445,451,520,531–534,638,644, ageing 8,25–27,79,93,104,109,118,
649–650 149,168,204,222,232,245,247,
intermittentporphyria 69
stemcells 531 253,276,281,305,313,328,339,
kidneyinjury 551
adjuvants 501 349,401–402,409,448,450–451,
lunginjury 307,495,553,seealso ADP-ribose 204,206,537 532,540,542,603,622,639–660,
ARDS andpain 635 639(def.),seealsocentenarians,
lymphoblasticleukaemia 209–210 ADR529,593(struc.) healthspan,lifespan
myelogenous/myeloid ADR925,592,593(struc.) andautophagy 615
leukaemia 476,581–582 adrenal andcancer 577–578,639,644,646
phaseresponse 133,139–140, glands 16,155,170,463 andcardiolipin 654
226,236–237,409,442,522,528, steroidhormones 644 andcarnosine 655
583,629 adrenalin 14,19,24,46,88–90,126, andCoQ 657
promyelocyticleukaemia 497,590 137,234,299,459–460,474(struc.), andcytochromeoxidase 654
475,548 andcytokines 642,652
respiratorydistresssyndrome,see
ARDS adrenicacid 268,633 andDNArepair 646,655
adrenochrome 88,299 andEC-SOD 653–654,660
acyl-peptidehydrolase 363
adrenodoxin 16 andflow-mediateddilatation 653
acylaminoacidreleasingenzyme 363
adriamycin 63,112,119,136,589 andhaemoxygenase 655
S-acylglutathionederivatives 681 (struc.),591–592,673,684,686 andHNE 653
AD32,seevalrubicin adult andH2O2 650,653–654
adalimumab 560 NCL 635 andHsp 385,643,655,659
adaphostin 590 neuronalstemcells 596 andimmuneresponse 642,652–654,
adaptiveimmunity 422,533,seealso respiratorydistresssyndrome,see 656,659
immunesystem/response ARDS andinsulin 643–644,647,659
T-cellleukaemia/lymphoma andisoprostanes 653,657
ADAM (A disintegrin and
573,636 andK+channels 654
metalloproteinases) 424,624
advancedglycationend-products,see andkidney 639
ADMA 55(struc.),521
AGE andKrebscycle 650
adenanthin 590,607
adversedrugreactions 557 andleakagerates 650
adenine 42,147,237–239,242,244,246, A2E 388,389(struc.),390 andMAO 650,653
248,323,475,585,587,694 Aedesaegypti 367 andmTOR 647
adeninenucleotidetranslocase 12–14 AEOLseries 666,670 andmuscle/exercise 410,645,
andageing 654 AEOL10110,seeMnTM-4-PyP5+ 653,660
adenocarcinoma 570–571,574 AEOL10112,seeMnTM-2-PyP5+ andNAD+ 646–647
S-adenosylmethionine,seeSAM
AEOL10113,seeMnTE-2-PyP5+ andNF-κB 642,652,655
AEOL10150,seeMnTDE-1,3-ImP5+ andNrf2 655,660
adenoviralvectors 665–666 AEOL10201,seeMnTBAP3– andOH • 649
adenoma 570,575,579
Aequoreavictoria 420 and8OHdG 649,659
adenomatouspolyposiscoli 574 aequorin 321,419–420 andp53 644–645
adenosine 42,237,442,540,546–547, aerobes 4,95,115,322,367,408,649 andperoxiredoxins 654
552,608,661,694 lackingSOD 95–96 andproteincarbonyls 627,653,657
deaminase 540 aerosolizedGSH 681 andreproduction 643
receptors 547 aerotaxis 17 cardiovascular 649,653,660
adenosylcobalamin 413,414(struc.) aerotolerantorganisms 1,79 caricatureof 646
adenylatecyclase 105 aflatoxin 112,179,463,587 changesiniron,seeironandageing
African databaseofageinggenes 641
adhesionmolecules 202,226,234–236,
421,424–425,427–430,432, American 363–364 effectonmitochondria,see
sleepingsickness 115 mitochondria,andageing
450,518–520,525,538,553,
agarose 324 genomics/metabolomics 645,659
560,566–567,569,581,606–607,
609,594 agepigment 635,658–659,seealso glutathionechanges 361,494,651,
ceroid;lipofuscin 655–659,681–682
andcatalase 665
AGE 112,446,450,536–539,642,653, glyoxalasechanges 655
andSOD 665 655,658,688 inC.elegans 641–643
effect on neutrophil ROS inneurodegenerativediseases 613, inerythrocytes 360,366
production 429,432 625–626,630 ineye 391–393
adipokines 532 receptors,seeRAGE innakedmolerats 650
adiponectin 532 age-1 641,643,651 inskin 404,406–407,674

--- Page 880 ---

INDEX 825
inyeast 646–647 alarmsignals 274,421 alkaline
inflammaging 652–654,659 albinism 150,391 earthmetals 700
lipidperoxidation 653,657–659 albumin 42,57,61,65,69,76–78,90, elution 323
nitration 653 98,105,127,131,134–135,138, phosphatase 323
nutrientsensing 659
139,141,143,154,158,208–209,
unwinding 323
ofnuclearpores 654 212,233,236,256,264,271,276, alkaloids 15,381,451,694
ofstemcells 639,659 348,350,359,400,441–442,450, alkanes 550
oxidativedamage 653–654,657 482,490,500,511,522,663–664, alkaptonuria 561
premature 644–646,657 682,686 alkenals 270
contaminationof 141,500–501
proteasomechanges 282,407,615, alkenes 41
andexercise 409
645–655 alkoxyradical 261
PUFAcontentofmembranes 650, asbiomarkerofoxidativestress 348 alkoxylradicals 31,33,40–41,48–50,
effectonMPO 442
652 90,100,115,126,132,141,143,257,
HOCl-modified 141,524
signaltransduction 643,655 261,263,265–266,276–277,309,
instroke 610 317,330,343,489,491,502,512,
sirtuins 646–647
infusionof 141 522,674
superoxidedismutase 643,645,
ischaemia-modified 141,348,450 actiononDNA 244
653–654,660
microcapsules 665
andSSpeptides 686
transgenicstudies 656–659
nitroso 57–58
incancer 580
aggrecan 558 reactionwithHNE 271
reactionwithiron 261
aggresomes 280–282,615,627,629 transientoxidation 141
alkyl
AGI-1067 524(struc.),673 transudation 359
carbonates 48
aglycones 366,592 alcoholdehydrogenase 275,311,313,
hydroperoxidereductase,seeAHPR
agonists 599 386,463,480,483
nitrites 60
AgriculturalResearchService, alcoholicliverdisease 104,480–481,
peroxynitrates/peroxynitrites 31
USA 352 seealsoethanol
1-alkyl-3-hydroxy-2-methylpyrid-4-
AhpB 220 aldehyde
ones 689
AhpC 108,123 reactiveprobe(ARP) 323,346
alkylatingagents 588
ahpCFgene 220 reductase 155
all-causemortality 153,190
AhpF 108 GSHconjugates 336
all-transretinal 68(struc.),274,387,
AHPR 108,125,133,220 aldehydes 100,149,173,266,323,345,
389–390,658
AIDS 511,636–637,639,seealsoHIV 420,493,525,535
all-transretinol,seeretinol
GSHmetabolism 104,637–638,681 adducts 248,271–272,323,328–326,
allantoate 146
336,346,354,480–482,515,580
dementiacomplex 637
fromlipidperoxidation 335–343 allantoicacid 147(struc.)
AIF(apoptosis-inducingfactor) 217,
allantoin 125,136,146,147(struc.),200,
inbreath 339
219
321,349,406,487,559
incigarettesmoke 492
AIPH 49(struc.) andexercise 409
inmitochondria 337
airpollution 31,41,148,158,305, asbiomarkerofoxidative
polymerization 339–340,658
339,359,381,384,387,403,451, damage 321
487–496,549,seealsoatmosphere; aldehydedehydrogenase 57,81,118,
270,273–274,390,480,482,484, inBPD 399
atmosphericparticulates;dusts;
602 inchemotherapy 592
fumes;indoorair;smokes
aldehydeoxidase 24,37,56,482,505 inmeningitis 606
airway
effectofDPI 433 instroke 609–610
epithelium 446,494,636,seealso
aldo-ketoreductaseenzyme 587 alleneoxide 454(struc.)
lung;respiratorytract
aldolcondensations 271 allergens/allergy/allergic 92,357–358,
hyper-responsiveness 446
aldolase 653 360,400,402,422,440–441,452,
smoothmuscle 358,446 aldosereductase 272,538–539,680 496,498,681,seealsoasthma
A/Jmice 190 aldosterone 16 photoallergy 68,404
akinesia 615 aldrin 15 allicin 184,185(struc.)
Akt 222–224,228,230–231,533–534, alfalfa 386 Alligatormississippiensis 17
577,581,643 aflatoxinB1 584,585(struc.) Allium 184
ALTappel 162,252,276 algae 86,109,115,121–122,151,247, allodynia 635
alagebrium 538 350 allopurinol 15(struc.),146,408,434,
alamarblue 213 blooms 386 545,547,550,556,693
alanine 85 alginate 555 andalloxan 92,119,126,242(struc.),
β-alanine 100,149,154,381,410 alkali 250,368,477–478,479,533,692
β-alanyl-L-histidine 145(struc.) disease 124 andskin,552
β-alanyl-3-methyl-L-histidine 145 labilesites 323,326 inangioplasty 546
(struc.) metals 700 inbabies 400

--- Page 881 ---

826 INDEX
allopurinol(continued) andhaemoxygenase 626,628 δ-aminolaevulinicacid 69(struc.),71
incysticfibrosis 555 andiron 625–626,628 dehydratase 500
ininfluenza 636 andoxidativedamage 625–629 synthetase 130
inischaemia-reperfusion 541–543, andsmoking 491 aminolipids 535–536
552 3-aminopropanal 608
andvitaminE 195,627
inorganpreservationfluids 552 S-2-(3-aminopropylamino)ethyl
genetics 624–625
inshock 547 phosphorothioicacid 683
glucosemetabolism 626
ALS,seeamyotrophiclateralsclerosis aminosalicylates 661
HNE 627
ALS-parkinsonism-dementia 4-aminosalicylate 564(struc.),566
complex 617 Amadoriproduct 536(struc.),537 5-aminosalicylate 460,560,564
allyl Ames,Bruce 245,395,578 (struc.),566
acetate 483 Amesdwarfmice 644,652 asantioxidants 566
alcohol 274,483–484 amifostine 683 aminotriazole 117(struc.),231,310,
radical 240 amineoxidase 369 312,378,391–392,568,602,656
allylichydrogen 257 aminoacids 10,14,38,49,66,91,96, aminotyrosine 302,306
almond 162 102–103,148,154,196,200,209, aminoxylradicals,seenitroxides
AloisAlzheimer 622 240,244,266,276,343,346,367, ammonia 7,59,437,491,567,568,602,
Alpha-Tocopherol,Beta-CaroteneTrial, 401,433,442,456,461,509,532, 703(struc.)
seeα-tocopherol/β-Carotenetrial 614,647 lyase 413
Alpineman 344 ammoniumion 703(struc.)
generatingMDA 338
ALT-711 538 amnesticmildcognitiveimpairment,
peroxides 276
alternativeoxidase 369 seeMCI
aluminium 385,403,491,495,497,501, radicals 53,132,263,344 amnioticfluid 40,110,334,397–398
D-aminoacidoxidase 14,63,294,439
568,691,700(struc.) amoeba 113,231
andalbumin 501 andpain 635–636 amosite 496
andlipidperoxidation 264,501,628 inhibitorsof 661 AMP 237,540
andtransferrin 501 L-aminoacidoxidase 63,434 activatedproteinkinase 146
fluoride 431 aminoacidoxidationproducts 344 AMPAreceptors 599,632
hydroxide 501 inatherosclerosis 521 amphetamine 15,459,484
inAlzheimerdisease 628 γ-aminobutyryl-L-histidine 145 Amphibacillusxylanus 119
inATP 501 (struc.) amphibians 143,404
silicate 429 2-amino-3-carboxymuconate amphipathic 253(def.),255
sulphate 500 semialdehyde 416(struc.) amphotericins 502,504(struc.)
alveoli/alveolar 18,19,357,399,430, α-amino-3-hydroxy-5-methyl-4- Amplexred 310,311(struc.)
446,seealsolung;respiratorytract AMVN 49(struc.),352,505,529
isoxazole-4-propionate 599
capillarybarrier 553 amygdala 596,622
4-(2-amino-3-hydroxyphenyl)-
epithelialcells 18,335,638 amylnitrite 56,57(struc.)
4-oxobutanoic acid
liningfluids 101,104,110,358–359, β-amyloid 125,390,535,538,615,
O-glucoside 391
528 622–629,639,647,693
macrophages 426,429,431,487–488, 2-am c in ar o b - o 4- x h a y ld d e r h ox y y d p e te 5 r 4 i 2 dine-6- Aβ 1–40 624–625
492,494,496,553 Aβ 1–42 624–625,628
oedema 204 4-amino-TEMPO 686 Aβ 25–35 625
permeabilitybarrier 210 2-aminoadipatesemialdehyde 277,279 export 628
typeIcells 18–19,357,470,487–488
(struc.),346
amyloid 237,629(def.)
typeIIcells 18–19,222,594 inAlzheimerdisease 626 depositsandp53 645
Alzheimerdisease 125,180,183, inpriondisease 630 diseases 629,seealsoAlzheimer
195–197,206,276,282,306,329, 2-aminoadipicacid 539 disease;priondiseases
346,500,556,603,605–607,612, 3-aminobenzamide 63,204,479 fibrils 625
615,622–629,654,672,682,684,
4-aminobenzoicacidhydrazide437 precursorprotein(APP) 125,131,
692–693 γ-aminobutyrate,seeGABA 144,623–625,628,684,692
andascorbate 627 richextracts 630
aminocarbonylradical 148(struc.),288
andcaloricrestriction 640 amyotrophic 630(def.)
6-aminodopamine 474(struc.),475
andcarotenoids 627–628 lateralsclerosis 84,502,612,617,
andcopper 626 2-aminoethanesulphonicacid 66,437 629,630–633,670,672,684,690,
andCOX 625 aminoglycosides 402 693
andcreatinekinase 627 nephrotoxicity 503 anaemia 37,92–93,126,130,133,
anddiabetes 626 aminoguanidine 305,538(struc.) 135–136,142,196,210,360–363,
andeducation 628 aminoiminopropeneSchiffbases 340 368,401,434,499,501,506,565
andexercise 195,628–629 (struc.) haemolytic,seehaemolyticanaemia

--- Page 882 ---

INDEX 827
ofchronicinflammation 135,565, antibiotics 28,68,274,403,434,471, inducedkidneydamage 692
607 502–504,506,548,555,567,661, presentation 441,443,501,518
pernicious 414 686 processing 446
•
sicklecell,seesickle-cellanaemia andOH formation 502 antimolestationspray 415,417
anaerobes 1,7,8,14,18,20,37,79,90, antibodiesagainst 275,306,331, antimonials 115
95,115,355,413,433,505 421–422,482,524,542,544–545, antimycinA 26,225,300,568
facultative 355 seealsomonoclonalantibodies; antioxidants/antioxidantdefence 1,
anaesthetics 465,468–469,543,547, polyclonalantibodies 4,5,7,8,13,14,19,20,27,28,
598,602,673 adhesionmolecules 694 30,37,50,63,71–72,77–152,77
preconditioningby 547 aldehydes 271,327,336,341,482 (def.)177,190,199,202,217,221,
analbuminaemia 141 bromotyrosine 345 224,231,285,326,374,393,487,
anaphase 569 bityrosine 344 553,662,seealsochain-breaking
Anaplasmaphagocytophilum 445 catalase 556 antioxidants,dietaryantioxidants,
ancient chlorotyrosine 307,345,528 dietarysupplements,extracellular
DNA 238 citrullinatedproteins 558 antioxidantdefences,sacrifi-
SODs 87 CuZnSOD 556 cialantioxidants,therapeutic
androgen 173 DNA 556 antioxidants
aneurysm 212,548,607,680 DNPH 346 acutephaseproteins 236–237
Angeli’ssalt 52(struc.) erythrocytes 556 additiontomeat 168
HNE 327,336,341 andairpollution 385,487,489
anginapectoris 56,57,542,546
IgG 558 andAlzheimerdisease 625
Angiostrongylus 367
angiogenesis 9(def.),19,92,140,
isoketals 334 andCl2toxicity 487
isoprostanes 334 andethanoltoxicity 483
184,201,231,234,356,390,398,
432,449,538,545,571,574,581, methioninesulphoxide 345 andHIV 637–638
582–583 MnSOD 638 andmetastasis 581
angioplasty 186,546 MPO 443,450 andpain 636
neutrophils 556 andstroke 190,195
angiotensinI 449
nitrotyrosine 62,306–307,336–337, antibioticsas 502
angiotensinII 222–223,446,449–450,
521,523,528 brainandCNS 190,599,603–606,
528
8OHdG/8OHG 324,326–327 625
receptorantagonists 661,680
oxidizedlipids 331,334,482,524, burns 408
angiotensinconvertingenzyme 449,
556–557 characterization 661–663
661
oxLDL 331,524 contentofthediet 187,198,356–357,
aniline 296,366,476(struc.),477,481
RNA 556 359,605,628
anion 702(def.)
TNF 554,562–563,566 depletion 515
channel 361
antibondingorbital 20(def.),22–23,52, dGTPpool 248
exchangeproteins 45,361
703 gendereffect 152,660
a
an
n
n
ir
e
id
xi
i
n
a
-V
119
214
α 1-antichymotrypsin 424,624 inageing 647,651,654–659
anti-depressant 68,365,602,656 inamnioticfluid 397
annonacin 619
anti-inflammatory 63,68,179,409,426, inamyloiddisease 625,629
anoikis 215,219,224,570,581
456,461–462,530,562,565,656, inatherosclerosis 521–531
Anopheles 101,107,367,440
680,684 inbabies 400
gambiae 149 cytokines 430–431 inβ-cells 533–534
stephensi 440 drugs 460,562 inC.elegans 641,651
anoxia 386,550 effectsofreactiveoxygen incancer 574–577,582,591
anserine 145(struc.),149,498 species 443–444,582,607 incannabis 484
Antabuse,seedisulphiram effectsofSOD 665 incartilage 558
Antarctic/Arcticwaters 5 lipidoxidationproducts 267–268, incellculturemedia 496–497,seealso
anterogradetransport 596,622 607 artefactsincellculture
antheraxanthin 378,379(struc.) anti-malarials 68,363–364,367–368, indiabetes 534–539
anthocyanins 174,176–177 474,562,590 inembryos 396
Anthopleuraelegantissima 94 anti-oestrogenactions 174,178 inerythrocytes 360–369
anthracyclines 111,568,588–593 anti-thrombotic 179,460,481 inexercise 408–410
cardiotoxicity 592,672 antigen 223,355,421–422,443,465, ineye 390–394,seealsoeye
interactionwithiron 592–593 501,513,518–519,558,562,seealso infertilizationmedia 397
anthranilicacid 416(struc.) immunesystem infoetallung 399
anthrax 91,445 antibodycomplexes 450 infruits 187
anti-angiogenic 397–398 fromdrugs 680 ingastrointestinaltract 355–356,367
anti-apoptoticeffectofROS 219,581 inducedexpansion 449 inheart 592

--- Page 883 ---

828 INDEX
antioxidants/antioxidantdefence antiproteinases 424,560,624, 462,498,508,513–514,520,533,
(continued) seealsoα 1-antiproteinase; 592–593,613–614,620–621,631,
inhibernation 549 α 2-macroglobulin;TIMP 637,652
ininsects 451–456 inrheumatoidarthritis 559 andcancer 570–575,579–583
inischaemia-reperfusion 539–553 α 1-antiproteinase 65–66,148,237,277, andMPT 217
in ischaemic 358–359,400,424,432,442,488, brain 597,603,609
preconditioning 547,551 528,553,555,561,565,662–663 GSHlevelsduring 219
inkidney 550 effectofcigarettesmoke 493 inerythrocytes 366–367
inLDL 526–529 fromphagocytes 441 inneutrophils 422,424,430,492
inmitochondria 14,seealso antipyrine 297(struc.) peroxidegenerationduring 215
mitochondria,antioxidant antisenseknockdown peroxide-induced 436
defencesof ofcatalase 385 preventionbyO • 2 – 219
inmuscle 408,seealsomuscle ofperoxiredoxin 94 roleofceramide 219
innakedmolerats 650 ofsuperoxidedismutase 94 roleoflipidperoxidation 219
inorganpreservationfluids 550–553 α 1-antitrypsin,seeα 1-antiproteinase roleofNO • 219
inoviductalliningfluid 397 anxiety 112,504,604,633 roleofPARP 217
inpancreatitis 567 aorta/aortic 5,88,140,146,178,223, apoptosissignal-regulatingkinase-1,
inphagocytes 442 516,546 seeASK1
inplacenta 397 aneurysm 548 apotransferrin 128,seealsotransferrin
inplants 377–382 endothelialcells 201 apples 153,157,177
inpolymers 678 smoothmusclecells 201,229 apurinic/apyrimidinicsites 238,248,
inrespiratorytract 357–360, APendonuclease 229,248,251 323,328
aquaporins 64,225,313,449
493–494,seealsolung,respiratory AP-1(activatorprotein-1) 178,221,
tract/liningfluids 223,229,247–248,493,551,573 aqueoushumor 110,159,387–388,392
Arabherdsmen 404
inrewarming 549 inageing 642
Arabidopsisthaliana 81–82,374,
inrootnodules 382 incancer 581
378–382,384–385,452,455
inseeds 456 inmuscle 409
vtcmutants 452
inseminalplasma 395 inskin 404
arabinose 588
insickpeople 511–512 AP-lyase 328
D-arabinono-1,4-lactoneoxidase 156
inskin 406–407,seealsoskin APsite 246,248,580,seealsoapurinic
arachidonicacid 15,50,63,75,206,
insperm 395,seealsosperm sites;apyrimidinicsites
253,255(struc.),257,259–260,
insynovialfluid 561 Apaf-1 217–218
262,266–267,269–270,331–332,
intears 390–391 APC 574
334,362,369,394,405,426,454,
iodideas 448 APE1,seeAPendonuclease
456–457,459,468,512,527,530,
ironsequestration 125–131,133–141, APF 317–319,319(struc.)
562,608
151 apigenin 175(struc.) contaminationof 458
nanoparticlesas 496 apocynin 433,632,666(struc.),694 innakedmolerats 650
nutrientdeficiency 198 non-specificity 433 ARDS 104,132,159,168,210,348,408,
nutrientmixture 628,632 apo(a) 531 441,495,528,553–554,555–556,
peroxynitriteas 63 apoA1/A2 521,530 567,681,693
PUFAsas 274 apoB 521,525–526,538 arecanut 494
responseelement 229–231,475,655, apoE/2/3/4 166–167,331,517, AREDS,seeAge-RelatedEyeDisease
673 624–625,627 Study
woundhealing(ARE) 407–408 andAlzheimerdisease 624–625 ARFprotein 573
antioxidantsupplements 146,359–360, deficientmice,seeknockoutmice; arginase 37,116
532 apoE arginine 277,279(struc.),281,305,
andradiotherapy 509 receptors 517 344–346,530,536,558,624,645
incancer 595 apoH 556 inglycation 536–537
indiabetes 539 apomorphine 661 kinase 123,224
inkidneypatients 450 apoplast 369,381,385 lysinecrosslink 537
AntioxidantSupplementationin apoprotein 128,276 nonamer 665
AtherosclerosisPreventionStudy B 521,525–526,538 argon 700(struc.)
(ASAP) 186–188,190,198 apoptosis 13,17,28,64,81,106,131, Armoraciarusticana 120
AntioxidantsandRedoxSignaling 477 133,143,170,184,200–201,208, aroclor 16,395
antiperspirants 403,501 212–219,221–222,224,226,228, aromatase 16
antiphospholipid 230,233–234,236,245,249,253, aromatic
antibodies 556 266–267,272,282,317,323,388, alkoxyl 48,164
syndrome 556–567 397,402,422,433,435,446,452, amines 459,584,679

--- Page 884 ---

INDEX 829
carboxylicacids 293 201,209,259,261,264,276,292, inmuscle 409
compounds 43,306,704(def.) 299–300,302–307,310,316–318, inoocytes/ovaries 395–396
endoperoxides 71 332–333,338,346,349,351–353, inoviductalliningfluid 397
hydrocarbons 476,584 355–356,358–359,362,382,385, inpancreatitis 567
hydroxylation vi,62,76,293–296, 401,407,438,441,451–452,471, inphagocytes 442
316,420,561 511,537,565,567,604–605,652, inplants 378–379,380–381,384–385
peroxyl 48 seealsodehydroascorbate,scurvy
inpre-eclampsia 398
probes 515 andageing 655–656
inrespiratorytract 359
aroxylradicalabsorptioncapacity andairpollution 385,487–489
inrheumatoidarthritis 559–561
(ARAC)assay 350 andcaloricrestriction 651
inseminalplasma/sperm 395
arrhythmias 206,266,321,453,514, andchemotherapy 592–593
542–544,546,592,692 andCr 498 insickpeople 511–512,548
arsenazoIII 507 andDFO 691 inskin 407
arsenic 115,294,491,497–498,584 andhaptoglobin 157 intransplantedhearts 500
arsenictrioxide 497–498,590 andironoverload 160 inwhitecells 182
andviruses 638 andnitrosamine 588 inwounds 407
artefacts/artefactual 325–326 andprobucol 527 interactionwithcopper 160
incellculture 7,28–29,51,55,60, andsmoking 493–494 interactionwithglutathione 160
64,67,101,115,124,128,144,159, andsocialclass 183–198 interactionwithMPO 441
169–170,173,178,200,203,213, andSODmimetics 669 interactionwithV 500
225,230,280,316,334,396,448, andstroke 182,610–611 interferencewithABTSassay 350
496–497,522,572,576,582,637, antioxidantproperties 157–161, interference with H2O2
648,677 672–673 determination 310
DNAoxidation 326 asenzymecofactor 155–156
kidney 157
lipidperoxidation 331,336 cardiovasculardisease 180–198,523
mitochondria 157
nitration 306 degradationproducts 156,362
nitroso 158
ofeating 529 dehydroascorbateratio 380
oxidase 160,350,381
ofsolventextraction 291 depletion 159,511–512,548
palmitate 406–407,673
peroxidationofLDL 524–526 dogs 628
placentaldeliveryof 397
proteinoxidation 344 duringcardiopulmonarybypass 546
superoxidegeneration 318,321 esters 158–159,406–407,673 pro-oxidanteffects 160–161,392,
withmitochondria,seemitochondria; glutathionecycle 357,380,382, 594,604,656
artefacts 384–385 γ-radiation 508
artemether 368 glycationby 161,387,392,536–537, radical,seeascorbylradical
Artemia 149,415,417 539 reactionwithnitroxides 505
Artemisiaannua 368 inALS 631 reactionwith1O2 74
artemisinin 368(struc.),369,464 inAlzheimerdisease 625,627–628 reactionwithSODmimetics 668
arterialwalls 140,seealsoaorta inARDS 528 recycling 159–160,161,286
Cu/Fecontent 211–212 inasthma 359–360 reductionpotential 157
arterioles 5,223,423 inbabies 392,400 slowrelease 186,188
artesunate 368,590 inbrain 598,604 supplements 160–161
arthritis 61,444,649,seealsocollagen- incancer 159,590,593 synthesis 155,381
inducedarthritis;osteoarthritis; inCharcot-Marie-Toothdisease 633 α-tocopherolrecycling 162–165,493
rheumatoidarthritis inCl2toxicity 487
transport/uptake 157,362,seealso
articularcartilage,seecartilage inCSF 604
SVCT1,SVCT2
aryl incysticfibrosis 555–556
ascorbateperoxidase 114–415,122,
alcoholoxidase 420 indiabetes 534,539
157–158,357,380,384–386,415
hydrocarbonhydroxylase 15 inembryos 396
inplants 384,386
hydrocarbonreceptor 185,469,493 inendometriosis 398
asbestos 186–187,190,443,496–497, inerythrocytes 362 inactivation 122
ascorbylradical 32–33,36,46,122,
582–584 ineye 387,390–393
158–159,161,318,321,349,357,
Ascaris 140 ingastricjuice 127,355,567
362,471,515,546
Ascophyllumnodosum 121 ingastrointestinaltract 157,357
ascorbate 14,20,26–29,32–33,43, inH.pyloriinfection 567 ESRspectrum 286
46–50,52,54,63,65–66,71,75, inIBD 566 inskin 407
77–78,89,91,97–100,106,114,122, ininsects 357 ASK1 225
125–127,130–131,136,138–139, inLDL 526–529 asparaginylhydroxylase 9,155,157
141,144,146,148,154,155–161, inlungtransplantation 553 aspartate 28,217,281,437,599
156(struc.),169,172,177,179–180, inmeningitis 606 proteinases 280,424,624

--- Page 885 ---

830 INDEX
Aspergillus 434 ATN-224 82,590 avidin 323,346
fumigatus 44 atomic Avogadro’snumber 34,705(def.)
nidulans 231 number 697(def.) axon 253,484,595–597,631
niger 384 orbital 20(def.),22 axonal
aspirin 189,191,194,458,460,463,464 atopicsensitization 360 degeneration 595,602
(struc.),559,562–563,626,661 Atox1 138 transport 613,631
incancer 578 ATP Ayurvedic 500
nitro 58 contaminationof 500–501 azide 60,71,84,118,132,209,237,308,
triggeredlipoxins 425,461 asaDAMP 421 330,362
astaxanthin 169(struc.),527 measurement 214 reactionwith1O2/OH • 308
asthma 153,267,303,306,357–360, sensitiveK+channels 534,547 azimuthalquantumnumber 697
440–441,446,462,487–489,495, synthesis 12,65,608,632,635 azo
556,670,680 ATP7B 136 anionfreeradical 507
andGSH 681 ATPases 214,500 bond 562(struc.)
roleofascorbate 359–360 ATR 569 compounds 45,305,505–507
Astragalus 124 atransferrinaemia 134 initiators 49,265,350
astrocytes 102,132,165,424,499, atrazine 112,382,383(struc.) Azotobacter 79
596–598,600–607 AtRBOHB 455 azurophilgranule 421,556
andHIV 637 AtRBOHC,D,F 452 AZN(azulenylnitrone) 289(struc.),
inALS 632 atrialfibrillation 321,543 293,610
inAlzheimerdisease 624–625 Aufbauprinciple 697 AZT 159,637
inParkinsondisease 617,619 auranofin 565,590 andoxidativedamage 638
astronauts 408,509 aureolicacid-basedantibiotics 588
B
asymmetricaldimethylarginine,see aurones 177
ADMA aurothioglucose 562,565 B12a,12r,12s 414
AT→CGtransversionmutations 247 aurothiomalate 562,seealsogold Bcells 235,421,422,449,558,582,638
AT→GCtransitionmutations 246,270 sodiumthiomalate B1-phytoprostanes 369,371(struc.)
ataxia 165(def.),606,629,633 autism 633,681 B-vitamins 10,197–198,482
telangiectasia 251,574,576,648 auto-oxidation 24–25,29,32,36,88–90, babies 25,56,120,196–197,211,
telangiectasiamutated,seeATM 115,120,126,134,159,178,252, 397–398,401,481,546,681,692,
withisolatedvitaminEdeficiency 362,370,400,475,512,600–601, seealsobirth;breastmilk;infant
165(def.),167–168,604,633 603 formulas;neonatal;neonates;
ATG4 281 autocatalyticcyclization 421 prematurebabies
AtGPX1-8genes 380 autofluorescence 309,453 babyhamsterkidneyfibroblasts 202
atherosclerosis 55,62,66,132,141, autoimmune/autoimmunity 62,215, bacillithiol 113(struc.)
143,153,167,169,178,183,186, 275,365,562 Bacillus
188,201,256,267–268,271,275, diseases 179,210,275,406,440,533, anthracis 91,113,445
331,334,443,462,490,494,497, 552,556–558,565,607,692 CalmetteGuerin 235
516–531,532,534–535,539,546, encephalomyelitis 179,607,681 cereus 87
548,551–552,556–557,560,562, inageing 642 popilliae 115
622,639,646,651,670,696 vasculitis 556 subtilis 87,113,220,413
andcarotenoids 173,527 autophagy 9,28,149,222,232–233, bacteria,seealsothenamesofspecific
andceroid 658–659 280–283,353,393,513,604,606, bacteria,e.g.E.coli
andcopper 521–523 611–635,647,652,659 avoidancestrategies 444–445,449
andhaemoxygenase 520,522 andageing 615,647,651,655,658 broths 235
andhaptoglobin 552 andcaloricrestriction 655 cellwalls 236,433,435
andiron 521–523,660 andROS 281 electrontransportchains 14
andOTC 681 chaperonemediated 281 ferritin 129
carotid 186–188,524,527 inAlzheimerdisease 628 Gram-positive/negative 54,433,477
infoetus 398 inHuntingtondisease 634 H2O2metabolism 123
mouse-humandifferences 523 inskin 406–407 intracellularFecontent 211,434–435,
plaquerupture 517,521,523 autosomes/autosomal 28,614,635 502
ATM 224,250–252,569,573–574,606 dominant 616,630–631,633 ironsequestration 133
andoxidativedamage 576–577 recessive 434,622,646 killingbyphagocytes 433–439
oxidativeactivation 252 autoxidation,seeauto-oxidation sensingresponse 447
knockoutmice 252 auxin 121 bacteriostaticeffect 470
ATMandRad-3related 569 AVED,seeataxiawithisolatedvitamin Bacteroidesfragilis 7,28,87,90
atmosphericparticulates 495–496, Edeficiency Bad 217,222
seealsoairpollution averagelifespan 640 baicalein 175(struc.)

--- Page 886 ---

INDEX 831
bak 217–218 benznidazole 505 inbraintrauma 611
baldness 511 benzoicacid 42,293,298,463 inrestenosis 550
balloonangioplasty 546,548,550,670 decarboxylation 435 biliverdin 142(struc.),143,338,652,
band 3,56,361,363 todetectOH • 293 668
Bangladesh 497 benzoporphyrin 390 ineye 392
barbiturates 16,464 benzopyrene 15,16,230,398,459,491, manganesecomplex 668
bardoxolonemethyl 683 493,570,577,584,585(struc.),587 reductase 142–143
barley 380,453 7,8-diol 585(struc.),587 biobreeding(BB)rat 533,691
Barrettoesophagus 567 7,8-diol-9,10-epoxide 584,585 BiochemicalJournal 155
basal (struc.) biofilms 7,27–28,64,477,555
cellcarcinoma 404,470 7,8-dione 585(struc.),587 biological
ganglia 605 benzoquinone 48,476(struc.) clock 641,647–649
metabolicrateandlifespan 640 1,4-benzothiazineintermediates 150 plausibility 183
basalO2uptake 449 (struc.) bioluminescence 309,419–421
bybrain 595 benzoylperoxide 577 biomarkers 514,545,653
base 705(def.) benzphetamine 16 global,caution 654
excisionrepair(BER) 248–252,271, benzylformate 312 oflipidperoxidation 329–343,
325,328,575 beryllium 497,700(struc.) seealsolipidperoxidation
propenals 209,272,322,338,593 Berzelius 110,252 ofOH • production 464
basementmembranes 440,442–443, betelquid 494 ofoxidativedamage 61,93,109,
524,538,556,570 141,173,178,182,185,187,245,
BG-12,607,683
basophils 422,440 284–353,358,515,524,539,549,
BH2,seedihydrobiopterin
bathocuproinesulphonate 350 seealsooxidativedamage
bathophenanthroline
BH4,seetetrahydrobiopterin
ofoxidativeDNAdamage 322–329,
BH3proteins 218
disulphonate 209,686 seealsooxidativeDNAdamage
BHA 42,536,673,677(struc.)
bats 640,660 ofoxidativeproteindamage
Bax 217–218,573,652 andcancer 677 343–346,seealsooxidativeprotein
inmultiplesclerosis 607
BayerCompany 562 damage;proteincarbonyls
BCDO2,seeβ-carotenedioxygenase 2 BHT 42,334,337–338,524,536,558, BiomarkersofOxidativeStress
656,673,677(struc.),678
Bcl-2 217,572,652 Study 467
andlifespan 656
Bcl-B,-w,-XL,-Xs 217 BioMimetixPharmaceuticals 666
bdelloidrotifers 509 andvitaminK 677 biopsies 327,549,576–577,645
BCMO1, see β-carotene inplastics 673 biopyrrins 143,321,349,504
interactionwithα-tocopherol 656
monooxygenase biosensorsofROS 309–310
BCNU 100,112,364,588 bicarbonate 33,38,41,43,61–62, biotin 323,346,413
109,224,245,302,306,313,361,
BDNF 234,598,605,647 BiP 233
499,554
andexercise 629 biphenyl 293(struc.)
bicyclicperoxide 259–262,270
inHuntingtondisease 634 bipyridyl 383(def.)
beagles 656 Bid 217–218 herbicides 383–384,470–471
beer 67,134,270,479,481,499 bidentate 689,693 inbraininjury 611
bees 63,179,653 bifunctional radicals 383–384,393,470
BeijingOlympics 490 catalase-peroxidase 116 birds 26,134,143,149,151,161,167,
bell-shapeddose-responsecurve 543 glycosylase 249 170–171,573,640,649,652
benign bile 67–69,102,112,127,131,136, mitochondria 26,649
papillomas 571 166–168,204,334,338,356–357, plumage 171
progressioninFALS 632 437,467,551,567–568 ratparadox 649
prostatichypertrophy 579 bileducts 68,554,568 birefringence 629
tumours 569–571 cancer 588 birth 157,211,394,398–401,539,601,
benserazide 617 epithelialcells 551 603,607,seealsobabies;premature
bentonite 470 inflammation 582 babies
benzamide 479 ligation 665 hyperoxia 604
benzanthracene 16,491,586(struc.) bilirubin 67,68(struc.),69,71,112,139, bis-allylichydrogen 257
benzene 42,173,293,297,364–365,475,
141–142,143–144,256,349,401,
bis-phenol 524(struc.)
476,481,491,495,505,584,704 515,611,652 bisulphite 385,459,489
(struc.) asasensitizer 68,143 bityrosine 45(struc.),49,120,141,
-1,4-dicarboxylicacid 297(struc.) asanantioxidant 139 200,276–277,278,302,344–345,
-oxide 476 asbiomarkerofROS 321–322, 509,625
benzenetriol 178,476(struc.) seealsobiopyrrins immunohistochemicaldetection 344
benzidine 120,584,586(struc.),587 biliverdincycle 143 inatherosclerosis 521,524

--- Page 887 ---

832 INDEX
bityrosine(continued) Bloomsyndrome 576 Bowman’scapsule 327
incysticfibrosis 555 blue boxers 628
indiabetes 539 babysyndrome 25 BP3 676
insleepapnoea 549 crab 85 brachialartery 349,681
inurine 344 greenalgae 1 bradykinesia 615
Bjerkanderaadusta 420 greenherb 368 bradykinin 636
black lightfilters 393 brain 8,13,16,18,19,26,53,55,69,79,
rhinoceros 134,363,367 blueberries 187,195,628 81,84,88,92,101–102,104,110,
tea 175,177,184 Blumeriagraminis 453 115,117–118,129–131,136–137,
walnut 473 BMI 532 140,142–144,146,148,151,157,
blackcurrants 177–178 BMPO 289(struc.) 159,164–165,180,195,206,212,
blackwaterfever 363 BMX-001,seeMnTnBuOE-2-PyP5+ 225,235,247,253,268,275,282,
bladdercancer 191–192,495,497,576, BN82451 634,667(struc.),673 297,302,340,344,350,363,401,
582,584 BNB 288(struc.) 416,426,440,443,447–449,458,
blastocoel/blastocyst 396 Bni1protein 226 476,482,484,490,496,501–502,
bleach 65,454,487 BO-563 525,673,676(struc.) 517,532,539–540,546–549,639,
bleaching 173,386 boar 395 651,653,665,684,692
blebbing,seemembraneblebbing BODIPY 71,342–343,348,350 alcoholmetabolism 481
bleeding,seehaemorrhage BODIPY581/591C11 319(struc.), Alzheimerdisease 627–628
Blenoxane 593 342–343 antioxidantdefences 602–606
bleomycin 98,197,201,208–211,236, bodyironstores,seeiron,bodystores ascorbate 195,604
400,430,588,593–595,594(struc.)
andcancer,seecancerandiron atrophy 621
chelatableiron(BCI) 209–211,544
Böhrmagneton 285 caloricrestriction 640
hydrolase 594
bombardierbeetles 415,417,471 cancer 191,576,578,672
inducedlungfibrosis 665,670
Bombyxmori 219 carbonyllevels 346
blindstaggers 124
bonding cardiolipin 611
blindness 19,171,386,388,391,
betweenatoms 702–705 carnosine 605
seealsoeye
β-blockers 661 molecularorbitals 703 carotenoids 605
bone 4,21,93,125,136,152,159, cytochromes 450,602
blo c o o d a 4 g , 0 s 7 u e , l e a 4 a t 2 i l o 2 so – n 4 p 2 6 l 3 a 1 , s , m 4 6 4 5 a 1 , ; , 1 s 4 3 e 5 9 r 0 u , , m 1 4 6 7 5 3 , , 2 4 3 9 7 0 , , 2 5 3 0 1 9 , , 2 5 8 6 6 0 , , 4 5 2 6 6 1 , – 4 5 3 6 4 2 , , 4 6 4 5 0 2 , , 4 se 5 e 1, al 5 s 0 o 0, d d a ev m e a lo g p e m by en v t ir 5 u 9 s 7 e , s 5 6 9 3 9 6 – – 6 6 0 3 0 7 ,607
osteoclasts;osteoblasts
531,538,542,seealsothrombosis energymetabolism 598,626
demineralization 501,646
ethanolconcentration 482 ergothioneine 603
extracorporealcirculation 210, grafts 509 flavonoids 180
mineraldensity 451
seealsocardiopulmonarybypass glutathione 600,603–604,606,611
resorption 128,136,235,267,560
immunecellcontent 422 haemorrhage 400,604
bonemarrow 18,79,127,142–143,210,
pressure,seehypertension; homogenates 208,601
252,287,363,422,426,440,474,
hypotension ironlevelswithage 607,660
476,496,507–508,553,557,569,
substitutes 133,360,475 lipidperoxidation 601–602,605,680
588,648
suckinginsects 367–369 metallothioneins 606
stemcells 648
transfusion 135,168,362–366,400, microvasculature 601
stromalcells 582
686
mitochondria 598,604
transplantation 70,443
Bloodjournal 317
borohydride 333 NADPHoxidases 446,600,603
bloodflow 180,442,508,518–519,548,
600 boron 343,700(struc.) nitricoxide,seenitricoxide,inbrain
bloodvessels 54,63,140,156,223,231, boronates 302,312–313,315–316,318, Nrf2 604,611
252,277,367,387,390,439,447, 665,688,693 oxidativedamage 595–603
538,552,556,598,655,661,seealso Borreliaburgdorferi 95,113,133,502 oxygenlevels 603
aorta;carotidarteries;capillaries bortezomib 282,636 oxygentoxicity 19
andageing 653 Bostaurus 437 peroxiredoxins 603–604
F3-isoprostanes 653 BOSSstudy 467 plasmalogens 605
grafts 143 bottlenosedolphins 134 selenium 603
inskin 402 botulism 55 trauma 92,151,154,253,340,399,
walls 349,423,443,445,448–449, bovine 496,597,602,606,611,624,628,
517,525–526,548,665,672 aorticendothelialcells 223 680,683
blood-brainbarrier 475,479,499,590, erythrocyteSOD 80–81,87,seealso ubiquitin-proteasomesystem 282,
598,600–602,605–606,609,611, CuZnSOD 606
616–617,620,665,669,671–672, spongiformencephalopathy vitaminEcontent 195,604–605,672
680–682,690 (BSE) 630 zinc 501,606,611,618,626

--- Page 888 ---

INDEX 833
brain-derivedneurotrophicfactor,see brown Caenorhabditiselegans 12,17,45,64,
BDNF adiposetissue(BAT) 26–27 71,81,94,118–119,204,222,273,
Brassicas 379,451,476 algae 121,448 313–314,334,339,448,647,649,
BRCA1or-2genes 204,570,576–577 rotfungi 297,417,420 655–657,659–660
BrdU 214,323,569 browningprocess 535,seealsoMaillard ageing 640,641–643,651,657,659
bread 454 browning catalase 642
breast 327–328,426,481 Brucellasp. 80,123 coenzymeQ 12,642
bruises 143,611 fluorescentpigments 658
cancer 153,182,193–194,475,570,
575–576,579,581,591,595,622 Brusselssprouts 393 insulin-likesignalling 642–644
cancerandFe 583 buccalcells 327,355,seealsooralcavity isoprostanes 653,659
bucillamine 552,562,564(struc.),661, oxygentoxicity 17
fedbabies,oxidativeDNA
680,683 proteincarbonyls 653
damage 401
buckwheat 68 SOD 651,657
implants 252,270
buffalo 433–434 caeruloplasmin 9,37,55,61,84,97,
milk 128,400–401,seealsolactoferrin
buffer 705(def.)
131–132,135–136,138–139,154,
stripes 151
Burkholderiacepacia 434 209,212,359,388,400,442,522,
breathcondensate 309,311,334,339, Burkittlymphoma 573,638 528,531,557,583,652
358,488,490,492,528,555,seealso burns 102,407–408,547,553 acutephaseresponse 237
exhaledair inducedcardiacinjury 408 breakdowninstoredfluids 132,557
breweries 499 contaminationwithEC-SOD 139
butadiene 491
bridginghistidine 82 deficiency 131,605,614
butane 704(struc.)
brineshrimp 149,415,417 glycation 537
butanol 42,118,337,481
British inARDS 528
butanone 269
Admiralty 157 inatherosclerosis 522
buthioninesulphoximine(BSO) 102
anti-Lewisite 497,683 (struc.),104,144,151,160,218,391, inbrain 605
HeartFoundation 188 508,568,604,621 inspinalcord 611
RubberProducers’Association 253 inmalaria 368 interactionwithMPO 132,442
broadbean 366 butterflyrash 556 membraneboundform 131,605
broccoli 155,184–185,393 butylatedhydroxyanisole,seeBHA peroxidaseactivity 132
bromamines 66,244,265,344 butylatedhydroxytoluene,seeBHT reactionwithO • 2 – 84,139
caeruloplasmin ferroxidase
bromine/bromide 31,36,120,438,440, BXT-51072 666(struc.),683
activity 528
465 bypass
chloride 31 grafting 546 inParkinsondisease 618
caffeicacid 174(struc.),175,177,356,
radicals 36,121 SODdeficiency 95
418
5-bromo-2-deoxyuridine,seeBrdU surgery 552
methyltransferase 418
bromobenzene 112,468
C phenethylester 179,185,228(struc.)
bromocriptine 617 caffeine 298(struc.)
bromocytosines 244,246 13C 293 cagedradicals 61
8-bromodG 328 labelledglycine 102,348 calcein 208,213,321
bromohydrins 66,265 C4photosynthesis 377 assay 688
bromoperoxidase 121–122 C57BL/6Jmice 517 blue 128
c-Ablkinase 123,224
bromophenol 468 detectableiron 128–130
bromotrichloromethane 469 c-Fos 223,229,673 green 128,129(struc.)
bromotyrosine 121,276–277,278 c-Fos/c-Junheterodimer 229 calcineurin 96,205,225
(struc.),307,358,440 c-JunN-terminalkinases,seeJNK,Jun calcireticulin 233
antibodymethods 345 c-myc 575,595 calcium 13,53,54,120,155,200,
bronchi 267,357,681,seealso
C-polysaccharide 236 203,204–208,222–225,236,266,
respiratorytract c-src,seesrc 274–275,283,367,402,408,419,
C-reactiveprotein,seeCRP 452,486,500,507,697,700(struc.)
bronchialepithelia 447,463
C-terminaltruncations 631 andanthracyclines 592
bronchioles 367
C8-OH-adductradical 239(struc.),322 ATPase 13,205,217,266,368,486,
bronchitis 490
Cav1.2Ca2+channels 206 653
bronchoalveolarlavage 210,359,
CA1regionofhippocampus 608 calmodulindependentkinaseII 56
431,555
cabbage 155 channels 98,105,136,206,367,399,
bronchogeniccarcinoma 496
whitebutterfly 455 500,620
bronchopulmonary
cachexia 234–235,582 effectsofoxidativestress 205
ciliaryclearance 555 cadmium 127,137–138,348,491,497, extracellularlevels 205
dysplasia(BPD) 399–400,670,681 499 inbrain 600

--- Page 889 ---

834 INDEX
calcium(continued) Camelliasinensis 175 breast,seebreastcancer
inmitochondria 9,204–208,599 CaMKII 543 carcinogenesis447,570(def.)
inphotosynthesis 373–375 CaMn4O5cluster 374–375 causinginflammation 582–584,
insperm 394 camphortree 87 seealsoinflammationandcancer
intracellular 208,215,466,468, cervical,seecervicalcancer
Campylobacterjejuni 7
473,478,486,512,534,540,543, chemotherapy 82,105,112,204,209,
canary 640,649
599–600,620,625,632 215,282,321–322,402,412,471,
leak 654 cancer 9,18,92–93,111–112,119,124, 551,568,573,581,583,588–595,
151–153,159,183,197,224,236,
overload 217,543 636,648
275,322,326,348,493,507,511,
probe,artefacts 507 chronic inflammation, see
556,566–567,568–595,639,645,
sequestration 466,468,600 inflammationandcancer
657
uptakemechanisms 501 colorectal,seecolorectalcancer
andageing 577–578,639,644,646
calcium-ATPase 13,205,217,266,368, fromasbestos 496
486,653 andalcohol 480–482 geneticchanges 572–574,seealso
calcium-calmodulindependentkinase andcaloricrestriction 640–641 oncogenes;p53;proto-oncogenes;
II 56 andcopper 583–585,591 tumoursuppressorgenes
calcium-dependent 447,608 anddiabetes 578–579 glucosemetabolism 570,574,576
endonuclease 206,236,473 andDNArepair 251–252,575, headandneck 509
esterases 530 578–580 HIFs 9,509,574,579–581
calcium-stimulatedproteinases 540, andglutathione 582,591 human-rodentdifferences 486
599,seealsocalpains andGPx 574,576,579,582 hypoxia 9
Caldariomycesfumago 121 incentenarians 659
andhaem 354,570
calfserum 331 inWernersyndrome 646
andhaemoxygenase 576,591
CALG,seealsocalceingreen larynx 490
andHNE 579–581
Callinectessapidus 85 liver,seelivercancer
calmodulin 54,205,225,280,282,452, andH2O2,seeH2O2incancer lung,seelungcancer
512,599 andHsp 577 m-tyrosinein 296
likedomain 447 andinflammation 572,578–579, nasal/nasopharyngeal 252,498
calnexin 233
581–584,587–588
oesophageal,seeoesophaguscancer
calor 425–426 andiron 398,583–584,591,659 ofthescrotum 584
•
caloricrestriction(CR) 93,155,184, andlipidperoxidation 579–580,583, OH and 296,577
195,402,595,603,640,646–647, 587 oral 183,490,579,595
651,seealsofasting andMnSOD 574,576,583 ovarian 398,473
andageing 653 andnakedmolerats 650 oxPTP 348
andautophagy 655 andNF-κB 228,581,583 pancreas,seepancreascancer
andcancer 640–641 promotion 190
and8NG 579,595
andDNArepair 651 • prostate,seeprostatecancer
andNO 579,588
andGSH 655 rectal,seerectalcancer
andNrf2 230,576,585,591,683
andH2O2 653–654
andONOO–– 576,579,588
renal,seerenalcancer
andinsulin 640–641,651 roleofCOX 578,582,585,587
andiron 660 andoxidativeDNAdamage roleofROS 573,584–595
andmetallothionein 660
577–580,seealso8OHdGincancer
skin,seemelanoma;skincancer;
andoxidativedamage 651 andoxidativeproteindamage 346, squamouscellcarcinoma
andproteasome 655 579–580 stomach,seestomachcancer
artefactual 656 andperoxiredoxins 575 superoxidedismutases 574,576,
inhumans 640–641 andPIP3 574 581,583
inmonkeys 640,641 andradiation 577–578 UVand 404
inrapidlyageingrodents 658 andrheumatoidarthritis 578 candesartan 661
neuroprotectiveeffects 647 andselenium 189 candicidin 502,504(struc.)
calpains 201,206,215,217,219,275, Candidaalbicans 85,140,149,156,439,
andsenescence 649
424,466,471,486,512,543,608, 444–445
andsmoking 490,491,493
611,680 cannabidiol 484,485(struc.),661
andstemcells 581–582
actiononXDH 206 cannabinoids 484
andtelomerase 648
calves 161,331 cannabinols 661
Calvincycle 369–370,376,379,384–385 andtocopherylsuccinate 673 Cannabissativa 484
cambialisticSODs 86 antioxidanttrials 189–195,seealso cannibalism 629
Cambrianexplosion 2–3 interventiontrials,cancer canthaxanthin 169(struc.),393
CambridgeHeartAntioxidantStudy ascorbateinvolvement 159,590,593 capacitation 394
(CHAOS) 186–189 bladder,seebladdercancer Capebuffalo 433–434

--- Page 890 ---

INDEX 835
capillaries 18,19,167,266,360,362, carbonylcompounds 52,195,239,266, 348,410,481,495,516–511,560,
390,404,423,430,544,561,598 307,331,339,366,455,622,seealso 562,639,seealsoheart;coronary
pO2 5 aldehydes;HHE;HNE;protein heartdisease;interventiontrials
capsaicin 185,635 carbonyls (cardiovascular)
Capsicum 185 2-carboxy-3-keto arabinitol andG6PDH 363
capsid 637 1,5-bisphosphate 377(struc.) andiron 135–136,660
capsule 79,445,569 carboxy-PTIO 304 andMPO 521
CaptainJamesCook 157 carboxyethyl-lysine 537 CARET,seeβ-CaroteneandRetinol
captopril 58,292,449,661 2-(ω-carboxyethyl)pyrroleadducts,see EfficacyTrial
carexhaust 75,483,488,496,500,549, CEPadducts caricatureofageing 646
584,seealsodieselexhaust carboxyfullerene,seefullerenes carmustine 588
Carassiusauratus 170,247,550 γ-carboxyglutamylcarboxylases 473 carnitine 156,605,628
3-carbamoyl-proxyl 292 carboxyhaemoglobin 549 carnosicacid 174(struc.),176
carbamylation 531,558–559 carboxymethyl-lysine 537(struc.),559 carnosinases 149
carbanion 419 carcinogens 184,240,244,246,248,327, carnosine 145(struc.),148–149,154,
carbidopa 617 459,469,486,489,494,498–499,570 252,410,498,652,661,663,673
carbon 700(struc.) (def.),570–573,577,580,584–590 andeye 673
black 496 andcaloricrestriction 640 astherapeuticantioxidant 672–673
centredradicals 30,42,49,100,126, andnakedmolerats 650 inageing 655
172,239,256–260,276,291–292, complete 584 inbrain 605
298,330,339,352,459,467,489, detoxificationof 570 instroke 610
491,495,510 DNAadducts 577,584,587 carnosol 174(struc.)
disulphide 81 hydrocarbons 491,495,570 α-carotene 169(struc.),170–171,527,
isotopes 698 incigarettesmoke 491–493 529,555
metalbond 414 carcinomas 570–571 β-carotene 67,71,74(struc.),169–173,
nanotubes 310,496,665,673 cardboardflavour 270 180–181,183–184,308,359,378,
particulates 495 cardiac,seealsoheart;heartfailure; 393,439,490,527,529,595
carbon-13,-14 698(struc.) myocardialinfarction;coronary andcigarettesmoke 493
carbondioxide 23,293,420,509 heartdisease andradiotherapy 509
fixation 382 arrest 610 assourceofvitaminA 171
historicallevels 6 arrhythmias,seearrhythmias breakdowninplants 378
radical 30–32,35,47,84,467 fibroblasts 54 degradation/oxidation
carbonmonoxide 15,23,142–143,264, myocytes 98,514,543 products 173,190,380
337,491–492,495,522,547,549, output 450 dioxygenase2,171,173
550,553,568,606–607 remodelling 449,545 inAIDS 638
dehydrogenase 37 surgery 543,547 inbrain 605
fromlipidperoxidation 549 topoisomerase 592 incysticfibrosis 555
inbraintrauma 611 toxicity 63,592,686 ineye 393–394
incysticfibrosis 555 cardiolipin 13,218,253,254(struc.), inLDL 527,529
releasingmolecules,seeCO-RMs 357,507,544,686 inpancreatitis 567
carbontetrachloride 48–49,161,203, antibodiesvs.oxidizedform 556 inskin 406
266,289,336,341,348,353,464, inbacteria 253 monooxygenase 171
465–468,481,568,602,665,692 interactionwithcytochromec 218 β-CaroteneandRetinolEfficacy
andneonates 466 cardiolipinoxidationproducts 340, Trial 186–187,189,191
carbonateradical 31,33,38,43,50,61, 556,611 carotenoids 71,78,169–173,184,274,
84,100,127,141,144,245,291,317, asDAMPs 421 356–357,369–370,380,436,454,
321–322,499,509,662,669,704–5 inageing 654 661,seealsonamesofspecific
(struc.) inbraintrauma 611 carotenoids
actiononDNA 244 cardiomyopathy 124,128,136,511,650 andAlzheimerdisease 627–628
andDFO 691 cardioprotective andatherosclerosis 173,527
andSODmimetics 669 effect 481,547,592 cleavage 652
detection 320 α-tocopherolanalogue 673 endgroups 171(struc.)
reactionwithnitroxides 672 cardiopulmonarybypass 159,210,511, inAIDS 638
carbonicanhydrase 37,60,93,361 546,553 inbrain 605
III,nitration 654 cardiovascularageing 649,653,660 incellculture 170
Carboniferousperiod 5–6,18 roleofO •– 653 incentenarians 659
2
carbonyl cardiovasculardisease 52,112,124, incysticfibrosis 555–556
oxide 75 141,148,155,180,182–183,185– inDeinococcus 509
reductase 592 187,189–190,196–197,307,329, ineye 393–394

--- Page 891 ---

836 INDEX
carotenoids(continued) conjugates 663 tat 663
ingastrointestinaltract 170,182,356 contaminationof 88,95,116,312, thymolcontent 557
inLDL 527,529 557,665 usetodetectH2O2 116,310–313,312
inS.aureus 436 ferroxyform 125 Vmax117
inskin 406 galactosylated 229,663,665 catalyticcopper 131,137,209,212,486
instability 173,184,190,230 inageing 643,657,659 inbrain 601,604,606
interactionwithvitaminE 173 inALS 632 incardiopulmonarybypass 546
radicalreactions 172–173 inARDS 553 catalyticiron 200,208–209,212,
reactionwith1O2 170–171 inasthma 358 300,317,360,365,376,382,
roleinplants 378–379,382,386 inbrain 602,606 401,486–487,491,502,544,565,
supplements 173,186–187,189,191 indiabetes 479,533,535 686,seealsolabileironpool;
synthesis 382–382 inC.elegans 642 non-transferrinboundiron
inDrosophilalifespan 657 inbrain 601,604,606,611
carotid
inembryos 396 incancer 583,592
arteries 8,450,539,608
inerythrocytes 360–361 incardiopulmonarybypass 546
atherosclerosis 186–188,524,527
inexercise 409 incysticfibrosis 555
body 8,9,142,450
ineye 391 inerythrocytes 366
carprofen 68
inFanconianaemia 577 inFriedreichataxia 633
carrageenan 557
infertilizationmedia 397 inHuntingtondisease 612
inpain 635
infoetallung 399 inIBD 566
inducedinflammation 635,670
inH.pyloriinfection 567 inischaemicpreconditioning 209,
Carratelliunits 329
inischaemia-reperfusion 542,543, 547
cartilage 128,140,223,225,235,286,
552 inkidney 551
558,560–561
inkidney 550 inmitochondria 128,633
carvedilol 661,679(struc.)
inlearningandmemory 666 inmuscle 408
case-controlstudies 180
inmalaria 368 inperiodontaldisease 558
caspases 52,64,143,201,214,217–220,
inmicewithdefectivemitochondrial inrheumatoidarthritis 561
233,276,422,579
DNApolymerase 650 inshock 547
activation,instroke 609
inmitochondria,seemitochondria; inskin 405
effector 217
catalase inspinalcord 611
incancer 581
inmultiplesclerosis 607 instroke 609–611
inactivationbyRS 214,219 inmuscle 408 insunburn 558
independentapoptosis 214 inneonates 401 cataract 40,104,111,130,144,364,386
initiator 217 inoocytes 396 (def.),387–388,390–391,505,507,
caspase-1 63,236,421 inpain 635 514,532,534,646,649,657
ininterleukinsynthesis 236 inParkinsondisease 618 andp53 645
caspase-6 7,10,217 inphagocytes 442 antioxidants 393–394
caspase-8 52,217–218 inplants 380,384,386,452 catechin 175,176(struc.),536
caspase-9 217–218,222 inseminalplasma 395 catechol 48,229,294(struc.),464,
caspase-activatedDNAse 215 inskin 406–407 474–475,587,619
castration 151,446,seealsotestes insynovialfluid 561 O-methyltransferase(COMT) 617
cats 184,392,499,541–542,573 inwounds 407 oestrogens 469,475,586(struc.)
catalase 4,26,36,37,42,45,63–64, inhibitors 117,568,seealso catecholamines 206,223,303,474(def.),
67,78,88,90–91,94–97,111,114, aminotriazole 541,604
115–119,121–125,131,136–138, manganesecontaining 4,95,118 insepsis 548
143,154–155,173,201–202, mannosylated 229,663 nerveterminals 475–476
208–209,215,220–224,226, micelacking,seeknockoutmice, catechu 494
229–230,252,259,264,276,281, catalase caterpillars 455
295,310–312,316,330,332,355, mimetics 666 cathelicidin 433
358–359,362,369,376,378,382, MPOasa 438 cathepsins 276,280,422,424,433,435
385,406,415,434,445,447,471, non-peroxisomal 118 cation/cationic 702(def.)
478,483,521,576,594,652,656, PECAM 553 channels 599,625
661,663,665–666 PEG-modified 665 cytotoxicproteins 422
andAlzheimerdisease 627 peroxidaseenzymes 365 granules 435
andAZT 638 peroxidaticaction 117–118,313,481, cationizedSOD 663
andcancer 575,587,592 602 caudatenucleus 596,601,634
andp53 575 regulation 123,224 Caulobacter 80
anti-inflammatoryeffects 557 specificactivities 117 cause-consequencerelationship 153,
antibodiesversus 556 targetedtomitochondria,see 182,183,627
cellpenetratingderivative 665 mitochondrially-targeted,catalase caveolae 256

--- Page 892 ---

INDEX 837
CC→TTtransitions 246,404 cellobiose chain-breakingantioxidants 139,151,
CCR2 518–519 dehydrogenase 420 162,167,178,283,337,448,524,
CCR5 637 oxidase 24,420
527,661–662,669,672–680
CD 428(def.) cellophane 443 andlifespan 656
CD4,CD8T-helperlymphocytes 422, cellularsentinels 421 chalcones 177,418
637 cellulose 417,420,495,691 ChamorroIndians 617,620
CD11b 18,430 Celsior 552 champagne 178
CD36 519,521,538,686 Celsus 426 chancroid 80
CD40 518 Celtic 135 Changlivercells 223
CD62E,L,P 428–429 centenarians 605,640,658–659 chaperones 77–78,81,94,106,109,130,
CD91receptor 140 cancer 659 139,201,221,232–234,237,272,
CD95(L) 217 cardiovasculardisease 659 281,382,387,514,520,559,615,
CD154 518 carotenoids 659 652,656
CD163 140,237,519 cognitivefunction 659 andageing 645
cdk 569 centralvacuoles 177,382,384 inbrain 606
cdk2 692 centrosome 280 ineye 387
CDNB 108,505 CentrumSilver 193
mediatedautophagy 281
Ce-DUOX1 448 CEPadducts 388,390–391
redoxregulated 233
α-CEHC 164(struc.),165 asDAMPs 421
Charcot-Marie-Toothdiseasetype
γ-CEHC 163(struc.),167 ceramide 254,367,508
1A 633
celecoxib(Celebrex) 562,563(struc.) inapoptosis 219
Chattonellamarina 386
celery 185,404 pathway 493
checkpoints,seecellcycle
β-cells 135,206,226,477–479,533,535 cercosporin 377,378(struc.)
cheese 67,265,620
exhaustion 533 cerebellum 161,252,499,596,599,
cheetah 168
humanvs.rodent 478 601–602,608,633,635
chelatingagents 15,39–40,133,337,
transplants 533,552 Cu/Fecontent 211–212
394,686,seealsocopperchelators;
cell cerebral
ironionchelators
blocks,roleofROS 396 aneurysm 548
chelationtherapy 687
body 596–597 bloodflow 539,599,607
Chelexresin 209
confluence 200 cortex 125,328,596,601–603,608,
division 568,569,574,588,590–591, 622,635,645 chelotropicagents 304
seealsomitogenic;cellcycle palsy 499,681 chemiluminescence 265,309,339,350,
divisionsperlifetime 569 vasoconstriction 670 509,618
junctions 396 cerebrocuprein 79 inexhaledair 309
mediatedimmuneresponse 558, cerebrospinalfluid(CSF) 138,144,159, chemoattractants 426–427,430,444,
seealsoimmuneresponse/system 233,324,334,352,400,441,601, 461
numberinthehumanbody 569 611,625–626 chemobrain 590
signalling,seesignaltransduction; ascorbatelevel 604 chemokines 234,236,421,423–424,
redoxsignalling F2-IsoPs 625,627,637,653 428,430,436,442,582,637
swelling 552,608 ironcontent 601 andAIDS 638
volume 204,542 TAC 352 receptors 519
cellculture,seealsoartefactsincell ceriumoxidenanoparticles 665 chemotaxis 17,234,425–426,442,520
culture ceroid 635,658–659 factors 423,429,442,462,560
effectonp53 576 Cerovive 672,seealsoNXY-059 chickensbreastextract 149
hypoxia-reperfusion 28 cerulein-inducedpancreatitis 671
children 126,168,200,360,367,488,
media 28–29,244,496,598,620,662 cervical 499–500,531,553,555–556,595,
cellcycle 201,203,217,245,249–250, cancer 490,509,531,579,636 638
282,568–569,572,588,593,625, mucus 331 autistic 633
652 CFTR 494,554
irondeprivation 607
arrest 222,644,647 CGD vi,229,331,349,433–434,436,
chilli 176,184,635
checkpoints 202,249,252,569,574 439,442,444,449,552,600
celldeath 212–219 andIBD 434,566 chillinginjury 385,549
chimericSOD 552
Celljournal 317 cGMP,seecyclicGMP
chimneysweeps 584
cellproliferation 138,184,204,236, Chagas’disease 115
402,570,578,seealsocellcycle; chain Chinesehamsterovary(CHO) 28
mitogenic;proliferation propagatingradicals 526 chitosan 681
anddesferrioxamine 692 reaction 5,30,173,259,265,330 Chlamydia 133,412,518
cellwalls 121,381,418,453 termination 265 Chlamydomonas 247,379–381

--- Page 893 ---

838 INDEX
chloramines 31,46,65–66,141,149, 1O2production 374–375 indiet 354
158,224,244,257,265,276,307, O •– production,seeO •– in ineye 388–390
2 2
344,437,441,521,528 chloroplasts inliverdisease 483
evasionof 445 OH • production 376 choline 224,274,629
fromhistidine 66,149 oxidativedamage 245 phosphate 254(struc.),256
fromnicotine 492 proteinsynthesis 382 tetrathiomolybdate 82
incysticfibrosis 555 vitaminEcontent 162 chondrocytes 223,558,560,seealso
inIBD 566 chloropropionicacid 568 cartilage
chloramphenicol 506(struc.) chorea 634(def.)
chloroquine 367,562,564(struc.)
Chlorella 385 choroidlayer 387,390–391,seeeye
chlorotyrosine 66,121,200,276–277,
chloride 361,437–438,702(struc.) chromanring 680
278(struc.),306–307,344–345,348,
channels 204 358,439,492 chromanolring 162,163(struc.)
transport 554 chromatin 213,215–217,238(def.),240,
antibodies 307,345,528
chlorinated 436,498–499,569,580,652
artefactualgeneration 307,346
aldehydes 275,521 Chromatiumgracile 113
inAlzheimerdisease 625
drinkingwater 469 chromatophorecells 393
inARDs 528
HDL 531 chromium 37,97,116,126,214,245,
hydrocarbons 48,567,seealsocarbon
inatherosclerosis 521,524 317,396,491,495,497,498–499,
inautism 633
tetrachloride;chloroform 700(struc.)
IgG 559 5-chlorouracil 242(struc.) picolinate 498
lipids 257,265,275,307,439,441 chlorpromazine 557,568 release 214
α 2-macroglobulin 441,559 chlortetracycline 503(struc.) chromosomes 238,328,569,647–648
proteins 397,439 chlorzoxazone 16 abnormality 125,250,572,574
sterols 521 chocolate 153,177–178,352,527,620 chromosome 2,623–624
chlorine 31,43,65,67,403,437,465, cholangiocarcinoma 346,579 chromosome 4,141,634
487,495,670,697,700(struc.),702 4-cholesten-3-one 625 chromosome 6,135
dioxide 31 cholestaticliverdisease 168 chromosome 7,554
isotopes 698(struc.) cholesterol 16,66,167,170,180–181, chromosome 8,646
monoxide 75 183–184,188,196–197,253,254 chromosome 9,633
radicals 75,121 (struc.),256,258,265,274,308, chromosome 10,224
water 66 338–339,480,517,521,523,527, chromosome 11,119
1-chloro-2,4-dinitrobenzene,seeCDNB 633,658 chromosome 13,136
3-chloro-4-hydroxyphenylacetate 307 artefactualoxidation 331 chromosome 16,137,140
8-chloroadenine 244 dehydroform 269,406 chromosome 19,624
5-chlorocytosine 242,244,323,328 epoxides 268,269(struc.) chromosome 21,125,631
8-chlorodG 328 esters 167–168,268,494,527,530 chronic
chlorofluorocarbon 75 esterperoxides 141,274,333,523, fatiguesyndrome 633
chloroform 48,79,85,112,331,465, 525 granulomatousdisease,seeCGD
467,469,481,602 fedrabbits 522 lymphocyticleukaemia 582
8-chlorodGTP 248 5α-hydroperoxide 74(struc.),265, obstructivepulmonarydisease,see
8-chloroguanine 244 268 COPD
chlorohydrins 66,265,268,333,521 inAlzheimerdisease 628–629 traumaticencephalopathy 628
chloromethane 465 inbrain 601–602,624–625 chronicinflammation 126,133,200,
c c h h l l o o r r o o p p e h r y o l x l i a d , a b se 68 1 , 2 3 1 6 – 9 1 – 2 7 2 2(struc.),375, l m in e o ta le b a o t l e is 5 m 27 andageing 645 2 4 3 9 5 2 – , 2 5 3 1 6 4 , , 3 5 2 1 9 7 , , 3 5 5 5 9 6 , –5 4 6 2 8 6 , –4 5 4 7 4 9 , , 4 5 4 8 6 2 , ,
454 607,636,692,seealsoinflammation;
ratiotovitaminE 168,181,528
inflammasome,pro-inflammatory
bleaching 378–379,382 reactionwith1O2 74
anaemiaof 135,565,607
degradation 456
reactionwithO3 268 andcancer 582–583
radicalcation 371,374–375
reversetransport 530 colon 566,seealsoCrohndisease;
tripletstates 378
synthesis 602 inflammatoryboweldisease;
chloroplasts 4,18,25,33,46,64,
cholesterolcrystals 516–517,520 ulcerativecolitis
71,100,107,118,122,158,162,
asDAMPs 421 injoints 558,seealsorheumatoid
253,299,312,357,385–386,471,
CholesterolLoweringAtherosclerosis arthritis
705,seealsochlorophyll;leaves;
Study 186–187 inliver 567,seealsohepatitis
photosynthesis;plants;thylakoid
membranes cholesteroloxidationproducts 187, inlung 430,496,554
ascorbatecontent 380
233,268–269,308,331,333,388, inpancreas,seepancreatitis
DNA 370,384 515,530,633 inskin 558
electrontransportchain 373,376 inatherosclerosis 523–524 chrysene 491
nuclearsignalling 380 inbrain 602,625 chrysotileasbestos 496

--- Page 894 ---

INDEX 839
chylomicrons 165–168,171,517,526 citrate 10,35,38,39–40,42,46,53,66, Cockaynesyndrome 248,251,646
remnants166–167,517 128,133,135,208,210,264,382, cocoa 177–178,527,seealsochocolate
chymotrypsin 424 501 coelenterate 99
likeproteolyticsites 281 ferric 133,135,208,210,264,382 coelenteramine 143,420
cider 157 citrullinatedproteins 560 coelenterazine 143,319(struc.),321,
cigarettesmoke 21,66,77,121, L-citrulline 54,558 419–420,661
158–159,164–165,177,180–183, CJD,seeCreutzfeldt-Jakobdisease coeliacdisease 566
186–187,189–190,195–197,286, CLA,seeconjugatedlinoleicacids
coenzymeA 105,113,221,614
310,321,324,326,328,337,339, Claracells 463(def.),469,486
glutathioneadduct 105
357,390,393,398,429,443–444, Clark 330,488
465,471,483–484,488,490–496, classBscavengerreceptor 140,seealso radical 414
coenzymeQ 11(struc.),12,136,139,
497,499,509,517–518,530,532, scavengerreceptors
146,154,264,400,402,474,634,
545,549,554,570,577,587,640, clastogenicfactors 557
642,656,661,seealsoubiquinol;
655,670,seealsotobacco Claudius 146
aldehydecontent 492 Clavicepspurpurea 115
ubiquinone;CoQ8;CoQ9;CoQ10
andcadmium 499 cleavageenzymes 455 andageing 657
andglutathione 494 Cleland’sreagent,seedithiothreitol inC.elegans 12,642
andmaculardegeneration 393 clinafloxacin 502 inALS 632
andNrf2 494 clinicaltrials 183–195,605,629, inbrain 605
andParkinsondisease 616,620 663,672,680,693,695,seealso inE.coli 12,642
andsperm 395 epidemiology inFriedreichataxia 633
andvitaminE 493–494 worldsfirst 157 inParkinsondisease 619–620
carcinogensin 491–493 Clinoril,seesulindac inrestenosis 546
effectonocularcarotenoids 393 clioquinol 626(struc.),634,686 mitochondriatargeted 684
ONOO––in 492–493 CLLcells 591 therapeuticuse 673
clk-1 642
RDAforascorbate 493 coenzyme Q-cytochrome c
clofibrate 16,465,587
sidestream 494 reductase 12
clonalexpansion 571,574
skin 498 coffee 64,177–178,185,298,356,535
clorgyline 602
thiocyanate 494 andParkinsondisease 620
Clostridium 7
ciliary
botulinum 55
H2O2levels 355
body 387 pasteurianum 7,79 cofilin 219
neurotrophicfactor(CNTF) 234,598 novyi 7 cognition/cognitive,seealsoMCI
cimetidine 661
clotting,seebloodcoagulation; andproteincarbonyls 627
cinnamicacid 418(struc)
thrombosis function 195,481,531,590,605,622,
Cinnamomumcamphora 87
clozapine 557 627–628,653,656,669
cinnamophilin 174(struc.)
clusterofdifferentiation 428(def.) impairment 177,195,481,625,671
ciprofibrate 587
clusteredlesions 322 tests 598
ciprofloxacin 502
clusterin 233 cohortstudies 180
circadianrhythms 109,144,247,361,
CNTF 234,598CNS,seecentral cold 161,549
647
nervoussystem
acclimationto 385,452
inROSgeneration 109 CO-RMs 549
bloodedanimals 19,640–641,649
cir G cu F l P arl 3 y 1 p 5 ermuted c [C oa o l (N 5 H ,4 3 8 ) 9 4 , C 4 O 95 3] , + 49 4 9 3 hyperoxicshock 399
YFP 310 dusts 495,497 hypoxia 550–551
circulatoryshock 670,seealso fires 488 injury 137,385–386,549
haemorrhagicshock flyash 495 ischaemia 549
cirrhosis,seeliver miners 495 preservation 551
cirsiliol 175(struc.) tar 584 sensitiveTRPA1channel 649
cis 170,255(def.),456 cobalamin 43,413,414(struc.),503 storage 550,553
cis-3-hexenal/nonenal 455 reactionwithO •– 414 stress,plants 385–386
2
cis-3,cis-6-nonadienal 455 cobalophilin 422 Coley 235
cis,cis-1,4-pentadienestructure 454 cobalt 9,37,43,97,126–127,134,226, collagen 3,4,9,14,21,61,106,155–156,
cis-parinaricacid 319(struc.),341 263,413–414,422,496–497,499, 267,346,359,387,402–404,406,
cis-platin 131,133,210,247,509,551, 593,700(struc.) 423,430,440–441,450,480,483,
588(struc.),590,684 cobra-venomfactor 553 516,519,536–538,548,558–559,
andhearingloss 402 cocaine 398,481,484–485,485(struc.), 581,604,653
11-cis-retinal 387,389(struc) 568 cross-linking 407
Citelluscitellus 549 cochlea 61,92,401 inducedarthritis 140,444,562,607,
11-cis-retinol 387,389(struc),390 seealsoear,hearingloss 671

--- Page 895 ---

840 INDEX
collagen(continued) complicatedplaques 516 cooking 56,256,324,344
typeI 441,447 compoundeye 393 oil 252,269,354,369,483
typeII 558,561 conalbumin 128,209 smoke 495
typeIV V440–441 concanavalinA 431 Cooley’sanaemia 135
collagenase 422,424,432,441,517 cones 387–393 co-ordinationsites 693
colon 7,14,167,176,178,180,184, CongoRed 629 COPD 153,219,247,443,490,493,
247,296,327,329,339,354–357, coniferylalcohol 417,418(struc.) 494–495,514,681–683
COPs,seecholesteroloxidation
409,447,481,565,570,580,seealso congenital
products
faeces erythropoieticporphyria 69–70
copper 12,20,25,28,32,38–39,51,
bacteria 25,180,355–356,481,566 hypothyroidism 448
56–57,61,64,78–79,81–85,91,
bleeding 112 congestiveheartfailure,seeheart
97–99,115,125–128,131,133–134,
cancer 127,184,191,193–194,197, failure
138–141,144,148–150,154,156,
251,354,490,531,565,570,574, conjugatebase 705
159–160,173,199,209,215,239,
578–579,581,660 conjugated
241,263,276–277,294,296–297,
epithelium 355,566 dienes 257,258(struc.),330,331,334, 304,355–356,369,379,381–382,
inflammation 92,566,seealsocolitis; 409,482 393–394,401,414–415,417,420,
inflammatoryboweldisease doublebonds 71(def.) 424,495,497,499,502–503,512,
OH • formation 355 linoleicacids 63,331 557,568,581,606,700(struc.)
polyps 251 trienestructure 462 aminoacidcomplexes 664
colony-stimulatingfactors(CSFs) 234 conjunctiva 387 andantibiotics 502
colostrum 400 connectivetissue 4,93,346,402, andcancer 583–585,591
404,426,440–441,516,536, andglycation 537
combustion 22,33,252,489,549,584
cometassay 323,326 538,seealsocartilage;collagen; andLDLoxidation 525–529
glycosaminoglycans ascorbateinteraction 159
commercialkits 89,346
connexins 173,203,572,581 axe 344
common
contact catalytic,seecatalyticcopper;
cold 161
dermatitis 366,404,seealsoskin non-caeruloplasmincopper;
piddock 420 hypersensitivity 676 phenanthroline-chelatablecopper
compartmentalization 78,160 inhibition 200,569,572 chaperoneforSOD(CCS) 81,91,
compensatoryanti-inflammatory contaminationofreagents 97–99,209, 131,219
responsesyndrome(CARS) 548 211,325,435,543–544,561,624, chaperones 131–132,138,379
complement 237,390,423,425–426, 628,seealsoironcontamination chemistry 37–39
430,432,443,553–554,692 ofalbumin 500–501 deficiency 127,131,154
activation 450,541,546,552,556 ofarachidonicacid 458 DNAbinding 238,244
protein,mosquito 367 ofATP 500–501 inagepigments 658
completecarcinogens 584,seealso of catalase, see catalase, inALS 631
cancer;carcinogens contaminationof inAlzheimerdisease 625–626
inatherosclerosis 521–523
complexI 12,14,26,27,61,63,91,105, ofcaeruloplasmin 139
218–219,277,293,369,394,473, ofCRP 237 inbetelquid 494
547,600,612,621,633,642,684, ofcytochromec 88 incardiopulmonarybypass 546
seealsomitochondria offertilizationmedia 394,396 indiabetes 538
in ischaemia-reperfusion
inbipolardisorder 633 ofparenteralnutritionfluids 401, injury 540–541,544
inParkinsondisease 617–621 501
inpriondisease 630
inhibitors 620,seealsorotenone; ofphenol 325
insweat 212
MPTP ofPON-1 530 metabolism 131–132
complexII 12,26,598,612,633,642, ofSOD 139,557,665
non-caeruloplasmin 131,137,212
seealsomitochondria ofxanthineoxidase 15
O
•–-dismutation
38,664
inHuntingtondisease 634 withendotoxin 557,665 ov 2 erload 134,136,154,241,seealso
inhibitors,seeantimycinA; contractilefunction 202,205,295,543, Wilsondisease
malonate;nitropropionicacid 545,547,seealsoheart oxide 394
complexIII 12,26,226,236,369,612, contrastmedia 287,450,496,681 pans 159
633,642,650,seealsomitochondria convicine 366(struc.) phenanthrolinecomplex 689
inHuntingtondisease 634 convulsions 18,20 placentaldeliveryof 397
complexIV 12,26,612,650,seealso Conyzaboriensis 385 releasebyoxidativestress 208–211
cytochromeoxidase;mitochondria co-oxidation 454,459 roleinlipidperoxidation 263,
complexV 26,277,612,seealso cookedfood 338,354,526,535,537, 525–529
mitochondria 584,660,seealsomeat;redmeat transporters 136,589,652

--- Page 896 ---

INDEX 841
copperchelators 136,149,212,522, COX-1 178,458,484,490,547 crystallins 386–387,391–392,536,607,
538,590,626,632,686 COX-2 169,178,223,226,356,458,502, 653,seealsoeye;lens
coproporphyrin 404 520,538,562,583,602,608,617, glycationbyascorbate 387,392
coproporphyrinogenIII 63,69(struc.), 680,694 CS-045 675(struc.)
403,413 andPBN 672 CSA/CSB 248,251
oxidase 8,69,221,413 inALS 632 ctl-1 642
CoQ8 /CoQ9 12,642,seealso inbrain 597,617,619,625 CTP 103
coenzymeQ incancer 578,582,587 Ctr1 131,589
CoQ10 187,527,619,632,656,684, ingastrointestinaltract 356 CTRF 359,554
seealsocoenzymeQ inradiation 508 CuII(atsm) 664,690(struc.)
andlifespan 656 inrheumatoidarthritis 560 cucumber 381,455
coral 149–151,386 COX17 131 cumenehydroperoxide 35,108–109,
corn 162,393 Coxsackieviruses 124,636 113,207,265(struc.),342,458
cornea 5,136,386–394,402,seealsoeye CP20,seedeferiprone cumylalcohol 265(struc.)
corneocytes 402,406,seealsoskin CP94 690 CUPRACassay 350,352
coronaryarteries 231,516,521,523, CpGislands 579 Curcumalonga 175
539,543–546 CPI-1429 667(struc.),672 curcumin 108,174(struc.),175,
atherosclerosis 186,188,542,550 CR-6 676(struc.) 178–179,184–185,628,661,680,
bypass 186 Cratoxylumcochinchinense 179 683
revascularization 186–187 creatine 632,634 inAlzheimerdisease 628
sinusblood 290 creatinekinase 63,96–97,213,306,408, oxidationproducts 178
stenosis 187–188,546 627,653 cuticle 307,344,448,475,509
coronaryheartdisease 143,153,177, creatinine 324 CuZnSOD 37,61–62,79–85,87–88,89,
180–198,490,545,seealsoheart; crematoria 33 91,94,99,105,118,125,131,133,
cardiovasculardisease creosotebush 179,678 138,154,219,221,302,358,379,
Creutzfeldt-Jakobdisease 612,629 382,451,475,478,483,610,651,
corpusluteum 170,395
Criegeeintermediates/ozonides 75 661,665
corrin 413,414(struc.)
cristae 12,seealsomitochondria anddeprenyl 617,650
corrodedmedicalimplants 443
Crithidiafasciculata 113,417 andethanol 483
corroles 666,668,670
crocidolite 496–497 andhearing 401
Cotesiaglomerata 455
crocin 350 andlifespan 650,657
corticosteroids 16,19,504,541,562–563
crocodiles 19,161 andONOO– 486,631
cortisol 504,541,563(struc.) Crohndisease 565–566 andradiation 508
cosmetics 158,403,406,505
cross-links 132,615,642 antibodiesversus 556
cosmeticsurgery 403,406
DNA-DNA 322 asallergen 358
cosmicrays 698
DNA-protein 240,322 glycationof 537
cotton 175,385,495 ofproteins 266,362,392 inALS 631–633,634
cough 469,492
oftyrosineresidues 415 inAlzheimerdisease 625–627
o-,p-coumaratehydroxylase 418
cross inasthma 358
p-coumarylalcohol 417,418(struc.)
culturalstudies 180,182 inataxiatelangiectasia 576–577
p-coumaricacid 418(struc.)
presentation 441 inbrain 600,603
coumarin 418 sectionalstudies 180 inC.elegans 651,657
7-boronate 315(struc.) crotonoil 572 incancer 574,576
3-carboxylicacid 297(struc.) Crotontiglium 572 indiabetes 398,534,537
glycosides 418 crotonaldehyde 491 inDownsyndrome 92,125
hydroxylation 296 crownethers 45–46 inDrosophila 657
covalentbonds 21,42,81,465,489, CRP 236–237,348,517 indwarfmice 652
702–705
andageing 652 inerythrocytes 360–361,363
COX 37,61,178,260,267,308,426, contaminationof 237 ineye 391
456–462,464,512,521,540,587
inatherosclerosis 517 inFanconianaemia 577
inageing 642 inexercise 409 infoetallung 399
inatherosclerosis 520 cruciferousvegetables 185 inhepatitis 568
incancer 585 crustacea 85,505,509 inIBD 566
inhibitors 184,458,562,seealso cryptochromes 247 inischaemia-reperfusion 539–553
aspirin;celecoxib;NSAIDs Cryptococcusneoformans 119,151,439, inmalaria 368
peroxidaseaction 565 445 inMDMAtoxicity 484
peroxidetone 459 cryptoxanthin 169(struc.),605 inmultiplesclerosis 607
usetoassayperoxides 332,337 crystalviolet 213 inmuscle 409

--- Page 897 ---

842 INDEX
CuZnSOD(continued) cyclopentenonecompounds 230,261, cytochromes 9,12(def),143,157,294,
inneonates 401 267–268,635 339,398,484,506,512,551,584,
inParkinsondisease 617–618 cyclopentenoneIsoPs 274,334,460, 587–588,600,602,675
inparacetamoltoxicity 486 608 andspintraps 672
inphagocytes 442 cyclopentenoneprostaglandins 457, b-fcomplex 371,373
inplacenta 397 460–461,520,632,684 b-type 14,127,432,434,445
inplants 384–385 cyclophilinD 13,208,626,684 infoetus 398
inpriondisease 630–631 cyclophosphamide 210,395–396,483, inplacenta 398
inseminalplasma 395 592,681 stimulationoflipidperoxidation 262
insenescence 648 cyclosporin 13,208,544,684 cytochromec 11,12,26,33,40,46,60,
instroke 609 instroke 610 87–90,120,133,157,217–219,264,
intestes 394 CYPMPO 289(struc.) 299–300,311,320,333,376,381,
intransplantedhearts 550 cystamine 634 490,507,512
inactivationbyH2O2 43,379 cystathionine 197 andmitochondriallytargeted
inhibitors 684
inhibitors 81,480,590 cystatin 424
interactionwithcardiolipin 218
interactionwithquinones 476 cysteamine 50,508
interferencewithDCFHDA
isoenzymes 82 cysteicacid 72
assay 317
knockout,seeknockoutmice, cysteine 16,24,33,42,43,49–54,60, peroxidase 119–120,122,221,311,
CuZnSOD 65–66,71,72(struc.),76,82,97,
411,415
nitrationof 62,486,631 100–102,103,104–105,112–113,
release 201,208,253,592
overexpression 91–92,603,657 135,137,141,150–151,197,221,
SODcontaminationof 88
periplasmic 91,436 275,343–344,359,380,391,411, cytochromeoxidase 1,11,12,14,23,
peroxidasereactions 43,631 437,482,486,490,517,521,600,
25,26,37,53–55,63,78,88,93,131,
recombinant 400,665 624,635,637,655,661,682–683
202,206,299,545,548–549,579,
CX-659S 676(struc.) andp53 576
626
CXCR3 518 conjugates 473
andageing 654
cyanamide 118,480–481 glutathionedisulphide 105 cytochromesP450 3,15–17,24,28,36,
cyanate 494,531,558–559 inplasma 101 54,61,94,106,133,167,184,202,
cyanide 4,26,56–58,81–82,84–85,87, neurotoxicity 604,615 264,292,321,365,411,455,458,
89–90,118,120,138,179,414,465, oxidation 344,680 463,466,476,544,551,600,652,
494,568,598
placentaldelivery 397 672
cyanine-basedprobe 347
protein-SH 343 actionontocopherols 164,167
cyanobacteria 1,4,79,115,122,375
proteinases 206,280,424,594 CYP1A1 16,272,403,584
cyanocobalamin 414
richproteins 137,406–407 CYP2A5 229
cyanosis 25,361
richregionsinPKC 224 CYP2B 16,27
cyanuricacid 200,245–246
sulphenicacid 108–109 CYP2D6 463,602
cycads 18,584,617
sulphinicacid 43,109 CYP2E1 16,27,111,265,272,465,
cycasin 584
thiylradicals 43,50,108,221,231,
467,476,480–483,484,544,551,
cyclic 473 577,602
AMP 223–224 transport 102,621 CYP2F2 486
electronflow 378 CYP3A4 16,185
cysteinyl
GMP 53 CYP4F2 167
DOPAs 150(struc.),151,618
hydroxylamines 292,299 CYP7A1 268
dopamine 600,615,618
peroxides 259,262,268,331–332 CYP11 16,17,19,46
glycine 103(struc.),348,603
polyamines 669 CYP26 620
leukotrienes 425
cyclins 282,569,588,692,seealsocell CYP27A1 269
cycle tyrosine 414–415,420 inlipidperoxidation 265
dependentproteinkinases 569 S-cysteinylglycylation 348 inhibitionbyNO • 54,55
kinaseinhibitor 573 cysticfibrosis 172,393,477,511, leakyforms 17,465,482
8,5
(cid:3)
-cyclo-2
(cid:3)
-deoxyadenosine/
554–556,681
peroxygenaseaction 265
guanosine,seecyclodA,cyclodG transmembraneconductance cytoglobins 8,55
cyclobutanepyrimidinedimers 245, regulator,seeCTRF cytokines 54,78,85,92,130,142,
405(struc.) cystine 42,72,100–103,680 144,206,215,221–223,225–226,
cyclodA/dG 240,242(struc.),248, inbrain 603 228–229,231,234(def.),234–236,
251,324–325,653 placentaldelivery 397 267–268,358,397,404–405,415,
cyclodopa 150(struc.) plasmalevel 101 421–422,424,426–427,429–430,
cyclooxygenase,seeCOX transport 102 432–433,435–436,441–443,446,
cyclopentane 456 cytidine 42 448–450,468,480,508,511,

--- Page 898 ---

INDEX 843
513–514,518–520,532–533,548, DAMPs(damageassociatedmolecular instroke 610
551,553,555,559–560,562, patterns) 109,215,235(def.), reductase 106,113,157,160,357,
566–567,582–583,602,606, 406,408,421(def.),423,425–427, 362
610–611,620,636,639,seealso 430–431,436,441,443,452, 7-dehydrocholesterol 269,406
specificnames,e.g.IL-1;IL-6; 466,468,480–481,486–487,492, dehydromethionine 65(struc.),307
TNF-α;TGF-β 496–497,501,508,511–513,517, dehydrozingerone 174(struc.),176
andageing 642,652 520,533,541,547,550–551,
Deinococcusradiodurans 87
andHIV 637–638 553,556–557,561,582,588,603,
delayedpreconditioning 547
andPBN 672 608–610,614,620,625,636,652
dementia 153,195,197,410,605,617,
fromadiposetissue 532 DanePy 308(struc.)
622(def.),633,635,673,seealso
inbrain 597 dansylchloride 347
Alzheimerdisease
incancer 581 dapsone 364,365(struc.),366,406
pugilistica 628
cytomegalovirus 518,638 databaseofageinggenes 641
withLewybodies 615,622
cytosine 42,236,238,240(struc.),244, dativecovalentbonding 702–3(def.)
Demerol 617
246,323,404–405,466 dauerlarvae 641
demethoxyubiquinone 642
arabinoside 588,590 daunomycin 589(struc.),591
demyelination 607,633
deamination 238 daunorubicin 589(struc.),591–592
dengue 367,638
dimers 404,seealsocyclobutane daunosamine 591
pyrimidinedimers DBNBS 289(struc.) DenhamHarman 649
glycol 239,242(struc) DCFHDA/DCF 316–317,318(struc.) denitration 62,306
nucleoside 246 DCMU 382,383(struc.) denitrosylatingenzymes 54
cytoskeleton 62,206,224,361,365,445, DCT 150 densegranules 450
595,609 DCT1 127 dentalplaque 7,558
assembly 204–205 DcytB 127 dendrimers 681
inphagocytes 433 ddC/ddI 637 dendrites 595,597
nitration 566 DDT 112 dendriticcells 421,427,440–441,443,
proteins 106,206,seealsoactin deSaussure 252,330 446
cytotoxicaldehydes 75,126,232, de-acetylation 233,646,seealsosirtuins deoxy-J2-isoprostanes 467
270–274,328,355,368,466,487,
de-epoxidation 378–379 deoxyJ1-phytoprostanes 369,371
502,seealsoacrolein;HHE;HNE; deamidation 614 (struc.)
lipidperoxidation deamination 238,242,246–247,322, 2-deoxyadenosine 237
D 325,328,405,442,489,558, deoxyadenosylradical 413
578–579,614 5 (cid:3) -deoxyadenosylcobalamin 414
d-block 36,701 death (struc.)
delectrons 697(def.) effectordomain 217 2-deoxyguanosine 237(def.)
d-orbitals 697,701 inducing-signallingcomplex deoxyhaemoglobin 55–56,360,seealso
15-D2c-IsoP 460 (DISC) 217 haemoglobin;oxyhaemoglobin
D-ringIsoPs 267–268 receptors 217–219,422 deoxyribonucleoside
D1-phytoprostanes 369,371(struc.) debrisoquine 463 diphosphates 412(struc.)
D-Romstest 329 decarbonylation 346
deoxyribonucleotides 411
D2-isoketals 261(struc.) decadienal 270
2-deoxyribose 42,50,236–240,264,
D2-isoprostanes 261(struc.),334 decanal 270
272,338,411,499,507,515,577,
D4-neuroprostanes 368 decidualcells 223
593,662
D1protein 370,373–374,375,381–382, decoyadhesionmolecules 694 assay 296,299
385 DED 217
degradation 322–323,435
D2protein 370,374 defensin 433
Febinding 299
D90A 84,631 defensiveperoxidases 417,440 DEPMPO 287–293,288(struc.),490,
DABCO 71,73(struc.),308,439 deferasirox,seeexjade
684
Dactyliumdendroides 85 deferiprone 129,392,689(struc.),690,
DEPPEPO 289
DAF-2-diacetate 304(struc.) 693
deprenyl 602,619(struc.),661,663
DAF-2-FM 304 deferoxamine 688, see also
andantioxidantdefences 617
DAF-2 641–643,651,657,659 desferrioxamine
DAF-16 641,643,647,651,659 deglutathionylation 106,109 andlifespan 650
daflon 673 degueline 619 depression 68,365,403,504,602,633
DAG 224,535,537,547 1,2-dehydro-N-acetyldopamine 475 andNAc 633,681
daidzein 174(struc.),175,178 dehydroalanine 125(struc.) depurination 245–248,578,585
Dakin 276 dehydroascorbate 33,36,100,114–115, dermatitis 366,404,seealsoskin
damage-accumulationtheoriesof 122,144,156(struc.),157,159–161, dermatophytes 402
ageing 641–642 304,357,362,604 dermis 402,404,407,seealsoskin

--- Page 899 ---

844 INDEX
(cid:3)
desferal 688 2,6-di-tert-butyl-4-(4-methoxyphenyl) dibromoethane 112,468
desferrithiocin 692 phenoxylradical 350 dibromotyrosine 278(struc.)
desferrioxamine 39,42,46,133–134, di-μ-oxobridge 374 Dicerosbicornis 134
136,160,209,295,316,326,368, diabetes 92,104,108,119,132,135, dichlorodimedon 307
384,402,408,468,471,478,487, 141,146,153,159,183,186,188, dichloroethane 112
503,512,522,594–595,601,621, 194,203,226,231,296,321,328, dichloromethane 465
661,664,686,688(struc.),691–692 387,391,398,407,410,478,481, dichlorophenolindophenol 27
andbrain 606,611 483–484,517,520,522–523,531, 2,4-dichlorophenoxyaceticacid 587
andHIF 692
532–539,543,545,548,551–552,
3,5-dichlorotyrosine 66,278(struc.),
andParkinsondisease 620 556,581,628–629,642,644,646, 307,344
high-molecular-massforms 691 671–673,680,682,684,691,694 dichromate 498
inARDS 553 andAlzheimerdisease 626 diclofenac 562,563(struc.),565
inCl2toxicity 487 andaminoadipicacid 539 dicoumarol 472(struc.),473–474
incysticfibrosis 555 andcancer 578–579 Dictyosteliumdiscoideum 231
indiabetes 533 andcardiovasculardiseases 484, dicyclohexyl-18-crown-6 45,46(struc.)
infiresmoketreatment 495 522–523 1,4-dideoxy-5,6-glucosone 536(struc.)
andcatalase 479,533,535
inischaemia-reperfusion 542, dideoxycytidine/inosine 637
544–545 a
an
n
d
d
O
iro •– n
5
4
3
7
5
8
,
,
5
5
3
3
7
3
–
,
5
6
3
6
8
0 dieselexhaust 495–496,497,seealsocar
inkidney 550 2 exhaust
andthioredoxin 533
inmalaria 369 diet 153,256,285,324–325,329,331,
cataract 538
inorganpreservationfluids 552 333,338,482,566,570–571,605,
geneticpredisposition 533
andParkinsondisease 620 627,seealsocaloricrestriction;
nephropathy 149,538,694–695
inrheumatoidarthritis 565 cruciferousvegetables;food;
neuropathy 144,539,635
inshock 547 fasting;fat;fruits;recommended
plants 377,380
inskin 552 dietaryallowance
roleofCu 538
instroke 610 andAlzheimerdisease 628–629
roleofSe 534
manganese 546,664 highfat,seehighfatdiet
retinopathy 532,534,538
desmin 61 Mediterranean 183,187
vitaminEand 533–534,539
d D e e s s s u i l c p a h t o io ar n cu 3 lu 86 s , b 5 a 0 a 9 rsi 90 diabetogenicdrugs 477–478,533 o p x h i e d n i o ze l d co l n ip te id n s t i 1 n 75 2 – 6 1 6 7 , 8 354,526
DIABLO 217–218
Desulphovibriovulgaris 7,90 phytoprostanes 354
diacetyl bis (N(4)-
DETA 57(struc.) questionaires 195
methylthiosemicarbazonato)
DETAPAC 40,46–47,60,312,478,594, Cu(II),seeCuII(atsm) recalls 182
686,687(struc.) dietaryantioxidants 151,180–188,199,
diaciddiamide 592,593(struc.)
detergents 64,85,133,259,266,483, 356–357,660
diacylglycerol,seeDAG
496 andstroke 610–611
diallylthiosulphinate,seeallicin
peroxidesin 64 dietarysupplements 160,182–183,187,
dialuricacid 477,478(struc.)
deubiquitinatingenzymes 282 322,331,359,378,488,660
dialysis 131,141,161,186,209,443,
deuterated andexercise 409
450,470,501,551,691
PUFAs 696 OH • generation 355
andamyloidosis 629
α-tocopherol 164 encephalopathy 501,628 N,N-diethyl-p-phenylenediamine 329,
tyrosine 306 679(struc.)
membranes 325
deuterium 164,257,286,306,326,696, diamine diethyldithiocarbamate 81(struc.),85,
698 91,303,480,656
oxidase 419,452
oxide 67,309,698 transporter 470 diethylenetriaminepenta-aceticacid,
Devonianperiod 5,6 4,6-diamino-5-formamidopyrimidine, seeDETAPAC
Dewarvalenceisomers 405(struc.) seeFapyA diethylstilboestrol 151,244
dexamethasone 562,563(struc.) 2,6-diamino-4-hydroxy-5- diferric
dexrazoxane,seeICRF-187 formamidoprimidine,see oxygencluster 411–412
dextran 691 FapyG peroxide 130
sodiumsulphate 92,566 diaminoanthroquinone 304 diffuseplaques 622
dGTP 237(def.),238,248 diaminobenzidine 300,310,312 diffusion-controlledrate 42
DHETs 458 2,3-diaminonaphthalene 305 diflunisal 563(struc.)
5,12-DHETEs 462 o-dianisidine 120 diformazan 47
DHR 123,302,320,662 diapedesis 423 Digeneasp. 599
di(4-carboxybenzyl)hyponitrile 45 diaphragm 408,554 digits 551–552
di-(2-ethylhexyl)phthalate 587 dicarbonyls 538 dihydrobiopterin 54,158,501
di-Fe(III)O 130 dicarboxylatecarrier 102 dihydroethidum 299,320,684

--- Page 900 ---

INDEX 845
dihydrofolatereductase 588 5-(2,2-dimethyl-1,3- diphenylhydantoin 398,557
dihydrooroticaciddehydrogenase 12 propoxycyclophosphoryl)-5- diphenylisobenzofuran 71,74(struc.),
dihydropropidium 320–321 methyl-1-pyrrolineN-oxide 289 308,459
dihydropteridinereductase 501 (struc.) diphosphatidylglycerol 254(struc.)
dihydropyridinedicarbaldehydes 340 dimethylbenzanthracene 16,570 Diplocardialonga 420
(struc.),658 dimethylbenzimidazole 414 diprivan 673
dihydrorhodamine,seeDHR dimethylfumarate 607 diquat 383–384,383(struc.),393,470
N-dimethylglycinate 674 directinhibitorofapoptosisprotein
5,6-dihydrothymine 242(struc.)
1,2-dimethylhydrazine 586 bindingproteinwithlow
5,6-dihydrouracil 242(struc.)
dimethylnitrosamine 585(struc.) pI 217–218
5,12-dihydroxy-6,8,10,14-
5,5-dimethylpyrroline-N-oxide,see dirigentproteins 419
eicosatetraenoic acid
DMPO diselenides 683
461–462
dimethylselenide 124 disintegraseenzymes 422,424,624
dihydroxyacetonephosphate 111 dimethylsulphoxide 14,16,42,45,59, dismutation 38,45,46(def.),47,48,80,
dihydroxyaciddehydratase 20,96 97–98,280,296–297,434,478,481 116,121,172,300
1,2-dihydroxybenzene- assubstrateforMSRs 280,296 disposablesomatheory 642,645
3,5-disulphonate 299 forOH • measurement 298,384 disproportionation 120,122,158,160,
(struc.) infiresmoketreatment 495 293,505
2,3-dihydroxybenzoate 294(struc.), inischaemia-reperfusion 542 disulphidebonds 21,50,100–101,
464,499,688,692 dimethylthiourea 296,553 220–221,225,231,233,275–276,
inrheumatoidarthritis 559,565 dimethyltyrosine 684 358,402,490,541,624
2,5-dihydroxybenzoate 294(struc.), dimolemission 307 disulphiram 81,118,480(struc.)
464,499 dinitrogen disuseatrophy 408
3,4-dihydroxybenzoate 294,298 pentoxide 488 5,5 (cid:3) -dithiobis(2-nitrobenzoicacid),see
para- tetraoxide 31,489 Ellmanreagent
hydroxybenzylideneimidazolidinone trioxide 31,53–54,56,173,244,300, 1,2-dithiolane-3-pentanoicacid 144
421 302,304,579,588,636 1,2-dithiole-3-thione 184,185(struc.)
(cid:3) (cid:3) 2,4-dinitrophenol 26,686
6,7-dihydroxybergamottin 185 dithionite 302,306
2-4-dinitrophenylhydrazine,seeDNPH
3,4-dihydroxycinnamicacid 418 dithiothreitol 52(struc.),233,280
dinitrophenylhydrazones 335
(struc.) dityrosine,seebityrosine
5,6-dihydroxycytosine 239,242(struc.)
2,3-dinor-5,6-dihydro-15F2t-IsoP 260
diuron,seeDCMU
(struc.),267,334
dihydroxyfumarate 90,126 divicine 366(struc.),368,477
5,6-dihydroxyindole 150(struc.)
2,3-dinor-15F2t-IsoP 260(struc.),267
diving 18,210,550
1,4-dihydroxynonanemercapturic d d i i n od or e i a s r o r p a r y o d st e a t n ec e t s io 3 n 70 333 DJ-1 391,618,621–622
acid 336,354 diol DMEM 28,29,98
3,4-dihydroxyphenylacetaldehyde dehydratase 413 DMPO 84,287–283,288(struc.),299,
602 epoxides 587 365,476,490,555,632,669
DNAadducts 293
3,4-dihydroxyphenylaceticacid,see diosmin 673
DOPAC dioxetanes 71–72,307,309,321, proteinadducts 293
dihydroxyphenylalanine,seeL-DOPA 419–420
reactionwith1O2 292
DMPO-OH 289–281,290(struc.),662
5,6-dihydroxyuracil 239,242(struc.) dioxin 185,348
reactionwithO
•–
289,292
1,25-dihydroxyvitaminD3 406 dioxolane-isoprostanes 262
reactionwithOH
2 •
289
3,5-diisopropylsalicylate 664 dipalmitoylphosphatidylcholine 358
reduction 292
2,3-diketo-L-gulonicacid 156(struc.), dipeptidases 103
362 diphenols 47,173,299,469,471–477, DMSO,seedimethylsulphoxide
677 Dmt,seedimethyltyrosine
dilantin 398
2,5-diphenyl-3,4-benzofuran 350 DMT1 127,478,618
dilatedcardiomyopathy 679
1,1-diphenyl-2-picrylhydrazyl,see DNA 128,236–238
dimanganese-tyrosylradical 412 DPPH ancient 238
dimedone 348 diphenyl-1-pyrenylphosphine 332,333 artefactualdeamination/
2,3-dimercapto-1-propanol 497 (struc.),342 oxidation 325–326
3,4-dimethoxybenzylalcohol 418 9,10-diphenylanthracene 308,439 asantigen 556–557
(struc.) diphenyldisulphide 365(struc.),366 chargetransfer 239
NG,NGdimethyl-L-arginine 55(struc.) diphenyleneiodonium 24,432,433 chloroplast 370,384
5,5-dimethyl-1,3- (struc.),445 cross-links 240,322–323,588,591
cyclohexanedione 348 non-specificity 432–433 deamination 322,325–326,356
1,2-dimethyl-3-hydroxy-pyridin-4-one, diphenyletherherbicides 382 DMPOadducts 293
seedeferiprone 2,5-diphenylfuran 439 doublehelix 238,247,249,591,646

--- Page 901 ---

846 INDEX
DNA(continued) docosahexaenoicacid 196,253–254, DsbA 107
doublestrandbreaks,seedouble 257,259,267,270,334,401,456, DT-diaphorase 146,474
strandbreaksinDNA 527–528,558–559,601,604 DTNB,seeEllmanreagent
fragmentation 217,323 inbrain 401,610,628–629 ductusarteriosus 399
gyrase 502 ineye 388 Dulbecco’smodifiedEagle’smedium,
laddering 214–216 insperm 394 seeDMEM
ligase 203,249 dolichols 615,618 Dunaliella 378
metalionbinding 238,244 dolor 425–426 duodenum 127,131,157,161,171,567
methylation/demethylation 3,247 dolphins 134 DUOXenzymes 202,222–223,314,
negativechargeof 238 domoicacid 568,599 355,358,367,415,433,446–447,
oxidativedamageto 442,534, L-DOPA 24,126,150,244,277,278, 449–450,477
seealsooxidativeDNAdamage 344–345,387,474(struc.),600,614, ingastrointestinaltract 354–357
photolyase 247,382,411 616–617,620–621,625 inrespiratorytract 358–360
reactionwithOH • 557 DOPAquinone 474(struc.) Dupuytrencontracture 552,693
reactionwithONOO– 296,556 DOPAC 602 dusts 402,495
reactionwithO •– 556 dopachrome 150(struc.) dwarfmice 644,652,660
2
reactionwith1O2 214 tautomerase 150
E
reactionswithRCS 66,328,437 dopamine 24,46,90,126,156,316,459,
reactionswithRNS 328 474(struc.),475,482,503,596,598, E ◦(cid:3) 2–33,38,40,43,48–50,66,107,148,
repairofradicalsbyGSH 247 600,602,606,614,616–617,621, 257,471
replication 240,570,588,591 625 15-E2t-IsoP 268,460
spontaneousbreakdown 238 cysteineconjugates 600 E-ringIsoPs 267–268
tandemlesions 240,246 GSHconjugates 600 E1-phytoprostanes 369,371(struc.)
DNA-aldehydeadducts 248,271–272, β-hydroxylase 37,156,604 E.coli12,14,18,20,25,27,28,29,
328,336,354,480–481,515,584 oxidation 615,618–620 37,64–66,78,80,85,87,89,91,
DNA-dependentproteinkinase 250 transporter 617 96–98,101,106–108,116,120,123,
DNApolymerase 203,238,245–251, dopaminergicneurons 596,620 129–130,133,199,202,220–221,
275,283,569,580,638,648,seealso dopaquinone 150 233,247–248,250–252,275,280,
polβ,polγ dorfin 612 300,309–310,357,412–413,436,
errorsby 246,250 dorsalhorn 635 439,444–445,471,502,508,566,
mitochondrialform 245,251,638, double-blind 189 641,647
650 double-strandbreaksinDNA 247, coenzymeQ 12,642
DNArepair 66,78,155,203,217, 250–251,507,508,569,573,591, GSHuptake 104
229,240,243,247–252,275,322, 593 H2O2levels 28,64,220
324,326,353,355,382,404,406, repair 251,seealsoDNArepair paraquattoxicity 470
409,478,497,499,570,573–574, Downsyndrome 92,125,148,195,321, O •–level 28,300
2
576–577,582,588,601,606,644, 576,603,605,622,624,628 useofnitriteandnitrate 357
652 doxorubicin,seeadriamycin E2-isoketals 261(struc.)
andageing 646,655 doxorubicinol 589(struc.),592 E2-isoprostanes 261(struc.),334
andcaloricrestriction 651 doxycycline 503(struc.) E4-neuroprostanes 268
baseexcisionrepair 248–252,271, DP-b99 610 E3ubiquitinligase 219,227,282,574,
325,328,575 DPI,seediphenyleneiodonium 612,616–617
effectofCo 499 DPPH 349–350,351(struc.),352 EAE,seeexperimentalautoimmune
effectofNi 498 Dps 129–130,220 encephalomyelitis
inautoimmunediseases 557 dragonflies 5,394 ear 61,252,280,401–402,590,600,
incancer 575,578–580 Drosophila 17,64,82,91,94,101, seealsocochlea;hearingloss
inmitochondria 245,250–251 107,119,122,202,222,247, earlyaggregates 625,634
insmokers 494 280,313–314,355,447,471,501, Earth 369
inborndefectsin 251–252 640–641,654–659 Earth’scrust 110,501
mismatchrepair 247,249,251,499 andageing 653 earthquakes 329
nucleotideexcisionrepair 248–252, andγ-GCS 657–658 earthworms 420
271,325,329,405–406,575 haemocytes 446 EasterIsland 281
transcription coupled H2O2levels 314 eatmesignals 215,427,430
repair 248–249,251 lifespanstudies 657–658 eauoxygénéé vi
DNAstrandbreakage 60,238,243,247, proteasomeandageing 655 ebselen 402,539,666(struc.),683,685,
250,322–324,473,478,507–508 drought 377,385–386 694
inphagocytes 442 drusen 390,629 effectonNOX 694
DNAtumourviruses 573 dryeye 391 instroke 610
DNPH 346,366 Dsb 106 mitochondriatargeted 684

--- Page 902 ---

INDEX 847
EBV,seeEpstein-Barrvirus paramagnetic(spin)resonance,see endocytosis 128,223,256,281,287,
EC-SOD,seeextracellularsuperoxide ESR 316,496,624,691
dismutase shell 697,699 endometrial 223
echinenone 169(struc.) transfer 41,172,411 cancer 475
ecstasy 484,568,seealsoMDMA transport 91,245 endometriosis 398,583,636
ectodomainshedding 424 electronleakage 225,650,652 endonucleases 154,250,323–324
eczema,seealsodermatitis,skin 68 fromchloroplastelectrontransport IV 220
edaravone 402,548,610,632,667 chain 376 G 620
(struc.),680 fromCYPs 17,465,482 endoperoxides 71,72,74,308(struc.),
EdmundStone 562 electrontransportchains 12,14,64, 350,368
EDRF vi,54,58,60,158,535 122,511,591,642,684 endoplasmicreticulum 15,27,52,
EDTA 15,39,42,46,60,89,98,264,324, backingupof 549 90,96,99,101,105–106,108,
396,478,592,593(struc.),594,664, inbacteria 14 111–112,118,142–143,155,160,
687 inchloroplasts 373,376–377 201,204–206,218,233,264,266,
likediaciddiamide 593 inendoplasmicreticulum 14,96 276,280,309,313,415,466,473,
EETs,seeepoxyeicosatrienoicacids inmitochondria,seemitochondria, 486,505,554,585,599,615
efferocytosis 215,427,430,443,492 electrontransportchain ascorbatesynthesisin 155
EGCG,seeepigallocatechingallate inplasmamembrane,seeplasma Ca2+metabolism 204–208
EGF 223,225,234,568,639 membraneredoxsystems GSH/GSSGratio 99,101,105–106,
receptor(EGFR) 222,224–225, inhibitors 382–383,seealsoantimycin 309
572–573 A;cyanide;rotenoneetc. oxidoreductase,seeEroproteins
elastase 65,237,358,422,424,433,436, electronegative 702–703 endoplasmicreticulumstress 65,218,
441,477,488,496,553,555,680, 233,266,272,275–276,480,535,
electronic
seealsomacrophageelastase 554,614,629
cigarettes 493
roleinphagocytekilling 433, andapoptosis 218
configuration of the
435–436,493 inplacenta 398
elements 700–703
elasticfibres 65,358,553 endosome 45,128–129,201,441
electrophile 230(def.),268,475,484,
elastin 65,140,346,402,441,488,516, endosymbiotic
584,587,589
519,548,581 dinoflagellates 386
responseelements 230
eicosanoids 15,112,206,266–267, theories 106,253
electrophoresis 82,84,seealsogel
270,332,338,421,432,442, endothelialcells/endothelium 18,54,
450,456–462,561–562,566,597, electrophoresis
65,102,141–143,158,177–178,
electroporation 257,512
599,608,614,seealsoCOX; 222,226,231,235–236,266–267,
electropositiveelements 702
leukotrienes;prostaglandins 272,307,358,421,423,428,
electrostaticfacilitation 81–82,86
andHIV 637 430,440–442,448,460–462,517,
elephants 161,170
inALS 632 520–521,532,538–539,544–546,
elesclomol 589(struc.),591
instroke 608–611 548,551,598–599,681,694,seealso
ELISA 148
synthesis,effectsofnitricoxide 462 eNOS
Ellmanreagent 343(struc.),345,347
eicosapentaenoicacid 196,257,259, contractingfactors 267
267,334,456,629 elongation 386 dependentvasodilation 158,535,
eicosatetraenoicacid 456 factors 275,376,413 seealsoEDRF
electrochemical offattyacids 361 glycosaminoglycans 443
detection 293,298,302,322–324,345, embryos 94,104,144,165,267, humanumbilical 223
350
396–398,415,482,484,641,seealso
progenitorcells 553
gradient 12,seealsoelectron teratogenesis endothelialdysfunction 349,552,625
transportchains;mitochondria embryonic andageing 653
electrodes death 398 endothelin 223–224
forH2O2 310,312 development 202,215–216,394,396 endothelium-derivedrelaxingfactor,
forNO • 303 fibroblasts 575 seeEDRF
forO •– 300,312 malformations 398 endotoxin/endotoxicshock 54(def.),
electrod 2 epotentials 32–34,seealsoE ◦(cid:3) stemcells 28,79 90,95,116,141,143,226,228–229,
electromagneticradiation 285 emphysema 65,358–359,441,488,490, 235–237,267–268,301–302,312,
electron 21,697,seealsohydrated 492–493 354,393,395,409,425–426,428,
electrons EMPO 288(struc.),289–290 432,458,471,480–481,483,508,
delocalization 25,170,172,287,343, enalapril 449 541,543,547,606,664,671
383,488,704 encephalopathy 501,605,seealso andethanol 480,483
in-boxesnotation 702 dialysis contaminationofcatalase/SOD
microscopy 149,384,423 endarterectomy 212 116,312,557,665
migration 276 endocrine 19,503 tolerance 95,235,237

--- Page 903 ---

848 INDEX
ene epirubicin 589(struc.),592 erythroleukaemia 128,573
diol 377 epithelial/epithelium 518,570,581 erythropoiesis/erythropoietin 9,123,
reaction 71–72 cells 18,54,64,204,243,301,335, 128,135,140,349,362,400,499,
energyutilizationinhumans 13 356,358,386,421,427,430,440, 568,692
energymetabolism 9–10,12–14,598, 447,554,569–571 erythropoieticprotoporphyria 69
632 mesenchymaltransition 581 ESerosS-GS 676
inAlzheimerdisease 626 epitopes 331,422,524 ESR vi20,35,51,89,151,159,284–293,
inHuntingtondisease 634 epoxide 173,269,378,389,461–462, 299–300,303–304,321,330,345,
enolase 105,275,306,627,632,653,658 486,584 350,383,411,470
enolate 270–271,419 hydratase 584 Lband 287,292
eNOS 20,54,55,63,105–106,158,206, hydrolase 116 long-livedsignals 149–151,509
222,231,252,256,349,402,407, epoxomycin 282 ofcigarettesmoke 491
409,448–449,518,538,591,647 epoxyradicals 261 ofcoal 495
andcaloricrestriction 647 5,6-epoxy-7,9,11,14-eicosatetraenoic ofmelanin 149–151
inatherosclerosis 521,525 acid 461 oximetry 287
inbrain 599 epoxyeicosatrienoicacids 458 silent 287,292(def.),299,304,316,
inischaemicpreconditioning 547 epoxy(hydroperoxy)tocopherones 162 662
inmuscle 408 EPR,seeESR todetectfoodirradiation 509
Epstein-Barrvirus 573,638,648
uncoupling 448,521 Xband 287
erbB 572–573
enoxacin 502
esterases 163,213,292,304,317–318,
erdosteine 682(struc.)
Entamoebahistolytica 113,115,505 463,484
erectiledysfunction 551–552,671
entacapone 505,617,619(struc.),661
etanercept 560
ergosterol 502
Enterococcus
ergotfungus 115 ethane 270,455,465,704(struc.)
faecalis 115,355
ergothioneine 113,114(struc.),115, biomarkeroflipidperoxidation
faecium 119
154,682
269–270,339,482,489
environmental
tobaccosmoke 339,494,seealso inbrain 603 inCCl4toxicity 467
inseminalplasma 395 incysticfibrosis 555
cigarettesmoke;tobacco
inskin 407 inlivertransplants 551
toxins 617,619–620
ERKkinases 222–223,229–230,639 withage 653
eosin 93 Eroproteins 106,108,111 ethane-β-sultam 684
eosinophils 357,422,431,440,446,461
error ethanol 16,42,79,85,93,118,155,289,
peroxidase 306,422,440
catastrophetheoryofageing 642 296–297,299,313,337,354,414,
EPC-K1 667(struc.),673 checkingfunction 238,245,247,650 464,479–483,490,493,530,544,
ephedrine 475
errorprone 507 551,553,567–568,598,640
EPI-743 668(struc.),673
bypass 580 andbone 451
epicatechin 175,178
eryptosis 215,366–368,473 andparacetamol 486
gallate 176(struc.)
D-erythroascorbate 156 cancerrisk 480–481
oxidationbyMPO 438
erythrocytes 5,25,45,55–56,85, foetaldamage 398,481–483
epigallocatechin 176(struc.) 87–88,101–102,104,109,118,122, GSHdepletion 482
epigallocatechingallate 175,176 125,127,133,135,138–140,142,
inbrain 483,602,608
(struc.),184–185,605 157,160,168,182,215,266,312,
inducedcognitiveimpairment 483
asneuroprotectiveagent 680 329–330,348–349,360–369,386,
inducedliverdamage 483
inmultiplesclerosis 607 399–400,422,451,456,477,501,
role in ischaemic
epidemiology 85,153,173,178, 537–538,546,555,611,654
180–198,359,392,393,481,539,
antibodiesversus 556
preconditioning 547
617,640 apoptosis,seeeryptosis roleofFeintoxicity 481–483
of
c
c
a
a
n
n
c
c
e
e
r
r,seeinterventiontrials; as
3
s
9
in
7
k
,
s
44
fo
2
rH2O2/O •
2
– 115,138,361,
eth
w
a
i
n
t
o
h
l
d
-i
r
n
a
d
w
u
a
c
l
ib
4
l
8
e
2
cytochromeP450,see
ofheartdisease,seeintervention astargetsfortoxins 363–366 CYP2E1
trials;cardiovascular enzymesasoxidativestress ethanolamine 254,274
epidermalgrowthfactor(receptor),see biomarkers 349 etheno-dG 272(struc.),329,492
EGF® foetal 400–401 etheno-DNAadducts 136–137,
epidermis 125,402,404,406–407, infertilizationmedia 397 271–272,329,492,523,566–568
seealsoskin lifespan 360–361 ethidium 209,213,320,323
epididymis 110,395,465 lipidperoxidation 362–369 β-ethoxyacrolein 337
epigenetics 579,659 oxidativestressinmalaria 367–369 5-ethoxycarbonyl-5-methyl-
Epilachnavariestis 162 stresshaemolysistest,seeperoxide 1-pyrroline-N-oxide,see
epilepsy 601,633 stresshaemolysistest EMPO
epinephrine,seeadrenalin uptakebymacrophages 426 ethoxyquin 167,656,679(struc.)

--- Page 904 ---

INDEX 849
7-ethoxyresorufin 16 excitotoxicity 387,402,416,484,502, inskeletalmuscle 552
ethyl 514,568,599–600,603–604,608, insynovialfluid 561
alcohol,seeethanol 610,613,623,625,627,632 knockout,seeknockoutmice
linoleate 330 andHIV 637 othereffectsof 477
monoesters 681 inALS 632 plasmalevels 138,140
paracetamol 484 inHuntingtondisease 634 extracorporealbloodcirculation 210
pyruvate 144,695 instroke/trauma 608–611 extrinsicproteins 253,257–258
ethylene 270,297,420,435,452,456, exercise 78,141,148,161,183,195–197, eye 8,67,75,92,102,110,150–151,
459,704(struc.) 202,230,286,297,321–322,327, 153,159,161,165,170,172,190,
dibromide 112,468
348,408–410,449,488,512–513, 206,252,265,271,312,386–394,
glycol 493 518,533–534,539,545,550–551, 404,439,481,487,532,538,
inbreath 339 595–596,605,639–640,660–661 548,seealsoage-relatedeye
acutephaseresponse 409 diseasestudy,cataract,cornea,
inplants 452
andageing 640,653,660 crystallins,glaucoma,lens,
ethylenediaminetetra-aceticacid,see
andAlzheimerdisease 195,628–629 maculardegeneration,lacrimal
EDTA
andBDNF 629 glands,retina,tears
ETS-GS 676(struc.)
endurance 408,410,480–490,650 andcarnosine 673
etoposide 210,219
exhaledair 64,310–311,339,358,528, antioxidants 390–394
eugenol 174(struc.),176,178
555,seealsobreathcondensate, carotenoids 393–394
Euglenagracilis 115 ethane,pentane,ethylene compound 393
EUK-8 666,668(struc.),670–671 exjade 661,690(struc.),693 damage by
andlifespan 656 exochelins 687 ischaemia-reperfusion 548
inALS 632 exocytosis 598 drops 673
indiabetes 533 Exodus 176 incysticfibrosis 555
inmultiplesclerosis 607 expensiveurine 161
vitaminEcontent 162,391–393
inpriondisease 630 experimental autoimmune
EUK-134 666,668(struc.),670–671 encephalitis 143,674,692 F
andlifespan 656 explosives 476,488,505
F420 102
inALS 632 extensivemetabolizers 463–464
f-block 701
EUK-139 670 extracellular
felectrons 697(def.)
EUK-189 252,577,668(struc.),671 antioxidantdefences 78,137–142,
F1 681
EU in K- in 20 fl 7 ue 6 n 7 z 0 a –6 6 7 3 1 6 Ca o 4 2 4 f + 5 m l , e s e v e t e e a l l a s l i s o 2 o n 0 a s 5 lbumin,sequestration 1 F 5 2 – - F is 2 o t- p Is r o o P sta 2 n 6 e 8 s 93,123,125,136,
Eukarion 666 148,151–152,159,161,164–165,
GPx 230,397
eukaryotes 6,7,13,14,25,64,79–81, 167–169,177–178,187,189,195,
matrix 202,206,215,236,443,480,
90,98–99,106,109,112,137,205, 197,260(struc.),262,265,331,348,
519,581,650
238,247,281,411,643,647,650 354,369,390,399–400,443,456,
eumelanin 150–151,406,615 Na+levels 205 468,469,475,482–483,486–488,
polysaccharide 555
Euplotesraikovi 277 501,512,528,639,676,679,681
extracellularsuperoxidedismutase 37,
Euprymmascolopes 440 80,88,94,131,136,138–140,154, andageing 653,657
EURAMIC 182 andairpollution 490,494
349,359,443,449,476,594,661,
Europe 135,180–182,309,488,490,634 andaluminium 628
665
EuropeanCommunityMulticentre andbone 451
andageing 653–654,660
StudyonAntioxidants, andcigarettesmoking 492–494
andasbestos 496
MyocardialInfarctionandBreast andcurcumin 680
anti-inflammatoryeffects 140,444,
Cancer(EURAMIC) 182 562 andexercise 409
europium-dopednanoparticles 320 contaminationofcaeruloplasmin andGSH 655
evolution 17,87,108,130,142,202, with 139 andHIV 638
444,446,640,645,649 effectofexercise 660 andstress 504
ofmitochondria 13 inbrain 600 effectonembryos 398
ofmulticellularorganisms 231 inC.elegans 657 effectonkidney 450
ofSODs 87 incartilage 558 glucuronides 334
exvivotrapping 290–291 inlung 359,399 inALS 632
excitatorysynapses 596,599 inplacenta 397 inamnioticfluid 398
excited inpreconditioning 549 inangioplasty 546
singletstate 67,370 inrestenosis 546 inatherosclerosis 521,523–529
state 71,309,420 inrheumatoidarthritis 562 inautism 633
tripletstate 67 inseminalplasma 395 inbrain 399,606,609–611

--- Page 905 ---

850 INDEX
F2-isoprostanes(continued) occultbloodtest 122 Fe-S,seeiron-sulphurclusters/proteins
•
inbreath 339 OH generation 355 Fe3O4nanoparticles 665
inCCl4toxicity 467 ironcontent 356 FeTM-4-PyP5+ 664,666,668(struc.),
inchemotherapy 592 vitaminEin 356–357 670–671
inCSF 625,627,634,653 water 356 febuxostat 15
incysticfibrosis 555–556 familial 631 females 247,seealsosex;women
indepression 633 adenomatouspolyposis 574 femoralarteries 516
indiabetes 539 ALS(FALS),seeamyotrophiclateral fenamicacids,radicalsfrom 565
indiet 354 sclerosis Fentonchemistry 1,4,15,34–36,38–40,
inear 402 Alzheimerdisease 624 47,53,58,64,96,106,130,240–241,
inendometriosis 398 amyloidpolyneuropathy 629 289,299,303,307,309,322,327,
ineye 388 Parkinsondisease 61 376,412,445,470–471,473,491,
inIBD 566 FANCC 577 502,561,662
inischaemia-reperfusion 542, FANCD1,G,J 577 andhydroxyurea 412
544–545 Fanconianaemia 574,576–577,583, inbrownrotfungi 420
inhypertension 449 693 ineye 388
inliver 551,568 FAPyA 242(struc.),243,246,250–251, inischaemia-reperfusion 544
inlupus 556 324 insilica 497
innakedmolerats 650,654 FAPyG 239(struc.),242–243,246, intermediateoxidizingspecies 38,
inneonates 399 249–251,322,324,618 seealsoferrate;ferryl
inneurodegenerativediseases 613, FAPyglycosylase 250–251,324,328 involvingantibiotics 502
618,625–627,634 farnesyltransferaseinhibitors 590 O •–-driven 45,97,473,561
2
inobesity 531–532 Fasligand 217,219,222 onDNA 239
inp66shcmutants 651 fasting 178,334,338,587,seealso semiquinone-driven 473
inpancreatitis 567 caloricrestriction site-specific 478,seealsohydroxyl
inpregnancy 397–399 fat 153,155,165,seealsodiet;food; radical;site-specificreactions
inpriondisease 630 triglycerides ferns 18
inradiation 507 absorption 167–168,674 ferrate 36,seealsoferryl
inrespiratorytractinfections 638 catabolism 644,647 ferredoxin 107,357,371,373,376,380,
inrheumatoidarthritis 559 intake 184,231 414
inscleroderma 552 malabsorptionsyndrome 604 NADP+reductase 373,376,383
insepsis 548 metabolism,abnormalities 659 ferrets 170,190
insleepapnoea 549 richdiet,seehighfatdiet ferric 36,133,259,477,594
insmokers 492–494 fatigue 236,507,549 bleomycin 593,seealsobleomycin
prostaglandinformationfrom 460 fattyacids 141,143,166,seealsoPUFAs citrate 133,135,208,210,264,382
toxicitytooligodendrocytes 399 bindingproteins 271,392 EDTA 15,32–33,39–40,46–47,62,
F3-isoprostanes 334 biosynthesis 101,471 160,292,296,299
inC.elegans 653,659 cross-links 258 haem 459
inpregnancy 397–398 ethylesters 482 hexacyanoferrate 310
F4-isoprostanes 159,334,388,482, free 206,533,535 nitrate 98
seealsoneuroprostanes longchain 633 nitrilotriacetate(NTA) 240,327,336,
inbrain 606,609–611 metabolism 413 583
inneurodegenerativediseases 613, oxidation,seeβ-oxidation peroxy 17
618,626 peroxides 109,113,274,332 reducingantioxidantpowerof
inRettsyndrome 633 synthesis 275,570 plasma,seeFRAP
insmokers 492 fatty reductase 127
withage 653 liver 266,268,333,480,483,534 superoxide 17
F1-phytoprostanes 369,371(struc.) streaks 516–517 uptakeregulator(fur) 97,220
FactorVIII 237 favism 364,366 Quin2,208
factorXII 423 Fcregion 558 ferricyanide 27,117,305,362,451
facultativeanaerobes 355 F2-dihomo-IsoPs 268,633 ferrioxamine 136,688,691–692
FAD 9,10,16,24,25,26,33,54,67,100, Fe2+-DETAPAC 686 ferriprox 693
106–108,154,247,357,361,364, Fe2+-dithiocarbamates 303 ferritin 32–33,40,97–99,126,128–131,
369,432,447,451,474,541 Fe2+-thiosulphate 303 134–137,142–143,185,201,208,
FADD 217 Fe(III) ortho N-glycolated 233,235,262,264,360,367,376,
FADH2 9,10,12,24,33,106,108 pyridylporphyrin 664,666 382,384,400,405,407,471,544,
faeces/faecal 122,126–127,165,177, Fe(IV)-haemcationradical 122,158, 560,592,600–601,611,614,618,
184,355,566,588,686 438 652,660
•
antioxidantcontent 357 Fe(IV)=OTrp-171 419,seealsoferryl aggregates 130

--- Page 906 ---

INDEX 851
andaluminium 501 fibrosarcoma 573 154,160,217,313,384,403,471,
ferroxidaseactivity 130 fibrosis 19(def.),141,201,236,267, 474,602
inatherosclerosis 522 272,399–400,425–427,430–431, effectsofDPI 433
incancer 583 442,446,466,468,470,477,480, flies,seeDrosophila,houseflies
incysticfibrosis 555 483,497–498,508,514,546,550, FLIP 217
ineye 391–392 552–553,556,594,670,681 floralnectar 453
inplants 129,376 fibrous flour 50,124,126
inplasma/serum 128,131 cap 516–517,519 flow-mediateddilatation 223,349
insynovialfluid 561 plaques 516 andageing 653
ferrochelatase 69,71 fibulin 140 inCGDpatients 433
ferrocyanide 40,66,305 Ficoll 557 flufenamicacid 563(struc.)
ferroportin 127,135,358,605 SOD 663 fluorescamine 345
filaggrin 406,558
incancer 583 fluorescein 350
fingernails 21,50,124,286
ferroptosis 212 fluorescence 309,320,345,370,374,
fingerprinting 284,321
ferrous 1,36,134,259,275,411,420 439,525
Finland 82,124,180–181,189,191
EDTA 32–33,39–40,46,244 inC.elegans 658
fire 5,6,408,495
oxidationxylenolorange,seeFOX fluorescent
smoke 21,495,670
ferroxidaseactivity 130–132,138,400 biosensors 654
fireflies 316,420
inARDs 528 firstorderrateconstant/reaction 34 chelators 129
inPD 618 first-derivativespectra 285 end-productsoflipidperoxidation
ofDFO 691 271,339–340,609
fisetin 175(struc.)
ferroxycatalase 125 fish 17,19,21,25,63,115,149–151,155, GSHadducts 347
ferrozine 98 162,164,183,196–197,313,354, MDApolymers 340
ferryl 36,39,53,158,173,259,263, 363,386,404,415,417,434,499, naptho [2,3-d] imidazole
356,362,382,411,459,544,seealso 501,505,509,536,620,640,seealso derivatives 304
haemferryl
zebrafish pigments 168,635,658,seealso
haemoglobin 361
meal 252,679 ceroid,lipofuscin
myoglobin 545,592
oil 167,188,196,253,257,337 probes 129,208,299,307
fertility 394–395,650
fishingcat 168 products,ineye 391
fertilization 394–396
fishytaste 261,270 proteins 559
eggs 396–397
fission-fusion,seemitochondria fluorine 6,75,700(struc.),703
envelope 45,344,415
fiveaday 153,seealsodiet;fruit; fluorodifen 383(struc.)
media 394,396 vegetables fluoromenadione 368,472(struc.),473
ferulicacid 418(struc.),605 Flagyl 505 fluoroquinolone 68,403
FeSOD 81,86–87,89–91,97,114,125, flamingo 161 5-fluorouracil 588,590
140,220,379,382,508 flavane/flavanone/flavone 175(struc.) flupirtine 661
inmalaria 368 flavin 97,383 flushreaction 155,480
fescuegrasses 296 adeninedinucleotide,seeFAD
FLVCR 140
fever 236,361–362,476,507,565, mononucleotide,seeFMN
fmet-leu-phe 430–431,433
in s e e x e e a r l c s i o se ac 4 u 0 t 9 ephaseresponse fla s v e o n h s a it e i m ze o d g 1 lo O b 2 in fo s rm 8, a 2 t 5 io , n 55, 6 4 7 45 F fo M am N c / e F ll M s N 51 H 6– 2 52 9 3 , , 1 5 0 3 , 0 1 , 2 5 , 5 1 7 6 , , 5 2 5 4 9 ,54,67
FeZnSOD 87 flavonoids 29,63,148,153,164,
focal
FGF 223,225,231,234,568,598 173–180,175(struc.),184–185,189,
adhesionkinase(FAK) 223
fibrin 450,531 369,418,455,462,481,524,588,
adhesionsites 206
fibrinogen 61,237,346,348,481 611,661,673,695
benignhepaticnodules 571
nitrationof 521 andLDL 527–528
fibroblast 94,101,138,201,203,223, ingastrointestinaltract 176–180,356 brainischaemia 610,676
235–236,248,276,300,342,358, inmultiplesclerosis 607 foetus/foetal 211,397–398,400,463,
402,406–407,448–449,512,546, insuncreams 406 484,490,605,648,seealsomaternal;
558,570,583,648,657,seealso inbrain 180,605 placenta;pregnancy;teratogenesis
fibrosis non-antioxidantactions 178 abnormalities 534
associatedcellsurfaceligandL,see pro-oxidanteffects 178–179 alcoholsyndrome 398,481–483
Fasligand recycling of α-tocopheryl arteries 398–399
growthfactor,seeFGF radical 177,286 brain 482,484,494
proliferation 143,430,442,552 flavanol 175(struc.),177,180–181 calfserum 331
typecells 558,560 flavodoxin 413 circulation 400
fibroblasticfeatures 560 flavoproteins 10,12,26,28,67,71,97, effectoftoxins 172,398,459,464,484
fibronectin 306c 106,108,113–114,118–119,122, erythrocytes 401

--- Page 907 ---

852 INDEX
foetus/foetal(continued) Fpg,seeFAPyglycosylase fungi 24,45,68,85,101,115,119,121,
fattystreaks 517 fractalkine 234 140,149–151,170,175,221,231,
growthrestriction 397–398 β-fragmentation 239 237,281,297,312,344,357,377,
hypoxia 398 frailty 408,seealsosarcopenia 380,384,402–403,414,419–420,
kidney 494 frameshifts 270 444–445,451–455,463,490,496,
liver 484,494 Francisellatularensis 87 502,658,seealsobrownrotfungi;
lung 172,399 FRAP 349–350,352 whiterotfungi
malformations 398 frataxin 612,633 avoidancestrategies 444–445
neurons 615 free penetration 453
oxygentoxicity 19 energychange 32 fungicide 469,619
folate 126,155,183,185,196–197,247, fattyacids 206,533,535,seealsofatty fur,seeferricuptakeregulator
542,661 acids;PUFAs furan 588
andAlzheimerdisease 628–629 iron 98,127,213,220,seealso furano-derivatives 389
food 56,77,78,102,110–112,124,144, catalyticironions;labileironpool; furanocoumarins 185
146,148,153–198,253,256–257,
non-transferrinboundiron furazolidone 364,506(struc.)
266,275,330,332,335,337,339, oxygenradicalstest(FORT) 329 2-furoicacid 156
344,352–353,399,455,489,499, freeradical(s) 7,20,67,285 Fusariumsp. 414
505,529,549,588,686,seealsodiet
asenzymesubstrate 357
cholesteroloxidation 268,354 G
inenzymemechanisms 411–420
compositiontables 182
intoxicology 463–510 gvalue 286
frequencyquestionnaire 182 theoryofageing 642,649–661
industry 50,673 G0 569,648
FreeRadicalBiologyandMedicine 477
irradiation 257,509–510 G1phase 569
FreeRadicalResearch 477
phytosterols 354 G1-phytoprostanes 370
Freedox 680
poisoning 55 G2phase 250,569
freeze/freezing 385,512
preservatives 79,293,489,673 GA-bindingprotein 225
drying 21,116
reductones 185 G-proteins 224,432–433,643
injury 549
smoked 176 G3PDH,seeglyceraldehyde-3-
quenching 287
wrappings 78 phosphatedehydrogenase
thawing 26,394,549,557
footprinting 284 G6PDH,seeglucose-6-phosphate
Frenchparadox 177
Foré 629 dehydrogenase
Friedreichataxia 605,612,633
forkheadtranscriptionfactorsofclass GABA 598–599
frostbite 549
O,seeFOXOs GADmouse 622
fructose 539
formaldehyde 41,118,298,483, Gadd45 573
bisphosphatase 64,376,380,382
491–493 gadolinium
formamidopyrimidines 328,seealso 6-phosphate 535 chloride 551
FapyA;FapyG fruit 153–198,352,356,360,381, corrole 670
formate/formicacid 35,42,97–98,118, 455–456,479,570,595,607,611, L-galactono-1,4-lactone 381
257,296,310–311,325,376,413, 628,660 galactoseoxidase 414,420
490 antioxidanteffects 187 β-galactosidase 648
dehydrogenase 311 bats 155
galangin 175(struc.)
formazan 46,47(struc.),84,88,213, ripening 121,456,509
gall
300–301,434 fruitingbody 231
bladder 568
formidase 416 frustratedphagocytosis 425,441
bladdercancer 531
N-formyl-peptides 421,423,430, FtSH 375
stones 567
seealsofmet-leu-phe Fuch endothelial corneal
gallicacid 176(struc.),677
N-formylkynurenine 24,73,277,279 dystrophy 391
(struc.),345–346,509 fuels 619,679 gallium 700(struc.)
ineye 387 additives 476,500 arsenide 497
5-formyluracil 239,241–242(struc.) fuller’searth 470 galvinoxyl 350,351(struc.),352
FORT 329 fullerenes 496,632,661,665–666 gammaradiation 144,seealsoionizing
Fos 573,seealsoc-Fos fumarase 10,20,96,652 radiation
fovea 387 C 20,78,202,220 gangrene 7,551
FOXassay 312,332,345 fumarate 10,14,407,683 gapjunctions 99,173,202–203,223,
FOXOs 222,235,569,574,641,644,647, esters 407,607 234,569,572,581
651 reductase 14,27,28 garlic 124,184,366
Foyer-Halliwell-Asadacycle 357 fumes 475,495–497,499,seealsodusts; breath 124
FP-15,664,666 smoke gartersnake 549

--- Page 908 ---

INDEX 853
gas knockouts 657,seealsoknockout gigahertz 287
chromatography 293,297,302,329, mice Gilbertsyndrome 143
335,339,seealsoGC-MS methylation 579–580 ginger 176
cookers 488 therapy 546 gingiva 558
gland 19 transcription 128,225–231,483,548, Ginkgobiloba 18,179,195,379,605,673
phase,seecigarettesmoke 587,642,650,seealsotranscription GirardPreagent 346
gastric,seealsoHelicobacterpylori, factors GISSI(study) 186–188,196
stomach transfer 80
GKT136901/137831 695(struc.)
acid 460,567 triplication 613
glaucoma 157,387,391–392,548
c p a a n ri c e e t r a , l s c ee el s l to 4 m 83 achcancer s s i p le e n ci c f i i n c g ox 2 id 47 a , ti 5 v 7 e 9 damage 328 glia 29,232,595–598,600,602–604,
606–607,611,620,630,635,
ulceration 458,567 genetic
seealsoastrocytes;microglia;
anticipation 634
gastricjuice 33,127,159,355–356
oligodendrocytes
background 92–93,101,112
ascorbatelevel 127,355,567
instability 571,578,582,584 inALS 632
gastrointestinaltract 13,16,110,
theoriesofageing 641–649 inAlzheimerdisease 623,625
115,120,134,138–139,157,163,
geneticpolymorphisms 78,112,119, inParkinsondisease 618
165,184–185,256,266,268,340,
354–357,426,446–447,460,473, 140,149,157,159,165,252,393 glioma 576,578,671–672
479,493,501,507,541,546–547, aldehydedehydrogenase 480 gliotoxin 366,445
554,567,689,692,seealsocolon; Alzheimerdisease 624–625 global
diet;duodenum;faeces;food; andageing 652 biomarkers,caution 654
mouth;oesophagus;oralcavity; andairpollution 487 genomicrepair 248–249
smallintestine;stomach BDNF 598 hypoxia/ischaemia 607–608
andMaillardproducts 536 complement 390 oxidativedamage 653(def.)
antioxidantdefences 355–356,367 drugmetabolismenzymes 453 globuspallidus 475,601,614
ischaemia-reperfusion 541–542,692 GST 112 Gloeophyllumtrabeum 420
haptoglobin 139–141,522
permeability 409,480 glomerular,seerenal
homocysteine 196
uptakeofascorbate 157 glomerulonephritis 450
incytokines 431
uptakeofcarotenoids 170,182 inROSproduction 444 glucagon 137
up p ta o k ly e p o h f e f n la o v ls on 1 o 7 i 6 d – s 1 / 8 p 0 henolics/ MPO 439,524 glucocorticoids 137,228,504,554
NQO1 476 glucokinase 478,533–534
uptakeofiron,seeironuptake
OGG1 250 Gluconacetobacterdiazotrophicus 79
uptake of oxidized
p53 645 gluconeogenesis 644
lipids/cholesterol 268
uptakeofvitaminE 165–168 PON-1 530 glucoraphanin 184
SVCT2 392 glucuronicacid/glucuronides/
GC-richsequences 239,328
GC→ATtransitionmutations 246,270, genistein 174(struc.),175,178,184–185 glucuronidation 143,165,177,
GenKyoTex 695 267,398,463,474,484,486,560,
578
genotoxiccarcinogen 587 647,677
GC→TAtransversionmutations 246,
578,584
gentamicin 402,413,450,503(struc.), F2-isoprostanes 334
671 glucuronidase 334
GC-MS 298,323–326,328,331,333,
Georgiacentenariansstudy 659 glucosamine-6-phosphate 535
338,345
gerbils 170,669,670
γGCS,seeγ-glutamylcysteine glucose 9–10,14,42,92,112,122,139,
germcells 280
synthetase 149,157,176,196,231,267,396,
germline 574,578 450,463,508,518,533,535–539,
GDP 224,572
germanium 700(struc.)
536(struc.),574,646,663,689
D-mannose 381 germin 369,453
andcancer 570,574,576
L-galactose 381 germinalepithelium 395
inAlzheimerdisease 626
gelelectrophoresis 215–216,323–324, GeyKF 181
326,526 GFP 71,307,309,313,419–421 inbrain 598,603,626
gelatinase 422,424,441,517 usetomeasureHOCl 439 incellculturemedia 28
gemfibrozil 587 GFP-likeredfluorescentprotein 421 induced mitochondrial
gender,seesex,women γGGT,seeγ-glutamyltransferase O • 2 –formation 535
gene Ghana 645 lysinedimer 536
amplification 572 GI-GPx,seeGPx2 metabolism 10,498,500,568
andcancer 572–574,578,584 giantcells 431 oxidase,vi 47,63–64,89,219,420,
duplication 138,613 Giardia 439,453
expression 374,547,549,568,570, intestinalis 90 6-phosphatase 266,466,468,553
•
579,609 lamblia 413,505 reactionwithOH 42,48

--- Page 909 ---

854 INDEX
glucose(continued) γ-glutamyltransferase/transpeptidase inepilepsy 633
tolerance 155,410,647 102–103,112,347,359,391,461, inerythrocytes 362
transporters 9,146,157,447,558, 473,603,618 inETS-GS 676
574,seealsoGLUT1;GLUT2; asbiomarkerofoxidativestress 348 ineye 391–392
GLUT3 glutaredoxin 106–107,109,112,160, inIBD 566
glucose-6-phosphatedehydro- 220,309,362,380,391,412–413, ininsects 357
genase 101–102,220,471,473, 478 inlivertransplants 551
501,511,576,seealsopentose glutathione 12,29,42,44,45,49–52,65, inlung 359,399
phosphatepathway
75,78,81–82,91,94,99–115,100
inmacrophages 520
andmalaria 367–368 (struc.),122–123,131–132,138,141, inMCI 627
andtrauma 363 143–144,146,151,154,157,160, inmitochondria 102,604
deficiency 168,363–364,367,505 164,179,184,197,199–200–201, innakedmolerats 650
importancetophagocytes 443 203,208,215,221,229,234,261, inorganpreservation 552,681
inDrosophilalifespan 657 267,272–273,276,300,302–304, inovaries 395
306–307,310,312,317–318,332, inParkinsondisease 618,620–622
inerythrocytes 361
336,343,357–360,368,382, inphagocytes 442
inischaemia-reperfusion 542
385,397,415,441,452,457–458, inplants 380–381,384–385
insmokers 494 461–462,464,466,470,478,482, inplasma 101–103,347
glucosepane 536(struc.),537 487,511,563,607,633,652,661, inrheumatoidarthritis 558
β-glucosidase 366 663,683,seealsoGSH/GSSGratio
inschizophrenia 633
GLUT1 157,362 acidityofaerolisedform 681 inseminalplasma 395
GLUT2 477–478 ageing 652,657–658,seealsoageing; inskin 406–407
GLUT3 4,157 glutathionechanges insynovialfluid 561
L-glutamate 42,102,103(struc.),112, amide 113 inwounds 407
207,281,346,362,387,437,462, andcaloricrestriction 498,655 inborndefects 103
473,481,598,600,602,611,632, anddeprenyl 617 interactionwithascorbate 160
681,seealsoexcitotoxicity andglutamate 102 interactionwithV 500
andHIV 637 andHIV 104,637–638 leak 368
asaneurotransmitter 598–599 andnitrocompounds 505 modifiedforms(UPF) 681
carboxylation 90 andNO • 2 – 489 nitrosoform 51,54,57–58
cysteine ligase, see andozone 487 γ-radiation 508
γ-glutamylcysteinesynthetase andSODmimetics 668–669 reactionwithHNE 271–273
dehydrogenase 490 artefactualoxidation 347 reactionwithO •– 46
effectonGSHlevels 102 astherapeuticagent 681–682 reactionwithqu 2 inones 473
inpriondisease 630 assays 343–344,347–348 reactionwithSODmimetics 668
oxaloacetatetransaminase 213 assays of oxidation redoxstate/potential 309,313,348
pyruvatetransaminase 213 products 347–348 repairofDNAradicals 247
receptors 599,610,637,680 changesindisease 104 roleinapoptosis 219
release 603,632 coenzymeAadduct 105 specificprobe 347
semialdehyde 277,279(struc.),345, conjugatesof 179,336,484 synthetase 102–104,381
626,630 depletion 123,218,468,483–486, thiosulphonate 66
transporters 601 492–493,497,510,606 thiylradical 53,291,489,508,666
donors 661 glutathionedisulphide 50,66,76,100
glutamine 83,103,206,396,530,598,
esters 402,681–682(struc.) (struc.),102,111,113,144,204,226,
602
export 494 234,312,332,347,349,471,528,
inHuntingtondisease 634
inALS 632 552,587,590,681,683–684,seealso
glutaminesynthetase 486,598,602,606
inanxiety/autism/depression/ GSH/GSSGratio
inAlzheimerdisease 627 stress 504,633 inbrain 603
γ-glutamylaminoacids 103(struc.) inARDS 528,554 inParkinsondisease 618
γ-glutamylcyclotransferase 103–104 inataxiatelangiectasia 576–577 inplasma 101,347
γ-glutamylcysteine 102,103(struc.), inatherosclerosis 520 inhibitionofenzymesby 105
104,113,137 inbrain 600,603–604,606,611 glutathioneperoxidases 20,91,94,96,
γ-glutamylcysteinesynthetase incancer 582,591,593 99,107,109–111,115,122,124–125,
102–104,144,195,229–230,252, incellculture 29,316 136–138,144,154,202,221–222,
272,483 incoeliacdisease 566 229,274,276,314,333,358–359,
andcigarettesmoke 494 incysticfibrosis 554–556,681 368,415,448,451–452,457–458,
inageing 655,657–658 indiabetes 534,537–539 462,471,478,499,508,521,565,
inParkinsondisease 618 inear 402 568,587,652,seealsoGPx1to-8
γ-glutamylcysteinylalanine 113 inER 99,101,105–106,309 andMPG 682

--- Page 910 ---

INDEX 855
assay 113 inplants 380 glycoproteins 65,110,127,138,234,
deficiency 111,364,seealsoknockout inseminalplasma 395 247,257,277,346,419–420,443,
mice insmokers 494 531,630,seealsoproteoglycans
inbrain 603 inactivationonadditionof glycosaminoglycans 140,522
inβ-cells 478 ONOO–– 112 bindingofxanthineoxidaseto 541
incancer 576 reactionwithHNE 273 glycoselenoprotein 110
inembryos 396 6/8-glutathionylquercetin 179(struc.) glycosidaseenzymes 176,280
ineye 391 glutathionylation 27,105–106,112,123, glycosides 175–176
infoetallung 399 204,206,219–220,224–225,229, glycosphingolipids 254
inmuscle 408 233,275,282,293,386,424,449, glycosylases 248–249,323
innakedmolerats 650 seealsoGSH/GSSGratio glycosylation 232–233,535,538,624
inoocytes/ovaries 395–396 andageing 654 glycosylphosphatidylinositol 131,605
inoviductalliningfluid 397 ofNOS 55 glycoxidation 238,275,346,534–539,
inParkinsondisease 618 ofp53 576 seealsodiabete,glycation
inphagocytes 442 inphagocytes 442 inALS 632
inplacenta 397 inplants 380 inneurodegenerativediseases 614,
inplants 380 gluten 566 619
inseminalplasma 395 glycation 139,149,178,232,238,275, glycylglycine 42
inskin 406–407 346,363,377,387,391,406,519, glycylradical 7,20,413
insynovialfluid 561 522,534–539,653,680,684,seealso glycyltyrosine 42
mimetics 683 diabetes,glycoxidation Glycyrrhizaglabra 179
nonSetypes 111,113 and mitochondrial O •– glycyrrhizin 174(struc.),179
regulation 123 production 538 2 glyoxal 112,420,537–538,684
glutathionereductase 100–102,104– byascorbate 161,387,392,536–537, oxidase 420
105,107,113–114,122–123,144, 539’ glyoxalases 37,99,111–112,113–114,
154–155,220,332,357,361,368, haemoglobin 522,536–537 154,221,537–538,633,655
380,384–385,393,412,470–471, inneurodegenerativediseases 614 andage 655
474,494,505,539,588,603 inrheumatoidarthritis 559 inbrain 604
deficiency 364,443 inplants 380
ofcaeruloplasmin 537
inbrain 604,606 inskin 406–407
ofCuZnSOD 537
ineye 391 inwounds 407
roleofcopper 537
inmuscle 408 roleinstress 504
theoryofageing 642
inParkinsondisease 618 glyoxylate 144,146,147(struc.),
glyceraldehyde 24
inplants 384 312–313,376
glyceraldehyde-3-phosphate 111,538,
inskin 407 H2O2scavenging 376
627
insmokers 494 GM-CSF 234,424,429,432,442
glyceraldehyde-3-phosphate
insperm 395 GMP 237(def.)
dehydrogenase 10,64,105,219,
glutathionesulphonamide 66,307,347 godnose 155
275–276,537,560,634,653
(struc.),359 goitre 448
glycerol 253,255(struc.),274,519
inBPD 399 gold
3-phosphate 64
glutathionesynthesisanddegrad- compounds 108,565,590
ation 102–104,381,391,494, 3-phosphatedehydrogenase 26,27 nanoparticles 496,665,681
591 trinitrate,seenitroglycerin sodiumthiomalate 564(struc.),565
andcysteineadministration 680 glycine 102,103(struc.),112,348,381, standard 185
measurementinvivo 348 413,598–600,655 thiolcomplexes 562
glutathione-S-transferases 57,61,99, 13C-labelled 102,348 goldfish 170,247,550
105,107–108,112–113,122,133, conjugation 463 Golgiapparatus 131,136,266,415,624
138,143,160,229,252,272–273, decarboxylase 384,386 Gomberg vi,287
355,368,382,398,452,457, glycocalyx 139,257,541,551 gonadotrophin-releasinghormone 652
460–461,463,473,486,494,584, glycogen 9,204,206,431,540,598,643 gonads 135,588,646,655,seealsotestes
603,652 glycolaldehyde 277 gonococcus,seeNeisseriagonorrhoeae
GSTA4-4,113,273,531 glycolipids 54 goodvascularoxidase 448
GSTO1-1,seeomegaclassGST glycollate 313,376 Good’sbuffers 59
GSTP 112 oxidase 118,313,369,376,380 gorgene 220
GSTM1nullgenotype 112,487 glycolysis 9,10,110,360,367,428,431, gossypetin/gossypin 175(struc.)
incancer 585,591 451,534–535,540,570,576,579, gossypol 174(struc.),175,178
ineye 391 598,603,627,692 gout 15,146,148,556
inParkinsondisease 618 β2-glycoproteinI,seeapoliproteinH gp41 637

--- Page 911 ---

856 INDEX
gp91phox 205,432,434,445–447,450 green artefactualoxidation 238,325–326
knockout,seeknockoutmice algae 247,378–380 Cubinding 238
gp91ds-Tat 694 fluorescentprotein,seeGFP nitrationof,see8-nitroguanine
gp120 637 peroxidase 436 radicalcations 239,507
GPx1 110,122–125,223,230–231,233, tea 175,177–179,184,680 reactionwith1O2 72
252,274,355,447,483 greenhousegases 2,41 ribose,see8OHGua
andageing 657 greeningmeat 132 guanosine 72(struc.),237(def.)
andalcohol 483 Griessreaction 305 guanylatecyclase 53
andp53 575 grinding guardianofthegenome 573
deficiency 364,seealsoknockout ofbone 21 guava 155
mice offlour 50 Guillain-Barrésyndrome 607
inbrain 603 ofproteins 50 guineapigs 95,118,123,138,155,
incancer 574,576,582 groundstate 23,71,307,309 158–161,164,168,363,392,400,
indiabetes 534 ofoxygen 22(struc.),23,115 489,493,544,605,670
inerythrocytes 360–361 groundsquirrel 549 L-gulono-γ-lactoneoxidase 155,159
inexercise 409 groundwater 497 Güntherdisease 70
ineye 391 group0,III,VII(PeriodicTable) 700 gut,seegastrointestinaltract
inFanconianaemia 577 groupI 700,702 flora 176,180,355,507,531,565,582,
infemales 152 groupII 697,700,702 584,605,seealsocolon,Helicobacter
inmuscle 409 groupIV 697,700 pylori
inneonates 401 groupV 497,700
inParkinsondisease 618 groupVI 683,700 H
insperm 395 growth
3H-thymidine 214,323
instroke 609 arrest and DNA damage
H-ras 573,seealsoK-,N-,Ras
inwounds 407 inducible 573
Haber-Weissreaction vi,97
phosphorylationof 224 hormone 630,644
haem 8(struc.),12,16,25,39,54,58,
responsetoSe 124 retardation 481,646
65,67,69,78,80,84,112,115–118,
usetoassayperoxides 332 growthfactors 29,85,92,173,215,
GPx2 110,124,229,355,447,494 219,221–222,225–227,229,234,
120–122,126,128,130,132–133,
134,136,139–143,148,208,215,
incancer 574,582 313,424,432,446,569–570,572,
221,264,269,302,354,360,362,
GPx3 110–111,221,252,355,397,494 581,583,598,603,631,644,651,
365,367–368,382,447,451,522,
inobesity 531–532 seealsosignaltransduction;redox
529,544,604,608,611,686
inseminalplasma/sperm 395 signalling
GPx4 110–111,122,124,355,seealso gruel 212
a,a3 12
andcancer 354,570
PHGPx Grx-1roGFP2 309
insperm 395 GS • radical,seeglutathionethiyl biosynthesis 8,69,469,500
GPx5 8,110 radical cationradicals 116,120–122,158,
438,459
GPx7 110 GSH/GSSGratio 99,105–106,309,363,
incancer 576,579 367,380,391,450 deficiency 133
gracileaxonaldystrophymouse 622 inageing 655 exportmechanism 133,140
graftrejection 143,553,556,696, inER 99,101,105–106,309 ferryl 53,115,120,132,292,459,
seealsoorgantransplantation GSSG,seeglutathionedisulphide seealsoferrate;ferryl
grain 196,356,595,660 GTP 128,224,237(def.),433,572 instroke 609
silos 385,488 bindingproteins 573,599 interferencewithDCFHDAassay
Gram-negative/positivebacteria 54, cyclohydrolaseII 248 317
433,477 GTPase 572,590 inskin 407
gramicidin 686 guaiacol 120,122,174(struc.),176 peptide 333
granularcationicproteins 422 Guam 617 protein/peroxidemixtures 208,333,
granulomas 434–444 guanidiniumchloride 79 604
granzyme 218,422,424 guanidinogroup 537 richdiet 336
grapes 177,184,451 5-guanidino-4-nitroimidazole 242 stimulationoflipidperoxidation 262
grapefruit 184–185 (struc.),245–246,328 tyrosinecross-links 133
graphenenanoparticles 496 guanidinohydantoin 242(struc.) uptake 127
GRAS 677 guanine 30,42,43,60,72(struc.),147, haemoxygenase 9,78,126,133,140,
grasses 296,455 236,238–239,242,244,270,274, 142–144,185,201,217,367,445,
Grays 507(def.) 322–323,475,507,584–585,587, 513,549,611,652,seealsoHO-1,
great 593,seealsoGproteins HO-2
potatofamine 157 artefactualdeamination/oxidation inARDs 528
tits 151 238,325–326 inbrain 606,611

--- Page 912 ---

INDEX 857
inatherosclerosis 520,522 Haemophilus 80 healthspan 652
inParkinsondisease 619 ducreyi 133 hearing 596,seealsoear
haemproteins 25,53,60,126,132–133, influenzae 104 andageing 651
265,303,307,309–310,356,380, haemorrhage 235,362,399,516,522, hearingloss 92–93,280,401–402,607,
388,511–512,522,549,551,686, 544,547–548,561,565–566,605, 657,671
seealsospecificproteins,e.g. 607,609,611,670,677 andcis-platin 402
cytochromes,haemoglobin ineye 388 andMsr 402
haematopoieticstemcell 79,422,434, inbrain 611,660 noiseinduced 683
507 inplaque 516,522 heart 8,9,13,26,55–56,84–85,88,
haematoporphyrinderivative 70 haemorrhagic 91–93,98,101,115,117–118,
disease 473 120,122,124,128–129,135,151,
haematoxylin 89,93,335
fever 637 202,204–206,213,223,225–226,
haemin/haematin 8,342,367,550
necrosis 235 253,266,274,277,294,337,
haemochromatosis 134–136,148,160,
shock 165,188,195,302,355,511, 339,399,408,437,439,467,
210,583,645,seealsoiron-overload 541,547–548,550–551,553,567, 475,484,499,517,535,539,
andjointeffects 565 607–608,611,692 543,545–547,550,562,592,596,
linktoethanol 481 haemosiderin 130,134–135,264,560, 612,638–639,650,653,673,675,
relationshiptoascorbate 160 601,611 seealsocardiovasculardisease;
haemocuprein 79 haemozoin 134,367–368 myocardialinfarction
haemocyanin 85 Hagemanfactor 423 adriamycincardiotoxicity 673
haemocytes 446 hair 124,149–151,402,406,473,646 andburns 408
haemoglobin 5,8,25,37,42,55,60, follicles 406,588 disease, epidemiology
79,88,115,122,126,132–134, Hallevorden-Spatzsyndrome 614 studies 186–188
139–140,143,148,154,158, halobacteria 113 failure 92,275,321,544–545,582,
184,208,233,264–265,320, haloperidol 568 592,646,686,693–694
360,362–365,367,399–400,473, halothane 468(struc.),481,602 inFriedreichataxia 633
512,522,544,561,603,605, Hansenulamrakii 24 ischaemia-reperfusion 542–547,550,
seealsodeoxyhaemoglobin; Hap1 221 669,675,678,692
oxyhaemoglobin haptoglobin 78,122,139–141,157,233, sensitivitytoFe 135–136,660
abnormal 25,364,368,seealsosickle 237,252,363,365,442,611,652,686 suddencardiacdeath 196
cellanaemia HP1-1,2–1 141,522 topoisomerase 592
HP2-2 141,157,188,522 transplantation 143,186,188,550,669
F 400
inatherosclerosis 522 valves 443
glycation 522,536–537
inCSF 605 HeartOutcomesPreventionEvaluation
inbraininjury 607,609,611
ineye 392 Study(HOPE) 186–188,194
insepsis 548
inmalaria 368 HeartProtectionStudy 186–187,
•
NO scavenging 55,133,303 interactionswithascorbate 157 194–195
peroxidasereactions 122,364 interactionswithvitaminE 187–188 heat 13,27,232–233,370,374,377,379,
stabilizingprotein 362 Hashimotothyroiditis 556 512
stimulationoflipidperoxidation HaslarNavalHospital 157 heatshockstress/response 63,142,
262,334,522 haustorium 453 220,222,230,231–233,236,247,
thiylradicals 365 Hawaii 180 268,655,seealsoHSF;Hsp
toxicity 133,360,475,604,607,611 Hawaiianbobtailsquid 440 andROS 484
haemojuvelin 135 hayfever 440–441 andsexualreproduction 247
Hayflicklimit 648 inC.elegans 651
haemolysis/haemolytic 103,122,138,
140–141,161,168,184,211,334, hazelnuts 162 inexercise 409
347,361–366,400–401,471,473, Hazlitt 444 plants 385–386,451
505,611,seealsoperoxidestress HBED 688(struc.),692 roleofH2O2 385
haemolysistest HBO,seehyperbaricoxygen treatmentofproteins 277
HBx 636 hedgehog 395,531
anaemia 123,168,361,477
HDL 61,66,136,165,167,171,181,186, Heilongjiangprovince 123
artefactsinlipidperoxidation 334
274,280,334,494,521,530–531, Heinzbodies 365
crisis 362,364
533,559,604,673 HeLacells 202,229,346
drugs 363–366,464,477
isoPlevels 334 Helicobacterpylori 37,62,108,125,328,
insepsis 548 HDL-AtherosclerosisTreatmentStudy 355,430,436,444–445,505,567,
haemopexin 78,139–141,237,368,392, (HATS) 186–187 579,582
605,611,652,686 headandneckcancer 509 helium 507,700(struc.)
knockout,seeknockoutmice HealthProfessionalsStudy 182,195 hemichannels 203
haemophilia 565 health-relatedqualityoflife 198 Henderson-Hasselbalchequation 705

--- Page 913 ---

858 INDEX
Henle’sloop 327 5-HPETE 461–462 Hmp 25
henna 404,473 hibernation 95,549 HNE 27,100,113,125,141–142,
heparin 138,140,349,443,672 HIFs 9,10,14,130,226,281,428,542, 149,158,200,204,230,232,267,
bindingdomains 138,140 608,647,691 270–274,273(struc.),275,283,327,
bindingSOD 449,468,594 andcancer 9,509,574,579–581 337,340–341,343,346,384,394,
hepatitis 137,480,483,567–568, anddesferrioxamine 692 407,442,450,482–483,508,515,
582–583 andMPG 682 526,528,557,679
Bvirus 567,582,636,638 andNAc 681 andage 653
Cvirus 328,483,567,582,636–638, high andcaloricrestriction 653
676,684 bloodpressure,seehypertension andHIV 637
mitoQeffect 684 densitylipoprotein,seeHDL andproteasome 614,628
hepatocellularcarcinoma,seeliver dosesupplements 660,seealso asantigen 271,327,336,341,556
cancer dietarysupplements histidine 336
hepatocuprein 79 fatdiet 226,231,293,328,483,493, inALS 631–632
hepatocyte 143,204,207,236,367,466, 531–535,640,651 inamyloiddiseases 629
473,480–481,483,486,551,569, lightintensity 377–378,382,390,392 inatherosclerosis 523
639,seealsoliver mobilitygroup1protein,seeHMGB1 inbreath 339
growthfactor(HGF) 234 performanceliquidchromatography, incancer 579–581,590,592
hepatorenalsyndrome 267 seeHPLC inCCl4toxicity 467
hepcidin 135,567 pressureoxygen,seehyperbaric ineye 390–392
HEPES 41,42,59,299 oxygen inischaemia-reperfusion 543,545
HepG2cells 144,214 spinstate 37 inliverdisease 483
hephaestin 127,132,154,388,652 temperaturederivatization 325 inlupus 556
heptachlor 15 hippocampus 92,231,481,596, inmeningitis 606
600–603,608,622,645,666
heptadienal 270 inneurodegenerativediseases 272,
heptanal 75,270 neurogenesis 596,639 601,613–614,618,621,626–628
Hippocrates 153,448
herbalmedicine/herbs 176,179,184, inobesity 271,273,531–532
histamine 58,422–423,428,440–441,
189,368 inpain 635
462
herbicides 68,296,378,380–383,469, inplacenta 397–398
effectsonphagocytes 411
587,617 inpriondisease 630
histidine 8,42,61–62,64,71–72,75,81
safeners 112 inrheumatoidarthritis 559
(struc.),82,84–86,117,131,141,
herbivores 386,451 inskin 404
148–149,209,212,220,244,271,
herbivorousinsects 451 instroke 608
274,276–277,297,308,344,346,
hereditary insynuclein 615
406,413–415,439,515,525,527,
coproporphyria 69–70 lysine 336
664
methaemoglobinaemia 361 measurementof 335–343
bridging 82
heroin 568,617 mercapturicacidconjugates 273,469
chloramines 66,149
herpes 518,636,638 metabolismof 272–274
reactionwithH2O2 149
HETEs 458,460(struc.),462 histidine-containingdipeptides 145, modifiedproteinsasDAMPs 421
Heterocephalusglaber,seenakedmolerat 148–149,154,498,605,661,seealso reactionwithGSH/GST 271–273
heterocyclicamines 536,584,588 tau 627
anerine,carnosine,homocarnosine
heterocysts 79 HNF-1α 533
histidinylradicals 132
heterolyticfission 21(def.),22,62,497, histidylhydrazide 149 HO-1 94,142,229,233,236,267,272,
705 282,392,405,407,461,524,546,
histochemicaldetection
hesperidin 673 ofHNE 341 553,607,680,686,seealsohaem
hesperitin 605 ofH2O2 310,312 oxygenase
hexachlorobenzene 48,469–470,583 oflipidperoxidation 341–343 andSODmimetics 669
hexachloroethane 468 ofO •– 300–301 inageing 655
hexadentate 688,693 of8O 2 HG 327 inAlzheimerdisease 626,628
hexamethylenediamine-SOD 663 histones 105,203,215,238,245,323, inatherosclerosis 520,522
hexanal 75,269–270,335,455 436,646, inbrain 606,611
hexane 568,619 HIV 159,187,215,636–638,681,seealso incancer 576,591
hexanediols/dione 619 AIDS incysticfibrosis 555
hexanol/hexanone 619 andGSH 104,637–638,681 inFanconianaemia 577
3-hexenol 455 HK-Green-2to-4 302 inischaemicpreconditioning 547
hexuronicacid 155 HKT 552 inpriondisease 630
HFE 135 HL60 436 inskin 407
HHE 270,337,626 HMGB1 215,421,430,436,441,538, insmokers 494
HHT 457(struc.),460,462 608,695 intransplantedhearts 550

--- Page 914 ---

INDEX 859
inwounds 407 Hsp27 232–233 hydrogen 32
viralvectors 666 Hsp32 142,233 asanantioxidant 696
HO-2 142,407 Hsp60 232,275,385,519 atom,seehydrogenradical
inbrain 606,611 Hsp70 232–233,282,385,606 atomabstraction 20,30,35,41,48,
Hodgkindisease 583,591,593 Hsp72 272 53,67,172,239,256,260–262,
Hoechst33258 213 Hsp90 232,282,385,632 268,276,344,412–413,454,459,
Homotirolensis 344 Hsp100 385 466–467,489,490,508,526
homocarnosine 145(struc.),148,605 incancer 577 bonds 82–83,108,238,246,271,580,
homocitrulline 531(struc.),558 instroke 610 704
homocysteine 51,141,146,155,185, smallHsp 385 cyanide 491–492,495
196(struc.),197,530,629,680 Tat 663 donation 677,679
thiolactone 197(struc.),530,594 HTGL 166–167 ion 21(struc.)
thiylradicals 197 HTLV-1 573,636 hydrogenperoxide 9,10,15,17,23–24,
homogenization 78,325,seealsotissue human 26–29,31,33–35,38–40,42–43,
homogenates longevitygenes 645 47,51–52,54,58–61,63–65,71,
homogentisateoxidase 561 mousedifferences,seerodent- 74–76,78,84,88,90–91,94–99,
homoglutathione 100(struc.),113, humanvariations;inter-species 106,109,111,113–120,122–123,
381–382 differences 126,128,130,132–134,136–139,
homologousrecombinationrepair 250 MutYhomologue,seeMUTYH 142,144,146,148–149,151,
homolyticfission 21(def.),35,40–41, papillomavirus 648 155,157–160,168,173,177–178,
50,61,63,75,199,269,465,469, T-cellleukaemiavirustypeI 573, 185,195,199–204,206,208–209,
491–492,497 636 214,219–221,223–225,229–231,
ofH2O2 404 umbilicalveinendothelialcells 223 233–235,238,243–245,251,
ofwater 21–22,199,244 Hund’srule 20(def.),37,701,703 266,272,275–276,280–282,286,
292–294,296,299–300,302,308,
homovanillicacid 310–311 Huntingtondisease(chorea) 502,605,
honey 63,111,seealsobees 612,615,633–634,672–673,694 316,321,324,328–330,332,343,
346,356–358,363,366–367,369,
Honoluluheartstudy 180 andreproduction 645
391,393,399,403,448,458,492,
Hordeumvulgare,seebarley huperzineA 693(struc.)
499,507,512,551–552,560,686
ho m rm it e o s h is or 2 m 3 e 3 s ( i d s ef 6 .) 5 , 7 651–652 Hutc s h y i n n d so ro n m -G e ilf 6 o 4 r 5 d –646 actiononDNA 240–244
activatablepro-chelator 688–689
hormonereplacementtherapy 152 hyaluronan 579
andageing 650,653–654
horseradishperoxidase(HRP) hyaluronicacid 40,43,406,487,551,
120–121,302,310,350,419,438 558–559,560(struc.),561 andascorbateperoxidase 122
usetoassayH2O2 311 asaDAMP 421 andautophagy 281
horseshoecrab 393 ineye 388 andHIV 638
hosttograftdiseasepropagation 615 injoints 558–560 andNAc 681
hotspots 40,246 SOD 663 andnecrosis 215
ofelevatedH2O2 654 hybridSOD 86–87 andshearstress 518
mutagenicity 580 hydantoin 322 andstress 385–386,503
housedustmites 402,441 Hydra 99 andSSpeptides 686
houseflies 393,640,649,654,656,658 hydralazine 365(struc.),557 aschemotacticagent 424,430,446
HPD,seehaematoporphyrinderivative hydrated assignallingmolecule 4,63,109,
HPETEs 461–462 electrons 20,32,33,35–36,40,53, 380,395,411,seealsosignal
HPF 317–319,319(struc.) 242,507–508 transduction;redoxsignalling;
HPLC 293,298,300,302,307,320,322, ferricoxide 130 redoxregulation
324,326–331,333,335,338,345, ions 704 bolus 222
347,618 hydrazine 149,346,363–366,365 cytochemicalstaining 310,312
basedTBAassay 338 (struc.),507,538 damagetoneutrophils 424,430,
3-HPMA, see N-acetyl-S-3- hydrocarbons 15,16,67,75,168,265, 442–443
hydroxypropylcysteine 340,455,704(def.),seealsobenzene; effectonadhesion 428
HSF 233,385,409,647,seealsoheat ethane;ethylene;methane; effect on intercellular
shock/stressresponse,Hsp pentane communication 203
Hsp 201–202,217,231–233,235, biomarkersoflipidperoxidation effectonNADPHoxidase 447
275,281–282,385–386,407,417,
269–270,339
effectonplatelets 450
445,478,513,519,607–608,613, hydrochloricacid 127,487,495 effectonthrombosis 450
641,663,seealsoheatshock hydrocortisone 16 electrodes 310,312
stress/response;stress hydroethidine 320 evasionof 445
andlifespan 385,643,659 hydrogel 663,681 fromCYPs 17,482
asDAMPs 421 hydrogenases 37 fromlettuce 452

--- Page 915 ---

860 INDEX
hydrogenperoxide(continued) measurementoflevels/production 4-hydroxy-phenylacetate 307
from mitochondria, see rates 310–319 N-hydroxy-2-pyridone 40–41,49
mitochondrialH2O2production mitochondrialevel 471,653 3-hydroxy-2-pyrone 156
fromNOX4 446 post-mortemgeneration 388 2-hydroxy-terephthalate 297
fromoxidases 414–415 reactionwithCo 499 N-hydroxy-2-thiopyridone 40–41
fromSODmimetics 668 reactionwithDCFHDA 317 β-hydroxyacrolein 271(struc.)
homolysisof 244,404 reactionwithhistidine 149 2-hydroxyadenine 242(struc.),243,250
hotspots 654 reactionwithketoacids 64,144,310 8-hydroxyadenine 242(struc.),243,
inalgalblooms 386 roleinvasodilation 231 246,251,324
inALS 631 sinks 361 α-hydroxyalkyperoxylradical 48,508
inAlzheimerdisease 625,628 tailregeneration 407 3-hydroxyacylcoenzymeA 626
inapoptosis 215 woundhealing 301,407,442 4-hydroxyaniline 296
inARDS 528,554 hydrogenperoxidebreakdown 122, 3-hydroxyanthranilicacid 416(struc.)
inasbestos 496 seealsomitochondria,H2O2 3,4-dioxygenase 416
inatherosclerosis 520–521 cooperationwithSOD 124–125 4-hydroxybenzoicacid 294,298
inbetelquid 494 erythrocytes 360–361 6-hydroxybenzopyrene 587
inbiofilms 28 ineye 391 β-hydroxybutyrate 661
inbombardierbeetles 415 hydrogenradical 20,21(struc.),30,35, 2/4-hydroxycatechol 475,585
inbone 451 291,696,700 hydroxychloroquine 562,564(struc.)
inbrain 599–600,602–603 ESRspectrum 284 7α-hydroxycholesterol 268,269(struc.)
inbreath 339 hydrogensulphide 50,66,197,491,604 7β-hydroxycholesterol 268,269
inbrineshrimp 415,417 hydroperoxidasesIandII 97,116,220 (struc.),333,618
inC.elegans 654 hydroperoxide 74,276,331,343, 24-hydroxycholesterol 602
incancer 576,578–579,581–582,587, 453–454,seealsolipidperoxidation 27-hydroxycholesterol 269(struc.)
590–591 lyase 454–455 4-hydroxycinnamicacid 418(struc.)
incapebuffalo 434 hydroperoxylradical 31,33,38,43–45, hydroxycobalamin 414
incellculturemedia 28–29,677
46,48–49,53,75,80,84,96,99–100,
7-hydroxycoumarin 315,332
158,257,263,300,339,434,705 hydroxycyclohexadienylradical 293
incigarettesmoke 491–492
anddesferrioxamine 691 (struc.)
incoffeeandtea 355
reactionwithnitroxides 672 5-hydroxycytosine 239,242(struc.),
indiabetes 535,537 (2S,3S)-γ-hydroperoxyvaline 277 246
ineye 388,391–392
hydrophobic 170,289 6-hydroxydopamine 89,92,126,474
infemales 152
patches 277,281–282 (struc.),475–476,484,568,621–622,
infertilization 415
hydropropidine 320–321 669
ingermination 455
(3-hydroxypropyl)mercapturic 5-hydroxyhydantoin 242(struc.),243
inheatshock 385
inhypersensitiveresponse 453 acid 492 2-hydroxyethidium 299,320(struc.)
hydroquinone 151,164,393,415,420, hydroxyethyl
inIBD 566
473–474,476(struc.),491–492 radical 42(struc.),53,289,414,479
ininsulinresistance 535,665
hydroresorufin 213 rutosides 673
in ischaemia-reperfusion
hydroxamates 687,691,seealso starch 552,691
injury 540–553
desferrioxamine 8-hydroxyguanine,see8OHG
inligninsynthesis 417–420
hydroxide(hydroxyl)ion 21(struc.), 8-hydroxyguanosine,see8OHGua
innectar 453 22,360 hydroxyhydroquinone 64,174(struc.),
inovulation 395 5-hydroxy-2-aminovalericacid 345 178,185,355
inpain 635 8-hydroxy-2 (cid:3) -deoxyguanosine,see 5-hydroxyisourate 147(struc.)
inparenteralnutrition 401 8OHdG 3-hydroxykynurenine 391,416(struc)
inParkinsondisease 617,620–621 4-hydroxy-2-hexenal,seeHHE monooxygenase 416
inpears 456 5-hydroxy-6-hydrocytosine 242(struc.) hydroxylradical 15,21(struc.),23,
inphagocytekilling 434–436 5-hydroxy-6-hydrothymine 241–242 27,30–36,38,40–43,45,50,53,
inplants 369,376,379–380,382, (struc.) 62,64,66–67,70,75–76,78,84,
384–385 5-hydroxy-6-hydrouracil 242(struc.) 88,90,95–96,97–99,100,126,
inrheumatoidarthritis 559–560 5-hydroxy-5-methyl-hydantoin 239, 130,132–133,136–137,144,148,
inskin 404,407 241–242(struc.),243 158–160,172–173,199,208–209,
intestes 394 3-hydroxy-2-naphthoic acid 214,219–220,243,245,250,259,
inurine 178,310,401,450 hydrazine 341 272,275–277,283–284,289,295,
inzebrafish 314 4-hydroxy-2-nonenoicacid 273 297,302,308,317–318,321–323,
inactivationofSODby 43,379 N-hydroxy-norcocaine 484,485(struc.) 329,343–344,346,359,388,400,
•
interactionswithNO 58 4-hydroxy-7-oxohept-5-enoicacid 388 403,412,479,493,499,512,530,
levelsinE.coli 28 4-hydroxy-PBN 402 543,557,566,704

--- Page 916 ---

INDEX 861
actiononantiproteinases/ rateconstants 296 hyperbaricoxygen 18,19,20,91,
proteinases 424 reactionwithazide 308 94–95,275,549,608
actiononDNA 238–244 reactionwithbuffers 41 preconditioningby 95,143,608
andageing 649 reactionwithDCFHDA 317 therapy 7,18,20
andcancer 396,571,577,591–592 reactionwithglucose 42,48 hyperbilirubinaemia 141
andFechelators 686,691 reactionwithH2 696 hypercholesterolaemia 306,517,
andoxypurinol 694 reaction with 1O2 519–521,524,539,545,607,628
andSSpeptides 684 scavengers/quenchers 308 andoxidativestress 624,661
fromalloxan 477 scavengersof,seehydroxylradical hyperfinestructure 286,287
fromantibiotics 502 scavengers hyperfunctiontheoryofageing 642,
fromAs 498 spintrappingof 289–292 653
fromasbestos 496 sitespecificreactions 99,201,259, hyperglycaemia 196,231,532(def.),
fromCo 499 296–297,299,478 533–534,539,542–543
fromCr 498 useinfootprinting 244 andROSproduction 535,seealso
fromfaeces 355 hydroxylradicalscavengers 39,52, diabetes
fromFechelates 686 63,97–98,139,149,244,257,259, hypericin 69,378(struc.),403,451
fromH2O2photolysis 244,412 296,299,302,308,384,434,445, Hypericumhirsutum 403
fromneutrophils 435 453,478,490,502,563,662,691, hyperlipidaemia 167,338,539
fromNi 498 seealsomannitol;sodiumformate, hyperlipoproteinaemia,typeIII 517
fromONOO– 296 thiourea hyperoxia 5,19,28,91–92,94,95,111,
fromozone 295,487 astherapeuticagents 663 151,210,268,314,325,334,339,
fromparaquat 384,470 inischaemia-reperfusion 542 341,354,358–359,396–397,446,
fromP.aeruginosa 477 hydroxylactam 268 464,471,594,seealsohyperbaricO2
fromradiation 507–508 hydroxylamines 60,89,291–292, andradiotherapy 509
fromsilver 496 365–366,406,505,672,684 eye 388,390
fromsuncreams 406 reactionwithO •– 292 inARDS 554
2
fromTCBQ 469 hydroxylysine 440 inbacteria 18,470
fromTi 500 hydroxymethyl incellculture 28
fromV 500 glutarylcoenzymeAreductase 170 inhistory 4–5
generationinstomach 355 glutathione 381 innakedmolerats 650
inALS 631
radicals 291 innewborns 400
inARDS 553
5-hydroxymethyluracil 239,241–242 hyperoxidation 109,348,654–655,
inatherosclerosis 521–523 (struc.),243,246,324 seealsoperoxiredoxins
inbetelquid 494
4-hydroxynonenal,seeHNE hyperplasia 567(def.)
inbrain 601,611
2-hydroxyoestradiol 244 hypersensitivityresponse 384,422,
inbrineshrimp 417
2/4-hydroxyoestrone 586(struc.) 452–453
incellwalldegradation 420,456
para-hydroxyphenylacetaldehyde 344 hypertension 53–56,60,102,140,148,
incigarettesmoke 491–492
hydroxyplastochromanol 381(struc.) 153,158,181,223–224,230–231,
inCOtoxicity 549 365,397,410,448–449,456,500,
5-hydroxyprimaquine 364
indiabetes 537,539 514,517–520,533,545,548–549,
hydroxyproline 42,604
inear 402 600,607,639
2-hydroxypropanal 277
ineye 392,548 andageing 653
inIBD 566 3-hydroxypropylmercapturic roleofisoketals 268
acid, see N-acetyl-S-3-
in ischaemia-reperfusion hypobromousacid 31,65–66,71,141,
injury 540–553,544,548 hydroxypropylcysteine 244,246,265,275–276,344,357,
inMDMAtoxicity 484 1-hydroxypyrene 316 437,440,579
inmuscle 408 hydroxypyridones 129,661,693 detection 307,317
inParkinsondisease 618 4-hydroxytamoxifen 661 hypochlorousacid 23,31,36,40,46,56,
inphagocytekilling 434–436,438 5-hydroxytryptamine 440,484 65–66,71,77,90,100,115,121,126,
inplants 376,384 hydroxytyrosol 174(struc.),176–177, 132–133,137,139,141,144,149,
inrheumatoidarthritis 558–559,561 529,673 158,173,213–214,217,219–221,
inskin 404 5-hydroxyuracil 239,242(struc.),243, 224,229,233,242,245,257,265,
instroke 608–611 246,250 275–277,283,292,294,296,302,
intheatmosphere 488,495 hydroxyurea 398,412(struc.),588 306,309,316,318,321–322,329,
invasospasm 611 andFentonchemistry 412 343–344,346–348,357–359,395,
initiatinglipidperoxidation 256–257 HyPer 310,313–314 435,440,487,492–494,496,502,
measurement 293–300,320 hyperaemia 349,427 512,520,530,566,684,705
quinones/semiquinones 471,473 hyperalgesia 635,671 actiononDNA 244

--- Page 917 ---

862 INDEX
hypochlorousacid(continued) inplacenta 397 IL-1β 228,234–236,421,496,519–520,
actiononantiproteinases/ induciblefactors,seeHIFs 532,566,597,637
proteinases 424 likeeffect 9 IL-2 130,226,234–235,568,670
amounts generated by roleofmitochondrialROS 226,247 IL-3 226,568
neutrophils 437,439 hypoxia-reoxygenation 294,seealso IL-4 518
andalbumin 141,521 ischaemia-reperfusion IL-6 235–237,424,442,514,532,534,
andDFO 691 birth 399 538,597,606
andebselen 683 incellculture 28 inexercise 409
andHDL/LDL 521 hypoxic 536,591 IL-7 560
andMEG 682 cellsensitizers 509 IL-8 226,236,424,428,432,442,560
andNAc 681 pulmonaryvasoconstriction 670 IL-9 234
andoxypurinol 694 regions 79,287,581,588 IL-10 228,235,236,426–427,430–432,
andquorumsensing 436 signallinginplants 386 518,554
andSSpeptides 684 HypT 221,280 andPBN 672
andtetracyclines 502
IL-11 236
detection 307,317,320,521 I
IL-12 235,426
evasionof 445
I-TAC 518–519 IL-17 560
inARDS 528,553 IκB 226–229,281,seealsoIKK IL-18 235,421
inatherosclerosis 520,523
IAC 667(struc.) IL-23 426
incancer 579
IBD,seeinflammatoryboweldisease ileocolitis 447,671
incigarettesmoke 493
ibuprofen 562,563(struc.),626 imidazolering 81(struc.),149
inIBD 566
ICAD,seeinhibitorofcaspase-activated iminonitroxides 304
inischaemia-reperfusion 544
DNAse immobilization 408,503
inLDL 529
ICAM-1and2 429,442,519–520,665 immunesystem 62,68,128,146,
inrheumatoidarthritis 558–559,561
ICL670 610,693 184,228,266,275,354,360,390,
inskin 406
instroke 610 403–404,421–445,465,468,482,
inactivationofMPO 437
ICRF-187 478,592,593(struc.), 500–501,503,513,532–533,538,
reactionwithcholesterol 268
594–595,661,686,689 550,553,556,558,561,570,582,
reactionwithDCFHDA 317
idarubicin 589(struc.) 597,602,636–637,640,692,seealso
reactionwithdrugs 486,565
idebenone 633–634,660,668(struc.), antibodies;antigen;complement;
reactionwithnitrotyrosine 307
673 eosinophils;inflammasome;
reactionwithparacetamol 486
idiopathichaemochromatosis,see inflammation;inflammaging;
Hypocrellabambuase 68
haemochromatosis macrophages;monocytes;
hypocrellinA 67
idiopathicpulmonaryfibrosis 104, neutrophils
hypocrellinB 67,68(struc.)
554,681,694–695 andimplants 443
hypodermis 402
IEISS 186–187 andMPO 443,450
hypoglycaemiccoma 598
IFN-γ 405,415,518–519 andnitrotyrosine 62,528,seealso
hyponitriteradical 52
IgE 440–441 antibodiesagainstnitrated
hypotaurine 143,437(struc.),438
IgG 363,430 protein/nitrotyrosine
inoviductalliningfluid 397
antibodiesagainst 558 andproductsofoxidative
inseminalplasma 395
chlorination/nitration/ damage 271,556
hypotension 231,267,548
oxidation 559,561 dysregulated 434–435
hypothalamus 146,532,596,601–602,
inlupus 558 evasionstrategy 582–583
608,652
IGF-1 223,568,642–643,645 inageing 640,642,656
hypothermia 610
andcaloricrestriction 651 inatherosclerosis 516–517
hypothiocyanite 66,120,437,440,531
hypoxanthine 14,15(struc.),24,45, knockout,seeknockoutmice surveillance 597
146–147,242,244,249,286,300, like 643 immuno-spintrapping 293,328,345,
322–323,328,400,420,434,482, receptorandlifespan 644 532
512,528,540–541,544,552,556, IGF-2 644 immunoglobulin,seeIg;IgE;IgG
694 ignose 155 immunostaining 326–327,334,seealso
DNAglycosylase 249 IKK 226–227,229,683 lipidperoxidation,visualizationof
inrheumatoidarthritis 561 IL-1 137,235,405,424,428–429,432, ofbityrosine 344
hypoxia 5,8(def.),9,19,28,127, 444,446,458,502,518,538,606 ofHNE 327,336,341
135,142,154,207,225–226,247, andageing 652 of nitrotyrosine, see anti-
399–400,402,425,428,446,450, inexercise 409 bodies against nitrated
452,538,539(def.),549,553–554, inrheumatoidarthritis 560 proteins/nitrotyrosine
571,573–574,583 receptorantagonist 235 of8OHdG 327
effectofCo 499 IL-1α 234–235,562 implantation 396–397

--- Page 918 ---

INDEX 863
inbornerrorsofmetabolism 155,363, inflammatoryboweldisease 444, insulinreceptor 231,533,644
439,490,seealsoCGD 565–566,579,661,675,694,seealso knockout,seeknockoutmice
InCHIANTI 659 Chrondisease;ulcerativecolitis insulinresistance 111,226,231,273,
incidentalLewybodydisease andCGD 434,566 520,533–535
(ILBD) 621 infliximab 560,694 roleofH2O2 535,665
inclusionbodies 361,615,617,634 influenza 328,400,447,636,670 insulinomas 479
incompletecarcinogens 584 initialratemeasurements 34 integrase 637
initiation 331,465,577 integrins 427,428–430
India/Indian 494,497
factors 275,609 intensivecare 159,511,660
ExperimentofInfarctSurvival
ofcancer 570–571 inter-individualvariation 182
Study 186–187
initiatorcaspase 217,seealsocaspases inter-speciesdifferences 54,399,422,
ink 287
injury 161,202(def.),455,seealsobrain 432,435,447–448,474,486,632,
indinavir 637 trauma;trauma seealsorodent-humanvariations
indoleglucosinolates 451 inks 121,404,seealsoIndianink; interferons 227,234,seealsoIFN-γ
indoleaminedioxygenase 24,415–416 tattoos interleukins 234,235,583,seealso
indomethacin 562,563(struc.),626, innateimmunity,seeimmunesystem specificones,e.g.IL-1
664,692 intermittentclaudication 297,551–552
INO-4885 495,670
radicalsfrom 565 iNOS 52,54,61,144,226,229,301,305, interphase 569
indoorair 298,488,seealsoair 358,402,404,408,444,465,492, internucleosomalDNAcleavage 323
pollution 502,508,562,567,694 interstitialspace 18
inducibleprotein-10 518–519 andHIV 637 intersystemcrossing 374
interventiontrials 153,183–198,285,
inductionexperiments 94 andMEG 682
523,539,627,seealsoepidemiology
inertgases 700,702 andPBN 672
cancer 189–195
infantformulas 127,401 inALS 632 cardiovascular 186–188
infantileNCL 635,672 inbrain 597,602,618,625
intestinal,seealsocolon;gastrointestinal
infectiousmononucleosis 638 incancer 579 tract
infertility 91,123,364,394–395,398 inischaemicpreconditioning 547 atrophyandp53 645
inmultiplesclerosis 607
inflammaging 642,645,652–654,659 ischaemia 511,540–542
inflammasome 217,235–236,390,421, inphagocytekilling 435 lymphocytes 355
inrespiratorytract 358
446,496,501,517,519,556,566, mucosa 440,483,569,588
inrheumatoidarthritis 560
594,625 parasites 505
inhibitorsof 680
roleofROS 235,444 intima-mediathickness 187
MTTreductionby 213
inflammation 123,127,135,137–138, intra
140,142,148,154,215–216, inosine 540 articularinjection 444,560–561
226,228,231–232,234–237,306, inositol 127–128,203,205,254,255 bacterial iron levels 211,
321,348,393,397,405,409, (struc.) 434–435,502
421–445,460,462,465,481,483, hexaphosphate 127(struc.) cerebralhaemorrhageandage 660
492–493,495,500,508,510–511, 1,4,5-triphosphate,seeIP3 ocularpressure 548
530,538,547–548,550–551,553, INS-7 642–643 phagosomalchlorination 435,439
558,570,609,652,672,seealso insects 5,17,45,63,78,109,149,177, plaquehaemorrhage 516,522
immunesystem;inflammasome; 179,307,357,367–369,393–394, ventricularhaemorrhage 611
pro-inflammatory 403,415,417,446,451,455,463, intra-lysosomal
andcancer 572,578–579,581, 471,475,509,640,660,seealso degradation 615
582–584,587–588 cuticle,Drosophila,houseflies ironions 281,405
brain 606–607,625 insecticides 15,377,530,617 intracellularcalcium,seecalcium
chronic,seechronicinflammation insulin 99,107,222,225,231,234,477, intracellularpH 581
dysregulated 434–435,seealso
531,532–539,625–626,641,651,
intralipid 98
inflammaging 675 intravenousfeeding 65,98,124,168,
andageing 643–644,647,659 692,seealsoparenteralnutrition
ofthereproductivetract 395
andcaloricrestriction 640–641,651 intrinsicprotein 253,258
inatherosclerosis 516–523
degradingenzyme 625 intron 245,247,328,633
inskin 405–406
likegrowthfactor 234,647 INV-315 521,694
lowgrade 532,655 likesignallingpathwayin iodide 120,121,307,312,332,437,447
productivephase 427 C.elegans 642–644 asanantioxidant 448
resolutionphase 215,228,236, receptorsubstrates(IRS) 533–534 iodine 124,312,448
425–427,seealsoresolvins secretion 206,226,478,534 methodforperoxides 332
roleofcytokines 234–236 sensitivity 155,409,534,647 iodoacetate 568
transitionphase 427 signalling 478,626 iodoniumion 447

--- Page 919 ---

864 INDEX
iodothyronines 447 box 97 inplants 376,381–382,384
iodothyronine-5 (cid:3) -deiodinase 110 catalytic,seecatalyticiron;labileiron inpreconditioning 209,547,680,686
iodotyrosine 121 pool;non-transferrinboundiron inrheumatoidarthritis 560,565
ionchannels/gradients 9,146, chelation,byNSAIDs 565 inskin 405,407
204–212,220,231,276,492,543, chemistry 36–40 insilica 497
595,598–599,608–609,680,seealso core 128,130 insunburn 558
calcium;potassiumchannels; corroles 670 insweat 211
Na+,K+-ATPase deficiency 126–127,131,154,469, intears 390
effectofROS 600 seealsoanaemia interactionwithparaquat 470–471
ionic dextran 565,583 intracellular 208,212,508,seealso
bonding 702 dietderived/fortification 126–127, labileironpool
134,401,692 loosely-bound 209
strength 81,238
DNAbinding 238 mal-placed 660
ionizingradiation 20,21,40,102,144,
heartsensitivityto 135–136,660 metabolism 125–131,611–635
151,199,203,250–251,340,387,
388,395–396,507–510,573,658, inacutephaseresponse 236 oxalatechelates 420
682,seealsoradiation,γ-rays inagepigments 658 placentaldelivery 397
inALS 632 pots 134
andcancer 577–578
inAlzheimerdisease 625–626,628 probe 1,128,129(struc.),208
IP3 205,222,224
inamnioticfluid 397 reactionwithnitroxides 672
IP-10 518–519
inasbestos 496 reaction with
iproniazid 365(struc.)
inatherosclerosis 521–523,660 quinones/semiquinones 471,473
IRAK1,-2,-4 227
inbacteria 211,434–435,502 regulatedtransporter-1 127
IRE,seeiron-responsiveelement inboxers 628 regulation of cellular Fe
IREG1 127 inbrain 401,600–601,607,628,660 balance 130–131
IRFI005/IRFI016 673,675(struc.) incardiopulmonarybypass 546 regulatoryproteins 130,143,220,
Irganox3114 678(struc.) inCCl4toxicity 466,468 281–282,614
irinotecan 590 incoals 495 release 134,437,468
iron 20,24,25,28,49,52,64,66,78,81, inCSF 601 release,byoxidativestress 208–211
84–86,90,99,115,116,119–120, incysticfibrosis 555 sequestration,asantibacterial/
126–127,130,133,138,141,144, indiabetes 478,533,660 antioxidantdefence 133–141,583
148,150–151,154,156–157,159, indieselexhaust 495 sucrose 210
173,178,200–201,215,221,233, inerythrocytes 360–361,365 sulphurclusters/proteins 1,7,
236,241,276,296,328,355–357, inexercise 409 24,43,46,54,78,91,96–99,
401,411,491,495,497,502,512, ineye 388,391 104,128,130–131,208,220,241,
568,606,700(struc.),seealsoiron infaeces 356 250,275–276,300,371,373,383,
ionchelators,ferritin,lactoferrin, inFriedreichataxia 633 413–414,435,437,470,612,633
transferrin inH.pyloriinfection 567 supplements 134,196,198,401
andacrolein 484 inhepatitis 567 uptake 97,126,157,161,184,412,
andageing 360,405,615,618,645, inIBD 566 645
651,660 inischaemia-reperfusioninjury ironcontamination
andaluminum 501,628 540–542,544,547,seealso offertilizationfluids 394,396
andantibiotics 502 ischaemia-reperfusion ofreagents 97–99,209,211,325,435,
andanthracyclines 592–593 inlipidperoxidation 259–263 543–544,561
andbleomycin 209–211,593 inlung 358,553 parenteralnutrition 401
andcaloricrestriction 660 inlysosomes 281,405 ironionchelators 9,39–40,97–98,
inmalaria 367–369 128–129,131,133,178,184,208,
andcancer 398,583–584,591,659
inMCI 627 259,316,325,392,405,478,501,
andcardiovasculardisease 546,660
inmitochondria 128,633 533,542,552,565,592,601,615,
andcigarettesmoke 491 inmucolipidosistypeIV 635 686–693
andethanoltoxicity 481,483
inmultiplesclerosis 607 actiononRNR 412
andgender 660,seealsowomen
innanoparticles 496 inALS 632
andgentamicin 503
inNCL 635 incancerchemotherapy 692
andlead 501 in neurodegenerative indiet 184
andradiation 508 diseases 611–635 inischaemia-reperfusion 544
andTCDD 469 innewborns/children 400–401,607 inmalaria 369
antagonismbyzinc 154,501 inoilflyash 495 inrheumatoidarthritis 565
availability 607 inParkinsondisease 617–618, plusMAOinhibitors 693
bodystores 129,134,241,478, 620–621 ironoverload 126,131,133–141,
583,660 inperiodontaldisease 558 154,160–161,208,210,241,

--- Page 920 ---

INDEX 865
259,286,321,363,388,470, inParkinsondisease 618 isotope 1,286,499,697(def.),seealso
478,481,483,514,544,558, inpre-eclampsia 398 deuterium;tritium
561,583,686,691–693,seealso inpregnancy 397–398 dilution 326
haemochromatosis;thalassaemia insepsis 548 isotretinoin 389
anddiabetes 533 isoketals 159,200,261,267–268, isouramil 366(struc.),477
effectonbone 451 270–271,275,283,331,333–335, isp-1mutant 657
ironoxide 583 341,449 Itai-itaidisease 499
nanoparticles 496 antibodiesagainst 334 itch 476,636
IsaacAsimov 199 D2-isoketal,seeunderD
ischaemia 140,202,349,354,388, E2-isoketal,seeunderE J
539(def.),549,seealsoischaemia- effectonproteasome 614
reperfusion;hypoxia-reperfusion; inhypertension 268
J2-isoprostanes 113,261(struc.),334
reperfusioninjury inischaemia-reperfusion 543
J4-neuroprostanes 268
ischaemia-modifiedalbumin 141,348, in neurodegenerative J1-phytoprostanes 369,371(struc.)
450 diseases 613–614 J-shapedcurve 481
ischaemia-reperfusion 13,55,92, isoleucine 346,515 JacquesCartier 156
101,111–112,119,143–144,146, James
isoleukotrienes 261(struc.)
151,162,202,209,230,232, Cook 157
isolevuglandins 261,268
235,257,267,281,293,303,362, Lind 157
isoluminol 333
386–387,398,426,428,443,448, Parkinson 615
isoniazid 365(struc.),437,557
468,484,512,539–553,556,665,
isonicotinicacidhydrazide 365 YoungSimpson 469
672,676,682–684,692,694,696, isonicotinylacylradical 365 JapanCollaborativeCohort 195
seealsohypoxia-reoxygenation;
isopenicillin-N-synthase 259 jasmonicacid 452,454(struc.),455
reperfusioninjury
isoprene 339,385,491–492 jaundice 69,143,338,363,401,seealso
andage 639
isoprenoid 473,615 bilirubin
inbiopsies 549
inbrain 599,603,606,607–611,628, N-isopropyl-N (cid:3) -phenyl-p- JeanneCalment 639
phenylenediamine 366 jellyfish 420
670,692,seealsostroke
isopropylhydrazine 365(struc.) jetlag 144
inCOexposure 549
isoprostanes 56,188,200,267– JNK 222,225,228–230,233,235,534,
ineye 548,665
268,331,333–335,350,369, 673
infreezing 549
509,515,530,558,seealso jocoistle 156
ingut 692
inheart 295,670,692,seealso
A2/D2/E2/F2/F3/F4/J2- John
myocardialinfarction;heart isoprostanes;A4/D4/E4/F4/J4- LangdonDown 125
failure neuroprostanes) Woodall 156
inkidney 671,692 artefactualgeneration 333–334 JosephPriestley vi,488
effectonoligodendrocytes 399
inliver 553,669,671 juglone 94,471,472(struc.),473,659
fasting 334
inlung 692 Jun 229,573,seealsoJNK
immunoassays 334
inrheumatoidarthritis 561 JurkatTcells 222,229
inAlzheimerdisease 625–629
inskin 692 juvenile
intransplantation 550–553 inARDS 528 haemochromatosis 135
inbrain 601–602,625–629
ischaemia-reoxygenation,see NCL 635
ischaemia-reperfusion inatherosclerosis 520,525 Juvenon 656
ischaemicpenumbra 607–608 inCGDpatients 433
ischaemicpreconditioning,see indiabetes 534–535 K
preconditioning inHDL 334
islets,pancreatic,seeβ-cells inhepatorenalsyndrome 267
Ka 705(def.)
isletamyloidpolypeptide 535 inlung 358 Km,forO2 54,433,561
8-iso-PGF2α 260(struc.),334 innakedmolerats 650,654 K-ras 447,573,595,seealsoH-ras,N-ras
isoamylnitrite 60 inobesity 531–532 K-shell 697
isocitratedehydrogenase 10,105,651 inParkinsondisease 618 kaempferol 175(struc.)
isodialuricacid 250 insmokers 492 kainate/kainicacid 568,599,604,606,
Isodonadenanthus 590 instroke 608 610,670
isoflavones 174–175,177 metabolismof 267 kale 393
isoflavonoids 184,418 sourceofprostaglandins 460 Kampomedicines 179
isoflurane 468(struc.),481,547,661 isoproterenol 474(struc.),475 kangaroorat 247
isofurans 200,262,268,331, isoquinoline 620 kaolinite 429
333–335,340 isosorbidedinitrate 57 Kareniamikimotoi 386
inobesity 531–532 isothromboxane 261(struc.) Kashin-Beckdisease 124

--- Page 921 ---

866 INDEX
Kat kinasereceptorinteractingprotein-1, TNFreceptor 235
A 116,119,220 seeRIP1 TNF-α 481
B 116,220 kinetics 32,34–36 α-TTP 165
E 116,133 KKAymouse 533 urateoxidase 146
G 116,133,220,309,365 Klebsiella 439 Krebscycle 10,12,14,20,26,96,130,
knockoutmice 104 379,534,598
KCNB1 654
AHSP 362 andageing 650
Keap1 230,272,281,497,683,seealso
apoE 178,517,521,523–524,527 Kuprotein 250
Nrf2
ATM 252 Ku70 606,647
andcigarettesmoke 494
Ca2+transporter 205 Kupffercells 127,142,363,426,440,
kelp 448
catalase 119,361,398,450,478,575 468,480–481,483,486,524,551,
Keshandisease 123,136
CuZnSOD 93–94,391,395–397,407, 567
α-keratin 50 451,486,534,574,607,609,627, Kurroapicroria 694
keratinocytes 229,235–236,402–408, 657 kuru 629–630
570,seealsoskin CYP2E1 486 KVS-1 654
differentiation 405 EC-SOD 140,231,444,552 kwashiorkor 104,168,200,211,344
growthfactor 234 G6PDH 398 kynurenicacid 416(struc.)
α-Ketoacids 64,144,661,seealso gp91phox 567 kynurenine 277,279(struc.),344,391,
pyruvate;α-ketoglutarate; GPx 122,124,231,361,450,566,609 416
glyoxylate GSTA4-4 273 pathway 415–416,599
H2O2scavenging 144,312,376,695 haemoxygenase 142 KyushuIsland 499
keto-enoltautomerism 322,680 haemopexin 141,605
2-keto-4-methylthiobutanoicacid 297 haptoglobin 141 L
(struc.) Hsp70 232 Lchains 129–131
6-keto-PGF1α 457(struc.),460 IGF-1receptor 644 L-012 319(struc.),321
iNOS 435
7-ketocholesterol 268,269(struc.), L-arginine 24,42,54,55(struc.),112
insulinreceptor 644
388,seealsocholesteroloxidation L-bandESR,seeESR
LDLreceptors 521,524
products L-NAME 305
12-/15-LOX 522
ketoconazole 661 L-NMMA 55(struc.),305
α-ketoglutarate 10,14,144,312,552 metallothionein 137,407,606 L-shell 697,701
MnSOD 91,391,407,483,627,657,
carriers 102 L-typeCa2+channels 620
659
decarboxylation 144 L1,seedeferiprone
MPO 439,443,561,617–618
dehydrogenase 10,26,144,154,612, MsrA 280,606 labileironpool 96,98,128–130,
626 MTH1 251,606 133–137,160,208–209,241,259,
dependentdioxygenase 130 MUTYH 251 317,688,seealsocatalyticiron;
non-transferrinboundiron
reactionwithH2O2 144,312 NADPHoxidase 434–435,581
inageing 660
ketoprofen 563(struc.) nicotinamide nucleotide
inamnioticfluid 397
KGF 234 transhydrogenase 534
incold 549
kidney 13,15,40,88,101–103,110,112, nNOS 599,617
inkidney 551
115,136–137,140,147,157,159, NOX1 230
inliver 551
161,186,192,209,211,223,240, NOX2 492,555,566–567,600
inlung 358
267,293,327,334,347,365,443, NOX3 446
laboratoryair 75,seealsoairpollution
449,456,458,460,463,467,470, NOX4 451,534
laboratoryanimals 548,640
473,475,482,484,486,499–501, NQO1 474
diet,vitaminEcontent 161
532,535,538,547,552,556,574, Nrf2 230,390,407
579,590,653,692,seealsorenal OGG1 251,606 laccases 417
aminoglycosideeffects 503 p47phox 566 lacquers 252
andage 639 PARP-1 478–479 lacrimalglands 93,391,393,552,
andMPO 450 peroxiredoxins 123,361,451,531, seealsotears
dialysis,seedialysis 603,605 lactacystin 282,620
prionprotein 630 lactasephlorizinhydrolase 176
preconditioning 551
stones 40,146,161
phospholipaseA2 594 lactate 10,42,112,122,204,313,540,
transplants 306,550–551 P pr O o N te - a 1 so 5 m 30 e 616,631 D- 5 la 7 c 0 t , a 5 te 98 1 , 1 6 2 03,608,632
Kiipeninsula 617 Prx2 603,605 dehydrogenase 10,46,88–89,99,
KillerRed 71 Prx3 531 213,598
kilocalories/kilojoules 22 PTEN 224 Lactobacillus 95,447
kinases 230,371,424,433,547,573, SVCT2 157,159 lactis 119
641,652,seealsoproteinkinases telomerase 648 plantarum 95,118,414

--- Page 922 ---

INDEX 867
lactobionicacid 552 receptorrelatedprotein1,627 leukocytosis 422
lactoferricin 692 seasonalvariationinperoxides 529 leukopaenia 422,443
lactoferrin 46,127–128,134,138–139, subclasses 527,530 leukoplakia 579,595
208,264,359,392,422,433,435, lead 127,134,348,497,500,501,568, leukotrienes 93,103,206,405,423,425,
477,555,652,661,686,691–692, 599,687 428,456–462,511–513,522,554,see
seealsomilk andAlzheimerdisease 628 alsoLTA4-E4
inARDS 554 andHgtoxicity 500 leupeptin 424
inbreastmilk 401 andlipidperoxidation 264 levuglandins 270–271,457,460–461,
inParkinsondisease 618 614
leafalcohol/aldehyde 455
inrheumatoidarthritis 560 inAlzheimerdisease 626
learning 140,434,599–600,605,622,
inseminalplasma 395
lewisite 497
628,666,seealsomemory
intears 390
Lewybodies 612,615–616,618,
lactoperoxidase 120,321,355,358,415, leaves 18,177,374–375,379,
621–622
439 381–382,384–385,455,562,
-H s 2 y O s 2 te -S m CN 55 –– 5 antibacterial s c e h e lo a r ls o o p p la h s o ts tosynthesis;plants; L L H GD O 2 N ,L 2 G 6 E –2 2 7 4 , 5 6 7 7 , 3 458(struc.),460
incancer 585 Leber hereditary optic Li-Fraumenisyndrome 573
oxidationofurate 321 neuropathy 26–27 lichens 121
S-lactoylglutathione 112 LEC,seeLong-EvansCinnamonrat licorice 179
ladderpattern,DNA 214–216 lecinoxoids 684 lidocaine 680
lag lecithin 42,253,254(struc.),256–257, lifespan 93–94,123,151–152,226,
time 329,448 358,seealsoLCAT;LRAT; 280,639–640,649,seealsoageing;
period/phase 525–529 phosphatidylcholine centenarians;healthspan
lambs 161,223 lecithinisedSOD 594,663 and8OHG 649
laminA,C 646 lectin 428,431 andcatalase 657,659
Laminariales 448 likeoxidizedLDLreceptor-1 520, andexercise 640,660
lanthanides 701 538 andmetabolicrate 640
LAP(oxidized/reduced) 690(struc.), leghaemoglobin 79,264,382 andmitochondrialoxidative
693 damage 657
Legionella 80,133,445
lapachol 472(struc.),473,590 andproteinsynthesis 647
leguminousplants 79,113,127,357,
laparascopicsurgery 541 canary 649
381–382,seealsorootnodules
Larrea Drosophila 657–658
Leishmania 115,140,417
divaricata 179 effectofantioxidants 656
lemon 155–157
tridentata 678 inyeast 646–647
lens 19,101,130,312,386–394,505,
larynx 192, 481, see also longevityofcontrols 656,658
507,536,538,655,seealsoeye;
nasopharyngeal nakedmolerat,seenakedmolerats
cataract
cancer 490
parrot/pigeon/quail 649
epithelium 387–388,391
late
rat 649
infantileNCL 635 fibres 386–387
roleofSIRT 647
preconditioning 549 nucleus 386,390–391
smoking 660
lateraleye 393 O2levels 390
ligase 203,248–249
lauricacid 587 leporipoxviruses 219
light
Lavoisier vi leprosy 556
harvestingcomplexes 371,373,
lawsone 472(struc.),473 leptin 532–533,644
377–378
lazaroids 524,546,610,680 Leptospermumscoparium 63
inducedretinaldegeneration 388,
LC-MS 298,323–326,333,340,345 Leptospira 95
392,669,676,679,seealsoretina
LCAT 274,494,530 lethalNAD+depletion 203,479,595, stressinplants 385–386,seealso
LDH,seelactatedehydrogenase
602 photoinhibition
LDL 77,131–132,136,141,146,148,
151,165–166,168,171–172,177, lettuce,H2O2production 452 lightproduction 419–421,seealso
183,195–196,212,263,267,276, leucine 27,91,277,345–346,515 chemiluminescence;luminescence
331,335,350,448,471,501, aminopeptidase 103 fromexhaledair 309
517–531,533,535,539 hydroxide 387 inlipidperoxidation 339
acetylated 519 richrepeatdomains 439 lignans 418
AGE 538 leukaemia 128,191,209–210,343,476, lignin 121,177,417–420,452
antioxidantdefences 526–529 497–498,569,573,578,581–583, peroxidase 419
exvivooxidation 525–530,seealso 590–591,636 limeys 157
oxLDL celllines 436 limonene 68,404
minimallymodified 520 leukocytes 234,266,301,314,328,409, Limulus 393
receptor-deficientmice 521,524 seealsophagocytes;neutrophils linearaccelerator 35

--- Page 923 ---

868 INDEX
linoleicacid 50,63,168,253,255 cytotoxicaldehydes 270–274,seealso lipidrafts 162,256
(struc.),257,259,265,269–270,331, HNE;HHE;malondialdehyde asartefacts 266
350,362,374,453–455,527,530 effectofdeuteration 696 lipidomics 340,507,645
conjugated 63,331 effectofO2concentration 258,262, lipoamide 144,693
hydroperoxide 220 267–268,334–335,339,526 lipoatesynthase 413
nitrated 63 effectofPb 264 lipoatrophy 638
reactionwith1O2 264 effectofsteroids 680 lipocalin 133,141,382,384,390,392
linolenicacid 50,63,196,255(struc.), fluorescentendproducts 271, LipoCardium 684
257,259,267,270,369–370,374, 339–340,609 lipofuscin 658–659,seealsoceroid
401,454–455,468 haem/haemoglobin/myoglobin 262, ineye 388,390
nitrated 63 334,522 lipoicacid/dihydrolipoate 125,
linseedoil 252 haemolysiscausing 334 144–146,145(struc.),406,508,605,
linsidomine,seeSIN-1 historyof 252 656,661–662,682–683,690
LinusPauling 159 HOBr/HOClaction 265 andgeneexpression 656
Linxianstudy 189,191,198 inAlzheimerdisease 624–627 andpain 636
Liperfluo 342 inBPD 400 inALS 632
lipid(s) inbrain 601–602,605,680 inAlzheimerdisease 627–628
asantioxidants 274 incancer 579–580,583,587 inbraininjury 611
bilayer 255,256,637 inchloroplasts 379 inchemotherapy 595
contaminationbyperoxides 259 inCOtoxicity 549 indiabetes 539
emulsions 165 incysticfibrosis 555 inHuntingtondisease 634
infusions,seeparenteralnutrition indiabetes 534–535 inmultiplesclerosis 607
mediatorclassswitching 426 inear 402 inrapidlyageingrodents 658
metabolism 638 inerythrocytes 362–369 inshock 547
radicals 266,552,555 ineye 388,390 instroke 610
whisker 266 ingastrointestinaltract 354–356 mitochondriatargeted 684
lipidperoxidation/hydroperoxides/ inIBD 566 lipopolysaccharide 54,227–228,244,
421,430,seealsoendotoxin
peroxides 18,19,27,30,40,48–50, inischaemia-reperfusion 545
lipoproteins 53,110,132,134,146,
53,62,77–78,99,110–111,113,123, inlupus 556
158,162,164,167–168,170,172,
132–134,136,139–140,142,146, inmitochondria 266
256–257,259,267–268,274,329,
149,151–152,158–162,164,167, inmultiplesclerosis 607
331–332,357,466,555,635,662,
173,176,178,187,200,203–204, innakedmolerats 650
seealsoLDL,HDL
2 2 8 3 3 0 , ,2 3 3 2 8 8 , , 2 3 4 3 6 1 , –3 2 3 5 5 2 , –2 3 7 4 5 2 , , 2 3 5 5 2 4, ( 3 d 5 ef 7 .) , , i i n n N pa C in L 6 6 3 3 5 5 (a) 531,533
365,381,384,386,388,405,408, inParkinsondisease 618
associatedphospholipaseA2 530
lipase 166–167,171
442–443,451,458,462,466,469, inplacenta 397
liposomes 40,124,255–257,259,339,
471,477,479,482–483,489–490, inplants 369
501,592,665
499,503,509,512–513,520,522, inRettsyndrome 633
encapsulatedSOD 408
524,530,611,613,662,669,686 inrheumatoidarthritis 559,562
multilamellar/unilamellar 256
andageing 653,658–659 instomach 354
lipotoxicity 480
andaluminium 264,501,628 instoredfluids 557
lipoxins 425–427,430,456,460–461,
andasbestos 496 insperm 395
554,562
anddieselexhaust 495 instroke 608–611
A4 425(struc.),426
anddiet 266,354,526 intransplantation/rejection 550 lipoxygenases,seeLOX
andliverfibrosis 480–483 inurine 331,334,336,338–339 Listeriamonocytogenes 91,102,133,
andparacetamol 486 initationof 43,256–257,468,489 434
anti-inflammatoryeffects 267–268, lightemissionduring 339,seealso lithium 48,655,700(struc.)
274,607,684 chemiluminescence ionbatteries 48
antibodiesagainst 215,267,331,334, microsomal 259,264 peroxide 48
482,524,556–557,607 peroxidetone 459 phthalocyanine 287
artefactual 334,336,557 repairof 266,274 superoxide 48
assays 267,329–343 roleinapoptosis 218–219,267 lithotripsy 40
azoinitiators 265 roleofcopper 263 liver 13,15,16,17,24,26,34,54–55,
biologicaleffects 265–275,607 roleofiron 259–263 65,68–69,79,81,84–85,87–88,91,
carbonmonoxidefrom 549 roleofO • 2 –/hydroperoxyl 43,257 93–94,98,101–104,110–112,115,
COXassay 332 seasonalvariation 529 117–118,122,125–129,131–132,
cytochromeccausing 218 1O2formation 265 135–137,140–143,153,155,159,
cytochromesP450 265 visualizationof 333,336,341–343 165–166,168,170–171,179,213,

--- Page 924 ---

INDEX 869
230–231,244,267,270,289,293, gradeinflammation 532,549,651, carotenoids 183
313,328,341,347,363,367,391, 655,seealsoinflammaging collapsed 553
422,426,434,440,463,465–470, levelchemiluminescence 309,339, fibrosis 594
474–476,484,496,498,530, seealsochemiluminescence lavagefluid 334,528
532–533,541,553–554,573,575, molecularmassiron 128,134,208, liningfluids 104,110,132,138,159,
577,583,605,644,653,655,671, 551,seealsocatalyticiron;labile 208,210,347,358–359,441,482,
seealsobile;bileducts;cirrhosis; ironpool;non-transferrinbound 489,492,494,528,553–554,637,
fattyliver;hepatitis;hepatocytes; iron 655,seealsorespiratorytractlining
NAFLD;NASH pHasneuroprotective 608 fluids
cancer 135,147,191,251,469, spinstate 37 maturation 400
480–483,490,497,531,568,571, LOX 173,178–179,260,309,426,452, NADPHoxidases 399,445–446,
574,577,582–583,587–588,636 458–459,512,520–522,526,530, 553–554
effectsofalcohol 480–481 562,582,680 transplantation 511,553–554
endothelialcells 524 animal 456–462 xanthineoxidase 553
failure 104,212,348,468,483,486, dualspecificity12/15-LOX 522 lutein 169(struc.),170–171,185,190,
551,568 inatherosclerosis 521,523 378,387,393,555
fataccumulation 483 ingastrointestinaltract 356 inbrain 605
fibrosis 135,480,483,568 inplants 453–456 incentenarians 659
fluke 115,346,465,567,582 inhibitors 184,455,462,632,677–678 inLDL 527,529
humanvs.rat 474 5-LOX 169,522,683 luteinizinghormone 395
ironoverload 481 12-LOX 105,522,625 luteolin 175(struc.)
ischaemia-reperfusion 551,673,695 15-LOX 520,522,625,683 LY178002 678(struc.)
necrosis 483 LOX-1 520 LY256548 678(struc.)
nuclearfactor-1α,seeHNF-1α LPBNAH 656,667(struc.),672 Lyciumbarbarum 393
rateofH2O2production 313 LPS,seelipopolysaccharide lycopene 169–173,169(struc.),190,555
stellatecells 267,480,483 LRAT 389 inbrain 605
transplantation 135,339,486,551 LRP1 627 inchemotherapy 595
triglyceridelipase 166–167 LTA4 461(struc.),462 inLDL 527,529
vitaminEmetabolism 165–167 LTB4 423–426,430,432–433,461 inskin 406
Lmo4 61,402 (struc.),462,522,636 instability 173,190
locuramanganica 37,475 LTC4 461(struc.),462 1O2scavenging 172
locuscoeruleus 615 LTD4/E4 461–462 radicalcation 173
luciferase 214,309,316,420 lycorine 381
lomefloxacin 502
Lonproteinase 281,382,652,655 ROSproductionby 309 Lymedisease 95
luciferin 89,214,309,316,419–420 lymph 167,426–427,541,570,581
lonepair 81,703(def.)
lucigenin 88,299,319(struc.),321,445 nodes 228,426–427,434,447
long
luminescence 80,309,seealso lymphocytefunctionantigen1,429
chainfattyacids 633
chemiluminescence lymphocytes 20,160,215,222,225,
EvansCinnamonrat 137,294,329,
bacteria 80,440 234–236,241,324,327,355,
583
earthworms 420
363,405,409–410,421,422,427,
patchBER 248,seealsobaseexcision
fromplasma,bloodandbreath 446,449,476,481,507,521,
repair
condensate 309 556,566–567,606,609,637,655,
termmemory 599
luminol 88–89,319(struc.),321,350, 692,seealsoB-lymphocytes;
termpotentiation 600,603,654
longevity 151–152,641,643,679, lun 3 g 52, 5 4 , 4 8 5 , , 1 4 3 5 , 9 1 , 8 5 , 0 1 9 9,25,45,65, cel T l - l l i y n m es ph 63 o 8 cytes
seealsoageing;lifespan
andmitochondrialO • 2 –/H2O2 7 1 0 0 , 8, 8 1 4 2 , 2 8 – 8 1 , 2 9 3 1 , , 1 9 2 4 6 – – 9 1 5 2 , 7 1 , 0 1 1 3 – 2 1 , 0 1 3 3 , 7, l l y y m m p p h h o o k m in a e 1 s 9 2 1 3 , 4 219,223,573–575,
production 657 140,159,183,202,204,206, 577–578,588,671
determinantstheoryofageing 642 219,223,247,266–267,294,301, lymphotactin 234
determininggenesandoxidative 328,331,334,339–340–341,347, lymphotoxins 234
damage 659 357–360,361,386,399,402,426, Lyn 424
DNArepair 646,655 430–431,434–435,439,443,467, Lynchsyndrome 251
longitudinalstudies 180,182 469–470–471,476–477,486–490, lyophilization 21,116
lordokyphosis 644 492–493,495–496,499,505,575, Lyophyllumconnatum 114
losartan 661 634,655,670,681,692,seealso lysine 91,112,206,268,270–271,277,
LouGehrigdisease 630 alveoli/alveolar;respiratorytract 279(struc.),281,336,338,344–346,
LouisCamilleMaillard 535 cancer 183,187,189–194,251–252, 440,515,531,536,558,664
low 393,439,490,494–498,532,576, 2,3-aminomutase 413
densitylipoprotein,seeLDL 579,587,622,681 acetylation 85–86

--- Page 925 ---

870 INDEX
lysine(continued) magnetic inParkinsondisease 618
argininecrosslink 537 quantumnumber 697(def.) inphotosynthesis 373–374
inglycation 536–537 resonanceimaging,seeMRI inradiation 509
lysophospholipids 266,530 MAHMA 57(struc.) ores 47,475
lysosomes 65,79,128–130,135–136, maidenhairtree 179 peroxidases 419–420
140,201,208,215,280–281,282, Maillardbrowning 354,535–539 phosphate/polyphosphate 38,664
316,367,389–390,405,424,430, maize 82,112,115,377 polyphosphate 664
448,508,606,615,633,690–691, majorbasicprotein 422,440 porphyrins 508,664,666
693 malaria 92,134,367–369,440,447,514, reactionwithO •– 38,95,300,664,
2
andagepigments 658 645,seealsoanti-malarials 668
andiron 281,405 maleicacid 676 mannitol 42,97,139,257,296,384,445,
inNCL 635 3-(N-maleimidylpropionyl) 452,478,661
lysozyme 49,422,433,441,560,629 biocytin 343 asOH • scavenger 453
lysyl malicenzyme 102 inischaemia-reperfusion 542
hydroxylase 3,14,155,157 malonate 568,599,603,605,634 inorganpreservationfluids 552
oxidase 37,63,346,407,575,578, semialdehyde 270 Manukahoneys 63
581–582,590 malondialdehyde 143,159,200,209, MAO 26,63–64,204,463,602,617,
239,262,270,271(struc.),275,283, 619–621
M
296,299,329,339,356,462,469, andage 650,653
Mphase 569 515,524,526,531,593 inhibitors 602,661,693
M10/M30 632,693(struc.) adducts 271–272,323,328–329,340, MAPkinases 221,222,225,229
M40401 664,667(struc.),669–671 482,492,556 Marburgvirus 637–638
M40403 557–558,664,666,667(struc.), andageing 653 MarcoPolo 124
669–671,684 artefacts 337 margination 423
M-CSF 518 fromaminoacids 338 marine
M14 219 fromcarbohydrates 338,seealso derivedtocopherols 162
M-shell 697,701 2-deoxyribose organisms 121,151,159,307,415,
macaques 645 inatherosclerosis 143,523 417,420,458
macroautophagy 281 inbreath 339 marsupials 247
α 2-macroglobulin 65,131,233,237, incancer 580 mastcells 235,440–441,462,582
424,432,441,488,561 ingastrointestinaltract 356 MAT 482
asachaperone 424 inSLE 556 maternal,seealsobabies;foetus;
chlorination 441,559 innakedmolerats 650,654 placenta;pregnancy
oxidation 559 inpriondisease 630 foetalcirculation/connection
macrophages 54,92,126–127,132–133, insleepapnoea 549 397–398
135,140,215–216,219,231, measurement 335–343 intra-placentalcirculation 397
235–236,357,363,390,421–445, modifiedLDL143 irondeficiency 401
451,462,468,491,493,497,516, modifiedproteinsasDAMPs 421 plasmacholesterol 517
518,520–521,523,530,532,538, mutagenicity 270,337 smoking 490
560–561,579,582,594,597,636,658 polymers 340 matingsignal 105
anderythrocytes 426 TBAassay,see(TBA)2-MDA,TBARS matrilysin 424,429,441,517,594
colony-stimulatingfactor,seeM-CSF malonylgroup647 matrixmetalloproteinases(MMP) 92,
elastase 424,432 mammarygland,seebreast 169,178,184,236,276,356,
glutathione 520 mancaniilla 156 404,406,424,429,442,444,502,
inatherosclerosis 518–523 maneb 619 518–520,523,545,548,560,562,
inbrain 607 manganese 25,28,37,43,47,62,81, 576,581,583,602,609
incancer 581,583 85–86,95,118,126–127,134,154, inmultiplesclerosis 607
ironoverload 368,426–427 220,263,302,374,412,420,475, MMP-7 424,429–430,594
M1,M2type 426–427,519,532,583 491,495,497,568,593,700(struc.) maturityonsetdiabetesoftheyoung,
M2→Mrestransition 427 andPerR 220 seeMODY
removalofneutrophils 422,426–427, chelates 95,420,664,666,669,687 massnumber 697(def.)
430,441 desferal 546,664 massspectrometry 76,148,188,293,
macula/maculardegneration 71,170, di-manganesetyrosylradical 412 302,306–307,315,323,325,327,
386–390,393–394,490,514,548, dioxide 59,350 330–331,333,335,337,339–340,
555,629,639,seealsoeye import,regulationbyOxyR 220 344,346,577,seealsoGC-MS;
madcowdisease 630 inbrain 37,475,600 LC-MS
Madopar 617 incatalase 4,95,118 artefactsofoxidation 275
magnesium 154,200,496,638,687,700 inlipoxygenases 454 maximumlifespan 639
(struc.) inoxalateoxidases 369 MCI 195,622,627

--- Page 926 ---

INDEX 871
MCLA 319(struc.),321 MEOS,seemicrosomalethanol andSOD 576,665
Mclk1 657,659 oxidizingsystem bonepain 635
MCP-1 234,518,520,536,560 mercaptoethanesulphonicacid 683 metazoans 2,8
MCSF 234 mercaptoethylamine,andlifespan 656 Metchnikoff 421,427
MDL 74,405,673,675(struc.) mercaptoethylguanidine 666(struc.), metformin 661
MDM2 573–574,647 682 methadone 16
MDMA 92,294,484,485(struc.) mercaptopropionylglycine 109,295, methaemoglobin 25,55–56,60,303,
meanlifespan 640 508,661,666(struc.),682 360,364,366,473,477,500
meat 21,56,126,132,149,187,196–197, mercaptosuccinate 109(struc.),568 reductase 361,364,399,401,477
277,331,338,354,536,570,588, mercapturicacids 112,273,467,486 methamphetamine 92,484–485(struc.),
seealsoredmeat;tinnedmeats mercury 118,137,197,497,499–500, 568,617
andstroke 611 568 methane 2,23,41,298,413,434,465,
Parmaham 270 mesalamine/mesalazine 566 491
preservation 55,168,661 mesangialcells 450 methanesulphinicacid 298
mechanicalventilation 408,543,554 mesenchymal 581 methanol 42,118,291,297,299,
mechanistictargetofrapamycin,see MESNA 667(struc.),683 310–311,313,329,331,337,467,
mTOR mesothelioma 576 483
meta-tyrosine 277–278(struc.),294–296, methcathinone 475
meciadonol 175(struc.)
307,345,387,494,seealso methional 297(struc.),420,435,459
Medicagosativa 386
o-tyrosine;tyrosine methionine 42,43,60,65–66,71–72,
Mediterranean 363–364,366
inatherosclerosis 521 75–76,89,91,102–103,107,141,
diet 183,187
inbabies 400 196–197,204–205,218–219,221,
mefenamicacid 562,563(struc.)
incancer 296 247,275–277,279(struc.),282,307,
MEG,seemercaptoethylguanidine
indiabetes 539 344–345,391,413,437,440,482,
megakaryocytes 451
metabisulphites 490 490,515,521,528,530,543,598,
Meganeuramonyi 5
metabolic 615
Mehlerreaction 376
intensity 649 adenosyltransferase 482
melanin 149–151,171,286,367,406,
rate 640,649–650 cycle 280
445,629,seealsoneuromelanin
syndrome 251,483,533(def.),539, inAlzheimerdisease 625–628
ineye 387,391–392
683 incalmodulin 205
melanocytes/melanosomes 150,402,
metabolomicsandageing 645 incaloricrestriction 640
406,629
metabotropicglutamatereceptors 599 inpancreatitis 567
melanoma 128,151,190–191,194,219,
metallochaperone 81 inparacetamoltoxicity 486
404,570,576,578,581
metalloelastase 517 inprions 630
melanoticencapsulation 367
metallophthalocyanineelectrodes 303 radicals 276
melanotransferrin 128
metalloporphyrins 303,495,662,664, sulphone 277,279(struc.),345
MELAS 27,673
666,669 methioninesulphoxide 60,65,72,
melatonin 144–145,145(struc.),661, metalloproteinase 131,424,520,seealso 275–276,279(struc.),344–345,348,
663 MMPs 387,406,456,530,622
membrane metallothionein 61,65,78,94,131,136, antibodiesagainst 345
attackcomplex 430 137–138,154,232,235,381–382, inionchannels 204
blebbing 206–207,213,216–217,222, 407,478,497,499–502,608,652, inParkinsondisease 618
366,473 661 methioninesulphoxidereductases 107,
fluidity 256,265,385,394,456 andlifespan 660 110,124,154,280,296,355,358,
hypothesisofageing 642 inbrain 606,626 382,385,445,563,652
permeabilization 502 inchemotherapy 592 actiononcrystallins 392
potential 206–207,218,596,621 inembryos 396 andhearing 402
stabilizationbyZn2+ 154 ineye 392 andlifespan 658
structure 253–256 inoocytes 396 DMSOassubstrate 280,296
memory 92,140,179,195,231,434, inskin 407 inbrain 606
596,598–600,603,622,666,seealso knockout,seeknockoutmice ineye 392
learning MT-1 2,137,392,407 inH.pyloriinfection 567
cells 422 MT-3 137,392,606 inphagocytes 442
menadione 94,207,220,369,471,472 MT-4 137 inplants 384–386
(struc.),473–475,590 metaplasia 567(def.) MsrA,B 280,382,606
meningitis 64,321,402,434,606–607, metarhodopsin 389 MsrR,S 280
636,671 metastasis 184,202,215,440,570–571, methotrexate 562,563(struc.),588,590
menopause 126,151,187,660 580,581,582–583,590 3-methoxy-4-hydroxyphenylacetic
menstruation 126,134,398,660 andcatalase 665 acid 310–311

--- Page 927 ---

872 INDEX
methoxyclor 396 humanrelevance 632 Miquel 649
2-methoxyoestradiol 81,89,244,590 knockout,seeknockoutmice mismatchrepair 247,249,251,499
3-methoxyphthalicacid 592(struc.) lifespan 640 misonidazole 506(struc.),509
methyl/methylation 144,176–177,463, obese 531–532 mis-sensemutations 616,631
497,585,588,617 overexpressingCuZnSOD 478 mito-Bodipy-tocopherol 343,684
chloride 465 redoxatlasof 106 mito-HE 320
donors 197 skin 570,577 mitoB 313,315(struc.),684
mercury 499 micelles 255–256,259 mitochondria 1–3,5,6,15,63–64,67,
parathion 395 Michaeladdition 273,484 85,87,91,96,105–106,110,112,
radical,ESRspectrum 286 miconazole 503 118–119,122,128,130,205,277,
viologen 383,seealsoparaquat microaerophiles 7,90 357,386,394,496,511,547,592,
2-methyl-1,3-butadiene 339,385 Microalbuminuria,Cardiovascular, 635,seealsocomplexI,II,III,IV,V;
methyl-CpGbindingprotein-2 633 andRenalOutcomesintheHOPE electrontransportchaininhibitors
N-methyl-D-aspartate 599 study(MICRO-HOPE) 186–187 aldehydedehydrogenase 57,480
α-methyl-DOPA 475,557 microautophagy 281 aldehydesin 337
7-methyl-8-hydroxyguanine 324 microbialpeptides 425–426,seealso andageing 649–654,657,659
N-methyl-N(cid:3) -nitrosoguanidine 584, fmet-leu-phe andNCL 635
586(struc.) microdialysisprobe 512 andSODmimetics 669
N-methyl-(R)Salsolinol 620 microfluidicchip 298 artefacts/caveats 9,11–12,26,
3-methyl-1-phenyl-2-pyrazoline-5- microglia 440,496,499,502,596–598, 649–651
one 680 600,602,610–611,613,620–621, ascorbatemetabolism 157
4-methyl-2-phenyl-5(pyridin-3- 647,652 ATM 252
ylmethyl)-1H-pyrazole[4,3-c] andHIV 637 ATP-dependentK+channel 547
pyridine-3,6(2H,5H)dione 694 andpain 635–636 autophagy 281
1-methyl-2-phenylindole 339 inALS 632 biogenesis 225,647,650–651
3 (cid:3) -O-methyl-epicatechin 178 inAlzheimerdisease 625–626 Ca2+metabolism 9,204–208,599,
methylamine 491 inParkinsondisease 617–618,620 608
methylazoxymethanol 584 α 1-microglobulin 141 carbonylcontent 538
methylcholanthrene 16,572 β 2-microglobulin 629 catalase 26,118,122,226,252,seealso
5-methylcytosine 238,244,246,578 micromolar/micromole 705(def.) mitochondriallytargetedcatalase
methyldopa 474(struc.) microperoxidase 333 CoQ10 12
α-methyldopamine 484,485(struc.) microsomes 27,118,128,259,264(def.), damagebyAZT 638
methyleneblue 67,68(struc.),332 292,311,337–338,468,470,481, damagebyparacetamol 486
methylenedioxyamphetamine 92,484, 490,501 DNA,seemtDNA
485(struc.) electrontransport 577,591 DNApolymerase 245,251,638,650
methylenetetrahydrofolate 196–197 ethanoloxidizingsystem 481 DNArepair 245,250–251
methylglyoxal 63,100,111,149,154, lipidperoxidation 259,264 effectofglucose 535
377,380,420,488,537–538 triglyceridetransferprotein 168 effectofradiation 508
andpain 635 microtubules 62,205,280,569,615, effectofzinc 502
methylmalonyl-CoAmutase 413–414 622,634 electrochemicalgradient 12,320,686
methylnitrosourea 479 midgut 367,654 electrontransportchain 9,25,33,55,
methylprednisolone 680 Mig 518–519 96,131,146,154,215,292,300,321,
4-methylsulphinylbutyl migration 202,236,440,447,449, 465,538,600,609,652
glucosinolate 184 seealsometastasis electrontransportchain,leak
N5-methyltetrahydrofolate 197 studies 180 rates 650,652
4-methylthio-2-oxobutyrate 420 mildcognitiveimpairment,seeMCI evolutionof 13
metmyoglobin 25,56,350 milk 15,66–67,110,120,127–128,146, females 152
metoprolol 661 233,265,277,seealsolactoferrin fission/fusion 9,106,226,598,604,
metronidazole 505,506(struc.),509 thistle 483 621,626
mev-1 642,651 vetch 124 fission/fusionandageing 651
M1dG 272(struc.),323,328–329,580 millimolar/millimole 705(def.) glutathionelevel 102,604
MG132 282 millipedes 120 glycationandO
•–production
538
2
micalprotein 219,280 MinamataBay 499 gradientofredoxpotential 33
mice/mouse miniferritins 130 heatgeneration 13,549
embryonic C3H/10T1/2 minimallymodifiedLDL 520 heterogeneity 650–651
fibroblasts 574,648 miniSOG 71 H2O2 levels 471,653,seealso
humandifferences,seerodent- minocycline 502,503(struc.),610,632, mitochondrialH2O2production
humanvariations;inter-species 634 H2O2removal 122
differences MIP 234,442,444,637 inbipolardisorder 633

--- Page 928 ---

INDEX 873
inbirds 26,649 mitochondrialO
•–production
13,14, ML171 695(struc.)
2
inbrain 598,600,604,616,625–629 25–26,29,170,394,399,449,465, Mn(IV)Fe(III)cluster 412
inburns 408 482,511–512,534–535,551,585, MnDiM-4-PyMAn-Corrole2+ 668
incancer 576,581 603 MnSOD 25,37,61,81,85–87,89,91,
inischaemia-reperfusion/ andageing 653,657,659 94,96–97,125,138,154–155,199,
preconditioning 544,547 andcaloricrestriction 651 220–221,225–226,232,235,252,
inductusarteriosus 399 effectofglycation 538 302,309,358,379,382,384–385,
inbirds 649 403,407,470,476,478,502,508,
inerythrocytes 360
incancer 578,582 548,554,617,653,661,665
ininflammasomes 444
fromCO 549 andageing 645,660
inlivertransplants 551
mitochondriallytargeted andasbestos 497
inplacenta 397
inhibitorsandcytochromec 507,684 andAZT 638
inresponsetocold 549
antioxidants 226,236,381,408–409, andcaloricrestriction 651
inSIRS 541
483,503,535,545,547–548,551, andethanol 483
innermembrane 13,26,64,157,165, 620,656,684–686,seealsoMitoQ, andHIV 638
218,253,381,684
SkQ1etc. andmetastasis 576
intermembranespace 12,26,79,102, •
NO donors 54,305,547,684,685 andoxalateoxidase 369
106,217,631
(struc.) andp53 575
ironmetabolism 128–129,633 peptides 686 andradiation 508
matrix 12,26,100,102,122,313, peroxidedetectors 313,315,343 antibodiesagainst 638
320 probeforcarbonyls 537 asastressprotein 232
nuclease 620 mitochondriallytargetedcatalase 684 chimeric 552
NOS 55 actiononbone 451 cytoplasmic 85
O • 2 s – ee co a n ls c o en m tr it a o t c io h n on 2 d 6 r , ia 3 l 00 O , • 2 3 – 20, a a n n d d A lif l e z s h p e a i n me 6 r 5 d 7 isease 627 e fe ff m ec a t le o s fe 1 x 5 e 2 rcise 660
production mitoE2 685(struc.) inataxiatelangiectasia 576–577
outermembrane 12,26,160,217, mitogen-activatedproteinkinases,see inbrain 599–600,603–604,609,617
451,602 MAPkinases inC.elegans 651,657
oxidativeproteindamage 277 mitogenic/mitogenesis/mitosis incancer 574,576,583,592
penetratingpeptides 686 222–224,277,280,396,443,520, inDeinococcus 509
peroxiredoxins 108,122,361 569,588,590,639,648,seealsocell indiabetes 534
plant 369,379 cycle;celldivision;proliferation ineye 391,393
pO2 5,78 oxidase 1,447 inFanconianaemia 577
proteindegradation 281 mitohormesis 657 infoetallung 399
qualitycontrol 9,622,seealso mitomycins 28,475,509,588,589 inischaemia-reperfusion/
mitochondriafission/fusion (struc.),591 preconditioning 542,547,549,552
redoxsensor 399 mitophagy 281,326,622,651 inliver 551
roleofparkin/PINK1 621–622 mitoP 313,315(struc.) inmuscle 409
ROSinTNF-αaction 235 MitoParkmouse 620 inphagocytes 442
mitoPerOx 343 inplacenta 397
ROSproductionbyauranofinin 565
mitoPeroxidase 685(struc.) inplants 385–386
ROSsignallingtonucleus 226,247,
659
o-Mi
3
to
1
P
6
h
(s
B
t
(
r
O
uc
H
.)
)2/o-MitoPhNO2 315, i
in
n
h
s
i
k
b
i
i
n
tio
4
n
07
byO •– 85,509
SIRT 647,651 2
o-MitoPhOH 316(struc.) knockoutmice,seeknockoutmice,
superoxidedismutases 13,25–26,87
mitoPY1 315 MnSOD
swelling 13,208,217
MitoQ 483–484,550–551,620,632,685 nitrationof 62,306,358,393,450,
thioredoxin 107–108,122 (struc.) 486,550–551,553,576,599,611,
transcriptionfactorA 620 mitoSNO 547,684,685(struc.) 636
vitaminEcontent 162,167 mitoSOD 685(struc.) regulationof 85,576,651,seealso
mitochondrialencephalomyopathy, mitoSOXRed 320 sirtuins
lacticacidosis,andstroke-like mitoTEMPO 543,547,672,684 withheparin-bindingdomain 665
episodes 27 mitoTEMPOL 685(struc.) MnTBAP3– 668(struc.),670–671,
mitochondrialH2O2production 14, mitoTrackerRed 321 700–701
310,313,399,471,532,534–535, mitoxantrone 589(struc.),592 contamination 669
585 mixed MnTDE-2-ImP5+ 487,632,664,666,668
andageing 653 disulphides 82,105(struc.),107,109, (struc.),669–671
andcaloricrestriction 651 141,221,471 MnTE-2-PyP5+ 400,592,664,666,668
andlifespan 657,659 functionoxidases 16,142 (struc.),669–671
inbirds 649 tocopherols 162 MnTM-2-PyP5+ 671

--- Page 929 ---

874 INDEX
MnTM-4-PyP5+ 664,669–671 mothercell 280,646 Mresolution(Mres) 427
reactionwithONOO– 669 motor MRI 287,293,348,601
MnTnBuOE-2-PyP5+ 664,666,668 ofmultiorganfailure 541 contrastagents 496
(struc.),669,671 neurons 612,630–632,657–658 mRNA 252,313,614
MnTnHex-2-PyP5+ 664,666,669–671 neurondisease 630,seealso oxidation,inAlzheimerdisease 627
MODS 541,553,556 amyotrophiclateralsclerosis splicing 247
MODY 533 mouth,seeoralcavity Msr,seealsomethioninesulphoxide
MOG,seemyelinoligodendrocyte movementdisorders 614–615,620 reductase
glycoprotein MOX1 447 mtDNA 13,14,26,92,225,325,587,
molarity/moles 705(def.) MPDP+ 617,619(struc.) 620
molecularorbital 20(def.),22,703 MPO 55,65,120,132–133,139,144, andageing 649–651
molsidomine 57 148,252,274,306–307,317,321, andAZT 638
MoLT7 448 415,421,430,433,436–439,441, asaDAMP 421,557
molybdenum 24,37,189,490,497,542 443,450,477,488,494,556,558, deletions 26,245,404,618,626,650
monkeys 161,246,392,539,621,629, 593,652 inbrain 600
637,641,645,651,653,665 actiononHDL 531 inCOPD 493
monoamineoxidase,seeMAO andageing 653 inrheumatoidarthritis 559
monobromobimane 347 andbenzenetoxicity 476 inskin 404
monochloramine 437,567 andcaeruloplasmin 132 insperm 394
monochlorodimedon 66,307 andcardiovasculardisease 521 oxidativedamageto 27,245,557
monoclonalantibodies 71,302,327, andnanoparticles 496,665
MTH1 248,251–252,388,409,606,648
422,428 antibodiesagainst 443,450
andcancer 575
oxidationof 275 asacatalase 438
andlifespan 655
monocytes 115,169,234–236,421–445, ascorbateinteraction 441
inchemotherapy 590
460–461,518–520,523,532,538, chemotacticagent 443
knockout,seeknockoutmice
560,566–567,637 damagetokidney 450
overexpression 251
antibodiesagainst 556 effectonneutrophils 443
MTH2 3,248
chemoattractantprotein1,seeMCP-1 inadversedrugreactions 557,565
mtNOS,seemitochondria,NOS
inatherosclerosis 518–523 inatherosclerosis 517,521
mTOR 281,645,647
inbrain 607 incancer 585
andageing 647
incysticfibrosis 555 inchronicinflammation 443–444
MTT 213
inflammatoryproteins,seeMIP incysticfibrosis 555
MUC5AC 493
migration 169,538 inischaemia-reperfusion 544–545
mucolipidosistypeIV 635
sensitivitytoROS 443 inmacrophages/monocytes 436
Mucomist 681
monodehydroascorbatereductase 357 inneurodegenerativediseases 443,
mucositis 590,671
monoformazan 47 617–618,625–626
monofunctionalglycosylase 249 inspinalcordinjury 611 mucus 120,126–127,134,138–139,
7-monohydroxyethylrutoside 686,689 inborndefectsin 439 331,355,358–359,493–494,541,
554–555
(struc.) inhibitorsof 437,443,521,661,694
monokines 234 knockoutmice,seeknockoutmice, hypersecretion 477
inducedbyIFN-γ,seeMig MPO incysticfibrosis 554
N-monomethyl-L-arginine,see overexpressionof 521 metaplasia 446
L-NMMA polymorphisms 439,524 mucins 139,390,493
monomolemission 307 reactionmechanism 438 mucolytic 493,681–682
mononuclearphagocytes 422,426,519, reactionwithHOCl 437 roleofROSinproduction 477,493
seealsomonocytes;macrophages reactionwithnitroxides 672 mulberryheartdisease 123
monooxygenases 16,54 reactionwithNO • 306,439,443 multidrugresistanceproteins 102,213,
monophenols 173,356,605,seealso reactionwithO • 2 – 438 219,229
phenols reactionwithparacetamol 486,694 multicellularorganisms 2,4,6,7,8,78,
monosodiumuratecrystals,seesodium reactionwithsalicylate 296,436 138,221,234–236,247,568
uratecrystals;urate reactionwithurate 436 O • 2 –inevolutionof 231
monounsaturated 252,525,seealso sourceof1O2 438–439 multilamellarliposomes 255–256
oleicacid;palmitoleicacid tyrosinenitrationby 439 multiorganfailure,seeMODS
morin 175(struc.) MPP+ 465,568,617,619(struc.),680 multiple
morphine 568,636 MPT 13,26,201,207,213,217–219,465, myeloma 282
mosquito 101,107,367,447,seealso 544,608–609,626,684 organdysfunction 548,seealso
malaria MPTP 92,599,603,605,617–618,619 MODS
mosses 105 (struc.),620,622,665,681 sclerosis 18,179,556,600,607,683

--- Page 930 ---

INDEX 875
multivitamins 189–190,193,198 myocardial NADH/NAD+ratios 480,482–483
MultiVitaminsandProbucol infarction 19,180,182,186–190, NADHdehydrogenase 12,591
Trial 186–187 296,348,516–517,535,542–543, inParkinsondisease 617
murineSindbisvirus 638 545,549,607–608,682,seealso NADH-coenzyme Q
muscle 8,12,13,16,26,53,61,88, heart;cardiovasculardisease; oxidoreductase 11,12
94,101,123,132–133,135,146, ischaemia-reperfusion effectofDPI 433
148–149,161,165,205,231,235, stunning 206,295,543–544,546,682, NADP+ 14,100–102,108,142,155,362,
285,293,322,327,408,440,512, 692 366,371,376,432
532–533,546,551,570,582,595, myocytes 102,128,205,207,226,545, ferredoxinoxidoreductase 470
598,629,650,652–654,655,seealso 547,592 radical(NADP • ) 50,126
heart;skeletalmuscle;smooth myofibrils 543,650–651 NADPH 14,16,27,28,46,50,54,76,
muscle myofilamentproteins 582 90,92,100–102,107–108,113,
biopsies 290,327,409 myoglobin 8,25,37,56,122,126, 116–118,127,142,144,154–155,
fatigue 409 132–133,143,148,154,158,208, 219,264,300,310,332,357,362,
O •–level 320 264–265,382,408,450,486,512, 366,368–369,371,374,376–378,
O
2 •–levelinageingmuscle
660
544,551–552,593,603,691,seealso 380,382,414,432,468,470–471,
2 oxymyoglobin;metmyoglobin 474,501,539,570,585,591,651,
paralysis 630
red 8
andH2O2 691 683
nitrosyl 56 bindingsite 116,447
wasting 54,93,408,476,630,
stimulationoflipidperoxidation 262 dependentferrireductase 128
641,644,646,657,681,seealso
myo-inositoloxygenase 259 ineye 391
sarcopenia
myosinATPase 13 NADPHoxidases 9,20,24,27,79,101,
musculardystrophy 206,512–513
myotubes 223 106,108,111,120,151,154,169,
mutagenic 178,322,489,495,536,577,
myricetin 175(struc.),605 178,201,204–205,219,221–223,
587
myrosinase 184 225,230–231,233,235–236,256,
mutations 27,91,220,245–247,251,
314,321,349,355,357–358,369,
275,326,479,570,572–575, N 386,394,402,407–409,432–433,
578,583–584,588,613–614,616,
N-shell 697,701
444,445–456,481,498,513,518,
641–642
N-ras 572,seealsoH-ras,K-ras 603,652,694,seealsoNOX;NOX1;
M M u u t t M Sα 2 2 5 5 0 0 N N a a+ + / -C H a + 2+ ex ex ch ch an an g g e e sy tr s a te n m spo 2 r 0 t 4 e , rs 21 2 9 05, act N io O n X o 2 f ; r N ot O en X o 4 n ; e DU 62 O 0 X
MutT 248 608 andageing 653
MutY 250–251 Na+,K+-ATPase 13,37,39,105,204, andAIDS 637
MUTYH 250–251,579 205,212,217,266,360,387–388, effectofcigarettesmoke 492
MVP 186–187 396,449,500,598 effectofH2O2 447
myc 582,seealsoc-myc (NAD)2 120 effectofstatins 661,695
mycobacteria 102,113,115 NAAQS 487–489 effectofzinc 502
Mycobacterium NAD+, 9,10,11,12,14,26,33,48,100, inadiposetissue 445,531–532
leprae 445 102,155,203–204,206,217,313, inaneurysms 548
tuberculosis 80–81,87,102,113,116, 362,365,451,479–480,541,598, inatherosclerosis 517,520–521,524
133,365,430,445,687 650 inbrain 446,600,603,618,625
Mycoplasma,312 dependenthistonedeacetylase 646 incancer 578–582,590
pneumoniae 64,95,115,125 depletion 203,245,479,602,609 incarotidbody 445
mycosporine inageing 646–647 indiabetes 533–534,538
glycine 145(struc.),151 inbrain 602 indendriticcells 441
likeaminoacids 151,386 radical(NAD • ) 46,48,50,62, inembryos 397
mycothiol 113(struc.),115,445 120–121,318 in 4 g 4 a 6 s – tr 4 o 4 i 7 ntestinaltract 354–357,
nadB 28
mycotoxins 124
NADH 9,10,11,12,14,16,24,27,33, ingrafting 546
MyD88 227
46,48,50,54,65,76,88–90,100, inH.pyloriinfection 567
myelin 399,501,597,601,607,633 119–121,123,144,155,160,219, inheart 445,544–545
associatedbasicglycoprotein 607 310,313,317–318,357,362,419, ininfluenza 636
basicprotein 607 451,474,480,535,539,647,650 inkidney 450,550
oligodendrocyteglycoprotein 607, cytochromeb5reductase 362,473 inligninsynthesis 419
681 ferricyanidereductase 451 inlimbischaemia 552
sheath 253,399,597,602,604,607 oxidases 119,217 inliverinflammation 567
myeloidleukaemia 573 semidehydroascorbate inlung 399,445,446,553–554
myeloperoxidase,seeMPO reductase 160 inphagocytes 431–445

--- Page 931 ---

876 INDEX
NADPHoxidases(continued) natriureticfactor 167 neuriticplaques 622
inplacenta 398 natural neurites 622
inplants 382,451–453,455 killercells 218,422 neuroblastoma 576
inrespiratorytract 358–360,636,638 selection 367,645,seealsoevolution neurodegenerativediseases 26,92,130,
inrestenosis 546 Nature 317 146,149,165,215,268,277,361,
inrheumatoidarthritis 561 NBIA 614 501–502,514,597–598,601–604,
inrootnodules 382 NBT,seenitrobluetetrazolium 606,611–635,639,673
inseaurchins 445 Ncf1 444,562,607 roleofMPO 443,617–618,625–626
insepsis 548 NCF2 557 withBrainIronAccumulation 614
inskin 445
NCL,seeneuronalceroidlipofuscinoses neuroendocrine theories of
insleepapnoea 549
NCX-4016 58 ageing 641–642
insperm 445
NDGA,seenordihydroguaireticacid neuroepithelial 8,9,450
instemcells 445
nebivolol 661(struc.) neuroferritinopathies 614
instroke 609 necroptosis 212,215,219 neurofibrillarytangles 622–629
inzebrafish 445
inhibitors 445,634,661,694–695 necrosis 200–201,208,212,213,215, neurofilaments 61,601,615,630–631
216–217,219,235,266,272, neurofurans 268
knockout,seeknockoutmice
327,405,423,430,465–466,468, neurogenesis 313,410,481,507,
NADPH-cytochromeP450reductase
480–481,483,497,508,512–514, 596–598,600,633,652
16,17,27,101,142,264,433,
470–471,473,505,507,591 516,519–520,582,599,609, neuroglobin 8,388,548,603
effectofDPI 433 613–614,652 neuroketals 268
NAD(P)Hquinoneoxidoreductase,see andDAMPs 421 neuromelanin 151,615,617–618,620
NQO;NQO1;quinonereductase regulated 212 neuronal
NAFLD 483 necroticcore 516–517,519–520 ceroidlipofuscinoses 635,658
nafenopin 587 nectar 369,453 NOS,seenNOS
nakedmolerats 111,579,640,650,654, negativeacute-phaseresponse 139, stemcells 313,600,seealso
658–660 236–237 hippocampus,neurogenesis
nanaerobe 7 Neisseriagonorrhoeae 80,95,119,220, neurons 29,37,61,63,92,122,165,204,
nanometre 704(def.) 280,445 206,217,222,232,266,272,328,
nanomolar/nanomole 705(def.) NEILglycosylases 250–251,601,606 387,475,482,484,502,532,535,
nanoparticles 58,71,213,495,496 nelaredoxins 90 552,568,595–637,654,659
(def.),500,665 nematodes 17,640–641,seealsoC. andischaemia 608,610
asantioxidants 663,665 elegans cellcycle 614,625
Fe3O4 665 NemR 221 inculture 446
gold 665 neocuproine 350 transplants 603,615
graphene 496 neoflavonoids 418 neuropathy 165,534–535,539
platinum 665 neon 700(struc.),702 neuroprostanes 195,263(struc.),
na s t p i i t h l a v t n h e i r a u l m e 2 n 13 e d , i 4 o 11 9 x 2 6 id , , 4 e 6 8 6 4 6 5 9 ( 6 struc.) ne a o n n b d a a t C e b s i C e l 9 s 4 ; 5 t b , o i 1 r x 0 t i h 2 c , i ; t p 1 y 6 re 8 4 m , 6 4 6 a 9 t 4 u , re se b e a a b ls i o es neuro 2 A 6 p 4 7 r - – o / 2 t D e 6 c 4 8 t - , i / n 2 E s 7 4 4 - 3 , / 8 s F e 8 e 4 , - 4 a / l 5 s J 6 o 4- F n 4 e - u is r o o p p r r o o s s t t a a n n e e s s ,
endoperoxides 71
erythropoiesis 400–401 Neurosporacrassa,24,170,231,380
3,3-naphthotriazole 305
ironmetabolism 400 neurotoxicity/neutoroxins 154,235,
naphthoicacidhydrazide 341
pulmonaryhypertension 399 484,598–599,602–603,608,610,
2-naphthylamine 587
rats 19,95,160 613,619–621,631
N-(1-naphthyl)ethylenediamine 305
resuscitation 19,399 ofZn 501
n n a a p ri r n o g x e e n n in 56 1 3 75 (s ( t s r t u r c u .) c.),605 α-tocopherol 19,392 neurotransmitters 204,224,388,475,
naringin 175(struc.) neoplastic 571,578,seealsocancer 512,596–598,606,609,614,616,
nasal/nose/nasopharyngeal 127,192, NER,seenucleotideexcisionrepair 622
194,252,357,359,498,501,692 Nereissuccinea,105 neurotrophicfactors 234,598,608,634,
liningfluid 359 Nernstequation 33 seealsoBDNF;NGF
sinuses 54 nerve 205,437,538 neutron 697–698
NASH 348,483,671 gases 530 neutropaenia 422
NationalAmbientAirQuality growthfactor,seeNGF neutrophils 62,65,95,127,133,
Standard 487–489 nestedcase-controlstudies 180 138,158,160,235–236,312,327,
NationalHealthandNutrition Netherlands 156,177 357,394,397,405,408,421–445,
ExaminationSurvey 185 NETs/NETosis 397,422,435–436, 446,449–450,460–462,468,481,
NationalInstitute 439–441,445,452,553–554,556, 486–487,492–493,496,499,519,
ofAging(NIA) 641 560 523,533,544,551–553,559,561,
ofStandardsandTechnology Neu2000 610,667(struc.),680 566–567,574,582,606,609,seealso
(NIST) 42,326 neuraltube 197,534 phagocytes

--- Page 932 ---

INDEX 877
adherence 542,544–545 nickel 37,81,87,97,126–127,149,226, ofHsp90,inALS 632
antibodiesversus 556 491,495,497,498–499,501,700 ofIgG 559
apoptosisof 422,424,430,492 (struc.) ofMnSOD 62,306,358,393,450,
countinrats/mice/humans 422 SOD,seeNiSOD 486,550–551,553,576,611,636
cytosolicfactor2,557 Nicotianatabacum 452 ofparasites 440
damagebyROS 430 nicotinamide/nicotinicacid 10,28,42, ofplatelets 450
elastase 432–436,seealsoelastase 155,158,200,203–204,530,595, ofprostacyclinsynthase 459
extracellulartraps,seeNETs 635,646–647 ofsalicylate 196
nicotinamideadeninedinucleotide oftocopherol 167,385,494,521
glycolysis 431
(phosphate),seeNAD+,NADP+ oftrp,seetryptophan.nitration
granuleproteins 422,436,443,567
nicotinamidenucleotidetran- 3-nitratomethyl-PROXYL 667(struc.),
HOClproduction 437,439
• shydrogenase 14,92,102, 672
OH production 435
534 nitreniumion 584–585
hypoxia 431
nicotine/nicotinic 490–492 nitricacid 488
inARDs 553–554
acetylcholinereceptors 535,600 nitricoxide 4,8,20,24,30–31,43,50,
incysticfibrosis 555 Niemann-Pickdisease 602,633 52–63,96,98–100,118,125,132,
inliver 551 nifurtimox 505 138–140,148,154,158,184,206,
inrheumatoidarthritis 560 NIH-3T3fibroblasts 223,447 219–222,231,234,238,257,295,
intraluminalcrawling 427–430 NIK 227–228 300,306,329,339,349,357–358,
KmforO2 433 nimesulide 506(struc.) 360,363–364,393,399,402,411,
lifetime 422 NiSOD 37,81,89,498 442,463,471,488,495,512–514,540
MPOcontent,seeMPO nitecapone 661 actiononCYPs 54–55
necrosis 436 nitrate 3,8,14,24,55–56,61–62,118, actiononLOX 455
phosphatases 433 302,305,435,566,588,704–705 actiononMPO 306,439,443
priming 432–433,492 (struc.) andageing 653
receptors 430–432 incigarettes 492 andapoptosis 219
removalbymacrophages,see inskin 405 andcancer 579,588
macrophages,removalof plasmalevels 56 andcaloricrestriction 647
neutrophils radical 31,488–490 andethanol 481
rolling/tethering/transmigration reductases 14,305 andexercise 410
427–430 salivacontent 56 andMPT 684
taurinelevel 437 tolerance 57,670 andpain 635–636
NewZealand 63,124 usebyE.coli,357 andRNR 412
newbornbabies/rats,seeneonates nitratedlipids 62–63,69,78,257,329, andstress 503
NF-κB 178,184,223,226–231,235,247, 331,430,489,515,545,635,661, andviruses 636
267–268,309,406,442,462,514, 684 bioavailability 518,521,660
520–521,532,538,551,567,573, nitratedproteins 125,301,306, electrodes 303
588,611,638,663,683,694 357,391,488,521,559,seealso ferulicacid 58
andtelomeres 648 3-nitrotyrosine fromspintraps 288,290,304,669
imaging 228 andageing 653 halflifeinblood 55
antibodiesagainst 62,528 inALS 632
inageing 642,652,655
inbraintrauma 611 inangioplasty 546
incancer 228,581,583,648
inbreath 339 inatherosclerosis 520–521,524
inHIV 636–638
γ-tocopherol, see inbrain 597,599,602,611,617–618,
inmuscle 409
5-nitro-γ-tocopherol 620,625
inParkinsondisease 619
nitration 54(def.),60,204,296, inbrineshrimp 417
inrespiratorytractinfections 638
357,402,412,531,576,seealso inCGDpatients 433
inrheumatoidarthritis 558,560
3-nitrotyrosine incigarettesmoke 491–492
inskin 404 artefacts 306 indamagebyCCl4 466
instroke 610 byEPO 440 inIBD 566
inviruses 636 byMPO 439 ininflammation 557
thioredoxininteraction 229 byozone 306,487 ininfluenza 636
8-NG,see8-nitroguanine denitration 306 inischaemia-reperfusion/
NGF 223,234,598 inbloodbrainbarrier 606 preconditioning 541,545–547
NHgroup 679 inidiopathicpulmonaryfibrosis 681 inkidney 449–450
NH-tocopherol 673,674(struc.) ofactin 566 inneurodegenerativediseases
NH-Trolox 674(struc.) ofCuZnSOD 62,486,631 613–614,617–618,620,625
NHANES 185 offibrinogen 521 inparacetamoltoxicity 486
niacin 155,186,188 ofguanine,see8-nitroguanine inparaquattoxicity 471
nicastrin 627 ofHDL 531 inphagocytekilling 54,435–436

--- Page 933 ---

878 INDEX
nitricoxide(continued) 5-nitro-γ-tocopherol 167,385 albumin 57–58
inplacenta 397 inatherosclerosis 521 ascorbate 158
inplants 54,453,455 insmokers 494 benzene 476(struc.),477
inplatelets 450 nitrobluetetrazolium 46,47(struc.), captopril 58
inradiation 508 84,88–89,299–301,434 chloramphenicol 506
inrespiratorytract 358,553 nitrofurantoin 364,505,506(struc.) peroxycarbonate 31,61–62
insepsis 548 nitrofurazone 364,505,506(struc.) proline 588
inskin 405 nitrogen 326,329,339,341,383,488, thiols 51–54,56–58,60,100,157–158,
instroke 608–611 700(struc.),702–703 303,358
inwounds 407 centredradicals 30,66,350–351, tyrosine 62,412
interactionwitheicosanoid 364–365,679 urea 478,588
pathway 462 fixation/nitrogenases 7,20,79,382 nitrosoniumcation 52,484
interactionswithH2O2 58 isotopes 698 nitrosyl
measurement 288,302–305,317–319 monoxide,seenitricoxide cation 31,54,304
reactionwithDCFHDA 317 mustard 588 haemoglobin 303
nitrogendioxide 30–31,50,52–54, myoglobin 56
releasingpolymers 58
61–62,75,77,84,100,141,144, S-nitrosylation 53,54(def.),55,61,
reservoirsof 58
148,158,172–173,245,257,276, 105–106,141,204,206,219–220,
scavenging 55,133,303,662
291,302–303,305–306,317,321, 275,348,357,489,618,seealso
nit s r p ic in ox tr i a d p e p d in o g no 3 r 0 s 3 5 , 6 6 – 6 5 9 8,302,661, 3 3 2 9 9 0 – , 3 4 3 6 0 4 , ,4 3 8 4 8 3 – , 4 3 8 5 9 9 , , 4 3 9 8 3 1 , , 6 3 6 8 2 4–385, in n is i c tr h o a s e o m c i o c m p p re o c u o n n d d s itioning 547
672,680
andα-tocopherol 673 andDFO 691 nitrotryptophan 62,276,279(struc.),
andSODmimetics 669 306,345
nit m ric ito o c x h id o e nd sy ri n a th ta a r s g e e s te 2 d 4, 6 5 8 3 4 –63,65, detection 320 3-nitrotyrosine 60–62,76,79,112,222,
incigarettesmoke 491–493 276–277,278(struc.),307,344–345,
101,154,159,205,275,295,321,
inskin 406 435,443,449,483–484,486,489,
512,540,545,seealsoeNOS;iNOS;
reactionwithnitroxides 672 550,557,662,seealsonitrated
nNOS
nitroglycerin 56–57,505 lipids/proteins;nitration
effectsofDPI 433
8-nitroguanine 242(struc.),245–246, antibodies,seeantibodiesagainst
glutathionylation 55
248,323,328,492 nitratedproteins/nitrotyrosine
inmitochondria 55
incancer 579,595 free 632
inhibitors,seeNOSinhibitors
inH.pyloriinfection 567 inALS 632
KmforO2 54
inhepatitis 568 inAlzheimerdisease 626–627
uncouplingof 24,55,63,155
ininfluenza 636 inARDS 528
nitrilotriaceticacid 53,133,209,seealso nitrones 304,505,656 inatherosclerosis 521,523–524
ferric-NTA
mitochondriatargeted 684 inautism 633
nitrite 3,14,24,25,43,52,55–56,60–62, spintraps 287–293 inblood-brainbarrier 606
84,89,118,132,139,172,183–184,
nitroniumcation,seenitrylcation incancer 579,581
302,305–306,355–356,360–361,
nitroniumchloride,seenitrylchloride incysticfibrosis 555
363,385,399,403,435,438,566,
nitronylnitroxides 304,508 indiabetes 539
661,669
3-nitroparacetamol 486(struc.) infibrinogen 521
actiononMPO 306,439,443
nitrophenylalanine 276–277,278 inIBD 566
asacarcinogen 56
(struc.),296,345 inidiopathicpulmonaryfibrosis 681
incolon 357 2-nitropropane 121,326,491,505 inmeningitis 606
indiet 355 nitropropanedioxygenase 24 inmultiplesclerosis 607
insaliva 56,356 3-nitropropionicacid 92,465,568, inp66shcmutants 651
inskin 405 598–599,603,605–606,608,634 inParkinsondisease/synuclein 62,
usebyE.coli,357 nitroproteomics 61,306,627,632,653 615,617,619–621
nitro inageing 653 inplacenta 397–398
aspirin 58 inALS 632 inpriondisease 630
benzene 476(struc.),505 inAlzheimerdisease 627 inrheumatoidarthritis 559,561
compounds 115,367,385,505–506, nitroprusside 56 measurement302,306
509–510,seealso3-nitrotyrosine nitrosamines 56,184,357,489,491,588 reactionwithHOCl 307
fattyacids,seenitratedlipids tobaccospecific 588 nitrotyrosylation 61
radicals 505 nitrosativestress 158,199,355–356 nitrousacid 31,41,53,56,61,244,306,
N-nitro-L-argininemethylester,see nitrosocompounds 31,51–53,54, 322,355,489,705
L-NAME 56–58,60–62,100,148,157–158, actiononDNA 244
3-nitro-4-hydroxyphenylacetate 306 220,287,305,358,405,505 andcancer 579,588
nitro-oleicacid 63,635,684 N-acetylpenicillamine,seeSNAP andviruses 636

--- Page 934 ---

INDEX 879
nitrousoxide 35,52,357 non-specificanti-inflammatoryeffects inParkinsondisease 618
nitrovasodilators 56–57,505,545 ofproteins 557 inrheumatoidarthritis 562
nitroxides 304,684 non-specificperoxidases,see NOX4 223,233,236,313,358,446–451,
andMPO 694 peroxidases 534,545,560,568,694
astherapeuticantioxidants 669,679 non-steroidalanti-inflammatorydrugs, andageing 653
inplastics 672 seeNSAIDS andbleomycin 594
mitochondriatargeted 684 non-transferrinboundiron 135–136, andpain 635–636
radicals 158,287,292,406,484 208,400,508,592,seealsocatalytic cellproliferation 568
radicals,fromdesferrioxamine 691 iron;labileironpool inbileducts 568
reactionwithO • 2 – 672 inbabies 400 inbrain 600,609–610
nitroxyl nonanal 75,270 incancer 578
anion 31,52,58,118,158,302 indiabetes 534
NONOates 58
radical 467 NOXA1 447
norcocaine 484,485(struc.)
nitryl NOXO1 446–447
norflurazon 378
cation 31,62,162 NQO185,229,474
NOS 54,seealsonitricoxidesynthases,
chloride 31,58,66,276,306–307,345 -NQO1 229,474,591
eNOS,iNOS
NKcells,seenaturalkillercells Nramp2 127
nNOS 54,206,222,402,408,599,600,
NLRP3 inflammasome, see NRF1/NRF2 225
608,617
inflammasome Nrf1 225,229
NMDAreceptors 92,481,599–600,634 inneurodegenerativediseases 614, Nrf2 63,146,173,178,183–184,196,
andageing 656 632 229–231,233,267–268,272,282,
andPb 500 instroke 610 358,366,390,482,514,545,652,
antagonists 610,680 inhibitors 680 683–684,695,seealsoKeap1
NMR,seenuclearmagneticresonance knockout,seeknockoutmice activationbyspintraps 292
NNT,seenicotinamidenucleotide roleinmethamphetamine andAs 497
transhydrogenase toxicity 484 andblueberries 195
no-reflowphenomenon 544,552,610 NOSinhibitors 55,302,305,312,315, andchloramines 684
NOC-5/-18 18,57 471,521 andcigarettesmoke 493–494
nociceptiveneurons 635 asROSscavengers 302 anddiquat 470
nocturnalanimals 392 noradrenalin 14,24,156,474(struc.), andebselen 683
NODmouse 533,671 475,548–549,598,600,602, andethanol 482
Nod-likereceptors 421 614–615 andnitrones 672
nodesofRanvier 597 nordihydroguaireticacid 179,455,632, andp53 576
non-alcoholicliverdisease,seeNASH, 656,678(struc.) andproteasome 655
NAFLD andviruses 636–637
norepinephrine,seenoradrenalin
non-caeruloplasmincopper 131,137, chlorination 559
NOV002 590,684
212 effectofPUFAs 196
NOX 445,447,seealsoNADPH
non-enzymaticantioxidantcapa- inageing 655,660
oxidases
city 351,seealsototalantioxidant inatherosclerosis 520
effectofebselen 694
capacity inbrain 604,611,622
non-genotoxiccarcinogen 587 indiabetes 534–535 incancer 230,576,585,591,683
non-haemironproteins 9,12(def.), knockout,seeknockoutmice ineye 391
90,454,600,seealsoironsulphur NOX3 402,446–447 ingastrointestinaltract 355–356
clusters;ironproteins NOX5 394,447–448,452,695 inIBD 566
inbrain 600 NOX1 402,447–450,694–695 inliverdisease 483
non-homologousendjoining 250 inbrain 600,609 inlung 358
non-idealcharacterofbonds 703 incancer 578 inmultiplesclerosis 607
non-obese-diabeticmouse,seeNOD inParkinsondisease 618–619 inrheumatoidarthritis 559,561–562
mouse inskin 407
NOX2 205,229,445–451,498,521,534,
non-phlogisticrecruitment 426 insperm 395
545,552,555,694
non-protein-bound iron, see knockout,seeknockoutmice
andpain 635–636
catalyticiron;labileironpool; NSAIDs 68,562,565,578,626,680
inALS 632
non-transferrinboundiron Fechelationby 565
inarsenictoxicity 498
non-receptortyrosinekinase 224 NTA,seeferric-NTA;nitrilotriacetic
inbrain 600,609
non-resolvinginflammation 430–431, acid
seealsoinflammation,chronic indiabetes 534 NTBI,seenon-transferrinboundiron
inflammation ineye 548 NTH1 251
non-selenium glutathione inHuntingtondisease 634 NtRBOHD 452
peroxidase 111,113 inlupus 557 nucleophile 43,48(def.)

--- Page 935 ---

880 INDEX
nucleosomes 215,238,246 oddsratio 180 inliverdisease 483,568
nucleotide 236,237(def.),246 ODSrat 159,164 innakedmolerats 650
excisionrepair 248–252,271,325, oesophagus 70,192,356,434,470,481, inneurodegenerativediseases 613,
329,405–406,575,seealsoDNA 567,582 617–618,626–627,632,634
repair cancer 189,490,532,576,579 inp66shcmutants 651
nucleus/nuclear 79,98,102,110,118, 17β-oestradiol 16,145(struc.),151,475, inpregnancy 397–398
122,128,220–221,238,280,309, 585 inrheumatoidarthritis 559
360,366,386,498,569,587,646, instroke 610 inscleroderma 552
657,697 17β-oestriol 145(struc.),151 inskin 404
electrontransportchains 591 17β-oestrone 145(struc.),151,475,585 insmokers 492,494
envelope 569,591,654 oestrogens 152,234,451,469,475, insperm 394–395
exclusioneffects 647 585–586,590 6-keto 8-enolform 324(struc.)
exportsignaldomain 221 off-flavours 67,132,270,275,455 onchromosomes 328
factorerythroid2-relatedfactors,see offpump 546 repair 250,seealsoDNArepair
Nrf1/Nrf2 ofloxacin 502 8OHdGTP 237(def.),248,251–252,382
magneticresonance 335,561 OGG1 249,251,579,606,658 8OHdGTPase 407,618
membranes 447,466 knockout,seeknockoutmice 8OHGua 237(def.),324–325,328,504,
NOX4 447 OHCU 147(struc.) 534,613
O2levels 325 8OHdG/8OHG 56,69,72,93,125, inAlzheimerdisease 626
permeabilitybarrier 654 136–137,143,151,159,177–178, OhrRprotein 220,342
pores,ageing 654 185,187,237(def.),239,242–244, oil(s) 5,77,176,252–253,332,679,
proteasome 280 246,248–252,322,324–326,328, seealsothenamesofspecificoils,
proteins 203,240,282,498,556,654 353,365,384,399,473,476,484, e.g.olive,soy
proteinoxidation 203 494,500,507,539 adulteration 476–477
respiratoryfactors,seeNRF1;NRF2 andairpollution 490,494 autoxidationof 252
signallingfrommitochondria andasbestos 497 flyash 495
225–226,235,247,659 andAZT 638 ofcloves 176
nudixhydrolaseprotein 248 anddieselexhaust 495 RedO 93
NUDT1,seeMTH1 andexercise 409 refineries 495
NUDT15,seeMTH2 andHIV 637 OKN-007,672
NUDT19,seeMTH3 andstress 504 Olaparib 204
nuo-6mutants 657 antibodiesagainst 324,326–327 OldTestament 176
nuptialcolourchange 394 antioxidantpropertiesof 245 oleanolicacid 683
Nurses’HealthStudy 180 6,8-diketoform 324(struc.) oleicacid 75,253,255(struc.),525,527
nutrition 633,638–639,seealsodiet; effectofascorbate 395 nitrated 63,635,684
multivitamins;recommended 6-enol 8-ketoform 324(struc.) oligodendrocytes 399,484,596–598,
dietaryallowance;vitaminpills furtheroxidation 244–245,322,498 600–601,603,607
nutritionalantioxidants,seedietary inageing 649–650,653–654,657,659 effectofisoprostanes 399
antioxidants;dietarysupplements inAstoxicity 498 oligomers 232–233,615,621,624,629
nuts 127,162,175,183,494,527 inasbestos 497 oligopeptide-bindingproteinA 275
NXY-059 610,667(struc.),672 inatherosclerosis 523 olive/oliveoil 176,183,253,476,529,
inautism 633 683
O
inbabies 399,401 oltipraz 183–184,185(struc.)
o-phthalaldehyde 345 inBPD 400 omegaclassGST 112–113
ob/obleptin––/––mouse 533 inbrain 600,626–627 omeprazole 661
obesity 111,153,155,182,184,188, incancer 574–579,581–583,584,587, omicstechnologiesandageing 645
196–197,231,251,271,408,410, 590,595 OmpD 64
443,481,483,531–532,533,539, inCCl4toxicity 467 oncogenes/oncogenic 479,571–574,
545,549,556,639–640 incoeliacdisease 566 576,582,622,648,seealsocancer
andcancer 570 incysticfibrosis 555 policemanofthe 573,648
oxidativedamage 293 indiabetes 533–535 one-electron
roleofHNE 271,273,531–532 ineye 387–388,391 oxidation 277,447,490,505
obliterativebronchiolitis 553 inFanconianaemia 577 reduction 383,413,474,505
octadeca-9(cis),11(trans)-dienoic infood 509 transfer 669
acid 331 inFriedreichataxia 633 onions 173,176–177,184
2-octadecylascorbate 673 inH.pyloriinfection 567 ONO-3144 678(struc.)
octanol 289 inhypoxia 550 oocytes 394
octanone 269 inIBD 566 OPC-6535 seetetomilast
OCTN1 115,604 inischaemia-reperfusion 545 OPC-14117 667(struc.),673

--- Page 936 ---

INDEX 881
open-heartsurgery 546,551,660 OTC 484,681,682(struc.) inautoimmunediseases 552,
open-chestdogs 543 otoliths 446 556–558
opioidreceptors 686 ovary 152,170,395,398,634 inbrainandCNS 595–603,606,
Opisthorchis 567–568,579,582 cancer 398,473,570,576–577 611–635
opossum 247 ovariectomy 152,469 inCOPD 493
opportunisticinfections 637 oviduct 138,396–397 indrugsideeffects 562
opsonin 237,430 ovoperoxidase 415 inendometriosis 398
opsonized ovothiols 113–114,415,417(struc.) ineye 387–388,392–393
latexbeads 423 ovotransferrin 128 inhearingloss 401–402
zymosan 431 ox-PAPC 267 inHuntingtondisease 634
opticnerve 27,387,391,seealsoeye oxalate 39,147(struc.),156,369,381, inMCI 627
OR10141 686,689(struc.),693 420 inmetaltoxicity 497
ORACassay 349–350,352–353 inligninbreakdown 420 inNCL 635
oral ironchelates 420 inobesity 271,273,293,531–532,
bacteria 55–56,355,481 manganesechelate 420 seealsoobesity
cancer 183,490,494,579,595 oxalateoxidase 369,455 inpain 635
cavity 7–8,192,194,327,339,355, inperiodontaldisease 558
andMnSOD 367
481,557–558 inplacenta 397
oxaloacetate 10
ironsalts 565 inrheumatoidarthritis 559–565
oxaluricacid 147(struc.),245–246
leukoplakia 579,595 insperm 394
oxalyl 413
orbitals 36,697(def.),699,703 inurine 294
oxanine 242(struc.),244
oregano 176 ratesof 134
organ transplantation/ OXANO 667(struc.),672 theoryofageing 649–661
oxazolone 242(struc.),245–246
rejection/preservationfluids 92, toABCA4transporter 390
98,143,186,208,443,550–553,660, oxidants 23(def.) toantibodies 275,558–559
oxidation 23(def.)
669,681,693,seealsolung;liver; toantibiotics 502
β-oxidation 12,27,118,122,154,267,
hearttransplantation toCaMKII 543
480,587,602
organicperoxides 49,108–109,111, tonuclearpores 654
N-oxidationpathway 484
113–115,123,125,133,208, tophagocytes 442–443
oxidative
220–221,224,238,265,280,312, toproteasome 655
332,342,362,380,403,498,577, burst 452 toRNA,seeoxidativeRNAdamage
seealsolipidperoxidation footprinting 244 oxidativeDNAdamage 20,26,28,92,
organophosphate 424,512,530 lipidomics 507 97–98,102,131,172,178,189,200,
ornithinedecarboxylase 282 modificationhypothesis 520–531, 203,236–253,322–329,350,384,
Orp1 221,313 seealsoatherosclerosis 469,471,475,498
orphandrugstatus 695 phosphorylation 12,13,394,431 andageing 648–649,651–654,657
ortho-dianisidine 89 oxidativedamage 4,10,12,16,43, andcancer 577–580,587,636,seealso
ortho-phthaldehyde 347 56,78,101,111,125,131,133, 8OHdGincancer
ortho-tyrosine 277–278,294(struc.), 135–136,141,143,149,151, andCr 498
295–296,306–307,344–345,387, 154,159–160,177,180,184–185, artefacts 325–326
399,494,509,seealsom-tyrosine;
188–189,195,199(def.),200–353,
byAZT 638
tyrosine 364,367,382,387–388,391,399, bynanoparticles 496
inARDs 528
408,450,483,495,511–638,seealso
genespecific 328
inatherosclerosis 521 biomarkersofoxidativedamage; inasbestos 496
inbabies 400–401 lipidperoxidation;oxidative inbrain 606,608,618,626–627
indiabetes 539 DNA/protein/RNAdamage, inCOPD 493
oxidativestress
inurine 344 incysticfibrosis 555
OstegenicDisorderShionogi,seeODS andageing 404,648,653–654,658 indiabetes 534–535
rat andbacterialinfections 636 ingallbladder 568
osteoarthritis 559,639 andcaloricrestriction 651 inIBD 566
osteoblasts 451,560,seealsobone andsleep 504 inmtDNA 27,245,650
osteoclasts 127,440,444,451,523,560, andstress/anxiety 503,633 inmultiplesclerosis 607
seealsobone andviruses 636–638 innakedmolerats 650
osteomyelitis 434 byethanol 482 inrheumatoidarthritis 559
osteonecrosis 102 effectoflifestyle 196–198,409 levels 323–325,577
osteoporosis 93,152–153,451,481,639, effectofZn 502 productsinurine 324–326
644,650,657,694 epigenetic/geneticfactors 652 recognitionof 251
osteosarcoma 573 exercise 196,409 repair 243,247–252,seealsoDNA
ostrich 530 global 653–654 repair

--- Page 937 ---

882 INDEX
oxidativeproteindamage 149,189, inplasma 523–524 radicalnature 7,22,23,31,702–703
209,275–283,382,384,386,388, inrheumatoidarthritis 559 rebound 17
395,471,477 oxo-copper 39,160 scavengingsystems 119
andageing 649,653 5-oxo-6,8,11,14-eicosatetraenoic sensing 3,8–9,14,142,154,156,
antigengenerationby 275 acid 461 449–450,seealsoHIF-1
biomarkersof 343–346 5-oxo-ETE 461
sinks 1
inbrain 598,613,626–627,632 8-oxo-7-hydro-2 (cid:3) -deoxyguanosine,see
solubility 5–6,8,330
incancer 579–580,582 8oxodG
thermodynamicsofreduction 33
incysticfibrosis 555 2-oxo-4-hydroxy-4-carboxy-
transport 8
indiabetes 534–539 5-ureidoimidazoline 147
inembryos 396 (struc.) oxygenlevels/pO2 4–5,8,12,19,78,
inmitochondria 277 4-oxo-2-nonenal 272,337,601–602,608 287,300,397–398
inmultiplesclerosis 607 5-oxo-prolinase 682(struc.) inbrain 603,618
innakedmolerats 650 oxoammoniumcations 291,672 inmitochondria 5,78
inrheumatoidarthritis 559 8-oxocaffeine 298(struc.) innewborns 399
repairof 280 8oxoG,see8OHdG/8OHG lens 390
oxidativeRNAdamage 64,125,200, 2-oxoglutarate,seeα-ketoglutarate nucleus 325
240,246,248,252,325,328,613, 4-oxohexenal 272 oviduct 396–397
618,626–627 2-oxohistidine 84,220,276–277,278
placenta 397–398
inAlzheimerdisease/MCI 626–627 (struc.),345–346,509,527,625
retina 388
inParkinsondisease 618 oxonicacid 147(struc.),200
uterus 396–397
wholebody 325 oxoperoxonitrate 58,seealso
oxygenradicalabsorbancecapacity
oxidativestress vi,28,102,105–106, peroxynitrite
assay,seeORACassay
109,123,131,137,141,144,146, 12-oxophytodienoicacid 454(struc.)
148,155,159,186–188,196,199 oxoprolinase 103,681 oxygentoxicity 1,5,6,7,92,123,
(def.),200–283,306,310,321,329, 5-oxoproline 103(struc.),104 140,358,seealsohyperoxia
339,344,351,353,358,367,382, N2-oxopropenyl-dG 272(struc.) alligators 16–18
386,388,399,467,469,473,482, 2-oxothiazolidine-4-carboxylate,see animals 18–21,94–96,123,142,151,
568–595,569 OTC 201
activatableFechelators 693,seealso oxPTPome 348 bacteria 16–18
H2O2activatablepro-chelators Oxyblot 346 C.elegans,17
andcaloricrestriction 640 oxyfluorfen 382,383(struc.) effectofcastration 446
andcancer 568–595 oxyhaemoglobin 37,55–56,303,473, gendereffects 19
andironrelease 208–211 477,500,seealsohaemoglobin;
inprematureanimals 400
andtelomerase 649 deoxyhaemoglobin insects 16–18
effectonCa2+levels 275 andphenylhydrazine 364
isoketals 268
changesinmethylation 247 oxygen 75,259,403,464,471,700
inARDS 554–555 (struc.) plants 16–18,374
inbrainandCNS 595–603,633 administration 554 roleofozone 488
incellblocks 396–397 anddiphenols/quinones 471 roleofvitaminE 168
incysticfibrosis 554–555 asacarcinogen/pollutant 487,583 superoxidetheoryof 23,91–99
indiabetes 533–539 atmosphericlevels 1,4,7 oxygenases 1,14,376–377
inmacrophages 520 derivedspecies 23(def.) oxyl(O •–)radical 374
inreproduction 394–402 discovery,vi oxylipins 454,455(def.)
postprandial 518 effectonradiation 507–509
oxymyoglobin 37,55,seealso
oxideions 23,702(struc.) effectonlipidperoxidation 258,262,
myoglobin
oxidizablesubstrate 77(def.) 267–268,334–335,339,526
oxyperoxidase 121
oxidizedproteinhydrolase 281,363 electrodes 312,330,350
oxypurinol 15(struc.),694
oxidizingagent 22,23(def.) enzymeinhibitionby 376
OxyR vi,123,199,220,309–310,
oxiranes 389 groundstate 22(struc.),23
435–436,445
oxHDL 530,seealsoHDL incellculture 28–29
oxLDL 158,178,348,446,517–531,534, inEarth’scrust 4 OXYSrat 658
556,558,684 isotopes 698 oxysterols,seecholesteroloxidation
andamyloid 629 measurementof 287 products
β2-glycoproteinIcomplexes 557 oxygenbond 23 oxysulphurradicals 51,146,158,296
immunoassays 331,524 pre-oxygenworld 130 oxytetracycline 503(struc.)
inangioplasty 546 production by ozone 1,4,40–41,60,71,75–76,77,92,
inischaemia-reperfusion 545 photosynthesis 369–374 94,109,111–112,137,140,148,158,
inSLE 556 radicaldiseasesofprematurity 400 244–245,257,275,302–303,329,

--- Page 938 ---

INDEX 883
346,359,381,384–385,390, paint 67,77,121,252,495 andmitoQ 684
406–407,448,452,487–488,490, pairedhelicalfilaments 622,626 andvitaminE 180,195
495 Palaeozoicperiod 6 effectofsmoking 616,620
actiononDNA 244 palm/palmoil 162,253,381 environmentaltoxins 617,619–620
actiononplants 452 palmarfascia 552,693 Parmaham 270
actiononskin 406 palmiticacid/palmitate 253,527,635 PARP-1 63,155,203–204,206,217,245,
and1O2 487 palmitoleicacid 75,527 249,272,478–479,537,595,602,
andpain 635 palmitoylproteinthioesterase1,635 647
layer 4,75,404,487 pamaquine 363–364 inALS 632
nitrationpromotedby 306,487 pamoicacid 89 inapoptosis 217
•
OH formation 295,487 PAMPs 54,227,421(def.),425,427,431, inhibitorsof 204,552,588
reactionwithlipids 257,268 443,452,465,512,541,551,553, structure 203
tolerance 385,488 636 instroke 609–610
ozonideintermediates 75,244,257,487 pancreas 439,477,499,533,547,554, parsnips 184,404
567,seealsoβ-cells parthanatos 204
P
cancer 88,191,219,490 particulateairpollutants 357,495–496,
p3 623 ischaemia 567 498–499,seealsoairpollution;
p15 583 transplants 551 cigarettesmoke
p16 583,648 pancreatitis 481,553,567,582,636,671, partitioncoefficient 289
p21 282,573,581,648 695 Parusmajor151
p22phox 205,432,434,446–448 pannus 560 parylation 203
p38kinases 222,225,230 pantothenatekinase 614 Pasteurellamultocida,102
p40phox 205,432,446 PAPA 57(struc.) pathogen 556,562,652
p47phox 205,432–434,444,447–449,548, paper/parchment 252 associatedmolecularpatterns,see
562 papillomavirus 636 PAMPs
p50,p52 226–227 PapuaNewGuinea 494,629 freeconditions 435
p52shc 644 para-tyrosine 277,294(struc.),295,345 patternrecognitionreceptors 421,452,
p53 28,85,154,203,220,230,245, seealsom-tyrosine;o-tyrosine 538
248,328,404,569,573–576,577, parabanicacid 147(struc.),200 Pauliprinciple 20(def.),22,697,703
579,583,588,590,622,647–648, paracetamol 15,28,93,112,230,236, pavementing 423
651–652 398,481,484,486(struc.),510,661, PBN 287–293,288(struc.),355,388,
andageing 644–646 671,681 402,467–468,478–479,484,491,
andamyloid 645 andMPO 486,694 542,544,552,592,656,667,672,
andNrf2 576 parafilm 673 683
attackbyROS 575–576 parallelspins 22 astherapeuticagent 610–611,669,
incellculture 576 paramagnetic 20(def.),287 672
inH.pyloriinfection 567 paraoxonase,seePON inrapidlyageingrodents 658
UVdamage 578 paraquat 32–33,91,93–94,111,137, PBT2 626(struc.),693
p62 627–628,654 161,220,282,286,383–384,383 PC12cells 223
p65 226–227 (struc.),385–386,393,464,470–471, PCBP1protein 130
p66shc 26,94,219,535,575,581, 478,510–511,568,617,651,670, PCR 328
644–645,651–652 692 PDGF 178,223,225,234,320,446,568,
andlifespan 644 andParkinsondisease 617 573
p67phox,205,432–434,446–448 interactionwithiron 470–471 PD146176 522
p100 227 parasites 113,114,115,122,160,309, PDI 106–107,160,233,272,276,486
P680/P680 •+ 371,373–375 367–369,415,422,435,440,445, PDK 222
P700 371,373 582,seealsomalaria;Trypanosoma pears 456
pelectrons 697(def.) parenteralnutrition 98,160,401,501, peas 384–386,393
P-glycoprotein 229 seealsointravenousfeeding peanuts 175
Pacificsalmon 645 pargyline 602,619 PECAM-1 429,442,553,665
paclitaxel,seetaxol parinaroyllipids 341 peckingorder 157
PAF 266–267,423,428–430,432,458, Parkinsondisease 62,104,132,148, PEG 610,672,691
462 151,180,184,195,282,345,475, albumin 682
acetylhydrolase 267,274,334,530 490,505,552,596,600,605,612, catalase 665
likeproducts 541 614,615–622,625–626,630,672, neuroprotectiveaction 611,665
pain 62,112,161,206,398,423,446, 684,690,693,seealsosubstantia nitrosoalbumin 58
460,487,557,559,562,565,567, nigra SOD 610–611,663,665
600,635–636,661,665,671,686, ALSdementiacomplex 617 tocopherol 168
694 andcaeruloplasmin 618 pegloticase 556

--- Page 939 ---

884 INDEX
pelargonidin 174(struc.) 317–318,321,323,355,364,369, peroxisomes 79,108,110,118,119,122,
pellino-1 227 411,415–420,447,452,455,459, 146,215,275,281,309,311–313,
Pendredsyndrome 402 490,500,587,661,684,seealso 376,379–380,481,587,602,605,
penicillamine 51,136,557,562,564 GPx;horseradishperoxidase; 633,651,657
(struc.),565,632,661,680,683,687 lactoperoxidase;peroxidasins; fattyacidoxidation 587,seealso
disulphide 562,564(struc.) thyroidperoxidase β-oxidation
radicalsfrom 565 actionofCOX 565 inbrain 602
Penicilliumchrysogenum 281 defensive 417,440 inC.elegans,651
penis 53,551–552,599 manganeseutilising 419–420 proliferators 16,520,587–588
curvature 636,665 mimetics 122 proliferator-activated-receptor-α,see
ischaemia 551 nonspecific 120–122,415,436 PPARα
pain 636 reactionsofhaemoglobin 364, proliferator-activated-receptorγ
pentachlorophenol 41,469 seealsohaemoglobin co-activator-1α,seePGC-1α
pentane 455,481,704(struc.) versatile 420 targetingsequence 118,665
biomarker of lipid peroxidasins 415,439–440 peroxomonocarbonate 31,43,84,225
peroxidation 269–270,339 peroxide(s) 509,seealsolipid peroxomonosulphateradical
inCCl4toxicity 467 peroxidation;hydrogenperoxide anion 490,587
incysticfibrosis 555 bridge 368 peroxy
inrheumatoidarthritis 559 equivalents 338 acetylnitrate 31,488(struc.)
metabolism 339 indetergents 64 cagedluciferin-1 316
radical 339 indietaryfats 266,268,354,526 fluor 6,313
withage 653 ion 22(struc.),23 orange 1,315
pentanol 339,481 stresshaemolysistest 168,329–330, radical 258,seealsoperoxylradicals
pentanone 269 362,555 yellow 1,313
pentosephosphatepathway 28,96, tone 458–459,462 peroxygenase 265
101–102,154,363,391,470,570, peroxidizability 329,337 peroxylanion 454
607,seealsoglucose-6-phosphate peroxiporins 64 peroxylradicals 31,33,42,48–50,53,
dehydrogenase peroxiredoxins 61,64,78,94,106–109, 62,90,115,126,132,141,143–144,
inbrain 603 111,115,119,122–123,125, 146,148–149,158,162,165,172,
incancer 576 137–138,140,168,215,220–222, 239,257–259,261–263,265–266,
inerythrocytes 361 225,233,276,348,355,358,368, 276–277,293,297,299–300,
inphagocytes 431–432 380,382,384,448,452,521,575, 308,317,321–322,329–330,337,
inseeds 455 608,652,661,665,seealsounder 339,343–344,346,350–351,381,
pentosidine 537(struc.) Prx 393,454–455,468,471,489–491,
pentoxifylline 483,661 andageing 650,654,657–658 493,502,507–508,512,521–522,
PEP-metallothioneinIII 692 andcancer 575–576,581 529,587,674–675,679,seealso
peppers 155,176,185,393 andcigarettesmoke 494 trichloromethylperoxylradical
pepstatin 424 andp53 575 actiononantiproteinases/
peptidylglutamylsites 281 asDAMPs 421 proteinases 424
perchloricacid 332 inatherosclerosis 521 actiononDNA 244
perchloroethylene 468 inbrain 603–604,618 andDFO 691
perchlorotriphenylmethylradical 300 incartilage 558 andSSpeptides 686
PercivalPott 584 inembryos 396 incancer 580
perferryl 46,259 inerythrocytes 108,361 incigarettesmoke 492
perforin 218,422 ineye 391 inlignin 417–418
pergolide 617 infoetallung 399 measurement 317–319
pericytes 598 inH.pyloriinfection 567 reactionwithDCFHDA 317
Periodictable 36,110,497,683,697, inmitochondria 108,122,361 reactionwithiron 261
701,702 inovaries 395–396 scavengers 173,662,seealso
periodontaldisease 8,557,671 inphagocytes 442 chain-breakingantioxidants
peripheralneuropathy 282,532,636 inplants 380 self-reaction 265,454
periplasmic 80,86,90,107,123,445 inskin 406 peroxynitrate 31,62,71,489,492
CuZnSOD 91,436 insperm 395 peroxynitrite 20,30–31,36,40,43,50,
periventricularleukomalacia 399 inwounds 407 52–55,57,58–63,65,71,79,96–97,
Permianperiod 5,6 inyeast 221 99–100,109,112,115,123,125–126,
perniciousanaemia 414 knockouts,seeknockoutmice 131,137,139–140,148,204,206,
peroxidase(s) 24,36,50,55,66,84, oxidized/hyperoxidized 391,521, 208–209,213–214,219,222,224,
115–116,119–122,132,138,154, 576,654–655 229,242,245–246,276,282–283,
177,292,297,299,304,306, phosphorylation 123,224 288,295–297,300,304–305,309,

--- Page 940 ---

INDEX 885
312,314–315,317–318,321–322, reactionwithMnSOD,seeMnSOD, killingmechanism 433–439
328,343,358,362,399,442, nitrationof O •–production 431–445,562–566,
2
448–450,458,462,471,488,490, reactionwithnitroxides 672 683
493,512,530,556,566 reactionwithRNS 167 oxidativedamageto 430,442–443
actiononantiproteinases/ scavenging 662–663 O2-independentkillingmech-
proteinases 424 peroxynitricacid 31,62 anisms 433, 435–436,
actiononDNA 244–245 peroxynitrousacid 31,62,90,141, 440
andDFO 691 143–144,158,173,275–277,292, recruitment 407,423–430,442,501,
andLDL 529 294,296,302,322,346,359,662, 514,560,566,694
andpain 635–636 682,690 respiratoryburst 431–445
andquorumsensing 436 andebselen 683 rodentvshuman 432
andRNR 412 andSSpeptides 684 phagocyticvacuole(phagosome)
andtetracyclines 502 PerR 220,276–277 307–308,426,430–433,435–436,
andZn 502 persistentpulmonaryhypertensionof 438,440–442,445,496
asanantioxidant 63 thenewborn 399 HOCllevel 435,437
bactericidalaction 567 3-perylenediphenylphosphine 333 nitration 435
decomposedcontrol 59,61 Peyer’spatches 228 O
•–level
432–433
2
decompositioncatalysts 636,669 Peyroniedisease 552,636,665 Phanerochaetechrysosporium,419–420
effectonGST 112 PeytonRous 572 phaseI/IIdetoxificationsystems 474,
inALS 631–632 PF6-AM 315 570
inARDS 528 PFL 7,413 enzymes 183–185,584,677
inatherosclerosis 521,523 PFOR,seepyruvate-ferredoxin reactions 463,570
inbenzenetoxicity 476 oxidoreductase phaseIIIclinicaltrials 695
inbrain 599–600,603,613,617–618, PGC-1α 225,647 phengreen 128,129(struc.),208
625,631–632 PGA2 461 phenacetin 484,486(struc.)
incancer 576,579,588,592 PGD2 457(struc.),460–462 phenanthroline 40,97,131,133,209,
inCCl4toxicity 466 PGE2 456,457(struc.),460,520 405,478,686,689(struc.)
incigarettesmoke 492–493 incancer 578 chelatablecopper 209,212,seealso
inCOtoxicity 549 PGF2α 260(struc.),456,460 catalyticcopper
indiabetes 539 PGG2 456,457(struc.),459–460 phenethylpolyacrylate 297(struc.)
inerythrocytes 361 PGH2 456,457(struc.),460,462 phenobarbital 16,27,173(struc.),467,
ineye 393 PGI2 456,457(struc.),460 584
inIBD 566 PGJ2 457,458(struc.),461 phenol(s)/phenoliccompounds 42,
ininfluenza 636 15d-PGJ2 457,461 120,144,151,162,173–180,
inischaemia-reperfusion 541, PGPx 110 293(struc.),325,415,417,
543, 545, 560, see also pH 705(def.) seealsodiphenols;flavonoids;
ischaemia-reperfusion PHGPx 110,111,113,268,274,332,407, monophenols;polyphenols
inkidney 550 451,652,seealsoGPx;glutathione metalioncontamination 325
inlung 553 peroxidases non-antioxidantactions 178
inmultiplesclerosis 607 phacoemulsification 40 pro-oxidanteffects 178–179
inmuscle 408–409 phaeophytin 371,373,376 reactionwithO • 2 – 173
inparacetamoltoxicity 486 phago-mimeticeffect 502 phenolase 175
inparaquattoxicity 471 phagocytes 20,54,65,80,119–120,136, phenothiazines 403,679(struc.)
inphagocytekilling 435–436,441, 138,141,143,202,206,216,224, phenoxyaceticacidherbicides 587
443,567 229,234,236,245,267,307–311, phenoxylradicals 43,45,121,145
inplants 453 321,331,355,363,368,390, (struc.),151,179,317,318,417
inplatelets 450 395,405,407–408,420,421–445, phenylradical 364–365,477
inpregnancy 397–398 452–453,483,490,495,502, phenylalanine 42,60,277,278(struc.),
inradiation 508 511–512,547–548,556,567,572, 281,302,345,355,412,417,475,
inrheumatoidarthritis 558,561 574,611,649,seealsoeosinophils; 515,554,561
insepsis 548 macrophages;monocytes; ammonialyase 418,452
inskin 405,407 neutrophils;retinalpigment hydroxylase 294–295
insperm 394 epithelium nitration 276–277,296,345
measurement 302,305,315–316,320 adhesion 62,138,158,235,427–430, todetectOH • 294–296,494
•
OH from 296 432,442,521,546,661,seealso phenylbutazone 158,562,563(struc.),
preparation 59–60 adhesionmolecules 565,661
reactionwithCuZnSOD 486,631 antioxidantcontent 442–443 phenyldiazineradical 364–365
reactionwithDCFHDA 317 avoidancestrategies 412,444–445 β-phenylethyl-isothiocyanate 184,185
reactionwithdrugs 565 chemotaxis 272,275 (struc.)

--- Page 941 ---

886 INDEX
phenylhydrazine 30,363–364,365 phospholipaseA2 108,169,206,266, eye 387
(struc.),368 274,458,512,530,562,594,608, inskin 403–404
phenylhydroxylamine 476(struc.),477 678 photosynthesis 4,18,37,49,171,245,
phenylpropanoidcompounds 418 instroke 610 369–386,411,seealsoplants;leaves;
phenytoin 398,568 knockout 594 chloroplasts
pheomelanin 150–151,406,615 removalofoxidizedlipids 266,274 photosystemIandII,seePSI;PSII
pheromones 247,277 phospholipids 128,167–168,206, phototoxicprotein 71
Philodina 656 222,253,255,265–266,271, phox 432
274,341,405,526–527,530, phthalichydrazide 297(struc.)
philothion 99
605,629,658,seealsonames β-phycoerythrin 350,428
Phocahispida 550
ofspecificphospholipids,e.g. phylloerythrin 68
Pholasdactylus/pholasin,420
phosphatidylcholine phylloquinone 371,473
phorbolesters 301,431,seealsoPMA
antibodiesagainst 482,556–557 Physarumpolycephalum,231
phosgene 495 bindingprotein 556 Physicians’HealthStudyIand
phosphatases 128,221–223,224–225, hydroperoxideglutathione II 186–187,189–191,193,195
229–230,235,267,280,348, peroxidase,seePHGPx phyticacid 127(struc.),184,356,686
449,500,533,587,652,seealso scrambling 366 phytoalexins 184,451–452
PTEN;purpleacidphosphatases; transferprotein 165 phytochelatins 138,381–382
proteinphosphatases;redox phosphorylation 108,123,199,203, phytodienoicacid 455
signalling;signaltransduction;
226,229,231,377,432,573,579, phytoestrogen 184
redoxregulation
581,seealsokinases;oxidative phytoferritin 129,376
phosphatidicacid 224,389 phosphorylation;photophos- phytoflueneinLDL 527,529
phosphatidylcholine 224,253,254 phorylation;proteinkinases; phytolchain 162,163(struc.)
(struc.),267,274,526,527 redoxregulation;redoxsignalling; phytoporphyrin 68
hydroperoxide 482 signaltransduction phytoprostanes 267–268,357,369,
oxidationproductsasDAMPs 421 inplants 370,373,380 370–371(struc.),386,451–453,
oxidized 267,482,519,556–557,684, photo-ageing 404 seealsoA1/B1/D1/deoxy
seealsolipidoxidationproducts; photoaddition 405 J1/E1/F1/G1/J1-phytoprostanes
lipidperoxidation photoallergy 68,404 indiet 354
phosphatidylethanolamine 254 Photobacteriumleiognathi 80,87 phytosterols 268,354
(struc.),265,268,271,339,389–390, PIH 688(struc.),692
photochemical,seealsophotodynamic;
535 PI3K 222–223,225,227,231,seealso
photosensitization
phosphatidylinositol 205,222,254 damage 67,150,309,317,378,388, signaltransduction
(struc.) 403–406 Aktpathway 222–225,227,231,574,
phosphatidylinositol 3,4,5- decomposition 8,75 610,644
triphosphate, see picolinicacid/carboxylase 264,416
reactions 64,75,487
PIP3
photocontrollableperoxynitrite
(struc.)
phosphatidylinositol-specific generator 60 pigeons 640,649
phospholipase C, in pinealgland 144
phagocytes 432–433 photocopying 487,495–496 PINK1 616,621–622
photodynamic
phosphatidylserine 215,265,271,339,
effects 309
PIP3 222,224,574
367,467 N-(1-(piperidin-4-yl)indolin-
insectide 377
oxidation 219,430 5-yl)thiophene-2-
therapy 70–71,382,390,404,590,
carboximidamide 305
oxidationproductsasDAMPs 421 684
piperlongumine 589(struc.),590
translocation 214–215,219 photofrinII 70
piroxicam 562,563(struc.)
phosphodiesterbond 238 photoinhibition 375,381,385–386 Pisumsativum 384
6-phosphogluconate 101 photoisomerization 69,389 Pithomyceschartarum 68
dehydratase 96 photolyase 382,413 pituitary
dehydrogenase 101 photolysis 244,488 adenomas 574
3-phosphoglycerate 370,376,377 photophosphorylation 370,373 gland 482,596,630,644
(struc.) 6-4photoproducts 245,405 transcriptionfactor 644
phosphoglycollate 376–377(struc.) photorespiration 376–377,380 pixantrone 592
phosphoinositide-3-kinase,seePI3 photosensitization 67,73,265,275,277, pKa 705(def.)
kinase 308,321,377,382,403,405,451, PKAN 614
phosphoinositide-dependentkinase, 456,463–464,470,500,684 PKC 169,224,272,535,547
seePDK byantibiotics 502 inphagocytes 432–433,seealso
phospholipases 15,332,540,547,599 byvitaminE 164 signaltransduction
C/D 224,272,608 endogenous 403 PLA2,seephospholipaseA2

--- Page 942 ---

INDEX 887
placebo 188–191,193–194 oxLDLlevels 523–524,seealso Pneumocystiscarinii,637
placenta 165,327,396,397–398,399, oxLDL pneumonia 236,434,477,490,553,630,
447,463,481,490 peroxidelevels 331,333,338 637,640
oxidativedamageto 397–399 proteincarbonyls 346 pO2,seeO2levels
O2levels 397–398 TAC 152,349,351,356 4-POBN 288(struc.),289–291,479,555,
Planck’sconstant 285 thiols 101,139,141,511,528 669
plankton 162,386 volume 141,409 Podosporaanserina,231
plants 86–87,100,108,113,118–122, plasmamembrane 27,45,64,98,103, pointmutations 245,616
129,133,137,149,155,157, 119,122,215,217,219,224,253, PON-1 530,533
167,170–171,174,179,183–184, 257,365,367,394,417,432,486, contaminationof 530
230,232–235,247,249,253,265, 547,599,605,615,650 PON-3 530
268,280,296,300,308–312,328, Ca2+transporters 205 ponyfish 80
355,363,369–386,404,415,418, redoxsystems 27,98,160,216,362, polβ 248–249,251
451–456,487–488,490,498 451 polγ 245,251,638
cellwalls 377,381,417,452, plasmalogens 78,143,265,274(struc.), policemanoftheoncogenes 573,648
seealsochloroplasts;leaves; 307,395,521,605 pollen 62,177,357–358,369,441,
photosynthesis;roots plasmidDNA 49,246 452–453,488,seealsobees
defenceresponses 369,384,451–456 plasmin 531 tube 452
diabetes 377,380 plasmin(ogen) 237,531 poly(ADP-ribose)glycohydrolase 203
ferritin 129,376 Plasmodium,367–369,474,seealso poly(ADP-ribose)polymerase,see
heatshockresponse 385–386 malaria PARP
mitochondria 369,379 antioxidantdefences 368 polyamine 114
•
NO production 54,453,455 plasticizers 587 conjugatedSOD 663
porphyria 381–382 plastics 7,24,77,161,252,483,495, oxidaseenzymes 608
patternrecognitionreceptors 452 505,572,673 polycarboxylatedfullerenes 665
redoxregulation/signalling 370, BHTcontent 673 polychlorinated
373,380,384,451–456 nitroxides 672 biphenyls 48,583
roleofcarotenoids 378–379,382,386 syringes 672 dibenzofurans 495
Seaccumulation 124,127 wrapping 252 polyclonalantibodies 302,327,422,
senescence 455–456 plastochromanol 381(struc.),386 seealsoantibodies
targetsforstressandtoxins 382,384, plastocyanin 46,371,379 polycyclicaromaticcompounds 16,
451 plastoquinol/plastoquinone 371,373, 484,495
plaque 167,516,639,seealso 381,471,473,684–685 polyeneantibiotics 502–503
atherosclerosis;dentalplaque platelets 62,138,169,266–267,397,407, polyethyleneglycol,seePEG
asneuroprotective 625 422–423,433,441–442,450–451, Polygonumcapsidatum,179
development 680 460,462,490,520–521,545,619, polyhydroxylatedfullerenes 665–666
disruption 523 661 polymerasechainreaction 328
rupture 517,521,542 ageing 653 polymers,antioxidants 678–679
plasma 8,43,56,61,63,66,71,77, NADPHoxidase 653 polymorphonuclear 421(def.)
100–102,105,110,127–128,131, nitration 450 polynucleotidephosphorylase252
134–136,138–139,141,146,155, plateletactivatingfactor(acet- polyps 251,570–571,574
157–160,164–165,167–168,170, ylhydrolase), see PAF polyphenols 29,63,126,153,160,
177–178,180,182–183,187–188, (acetylhydrolase) 173–180,524,seealsoflavonoids
190,195–196,208–209,259, platelet-derivedgrowthfactor,see ingastrointestinaltract 176,180,
267–268,274,277,286,305–306, PDGF 356
309,321,329,331–332,334, platinum 32,312,588,665 non-antioxidantactions 178
348–349,358–359,362,408,437, porphyrin-coumarin-343,287 oxidationbyMPO 438
449,467,522–536,525–526,530, β-pleated sheet, see β-sheet pro-oxidanteffects 178–179,656
557–558,565,629,seealsoserum conformation plasmalevel 177
aged 131 plumbagin 471,472(struc.),473 polyunsaturatedfattyacids,seePUFAs
caeruloplasminbreakdownin 132 plutonium 687 poplar 385
cysteine/cystinelevels 101 PMA 431,433,572(struc.) porin 13,64,394,451
EC-SODlevels 138 cautionsinuse 433,444 porphobilinogen 69(struc.)
ferritinlevels 128 PMC 675 porphyria 67–70,171,404,514
ferroxidaseactivity 132 Pmel17protein 150,629 cutaneatarda 69–70,470
GSH/GSSGlevels/ratios 101–103, PN600 302 inplants 381–382
347,655 PNAP 60 porphyrinicprobe 303
isoprostanesinAD 627 Pnc1 647 porphyrins 8,67,70,117,171,669;
lightemission 309 pneumococcalmeningitis 402,607 seealsohaem

--- Page 943 ---

888 INDEX
Porphyromonasgingivalis 8 preuroporphyrinogen 69(struc.) progressionofcancer 571–572
post-menopausalfemales 151,187 Prevotellamelaninogenica 7,20 prokaryotes 1,13–14,79,81,99,106,
postmortemH2O2generation 388 primaquine 363–364,564(struc.) 109,113,411
postprandialoxidativestress 518 PrimaryPreventionProject 186–187 proliferation 169,200–201,222,224,
potassium 697,700(struc.) primates 118,146,148,155,200,321, 234,236,266,272,358,390,399,
bromate 579 387,393,531,653,672 407–408,412,446–447,449,480,
ferrate 36 primer 238,648 514,545–546,553,558,569–573,
permanganate 475 priming 235,432–433,492 576,579–583,590,648,659,seealso
superoxide 36,45,59–60,87–89,662 principalquantumnumber 697 cellcycle,cellproliferation,
potassiumchannels 142,204,399,608 priondiseases 131,612,629–630 mitogenic
andageing 654 prion-likemechanism 615 proline 277,279(struc.),338,345–346,
andAlzheimersdisease 627 foramyloid 630 578,588,645
andlipidperoxidation 266 forCuZnSOD 631 oxidase 575,578,582,590
ATPsensitive 534,547 forα-synuclein 615 prolylhydroxylase 3,9,14,106,130,
potatoes 157,455 pro 155,157,499,692
potentiallifespan 639 apoptotic 218,436,569,573,576,647 promethazine 30,167,467–468,679
PPARs 63,480,520,587,680 carcinogens 587 (struc.)
Pr3 556 caspases 217,236 promoter 97,119,230,233,247,309,
pramipexole 617 longevitygenes 643 328,493,521,577,587,627,654
PranaBiotechnologyLtd 626 resolvingmediators 427 promotionofcancer 571–572,577,584
PrC-210/211 508,666(struc.),683 thrombotic 277,523 propagationphase 525
pre pro-inflammatory 431,456,492,531, propano-dGadducts 248,272,329
eclampsia 397–398,441 538,557,561 N2-propano-2 (cid:3) -deoxyguanosine 272
oxygenworld 130 cytokines 496,532,534,538,541, (struc.)
Precambrianperiod 2,3 554,694 propanol 42,49,118
preconditioning95,136,143,202, effectsofROS 236,443–444,492,557, N-(2-propenal)ethanolamine 336
226,230,468,481,513–514,545, 582,607 (struc.)
546–547,549,659 phenotype 632 N-(2-propenal)serine 336(struc.)
(cid:7)
andage 639 pro-oxidant 133–134,139–142,144, N -(2-propenal)lysine 336(struc.)
andDFO 692 149,151,154,178–179,195,215, N-(2-propenal)ethanolamine 336
andiron 209,547 230,354–356,358,360,363,367, (struc.)
andproteasome 547 385,500,523,566,590,603–604, propidiumiodide 213
bycarbonmonoxide 550 607,615,631,656,660,669, propionaldehyde 493
inbrain 608–609 680–681,683–684,692,seealso Propionibacterium
inkidney 551 catalyticiron acnes,403–404
inliver 551 ascorbate 160–161 shermanii,87,115
inretina 548–549 drugs 368,502–503,565,684 propionicacid 69,413
inskin 552 flavonoids 178–179 propofol 547,661,677(struc.)
remote 547 retinol 172 propolis 63,179,228
prednisolone 562,563(struc.) α-tocopherol165,528 propylgallate 455,467,594,677(struc.)
pregnancy 92,124,172,266,394, complex,aluminium 501 propyl-2-nitronate 24
397–398,399–401,481,484,494, copperions 537 prospective 180
531,556,645 inLDL 528 prostacyclin 456,460–462,520
andselenium 397,seealsobirth; inrheumatoidarthritis 560 prostacyclinsynthase 61,457,539
maternal;placenta;pre-eclampsia; cytokines 554 nitrationof 458
uterus state 578 prostaglandins 16,49,206,267,331,
oxygentoxicity 19 probucol 186,524(struc.),527,546,592, 369,405,423,425,456–462,480,
prematureageing 644–646,657 661,673 511–513,554,562
prematurebabies 18,19,69,98,134, andascorbate 527 D2 425–426
143–144,148,211,321,359,363, succinateester 673 E1 425
386,398,399–400,601,665,672 procainamide 557 E2 399,425–426
ascorbate 392 procarcinogen 584 F2α 260
incubators 19 progeroidsyndromes 645–646,648, fromisoprostanes 460
α-tocopherol 19,392 653 G/Hsynthase 458,484
pre-menopausalwomen 126,151 progesterone 395 I 425
preneoplasticlesions 493,587 programmed inageing 642
presenilins 624 celldeath 215,452,seealsoapoptosis inAlzheimerdisease 625
presynapticnerveterminals necrosis 212 initch 636
615,632 senescence 215 inrheumatoidarthritis 560

--- Page 944 ---

INDEX 889
prostanoicacid 457(struc.) 408,450,483,512–513,515,528, proteostasis 232,659
prostanoid 456 532,656 prothrombin 237
prostategland 137,151,170,173, andageing 652–653,657 proto-oncogenes 229,572–574,577,584
446–447,456 andcognition 627 proton 697,seealsohydrogenion
cancer 170,173,189–191,193–194, andfrailty 408 conductance 649
252,327,576,579,581,595,622 brain 618,626–629,669 gradient 14,26,27,100,205,230,
protectins 425,427,456 decarbonylation 346 357,370,373,379
D1 425(struc.),426 effectofPBN 669 leak 12–13,27,651
proteasome 9,62,81,92,135,178, inALS 632 protoporphyrin 8,69(struc.),71,382
203–204,218,222,224,226, inBPD 399
protoporphyrinogen 69(struc.)
229–230,232–233,281–283,353,
incancer 579,590
oxidase 8,221,382
355,382,461,513,569,573,591, incysticfibrosis 555
protozoa 17,90,113,277,280,309,311,
596,611–635,641,651–652,659 ineye 387–388
367,413,505
andageing 282,407,615,645,655 inlupus 556
proximatecarcinogens 584
andBO-653,673 innakedmolerats 650
PrPc/PrPSc 630
andHNE 614,628 inobesity 531–532
Prussianblue 310
andNrf2 655 inplants 377,380
andtau 628 inplasma 346
Prx,seealsoperoxiredoxins
caloricrestriction 655 inpriondisease 630 Prx1 108,123,221,224,229,483,487,
cloggingup 631 irreproducibleresults 654 575,590
dysfunction 610,613 inrheumatoidarthritis 559 andethanol 483
inapoptosis 218 proteinkinases 37,178,206,221–231, innakedmolerats 650
inbrain 282,606,611–635 371,572,590,seealsoredox Prx2 108,122,221,361,368,451
inerythrocytes 363 signalling;redoxregulation;signal Prx3 94,108,109,122,397
ineye 392 transduction inobesity 531–532
innakedmolerats 650 andage 639 instroke 610
insenescence 648 B,seeAkt Prx4 108,110
inskin 406–407 C,seePKC intestis 395
insperm 395’ G 224,231,548 Prx5 108,118,122,380,656
instroke 610 proteinphosphatases 37,43,64,224– Prx6 108,123,266,358,471
inhibitors 185,282–283,568,588, 225,443,638,seealsophosphatases; PrxQ 380
590,610,613,615,620,636 PTEN;signaltransduction PSI 371,376,378,383
nuclear 280 identificationofoxidizedformsin PSII 4,370–371,373–376,380,382,385
oxidativedamageto 655 cells 348
pseudocatalase 118
roleinpreconditioning 547 proteinsR1,R2 411
Pseudomonassp.,144,384,434
19Scapcomplexes 282 proteinradicals 49,240,345,507
Pseudomonasaeruginosa,91,116,
protein(s),seealsonitratedproteins, ESRsignals 293 119–120,133,220,439,445,477,
oxidativeproteindamage,protein immunospintrapping 293 555,556
carbonyls proteinases/proteolysis 204,233,
psoralen 68(struc.),69,185,404
artefactualoxidation 344 280–283,346,375,382,394,
caloriemalnutrition 124,seealso 405,421,424,432–433,450–451, psoriasis 69–70,405–407,441,683
andcancer 579
kwashiorkor 528,541,553–554,561,566,582,
PTEN 224–225,231,433,574,581
crosslinkingbyMDA 270 610,625,637,646,652,seealso
PTEN-inducedputativekinase1,see
disulphideisomerase,seePDI autophagy,lysosomes,MMP,
PINK1
hydrophobicpatches 277,281–282 proteasome
longlived 386 inhibitors 424,624,637,seealso pteridines 7,seealsoBH2;BH4
peroxides 49,72,276,332,344–345, α 1-antiproteinase;antiproteinases, pterinaldehyde 542
515 α 2-macroglobulin,TIMP PTPome 348
SSGadducts,inageing 655 proteoglycans 65–66,346,358, PUFAs 20,78,139,146,155,167–168,
synthesis 9,13,105,204,228, 402,516–517,522,558,560, 172,183,188,196,252(def.),253,
232–233,246,272,275,281,375, 624,seealsoglycoproteins; 256–257,261,263,265,267–268,
382,396–397,413,421,466,470, glycosaminoglycans 270,330,334,339,343,360,369,
609,642,647’ proteomics 275,346 374–375,391,401,453,455–456,
transductionpeptide 692 andageing 645,653 459,482,487,490,493,521,525,
proteinaggregates 393,611–635,655 inAlzheimerdisease 627 527–530,658
toxicity 615 inHuntingtondisease634 asantioxidants 274
proteincarbonyls 52,77,93,123,136, ofaldehydes 337 inbrain 601,628
141,148,189,195,200,203,210, nitro 61,306,627,632,653 inchloroplasts 374
276,280,344–346,350,366–367, proteincarbonyls 346 ineye 388

--- Page 945 ---

890 INDEX
PUFAs(continued) pyroptosis 212,217,421,637 Racproteins 205,225,432,434,
innakedmolerats 650 pyrrole 8,268 445–446,448
reaction with tocopheryl pyrrolidinedithiocarbamate 229 inphagocytes 432,433
radicals 165 pyrroline-5-carboxylate 578 racemicprostaglandins 460
pufferfish 393 pyrrolizidinealkaloid 270 Radproteins 250
pulmonary pyrrolopyrimidines 680 radiation 18,20,104,219,222,235,239,
fibrosis,idiopathic 104,554,681, pyruvate 10,28,64,102,144,312–313, 257,296,322,403,500,507–510,
694–695 396,413–414,598,661 511–512,seealsoionizingradiation,
hypertension 399,670 asH2O2scavenger 144,695 γ-rays
macrophages 429,594 dehydrogenase 154,626 antioxidantsupplementsand 509
vessels/vascularresistance 358,399, dehydrogenasekinase 2,10,26,224 damage 507,670–671
446,553 esters 661,695 inducedcarcinogenesis 577–578
pulmonaryoxygentoxicity 358,seealso ferredoxinoxidoreductase 413–414 resistance 508–509
oxygentoxicity formatelyase 7,413 therapy 499,507,509,581,583,588,
effectofcastration 446 kinaseM2 570 590,595–596
pulseradiolysis 35–36,41,45,79–80, inembryos 397 radical
87,164,172,300,662 oxidase 414 addition 172
pumpkin 381 PZ51,seeebselen anion 21,36
punch-drunksyndrome 628 Q cation 21,30,321,419,507
purines 236,238,244,322,352,544, chemistry 32–36
577,584,seealsoadenine;guanine QA/QB 371,373,376 copperoxidase 414
puromycin 470 qinghaosu 368 recombination 35,41,43,53,309,489
purpleacidphosphatases 133 quantumnumbers 697 SAMenzymes 413,503
pus 436 quartiles 183,198 sponges 665
putamen 596,601,634 quartz 496–497
Radicut 680
putrescine 369,470(struc.) quaternaryammoniumcompounds 75
radioactiveisotopes 499,508,697–698
PUVAtherapy 69 quelamycin 592
radiocontrastmedia 681
PVC 58,673 quenching 71,78,307
radiolysis 32,35,41,49,299
pyBor 316 of1O2 72,307–308,393
ofwater 244
pyknosis 216 quercetin 173,175,176–178,179 radioprotection 99–100,304,507–509,
pyochelin/pyoverdine 477 (struc.),605
663,671,681–682,684
pyocyanin 94,477(struc.) conjugateswithGSH 179(struc.)
bySODgenes 665
pyramidalneurons 608 glucosides 176
nitroxides 672
pyran-SOD 663 quercitrin 175(struc.),176
raffinose 552
pyrazole 483 Quin-2,208
RAGE 538,626,630
pyrazolopyridines 694 quinacrine 367,564(struc.)
rainwater 4,64
pyrazolopyrimidine 695 quinapril 661
ramipril 661
pyrazolynate 381 quinolinicacid 416(struc.),568,599
rancidity 77,252–253,337,355,455,
pyrene8-boronicacid 316(struc.) quinoloneantibiotics 502
pyriclor 378 quinones 14,29,41,47–48,90,97, 673
RANK(L) 560,562
pyridine 313,383,568 102,115,151,178–179,316,344,
pyridinoline 403 366,406,415,420,459,471–477, RANTE 234,637
pyridoxal 377 484,486,491–492,495,510,561, andAIDS 638
isonicotinoylhydrazine,seePIH 566,585–587,591,600,614–615, rapamycin 281
phosphate 42 619–621,675 andlifespan 647
pyridoxamine 538(struc.),661,663 antibiotics 502–503 rapeplant/oil 162,253,476
pyridoxine 155,538 methide 472(struc.),474 rapidlyageingrodents 649,658
pyrimidines 12,66,236,239–240,244, quinonereductase 185,229,474–475, ras 572,575,582–583,648,seealsoH-,
250,322,324,366,405,477,577, 476,493–494,591 K-,N-ras
584 inhumanvsratliver 474,seealso rasburicase 364
dimers 248,251,382,405(struc.), NQO;NQO1 rateconstants 34,36,41–43,46,48,50,
406,seealsocytosine;thymine, quinoneimine 486 53,80,85,109,146,164–165,172,
uracil quinghao 368 257,289,296,300,343,563
hydrates 404 quintiles 183,198 measurement 296,299,seealsopulse
radicals 247,411 quorumsensing 436 radiolysis,stoppedflow
pyrimidol[1,2-α]purine-10(3H)-one, ratelaw 34
R
seeM1G rat
Pyrococcusfuriosus,90 R-stereoisomers 280 birdparadox 649
pyrogallol 89,120,122,299,350,662 rabbitfish 434 chow 159
pyrophosphate 38,264 rabies 636 lifespan 649

--- Page 946 ---

INDEX 891
Long-EvansCinnamon 137,294, pro-inflammatoryeffect 492 redox
329,583 roleinadhesion 429 atlasofthemouse 106
newborn 19 roleinpreconditioning,see balance 178,471,518,534,638
oxygentoxicity 201 preconditioning inactive 178,471
reproductiontest 162 roleinkidney 449 modulationbyNAc 681
spontaneouslyhypertensive 230 roleinNF-κB 228–229 potential,seereductionpotential
ratiometricprobes 653 scavenging,bynanoparticles 665 proteomics,seeproteomics
γ –rays 40,226,404,507,509,seealso reactivenitrogenspecies 23,30,77, reactions 383,394,497,577,631,668
ionizingradiation 130,277,280,282,306,322,356, sensor 78,399
raxofelast 408,673,675(struc.) 445,484,seealsonamesofspecific state 99,199,201–202,205,309,314,
RBOHproteins 451,seealsoAtRBOH, RNS,e.g.ONOO––,O • 2 – 322,361,669
NtRBOHD actiononDNA 244,328 redox-active 135,212,291,392,435,
RclR 221 inatherosclerosis 521,523 615,626,687
RDA,seerecommendeddietary incancer 579,636 iron,seecatalyticiron;labileiron
allowance incigarettesmoke 492–493 pool;non-transferrinboundiron
reaction inParkinsondisease 618 RedoxBiology,477
centrechlorophylls 371,375 reactivespecies 77,125,141,146, redoxcycling 62,220,383–384,464,
rate 34(def.),36 148,158,200,217,230,246,420, 470–478,484,486,492,495,502,
reactive seealsoreactivebromine;chlorine; 505,510,555,585,591–592,659
astrogliosis 597 halogen;iron;nitrogen;oxygen;
redoxeffectorfactor1,seeRef1
brominespecies 23,30 sulphurspecies
redoxregulation 25,51,107,122–123,
chlorinespecies 23,30,322,328,521 andcocaine 484 199,204,219–231,233,281,380,
hyperaemia 349 criteriaforestablishingrolein 464,580–581,583,seealsoprotein
ironspecies 23 disease 514 kinases;proteinphosphatases;
reactivehalogenspecies 23,30,77,265, in chronic inflammatory PTEN;redoxsignalling;signal
277,322,521 diseases 565–568 transduction
detection 307 incigarettesmoke 491–494 chaperone 233
reactiveoxygenspecies 7,19,23 in inflammatory bowel inanimals 221–231
(def.),31,54,77,79,130,152, diseases 565–566
inbacteria 220–221
158,223,226,236,245,316,368, measurementof 284–353
inyeasts 221
394–395,397,481,seealsooxidative roleinapoptosis 218–219 ofthewholeorganism 234–236
DNA/proteindamage,lipid roleinautoimmunediseases 557
ofviralexpression 638
peroxidationandnamesofspecific roleinrheumatoidarthritis 558–565
ROS,e.g.HOCl,H2O2,OH • roleintoxicology 464–510 RedoxReport,477
redoxsignalling 45,106,118,123,199,
actiononp53 575–576 reactivesulphurspecies 23,30,77
267,280,369,374
actiononproteinases 424 recallbias 180
inplants 380,384,451–456
andageing 642,653–654 receptors 204,225,424,442,538,568,
inskin 404
andautophagy 281 597–598,600,643,seealsosignal
mitochondriatonucleus 225–226,
andcancer 573,584–595 transduction;ryanodinereceptors;
235,247,659
andHIV 637 L-glutamatereceptors
reducing
andinflammasomes 235,444 forAGE,seeRAGE
agent 23(def.)
andmucusproduction 477,493 receptorinteractingproteinkinase 212
sugars 535–536
andpain 635–636 receptortyrosinekinase,seeRTK
reduction 23(def.)
anti-apoptoticeffect 219,581 recognitionofoxidativeDNA
anti-inflammatoryeffects 236, damage 251 potentials 12,32–34,36,39,41,50,
443–444,557,561,582,607 recombinanthumanSOD 19,400,545, 99,107,144,148,157,257,322,371,
374,432,471,590,686
asstresssignals 385–386 636,663,665
biosensorsof 309–310 andpain 636 reduction-oxidation-sensitiveGFP
variant,seeroGFP
circadianrhythms 109 recommendeddietaryallowance 124,
effectoncytokineproduction 442 188,197–198,501,seealsodiet; reductivestress 199
goodorbadinbloodvessels?,448 nutrition;food Ref 1,229,248,576
inAstoxicity 498 recreationaldrugs 56–57,463,484–485 regulation-upon-activation,normal
inbone 451 rectum 178,327,356,565,570 T-cellexpressedandsecreted,see
inbrain 600–606 cancer 191,193–194,579 RANTES
inethanoltoxicity 481–483 red rejectionoftransplantedorgans,see
inheartfunction 545 bloodcells,seeerythrocytes organtransplantation
ininfluenza 636 meat 197,356,seealsomeat Relfamily 226
ininsulinaction 533–534 tideplankton 386 relativerisk 180–181,189
inplants 451–456 wine 177,261,270,352,356,481,527, Remicade 560
inwounds 407 647 remotepreconditioning 547

--- Page 947 ---

892 INDEX
renal,seealsokidney liningfluids 146,358–359,487–488, 441,511,558–565,582,588,629,
bloodflow 450 491,555,seealsolungliningfluids 636,678,680,693,seealsosynovial
brushbordermembranes 451 RESTprotein 627,645 andanaemia 565
cancer 133,490,497–498,531,583 restenosis 186,546,550,670 andcancer 578
cortex 327 restraint 504 rhinoceros 134,363,367
failure 133,136,267–268,277,348, resurrectionplants 149 Rhizobium 452
◦
499,532,548,551,seealsodialysis resuscitationofnewborns 19,399 Rho state 91
function,roleofNOS 449–450 resveratrol 174(struc.),175,177–179, rhodamine 123,302,307,320
glomerular/glomerulus/ 184–185,409,451,647,656,661, Rhodniusprolixus 367
glomerulonephritis 327,449–450, 683 rhodopsin 387,389,393
556 reticulocytes 363–364,456 rhodotorulicacid 687(struc.)
inflammation 450 reticuloendothelialsystem 140,143, RhoNox-1 129
medulla 223,327 368 riboflavin 10,64,67,89,154,364
nephropathy 186 retina 19,93,132,162,165,168,171, ribonuclease 42
pelvis 192 253,385–394,401,437,447,532, ribonucleosidediphosphate 411,412
(struc.)
proximaltubules 473 538,546,605,635,655,seealsoeye
ribonucleotidereductase 7,37,49,
RENOX 450 ironoverload 388
53–54,96,106–107,114,131,395,
reoxygenation/reperfusioninjury,see ischaemia-reperfusionin- 411–413,445,588,692
ischaemia-reperfusion jury/preconditioning 548–549,
ribose 42,237,239,252,324,411–412,
reportergene 309 665
588,646
repressorelement1-silencing light-induceddamage 388,392,669,
ribosomes 26,232,502,631
transcriptionfactor,seeREST 676,679
ribozymetechnology 391
reproduction 124,161,174,394–395, O2level 388
ribulose1,5-bisphosphate 370,376,377
397,642,seealsoneonates;ovaries; pigmentepithelium 388–391,393,
(struc.)
pregnancy;sperm 426,492,548,658
carboxylase,seeRubisco
andageing 643 protectionbydrugs 669,676,679 ribulose-phosphate3-epimerase 96
andcaloricrestriction 640 retinal,seeall-transretinal rice 377,381,451,499
andoxidativestress 394–402 retinitispigmentosa 388 RieskeFeSprotein 373
reproductiveyears 444,649 retinoicacid 15,223,403,459 rifampicin 16
reservoirsofnitricoxide 58 retinol 20,155,171–172,186–187,190, riluzole 632
residentmacrophages 426,430–431, 274,356,387,389(struc.),393,480 ringedseal 550
481,558,seealsoalveolar dehydrogenase 389 RIP1 227
macrophages;Kupffercells; fromcarotenoids 171 ritonavir 637
macrophages oxidationof 274 riverwater 5,497
resolutionofinflammation 228, pro-oxidanteffects 172 RNA 238,325,327,647
425–427,seealsochronic retinopathy 92,539 antibodiesagainst 556
inflammation;inflammation
ofprematurity vi,19,20,168,386, chlorination 66
resolvins 425–427,430,456,520,554, 392,399–400,447,514,548 interference 94,648
636 retinylpalmitate 186–187,190 oxidativedamage,seeoxidative
D1 425(struc.),636 damagetoRNA
N-retinylidene-N-retinylethanolamine,
E1 425(struc.),636 polymerase 37,246,248
seeA2E
resorufin 310,311(struc.) precursorpool 325,328
retrogradetransport 596,622
respiratorysyncytialvirus 638,673 primer 238
respiratoryburst 431–445,462,572, retrolentalfibroplasia 19 RNS,seereactivenitrogenspecies
retroviruses 637,665
seealsoeosinophils;macrophages; 60kDRoribonucleoprotein 557
Rettsyndrome 511,633
monocytes;neutrophils; rock-boringmollusk 420
phagocytes reverse rocketfuels 365
effectofROS 443 cholesteroltransport 530 rods 162,387–393,seealsoeye
individualvariation 431 transcriptase 637 rodent lifespan, effect of
oxidasehomologues,seeRBOH Rezulin 675 antioxidants 656
proteins rhabdomyolysis 551 rodent-humanvariations 486,531,
priming 432–433,492 rhamnose 175–176,689 544,548,seealsointer-species
respiratorytract 5,8,18,54,64, rhesushaemolyticdisease 211 differences
75–76,120,125,138–139,148,243, Rhesusmacaquemonkeys 637,641, β-cells 533
339,357–360,445–447,463,477, 645,651,653 inAlzheimerdisease 627,645
487–488,492–493,635,638 rheumatoidarthritis 61,108,132, inatherosclerosis 523
antioxidantdefences 357–360, 134–135,136,148,153,159,201, inbrain 598
493–494,seealsoalveoli/alveolar 210,226,236,275,295,328,339,365, phagocytes 422,435,439

--- Page 948 ---

INDEX 893
rofecoxib 563(struc.) salicylaldehyde scrapie 629–630
roGFP 309 isonicotinoylhydrazone,seeSIH scurvy 156–157,160
roGFP2 313,361 salicylate 184,294,452,464(struc),499, SDA,seesemidehydroascorbate
roGFP2-Grx1/Orp1 313 515,559,561,563,565,661–662, sdLDL 530,533
ROMStest 329 seealsoaspirin sea 135
roots 18,382,452,501 inplants 452 anemone 94
hairs 452 hydroxylation 294–296,484, food 261,270,335
nodules 79,355,357,382,452,seealso 497–498,507,552 transportoffishmeal 679
leghaemoglobin;leguminous nitration 196 urchin 45,113,344,415,417
plants pyruvate 144 water 5,7,47,64,135,157
ropinirole 617 reactionwithMPO 296,436 weed 448,557,599
ROS,seereactiveoxygenspecies reactionwith1O2 296 seasonalvariation 160,385
roseBengal 67,68(struc.) saliva/salivary 56,66,120,127,146, inLDLperoxides 529
rosemary 176,184,673 285,324,355–356,447,481 sebaceousglands 406
Roseobactersp. 47 glands 56,355,367,552,671 second-derivativespectrosopcy 331
rosmarinicacid 174(struc.),176 peroxidase 355, see also secondmitochondria-derivedactivator
rostral lactoperoxidase ofcaspases 217–218
ventrolateralmedulla 449 TAC 352,356 secondorderrateconstant 34,96
ventromedialmedulla 635–636 salmon 162,170,417,645 secondary
Rota 617 Salmonella 80,251,445 (adaptive)changes 657
rotenone 26,568,598,622 typhimurium 14,64,78,108,120,133, amines 56,588
actiononNADPHoxidase 620 220,436 granules 422
andParkinsondisease 620 saltstress,plants 385–386 oxidativedamage 465,510
rotifers 509 SAM 413,463,482 tumours 570
Rotterdamstudy 195 sand 496 SecondaryPreventionwithAn-
Roussarcomavirus 572 sanitizationofthenucleotidepool 248, tioxidantsofCardiovascular
RPE,seeretinalpigmentepithelium 250,325,382,407,590,606 diseaseinEndstageRenalDisease
Rpe65protein 389 santoquin,seeethoxyquin (SPACE) 186–187
RTK 227 SAP,seeserumamyloidPprotein secosterols 268
rubber 24,58,77,252–253,365–366,495 saquinavir 637 α-secretase 623–624,640,647
Rubisco 369–370,376,380,456 sarcomas 570,572–573,575 β-,γ-secretase 623–624,626–627
oxidativedamageto 377 sarcomeres 11,12 sedimentationcoefficient 281
rubor 425–426 sarcopenia 275,408,649,653,seealso sedoheptulosebisphosphate 376,380,
rubredoxin 90 musclewasting 382
Russellmechanism 48,66–71,309 andcaloricrestriction 651 seeds 18,165,280,381,386,455–456,
Russiancocktail 475 proteincarbonyls 408 473,572
ruthenium 57,208 sarcoplasmicreticulum 12,205, germination 266,386,455–456,509
nitrosylpentachloride 57 408–409,653 seedingperoxide 459,522,526
red 208 sarin 530 selectins 427,428–430,442
rutin/rutinose 175(struc.),176,680 SB211475 679 selectionbias 183
ryanodinereceptors 205,408,654 SC-54417,-55858 664,667(struc.),669 selegiline,seedeprenyl
SCA,seesenescentcellantigen selenenicacid 110,683
S
scaffoldprotein 249 selenium 28,107,110,115,122,
s-block 701 scallops 261 123–124,154,159,167,184,
s-electrons 697(def.) Scandinavia 635 186–190,193,252,391,462,471,
20S 26Sproteasome,seeproteasome scandium 700(struc.) 482,497,629,683
S1-,S2-,S3-,S4-states 374 scavengerreceptors 141,169,266,363, andbrain 603
Sphase 250,574 518,519–520,521,524,530–531, andcancer 189,193,595
S-stereoisomers 280 538,686 anddiabetes 534
S100proteins 421,430,441 Scheele vi andmiscarriage 397
S17834 695(struc.) Schiffbases 268,340,536–537,658 andVitaminECancerPrevention
SAA,seeserumamyloidAprotein Schistocercagregaria 307 Trial(SELECT) 189,193
sabretoothsausages 650 Schistosoma 140,367,582 andviruses 124,636,638
Saccharomycescerevisiae 91,95,104, schizophrenia 104 deficiency 123–124,280,603
118–119,123,146,149,156,275, scid 251 incysticfibrosis 556
280,654,seealsoyeast β-scission 276 inpancreatitis 567
asageingmodel 646–647 sclera 387 inplants 124,380
redoxregulation 221 scleroderma 201,275,339,552,556 interactionwithvitaminE 123
sacrificialantioxidants 134,139,154 scopoletin 310,311(struc.) toxicity 124

--- Page 949 ---

894 INDEX
selenocysteine 107,110,125,221,280, Sertolicells 172,395 569,572,577,639,644,649,seealso
380,385,683 serum 557,569,seealsoplasma redoxsignalling;proteinkinases;
selenols 110,499,683 amyloidAprotein 237,629 phosphatases
selenomethionine 680 amyloidPprotein 237,624 inageing 643,655
selenoneine 115 ferritin 128,131 incancer 570,581
selenoproteins 110,124,154,252,499, totalantioxidantcapacity 152,349, inphagocytes 432–433
603 351,356 mitochondriatonucleus 225–226,
semen/seminal 138,456 sesamol 175 235,247,659
fluid 110,127,159,233,394–395,456 sesquiterpeneendoperoxide 368 Siganusoramin 434
plasma 138,334,394–395 severecombinedimmunodeficient,see SIH 129,632,688(struc.),693
vesicle 456 scid inALS 632
semidehydroascorbate 126,158,160, sevoflurane 468(struc.),547,608,661 silentinformationregulator 2,seeSir2
381,526 inbrain 608 silibinin/silybin 483(struc.)
seminapthofluorescein 304 sex 92,94,101,126,134,151–152, silica 430,443,496–497
semiquinone 11,12,29,36,41,47–48, 171,180,190,247,277,352,360, silicate
90,97,102,126,151,178–179, 394–396,451,469,558,584,610, dusts 294,497
299,316,415,417,420,469,471, 652,660,680,seealsowomen fibres 430,seealsoasbestos
474–476,484,491,495,502,561, andiron 660
ion 496
585,591,600,614–615,619–621, chromosomes 238
silicon 496,501,628,700(struc.)
675,677 inrelationtooxidativeDNA
dioxide 495–496
drivenFentonreaction 473 damage 247
radicals 497
senecionine 270 linkedgenes 238
silicosis 496,694
senescence/senescent 28,94,101, oxygentoxicity 19
silkworm 219
199,202–203,214–215,236,248, sexual
silver 131,137,496
251,280,363,447,455–456, inducer 247
nanoparticles 213,496,665
514,574–575,583,590,645–646, maturity 394,641
647–649,652,655,658–659 ornamentation 171 silymarin 483
simianimmunodeficiencyvirus 637
acceleratedmouse 658 SFRBM/SFRR 477
simvastatin 186,188
andcancer 649 Shcprotein 644
SIN-1,1A,1C 56–57,59(struc.),63
andCuZnSOD 648 shearstress 222–223,448,518
associatedβ-galactosidase 648 β-sheetconformation 81,116,622, sinapicacid 418(struc.)
sinapylalcohol 417,418(struc.)
cellantigen 168,363,368 629–630
fibroblasts 653 shelterin 648 Sinemet 617
ofrootnodules 382 SHR,seespontaneouslyhypertensive singletO2 22(struc.),48,66,67–74,
redbloodcells 143 rats 70,78,89–90,100,115,137,139,
senileplaques 622–629 Shibatastudy 190 143,149,151,158,162,171,185,
SEPP1 124 Shionogi&Co 159 245–246,257–258,275–277,292,
sepsis 133,140–141,143,231,236,268, shippingregulations 252 309,320,322,329,343–344,346,
344,364,367,434,444,547–548, ShiranuiSea 499 350,377,380,384–385,421,435,
553–554,598,606,684,692,695 shock 408,547–548,553–554,669,672, 438–440,455,698
encephalopathy 606 seealsohaemorrhagicshock,septic absorptioncapacity(SOAC) 350
shock 303,541,548,550–551,691 shock actionsonDNA 244
sequestrationofmetalions 125–131, wavelithotripsy 40 andlipidoxidation 257,264–265
151, short-beakedechidna 652 fromantibiotics 502
ineye 392 short-patchBER 248 fromflavins 67
inplants 381–382 ShigechiyoIzumi 637 fromMPO 438–439
serine 110,206,221,250,277,346,381, sialicacid 338 fromozone 487
433 sickle-cellanaemia 160,168,362,367, fromsuncreams 406
/threoninekinases 123,222,224, 412,539,548,693 inchloroplasts 374–375,378,382,
252,281,534,569,621,643,647 xanthineoxidaseinvolvment 362 384
proteinases 280,424,441,450,556 siderocalins 133 ineye 387–393
serine-tyrosine-glycinesequence 421 siderophores 133,390,445,477,555, inphagocytekilling 435,438–440
serotonin 92,125,144,145(struc.),416, 687 insignalling 452
438,440–441,482,484,598,600, sidestreamsmoke,seecigarette inskin 404
602,614 smoke 494 measurement 307–309,317–319
inESeroS-GS 676 signaltransduction 61–62,78,96,106, quenchers 72,307–308,378–379,381,
serpins 424 109,122,137,173,178,212,217, 393,662
Serratiamarcesens 434
219–231,236,255,275,497,500,
reactionwithazide 308

--- Page 950 ---

INDEX 895
reactionwithcarotenoids 170–172 SkQ1 656,658 sonsofSAM 413
reactionwithDCFHDA 317 SkQ1H2, SkQ3H2, SkQ4H2, soot 495,584
reactionwithDMPO 292 SkQ5H2 685(struc.) SOR,seesuperoxidereductases
reactionwithsalicylate 296 SkQMH2 684 sorbitol 538–539
scavengers 72,307–308,377,459,662 SkQR1 402,503 SOTS 45(struc.),59,507
sensitizersofformation 265,seealso Skulachev 684 southernelephantseals 550
photosensitization;photochemical SLC23A1,SLC23A2 157 Souvenaid 629
reactions/damage,photodynamic SLE 275,365,556–558 soxR/S 220–221
effects sleep soy 162,185,196,353
sensorgreen 308,375 apnoea 549–550 soybean 175,177,253,381–382
spintrapsfor 288–289,308 deprivation 504 lipoxygenases 453–454
Sinorhizobiummeliloti 87 slimemould 231,446 spaceflight 408,509
Sir2 646 SMAC 217–218 Spanishcooking-oilsyndrome 476–477
siRNA 657,695 small sparfloxacin 502
sirolimus 281 denseLDL,seesdLDL spatialsegregation 280
SIRS 541,548 Gproteins 224,432 speciesdifferences,seeinter-species
SIRT 576,602,645,647,651 intestine 24,178,184,355–356,463, differences
sirtuins 85,155,178,204,233,647,650, 541,566,seealsogastrointestinal specificgranules 422,432
656,680 tract sperm 110,124,138,159,247,266,275,
Sis 573 proline-richproteins 407 327,394–395,415,447,465,492,
site-specific 687,689 smallpox 180 549,641
Fentonchemistry 478,seealso Smith-Lemli-Opitzsyndrome 269,602 andcigarettesmoke 395
hydroxylradical,site-specific smoke 408,495–496 mtDNA 394
reactions injury 495,seealsocigarettesmoke;
oxidativedamage 394
freeradicalreactions 99,201,241, dusts;firesmoke;fumes;toxic
spermicidaleffects 175
244,259,296–297,299,362,527 smokes;woodsmoke
OH • generation 99,201,259, smokedfoods 176 spermidine 114,369
spermine 57(struc.),274,608
296–297,299,478 smokers’inclusions 429
NONOate 59
oxidativedamagetoDNA 241,244 smoothmuscle 53,138,169,201,204,
oxidase 274
Sjögrensyndrome 552 206,222–223,236,267,358,446,
sphingolipids 170,253,256
skeletalmuscle 54,91,115,118,126, 448,456,516,519–521,523,546,
sphingomyelin 254(struc.)
218,226,232,286,306,320, 549
408–410,535,540–541,619,653, SMP30mice 468 sphingomyelinase 219
sphingosine 254,255(struc.)
655,seealsomuscle SNAP 56–58
andageing 645,653,660 SnowballEarth 2,3 spices 176,252
ischaemia-reperfusion 552 snuff 490,494 spin
mitochondria 649 SOAC 350 adducts 491,544,seealsoESR;spin
skin 5,56,67–69,135,142,149–151,155, SOD5 140 traps,trapping
158,171–172,182,190,208,223, sodium 157,167,700(struc.),702, quantumnumber 20(def.),22,697,
229,251,276,285,308,327,339, seealsounderNa+ 699,703
393,402–408,424,428,434,441, borohydride 344,346 restriction 22,36,67
450,462,487,490,501,508,539, channelsandpain 635 spintraps/trapping 63,84,89,229,
546,549,552,554,556,570–571, chloride 702(struc.)
266,284–293,294,302,308,316,
604,646,649,652,655,692,seealso dodecylsulphate 79 350,375,435,467,478–479,484,
keratinocytes;corneocytes;sun formate 35,98,296 490,505,515,542,555,632,662,
creams hypochlorite 65,487 684
andageing 404,406–407,674 influx 598 asNrf2activators 292
antioxidants 406–407 pump,seeNa+,K+-ATPase astherapeuticantioxidants 669,678
atrophy 93,644,657 selenite 123–124 effectonCYPs 672
bacteria 403,405 uratecrystals 146,421,556,625 exvivo 290–291
cancer 70,177,190,251,403–406, vanadate 500 for1O2 288–289,308
497–498,502,570,572,574, vitaminCtransporters,seeSVCT1; immuno 293,328,345,532
seealsomelanoma;squamouscell SVCT2 impurities 288
carcinoma SOG,seesingletO2sensorgreen inbrain 606
•
flaps/grafts 552 olute 705(def.) NO generation 288,290,304,669
•
lipids 406,487 soman 530 ofCCl 467
3
tanningagents 393 somaticcells 655 ofcigarettesmoke 491
•
SkinCancerPreventionStudy 186–187, sonication 40,257,259 ofNO 303,669
189 sonoporation 257 ofO •–/OH • 289–292
2

--- Page 951 ---

896 INDEX
spintraps/trapping(continued) standard stomata 452
ofthiylradicals 291–293 hydrogenelectrode 32 stopcodon 110,146
metabolism 292,672 reductionpotentials 32–34,40 stoppedflow 35–36,45,59,87,662
reactionwithHOCl 292 ReferenceMaterial 326 stratosphere 404
reactionwith1O2 292 Staphylococcusaureus 97,113,133, stratumcorneum 402,406,seealsoskin
reactionwithONOOH 292 170–171,428,434,436–437,439, Streptococcus
tostudylipidperoxidation 330 488 mutans 87,104,119
spinalcord 596,601,611–612,630–632, staphyloxanthin 171,436 pneumoniae 64,104,119,236,435
635,665 starch-like 629 pyogenes 436
andpain 635–636 Stargardtdisease 390 sanguis 87,120
trauma 611,670,673,680,683 starvation 101–102,281 streptokinase 545
spiracles 78 STAT3 583 Streptomyces 113,282,591
spirodimer 406 statins 186,188,306,517,523–524 caespitosus 591
spiroiminodihydantoin 242(struc.), actiononNADPHoxidase 661,695 coelicolor 87
245–246,498 inAlzheimerdisease 624 flocculus 502
spleen 127,129,135–136,140–143,347, STAZN 610,667(struc.),672 hygroscopicus 281
361,363,422,426,434,439,447, Steap3 127 peucetius 591
477,573 stearicacid 253,527 pilosus 686
tyrosinekinase(SYK) 227 suis 130
steel 275,498,500
splicingmutations 119 sviceus 103
Steinberg 520
splittingfactor 285 verticillus 590
stellatecells,seehepatic
sponges 557 stemcells 18,20,28,79,226,280, streptomycin 338
spongiformencephalopathy 630,670, streptonigrin 94,502,503(struc.),588,
287,313,358,394,434,447,531,
seealsopriondiseases 591
552–553,600,648,650,652,659,
spontaneous streptozotocin 203,398,478–479,478
seealsoembryonicstemcells;
combustion 33,252 (struc.),534,692
neuronalstemcells
deamination 246–247,578 stress 224,226,229,321,360,417,449,
ageing 639,659
depurination 245–247,578 503–504,554,575,633,641,655
andROS 201
spontaneouslyhypertensiverats 230, andMnSOD 232
andSIRT 651
449–450 proteins 221,231–233,seealsoheat
inadiposetissue 531
sporadic 630–631 shockstress/response
incancer 581–582
inclusionbodymyositis 629 signals 173,378
Parkinsondisease 612,616–617,622 inheart 545 striatum 475,596,601,605,608,
tumours 574 niches 440 615–616,621,634
spores 231,247,413,445,453 stents 546 dopaminedeficiency 596
photoproductlyase 413 Stephaniatetrandra 694 strongacids 705(def.)
sporidesmin 68,404 stereoisomers 167,240,280,seealso Strongylocentrotuspurpuratus 415
Sporotrichumpulverulentum 24 R-stereoisomers;S-stereoisomers stroke 92,109,140–141,143,148,151,
Sprague-Dawley 56 stereospecificity 454,522 153,170,177,183–184,186–188,
spurs 35,41,507 oflipidoxidationproducts 456–462, 190,195–196,204,336,340,348,
sputum 440,555 522 490,502,514,516,602,604,
Spy-LHP 342 sterileinflammation 443,487,541,544 606,607–611,628–629,640,646,
squalene 406 inCGD 444 660,663,669,672–673,678,692,
squamouscellcarcinoma 404,571,579 sterileinjury 423,425–426 694–695
squashbeetle 163 steroids 15,16,112,400,434,566, andalbumin 610
squid 440 seealsocholesterol andantioxidants 190,195,610–611
SR-A 538 hormones 16,588 anddiet 153,195,610–611
SRAIandII 519 sterolregulatoryelementbinding andebselen 683
SRB1 530 protein 1,480 andedaravone 680
Src 224,572–573 stilbazulenylnitrone,seeSTAZN andmeatconsumption 611
SREBP-1 480 stilbenes 15 andproteasome 610
SRM2396,seeStandardReference stochasticity 640 andurate 148,610
Material StockholmHeartEpidemiology andvitaminC 182,610–611
SSpeptides 684 Program(SHEEP) 190 andvitaminE 188,511,610–611
SS-31 408,545,632,684,685(struc.) stomach 13,56,153,158,160,178,184, likeepisodes 27
St.John’swort 69,403 226,266,328,354–357,483–484, stromelysins 424,517
stability 547,567,575,579,599,705,seealso styrylpyrones 418
constant 691 gastricjuice subarachnoidhaemorrhage 144,
genes 574,577 cancer 153,180,189,191–192,194, 606–607,611,614,670,680,683
stalledDNAreplication 569,573,588 490,576,677,695 substanceP 636

--- Page 952 ---

INDEX 897
substantianigra 471,596,601–602,612, sulphoxide 442,480,563,seealso frombasophils 440
615,617–619,seealsoParkinson dimethylsulphoxide fromCYP2E1 482
disease reductases 14 fromDFO 691
Cu/Fecontent 211–212 containinghaemolyticdrugs 366 fromerythrocytes 360–361
N-substitutedpyridylporphyrins 669 dioxide 48,51,384–385,390, fromhaemproteins 25,360–361,400
substratecycling 13 489–490,587 fromkeratinocytes 402–403
subunitc 635 radicals 21,40,50–52,184,277,385, frommastcells 440
succinate 10,14,163 490,508,680,seealsothiylradicals from mitochondria, see
dehydrogenase 10,12,27,37,91, sulphurousacid 489 mitochondria,O
•–production
2
93–94,598–599 SUN-8075 676,679(struc.),680 frommyoglobin 25
esters 524,673 suncreams 151,172,403,406,500 fromnitro-compounds 505
succinylgroup 647 sunburn 68,406,558 fromNOS 24,55,63,155
coenzymeA 10,61,413–414 sunlight 251,387,404–406,488,556, fromsperm 394
suddencardiacdeath 196,542,seealso seealsoUVlight fromV 500
myocardialinfarction superflies 658 imaginginplants 375,382,384
sugarradicals 239,412 superoxidase 438 inageingmuscle 660
sulindac 280,460,563(struc.) superoxide 7,9,15,17,20–21,22 inangioplasty 546
sulphamethoxazole 365(struc.),366 (struc.),23,27,29–32,35–36, inARDS 554
sulphanilamide 305 39–40,43–48,49–50,54,59,61–64, inasbestos 496
sulphapyridine 562,564(struc.) 66–67,80,84–85,88–91,94–95, inatherosclerosis 520–521
sulphasalazine 507,562,564(struc.), 97,104–105,114–115,117,120, inautophagy 281
565–566,661 125–126,130,132,134,137–138, inbetelquid 494
andNeu2000 680 148,151,158,169,206,208, inbiofilms 27
sulphatases 280 213,217–218,220–221,223–226, inbrain 599–600,608–611,617,620,
230–231,238,256–257,263, 625
sulphate 167,490
275–277,281,284,286–287,289, incancer 582,587,591
anionradical 490
296,299,301–302,304,306,308,
incardiovascularageing 653
reducingbacteria 2 310,316–318,320,322,329,343,
inchloroplasts 376,378–380,384
transportsystems 498 349,355,357,362–363,366–369,
incigarettesmoke 491–492
sulphatedpolysaccharide 566 385,393,399,448,463–464,470,
incocainetoxicity 484
sulphation 165,177,344,463,484,584, 477,484,500,507,512,546
indiabetes 535,537–538
647,677 aconitaseassay 300,320
inDupuytrencontracture 552
sulphenicacid 64,105,141,221,224, andaluminium 501
inear 402
274,276,345,348 andapoptosis 219
ineye 392
sulphenyl 348 andCr 498
inH.pyloriinfection 567
sulphenylamide 225 anddiphenols 471 inhypersensitivityresponse 453
sulphilimine 440 andexercise 408,660
ininactivity 408
sulphinicacid 106,123,141,225,276 andhyperglycaemia 535
in ischaemia-reperfusion
sulphinylradical 51 andindoleaminedioxygenase 415
injury 540–553, see also
sulphiredoxin 109,123,229,652, andlifespan 657
ischaemia-reperfusion
654–655 andlipidperoxidation 43,257,263 inlung 553
andcigarettesmoke 494 andpain 635–636 inMDMAtoxicity 484
incancer 576 andRNR 412 inplacenta 397
inplants 380 andSSpeptides 686 inradiationdamage 508–509
sulphite 89,355,385,402,459,489–490, andstellatecells 483 inrheumatoidarthritis 561
568,587 andstress 503,518,seealsoshear intestes 394
asapreservative 489 stress inwounds 407
oxidase 37,490 assistedFentonreaction 45,97,473, interactionwithquinones 471,476
radical 490 561 levelinE.coli 91,300
reductase 27 concentrationinphagocytes 432–433 levelinmitochondria 26,300,320
sulphitolysis 402,490 cytotoxicity 96–99 levelinmuscle 320
sulphoacetaldehyde 437 detection 299–302,317–321 lithiumsalt 48
Sulpholobusacidocaldarius 86 dismutation 46,300,437 potassiumsalt,seepotassium
sulphonamides 364 drivingevolution 231 superoxide
sulphonicacids 51,106,141,225,276, flashes 26,310 productionbyautoxidations 24–25
345,622 fromAIF 217 productionbyenzymes 15,24
sulphonyl 51,348 fromalloxan 477 productionbyphagocytes 431–445
sulphoraphane 183–184,185(struc.), fromantibiotics 502 protonatedform,seehydroperoxyl
230,355,493,683 frombacteria 27,28,91,300 radical

--- Page 953 ---

898 INDEX
superoxide(continued) infoetallung 399 synapse/synaptic 481,502,596–598,
rateofproductioninvivo 28–29,see infrostbite 549 615,622,624–625,632
alsomitochondrialO
•–production
ininfluenza 636 excitatory 596
2
reactionwithcobalamin 414 in ischaemia-reperfusion inhibitory 596
reactionwithDCFHDA 317 injury 539–553 mitochondria 626
reactionwithDMPO 292 inkidney 550 plasticity 599,633,645
reactionwithhydroxylamines/ inlearningandmemory 666 remodelling 597,610
nitroxides 292,672 inmuscle 408 transmission 603,654
reactionwithmanganese 38,95,300, inovaries 395–396 synaptosomes 501
666,669 inoviductalliningfluid 397 Synceruscaffer 433–434
reactionwithMPO 438 inpain 635 Synechocystis 375
reactionwithphenols 173 inplants 379,385–386 synovial/synovium 578,693,seealso
reductases 90,95,661 inquinonereactions 473 rheumatoidarthritis
reductionpotential 33,34 inshock 547 fluid 138,146,159,210,324,334,441,
roleinmitochondrialdiseases 27 inskin 406,552 558–561
roleinsulphiteoxidation 490 insperm 395 membrane 558,565
sinks 151,361 inwounds 407 synoviocytes 558
spintrappingof 289–292 PEGylated,seePEG-SOD α-synuclein 62,615–617,620–621,630,
theoryofoxygentoxicity 23,91–99 rateconstants 300 634
superoxidedismutases 13,36,39, recombinant 19,400,545,636,663, nitration 62,615,620
58,61,78,79–99,106,116,126, 665 overexpression 614,621
136,138,202,215,222,231,295, SOD5 140 syringes 7
299–300,302,310,312,321,348, therapeuticuse 663,665–666 systemic
355,364,408,445,471,478,482, unitsofactivity 87 acquiredresistance 234,452
549,576,594,603,652,656,seealso usetodetectO • 2 – 90,490 inflammatoryresponsesyndrome,
SOD1,-2,-3,-5;CuZnSOD; withheparin-bindingdomains 665 seeSIRS
FeSOD;FeZnSOD;MnSOD;NiSOD superoxidedismutasemimetics 92, lupuserythematosus,seeSLE
absenceinsomeaerobes 95–96 557,590,610,661,664,666(def.),
sclerosis 552
andageing 643,645,650,653–654, 666–672,684,690
Szent-Györgyi 155
660 andblood-brainbarrier 669
Szeto-Schillerpeptides 684
andbabies 19,400 andlifespan 656
andcancer 574,576,581,583 aspro-oxidants 668–669 T
anti-inflammatoryeffects 557 effectonHO-1 669 (cid:3)
assays 15,46,87–90,299–302,475,650 insepsis 548 T3,see3,3,5-triiodothyronine
bovineerythrocyte,seebovine mitochondriatargeted 684
T4,seethyroxine
erythrocyteSOD surfaceboundROS 497 Thelpercells 421,519
cambialistic 86 surfactant 19,65,76,138,358,400,471, t-butylhydroquinone 230,677
cooperation with H2O2 487–488,493,528,553 3-t-butyl-4-hydroxyanisole 677
metabolism 124–125 effectofcigarettesmoke 493 t-butylhydroxylamine 635,648,672
conjugates 663 surgery 511,528,541,546,551–553, t-butylhydroperoxide 35,109,113,128,
contaminationof 90,95,557,665 588,660,seealsosterileinjury; 137,204,265(struc.),267,362,368
contaminationofcaeruloplasmin inflammation t-butylnitrosobenzene,seeBNB
with 139 SUVIMAX 186–187,190,194,198,406 t-nitrosobutane 288(struc.)
contaminationofcatalasewith 116, SVCT1 157,655 T-lymphocytes 204,218,235,421,
312 SVCT2 157,159,392,558,604 442–443,449,513,519–520,533,
contaminationofcytochromec knockoutmice,seeknockoutmice 538,558–559,582–583,637
with 88 swallow-tailed perylene roleinatherosclerosis 516–520
earliestuse 490 derivativefordetecting TAC,seetotalantioxidantcapacity
electrodes 300,312 lipidhydroperoxides 342 tachycardia 543
evidenceforroleinvivo 91–96 sweat 126,208,134,403,405,501 Tachyglossusaculeatus 652
evolutionof 87 Cu/Fecontent 211–212 tacrolimus 661
hybrid 86–87 swimbladder 19,354 TAK1 227
inARDS 553 Switzerland 119,181 Takahara’sdisease 119
inautoimmunediseases 556–557 SybrGold 324 tallysomycin 588
inC.elegans 657 sydnonimines 56 tamoxifen 588
indiabetes 533 SYK 227 TAMOXO63 300(struc.)
inembryos 396 symbiotic 440,452 tandem
inexercise 409 algae 94 lesions 246
ineye 391 bacteria 382,447 mutations 578

--- Page 954 ---

INDEX 899
tapwater 160 TEMPOL 577,667(struc.),672 tetrandrine 694(struc.)
tardivedyskinesia 633 inALS 632 tetranitromethane 89
tartrate/tartaricacid 38,66,128,381, inbraininjury 610–611 tetraoxideintermediate 48
420 inpain 635 tetrapyrrole 350
manganesechelate 420 tenoxicam 563(struc.) tetrasulphides 184
resistantacidphosphatase 264 TEP1 367 tetrathiatriarylmethylradical 300
tartrazine 505 teratogenesis 172,398,459,464,seealso tetrathiomolybdate 136,522
Tat 637–638,694 embryo tetrazolinylradical 47(struc.)
asdeliveryprotein 637–638,663,692 terephthalicacid 297(struc.) tetrazolium
catalase 663 terminal deoxynucleotidyl oxidase 84
Hsp 663 transferase 323 salts 213,300,474,seealsonitroblue
metallothioneins 692 α-terthienyl 377,378(struc.) tetrazolium
SOD 663 tertiary TFA-12 674(struc.)
tattoos 67,404,584 amines 588,675 TfR1 2,128,135
tau 613,622–625,628,634 granules 422 TGF-α 234,595
HNE 627 tertiles 183 TGF-β 223,225,234,236,427,430,446,
hyperphosphorylation see613, testes/testicles 19,88,110,124,137, 449,480,497,568,594
622–623,628 151,173,394–395,446–447,634, TGF-β-activatedkinase,seeTAK1
taurine 66,143,197,307,437(struc.), seealsocastration TGF-βreceptortypeII 328
662,676 cancer 578 thalassaemia 25,135–136,160,168,
antioxidantproperties 437–438 heatshock 394 210,348,362–363,367,645,686,
assay 307 testosterone 16,19,151,234,482 687,689–692
concentrationinneutrophils 437 TETA,seetrientine relationtoascorbate 160
donor 684 tetomilast 564(struc.),565–566,668, thalidomide 398,459
inETS-GS 676 694 Thamnophissirtalisparietalis 549
taurinechloramines 66,218,230,437 7,7,8,8-tetra-methyl-o- theaflavins/thearubigins 175
(struc.),438,442 quinodimethane 304 theobromine 204
andNrf2 684 tetraalkylammoniumsuperoxide 45 theophylline 204,479
asanti-inflammatoryagents 444 tetrachlorobenzoquinone 41,469 theoriesofageing 640–660,seealso
tautomerization 150 2,3,7,8-tetrachlorodibenzo-p-dioxin,see ageing
taxprotein 636 TCDD therapeuticantioxidants 284,513,627,
taxifolin 175(struc.) tetrachlorohydroquinone 469(struc.), 660–696
taxol 588,590,636 471 Cuchelators 686
TBAassay/TBARS 149,168,209,270, tetracyclines 68,403,502,503(struc.), Fechelators 686–693
299,337–339,409,462,469,509, 591,661 thermalenergydissipation 370
525,555,593,601 12-O-tetradecanoylphorbol-13-acetate, thermodynamics 22,32–34,40
(TBA)2-MDA 209,296,337(struc.) seePMA ofoxygenreduction 33
TBHQ 677 1,1,3,3-tetraethoxy(methoxy) thiamine 154,200,481,602,628
TCDD 16,469–470,469(struc.),572 propane 337(struc.) deficiency 568
TdT-mediateddUTP-biotinnick tetrahydro-β-carbolines 482,620 pyrophosphate 414
end-labelling 323 tetrahydrobiopterin 24,54–55,126, thiazolidinediones 520
tea 173,175,177–178,195,501,seealso 155,157–159,272,349,449,501, thio-histidinederivative 417
greentea,blacktea 503 thiobarbituricacid 209,296,337
andParkinsondisease 620 δ9-tetrahydrocannabinol 484,485 (struc.),seealsoTBAassay
H2O2levels 355 (struc.),661 thiocticacid,seelipoicacid
tears 66,127,146,392,seealsolacrimal tetrahydrofolates 126,197 thiocyanate 36,66,120,307,355,
glands tetrahydrofuran 170,268 437–438,440,531,554–555,558
antioxidantcontent 390–391 tetrahydroindoles 694 insmokers 494
teeth 28,156,286,558 tetrahydroisoquinolines 482,620 thioglycollate 431,443
TEI-6720 15(struc.) tetrahydropteridines 24 thiols 672,seealsocysteine,GSH,etc.
telangiectasias 252(def.) N,N,N (cid:3) ,Ntetrahydropteridines 24- asradioprotectors 682
teleostfish 155 tetrakis(2- astherapeuticantioxidants 680–683
tellurium 683 pyridylmethyl)ethylenediamine, totreatrheumatoidarthritis 562
telomerase 178,647–649 seeTPEN thiolperoxidases 123,221,313
telomeres 28,238,328,504,647–649, tetramethylammonium thiol-bindingproteinancestor 107
659 peroxynitrite 59 thiol-ome 348
andNF-κB 648 superoxide 45,59 thiolateanion 16,51,64–66,105,137,489
TEMP(D) 288(struc.),308 3,3tetrahydropteridines 24,5,5 (cid:3) - thioltransferase 106
TEMPO 667(struc.),672 tetramethylbenzidine 307 thionitriles 53,57

--- Page 955 ---

900 INDEX
thionitrobenzoate 343(struc.),662 thromboticstroke 607–608 TMINO 289(struc.)
thiophenol 365(struc.),366 thromboxane 456 tNB 288(struc.)
thioredoxin 100,106–108,109–110,112, A2 425,450,456,457(struc.),460, TNB,seethionitrobenzoate
138,154,221,225,229,234–235, 462 TNF 217–218,228,234,518,583
248,280,346,368,371,376,380, A2-prostanoidreceptor 628 TNF-α 130,133,223,226,229,235,236,
382,395,412–413,478,535,576, B2 457(struc.),462 405,426,428–429,431–432,442,
661,683 synthase 457,462,680 444,446,458,480–481,483,514,
andcrystallins 392 thylakoidmembranes 162,253, 519–520,532,534,538,554–555,
fold 107 370–371,373–374,378–382,384 559,562,566,582,590,606
inataxiatelangiectasia 576–577 thymidylatesynthase 282,588 andageing 652
inbrain 603,609 thymine 42,43,50,197,236,238,240 andHIV 637
indiabetes 533 (struc.),241–242,244,246,404,569, bindingagents 560
inerythrocytes 361 578,588 inbrain 597,610
ineye 392 dimers 404–406,405(struc.) inexercise 409
infertilizationmedia 397 glycols 239,241–242(struc.), inrheumatoidarthritis 560
infoetallung 399 243–244,246,324,509 TNFreceptor-associated
inmitochondria 107–108,122 peroxide 108 deathdomain 227
inplants 386,455 radical 43,240 factor6,227
tyrosinecross-link 240 TNF-relatedapoptosis-inducingligand
interactingprotein 108,535
interactionwithNF-κB 229 thymol 116,173,174(struc.),312 (TRAIL) 217
incatalasepreparations 557 TNFR1and2 235
thioredoxinreductase 47,107–108,110,
thymus 92,228 tobacco 21,381,384–386,452,490,501,
114,122,124,144,146,154–155,
thyroid 588,595,seealsocigarettesmoke
178,229,362,368,412,461,
gland 19,45,88,191,447–448,556 chewing 494
470–471,474,494,499,505,539,
565,576,603,683 hormones 110,112,124,234, mosaicvirus 384
447–448,seealsothyroxine; specificnitrosamines 588
andebselen 683
(cid:3)
3,3,5-triiodothyronine tocopheramines 674
effectofCr 498
oxidase/peroxidase 120,415, tocopherols 173,175,356,661,seealso
inbrain 603,609
447–448,556 α-/β-/γ-δ-tocopherol;vitaminE
inerythrocytes 361
thyroxine 19,110,447,448(struc.),629 andAlzheimerdisease 195,198,
insmokers 494
tightjunctions 267,602 627–629
inhibitorsof 565
TIMP 223,424,561 andCYPs 163–164,167
thiosulphinate/thiosulphonate 51,184
tin 218,497,568 astherapeuticantioxidants 672–673
thiourea 42,52,63,97–98,296,502
metalloporphyrin 143,217 biosynthesis 381
2-thioxanthines 694
tinnedmeats 55,509 inbrain 180,195,604–605,618,
third-orderratelaw 52
Tiopronin 682 672–673
thiylperoxylradical 51
tiptoewalking 606 infaeces 356–357
thiylradicals 41,43,49,50–52,53,
TIR-domain-containingadaptor ingastrointestinaltract 165–168,
56–57,81,100,105,121,132,137,
protein(TIRAP) 227 356–357
146,158,172,197,276,317–318,
tirapazamine 506(struc.),509 inplants 162,381,385–386
321,366,604,seealsocysteinethiyl
tirilizadmesylate 611,680,seealso insuncreams 406
radical;glutathionethiylradical
U74006F marine-derived 162
ESRspectrum 292
tiron 299(struc.) mediatedperoxidation 165
fromhaemoglobin 365
tissue mixed 162
fromhomocysteine 197
antioxidantpotential 656,660 nitrationof 167,385,494,521
frompenicillamine 565 factor 517–519,538 quinone 73,162,164(struc.),474
inRNRenzymes 411–413 homogenates 168,209,212,329,337 turnoverinsmokers 493–494
spintrappingof 291–293 inhibitorsofmetalloproteinases,see α-tocopherol 32,33,48,71,73,78,
THOX-1,2 448 TIMP 123–125,136,139,144,146,158,
threonate 156 plasminogenactivator 545,608 160,162,163(struc.),165,167–170,
threonine 206,222,274,277,346 regeneration 442 172,180–183,187–189,264,283,
kinases 123,seealsoserine-threonine remodelling 202,215–216,426,583 342–343,351,357–359,397,401,
kinases slices 312 467,482,500,523–524,526,
thrombin 65,223,407,423–424,428, titanium 97,495,497,500–501,700 530,595,605,621,656,seealso
449–450 (struc.) tocopherols;vitaminE
thrombolyticagent 542,545,608,680 dioxide 67,406,496,500 acetate 163(struc.),165,188
thrombomodulin 65 TLR 227,421,480 andatherosclerosis 523,525
thrombosis 111,196,277,450,516–517, TLR4 421,430 andethanoltoxicity 483
521,523,539,541,550–551–552, TMB 298,307 andexercise 409
607,653,seealsobloodcoagulation TMG 675(struc.) andgeneexpression 656

--- Page 956 ---

INDEX 901
andhaptoglobin 187–188 γ-tocopherol 162,163(struc.),167,169, transcription 97,591,636,642,646,655,
andimmunesystem 195,660 184,188,342,357,381,385,529 seealsogenetranscription
•
andlifespan 656 andNO 489 coupledrepair 248–249,251
2
andO2toxicity 168 effectofα-tocopherolonlevels 167, ofgenesencodingmitochondrial
andozone 488 188 proteins 225–226
andpain 636 nitration,see5-nitro-γ-tocopherol transcriptionfactors 9,14,123,154,
andprematurity 19,392 δ-tocopherol 162,163(struc.),167 185,199,201,221–222,226–231,
andradiotherapy 509 tocopherones 162 238,244,247,280,328,405,480,
deficiency 167–168,467,489,514, α-tocopherylradical 32,144,158,162, 501–502,508,514,520,538,547,
604,610,672 164(struc.),173,177,362,381, 573,576,611,641,645,654,seealso
degradation 163 526–528 NF-κB;AP-1
deuterated 164 ESRspectrum 286 redoxsensitive 220–221,227–231,
dihydroxydimer 406 reactionwithPUFAs 165 seealsoredoxregulation;redox
inALS 632 recycling 162–165,177,286,392,493 signalling
inanimaldiets 654 tocopherylpolyethyleneglycol 168 transcuprein 131,138,424
inARDs 528 succinate 672,674(struc.) transferRNAs 26,27
inbabies 19,392,397,400 α-tocopheryloxyaceticacid 170 transferrin 9,32–33,46,78,98,127–131,
inbrain 604–605,672 α-tocopherylquinone 73,162,164 132–134,136,138–139,141,200,
(struc.),474 208–210,237,264,359,400,477,
inchemotherapy 592,595
tocotrienamines 674 498,528,565,583,601,652,661,
incysticfibrosis 555–556
tocotrienols 162,163(struc.),173,356, 686,691,693
indiabetes 533–534,539
381,661 andaluminium 501
indialysis 443
andAlzheimerdisease 627–628 inCSF 601
inembryos 396–397
ingastrointestinaltract 356–357 ineye 392
inerythrocytes 361–362
α-tocotrienol 162,163(struc.),167,610 infertilizationmedia 397
inETS-GS 676
β,δ-tocotrienol 162,163(struc.) inseminalplasma 395
ineye 162,391–393
γ -tocotrienol 162,163(struc.),167,170 intears 390
infiresmoketreatment 495
tolcapone 505,617,619(struc.),661 saturation 210–211,546,seealsoiron
inFriedreichataxia 633
Toll-likereceptors 227,421,430,480 overload
inH.pyloriinfection 567
toluene 16,395,491,568 receptors 9,128,130,501
inhepatitis 568
toluidineblue 67 transformation 173,184,572,574–575,
inIBD 566
TomKirkwood 640 seealsocancer
inmalaria 368 tomato 170,173,187,196,379,385,452 transgenicanimals 91–94,125,180,
inmeat 168,661
tongue 92,125 530,542,566,606,684,seealso
inmuscle 408
Top26 592 knockoutmice
inoocytes 396
topoisomeraseII 591–592 caveats 93–94,632–633,657–658
inpancreatitis 567
totalantioxidantcapacity 30,49,175, humanrelevance 632–633
inpre-eclampsia 398 349–353,662,674 models, of Alzheimer
inrheumatoidarthritis 559
ofCSF 352 disease 624–627
inskin 406–407
ofplasma/serum 152,349,351,356 transglutaminases 206–207,402
insperm 395 ofsaliva 352,356 transitionmetals 25,30,36–40,52,
instroke 188,511,610–611
toxic-oilsyndrome 476–477 56,126,133,137,159–161,173,
intransplantedhearts 550 toxicsmokes 490–496 201,208–212,276–277,281,286,
interactionwithBHT 656 TPA,seetissueplasminogenactivator 302,317,322,325,331,339,344,
interactionwithCoQ 164 TPEN 610 355,364–365,403,475,477,490,
interactionwithselenium 123 trachea 64,115,357,359,447,497, 498–499,543–544,552,593,605,
lipidstandardization 168,181,528, seealsorespiratorytract 624,686,701(def.),seealsocobalt,
654 TraditionalChinesemedicine,see copper,iron,etc.
mitochondriatargeted 684,685 herbalmedicine effectonlipidperoxidation 259–264
photooxidationof 406 TRADD 227 transketolase 96,154
pro-oxidanteffects 164–165,528 TRAF6 227 translesionalDNAsynthesis 245,249,
structuralanalogues 673 TRAM 227 326
succinate 163(struc.),169–170 trans 170,255(def.) transmissiblespongiformenceph-
transferprotein 165,167,252,391, trans-4-hydroxy-2-hexenal,seeHHE alopathies,seespongiform
397,604 trans-1-(2 (cid:3) -methoxyvinylpyrene) 308 encephalopathy,priondiseases
watersolubleform 674–675 trans-2-nonenal 270 transnitrosation 57
α-tocopherol/β-Carotene trans-urocanicacid 406(struc.) transthyretin 529
trial 186–187,189,191 trans,trans-2-4-decadienal 269,495 TRAPassay 49,349–352,seealsototal
β-tocopherol 162,163(struc.),167 transaldolase 607 antioxidantcapacity

--- Page 957 ---

902 INDEX
trauma 511–512,541,553–554,seealso trityl,seetriphenylmethyl two-electron
braintrauma triuret 148(struc.),398 oxidation 414,438,447
andG6PDH 363 troglitazone 661,673,675(struc.) reduction 474,477,591
traumaticacid 454 radicalsfrom 675 transfer 669
traumatin 454(struc.) Trojanhorsemechanism 585 TXA2,B2,seethromboxaneA2,B2
trehalose 149(struc.),281,417,615, Trolox 351(struc.),353,468,498,673, typeI,II,IV,Vcollagen,seecollagen
632,655,661 674,686 typeI/IIreaction 67,403
andautophagy 621,628,634 radicalandascorbate 674 typeI/IIcells,seealveoli/alveolar
Treponema trophectoderm 396 typeIIIhyperlipoproteinaemia 517
denticola 7 tropomyosin 169 type5(tartrate-resistant)acid
pallidum 7,90,115,430 TRPA1channels 206,487,649 phosphatase 128
tri-iodideion 332 TRPMchannels 128,206,215,478,610, TYR-relatedprotein 2,150
triazolopyrimidines 694 625,635
tyrosinases 150,475,680
tributyltin 218 andpain 625
tyrosine 14,43,60,61,71,75,112,117,
tricarbonylchloro(glycinato) inbrain 600,602,607
128,135,150,156,172,200,204,
ruthenium(II) 549 initch 636 227,276–277,278(struc.),281,
trichloroethylene 468,587,619 TRPV1channels 155,635 294–295,302,307,367,417–419,
trichloromethyl(peroxyl)radical 33, trypanblue 213 438,448,468,515,561,625,seealso
48,49–50,172,466–469,662 Trypanosoma meta-tyrosine,ortho-tyrosine
Trichinella 140 brucei 113,115,369,417 ammonialyase 418
Trichodesmium 79 cruzi 115,367,417,505 bromination,seebromotyrosine;
trichothiodystrophy 646 trypanosomes 86,497 dibromotyrosine
tricine 41,42 trypanothione 113–115,113(struc.), chlorination 307, see also
tridentateligand 690,693 160,367,417
chlorotyrosine;dichlorotyrosine
trientine 136,538,626,688(struc.) disulphideanionradical 114
deuterated 306
inALS 632 tryparedoxin 114
hydroperoxide 43–44
triethylenetetramine 538,seealso trypsin 29,424
hydroxylase 3,14,150,600
trientine likesites 281
iodination,seethyroidhormones
TRIF 227 tryptase 424,441
kinase 61,123,225,572–573,seealso
N-trifluoroacetyladriamycin-14- tryptophan 24,42,60,71–72,75,
signaltransduction
valerate 589(struc.) 84,119,120,143,148,247,274,
thyminecrosslink 240
trifluoroacetylatedproteins 468 276–277,279(struc.),302,346,367, nitration 60–62,76,79,112,222,306,
triglycerides 167–168,480,517,527, 387,468,490,515,531
663,seealso3-nitrotyrosine
530,532–533,658 dioxygenase 24,415–416
(cid:3) nitroso 62,412
3,3,5-triiodothyronine 110,447,448 fluorescence 344–345
tyrosylradical 43–45,48–50,53,62,76,
(struc.) hydroxylase 600
96,117,120,130,148,172,276,278
1,3,5-trimethylbenzene(TMB) 298,307 metabolitesineye 391
(struc.),302,306,343,411,414–415,
trimethylphenylammonium nitration 62,276,279,306,345
447,489
superoxide 45 oxidationproducts 345
andDFO 691
2,7,11-trimethyltetradecahexaene-1,14- radicals 132,276,411,419–420
inphotosynthesis 374
dial 173 tuberculosis 235,365,431,435,
TYRP2 150
triosephosphates 537 437,445,556,629,seealso
triosephosphateisomerase 306,627 Mycobacteriumtuberculosis U
innakedmolerats 650 tularaemia 97
1,2,3-trioxolane 75,268 tumour 425–426, 569–584, U74006F 667(struc.),680
tripeptidylpeptidase 1,635 seealsocancer;oncogenes; U75412E 495
triphenylradical-basedprobes 300 proto-oncogenes U78517F 512,667(struc.)
triphenylmethylradical vi,287(struc.) initiatingcells 581 U83836E 611,666(struc.),680
triphenylphosphonium 289,305,320, microenvironments 582–584 U101033E 666(struc.)
684,686 progression 578 U104067F 666(struc.),680
tripletstate 67 promotion 571–572,577,581–582, ubisemiquinone 11(struc.),33,146,286
tripyridyl-s-triazine 350 584 ubiquilin 2,612
trinitrobenzenesulphonicacid-induced suppressorgenes 404,572–576,577, ubiquinol/ubiquinone 11(struc.),
colitis 671 583,645,649,seealsop53 12,32–33,71,141,146,164,168,
trinitrotoluene 505 tuna 115 173,266,321,369,381,407,471,
trinucleotiderepeats 633 TUNEL 323 473–474,605,619,684,seealso
tris 41,42 tungsten 37,542 coenzymeQ
trisomy 21,seeDownsyndrome tunicamycin 233 inLDL 527
tritium 214,346,698 two-cellblock 396 mitochondriallytargeted 685

--- Page 958 ---

INDEX 903
recyclingofvitaminE 164 in ischaemia-reperfusion vanadium 37,97–98,121–122,141,495,
toubiquinoneratio 146 injury 540–553 497,500,593,700(struc.)
ubiquitin/uiquitination 9,219,224, inmultiplesclerosis 607 andalbumin 500
227,229,233,282–283,569,573, insaliva 356 inATP 500
588,615–616,620,622,624,628, inseminalplasma 395 vanillin 174(struc.)
634 inskin 407 variantCJD 630
andsynuclein 615 instomach 356 variegateporphyria 69–70
C-terminalhydrolase,seeUCHL1 instroke 148,610 varnish 121,619
positiveinclusionbodies 630 inTACassays 351–352 VAS2870 695(struc.)
proteasomesystem,seeproteasome oxidase 63,118,146–148,155,200, vascular 55,120,132,138,153,605,655,
UCHL1 282,616 364,556,653 664,seealsoshearstress
inALS 632 oxidationbylactoperoxidase/ autoimmunediseases 556
inAlzheimerdisease 626–628 MPO 321,436 celladhesionmolecule 1,see
inParkinsondisease 616,618–622 radical 132,139,148,158,489 VCAM-1
Udenfriendsystem 47,160 urea 42,79,98,146,147(struc.),204, dementia 622
UDP-glucuronyltransferase 229 498,531 endothelialcells/endothelium 51,
UDP-N-acetylglucosamine 535 cycle 568 53–54,60,62–63,138,141,146,
Udx1 415 urease 37,62,498 196,206,223,231,235,367,407,
ulcerativecolitis 565–566,570,582 inH.pyloriinfection 567 410,427,456–457,481,490,492,
ultimatecarcinogen 584 URICO-ICTUSstudy 148 512,517–519,521–523,531,538,
ultrasound 40,257 uridinediphosphoglucuronyl 552–553,600,607,626,665
uncoupling 26,54,105–106,449,686 transferase 69 endothelialgrowthfactor,seeVEGF
ofNOS 448,521
urine 126,144,161,311–312,501 function/dysfunction 178,180,195,
proteins 12,26,27,78,105,235,369, aldehydes 336 306,408–409,448–449,494,605,
410,650 bityrosine 344 609,647,673
unfoldedproteinresponse 233,535
H2O2content 178,310,401,450 glycosaminoglycans 541
unidentifiedantioxidant 351
IsoPlevels 331,334 hardeningandageing 653
uniqueManukafactor 63
UniversityofWisconsinorgan
M1dG 329 occlusion 548
ortho-tyrosine 344 permeability 425–426,462,562
preservationfluid 98,552,681
oxidative DNA damage peroxidases1and2 120,439,seealso
unpairedelectrons 20(def.),21,36–38, products 324–326 peroxidasins
100,151,285,489 spotsamples 325 reactivity 349
unsaturatedcompounds 704(def.)
TBARS 338–339 remodelling 449
UPFpeptides 681
uroporphyrinogenIII 69(struc.) smoothmusclecells 223,424,447,
uracil 42,197,238–239,244,246,
synthase 70 449
249–250,322–323,328,405(struc.)
uroporphyrinogendecarboxylase 69, O
•–production
140
glycol 239,242(struc.) 2
470 vasoconstriction 60,105,144,267,397,
glycosylase 249–251
urothelium 192,450 399,402–403,425,450,490,520,
urate 14,15(struc.),33,59,63,71,
76–78,84,88,130,132,136,139, uterus 128,140,396,398–399,447, 549–550,611,627
146–148,147,158,160,200,288, seealsopregnancy;placenta vasodilation 54,56–57,63,155,231,
350–352,359,367,406,409,438, cancer 531 349,403,425–427,449,505,540,
515,541,652 O2levels 396–397 550
andcigarettesmoke 493 uteroferrin 128,133 roleofH2O2 231
andLDL 528 UV 21,40,43,60,69,75,77,151,171, VasopharmGmbH 695
andNO • 489 177,208,226,246–248,251,277, VB-201 684
2
andONOOHscavenging 663 309,331,382,386–387,390–392, VCAM-1 429,442,517–520,538
andozone 487 402–403,404–406,407,413,465, VDAC 13
andSODmimetics 669 487,507,529,569,573–574,578 VDAC1 451,470,626
asaDAMP 421 V vegetables 55–56,153–198,352,356,
asbiomarkerofROS 321–322,559, 360,381,570,595,607,611,660
seealsoallantoin v-rel 573 antioxidanteffects 187
crystals 146,421,444,seealsosodium v-src 572 cruciferous 185,seealsobroccoli
urate vaccines 501,546 VEGF 9,19,20,184,223,225,234,247,
inBPD 399 valine 18,20,85,277,344–346,362,515, 390,407,446–447,449,493,538,
inbrain 606,619 537,598 574,581,681
ineye 390 valrubicin 589(struc.) Velcade 282
ingout 15,146,148 valsartan 661 vendobionts 2
ininsects 367 vampirebats 660 venousulcers 321,649

--- Page 959 ---

904 INDEX
ventricular arrhythmias, see VitaminEAtherosclerosisPrevention wheat 124,126,381
arrhythmias Study(VEAPS) 186–187,524 flourcarotenoids 454
veratrylalcohol 418(struc.),419–420 vitaminK1–K3 90,165,373,472 germ 162
verdoperoxidase 436 (struc.),473–474 white
versatileperoxidases 420 andBHT 677 bloodcells 327–328,404,492,504,
Verteporfin 390 antagonist 472(struc.) seealsoneutrophils
verylowdensitylipoproteins,see vitaminpills 160,183,seealsodietary lead 500
VLDL antioxidants;dietarysupplements; muscledisease 123,161
VHL 574 multivitamins rotfungi 24,417,419–420
Vibrio VitaminsandLifestyleStudy 190 wine 489
vitellogenin 642,653 wildfires 5,495
cholerae 108
vitiligo 321,406 Wilms’tumour 119
fischeri 440
vitreoushumour 387–388,392,see Wilsondisease 104,136,148,212,514,
vulnificus 133
alsoeye 687
Viciafaba 366
VLDL 165–168,171,517,533 wines 24,42,153,173,175,177–178,
vicine 366(struc.)
volatilealdehydes 455,487,509 183–184,289,451,479,481,489,
Viking 135
voltage-dependent 620,647,seealsoredwhite;white
villi 397,541
anionselectivechannel,seeVDAC1 wine
vimentin 558 aniontransporter 13 sulphitecontent 489
vinblastine/vincristine 588 Ca2+channels 205–206,598 WisconsinNationalPrimateResearch
vinylchloride 468,491,586 Volvoxcarteri 247 Center 641
violaxanthin 378,379(struc.) von Wistarrats 327
de-epoxidase 381 Hippel-Lindauprotein 574 wolfberry 393
viologens 383 Willebrandfactor 277,450 women 151,186–188,194,seealsosex
viruses/viral 124,215,219,226,228, VEPI-100 694 ironandheartdisease 660
357,384,422,483,572–573,636– VPO1andVPO2,seevascular O2toxicity 19
638,648,665,seealsoCoxsackie; peroxidases 1,2 post-menopausal 151,187
hepatitis;herpes;HIV;HTLV-1; vtcmutants 385 pre-menopausal 126,151
influenza;Marburg;retroviruses reproductivetract 394
W
apoptosis 219 Women’s
evolution 636 WAVE 186–188 AngiographicVitaminand
load 637 walnut 162,252,330,471,473 OestrogenTrial 186–188,
vectors 449,665 WalterReedArmyHospital 683 AntioxidantCardiovascularStudy
visceralfat 638,seealsoadiposetissue warmhypoxia/ischaemia 549–551, (WACS) 186–187,194–195
vision 68,171,393,596,seealsoeye seealsoorgantransplantation HealthStudy(WHS) 188–189,194
Visudyne 390 water 704(struc.) wood 41,297,417,473,495
Antarctic/Arctic 5 burningstoves 488
VITAL 190
deprivation 385–386,seealso preservative 469,497
vitaldyes 213
droughtstress smoke 176,549
vitamin
drinking 469,484,487,500–501 transitionmetalsand 420
A,seeretinol ground 497 wounds 334,407–408,430,447
BandAlzheimerdisease 629
heterolyticfission 21–22 dressing 408
B2 67
homolyticfission 21–22,199,244 woundhealing 112,156,201–202,234,
B3 154
pollution 386,505 236,402,514,532,534,644,646,
B6 155,196–197,377,538 rain 4,64 675
B12 37,196–197,413,414(struc.), river 5,497 andage 655
422,499,638 sea,seeseawater andglyoxalase 407
C,seeascorbate splitting 369–374 effectofeNOS 665
D 155,200,406 tap 160 effectofMnSOD 665
vitaminE 20,28,154,158–160, waste 499 roleofH2O2 301,407,442
161–170,177,184,334,350–351,
well 617 wounding 202,310,314
369,398,478,511,seealso weakacid 489,705(def.) WR-1065 666(struc.),683
α-/β-/γ-/δ-tocopherols;
weanlingguineapigs 164,605 WW-85 495
tocotrienols Wegenergranulomatosis 556
X
inmitochondria 162,167 weightloss 661,seealsoobesity
interactionwithcarotenoids 173 weldingfumes 495,497,499 Xchromosome 238,363
non-antioxidantroles 161,169–170 Wernersyndrome 574,645–646,648, X-bandESR,seeESR
plasmalevels 168 653 X-linked 364,434,seealsoCGD
supplements 162,182 Wernickeencephalopathy 154 adrenoleukodystrophy 633

--- Page 960 ---

INDEX 905
Z
X-rays 404,507,509 xanthophyll 170–171,370,378,379
crystallography 85,275,507 (struc.) Zscheme 373
xanthine 14,15(struc.),24,45,59,87, cycle 381 zeaxanthin 169(struc.),170–171,190,
89,125,146–147,242,244,287,296, Xanthoriaparietina 121 378–379,381,387,393,555
300,322–323,328,482,541,561, inbrain 605
xanthurenicacid 367,416(struc.)
574,662 incentenarians 659
Xenopustadpole 407
inischaemia-reperfusion 540–553 inLDL 527,529
xerodermapigmentosum 248,251,
oxidoreductase 24,56 zebrafish 155,202,314,355,407,424
574,646
xanthinedehydrogenase 24,37,56, H2O2production 314
146–147,206,471,512,540–553 XIAP 218 neutrophils 446
actionofcalpains 206 XJBpeptides 686 Zellwegersyndrome 633
xanthineoxidase 14,15,24,37,45,59, XPproteins,BtoG 248,251 zinc 20,28,32,36,37,54,60–61,65–66,
63,81,87–89,125,138,146–147, XPDgene 646 79,81–83,112,126–127,134,
178,222,286–287,296,300,321, XRCC1 249 136–138,140,154,187,190,200,
337,364,409,420,433–434,448, XTT 88,89(struc.),90,213,299 236,263,375,382,391,393,499,
466,471,505,507,512,540–553, 501,502–503,625–626,687,689,
xylenolorange 332,seealsoFOXassay
556,561,574,582,591,609,662 691,700(struc.)
xylosone 156(struc.)
andageing 653 andageing 660
andethanol 482 andNADPHoxidases 502
Y
bindingtoglycosaminoglycans 541 andp53 576
bindingtolung 553 Ychromosome 238 antagonismofFe 154,501
contaminationof 15 Yz 373–374 chelators 502,610
dehydrogenaseratio 482 desferrioxamine 388
Y-700 15(struc.)
effectofDPI 433 eye 393–394
YaaA 220
inARDS 528 fingers 37,502
YaP1 221
inatherosclerosis 521 free 501–502,626
inbabies 400 yeast 21,24,25,26,45,64,81,85–86,91, inacutephaseresponse 236
inbrain 599 98,100,104–105,112,119,122–123, inagepigments 658
inburns 408 149,156,253,280,313,641,643, inAIDS 638
inDupuytrencontracture 552 657,seealsoSaccharomycescerevisiae inALS 631–632
ininfluenza 636 asageingmodel 646–647 inbrain 501,606,610–611,618,626
inischaemia-reperfusion 540–553 cellwalls 431 inexercise 409
inkidney 550 redoxregulation 221 inFeZnSOD 87
inliver 551 yellow membranestabilization 154
inlung 553 curryspice 680 metalloporphyrin 143,217
inplacenta 398 oxide 393
fatdisease 16
inplasma 541 supplements 502
fever 367
inrheumatoidarthritis 561 thiolateligands 60
fluorescentprotein(YFP) 299,
insepsis 548 zoo 134,167–168,363
309–310,313,342
insicklecellanaemia 362 zooxanthellae 386
instroke 610 starthistle 619 Zuckerdiabeticfat(ZDF)rat 539
intransplantation 550 YjiE 221 Zutphenstudy 177,180–181
inhibitors 542,556,661,693–694 yolkprotein 642–643 zymosan 431,443–444,561

--- Page 961 ---

